PT	AU	BA	BE	GP	AF	BF	CA	TI	SO	SE	BS	LA	DT	CT	CY	CL	SP	HO	DE	ID	AB	C1	C3	RP	EM	RI	OI	FU	FP	FX	CR	NR	TC	Z9	U1	U2	PU	PI	PA	SN	EI	BN	J9	JI	PD	PY	VL	IS	PN	SU	SI	MA	BP	EP	AR	DI	DL	D2	EA	PG	WC	WE	SC	GA	PM	OA	HC	HP	DA	UT
J	Joensson, TJ; Murray, MS; Johnson, LC; Lowther, WT				Joensson, Thomas J.; Murray, Michael S.; Johnson, Lynnette C.; Lowther, W. Todd			Reduction of cysteine sulfinic acid in peroxiredoxin by sulfiredoxin proceeds directly through a sulfinic phosphoryl ester intermediate	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							2-CYS PEROXIREDOXIN; HYDROGEN-PEROXIDE; OXIDATIVE STRESS; MAMMALIAN SULFIREDOXIN; CRYSTALLOGRAPHY; SULPHIREDOXIN; MECHANISM; RECOVERY	Sulfiredoxin (Srx) catalyzes a novel enzymatic reaction, the reduction of protein cysteine sulfinic acid, Cys-SO2-. This reaction is unique to the typical 2-Cys peroxiredoxins (Prx) and plays a role in peroxide-mediated signaling by regulating the activity of Prxs. Two mechanistic schemes have been proposed that differ regarding the first step of the reaction. This step involves either the direct transfer of the gamma-phosphate of ATP to the Prx molecule or through Srx acting as a phosphorylated intermediary. In an effort to clarify this step of the Srx reaction, we have determined the 1.8 angstrom resolution crystal structure of Srx in complex with ATP and Mg2+. This structure reveals the role of the Mg2+ ion to position the gamma-phosphate toward solvent, thus preventing an in-line attack by the catalytic residue Cys-99 of Srx. A model of the quaternary complex is consistent with this proposal. Furthermore, phosphorylation studies on several site-directed mutants of Srx and Prx, including the Prx-Asp mimic of the Prx-SO2- species, support a mechanism where phosphorylation of Prx-SO2- is the first chemical step.	[Lowther, W. Todd] Wake Forest Univ, Struct Biol Ctr, Sch Med, Winston Salem, NC 27157 USA; Wake Forest Univ, Sch Med, Dept Biochem, Winston Salem, NC 27157 USA	Wake Forest University; Wake Forest University	Lowther, WT (corresponding author), Wake Forest Univ, Struct Biol Ctr, Sch Med, Winston Salem, NC 27157 USA.	tlowther@wfubmc.edu		Furdui, Cristina M./0000-0003-3771-7999	United States Department of Energy; National Institutes of Health [R01GM072866]; American Heart Association Postdoctoral Fellowship [0725399U]	United States Department of Energy(United States Department of Energy (DOE)); National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); American Heart Association Postdoctoral Fellowship(American Heart Association)	This work was supported, in whole or in part, by National Institutes of Health Grant R01GM072866 (to W.T.L.). This work was also supported by American Heart Association Postdoctoral Fellowship 0725399U (to T.J.J.). The costs of publication of this article were defrayed in part by the payment of page charges. This article must therefore be hereby marked "advertisement" in accordance with 18 U.S.C. Section 1734 solely to indicate this fact.; We thank the staff of NSLS and beamline X4A for their assistance during data collection and the RapiData course. National Synchrotron Light Source is supported by the United States Department of Energy and National Institutes of Health.	Biteau B, 2003, NATURE, V425, P980, DOI 10.1038/nature02075; Bozonet SM, 2005, J BIOL CHEM, V280, P23319, DOI 10.1074/jbc.M502757200; Brunger AT, 1998, ACTA CRYSTALLOGR D, V54, P905, DOI 10.1107/S0907444998003254; Chang TS, 2004, J BIOL CHEM, V279, P50994, DOI 10.1074/jbc.M409482200; Chevallet M, 2003, J BIOL CHEM, V278, P37146, DOI 10.1074/jbc.M305161200; Choi MH, 2005, NATURE, V435, P347, DOI 10.1038/nature03587; Emsley P, 2004, ACTA CRYSTALLOGR D, V60, P2126, DOI 10.1107/S0907444904019158; Hofmann B, 2002, BIOL CHEM, V383, P347, DOI 10.1515/BC.2002.040; Jang HH, 2004, CELL, V117, P625, DOI 10.1016/j.cell.2004.05.002; Jeong W, 2006, J BIOL CHEM, V281, P14400, DOI 10.1074/jbc.M511082200; Joensson Thomas J., 2007, V44, P115; Jonsson TJ, 2008, NATURE, V451, P98, DOI 10.1038/nature06415; Jonsson TJ, 2005, BIOCHEMISTRY-US, V44, P8634, DOI 10.1021/bi050131i; Matte A, 1998, STRUCT FOLD DES, V6, P413, DOI 10.1016/S0969-2126(98)00043-4; Moon JC, 2005, J BIOL CHEM, V280, P28775, DOI 10.1074/jbc.M505362200; Murshudov GN, 1997, ACTA CRYSTALLOGR D, V53, P240, DOI 10.1107/S0907444996012255; PALMIERI F, 1979, BIOCHIM BIOPHYS ACTA, V555, P531, DOI 10.1016/0005-2736(79)90407-3; Pannifer ADB, 1998, J BIOL CHEM, V273, P10454, DOI 10.1074/jbc.273.17.10454; Papadia S, 2008, NAT NEUROSCI, V11, P476, DOI 10.1038/nn2071; Phalen TJ, 2006, J CELL BIOL, V175, P779, DOI 10.1083/jcb.200606005; Purich DL, 2002, METHOD ENZYMOL, V354, P168; Rhee SG, 2005, CURR OPIN CELL BIOL, V17, P183, DOI 10.1016/j.ceb.2005.02.004; Rhee SG, 2001, IUBMB LIFE, V52, P35, DOI 10.1080/15216540252774748; Rhee SG, 2006, SCIENCE, V312, P1882, DOI 10.1126/science.1130481; Schroder E, 2000, STRUCTURE, V8, P605, DOI 10.1016/S0969-2126(00)00147-7; Vivancos AP, 2005, P NATL ACAD SCI USA, V102, P8875, DOI 10.1073/pnas.0503251102; WEAST RC, 1983, CRC HDB CHEM PHYS, pC719; Woo HA, 2005, J BIOL CHEM, V280, P3125, DOI 10.1074/jbc.C400496200; Woo HA, 2003, SCIENCE, V300, P653, DOI 10.1126/science.1080273; Wood ZA, 2003, SCIENCE, V300, P650, DOI 10.1126/science.1080405; Wood ZA, 2003, TRENDS BIOCHEM SCI, V28, P32, DOI 10.1016/S0968-0004(02)00003-8	32	89	89	3	11	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	AUG 29	2008	283	35					23846	23851		10.1074/jbc.M803244200	http://dx.doi.org/10.1074/jbc.M803244200			6	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	340II	18579529	Green Published, hybrid			2022-12-27	WOS:000258638900039
J	Jonsson, TJ; Tsang, AW; Lowther, WT; Furdui, CM				Jonsson, Thomas J.; Tsang, Allen W.; Lowther, W. Todd; Furdui, Cristina M.			Identification of intact protein thiosulfinate intermediate in the reduction of cysteine sulfinic acid in peroxiredoxin by human sulfiredoxin	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							IONIZATION MASS-SPECTROMETRY; ESCHERICHIA-COLI; OXIDATIVE STRESS; ENZYME CATALYSIS; MECHANISM	The reversible oxidation of the active site cysteine in typical 2-Cys peroxiredoxins (Prx) to sulfinic acid during oxidative stress plays an important role in peroxide-mediated cell signaling. The catalytic retroreduction of Prx-SO2- by sulfiredoxin (Srx) has been proposed to proceed through two novel reaction intermediates, a sulfinic phosphoryl ester and protein-based thiosulfinate. Two scenarios for the repair mechanism have been suggested that differ in the second step of the reaction. The attack of Srx or GSH on the Prx-SO2PO32- intermediate would result in either the formation of Prx-Cys-S(=O)-S-Cys-Srx or the formation of Prx-Cys-S(=O)-S-G thiosulfinates, respectively. To elucidate the mechanism of Prx repair, we monitored the reduction of human PrxII-SO2- using rapid chemical quench methodology and electrospray ionization time-of-flight mass spectrometry. An O-18 exchange study revealed that the Prx sulfinic acid phosphoryl ester is rapidly formed and hydrolyzed (k = 0.35 min(-1)). Furthermore, we observed the exclusive formation of a thiosulfinate linkage between Prx and Srx(k = 1.4 min(-1)) that collapses to the disulfide-bonded Srx-Prx species (k = 0.14 min(-1)). Thus, the kinetic and chemical competences of the first two steps in the Srx reaction have been demonstrated. It is clear, however, that GSH may influence thiosulfinate formation and that GSH and Srx may play additional roles in the resolution of the thiosulfinate intermediate.	[Jonsson, Thomas J.; Lowther, W. Todd] Wake Forest Univ, Bowman Gray Sch Med, Ctr Struct Biol, Winston Salem, NC 27157 USA; [Jonsson, Thomas J.; Lowther, W. Todd] Wake Forest Univ, Bowman Gray Sch Med, Dept Biochem, Winston Salem, NC 27157 USA; [Tsang, Allen W.; Furdui, Cristina M.] Wake Forest Univ, Bowman Gray Sch Med, Dept Internal Med, Sect Mol Med, Winston Salem, NC 27157 USA	Wake Forest University; Wake Forest Baptist Medical Center; Wake Forest University; Wake Forest Baptist Medical Center; Wake Forest University; Wake Forest Baptist Medical Center	Lowther, WT (corresponding author), Wake Forest Univ, Bowman Gray Sch Med, Ctr Struct Biol, Med Ctr Blvd, Winston Salem, NC 27157 USA.	tlowther@wfubmc.edu; cfurdui@wfubmc.edu		Furdui, Cristina M./0000-0003-3771-7999	National Institutes of Health [R01GM072866]; American Heart Association [0725399U, SDG 0730069N]	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); American Heart Association(American Heart Association)	This work was supported, in whole or in part, by National Institutes of Health Grant R01GM072866 (to W. T. L.). This work was also supported by American Heart Association Postdoctoral Fellowship 0725399U (to T. J. J.) and American Heart Association Grant SDG 0730069N (to C. M. F.).	Biteau B, 2003, NATURE, V425, P980, DOI 10.1038/nature02075; Bothner B, 2000, J BIOL CHEM, V275, P13455, DOI 10.1074/jbc.275.18.13455; Bozonet SM, 2005, J BIOL CHEM, V280, P23319, DOI 10.1074/jbc.M502757200; Ellis HR, 1997, BIOCHEMISTRY-US, V36, P15013, DOI 10.1021/bi972191x; Furdui C. M., 2006, MOL CELL, V17, P1; Giles GI, 2002, BIOL CHEM, V383, P375, DOI 10.1515/BC.2002.042; Gross JW, 2000, BIOCHEMISTRY-US, V39, P13633, DOI 10.1021/bi001963d; Jacob C, 2006, NAT PROD REP, V23, P851, DOI 10.1039/b609523m; Jeong W, 2006, J BIOL CHEM, V281, P14400, DOI 10.1074/jbc.M511082200; Jonsson TJ, 2008, J BIOL CHEM, V283, P22890, DOI [10.1074/jbc.C800124200, 10.1074/jbc.M803244200]; Jonsson TJ, 2008, NATURE, V451, P98, DOI 10.1038/nature06415; Jonsson TJ, 2005, BIOCHEMISTRY-US, V44, P8634, DOI 10.1021/bi050131i; KICE JL, 1974, J AM CHEM SOC, V96, P8015, DOI 10.1021/ja00833a029; Konermann L, 1997, BIOCHEMISTRY-US, V36, P5554, DOI 10.1021/bi970046d; Li ZL, 2005, ANAL BIOCHEM, V343, P35, DOI 10.1016/j.ab.2005.04.021; Li ZL, 2003, J AM CHEM SOC, V125, P9938, DOI 10.1021/ja0354768; Paiva AA, 1997, BIOCHEMISTRY-US, V36, P15472, DOI 10.1021/bi971883i; Phalen TJ, 2006, J CELL BIOL, V175, P779, DOI 10.1083/jcb.200606005; Roussel X, 2008, J BIOL CHEM, V283, P22371, DOI 10.1074/jbc.M800493200; Sevier CS, 2006, ANTIOXID REDOX SIGN, V8, P797, DOI 10.1089/ars.2006.8.797; Shen CX, 2002, J AGR FOOD CHEM, V50, P2644, DOI 10.1021/jf011013e; Toledano MB, 2007, FEBS LETT, V581, P3598, DOI 10.1016/j.febslet.2007.07.002; Vivancos AP, 2005, P NATL ACAD SCI USA, V102, P8875, DOI 10.1073/pnas.0503251102; Wood ZA, 2003, SCIENCE, V300, P650, DOI 10.1126/science.1080405; Wood ZA, 2003, TRENDS BIOCHEM SCI, V28, P32, DOI 10.1016/S0968-0004(02)00003-8	25	89	89	3	11	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	AUG 22	2008	283	34					22890	22894		10.1074/jbc.C800124200	http://dx.doi.org/10.1074/jbc.C800124200			5	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	337SI	18579529	Green Published, hybrid			2022-12-27	WOS:000258455400002
J	Comini, MA; Rettig, J; Dirdjaja, N; Hanschmann, EM; Berndt, C; Krauth-Siegel, RL				Comini, Marcelo A.; Rettig, Jochen; Dirdjaja, Natalie; Hanschmann, Eva-Maria; Berndt, Carsten; Krauth-Siegel, R. Luise			Monothiol glutaredoxin-1 is an essential iron-sulfur protein in the mitochondrion of African trypanosomes	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							BLOOD-STREAM FORMS; RNA INTERFERENCE; SACCHAROMYCES-CEREVISIAE; ESCHERICHIA-COLI; BRUCEI; CLUSTERS; EXPRESSION; GRX5; GLUTATHIONYLATION; GLYCOSOMES	African trypanosomes encode three monothiol glutaredoxins (1-C-Grx). 1-C-Grx1 occurs exclusively in the mitochondrion, and 1-C-Grx2 and -3 are predicted to be mitochondrial and cytosolic proteins, respectively. All three 1-C-Grx are expressed in both the mammalian bloodstream and the insect procyclic form of Trypanosoma brucei, with the highest levels found in stationary phase and starving parasites. In the rudimentary mitochondrion of bloodstream cells, 1-C-Grx1 reaches concentrations above 200 mu M/subunit. Recombinant T. brucei 1-C-Grx1 exists as a noncovalent homodimer, whereas 1-C-Grx2 and 1-C-Grx3 are monomeric proteins. In vitro, dimeric 1-C-Grx1 coordinated an H2O2-sensitive [2Fe-2S] cluster that required GSH as an additional ligand. Both bloodstream and procyclic trypanosomes were refractory to down-regulation of 1-C-Grx1 expression by RNA interference. In procyclic parasites, the 1-c-grx1 alleles could only be deleted if an ectopic copy of the gene was expressed. A 5-10-fold overexpression of 1-C-Grx1 in both parasite forms did not yield a growth phenotype under optimal culture conditions. However, exposure of these cells to the iron chelator deferoxamine or H2O2, but not to iron or menadione, impaired cell growth. Treatment of wild-type bloodstream parasites with deferoxamine and H2O2 caused a 2-fold down- and up-regulation of 1-C-Grx1, respectively. The results point to an essential role of the mitochondrial 1-C-Grx1 in the iron metabolism of these parasites.	[Comini, Marcelo A.; Rettig, Jochen; Dirdjaja, Natalie; Krauth-Siegel, R. Luise] Heidelberg Univ, Ctr Biochem, D-69120 Heidelberg, Germany; [Hanschmann, Eva-Maria; Berndt, Carsten] Karolinska Inst, Med Nobel Inst Biochem, SE-17177 Stockholm, Sweden; [Berndt, Carsten] Univ Marburg, Dept Clin Cytobiol & Cytopathol, D-35037 Marburg, Germany	Ruprecht Karls University Heidelberg; Karolinska Institutet; Philipps University Marburg	Comini, MA (corresponding author), Inst Pasteur Montevideo, Mataojo 2020, Montevideo 11400, Uruguay.	mcomini@pasteur.edu.uy	Hanschmann, Eva-Maria/AAS-9261-2021; Berndt, Carsten/X-6260-2018	Berndt, Carsten/0000-0001-8583-7966; Comini, Marcelo/0000-0001-5000-1333	Deutsche Forschungsgemeinschaft (Sonderforschungsbereich 544 "Control of Tropical Infectious Diseases [B3]; Karolinska Institutet; Swedish Cancer Society;  [BE 3259/1]	Deutsche Forschungsgemeinschaft (Sonderforschungsbereich 544 "Control of Tropical Infectious Diseases(German Research Foundation (DFG)); Karolinska Institutet(Karolinska Institutet); Swedish Cancer Society(Swedish Cancer Society); 	This work was supported by the Deutsche Forschungsgemeinschaft (Sonderforschungsbereich 544 "Control of Tropical Infectious Diseases," project B3) and Research Fellowship BE 3259/1 (to C. B.), the Karolinska Institutet, and the Swedish Cancer Society (Cancerfonden, to Arne Holmgren). The costs of publication of this article were defrayed in part by the payment of page charges. This article must therefore be hereby marked " advertisement" in accordance with 18 U. S. C. Section 1734 solely to indicate this fact.	Alibu VP, 2005, MOL BIOCHEM PARASIT, V139, P75, DOI 10.1016/j.molbiopara.2004.10.002; Berndt C, 2007, ANTIOXID REDOX SIGN, V9, P151, DOI 10.1089/ars.2007.9.151; Biebinger S, 1997, MOL BIOCHEM PARASIT, V85, P99, DOI 10.1016/S0166-6851(96)02815-0; Breidbach T, 2002, INT J PARASITOL, V32, P473, DOI 10.1016/S0020-7519(01)00310-1; Broderick JB, 2000, BIOCHEM BIOPH RES CO, V269, P451, DOI 10.1006/bbrc.2000.2313; CAMASCHELLA C, 2007, BLOOD, V725, P1; Cevallos AM, 2005, FEMS MICROBIOL LETT, V246, P259, DOI 10.1016/j.femsle.2005.04.017; Chaudhuri M, 2001, GENE, V266, P1, DOI 10.1016/S0378-1119(01)00367-5; Cheng NH, 2006, J BIOL CHEM, V281, P26280, DOI 10.1074/jbc.M601354200; Chung WH, 2005, BIOCHEM BIOPH RES CO, V330, P604, DOI 10.1016/j.bbrc.2005.02.183; Clayton CE, 2002, EMBO J, V21, P1881, DOI 10.1093/emboj/21.8.1881; Comini MA, 2007, BIOCHEM J, V402, P43, DOI 10.1042/BJ20061341; Deponte M, 2005, BIOL CHEM, V386, P33, DOI 10.1515/BC.2005.005; ELLMAN GL, 1959, ARCH BIOCHEM BIOPHYS, V82, P70, DOI 10.1016/0003-9861(59)90090-6; Fernandes AP, 2005, J BIOL CHEM, V280, P24544, DOI 10.1074/jbc.M500678200; Filser M, 2008, BIOL CHEM, V389, P21, DOI 10.1515/BC.2007.147; FISH WW, 1988, METHOD ENZYMOL, V158, P357, DOI 10.1016/0076-6879(88)58067-9; Gerdes SY, 2003, J BACTERIOL, V185, P5673, DOI 10.1128/JB.185.19.5673-5684.2003; Helfert S, 2001, BIOCHEM J, V357, P117, DOI 10.1042/0264-6021:3570117; HERRERO E, 2007, CELL MOL LIFE SCI, V655, P1; HIRUMI H, 1989, J PARASITOL, V75, P985, DOI 10.2307/3282883; Imlay JA, 2006, MOL MICROBIOL, V59, P1073, DOI 10.1111/j.1365-2958.2006.05028.x; Johansson C, 2007, J BIOL CHEM, V282, P3077, DOI 10.1074/jbc.M608179200; Kim HG, 2005, MOL CELLS, V20, P43; Krieger S, 2000, MOL MICROBIOL, V35, P542, DOI 10.1046/j.1365-2958.2000.01721.x; Lillig CH, 2005, P NATL ACAD SCI USA, V102, P8168, DOI 10.1073/pnas.0500735102; Lorenz P, 1998, EMBO J, V17, P3542, DOI 10.1093/emboj/17.13.3542; McAmis WC, 2003, BBA-MOL CELL RES, V1641, P43, DOI 10.1016/S0167-4889(03)00063-6; Melchers J, 2007, J BIOL CHEM, V282, P8678, DOI 10.1074/jbc.M608140200; Melville SE, 2000, MOL BIOCHEM PARASIT, V111, P261, DOI 10.1016/S0166-6851(00)00316-9; Mesecke N, 2008, BIOCHEMISTRY-US, V47, P1452, DOI 10.1021/bi7017865; MESHNICK SR, 1978, J EXP MED, V148, P569, DOI 10.1084/jem.148.2.569; Molina MM, 2004, J BIOL CHEM, V279, P51923, DOI 10.1074/jbc.M410219200; Molina-Navarro MM, 2006, FEBS LETT, V580, P2273, DOI 10.1016/j.febslet.2006.03.037; Muhlenhoff U, 2003, EMBO J, V22, P4815, DOI 10.1093/emboj/cdg446; Noguera-Mazon V, 2006, J BIOL CHEM, V281, P31736, DOI 10.1074/jbc.M602188200; NOLAN DP, 1992, EUR J BIOCHEM, V209, P207, DOI 10.1111/j.1432-1033.1992.tb17278.x; Ochatt CM, 1999, MOL BIOCHEM PARASIT, V103, P35, DOI 10.1016/S0166-6851(99)00111-5; OPPERDOES FR, 1984, J CELL BIOL, V98, P1178, DOI 10.1083/jcb.98.4.1178; Park S, 2005, P NATL ACAD SCI USA, V102, P9317, DOI 10.1073/pnas.0502051102; Picciocchi A, 2007, BIOCHEMISTRY-US, V46, P15018, DOI 10.1021/bi7013272; Rodriguez-Manzaneque MT, 1999, MOL CELL BIOL, V19, P8180; Rodriguez-Manzaneque MT, 2002, MOL BIOL CELL, V13, P1109, DOI 10.1091/mbc.01-10-0517; Rouhier N, 2007, P NATL ACAD SCI USA, V104, P7379, DOI 10.1073/pnas.0702268104; Selzer PM, 1996, EUR J CELL BIOL, V69, P173; Shi HF, 2004, EUKARYOT CELL, V3, P1445, DOI 10.1128/EC.3.6.1445-1453.2004; Smid O, 2006, J BIOL CHEM, V281, P28679, DOI 10.1074/jbc.M513781200; Wang ZF, 2000, J BIOL CHEM, V275, P40174, DOI 10.1074/jbc.M008405200; Wingert RA, 2005, NATURE, V436, P1035, DOI 10.1038/nature03887	49	52	52	0	5	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	OCT 10	2008	283	41					27785	27798		10.1074/jbc.M802010200	http://dx.doi.org/10.1074/jbc.M802010200			14	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	355OW	18669638	hybrid			2022-12-27	WOS:000259719200050
J	Teplyuk, NM; Galindo, M; Teplyuk, VI; Pratap, J; Young, DW; Lapointe, D; Javed, A; Stein, JL; Lian, JB; Stein, GS; van Wijnen, AJ				Teplyuk, Nadiya M.; Galindo, Mario; Teplyuk, Viktor I.; Pratap, Jitesh; Young, Daniel W.; Lapointe, David; Javed, Amjad; Stein, Janet L.; Lian, Jane B.; Stein, Gary S.; van Wijnen, Andre J.			Runx2 regulates G protein-coupled signaling pathways to control growth of osteoblast progenitors	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ESTROGEN-RECEPTOR EXPRESSION; TRANSCRIPTION FACTOR RUNX2; CELL-CYCLE; GENE-EXPRESSION; PARATHYROID-HORMONE; CHONDROCYTE PROLIFERATION; TGF-BETA; GPR30; BINDING; PHOSPHORYLATION	Runt-related transcription factor 2 (Runx2) controls lineage commitment, proliferation, and anabolic functions of osteoblasts as the subnuclear effector of multiple signaling axes (e. g. transforming growth factor-beta/BMP-SMAD, SRC/YES-YAP, and GROUCHO/TLE). Runx2 levels oscillate during the osteoblast cell cycle with maximal levels in G1. Here we examined what functions and target genes of Runx2 control osteoblast growth. Forced expression of wild type Runx2 suppresses growth of Runx2(-/-) osteoprogenitors. Point mutants defective for binding to WW domain or SMAD proteins or the nuclear matrix retain this growth regulatory ability. Hence, key signaling pathways are dispensable for growth control by Runx2. However, mutants defective for DNA binding or C-terminal gene repression/activation functions do not block proliferation. Target gene analysis by Affymetrix expression profiling shows that the C terminus of Runx2 regulates genes involved in G protein-coupled receptor signaling (e. g. Rgs2, Rgs4, Rgs5, Rgs16, Gpr23, Gpr30, Gpr54, Gpr64, and Gna13). We further examined the function of two genes linked to cAMP signaling as follows: Gpr30 that is stimulated and Rgs2 that is down-regulated by Runx2. RNA interference of Gpr30 and forced expression of Rgs2 in each case inhibit osteoblast proliferation. Notwithstanding its growth-suppressive potential, our results surprisingly indicate that Runx2 may sensitize cAMP-relatedGprotein-coupled receptor signaling by activating Gpr30 and repressing Rgs2 gene expression in osteoblasts to increase responsiveness to mitogenic signals.	[van Wijnen, Andre J.] Univ Massachusetts, Sch Med, Dept Cell Biol, Worcester, MA 01655 USA; [Teplyuk, Nadiya M.; Galindo, Mario; Pratap, Jitesh; Young, Daniel W.; Lapointe, David; Javed, Amjad; Stein, Janet L.; Lian, Jane B.; Stein, Gary S.; van Wijnen, Andre J.] Univ Massachusetts, Sch Med, Ctr Canc, Worcester, MA 01655 USA; [Teplyuk, Viktor I.] Univ Massachusetts, Sch Med, Program Mol Med, Worcester, MA 01655 USA; [Lapointe, David] Univ Massachusetts, Sch Med, Informat Serv, Worcester, MA 01655 USA	University of Massachusetts System; University of Massachusetts Worcester; University of Massachusetts System; University of Massachusetts Worcester; University of Massachusetts System; University of Massachusetts Worcester; University of Massachusetts System; University of Massachusetts Worcester	van Wijnen, AJ (corresponding author), Univ Massachusetts, Sch Med, Dept Cell Biol, 55 Lake Ave N, Worcester, MA 01655 USA.	andre.vanwijnen@umassmed.edu	van Wijnen, Andre J./AAG-3578-2019	van Wijnen, Andre J./0000-0002-4458-0946; Javed, Amjad/0000-0002-0847-8266	National Institutes of Health [R01 AR49069, R01 AR39588, P01 CA82834, P30 DK32520]; NATIONAL CANCER INSTITUTE [P01CA082834] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES [R01AR049069, R01AR045688, R01AR039588] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [P30DK032520] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	This work was supported, in whole or in part, by National Institutes of Health Grants R01 AR49069 (to A. v. W.) and R01 AR39588, P01 CA82834, and P30 DK32520 (to G. S. S. and J. B. L.). The costs of publication of this article were defrayed in part by the payment of page charges. This article must therefore be hereby marked "advertisement" in accordance with 18 U. S. C. Section 1734 solely to indicate this fact.	Bae JS, 2007, J CELL BIOCHEM, V100, P434, DOI 10.1002/jcb.21039; Balint E, 2003, J CELL BIOCHEM, V89, P401, DOI 10.1002/jcb.10515; Beier F, 2001, MOL BIOL CELL, V12, P3852, DOI 10.1091/mbc.12.12.3852; Bellido T, 2003, J BIOL CHEM, V278, P50259, DOI 10.1074/jbc.M307444200; Bertaux K, 2006, BONE, V38, P943, DOI 10.1016/j.bone.2005.11.025; Bertrand-Philippe M, 2004, J BIOL CHEM, V279, P24530, DOI 10.1074/jbc.M311804200; Blyth K, 2006, CANCER RES, V66, P2195, DOI 10.1158/0008-5472.CAN-05-3558; Blyth K, 2005, NAT REV CANCER, V5, P376, DOI 10.1038/nrc1607; Bodine PVN, 2006, REV ENDOCR METAB DIS, V7, P33, DOI 10.1007/s11154-006-9002-4; Carmeci C, 1997, GENOMICS, V45, P607, DOI 10.1006/geno.1997.4972; Chagin AS, 2007, J CLIN ENDOCR METAB, V92, P4873, DOI 10.1210/jc.2007-0814; Cui CB, 2003, MOL CELL BIOL, V23, P1004, DOI 10.1128/MCB.23.3.1004-1013.2003; D'Amico M, 2000, J BIOL CHEM, V275, P32649, DOI 10.1074/jbc.M000643200; Dennis G, 2003, GENOME BIOL, V4, DOI 10.1186/gb-2003-4-9-r60; DESDOUETS C, 1995, MOL CELL BIOL, V15, P3301; Drissi H, 1999, CANCER RES, V59, P3705; Dvorak MM, 2004, CELL CALCIUM, V35, P249, DOI 10.1016/j.ceca.2003.10.014; Filardo EJ, 2005, TRENDS ENDOCRIN MET, V16, P362, DOI 10.1016/j.tem.2005.08.005; Filardo EJ, 2002, MOL ENDOCRINOL, V16, P70, DOI 10.1210/me.16.1.70; Galindo M, 2006, J BONE MINER RES, V21, pS384; Galindo M, 2005, J BIOL CHEM, V280, P20274, DOI 10.1074/jbc.M413665200; Galindo M, 2007, J MOL HISTOL, V38, P501, DOI 10.1007/s10735-007-9143-0; Gautier L, 2004, BIOINFORMATICS, V20, P307, DOI 10.1093/bioinformatics/btg405; Guenou H, 2005, HUM MOL GENET, V14, P1429, DOI 10.1093/hmg/ddi152; Harada Y, 2001, BIOCHEM BIOPH RES CO, V284, P714, DOI 10.1006/bbrc.2001.5005; Harrington KS, 2002, J CELL SCI, V115, P4167, DOI 10.1242/jcs.00095; Hinoi E, 2006, GENE DEV, V20, P2937, DOI 10.1101/gad.1482906; Hsiao EC, 2008, P NATL ACAD SCI USA, V105, P1209, DOI 10.1073/pnas.0707457105; Inman CK, 2003, J BIOL CHEM, V278, P48684, DOI 10.1074/jbc.M308001200; Javed A, 2000, J CELL SCI, V113, P2221; Javed A, 2008, J BIOL CHEM, V283, P8412, DOI 10.1074/jbc.M705578200; Jensen ED, 2008, J CELL BIOCHEM, V103, P1438, DOI 10.1002/jcb.21526; Jensen ED, 2008, J BONE MINER RES, V23, P361, DOI 10.1359/JBMR.071104; Jilka RL, 2007, BONE, V40, P1434, DOI 10.1016/j.bone.2007.03.017; Jones DC, 2006, SCIENCE, V312, P1223, DOI 10.1126/science.1126313; Kanda N, 2004, J INVEST DERMATOL, V123, P319, DOI 10.1111/j.0022-202X.2004.12645.x; Kang JS, 2005, EMBO J, V24, P2543, DOI 10.1038/sj.emboj.7600729; Kilbey A, 2007, CANCER RES, V67, P11263, DOI 10.1158/0008-5472.CAN-07-3016; Kim HJ, 2003, J BIOL CHEM, V278, P319, DOI 10.1074/jbc.M203750200; Komori T, 2008, FRONT BIOSCI-LANDMRK, V13, P898, DOI 10.2741/2730; Kronenberg HM, 2006, ANN NY ACAD SCI, V1068, P1, DOI 10.1196/annals.1346.002; Lee MH, 2005, J BIOL CHEM, V280, P35579, DOI 10.1074/jbc.M502267200; Li X, 2007, J BIOL CHEM, V282, P33086, DOI 10.1074/jbc.M705194200; Lian JB, 2006, REV ENDOCR METAB DIS, V7, P1, DOI 10.1007/s11154-006-9001-5; Manavathi B, 2006, J CELL PHYSIOL, V207, P594, DOI 10.1002/jcp.20551; Marie PJ, 2003, GENE, V316, P23, DOI 10.1016/S0378-1119(03)00748-0; Pi M, 2005, J CELL BIOCHEM, V95, P1081, DOI 10.1002/jcb.20500; Pratap J, 2006, CANCER METAST REV, V25, P589, DOI 10.1007/s10555-006-9032-0; Pratap J, 2003, CANCER RES, V63, P5357; Prossnitz ER, 2007, MOL CELL ENDOCRINOL, V265, P138, DOI 10.1016/j.mce.2006.12.010; Qiao M, 2006, J BIOL CHEM, V281, P7118, DOI 10.1074/jbc.M508162200; Rajgopal A, 2007, J CELL BIOCHEM, V100, P1509, DOI 10.1002/jcb.21137; Revankar CM, 2005, SCIENCE, V307, P1625, DOI 10.1126/science.1106943; Rosen CJ, 2003, CRIT REV EUKAR GENE, V13, P25, DOI 10.1615/CritRevEukaryotGeneExpr.v13.i1.30; Roy AA, 2006, J BIOL CHEM, V281, P32684, DOI 10.1074/jbc.M604416200; Rozengurt E, 2007, J CELL PHYSIOL, V213, P589, DOI 10.1002/jcp.21246; Selvamurugan Nagarajan, 2000, Molecular Cell Biology Research Communications, V3, P218, DOI 10.1006/mcbr.2000.0215; Shen R, 2006, J BIOL CHEM, V281, P16347, DOI 10.1074/jbc.M603439200; Stewart M, 1997, P NATL ACAD SCI USA, V94, P8646, DOI 10.1073/pnas.94.16.8646; Stewart M, 2007, CANCER RES, V67, P5126, DOI 10.1158/0008-5472.CAN-07-0433; Swarthout JT, 2002, GENE, V282, P1, DOI 10.1016/S0378-1119(01)00798-3; Thirunavukkarasu K, 2002, J CELL BIOCHEM, V85, P837, DOI 10.1002/jcb.10176; Thomas DM, 2004, J CELL BIOL, V167, P925, DOI 10.1083/jcb.200409187; Thomas DM, 2001, MOL CELL, V8, P303, DOI 10.1016/S1097-2765(01)00327-6; Vaillant F, 2002, J IMMUNOL, V169, P2866, DOI 10.4049/jimmunol.169.6.2866; van Wijnen AJ, 2004, ONCOGENE, V23, P4209, DOI 10.1038/sj.onc.1207758; Westendorf JJ, 2002, MOL CELL BIOL, V22, P7982, DOI 10.1128/MCB.22.22.7982-7992.2002; Young DW, 2007, P NATL ACAD SCI USA, V104, P3189, DOI 10.1073/pnas.0611419104; Young DW, 2007, NATURE, V445, P442, DOI 10.1038/nature05473; Zaidi SK, 2007, P NATL ACAD SCI USA, V104, P19861, DOI 10.1073/pnas.0709650104; Zaidi SK, 2007, NAT REV CANCER, V7, P454, DOI 10.1038/nrc2149; Zaidi SK, 2004, EMBO J, V23, P790, DOI 10.1038/sj.emboj.7600073; Zaidi SK, 2001, J CELL SCI, V114, P3093; Zhao M, 2003, J BIOL CHEM, V278, P27939, DOI 10.1074/jbc.M304132200; Zheng QP, 2003, J CELL BIOL, V162, P833, DOI 10.1083/jcb.200211089	75	102	108	1	7	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	OCT 10	2008	283	41					27585	27597		10.1074/jbc.M802453200	http://dx.doi.org/10.1074/jbc.M802453200			13	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	355OW	18625716	Green Published, hybrid			2022-12-27	WOS:000259719200029
J	Zaarur, N; Meriin, AB; Gabai, VL; Sherman, MY				Zaarur, Nava; Meriin, Anatoli B.; Gabai, Vladimir L.; Sherman, Michael Y.			Triggering aggresome formation - Dissecting aggresome-targeting and aggregation signals in synphilin 1	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							LEWY-BODY FORMATION; UBIQUITIN-PROTEASOME SYSTEM; ALPHA-SYNUCLEIN; PARKINSONS-DISEASE; HEAT-SHOCK; NEURODEGENERATIVE DISORDERS; INTERACTING PROTEIN; DEGRADATION; CELLS; INHIBITION	Abnormal polypeptides that escape proteasome-dependent degradation and aggregate in cytosol can be transported via microtubules to an aggresome, a recently discovered organelle where aggregated proteins are stored or degraded by autophagy. We used synphilin 1, a protein implicated in Parkinson disease, as a model to study mechanisms of aggresome formation. When expressed in naive HEK293 cells, synphilin 1 forms multiple small highly mobile aggregates. However, proteasome or Hsp90 inhibition rapidly triggered their translocation into the aggresome, and surprisingly, this response was independent on the expression level of synphilin 1. Therefore, aggresome formation, but not aggregation of synphilin 1, represents a special cellular response to a failure of the proteasome/chaperone machinery. Importantly, translocation to aggresomes required a special aggresome-targeting signal within the sequence of synphilin 1, an ankyrin-like repeat domain. On the other hand, formation of multiple small aggregates required an entirely different segment within synphilin 1, indicating that aggregation and aggresome formation determinants can be separated genetically. Furthermore, substitution of the ankyrin-like repeat in synphilin 1 with an aggresome-targeting signal from huntingtin was sufficient for aggresome formation upon inhibition of the proteasome. Analogously, attachment of the ankyrin-like repeat to a huntingtin fragment lacking its aggresome-targeting signal promoted its transport to aggresomes. These findings indicate the existence of transferable signals that target aggregation-prone polypeptides to aggresomes.	[Zaarur, Nava; Meriin, Anatoli B.; Gabai, Vladimir L.; Sherman, Michael Y.] Boston Univ, Sch Med, Dept Biochem, Boston, MA 02118 USA	Boston University	Sherman, MY (corresponding author), Boston Univ, Sch Med, Dept Biochem, 715 Albany St,K323, Boston, MA 02118 USA.	sherma1@bu.edu	Gabai, Vladimir L/I-1650-2013	Gabai, Vladimir L/0000-0003-4505-4718; Meriin, Anatoli/0000-0003-0087-814X; Sherman, Michael/0000-0003-3345-073X				Arrasate M, 2004, NATURE, V431, P805, DOI 10.1038/nature02998; Bandopadhyay R, 2005, NEUROBIOL DIS, V20, P401, DOI 10.1016/j.nbd.2005.03.021; Boeddrich Annett, 2003, Methods Mol Biol, V232, P217; Boyault C, 2007, GENE DEV, V21, P2172, DOI 10.1101/gad.436407; Burnett BG, 2005, P NATL ACAD SCI USA, V102, P4330, DOI 10.1073/pnas.0407252102; Chung KKK, 2001, NAT MED, V7, P1144, DOI 10.1038/nm1001-1144; Corboy Michael J., 2005, V301, P305; Davenport EL, 2007, BLOOD, V110, P2641, DOI 10.1182/blood-2006-11-053728; Donaldson KM, 2003, P NATL ACAD SCI USA, V100, P8892, DOI 10.1073/pnas.1530212100; Elsasser S, 2002, NAT CELL BIOL, V4, P725, DOI 10.1038/ncb845; Engelender S, 1999, NAT GENET, V22, P110, DOI 10.1038/8820; Garcia-Mata R, 1999, J CELL BIOL, V146, P1239, DOI 10.1083/jcb.146.6.1239; Garcia-Mata R, 2002, TRAFFIC, V3, P388, DOI 10.1034/j.1600-0854.2002.30602.x; Hanna J, 2006, CELL, V127, P99, DOI 10.1016/j.cell.2006.07.038; Heir R, 2006, EMBO REP, V7, P1252, DOI 10.1038/sj.embor.7400823; Hershko A, 1998, ANNU REV BIOCHEM, V67, P425, DOI 10.1146/annurev.biochem.67.1.425; Johnston JA, 1998, J CELL BIOL, V143, P1883, DOI 10.1083/jcb.143.7.1883; Junn E, 2002, J BIOL CHEM, V277, P47870, DOI 10.1074/jbc.M203159200; Kawaguchi Y, 2003, CELL, V115, P727, DOI 10.1016/S0092-8674(03)00939-5; Kovacs I, 2006, J MOL NEUROSCI, V29, P9, DOI 10.1385/JMN:29:1:9; Layfield R, 2005, ESSAYS BIOCHEM, V41, P157, DOI 10.1042/EB0410157; Liani E, 2004, P NATL ACAD SCI USA, V101, P5500, DOI 10.1073/pnas.0401081101; Lim KL, 2006, NEUROBIOL AGING, V27, P524, DOI 10.1016/j.neurobiolaging.2005.07.023; Lim KL, 2005, J NEUROSCI, V25, P2002, DOI 10.1523/JNEUROSCI.4474-04.2005; Luo GR, 2007, INT J BIOL SCI, V3, P20; Marx FP, 2007, FASEB J, V21, P1759, DOI 10.1096/fj.06-6734com; McNaught KSP, 2002, EUR J NEUROSCI, V16, P2136, DOI 10.1046/j.1460-9568.2002.02301.x; Meriin AB, 2005, INT J HYPERTHER, V21, P403, DOI 10.1080/02656730500041871; Meriin AB, 2001, J CELL BIOL, V153, P851, DOI 10.1083/jcb.153.4.851; Nagano Y, 2003, J BIOL CHEM, V278, P51504, DOI 10.1074/jbc.M306347200; Olanow CW, 2004, LANCET NEUROL, V3, P496, DOI 10.1016/S1474-4422(04)00827-0; Olzmann JA, 2008, CURR MED CHEM, V15, P47; Olzmann JA, 2008, AUTOPHAGY, V4, P85, DOI 10.4161/auto.5172; Quinlan RA, 2007, EXP CELL RES, V313, P2077, DOI 10.1016/j.yexcr.2007.04.004; Shah Imtiaz M., 2007, Cardiovascular & Hematological Disorders - Drug Targets, V7, P250, DOI 10.2174/187152907782793572; Spillantini MG, 1997, NATURE, V388, P839, DOI 10.1038/42166; Tanaka M, 2004, J BIOL CHEM, V279, P4625, DOI 10.1074/jbc.M310994200; Taylor JP, 2003, HUM MOL GENET, V12, P749, DOI 10.1093/hmg/ddg074; TSENG BP, 2007, NEUROBIOL A IN PRESS; von Coelln R, 2004, CELL TISSUE RES, V318, P175, DOI 10.1007/s00441-004-0924-4; Wakabayashi K, 2007, NEUROPATHOLOGY, V27, P494, DOI 10.1111/j.1440-1789.2007.00803.x; Waza M, 2006, J MOL MED, V84, P635, DOI 10.1007/s00109-006-0066-0; Webb JL, 2004, INT J BIOCHEM CELL B, V36, P2541, DOI 10.1016/j.biocel.2004.02.003; Yew EHJ, 2005, J NEUROCHEM, V94, P943, DOI 10.1111/j.1471-4159.2005.03220.x; Zaarur N, 2006, CANCER RES, V66, P1783, DOI 10.1158/0008-5472.CAN-05-3692	45	68	69	2	5	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	OCT 10	2008	283	41					27575	27584		10.1074/jbc.M802216200	http://dx.doi.org/10.1074/jbc.M802216200			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	355OW	18635553	hybrid			2022-12-27	WOS:000259719200028
J	Alpadi, K; Magupalli, VG; Kappel, S; Koblitz, L; Schwarz, K; Seigel, GM; Sung, CH; Schmitz, F				Alpadi, Kannan; Magupalli, Venkat Giri; Kaeppel, Stefanie; Koeblitz, Louise; Schwarz, Karin; Seigel, Gail M.; Sung, Ching-Hwa; Schmitz, Frank			RIBEYE recruits munc119, a mammalian ortholog of the Caenorhabditis elegans protein unc119, to synaptic ribbons of photoreceptor Synapses	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							TRANSCRIPTIONAL COREPRESSOR; PDE-DELTA; HRG4; BINDING; IDENTIFICATION; ACTIVATOR; CTBP	Munc119 (also denoted as RG4) is a mammalian ortholog of the Caenorhabditis elegans protein unc119 and is essential for vision and synaptic transmission at photoreceptor ribbon synapses by unknown molecular mechanisms. Munc119/RG4 is related to the prenyl-binding protein PrBP/delta and expressed at high levels in photoreceptor ribbon synapses. Synaptic ribbons are presynaptic specializations in the active zone of these tonically active synapses and contain RIBEYE as a unique and major component. In the present study, we identified Munc119 as a RIBEYE-interacting protein at photoreceptor ribbon synapses using five independent approaches. The PrBP/delta homology domain of Munc119 is essential for the interaction with the NADH binding region of RIBEYE(B) domain. But RIBEYE-Munc119 interaction does not depend on NADH binding. A RIBEYE point mutant (RE(B) E844Q) that no longer interacted with Munc119 still bound NADH, arguing that binding of Munc119 and NADH to RIBEYE are independent from each other. Our data indicate that Munc119 is a synaptic ribbon-associated component. Weshow that Munc119 can be recruited to synaptic ribbons via its interaction with RIBEYE. Our data suggest that the RIBEYE-Munc119 interaction is essential for synaptic transmission at the photoreceptor ribbon synapse.	[Alpadi, Kannan; Magupalli, Venkat Giri; Kaeppel, Stefanie; Koeblitz, Louise; Schwarz, Karin; Schmitz, Frank] Univ Saarland, Med Sch Homburg Saar, Inst Anat & Cell Biol, Dept Neuroanat, D-66421 Homburg, Germany; [Seigel, Gail M.] SUNY Buffalo, Dept Ophthalmol Physiol & Biophys, Buffalo, NY 14214 USA; [Sung, Ching-Hwa] Cornell Univ, Weill Med Coll, Margaret M Dyson Vis Res Inst, Dept Ophthalmol Cell & Dev Biol, New York, NY 10021 USA	Saarland University; State University of New York (SUNY) System; State University of New York (SUNY) Buffalo; Cornell University	Schmitz, F (corresponding author), Univ Saarland, Med Sch Homburg Saar, Inst Anat & Cell Biol, Dept Neuroanat, Bldg 61, D-66421 Homburg, Germany.	frank.schmitz@uniklinikum-saarland.de	Schwarz, Karin/AAO-2819-2020	Magupalli, Venkat/0000-0003-4638-3062; Schwarz, Karin/0000-0002-7328-1427	Sonderforschungsbereich 530 (SFB530) [TPC11]; HOMFOR; NATIONAL EYE INSTITUTE [R01EY011307] Funding Source: NIH RePORTER	Sonderforschungsbereich 530 (SFB530)(German Research Foundation (DFG)); HOMFOR; NATIONAL EYE INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI))	This work was supported by the Sonderforschungsbereich 530 (SFB530) (TPC11) and by HOMFOR (to F. S.). The costs of publication of this article were defrayed in part by the payment of page charges. This article must therefore be hereby marked "advertisement" in accordance with 18 U. S. C. Section 1734 solely to indicate this fact.	Bai C, 1996, METHOD ENZYMOL, V273, P331; Cen O, 2003, J BIOL CHEM, V278, P8837, DOI 10.1074/jbc.M208261200; Chinnadurai G, 2002, MOL CELL, V9, P213, DOI 10.1016/S1097-2765(02)00443-4; Dieck ST, 2006, CELL TISSUE RES, V326, P339, DOI 10.1007/s00441-006-0234-0; Fjeld CC, 2003, P NATL ACAD SCI USA, V100, P9202, DOI 10.1073/pnas.1633591100; Gorska MM, 2004, J EXP MED, V199, P369, DOI 10.1084/jem.20030589; Haeseleer F, 2008, INVEST OPHTH VIS SCI, V49, P2366, DOI 10.1167/iovs.07-1166; Hanzal-Bayer M, 2002, EMBO J, V21, P2095, DOI 10.1093/emboj/21.9.2095; HARPER JW, 1993, CELL, V75, P805; Heidelberger R, 2005, PROG RETIN EYE RES, V24, P682, DOI 10.1016/j.preteyeres.2005.04.002; Helmuth M, 2001, ANAL BIOCHEM, V293, P149, DOI 10.1006/abio.2001.5107; Higashide T, 1996, J BIOL CHEM, V271, P1797, DOI 10.1074/jbc.271.3.1797; Higashide T, 1998, INVEST OPHTH VIS SCI, V39, P690; James P, 1996, GENETICS, V144, P1425; Kobayashi A, 2003, FEBS LETT, V534, P26, DOI 10.1016/S0014-5793(02)03766-3; KOBAYASHI A, 2000, INVESTIG OPHTHALMOL, V11, P3268; Kubota S, 2002, INVEST OPHTH VIS SCI, V43, P308; Kumar V, 2002, MOL CELL, V10, P857, DOI 10.1016/S1097-2765(02)00650-0; Li N, 1998, GENOMICS, V49, P76, DOI 10.1006/geno.1998.5210; Mori N, 2006, INVEST OPHTH VIS SCI, V47, P1281, DOI 10.1167/iovs.05-0493; Nardini M, 2003, EMBO J, V22, P3122, DOI 10.1093/emboj/cdg283; Schmitz F, 2006, P NATL ACAD SCI USA, V103, P2926, DOI 10.1073/pnas.0510060103; Schmitz F, 2000, NEURON, V28, P857, DOI 10.1016/S0896-6273(00)00159-8; Schmitz F, 1996, J NEUROSCI, V16, P7109; Seigel GM, 1996, IN VITRO CELL DEV-AN, V32, P66; Seigel GM, 2004, CURR EYE RES, V28, P257, DOI 10.1076/ceyr.28.4.257.27831; Stahl B, 1999, J BIOL CHEM, V274, P9141, DOI 10.1074/jbc.274.14.9141; Sterling P, 2005, TRENDS NEUROSCI, V28, P20, DOI 10.1016/j.tins.2004.11.009; Swanson DA, 1998, INVEST OPHTH VIS SCI, V39, P2085; Tai AW, 1999, CELL, V97, P877, DOI 10.1016/S0092-8674(00)80800-4; Van Valkenburgh H, 2001, J BIOL CHEM, V276, P22826, DOI 10.1074/jbc.M102359200; Wan L, 2005, J NEUROSCI, V25, P941, DOI 10.1523/JNEUROSCI.4657-04.2005; Wang Y, 1997, NATURE, V388, P593, DOI 10.1038/41580; Zenisek D, 2004, J NEUROSCI, V24, P9752, DOI 10.1523/JNEUROSCI.2886-04.2004; Zhang H, 2007, P NATL ACAD SCI USA, V104, P8857, DOI 10.1073/pnas.0701681104; Zhang HB, 2004, J BIOL CHEM, V279, P407, DOI 10.1074/jbc.M306559200	36	48	48	0	3	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	SEP 26	2008	283	39					26461	26467		10.1074/jbc.M801625200	http://dx.doi.org/10.1074/jbc.M801625200			7	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	350GV	18664567	Green Published, hybrid			2022-12-27	WOS:000259341600021
J	Woodard-Grice, AV; McBrayer, AC; Wakefield, JK; Zhuo, Y; Bellis, SL				Woodard-Grice, Alencia V.; McBrayer, Alexis C.; Wakefield, John K.; Zhuo, Ya; Bellis, Susan L.			Proteolytic shedding of ST6Gal-I by BACE1 regulates the glycosylation and function of alpha 4 beta 1 integrins	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							AMYLOID PRECURSOR PROTEIN; MYELOID FIBRONECTIN RECEPTORS; ALZHEIMERS BETA-SECRETASE; CELL-ADHESION; DIFFERENTIAL GLYCOSYLATION; ACTIVATED RECEPTOR; KNOCKOUT MICE; BINDING-SITE; HL60 CELLS; N-GLYCANS	Differentiation of monocytes into macrophages is accompanied by increased cell adhesiveness, due in part to the activation of alpha 4 beta 1 integrins. Here we report that the sustained alpha 4 beta 1 activation associated with macrophage differentiation results from expression of beta 1 integrin subunits that lack alpha 2-6-linked sialic acids, a carbohydrate modification added by the ST6Gal-I sialyltransferase. During differentiation of U937 monocytic cells and primary human CD14(+) monocytes, ST6Gal-I is down-regulated, leading to beta 1 hyposialylation and enhanced alpha 4 beta 1-dependent VCAM-1 binding. Importantly, ST6Gal-I down-regulation results from cleavage by the BACE1 secretase, which we show is dramatically up-regulated during macrophage differentiation. BACE1 up-regulation, ST6Gal-I shedding, beta 1 hyposialylation, and alpha 4 beta 1-dependent VCAM-1 binding are all temporally correlated and share the same signaling mechanism (protein kinase C/Ras/ERK). Preventing ST6Gal-I down-regulation (and therefore integrin hyposialylation), through BACE1 inhibition or ST6Gal-I constitutive overexpression, eliminates VCAM-1 binding. Similarly, preventing integrin hyposialylation inhibits a differentiation-induced increase in the expression of an activation-dependent conformational epitope on the beta 1 subunit. Collectively, these results describe a novel mechanism for alpha 4 beta 1 regulation and further suggest an unanticipated role for BACE1 in macrophage function.	[Woodard-Grice, Alencia V.; Zhuo, Ya; Bellis, Susan L.] Univ Alabama, Dept Physiol & Biophys, Birmingham, AL 35294 USA; [McBrayer, Alexis C.] Univ Alabama, Dept Surg, Birmingham, AL 35294 USA; [Wakefield, John K.] Tranzyme Pharma, Birmingham, AL 35294 USA	University of Alabama System; University of Alabama Birmingham; University of Alabama System; University of Alabama Birmingham	Bellis, SL (corresponding author), Univ Alabama, Dept Physiol & Biophys, Rm 982A MCLM,1918 Univ Blvd, Birmingham, AL 35294 USA.	bellis@physiology.uab.edu			NCI NIH HHS [R01CA84248] Funding Source: Medline; NATIONAL CANCER INSTITUTE [R01CA084248] Funding Source: NIH RePORTER	NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))		Amano M, 2003, J BIOL CHEM, V278, P7469, DOI 10.1074/jbc.M209595200; Bellis SL, 2004, BBA-BIOMEMBRANES, V1663, P52, DOI 10.1016/j.bbamem.2004.03.012; Brennan PJ, 2006, INT IMMUNOL, V18, P627, DOI 10.1093/intimm/dxh344; Cai HB, 2001, NAT NEUROSCI, V4, P233, DOI 10.1038/85064; Chen C, 2000, GLYCOBIOLOGY, V10, P531, DOI 10.1093/glycob/10.5.531; Chen C, 1999, J IMMUNOL, V162, P1084; Chigaev A, 2001, J BIOL CHEM, V276, P48670, DOI 10.1074/jbc.M103194200; Cho HJ, 2007, GLIA, V55, P253, DOI 10.1002/glia.20451; Dall'Olio Fabio, 2000, Glycoconjugate Journal, V17, P669, DOI 10.1023/A:1011077000164; Danciger JS, 2004, J IMMUNOL METHODS, V288, P123, DOI 10.1016/j.jim.2004.03.003; Daniels MA, 2002, NAT IMMUNOL, V3, P903, DOI 10.1038/ni1002-903; Dominguez D, 2005, J BIOL CHEM, V280, P30797, DOI 10.1074/jbc.M505249200; FEHR J, 1977, J EXP MED, V146, P641, DOI 10.1084/jem.146.3.641; Feigelson S, 2001, J BIOL CHEM, V276, P13891, DOI 10.1074/jbc.M004939200; Ghribi O, 2006, EXP NEUROL, V200, P460, DOI 10.1016/j.expneurol.2006.03.019; GILBERT HS, 1978, METABOLISM, V27, P889, DOI 10.1016/0026-0495(78)90132-4; Ginsberg MH, 2005, CURR OPIN CELL BIOL, V17, P509, DOI 10.1016/j.ceb.2005.08.010; Grabovsky V, 2000, J EXP MED, V192, P495, DOI 10.1084/jem.192.4.495; Gu JG, 2004, GLYCOCONJUGATE J, V21, P9, DOI 10.1023/B:GLYC.0000043741.47559.30; He HC, 1999, CELL GROWTH DIFFER, V10, P307; Hu XT, 2000, CELL GROWTH DIFFER, V11, P191; Hynes RO, 2002, CELL, V110, P673, DOI 10.1016/S0092-8674(02)00971-6; ISSEKUTZ TB, 1981, AM J PATHOL, V103, P47; Jenner J, 2006, EXP HEMATOL, V34, P1212, DOI 10.1016/j.exphem.2006.04.016; Kaneko Y, 2006, SCIENCE, V313, P670, DOI 10.1126/science.1129594; KHARBANDA S, 1994, J BIOL CHEM, V269, P872; Kitazume S, 2005, J BIOL CHEM, V280, P8589, DOI 10.1074/jbc.M409417200; Kitazume S, 2004, GLYCOCONJUGATE J, V21, P25, DOI 10.1023/B:GLYC.0000043743.21735.ff; Ley K, 1996, CARDIOVASC RES, V32, P733, DOI 10.1016/0008-6363(96)00066-1; Lichtenthaler SF, 2003, J BIOL CHEM, V278, P48713, DOI 10.1074/jbc.M303861200; Lin XL, 2000, P NATL ACAD SCI USA, V97, P1456, DOI 10.1073/pnas.97.4.1456; LIU Y, 2008, PROTEINS IN PRESS; Luo BH, 2007, ANNU REV IMMUNOL, V25, P619, DOI 10.1146/annurev.immunol.25.022106.141618; Luo Y, 2003, NEUROBIOL DIS, V14, P81, DOI 10.1016/S0969-9961(03)00104-9; Luo Y, 2001, NAT NEUROSCI, V4, P231, DOI 10.1038/85059; Ma JY, 1996, J BIOL CHEM, V271, P7758, DOI 10.1074/jbc.271.13.7758; McIntyre TM, 2003, CURR OPIN HEMATOL, V10, P150, DOI 10.1097/00062752-200303000-00009; Miranda MB, 2002, LEUKEMIA, V16, P683, DOI 10.1038/sj.leu.2402400; MOULD AP, 1995, FEBS LETT, V363, P118, DOI 10.1016/0014-5793(95)00301-O; PAWLOWSKI NA, 1988, J EXP MED, V168, P1865, DOI 10.1084/jem.168.5.1865; Pretzlaff RK, 2000, CELL ADHES COMMUN, V7, P491, DOI 10.3109/15419060009040306; Roberds SL, 2001, HUM MOL GENET, V10, P1317, DOI 10.1093/hmg/10.12.1317; Rose DM, 2007, IMMUNOL REV, V218, P126, DOI 10.1111/j.1600-065X.2007.00536.x; Rossner S, 2006, PROG NEUROBIOL, V79, P95, DOI 10.1016/j.pneurobio.2006.06.001; Sastre M, 2003, J NEUROSCI, V23, P9796; Seales EC, 2005, J BIOL CHEM, V280, P37610, DOI 10.1074/jbc.M508476200; Seales EC, 2005, CANCER RES, V65, P4645, DOI 10.1158/0008-5472.CAN-04-3117; Seales EC, 2003, ONCOGENE, V22, P7137, DOI 10.1038/sj.onc.1206834; Semel AC, 2002, J BIOL CHEM, V277, P32830, DOI 10.1074/jbc.M202493200; Shimizu Y, 1999, ADV IMMUNOL, V72, P325, DOI 10.1016/S0065-2776(08)60024-3; Sinha S, 1999, NATURE, V402, P537, DOI 10.1038/990114; Smith JW, 1997, MATRIX BIOL, V16, P173, DOI 10.1016/S0945-053X(97)90005-6; Tan SL, 2003, BIOCHEM J, V376, P545, DOI 10.1042/BJ20031406; Toscano MA, 2007, NAT IMMUNOL, V8, P825, DOI 10.1038/ni1482; Vassar R, 1999, SCIENCE, V286, P735, DOI 10.1126/science.286.5440.735; Villavicencio-Lorini P, 2002, J MOL MED-JMM, V80, P671, DOI 10.1007/s00109-002-0382-y; Weber C, 2003, J MOL MED, V81, P4, DOI 10.1007/s00109-002-0391-x; Yamamoto M, 2007, AM J PATHOL, V170, P680, DOI 10.2353/ajpath.2007.060378; Yang GX, 2003, MED RES REV, V23, P369, DOI 10.1002/med.10044; Yusuf-Makagiansar H, 2002, MED RES REV, V22, P146, DOI 10.1002/med.10001	60	55	57	0	2	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	SEP 26	2008	283	39					26364	26373		10.1074/jbc.M800836200	http://dx.doi.org/10.1074/jbc.M800836200			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	350GV	18650447	hybrid, Green Published			2022-12-27	WOS:000259341600010
J	Bruysters, M; Verhoef-Post, M; Themmen, APN				Bruysters, Martijn; Verhoef-Post, Miriam; Themmen, Axel P. N.			Asp(330) and Tyr(331) in the C-terminal cysteine-rich region of the luteinizing hormone receptor are key residues in hormone-induced receptor activation	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							HUMAN CHORIONIC-GONADOTROPIN; PLATELET GLYCOPROTEIN-IB; STIMULATING-HORMONE; HINGE REGION; VONWILLEBRAND DISEASE; EXTRACELLULAR DOMAIN; TSH RECEPTOR; LH RECEPTOR; BINDING; AGONIST	The luteinizing hormone (LH) receptor plays an essential role in male and female gonadal function. Together with the follicle-stimulating hormone (FSH) and thyroid stimulating hormone (TSH) receptors, the LH receptor forms the family of glycoprotein hormone receptors. All glycoprotein hormone receptors share a common modular topography, with an N-terminal extracellular ligand binding domain and a C-terminal seven-transmembrane transduction domain. The ligand binding domain consists of 9 leucine-rich repeats, flanked by N-and C-terminal cysteine-rich regions. Recently, crystal structures have been published of the extracellular domains of the FSH and TSH receptors. However, the C-terminal cysteine-rich region (CCR), also referred to as the "hinge region," was not included in these structures. Both structure and function of the CCR therefore remain unknown. In this study we set out to characterize important domains within the CCR of the LH receptor. First, we mutated all cysteines and combinations of cysteines in the CCR to identify the most probable disulfide bridges. Second, we exchanged large parts of the LH receptor CCR by its FSH receptor counterparts, and characterized the mutant receptors in transiently transfected HEK 293 cells. We zoomed in on important regions by focused exchange and deletion mutagenesis followed by alanine scanning. Mutations in the CCR specifically decreased the potencies of LH and hCG, because the potency of the low molecular weight agonist Org 41841 was unaffected. Using this unbiased approach, we identified Asp(330) and Tyr(331) as key amino acids in LH/hCG mediated signaling.	[Bruysters, Martijn; Verhoef-Post, Miriam; Themmen, Axel P. N.] Erasmus MC, Dept Internal Med, NL-3000 CA Rotterdam, Netherlands	Erasmus University Rotterdam; Erasmus MC	Themmen, APN (corresponding author), Erasmus MC, Dept Internal Med, POB 2040, NL-3000 CA Rotterdam, Netherlands.	a.themmen@erasmusmc.nl			National Institutes of Health [5R01DK069711-02]; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK069711] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	This work was supported, in whole or in part, by National Institutes of Health Grant 5R01DK069711-02 ( to A. P. N. T.). The costs of publication of this article were defrayed in part by the payment of page charges. This article must therefore be hereby marked "advertisement" in accordance with 18 U. S. C. Section 1734 solely to indicate this fact.	Barton WA, 2003, EMBO J, V22, P3291, DOI 10.1093/emboj/cdg325; Basu A, 2005, J IMMUNOASS IMMUNOCH, V26, P313, DOI 10.1080/15321810500220910; Beinborn M, 2006, MOL PHARMACOL, V70, P1, DOI 10.1124/mol.106.025932.; Bonomi M, 2006, MOL ENDOCRINOL, V20, P3351, DOI 10.1210/me.2005-0521; BRAUN T, 1991, EMBO J, V10, P1885, DOI 10.1002/j.1460-2075.1991.tb07714.x; COSTAGLIOLA S, 1992, J CLIN ENDOCR METAB, V75, P1540, DOI 10.1210/jc.75.6.1540; Costagliola S, 2002, EMBO J, V21, P504, DOI 10.1093/emboj/21.4.504; Fan QR, 2005, NATURE, V433, P269, DOI 10.1038/nature03206; Galet C, 2000, J ENDOCRINOL, V167, P117, DOI 10.1677/joe.0.1670117; Gromoll J, 2000, J CLIN ENDOCR METAB, V85, P2281, DOI 10.1210/jc.85.6.2281; Hollenberg MD, 2002, PHARMACOL REV, V54, P203, DOI 10.1124/pr.54.2.203; Hong SH, 1998, J BIOL CHEM, V273, P13835, DOI 10.1074/jbc.273.22.13835; Huizinga EG, 2002, SCIENCE, V297, P1176, DOI 10.1126/science.107355; Jaschke H, 2006, J BIOL CHEM, V281, P9841, DOI 10.1074/jbc.C600014200; KELDER J, 2004, CHEMINFORMATICS DEV, V1, P111; Kobe B, 2001, CURR OPIN STRUC BIOL, V11, P725, DOI 10.1016/S0959-440X(01)00266-4; KOBE B, 1995, CURR OPIN STRUC BIOL, V5, P409, DOI 10.1016/0959-440X(95)80105-7; KRAAIJ R, 1995, J CLIN ENDOCR METAB, V80, P3168, DOI 10.1210/jc.80.11.3168; Matsushima N, 2005, CELL MOL LIFE SCI, V62, P2771, DOI 10.1007/s00018-005-5187-z; MILLER JL, 1991, P NATL ACAD SCI USA, V88, P4761, DOI 10.1073/pnas.88.11.4761; MINEGISHI T, 1994, J ENDOCRINOL, V141, P369, DOI 10.1677/joe.0.1410369; Mizutori Y, 2008, MOL ENDOCRINOL, V22, P1171, DOI 10.1210/me.2007-0407; Moore S, 2006, J MED CHEM, V49, P3888, DOI 10.1021/jm060247s; Mueller S, 2006, J BIOL CHEM, V281, P31638, DOI 10.1074/jbc.M604770200; Muller T, 2003, J CLIN ENDOCR METAB, V88, P2242, DOI 10.1210/jc.2002-021946; Nakabayashi K, 2000, J BIOL CHEM, V275, P30264, DOI 10.1074/jbc.M005568200; Roseman DS, 2000, P NATL ACAD SCI USA, V97, P9949, DOI 10.1073/pnas.170184597; RUSSELL SD, 1993, BLOOD, V81, P1787; Sanders J, 2007, THYROID, V17, P395, DOI 10.1089/thy.2007.0034; Themmen APN, 2000, ENDOCR REV, V21, P551, DOI 10.1210/er.21.5.551; Themmen APN, 2005, REPRODUCTION, V130, P263, DOI 10.1530/rep.1.00663; Thomas D, 1996, MOL ENDOCRINOL, V10, P760, DOI 10.1210/me.10.6.760; van Straten NCR, 2002, CHEMBIOCHEM, V3, P1023, DOI 10.1002/1439-7633(20021004)3:10<1023::AID-CBIC1023>3.0.CO;2-9; Vassart G, 2004, TRENDS BIOCHEM SCI, V29, P119, DOI 10.1016/j.tibs.2004.01.006; Vlaeminck-Guillem V, 2002, MOL ENDOCRINOL, V16, P736, DOI 10.1210/me.16.4.736; Zhang R, 1996, J BIOL CHEM, V271, P5755, DOI 10.1074/jbc.271.10.5755	36	41	42	0	2	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	SEP 19	2008	283	38					25821	25828		10.1074/jbc.M804395200	http://dx.doi.org/10.1074/jbc.M804395200			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	348GX	18641392	Green Published, hybrid			2022-12-27	WOS:000259200100008
J	Chung, HJ; Steplewski, A; Chung, KY; Uitto, J; Fertala, A				Chung, Hye Jin; Steplewski, Andrzej; Chung, Kee Yang; Uitto, Jouni; Fertala, Andrzej			Collagen fibril formation - A new target to limit fibrosis	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							PROCOLLAGEN C-PROTEINASE; BONE MORPHOGENETIC PROTEIN-1; ALZHEIMERS-DISEASE; PREVENTION; INHIBITION; METALLOPROTEINASES; MONOMERS; CLEAVAGE; POSITION; DRIVEN	We present a concept for reducing formation of fibrotic deposits by inhibiting self-assembly of collagen molecules into fibrils, a main component of fibrotic lesions. Employing monoclonal antibodies that bind to the telopeptide region of a collagen molecule, we found that blocking telopeptide-mediated collagen/collagen interactions reduces the amount of collagen fibrils accumulated in vitro and in keloid-like organotypic constructs. We conclude that inhibiting extracellular steps of the fibrotic process provides a novel approach to limit fibrosis in a number of tissues and organs.	[Chung, Hye Jin; Steplewski, Andrzej; Uitto, Jouni; Fertala, Andrzej] Thomas Jefferson Univ, Jefferson Med Coll, Dept Dermatol & Cutaneous Biol, Philadelphia, PA 19107 USA; [Chung, Kee Yang] Yonsei Univ, Coll Med, Dept Dermatol, Seoul 120752, South Korea; [Chung, Kee Yang] Yonsei Univ, Coll Med, Cutaneous Biol Res Inst, Seoul 120752, South Korea	Jefferson University; Yonsei University; Yonsei University Health System; Yonsei University; Yonsei University Health System	Fertala, A (corresponding author), Thomas Jefferson Univ, Jefferson Med Coll, Dept Dermatol & Cutaneous Biol, BLSB,Rm 424,233 S 10th St, Philadelphia, PA 19107 USA.	andrzej.fertala@jefferson.edu		Chung, Hye Jin/0000-0003-0204-4085; Chung, Kee Yang/0000-0003-3257-0297	National Institutes of Health [R01AR048544, R01AR049537, R01AR41439]; NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES [R01AR041439, R01AR048544, R01AR049537] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS))	This work was supported, in whole or in part, by National Institutes of Health Grants R01AR048544 and R01AR049537 (to A. F.) and R01AR41439 (to J.U.). The costs of publication of this article were defrayed in part by the payment of page charges. This article must therefore be hereby marked "advertisement" in accordance with 18 U. S. C. Section 1734 solely to indicate this fact.	ADDICKS EM, 1983, ARCH OPHTHALMOL-CHIC, V101, P795; Amano S, 2000, J BIOL CHEM, V275, P22728, DOI 10.1074/jbc.M002345200; Butler PD, 2008, J AM COLL SURGEONS, V206, P731, DOI 10.1016/j.jamcollsurg.2007.12.001; Cabral WA, 2007, HUM MUTAT, V28, P396, DOI 10.1002/humu.20456; CHANG K, 1980, DIABETES, V29, P778, DOI 10.2337/diabetes.29.10.778; Colige A, 2002, J BIOL CHEM, V277, P5756, DOI 10.1074/jbc.M105601200; ELLIOTT BW, 1986, J BIOL CHEM, V261, P1259; EYRE DR, 1984, ANNU REV BIOCHEM, V53, P717, DOI 10.1146/annurev.bi.53.070184.003441; Fertala A, 1996, J BIOL CHEM, V271, P14864, DOI 10.1074/jbc.271.25.14864; FERTALA A, 1994, J BIOL CHEM, V269, P11584; FIEDLERNAGY C, 1981, ARCH BIOCHEM BIOPHYS, V212, P668, DOI 10.1016/0003-9861(81)90411-2; Fish PV, 2007, J MED CHEM, V50, P3442, DOI 10.1021/jm061010z; Fisher LW, 1995, ACTA ORTHOP SCAND, V66, P61, DOI 10.3109/17453679509157649; FLEISCHMAJER R, 1983, P NATL ACAD SCI-BIOL, V80, P3354, DOI 10.1073/pnas.80.11.3354; FLEISCHMAJER R, 1981, P NATL ACAD SCI-BIOL, V78, P7360, DOI 10.1073/pnas.78.12.7360; GELMAN RA, 1979, J BIOL CHEM, V254, P180; HOJIMA Y, 1985, J BIOL CHEM, V260, P5996; Hopkins DR, 2007, MATRIX BIOL, V26, P508, DOI 10.1016/j.matbio.2007.05.004; Imamura Y, 1998, J BIOL CHEM, V273, P27511, DOI 10.1074/jbc.273.42.27511; Ito H, 2005, J MOL BIOL, V352, P382, DOI 10.1016/j.jmb.2005.07.019; KADLER KE, 1987, J BIOL CHEM, V262, P15696; Kessler E, 1996, SCIENCE, V271, P360, DOI 10.1126/science.271.5247.360; KISILEVSKY R, 1995, NAT MED, V1, P143, DOI 10.1038/nm0295-143; Lansbury PT, 1997, CURR OPIN CHEM BIOL, V1, P260, DOI 10.1016/S1367-5931(97)80018-X; Lim XH, 2006, ANN OTO RHINOL LARYN, V115, P921, DOI 10.1177/000348940611501212; MERLINI G, 1995, P NATL ACAD SCI USA, V92, P2959, DOI 10.1073/pnas.92.7.2959; Ovens A, 2000, J PEPT SCI, V6, P489, DOI 10.1002/1099-1387(200009)6:9<489::AID-PSC282>3.3.CO;2-B; PROCKOP DJ, 1995, ANNU REV BIOCHEM, V64, P403, DOI 10.1146/annurev.biochem.64.1.403; Prockop DJ, 1998, J STRUCT BIOL, V122, P111, DOI 10.1006/jsbi.1998.3976; Prockop DJ, 1998, J BIOL CHEM, V273, P15598, DOI 10.1074/jbc.273.25.15598; RILEY DJ, 1980, J CLIN INVEST, V65, P643, DOI 10.1172/JCI109709; ROMANIC AM, 1991, J BIOL CHEM, V266, P12703; Roseborough IE, 2004, J NATL MED ASSOC, V96, P108; Sanders KW, 2005, ARCH FACIAL PLAST S, V7, P172, DOI 10.1001/archfaci.7.3.172; Scott IC, 1999, DEV BIOL, V213, P283, DOI 10.1006/dbio.1999.9383; Scott IC, 2000, J BIOL CHEM, V275, P30504, DOI 10.1074/jbc.M004846200; SHAH M, 1995, J CELL SCI, V108, P985; Steplewski A, 2004, J STRUCT BIOL, V148, P326, DOI 10.1016/j.jsb.2004.07.006; Suzuki N, 1996, DEVELOPMENT, V122, P3587; Wang HJ, 2003, TISSUE ENG, V9, P909, DOI 10.1089/107632703322495556; WOESSNER JF, 1961, ARCH BIOCHEM BIOPHYS, V93, P440, DOI 10.1016/0003-9861(61)90291-0	41	51	55	0	8	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	SEP 19	2008	283	38					25879	25886		10.1074/jbc.M804272200	http://dx.doi.org/10.1074/jbc.M804272200			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	348GX	18650436	Green Published, hybrid			2022-12-27	WOS:000259200100015
J	Suzuki, M; Lee, DY; Inyamah, N; Stadtman, TC; Tjandra, N				Suzuki, Motoshi; Lee, Duck-Yeon; Inyamah, Nwakaego; Stadtman, Thressa C.; Tjandra, Nico			Solution NMR structure of selenium-binding protein from Methanococcus vannielii	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ORIENTED MACROMOLECULES; C-13; SPECTROSCOPY; ENHANCEMENT; METABOLISM; COUPLINGS; N-15	Selenium is an important nutrient. The lack of selenium will suppress expression of various enzymes that will lead to cell abnormality and diseases. However, high concentrations of free selenium are toxic to the cell because it adversely affects numerous cell metabolic pathways. In Methanonoccus vannielii, selenium transport in the cell is established by the selenium-binding protein, SeBP. SeBP sequesters selenium during transport, thus regulating the level of free selenium in the cell, and delivers it specifically to the selenophosphate synthase enzyme. In solution, SeBP is an oligomer of 8.8-kDa subunits. It is a symmetric pentamer. The solution structure of SeBP was determined by NMR spectroscopy. Each subunit of SeBP is composed of an alpha-helix on top of a 4-stranded twisted beta-sheet. The stability of the five subunits stems mainly from hydrophobic interactions and supplemented by hydrogen bond interactions. The loop containing Cys(59) has been shown to be important for selenium binding, is flexible, and adopts multiple conformations. However, the cysteine accessibility is restricted in the structure, reducing the possibility of the binding of free selenium readily. Therefore, a different selenium precursor or other factors might be needed to facilitate opening of this loop to expose Cys(59) for selenium binding.	[Suzuki, Motoshi; Tjandra, Nico] NIH, Lab Mol Biophys, Bethesda, MD 20892 USA; [Lee, Duck-Yeon; Inyamah, Nwakaego; Stadtman, Thressa C.] NHLBI, NIH, Biochem Lab, Bethesda, MD 20892 USA	National Institutes of Health (NIH) - USA; National Institutes of Health (NIH) - USA; NIH National Heart Lung & Blood Institute (NHLBI)	Stadtman, TC (corresponding author), 50 South Dr,Bldg 50,Rm 3503,MSC-8012, Bethesda, MD 20892 USA.	stadtmat@nhlbi.nih.gov; tjandran@nhlbi.nih.gov		Suzuki, Motoshi/0000-0002-4346-7677	Intramural Research Program of the NHLBI; National Institutes of Health; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [Z01HL001048, ZIAHL001048, Z01HL000205] Funding Source: NIH RePORTER	Intramural Research Program of the NHLBI(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	This work was supported, in whole or in part, by the Intramural Research Program of the NHLBI, National Institutes of Health. The costs of publication of this article were defrayed in part by the payment of page charges. This article must therefore be hereby marked "advertisement" in accordance with 18 U. S. C. Section 1734 solely to indicate this fact.	BARBATO G, 1992, BIOCHEMISTRY-US, V31, P5269, DOI 10.1021/bi00138a005; BAX A, 1993, ACCOUNTS CHEM RES, V26, P131, DOI 10.1021/ar00028a001; Bock A, 1988, Biofactors, V1, P245; BROOKS BR, 1983, J COMPUT CHEM, V4, P187, DOI 10.1002/jcc.540040211; CLORE GM, 1991, BIOCHEMISTRY-US, V30, P12, DOI 10.1021/bi00215a002; Cornilescu G, 1999, J BIOMOL NMR, V13, P289, DOI 10.1023/A:1008392405740; DELAGLIO F, 1995, J BIOMOL NMR, V6, P277, DOI 10.1007/BF00197809; Ganther HE, 1999, CARCINOGENESIS, V20, P1657, DOI 10.1093/carcin/20.9.1657; GARRETT DS, 1991, J MAGN RESON, V95, P214, DOI 10.1016/0022-2364(91)90341-P; Haratake M, 2005, BBA-GEN SUBJECTS, V1723, P215, DOI 10.1016/j.bbagen.2005.02.002; HOLM L, 1993, J MOL BIOL, V233, P123, DOI 10.1006/jmbi.1993.1489; Horn MJ, 1941, J BIOL CHEM, V139, P649; KAY LE, 1990, SCIENCE, V249, P411, DOI 10.1126/science.2377896; Koradi R, 1996, J MOL GRAPHICS, V14, P51, DOI 10.1016/0263-7855(96)00009-4; KUSZEWSKI J, 1992, J BIOMOL NMR, V2, P33, DOI 10.1007/BF02192799; Lacourciere GM, 2002, P NATL ACAD SCI USA, V99, P9150, DOI 10.1073/pnas.142291199; Laskowski RA, 1996, J BIOMOL NMR, V8, P477, DOI 10.1007/BF00228148; LEE W, 1994, FEBS LETT, V350, P87, DOI 10.1016/0014-5793(94)00740-3; LEINFELDER W, 1988, J BACTERIOL, V170, P540, DOI 10.1128/jb.170.2.540-546.1988; LEINFELDER W, 1990, P NATL ACAD SCI USA, V87, P543, DOI 10.1073/pnas.87.2.543; NERI D, 1989, BIOCHEMISTRY-US, V28, P7510, DOI 10.1021/bi00445a003; Ogasawara Y, 2005, P NATL ACAD SCI USA, V102, P1012, DOI 10.1073/pnas.0409042102; Ottiger M, 1998, J MAGN RESON, V134, P365, DOI 10.1006/jmre.1998.1546; Patteson KG, 2005, P NATL ACAD SCI USA, V102, P12029, DOI 10.1073/pnas.0505650102; Rayman MP, 2000, LANCET, V356, P233, DOI 10.1016/S0140-6736(00)02490-9; SCHWARZ K, 1957, J AM CHEM SOC, V79, P3292, DOI 10.1021/ja01569a087; Schwieters CD, 2003, J MAGN RESON, V160, P65, DOI 10.1016/S1090-7807(02)00014-9; Self WT, 2004, IUBMB LIFE, V56, P501, DOI 10.1080/15216540400010818; Stadtman TC, 2004, IUBMB LIFE, V56, P427, DOI 10.1080/15216540400008911; STADTMAN TC, 1974, SCIENCE, V183, P915, DOI 10.1126/science.183.4128.915; Tjandra N, 1997, NAT STRUCT BIOL, V4, P732, DOI 10.1038/nsb0997-732; VERES Z, 1992, P NATL ACAD SCI USA, V89, P2975, DOI 10.1073/pnas.89.7.2975; VUISTER GW, 1992, J MAGN RESON, V98, P428, DOI 10.1016/0022-2364(92)90144-V; Wang YX, 1999, J BIOMOL NMR, V14, P181, DOI 10.1023/A:1008346517302; WITTEKIND M, 1993, J MAGN RESON SER B, V101, P201, DOI 10.1006/jmrb.1993.1033; YAMAZAKI T, 1994, J AM CHEM SOC, V116, P11655, DOI 10.1021/ja00105a005	36	11	11	1	6	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	SEP 19	2008	283	38					25936	25943		10.1074/jbc.M803773200	http://dx.doi.org/10.1074/jbc.M803773200			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	348GX	18650445	hybrid, Green Published			2022-12-27	WOS:000259200100021
J	Wang, GL; Salisbury, E; Shi, X; Timchenko, L; Medrano, EE; Timchenko, NA				Wang, Guo-Li; Salisbury, Elizabeth; Shi, Xiurong; Timchenko, Lubov; Medrano, Estela E.; Timchenko, Nikolai A.			HDAC1 promotes liver proliferation in young mice via interactions with C/EBP beta	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							BINDING PROTEIN-BETA; INCREASES TRANSLATION; MESSENGER-RNA; ALPHA; EXPRESSION; OVEREXPRESSION; INHIBITION; CUGBP1; AGE; DNA	HDAC1 (histone deacetylase 1) regulates a number of biological processes in cells. Our previous studies revealed that HDAC1 inhibits proliferation of the livers in old mice. We have surprisingly observed that HDAC1 is also increased in young livers proliferating after partial hepatectomy (PH) and in human liver tumors. Increased levels of HDAC1 after PH lead to its interaction with a member of the C/EBP family, C/EBP beta, which is also elevated after PH. At early time points after PH, the HDAC1-C/EBP beta complex binds to the C/EBP alpha promoter and represses expression of C/EBP alpha. A detailed analysis of the role of HDAC1 and C/EBP beta proteins in the regulation of C/EBP alpha promoter showed that, whereas C/EBP beta alone activates the promoter, HDAC1 represses the promoter in a C/EBP beta-dependent manner. The inhibition of HDAC1 in the livers of young mice inhibits liver proliferation after PH, which is associated with high levels of C/EBP alpha. Consistent with the positive role of HDAC1-C/EBP beta complexes in liver proliferation, we have found that the CUGBP1-HDAC1-C/EBP beta pathway is activated in human tumor liver samples, suggesting that HDAC1-C/EBP beta complexes are involved in the development of liver tumors. The causal role of the CUGBP1-HDAC1 pathway in liver proliferation was examined in CUGBP1 transgenic mice, which display high levels of the CUGBP1-eIF2 complex. We have demonstrated that elevation of the HDAC1-C/EBP beta complexes in CUGBP1 transgenic mice reduces expression of C/EBP alpha and increases the rate of liver proliferation. Thus, these studies have identified a new pathway that promotes liver proliferation in young mice and might contribute to the malignant transformations in the liver.	[Wang, Guo-Li; Salisbury, Elizabeth; Shi, Xiurong; Timchenko, Nikolai A.] Baylor Coll Med, Dept Pathol, Houston, TX 77030 USA; [Wang, Guo-Li; Salisbury, Elizabeth; Shi, Xiurong; Timchenko, Nikolai A.] Baylor Coll Med, Huffington Ctr Aging, Houston, TX 77030 USA; [Timchenko, Lubov] Baylor Coll Med, Dept Med, Houston, TX 77030 USA; [Medrano, Estela E.] Baylor Coll Med, Dept Mol & Cellular Biol, Houston, TX 77030 USA	Baylor College of Medicine; Baylor College of Medicine; Baylor College of Medicine; Baylor College of Medicine	Timchenko, NA (corresponding author), Baylor Coll Med, Dept Pathol, 1 Baylor Plaza, Houston, TX 77030 USA.	nikolait@bcm.tmc.edu		Salisbury, Elizabeth/0000-0003-3607-2367	National Institutes of Health [GM55188, CA100070, AG20752, AR49222, AR052781, AR44387, AG032135]; Ellison Medical Foundation; NATIONAL CANCER INSTITUTE [R01CA100070] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES [R01AR044387, R01AR049222] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON AGING [P01AG020752, R01AG032135] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Ellison Medical Foundation(Lawrence Ellison Foundation); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))	This work was supported, in whole or in part, by National Institutes of Health Grants GM55188, CA100070, and AG20752 (to N.A.T.); AR49222, AR052781, and AR44387 (to L.T.T.); and AG032135. This work was also supported by an Ellison Medical Foundation grant ( to E. E. M.). The costs of publication of this article were defrayed in part by the payment of page charges. This article must therefore be hereby marked "advertisement" in accordance with 18 U. S. C. Section 1734 solely to indicate this fact.	Bandyopadhyay D, 2004, CANCER RES, V64, P7706, DOI 10.1158/0008-5472.CAN-03-3897; Bandyopadhyay D, 2007, AGING CELL, V6, P577, DOI 10.1111/j.1474-9726.2007.00308.x; BUCHER NLR, 1964, CANCER RES, V24, P509; CHRISTY RJ, 1991, P NATL ACAD SCI USA, V88, P2593, DOI 10.1073/pnas.88.6.2593; Fausto N, 2006, HEPATOLOGY, V43, pS45, DOI 10.1002/hep.20969; FRY M, 1984, J CELL PHYSIOL, V118, P225, DOI 10.1002/jcp.1041180302; Greenbaum LE, 1998, J CLIN INVEST, V102, P996, DOI 10.1172/JCI3135; Halkidou K, 2004, PROSTATE, V59, P177, DOI 10.1002/pros.20022; Iakova P, 2003, CELL, V113, P495, DOI 10.1016/S0092-8674(03)00318-0; Johnstone RW, 2002, NAT REV DRUG DISCOV, V1, P287, DOI 10.1038/nrd772; Lindemann RK, 2004, GENE THER MOL BIOL, V8, P61; Timchenko LT, 2006, J BIOL CHEM, V281, P32806, DOI 10.1074/jbc.M605701200; Timchenko NA, 1999, NUCLEIC ACIDS RES, V27, P4517, DOI 10.1093/nar/27.22.4517; Timchenko NA, 1998, NUCLEIC ACIDS RES, V26, P3293, DOI 10.1093/nar/26.13.3293; Timchenko NA, 2005, J BIOL CHEM, V280, P20549, DOI 10.1074/jbc.M409563200; Timchenko NA, 2004, J BIOL CHEM, V279, P13129, DOI 10.1074/jbc.M312923200; Wang GL, 2004, GENE DEV, V18, P912, DOI 10.1101/gad.1183304; Wang GL, 2008, J BIOL CHEM, V283, P26169, DOI 10.1074/jbc.M803544200; Wang GL, 2007, J BIOL CHEM, V282, P1468, DOI 10.1074/jbc.M608226200; Wang HM, 2001, MOL CELL, V8, P817, DOI 10.1016/S1097-2765(01)00366-5; Zhang ZH, 2005, BREAST CANCER RES TR, V94, P11, DOI 10.1007/s10549-005-6001-1; Zuo Y, 2006, J BIOL CHEM, V281, P7960, DOI 10.1074/jbc.M510682200	22	54	56	0	4	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	SEP 19	2008	283	38					26179	26187		10.1074/jbc.M803545200	http://dx.doi.org/10.1074/jbc.M803545200			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	348GX	18622014	hybrid, Green Published			2022-12-27	WOS:000259200100046
J	Slepenkov, SV; Korneeva, NL; Rhoads, RE				Slepenkov, Sergey V.; Korneeva, Nadejda L.; Rhoads, Robert E.			Kinetic mechanism for assembly of the m(7)GpppG center dot eIF4E center dot eIF4G complex	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							CAP-BINDING PROTEIN; MESSENGER-RNA-CAP; DEPENDENT TRANSLATION INITIATION; FACTOR EIF-4E; STOPPED-FLOW; FACTOR EIF4E; FACTOR 4E; AFFINITY; ANALOGS; YEAST	Interaction of the mRNA cap with the translational machinery is a critical and early step in the initiation of protein synthesis. To better understand this process, we determined kinetic constants for the interaction of m(7)GpppG with human eIF4E by stopped-flow fluorescence quenching in the presence of a 90-amino acid fragment of human eIF4G that contains the eIF4E-binding domain (eIF4G(557-646)). The values obtained, k(on) = 179 x 10(6) M-1 s(-1) and k(off) = 79 s(-1), were the same as reported previously in the absence of an eIF4G-derived peptide. We also used surface plasmon resonance to determine kinetic constants for the binding of eIF4E to eIF4G(557-646), both in the presence and absence of m7GpppG. The results indicated that eIF4G(557-646) binds eIF4E and eIF4E center dot m7GpppG at the same rate, with k(on) = 3 x 10(6) M-1 s(-1) and k(off) = 0.01 s(-1). Our data represent the first full kinetic description of the interaction of eIF4E with its two specific ligands. The results demonstrate that the formation of the m(7)GpppG center dot eIF4E center dot eIF4G(557-646) complex obeys a sequential, random kinetic mechanism and that there is no preferential pathway for its formation. Thus, even though eIF4G(557-646) binds eIF4E tightly, it does not increase the affinity of eIF4E for m7GpppG, as has been claimed in several previous publications. We did, in fact, observe increased binding to m(7)GTP-Sepharose in the presence of eIF4G(557-646), but only with recombinant eIF4E that was prepared from inclusion bodies.	[Slepenkov, Sergey V.; Korneeva, Nadejda L.; Rhoads, Robert E.] Louisiana State Univ, Hlth Sci Ctr, Dept Biochem & Mol Biol, Shreveport, LA 71130 USA	Louisiana State University System; Louisiana State University Health Sciences Center at Shreveport	Rhoads, RE (corresponding author), 1501 Kings Highway, Shreveport, LA 71130 USA.	rrhoad@lsuhsc.edu			National Institutes of Health NIGMS [2R01GM20818]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM020818] Funding Source: NIH RePORTER	National Institutes of Health NIGMS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported, in whole or in part, by National Institutes of Health NIGMS Grant 2R01GM20818. The costs of publication of this article were defrayed in part by the payment of page charges. This article must therefore be hereby marked "advertisement" in accordance with 18 U. S. C. Section 1734 solely to indicate this fact.	Altmann M, 1997, EMBO J, V16, P1114, DOI 10.1093/emboj/16.5.1114; Berset C, 2003, RNA, V9, P871, DOI 10.1261/rna.5380903; Bevington P. R, 1969, DATA REDUCTION ERROR; Blachut-Okrasinska E, 2000, EUR BIOPHYS J BIOPHY, V29, P487, DOI 10.1007/s002490000096; Bradley CA, 2002, J BIOL CHEM, V277, P12559, DOI 10.1074/jbc.M111134200; Clark EDB, 1998, CURR OPIN BIOTECH, V9, P157; Cohen FE, 2003, NATURE, V426, P905, DOI 10.1038/nature02265; Dlugosz M, 2003, EUR BIOPHYS J BIOPHY, V31, P608, DOI 10.1007/s00249-002-0258-7; EDERY I, 1988, GENE, V74, P517, DOI 10.1016/0378-1119(88)90184-9; Fersht A., 1999, STRUCTURE MECH PROTE, DOI 10.1142/10574; Friedland DE, 2005, BIOCHEMISTRY-US, V44, P4546, DOI 10.1021/bi047645m; Gingras AC, 1999, GENE DEV, V13, P1422, DOI 10.1101/gad.13.11.1422; GOSS DJ, 1990, BIOCHIM BIOPHYS ACTA, V1050, P163, DOI 10.1016/0167-4781(90)90160-4; GOYER C, 1993, MOL CELL BIOL, V13, P4860, DOI 10.1128/MCB.13.8.4860; Gross JD, 2003, CELL, V115, P739, DOI 10.1016/S0092-8674(03)00975-9; Haghighat A, 1997, J BIOL CHEM, V272, P21677, DOI 10.1074/jbc.272.35.21677; Hershey PEC, 1999, J BIOL CHEM, V274, P21297, DOI 10.1074/jbc.274.30.21297; Kapp LD, 2004, ANNU REV BIOCHEM, V73, P657, DOI 10.1146/annurev.biochem.73.030403.080419; MADER S, 1995, MOL CELL BIOL, V15, P4990; Marcotrigiano J, 1999, MOL CELL, V3, P707, DOI 10.1016/S1097-2765(01)80003-4; Marcotrigiano J, 1997, CELL, V89, P951, DOI 10.1016/S0092-8674(00)80280-9; Matsuo H, 1997, NAT STRUCT BIOL, V4, P717, DOI 10.1038/nsb0997-717; MATTHEWS CR, 1993, ANNU REV BIOCHEM, V62, P653, DOI 10.1146/annurev.bi.62.070193.003253; Michon T, 2006, FEBS J, V273, P1312, DOI 10.1111/j.1742-4658.2006.05156.x; Monzingo AF, 2007, PLANT PHYSIOL, V143, P1504, DOI 10.1104/pp.106.093146; MORRISSEY JH, 1981, ANAL BIOCHEM, V117, P307, DOI 10.1016/0003-2697(81)90783-1; Niedzwiecka A, 2005, NUCLEOS NUCLEOT NUCL, V24, P507, DOI 10.1081/NCN-200061784; Niedzwiecka A, 2005, J PHYS-CONDENS MAT, V17, pS1483, DOI 10.1088/0953-8984/17/18/006; Niedzwiecka A, 2002, BIOCHEMISTRY-US, V41, P12140, DOI 10.1021/bi0258142; Niedzwiecka A, 2002, J MOL BIOL, V319, P615, DOI 10.1016/S0022-2836(02)00328-5; Pestova TV, 1996, MOL CELL BIOL, V16, P6870; Ptushkina M, 1998, EMBO J, V17, P4798, DOI 10.1093/emboj/17.16.4798; Rau M, 1996, J BIOL CHEM, V271, P8983, DOI 10.1074/jbc.271.15.8983; RYCHLIK W, 1986, J BIOL CHEM, V261, P71; SHA M, 1995, J BIOL CHEM, V270, P29904; Slepenkov SV, 2006, J BIOL CHEM, V281, P14927, DOI 10.1074/jbc.M601653200; Stepinski J, 2001, RNA, V7, P1486; Tomoo K, 2003, J MOL BIOL, V328, P365, DOI 10.1016/S0022-2836(03)00314-0; TRYBUS KM, 1982, BIOCHEMISTRY-US, V21, P1284, DOI 10.1021/bi00535a028; Volpon L, 2006, EMBO J, V25, P5138, DOI 10.1038/sj.emboj.7601380; von der Haar T, 2000, J BIOL CHEM, V275, P30551, DOI 10.1074/jbc.M004565200; von der Haar T, 2006, J MOL BIOL, V356, P982, DOI 10.1016/j.jmb.2005.12.034; WEBB NR, 1984, BIOCHEMISTRY-US, V23, P177, DOI 10.1021/bi00297a001	43	35	35	0	3	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	SEP 12	2008	283	37					25227	25237		10.1074/jbc.M801786200	http://dx.doi.org/10.1074/jbc.M801786200			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	345QZ	18614538	hybrid, Green Published			2022-12-27	WOS:000259012700015
J	Yin, S; Fan, X; Yu, S; Li, C; Sy, MS				Yin, Shaoman; Fan, Xingjun; Yu, Shuiliang; Li, Chaoyang; Sy, Man-Sun			Binding of recombinant but not endogenous prion protein to DNA causes DNA internalization and expression in mammalian cells	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							NUCLEIC-ACID; PLASMID DNA; SPONGIFORM ENCEPHALOPATHY; THERMODYNAMIC STABILITY; CONFORMATIONAL-CHANGES; NUCLEOCAPSID PROTEIN; INSERTION MUTATIONS; HORIZONTAL TRANSFER; APOPTOTIC BODIES; SCRAPIE PRION	Recombinant prion protein, rPrP, binds DNA. Both the KKRPK motif and the octapeptide repeat region of rPrP are essential for maximal binding. rPrP with pathogenic insertional mutations binds more DNA than wild-type rPrP. DNA promotes the aggregation of rPrP and protects its N terminus from proteinase K digestion. When rPrP is mixed with an expression plasmid and Ca2+, the rPrP center dot DNA complex is taken up by mammalian cells leading to gene expression. In the presence of Ca2+, rPrP by itself is also taken up by cells in a temperature- and pinocytosis-dependent manner. Cells do not take up rPrP(Delta KKRPK), which lacks the KKRPK motif. Thus, rPrP is the carrier for DNA and the KKRPK motif is essential for its uptake. When mixed with DNA, a pentapeptide KKRPK, but not KKKKK, is sufficient for DNA internalization and expression. In contrast, whereas the normal cellular prion protein, PrPC, on the cell surface can also internalize DNA, the imported DNA is not expressed. These findings may have relevance to the normal functions of PrPC and the pathogenic mechanisms of human prion disease.	[Yin, Shaoman; Fan, Xingjun; Yu, Shuiliang; Li, Chaoyang; Sy, Man-Sun] Case Western Reserve Univ, Sch Med, Dept Pathol, Cleveland, OH 44106 USA	Case Western Reserve University	Sy, MS (corresponding author), Case Western Reserve Univ, Sch Med, Dept Pathol, Rm 5131,Wolstein Res Bldg,2103 Cornell Rd, Cleveland, OH 44106 USA.	mxs92@po.cwru.edu			National Institutes of Health [NS-045981-01]; United States Department of Army [DAMD17-03-1-0286]; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS045981] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); United States Department of Army; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	This work was supported, in whole or in part, by National Institutes of Health Grant NS-045981-01 (to M. S. S.). This work was also supported by United States Department of Army Contract DAMD17-03-1-0286 (to M. S. S.). The costs of publication of this article were defrayed in part by the payment of page charges. This article must therefore be hereby marked "advertisement" in accordance with 18 U. S. C. Section 1734 solely to indicate this fact.	Belting M, 2005, ADV DRUG DELIVER REV, V57, P505, DOI 10.1016/j.addr.2004.10.004; Bergsmedh A, 2001, P NATL ACAD SCI USA, V98, P6407, DOI 10.1073/pnas.101129998; BOLTON DC, 1982, SCIENCE, V218, P1309, DOI 10.1126/science.6815801; Cappai R, 1999, BIOCHEMISTRY-US, V38, P3280, DOI 10.1021/bi982328z; CAUGHEY B, 1994, ANN NY ACAD SCI, V724, P290, DOI 10.1111/j.1749-6632.1994.tb38918.x; Caughey B, 2006, NATURE, V443, P803, DOI 10.1038/nature05294; CHEN C, 1987, MOL CELL BIOL, V7, P2745, DOI 10.1128/MCB.7.8.2745; Cohen FE, 1999, J MOL BIOL, V293, P313, DOI 10.1006/jmbi.1999.2990; Deleault NR, 2005, J BIOL CHEM, V280, P26873, DOI 10.1074/jbc.M503973200; Deleault NR, 2003, NATURE, V425, P717, DOI 10.1038/nature01979; Doh-Ura K, 2004, J VIROL, V78, P4999, DOI 10.1128/JVI.78.10.4999-5006.2004; Donnelly JJ, 1997, ANNU REV IMMUNOL, V15, P617, DOI 10.1146/annurev.immunol.15.1.617; Edenhofer F, 1996, J VIROL, V70, P4724, DOI 10.1128/JVI.70.7.4724-4728.1996; Esser D, 2000, NAT BIOTECHNOL, V18, P1211, DOI 10.1038/81221; Feraudet C, 2005, J BIOL CHEM, V280, P11247, DOI 10.1074/jbc.M407006200; Fritz JD, 1996, HUM GENE THER, V7, P1395, DOI 10.1089/hum.1996.7.12-1395; Gabus C, 2001, J BIOL CHEM, V276, P19301, DOI 10.1074/jbc.M009754200; Gabus C, 2001, J MOL BIOL, V307, P1011, DOI 10.1006/jmbi.2001.4544; GRIFFITH JS, 1967, NATURE, V215, P1043, DOI 10.1038/2151043a0; Gu YP, 2003, NEUROBIOL DIS, V12, P133, DOI 10.1016/S0969-9961(02)00014-1; Hijazi N, 2005, J BIOL CHEM, V280, P17057, DOI 10.1074/jbc.M411314200; Holmgren L, 2002, VOX SANG, V83, P305, DOI 10.1111/j.1423-0410.2002.tb05323.x; HSIAO K, 1990, NEUROLOGY, V40, P1820, DOI 10.1212/WNL.40.12.1820; Huang Z, 1996, CURR TOP MICROBIOL, V207, P49; Ignatovich IA, 2003, J BIOL CHEM, V278, P42625, DOI 10.1074/jbc.M301431200; Jones EM, 2005, CELL, V121, P63, DOI 10.1016/j.cell.2005.01.034; Karpuj MV, 2007, MOL MED, V13, P190, DOI 10.2119/2006-00073.Karpuj; Kim NH, 2005, FASEB J, V19, P783, DOI 10.1096/fj.04-2117fje; King DJ, 2007, J MOL BIOL, V369, P1001, DOI 10.1016/j.jmb.2007.02.004; Li CY, 2007, BIOCHEM J, V406, P333, DOI 10.1042/BJ20061857; Liemann S, 1999, BIOCHEMISTRY-US, V38, P3258, DOI 10.1021/bi982714g; Magzoub M, 2006, BIOCHEM BIOPH RES CO, V348, P379, DOI 10.1016/j.bbrc.2006.07.065; Mukherjee S, 1997, PHYSIOL REV, V77, P759, DOI 10.1152/physrev.1997.77.3.759; Nandi PK, 2004, J MOL BIOL, V344, P827, DOI 10.1016/j.jmb.2004.09.080; Nandi PK, 1999, ARCH VIROL, V144, P1751, DOI 10.1007/s007050050702; Nandi PK, 2002, J MOL BIOL, V322, P153, DOI 10.1016/S0022-2836(02)00750-7; NARANG HK, 1988, P NATL ACAD SCI USA, V85, P3575, DOI 10.1073/pnas.85.10.3575; Pan T, 2002, BIOCHEM J, V368, P81, DOI 10.1042/BJ20020773; Prusiner SB, 1998, P NATL ACAD SCI USA, V95, P13363, DOI 10.1073/pnas.95.23.13363; Qin KF, 2000, J BIOL CHEM, V275, P19121, DOI 10.1074/jbc.275.25.19121; Rhie A, 2003, J BIOL CHEM, V278, P39697, DOI 10.1074/jbc.M305297200; Ross CA, 2004, NAT MED, V10, pS10, DOI 10.1038/nm1066; Sanghera N, 2002, J MOL BIOL, V315, P1241, DOI 10.1006/jmbi.2001.5322; Sethi S, 2002, LANCET, V360, P229, DOI 10.1016/S0140-6736(02)09513-2; SHYNG SL, 1994, J CELL BIOL, V125, P1239, DOI 10.1083/jcb.125.6.1239; Silva JL, 2008, TRENDS BIOCHEM SCI, V33, P132, DOI 10.1016/j.tibs.2007.11.003; Sloots A, 2005, FEBS J, V272, P4221, DOI 10.1111/j.1742-4658.2005.04834.x; Swietnicki W, 1998, J BIOL CHEM, V273, P31048, DOI 10.1074/jbc.273.47.31048; TAGLIAVINI F, 1991, EMBO J, V10, P513, DOI 10.1002/j.1460-2075.1991.tb07977.x; TELLING GC, 1995, CELL, V83, P79, DOI 10.1016/0092-8674(95)90236-8; Lima LMTR, 2006, BIOCHEMISTRY-US, V45, P9180, DOI 10.1021/bi060532d; Vey M, 1996, P NATL ACAD SCI USA, V93, P14945, DOI 10.1073/pnas.93.25.14945; Wadsworth JD, 2003, BRIT MED BULL, V66, P241, DOI 10.1093/bmb/66.1.241; WALTERS MNI, 1978, CRC CR REV TOXICOL, V5, P377, DOI 10.3109/10408447809081012; Wang F, 2007, BIOCHEMISTRY-US, V46, P7045, DOI 10.1021/bi700299h; Weiss S, 1997, J VIROL, V71, P8790, DOI 10.1128/JVI.71.11.8790-8797.1997; Wittrup A, 2007, J BIOL CHEM, V282, P27897, DOI 10.1074/jbc.M701611200; Wong C, 2001, EMBO J, V20, P377, DOI 10.1093/emboj/20.3.377; YAMAGUCHI H, 1965, J BIOCHEM, V57, P667; Yin SM, 2007, P NATL ACAD SCI USA, V104, P7546, DOI 10.1073/pnas.0610827104; Yin SM, 2006, J BIOL CHEM, V281, P10698, DOI 10.1074/jbc.M511819200; Yin SM, 2003, PROTEIN EXPRES PURIF, V32, P104, DOI 10.1016/S1046-5928(03)00195-5; Yu SL, 2007, BIOCHEM J, V403, P343, DOI 10.1042/BJ20061592; Zanusso G, 1998, P NATL ACAD SCI USA, V95, P8812, DOI 10.1073/pnas.95.15.8812; Zhang YB, 2000, J BIOL CHEM, V275, P33650, DOI 10.1074/jbc.C000483200	65	22	22	0	5	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	SEP 12	2008	283	37					25446	25454		10.1074/jbc.M800814200	http://dx.doi.org/10.1074/jbc.M800814200			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	345QZ	18622017	hybrid, Green Published			2022-12-27	WOS:000259012700040
J	Hoffert, JD; Fenton, RA; Moeller, HB; Simons, B; Tchapyjnikov, D; McDill, BW; Yu, MJ; Pisitkun, T; Chen, F; Knepper, MA				Hoffert, Jason D.; Fenton, Robert A.; Moeller, Hanne B.; Simons, Brigitte; Tchapyjnikov, Dmitry; McDill, Bradley W.; Yu, Ming-Jiun; Pisitkun, Trairak; Chen, Feng; Knepper, Mark A.			Vasopressin-stimulated increase in phosphorylation at Ser(269) potentiates plasma membrane retention of aquaporin-2	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							KIDNEY COLLECTING DUCT; WATER CHANNEL; RAT; PERMEABILITY; ENDOCYTOSIS; PROTEIN; CELLS; TRAFFICKING; KINASE; LOCALIZATION	Vasopressin controls water excretion through regulation of aquaporin-2 (AQP2) trafficking in renal collecting duct cells. Using mass spectrometry, we previously demonstrated four phosphorylated serines (Ser(256), Ser(261), Ser(264), and Ser(269)) in the carboxyl-terminal tail of rat AQP2. Here, we used phospho-specific antibodies and protein mass spectrometry to investigate the roles of vasopressin and cyclic AMP in the regulation of phosphorylation at Ser(269) and addressed the role of this site in AQP2 trafficking. The V2 receptor-specific vasopressin analog dDAVP increased Ser(P)(269)-AQP2 abundance more than 10-fold, but at a rate much slower than the corresponding increase in Ser(256) phosphorylation. Vasopressin-mediated changes in phosphorylation at both sites were mimicked by cAMP addition and inhibited by protein kinase A (PKA) antagonists. In vitro kinase assays, however, demonstrated that PKA phosphorylates Ser(256), but not Ser(269). Phosphorylation of AQP2 at Ser(269) did not occur when Ser(256) was replaced by an unphosphorylatable amino acid, as seen in both S256L-AQP2 mutant mice and in Madin-Darby canine kidney cells expressing an S256A mutant, suggesting that Ser(269) phosphorylation depends upon prior phosphorylation at Ser256. Immunogold electron microscopy localized Ser(P)(269)-AQP2 solely in the apical plasma membrane of rat collecting duct cells, in contrast to the other three phospho-forms (found in both apical plasma membrane and intracellular vesicles). Madin-Darby canine kidney cells expressing an S269D "phosphomimic" AQP2 mutant showed constitutive localization at the plasma membrane. The data support a model in which vasopressin-mediated phosphorylation of AQP2 at Ser(269): (a) depends on prior PKA-mediated phosphorylation of Ser(256) and (b) enhances apical plasma membrane retention of AQP2.	[Hoffert, Jason D.; Simons, Brigitte; Tchapyjnikov, Dmitry; Yu, Ming-Jiun; Pisitkun, Trairak; Knepper, Mark A.] NHLBI, NIH, Bethesda, MD 20892 USA; [Fenton, Robert A.; Moeller, Hanne B.] Univ Aarhus, Water & Salt Res Ctr, DK-8000 Aarhus, Denmark; [Simons, Brigitte] Appl Biosyst MDS Sciex, Concord, ON L4K 4V8, Canada; [McDill, Bradley W.; Chen, Feng] Washington Univ, Sch Med, Dept Internal Med, St Louis, MO 63110 USA	National Institutes of Health (NIH) - USA; NIH National Heart Lung & Blood Institute (NHLBI); Aarhus University; Thermo Fisher Scientific; Applied Biosystems; Washington University (WUSTL)	Knepper, MA (corresponding author), NHLBI, NIH, 10 Ctr Dr,Bldg 10,Rm 6N260, Bethesda, MD 20892 USA.	KnepperM@nhlbi.nih.gov	Fenton, Robert/AFR-6983-2022; Fenton, Robert A/ABD-9824-2021; Knepper, Mark/AAF-8412-2020	Fenton, Robert/0000-0003-1623-199X; YU, MING-JIUN/0000-0003-0393-4696; Tchapyjnikov, Dmitry/0000-0001-5649-5880; Pisitkun, Trairak/0000-0001-6677-2271	National Institutes of Health [RO1DK067386, P30DK079333]; NHLBI [Z01-HL001285]; Danish National Research Foundation (Danmarks Grundforskningsfond); Department of Internal Medicine/Renal Division at Washington University School of Medicine; March of Dimes Award [FY06-343]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [ZIAHL001285] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK067386, P30DK079333] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NHLBI(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); Danish National Research Foundation (Danmarks Grundforskningsfond)(Danmarks Grundforskningsfond); Department of Internal Medicine/Renal Division at Washington University School of Medicine; March of Dimes Award(March of Dimes); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	This work was supported, in whole or in part, by National Institutes of Health Grants RO1DK067386 and P30DK079333 (to F. C.) and by NHLBI, National Institutes of Health Intramural Budget Project Z01-HL001285 (to J. D. H., M. Y., T. P., and M. A. K.). This work was also supported by a Marie Curie Intra-European Fellowship and funds from the Danish National Research Foundation (Danmarks Grundforskningsfond) (to R. A. F.) and by funds from the Department of Internal Medicine/Renal Division at Washington University School of Medicine and March of Dimes Award FY06-343 (to F. C.). The costs of publication of this article were defrayed in part by the payment of page charges. This article must therefore be hereby marked "advertisement" in accordance with 18 U. S. C. Section 1734 solely to indicate this fact.	Bonifacino JS, 2003, ANNU REV BIOCHEM, V72, P395, DOI 10.1146/annurev.biochem.72.121801.161800; Brown D, 2003, AM J PHYSIOL-RENAL, V284, pF893, DOI 10.1152/ajprenal.00387.2002; Chetkovich DM, 2002, J NEUROSCI, V22, P5791; Choi J, 2002, J BIOL CHEM, V277, P12359, DOI 10.1074/jbc.M200528200; CHOU CL, 1995, AM J PHYSIOL-RENAL, V269, pF78, DOI 10.1152/ajprenal.1995.269.1.F78; Chou CL, 2004, J BIOL CHEM, V279, P49026, DOI 10.1074/jbc.M408565200; Cohen P, 2001, NAT REV MOL CELL BIO, V2, P769, DOI 10.1038/35096075; DIGIOVANNI SR, 1994, P NATL ACAD SCI USA, V91, P8984, DOI 10.1073/pnas.91.19.8984; Fenton RA, 2008, P NATL ACAD SCI USA, V105, P3134, DOI 10.1073/pnas.0712338105; Ferraris JD, 2002, P NATL ACAD SCI USA, V99, P16800, DOI 10.1073/pnas.222659799; Frohlich O, 2004, AM J PHYSIOL-CELL PH, V286, pC1264, DOI 10.1152/ajpcell.00499.2003; Frokiaer J, 1999, AM J PHYSIOL-RENAL, V276, pF179; Fushimi K, 1997, J BIOL CHEM, V272, P14800, DOI 10.1074/jbc.272.23.14800; FUSHIMI K, 1993, NATURE, V361, P549, DOI 10.1038/361549a0; Gustafson CE, 2000, AM J PHYSIOL-RENAL, V278, pF317, DOI 10.1152/ajprenal.2000.278.2.F317; Hoffert JD, 2007, J PROTEOME RES, V6, P3501, DOI 10.1021/pr0701153; Hoffert JD, 2007, AM J PHYSIOL-RENAL, V292, pF691, DOI 10.1152/ajprenal.00284.2006; Hoffert JD, 2006, P NATL ACAD SCI USA, V103, P7159, DOI 10.1073/pnas.0600895103; Kamsteeg EJ, 2000, J CELL BIOL, V151, P919, DOI 10.1083/jcb.151.4.919; Kamsteeg EJ, 2006, P NATL ACAD SCI USA, V103, P18344, DOI 10.1073/pnas.0604073103; Katsura T, 1997, Am J Physiol, V272, pF817; KNEPPER MA, 1993, AM J PHYSIOL, V265, pF214, DOI 10.1152/ajprenal.1993.265.2.F214; Knepper MA, 2001, ACTA PHYSIOL SCAND, V173, P11, DOI 10.1046/j.1365-201X.2001.00880.x; Kozono D, 2002, J CLIN INVEST, V109, P1395, DOI 10.1172/JCI200215851; KUWAHARA M, 1995, J BIOL CHEM, V270, P10384, DOI 10.1074/jbc.270.18.10384; LAEMMLI UK, 1970, NATURE, V227, P680, DOI 10.1038/227680a0; Lande MB, 1996, J BIOL CHEM, V271, P5552, DOI 10.1074/jbc.271.10.5552; Liu CM, 2002, CELL, V108, P837, DOI 10.1016/S0092-8674(02)00685-2; Lu H, 2004, AM J PHYSIOL-RENAL, V286, pF233, DOI 10.1152/ajprenal.00179.2003; Lu HAJ, 2007, J BIOL CHEM, V282, P28721, DOI 10.1074/jbc.M611101200; McDill BW, 2006, P NATL ACAD SCI USA, V103, P6952, DOI 10.1073/pnas.0602087103; NIELSEN S, 1993, AM J PHYSIOL, V265, pF204, DOI 10.1152/ajprenal.1993.265.2.F204; Nielsen S, 2002, PHYSIOL REV, V82, P205, DOI 10.1152/physrev.00024.2001; NIELSEN S, 1995, P NATL ACAD SCI USA, V92, P1013, DOI 10.1073/pnas.92.4.1013; Nishimoto G, 1999, AM J PHYSIOL-RENAL, V276, pF254, DOI 10.1152/ajprenal.1999.276.2.F254; Noda Y, 2004, FEBS LETT, V568, P139, DOI 10.1016/j.febslet.2004.05.021; Pisitkun T, 2007, PHYSIOLOGY, V22, P390, DOI 10.1152/physiol.00025.2007; Robben JH, 2006, AM J PHYSIOL-RENAL, V291, pF257, DOI 10.1152/ajprenal.00491.2005; Stefan E, 2007, J AM SOC NEPHROL, V18, P199, DOI 10.1681/ASN.2006020132; Sun TX, 2002, AM J PHYSIOL-RENAL, V282, pF998, DOI 10.1152/ajprenal.00257.2001; van Balkom BWM, 2004, AM J PHYSIOL-CELL PH, V286, pC372, DOI 10.1152/ajpcell.00271.2003; Wang H, 2006, J BIOL CHEM, V281, P14129, DOI 10.1074/jbc.M512511200; Yu MJ, 2006, MOL CELL PROTEOMICS, V5, P2131, DOI 10.1074/mcp.M600177-MCP200	43	183	186	0	11	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	SEP 5	2008	283	36					24617	24627		10.1074/jbc.M803074200	http://dx.doi.org/10.1074/jbc.M803074200			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	342YR	18606813	hybrid, Green Published			2022-12-27	WOS:000258820000034
J	Kawashima, Y; Miyazaki, E; Muller, M; Tokuda, H; Nishiyama, K				Kawashima, Yosuke; Miyazaki, Emi; Mueller, Matthias; Tokuda, Hajime; Nishiyama, Ken-ichi			Diacylglycerol specifically blocks spontaneous integration of membrane proteins and allows detection of a factor-assisted integration	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							M13 PROCOAT PROTEIN; F1F0 ATP SYNTHASE; PF3 COAT PROTEIN; ESCHERICHIA-COLI; SUBUNIT-C; PURIFIED COMPONENTS; DIGLYCERIDE KINASE; BOUND PHOSPHATASES; MANNITOL PERMEASE; PLASMA-MEMBRANE	We recently found that the spontaneous integration of M13 procoat is blocked by diacylglycerol (DAG) (Nishiyama, K., Ikegami, A., Moser, M., Schiltz, E., Tokuda, H., and Muller, M. (2006) J. Biol. Chem. 281, 35667-35676). Here, we demonstrate that the spontaneous integration of Pf3 coat, another membrane protein that has been thought to be integrated spontaneously into liposomes, can be blocked by DAG at physiological concentrations. Moreover, the spontaneous integration of the membrane potential-independent version of Pf3 coat (3L-Pf3 coat), which is independent of YidC, was also blocked by DAG. To clarify the mechanism by which DAG blocks spontaneous integration, we examined lipid compounds similar to DAG and DAG derivatives. The blockage of spontaneous integration was specific to DAG, as fatty acids, monoacylglycerol, and phosphatidic acids were not effective for the blockage. When the acyl chains in DAG were shortened even to octanoyl residues, it still blocked spontaneous integration, whereas diheptanoylglycerol did not block it at all. Triacylglycerol was more effective than DAG. However, the lipid A-derivative-dependent integration of M13 procoat could not be reconstituted when triacylglycerol was included in the liposomes. On the other hand, when DAG was included in the liposomes, we found that the integration of 3L-Pf3 coat was strictly dependent on the lipid A-derived integration factor. We propose that the bulky structure of DAG rather than changes in membrane curvature is essential for the blockage of spontaneous integration. We also demonstrated that the blockage of spontaneous integration by DAG is also operative in native membrane vesicles.	[Kawashima, Yosuke; Miyazaki, Emi; Tokuda, Hajime; Nishiyama, Ken-ichi] Univ Tokyo, Inst Mol & Cellular Biosci, Tokyo 1130032, Japan; [Mueller, Matthias] Univ Freiburg, Inst Biochem & Mol Biol, Zentrum Biochem & Mol Zellforsch, D-79104 Freiburg, Germany	University of Tokyo; University of Freiburg	Nishiyama, K (corresponding author), Univ Tokyo, Inst Mol & Cellular Biosci, Tokyo 1130032, Japan.	unishiy@mail.ecc.u-tokyo.ac.jp			Ministry of Education, Culture, Sports, Science and Technology of Japan	Ministry of Education, Culture, Sports, Science and Technology of Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT))	This work was supported by grants-in-aid for Scientific Research from the Ministry of Education, Culture, Sports, Science and Technology of Japan.	AKIMARU J, 1991, P NATL ACAD SCI USA, V88, P6545, DOI 10.1073/pnas.88.15.6545; Alami M, 2002, J BIOL CHEM, V277, P20499, DOI 10.1074/jbc.M201711200; Baba T, 2006, MOL SYST BIOL, V2, DOI 10.1038/msb4100050; Beck K, 2001, EMBO REP, V2, P709, DOI 10.1093/embo-reports/kve154; CASADABAN MJ, 1976, J MOL BIOL, V104, P541, DOI 10.1016/0022-2836(76)90119-4; Chen MY, 2002, J BIOL CHEM, V277, P7670, DOI 10.1074/jbc.M110644200; CHEREPANOV PP, 1995, GENE, V158, P9, DOI 10.1016/0378-1119(95)00193-A; Datsenko KA, 2000, P NATL ACAD SCI USA, V97, P6640, DOI 10.1073/pnas.120163297; DEBOECK H, 1992, BIOCHEMISTRY-US, V31, P623, DOI 10.1021/bi00117a046; FIEDLER W, 1985, J BIOL CHEM, V260, P4799; FUNK CR, 1992, J BACTERIOL, V174, P205, DOI 10.1128/jb.174.1.205-213.1992; GELLER BL, 1985, J BIOL CHEM, V260, P3281; HOFFSCHUTE HK, 1994, J BIOL CHEM, V269, P12833; HUSSAIN M, 1980, J BIOL CHEM, V255, P3707; ICHO T, 1983, J BACTERIOL, V153, P722, DOI 10.1128/JB.153.2.722-730.1983; ICHO T, 1988, J BACTERIOL, V170, P5117, DOI 10.1128/jb.170.11.5117-5124.1988; JACKSON BJ, 1984, J BACTERIOL, V160, P976, DOI 10.1128/JB.160.3.976-981.1984; Kiefer D, 1999, EMBO J, V18, P6299, DOI 10.1093/emboj/18.22.6299; Koch HG, 2000, J CELL BIOL, V150, P689, DOI 10.1083/jcb.150.3.689; Koch HG, 1999, MOL BIOL CELL, V10, P2163, DOI 10.1091/mbc.10.7.2163; Kol S, 2006, J BIOL CHEM, V281, P29762, DOI 10.1074/jbc.M605317200; KUHN A, 1985, J BIOL CHEM, V260, P5914; KUHN A, 1995, FEMS MICROBIOL REV, V17, P185; Luirink J, 2005, ANNU REV MICROBIOL, V59, P329, DOI 10.1146/annurev.micro.59.030804.121246; MULLER M, 1984, P NATL ACAD SCI-BIOL, V81, P7421, DOI 10.1073/pnas.81.23.7421; Nishiyama KI, 2006, J BIOL CHEM, V281, P35667, DOI 10.1074/jbc.M608228200; RAETZ CRH, 1978, J BIOL CHEM, V253, P3882; RAETZ CRH, 1978, MICROBIOL REV, V42, P614, DOI 10.1128/MMBR.42.3.614-659.1978; Reynolds CM, 2005, J BIOL CHEM, V280, P21202, DOI 10.1074/jbc.M500964200; ROHRER J, 1990, SCIENCE, V250, P1418, DOI 10.1126/science.2124001; ROTERING H, 1983, J BIOL CHEM, V258, P8068; Samuelson JC, 2000, NATURE, V406, P637, DOI 10.1038/35020586; Samuelson JC, 2001, J BIOL CHEM, V276, P34847, DOI 10.1074/jbc.M105793200; Serek J, 2004, EMBO J, V23, P294, DOI 10.1038/sj.emboj.7600063; SHIBUI T, 1988, AGR BIOL CHEM TOKYO, V52, P983; Soekarjo M, 1996, BIOCHEMISTRY-US, V35, P1232, DOI 10.1021/bi951087h; SUGIYAMA JE, 1991, P NATL ACAD SCI USA, V88, P9603, DOI 10.1073/pnas.88.21.9603; SZOKA F, 1978, P NATL ACAD SCI USA, V75, P4194, DOI 10.1073/pnas.75.9.4194; van der Laan M, 2004, J CELL BIOL, V165, P213, DOI 10.1083/jcb.200402100; van der Laan M, 2003, P NATL ACAD SCI USA, V100, P5801, DOI 10.1073/pnas.0636761100; Vervoort EB, 2005, J MOL BIOL, V346, P733, DOI 10.1016/j.jmb.2004.12.011; WOLFE PB, 1985, J BIOL CHEM, V260, P1836; Yi L, 2004, J BIOL CHEM, V279, P39260, DOI 10.1074/jbc.M405490200; Zhou C, 1997, BBA-LIPID LIPID MET, V1348, P273, DOI 10.1016/S0005-2760(97)00066-0	44	35	35	0	3	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	SEP 5	2008	283	36					24489	24496		10.1074/jbc.M801812200	http://dx.doi.org/10.1074/jbc.M801812200			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	342YR	18614537	Green Published, hybrid			2022-12-27	WOS:000258820000024
J	Choi, E; Dial, JM; Jeong, DE; Hall, MC				Choi, Eunyoung; Dial, J. Michael; Jeong, Dah-Eun; Hall, Mark C.			Unique D box and KEN box sequences limit ubiquitination of Acm1 and promote pseudosubstrate inhibition of the anaphase-promoting complex	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							SISTER-CHROMATID SEPARATION; DESTRUCTION BOX; BUDDING YEAST; SUBSTRATE RECOGNITION; FISSION YEAST; CELL-CYCLE; SACCHAROMYCES-CEREVISIAE; DEPENDENT DEGRADATION; AURORA-A; APC/C	The anaphase-promoting complex (APC) regulates cell division in eukaryotes by targeting specific proteins for destruction. APC substrates generally contain one or more short degron sequences that help mediate their recognition and poly- ubiquitination by the APC. The most common and well characterized degrons are the destruction box ( D box) and the KEN box. The budding yeast Acm1 protein, an inhibitor of Cdh1- activated APC ( APCCdh1) also contains several conserved D and KEN boxes, and here we report that two of these located in the central region of Acm1 constitute a pseudosubstrate sequence required for APCCdh1 inhibition. Acm1 interacted with and inhibited substrate binding to the WD40 repeat domain of Cdh1. Combined mutation of the central D and KEN boxes strongly reduced both binding to the Cdh1 WD40 domain and APCCdh1 inhibition. Despite this, the double mutant, but not wild- type Acm1, was poly- ubiquitinated by APCCdh1 in vitro. Thus, unlike substrates in which D and KEN boxes promote ubiquitination, these same elements in the central region of Acm1 prevent ubiquitination. We propose that this unique property of the Acm1 degron sequences results from an unusually high affinity interaction with the substrate receptor site on theWD40domain of Cdh1 that may serve both to promote APC inhibition and protect Acm1 from destruction.	[Choi, Eunyoung; Jeong, Dah-Eun; Hall, Mark C.] Purdue Univ, Dept Biochem, W Lafayette, IN 47907 USA; [Hall, Mark C.] Purdue Univ, Purdue Canc Ctr, W Lafayette, IN 47907 USA; [Dial, J. Michael] Univ N Carolina, Dept Biochem & Biophys, Chapel Hill, NC 27599 USA	Purdue University System; Purdue University; Purdue University West Lafayette Campus; Purdue University System; Purdue University; Purdue University West Lafayette Campus; University of North Carolina; University of North Carolina Chapel Hill	Hall, MC (corresponding author), Purdue Univ, Dept Biochem, 175 S Univ St, W Lafayette, IN 47907 USA.	mchall@purdue.edu	Hall, Mark C./D-1698-2011	Hall, Mark/0000-0001-6429-2506				Burton JL, 2007, GENE DEV, V21, P655, DOI 10.1101/gad.1511107; Burton JL, 2005, MOL CELL, V18, P533, DOI 10.1016/j.molcel.2005.04.022; Burton JL, 2001, GENE DEV, V15, P2381, DOI 10.1101/gad.917901; Carroll CW, 2005, METHOD ENZYMOL, V398, P219, DOI 10.1016/S0076-6879(05)98018-X; Carroll CW, 2005, CURR BIOL, V15, P11, DOI 10.1016/j.cub.2004.12.066; Castro A, 2003, MOL CELL BIOL, V23, P4126, DOI 10.1128/MCB.23.12.4126-4138.2003; Castro A, 2002, EMBO REP, V3, P1209, DOI 10.1093/embo-reports/kvf241; CohenFix O, 1996, GENE DEV, V10, P3081, DOI 10.1101/gad.10.24.3081; Crasta K, 2008, NAT CELL BIOL, V10, P665, DOI 10.1038/ncb1729; Dial JM, 2007, J BIOL CHEM, V282, P5237, DOI 10.1074/jbc.M606589200; Enquist-Newman M, 2008, MOL CELL, V30, P437, DOI 10.1016/j.molcel.2008.04.004; Eytan E, 2006, P NATL ACAD SCI USA, V103, P2081, DOI 10.1073/pnas.0510695103; Funabiki H, 1996, NATURE, V381, P438, DOI 10.1038/381438a0; GLOTZER M, 1991, NATURE, V349, P132, DOI 10.1038/349132a0; Hagting A, 2002, J CELL BIOL, V157, P1125, DOI 10.1083/jcb.200111001; Hall MC, 2008, J BIOL CHEM, V283, P10396, DOI 10.1074/jbc.M710011200; Hall MC, 2004, CELL CYCLE, V3, P1278, DOI 10.4161/cc.3.10.1153; Hall MC, 2003, J BIOL CHEM, V278, P16698, DOI 10.1074/jbc.M213109200; Hayes MJ, 2006, NAT CELL BIOL, V8, P607, DOI 10.1038/ncb1410; Hendrickson C, 2001, CURR BIOL, V11, P1781, DOI 10.1016/S0960-9822(01)00564-4; Hershko A, 1998, ANNU REV BIOCHEM, V67, P425, DOI 10.1146/annurev.biochem.67.1.425; Hilioti Z, 2001, CURR BIOL, V11, P1347, DOI 10.1016/S0960-9822(01)00399-2; HOLLOWAY SL, 1993, CELL, V73, P1393, DOI 10.1016/0092-8674(93)90364-V; Izawa D, 2005, NATURE, V434, P529, DOI 10.1038/nature03406; Jin LY, 2008, CELL, V133, P653, DOI 10.1016/j.cell.2008.04.012; KEMP BE, 1989, CELL SIGNAL, V1, P303, DOI 10.1016/0898-6568(89)90049-1; Kimata Y, 2008, DEV CELL, V14, P446, DOI 10.1016/j.devcel.2007.12.010; King EMJ, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000342; Kraft C, 2005, MOL CELL, V18, P543, DOI 10.1016/j.molcel.2005.04.023; Lehman NL, 2007, AM J PATHOL, V170, P1793, DOI 10.2353/ajpath.2007.060767; Leismann O, 2000, GENE DEV, V14, P2192, DOI 10.1101/gad.176700; Littlepage LE, 2002, GENE DEV, V16, P2274, DOI 10.1101/gad.1007302; Marangos P, 2008, NAT CELL BIOL, V10, P445, DOI 10.1038/ncb1707; Martinez JS, 2006, MOL CELL BIOL, V26, P9162, DOI 10.1128/MCB.00603-06; Miller JJ, 2006, GENE DEV, V20, P2410, DOI 10.1101/gad.1454006; OSTAPENKO D, 2008, MOL CELL BI IN PRESS; Passmore LA, 2005, METHOD ENZYMOL, V398, P195, DOI 10.1016/S0076-6879(05)98017-8; Passmore LA, 2005, EMBO REP, V6, P873, DOI 10.1038/sj.embor.7400482; Passmore LA, 2003, EMBO J, V22, P786, DOI 10.1093/emboj/cdg084; Peters JM, 2002, MOL CELL, V9, P931, DOI 10.1016/S1097-2765(02)00540-3; Pfleger CM, 2000, GENE DEV, V14, P655; Pfleger CM, 2001, GENE DEV, V15, P2396, DOI 10.1101/gad.918201; Rape M, 2006, CELL, V124, P89, DOI 10.1016/j.cell.2005.10.032; Reimann JDR, 2001, GENE DEV, V15, P3278, DOI 10.1101/gad.945701; Reis A, 2006, EMBO REP, V7, P1040, DOI 10.1038/sj.embor.7400772; Schwab M, 2001, EMBO J, V20, P5165, DOI 10.1093/emboj/20.18.5165; Schwab M, 1997, CELL, V90, P683, DOI 10.1016/S0092-8674(00)80529-2; SIGRIST S, 1995, EMBO J, V14, P4827, DOI 10.1002/j.1460-2075.1995.tb00164.x; Sorensen CS, 2001, MOL CELL BIOL, V21, P3692, DOI 10.1128/MCB.21.11.3692-3703.2001; Sullivan M, 2007, J BIOL CHEM, V282, P19710, DOI 10.1074/jbc.M701507200; SURANA U, 1993, EMBO J, V12, P1969, DOI 10.1002/j.1460-2075.1993.tb05846.x; Visintin R, 1997, SCIENCE, V278, P460, DOI 10.1126/science.278.5337.460; Vodermaier HC, 2001, CURR BIOL, V11, pR834, DOI 10.1016/S0960-9822(01)00498-5; Woodbury EL, 2007, NAT CELL BIOL, V9, P106, DOI 10.1038/ncb1523; Yamano H, 2004, MOL CELL, V13, P137, DOI 10.1016/S1097-2765(03)00480-5; Zur A, 2002, EMBO J, V21, P4500, DOI 10.1093/emboj/cdf452	56	31	31	0	1	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	AUG 29	2008	283	35					23701	23710		10.1074/jbc.M803695200	http://dx.doi.org/10.1074/jbc.M803695200			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	340II	18596038	Green Published, hybrid			2022-12-27	WOS:000258638900024
J	Rozeboom, HJ; Bjerkan, TM; Kalk, KH; Ertesvag, H; Holtan, S; Aachmann, FL; Valla, S; Dijkstra, BW				Rozeboom, Henriette J.; Bjerkan, Tonje M.; Kalk, Kor H.; Ertesvag, Helga; Holtan, Synnove; Aachmann, Finn L.; Valla, Svein; Dijkstra, Bauke W.			Structural and mutational characterization of the catalytic A-module of the mannuronan C-5-epimerase AlgE4 from Azotobacter vinelandii	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ALGINATE LYASE A1-III; CRYSTAL-STRUCTURE; ACTIVE-SITE; SECONDARY STRUCTURE; C-5 EPIMERASES; PROTEIN; EPIMERIZATION; PATTERN; FAMILY; GENES	Alginate is a family of linear copolymers of (1 -> 4)-linked beta-D-mannuronic acid and its C-5 epimer alpha-L-guluronic acid. The polymer is first produced as polymannuronic acid and the guluronic acid residues are then introduced at the polymer level by mannuronan C-5-epimerases. The structure of the catalytic A-module of the Azotobacter vinelandii mannuronan C-5-epimerase AlgE4 has been determined by x-ray crystallography at 2.1-angstrom resolution. AlgE4A folds into a right-handed parallel beta-helix structure originally found in pectate lyase C and subsequently in several polysaccharide lyases and hydrolases. The beta-helix is composed of four parallel beta-sheets, comprising 12 complete turns, and has an amphipathic alpha-helix near the N terminus. The catalytic site is positioned in a positively charged cleft formed by loops extending from the surface encompassing Asp(152), an amino acid previously shown to be important for the reaction. Site-directed mutagenesis further implicates Tyr(149), His(154), and Asp(178) as being essential for activity. Tyr(149) probably acts as the proton acceptor, whereas His(154) is the proton donor in the epimerization reaction.	[Rozeboom, Henriette J.; Kalk, Kor H.; Dijkstra, Bauke W.] Univ Groningen, Biophys Chem Lab, GBB, NL-9747 AG Groningen, Netherlands; [Bjerkan, Tonje M.; Ertesvag, Helga; Holtan, Synnove; Aachmann, Finn L.; Valla, Svein] Norwegian Univ Sci & Technol, Dept Biotechnol, N-7491 Trondheim, Norway	University of Groningen; Norwegian University of Science & Technology (NTNU)	Dijkstra, BW (corresponding author), Univ Groningen, Biophys Chem Lab, GBB, Nijenborgh 4, NL-9747 AG Groningen, Netherlands.	b.w.dijkstra@rug.nl	Heggeset, Tonje Marita Bjerkan/I-9077-2019; Dijkstra, Bauke W./H-4308-2019; Aachmann, Finn/G-4136-2015	Dijkstra, Bauke W./0000-0001-9731-6586; Aachmann, Finn/0000-0003-1613-4663; Heggeset, Tonje/0000-0002-1221-8598; Ertesvag, helga/0000-0001-9437-9469; Rozeboom, Henriette/0000-0002-1656-6477	Norwegian Research Council	Norwegian Research Council(Research Council of NorwayEuropean Commission)	This work was supported by a grant from the Norwegian Research Council. The costs of publication of this article were defrayed in part by the payment of page charges. This article must therefore be hereby marked "advertisement" in accordance with 18 U.S.C. Section 1734 solely to indicate this fact.	Aachmann FL, 2006, J BIOL CHEM, V281, P7350, DOI 10.1074/jbc.M510069200; ANDRADE MA, 1993, PROTEIN ENG, V6, P383, DOI 10.1093/protein/6.4.383; Bjerkan TM, 2004, BIOCHEM J, V381, P813, DOI 10.1042/BJ20031580; Blatny JM, 1997, PLASMID, V38, P35, DOI 10.1006/plas.1997.1294; BLUHM MM, 1958, PROC R SOC LON SER-A, V246, P369, DOI 10.1098/rspa.1958.0145; BRADFORD MM, 1976, ANAL BIOCHEM, V72, P248, DOI 10.1016/0003-2697(76)90527-3; Brunger AT, 1998, ACTA CRYSTALLOGR D, V54, P905, DOI 10.1107/S0907444998003254; Campa C, 2004, BIOCHEM J, V381, P155, DOI 10.1042/BJ20031265; Campos ME, 1996, J BACTERIOL, V178, P1793, DOI 10.1128/jb.178.7.1793-1799.1996; Coutinho PM, 1999, ROY SOC CH, P3; DeLano W.L, PYMOL MOL GRAPHICS S; Donati I, 2005, BIOMACROMOLECULES, V6, P1031, DOI 10.1021/bm049306e; Douthit SA, 2005, J BACTERIOL, V187, P4573, DOI 10.1128/JB.187.13.4573-4583.2005; DRUMMOND DW, 1962, J CHEM SOC, P1208, DOI 10.1039/jr9620001208; ERTESVAG H, 1995, MOL MICROBIOL, V16, P719, DOI 10.1111/j.1365-2958.1995.tb02433.x; Ertesvag H, 1999, J BACTERIOL, V181, P3033; FISCHER FG, 1955, H-S Z PHYSIOL CHEM, V302, P186, DOI 10.1515/bchm2.1955.302.1-2.186; GACESA P, 1987, FEBS LETT, V212, P199, DOI 10.1016/0014-5793(87)81344-3; GORIN PAJ, 1966, CAN J CHEMISTRY, V44, P993, DOI 10.1139/v66-147; Hartmann M, 2002, BIOPOLYMERS, V63, P77, DOI 10.1002/bip.10017.abs; Hoidal HK, 1999, J BIOL CHEM, V274, P12316, DOI 10.1074/jbc.274.18.12316; HOLM L, 1993, J MOL BIOL, V233, P123, DOI 10.1006/jmbi.1993.1489; Huang WJ, 2001, BIOCHEMISTRY-US, V40, P2359, DOI 10.1021/bi0024254; Jabs A, 1999, J MOL BIOL, V286, P291, DOI 10.1006/jmbi.1998.2459; Jenkins J, 2004, J BIOL CHEM, V279, P9139, DOI 10.1074/jbc.M311390200; JONES TA, 1991, ACTA CRYSTALLOGR A, V47, P110, DOI 10.1107/S0108767390010224; KABSCH W, 1983, BIOPOLYMERS, V22, P2577, DOI 10.1002/bip.360221211; LASKOWSKI RA, 1993, J APPL CRYSTALLOGR, V26, P283, DOI 10.1107/S0021889892009944; LIN LP, 1969, J BACTERIOL, V100, P480, DOI 10.1128/JB.100.1.480-486.1969; LINKER A, 1964, NATURE, V204, P187, DOI 10.1038/204187a0; MATTHEWS BW, 1968, J MOL BIOL, V33, P491, DOI 10.1016/0022-2836(68)90205-2; McPherson A, 2001, PROTEIN SCI, V10, P418, DOI 10.1110/ps.32001; Morris RJ, 2003, METHOD ENZYMOL, V374, P229, DOI 10.1016/S0076-6879(03)74011-7; Nyvall P, 2003, PLANT PHYSIOL, V133, P726, DOI 10.1104/pp.103.025981; Osawa T, 2005, J MOL BIOL, V345, P1111, DOI 10.1016/j.jmb.2004.10.081; Otwinowski Z, 1997, METHOD ENZYMOL, V276, P307, DOI 10.1016/S0076-6879(97)76066-X; Ramstad MV, 1999, ENZYME MICROB TECH, V24, P636, DOI 10.1016/S0141-0229(98)00148-3; Rehm BH, 1996, J BACTERIOL, V178, P5884, DOI 10.1128/jb.178.20.5884-5889.1996; Rye CS, 2006, CHEMBIOCHEM, V7, P631, DOI 10.1002/cbic.200500428; Sabra W, 2000, APPL ENVIRON MICROB, V66, P4037, DOI 10.1128/AEM.66.9.4037-4044.2000; SADOFF HL, 1975, BACTERIOL REV, V39, P516, DOI 10.1128/MMBR.39.4.516-539.1975; Sambrook J., 2001, MOL CLONING LAB MANU, Vthird edition; Sletmoen M, 2004, BIOMACROMOLECULES, V5, P1288, DOI 10.1021/bm0345211; Svanem BIG, 2001, J BIOL CHEM, V276, P31542, DOI 10.1074/jbc.M102562200; Svanem BIG, 1999, J BACTERIOL, V181, P68, DOI 10.1128/JB.181.1.68-77.1999; Terwilliger TC, 2003, METHOD ENZYMOL, V374, P22, DOI 10.1016/S0076-6879(03)74002-6; Valla S, 2001, BIOCHIMIE, V83, P819, DOI 10.1016/S0300-9084(01)01313-X; van Pouderoyen G, 2003, FEBS LETT, V554, P462, DOI 10.1016/S0014-5793(03)01221-3; van Santen Y, 1999, J BIOL CHEM, V274, P30474, DOI 10.1074/jbc.274.43.30474; Yamasaki M, 2005, J MOL BIOL, V352, P11, DOI 10.1016/j.jmb.2005.06.075; Yamasaki M, 2004, J BIOL CHEM, V279, P31863, DOI 10.1074/jbc.M402466200; Yoon HJ, 1999, J MOL BIOL, V290, P505, DOI 10.1006/jmbi.1999.2883; Yoon HJ, 2001, J MOL BIOL, V307, P9, DOI 10.1006/jmbi.2000.4509	53	35	37	2	17	ELSEVIER	AMSTERDAM	RADARWEG 29, 1043 NX AMSTERDAM, NETHERLANDS		1083-351X		J BIOL CHEM	J. Biol. Chem.	AUG 29	2008	283	35					23819	23828		10.1074/jbc.M804119200	http://dx.doi.org/10.1074/jbc.M804119200			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	340II	18574239	Green Published, hybrid			2022-12-27	WOS:000258638900036
J	Tang, Y; Liu, ZY; Zhao, L; Clemens, TL; Cao, X				Tang, Yi; Liu, Zhongyu; Zhao, Ling; Clemens, Thomas L.; Cao, Xu			Smad7 stabilizes beta-catenin binding to E-cadherin complex and promotes cell-cell adhesion	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							GROWTH-FACTOR-BETA; STABLE OVEREXPRESSION; NUCLEAR-LOCALIZATION; CARCINOMA CELLS; IN-VIVO; PROTEIN; CANCER; METASTASIS; EXPRESSION; IDENTIFICATION	beta-Catenin functions both as an adherens junction adhesion protein and as an essential mediator of the canonical Wnt signaling pathway. Wnts stabilize beta-catenin and promote its accumulation in the nucleus, where it regulates transcription of the target genes. Here we show that Smad7 promotes cell-cell adhesion by stabilizing beta-catenin and consequently increases the beta-catenin-E-cadherin complex level at the plasma membrane. A Smad7-Axin interaction disassociates GSK-3 beta and beta-catenin from Axin, as well as inhibits the recruitment of Smurf2, an E3 ligase, to beta-catenin, thus protecting beta-catenin from phosphorylation and degradation. Smad7 increases the stabilized beta-catenin to form a complex with E-cadherin and stabilizes the E-cadherin-beta-catenin complex. Thereby, rather than being translocated to the nucleus for regulating the target gene transcription, Smad7-stabilized-beta-catenin is shunted to the E-cadherin complex to modulate cell-cell adhesion.	[Tang, Yi; Liu, Zhongyu; Zhao, Ling; Clemens, Thomas L.; Cao, Xu] Univ Alabama, Dept Pathol, Birmingham, AL 35294 USA	University of Alabama System; University of Alabama Birmingham	Cao, X (corresponding author), 1670 Univ Blvd, Birmingham, AL 35294 USA.	cao@uab.edu			National Institutes of Health [DK57501]	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA)	This work was supported, in whole or in part, by National Institutes of Health Grant DK57501 ( to X. C.). The costs of publication of this article were defrayed in part by the payment of page charges. This article must therefore be hereby marked "advertisement" in accordance with 18 U.S.C. Section 1734 solely to indicate this fact.	Azuma H, 2005, JNCI-J NATL CANCER I, V97, P1734, DOI 10.1093/jnci/dji399; Barth AIM, 1997, J CELL BIOL, V136, P693, DOI 10.1083/jcb.136.3.693; Bienz M, 2005, CURR BIOL, V15, pR64, DOI 10.1016/j.cub.2004.12.058; Bitzer M, 2000, GENE DEV, V14, P187; Brembeck FH, 2006, CURR OPIN GENET DEV, V16, P51, DOI 10.1016/j.gde.2005.12.007; Broderick P, 2007, NAT GENET, V39, P1315, DOI 10.1038/ng.2007.18; Chen YT, 1999, J CELL BIOL, V144, P687, DOI 10.1083/jcb.144.4.687; Derynck R, 2003, NATURE, V425, P577, DOI 10.1038/nature02006; Edlund S, 2005, MOL CELL BIOL, V25, P1475, DOI 10.1128/MCB.25.4.1475-1488.2005; Fink SP, 2003, ONCOGENE, V22, P1317, DOI 10.1038/sj.onc.1206128; Fujimuro M, 2003, NAT MED, V9, P300, DOI 10.1038/nm829; Gumbiner BM, 2000, J CELL BIOL, V148, P399, DOI 10.1083/jcb.148.3.399; Guo X, 2008, GENE DEV, V22, P106, DOI 10.1101/gad.1590908; Han GW, 2006, DEV CELL, V11, P301, DOI 10.1016/j.devcel.2006.06.014; Hayashi H, 1997, CELL, V89, P1165, DOI 10.1016/S0092-8674(00)80303-7; He TC, 1998, SCIENCE, V281, P1509, DOI 10.1126/science.281.5382.1509; HINCK L, 1994, J CELL BIOL, V124, P729, DOI 10.1083/jcb.124.5.729; Huber AH, 2001, CELL, V105, P391, DOI 10.1016/S0092-8674(01)00330-0; Jamora C, 2002, NAT CELL BIOL, V4, pE101, DOI 10.1038/ncb0402-e101; Javelaud D, 2005, ONCOGENE, V24, P7624, DOI 10.1038/sj.onc.1208900; Javelaud D, 2007, CANCER RES, V67, P2317, DOI 10.1158/0008-5472.CAN-06-3950; Jian HY, 2006, GENE DEV, V20, P666, DOI 10.1101/gad.1388806; KALKHOVEN E, 1995, CELL GROWTH DIFFER, V6, P1151; Klingelhofer J, 2003, ONCOGENE, V22, P1181, DOI 10.1038/sj.onc.1206245; Landstrom M, 2000, CURR BIOL, V10, P535, DOI 10.1016/S0960-9822(00)00470-X; Liu W, 2006, EMBO J, V25, P1646, DOI 10.1038/sj.emboj.7601057; Lu ZM, 2003, CANCER CELL, V4, P499, DOI 10.1016/S1535-6108(03)00304-0; Mikula M, 2006, J CELL PHYSIOL, V209, P560, DOI 10.1002/jcp.20772; Morin PJ, 1999, BIOESSAYS, V21, P1021, DOI 10.1002/(SICI)1521-1878(199912)22:1<1021::AID-BIES6>3.0.CO;2-P; Munemitsu S, 1996, MOL CELL BIOL, V16, P4088; Nakao A, 1997, NATURE, V389, P631, DOI 10.1038/39369; Nelson WJ, 2004, SCIENCE, V303, P1483, DOI 10.1126/science.1094291; Oft M, 1998, CURR BIOL, V8, P1243, DOI 10.1016/S0960-9822(07)00533-7; Orsulic S, 1999, J CELL SCI, V112, P1237; Peifer M, 2000, SCIENCE, V287, P1606, DOI 10.1126/science.287.5458.1606; Perego C, 2000, EMBO J, V19, P3978, DOI 10.1093/emboj/19.15.3978; Reiss K, 2005, EMBO J, V24, P742, DOI 10.1038/sj.emboj.7600548; Tetsu O, 1999, NATURE, V398, P422, DOI 10.1038/18884; Thiery JP, 2003, CURR OPIN CELL BIOL, V15, P740, DOI 10.1016/j.ceb.2003.10.006; Topper JN, 1997, P NATL ACAD SCI USA, V94, P9314, DOI 10.1073/pnas.94.17.9314; Tsunobuchi H, 2004, BIOCHEM BIOPH RES CO, V316, P712, DOI 10.1016/j.bbrc.2004.02.104; Ulloa L, 1999, NATURE, V397, P710, DOI 10.1038/17826; Yost C, 1996, GENE DEV, V10, P1443, DOI 10.1101/gad.10.12.1443	43	54	56	0	4	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	AUG 29	2008	283	35					23956	23963		10.1074/jbc.M800351200	http://dx.doi.org/10.1074/jbc.M800351200			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	340II	18593713	Green Published, hybrid			2022-12-27	WOS:000258638900051
J	Sugeno, N; Takeda, A; Hasegawa, T; Kobayashi, M; Kikuchi, A; Mori, F; Wakabayashi, K; Itoyama, Y				Sugeno, Naoto; Takeda, Atsushi; Hasegawa, Takafumi; Kobayashi, Michiko; Kikuchi, Akio; Mori, Fumiaki; Wakabayashi, Koichi; Itoyama, Yasuto			Serine 129 phosphorylation of alpha-synuclein induces unfolded protein response-mediated cell death	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ENDOPLASMIC-RETICULUM STRESS; SPORADIC PARKINSONS-DISEASE; LEWY BODIES; IN-VIVO; NEURODEGENERATIVE DISEASES; PROTEASOMAL FUNCTION; INCLUSION FORMATION; SUBSTANTIA-NIGRA; OXIDATIVE STRESS; BODY FORMATION	alpha-Synuclein is a major protein component deposited in Lewy bodies and Lewy neurites that is extensively phosphorylated at Ser(129), although its role in neuronal degeneration is still elusive. In this study, several apoptotic pathways were examined in alpha-synuclein-overexpressing SH-SY5Y cells. Following the treatment with rotenone, a mitochondrial complex I inhibitor, wildtype alpha-synuclein-overexpressing cells demonstrated intracellular aggregations, which shared a number of features with Lewy bodies, although cells overexpressing the S129A mutant, in which phosphorylation at Ser129 was blocked, showed few aggregations. In wildtype alpha-synuclein cells treated with rotenone, the proportion of phosphorylated alpha-synuclein was about 1.6 times higher than that of untreated cells. Moreover, induction of unfolded protein response (UPR) markers was evident several hours before the induction of mitochondrial disruption and caspase-3 activation. Eukaryotic initiation factor 2 alpha, a member of the PERK pathway family, was remarkably activated at early phases. On the other hand, the S129A mutant failed to activate UPR. Casein kinase 2 inhibitor, which decreased alpha-synuclein phosphorylation, also reduced UPR activation. The alpha-synuclein aggregations were colocalized with a marker for the endoplasmic reticulum-Golgi intermediate compartment. Taken together, it seems plausible that alpha-synuclein toxicity is dependent on the phosphorylation at Ser129 that induces the UPRs, possibly triggered by the disturbed endoplasmic reticulum-Golgi trafficking.	[Sugeno, Naoto; Takeda, Atsushi; Hasegawa, Takafumi; Kobayashi, Michiko; Kikuchi, Akio; Itoyama, Yasuto] Tohoku Univ, Dept Neurol, Sch Med, Sendai, Miyagi 9808574, Japan; [Mori, Fumiaki; Wakabayashi, Koichi] Hirosaki Univ, Dept Neuropathol, Inst Brain Sci, Sch Med, Hirosaki, Aomori 0368562, Japan	Tohoku University; Hirosaki University	Takeda, A (corresponding author), 1-1 Seiryomachi, Sendai, Miyagi 9808574, Japan.	atakeda@em.neurol.med.tohoku.ac.jp	MORI, Fumiaki/L-5789-2019					Anderson JP, 2006, J BIOL CHEM, V281, P29739, DOI 10.1074/jbc.M600933200; Appenzeller-Herzog C, 2006, J CELL SCI, V119, P2173, DOI 10.1242/jcs.03019; Arawaka S, 2006, J NEUROSCI, V26, P9227, DOI 10.1523/JNEUROSCI.0341-06.2006; Baumeister P, 2005, MOL CELL BIOL, V25, P4529, DOI 10.1128/MCB.25.11.4529-4540.2005; Betarbet R, 2000, NAT NEUROSCI, V3, P1301, DOI 10.1038/81834; Borsello T, 2007, CURR PHARM DESIGN, V13, P1875; Chen L, 2005, NAT NEUROSCI, V8, P657, DOI 10.1038/nn1443; Cooper AA, 2006, SCIENCE, V313, P324, DOI 10.1126/science.1129462; Dawson TM, 2003, SCIENCE, V302, P819, DOI 10.1126/science.1087753; Dev KK, 2003, NEUROPHARMACOLOGY, V45, P14, DOI 10.1016/S0028-3908(03)00140-0; Dobson CM, 2003, NATURE, V426, P884, DOI 10.1038/nature02261; DUDEN R, 1991, CELL, V64, P649, DOI 10.1016/0092-8674(91)90248-W; Eriksen JL, 2003, NEURON, V40, P453, DOI 10.1016/S0896-6273(03)00684-6; Fujiwara H, 2002, NAT CELL BIOL, V4, P160, DOI 10.1038/ncb748; Furukawa Y, 2002, ANN NEUROL, V51, P779, DOI 10.1002/ana.10207; Goedert M, 2001, NAT REV NEUROSCI, V2, P492, DOI 10.1038/35081564; GOLDMAN JE, 1983, SCIENCE, V221, P1082, DOI 10.1126/science.6308771; Holtz WA, 2003, J BIOL CHEM, V278, P19367, DOI 10.1074/jbc.M211821200; Holtz WA, 2006, J NEUROCHEM, V99, P54, DOI 10.1111/j.1471-4159.2006.04025.x; Hoozemans JJM, 2007, BIOCHEM BIOPH RES CO, V354, P707, DOI 10.1016/j.bbrc.2007.01.043; Imai Y, 2001, CELL, V105, P891, DOI 10.1016/S0092-8674(01)00407-X; Ishii A, 2007, FEBS LETT, V581, P4711, DOI 10.1016/j.febslet.2007.08.067; Kahle PJ, 2002, EMBO REP, V3, P583, DOI 10.1093/embo-reports/kvf109; Kanemoto S, 2005, BIOCHEM BIOPH RES CO, V331, P1146, DOI 10.1016/j.bbrc.2005.04.039; Kruger R, 1998, NAT GENET, V18, P106, DOI 10.1038/ng0298-106; KUZUHARA S, 1988, ACTA NEUROPATHOL, V75, P345, DOI 10.1007/BF00687787; LANGSTON JW, 1983, SCIENCE, V219, P979, DOI 10.1126/science.6823561; Lansbury PT, 2006, NATURE, V443, P774, DOI 10.1038/nature05290; Lin MT, 2006, NATURE, V443, P787, DOI 10.1038/nature05292; Liu C, 2007, J BIOL CHEM, V282, P14558, DOI 10.1074/jbc.M700422200; Ma YJ, 2004, J BIOL CHEM, V279, P13792, DOI 10.1074/jbc.M313724200; MARSDEN CD, 1990, LANCET, V335, P948, DOI 10.1016/0140-6736(90)91006-V; Martin-Clemente B, 2004, J BIOL CHEM, V279, P52984, DOI 10.1074/jbc.M409028200; Masliah E, 2000, SCIENCE, V287, P1265, DOI 10.1126/science.287.5456.1265; Matsuzaki M, 2004, BRAIN RES, V1004, P83, DOI 10.1016/j.brainres.2004.01.017; McNaught KSP, 2001, NEUROSCI LETT, V297, P191, DOI 10.1016/S0304-3940(00)01701-8; Munoz E, 1997, NEUROSCI LETT, V235, P57, DOI 10.1016/S0304-3940(97)00710-6; Okochi M, 2000, J BIOL CHEM, V275, P390, DOI 10.1074/jbc.275.1.390; Olanow CW, 2004, LANCET NEUROL, V3, P496, DOI 10.1016/S1474-4422(04)00827-0; Olanow CW, 1999, ANNU REV NEUROSCI, V22, P123, DOI 10.1002/mds.23732; PEPPERKOK R, 1993, CELL, V74, P71, DOI 10.1016/0092-8674(93)90295-2; Periquet M, 2007, J NEUROSCI, V27, P3338, DOI 10.1523/JNEUROSCI.0285-07.2007; Pronin AN, 2000, J BIOL CHEM, V275, P26515, DOI 10.1074/jbc.M003542200; Ryu MY, 2008, J NEUROL SCI, V266, P9, DOI 10.1016/j.jns.2007.08.027; Sasakawa H, 2007, BIOCHEM BIOPH RES CO, V363, P795, DOI 10.1016/j.bbrc.2007.09.048; Schroder M, 2005, ANNU REV BIOCHEM, V74, P739, DOI 10.1146/annurev.biochem.73.011303.074134; Sherer TB, 2003, EXP NEUROL, V179, P9, DOI 10.1006/exnr.2002.8072; Sherer TB, 2001, BRAIN RES, V891, P94, DOI 10.1016/S0006-8993(00)03203-0; Sherer TB, 2007, J NEUROCHEM, V100, P1469, DOI 10.1111/j.1471-4159.2006.04333.x; Shults CW, 2006, P NATL ACAD SCI USA, V103, P1661, DOI 10.1073/pnas.0509567103; Silva RM, 2005, J NEUROCHEM, V95, P974, DOI 10.1111/j.1471-4159.2005.03428.x; Singleton AB, 2003, SCIENCE, V302, P841, DOI 10.1126/science.1090278; SMILEY ST, 1991, P NATL ACAD SCI USA, V88, P3671, DOI 10.1073/pnas.88.9.3671; Smith WW, 2005, J NEUROSCI, V25, P5544, DOI 10.1523/JNEUROSCI.0482-05.2005; Spillantini MG, 1997, NATURE, V388, P839, DOI 10.1038/42166; Stefanis L, 2001, J NEUROSCI, V21, P9549, DOI 10.1523/JNEUROSCI.21-24-09549.2001; Takahashi M, 2003, NEUROSCI LETT, V336, P155, DOI 10.1016/S0304-3940(02)01258-2; Takahashi M, 2006, J NEUROPATH EXP NEUR, V65, P1157, DOI 10.1097/01.jnen.0000248542.82681.12; Takeda A, 2006, J BIOMED BIOTECHNOL, DOI 10.1155/JBB/2006/19365; Tanaka Y, 2001, HUM MOL GENET, V10, P919, DOI 10.1093/hmg/10.9.919; Volles MJ, 2003, BIOCHEMISTRY-US, V42, P7871, DOI 10.1021/bi030086j; Wacker JL, 2004, NAT STRUCT MOL BIOL, V11, P1215, DOI 10.1038/nsmb860; Wang HQ, 2007, ANTIOXID REDOX SIGN, V9, P553, DOI 10.1089/ars.2006.1524; Xu J, 2002, NAT MED, V8, P600, DOI 10.1038/nm0602-600; Zarranz JJ, 2004, ANN NEUROL, V55, P164, DOI 10.1002/ana.10795	65	101	102	1	6	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	AUG 22	2008	283	34					23179	23188		10.1074/jbc.M802223200	http://dx.doi.org/10.1074/jbc.M802223200			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	337SI	18562315	hybrid			2022-12-27	WOS:000258455400031
J	Cole, SL; Vassar, R				Cole, Sarah L.; Vassar, Robert			The Role of Amyloid Precursor Protein Processing by BACE1, the beta-Secretase, in Alzheimer Disease Pathophysiology	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Review							APP TRANSGENIC MICE; MEMORY DEFICITS; GENE-EXPRESSION; KNOCKOUT MICE; ALPHA-SECRETASE; NEURON LOSS; BRAIN; GENERATION; PATHOGENESIS; PROMOTER	Amyloid plaques, composed of the amyloid beta-protein (A beta), are hallmark neuropathological lesions in Alzheimer disease (AD) brain. A beta fulfills a central role in AD pathogenesis, and reduction of A beta levels should prove beneficial for AD treatment. A beta generation is initiated by proteolysis of amyloid precursor protein (APP) by the beta-secretase enzyme BACE1. Bace1 knockout (Bace1(-/-)) mice have validated BACE1 as the authentic beta-secretase in vivo. BACE1 is essential for A beta generation and represents a suitable drug target for AD therapy, especially because this enzyme is up-regulated in AD. However, although initial data indicated that Bace1(-/-) mice lack an overt phenotype, the BACE1-mediated processing of APP and other substrates may be important for specific biological processes. In this minireview, topics range from the initial identification of BACE1 to the fundamental knowledge gaps that remain in our understanding of this protease. We address pertinent questions such as putative causes of BACE1 elevation in AD and discuss why, nine years since the identification of BACE1, treatments that address the underlying pathological mechanisms of AD are still lacking.	[Cole, Sarah L.; Vassar, Robert] Northwestern Univ, Dept Cell & Mol Biol, Feinberg Sch Med, Chicago, IL 60611 USA	Northwestern University; Feinberg School of Medicine	Vassar, R (corresponding author), Northwestern Univ, Dept Cell & Mol Biol, Feinberg Sch Med, Chicago, IL 60611 USA.	r-vassar@northwestern.edu						Bennett BD, 2000, J BIOL CHEM, V275, P20647, DOI 10.1074/jbc.M002688200; Bennett BD, 2000, J BIOL CHEM, V275, P37712, DOI 10.1074/jbc.M005339200; Cho HJ, 2007, GLIA, V55, P253, DOI 10.1002/glia.20451; Citron M, 1996, NEURON, V17, P171, DOI 10.1016/S0896-6273(00)80290-1; CITRON M, 1995, NEURON, V14, P661, DOI 10.1016/0896-6273(95)90323-2; Clarimon J, 2003, J NEUROL, V250, P956, DOI 10.1007/s00415-003-1127-8; Cole SL, 2007, MOL NEURODEGENER, V2, DOI 10.1186/1750-1326-2-22; Dominguez D, 2005, J BIOL CHEM, V280, P30797, DOI 10.1074/jbc.M505249200; Fluhrer R, 2002, J NEUROCHEM, V81, P1011, DOI 10.1046/j.1471-4159.2002.00908.x; Fukumoto H, 2002, ARCH NEUROL-CHICAGO, V59, P1381, DOI 10.1001/archneur.59.9.1381; Fukumoto H, 2004, AM J PATHOL, V164, P719, DOI 10.1016/S0002-9440(10)63159-8; Glabe CG, 2008, J BIOL CHEM, V283, P29639, DOI 10.1074/jbc.R800016200; Golde Todd E., 2006, Current Alzheimer Research, V3, P421, DOI 10.2174/156720506779025189; Gouras GK, 1998, J NEUROCHEM, V71, P1920; HAASS C, 1992, NATURE, V359, P325; Haniu M, 2000, J BIOL CHEM, V275, P21099, DOI 10.1074/jbc.M002095200; Harrison SM, 2003, MOL CELL NEUROSCI, V24, P646, DOI 10.1016/S1044-7431(03)00227-6; Heneka MT, 2005, J NEUROINFLAMM, V2, DOI 10.1186/1742-2094-2-22; Holsinger RMD, 2002, ANN NEUROL, V51, P783, DOI 10.1002/ana.10208; Hong L, 2000, SCIENCE, V290, P150, DOI 10.1126/science.290.5489.150; Hsiao K, 1996, SCIENCE, V274, P99, DOI 10.1126/science.274.5284.99; Hussain I, 1999, MOL CELL NEUROSCI, V14, P419, DOI 10.1006/mcne.1999.0811; John V, 2006, CURR TOP MED CHEM, V6, P569, DOI 10.2174/156802606776743084; Kamenetz F, 2003, NEURON, V37, P925, DOI 10.1016/S0896-6273(03)00124-7; Kuo YM, 1996, J BIOL CHEM, V271, P4077; Laird FM, 2005, J NEUROSCI, V25, P11693, DOI 10.1523/JNEUROSCI.2766-05.2005; Lazarov O, 2002, J NEUROSCI, V22, P9785; Li R, 2004, P NATL ACAD SCI USA, V101, P3632, DOI 10.1073/pnas.0205689101; Lin XL, 2000, P NATL ACAD SCI USA, V97, P1456, DOI 10.1073/pnas.97.4.1456; Luo Y, 2003, NEUROBIOL DIS, V14, P81, DOI 10.1016/S0969-9961(03)00104-9; Luo Y, 2001, NAT NEUROSCI, V4, P231, DOI 10.1038/85059; McConlogue L, 2007, J BIOL CHEM, V282, P26326, DOI 10.1074/jbc.M611687200; Oakley H, 2006, J NEUROSCI, V26, P10129, DOI 10.1523/JNEUROSCI.1202-06.2006; Ohno M, 2006, EUR J NEUROSCI, V23, P251, DOI 10.1111/j.1460-9568.2005.04551.x; Ohno M, 2004, NEURON, V41, P27, DOI 10.1016/S0896-6273(03)00810-9; Ohno M, 2007, NEUROBIOL DIS, V26, P134, DOI 10.1016/j.nbd.2006.12.008; Riddell DR, 2001, CURR BIOL, V11, P1288, DOI 10.1016/S0960-9822(01)00394-3; Roberds SL, 2001, HUM MOL GENET, V10, P1317, DOI 10.1093/hmg/10.12.1317; Rovelet-Lecrux A, 2006, NAT GENET, V38, P24, DOI 10.1038/ng1718; Sambamurti K, 2004, FASEB J, V18, P1034, DOI 10.1096/fj.03-1378fje; Sastre M, 2006, P NATL ACAD SCI USA, V103, P443, DOI 10.1073/pnas.0503839103; Sheng JG, 2003, EXP NEUROL, V184, P1053, DOI 10.1016/j.expneurol.2003.08.018; Singer O, 2005, NAT NEUROSCI, V8, P1343, DOI 10.1038/nn1531; Sinha S, 1999, NATURE, V402, P537, DOI 10.1038/990114; Skovronsky DM, 2000, J BIOL CHEM, V275, P2568, DOI 10.1074/jbc.275.4.2568; Sun X, 2006, P NATL ACAD SCI USA, V103, P18727, DOI 10.1073/pnas.0606298103; Sun XL, 2005, FASEB J, V19, P739, DOI 10.1096/fj.04-3426com; Tesco G, 2007, NEURON, V54, P721, DOI 10.1016/j.neuron.2007.05.012; Tong Y, 2005, J NEURAL TRANSM, V112, P455, DOI 10.1007/s00702-004-0255-3; Vassar R, 1999, SCIENCE, V286, P735, DOI 10.1126/science.286.5440.735; Vassar R, 2004, J MOL NEUROSCI, V23, P105, DOI 10.1385/JMN:23:1-2:105; Velliquette RA, 2005, J NEUROSCI, V25, P10874, DOI 10.1523/JNEUROSCI.2350-05.2005; Willem M, 2006, SCIENCE, V314, P664, DOI 10.1126/science.1132341; Wong HK, 2005, J BIOL CHEM, V280, P23009, DOI 10.1074/jbc.M414648200; Yan RQ, 2001, J BIOL CHEM, V276, P34019, DOI 10.1074/jbc.M105583200; Yan RQ, 1999, NATURE, V402, P533, DOI 10.1038/990107; Zhao J, 1996, J BIOL CHEM, V271, P31407, DOI 10.1074/jbc.271.49.31407; Zhao J, 2007, J NEUROSCI, V27, P3639, DOI 10.1523/JNEUROSCI.4396-06.2007	58	173	182	1	28	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	OCT 31	2008	283	44					29621	29625		10.1074/jbc.R800015200	http://dx.doi.org/10.1074/jbc.R800015200			5	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	364WS	18650431	hybrid, Green Published			2022-12-27	WOS:000260366900003
J	Green, CJ; Goransson, O; Kular, GS; Leslie, NR; Gray, A; Alessi, DR; Sakamoto, K; Hundal, HS				Green, Charlotte J.; Goransson, Olga; Kular, Gursant S.; Leslie, Nick R.; Gray, Alexander; Alessi, Dario R.; Sakamoto, Kei; Hundal, Harinder S.			Use of Akt inhibitor and a drug-resistant mutant validates a critical role for protein kinase B/Akt in the insulin-dependent regulation of glucose and system A amino acid uptake	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							SKELETAL-MUSCLE CELLS; PLECKSTRIN-HOMOLOGY-DOMAIN; GROWTH-FACTOR-I; GLYCOGEN-SYNTHASE; PHOSPHATIDYLINOSITOL 3,4,5-TRISPHOSPHATE; GLUT4 VESICLES; B-ALPHA; TRANSPORT; ACTIVATION; MEMBRANE	Protein kinase B (PKB)/Akt has been strongly implicated in the insulin-dependent stimulation of GLUT4 translocation and glucose transport in skeletal muscle and fat cells. Recently an allosteric inhibitor of PKB (Akti) that selectively targets PKB alpha and -beta was reported, but as yet its precise mechanism of action or ability to suppress key insulin-regulated events such as glucose and amino acid uptake and glycogen synthesis in muscle cells has not been reported. We show here that Akti ablates the insulin-dependent regulation of these processes in L6 myotubes at submicromolar concentrations and that inhibition correlates tightly with loss of PKB activation/phosphorylation. Similar findings were obtained using 3T3-L1 adipocytes. Akti did not inhibit IRS1 tyrosine phosphorylation, phosphatidylinositol 3-kinase signaling, or activation of Erks, ribosomal S6 kinase, or atypical protein kinases C but significantly impaired regulation of downstream PKB targets glycogen synthase kinase-3 and AS160. Akti-mediated inhibition of PKB requires an intact kinase pleckstrin homology domain but does not involve suppression of 3-phosphoinositide binding to this domain. Importantly, we have discovered that Akti inhibition is critically dependent upon a solvent-exposed tryptophan residue (Trp-80) that is present within the pleckstrin homology domain of all three PKB isoforms and whose mutation to an alanine (PKBW80A) yields an Akti-resistant kinase. Cellular expression of PKBW80A antagonized the Akti-mediated inhibition of glucose and amino acid uptake. Our findings support a critical role for PKB in the hormonal regulation of glucose and system A amino acid uptake and indicate that use of Akti and expression of the drug-resistant kinase will be valuable tools in delineating cellular PKB functions.	[Green, Charlotte J.; Leslie, Nick R.; Gray, Alexander; Hundal, Harinder S.] Univ Dundee, Coll Life Sci, James Black Ctr, Div Mol Physiol, Dundee DD1 5EH, Scotland; [Kular, Gursant S.; Alessi, Dario R.; Sakamoto, Kei] Univ Dundee, Coll Life Sci, James Black Ctr, MRC Prot Phosphorylat Unit, Dundee DD1 5EH, Scotland; [Goransson, Olga] Lund Univ, Biomed Ctr, Dept Expt Med Sci, S-22184 Lund, Sweden	University of Dundee; University of Dundee; Lund University	Hundal, HS (corresponding author), Univ Dundee, Coll Life Sci, James Black Ctr, Div Mol Physiol, Dundee DD1 5EH, Scotland.	h.s.hundal@dundee.ac.uk	GREEN, Charlotte/B-9742-2014; Hundal, Hari/A-8990-2008; sakamoto, kei/C-8806-2019; Leslie, Nicholas/D-2699-2009	GREEN, Charlotte/0000-0003-1631-3186; Hundal, Hari/0000-0002-7621-4932; sakamoto, kei/0000-0001-8839-5980; LESLIE, Nicholas/0000-0001-5131-0541; Gray, Alexander/0000-0001-9227-0363; Goransson, Olga/0000-0002-7209-8022; Alessi, Dario/0000-0002-2140-9185	Medical Research Council; AstraZeneca; Boehringer-Ingelheim; GlaxoSmithKline; Merck; Pfizer; Swedish Wenner-Gren Foundations; European Commission [LSHM-CT-20004-005272]; Diabetes Research and Wellness Foundation; Merck KGaA; Diabetes UK; Medical Research Council [MC_U127088492, MC_U127015387, G9403619] Funding Source: researchfish; MRC [G9403619, MC_U127015387, MC_U127088492] Funding Source: UKRI	Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); AstraZeneca(AstraZeneca); Boehringer-Ingelheim(Boehringer Ingelheim); GlaxoSmithKline(GlaxoSmithKline); Merck(Merck & Company); Pfizer(Pfizer); Swedish Wenner-Gren Foundations; European Commission(European CommissionEuropean Commission Joint Research Centre); Diabetes Research and Wellness Foundation; Merck KGaA; Diabetes UK(Diabetes UK); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC))	This work was supported by the Medical Research Council (to K. S. and D. R. A.), pharmaceutical companies supporting the Division of Signal Transduction Therapy Unit (AstraZeneca, Boehringer-Ingelheim, GlaxoSmithKline, Merck, Merck KGaA, and Pfizer), The Swedish Wenner-Gren Foundations (to O. G.), European Commission Contract LSHM-CT-20004-005272 (to H. S. H.), and the Diabetes Research and Wellness Foundation (to H. S. H.) and Diabetes UK(to K. S. and H. S. H.). The costs of publication of this article were defrayed in part by the payment of page charges. This article must therefore be hereby marked "advertisement" in accordance with 18 U. S. C. Section 1734 solely to indicate this fact.	Alessi DR, 1996, FEBS LETT, V399, P333, DOI 10.1016/S0014-5793(96)01370-1; Barnett SF, 2005, BIOCHEM J, V385, P399, DOI 10.1042/BJ20041140; Batty IH, 2004, BIOCHEM J, V379, P641, DOI 10.1042/BJ20031700; Bayascas JR, 2008, MOL CELL BIOL, V28, P3258, DOI 10.1128/MCB.02032-07; Bouskila M, 2008, AM J PHYSIOL-ENDOC M, V294, pE28, DOI 10.1152/ajpendo.00481.2007; BRADFORD MM, 1976, ANAL BIOCHEM, V72, P248, DOI 10.1016/0003-2697(76)90527-3; Cartee GD, 2007, APPL PHYSIOL NUTR ME, V32, P557, DOI 10.1139/H07-026; Dowler S., 2002, SCI STKE, V2002, P16; Dummler B, 2007, BIOCHEM SOC T, V35, P231, DOI 10.1042/BST0350231; Farese RV, 2007, J CLIN INVEST, V117, P2289, DOI 10.1172/JCI31408; Frame S, 2001, BIOCHEM J, V359, P1, DOI 10.1042/0264-6021:3590001; Frias MA, 2006, CURR BIOL, V16, P1865, DOI 10.1016/j.cub.2006.08.001; Gonzalez E, 2006, MOL BIOL CELL, V17, P4484, DOI 10.1091/mbc.E06-07-0585; Gray A, 1999, BIOCHEM J, V344, P929, DOI 10.1042/0264-6021:3440929; Greer EL, 2005, ONCOGENE, V24, P7410, DOI 10.1038/sj.onc.1209086; GUMA A, 1988, BIOCHEM J, V253, P625, DOI 10.1042/bj2530625; Hajduch E, 2001, FEBS LETT, V492, P199, DOI 10.1016/S0014-5793(01)02242-6; Hajduch E, 2001, DIABETOLOGIA, V44, P173, DOI 10.1007/s001250051596; Hajduch E, 1998, DIABETES, V47, P1006, DOI 10.2337/diabetes.47.7.1006; HUNDAL HS, 1994, BIOCHEM J, V297, P289, DOI 10.1042/bj2970289; Hyde R, 2002, J BIOL CHEM, V277, P13628, DOI 10.1074/jbc.M108609200; Hyde R, 2001, BIOCHEM J, V355, P563, DOI 10.1042/bj3550563; Hyde R, 2007, J BIOL CHEM, V282, P19788, DOI 10.1074/jbc.M611520200; Kumar A, 2008, MOL CELL BIOL, V28, P61, DOI 10.1128/MCB.01405-07; Lawrence JC, 1997, DIABETES, V46, P541, DOI 10.2337/diabetes.46.4.541; LAWRENCE JC, 1977, J BIOL CHEM, V252, P444; Lindsley CW, 2005, BIOORG MED CHEM LETT, V15, P761, DOI 10.1016/j.bmcl.2004.11.011; Logie L, 2007, DIABETES, V56, P2218, DOI 10.2337/db07-0343; Mackenzie B, 2004, PFLUG ARCH EUR J PHY, V447, P784, DOI 10.1007/s00424-003-1117-9; Manning BD, 2007, CELL, V129, P1261, DOI 10.1016/j.cell.2007.06.009; McDowell HE, 1998, FEBS LETT, V441, P15, DOI 10.1016/S0014-5793(98)01508-7; McManus EJ, 2005, EMBO J, V24, P1571, DOI 10.1038/sj.emboj.7600633; Milburn CC, 2003, BIOCHEM J, V375, P531, DOI 10.1042/BJ20031229; Plas DR, 2005, ONCOGENE, V24, P7435, DOI 10.1038/sj.onc.1209097; Powell DJ, 2003, MOL CELL BIOL, V23, P7794, DOI 10.1128/MCB.23.21.7794-7808.2003; Sakamoto K, 2008, AM J PHYSIOL-ENDOC M, V295, pE29, DOI 10.1152/ajpendo.90331.2008; Sarbassov DD, 2005, SCIENCE, V307, P1098, DOI 10.1126/science.1106148; Standaert ML, 1999, J BIOL CHEM, V274, P25308, DOI 10.1074/jbc.274.36.25308; TSAKIRIDIS T, 1995, BIOCHEM J, V309, P1; TSAKIRIDIS T, 1995, ENDOCRINOLOGY, V136, P4315, DOI 10.1210/en.136.10.4315; Tsuru M, 2002, AM J PHYSIOL-ENDOC M, V283, pE338, DOI 10.1152/ajpendo.00457.2001; Vander Haar E, 2007, NAT CELL BIOL, V9, P316, DOI 10.1038/ncb1547; Vanhaesebroeck B, 2000, BIOCHEM J, V346, P561, DOI 10.1042/0264-6021:3460561; Walker KS, 1998, BIOCHEM J, V331, P299, DOI 10.1042/bj3310299; Zhou QL, 2004, BIOCHEM SOC T, V32, P817, DOI 10.1042/BST0320817	45	86	91	0	8	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	OCT 10	2008	283	41					27653	27667		10.1074/jbc.M802623200	http://dx.doi.org/10.1074/jbc.M802623200			15	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	355OW	18669636	hybrid			2022-12-27	WOS:000259719200037
J	Haglund, E; Lindberg, MO; Oliveberg, M				Haglund, Ellinor; Lindberg, Magnus O.; Oliveberg, Mikael			Changes of protein folding pathways by circular permutation - Overlapping nuclei promote global cooperativity	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							SINGLE-DOMAIN PROTEINS; TRANSITION-STATE; ENERGY LANDSCAPE; REPEAT PROTEINS; CONTACT ORDER; NATIVE-STATE; AGGREGATION; S6; KINETICS; FAMILY	The evolved properties of proteins are not limited to structure and stability but also include their propensity to undergo local conformational changes. The latter, dynamic property is related to structural cooperativity and is controlled by the folding-energy landscape. Here we demonstrate that the structural cooperativity of the ribosomal protein S6 is optimized by geometric overlap of two competing folding nuclei: they both include the central beta-strand 1. In this way, folding of one nucleus catalyzes the formation of the other, contributing to make the folding transition more concerted overall. The experimental evidence is provided by an extended set of circular permutations of S6 that allows quantitative analysis of pathway plasticity at the level of individual side chains. Because similar overlap between competing nuclei also has been discerned in other proteins, we hypothesize that the coupling of several small nuclei into extended "supernuclei" represents a general principle for propagating folding cooperativity across large structural distances.	[Haglund, Ellinor; Lindberg, Magnus O.; Oliveberg, Mikael] Stockholm Univ, Dept Biochem & Biophys, Arrhenius Labs Nat Sci, S-10691 Stockholm, Sweden	Stockholm University	Oliveberg, M (corresponding author), Stockholm Univ, Dept Biochem & Biophys, Arrhenius Labs Nat Sci, S-10691 Stockholm, Sweden.	mikael.oliveberg@dbb.su.se			Swedish Research Council; Sven and Lilly Lawski Foundation; Knut and Alice Wallenberg Foundation	Swedish Research Council(Swedish Research CouncilEuropean Commission); Sven and Lilly Lawski Foundation; Knut and Alice Wallenberg Foundation(Knut & Alice Wallenberg Foundation)	This work was supported by the Swedish Research Council, the Sven and Lilly Lawski Foundation, and the Knut and Alice Wallenberg Foundation. The costs of publication of this article were defrayed in part by the payment of page charges. This article must therefore be hereby marked "advertisement" in accordance with 18 U.S.C. Section 1734 solely to indicate this fact.	BENNETT MJ, 1994, P NATL ACAD SCI USA, V91, P3127, DOI 10.1073/pnas.91.8.3127; Chavez LL, 2006, P NATL ACAD SCI USA, V103, P10254, DOI 10.1073/pnas.0510110103; Chen J, 2004, PROTEINS, V57, P153, DOI 10.1002/prot.20175; Chiti F, 2002, P NATL ACAD SCI USA, V99, P16419, DOI 10.1073/pnas.212527999; Dumoulin M, 2005, J MOL BIOL, V346, P773, DOI 10.1016/j.jmb.2004.11.020; Fandrich M, 2001, NATURE, V410, P165, DOI 10.1038/35065514; Ferguson N, 2001, P NATL ACAD SCI USA, V98, P13002, DOI 10.1073/pnas.221467198; Ferreiro DU, 2007, P NATL ACAD SCI USA, V104, P7735, DOI 10.1073/pnas.0702682104; Ferreiro DU, 2005, J MOL BIOL, V354, P679, DOI 10.1016/j.jmb.2005.09.078; Fersht A., 1999, STRUCTURE MECH PROTE, DOI 10.1142/10574; Guo ZF, 2006, P NATL ACAD SCI USA, V103, P8042, DOI 10.1073/pnas.0602607103; Jackson SE, 1998, FOLD DES, V3, pR81, DOI 10.1016/S1359-0278(98)00033-9; Lappalainen I, 2008, J MOL BIOL, V375, P547, DOI 10.1016/j.jmb.2007.09.088; LINDAHL M, 1994, EMBO J, V13, P1249, DOI 10.1002/j.1460-2075.1994.tb06376.x; Lindberg M, 2002, NAT STRUCT BIOL, V9, P818, DOI 10.1038/nsb847; Lindberg MO, 2007, CURR OPIN STRUC BIOL, V17, P21, DOI 10.1016/j.sbi.2007.01.008; Lindberg MO, 2006, P NATL ACAD SCI USA, V103, P4083, DOI 10.1073/pnas.0508863103; Lindberg MO, 2001, J MOL BIOL, V314, P891, DOI 10.1006/jmbi.2001.5186; Lowe AR, 2007, P NATL ACAD SCI USA, V104, P2679, DOI 10.1073/pnas.0604653104; MATTHEWS JM, 1995, BIOCHEMISTRY-US, V34, P6805, DOI 10.1021/bi00020a027; Matysiak S, 2004, J MOL BIOL, V343, P235, DOI 10.1016/j.jmb.2004.08.006; Matysiak S, 2006, J MOL BIOL, V363, P297, DOI 10.1016/j.jmb.2006.07.088; Miller EJ, 2002, P NATL ACAD SCI USA, V99, P10359, DOI 10.1073/pnas.162219099; Nordlund A, 2006, P NATL ACAD SCI USA, V103, P10218, DOI 10.1073/pnas.0601696103; Oliveberg M, 1998, ACCOUNTS CHEM RES, V31, P765, DOI 10.1021/ar970089m; Oliveberg M, 2005, Q REV BIOPHYS, V38, P245, DOI 10.1017/S0033583506004185; Olofsson M, 2007, J MOL BIOL, V365, P237, DOI 10.1016/j.jmb.2006.09.016; Otzen DE, 2002, J MOL BIOL, V317, P613, DOI 10.1006/jmbi.2002.5423; Otzen DE, 1999, BIOCHEMISTRY-US, V38, P6499, DOI 10.1021/bi982819j; Otzen DE, 2000, P NATL ACAD SCI USA, V97, P9907, DOI 10.1073/pnas.160086297; Panchenko AR, 1997, J MOL BIOL, V272, P95, DOI 10.1006/jmbi.1997.1205; Panchenko AR, 1996, P NATL ACAD SCI USA, V93, P2008, DOI 10.1073/pnas.93.5.2008; Plaxco KW, 1998, J MOL BIOL, V277, P985, DOI 10.1006/jmbi.1998.1645; Plotkin SS, 2000, P NATL ACAD SCI USA, V97, P6509, DOI 10.1073/pnas.97.12.6509; Richardson JS, 2002, P NATL ACAD SCI USA, V99, P2754, DOI 10.1073/pnas.052706099; Sandelin E, 2007, J BIOL CHEM, V282, P21230, DOI 10.1074/jbc.M700765200; Silow M, 1999, BIOCHEMISTRY-US, V38, P13006, DOI 10.1021/bi9909997; Stoycheva AD, 2004, J MOL BIOL, V340, P571, DOI 10.1016/j.jmb.2004.04.073; Thirumalai D, 2003, CURR OPIN STRUC BIOL, V13, P146, DOI 10.1016/S0959-440X(03)00032-0; Weikl TR, 2008, ARCH BIOCHEM BIOPHYS, V469, P67, DOI 10.1016/j.abb.2007.06.018; Weikl TR, 2003, J MOL BIOL, V332, P953, DOI 10.1016/S0022-2836(03)00884-2; Werbeck ND, 2007, P NATL ACAD SCI USA, V104, P7863, DOI 10.1073/pnas.0610315104; Wu L, 2007, PHYS REV E, V75, DOI 10.1103/PhysRevE.75.031914; Yang SC, 2004, P NATL ACAD SCI USA, V101, P13786, DOI 10.1073/pnas.0403724101; Zarrine-Afsar A, 2005, CURR OPIN STRUC BIOL, V15, P42, DOI 10.1016/j.sbi.2005.01.011	45	48	49	0	8	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	OCT 10	2008	283	41					27904	27915		10.1074/jbc.M801776200	http://dx.doi.org/10.1074/jbc.M801776200			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	355OW	18562318	hybrid			2022-12-27	WOS:000259719200061
J	Shimizu, A; Mammoto, A; Italiano, JE; Pravda, E; Dudley, AC; Ingber, DE; Klagsbrun, M				Shimizu, Akio; Mammoto, Akiko; Italiano, Joseph E., Jr.; Pravda, Elke; Dudley, Andrew C.; Ingber, Donald E.; Klagsbrun, Michael			ABL2/ARG tyrosine kinase mediates SEMA3F-induced RhoA inactivation and cytoskeleton collapse in human glioma cells	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							P190 RHOGAP; GROWTH; ABL; ACTIN; BRAIN; GUIDANCE; FAMILY; SUBSTRATE; PROTEIN; SEMAPHORINS	Class three semaphorins (SEMAs) were originally shown to be mediators of axon guidance that repelled axons and collapsed growth cones, but it is now evident that SEMA3F, for example, has similar effects on tumor cells and endothelial cells (EC). In both human U87MG glioma cells and human umbilical vein EC, SEMA3F induced rapid cytoskeletal collapse, suppressed cell contractility, decreased phosphorylation of cofilin, and inhibited cell migration in culture. Analysis of the signaling pathways showed that SEMA3F formed a complex with NRP2 (neuropilin2) and plexin A1. These interactions eventually led to inactivation of the small GTPase, RhoA, which is necessary for stress fiber formation and cytoskeleton integrity. A novel upstream RhoA mediator was shown to be ABL2, also known as ARG, a membrane- anchored nonreceptor tyrosine kinase. Within minutes after the addition of SEMA3F, ABL2 directly bound plexin A1 but not to a plexin A1 mutant lacking the cytoplasmic domain. In addition, ABL2 phosphorylated and thereby activated p190RhoGAP, which inactivated RhoA (GTP to GDP), resulting in cytoskeleton collapse and inhibition of cell migration. On the other hand, cells overexpressing an ABL2 inactive kinase mutant or treated with ABL2 small interfering RNA did not inactivate RhoA. Cells treated with p190RhoGAP small interfering RNA also did not inactivate RhoA. Together, these results suggested that ABL2/ARG is a novel mediator of SEMA3F- induced RhoA inactivation and collapsing activity.	[Ingber, Donald E.; Klagsbrun, Michael] Childrens Hosp, Dept Pathol, Boston, MA 02115 USA; [Italiano, Joseph E., Jr.] Brigham & Womens Hosp, Div Translat Med, Boston, MA 02115 USA; [Klagsbrun, Michael] Harvard Univ, Childrens Hosp Boston, Sch Med, Vasc Biol Program,Dept Surg,Karp Family Res Labs, Boston, MA 02115 USA	Harvard University; Boston Children's Hospital; Harvard University; Brigham & Women's Hospital; Harvard University; Boston Children's Hospital; Harvard Medical School	Klagsbrun, M (corresponding author), Harvard Univ, Childrens Hosp Boston, Sch Med, Vasc Biol Program,Dept Surg,Karp Family Res Labs, 12-210,300 Longwood Ave, Boston, MA 02115 USA.	michael.klagsbrun@childrens.harvard.edu	Ingber, Donald E/AAC-5894-2019		National Institutes of Health [CA37392, CA45548]; NATIONAL CANCER INSTITUTE [P01CA045548, R37CA037392, R01CA037392, R56CA037392, S15CA058833] Funding Source: NIH RePORTER; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL068130] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	This work was supported, in whole or in part, by National Institutes of Health Grants CA37392 (to M. K.), CA45548 (to M. K. and D. I.), CA58833 (to D. I.), and HL068130 (to J. I.). The costs of publication of this article were defrayed in part by the payment of page charges. This article must therefore be hereby marked "advertisement" in accordance with 18 U. S. C. Section 1734 solely to indicate this fact.	Amano M, 1996, J BIOL CHEM, V271, P20246, DOI 10.1074/jbc.271.34.20246; Amstad PA, 2001, BIOTECHNIQUES, V31, P608, DOI 10.2144/01313pf01; Bamburg JR, 1999, ANNU REV CELL DEV BI, V15, P185, DOI 10.1146/annurev.cellbio.15.1.185; Barberis D, 2005, J CELL SCI, V118, P4689, DOI 10.1242/jcs.02590; Bielenberg DR, 2007, CANCER METAST REV, V26, P421, DOI 10.1007/s10555-007-9097-4; Bielenberg DR, 2006, EXP CELL RES, V312, P584, DOI 10.1016/j.yexcr.2005.11.024; Bielenberg DR, 2004, J CLIN INVEST, V114, P1260, DOI 10.1172/JCI200421378; Brouns MR, 2001, NAT CELL BIOL, V3, P361, DOI 10.1038/35070042; Burridge K, 2004, CELL, V116, P167, DOI 10.1016/S0092-8674(04)00003-0; Butler JP, 2002, AM J PHYSIOL-CELL PH, V282, pC595, DOI 10.1152/ajpcell.00270.2001; Chauvet S, 2007, NEURON, V56, P807, DOI 10.1016/j.neuron.2007.10.019; Chen H, 1998, NAT NEUROSCI, V1, P436, DOI 10.1038/2154; CHEN WT, 1981, J CELL BIOL, V90, P187, DOI 10.1083/jcb.90.1.187; Christensen C, 2005, CANCER RES, V65, P6167, DOI 10.1158/0008-5472.CAN-04-4309; Dembo M, 1999, BIOPHYS J, V76, P2307, DOI 10.1016/S0006-3495(99)77386-8; Etienne-Manneville S, 2002, NATURE, V420, P629, DOI 10.1038/nature01148; FAN JH, 1993, J CELL BIOL, V121, P867, DOI 10.1083/jcb.121.4.867; Geretti E, 2007, J BIOL CHEM, V282, P25698, DOI 10.1074/jbc.M702942200; GERTLER FB, 1989, CELL, V58, P103, DOI 10.1016/0092-8674(89)90407-8; Ghosh M, 2004, SCIENCE, V304, P743, DOI 10.1126/science.1094561; Gu CH, 2005, SCIENCE, V307, P265, DOI 10.1126/science.1105416; Hall A, 2005, BIOCHEM SOC T, V33, P891, DOI 10.1042/BST0330891; He ZG, 1997, CELL, V90, P739, DOI 10.1016/S0092-8674(00)80534-6; Hernandez SE, 2004, CURR BIOL, V14, P691, DOI 10.1016/j.cub.2004.03.062; Hernandez SE, 2004, TRENDS CELL BIOL, V14, P36, DOI 10.1016/j.tcb.2003.11.003; Hu HL, 2005, CURR BIOL, V15, P815, DOI 10.1016/j.cub.2005.03.049; Huang TY, 2006, CURR OPIN CELL BIOL, V18, P26, DOI 10.1016/j.ceb.2005.11.005; Jin Z, 1997, J NEUROSCI, V17, P6256; Kessler O, 2004, CANCER RES, V64, P1008, DOI 10.1158/0008-5472.CAN-03-3090; Klagsbrun M, 2005, CYTOKINE GROWTH F R, V16, P535, DOI 10.1016/j.cytogfr.2005.05.002; Koleske AJ, 1998, NEURON, V21, P1259, DOI 10.1016/S0896-6273(00)80646-7; Kolodkin AL, 1997, CELL, V90, P753, DOI 10.1016/S0092-8674(00)80535-8; LUO YL, 1993, CELL, V75, P217, DOI 10.1016/0092-8674(93)80064-L; Maekawa M, 1999, SCIENCE, V285, P895, DOI 10.1126/science.285.5429.895; Mammoto A, 2007, J CELL SCI, V120, P456, DOI 10.1242/jcs.03353; Mammoto T, 2007, J BIOL CHEM, V282, P23910, DOI 10.1074/jbc.M702169200; Miao HQ, 1999, J CELL BIOL, V146, P233, DOI 10.1083/jcb.146.1.233; Mitsui N, 2002, EMBO J, V21, P3274, DOI 10.1093/emboj/cdf328; Morita A, 2006, J NEUROSCI, V26, P2971, DOI 10.1523/JNEUROSCI.5453-05.2006; Mostoslavsky G, 2005, MOL THER, V11, P932, DOI 10.1016/j.ymthe.2005.01.005; Nakajima M, 2003, EUR J PHARMACOL, V459, P113, DOI 10.1016/S0014-2999(02)02869-8; Olson MF, 2008, CURR OPIN CELL BIOL, V20, P242, DOI 10.1016/j.ceb.2008.01.002; PEACOCK JG, 2007, J MOL BIOL; Pelham RJ, 1997, P NATL ACAD SCI USA, V94, P13661, DOI 10.1073/pnas.94.25.13661; PUSCHEL AW, 1995, NEURON, V14, P941, DOI 10.1016/0896-6273(95)90332-1; RAPER JA, 1990, NEURON, V4, P21, DOI 10.1016/0896-6273(90)90440-Q; Serini G, 2003, NATURE, V424, P391, DOI 10.1038/nature01784; Takahashi T, 2001, NEURON, V29, P429, DOI 10.1016/S0896-6273(01)00216-1; Takahashi T, 1999, CELL, V99, P59, DOI 10.1016/S0092-8674(00)80062-8; Tamagnone L, 1999, CELL, V99, P71, DOI 10.1016/S0092-8674(00)80063-X; Toyofuku T, 2004, NAT CELL BIOL, V6, P1204, DOI 10.1038/ncb1193; Wong S, 2004, ANNU REV IMMUNOL, V22, P247, DOI 10.1146/annurev.immunol.22.012703.104753; Xue F, 2008, HEPATOL RES, V38, P810, DOI 10.1111/j.1872-034X.2008.00333.x; Yaron A, 2005, NEURON, V45, P513, DOI 10.1016/j.neuron.2005.01.013; Yazdani U, 2006, GENOME BIOL, V7, DOI 10.1186/gb-2006-7-3-211; Ying H, 2006, MOL CANCER THER, V5, P2158, DOI 10.1158/1535-7163.MCT-05-0440; Zalutsky MR, 2005, J NUCL MED, V46, p151S	57	78	85	1	10	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	OCT 3	2008	283	40					27230	27238		10.1074/jbc.M804520200	http://dx.doi.org/10.1074/jbc.M804520200			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	353RT	18660502	Green Published, hybrid			2022-12-27	WOS:000259586600043
J	Cheng, GL; Basha, E; Wysocki, VH; Vierling, E				Cheng, Guilong; Basha, Eman; Wysocki, Vicki H.; Vierling, Elizabeth			Insights into small heat shock protein and substrate structure during chaperone action derived from hydrogen/deuterium exchange and mass spectrometry	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							AMIDE HYDROGEN-EXCHANGE; ALPHA-B-CRYSTALLIN; SUBUNIT EXCHANGE; CONFORMATIONAL-CHANGES; A-CRYSTALLIN; DOMAIN; DYNAMICS; REVEALS; BINDING; STATES	Small heat shock proteins (sHSPs) and the related alpha-crystallins are ubiquitous chaperones linked to neurodegenerative diseases, myopathies, and cataract. To better define their mechanism of chaperone action, we used hydrogen/deuterium exchange and mass spectrometry (HXMS) to monitor conformational changes during complex formation between the structurally defined sHSPs, pea PsHsp18.1, and wheat TaHsp16.9, and the heat-denatured model substrates malate dehydrogenase (MDH) and firefly luciferase. Remarkably, we found that even when complexed with substrate, the highly dynamic local structure of the sHSPs, especially in the N-terminal arm (> 70% exchange in 5 s), remains unchanged. These results, coupled with sHSP-substrate complex stability, indicate that sHSPs do not adopt new secondary structure when binding substrate and suggest sHSPs are tethered to substrate at multiple sites that are locally dynamic, a feature that likely facilitates recognition and refolding of sHSP-bound substrate by the Hsp70/DnaK chaperone system. Both substrates were found to be stabilized in a partially unfolded state that is observed only in the presence of sHSP. Furthermore, peptide-level HXMS showed MDH was substantially protected in two core regions (residues 95-156 and 228-252), which overlap with the MDH structure protected in the GroEL-bound MDH refolding intermediate. Significantly, despite differences in the size and structure of TaHsp16.9-MDH and PsHsp18.1-MDH complexes, peptide-level HXMS patterns for MDH in both complexes are virtually identical, indicating that stabilized MDH thermal unfolding intermediates are not determined by the identity of the sHSP.	[Basha, Eman; Wysocki, Vicki H.; Vierling, Elizabeth] Univ Arizona, Dept Biochem & Mol Biophys, Tucson, AZ 85721 USA; [Cheng, Guilong; Wysocki, Vicki H.] Univ Arizona, Dept Chem, Tucson, AZ 85721 USA	University of Arizona; University of Arizona	Vierling, E (corresponding author), Univ Arizona, Dept Biochem & Mol Biophys, 1007 E Lowell St, Tucson, AZ 85721 USA.	vierling@u.arizona.edu		Wysocki, Vicki/0000-0003-0495-2538; Vierling, Elizabeth/0000-0002-0066-4881	National Institutes of Health [GM42762, GM051387]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM051387] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported, in whole or in part, by National Institutes of Health Grant GM42762 (to E. V.) and Grant GM051387 (to V. H. W.). This work was also supported by the 2005 - 2006 Pfizer Graduate Research Fellowship in Analytical Chemistry (to G. C.). The costs of publication of this article were defrayed in part by the payment of page charges. This article must therefore be hereby marked "advertisement" in accordance with 18 U. S. C. Section 1734 solely to indicate this fact.	Aquilina JA, 2007, BIOCHEM BIOPH RES CO, V353, P1115, DOI 10.1016/j.bbrc.2006.12.176; Arrigo AP, 2007, ADV EXP MED BIOL, V594, P14; BAI YW, 1993, PROTEINS, V17, P75, DOI 10.1002/prot.340170110; Basha E, 2004, EUR J BIOCHEM, V271, P1426, DOI 10.1111/j.1432-1033.2004.04033.x; Basha E, 2006, J BIOL CHEM, V281, P39943, DOI 10.1074/jbc.M607677200; Bjorkdahl C, 2008, J NEUROSCI RES, V86, P1343, DOI 10.1002/jnr.21589; Bova MP, 2000, J BIOL CHEM, V275, P1035, DOI 10.1074/jbc.275.2.1035; Bova MP, 1997, J BIOL CHEM, V272, P29511, DOI 10.1074/jbc.272.47.29511; Brady JP, 1997, P NATL ACAD SCI USA, V94, P884, DOI 10.1073/pnas.94.3.884; Carulla N, 2005, NATURE, V436, P554, DOI 10.1038/nature03986; Carver JA, 2002, J MOL BIOL, V318, P815, DOI 10.1016/S0022-2836(02)00144-4; Chen JW, 2001, NAT STRUCT BIOL, V8, P721, DOI 10.1038/90443; Cheng GL, 2006, J AM SOC MASS SPECTR, V17, P1518, DOI 10.1016/j.jasms.2006.04.028; Cheng GL, 2006, BIOCHEMISTRY-US, V45, P11744, DOI 10.1021/bi0608663; Dierick I, 2005, ANN MED, V37, P413, DOI 10.1080/07853890500296410; Elad N, 2007, MOL CELL, V26, P415, DOI 10.1016/j.molcel.2007.04.004; ENGLANDER JJ, 1985, ANAL BIOCHEM, V147, P234, DOI 10.1016/0003-2697(85)90033-8; Farr GW, 2000, CELL, V100, P561, DOI 10.1016/S0092-8674(00)80692-3; Fenton WA, 2003, Q REV BIOPHYS, V36, P229, DOI 10.1017/S0033583503003883; Friedrich KL, 2004, J BIOL CHEM, V279, P1080, DOI 10.1074/jbc.M311104200; Giese KC, 2005, P NATL ACAD SCI USA, V102, P18896, DOI 10.1073/pnas.0506169103; Haslbeck M, 1999, EMBO J, V18, P6744, DOI 10.1093/emboj/18.23.6744; Haslbeck M, 2004, J MOL BIOL, V343, P445, DOI 10.1016/j.jmb.2004.08.048; Haslbeck M, 2005, NAT STRUCT MOL BIOL, V12, P842, DOI 10.1038/nsmb993; Horst R, 2005, P NATL ACAD SCI USA, V102, P12748, DOI 10.1073/pnas.0505642102; Kheterpal I, 2006, METHOD ENZYMOL, V413, P140, DOI 10.1016/S0076-6879(06)13008-6; Kim KK, 1998, NATURE, V394, P595, DOI 10.1038/29106; Komives EA, 2005, INT J MASS SPECTROM, V240, P285, DOI 10.1016/j.ijms.2004.09.016; Lee GJ, 2000, PLANT PHYSIOL, V122, P189, DOI 10.1104/pp.122.1.189; LEE GJ, 1995, J BIOL CHEM, V270, P10432, DOI 10.1074/jbc.270.18.10432; Lee GJ, 1997, EMBO J, V16, P659, DOI 10.1093/emboj/16.3.659; Lindner RA, 2001, BIOCHEM J, V354, P79, DOI 10.1042/0264-6021:3540079; Mogk A, 2003, J BIOL CHEM, V278, P31033, DOI 10.1074/jbc.M303587200; Ousman SS, 2007, NATURE, V448, P474, DOI 10.1038/nature05935; Rist W, 2006, J BIOL CHEM, V281, P16493, DOI 10.1074/jbc.M600847200; Sharp PS, 2008, NEUROBIOL DIS, V30, P42, DOI 10.1016/j.nbd.2007.12.002; Shi JX, 2006, J BIOL CHEM, V281, P12170, DOI 10.1074/jbc.M600154200; Smith DL, 1997, J MASS SPECTROM, V32, P135, DOI 10.1002/(SICI)1096-9888(199702)32:2<135::AID-JMS486>3.0.CO;2-M; Sobott F, 2002, J BIOL CHEM, V277, P38921, DOI 10.1074/jbc.M206060200; Sun Y, 2005, CELL MOL LIFE SCI, V62, P2460, DOI 10.1007/s00018-005-5190-4; Treweek TM, 2000, BBA-PROTEIN STRUCT M, V1481, P175, DOI 10.1016/S0167-4838(00)00109-6; Van Montfort R, 2002, ADV PROTEIN CHEM, V59, P105; van Montfort RLM, 2001, NAT STRUCT BIOL, V8, P1025, DOI 10.1038/nsb722; Veinger L, 1998, J BIOL CHEM, V273, P11032, DOI 10.1074/jbc.273.18.11032; Wales TE, 2006, MASS SPECTROM REV, V25, P158, DOI 10.1002/mas.20064; Wang LT, 2002, MOL CELL PROTEOMICS, V1, P132, DOI 10.1074/mcp.M100009-MCP200; Wintrode PL, 2003, BIOCHEMISTRY-US, V42, P10667, DOI 10.1021/bi034117m; Wu Z, 2007, NAT STRUCT MOL BIOL, V14, P861, DOI 10.1038/nsmb1284; Zhang ZQ, 1998, J AM SOC MASS SPECTR, V9, P225, DOI 10.1016/S1044-0305(97)00284-5	49	58	60	1	17	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	SEP 26	2008	283	39					26634	26642		10.1074/jbc.M802946200	http://dx.doi.org/10.1074/jbc.M802946200			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	350GV	18621732	hybrid, Green Accepted, Green Published			2022-12-27	WOS:000259341600039
J	Good, DW; George, T; Watts, BA				Good, David W.; George, Thampi; Watts, Bruns A., III			Nerve growth factor inhibits Na+/H+ exchange and HCO3- absorption through parallel phosphatidylinositol 3-kinase-mTOR and ERK pathways in thick ascending limb	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							CALCINEURIN HOMOLOGOUS PROTEIN; NA-H EXCHANGE; PHOSPHOINOSITIDE 3-KINASE; MAMMALIAN TARGET; APICAL MEMBRANE; S6 KINASE; PHOSPHATASE 2A; CELL-GROWTH; RAT-KIDNEY; NHE1	In the medullary thick ascending limb, inhibiting the basolateral NHE1 Na+/H+ exchanger with nerve growth factor (NGF) induces actin cytoskeleton remodeling that secondarily inhibits apical NHE3 and transepithelial HCO3- absorption. The inhibition by NGF is mediated 50% through activation of extracellular signal-regulated kinase (ERK). Here we examined the signaling pathway responsible for the remainder of the NGF-induced inhibition. Inhibition of HCO3- absorption was reduced 45% by the phosphatidylinositol 3-kinase (PI3K) inhibitors wortmannin or LY294002 and 50% by rapamycin, a specific inhibitor of mammalian target of rapamycin (mTOR), a downstream effector of PI3K. The combination of a PI3K inhibitor plus rapamycin did not cause a further reduction in the inhibition by NGF. In contrast, the combination of a PI3K inhibitor plus the MEK/ERK inhibitor U0126 completely eliminated inhibition by NGF. Rapamycin decreased NGF-induced inhibition of basolateral NHE1 by 45%. NGF induced a 2-fold increase in phosphorylation of Akt, a PI3K target linked to mTOR activation, and a 2.2-fold increase in the activity of p70 S6 kinase, a downstream effector of mTOR. p70 S6 kinase activation was blocked by wortmannin and rapamycin, consistent with PI3K, mTOR, and p70 S6 kinase in a linear pathway. Rapamycin-sensitive inhibition of NHE1 by NGF was associated with an increased level of phosphorylated mTOR in the basolateral membrane domain. These findings indicate that NGF inhibits HCO3- absorption in the medullary thick ascending limb through the parallel activation of PI3K-mTOR and ERK signaling pathways, which converge to inhibit NHE1. The results identify a role for mTOR in the regulation of Na+/H+ exchange activity and implicate NHE1 as a possible downstream effector contributing to mTOR's effects on cell growth, proliferation, survival, and tumorigenesis.	[Good, David W.] Univ Texas Galveston, Med Branch, Dept Med, Galveston, TX 77555 USA; Univ Texas Galveston, Med Branch, Dept Neurosci & Cell Biol, Galveston, TX 77555 USA	University of Texas System; University of Texas Medical Branch Galveston; University of Texas System; University of Texas Medical Branch Galveston	Good, DW (corresponding author), Univ Texas Galveston, Med Branch, Dept Med, 4-200 John Sealy Annex,301 Univ Blvd, Galveston, TX 77555 USA.	dgood@utmb.edu			National Institutes of Health [R01 DK-038217]; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK038217] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	This work was supported, in whole or in part, by National Institutes of Health Grant R01 DK-038217. The costs of publication of this article were defrayed in part by the payment of page charges. This article must therefore be hereby marked "advertisement" in accordance with 18 U. S. C. Section 1734 solely to indicate this fact.	Alper SL, 1997, AM J PHYSIOL-RENAL, V273, pF601, DOI 10.1152/ajprenal.1997.273.4.F601; Alpern RJ, 2000, KIDNEY, P455; AMEMIYA M, 1995, KIDNEY INT, V48, P1206, DOI 10.1038/ki.1995.404; Avruch J, 2005, CURR OPIN CLIN NUTR, V8, P67, DOI 10.1097/00075197-200501000-00010; Biemesderfer D, 1997, AM J PHYSIOL-RENAL, V273, pF289, DOI 10.1152/ajprenal.1997.273.2.F289; Brunn GJ, 1996, EMBO J, V15, P5256, DOI 10.1002/j.1460-2075.1996.tb00911.x; Buhaescu I, 2006, THER DRUG MONIT, V28, P577, DOI 10.1097/01.ftd.0000245377.93401.39; Cantley LC, 2002, SCIENCE, V296, P1655, DOI 10.1126/science.296.5573.1655; Cardone RA, 2005, NAT REV CANCER, V5, P786, DOI 10.1038/nrc1713; Chiang GG, 2005, J BIOL CHEM, V280, P25485, DOI 10.1074/jbc.M501707200; Counillon L, 2000, J BIOL CHEM, V275, P1, DOI 10.1074/jbc.275.1.1; Davies SP, 2000, BIOCHEM J, V351, P95, DOI 10.1042/0264-6021:3510095; Donowitz M, 2007, PHYSIOL REV, V87, P825, DOI 10.1152/physrev.00030.2006; Eguchi S, 1999, J BIOL CHEM, V274, P36843, DOI 10.1074/jbc.274.52.36843; Fingar DC, 2004, ONCOGENE, V23, P3151, DOI 10.1038/sj.onc.1207542; Fukao T, 2003, TRENDS IMMUNOL, V24, P358, DOI 10.1016/S1471-4906(03)00139-X; Good DW, 1999, AM J PHYSIOL-RENAL, V276, pF726, DOI 10.1152/ajprenal.1999.276.5.F726; Good DW, 2006, AM J PHYSIOL-CELL PH, V290, pC757, DOI 10.1152/ajpcell.00391.2005; Good DW, 2004, AM J PHYSIOL-RENAL, V287, pF1244, DOI 10.1152/ajprenal.00176.2004; Good DW, 1996, AM J PHYSIOL-RENAL, V270, pF691, DOI 10.1152/ajprenal.1996.270.4.F691; Good DW, 1998, AM J PHYSIOL-CELL PH, V274, pC931, DOI 10.1152/ajpcell.1998.274.4.C931; GOOD DW, 1993, SEMIN NEPHROL, V13, P225; GOOD DW, 1990, J CLIN INVEST, V85, P1006, DOI 10.1172/JCI114530; Good DW, 2000, AM J PHYSIOL-CELL PH, V279, pC1443, DOI 10.1152/ajpcell.2000.279.5.C1443; Good DW, 1995, P NATL ACAD SCI USA, V92, P12525, DOI 10.1073/pnas.92.26.12525; Guertin DA, 2007, CANCER CELL, V12, P9, DOI 10.1016/j.ccr.2007.05.008; Harwood FC, 2008, J BIOL CHEM, V283, P2575, DOI 10.1074/jbc.M706173200; Holz MK, 2005, J BIOL CHEM, V280, P26089, DOI 10.1074/jbc.M504045200; Kenerson HL, 2002, CANCER RES, V62, P5645; Kurashima K, 1998, J BIOL CHEM, V273, P20828, DOI 10.1074/jbc.273.33.20828; Lagana A, 2000, J CELL SCI, V113, P3649; Lin X, 1996, P NATL ACAD SCI USA, V93, P12631, DOI 10.1073/pnas.93.22.12631; Liu Y, 2006, KIDNEY INT, V69, P1925, DOI 10.1038/sj.ki.5001543; MA YH, 1994, J BIOL CHEM, V269, P30734; Manning BD, 2005, GENE DEV, V19, P1773, DOI 10.1101/gad.1314605; Mora A, 2004, SEMIN CELL DEV BIOL, V15, P161, DOI 10.1016/j.semcdb.2003.12.022; Orlowski J, 1997, J BIOL CHEM, V272, P22373, DOI 10.1074/jbc.272.36.22373; Pang TX, 2001, J BIOL CHEM, V276, P17367, DOI 10.1074/jbc.M100296200; Peterson RT, 1999, P NATL ACAD SCI USA, V96, P4438, DOI 10.1073/pnas.96.8.4438; Putney LK, 2002, ANNU REV PHARMACOL, V42, P527, DOI 10.1146/annurev.pharmtox.42.092001.143801; Rameh LE, 1999, J BIOL CHEM, V274, P8347, DOI 10.1074/jbc.274.13.8347; Reshkin SJ, 2000, J BIOL CHEM, V275, P5361, DOI 10.1074/jbc.275.8.5361; Slepkov ER, 2007, BIOCHEM J, V401, P623, DOI 10.1042/BJ20061062; Stock C, 2006, ACTA PHYSIOL, V187, P149, DOI 10.1111/j.1748-1716.2006.01543.x; Takahashi E, 1999, J BIOL CHEM, V274, P20206, DOI 10.1074/jbc.274.29.20206; Tee AR, 2003, J BIOL CHEM, V278, P37288, DOI 10.1074/jbc.M303257200; Tominaga T, 1998, EMBO J, V17, P4712, DOI 10.1093/emboj/17.16.4712; Volarevic S, 2001, PROG NUCLEIC ACID RE, V65, P101; WAKABAYASHI S, 1994, J BIOL CHEM, V269, P13710; Watts BA, 2005, J BIOL CHEM, V280, P11439, DOI 10.1074/jbc.M410719200; Watts BA, 2002, AM J PHYSIOL-RENAL, V282, pF1056, DOI 10.1152/ajprenal.00133.2001; Watts BA, 1998, AM J PHYSIOL-RENAL, V275, pF478, DOI 10.1152/ajprenal.1998.275.4.F478; Watts BA, 1999, J CLIN INVEST, V104, P1593, DOI 10.1172/JCI7332; WATTS BA, 1994, J BIOL CHEM, V269, P20250; Watts BA, 1999, J BIOL CHEM, V274, P7841, DOI 10.1074/jbc.274.12.7841; WATTS BA, 2005, AM J PHYSIOL, V291, pF1005; WATTS BA, 2006, J AM SOC NEPHROL, V17; Wee S, 2008, CURR OPIN ONCOL, V20, P77, DOI 10.1097/CCO.0b013e3282f3111e; Williams DL, 2006, SHOCK, V25, P432, DOI 10.1097/01.shk.0000209542.76305.55; Woods TC, 2004, ANNU REV MED, V55, P169, DOI 10.1146/annurev.med.55.091902.105243; Yan WH, 2001, J BIOL CHEM, V276, P31349, DOI 10.1074/jbc.M102679200; YANO H, 1993, J BIOL CHEM, V268, P25846	62	25	25	0	0	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	SEP 26	2008	283	39					26602	26611		10.1074/jbc.M803019200	http://dx.doi.org/10.1074/jbc.M803019200			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	350GV	18660503	Green Published, hybrid			2022-12-27	WOS:000259341600036
J	Jasiak, AJ; Hartmann, H; Karakasili, E; Kalocsay, M; Flatley, A; Kremmer, E; Strasser, K; Martin, DE; Soding, J; Cramer, P				Jasiak, Anna J.; Hartmann, Holger; Karakasili, Elena; Kalocsay, Marian; Flatley, Andrew; Kremmer, Elisabeth; Straesser, Katja; Martin, Dietmar E.; Soeding, Johannes; Cramer, Patrick			Genome-associated RNA polymerase II includes the dissociable Rpb4/7 subcomplex	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							SACCHAROMYCES-CEREVISIAE; SUBUNIT RPB4; TRANSCRIPTION; INITIATION; RECRUITMENT; ELONGATION; RESOLUTION; STRESS	Yeast RNA polymerase (Pol) II consists of a 10-subunit core enzyme and the Rpb4/7 subcomplex, which is dispensable for catalytic activity and dissociates in vitro. To investigate whether Rpb4/7 is an integral part of DNA-associated Pol II in vivo, we used chromatin immunoprecipitation coupled to high resolution tiling microarray analysis. We show that the genome-wide occupancy profiles for Rpb7 and the core subunit Rpb3 are essentially identical. Thus, the complete Pol II associates with DNA in vivo, consistent with functional roles of Rpb4/7 throughout the transcription cycle.	[Jasiak, Anna J.; Hartmann, Holger; Karakasili, Elena; Straesser, Katja; Martin, Dietmar E.; Soeding, Johannes; Cramer, Patrick] Univ Munich, Gene Ctr, D-81377 Munich, Germany; [Jasiak, Anna J.; Hartmann, Holger; Karakasili, Elena; Straesser, Katja; Martin, Dietmar E.; Soeding, Johannes; Cramer, Patrick] Univ Munich, Ctr Integrated Prot Sci Munich, Dept Chem & Biochem, D-81377 Munich, Germany; [Kalocsay, Marian] Max Planck Inst Biochem, Dept Mol Cell Biol, D-82152 Martinsried, Germany; [Flatley, Andrew; Kremmer, Elisabeth] Helmholtz Zentrum Munchen, Inst Mol Immunol, D-81377 Munich, Germany	University of Munich; University of Munich; Max Planck Society; Helmholtz Association; Helmholtz-Center Munich - German Research Center for Environmental Health	Cramer, P (corresponding author), Univ Munich, Gene Ctr, Feodor Lynen Str 25, D-81377 Munich, Germany.	cramer@LMB.uni-muenchen.de	Söding, Johannes/A-3341-2013; Kalocsay, Marian/ABH-5959-2020	Söding, Johannes/0000-0001-9642-8244; Kalocsay, Marian/0000-0002-4187-5829; Strasser, Katja/0000-0003-3533-5516	Deutsche Forschungsgemeinschaft, the Sonderforschungsbereich [SFB646]; Nanoscience Initiative Munich NIM, the Elitenetzwerk Bayern; Transregio 5 Chromatin; Chemischen Industrie	Deutsche Forschungsgemeinschaft, the Sonderforschungsbereich(German Research Foundation (DFG)); Nanoscience Initiative Munich NIM, the Elitenetzwerk Bayern(Department of Science & Technology (India)); Transregio 5 Chromatin; Chemischen Industrie	This work was supported by the Deutsche Forschungsgemeinschaft, the Sonderforschungsbereich SFB646, the Nanoscience Initiative Munich NIM, the Elitenetzwerk Bayern, the Transregio 5 Chromatin, and the Fonds der Chemischen Industrie. The costs of publication of this article were defrayed in part by the payment of page charges. This article must therefore be hereby marked "advertisement" in accordance with 18 U. S. C. Section 1734 solely to indicate this fact.	APARICIO O, 2005, CURR PROT MOL BIOL, V21; Armache KJ, 2005, J BIOL CHEM, V280, P7131, DOI 10.1074/jbc.M413038200; Armache KJ, 2003, P NATL ACAD SCI USA, V100, P6964, DOI 10.1073/pnas.1030608100; Bushnell DA, 2003, P NATL ACAD SCI USA, V100, P6969, DOI 10.1073/pnas.1130601100; Cojocaru M, 2008, BIOCHEM J, V409, P139, DOI 10.1042/BJ20070751; Cramer Patrick, 2001, Science (Washington D C), V292, P1863, DOI 10.1126/science.1059493; Do JH, 2006, MOL CELLS, V22, P254; EDWARDS AM, 1991, J BIOL CHEM, V266, P71; Liu CL, 2005, PLOS BIOL, V3, P1753, DOI 10.1371/journal.pbio.0030328; Lotan R, 2005, GENE DEV, V19, P3004, DOI 10.1101/gad.353205; Mitsuzawa H, 2003, NUCLEIC ACIDS RES, V31, P4696, DOI 10.1093/nar/gkg688; Miyao T, 2001, J BIOL CHEM, V276, P46408, DOI 10.1074/jbc.M107012200; Orlicky SM, 2001, J BIOL CHEM, V276, P10097, DOI 10.1074/jbc.M003165200; Pillai B, 2003, J BIOL CHEM, V278, P3339, DOI 10.1074/jbc.M112180200; Radonjic M, 2005, MOL CELL, V18, P171, DOI 10.1016/j.molcel.2005.03.010; Runner VM, 2008, MOL CELL BIOL, V28, P1883, DOI 10.1128/MCB.01714-07; Sakurai H, 1999, MOL CELL BIOL, V19, P7511; Selitrennik M, 2006, EUKARYOT CELL, V5, P2092, DOI 10.1128/EC.00288-06; Steinmetz EJ, 2006, MOL CELL, V24, P735, DOI 10.1016/j.molcel.2006.10.023; Verma-Gaur J, 2008, EUKARYOT CELL, V7, P1009, DOI 10.1128/EC.00057-08; Wade JT, 2008, CURR OPIN GENET DEV, V18, P130, DOI 10.1016/j.gde.2007.12.008; WOYCHIK NA, 1989, MOL CELL BIOL, V9, P2854, DOI 10.1128/MCB.9.7.2854; Yang YH, 2002, NAT REV GENET, V3, P579, DOI 10.1038/nrg863	23	40	40	0	3	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	SEP 26	2008	283	39					26423	26427		10.1074/jbc.M803237200	http://dx.doi.org/10.1074/jbc.M803237200			5	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	350GV	18667430	Green Published, hybrid			2022-12-27	WOS:000259341600016
J	Nair, MS; Dean, DH				Nair, Manoj S.; Dean, Donald H.			All domains of Cry1A toxins insert into insect brush border membranes	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							THURINGIENSIS DELTA-ENDOTOXIN; HORNWORM MANDUCA-SEXTA; PLANAR LIPID BILAYERS; BACILLUS-THURINGIENSIS; CRYSTAL-STRUCTURE; IRREVERSIBLE BINDING; CHANNEL FORMATION; LYMANTRIA-DISPAR; AMINOPEPTIDASE-N; LARVAL MIDGUT	A critical step in understanding the mode of action of insecticidal crystal toxins from Bacillus thuringiensis is their partitioning into membranes and, in particular, the insertion of the toxin into insect brush border membranes. The Umbrella and Penknife models predict that only alpha-helix 5 of domain I along with adjacent helices alpha-4 or alpha-6 insert into the brush border membranes because of their hydrophobic nature. By employing fluorescent-labeled cysteine mutations, we observe that all three domains of the toxin insert into the insect membrane. Using proteinase K protection assays, steady state fluorescence quenching measurements, and blue shift analysis of acrylodan-labeled cysteine mutants, we show that regions beyond those proposed by the two models insert into the membrane. Based on our studies, the only extended region that does not partition into the membrane is that of alpha-helix 1. Bioassays and voltage clamping studies show that all mutations examined, except certain domain II mutations in loop 2 (e.g. F371C and G374C), which disrupt membrane partitioning, retain their ability to form ion channels and toxicity in Manduca sexta larvae. This study confirms our earlier hypothesis that insertion of crystal toxin does not occur as separate helices alone, but virtually the entire molecule inserts as one or more units of the whole molecule.	[Nair, Manoj S.; Dean, Donald H.] Ohio State Univ, Biophys Program, Columbus, OH 43210 USA; [Dean, Donald H.] Ohio State Univ, Dept Biochem, Columbus, OH 43210 USA	University System of Ohio; Ohio State University; University System of Ohio; Ohio State University	Dean, DH (corresponding author), 772 Biosci Bldg,484 W 12th Ave, Columbus, OH 43210 USA.	dean.10@osu.edu	Nair, Manoj/B-4389-2009	Nair, Manoj/0000-0002-5994-3957	NIAID NIH HHS [R01 AI029092] Funding Source: Medline	NIAID NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))		Alzate O, 2006, BIOCHEMISTRY-US, V45, P13597, DOI 10.1021/bi061474z; Arnold S, 2001, FEBS LETT, V490, P70, DOI 10.1016/S0014-5793(01)02139-1; Aronson A, 2000, APPL ENVIRON MICROB, V66, P4568, DOI 10.1128/AEM.66.10.4568-4570.2000; Aronson AI, 1999, APPL ENVIRON MICROB, V65, P2503; Boonserm P, 2006, J BACTERIOL, V188, P3391, DOI 10.1128/JB.188.9.3391-3401.2006; Boonserm P, 2005, J MOL BIOL, V348, P363, DOI 10.1016/j.jmb.2005.02.013; Bravo A, 2004, BBA-BIOMEMBRANES, V1667, P38, DOI 10.1016/j.bbamem.2004.08.013; CHAMBERLIN ME, 1994, PHYSIOL ZOOL, V67, P82, DOI 10.1086/physzool.67.1.30163836; Francis BR, 1997, INSECT BIOCHEM MOLEC, V27, P541, DOI 10.1016/S0965-1748(97)00029-5; Galitsky N, 2001, ACTA CRYSTALLOGR D, V57, P1101, DOI 10.1107/S0907444901008186; Gazit E, 1998, P NATL ACAD SCI USA, V95, P12289, DOI 10.1073/pnas.95.21.12289; GAZIT E, 1993, BIOCHEMISTRY-US, V32, P3429, DOI 10.1021/bi00064a029; Griffitts JS, 2001, SCIENCE, V293, P860, DOI 10.1126/science.1062441; Griffitts JS, 2005, SCIENCE, V307, P922, DOI 10.1126/science.1104444; GROCHULSKI P, 1995, J MOL BIOL, V254, P447, DOI 10.1006/jmbi.1995.0630; HOFTE H, 1989, MICROBIOL REV, V53, P242; Hua G, 2004, J BIOL CHEM, V279, P28051, DOI 10.1074/jbc.M400237200; KNIGHT PJK, 1994, MOL MICROBIOL, V11, P429, DOI 10.1111/j.1365-2958.1994.tb00324.x; KNOWLES BH, 1994, ADV INSECT PHYSIOL, V24, P275, DOI 10.1016/S0065-2806(08)60085-5; KUNKEL TA, 1985, P NATL ACAD SCI USA, V82, P488, DOI 10.1073/pnas.82.2.488; Lee MK, 1996, BIOCHEM BIOPH RES CO, V229, P139, DOI 10.1006/bbrc.1996.1770; LEE MK, 1992, J BIOL CHEM, V267, P3115; LI JD, 1991, NATURE, V353, P815, DOI 10.1038/353815a0; LIEBIG B, 1995, J INSECT PHYSIOL, V41, P17, DOI 10.1016/0022-1910(94)00093-V; Loseva OI, 2001, BIOCHEMISTRY-US, V40, P14143, DOI 10.1021/bi010171w; Masson L, 1999, J BIOL CHEM, V274, P31996, DOI 10.1074/jbc.274.45.31996; Masson L, 2002, BBA-PROTEIN STRUCT M, V1594, P266, DOI 10.1016/S0167-4838(01)00312-0; Morse RJ, 2001, STRUCTURE, V9, P409, DOI 10.1016/S0969-2126(01)00601-3; Nair MS, 2008, BIOCHEMISTRY-US, V47, P5814, DOI 10.1021/bi7014234; Peyronnet O, 2001, J MEMBRANE BIOL, V184, P45, DOI 10.1007/s00232-001-0071-8; Pitcher WH, 2002, BIOCHEM BIOPH RES CO, V296, P1352, DOI 10.1016/S0006-291X(02)02092-2; Rajamohan F, 1996, J BIOL CHEM, V271, P2390, DOI 10.1074/jbc.271.5.2390; RAJAMOHAN F, 1995, J BACTERIOL, V177, P2276, DOI 10.1128/jb.177.9.2276-2282.1995; SANGADALA S, 1994, J BIOL CHEM, V269, P10088; Schnepf E, 1998, MICROBIOL MOL BIOL R, V62, P775, DOI 10.1128/MMBR.62.3.775-806.1998; SCHNEPF HE, 1981, P NATL ACAD SCI-BIOL, V78, P2893, DOI 10.1073/pnas.78.5.2893; SCHWARTZ JL, 1993, J MEMBRANE BIOL, V132, P53, DOI 10.1007/BF00233051; Tomimoto K, 2006, COMP BIOCHEM PHYS B, V144, P413, DOI 10.1016/j.cbpb.2006.04.013; Valaitis AP, 2001, ARCH INSECT BIOCHEM, V46, P186, DOI 10.1002/arch.1028; WOLFERSBERGER M, 1987, COMP BIOCHEM PHYS A, V86, P301, DOI 10.1016/0300-9629(87)90334-3	40	25	27	1	4	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	SEP 26	2008	283	39					26324	26331		10.1074/jbc.M802895200	http://dx.doi.org/10.1074/jbc.M802895200			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	350GV	18635544	Green Published, hybrid			2022-12-27	WOS:000259341600005
J	Bjelke, JR; Olsen, OH; Fodje, M; Svensson, LA; Bang, S; Bolt, G; Kragelund, BB; Persson, E				Bjelke, Jais R.; Olsen, Ole H.; Fodje, Michel; Svensson, L. Anders; Bang, Susanne; Bolt, Gert; Kragelund, Birthe B.; Persson, Egon			Mechanism of the Ca2+-induced enhancement of the intrinsic factor VIIa activity	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							BLOOD-COAGULATION FACTOR; TRYPSINOGEN-TRYPSIN TRANSITION; TISSUE FACTOR-BINDING; FACTOR-X; POSTTRANSLATIONAL MODIFICATIONS; CATALYTIC FUNCTION; ANTITHROMBIN-III; PROTEASE DOMAIN; FACTOR-IX; ACTIVATION	The intrinsic activity of coagulation factor VIIa (FVIIa) is dependent on Ca2+ binding to a loop (residues 210-220) in the protease domain. Structural analysis revealed that Ca2+ may enhance the activity by attenuating electrostatic repulsion of Glu(296) and/or by facilitating interactions between the loop and Lys(161) in the N-terminal tail. In support of the first mechanism, the mutations E296V and D212N resulted in similar, about 2-fold, enhancements of the amidolytic activity. Moreover, mutation of the Lys(161)-interactive residue Asp(217) or Asp(219) to Ala reduced the amidolytic activity by 40-50%, whereas the K161A mutation resulted in 80% reduction. Hence one of these Asp residues in the Ca2+-binding loop appears to suffice for some residual interaction with Lys(161), whereas the more severe effect upon replacement of Lys(161) is due to abrogation of the interaction with the N-terminal tail. However, Ca2+ attenuation of the repulsion between Asp(212) and Glu(296) keeps the activity above that of apoFVIIa. Altogether, our data suggest that repulsion involving Asp(212) in the Ca2+-binding loop suppresses FVIIa activity and that optimal activity requires a favorable interaction between the Ca2+-binding loop and the N-terminal tail. Crystal structures of tissue factor-bound FVIIa(D212N) and FVIIa(V158D/E296V/M298Q) revealed altered hydrogen bond networks, resembling those in factor Xa and thrombin, after introduction of the D212N and E296V mutations plausibly responsible for tethering the N-terminal tail to the activation domain. The charge repulsion between the Ca2+-binding loop and the activation domain appeared to be either relieved by charge removal and new hydrogen bonds (D212N) or abolished (E296V). We propose that Ca2+ stimulates the intrinsic FVIIa activity by a combination of charge neutralization and loop stabilization.	[Olsen, Ole H.; Persson, Egon] Novo Nordisk AS, Dept Haemostasis Biochem, DK-2760 Malov, Denmark; [Bjelke, Jais R.; Fodje, Michel; Svensson, L. Anders] Novo Nordisk AS, Dept Prot Struct & Biophys, DK-2760 Malov, Denmark; [Bang, Susanne] Novo Nordisk AS, Dept Prot Purificat, DK-2760 Malov, Denmark; [Bolt, Gert] Novo Nordisk AS, Dept Mammalian Cell Technol, DK-2760 Malov, Denmark; [Kragelund, Birthe B.] Univ Copenhagen, Dept Biol, NMR Lab, DK-2200 Copenhagen, Denmark	Novo Nordisk; Novo Nordisk; Novo Nordisk; Novo Nordisk; University of Copenhagen	Persson, E (corresponding author), Novo Nordisk AS, Dept Haemostasis Biochem, Novo Nordisk Pk, DK-2760 Malov, Denmark.	egpe@novonordisk.com	Kragelund, Birthe/M-3927-2014	Kragelund, Birthe/0000-0002-7454-1761; Fodje, Michel/0000-0003-1367-8868				BAILEY S, 1994, ACTA CRYSTALLOGR D, V50, P760, DOI 10.1107/s0907444994003112; Banner DW, 1996, NATURE, V380, P41, DOI 10.1038/380041a0; BODE W, 1976, FEBS LETT, V68, P231, DOI 10.1016/0014-5793(76)80443-7; Bolt G, 2007, THROMB HAEMOSTASIS, V98, P988, DOI 10.1160/TH07-05-0332; BOM VJJ, 1990, BIOCHEM J, V265, P327, DOI 10.1042/bj2650327; BRUNGER AT, 1987, BIOCHEMISTRY-US, V26, P5153; Cerenius Y, 2000, J SYNCHROTRON RADIAT, V7, P203, DOI 10.1107/S0909049500005331; DAVIE EW, 1991, BIOCHEMISTRY-US, V30, P10363, DOI 10.1021/bi00107a001; DeLano W.L, PYMOL MOL GRAPHICS S; Dickinson CD, 1996, P NATL ACAD SCI USA, V93, P14379, DOI 10.1073/pnas.93.25.14379; Dickinson CD, 1998, J MOL BIOL, V277, P959, DOI 10.1006/jmbi.1998.1639; Emsley P, 2004, ACTA CRYSTALLOGR D, V60, P2126, DOI 10.1107/S0907444904019158; Freskgard PO, 1996, PROTEIN SCI, V5, P1531, DOI 10.1002/pro.5560050809; HIGASHI S, 1994, J BIOL CHEM, V269, P18891; HUBER R, 1978, ACCOUNTS CHEM RES, V11, P114, DOI 10.1021/ar50123a006; KABSCH W, 1993, J APPL CRYSTALLOGR, V26, P795, DOI 10.1107/S0021889893005588; Kalafatis M, 1997, CRIT REV EUKAR GENE, V7, P241, DOI 10.1615/CritRevEukarGeneExpr.v7.i3.40; KOMIYAMA Y, 1990, BIOCHEMISTRY-US, V29, P9418, DOI 10.1021/bi00492a016; LAWSON JH, 1993, J BIOL CHEM, V268, P767; MIYATA T, 1995, J BIOCHEM-TOKYO, V117, P836, DOI 10.1093/oxfordjournals.jbchem.a124784; OSTERUD B, 1977, P NATL ACAD SCI USA, V74, P5260, DOI 10.1073/pnas.74.12.5260; Persson E, 2004, BIOCHEM J, V379, P497, DOI 10.1042/BJ20031596; Persson E, 2002, EUR J BIOCHEM, V269, P5950, DOI 10.1046/j.1432-1033.2002.03323.x; PERSSON E, 1995, EUR J BIOCHEM, V234, P293, DOI 10.1111/j.1432-1033.1995.293_c.x; Persson E, 2001, P NATL ACAD SCI USA, V98, P13583, DOI 10.1073/pnas.241339498; Persson E, 1996, FEBS LETT, V385, P241, DOI 10.1016/0014-5793(96)00400-0; Petrovan RJ, 2002, BIOCHEMISTRY-US, V41, P9302, DOI 10.1021/bi0202169; Petrovan RJ, 2001, J BIOL CHEM, V276, P6616, DOI 10.1074/jbc.M004726200; Potterton E, 2003, ACTA CRYSTALLOGR D, V59, P1131, DOI 10.1107/S0907444903008126; Rand KD, 2008, J BIOL CHEM, V283, P13378, DOI 10.1074/jbc.M709716200; Rand KD, 2006, J BIOL CHEM, V281, P23018, DOI 10.1074/jbc.M602968200; RAO LVM, 1993, BLOOD, V81, P2600; REZAIE AR, 1994, J BIOL CHEM, V269, P21495; SABHARWAL AK, 1995, J BIOL CHEM, V270, P15523, DOI 10.1074/jbc.270.26.15523; Schmidt AE, 2005, J MOL BIOL, V350, P78, DOI 10.1016/j.jmb.2005.04.052; SHERRILL GB, 1988, THROMB RES, V52, P53; Shobe J, 1999, BIOCHEMISTRY-US, V38, P2745, DOI 10.1021/bi981951g; Soejima K, 2001, J BIOL CHEM, V276, P17229, DOI 10.1074/jbc.M009206200; Sorensen BB, 1997, J BIOL CHEM, V272, P11863, DOI 10.1074/jbc.272.18.11863; THIM L, 1988, BIOCHEMISTRY-US, V27, P7785, DOI 10.1021/bi00420a030; TORBET J, 1995, THROMB HAEMOSTASIS, V73, P785; Vagin A, 1997, J APPL CRYSTALLOGR, V30, P1022, DOI 10.1107/S0021889897006766; Walsh PN, 2001, THROMB HAEMOSTASIS, V86, P75; WILDGOOSE P, 1993, BIOCHEMISTRY-US, V32, P114, DOI 10.1021/bi00052a016; Zhang E, 1999, J MOL BIOL, V285, P2089, DOI 10.1006/jmbi.1998.2452	45	13	18	0	2	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	SEP 19	2008	283	38					25863	25870		10.1074/jbc.M800841200	http://dx.doi.org/10.1074/jbc.M800841200			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	348GX	18640965	Green Published, hybrid			2022-12-27	WOS:000259200100013
J	Koul, A; Vranckx, L; Dendouga, N; Balemans, W; Van den Wyngaert, I; Vergauwen, K; Goehlmann, HWH; Willebrords, R; Poncelet, A; Guillemont, J; Bald, D; Andries, K				Koul, Anil; Vranckx, Luc; Dendouga, Najoua; Balemans, Wendy; Van den Wyngaert, Ilse; Vergauwen, Karen; Goehlmann, Hinrich W. H.; Willebrords, Rudy; Poncelet, Alain; Guillemont, Jerome; Bald, Dirk; Andries, Koen			Diarylquinolines are bactericidal for dormant mycobacteria as a result of disturbed ATP homeostasis	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							IN-VITRO; GENE-EXPRESSION; TUBERCULOSIS; RESPIRATION; SYNTHASE; LATENCY; GROWTH; MICE; PERSISTENCE; ADAPTATION	An estimated one-third of the world population is latently infected with Mycobacterium tuberculosis. These nonreplicating, dormant bacilli are tolerant to conventional anti-tuberculosis drugs, such as isoniazid. We recently identified diarylquinoline R207910 (also called TMC207) as an inhibitor of ATP synthase with a remarkable activity against replicating mycobacteria. In the present study, we show that R207910 kills dormant bacilli as effectively as aerobically grown bacilli with the same target specificity. Despite a transcriptional down- regulation of the ATP synthase operon and significantly lower cellular ATP levels, we show that dormant mycobacteria do possess residual ATP synthase enzymatic activity. This activity is blocked by nanomolar concentrations of R207910, thereby further reducing ATP levels and causing a pronounced bactericidal effect. We conclude that this residual ATP synthase activity is indispensable for the survival of dormant mycobacteria, making it a promising drug target to tackle dormant infections. The unique dual bactericidal activity of diarylquinolines on dormant as well as replicating bacterial subpopulations distinguishes them entirely from the current anti-tuberculosis drugs and underlines the potential of R207910 to shorten tuberculosis treatment.	[Koul, Anil; Vranckx, Luc; Dendouga, Najoua; Balemans, Wendy; Vergauwen, Karen; Willebrords, Rudy; Andries, Koen] Johnson & Johnson Consumer Prod Inc, Tibotec NV, Dept Antimicrobial Res, B-2340 Beerse, Belgium; [Van den Wyngaert, Ilse; Goehlmann, Hinrich W. H.] Johnson & Johnson Consumer Prod Inc, Dept Funct Genom, B-2340 Beerse, Belgium; [Poncelet, Alain; Guillemont, Jerome] Johnson & Johnson Consumer Prod Inc, Tibotec NV, F-27106 Val De Reuil, France; [Bald, Dirk] Vrije Univ Amsterdam, Dept Biol Struct, NL-1081 HV Amsterdam, Netherlands	Johnson & Johnson; Johnson & Johnson; Johnson & Johnson; Vrije Universiteit Amsterdam	Koul, A (corresponding author), Johnson & Johnson Consumer Prod Inc, Tibotec NV, Dept Antimicrobial Res, Turnhoutseweg 30, B-2340 Beerse, Belgium.	akoul@prdbe.jnj.com						Andries K, 2005, SCIENCE, V307, P223, DOI 10.1126/science.1106753; Bald D, 2001, J BIOL CHEM, V276, P39505, DOI 10.1074/jbc.C100436200; Boshoff HIM, 2005, NAT REV MICROBIOL, V3, P70, DOI 10.1038/nrmicro1065; Brooks JV, 1999, ANTIMICROB AGENTS CH, V43, P1285, DOI 10.1128/AAC.43.5.1285; Corbett EL, 2003, ARCH INTERN MED, V163, P1009, DOI 10.1001/archinte.163.9.1009; Cox RA, 2007, CURR MOL MED, V7, P231, DOI 10.2174/156652407780598584; DeckersHebestreit G, 1996, ANNU REV MICROBIOL, V50, P791, DOI 10.1146/annurev.micro.50.1.791; Dye C, 1999, JAMA-J AM MED ASSOC, V282, P677, DOI 10.1001/jama.282.7.677; Flynn JL, 2001, INFECT IMMUN, V69, P4195, DOI 10.1128/IAI.69.7.4195-4201.2001; Gomez JE, 2004, TUBERCULOSIS, V84, P29, DOI 10.1016/j.tube.2003.08.003; HIGASHI T, 1975, J BIOL CHEM, V250, P6541; Junge W, 2005, SCIENCE, V308, P642, DOI 10.1126/science.1112617; Karakousis PC, 2004, J EXP MED, V200, P647, DOI 10.1084/jem.20040646; Koul A, 2004, NAT REV MICROBIOL, V2, P189, DOI 10.1038/nrmicro840; Koul A, 2007, NAT CHEM BIOL, V3, P323, DOI 10.1038/nchembio884; Lenaerts AJ, 2005, ANTIMICROB AGENTS CH, V49, P2294, DOI 10.1128/AAC.49.6.2294-2301.2005; Lenaerts AJ, 2007, ANTIMICROB AGENTS CH, V51, P3338, DOI 10.1128/AAC.00276-07; Mitchison DA, 2005, NAT BIOTECHNOL, V23, P187, DOI 10.1038/nbt0205-187; Mitchison DA, 2004, FRONT BIOSCI-LANDMRK, V9, P1059, DOI 10.2741/1293; Munoz-Elias EJ, 2005, NAT MED, V11, P638, DOI 10.1038/nm1252; Rao M, 2001, MICROBIOL-UK, V147, P1017, DOI 10.1099/00221287-147-4-1017; Schnappinger D, 2003, J EXP MED, V198, P693, DOI 10.1084/jem.20030846; Shemesh M, 2007, MICROBIOL-SGM, V153, P1307, DOI 10.1099/mic.0.2006/002030-0; Shi LB, 2005, P NATL ACAD SCI USA, V102, P15629, DOI 10.1073/pnas.0507850102; Stover CK, 2000, NATURE, V405, P962, DOI 10.1038/35016103; Timm J, 2003, P NATL ACAD SCI USA, V100, P14321, DOI 10.1073/pnas.2436197100; VEZIRIS N, 2007, INT C ANT AG CHEM CH; Voskuil MI, 2004, TUBERCULOSIS, V84, P218, DOI 10.1016/j.tube.2004.02.003; Voskuil MI, 2003, J EXP MED, V198, P705, DOI 10.1084/jem.20030205; Wayne LG, 1996, INFECT IMMUN, V64, P2062, DOI 10.1128/IAI.64.6.2062-2069.1996; WAYNE LG, 1994, EUR J CLIN MICROBIOL, V13, P908, DOI 10.1007/BF02111491; Zhang Y, 2006, DRUG DISCOV TODAY, V11, P21, DOI 10.1016/S1359-6446(05)03626-3	32	257	269	0	17	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	SEP 12	2008	283	37					25273	25280		10.1074/jbc.M803899200	http://dx.doi.org/10.1074/jbc.M803899200			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	345QZ	18625705	hybrid, Green Published			2022-12-27	WOS:000259012700020
J	Ordonez, E; Thiyagarajan, S; Cook, JD; Stemmler, TL; Gil, JA; Mateos, LM; Rosen, BP				Ordonez, Efren; Thiyagarajan, Saravanamuthu; Cook, Jeremy D.; Stemmler, Timothy L.; Gil, Jose A.; Mateos, Luis M.; Rosen, Barry P.			Evolution of metal(loid) binding sites in transcriptional regulators	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							CADC CD(II)/PB(II)/ZN(II)-RESPONSIVE REPRESSOR; BREVIBACTERIUM-LACTOFERMENTUM; CORYNEBACTERIUM-GLUTAMICUM; METALLOREGULATORY PROTEINS; CRYSTAL-STRUCTURE; ARS OPERON; METAL; RESISTANCE; FAMILY; GENES	Expression of the genes for resistance to heavy metals and metalloids is transcriptionally regulated by the toxic ions themselves. Members of the ArsR/SmtB family of small metalloregulatory proteins respond to transition metals, heavy metals, and metalloids, including As(III), Sb(III), Cd(II), Pb(II), Zn(II), Co(II), and Ni(II). These homodimeric repressors bind to DNA in the absence of inducing metal(loid) ion and dissociate from the DNA when inducer is bound. The regulatory sites are often three- or four-coordinate metal binding sites composed of cysteine thiolates. Surprisingly, in two different As(III)-responsive regulators, the metalloid binding sites were in different locations in the repressor, and the Cd(II) binding sites were in two different locations in two Cd(II)-responsive regulators. We hypothesize that ArsR/SmtB repressors have a common backbone structure, that of a winged helix DNA-binding protein, but have considerable plasticity in the location of inducer binding sites. Here we show that an As(III)-responsive member of the family, CgArsR1 from Corynebacterium glutamicum, binds As(III) to a cysteine triad composed of Cys(15), Cys(16), and Cys(55). This binding site is clearly unrelated to the binding sites of other characterized ArsR/SmtB family members. This is consistent with our hypothesis that metal(loid) binding sites in DNA binding proteins evolve convergently in response to persistent environmental pressures.	[Thiyagarajan, Saravanamuthu; Cook, Jeremy D.; Stemmler, Timothy L.; Rosen, Barry P.] Wayne State Univ, Sch Med, Dept Biochem & Mol Biol, Detroit, MI 48201 USA; [Ordonez, Efren; Gil, Jose A.; Mateos, Luis M.] Univ Leon, Fac Biol Ambientales, Area Microbiol, Dept Biol Mol, E-24071 Leon, Spain	Wayne State University; Universidad de Leon	Rosen, BP (corresponding author), Wayne State Univ, Sch Med, Dept Biochem & Mol Biol, Detroit, MI 48201 USA.	brosen@med.wayne.edu	MATEOS DELGADO, LUIS MARIANO/ABB-8848-2021; Gil, Jose A./C-3902-2009; Gil, José A./L-1800-2019; S, Thiyagarajan/AAU-3934-2021	MATEOS DELGADO, LUIS MARIANO/0000-0001-7763-582X; Gil, Jose A./0000-0002-5069-2637; Gil, José A./0000-0002-5069-2637; Rosen, Barry P./0000-0002-5230-4271; Thiyagarajan, Saravanamuthu/0000-0001-6960-2729	National Institutes of Health [R01 AI043428, R01 DK068139, LE040A07, BIO2005-02723, BIO2008-00519]; Department of Energy, Office of Biological and Environmental Research; National Center for Research Resources; Biomedical Technology Program; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI043428] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF BIOMEDICAL IMAGING AND BIOENGINEERING [P30EB009998] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK068139] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Department of Energy, Office of Biological and Environmental Research(United States Department of Energy (DOE)); National Center for Research Resources(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); Biomedical Technology Program; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF BIOMEDICAL IMAGING AND BIOENGINEERING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Biomedical Imaging & Bioengineering (NIBIB)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	This work was supported, in whole or in part, by National Institutes of Health Grants R01 AI043428 ( to B. P. R.), R01 DK068139 ( to T. L. S.), and LE040A07, BIO2005-02723, and BIO2008-00519 ( to J.A.G. and L. M. M.). The Stanford Synchrotron Radiation Laboratory Structural Molecular Biology Program is supported by the Department of Energy, Office of Biological and Environmental Research, and by the National Institutes of Health, National Center for Research Resources, Biomedical Technology Program. The costs of publication of this article were defrayed in part by the payment of page charges. This article must therefore be hereby marked "advertisement" in accordance with 18 U. S. C. Section 1734 solely to indicate this fact.	Ankudinov AL, 1997, PHYS REV B, V56, pR1712, DOI 10.1103/PhysRevB.56.R1712; Banci L, 2007, J BIOL CHEM, V282, P30181, DOI 10.1074/jbc.M701119200; BRADFORD MM, 1976, ANAL BIOCHEM, V72, P248, DOI 10.1016/0003-2697(76)90527-3; Busenlehner LS, 2003, FEMS MICROBIOL REV, V27, P131, DOI 10.1016/S0168-6445(03)00054-8; Butcher BG, 2002, MICROBIOL-SGM, V148, P3983, DOI 10.1099/00221287-148-12-3983; Campbell DR, 2007, J BIOL CHEM, V282, P32298, DOI 10.1074/jbc.M703451200; Cook WJ, 1998, J MOL BIOL, V275, P337, DOI 10.1006/jmbi.1997.1443; DeLano W. L., 2001, PYMOL USERS MANUAL; FernandezGonzalez C, 1996, APPL MICROBIOL BIOT, V46, P554, DOI 10.1007/s002530050860; GILL SC, 1989, ANAL BIOCHEM, V182, P319, DOI 10.1016/0003-2697(89)90602-7; Harvie DR, 2006, MOL MICROBIOL, V59, P1341, DOI 10.1111/j.1365-2958.2006.05029.x; KOSOWER NS, 1979, P NATL ACAD SCI USA, V76, P3382, DOI 10.1073/pnas.76.7.3382; LAEMMLI UK, 1970, NATURE, V227, P680, DOI 10.1038/227680a0; Letek M, 2006, J BACTERIOL, V188, P409, DOI 10.1128/JB.188.2.409-423.2006; Martinez GL, 2000, J ELECTRON MATER, V29, P325, DOI 10.1007/s11664-000-0072-x; Mateos LM, 1996, J BACTERIOL, V178, P5768, DOI 10.1128/jb.178.19.5768-5775.1996; Ordonez E, 2005, APPL ENVIRON MICROB, V71, P6206, DOI 10.1128/AEM.71.10.6206-6215.2005; Qin J, 2007, J BIOL CHEM, V282, P34346, DOI 10.1074/jbc.M706565200; Ramirez-Solis A, 2004, INORG CHEM, V43, P2954, DOI 10.1021/ic0351592; Ramos A, 2003, MICROBIOL-SGM, V149, P3531, DOI 10.1099/mic.0.26653-0; Sambrook J., 1989, MOL CLONING LAB MANU, V1, P21, DOI DOI 10.51-10.67; SANFRANCISCO MJD, 1990, NUCLEIC ACIDS RES, V18, P619; SHI WP, 1994, J BIOL CHEM, V269, P19826; Turner JS, 1996, NUCLEIC ACIDS RES, V24, P3714, DOI 10.1093/nar/24.19.3714; Wong MD, 2002, J BIOL CHEM, V277, P40930, DOI 10.1074/jbc.M206536200; WU JH, 1993, J BIOL CHEM, V268, P52; Xu C, 1999, METALS AND GENETICS, P5; Ye J, 2005, J BACTERIOL, V187, P4214, DOI 10.1128/JB.187.12.4214-4221.2005; YOON KP, 1991, J BACTERIOL, V173, P7643, DOI 10.1128/jb.173.23.7643-7649.1991	29	55	56	2	5	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	SEP 12	2008	283	37					25706	25714		10.1074/jbc.M803209200	http://dx.doi.org/10.1074/jbc.M803209200			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	345QZ	18591244	Green Submitted, Green Published, hybrid			2022-12-27	WOS:000259012700065
J	Preumont, A; Snoussi, K; Stroobant, V; Collet, JF; Van Schaftingen, E				Preumont, Alice; Snoussi, Karim; Stroobant, Vincent; Collet, Jean-Francois; Van Schaftingen, Emile			Molecular identification of pseudouridine-metabolizing enzymes	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							NUCLEAR MAGNETIC-RESONANCE; ESCHERICHIA-COLI; BLUE PIGMENT; SYNTHETASE; BIOSYNTHESIS; ACID; NUCLEOSIDES; EVOLUTION; EXCRETION; DIAGNOSIS	Pseudouridine, a non-classical nucleoside present in human urine as a degradation product of RNAs, is one of the few molecules that has a glycosidic C-C bond. Through a data base mining approach involving transcriptomic data, we have molecularly identified two enzymes that are involved in the metabolism of pseudouridine in uropathogenic Escherichia coli, the principal agent of urinary tract infections in humans. The first enzyme, coded by the gene yeiC, specifically phosphorylates pseudouridine to pseudouridine 5'-phosphate. Accordingly, yeiC-mutants are unable to metabolize pseudouridine, in contrast to wild-type E. coli UTI89. The second enzyme, encoded by the gene yeiN belonging to the same operon as yeiC, catalyzes the conversion of pseudouridine 5'-phosphate to uracil and ribose 5-phosphate in a divalent cation-dependent manner. Remarkably, the glycosidic C-C bond of pseudouridine is cleaved in the course of this reaction, indicating that YeiN is the first molecularly identified enzyme able to hydrolyze a glycosidic C-C bond. Though this reaction is easily reversible, the association of YeiN with pseudouridine kinase indicates that it serves physiologically to metabolize pseudouridine 5'-phosphate rather than to form it. YeiN is homologous to Thermotoga maritima IndA, a protein with a new fold, which we now show to act also as a pseudouridine-5'-phosphate glycosidase. Data base mining indicates that most eukaryotes possess homologues of pseudouridine kinase and pseudouridine-5'-phosphate glycosidase and that these are most often associated in a single bifunctional protein. The gene encoding this bifunctional protein is absent from the genomes of man and other mammals, indicating that the capacity for metabolizing pseudouridine has been lost late in evolution.	[Preumont, Alice; Collet, Jean-Francois; Van Schaftingen, Emile] Catholic Univ Louvain, Physiol Chem Lab, de Duve Inst, B-1200 Brussels, Belgium; [Snoussi, Karim] Catholic Univ Louvain, Dept Chim, B-1348 Louvain, Belgium; [Stroobant, Vincent] Ludwig Inst Canc Res, B-1200 Brussels, Belgium	Universite Catholique Louvain; Universite Catholique Louvain; Ludwig Institute for Cancer Research	Van Schaftingen, E (corresponding author), Catholic Univ Louvain, Physiol Chem Lab, de Duve Inst, Ave Hippocrate 75, B-1200 Brussels, Belgium.	emile.vanschaftingen@uclouvain.be	Van+Schaftingen, Emile/AAF-5532-2020; Collet, Jean Francois/F-2105-2010	Collet, Jean-Francois/0000-0001-8069-7036; Van Schaftingen, Emile/0000-0002-6199-7647	Directorate General Higher Education and Scientific Research; French Community of Belgium; Fund for Medical Scientific Research; Interuniversity Attraction Poles Program [P6/05]	Directorate General Higher Education and Scientific Research; French Community of Belgium; Fund for Medical Scientific Research(Fonds de la Recherche Scientifique - FNRS); Interuniversity Attraction Poles Program(Belgian Federal Science Policy Office)	This work was supported in part by the Directorate General Higher Education and Scientific Research, French Community of Belgium, the Fund for Medical Scientific Research, and the Interuniversity Attraction Poles Program (Network P6/05), Belgian Science Policy. The costs of publication of this article were defrayed in part by the payment of page charges. This article must therefore be hereby marked "advertisement" in accordance with 18 U. S. C. Section 1734 solely to indicate this fact.	ADAMS WS, 1960, AM J MED, V28, P726, DOI 10.1016/0002-9343(60)90130-3; Baba T, 2006, MOL SYST BIOL, V2, DOI 10.1038/msb4100050; BORK P, 1993, PROTEIN SCI, V2, P31; BREITMAN TR, 1970, J BACTERIOL, V103, P263, DOI 10.1128/JB.103.1.263-264.1970; BREITMAN TR, 1968, J BACTERIOL, V96, P1873, DOI 10.1128/JB.96.5.1873-1874.1968; CAMICI M, 1980, ARCH BIOCHEM BIOPHYS, V205, P191, DOI 10.1016/0003-9861(80)90098-3; Charette M, 2000, IUBMB LIFE, V49, P341; DUGAICZYK A, 1970, BIOCHEMISTRY-US, V9, P1557, DOI 10.1021/bi00809a013; Feng B, 2005, J GASTROEN HEPATOL, V20, P1913, DOI 10.1111/j.1440-1746.2005.03888.x; Follens A, 1999, J BACTERIOL, V181, P2001, DOI 10.1128/JB.181.7.2001-2007.1999; Furmanek A, 2000, ACTA BIOCHIM POL, V47, P781, DOI 10.18388/abp.2000_3996; Hammal T, 2006, CHEM BIOL, V13, P1125, DOI 10.1016/j.chembiol.2006.09.009; HEINRIKSON RL, 1964, J BIOL CHEM, V239, P1177; HEINRIKSON RL, 1963, J BIOL CHEM, V238, P485; Levin I, 2005, PROTEINS, V59, P864, DOI 10.1002/prot.20420; Maliekal P, 2006, GLYCOBIOLOGY, V16, P165, DOI 10.1093/glycob/cwj050; MATSUSHITA T, 1971, BIOCHIM BIOPHYS ACTA, V238, P165, DOI 10.1016/0005-2787(71)90082-7; MUTING D, 1963, H-S Z PHYSIOL CHEM, V332, P276, DOI 10.1515/bchm2.1963.332.1.276; MUTING D, 1954, H-S Z PHYSIOL CHEM, V297, P61, DOI 10.1515/bchm2.1954.297.1.61; NEUMANN JM, 1980, EUR J BIOCHEM, V108, P457, DOI 10.1111/j.1432-1033.1980.tb04742.x; PIOTTO M, 1992, J BIOMOL NMR, V2, P661, DOI 10.1007/BF02192855; Reverchon S, 2002, J BACTERIOL, V184, P654, DOI 10.1128/JB.184.3.654-665.2002; Scannell DR, 2007, YEAST, V24, P929, DOI 10.1002/yea.1515; SEELIG J, 1978, BIOCHIM BIOPHYS ACTA, V515, P105, DOI 10.1016/0304-4157(78)90001-1; Seidel A, 2006, BRIT J CANCER, V94, P1726, DOI 10.1038/sj.bjc.6603164; Snyder JA, 2004, INFECT IMMUN, V72, P6373, DOI 10.1128/IAI.72.11.6373-6381.2004; SOLOMON LR, 1971, J BACTERIOL, V107, P535, DOI 10.1128/JB.107.2.535-542.1971; SOLOMON LR, 1971, BIOCHEM BIOPH RES CO, V44, P299, DOI 10.1016/0006-291X(71)90599-7; SUZUKI T, 1966, CAN J BIOCHEM CELL B, V44, P259, DOI 10.1139/o66-029; Takahashi H, 2007, J BIOL CHEM, V282, P9073, DOI 10.1074/jbc.M611319200; Vassiliadis G, 2007, ANTIMICROB AGENTS CH, V51, P3546, DOI 10.1128/AAC.00261-07; VITA A, 1983, ARCH BIOCHEM BIOPHYS, V226, P687, DOI 10.1016/0003-9861(83)90339-9; WARD DC, 1969, J BIOL CHEM, V244, P3243; WEISSMAN S, 1962, J LAB CLIN MED, V59, P852; WESTHEAD JE, 1974, ANTIMICROB AGENTS CH, V5, P90, DOI 10.1128/AAC.5.1.90; Yoshikawa T, 2002, FOOD CHEM TOXICOL, V40, P1165, DOI 10.1016/S0278-6915(02)00060-1; Zhu J, 2000, J BACTERIOL, V182, P3885, DOI 10.1128/JB.182.14.3885-3895.2000	37	33	37	3	18	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	SEP 12	2008	283	37					25238	25246		10.1074/jbc.M804122200	http://dx.doi.org/10.1074/jbc.M804122200			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	345QZ	18591240	hybrid			2022-12-27	WOS:000259012700016
J	Seifert, EL; Bezaire, V; Estey, C; Harper, ME				Seifert, Erin L.; Bezaire, Veronic; Estey, Carmen; Harper, Mary-Ellen			Essential role for uncoupling protein-3 in mitochondrial adaptation to fasting but not in fatty acid oxidation or fatty acid anion export	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							SKELETAL-MUSCLE MITOCHONDRIA; ACYL-COA THIOESTERASES; ACTIVATED-RECEPTOR-ALPHA; BROWN ADIPOSE-TISSUE; LIPID-METABOLISM; LIVER-MITOCHONDRIA; INSULIN-RESISTANCE; LONG-CHAIN; RAT-HEART; CELL-FREE	Uncoupling protein-3 (UCP3) is a mitochondrial inner membrane protein expressed most abundantly in skeletal muscle and to a lesser extent in heart and brown adipose tissue. Evidence supports a role for UCP3 in fatty acid oxidation (FAO); however, the underlying mechanism has not been explored. In 2001 we proposed a role for UCP3 in fatty acid export, leading to higher FAO rates (Himms-Hagen, J., and Harper, M. E. (2001) Exp. Biol. Med. (Maywood) 226, 78 -84). Specifically, this widely held hypothesis states that during elevated FAO rates, UCP3 exports fatty acid anions, thereby maintaining mitochondrial co-enzyme A availability; reactivation of exported fatty acid anions would ultimately enable increased FAO. Here we tested mechanistic aspects of this hypothesis as well as its functional implications, namely increased FAO rates. Using complementary mechanistic approaches in mitochondria from wild-type and Ucp3(-/-) mice, we find that UCP3 is not required for FAO regardless of substrate type or supply rate covering a 20-fold range. Fatty acid anion export and reoxidation during elevated FAO, although present in skeletal muscle mitochondria, are independent of UCP3 abundance. Interestingly, UCP3 was found to be necessary for the fasting-induced enhancement of FAO rate and capacity, possibly via mitigated mitochondrial oxidative stress. Thus, although our observations indicate that UCP3 can impact FAO rates, the mechanistic basis is not via an integral function for UCP3 in the FAO machinery. Overall our data indicate a function for UCP3 in mitochondrial adaptation to perturbed cellular energy balance and integrate previous observations that have linked UCP3 to reduced oxidative stress and FAO.	[Seifert, Erin L.; Bezaire, Veronic; Estey, Carmen; Harper, Mary-Ellen] Univ Ottawa, Fac Med, Dept Biochem Microbiol & Immunol, Ottawa, ON K1H 8M5, Canada	University of Ottawa	Harper, ME (corresponding author), Univ Ottawa, Fac Med, Dept Biochem Microbiol & Immunol, 451 Smyth Rd, Ottawa, ON K1H 8M5, Canada.	Maryellen.Harper@uottawa.ca		Harper, Mary-Ellen/0000-0003-3864-5886	Canadian Institutes of Health Research (Institute of Nutrition, Metabolism, and Diabetes); Canadian Diabetes Association; Natural Sciences and Engineering Research Council	Canadian Institutes of Health Research (Institute of Nutrition, Metabolism, and Diabetes)(Canadian Institutes of Health Research (CIHR)); Canadian Diabetes Association; Natural Sciences and Engineering Research Council(Natural Sciences and Engineering Research Council of Canada (NSERC))	This work was supported by the Canadian Institutes of Health Research (Institute of Nutrition, Metabolism, and Diabetes) (to M.-E. H.), the Canadian Diabetes Association (to E. L. S.), and the Natural Sciences and Engineering Research Council (to V. B.). The costs of publication of this article were defrayed in part by the payment of page charges. This article must therefore be hereby marked "advertisement" in accordance with 18 U. S. C. Section 1734 solely to indicate this fact.	Anderson EJ, 2007, J BIOL CHEM, V282, P31257, DOI 10.1074/jbc.M706129200; Argyropoulos G, 1998, J CLIN INVEST, V102, P1345, DOI 10.1172/JCI4115; Benderdour M, 2003, J BIOL CHEM, V278, P45154, DOI 10.1074/jbc.M306285200; Bergmeyer HU., 1974, METHOD ENZYMAT AN, V1, P474; Bevilacqua L, 2005, AM J PHYSIOL-ENDOC M, V289, pE429, DOI 10.1152/ajpendo.00435.2004; BEVILACQUA L, 2007, THESIS U OTTAWA OTTA; Bezaire V, 2005, FASEB J, V19, P977, DOI 10.1096/fj.04-2765fje; Bezaire V, 2001, AM J PHYSIOL-ENDOC M, V281, pE975, DOI 10.1152/ajpendo.2001.281.5.E975; Brand MD, 2002, BIOCHEM J, V368, P597, DOI 10.1042/BJ20021077; BRASS EP, 1980, BIOCHEM J, V190, P495, DOI 10.1042/bj1900495; BRASS EP, 1980, BIOCHEM J, V188, P451, DOI 10.1042/bj1880451; Cadenas S, 2002, J BIOL CHEM, V277, P2773, DOI 10.1074/jbc.M109736200; Cannon B, 2004, PHYSIOL REV, V84, P277, DOI 10.1152/physrev.00015.2003; CHAPPELL JB, 1954, NATURE, V173, P1094, DOI 10.1038/1731094a0; Choi CS, 2007, J CLIN INVEST, V117, P1995, DOI 10.1172/JCI13579; Costford SR, 2006, AM J PHYSIOL-ENDOC M, V290, pE1304, DOI 10.1152/ajpendo.00401.2005; Eaton S, 2002, PROG LIPID RES, V41, P197, DOI 10.1016/S0163-7827(01)00024-8; Echtay KS, 2003, EMBO J, V22, P4103, DOI 10.1093/emboj/cdg412; Echtay KS, 2002, NATURE, V415, P96, DOI 10.1038/415096a; FOLCH J, 1957, J BIOL CHEM, V226, P497; Garcia-Martinez C, 2001, FASEB J, V15, P2033, DOI 10.1096/fj.00-0828fje; Gerber LK, 2006, AM J PHYSIOL-CELL PH, V291, pC1198, DOI 10.1152/ajpcell.00246.2006; GLATZ JFC, 1984, BIOCHIM BIOPHYS ACTA, V794, P454, DOI 10.1016/0005-2760(84)90012-2; Harper ME, 2001, BIOCHEM SOC T, V29, P768, DOI 10.1042/bst0290768; Himms-Hagen J, 2001, EXP BIOL MED, V226, P78, DOI 10.1177/153537020122600204; Hunt M, 1999, ADV EXP MED BIOL, V466, P195; Hunt MC, 2002, PROG LIPID RES, V41, P99, DOI 10.1016/S0163-7827(01)00017-0; Hunt MC, 1999, J BIOL CHEM, V274, P34317, DOI 10.1074/jbc.274.48.34317; Hussain SNA, 2006, AM J PHYSIOL-LUNG C, V290, pL996, DOI 10.1152/ajplung.00337.2005; HYSLOP PA, 1984, ANAL BIOCHEM, V141, P280, DOI 10.1016/0003-2697(84)90457-3; Iossa S, 2001, FEBS LETT, V505, P53, DOI 10.1016/S0014-5793(01)02772-7; Jezek P, 2000, IUBMB LIFE, V49, P63; King KL, 2007, J LIPID RES, V48, P1511, DOI 10.1194/jlr.M600364-JLR200; Koves TR, 2008, CELL METAB, V7, P45, DOI 10.1016/j.cmet.2007.10.013; Koves TR, 2005, J BIOL CHEM, V280, P33588, DOI 10.1074/jbc.M507621200; LIN CH, 1970, CAN J BIOCHEM CELL B, V48, P566, DOI 10.1139/o70-093; LYSIAK W, 1988, J BIOL CHEM, V263, P1151; MacLellan JD, 2005, DIABETES, V54, P2343, DOI 10.2337/diabetes.54.8.2343; McLeod CJ, 2005, J BIOL CHEM, V280, P33470, DOI 10.1074/jbc.M505258200; Moreno M, 2003, FASEB J, V17, P1112, DOI 10.1096/fj.02-0839fje; Muoio DM, 2006, ANNU REV BIOCHEM, V75, P367, DOI 10.1146/annurev.biochem.75.103004.142512; Murphy MP, 2003, J BIOL CHEM, V278, P48534, DOI 10.1074/jbc.M308529200; Nedergaard J, 2001, BBA-BIOENERGETICS, V1504, P82, DOI 10.1016/S0005-2728(00)00247-4; Pedraza N, 2006, ENDOCRINOLOGY, V147, P4695, DOI 10.1210/en.2006-0226; Power RA, 2007, DIABETOLOGIA, V50, P824, DOI 10.1007/s00125-007-0605-4; Riquet FB, 2003, BIOCHEM BIOPH RES CO, V311, P583, DOI 10.1016/j.bbrc.2003.10.034; Samec S, 1998, DIABETES, V47, P1693, DOI 10.2337/diabetes.47.11.1693; Samec S, 1998, FASEB J, V12, P715, DOI 10.1096/fasebj.12.9.715; Schrauwen P, 2001, FASEB J, V15, P2497, DOI 10.1096/fj.01-0400hyp; Silva JP, 2005, EMBO J, V24, P4061, DOI 10.1038/sj.emboj.7600866; Solanes G, 2003, MOL ENDOCRINOL, V17, P1944, DOI 10.1210/me.2002-0395; SRERE PA, 1969, METHOD ENZYMOL, V8, P3; STALLKNECHT B, 1991, AM J PHYSIOL, V261, pE410, DOI 10.1152/ajpendo.1991.261.3.E410; Stephens FB, 2007, J PHYSIOL-LONDON, V581, P431, DOI 10.1113/jphysiol.2006.125799; Stuart JA, 2001, BIOCHEM J, V356, P779, DOI 10.1042/0264-6021:3560779; SVENSSON LT, 1995, J BIOL CHEM, V270, P12177, DOI 10.1074/jbc.270.20.12177; Svensson LT, 1998, BIOCHEM J, V329, P601, DOI 10.1042/bj3290601; Talbot DA, 2005, BBA-BIOENERGETICS, V1709, P150, DOI 10.1016/j.bbabio.2005.07.001; Talbot DA, 2004, FEBS LETT, V556, P111, DOI 10.1016/S0014-5793(03)01386-3; Tsai L, 1998, P NATL ACAD SCI USA, V95, P7975, DOI 10.1073/pnas.95.14.7975; VEERKAMP JH, 1983, BIOCHIM BIOPHYS ACTA, V753, P399, DOI 10.1016/0005-2760(83)90064-4; Wang S, 2003, DIABETES OBES METAB, V5, P295, DOI 10.1046/j.1463-1326.2003.00273.x	62	81	84	0	7	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	SEP 12	2008	283	37					25124	25131		10.1074/jbc.M803871200	http://dx.doi.org/10.1074/jbc.M803871200			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	345QZ	18628202	hybrid			2022-12-27	WOS:000259012700004
J	Caldwell, JH; Herin, GA; Nagel, G; Bamberg, E; Scheschonka, A; Betz, H				Caldwell, John H.; Herin, Greta Ann; Nagel, Georg; Bamberg, Ernst; Scheschonka, Astrid; Betz, Heinrich			Increases in intracellular calcium triggered by channelrhodopsin-2 potentiate the response of metabotropic glutamate receptor mGluR7	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							PROTEIN-COUPLED RECEPTORS; CEREBELLAR GRANULE CELLS; ACTIVATED K+ CHANNEL; XENOPUS OOCYTES; KINASE-C; NEURONS; INHIBITION; SYNAPSE; CA2+; DEPRESSION	The metabotropic glutamate receptor 7a (mGluR7a), a hepta-helical G alpha(i/o)-coupled protein, has been shown to be important for presynaptic feedback inhibition at central synapses and certain forms of long term potentiation and long term depression. The intracellular C terminus of mGluR7a interacts with calmodulin in a Ca2+-dependent manner, and calmodulin antagonists have been found to abolish presynaptic inhibition of glutamate release in neurons and mGluR7a-induced activation of G-protein-activated inwardly rectifying K+ channel (GIRK) channels in HEK293 cells. Here, we characterized the Ca2+ dependence of mGluR7a signaling in Xenopus oocytes by using channelrhodopsin-2 (ChR2), a Ca2+-permeable, light-activated ion channel for triggering Ca2+ influx, and a GIRK3.1/3.2 concatemer to monitor mGluR7a responses. Application of the agonist (S)-2-amino- 4-phosphonobutanoic acid (L-AP4) (1-100 mu M) caused a dose-dependent inward current in high K+ solutions due to activation of GIRK channels by G-protein beta gamma subunits released from mGluR7a. Elevation of intracellular free Ca2+ by light stimulation of ChR2 markedly increased the amplitude of L-AP4 responses, and this effect was attenuated by the calcium chelator 1,2-bis(2-aminophenoxy) ethane-N,N,N',N'-tetraacetic acid tetrakis (acetoxymethyl ester). L-AP4 responses were potentiated by submembranous [Ca2+] levels within physiological ranges and with a threshold close to resting [Ca2+](i) values, as determined by recording the endogenous Xenopus Ca2+-activated chloride conductance. Together, these results show that L-AP4-dependent mGluR7a signaling is potentiated by physiological levels of [Ca2+](i), consistent with a model in which presynaptic mGluR7a acts as a coincidence detector of Ca2+ influx and glutamate release.	[Caldwell, John H.] Univ Colorado Hlth Sci Ctr, Dept Cell & Dev Biol, Aurora, CO 80045 USA; [Caldwell, John H.; Herin, Greta Ann; Scheschonka, Astrid; Betz, Heinrich] Max Planck Inst Brain Res, Dept Neurochem, D-60528 Frankfurt, Germany; [Nagel, Georg; Bamberg, Ernst] Max Planck Inst Biophys, D-60438 Frankfurt, Germany; [Nagel, Georg] Univ Wurzburg, D-97082 Wurzburg, Germany	University of Colorado System; University of Colorado Anschutz Medical Campus; Max Planck Society; Max Planck Society; University of Wurzburg	Caldwell, JH (corresponding author), Univ Colorado Hlth Sci Ctr, Dept Cell & Dev Biol, Mail Stop 8315,POB 6511, Aurora, CO 80045 USA.	john.caldwell@uchsc.edu		Nagel, Georg/0000-0001-8174-8712	National Institutes of Health [R01 26505]; MaxPlanck-Gesellschaft; European Community [QLG3-CT-2001-00929]; Fonds der Chemischen Industrie; Deutsche Forschungsgemeinschaft [SFB 472/P1, DFG-NA207/6]	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); MaxPlanck-Gesellschaft(Max Planck Society); European Community(European Commission); Fonds der Chemischen Industrie(Fonds der Chemischen IndustrieEuropean Commission); Deutsche Forschungsgemeinschaft(German Research Foundation (DFG))	This work was supported in part by National Institutes of Health Grant R01 26505 (to J. H. C.). Primary support for the work was from grants from MaxPlanck-Gesellschaft, European Community Grant QLG3-CT-2001-00929, and Fonds der Chemischen Industrie (to H. B.) and Deutsche Forschungsgemeinschaft (Grants SFB 472/P1 and DFG-NA207/6)(to G. N.).	AbdulGhani MA, 1996, J NEUROPHYSIOL, V76, P2691, DOI 10.1152/jn.1996.76.4.2691; Angleson JK, 2001, J NEUROPHYSIOL, V85, P287, DOI 10.1152/jn.2001.85.1.287; Augustine GJ, 2003, NEURON, V40, P331, DOI 10.1016/S0896-6273(03)00639-1; Bockaert J, 2003, FEBS LETT, V546, P65, DOI 10.1016/S0014-5793(03)00453-8; Borst JGG, 1999, J PHYSIOL-LONDON, V521, P123, DOI 10.1111/j.1469-7793.1999.00123.x; CHAVIS P, 1995, NEUROPHARMACOLOGY, V34, P929, DOI 10.1016/0028-3908(95)00082-H; Cho K, 2002, TRENDS NEUROSCI, V25, P405, DOI 10.1016/S0166-2236(02)02228-2; Conn PJ, 1997, ANNU REV PHARMACOL, V37, P205, DOI 10.1146/annurev.pharmtox.37.1.205; Dev KK, 2000, J NEUROSCI, V20, P7252; Dittman JS, 2000, J NEUROSCI, V20, P1374; El Far O, 2002, BIOCHEM J, V365, P329, DOI 10.1042/BJ20020481; El Far O, 2001, J BIOL CHEM, V276, P30662, DOI 10.1074/jbc.M102573200; El Far O, 2000, EUR J NEUROSCI, V12, P4215, DOI 10.1046/j.1460-9568.2000.01309.x; Enz R, 2007, BIOESSAYS, V29, P60, DOI 10.1002/bies.20518; Evans DI, 2000, J NEUROPHYSIOL, V83, P2519, DOI 10.1152/jn.2000.83.5.2519; Fagni L, 2000, TRENDS NEUROSCI, V23, P80, DOI 10.1016/S0166-2236(99)01492-7; Flor PJ, 1997, NEUROPHARMACOLOGY, V36, P153, DOI 10.1016/S0028-3908(96)00176-1; GEREAU RW, 1995, J NEUROSCI, V15, P6879; GRAHAM ME, 1994, EUR J PHARM-MOLEC PH, V288, P115, DOI 10.1016/0922-4106(94)90016-7; Haase A, 2006, PFLUG ARCH EUR J PHY, V452, P81, DOI 10.1007/s00424-005-0004-y; Hill JJ, 2001, J BIOL CHEM, V276, P5505, DOI 10.1074/jbc.M008213200; Kobayashi K, 1999, EUR J NEUROSCI, V11, P1633, DOI 10.1046/j.1460-9568.1999.00578.x; Kubo Y, 1998, SCIENCE, V279, P1722, DOI 10.1126/science.279.5357.1722; Kuruma A, 1999, AM J PHYSIOL-CELL PH, V276, pC161, DOI 10.1152/ajpcell.1999.276.1.C161; Lafon-Cazal M, 1999, EUR J NEUROSCI, V11, P663, DOI 10.1046/j.1460-9568.1999.00475.x; Leaney JL, 2001, J PHYSIOL-LONDON, V534, P367, DOI 10.1111/j.1469-7793.2001.00367.x; Mitchell SJ, 2000, NATURE, V404, P498, DOI 10.1038/35006649; Nagel G, 2003, P NATL ACAD SCI USA, V100, P13940, DOI 10.1073/pnas.1936192100; Nagel G, 2005, CURR BIOL, V15, P2279, DOI 10.1016/j.cub.2005.11.032; O'Connor V, 1999, SCIENCE, V286, P1180, DOI 10.1126/science.286.5442.1180; OKAMOTO N, 1994, J BIOL CHEM, V269, P1231; Peleg S, 2002, NEURON, V33, P87, DOI 10.1016/S0896-6273(01)00567-0; Pelkey KA, 2005, NEURON, V46, P89, DOI 10.1016/j.neuron.2005.02.011; Perroy J, 2000, J NEUROSCI, V20, P7896; Riccardi D, 2002, EXP PHYSIOL, V87, P403, DOI 10.1111/j.1469-445X.2002.tb00053.x; Sansig G, 2001, J NEUROSCI, V21, P8734, DOI 10.1523/JNEUROSCI.21-22-08734.2001; Saugstad JA, 1996, J NEUROSCI, V16, P5979; SAUGSTAD JA, 1994, MOL PHARMACOL, V45, P367; Sharon D, 1997, J GEN PHYSIOL, V109, P477, DOI 10.1085/jgp.109.4.477; Shigemoto R, 1997, J NEUROSCI, V17, P7503, DOI 10.1523/jneurosci.17-19-07503.1997; vonGersdorff H, 1997, J NEUROSCI, V17, P8137; Wise A, 1999, NEUROPHARMACOLOGY, V38, P1647, DOI 10.1016/S0028-3908(99)00119-7; Wolfel M, 2003, J NEUROSCI, V23, P7059, DOI 10.1523/JNEUROSCI.23-18-07059.2003	43	16	16	1	8	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	SEP 5	2008	283	36					24300	24307		10.1074/jbc.M802593200	http://dx.doi.org/10.1074/jbc.M802593200			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	342YR	18599484	hybrid, Green Published			2022-12-27	WOS:000258820000004
J	Ghosh, AK; Ramakrishnan, G; Chandramohan, C; Rajasekharan, R				Ghosh, Ananda K.; Ramakrishnan, Geetha; Chandramohan, Chitraju; Rajasekharan, Ram			CGI-58, the causative gene for Chanarin-Dorfman syndrome, mediates acylation of lysophosphatidic acid	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							DEVELOPING PEANUT COTYLEDONS; ALPHA/BETA-HYDROLASE FOLD; LIPID STORAGE DISEASE; SACCHAROMYCES-CEREVISIAE; MOLECULAR-CLONING; ACYLTRANSFERASE; PHOSPHATASE; PERILIPIN; LIPOLYSIS; DROPLETS	cgi-58 (comparative gene identification-58) is a member of alpha/beta-hydrolase family of proteins. Mutations in CGI-58 are shown to be responsible for a rare genetic disorder known as Chanarin-Dorfman syndrome, characterized by an excessive accumulation of triacylglycerol in several tissues and ichthyosis. We have earlier reported that YLR099c encoding Ict1p in Saccharomyces cerevisiae can acylate lysophosphatidic acid to phosphatidic acid. Here we report that human CGI-58 is closely related to ICT1. To understand the biochemical function of cgi-58, the gene was overexpressed in Escherichia coli, and the purified recombinant protein was found to specifically acylate lysophosphatidic acid in an acyl-CoA-dependent manner. Overexpression of CGI-58 in S. cerevisiae showed an increase in the formation of phosphatidic acid resulting in an overall increase in the total phospholipids. However, the triacylglycerol level was found to be significantly reduced. In addition, the physiological significance of cgi-58 in mice white adipose tissue was studied. We found soluble lysophosphatidic acid acyltransferase activity in mouse white adipose tissue. Immunoblot analysis using anti-Ict1p antibodies followed by mass spectrometry of the immunocross-reactive protein in lipid droplets revealed its identity as cgi-58. These observations suggest the existence of an alternate cytosolic phosphatidic acid biosynthetic pathway in the white adipose tissue. Collectively, these results reveal the role of cgi-58 as an acyltransferase.	[Ghosh, Ananda K.; Chandramohan, Chitraju; Rajasekharan, Ram] Indian Inst Sci, Dept Biochem, Bangalore 560012, Karnataka, India; [Ramakrishnan, Geetha; Rajasekharan, Ram] Monash Univ, Sch Sci, Petaling Jaya 46150, Malaysia	Indian Institute of Science (IISC) - Bangalore; Monash University; Monash University Sunway	Rajasekharan, R (corresponding author), Indian Inst Sci, Dept Biochem, Bangalore 560012, Karnataka, India.	lipid@biochem.iisc.ernet.in	Rajasekharan, Ram/R-2257-2019; R, Rajasekharan/D-3420-2009; Chitraju, Chandramohan/O-8188-2018	Ram, Rajasekharan/0000-0002-4114-0654; Chitraju, Chandramohan/0000-0001-8338-8976; Rajasekharan, Ram/0000-0002-2124-6013				Akiyama M, 2003, J INVEST DERMATOL, V121, P1029, DOI 10.1046/j.1523-1747.2003.12520.x; Brasaemle DL, 2007, J LIPID RES, V48, P2547, DOI 10.1194/jlr.R700014-JLR200; Brasaemle DL, 2000, J BIOL CHEM, V275, P38486, DOI 10.1074/jbc.M007322200; Brown JM, 2007, J LIPID RES, V48, P2295, DOI 10.1194/jlr.M700279-JLR200; Bunting M, 1996, J BIOL CHEM, V271, P10230, DOI 10.1074/jbc.271.17.10230; Gangar A, 2001, J BIOL CHEM, V276, P10290, DOI 10.1074/jbc.M009550200; Ghosh AK, 2008, J BIOL CHEM, V283, P9768, DOI 10.1074/jbc.M708418200; Han GS, 2006, J BIOL CHEM, V281, P9210, DOI 10.1074/jbc.M600425200; Heath RJ, 1998, J BACTERIOL, V180, P1425, DOI 10.1128/JB.180.6.1425-1430.1998; HILTON S, 1991, J BIOL CHEM, V266, P997; Igal RA, 1998, J LIPID RES, V39, P31; Kurat CF, 2006, J BIOL CHEM, V281, P491, DOI 10.1074/jbc.M508414200; Lass A, 2006, CELL METAB, V3, P309, DOI 10.1016/j.cmet.2006.03.005; Lefevre C, 2001, AM J HUM GENET, V69, P1002, DOI 10.1086/324121; Liu PS, 2004, J BIOL CHEM, V279, P3787, DOI 10.1074/jbc.M311945200; MUSUMECI S, 1988, AM J MED GENET, V29, P377, DOI 10.1002/ajmg.1320290219; Nardini M, 1999, CURR OPIN STRUC BIOL, V9, P732, DOI 10.1016/S0959-440X(99)00037-8; OLLIS DL, 1992, PROTEIN ENG, V5, P197, DOI 10.1093/protein/5.3.197; Reddy VS, 2008, J BIOL CHEM, V283, P8846, DOI 10.1074/jbc.M706752200; Saha S, 2006, PLANT PHYSIOL, V141, P1533, DOI 10.1104/pp.106.082198; SCHIESTL RH, 1989, CURR GENET, V16, P339, DOI 10.1007/BF00340712; Shekar S, 2002, PLANT PHYSIOL, V128, P988, DOI 10.1104/pp.010654; Simon GM, 2006, J BIOL CHEM, V281, P26465, DOI 10.1074/jbc.M604660200; Tumaney AW, 2001, J BIOL CHEM, V276, P10847, DOI 10.1074/jbc.M100005200; Yamaguchi T, 2004, J BIOL CHEM, V279, P30490, DOI 10.1074/jbc.M403920200	25	101	109	0	13	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	SEP 5	2008	283	36					24525	24533		10.1074/jbc.M801783200	http://dx.doi.org/10.1074/jbc.M801783200			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	342YR	18606822	Green Published, hybrid			2022-12-27	WOS:000258820000027
J	Harrington, AW; Li, QM; Tep, C; Park, JB; He, ZG; Yoon, SO				Harrington, Anthony W.; Li, Qi Ming; Tep, Chhavy; Park, Jong Bae; He, Zhigang; Yoon, Sung Ok			The Role of Kalirin9 in p75/Nogo Receptor-mediated RhoA Activation in Cerebellar Granule Neurons	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							MYELIN-ASSOCIATED GLYCOPROTEIN; GDP/GTP EXCHANGE FACTOR; INHIBIT NEURITE OUTGROWTH; NOGO RECEPTOR; NEUROTROPHIN RECEPTOR; AXONAL REGENERATION; GEF TRIO; GROWTH; DROSOPHILA; INTERACTS	p75 and the Nogo receptor form a signaling unit for myelin inhibitory molecules, with p75 being responsible for RhoA activation. Because p75 lacks the GDP/GTP exchange factor domain, it has remained unclear how p75 activates RhoA. Here, we report that Kalirin9, a dual RhoGEF, binds p75 directly and regulates p75-Nogo receptor-dependent RhoA activation and neurite inhibition in response to myelin-associated glycoprotein. The region of p75 that Kalirin9 binds includes its mastoparan-like fifth helix, which was shown to recruit RhoGDI-RhoA. As predicted from the presence of a shared binding site, we found that Kalirin9 competes with RhoGDI for p75 binding in a dose-dependent manner in vitro. In line with these data, myelin-associated glycoprotein addition to cerebellar granule neurons resulted in a reduction in the association of Kalirin9 with p75, and a simultaneous increase in the binding of RhoGDI to p75. These results reveal a mechanism by which the fifth helix of p75 regulates RhoA activation.	[Harrington, Anthony W.; Li, Qi Ming; Tep, Chhavy; Yoon, Sung Ok] Ohio State Univ, Ctr Mol Neurobiol, Dept Mol & Cellular Biochem, Columbus, OH 43210 USA; [Harrington, Anthony W.; Tep, Chhavy] Ohio State Univ, Biochem Program, Columbus, OH 43210 USA; [Li, Qi Ming] Ohio State Univ, Mol Cellular & Dev Biol Program, Columbus, OH 43210 USA; [He, Zhigang] Harvard Univ, Sch Med, Childrens Hosp, Div Neurosci, Boston, MA 02115 USA; [Park, Jong Bae] Natl Canc Ctr, Neurooncol Branch, Goyang Si 410769, South Korea	University System of Ohio; Ohio State University; University System of Ohio; Ohio State University; University System of Ohio; Ohio State University; Harvard University; Boston Children's Hospital; Harvard Medical School; National Cancer Center - Korea (NCC)	Yoon, SO (corresponding author), Ohio State Univ, Ctr Mol Neurobiol, Dept Mol & Cellular Biochem, 184 Rightmire Hall,1060 Carmack Rd, Columbus, OH 43210 USA.	Yoon.84@osu.edu	Yoon, Sung Ok/C-5992-2012		National Institutes of Health [NS 39472, NS045758]; Christopher and Dana Reeve Paralysis Foundation; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS051788, R01NS039472, R01NS050626, P30NS045758] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Christopher and Dana Reeve Paralysis Foundation; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	This work was supported, in whole or in part, by National Institutes of Health Grants NS 39472 (to S. O. Y.) and NS045758. This work was also supported by the Christopher and Dana Reeve Paralysis Foundation. The costs of publication of this article were defrayed in part by the payment of page charges.	Awasaki T, 2000, NEURON, V26, P119, DOI 10.1016/S0896-6273(00)81143-5; Bateman J, 2000, NEURON, V26, P93, DOI 10.1016/S0896-6273(00)81141-1; Benson MD, 2005, P NATL ACAD SCI USA, V102, P10694, DOI 10.1073/pnas.0504021102; Chakrabarti K, 2005, MOL CELL BIOL, V25, P5106, DOI 10.1128/MCB.25.12.5106-5118.2005; Chen MS, 2000, NATURE, V403, P434, DOI 10.1038/35000219; Domeniconi M, 2005, NEURON, V46, P849, DOI 10.1016/j.neuron.2005.05.029; Domeniconi M, 2002, NEURON, V35, P283, DOI 10.1016/S0896-6273(02)00770-5; Estrach S, 2002, CURR BIOL, V12, P307, DOI 10.1016/S0960-9822(02)00658-9; Fournier AE, 2001, NATURE, V409, P341, DOI 10.1038/35053072; GrandPre T, 2000, NATURE, V403, P439, DOI 10.1038/35000226; Hansel DE, 2001, J HISTOCHEM CYTOCHEM, V49, P833, DOI 10.1177/002215540104900704; Hisata S, 2007, J CELL BIOL, V178, P843, DOI 10.1083/jcb.200610073; Liebl EC, 2000, NEURON, V26, P107, DOI 10.1016/S0896-6273(00)81142-3; Low K, 2008, J NEUROSCI, V28, P1099, DOI 10.1523/JNEUROSCI.4906-07.2008; Mi S, 2004, NAT NEUROSCI, V7, P221, DOI 10.1038/nn1188; MUKHOPADHYAY G, 1994, NEURON, V13, P757, DOI 10.1016/0896-6273(94)90042-6; Newsome TP, 2000, CELL, V101, P283, DOI 10.1016/S0092-8674(00)80838-7; Penzes P, 2001, J NEUROSCI, V21, P8426, DOI 10.1523/JNEUROSCI.21-21-08426.2001; Penzes P, 2000, J BIOL CHEM, V275, P6395, DOI 10.1074/jbc.275.9.6395; Penzes P, 2003, NEURON, V37, P263, DOI 10.1016/S0896-6273(02)01168-6; Schiller MR, 2006, J BIOL CHEM, V281, P18774, DOI 10.1074/jbc.M512482200; Shin EY, 2004, J BIOL CHEM, V279, P1994, DOI 10.1074/jbc.M307330200; Wang KC, 2002, NATURE, V420, P74, DOI 10.1038/nature01176; Wang KC, 2002, NATURE, V417, P941, DOI 10.1038/nature00867; Wong ST, 2002, NAT NEUROSCI, V5, P1302, DOI 10.1038/nn975; Yamashita T, 2003, NAT NEUROSCI, V6, P461, DOI 10.1038/nn1045; Yamashita T, 2002, J CELL BIOL, V157, P565, DOI 10.1083/jcb.200202010; Yoon SO, 1997, J BIOL CHEM, V272, P23231, DOI 10.1074/jbc.272.37.23231	28	31	31	0	2	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	SEP 5	2008	283	36					24690	24697		10.1074/jbc.M802188200	http://dx.doi.org/10.1074/jbc.M802188200			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	517MA	18625710	hybrid, Green Published			2022-12-27	WOS:000271617300003
J	Lee, K; Song, EH; Kim, HS; Yoo, JH; Han, HJ; Jung, MS; Lee, SM; Kim, KE; Kim, MC; Cho, MJ; Chung, WS				Lee, Kyunghee; Song, Eun Hyeon; Kim, Ho Soo; Yoo, Jae Hyuk; Han, Hay Ju; Jung, Mi Soon; Lee, Sang Min; Kim, Kyung Eun; Kim, Min Chul; Cho, Moo Je; Chung, Woo Sik			Regulation of MAPK phosphatase 1 (AtMKP1) by calmodulin in Arabidopsis	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ACTIVATED PROTEIN-KINASE; CATALYTIC DOMAIN; TARGET RECOGNITION; CYTOSOLIC CALCIUM; CRYSTAL-STRUCTURE; BINDING PROTEINS; ABSCISIC-ACID; PHOSPHATASE; PLANTS; STRESS	The mitogen-activated protein kinases ( MAPKs) are key signal transduction molecules, which respond to various external stimuli. The MAPK phosphatases ( MKPs) are known to be negative regulators of MAPKs in eukaryotes. We screened an Arabidopsis cDNA library using horseradish peroxidase- conjugated calmodulin ( CaM), and isolated AtMKP1 as a CaM- binding protein. Recently, tobacco NtMKP1 and rice OsMKP1, two orthologs of Arabidopsis AtMKP1, were reported to bind CaM via a single putative CaM binding domain ( CaMBD). However, little is known about the regulation of phosphatase activity of plant MKP1s by CaM binding. In this study, we identified two Ca2+-dependent CaMBDs within AtMKP1. Specific binding of CaM to two different CaMBDs was verified using a gel mobility shift assay, a competition assay with a Ca2+/CaM-dependent enzyme, and a split- ubiquitin assay. The peptides for two CaMBDs, CaMBDI and CaMBDII, bound CaM in a Ca2+-dependent manner, and the binding affinity of CaMBDII was found to be higher than that of CaMBDI. CaM overlay assays using mutated CaMBDs showed that four amino acids, Trp453 and Leu456 in CaMBDI and Trp678 and Ile684 in CaMBDII, play a pivotal role in CaM binding. Moreover, the phosphatase activity ofAtMKP1was increased byCaMin a Ca2+-dependent manner. Our results suggest that two important signaling pathways, Ca2+ signaling and the MAPK signaling cascade, are connected in plants via the regulation of AtMKP1 activity. To our knowledge, this is the first report to show that the biochemical activity of MKP1 in plants is regulated by CaM.	[Lee, Kyunghee; Song, Eun Hyeon; Han, Hay Ju; Jung, Mi Soon; Lee, Sang Min; Kim, Kyung Eun; Kim, Min Chul; Cho, Moo Je; Chung, Woo Sik] Gyeongsang Natl Univ, Plant Mol Biol & Biotechnol Res Ctr, Program BK21, Div Appl Life Sci, Jinju 660701, South Korea; [Lee, Kyunghee; Yoo, Jae Hyuk; Lee, Sang Min; Chung, Woo Sik] Gyeongsang Natl Univ, Environm Biotechnol Natl Core Res Ctr, Jinju 660701, South Korea	Gyeongsang National University; Gyeongsang National University	Chung, WS (corresponding author), Gyeongsang Natl Univ, Plant Mol Biol & Biotechnol Res Ctr, Program BK21, Div Appl Life Sci, Jinju 660701, South Korea.	chungws@gnu.ac.kr	Cho, Moo Je/F-1649-2010	Song, Eun Hyeon/0000-0001-9524-2595				Berridge MJ, 2003, NAT REV MOL CELL BIO, V4, P517, DOI 10.1038/nrm1155; Blume B, 2000, PLANT CELL, V12, P1425, DOI 10.1105/tpc.12.8.1425; Carafoli E, 2005, FEBS J, V272, P1073, DOI 10.1111/j.1742-4658.2005.04546.x; Chen L, 1996, BIOCHEMISTRY-US, V35, P9349, DOI 10.1021/bi960700+; CRIVICI A, 1995, ANNU REV BIOPH BIOM, V24, P85, DOI 10.1146/annurev.bb.24.060195.000505; ERICKSONVIITANEN S, 1987, METHOD ENZYMOL, V139, P455; Fauman EB, 1996, TRENDS BIOCHEM SCI, V21, P413, DOI 10.1016/S0968-0004(96)10059-1; Gottlin EB, 1996, J BIOL CHEM, V271, P27445, DOI 10.1074/jbc.271.44.27445; Grant M, 2000, PLANT J, V23, P441, DOI 10.1046/j.1365-313x.2000.00804.x; Hoeflich KP, 2002, CELL, V108, P739, DOI 10.1016/S0092-8674(02)00682-7; Katou S, 2005, J BIOL CHEM, V280, P39569, DOI 10.1074/jbc.M508115200; Katou S, 2007, PLANT CELL PHYSIOL, V48, P332, DOI 10.1093/pcp/pcm007; Kerk D, 2002, PLANT PHYSIOL, V129, P908, DOI 10.1104/pp.004002; Keyse SM, 2000, CURR OPIN CELL BIOL, V12, P186, DOI 10.1016/S0955-0674(99)00075-7; Kim HS, 2007, J BIOL CHEM, V282, P36292, DOI 10.1074/jbc.M705217200; Kim MC, 2002, NATURE, V416, P447, DOI 10.1038/416447a; KNIGHT MR, 1991, NATURE, V352, P524, DOI 10.1038/352524a0; Kudla J, 1999, P NATL ACAD SCI USA, V96, P4718, DOI 10.1073/pnas.96.8.4718; Kyriakis JM, 2001, PHYSIOL REV, V81, P807, DOI 10.1152/physrev.2001.81.2.807; Laser H, 2000, P NATL ACAD SCI USA, V97, P13732, DOI 10.1073/pnas.250400997; Lee JS, 2007, J BIOL CHEM, V282, P25020, DOI 10.1074/jbc.M701888200; LEE SH, 1995, J BIOL CHEM, V270, P21806, DOI 10.1074/jbc.270.37.21806; Lee SH, 1999, BBA-PROTEIN STRUCT M, V1433, P56, DOI 10.1016/S0167-4838(99)00149-1; Liang L, 2000, J BIOL CHEM, V275, P30075, DOI 10.1074/jbc.M004843200; MEADOR WE, 1992, SCIENCE, V257, P1251, DOI 10.1126/science.1519061; Monroe-Augustus M, 2003, PLANT CELL, V15, P2979, DOI 10.1105/tpc.017046; ONEIL KT, 1990, TRENDS BIOCHEM SCI, V15, P59, DOI 10.1016/0968-0004(90)90177-D; PRICE AH, 1994, PLANT CELL, V6, P1301, DOI 10.1105/tpc.6.9.1301; Quettier AL, 2006, PLANT J, V47, P711, DOI 10.1111/j.1365-313X.2006.02823.x; Rainaldi M, 2007, J BIOL CHEM, V282, P6031, DOI 10.1074/jbc.M608970200; Reddy ASN, 2001, PLANT SCI, V160, P381, DOI 10.1016/S0168-9452(00)00386-1; Reddy VS, 2004, PHYTOCHEMISTRY, V65, P1745, DOI 10.1016/j.phytochem.2004.04.033; Reddy VS, 2002, J BIOL CHEM, V277, P9840, DOI 10.1074/jbc.M111626200; Rhoads AR, 1997, FASEB J, V11, P331, DOI 10.1096/fasebj.11.5.9141499; Samuel MA, 2000, PLANT J, V22, P367, DOI 10.1046/j.1365-313x.2000.00741.x; Sanders D, 2002, PLANT CELL, V14, pS401, DOI 10.1105/tpc.002899; Sanders D, 1999, PLANT CELL, V11, P691, DOI 10.1105/tpc.11.4.691; Snedden WA, 2001, NEW PHYTOL, V151, P35, DOI 10.1046/j.1469-8137.2001.00154.x; Stagljar I, 1998, P NATL ACAD SCI USA, V95, P5187, DOI 10.1073/pnas.95.9.5187; Stewart AE, 1999, NAT STRUCT BIOL, V6, P174; Takahashi Y, 2003, PLANT J, V36, P820, DOI 10.1046/j.1365-313X.2003.01923.x; Theodosiou A, 2002, GENOME BIOL, V3; Ulm R, 2002, EMBO J, V21, P6483, DOI 10.1093/emboj/cdf646; Varshavsky A, 1996, P NATL ACAD SCI USA, V93, P12142, DOI 10.1073/pnas.93.22.12142; White PJ, 2003, ANN BOT-LONDON, V92, P487, DOI 10.1093/aob/mcg164; Widmann C, 1999, PHYSIOL REV, V79, P143, DOI 10.1152/physrev.1999.79.1.143; WurglerMurphy SM, 1997, TRENDS BIOCHEM SCI, V22, P172, DOI 10.1016/S0968-0004(97)01036-0; Yamakawa H, 2004, J BIOL CHEM, V279, P928, DOI 10.1074/jbc.M310277200; Yoo JH, 2004, J BIOL CHEM, V279, P848, DOI 10.1074/jbc.M310709200; Yuvaniyama J, 1996, SCIENCE, V272, P1328, DOI 10.1126/science.272.5266.1328; Zhou B, 1999, J BIOL CHEM, V274, P35526, DOI 10.1074/jbc.274.50.35526	51	39	42	0	16	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	AUG 29	2008	283	35					23581	23588		10.1074/jbc.M801549200	http://dx.doi.org/10.1074/jbc.M801549200			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	340II	18579522	hybrid, Green Published			2022-12-27	WOS:000258638900010
J	Toyoda, E; Kagaya, S; Cowell, IG; Kurosawa, A; Kamoshita, K; Nishikawa, K; Iiizumi, S; Koyama, H; Austin, CA; Adachi, N				Toyoda, Eriko; Kagaya, Shigehide; Cowell, Ian G.; Kurosawa, Aya; Kamoshita, Keiichi; Nishikawa, Kiyohiro; Iiizumi, Susumu; Koyama, Hideki; Austin, Caroline A.; Adachi, Noritaka			NK314, a topoisomerase II inhibitor that specifically targets the alpha isoform	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							DNA-LIGASE-IV; STRAND BREAK REPAIR; CELL-CYCLE; V(D)J RECOMBINATION; COVALENT COMPLEXES; IN-SITU; BETA; EXPRESSION; GENE; INVOLVEMENT	Topoisomerase II ( Top2) is a ubiquitous nuclear enzyme that relieves torsional stress in chromosomal DNA during various cellular processes. Agents that target Top2, involving etoposide, doxorubicin, and mitoxantrone, are among the most effective anticancer drugs used in the clinic. Mammalian cells possess two genetically distinct Top2 isoforms, both of which are the target of these agents. Top2 beta is essential for cell proliferation and is highly expressed in vigorously growing cells, whereas Top2 beta is nonessential for growth and has recently been implicated in treatment- associated secondary malignancies, highlighting the validity of a Top2 beta-specific drug for future cancer treatment; however, no such agent has been hitherto reported. Here we show that NK314, a novel synthetic benzo[c] phenanthridine alkaloid, targets Top2 beta and not Top2 beta in vivo. Unlike other Top2 inhibitors, NK314 induces Top2- DNA complexes and double- strand breaks ( DSBs) in an beta isoform- specific manner. Heterozygous disruption of the humanTOP2 beta gene confers increased NK314 resistance, whereas TOP2 beta homozygous knock- out cells display increased NK314 sensitivity, indicating that the beta isoform is the cellular target. Wefurther show that the absence of Top2 beta does not alleviate NK314 hypersensitivity of cells deficient in non- homologous end- joining, a critical pathway for repairing Top2- mediated DSBs. Our results indicate that NK314 acts as a Top2 beta- specific poison in mammalian cells, with excellent potential as an efficacious and safe chemotherapeutic agent. We also suggest that a series of human knock- out cell lines are useful in assessingDNAdamage and repair induced by potential topoisomerase- targeting agents.	[Toyoda, Eriko; Kurosawa, Aya; Iiizumi, Susumu; Koyama, Hideki; Adachi, Noritaka] Yokohama City Univ, Int Grad Sch Arts & Sci, Kanazawa Ku, Yokohama, Kanagawa 2360027, Japan; [Toyoda, Eriko; Kagaya, Shigehide; Kamoshita, Keiichi; Nishikawa, Kiyohiro] Nippon Kayaku Co Ltd, Pharmaceut Res Labs, Kita Ku, Tokyo 1158588, Japan; [Cowell, Ian G.; Austin, Caroline A.] Univ Newcastle, Sch Med, Inst Cell & Mol Biosci, Newcastle Upon Tyne NE2 4HH, Tyne & Wear, England	Yokohama City University; Nippon Kayaku Co., Ltd.; Newcastle University - UK	Adachi, N (corresponding author), Yokohama City Univ, Int Grad Sch Arts & Sci, Kanazawa Ku, Seto 22-2, Yokohama, Kanagawa 2360027, Japan.	nadachi@yokohama-cu.ac.jp	Kurosawa, Aya/O-5165-2018	Kurosawa, Aya/0000-0001-8909-2789; Cowell, Ian/0000-0002-8606-0447; Austin, Caroline/0000-0002-1921-5947				Adachi N, 2006, DNA CELL BIOL, V25, P19, DOI 10.1089/dna.2006.25.19; Adachi N, 2000, GENE, V245, P49, DOI 10.1016/S0378-1119(00)00040-8; Adachi N, 2003, J BIOL CHEM, V278, P35897, DOI 10.1074/jbc.M306500200; Adachi N, 2001, P NATL ACAD SCI USA, V98, P12109, DOI 10.1073/pnas.201271098; Adachi N, 2004, BIOCHEM BIOPH RES CO, V318, P856, DOI 10.1016/j.bbrc.2004.04.099; Akimitsu N, 2003, GENES CELLS, V8, P393, DOI 10.1046/j.1365-2443.2003.00643.x; Andoh T, 1998, BIOCHIMIE, V80, P235, DOI 10.1016/S0300-9084(98)80006-0; AUSTIN CA, 1995, J BIOL CHEM, V270, P15739, DOI 10.1074/jbc.270.26.15739; Austin CA, 1998, BIOESSAYS, V20, P215, DOI 10.1002/(SICI)1521-1878(199803)20:3<215::AID-BIES5>3.0.CO;2-Q; Azarova AM, 2007, P NATL ACAD SCI USA, V104, P11014, DOI 10.1073/pnas.0704002104; CAPRANICO G, 1992, BIOCHIM BIOPHYS ACTA, V1132, P43, DOI 10.1016/0167-4781(92)90050-A; Carpenter AJ, 2004, MOL BIOL CELL, V15, P5700, DOI 10.1091/mbc.E04-08-0732; Chaly N, 1996, CHROMOSOME RES, V4, P457, DOI 10.1007/BF02265053; Champoux JJ, 2001, ANNU REV BIOCHEM, V70, P369, DOI 10.1146/annurev.biochem.70.1.369; Christensen MO, 2002, J CELL BIOL, V157, P31, DOI 10.1083/jcb.200112023; CUMMINGS J, 1993, ANN ONCOL, V4, P533, DOI 10.1093/oxfordjournals.annonc.a058584; Dong KC, 2007, NATURE, V450, P1201, DOI 10.1038/nature06396; Errington F, 1999, MOL PHARMACOL, V56, P1309, DOI 10.1124/mol.56.6.1309; Gao HL, 1999, P NATL ACAD SCI USA, V96, P12168, DOI 10.1073/pnas.96.21.12168; Grawunder U, 1998, MOL CELL, V2, P477, DOI 10.1016/S1097-2765(00)80147-1; Grawunder U, 1998, J BIOL CHEM, V273, P24708, DOI 10.1074/jbc.273.38.24708; Guo L, 2007, MOL CANCER THER, V6, P1501, DOI 10.1158/1535-7163.MCT-06-0780; Haber JE, 2000, TRENDS GENET, V16, P259, DOI 10.1016/S0168-9525(00)02022-9; Heyer WD, 2006, NUCLEIC ACIDS RES, V34, P4115, DOI 10.1093/nar/gkl481; Iiizumi S, 2006, BIOTECHNIQUES, V41, P311, DOI 10.2144/000112233; Ju BG, 2006, SCIENCE, V312, P1798, DOI 10.1126/science.1127196; KOBORI O, 1982, INT J CANCER, V30, P65, DOI 10.1002/ijc.2910300112; Li TK, 2001, ANNU REV PHARMACOL, V41, P53, DOI 10.1146/annurev.pharmtox.41.1.53; Lieber MR, 2008, J BIOL CHEM, V283, P1, DOI 10.1074/jbc.R700039200; Lieber MR, 2003, NAT REV MOL CELL BIO, V4, P712, DOI 10.1038/nrm1202; Lieber MR, 1999, GENES CELLS, V4, P77, DOI 10.1046/j.1365-2443.1999.00245.x; Linka RM, 2007, NUCLEIC ACIDS RES, V35, P3810, DOI 10.1093/nar/gkm102; LIU LF, 1989, ANNU REV BIOCHEM, V58, P351, DOI 10.1146/annurev.bi.58.070189.002031; Lyu YL, 2003, P NATL ACAD SCI USA, V100, P7123, DOI 10.1073/pnas.1232376100; Nitiss JL, 1996, MOL PHARMACOL, V50, P1095; Onda T, 2008, CANCER LETT, V259, P99, DOI 10.1016/j.canlet.2007.10.004; OSHEROFF N, 1989, BIOCHEMISTRY-US, V28, P6157, DOI 10.1021/bi00441a005; Padget K, 2000, LEUKEMIA, V14, P1997, DOI 10.1038/sj.leu.2401928; ROCA J, 1994, P NATL ACAD SCI USA, V91, P1781, DOI 10.1073/pnas.91.5.1781; Sakaguchi A, 2004, J CELL SCI, V117, P1047, DOI 10.1242/jcs.00977; Sakaguchi A, 2002, J BIOCHEM, V132, P409, DOI 10.1093/oxfordjournals.jbchem.a003237; So S, 2006, GENES CELLS, V11, P363, DOI 10.1111/j.1365-2443.2006.00944.x; So S, 2004, J BIOL CHEM, V279, P55433, DOI 10.1074/jbc.M409827200; So S, 2007, DNA CELL BIOL, V26, P517, DOI 10.1089/dna.2007.0578; SPITZNER JR, 1990, NUCLEIC ACIDS RES, V18, P1, DOI 10.1093/nar/18.1.1; TRASK DK, 1988, P NATL ACAD SCI USA, V85, P1417, DOI 10.1073/pnas.85.5.1417; Tsutsui K, 2001, J BIOL CHEM, V276, P5769, DOI 10.1074/jbc.M008517200; Tsutsui K, 2001, J COMP NEUROL, V431, P228, DOI 10.1002/1096-9861(20010305)431:2<228::AID-CNE1067>3.0.CO;2-M; Uegaki K, 2006, DNA REPAIR, V5, P303, DOI 10.1016/j.dnarep.2005.10.008; Wang JC, 2002, NAT REV MOL CELL BIO, V3, P430, DOI 10.1038/nrm831; Wang JC, 1996, ANNU REV BIOCHEM, V65, P635, DOI 10.1146/annurev.bi.65.070196.003223; WATANABE M, 1994, NEUROSCI RES, V19, P51, DOI 10.1016/0168-0102(94)90007-8; Willmore E, 1998, MOL PHARMACOL, V54, P78, DOI 10.1124/mol.54.1.78; WOESSNER RD, 1991, CELL GROWTH DIFFER, V2, P209; Yang X, 2000, SCIENCE, V287, P131, DOI 10.1126/science.287.5450.131; Zandvliet DWJ, 1996, BBA-GENE STRUCT EXPR, V1307, P239, DOI 10.1016/0167-4781(96)00063-2	56	85	87	0	9	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	AUG 29	2008	283	35					23711	23720		10.1074/jbc.M803936200	http://dx.doi.org/10.1074/jbc.M803936200			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	340II	18596031	Green Published, hybrid			2022-12-27	WOS:000258638900025
J	Cailhier, JF; Sirois, I; Laplante, P; Lepage, S; Raymond, MA; Brassard, N; Prat, A; Iozzo, RV; Pshezhetsky, AV; Hebert, MJ				Cailhier, Jean-Francois; Sirois, Isabelle; Laplante, Patrick; Lepage, Stephanie; Raymond, Marc-Andre; Brassard, Nathalie; Prat, Alexandre; Iozzo, Renato V.; Pshezhetsky, Alexey V.; Hebert, Marie-Josee			Caspase-3 activation triggers extracellular cathepsin L release and endorepellin proteolysis	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							LOW-DENSITY-LIPOPROTEIN; ENDOTHELIAL-CELL APOPTOSIS; ABDOMINAL AORTIC-ANEURYSM; BCL-X; PERITUBULAR CAPILLARIES; REDUCES ATHEROSCLEROSIS; CYSTEINE PROTEASES; EXPRESSION; DEATH; RECEPTOR	Proteolysis of extracellular matrix components and the production of cryptic bioactive factors play key roles in vascular remodeling. We showed previously that extracellular matrix proteolysis is triggered by the apoptosis of endothelial cells (EC), resulting in the release of an anti-apoptotic C-terminal fragment of endorepellin (LG3). Here, we characterize the endorepellin-cleaving proteases released by apoptotic EC using a multifaceted proteomics strategy. Cathepsin L (CathL), a cysteine protease known to be associated with cardiovascular disease progression in animal models and humans, was isolated from medium conditioned by apoptotic EC. CathL cleaved recombinant endorepellin in vitro, leading to LG3 release. Inhibition of CathL activity in EC exposed to pro-apoptotic stimuli prevented LG3 release without modulating the development of apoptosis in EC. Inhibition of caspase-3 activation in EC with the biochemical inhibitor DEVD-fluoromethyl ketone or small interfering RNAs concomitantly prevented CathL release by EC, LG3 production, and the development of paracrine anti-apoptotic activity. These data demonstrate that caspase-3 activation is a novel pathway of importance for triggering extracellular CathL release and the cleavage of extracellular matrix components.	[Cailhier, Jean-Francois; Sirois, Isabelle; Laplante, Patrick; Lepage, Stephanie; Raymond, Marc-Andre; Brassard, Nathalie; Hebert, Marie-Josee] CRCHUM, Montreal, PQ H2L 4M1, Canada; [Prat, Alexandre] Univ Montreal, CHUM, Res Ctr, Neuroimmunol Res Lab, Montreal, PQ H2L 4M1, Canada; [Cailhier, Jean-Francois; Sirois, Isabelle; Laplante, Patrick; Lepage, Stephanie; Raymond, Marc-Andre; Brassard, Nathalie; Hebert, Marie-Josee] Univ Montreal, CHUM, Res Ctr, Inst Canc Montreal, Montreal, PQ H2L 4M1, Canada; [Iozzo, Renato V.] Thomas Jefferson Univ, Dept Pathol Anat & Cell Biol, Philadelphia, PA 19107 USA; [Pshezhetsky, Alexey V.] Univ Montreal, Ctr Hosp Univ St Justine, Dept Med Genet, Montreal, PQ H3T 1C5, Canada	Universite de Montreal; Universite de Montreal; Universite de Montreal; Jefferson University; Universite de Montreal; Centre Hospitalier Universitaire Sainte-Justine	Hebert, MJ (corresponding author), CRCHUM, 1560 Sherbrooke St E, Montreal, PQ H2L 4M1, Canada.	marie-josee.hebert.chum@ssss.gouv.qc.ca	Iozzo, Renato/AAS-1980-2020	Iozzo, Renato/0000-0002-5908-5112; A, Pshezhetsky/0000-0002-6612-1062	Canadian Institutes of Health Research [MOP-15447]; Fonds de la Recherche en Sante du Que bec	Canadian Institutes of Health Research(Canadian Institutes of Health Research (CIHR)); Fonds de la Recherche en Sante du Que bec(Fonds de la Recherche en Sante du Quebec)	This work was supported in part by Canadian Institutes of Health Research Grants MOP-15447 ( to M.- J. H.) and MOP-66980 (to A. V. P.) and a grant from the Fonds de la Recherche en Sante du Que bec (Interdisciplinary group grant on predictors of rejection (to M.- J. H.)). The costs of publication of this article were defrayed in part by the payment of page charges. This article must therefore be hereby marked " advertisement" in accordance with 18 U. S. C. Section 1734 solely to indicate this fact.	BAUMGARTNERPARZER SM, 1995, DIABETES, V44, P1323, DOI 10.2337/diabetes.44.11.1323; Bix G, 2004, J CELL BIOL, V166, P97, DOI 10.1083/jcb.200401150; Bix G, 2007, BLOOD, V109, P3745, DOI 10.1182/blood-2006-08-039925; Choy JC, 2005, AM J TRANSPLANT, V5, P494, DOI 10.1111/j.1600-6143.2004.00710.x; Choy JC, 2004, AM J PATHOL, V165, P127, DOI 10.1016/S0002-9440(10)63281-6; Choy JC, 2001, J MOL CELL CARDIOL, V33, P1673, DOI 10.1006/jmcc.2001.1419; Degterev A, 2008, NAT REV MOL CELL BIO, V9, P378, DOI 10.1038/nrm2393; Dimmeler S, 1997, CIRCULATION, V95, P1760; Du XL, 1998, DIABETOLOGIA, V41, P249, DOI 10.1007/s001250050900; Felbor U, 2000, EMBO J, V19, P1187, DOI 10.1093/emboj/19.6.1187; Gacko M, 1998, CLIN CHIM ACTA, V271, P171, DOI 10.1016/S0009-8981(97)00246-5; Gacko M, 1998, CLIN CHEM LAB MED, V36, P449, DOI 10.1515/CCLM.1998.075; Goligorsky MS, 2007, J AM SOC NEPHROL, V18, P2233, DOI 10.1681/ASN.2006121399; Gonzalez EM, 2005, J BIOL CHEM, V280, P7080, DOI 10.1074/jbc.M409841200; Hamet P, 2001, CAN J CARDIOL, V17, p26A; Heermeier K, 1999, KIDNEY INT, V56, P1310, DOI 10.1046/j.1523-1755.1999.00685.x; Hristov M, 2004, BLOOD, V104, P2761, DOI 10.1182/blood-2003-10-3614; Iozzo RV, 2005, NAT REV MOL CELL BIO, V6, P646, DOI 10.1038/nrm1702; Isermann B, 2007, NAT MED, V13, P1349, DOI 10.1038/nm1667; Ishii Y, 2005, KIDNEY INT, V67, P321, DOI 10.1111/j.1523-1755.2005.00085.x; Jaattela M, 2003, NAT IMMUNOL, V4, P416, DOI 10.1038/ni0503-416; Jormsjo S, 2002, AM J PATHOL, V161, P939, DOI 10.1016/S0002-9440(10)64254-X; Keeling W Brent, 2005, Vasc Endovascular Surg, V39, P457, DOI 10.1177/153857440503900601; Kitamoto S, 2007, CIRCULATION, V115, P2065, DOI 10.1161/CIRCULATIONAHA.107.688523; Laplante P, 2005, J IMMUNOL, V174, P5740, DOI 10.4049/jimmunol.174.9.5740; Laplante P, 2006, J BIOL CHEM, V281, P30383, DOI 10.1074/jbc.M606412200; Leist M, 2001, NAT REV MOL CELL BIO, V2, P589, DOI 10.1038/35085008; Levine B, 2008, CELL, V132, P27, DOI 10.1016/j.cell.2007.12.018; Li DY, 1998, AM J PHYSIOL-HEART C, V275, pH568, DOI 10.1152/ajpheart.1998.275.2.H568; Liu J, 2006, ATHEROSCLEROSIS, V184, P302, DOI 10.1016/j.atherosclerosis.2005.05.012; Liu JA, 2004, ARTERIOSCL THROM VAS, V24, P1359, DOI 10.1161/01.ATV.0000134530.27208.41; Lutgens E, 2006, CIRCULATION, V113, P98, DOI 10.1161/CIRCULATIONAHA.105.561449; Lutgens SPM, 2007, FASEB J, V21, P3029, DOI 10.1096/fj.06-7924com; Mongiat M, 2003, J BIOL CHEM, V278, P4238, DOI 10.1074/jbc.M210445200; Newby AC, 2005, PHYSIOL REV, V85, P1, DOI 10.1152/physrev.00048.2003; Pollman MJ, 1998, NAT MED, V4, P222, DOI 10.1038/nm0298-222; Pshezhetsky AV, 2007, PROTEOMICS, V7, P2201, DOI 10.1002/pmic.200600956; Ramachandran R, 2007, AM J PHYSIOL-LUNG C, V292, pL788, DOI 10.1152/ajplung.00226.2006; Raymond MA, 2004, FASEB J, V18, P705, DOI 10.1096/fj.03-0573fje; Raymond MA, 2003, FASEB J, V17, P515, DOI 10.1096/fj.02-0500fje; Raymond MA, 2002, BIOCHEM BIOPH RES CO, V291, P261, DOI 10.1006/bbrc.2002.6449; Sambrano GR, 2000, J BIOL CHEM, V275, P6819, DOI 10.1074/jbc.275.10.6819; Sata M, 1998, J CLIN INVEST, V102, P1682, DOI 10.1172/JCI3531; Saxena A, 2002, J PATHOL, V196, P335, DOI 10.1002/path.1040; Shimizu A, 2000, KIDNEY INT, V58, P2546, DOI 10.1046/j.1523-1755.2000.00440.x; Shimizu A, 2002, KIDNEY INT, V61, P1867, DOI 10.1046/j.1523-1755.2002.00309.x; Shimizu A, 2000, J AM SOC NEPHROL, V11, P2371, DOI 10.1681/ASN.V11122371; Sukhova GK, 2006, ANN NY ACAD SCI, V1085, P161, DOI 10.1196/annals.1383.028; Sukhova GK, 2003, J CLIN INVEST, V111, P897, DOI 10.1172/JCI200314915; Sukhova GK, 1998, J CLIN INVEST, V102, P576, DOI 10.1172/JCI181; Suzuki J, 2000, CARDIOVASC RES, V45, P783, DOI 10.1016/S0008-6363(99)00356-9; Vogt CJ, 2001, MICROCIRCULATION, V8, P129, DOI 10.1080/713774024; Woodall BP, 2008, J BIOL CHEM, V283, P2335, DOI 10.1074/jbc.M708364200; Zhang Y, 2006, J BIOL CHEM, V281, P39096, DOI 10.1074/jbc.M601362200; Zong WX, 2006, GENE DEV, V20, P1, DOI 10.1101/gad.1376506	55	90	93	0	12	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	OCT 3	2008	283	40					27220	27229		10.1074/jbc.M801164200	http://dx.doi.org/10.1074/jbc.M801164200			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	353RT	18658137	hybrid			2022-12-27	WOS:000259586600042
J	Xiao, YC; Bingham, JP; Zhu, WG; Moczydlowski, E; Liang, S; Cummins, TR				Xiao, Yucheng; Bingham, Jon-Paul; Zhu, Weiguo; Moczydlowski, Edward; Liang, Songping; Cummins, Theodore R.			Tarantula huwentoxin-IV inhibits neuronal sodium channels by binding to receptor site 4 and trapping the domain II voltage sensor in the closed configuration	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article; Proceedings Paper	37th Annual Meeting of the Society-for-Neuroscience	NOV 03-07, 2007	San Diego, CA	Soc Neurosci			SPIDER SELENOCOSMIA-HUWENA; ROOT GANGLION NEURONS; SCORPION TOXIN; MOLECULAR DETERMINANTS; STATE INACTIVATION; CONFORMATIONAL-CHANGES; NA+ CHANNELS; ACTIVATION; NEUROTOXIN; CELLS	Peptide toxins with high affinity, divergent pharmacological functions, and isoform-specific selectivity are powerful tools for investigating the structure-function relationships of voltage-gated sodium channels (VGSCs). Although a number of interesting inhibitors have been reported from tarantula venoms, little is known about the mechanism for their interaction with VGSCs. We show that huwentoxin-IV (HWTX-IV), a 35-residue peptide from tarantula Ornithoctonus huwena venom, preferentially inhibits neuronal VGSC subtypes rNav1.2, rNav1.3, and hNav1.7 compared with muscle subtypes rNav1.4 and hNav1.5. Of the five VGSCs examined, hNav1.7 was most sensitive to HWTX-IV (IC50 similar to 26 nM). Following application of 1 mu M HWTX-IV, hNav1.7 currents could only be elicited with extreme depolarizations (>+ 100 mV). Recovery of hNav1.7 channels from HWTX-IV inhibition could be induced by extreme depolarizations or moderate depolarizations lasting several minutes. Site-directed mutagenesis analysis indicated that the toxin docked at neurotoxin receptor site 4 located at the extracellular S3-S4 linker of domain II. Mutations E818Q and D816N in hNav1.7 decreased toxin affinity for hNav1.7 by similar to 300-fold, whereas the reverse mutations in rNav1.4 (N655D/Q657E) and the corresponding mutations in hNav1.5 (R812D/S814E) greatly increased the sensitivity of the muscle VGSCs to HWTX-IV. Our data identify a novel mechanism for sodium channel inhibition by tarantula toxins involving binding to neurotoxin receptor site 4. In contrast to scorpion beta-toxins that trap the IIS4 voltage sensor in an outward configuration, we propose that HWTX-IV traps the voltage sensor of domain II in the inward, closed configuration.	[Xiao, Yucheng; Liang, Songping] Hunan Normal Univ, Life Sci Coll, Changsha 410081, Hunan, Peoples R China; [Xiao, Yucheng; Zhu, Weiguo; Cummins, Theodore R.] Indiana Univ, Sch Med, Dept Pharmacol & Toxicol, Stark Neurosci Res Inst, Indianapolis, IN 46202 USA; [Bingham, Jon-Paul] Univ Hawaii, Dept Mol Biosci & Bioengn, Honolulu, HI 96822 USA; [Moczydlowski, Edward] Clarkson Univ, Dept Biol, Potsdam, NY 13699 USA	Hunan Normal University; Indiana University System; Indiana University-Purdue University Indianapolis; University of Hawaii System; Clarkson University	Liang, S (corresponding author), Hunan Normal Univ, Life Sci Coll, Changsha 410081, Hunan, Peoples R China.	liangsp@hunnu.edu.cn; trcummin@iupui.edu	BINGHAM, Jon-Paul/AAW-9377-2021; Xiao, Yucheng/H-3600-2012; Moczydlowski, Edward G/D-1734-2013		NINDS NIH HHS [NS054642] Funding Source: Medline; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R21NS054642] Funding Source: NIH RePORTER	NINDS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))		Bendahhou S, 1997, AM J PHYSIOL-CELL PH, V272, pC592, DOI 10.1152/ajpcell.1997.272.2.C592; Bosmans F, 2006, MOL PHARMACOL, V69, P419, DOI 10.1124/mol.105.015941; Campos FV, 2007, J GEN PHYSIOL, V130, P257, DOI 10.1085/jgp.200609719; Catterall WA, 2000, NEURON, V26, P13, DOI 10.1016/S0896-6273(00)81133-2; Catterall WA, 2005, PHARMACOL REV, V57, P397, DOI 10.1124/pr.57.4.4; Cestele S, 1998, NEURON, V21, P919, DOI 10.1016/S0896-6273(00)80606-6; Cestele S, 2000, BIOCHIMIE, V82, P883, DOI 10.1016/S0300-9084(00)01174-3; Chanda B, 2002, J GEN PHYSIOL, V120, P629, DOI 10.1085/jgp.20028679; Corzo G, 2007, J BIOL CHEM, V282, P4643, DOI 10.1074/jbc.M605403200; Cox JJ, 2006, NATURE, V444, P894, DOI 10.1038/nature05413; Cummins Theodore R, 2007, Expert Rev Neurother, V7, P1597, DOI 10.1586/14737175.7.11.1597; Cummins TR, 1998, J NEUROSCI, V18, P9607; Cummins TR, 2002, MOL PHARMACOL, V61, P1192, DOI 10.1124/mol.61.5.1192; Cummins TR, 2001, J NEUROSCI, V21, P5952, DOI 10.1523/JNEUROSCI.21-16-05952.2001; CUMMINS TR, 2004, SOC NEUR ANN M SAN D; Dib-Hajj SD, 2007, TRENDS NEUROSCI, V30, P555, DOI 10.1016/j.tins.2007.08.004; Escoubas P, 2000, BIOCHIMIE, V82, P893, DOI 10.1016/S0300-9084(00)01166-4; Gilles N, 2001, BIOCHEMISTRY-US, V40, P14576, DOI 10.1021/bi010973r; Goldin AL, 2000, NEURON, V28, P365, DOI 10.1016/S0896-6273(00)00116-1; Herzog RI, 2003, J PHYSIOL-LONDON, V551, P741, DOI 10.1113/jphysiol.2003.047357; Huang CJ, 2001, BIOPHYS J, V80, P1262, DOI 10.1016/S0006-3495(01)76102-4; Kearney JA, 2001, NEUROSCIENCE, V102, P307, DOI 10.1016/S0306-4522(00)00479-6; KLUGBAUER N, 1995, EMBO J, V14, P1084, DOI 10.1002/j.1460-2075.1995.tb07091.x; Lee HC, 2003, NEURON, V40, P527, DOI 10.1016/S0896-6273(03)00636-6; Li DL, 2003, FEBS LETT, V555, P616, DOI 10.1016/S0014-5793(03)01303-6; Li-Smerin Y, 2000, J GEN PHYSIOL, V115, P673, DOI 10.1085/jgp.115.6.673; LIANG SP, 1993, TOXICON, V31, P969, DOI 10.1016/0041-0101(93)90256-I; Lossin C, 2002, NEURON, V34, P877, DOI 10.1016/S0896-6273(02)00714-6; Mantegazza M, 2005, J PHYSIOL-LONDON, V568, P13, DOI 10.1113/jphysiol.2005.093484; Matavel A, 2002, FEBS LETT, V523, P219, DOI 10.1016/S0014-5793(02)02988-5; McDonough SI, 1997, MOL PHARMACOL, V52, P1095, DOI 10.1124/mol.52.6.1095; Middleton RE, 2002, BIOCHEMISTRY-US, V41, P14734, DOI 10.1021/bi026546a; Nicholson GM, 1998, PFLUG ARCH EUR J PHY, V436, P117, DOI 10.1007/s004240050612; OGATA N, 1993, J PHYSIOL-LONDON, V466, P9; Peng K, 2001, TOXICON, V39, P491, DOI 10.1016/S0041-0101(00)00150-1; Peng K, 2002, J BIOL CHEM, V277, P47564, DOI 10.1074/jbc.M204063200; Phillips LR, 2005, NATURE, V436, P857, DOI 10.1038/nature03873; Rogers JC, 1996, J BIOL CHEM, V271, P15950, DOI 10.1074/jbc.271.27.15950; Rush AM, 2007, J PHYSIOL-LONDON, V579, P1, DOI 10.1113/jphysiol.2006.121483; Saab CY, 2002, NEUROSCI LETT, V331, P79, DOI 10.1016/S0304-3940(02)00860-1; Sheets MF, 1999, J PHYSIOL-LONDON, V514, P425, DOI 10.1111/j.1469-7793.1999.425ae.x; Sheets PL, 2007, J PHYSIOL-LONDON, V581, P1019, DOI 10.1113/jphysiol.2006.127027; Shon KJ, 1998, J NEUROSCI, V18, P4473; Smith JJ, 2007, J BIOL CHEM, V282, P12687, DOI 10.1074/jbc.M610462200; Smith JJ, 2005, J BIOL CHEM, V280, P11127, DOI 10.1074/jbc.M412552200; Swartz KJ, 2007, TOXICON, V49, P213, DOI 10.1016/j.toxicon.2006.09.024; SWARTZ KJ, 1995, NEURON, V15, P941, DOI 10.1016/0896-6273(95)90184-1; Szeto TH, 2000, FEBS LETT, V470, P293, DOI 10.1016/S0014-5793(00)01339-9; UKOMADU C, 1992, NEURON, V8, P663, DOI 10.1016/0896-6273(92)90088-U; Wang MC, 2007, BIOCHEM BIOPH RES CO, V357, P579, DOI 10.1016/j.bbrc.2007.02.168; Winterfield JR, 2000, J GEN PHYSIOL, V116, P637, DOI 10.1085/jgp.116.5.637; Xiao XC, 2003, EUR J PHARMACOL, V477, P1, DOI 10.1016/S0014-2999(03)02190-3; Xiao YC, 2005, J BIOL CHEM, V280, P12069, DOI 10.1074/jbc.M411651200; Zhu SY, 2004, J MOL EVOL, V58, P145, DOI 10.1007/s00239-003-2534-2	54	142	155	1	9	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	OCT 3	2008	283	40					27300	27313		10.1074/jbc.M708447200	http://dx.doi.org/10.1074/jbc.M708447200			14	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED); Conference Proceedings Citation Index - Science (CPCI-S)	Biochemistry & Molecular Biology	353RT	18628201	hybrid, Green Published			2022-12-27	WOS:000259586600049
J	Zuo, PY; Picher, M; Okada, SF; Lazarowski, ER; Button, B; Boucher, RC; Elston, TC				Zuo, Peiying; Picher, Maryse; Okada, Seiko F.; Lazarowski, Eduardo R.; Button, Brian; Boucher, Richard C.; Elston, Timothy C.			Mathematical model of nucleotide regulation on airway epithelia - Implications for airway homeostasis	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							TRANSMEMBRANE CONDUCTANCE REGULATOR; EXTRACELLULAR ADENINE-NUCLEOTIDES; P2Y(2) RECEPTOR AGONIST; SURFACE LIQUID VOLUME; SMOOTH-MUSCLE-CELLS; CYSTIC-FIBROSIS; ATP RELEASE; ALKALINE-PHOSPHATASE; ENDOTHELIAL-CELLS; ADENYLATE KINASE	In the airways, adenine nucleotides support a complex signaling network mediating host defenses. Released by the epithelium into the airway surface liquid (ASL) layer, they regulate mucus clearance through P2 (ATP) receptors, and following surface metabolism through P1 (adenosine; Ado) receptors. The complexity of ASL nucleotide regulation provides an ideal subject for biochemical network modeling. A mathematical model was developed to integrate nucleotide release, the ectoenzymes supporting the dephosphorylation of ATP into Ado, Ado deamination into inosine (Ino), and nucleoside uptake. The model also includes ecto-adenylate kinase activity and feed-forward inhibition of Ado production by ATP and ADP. The parameters were optimized by fitting the model to experimental data for the steady-state and transient concentration profiles generated by adding ATP to polarized primary cultures of human bronchial epithelial (HBE) cells. The model captures major aspects of ATP and Ado regulation, including their > 4-fold increase in concentration induced by mechanical stress mimicking normal breathing. The model also confirmed the independence of steady-state nucleotide concentrations on the ASL volume, an important regulator of airway clearance. An interactive approach between simulations and assays revealed that feed-forward inhibition is mediated by selective inhibition of ecto5 '-nucleotidase. Importantly, the model identifies ecto-adenylate kinase as a key regulator of ASL ATP and proposes novel strategies for the treatment of airway diseases characterized by impaired nucleotide-mediated clearance. These new insights into the biochemical processes supporting ASL nucleotide regulation illustrate the potential of this mathematical model for fundamental and clinical research.	[Elston, Timothy C.] Univ N Carolina, Dept Pharmacol, Chapel Hill, NC 27599 USA; [Elston, Timothy C.] Univ N Carolina, Virtual Lung Grp, Chapel Hill, NC 27599 USA; [Zuo, Peiying] Univ N Carolina, Dept Math, Chapel Hill, NC 27599 USA; [Picher, Maryse; Okada, Seiko F.; Lazarowski, Eduardo R.; Button, Brian; Boucher, Richard C.] Univ N Carolina, Cyst Fibrosis Pulm Res & Treatment Ctr, Chapel Hill, NC 27599 USA	University of North Carolina; University of North Carolina Chapel Hill; University of North Carolina; University of North Carolina Chapel Hill; University of North Carolina; University of North Carolina Chapel Hill; University of North Carolina; University of North Carolina Chapel Hill	Elston, TC (corresponding author), Univ N Carolina, Dept Pharmacol, Chapel Hill, NC 27599 USA.	telston@med.unc.edu	Zuo, Peiying/AAF-2856-2020	Zuo, Peiying/0000-0003-4621-8526	National Institutes of Health [PPG-P01-HL034332, P30 DK065988, SCOR 1-P50-HL060280, SCCOR 1-P50-HL084934, R01-GM079271]; Cystic Fibrosis Foundation [BUTTON06G0, OKADA0610, PICHER0710]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R13HL034332, P50HL084934, P50HL060280] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [P30DK065988] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM079271] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Cystic Fibrosis Foundation(Italian Cystic Fibrosis Research Foundation); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported, in whole or in part, by National Institutes of Health Grants PPG-P01-HL034332, P30 DK065988, SCOR 1-P50-HL060280, SCCOR 1-P50-HL084934, and R01-GM079271. This work was also supported by Cystic Fibrosis Foundation Grants BUTTON06G0, OKADA0610, and PICHER0710. The costs of publication of this article were defrayed in part by the payment of page charges. This article must therefore be hereby marked "advertisement" in accordance with 18 U. S. C. Section 1734 solely to indicate this fact.	Adinolfi Elena, 2005, Purinergic Signal, V1, P219, DOI 10.1007/s11302-005-6322-x; Basoglu OK, 2005, CHEST, V128, P1905, DOI 10.1378/chest.128.4.1905; Bennett WD, 1996, AM J RESP CRIT CARE, V153, P1796, DOI 10.1164/ajrccm.153.6.8665037; Bodin P, 2001, J CARDIOVASC PHARM, V38, P900, DOI 10.1097/00005344-200112000-00012; Boucher RC, 2007, J INTERN MED, V261, P5, DOI 10.1111/j.1365-2796.2006.01744.x; Boucher RC, 2003, PFLUG ARCH EUR J PHY, V445, P495, DOI 10.1007/s00424-002-0955-1; Boucher RC, 2007, ANNU REV MED, V58, P157, DOI 10.1146/annurev.med.58.071905.105316; Burnstock Geoffrey, 2006, Novartis Found Symp, V276, P26; Button B, 2007, J PHYSIOL-LONDON, V580, P577, DOI 10.1113/jphysiol.2006.126086; CHRISTOFORIDIS S, 1995, EUR J BIOCHEM, V234, P66, DOI 10.1111/j.1432-1033.1995.066_c.x; Davis CW, 2002, NOVART FDN SYMP, V248, P113; Demenis MA, 2003, BBA-PROTEINS PROTEOM, V1646, P216, DOI 10.1016/S1570-9639(03)00021-9; Deterding R, 2005, PEDIATR PULM, V39, P339, DOI 10.1002/ppul.20192; Dixon M., 1979, ENZYMES, Vthird; Donaldson SH, 2002, AM J RESP CELL MOL, V26, P209, DOI 10.1165/ajrcmb.26.2.4650; Donaldson SH, 2000, MOL MED, V6, P969, DOI 10.1007/BF03401831; DONALDSON SH, 1998, P2 NUCLEOTIDE RECEPT, P413; Eltzschig HK, 2006, METH MOL B, V341, P73; Evans CM, 2004, AM J RESP CELL MOL, V31, P382, DOI 10.1165/rcmb.2004-0060OC; Fabre ACS, 2006, CELL MOL LIFE SCI, V63, P2829, DOI 10.1007/s00018-006-6325-y; Fadini GP, 2007, ATHEROSCLEROSIS, V193, P241, DOI 10.1016/j.atherosclerosis.2007.05.015; Ferrari D, 2006, J IMMUNOL, V176, P3877, DOI 10.4049/jimmunol.176.7.3877; FLEETWOOD G, 1989, AM J PHYSIOL, V256, pH1565, DOI 10.1152/ajpheart.1989.256.6.H1565; Fulcher M Leslie, 2005, Methods Mol Med, V107, P183; Gayle S, 2005, CELL TISSUE RES, V319, P27, DOI 10.1007/s00441-004-0979-2; GORDON EL, 1986, J BIOL CHEM, V261, P5496; GORDON EL, 1989, J BIOL CHEM, V264, P18986; Guyot A, 2002, J PHYSIOL-LONDON, V545, P199, DOI 10.1113/jphysiol.2002.030148; Hazama A, 1999, J GEN PHYSIOL, V114, P525, DOI 10.1085/jgp.114.4.525; Hazama A, 1998, PFLUG ARCH EUR J PHY, V437, P31, DOI 10.1007/s004240050742; Hirschberg CB, 1998, ANNU REV BIOCHEM, V67, P49, DOI 10.1146/annurev.biochem.67.1.49; Hirsh AJ, 2007, BIOCHEMISTRY-US, V46, P10373, DOI 10.1021/bi7009647; Hourani SMO, 1996, J AUTON PHARMACOL, V16, P349, DOI 10.1111/j.1474-8673.1996.tb00051.x; Huang PB, 2001, P NATL ACAD SCI USA, V98, P14120, DOI 10.1073/pnas.241318498; IKEHARA Y, 1978, J BIOCHEM, V83, P1471, DOI 10.1093/oxfordjournals.jbchem.a132057; Kahner BN, 2006, J THROMB HAEMOST, V4, P2317, DOI 10.1111/j.1538-7836.2006.02192.x; Kim CH, 2004, AM J PHYSIOL-LUNG C, V287, pL835, DOI 10.1152/ajplung.00285.2003; Knight GE, 2002, AM J PHYSIOL-RENAL, V282, pF281, DOI 10.1152/ajprenal.00293.2000; Kreda SM, 2007, J PHYSIOL-LONDON, V584, P245, DOI 10.1113/jphysiol.2007.139840; Kukulski F, 2005, Purinergic Signal, V1, P193, DOI 10.1007/s11302-005-6217-x; Kunzelmann K, 2006, FASEB J, V20, P545, DOI 10.1096/fj.05-4454fje; Lazarowski ER, 2004, J BIOL CHEM, V279, P36855, DOI 10.1074/jbc.M405367200; Lazarowski ER, 2003, MOL PHARMACOL, V64, P785, DOI 10.1124/mol.64.4.785; LEHIR M, 1989, ENZYME, V41, P87, DOI 10.1159/000469058; Marcet B, 2006, PHARMACOL THERAPEUT, V112, P719, DOI 10.1016/j.pharmthera.2006.05.010; Matharu AL, 2001, J BIOL CHEM, V276, P30199, DOI 10.1074/jbc.M010650200; MEGHJI P, 1995, BIOCHEM J, V308, P725, DOI 10.1042/bj3080725; Millan Jose Luis, 2006, Purinergic Signal, V2, P335, DOI 10.1007/s11302-005-5435-6; Mitchell CH, 1998, P NATL ACAD SCI USA, V95, P7174, DOI 10.1073/pnas.95.12.7174; Mohsenin A, 2006, CURR OPIN PULM MED, V12, P54, DOI 10.1097/01.mcp.0000199002.46038.cb; Morse DM, 2001, AM J PHYSIOL-CELL PH, V280, pC1485, DOI 10.1152/ajpcell.2001.280.6.C1485; Munkonda MN, 2007, BIOCHEM PHARMACOL, V74, P1524, DOI 10.1016/j.bcp.2007.07.033; Noone PG, 1999, AM J RESP CRIT CARE, V160, P144, DOI 10.1164/ajrccm.160.1.9806146; Okada SF, 2006, J BIOL CHEM, V281, P22992, DOI 10.1074/jbc.M603019200; Pankratov Y, 2006, PFLUG ARCH EUR J PHY, V452, P589, DOI 10.1007/s00424-006-0061-x; PEARSON JD, 1980, BIOCHEM J, V190, P421, DOI 10.1042/bj1900421; Picher M, 2000, AM J RESP CELL MOL, V23, P255, DOI 10.1165/ajrcmb.23.2.4088; Picher M, 2004, J BIOL CHEM, V279, P20234, DOI 10.1074/jbc.M400305200; Picher M, 2003, J BIOL CHEM, V278, P11256, DOI 10.1074/jbc.M208071200; Picher M, 2003, J BIOL CHEM, V278, P13468, DOI 10.1074/jbc.M300569200; Picher M, 2001, DRUG DEVELOP RES, V52, P66, DOI 10.1002/ddr.1099; PICHER M, 2006, PURINERG SIGNAL, V2, P399; PIZAURO JM, 1993, BIOCHIM BIOPHYS ACTA, V1202, P22, DOI 10.1016/0167-4838(93)90058-Y; SAY JC, 1991, BIOCHIM BIOPHYS ACTA, V1074, P256, DOI 10.1016/0304-4165(91)90161-9; Schwiebert EM, 2003, BBA-BIOMEMBRANES, V1615, P7, DOI 10.1016/S0005-2736(03)00210-4; SEARGEANT LE, 1979, CAN J BIOCHEM CELL B, V57, P1000, DOI 10.1139/o79-124; Shaver Sammy R, 2005, Purinergic Signal, V1, P183, DOI 10.1007/s11302-005-0648-2; SLAKEY LL, 1986, J BIOL CHEM, V261, P5505; Smith TM, 1998, BBA-PROTEIN STRUCT M, V1386, P65, DOI 10.1016/S0167-4838(98)00063-6; Spicuzza L, 2003, CURR OPIN ALLERGY CL, V3, P65, DOI 10.1097/01.all.0000053270.39029.86; STEFANOVIC V, 1988, RENAL PHYSIOL BIOCH, V11, P89; SUNDERMAN FW, 1990, ANN CLIN LAB SCI, V20, P123; Takemura H, 2003, JPN J PHYSIOL, V53, P319, DOI 10.2170/jjphysiol.53.319; Tarran R, 2006, ANNU REV PHYSIOL, V68, P543, DOI 10.1146/annurev.physiol.68.072304.112754; Tarran R, 2005, J BIOL CHEM, V280, P35751, DOI 10.1074/jbc.M505832200; Taylor AL, 1999, J CLIN INVEST, V104, P875, DOI 10.1172/JCI7270; Valero E, 2006, FEBS J, V273, P3598, DOI 10.1111/j.1742-4658.2006.05366.x; VANBELLE H, 1976, CLIN CHEM, V22, P972; Vaughan RP, 2006, TOXICOL SCI, V93, P411, DOI 10.1093/toxsci/kfl061; Williams OW, 2006, AM J RESP CELL MOL, V34, P527, DOI 10.1165/rcmb.2005-0436SF; Yerxa BR, 2002, J PHARMACOL EXP THER, V302, P871, DOI 10.1124/jpet.102.035485; Zimmermann H, 2000, N-S ARCH PHARMACOL, V362, P299, DOI 10.1007/s002100000309	82	32	34	0	1	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	SEP 26	2008	283	39					26805	26819		10.1074/jbc.M801516200	http://dx.doi.org/10.1074/jbc.M801516200			15	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	350GV	18662982	Green Published, hybrid			2022-12-27	WOS:000259341600052
J	Fujikake, N; Nagai, Y; Popiel, HA; Okamoto, Y; Yamaguchi, M; Toda, T				Fujikake, Nobuhiro; Nagai, Yoshitaka; Popiel, H. Akiko; Okamoto, Yuma; Yamaguchi, Masamitsu; Toda, Tatsushi			Heat shock transcription factor 1-activating compounds suppress polyglutamine-induced neurodegeneration through induction of multiple molecular chaperones	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							TRUNCATED ANDROGEN RECEPTOR; HUNTINGTONS-DISEASE; AGGREGATE FORMATION; DROSOPHILA MODEL; PROTEIN-KINASE; HSP70; MODULATION; ACTIVATION; TOXICITY; HSP90	Many neurodegenerative diseases including Alzheimer, Parkinson, and polyglutamine ( polyQ) diseases are thought to be caused by protein misfolding. The polyQ diseases, including Huntington disease and spinocerebellar ataxias (SCAs), are caused by abnormal expansions of the polyQ stretch in disease-causing proteins, which trigger misfolding of these proteins, resulting in their deposition as inclusion bodies in affected neurons. Although genetic expression of molecular chaperones has been shown to suppress polyQ protein misfolding and neurodegeneration, toward developing a therapy, it is ideal to induce endogenous molecular chaperones by chemical administration. In this study, we assessed the therapeutic effects of heat shock transcription factor 1 ( HSF1)-activating compounds, which induce multiple molecular chaperones, on polyQ-induced neurodegeneration in vivo. We found that oral administration of 17-(allylamino)-17-demethoxygeldanamycin (17-AAG) markedly suppresses compound eye degeneration and inclusion body formation in a Drosophila model of SCA. 17-AAG also dramatically rescued the lethality of the SCA model (74.1% rescue) and suppressed neurodegeneration in a Huntington disease model (46.3% rescue), indicating that 17-AAG is widely effective against various polyQ diseases. 17-AAG induced Hsp70, Hsp40, and Hsp90 expression in a dose-dependent manner, and the expression levels correlated with its therapeutic effects. Furthermore, knockdown of HSF1 abolished the induction of molecular chaperones and the therapeutic effect of 17-AAG, indicating that its therapeutic effects depend on HSF1 activation. Our study indicates that induction of multiple molecular chaperones by 17-AAG treatment is a promising therapeutic approach for a wide range of polyQ diseases and possibly other neurodegenerative diseases.	[Fujikake, Nobuhiro; Nagai, Yoshitaka; Popiel, H. Akiko; Okamoto, Yuma; Toda, Tatsushi] Osaka Univ, Grad Sch Med, Div Clin Genet, Dept Med Genet, Suita, Osaka 5650871, Japan; [Yamaguchi, Masamitsu] Kyoto Inst Technol, Dept Appl Biol, Sakyo Ku, Kyoto 6068585, Japan	Osaka University; Kyoto Institute of Technology	Nagai, Y (corresponding author), Osaka Univ, Grad Sch Med, Div Clin Genet, Dept Med Genet, 2-2 Yamadaoka, Suita, Osaka 5650871, Japan.	nagai@clgene.med.osaka-u.ac.jp		Yamaguchi, Masamitsu/0000-0002-6321-9750	Scientific Research on Priority Areas; Ministry of Education, Culture, Sports, Science, and Technology, Japan; Ministry of Health, Labor and Welfare, Japan; Japan Society for the Promotion of Science	Scientific Research on Priority Areas(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI)); Ministry of Education, Culture, Sports, Science, and Technology, Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); Ministry of Health, Labor and Welfare, Japan(Ministry of Health, Labour and Welfare, Japan); Japan Society for the Promotion of Science(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science)	This work was supported in part by Grants-in-Aid for Scientific Research on Priority Areas (to Y.N.; Advanced Brain Science Project, Research on Patho-mechanisms of Brain Disorders, Life of Proteins, and Protein Community) from the Ministry of Education, Culture, Sports, Science, and Technology, Japan; by a Grant-in-Aid for the Research Committee for Ataxic Diseases (to Y.N.) from the Ministry of Health, Labor and Welfare, Japan; and by Grants-in-Aid for Scientific Research (B) (to Y.N.) and for Young Scientists (B) (to N.F.) from the Japan Society for the Promotion of Science. The costs of publication of this article were defrayed in part by the payment of page charges. This article must therefore be hereby marked "advertisement" in accordance with 18 U.S.C. Section 1734 solely to indicate this fact.	Auluck PK, 2002, NAT MED, V8, P1185, DOI 10.1038/nm1102-1185; Auluck PK, 2002, SCIENCE, V295, P865, DOI 10.1126/science.1067389; BALER R, 1993, MOL CELL BIOL, V13, P2486, DOI 10.1128/MCB.13.4.2486; Batulan Z, 2006, NEUROBIOL DIS, V24, P213, DOI 10.1016/j.nbd.2006.06.017; Bruening W, 1999, J NEUROCHEM, V72, P693, DOI 10.1046/j.1471-4159.1999.0720693.x; Chan HYE, 2000, HUM MOL GENET, V9, P2811, DOI 10.1093/hmg/9.19.2811; Chu BY, 1996, J BIOL CHEM, V271, P30847, DOI 10.1074/jbc.271.48.30847; Cummings CJ, 2001, HUM MOL GENET, V10, P1511, DOI 10.1093/hmg/10.14.1511; Fujikake N, 2005, FEBS LETT, V579, P3842, DOI 10.1016/j.febslet.2005.05.074; Fujimoto M, 2005, J BIOL CHEM, V280, P34908, DOI 10.1074/jbc.M506288200; Gusella JF, 2000, NAT REV NEUROSCI, V1, P109, DOI 10.1038/35039051; Hay DG, 2004, HUM MOL GENET, V13, P1389, DOI 10.1093/hmg/ddh144; Herbst M, 2007, NEURODEGENER DIS, V4, P254, DOI 10.1159/000101849; Holmberg CI, 2000, CELL STRESS CHAPERON, V5, P219, DOI 10.1379/1466-1268(2000)005<0219:FONHGV>2.0.CO;2; Ishihara K, 2003, J BIOL CHEM, V278, P25143, DOI 10.1074/jbc.M302975200; Katsuno M, 2005, P NATL ACAD SCI USA, V102, P16801, DOI 10.1073/pnas.0506249102; Kazemi-Esfarjani P, 2000, SCIENCE, V287, P1837, DOI 10.1126/science.287.5459.1837; Kieran D, 2004, NAT MED, V10, P402, DOI 10.1038/nm1021; Kobayashi Y, 2000, J BIOL CHEM, V275, P8772, DOI 10.1074/jbc.275.12.8772; Lee WCM, 2004, P NATL ACAD SCI USA, V101, P3224, DOI 10.1073/pnas.0400243101; Mitsui K, 2002, J NEUROSCI, V22, P9267; Muchowski PJ, 2000, P NATL ACAD SCI USA, V97, P7841, DOI 10.1073/pnas.140202897; Muchowski PJ, 2005, NAT REV NEUROSCI, V6, P11, DOI 10.1038/nrn1587; Nagai Y, 1999, EXP NEUROL, V155, P195, DOI 10.1006/exnr.1998.6991; Nollen EAA, 2004, P NATL ACAD SCI USA, V101, P6403, DOI 10.1073/pnas.0307697101; Page J., 1997, Proceedings of the American Association for Cancer Research Annual Meeting, V38, P308; Ronnen EA, 2006, INVEST NEW DRUG, V24, P543, DOI 10.1007/s10637-006-9208-z; Rorth P, 1996, P NATL ACAD SCI USA, V93, P12418, DOI 10.1073/pnas.93.22.12418; Ross CA, 2005, NAT REV MOL CELL BIO, V6, P891, DOI 10.1038/nrm1742; Rujano MA, 2007, EXP CELL RES, V313, P3568, DOI 10.1016/j.yexcr.2007.07.034; Sato T, 2006, BIOCHEM BIOPH RES CO, V346, P339, DOI 10.1016/j.bbrc.2006.05.133; Schulte TW, 1998, CELL STRESS CHAPERON, V3, P100, DOI 10.1379/1466-1268(1998)003<0100:ARBTTN>2.3.CO;2; Steffan JS, 2001, NATURE, V413, P739, DOI 10.1038/35099568; Steffan JS, 2000, P NATL ACAD SCI USA, V97, P6763, DOI 10.1073/pnas.100110097; Thomas M, 2006, HUM MOL GENET, V15, P1876, DOI 10.1093/hmg/ddl110; Warrick JM, 2005, MOL CELL, V18, P37, DOI 10.1016/j.molcel.2005.02.030; Warrick JM, 1999, NAT GENET, V23, P425, DOI 10.1038/70532; Warrick JM, 1998, CELL, V93, P939, DOI 10.1016/S0092-8674(00)81200-3; Waza M, 2005, NAT MED, V11, P1088, DOI 10.1038/nm1298; Westerheide SD, 2004, J BIOL CHEM, V279, P56053, DOI 10.1074/jbc.M409267200; Westerheide SD, 2005, J BIOL CHEM, V280, P33097, DOI 10.1074/jbc.R500010200; Wyttenbach A, 2002, HUM MOL GENET, V11, P1137, DOI 10.1093/hmg/11.9.1137; Xia WL, 1999, CELL STRESS CHAPERON, V4, P8, DOI 10.1054/csac.1998.0113; Yamanaka K, 2003, J MOL CELL CARDIOL, V35, P785, DOI 10.1016/S0022-2828(03)00133-0; Zoghbi HY, 2000, ANNU REV NEUROSCI, V23, P217, DOI 10.1146/annurev.neuro.23.1.217; Zou JY, 1998, CELL, V94, P471, DOI 10.1016/S0092-8674(00)81588-3	46	166	170	0	8	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	SEP 19	2008	283	38					26188	26197		10.1074/jbc.M710521200	http://dx.doi.org/10.1074/jbc.M710521200			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	348GX	18632670	Green Published, hybrid			2022-12-27	WOS:000259200100047
J	Lamothe, B; Campos, AD; Webster, WK; Gopinathan, A; Hur, L; Darnay, BG				Lamothe, Betty; Campos, Alejandro D.; Webster, William K.; Gopinathan, Ambily; Hur, Lana; Darnay, Bryant G.			The RING Domain and First Zinc Finger of TRAF6 Coordinate Signaling by Interleukin-1, Lipopolysaccharide, and RANKL	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							NF-KAPPA-B; LYS63-LINKED POLYUBIQUITINATION; DEFECTIVE INTERLEUKIN-1; TRAF6-DEFICIENT MICE; UBIQUITIN LIGASE; CUTTING EDGE; ACTIVATION; RECEPTOR; KINASE; REQUIRES	TRAF6, a crucial adaptor molecule in innate and adaptive immunity, contains three distinct functional domains. The C-terminal TRAF domain facilitates oligomerization and sequence-specific interaction with receptors or other adaptor proteins. In conjunction with the dimeric E2 enzyme Ubc13-Uev1A, the N-terminal RING domain of TRAF6 functions as an E3 ubiquitin (Ub) ligase that facilitates its own site-specific ubiquitination through the generation of a Lys-63-linked poly-Ub chain. This modification does not cause its proteasomal degradation but rather serves as a scaffold to activate both the IKK and stress kinase pathways. Connecting the N- and C-terminal regions, the four internal zinc finger (ZF) motifs have yet to be functionally defined. In this study, we examined the role of the ZF domains in interleukin-1, lipopolysaccharide, and RANKL signaling by reconstitution of TRAF6-deficient cells with point mutations or deletions of these ZF motifs. Although ZF domains 2-4 are dispensable for activating IKK, p38, and JNK by interleukin-1 and lipopolysaccharide, the first ZF domain together with an intact RING domain of TRAF6 is essential for activating these pathways. Furthermore, TRAF6 autoubiquitination and its interaction with Ubc13 are dependent on ZF1 and an intact RING domain. Additionally, expression of TRAF6 lacking ZF2-4 in TRAF6-deficient monocytes rescues RANKL-mediated osteoclast differentiation and LPS-stimulated interleukin-6 production. These data provide evidence for the critical role of the Ub ligase activity of TRAF6, which is coordinated via the RING domain and ZF1 to supply the necessary elements in signaling by cytokines dependent upon TRAF6.	[Lamothe, Betty; Campos, Alejandro D.; Webster, William K.; Gopinathan, Ambily; Hur, Lana; Darnay, Bryant G.] Univ Texas MD Anderson Canc Ctr, Dept Expt Therapeut, Houston, TX 77030 USA	University of Texas System; UTMD Anderson Cancer Center	Darnay, BG (corresponding author), Univ Texas MD Anderson Canc Ctr, Dept Expt Therapeut, Box 143,1515 Holcombe Blvd, Houston, TX 77030 USA.	bdarnay@mdanderson.org			National Institutes of Health [RO1 AR053540]; NCI, National Institutes of Health [CA16672DAF]; University of Texas M. D. Anderson Cancer Center; NATIONAL CANCER INSTITUTE [P30CA016672] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES [R01AR053540] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NCI, National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); University of Texas M. D. Anderson Cancer Center; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS))	This work was supported, in whole or in part, by National Institutes of Health Grant RO1 AR053540 (to B. G. D.). The DNA Sequencing Core facility is funded in part through NCI, National Institutes of Health, Grant CA16672DAF. This work was also supported in part by institutional start-up funds from the University of Texas M. D. Anderson Cancer Center.	Besse A, 2007, J BIOL CHEM, V282, P3918, DOI 10.1074/jbc.M608867200; Choi YW, 2005, ADV EXP MED BIOL, V560, P77; Chung JY, 2002, J CELL SCI, V115, P679; Conze DB, 2008, MOL CELL BIOL, V28, P3538, DOI 10.1128/MCB.02098-07; Darnay BG, 1998, J BIOL CHEM, V273, P20551, DOI 10.1074/jbc.273.32.20551; Darnay BG, 1999, J BIOL CHEM, V274, P7724, DOI 10.1074/jbc.274.12.7724; Darnay BG, 2007, ADV EXP MED BIOL, V597, P152; Deng L, 2000, CELL, V103, P351, DOI 10.1016/S0092-8674(00)00126-4; Ea CK, 2006, MOL CELL, V22, P245, DOI 10.1016/j.molcel.2006.03.026; Gohda J, 2004, J IMMUNOL, V173, P2913, DOI 10.4049/jimmunol.173.5.2913; Ishida N, 2002, J BIOL CHEM, V277, P41147, DOI 10.1074/jbc.M205063200; King CG, 2008, J IMMUNOL, V180, P34, DOI 10.4049/jimmunol.180.1.34; King CG, 2006, NAT MED, V12, P1088, DOI 10.1038/nm1449; Kobayashi N, 2001, EMBO J, V20, P1271, DOI 10.1093/emboj/20.6.1271; Kobayashi T, 2003, IMMUNITY, V19, P353, DOI 10.1016/S1074-7613(03)00230-9; Kobayashi T, 2004, MICROBES INFECT, V6, P1333, DOI 10.1016/j.micinf.2004.09.001; Lamothe B, 2007, BIOCHEM BIOPH RES CO, V359, P1044, DOI 10.1016/j.bbrc.2007.06.017; Lamothe B, 2007, J BIOL CHEM, V282, P4102, DOI 10.1074/jbc.M609503200; Lomaga MA, 1999, GENE DEV, V13, P1015, DOI 10.1101/gad.13.8.1015; Mercier P, 2007, PROTEIN SCI, V16, P602, DOI 10.1110/ps.062358007; Naito A, 2002, P NATL ACAD SCI USA, V99, P8766, DOI 10.1073/pnas.132636999; Naito A, 1999, GENES CELLS, V4, P353, DOI 10.1046/j.1365-2443.1999.00265.x; Polek TC, 2003, J BIOL CHEM, V278, P32317, DOI 10.1074/jbc.M302518200; Takayanagi H, 2002, DEV CELL, V3, P889, DOI 10.1016/S1534-5807(02)00369-6; Wang C, 2001, NATURE, V412, P346, DOI 10.1038/35085597; Windheim M, 2008, MOL CELL BIOL, V28, P1783, DOI 10.1128/MCB.02380-06; Wong A, 2002, P NATL ACAD SCI USA, V99, P6684, DOI 10.1073/pnas.052138899; Wu CJ, 2006, NAT CELL BIOL, V8, P398, DOI 10.1038/ncb1384; Wu H, 2003, BIOESSAYS, V25, P1096, DOI 10.1002/bies.10352; Ye H, 2002, NATURE, V418, P443, DOI 10.1038/nature00888	30	89	96	0	12	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	SEP 5	2008	283	36					24871	24880		10.1074/jbc.M802749200	http://dx.doi.org/10.1074/jbc.M802749200			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	517MA	18617513	Green Published, hybrid			2022-12-27	WOS:000271617300006
J	Zeng, H; Chen, YH; Yu, M; Xue, LQ; Gao, X; Morris, SW; Wang, DM; Wen, RR				Zeng, Hu; Chen, Yuhong; Yu, Mei; Xue, Liquan; Gao, Xiang; Morris, Stephan W.; Wang, Demin; Wen, Renren			T cell receptor-mediated activation of CD4(+)CD44(hi) T cells bypasses Bcl10 - An implication of differential NF-kappa B dependence of naive and memory T cells during T cell receptor-mediated responses	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ANTIGEN RECEPTOR; LYMPHOCYTE-PROLIFERATION; EXHIBIT DEFECTS; MICE LACKING; REQUIREMENT; CARMA1; KINASE; EXPRESSION; GENERATION; IMMUNITY	Previous studies have demonstrated that Bcl10 (B-cell leukemia/lymphoma 10) is essential for T cell receptor-mediated NF-kappa B activation and subsequent proliferation and interleukin 2 (IL2) production. However, here we demonstrate that, contrary to expectations, Bcl10 is differentially required for T cell activation, including for both proliferation and cytokine production. When CD4(+) and CD8(+) T cells were divided based on expression levels of CD44, which distinguishes naive cells (CD44(lo)) versus those that are antigen-experienced (CD44(hi)), IL2 production by and proliferation of CD4(+) CD44(lo) naive cells and both subpopulations of CD8(+) T cells were clearly Bcl10-dependent, whereas these same functional properties of CD4(+) CD44(hi) T cells occurred largely independent of Bcl10. As with the other subpopulations of T cells, CD4(+) CD44(hi) T cells did not activate the NF-kappa B pathway in the absence of Bcl10; nevertheless, these CD4(+) CD44(hi) antigen-experienced T cells efficiently secreted IL2 after T cell receptor stimulation. Strikingly, therefore, T cell receptor-mediated IL2 production in these cells is NF-kappa B-independent. Our studies suggest that antigen-experienced CD4(+) T cells differ from their naive counterparts and from CD8(+) T cells in their ability to achieve activation independent of the Bcl10/NF-kappa B pathway.	[Zeng, Hu; Chen, Yuhong; Yu, Mei; Wang, Demin; Wen, Renren] Blood Ctr Wisconsin, Blood Res Inst, Milwaukee, WI 53226 USA; [Zeng, Hu; Yu, Mei; Gao, Xiang] Nanjing Univ, Model Anim Res Ctr, State Key Lab Pharmaceut Biotechnol, Nanjing 225001, Peoples R China; [Xue, Liquan; Morris, Stephan W.] St Jude Childrens Hosp, Dept Pathol, Memphis, TN 38105 USA; [Xue, Liquan; Morris, Stephan W.] St Jude Childrens Hosp, Dept Oncol, Memphis, TN 38105 USA; [Wang, Demin] Med Coll Wisconsin, Dept Microbiol & Mol Genet, Milwaukee, WI 53226 USA	Versiti Blood Center of Wisconsin; Nanjing University; St Jude Children's Research Hospital; St Jude Children's Research Hospital; Medical College of Wisconsin	Wen, RR (corresponding author), Blood Ctr Wisconsin, Blood Res Inst, 8727 Watertown Plank Rd, Milwaukee, WI 53226 USA.	renren.wen@bcw.edu	Yu, Mei/K-2206-2017; Zeng, Hu/AAA-2706-2020; Wang, Demin/AAX-4449-2020	Zeng, Hu/0000-0002-9909-7732; Wang, Demin/0000-0001-5549-3795	National Institutes of Health [AI52327, U19 AI062627, HL073284, CA87064, CA21765]; American Cancer Society [RSG CCG-106204]; American Lebanese Syrian Associated Charities; St.Jude Children's Research Hospital; NATIONAL CANCER INSTITUTE [P30CA021765, R01CA087064] Funding Source: NIH RePORTER; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL073284] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [U19AI062627, R01AI052327] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); American Cancer Society(American Cancer Society); American Lebanese Syrian Associated Charities(American Lebanese Syrian Associated Charities (ALSAC)); St.Jude Children's Research Hospital; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This work was supported, in whole or in part, by National Institutes of Health Grants AI52327 (to R.W.), U19 AI062627 pilot grant (to R.W.), HL073284 (to D.W.), CA87064 (NCI, to S.W.M.), and CA21765 (NCI Cancer Center CORE, to L.X.and S.W.M.). This work was also supported by American Cancer Society Grant RSG CCG-106204 (to D.W.) and by the American Lebanese Syrian Associated Charities, St.Jude Children's Research Hospital.	Blonska M, 2007, IMMUNITY, V26, P55, DOI 10.1016/j.immuni.2006.11.008; Boyman O, 2006, J EXP MED, V203, P1817, DOI 10.1084/jem.20052495; Dienz O, 2007, P NATL ACAD SCI USA, V104, P7175, DOI 10.1073/pnas.0610442104; Egawa T, 2003, CURR BIOL, V13, P1252, DOI 10.1016/S0960-9822(03)00491-3; Farber DL, 1997, EUR J IMMUNOL, V27, P2094, DOI 10.1002/eji.1830270838; Gerondakis S, 1996, P NATL ACAD SCI USA, V93, P3405, DOI 10.1073/pnas.93.8.3405; Hall SR, 1999, EUR J IMMUNOL, V29, P2098, DOI 10.1002/(SICI)1521-4141(199907)29:07<2098::AID-IMMU2098>3.3.CO;2-2; Hamilton SE, 2006, NAT IMMUNOL, V7, P475, DOI 10.1038/ni1326; Hara H, 2003, IMMUNITY, V18, P763, DOI 10.1016/S1074-7613(03)00148-1; Isakov N, 2002, ANNU REV IMMUNOL, V20, P761, DOI 10.1146/annurev.immunol.20.100301.064807; JAIN J, 1995, CURR OPIN IMMUNOL, V7, P333, DOI 10.1016/0952-7915(95)80107-3; Kieper WC, 1999, P NATL ACAD SCI USA, V96, P13306, DOI 10.1073/pnas.96.23.13306; KONTGEN F, 1995, GENE DEV, V9, P1965, DOI 10.1101/gad.9.16.1965; Li QT, 2002, NAT REV IMMUNOL, V2, P725, DOI 10.1038/nri910; Lin X, 2004, SEMIN IMMUNOL, V16, P429, DOI 10.1016/j.smim.2004.08.022; London CA, 2000, J IMMUNOL, V164, P265, DOI 10.4049/jimmunol.164.1.265; Murphy KM, 2000, ANNU REV IMMUNOL, V18, P451, DOI 10.1146/annurev.immunol.18.1.451; Newton K, 2003, CURR BIOL, V13, P1247, DOI 10.1016/S0960-9822(03)00458-5; Ruefli-Brasse AA, 2003, SCIENCE, V302, P1581, DOI 10.1126/science.1090769; Ruland J, 2003, IMMUNITY, V19, P749, DOI 10.1016/S1074-7613(03)00293-0; Ruland J, 2001, CELL, V104, P33, DOI 10.1016/S0092-8674(01)00189-1; Samelson LE, 2002, ANNU REV IMMUNOL, V20, P371, DOI 10.1146/annurev.immunol.20.092601.111357; Schmidt-Supprian M, 2004, P NATL ACAD SCI USA, V101, P4566, DOI 10.1073/pnas.0400885101; SCHREIBER SL, 1992, IMMUNOL TODAY, V13, P136, DOI 10.1016/0167-5699(92)90111-J; Sprent J, 2002, ANNU REV IMMUNOL, V20, P551, DOI 10.1146/annurev.immunol.20.100101.151926; Stockinger B, 2006, IMMUNOL REV, V211, P39, DOI 10.1111/j.0105-2896.2006.00381.x; Sun ZM, 2000, NATURE, V404, P402, DOI 10.1038/35006090; Swain SL, 2006, IMMUNOL REV, V211, P8, DOI 10.1111/j.0105-2896.2006.00388.x; Tewari K, 2006, P NATL ACAD SCI USA, V103, P16388, DOI 10.1073/pnas.0602565103; Xue LQ, 2003, NAT IMMUNOL, V4, P857, DOI 10.1038/ni963; Yang DD, 1998, IMMUNITY, V9, P575, DOI 10.1016/S1074-7613(00)80640-8	31	15	16	0	1	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	SEP 5	2008	283	36					24392	24399		10.1074/jbc.M802344200	http://dx.doi.org/10.1074/jbc.M802344200			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	342YR	18583339	hybrid, Green Published			2022-12-27	WOS:000258820000013
J	Barinova, N; Kuznedelov, K; Severinov, K; Kulbachinskiy, A				Barinova, Nataliya; Kuznedelov, Konstantin; Severinov, Konstantin; Kulbachinskiy, Andrey			Structural modules of RNA polymerase required for transcription from promoters containing downstream basal promoter element GGGA	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							OPEN COMPLEX-FORMATION; C-TERMINAL DOMAIN; ALPHA-SUBUNIT; RECOGNITION ELEMENT; SIGMA-SUBUNIT; UPSTREAM DNA; FLAP DOMAIN; HOLOENZYME; SEQUENCE; BINDING	We recently described a novel basal bacterial promoter element that is located downstream of the -10 consensus promoter element and is recognized by region 1.2 of the sigma subunit of RNA polymerase (RNAP). In the case of Thermus aquaticus RNAP, this element has a consensus sequence GGGA and allows transcription initiation in the absence of the -35 element. In contrast, the Escherichia coli RNAP is unable to initiate transcription from GGGA-containing promoters that lack the -35 element. In the present study, we demonstrate that sigma subunits from both E. coli and T. aquaticus specifically recognize the GGGA element and that the observed species specificity of recognition of GGGA-containing promoters is determined by the RNAP core enzyme. We further demonstrate that transcription initiation by T. aquaticus RNAP on GGGA-containing promoters in the absence of the -35 element requires sigma region 4 and C-terminal domains of the alpha subunits, which interact with upstream promoter DNA. When in the context of promoters containing the -35 element, the GGGA element is recognized by holoenzyme RNAPs from both E. coli and T. aquaticus and increases stability of promoter complexes formed on these promoters. Thus, GGGA is a bona fide basal promoter element that can function in various bacteria and, depending on the properties of the RNAP core enzyme and the presence of additional promoter elements, determine species-specific differences in promoter recognition.	[Kuznedelov, Konstantin; Severinov, Konstantin] Rutgers State Univ, Waksman Inst, Piscataway, NJ 08854 USA; [Barinova, Nataliya; Severinov, Konstantin; Kulbachinskiy, Andrey] Russian Acad Sci, Inst Mol Genet, Moscow 123182, Russia	Rutgers State University New Brunswick; Russian Academy of Sciences	Severinov, K (corresponding author), Rutgers State Univ, Waksman Inst, Piscataway, NJ 08854 USA.	severik@waksman.rutgers.edu; akulb@img.ras.ru	Kulbachinskiy, Andrey/P-5401-2016; Severinov, Konstantin/C-8545-2016	Kulbachinskiy, Andrey/0000-0002-2292-6424; 	NIGMS NIH HHS [R01 GM64530] Funding Source: Medline; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM064530] Funding Source: NIH RePORTER	NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		ANISKOVITCH LP, 1995, J BACTERIOL, V177, P6301, DOI 10.1128/jb.177.21.6301-6303.1995; Artsimovitch I, 2000, J BACTERIOL, V182, P6027, DOI 10.1128/JB.182.21.6027-6035.2000; Barne KA, 1997, EMBO J, V16, P4034, DOI 10.1093/emboj/16.13.4034; Davis CA, 2005, P NATL ACAD SCI USA, V102, P285, DOI 10.1073/pnas.0405779102; Feklistov A, 2006, MOL CELL, V23, P97, DOI 10.1016/j.molcel.2006.06.010; Gross CA, 1998, COLD SPRING HARB SYM, V63, P141, DOI 10.1101/sqb.1998.63.141; Haugen SP, 2008, P NATL ACAD SCI USA, V105, P3292, DOI [10.1073/pnas.0709513105, 10.1073/pnas.07095l3105]; Haugen SP, 2006, CELL, V125, P1069, DOI 10.1016/j.cell.2006.04.034; Kulbachinskiy A, 2004, J BACTERIOL, V186, P7818, DOI 10.1128/JB.186.22.7818-7820.2004; Kuznedelov K, 2003, METHOD ENZYMOL, V370, P94; Kuznedelov K, 2002, SCIENCE, V295, P855, DOI 10.1126/science.1066303; Kuznedelov K. D., 2006, Doklady Akademii Nauk, V410, P263, DOI 10.1134/S1607672906050036; Kuznedelov K, 2006, J MOL BIOL, V359, P110, DOI 10.1016/j.jmb.2006.03.009; Minakhin L, 2003, J BIOL CHEM, V278, P29710, DOI 10.1074/jbc.M304906200; Minakhin L, 2001, J BACTERIOL, V183, P71, DOI 10.1128/JB.183.1.71-76.2001; Murakami KS, 2002, SCIENCE, V296, P1285, DOI 10.1126/science.1069595; NUDLER E, 1995, CELL, V81, P351, DOI 10.1016/0092-8674(95)90388-7; Ross W, 2003, GENE DEV, V17, P1293, DOI 10.1101/gad.1079403; ROSS W, 1993, SCIENCE, V262, P1407, DOI 10.1126/science.8248780; Ross W, 2005, P NATL ACAD SCI USA, V102, P291, DOI 10.1073/pnas.0405814102; Sclavi B, 2005, P NATL ACAD SCI USA, V102, P4706, DOI 10.1073/pnas.0408218102; Tang Y, 1996, J BACTERIOL, V178, P6945, DOI 10.1128/jb.178.23.6945-6951.1996; TRAVERS AA, 1980, J BACTERIOL, V141, P973, DOI 10.1128/JB.141.2.973-976.1980; Vassylyev DG, 2002, NATURE, V417, P712, DOI 10.1038/nature752; Wada T, 2000, J BIOL CHEM, V275, P16057, DOI 10.1074/jbc.275.21.16057; WILSON KS, 1994, J MOL BIOL, V244, P36, DOI 10.1006/jmbi.1994.1702	26	12	13	0	3	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	AUG 15	2008	283	33					22482	22489		10.1074/jbc.M802445200	http://dx.doi.org/10.1074/jbc.M802445200			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	335VR	18574242	Green Published, hybrid			2022-12-27	WOS:000258321000016
J	Schar, CR; Jensen, JK; Christensen, A; Blouse, GE; Andreasen, PA; Peterson, CB				Schar, Christine R.; Jensen, Jan K.; Christensen, Anni; Blouse, Grant E.; Andreasen, Peter A.; Peterson, Cynthia B.			Characterization of a site on PAI-1 that binds to vitronectin outside of the somatomedin B domain	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							PLASMINOGEN-ACTIVATOR INHIBITOR-1; REACTIVE CENTER; CELL-MIGRATION; S-PROTEIN; TYPE-1; MECHANISM; SERPIN; FIBRINOLYSIS; EPITOPE; LATENT	Vitronectin and plasminogen activator inhibitor-1 (PAI-1) are proteins that interact in the circulatory system and pericellular region to regulate fibrinolysis, cell adhesion, and migration. The interactions between the two proteins have been attributed primarily to binding of the somatomedin B (SMB) domain, which comprises the N-terminal 44 residues of vitronectin, to the flexible joint region of PAI-1, including residues Arg-103, Met-112, and Gln-125 of PAI-1. A strategy for deletion mutagenesis that removes the SMB domain demonstrates that this mutant form of vitronectin retains PAI-1 binding Schar, C. R., Blouse, G. E., Minor, K. M., and Peterson, C. B. (2008) J. Biol. Chem. 283, 10297-10309). In the current study, the complementary binding site on PAI-1 was mapped by testing for the ability of a battery of PAI-1 mutants to bind to the engineered vitronectin lacking the SMB domain. This approach identified a second, separate site for interaction between vitronectin and PAI-1. The binding of PAI-1 to this site was defined by a set of mutations in PAI-1 distinct from the mutations that disrupt binding to the SMB domain. Using the mutations in PAI-1 to map the second site suggested interactions between alpha-helices D and E in PAI-1 and a site in vitronectin outside of the SMB domain. The affinity of this second interaction exhibited a K-D value similar to 100-fold higher than that of the PAI-1-somatomedin B interaction. In contrast to the PAI-1-somatomedin B binding, the second interaction had almost the same affinity for active and latent PAI-1. We hypothesize that, together, the two sites form an extended binding area that may promote assembly of higher order vitronectin-PAI-1 complexes.	[Schar, Christine R.; Peterson, Cynthia B.] Univ Tennessee, Dept Biochem & Cellular & Mol Biol, Knoxville, TN 37996 USA; [Jensen, Jan K.; Christensen, Anni; Blouse, Grant E.; Andreasen, Peter A.] Univ Aarhus, Dept Mol & Struct Biol, Lab Cellular Protein Sci, DK-8000 Aarhus, Denmark	University of Tennessee System; University of Tennessee Knoxville; Aarhus University	Peterson, CB (corresponding author), Univ Tennessee, Dept Biochem & Cellular & Mol Biol, M407 Walters Life Sci Bldg, Knoxville, TN 37996 USA.	cynthia_peterson@utk.edu			NHLBI [HL50676]; Danish Cancer Society; Danish Research Agency; University of Aarhus; European Commission; Carlsberg Foundation; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R29HL050676, R01HL050676] Funding Source: NIH RePORTER	NHLBI(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); Danish Cancer Society(Danish Cancer Society); Danish Research Agency; University of Aarhus; European Commission(European CommissionEuropean Commission Joint Research Centre); Carlsberg Foundation(Carlsberg Foundation); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	This work was supported, in whole or in part, by National Institutes of Health Grant HL50676 from NHLBI (to C. B. P.). This work was also supported by grants from the Danish Cancer Society, the Danish Research Agency, the University of Aarhus, and the European Commission (to P. A. A.) and by a grant from the Carlsberg Foundation ( to G. E. B.). The costs of publication of this article were defrayed in part by the payment of page charges. This article must therefore be hereby marked " advertisement" in accordance with 18 U. S. C. Section 1734 solely to indicate this fact.	ANDREASEN PA, 1986, FEBS LETT, V209, P213, DOI 10.1016/0014-5793(86)81113-9; Arteel GE, 2008, J GASTROEN HEPATOL, V23, pS54, DOI 10.1111/j.1440-1746.2007.05285.x; Aso Y, 2007, FRONT BIOSCI-LANDMRK, V12, P2957, DOI 10.2741/2285; BAKER D, 1994, BIOCHEMISTRY-US, V33, P7505, DOI 10.1021/bi00190a002; Bijnens AP, 2001, THROMB HAEMOSTASIS, V85, P866; BITTORF SV, 1993, J BIOL CHEM, V268, P24838; Blouse GE, 2003, BIOCHEMISTRY-US, V42, P12260, DOI 10.1021/bi034737n; Bodker JS, 2003, EUR J BIOCHEM, V270, P1672, DOI 10.1046/j.1432-1033.2003.03523.x; Cate JM, 2007, CURR DRUG TARGETS, V8, P971, DOI 10.2174/138945007781662337; DAHLBACK B, 1985, BIOCHEMISTRY-US, V24, P2368, DOI 10.1021/bi00330a036; De Prada NA, 2002, EUR J BIOCHEM, V269, P184, DOI 10.1046/j.0014-2956.2002.02639.x; DECLERCK PJ, 1988, J BIOL CHEM, V263, P15454; Demiralp DO, 2008, CLIN APPL THROMB-HEM, V14, P438, DOI 10.1177/1076029607305081; Deng G, 1996, J BIOL CHEM, V271, P12716, DOI 10.1074/jbc.271.22.12716; Durand MK, 2004, THROMB HAEMOSTASIS, V91, P438, DOI 10.1160/TH03-12-0784; Ekmekci OB, 2006, CLIN CHIM ACTA, V368, P77, DOI 10.1016/j.cca.2005.12.015; Gibson A, 1997, J BIOL CHEM, V272, P5112, DOI 10.1074/jbc.272.8.5112; Gorlatova NV, 2003, J BIOL CHEM, V278, P16329, DOI 10.1074/jbc.M208420200; Hansen M, 2001, EUR J BIOCHEM, V268, P6274, DOI 10.1046/j.0014-2956.2001.02582.x; Jensen JK, 2004, FEBS LETT, V556, P175, DOI 10.1016/S0014-5793(03)01405-4; Jensen JK, 2002, FEBS LETT, V521, P91, DOI 10.1016/S0014-5793(02)02830-2; Kamikubo Y, 2006, BIOCHEMISTRY-US, V45, P3297, DOI 10.1021/bi052278f; Kamikubo Y, 2004, BIOCHEMISTRY-US, V43, P6519, DOI 10.1021/bi049647c; Kjaergaard M, 2007, PROTEIN SCI, V16, P1934, DOI 10.1110/ps.072949607; LAWRENCE DA, 1994, J BIOL CHEM, V269, P15223; Lawrence DA, 1997, J BIOL CHEM, V272, P7676, DOI 10.1074/jbc.272.12.7676; Li XQ, 2007, J BIOL CHEM, V282, P5318, DOI 10.1074/jbc.M611396200; LINDAHL TL, 1989, THROMB HAEMOSTASIS, V62, P748; Mathiasen L, 2008, MOL PHARMACOL, V74, P641, DOI 10.1124/mol.108.046417; Mayasundari A, 2004, J BIOL CHEM, V279, P29359, DOI 10.1074/jbc.M401279200; Minor KH, 2005, J BIOL CHEM, V280, P28711, DOI 10.1074/jbc.M500478200; Minor KH, 2002, J BIOL CHEM, V277, P10337, DOI 10.1074/jbc.M109564200; MOTTONEN J, 1992, NATURE, V355, P270, DOI 10.1038/355270a0; Nar H, 2000, J MOL BIOL, V297, P683, DOI 10.1006/jmbi.2000.3604; PADMANABHAN J, 1995, THROMB HAEMOSTASIS, V73, P829; Podor TJ, 2000, J BIOL CHEM, V275, P25402, DOI 10.1074/jbc.M000362200; Preissner KT, 1998, THROMB RES, V89, P1, DOI 10.1016/S0049-3848(97)00298-3; Rich RL, 2001, J MOL RECOGNIT, V14, P223, DOI 10.1002/jmr.535; Schar CR, 2008, J BIOL CHEM, V283, P10297, DOI 10.1074/jbc.M708017200; SEIFFERT D, 1994, J BIOL CHEM, V269, P2659; Seiffert D, 1996, J BIOL CHEM, V271, P29644, DOI 10.1074/jbc.271.47.29644; Sharp AM, 1999, STRUCTURE, V7, P111, DOI 10.1016/S0969-2126(99)80018-5; Stout TJ, 2000, BIOCHEMISTRY-US, V39, P8460, DOI 10.1021/bi000290w; VANMEIJER M, 1994, FEBS LETT, V352, P342, DOI 10.1016/0014-5793(94)00990-2; Wanhainen A, 2007, J VASC SURG, V45, P1109, DOI 10.1016/j.jvs.2007.02.001; Wind T, 2001, EUR J BIOCHEM, V268, P1095, DOI 10.1046/j.1432-1327.2001.2680041095.x; WUN TC, 1989, J BIOL CHEM, V264, P7862; Zhou AW, 2007, PROTEIN SCI, V16, P1502, DOI 10.1110/ps.072819107; Zhou AW, 2003, NAT STRUCT BIOL, V10, P541, DOI 10.1038/nsb943; Zhou AW, 2001, J BIOL CHEM, V276, P27541, DOI 10.1074/jbc.M102594200	50	24	26	0	5	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	OCT 17	2008	283	42					28487	28496		10.1074/jbc.M804257200	http://dx.doi.org/10.1074/jbc.M804257200			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	359EN	18658131	hybrid, Green Published			2022-12-27	WOS:000259969300051
J	Vaidya, KS; Harihar, S; Phadke, PA; Stafford, LJ; Hurst, DR; Hicks, DG; Casey, G; DeWald, DB; Welch, DR				Vaidya, Kedar S.; Harihar, Sitaram; Phadke, Pushkar A.; Stafford, Lewis J.; Hurst, Douglas R.; Hicks, David G.; Casey, Graham; DeWald, Daryll B.; Welch, Danny R.			Breast cancer metastasis suppressor-1 differentially modulates growth factor signaling	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							FACTOR-KAPPA-B; GENE-EXPRESSION; CARCINOMA CELLS; BRMS1; ACTIVATION; AKT/PKB; TISSUES; LINE	That metastatic tumor cells grow in selective non-native environments suggests an ability to differentially respond to local microenvironments. BRMS1, like other metastasis suppressors, halts ectopic growth (metastasis) without blocking orthotopic tumor formation. BRMS1-expressing tumor cells reach secondary sites but do not colonize distant tissues, compelling the hypothesis that BRMS1 selectively restricts the ability of tumor cells to respond to exogenous regulators in different tissues. Here we report that BRMS1 expression in metastatic human breast cancer cells leads to a selective reduction in epidermal growth factor receptor expression and downstream (AKT) signaling. Signaling through another receptor tyrosine kinase, hepatocyte growth factor receptor (c-Met), remains unaltered despite reduced levels of the signaling intermediate phosphatidylinositol (4,5)-bisphosphate. Interestingly, reduced downstream calcium signaling is observed following treatment with platelet-derived growth factor, consistent with decreased phosphatidylinositol (4,5)-bisphosphate. However, platelet-derived growth factor receptor expression is unaltered. Thus, BRMS1 differentially attenuates cellular responses to mitogenic signals, not only dependent upon the specific signal received, but at varying steps within the same signaling cascade. Specific modulation of signaling responses received from the microenvironment may ultimately dictate which environments are permissive/restrictive for tumor cell growth and provide insights into the biology underlying metastasis.	[Vaidya, Kedar S.; Phadke, Pushkar A.; Stafford, Lewis J.; Hurst, Douglas R.; Welch, Danny R.] Univ Alabama, Dept Pathol, Birmingham, AL 35294 USA; [Welch, Danny R.] Univ Alabama, Dept Cell Biol, Birmingham, AL 35294 USA; [Welch, Danny R.] Univ Alabama, Dept Pharmacol & Toxicol, Birmingham, AL 35294 USA; [Welch, Danny R.] Univ Alabama, Ctr Comprehens Canc, Birmingham, AL 35294 USA; [Welch, Danny R.] Univ Alabama, Natl Fdn Canc Res Ctr Metastasis Res, Birmingham, AL 35294 USA; [Harihar, Sitaram; DeWald, Daryll B.] Utah State Univ, Dept Biol, Logan, UT 84322 USA; [Hicks, David G.; Casey, Graham] Cleveland Clin, Lerner Sch Med, Dept Canc Biol, Lerner Res Inst, Cleveland, OH 44195 USA	University of Alabama System; University of Alabama Birmingham; University of Alabama System; University of Alabama Birmingham; University of Alabama System; University of Alabama Birmingham; University of Alabama System; University of Alabama Birmingham; University of Alabama System; University of Alabama Birmingham; Utah System of Higher Education; Utah State University; Case Western Reserve University; Cleveland Clinic Foundation	Welch, DR (corresponding author), Univ Alabama, Dept Pathol, G-019 Volker Hall,1670 Univ Blvd, Birmingham, AL 35294 USA.	DanWelch@uab.edu	Welch, Danny R/B-7310-2009; Hurst, Douglas R/B-7341-2009; vaidya, kedar/B-7339-2009; Harihar, Sitaram/Q-4088-2016; harihar, sitaram/AAO-1476-2020	Welch, Danny R/0000-0002-1951-4947; Harihar, Sitaram/0000-0003-4953-7282; harihar, sitaram/0000-0003-4953-7282; Hurst, Douglas/0000-0002-1296-2210; Vaidya, Kedar/0000-0001-6600-2648	United States Public Health Service [R01-CA87728]; United States Army Medical Research and Materiel Command [DAMD-17-02-1-0541]; National Foundation for Cancer Research Center for Metastasis Research; NATIONAL CANCER INSTITUTE [F32CA113037, R01CA087728] Funding Source: NIH RePORTER	United States Public Health Service(United States Department of Health & Human ServicesUnited States Public Health Service); United States Army Medical Research and Materiel Command(United States Department of DefenseUnited States ArmyU.S. Army Medical Research & Materiel Command (USAMRMC)); National Foundation for Cancer Research Center for Metastasis Research; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This work was supported in part by United States Public Health Service Grant R01-CA87728, United States Army Medical Research and Materiel Command Grant DAMD-17-02-1-0541, and the National Foundation for Cancer Research Center for Metastasis Research (to D. R. W.). The costs of publication of this article were defrayed in part by the payment of page charges. This article must therefore be hereby marked "advertisement" in accordance with 18 U. S. C. Section 1734 solely to indicate this fact.	Ada-Nguema AS, 2006, J CELL SCI, V119, P1307, DOI 10.1242/jcs.02835; Blanquicett C, 2002, ANAL BIOCHEM, V303, P209, DOI 10.1006/abio.2001.5570; Cicek M, 2005, CANCER RES, V65, P3586, DOI 10.1158/0008-5472.CAN-04-3139; DeWald DB, 2005, CANCER RES, V65, P713; Di Maira G, 2005, CELL DEATH DIFFER, V12, P668, DOI 10.1038/sj.cdd.4401604; Dillon RL, 2007, ONCOGENE, V26, P1338, DOI 10.1038/sj.onc.1210202; Eccles SA, 2007, LANCET, V369, P1742, DOI 10.1016/S0140-6736(07)60781-8; Gschwantler-Kaulich D, 2005, ONCOL REP, V14, P305; Hicks DG, 2006, CLIN CANCER RES, V12, P6702, DOI 10.1158/1078-0432.CCR-06-0635; Hurst DR, 2008, J BIOL CHEM, V283, P7438, DOI 10.1074/jbc.M709446200; IRVINE RF, 2002, SCI STKE, pRE13; Jemal A, 2007, CA-CANCER J CLIN, V57, P43, DOI 10.3322/canjclin.57.1.43; Kaplan RN, 2005, NATURE, V438, P820, DOI 10.1038/nature04186; KOZMA SC, 1987, NUCLEIC ACIDS RES, V15, P5963; Liu Y, 2006, MOL CELL BIOL, V26, P8683, DOI 10.1128/MCB.00940-06; Meehan WJ, 2004, J BIOL CHEM, V279, P1562, DOI 10.1074/jbc.M307969200; Mueller MM, 2004, NAT REV CANCER, V4, P839, DOI 10.1038/nrc1477; Nakamura Y, 2007, CANCER SCI, V98, P1006, DOI 10.1111/j.1349-7006.2007.00493.x; Nishi H, 2003, INT J MOL MED, V11, P49; Phadke PA, 2008, AM J PATHOL, V172, P809, DOI 10.2353/ajpath.2008.070772; Prestwich GD, 2004, CHEM BIOL, V11, P619, DOI 10.1016/j.chembiol.2004.03.025; Price LS, 2003, J BIOL CHEM, V278, P39413, DOI 10.1074/jbc.M302083200; Reardon DB, 1999, ONCOGENE, V18, P4756, DOI 10.1038/sj.onc.1202849; Rhee SG, 2001, ANNU REV BIOCHEM, V70, P281, DOI 10.1146/annurev.biochem.70.1.281; ROSEN PP, 1978, AM J SURG PATHOL, V2, P225, DOI 10.1097/00000478-197809000-00001; Samant RS, 2001, CLIN EXP METASTAS, V18, P683, DOI 10.1023/A:1013124725690; Sellappan S, 2004, CANCER RES, V64, P3479, DOI 10.1158/0008-5472.CAN-3299-2; Seraj MJ, 2000, CANCER RES, V60, P2764; Vaidya KS, 2007, J MAMMARY GLAND BIOL, V12, P175, DOI 10.1007/s10911-007-9049-1; Welch DR, 1997, CLIN EXP METASTAS, V15, P272, DOI 10.1023/A:1018477516367; Yoeli-Lerner M, 2006, CELL CYCLE, V5, P603, DOI 10.4161/cc.5.6.2561	31	47	48	0	2	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	OCT 17	2008	283	42					28354	28360		10.1074/jbc.M710068200	http://dx.doi.org/10.1074/jbc.M710068200			7	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	359EN	18664570	Green Published, hybrid			2022-12-27	WOS:000259969300037
J	Mitchell, SF; Lorsch, JR				Mitchell, Sarah F.; Lorsch, Jon R.			Should I stay or should I go? Eukaryotic translation initiation factors 1 and 1A control start codon recognition	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Review							40S RIBOSOMAL-SUBUNIT; C-TERMINAL DOMAIN; PREINITIATION COMPLEX; PROTEIN-SYNTHESIS; AUG SELECTION; FACTOR EIF1; SACCHAROMYCES-CEREVISIAE; MULTIFACTOR COMPLEX; STRUCTURAL FEATURES; SITE SELECTION	Start codon selection is a key step in translation initiation as it sets the reading frame for decoding. Two eukaryotic initiation factors, eIF1 and eIF1A, are key actors in this process. Recent work has elucidated many details of the mechanisms these factors use to control start site selection. eIF1 prevents the irreversible GTP hydrolysis that commits the ribosome to initiation at a particular codon. eIF1A both promotes and inhibits commitment through the competing influences of its two unstructured termini. Both factors perform their tasks through a variety of interactions with other components of the initiation machinery, in many cases mediated by the unstructured regions of the two proteins.	[Mitchell, Sarah F.; Lorsch, Jon R.] Johns Hopkins Univ, Sch Med, Dept Biophys & Biophys Chem, Baltimore, MD 21205 USA	Johns Hopkins University	Lorsch, JR (corresponding author), Johns Hopkins Univ, Sch Med, Dept Biophys & Biophys Chem, Baltimore, MD 21205 USA.	jlorsch@jhmi.edu		Lorsch, Jon/0000-0002-4521-4999	National Institutes of Health [GM62128, DK078633]; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R21DK078633] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM062128] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported, in whole or in part, by National Institutes of Health Grants GM62128 and DK078633 from NIGMS and NIDDK. This minireview will be reprinted in the 2008 Minireview Compendium, which will be available in January, 2009.	Algire MA, 2005, MOL CELL, V20, P251, DOI 10.1016/j.molcel.2005.09.008; Algire MA, 2002, RNA, V8, P382, DOI 10.1017/S1355838202029527; Algire MA, 2006, CURR OPIN CHEM BIOL, V10, P480, DOI 10.1016/j.cbpa.2006.08.010; Asano K, 2001, EMBO J, V20, P2326, DOI 10.1093/emboj/20.9.2326; Battiste JL, 2000, MOL CELL, V5, P109, DOI 10.1016/S1097-2765(00)80407-4; Chaudhuri J, 1999, J BIOL CHEM, V274, P17975, DOI 10.1074/jbc.274.25.17975; Cheung YN, 2007, GENE DEV, V21, P1217, DOI 10.1101/gad.1528307; CIGAN AM, 1987, GENE, V59, P1; Conte MR, 2006, BIOCHEMISTRY-US, V45, P4550, DOI 10.1021/bi052387u; Cui Y, 1998, MOL CELL BIOL, V18, P1506, DOI 10.1128/MCB.18.3.1506; Das S, 2001, J BIOL CHEM, V276, P6720, DOI 10.1074/jbc.M008863200; Fekete CA, 2005, EMBO J, V24, P3588, DOI 10.1038/sj.emboj.7600821; Fekete CA, 2007, EMBO J, V26, P1602, DOI 10.1038/sj.emboj.7601613; Fletcher CM, 1999, EMBO J, V18, P2631, DOI 10.1093/emboj/18.9.2631; Fraser CS, 2007, MOL CELL, V26, P811, DOI 10.1016/j.molcel.2007.05.019; Gilbertt RJC, 2007, P NATL ACAD SCI USA, V104, P5788, DOI 10.1073/pnas.0606880104; He H, 2003, MOL CELL BIOL, V23, P5431, DOI 10.1128/MCB.23.15.5431-5445.2003; Jivotovskaya AV, 2006, MOL CELL BIOL, V26, P1355, DOI 10.1128/MCB.26.4.1355-1372.2006; Kainuma M, 2001, BIOCHIMIE, V83, P505, DOI 10.1016/S0300-9084(01)01279-2; Kapp LD, 2004, ANNU REV BIOCHEM, V73, P657, DOI 10.1146/annurev.biochem.73.030403.080419; KOZAK M, 1991, J BIOL CHEM, V266, P19867; KOZAK M, 1986, CELL, V44, P283, DOI 10.1016/0092-8674(86)90762-2; Lomakin IB, 2003, GENE DEV, V17, P2786, DOI 10.1101/gad.1141803; Maag D, 2006, J MOL BIOL, V356, P724, DOI 10.1016/j.jmb.2005.11.083; Maag D, 2005, MOL CELL, V17, P265, DOI 10.1016/j.molcel.2004.11.051; Maag D, 2003, J MOL BIOL, V330, P917, DOI 10.1016/S0022-2836(03)00665-X; Majumdar R, 2005, EMBO J, V24, P3737, DOI 10.1038/sj.emboj.7600844; Majumdar R, 2003, J BIOL CHEM, V278, P6580, DOI 10.1074/jbc.M210357200; Olsen DS, 2003, EMBO J, V22, P193, DOI 10.1093/emboj/cdg030; Passmore LA, 2007, MOL CELL, V26, P41, DOI 10.1016/j.molcel.2007.03.018; Paulin FEM, 2001, CURR BIOL, V11, P55, DOI 10.1016/S0960-9822(00)00025-7; Pestova TV, 2002, GENE DEV, V16, P2906, DOI 10.1101/gad.1020902; Pestova TV, 1998, NATURE, V394, P854, DOI 10.1038/29703; Pestova TV, 2001, P NATL ACAD SCI USA, V98, P7029, DOI 10.1073/pnas.111145798; Reibarkh M, 2008, J BIOL CHEM, V283, P1094, DOI 10.1074/jbc.M708155200; Singh CR, 2004, J BIOL CHEM, V279, P31910, DOI 10.1074/jbc.M313940200; Siridechadilok B, 2005, SCIENCE, V310, P1513, DOI 10.1126/science.1118977; SRIVASTAVA S, 1992, J MOL BIOL, V226, P301, DOI 10.1016/0022-2836(92)90946-H; THOMAS A, 1980, EUR J BIOCHEM, V107, P39, DOI 10.1111/j.1432-1033.1980.tb04621.x; THOMAS A, 1980, FEBS LETT, V116, P67, DOI 10.1016/0014-5793(80)80530-8; TRACHSEL H, 1977, J MOL BIOL, V116, P755, DOI 10.1016/0022-2836(77)90269-8; Unbehaun A, 2004, GENE DEV, V18, P3078, DOI 10.1101/gad.1255704; Valasek L, 2004, MOL CELL BIOL, V24, P9437, DOI 10.1128/MCB.24.21.9437-9455.2004; YOON HJ, 1992, MOL CELL BIOL, V12, P248, DOI 10.1128/MCB.12.1.248	44	40	40	0	3	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	OCT 10	2008	283	41					27345	27349		10.1074/jbc.R800031200	http://dx.doi.org/10.1074/jbc.R800031200			5	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	355OW	18593708	hybrid, Green Published			2022-12-27	WOS:000259719200001
J	Ozvegy-Laczka, C; Laczko, R; Hegedus, C; Litman, T; Varady, G; Goda, K; Hegedus, T; Dokholyan, NV; Sorrentino, BP; Varadi, A; Sarkadi, B				Ozvegy-Laczka, Csilla; Laczko, Rozalia; Hegedus, Csilla; Litman, Thomas; Varady, Gyoergy; Goda, Katalin; Hegedus, Tamas; Dokholyan, Nikolay V.; Sorrentino, Brian P.; Varadi, Andras; Sarkadi, Balazs			Interaction with the 5D3 monoclonal antibody is regulated by intramolecular rearrangements but not by covalent dimer formation of the human ABCG2 multidrug transporter	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							CANCER RESISTANCE PROTEIN; DISCRETE MOLECULAR-DYNAMICS; DRUG TRANSPORT; BCRP/ABCG2; CELLS; SPECIFICITY; INHIBITION; EXPRESSION; SUBSTRATE; SURVIVAL	Human ABCG2 is a plasma membrane glycoprotein working as a homodimer or homo-oligomer. The protein plays an important role in the protection/detoxification of various tissues and may also be responsible for the multidrug-resistant phenotype of cancer cells. In our previous study we found that the 5D3 monoclonal antibody shows a function-dependent reactivity to an extracellular epitope of the ABCG2 transporter. In the current experiments we have further characterized the 5D3-ABCG2 interaction. The effect of chemical cross-linking and the modulation of extracellular S-S bridges on the transporter function and 5D3 reactivity of ABCG2 were investigated in depth. We found that several protein cross-linkers greatly increased 5D3 labeling in ABCG2 expressing HEK cells; however, there was no correlation between covalent dimer formation, the inhibition of transport activity, and the increase in 5D3 binding. Dithiothreitol treatment, which reduced the extracellular S-S bridge-forming cysteines of ABCG2, had no effect on transport function but caused a significant decrease in 5D3 binding. When analyzing ABCG2 mutants carrying Cys-to-Ala changes in the extracellular loop, we found that the mutant C603A (lacking the intermolecular S-S bond) showed comparable transport activity and 5D3 reactivity to the wild-type ABCG2. However, disruption of the intramolecular S-S bridge (in C592A, C608A, or C592A/C608A mutants) in this loop abolished 5D3 binding, whereas the function of the protein was preserved. Based on these results and ab initio folding simulations, we propose a model for the large extracellular loop of the ABCG2 protein.	[Ozvegy-Laczka, Csilla; Laczko, Rozalia; Hegedus, Csilla; Varady, Gyoergy; Sarkadi, Balazs] Semmelweis Univ, Hungarian Acad Sci, Membrane Res Grp, H-1113 Budapest, Hungary; [Ozvegy-Laczka, Csilla; Laczko, Rozalia; Hegedus, Csilla; Varady, Gyoergy; Sarkadi, Balazs] Natl Blood Ctr, H-1113 Budapest, Hungary; [Litman, Thomas] Univ Copenhagen, Bioinformat Ctr, DK-2100 Copenhagen, Denmark; [Goda, Katalin] Univ Debrecen, Dept Biophys & Cell Biol, Med & Hlth Sci Ctr, H-4012 Debrecen, Hungary; [Hegedus, Tamas] Univ N Carolina, Cyst Fibrosis Treatment & Res Ctr, Dept Biochem & Biophys, Chapel Hill, NC 27599 USA; [Dokholyan, Nikolay V.] Univ N Carolina, Sch Med, Dept Biochem & Biophys, Chapel Hill, NC 27599 USA; [Sorrentino, Brian P.] St Jude Childrens Res Hosp, Dept Hematol Oncol, Div Expt Hematol, Memphis, TN 38105 USA; [Varadi, Andras] Hungarian Acad Sci, Inst Enzymol, H-1113 Budapest, Hungary	Hungarian Academy of Sciences; Semmelweis University; University of Copenhagen; University of Debrecen; University of North Carolina; University of North Carolina Chapel Hill; University of North Carolina; University of North Carolina Chapel Hill; University of North Carolina School of Medicine; St Jude Children's Research Hospital; Hungarian Academy of Sciences; Hungarian Research Centre for Natural Sciences	Sarkadi, B (corresponding author), Semmelweis Univ, Hungarian Acad Sci, Membrane Res Grp, Dioszegi U 64, H-1113 Budapest, Hungary.	sarkadi@biomembrane.hu	Sarkadi, Balazs/I-5024-2013; Varadi, Andras/A-2055-2012; Laczka, Csilla/AAE-5543-2021; Goda, Katalin/L-8986-2019; Dokholyan, Nikolay/B-2238-2009; Hegedus, Tamas/P-8625-2015; Dokholyan, Nikolay/D-8081-2018; György, Várady/J-8118-2017	Dokholyan, Nikolay/0000-0002-8225-4025; Hegedus, Tamas/0000-0002-5195-749X; Dokholyan, Nikolay/0000-0002-8225-4025; Litman, Thomas/0000-0002-6068-901X	Hungarian Scientific Research Fund (OTKA) [AT 048986, NK72057]; National Research and Development Programmes (NKFP) [FP6-INTHER, FP6-MEMTRANS, NEDO]; National Health Council (ETT)	Hungarian Scientific Research Fund (OTKA)(Orszagos Tudomanyos Kutatasi Alapprogramok (OTKA)); National Research and Development Programmes (NKFP); National Health Council (ETT)	This work was supported by grants from the Hungarian Scientific Research Fund (OTKA) (AT 048986 and NK72057) National Research and Development Programmes (NKFP), FP6-INTHER, FP6-MEMTRANS, NEDO, and National Health Council (ETT). The costs of publication of this article were defrayed in part by the payment of page charges. This article must therefore be hereby marked "advertisement" in accordance with 18 U.S.C. Section 1734 solely to indicate this fact.	Abbott BL, 2002, BLOOD, V100, P4594, DOI 10.1182/blood-2002-01-0271; Allen JD, 2002, MOL CANCER THER, V1, P417; Chandra P, 2004, PHARM RES-DORDR, V21, P719, DOI 10.1023/B:PHAM.0000026420.79421.8f; Ding F, 2005, TRENDS BIOTECHNOL, V23, P450, DOI 10.1016/j.tibtech.2005.07.001; Ding F, 2008, STRUCTURE, V16, P1010, DOI 10.1016/j.str.2008.03.013; Ding F, 2006, PLOS COMPUT BIOL, V2, P725, DOI 10.1371/journal.pcbi.0020085; Dokholyan NV, 1998, FOLD DES, V3, P577, DOI 10.1016/S1359-0278(98)00072-8; Elkind NB, 2005, CANCER RES, V65, P1770, DOI 10.1158/0008-5472.CAN-04-3303; Hazai E, 2008, J STRUCT BIOL, V162, P63, DOI 10.1016/j.jsb.2007.12.001; Hegedus T, 2008, J MOL BIOL, V378, P1052, DOI 10.1016/j.jmb.2008.03.033; Henriksen U, 2005, J BIOL CHEM, V280, P36926, DOI 10.1074/jbc.M502937200; Kage K, 2005, CANCER SCI, V96, P866, DOI 10.1111/j.1349-7006.2005.00126.x; Kage K, 2002, INT J CANCER, V97, P626, DOI 10.1002/ijc.10100; Krishnamurthy P, 2005, BIOMETALS, V18, P349, DOI 10.1007/s10534-005-3709-7; Krishnamurthy P, 2004, J BIOL CHEM, V279, P24218, DOI 10.1074/jbc.M313599200; Maliepaard M, 2001, CANCER RES, V61, P3458; Mitomo H, 2003, BIOCHEM J, V373, P767, DOI 10.1042/BJ20030150; Ozvegy C, 2001, BIOCHEM BIOPH RES CO, V285, P111, DOI 10.1006/bbrc.2001.5130; Ozvegy C, 2002, J BIOL CHEM, V277, P47980, DOI 10.1074/jbc.M207857200; Ozvegy-Laczka C, 2005, J BIOL CHEM, V280, P4219, DOI 10.1074/jbc.M411338200; Ozvegy-Laczka C, 2004, MOL PHARMACOL, V65, P1485, DOI 10.1124/mol.65.6.1485; Robey RW, 2007, CANCER METAST REV, V26, P39, DOI 10.1007/s10555-007-9042-6; Robey RW, 2003, BRIT J CANCER, V89, P1971, DOI 10.1038/sj.bjc.6601370; Sarkadi B, 2006, PHYSIOL REV, V86, P1179, DOI 10.1152/physrev.00037.2005; SPACK EG, 1986, ANAL BIOCHEM, V158, P233, DOI 10.1016/0003-2697(86)90614-7; Sugita Y, 1999, CHEM PHYS LETT, V314, P141, DOI 10.1016/S0009-2614(99)01123-9; Szollosi J, 1996, J IMMUNOL, V157, P2939; Takada T, 2005, PHARM RES-DORDR, V22, P458, DOI 10.1007/s11095-004-1884-9; Wakabayashi K, 2007, J BIOL CHEM, V282, P27841, DOI 10.1074/jbc.C700133200; Wakabayashi K, 2006, J EXP THER ONCOL, V5, P205; Zhou S, 2001, NAT MED, V7, P1028, DOI 10.1038/nm0901-1028	31	34	35	0	7	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	SEP 19	2008	283	38					26059	26070		10.1074/jbc.M803230200	http://dx.doi.org/10.1074/jbc.M803230200			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	348GX	18644784	Green Published, hybrid			2022-12-27	WOS:000259200100034
J	Young, MT; Fisher, JA; Fountain, SJ; Ford, RC; North, RA; Khakh, BS				Young, Mark T.; Fisher, James A.; Fountain, Samuel J.; Ford, Robert C.; North, R. Alan; Khakh, Baljit S.			Molecular shape, architecture, and size of P2X(4) receptors determined using fluorescence resonance energy transfer and electron microscopy	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ATP-GATED P2X(2); NICOTINIC ACETYLCHOLINE-RECEPTORS; INTERLEUKIN-1-BETA RELEASE; MEMBRANE-PROTEINS; ION CHANNELS; SUBUNITS; TRAFFICKING; RESOLUTION; NEURONS; DOMAIN	P2X receptors are ATP-gated nonselective cation channels with important physiological roles. However, their structures are poorly understood. Here, we analyzed the architecture of P2X receptors using fluorescence resonance energy transfer (FRET) microscopy and direct structure determination using electron microscopy. FRET efficiency measurements indicated that the distance between the C-terminal tails of P2X(4) receptors was 5.6 nm. Single particle analysis of purified P2X(4) receptors was used to determine the three-dimensional structure at a resolution of 21 angstrom; the orientation of the particle with respect to the membrane was assigned by labeling the intracellular C termini with 1.8-nm gold particles and the carbohydrate-rich ectodomain with lectin. We found that human P2X(4) is a globular torpedo-like molecule with an approximate volume of 270 nm(3) and a compact propeller-shaped ectodomain. In this structure, the distance between the centers of the gold particles was 6.1 nm, which closely matches FRET data. Thus, our data provide the first views of the architecture, shape, and size of single P2X receptors, furthering our understanding of this important family of ligand-gated ion channels.	[Khakh, Baljit S.] Univ Calif Los Angeles, David Geffen Sch Med, Dept Physiol, Los Angeles, CA 90095 USA; [Khakh, Baljit S.] Univ Calif Los Angeles, David Geffen Sch Med, Dept Neurobiol, Los Angeles, CA 90095 USA; [Young, Mark T.; Ford, Robert C.] Univ Manchester, Manchester Interdisciplinary Bioctr, Manchester M1 7DN, Lancs, England; [Fisher, James A.; Khakh, Baljit S.] MRC, Mol Biol Lab, Cambridge CB2 0QH, England; [Fountain, Samuel J.; North, R. Alan] Univ Manchester, Fac Life Sci, Manchester M13 9PT, Lancs, England	University of California System; University of California Los Angeles; University of California Los Angeles Medical Center; David Geffen School of Medicine at UCLA; University of California System; University of California Los Angeles; University of California Los Angeles Medical Center; David Geffen School of Medicine at UCLA; University of Manchester; MRC Laboratory Molecular Biology; University of Manchester	Khakh, BS (corresponding author), Univ Calif Los Angeles, David Geffen Sch Med, Dept Physiol, 10833 Le Conte Ave, Los Angeles, CA 90095 USA.	bkhakh@mednet.ucla.edu	North, Richard/GQA-6156-2022; Fountain, Samuel J/C-2142-2011; Young, Mark T/E-8928-2010	Young, Mark T/0000-0002-9615-9002; Ford, Robert/0000-0002-0958-1505	National Institutes of Health [GM070925]; Wellcome Trust; Medical Research Council; Human Frontier Science Program; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM070925] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Wellcome Trust(Wellcome Trust); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Human Frontier Science Program(Human Frontier Science Program); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported, in whole or in part, by the National Institutes of Health (to B. S. K., subcontract on Grant GM070925). This work was also supported by the Wellcome Trust (to R. A. N.), the Medical Research Council (to J. A. F. and B. S. K.), and the Human Frontier Science Program (to B. S. K.). The costs of publication of this article were defrayed in part by the payment of page charges. This article must therefore be hereby marked "advertisement" in accordance with 18 U. S. C. Section 1734 solely to indicate this fact.	Aschrafi A, 2004, J MOL BIOL, V342, P333, DOI 10.1016/j.jmb.2004.06.092; Barrera NP, 2005, J BIOL CHEM, V280, P10759, DOI 10.1074/jbc.M412265200; Bo XN, 2003, MOL PHARMACOL, V63, P1407, DOI 10.1124/mol.63.6.1407; Bobanovic LK, 2002, J NEUROSCI, V22, P4814, DOI 10.1523/JNEUROSCI.22-12-04814.2002; BRISSON A, 1985, NATURE, V315, P474, DOI 10.1038/315474a0; Bunt G, 2004, INT REV CYTOL, V237, P205, DOI 10.1016/S0074-7696(04)37005-1; Burnstock G, 2007, PHYSIOL REV, V87, P659, DOI 10.1152/physrev.00043.2006; Drenan RM, 2008, MOL PHARMACOL, V73, P27, DOI 10.1124/mol.107.039180; Egan TM, 1998, J NEUROSCI, V18, P2350; Fisher JA, 2004, J NEUROSCI, V24, P10475, DOI 10.1523/JNEUROSCI.3250-04.2004; FORD RC, 1987, EMBO J, V6, P1581, DOI 10.1002/j.1460-2075.1987.tb02403.x; Fountain SJ, 2007, NATURE, V448, P200, DOI 10.1038/nature05926; Fountain SJ, 2006, J BIOL CHEM, V281, P15044, DOI 10.1074/jbc.M600442200; Jasti J, 2007, NATURE, V449, P316, DOI 10.1038/nature06163; Jiang LH, 2003, J NEUROSCI, V23, P8903; Kashino Y, 2003, J CHROMATOGR B, V797, P191, DOI 10.1016/S1570-0232(03)00428-8; Kawate T, 2006, STRUCTURE, V14, P673, DOI 10.1016/j.str.2006.01.013; Khakh BS, 2006, NATURE, V442, P527, DOI 10.1038/nature04886; Khakh BS, 2005, J NEUROSCI, V25, P6911, DOI 10.1523/JNEUROSCI.0561-05.2005; Khakh BS, 2005, J BIOL CHEM, V280, P6118, DOI 10.1074/jbc.M411324200; Khakh BS, 2001, P NATL ACAD SCI USA, V98, P5288, DOI 10.1073/pnas.081089198; Khakh BS, 2001, PHARMACOL REV, V53, P107; Kim M, 2001, EMBO J, V20, P6347, DOI 10.1093/emboj/20.22.6347; Lata S, 2006, J AM CHEM SOC, V128, P2365, DOI 10.1021/ja0563105; Le KT, 1998, J NEUROSCI, V18, P7152; Lester HA, 2004, TRENDS NEUROSCI, V27, P329, DOI 10.1016/j.tins.2004.04.002; Ludtke SJ, 1999, J STRUCT BIOL, V128, P82, DOI 10.1006/jsbi.1999.4174; Mayer ML, 2004, ANNU REV PHYSIOL, V66, P161, DOI 10.1146/annurev.physiol.66.050802.084104; Michalet X, 2003, ANNU REV BIOPH BIOM, V32, P161, DOI 10.1146/annurev.biophys.32.110601.142525; Mio K, 2005, BIOCHEM BIOPH RES CO, V337, P998, DOI 10.1016/j.bbrc.2005.09.141; Nakazawa K, 2005, EUR J PHARMACOL, V518, P107, DOI 10.1016/j.ejphar.2005.06.018; Nashmi R, 2003, J NEUROSCI, V23, P11554; Nicke A, 1998, EMBO J, V17, P3016, DOI 10.1093/emboj/17.11.3016; Pelegrin P, 2007, J BIOL CHEM, V282, P2386, DOI 10.1074/jbc.M610351200; Pelegrin P, 2006, EMBO J, V25, P5071, DOI 10.1038/sj.emboj.7601378; Ramjeesingh M, 1999, BIOCHEM J, V342, P119, DOI 10.1042/0264-6021:3420119; Richler E, 2008, NAT METHODS, V5, P87, DOI 10.1038/NMETH1144; Roger B, 2008, J NEUROSCI, V28, P6393, DOI 10.1523/JNEUROSCI.0696-08.2008; Royle SJ, 2005, J CELL SCI, V118, P3073, DOI 10.1242/jcs.02451; Royle SJ, 2002, J BIOL CHEM, V277, P35378, DOI 10.1074/jbc.M204844200; Samways DSK, 2007, J GEN PHYSIOL, V129, P245, DOI 10.1085/jgp.200609677; Sine SM, 2006, NATURE, V440, P448, DOI 10.1038/nature04708; Surprenant A, 1996, SCIENCE, V272, P735, DOI 10.1126/science.272.5262.735; Tsien RY, 1998, ANNU REV BIOCHEM, V67, P509, DOI 10.1146/annurev.biochem.67.1.509; Unwin N, 2005, J MOL BIOL, V346, P967, DOI 10.1016/j.jmb.2004.12.031; Yan ZH, 2005, MOL PHARMACOL, V67, P1078, DOI 10.1124/mol.104.010108	46	33	36	0	5	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	SEP 19	2008	283	38					26241	26251		10.1074/jbc.M804458200	http://dx.doi.org/10.1074/jbc.M804458200			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	348GX	18635539	Green Published, Green Accepted, hybrid			2022-12-27	WOS:000259200100052
J	Kang, S; Kang, J; Kwon, H; Frueh, D; Yoo, SH; Wagner, G; Park, S				Kang, Sunmi; Kang, Jinho; Kwon, Hyuknam; Frueh, Dominique; Yoo, Seung Hyun; Wagner, Gerhard; Park, Sunghyouk			Effects of redox potential and Ca2+ on the inositol 1,4,5-trisphosphate receptor L3-1 loop region - Implications for receptor regulation	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							DEPENDENT K+ CHANNEL; N-TERMINAL REGION; LUMINAL CA2+; SECRETORY GRANULES; CHROMOGRANIN-A; IP3 RECEPTORS; ENDOPLASMIC-RETICULUM; ALZHEIMERS-DISEASE; NMR-SPECTROSCOPY; CHEMICAL-SHIFTS	Inositol 1,4,5-trisphosphate receptor (IP3R) is a major intracellular Ca2+ channel, modulated by many factors in the cytosolic and lumenal compartments. Compared with cytosolic control, lumenal-side regulation has been much less studied, and some of its mechanistic aspects have been controversial. Of particular interest with regard to lumenal regulation are whether it involves direct interactions between IP3R and the regulators, and whether it involves conformational changes of the lumenal regions of IP3R. To understand these lumenal-side regulation mechanisms, we studied the effects of two important lumenal regulatory factors, the redox potential and Ca2+, on the L3-1 lumenal loop region of IP3R. The redox potential exerted direct and significant effects on the conformation of the loop region. By sharp contrast, Ca2+ showed little effect on the L3-1 conformation, suggesting that the regulation of Ca2+ is indirect or involves other receptor regions. GSH/oxidized glutathione-mediated oxidation introduced a unique intramolecular disulfide bond between Cys(34) and Cys(42). A variety of NMR experiments revealed that oxidation also induces localized helical characteristics in the Cys(34)-Cys(42) region. Dynamics studies also showed reduced motions in the region upon oxidation, consistent with the conformational changes. The results raise the interesting possibility that Cys(34) and Cys(42) may act together as a reduction sensor, and that Cys(65) may function as an oxidation sensor. Overall, our studies suggest that the redox potential and Ca2+ can regulate IP3R through totally different mechanisms: Ca2+ by the indirect effect and the redox potential by direct action causing conformational changes.	[Kang, Sunmi; Kang, Jinho; Kwon, Hyuknam; Yoo, Seung Hyun; Park, Sunghyouk] Inha Univ, Sch Med, Dept Biochem, BK21 Project, Inchon 400712, South Korea; [Kang, Sunmi; Kang, Jinho; Kwon, Hyuknam; Yoo, Seung Hyun; Park, Sunghyouk] Inha Univ, Sch Med, Ctr Adv Med Educ, BK21 Project, Inchon 400712, South Korea; [Frueh, Dominique; Wagner, Gerhard] Harvard Univ, Sch Med, Dept Biol Chem & Mol Pharmacol, Boston, MA 02115 USA	Inha University; Inha University; Harvard University; Harvard Medical School	Park, S (corresponding author), Inha Univ, Sch Med, Dept Biochem, BK21 Project, Chungsuk Bldg,Room 505,Shinheung Dong, Inchon 400712, South Korea.	spark@inha.ac.kr	Frueh, Dominique P/A-6462-2008; Kwon, Hyuk Nam/V-2301-2018	Frueh, Dominique P/0000-0003-4605-3776; Kwon, Hyuk Nam/0000-0003-4096-4712	Inha University	Inha University	This work was supported by Inha University. The costs of publication of this article were defrayed in part by the payment of page charges. This article must therefore be hereby marked "advertisement" in accordance with 18 U. S. C. Section 1734 solely to indicate this fact.	Adkins CE, 2000, BIOCHEM J, V345, P357, DOI 10.1042/0264-6021:3450357; BAX A, 1993, ACCOUNTS CHEM RES, V26, P131, DOI 10.1021/ar00028a001; Berridge MJ, 2003, NAT REV MOL CELL BIO, V4, P517, DOI 10.1038/nrm1155; Berridge MJ, 2003, BIOCHEM SOC T, V31, P930; Biekofsky RR, 1998, BIOCHEMISTRY-US, V37, P7617, DOI 10.1021/bi9800449; BLONDEL O, 1994, P NATL ACAD SCI USA, V91, P7777, DOI 10.1073/pnas.91.16.7777; Boehning D, 2000, J BIOL CHEM, V275, P21492, DOI 10.1074/jbc.M001724200; Boehning D, 2001, J BIOL CHEM, V276, P13509, DOI 10.1074/jbc.C100094200; Bosanac I, 2004, BBA-MOL CELL RES, V1742, P89, DOI 10.1016/j.bbamcr.2004.09.016; Bosanac I, 2002, NATURE, V420, P696, DOI 10.1038/nature01268; Braunewell KH, 2005, TRENDS PHARMACOL SCI, V26, P345, DOI 10.1016/j.tips.2005.04.008; BULENDA D, 1985, BIOCHEMISTRY-US, V24, P7760, DOI 10.1021/bi00347a039; Caroppo R, 2003, J BIOL CHEM, V278, P39503, DOI 10.1074/jbc.M305823200; COZENS B, 1984, J BIOL CHEM, V259, P6248; DELAGLIO F, 1995, J BIOMOL NMR, V6, P277, DOI 10.1007/BF00197809; Devogelaere B, 2008, CELL CALCIUM, V43, P17, DOI 10.1016/j.ceca.2007.04.005; Eisenmesser EZ, 2005, NATURE, V438, P117, DOI 10.1038/nature04105; FARROW NA, 1994, BIOCHEMISTRY-US, V33, P5984, DOI 10.1021/bi00185a040; Ferentz AE, 2000, Q REV BIOPHYS, V33, P29, DOI 10.1017/S0033583500003589; Foskett JK, 2007, PHYSIOL REV, V87, P593, DOI 10.1152/physrev.00035.2006; Gifford JL, 2007, BIOCHEM J, V405, P199, DOI 10.1042/BJ20070255; Gyorke I, 2004, BIOPHYS J, V86, P2121, DOI 10.1016/S0006-3495(04)74271-X; Hamada K, 2003, J BIOL CHEM, V278, P52881, DOI 10.1074/jbc.M309743200; Higo T, 2005, CELL, V120, P85, DOI 10.1016/j.cell.2004.11.048; HIROSE K, 1994, NATURE, V372, P791; Hoch JC, 2001, METHOD ENZYMOL, V338, P159; HWANG C, 1992, SCIENCE, V257, P1496, DOI 10.1126/science.1523409; IINO M, 1990, J GEN PHYSIOL, V95, P1103, DOI 10.1085/jgp.95.6.1103; IRVINE RF, 1990, FEBS LETT, V263, P5, DOI 10.1016/0014-5793(90)80692-C; Ishikawa H, 2007, P NATL ACAD SCI USA, V104, P19309, DOI 10.1073/pnas.0709760104; Jiang YX, 2003, NATURE, V423, P42, DOI 10.1038/nature01581; Jiang YX, 2003, NATURE, V423, P33, DOI 10.1038/nature01580; JOHNSON BA, 1994, J BIOMOL NMR, V4, P603, DOI 10.1007/BF00404272; Kang JH, 2007, BBA-PROTEINS PROTEOM, V1774, P502, DOI 10.1016/j.bbapap.2007.02.007; Kasri NN, 2004, EMBO J, V23, P312, DOI 10.1038/sj.emboj.7600037; Kern D, 2003, CURR OPIN STRUC BIOL, V13, P748, DOI 10.1016/j.sbi.2003.10.008; Kern D, 2005, METHOD ENZYMOL, V394, P507, DOI 10.1016/S0076-6879(05)94021-4; LaFerla FM, 2002, NAT REV NEUROSCI, V3, P862, DOI 10.1038/nrn960; Meldolesi J, 1998, TRENDS BIOCHEM SCI, V23, P10, DOI 10.1016/S0968-0004(97)01143-2; MISSIAEN L, 1992, J PHYSIOL-LONDON, V455, P623, DOI 10.1113/jphysiol.1992.sp019319; Missiaen L, 1999, J BIOL CHEM, V274, P13748, DOI 10.1074/jbc.274.20.13748; OLDERSHAW KA, 1993, BIOCHEM J, V292, P631, DOI 10.1042/bj2920631; Park S, 2000, FEBS LETT, V485, P81, DOI 10.1016/S0014-5793(00)02186-4; PARYS JB, 1993, J BIOL CHEM, V268, P25206; Patterson RL, 2004, ANNU REV BIOCHEM, V73, P437, DOI 10.1146/annurev.biochem.73.071403.161303; Sharma D, 2000, J BIOMOL NMR, V18, P165, DOI 10.1023/A:1008398416292; SHUTTLEWORTH TJ, 1995, CELL CALCIUM, V17, P393, DOI 10.1016/0143-4160(95)90085-3; Sienaert I, 2002, BIOCHEM J, V365, P269, DOI 10.1042/BJ20020144; Sienaert I, 1997, J BIOL CHEM, V272, P25899, DOI 10.1074/jbc.272.41.25899; Sienaert I, 1996, J BIOL CHEM, V271, P27005, DOI 10.1074/jbc.271.43.27005; Taylor CW, 2004, TRENDS BIOCHEM SCI, V29, P210, DOI 10.1016/j.tibs.2004.02.010; Taylor CW, 2002, CELL CALCIUM, V32, P321, DOI 10.1016/S0143416002001859; Thrower EC, 2003, J BIOL CHEM, V278, P49699, DOI 10.1074/jbc.M309307200; Thrower EC, 2002, J BIOL CHEM, V277, P15801, DOI 10.1074/jbc.M110139200; Thrower EC, 2000, J BIOL CHEM, V275, P36049, DOI 10.1074/jbc.M000970200; Tu JC, 1998, NEURON, V21, P717, DOI 10.1016/S0896-6273(00)80589-9; Uchida K, 2003, J BIOL CHEM, V278, P16551, DOI 10.1074/jbc.M300646200; VUISTER GW, 1993, J AM CHEM SOC, V115, P7772, DOI 10.1021/ja00070a024; Wuthrich K, 1986, NMR PROTEINS NUCL AC; Yoo SH, 2001, J BIOL CHEM, V276, P45806, DOI 10.1074/jbc.M107532200; YOO SH, 1991, J BIOL CHEM, V266, P7740; Yoo SH, 2000, TRENDS NEUROSCI, V23, P424, DOI 10.1016/S0166-2236(00)01621-0; Yoshikawa F, 1996, J BIOL CHEM, V271, P18277, DOI 10.1074/jbc.271.30.18277	63	35	35	0	2	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	SEP 12	2008	283	37					25567	25575		10.1074/jbc.M803321200	http://dx.doi.org/10.1074/jbc.M803321200			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	345QZ	18635540	hybrid			2022-12-27	WOS:000259012700052
J	Missner, A; Kugler, P; Saparov, SM; Sommer, K; Mathai, JC; Zeidel, ML; Pohl, P				Missner, Andreas; Kuegler, Philipp; Saparov, Sapar M.; Sommer, Klaus; Mathai, John C.; Zeidel, Mark L.; Pohl, Peter			Carbon dioxide transport through membranes	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							LIPID BILAYER-MEMBRANES; HUMAN ERYTHROCYTE-MEMBRANE; RED-BLOOD-CELLS; UNSTIRRED LAYERS; AMMONIA TRANSPORT; CO2 PERMEABILITY; OXYGEN-UPTAKE; PH PROFILES; AQUAPORIN 1; WATER	Several membrane channels, like aquaporin-1 (AQP1) and the RhAG protein of the rhesus complex, were hypothesized to be of physiological relevance for CO2 transport. However, the underlying assumption that the lipid matrix imposes a significant barrier to CO2 diffusion was never confirmed experimentally. Here we have monitored transmembrane CO2 flux (J(CO2)) by imposing a CO2 concentration gradient across planar lipid bilayers and detecting the resulting small pH shift in the immediate membrane vicinity. An analytical model, which accounts for the presence of both carbonic anhydrase and buffer molecules, was fitted to the experimental pH profiles using inverse problems techniques. At pH 7.4, the model revealed that J(CO2) was entirely rate-limited by near-membrane unstirred layers (USL), which act as diffusional barriers in series with the membrane. Membrane tightening by sphingomyelin and cholesterol did not alter J(CO2) confirming that membrane resistance was comparatively small. In contrast, a pH-induced shift of the CO2 hydration-dehydration equilibrium resulted in a relative membrane contribution of about 15% to the total resistance (pH 9.6). Under these conditions, a membrane CO2 permeability (3.2 +/- 1.6 cm/s) was estimated. It indicates that cellular CO2 uptake (pH 7.4) is always USL-limited, because the USL size always exceeds 1 mu m. Consequently, facilitation of CO2 transport by AQP1, RhAG, or any other protein is highly unlikely. The conclusion was confirmed by the observation that CO2 permeability of epithelial cell mono-layers was always the same whether AQP1 was overexpressed in both the apical and basolateral membranes or not.	[Missner, Andreas; Saparov, Sapar M.; Sommer, Klaus; Pohl, Peter] Johannes Kepler Univ Linz, Inst Biophys, A-4040 Linz, Austria; [Kuegler, Philipp] Johannes Kepler Univ Linz, Inst Ind Mathemat, A-4040 Linz, Austria; [Kuegler, Philipp] Austrian Acad Sci, Johan Radon Inst Computat & Appl Math, A-4040 Linz, Austria; [Mathai, John C.; Zeidel, Mark L.] Beth Israel Deaconess Med Ctr, Boston, MA 02215 USA; [Mathai, John C.; Zeidel, Mark L.] Harvard Univ, Sch Med, Boston, MA 02215 USA	Johannes Kepler University Linz; Johannes Kepler University Linz; Austrian Academy of Sciences; Harvard University; Beth Israel Deaconess Medical Center; Harvard University; Harvard Medical School	Pohl, P (corresponding author), Altenbergerstr 69, A-4040 Linz, Austria.	peter.pohl@jku.at	Pohl, Peter/A-5361-2008; Kügler, Philipp/B-4444-2015	Pohl, Peter/0000-0002-1792-2314; Kügler, Philipp/0000-0002-1041-9265	National Institutes of Health [DK43955, DK048217]; Austrian Science Fund [FWFW1201-N13]; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R37DK048217, R01DK048217, R01DK043955] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Austrian Science Fund(Austrian Science Fund (FWF)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	This work was supported, in whole or in part, by National Institutes of Health Grants DK43955 and DK048217 (to M.Z.L. and J.C.M.). This work was also supported by Austrian Science Fund FWFW1201-N13 (to P. P.). The costs of publication of this article were defrayed in part by the payment of page charges. This article must therefore be hereby marked "advertisement" in accordance with 18 U. S. C. Section 1734 solely to indicate this fact.	Antonenko YN, 1997, BIOPHYS J, V72, P2187, DOI 10.1016/S0006-3495(97)78862-3; ANTONENKO YN, 1993, BIOPHYS J, V64, P1701, DOI 10.1016/S0006-3495(93)81542-X; Antonenko YN, 1996, ARCH BIOCHEM BIOPHYS, V333, P225, DOI 10.1006/abbi.1996.0385; BARRY PH, 1984, PHYSIOL REV, V64, P763, DOI 10.1152/physrev.1984.64.3.763; Blank ME, 2003, J PHYSIOL-LONDON, V550, P419, DOI 10.1113/jphysiol.2003.040113; COIN JT, 1979, J BIOL CHEM, V254, P1178; Cooper GJ, 2002, J PHYSIOL-LONDON, V542, P17, DOI 10.1113/jphysiol.2002.023218; Cooper GJ, 1998, AM J PHYSIOL-CELL PH, V275, pC1481, DOI 10.1152/ajpcell.1998.275.6.C1481; Deen PMT, 1997, PFLUG ARCH EUR J PHY, V433, P780, DOI 10.1007/s004240050345; Deuflhard P., 2004, SPR S COMP, V35; DEVAUX PF, 1985, BIOCHIM BIOPHYS ACTA, V822, P63, DOI 10.1016/0304-4157(85)90004-8; Endeward V, 2006, FASEB J, V20, P1974, DOI 10.1096/fj.04-3300com; ENDEWARD V, 2007, FASEB J, V22, P1; ENGL HW, 2005, SERIES MATH IND, P3; FINKELSTEIN A, 1986, ANNU REV PHYSIOL, V48, P163, DOI 10.1146/annurev.ph.48.030186.001115; Forster RE, 1998, P NATL ACAD SCI USA, V95, P15815, DOI 10.1073/pnas.95.26.15815; GUTKNECHT J, 1977, J GEN PHYSIOL, V69, P779; GUTMAN M, 1995, BBA-BIOENERGETICS, V1231, P123, DOI 10.1016/0005-2728(95)00074-S; Hill WG, 2000, J BIOL CHEM, V275, P30176, DOI 10.1074/jbc.M003494200; Hub JS, 2006, BIOPHYS J, V91, P842, DOI 10.1529/biophysj.106.081406; Huster D, 1998, BIOCHEMISTRY-US, V37, P17299, DOI 10.1021/bi980078g; HUXLEY VH, 1981, J PHYSIOL-LONDON, V316, P75, DOI 10.1113/jphysiol.1981.sp013773; Khademi S, 2004, SCIENCE, V305, P1587, DOI 10.1126/science.1101952; Krylov AV, 2001, J GEN PHYSIOL, V118, P333, DOI 10.1085/jgp.118.4.333; LANDE MB, 1995, J GEN PHYSIOL, V106, P67, DOI 10.1085/jgp.106.1.67; MUELLER P, 1963, J PHYS CHEM-US, V67, P534, DOI 10.1021/j100796a529; POHL P, 1993, BIOCHIM BIOPHYS ACTA, V1152, P155, DOI 10.1016/0005-2736(93)90242-R; Prasad GVR, 1998, J BIOL CHEM, V273, P33123, DOI 10.1074/jbc.273.50.33123; PRESTON GM, 1993, J BIOL CHEM, V268, P17; Saparov SM, 2007, J BIOL CHEM, V282, P5296, DOI 10.1074/jbc.M609343200; Saparov SM, 2006, BIOPHYS J, V90, pL86, DOI 10.1529/biophysj.106.084343; SIMON SA, 1980, BIOCHIM BIOPHYS ACTA, V596, P352, DOI 10.1016/0005-2736(80)90122-4; SMABY JM, 1994, BIOCHEMISTRY-US, V33, P9135, DOI 10.1021/bi00197a016; Soupene E, 2002, P NATL ACAD SCI USA, V99, P7769, DOI 10.1073/pnas.112225599; Uehlein N, 2003, NATURE, V425, P734, DOI 10.1038/nature02027; VANDEGRIFF KD, 1984, J BIOL CHEM, V259, P2609; WAISBREN SJ, 1994, NATURE, V368, P332, DOI 10.1038/368332a0; WALTER A, 1986, J MEMBRANE BIOL, V90, P207, DOI 10.1007/BF01870127; Wang Y, 2007, J STRUCT BIOL, V157, P534, DOI 10.1016/j.jsb.2006.11.008; Yang BX, 2000, J BIOL CHEM, V275, P2686, DOI 10.1074/jbc.275.4.2686	40	122	123	0	34	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	SEP 12	2008	283	37					25340	25347		10.1074/jbc.M800096200	http://dx.doi.org/10.1074/jbc.M800096200			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	345QZ	18617525	hybrid, Green Published			2022-12-27	WOS:000259012700028
J	Oosterveer, MH; Van Dijk, TH; Grefhorst, A; Bloks, VW; Havinga, R; Kuipers, F; Reijngoud, DJ				Oosterveer, Maaike H.; Van Dijk, Theo H.; Grefhorst, Aldo; Bloks, Vincent W.; Havinga, Rick; Kuipers, Folkert; Reijngoud, Dirk-Jan			Lxr alpha deficiency hampers the hepatic adaptive response to fasting in mice	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							NUCLEAR RECEPTOR LXR; DE-NOVO SYNTHESIS; X-RECEPTOR; LIVER; GLUCOSE; METABOLISM; ACTIVATION; GLYCOGEN; GENE; GLUCOSE-6-PHOSPHATE	Besides its well established role in control of cellular cholesterol homeostasis, the liver X receptor (LXR) has been implicated in the regulation of hepatic gluconeogenesis. We investigated the role of the major hepatic LXR isoform in hepatic glucose metabolism during the feeding-to-fasting transition in vivo. In addition, we explored hepatic glucose sensing by LXR during carbohydrate refeeding. Lxr alpha(-/-) mice and their wild-type littermates were subjected to a fasting-refeeding protocol and hepatic carbohydrate fluxes as well as whole body insulin sensitivity were determined in vivo by stable isotope procedures. Lxr alpha(-/-) mice showed an impaired response to fasting in terms of hepatic glycogen depletion and triglyceride accumulation. Hepatic glucose 6-phosphate turnover was reduced in 9-h fasted Lxr alpha(-/-) mice as compared with controls. Although hepatic gluconeogenic gene expression was increased in 9-h fasted Lxr alpha(-/-) mice compared with wild-type controls, the actual gluconeogenic flux was not affected by Lxr alpha deficiency. Hepatic and peripheral insulin sensitivity were similar in Lxr alpha(-/-) and wildtype mice. Compared with wild-type controls, the induction of hepatic lipogenic gene expression was blunted in carbohydrate-refed Lxr alpha(-/-) mice, which was associated with lower plasma triglyceride concentrations. Yet, expression of "classic" LXR target genes Abca1, Abcg5, and Abcg8 was not affected by Lxr alpha deficiency in carbohydrate-refed mice. In summary, these studies identify LXR alpha as a physiologically relevant mediator of the hepatic response to fasting. However, the data do not support a role for LXR in hepatic glucose sensing.	[Oosterveer, Maaike H.; Van Dijk, Theo H.; Grefhorst, Aldo; Bloks, Vincent W.; Havinga, Rick; Kuipers, Folkert; Reijngoud, Dirk-Jan] Univ Groningen, Univ Med Ctr Groningen, Dept Pediat, Ctr Liver Digest & Metab Dis, NL-9700 RB Groningen, Netherlands; [Van Dijk, Theo H.; Reijngoud, Dirk-Jan] Univ Groningen, Univ Med Ctr Groningen, Dept Lab Med, Ctr Liver Digest & Metab Dis, NL-9700 RB Groningen, Netherlands	University of Groningen; University of Groningen	Oosterveer, MH (corresponding author), Univ Groningen, Univ Med Ctr Groningen, Dept Pediat, Ctr Liver Digest & Metab Dis, POB 30-001, NL-9700 RB Groningen, Netherlands.	M.H.Oosterveer@med.umcg.nl	Bloks, Vincent/A-7609-2012; oosterveer, maaike h/C-3374-2013	Bloks, Vincent/0000-0001-6493-7482; Reijngoud, Dirk-Jan/0000-0003-1157-4491; Kuipers, Folkert/0000-0003-2518-737X	Dutch Diabetes Foundation [2002.00.041]	Dutch Diabetes Foundation	This work was supported by the Dutch Diabetes Foundation (Grant 2002.00.041). The costs of publication of this article were defrayed in part by the payment of page charges. This article must therefore be hereby marked "advertisement" in accordance with 18 U. S. C. Section 1734 solely to indicate this fact.	Bandsma RHJ, 2004, DIABETOLOGIA, V47, P2022, DOI 10.1007/s00125-004-1571-8; Bandsma RHJ, 2004, J BIOL CHEM, V279, P8930, DOI 10.1074/jbc.M310067200; BLIGH EG, 1959, CAN J BIOCHEM PHYS, V37, P911; Burgess SC, 2006, J BIOL CHEM, V281, P19000, DOI 10.1074/jbc.M600050200; Cao GQ, 2003, J BIOL CHEM, V278, P1131, DOI 10.1074/jbc.M210208200; Cha JY, 2007, J BIOL CHEM, V282, P743, DOI 10.1074/jbc.M605023200; Commerford SR, 2007, MOL ENDOCRINOL, V21, P3002, DOI 10.1210/me.2007-0156; Denechaud PD, 2008, FEBS LETT, V582, P68, DOI 10.1016/j.febslet.2007.07.084; Denechaud PD, 2008, J CLIN INVEST, V118, P956, DOI 10.1172/JCI34314; Derks TGJ, 2008, HEPATOLOGY, V47, P1032, DOI 10.1002/hep.22101; Greenberg CC, 2006, AM J PHYSIOL-ENDOC M, V291, pE1, DOI 10.1152/ajpendo.00652.2005; Grefhorst A, 2005, AM J PHYSIOL-ENDOC M, V289, pE829, DOI 10.1152/ajpendo.00165.2005; Grefhorst A, 2002, J BIOL CHEM, V277, P34182, DOI 10.1074/jbc.M204887200; Grempler R, 2005, BIOCHEM BIOPH RES CO, V338, P981, DOI 10.1016/j.bbrc.2005.10.030; Hellerstein MK, 1997, J CLIN INVEST, V100, P1305, DOI 10.1172/JCI119644; HOHORST HJ, 1970, METHODEN ENZYMATISCH, P1200; Jungermann K, 1996, ANNU REV NUTR, V16, P179, DOI 10.1146/annurev.nu.16.070196.001143; KEPPLER D, 1970, METHODEN ENZYMATISCH, V2, P1089; KUIPERS F, 1985, GASTROENTEROLOGY, V88, P403, DOI 10.1016/0016-5085(85)90499-8; Laffitte BA, 2003, P NATL ACAD SCI USA, V100, P5419, DOI 10.1073/pnas.0830671100; Lazar MA, 2007, CELL METAB, V5, P159, DOI 10.1016/j.cmet.2007.02.001; LEE WNP, 1991, BIOL MASS SPECTROM, V20, P451, DOI 10.1002/bms.1200200804; Lehmann JM, 1997, J BIOL CHEM, V272, P3137, DOI 10.1074/jbc.272.6.3137; Mitro N, 2007, NATURE, V445, P219, DOI 10.1038/nature05449; Repa JJ, 2000, GENE DEV, V14, P2819, DOI 10.1101/gad.844900; Schultz JR, 2000, GENE DEV, V14, P2831, DOI 10.1101/gad.850400; TEBOUL M, 1995, P NATL ACAD SCI USA, V92, P2096, DOI 10.1073/pnas.92.6.2096; van der Veen JN, 2007, J LIPID RES, V48, P337, DOI 10.1194/jlr.M600170-JLR200; van Dijk TH, 2003, ANAL BIOCHEM, V322, P1, DOI 10.1016/j.ab.2003.07.008; van Ginneken V, 2007, BBA-MOL CELL BIOL L, V1771, P1263, DOI 10.1016/j.bbalip.2007.07.007; WILLY PJ, 1995, GENE DEV, V9, P1033, DOI 10.1101/gad.9.9.1033; Xu J, 2002, J BIOL CHEM, V277, P50237, DOI 10.1074/jbc.M201208200; Yoshikawa T, 2001, MOL CELL BIOL, V21, P2991, DOI 10.1128/MCB.21.9.2991-3000.2001; YOUN JH, 1990, AM J PHYSIOL, V258, pE899, DOI 10.1152/ajpendo.1990.258.6.E899	34	28	29	0	2	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	SEP 12	2008	283	37					25437	25445		10.1074/jbc.M801922200	http://dx.doi.org/10.1074/jbc.M801922200			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	345QZ	18611859	hybrid, Green Published			2022-12-27	WOS:000259012700039
J	Pacquelet, S; Lehmann, M; Luxen, S; Regazzoni, K; Frausto, M; Noack, D; Knaus, UG				Pacquelet, Sandrine; Lehmann, Mandy; Luxen, Sylvia; Regazzoni, Karine; Frausto, Monika; Noack, Deborah; Knaus, Ulla G.			Inhibitory action of NoxA1 on dual oxidase activity in airway cells	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							NADPH OXIDASE; EPITHELIAL-CELLS; HYDROGEN-PEROXIDE; SUPEROXIDE-PRODUCTION; ACTIVATION DOMAIN; HOST-DEFENSE; P67(PHOX); BINDING; GENE; DIFFERENTIATION	Imbalance between pro-and antioxidant mechanisms in the lungs can compromise pulmonary functions, including blood oxygenation, host defense, and maintenance of an anti-inflammatory environment. Thus, tight regulatory control of reactive oxygen species is critical for proper lung function. Increasing evidence supports a role for the NADPH oxidase dual oxidase (Duox) as an important source for regulated H2O2 production in the respiratory tract epithelium. In this study Duox expression, function, and regulation were investigated in a fully differentiated, mucociliary airway epithelium model. Duox-mediated H2O2 generation was dependent on calcium flux, which was required for dissociation of the NADPH oxidase regulatory protein Noxa1 from plasma membrane-bound Duox. A functional Duox1-based oxidase was reconstituted in model cell lines to permit mutational analysis of Noxa1 and Duox1. Although the activation domain of Noxa1 was not required for Duox function, mutation of a proline-rich domain in the Duox C terminus, a potential interaction motif for the Noxa1 Src homology domain 3, caused up-regulation of basal and stimulated H2O2 production. Similarly, knockdown of Noxa1 in airway cells increased basal H2O2 generation. Our data indicate a novel, inhibitory function for Noxa1 in Duox regulation. This represents a new paradigm for control of NADPH oxidase activity, where second messenger-promoted conformational change of the Nox structure promotes oxidase activation by relieving constraint induced by regulatory components.	[Pacquelet, Sandrine; Lehmann, Mandy; Luxen, Sylvia; Regazzoni, Karine; Frausto, Monika; Noack, Deborah; Knaus, Ulla G.] Scripps Res Inst, Dept Immunol & Microbiol Sci, La Jolla, CA 92037 USA	Scripps Research Institute	Knaus, UG (corresponding author), 10550 N Torrey Pines Rd, La Jolla, CA 92037 USA.	uknaus@scripps.edu		Pacquelet-Cheli, Sandrine/0000-0003-4958-2614	National Institutes of Health [AI024838, CI000095]; NATIONAL CENTER FOR INFECTIOUS DISEASES (NCID) [P01CI000095] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI024838] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CENTER FOR INFECTIOUS DISEASES (NCID)(United States Department of Health & Human ServicesCenters for Disease Control & Prevention - USA); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This work was supported, in whole or in part, by National Institutes of Health Grants AI024838 and CI000095 (to U. G. K.). The costs of publication of this article were defrayed in part by the payment of page charges. This article must therefore be hereby marked "advertisement" in accordance with 18 U. S. C. Section 1734 solely to indicate this fact.	Ameziane-El-Hassani R, 2005, J BIOL CHEM, V280, P30046, DOI 10.1074/jbc.M500516200; Babior B M, 1995, Curr Opin Hematol, V2, P55; Babior BM, 1999, BLOOD, V93, P1464, DOI 10.1182/blood.V93.5.1464.405a32_1464_1476; Banfi B, 2004, J BIOL CHEM, V279, P18583, DOI 10.1074/jbc.M310268200; Banfi B, 2003, J BIOL CHEM, V278, P3510, DOI 10.1074/jbc.C200613200; BURDON RH, 1995, FREE RADICAL BIO MED, V18, P775, DOI 10.1016/0891-5849(94)00198-S; Cheng GJ, 2004, J BIOL CHEM, V279, P4737, DOI 10.1074/jbc.M305968200; Cheng G, 2006, J BIOL CHEM, V281, P17718, DOI 10.1074/jbc.M512751200; CROSS AR, 1991, BIOCHIM BIOPHYS ACTA, V1057, P281, DOI 10.1016/S0005-2728(05)80140-9; DE D, 2002, EXP CELL RES, V273, P187; De Deken X, 2000, J BIOL CHEM, V275, P23227, DOI 10.1074/jbc.M000916200; DINAUER MC, 1990, J CLIN INVEST, V86, P1729, DOI 10.1172/JCI114898; DUPUY C, 1992, BIOCHEM J, V283, P591, DOI 10.1042/bj2830591; Dupuy C, 1999, J BIOL CHEM, V274, P37265, DOI 10.1074/jbc.274.52.37265; El Hassani RA, 2005, AM J PHYSIOL-GASTR L, V288, pG933, DOI 10.1152/ajpgi.00198.2004; Finkel T, 1999, J LEUKOCYTE BIOL, V65, P337, DOI 10.1002/jlb.65.3.337; Foreman J, 2003, NATURE, V422, P442, DOI 10.1038/nature01485; Forteza R, 2005, AM J RESP CELL MOL, V32, P462, DOI 10.1165/rcmb.2004-0302OC; Fuchs S, 2003, CELL TISSUE RES, V311, P31, DOI 10.1007/s00441-002-0653-5; Geiszt M, 2003, J BIOL CHEM, V278, P20006, DOI 10.1074/jbc.M301289200; Geiszt M, 2003, FASEB J, V17, P1502, DOI 10.1096/fj.02-1104fje; Grasberger H, 2006, J BIOL CHEM, V281, P18269, DOI 10.1074/jbc.C600095200; Gray TE, 1996, AM J RESP CELL MOL, V14, P104, DOI 10.1165/ajrcmb.14.1.8534481; Han CH, 1998, J BIOL CHEM, V273, P16663, DOI 10.1074/jbc.273.27.16663; Kim JS, 2007, J BIOL CHEM, V282, P34787, DOI 10.1074/jbc.M704754200; Kwak JM, 2003, EMBO J, V22, P2623, DOI 10.1093/emboj/cdg277; MacNee W, 2001, EUR J PHARMACOL, V429, P195, DOI 10.1016/S0014-2999(01)01320-6; Martyn KD, 2006, CELL SIGNAL, V18, P69, DOI 10.1016/j.cellsig.2005.03.023; Meng QR, 2006, INHAL TOXICOL, V18, P555, DOI 10.1080/08958370600686226; Moreno JC, 2002, NEW ENGL J MED, V347, P95, DOI 10.1056/NEJMoa012752; Moskwa P, 2007, AM J RESP CRIT CARE, V175, P174, DOI 10.1164/rccm.200607-1029OC; Nisimoto Y, 1999, J BIOL CHEM, V274, P22999, DOI 10.1074/jbc.274.33.22999; Pantano C, 2007, AM J RESP CELL MOL, V36, P473, DOI 10.1165/rcmb.2006-0109OC; Paquette JS, 2003, IN VITRO CELL DEV-AN, V39, P213; Takeya R, 2003, J BIOL CHEM, V278, P25234, DOI 10.1074/jbc.M212856200; Ueno N, 2005, J BIOL CHEM, V280, P23328, DOI 10.1074/jbc.M414548200; Ueyama T, 2006, MOL CELL BIOL, V26, P2160, DOI 10.1128/MCB.26.6.2160-2174.2006; Valente AJ, 2007, FREE RADICAL BIO MED, V43, P384, DOI 10.1016/j.freeradbiomed.2007.04.022; Vigone Maria Cristina, 2005, Hum Mutat, V26, P395; Ward C, 2005, EUR J IMMUNOL, V35, P2728, DOI 10.1002/eji.200425561; Yu LX, 1998, P NATL ACAD SCI USA, V95, P7993, DOI 10.1073/pnas.95.14.7993; Zhang XC, 2006, J CLIN INVEST, V116, P3050, DOI 10.1172/JCI28139	42	34	34	0	0	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	SEP 5	2008	283	36					24649	24658		10.1074/jbc.M709108200	http://dx.doi.org/10.1074/jbc.M709108200			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	342YR	18606821	hybrid, Green Published			2022-12-27	WOS:000258820000036
J	Andreev, YA; Kozlov, SA; Koshelev, SG; Ivanova, EA; Monastyrnaya, MM; Kozlovskaya, EP; Grishin, EV				Andreev, Yaroslav A.; Kozlov, Sergey A.; Koshelev, Sergey G.; Ivanova, Ekaterina A.; Monastyrnaya, Margarita M.; Kozlovskaya, Emma P.; Grishin, Eugene V.			Analgesic compound from sea anemone Heteractis crispa is the first polypeptide inhibitor of vanilloid receptor 1 (TRPV1)	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							AMINO-ACID-SEQUENCE; PANCREATIC TRYPSIN-INHIBITOR; CAPSAICIN RECEPTOR; VANILLOID RECEPTOR; RADIANTHUS-MACRODACTYLUS; STICHODACTYLA-HELIANTHUS; PROTEINASE-INHIBITOR; SODIUM-CHANNEL; HIGH-AFFINITY; PAIN PATHWAY	Venomous animals from distinct phyla such as spiders, scorpions, snakes, cone snails, or sea anemones produce small toxic proteins interacting with a variety of cell targets. Their bites often cause pain. One of the ways of pain generation is the activation of TRPV1 channels. Screening of 30 different venoms from spiders and sea anemones for modulation of TRPV1 activity revealed inhibitors in tropical sea anemone Heteractis crispa venom. Several separation steps resulted in isolation of an inhibiting compound. This is a 56-residue-long polypeptide named APHC1 that has a Bos taurus trypsin inhibitor (BPTI)/Kunitztype fold, mostly represented by serine protease inhibitors and ion channel blockers. APHC1 acted as a partial antagonist of capsaicin-induced currents (32 +/- 9% inhibition) with half-maximal effective concentration (EC50) 54 +/- 4 nM. In vivo, a 0.1 mg/kg dose of APHC1 significantly prolonged tail-flick latency and reduced capsaicin-induced acute pain. Therefore, our results can make an important contribution to the research into molecular mechanisms of TRPV1 modulation and help to solve the problem of overactivity of this receptor during a number of pathological processes in the organism.	[Andreev, Yaroslav A.; Kozlov, Sergey A.; Koshelev, Sergey G.; Ivanova, Ekaterina A.; Grishin, Eugene V.] Russian Acad Sci, Shemyakin Ovchinnikov Inst Bioorgan Chem, Moscow 117997, Russia; [Monastyrnaya, Margarita M.; Kozlovskaya, Emma P.] Russian Acad Sci, Pacific Inst Bioorgan Chem, Far Eastern Branch, Vladivostok 690022, Russia	Russian Academy of Sciences; Pushchino Scientific Center for Biological Research (PSCBI) of the Russian Academy of Sciences; Institute of Bioorganic Chemistry of the Russian Academy of Sciences; Elyakov Pacific Institute of Bioorganic Chemistry; Russian Academy of Sciences	Andreev, YA (corresponding author), Russian Acad Sci, Shemyakin Ovchinnikov Inst Bioorgan Chem, Ul Miklukho Maklaya 16-10, Moscow 117997, Russia.	ay@land.ru	Kozlov, Sergey A/D-1548-2012; Andreev, Yaroslav A/C-6627-2012; Kozlovskaya, Emma/G-3618-2017	Kozlov, Sergey A/0000-0002-0242-4240; Andreev, Yaroslav/0000-0002-7628-0980	Russian Federation Federal Agency for Science and Innovations [02.467.11.3003 of 20.04.2005]; Russian Foundation for Basic Research; Cellular and Molecular Biology program of Russian Academy of Science; Zoological Institute of the Russian Academy of Sciences, Sankt-Peterburg; Pacific Institute of Bioorganic Chemistry, Far East Branch of the Russian Academy of Sciences, Vladivostok; Shemyakin-Ovchinnikov Institute of Bioorganic Chemistry, Russian Academy of Sciences	Russian Federation Federal Agency for Science and Innovations(Federal Agency for Science & Innovations (FASI)); Russian Foundation for Basic Research(Russian Foundation for Basic Research (RFBR)); Cellular and Molecular Biology program of Russian Academy of Science(Russian Academy of Sciences); Zoological Institute of the Russian Academy of Sciences, Sankt-Peterburg(Russian Academy of Sciences); Pacific Institute of Bioorganic Chemistry, Far East Branch of the Russian Academy of Sciences, Vladivostok(Russian Academy of Sciences); Shemyakin-Ovchinnikov Institute of Bioorganic Chemistry, Russian Academy of Sciences(Russian Academy of Sciences)	This work was supported by the Russian Federation Federal Agency for Science and Innovations (the State Contract 02.467.11.3003 of 20.04.2005), the Russian Foundation for Basic Research, and the Cellular and Molecular Biology program of Russian Academy of Science. The costs of publication of this article were defrayed in part by the payment of page charges. This article must therefore be hereby marked "advertisement" in accordance with 18 U.S.C. Section 1734 solely to indicate this fact.; We gratefully acknowledge the scientific support of S. D. Grebelny (Zoological Institute of the Russian Academy of Sciences, Sankt-Peterburg); E. I. Vozhova, E. V. Leychenko, and I. N. Lie (Pacific Institute of Bioorganic Chemistry, Far East Branch of the Russian Academy of Sciences, Vladivostok), and T. A. Egorov, and A. Kh. Musolyamov (Shemyakin-Ovchinnikov Institute of Bioorganic Chemistry, Russian Academy of Sciences) for technical assistance.	Ahern GP, 2006, J BIOL CHEM, V281, P8991, DOI 10.1074/jbc.M513429200; Anderluh G, 2002, TOXICON, V40, P111, DOI 10.1016/S0041-0101(01)00191-X; ANEIROS A, 1993, BIOCHIM BIOPHYS ACTA, V1157, P86, DOI 10.1016/0304-4165(93)90082-J; ANTUCH W, 1993, EUR J BIOCHEM, V212, P675, DOI 10.1111/j.1432-1033.1993.tb17705.x; Beress L, 2004, J TOXICOL-TOXIN REV, V23, P451, DOI 10.1081/TXR-200038380; Carlton SM, 2001, NEUROSCI LETT, V310, P53, DOI 10.1016/S0304-3940(01)02093-6; CASTANEDA O, 1995, TOXICON, V33, P605; Caterina MJ, 2001, ANNU REV NEUROSCI, V24, P487, DOI 10.1146/annurev.neuro.24.1.487; Caterina MJ, 2000, SCIENCE, V288, P306, DOI 10.1126/science.288.5464.306; Caterina MJ, 1997, NATURE, V389, P816, DOI 10.1038/39807; CREIGHTON TE, 1987, J MOL BIOL, V194, P11, DOI 10.1016/0022-2836(87)90711-X; Cuypers E, 2006, FEBS LETT, V580, P5728, DOI 10.1016/j.febslet.2006.09.030; Davis JB, 2000, NATURE, V405, P183, DOI 10.1038/35012076; Delfin J, 1996, TOXICON, V34, P1367, DOI 10.1016/S0041-0101(96)00114-6; Diochot S, 1998, J BIOL CHEM, V273, P6744, DOI 10.1074/jbc.273.12.6744; Diochot S, 2004, EMBO J, V23, P1516, DOI 10.1038/sj.emboj.7600177; DIXON M, 1953, BIOCHEM J, V55, P170, DOI 10.1042/bj0550170; FRITZ H, 1972, H-S Z PHYSIOL CHEM, V353, P19, DOI 10.1515/bchm2.1972.353.1.19; Garcia-Martinez C, 2002, P NATL ACAD SCI USA, V99, P2374, DOI 10.1073/pnas.022285899; Garcia-Martinez C, 2006, J PAIN, V7, P735, DOI 10.1016/j.jpain.2006.03.008; Gasparini S, 1998, J BIOL CHEM, V273, P25393, DOI 10.1074/jbc.273.39.25393; Grotendorst GR, 1999, TOXICON, V37, P1779, DOI 10.1016/S0041-0101(99)00120-8; Guo A, 1999, EUR J NEUROSCI, V11, P946, DOI 10.1046/j.1460-9568.1999.00503.x; JOUBERT FJ, 1980, H-S Z PHYSIOL CHEM, V361, P661, DOI 10.1515/bchm2.1980.361.1.661; KAWAI N, 1993, NATURAL SYNTHETIC NE, P319; Kitaguchi T, 2005, BIOCHEMISTRY-US, V44, P15544, DOI 10.1021/bi051494l; Klionsky L, 2006, J PHARMACOL EXP THER, V319, P192, DOI 10.1124/jpet.106.108092; Krause James E, 2005, Curr Opin Investig Drugs, V6, P48; Matz M, 1999, NUCLEIC ACIDS RES, V27, P1558, DOI 10.1093/nar/27.6.1558; MILJANICH GP, 1997, SCI MED, V4, P6; Mortari MR, 2007, PHARMACOL THERAPEUT, V114, P171, DOI 10.1016/j.pharmthera.2007.01.009; NORTON RS, 1991, TOXICON, V29, P1051, DOI 10.1016/0041-0101(91)90205-6; Olivera BM, 2006, J BIOL CHEM, V281, P31173, DOI 10.1074/jbc.R600020200; PERONA JJ, 1995, PROTEIN SCI, V4, P337; Planells-Cases R, 2000, FEBS LETT, V481, P131, DOI 10.1016/S0014-5793(00)01982-7; Scheidig AJ, 1997, PROTEIN SCI, V6, P1806, DOI 10.1002/pro.5560060902; SCHWEITZ H, 1994, P NATL ACAD SCI USA, V91, P878, DOI 10.1073/pnas.91.3.878; SCHWEITZ H, 1995, J BIOL CHEM, V270, P25121, DOI 10.1074/jbc.270.42.25121; Siemens J, 2006, NATURE, V444, P208, DOI 10.1038/nature05285; Smith LA, 1997, BIOCHEMISTRY-US, V36, P7690, DOI 10.1021/bi963105g; Standker L, 2006, TOXICON, V48, P211, DOI 10.1016/j.toxicon.2006.05.001; STRYDOM DJ, 1977, BIOCHIM BIOPHYS ACTA, V491, P361, DOI 10.1016/0005-2795(77)90279-3; Suput D, 2001, TOXICON, V39, P1421, DOI 10.1016/S0041-0101(01)00102-7; Szallasi A, 2002, LANCET NEUROL, V1, P167, DOI 10.1016/S1474-4422(02)00072-8; Szallasi A, 2007, NAT REV DRUG DISCOV, V6, P357, DOI 10.1038/nrd2280; Tang L, 2007, J PHARMACOL EXP THER, V321, P791, DOI 10.1124/jpet.106.117572; Valtschanoff JG, 2001, J COMP NEUROL, V436, P225, DOI 10.1002/cne.1063; Wang YW, 2000, BBA-PROTEIN STRUCT M, V1478, P9, DOI 10.1016/S0167-4838(99)00289-7; Watters MR, 2005, SEMIN NEUROL, V25, P278, DOI 10.1055/s-2005-917664; ZYKOVA TA, 1985, BIOORG KHIM+, V11, P293; ZYKOVA TA, 1985, BIOORG KHIM+, V11, P302	51	118	130	0	6	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	AUG 29	2008	283	35					23914	23921		10.1074/jbc.M800776200	http://dx.doi.org/10.1074/jbc.M800776200			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	340II	18579526	hybrid, Green Published			2022-12-27	WOS:000258638900046
J	Ram, N; Aroui, S; Jaumain, E; Bichraoui, H; Mabrouk, K; Ronjat, M; Lortat-Jacob, H; De Waard, M				Ram, Narendra; Aroui, Sonia; Jaumain, Emilie; Bichraoui, Hicham; Mabrouk, Kamel; Ronjat, Michel; Lortat-Jacob, Hugues; De Waard, Michel			Direct peptide interaction with surface glycosaminoglycans contributes to the cell penetration of maurocalcine	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							AMINO-ACID-RESIDUES; ANTENNAPEDIA HOMEODOMAIN; 3RD HELIX; INTERNALIZATION; BINDING; MECHANISM; MEMBRANE; DOMAIN; ENTRY	Maurocalcine (MCa), initially identified from a tunisian scorpion venom, defines a new member of the family of cell penetrating peptides by its ability to efficiently cross the plasma membrane. The initiating mechanistic step required for the cell translocation of a cell penetrating peptide implicates its binding onto cell surface components such as membrane lipids and/or heparan sulfate proteoglycans. Here we characterized the interaction of wild-type MCa and MCa K20A, a mutant analogue with reduced cell-penetration efficiency, with heparin (HP) and heparan sulfates (HS) through surface plasma resonance. HP and HS bind both to MCa, indicating that heparan sulfate proteoglycans may represent an important entry route of the peptide. This is confirmed by the fact that (i) both compounds bind with reduced affinity to MCa K20A and (ii) the cell penetration of wild-type or mutant MCa coupled to fluorescent streptavidin is reduced by about 50% in mutant Chinese hamster ovary cell lines lacking either all glycosaminoglycans (GAGs) or just HS. Incubating MCa with soluble HS, HP, or chondroitin sulfates also inhibits the cell penetration of MCa-streptavidin complexes. Analyses of the cell distributions of MCa/streptavidin in several Chinese hamster ovary cell lines show that the distribution of the complex coincides with the endosomal marker Lyso-Tracker red and is not affected by the absence of GAGs. The distribution of MCa/streptavidin is not coincident with that of transferrin receptors nor affected by a dominant-negative dynamin 2 K44A mutant, an inhibitor of clathrin-mediated endocytosis. However, entry of the complex is greatly diminished by amiloride, indicating the importance of macropinocytosis in MCa/streptavidin entry. It is concluded that (i) interaction of MCa with GAGs quantitatively improves the cell penetration of MCa, and (ii) GAG-dependent and - independent MCa penetration rely similarly on the macropinocytosis pathway.	[Ram, Narendra; Aroui, Sonia; Jaumain, Emilie; Bichraoui, Hicham; Ronjat, Michel; De Waard, Michel] Univ Grenoble 1, Funct & Pathol Lab, Res Grp 3, INSERM,Grenoble Inst Neurosci,U836, F-38042 Grenoble 9, France; [Mabrouk, Kamel] Univ Aix Marseille 1, CNRS, UMR 6517, F-13397 Marseille 20, France; [Mabrouk, Kamel] Univ Aix Marseille 2, CNRS, UMR 6517, F-13397 Marseille 20, France; [Mabrouk, Kamel] Univ Aix Marseille 3, CNRS, UMR 6517, F-13397 Marseille 20, France; [Lortat-Jacob, Hugues] Univ Grenoble 1, Inst Biol Struct, UMR 5075, CEA,CNRS, F-38027 Grenoble 1, France	Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Communaute Universite Grenoble Alpes; Universite Grenoble Alpes (UGA); Centre National de la Recherche Scientifique (CNRS); UDICE-French Research Universities; Aix-Marseille Universite; Centre National de la Recherche Scientifique (CNRS); UDICE-French Research Universities; Aix-Marseille Universite; Centre National de la Recherche Scientifique (CNRS); UDICE-French Research Universities; Aix-Marseille Universite; Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Biology (INSB); UDICE-French Research Universities; Communaute Universite Grenoble Alpes; Universite Grenoble Alpes (UGA); CEA	De Waard, M (corresponding author), Univ Grenoble 1, Funct & Pathol Lab, Res Grp 3, INSERM,Grenoble Inst Neurosci,U836, F-38042 Grenoble 9, France.	michel.dewaard@ujf-grenoble.fr	De Waard, Michel/G-7406-2014	De Waard, Michel/0000-0002-2782-9615; Ronjat, Michel/0000-0002-9728-6425	INSERM; Universite Joseph Fourier; Commissariat a l'Energie Atomique (Saclay, France); Commissariat a l'Energie Atomique (Saclay, France	INSERM(Institut National de la Sante et de la Recherche Medicale (Inserm)European Commission); Universite Joseph Fourier; Commissariat a l'Energie Atomique (Saclay, France)(French Atomic Energy Commission); Commissariat a l'Energie Atomique (Saclay, France(French Atomic Energy Commission)	This work was supported by INSERM, Universite Joseph Fourier, and Commissariat a l'Energie Atomique (Saclay, France). The costs of publication of this article were defrayed in part by the payment of page charges. This article must therefore be hereby marked "advertisement" in accordance with 18 U. S. C. Section 1734 solely to indicate this fact.	Berlose JP, 1996, EUR J BIOCHEM, V242, P372, DOI 10.1111/j.1432-1033.1996.0372r.x; Boisseau S, 2006, BBA-BIOMEMBRANES, V1758, P308, DOI 10.1016/j.bbamem.2006.02.007; Chen L, 2003, J BIOL CHEM, V278, P16095, DOI 10.1074/jbc.M209501200; Conner SD, 2003, NATURE, V422, P37, DOI 10.1038/nature01451; Derossi D, 1996, J BIOL CHEM, V271, P18188, DOI 10.1074/jbc.271.30.18188; Esteve E, 2005, J BIOL CHEM, V280, P12833, DOI 10.1074/jbc.M412521200; Esteve E, 2003, J BIOL CHEM, V278, P37822, DOI 10.1074/jbc.M305798200; Foerg C, 2005, BIOCHEMISTRY-US, V44, P72, DOI 10.1021/bi048330+; Kurten RC, 2003, ADV DRUG DELIVER REV, V55, P1405, DOI 10.1016/j.addr.2003.07.003; Laguri C, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0001110; Mabrouk K, 2007, BBA-BIOMEMBRANES, V1768, P2528, DOI 10.1016/j.bbamem.2007.06.030; Magzoub M, 2004, Q REV BIOPHYS, V37, P147, DOI 10.1017/S0033583505004014; Mano M, 2005, BIOCHEM J, V390, P603, DOI 10.1042/BJ20050577; Mosbah A, 2000, PROTEINS, V40, P436, DOI 10.1002/1097-0134(20000815)40:3&lt;436::AID-PROT90&gt;3.0.CO;2-9; Nakase I, 2007, BIOCHEMISTRY-US, V46, P492, DOI 10.1021/bi0612824; Nascimento FD, 2007, J BIOL CHEM, V282, P21349, DOI 10.1074/jbc.M604876200; Richard JP, 2003, J BIOL CHEM, V278, P585, DOI 10.1074/jbc.M209548200; Rinne J, 2007, BMC BIOTECHNOL, V7, DOI 10.1186/1472-6750-7-1; Sadir R, 2001, J BIOL CHEM, V276, P8288, DOI 10.1074/jbc.M008110200; Sandgren S, 2002, J BIOL CHEM, V277, P38877, DOI 10.1074/jbc.M205395200; Sarrazin S, 2005, J BIOL CHEM, V280, P37558, DOI 10.1074/jbc.M507729200; Sun TX, 2002, AM J PHYSIOL-RENAL, V282, pF998, DOI 10.1152/ajprenal.00257.2001; Suzuki T, 2002, J BIOL CHEM, V277, P2437, DOI 10.1074/jbc.M110017200; Terrone D, 2003, BIOCHEMISTRY-US, V42, P13787, DOI 10.1021/bi035293y; Vives E, 1997, J BIOL CHEM, V272, P16010, DOI 10.1074/jbc.272.25.16010; Vives E, 2003, CURR PROTEIN PEPT SC, V4, P125, DOI 10.2174/1389203033487306; Vives RR, 2005, J BIOL CHEM, V280, P21353, DOI 10.1074/jbc.M500911200; Vives RR, 2002, BIOCHEMISTRY-US, V41, P14779, DOI 10.1021/bi026459i; Wadia JS, 2004, NAT MED, V10, P310, DOI 10.1038/nm996	29	38	40	0	4	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	AUG 29	2008	283	35					24274	24284		10.1074/jbc.M709971200	http://dx.doi.org/10.1074/jbc.M709971200			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	340II	18603532	Green Submitted, hybrid, Green Published, Green Accepted			2022-12-27	WOS:000258638900081
J	Kiely, PA; Baillie, GS; Lynch, MJ; Houslay, MD; O'Connor, R				Kiely, Patrick A.; Baillie, George S.; Lynch, Martin J.; Houslay, Miles D.; O'Connor, Rosemary			Tyrosine 302 in RACK1 is essential for insulin-like growth factor-I-mediated competitive binding of PP2A and beta 1 integrin and for tumor cell proliferation and migration	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							PROTEIN PHOSPHATASE 2A; CAMP-SPECIFIC PHOSPHODIESTERASE; RECEPTOR-INTERACTING PROTEIN; SIGNALING SCAFFOLD PROTEINS; KINASE-C; MEMBRANE SUPPORTS; AKT ACTIVATION; PEPTIDE ARRAYS; SPOT SYNTHESIS; BETA-ARRESTIN	Insulin-like growth factor (IGF)-I regulates a mutually exclusive interaction of PP2A and beta 1 integrin with the WD repeat scaffolding protein RACK1. This interaction is required for the integration of IGF-I receptor (IGF-IR) and adhesion signaling. Here we investigated the nature of the binding site for PP2A and beta 1 integrin in RACK1. A WD7 deletion mutant of RACK1 did not associate with PP2A but retained some interaction with beta 1 integrin, whereas a WD6/WD7 mutant lost the ability to bind to both PP2A and beta 1 integrin. Using immobilized peptide arrays representing the entire RACK1 protein, we identified a common cluster of amino acids (FAGY) at positions 299-302 within WD7 of RACK1 which were essential for binding of both PP2A and beta 1 integrin to RACK1. PP2A showed a higher level of association with a peptide in which Tyr-302 was phosphorylated compared with an unphosphorylated peptide, whereas beta 1 integrin binding was not affected by phosphorylation. RACK1 mutants in which either the FAGY cluster or Tyr- 302 were mutated to AAAF, or Phe, respectively, did not interact with either PP2A or beta 1 integrin. These mutants were unable to rescue the decrease in PP2A activity caused by suppression of RACK1 in MCF-7 cells with small interfering RNA. MCF-7 cells and R+ (IGF-IR-overexpressing fibroblasts) expressing these mutants exhibited decreased proliferation and migration, whereas R-cells (IGF-IR null fibroblasts) were unaffected. Taken together, the data demonstrate that Tyr-302 in RACK1 is required for interaction with PP2A and beta 1 integrin, for regulation of PP2A activity, and for IGF-I-mediated cell migration and proliferation.	[Kiely, Patrick A.; O'Connor, Rosemary] Natl Univ Ireland Univ Coll Cork, BioSci Inst, Dept Biochem, Cell Biol Lab, Cork, Ireland; [Baillie, George S.; Lynch, Martin J.; Houslay, Miles D.] Univ Glasgow, Inst Biomed & Life Sci, Div Biochem & Mol Biol, Mol Pharmacol Grp, Glasgow G12 8QQ, Lanark, Scotland	University College Cork; University of Glasgow	O'Connor, R (corresponding author), Natl Univ Ireland Univ Coll Cork, BioSci Inst, Dept Biochem, Cell Biol Lab, Cork, Ireland.	r.oconnor@ucc.ie	Houslay, Miles/AAM-5281-2020; Houslay, Miles D/A-6825-2011; O'Connor, Rosemary/B-7902-2014	O'Connor, Rosemary/0000-0002-0687-3422; Houslay, Miles/0000-0002-3826-8091	Health Research Board of Ireland; Cancer Research Ireland; Science Foundation Ireland; Medical Research Council [G8604010, G0400053]; European Union [037189]; Foundation Leducq (Paris); MRC [G0400053, G8604010, G0600765] Funding Source: UKRI; Medical Research Council [G0600765] Funding Source: researchfish	Health Research Board of Ireland; Cancer Research Ireland; Science Foundation Ireland(Science Foundation IrelandEuropean Commission); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); European Union(European Commission); Foundation Leducq (Paris)(Leducq Foundation); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission)	This work is supported by the Health Research Board of Ireland, Cancer Research Ireland, and Science Foundation Ireland. Work in the laboratories of G. S. B. and M. D. H. Laboratory was supported by Medical Research Council Grants G8604010 and G0400053, the European Union Grant 037189, and the Foundation Leducq ( Paris).	Baillie GS, 2007, BIOCHEM J, V404, P71, DOI 10.1042/BJ20070005; Blakesley VA, 1998, J BIOL CHEM, V273, P18411, DOI 10.1074/jbc.273.29.18411; Blom N, 1999, J MOL BIOL, V294, P1351, DOI 10.1006/jmbi.1999.3310; Bolger GB, 2006, BIOCHEM J, V398, P23, DOI 10.1042/BJ20060423; Buensuceso CS, 2001, J CELL SCI, V114, P1691; Chang BY, 2002, ONCOGENE, V21, P7619, DOI 10.1038/sj.onc.1206002; Chang BY, 2001, J BIOL CHEM, V276, P20346, DOI 10.1074/jbc.M101375200; Chung HY, 1999, CELL SIGNAL, V11, P575, DOI 10.1016/S0898-6568(99)00033-9; Doan AT, 2007, EXP CELL RES, V313, P2667, DOI 10.1016/j.yexcr.2007.05.013; Frank R, 1996, Methods Mol Biol, V66, P149; Frank R, 2002, J IMMUNOL METHODS, V267, P13, DOI 10.1016/S0022-1759(02)00137-0; Hermanto U, 2002, MOL CELL BIOL, V22, P2345, DOI 10.1128/MCB.22.7.2345-2365.2002; Hongo A, 1996, ONCOGENE, V12, P1231; Kiely PA, 2005, J BIOL CHEM, V280, P7624, DOI 10.1074/jbc.M412889200; Kiely PA, 2002, J BIOL CHEM, V277, P22581, DOI 10.1074/jbc.M201758200; Kiely PA, 2006, MOL CELL BIOL, V26, P4041, DOI 10.1128/MCB.01868-05; Kramer A, 1998, METH MOL B, V87, P25; Leahy M, 2004, J BIOL CHEM, V279, P18306, DOI 10.1074/jbc.M309234200; Liliental J, 1998, J BIOL CHEM, V273, P2379, DOI 10.1074/jbc.273.4.2379; Liu YV, 2007, J BIOL CHEM, V282, P37064, DOI 10.1074/jbc.M705015200; McCahill A, 2002, MOL PHARMACOL, V62, P1261, DOI 10.1124/mol.62.6.1261; MOCHLYROSEN D, 1995, BIOCHEM SOC T, V23, P596, DOI 10.1042/bst0230596; Moreno CS, 2000, J BIOL CHEM, V275, P5257, DOI 10.1074/jbc.275.8.5257; Murdoch H, 2007, J NEUROSCI, V27, P9513, DOI 10.1523/JNEUROSCI.1493-07.2007; Nilsson J, 2004, EMBO REP, V5, P1137, DOI 10.1038/sj.embor.7400291; OConnor R, 1997, MOL CELL BIOL, V17, P427, DOI 10.1128/MCB.17.1.427; Rodriguez-Viciana P, 2006, P NATL ACAD SCI USA, V103, P19290, DOI 10.1073/pnas.0609343103; Ron D, 1999, J BIOL CHEM, V274, P27039, DOI 10.1074/jbc.274.38.27039; Sachs BD, 2007, J CELL BIOL, V177, P1119, DOI 10.1083/jcb.200701040; SELL C, 1994, MOL CELL BIOL, V14, P3604, DOI 10.1128/MCB.14.6.3604; Sieburth DS, 1999, GENE DEV, V13, P2562, DOI 10.1101/gad.13.19.2562; Sklan EH, 2006, PROG NEUROBIOL, V78, P117, DOI 10.1016/j.pneurobio.2005.12.002; Smith KJ, 2007, CELL SIGNAL, V19, P2612, DOI 10.1016/j.cellsig.2007.08.015; Strack S, 2002, J BIOL CHEM, V277, P20750, DOI 10.1074/jbc.M202992200; Ugi S, 2004, MOL CELL BIOL, V24, P8778, DOI 10.1128/MCB.24.19.8778-8789.2004; Ugi S, 2002, MOL CELL BIOL, V22, P2375, DOI 10.1128/MCB.22.7.2375-2387.2002; Vomastek T, 2007, MOL CELL BIOL, V27, P8296, DOI 10.1128/MCB.00598-07; Yarwood SJ, 1999, J BIOL CHEM, V274, P14909, DOI 10.1074/jbc.274.21.14909; Zhao WQ, 2003, NEUROBIOL DIS, V14, P458, DOI 10.1016/S0969-9961(03)00124-4	39	60	62	1	5	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	AUG 22	2008	283	34					22952	22961		10.1074/jbc.M800802200	http://dx.doi.org/10.1074/jbc.M800802200			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	337SI	18567578	hybrid			2022-12-27	WOS:000258455400008
J	Colomina, N; Ferrezuelo, F; Wang, HY; Aldea, M; Gari, E				Colomina, Neus; Ferrezuelo, Francisco; Wang, Hongyin; Aldea, Marti; Gari, Eloi			Whi3, a developmental regulator of budding yeast, binds a large set of mRNAs functionally related to the endoplasmic reticulum	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							CYCLIN CLN3; PROTEIN; GENE; IDENTIFICATION; LOCALIZATION; TRANSCRIPTION; COMPLEX; ER; COORDINATION; DEPRIVATION	Whi3 is an RNA-binding protein associated with the endoplasmic reticulum (ER) that binds the CLN3 mRNA and plays a key role in the efficient retention of cyclin Cln3 at the ER. In the present work, we have identified new Whi3-associated mRNAs by a genomic approach. A large and significant number of these Whi3 targets encode for membrane and exocytic proteins involved in processes such as transport and cell wall biogenesis. Consistent with the genomic data, we have observed that cell wall integrity is compromised in Whi3-deficient cells and found strong genetic interactions between WHI3 and the cell integrity pathway. Whi3-associated mRNAs are enriched in clusters of the tetranucleotide GCAU, and mutation of the GCAU clusters in the CLN3 mRNA caused a reduction in its association to Whi3, suggesting that these sequences may act as cis-determinants for binding. Our data suggest that Whi3 is involved in the regulation and/or localization of a large subset of mRNAs functionally related to the ER and, since it is important for different molecular processes such as cytoplasmic retention or exocytic traffic of proteins, we propose that Whi3 is a general modulator of protein fate in budding yeast.	[Colomina, Neus; Ferrezuelo, Francisco; Wang, Hongyin; Aldea, Marti; Gari, Eloi] Univ Lleida, Fac Med, Dept Ciencies Med Basiques, Inst Recerca Biomed Lleida, Lleida 25008, Catalunya, Spain	Institut de Recerca Biomedica - IRB Lleida; Universitat de Lleida	Gari, E (corresponding author), Univ Lleida, Fac Med, Dept Ciencies Med Basiques, Inst Recerca Biomed Lleida, Montserrat Roig 2, Lleida 25008, Catalunya, Spain.	eloi.gari@cmb.udl.cat	Aldea, Marti/K-3962-2014; Colomina Gabarrella, Neus/C-4449-2011; Colomina, Neus/ABF-7179-2021; Garí, Eloi/A-5996-2010; Aldea, Marti/A-9721-2010; Ferrezuelo, Francisco/E-7511-2010	Aldea, Marti/0000-0002-8710-5336; Colomina Gabarrella, Neus/0000-0002-1986-1199; Colomina, Neus/0000-0002-1986-1199; Garí, Eloi/0000-0002-3505-4901; Ferrezuelo, Francisco/0000-0001-9403-0355	Ministry of Education and Science of Spain; Fundacio La Caixa; European Union	Ministry of Education and Science of Spain(Spanish Government); Fundacio La Caixa(La Caixa FoundationEuropean Commission); European Union(European Commission)	This work was funded by grants from the Ministry of Education and Science of Spain (Consolider-Ingenio 2010), the Fundacio La Caixa, and the European Union (Fondos FEDER). The costs of publication of this article were defrayed in part by the payment of page charges. This article must therefore be hereby marked "advertisement" in accordance with 18 U. S. C. Section 1734 solely to indicate this fact.	Aronov S, 2007, MOL CELL BIOL, V27, P3441, DOI 10.1128/MCB.01643-06; AUSUBEL FM, 1999, SHORT PROTOCOLS MOL; Costanzo M, 2004, CELL, V117, P899, DOI 10.1016/j.cell.2004.05.024; de Bruin RAM, 2004, CELL, V117, P887, DOI 10.1016/j.cell.2004.05.025; de la Torre-Ruiz MA, 2002, J BIOL CHEM, V277, P33468, DOI 10.1074/jbc.M203515200; DERISI J, 2002, DNA MICROARRAYS MOL, P187; Diehn M, 2000, NAT GENET, V25, P58, DOI 10.1038/75603; Eisen MB, 1998, P NATL ACAD SCI USA, V95, P14863, DOI 10.1073/pnas.95.25.14863; Gallego C, 1997, EMBO J, V16, P7196, DOI 10.1093/emboj/16.23.7196; Gari E, 2001, GENE DEV, V15, P2803; Gerber AP, 2004, PLOS BIOL, V2, P342, DOI 10.1371/journal.pbio.0020079; Gerst JE, 2008, TRENDS CELL BIOL, V18, P68, DOI 10.1016/j.tcb.2007.11.005; GIETZ D, 1992, NUCLEIC ACIDS RES, V20, P1425, DOI 10.1093/nar/20.6.1425; Guthrie C, 1991, METHODS ENZYMOLOGY, V194; Hoppe T, 2000, CELL, V102, P577, DOI 10.1016/S0092-8674(00)00080-5; Issel-Tarver L, 2002, METHOD ENZYMOL, V350, P329, DOI 10.1016/S0076-6879(02)50972-1; JACKMAN M, 1995, EMBO J, V14, P1646, DOI 10.1002/j.1460-2075.1995.tb07153.x; Jambhekar A, 2007, RNA, V13, P625, DOI 10.1261/rna.262607; Jansen RP, 2001, NAT REV MOL CELL BIO, V2, P247, DOI 10.1038/35067016; Jin QW, 2003, EUKARYOT CELL, V2, P510, DOI 10.1128/EC.2.3.510-520.2003; Karagiannis J, 2002, GENETICS, V162, P45; Keene JD, 2007, NAT REV GENET, V8, P533, DOI 10.1038/nrg2111; Keene JD, 2002, MOL CELL, V9, P1161, DOI 10.1016/S1097-2765(02)00559-2; Kumar A, 2002, GENE DEV, V16, P707, DOI 10.1101/gad.970902; Lesage G, 2006, MICROBIOL MOL BIOL R, V70, P317, DOI 10.1128/MMBR.00038-05; Letunic I, 2006, NUCLEIC ACIDS RES, V34, pD257, DOI 10.1093/nar/gkj079; Maris C, 2005, FEBS J, V272, P2118, DOI 10.1111/j.1742-4658.2005.04653.x; Mewes HW, 2008, NUCLEIC ACIDS RES, V36, pD196, DOI 10.1093/nar/gkm980; Montaner D, 2006, NUCLEIC ACIDS RES, V34, pW486, DOI 10.1093/nar/gkl197; Moore MJ, 2005, SCIENCE, V309, P1514, DOI 10.1126/science.1111443; Mosch HU, 1997, GENETICS, V145, P671; Mutka SC, 2001, MOL BIOL CELL, V12, P577, DOI 10.1091/mbc.12.3.577; Nakajima H, 2008, J CELL BIOL, V181, P89, DOI 10.1083/jcb.200708176; Nash RS, 2001, GENETICS, V157, P1469; Nicchitta CV, 2005, BIOCHEM CELL BIOL, V83, P687, DOI 10.1139/O05-147; Philpott CC, 2008, EUKARYOT CELL, V7, P20, DOI 10.1128/EC.00354-07; Prinz S, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000249; Rigaut G, 1999, NAT BIOTECHNOL, V17, P1030, DOI 10.1038/13732; Robinson MD, 2002, BMC BIOINFORMATICS, V3, DOI 10.1186/1471-2105-3-35; Schmid M, 2006, CURR BIOL, V16, P1538, DOI 10.1016/j.cub.2006.06.025; Sengupta DJ, 1999, RNA, V5, P596, DOI 10.1017/S1355838299002113; SenGupta DJ, 1996, P NATL ACAD SCI USA, V93, P8496, DOI 10.1073/pnas.93.16.8496; Shepard KA, 2003, P NATL ACAD SCI USA, V100, P11429, DOI 10.1073/pnas.2033246100; Sopko R, 2006, MOL CELL, V21, P319, DOI 10.1016/j.molcel.2005.12.011; Spellman PT, 1998, MOL BIOL CELL, V9, P3273, DOI 10.1091/mbc.9.12.3273; St Johnston D, 2005, NAT REV MOL CELL BIO, V6, P363, DOI 10.1038/nrm1643; Takizawa PA, 2000, SCIENCE, V290, P341, DOI 10.1126/science.290.5490.341; Tenenbaum SA, 2000, P NATL ACAD SCI USA, V97, P14085, DOI 10.1073/pnas.97.26.14085; Tsang WY, 2007, J CELL BIOL, V178, P621, DOI 10.1083/jcb.200701166; Verges E, 2007, MOL CELL, V26, P649, DOI 10.1016/j.molcel.2007.04.023; WACH A, 1994, YEAST, V10, P1793, DOI 10.1002/yea.320101310; Wang HY, 2004, EMBO J, V23, P180, DOI 10.1038/sj.emboj.7600022; Zurita-Martinez SA, 2007, GENETICS, V176, P2139, DOI 10.1534/genetics.107.072835	53	32	33	0	8	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	OCT 17	2008	283	42					28670	28679		10.1074/jbc.M804604200	http://dx.doi.org/10.1074/jbc.M804604200			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	359EN	18667435	Green Published, hybrid			2022-12-27	WOS:000259969300069
J	Jirasko, V; Montserret, R; Appel, N; Janvier, A; Eustachi, L; Brohm, C; Steinmann, E; Pietschmann, T; Penin, F; Bartenschlager, R				Jirasko, Vlastimil; Montserret, Roland; Appel, Nicole; Janvier, Anne; Eustachi, Leah; Brohm, Christiane; Steinmann, Eike; Pietschmann, Thomas; Penin, Francois; Bartenschlager, Ralf			Structural and functional characterization of nonstructural protein 2 for its role in hepatitis C virus assembly	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							SECONDARY STRUCTURE; NS2 PROTEIN; P7; REPLICATION; EXPRESSION; PREDICTION; STABILITY; TOPOLOGY; IDENTIFICATION; DETERMINANT	The hepatitis C virus (HCV) is a flavivirus replicating in the cytoplasm of infected cells. The HCV genome is a single-stranded RNA encoding a polyprotein that is cleaved by cellular and viral proteases into 10 different products. While the structural proteins core protein, envelope protein 1 (E1) and E2 build up the virus particle, most nonstructural (NS) proteins are required for RNA replication. One of the least studied proteins is NS2, which is composed of a C-terminal cytosolic protease domain and a highly hydrophobic N-terminal domain. It is assumed that the latter is composed of three trans-membrane segments (TMS) that tightly attach NS2 to intracellular membranes. Taking advantage of a system to study HCV assembly in a hepatoma cell line, in this study we performed a detailed characterization of NS2 with respect to its role for virus particle assembly. In agreement with an earlier report (Jones, C. T., Murray, C. L., Eastman, D. K., Tassello, J., and Rice, C. M. (2007) J. Virol. 81, 8374-8383), we demonstrate that the protease domain, but not its enzymatic activity, is required for infectious virus production. We also show that serine residue 168 in NS2, implicated in the phosphorylation and stability of this protein, is dispensable for virion formation. In addition, we determined the NMR structure of the first TMS of NS2 and show that the N-terminal segment (amino acids 3-11) forms a putative flexible helical element connected to a stable alpha-helix (amino acids 12-21) that includes an absolutely conserved helix side in genotype 1b. By using this structure as well as the amino acid conservation as a guide for a functional study, we determined the contribution of individual amino acid residues in TMS1 for HCV assembly. We identified several residues that are critical for virion formation, most notably a central glycine residue at position 10 of TMS1. Finally, we demonstrate that mutations in NS2 blocking HCV assembly can be rescued by trans-complementation.	[Jirasko, Vlastimil; Appel, Nicole; Eustachi, Leah; Brohm, Christiane; Steinmann, Eike; Pietschmann, Thomas; Bartenschlager, Ralf] Heidelberg Univ, Dept Mol Virol, D-69120 Heidelberg, Germany; [Montserret, Roland; Janvier, Anne; Penin, Francois] Univ Lyon, CNRS, UMR 5086, Inst Biol & Chim Prot,BioSci Gerland Lyon Sud IFR, F-69367 Lyon 07, France	Ruprecht Karls University Heidelberg; Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Biology (INSB)	Bartenschlager, R (corresponding author), Heidelberg Univ, Dept Mol Virol, Neuenheimer Feld 345, D-69120 Heidelberg, Germany.	ralf.bartenschlager@med.uni-heidelberg.de	Pietschmann, Thomas/E-9241-2015; Bartenschlager, Ralf/L-2582-2015	Pietschmann, Thomas/0000-0001-5138-6239; Bartenschlager, Ralf/0000-0001-5601-9307; Steinmann, Eike/0000-0002-3654-9965; Jirasko, Vlastimil/0000-0003-1561-1499	Ministry of Science, Research, and the Arts of Baden-Wurrttemberg [Az 23-7532.24-22-21-12/1]; German Research Council [BA 1505/2-1]; CNRS; Agence Nationale pour la Recherche sur le SIDA et les Hepatites Virales	Ministry of Science, Research, and the Arts of Baden-Wurrttemberg; German Research Council(German Research Foundation (DFG)); CNRS(Centre National de la Recherche Scientifique (CNRS)); Agence Nationale pour la Recherche sur le SIDA et les Hepatites Virales(ANRSFrench National Research Agency (ANR))	This work was supported by the Bioquant Ph. D. program, Ministry of Science, Research, and the Arts of Baden-Wurrttemberg Grant Az 23-7532.24-22-21-12/1 (to R. B. and T. P.), German Research Council Grants BA 1505/2-1 (to N. A. and R. B.), SFB 638, Teilprojekt A5 ( to R. B.), and grants from the CNRS ( to F. P.) and the Agence Nationale pour la Recherche sur le SIDA et les Hepatites Virales (to F. P.). The costs of publication of this article were defrayed in part by the payment of page charges. This article must therefore be hereby marked "advertisement" in accordance with 18 U. S. C. Section 1734 solely to indicate this fact.	Agapov EV, 2004, J VIROL, V78, P2414, DOI 10.1128/JVI.78.5.2414-2425.2004; Appel N, 2006, J BIOL CHEM, V281, P9833, DOI 10.1074/jbc.R500026200; Appel N, 2008, PLOS PATHOG, V4, DOI 10.1371/journal.ppat.1000035; Bartenschlager R, 2004, ADV VIRUS RES, V63, P71, DOI 10.1016/S0065-3527(04)63002-8; Behrens SE, 1998, J VIROL, V72, P2364, DOI 10.1128/JVI.72.3.2364-2372.1998; Blight KJ, 2002, J VIROL, V76, P13001, DOI 10.1128/JVI.76.24.13001-13014.2002; Carrere-Kremer S, 2004, J BIOL CHEM, V279, P41384, DOI 10.1074/jbc.M406315200; CLAROS MG, 1994, COMPUT APPL BIOSCI, V10, P685; Combet C, 2000, TRENDS BIOCHEM SCI, V25, P147, DOI 10.1016/S0968-0004(99)01540-6; Combet C, 2007, NUCLEIC ACIDS RES, V35, pD363, DOI 10.1093/nar/gkl970; Erdtmann L, 2003, J BIOL CHEM, V278, P18256, DOI 10.1074/jbc.M209732200; Favier A, 2002, J MOL BIOL, V317, P131, DOI 10.1006/jmbi.2002.5397; Flajolet M, 2000, GENE, V242, P369, DOI 10.1016/S0378-1119(99)00511-9; Franck N, 2005, J VIROL, V79, P2700, DOI 10.1128/JVI.79.5.2700-2708.2005; Gastaminza P, 2006, J VIROL, V80, P11074, DOI 10.1128/JVI.01150-06; GRAKOUI A, 1993, P NATL ACAD SCI USA, V90, P10583, DOI 10.1073/pnas.90.22.10583; GRAKOUI A, 1993, J VIROL, V67, P1385, DOI 10.1128/JVI.67.3.1385-1395.1993; Griffin SDC, 2003, FEBS LETT, V535, P34, DOI 10.1016/S0014-5793(02)03851-6; HIJIKATA M, 1993, J VIROL, V67, P4665, DOI 10.1128/JVI.67.8.4665-4675.1993; Hirokawa T, 1998, BIOINFORMATICS, V14, P378, DOI 10.1093/bioinformatics/14.4.378; Hofmann K., 1993, BIOL CHEM H-S, V374, P166, DOI DOI 10.1515/BCHM3.1993.374.1-6.143; Humphrey W, 1996, J MOL GRAPH MODEL, V14, P33, DOI 10.1016/0263-7855(96)00018-5; Hwang DR, 2005, J VIROL METHODS, V129, P170, DOI 10.1016/j.jviromet.2005.05.026; Jones CT, 2007, J VIROL, V81, P8374, DOI 10.1128/JVI.00690-07; Kalinina O, 2002, J VIROL, V76, P4034, DOI 10.1128/JVI.76.8.4034-4043.2002; Kiiver K, 2006, VIRUS RES, V117, P264, DOI 10.1016/j.virusres.2005.10.021; Kim KM, 2007, BIOCHEM BIOPH RES CO, V356, P948, DOI 10.1016/j.bbrc.2007.03.070; Kolykhalov AA, 2000, J VIROL, V74, P2046, DOI 10.1128/JVI.74.4.2046-2051.2000; Koradi R, 1996, J MOL GRAPHICS, V14, P51, DOI 10.1016/0263-7855(96)00009-4; Koutsoudakis G, 2007, J VIROL, V81, P588, DOI 10.1128/JVI.01534-06; Krogh A, 2001, J MOL BIOL, V305, P567, DOI 10.1006/jmbi.2000.4315; Laskowski RA, 1996, J BIOMOL NMR, V8, P477, DOI 10.1007/BF00228148; Lindenbach BD, 2005, SCIENCE, V309, P623, DOI 10.1126/science.1114016; Lohmann V, 1999, SCIENCE, V285, P110, DOI 10.1126/science.285.5424.110; Lorenz IC, 2006, NATURE, V442, P831, DOI 10.1038/nature04975; MacKenzie KR, 1998, P NATL ACAD SCI USA, V95, P3583, DOI 10.1073/pnas.95.7.3583; MANAVALAN P, 1987, ANAL BIOCHEM, V167, P76, DOI 10.1016/0003-2697(87)90135-7; MERUTKA G, 1995, J BIOMOL NMR, V5, P14, DOI 10.1007/BF00227466; MIZUSHIMA H, 1994, J VIROL, V68, P2731, DOI 10.1128/JVI.68.4.2731-2734.1994; Moradpour D, 2007, NAT REV MICROBIOL, V5, P453, DOI 10.1038/nrmicro1645; Moreau I, 2006, VIROL J, V3, DOI 10.1186/1743-422X-3-95; Murray CL, 2007, J VIROL, V81, P10220, DOI 10.1128/JVI.00793-07; Noppornpanth S, 2006, J VIROL, V80, P7569, DOI 10.1128/JVI.00312-06; Opella SJ, 1997, NAT STRUCT BIOL, V4, P845; Penin F, 1997, J MOL BIOL, V270, P496, DOI 10.1006/jmbi.1997.1123; Pietschmann T, 2006, P NATL ACAD SCI USA, V103, P7408, DOI 10.1073/pnas.0504877103; Poynard T, 2003, LANCET, V362, P2095, DOI 10.1016/S0140-6736(03)15109-4; ROST B, 1995, PROTEIN SCI, V4, P521; Sakai A, 2003, P NATL ACAD SCI USA, V100, P11646, DOI 10.1073/pnas.1834545100; SANTOLINI E, 1995, J VIROL, V69, P7461, DOI 10.1128/JVI.69.12.7461-7471.1995; Schwieters CD, 2003, J MAGN RESON, V160, P65, DOI 10.1016/S1090-7807(02)00014-9; SELBY MJ, 1994, VIROLOGY, V204, P114, DOI 10.1006/viro.1994.1515; Senes A, 2001, P NATL ACAD SCI USA, V98, P9056, DOI 10.1073/pnas.161280798; Simmonds P, 2005, HEPATOLOGY, V42, P962, DOI 10.1002/hep.20819; Steinmann E, 2008, J VIROL, V82, P7034, DOI 10.1128/JVI.00118-08; Steinmann E, 2007, PLOS PATHOG, V3, P962, DOI 10.1371/journal.ppat.0030103; THOMPSON JD, 1994, NUCLEIC ACIDS RES, V22, P4673, DOI 10.1093/nar/22.22.4673; TOMEI L, 1993, J VIROL, V67, P4017, DOI 10.1128/JVI.67.7.4017-4026.1993; Tusnady GE, 1998, J MOL BIOL, V283, P489, DOI 10.1006/jmbi.1998.2107; VANDENHOFF MJB, 1990, NUCLEIC ACIDS RES, V18, P6464, DOI 10.1093/nar/18.21.6464; VANREGENMORTEL MHV, 2000, VIRUS TAXONOMY 7 REP, P872; Wakita T, 2005, NAT MED, V11, P791, DOI 10.1038/nm1268; Welbourn S, 2005, J BIOL CHEM, V280, P29604, DOI 10.1074/jbc.M505019200; Whitmore L, 2004, NUCLEIC ACIDS RES, V32, pW668, DOI 10.1093/nar/gkh371; WISHART DS, 1992, BIOCHEMISTRY-US, V31, P1647, DOI 10.1021/bi00121a010; Wuthrich K, 1986, NMR PROTEINS NUCL AC; Yamaga AK, 2002, J BIOL CHEM, V277, P33228, DOI 10.1074/jbc.M202304200; Yang XJ, 2006, VIRUS RES, V121, P134, DOI 10.1016/j.virusres.2006.02.004; Yi MK, 2007, J VIROL, V81, P629, DOI 10.1128/JVI.01890-06	69	121	128	0	8	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	OCT 17	2008	283	42					28546	28562		10.1074/jbc.M803981200	http://dx.doi.org/10.1074/jbc.M803981200			17	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	359EN	18644781	Green Published, hybrid			2022-12-27	WOS:000259969300058
J	Fedrizzi, L; Lim, D; Carafoli, E; Brini, M				Fedrizzi, Laura; Lim, Dmitry; Carafoli, Ernesto; Brini, Marisa			Interplay of the Ca2+-binding protein DREAM with presenilin in neuronal Ca2+ signaling	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							FAMILIAL ALZHEIMERS-DISEASE; ENDOPLASMIC-RETICULUM; PLASMA-MEMBRANE; CALSENILIN; MUTATIONS; MODULATION; APOPTOSIS; CHANNELS; CELLS; ENTRY	The Ca2+ binding protein DREAM regulates gene transcription and Kv potassium channels in neurons but has also been claimed to interact with presenilins, which are involved in the generation of beta-amyloid and in the regulation of the Ca2+ content in the endoplasmic reticulum. The role of DREAM in Ca2+ homeostasis was thus explored in SH-SY5Y cells stably or transiently overexpressing DREAM or a Ca2+ -insensitive mutant of it. The overexpression of DREAM had transcriptional and post-transcriptional effects. Endoplasmic reticulum Ca2+ and capacitative Ca2+ influx were reduced in stably expressing cells. The previously shown down-regulation of Na+/Ca2+ exchanger 3 expression was confirmed; it could cause a local increase of sub-plasma membrane Ca2+ and thus inhibit capacitative Ca2+ influx. DREAM up-regulated the expression of the inositol 1,4,5-trisphosphate receptor and could thus increase the unstimulated release of Ca2+ through it. The transient coexpression of DREAM and presenilin potentiated the decrease of endoplasmic reticulum Ca2+ observed in presenilin-overexpressing cells. This could be due to a direct effect of DREAM on presenilin as the two proteins interacted in a Ca2+ -independent fashion.	[Fedrizzi, Laura; Lim, Dmitry; Carafoli, Ernesto; Brini, Marisa] Univ Padua, Dept Biochem, I-35131 Padua, Italy; [Fedrizzi, Laura; Brini, Marisa] Univ Padua, Dept Expt Vet Sci, I-35131 Padua, Italy; [Lim, Dmitry; Carafoli, Ernesto] Venetian Inst Mol Med, I-35129 Padua, Italy	University of Padua; University of Padua; Veneto Institute Molecular Medicine	Brini, M (corresponding author), Univ Padua, Dept Biochem, Viale G Colombo 3, I-35131 Padua, Italy.	marisa.brini@unipd.it	Brini, Marisa/K-5189-2016; Lim, Dmitry/H-9101-2012; Carafoli, Ernesto/K-5192-2016	Carafoli, Ernesto/0000-0002-7826-0094; Brini, Marisa/0000-0001-5141-0243	Telethon Foundation [GGP04169]; Italian Ministry of University and Research [PRIN 2003]; European Union FP6 Integrated Projects NeuroNe;  [LSH-2003-2.1.3-3]	Telethon Foundation(Fondazione Telethon); Italian Ministry of University and Research(Ministry of Education, Universities and Research (MIUR)); European Union FP6 Integrated Projects NeuroNe(European Commission); 	The work was supported by Telethon Foundation Project GGP04169 (to M. B.), Italian Ministry of University and Research Grant PRIN 2003 and 2005 (to M. B.), and FP6 program of the European Union FP6 Integrated Projects NeuroNe and LSH-2003-2.1.3-3 (to E. C.). The costs of publication of this article were defrayed in part by the payment of page charges. This article must therefore be hereby marked "advertisement" in accordance with 18 at ISI, Thomson Scientific on October 6, 2008 www. jbc. org Downloaded from	An WF, 2000, NATURE, V403, P553, DOI 10.1038/35000592; Arnaudeau S, 2002, J BIOL CHEM, V277, P46696, DOI 10.1074/jbc.M202395200; Bano D, 2005, CELL, V120, P275, DOI 10.1016/j.cell.2004.11.049; Barrero MJ, 1997, J BIOL CHEM, V272, P27694, DOI 10.1074/jbc.272.44.27694; BRINI M, 1995, J BIOL CHEM, V270, P9896, DOI 10.1074/jbc.270.17.9896; Burgoyne RD, 2004, TRENDS NEUROSCI, V27, P203, DOI 10.1016/j.tins.2004.01.010; Buxbaum JD, 1998, NAT MED, V4, P1177, DOI 10.1038/2673; Carrion AM, 1999, NATURE, V398, P80, DOI 10.1038/18044; Cheung KH, 2008, NEURON, V58, P871, DOI 10.1016/j.neuron.2008.04.015; Choi EK, 2001, J BIOL CHEM, V276, P19197, DOI 10.1074/jbc.M008597200; De Strooper B, 2007, EMBO REP, V8, P141, DOI 10.1038/sj.embor.7400897; Dettbarn C, 1998, J PHARMACOL EXP THER, V285, P739; Ellgaard L, 2003, NAT REV MOL CELL BIO, V4, P181, DOI 10.1038/nrm1052; GATTO C, 1995, BIOCHEMISTRY-US, V34, P965, DOI 10.1021/bi00003a031; Giacomello M, 2005, NEUROBIOL DIS, V18, P638, DOI 10.1016/j.nbd.2004.10.016; Gomez-Villafuertes R, 2005, J NEUROSCI, V25, P10822, DOI 10.1523/JNEUROSCI.3912-05.2005; Green KN, 2008, J CELL BIOL, V181, P1107, DOI 10.1083/jcb.200706171; Iwamoto T, 1996, J BIOL CHEM, V271, P22391, DOI 10.1074/jbc.271.37.22391; Jo DG, 2004, J NEUROCHEM, V88, P604, DOI 10.1046/j.1471-4159.2003.02159.x; Jo DG, 2001, FASEB J, V15, P589; Kasri NN, 2006, CELL CALCIUM, V40, P41, DOI 10.1016/j.ceca.2006.03.005; Krause KH, 1997, CELL, V88, P439, DOI 10.1016/S0092-8674(00)81884-X; Leissring MA, 2000, P NATL ACAD SCI USA, V97, P8590, DOI 10.1073/pnas.97.15.8590; Leissring MA, 1999, J NEUROCHEM, V72, P1061, DOI 10.1046/j.1471-4159.1999.0721061.x; Leissring MA, 1999, J BIOL CHEM, V274, P32535, DOI 10.1074/jbc.274.46.32535; Leissring MA, 2000, J CELL BIOL, V149, P793, DOI 10.1083/jcb.149.4.793; LEVYLAHAD E, 1995, SCIENCE, V269, P970, DOI 10.1126/science.7638621; Lievremont JP, 1997, J BIOL CHEM, V272, P30873, DOI 10.1074/jbc.272.49.30873; Lilliehook C, 2002, MOL CELL NEUROSCI, V19, P552, DOI 10.1006/mcne.2001.1096; MALGAROLI A, 1987, J CELL BIOL, V105, P2145, DOI 10.1083/jcb.105.5.2145; Marsault R, 1997, EMBO J, V16, P1575, DOI 10.1093/emboj/16.7.1575; Mattson MP, 2000, TRENDS NEUROSCI, V23, P222, DOI 10.1016/S0166-2236(00)01548-4; MONTERO M, 1995, EMBO J, V14, P5467, DOI 10.1002/j.1460-2075.1995.tb00233.x; Oakes SA, 2005, P NATL ACAD SCI USA, V102, P105, DOI 10.1073/pnas.0408352102; Penner R, 1993, Curr Opin Neurobiol, V3, P368, DOI 10.1016/0959-4388(93)90130-Q; Pfaffl MW, 2001, NUCLEIC ACIDS RES, V29, DOI 10.1093/nar/29.9.e45; ROGAEV EI, 1995, NATURE, V376, P775, DOI 10.1038/376775a0; Sanz C, 2001, EMBO J, V20, P2286, DOI 10.1093/emboj/20.9.2286; Scsucova S, 2005, NUCLEIC ACIDS RES, V33, P2269, DOI 10.1093/nar/gki503; Smith IF, 2005, CELL CALCIUM, V38, P427, DOI 10.1016/j.ceca.2005.06.021; Smith IF, 2002, BRAIN RES, V949, P105, DOI 10.1016/S0006-8993(02)02970-0; Thinakaran G, 1997, J BIOL CHEM, V272, P28415, DOI 10.1074/jbc.272.45.28415; Thinakaran G, 1996, NEURON, V17, P181, DOI 10.1016/S0896-6273(00)80291-3; Tu HP, 2006, CELL, V126, P981, DOI 10.1016/j.cell.2006.06.059; Vito P, 1996, J BIOL CHEM, V271, P31025, DOI 10.1074/jbc.271.49.31025; White C, 2005, NAT CELL BIOL, V7, P1021, DOI 10.1038/ncb1302; Yoo AS, 2000, NEURON, V27, P561, DOI 10.1016/S0896-6273(00)00066-0; Zaidi NF, 2002, NEUROSCIENCE, V114, P247, DOI 10.1016/S0306-4522(02)00251-8; Zatti G, 2006, CELL CALCIUM, V39, P539, DOI 10.1016/j.ceca.2006.03.002	49	19	19	0	0	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	OCT 10	2008	283	41					27494	27503		10.1074/jbc.M804152200	http://dx.doi.org/10.1074/jbc.M804152200			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	355OW	18664571	hybrid			2022-12-27	WOS:000259719200020
J	Schauwienold, D; Sastre, AP; Genzel, N; Schaefer, M; Reusch, HP				Schauwienold, Dag; Sastre, Alejandra Perez; Genzel, Nadine; Schaefer, Michael; Reusch, H. Peter			The transactivated epidermal growth factor receptor recruits Pyk2 to regulate Src kinase activity	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							VASCULAR SMOOTH-MUSCLE; PROTEIN-COUPLED RECEPTORS; TYROSINE KINASE; ANGIOTENSIN-II; EGF RECEPTOR; CELLS; ACTIVATION; CALCIUM; BINDING; PHOSPHORYLATION	G protein-coupled receptors such as proteinase-activated receptor 1 induce phosphorylation of mitogen-activated protein kinases through multiple pathways including transactivation of receptor tyrosine kinases. In vascular smooth muscle cells, both matrix-metalloproteinase-dependent extracellular shedding of membrane-bound epidermal growth factor (EGF) receptor ligands and activation of the nonreceptor tyrosine kinases Pyk2 and Src contributed to the thrombin-induced ERK1/2 phosphorylation. Surprisingly, disruption of the HB-EGF-mediated extracellular mode of EGF receptor transactivation also prevented the phosphorylation of the nonreceptor tyrosine kinases Pyk2 and Src, locating these kinases downstream of the transactivated EGF receptor. The ionomycin-induced Pyk2 phosphorylation was partially sensitive to AG1478, heparin, or the matrix-metalloproteinase inhibitor BB2116, and the ionomycin-induced EGF receptor phosphorylation was almost completely blocked by these inhibitors of extracellular transactivation. Coimmunoprecipitation experiments revealed that, upon thrombin stimulation, a signaling complex consisting of Pyk2 and Src assembles at the EGF receptor. Reconstitution of the signaling molecules in HEK293 or vascular smooth muscle cells and subsequent determination of the EGF-induced Src kinase activity applying fluorescent sensor proteins demonstrated that a Ca2+-independent mode of Pyk2 activation is critical for the activation of Src downstream of the EGF receptor.	[Schauwienold, Dag; Reusch, H. Peter] Ruhr Univ Bochum, Klin Pharmakol Abt, D-44780 Bochum, Germany; [Sastre, Alejandra Perez; Genzel, Nadine; Schaefer, Michael] Charite Univ Med Berlin, Neurowissensch Forshungszentrum Mol Pharmacol & C, D-14195 Berlin, Germany; [Genzel, Nadine] ImaGenes GmbH, D-13125 Berlin, Germany	Ruhr University Bochum; Free University of Berlin; Humboldt University of Berlin; Charite Universitatsmedizin Berlin	Schaefer, M (corresponding author), Univ Leipzig, Rudolf Boehm Inst Pharmakol & Toxikol, Hartelstr 16-18, D-04107 Leipzig, Germany.	michael.schaefer@medizin.uni-leipzig.de			Forschergruppe 341; Graduiertenkolleg 276; 865 of the Deutsche Forschungsgemeinschaft	Forschergruppe 341; Graduiertenkolleg 276(German Research Foundation (DFG)); 865 of the Deutsche Forschungsgemeinschaft(German Research Foundation (DFG))	This work was supported by Forschergruppe 341 and Graduiertenkolleg 276 and 865 of the Deutsche Forschungsgemeinschaft. The costs of publication of this article were defrayed in part by the payment of page charges. This article must therefore be hereby marked "advertisement" in accordance with 18 U. S. C. Section 1734 solely to indicate this fact.	Abram CL, 2000, EXP CELL RES, V254, P1, DOI 10.1006/excr.1999.4732; Andreev J, 2001, J BIOL CHEM, V276, P20130, DOI 10.1074/jbc.M102307200; Blaukat A, 1999, J BIOL CHEM, V274, P14893, DOI 10.1074/jbc.274.21.14893; Bobe R, 2003, AM J PHYSIOL-HEART C, V285, pH745, DOI 10.1152/ajpheart.01042.2002; Brinson AE, 1998, J BIOL CHEM, V273, P1711, DOI 10.1074/jbc.273.3.1711; Daub H, 1996, NATURE, V379, P557, DOI 10.1038/379557a0; DIKIC I, 1995, J BIOL CHEM, V270, P15125, DOI 10.1074/jbc.270.25.15125; Dikic I, 1996, NATURE, V383, P547, DOI 10.1038/383547a0; Eguchi S, 1999, HYPERTENSION, V33, P201, DOI 10.1161/01.HYP.33.1.201; Eguchi S, 2001, J BIOL CHEM, V276, P7957, DOI 10.1074/jbc.M008570200; Gil-Henn H, 2007, J CELL BIOL, V178, P1053, DOI 10.1083/jcb.200701148; Ginnan R, 2002, AM J PHYSIOL-CELL PH, V282, pC754, DOI 10.1152/ajpcell.00335.2001; HIGASHIYAMA S, 1991, SCIENCE, V251, P936, DOI 10.1126/science.1840698; HUNTER T, 1987, CELL, V49, P1, DOI 10.1016/0092-8674(87)90745-8; Kalmes A, 2001, ANN NY ACAD SCI, V947, P42; Kalmes A, 2000, CIRC RES, V87, P92, DOI 10.1161/01.RES.87.2.92; KYPTA RM, 1990, CELL, V62, P481, DOI 10.1016/0092-8674(90)90013-5; LEV S, 1995, NATURE, V376, P737, DOI 10.1038/376737a0; MAA MC, 1995, P NATL ACAD SCI USA, V92, P6981, DOI 10.1073/pnas.92.15.6981; MARSHALL CJ, 1995, CELL, V80, P179, DOI 10.1016/0092-8674(95)90401-8; Mitra SK, 2005, NAT REV MOL CELL BIO, V6, P56, DOI 10.1038/nrm1549; Prenzel N, 2000, BREAST CANCER RES, V2, P184, DOI 10.1186/bcr52; Reusch HP, 2001, J BIOL CHEM, V276, P19540, DOI 10.1074/jbc.M101963200; Schauwienold D, 2003, HYPERTENSION, V41, P546, DOI 10.1161/01.HYP.0000054213.37471.84; Shah BH, 2002, MOL PHARMACOL, V61, P343, DOI 10.1124/mol.61.2.343; Ting AY, 2001, P NATL ACAD SCI USA, V98, P15003, DOI 10.1073/pnas.211564598; Touyz RM, 2002, HYPERTENSION, V39, P479, DOI 10.1161/hy02t2.102909; Wilde A, 1999, CELL, V96, P677, DOI 10.1016/S0092-8674(00)80578-4; Zwick E, 1999, J BIOL CHEM, V274, P20989, DOI 10.1074/jbc.274.30.20989	29	15	15	0	1	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	OCT 10	2008	283	41					27748	27756		10.1074/jbc.M801431200	http://dx.doi.org/10.1074/jbc.M801431200			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	355OW	18667434	hybrid			2022-12-27	WOS:000259719200046
J	Nolen, BJ; Pollard, TD				Nolen, Brad J.; Pollard, Thomas D.			Structure and biochemical properties of fission yeast Arp2/3 complex lacking the Arp2 subunit	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							WASP FAMILY PROTEINS; WASP/SCAR PROTEINS; ACTIN-BINDING; ACTIVATION; ROLES; POLYMERIZATION; IDENTIFICATION; CYTOKINESIS; EFFICIENT; INTERACTS	Arp2/3 (actin-related protein 2/3) complex is a seven-subunit complex that nucleates branched actin filaments in response to cellular signals. Nucleation-promoting factors such as WASp/Scar family proteins activate the complex by facilitating the activating conformational change and recruiting the first actin monomer for the daughter branch. Here we address the role of the Arp2 subunit in the function of Arp2/3 complex by isolating a version of the complex lacking Arp2 (Arp2 Delta Arp2/3 complex) from fission yeast. An x-ray crystal structure of the Delta Arp2 Arp2/3 complex showed that the rest of the complex is unperturbed by the loss of Arp2. However, the Arp2 Delta Arp2/3 complex was inactive in actin nucleation assays, indicating that Arp2 is essential to form a branch. A fluorescence anisotropy assay showed that Arp2 does not contribute to the affinity of the complex for Wsp1-VCA, a Schizosaccharomyces pombe nucleation-promoting factor protein. Fluorescence resonance energy transfer experiments showed that the loss of Arp2 does not prevent VCA from recruiting an actin monomer to the complex. Truncation of the N terminus of ARPC5, the smallest subunit in the complex, increased the yield of Arp2 Delta Arp2/3 complex during purification but did not compromise nucleation activity of the full Arp2/3 complex.	[Nolen, Brad J.] Yale Univ, Dept Mol Cellular & Dev Biol, New Haven, CT 06520 USA; Yale Univ, Dept Cell Biol, New Haven, CT 06520 USA; Yale Univ, Dept Mol Biophys & Biochem, New Haven, CT 06520 USA	Yale University; Yale University; Yale University	Nolen, BJ (corresponding author), Yale Univ, Dept Mol Cellular & Dev Biol, New Haven, CT 06520 USA.	bradley.nolen@yale.edu			National Institutes of Health [GM066311, GM074374-02]; NATIONAL INSTITUTE OF BIOMEDICAL IMAGING AND BIOENGINEERING [P30EB009998] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [F32GM074374, P01GM066311] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF BIOMEDICAL IMAGING AND BIOENGINEERING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Biomedical Imaging & Bioengineering (NIBIB)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported, in whole or in part, by National Institutes of Health Grant GM066311. This work was also supported by National Institutes of Health Ruth Kirschstein postdoctoral fellowship GM074374-02. The costs of publication of this article were defrayed in part by the payment of page charges. This article must therefore be hereby marked "advertisement" in accordance with 18 U. S. C. Section 1734 solely to indicate this fact.	Aguda AH, 2005, EMBO REP, V6, P220, DOI 10.1038/sj.embor.7400363; Amann KJ, 2001, NAT CELL BIOL, V3, P306, DOI 10.1038/35060104; Bahler J, 1998, YEAST, V14, P943, DOI 10.1002/(SICI)1097-0061(199807)14:10<943::AID-YEA292>3.0.CO;2-Y; Beltzner CC, 2004, J MOL BIOL, V336, P551, DOI 10.1016/j.jmb.2003.12.017; Beltzner CC, 2008, J BIOL CHEM, V283, P7135, DOI 10.1074/jbc.M705894200; Boczkowska M, 2008, STRUCTURE, V16, P695, DOI 10.1016/j.str.2008.02.013; Boujemaa-Paterski R, 2001, BIOCHEMISTRY-US, V40, P11390, DOI 10.1021/bi010486b; Chang F, 1997, J CELL BIOL, V137, P169, DOI 10.1083/jcb.137.1.169; Chereau D, 2005, P NATL ACAD SCI USA, V102, P16644, DOI 10.1073/pnas.0507021102; Feierbach B, 2001, CURR BIOL, V11, P1656, DOI 10.1016/S0960-9822(01)00525-5; GILL SC, 1989, ANAL BIOCHEM, V182, P319, DOI 10.1016/0003-2697(89)90602-7; Gournier H, 2001, MOL CELL, V8, P1041, DOI 10.1016/S1097-2765(01)00393-8; Higgs HN, 1999, BIOCHEMISTRY-US, V38, P15212, DOI 10.1021/bi991843+; Irobi E, 2004, EMBO J, V23, P3599, DOI 10.1038/sj.emboj.7600372; Kapust RB, 2001, PROTEIN ENG, V14, P993, DOI 10.1093/protein/14.12.993; KEENEY JB, 1994, GENETICS, V136, P849; Kelly AE, 2006, J BIOL CHEM, V281, P10589, DOI 10.1074/jbc.M507470200; Kiselar JG, 2007, P NATL ACAD SCI USA, V104, P1552, DOI 10.1073/pnas.0605380104; Kreishman-Deitrick M, 2005, BIOCHEMISTRY-US, V44, P15247, DOI 10.1021/bi051065n; Kuhn JR, 2005, BIOPHYS J, V88, P1387, DOI 10.1529/biophysj.104.047399; MACLEANFLETCHER S, 1980, BIOCHEM BIOPH RES CO, V96, P18, DOI 10.1016/0006-291X(80)91175-4; Marchand JB, 2001, NAT CELL BIOL, V3, P76, DOI 10.1038/35050590; McCollum D, 1996, EMBO J, V15, P6438, DOI 10.1002/j.1460-2075.1996.tb01035.x; Mccoy AJ, 2007, J APPL CRYSTALLOGR, V40, P658, DOI 10.1107/S0021889807021206; Morrell JL, 1999, MOL BIOL CELL, V10, P4201, DOI 10.1091/mbc.10.12.4201; Mullins RD, 1997, J CELL BIOL, V136, P331, DOI 10.1083/jcb.136.2.331; Nolen BJ, 2004, P NATL ACAD SCI USA, V101, P15627, DOI 10.1073/pnas.0407149101; Nolen BJ, 2007, MOL CELL, V26, P449, DOI 10.1016/j.molcel.2007.04.017; Pan F, 2004, J BIOL CHEM, V279, P54629, DOI 10.1074/jbc.M402357200; Panchal SC, 2003, NAT STRUCT BIOL, V10, P591, DOI 10.1038/nsb952; Pollard TD, 2000, ANNU REV BIOPH BIOM, V29, P545, DOI 10.1146/annurev.biophys.29.1.545; POLLARD TD, 1984, J CELL BIOL, V99, P769, DOI 10.1083/jcb.99.3.769; Pollard TD, 2007, ANNU REV BIOPH BIOM, V36, P451, DOI 10.1146/annurev.biophys.35.040405.101936; Robinson RC, 2001, SCIENCE, V294, P1679, DOI 10.1126/science.1066333; Rouiller I, 2008, J CELL BIOL, V180, P887, DOI 10.1083/jcb.200709092; Sirotkin V, 2005, J CELL BIOL, V170, P637, DOI 10.1083/jcb.200502053; Toshima JY, 2006, P NATL ACAD SCI USA, V103, P5793, DOI 10.1073/pnas.0601042103; WELCH MD, 1994, CURR OPIN CELL BIOL, V6, P110, DOI 10.1016/0955-0674(94)90124-4; Winn MD, 2001, ACTA CRYSTALLOGR D, V57, P122, DOI 10.1107/S0907444900014736; Winter DC, 1999, P NATL ACAD SCI USA, V96, P7288, DOI 10.1073/pnas.96.13.7288; Wu JQ, 2003, DEV CELL, V5, P723, DOI 10.1016/S1534-5807(03)00324-1; Wu JQ, 2005, SCIENCE, V310, P310, DOI 10.1126/science.1113230; Zalevsky J, 2001, CURR BIOL, V11, P1903, DOI 10.1016/S0960-9822(01)00603-0; Zalevsky J, 2001, J BIOL CHEM, V276, P3468, DOI 10.1074/jbc.M006407200	44	32	33	0	3	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	SEP 26	2008	283	39					26490	26498		10.1074/jbc.M802607200	http://dx.doi.org/10.1074/jbc.M802607200			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	350GV	18640983	Green Published, hybrid			2022-12-27	WOS:000259341600025
J	Farin, HF; Mansouri, A; Petry, M; Kispert, A				Farin, Henner F.; Mansouri, Ahmed; Petry, Marianne; Kispert, Andreas			T-box protein Tbx18 interacts with the paired box protein Pax3 in the development of the paraxial mesoderm	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							TRANSCRIPTIONAL REPRESSION; BOUNDARY FORMATION; VERTEBRAL COLUMN; NOTCH ACTIVITY; MESSENGER-RNA; PROXIMAL RIBS; MOUSE GENE; EXPRESSION; SOMITE; MESP2	The compartmentalization of somites along their anterior-posterior axis is crucial to the segmental organization of the vertebral column. Anterior-posterior somite polarity is generated in the anterior presomitic mesoderm by Mesp2 and Delta/Notch signaling and is further maintained by two transcriptional regulators, Uncx4.1 and Tbx18, acting in the posterior and anterior somite compartment, respectively. Here, we report that the paired box transcription factor Pax3 cooperates with the T-box protein Tbx18 in maintaining anterior somite half identity. Our findings that both genes are co-expressed in the anterior presomitic mesoderm and in early somites, that Pax3 and Tbx18 proteins physically interact, and that the loss of Pax3 gene function enhances the vertebral defects (i.e. the gain of vertebral elements derived from posterior somite halves in Tbx18 mutant mice) suggests that the two proteins cooperatively regulate the gene expression program necessary for maintaining anterior-posterior somite polarity. Genetic interaction of Pax3 with Tbx18 and the closely related T-box gene Tbx15 was also observed in the development of the scapula blade, indicating an additional cooperative function for these genes in the paraxial mesoderm.	[Farin, Henner F.; Petry, Marianne; Kispert, Andreas] Hannover Med Sch, Inst Mol Biol, D-30625 Hannover, Germany; [Mansouri, Ahmed] Max Planck Inst Biophys Chem, Dept Mol Cell Biol, D-37077 Gottingen, Germany	Hannover Medical School; Max Planck Society	Kispert, A (corresponding author), Hannover Med Sch, Inst Mol Biol, OE5250,Carl Neuberg Str 1, D-30625 Hannover, Germany.	kispert.andreas@mh-hannover.de	Farin, Henner/AAC-2574-2021	Farin, Henner/0000-0003-1558-5366	German Research Council; REBIRTH	German Research Council(German Research Foundation (DFG)); REBIRTH	This work was supported by grants from the German Research Council (Deutsche Forschungsgemeinschaft (DFG)) and by the DFG-funded cluster of excellence "REBIRTH" (to A. K.). The costs of publication of this article were defrayed in part by the payment of page charges. This article must therefore be hereby marked "advertisement" in accordance with 18 U. S. C. Section 1734 solely to indicate this fact.	Andreou AM, 2007, AM J HUM GENET, V81, P700, DOI 10.1086/521033; Aoyama H, 2000, MECH DEVELOP, V99, P71, DOI 10.1016/S0925-4773(00)00481-0; Aulehla A, 2004, GENE DEV, V18, P2060, DOI 10.1101/gad.1217404; Barrantes ID, 1999, CURR BIOL, V9, P470, DOI 10.1016/S0960-9822(99)80212-7; BOBER E, 1994, DEVELOPMENT, V120, P603; Borycki AG, 1999, DEVELOPMENT, V126, P1665; Bruneau BG, 2001, CELL, V106, P709, DOI 10.1016/S0092-8674(01)00493-7; Buckingham M, 2007, ANNU REV CELL DEV BI, V23, P645, DOI 10.1146/annurev.cellbio.23.090506.123438; Bussen M, 2004, GENE DEV, V18, P1209, DOI 10.1101/gad.300104; Christ B, 2007, DEV DYNAM, V236, P2382, DOI 10.1002/dvdy.21189; Daston G, 1996, DEVELOPMENT, V122, P1017; EDMONDSON DG, 1989, GENE DEV, V3, P628, DOI 10.1101/gad.3.5.628; EPSTEIN DJ, 1993, P NATL ACAD SCI USA, V90, P532, DOI 10.1073/pnas.90.2.532; Farin HF, 2007, J BIOL CHEM, V282, P25748, DOI 10.1074/jbc.M703724200; Garg V, 2003, NATURE, V424, P443, DOI 10.1038/nature01827; GOLDSTEIN RS, 1992, DEVELOPMENT, V116, P441; Habets PEMH, 2002, GENE DEV, V16, P1234, DOI 10.1101/gad.222902; Henderson DJ, 1999, DEV BIOL, V209, P143, DOI 10.1006/dbio.1999.9215; Hiroi Y, 2001, NAT GENET, V28, P276, DOI 10.1038/90123; Huang RJ, 2000, DEVELOPMENT, V127, P3789; Huang RJ, 2006, ANAT EMBRYOL, V211, pS65, DOI 10.1007/s00429-006-0126-9; Kraus F, 2001, MECH DEVELOP, V100, P83, DOI 10.1016/S0925-4773(00)00494-9; Kuijper S, 2005, DEVELOPMENT, V132, P1601, DOI 10.1242/dev.01735; Leconte L, 2004, J BIOL CHEM, V279, P47272, DOI 10.1074/jbc.M406624200; Leitges M, 2000, DEVELOPMENT, V127, P2259; Mansouri A, 2000, DEVELOPMENT, V127, P2251; Mansouri A, 2001, DEVELOPMENT, V128, P1995; Morimoto M, 2005, NATURE, V435, P354, DOI 10.1038/nature03591; Morimoto M, 2006, DEV BIOL, V300, P687, DOI 10.1016/j.ydbio.2006.08.043; Neidhardt LM, 1997, DEV GENES EVOL, V207, P330, DOI 10.1007/s004270050120; NEUBUSER A, 1995, DEV BIOL, V170, P701, DOI 10.1006/dbio.1995.1248; Ovcharenko I, 2005, NUCLEIC ACIDS RES, V33, pW403, DOI 10.1093/nar/gki466; Pellegrini M, 2001, DEV BIOL, V232, P149, DOI 10.1006/dbio.2001.0159; Plageman TF, 2004, J BIOL CHEM, V279, P19026, DOI 10.1074/jbc.M314041200; Saga Y, 1997, GENE DEV, V11, P1827, DOI 10.1101/gad.11.14.1827; Saga Y, 2007, DEV DYNAM, V236, P1450, DOI 10.1002/dvdy.21143; Schubert FR, 2001, DEV DYNAM, V222, P506, DOI 10.1002/dvdy.1211; Singh MK, 2005, MECH DEVELOP, V122, P131, DOI 10.1016/j.mod.2004.10.011; Stennard FA, 2003, DEV BIOL, V262, P206, DOI 10.1016/S0012-1606(03)00385-3; Takahashi Y, 2007, DEV DYNAM, V236, P1484, DOI 10.1002/dvdy.21178; Takahashi Y, 2007, DEV BIOL, V304, P593, DOI 10.1016/j.ydbio.2007.01.007; TASSABEHJI M, 1993, NAT GENET, V3, P26, DOI 10.1038/ng0193-26; WILKINSON DG, 1993, METHOD ENZYMOL, V225, P361; WILLIAMS BA, 1994, DEVELOPMENT, V120, P785	44	25	28	0	2	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	SEP 12	2008	283	37					25372	25380		10.1074/jbc.M802723200	http://dx.doi.org/10.1074/jbc.M802723200			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	345QZ	18644785	hybrid, Green Published			2022-12-27	WOS:000259012700032
J	Quintanilla, RA; Jin, YN; Fuenzalida, K; Bronfman, M; Johnson, GVW				Quintanilla, Rodrigo A.; Jin, Youngnam N.; Fuenzalida, Karen; Bronfman, Miguel; Johnson, Gail V. W.			Rosiglitazone treatment prevents mitochondrial dysfunction in mutant huntingtin-expressing cells - Possible role of peroxisome proliferator-activated receptor-gamma (PPAR gamma) in the pathogenesis of Huntington disease	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							BETA-AMYLOID NEURODEGENERATION; AMYOTROPHIC-LATERAL-SCLEROSIS; STRIATAL CELLS; ALZHEIMERS-DISEASE; ENDOPLASMIC-RETICULUM; TRINUCLEOTIDE REPEAT; INSULIN-RESISTANCE; OXIDATIVE STRESS; AGONISTS; NEURONS	Peroxisome proliferator-activated receptor-gamma (PPAR gamma) is a member of the PPAR family of transcription factors. Synthetic PPAR gamma agonists are used as oral anti-hyperglycemic drugs for the treatment of non-insulin-dependent diabetes. However, emerging evidence indicates that PPAR gamma activators can also prevent or attenuate neurodegeneration. Given these previous findings, the focus of this report is on the potential neuroprotective role of PPAR gamma activation in preventing the loss of mitochondrial function in Huntington disease (HD). For these studies we used striatal cells that express wild-type (STHdh(Q7/Q7)) or mutant (STHdh(Q111/Q111)) huntingtin protein at physiological levels. Treatment of mutant cells with thapsigargin resulted in a significant decrease in mitochondrial calcium uptake, an increase in reactive oxygen species production, and a significant decrease in mitochondrial membrane potential. PPAR gamma activation by rosiglitazone prevented the mitochondrial dysfunction and oxidative stress that occurred when mutant striatal cells were challenged with pathological increases in calcium. The beneficial effects of rosiglitazone were likely mediated by activation of PPAR gamma, as all protective effects were prevented by the PPAR gamma antagonist GW9662. Additionally, the PPAR gamma signaling pathway was significantly impaired in the mutant striatal cells with decreases in PPAR gamma expression and reduced PPAR gamma transcriptional activity. Treatment with rosiglitazone increased mitochondrial mass levels, suggesting a role for the PPAR gamma pathway in mitochondrial function in striatal cells. Altogether, this evidence indicates that PPAR gamma activation by rosiglitazone attenuates mitochondrial dysfunction in mutant huntingtin-expressing striatal cells, and this could be an important therapeutic avenue to ameliorate the mitochondrial dysfunction that occurs in HD.	[Johnson, Gail V. W.] Univ Rochester, Med Ctr, Dept Anesthesiol, Rochester, NY 14642 USA; [Jin, Youngnam N.; Johnson, Gail V. W.] Univ Rochester, Dept Physiol & Pharmacol, Rochester, NY 14642 USA; [Fuenzalida, Karen; Bronfman, Miguel] Pontificia Univ Catolica Chile, Fac Ciencias Biol, Dept Cellular & Mol Biol, Ctr Regulac Celular & Patol Joaquin V Luca, Santiago, Chile; [Fuenzalida, Karen; Bronfman, Miguel] Pontificia Univ Catolica Chile, Fac Ciencias Biol, Dept Cellular & Mol Biol, Millennium Inst Fundamental & Appl Biol, Santiago, Chile	University of Rochester; University of Rochester; Pontificia Universidad Catolica de Chile; Pontificia Universidad Catolica de Chile	Johnson, GVW (corresponding author), Univ Rochester, Med Ctr, Dept Anesthesiol, 601 Elmwood Ave,Box 604,Courier Rm 4-6314, Rochester, NY 14642 USA.	gail_johnsonvoll@urmc.rochester.edu	Jin, Youngnam/G-2655-2012; QUINTANILLA, RODRIGO/ABG-8829-2021		National Institutes of Health [NS041744]; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS041744] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	This work was supported, in whole or in part, by National Institutes of Health Grant NS041744. The costs of publication of this article were defrayed in part by the payment of page charges. This article must therefore be hereby marked "advertisement" in accordance with 18 U. S. C. Section 1734 solely to indicate this fact.	Berger J, 2002, ANNU REV MED, V53, P409, DOI 10.1146/annurev.med.53.082901.104018; Bernardo A, 2006, CURR PHARM DESIGN, V12, P93, DOI 10.2174/138161206780574579; Brandt J, 1996, NEUROLOGY, V46, P527, DOI 10.1212/WNL.46.2.527; Browne SE, 1997, ANN NEUROL, V41, P646, DOI 10.1002/ana.410410514; Collino M, 2006, EUR J PHARMACOL, V530, P70, DOI 10.1016/j.ejphar.2005.11.049; Collins TJ, 2001, J BIOL CHEM, V276, P26411, DOI 10.1074/jbc.M101101200; Cui LB, 2006, CELL, V127, P59, DOI 10.1016/j.cell.2006.09.015; Darios F, 2005, J NEUROSCI, V25, P4159, DOI 10.1523/JNEUROSCI.0060-05.2005; Diaz-Hernandez M, 2003, J NEUROSCI, V23, P11653; Fan MMY, 2007, PROG NEUROBIOL, V81, P272, DOI 10.1016/j.pneurobio.2006.11.003; Fuenzalida K, 2007, J BIOL CHEM, V282, P37006, DOI 10.1074/jbc.M700447200; Garcia-Bueno B, 2007, NEUROPSYCHOPHARMACOL, V32, P1251, DOI 10.1038/sj.npp.1301252; He TC, 1999, CELL, V99, P335, DOI 10.1016/S0092-8674(00)81664-5; Heneka MT, 2007, BBA-MOL CELL BIOL L, V1771, P1031, DOI 10.1016/j.bbalip.2007.04.016; Hunter RL, 2007, J NEUROCHEM, V100, P1375, DOI 10.1111/j.1471-4159.2006.04327.x; Inestrosa NC, 2005, EXP CELL RES, V304, P91, DOI 10.1016/j.yexcr.2004.09.032; Jung TW, 2006, BIOCHEM BIOPH RES CO, V340, P221, DOI 10.1016/j.bbrc.2005.11.177; Kiaei M, 2005, EXP NEUROL, V191, P331, DOI 10.1016/j.expneurol.2004.10.007; Kim GJ, 2006, CANCER RES, V66, P10377, DOI 10.1158/0008-5472.CAN-05-3036; Kim JB, 1998, P NATL ACAD SCI USA, V95, P4333, DOI 10.1073/pnas.95.8.4333; Landreth G, 2006, EXP NEUROL, V199, P245, DOI 10.1016/j.expneurol.2006.04.006; Lee KJ, 2008, EUR J NEUROSCI, V27, P334, DOI 10.1111/j.1460-9568.2007.06007.x; Lim D, 2008, J BIOL CHEM, V283, P5780, DOI 10.1074/jbc.M704704200; MACDONALD ME, 1993, CELL, V72, P971, DOI 10.1016/0092-8674(93)90585-E; MANN VM, 1990, LANCET, V336, P749, DOI 10.1016/0140-6736(90)92242-A; Milakovic T, 2005, J BIOL CHEM, V280, P30773, DOI 10.1074/jbc.M504749200; Milakovic T, 2006, J BIOL CHEM, V281, P34785, DOI 10.1074/jbc.M603845200; Mironov SL, 2005, J BIOL CHEM, V280, P715, DOI 10.1074/jbc.M409819200; Oliveira JMA, 2006, J NEUROSCI, V26, P11174, DOI 10.1523/JNEUROSCI.3004-06.2006; Panov AV, 2002, NAT NEUROSCI, V5, P731, DOI 10.1038/nn884; Pedersen WA, 2006, EXP NEUROL, V199, P265, DOI 10.1016/j.expneurol.2006.01.018; Pendergrass W, 2004, CYTOM PART A, V61A, P162, DOI 10.1002/cyto.a.20033; Quintanilla RA, 2005, J BIOL CHEM, V280, P11615, DOI 10.1074/jbc.M411936200; Rosen ED, 2001, J BIOL CHEM, V276, P37731, DOI 10.1074/jbc.R100034200; Ruan QM, 2007, J NEUROCHEM, V102, P25, DOI 10.1111/j.1471-4159.2007.04491.x; Santos MJ, 2005, J BIOL CHEM, V280, P41057, DOI 10.1074/jbc.M505160200; Sawa A, 1999, NAT MED, V5, P1194, DOI 10.1038/13518; Schopfer FJ, 2005, P NATL ACAD SCI USA, V102, P2340, DOI 10.1073/pnas.0408384102; Schutz B, 2005, J NEUROSCI, V25, P7805, DOI 10.1523/JNEUROSCI.2038-05.2005; Soane L, 2005, J BIOENERG BIOMEMBR, V37, P179, DOI 10.1007/s10863-005-6590-8; STAHL WL, 1974, NEUROLOGY, V24, P813, DOI 10.1212/WNL.24.9.813; Strum JC, 2007, J ALZHEIMERS DIS, V11, P45; Trettel F, 2000, HUM MOL GENET, V9, P2799, DOI 10.1093/hmg/9.19.2799; Watson GS, 2006, J NEUROL SCI, V245, P21, DOI 10.1016/j.jns.2005.08.017; Watson GS, 2005, AM J GERIAT PSYCHIAT, V13, P950, DOI 10.1176/appi.ajgp.13.11.950; Watson GS, 2003, CNS DRUGS, V17, P27, DOI 10.2165/00023210-200317010-00003; Wilson-Fritch L, 2004, J CLIN INVEST, V114, P1281, DOI 10.1172/JCI200421752; Wilson-Fritch L, 2003, MOL CELL BIOL, V23, P1085, DOI 10.1128/MCB.23.3.1085-1094.2003; Xing B, 2008, J NEUROINFLAMM, V5, DOI 10.1186/1742-2094-5-4; Zhu LP, 2000, CELL CALCIUM, V28, P107, DOI 10.1054/ceca.2000.0138	50	105	108	0	5	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	SEP 12	2008	283	37					25628	25637		10.1074/jbc.M804291200	http://dx.doi.org/10.1074/jbc.M804291200			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	345QZ	18640979	Green Published, hybrid			2022-12-27	WOS:000259012700058
J	Lezhneva, L; Kuras, R; Ephritikhine, G; de Vitry, C				Lezhneva, Lina; Kuras, Richard; Ephritikhine, Genevieve; de Vitry, Catherine			A novel pathway of cytochrome c biogenesis is involved in the assembly of the cytochrome b(6)f complex in Arabidopsis chloroplasts	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							TRANSFER-RNA SYNTHETASE; STATE TRANSITIONS; PHOTOSYSTEM-I; PROTEIN; HEME; THALIANA; BINDING; GENE; MATURATION; DISULFIDE	We recently characterized a novel heme biogenesis pathway required for heme c(i)' covalent binding to cytochrome b(6) in Chlamydomonas named system IV or CCB (cofactor assembly, complex C (b(6)f), subunit B (PetB)). To find out whether this CCB pathway also operates in higher plants and extend the knowledge of the c-type cytochrome biogenesis, we studied Arabidopsis insertion mutants in the orthologs of the CCB genes. The ccb1, ccb2, and ccb4 mutants show a phenotype characterized by a deficiency in the accumulation of the subunits of the cytochrome b(6)f complex and lack covalent heme binding to cytochrome b(6). These mutants were functionally complemented with the corresponding wild type cDNAs. Using fluorescent protein reporters, we demonstrated that the CCB1, CCB2, CCB3, and CCB4 proteins are targeted to the chloroplast compartment of Arabidopsis. We have extended our study to the YGGT family, to which CCB3 belongs, by studying insertion mutants of two additional members of this family for which no mutants were previously characterized, and we showed that they are not functionally involved in the CCB system. Thus, we demonstrate the ubiquity of the CCB proteins in chloroplast heme c(i)' binding.	[Lezhneva, Lina; Kuras, Richard; de Vitry, Catherine] Univ Paris 06, UMR 7141, F-75005 Paris, France; [Lezhneva, Lina; Kuras, Richard; de Vitry, Catherine] Inst Biol Phys Chim, Lab Physiol Membranaire & Mol Chloroplaste, UMR 7141, CNRS, F-75005 Paris, France; [Ephritikhine, Genevieve] CNRS, Inst Sci Vegetal, UPR 2355, F-91198 Gif Sur Yvette, France; [Ephritikhine, Genevieve] Univ Paris Diderot, UFR Sci Vivant, F-75251 Paris 05, France	Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Biology (INSB); UDICE-French Research Universities; Sorbonne Universite; Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Biology (INSB); Centre National de la Recherche Scientifique (CNRS); UDICE-French Research Universities; Universite Paris Saclay; UDICE-French Research Universities; Universite Paris Cite	de Vitry, C (corresponding author), Univ Paris 06, UMR 7141, F-75005 Paris, France.	catherine.devitry@ibpc.fr			CNRS; UPMC Universite Paris 6; Universite Paris-Diderot	CNRS(Centre National de la Recherche Scientifique (CNRS)); UPMC Universite Paris 6; Universite Paris-Diderot	This work was supported in part by the CNRS, the UPMC Universite Paris 6, and the Universite Paris-Diderot. The costs of publication of this article were defrayed in part by the payment of page charges. This article must therefore be hereby marked "advertisement" in accordance with 18 U. S. C. Section 1734 solely to indicate this fact.	Alergand T, 2006, PLANT CELL PHYSIOL, V47, P540, DOI 10.1093/pcp/pcj023; Allen JF, 2004, TRENDS PLANT SCI, V9, P130, DOI 10.1016/j.tplants.2004.01.009; Alric J, 2005, P NATL ACAD SCI USA, V102, P15860, DOI 10.1073/pnas.0508102102; ARNON DI, 1949, PLANT PHYSIOL, V24, P1, DOI 10.1104/pp.24.1.1; Baymann F, 2007, P NATL ACAD SCI USA, V104, P519, DOI 10.1073/pnas.0606369104; Bellafiore S, 2005, NATURE, V433, P892, DOI 10.1038/nature03286; Bennoun Pierre, 1998, Advances in Photosynthesis, V7, P451; Caprara MG, 1996, CELL, V87, P1135, DOI 10.1016/S0092-8674(00)81807-3; Clough SJ, 1998, PLANT J, V16, P735, DOI 10.1046/j.1365-313x.1998.00343.x; de Vitry C, 2004, BIOCHEMISTRY-US, V43, P3956, DOI 10.1021/bi036093p; Depege N, 2003, SCIENCE, V299, P1572, DOI 10.1126/science.1081397; DEVITRY C, 2007, CHLAMYDOMONAS SOURCE, V2, P603; Emanuelsson O, 2000, J MOL BIOL, V300, P1005, DOI 10.1006/jmbi.2000.3903; Emanuelsson O, 1999, PROTEIN SCI, V8, P978, DOI 10.1110/ps.8.5.978; Fadda D, 2003, J BACTERIOL, V185, P6209, DOI 10.1128/JB.185.20.6209-6214.2003; Finazzi G, 2005, J EXP BOT, V56, P383, DOI 10.1093/jxb/erh230; Friso G, 2004, PLANT CELL, V16, P478, DOI 10.1105/tpc.017814; Froehlich JE, 2003, J PROTEOME RES, V2, P413, DOI 10.1021/pr034025j; GAVEL Y, 1991, FEBS LETT, V282, P41, DOI 10.1016/0014-5793(91)80440-E; Giege P, 2008, MITOCHONDRION, V8, P61, DOI 10.1016/j.mito.2007.10.001; Hadi MZ, 2002, PLANT CELL REP, V21, P130, DOI 10.1007/s00299-002-0473-9; Hsu JL, 2006, J BIOL CHEM, V281, P23075, DOI 10.1074/jbc.M601606200; Inoue K, 1997, J BIOL CHEM, V272, P31747, DOI 10.1074/jbc.272.50.31747; JOLIOT P, 1988, BIOCHIM BIOPHYS ACTA, V933, P319, DOI 10.1016/0005-2728(88)90039-4; Joliot Pierre, 2006, V24, P639; Kleffmann T, 2004, CURR BIOL, V14, P354, DOI 10.1016/j.cub.2004.02.039; KONCZ C, 1994, PLANT MOL BIOL MAN B, V2, P1; Kranz R, 1998, MOL MICROBIOL, V29, P383, DOI 10.1046/j.1365-2958.1998.00869.x; Kuras R, 1997, J BIOL CHEM, V272, P32427, DOI 10.1074/jbc.272.51.32427; Kuras R, 2007, P NATL ACAD SCI USA, V104, P9906, DOI 10.1073/pnas.0702340104; Kurisu G, 2003, SCIENCE, V302, P1009, DOI 10.1126/science.1090165; LAVERGNE J, 1983, BIOCHIM BIOPHYS ACTA, V725, P25, DOI 10.1016/0005-2728(83)90220-7; Lennartz K, 2001, PLANT CELL, V13, P2539, DOI 10.1105/tpc.13.11.2539; Lyska D, 2007, PLANT CELL PHYSIOL, V48, P1737, DOI 10.1093/pcp/pcm146; Merchant S, 2005, PLANT CELL, V17, P648, DOI 10.1105/tpc.105.030676; Meurer J, 1996, PLANTA, V198, P385, DOI 10.1007/BF00620055; Mollier P, 2002, CURR GENET, V40, P405, DOI 10.1007/s00294-002-0271-5; MURASHIGE T, 1962, PHYSIOL PLANTARUM, V15, P473, DOI 10.1111/j.1399-3054.1962.tb08052.x; Nakamoto SS, 2000, BIOCHIMIE, V82, P603, DOI 10.1016/S0300-9084(00)00605-2; Page MLD, 2004, J BIOL CHEM, V279, P32474, DOI 10.1074/jbc.M404285200; Perron K, 1999, EMBO J, V18, P6481, DOI 10.1093/emboj/18.22.6481; PERSSON B, 1994, J MOL BIOL, V237, P182, DOI 10.1006/jmbi.1994.1220; Reiss B, 1996, P NATL ACAD SCI USA, V93, P3094, DOI 10.1073/pnas.93.7.3094; Rolland N, 2003, PHOTOSYNTH RES, V78, P205, DOI 10.1023/B:PRES.0000006891.12416.6c; Seki M, 1998, PLANT J, V15, P707, DOI 10.1046/j.1365-313x.1998.00237.x; Seki M, 2002, SCIENCE, V296, P141, DOI 10.1126/science.1071006; Shikanai T, 2007, ANNU REV PLANT BIOL, V58, P199, DOI 10.1146/annurev.arplant.58.091406.110525; Small I, 2004, PROTEOMICS, V4, P1581, DOI 10.1002/pmic.200300776; Stroebel D, 2003, NATURE, V426, P413, DOI 10.1038/nature02155; Tatusova TA, 1999, FEMS MICROBIOL LETT, V174, P247, DOI 10.1016/S0378-1097(99)00149-4; Thomine S, 2003, PLANT J, V34, P685, DOI 10.1046/j.1365-313X.2003.01760.x; Thony-Meyer L, 2002, BIOCHEM SOC T, V30, P633; Wollman FA, 2001, EMBO J, V20, P3623, DOI 10.1093/emboj/20.14.3623; Xie ZY, 1996, J BIOL CHEM, V271, P4632; Xie ZY, 1998, GENETICS, V148, P681; Yamashita E, 2007, J MOL BIOL, V370, P39, DOI 10.1016/j.jmb.2007.04.011; Zatsman AI, 2006, J AM CHEM SOC, V128, P14246, DOI 10.1021/ja065798m; Zhang HM, 2004, BIOCHEMISTRY-US, V43, P16329, DOI 10.1021/bi048363p	58	29	35	0	6	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	SEP 5	2008	283	36					24608	24616		10.1074/jbc.M803869200	http://dx.doi.org/10.1074/jbc.M803869200			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	342YR	18593701	Green Published, hybrid			2022-12-27	WOS:000258820000033
J	Nakajima, A; Kurihara, H; Yagita, H; Okumura, K; Nakano, H				Nakajima, Akihito; Kurihara, Hidetake; Yagita, Hideo; Okumura, Ko; Nakano, Hiroyasu			Mitochondrial extrusion through the cytoplasmic vacuoles during cell death	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							NF-KAPPA-B; JNK ACTIVATION; C-FLIPL; APOPTOSIS; AUTOPHAGY; ACCUMULATION; MECHANISM; PROTEIN	Under various conditions, noxious stimuli damage mitochondria, resulting in mitochondrial fragmentation; however, the mechanisms by which fragmented mitochondria are eliminated from the cells remain largely unknown. Here we show that cytoplasmic vacuoles originating from the plasma membrane engulfed fragmented mitochondria and subsequently extruded them into the extracellular spaces in undergoing acute tumor necrosis factor alpha-induced cell death in a caspase-dependent fashion. Notably, upon fusion of the membrane encapsulating mitochondria to the plasma membrane, naked mitochondria were released into the extracellular spaces in an exocytotic manner. Mitochondrial extrusion was specific to tumor necrosis factor alpha-induced cell death, because a genotoxic stress-inducing agent such as cisplatin did not elicit mitochondrial extrusion. Moreover, intact actin and tubulin cytoskeletons were required for mitochondrial extrusion as well as membrane blebbing. Furthermore, fragmented mitochondria were engulfed by cytoplasmic vacuoles and extruded from hepatocytes of mice injected with anti-Fas antibody, suggesting that mitochondrial extrusion can be observed in vivo under pathological conditions. Mitochondria are eliminated during erythrocyte maturation under physiological conditions, and anti-mitochondrial antibody is detected in some autoimmune diseases. Thus, elucidating the mechanism underlying mitochondrial extrusion will open a novel avenue leading to better understanding of various diseases caused by mitochondrial malfunction as well as mitochondrial biology.	[Nakajima, Akihito; Yagita, Hideo; Okumura, Ko; Nakano, Hiroyasu] Juntendo Univ, Sch Med, Dept Immunol, Bunkyo Ku, Tokyo 1138421, Japan; [Kurihara, Hidetake] Juntendo Univ, Sch Med, Dept Anat, Bunkyo Ku, Tokyo 1138421, Japan	Juntendo University; Juntendo University	Nakajima, A (corresponding author), Juntendo Univ, Sch Med, Dept Immunol, Bunkyo Ku, 2-1-1 Hongo, Tokyo 1138421, Japan.	anakaji@med.juntendo.ac.jp; hnakano@med.juntendo.ac.jp		Nakano, Hiroyasu/0000-0003-4843-1427	21st Century Center of Excellence Research; High-Tech Research Center Project for Private Universities; Ministry of Education, Culture, Sports, Science and Technology, Japan; Japan Society for the Promotion of Science, Japan; Tokyo Biochemical Research Foundation; Mitsubishi Pharma Foundation; NOVARTIS Foundation (Japan)	21st Century Center of Excellence Research(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); High-Tech Research Center Project for Private Universities(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); Ministry of Education, Culture, Sports, Science and Technology, Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); Japan Society for the Promotion of Science, Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science); Tokyo Biochemical Research Foundation; Mitsubishi Pharma Foundation; NOVARTIS Foundation (Japan)(Novartis)	This work was supported in part by grants-in-aid for 21st Century Center of Excellence Research, High-Tech Research Center Project for Private Universities; a matching fund subsidy from the Ministry of Education, Culture, Sports, Science and Technology, Japan, and Scientific Research (B) and (C), and Young Scientists (B) from Japan Society for the Promotion of Science, Japan; and grants from the Tokyo Biochemical Research Foundation, the Mitsubishi Pharma Foundation, and NOVARTIS Foundation (Japan) for the Promotion of Science. The costs of publication of this article were defrayed in part by the payment of page charges. This article must therefore be hereby marked "advertisement" in accordance with 18 U.S.C. Section 1734 solely to indicate this fact.	Asanuma K, 2003, FASEB J, V17, P1165, DOI 10.1096/fj.02-0580fje; Blott EJ, 2002, NAT REV MOL CELL BIO, V3, P122, DOI 10.1038/nrm732; Brooks C, 2007, P NATL ACAD SCI USA, V104, P11649, DOI 10.1073/pnas.0703976104; Budd RC, 2006, NAT REV IMMUNOL, V6, P196, DOI 10.1038/nri1787; Cereghetti GM, 2006, ONCOGENE, V25, P4717, DOI 10.1038/sj.onc.1209605; Chan DC, 2006, CELL, V125, P1241, DOI 10.1016/j.cell.2006.06.010; Chang LF, 2006, CELL, V124, P601, DOI 10.1016/j.cell.2006.01.021; Coleman ML, 2001, NAT CELL BIOL, V3, P339, DOI 10.1038/35070009; Edinger AL, 2004, ONCOGENE, V23, P5654, DOI 10.1038/sj.onc.1207738; Erwig LP, 2008, CELL DEATH DIFFER, V15, P243, DOI 10.1038/sj.cdd.4402184; Green DR, 2004, SCIENCE, V305, P626, DOI 10.1126/science.1099320; Kaplan MM, 2005, NEW ENGL J MED, V353, P1261, DOI 10.1056/NEJMra043898; Karin M, 2002, NAT IMMUNOL, V3, P221, DOI 10.1038/ni0302-221; Levine B, 2005, J CLIN INVEST, V115, P2679, DOI 10.1172/JCI26390; Lyamzaev KG, 2008, BBA-BIOENERGETICS, V1777, P817, DOI 10.1016/j.bbabio.2008.03.027; Mizushima N, 1998, NATURE, V395, P395, DOI 10.1038/26506; Nakajima A, 2008, ONCOGENE, V27, P76, DOI 10.1038/sj.onc.1210624; Nakajima A, 2006, EMBO J, V25, P5549, DOI 10.1038/sj.emboj.7601423; Nakano H, 2006, CELL DEATH DIFFER, V13, P730, DOI 10.1038/sj.cdd.4401830; OGASAWARA J, 1993, NATURE, V364, P806, DOI 10.1038/364806a0; Ohsumi Y, 2001, NAT REV MOL CELL BIO, V2, P211, DOI 10.1038/35056522; Sakon S, 2003, EMBO J, V22, P3898, DOI 10.1093/emboj/cdg379; Sasazuki T, 2002, J BIOL CHEM, V277, P28853, DOI 10.1074/jbc.M203190200; Sebbagh M, 2005, J EXP MED, V201, P465, DOI 10.1084/jem.20031877; SIMPSON CF, 1967, J CELL BIOL, V35, P237, DOI 10.1083/jcb.35.1.237; Stollar BD, 2002, LUPUS, V11, P787, DOI 10.1191/0961203302lu318oa; Sun MG, 2007, NAT CELL BIOL, V9, P1057, DOI 10.1038/ncb1630; Wallach D, 1999, ANNU REV IMMUNOL, V17, P331, DOI 10.1146/annurev.immunol.17.1.331; Wang XD, 2001, GENE DEV, V15, P2922; Youle RJ, 2005, NAT REV MOL CELL BIO, V6, P657, DOI 10.1038/nrm1697	30	50	54	0	4	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	AUG 29	2008	283	35					24128	24135		10.1074/jbc.M802996200	http://dx.doi.org/10.1074/jbc.M802996200			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	340II	18593703	Green Published, hybrid			2022-12-27	WOS:000258638900066
J	Saxena, R; Kanudia, P; Datt, M; Dar, HH; Karthikeyan, S; Singh, B; Chakraborti, PK				Saxena, Rahul; Kanudia, Pavitra; Datt, Manish; Dar, Haider Hussain; Karthikeyan, Subramanian; Singh, Balvinder; Chakraborti, Pradip K.			Three consecutive arginines are important for the mycobacterial peptide deformylase enzyme activity	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							BACTERIUM LEPTOSPIRA-INTERROGANS; TERMINAL METHIONINE EXCISION; POLYPEPTIDE DEFORMYLASE; ESCHERICHIA-COLI; METHIONYL-TRNA(F)(MET) FORMYLTRANSFERASE; STAPHYLOCOCCUS-AUREUS; TUBERCULOSIS; INHIBITORS; TARGET; TRANSLATION	Genes encoding the peptide deformylase enzyme (def) are present in all eubacteria and are involved in the deformylation of the N-formyl group of newly synthesized polypeptides during protein synthesis. We compared the amino acid sequences of this enzyme in different mycobacterial species and found that they are highly conserved (76% homology with 62% identity); however, when this comparison was extended to other eubacterial homologs, it emerged that the mycobacterial proteins have an insertion region containing three consecutive arginine residues (residues 77-79 in Mycobacterium tuberculosis peptide deformylase (mPDF)). Here, we demonstrate that these three arginines are important for the activity of mPDF. Circular dichroism studies of wild-type mPDF and of mPDF containing individual conservative substitutions (R77K, R78K, or R79K) or combined substitutions incorporated into a triple mutant (R77K/R78K/R79K) indicate that such mutations cause mPDF to undergo structural alterations. Molecular modeling of mPDF suggests that the three arginines are distal to the active site. Molecular dynamics simulations of wild-type and mutant mPDF structures indicate that the arginines may be involved in the stabilization of substrate binding pocket residues for their proper interaction with peptide(s). Treatment with 5 '-phosphothiorate-modified antisense oligodeoxyribonucleotides directed against different regions of def from M. tuberculosis inhibits growth of Mycobacterium smegmatis in culture. Taken together, these results hold out the possibility of future design of novel mycobacteria-specific PDF inhibitors.	[Saxena, Rahul; Kanudia, Pavitra; Datt, Manish; Dar, Haider Hussain; Karthikeyan, Subramanian; Singh, Balvinder; Chakraborti, Pradip K.] CSIR, Inst Microbial Technol, Chandigarh 160036, India	Council of Scientific & Industrial Research (CSIR) - India; CSIR - Institute of Microbial Technology (IMTECH)	Chakraborti, PK (corresponding author), CSIR, Inst Microbial Technol, Sector 39A, Chandigarh 160036, India.	pradip@imtech.res.in	Dar, Haider/AAE-3582-2021; DAR, HILAL/HHM-3664-2022; Karthikeyan, Subramanian/F-8808-2010; Datt, Manish/AAD-6989-2019	Dar, Haider H./0000-0001-9586-7288; Datt, Manish/0000-0002-9578-4113	Council of Scientific and Industrial Research, New Delhi [SMM003]; Department of Biotechnology (New Delhi, India)	Council of Scientific and Industrial Research, New Delhi(Council of Scientific & Industrial Research (CSIR) - India); Department of Biotechnology (New Delhi, India)(Department of Biotechnology (DBT) India)	This work was supported by Council of Scientific and Industrial Research, New Delhi (under network program SMM003) and Department of Biotechnology (New Delhi, India) and financial support in the form of research fellowships (to R. S., P. K., H. H. D., and M. D.). The costs of publication of this article were defrayed in part by the payment of page charges. This article must therefore be hereby marked "advertisement" in accordance with 18 U.S.C. Section 1734 solely to indicate this fact.	ALTSCHUL SF, 1997, NUCLEIC ACIDS RES, V25, P3402; Becker A, 1998, NAT STRUCT BIOL, V5, P1053, DOI 10.1038/4162; Boggetto N, 2002, BIOL CHEM, V383, P1321, DOI 10.1515/BC.2002.150; Case DA, 2005, J COMPUT CHEM, V26, P1668, DOI 10.1002/jcc.20290; Chaba R, 2002, EUR J BIOCHEM, V269, P1078, DOI 10.1046/j.1432-1033.2002.02778.x; Chivian D, 2003, PROTEINS, V53, P524, DOI 10.1002/prot.10529; Cynamon MH, 2004, J ANTIMICROB CHEMOTH, V53, P403, DOI 10.1093/jac/dkh054; DeLano WL, 1998, PYMOL MOL GRAPHICS S; Duan Y, 2003, J COMPUT CHEM, V24, P1999, DOI 10.1002/jcc.10349; Fieulaine S, 2005, J BIOL CHEM, V280, P42315, DOI 10.1074/jbc.M507155200; Flint JL, 2004, P NATL ACAD SCI USA, V101, P12598, DOI 10.1073/pnas.0404892101; Giglione C, 2004, CELL MOL LIFE SCI, V61, P1455, DOI 10.1007/s00018-004-3466-8; Giglione C, 2003, EMBO J, V22, P13, DOI 10.1093/emboj/cdg007; Giglione C, 2001, TRENDS PLANT SCI, V6, P566, DOI 10.1016/S1360-1385(01)02151-3; Giglione C, 2000, MOL MICROBIOL, V36, P1197, DOI 10.1046/j.1365-2958.2000.01908.x; Ginsberg AM, 2007, NAT MED, V13, P290, DOI 10.1038/nm0307-290; Harth G, 2002, P NATL ACAD SCI USA, V99, P15614, DOI 10.1073/pnas.242612299; Harth G, 2000, P NATL ACAD SCI USA, V97, P418, DOI 10.1073/pnas.97.1.418; KOZAK M, 1983, MICROBIOL REV, V47, P1; Kreusch A, 2003, J MOL BIOL, V330, P309, DOI 10.1016/S0022-2836(03)00596-5; LANDT O, 1990, GENE, V96, P125, DOI 10.1016/0378-1119(90)90351-Q; LASKOWSKI RA, 1993, J APPL CRYSTALLOGR, V26, P283, DOI 10.1107/S0021889892009944; Leeds JA, 2006, CURR OPIN PHARMACOL, V6, P445, DOI 10.1016/j.coph.2006.06.003; Li YK, 2002, BIOCHEM BIOPH RES CO, V295, P884, DOI 10.1016/S0006-291X(02)00777-5; Margolis PS, 2000, ANTIMICROB AGENTS CH, V44, P1825, DOI 10.1128/AAC.44.7.1825-1831.2000; Mazel D, 1997, J MOL BIOL, V266, P939, DOI 10.1006/jmbi.1996.0835; MAZEL D, 1994, EMBO J, V13, P914, DOI 10.1002/j.1460-2075.1994.tb06335.x; Meinnel T, 1996, FEBS LETT, V385, P91, DOI 10.1016/0014-5793(96)00357-2; MEINNEL T, 1993, BIOCHIMIE, V75, P1061, DOI 10.1016/0300-9084(93)90005-D; MEINNEL T, 1994, J BACTERIOL, V176, P7387, DOI 10.1128/JB.176.23.7387-7390.1994; MEINNEL T, 1993, J BACTERIOL, V175, P7737, DOI 10.1128/JB.175.23.7737-7740.1993; Nguyen KT, 2003, BIOCHEMISTRY-US, V42, P9952, DOI 10.1021/bi0346446; Rajagopalan PTR, 1997, BIOCHEMISTRY-US, V36, P13910, DOI 10.1021/bi971155v; Rajagopalan PTR, 1998, J BIOL CHEM, V273, P22305, DOI 10.1074/jbc.273.35.22305; RYCKAERT JP, 1977, J COMPUT PHYS, V23, P327, DOI 10.1016/0021-9991(77)90098-5; Sarin J, 2001, J BIOL CHEM, V276, P44590, DOI 10.1074/jbc.M105401200; Saxena R, 2005, J BACTERIOL, V187, P8216, DOI 10.1128/JB.187.23.8216-8220.2005; Saxena R, 2005, BIOCHEM BIOPH RES CO, V332, P418, DOI 10.1016/j.bbrc.2005.04.142; SHIRLEY K, 1995, PCR PRIMER LAB MANUA, P143; Smith KJ, 2003, PROTEIN SCI, V12, P349, DOI 10.1110/ps.0229303; Teo JWP, 2006, ANTIMICROB AGENTS CH, V50, P3665, DOI 10.1128/AAC.00555-06; Thompson JD, 1997, NUCLEIC ACIDS RES, V25, P4876, DOI 10.1093/nar/25.24.4876; Vullo A, 2006, NUCLEIC ACIDS RES, V34, pW164, DOI 10.1093/nar/gkl166; Yuan ZY, 2006, BIOCHEM PHARMACOL, V71, P1042, DOI 10.1016/j.bcp.2005.10.015; Zhou ZC, 2004, J MOL BIOL, V339, P207, DOI 10.1016/j.jmb.2004.03.045	45	5	5	0	4	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	AUG 29	2008	283	35					23754	23764		10.1074/jbc.M709672200	http://dx.doi.org/10.1074/jbc.M709672200			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	340II	18574247	Green Published, hybrid			2022-12-27	WOS:000258638900029
J	Shi, JH; Zhang, TY; Zhou, CL; Chohan, MO; Gu, XS; Wegiel, J; Zhou, JH; Hwang, YW; Iqbal, K; Grundke-Iqbal, I; Gong, CX; Liu, F				Shi, Jianhua; Zhang, Tianyi; Zhou, Chunlei; Chohan, Muhammad Omar; Gu, Xiaosong; Wegiel, Jerzy; Zhou, Jianhua; Hwang, Yu-Wen; Iqbal, Khalid; Grundke-Iqbal, Inge; Gong, Cheng-Xin; Liu, Fei			Increased dosage of Dyrk1A alters alternative splicing factor (ASF)-regulated alternative splicing of tau in Down syndrome	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							GLYCOGEN-SYNTHASE KINASE-3; PRE-MESSENGER-RNA; ALZHEIMERS-DISEASE; FRONTOTEMPORAL DEMENTIA; PROTEIN-KINASE; INTRANUCLEAR DISTRIBUTION; NEUROFIBRILLARY TANGLES; FACTOR ASF/SF2; HUMAN BRAIN; PHOSPHORYLATION	Two groups of tau, 3R-and 4R-tau, are generated by alternative splicing of tau exon 10. Normal adult human brain expresses equal levels of them. Disruption of the physiological balance is a common feature of several tauopathies. Very early in their life, individuals with Down syndrome (DS) develop Alzheimer-type tau pathology, the molecular basis for which is not fully understood. Here, we demonstrate that Dyrk1A, a kinase encoded by a gene in the DS critical region, phosphorylates alternative splicing factor (ASF) at Ser-227, Ser-234, and Ser-238, driving it into nuclear speckles and preventing it from facilitating tau exon 10 inclusion. The increased dosage of Dyrk1A in DS brain due to trisomy of chromosome 21 correlates to an increase in 3R-tau level, which on abnormal hyperphosphorylation and aggregation of tau results in neurofibrillary degeneration. Imbalance of 3R-and 4R-tau in DS brain by Dyrk1A-induced dysregulation of alternative splicing factor-mediated alternative splicing of tau exon 10 represents a novel mechanism of neurofibrillary degeneration and may help explain early onset tauopathy in individuals with DS.	[Shi, Jianhua; Zhang, Tianyi; Zhou, Chunlei; Gu, Xiaosong; Liu, Fei] Nantong Univ, Jiangsu Key Lab Neuroregenerat, Nantong 226001, Peoples R China; [Chohan, Muhammad Omar; Iqbal, Khalid; Grundke-Iqbal, Inge; Gong, Cheng-Xin; Liu, Fei] New York State Inst Basic Res Dev Disabil, Dept Neurochem, New York, NY 10314 USA; [Wegiel, Jerzy] New York State Inst Basic Res Dev Disabil, Dept Dev Neurobiol, New York, NY 10314 USA; [Hwang, Yu-Wen] New York State Inst Basic Res Dev Disabil, Dept Mol Biol, New York, NY 10314 USA; [Zhou, Jianhua] Univ Massachusetts, Sch Med, Dept Med, Worcester, MA 01605 USA; [Zhou, Jianhua] Univ Massachusetts, Sch Med, Program Neurosci, Worcester, MA 01605 USA	Nantong University; Institute for Basic Research in Developmental Disabilities; Institute for Basic Research in Developmental Disabilities; Institute for Basic Research in Developmental Disabilities; University of Massachusetts System; University of Massachusetts Worcester; University of Massachusetts System; University of Massachusetts Worcester	Liu, F (corresponding author), 1050 Forest Hill Rd, Staten Isl, NY 10314 USA.	feiliu63@hotmail.com	Shi, Jianhua/L-8463-2016; Chohan, Muhammad/ABG-1163-2021	Shi, Jianhua/0000-0002-5351-406X; Chohan, Muhammad/0000-0003-4542-4651	National Institutes of Health Grant [AG027429, AG019158, HD43960]; Nantong University; New York State Office of Mental Retardation and Developmental Disabilities; University of Massachusetts Medical School; National Natural Science Foundation of China [30572076, 30770468]; Alzheimer's Association [NIRG-08-91126]; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT [R01HD043960] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON AGING [R01AG019158, R01AG027429] Funding Source: NIH RePORTER	National Institutes of Health Grant(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Nantong University; New York State Office of Mental Retardation and Developmental Disabilities; University of Massachusetts Medical School; National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Alzheimer's Association(Alzheimer's Association); EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))	This work was supported, in whole or in part, by National Institutes of Health Grant Grants AG027429 (to C.- X. G.), AG019158 (to K. I.), and HD43960 (to J. W.). This work was also supported by grants from Nantong University, the New York State Office of Mental Retardation and Developmental Disabilities, and the University of Massachusetts Medical School and by grants from the National Natural Science Foundation of China (Grants 30572076 and 30770468 to F. L.) and Alzheimer's Association (NIRG-08-91126 to F. L.). The costs of publication of this article were defrayed in part by the payment of page charges. This article must therefore be hereby marked " advertisement" in accordance with 18 U. S. C. Section 1734 solely to indicate this fact.	Alonso AD, 2001, J BIOL CHEM, V276, P37967; Alvarez M, 2003, J CELL SCI, V116, P3099, DOI 10.1242/jcs.00618; Andorfer C, 2003, J NEUROCHEM, V86, P582, DOI 10.1046/j.1471-4159.2003.01879.x; ANDREADIS A, 1992, BIOCHEMISTRY-US, V31, P10626, DOI 10.1021/bi00158a027; Arron JR, 2006, NATURE, V441, P595, DOI 10.1038/nature04678; Ballatore C, 2007, NAT REV NEUROSCI, V8, P663, DOI 10.1038/nrn2194; Chen-Hwang MC, 2002, J BIOL CHEM, V277, P17597, DOI 10.1074/jbc.M111101200; Colwill K, 1996, EMBO J, V15, P265, DOI 10.1002/j.1460-2075.1996.tb00357.x; D'Souza I, 2006, J BIOL CHEM, V281, P2460, DOI 10.1074/jbc.M505809200; D'Souza I, 2005, BBA-MOL BASIS DIS, V1739, P104, DOI 10.1016/j.bbadis.2004.08.009; D'Souza I, 1999, P NATL ACAD SCI USA, V96, P5598, DOI 10.1073/pnas.96.10.5598; de Graaf Katrin, 2006, BMC Biochemistry, V7, DOI 10.1186/1471-2091-7-7; Duff K, 2000, NEUROBIOL DIS, V7, P87, DOI 10.1006/nbdi.1999.0279; Galceran J, 2003, J NEURAL TRANSM-SUPP, P139; Gao L, 2007, MOL CELL NEUROSCI, V34, P48, DOI 10.1016/j.mcn.2006.10.004; GOEDERT M, 1989, NEURON, V3, P519, DOI 10.1016/0896-6273(89)90210-9; Goedert M, 2005, BBA-MOL BASIS DIS, V1739, P240, DOI 10.1016/j.bbadis.2004.08.007; Goode BL, 2000, J BIOL CHEM, V275, P38182, DOI 10.1074/jbc.M007489200; GOTZ J, 1995, EMBO J, V14, P1304, DOI 10.1002/j.1460-2075.1995.tb07116.x; Gotz J, 2001, SCIENCE, V293, P1491, DOI 10.1126/science.1062097; GRUNDKEIQBAL I, 1986, P NATL ACAD SCI USA, V83, P4913, DOI 10.1073/pnas.83.13.4913; GRUNDKEIQBAL I, 1986, J BIOL CHEM, V261, P6084; GUI JF, 1994, NATURE, V369, P678, DOI 10.1038/369678a0; GUI JF, 1994, P NATL ACAD SCI USA, V91, P10824, DOI 10.1073/pnas.91.23.10824; Gwack Y, 2006, NATURE, V441, P646, DOI 10.1038/nature04631; Hernandez F, 2004, J BIOL CHEM, V279, P3801, DOI 10.1074/jbc.M311512200; Holtzman DM, 1996, P NATL ACAD SCI USA, V93, P13333, DOI 10.1073/pnas.93.23.13333; Hutton M, 1998, NATURE, V393, P702, DOI 10.1038/31508; Iqbal K, 2005, BBA-MOL BASIS DIS, V1739, P198, DOI 10.1016/j.bbadis.2004.09.008; Ishihara T, 1999, NEURON, V24, P751, DOI 10.1016/S0896-6273(00)81127-7; Karni R, 2007, NAT STRUCT MOL BIOL, V14, P185, DOI 10.1038/nsmb1209; Koizumi J, 1999, J BIOL CHEM, V274, P11125, DOI 10.1074/jbc.274.16.11125; Kondo S, 2004, GENES CELLS, V9, P121, DOI 10.1111/j.1356-9597.2004.00709.x; KOSIK KS, 1989, NEURON, V2, P1389, DOI 10.1016/0896-6273(89)90077-9; Lewis J, 2001, SCIENCE, V293, P1487, DOI 10.1126/science.1058189; Liu F, 2004, P NATL ACAD SCI USA, V101, P10804, DOI 10.1073/pnas.0400348101; LIU F, 2008, FASEB J IN PRESS; Lu M, 2001, MOL BIOL CELL, V12, P171, DOI 10.1091/mbc.12.1.171; Ngo JCK, 2005, MOL CELL, V20, P77, DOI 10.1016/j.molcel.2005.08.025; Rossi F, 1996, NATURE, V381, P80, DOI 10.1038/381080a0; Sengupta A, 2006, FEBS LETT, V580, P5925, DOI 10.1016/j.febslet.2006.09.060; Stanford PM, 2003, BRAIN, V126, P814, DOI 10.1093/brain/awg090; TAKASHIMA A, 1993, P NATL ACAD SCI USA, V90, P7789, DOI 10.1073/pnas.90.16.7789; Vanswieten JC, 2007, J NEUROPATH EXP NEUR, V66, P17, DOI 10.1097/nen.0b013e31802c39a4; Wang J, 1998, GENE DEV, V12, P2222, DOI 10.1101/gad.12.14.2222; Wang YZ, 2005, J BIOL CHEM, V280, P14230, DOI 10.1074/jbc.M413846200; Wegiel J, 2004, BRAIN RES, V1010, P69, DOI 10.1016/j.brainres.2004.03.008; WISNIEWSKI KE, 1985, ANN NEUROL, V17, P278, DOI 10.1002/ana.410170310; Xiao SH, 1998, EMBO J, V17, P6359, DOI 10.1093/emboj/17.21.6359; Xu XD, 2005, CELL, V120, P59, DOI 10.1016/j.cell.2004.11.036; Yoshida M, 2006, NEUROPATHOLOGY, V26, P457, DOI 10.1111/j.1440-1789.2006.00743.x; Yu QM, 2004, J NEUROCHEM, V90, P164, DOI 10.1111/j.1471-4159.2004.02477.x	52	117	120	1	22	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	OCT 17	2008	283	42					28660	28669		10.1074/jbc.M802645200	http://dx.doi.org/10.1074/jbc.M802645200			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	359EN	18658135	Green Published, hybrid			2022-12-27	WOS:000259969300068
J	Pagant, S; Brovman, EY; Halliday, JJ; Miller, EA				Pagant, Silvere; Brovman, Ethan Y.; Halliday, John J.; Miller, Elizabeth A.			Mapping of interdomain interfaces required for the functional architecture of yor1p, a eukaryotic ATP-binding cassette (ABC) transporter	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							TRANSMEMBRANE CONDUCTANCE REGULATOR; DISEASE-ASSOCIATED MUTATIONS; CHLORIDE CHANNEL ACTIVITY; DELTA-F508 MUTATION; CYTOPLASMIC LOOP; P-GLYCOPROTEIN; DOMAIN; MECHANISM; COMPLEX; SIGNAL	ATP-binding cassette (ABC) transporters are a large superfamily of proteins that mediate substrate translocation across biological membranes. Our goal was to define the intramolecular interactions that contribute to quaternary assembly of a eukaryotic ABC transporter and determine how the architecture of this protein influences its biogenesis within the secretory pathway. We used chemical cross-linking approaches to map interdomain interactions in the yeast ABC transporter, Yor1p, which functions as a pleiotropic drug pump at the plasma membrane. We have defined interactions between the two nucleotide-binding domains (NBDs) and between the NBDs and specific intracellular loops (ICLs) that are consistent with current structural models of bacterial ABC exporters. Furthermore, we detected relatively weak NBD-NBD and ICL-ICL interactions that may correspond to transient sites of cross-talk between domains required for coupling of ATP hydrolysis with substrate translocation. Mutation of a key residue in ICL2 caused misassembly of the altered protein, leading to increased sensitivity to the mitochondrial poison, oligomycin. We identified intragenic suppressing mutations that rescued the oligomycin resistance associated with this aberrant protein and demonstrated that the suppressing mutations restored multiple interdomain interfaces. Together, our biochemical and genetic approaches contribute to a greater understanding of the architecture of this important class of proteins and provide insight into the quality control surveillance that regulates their biogenesis and deployment within the eukaryotic cell.	[Pagant, Silvere; Brovman, Ethan Y.; Halliday, John J.; Miller, Elizabeth A.] Columbia Univ, Dept Biol Sci, New York, NY 10027 USA	Columbia University	Miller, EA (corresponding author), 617A Fairchild Ctr, MC 2456, New York, NY 10027 USA.	em2282@columbia.edu		Miller, Elizabeth/0000-0002-1033-8369	National Institutes of Health [GM078186]; Cystic Fibrosis Foundation [PAGANT08F0]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM078186] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Cystic Fibrosis Foundation(Italian Cystic Fibrosis Research Foundation); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported, in whole or in part, by National Institutes of Health Grant GM078186 (to E. M.). This work was also supported by Cystic Fibrosis Foundation Grant PAGANT08F0 (to S. P.). The costs of publication of this article were defrayed in part by the payment of page charges. This article must therefore be hereby marked "advertisement" in accordance with 18 U. S. C. Section 1734 solely to indicate this fact.	Chen EY, 2004, J BIOL CHEM, V279, P39620, DOI 10.1074/jbc.M407887200; Chen J, 2003, MOL CELL, V12, P651, DOI 10.1016/j.molcel.2003.08.004; Dawson RJP, 2007, FEBS LETT, V581, P935, DOI 10.1016/j.febslet.2007.01.073; Dawson RJP, 2006, NATURE, V443, P180, DOI 10.1038/nature05155; Fetsch EE, 2002, P NATL ACAD SCI USA, V99, P9685, DOI 10.1073/pnas.152204499; Herget M, 2007, J BIOL CHEM, V282, P3871, DOI 10.1074/jbc.M608480200; Hollenstein K, 2007, NATURE, V446, P213, DOI 10.1038/nature05626; Hopfner KP, 2000, CELL, V101, P789, DOI 10.1016/S0092-8674(00)80890-9; KATZMANN DJ, 1995, MOL CELL BIOL, V15, P6875; Kopito Ron R., 1999, Physiological Reviews, V79, pS167; Lewis HA, 2005, J BIOL CHEM, V280, P1346, DOI 10.1074/jbc.M410968200; Linton KJ, 2007, PHYSIOLOGY, V22, P122, DOI 10.1152/physiol.00046.2006; Locher KP, 2002, SCIENCE, V296, P1091, DOI 10.1126/science.1071142; Loo TW, 2002, J BIOL CHEM, V277, P41303, DOI 10.1074/jbc.C200484200; Mense M, 2006, EMBO J, V25, P4728, DOI 10.1038/sj.emboj.7601373; Pagant S, 2007, MOL BIOL CELL, V18, P3398, DOI 10.1091/mbc.E07-01-0046; Pinkett HW, 2007, SCIENCE, V315, P373, DOI 10.1126/science.1133488; RIORDAN JR, 1989, SCIENCE, V245, P1066; Seibert FS, 1996, J BIOL CHEM, V271, P27493, DOI 10.1074/jbc.271.44.27493; Seibert FS, 1997, BIOCHEMISTRY-US, V36, P11966, DOI 10.1021/bi9712652; Seibert FS, 1996, J BIOL CHEM, V271, P15139, DOI 10.1074/jbc.271.25.15139; Serohijos AWR, 2008, P NATL ACAD SCI USA, V105, P3256, DOI 10.1073/pnas.0800254105; Smith PC, 2002, MOL CELL, V10, P139, DOI 10.1016/S1097-2765(02)00576-2; Ward A, 2007, P NATL ACAD SCI USA, V104, P19005, DOI 10.1073/pnas.0709388104; Zaitseva J, 2005, BIOCHEMISTRY-US, V44, P9680, DOI 10.1021/bi0506122; Zolnerciks JK, 2007, FASEB J, V21, P3937, DOI 10.1096/fj.07-8610com	26	22	22	0	1	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	SEP 26	2008	283	39					26444	26451		10.1074/jbc.M803912200	http://dx.doi.org/10.1074/jbc.M803912200			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	350GV	18644782	Green Published, hybrid			2022-12-27	WOS:000259341600019
J	Szczesny, B; Tann, AW; Longley, MJ; Copeland, WC; Mitra, S				Szczesny, Bartosz; Tann, Anne W.; Longley, Matthew J.; Copeland, William C.; Mitra, Sankar			Long patch base excision repair in mammalian mitochondrial Genomes	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							DNA-POLYMERASE-GAMMA; OXIDATIVE DAMAGE; ABASIC SITES; HUMAN-CELLS; IDENTIFICATION; NUCLEAR; ENDONUCLEASE; BINDING; URACIL; PURIFICATION	The mitochondrial genome is highly susceptible to damage by reactive oxygen species (ROS) generated endogenously as a by-product of respiration. ROS-induced DNA lesions, including oxidized bases, abasic (AP) sites, and oxidized AP sites, cause DNA strand breaks and are repaired via the base excision repair (BER) pathway in both the nucleus and mitochondria. Repair of damaged bases and AP sites involving 1-nucleotide incorporation, named single nucleotide (SN)-BER, was observed with mitochondrial and nuclear extracts. During SN-BER, the 5'-phosphodeoxyribose (dRP) moiety, generated by AP-endonuclease (APE1), is removed by the lyase activity of DNA polymerase gamma (pol gamma) and polymerase beta in the mitochondria and nucleus, respectively. However, the repair of oxidized deoxyribose fragments at the 5' terminus after strand break would require 5'-exo/endonuclease activity that is provided by the flap endonuclease (FEN-1) in the nucleus, resulting in multinucleotide repair patch (long patch (LP)-BER). Here we show the presence of a 5'-exo/endonuclease in the mitochondrial extracts of mouse and human cells that is involved in the repair of a lyase-resistant AP site analog via multinucleotide incorporation, upstream and downstream to the lesion site. We conclude that LP-BER also occurs in the mitochondria requiring the 5'-exo/endonuclease and pol gamma with 3'-exonuclease activity. Although a FEN-1 antibody cross-reacting species was detected in the mitochondria, it was absent in the LP-BER-proficient APE1 immunocomplex isolated from the mitochondrial extract that contains APE1, pol gamma, and DNA ligase 3. The LP-BER activity was marginally affected in FEN-1-depleted mitochondrial extracts, further supporting the involvement of an unidentified 5'-exo/endonuclease in mitochondrial LP-BER.	[Szczesny, Bartosz; Tann, Anne W.; Mitra, Sankar] Univ Texas Med Branch, Dept Biochem & Mol Biol, Galveston, TX 77555 USA; [Longley, Matthew J.; Copeland, William C.] NIEHS, NIH, Res Triangle Pk, NC 27709 USA	University of Texas System; University of Texas Medical Branch Galveston; National Institutes of Health (NIH) - USA; NIH National Institute of Environmental Health Sciences (NIEHS)	Mitra, S (corresponding author), Univ Texas Med Branch, Dept Biochem & Mol Biol, Galveston, TX 77555 USA.	samitra@utmb.edu	Copeland, William/C-4242-2019	Copeland, William/0000-0002-0359-0953	National Institutes of Health; United States Public Health Service [P01 AG10514, R01 CA53791]; NATIONAL CANCER INSTITUTE [R01CA053791] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES [Z01ES065078] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON AGING [P01AG010514] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); United States Public Health Service(United States Department of Health & Human ServicesUnited States Public Health Service); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))	This work was supported, in whole or in part, by National Institutes of Health intramural research funds (to W. C. C.). This work was also supported by United States Public Health Service Grants P01 AG10514 and R01 CA53791 (to S. M.). The costs of publication of this article were defrayed in part by the payment of page charges. This article must therefore be hereby marked "advertisement" in accordance with 18 U. S. C. Section 1734 solely to indicate this fact.	Akbari M, 2008, DNA REPAIR, V7, P605, DOI 10.1016/j.dnarep.2008.01.002; Almeida KH, 2007, DNA REPAIR, V6, P695, DOI 10.1016/j.dnarep.2007.01.009; ANDERSON S, 1981, NATURE, V290, P457, DOI 10.1038/290457a0; BARZILAY G, 1995, NAT STRUCT BIOL, V2, P561, DOI 10.1038/nsb0795-561; Bogenhagen DF, 2001, PROG NUCLEIC ACID RE, V68, P257; Bouex P, 2002, BBA-GENE STRUCT EXPR, V1574, P72, DOI 10.1016/S0167-4781(01)00347-5; CLAYTON DA, 1974, P NATL ACAD SCI USA, V71, P2777, DOI 10.1073/pnas.71.7.2777; Das A, 2006, DNA REPAIR, V5, P1439, DOI 10.1016/j.dnarep.2006.07.003; Dizdaroglu M, 2002, FREE RADICAL BIO MED, V32, P1102, DOI 10.1016/S0891-5849(02)00826-2; DOMENA JD, 1985, BIOCHEMISTRY-US, V24, P7320, DOI 10.1021/bi00346a045; Fortini P, 2007, DNA REPAIR, V6, P398, DOI 10.1016/j.dnarep.2006.10.008; Gordon DM, 2001, BIOCHEM J, V356, P207, DOI 10.1042/0264-6021:3560207; Hegde ML, 2008, CELL RES, V18, P27, DOI 10.1038/cr.2008.8; Holt IJ, 2000, CELL, V100, P515, DOI 10.1016/S0092-8674(00)80688-1; Izumi T, 1998, CARCINOGENESIS, V19, P525, DOI 10.1093/carcin/19.3.525; Kaguni LS, 2004, ANNU REV BIOCHEM, V73, P293, DOI 10.1146/annurev.biochem.72.121801.161455; Laquel-Robert P, 2007, BBA-GEN SUBJECTS, V1770, P527, DOI 10.1016/j.bbagen.2006.10.003; Larsen NB, 2005, MITOCHONDRION, V5, P89, DOI 10.1016/j.mito.2005.02.002; LINDAHL T, 1972, BIOCHEMISTRY-US, V11, P3618, DOI 10.1021/bi00769a019; Liu P, 2008, MOL CELL BIOL, V28, P4975, DOI 10.1128/MCB.00457-08; Longley MJ, 1998, P NATL ACAD SCI USA, V95, P12244, DOI 10.1073/pnas.95.21.12244; Mandavilli BS, 2002, MUTAT RES-FUND MOL M, V509, P127, DOI 10.1016/S0027-5107(02)00220-8; MATSUMOTO Y, 1995, SCIENCE, V269, P699, DOI 10.1126/science.7624801; MATSUMOTO Y, 1994, MOL CELL BIOL, V14, P6187, DOI 10.1128/MCB.14.9.6187; Piersen CE, 1996, J BIOL CHEM, V271, P17811, DOI 10.1074/jbc.271.30.17811; Pinz KG, 1998, MOL CELL BIOL, V18, P1257, DOI 10.1128/MCB.18.3.1257; Ramana CV, 1998, P NATL ACAD SCI USA, V95, P5061, DOI 10.1073/pnas.95.9.5061; RICHTER C, 1995, INT J BIOCHEM CELL B, V27, P647, DOI 10.1016/1357-2725(95)00025-K; RICHTER C, 1988, P NATL ACAD SCI USA, V85, P6465, DOI 10.1073/pnas.85.17.6465; ROBIN ED, 1988, J CELL PHYSIOL, V136, P507, DOI 10.1002/jcp.1041360316; Roginskaya M, 2005, RADIAT RES, V163, P85, DOI 10.1667/RR3288; Schulke N, 1999, J BIOL CHEM, V274, P22847, DOI 10.1074/jbc.274.32.22847; Stierum RH, 1999, NUCLEIC ACIDS RES, V27, P3712, DOI 10.1093/nar/27.18.3712; Stucki M, 2001, J BIOL CHEM, V276, P7843, DOI 10.1074/jbc.M008829200; Sung JS, 2006, FEBS J, V273, P1620, DOI 10.1111/j.1742-4658.2006.05192.x; Szczesny B, 2005, MECH AGEING DEV, V126, P1071, DOI 10.1016/j.mad.2005.04.001; Szczesny B, 2003, P NATL ACAD SCI USA, V100, P10670, DOI 10.1073/pnas.1932854100	37	122	126	1	3	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	SEP 26	2008	283	39					26349	26356		10.1074/jbc.M803491200	http://dx.doi.org/10.1074/jbc.M803491200			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	350GV	18635552	Green Published, hybrid			2022-12-27	WOS:000259341600008
J	Agarwal, R; Swaminathan, S				Agarwal, Rakhi; Swaminathan, Subramanyam			SNAP-25 substrate peptide (residues 180-183) binds to but bypasses cleavage by catalytically active Clostridium botulinum neurotoxin E	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							AMINO-ACID-COMPOSITION; LIGHT-CHAIN; ANGSTROM RESOLUTION; STRUCTURAL-ANALYSIS; POTENT INHIBITORS; CRYSTAL-STRUCTURE; SEROTYPE-F; RECOGNITION; PROTEASE; PURIFICATION	Clostridium botulinum neurotoxins are the most potent toxins to humans. The recognition and cleavage of SNAREs are prime evente in exhibiting their toxicity. We report here the crystal structure of the catalytically active full-length botulinum serotype E catalytic domain (BoNT E) in complex with SNAP-25 (a SNARE protein) substrate peptide Arg(180)-Ile(181)-Met(182)-Glu(183) (P1-P3'). It is remarkable that the peptide spanning the scissile bond binds to but bypasses cleavage by the enzyme and inhibits the catalysis fairly with K-i similar to 69 mu M. The inhibitory peptide occupies the active site of BoNT E and shows well defined electron density. The catalytic zinc and the conserved key residue Tyr(350) of the enzyme facilitate the docking of Arg(180) (P1) by interacting with its carbonyl oxygen that displaces the nucleophilic water. The general base Glu(212) side chain interacts with the main chain amino group of P1 and P1'. Conserved Arg(347) of BoNT E stabilizes the proper docking of the Ile(181) (P1') main chain, whereas the hydrophobic pockets stabilize the side chains of Ile181 (P1') and Met(182) (P2'), and the 250 loop stabilizes Glu(183) (P3'). Structural and functional analysis revealed an important role for the P1' residue and S1' pocket in driving substrate recognition and docking at the active site. This study is the first of its kind and rationalizes the substrate cleavage strategy of BoNT E. Also, our complex structure opens up an excellent opportunity of structure-based drug design for this fast acting and extremely toxic high priority BoNT E.	[Agarwal, Rakhi; Swaminathan, Subramanyam] Brookhaven Natl Lab, Dept Biol, Upton, NY 11973 USA	United States Department of Energy (DOE); Brookhaven National Laboratory	Swaminathan, S (corresponding author), Brookhaven Natl Lab, Dept Biol, Upton, NY 11973 USA.	swami@bnl.gov			National Institutes of Health [1R56Al058175]; Department of Energy Prime [DEAC02-98CH10886];  [DAMD1702-2];  [DTRA BO742081]	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Department of Energy Prime(United States Department of Energy (DOE)); ; 	This work was supported, in whole or in part, by National Institutes of Health Grant 1R56Al058175. This work was also supported by Grants DAMD1702-2 and DTRA BO742081 under Department of Energy Prime Contract DEAC02-98CH10886 with the Brookhaven National Laboratory. The costs of publication of this article were defrayed in part by the payment of page charges. This article must therefore be hereby marked "advertisement" in accordance with 18 U. S. C. Section 1734 solely to indicate this fact.	Adler M, 1998, FEBS LETT, V429, P234, DOI 10.1016/S0014-5793(98)00492-X; Agarwal R, 2005, BIOCHEMISTRY-US, V44, P11758, DOI 10.1021/bi0510072; Agarwal R, 2005, BIOCHEMISTRY-US, V44, P8291, DOI 10.1021/bi050253a; Agarwal R, 2004, BIOCHEMISTRY-US, V43, P6637, DOI 10.1021/bi036278w; Agarwal R, 2004, PROTEIN EXPRES PURIF, V34, P95, DOI 10.1016/j.pep.2003.10.017; Anne C, 2005, CHEMBIOCHEM, V6, P1375, DOI 10.1002/cbic.200400398; Anne C, 2003, J MED CHEM, V46, P4648, DOI 10.1021/jm0300680; Arndt JW, 2006, BIOCHEMISTRY-US, V45, P3255, DOI 10.1021/bi052518r; Arndt JW, 2005, BIOCHEMISTRY-US, V44, P9574, DOI 10.1021/bi0505924; Blommaert A, 2004, BIOORGAN MED CHEM, V12, P3055, DOI 10.1016/j.bmc.2004.03.006; Breidenbach MA, 2004, NATURE, V432, P925, DOI 10.1038/nature03123; Brunger AT, 1998, ACTA CRYSTALLOGR D, V54, P905, DOI 10.1107/S0907444998003254; Burnett JC, 2007, J MED CHEM, V50, P2127, DOI 10.1021/jm061446e; Burnett JC, 2007, J BIOL CHEM, V282, P5004, DOI 10.1074/jbc.M608166200; Burnett JC, 2005, BIOORGAN MED CHEM, V13, P333, DOI 10.1016/j.bmc.2004.10.026; Chen S, 2006, J BIOL CHEM, V281, P10906, DOI 10.1074/jbc.M513032200; Chen S, 2007, J BIOL CHEM, V282, P25540, DOI 10.1074/jbc.M701922200; DASGUPTA BR, 1983, TOXICON, V21, P566, DOI 10.1016/0041-0101(83)90136-8; DASGUPTA BR, 1983, TOXICON, V21, P535, DOI 10.1016/0041-0101(83)90131-9; DeLano WL, 2002, PYMOL USERS MANUAL; Fiebig KM, 1999, NAT STRUCT BIOL, V6, P117; Foran P, 1996, BIOCHEMISTRY-US, V35, P2630, DOI 10.1021/bi9519009; Hanson MA, 2000, NAT STRUCT BIOL, V7, P687, DOI 10.1038/77997; Jin RS, 2007, BIOCHEMISTRY-US, V46, P10685, DOI 10.1021/bi701162d; Johnson SL, 2008, CHEM BIOL DRUG DES, V71, P131, DOI 10.1111/j.1747-0285.2007.00617.x; Kumaran D, 2008, J BIOL CHEM, V283, P18883, DOI 10.1074/jbc.M801240200; MONTECUCCO C, 1994, MOL MICROBIOL, V13, P1, DOI 10.1111/j.1365-2958.1994.tb00396.x; SATHYAMOORTHY V, 1985, J BIOL CHEM, V260, P461; SATHYAMOORTHY V, 1985, BIOCHEM BIOPH RES CO, V127, P768, DOI 10.1016/S0006-291X(85)80009-7; Schiavo G, 2000, PHYSIOL REV, V80, P717, DOI 10.1152/physrev.2000.80.2.717; Schmidt JJ, 2005, BIOCHEMISTRY-US, V44, P4067, DOI 10.1021/bi0477642; Segelke B, 2004, P NATL ACAD SCI USA, V101, P6888, DOI 10.1073/pnas.0400584101; Silvaggi NR, 2008, BIOCHEMISTRY-US, V47, P5736, DOI 10.1021/bi8001067; Silvaggi NR, 2007, CHEM BIOL, V14, P533, DOI 10.1016/j.chembiol.2007.03.014; Studier FW, 2005, PROTEIN EXPRES PURIF, V41, P207, DOI 10.1016/j.pep.2005.01.016; Vaidyanathan VV, 1999, J NEUROCHEM, V72, P327, DOI 10.1046/j.1471-4159.1999.0720327.x; Wang JF, 2008, J BIOL CHEM, V283, P16993, DOI 10.1074/jbc.M710442200; Washbourne P, 1997, FEBS LETT, V418, P1, DOI 10.1016/S0014-5793(97)01328-8	38	21	21	0	3	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	SEP 19	2008	283	38					25944	25951		10.1074/jbc.M803756200	http://dx.doi.org/10.1074/jbc.M803756200			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	348GX	18658150	Green Published, hybrid			2022-12-27	WOS:000259200100022
J	Romanowska, E; Kargul, J; Powikrowska, M; Finazzi, G; Nield, J; Drozak, A; Pokorska, B				Romanowska, Elzbieta; Kargul, Joanna; Powikrowska, Marta; Finazzi, Giovanni; Nield, Jon; Drozak, Anna; Pokorska, Berenika			Structural organization of photosynthetic apparatus in agranal chloroplasts of Maize	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							BUNDLE-SHEATH CHLOROPLASTS; PLANT PHOTOSYSTEM-I; HARVESTING-COMPLEX-II; PROTEIN COMPLEXES; C-4 PHOTOSYNTHESIS; THYLAKOID MEMBRANE; PROTEOMIC APPROACH; ZEA-MAYS; SUPRAMOLECULAR ORGANIZATION; DIFFERENTIAL EXPRESSION	We investigated the organization of photosystem II (PSII) in agranal bundle sheath thylakoids from a C-4 plant maize. Using blue native/SDS-PAGE and single particle analysis, we show for the first time that PSII in the bundle sheath (BS) chloroplasts exists in a dimeric form and forms light-harvesting complex II (LHCII)center dot PSII supercomplexes. We also demonstrate that a similar set of photosynthetic membrane complexes exists in mesophyll and agranal BS chloroplasts, including intact LHCI center dot PSI supercomplexes, PSI monomers, PSII core dimers, PSII monomers devoid of CP43, LHCII trimers, LHCII monomers, ATP synthase, and cytochrome b(6)f complex. Fluorescence functional measurements clearly indicate that BS chloroplasts contain PSII complexes that are capable of performing charge separation and are efficiently sensitized by the associated LHCII. We identified a fraction of LHCII present within BS thylakoids that is weakly energetically coupled to the PSII reaction center; however, the majority of BS LHCII is shown to be tightly connected to PSII. Overall, we demonstrate that organization of the photosynthetic apparatus in BS agranal chloroplasts of a model C-4 plant is clearly distinct from that of the stroma lamellae of the C-3 plants. In particular, supramolecular organization of the dimeric LHCII center dot PSII in the BS thylakoids strongly suggests that PSII in the BS agranal membranes may donate electrons to PSI. We propose that the residual PSII activity may supply electrons to poise cyclic electron flow around PSI and prevent PSI overoxidation, which is essential for the CO2 fixation in BS cells, and hence, may optimize ATP production within this compartment.	[Romanowska, Elzbieta; Powikrowska, Marta; Drozak, Anna; Pokorska, Berenika] Warsaw Univ, Dept Plant Physiol, PL-02096 Warsaw, Poland; [Kargul, Joanna] Univ London Imperial Coll Sci Technol & Med, Fac Nat Sci, Div Mol Biosci, London SW7 2AZ, England; [Nield, Jon] Univ London, Sch Biol & Chem Sci, London E1 4NS, England; [Finazzi, Giovanni] Univ Paris 06, F-75005 Paris, France; [Finazzi, Giovanni] CNRS, UMR 7141, F-75005 Paris, France	University of Warsaw; Imperial College London; University of London; UDICE-French Research Universities; Sorbonne Universite; Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Biology (INSB)	Romanowska, E (corresponding author), Warsaw Univ, Dept Plant Physiol, Miecznikowa 1, PL-02096 Warsaw, Poland.	romanela@biol.uw.edu.pl	Kargul, Joanna/AGD-9163-2022; Kargul, Joanna/AAN-4227-2021; Drozak, Anna/AAJ-8794-2021; Nield, Jon/C-5892-2013	Kargul, Joanna/0000-0003-1410-1905; Nield, Jon/0000-0001-9983-0239; Drozak, Anna/0000-0002-9616-0214; Romanowska, Elzbieta/0000-0002-7359-0537	Polish Ministry of Science and High Education [N303 036 31/1086]	Polish Ministry of Science and High Education(Ministry of Science and Higher Education, Poland)	The work was supported by Polish Ministry of Science and High Education Grant N303 036 31/1086. The costs of publication of this article were defrayed in part by the payment of page charges. This article must therefore be hereby marked "advertisement" in accordance with 18 U.S.C. Section 1734 solely to indicate this fact.	Albertsson PA, 2001, TRENDS PLANT SCI, V6, P349, DOI 10.1016/S1360-1385(01)02021-0; Allen JF, 2003, SCIENCE, V299, P1530, DOI 10.1126/science.1082833; Allen JF, 2002, CELL, V110, P273, DOI 10.1016/S0092-8674(02)00870-X; AMESZ J, 1962, BIOCHIM BIOPHYS ACTA, V64, P261, DOI 10.1016/0006-3002(62)90736-9; Amunts A, 2007, NATURE, V447, P58, DOI 10.1038/nature05687; ANDERSEN KS, 1972, PLANT PHYSIOL, V49, P461, DOI 10.1104/pp.49.4.461; ANDERSON JM, 1971, BIOCHIM BIOPHYS ACTA, V245, P398, DOI 10.1016/0005-2728(71)90158-7; ARNON DI, 1949, PLANT PHYSIOL, V24, P1, DOI 10.1104/pp.24.1.1; Aro EM, 2005, J EXP BOT, V56, P347, DOI 10.1093/jxb/eri041; Baena-Gonzalez E, 1999, PLANTA, V208, P196, DOI 10.1007/s004250050550; Baena-Gonzalez E, 2002, PHILOS T R SOC B, V357, P1451, DOI 10.1098/rstb.2002.1141; BASSI R, 1986, CARLSBERG RES COMMUN, V51, P363, DOI 10.1007/BF02907312; BASSI R, 1995, EUR J BIOCHEM, V233, P709, DOI 10.1111/j.1432-1033.1995.709_3.x; BASSI R, 1985, EUR J BIOCHEM, V146, P589, DOI 10.1111/j.1432-1033.1985.tb08692.x; Ben-Shem A, 2003, NATURE, V426, P630, DOI 10.1038/nature02200; BISHOP DG, 1970, PHOTOSYNTHESIS PHOTO, P323; Boekema EJ, 2001, BIOCHEMISTRY-US, V40, P1029, DOI 10.1021/bi0015358; BUTLER WL, 1979, BIOCHIM BIOPHYS ACTA, V545, P309, DOI 10.1016/0005-2728(79)90208-1; CHAPMAN KSR, 1980, ARCH BIOCHEM BIOPHYS, V202, P330, DOI 10.1016/0003-9861(80)90435-X; Ciambella C, 2005, PROTEOMICS, V5, P746, DOI 10.1002/pmic.200401129; Danielsson R, 2006, J BIOL CHEM, V281, P14241, DOI 10.1074/jbc.M600634200; Darie CC, 2006, J PLANT PHYSIOL, V163, P800, DOI 10.1016/j.jplph.2005.11.014; Dekker JP, 2005, BBA-BIOENERGETICS, V1706, P12, DOI 10.1016/j.bbabio.2004.09.009; DOWNTON W. J. S., 1971, Photosynthesis and photorespiration, P3; Drozak A, 2006, BBA-BIOENERGETICS, V1757, P1539, DOI 10.1016/j.bbabio.2006.09.001; DUYSENS L. N. M., 1963, P353; Hankamer B, 1997, EUR J BIOCHEM, V243, P422, DOI 10.1111/j.1432-1033.1997.0422a.x; HATCH MD, 1987, BIOCHIM BIOPHYS ACTA, V895, P81, DOI 10.1016/S0304-4173(87)80009-5; Heinemeyer J, 2004, PHYTOCHEMISTRY, V65, P1683, DOI 10.1016/j.phytochem.2004.04.022; Ivanov B, 2005, PLANTA, V220, P572, DOI 10.1007/s00425-004-1367-6; Johnson GN, 2005, J EXP BOT, V56, P407, DOI 10.1093/jxb/eri106; JOLIOT A, 1964, CR HEBD ACAD SCI, V258, P4622; JOLIOT P, 1974, BIOCHIM BIOPHYS ACTA, V357, P267, DOI 10.1016/0005-2728(74)90066-8; Kargul J, 2005, FEBS J, V272, P4797, DOI 10.1111/j.1742-4658.2005.04894.x; Kargul J, 2008, FEBS J, V275, P1056, DOI 10.1111/j.1742-4658.2008.06262.x; Kirchhoff H, 2008, BIOCHEMISTRY-US, V47, P431, DOI 10.1021/bi7017877; Kouril R, 2005, BIOCHEMISTRY-US, V44, P10935, DOI 10.1021/bi051097a; Kugler M, 1997, PHOTOSYNTH RES, V53, P35, DOI 10.1023/A:1005882406718; LAEMMLI UK, 1970, NATURE, V227, P680, DOI 10.1038/227680a0; LAETSCH W. M., 1971, Photosynthesis and photorespiration. Proceedings of a Conference held at Australian National University, Canberra, 23 November-5 December 1970. Sponsored by the Australian Academy of Sciences under the auspices of the Australia-U.S. Agreement on Scientific and Technical Cooperation., P323; LAVERGNE J, 1995, BIOPHYS J, V68, P2474, DOI 10.1016/S0006-3495(95)80429-7; LAVERGNE J, 1991, TRENDS BIOCHEM SCI, V16, P129, DOI 10.1016/0968-0004(91)90054-Y; Leegood RC, 2002, J EXP BOT, V53, P581, DOI 10.1093/jexbot/53.369.581; Ludtke SJ, 2004, STRUCTURE, V12, P1129, DOI 10.1016/j.str.2004.05.006; Mamedov F, 2003, PHYSIOL PLANTARUM, V119, P328, DOI 10.1034/j.1399-3054.2003.00187.x; MAYNE BC, 1970, PHOTOSYNTHESIS PHOTO, P361; MEIERHOFF K, 1993, PLANTA, V191, P23, DOI 10.1007/BF00240892; Nield J, 2006, BBA-BIOENERGETICS, V1757, P353, DOI 10.1016/j.bbabio.2006.03.019; OSWALD A, 1990, EUR J BIOCHEM, V190, P185, DOI 10.1111/j.1432-1033.1990.tb15563.x; Pfundel E, 1996, PLANT PHYSIOL, V112, P1055, DOI 10.1104/pp.112.3.1055; Pokorska B, 2007, FUNCT PLANT BIOL, V34, P844, DOI 10.1071/FP07067; Romanowska E, 2006, J PLANT PHYSIOL, V163, P607, DOI 10.1016/j.jplph.2005.06.007; RUBAN AV, 1992, BIOCHIM BIOPHYS ACTA, V1102, P30, DOI 10.1016/0005-2728(92)90061-6; Sage RF, 2004, NEW PHYTOL, V161, P341, DOI 10.1111/j.1469-8137.2004.00974.x; Schagger H, 2001, METHOD CELL BIOL, V65, P231, DOI 10.1016/S0091-679X(01)65014-3; SCHAGGER H, 1987, ANAL BIOCHEM, V166, P379; SCHUSTER G, 1985, J BIOL CHEM, V260, P1866; SHEEN JY, 1986, P NATL ACAD SCI USA, V83, P7811, DOI 10.1073/pnas.83.20.7811; Tikkanen M, 2008, BBA-BIOENERGETICS, V1777, P425, DOI 10.1016/j.bbabio.2008.02.001; vanHeel M, 1996, J STRUCT BIOL, V116, P17, DOI 10.1006/jsbi.1996.0004; WITT HT, 1979, BIOCHIM BIOPHYS ACTA, V505, P355, DOI 10.1016/0304-4173(79)90008-9; WOO KC, 1970, P NATL ACAD SCI USA, V67, P18, DOI 10.1073/pnas.67.1.18; Yoshimura Y, 2004, PLANTA, V220, P307, DOI 10.1007/s00425-004-1335-1	63	31	33	0	12	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	SEP 19	2008	283	38					26037	26046		10.1074/jbc.M803711200	http://dx.doi.org/10.1074/jbc.M803711200			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	348GX	18632664	hybrid, Green Published			2022-12-27	WOS:000259200100032
J	Gaspar, ML; Jesch, SA; Viswanatha, R; Antosh, AL; Brown, WJ; Kohlwein, SD; Henry, SA				Gaspar, Maria L.; Jesch, Stephen A.; Viswanatha, Raghuvir; Antosh, Amy L.; Brown, William J.; Kohlwein, Sepp D.; Henry, Susan A.			A block in endoplasmic reticulum-to-golgi trafficking inhibits phospholipid synthesis and induces neutral lipid accumulation	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							UNFOLDED PROTEIN RESPONSE; YEAST SECRETORY PATHWAY; SACCHAROMYCES-CEREVISIAE; VESICLE FORMATION; GENE-EXPRESSION; TRANSMEMBRANE PROTEIN; TRANSCRIPTION FACTOR; INO1 EXPRESSION; SEC13P COMPLEX; BIOSYNTHESIS	Seeking to better understand how membrane trafficking is coordinated with phospholipid synthesis in yeast, we investigated lipid synthesis in several Sec(-) temperature-sensitive mutants, including sec13-1. Upon shift of sec13-1 cells to the restrictive temperature of 37 degrees C, phospholipid synthesis decreased dramatically relative to the wild type control, whereas synthesis of neutral lipids, especially triacylglycerol ( TAG), increased. When examined by fluorescence microscopy, the number of lipid droplets appeared to increase and formed aggregates in sec13-1 cells shifted to 37 degrees C. Electron microscopy confirmed the increase in lipid droplet number and revealed that many were associated with the vacuole. Analysis of lipid metabolism in strains lacking TAG synthase genes demonstrated that the activities of the products of these genes contribute to accumulation of TAG in sec13-1 cells after the shift to 37 degrees C. Furthermore, the permissive temperature for growth of the sec13-1 strain lacking TAG synthase genes was 3 degrees C lower than sec13-1 on several different growth media, indicating that the synthesis of TAG has physiological significance under conditions of secretory stress. Together these results suggest that following a block in membrane trafficking, yeast cells channel lipid metabolism from phospholipid synthesis into synthesis of TAG and other neutral lipids to form lipid droplets. We conclude that this metabolic switch provides a degree of protection to cells during secretory stress.	[Gaspar, Maria L.; Jesch, Stephen A.; Viswanatha, Raghuvir; Antosh, Amy L.; Brown, William J.; Henry, Susan A.] Cornell Univ, Dept Mol Biol & Genet, Ithaca, NY 14853 USA; [Kohlwein, Sepp D.] Graz Univ, Inst Mol Biosci, A-8010 Graz, Austria	Cornell University; University of Graz	Henry, SA (corresponding author), Cornell Univ, Dept Mol Biol & Genet, 260 Roberts Hall, Ithaca, NY 14853 USA.	sah42@cornell.edu	Henry, Susan/K-5464-2014; Brown, William/GXN-2777-2022	Kohlwein, Sepp Dieter/0000-0002-1030-0598	National Institutes of Health [GM019629, DK51596]; NIGMS; NIDDK; Austrian Science Fund; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK051596, R56DK051596] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM019629, R37GM019629] Funding Source: NIH RePORTER; Austrian Science Fund (FWF) [F 3005] Funding Source: researchfish	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NIGMS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NIDDK(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); Austrian Science Fund(Austrian Science Fund (FWF)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); Austrian Science Fund (FWF)(Austrian Science Fund (FWF))	This work was supported, in whole or in part, by National Institutes of Health Grants GM019629 ( to S. A. H.) and DK51596 ( to W. J. B.) from the NIGMS and NIDDK, respectively. This work was also supported by SFB Lipotox P3005 of the Austrian Science Fund ( to S. D. K.). The costs of publication of this article were defrayed in part by the payment of page charges. This article must therefore be hereby marked "advertisement" in accordance with 18 U. S. C. Section 1734 solely to indicate this fact.	Arvindekar AU, 2002, YEAST, V19, P131, DOI 10.1002/yea.802; ATKINSON K, 1980, J BIOL CHEM, V255, P6653; ATKINSON KD, 1977, J BACTERIOL, V132, P806, DOI 10.1128/JB.132.3.806-817.1977; BARLOWE C, 1994, CELL, V77, P895, DOI 10.1016/0092-8674(94)90138-4; Bernales S, 2006, PLOS BIOL, V4, P2311, DOI 10.1371/journal.pbio.0040423; Block-Alper L, 2002, MOL BIOL CELL, V13, P40, DOI 10.1091/mbc.01-07-0366; Borradaile NM, 2006, J LIPID RES, V47, P2726, DOI 10.1194/jlr.M600299-JLR200; Burnett WV, 1997, BIOTECHNIQUES, V22, P668, DOI 10.2144/97224st01; Cahill G, 2000, BIOTECHNOL BIOENG, V69, P312, DOI 10.1002/1097-0290(20000805)69:3<312::AID-BIT9>3.3.CO;2-P; Carman GM, 1999, PROG LIPID RES, V38, P361, DOI 10.1016/S0163-7827(99)00010-7; CASEY WM, 1993, BIOCHEM BIOPH RES CO, V193, P1297, DOI 10.1006/bbrc.1993.1766; Chang HJ, 2004, GENETICS, V168, P1899, DOI 10.1534/genetics.104.032961; Chang HJ, 2002, GENETICS, V162, P29; COX JS, 1993, CELL, V73, P1197, DOI 10.1016/0092-8674(93)90648-A; Cox JS, 1997, MOL BIOL CELL, V8, P1805, DOI 10.1091/mbc.8.9.1805; Cox JS, 1996, CELL, V87, P391, DOI 10.1016/S0092-8674(00)81360-4; Credle JJ, 2005, P NATL ACAD SCI USA, V102, P18773, DOI 10.1073/pnas.0509487102; Czabany T, 2007, BBA-MOL CELL BIOL L, V1771, P299, DOI 10.1016/j.bbalip.2006.07.001; DONAHUE TF, 1981, J BIOL CHEM, V256, P7077; Fatal N, 2002, MOL BIOL CELL, V13, P4130, DOI 10.1091/mbc.02-05-0082; Gaspar ML, 2007, BBA-MOL CELL BIOL L, V1771, P241, DOI 10.1016/j.bbalip.2006.06.011; Gaspar ML, 2006, J BIOL CHEM, V281, P22773, DOI 10.1074/jbc.M603548200; Gilstring CF, 1999, MOL BIOL CELL, V10, P3549, DOI 10.1091/mbc.10.11.3549; HENRY SA, 1977, J BACTERIOL, V130, P472, DOI 10.1128/JB.130.1.472-484.1977; HIRSCH JP, 1986, MOL CELL BIOL, V6, P3320, DOI 10.1128/MCB.6.10.3320; HOSAKA K, 1984, BIOCHIM BIOPHYS ACTA, V796, P110; Hyde M, 2002, J CELL BIOL, V156, P993, DOI 10.1083/jcb.200112008; Jesch SA, 2005, J BIOL CHEM, V280, P9106, DOI 10.1074/jbc.M411770200; Jesch SA, 2006, J BIOL CHEM, V281, P24070, DOI 10.1074/jbc.M604541200; KAISER CA, 1990, CELL, V61, P723, DOI 10.1016/0092-8674(90)90483-U; KELLEY MJ, 1988, J BIOL CHEM, V263, P18078; Kirchhausen T, 2007, CELL, V129, P1251, DOI 10.1016/j.cell.2007.06.015; Kurat CF, 2006, J BIOL CHEM, V281, P491, DOI 10.1074/jbc.M508414200; Larson LL, 2002, YEAST, V19, P373, DOI 10.1002/yea.839; Leber JH, 2004, PLOS BIOL, V2, P1197, DOI 10.1371/journal.pbio.0020235; LETTS VA, 1983, J BACTERIOL, V156, P212, DOI 10.1128/JB.156.1.212-221.1983; Listenberger LL, 2003, P NATL ACAD SCI USA, V100, P3077, DOI 10.1073/pnas.0630588100; Loewen CJR, 2004, SCIENCE, V304, P1644, DOI 10.1126/science.1096083; Longtine MS, 1998, YEAST, V14, P953, DOI 10.1002/(SICI)1097-0061(199807)14:10<953::AID-YEA293>3.3.CO;2-L; Matsuoka K, 1998, CELL, V93, P263, DOI 10.1016/S0092-8674(00)81577-9; MORI K, 1993, CELL, V74, P743; NIKAWA J, 1995, J BIOCHEM, V118, P39, DOI 10.1093/oxfordjournals.jbchem.a124889; NOVICK P, 1980, CELL, V21, P205, DOI 10.1016/0092-8674(80)90128-2; Oelkers P, 2002, J BIOL CHEM, V277, P8877, DOI 10.1074/jbc.M111646200; PRYER NK, 1993, J CELL BIOL, V120, P865, DOI 10.1083/jcb.120.4.865; RAMIREZ RM, 1983, J BACTERIOL, V154, P1276, DOI 10.1128/JB.154.3.1276-1283.1983; Ron D, 2007, NAT REV MOL CELL BIO, V8, P519, DOI 10.1038/nrm2199; Ryan KJ, 2002, BMC GENET, V3, DOI 10.1186/1471-2156-3-17; Salama NR, 1997, MOL BIOL CELL, V8, P205, DOI 10.1091/mbc.8.2.205; SALAMA NR, 1993, EMBO J, V12, P4073, DOI 10.1002/j.1460-2075.1993.tb06091.x; Sandager L, 2002, J BIOL CHEM, V277, P6478, DOI 10.1074/jbc.M109109200; SEMENZA JC, 1990, CELL, V61, P1349, DOI 10.1016/0092-8674(90)90698-E; Siniossoglou S, 1996, CELL, V84, P265, DOI 10.1016/S0092-8674(00)80981-2; Siniossoglou S, 2000, J CELL BIOL, V149, P41, DOI 10.1083/jcb.149.1.41; Sriburi R, 2004, J CELL BIOL, V167, P35, DOI 10.1083/jcb.200406136; Sriburi R, 2007, J BIOL CHEM, V282, P7024, DOI 10.1074/jbc.M609490200; STEVENS T, 1982, CELL, V30, P439, DOI 10.1016/0092-8674(82)90241-0; Szymanski KM, 2007, P NATL ACAD SCI USA, V104, P20890, DOI 10.1073/pnas.0704154104; TAYLOR FR, 1979, BIOCHIM BIOPHYS ACTA, V575, P204, DOI 10.1016/0005-2760(79)90022-5; TerBush DR, 1996, EMBO J, V15, P6483, DOI 10.1002/j.1460-2075.1996.tb01039.x; Travers KJ, 2000, CELL, V101, P249, DOI 10.1016/S0092-8674(00)80835-1; WHITTERS EA, 1993, J CELL BIOL, V122, P79, DOI 10.1083/jcb.122.1.79; WOLINSKI H, 2008, METHODS MOL IN PRESS; Wright R, 2000, MICROSC RES TECHNIQ, V51, P496, DOI 10.1002/1097-0029(20001215)51:6<496::AID-JEMT2>3.3.CO;2-0; Yamanushi T, 1996, J BIOCHEM-TOKYO, V120, P452; Zhang SR, 1999, GENETICS, V151, P473; Zhou JH, 2006, P NATL ACAD SCI USA, V103, P14343, DOI 10.1073/pnas.0606480103	67	53	54	2	7	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	SEP 12	2008	283	37					25735	25751		10.1074/jbc.M802685200	http://dx.doi.org/10.1074/jbc.M802685200			17	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	345QZ	18614533	Green Published, hybrid			2022-12-27	WOS:000259012700068
J	Jacquet, E; Girard, JM; Ramaen, O; Pamlard, O; Levaique, H; Betton, JM; Dassa, E; Chesneau, O				Jacquet, Eric; Girard, Jean-Marie; Ramaen, Odile; Pamlard, Olivier; Levaique, Helene; Betton, Jean-Michel; Dassa, Elie; Chesneau, Olivier			ATP hydrolysis and pristinamycin IIA inhibition of the Staphylococcus aureus vga(A), a dual ABC protein involved in streptogramin a resistance	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							BINDING CASSETTE TRANSPORTERS; ESCHERICHIA-COLI; ANTIBIOTIC-RESISTANCE; CARBOXYLATE RESIDUES; ERYTHROMYCIN RESISTANCE; SUBSTRATE-SPECIFICITY; MULTIDRUG-RESISTANCE; STRUCTURAL BASIS; CATALYTIC CYCLE; P-GLYCOPROTEIN	In Gram-positive bacteria, a large subfamily of dual ATP-binding cassette proteins confers acquired or intrinsic resistance to macrolide, lincosamide, and streptogramin antibiotics by a far from well understood mechanism. Here, we report the first biochemical characterization of one such protein, Vga(A), which is involved in streptogramin A (SgA) resistance among staphylococci. Vga(A) is composed of two nucleotide-binding domains (NBDs), separated by a charged linker, with a C-terminal extension and without identified transmembrane domains. Highly purified Vga(A) displays a strong ATPase activity (K-m = 78 mu M, V-m = 6.8 min(-1)) that was hardly inhibited by orthovanadate. Using mutants of the conserved catalytic glutamate residues, the two NBDs of Vga(A) were shown to contribute unequally to the total ATPase activity, the mutation at NBD2 being more detrimental than the other. ATPase activity of both catalytic sites was essential for Vga(A) biological function because each single Glu mutant was unable to confer SgA resistance in the staphylococcal host. Of great interest, Vga(A) ATPase was specifically inhibited in a non-competitive manner by the SgA substrate, pristinamycin IIA (PIIA). A deletion of the last 18 amino acids of Vga(A) slightly affected the ATPase activity without modifying the PIIA inhibition values. In contrast, this deletion reduced 4-fold the levels of SgA resistance. Altogether, our results suggest a role for the C terminus in regulation of the SgA antibiotic resistance mechanism conferred by Vga(A) and demonstrate that this dual ATP-binding cassette protein interacts directly and specifically with PIIA, its cognate substrate.	[Jacquet, Eric; Girard, Jean-Marie; Ramaen, Odile; Pamlard, Olivier; Levaique, Helene] CNRS, Inst Chim Subst Nat, UPR 2301, F-91190 Gif Sur Yvette, France; [Dassa, Elie; Chesneau, Olivier] Inst Pasteur, CNRS, Unite Membranes Bacteriennes, URA 2172, F-75724 Paris, France; [Betton, Jean-Michel] Inst Pasteur, CNRS, Unite Biochim Struct, URA 2172, F-75724 Paris, France	Centre National de la Recherche Scientifique (CNRS); CNRS - Institute of Chemistry (INC); UDICE-French Research Universities; Universite Paris Saclay; Centre National de la Recherche Scientifique (CNRS); Le Reseau International des Instituts Pasteur (RIIP); Institut Pasteur Paris; Centre National de la Recherche Scientifique (CNRS); Le Reseau International des Instituts Pasteur (RIIP); Institut Pasteur Paris	Jacquet, E (corresponding author), CNRS, Inst Chim Subst Nat, UPR 2301, Ave Terrasse, F-91190 Gif Sur Yvette, France.	Eric.Jacquet@icsn.cnrs-gif.fr		JACQUET, Eric/0000-0001-6366-8436	Institut de Chimie des Substances Naturelles; CNRS; Gif-sur-Yvette, France	Institut de Chimie des Substances Naturelles; CNRS(Centre National de la Recherche Scientifique (CNRS)); Gif-sur-Yvette, France	We are grateful to Cecile Wandersman and Jean-Yves Lallemand for their continuous support and helpful discussions during this work. We thank Jean-Pierre Lecaer (Institut de Chimie des Substances Naturelles, CNRS, Gif-sur-Yvette, France) for performing mass spectrometry measurements, and Cecile Wandersman and Christina Sizun for critical reading of the manuscript.	ALLIGNET J, 1992, GENE, V117, P45, DOI 10.1016/0378-1119(92)90488-B; Barriere JC, 1998, CURR PHARM DESIGN, V4, P155; Benabdelhak H, 2005, BIOCHEM J, V386, P489, DOI 10.1042/BJ20041282; Bouige P, 2002, CURR PROTEIN PEPT SC, V3, P541, DOI 10.2174/1389203023380486; Carrier I, 2008, FEBS J, V275, P3312, DOI 10.1111/j.1742-4658.2008.06479.x; Casey AL, 2007, INT J ANTIMICROB AG, V29, pS23, DOI 10.1016/S0924-8579(07)72175-1; Chesneau O, 2005, ANTIMICROB AGENTS CH, V49, P973, DOI 10.1128/AAC.49.3.973-980.2005; CRANE RK, 1953, J BIOL CHEM, V201, P235; Cuthbertson L, 2007, P NATL ACAD SCI USA, V104, P19529, DOI 10.1073/pnas.0705709104; Davidson AL, 2004, ANNU REV BIOCHEM, V73, P241, DOI 10.1146/annurev.biochem.73.011303.073626; Davidson AL, 2002, J BACTERIOL, V184, P1225, DOI 10.1128/JB.184.5.1225-1233.2002; ELSOLH N, 1986, ANTIMICROB AGENTS CH, V30, P161, DOI 10.1128/AAC.30.1.161; Gurk-Turner C, 2000, Proc (Bayl Univ Med Cent), V13, P83; Harms JM, 2004, BMC BIOL, V2, DOI 10.1186/1741-7007-2-4; Holland IB, 1999, J MOL BIOL, V293, P381, DOI 10.1006/jmbi.1999.2993; Huda N, 2003, ANTIMICROB AGENTS CH, V47, P2413, DOI 10.1128/AAC.47.8.2413-2417.2003; HUNKE S, 1995, BIOCHEM BIOPH RES CO, V216, P589, DOI 10.1006/bbrc.1995.2663; Jin HJ, 2002, PROTEIN EXPRES PURIF, V25, P149, DOI 10.1006/prep.2002.1621; KASHIWAGI K, 1995, J BIOL CHEM, V270, P25377, DOI 10.1074/jbc.270.43.25377; Kehoe LE, 2003, J BIOL CHEM, V278, P29963, DOI 10.1074/jbc.M303766200; Kobayashi N, 2001, J BACTERIOL, V183, P5639, DOI 10.1128/JB.183.19.5639-5644.2001; Korczynska M, 2007, P NATL ACAD SCI USA, V104, P10388, DOI 10.1073/pnas.0701809104; Leclercq R, 1998, LANCET, V352, P591, DOI 10.1016/S0140-6736(05)79570-2; Lubelski J, 2007, MICROBIOL MOL BIOL R, V71, P463, DOI 10.1128/MMBR.00001-07; Mendez C, 2001, RES MICROBIOL, V152, P341, DOI 10.1016/S0923-2508(01)01205-0; Mukhtar TA, 2005, CHEM REV, V105, P529, DOI 10.1021/cr030110z; Murat D, 2006, J BIOL CHEM, V281, P6850, DOI 10.1074/jbc.M509926200; Ng J, 2005, J ANTIMICROB CHEMOTH, V55, P1008, DOI 10.1093/jac/dki108; Novotna G, 2006, ANTIMICROB AGENTS CH, V50, P4070, DOI 10.1128/AAC.00799-06; Okusu H, 1996, J BACTERIOL, V178, P306, DOI 10.1128/JB.178.1.306-308.1996; Payen LF, 2003, J BIOL CHEM, V278, P38537, DOI 10.1074/jbc.M305786200; Poelarends GJ, 2000, DRUG RESIST UPDATE, V3, P330, DOI 10.1054/drup.2000.0173; RICHARME G, 1993, J BIOL CHEM, V268, P9473; Roge J, 2005, MICROB CELL FACT, V4, DOI 10.1186/1475-2859-4-18; ROSS JI, 1990, MOL MICROBIOL, V4, P1207, DOI 10.1111/j.1365-2958.1990.tb00696.x; Ross JI, 1996, GENE, V183, P143, DOI 10.1016/S0378-1119(96)00541-0; Smith PC, 2002, MOL CELL, V10, P139, DOI 10.1016/S1097-2765(02)00576-2; Tikhonova EB, 2007, MOL MICROBIOL, V63, P895, DOI 10.1111/j.1365-2958.2006.05549.x; Tombline G, 2004, J BIOL CHEM, V279, P46518, DOI 10.1074/jbc.M408052200; Urbatsch IL, 2000, BIOCHEMISTRY-US, V39, P14138, DOI 10.1021/bi001128w; Vannuffel P, 1996, DRUGS, V51, P20, DOI 10.2165/00003495-199600511-00006; Verdon G, 2003, J MOL BIOL, V334, P255, DOI 10.1016/j.jmb.2003.08.065; Zaitseva J, 2005, BIOCHEM SOC T, V33, P990, DOI 10.1042/BST0330990; Zaitseva J, 2005, BIOCHEMISTRY-US, V44, P9680, DOI 10.1021/bi0506122; Zaitseva J, 2005, EMBO J, V24, P1901, DOI 10.1038/sj.emboj.7600657	47	29	30	1	27	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258			J BIOL CHEM	J. Biol. Chem.	SEP 12	2008	283	37					25332	25339		10.1074/jbc.M800418200	http://dx.doi.org/10.1074/jbc.M800418200			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	345QZ	18562322	hybrid			2022-12-27	WOS:000259012700027
J	Kyriazis, GA; Wei, Z; Vandermey, M; Jo, DG; Xin, O; Mattson, MP; Chan, SL				Kyriazis, George A.; Wei, Zelan; Vandermey, Miriam; Jo, Dong-Gyu; Xin, Ouyang; Mattson, Mark P.; Chan, Sic L.			Numb Endocytic adapter proteins regulate the transport and processing of the amyloid precursor protein in an isoform-dependent manner - Implications for Alzheimer disease pathogenesis	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							PHOSPHOTYROSINE-BINDING DOMAIN; FATE DETERMINANT NUMB; CELL FATE; MAMMALIAN NUMB; MEDIATED ENDOCYTOSIS; BETA-PROTEIN; PTB DOMAIN; INTRACELLULAR DOMAIN; CALCIUM HOMEOSTASIS; GAMMA-SECRETASE	Central to the pathogenesis of Alzheimer disease is the aberrant processing of the amyloid precursor protein (APP) to generate amyloid beta-peptide (A beta), the principle component of amyloid plaques. The cell fate determinant Numb is a phosphotyrosine binding domain (PTB)-containing endocytic adapter protein that interacts with the carboxyl-terminal domain of APP. The physio-logical relevance of this interaction is unknown. Mammals produce four alternatively spliced variants of Numb that differ in the length of their PTB and proline-rich region. In the current study, we determined the influence of the four human Numb isoforms on the intracellular trafficking and processing of APP. Stable expression of Numb isoforms that differ in the PTB but not in the proline-rich region results in marked differences in the sorting of APP to the recycling and degradative pathways. Neural cells expressing Numb isoforms that lack the insert in the PTB (short PTB (SPTB)) exhibited marked accumulation of APP in Rab5A-labeled early endosomal and recycling compartments, whereas those expressing isoforms with the insertion in the PTB (long PTB (LPTB)) exhibited reduced amounts of cellular APP and its proteolytic derivatives relative to parental control cells. Neither the activities of the beta- and gamma-secretases nor the expression of APP mRNA were significantly different in the stably transfected cells, suggesting that the differential effects of the Numb proteins on APP metabolism is likely to be secondary to altered APP trafficking. In addition, the expression of SPTB-Numb increases at the expense of LPTB-Numb in neuronal cultures subjected to stress, suggesting a role for Numb in stress-induced A beta production. Taken together, these results suggest distinct roles for the human Numb isoforms in APP metabolism and may provide a novel potential link between altered Numb isoform expression and increased A beta generation.	[Kyriazis, George A.; Wei, Zelan; Vandermey, Miriam; Chan, Sic L.] Univ Cent Florida, Burnett Sch Biomed Sci, Biomol Sci Ctr, Orlando, FL 32816 USA; [Jo, Dong-Gyu] Sungkyunkwan Univ, Coll Pharm, Suwon 440746, South Korea; [Xin, Ouyang; Mattson, Mark P.] NIA, Neurosci Lab, Natl Inst Hlth, Intramural Res Program, Baltimore, MD 21224 USA	State University System of Florida; University of Central Florida; Sungkyunkwan University (SKKU); National Institutes of Health (NIH) - USA; NIH National Institute on Aging (NIA)	Chan, SL (corresponding author), Univ Cent Florida, Burnett Sch Biomed Sci, Biomol Sci Ctr, 4000 Cent Florida Blvd, Orlando, FL 32816 USA.	schan@mail.ucf.edu	Mattson, Mark P/F-6038-2012; Jo, Dong-Gyu/AAN-9278-2021	Jo, Dong-Gyu/0000-0003-2271-1076; Kyriazis, George/0000-0001-9514-3482	NATIONAL INSTITUTE ON AGING [Z01AG000314, ZIAAG000317, ZIAAG000312, Z01AG000312, ZIAAG000314, Z01AG000317] Funding Source: NIH RePORTER	NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))		Bani-Yaghoub M, 2007, DEV DYNAM, V236, P696, DOI 10.1002/dvdy.21072; Beers MF, 1996, J BIOL CHEM, V271, P14361, DOI 10.1074/jbc.271.24.14361; Berdnik D, 2002, DEV CELL, V3, P221, DOI 10.1016/S1534-5807(02)00215-0; CAPORASO GL, 1994, J NEUROSCI, V14, P3122; Carey RM, 2005, BMC CELL BIOL, V6, DOI 10.1186/1471-2121-6-30; Cataldo AM, 1997, J NEUROSCI, V17, P6142; Chan SL, 2000, J BIOL CHEM, V275, P18195, DOI 10.1074/jbc.M000040200; Chan SL, 2004, J BIOL CHEM, V279, P28733, DOI 10.1074/jbc.M404272200; Chan SL, 2002, NEUROMOL MED, V1, P55; D'SOUZA-SCHOREY C, 1995, SCIENCE, V267, P1175, DOI 10.1126/science.7855600; Dho SE, 1999, J BIOL CHEM, V274, P33097, DOI 10.1074/jbc.274.46.33097; Dho SE, 1998, J BIOL CHEM, V273, P9179, DOI 10.1074/jbc.273.15.9179; Di Marcotullio L, 2006, NAT CELL BIOL, V8, P1415, DOI 10.1038/ncb1510; FENTEANY G, 1995, SCIENCE, V268, P726, DOI 10.1126/science.7732382; FERREIRA A, 1993, J NEUROSCI, V13, P3112; Frise E, 1996, P NATL ACAD SCI USA, V93, P11925, DOI 10.1073/pnas.93.21.11925; GANDY S, 1994, NEUROBIOL AGING, V15, P253, DOI 10.1016/0197-4580(94)90125-2; Grbovic OM, 2003, J BIOL CHEM, V278, P31261, DOI 10.1074/jbc.M304122200; Guo M, 1996, NEURON, V17, P27, DOI 10.1016/S0896-6273(00)80278-0; HAASS C, 1992, NATURE, V357, P500, DOI 10.1038/357500a0; Huang EJ, 2005, GENE DEV, V19, P138, DOI 10.1101/gad.1246005; Ikin AF, 1996, J BIOL CHEM, V271, P31783, DOI 10.1074/jbc.271.50.31783; Juven-Gershon T, 1998, MOL CELL BIOL, V18, P3974, DOI 10.1128/MCB.18.7.3974; King GD, 2004, EXP NEUROL, V185, P208, DOI 10.1016/j.expneurol.2003.10.011; KOO EH, 1994, J BIOL CHEM, V269, P17386; LAI A, 1995, J BIOL CHEM, V270, P3565, DOI 10.1074/jbc.270.8.3565; Lai EC, 2002, CURR BIOL, V12, pR74, DOI 10.1016/S0960-9822(01)00679-0; Li SC, 1998, NAT STRUCT BIOL, V5, P1075, DOI 10.1038/4185; Lu BW, 1998, CELL, V95, P225, DOI 10.1016/S0092-8674(00)81753-5; Mattson MP, 1997, PHYSIOL REV, V77, P1081, DOI 10.1152/physrev.1997.77.4.1081; Mattson MP, 2001, J MOL NEUROSCI, V17, P205, DOI 10.1385/JMN:17:2:205; McGill MA, 2003, J BIOL CHEM, V278, P23196, DOI 10.1074/jbc.M302827200; Mumm JS, 2000, DEV BIOL, V228, P151, DOI 10.1006/dbio.2000.9960; Nie J, 2002, EMBO J, V21, P93, DOI 10.1093/emboj/21.1.93; Nishimura T, 2003, NAT CELL BIOL, V5, P819, DOI 10.1038/ncb1039; Nishimura T, 2007, DEV CELL, V13, P15, DOI 10.1016/j.devcel.2007.05.003; Pedersen WA, 2002, J NEUROCHEM, V82, P976, DOI 10.1046/j.1471-4159.2002.01036.x; Rebel VI, 1999, BLOOD, V93, P2217, DOI 10.1182/blood.V93.7.2217.407a01_2217_2224; RHYU MS, 1994, CELL, V76, P477, DOI 10.1016/0092-8674(94)90112-0; Roncarati R, 2002, P NATL ACAD SCI USA, V99, P7102, DOI 10.1073/pnas.102192599; Santolini E, 2000, J CELL BIOL, V151, P1345, DOI 10.1083/jcb.151.6.1345; Schmidlin F, 2001, J BIOL CHEM, V276, P25427, DOI 10.1074/jbc.M101688200; Selkoe DJ, 2001, PHYSIOL REV, V81, P741, DOI 10.1152/physrev.2001.81.2.741; Selkoe DJ, 1996, ANN NY ACAD SCI, V777, P57, DOI 10.1111/j.1749-6632.1996.tb34401.x; Seugnet L, 1997, DEV BIOL, V192, P585, DOI 10.1006/dbio.1997.8723; Sever S, 2000, J CELL BIOL, V150, P1137, DOI 10.1083/jcb.150.5.1137; Spana EP, 1996, NEURON, V17, P21, DOI 10.1016/S0896-6273(00)80277-9; STEIN BS, 1984, J BIOL CHEM, V259, P4762; Susini L, 2001, P NATL ACAD SCI USA, V98, P15067, DOI 10.1073/pnas.261571998; UEMURA T, 1989, CELL, V58, P349, DOI 10.1016/0092-8674(89)90849-0; Verbeek MM, 2002, J HISTOCHEM CYTOCHEM, V50, P681, DOI 10.1177/002215540205000509; Verdi J, 1996, CURR BIOL, V6, P1134, DOI 10.1016/S0960-9822(02)70680-5; Verdi JM, 1999, P NATL ACAD SCI USA, V96, P10472, DOI 10.1073/pnas.96.18.10472; Wakamatsu Y, 1999, NEURON, V23, P71, DOI 10.1016/S0896-6273(00)80754-0; WEIDEMANN A, 1989, CELL, V57, P115, DOI 10.1016/0092-8674(89)90177-3; Wolfe MS, 2008, CURR TOP MED CHEM, V8, P2, DOI 10.2174/156802608783334024; Yaich L, 1998, J BIOL CHEM, V273, P10381, DOI 10.1074/jbc.273.17.10381; ZHOU MM, 1995, NATURE, V378, P584, DOI 10.1038/378584a0; ZMITH CA, 2004, MOL BIOL CELL, V15, P3698; Zwahlen C, 2000, EMBO J, V19, P1505, DOI 10.1093/emboj/19.7.1505	60	62	64	0	2	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	SEP 12	2008	283	37					25492	25502		10.1074/jbc.M802072200	http://dx.doi.org/10.1074/jbc.M802072200			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	345QZ	18599481	hybrid, Green Published			2022-12-27	WOS:000259012700045
J	Feijoo-Cuaresma, M; Mendez, F; Maqueda, A; Esteban, MA; Naranjo-Suarez, S; Castellanos, MC; del Cerro, MH; Vazquez, SN; Garcia-Pardo, A; Landazuri, MO; Calzada, MJ				Feijoo-Cuaresma, Monica; Mendez, Fernando; Maqueda, Alfredo; Esteban, Miguel A.; Naranjo-Suarez, Salvador; Castellanos, Maria C.; Hernandez del Cerro, Mercedes; Vazquez, Silvia N.; Garcia-Pardo, Angeles; Landazuri, Manuel O.; Calzada, Maria J.			Inadequate Activation of the GTPase RhoA Contributes to the Lack of Fibronectin Matrix Assembly in von Hippel-Lindau Protein-defective Renal Cancer Cells	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							TUMOR-SUPPRESSOR PROTEIN; HYPOXIA-INDUCIBLE FACTORS; CARCINOMA-CELLS; BARRIER FUNCTION; DOWN-REGULATION; GENE-PRODUCT; E-CADHERIN; HIF-ALPHA; VHL; GROWTH	The von Hippel-Lindau (VHL) tumor suppressor gene regulates extracellular matrix deposition. InVHLnegative renal cancer cells, VHL(-), the lack of fibronectin matrix assembly is thought to promote and maintain tumor angiogenesis allowing vessels to infiltrate tumors. Therefore, and considering the importance of this process in tumor growth, we aimed to study why VHL(-) renal cancer cells fail to form a proper extracellular matrix. Our results showed that VHL(-) cells were not defective in fibronectin production and that the fibronectin produced by these cells was equally functional in promoting cell adhesion and matrix assembly as that produced by VHL(-) cells. We have previously reported that VHL(-) cells fail to form beta 1 integrin fibrillar adhesions and have a diminished organization of actin stress fibers; therefore, we aimed to study if the small GTPase family is involved in this process. We found that activation of the RhoA GTPase was defective in VHL(-) cells, and this was possibly mediated by an increased activation of its inhibitor, p190RhoGAP. Additionally, the expression of constitutively active RhoA in VHL(-) cells resulted in formation of a fibronectin matrix. These results strongly suggest an important role for RhoA in some of the defects observed in renal cancer cells.	[Feijoo-Cuaresma, Monica; Mendez, Fernando; Naranjo-Suarez, Salvador; Castellanos, Maria C.; Vazquez, Silvia N.; Landazuri, Manuel O.; Calzada, Maria J.] Univ Autonoma Madrid, Dept Med, Hosp Princesa, Serv Immunol, Madrid 28006, Spain; [Maqueda, Alfredo; Hernandez del Cerro, Mercedes; Garcia-Pardo, Angeles] CSIC, Ctr Invest Biol, Dept Fisiopathol Celular & Mol, Madrid 28040, Spain; [Esteban, Miguel A.] Chinese Acad Sci, Guangzhou Inst Biomed & Hlth, Guangzhou 510663, Guangdong, Peoples R China	Autonomous University of Madrid; Hospital de La Princesa; Consejo Superior de Investigaciones Cientificas (CSIC); CSIC - Centro de Investigaciones Biologicas (CIB); Chinese Academy of Sciences; Guangzhou Institute of Biomedicine & Health, CAS	Calzada, MJ (corresponding author), Univ Autonoma Madrid, Dept Med, Hosp Princesa, Serv Immunol, Diego de Leon 62, Madrid 28006, Spain.	mcalzada.hlpr@salud.madrid.org	Suarez, Salvador Naranjo/K-8450-2017; Garcia Pardo, Angeles/G-5987-2015	Suarez, Salvador Naranjo/0000-0002-7038-0753; Garcia Pardo, Angeles/0000-0001-5577-2954; Vazquez Cuesta, Silvia Noemi/0000-0002-9065-9487; Maqueda Fernandez, Alfredo/0000-0002-0117-5422	Ministerio de Educacion y Ciencia [SAF2006-04013, SAF2007-60592]; Ministerio de Sanidad y Consumo [PI060400]; Fundacion de Investigacion Medica Mutua Madrilena;  [RECAVA C03/01]	Ministerio de Educacion y Ciencia(Spanish Government); Ministerio de Sanidad y Consumo(Instituto de Salud Carlos III); Fundacion de Investigacion Medica Mutua Madrilena; 	This work was supported in part by SAF2006-04013 from the Ministerio de Educacion y Ciencia (MEC) (to M. J. C.), SAF2007-60592 and RECAVA C03/01 (to M. O. L.), and PI060400 from the Ministerio de Sanidad y Consumo and the Fundacion de Investigacion Medica Mutua Madrilena (to A. G. -P.).	Arthur WT, 2000, CURR BIOL, V10, P719, DOI 10.1016/S0960-9822(00)00537-6; Bindra RS, 2002, CANCER RES, V62, P3014; Bluyssen HAR, 2004, FEBS LETT, V556, P137, DOI 10.1016/S0014-5793(03)01392-9; Cali G, 1999, J CELL SCI, V112, P957; Calzada MJ, 2006, CANCER RES, V66, P1553, DOI 10.1158/0008-5472.CAN-05-3236; Clifford SC, 2001, HUM MOL GENET, V10, P1029, DOI 10.1093/hmg/10.10.1029; Davidowitz EJ, 2001, MOL CELL BIOL, V21, P865, DOI 10.1128/MCB.21.3.865-874.2001; Esteban MA, 2006, CANCER RES, V66, P3567, DOI 10.1158/0008-5472.CAN-05-2670; Esteban MA, 2006, J AM SOC NEPHROL, V17, P1801, DOI 10.1681/ASN.2006020181; Esteban-Barragan MA, 2002, CANCER RES, V62, P2929; Grosfeld A, 2007, J BIOL CHEM, V282, P13264, DOI 10.1074/jbc.M611648200; Hanahan D, 2000, CELL, V100, P57, DOI 10.1016/S0092-8674(00)81683-9; Harrington EO, 2005, EXP CELL RES, V308, P407, DOI 10.1016/j.yexcr.2005.05.005; He Z, 2004, CANCER GENET CYTOGEN, V152, P89, DOI 10.1016/j.cancergencyto.2003.11.001; Hergovich A, 2003, NAT CELL BIOL, V5, P64, DOI 10.1038/ncb899; Hoffman MA, 2001, HUM MOL GENET, V10, P1019, DOI 10.1093/hmg/10.10.1019; Holinstat M, 2003, J BIOL CHEM, V278, P28793, DOI 10.1074/jbc.M303900200; Hsu T, 2006, J BIOL CHEM, V281, P12069, DOI 10.1074/jbc.M511621200; HYNES RO, 1992, CELL, V69, P11, DOI 10.1016/0092-8674(92)90115-S; ILIOPOULOS O, 1995, NAT MED, V1, P822, DOI 10.1038/nm0895-822; Iturrioz X, 2006, BIOCHEM J, V397, P109, DOI 10.1042/BJ20060354; Ivan M, 2001, SCIENCE, V292, P464, DOI 10.1126/science.1059817; Jaakkola P, 2001, SCIENCE, V292, P468, DOI 10.1126/science.1059796; Jiang YD, 2003, MOL CANCER RES, V1, P453; Kaelin WG, 2002, NAT REV CANCER, V2, P673, DOI 10.1038/nrc885; Kamada M, 2001, CANCER RES, V61, P4184; Kim M, 2004, BIOCHEM BIOPH RES CO, V320, P945, DOI 10.1016/j.bbrc.2004.06.042; Koochekpour S, 1999, MOL CELL BIOL, V19, P5902; Krieg M, 2000, ONCOGENE, V19, P5435, DOI 10.1038/sj.onc.1203938; Krishnamachary B, 2006, CANCER RES, V66, P2725, DOI 10.1158/0008-5472.CAN-05-3719; Kurban G, 2006, CANCER RES, V66, P1313, DOI 10.1158/0008-5472.CAN-05-2560; Kurban G, 2007, ONCOGENE, V13; Lewis MD, 2003, ONCOGENE, V22, P3992, DOI 10.1038/sj.onc.1206683; Li XY, 2003, ONCOL RES, V13, P323; Lolkema MP, 2007, FEBS LETT, V581, P4571, DOI 10.1016/j.febslet.2007.08.050; LOLKEMA MP, 2007, EUR J HUM GENET, V3, P3; Mack FA, 2003, CANCER CELL, V3, P75, DOI 10.1016/S1535-6108(02)00240-4; Maher ER, 1997, MEDICINE, V76, P381, DOI 10.1097/00005792-199711000-00001; Maxwell PH, 1999, NATURE, V399, P271, DOI 10.1038/20459; Mehta D, 2001, J BIOL CHEM, V276, P22614, DOI 10.1074/jbc.M101927200; Moyano JV, 2003, MOL BIOL CELL, V14, P3699, DOI 10.1091/mbc.E02-10-0667; Naranjo-Suarez S, 2003, J BIOL CHEM, V278, P31895, DOI 10.1074/jbc.M304079200; Ohh M, 1999, J CLIN INVEST, V104, P1583, DOI 10.1172/JCI8161; Ohh M, 1998, MOL CELL, V1, P959, DOI 10.1016/S1097-2765(00)80096-9; Pal S, 1997, J BIOL CHEM, V272, P27509, DOI 10.1074/jbc.272.44.27509; Pang HP, 2005, AM J PHYSIOL-CELL PH, V289, pC982, DOI 10.1152/ajpcell.00364.2004; Pankov R, 2000, J CELL BIOL, V148, P1075, DOI 10.1083/jcb.148.5.1075; Ridley AJ, 2001, TRENDS CELL BIOL, V11, P471, DOI 10.1016/S0962-8924(01)02153-5; Roe JS, 2006, MOL CELL, V22, P395, DOI 10.1016/j.molcel.2006.04.006; Sechler JL, 1996, J CELL BIOL, V134, P573, DOI 10.1083/jcb.134.2.573; Stickle NH, 2004, MOL CELL BIOL, V24, P3251, DOI 10.1128/MCB.24.8.3251-3261.2004; Tang N, 2006, MOL CELL BIOL, V26, P2519, DOI 10.1128/MCB.26.7.2519-2530.2006; Wierzbicka-Patynowski I, 2003, J CELL SCI, V116, P3269, DOI 10.1242/jcs.00670; Yang H, 2007, MOL CELL, V28, P15, DOI 10.1016/j.molcel.2007.09.010; Zhang QH, 1997, MOL BIOL CELL, V8, P1415, DOI 10.1091/mbc.8.8.1415; Zhong CL, 1998, J CELL BIOL, V141, P539, DOI 10.1083/jcb.141.2.539	56	13	14	0	12	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	SEP 5	2008	283	36					24982	24990		10.1074/jbc.M709390200	http://dx.doi.org/10.1074/jbc.M709390200			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	517MA	18567581	Green Published, hybrid			2022-12-27	WOS:000271617300009
J	Hayakawa, F; Abe, A; Kitabayashi, I; Pandolfi, PP; Naoe, T				Hayakawa, Fumihiko; Abe, Akihiro; Kitabayashi, Issay; Pandolfi, Pier Paolo; Naoe, Tomoki			Acetylation of PML is involved in histone deacetylase inhibitor-mediated apoptosis	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ACUTE PROMYELOCYTIC LEUKEMIA; ARSENIC-TRIOXIDE; TRANSCRIPTIONAL REPRESSION; NUCLEAR-BODIES; CELLS; SUMO-1; PHOSPHORYLATION; LOCALIZATION; SUMOYLATION; INDUCTION	PML is a potent tumor suppressor and proapoptotic factor and is functionally regulated by post-translational modifications such as phosphorylation, sumoylation, and ubiquitination. Histone deacetylase (HDAC) inhibitors are a promising class of targeted anticancer agents and induce apoptosis in cancer cells by largely unknown mechanisms. We report here a novel post-transcriptional modification, acetylation, of PML. PML exists as an acetylated protein in HeLa cells, and its acetylation is enhanced by coexpression of p300 or treatment with a HDAC inhibitor, trichostatin A. Increased PML acetylation is associated with increased sumoylation of PML in vitro and in vivo. PML is involved in trichostatin A-induced apoptosis and PML with an acetylation-defective mutation shows an inability to mediate apoptosis, suggesting the importance of PML acetylation. Our work provides new insights into PML regulation by post-translational modification and new information about the therapeutic mechanism of HDAC inhibitors.	[Hayakawa, Fumihiko; Abe, Akihiro; Naoe, Tomoki] Nagoya Univ, Grad Sch Med, Dept Hematol & Oncol, Showa Ku, Nagoya, Aichi 4668550, Japan; [Kitabayashi, Issay] Natl Canc Ctr, Div Mol Oncol, Chuo Ku, Tokyo 1040045, Japan; [Pandolfi, Pier Paolo] Harvard Univ, Beth Israel Deaconess Med Ctr, Sch Med, Dept Med,Canc Genet Program, Boston, MA 02215 USA	Nagoya University; National Cancer Center - Japan; Harvard University; Beth Israel Deaconess Medical Center; Harvard Medical School	Hayakawa, F (corresponding author), Nagoya Univ, Grad Sch Med, Dept Hematol & Oncol, Showa Ku, 65 Tsurumai Cho, Nagoya, Aichi 4668550, Japan.	bun-hy@med.nagoya-u.ac.jp	Naoe, Tomoki/I-1888-2012; Hayakawa, Fumihiko/I-7288-2014; Kitabayashi, Issay/G-2204-2017	Kitabayashi, Issay/0000-0002-8409-0407	Uehara Memorial Foundation; National Institute of Biomedical Innovation; Ministry of Education, Culture, Sports, Science, and Technology of Japan	Uehara Memorial Foundation(Uehara Memorial Foundation); National Institute of Biomedical Innovation(National Institute of Biomedical Innovation); Ministry of Education, Culture, Sports, Science, and Technology of Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT))	This work was supported by grants-in-aid from the Uehara Memorial Foundation, the National Institute of Biomedical Innovation, and the Ministry of Education, Culture, Sports, Science, and Technology of Japan.	Bandyopadhyay D, 2004, CANCER RES, V64, P7706, DOI 10.1158/0008-5472.CAN-03-3897; Chen GQ, 1997, BLOOD, V89, P3345; Dellaire G, 2004, BIOESSAYS, V26, P963, DOI 10.1002/bies.20089; DYCK JA, 1994, CELL, V76, P333, DOI 10.1016/0092-8674(94)90340-9; Glozak MA, 2005, GENE, V363, P15, DOI 10.1016/j.gene.2005.09.010; Gregoire S, 2005, MOL CELL BIOL, V25, P2273, DOI 10.1128/MCB.25.6.2273-2287.2005; Hayakawa F, 2004, CANCER CELL, V5, P389, DOI 10.1016/S1535-6108(04)00082-0; Hayakawa F, 2004, J LEUKOCYTE BIOL, V75, P529, DOI 10.1189/jlb.0603289; Hietakangas V, 2006, P NATL ACAD SCI USA, V103, P45, DOI 10.1073/pnas.0503698102; Ishov AM, 1999, J CELL BIOL, V147, P221, DOI 10.1083/jcb.147.2.221; Kamitani T, 1998, J BIOL CHEM, V273, P26675, DOI 10.1074/jbc.273.41.26675; Kim KI, 2002, J CELL PHYSIOL, V191, P257, DOI 10.1002/jcp.10100; KOKEN MHM, 1994, EMBO J, V13, P1073, DOI 10.1002/j.1460-2075.1994.tb06356.x; Kwek SSS, 2001, ONCOGENE, V20, P2587, DOI 10.1038/sj.onc.1204362; Marks PA, 2000, JNCI-J NATL CANCER I, V92, P1210, DOI 10.1093/jnci/92.15.1210; MU ZM, 1994, MOL CELL BIOL, V14, P6858, DOI 10.1128/MCB.14.10.6858; Muller S, 1998, EMBO J, V17, P61, DOI 10.1093/emboj/17.1.61; Niu C, 1999, BLOOD, V94, P3315, DOI 10.1182/blood.V94.10.3315.422k16_3315_3324; Salomoni P, 2002, CELL, V108, P165, DOI 10.1016/S0092-8674(02)00626-8; Stankovic-Valentin N, 2007, MOL CELL BIOL, V27, P2661, DOI 10.1128/MCB.01098-06; Terui T, 2003, CANCER RES, V63, P8948; Wang ZG, 1998, NAT GENET, V20, P266, DOI 10.1038/3073; Wang ZG, 1998, SCIENCE, V279, P1547; WEIS K, 1994, CELL, V76, P345, DOI 10.1016/0092-8674(94)90341-7; Wolffe AP, 1996, CELL, V84, P817, DOI 10.1016/S0092-8674(00)81059-4; Yang XJ, 2006, MOL CELL, V23, P779, DOI 10.1016/j.molcel.2006.08.009; Zhong S, 2000, BLOOD, V95, P2748, DOI 10.1182/blood.V95.9.2748.009k31a_2748_2752; Zhu J, 1997, P NATL ACAD SCI USA, V94, P3978, DOI 10.1073/pnas.94.8.3978	28	32	34	0	3	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	SEP 5	2008	283	36					24420	24425		10.1074/jbc.M802217200	http://dx.doi.org/10.1074/jbc.M802217200			6	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	342YR	18621739	Green Published, hybrid			2022-12-27	WOS:000258820000017
J	Slugoski, MD; Smith, KM; Mulinta, R; Ng, AML; Yao, SYM; Morrison, EL; Lee, QOT; Zhang, J; Karpinski, E; Cass, CE; Baldwin, SA; Young, JD				Slugoski, Melissa D.; Smith, Kyla M.; Mulinta, Ras; Ng, Amy M. L.; Yao, Sylvia Y. M.; Morrison, Ellen L.; Lee, Queenie O. T.; Zhang, Jing; Karpinski, Edward; Cass, Carol E.; Baldwin, Stephen A.; Young, James D.			A conformationally mobile cysteine residue (Cys-561) modulates Na+ and H+ activation of human CNT3	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							CONCENTRATIVE NUCLEOSIDE TRANSPORTERS; H+/NUCLEOSIDE COTRANSPORTER CACNT; FUNCTIONAL EXPRESSION; SCANNING MUTAGENESIS; GLUCOSE-TRANSPORTER; MOLECULAR-CLONING; CANDIDA-ALBICANS; PROTEINS HCNT3; IDENTIFICATION; TOPOLOGY	In humans, the SLC28 concentrative nucleoside transporter (CNT) protein family is represented by three Na+-coupled members; human CNT1 (hCNT1) and hCNT2 are pyrimidine and purine nucleoside-selective, respectively, whereas hCNT3 transports both purine and pyrimidine nucleosides and nucleoside drugs. Belonging to a phylogenetic CNT subfamily distinct from hCNT1/2, hCNT3 also mediates H+/nucleoside cotransport. Using heterologous expression in Xenopus oocytes, we have characterized a cysteineless version of hCNT3 (hCNT3C-). Processed normally to the cell surface, hCNT3C-exhibited hCNT3-like transport properties, but displayed a decrease in apparent affinity specific for Na+ and not H+. Site-directed mutagenesis experiments in wild-type and hCNT3C- backgrounds identified intramembranous Cys-561 as the residue responsible for this altered Na+-binding phenotype. Alanine at this position restored Na+-binding affinity, whereas substitution with larger neutral amino acids ( threonine, valine, and isoleucine) abolished hCNT3 H+-dependent nucleoside transport activity. Independent of these findings, we have established that Cys-561 is located in a mobile region of the hCNT3 translocation pore adjacent to the nucleoside binding pocket and that access of p-chloromercuribenzene sulfonate to this residue reports a specific H+-induced conformational state of the protein (Slugoski, M. D., Ng, A. M. L., Yao, S.Y.M., Smith, K. M., Lin, C. C., Zhang, J., Karpinski, E., Cass, C. E., Baldwin, S. A., and Young, J. D. ( 2008) J. Biol. Chem. 283, 8496 - 8507). The present investigation validates hCNT3C - as a template for substituted cysteine accessibility method studies of CNTs and reveals a pivotal functional role for Cys-561 in Na+-as well as H+-coupled modes of hCNT3 nucleoside transport.	[Slugoski, Melissa D.; Smith, Kyla M.; Mulinta, Ras; Ng, Amy M. L.; Yao, Sylvia Y. M.; Morrison, Ellen L.; Lee, Queenie O. T.; Karpinski, Edward; Young, James D.] Univ Alberta, Dept Physiol, Membrane Prot Res Grp, Edmonton, AB T6G 2H7, Canada; [Zhang, Jing; Cass, Carol E.] Univ Alberta, Dept Oncol, Edmonton, AB T6G 2H7, Canada; [Cass, Carol E.] Cross Canc Inst, Edmonton, AB T6G 1Z2, Canada; [Baldwin, Stephen A.] Univ Leeds, Astbury Ctr Struct Mol Biol, Inst Membrane & Syst Biol, Leeds LS2 9JT, W Yorkshire, England	University of Alberta; University of Alberta; University of Alberta; University of Leeds	Young, JD (corresponding author), Univ Alberta, Dept Physiol, Membrane Prot Res Grp, 7-55 Med Sci Bldg, Edmonton, AB T6G 2H7, Canada.	james.young@ualberta.ca			National Cancer Institute of Canada; Canadian Cancer Society; Alberta Cancer Board	National Cancer Institute of Canada(Canadian Cancer Society (CCS)); Canadian Cancer Society(Canadian Cancer Society (CCS)); Alberta Cancer Board	This work was supported in part by the National Cancer Institute of Canada, with funds from the Canadian Cancer Society and the Alberta Cancer Board. The costs of publication of this article were defrayed in part by the payment of page charges. This article must therefore be hereby marked "advertisement" in accordance with 18 U. S. C. Section 1734 solely to indicate this fact.	Baldwin SA, 2004, PFLUG ARCH EUR J PHY, V447, P735, DOI 10.1007/s00424-003-1103-2; CASS CE, 1995, DRUG TRANSPORT ANTIM, P403; CRAIG JE, 1994, MOL MICROBIOL, V11, P1159, DOI 10.1111/j.1365-2958.1994.tb00392.x; Damaraju VL, 2007, AM J PHYSIOL-RENAL, V293, pF200, DOI 10.1152/ajprenal.00007.2007; Damaraju VL, 2003, ONCOGENE, V22, P7524, DOI 10.1038/sj.onc.1206952; Elwi AN, 2006, BIOCHEM CELL BIOL, V84, P844, DOI 10.1139/O06-198; Errasti-Murugarren E, 2008, MOL PHARMACOL, V73, P379, DOI 10.1124/mol.107.041848; Fujinaga J, 1999, J BIOL CHEM, V274, P6626, DOI 10.1074/jbc.274.10.6626; Gray JH, 2004, PFLUG ARCH EUR J PHY, V447, P728, DOI 10.1007/s00424-003-1107-y; Griffith DA, 1996, BBA-REV BIOMEMBRANES, V1286, P153, DOI 10.1016/S0304-4157(96)00008-1; Hamilton SR, 2001, J BIOL CHEM, V276, P27981, DOI 10.1074/jbc.M100518200; Heinze M, 2004, BIOCHEMISTRY-US, V43, P931, DOI 10.1021/bi030175w; HUANG QQ, 1994, J BIOL CHEM, V269, P17757; Kaback HR, 2005, CR BIOL, V328, P557, DOI 10.1016/j.crvi.2005.03.008; King AE, 2006, TRENDS PHARMACOL SCI, V27, P416, DOI 10.1016/j.tips.2006.06.004; Kirsch RD, 1998, NUCLEIC ACIDS RES, V26, P1848, DOI 10.1093/nar/26.7.1848; LAEMMLI UK, 1970, NATURE, V227, P680, DOI 10.1038/227680a0; Latini S, 2001, J NEUROCHEM, V79, P463, DOI 10.1046/j.1471-4159.2001.00607.x; LIMAN ER, 1992, NEURON, V9, P861, DOI 10.1016/0896-6273(92)90239-A; Loewen SK, 1999, J BIOL CHEM, V274, P24475, DOI 10.1074/jbc.274.35.24475; Loewen SK, 2004, MOL MEMBR BIOL, V21, P1, DOI 10.1080/0968768031000140836; Loewen SK, 2003, YEAST, V20, P661, DOI 10.1002/yea.1000; Mueckler M, 2004, J BIOL CHEM, V279, P10494, DOI 10.1074/jbc.M310786200; Pastor-Anglada M, 2007, J PHYSIOL BIOCHEM, V63, P97, DOI 10.1007/BF03174089; Ritzel MWL, 1998, MOL MEMBR BIOL, V15, P203; Ritzel MWL, 1997, AM J PHYSIOL-CELL PH, V272, pC707, DOI 10.1152/ajpcell.1997.272.2.C707; Ritzel MWL, 2001, MOL MEMBR BIOL, V18, P65, DOI 10.1080/09687680010026313; Ritzel MWL, 2001, J BIOL CHEM, V276, P2914, DOI 10.1074/jbc.M007746200; Slepkov ER, 2005, J BIOL CHEM, V280, P17863, DOI 10.1074/jbc.M409608200; Slugoski MD, 2004, YEAST, V21, P1269, DOI 10.1002/yea.1178; Slugoski MD, 2008, J BIOL CHEM, V283, P8496, DOI 10.1074/jbc.M710433200; Slugoski MD, 2007, BIOCHEMISTRY-US, V46, P1684, DOI 10.1021/bi061692s; Smith FM, 2007, MOL MEMBR BIOL, V24, P53, DOI 10.1080/09687860600942534; Smith KM, 2005, J BIOL CHEM, V280, P25436, DOI 10.1074/jbc.M409454200; Smith KM, 2004, J PHYSIOL-LONDON, V558, P807, DOI 10.1113/jphysiol.2004.068189; Tang XB, 1999, J BIOL CHEM, V274, P3557, DOI 10.1074/jbc.274.6.3557; Xiao GQ, 2001, MOL PHARMACOL, V59, P339, DOI 10.1124/mol.59.2.339; Yao SY, 2002, AM J PHYSIOL-CELL PH, V283, pC155, DOI 10.1152/ajpcell.00587.2001; Yao SYM, 2007, J BIOL CHEM, V282, P30607, DOI 10.1074/jbc.M703285200; Yao SYM, 2000, PRACT APPROACH SER, P47; Young JD, 2001, CURR TOP MEMBR, V50, P329; Zhang J, 2006, BIOCHEM J, V394, P389, DOI 10.1042/BJ20051476; Zhu QS, 2003, J BIOL CHEM, V278, P3112, DOI 10.1074/jbc.M207797200; Zhu QS, 2007, METHODS, V41, P439, DOI 10.1016/j.ymeth.2006.08.004	44	16	16	0	1	ELSEVIER	AMSTERDAM	RADARWEG 29, 1043 NX AMSTERDAM, NETHERLANDS		1083-351X		J BIOL CHEM	J. Biol. Chem.	SEP 5	2008	283	36					24922	24934		10.1074/jbc.M801793200	http://dx.doi.org/10.1074/jbc.M801793200			13	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	342YR	18621735	Green Published, hybrid			2022-12-27	WOS:000258820000055
J	O'Brien, DP; Romero-Gallo, J; Schneider, BG; Chaturvedi, R; Delgado, A; Harris, EJ; Krishna, U; Ogden, SR; Israel, DA; Wilson, KT; Peek, RM				O'Brien, Daniel P.; Romero-Gallo, Judith; Schneider, Barbara G.; Chaturvedi, Rupesh; Delgado, Alberto; Harris, Elizabeth J.; Krishna, Uma; Ogden, Seth R.; Israel, Dawn A.; Wilson, Keith T.; Peek, Richard M., Jr.			Regulation of the Helicobacter pylori cellular receptor decay-accelerating factor	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							GASTRIC EPITHELIAL-CELLS; ACTIVATED PROTEIN-KINASES; KAPPA-B; CAGA PROTEIN; IV SECRETION; FACTOR GENE; IN-VITRO; EXPRESSION; CANCER; INFECTION	Chronic gastritis induced by Helicobacter pylori is the strongest known risk factor for peptic ulceration and distal gastric cancer, and adherence of H. pylori to gastric epithelial cells is critical for induction of inflammation. One H. pylori constituent that increases disease risk is the cag pathogenicity island, which encodes a secretion system that translocates bacterial effector molecules into host cells. Decay-accelerating factor (DAF) is a cellular receptor for H. pylori and a mediator of the inflammatory response to this pathogen. H. pylori induces DAF expression in human gastric epithelial cells; therefore, we sought to define the mechanism by which H. pylori up-regulates DAF and to extend these findings into a murine model of H. pylori-induced injury. Co-culture of MKN28 gastric epithelial cells with the wild-type H. pylori cag(+) strain J166 induced transcriptional expression of DAF, which was attenuated by disruption of a structural component of the cag secretion system (cagE). H. pylori-induced expression of DAF was dependent upon activation of the p38 mitogen-activated protein kinase pathway but not NF-kappa B. Hypergastrinemic INS-GAS mice infected with wildtype H. pylori demonstrated significantly increased DAF expression in gastric epithelium versus uninfected controls or mice infected with an H. pylori cagE(-) isogenic mutant strain. These results indicate that H. pylori cag(+) strains induce up-regulation of a cognate cellular receptor in vitro and in vivo in a cag-dependent manner, representing the first evidence of regulation of an H. pylori host receptor by the cag pathogenicity island.	[O'Brien, Daniel P.; Romero-Gallo, Judith; Schneider, Barbara G.; Chaturvedi, Rupesh; Delgado, Alberto; Krishna, Uma; Ogden, Seth R.; Israel, Dawn A.; Wilson, Keith T.; Peek, Richard M., Jr.] Vanderbilt Univ, Sch Med, Div Gastroenterol, Dept Med, Nashville, TN 37232 USA; [Harris, Elizabeth J.] Vanderbilt Univ, Sch Med, Dept Pathol, Nashville, TN 37232 USA; [O'Brien, Daniel P.; Romero-Gallo, Judith; Chaturvedi, Rupesh; Krishna, Uma; Ogden, Seth R.; Israel, Dawn A.; Wilson, Keith T.; Peek, Richard M., Jr.] Vanderbilt Univ, Sch Med, Dept Canc Biol, Nashville, TN 37232 USA; [Peek, Richard M., Jr.] Dept Vet Affairs Med Ctr, Nashville, TN 37212 USA	Vanderbilt University; Vanderbilt University; Vanderbilt University; US Department of Veterans Affairs; Veterans Health Administration (VHA); VA Tennessee Valley Healthcare System	Peek, RM (corresponding author), Vanderbilt Univ, Sch Med, Div Gastroenterol, Dept Med, 2215 Garland Ave,1030C MRB 4, Nashville, TN 37232 USA.	richard.peek@vanderbilt.edu		Wilson, Keith/0000-0003-4421-1830; Schneider, Barbara/0000-0003-4421-1355	National Institutes of Health [DK73902, DK58587, DK7795, DK053620]; Vanderbilt Digestive Diseases Research Center [DK058404]; Office of Medical Research, Department of Veterans Affairs; NATIONAL CANCER INSTITUTE [T32CA009592] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK058587, R01DK073902, R01DK053620, P30DK058404] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Vanderbilt Digestive Diseases Research Center; Office of Medical Research, Department of Veterans Affairs(US Department of Veterans Affairs); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	This work was supported, in whole or in part, by National Institutes of Health Grants DK73902, DK58587, and DK7795 (to R. M. P.) and DK053620 (to K. T. W.). This work was also supported by Vanderbilt Digestive Diseases Research Center Grant DK058404 and by the Office of Medical Research, Department of Veterans Affairs (to K. T. W.). The costs of publication of this article were defrayed in part by the payment of page charges. This article must therefore be hereby marked "advertisement" in accordance with 18 U.S.C. Section 1734 solely to indicate this fact.	Aihara M, 1997, INFECT IMMUN, V65, P3218, DOI 10.1128/IAI.65.8.3218-3224.1997; Andoh A, 2001, J IMMUNOL, V167, P3887, DOI 10.4049/jimmunol.167.7.3887; Backert S, 2000, CELL MICROBIOL, V2, P155, DOI 10.1046/j.1462-5822.2000.00043.x; BACKERT S, 2008, CELL MICROB IN PRESS; BERGELSON JM, 1995, J VIROL, V69, P1903, DOI 10.1128/JVI.69.3.1903-1906.1995; Berstad AE, 1998, GUT, V42, P522, DOI 10.1136/gut.42.4.522; Beswick EJ, 2006, WORLD J GASTROENTERO, V12, P5599, DOI 10.3748/wjg.v12.i35.5599; Betis F, 2003, INFECT IMMUN, V71, P1068, DOI 10.1128/IAI.71.3.1068-1074.2003; Blanchard TG, 2004, CURR OPIN GASTROEN, V20, P10, DOI 10.1097/00001574-200401000-00004; Brandt S, 2005, P NATL ACAD SCI USA, V102, P9300, DOI 10.1073/pnas.0409873102; Camorlinga-Ponce M, 2004, J CLIN PATHOL, V57, P822, DOI 10.1136/jcp.2004.017087; CLARKSON NA, 1995, J VIROL, V69, P5497, DOI 10.1128/JVI.69.9.5497-5501.1995; Correa P, 2004, GUT, V53, P1217, DOI 10.1136/gut.2004.039834; Crawford HC, 2003, GASTROENTEROLOGY, V125, P1125, DOI 10.1016/S0016-5085(03)01206-X; DERIJARD B, 1994, CELL, V76, P1025, DOI 10.1016/0092-8674(94)90380-8; Ernst PB, 2006, GASTROENTEROLOGY, V130, P188, DOI 10.1053/j.gastro.2005.06.032; EWULONU UK, 1991, P NATL ACAD SCI USA, V88, P4675, DOI 10.1073/pnas.88.11.4675; Fishelson Z, 2003, MOL IMMUNOL, V40, P109, DOI 10.1016/S0161-5890(03)00112-3; Fox JG, 2003, GASTROENTEROLOGY, V124, P1879, DOI 10.1016/S0016-5085(03)00406-2; Fox JG, 2003, CANCER RES, V63, P942; Franco AT, 2008, CANCER RES, V68, P379, DOI 10.1158/0008-5472.CAN-07-0824; Franco AT, 2005, P NATL ACAD SCI USA, V102, P10646, DOI 10.1073/pnas.0504927102; Frevel MAE, 2003, MOL CELL BIOL, V23, P425, DOI 10.1128/MCB.23.2.425-436.2003; Gelderman KA, 2004, TRENDS IMMUNOL, V25, P158, DOI 10.1016/j.it.2004.01.008; Gerhard M, 1999, P NATL ACAD SCI USA, V96, P12778, DOI 10.1073/pnas.96.22.12778; Gewirtz AT, 2004, J INFECT DIS, V189, P1914, DOI 10.1086/386289; Glocker E, 1998, INFECT IMMUN, V66, P2346, DOI 10.1128/IAI.66.5.2346-2348.1998; HESSEY SJ, 1990, GUT, V31, P134, DOI 10.1136/gut.31.2.134; Higashi H, 2002, SCIENCE, V295, P683, DOI 10.1126/science.1067147; Holla VR, 2005, J BIOL CHEM, V280, P476, DOI 10.1074/jbc.M407403200; Ilver D, 1998, SCIENCE, V279, P373, DOI 10.1126/science.279.5349.373; Jurianz K, 1999, MOL IMMUNOL, V36, P929, DOI 10.1016/S0161-5890(99)00115-7; Keates S, 1999, J IMMUNOL, V163, P5552; Kiso T, 2002, HISTOPATHOLOGY, V40, P339, DOI 10.1046/j.1365-2559.2002.01350.x; Kobayashi M, 2007, J HISTOCHEM CYTOCHEM, V55, P263, DOI 10.1369/jhc.6A7097.2006; Kudo T, 2007, GASTROENTEROLOGY, V132, P1024, DOI 10.1053/j.gastro.2007.01.009; Kwok T, 2007, NATURE, V449, P862, DOI 10.1038/nature06187; Lidington EA, 2000, BLOOD, V96, P2784; Mahdavi J, 2002, SCIENCE, V297, P573, DOI 10.1126/science.1069076; Moss SF, 2005, NAT CLIN PRACT ONCOL, V2, P90, DOI 10.1038/ncponc0081; Moss SF, 2003, CURR OPIN INFECT DIS, V16, P445, DOI 10.1097/00001432-200310000-00011; NOWICKI B, 1993, J EXP MED, V178, P2115, DOI 10.1084/jem.178.6.2115; O'Brien DP, 2006, J BIOL CHEM, V281, P13317, DOI 10.1074/jbc.M601805200; Odenbreit S, 2000, SCIENCE, V287, P1497, DOI 10.1126/science.287.5457.1497; Ohtani M, 2007, CARCINOGENESIS, V28, P2597, DOI 10.1093/carcin/bgm150; Opitz B, 2006, J IMMUNOL, V176, P484, DOI 10.4049/jimmunol.176.1.484; Peek RM, 2002, NAT REV CANCER, V2, P28, DOI 10.1038/nrc703; Peek RM, 1999, CANCER RES, V59, P6124; Rautemaa R, 2001, GASTROENTEROLOGY, V120, P470, DOI 10.1053/gast.2001.21197; Romero-Gallo J, 2008, LAB INVEST, V88, P328, DOI 10.1038/labinvest.3700719; ROUSE J, 1994, CELL, V78, P1027, DOI 10.1016/0092-8674(94)90277-1; Selbach M, 2002, J BIOL CHEM, V277, P6775, DOI 10.1074/jbc.C100754200; Servin AL, 2005, CLIN MICROBIOL REV, V18, P264, DOI 10.1128/CMR.18.2.264-292.2005; Shafren DR, 1998, J VIROL, V72, P9407, DOI 10.1128/JVI.72.11.9407-9412.1998; Sharma SA, 1998, J IMMUNOL, V160, P2401; Shattuck-Brandt RL, 1999, MOL CARCINOGEN, V24, P177, DOI 10.1002/(SICI)1098-2744(199903)24:3<177::AID-MC4>3.0.CO;2-6; Solnick JV, 2004, P NATL ACAD SCI USA, V101, P2106, DOI 10.1073/pnas.0308573100; Steele IA, 2007, AM J PHYSIOL-GASTR L, V293, pG347, DOI 10.1152/ajpgi.00076.2007; Strober W, 2006, NAT REV IMMUNOL, V6, P9, DOI 10.1038/nri1747; Tammer I, 2007, GASTROENTEROLOGY, V132, P1309, DOI 10.1053/j.gastro.2007.01.050; THOMAS DJ, 1993, J IMMUNOL, V150, P151; Viala J, 2004, NAT IMMUNOL, V5, P1166, DOI 10.1038/ni1131; Wang TC, 2000, GASTROENTEROLOGY, V118, P36, DOI 10.1016/S0016-5085(00)70412-4; WHITEHEAD RH, 1993, P NATL ACAD SCI USA, V90, P587, DOI 10.1073/pnas.90.2.587; ZENG H, 2006, AM J PHYSIOL-GASTR L, V290, P96, DOI 10.1152/ajpgi.00273.2005	65	19	19	0	1	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	AUG 29	2008	283	35					23922	23930		10.1074/jbc.M801144200	http://dx.doi.org/10.1074/jbc.M801144200			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	340II	18579524	Green Published, hybrid			2022-12-27	WOS:000258638900047
J	Zhang, Y; Liao, MJ; Dufau, ML				Zhang, Ying; Liao, Mingjuan; Dufau, Maria L.			Unlocking repression of the human luteinizing hormone receptor gene by trichostatin A-induced cell-specific phosphatase release	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							HISTONE DEACETYLASE INHIBITOR; KINASE-C ZETA; REGULATE TRANSCRIPTION; SP1 SITES; PROMOTER; ACETYLATION; EXPRESSION; COMPLEX; PHOSPHORYLATION; RECRUITMENT	Our previous studies demonstrated that the histone deacetylase inhibitor, trichostatin A (TSA), induces derepression of the human luteinizing hormone receptor (LHR) gene by de-recruitment of the pRB homologue p107 repressor from the promoter in JAR and MCF-7 cancer cells. TSA initiates a mechanism whereby the phosphatidylinositol 3-kinase/protein kinase zeta (PKC zeta) cascade phosphorylates Sp1 at Ser-641, which is essential for the release of the repression of LHR transcription. The present studies have revealed that dissociation of serine/threonine protein phosphatases PP2A and PP1 from the LHR promoter mediates TSA-induced activation of LHR gene transcription in a cell-specific manner. Changes in chromatin structure induced by TSA cause the release of PP2A in JAR cells or of PP1 in MCF-7 cells, which is associated with Sp1 directly or through histone deacetylase 1/2, respectively, at the promoter. This favors the phosphorylation of Sp1 mediated by the phosphatidylinositol 3-kinase/PKC zeta pathway, which in turn causes the release of the p107 inhibitor from Sp1 and marked transcriptional activation of the LHR. These findings reveal the importance of phosphatases in the control of LHR transcription, where the balance between phosphatidylinositol 3-kinase/PKC zeta and phosphatases could be critical for up- and down-regulation of LHR gene expression in physiological and pathological settings.	[Zhang, Ying; Liao, Mingjuan; Dufau, Maria L.] Eunice Kennedy Shriver NICHD, Sect Mol Endocrinol, Endocrinol & Reprod Res Branch, Program Dev Endocrinol & Genet,NIH, Bethesda, MD 20892 USA	National Institutes of Health (NIH) - USA; NIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)	Dufau, ML (corresponding author), NIH, Bldg 49,Rm 6A-36,49 Convent Dr,MSC 4510, Bethesda, MD 20892 USA.	dufaum@mail.nih.gov			National Institutes of Health (Intramural Research Program of the NICHD); EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT [ZIAHD000150] Funding Source: NIH RePORTER; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT [Z01HD000150] Funding Source: NIH RePORTER	National Institutes of Health (Intramural Research Program of the NICHD)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD))	This work was supported, in whole or in part, by National Institutes of Health (Intramural Research Program of the NICHD). The costs of publication of this article were defrayed in part by the payment of page charges. This article must therefore be hereby marked "advertisement" in accordance with 18 U.S.C. Section 1734 solely to indicate this fact.	Ammanamanchi S, 2003, J BIOL CHEM, V278, P35775, DOI 10.1074/jbc.M305961200; Camarero N, 2003, NUCLEIC ACIDS RES, V31, P1693, DOI 10.1093/nar/gkg262; Canettieri G, 2003, NAT STRUCT BIOL, V10, P175, DOI 10.1038/nsb895; Ceulemans H, 2004, PHYSIOL REV, V84, P1, DOI 10.1152/physrev.00013.2003; Chou MM, 1998, CURR BIOL, V8, P1069, DOI 10.1016/S0960-9822(98)70444-0; Dong J, 2006, J BIOL CHEM, V281, P18825, DOI 10.1074/jbc.M512826200; Dufau ML, 1998, ANNU REV PHYSIOL, V60, P461, DOI 10.1146/annurev.physiol.60.1.461; Eickhoff B, 2000, BIOL CHEM, V381, P107, DOI 10.1515/BC.2000.015; Espinos E, 1999, MOL CELL BIOL, V19, P3474; Geng Y, 1999, BIOCHEM BIOPH RES CO, V263, P366, DOI 10.1006/bbrc.1999.1374; Hsu LC, 2007, BIOCHEM BIOPH RES CO, V360, P507, DOI 10.1016/j.bbrc.2007.06.090; Huang WQ, 2005, J BIOL CHEM, V280, P10047, DOI 10.1074/jbc.M408680200; Ivanov GS, 2007, MOL CELL BIOL, V27, P6756, DOI 10.1128/MCB.00460-07; Jaskelioff M, 2003, NAT CELL BIOL, V5, P395, DOI 10.1038/ncb0503-395; Kim YK, 2003, ONCOGENE, V22, P6023, DOI 10.1038/sj.onc.1206875; Li AG, 2007, MOL CELL, V28, P408, DOI 10.1016/j.molcel.2007.09.006; Mustelin Tomas, 2007, V365, P9; Roy S, 2007, J BIOL CHEM, V282, P4765, DOI 10.1074/jbc.M609588200; Sontag E, 1997, EMBO J, V16, P5662, DOI 10.1093/emboj/16.18.5662; Sowa Y, 1999, CANCER RES, V59, P4266; TSAIMORRIS CH, 1994, J BIOL CHEM, V269, P15868; TSAIMORRIS CH, 1993, J BIOL CHEM, V268, P4447; Yang JQ, 2001, J BIOL CHEM, V276, P25742, DOI 10.1074/jbc.M102821200; Yang SH, 2001, MOL CELL BIOL, V21, P2802, DOI 10.1128/MCB.21.8.2802-2814.2001; Zhang Y, 2005, MOL CELL BIOL, V25, P7929, DOI 10.1128/MCB.25.18.7929-7939.2005; Zhang Y, 2003, MOL CELL BIOL, V23, P6958, DOI 10.1128/MCB.23.19.6958-6972.2003; Zhang Y, 2002, J BIOL CHEM, V277, P33431, DOI 10.1074/jbc.M204417200; Zhang Y, 2000, J BIOL CHEM, V275, P2763, DOI 10.1074/jbc.275.4.2763; Zhang Y, 2001, MOL ENDOCRINOL, V15, P1891, DOI 10.1210/me.15.11.1891; Zhang Y, 2006, MOL CELL BIOL, V26, P6748, DOI 10.1128/MCB.00560-06; Zhou CL, 2006, INT J ONCOL, V29, P269	31	14	15	0	0	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	AUG 29	2008	283	35					24039	24046		10.1074/jbc.M801878200	http://dx.doi.org/10.1074/jbc.M801878200			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	340II	18596044	Green Published, hybrid			2022-12-27	WOS:000258638900059
J	Buzza, MS; Dyson, JM; Choi, H; Gardiner, EE; Andrews, RK; Kaiserman, D; Mitchell, CA; Berndt, MC; Dong, JF; Bird, PI				Buzza, Marguerite S.; Dyson, Jennifer M.; Choi, Hiuwan; Gardiner, Elizabeth E.; Andrews, Robert K.; Kaiserman, Dion; Mitchell, Christina A.; Berndt, Michael C.; Dong, Jing-Fei; Bird, Phillip I.			Antihemostatic activity of human granzyme B mediated by cleavage of von Willebrand factor	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							MEMBRANE GLYCOPROTEIN-IB; INDUCED PLATELET-AGGREGATION; VONWILLEBRAND-FACTOR; IIB-IIIA; IX-V; RHEUMATOID-ARTHRITIS; PROTEASE GRANZYME; FACTOR-BINDING; CATHEPSIN-G; CELL-DEATH	The cytotoxic lymphocyte protease granzyme B (GrB) is elevated in the plasma of individuals with diseases that elicit a cytotoxic lymphocyte-mediated immune response. Given the recently recognized ability of GrB to cleave extracellular matrix proteins, we examined the effect of GrB on the pro-hemostatic molecule von Willebrand factor (VWF). GrB delays ristocetin-induced platelet aggregation and inhibits platelet adhesion and spreading on immobilized VWF under static conditions. It efficiently cleaves VWF at two sites within the A1-3 domains that are essential for the VWF-platelet interaction. Like the VWF regulatory proteinase ADAMTS-13, GrB-mediated cleavage is dependent upon VWF conformation. In vitro, GrB cannot cleave the VWF conformer found in solution, but cleavage is induced when VWF is artificially unfolded or presented as a matrix. GrB cleaves VWF with comparable efficiency to ADAMTS-13 and rapidly processes ultra-large VWF multimers released from activated endothelial cells under physiological shear. GrB also cleaves the matrix form of fibrinogen at several sites. These studies suggest extracellular GrB may help control localized coagulation during inflammation.	[Buzza, Marguerite S.; Dyson, Jennifer M.; Kaiserman, Dion; Mitchell, Christina A.; Bird, Phillip I.] Monash Univ, Dept Biochem & Mol Biol, Clayton, Vic 3800, Australia; [Choi, Hiuwan; Dong, Jing-Fei] Baylor Coll Med, Thrombosis Res Sect, Dept Med, Houston, TX 77030 USA; [Gardiner, Elizabeth E.; Andrews, Robert K.; Berndt, Michael C.] Monash Univ, Dept Immunol, Alfred Med Res & Educ Precinct, Melbourne, Vic 3004, Australia	Monash University; Baylor College of Medicine; Monash University	Bird, PI (corresponding author), Monash Univ, Dept Biochem & Mol Biol, Clayton, Vic 3800, Australia.	phil.bird@med.monash.edu.au	Gardiner, Elizabeth/P-8716-2019; Berndt, Michael C/D-5580-2012; Gardiner, Elizabeth/E-7774-2011	Gardiner, Elizabeth/0000-0001-9453-9688; Bird, Phillip/0000-0002-6695-606X; Andrews, Robert Keith/0000-0001-9577-8082; Mitchell, Christina A/0000-0001-9372-3192				Andrews RK, 2004, THROMB RES, V114, P447, DOI 10.1016/j.thromres.2004.07.020; Andrews RK, 2003, INT J BIOCHEM CELL B, V35, P1170, DOI 10.1016/S1357-2725(02)00280-7; ANDREWS RK, 1989, BIOCHEMISTRY-US, V28, P8326, DOI 10.1021/bi00447a010; Banno F, 2006, BLOOD, V107, P3161, DOI 10.1182/blood-2005-07-2765; Bennett JS, 2001, ANN NY ACAD SCI, V936, P340; BERNDT MC, 1985, EUR J BIOCHEM, V151, P637, DOI 10.1111/j.1432-1033.1985.tb09152.x; BERNDT MC, 1988, BIOCHEMISTRY-US, V27, P633, DOI 10.1021/bi00402a021; Bird CH, 2005, MOL CELL BIOL, V25, P7854, DOI 10.1128/MCB.25.17.7854-7867.2005; Bonnefoy A, 2000, THROMB RES, V98, P323, DOI 10.1016/S0049-3848(99)00242-X; BOOTH WJ, 1984, BIOCHEM BIOPH RES CO, V118, P495, DOI 10.1016/0006-291X(84)91330-5; Borthakur G, 2003, J THROMB HAEMOST, V1, P1288, DOI 10.1046/j.1538-7836.2003.00156.x; Buzza MS, 2006, BIOL CHEM, V387, P827, DOI 10.1515/BC.2006.106; Buzza MS, 2005, J BIOL CHEM, V280, P23549, DOI 10.1074/jbc.M412001200; Canobbio H, 2004, CELL SIGNAL, V16, P1329, DOI 10.1016/j.cellsig.2004.05.008; Chamberlain CM, 2007, CAN J PHYSIOL PHARM, V85, P89, DOI 10.1139/Y06-090; Chang AK, 2005, J BACTERIOL, V187, P6909, DOI 10.1128/JB.187.20.6909-6916.2005; Choy JC, 2004, ARTERIOSCL THROM VAS, V24, P2245, DOI 10.1161/01.ATV.0000147162.51930.b7; Choy JC, 2003, MODERN PATHOL, V16, P460, DOI 10.1097/01.MP.0000067424.12280.BC; CLEMETSON KJ, 1981, P NATL ACAD SCI-BIOL, V78, P2712, DOI 10.1073/pnas.78.5.2712; De Cristofaro R, 2005, J BIOL CHEM, V280, P23295, DOI 10.1074/jbc.M501143200; De Cristofaro R, 2006, J BIOL CHEM, V281, P30400, DOI 10.1074/jbc.M603321200; De Luca M, 2000, BLOOD, V95, P164; Dong JF, 2005, J THROMB HAEMOST, V3, P1710, DOI 10.1111/j.1538-7836.2005.01360.x; Dong JF, 2002, BLOOD, V100, P4033, DOI 10.1182/blood-2002-05-1401; Dyson JM, 2003, BLOOD, V102, P940, DOI 10.1182/blood-2002-09-2897; ESCOLAR G, 1988, BRIT J HAEMATOL, V69, P379, DOI 10.1111/j.1365-2141.1988.tb02377.x; Furlan M, 1996, BLOOD, V87, P4223, DOI 10.1182/blood.V87.10.4223.bloodjournal87104223; FURLAN M, 1987, BIOCHIM BIOPHYS ACTA, V924, P27, DOI 10.1016/0304-4165(87)90067-5; Goldbach-Mansky R, 2005, ANN RHEUM DIS, V64, P715, DOI 10.1136/ard.2003.007039; Hamako J, 1998, THROMB HAEMOSTASIS, V80, P499, DOI 10.1055/s-0037-1615236; Hermsen CC, 2003, CLIN EXP IMMUNOL, V132, P467, DOI 10.1046/j.1365-2249.2003.02160.x; HOWARD MA, 1971, THROMB DIATH HAEMOST, V26, P362; Kaiserman D, 2006, J CELL BIOL, V175, P619, DOI 10.1083/jcb.200606073; Kim WJ, 2007, IMMUNOL LETT, V111, P57, DOI 10.1016/j.imlet.2007.05.004; Lieberman J, 2003, NAT REV IMMUNOL, V3, P361, DOI 10.1038/nri1083; Majerus EM, 2005, J BIOL CHEM, V280, P21773, DOI 10.1074/jbc.M502529200; Marshall SJ, 2002, BIOCHEM J, V361, P297, DOI 10.1042/0264-6021:3610297; MEYER D, 1991, MAYO CLIN PROC, V66, P516, DOI 10.1016/S0025-6196(12)62394-5; MOAKE JL, 1986, J CLIN INVEST, V78, P1456, DOI 10.1172/JCI112736; Mosesson MW, 2005, J THROMB HAEMOST, V3, P1894, DOI 10.1111/j.1538-7836.2005.01365.x; Nishio K, 2004, P NATL ACAD SCI USA, V101, P10578, DOI 10.1073/pnas.0402041101; Pardo J, 2007, CELL DEATH DIFFER, V14, P1768, DOI 10.1038/sj.cdd.4402183; PETERSON DM, 1987, BLOOD, V69, P625; Pimanda J, 2002, BLOOD REV, V16, P185, DOI 10.1016/S0268-960X(02)00017-6; POE M, 1991, J BIOL CHEM, V266, P98; Rayes J, 2007, J THROMB HAEMOST, V5, P321, DOI 10.1111/j.1538-7836.2007.02296.x; Ruggeri ZM, 2003, J THROMB HAEMOST, V1, P1335, DOI 10.1046/j.1538-7836.2003.00260.x; Russell JH, 2002, ANNU REV IMMUNOL, V20, P323, DOI 10.1146/annurev.immunol.20.100201.131730; SADLER JE, 1993, THROMB HAEMOSTASIS, V69, P185; SADLER JE, 1991, J BIOL CHEM, V266, P22777; Sambrano GR, 2000, J BIOL CHEM, V275, P6819, DOI 10.1074/jbc.275.10.6819; SAVAGE B, 1992, J BIOL CHEM, V267, P11300; Siedlecki CA, 1996, BLOOD, V88, P2939, DOI 10.1182/blood.V88.8.2939.bloodjournal8882939; Skjelland M, 2007, ATHEROSCLEROSIS, V195, pE142, DOI 10.1016/j.atherosclerosis.2007.05.001; Strik MCM, 2007, MOL IMMUNOL, V44, P3462, DOI 10.1016/j.molimm.2007.03.024; Suidan HS, 1996, BIOCHEM J, V315, P939, DOI 10.1042/bj3150939; Tao ZY, 2005, BLOOD, V106, P141, DOI 10.1182/blood-2004-11-4188; TITANI K, 1987, P NATL ACAD SCI USA, V84, P5610, DOI 10.1073/pnas.84.16.5610; TSAI HM, 1994, BLOOD, V83, P2171; Tsai HM, 1996, BLOOD, V87, P4235, DOI 10.1182/blood.V87.10.4235.bloodjournal87104235; Tsuru R, 2008, HEART, V94, P305, DOI 10.1136/hrt.2006.110023; Wowk ME, 2004, MICROBES INFECT, V6, P752, DOI 10.1016/j.micinf.2004.03.008	62	42	42	0	5	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	AUG 15	2008	283	33					22498	22504		10.1074/jbc.M709080200	http://dx.doi.org/10.1074/jbc.M709080200			7	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	335VR	18577516	hybrid			2022-12-27	WOS:000258321000018
J	Thinakaran, G; Koo, EH				Thinakaran, Gopal; Koo, Edward H.			Amyloid Precursor Protein Trafficking, Processing, and Function	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Review							APP-LIKE PROTEIN-2; ALZHEIMERS-DISEASE; GAMMA-SECRETASE; MICE LACKING; AXONAL-TRANSPORT; BETA-PROTEIN; LIPID RAFTS; FAMILY-MEMBERS; DENSITY; MEMBRANE	Intracellular trafficking and proteolytic processing of amyloid precursor protein (APP) have been the focus of numerous investigations over the past two decades. APP is the precursor to the amyloid beta-protein (A beta), the 38-43-amino acid residue peptide that is at the heart of the amyloid cascade hypothesis of Alzheimer disease (AD). Tremendous progress has been made since the initial identification of A beta as the principal component of brain senile plaques of individuals with AD. Specifically, molecular characterization of the secretases involved in A beta production has facilitated cell biological investigations on APP processing and advanced efforts to model AD pathogenesis in animal models. This minireview summarizes salient features of APP trafficking and amyloidogenic processing and discusses the putative biological functions of APP.	[Thinakaran, Gopal] Univ Chicago, Dept Neurobiol, Chicago, IL 60637 USA; [Thinakaran, Gopal] Univ Chicago, Dept Neurol, Chicago, IL 60637 USA; [Thinakaran, Gopal] Univ Chicago, Dept Pathol, Chicago, IL 60637 USA; [Koo, Edward H.] Univ Calif San Diego, Dept Neurosci, La Jolla, CA 92093 USA	University of Chicago; University of Chicago; University of Chicago; University of California System; University of California San Diego	Thinakaran, G (corresponding author), Univ Chicago, Dept Neurobiol, Chicago, IL 60637 USA.	gopal@uchicago.edu; edkoo@ucsd.edu			National Institutes of Health [AG019070, AG021495]; NIA [AG032179]; American Health Assistance Foundation Alzheimer's Disease Research Program and the Alzheimer's Association; Glenn Foundation for Medical Research; NATIONAL INSTITUTE ON AGING [R01AG021495, R01AG019070, R01AG032179, R01AG012376] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NIA(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA)); American Health Assistance Foundation Alzheimer's Disease Research Program and the Alzheimer's Association; Glenn Foundation for Medical Research; NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))	This work was supported, in whole or in part, by National Institutes of Health Grants AG019070 and AG021495 (to G.T.) and AG12376 and AG032179 (to E. H. K.) from NIA. This work was also supported by the American Health Assistance Foundation Alzheimer's Disease Research Program and the Alzheimer's Association (to G.T.) and by the Glenn Foundation for Medical Research (to E. H. K.). This is the first article of eleven in the Thematic Minireview Series on the Molecular Basis of Alzheimer Disease. This minireview will be reprinted in the 2008 Minireview Compendium, which will be available in January, 2009.	Allinson TMJ, 2003, J NEUROSCI RES, V74, P342, DOI 10.1002/jnr.10737; Ando K, 2001, J BIOL CHEM, V276, P40353, DOI 10.1074/jbc.M104059200; Anliker B, 2006, NEURODEGENER DIS, V3, P239, DOI 10.1159/000095262; Ashley J, 2005, J NEUROSCI, V25, P5943, DOI 10.1523/JNEUROSCI.1144-05.2005; Baek SH, 2002, CELL, V110, P55, DOI 10.1016/S0092-8674(02)00809-7; Buxbaum JD, 1998, J NEUROSCI, V18, P9629; Caille I, 2004, DEVELOPMENT, V131, P2173, DOI 10.1242/dev.01103; Cao XW, 2001, SCIENCE, V293, P115, DOI 10.1126/science.1058783; Cao XW, 2004, J BIOL CHEM, V279, P24601, DOI 10.1074/jbc.M402248200; Dawson GR, 1999, NEUROSCIENCE, V90, P1, DOI 10.1016/S0306-4522(98)00410-2; Ehehalt R, 2003, J CELL BIOL, V160, P113, DOI 10.1083/jcb.200207113; GHISO J, 1992, BIOCHEM J, V288, P1053, DOI 10.1042/bj2881053; Herms J, 2004, EMBO J, V23, P4106, DOI 10.1038/sj.emboj.7600390; Hill K, 2003, J BIOL CHEM, V278, P36032, DOI 10.1074/jbc.M301632200; Ho A, 2004, P NATL ACAD SCI USA, V101, P2548, DOI 10.1073/pnas.0308655100; Hornsten A, 2007, P NATL ACAD SCI USA, V104, P1971, DOI 10.1073/pnas.0603997104; HUNG AY, 1992, P NATL ACAD SCI USA, V89, P9439, DOI 10.1073/pnas.89.20.9439; Iwatsubo T, 2004, CURR OPIN NEUROBIOL, V14, P379, DOI 10.1016/j.conb.2004.05.010; Kamal A, 2000, NEURON, V28, P449, DOI 10.1016/S0896-6273(00)00124-0; KOO EH, 1990, P NATL ACAD SCI USA, V87, P1561, DOI 10.1073/pnas.87.4.1561; KOO EH, 1994, J BIOL CHEM, V269, P17386; Kopan R, 2004, NAT REV MOL CELL BIO, V5, P499, DOI 10.1038/nrm1406; Kwak YD, 2006, STEM CELLS DEV, V15, P381, DOI 10.1089/scd.2006.15.381; Lazarov O, 2005, J NEUROSCI, V25, P2386, DOI 10.1523/JNEUROSCI.3089-04.2005; Lee MS, 2003, J CELL BIOL, V163, P83, DOI 10.1083/jcb.200301115; Liu Q, 2007, NEURON, V56, P66, DOI 10.1016/j.neuron.2007.08.008; Ma QH, 2008, NAT CELL BIOL, V10, P283, DOI 10.1038/ncb1690; Mattson MP, 1997, PHYSIOL REV, V77, P1081, DOI 10.1152/physrev.1997.77.4.1081; Meziane H, 1998, P NATL ACAD SCI USA, V95, P12683, DOI 10.1073/pnas.95.21.12683; Miller CCJ, 2006, TRENDS NEUROSCI, V29, P280, DOI 10.1016/j.tins.2006.03.001; NINOMIYA H, 1993, J CELL BIOL, V121, P879, DOI 10.1083/jcb.121.4.879; Pardossi-Piquard R, 2005, NEURON, V46, P541, DOI 10.1016/j.neuron.2005.04.008; Perez RG, 1999, J BIOL CHEM, V274, P18851, DOI 10.1074/jbc.274.27.18851; Pietrzik CU, 2004, J NEUROSCI, V24, P4259, DOI 10.1523/JNEUROSCI.5451-03.2004; Riddell DR, 2001, CURR BIOL, V11, P1288, DOI 10.1016/S0960-9822(01)00394-3; ROCH JM, 1994, P NATL ACAD SCI USA, V91, P7450, DOI 10.1073/pnas.91.16.7450; Rogaeva E, 2007, NAT GENET, V39, P168, DOI 10.1038/ng1943; Rossjohn J, 1999, NAT STRUCT BIOL, V6, P327; SAITOH T, 1989, CELL, V58, P615, DOI 10.1016/0092-8674(89)90096-2; Schmidt V, 2007, J BIOL CHEM, V282, P32956, DOI 10.1074/jbc.M705073200; Selkoe DJ, 2007, CELL, V131, P215, DOI 10.1016/j.cell.2007.10.012; SISODIA SS, 1992, P NATL ACAD SCI USA, V89, P6075, DOI 10.1073/pnas.89.13.6075; Small SA, 2006, NEURON, V52, P15, DOI 10.1016/j.neuron.2006.09.001; Storey E, 1996, BRAIN RES, V735, P59; Vassar R, 2004, J MOL NEUROSCI, V23, P105, DOI 10.1385/JMN:23:1-2:105; Vetrivel KS, 2004, J BIOL CHEM, V279, P44945, DOI 10.1074/jbc.M407986200; Vetrivel KS, 2005, J BIOL CHEM, V280, P25892, DOI 10.1074/jbc.M503570200; Wang B, 2007, P NATL ACAD SCI USA, V104, P14140, DOI 10.1073/pnas.0704070104; Wang P, 2005, J NEUROSCI, V25, P1219, DOI 10.1523/JNEUROSCI.4660-04.2005; Yamazaki T, 1997, J NEUROSCI, V17, P1004; Yang G, 2005, NEUROSCI LETT, V384, P66, DOI 10.1016/j.neulet.2005.04.040; Young-Pearse TL, 2007, J NEUROSCI, V27, P14459, DOI 10.1523/JNEUROSCI.4701-07.2007; Zhang YW, 2007, P NATL ACAD SCI USA, V104, P10613, DOI 10.1073/pnas.0703903104; ZHENG H, 1995, CELL, V81, P525, DOI 10.1016/0092-8674(95)90073-X	54	812	848	1	147	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	OCT 31	2008	283	44					29615	29619		10.1074/jbc.R800019200	http://dx.doi.org/10.1074/jbc.R800019200			5	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	364WS	18650430	Green Published, hybrid			2022-12-27	WOS:000260366900002
J	Ding, Q; Gladson, CL; Wu, HJ; Hayasaka, H; Olman, MA				Ding, Qiang; Gladson, Candece L.; Wu, Hongju; Hayasaka, Haurko; Olman, Mitchell A.			Focal adhesion kinase (FAK)-related non-kinase inhibits myofibroblast differentiation through differential MAPK activation in a FAK-dependent manner	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							SMOOTH MUSCLE ACTIN; IDIOPATHIC PULMONARY FIBROSIS; GROWTH-FACTOR-BETA; TYROSINE PHOSPHORYLATION; PLASMINOGEN-ACTIVATOR; GENE-EXPRESSION; TRANSFORMING GROWTH-FACTOR-BETA-1; CELL-PROLIFERATION; GLIOBLASTOMA CELLS; LATENT TGF-BETA-1	Transforming growth factor (TGF)-beta 1 induces fibroblast transdifferentiation to myofibroblasts, a process that requires the involvement of integrin-mediated signaling and focal adhesion kinase (FAK). FAK-related non-kinase (FRNK) is known for its role in inhibiting integrin-mediated cell migration; however, its role in myofibroblast differentiation has not been defined. Here, we report that FRNK abrogates TGF-beta 1-induced myofibroblast differentiation in vitro and in vivo. TGF-beta 1 can induce alpha-smooth muscle actin (alpha-SMA) expression in the presence or absence of FAK; however, TGF-beta 1-induced alpha-SMA expression is reduced (similar to 73%) in FAK-deficient fibroblasts. Although both ERK and p38 MAPK activation is required for maximal TGF-beta 1-induced alpha-SMA expression, ERK is the major signaling intermediate in cells that express FAK. In contrast, p38 MAPK is the dominant mediator of TGF-beta 1-induced alpha-SMA expression in FAK-deficient cells. FRNK overexpression blocks TGF-beta 1-induced ERK or p38 MAPK activation in the presence, and surprisingly, in the absence of FAK. The loss of FRNK was tested in vivo during experimentally induced pulmonary fibrosis in mice. FRNK knock-out mice have a greater increase in alpha-SMA-expressing cells in response to a pulmonary fibrotic stimulus in vivo, as compared with congenic wild type mice. This is the first time that FRNK loss has been shown to modify the pathobiology in any animal disease model. Together, the data demonstrate that FRNK negatively regulates myofibroblast differentiation in vitro and in vivo. These data further suggest that modulation FRNK expression may be a novel avenue for therapeutic intervention in tissue fibrosis.	[Ding, Qiang; Olman, Mitchell A.] Univ Alabama Birmingham, Dept Med, Div Pulm & Crit Care Med, Birmingham, AL 35294 USA; [Gladson, Candece L.; Olman, Mitchell A.] Univ Alabama Birmingham, Dept Pathol, Birmingham, AL 35294 USA; [Wu, Hongju] Univ Alabama Birmingham, Div Human Gene Therapy, Birmingham, AL 35294 USA; [Hayasaka, Haurko] Osaka Univ, Dept Microbiol, Suita, Osaka 5650871, Japan; [Hayasaka, Haurko] Osaka Univ, Dept Immunol, Suita, Osaka 5650871, Japan	University of Alabama System; University of Alabama Birmingham; University of Alabama System; University of Alabama Birmingham; University of Alabama System; University of Alabama Birmingham; Osaka University; Osaka University	Ding, Q (corresponding author), Univ Alabama Birmingham, Dept Med, Div Pulm & Crit Care Med, 1900 Univ Blvd,422 THT, Birmingham, AL 35294 USA.	qding@uab.edu			National Institutes of Health [HL085324, HL58655]; American Heart Association; Veterans Affairs merit award; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL085324, R01HL058655] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); American Heart Association(American Heart Association); Veterans Affairs merit award(US Department of Veterans Affairs); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	This work was supported, in whole or in part, by National Institutes of Health Grants HL085324 (to Q. D.) and HL58655 (to M. A. O.). This work was also supported by a grant from the American Heart Association (to Q. D.) and a Veterans Affairs merit award (to M. A. O.). The costs of publication of this article were defrayed in part by the payment of page charges. This article must therefore be hereby marked "advertisement" in accordance with 18 U. S. C. Section 1734 solely to indicate this fact.	CALALB MB, 1995, MOL CELL BIOL, V15, P954; Chen HC, 1996, J BIOL CHEM, V271, P26329, DOI 10.1074/jbc.271.42.26329; Crystal RG, 2002, AM J RESP CRIT CARE, V166, P236, DOI 10.1164/rccm.2201069; Desmouliere A, 2005, WOUND REPAIR REGEN, V13, P7, DOI 10.1111/j.1067-1927.2005.130102.x; Desmouliere A, 2003, LAB INVEST, V83, P1689, DOI 10.1097/01.LAB.0000101911.53973.90; DESMOULIERE A, 1993, J CELL BIOL, V122, P103, DOI 10.1083/jcb.122.1.103; DESMOULIERE A, 1995, CELL BIOL INT, V19, P471, DOI 10.1006/cbir.1995.1090; Ding Q, 2005, J BIOL CHEM, V280, P6802, DOI 10.1074/jbc.M409180200; Ding Q, 2003, J BIOL CHEM, V278, P39882, DOI 10.1074/jbc.M304685200; Ding Q, 2002, CANCER RES, V62, P5336; Dugina V, 1998, EXP CELL RES, V238, P481, DOI 10.1006/excr.1997.3868; Finlay GA, 2000, J BIOL CHEM, V275, P27650; Gabbiani G, 2003, J PATHOL, V200, P500, DOI 10.1002/path.1427; Galliher AJ, 2006, BREAST CANCER RES, V8, DOI 10.1186/bcr1524; Galliher AJ, 2007, CANCER RES, V67, P3752, DOI 10.1158/0008-5472.CAN-06-3851; Galliher-Beckley AJ, 2008, CARCINOGENESIS, V29, P244, DOI 10.1093/carcin/bgm245; Giancotti FG, 1999, SCIENCE, V285, P1028, DOI 10.1126/science.285.5430.1028; Greenberg RS, 2006, FASEB J, V20, P1006, DOI 10.1096/fj.05-4838fje; Hagood JS, 2007, AM J RESP CELL MOL, V37, P503, DOI 10.1165/rcmb.2007-0005ED; Hagood JS, 1996, BLOOD, V87, P3749, DOI 10.1182/blood.V87.9.3749.bloodjournal8793749; Hanks SK, 2003, FRONT BIOSCI-LANDMRK, V8, pD982, DOI 10.2741/1114; Haskell H, 2003, CLIN CANCER RES, V9, P2157; Hauck CR, 2002, EMBO J, V21, P6289, DOI 10.1093/emboj/cdf631; Hauck CR, 2001, CANCER RES, V61, P7079; Hayasaka H, 2005, J CELL BIOCHEM, V95, P1248, DOI 10.1002/jcb.20501; Hayasaka H, 2007, J CELL BIOCHEM, V102, P947, DOI 10.1002/jcb.21329; Hecker TP, 2004, ONCOGENE, V23, P3962, DOI 10.1038/sj.onc.1207541; Hinz B, 2001, MOL BIOL CELL, V12, P2730, DOI 10.1091/mbc.12.9.2730; Hinz B, 2003, MOL BIOL CELL, V14, P2508, DOI 10.1091/mbc.E02-11-0729; Hinz B, 2002, J CELL BIOL, V157, P657, DOI 10.1083/jcb.200201049; Hinz B, 2007, AM J PATHOL, V170, P1807, DOI 10.2353/ajpath.2007.070112; Jenkins RG, 2006, J CLIN INVEST, V116, P1606, DOI 10.1172/JCI27183; King Jr TE, 2000, AM J RESP CRIT CARE, V161, P646; King TE, 2001, AM J RESP CRIT CARE, V164, P1025, DOI 10.1164/ajrccm.164.6.2001056; Kolodsick JE, 2003, AM J RESP CELL MOL, V29, P537, DOI 10.1165/rcmb.2002-0243OC; Kutz SM, 2001, J CELL SCI, V114, P3905; LAZO JS, 1990, PHARMACOL THERAPEUT, V47, P347, DOI 10.1016/0163-7258(90)90061-6; Liu XJ, 2006, LIVER INT, V26, P8, DOI 10.1111/j.1478-3231.2005.01192.x; Meyer-ter-Vehn T, 2006, INVEST OPHTH VIS SCI, V47, P1500, DOI 10.1167/iovs.05-0361; Mitra SK, 2005, NAT REV MOL CELL BIO, V6, P56, DOI 10.1038/nrm1549; Mulder KM, 2000, CYTOKINE GROWTH F R, V11, P23, DOI 10.1016/S1359-6101(99)00026-X; Munger JS, 1999, CELL, V96, P319, DOI 10.1016/S0092-8674(00)80545-0; Muro AF, 2008, AM J RESP CRIT CARE, V177, P638, DOI 10.1164/rccm.200708-1291OC; Okutani D, 2006, AM J PHYSIOL-LUNG C, V291, pL129, DOI 10.1152/ajplung.00261.2005; Olman MA, 1996, AM J PHYSIOL-LUNG C, V271, pL519, DOI 10.1152/ajplung.1996.271.4.L519; Olman MA, 1999, BLOOD, V94, P2029, DOI 10.1182/blood.V94.6.2029.418k25_2029_2038; OLMAN MA, 1995, J CLIN INVEST, V96, P1621, DOI 10.1172/JCI118201; Olman MA, 2003, ACUTE RESP DISTRESS, P313; Owen JD, 1999, MOL CELL BIOL, V19, P4806; Parsons JT, 2003, J CELL SCI, V116, P1409, DOI 10.1242/jcs.00373; Phan SH, 2002, CHEST, V122, p286S, DOI 10.1378/chest.122.6_suppl.286S; Renshaw MW, 1999, J CELL BIOL, V147, P611, DOI 10.1083/jcb.147.3.611; Schaller MD, 2004, J CELL BIOL, V166, P157, DOI 10.1083/jcb.200406151; SCHALLER MD, 1993, MOL CELL BIOL, V13, P785, DOI 10.1128/MCB.13.2.785; Schildmeyer LA, 2000, FASEB J, V14, P2213, DOI 10.1096/fj.99-0927com; Schlaepfer DD, 2004, BBA-MOL CELL RES, V1692, P77, DOI 10.1016/j.bbamcr.2004.04.008; Schlaepfer DD, 1997, J BIOL CHEM, V272, P13189, DOI 10.1074/jbc.272.20.13189; Selman M, 2001, ANN INTERN MED, V134, P136, DOI 10.7326/0003-4819-134-2-200101160-00015; Serini G, 1998, J CELL BIOL, V142, P873, DOI 10.1083/jcb.142.3.873; Sheppard Dean, 2006, Proc Am Thorac Soc, V3, P413, DOI 10.1513/pats.200601-008AW; Sieg DJ, 1999, J CELL SCI, V112, P2677; Simmons WL, 1998, AM J RESP CELL MOL, V18, P307, DOI 10.1165/ajrcmb.18.3.2892; Tager AM, 2004, AM J RESP CELL MOL, V31, P395, DOI 10.1165/rcmb.2004-0175OC; Takeji M, 2006, J BIOL CHEM, V281, P40193, DOI 10.1074/jbc.M602182200; Taylor JM, 2001, MOL CELL BIOL, V21, P1565, DOI 10.1128/MCB.21.5.1565-1572.2001; Thannickal VJ, 2003, J BIOL CHEM, V278, P12384, DOI 10.1074/jbc.M208544200; Thomas PE, 2007, AM J PHYSIOL-LUNG C, V293, pL417, DOI 10.1152/ajplung.00489.2006; UNDERWOOD DC, 2001, AM J PHYSIOL, V279, pL895; Walker HA, 2003, MOL BIOL CELL, V14, P1941, DOI 10.1091/mbc.E02-08-0508; Wang HB, 2001, P NATL ACAD SCI USA, V98, P11295, DOI 10.1073/pnas.201201198; Williams JC, 1998, TRENDS BIOCHEM SCI, V23, P179, DOI 10.1016/S0968-0004(98)01202-X; Wipff PJ, 2007, J CELL BIOL, V179, P1311, DOI 10.1083/jcb.200704042; Wu HJ, 2002, J VIROL, V76, P12775, DOI 10.1128/JVI.76.24.12775-12782.2002; Wu XY, 2004, J BIOL CHEM, V279, P43392, DOI 10.1074/jbc.M408959200; Yang M, 2004, FASEB J, V18, P1920, DOI 10.1096/fj.04-2357fje; Yu L, 2002, EMBO J, V21, P3749, DOI 10.1093/emboj/cdf366; Yue JB, 2000, J BIOL CHEM, V275, P30765, DOI 10.1074/jbc.M000039200; ZHANG K, 1994, AM J PATHOL, V145, P114	78	75	88	0	8	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	OCT 3	2008	283	40					26839	26849		10.1074/jbc.M803645200	http://dx.doi.org/10.1074/jbc.M803645200			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	353RT	18669633	Green Published, hybrid			2022-12-27	WOS:000259586600003
J	Du, M; Rambhadran, A; Jayaraman, V				Du, Mei; Rambhadran, Anu; Jayaraman, Vasanthi			Luminescence resonance energy transfer investigation of conformational changes in the ligand binding domain of a kainate receptor	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							IONOTROPIC GLUTAMATE-RECEPTOR; CRYSTAL-STRUCTURES; ION CHANNELS; PROTEIN INTERACTIONS; NMR-SPECTROSCOPY; AMPA RECEPTORS; DOMOIC ACID; CORE; ACTIVATION; AGONIST	The apo state structure of the isolated ligand binding domain of the GluR6 subunit and the conformational changes induced by agonist binding to this protein have been investigated by luminescence resonance energy transfer (LRET) measurements. The LRET-based distances show that agonist binding induces cleft closure, and the extent of cleft closure is proportional to the extent of activation over a wide range of activations, thus establishing that the cleft closure conformational change is one of the mechanisms by which the agonist mediates receptor activation. The LRET distances also provide insight into the apo state structure, for which there is currently no crystal structure available. The distance change between the glutamate-bound state and the apo state is similar to that observed between the glutamate-bound and antagonist UBP-310-bound form of the GluR5 ligand binding domain, indicating that the cleft for the apo state of the GluR6 ligand binding domain should be similar to the UBP-310-bound form of GluR5. This observation implies that the apo state of GluR6 undergoes a cleft closure of 29-30 degrees upon binding full agonists, one of the largest observed in the glutamate receptor family.	[Du, Mei; Rambhadran, Anu; Jayaraman, Vasanthi] Univ Texas Hlth Sci Ctr, Dept Biochem & Mol Biol, Ctr Membrane Biol, Houston, TX 77030 USA	University of Texas System; University of Texas Health Science Center Houston	Jayaraman, V (corresponding author), Univ Texas Hlth Sci Ctr, Dept Biochem & Mol Biol, Ctr Membrane Biol, MSB 4-106,6431 Fannin St, Houston, TX 77030 USA.	vasanthi.jayaraman@uth.tmc.edu			National Institutes of Health [R01GM073102]; National Science Foundation [MCB-0444352]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM073102] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); National Science Foundation(National Science Foundation (NSF)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported, in whole or in part, by National Institutes of Health Grant R01GM073102. This work was also supported by National Science Foundation Grant MCB-0444352. The costs of publication of this article were defrayed in part by the payment of page charges. This article must therefore be hereby marked "advertisement" in accordance with 18 U.S.C. Section 1734 solely to indicate this fact.	Ahmed AH, 2007, J BIOL CHEM, V282, P12773, DOI 10.1074/jbc.M610077200; Armstrong N, 2000, NEURON, V28, P165, DOI 10.1016/S0896-6273(00)00094-5; Armstrong N, 2006, CELL, V127, P85, DOI 10.1016/j.cell.2006.08.037; Cheng Q, 2005, NAT CHEM BIOL, V1, P329, DOI 10.1038/nchembio738; Cheng Q, 2004, J BIOL CHEM, V279, P26346, DOI 10.1074/jbc.M403111200; Cheng Q, 2002, BIOCHEMISTRY-US, V41, P1602, DOI 10.1021/bi015729e; Deming D, 2003, J BIOL CHEM, V278, P17589, DOI 10.1074/jbc.C300105200; Dingledine R, 1999, PHARMACOL REV, V51, P7; Du M, 2005, J BIOL CHEM, V280, P8633, DOI 10.1074/jbc.C400590200; Fenwick MK, 2008, J MOL BIOL, V378, P673, DOI 10.1016/j.jmb.2008.03.012; Fleck MW, 2003, J NEUROSCI, V23, P1219; Furukawa H, 2005, NATURE, V438, P185, DOI 10.1038/nature04089; Furukawa H, 2003, EMBO J, V22, P2873, DOI 10.1093/emboj/cdg303; Gouaux E, 2004, J PHYSIOL-LONDON, V554, P249, DOI 10.1113/jphysiol.2003.054320; Hald H, 2007, J BIOL CHEM, V282, P25726, DOI 10.1074/jbc.M700137200; Jayaraman V, 2000, BIOCHEMISTRY-US, V39, P8693, DOI 10.1021/bi000892f; Jayaraman V, 2004, METHOD ENZYMOL, V380, P170; Li G, 2003, BIOCHEMISTRY-US, V42, P12367, DOI 10.1021/bi034797t; Madden DR, 2004, BIOCHEMISTRY-US, V43, P15838, DOI 10.1021/bi048447y; Madden DR, 2002, NAT REV NEUROSCI, V3, P91, DOI 10.1038/nrn725; Madden DR, 2001, J BIOL CHEM, V276, P37821; Mankiewicz KA, 2007, BRAZ J MED BIOL RES, V40, P1419, DOI 10.1590/S0100-879X2007001100001; Mankiewicz KA, 2008, BIOCHEMISTRY-US, V47, P398, DOI 10.1021/bi702004b; Mankiewicz KA, 2007, BIOCHEMISTRY-US, V46, P1343, DOI 10.1021/bi062270l; Mayer ML, 2005, NEURON, V45, P539, DOI 10.1016/j.neuron.2005.01.031; Mayer ML, 2006, NATURE, V440, P456, DOI 10.1038/nature04709; Mayer ML, 2006, J NEUROSCI, V26, P2852, DOI 10.1523/JNEUROSCI.0123-06.2005; Mayer ML, 2005, CURR OPIN NEUROBIOL, V15, P282, DOI 10.1016/j.conb.2005.05.004; Mayer ML, 2004, ANNU REV PHYSIOL, V66, P161, DOI 10.1146/annurev.physiol.66.050802.084104; McFeeters RL, 2004, FASEB J, V18, P428, DOI 10.1096/fj.03-0873rev; Nanao MH, 2005, P NATL ACAD SCI USA, V102, P1708, DOI 10.1073/pnas.0409573102; Naur P, 2005, FEBS LETT, V579, P1154, DOI 10.1016/j.febslet.2005.01.012; Oswald RE, 2004, ADV PROTEIN CHEM, V68, P313; Ramanoudjame G, 2006, P NATL ACAD SCI USA, V103, P10473, DOI 10.1073/pnas.0603225103; Sun Y, 2002, NATURE, V417, P245, DOI 10.1038/417245a	35	6	6	0	3	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	OCT 3	2008	283	40					27074	27078		10.1074/jbc.M805040200	http://dx.doi.org/10.1074/jbc.M805040200			5	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	353RT	18658129	Green Published, hybrid			2022-12-27	WOS:000259586600028
J	Tenhumberg, S; Waetzig, GH; Chalaris, A; Rabe, B; Seegert, D; Scheller, J; Rose-John, S; Grotzinger, J				Tenhumberg, Stephanie; Waetzig, Georg H.; Chalaris, Athena; Rabe, Bjoern; Seegert, Dirk; Scheller, Juergen; Rose-John, Stefan; Groetzinger, Joachim			Structure-guided optimization of the interleukin-6 trans-signaling antagonist sgp130	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							SOLUBLE RECEPTORS; RHEUMATOID-ARTHRITIS; IN-VIVO; GP130; CYTOKINES; INFLAMMATION; FAMILY; MEMBRANE; COMPLEX; SYSTEM	Binding of interleukin-6 (IL-6) to its specific receptor IL-6R is a prerequisite for the activation of the signal-transducing receptor glycoprotein 130 (gp130). A soluble form of the IL-6R (sIL-6R) in complex with IL-6 can activate cells lacking membrane-bound IL-6R (trans-signaling). IL-6-trans-signaling is counterbalanced by a naturally occurring, soluble form of gp130 (sgp130), whereby signaling via the membrane-bound IL-6R is not affected. Many inflammatory and neoplastic disorders are driven by IL-6 trans-signaling. By analysis of the three-dimensional structure of gp130 in complex with IL-6 and sIL-6R, we identified amino acid side chains in gp130 as candidates for the generation of sgp130 muteins with increased binding affinity to IL-6/sIL-6R. In addition, with information from modeling and NMR analysis of the membrane proximal domain of gp130, we generated a more stable variant of sgp130Fc. Proteins were tested for binding to the IL-6/sIL-6R-complex, for inhibition of IL-6/sIL-6R-induced cell proliferation and of acute phase gene expression. Several mutations showed an additive effect in improving the binding affinity of human sgp130 toward human IL-6/sIL-6R. Finally, we demonstrate the species specificity of these mutations in the optimal triple mutein ( T102Y/Q113F/N114L) both in vitro and in a mouse model of acute inflammation.	[Rose-John, Stefan] Univ Kiel, Dept Biochem, Inst Biochem, D-24098 Kiel, Germany; [Waetzig, Georg H.; Seegert, Dirk] CONARIS Res Inst AG, D-24118 Kiel, Germany	University of Kiel	Rose-John, S (corresponding author), Univ Kiel, Dept Biochem, Inst Biochem, Olshausenstr 40, D-24098 Kiel, Germany.	rosejohn@biochem.uni-kiel.de	Seegert, Dirk/B-8826-2011; Scheller, Jürgen/K-5290-2015; Waetzig, Georg/AAV-7486-2021; Rose-John, Stefan/A-7998-2010	Rose-John, Stefan/0000-0002-7519-3279	Hensel-Stiftung; Deutsche Forschungsgemeinschaft	Hensel-Stiftung; Deutsche Forschungsgemeinschaft(German Research Foundation (DFG))	This work was supported by Hensel-Stiftung (to S. T.) and the Deutsche Forschungsgemeinschaft (SFB 415, to S. R. J., J. G., and J. S.). The costs of publication of this article were defrayed in part by the payment of page charges. This article must therefore be hereby marked "advertisement" in accordance with 18 U. S. C. Section 1734 solely to indicate this fact.	Alonzi T, 1998, J EXP MED, V187, P461, DOI 10.1084/jem.187.4.461; Atreya R, 2000, NAT MED, V6, P583, DOI 10.1038/75068; Becker C, 2004, IMMUNITY, V21, P491, DOI 10.1016/j.immuni.2004.07.020; Boe A, 1999, CYTOKINE, V11, P1057, DOI 10.1006/cyto.1999.0502; Boulanger MJ, 2004, ADV PROTEIN CHEM, V68, P107; Boulanger MJ, 2003, SCIENCE, V300, P2101, DOI 10.1126/science.1083901; CARSON M, 1991, J APPL CRYSTALLOGR, V24, P946; Chalaris A, 2007, BLOOD, V110, P1748, DOI 10.1182/blood-2007-01-067918; Chow DC, 2001, SCIENCE, V291, P2150, DOI 10.1126/science.1058308; Cressman DE, 1996, SCIENCE, V274, P1379, DOI 10.1126/science.274.5291.1379; EDWARDS JCW, 1981, J PATHOL, V134, P147, DOI 10.1002/path.1711340205; Feldmann M, 2001, ANNU REV IMMUNOL, V19, P163, DOI 10.1146/annurev.immunol.19.1.163; Feldmann M, 2005, NATURE, V435, P612, DOI 10.1038/nature03727; FISCHER M, 1997, NAT BIOTECHNOL, V15, P145; Grotzinger J, 1999, BIOL CHEM, V380, P803, DOI 10.1515/BC.1999.100; Grotzinger J, 1997, PROTEINS, V27, P96; Heinrich PC, 2003, BIOCHEM J, V374, P1, DOI 10.1042/BJ20030407; HIBI M, 1990, CELL, V63, P1149, DOI 10.1016/0092-8674(90)90411-7; Hibi M, 1996, J MOL MED-JMM, V74, P1, DOI 10.1007/BF00202068; Jostock T, 2001, EUR J BIOCHEM, V268, P160, DOI 10.1046/j.1432-1327.2001.01867.x; Kallen KJ, 1999, J BIOL CHEM, V274, P11859, DOI 10.1074/jbc.274.17.11859; KISHIMOTO T, 1995, BLOOD, V86, P1243, DOI 10.1182/blood.V86.4.1243.bloodjournal8641243; MCMAHAN CJ, 1991, EMBO J, V10, P2821, DOI 10.1002/j.1460-2075.1991.tb07831.x; NARAZAKI M, 1993, BLOOD, V82, P1120, DOI 10.1182/blood.V82.4.1120.bloodjournal8241120; Nishimoto N, 2004, ARTHRITIS RHEUM-US, V50, P1761, DOI 10.1002/art.20303; NORTHRUP SH, 1992, P NATL ACAD SCI USA, V89, P3338, DOI 10.1073/pnas.89.8.3338; Okuda Y, 1998, INT IMMUNOL, V10, P703, DOI 10.1093/intimm/10.5.703; Oppmann B, 1996, J IMMUNOL METHODS, V195, P153, DOI 10.1016/0022-1759(96)00110-X; PACHTA M, 2004, THESIS U KIEL KIEL; Peters M, 1998, BLOOD, V92, P3495, DOI 10.1182/blood.V92.10.3495.422k47_3495_3504; Peters M, 1998, J IMMUNOL, V161, P3575; Rabe B, 2008, BLOOD, V111, P1021, DOI 10.1182/blood-2007-07-102137; Rose-John S, 2006, J LEUKOCYTE BIOL, V80, P227, DOI 10.1189/jlb.1105674; Rose-John Stefan, 2007, V174, P57; ROSEJOHN S, 1994, BIOCHEM J, V300, P281, DOI 10.1042/bj3000281; ROSEJOHN S, 1990, EUR J BIOCHEM, V190, P79, DOI 10.1111/j.1432-1033.1990.tb15548.x; Scheller J, 2006, SIGNAL TRANSDUCTION, V6, P240, DOI [DOI 10.1002/SITA.200600086, 10.1002/sita.200600086]; Schroers A, 2005, PROTEIN SCI, V14, P783, DOI 10.1110/ps.041117105; SPRANG SR, 1993, CURR OPIN STRUC BIOL, V3, P815, DOI 10.1016/0959-440X(93)90144-A; Steinman L, 2007, NAT MED, V13, P139, DOI 10.1038/nm1551; Vollmer P, 1999, EUR J BIOCHEM, V263, P438, DOI 10.1046/j.1432-1327.1999.00511.x; VRIEND G, 1990, J MOL GRAPHICS, V8, P52, DOI 10.1016/0263-7855(90)80070-V; WAXMAN E, 1993, ANAL BIOCHEM, V210, P425, DOI 10.1006/abio.1993.1220	43	51	58	0	1	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	OCT 3	2008	283	40					27200	27207		10.1074/jbc.M803694200	http://dx.doi.org/10.1074/jbc.M803694200			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	353RT	18650419	hybrid			2022-12-27	WOS:000259586600040
J	Winborn, BJ; Travis, SM; Todi, SV; Scaglione, KM; Xu, P; Williams, AJ; Cohen, RE; Peng, JM; Paulson, HL				Winborn, Brett J.; Travis, Sue M.; Todi, Sokol V.; Scaglione, K. Matthew; Xu, Ping; Williams, Aislinn J.; Cohen, Robert E.; Peng, Junmin; Paulson, Henry L.			The deubiquitinating enzyme ataxin-3, a polyglutamine disease protein, edits Lys(63) linkages in mixed linkage ubiquitin chains	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							INTRANUCLEAR INCLUSIONS; POLYUBIQUITIN CHAINS; JOSEPHIN DOMAIN; RETROTRANSLOCATION; TETRAUBIQUITIN; SPECIFICITY; RECOGNIZES; PROTEASOME; BINDING; LIGASE	Ubiquitin chain complexity in cells is likely regulated by a diverse set of deubiquitinating enzymes (DUBs) with distinct ubiquitin chain preferences. Here we show that the polyglutamine disease protein, ataxin-3, binds and cleaves ubiquitin chains in a manner suggesting that it functions as a mixed linkage, chain-editing enzyme. Ataxin-3 cleaves ubiquitin chains through its amino-terminal Josephin domain and binds ubiquitin chains through a carboxyl-terminal cluster of ubiquitin interaction motifs neighboring the pathogenic polyglutamine tract. Ataxin-3 binds both Lys48- or Lys63-linked chains yet preferentially cleaves Lys63 linkages. Ataxin-3 shows even greater activity toward mixed linkage polyubiquitin, cleaving Lys63 linkages in chains that contain both Lys48 and Lys63 linkages. The ubiquitin interaction motifs regulate the specificity of this activity by restricting what can be cleaved by the protease domain, demonstrating that linkage specificity can be determined by elements outside the catalytic domain of a DUB. These findings establish ataxin-3 as a novel DUB that edits topologically complex chains.	[Paulson, Henry L.] Univ Iowa, Program Mol & Cellular Biol, Carver Coll Med, Iowa City, IA 52242 USA; [Travis, Sue M.; Paulson, Henry L.] Univ Iowa, Dept Biochem, Carver Coll Med, Iowa City, IA 52242 USA; [Winborn, Brett J.; Todi, Sokol V.; Scaglione, K. Matthew] Univ Michigan, Dept Neurol, Ann Arbor, MI 48108 USA; [Xu, Ping; Peng, Junmin] Emory Univ, Sch Med, Dept Human Genet, Atlanta, GA 30322 USA; [Williams, Aislinn J.] Univ Iowa, Carver Coll Med, Program Neurosci & Med Scientist Training Program, Iowa City, IA 52242 USA; [Cohen, Robert E.] Johns Hopkins Univ, Bloomberg Sch Publ Hlth, Dept Biochem & Mol Biol, Baltimore, MD 21205 USA	University of Iowa; University of Iowa; University of Michigan System; University of Michigan; Emory University; University of Iowa; Johns Hopkins University; Johns Hopkins Bloomberg School of Public Health	Paulson, HL (corresponding author), Univ Michigan, Dept Neurol, 4001 BSRB,109 Zina Pitcher Pl, Ann Arbor, MI 48109 USA.	henryp@umich.edu	Williams, Aislinn/T-5661-2017; Peng, Junmin/N-2614-2018; Williams, Aislinn/V-2742-2019	Williams, Aislinn/0000-0002-8139-2303; Peng, Junmin/0000-0003-0472-7648; Williams, Aislinn/0000-0002-8139-2303; Scaglione, Kenneth/0000-0002-3858-9418; TODI, SOKOL/0000-0003-4399-5549	National Institutes of Health [NS038712, AG025688]; National Ataxia Foundation; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS038712] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON AGING [P50AG025688] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); National Ataxia Foundation; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))	This work was supported, in whole or in part, by National Institutes of Health Grants NS038712 (to H. L. P.) and AG025688 (to J. P.). This work was also supported by a National Ataxia Foundation grant (to S. M. T.). The costs of publication of this article were defrayed in part by the payment of page charges. This article must therefore be hereby marked "advertisement" in accordance with 18 U. S. C. Section 1734 solely to indicate this fact.	Abr?moff M.D., 2004, BIOPHOTONICS INT, V11, P36, DOI DOI 10.1117/1.3589100; Amerik AY, 2004, BBA-MOL CELL RES, V1695, P189, DOI 10.1016/j.bbamcr.2004.10.003; Ben-Saadon R, 2006, MOL CELL, V24, P701, DOI 10.1016/j.molcel.2006.10.022; Bennett EJ, 2007, NATURE, V448, P704, DOI 10.1038/nature06022; Berke SJS, 2005, J BIOL CHEM, V280, P32026, DOI 10.1074/jbc.M506084200; Bevivino AE, 2001, P NATL ACAD SCI USA, V98, P11955, DOI 10.1073/pnas.211305198; Bolon DN, 2005, P NATL ACAD SCI USA, V102, P12724, DOI 10.1073/pnas.0506124102; Burnett B, 2003, HUM MOL GENET, V12, P3195, DOI 10.1093/hmg/ddg344; Burnett BG, 2005, P NATL ACAD SCI USA, V102, P4330, DOI 10.1073/pnas.0407252102; Chai YH, 2004, J BIOL CHEM, V279, P3605, DOI 10.1074/jbc.M310939200; Chow MKM, 2006, METHOD ENZYMOL, V413, P1, DOI 10.1016/S0076-6879(06)13001-3; Cohn MA, 2007, MOL CELL, V28, P786, DOI 10.1016/j.molcel.2007.09.031; COOK WJ, 1994, J MOL BIOL, V236, P601, DOI 10.1006/jmbi.1994.1169; COOK WJ, 1992, J BIOL CHEM, V267, P16467; Doss-Pepe EW, 2003, MOL CELL BIOL, V23, P6469, DOI 10.1128/MCB.23.18.6469-6483.2003; Eddins MJ, 2007, J MOL BIOL, V367, P204, DOI 10.1016/j.jmb.2006.12.065; Hershko A, 1998, ANNU REV BIOCHEM, V67, P425, DOI 10.1146/annurev.biochem.67.1.425; Hofmann K, 2001, TRENDS BIOCHEM SCI, V26, P347, DOI 10.1016/S0968-0004(01)01835-7; JOHNSON ES, 1995, J BIOL CHEM, V270, P17442, DOI 10.1074/jbc.270.29.17442; KAWAGUCHI Y, 1994, NAT GENET, V8, P221, DOI 10.1038/ng1194-221; Kayagaki N, 2007, SCIENCE, V318, P1628, DOI 10.1126/science.1145918; Kim HT, 2007, J BIOL CHEM, V282, P17375, DOI 10.1074/jbc.M609659200; Komander D, 2008, MOL CELL, V29, P451, DOI 10.1016/j.molcel.2007.12.018; La Spada AR, 2003, NEURON, V38, P681, DOI 10.1016/S0896-6273(03)00328-3; Mao Y, 2005, P NATL ACAD SCI USA, V102, P12700, DOI 10.1073/pnas.0506344102; Matsumoto M, 2004, EMBO J, V23, P659, DOI 10.1038/sj.emboj.7600081; Michalik A, 2003, HUM MOL GENET, V12, pR173, DOI 10.1093/hmg/ddg295; Nicastro G, 2005, P NATL ACAD SCI USA, V102, P10493, DOI 10.1073/pnas.0501732102; Nicastro G, 2006, J BIOMOL NMR, V36, P267, DOI 10.1007/s10858-006-9092-z; Nijman SMB, 2005, CELL, V123, P773, DOI 10.1016/j.cell.2005.11.007; Orr HT, 2007, ANNU REV NEUROSCI, V30, P575, DOI 10.1146/annurev.neuro.29.051605.113042; Paulson HL, 1997, NEURON, V19, P333, DOI 10.1016/S0896-6273(00)80943-5; Peng JM, 2003, NAT BIOTECHNOL, V21, P921, DOI 10.1038/nbt849; Perutz MF, 1999, TRENDS BIOCHEM SCI, V24, P58, DOI 10.1016/S0968-0004(98)01350-4; Pickart CM, 2004, CURR OPIN CHEM BIOL, V8, P610, DOI 10.1016/j.cbpa.2004.09.009; Pickart CM, 1997, FASEB J, V11, P1055, DOI 10.1096/fasebj.11.13.9367341; Reyes-Turcu FE, 2006, CELL, V124, P1197, DOI 10.1016/j.cell.2006.02.038; Scheel H, 2003, HUM MOL GENET, V12, P2845, DOI 10.1093/hmg/ddg297; Schmitt I, 2007, BIOCHEM BIOPH RES CO, V362, P734, DOI 10.1016/j.bbrc.2007.08.062; Sun LJ, 2004, CURR OPIN CELL BIOL, V16, P119, DOI 10.1016/j.ceb.2004.02.005; Takahashi J, 2001, J NEUROPATH EXP NEUR, V60, P369, DOI 10.1093/jnen/60.4.369; Taylor JP, 2002, SCIENCE, V296, P1991, DOI 10.1126/science.1067122; Tenno T, 2004, GENES CELLS, V9, P865, DOI 10.1111/j.1365-2443.2004.00780.x; Todi SV, 2007, J BIOL CHEM, V282, P29348, DOI 10.1074/jbc.M704126200; Uchihara T, 2001, ACTA NEUROPATHOL, V102, P149; Varadan R, 2004, J BIOL CHEM, V279, P7055, DOI 10.1074/jbc.M309184200; Varadan R, 2002, J MOL BIOL, V324, P637, DOI 10.1016/S0022-2836(02)01198-1; Varshavsky A, 2005, TRENDS BIOCHEM SCI, V30, P283, DOI 10.1016/j.tibs.2005.04.005; Wang QY, 2006, J CELL BIOL, V174, P963, DOI 10.1083/jcb.200605100; Warrick JM, 2005, MOL CELL, V18, P37, DOI 10.1016/j.molcel.2005.02.030; Xu P, 2006, ISRAEL J CHEM, V46, P171, DOI 10.1560/1JVL-J4EE-FVW4-MXRE; Yao TT, 2006, NAT CELL BIOL, V8, P994, DOI 10.1038/ncb1460; Zhang MH, 2005, MOL CELL, V20, P525, DOI 10.1016/j.molcel.2005.09.023; Zhong XY, 2006, HUM MOL GENET, V15, P2409, DOI 10.1093/hmg/ddl164	54	190	192	1	10	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	SEP 26	2008	283	39					26436	26443		10.1074/jbc.M803692200	http://dx.doi.org/10.1074/jbc.M803692200			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	350GV	18599482	Green Published, hybrid			2022-12-27	WOS:000259341600018
J	Wang, GL; Salisbury, E; Shi, XR; Timchenko, L; Medrano, EE; Timchenko, NA				Wang, Guo-Li; Salisbury, Elizabeth; Shi, Xiurong; Timchenko, Lubov; Medrano, Estela E.; Timchenko, Nikolai A.			HDAC1 cooperates with C/EBP alpha in the inhibition of liver proliferation in old mice	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							CCAAT/ENHANCER-BINDING-PROTEIN; CELL-CYCLE; INCREASES TRANSLATION; REGENERATING LIVER; BETA; TRANSCRIPTION; EXPRESSION; AGE; OVEREXPRESSION; REPRESSION	Epigenetic control of liver proliferation involves cooperation between transcription factors and chromatin-remodeling proteins. In this work, we found that the levels of HDAC1 (histone deacetylase 1) are increased in quiescent livers of old mice. The elevation of HDAC1 in liver is mediated by the RNA-binding protein CUGBP1. We found that the age-associated CUGBP1-eIF2 complex binds to the 5' region of HDAC1 mRNA and increases translation of HDAC1 in the liver. Further analyses showed that CUGBP1 also increases expression of HDAC1 in cultured cells, in the livers of CUGBP1 transgenic mice, and in the livers of mice injected with cyclin D3, which enhances the formation of the CUGBP1-eIF2 complex. In livers of old mice, HDAC1 interacts with the transcription factor C/EBP alpha and is recruited by this protein to E2F-dependent promoters as a component of high M-r C/EBP alpha-Brm complexes. The recruitment of HDAC1 to c-Myc and FoxM1B promoters leads to deacetylation of histone H3 at Lys-9 on these E2F-dependent promoters. We show that HDAC1 is an important mediator of growth-inhibitory activity of C/EBP alpha and that small interfering RNA-mediated inhibition of HDAC1 reduces the ability of C/EBP alpha to inhibit cell proliferation. In addition, we have found that both elevation of HDAC1 and interaction of C/EBP alpha with HDAC1 are controlled by cyclin D3-dependent mechanisms. Treatment of old mice with growth hormone, which reduces cyclin D3 levels, leads to the reduction of the CUGBP1-eIF2 complex, normalization of HDAC1 levels, and inhibition of interactions of HDAC1 with C/EBP alpha-Brm complexes. Thus, our data demonstrate that translational elevation of HDAC1 in livers of old mice is involved in the assembly of high Mr protein-protein complexes that inhibit liver proliferation.	[Wang, Guo-Li; Salisbury, Elizabeth; Shi, Xiurong; Timchenko, Nikolai A.] Baylor Coll Med, Dept Pathol, Houston, TX 77030 USA; [Wang, Guo-Li; Salisbury, Elizabeth; Shi, Xiurong; Timchenko, Nikolai A.] Baylor Coll Med, Huffington Ctr Aging, Houston, TX 77030 USA; [Medrano, Estela E.] Baylor Coll Med, Dept Mol & Cellular Biol, Houston, TX 77030 USA; [Timchenko, Lubov] Baylor Coll Med, Dept Med, Houston, TX 77030 USA	Baylor College of Medicine; Baylor College of Medicine; Baylor College of Medicine; Baylor College of Medicine	Timchenko, NA (corresponding author), Baylor Coll Med, Dept Pathol, 1 Baylor Plaza, Houston, TX 77030 USA.	nikolait@bcm.tmc.edu		Salisbury, Elizabeth/0000-0003-3607-2367	National Institutes of Health [GM55188, CA100070, AG20752, AR49222, AR052781, AR44387, AG032135]; Ellison Medical Foundation; NATIONAL CANCER INSTITUTE [R01CA100070] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES [R01AR049222, R01AR044387] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON AGING [R01AG032135, P01AG020752] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Ellison Medical Foundation(Lawrence Ellison Foundation); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))	This work was supported, in whole or in part, by National Institutes of Health Grants GM55188, CA100070, and AG20752 (to N.A.T.); AR49222, AR052781, and AR44387 (to L.T.T.); and AG032135. This work was also supported by an Ellison Medical Foundation grant (to E.E.M.). The costs of publication of this article were defrayed in part by the payment of page charges. This article must therefore be hereby marked "advertisement" in accordance with 18 U. S. C. Section 1734 solely to indicate this fact.	Bandyopadhyay D, 2004, CANCER RES, V64, P7706, DOI 10.1158/0008-5472.CAN-03-3897; Bandyopadhyay D, 2007, AGING CELL, V6, P577, DOI 10.1111/j.1474-9726.2007.00308.x; BIRKENMEIER EH, 1989, GENE DEV, V3, P1146, DOI 10.1101/gad.3.8.1146; BUCHER NLR, 1964, CANCER RES, V24, P509; Conboy IM, 2005, NATURE, V433, P760, DOI 10.1038/nature03260; Demarco IA, 2006, NAT METHODS, V3, P519, DOI 10.1038/NMETH889; FRY M, 1984, J CELL PHYSIOL, V118, P225, DOI 10.1002/jcp.1041180302; Han JQ, 2006, NUCLEIC ACIDS RES, V34, P3095, DOI 10.1093/nar/gkl389; Iakova P, 2003, CELL, V113, P495, DOI 10.1016/S0092-8674(03)00318-0; Johnson PF, 2005, J CELL SCI, V118, P2545, DOI 10.1242/jcs.02459; Krupczak-Hollis K, 2003, HEPATOLOGY, V38, P1552, DOI 10.1016/j.hep.2003.08.052; Tan EH, 2005, CANCER RES, V65, P10330, DOI 10.1158/0008-5472.CAN-04-4486; Timchenko LT, 2002, MOL CELL BIOL, V22, P7242, DOI 10.1128/MCB.22.20.7242-7257.2002; Timchenko LT, 2006, J BIOL CHEM, V281, P32806, DOI 10.1074/jbc.M605701200; Timchenko NA, 1999, NUCLEIC ACIDS RES, V27, P4517, DOI 10.1093/nar/27.22.4517; Timchenko NA, 1998, NUCLEIC ACIDS RES, V26, P3293, DOI 10.1093/nar/26.13.3293; Timchenko NA, 2005, J BIOL CHEM, V280, P20549, DOI 10.1074/jbc.M409563200; Timchenko NA, 2004, J BIOL CHEM, V279, P13129, DOI 10.1074/jbc.M312923200; Timchenko NA, 1997, MOL CELL BIOL, V17, P7353, DOI 10.1128/MCB.17.12.7353; Wang AG, 2005, BIOL PHARM BULL, V28, P1966, DOI 10.1248/bpb.28.1966; Wang GL, 2006, MOL CELL BIOL, V26, P2570, DOI 10.1128/MCB.26.7.2570-2582.2006; Wang GL, 2004, GENE DEV, V18, P912, DOI 10.1101/gad.1183304; Wang GL, 2008, EXP CELL RES, V314, P1626, DOI 10.1016/j.yexcr.2008.01.028; Wang GL, 2007, J BIOL CHEM, V282, P1468, DOI 10.1074/jbc.M608226200; Wang HM, 2001, MOL CELL, V8, P817, DOI 10.1016/S1097-2765(01)00366-5; Wang XH, 2001, P NATL ACAD SCI USA, V98, P11468, DOI 10.1073/pnas.201360898; Welm AL, 2000, J BIOL CHEM, V275, P27406; Zuo Y, 2006, J BIOL CHEM, V281, P7960, DOI 10.1074/jbc.M510682200	28	68	68	0	5	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	SEP 19	2008	283	38					26169	26178		10.1074/jbc.M803544200	http://dx.doi.org/10.1074/jbc.M803544200			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	348GX	18622015	Green Published, hybrid			2022-12-27	WOS:000259200100045
J	Barreras, M; Salinas, SR; Abdian, PL; Kampel, MA; Ielpi, L				Barreras, Maximo; Salinas, Silvina R.; Abdian, Patricia L.; Kampel, Matias A.; Ielpi, Luis			Structure and mechanism of GumK, a membrane-associated glucuronosyltransferase	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							XANTHAN POLYSACCHARIDE SYNTHESIS; CARBOHYDRATE-BINDING MODULES; CAMPESTRIS PV. CAMPESTRIS; XANTHOMONAS-CAMPESTRIS; CRYSTAL-STRUCTURE; BETA-GLUCOSYLTRANSFERASE; ESCHERICHIA-COLI; GLYCOSYLTRANSFERASES; SUBSTRATE; COMPLEX	Xanthomonas campestris GumK (beta-1,2-glucuronosyltransferase) is a 44-kDa membrane-associated protein that is involved in the biosynthesis of xanthan, an exopolysaccharide crucial for this bacterium's phytopathogenicity. Xanthan also has many important industrial applications. The GumK enzyme is the founding member of the glycosyltransferase family 70 of carbohydrate-active enzymes, which is composed of bacterial glycosyltransferases involved in exopolysaccharide synthesis. No x-ray structures have been reported for this family. To better understand the mechanism of action of the bacterial glycosyltransferases in this family, the x-ray crystal structure of apo-GumK was solved at 1.9 angstrom resolution. The enzyme has two well defined Rossmann domains with a catalytic cleft between them, which is a typical feature of the glycosyltransferase B superfamily. Additionally, the crystal structure of GumK complexed with UDP was solved at 2.28 angstrom resolution. We identified a number of catalytically important residues, including Asp(157), which serves as the general base in the transfer reaction. Residues Met(231), Met(273), Glu(272), Tyr(292), Met(306), Lys(307), and Gln(310) interact with UDP, and mutation of these residues affected protein activity both in vitro and in vivo. The biological and structural data reported here shed light on the molecular basis for donor and acceptor selectivity in this glycosyltransferase family. These results also provide a rationale to obtain new polysaccharides by varying residues in the conserved alpha/beta/alpha structural motif of GumK.	[Barreras, Maximo; Salinas, Silvina R.; Abdian, Patricia L.; Kampel, Matias A.; Ielpi, Luis] IIBBA Consejo Nacl Invest Cientificas & Tecnicas, Lab Bacterial Genet, Fdn Inst Leloir, Buenos Aires, DF, Argentina	Consejo Nacional de Investigaciones Cientificas y Tecnicas (CONICET); Leloir Institute	Ielpi, L (corresponding author), IIBBA Consejo Nacl Invest Cientificas & Tecnicas, Lab Bacterial Genet, Fdn Inst Leloir, Av Patricias Argentinas 435,C1405BWE, Buenos Aires, DF, Argentina.	Lielpi@leloir.org.ar	Abdian, Patricia/AAW-2420-2020	Abdian, Patricia/0000-0002-8366-8115; Salinas, Silvina/0000-0002-2285-3886	Agencia Nacional de Promocion Cientifica y Tecnologica [PICT 1-11703]; Universidad de Buenos Aires ( Argentina) [UBACyT X-193]	Agencia Nacional de Promocion Cientifica y Tecnologica(ANPCyT); Universidad de Buenos Aires ( Argentina)(University of Buenos Aires)	This work was supported by Agencia Nacional de Promocion Cientifica y Tecnologica Grant PICT 1-11703 and Universidad de Buenos Aires ( Argentina) Grant UBACyT X-193. The costs of publication of this article were defrayed in part by the payment of page charges. This article must therefore be hereby marked "advertisement" in accordance with 18 U. S. C. Section 1734 solely to indicate this fact.	Abdian PL, 2000, J BIOL CHEM, V275, P40568, DOI 10.1074/jbc.M007496200; Baker NA, 2001, P NATL ACAD SCI USA, V98, P10037, DOI 10.1073/pnas.181342398; BAKER PJ, 1992, J MOL BIOL, V228, P662, DOI 10.1016/0022-2836(92)90848-E; Barreras M, 2004, GLYCOBIOLOGY, V14, P233, DOI 10.1093/glycob/cwh056; Barreras M, 2006, ACTA CRYSTALLOGR F, V62, P880, DOI 10.1107/S1744309106028764; Becker A, 1998, APPL MICROBIOL BIOT, V50, P145, DOI 10.1007/s002530051269; Berg S, 2007, GLYCOBIOLOGY, V17, p35R, DOI 10.1093/glycob/cwm010; Boraston AB, 2004, BIOCHEM J, V382, P769, DOI 10.1042/BJ20040892; Bourne Y, 2001, CURR OPIN STRUC BIOL, V11, P593, DOI 10.1016/S0959-440X(00)00253-0; Bowles D, 2005, CURR OPIN PLANT BIOL, V8, P254, DOI 10.1016/j.pbi.2005.03.007; Breton C, 2006, GLYCOBIOLOGY, V16, p29R, DOI 10.1093/glycob/cwj016; Buschiazzo A, 2004, EMBO J, V23, P3196, DOI 10.1038/sj.emboj.7600324; Collaborative Computational Project, 1994, ACTA CRYSTALLOGR D, V50, P760, DOI DOI 10.1107/S0907444994003112; Coutinho PM, 2003, J MOL BIOL, V328, P307, DOI 10.1016/S0022-2836(03)00307-3; Crossman L, 2004, MICROBES INFECT, V6, P623, DOI 10.1016/j.micinf.2004.01.013; Davies GJ, 2005, CURR OPIN STRUC BIOL, V15, P637, DOI 10.1016/j.sbi.2005.10.008; Doores KJ, 2006, CHEM-EUR J, V12, P656, DOI 10.1002/chem.200500557; Edman M, 2003, J BIOL CHEM, V278, P8420, DOI 10.1074/jbc.M211492200; Emsley P, 2004, ACTA CRYSTALLOGR D, V60, P2126, DOI 10.1107/S0907444904019158; Faijes M, 2007, CARBOHYD RES, V342, P1581, DOI 10.1016/j.carres.2007.06.015; Feizi T, 2003, CURR OPIN STRUC BIOL, V13, P602, DOI 10.1016/j.sbi.2003.09.001; Guerin ME, 2007, J BIOL CHEM, V282, P20705, DOI 10.1074/jbc.M702087200; Ha S, 2000, PROTEIN SCI, V9, P1045, DOI 10.1110/ps.9.6.1045; Hancock SM, 2006, CURR OPIN CHEM BIOL, V10, P509, DOI 10.1016/j.cbpa.2006.07.015; He YQ, 2007, GENOME BIOL, V8, DOI 10.1186/gb-2007-8-10-r218; Hu YN, 2003, P NATL ACAD SCI USA, V100, P845, DOI 10.1073/pnas.0235749100; Hu YN, 2002, CHEM BIOL, V9, P1287, DOI 10.1016/S1074-5521(02)00295-8; IELPI L, 1993, J BACTERIOL, V175, P2490, DOI 10.1128/JB.175.9.2490-2500.1993; Katzen F, 1998, J BACTERIOL, V180, P1607, DOI 10.1128/JB.180.7.1607-1617.1998; Lariviere L, 2003, J MOL BIOL, V330, P1077, DOI 10.1016/S0022-2836(03)00635-1; Lind J, 2007, BIOCHEMISTRY-US, V46, P5664, DOI 10.1021/bi700042x; Liu J, 2003, PROTEIN SCI, V12, P1418, DOI 10.1110/ps.0302103; Martinez-Fleites C, 2006, CHEM BIOL, V13, P1143, DOI 10.1016/j.chembiol.2006.09.005; Mohammadi T, 2007, MOL MICROBIOL, V65, P1106, DOI 10.1111/j.1365-2958.2007.05851.x; Morera S, 2001, J MOL BIOL, V311, P569, DOI 10.1006/jmbi.2001.4905; Pedersen LC, 2002, J BIOL CHEM, V277, P21869, DOI 10.1074/jbc.M112343200; Rosen ML, 2004, J BIOL CHEM, V279, P38683, DOI 10.1074/jbc.M402925200; SCOTT J. E., 1965, METHOD CARBOHYD CHEM, V5, P38; Shoseyov O, 2006, MICROBIOL MOL BIOL R, V70, P283, DOI 10.1128/MMBR.00028-05; Sun HY, 2007, J BIOL CHEM, V282, P9973, DOI 10.1074/jbc.M610285200; Vetting MW, 2008, J BIOL CHEM, V283, P15834, DOI 10.1074/jbc.M801017200; Vonrhein Clemens, 2007, Methods Mol Biol, V364, P215, DOI 10.1385/1-59745-266-1:215; VRIELINK A, 1994, EMBO J, V13, P3413, DOI 10.1002/j.1460-2075.1994.tb06646.x; Watts Andrew G, 2004, Biochem J, V380, pe9, DOI 10.1042/BJ20040633; Wrabl JO, 2001, J MOL BIOL, V314, P365, DOI 10.1006/jmbi.2001.5151	45	21	22	0	6	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	SEP 5	2008	283	36					25027	25035		10.1074/jbc.M801227200	http://dx.doi.org/10.1074/jbc.M801227200			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	342YR	18596046	hybrid, Green Published			2022-12-27	WOS:000258820000061
J	Chen, JK; Chen, JC; Imig, JD; Wei, S; Hachey, DL; Guthi, JS; Falck, JR; Capdevila, JH; Harris, RC				Chen, Jian-Kang; Chen, Jianchun; Imig, John D.; Wei, Shouzuo; Hachey, David L.; Guthi, Jagadeesh Setti; Falck, John R.; Capdevila, Jorge H.; Harris, Raymond C.			Identification of novel endogenous cytochrome P450 arachidonate metabolites with high affinity for cannabinoid receptors	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							EPOXYEICOSATRIENOIC ACIDS; CB1 RECEPTOR; EPOXYGENASE METABOLITES; 20-HYDROXYEICOSATETRAENOIC ACID; TYROSINE PHOSPHORYLATION; ENDOCANNABINOID SYSTEM; INTERNATIONAL UNION; CORONARY-ARTERIES; ENDOTHELIAL-CELLS; EPITHELIAL-CELLS	Arachidonic acid is an essential constituent of cell membranes that is esterified to the sn-2-position of glycerophospholipids and is released from selected lipid pools by phospholipase cleavage. The released arachidonic acid can be metabolized by three enzymatic pathways: the cyclooxygenase pathway forming prostaglandins and thromboxanes, the lipoxygenase pathway generating leukotrienes and lipoxins, and the cytochrome P450 (cP450) pathway producing epoxyeicosatrienoic acids and hydroxyeicosatetraenoic acids. The present study describes a novel group of cP450 epoxygenase-dependent metabolites of arachidonic acid, termed 2-epoxyeicosatrienoylglycerols (2-EG), including two regioisomers, 2-(11,12-epoxyeicosatrienoyl) glycerol (2-11,12-EG) and 2-(14,15-epoxyeicosatrienoyl)glycerol (2-14,15-EG), which are both produced in the kidney and spleen, whereas 2-11,12-EG is also detected in the brain. Both 2-11,12-EG and 2-14,15-EG activated the two cannabinoid (CB) receptor subtypes, CB1 and CB2, with high affinity and elicited biological responses in cultured cells expressing CB receptors and in intact animals. In contrast, the parental arachidonic acid and epoxyeicosatrienoic acids failed to activate CB1 or CB2 receptors. Thus, these cP450 epoxygenase-dependent metabolites are a novel class of endogenously produced, biologically active lipid mediators with the characteristics of endocannabinoids. This is the first evidence of a cytochrome P450-dependent arachidonate metabolite that can activate G-protein-coupled cell membrane receptors and suggests a functional link between the cytochrome P450 enzyme system and the endocannabinoid system.	[Hachey, David L.; Capdevila, Jorge H.] Vanderbilt Univ, Dept Biochem, Nashville, TN 37232 USA; [Harris, Raymond C.] Dept Vet Affairs Med Ctr, Nashville, TN 37212 USA; [Imig, John D.] Med Coll Georgia, Vasc Biol Ctr, Augusta, GA 30912 USA; [Guthi, Jagadeesh Setti; Falck, John R.] Univ Texas SW Med Ctr Dallas, Dept Biochem, Dallas, TX 75390 USA	Vanderbilt University; US Department of Veterans Affairs; Veterans Health Administration (VHA); VA Tennessee Valley Healthcare System; University System of Georgia; Augusta University; University of Texas System; University of Texas Southwestern Medical Center Dallas	Harris, RC (corresponding author), Vanderbilt Univ, Sch Med, Dept Med, S-3223 Med Ctr N, Nashville, TN 37232 USA.	ray.harris@vanderbilt.edu	Falck, John R/B-3030-2011	Falck, John R/0000-0002-9219-7845; Imig, John/0000-0002-9668-2899	NIDDK NIH HHS [P01 DK038226-210011, DK38226, P01 DK038226] Funding Source: Medline; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [P01DK038226] Funding Source: NIH RePORTER	NIDDK NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))		Abood ME, 1997, BIOCHEM PHARMACOL, V53, P207, DOI 10.1016/S0006-2952(96)00727-7; Begg M, 2005, PHARMACOL THERAPEUT, V106, P133, DOI 10.1016/j.pharmthera.2004.11.005; Ben-Shabat S, 1998, EUR J PHARMACOL, V353, P23, DOI 10.1016/S0014-2999(98)00392-6; Bisogno T, 2000, BIOCHEM J, V351, P817, DOI 10.1042/0264-6021:3510817; Breyer RM, 2001, ANNU REV PHARMACOL, V41, P661, DOI 10.1146/annurev.pharmtox.41.1.661; Brink C, 2003, PHARMACOL REV, V55, P195, DOI 10.1124/pr.55.1.8; Campbell WB, 1996, CIRC RES, V78, P415, DOI 10.1161/01.RES.78.3.415; CAPDEVILA J, 1981, P NATL ACAD SCI-BIOL, V78, P5362, DOI 10.1073/pnas.78.9.5362; Capdevila JH, 2000, J LIPID RES, V41, P163; CAPDEVILA JH, 1991, METHOD ENZYMOL, V206, P441; Chen JC, 2007, MOL CELL BIOL, V27, P3023, DOI 10.1128/MCB.01482-06; Chen JK, 1999, J BIOL CHEM, V274, P4764, DOI 10.1074/jbc.274.8.4764; Chen JK, 2002, P NATL ACAD SCI USA, V99, P6029, DOI 10.1073/pnas.092671899; Chen JK, 1998, J BIOL CHEM, V273, P29254, DOI 10.1074/jbc.273.44.29254; Chen JR, 2000, J BIOL CHEM, V275, P13789, DOI 10.1074/jbc.275.18.13789; Coutts AA, 2004, CURR OPIN PHARMACOL, V4, P572, DOI 10.1016/j.coph.2004.05.007; Deutsch DG, 1997, J CLIN INVEST, V100, P1538, DOI 10.1172/JCI119677; DEVANE WA, 1988, MOL PHARMACOL, V34, P605; DEVANE WA, 1992, SCIENCE, V258, P1946, DOI 10.1126/science.1470919; DEWEY WL, 1986, PHARMACOL REV, V38, P151; Di Marzo V, 2006, ANNU REV MED, V57, P553, DOI 10.1146/annurev.med.57.011205.135648; Di Marzo V, 2007, CURR OPIN LIPIDOL, V18, P129, DOI 10.1097/MOL.0b013e32803dbdec; DIMARZO V, 1994, NATURE, V372, P686, DOI 10.1038/372686a0; Fang X, 2006, AM J PHYSIOL-HEART C, V290, pH55, DOI 10.1152/ajpheart.00427.2005; Fisslthaler B, 1999, NATURE, V401, P493, DOI 10.1038/46816; Fleming I, 2007, ARTERIOSCL THROM VAS, V27, P2612, DOI 10.1161/ATVBAHA.107.152074; Gauthier KM, 2005, AM J PHYSIOL-HEART C, V288, pH1344, DOI 10.1152/ajpheart.00537.2004; GRAIER WF, 1995, J PHYSIOL-LONDON, V482, P259, DOI 10.1113/jphysiol.1995.sp020515; Hanus L, 2001, P NATL ACAD SCI USA, V98, P3662, DOI 10.1073/pnas.061029898; Hohmann AG, 2005, NATURE, V435, P1108, DOI 10.1038/nature03658; Holla VR, 1999, J CLIN INVEST, V104, P751, DOI 10.1172/JCI7013; Howlett AC, 2002, PHARMACOL REV, V54, P161, DOI 10.1124/pr.54.2.161; Hwang SH, 2007, J MED CHEM, V50, P3825, DOI 10.1021/jm070270t; Idris AI, 2005, NAT MED, V11, P774, DOI 10.1038/nm1255; Imig JD, 1996, J AM SOC NEPHROL, V7, P2364; Imig JD, 2001, J VASC RES, V38, P247, DOI 10.1159/000051053; Juan-Pico P, 2006, CELL CALCIUM, V39, P155, DOI 10.1016/j.ceca.2005.10.005; KARARA A, 1991, J BIOL CHEM, V266, P7561; Kishimoto S, 2003, J BIOL CHEM, V278, P24469, DOI 10.1074/jbc.M301359200; Mackie K, 2006, ANNU REV PHARMACOL, V46, P101, DOI 10.1146/annurev.pharmtox.46.120604.141254; Mackie K, 2006, AAPS J, V8, pE298, DOI 10.1007/BF02854900; MATSUDA LA, 1990, NATURE, V346, P561, DOI 10.1038/346561a0; McGiff JC, 2001, CURR OPIN NEPHROL HY, V10, P231, DOI 10.1097/00041552-200103000-00012; MECHOULAM R, 1995, BIOCHEM PHARMACOL, V50, P83, DOI 10.1016/0006-2952(95)00109-D; Merkler DJ, 2004, BIOCHEMISTRY-US, V43, P12667, DOI 10.1021/bi049529p; Morisseau C, 2002, BIOCHEM PHARMACOL, V63, P1599, DOI 10.1016/S0006-2952(02)00952-8; MORRISON AR, 1981, P NATL ACAD SCI-BIOL, V78, P7375, DOI 10.1073/pnas.78.12.7375; MUNRO S, 1993, NATURE, V365, P61, DOI 10.1038/365061a0; NEEDLEMAN P, 1986, ANNU REV BIOCHEM, V55, P69, DOI 10.1146/annurev.biochem.55.1.69; Node K, 1999, SCIENCE, V285, P1276, DOI 10.1126/science.285.5431.1276; OLIW EH, 1981, J BIOL CHEM, V256, P9924; Pacher P, 2006, PHARMACOL REV, V58, P389, DOI 10.1124/pr.58.3.2; Pagotto U, 2006, ENDOCR REV, V27, P73, DOI 10.1210/er.2005-0009; Pertwee RG, 1997, PHARMACOL THERAPEUT, V74, P129, DOI 10.1016/S0163-7258(97)82001-3; Piomelli Daniele, 2005, Curr Opin Investig Drugs, V6, P672; Porter AC, 2002, J PHARMACOL EXP THER, V301, P1020, DOI 10.1124/jpet.301.3.1020; Pratt Phillip F, 2004, Curr Opin Investig Drugs, V5, P952; Rzigalinski BA, 1999, J BIOL CHEM, V274, P175, DOI 10.1074/jbc.274.1.175; Sarkis A, 2004, CURR OPIN NEPHROL HY, V13, P205, DOI 10.1097/00041552-200403000-00009; Schramm NL, 2001, J NEUROSCI, V21, P4875, DOI 10.1523/JNEUROSCI.21-13-04875.2001; Seubert JM, 2007, PROSTAG OTH LIPID M, V82, P50, DOI 10.1016/j.prostaglandins.2006.05.017; Sugiura T, 2000, J BIOL CHEM, V275, P605, DOI 10.1074/jbc.275.1.605; SUGIURA T, 1995, BIOCHEM BIOPH RES CO, V215, P89, DOI 10.1006/bbrc.1995.2437; Sugiura T, 1998, BIOCHEM BIOPH RES CO, V243, P838, DOI 10.1006/bbrc.1998.8187; Sugiura T, 2006, PROG LIPID RES, V45, P405, DOI 10.1016/j.plipres.2006.03.003; Thomas BF, 1998, J PHARMACOL EXP THER, V285, P285; Van Sickle MD, 2005, SCIENCE, V310, P329, DOI 10.1126/science.1115740; Watanabe H, 2003, NATURE, V424, P434, DOI 10.1038/nature01807; ZELDIN DC, 1995, ARCH BIOCHEM BIOPHYS, V322, P76, DOI 10.1006/abbi.1995.1438; Zimmer A, 1999, P NATL ACAD SCI USA, V96, P5780, DOI 10.1073/pnas.96.10.5780	70	58	58	0	3	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	SEP 5	2008	283	36					24514	24524		10.1074/jbc.M709873200	http://dx.doi.org/10.1074/jbc.M709873200			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	342YR	18606824	hybrid, Green Published			2022-12-27	WOS:000258820000026
J	Greaves, J; Salaun, C; Fukata, Y; Fukata, M; Chamberlain, LH				Greaves, Jennifer; Salaun, Christine; Fukata, Yuko; Fukata, Masaki; Chamberlain, Luke H.			Palmitoylation and membrane interactions of the neuroprotective chaperone cysteine-string protein	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							SYNAPTIC VESICLE PROTEIN; GABA(A) RECEPTORS; PLASMA-MEMBRANE; BREFELDIN-A; H-RAS; DROSOPHILA; GOLGI; TRANSFERASE; TRAFFICKING; DOMAIN	Cysteine-string protein (CSP) is an extensively palmitoylated DnaJ-family chaperone, which exerts an important neuroprotective function. Palmitoylation is required for the intracellular sorting and function of CSP, and thus it is important to understand how this essential modification of CSP is regulated. Recent work identified 23 putative palmitoyl transferases containing a conserved DHHC domain in mammalian cells, and here we show that palmitoylation of CSP is enhanced specifically by co-expression of the Golgi-localized palmitoyl transferases DHHC3, DHHC7, DHHC15, or DHHC17. Indeed, these DHHC proteins promote stable membrane attachment of CSP, which is otherwise cytosolic. An inverse correlation was identified between membrane affinity of unpalmitoylated CSP mutants and subsequent palmitoylation: mutants with an increased membrane affinity localize to the endoplasmic reticulum ( ER) and are physically separated from the Golgi-localized DHHC proteins. Palmitoylation of an ER-localized mutant could be rescued by brefeldin A treatment, which promotes the mixing of ER and Golgi membranes. Interestingly though, the palmitoylated mutant remained at the ER following brefeldin A washout and did not traffic to more distal membrane compartments. We propose that CSP has a weak membrane affinity that allows the protein to locate its partner Golgi-localized DHHC proteins directly by membrane "sampling." Mutations that enhance membrane association prevent sampling and lead to accumulation of CSP on cellular membranes such as the ER. The coupling of CSP palmitoylation to Golgi membranes may thus be an important requirement for subsequent sorting.	[Greaves, Jennifer; Chamberlain, Luke H.] Univ Edinburgh, Ctr Integrat Physiol, Sch Biomed Sci, Edinburgh EH8 9XD, Midlothian, Scotland; [Salaun, Christine] INSERM, U845, Fac Med Paris Descartes, F-75730 Paris 15, France; [Fukata, Yuko; Fukata, Masaki] Natl Inst Physiol Sci, Div Membrane Physiol, Okazaki, Aichi 4448787, Japan; [Fukata, Yuko; Fukata, Masaki] Japan Sci & Technol Agcy, Tokyo 1020075, Japan	University of Edinburgh; Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universite Paris Cite; National Institutes of Natural Sciences (NINS) - Japan; National Institute for Physiological Sciences (NIPS); Japan Science & Technology Agency (JST)	Chamberlain, LH (corresponding author), Univ Edinburgh, Ctr Integrat Physiol, Sch Biomed Sci, Hugh Robson Bldg, Edinburgh EH8 9XD, Midlothian, Scotland.	Luke.Chamberlain@ed.ac.uk	Fukata, Masaki/AAZ-2476-2021	Fukata, Masaki/0000-0001-5200-9806; Salaun, Christine/0000-0003-3002-6810; Greaves, Jennifer/0000-0001-8445-789X; Fukata, Yuko/0000-0001-7724-8643	Wellcome Trust Research Career Development; Medical Research Council; Tenovus Scotland [S06/1]; Medical Research Council [G0601597] Funding Source: researchfish; MRC [G0601597] Funding Source: UKRI	Wellcome Trust Research Career Development(Wellcome Trust); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Tenovus Scotland; Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC))	This work was funded by a Wellcome Trust Research Career Development fellowship ( to L. H. C.), by an Medical Research Council Senior Research fellowship ( to L. H. C.), and by Tenovus Scotland ( Grant S06/1 to L. H. C.). The costs of publication of this article were defrayed in part by the payment of page charges. This article must therefore be hereby marked "advertisement" in accordance with 18 U. S. C. Section 1734 solely to indicate this fact.	Boal F, 2007, BBA-MOL CELL RES, V1773, P109, DOI 10.1016/j.bbamcr.2006.08.054; Chamberlain LH, 1998, BIOCHEM J, V335, P205, DOI 10.1042/bj3350205; Chamberlain LH, 1998, MOL BIOL CELL, V9, P2259, DOI 10.1091/mbc.9.8.2259; Chamberlain LH, 1996, J BIOL CHEM, V271, P7320, DOI 10.1074/jbc.271.13.7320; Chamberlain LH, 2001, J CELL SCI, V114, P445; Coppola T, 1996, FEBS LETT, V391, P269, DOI 10.1016/0014-5793(96)00750-8; DONALDSON JG, 1991, SCIENCE, V254, P1197, DOI 10.1126/science.1957170; Eberle KK, 1998, CELL TISSUE RES, V294, P203, DOI 10.1007/s004410051170; Fang C, 2006, J NEUROSCI, V26, P12758, DOI 10.1523/JNEUROSCI.4214-06.2006; Fernandez-Chacon R, 2004, NEURON, V42, P237, DOI 10.1016/S0896-6273(04)00190-4; Fernandez-Hernando C, 2006, J CELL BIOL, V174, P369, DOI 10.1083/jcb.200601051; Fukata M, 2004, NEURON, V44, P987, DOI 10.1016/j.neuron.2004.12.005; Gonzalo S, 1998, MOL BIOL CELL, V9, P585, DOI 10.1091/mbc.9.3.585; Goodwin JS, 2005, J CELL BIOL, V170, P261, DOI 10.1083/jcb.200502063; Greaves J, 2007, J CELL BIOL, V176, P249, DOI 10.1083/jcb.200610151; Greaves J, 2006, MOL BIOL CELL, V17, P4748, DOI 10.1091/mbc.E06-03-0183; GUNDERSEN CB, 1994, J BIOL CHEM, V269, P19197; Hayashi T, 2005, NEURON, V47, P709, DOI 10.1016/j.neuron.2005.06.035; Huang K, 2004, NEURON, V44, P977, DOI 10.1016/j.neuron.2004.11.027; Keller CA, 2004, J NEUROSCI, V24, P5881, DOI 10.1523/JNEUROSCI.1037-04.2004; Linder ME, 2007, NAT REV MOL CELL BIO, V8, P74, DOI 10.1038/nrm2084; LIPPINCOTTSCHWARTZ J, 1990, CELL, V60, P821, DOI 10.1016/0092-8674(90)90096-W; LIPPINCOTTSCHWARTZ J, 1989, CELL, V56, P801, DOI 10.1016/0092-8674(89)90685-5; Lobo S, 2002, J BIOL CHEM, V277, P41268, DOI 10.1074/JBC.M206573200; MAGEE AI, 1987, EMBO J, V6, P3353, DOI 10.1002/j.1460-2075.1987.tb02656.x; Mastrogiacomo A, 1998, FEBS LETT, V436, P85, DOI 10.1016/S0014-5793(98)01092-8; Nadolski MJ, 2007, FEBS J, V274, P5202, DOI 10.1111/j.1742-4658.2007.06056.x; Ohno Y, 2006, BBA-MOL CELL BIOL L, V1761, P474, DOI 10.1016/j.bbalip.2006.03.010; Ohyama T, 2007, J CELL BIOL, V179, P1481, DOI 10.1083/jcb.200710061; Politis EG, 2005, J BIOL CHEM, V280, P10156, DOI 10.1074/jbc.M411946200; Resh MD, 2006, NAT CHEM BIOL, V2, P584, DOI 10.1038/nchembio834; Rocks O, 2005, SCIENCE, V307, P1746, DOI 10.1126/science.1105654; Roth AF, 2002, J CELL BIOL, V159, P23, DOI 10.1083/jcb.200206120; Roth AF, 2006, CELL, V125, P1003, DOI 10.1016/j.cell.2006.03.042; Roy S, 2005, MOL CELL BIOL, V25, P6722, DOI 10.1128/MCB.25.15.6722-6733.2005; Salaun C, 2005, J BIOL CHEM, V280, P1236, DOI 10.1074/jbc.M410674200; SHAHINIAN S, 1995, BIOCHEMISTRY-US, V34, P3813, DOI 10.1021/bi00011a039; Stowers RS, 2007, J NEUROSCI, V27, P12874, DOI 10.1523/JNEUROSCI.2464-07.2007; Swarthout JT, 2005, J BIOL CHEM, V280, P31141, DOI 10.1074/jbc.M504113200; UMBACH JA, 1994, NEURON, V13, P899, DOI 10.1016/0896-6273(94)90255-0; vandeGoor J, 1996, FEBS LETT, V380, P251, DOI 10.1016/0014-5793(96)00026-9; Zhang H, 1998, FEBS LETT, V437, P267, DOI 10.1016/S0014-5793(98)01233-2; ZINSMAIER KE, 1994, SCIENCE, V263, P977, DOI 10.1126/science.8310297	43	88	89	0	4	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	SEP 5	2008	283	36					25014	25026		10.1074/jbc.M802140200	http://dx.doi.org/10.1074/jbc.M802140200			13	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	342YR	18596047	Green Accepted, hybrid, Green Published			2022-12-27	WOS:000258820000060
J	Vives-Bauza, C; Anand, M; Shirazi, AK; Magrane, J; Gao, JP; Vollmer-Snarr, HR; Manfredi, G; Finnemann, SC				Vives-Bauza, Cristofol; Anand, Monika; Shirazi, Arash K.; Magrane, Jordi; Gao, Junping; Vollmer-Snarr, Heidi R.; Manfredi, Giovanni; Finnemann, Silvia C.			The age lipid A2E and mitochondrial dysfunction synergistically impair phagocytosis by retinal pigment epithelial cells	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							N-RETINYLIDENE ETHANOLAMINE; LIPOFUSCIN FLUOROPHORE; MACULAR DEGENERATION; RPE CELLS; DNA; DYSTROPHY; COMPONENT; BINDING; GENE; BIOSYNTHESIS	Accumulation of indigestible lipofuscin and decreased mitochondrial energy production are characteristic age-related changes of post-mitotic retinal pigment epithelial (RPE) cells in the human eye. To test whether these two forms of age-related impairment have interdependent effects, we quantified the ATP dependent phagocytic function of RPE cells loaded or not with the lipofuscin component A2E and inhibiting or not mitochondrial ATP synthesis either pharmacologically or genetically. We found that physiological levels of lysosomal A2E reduced mitochondrial membrane potential and inhibited oxidative phosphorylation (OXPHOS) of RPE cells. Furthermore, in media with physiological concentrations of glucose or pyruvate, A2E significantly inhibited phagocytosis. Antioxidants reversed these effects of A2E, suggesting that A2E damage is mediated by oxidative processes. Because mitochondrial mutations accumulate with aging, we generated novel genetic cellular models of RPE carrying mitochondrial DNA point mutations causing either moderate or severe mitochondrial dysfunction. Exploring these mutant RPE cells we found that, by itself, only the severe but not the moderate OXPHOS defect reduces phagocytosis. However, sub-toxic levels of lysosomal A2E are sufficient to reduce phagocytic activity of RPE with moderate OXPHOS defect and cause cell death of RPE with severe OXPHOS defect. Taken together, RPE cells rely on OXPHOS for phagocytosis when the carbon energy source is limited. Our results demonstrate that A2E accumulation exacerbates the effects of moderate mitochondrial dysfunction. They suggest that synergy of sub-toxic lysosomal and mitochondrial changes in RPE cells with age may cause RPE dysfunction that is known to contribute to human retinal diseases like age-related macular degeneration.	[Vives-Bauza, Cristofol; Magrane, Jordi; Manfredi, Giovanni] Cornell Univ, Dept Neurol & Neurosci, Weill Med Coll, New York, NY 10065 USA; [Anand, Monika; Shirazi, Arash K.; Finnemann, Silvia C.] Cornell Univ, Dept Ophthalmol, Weill Med Coll, Dyson Vis Res Inst, New York, NY 10065 USA; [Finnemann, Silvia C.] Cornell Univ, Dept Physiol & Biophys, Weill Med Coll, New York, NY 10065 USA; [Finnemann, Silvia C.] Cornell Univ, Dept Cell & Dev Biol, Weill Med Coll, New York, NY 10065 USA; [Gao, Junping; Vollmer-Snarr, Heidi R.] Brigham Young Univ, Dept Chem & Biochem, Provo, UT 84602 USA	Cornell University; Cornell University; Dyson; Cornell University; Cornell University; Brigham Young University	Finnemann, SC (corresponding author), Weill Cornell Med Coll, Dyson Vis Res Inst, LC305,Box 233,1300 York Ave, New York, NY 10065 USA.	sfinne@med.cornell.edu	Vives-Bauza, Cristofol/N-7044-2015; Magrané, Jordi/AAJ-2967-2020; Vives-Bauza, Cristofol/AAS-1301-2021	Magrané, Jordi/0000-0002-6785-2166; Vives-Bauza, Cristofol/0000-0001-5735-8335; Vollmer-Snarr, Heidi/0000-0002-7312-4907	National Institutes of Health [R01-EY13295, K02-NS47306]; NATIONAL EYE INSTITUTE [R01EY013295] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [K02NS047306] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL EYE INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	This work was supported, in whole or in part, by National Institutes of Health Grants R01-EY13295 (to S. C. F.) and K02-NS47306 (to G. M.). The costs of publication of this article were defrayed in part by the payment of page charges. This article must therefore be hereby marked "advertisement" in accordance with 18 U. S. C. Section 1734 solely to indicate this fact. 1 Both authors contributed equally to this study.	Barron MJ, 2001, INVEST OPHTH VIS SCI, V42, P3016; Bayona-Bafaluy MP, 2003, NUCLEIC ACIDS RES, V31, DOI 10.1093/nar/gng100; BOK D, 1971, J CELL BIOL, V49, P664, DOI 10.1083/jcb.49.3.664; Brunk UT, 2002, EUR J BIOCHEM, V269, P1996, DOI 10.1046/j.1432-1033.2002.02869.x; BULLOCK WE, 1987, J EXP MED, V165, P195, DOI 10.1084/jem.165.1.195; Cadenas E, 2000, FREE RADICAL BIO MED, V29, P222, DOI 10.1016/S0891-5849(00)00317-8; Chang YG, 2007, J CELL SCI, V120, P3053, DOI 10.1242/jcs.006361; D'Aurelio M, 2001, J BIOL CHEM, V276, P46925, DOI 10.1074/jbc.M106429200; Del Priore LV, 2002, INVEST OPHTH VIS SCI, V43, P3312; DOWLING JE, 1962, J CELL BIOL, V14, P73, DOI 10.1083/jcb.14.1.73; FEENEY L, 1978, INVEST OPHTH VIS SCI, V17, P583; Feher J, 2006, NEUROBIOL AGING, V27, P983, DOI 10.1016/j.neurobiolaging.2005.05.012; Finnemann SC, 1997, P NATL ACAD SCI USA, V94, P12932, DOI 10.1073/pnas.94.24.12932; Finnemann SC, 2003, EMBO J, V22, P4143, DOI 10.1093/emboj/cdg416; Finnemann SC, 2002, P NATL ACAD SCI USA, V99, P3842, DOI 10.1073/pnas.052025899; Finnemann SC, 1999, J EXP MED, V190, P861, DOI 10.1084/jem.190.6.861; Gal A, 2000, NAT GENET, V26, P270, DOI 10.1038/81555; Harman D, 2003, ANTIOXID REDOX SIGN, V5, P557, DOI 10.1089/152308603770310202; Harman D, 2001, ANN NY ACAD SCI, V928, P1, DOI 10.1111/j.1749-6632.2001.tb05631.x; HOLT IJ, 1990, AM J HUM GENET, V46, P428; Holz FG, 1999, INVEST OPHTH VIS SCI, V40, P737; Holz FG, 2007, AM J OPHTHALMOL, V143, P463, DOI 10.1016/j.ajo.2006.11.041; KING MP, 1989, SCIENCE, V246, P500, DOI 10.1126/science.2814477; Kwong JQ, 2006, J NEUROCHEM, V97, P1659, DOI 10.1111/j.1471-4159.2006.03990.x; Lakkaraju A, 2007, P NATL ACAD SCI USA, V104, P11026, DOI 10.1073/pnas.0702504104; Liu JH, 2000, J BIOL CHEM, V275, P29354, DOI 10.1074/jbc.M910191199; MASUCCI JP, 1995, MOL CELL BIOL, V15, P2872; Mata NL, 2000, P NATL ACAD SCI USA, V97, P7154, DOI 10.1073/pnas.130110497; MOLDAY RS, 1987, INVEST OPHTH VIS SCI, V28, P50; MULLEN RJ, 1976, SCIENCE, V192, P799, DOI 10.1126/science.1265483; Nandrot EE, 2004, J EXP MED, V200, P1539, DOI 10.1084/jem.20041447; Parish CA, 1998, P NATL ACAD SCI USA, V95, P14609, DOI 10.1073/pnas.95.25.14609; Petrukhin K, 1998, NAT GENET, V19, P241, DOI 10.1038/915; Rakoczy PE, 2002, AM J PATHOL, V161, P1515, DOI 10.1016/S0002-9440(10)64427-6; Robertson Carolyn, 2003, J Am Dent Assoc, V134 Spec No, p16S; Schutt F, 2000, INVEST OPHTH VIS SCI, V41, P2303; Schutt F, 2007, GRAEF ARCH CLIN EXP, V245, P391, DOI 10.1007/s00417-006-0376-5; Shaban H, 2001, ARCH BIOCHEM BIOPHYS, V394, P111, DOI 10.1006/abbi.2001.2535; SHOFFNER JM, 1990, CELL, V61, P931, DOI 10.1016/0092-8674(90)90059-N; Sparrow JR, 1999, INVEST OPHTH VIS SCI, V40, P2988; Sparrow JR, 2005, EXP EYE RES, V80, P595, DOI 10.1016/j.exer.2005.01.007; Sparrow JR, 2003, J BIOL CHEM, V278, P18207, DOI 10.1074/jbc.M300457200; Sparrow JR, 2003, INVEST OPHTH VIS SCI, V44, P2245, DOI 10.1167/iovs.02-0746; Sparrow JR, 2000, INVEST OPHTH VIS SCI, V41, P1981; Strauss O, 2005, PHYSIOL REV, V85, P845, DOI 10.1152/physrev.00021.2004; Suter M, 2000, J BIOL CHEM, V275, P39625, DOI 10.1074/jbc.M007049200; Terman A, 2007, J PATHOL, V211, P134, DOI 10.1002/path.2094; Terman A, 2003, EXP GERONTOL, V38, P863, DOI 10.1016/S0531-5565(03)00114-1; Vives-Bauza C, 2007, METHOD CELL BIOL, V80, P155, DOI 10.1016/S0091-679X(06)80007-5; Wang Z, 2006, PHOTOCHEM PHOTOBIOL, V82, P1251, DOI 10.1562/2006-04-01-RA-864; Williams AJ, 1999, HUM MOL GENET, V8, P1691, DOI 10.1093/hmg/8.9.1691; Zarbin MA, 2004, ARCH OPHTHALMOL-CHIC, V122, P598, DOI 10.1001/archopht.122.4.598; Zareparsi S, 2005, HUM MOL GENET, V14, P1449, DOI 10.1093/hmg/ddi154	53	119	122	1	15	ELSEVIER	AMSTERDAM	RADARWEG 29, 1043 NX AMSTERDAM, NETHERLANDS		1083-351X		J BIOL CHEM	J. Biol. Chem.	SEP 5	2008	283	36					24770	24780		10.1074/jbc.M800706200	http://dx.doi.org/10.1074/jbc.M800706200			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	342YR	18621729	Green Published, hybrid			2022-12-27	WOS:000258820000045
J	Prochazkova, K; Satchell, KJF				Prochazkova, Katerina; Satchell, Karla J. Fullner			Structure-function analysis of inositol hexakisphosphate-induced autoprocessing of the Vibrio cholerae multifunctional autoprocessing RTX toxin	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							CROSS-LINKING DOMAIN; CLEAVAGE; ACTIN; PENTAKISPHOSPHATE; PHOSPHATES; DEPENDS; CELLS; MICE	Vibrio cholerae secretes a large virulence-associated multifunctional autoprocessing RTX toxin ( MARTXVc). Autoprocessing of this toxin by an embedded cysteine protease domain (CPD) is essential for this toxin to induce actin depolymerization in a broad range of cell types. A homologous CPD is also present in the large clostridial toxin TcdB and recent studies showed that inositol hexakisphosphate (Ins(1,2,3,4,5,6) P6 or InsP6) stimulated the autoprocessing of TcdB dependent upon the CPD ( Egerer, M., Giesemann, T., Jank, T., Satchell, K. J., and Aktories, K. (2007) J. Biol. Chem. 282, 25314-25321). In this work, the autoprocessing activity of the CPD within MARTXVc is similarly found to be inducible by InsP6. The CPD is shown to bind InsP6 ( Kd, 0.6 mu M), and InsP6 is shown to stimulate intramolecular autoprocessing at both physiological concentrations and as low as 0.01 mu M. Processed CPD did not bind InsP6 indicating that, subsequent to cleavage, the activated CPD may shift to an inactive conformation. To further pursue the mechanism of autoprocessing, conserved residues among 24 identified CPDs were mutagenized. In addition to cysteine and histidine residues that form the catalytic site, 2 lysine residues essential for InsP6 binding and 5 lysine and arginine residues resulting in loss of activity at low InsP6 concentrations were identified. Overall, our data support a model in which basic residues located across the CPD structure form an InsP6 binding pocket and that the binding of InsP6 stimulates processing by altering the CPD to an activated conformation. After processing, InsP6 is shown to be recycled, while the cleaved CPD becomes incapable of further binding of InsP6.	[Prochazkova, Katerina; Satchell, Karla J. Fullner] Northwestern Univ, Feinberg Sch Med, Dept Microbiol Immunol, Chicago, IL 60611 USA	Northwestern University; Feinberg School of Medicine	Satchell, KJF (corresponding author), 303 E Chicago Ave,Tarry 3-713, Chicago, IL 60611 USA.	k-satchell@northwestern.edu	Satchell, Karla/GSN-3100-2022		NIAID NIH HHS [R01 AI051490-06A1, R01 AI051490, R01 AI 051490, U54 AI 057153] Funding Source: Medline; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI051490, U54AI057153] Funding Source: NIH RePORTER	NIAID NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))		[Anonymous], 2007, Wkly Epidemiol Rec, V82, P273; [Anonymous], 2001, Wkly Epidemiol Rec, V76, P117; BARROSO LA, 1994, MICROB PATHOGENESIS, V16, P297, DOI 10.1006/mpat.1994.1030; Cordero CL, 2007, J CLIN MICROBIOL, V45, P2289, DOI 10.1128/JCM.00349-07; Cordero CL, 2006, J BIOL CHEM, V281, P32366, DOI 10.1074/jbc.M605275200; Dalsgaard A, 2001, J CLIN MICROBIOL, V39, P4086, DOI 10.1128/JCM.39.11.4086-4092.2001; Egerer M, 2007, J BIOL CHEM, V282, P25314, DOI 10.1074/jbc.M703062200; Faruque SM, 2004, P NATL ACAD SCI USA, V101, P2123, DOI 10.1073/pnas.0308485100; FRENCH PJ, 1991, P ROY SOC B-BIOL SCI, V245, P193, DOI 10.1098/rspb.1991.0109; JACKSON TR, 1987, EMBO J, V6, P49, DOI 10.1002/j.1460-2075.1987.tb04717.x; Kim YR, 2008, CELL MICROBIOL, V10, P848, DOI 10.1111/j.1462-5822.2007.01088.x; Kudryashov DS, 2008, J BIOL CHEM, V283, P445, DOI 10.1074/jbc.M703910200; Macbeth MR, 2005, SCIENCE, V309, P1534, DOI 10.1126/science.1113150; Olivier V, 2007, INFECT IMMUN, V75, P5043, DOI 10.1128/IAI.00508-07; Olivier V, 2007, INFECT IMMUN, V75, P5035, DOI 10.1128/IAI.00506-07; Pfeifer G, 2003, J BIOL CHEM, V278, P44535, DOI 10.1074/jbc.M307540200; Reineke J, 2007, NATURE, V446, P415, DOI 10.1038/nature05622; Rupnik M, 2005, MICROBIOL-SGM, V151, P199, DOI 10.1099/mic.0.27474-0; SASAKAWA N, 1995, BIOCHEM PHARMACOL, V50, P137, DOI 10.1016/0006-2952(95)00059-9; Satchell KJF, 2007, INFECT IMMUN, V75, P5079, DOI 10.1128/IAI.00525-07; Sheahan KL, 2007, EMBO J, V26, P2552, DOI 10.1038/sj.emboj.7601700; Sheahan KL, 2007, CELL MICROBIOL, V9, P1324, DOI 10.1111/j.1462-5822.2006.00876.x; Sheahan KL, 2004, P NATL ACAD SCI USA, V101, P9798, DOI 10.1073/pnas.0401104101; Stols L, 2002, PROTEIN EXPRES PURIF, V25, P8, DOI 10.1006/prep.2001.1603; Tan X, 2007, NATURE, V446, P640, DOI 10.1038/nature05731; VALLEJO M, 1987, NATURE, V330, P656, DOI 10.1038/330656a0	26	48	51	0	2	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	AUG 29	2008	283	35					23656	23664		10.1074/jbc.M803334200	http://dx.doi.org/10.1074/jbc.M803334200			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	340II	18591243	Green Published, hybrid			2022-12-27	WOS:000258638900018
J	Xu, DK; Dwyer, J; Li, H; Duan, W; Liu, JP				Xu, Dakang; Dwyer, Julie; Li, He; Duan, Wei; Liu, Jun-Ping			Ets2 maintains hTERT gene expression and breast cancer cell proliferation by interacting with c-Myc	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ANCHORAGE-INDEPENDENT GROWTH; TELOMERASE ACTIVITY; TRANSCRIPTION FACTORS; MAMMARY-TUMORS; PROTEINS; DNA; FAMILY; ROLES; PHOSPHORYLATION; TRANSACTIVATION	Human telomerase reverse transcriptase ( hTERT) underlies cancer cell immortalization, and the expression of hTERTis regulated strictly at the gene transcription. Here, we report that transcription factor Ets2 is required for hTERT gene expression and breast cancer cell proliferation. Silencing Ets2 induces a decrease of hTERT gene expression and increase in human breast cancer cell death. Reconstitution with recombinant hTERT rescues the apoptosis induced by Ets2 depression. In vitro and in vivo analyses show that Ets2 binds to the EtsA and EtsB DNA motifs on the hTERT gene promoter. Mutation of either Ets2 binding site reduces the hTERT promoter transcriptional activity. Moreover, Ets2 forms a complex with c- Myc as demonstrated by co- immunoprecipitation and glutathione S- transferase pulldown assays. Immunological depletion of Ets2, or mutation of the EtsA DNA motif, disables c- Myc binding to the E- box, whereas removal of c- Myc or mutation of the E- box also compromises Ets2 binding to EtsA. Thus, hTERT gene expression is maintained by a mechanism involving Ets2 interactions with the c- Myc transcription factor and the hTERT gene promoter, a protein- DNA complex critical for hTERT gene expression and breast cancer cell proliferation.	[Xu, Dakang] Monash Inst Med Res, Ctr Canc Res, Clayton, Vic 3168, Australia; [Dwyer, Julie; Li, He; Liu, Jun-Ping] Monash Univ, Cent & Eastern Clin Sch, Dept Immunol, Prahran, Vic 3181, Australia; [Duan, Wei] Deakin Univ, Sch Med, Geelong, Vic 3217, Australia	Monash University; Monash University; Deakin University	Xu, DK (corresponding author), Monash Inst Med Res, Ctr Canc Res, 246 Clayton Rd, Clayton, Vic 3168, Australia.	Dakang.xu@med.monash.edu.au; Jun-ping.liu@med.monash.edu.au	Duan, Wei/A-5181-2015; Liu, Jun-Ping/AAA-5521-2020	Duan, Wei/0000-0001-5782-9184; Liu, Jun-Ping/0000-0001-7442-2116; Xu, Dakang/0000-0003-2415-4920				Bayne S, 2007, ANN NY ACAD SCI, V1114, P48, DOI 10.1196/annals.1396.023; Cao Y, 2002, ONCOGENE, V21, P3130, DOI 10.1038/sj.onc.1205419; Carbone GM, 2004, NUCLEIC ACIDS RES, V32, P4358, DOI 10.1093/nar/gkh744; Dwyer J, 2007, ANN NY ACAD SCI, V1114, P36, DOI 10.1196/annals.1396.022; Foos G, 2000, ONCOGENE, V19, P5507, DOI 10.1038/sj.onc.1203946; Galang CK, 2004, J BIOL CHEM, V279, P11281, DOI 10.1074/jbc.M311887200; GONG JP, 1994, ANAL BIOCHEM, V218, P314, DOI 10.1006/abio.1994.1184; Hahne JC, 2005, ONCOGENE, V24, P5384, DOI 10.1038/sj.onc.1208761; Hsu CP, 2006, EUR J CANCER, V42, P1466, DOI 10.1016/j.ejca.2006.02.014; Hsu T, 2004, J CELL BIOCHEM, V91, P896, DOI 10.1002/jcb.20012; Lee GM, 2005, J BIOL CHEM, V280, P7088, DOI 10.1074/jbc.M410722200; Li H, 1998, J BIOL CHEM, V273, P33436, DOI 10.1074/jbc.273.50.33436; Li H, 2006, J BIOL CHEM, V281, P25588, DOI 10.1074/jbc.M602381200; Li RZ, 2000, ONCOGENE, V19, P6514, DOI 10.1038/sj.onc.1204035; Li S, 2005, J BIOL CHEM, V280, P23709, DOI 10.1074/jbc.M502782200; Lindemann RK, 2003, BIOCHEM J, V372, P787, DOI 10.1042/BJ20030046; Liu JP, 1999, FASEB J, V13, P2091, DOI 10.1096/fasebj.13.15.2091; Maida Y, 2002, ONCOGENE, V21, P4071, DOI 10.1038/sj.onc.1205509; Man AK, 2003, MOL CELL BIOL, V23, P8614, DOI 10.1128/MCB.23.23.8614-8625.2003; Massard C, 2006, ONCOGENE, V25, P4505, DOI 10.1038/sj.onc.1209487; Mavrothalassitis G, 2000, ONCOGENE, V19, P6524, DOI 10.1038/sj.onc.1204045; Myers E, 2005, CLIN CANCER RES, V11, P2111, DOI 10.1158/1078-0432.CCR-04-1192; Neznanov N, 1999, CANCER RES, V59, P4242; Rahman R, 2005, ONCOGENE, V24, P1320, DOI 10.1038/sj.onc.1208232; Sapi E, 1998, CANCER RES, V58, P1027; Sementchenko VI, 1998, ONCOGENE, V17, P2883, DOI 10.1038/sj.onc.1202220; Seth A, 2005, EUR J CANCER, V41, P2462, DOI 10.1016/j.ejca.2005.08.013; Svensson S, 2005, ONCOGENE, V24, P4370, DOI 10.1038/sj.onc.1208626; Takahashi A, 2003, CANCER RES, V63, P8338; Xiao X, 2002, LEUKEMIA, V16, P1877, DOI 10.1038/sj.leu.2402607; Xiao XD, 2003, EXP MOL PATHOL, V75, P238, DOI 10.1016/S0014-4800(03)00092-3; Yamamoto H, 1998, GENE DEV, V12, P1315, DOI 10.1101/gad.12.9.1315; Yang BS, 1996, MOL CELL BIOL, V16, P538; Zinn RL, 2007, CANCER RES, V67, P194, DOI 10.1158/0008-5472.CAN-06-3396	34	115	120	0	8	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	AUG 29	2008	283	35					23567	23580		10.1074/jbc.M800790200	http://dx.doi.org/10.1074/jbc.M800790200			14	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	340II	18586674	Green Published, hybrid			2022-12-27	WOS:000258638900009
J	Arias-Moreno, X; Velazquez-Campoy, A; Rodriguez, JC; Pocovi, M; Sancho, J				Arias-Moreno, Xabier; Velazquez-Campoy, Adrian; Rodriguez, Jose Carlos; Pocovi, Miguel; Sancho, Javier			Mechanism of low density lipoprotein (LDL) release in the endosome - Implications of the stability and Ca2+ affinity of the fifth binding module of the LDL receptor	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							FAMILIAL HYPERCHOLESTEROLEMIA MUTATIONS; LIGAND-BINDING; HUMAN FIBROBLASTS; CYSTEINE-RICH; CALCIUM-BINDING; 3-HYDROXY-3-METHYLGLUTARYL COENZYME; DIFFERENT PROTEINS; REDUCTASE-ACTIVITY; MOLECULAR-BASIS; PH-DEPENDENCE	Uptake of low density lipoproteins ( LDL) by their receptor, LDLR, is the primary mechanism by which cells incorporate cholesterol from plasma. Mutations in LDLR lead to familial hypercholesterolemia, a common disease affecting 1 in 500 of the human population. LDLR is a modular protein that uses several small repeats to bind LDL. The repeats contain around 40 residues, including three disulfide bonds and a calcium ion. Repeat 5 ( LR5) is critical for LDL and beta-migrating very low density lipoprotein binding. Based on the crystal structure of LDLR at endosomal pH ( but close to extracellular calcium concentration), LR5 has been proposed to bind to the epidermal growth factor ( EGF) precursor domain of LDLR in the endosome, thus releasing the LDL particles previously bound in extracellular conditions. We report here the conformational stability of LR5 as a function of temperature and calcium concentration under both extracellular and endosomal pH conditions. The repeat was very stable when it bore a bound calcium ion but was severely destabilized in the absence of calcium and even further destabilized at acidic versus neutral pH. The temperature and calcium concentration dependence of LR5 stability clearly indicate that under endosomal conditions the unfolded conformation of the repeat is largely dominant. We thus propose a new mechanism for LDL release in the endosome in which calcium depletion and decreased stability at acidic pH drives LR5 unfolding, which triggers LDL release from the receptor. Subsequent binding of LR5 to the EGF precursor domain, if it takes place at low calcium concentrations, would contribute to a further shifting of the equilibrium toward dissociation.	[Arias-Moreno, Xabier; Velazquez-Campoy, Adrian; Sancho, Javier] Univ Zaragoza, Biocomputat & Complex Syst Phys Inst, E-50009 Zaragoza, Spain; [Arias-Moreno, Xabier; Pocovi, Miguel; Sancho, Javier] Univ Zaragoza, Dept Bioquim & Biol Mol & Celular, Fac Ciencias, E-50009 Zaragoza, Spain; [Rodriguez, Jose Carlos] Univ Cantabria, Dept Bioquim & Biol Mol, Fac Med, Santander 39011, Spain	University of Zaragoza; University of Zaragoza; Universidad de Cantabria	Sancho, J (corresponding author), Univ Zaragoza, Biocomputat & Complex Syst Phys Inst, E-50009 Zaragoza, Spain.	jsancho@unizar.es	Velazquez-Campoy, Adrian/E-7946-2012; MORENO, XABIER ARIAS/AAA-1176-2021; Sancho, javier/AAA-1225-2019	Velazquez-Campoy, Adrian/0000-0001-5702-4538; MORENO, XABIER ARIAS/0000-0001-8601-9092; Sancho, javier/0000-0002-2879-9200; Rodriguez-Rey, Jose/0000-0002-8369-3118				ANDERSON RGW, 1977, NATURE, V270, P695, DOI 10.1038/270695a0; ANDERSON RGW, 1977, CELL, V10, P351, DOI 10.1016/0092-8674(77)90022-8; ANDERSON RGW, 1976, P NATL ACAD SCI USA, V73, P2434, DOI 10.1073/pnas.73.7.2434; ANDERSON RGW, 1978, CELL, V15, P919, DOI 10.1016/0092-8674(78)90276-3; Arias-Moreno X, 2008, J BIOL CHEM, V283, P13627, DOI 10.1074/jbc.M800755200; Atkins AR, 1998, BIOCHEMISTRY-US, V37, P1662, DOI 10.1021/bi972529n; Beffert U, 2004, J LIPID RES, V45, P403, DOI 10.1194/jlr.R300017-JLR200; Beglova N, 2005, TRENDS BIOCHEM SCI, V30, P309, DOI 10.1016/j.tibs.2005.03.007; Beglova N, 2004, BIOCHEM SOC T, V32, P721, DOI 10.1042/BST0320721; Beglova N, 2004, MOL CELL, V16, P281, DOI 10.1016/j.molcel.2004.09.038; Blacklow SC, 1996, NAT STRUCT BIOL, V3, P758, DOI 10.1038/nsb0996-758; Blacklow SC, 2007, CURR OPIN STRUC BIOL, V17, P419, DOI 10.1016/j.sbi.2007.08.017; BROWN MS, 1974, P NATL ACAD SCI USA, V71, P788, DOI 10.1073/pnas.71.3.788; BROWN MS, 1986, SCIENCE, V232, P34, DOI 10.1126/science.3513311; BROWN MS, 1983, CELL, V32, P663, DOI 10.1016/0092-8674(83)90052-1; Bu GJ, 2001, INT REV CYTOL, V209, P79; Campos LA, 2006, PROTEINS, V63, P581, DOI 10.1002/prot.20855; CHEN SH, 1986, J BIOL CHEM, V261, P2918; Cuesta-Lopez S, 2007, PROTEINS, V66, P87, DOI 10.1002/prot.21181; DALY NL, 1995, P NATL ACAD SCI USA, V92, P6334, DOI 10.1073/pnas.92.14.6334; DAVIS CG, 1987, NATURE, V326, P760, DOI 10.1038/326760a0; DeBose-Boyd RA, 2004, MOL CELL, V16, P160, DOI 10.1016/j.molcel.2004.10.009; Dedoussis GVZ, 2004, HUM MUTAT, V24, P443, DOI 10.1002/humu.20105; Dolmer K, 1998, BIOCHEMISTRY-US, V37, P17016, DOI 10.1021/bi982022s; ESSER V, 1988, J BIOL CHEM, V263, P13282; Fass D, 1997, NATURE, V388, P691, DOI 10.1038/41798; Fisher C, 2004, BIOCHEMISTRY-US, V43, P1037, DOI 10.1021/bi035529y; Genzor CG, 1996, PROTEIN SCI, V5, P1376, DOI 10.1002/pro.5560050716; Gerasimenko JV, 1998, CURR BIOL, V8, P1335, DOI 10.1016/S0960-9822(07)00565-9; GOLDSTEIN JL, 1973, P NATL ACAD SCI USA, V70, P2804, DOI 10.1073/pnas.70.10.2804; GOLDSTEIN JL, 1974, J BIOL CHEM, V249, P5153; Goldstein JL, 2001, METABOLIC MOL BASES, V8th, P2863; Griko YV, 1999, BIOPHYS CHEM, V79, P117, DOI 10.1016/S0301-4622(99)00047-2; Jeon H, 2005, ANNU REV BIOCHEM, V74, P535, DOI 10.1146/annurev.biochem.74.082803.133354; Kampmann T, 2006, STRUCTURE, V14, P1481, DOI 10.1016/j.str.2006.07.011; Koduri V, 2001, BIOCHEMISTRY-US, V40, P12801, DOI 10.1021/bi011344k; Kwon HJ, 2008, P NATL ACAD SCI USA, V105, P1820, DOI 10.1073/pnas.0712064105; Lee D, 2006, MOL CELL, V22, P423, DOI 10.1016/j.molcel.2006.04.011; Li YH, 2002, BIOCHEMISTRY-US, V41, P4921, DOI 10.1021/bi011894i; MAKHATADZE GI, 1993, PROTEIN SCI, V2, P2028, DOI 10.1002/pro.5560021204; Minton AP, 2005, BIOPHYS J, V88, P971, DOI 10.1529/biophysj.104.050351; Nielsen AD, 2003, ANAL BIOCHEM, V314, P227, DOI 10.1016/S0003-2697(02)00655-3; North CL, 2000, BIOCHEMISTRY-US, V39, P13127, DOI 10.1021/bi0015156; North CL, 1999, BIOCHEMISTRY-US, V38, P3926, DOI 10.1021/bi9821622; PACE CN, 1990, BIOCHEMISTRY-US, V29, P2564, DOI 10.1021/bi00462a019; Permyakov SE, 2006, PROTEINS, V65, P984, DOI 10.1002/prot.21159; Rainey GJA, 2005, P NATL ACAD SCI USA, V102, P13278, DOI 10.1073/pnas.0505865102; Rudenko G, 2003, CURR OPIN STRUC BIOL, V13, P683, DOI 10.1016/j.sbi.2003.10.001; Rudenko G, 2002, SCIENCE, V298, P2353, DOI 10.1126/science.1078124; RUSSELL DW, 1989, J BIOL CHEM, V264, P21682; Saha S, 2001, STRUCTURE, V9, P451, DOI 10.1016/S0969-2126(01)00606-2; Saito M, 2007, J BIOL CHEM, V282, P27327, DOI 10.1074/jbc.M702557200; SCHNEIDER WJ, 1979, P NATL ACAD SCI USA, V76, P5577, DOI 10.1073/pnas.76.11.5577; Simonovic M, 2001, BIOCHEMISTRY-US, V40, P15127, DOI 10.1021/bi015688m; STRAUME M, 1992, ANAL BIOCHEM, V203, P259, DOI 10.1016/0003-2697(92)90311-T; Strickland DK, 2002, TRENDS ENDOCRIN MET, V13, P66, DOI 10.1016/S1043-2760(01)00526-4; SUDHOF TC, 1985, SCIENCE, V228, P815, DOI 10.1126/science.2988123; Uversky VN, 2002, EUR J BIOCHEM, V269, P2, DOI 10.1046/j.0014-2956.2001.02649.x; Wilkins MR, 1999, METH MOL B, V112, P531; Willnow TE, 1999, NAT CELL BIOL, V1, pE157, DOI 10.1038/14109; YAMAMOTO T, 1984, CELL, V39, P27, DOI 10.1016/0092-8674(84)90188-0; Zhou HX, 2008, ARCH BIOCHEM BIOPHYS, V469, P76, DOI 10.1016/j.abb.2007.07.013	62	38	39	0	7	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	AUG 15	2008	283	33					22670	22679		10.1074/jbc.M802153200	http://dx.doi.org/10.1074/jbc.M802153200			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	335VR	18574243	hybrid			2022-12-27	WOS:000258321000036
J	Ishikita, H				Ishikita, Hiroshi			Light-induced hydrogen bonding pattern and driving force of electron transfer in AppA BLUF domain photoreceptor	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							RHODOBACTER-SPHAEROIDES; CLOSTRIDIUM-BEIJERINCKII; REDOX POTENTIALS; REACTION CENTERS; GENE-EXPRESSION; TYROSINE; MECHANISM; OXIDATION; PROTEIN; PROTON	The AppA BLUF (blue light sensing using FAD) domain from Rhodobacter sphaeroides serves as a blue light-sensing photoreceptor. The charge separation process between Tyr-21 and flavin plays an important role in the light signaling state by transforming the dark state conformation to the light state one. By solving the linearized Poisson-Boltzmann equation, I calculated E(m) for Tyr-21, flavin, and redox-active Trp-104 and revealed the electron transfer (ET) driving energy. Rotation of the Gln-63 side chain that converts protein conformation from the dark state to the light state is responsible for the decrease of 150 mV in E(m) for Tyr-21, leading to the significantly larger ET driving energy in the light state conformation. The pK(alpha) values of protonation for flavin anions are essentially the same in both dark and light state crystal structures. In contrast to the ET via Tyr-21, formation of the W.(+) state results in generation of only the dark state conformation (even if the initial conformation is in the light state); this could explain why Trp-104-mediated ET deactivates the light-sensing yield and why the activity of W104A mutant is similar to that of the light-adapted native BLUF.	Univ Tokyo, Inst Mol & Cellular Biosci, Bunkyo Ku, Tokyo 1130032, Japan	University of Tokyo	Ishikita, H (corresponding author), Univ Tokyo, Inst Mol & Cellular Biosci, Bunkyo Ku, 1-1-1 Yayoi, Tokyo 1130032, Japan.	hiro@iam.u-tokyo.ac.jp	Ishikita, Hiroshi/G-9864-2018	Ishikita, Hiroshi/0000-0002-5849-8150				Anderson S, 2005, BIOCHEMISTRY-US, V44, P7998, DOI 10.1021/bi0502691; BASHFORD D, 1990, BIOCHEMISTRY-US, V29, P10219, DOI 10.1021/bi00496a010; BROOKS BR, 1983, J COMPUT CHEM, V4, P187, DOI 10.1002/jcc.540040211; DRAPER RD, 1968, ARCH BIOCHEM BIOPHYS, V125, P802, DOI 10.1016/0003-9861(68)90517-1; Gauden M, 2007, BIOCHEMISTRY-US, V46, P7405, DOI 10.1021/bi7006433; Gauden M, 2006, P NATL ACAD SCI USA, V103, P10895, DOI 10.1073/pnas.0600720103; Grinstead JS, 2006, J AM CHEM SOC, V128, P15066, DOI 10.1021/ja0660103; Grinstead JS, 2006, CHEMBIOCHEM, V7, P187, DOI 10.1002/cbic.200500270; Han YC, 2004, P NATL ACAD SCI USA, V101, P12306, DOI 10.1073/pnas.0403547101; HARRIMAN A, 1987, J PHYS CHEM-US, V91, P6102, DOI 10.1021/j100308a011; Ishikita H, 2005, FEBS LETT, V579, P712, DOI 10.1016/j.febslet.2004.12.049; Ishikita H, 2008, BIOCHEMISTRY-US, V47, P4394, DOI 10.1021/bi702151k; Ishikita H, 2007, J AM CHEM SOC, V129, P11146, DOI 10.1021/ja072708k; Ishikita H, 2007, J BIOL CHEM, V282, P25240, DOI 10.1074/jbc.M702788200; Ishikita H, 2006, P NATL ACAD SCI USA, V103, P9855, DOI 10.1073/pnas.0601446103; Ishikita H, 2006, BIOPHYS J, V90, P3886, DOI 10.1529/biophysj.105.076984; Jung A, 2006, J MOL BIOL, V362, P717, DOI 10.1016/j.jmb.2006.07.024; Kita A, 2005, J MOL BIOL, V349, P1, DOI 10.1016/j.jmb.2005.03.067; Kraft BJ, 2003, BIOCHEMISTRY-US, V42, P6726, DOI 10.1021/bi030055o; Kumler WD, 1943, J AM CHEM SOC, V65, P2355, DOI 10.1021/ja01252a028; Laan W, 2006, BIOCHEMISTRY-US, V45, P51, DOI 10.1021/bi051367p; Laan W, 2003, PHOTOCHEM PHOTOBIOL, V78, P290, DOI 10.1562/0031-8655(2003)078<0290:ICOTPP>2.0.CO;2; Masuda S, 2005, BIOCHEMISTRY-US, V44, P1215, DOI 10.1021/bi047876t; Masuda S, 2002, CELL, V110, P613, DOI 10.1016/S0092-8674(02)00876-0; Masuda S, 2007, J MOL BIOL, V368, P1223, DOI 10.1016/j.jmb.2007.02.087; MOSER CC, 1992, NATURE, V355, P796, DOI 10.1038/355796a0; Muh F, 1998, BIOCHEMISTRY-US, V37, P13066, DOI 10.1021/bi980799f; Page CC, 1999, NATURE, V402, P47, DOI 10.1038/46972; Popovic DM, 2002, J AM CHEM SOC, V124, P3775, DOI 10.1021/ja016249d; Takahashi R, 2007, BIOCHEMISTRY-US, V46, P6459, DOI 10.1021/bi7004653; Tommos C, 1999, BIOCHEMISTRY-US, V38, P9495, DOI 10.1021/bi990609g; Tommos C, 2000, BBA-BIOENERGETICS, V1458, P199, DOI 10.1016/S0005-2728(00)00069-4; Unno M, 2006, J AM CHEM SOC, V128, P5638, DOI 10.1021/ja060633z	33	18	18	0	11	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258			J BIOL CHEM	J. Biol. Chem.	NOV 7	2008	283	45					30618	30623		10.1074/jbc.M803864200	http://dx.doi.org/10.1074/jbc.M803864200			6	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	367ID	18647748	Green Published, hybrid			2022-12-27	WOS:000260544800085
J	Li, H; Koshiba, S; Hayashi, F; Tochio, N; Tomizawa, T; Kasai, T; Yabuki, T; Motoda, Y; Harada, T; Watanabe, S; Inoue, M; Hayashizaki, Y; Tanaka, A; Kigawa, T; Yokoyama, S				Li, Hua; Koshiba, Seizo; Hayashi, Fumiaki; Tochio, Naoya; Tomizawa, Tadashi; Kasai, Takuma; Yabuki, Takashi; Motoda, Yoko; Harada, Takushi; Watanabe, Satoru; Inoue, Makoto; Hayashizaki, Yoshihide; Tanaka, Akiko; Kigawa, Takanori; Yokoyama, Shigeyuki			Structure of the C-terminal phosphotyrosine interaction domain of Fe65L1 complexed with the cytoplasmic tail of amyloid precursor protein reveals a novel peptide binding mode	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							TORSION ANGLE DYNAMICS; PTB DOMAIN; NMR STRUCTURE; FUNCTIONAL ANNOTATION; INTRACELLULAR DOMAIN; ALZHEIMERS-DISEASE; PROGRAM; PHOSPHORYLATION; MUTAGENESIS; RECOGNITION	Fe65L1, a member of the Fe65 family, is an adaptor protein that interacts with the cytoplasmic domain of Alzheimer amyloid precursor protein (APP) through its C-terminal phosphotyrosine interaction/phosphotyrosine binding (PID/PTB) domain. In the present study, the solution structures of the C-terminal PID domain of mouse Fe65L1, alone and in complex with a 32-mer peptide (DAAVTPEERHLSKMQQNGYENPTYKFFEQMQN) derived from the cytoplasmic domain of APP, were determined using NMR spectroscopy. The C-terminal PID domain of Fe65L1 alone exhibits a canonical PID/PTB fold, whereas the complex structure reveals a novel mode of peptide binding. In the complex structure, the NPTY motif forms a type-I beta-turn, and the residues immediately N-terminal to the NPTY motif form an antiparallel beta-sheet with the beta 5 strand of the PID domain, the binding mode typically observed in the PID/PTB center dot peptide complex. On the other hand, the N-terminal region of the peptide forms a 2.5- turn alpha-helix and interacts extensively with the C-terminal alpha-helix and the peripheral regions of the PID domain, representing a novel mode of peptide binding that has not been reported previously for the PID/PTB center dot peptide complex. The indispensability of the N-terminal region of the peptide for the high affinity of the PID-peptide interaction is consistent with NMR titration and isothermal calorimetry data. The extensive binding features of the PID domain of Fe65L1 with the cytoplasmic domain of APP provide a framework for further understanding of the function, trafficking, and processing of APP modulated by adapter proteins.	[Li, Hua; Koshiba, Seizo; Hayashi, Fumiaki; Tochio, Naoya; Tomizawa, Tadashi; Kasai, Takuma; Yabuki, Takashi; Motoda, Yoko; Harada, Takushi; Watanabe, Satoru; Inoue, Makoto; Tanaka, Akiko; Kigawa, Takanori; Yokoyama, Shigeyuki] RIKEN, Yokohama Inst, Syst & Struct Biol Ctr, Yokohama, Kanagawa 2300045, Japan; [Hayashizaki, Yoshihide] RIKEN, Yokohama Inst, Om Sci Ctr, Yokohama, Kanagawa 2300045, Japan; [Kigawa, Takanori] Tokyo Inst Technol, Interdisciplinary Grad Sch Sci & Engn, Dept Computat Intelligence & Syst Sci, Midori Ku, Yokohama, Kanagawa 2268502, Japan; [Yokoyama, Shigeyuki] Univ Tokyo, Grad Sch Sci, Dept Biophys & Biochem, Bunkyo Ku, Tokyo 1130033, Japan	RIKEN; RIKEN; Tokyo Institute of Technology; University of Tokyo	Kigawa, T (corresponding author), RIKEN, Yokohama Inst, Syst & Struct Biol Ctr, 1-7-22 Suehiro Cho, Yokohama, Kanagawa 2300045, Japan.	kigawa@jota.gsc.riken.jp; yokoyama@biochem.s.u-tokyo.ac.jp	Kigawa, Takanori/A-7679-2010; Hayashizaki, Yoshihide/N-6590-2015; watanabe, satoru s/E-9501-2012; Yokoyama, Shigeyuki/N-6911-2015	Kigawa, Takanori/0000-0003-0146-9719; watanabe, satoru s/0000-0001-5329-9278; Yokoyama, Shigeyuki/0000-0003-3133-7338; Kasai, Takuma/0000-0002-0089-533X	RIKEN Structural Genomics/Proteomics Initiative of the National Project on Protein Structural and Functional Analyses, Ministry of Education, Culture, Sports, Science and Technology of Japan	RIKEN Structural Genomics/Proteomics Initiative of the National Project on Protein Structural and Functional Analyses, Ministry of Education, Culture, Sports, Science and Technology of Japan	This work was supported by the RIKEN Structural Genomics/Proteomics Initiative of the National Project on Protein Structural and Functional Analyses, Ministry of Education, Culture, Sports, Science and Technology of Japan. The costs of publication of this article were defrayed in part by the payment of page charges. This article must therefore be hereby marked "advertisement" in accordance with 18 U. S. C. Section 1734 solely to indicate this fact.	Ando K, 2001, J BIOL CHEM, V276, P40353, DOI 10.1074/jbc.M104059200; Ayed A, 2001, NAT STRUCT BIOL, V8, P756, DOI 10.1038/nsb0901-756; BAX A, 1994, CURR OPIN STRUC BIOL, V4, P738, DOI 10.1016/S0959-440X(94)90173-2; Borg JP, 1996, MOL CELL BIOL, V16, P6229; Chang Y, 2003, J BIOL CHEM, V278, P51100, DOI 10.1074/jbc.M309561200; Chow NW, 1996, J BIOL CHEM, V271, P11339, DOI 10.1074/jbc.271.19.11339; Cornilescu G, 1999, J BIOMOL NMR, V13, P289, DOI 10.1023/A:1008392405740; DELAGLIO F, 1995, J BIOMOL NMR, V6, P277, DOI 10.1007/BF00197809; DeLano W.L, PYMOL MOL GRAPHICS S; Dhalluin C, 2000, MOL CELL, V6, P921, DOI 10.1016/S1097-2765(00)00089-7; DUILIO A, 1991, NUCLEIC ACIDS RES, V19, P5269, DOI 10.1093/nar/19.19.5269; Duilio A, 1998, BIOCHEM J, V330, P513, DOI 10.1042/bj3300513; Fiore F, 1995, J BIOL CHEM, V270, P30853, DOI 10.1074/jbc.270.52.30853; Geyer JP, 2005, J MOL BIOL, V348, P711, DOI 10.1016/j.jmb.2005.02.033; Guenette SY, 1996, P NATL ACAD SCI USA, V93, P10832, DOI 10.1073/pnas.93.20.10832; Guenette SY, 1999, J NEUROCHEM, V73, P985, DOI 10.1046/j.1471-4159.1999.0730985.x; Guntert P, 1997, J MOL BIOL, V273, P283, DOI 10.1006/jmbi.1997.1284; Guntert Peter, 2004, Methods Mol Biol, V278, P353; Herrmann T, 2002, J MOL BIOL, V319, P209, DOI 10.1016/S0022-2836(02)00241-3; Homayouni R, 1999, J NEUROSCI, V19, P7507, DOI 10.1523/JNEUROSCI.19-17-07507.1999; Howell BW, 1999, MOL CELL BIOL, V19, P5179; Inomata H, 2003, J BIOL CHEM, V278, P22946, DOI 10.1074/jbc.M212160200; Iwahara J, 2001, J BIOMOL NMR, V19, P231, DOI 10.1023/A:1011296112710; Jee JunGoo, 2003, Journal of Structural and Functional Genomics, V4, P179, DOI 10.1023/A:1026122726574; JOHNSON BA, 1994, J BIOMOL NMR, V4, P603, DOI 10.1007/BF00404272; Johnson Bruce A, 2004, Methods Mol Biol, V278, P313; Kawai J, 2001, NATURE, V409, P685, DOI 10.1038/35055500; Kigawa T, 1999, FEBS LETT, V442, P15, DOI 10.1016/S0014-5793(98)01620-2; Kigawa Takanori, 2004, Journal of Structural and Functional Genomics, V5, P63, DOI 10.1023/B:JSFG.0000029204.57846.7d; Kobayashi N, 2007, J BIOMOL NMR, V39, P31, DOI 10.1007/s10858-007-9175-5; Koradi R, 1996, J MOL GRAPHICS, V14, P51, DOI 10.1016/0263-7855(96)00009-4; Laskowski RA, 1996, J BIOMOL NMR, V8, P477, DOI 10.1007/BF00228148; Lau KF, 2000, NEUROREPORT, V11, P3607, DOI 10.1097/00001756-200011090-00041; Li SC, 1998, NAT STRUCT BIOL, V5, P1075, DOI 10.1038/4185; Matsuda T, 2007, J BIOMOL NMR, V37, P225, DOI 10.1007/s10858-006-9127-5; McLoughlin DM, 1996, FEBS LETT, V397, P197; NISHIMOTO I, 1993, NATURE, V362, P75, DOI 10.1038/362075a0; Okazaki Y, 2002, NATURE, V420, P563, DOI 10.1038/nature01266; Perez RG, 1999, J BIOL CHEM, V274, P18851, DOI 10.1074/jbc.274.27.18851; Ramelot TA, 2000, BIOCHEMISTRY-US, V39, P2714, DOI 10.1021/bi992580m; Russo T, 1998, FEBS LETT, V434, P1, DOI 10.1016/S0014-5793(98)00941-7; Sabo SL, 1999, J BIOL CHEM, V274, P7952, DOI 10.1074/jbc.274.12.7952; Scheinfeld MH, 2002, J BIOL CHEM, V277, P3767, DOI 10.1074/jbc.M108357200; Selkoe DJ, 2001, PHYSIOL REV, V81, P741, DOI 10.1152/physrev.2001.81.2.741; SIMEONE A, 1994, DEV NEUROSCI-BASEL, V16, P53, DOI 10.1159/000112088; Uhlik MT, 2005, J MOL BIOL, V345, P1, DOI 10.1016/j.jmb.2004.10.038; WALLACE AC, 1995, PROTEIN ENG, V8, P127, DOI 10.1093/protein/8.2.127; Wegener KL, 2007, CELL, V128, P171, DOI 10.1016/j.cell.2006.10.048; Yun M, 2003, J BIOL CHEM, V278, P36572, DOI 10.1074/jbc.M304384200; Zambrano N, 1997, J BIOL CHEM, V272, P6399, DOI 10.1074/jbc.272.10.6399; Zhang ZT, 1997, EMBO J, V16, P6141, DOI 10.1093/emboj/16.20.6141; Zheng PZ, 1998, P NATL ACAD SCI USA, V95, P14745, DOI 10.1073/pnas.95.25.14745; Zhou MM, 1996, NAT STRUCT BIOL, V3, P388, DOI 10.1038/nsb0496-388; Zwahlen C, 1997, J AM CHEM SOC, V119, P6711, DOI 10.1021/ja970224q	54	26	26	0	4	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	OCT 3	2008	283	40					27165	27178		10.1074/jbc.M803892200	http://dx.doi.org/10.1074/jbc.M803892200			14	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	353RT	18650440	hybrid			2022-12-27	WOS:000259586600037
J	Caunt, CJ; Armstrong, SP; Rivers, CA; Norman, MR; McArdle, CA				Caunt, Christopher J.; Armstrong, Stephen P.; Rivers, Caroline A.; Norman, Michael R.; McArdle, Craig A.			Spatiotemporal regulation of ERK2 by dual specificity phosphatases	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ACTIVATED PROTEIN-KINASE; OF-FUNCTION MUTATION; EARLY GENE-PRODUCTS; MAP KINASE; CELL-CYCLE; IN-VIVO; DIFFERENTIAL REGULATION; TYROSINE PHOSPHATASES; NUCLEAR TRANSLOCATION; MOLECULAR-CLONING	Although many stimuli activate extracellular signal-regulated kinases 1 and 2 (ERK1/2), the kinetics and compartmentalization of ERK1/2 signals are stimulus-dependent and dictate physiological consequences. ERKscan be inactivated by dual specificity phosphatases (DUSPs), notably the MAPK phosphatases (MKPs) and atypical DUSPs, that can both dephosphorylate and scaffold ERK1/2. Using a cell imaging model (based on knockdown of endogenous ERKs and add-back of wild-type or mutated ERK2-GFP reporters), we explored possible effects of DUSPs on responses to transient or sustained ERK2 activators (epidermal growth factor and phorbol 12,13-dibutyrate, respectively). For both stimuli, a D319N mutation (which impairs DUSP binding) increased ERK2 activity and reduced nuclear accumulation. These stimuli also increased mRNA levels for eight DUSPs. In a short inhibitory RNA screen, 12 of 16 DUSPs influenced ERK2 responses. These effects were evident among nuclear inducible MKP, cytoplasmic ERK MKP, JNK/p38 MKP, and atypical DUSP subtypes and, with the exception of the nuclear inducible MKPs, were paralleled by corresponding changes in Egr-1 luciferase activation. Simultaneous removal of all JNK/p38 MKPs or nuclear inducible MKPs revealed them as positive and negative regulators of ERK2 signaling, respectively. The effects of JNK/p38 MKP short inhibitory RNAs were not dependent on protein neosynthesis but were reversed in the presence of JNK and p38 kinase inhibitors, indicating DUSP-mediated cross-talk between MAPK pathways. Overall, our data reveal that a large number of DUSPs influence ERK2 signaling. Together with the known tissue-specific expression of DUSPs and the importance of ERK1/2 in cell regulation, our data support the potential value of DUSPs as targets for drug therapy.	[Caunt, Christopher J.; Armstrong, Stephen P.; Rivers, Caroline A.; Norman, Michael R.; McArdle, Craig A.] Univ Bristol, Dept Clin Sci S Bristol, Labs Integrated Neurosci & Endocrinol, Bristol BS1 3NY, Avon, England	University of Bristol	McArdle, CA (corresponding author), Univ Bristol, Dept Clin Sci S Bristol, Labs Integrated Neurosci & Endocrinol, Whitson St, Bristol BS1 3NY, Avon, England.	craig.mcardle@bris.ac.uk	McArdle, Craig/AAQ-5660-2021	McArdle, Craig/0000-0003-4836-5351	Wellcome Trust Project and Equipment [062918, 076557, 078407]	Wellcome Trust Project and Equipment(Wellcome Trust)	This work was supported by Wellcome Trust Project and Equipment Grants 062918, 076557, and 078407. The costs of publication of this article were defrayed in part by the payment of page charges. This article must therefore be hereby marked "advertisement" in accordance with 18 U. S. C. Section 1734 solely to indicate this fact.	ALESSI DR, 1993, ONCOGENE, V8, P2015; Alonso A, 2004, CELL, V117, P699, DOI 10.1016/j.cell.2004.05.018; Anderson RD, 2000, GENE THER, V7, P1034, DOI 10.1038/sj.gt.3301197; Aoyama K, 2001, J BIOL CHEM, V276, P27575, DOI 10.1074/jbc.M100408200; BOTT CM, 1994, FEBS LETT, V352, P201, DOI 10.1016/0014-5793(94)00958-9; Brunet A, 1999, EMBO J, V18, P664, DOI 10.1093/emboj/18.3.664; BRUNNER D, 1994, CELL, V76, P875, DOI 10.1016/0092-8674(94)90362-X; Caunt CJ, 2008, J BIOL CHEM, V283, P6241, DOI 10.1074/jbc.M706624200; Caunt CJ, 2006, TRENDS ENDOCRIN MET, V17, P276, DOI 10.1016/j.tem.2006.07.008; Caunt CJ, 2006, J BIOL CHEM, V281, P2701, DOI 10.1074/jbc.M507242200; Chen AJ, 2002, J BIOL CHEM, V277, P36592, DOI 10.1074/jbc.M200453200; CHEN RH, 1992, MOL CELL BIOL, V12, P915, DOI 10.1128/MCB.12.3.915; Chu YF, 1996, J BIOL CHEM, V271, P6497, DOI 10.1074/jbc.271.11.6497; Cohen DM, 1996, J BIOL CHEM, V271, P12903, DOI 10.1074/jbc.271.22.12903; Cook SJ, 1999, MOL CELL BIOL, V19, P330; Dimitri CA, 2005, CURR BIOL, V15, P1319, DOI 10.1016/j.cub.2005.06.037; Dowd S, 1998, J CELL SCI, V111, P3389; Ebisuya M, 2005, J CELL SCI, V118, P2997, DOI 10.1242/jcs.02505; Groom LA, 1996, EMBO J, V15, P3621, DOI 10.1002/j.1460-2075.1996.tb00731.x; Jeffrey KL, 2007, NAT REV DRUG DISCOV, V6, P391, DOI 10.1038/nrd2289; Jeffrey KL, 2006, NAT IMMUNOL, V7, P274, DOI 10.1038/ni1310; Lazo JS, 2006, BIOORGAN MED CHEM, V14, P5643, DOI 10.1016/j.bmc.2006.04.036; LENORMAND P, 1993, J CELL BIOL, V122, P1079, DOI 10.1083/jcb.122.5.1079; MacKeigan JP, 2005, NAT CELL BIOL, V7, P591, DOI 10.1038/ncb1258; Mandl M, 2005, MOL CELL BIOL, V25, P1830, DOI 10.1128/MCB.25.5.1830-1845.2005; Muda M, 1996, J BIOL CHEM, V271, P27205, DOI 10.1074/jbc.271.44.27205; Muda M, 1997, J BIOL CHEM, V272, P5141, DOI 10.1074/jbc.272.8.5141; Murphy LO, 2006, TRENDS BIOCHEM SCI, V31, P268, DOI 10.1016/j.tibs.2006.03.009; Murphy LO, 2002, NAT CELL BIOL, V4, P556, DOI 10.1038/ncb822; Murphy LO, 2004, MOL CELL BIOL, V24, P144, DOI 10.1128/MCB.24.1.144-153.2004; Owens DM, 2007, ONCOGENE, V26, P3203, DOI 10.1038/sj.onc.1210412; Rahmouni S, 2006, NAT CELL BIOL, V8, P524, DOI 10.1038/ncb1398; ROHAN PJ, 1993, SCIENCE, V259, P1763, DOI 10.1126/science.7681221; Shen YH, 2003, J BIOL CHEM, V278, P26715, DOI 10.1074/jbc.M303264200; Tanoue T, 2002, J BIOL CHEM, V277, P22942, DOI 10.1074/jbc.M202096200; Tanoue T, 2001, J BIOL CHEM, V276, P26629, DOI 10.1074/jbc.M101981200; Tanoue T, 2000, NAT CELL BIOL, V2, P110, DOI 10.1038/35000065; Theodosiou A, 1999, ONCOGENE, V18, P6981, DOI 10.1038/sj.onc.1203185; Todd JL, 1999, J BIOL CHEM, V274, P13271, DOI 10.1074/jbc.274.19.13271; Tonks NK, 2006, NAT REV MOL CELL BIO, V7, P833, DOI 10.1038/nrm2039; Usui T, 2001, CHEM BIOL, V8, P1209, DOI 10.1016/S1074-5521(01)00089-8; Vogt A, 2005, J BIOL CHEM, V280, P19078, DOI 10.1074/jbc.M501467200; Vogt A, 2003, CHEM BIOL, V10, P733, DOI 10.1016/S1074-5521(03)00170-4; Volmat V, 2001, J CELL SCI, V114, P3433; Wu Q, 2006, FRONT BIOSCI-LANDMRK, V11, P2714, DOI 10.2741/2001; Yamamoto T, 2006, CURR BIOL, V16, P1171, DOI 10.1016/j.cub.2006.04.044	46	70	71	0	4	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	SEP 26	2008	283	39					26612	26623		10.1074/jbc.M801500200	http://dx.doi.org/10.1074/jbc.M801500200			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	350GV	18650424	Green Published, hybrid			2022-12-27	WOS:000259341600037
J	Nagaoka, M; Hagiwara, Y; Takemura, K; Murakami, Y; Li, JX; Duncan, SA; Akaike, T				Nagaoka, Masato; Hagiwara, Yuko; Takemura, Keiko; Murakami, Yuta; Li, Jixuan; Duncan, Stephen A.; Akaike, Toshihiro			Design of the artificial acellular feeder layer for the efficient propagation of mouse embryonic stem cells	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							LEUKEMIA-INHIBITORY FACTOR; SELF-RENEWAL; ES CELLS; CELLULAR-RESPONSES; FACTOR-RECEPTOR; FACTOR LIF; EXPRESSION; PLURIPOTENCY; DIFFERENTIATION; CULTURE	Embryonic stem (ES) cells are pluripotent-undifferentiated cells that have a great interest for the investigation of developmental biology. Murine ES cells maintain their pluripotency by the supplementation of the leukemia inhibitory factor (LIF). LIF is reported to act as a matrix-anchored form, and immobilized cytokines are useful to sustain their signaling on target cells. In this study, we used the immobilizable fusion protein composed of LIF and IgG-Fc region, which was used as a model of the matrix-anchored form of LIF to establish a novel system for ES cell culture and to investigate the effect of immobilized LIF on maintenance of ES cell pluripotency. Mouse ES cells maintained their undifferentiated state on the surface coated with LIF-Fc. Furthermore, when cultured on the co-immobilized surface with LIF-Fc and E-cadherin-Fc, mouse ES cells showed characteristic scattering morphologies without colony formation, and they could maintain their undifferentiated state and pluripotency without additional LIF supplementation. The activation of LIF signaling was sustained on the co-immobilized surface. These results indicate that immobilized LIF and E-cadherin can maintain mouse ES cells efficiently and that the immobilizable LIF-Fc fusion protein is useful for the investigation of signaling pathways of an immobilized form of LIF in the maintenance of ES cell pluripotency.	[Hagiwara, Yuko; Takemura, Keiko; Murakami, Yuta; Akaike, Toshihiro] Tokyo Inst Technol, Dept Biomol Engn, Grad Sch Biosci & Biotechnol, Midori Ku, Yokohama, Kanagawa 2268501, Japan; [Nagaoka, Masato; Li, Jixuan; Duncan, Stephen A.] Med Coll Wisconsin, Dept Cell Biol Neurobiol & Anat, Milwaukee, WI 53226 USA	Tokyo Institute of Technology; Medical College of Wisconsin	Akaike, T (corresponding author), Tokyo Inst Technol, Dept Biomol Engn, Grad Sch Biosci & Biotechnol, Midori Ku, 4259-B-57 Nagatsuta Cho, Yokohama, Kanagawa 2268501, Japan.	takaike@bio.titech.ac.jp	Nagaoka, Masato/GRF-5030-2022; Nagaoka, Masato/J-1551-2014	Duncan, Stephen/0000-0002-2507-7827	Ministry of Education, Culture, Sports, Science and Technology of Japan	Ministry of Education, Culture, Sports, Science and Technology of Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT))	This work was supported by a grant from the 21st Century Centers of Excellence Program and a grant-in-aid for Scientific Research from the Ministry of Education, Culture, Sports, Science and Technology of Japan. The costs of publication of this article were defrayed in part by the payment of page charges. This article must therefore be hereby marked "advertisement" in accordance with 18 U. S. C. Section 1734 solely to indicate this fact.	Alberti K, 2008, NAT METHODS, V5, P645, DOI 10.1038/nmeth.1222; Amit M, 2004, BIOL REPROD, V70, P837, DOI 10.1095/biolreprod.103.021147; BAUMANN H, 1989, J IMMUNOL, V143, P1163; Beattie GM, 2005, STEM CELLS, V23, P489, DOI 10.1634/stemcells.2004-0279; Bendall SC, 2007, NATURE, V448, P1015, DOI 10.1038/nature06027; Blanchard F, 2000, J BIOL CHEM, V275, P28793, DOI 10.1074/jbc.M003986200; Cetinkaya G, 2007, J BIOMED MATER RES A, V81A, P911, DOI 10.1002/jbm.a.31107; Chambers I, 2003, CELL, V113, P643, DOI 10.1016/S0092-8674(03)00392-1; Cui L, 2004, J HISTOCHEM CYTOCHEM, V52, P1447, DOI 10.1369/jhc.3A6241.2004; Davey RE, 2006, STEM CELLS, V24, P2538, DOI 10.1634/stemcells.2006-0216; Duncan SA, 1997, DEVELOPMENT, V124, P279; EVANS MJ, 1981, NATURE, V292, P154, DOI 10.1038/292154a0; FERRARA N, 1992, P NATL ACAD SCI USA, V89, P698, DOI 10.1073/pnas.89.2.698; GEARING DP, 1987, EMBO J, V6, P3995, DOI 10.1002/j.1460-2075.1987.tb02742.x; GRELL M, 1995, CELL, V83, P793, DOI 10.1016/0092-8674(95)90192-2; James D, 2005, DEVELOPMENT, V132, P1273, DOI 10.1242/dev.01706; Makino H, 2004, J BIOSCI BIOENG, V98, P374, DOI 10.1263/jbb.98.374; MARTIN GR, 1981, P NATL ACAD SCI-BIOL, V78, P7634, DOI 10.1073/pnas.78.12.7634; MEREAU A, 1993, J CELL BIOL, V122, P713, DOI 10.1083/jcb.122.3.713; METCALF D, 1988, LEUKEMIA, V2, P216; Mitsui K, 2003, CELL, V113, P631, DOI 10.1016/S0092-8674(03)00393-3; Nagaoka M, 2003, PROTEIN ENG, V16, P243, DOI 10.1093/proeng/gzg037; Nagaoka M, 2008, J CELL BIOCHEM, V103, P296, DOI 10.1002/jcb.21406; Nagaoka M, 2006, PLOS ONE, V1, DOI 10.1371/journal.pone.0000015; NAGY A, 1990, DEVELOPMENT, V110, P815; NAGY A, 1993, P NATL ACAD SCI USA, V90, P8424, DOI 10.1073/pnas.90.18.8424; Niwa H, 2000, NAT GENET, V24, P372, DOI 10.1038/74199; Niwa H, 2002, MOL CELL BIOL, V22, P1526, DOI 10.1128/MCB.22.5.1526-1536.2002; Ogawa K, 2004, GENES CELLS, V9, P471, DOI 10.1111/j.1356-9597.2004.00736.x; Ogiwara K, 2006, BIOCHEM BIOPH RES CO, V345, P255, DOI 10.1016/j.bbrc.2006.04.001; Qi XX, 2004, P NATL ACAD SCI USA, V101, P6027, DOI 10.1073/pnas.0401367101; RATHJEN PD, 1990, CELL, V62, P1105, DOI 10.1016/0092-8674(90)90387-T; ROGERS MB, 1991, DEVELOPMENT, V113, P815; Sato N, 2004, NAT MED, V10, P55, DOI 10.1038/nm979; Singh AB, 2004, J CELL SCI, V117, P1365, DOI 10.1242/jcs.01037; Singh AM, 2007, STEM CELLS, V25, P2534, DOI 10.1634/stemcells.2007-0126; Stewart MH, 2006, NAT METHODS, V3, P807, DOI 10.1038/nmeth939; Tanaka Y, 1998, P ASSOC AM PHYSICIAN, V110, P118; Xu CH, 2001, NAT BIOTECHNOL, V19, P971, DOI 10.1038/nbt1001-971; Ying QL, 2003, CELL, V115, P281, DOI 10.1016/S0092-8674(03)00847-X	40	27	30	0	6	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	SEP 26	2008	283	39					26468	26476		10.1074/jbc.M805037200	http://dx.doi.org/10.1074/jbc.M805037200			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	350GV	18614540	hybrid, Green Published			2022-12-27	WOS:000259341600022
J	Pless, O; Kowenz-Leutz, E; Knoblich, M; Lausen, J; Beyermann, M; Walsh, MJ; Leutz, A				Pless, Ole; Kowenz-Leutz, Elisabeth; Knoblich, Maria; Lausen, Joern; Beyermann, Michael; Walsh, Martin J.; Leutz, Achim			G9a-mediated lysine methylation alters the function of CCAAT/enhancer-binding protein-beta	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							C/EBP-BETA; IN-VITRO; HEPATOCYTE PROLIFERATION; SUBSTRATE-SPECIFICITY; P53 ACTIVITY; KINASE-A; NF-M; PHOSPHORYLATION; G9A; TRANSCRIPTION	The functional capacity of the transcriptional regulatory CCAAT/enhancer-binding protein-beta (C/EBP beta) is governed by protein interactions and post-translational protein modifications. In a proteome-wide interaction screen, the histone-lysine N-methyltransferase, H3 lysine 9-specific 3 (G9a), was found to directly interact with the C/EBP beta transactivation domain (TAD). Binding between G9a and C/EBP beta was confirmed by glutathione S-transferase pulldown and co-immunoprecipitation. Metabolic labeling showed that C/EBP beta is post-translationally modified by methylation in vivo. Aconserved lysine residue in the C/EBP beta TADserved as a substrate for G9a-mediated methylation. G9a, but not a methyltransferase-defective G9a mutant, abrogated the transactivation potential of wild type C/EBP beta. A C/EBP beta TAD mutant that contained a lysine-toalanine exchange was resistant to G9a-mediated inhibition. Moreover, the same mutation conferred super-activation of a chromatin-embedded, endogenous C/EBP beta target gene. Our data identify C/EBP beta as a direct substrate of G9a-mediated post-translational modification that alters the functional properties of C/EBP beta during gene regulation.	[Pless, Ole; Kowenz-Leutz, Elisabeth; Knoblich, Maria; Leutz, Achim] Humboldt Univ, Max Delbruck Ctr Mol Med, D-13125 Berlin, Germany; [Beyermann, Michael] Leibniz Inst Mol Pharmacol, D-13125 Berlin, Germany; [Lausen, Joern] Georg Speyer Haus, D-60596 Frankfurt, Germany; [Walsh, Martin J.] Mt Sinai Sch Med, Dept Pediat, New York, NY 10029 USA; [Walsh, Martin J.] Mt Sinai Sch Med, Dept Struct & Chem Biol, New York, NY 10029 USA	Helmholtz Association; Max Delbruck Center for Molecular Medicine; Humboldt University of Berlin; Leibniz Forschungsinstitut furr Molekulare Pharmakologie (FMP); Icahn School of Medicine at Mount Sinai; Icahn School of Medicine at Mount Sinai	Leutz, A (corresponding author), Humboldt Univ, Max Delbruck Ctr Mol Med, Robert Rossle Str 10, D-13125 Berlin, Germany.	aleutz@mdc-berlin.de	Pless, Ole/E-8348-2016; Leutz, Achim/K-9643-2013; Horstmann, Britta/C-2154-2008	Pless, Ole/0000-0002-1468-316X; Leutz, Achim/0000-0001-8259-927X; 				ALLFREY VG, 1964, P NATL ACAD SCI USA, V51, P786, DOI 10.1073/pnas.51.5.786; Berberich-Siebelt F, 2006, J IMMUNOL, V176, P4843, DOI 10.4049/jimmunol.176.8.4843; BEUG H, 1982, J CELL PHYSIOL, P195; Buck M, 1999, MOL CELL, V4, P1087, DOI 10.1016/S1097-2765(00)80237-3; Calkhoven CF, 2000, GENE DEV, V14, P1920; Cesena TI, 2007, J BIOL CHEM, V282, P956, DOI 10.1074/jbc.M511451200; Chen DH, 2004, J BIOCHEM, V136, P371, DOI 10.1093/jb/mvh131; Chin HG, 2007, NUCLEIC ACIDS RES, V35, P7313, DOI 10.1093/nar/gkm726; Chin HG, 2005, BIOCHEMISTRY-US, V44, P12998, DOI 10.1021/bi0509907; Chinery R, 1997, J BIOL CHEM, V272, P30356, DOI 10.1074/jbc.272.48.30356; Chuikov S, 2004, NATURE, V432, P353, DOI 10.1038/nature03117; Collins RE, 2005, J BIOL CHEM, V280, P5563, DOI 10.1074/jbc.M410483200; Collins RE, 2008, NAT STRUCT MOL BIOL, V15, P245, DOI 10.1038/nsmb.1384; COMB DG, 1966, J BIOL CHEM, V241, P1857; DESCOMBES P, 1991, CELL, V67, P569, DOI 10.1016/0092-8674(91)90531-3; Eaton EM, 2003, J BIOL CHEM, V278, P33416, DOI 10.1074/jbc.M305680200; Greenbaum LE, 1998, J CLIN INVEST, V102, P996, DOI 10.1172/JCI3135; Hanlon M, 2001, J BIOL CHEM, V276, P38449, DOI 10.1074/jbc.M102165200; Huang J, 2007, NATURE, V449, P105, DOI 10.1038/nature06092; Huang J, 2006, NATURE, V444, P629, DOI 10.1038/nature05287; Huq MDM, 2007, MOL CELL PROTEOMICS, V6, P677, DOI 10.1074/mcp.M600223-MCP200; Jenuwein T, 2001, SCIENCE, V293, P1074, DOI 10.1126/science.1063127; Joo M, 2004, J BIOL CHEM, V279, P6658, DOI 10.1074/jbc.M306267200; Kim J, 2002, J BIOL CHEM, V277, P38037, DOI 10.1074/jbc.M207235200; Kouskouti A, 2004, MOL CELL, V14, P175, DOI 10.1016/S1097-2765(04)00182-0; KOWENZLEUTZ E, 1994, GENE DEV, V8, P2781, DOI 10.1101/gad.8.22.2781; Lamb J, 2003, CELL, V114, P323, DOI 10.1016/S0092-8674(03)00570-1; Lausen J, 2006, ONCOGENE, V25, P1349, DOI 10.1038/sj.onc.1209181; Li X, 2007, P NATL ACAD SCI USA, V104, P11597, DOI 10.1073/pnas.0703771104; LIU Q, 1995, MOL CELL BIOL, V15, P2800; Mo XM, 2004, MOL CELL, V13, P241, DOI 10.1016/S1097-2765(03)00521-5; NAKAJIMA T, 1993, P NATL ACAD SCI USA, V90, P2207, DOI 10.1073/pnas.90.6.2207; Nishio H, 2004, P NATL ACAD SCI USA, V101, P11257, DOI 10.1073/pnas.0401343101; Nuchprayoon I, 1997, BLOOD, V89, P4546, DOI 10.1182/blood.V89.12.4546; Patnaik D, 2004, J BIOL CHEM, V279, P53248, DOI 10.1074/jbc.M409604200; Piwien-Pilipuk G, 2001, J BIOL CHEM, V276, P19664, DOI 10.1074/jbc.M010193200; Poli V, 1998, J BIOL CHEM, V273, P29279, DOI 10.1074/jbc.273.45.29279; Rea S, 2000, NATURE, V406, P593, DOI 10.1038/35020506; SADOWSKI I, 1989, NUCLEIC ACIDS RES, V17, P7539, DOI 10.1093/nar/17.18.7539; Sampath SC, 2007, MOL CELL, V27, P596, DOI 10.1016/j.molcel.2007.06.026; Screpanti I, 1996, J EXP MED, V184, P1561, DOI 10.1084/jem.184.4.1561; Shi XB, 2007, MOL CELL, V27, P636, DOI 10.1016/j.molcel.2007.07.012; Shuman JD, 2004, MOL CELL BIOL, V24, P7380, DOI 10.1128/MCB.24.17.7380-7391.2004; Sterneck E, 1997, GENE DEV, V11, P2153, DOI 10.1101/gad.11.17.2153; STERNECK E, 1992, MOL CELL BIOL, V12, P1728, DOI 10.1128/MCB.12.4.1728; STERNECK E, 1992, EMBO J, V11, P115, DOI 10.1002/j.1460-2075.1992.tb05034.x; Stewart MD, 2005, MOL CELL BIOL, V25, P2525, DOI 10.1128/MCB.25.7.2525-2538.2005; Subramanian L, 2003, J BIOL CHEM, V278, P9134, DOI 10.1074/jbc.M210440200; Tachibana M, 2002, GENE DEV, V16, P1779, DOI 10.1101/gad.989402; TANAKA T, 1995, CELL, V80, P353, DOI 10.1016/0092-8674(95)90418-2; TRAUTWEIN C, 1994, J CLIN INVEST, V93, P2554, DOI 10.1172/JCI117266; TRAUTWEIN C, 1993, NATURE, V364, P544, DOI 10.1038/364544a0; WEGNER M, 1992, SCIENCE, V256, P370, DOI 10.1126/science.256.5055.370; Weinmann AS, 2001, MOL CELL BIOL, V21, P6820, DOI 10.1128/MCB.21.20.6820-6832.2001; WILLIAMS SC, 1995, EMBO J, V14, P3170, DOI 10.1002/j.1460-2075.1995.tb07319.x; Xu M, 2003, EMBO J, V22, P893, DOI 10.1093/emboj/cdg094	56	71	74	0	4	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	SEP 26	2008	283	39					26357	26363		10.1074/jbc.M802132200	http://dx.doi.org/10.1074/jbc.M802132200			7	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	350GV	18647749	Green Published, hybrid			2022-12-27	WOS:000259341600009
J	Wu, SR; Haag, L; Sjoberg, M; Garoff, H; Hammar, L				Wu, Shang-Rung; Haag, Lars; Sjoberg, Mathilda; Garoff, Henrik; Hammar, Lena			The dynamic envelope of a fusion class II virus E3 - Domain of glycoprotein E2 precursor in semliki forest virus provides a unique contact with the fusion protein E1	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							MEMBRANE-FUSION; CRYOELECTRON MICROSCOPY; CONFORMATIONAL-CHANGE; SPIKE COMPLEX; OLIGOMERIZATION; ORGANIZATION; ACTIVATION; PH; ALPHAVIRUSES; MATURATION	In alphaviruses, here represented by Semliki Forest virus, infection requires an acid-responsive spike configuration to facilitate membrane fusion. The creation of this relies on the chaperon function of glycoprotein E2 precursor (p62) and its maturation cleavage into the small external E3 and the membrane-anchored E2 glycoproteins. To reveal how the E3 domain of p62 exerts its control of spike functions, we determine the structure of a p62 cleavage-impaired mutant virus particle (SQL) by electron cryomicroscopy. A comparison with the earlier solved wild type virus structure reveals that the E3 domain of p62(SQL) forms a bulky side protrusion in the spike head region. This establishes a gripper over part of domain II of the fusion protein, with a cotter-like connection downward to a hydrophobic cluster in its central beta-sheet. This finding reevaluates the role of the precursor from being only a provider of a shield over the fusion loop to a structural playmate in formation of the fusogenic architecture.	[Wu, Shang-Rung; Haag, Lars; Sjoberg, Mathilda; Garoff, Henrik; Hammar, Lena] Karolinska Inst, Dept Biosci & Nutr, SE-14157 Huddinge, Sweden	Karolinska Institutet	Wu, SR (corresponding author), Karolinska Inst, Dept Biosci & Nutr, SE-14157 Huddinge, Sweden.	Shang-Rung.Wu@ki.se		Sjoberg, Mathilda/0000-0002-7434-520X	Swedish Medical Research Council, European Union 6th Framework Program [512740]; Karolinska Institutet, Sweden	Swedish Medical Research Council, European Union 6th Framework Program(Swedish Medical Research Council (SMRC)); Karolinska Institutet, Sweden(Karolinska Institutet)	This work has been supported by Swedish Medical Research Council, European Union 6th Framework Program (Project 512740) and by The Swedish Knowledge Foundation together with Crystal Research AB (Lund, Sweden), through the Industrial Ph. D. program in Medical Bioinformatics (to S.-R. W.) at the Karolinska Institutet, Sweden. The costs of publication of this article were defrayed in part by the payment of page charges. This article must therefore be hereby marked "advertisement" in accordance with 18 U. S. C. Section 1734 solely to indicate this fact.	Andersson H, 1997, J VIROL, V71, P9654, DOI 10.1128/JVI.71.12.9654-9663.1997; Baker TS, 1996, J STRUCT BIOL, V116, P120, DOI 10.1006/jsbi.1996.0020; BARTH BU, 1995, J CELL BIOL, V128, P283, DOI 10.1083/jcb.128.3.283; BERGLUND P, 1993, BIO-TECHNOL, V11, P916, DOI 10.1038/nbt0893-916; BRON R, 1993, EMBO J, V12, P693, DOI 10.1002/j.1460-2075.1993.tb05703.x; CHENG RH, 1995, CELL, V80, P621; Ferlenghi I, 1998, J MOL BIOL, V283, P71, DOI 10.1006/jmbi.1998.2066; FULLER SD, 1995, CELL, V81, P715, DOI 10.1016/0092-8674(95)90533-2; GAROFF H, 1994, ARCH VIROL, P329; GAROFF H, 1990, J CELL BIOL, V111, P867, DOI 10.1083/jcb.111.3.867; Gibbons DL, 2000, J VIROL, V74, P7772, DOI 10.1128/JVI.74.17.7772-7780.2000; Gibbons DL, 2004, J VIROL, V78, P3514, DOI 10.1128/JVI.78.7.3514-3523.2004; Gibbons DL, 2003, CELL, V114, P573, DOI 10.1016/S0092-8674(03)00683-4; Gibbons DL, 2004, NATURE, V427, P320, DOI 10.1038/nature02239; GLASGOW GM, 1991, VIROLOGY, V185, P741, DOI 10.1016/0042-6822(91)90545-M; Glomb-Reinmund S, 1998, J VIROL, V72, P4281, DOI 10.1128/JVI.72.5.4281-4287.1998; Haag L, 2002, EMBO J, V21, P4402, DOI 10.1093/emboj/cdf442; HAAG L, 2006, THESIS KAROLINSKA I; Hammar L, 2003, J BIOL CHEM, V278, P7189, DOI 10.1074/jbc.M206015200; JAIN SK, 1991, J BIOL CHEM, V266, P5756; Kielian M, 2006, NAT REV MICROBIOL, V4, P67, DOI 10.1038/nrmicro1326; Kielian M, 2006, VIROLOGY, V344, P38, DOI 10.1016/j.virol.2005.09.036; KLIMJACK MR, 1994, J VIROL, V68, P6940, DOI 10.1128/JVI.68.11.6940-6946.1994; Lau WL, 2004, BIOPHYS J, V86, P272, DOI 10.1016/S0006-3495(04)74103-X; Lescar J, 2001, CELL, V105, P137, DOI 10.1016/S0092-8674(01)00303-8; LILJESTROM P, 1991, J VIROL, V65, P4107; LOBIGS M, 1990, J VIROL, V64, P5214, DOI 10.1128/JVI.64.10.5214-5218.1990; LOBIGS M, 1990, J VIROL, V6443, P46; Malashkevich VN, 2001, P NATL ACAD SCI USA, V98, P8502, DOI 10.1073/pnas.151254798; Mancini EJ, 2000, MOL CELL, V5, P255, DOI 10.1016/S1097-2765(00)80421-9; MAYNE JT, 1984, VIROLOGY, V134, P338, DOI 10.1016/0042-6822(84)90302-7; Mukhopadhyay S, 2006, STRUCTURE, V14, P63, DOI 10.1016/j.str.2005.07.025; Mulvey M, 1996, VIROLOGY, V219, P125, DOI 10.1006/viro.1996.0229; Paredes AM, 1998, J VIROL, V72, P1534, DOI 10.1128/JVI.72.2.1534-1541.1998; Pletnev SV, 2001, CELL, V105, P127, DOI 10.1016/S0092-8674(01)00302-6; REY FA, 1995, NATURE, V375, P291, DOI 10.1038/375291a0; Roussel A, 2006, STRUCTURE, V14, P75, DOI 10.1016/j.str.2005.09.014; SALMINEN A, 1992, J CELL BIOL, V116, P349, DOI 10.1083/jcb.116.2.349; SMITH TJ, 1995, P NATL ACAD SCI USA, V92, P10648, DOI 10.1073/pnas.92.23.10648; Tubulekas I, 1998, J VIROL, V72, P2825, DOI 10.1128/JVI.72.4.2825-2831.1998; VENIENBRYAN C, 1994, J MOL BIOL, V236, P572, DOI 10.1006/jmbi.1994.1166; WAHLBERG JM, 1992, J VIROL, V66, P7309, DOI 10.1128/JVI.66.12.7309-7318.1992; WHITE JM, 1997, STRUCTURAL BIOL VIRU, P80; Wu SR, 2007, J BIOL CHEM, V282, P6752, DOI 10.1074/jbc.M609125200; Zhang XY, 2003, J VIROL, V77, P2981, DOI 10.1128/JVI.77.5.2981-2989.2003	45	8	8	0	2	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	SEP 26	2008	283	39					26452	26460		10.1074/jbc.M801470200	http://dx.doi.org/10.1074/jbc.M801470200			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	350GV	18596032	Green Published, hybrid			2022-12-27	WOS:000259341600020
J	Bracamontes, JR; Steinbach, JH				Bracamontes, John R.; Steinbach, Joe Henry			Multiple modes for conferring surface expression of homomeric beta 1 GABA(A) receptors	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							RECEPTOR-BETA SUBUNITS; AMINOBUTYRIC ACID(A) RECEPTORS; LIGAND-BINDING DOMAIN; GABA(A) RECEPTORS; ION CHANNELS; A RECEPTORS; ALPHA-SUBUNITS; IDENTIFICATION; RESIDUES; PHARMACOLOGY	The gamma-aminobutyric acid typeA (GABA(A)) receptor assembles from individual subunits to form ligand-gated ion channels. Human (h) beta 3 subunits assemble to form homomeric surface receptors in somatic cells, but h beta 1 subunits do not. We have identified three distinct sets of amino acid residues in the N-terminal extracellular domain of the h beta 1 subunit, which when mutated to the homologous residue in h beta 3 allow expression as a functional homomeric receptor. The three sets likely result in three modes of assembly. Mode 1 expression results from a single amino acid change at residue h beta 1 Asp-37. Mode 2 expression results from mutations of residues between positions 44 and 73 together with residues between positions 169 and 173. Finally, mode 3 results from the mutations A45V and K196R. Examination of homology-based structural models indicates that many of the residues are unlikely to be involved in physical inter-subunit interactions, suggesting that a major alteration is stabilization of an assembly competent form of the subunit. These mutations do not, however, have a major effect on the surface expression of heteromeric receptors which include the alpha 1 subunit.	[Bracamontes, John R.; Steinbach, Joe Henry] Washington Univ, Sch Med, Dept Anaesthesiol, St Louis, MO 63110 USA	Washington University (WUSTL)	Bracamontes, JR (corresponding author), Washington Univ, Sch Med, Dept Anaesthesiol, 660 S Euclid Ave,Campus Box 8054, St Louis, MO 63110 USA.	john@morpheus.wustl.edu			National Institutes of Health [P01 GM47969, NS22356]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [P01GM047969] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS022356] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	This work was supported, in whole or in part, by National Institutes of Health Grants P01 GM47969 and NS22356. The costs of publication of this article were defrayed in part by the payment of page charges. This article must therefore be hereby marked "advertisement" in accordance with 18 U.S.C. Section 1734 solely to indicate this fact.	Amin J, 1996, P ROY SOC B-BIOL SCI, V263, P273, DOI 10.1098/rspb.1996.0042; ANGELOTTI TP, 1993, J NEUROSCI, V13, P1429; AUSUBEL FM, 1992, SHORT PROTOCOLS MOL, P9; BLAIR LAC, 1988, SCIENCE, V242, P577, DOI 10.1126/science.2845583; Bollan K, 2003, J BIOL CHEM, V278, P4747, DOI 10.1074/jbc.M210229200; Bonnert TP, 1999, P NATL ACAD SCI USA, V96, P9891, DOI 10.1073/pnas.96.17.9891; Brejc K, 2001, NATURE, V411, P269, DOI 10.1038/35077011; Cestari IN, 2000, J NEUROCHEM, V74, P827, DOI 10.1046/j.1471-4159.2000.740827.x; Connolly CN, 1996, J BIOL CHEM, V271, P89, DOI 10.1074/jbc.271.1.89; Connolly CN, 1996, P NATL ACAD SCI USA, V93, P9899, DOI 10.1073/pnas.93.18.9899; Cromer BA, 2002, TRENDS BIOCHEM SCI, V27, P280, DOI 10.1016/S0968-0004(02)02092-3; Darbandi-Tonkabon R, 2003, J BIOL CHEM, V278, P13196, DOI 10.1074/jbc.M213168200; Davies PA, 1997, NATURE, V385, P820, DOI 10.1038/385820a0; Ehya N, 2003, J NEUROCHEM, V84, P127, DOI 10.1046/j.1471-4159.2003.01509.x; Enz R, 1999, BRAIN RES, V846, P177, DOI 10.1016/S0006-8993(99)02008-9; Enz R, 1998, VISION RES, V38, P1431, DOI 10.1016/S0042-6989(97)00277-0; Griffon N, 1999, EMBO J, V18, P4711, DOI 10.1093/emboj/18.17.4711; HADINGHAM KL, 1993, MOL PHARMACOL, V43, P970; Karlin A, 1995, NEURON, V15, P1231, DOI 10.1016/0896-6273(95)90004-7; Klausberger T, 2000, J BIOL CHEM, V275, P8921, DOI 10.1074/jbc.275.12.8921; Krishek BJ, 1996, MOL PHARMACOL, V49, P494; Li P, 2006, MOL PHARMACOL, V69, P2015, DOI 10.1124/mol.106.022590; MACDONALD RL, 1994, ANNU REV NEUROSCI, V17, P569, DOI 10.1146/annurev.neuro.17.1.569; McCann CM, 2006, P NATL ACAD SCI USA, V103, P5149, DOI 10.1073/pnas.0600847103; ORTELLS MO, 1995, TRENDS NEUROSCI, V18, P121, DOI 10.1016/0166-2236(95)93887-4; SANNA E, 1995, MOL PHARMACOL, V47, P213; Sarto I, 2002, J BIOL CHEM, V277, P30656, DOI 10.1074/jbc.M203597200; Sarto I, 2002, NEUROPHARMACOLOGY, V43, P482, DOI 10.1016/S0028-3908(02)00160-0; Sarto-Jackson I, 2006, J NEUROCHEM, V96, P983, DOI 10.1111/j.1471-4159.2005.03626.x; Serafini R, 2000, J PHYSIOL-LONDON, V524, P649, DOI 10.1111/j.1469-7793.2000.00649.x; Sieghart W, 1999, NEUROCHEM INT, V34, P379, DOI 10.1016/S0197-0186(99)00045-5; Sine SM, 2002, J BIOL CHEM, V277, P29210, DOI 10.1074/jbc.M203396200; Srinivasan S, 1999, J BIOL CHEM, V274, P26633, DOI 10.1074/jbc.274.38.26633; Taylor PM, 2000, J NEUROSCI, V20, P1297; Taylor PM, 1999, J NEUROSCI, V19, P6360; Ueno S, 1996, MOL PHARMACOL, V50, P931; WAGSTAFF J, 1991, GENOMICS, V11, P1071, DOI 10.1016/0888-7543(91)90034-C; Xue H, 2000, J MOL BIOL, V296, P739, DOI 10.1006/jmbi.2000.3502	38	9	9	0	1	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	SEP 19	2008	283	38					26128	26136		10.1074/jbc.M801292200	http://dx.doi.org/10.1074/jbc.M801292200			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	348GX	18650446	hybrid, Green Published			2022-12-27	WOS:000259200100041
J	Bailleul, B; Johnson, X; Finazzi, G; Barber, J; Rappaport, F; Telfer, A				Bailleul, Benjamin; Johnson, Xenie; Finazzi, Giovanni; Barber, James; Rappaport, Fabrice; Telfer, Alison			The thermodynamics and kinetics of electron transfer between cytochrome b(6)f and photosystem I in the chlorophyll d-dominated cyanobacterium, Acaryochloris marina	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							OXYGENIC PHOTOSYNTHETIC PROKARYOTE; CHLAMYDOMONAS-REINHARDTII; REACTION CENTERS; PLASTOQUINONE COMPARTMENTATION; HELIOBACILLUS-MOBILIS; SPINACH-CHLOROPLASTS; LA PHOTOSYNTHESE; ENERGY-TRANSFER; RED ALGAE; FLUORESCENCE	We have investigated the photosynthetic properties of Acaryochloris marina, a cyanobacterium distinguished by having a high level of chlorophyll d, which has its absorption bands shifted to the red when compared with chlorophyll a. Despite this unusual pigment content, the overall rate and thermodynamics of the photosynthetic electron flow are similar to those of chlorophyll a-containing species. The midpoint potential of both cytochrome f and the primary electron donor of photosystem I (P-740) were found to be unchanged with respect to those prevailing in organisms having chlorophyll a, being 345 and 425 mV, respectively. Thus, contrary to previous reports (Hu, Q., Miyashita, H., Iwasaki, I. I., Kurano, N., Miyachi, S., Iwaki, M., and Itoh, S. (1998) Proc. Natl. Acad. Sci. U. S. A. 95, 13319 - 13323), the midpoint potential of the electron donor P740 has not been tuned to compensate for the decrease in excitonic energy in A. marina and to maintain the reducing power of photosystem I. We argue that this is a weaker constraint on the engineering of the oxygenic photosynthetic electron transfer chain than preserving the driving force for plastoquinol oxidation by P-740, via the cytochrome b(6)f complex. We further show that there is no restriction in the diffusion of the soluble electron carrier between cytochrome b(6)f and photosystem I in A. marina, at variance with plants. This difference probably reflects the simplified ultrastructure of the thylakoids of this organism, where no segregation into grana and stroma lamellae is observed. Nevertheless, chlorophyll fluorescence measurements suggest that there is energy transfer between adjacent photosystem II complexes but not from photosystem II to photosystem I, indicating spatial separation between the two photosystems.	[Bailleul, Benjamin; Johnson, Xenie; Finazzi, Giovanni; Rappaport, Fabrice] Univ Paris 06, CNRS, Inst Biol Physicochim, UMR 7141, F-75005 Paris, France; [Barber, James; Telfer, Alison] Univ London Imperial Coll Sci Technol & Med, Div Mol Biosci, London SW7 2AZ, England	Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Biology (INSB); UDICE-French Research Universities; Sorbonne Universite; Imperial College London	Rappaport, F (corresponding author), Univ Paris 06, CNRS, Inst Biol Physicochim, UMR 7141, 13 Rue Pierre & Marie Curie, F-75005 Paris, France.	Fabrice.Rappaport@ibpc.fr; a.telfer@imperial.ac.uk	Johnson, Xenie/T-7151-2019	Johnson, Xenie/0000-0003-3424-7047; Rappaport, Fabrice/0000-0001-9377-4934	Biotechnology and Biological Science Research Council, United Kingdom; CNRS; Universite Pierre et marie Curie, Paris 6	Biotechnology and Biological Science Research Council, United Kingdom(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); CNRS(Centre National de la Recherche Scientifique (CNRS)); Universite Pierre et marie Curie, Paris 6	This work was supported by the Biotechnology and Biological Science Research Council, United Kingdom, and by CNRS and Universite Pierre et marie Curie, Paris 6. The costs of publication of this article were defrayed in part by the payment of page charges. This article must therefore be hereby marked "advertisement" in accordance with 18 U. S. C. Section 1734 solely to indicate this fact.	AIBA H, 1981, J BIOL CHEM, V256, P1905; ALBERTSSON PA, 1991, BIOCHIM BIOPHYS ACTA, V1098, P90; ALBERTSSON PA, 1988, Q REV BIOPHYS, V21, P61, DOI 10.1017/S0033583500005023; Alric J, 2005, P NATL ACAD SCI USA, V102, P15860, DOI 10.1073/pnas.0508102102; Baymann F, 2001, BIOCHEMISTRY-US, V40, P10570, DOI 10.1021/bi010194a; Beal D, 1999, REV SCI INSTRUM, V70, P202, DOI 10.1063/1.1149566; BIGGINS J, 1989, PHOTOSYNTH RES, V20, P1, DOI 10.1007/BF00028620; BLANKENSHIP RE, 1992, PHOTOSYNTH RES, V33, P91, DOI 10.1007/BF00039173; Boichenko VA, 2000, PHOTOSYNTH RES, V65, P269, DOI 10.1023/A:1010637631417; BUTLER WL, 1978, ANNU REV PLANT PHYS, V29, P345, DOI 10.1146/annurev.pp.29.060178.002021; Campbell D, 1998, MICROBIOL MOL BIOL R, V62, P667, DOI 10.1128/MMBR.62.3.667-683.1998; Chen M, 2005, FEBS LETT, V579, P1306, DOI 10.1016/j.febslet.2005.01.023; Chen M, 2002, FEBS LETT, V514, P149, DOI 10.1016/S0014-5793(02)02315-3; DELOSME R, 1959, CR HEBD ACAD SCI, V249, P1409; Finazzi G, 1999, BBA-BIOENERGETICS, V1413, P117, DOI 10.1016/S0005-2728(99)00089-4; GENTY B, 1989, BIOCHIM BIOPHYS ACTA, V990, P87, DOI 10.1016/S0304-4165(89)80016-9; Holzwarth AR, 2006, BIOPHYS J, V90, P552, DOI 10.1529/biophysj.105.059824; Hope AB, 2000, BBA-BIOENERGETICS, V1456, P5, DOI 10.1016/S0005-2728(99)00101-2; Hu Q, 1999, BBA-BIOENERGETICS, V1412, P250, DOI 10.1016/S0005-2728(99)00067-5; Hu Q, 1998, P NATL ACAD SCI USA, V95, P13319, DOI 10.1073/pnas.95.22.13319; HURT E, 1981, EUR J BIOCHEM, V117, P591; Itoh S, 2001, BBA-BIOENERGETICS, V1507, P115, DOI 10.1016/S0005-2728(01)00199-2; Itoh S, 2007, BIOCHEMISTRY-US, V46, P12473, DOI 10.1021/bi7008085; JOLIOT A, 1964, CR HEBD ACAD SCI, V258, P4622; JOLIOT P, 1992, BIOCHIM BIOPHYS ACTA, V1101, P1, DOI 10.1016/0167-4838(92)90460-U; KELLER MD, 1987, J PHYCOL, V23, P633; Kirchhoff H, 2004, BBA-BIOENERGETICS, V1659, P63, DOI 10.1016/j.bbabio.2004.08.004; KLEINHERENBRINK FAM, 1994, BIOCHEMISTRY-US, V33, P3096, DOI 10.1021/bi00176a044; Kobayashi M, 2007, BBA-BIOENERGETICS, V1767, P596, DOI 10.1016/j.bbabio.2007.02.015; KRAMER DM, 1994, BBA-BIOENERGETICS, V1184, P193, DOI 10.1016/0005-2728(94)90223-2; Kramer DM, 1997, BIOCHEMISTRY-US, V36, P4203, DOI 10.1021/bi962241i; Kuhl M, 2005, NATURE, V433, P820, DOI 10.1038/433820a; Kumazaki S, 2002, FEBS LETT, V530, P153, DOI 10.1016/S0014-5793(02)03446-4; LAVERGNE J, 1995, BIOPHYS J, V68, P2474, DOI 10.1016/S0006-3495(95)80429-7; LAVERGNE J, 1991, TRENDS BIOCHEM SCI, V16, P129, DOI 10.1016/0968-0004(91)90054-Y; LAVERGNE J, 1992, BIOCHIM BIOPHYS ACTA, V1101, P13, DOI 10.1016/0167-4838(92)90461-L; Li YJ, 2006, P NATL ACAD SCI USA, V103, P2144, DOI 10.1073/pnas.0506537103; Li YJ, 2004, BIOCHEMISTRY-US, V43, P12634, DOI 10.1021/bi036329p; Manning WM, 1943, J BIOL CHEM, V151, P1; Marquardt J, 1997, FEBS LETT, V410, P428, DOI 10.1016/S0014-5793(97)00631-5; Miller SR, 2005, P NATL ACAD SCI USA, V102, P850, DOI 10.1073/pnas.0405667102; Miyashita H, 1997, PLANT CELL PHYSIOL, V38, P274, DOI 10.1093/oxfordjournals.pcp.a029163; Miyashita H, 1996, NATURE, V383, P402, DOI 10.1038/383402a0; Murakami A, 2004, SCIENCE, V303, P1633, DOI 10.1126/science.1095459; Nakamura A, 2005, FEBS LETT, V579, P2273, DOI 10.1016/j.febslet.2005.02.076; NITSCHKE W, 1995, BIOCHEMISTRY-US, V34, P11831, DOI 10.1021/bi00037a022; OLIVE J, 1986, FEBS LETT, V208, P308, DOI 10.1016/0014-5793(86)81039-0; PETTIGREW GW, 1987, CYTOCHROMES C, P14; PIERRE Y, 1995, J BIOL CHEM, V270, P29342, DOI 10.1074/jbc.270.49.29342; Rappaport F, 2007, BBA-BIOENERGETICS, V1767, P56, DOI 10.1016/j.bbabio.2006.10.002; SCHENDERLEIN MC, 2007, 14 INT C PHOT RES, P215; Schiller H, 1997, FEBS LETT, V410, P433, DOI 10.1016/S0014-5793(97)00620-0; Schlodder E, 2007, BBA-BIOENERGETICS, V1767, P589, DOI 10.1016/j.bbabio.2007.02.018; Swingley WD, 2005, APPL ENVIRON MICROB, V71, P8606, DOI 10.1128/AEM.71.12.8606-8610.2005; Swingley WD, 2008, P NATL ACAD SCI USA, V105, P2005, DOI 10.1073/pnas.0709772105; Tomo T, 2008, J BIOL CHEM, V283, P18198, DOI 10.1074/jbc.M801805200; Trebst A., 1980, METH ENZYMOL, V69, P675, DOI DOI 10.1016/S0076-6879(80)69067-3; VOS MH, 1990, BIOPHYS J, V58, P1547, DOI 10.1016/S0006-3495(90)82499-1; Witt H, 2003, J BIOL CHEM, V278, P46760, DOI 10.1074/jbc.M304776200; WITT HT, 1979, BIOCHIM BIOPHYS ACTA, V505, P355, DOI 10.1016/0304-4173(79)90008-9	60	14	14	0	22	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	SEP 12	2008	283	37					25218	25226		10.1074/jbc.M803047200	http://dx.doi.org/10.1074/jbc.M803047200			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	345QZ	18635535	hybrid			2022-12-27	WOS:000259012700014
J	Chandrasekar, B; Boylston, WH; Venkatachalam, K; Webster, NJG; Prabhu, SD; Valente, AJ				Chandrasekar, Bysani; Boylston, William H.; Venkatachalam, Kaliyamurthi; Webster, Nicholas J. G.; Prabhu, Sumanth D.; Valente, Anthony J.			Adiponectin Blocks Interleukin-18-mediated Endothelial Cell Death via APPL1-dependent AMP-activated Protein Kinase (AMPK) Activation and IKK/NF-kappa B/PTEN Suppression	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							HUMAN ATHEROSCLEROTIC PLAQUES; CORONARY-ARTERY-DISEASE; NITRIC-OXIDE SYNTHASE; NECROSIS-FACTOR-ALPHA; B ACTIVATION; STIMULATES ANGIOGENESIS; INSULIN-RESISTANCE; SIGNALING PATHWAY; FUNCTIONAL IL-18; HIGH-GLUCOSE	The adipocyte-derived cytokine adiponectin is known to exert anti-inflammatory and anti-apoptotic effects. In patients with atherosclerotic cardiovascular disease, circulating levels of adiponectin correlate inversely with those of the proinflammatory, proapoptotic cytokine interleukin (IL)-18. The opposing actions of IL-18 and adiponectin on both cell survival and inflammation led us to investigate whether adiponectin signaling antagonizes IL-18-mediated endothelial cell death and to identify the underlying molecular mechanisms. Treatment with IL-18 suppressed Akt phosphorylation and its associated kinase activity, induced I kappa B kinase (IKK)-NF-kappa B-dependent PTEN activation, and promoted endothelial cell death. Pretreatment with adiponectin stimulated APPL1-dependent AMPK activation, reversed Akt inhibition in a phosphatidylinositol 3-kinase-dependent manner, blocked IKK-NF-kappa B-PTEN signaling, reduced caspase-3 activity, blocked Bax translocation, and inhibited endothelial cell death. The cytoprotective effect of adiponectin signaling was recapitulated by treatment with the pharmacological AMPK activator 5-aminoimidazole-4-carboxamide-1-beta-riboside. Collectively, these results demonstrated that adiponectin reverses IL-18-mediated endothelial cell death through an AMPK-associated mechanism, which may thus have therapeutic potential for diminishing IL-18-dependent vascular injury and inflammation.	[Chandrasekar, Bysani; Valente, Anthony J.] Univ Texas Hlth Sci Ctr San Antonio, Dept Med, San Antonio, TX 78229 USA; [Chandrasekar, Bysani; Venkatachalam, Kaliyamurthi] S Texas Vet Hlth Care Syst, Dept Vet Affairs, San Antonio, TX 78229 USA; [Boylston, William H.] Univ Texas Hlth Sci Ctr San Antonio, Dept Biochem, San Antonio, TX 78229 USA; [Webster, Nicholas J. G.] Univ Calif San Diego, Dept Med, San Diego, CA 92093 USA; [Prabhu, Sumanth D.] Univ Louisville, Dept Med, Inst Mol Cardiol, Louisville, KY 40292 USA; [Prabhu, Sumanth D.] Louisville Vet Affairs Med Ctr, Med Serv, Louisville, KY 40292 USA	University of Texas System; University of Texas Health San Antonio; US Department of Veterans Affairs; Veterans Health Administration (VHA); Audie L. Murphy Memorial Veterans Hospital; University of Texas System; University of Texas Health San Antonio; University of California System; University of California San Diego; University of Louisville	Chandrasekar, B (corresponding author), Univ Texas Hlth Sci Ctr San Antonio, Dept Med, San Antonio, TX 78229 USA.	chandraseka@uthscsa.edu	Prabhu, Sumanth/D-5223-2009; Venkatachalam, Kaliyamurthi/GXM-4890-2022; Webster, Nick/AAI-8410-2021		Research Service of the Department of Veterans Affairs; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT [U54HD012303] Funding Source: NIH RePORTER; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT [R01HD047400] Funding Source: NIH RePORTER	Research Service of the Department of Veterans Affairs(US Department of Veterans Affairs); EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD))	This work was supported in part by the Research Service of the Department of Veterans Affairs.	Chandrasekar B, 2006, BIOCHEM BIOPH RES CO, V339, P956, DOI 10.1016/j.bbrc.2005.11.100; Chandrasekar B, 2004, J BIOL CHEM, V279, P20221, DOI 10.1074/jbc.M313980200; Chen MC, 2007, HEART VESSELS, V22, P371, DOI 10.1007/s00380-007-0991-z; Cheng KKY, 2007, DIABETES, V56, P1387, DOI 10.2337/db06-1580; Diamant Michaela, 2006, Curr Diab Rep, V6, P279, DOI 10.1007/s11892-006-0061-4; Dimmeler S, 1998, EUR CYTOKINE NETW, V9, P697; Fan CG, 2003, J BIOL CHEM, V278, P2072, DOI 10.1074/jbc.M206718200; Frigerio S, 2002, HORM RES, V57, P94, DOI 10.1159/000057959; Gerdes N, 2002, J EXP MED, V195, P245, DOI 10.1084/jem.20011022; Goldstein Barry J, 2007, Curr Diab Rep, V7, P25, DOI 10.1007/s11892-007-0006-6; Hattori Y, 2006, HYPERTENSION, V47, P1183, DOI 10.1161/01.HYP.0000221429.94591.72; HOTAMISLIGIL GS, 1993, SCIENCE, V259, P87, DOI 10.1126/science.7678183; Hu E, 1996, J BIOL CHEM, V271, P10697, DOI 10.1074/jbc.271.18.10697; Kadowaki T, 2006, J CLIN INVEST, V116, P1784, DOI 10.1172/JCI29126; Kadowaki Takashi, 2007, Novartis Found Symp, V286, P164; Kim JE, 2008, J PHARMACOL SCI, V106, P394, DOI 10.1254/jphs.FP0071857; Kobayashi H, 2004, CIRC RES, V94, pE27, DOI 10.1161/01.RES.0000119921.86460.37; Kockx MM, 1998, CIRCULATION, V97, P2307, DOI 10.1161/01.CIR.97.23.2307; Koenig W, 2007, ARTERIOSCL THROM VAS, V27, P15, DOI 10.1161/01.ATV.0000251503.35795.4f; Kola B, 2006, TRENDS ENDOCRIN MET, V17, P205, DOI 10.1016/j.tem.2006.05.006; Korshunov VA, 2006, ARTERIOSCL THROM VAS, V26, P295, DOI 10.1161/01.ATV.0000196544.73761.82; Lam Karen S L, 2005, Curr Diab Rep, V5, P254, DOI 10.1007/s11892-005-0019-y; Landmesser U, 2004, CIRCULATION, V109, P27, DOI 10.1161/01.CIR.0000129501.88485.1f; Lee YR, 2005, LEUKEMIA RES, V29, P401, DOI 10.1016/j.leukres.2004.09.010; Lin LY, 2004, FEBS LETT, V574, P106, DOI 10.1016/j.febslet.2004.08.012; Lu M, 2008, MOL ENDOCRINOL, V22, P760, DOI 10.1210/me.2007-0330; Mallat Z, 2002, HEART, V88, P467, DOI 10.1136/heart.88.5.467; Mallat Z, 2001, CIRCULATION, V104, P1598, DOI 10.1161/hc3901.096721; Mao XM, 2006, NAT CELL BIOL, V8, P516, DOI 10.1038/ncb1404; Meng FY, 2007, GASTROENTEROLOGY, V133, P647, DOI 10.1053/j.gastro.2007.05.022; Mitsuuchi Y, 1999, ONCOGENE, V18, P4891, DOI 10.1038/sj.onc.1203080; Ohashi K, 2006, HYPERTENSION, V47, P1108, DOI 10.1161/01.HYP.0000222368.43759.a1; Ouchi N, 2003, HYPERTENSION, V42, P231, DOI 10.1161/01.HYP.0000083488.67550.B8; Ouchi N, 2000, CIRCULATION, V102, P1296, DOI 10.1161/01.CIR.102.11.1296; Ouchi N, 2004, J BIOL CHEM, V279, P1304, DOI 10.1074/jbc.M310389200; Ouedraogo R, 2006, DIABETES, V55, P1840, DOI 10.2337/db05-1174; Parcellier A, 2008, CELL SIGNAL, V20, P21, DOI 10.1016/j.cellsig.2007.07.010; Qin SF, 2008, INVEST OPHTH VIS SCI, V49, P1274, DOI 10.1167/iovs.07-1109; Reddy VS, 2008, J CELL PHYSIOL, V215, P697, DOI 10.1002/jcp.21348; Saito T, 2007, J BIOL CHEM, V282, P32280, DOI 10.1074/jbc.M704150200; Schnabel R, 2008, EUR HEART J, V29, P649, DOI 10.1093/eurheartj/ehn009; Shibata R, 2004, J BIOL CHEM, V279, P28670, DOI 10.1074/jbc.M402558200; Shimomura I, 1996, NAT MED, V2, P800, DOI 10.1038/nm0796-800; Stambolic V, 1998, CELL, V95, P29, DOI 10.1016/S0092-8674(00)81780-8; Winder WW, 2007, CELL BIOCHEM BIOPHYS, V47, P332, DOI 10.1007/s12013-007-0008-7; Wu X, 2007, AM J PHYSIOL-ENDOC M, V293, pE1836, DOI 10.1152/ajpendo.00115.2007; Yamagami H, 2005, ARTERIOSCL THROM VAS, V25, P1458, DOI 10.1161/01.ATV.0000168417.52486.56; Yamauchi T, 2003, NATURE, V423, P762, DOI 10.1038/nature01705; Zabalgoitia M, 2008, FREE RADICAL BIO MED, V44, P284, DOI 10.1016/j.freeradbiomed.2007.08.012	49	120	133	0	8	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	SEP 5	2008	283	36					24889	24898		10.1074/jbc.M804236200	http://dx.doi.org/10.1074/jbc.M804236200			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	517MA	18632660	Green Published, hybrid			2022-12-27	WOS:000271617300007
J	Villone, D; Fritsch, A; Koch, M; Bruckner-Tuderman, L; Hansen, U; Bruckner, P				Villone, Daniela; Fritsch, Anja; Koch, Manuel; Bruckner-Tuderman, Leena; Hansen, Uwe; Bruckner, Peter			Supramolecular interactions in the dermo-epidermal junction zone - Anchoring fibril-collagen VII tightly binds to banded collagen fibrils	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							DYSTROPHIC EPIDERMOLYSIS-BULLOSA; HUMAN-SKIN; MONOCLONAL-ANTIBODY; PROCOLLAGEN-VII; CROSS-LINKING; NC1 DOMAIN; MEMBRANE; IDENTIFICATION; LAMININ-5; ADHERENCE	The dermis and the epidermis of normal human skin are functionally separated by a basement membrane but, together, form a stable structural continuum. Anchoring fibrils reinforce this connection by insertion into the basement membrane and by intercalation with banded collagen fibrils of the papillary dermis. Structural abnormalities in collagen VII, the major molecular constituent of anchoring fibrils, lead to a congenital skin fragility condition, dystrophic epidermolysis bullosa, associated with skin blistering. Here, we characterized the molecular basis of the interactions between anchoring fibrils and banded collagen fibrils. Suprastructural fragments of the dermo-epidermal junction zone were generated by mechanical disruption and by separation with magnetic Immunobeads. Anchoring fibrils were tightly attached to banded collagen fibrils. In vitro binding studies demonstrated that a von Willebrand factor A-like motif in collagen VII was essential for binding of anchoring fibrils to reconstituted collagen I fibrils. Since collagen I and VII molecules reportedly undergo only weak interactions, the attachment of anchoring fibrils to collagen fibrils depends on supramolecular organization of their constituents. This complex is stabilized in situ and resists dissociation by strong denaturants.	[Villone, Daniela; Hansen, Uwe; Bruckner, Peter] Munster Univ Hosp, Inst Physiol Chem & Pathobiochem, D-48149 Munster, Germany; [Koch, Manuel] Univ Cologne, Fac Med, Dept Dermatol, D-50931 Cologne, Germany; [Koch, Manuel] Univ Cologne, Fac Med, Ctr Biochem, D-50931 Cologne, Germany; [Fritsch, Anja; Bruckner-Tuderman, Leena] Univ Med Ctr Freiburg, Dept Dermatol, D-79104 Freiburg, Germany	University of Munster; University of Cologne; University of Cologne; University of Freiburg	Bruckner, P (corresponding author), Munster Univ Hosp, Inst Physiol Chem & Pathobiochem, Waldeyerstr 15, D-48149 Munster, Germany.	peter.bruckner@uni-muenster.de	Bruckner, Peter/F-4817-2019; Koch, Manuel/AAG-9914-2021	Bruckner, Peter/0000-0002-5566-5611; Koch, Manuel/0000-0002-2962-7814	Deutsche Forschungsgemeinschaft SFB [A2, KO 2247/3-1, Br 1475/8-2]	Deutsche Forschungsgemeinschaft SFB(German Research Foundation (DFG))	This work was supported by the Deutsche Forschungsgemeinschaft SFB 492 Grants A2 (to P. B.), KO 2247/3-1 (to M. K.), and Br 1475/8-2 (to L. B.-T.).	Aumailley Monique, 2006, Expert Reviews in Molecular Medicine, V8, P1, DOI 10.1017/S1462399406000123; BACHINGER HP, 1990, J BIOL CHEM, V265, P10095; BENTZ H, 1983, P NATL ACAD SCI-BIOL, V80, P3168, DOI 10.1073/pnas.80.11.3168; Blaschke UK, 2000, J BIOL CHEM, V275, P10370, DOI 10.1074/jbc.275.14.10370; Brittingham R, 2006, BIOCHEM BIOPH RES CO, V343, P692, DOI 10.1016/j.bbrc.2006.03.034; Bruckner-Tuderman L, 1999, MATRIX BIOL, V18, P43, DOI 10.1016/S0945-053X(98)00007-9; BRUCKNERTUDERMAN L, 1989, J INVEST DERMATOL, V93, P3, DOI 10.1111/1523-1747.ep12277331; BRUCKNERTUDERMAN L, 1987, EUR J BIOCHEM, V165, P607, DOI 10.1111/j.1432-1033.1987.tb11483.x; BRUCKNERTUDERMAN L, 1995, J CELL BIOL, V131, P551, DOI 10.1083/jcb.131.2.551; BURGESON RE, 1990, ANN NY ACAD SCI, V580, P32, DOI 10.1111/j.1749-6632.1990.tb17915.x; Chen M, 1997, J BIOL CHEM, V272, P14516, DOI 10.1074/jbc.272.23.14516; CHRISTIANO AM, 1994, J BIOL CHEM, V269, P20256; CLERMONT Y, 1988, ANAT REC, V221, P482, DOI 10.1002/ar.1092210105; ELLISON J, 1984, J CELL SCI, V72, P163; Gayraud B, 1997, J BIOL CHEM, V272, P9531; GESELOWITZ DA, 1995, BIOCONJUGATE CHEM, V6, P502, DOI 10.1021/bc00034a021; Hansen U, 2006, MATRIX BIOL, V25, P252, DOI 10.1016/j.matbio.2006.01.005; Hansen U, 2003, J BIOL CHEM, V278, P37352, DOI 10.1074/jbc.M304325200; HEAGERTY AHM, 1986, BRIT J DERMATOL, V115, P125, DOI 10.1111/j.1365-2133.1986.tb05707.x; HENKEL W, 1982, EUR J BIOCHEM, V122, P205, DOI 10.1111/j.1432-1033.1982.tb05868.x; Henkel W, 2007, J PROTEOME RES, V6, P4269, DOI 10.1021/pr070318r; Jokinen J, 2004, J BIOL CHEM, V279, P31956, DOI 10.1074/jbc.M401409200; Kassner A, 2003, MATRIX BIOL, V22, P131, DOI 10.1016/S0945-053X(03)00008-8; KEENE DR, 1987, J CELL BIOL, V104, P611, DOI 10.1083/jcb.104.3.611; KEENE DR, 1991, J CELL BIOL, V113, P971, DOI 10.1083/jcb.113.4.971; LUNSTRUM GP, 1986, J BIOL CHEM, V261, P9042; PALADE GE, 1965, J CELL BIOL, V27, P215, DOI 10.1083/jcb.27.1.215; Raghunath M, 1996, J CLIN INVEST, V98, P1174, DOI 10.1172/JCI118901; Rattenholl A, 2002, J BIOL CHEM, V277, P26372, DOI 10.1074/jbc.M203247200; Rousselle P, 1997, J CELL BIOL, V138, P719, DOI 10.1083/jcb.138.3.719; SAKAI LY, 1986, J CELL BIOL, V103, P1577, DOI 10.1083/jcb.103.4.1577; Shimizu H, 1997, LAB INVEST, V76, P753	32	92	93	0	6	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	SEP 5	2008	283	36					24506	24513		10.1074/jbc.M802415200	http://dx.doi.org/10.1074/jbc.M802415200			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	342YR	18599485	Green Published, hybrid			2022-12-27	WOS:000258820000025
J	Chandra, S; Shao, J; Li, JX; Li, M; Longo, FM; Diamond, MI				Chandra, Shweta; Shao, Jieya; Li, Jennifer X.; Li, Mei; Longo, Frank M.; Diamond, Marc I.			A common motif targets huntingtin and the androgen receptor to the proteasome	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							NEURONAL INTRANUCLEAR INCLUSIONS; EXPANDED POLYGLUTAMINE PROTEIN; MUTANT HUNTINGTIN; NUCLEAR INCLUSIONS; MOUSE MODEL; AGGREGATION; DEGRADATION; AUTOPHAGY; DISEASE; LOCALIZATION	Huntington disease derives from a critically expanded polyglutamine tract in the huntingtin (Htt) protein; a similar polyglutamine expansion in the androgen receptor (AR) causes spinobulbar muscular atrophy. AR activity also plays an essential role in prostate cancer. Molecular mechanisms that regulate Htt and AR degradation are not well understood but could have important therapeutic implications. We find that a pentapeptide motif (FQKLL) within the Htt protein regulates its degradation and subcellular localization to cytoplasm puncta. Disruption of the motif by alanine substitution at the hydrophobic residues increases the steady state level of the protein. Pulse-chase analyses indicate that the motif regulates degradation. A similar motif (FQNLF) has corresponding activities in the AR protein. Transfer of the Htt motif with five flanking amino acids on either side to YFP reduces the steady state YFP level by rendering it susceptible to proteasome degradation. This work defines a novel proteasome-targeting motif that is necessary and sufficient to regulate the degradation of two disease-associated proteins.	[Chandra, Shweta; Shao, Jieya; Li, Jennifer X.; Li, Mei; Diamond, Marc I.] Univ Calif San Francisco, Dept Neurol, San Francisco, CA 94143 USA; [Chandra, Shweta; Shao, Jieya; Li, Jennifer X.; Li, Mei; Diamond, Marc I.] Univ Calif San Francisco, Dept Cellular & Mol Pharmacol, San Francisco, CA 94143 USA; [Longo, Frank M.] Stanford Univ, Sch Med, Dept Neurol, Stanford, CA 94305 USA	University of California System; University of California San Francisco; University of California System; University of California San Francisco; Stanford University	Diamond, MI (corresponding author), GH-S572B,600 16th St, San Francisco, CA 94143 USA.	marc.diamond@ucsf.edu			National Institutes of Health [1R01CA131226-01, 1R01NS50284-01A1]; Sandler Family Supporting Foundation; Taube Family Foundation Program in Huntington's Disease Research; Prostate Cancer Foundation; National Science Foundation; Muscular Dystrophy Association; NATIONAL CANCER INSTITUTE [R01CA131226] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS050284] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Sandler Family Supporting Foundation; Taube Family Foundation Program in Huntington's Disease Research; Prostate Cancer Foundation; National Science Foundation(National Science Foundation (NSF)); Muscular Dystrophy Association(Muscular Dystrophy Association); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	This work was supported, in whole or in part, by National Institutes of Health Grants 1R01CA131226-01 and 1R01NS50284-01A1. This work was also supported by the Sandler Family Supporting Foundation, the Taube Family Foundation Program in Huntington's Disease Research, and funds from the Prostate Cancer Foundation (to M. I. D.), the National Science Foundation (to J. X. L.), and the Muscular Dystrophy Association (to J. S., M. L., and M. I. D.). The costs of publication of this article were defrayed in part by the payment of page charges. This article must therefore be hereby marked "advertisement" in accordance with 18 U.S.C. Section 1734 solely to indicate this fact.	Abel A, 2001, HUM MOL GENET, V10, P107, DOI 10.1093/hmg/10.2.107; Bence NF, 2001, SCIENCE, V292, P1552, DOI 10.1126/science.292.5521.1552; Bhutani N, 2007, EMBO J, V26, P1385, DOI 10.1038/sj.emboj.7601592; Bogusz AM, 2006, FEBS J, V273, P2913, DOI 10.1111/j.1742-4658.2006.05304.x; Chai YH, 1999, HUM MOL GENET, V8, P673, DOI 10.1093/hmg/8.4.673; Culig ZR, 2003, J UROLOGY, V170, P1363, DOI 10.1097/01.ju.0000075099.20662.7f; Cummings CJ, 1998, NAT GENET, V19, P148, DOI 10.1038/502; Davies SW, 1997, CELL, V90, P537, DOI 10.1016/S0092-8674(00)80513-9; Diamond MI, 2000, P NATL ACAD SCI USA, V97, P657, DOI 10.1073/pnas.97.2.657; DiFiglia M, 1997, SCIENCE, V277, P1990, DOI 10.1126/science.277.5334.1990; Gelmann EP, 2002, J CLIN ONCOL, V20, P3001, DOI 10.1200/JCO.2002.10.018; Hara T, 2006, NATURE, V441, P885, DOI 10.1038/nature04724; HARDING AE, 1982, J NEUROL NEUROSUR PS, V45, P1012, DOI 10.1136/jnnp.45.11.1012; He B, 2002, MOL GENET METAB, V75, P293, DOI 10.1016/S1096-7192(02)00009-4; He B, 2000, J BIOL CHEM, V275, P22986, DOI 10.1074/jbc.M002807200; Heery DM, 1997, NATURE, V387, P733, DOI 10.1038/42750; Hodgson JG, 1999, NEURON, V23, P181, DOI 10.1016/S0896-6273(00)80764-3; Jana NR, 2005, J BIOL CHEM, V280, P11635, DOI 10.1074/jbc.M412042200; Johnson PR, 1998, CELL, V94, P217, DOI 10.1016/S0092-8674(00)81421-X; KENNEDY WR, 1968, NEUROLOGY, V18, P671, DOI 10.1212/WNL.18.7.671; Kim YJ, 2001, P NATL ACAD SCI USA, V98, P12784, DOI 10.1073/pnas.221451398; Komatsu M, 2006, NATURE, V441, P880, DOI 10.1038/nature04723; LASPADA AR, 1991, NATURE, V352, P77, DOI 10.1038/352077a0; Leavitt BR, 1999, SEMIN NEUROL, V19, P385, DOI 10.1055/s-2008-1040853; Li M, 1998, ANN NEUROL, V44, P249, DOI 10.1002/ana.410440216; Li M, 2007, J BIOL CHEM, V282, P3157, DOI 10.1074/jbc.M609972200; MACDONALD ME, 1993, CELL, V72, P971, DOI 10.1016/0092-8674(93)90585-E; Merry DE, 1998, HUM MOL GENET, V7, P693, DOI 10.1093/hmg/7.4.693; Pandey UB, 2007, AUTOPHAGY, V3, P643, DOI 10.4161/auto.5050; Pandey UB, 2007, NATURE, V447, P859, DOI 10.1038/nature05853; Ravikumar B, 2004, NAT GENET, V36, P585, DOI 10.1038/ng1362; Ross CA, 2004, NAT MED, V10, pS10, DOI 10.1038/nm1066; Savkur RS, 2004, J PEPT RES, V63, P207, DOI 10.1111/j.1399-3011.2004.00126.x; Schaufele F, 2005, P NATL ACAD SCI USA, V102, P9802, DOI 10.1073/pnas.0408819102; Takahashi T, 2008, HUM MOL GENET, V17, P345, DOI 10.1093/hmg/ddm311; Taylor JP, 2003, HUM MOL GENET, V12, P749, DOI 10.1093/hmg/ddg074; Venkatraman P, 2004, MOL CELL, V14, P95, DOI 10.1016/S1097-2765(04)00151-0; Waelter S, 2001, MOL BIOL CELL, V12, P1393, DOI 10.1091/mbc.12.5.1393	38	14	14	0	2	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	AUG 29	2008	283	35					23950	23955		10.1074/jbc.M800467200	http://dx.doi.org/10.1074/jbc.M800467200			6	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	340II	18586675	Green Published, hybrid			2022-12-27	WOS:000258638900050
J	Gao, Z; Wen, CK; Binder, BM; Chen, YF; Chang, J; Chiang, YH; Ill, RJK; Chang, C; Schaller, GE				Gao, Zhiyong; Wen, Chi-Kuang; Binder, Brad M.; Chen, Yi-Feng; Chang, Jianhong; Chiang, Yi-Hsuan; Ill, Robert J. Kerris; Chang, Caren; Schaller, G. Eric			Heteromeric interactions among ethylene receptors mediate signaling in Arabidopsis	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							HISTIDINE KINASE-ACTIVITY; SEEDLING-GROWTH-RESPONSE; RAF-LIKE KINASE; ENDOPLASMIC-RETICULUM; GENE FAMILY; ETR1; PROTEIN; BINDING; DOMAIN; TRANSDUCTION	The gaseous hormone ethylene is perceived in Arabidopsis by a five member receptor family that consists of the subfamily 1 receptors ETR1 and ERS1 and the subfamily 2 receptors ETR2, ERS2, and EIN4. Previous work has demonstrated that the basic functional unit for the ethylene receptor, ETR1, is a disulfide-linked homodimer. We demonstrate here that ethylene receptors isolated from Arabidopsis also interact with each other through noncovalent interactions. Evidence that ETR1 associates with other ethylene receptors was obtained by co-purification of ETR1 with tagged versions of ERS1, ETR2, ERS2, and EIN4 from Arabidopsis membrane extracts. ETR1 preferentially associated with the subfamily 2 receptors compared with the subfamily 1 receptor ERS1, but ethylene treatment affected the interactions and relative composition of the receptor complexes. When transgenically expressed in yeast, ETR1 and ERS2 can form disulfide-linked heterodimers. In plant extracts, however, the association of ETR1 and ERS2 can be largely disrupted by treatment with SDS, supporting a higher order noncovalent interaction between the receptors. Yeast two-hybrid analysis demonstrated that the receptor GAF domains are capable of mediating heteromeric receptor interactions. Kinetic analysis of ethylene-insensitive mutants of ETR1 is consistent with their dominance being due in part to an ability to associate with other ethylene receptors. These data suggest that the ethylene receptors exist in plants as clusters in a manner potentially analogous to that found with the histidine kinase-linked chemoreceptors of bacteria and that interactions among receptors contribute to ethylene signal output.	[Gao, Zhiyong; Chen, Yi-Feng; Chiang, Yi-Hsuan; Ill, Robert J. Kerris; Schaller, G. Eric] Dartmouth Coll, Dept Biol Sci, Hanover, NH 03755 USA; [Binder, Brad M.] Univ Wisconsin, Dept Hort, Madison, WI 53706 USA; [Wen, Chi-Kuang; Chang, Jianhong; Chang, Caren] Univ Maryland, Dept Cell Biol & Mol Genet, College Pk, MD 20742 USA	Dartmouth College; University of Wisconsin System; University of Wisconsin Madison; University System of Maryland; University of Maryland College Park	Schaller, GE (corresponding author), Dartmouth Coll, Dept Biol Sci, Hanover, NH 03755 USA.	george.e.schaller@dartmouth.edu	Chen, Yi/HIR-2608-2022; Chiang, Yi-Hsuan/B-2662-2014; Wen, Chi-Kuang/AAI-4308-2020	Wen, Chi-Kuang/0000-0002-5345-0756; Binder, Brad/0000-0002-8172-2034	NIGMS NIH HHS [1R01 GM 071855] Funding Source: Medline; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM071855] Funding Source: NIH RePORTER	NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		Abeles F, 1992, ETHYLENE PLANT BIOL; Aravind L, 1997, TRENDS BIOCHEM SCI, V22, P458, DOI 10.1016/S0968-0004(97)01148-1; Ausubel FM, 1994, CURRENT PROTOCOLS MO; Baker MD, 2006, BIOESSAYS, V28, P9, DOI 10.1002/bies.20343; Binder BM, 2004, PLANT PHYSIOL, V136, P2913, DOI 10.1104/pp.104.050369; Binder BM, 2004, PLANT PHYSIOL, V136, P2921, DOI 10.1104/pp.104.050393; BLEECKER AB, 1988, SCIENCE, V241, P1086, DOI 10.1126/science.241.4869.1086; Cancel JD, 2002, PLANT PHYSIOL, V129, P1557, DOI 10.1104/pp.003780; CHANG C, 1993, SCIENCE, V262, P539, DOI 10.1126/science.8211181; CHEN QHG, 1995, PLANT PHYSIOL, V108, P597, DOI 10.1104/pp.108.2.597; Chen YF, 2005, ANN BOT-LONDON, V95, P901, DOI 10.1093/aob/mci100; Chen YF, 2002, J BIOL CHEM, V277, P19861, DOI 10.1074/jbc.M201286200; Chen YF, 2007, J BIOL CHEM, V282, P24752, DOI 10.1074/jbc.M704419200; Cho YH, 2007, PLANT PHYSIOL, V143, P612, DOI 10.1104/pp.106.091504; Clark KL, 1998, P NATL ACAD SCI USA, V95, P5401, DOI 10.1073/pnas.95.9.5401; Clough SJ, 1998, PLANT J, V16, P735, DOI 10.1046/j.1365-313x.1998.00343.x; Dong CH, 2008, PLANT J, V53, P275, DOI 10.1111/j.1365-313X.2007.03339.x; Gamble RL, 1998, P NATL ACAD SCI USA, V95, P7825, DOI 10.1073/pnas.95.13.7825; Gamble RL, 2002, PLANT PHYSIOL, V128, P1428, DOI 10.1104/pp.010777; Gao ZY, 2003, J BIOL CHEM, V278, P34725, DOI 10.1074/jbc.M305548200; Grefen C, 2008, MOL PLANT, V1, P308, DOI 10.1093/mp/ssm015; Hall AE, 1999, PLANT PHYSIOL, V121, P291, DOI 10.1104/pp.121.1.291; Hall AE, 2000, PLANT PHYSIOL, V123, P1449, DOI 10.1104/pp.123.4.1449; HOFTE H, 1992, PLANT CELL, V4, P995, DOI 10.1105/tpc.4.8.995; Hua J, 1998, PLANT CELL, V10, P1321, DOI 10.1105/tpc.10.8.1321; Hua J, 1998, CELL, V94, P261, DOI 10.1016/S0092-8674(00)81425-7; Huang YF, 2003, PLANT J, V33, P221, DOI 10.1046/j.1365-313X.2003.01620.x; Keefe AD, 2001, PROTEIN EXPRES PURIF, V23, P440, DOI 10.1006/prep.2001.1515; KIEBER JJ, 1993, CELL, V72, P427, DOI 10.1016/0092-8674(93)90119-B; Martinez SE, 2002, P NATL ACAD SCI USA, V99, P13260, DOI 10.1073/pnas.192374899; MITCHELL DA, 1993, YEAST, V9, P715, DOI 10.1002/yea.320090705; Moussatche P, 2004, J BIOL CHEM, V279, P48734, DOI 10.1074/jbc.M403100200; Muller-Dieckmann HJ, 1999, STRUCT FOLD DES, V7, P1547, DOI 10.1016/S0969-2126(00)88345-8; O'Malley RC, 2005, PLANT J, V41, P651, DOI [10.1111/j.1365-313X.2004.02331.x, 10.1111/j.1365-313X.2004.02331.X]; Qu X, 2004, PLANT PHYSIOL, V136, P2961, DOI 10.1104/pp.104.047126; Qu X, 2007, BMC PLANT BIOL, V7, DOI 10.1186/1471-2229-7-3; Rigaut G, 1999, NAT BIOTECHNOL, V17, P1030, DOI 10.1038/13732; Rodriguez FI, 1999, SCIENCE, V283, P996, DOI 10.1126/science.283.5404.996; SCHALLER GE, 1995, J BIOL CHEM, V270, P12526, DOI 10.1074/jbc.270.21.12526; SCHALLER GE, 1995, SCIENCE, V270, P1809, DOI 10.1126/science.270.5243.1809; Schaller GE, 2000, ADV BOT RES, V32, P109, DOI 10.1016/S0065-2296(00)32023-7; Schaller GE, 2002, ARABIDOPSIS BOOK, V1, pe0071, DOI DOI 10.1199/TAB.0071; SCHIESTL RH, 1989, CURR GENET, V16, P339, DOI 10.1007/BF00340712; Takahashi H, 2002, J EXP BOT, V53, P415, DOI 10.1093/jexbot/53.368.415; Wang WY, 2003, P NATL ACAD SCI USA, V100, P352, DOI 10.1073/pnas.0237085100; Wolanin PM, 2002, GENOME BIOL, V3; Xie F, 2006, PLANT PHYSIOL, V142, P492, DOI 10.1104/pp.106.082628; YANG SF, 1984, ANNU REV PLANT PHYS, V35, P155, DOI 10.1146/annurev.pp.35.060184.001103; Zhao XC, 2002, PLANT PHYSIOL, V130, P1983, DOI 10.1104/pp.011635	49	101	111	4	17	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	AUG 29	2008	283	35					23801	23810		10.1074/jbc.M800641200	http://dx.doi.org/10.1074/jbc.M800641200			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	340II	18577522	Green Published, hybrid			2022-12-27	WOS:000258638900034
J	Sharma, A; Yogavel, M; Akhouri, RR; Gill, J; Sharma, A				Sharma, Ashwani; Yogavel, M.; Akhouri, Reetesh Raj; Gill, Jasmita; Sharma, Amit			Crystal structure of soluble domain of malaria sporozoite protein UIS3 in complex with lipid	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ACID-BINDING PROTEIN; PLASMODIUM-FALCIPARUM; FATTY-ACIDS; LIVER; MEMBRANES; LIGANDS; CELLS	Malaria parasite UIS3 (up-regulated in infective sporozoites gene 3) is essential for sporozoite development in infected hepatocytes. UIS3 encodes for a membrane protein that is localized to the parasite parasitophorous vacuolar membrane in infected hepatocytes. We describe here 2.5-angstrom resolution crystal structure of Plasmodium falciparum UIS3 soluble domain (PfUIS3(130-229)) in complex with the lipid phosphatidylethanolamine ( PE). PfUIS3(130-229) is a novel, compact, and all alpha-helical structure bound to one molecule of PE. The PfUIS3(130-229)-PE complex structure reveals a novel binding site with specific interactions between PfUIS3(130-229) and the PE head group. One acyl chain of PE wraps around part of PfUIS3(130-229) and docks onto a hydrophobic channel. We additionally provide new structural and biochemical evidence of PfUIS3(130-229) interactions with lipids ( phosphatidylethanolamine), with phospholipid liposomes, and with the human liver fatty acid-binding protein. The direct interaction of PfUIS3(130-229) with liver fatty acid-binding protein most likely provides the parasite with a conduit for importing essential fatty acids/lipids. Therefore, our analyses have implications for lipid transport into the parasite during the rapid growth phases of sporozoites. Given that PfUIS3 is essential for establishment of liver stage infection by P. falciparum, our data provide a new target for abrogating parasite development within liver cells before typical symptoms of malaria can manifest.	[Sharma, Ashwani; Yogavel, M.; Akhouri, Reetesh Raj; Gill, Jasmita; Sharma, Amit] Int Ctr Genet Engn & Biotechnol, Struct & Computat Biol Grp, New Delhi 110067, India	Department of Biotechnology (DBT) India; International Center for Genetic Engineering & Biotechnology (ICGEB); International Center for Genetic Engineering & Biotechnology (ICGEB), New Delhi	Sharma, A (corresponding author), Int Ctr Genet Engn & Biotechnol, Struct & Computat Biol Grp, Aruna Asaf Ali Rd, New Delhi 110067, India.	amit.icgeb@gmail.com	Manickam, Yogavel/O-4570-2015	Manickam, Yogavel/0000-0002-2119-062X; Gill, Jasmita/0000-0002-7004-2850; Akhouri, Reetesh/0000-0001-5995-2418	Department of Biotechnology ( Government of India); Medical Research Council [G0500367] Funding Source: researchfish; MRC [G0500367] Funding Source: UKRI	Department of Biotechnology ( Government of India)(Department of Biotechnology (DBT) India); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC))	This work is supported by a Department of Biotechnology ( Government of India) career development award (to A.S.). The costs of publication of this article were defrayed in part by the payment of page charges. This article must therefore be hereby marked "advertisement" in accordance with 18 U. S. C. Section 1734 solely to indicate this fact.	Adams PD, 2002, ACTA CRYSTALLOGR D, V58, P1948, DOI 10.1107/S0907444902016657; Di Pietro SM, 2003, BIOCHEMISTRY-US, V42, P8192, DOI 10.1021/bi034213n; Emsley P, 2004, ACTA CRYSTALLOGR D, V60, P2126, DOI 10.1107/S0907444904019158; Falomir-Lockhart LJ, 2006, J BIOL CHEM, V281, P13979, DOI 10.1074/jbc.M511943200; Furuhashi M, 2007, NATURE, V447, P959, DOI 10.1038/nature05844; HENDRICKSON WA, 1990, EMBO J, V9, P1665, DOI 10.1002/j.1460-2075.1990.tb08287.x; Hodsdon ME, 1997, BIOCHEMISTRY-US, V36, P1450, DOI 10.1021/bi961890r; Kaiser K, 2004, MOL MICROBIOL, V51, P1221, DOI 10.1046/j.1365-2958.2003.03909.x; LEVI AJ, 1969, J CLIN INVEST, V48, P2156, DOI 10.1172/JCI106182; LiCata VJ, 1998, PROTEINS, V33, P577, DOI 10.1002/(SICI)1097-0134(19981201)33:4<577::AID-PROT10>3.0.CO;2-2; Lingelbach K, 1998, J CELL SCI, V111, P1467; LINGELBACH KR, 1993, EXP PARASITOL, V76, P318, DOI 10.1006/expr.1993.1039; Mikolajczak SA, 2007, INT J PARASITOL, V37, P483, DOI 10.1016/j.ijpara.2007.01.002; Morein S, 1996, J BIOL CHEM, V271, P6801, DOI 10.1074/jbc.271.12.6801; Mueller AK, 2005, NATURE, V433, P164, DOI 10.1038/nature03188; Murshudov GN, 1997, ACTA CRYSTALLOGR D, V53, P240, DOI 10.1107/S0907444996012255; OCKNER RK, 1972, SCIENCE, V177, P56, DOI 10.1126/science.177.4043.56; Otwinowski Z, 1997, METHOD ENZYMOL, V276, P307, DOI 10.1016/S0076-6879(97)76066-X; Ralph SA, 2004, NAT REV MICROBIOL, V2, P203, DOI 10.1038/nrmicro843; Snow RW, 2005, NATURE, V434, P214, DOI 10.1038/nature03342; STORCH J, 1993, MOL CELL BIOCHEM, V123, P45, DOI 10.1007/BF01076474; SZOKA F, 1978, P NATL ACAD SCI USA, V75, P4194, DOI 10.1073/pnas.75.9.4194; Thompson J, 1999, BBA-MOL CELL BIOL L, V1441, P117, DOI 10.1016/S1388-1981(99)00146-8; Thumser AEA, 2000, J LIPID RES, V41, P647	24	26	29	0	2	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	AUG 29	2008	283	35					24077	24088		10.1074/jbc.M801946200	http://dx.doi.org/10.1074/jbc.M801946200			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	340II	18577521	Green Published, hybrid			2022-12-27	WOS:000258638900062
J	Monterroso, B; Saiz, JL; Garcia, P; Garcia, JL; Menendez, M				Monterroso, Begona; Saiz, Jose Luis; Garcia, Pedro; Garcia, Jose Luis; Menendez, Margarita			Insights into the structure-function relationships of pneumococcal cell wall lysozymes, LytC and Cpl-1	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							STREPTOCOCCUS-PNEUMONIAE; ESCHERICHIA-COLI; CHOLINE-BINDING; PHOSPHORYLCHOLINE ESTERASE; SCANNING CALORIMETRY; AUTOLYTIC LYSOZYME; CIRCULAR-DICHROISM; MUREIN HYDROLASES; PHAGE CP-1; PROTEINS	The LytC lysozyme belongs to the autolytic system of Streptococcus pneumoniae and carries out a slow autolysis with optimum activity at 30 C. Like all pneumococcal murein hydrolases, LytC is a modular enzyme. Its mature form comprises a catalytic module belonging to the GH25 family of glycosyl-hydrolases and a cell wall binding module (CBM), made of 11 sequence repeats, that is essential for activity and specifically targets choline residues present in pneumococcal lipoteichoic and teichoic acids. Here we show that the catalytic module is natively folded, and its thermal denaturation takes place at 45.4 degrees C. However, the CBM is intrinsically unstable, and the ultimate folding and stabilization of the active, monomeric form of LytC relies on choline binding. The complex formation proceeds in a rather slow way, and all sites (8.0 +/- 0.5 sites/monomer) behave as equivalent (K-d = 2.7 +/- 0.3 mM). The CBM stabilization is, nevertheless, marginal, and irreversible denaturation becomes measurable at 37 C even at high choline concentration, compromising LytC activity. In contrast, the Cpl-1 lysozyme, a homologous endolysin encoded by pneumococcal Cp-1 bacteriophage, is natively folded in the absence of choline and has maximum activity at 37 degrees C. Choline binding is fast and promotes Cpl-1 dimerization. Coupling between choline binding and folding of the CBM of LytC indicates a high conformational plasticity that could correlate with the unusual alternation of short and long choline-binding repeats present in this enzyme. Moreover, it can contribute to regulate LytC activity by means of a tight, complementary binding to the pneumococcal envelope, a limited motility, and a moderate resistance to thermal denaturation that could also account for its activity versus temperature profile.	[Monterroso, Begona; Saiz, Jose Luis; Menendez, Margarita] Consejo Super Invest Cient, Inst Quim Fis Rocasolano, Madrid 28006, Spain; [Saiz, Jose Luis; Garcia, Pedro; Menendez, Margarita] Consejo Super Invest Cient, CIBER Enfermedades Resp, Madrid 28040, Spain; [Garcia, Pedro; Garcia, Jose Luis] Consejo Super Invest Cient, Ctr Invest Biol, Madrid 28040, Spain	Consejo Superior de Investigaciones Cientificas (CSIC); CSIC - Instituto de Quimica Fisica Rocasolano (IQFR); CIBER - Centro de Investigacion Biomedica en Red; CIBERES; Consejo Superior de Investigaciones Cientificas (CSIC); Consejo Superior de Investigaciones Cientificas (CSIC); CSIC - Centro de Investigaciones Biologicas (CIB)	Menendez, M (corresponding author), Consejo Super Invest Cient, Inst Quim Fis Rocasolano, Serrano 119, Madrid 28006, Spain.	mmenendez@iqfr.csic.es	García, Pedro/L-2808-2017; Monterroso, Begoña/J-9748-2014; Menendez, Margarita/AAD-2043-2020; Menendez, Margarita/M-1795-2014; Garcia Lopez, Jose Luis/G-9139-2015	García, Pedro/0000-0001-6717-8717; Monterroso, Begoña/0000-0003-2538-084X; Menendez, Margarita/0000-0002-6590-7960; Menendez, Margarita/0000-0002-3267-4443; Garcia Lopez, Jose Luis/0000-0002-9238-2485	Direccion General de Investigacion Cientifica y Tecnica [BIO2003-01952, BFU2006-10288, SAF2006-00390]; COMBACT [S-BIO-0260/ 2006]; CIBER of Respiratory Diseases (CIBERES)	Direccion General de Investigacion Cientifica y Tecnica(Ministry of Science and Innovation, Spain (MICINN)Spanish Government); COMBACT; CIBER of Respiratory Diseases (CIBERES)	This work was supported by Direccion General de Investigacion Cientifica y Tecnica Grants BIO2003-01952, BFU2006-10288, and SAF2006-00390. Additional funding was provided by the COMBACT program (S-BIO-0260/ 2006) of the Comunidad de Madrid, the CIBER of Respiratory Diseases (CIBERES), an initiative of the ISCIII, and the Glycodynamics Network (FP6-UE and MCTN-CT-2005-019561). The costs of publication of this article were defrayed in part by the payment of page charges. This article must therefore be hereby marked " advertisement" in accordance with 18 U. S. C. Section 1734 solely to indicate this fact.	BAINS G, 1992, BIOCHEMISTRY-US, V31, P12624, DOI 10.1021/bi00165a012; BRANDTS JF, 1989, BIOCHEMISTRY-US, V28, P8588, DOI 10.1021/bi00447a048; Claverys JP, 2007, NAT REV MICROBIOL, V5, P219, DOI 10.1038/nrmicro1613; DIN N, 1994, P NATL ACAD SCI USA, V91, P11383, DOI 10.1073/pnas.91.24.11383; Dyson HJ, 2002, CURR OPIN STRUC BIOL, V12, P54, DOI 10.1016/S0959-440X(02)00289-0; Eftink M., 1980, BIOL MICROCALORIM, P343; Fernandez-Tornero C, 2001, NAT STRUCT BIOL, V8, P1020, DOI 10.1038/nsb724; FREIRE E, 1990, ANNU REV BIOPHYS BIO, V19, P159; FRESKGARD PO, 1994, BIOCHEMISTRY-US, V33, P14281, DOI 10.1021/bi00251a041; Garcia JL, 2000, STREPTOCOCCUS PNEUMO, P231; Garcia P, 1999, MOL MICROBIOL, V33, P128, DOI 10.1046/j.1365-2958.1999.01455.x; Gill J, 1999, BIOCHEM J, V342, P473, DOI 10.1042/0264-6021:3420473; GILL SJ, 1990, BINDING LINKAGE, P80; Gosink KK, 2000, INFECT IMMUN, V68, P5690, DOI 10.1128/IAI.68.10.5690-5695.2000; Hermoso JA, 2005, NAT STRUCT MOL BIOL, V12, P533, DOI 10.1038/nsmb940; Hermoso JA, 2003, STRUCTURE, V11, P1239, DOI 10.1016/j.str.2003.09.005; Holtje JV, 1998, MICROBIOL MOL BIOL R, V62, P181; HOLTJE JV, 1991, J GEN MICROBIOL, V137, P441, DOI 10.1099/00221287-137-3-441; Lagartera L, 2005, PROTEIN SCI, V14, P3013, DOI 10.1110/ps.051575005; Laue T.M., 1992, ANAL ULTRACENTRIFUGA, P90; Lopez R, 2004, FEMS MICROBIOL REV, V28, P553, DOI 10.1016/j.femsre.2004.05.002; Lopez R, 1997, MICROB DRUG RESIST, V3, P199, DOI 10.1089/mdr.1997.3.199; Luque I, 2002, ANNU REV BIOPH BIOM, V31, P235, DOI 10.1146/annurev.biophys.31.082901.134215; Martin AC, 1998, J BACTERIOL, V180, P210; MARTINEZBUEY R, 2007, J MOL BIOL, V365, P411; Medrano FJ, 1996, J BIOL CHEM, V271, P29152, DOI 10.1074/jbc.271.46.29152; Monterroso B, 2005, BIOCHEM J, V391, P41, DOI 10.1042/BJ20050612; PARSELL DA, 1989, J BIOL CHEM, V264, P7590; Perez-Dorado I, 2007, J BIOL CHEM, V282, P24990, DOI 10.1074/jbc.M704317200; Saiz JL, 2002, PROTEIN SCI, V11, P1788, DOI 10.1110/ps.4680102; SANCHEZRUIZ JM, 1992, BIOPHYS J, V61, P921, DOI 10.1016/S0006-3495(92)81899-4; SANZ JM, 1993, J BIOL CHEM, V268, P6125; SANZ JM, 1992, MOL MICROBIOL, V6, P921, DOI 10.1111/j.1365-2958.1992.tb01542.x; Severin A, 1997, MICROB DRUG RESIST, V3, P391, DOI 10.1089/mdr.1997.3.391; Shockman GD., 1994, BACTERIAL CELL WALL, P131, DOI 10.1016/S0167-7306(08)60410-X; STRICKLA.EH, 1969, BIOCHEMISTRY-US, V8, P3205, DOI 10.1021/bi00836a012; TOMASZ A, 1967, SCIENCE, V157, P694, DOI 10.1126/science.157.3789.694; TOMASZ A, 1968, P NATL ACAD SCI USA, V59, P86, DOI 10.1073/pnas.59.1.86; Usobiaga P, 1996, J BIOL CHEM, V271, P6832, DOI 10.1074/jbc.271.12.6832; Varea J, 2004, J BIOL CHEM, V279, P43697, DOI 10.1074/jbc.M407067200; Varea J, 2000, J BIOL CHEM, V275, P26842; VELAZQUEZCAMPOY A, 2004, CURR PROTEIN CELL BI, V23	42	19	20	0	2	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	OCT 17	2008	283	42					28618	28628		10.1074/jbc.M802808200	http://dx.doi.org/10.1074/jbc.M802808200			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	359EN	18667432	Green Published, hybrid			2022-12-27	WOS:000259969300064
J	Bhatia, B; Jiang, M; Suraneni, M; Patrawala, L; Badeaux, M; Schneider-Broussard, R; Multani, AS; Jeter, CR; Calhoun-Davis, T; Hu, LM; Hu, JH; Tsavachidis, S; Zhang, W; Chang, S; Hayward, SW; Tang, DG				Bhatia, Bobby; Jiang, Ming; Suraneni, Mahipal; Patrawala, Lubna; Badeaux, Mark; Schneider-Broussard, Robin; Multani, Asha S.; Jeter, Collene R.; Calhoun-Davis, Tammy; Hu, Limei; Hu, Jianhua; Tsavachidis, Spiridon; Zhang, Wei; Chang, Sandy; Hayward, Simon W.; Tang, Dean G.			Critical and distinct roles of p16 and telomerase in regulating the proliferative life span of normal human prostate epithelial progenitor cells	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							STEM-CELLS; CELLULAR SENESCENCE; CANCER-CELLS; 15-LIPOXYGENASE-2 15-LOX2; REPLICATIVE SENESCENCE; DIFFERENTIATION; BENIGN; GROWTH; HYPERPLASIA; POPULATION	Normal human prostate (NHP) epithelial cells undergo senescence in vitro and in vivo, but the underlying molecular mechanisms remain obscure. Here we show that the senescence of primary NHP cells, which are immunophenotyped as intermediate basal-like cells expressing progenitor cell markers CD44, alpha 2 beta 1, p63, hTERT, and CK5/CK18, involves loss of telomerase expression, up-regulation of p16, and activation of p53. Using genetically defined manipulations of these three signaling pathways, we show that p16 is the primary determinant of the NHP cell proliferative capacity and that hTERT is required for unlimited proliferative life span. Hence, suppression of p16 significantly extends NHP cell life span, but both p16 inhibition and hTERT are required to immortalize NHP cells. Importantly, immortalized NHP cells retain expression of most progenitor markers, demonstrate gene expression profiles characteristic of proliferating progenitor cells, and possess multilineage differentiation potential generating functional prostatic glands. Our studies shed important light on the molecular mechanisms regulating the proliferative life span of NHP progenitor cells.	[Bhatia, Bobby; Suraneni, Mahipal; Patrawala, Lubna; Badeaux, Mark; Schneider-Broussard, Robin; Jeter, Collene R.; Calhoun-Davis, Tammy; Tang, Dean G.] Univ Texas MD Anderson Canc Ctr, Dept Carcinogenesis, Div Sci Pk Res, Smithville, TX 78957 USA; [Jiang, Ming; Hayward, Simon W.] Vanderbilt Univ, Med Ctr, Dept Urol Surg, Nashville, TN 37232 USA; [Multani, Asha S.; Chang, Sandy] Univ Texas MD Anderson Canc Ctr, Dept Canc Genet, Houston, TX 77030 USA; [Hu, Limei; Zhang, Wei] Univ Texas MD Anderson Canc Ctr, Dept Pathol, Houston, TX 77030 USA; [Hu, Jianhua; Tsavachidis, Spiridon] Univ Texas MD Anderson Canc Ctr, Dept Biostat, Houston, TX 77030 USA; [Chang, Sandy] Univ Texas MD Anderson Canc Ctr, Dept Hematopathol, Houston, TX 77030 USA; [Tang, Dean G.] Univ Texas Houston, Hlth Sci Ctr, Grad Sch Biomed Sci, Program Mol Carcinogenesis, Houston, TX 77030 USA	University of Texas System; UTMD Anderson Cancer Center; Vanderbilt University; University of Texas System; UTMD Anderson Cancer Center; University of Texas System; UTMD Anderson Cancer Center; University of Texas System; UTMD Anderson Cancer Center; University of Texas System; UTMD Anderson Cancer Center; University of Texas System; University of Texas Health Science Center Houston	Tang, DG (corresponding author), Univ Texas MD Anderson Canc Ctr, Dept Carcinogenesis, Div Sci Pk Res, POB 389, Smithville, TX 78957 USA.	dtang@mdanderson.org	Jiang, Ming/F-2060-2011; Tang, Dean/AAI-3457-2020	Tang, Dean/0000-0001-5029-1174; Hayward, Simon/0000-0002-6059-6550; Jiang, Ming/0000-0002-1927-5667; Jiang, Ming/0000-0003-3361-9881; Jeter, Collene/0000-0002-9627-4529	National Institutes of Health [R01-AG023374, R01-ES015888, R21-ES015893-01A1]; American Cancer Society [RSG MGO-105961]; Department of Defense [W81XWH-07-1-0616, PC073751]; Prostate Cancer Foundation; Elsa Pardee Foundation; two Center [CCSG-5 P30 CA166672, ES07784]; NATIONAL CANCER INSTITUTE [R01CA166672] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES [R21ES015893, P30ES007784, R01ES015888] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON AGING [R01AG023374] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); American Cancer Society(American Cancer Society); Department of Defense(United States Department of Defense); Prostate Cancer Foundation; Elsa Pardee Foundation; two Center; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))	This work was supported, in whole or in part, by National Institutes of Health Grants R01-AG023374, R01-ES015888, and R21-ES015893-01A1. This work was also supported by American Cancer Society Grant RSG MGO-105961, Department of Defense Grants W81XWH-07-1-0616 and PC073751, the Prostate Cancer Foundation, the Elsa Pardee Foundation (to D. G. T.), and two Center Grants, CCSG-5 P30 CA166672 and ES07784. The costs of publication of this article were defrayed in part by the payment of page charges. This article must therefore be hereby marked "advertisement" in accordance with 18 U. S. C. Section 1734 solely to indicate this fact.	Benanti JA, 2004, MOL CELL BIOL, V24, P2842, DOI 10.1128/MCB.24.7.2842-2852.2004; Berger R, 2004, CANCER RES, V64, P8867, DOI 10.1158/0008-5472.CAN-04-2938; Bhatia B, 2005, ONCOGENE, V24, P3583, DOI 10.1038/sj.onc.1208406; Bhatia B, 2003, J BIOL CHEM, V278, P25091, DOI 10.1074/jbc.M301920200; Bhatia B, 2008, INT J CANCER, V122, P1483, DOI 10.1002/ijc.23222; Bright RK, 1997, CANCER RES, V57, P995; Brown MD, 2007, PROSTATE, V67, P1384, DOI 10.1002/pros.20620; Campisi J, 2005, CELL, V120, P513, DOI 10.1016/j.cell.2005.02.003; Castro P, 2003, PROSTATE, V55, P30, DOI 10.1002/pros.10204; Chen ZB, 2005, NATURE, V436, P725, DOI 10.1038/nature03918; Cho KA, 2004, J BIOL CHEM, V279, P42270, DOI 10.1074/jbc.M402352200; Choi J, 2000, UROLOGY, V56, P160, DOI 10.1016/S0090-4295(00)00538-0; Chopra DP, 1996, J CELL PHYSIOL, V169, P269, DOI 10.1002/(SICI)1097-4652(199611)169:2<269::AID-JCP6>3.0.CO;2-M; Collins AT, 2001, J CELL SCI, V114, P3865; Gevry N, 2007, GENE DEV, V21, P1869, DOI 10.1101/gad.1545707; Gil J, 2006, NAT REV MOL CELL BIO, V7, P667, DOI 10.1038/nrm1987; Goto K, 2006, STEM CELLS, V24, P1859, DOI 10.1634/stemcells.2005-0585; Hayward SW, 1998, DIFFERENTIATION, V63, P131, DOI 10.1046/j.1432-0436.1998.6330131.x; Heer R, 2007, J CELL PHYSIOL, V212, P572, DOI 10.1002/jcp.21154; Hemann MT, 2003, NAT GENET, V33, P396, DOI 10.1038/ng1091; Huang WC, 2006, CANCER RES, V66, P9108, DOI 10.1158/0008-5472.CAN-06-1996; Hudson DL, 2000, LAB INVEST, V80, P1243, DOI 10.1038/labinvest.3780132; Jarrard DF, 1999, CANCER RES, V59, P2957; Keyes WM, 2005, GENE DEV, V19, P1986, DOI 10.1101/gad.342305; Kim WY, 2006, CELL, V127, P265, DOI 10.1016/j.cell.2006.10.003; Kiyono T, 1998, NATURE, V396, P84, DOI 10.1038/23962; Kogan I, 2006, CANCER RES, V66, P3531, DOI 10.1158/0008-5472.CAN-05-2183; Konishi N, 2002, AM J PATHOL, V160, P1207, DOI 10.1016/S0002-9440(10)62547-3; Lawson DA, 2007, J CLIN INVEST, V117, P2044, DOI 10.1172/JCI32810; Liu AY, 1997, P NATL ACAD SCI USA, V94, P10705, DOI 10.1073/pnas.94.20.10705; Mitchell PJ, 2003, MOL CELL BIOL, V23, P2530, DOI 10.1128/MCB.23.7.2530-2542.2003; Oudes AJ, 2006, BMC GENOMICS, V7, DOI 10.1186/1471-2164-7-92; Pascal Laura E, 2007, BMC Urol, V7, P6, DOI 10.1186/1471-2490-7-6; Patrawala L, 2006, ONCOGENE, V25, P1696, DOI 10.1038/sj.onc.1209327; Patrawala L, 2005, CANCER RES, V65, P6207, DOI 10.1158/0008-5472.CAN-05-0592; Patrawala L, 2007, CANCER RES, V67, P6796, DOI 10.1158/0008-5472.CAN-07-0490; PEEHL DM, 1986, IN VITRO CELL DEV B, V22, P82; Pounds S, 2003, BIOINFORMATICS, V19, P1236, DOI 10.1093/bioinformatics/btg148; Ramirez RD, 2001, GENE DEV, V15, P398, DOI 10.1101/gad.859201; Rheinwald JG, 2002, MOL CELL BIOL, V22, P5157, DOI 10.1128/MCB.22.14.5157-5172.2002; Richardson GD, 2004, J CELL SCI, V117, P3539, DOI 10.1242/jcs.01222; Robinson EJ, 1998, PROSTATE, V37, P149, DOI 10.1002/(SICI)1097-0045(19981101)37:3<149::AID-PROS4>3.0.CO;2-E; Sandhu C, 2000, CANCER RES, V60, P2616; Schwarze SR, 2002, J BIOL CHEM, V277, P14877, DOI 10.1074/jbc.M200373200; Senoo M, 2007, CELL, V129, P523, DOI 10.1016/j.cell.2007.02.045; Sharpless NE, 2007, NAT REV MOL CELL BIO, V8, P703, DOI 10.1038/nrm2241; Stern M, 1996, AM J PATHOL, V149, P911; Tang DG, 2007, MOL CARCINOGEN, V46, P1, DOI 10.1002/mc.20255; Tang DG, 2001, SCIENCE, V291, P868, DOI 10.1126/science.1056780; Tang SH, 2002, J BIOL CHEM, V277, P16189, DOI 10.1074/jbc.M111936200; Taylor RA, 2006, NAT METHODS, V3, P179, DOI 10.1038/nmeth855; Uzgare AR, 2004, J CELL BIOCHEM, V91, P196, DOI 10.1002/jcb.10764; van Leenders G, 2000, LAB INVEST, V80, P1251, DOI 10.1038/labinvest.3780133; Wang SY, 2006, P NATL ACAD SCI USA, V103, P1480, DOI 10.1073/pnas.0510652103; Wang YZ, 2001, DIFFERENTIATION, V68, P270, DOI 10.1046/j.1432-0436.2001.680414.x; Welford SM, 2006, GENE DEV, V20, P3366, DOI 10.1101/gad.1471106; Yasunaga Y, 2001, CANCER RES, V61, P5969; Yaswen P, 2007, CELL, V128, P233, DOI 10.1016/j.cell.2007.01.005	58	28	28	0	3	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	OCT 10	2008	283	41					27957	27972		10.1074/jbc.M803467200	http://dx.doi.org/10.1074/jbc.M803467200			16	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	355OW	18662989	Green Published, hybrid			2022-12-27	WOS:000259719200066
J	Randhawa, VK; Ishikura, S; Talior-Volodarsky, I; Cheng, AWP; Patel, N; Hartwig, JH; Klip, A				Randhawa, Varinder K.; Ishikura, Shuhei; Talior-Volodarsky, Ilana; Cheng, Alex W. P.; Patel, Nish; Hartwig, John H.; Klip, Amira			GLUT4 vesicle recruitment and fusion are differentially regulated by Rac, AS160, and Rab8A in muscle cells	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							GTPASE-ACTIVATING-PROTEIN; INSULIN-STIMULATED PHOSPHORYLATION; PLASMA-MEMBRANE; GLUCOSE-UPTAKE; SKELETAL-MUSCLE; L6 MYOBLASTS; PHOSPHATIDYLINOSITOL 3-KINASE; 3T3-L1 ADIPOCYTES; CORTICAL ACTIN; ADIPOSE-CELLS	Insulin increases glucose uptake into muscle by enhancing the surface recycling of GLUT4 transporters. In myoblasts, insulin signals bifurcate downstream of phosphatidylinositol 3-kinase into separate Akt and Rac/actin arms. Akt-mediated Rab-GAP AS160 phosphorylation and Rac/actin are required for net insulin gain of GLUT4, but the specific steps (vesicle recruitment, docking or fusion) regulated by Rac, actin dynamics, and AS160 target Rab8A are unknown. In L6 myoblasts expressing GLUT4myc, blocking vesicle fusion by tetanus toxin cleavage of VAMP2 impeded GLUT4myc membrane insertion without diminishing its build-up at the cell periphery. Conversely, actin disruption by dominant negative Rac or Latrunculin B abolished insulin-induced surface and submembrane GLUT4myc accumulation. Expression of non-phosphorylatable AS160 (AS1604P) abrogated membrane insertion of GLUT4myc and partially reduced its cortical build-up, an effect magnified by selective Rab8A knockdown. We propose that insulin-induced actin dynamics participates in GLUT4myc vesicle retention beneath the membrane, whereas AS160 phosphorylation is essential for GLUT4myc vesicle-membrane docking/fusion and also contributes to GLUT4myc cortical availability through Rab8A.	[Randhawa, Varinder K.; Ishikura, Shuhei; Talior-Volodarsky, Ilana; Cheng, Alex W. P.; Patel, Nish; Klip, Amira] Hosp Sick Children, Cell Biol Program, Toronto, ON M5G 1X8, Canada; [Randhawa, Varinder K.; Klip, Amira] Univ Toronto, Dept Biochem, Toronto, ON M5S 1A8, Canada; [Hartwig, John H.] Harvard Univ, Brigham & Womens Hosp, Sch Med, Div Hematol,Dept Med, Boston, MA 02115 USA	University of Toronto; University Toronto Affiliates; Hospital for Sick Children (SickKids); University of Toronto; Harvard University; Brigham & Women's Hospital; Harvard Medical School	Klip, A (corresponding author), Hosp Sick Children, Cell Biol Program, 555 Univ Ave, Toronto, ON M5G 1X8, Canada.	amira@sickkids.ca			Canadian Institutes of Health Research (CIHR)	Canadian Institutes of Health Research (CIHR)(Canadian Institutes of Health Research (CIHR))	This study was supported by Grant MOP-7307 (to A. K.) from the Canadian Institutes of Health Research (CIHR). The costs of publication of this article were defrayed in part by the payment of page charges. This article must therefore be hereby marked "advertisement" in accordance with 18 U. S. C. Section 1734 solely to indicate this fact.	Ang AL, 2003, J CELL BIOL, V163, P339, DOI 10.1083/jcb.200307046; ANTONESCU CN, 2008, DISSECTING GLUT 4 TR; Antonescu CN, 2008, TRAFFIC, V9, P1173, DOI 10.1111/j.1600-0854.2008.00755.x; Bai L, 2007, CELL METAB, V5, P47, DOI 10.1016/j.cmet.2006.11.013; Blot V, 2006, EMBO J, V25, P5648, DOI 10.1038/sj.emboj.7601462; Brown TC, 2007, J NEUROSCI, V27, P13311, DOI 10.1523/JNEUROSCI.4258-07.2007; Chabrillat ML, 2005, MOL BIOL CELL, V16, P1640, DOI 10.1091/mbc.e04-09-0770; Chen XW, 2007, DEV CELL, V13, P391, DOI 10.1016/j.devcel.2007.07.007; Coster ACF, 2004, TRAFFIC, V5, P763, DOI 10.1111/j.1600-0854.2004.00218.x; DEFRONZO RA, 1981, J CLIN INVEST, V68, P1468, DOI 10.1172/JCI110399; Dugani CB, 2005, EMBO REP, V6, P1137, DOI 10.1038/sj.embor.7400584; Eguez L, 2005, CELL METAB, V2, P263, DOI 10.1016/j.cmet.2005.09.005; Fletcher LM, 2000, BIOCHEM J, V352, P267, DOI 10.1042/0264-6021:3520267; Foster LJ, 2000, AM J PHYSIOL-CELL PH, V279, pC877, DOI 10.1152/ajpcell.2000.279.4.C877; Foster LJ, 2006, J PROTEOME RES, V5, P64, DOI 10.1021/pr0502626; Foster LJ, 1999, AM J PHYSIOL-CELL PH, V276, pC1108, DOI 10.1152/ajpcell.1999.276.5.C1108; Foster LJ, 2001, J BIOL CHEM, V276, P44212, DOI 10.1074/jbc.M102964200; Geraghty KM, 2007, BIOCHEM J, V407, P231, DOI 10.1042/BJ20070649; Glodowski DR, 2007, MOL BIOL CELL, V18, P4387, DOI 10.1091/mbc.E07-05-0486; Govers R, 2004, MOL CELL BIOL, V24, P6456, DOI 10.1128/MCB.24.14.6456-6466.2004; Graham ME, 2008, BIOCHEM J, V409, P407, DOI 10.1042/BJ20071094; Hattula K, 2006, J CELL SCI, V119, P4866, DOI 10.1242/jcs.03275; Hou JCQ, 2003, MOL BIOL CELL, V14, P3578, DOI 10.1091/mbc.E03-02-0012; Huang C, 2002, DIABETES, V51, P2090, DOI 10.2337/diabetes.51.7.2090; Huang SH, 2007, MOL CELL BIOL, V27, P3456, DOI 10.1128/MCB.01719-06; Inoue M, 2006, MOL BIOL CELL, V17, P2303, DOI 10.1091/mbc.E06-01-0030; ISHIKAWA H, 1969, J CELL BIOL, V43, P312; Ishiki M, 2005, J BIOL CHEM, V280, P28792, DOI 10.1074/jbc.M500501200; Ishikura S, 2008, ACTA PHYSIOL, V192, P61, DOI 10.1111/j.1748-1716.2007.01778.x; Ishikura S, 2007, BIOCHEM BIOPH RES CO, V353, P1074, DOI 10.1016/j.bbrc.2006.12.140; Jebailey L, 2004, MOL ENDOCRINOL, V18, P359, DOI 10.1210/me.2003-0294; JeBailey L, 2007, DIABETES, V56, P394, DOI 10.2337/db06-0823; Jiang L, 2008, J BIOL CHEM, V283, P8508, DOI 10.1074/jbc.M708688200; Kaddai V, 2008, ACTA PHYSIOL, V192, P75, DOI 10.1111/j.1748-1716.2007.01787.x; Karlsson HKR, 2005, DIABETES, V54, P1692, DOI 10.2337/diabetes.54.6.1692; KARNIELI E, 1993, ENDOCRINOLOGY, V133, P2943, DOI 10.1210/en.133.6.2943; Khayat ZA, 2000, J CELL SCI, V113, P279; Koumanov F, 2005, CELL METAB, V2, P179, DOI 10.1016/j.cmet.2005.08.007; Lang Thorsten, 2008, V184, P107; Larance M, 2005, J BIOL CHEM, V280, P37803, DOI 10.1074/jbc.M503897200; Li DL, 2001, J BIOL CHEM, V276, P22883, DOI 10.1074/jbc.M010143200; Lizunov VA, 2005, J CELL BIOL, V169, P481, DOI 10.1083/jcb.200412069; MATSUDAIRA P, 1991, TRENDS BIOCHEM SCI, V16, P87, DOI 10.1016/0968-0004(91)90039-X; Muretta JM, 2008, J BIOL CHEM, V283, P311, DOI 10.1074/jbc.M705756200; Oatey PB, 1997, BIOCHEM J, V327, P637; Patel N, 2003, MOL CELL BIOL, V23, P4611, DOI 10.1128/MCB.23.13.4611-4626.2003; Patel N, 2006, PFLUG ARCH EUR J PHY, V451, P499, DOI 10.1007/s00424-005-1475-6; Patki V, 2001, MOL BIOL CELL, V12, P129, DOI 10.1091/mbc.12.1.129; Peranen J, 1996, J CELL BIOL, V135, P153, DOI 10.1083/jcb.135.1.153; Randhawa VK, 2000, MOL BIOL CELL, V11, P2403, DOI 10.1091/mbc.11.7.2403; Randhawa VK, 2004, MOL BIOL CELL, V15, P5565, DOI 10.1091/mbc.E04-03-0266; Regazzi R, 1996, EMBO J, V15, P6951, DOI 10.1002/j.1460-2075.1996.tb01087.x; Rudich A, 2003, ACTA PHYSIOL SCAND, V178, P297, DOI 10.1046/j.1365-201X.2003.01163.x; Sano H, 2003, J BIOL CHEM, V278, P14599, DOI 10.1074/jbc.C300063200; Sano H, 2007, CELL METAB, V5, P293, DOI 10.1016/j.cmet.2007.03.001; Semiz S, 2003, EMBO J, V22, P2387, DOI 10.1093/emboj/cdg237; Sweeney G, 2004, J BIOL CHEM, V279, P32233, DOI 10.1074/jbc.M402897200; TALIORVOLODARSK.I, 2008, J BIOL CHEM     0710; Thong FSL, 2007, DIABETES, V56, P414, DOI 10.2337/db06-0900; Thong FSL, 2005, PHYSIOLOGY, V20, P271, DOI 10.1152/physiol.00017.2005; Tong P, 2001, J CLIN INVEST, V108, P371, DOI 10.1172/JCI12348; Ueyama A, 1999, AM J PHYSIOL-ENDOC M, V277, pE572, DOI 10.1152/ajpendo.1999.277.3.E572; Wang QH, 1998, FEBS LETT, V427, P193, DOI 10.1016/S0014-5793(98)00423-2; Wang QH, 1999, MOL CELL BIOL, V19, P4008; Watson RT, 2007, CELL SIGNAL, V19, P2209, DOI 10.1016/j.cellsig.2007.06.003; Williams D, 2008, J CELL BIOL, V180, P375, DOI 10.1083/jcb.200709108; Xu Z, 2002, J BIOL CHEM, V277, P47972, DOI 10.1074/jbc.C200486200; Yeung T, 2006, SCIENCE, V313, P347, DOI 10.1126/science.1129551; Zeigerer A, 2002, MOL BIOL CELL, V13, P2421, DOI 10.1091/mbc.E02-02-0071; Zeigerer A, 2004, MOL BIOL CELL, V15, P4406, DOI 10.1091/mbc.e04-04-0333	70	91	94	0	10	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	OCT 3	2008	283	40					27208	27219		10.1074/jbc.M804282200	http://dx.doi.org/10.1074/jbc.M804282200			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	353RT	18650435	hybrid			2022-12-27	WOS:000259586600041
J	Wei, S; Yang, HC; Chuang, HC; Yang, J; Kulp, SK; Lu, PJ; Lai, MD; Chen, CS				Wei, Shuo; Yang, Hsiao-Ching; Chuang, Hsiao-Ching; Yang, Jian; Kulp, Samuel K.; Lu, Pei-Jung; Lai, Ming-Derg; Chen, Ching-Shih			A novel mechanism by which thiazolidinediones facilitate the proteasomal degradation of cyclin D1 in cancer cells	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ACTIVATED-RECEPTOR-GAMMA; KAPPA-B; DEPENDENT UBIQUITINATION; TRANSFORMED PHENOTYPE; INHIBITS GROWTH; SOMATIC WEE1; PHOSPHORYLATION; ANTISENSE; EXPRESSION; KINASE	This study identifies a novel mechanism by which thiazolidinediones mediate cyclin D1 repression in prostate cancer cells. Based on the finding that the thiazolidinedione family of peroxisome proliferator-activated receptor gamma(PPAR gamma) agonists mediatedPPAR gamma-independent cyclin D1 degradation, we developed a novel PPAR gamma-inactive troglitazone derivative, STG28, with high potency in cyclin D1 ablation. STG28-mediated cyclin D1 degradation was preceded by Thr-286 phosphorylation and nuclear export, which however, were independent of glycogen synthase kinase 3 beta. Mutational analysis further confirmed the pivotal role of Thr-286 phosphorylation in STG28-induced nuclear export and proteolysis. Of several kinases examined, inhibition of I kappa B kinase alpha blocked STG28-mediated cytoplasmic sequestration and degradation of cyclin D1. Pulldown of ectopically expressed Cul1, the scaffold protein of the Skp-Cullin-F- box E3 ligase, in STG28-treated cells revealed an increased association of cyclin D1 with beta-TrCP, whereas no specific binding was noted with other F-box proteins examined, including Skp2, Fbw7, Fbx4, and Fbxw8. This finding represents the first evidence that cyclin D1 is targeted by beta-TrCP. Moreover, beta-TrCP expression was up-regulated in response to STG28, and ectopic expression and small interfering RNA-mediated knockdown of beta-TrCP enhanced and protected against STG28-facilitated cyclin D1 degradation, respectively. Because cyclin D1 lacks the DSG destruction motif, mutational and modeling analyses indicate that cyclin D1 was targeted by beta-TrCP through an unconventional recognition site, (279)EEVDLACpT(286), reminiscent to that of Wee1. Moreover, we obtained evidence that this beta-TrCP-dependent degradation takes part in controlling cyclin D1 turnover when cancer cells undergo glucose starvation, which endows physiological relevance to this novel mechanism.	[Wei, Shuo; Chuang, Hsiao-Ching; Yang, Jian; Kulp, Samuel K.; Chen, Ching-Shih] Ohio State Univ, Coll Pharm, Div Med Chem & Pharmacognosy, Columbus, OH 43210 USA; [Yang, Hsiao-Ching] Fu Jen Catholic Univ, Dept Chem, Taipei 24205, Taiwan; [Lu, Pei-Jung] Natl Cheng Kung Univ, Inst Clin Med, Tainan 704, Taiwan; [Lai, Ming-Derg] Natl Cheng Kung Univ, Dept Biochem & Mol Biol, Tainan 704, Taiwan	University System of Ohio; Ohio State University; Fu Jen Catholic University; National Cheng Kung University; National Cheng Kung University	Chen, CS (corresponding author), Ohio State Univ, Coll Pharm, Div Med Chem & Pharmacognosy, 500 W 12th Ave, Columbus, OH 43210 USA.	chen.844@osu.edu	Lai, Ming-Derg/M-8028-2014; Yang, Hsiao-Ching/AGI-3553-2022; Yang, Jian/B-9451-2012	Yang, Hsiao-Ching/0000-0002-7970-1357; 	National Institutes of Health Public Health Service [CA112250]; Ohio State University Medical Center; NATIONAL CANCER INSTITUTE [R01CA112250] Funding Source: NIH RePORTER	National Institutes of Health Public Health Service(United States Department of Health & Human ServicesUnited States Public Health ServiceNational Institutes of Health (NIH) - USA); Ohio State University Medical Center; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This work was supported, in whole or in part, by National Institutes of Health Public Health Service Grant CA112250 (NCI). This work was also supported by the Lucius A. Wing Endowed Chair Fund from The Ohio State University Medical Center. The costs of publication of this article were defrayed in part by the payment of page charges. This article must therefore be hereby marked " advertisement" in accordance with 18 U. S. C. Section 1734 solely to indicate this fact.	Alao JP, 2007, MOL CANCER, V6, DOI 10.1186/1476-4598-6-24; Alao JP, 2006, MOL CANCER, V5, DOI 10.1186/1476-4598-5-8; Alt JR, 2000, GENE DEV, V14, P3102, DOI 10.1101/gad.854900; Arber N, 1997, CANCER RES, V57, P1569; Casanovas O, 2000, J BIOL CHEM, V275, P35091, DOI 10.1074/jbc.M006324200; Chen B, 1999, WORLD J GASTROENTERO, V5, P18; Chung DC, 2004, ANN NY ACAD SCI, V1014, P209, DOI 10.1196/annals.1294.022; Coqueret O, 2002, GENE, V299, P35, DOI 10.1016/S0378-1119(02)01055-7; Diehl JA, 1997, GENE DEV, V11, P957, DOI 10.1101/gad.11.8.957; Diehl JA, 2002, CANCER BIOL THER, V1, P226, DOI 10.4161/cbt.72; Ewen ME, 2004, TRENDS MOL MED, V10, P158, DOI 10.1016/j.molmed.2004.02.005; Fiser A, 2000, PROTEIN SCI, V9, P1753, DOI 10.1110/ps.9.9.1753; Fu MF, 2004, ENDOCRINOLOGY, V145, P5439, DOI 10.1210/en.2004-0959; Huang JW, 2006, J MED CHEM, V49, P4684, DOI 10.1021/jm060057h; Huang JW, 2005, MOL PHARMACOL, V67, P1342, DOI 10.1124/mol.104.007732; Hung JH, 2004, J BIOL CHEM, V279, P46384, DOI 10.1074/jbc.M403568200; Kornmann M, 1998, J CLIN INVEST, V101, P344, DOI 10.1172/JCI1323; Kwak YT, 2005, J BIOL CHEM, V280, P33945, DOI 10.1074/jbc.M506206200; Langenfeld J, 1997, P NATL ACAD SCI USA, V94, P12070, DOI 10.1073/pnas.94.22.12070; Lapillonne H, 2003, CANCER RES, V63, P5926; Lin DI, 2006, MOL CELL, V24, P355, DOI 10.1016/j.molcel.2006.09.007; Mackerell AD, 2004, J COMPUT CHEM, V25, P1584, DOI 10.1002/jcc.20082; Mukhopadhyay A, 2002, ONCOGENE, V21, P8852, DOI 10.1038/sj.onc.1206048; Nakayama KI, 2005, SEMIN CELL DEV BIOL, V16, P323, DOI 10.1016/j.semcdb.2005.02.010; Okabe H, 2006, PLOS ONE, V1, DOI 10.1371/journal.pone.0000128; Qin CH, 2004, MOL CANCER THER, V3, P247; Qin CH, 2003, CANCER RES, V63, P958; Sauter ER, 2002, CANCER RES, V62, P3200; Sauter ER, 2000, CLIN CANCER RES, V6, P654; Schrump DS, 1996, CANCER GENE THER, V3, P131; Shtutman M, 1999, P NATL ACAD SCI USA, V96, P5522, DOI 10.1073/pnas.96.10.5522; Stacey DW, 2003, CURR OPIN CELL BIOL, V15, P158, DOI 10.1016/S0955-0674(03)00008-5; Thoms HC, 2007, CANCER RES, V67, P1660, DOI 10.1158/0008-5472.CAN-06-1038; Wang CG, 2001, MOL CELL BIOL, V21, P3057, DOI 10.1128/MCB.21.9.3057-3070.2001; Wang Chenguang, 2004, Cancer Treat Res, V119, P217; Watanabe N, 2004, P NATL ACAD SCI USA, V101, P4419, DOI 10.1073/pnas.0307700101; Watanabe N, 2005, P NATL ACAD SCI USA, V102, P11663, DOI 10.1073/pnas.0500410102; Wei S, 2007, MOL PHARMACOL, V72, P725, DOI 10.1124/mol.107.035287; Weinstein IB, 2000, CARCINOGENESIS, V21, P857, DOI 10.1093/carcin/21.5.857; Wu G, 2003, MOL CELL, V11, P1445, DOI 10.1016/S1097-2765(03)00234-X; Yang CC, 2007, CANCER RES, V67, P3229, DOI 10.1158/0008-5472.CAN-06-2759; Yang CS, 2005, J BIOL CHEM, V280, P10083, DOI 10.1074/jbc.M413986200; Yin F, 2001, BIOCHEM BIOPH RES CO, V286, P916, DOI 10.1006/bbrc.2001.5491; Yu ZK, 1998, P NATL ACAD SCI USA, V95, P11324, DOI 10.1073/pnas.95.19.11324; ZHOU P, 1995, ONCOGENE, V11, P571	45	60	61	0	8	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	SEP 26	2008	283	39					26759	26770		10.1074/jbc.M802160200	http://dx.doi.org/10.1074/jbc.M802160200			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	350GV	18650423	Green Published, hybrid			2022-12-27	WOS:000259341600048
J	Giles, TN; Graham, DE				Giles, Teresa N.; Graham, David E.			Crenarchaeal arginine decarboxylase evolved from an S-adenosylmethionine decarboxylase enzyme	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							IONIZATION-MASS SPECTROMETRY; COVALENTLY BOUND PYRUVATE; METHANOCOCCUS-JANNASCHII; POLYAMINE BIOSYNTHESIS; EXTREME THERMOPHILE; ESCHERICHIA-COLI; SULFOLOBUS-SOLFATARICUS; CALDARIELLA-ACIDOPHILA; THERMUS-THERMOPHILUS; AMINO-ACIDS	The crenarchaeon Sulfolobus solfataricus uses arginine to produce putrescine for polyamine biosynthesis. However, genome sequences from S. solfataricus and most crenarchaea have no known homologs of the previously characterized pyridoxal 5'-phosphate or pyruvoyl-dependent arginine decarboxylases that catalyze the first step in this pathway. Instead they have two paralogs of the S-adenosylmethionine decarboxylase (AdoMetDC). The gene at locus SSO0585 produces an AdoMetDC enzyme, whereas the gene at locus SSO0536 produces a novel arginine decarboxylase (ArgDC). Both thermostable enzymes self-cleave at conserved serine residues to form amino-terminal beta-domains and carboxyl-terminal alpha-domains with reactive pyruvoyl cofactors. The ArgDC enzyme specifically catalyzed arginine decarboxylation more efficiently than previously studied pyruvoyl enzymes. alpha-Difluoromethylarginine significantly reduced the ArgDC activity of purified enzyme, and treating growing S. solfataricus cells with this inhibitor reduced the cells' ratio of spermidine to norspermine by decreasing the putrescine pool. The crenarchaeal ArgDC had no AdoMetDC activity, whereas its AdoMetDC paralog had no ArgDC activity. A chimeric protein containing the beta-subunit of SSO0536 and the alpha-subunit of SSO0585 had ArgDC activity, implicating residues responsible for substrate specificity in the amino-terminal domain. This crenarchaeal ArgDC is the first example of alternative substrate specificity in the AdoMetDC family. ArgDC activity has evolved through convergent evolution at least five times, demonstrating the utility of this enzyme and the plasticity of amino acid decarboxylases.	[Giles, Teresa N.; Graham, David E.] Univ Texas Austin, Dept Chem & Biochem, Austin, TX 78712 USA; [Giles, Teresa N.; Graham, David E.] Univ Texas Austin, Inst Cellular & Mol Biol, Austin, TX 78712 USA	University of Texas System; University of Texas Austin; University of Texas System; University of Texas Austin	Graham, DE (corresponding author), 1 Univ Stn A5300, Austin, TX 78712 USA.	degraham@mail.utexas.edu	Graham, David E/F-8578-2010	Graham, David E/0000-0001-8968-7344	National Institutes of Health; NIAID; Public Health Service [AI064444]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R21AI064444] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES [P30ES007784] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NIAID(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); Public Health Service(United States Department of Health & Human ServicesUnited States Public Health Service); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS))	This work was supported, in whole or in part, by National Institutes of Health Grant, NIAID, Public Health Service Grant AI064444. The costs of publication of this article were defrayed in part by the payment of page charges. This article must therefore be hereby marked "advertisement" in accordance with 18 U. S. C. Section 1734 solely to indicate this fact.	Andersson AF, 2006, GENOME BIOL, V7, DOI 10.1186/gb-2006-7-10-r99; BEY P, 1979, J ORG CHEM, V44, P2732, DOI 10.1021/jo01329a029; BLETHEN SL, 1968, J BIOL CHEM, V243, P1671; BROCK TD, 1972, ARCH MIKROBIOL, V84, P54, DOI 10.1007/BF00408082; CACCIAPUOTI G, 1986, EUR J BIOCHEM, V161, P263, DOI 10.1111/j.1432-1033.1986.tb10442.x; CACCIAPUOTI G, 1991, EUR J BIOCHEM, V199, P395, DOI 10.1111/j.1432-1033.1991.tb16136.x; Cacciapuoti G, 2007, J BACTERIOL, V189, P6057, DOI 10.1128/JB.00151-07; DEROSA M, 1976, BIOCHEM BIOPH RES CO, V69, P253, DOI 10.1016/S0006-291X(76)80300-2; DEROSA M, 1978, BIOCHEM J, V176, P1; Gaboriau F, 2003, ANAL BIOCHEM, V318, P212, DOI 10.1016/S0003-2697(03)00214-8; Giles TN, 2007, J BACTERIOL, V189, P7376, DOI 10.1128/JB.00772-07; Goda S, 2005, BBA-PROTEINS PROTEOM, V1748, P110, DOI 10.1016/j.bbapap.2004.12.010; Graham DE, 2002, J BIOL CHEM, V277, P23500, DOI 10.1074/jbc.M203467200; Graham DE, 2000, J BIOL CHEM, V275, P4055, DOI 10.1074/jbc.275.6.4055; HAMANA K, 1994, MICROBIOS, V79, P109; Helgadottir S, 2007, J BACTERIOL, V189, P575, DOI 10.1128/JB.01269-06; HOFFMAN JL, 1986, BIOCHEMISTRY-US, V25, P4444, DOI 10.1021/bi00363a041; HORTON RM, 1990, BIOTECHNIQUES, V8, P528; Kezmarsky ND, 2005, BBA-GEN SUBJECTS, V1722, P175, DOI 10.1016/j.bbagen.2004.12.003; Kim AD, 2000, J BACTERIOL, V182, P6667, DOI 10.1128/JB.182.23.6667-6672.2000; Lord PW, 2002, BIOINFORMATICS, V18, P1402, DOI 10.1093/bioinformatics/18.10.1402; Mukhopadhyay B, 1999, APPL ENVIRON MICROB, V65, P5059; NICOLAUS B, 1988, SYST APPL MICROBIOL, V10, P215, DOI 10.1016/S0723-2020(88)80003-1; Notredame C, 2000, J MOL BIOL, V302, P205, DOI 10.1006/jmbi.2000.4042; Ohnuma M, 2005, J BIOL CHEM, V280, P30073, DOI 10.1074/jbc.M413332200; POULIN R, 1992, J BIOL CHEM, V267, P150; Ray SS, 2002, STRUCTURE, V10, P1499, DOI 10.1016/S0969-2126(02)00880-8; RILEY WD, 1968, BIOCHEMISTRY-US, V7, P3520, DOI 10.1021/bi00850a029; SANDMEIER E, 1994, EUR J BIOCHEM, V221, P997, DOI 10.1111/j.1432-1033.1994.tb18816.x; SCHAGGER H, 1987, ANAL BIOCHEM, V166, P379; Shah R, 2004, J BIOL CHEM, V279, P35760, DOI 10.1074/jbc.M405366200; SHIPE JR, 1979, CLIN CHEM, V25, P1564; Snider MJ, 2000, J AM CHEM SOC, V122, P11507, DOI 10.1021/ja002851c; TABOR H, 1980, J BACTERIOL, V144, P952, DOI 10.1128/JB.144.3.952-956.1980; Terui Y, 2005, BIOCHEM J, V388, P427, DOI 10.1042/BJ20041778; Tolbert WD, 2003, STRUCTURE, V11, P285, DOI 10.1016/S0969-2126(03)00026-1; Tolbert WD, 2001, BIOCHEMISTRY-US, V40, P9484, DOI 10.1021/bi010735w; Toms AV, 2004, J BIOL CHEM, V279, P33837, DOI 10.1074/jbc.M403369200; Toney MD, 2005, ARCH BIOCHEM BIOPHYS, V433, P279, DOI 10.1016/j.abb.2004.09.037; WU WH, 1973, J BIOL CHEM, V248, P1687; Zabinski RF, 2001, J AM CHEM SOC, V123, P193, DOI 10.1021/ja0026354	41	22	24	0	9	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	SEP 19	2008	283	38					25829	25838		10.1074/jbc.M802674200	http://dx.doi.org/10.1074/jbc.M802674200			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	348GX	18650422	Green Published, hybrid			2022-12-27	WOS:000259200100009
J	Klein, RM; Ufret-Vincenty, CA; Hua, L; Gordon, SE				Klein, Rebecca M.; Ufret-Vincenty, Carmen A.; Hua, Li; Gordon, Sharona E.			Determinants of molecular specificity in phosphoinositide regulation	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							PLECKSTRIN HOMOLOGY DOMAINS; PHOSPHATIDYLINOSITOL 4,5-BISPHOSPHATE; ION CHANNELS; PLASMA-MEMBRANE; CELL-LINE; PIP2; INHIBITION; ACTIVATION; BINDING; TRPV1	Once thought of as simply an oily barrier that maintains cellular integrity, lipids are now known to play an active role in a large variety of cellular processes. Phosphoinositides are of particular interest because of their remarkable ability to affect many signaling pathways. Ion channels and transporters are an important target of phosphoinositide signaling, but identification of the specific phosphoinositides involved has proven elusive. TRPV1 is a good example; although phosphatidylinositol (4,5)-bisphosphate (PI(4,5)P-2) can potently regulate its activation, we show that phosphatidylinositol (4)-phosphate (PI(4)P) and phosphatidylinositol (3,4,5)-trisphosphate (PI(3,4,5)P-3) can as well. To determine the identity of the endogenous phosphoinositide regulating TRPV1, we applied recombinant pleckstrin homology domains to inside-out excised patches. Although a PI(4,5)P-2-specific pleckstrin homology domain inhibited TRPV1, a PI(3,4,5)P-3-specific pleckstrin homology domain had no effect. Simultaneous confocal imaging and electrophysiological recording of whole cells expressing a rapamycin-inducible lipid phosphatase also demonstrates that depletion of PI(4,5)P-2 inhibits capsaicin-activated TRPV1 current; the PI(4)P generated by the phosphatases was not sufficient to support TRPV1 function. We conclude that PI(4,5)P-2, and not other phosphoinositides or other lipids, is the endogenous phosphoinositide regulating TRPV1 channels.	[Klein, Rebecca M.; Ufret-Vincenty, Carmen A.; Hua, Li; Gordon, Sharona E.] Univ Washington, Dept Physiol & Biophys, Seattle, WA 98195 USA	University of Washington; University of Washington Seattle	Gordon, SE (corresponding author), Univ Washington, Dept Physiol & Biophys, Box 357290, Seattle, WA 98195 USA.	seg@u.washington.edu			National Institutes of Health [R01EY017564]; University of Washington [2T32EY007031-31]; University of Washington Molecular Neuroscience [5T32NS007332-19]; NATIONAL EYE INSTITUTE [T32EY007031, R01EY017564] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [T32NS007332] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); University of Washington(University of Washington); University of Washington Molecular Neuroscience(University of Washington); NATIONAL EYE INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	This work was supported, in whole or in part, by National Institutes of Health Grant R01EY017564 from the NEI (to S.E.G.). This work was also supported by the University of Washington Vision Training Grant 2T32EY007031-31 (to R.M.K.) and the University of Washington Molecular Neuroscience Training Grant 5T32NS007332-19 (to C.A.U.). The costs of publication of this article were defrayed in part by the payment of page charges. This article must therefore be hereby marked "advertisement" in accordance with 18 U.S.C. Section 1734 solely to indicate this fact.	BenTal N, 1996, BIOPHYS J, V71, P561, DOI 10.1016/S0006-3495(96)79280-9; Brown DA, 2007, J PHYSIOL-LONDON, V582, P917, DOI 10.1113/jphysiol.2007.132498; Chuang HH, 2001, NATURE, V411, P957, DOI 10.1038/35082088; Czech MP, 2000, CELL, V100, P603, DOI 10.1016/S0092-8674(00)80696-0; Ferguson KM, 2000, MOL CELL, V6, P373, DOI 10.1016/S1097-2765(00)00037-X; FRANCEL PC, 1987, J NEUROCHEM, V48, P1624, DOI 10.1111/j.1471-4159.1987.tb05711.x; GABEV E, 1989, BIOCHIM BIOPHYS ACTA, V979, P105, DOI 10.1016/0005-2736(89)90529-4; Gamper N, 2007, J PHYSIOL-LONDON, V582, P967, DOI 10.1113/jphysiol.2007.132787; Hardie RC, 2007, J PHYSIOL-LONDON, V578, P9, DOI 10.1113/jphysiol.2006.118372; HARLAN JE, 1995, BIOCHEMISTRY-US, V34, P9859, DOI 10.1021/bi00031a006; Hilgemann D W, 2001, Sci STKE, V2001, pre19, DOI 10.1126/stke.2001.111.re19; Iwasaki H, 2008, P NATL ACAD SCI USA, V105, P7970, DOI 10.1073/pnas.0803936105; Jahnel R, 2003, EUR J BIOCHEM, V270, P4264, DOI 10.1046/j.1432-1033.2003.03811.x; Klarlund JK, 2000, J BIOL CHEM, V275, P32816, DOI 10.1074/jbc.M002435200; Kozak JA, 2005, J GEN PHYSIOL, V126, P499, DOI 10.1085/jgp.200509324; Kwon Y, 2007, MOL CELL, V25, P491, DOI 10.1016/j.molcel.2007.01.021; Lee J, 2005, J GEN PHYSIOL, V126, P439, DOI 10.1085/jgp.200509314; Lemmon MA, 2003, TRAFFIC, V4, P201, DOI 10.1034/j.1600-0854.2004.00071.x; LEMMON MA, 1995, P NATL ACAD SCI USA, V92, P10472, DOI 10.1073/pnas.92.23.10472; Liu BY, 2005, J NEUROSCI, V25, P4835, DOI 10.1523/JNEUROSCI.1296-05.2005; Liu BY, 2005, J NEUROSCI, V25, P1674, DOI 10.1523/JNEUROSCI.3632-04.2005; Liu D, 2003, P NATL ACAD SCI USA, V100, P15160, DOI 10.1073/pnas.2334159100; Lukacs V, 2007, J NEUROSCI, V27, P7070, DOI 10.1523/JNEUROSCI.1866-07.2007; McLaughlin S, 2005, NATURE, V438, P605, DOI 10.1038/nature04398; McLaughlin S, 2002, ANNU REV BIOPH BIOM, V31, P151, DOI 10.1146/annurev.biophys.31.082901.134259; Murata Y, 2005, NATURE, V435, P1239, DOI 10.1038/nature03650; Murata Y, 2007, J PHYSIOL-LONDON, V583, P875, DOI 10.1113/jphysiol.2007.134775; Rohacs T, 2003, P NATL ACAD SCI USA, V100, P745, DOI 10.1073/pnas.0236364100; Rohacs T, 1999, J BIOL CHEM, V274, P36065, DOI 10.1074/jbc.274.51.36065; Rohacs T, 2005, NAT NEUROSCI, V8, P626, DOI 10.1038/nn1451; Rosenbaum T, 2004, J GEN PHYSIOL, V123, P53, DOI 10.1085/jgp.200308906; Schulze D, 2003, J PHYSIOL-LONDON, V552, P357, DOI 10.1113/jphysiol.2003.047035; Stein AT, 2006, J GEN PHYSIOL, V128, P509, DOI 10.1085/jgp.200609576; Suh BC, 2005, CURR OPIN NEUROBIOL, V15, P370, DOI 10.1016/j.conb.2005.05.005; Suh BC, 2006, SCIENCE, V314, P1454, DOI 10.1126/science.1131163; TONER M, 1988, BIOCHEMISTRY-US, V27, P7435, DOI 10.1021/bi00419a039; Tong QS, 2004, J BIOL CHEM, V279, P22654, DOI 10.1074/jbc.M401004200; Varnai P, 2006, J CELL BIOL, V175, P377, DOI 10.1083/jcb.200607116; Voets T, 2007, J PHYSIOL-LONDON, V582, P939, DOI 10.1113/jphysiol.2007.132522; Zhang Z, 2005, J BIOL CHEM, V280, P39185, DOI 10.1074/jbc.M506965200	40	81	83	0	3	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	SEP 19	2008	283	38					26208	26216		10.1074/jbc.M801912200	http://dx.doi.org/10.1074/jbc.M801912200			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	348GX	18574245	Green Published, hybrid			2022-12-27	WOS:000259200100049
J	Manna, D; Bhardwaj, N; Vora, MS; Stahelin, RV; Lu, H; Cho, WH				Manna, Debasis; Bhardwaj, Nitin; Vora, Mohsin S.; Stahelin, Robert V.; Lu, Hui; Cho, Wonhwa			Differential roles of phosphatidylserine, PtdIns(4,5)P-2, and PtdIns(3,4,5)P-3 in plasma membrane targeting of C2 domains - Molecular dynamics simulation, membrane binding, and cell translocation studies of the PKC alpha C2 domain	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							PARTICLE MESH EWALD; EFFICIENT GENERATION; PROTEIN INTERACTIONS; AM1-BCC MODEL; PKC-ALPHA; BILAYER; SURFACE; CA2+; LOCALIZATION; MECHANISM	Many cytosolic proteins are recruited to the plasma membrane ( PM) during cell signaling and other cellular processes. Recent reports have indicated that phosphatidylserine ( PS), phosphatidylinositol 4,5-bisphosphate (PtdIns(4,5)P-2), and phosphatidylinositol 3,4,5-trisphosphate (PtdIns(3,4,5)P-3) that are present in the PM play important roles for their specific PM recruitment. To systematically analyze how these lipids mediate PM targeting of cellular proteins, we performed biophysical, computational, and cell studies of the Ca2+-dependent C2 domain of protein kinase C alpha(PKC alpha) that is known to bind PS and phosphoinositides. In vitro membrane binding measurements by surface plasmon resonance analysis show that PKC alpha-C2 nonspecifically binds phosphoinositides, including PtdIns(4,5)P-2 and PtdIns(3,4,5)P-3, but that PS and Ca2+ binding is prerequisite for productive phosphoinositide binding. PtdIns(4,5)P-2 or PtdIns(3,4,5)P-3 augments the Ca2+- and PS-dependent membrane binding of PKC alpha-C2 by slowing its membrane dissociation. Molecular dynamics simulations also support that Ca2+-dependent PS binding is essential for membrane interactions of PKC alpha-C2. PtdIns(4,5)P-2 alone cannot drive the membrane attachment of the domain but further stabilizes the Ca2+- and PS-dependent membrane binding. When the fluorescence protein-tagged PKC alpha-C2 was expressed in NIH-3T3 cells, mutations of phosphoinositide-binding residues or depletion of PtdIns(4,5)P-2 and/or PtdIns(3,4,5)P-3 from PM did not significantly affect the PM association of the domain but accelerated its dissociation from PM. Also, local synthesis of PtdIns( 4,5) P2 or PtdIns( 3,4,5) P3 at the PM slowed membrane dissociation of PKC alpha-C2. Collectively, these studies show that PtdIns(4,5)P-2 and PtdIns(3,4,5)P-3 augment the Ca2+- and PS-dependent membrane binding of PKC alpha-C2 by elongating the membrane residence of the domain but cannot drive the PM recruitment of PKC alpha-C2. These studies also suggest that effective PM recruitment of many cellular proteins may require synergistic actions of PS and phosphoinositides.	[Bhardwaj, Nitin; Lu, Hui] Univ Illinois, Dept Bioengn, Bioinformat Program, Chicago, IL 60607 USA; [Manna, Debasis; Cho, Wonhwa] Univ Illinois, Dept Chem, Chicago, IL 60607 USA; [Lu, Hui] Univ Notre Dame, Walther Ctr Canc Res, South Bend, IN 46617 USA; [Vora, Mohsin S.] Indiana Univ, Sch Med, Dept Biochem & Mol Biol, South Bend, IN 46617 USA; [Stahelin, Robert V.] Univ Notre Dame, Dept Chem & Biochem, Notre Dame, IN 46556 USA	University of Illinois System; University of Illinois Chicago; University of Illinois Chicago Hospital; University of Illinois System; University of Illinois Chicago; University of Illinois Chicago Hospital; University of Notre Dame; Walther Cancer Institute; Indiana University System; Indiana University South Bend; University of Notre Dame	Lu, H (corresponding author), Univ Illinois, Dept Bioengn, Bioinformat Program, M-C 563, Chicago, IL 60607 USA.	huilu@uic.edu	Stahelin, Robert/L-3567-2019; Lu, Hui/K-3264-2019	Stahelin, Robert/0000-0001-5443-7863; Manna, Debasis/0000-0002-6920-9000; Lu, Hui/0000-0001-8347-0830	National Institutes of Health [P01AI060915, GM52598, GM68849, GM76581]; Indiana University; American Heart Association [0735350N]; American Cancer Society [IRG-84-002-22]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [P01AI060915] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM076581, R01GM052598, R01GM068849] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Indiana University; American Heart Association(American Heart Association); American Cancer Society(American Cancer Society); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported, in whole or in part, by National Institutes of Health Grants P01AI060915 (to H.L.) and GM52598, GM68849, and GM76581 (to W.C.). This work was also supported by an Indiana University Biomedical Research Grant, American Heart Association Grant SDG 0735350N, and American Cancer Society Grant IRG-84-002-22) (to R.V.S.). The costs of publication of this article were defrayed in part by the payment of page charges. This article must therefore be hereby marked "advertisement" in accordance with 18 U. S. C. Section 1734 solely to indicate this fact.	Bai JH, 2004, TRENDS BIOCHEM SCI, V29, P143, DOI 10.1016/j.tibs.2004.01.008; Berneche S, 1998, BIOPHYS J, V75, P1603, DOI 10.1016/S0006-3495(98)77604-0; Bhardwaj N, 2007, BIOINFORMATICS, V23, P3110, DOI 10.1093/bioinformatics/btm395; Blood PD, 2006, P NATL ACAD SCI USA, V103, P15068, DOI 10.1073/pnas.0603917103; Case DA, 2005, J COMPUT CHEM, V26, P1668, DOI 10.1002/jcc.20290; Cho W, 2001, J BIOL CHEM, V276, P32407, DOI 10.1074/jbc.R100007200; CHO W, 2006, SCI STKE, pPE7, DOI DOI 10.1126/STKE.3212006PE7; Cho WH, 2005, ANNU REV BIOPH BIOM, V34, P119, DOI 10.1146/annurev.biophys.33.110502.133337; Cho W, 2006, BBA-MOL CELL BIOL L, V1761, P838, DOI 10.1016/j.bbalip.2006.06.014; Cho WW, 2001, ANAL BIOCHEM, V296, P153, DOI 10.1006/abio.2001.5225; Conesa-Zamora P, 2001, BIOCHEMISTRY-US, V40, P13898, DOI 10.1021/bi011303o; Corbalan-Garcia S, 2003, J BIOL CHEM, V278, P4972, DOI 10.1074/jbc.M209385200; Corbin JA, 2007, BIOCHEMISTRY-US, V46, P4322, DOI 10.1021/bi062140c; DARDEN T, 1993, J CHEM PHYS, V98, P10089, DOI 10.1063/1.464397; Di Paolo G, 2002, NATURE, V420, P85, DOI 10.1038/nature01147; ESSMANN U, 1995, J CHEM PHYS, V103, P8577, DOI 10.1063/1.470117; Evans JH, 2006, MOL BIOL CELL, V17, P56, DOI 10.1091/mbc.e05-06-0499; FELLER SE, 1995, J CHEM PHYS, V103, P4613, DOI 10.1063/1.470648; Guerrero-Valero M, 2007, J MOL BIOL, V371, P608, DOI 10.1016/j.jmb.2007.05.086; Hauser H, 1992, STRUCTURE BIOL MEMBR, P3; Heo WD, 2006, SCIENCE, V314, P1458, DOI 10.1126/science.1134389; Humphrey W, 1996, J MOL GRAPH MODEL, V14, P33, DOI 10.1016/0263-7855(96)00018-5; Hurley JH, 2001, CURR OPIN CELL BIOL, V13, P146, DOI 10.1016/S0955-0674(00)00191-5; Inoue T, 2005, NAT METHODS, V2, P415, DOI 10.1038/NMETH763; Jakalian A, 2002, J COMPUT CHEM, V23, P1623, DOI 10.1002/jcc.10128; Jakalian A, 2000, J COMPUT CHEM, V21, P132, DOI 10.1002/(SICI)1096-987X(20000130)21:2<132::AID-JCC5>3.0.CO;2-P; Kasson PM, 2004, BIOPHYS J, V86, P3744, DOI 10.1529/biophysj.103.029652; Kohout SC, 2003, BIOCHEMISTRY-US, V42, P1254, DOI 10.1021/bi026596f; Liepina I, 2003, BIOPOLYMERS, V71, P49, DOI 10.1002/bip.10375; Malmberg NJ, 2005, ANNU REV BIOPH BIOM, V34, P71, DOI 10.1146/annurev.biophys.34.040204.144534; Manna D, 2007, J BIOL CHEM, V282, P32093, DOI 10.1074/jbc.M703517200; McLaughlin S, 2005, NATURE, V438, P605, DOI 10.1038/nature04398; McLaughlin S, 2002, ANNU REV BIOPH BIOM, V31, P151, DOI 10.1146/annurev.biophys.31.082901.134259; Medkova M, 1998, J BIOL CHEM, V273, P17544, DOI 10.1074/jbc.273.28.17544; Mihailescu D, 2000, BIOPHYS J, V79, P1718, DOI 10.1016/S0006-3495(00)76424-1; Mukhopadhyay P, 2004, BIOPHYS J, V86, P1601, DOI 10.1016/S0006-3495(04)74227-7; Murray D, 2002, MOL CELL, V9, P145, DOI 10.1016/S1097-2765(01)00426-9; Phillips JC, 2005, J COMPUT CHEM, V26, P1781, DOI 10.1002/jcc.20289; Sanchez-Bautista S, 2006, J MOL BIOL, V362, P901, DOI 10.1016/j.jmb.2006.07.093; Smondyrev AM, 2002, BIOPHYS J, V82, P1460, DOI 10.1016/S0006-3495(02)75500-8; Smondyrev AM, 2000, BIOPHYS J, V78, P1672, DOI 10.1016/S0006-3495(00)76719-1; Stahelin RV, 2005, J BIOL CHEM, V280, P43030, DOI 10.1074/jbc.M507574200; Stahelin RV, 2004, J BIOL CHEM, V279, P29501, DOI 10.1074/jbc.M403191200; Stahelin RV, 2003, J BIOL CHEM, V278, P12452, DOI 10.1074/jbc.M212864200; Stahelin RV, 2003, J BIOL CHEM, V278, P28993, DOI 10.1074/jbc.M302865200; Stahelin RV, 2001, BIOCHEMISTRY-US, V40, P4672, DOI 10.1021/bi0020325; Stahelin RV, 2001, BIOCHEM J, V359, P679, DOI 10.1042/0264-6021:3590679; Teruel MN, 2000, CELL, V103, P181, DOI 10.1016/S0092-8674(00)00109-4; Vance JE, 2005, PROG LIPID RES, V44, P207, DOI 10.1016/j.plipres.2005.05.001; Verdaguer N, 1999, EMBO J, V18, P6329, DOI 10.1093/emboj/18.22.6329; Villarreal MA, 2004, LANGMUIR, V20, P7844, DOI 10.1021/la049485l; Wang JM, 2004, J COMPUT CHEM, V25, P1157, DOI 10.1002/jcc.20035; Wang JM, 2006, J MOL GRAPH MODEL, V25, P247, DOI 10.1016/j.jmgm.2005.12.005; Yeung T, 2008, SCIENCE, V319, P210, DOI 10.1126/science.1152066	54	68	69	0	10	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	SEP 19	2008	283	38					26047	26058		10.1074/jbc.M802617200	http://dx.doi.org/10.1074/jbc.M802617200			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	348GX	18621733	Green Published, hybrid			2022-12-27	WOS:000259200100033
J	Omori, E; Morioka, S; Matsumoto, K; Ninomiya-Tsuji, J				Omori, Emily; Morioka, Sho; Matsumoto, Kunihiro; Ninomiya-Tsuji, Jun			TAK1 regulates reactive oxygen species and cell death in keratinocytes, which is essential for skin integrity	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							NF-KAPPA-B; UBIQUITIN LIGASE ITCH; KINASE TAK1; SIGNALING PATHWAYS; JNK ACTIVATION; ALPHA; EXPRESSION; INDUCTION; STRESS; INNATE	Mice with a keratinocyte-specific deletion of Tak1 exhibit severe skin inflammation due to hypersensitivity to tumor necrosis factor (TNF) killing. Here we have examined the mechanisms underlying this hypersensitivity. We found that TAK1 deficiency up-regulates reactive oxygen species (ROS) resulting in cell death upon TNF or oxidative stress challenge. Because blockade of NF-kappa B did not increase ROS or did not sensitize cells to oxidative stress in keratinocytes TAK1 regulates ROS mainly through the mechanisms other than those mediated by NF-kappa B. We found that c-Jun was decreased in TAK1-deficient keratinocytes and that ectopic expression of c-Jun could partially inhibit TNF-induced increase of ROS and cell death. Finally, we show that, in an in vivo setting, the antioxidant treatment could reduce an inflammatory condition in keratinocyte-specific Tak1 deletion mice. Thus, TAK1 regulates ROS partially through c-Jun, which is important for preventing ROS-induced skin inflammation.	[Omori, Emily; Morioka, Sho; Ninomiya-Tsuji, Jun] N Carolina State Univ, Dept Environm & Mol Toxicol, Raleigh, NC 27695 USA; [Morioka, Sho; Matsumoto, Kunihiro] Nagoya Univ, Grad Sch Sci, Dept Mol Biol, Nagoya, Aichi 4648602, Japan; [Matsumoto, Kunihiro] Japan Sci & Technol Agcy, SORST, Tokyo, Japan	University of North Carolina; North Carolina State University; Nagoya University; Japan Science & Technology Agency (JST)	Ninomiya-Tsuji, J (corresponding author), Campus Box 7633, Raleigh, NC 27695 USA.	Jun_Tsuji@ncsu.edu	Morioka, Sho/I-2074-2019	Morioka, Sho/0000-0002-1153-4919; Ninomiya-Tsuji, Jun/0000-0002-5584-0176	National Institutes of Health [GM068812]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM068812] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported, in whole or in part, by National Institutes of Health Grant GM068812 (to J.N.-T.). The costs of publication of this article were defrayed in part by the payment of page charges. This article must therefore be hereby marked "advertisement" in accordance with 18 U.S.C. Section 1734 solely to indicate this fact.	Aggarwal BB, 2003, NAT REV IMMUNOL, V3, P745, DOI 10.1038/nri1184; Ashkenazi A, 2002, NAT REV CANCER, V2, P420, DOI 10.1038/nrc821; Bickers DR, 2006, J INVEST DERMATOL, V126, P2565, DOI 10.1038/sj.jid.5700340; BROCKMAN JA, 1995, MOL CELL BIOL, V15, P2809; Chang LF, 2006, CELL, V124, P601, DOI 10.1016/j.cell.2006.01.021; Chen ZJ, 2006, CELL DEATH DIFFER, V13, P687, DOI 10.1038/sj.cdd.4401869; Gallagher E, 2006, P NATL ACAD SCI USA, V103, P1717, DOI 10.1073/pnas.0510664103; Hayden MS, 2008, CELL, V132, P344, DOI 10.1016/j.cell.2008.01.020; HuangFu WC, 2006, J BIOL CHEM, V281, P28802, DOI 10.1074/jbc.M603627200; Kajino-Sakamoto R, 2008, J IMMUNOL, V181, P1143, DOI 10.4049/jimmunol.181.2.1143; Kamata H, 2005, CELL, V120, P649, DOI 10.1016/j.cell.2004.12.041; Karin M, 2002, NAT IMMUNOL, V3, P221, DOI 10.1038/ni0302-221; Kim YS, 2007, MOL CELL, V26, P675, DOI 10.1016/j.molcel.2007.04.021; Kitamura T, 1998, INT J HEMATOL, V67, P351; Micheau O, 2001, MOL CELL BIOL, V21, P5299, DOI 10.1128/MCB.21.16.5299-5305.2001; Nenci A, 2007, NATURE, V446, P557, DOI 10.1038/nature05698; Ninomiya-Tsuji J, 1999, NATURE, V398, P252, DOI 10.1038/18465; Omori E, 2006, J BIOL CHEM, V281, P19610, DOI 10.1074/jbc.M603384200; Pham CG, 2004, CELL, V119, P529, DOI 10.1016/j.cell.2004.10.017; Reiley WW, 2007, J EXP MED, V204, P1475, DOI 10.1084/jem.20062694; Sakon S, 2003, EMBO J, V22, P3898, DOI 10.1093/emboj/cdg379; Sato S, 2005, NAT IMMUNOL, V6, P1087, DOI 10.1038/ni1255; Shim JH, 2005, GENE DEV, V19, P2668, DOI 10.1101/gad.1360605; Takaesu G, 2003, J MOL BIOL, V326, P105, DOI 10.1016/S0022-2836(02)01404-3; Thome M, 2001, NAT REV IMMUNOL, V1, P50, DOI 10.1038/35095508; Vasioukhin V, 1999, P NATL ACAD SCI USA, V96, P8551, DOI 10.1073/pnas.96.15.8551; Wang CY, 1998, SCIENCE, V281, P1680, DOI 10.1126/science.281.5383.1680; Winyard PG, 2005, TRENDS BIOCHEM SCI, V30, P453, DOI 10.1016/j.tibs.2005.06.001	28	79	81	0	2	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	SEP 19	2008	283	38					26161	26168		10.1074/jbc.M804513200	http://dx.doi.org/10.1074/jbc.M804513200			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	348GX	18606807	hybrid, Green Published			2022-12-27	WOS:000259200100044
J	Wang, L; Gao, J; Dai, W; Lu, L				Wang, Ling; Gao, Jie; Dai, Wei; Lu, Luo			Activation of polo-like kinase 3 by hypoxic stresses	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							CORNEAL EPITHELIAL-CELLS; POLO-LIKE KINASE; C-JUN; INDUCIBLE FACTOR; SERINE/THREONINE KINASE; DOWN-REGULATION; CYCLE ARREST; DNA-DAMAGE; BOX DOMAIN; KAPPA-B	Hypoxia/reoxygenation stress induces the activation of specific signaling proteins and activator protein 1 (AP-1) to regulate cell cycle regression and apoptosis. In the present study, we report that hypoxia/reoxygenation stress activates AP-1 by increasing c-Jun phosphorylation and DNA binding activity through activation of Polo-like-kinase 3 (Plk3) resulting in apoptosis. The specific effect of hypoxia/reoxygenation stress on Plk3 activation resulting in c-Jun phosphorylation was the opposite of UV irradiation-induced responses that are meanly independent on activation of the stress-induced JNK signaling pathway in human corneal epithelial (HCE) cells. The effect of hypoxia/reoxygenation stress-induced Plk3 activation on increased c-Jun phosphorylation and apoptosis was also mimicked by exposure of cells to CoCl2. Hypoxia/reoxygenation activated Plk3 in HCE cells to directly phosphorylate c-Jun proteins at phosphorylation sites Ser-63 and Ser-73, and to increase DNA binding activity of c-Jun, detected by EMSA. Further evidence demonstrated that Plk3 and phospho-c-Jun were immunocolocalized in the nuclear compartment of hypoxia/reoxygenation stress-induced cells. Increased Plk3 activity by overexpression of wild-type and dominantly positive Plk3 enhanced the effect of hypoxia/reoxygenation on c-Jun phosphorylation and cell death. In contrast, knocking-down Plk3 mRNA suppressed hypoxia-induced c-Jun phosphorylation. Our results provide a new mechanism indicating that hypoxia/reoxygenation induces Plk3 activation instead of the JNK effect to directly phosphorylate and activate c-Jun, subsequently contributing to apoptosis in HCE cells.	[Wang, Ling; Gao, Jie; Lu, Luo] Univ Calif Los Angeles, David Geffen Sch Med, Dept Med, Torrance, CA 90502 USA; [Dai, Wei] New York Univ, Sch Med, Dept Environm Med, New York, NY 10987 USA	University of California System; University of California Los Angeles; University of California Los Angeles Medical Center; David Geffen School of Medicine at UCLA; New York University	Lu, L (corresponding author), Univ Calif Los Angeles, David Geffen Sch Med, Dept Med, 1124 W Carson St,C-2, Torrance, CA 90502 USA.	lluou@ucla.edu		Dai, Wei/0000-0003-0169-8327	National Institutes of Health [EY12953, CA074229]; NATIONAL CANCER INSTITUTE [R01CA074229] Funding Source: NIH RePORTER; NATIONAL EYE INSTITUTE [R01EY012953] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL EYE INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI))	This work was supported, in whole or in part, by National Institutes of Health Grants EY12953 (to L. L.) and CA074229 (to W. D.). The costs of publication of this article were defrayed in part by the payment of page charges. This article must therefore be hereby marked "advertisement" in accordance with 18 U. S. C. Section 1734 solely to indicate this fact.	ABRAHAMS PJ, 1995, MUTAT RES-DNA REPAIR, V336, P169, DOI 10.1016/0921-8777(94)00049-C; Appelhoff RJ, 2004, J BIOL CHEM, V279, P38458, DOI 10.1074/jbc.M406026200; Bahassi EM, 2002, ONCOGENE, V21, P6633, DOI 10.1038/sj.onc.1205850; Bin OY, 1997, J BIOL CHEM, V272, P28646, DOI 10.1074/jbc.272.45.28646; Bindra RS, 2004, MOL CELL BIOL, V24, P8504, DOI 10.1128/MCB.24.19.8504-8518.2004; Bruick RK, 2001, SCIENCE, V294, P1337, DOI 10.1126/science.1066373; Budanov AV, 2002, ONCOGENE, V21, P6017, DOI 10.1038/sj.onc.1205877; Comerford KM, 2004, CANCER RES, V64, P9057, DOI 10.1158/0008-5472.CAN-04-1919; Conn CW, 2000, CANCER RES, V60, P6826; Cursiefen C, 2006, CORNEA, V25, P443, DOI 10.1097/01.ico.0000183485.85636.ff; Dai W, 2005, ONCOGENE, V24, P214, DOI 10.1038/sj.onc.1208270; DONOHUE PJ, 1995, J BIOL CHEM, V270, P10351, DOI 10.1074/jbc.270.17.10351; Dougherty CJ, 2004, FASEB J, V18, P1060, DOI 10.1096/fj.04-1505com; Elia AEH, 2003, CELL, V115, P83, DOI 10.1016/S0092-8674(03)00725-6; HAMANAKA R, 1995, J BIOL CHEM, V270, P21086, DOI 10.1074/jbc.270.36.21086; Hammond EM, 2002, MOL CELL BIOL, V22, P1834, DOI 10.1128/MCB.22.6.1834-1843.2002; Jiang N, 2006, J BIOL CHEM, V281, P10577, DOI 10.1074/jbc.M513156200; Karin M, 1997, CURR OPIN CELL BIOL, V9, P240, DOI 10.1016/S0955-0674(97)80068-3; Laderoute KR, 2004, MOL CELL BIOL, V24, P4128, DOI 10.1128/MCB.24.10.4128-4137.2004; Laderoute KR, 2002, MOL CELL BIOL, V22, P2515, DOI 10.1128/MCB.22.8.2515-2523.2002; Li B, 1996, J BIOL CHEM, V271, P19402, DOI 10.1074/jbc.271.32.19402; Li T, 2005, J BIOL CHEM, V280, P12988, DOI 10.1074/jbc.M412458200; Li T, 2002, J BIOL CHEM, V277, P32668, DOI 10.1074/jbc.M203519200; Li W, 2001, TRANSPLANTATION, V72, P1423, DOI 10.1097/00007890-200110270-00016; Liu HT, 2004, J IMMUNOL, V172, P1907, DOI 10.4049/jimmunol.172.3.1907; Lu L, 2003, INVEST OPHTH VIS SCI, V44, P5102, DOI 10.1167/iovs.03-0591; McCloskey CA, 2004, SHOCK, V22, P380, DOI 10.1097/01.shk.0000140660.78744.bf; Mwaikambo BR, 2006, INVEST OPHTH VIS SCI, V47, P4356, DOI 10.1167/iovs.05-1656; Nishi H, 2002, CANCER RES, V62, P827; Ruan YW, 2003, BRAIN RES, V982, P228, DOI 10.1016/S0006-8993(03)03021-X; Seagroves TN, 2001, MOL CELL BIOL, V21, P3436, DOI 10.1128/MCB.21.10.3436-3444.2001; SIMMONS DL, 1992, MOL CELL BIOL, V12, P4164, DOI 10.1128/MCB.12.9.4164; Singh N, 2005, INVEST OPHTH VIS SCI, V46, P1647, DOI 10.1167/iovs.04-1172; Singh N, 2006, INVEST OPHTH VIS SCI, V47, P4787, DOI 10.1167/iovs.06-0419; Smirnova IS, 2001, CELL BIOL INT, V25, P1101, DOI 10.1006/cbir.2001.0709; Wang L, 1999, J BIOL CHEM, V274, P3678, DOI 10.1074/jbc.274.6.3678; Wang L, 2007, J BIOL CHEM, V282, P32121, DOI 10.1074/jbc.M702791200; Wang Q, 2002, MOL CELL BIOL, V22, P3450, DOI 10.1128/MCB.22.10.3450-3459.2002; Xie SQ, 2001, J BIOL CHEM, V276, P43305, DOI 10.1074/jbc.M106050200; Xie SQ, 2002, CELL CYCLE, V1, P424, DOI 10.4161/cc.1.6.271; Zhang MC, 2006, OCUL IMMUNOL INFLAMM, V14, P359, DOI 10.1080/09273940601001322; Zhou BBS, 2000, NATURE, V408, P433, DOI 10.1038/35044005; Zhou H, 2007, CELL PROLIFERAT, V40, P431, DOI 10.1111/j.1365-2184.2007.00444.x	43	38	40	0	1	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	SEP 19	2008	283	38					25928	25935		10.1074/jbc.M801326200	http://dx.doi.org/10.1074/jbc.M801326200			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	348GX	18650425	Green Published, hybrid			2022-12-27	WOS:000259200100020
J	de Seigneux, S; Leroy, V; Ghzili, H; Rousselot, M; Nielsen, S; Rossier, BC; Martin, PY; Feraille, E				de Seigneux, Sophie; Leroy, Valerie; Ghzili, Hafida; Rousselot, Martine; Nielsen, Soren; Rossier, Bernard C.; Martin, Pierre-Yves; Feraille, Eric			NF-kappa B inhibits sodium transport via down-regulation of SGK1 in renal collecting duct principal cells	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							UNILATERAL URETERAL OBSTRUCTION; INDUCIBLE PROTEIN-KINASE; SURFACE EXPRESSION; ALPHA-SUBUNIT; CHANNEL-ALPHA; RAT-KIDNEY; ALDOSTERONE; SERUM; NA+; ACTIVATION	Tubulointerstitial inflammation is a common feature of renal diseases. We have investigated the relationship between inflammation and Na+ transport in the collecting duct ( CD) using the mCCDc(l1) and mpkCDD(c14) principal cell models. Lipopolysaccharide (LPS) decreased basal and aldosterone-stimulated amiloride-sensitive transepithelial current in a time-dependent manner. This effect was associated with a decrease in serum and gucocorticoid-regulated kinase 1 ( SGK1) mRNA and protein levels followed by a decrease in epithelial sodium channel ( ENaC) alpha-subunit mRNA levels. The LPS-induced decrease in SGK1 expression was confirmed in isolated rat CD. This decreased expression of either SGK1 or the ENaC alpha-subunit was not due to enhanced degradation of mRNA. In contrast, LPS inhibited transcriptional activity of the SGK1 promoter measured by luciferase-reporter gene assay. The effect of LPS was not mediated by inhibition of mineralocorticoid or glucocorticoid receptor, because expression of both receptors was unchanged and blockade of either receptor by spironolactone or RU486, respectively, did not prevent the down-regulation of SGK1. The effect of LPS was mediated by the canonical NF-kappa B pathway, as overexpression of a constitutively active mutant, IKK beta ( inhibitor of nuclear factor kappa B kinase-beta) decreased SGK1 mRNA levels, and knockdown of p65 NF-kappa B subunit by small interfering RNA increased SGK1 mRNA levels. Chromatin immunoprecipitation showed that LPS increased p65 binding to two NF-kappa B sites along the SGK1 promoter. In conclusion, we show that activation of the NF-kappa B pathway down-regulates SGK1 expression, which might lead to decreased ENaC alpha-subunit expression, ultimately resulting in decreased Na+ transport.	[de Seigneux, Sophie; Leroy, Valerie; Ghzili, Hafida; Rousselot, Martine; Martin, Pierre-Yves; Feraille, Eric] Fdn Rech Med, Serv Nephrol, CH-1211 Geneva 4, Switzerland; [Rossier, Bernard C.] Univ Lausanne, Dept Pharmacol & Toxicol, CH-1005 Lausanne, Switzerland; [Nielsen, Soren] Univ Aarhus, Inst Anat, Water & Salt Res Ctr, DK-8000 Aarhus, Denmark	University of Geneva; University of Lausanne; Aarhus University	Feraille, E (corresponding author), Fdn Rech Med, Serv Nephrol, 64 Ave Roseraie, CH-1211 Geneva 4, Switzerland.	Eric.Feraille@medecine.unige.ch		Feraille, Eric/0000-0003-1656-8365	Swiss National Foundation [31-109473]; Novartis Foundation; Ernest Boninchi Foundation; Societe Academique de Geneve; Ernst and Lucie Schmidheiny Foundation	Swiss National Foundation(Swiss National Science Foundation (SNSF)); Novartis Foundation(Novartis); Ernest Boninchi Foundation; Societe Academique de Geneve; Ernst and Lucie Schmidheiny Foundation	This work was supported by Swiss National Foundation Grant 31-109473 and by grants from the Novartis Foundation ( to E. F.), the Ernest Boninchi Foundation, the Societe Academique de Geneve, and the Ernst and Lucie Schmidheiny Foundation ( to S.d.S.). The costs of publication of this article were defrayed in part by the payment of page charges. This article must therefore be hereby marked "advertisement" in accordance with 18 U. S. C. Section 1734 solely to indicate this fact.	Ayroldi E, 2001, BLOOD, V98, P743, DOI 10.1182/blood.V98.3.743; Baldwin AS, 1996, ANNU REV IMMUNOL, V14, P649, DOI 10.1146/annurev.immunol.14.1.649; Bens M, 1999, J AM SOC NEPHROL, V10, P923; Berrebi D, 2003, BLOOD, V101, P729, DOI 10.1182/blood-2002-02-0538; Bhalla V, 2006, AM J PHYSIOL-RENAL, V291, pF714, DOI 10.1152/ajprenal.00061.2006; Bustamante M, 2008, J AM SOC NEPHROL, V19, P109, DOI 10.1681/ASN.2007010092; Carranza ML, 1996, AM J PHYSIOL-CELL PH, V271, pC136, DOI 10.1152/ajpcell.1996.271.1.C136; Chen SC, 2004, HYPERTENSION, V43, P866, DOI 10.1161/01.HYP.0000121883.55722.45; Chen SY, 1999, P NATL ACAD SCI USA, V96, P2514, DOI 10.1073/pnas.96.5.2514; Debonneville C, 2001, EMBO J, V20, P7052, DOI 10.1093/emboj/20.24.7052; Esteban V, 2004, J AM SOC NEPHROL, V15, P1514, DOI 10.1097/01.ASN.0000130564.75008.F5; Feraille E, 2001, PHYSIOL REV, V81, P345, DOI 10.1152/physrev.2001.81.1.345; Firestone GL, 2003, CELL PHYSIOL BIOCHEM, V13, P1, DOI 10.1159/000070244; Flores SY, 2005, J AM SOC NEPHROL, V16, P2279, DOI 10.1681/ASN.2004100828; Gaeggeler HP, 2005, J AM SOC NEPHROL, V16, P878, DOI 10.1681/ASN.2004121110; Gonzalez-Rodriguez E, 2007, KIDNEY INT, V71, P116, DOI 10.1038/sj.ki.5002018; GROSS JB, 1975, J CLIN INVEST, V55, P1284, DOI 10.1172/JCI108048; Henke G, 2002, KIDNEY BLOOD PRESS R, V25, P370, DOI 10.1159/000068699; Itani OA, 2002, AM J PHYSIOL-ENDOC M, V283, pE971, DOI 10.1152/ajpendo.00021.2002; Kostadinova RM, 2005, FASEB J, V19, P650, DOI 10.1096/fj.04-2820fje; Lebowitz J, 2004, J BIOL CHEM, V279, P41985, DOI 10.1074/jbc.M403923200; Li CL, 2007, AM J PHYSIOL-RENAL, V293, pF333, DOI 10.1152/ajprenal.00372.2006; Masilamani S, 1999, J CLIN INVEST, V104, pR19, DOI 10.1172/JCI7840; May A, 1997, J AM SOC NEPHROL, V8, P1813; McKay LI, 1998, MOL ENDOCRINOL, V12, P45, DOI 10.1210/mend.12.1.0044; Mercurio F, 1997, SCIENCE, V278, P860, DOI 10.1126/science.278.5339.860; Perkins ND, 2007, NAT REV MOL CELL BIO, V8, P49, DOI 10.1038/nrm2083; REIF MC, 1986, J CLIN INVEST, V77, P1291, DOI 10.1172/JCI112433; Ryser S, 2007, J BIOL CHEM, V282, P5075, DOI 10.1074/jbc.M607847200; Schmidt C, 2007, J AM SOC NEPHROL, V18, P1072, DOI 10.1681/ASN.2006050454; Setiawan I, 2002, PFLUG ARCH EUR J PHY, V444, P426, DOI 10.1007/s00424-002-0823-z; Shi XZ, 2005, GASTROENTEROLOGY, V129, P1518, DOI 10.1053/j.gastro.2005.07.058; Sitcheran R, 2005, EMBO J, V24, P510, DOI 10.1038/sj.emboj.7600555; Soundararajan R, 2007, J BIOL CHEM, V282, P36303, DOI 10.1074/jbc.M707287200; Summa V, 2001, J BIOL CHEM, V276, P47087, DOI 10.1074/jbc.M107165200; Takase O, 2003, KIDNEY INT, V63, P501, DOI 10.1046/j.1523-1755.2003.00781.x; TOMITA K, 1985, J CLIN INVEST, V76, P132, DOI 10.1172/JCI111935; VERREY F, 1987, J CELL BIOL, V104, P1231, DOI 10.1083/jcb.104.5.1231; Vinciguerra M, 2005, J AM SOC NEPHROL, V16, P2576, DOI 10.1681/ASN.2005040448; WELLING PA, 1993, J BIOL CHEM, V268, P23469; Zecevic M, 2004, PFLUG ARCH EUR J PHY, V448, P29, DOI 10.1007/s00424-003-1222-9; Zhang LP, 2005, CANCER RES, V65, P457; Zhang WZ, 2007, J CLIN INVEST, V117, P773, DOI 10.1172/JCI29850	43	33	33	0	0	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	SEP 12	2008	283	37					25671	25681		10.1074/jbc.M803812200	http://dx.doi.org/10.1074/jbc.M803812200			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	345QZ	18586672	hybrid			2022-12-27	WOS:000259012700062
J	Zeth, K; Romer, C; Patzer, SI; Braun, V				Zeth, Kornelius; Roemer, Christin; Patzer, Silke I.; Braun, Volkmar			Crystal structure of colicin M, a novel phosphatase specifically imported by Escherichia coli	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							OUTER-MEMBRANE; FHUA RECEPTOR; TONB PROTEIN; TRANSPORT; TRANSDUCTION; INHIBITOR; SEQUENCE; PLASMID; DOMAINS	Colicins are cytotoxic proteins secreted by certain strains of Escherichia coli. Colicin Mis unique among these toxins in that it acts in the periplasm and specifically inhibits murein biosynthesis by hydrolyzing the pyrophosphate linkage between bactoprenol and the murein precursor. We crystallized colicin M and determined the structure at 1.7 A resolution using x-ray crystallography. The protein has a novel structure composed of three domains with distinct functions. The N-domain is a short random coil and contains the exposed TonB box. The central domain includes a hydrophobic alpha-helix and binds presumably to the FhuA receptor. The C-domain is composed of a mixed alpha/beta-fold and forms the phosphatase. The architectures of the individual modules show no similarity to known structures. Amino acid replacements in previously isolated inactive colicin M mutants are located in the phosphatase domain, which contains a number of surface-exposed residues conserved in predicted bacteriocins of other bacteria. The novel phosphatase domain displays no sequence similarity to known phosphatases. The N-terminal and central domains are not conserved among bacteriocins, which likely reflect the distinct import proteins required for the uptake of the various bacteriocins. The homology pattern supports our previous proposal that colicins evolved by combination of distinct functional domains.	[Zeth, Kornelius; Roemer, Christin; Patzer, Silke I.; Braun, Volkmar] Max Planck Inst Dev Biol, Dept Prot Evolut, D-72076 Tubingen, Germany	Max Planck Society	Braun, V (corresponding author), Max Planck Inst Dev Biol, Dept Prot Evolut, Spemannstr 35, D-72076 Tubingen, Germany.	volkmar.braun@tuebingen.mpg.de			Department of Protein Evolution	Department of Protein Evolution	We thank Dr. Reinhard Albrecht for very helpful contributions in protein crystallization. We acknowledge Dr. Ehmke Pohl from Beamline PX10 at the Swiss Light Source, Villigen, Switzerland, for excellent technical assistance and the Beamline support, and Karen A. Brune for critically reading the manuscript. This work was carried out in the Department of Protein Evolution, and the support of Dr. Andrei Lupas, head of the department, is greatly acknowledged.	BAILEY S, 1994, ACTA CRYSTALLOGR D, V50, P760, DOI 10.1107/s0907444994003112; BRAUN V, 1980, J BACTERIOL, V142, P162, DOI 10.1128/JB.142.1.162-168.1980; BRAUN V, 1974, ANTIMICROB AGENTS CH, V5, P520, DOI 10.1128/AAC.5.5.520; BRAUN V, 1995, FEMS MICROBIOL REV, V16, P295, DOI 10.1111/j.1574-6976.1995.tb00177.x; Braun V, 2002, BIOCHIMIE, V84, P365, DOI 10.1016/S0300-9084(02)01427-X; Buchanan SK, 2007, EMBO J, V26, P2594, DOI 10.1038/sj.emboj.7601693; Cascales E, 2007, MICROBIOL MOL BIOL R, V71, P158, DOI 10.1128/MMBR.00036-06; Chu BCH, 2007, BIOMETALS, V20, P467, DOI 10.1007/s10534-006-9049-4; Devanathan S, 2007, MOL MICROBIOL, V65, P441, DOI 10.1111/j.1365-2958.2007.05808.x; DREHER R, 1985, ARCH MICROBIOL, V140, P343, DOI 10.1007/BF00446975; El Ghachi M, 2006, J BIOL CHEM, V281, P22761, DOI 10.1074/jbc.M602834200; Emsley P, 2004, ACTA CRYSTALLOGR D, V60, P2126, DOI 10.1107/S0907444904019158; Ferguson AD, 1998, SCIENCE, V282, P2215, DOI 10.1126/science.282.5397.2215; Gross P, 1996, MOL GEN GENET, V251, P388, DOI 10.1007/BF02172531; HARKNESS RE, 1990, MOL GEN GENET, V222, P37, DOI 10.1007/BF00283020; HARKNESS RE, 1989, J BIOL CHEM, V264, P14716; HARKNESS RE, 1989, J BIOL CHEM, V264, P6177; Hilsenbeck JL, 2004, MOL MICROBIOL, V51, P711, DOI 10.1111/j.1365-2958.2003.03884.x; Hullmann J, 2008, MOL MICROBIOL, V69, P926, DOI 10.1111/j.1365-2958.2008.06327.x; Johnson TJ, 2006, J BACTERIOL, V188, P5975, DOI 10.1128/JB.00204-06; KABSCH W, 1993, J APPL CRYSTALLOGR, V26, P795, DOI 10.1107/S0021889893005588; KOCK J, 1987, J BACTERIOL, V169, P3358; Locher KP, 1998, CELL, V95, P771, DOI 10.1016/S0092-8674(00)81700-6; MENDE J, 1990, MOL MICROBIOL, V4, P1523, DOI 10.1111/j.1365-2958.1990.tb02063.x; Meng GY, 2006, EMBO J, V25, P2297, DOI 10.1038/sj.emboj.7601132; OLSCHLAGER T, 1991, MOL MICROBIOL, V5, P1105, DOI 10.1111/j.1365-2958.1991.tb01883.x; Pawelek PD, 2006, SCIENCE, V312, P1399, DOI 10.1126/science.1128057; PILSL H, 1993, MOL GEN GENET, V240, P103, DOI 10.1007/BF00276889; Postle K, 2007, BIOMETALS, V20, P453, DOI 10.1007/s10534-006-9071-6; ROOS U, 1989, MOL MICROBIOL, V3, P891, DOI 10.1111/j.1365-2958.1989.tb00238.x; SCHALLER K, 1982, J BACTERIOL, V152, P994; SCHALLER K, 1981, J BACTERIOL, V147, P135, DOI 10.1128/JB.147.1.135-139.1981; SCHALLER K, 1981, J BACTERIOL, V146, P54, DOI 10.1128/JB.146.1.54-63.1981; SCHOFFLER H, 1989, MOL GEN GENET, V217, P378, DOI 10.1007/BF02464907; Shultis DD, 2006, SCIENCE, V312, P1396, DOI 10.1126/science.1127694; Soelaiman S, 2001, MOL CELL, V8, P1053, DOI 10.1016/S1097-2765(01)00396-3; THUMM G, 1988, PLASMID, V20, P75, DOI 10.1016/0147-619X(88)90009-1; Vonrhein Clemens, 2007, Methods Mol Biol, V364, P215, DOI 10.1385/1-59745-266-1:215; Wiener M, 1997, NATURE, V385, P461, DOI 10.1038/385461a0; Wilcox AJ, 2005, P NATL ACAD SCI USA, V102, P15435, DOI 10.1073/pnas.0507324102	40	50	51	0	2	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	SEP 12	2008	283	37					25324	25331		10.1074/jbc.M802591200	http://dx.doi.org/10.1074/jbc.M802591200			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	345QZ	18640984	hybrid, Green Published			2022-12-27	WOS:000259012700026
J	An, NF; Blumer, JB; Bernard, ML; Lanier, SM				An, Ningfei; Blumer, Joe B.; Bernard, Michael L.; Lanier, Stephen M.			The PDZ and Band 4.1 Containing Protein Frmpd1 Regulates the Subcellular Location of Activator of G-protein Signaling 3 and Its Interaction with G-proteins	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							HETEROTRIMERIC G-PROTEINS; ASYMMETRIC CELL-DIVISION; RECEPTOR-INDEPENDENT ACTIVATORS; HEROIN-SEEKING BEHAVIOR; SPINDLE ORIENTATION; DROSOPHILA NEUROBLASTS; CYCLE PROGRESSION; GOLGI MEMBRANES; MAMMALIAN PINS; ALPHA-SUBUNITS	Activator of G-protein signaling 3 (AGS3) is one of nine mammalian proteins containing one or more G-protein regulatory (GPR) motifs that stabilize the GDP-bound conformation of G alpha(i). Such proteins have revealed unexpected functional diversity for the "G-switch" in the control of events within the cell independent of the role of heterotrimeric G-proteins as transducers for G-protein-coupled receptors at the cell surface. A key question regarding this class of proteins is what controls their subcellular positioning and interaction with G-proteins. We conducted a series of yeast two-hybrid screens to identify proteins interacting with the tetratricopeptide repeat (TPR) of AGS3, which plays an important role in subcellular positioning of the protein. We report the identification of Frmpd1 (FERM and PDZ domain containing 1) as a regulatory binding partner of AGS3. Frmpd1 binds to the TPR domain of AGS3 and coimmunoprecipitates with AGS3 from cell lysates. Cell fractionation indicated that Frmpd1 stabilizes AGS3 in a membrane fraction. Upon cotransfection of COS7 cells with Frmpd1-GFP and AGS3-mRFP, AGS3-mRFP is observed in regions of the cell cortex and also in membrane extensions or processes where it appears to be colocalized with Frmpd1-GFP based upon the merged fluorescent signals. Frmpd1 knockdown (siRNA) in Cath.a-differentiated neuronal cells decreased the level of endogenous AGS3 in membrane fractions by similar to 50% and enhanced the alpha(2)-adrenergic receptor-mediated inhibition of forskolin-induced increases in cAMP. The coimmunoprecipitation of Frmpd1 with AGS3 is lost as the amount of G alpha(i3) in the cell is increased and AGS3 apparently switches its binding partner from Frmpd1 to G alpha(i3) indicating that the interaction of AGS3 with Frmpd1 and G alpha(i3) is mutually exclusive. Mechanistically, Frmpd1 may position AGS3 in a membrane environment where it then interacts with G alpha(i) in a regulated manner.	[An, Ningfei; Blumer, Joe B.; Bernard, Michael L.; Lanier, Stephen M.] Med Univ S Carolina, Dept Pharmacol, Charleston, SC 29425 USA; [An, Ningfei; Blumer, Joe B.; Lanier, Stephen M.] Louisiana State Univ, Hlth Sci Ctr, Dept Pharmacol & Expt Therapeut, New Orleans, LA 70112 USA	Medical University of South Carolina; Louisiana State University System; Louisiana State University Health Sciences Center New Orleans	Lanier, SM (corresponding author), Med Univ S Carolina, Dept Pharmacol, Charleston, SC 29425 USA.	lanier@musc.edu	Bernard, Michael/AAW-3944-2021	Lanier, Stephen/0000-0002-2740-7607; Blumer, Joe/0000-0002-0020-3815	National Institutes of Health [MH90531, NS24821, F32MH65092]; NATIONAL INSTITUTE OF MENTAL HEALTH [F32MH065092] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R29NS024821, R01NS024821] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	This work was supported, in whole or in part, by National Institutes of Health Grants MH90531 (to S. M. L.), NS24821 (to S. M. L.), and F32MH65092 (to J. B. B.).	Adhikari A, 2003, J BIOL CHEM, V278, P51825, DOI 10.1074/jbc.M306300200; Bellaiche Y, 2001, CELL, V106, P355, DOI 10.1016/S0092-8674(01)00444-5; Bernard ML, 2001, J BIOL CHEM, V276, P1585, DOI 10.1074/jbc.M005291200; Betschinger J, 2004, CURR BIOL, V14, pR674, DOI 10.1016/j.cub.2004.08.017; Blumer JB, 2003, J BIOL CHEM, V278, P23217, DOI 10.1074/jbc.C200686200; Blumer JB, 2002, J BIOL CHEM, V277, P15897, DOI 10.1074/jbc.M112185200; Blumer JB, 2007, PHARMACOL THERAPEUT, V113, P488, DOI 10.1016/j.pharmthera.2006.11.001; Blumer JB, 2006, EUR J CELL BIOL, V85, P1233, DOI 10.1016/j.ejcb.2006.08.002; Bohil AB, 2006, P NATL ACAD SCI USA, V103, P12411, DOI 10.1073/pnas.0602443103; Bompard G, 2003, J CELL SCI, V116, P2519, DOI 10.1242/jcs.00448; Bowers MS, 2004, NEURON, V42, P269, DOI 10.1016/S0896-6273(04)00159-X; Cao XQ, 2004, J BIOL CHEM, V279, P27567, DOI 10.1074/jbc.M312786200; Chishti AH, 1998, TRENDS BIOCHEM SCI, V23, P281, DOI 10.1016/S0968-0004(98)01237-7; Cho H, 2007, J CELL BIOL, V178, P245, DOI 10.1083/jcb.200604114; Cho WH, 2005, ANNU REV BIOPH BIOM, V34, P119, DOI 10.1146/annurev.biophys.33.110502.133337; Cismowski MJ, 2005, REV PHYSIOL BIOCH P, V155, P57, DOI 10.1007/s10254-005-0042-z; Cismowski MJ, 1999, NAT BIOTECHNOL, V17, P878, DOI 10.1038/12867; Colombo K, 2003, SCIENCE, V300, P1957, DOI 10.1126/science.1084146; De Vries L, 2000, P NATL ACAD SCI USA, V97, P14364, DOI 10.1073/pnas.97.26.14364; Diakowski W, 2006, FOLIA HISTOCHEM CYTO, V44, P231; Du QS, 2004, CELL, V119, P503, DOI 10.1016/j.cell.2004.10.028; Du QS, 2001, NAT CELL BIOL, V3, P1069, DOI 10.1038/ncb1201-1069; Gotta M, 2003, CURR BIOL, V13, P1029, DOI 10.1016/S0960-9822(03)00371-3; Hung AY, 2002, J BIOL CHEM, V277, P5699, DOI 10.1074/jbc.R100065200; Izumi Y, 2006, NAT CELL BIOL, V8, P586, DOI 10.1038/ncb1409; Kaushik R, 2003, MOL BIOL CELL, V14, P3144, DOI 10.1091/mbc.E03-04-0212; Lechler T, 2005, NATURE, V437, P275, DOI 10.1038/nature03922; Letunic I, 2006, NUCLEIC ACIDS RES, V34, pD257, DOI 10.1093/nar/gkj079; Nagase T, 2000, DNA RES, V7, P65, DOI 10.1093/dnares/7.1.65; Natochin M, 2000, J BIOL CHEM, V275, P40981, DOI 10.1074/jbc.M006478200; Pattingre S, 2003, J BIOL CHEM, V278, P20995, DOI 10.1074/jbc.M300917200; Peterson YK, 2000, J BIOL CHEM, V275, P33193, DOI 10.1074/jbc.C000509200; Petiot A, 1999, BIOCHEM J, V337, P289, DOI 10.1042/0264-6021:3370289; Pizzinat N, 2001, J BIOL CHEM, V276, P16601, DOI 10.1074/jbc.M007573200; RAYMOND JR, 1993, BIOCHEMISTRY-US, V32, P11064, DOI 10.1021/bi00092a016; Sanada K, 2005, CELL, V122, P119, DOI 10.1016/j.cell.2005.05.009; Sans N, 2005, NAT CELL BIOL, V7, P1179, DOI 10.1038/ncb1325; Sato M, 2006, P NATL ACAD SCI USA, V103, P797, DOI 10.1073/pnas.0507467103; Sato M, 2004, J BIOL CHEM, V279, P13375, DOI 10.1074/jbc.M312660200; Sato M, 2006, ANNU REV PHARMACOL, V46, P151, DOI 10.1146/annurev.pharmtox.46.120604.141115; Schaefer M, 2000, CURR BIOL, V10, P353, DOI 10.1016/S0960-9822(00)00401-2; Schaefer M, 2001, CELL, V107, P183, DOI 10.1016/S0092-8674(01)00521-9; Sheng M, 2001, ANNU REV NEUROSCI, V24, P1, DOI 10.1146/annurev.neuro.24.1.1; Siegrist SE, 2005, CELL, V123, P1323, DOI 10.1016/j.cell.2005.09.043; Siller KH, 2006, NAT CELL BIOL, V8, P594, DOI 10.1038/ncb1412; STOW JL, 1991, J CELL BIOL, V114, P1113, DOI 10.1083/jcb.114.6.1113; Strausberg RL, 2002, P NATL ACAD SCI USA, V99, P16899, DOI 10.1073/pnas.242603899; Takesono A, 1999, J BIOL CHEM, V274, P33202, DOI 10.1074/jbc.274.47.33202; Weiss TS, 2001, P NATL ACAD SCI USA, V98, P14961, DOI 10.1073/pnas.261572098; Willard FS, 2004, ANNU REV BIOCHEM, V73, P925, DOI 10.1146/annurev.biochem.73.011303.073756; Wiser O, 2006, NEURON, V50, P561, DOI 10.1016/j.neuron.2006.03.046; Yao L, 2005, P NATL ACAD SCI USA, V102, P8746, DOI 10.1073/pnas.0503419102; Yao LN, 2006, P NATL ACAD SCI USA, V103, P7877, DOI 10.1073/pnas.0602661103; Yasumi M, 2005, J BIOL CHEM, V280, P6761, DOI 10.1074/jbc.C400440200; Yu FW, 2000, CELL, V100, P399, DOI 10.1016/S0092-8674(00)80676-5; Zigman M, 2005, NEURON, V48, P539, DOI 10.1016/j.neuron.2005.09.030	56	24	26	0	2	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	SEP 5	2008	283	36					24718	24728		10.1074/jbc.M803497200	http://dx.doi.org/10.1074/jbc.M803497200			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	517MA	18566450	hybrid, Green Published			2022-12-27	WOS:000271617300004
J	Andres-Hernando, A; Lanaspa, MA; Rivard, CJ; Berl, T				Andres-Hernando, Ana; Lanaspa, Miguel A.; Rivard, Christopher J.; Berl, Tomas			Nucleoporin 88 (Nup88) Is Regulated by Hypertonic Stress in Kidney Cells to Retain the Transcription Factor Tonicity Enhancer-binding Protein (TonEBP) in the Nucleus	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							NA-K-ATPASE; GENE-EXPRESSION; OSMOTIC-STRESS; STIMULATES TRANSCRIPTION; RENAL-CELLS; EXPORT; ADAPTATION; DROSOPHILA; ACTIVATOR; CRM1	Antibody microarray technology identified Nup88 (nucleoporin 88) as a highly up-regulated protein in response to osmotic stress in inner medullary collecting duct (IMCD3) cells. Changes in expression were verified by Western blot and quantitative PCR for protein and message expression. In mouse and human kidney, Nup88 expression was substantial in the papilla, whereas it was nearly absent in the cortex. Furthermore, the expression of Nup88 increased 410.4 +/- 22% in the papilla of mice after 36 h of thirsting. Nup88 protein expression in IMCD3 cells was significantly up-regulated in the first 8 h following exposure to acute osmotic stress, indicating that Nup88 is an early response protein. To define the function of Nup88 in the osmotic stress response, the transcription factor associated with hypertonicity, tonicity enhancer-binding protein (TonEBP), was cloned upstream of the green fluorescent protein. Employing this construct, we demonstrate that silencing Nup88 in IMCD3 cells acutely stressed to hypertonic conditions reduces nuclear retention of TonEBP, resulting in a substantial blunting in transcription of important osmotic stress response target genes and reduced cell viability. Finally, we show that in IMCD3 cells, nuclear export of TonEBP under isotonic conditions involves CRM-1 but under hypertonic stress is CRM1-independent. Our data, therefore, suggest that Nup88 is up-regulated in response to hypertonic stress and acts to retain TonEBP in the nucleus, activating transcription of critical osmoprotective genes.	[Andres-Hernando, Ana; Lanaspa, Miguel A.; Rivard, Christopher J.; Berl, Tomas] Univ Colorado, Hlth Sci Ctr, Sch Med, Div Renal Dis & Hypertens, Denver, CO 80262 USA	University of Colorado System; University of Colorado Anschutz Medical Campus; University of Colorado Denver	Berl, T (corresponding author), Univ Colorado, Hlth Sci Ctr, Sch Med, Div Renal Dis & Hypertens, 4200 E 9th Ave, Denver, CO 80262 USA.	tomas.berl@uchsc.edu	Lanaspa, Miguel/AAO-4971-2020	Andres-Hernando, Ana/0000-0002-0676-0188	National Institutes of Health [DK-19928, DK-66544]; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK066544, P01DK019928] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	work was supported, in whole or in part, by National Institutes of Health Grants DK-19928 and DK-66544 (to T. B.).	Bernad R, 2004, MOL CELL BIOL, V24, P2373, DOI 10.1128/MCB.24.6.2373-2384.2004; Bernad R, 2006, J BIOL CHEM, V281, P19378, DOI 10.1074/jbc.M512585200; Burg MB, 1997, ANNU REV PHYSIOL, V59, P437, DOI 10.1146/annurev.physiol.59.1.437; Burg MB, 1996, FASEB J, V10, P1598, DOI 10.1096/fasebj.10.14.9002551; Capasso JM, 2003, ANN NY ACAD SCI, V986, P410, DOI 10.1111/j.1749-6632.2003.tb07222.x; Capasso JM, 2001, P NATL ACAD SCI USA, V98, P13414, DOI 10.1073/pnas.231309198; Capasso JM, 2001, AM J PHYSIOL-RENAL, V280, pF768, DOI 10.1152/ajprenal.2001.280.5.F768; Cha JH, 2001, J AM SOC NEPHROL, V12, P2221, DOI 10.1681/ASN.V12112221; Dmitrieva NI, 2005, MUTAT RES-FUND MOL M, V569, P65, DOI 10.1016/j.mrfmmm.2004.06.053; Ferraris JD, 2006, CONTRIB NEPHROL, V152, P125, DOI 10.1159/000096320; Fornerod M, 1997, EMBO J, V16, P807, DOI 10.1093/emboj/16.4.807; Handler JS, 2001, KIDNEY INT, V60, P408, DOI 10.1046/j.1523-1755.2001.060002408.x; Handler JS, 2001, NEPHRON, V87, P106, DOI 10.1159/000045897; Handler JS, 1996, KIDNEY INT, V49, P1682, DOI 10.1038/ki.1996.246; Hutten S, 2006, MOL CELL BIOL, V26, P6772, DOI 10.1128/MCB.00342-06; Ito T, 2004, BIOCHEM J, V382, P177, DOI 10.1042/BJ20031838; Jeon US, 2006, ACTA PHYSIOL, V187, P241, DOI 10.1111/j.1748-1716.2006.01551.x; Kodiha M, 2008, BBA-MOL CELL RES, V1783, P405, DOI 10.1016/j.bbamcr.2007.10.022; Lanaspa MA, 2007, P NATL ACAD SCI USA, V104, P13672, DOI 10.1073/pnas.0702752104; Lim SW, 2007, J AM SOC NEPHROL, V18, P421, DOI 10.1681/ASN.2006060664; Lopez-Rodriguez C, 2004, P NATL ACAD SCI USA, V101, P2392, DOI 10.1073/pnas.0308703100; Miyakawa H, 1999, P NATL ACAD SCI USA, V96, P2538, DOI 10.1073/pnas.96.5.2538; Miyakawa H, 1998, AM J PHYSIOL-RENAL, V274, pF753, DOI 10.1152/ajprenal.1998.274.4.F753; Na KY, 2003, J AM SOC NEPHROL, V14, P283, DOI 10.1097/01.ASN.0000045050.19544.B2; Nakayama Y, 2000, J BIOL CHEM, V275, P38275, DOI 10.1074/jbc.M004678200; RAUCHMAN MI, 1993, AM J PHYSIOL, V265, pF416, DOI 10.1152/ajprenal.1993.265.3.F416; Rivard CJ, 2007, J BIOL CHEM, V282, P6644, DOI 10.1074/jbc.M609432200; Roth P, 2003, J CELL BIOL, V163, P701, DOI 10.1083/jcb.200304046; Tong EHY, 2006, J BIOL CHEM, V281, P23870, DOI 10.1074/jbc.M602556200; Uv AE, 2000, GENE DEV, V14, P1945; Woo SK, 2002, PFLUG ARCH EUR J PHY, V444, P579, DOI 10.1007/s00424-002-0849-2; Woo SK, 2002, INT REV CYTOL, V215, P189; Woo SK, 2002, MOL CELL BIOL, V22, P5753, DOI 10.1128/MCB.22.16.5753-5760.2002; Xylourgidis N, 2006, J CELL SCI, V119, P4409, DOI 10.1242/jcs.03201; Zhang Z, 2003, AM J PHYSIOL-RENAL, V285, pF688, DOI 10.1152/ajprenal.00028.2003	35	13	16	0	3	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	SEP 5	2008	283	36					25082	25090		10.1074/jbc.M802381200	http://dx.doi.org/10.1074/jbc.M802381200			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	517MA	18606815	Green Published, hybrid			2022-12-27	WOS:000271617300013
J	Frank, H; Groger, N; Diener, M; Becker, C; Braun, T; Boettger, T				Frank, Henning; Groeger, Nicole; Diener, Martin; Becker, Christoph; Braun, Thomas; Boettger, Thomas			Lactaturia and loss of sodium-dependent lactate uptake in the colon of SLC5A8-deficient mice	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							CHAIN FATTY-ACIDS; SUPPRESSOR GENE SLC5A8; APICAL IODIDE EFFLUX; TUMOR-SUPPRESSOR; C/EBP-DELTA; FUNCTIONAL-CHARACTERIZATION; BICARBONATE SECRETION; NONIONIC DIFFUSION; PENDRED-SYNDROME; RAT COLON	SLC5A8 is a member of the sodium/glucose cotransporter family. It has been proposed that SLC5A8 might act as an apical iodide transporter in the thyroid follicular cells or as a transporter of short chain monocarboxylates. We have directly addressed the functional role of SLC5A8 in vivo by generation of SLC5A8 mutant mice. We found that SLC5A8 is responsible for the re-absorption of lactate at the apical membrane of the kidney proximal tubules and of serous salivary gland ducts. In addition, SLC5A8 mediated the uptake of lactate into colonocytes under physiological conditions. We did not find any evidence of SLC5A8 being essential for the apical iodide transport in the thyroid gland, even if the ion-cotransporter SLC26A4, causing the human Pendred syndrome, is missing. Because SLC5A8 is transcriptionally silenced in many tumors, it has been proposed that SLC5A8-mediated transport of butyrate suppresses tumor formation. Treatment of Slc5a8(-/-) mice with carcinogens and breeding to the Apc(min) mouse line did not reveal a higher incidence of tumor formation. We conclude that SLC5A8 is instrumental in preventing lactaturia and loss of sodium dependent uptake of lactate in the colon but does not have any apparent role in the prevention of tumor formation and growth.	[Frank, Henning; Groeger, Nicole; Braun, Thomas; Boettger, Thomas] Max Planck Inst Heart & Lung Res, Dept Cardiac Dev & Remodelling, D-61231 Bad Nauheim, Germany; [Diener, Martin] Univ Giessen, Inst Vet Physiol, D-35392 Giessen, Germany; [Becker, Christoph] Johannes Gutenberg Univ Mainz, Immunol Lab, I Med Clin, D-55131 Mainz, Germany	Max Planck Society; Justus Liebig University Giessen; Johannes Gutenberg University of Mainz	Boettger, T (corresponding author), Max Planck Inst Heart & Lung Res, Dept Cardiac Dev & Remodelling, Pk Str 1, D-61231 Bad Nauheim, Germany.	thomas.boettger@mpi-bn.mpg.de	Boettger, Thomas/E-3406-2012; Becker, Christoph/A-6694-2008; Becker, Christoph/L-2996-2016; Braun, Thomas/B-2310-2008	Boettger, Thomas/0000-0003-4280-8449; Becker, Christoph/0000-0002-1388-1041; Braun, Thomas/0000-0002-6165-4804	Deutsche Forschungsgemeinschaft; Max-Planck Society; Excellence Cluster Cardiopulmonary System	Deutsche Forschungsgemeinschaft(German Research Foundation (DFG)); Max-Planck Society(Max Planck Society); Excellence Cluster Cardiopulmonary System(German Research Foundation (DFG))	This work was supported in part by a grant from the Deutsche Forschungsgemeinschaft (to T. B.), by the Max-Planck Society, and by the Excellence Cluster Cardiopulmonary System. The costs of publication of this article were defrayed in part by the payment of page charges. This article must therefore be hereby marked "advertisement" in accordance with 18 U. S. C. Section 1734 solely to indicate this fact.	BARACNIETO M, 1980, AM J PHYSIOL, V239, pF496, DOI 10.1152/ajprenal.1980.239.5.F496; Becker C, 2006, NAT PROTOC, V1, P2900, DOI 10.1038/nprot.2006.446; BENJAMINI Y, 1995, J R STAT SOC B, V57, P289, DOI 10.1111/j.2517-6161.1995.tb02031.x; Binder HJ, 2005, J CLIN GASTROENTEROL, V39, pS53, DOI 10.1097/01.mcg.0000155521.81382.3a; Bissahoyo A, 2005, TOXICOL SCI, V88, P340, DOI 10.1093/toxsci/kfi313; Charney AN, 1998, AM J PHYSIOL-GASTR L, V274, pG518, DOI 10.1152/ajpgi.1998.274.3.G518; Chu SY, 1996, J PHYSIOL-LONDON, V494, P783, DOI 10.1113/jphysiol.1996.sp021532; Coady MJ, 2004, J PHYSIOL-LONDON, V557, P719, DOI 10.1113/jphysiol.2004.063859; DIENER M, 1994, ACTA PHYSIOL SCAND, V151, P385, DOI 10.1111/j.1748-1716.1994.tb09758.x; DOHGEN M, 1994, JPN J PHYSIOL, V44, P519, DOI 10.2170/jjphysiol.44.519; Dong SM, 2005, MODERN PATHOL, V18, P170, DOI 10.1038/modpathol.3800261; Everett LA, 1997, NAT GENET, V17, P411, DOI 10.1038/ng1297-411; Everett LA, 2001, HUM MOL GENET, V10, P153, DOI 10.1093/hmg/10.2.153; FRASER GR, 1965, ANN HUM GENET, V28, P201; Ganapathy V, 2005, BIOCHEM SOC T, V33, P237, DOI 10.1042/BST0330237; Gillam MP, 2004, J BIOL CHEM, V279, P13004, DOI 10.1074/jbc.M313648200; Gopal E, 2007, BBA-BIOMEMBRANES, V1768, P2690, DOI 10.1016/j.bbamem.2007.06.031; Gopal E, 2004, J BIOL CHEM, V279, P44522, DOI 10.1074/jbc.M405365200; HARMATZ PR, 1987, J IMMUNOL METHODS, V102, P213, DOI 10.1016/0022-1759(87)90079-2; Hong CB, 2005, CANCER RES, V65, P3617, DOI 10.1158/0008-5472.CAN-05-0048; Irizarry RA, 2003, BIOSTATISTICS, V4, P249, DOI 10.1093/biostatistics/4.2.249; Leneuve P, 2003, NUCLEIC ACIDS RES, V31, DOI 10.1093/nar/gng021; Li H, 2003, P NATL ACAD SCI USA, V100, P8412, DOI 10.1073/pnas.1430846100; Maritzen T, 2006, THYROID, V16, P725, DOI 10.1089/thy.2006.16.725; Miyauchi S, 2004, J BIOL CHEM, V279, P13293, DOI 10.1074/jbc.C400059200; Nambiar PR, 2003, INT J ONCOL, V22, P145; OKAYASU I, 1990, GASTROENTEROLOGY, V98, P694, DOI 10.1016/0016-5085(90)90290-H; Paroder V, 2006, P NATL ACAD SCI USA, V103, P7270, DOI 10.1073/pnas.0602365103; Piwon N, 2000, NATURE, V408, P369, DOI 10.1038/35042597; Porra V, 2005, J CLIN ENDOCR METAB, V90, P3028, DOI 10.1210/jc.2004-1394; Rodriguez AM, 2002, J CLIN ENDOCR METAB, V87, P3500, DOI 10.1210/jc.87.7.3500; Roy Claude C, 2006, Nutr Clin Pract, V21, P351, DOI 10.1177/0115426506021004351; Schagdarsurengin U, 2006, THYROID, V16, P633, DOI 10.1089/thy.2006.16.633; Srinivas SR, 2005, BIOCHEM J, V392, P655, DOI 10.1042/BJ20050927; Sterneck E, 1998, P NATL ACAD SCI USA, V95, P10908, DOI 10.1073/pnas.95.18.10908; SU LK, 1992, SCIENCE, V256, P668, DOI 10.1126/science.1350108; Tanaka T, 1997, EMBO J, V16, P7432, DOI 10.1093/emboj/16.24.7432; Thangaraju M, 2005, DEVELOPMENT, V132, P4675, DOI 10.1242/dev.02050; Thangaraju M, 2006, J BIOL CHEM, V281, P26769, DOI 10.1074/jbc.C600189200; Thangaraju M, 2006, CANCER RES, V66, P11560, DOI 10.1158/0008-5472.CAN-06-1950; Ueno M, 2004, TUMOR BIOL, V25, P134, DOI 10.1159/000079145; van den Hove MF, 2006, ENDOCRINOLOGY, V147, P1287, DOI 10.1210/en.2005-1149; Westfall P.H., 1993, RESAMPLING BASED MUL; Wong JMW, 2006, J CLIN GASTROENTEROL, V40, P235, DOI 10.1097/00004836-200603000-00015; Wright EM, 2004, PFLUG ARCH EUR J PHY, V447, P510, DOI 10.1007/s00424-003-1063-6	45	50	52	0	1	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	SEP 5	2008	283	36					24729	24737		10.1074/jbc.M802681200	http://dx.doi.org/10.1074/jbc.M802681200			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	342YR	18562324	Green Published, hybrid			2022-12-27	WOS:000258820000041
J	Hager, M; Bigotti, MG; Meszaros, R; Carmignac, V; Holmberg, J; Allamand, V; Akerlund, M; Kalamajski, S; Brancaccio, A; Mayer, U; Durbeej, M				Haeger, Mattias; Bigotti, Maria Giulia; Meszaros, Renata; Carmignac, Virginie; Holmberg, Johan; Allamand, Valerie; Akerlund, Mikael; Kalamajski, Sebastian; Brancaccio, Andrea; Mayer, Ulrike; Durbeej, Madeleine			Cib2 binds integrin alpha 7B beta 1D and is reduced in laminin alpha 2 chain-deficient muscular dystrophy	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ALPHA(IIB) CYTOPLASMIC DOMAIN; SKELETAL-MUSCLE; GENE-EXPRESSION; ALPHA-7-BETA-1 INTEGRIN; CHROMOSOME 15Q24; CALCIUM-BINDING; MUTANT MICE; PROTEIN; IDENTIFICATION; REDUCTION	Mutations in the gene encoding laminin alpha 2 chain cause congenital muscular dystrophy type 1A. In skeletal muscle, laminin alpha 2 chain binds at least two receptor complexes: the dystrophin-glycoprotein complex and integrin alpha 7 beta 1. To gain insight into the molecular mechanisms underlying this disorder, we performed gene expression profiling of laminin alpha 2 chain-deficient mouse limb muscle. One of the down-regulated genes encodes a protein called Cib2 (calcium-and integrin-binding protein 2) whose expression and function is unknown. However, the closely related Cib1 has been reported to bind integrin alpha IIb and may be involved in outside-in-signaling in platelets. Since Cib2 might be a novel integrin alpha 7 beta 1-binding protein in muscle, we have studied Cib2 expression in the developing and adult mouse. Cib2 mRNA is mainly expressed in the developing central nervous system and in developing and adult skeletal muscle. In skeletal muscle, Cib2 colocalizes with the integrin alpha 7B subunit at the sarcolemma and at the neuromuscular and myotendinous junctions. Finally, we demonstrate that Cib2 is a calcium-binding protein that interacts with integrin alpha 7B beta 1D. Thus, our data suggest a role for Cib2 as a cytoplasmic effector of integrin alpha 7B beta 1D signaling in skeletal muscle.	[Haeger, Mattias; Meszaros, Renata; Carmignac, Virginie; Holmberg, Johan; Akerlund, Mikael; Kalamajski, Sebastian; Durbeej, Madeleine] Lund Univ, Dept Expt Med Sci, Div Cell & Matrix Biol, S-22184 Lund, Sweden; [Bigotti, Maria Giulia] Univ Roma La Sapienza, Dept Biochem, I-00185 Rome, Italy; [Allamand, Valerie] INSERM, U582, F-75651 Paris, France; [Allamand, Valerie] Univ Paris 06, IFR14, Inst Myol, UMR S582, F-75250 Paris, France; [Brancaccio, Andrea] Univ Cattolica Sacro Cuore, Ist Chim Riconoscimento Mol, Ist Biochim Clin, I-00168 Rome, Italy; [Mayer, Ulrike] Univ E Anglia, Sch Biol Sci, Norwich NR4 7TJ, Norfolk, England	Lund University; Sapienza University Rome; Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Sorbonne Universite; Catholic University of the Sacred Heart; IRCCS Policlinico Gemelli; Consiglio Nazionale delle Ricerche (CNR); Istituto di Chimica del Riconoscimento Molecolare (ICRM-CNR); University of East Anglia	Durbeej, M (corresponding author), Lund Univ, Dept Expt Med Sci, Div Cell & Matrix Biol, BMC B12, S-22184 Lund, Sweden.	madeleine.durbeej-hjalt@med.lu.se	Brancaccio, Andrea/C-5876-2009; Allamand, Valerie/M-4333-2017; Allamand, Valérie/AAH-6272-2021	Brancaccio, Andrea/0000-0003-4690-8826; Allamand, Valérie/0000-0001-8997-9742; Kalamajski, Sebastian/0000-0002-6600-9302; Bigotti, Giulia/0000-0001-9595-3338; Durbeej Hjalt, Madeleine/0000-0002-5491-2457; Mayer, Ulrike/0000-0003-2328-0052	Muscular Dystrophy Association and Association Francaise contre les Myopathies; Wenner-Gren Foundations	Muscular Dystrophy Association and Association Francaise contre les Myopathies; Wenner-Gren Foundations	This work was supported by grants from the Muscular Dystrophy Association and Association Francaise contre les Myopathies (to M. D.) and by the Wenner-Gren Foundations (to V. C.). The costs of publication of this article were defrayed in part by the payment of page charges. This article must therefore be hereby marked "advertisement" in accordance with 18 U. S. C. Section 1734 solely to indicate this fact.	Barry WT, 2002, J BIOL CHEM, V277, P28877, DOI 10.1074/jbc.M202983200; Chen YW, 2000, J CELL BIOL, V151, P1321, DOI 10.1083/jcb.151.6.1321; Cohn RD, 1999, J NEUROL SCI, V163, P140, DOI 10.1016/S0022-510X(99)00012-X; Cushman LJ, 2005, AM J MED GENET A, V137A, P65, DOI 10.1002/ajmg.a.30836; Durbeej M, 2002, CURR OPIN GENET DEV, V12, P349, DOI 10.1016/S0959-437X(02)00309-X; Eftink MR, 1997, METHOD ENZYMOL, V278, P258; Flintoff-Dye NL, 2005, DEV DYNAM, V234, P11, DOI 10.1002/dvdy.20462; Gawlik K, 2004, HUM MOL GENET, V13, P1775, DOI 10.1093/hmg/ddh190; Gawlik KI, 2006, FEBS LETT, V580, P1759, DOI 10.1016/j.febslet.2006.02.027; Gentry HR, 2005, J BIOL CHEM, V280, P8407, DOI 10.1074/jbc.M411515200; Guo LT, 2003, NEUROMUSCULAR DISORD, V13, P207, DOI 10.1016/s0960-8966(02)00266-3; Hodges BL, 1997, J CELL SCI, V110, P2873; Hosack DA, 2003, GENOME BIOL, V4, DOI 10.1186/gb-2003-4-10-r70; Kalamajski S, 2007, J BIOL CHEM, V282, P26740, DOI 10.1074/jbc.M704026200; Li C, 2001, P NATL ACAD SCI USA, V98, P31, DOI 10.1073/pnas.011404098; Mayer U, 2003, J BIOL CHEM, V278, P14587, DOI 10.1074/jbc.R200022200; Mitchell SJ, 1998, AM J HUM GENET, V62, P1070, DOI 10.1086/301821; Miyagoe Y, 1997, FEBS LETT, V415, P33, DOI 10.1016/S0014-5793(97)01007-7; Naik MU, 2003, BLOOD, V102, P3629, DOI 10.1182/blood-2003-05-1703; Naik UP, 1997, J BIOL CHEM, V272, P4651, DOI 10.1074/jbc.272.8.4651; Ohlendieck K., 2002, BASIC APPL MYOL, V12, P147; PIZARD A, 2004, CURRENT PROTOCOLS MO; Rouger K, 2002, AM J PHYSIOL-CELL PH, V283, pC773, DOI 10.1152/ajpcell.00112.2002; Seki N, 1999, BBA-GENE STRUCT EXPR, V1444, P143, DOI 10.1016/S0167-4781(98)00253-X; Taniguchi M, 2006, BIOCHEM BIOPH RES CO, V342, P489, DOI 10.1016/j.bbrc.2005.12.224; Turk R, 2005, FASEB J, V19, P127, DOI 10.1096/fj.05-4678fje; Vachon PH, 1997, J CLIN INVEST, V100, P1870, DOI 10.1172/JCI119716; van Lunteren E, 2006, PHYSIOL GENOMICS, V25, P85, DOI 10.1152/physiolgenomics.00226.2005; Velling T, 1996, DEV DYNAM, V207, P355, DOI 10.1002/(SICI)1097-0177(199612)207:4<355::AID-AJA1>3.0.CO;2-G; VOIT T, 2004, MYOLOGY, P1203; von der Hagen M, 2005, NEUROMUSCULAR DISORD, V15, P863, DOI 10.1016/j.nmd.2005.09.002; Yamniuk AP, 2006, CALCIUM BINDING PROT, V1, P150; Yuan W, 2006, MOL CELL BIOL, V26, P8507, DOI 10.1128/MCB.01488-06; Yuan WP, 2006, J CELL BIOL, V172, P169, DOI 10.1083/jcb.200505131	34	32	35	2	10	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	SEP 5	2008	283	36					24760	24769		10.1074/jbc.M801166200	http://dx.doi.org/10.1074/jbc.M801166200			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	342YR	18611855	hybrid, Green Published			2022-12-27	WOS:000258820000044
J	Ryan, AJ; Chen, BB; Vennalaganti, PR; Henderson, FC; Tephly, LA; Carter, AB; Mallampalli, RK				Ryan, Alan J.; Chen, Bill B.; Vennalaganti, Prashanth R.; Henderson, Florita C.; Tephly, Linda A.; Carter, A. Brent; Mallampalli, Rama K.			15-deoxy-Delta(12,14)-prostaglandin J(2) impairs phosphatidylcholine synthesis and induces nuclear accumulation of thiol-modified cytidylyltransferase	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							CTP-PHOSPHOCHOLINE CYTIDYLYLTRANSFERASE; CHINESE-HAMSTER OVARY; PROLIFERATOR-ACTIVATED RECEPTOR; DNA-BINDING; CYCLOPENTENONE PROSTAGLANDINS; PPAR-GAMMA; IN-VIVO; COVALENT MODIFICATION; PROTEIN OXIDATION; RAT-LIVER	Synthesis of phosphatidylcholine, the major phospholipid of animal cell membranes, requires the key enzyme cytidylyltransferase (CCT alpha). Cysteine sulfhydryls within CCT alpha are needed for full catalytic activity. Here we show that prostaglandin 15-deoxy-Delta(12,14)-PGJ(2) (15d-PGJ(2)) inactivates CCT alpha by inducing generation of reactive oxidant species and the appearance of a cross-linked CCT alpha dimer in cells. N-Acetyl-L-cysteine reduced oxidative stress, prevented CCT alpha cross-linking, and restored CCT function in 15d-PGJ(2)-treated cells. 15d-PGJ(2) modified critical cysteine residues within CCT alpha as determined by mutagenesis studies and by incorporation of biotin-15d-PGJ(2) into CCT alpha. These effects of 15d-PGJ(2) were associated with CCT alpha accumulation within the nucleus. The data indicate that bioactive prostanoids significantly impair membrane phospholipid production by promoting cysteine cross-bridging within CCT alpha.	[Vennalaganti, Prashanth R.; Carter, A. Brent; Mallampalli, Rama K.] Univ Iowa, Vet Affairs Med Ctr, Roy J & Lucille A Carver Coll Med, Iowa City, IA 52242 USA; [Ryan, Alan J.; Henderson, Florita C.; Tephly, Linda A.; Carter, A. Brent; Mallampalli, Rama K.] Univ Iowa, Dept Internal Med, Roy J & Lucille A Carver Coll Med, Iowa City, IA 52242 USA; Univ Iowa, Dept Biochem, Roy J & Lucille A Carver Coll Med, Iowa City, IA 52242 USA	University of Iowa; US Department of Veterans Affairs; Veterans Health Administration (VHA); Iowa City VA Health Care System; University of Iowa; University of Iowa	Mallampalli, RK (corresponding author), Univ Iowa, Coll Med, Dept Internal Med, Div Pulm Dis,Crit Care & Occupat Med, C-33K,GH, Iowa City, IA 52242 USA.	rama-mallampalli@uiowa.edu			NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL080229, R01HL068135, R01HL071040, T32HL007344, R01HL081784] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES [R01ES015981, R01ES014871] Funding Source: NIH RePORTER; NHLBI NIH HHS [HL080229, HL081784, T32 HL007344, HL071040, R01 HL068135] Funding Source: Medline; NIEHS NIH HHS [R01 ES014871, ES015981] Funding Source: Medline	NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS)); NHLBI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NIEHS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS))		Aldini G, 2007, BIOCHEMISTRY-US, V46, P2707, DOI 10.1021/bi0618565; ATSMON J, 1990, CANCER RES, V50, P1879; ATSMON J, 1990, BIOCHEMISTRY-US, V29, P3760, DOI 10.1021/bi00467a023; Baburina I, 1998, J BIOL CHEM, V273, P2169, DOI 10.1074/jbc.273.4.2169; BASS DA, 1983, J IMMUNOL, V130, P1910; Bell-Parikh LC, 2003, J CLIN INVEST, V112, P945, DOI 10.1172/JCI200318012; Berlett BS, 1997, J BIOL CHEM, V272, P20313, DOI 10.1074/jbc.272.33.20313; BLIGH EG, 1959, CAN J BIOCHEM PHYS, V37, P911; Bogan MJ, 2005, J BIOL CHEM, V280, P19613, DOI 10.1074/jbc.M414028200; Cernuda-Morollon E, 2001, J BIOL CHEM, V276, P35530, DOI 10.1074/jbc.M104518200; Chen BB, 2007, J BIOL CHEM, V282, DOI 10.1074/jbc.M706472200; Chen XN, 2006, P NATL ACAD SCI USA, V103, P11724, DOI 10.1073/pnas.0604946103; Chen Y, 1999, J BIOL CHEM, V274, P10863, DOI 10.1074/jbc.274.16.10863; CORNELL R, 1989, J BIOL CHEM, V264, P9077; Cornell RB, 2000, TRENDS BIOCHEM SCI, V25, P441, DOI 10.1016/S0968-0004(00)01625-X; CRAIG L, 1994, J BIOL CHEM, V269, P3311; Cui Z, 1996, J BIOL CHEM, V271, P14668, DOI 10.1074/jbc.271.25.14668; Dahlen SE, 2004, THORAX, V59, P453, DOI 10.1136/thx.2004.026641; Dean RT, 1997, BIOCHEM J, V324, P1; EXTON JH, 1990, J BIOL CHEM, V265, P1; Flaherty DM, 2002, J IMMUNOL, V168, P5675, DOI 10.4049/jimmunol.168.11.5675; FORMAN BM, 1995, CELL, V83, P803, DOI 10.1016/0092-8674(95)90193-0; Gehrig K, 2008, MOL BIOL CELL, V19, P237, DOI 10.1091/mbc.E07-02-0179; Henderson FC, 2006, J LIPID RES, V47, P2314, DOI 10.1194/jlr.M600284-JLR200; HIRATA Y, 1988, J BIOL CHEM, V263, P16619; JACKOWSKI S, 1994, J BIOL CHEM, V269, P3858; Jackowski S, 2005, J BIOL CHEM, V280, P853, DOI 10.1074/jbc.R400031200; Kent C, 1997, BBA-LIPID LIPID MET, V1348, P79, DOI 10.1016/S0005-2760(97)00112-4; Kim HJ, 2007, CANCER RES, V67, P2595, DOI 10.1158/0008-5472.CAN-06-3043; Kondo M, 2001, J BIOL CHEM, V276, P12076, DOI 10.1074/jbc.M009630200; Levonen AL, 2004, BIOCHEM J, V378, P373, DOI 10.1042/BJ20031049; Levonen AL, 2001, ARTERIOSCL THROM VAS, V21, P1846, DOI 10.1161/hq1101.098488; Longo CA, 1997, AM J RESP CELL MOL, V16, P605, DOI 10.1165/ajrcmb.16.5.9160843; Mallampalli RK, 2000, J BIOL CHEM, V275, P9699, DOI 10.1074/jbc.275.13.9699; MURRAY JJ, 1986, NEW ENGL J MED, V315, P800, DOI 10.1056/NEJM198609253151304; NARUMIYA S, 1987, J PHARMACOL EXP THER, V242, P306; Oh JY, 2008, BIOCHEM J, V411, P297, DOI [10.1042/BJ20071189, 10.1042/bj20071189]; Oliva JL, 2003, P NATL ACAD SCI USA, V100, P4772, DOI 10.1073/pnas.0735842100; Perez-Sala D, 2003, J BIOL CHEM, V278, P51251, DOI 10.1074/jbc.M309409200; Person EC, 2001, ENDOCRINOLOGY, V142, P551, DOI 10.1210/en.142.2.551; Pignatelli M, 2005, CARCINOGENESIS, V26, P81, DOI 10.1093/carcin/bgh308; Rehan VK, 2007, AM J PHYSIOL-LUNG C, V292, pL323, DOI 10.1152/ajplung.00071.2006; Renedo M, 2007, BIOCHEMISTRY-US, V46, P6607, DOI 10.1021/bi602389p; Ridsdale R, 2001, J BIOL CHEM, V276, P49148, DOI 10.1074/jbc.M103566200; Rossi A, 2000, NATURE, V403, P103, DOI 10.1038/47520; Sanchez-Gomez FJ, 2004, MOL PHARMACOL, V66, P1349, DOI 10.1124/mol.104.002824; Schafer FQ, 2001, FREE RADICAL BIO MED, V30, P1191, DOI 10.1016/S0891-5849(01)00480-4; Shibata T, 2002, J BIOL CHEM, V277, P10459, DOI 10.1074/jbc.M110314200; Shibata T, 2003, J BIOL CHEM, V278, P26046, DOI 10.1074/jbc.M303690200; Shiraki T, 2005, J BIOL CHEM, V280, P14145, DOI 10.1074/jbc.M500901200; SLEIGHT R, 1983, J BIOL CHEM, V258, P836; Straus DS, 2000, P NATL ACAD SCI USA, V97, P4844, DOI 10.1073/pnas.97.9.4844; UCHIDA K, 1993, FEBS LETT, V332, P208, DOI 10.1016/0014-5793(93)80632-5; Wang LM, 2005, MOL CELL BIOL, V25, P3357, DOI 10.1128/MCB.25.8.3357-3363.2005; WATKINS JD, 1992, J BIOL CHEM, V267, P5686; WEINHOLD PA, 1986, J BIOL CHEM, V261, P5104; WIKENHEISER KA, 1993, P NATL ACAD SCI USA, V90, P11029, DOI 10.1073/pnas.90.23.11029; Xie MT, 2004, J BIOL CHEM, V279, P28817, DOI 10.1074/jbc.M403311200; Zhou J, 2006, GENE THER, V13, P974, DOI 10.1038/sj.gt.3302746; Zhou JM, 2003, J BIOL CHEM, V278, P37032, DOI 10.1074/jbc.M304316200	60	10	10	0	1	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	SEP 5	2008	283	36					24628	24640		10.1074/jbc.M801167200	http://dx.doi.org/10.1074/jbc.M801167200			13	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	342YR	18614529	Green Published, hybrid			2022-12-27	WOS:000258820000035
J	Sanchez-Olea, R; Ortiz, S; Barreto, O; Yang, Q; Xu, CJ; Zhu, H; Yuan, JY				Sanchez-Olea, Roberto; Ortiz, Sara; Barreto, Odmara; Yang, Qing; Xu, Chi-jie; Zhu, Hong; Yuan, Junying			Parcs is a dual regulator of cell proliferation and Apaf-1 function	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							CYTOCHROME-C; NEGATIVE REGULATION; CASPASE ACTIVATION; PROCASPASE-9; RNAI; REQUIREMENT; APOPTOSOME; DAMAGE; DATP	Here we identify a novel protein, named Parcs for pro-apoptotic protein required for cell survival, that is involved in both cell cycle progression and apoptosis. Parcs interacted with Apaf-1 by binding to the oligomerization domain of Apaf-1. Apaf-1-mediated activation of caspase-9 and caspase-3 was markedly decreased in a cytosolic fraction isolated from HeLa cells with reduced parcs expression. Interestingly, parcs deficiency blocked cell proliferation in non-tumorigenic cells but not in multiple tumor cell lines. In MCF-10A cells, parcs deficiency led to early G(1) arrest. Conditional inactivation of parcs in genetically modified primary mouse embryonic fibroblasts using the Cre-LoxP system also resulted in the inhibition of cell proliferation. We conclude that Parcs may define a molecular checkpoint in the control of cell proliferation for normal cells that is lost in tumor cells.	[Sanchez-Olea, Roberto; Ortiz, Sara; Barreto, Odmara; Yang, Qing; Xu, Chi-jie; Zhu, Hong; Yuan, Junying] Harvard Univ, Sch Med, Dept Cell Biol, Boston, MA 02115 USA	Harvard University; Harvard Medical School	Yuan, JY (corresponding author), Harvard Univ, Sch Med, Dept Cell Biol, Boston, MA 02115 USA.	junying_yuan@hms.harvard.edu		Barreto Chang, Odmara/0000-0002-4781-404X; Zhu, Hong/0000-0002-2575-4031; Sanchez-Olea, Roberto/0000-0002-6523-7821	National Institutes of Health [R37-AG012859]; Department of Defense Breast Cancer Research Program [DAMD1702-1-0403]; NATIONAL INSTITUTE ON AGING [R37AG012859] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Department of Defense Breast Cancer Research Program(United States Department of Defense); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))	This work was supported, in whole or in part, by National Institutes of Health Grant R37-AG012859 from NIA (to J.Y.). This work was also supported by Department of Defense Breast Cancer Research Program Grant DAMD1702-1-0403 (to J.Y.).	Bao Q, 2007, CELL DEATH DIFFER, V14, P56, DOI 10.1038/sj.cdd.4402028; Beere HM, 2000, NAT CELL BIOL, V2, P469, DOI 10.1038/35019501; Chau BN, 2000, MOL CELL, V6, P31, DOI 10.1016/S1097-2765(00)00005-8; Cho DH, 2004, J BIOL CHEM, V279, P39942, DOI 10.1074/jbc.M405747200; Chu ZL, 2001, J BIOL CHEM, V276, P9239, DOI 10.1074/jbc.M006309200; Giaever G, 2002, NATURE, V418, P387, DOI 10.1038/nature00935; Gonczy P, 2000, NATURE, V408, P331, DOI 10.1038/35042526; Hao ZY, 2005, CELL, V121, P579, DOI 10.1016/j.cell.2005.03.016; Heidebrecht HJ, 2001, LAB INVEST, V81, P1163, DOI 10.1038/labinvest.3780328; Li HL, 1998, CELL, V94, P491, DOI 10.1016/S0092-8674(00)81590-1; Li P, 1997, CELL, V91, P479, DOI 10.1016/S0092-8674(00)80434-1; Liu XS, 1996, CELL, V86, P147, DOI 10.1016/S0092-8674(00)80085-9; Mouhamad S, 2007, CELL CYCLE, V6, P3103, DOI 10.4161/cc.6.24.5046; Pandey P, 2000, EMBO J, V19, P4310, DOI 10.1093/emboj/19.16.4310; Rual JF, 2004, GENOME RES, V14, P2162, DOI 10.1101/gr.2505604; Saleh A, 2000, NAT CELL BIOL, V2, P476, DOI 10.1038/35019510; Sonnichsen B, 2005, NATURE, V434, P462, DOI 10.1038/nature03353; Srinivasula SM, 1998, MOL CELL, V1, P949, DOI 10.1016/S1097-2765(00)80095-7; Zermati Y, 2007, MOL CELL, V28, P624, DOI 10.1016/j.molcel.2007.09.030; Zou H, 1997, CELL, V90, P405, DOI 10.1016/S0092-8674(00)80501-2	20	10	10	0	1	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	SEP 5	2008	283	36					24400	24405		10.1074/jbc.M804664200	http://dx.doi.org/10.1074/jbc.M804664200			6	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	342YR	18562310	Green Published, hybrid			2022-12-27	WOS:000258820000014
J	Caroline, G; Eric, F; Bohn, YST; Sylvie, E; Attree, I				Caroline, Gebus; Eric, Faudry; Bohn, Yu-Sing Tammy; Sylvie, Elsen; Attree, Ina			Oligomerization of PcrV and LcrV, protective antigens of Pseudomonas aeruginosa and Yersinia pestis	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							III SECRETION SYSTEM; YOP TRANSLOCATION PORE; RECOMBINANT V-ANTIGEN; SHIGELLA-FLEXNERI; POLYMORPHONUCLEAR NEUTROPHILS; ACTIVE IMMUNIZATION; EUKARYOTIC CELLS; GENETIC-ANALYSIS; HOST MEMBRANES; TIP COMPLEX	Protective antigens of Pseudomonas aeruginosa (PcrV) and Yersinia pestis (LcrV) are key elements of specialized machinery, the type III secretion system ( T3SS), which enables the injection of effector molecules into eukaryotic cells. Being positioned at the injectisome extremity, V proteins participate in the translocation process across the host cell plasma membrane. In this study, we demonstrate the assembly of V proteins into oligomeric doughnut-like complexes upon controlled refolding of the proteins in vitro. The oligomeric nature of refolded PcrV was revealed by size exclusion chromatography, native gel electrophoresis, and native mass spectrometry, which ascertain the capacity of the protein to multimerize into higher-order species. Furthermore, transmission electron microscopy performed on oligomers of both PcrV and LcrV revealed the presence of distinct structures with approximate internal and external diameters of 3-4 and 8-10 nm, respectively. The C-terminal helix, alpha 12, of PcrV and notably the hydrophobic residues Val(255), Leu(262), and Leu(276) located within this helix, were shown to be crucial for oligomerization. Moreover, the corresponding mutant proteins produced in P. aeruginosa were found to be non-functional in in vivo type III-dependent cytotoxicity assays by directly affecting the correct assembly of PopB/D translocon within the host cell membranes. The detailed understanding of structure-function relationships of T3SS needle tip proteins will be of value in further developments of new vaccines and antimicrobials.	[Caroline, Gebus; Eric, Faudry; Bohn, Yu-Sing Tammy; Sylvie, Elsen; Attree, Ina] Univ Grenoble 1, Lab Biochim & Biophys Syst Integres, UMR 5092, CNRS,CEA,DSV,iRTSV, F-38054 Grenoble 09, France	CEA; Centre National de la Recherche Scientifique (CNRS); UDICE-French Research Universities; Communaute Universite Grenoble Alpes; Universite Grenoble Alpes (UGA)	Attree, I (corresponding author), Commissariat Energie Atom Grenoble, iRTSV BBSI, 17 Rue Martyrs, F-38054 Grenoble 09, France.	iattreedelic@cea.fr	Faudry, Eric/I-9154-2014	Faudry, Eric/0000-0001-9958-6029; Attree, Ina/0000-0002-2580-764X	Delegation Generale pour l'Armement (DGA) [06.70.151.00.470.75.96]; French Cystic Fibrosis Association Vaincre la Mucoviscidose	Delegation Generale pour l'Armement (DGA); French Cystic Fibrosis Association Vaincre la Mucoviscidose	This work was supported in part by Research Contract 06.70.151.00.470.75.96 from Delegation Generale pour l'Armement (DGA) and the French Cystic Fibrosis Association Vaincre la Mucoviscidose. The costs of publication of this article were defrayed in part by the payment of page charges. This article must therefore be hereby marked "advertisement" in accordance with 18 U. S. C. Section 1734 solely to indicate this fact.	Akeda Y, 2005, NATURE, V437, P911, DOI 10.1038/nature03992; Akeda Y, 2004, J BACTERIOL, V186, P2402, DOI 10.1128/JB.186.8.2402-2412.2004; Anderson GW, 1996, INFECT IMMUN, V64, P4580, DOI 10.1128/IAI.64.11.4580-4585.1996; Arai M, 2000, ADV PROTEIN CHEM, V53, P209; BENNETT MJ, 1994, P NATL ACAD SCI USA, V91, P3127, DOI 10.1073/pnas.91.8.3127; Blocker A, 1999, J CELL BIOL, V147, P683, DOI 10.1083/jcb.147.3.683; Blocker A, 2003, P NATL ACAD SCI USA, V100, P3027, DOI 10.1073/pnas.0535335100; Broms JE, 2003, J INFECT DIS, V188, P239, DOI 10.1086/376452; Broz P, 2007, MOL MICROBIOL, V65, P1311, DOI 10.1111/j.1365-2958.2007.05871.x; BURROWS TW, 1956, BRIT J EXP PATHOL, V37, P481; Chuanchuen R, 2002, BIOTECHNIQUES, V33, P760, DOI 10.2144/02334bm08; Cordes FS, 2003, J BIOL CHEM, V278, P17103, DOI 10.1074/jbc.M300091200; Cornelis GR, 2006, NAT REV MICROBIOL, V4, P811, DOI 10.1038/nrmicro1526; Dacheux D, 1999, INFECT IMMUN, V67, P6164, DOI 10.1128/IAI.67.11.6164-6167.1999; Dacheux D, 2000, INFECT IMMUN, V68, P2916, DOI 10.1128/IAI.68.5.2916-2924.2000; Dacheux D, 2001, MOL MICROBIOL, V40, P76, DOI 10.1046/j.1365-2958.2001.02368.x; Deane JE, 2006, P NATL ACAD SCI USA, V103, P12529, DOI 10.1073/pnas.0602689103; DeLano W, 2002, PYMOL 0 99; Derewenda U, 2004, STRUCTURE, V12, P301, DOI 10.1016/j.str.2004.01.010; Espina M, 2007, PROTEIN SCI, V16, P704, DOI 10.1110/ps.062645007; Espina M, 2006, INFECT IMMUN, V74, P4391, DOI 10.1128/IAI.00440-06; Faudry E, 2006, BIOCHEMISTRY-US, V45, P8117, DOI 10.1021/bi060452+; Frank DW, 2002, J INFECT DIS, V186, P64, DOI 10.1086/341069; Frithz-Lindsten E, 1998, MOL MICROBIOL, V29, P1155, DOI 10.1046/j.1365-2958.1998.00994.x; Galan JE, 2006, NATURE, V444, P567, DOI 10.1038/nature05272; Gauthier A, 2003, J BACTERIOL, V185, P6747, DOI 10.1128/JB.185.23.6747-6755.2003; Goure J, 2005, J INFECT DIS, V192, P218, DOI 10.1086/430932; Goure J, 2004, INFECT IMMUN, V72, P4741, DOI 10.1128/IAI.72.8.4741-4750.2004; HAKANSSON S, 1993, INFECT IMMUN, V61, P71; Hamad MA, 2007, J BACTERIOL, V189, P6734, DOI 10.1128/JB.00539-07; Hill J, 1997, INFECT IMMUN, V65, P4476, DOI 10.1128/IAI.65.11.4476-4482.1997; Hoiczyk E, 2001, P NATL ACAD SCI USA, V98, P4669, DOI 10.1073/pnas.071065798; Holder IA, 2001, INFECT IMMUN, V69, P5908, DOI 10.1128/IAI.69.9.5908-5910.2001; Johnson S, 2007, J BIOL CHEM, V282, P4035, DOI 10.1074/jbc.M607945200; Journet L, 2003, SCIENCE, V302, P1757, DOI 10.1126/science.1091422; Lawton DG, 2002, J BIOL CHEM, V277, P38714, DOI 10.1074/jbc.M203632200; LEARY SEC, 1995, INFECT IMMUN, V63, P2854, DOI 10.1128/IAI.63.8.2854-2858.1995; Lee VT, 2000, J BIOL CHEM, V275, P36869, DOI 10.1074/jbc.M002467200; Marenne MN, 2003, MICROB PATHOGENESIS, V35, P243, DOI 10.1016/S0882-4010(03)00154-2; Marlovits TC, 2004, SCIENCE, V306, P1040, DOI 10.1126/science.1102610; Mueller CA, 2005, SCIENCE, V310, P674, DOI 10.1126/science.1118476; Nanao M, 2003, BMC MICROBIOL, V3, DOI 10.1186/1471-2180-3-21; Neyt C, 1999, MOL MICROBIOL, V33, P971, DOI 10.1046/j.1365-2958.1999.01537.x; Nilles ML, 2004, STRUCTURE, V12, P357, DOI 10.1016/j.str.2004.02.026; Nilles ML, 1997, J BACTERIOL, V179, P1307, DOI 10.1128/jb.179.4.1307-1316.1997; Rousseau F, 2003, STRUCTURE, V11, P243, DOI 10.1016/S0969-2126(03)00029-7; Sani M, 2007, BBA-GEN SUBJECTS, V1770, P307, DOI 10.1016/j.bbagen.2006.10.007; Sarker MR, 1998, J BACTERIOL, V180, P1207, DOI 10.1128/JB.180.5.1207-1214.1998; Schoehn G, 2003, EMBO J, V22, P4957, DOI 10.1093/emboj/cdg499; Stebbins CE, 2003, NAT REV MOL CELL BIO, V4, P738, DOI 10.1038/nrm1201; TOUSSAINT B, 1993, BIOCHEM BIOPH RES CO, V196, P416, DOI 10.1006/bbrc.1993.2265; Veenendaal AKJ, 2007, MOL MICROBIOL, V63, P1719, DOI 10.1111/j.1365-2958.2007.05620.x; Weeks S, 2002, MICROB PATHOGENESIS, V32, P227, DOI 10.1006/mpat.2002.0498	53	34	34	1	8	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	AUG 29	2008	283	35					23940	23949		10.1074/jbc.M803146200	http://dx.doi.org/10.1074/jbc.M803146200			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	340II	18583342	Green Published, hybrid			2022-12-27	WOS:000258638900049
J	Haugaard-Jonsson, LM; Hossain, MA; Daly, NL; Bathgate, RAD; Wade, JD; Craik, DJ; Rosengren, KJ				Haugaard-Jonsson, Linda M.; Hossain, Mohammed Akhter; Daly, Norelle L.; Bathgate, Ross A. D.; Wade, John D.; Craik, David J.; Rosengren, K. Johan			Structure of the R3/I5 chimeric relaxin peptide, a selective GPCR135 and GPCR142 agonist	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							RECEPTOR-BINDING; IN-VITRO; INSULIN; IDENTIFICATION; FAMILY; LIGAND; RAT; SUGGESTS; MEMBER; GENE	The human relaxin family comprises seven peptide hormones with various biological functions mediated through interactions with G-protein-coupled receptors. Interestingly, among the hitherto characterized receptors there is no absolute selectivity toward their primary ligand. The most striking example of this is the relaxin family ancestor, relaxin-3, which is an agonist for three of the four currently known relaxin receptors: GPCR135, GPCR142, and LGR7. Relaxin-3 and its endogenous receptor GPCR135 are both expressed predominantly in the brain and have been linked to regulation of stress and feeding. However, to fully understand the role of relaxin-3 in neurological signaling, the development of selective GPCR135 agonists and antagonists for in vivo studies is crucial. Recent reports have demonstrated that such selective ligands can be achieved by making chimeric peptides comprising the relaxin-3 B-chain combined with the INSL5 A-chain. To obtain structural insights into the consequences of combining A-and B-chains from different relaxins we have determined the NMR solution structure of a human relaxin-3/INSL5 chimeric peptide. The structure reveals that the INSL5 A-chain adopts a conformation similar to the relaxin-3 A-chain, and thus has the ability to structurally support a native-like conformation of the relaxin-3 B-chain. These findings suggest that the decrease in activity at the LGR7 receptor seen for this peptide is a result of the removal of a secondary LGR7 binding site present in the relaxin-3 A-chain, rather than conformational changes in the primary B-chain receptor binding site.	[Haugaard-Jonsson, Linda M.; Rosengren, K. Johan] Univ Kalmar, Sch Pure & Appl Nat Sci, SE-39182 Kalmar, Sweden; [Hossain, Mohammed Akhter; Bathgate, Ross A. D.; Wade, John D.] Univ Melbourne, Howard Florey Inst, Melbourne, Vic 3010, Australia; [Daly, Norelle L.; Craik, David J.] Univ Queensland, Inst Mol Biosci, Brisbane, Qld 4072, Australia	Linnaeus University; University of Kalmar; Florey Institute of Neuroscience & Mental Health; University of Melbourne; University of Queensland	Rosengren, KJ (corresponding author), Univ Kalmar, Sch Pure & Appl Nat Sci, SE-39182 Kalmar, Sweden.	johan.rosengren@hik.se	Haugaard-Kedstrom, Linda/O-7121-2014; Rosengren, K. Johan/P-4450-2016; Daly, Norelle L/D-4302-2013; Haugaard-Kedstrom, Linda/F-3705-2011; Bathgate, Ross/ABE-6471-2020; Craik, David/B-1695-2010	Haugaard-Kedstrom, Linda/0000-0003-0113-6535; Rosengren, K. Johan/0000-0002-5007-8434; Daly, Norelle L/0000-0002-4697-6602; Haugaard-Kedstrom, Linda/0000-0003-0113-6535; Bathgate, Ross/0000-0001-6301-861X; Craik, David/0000-0003-0007-6796; Wade, John/0000-0002-1352-6568; Hossain, Mohammed/0000-0002-9961-0006	NHMRC Project [350284]	NHMRC Project(National Health and Medical Research Council (NHMRC) of Australia)	This work was supported in part by NHMRC Project Grant 350284 ( to J.D.W.). The costs of publication of this article were defrayed in part by the payment of page charges. This article must therefore be hereby marked "advertisement" in accordance with 18 U.S.C. Section 1734 solely to indicate this fact.	Bathgate RAD, 2002, J BIOL CHEM, V277, P1148, DOI 10.1074/jbc.M107882200; Bathgate RAD, 2006, BIOCHEMISTRY-US, V45, P1043, DOI 10.1021/bi052233e; Brunger AT, 1998, ACTA CRYSTALLOGR D, V54, P905, DOI 10.1107/S0907444998003254; Bullesbach EE, 2000, J BIOL CHEM, V275, P35276, DOI 10.1074/jbc.M005728200; Bullesbach EE, 1999, BIOCHEMISTRY-US, V38, P3073, DOI 10.1021/bi982687u; Burazin TCD, 2002, J NEUROCHEM, V82, P1553, DOI 10.1046/j.1471-4159.2002.01114.x; BURKHARDT E, 1994, HUM GENET, V94, P91, DOI 10.1007/BF02272850; CHASSIN D, 1995, GENOMICS, V29, P465, DOI 10.1006/geno.1995.9980; Cierpicki T, 2001, J BIOMOL NMR, V21, P249, DOI 10.1023/A:1012911329730; Conklin D, 1999, GENOMICS, V60, P50, DOI 10.1006/geno.1999.5899; EIGENBROT C, 1991, J MOL BIOL, V221, P15, DOI 10.1016/0022-2836(91)90796-9; Guntert P, 1997, J MOL BIOL, V273, P283, DOI 10.1006/jmbi.1997.1284; Hossain MA, 2008, J BIOL CHEM, V283, P17287, DOI 10.1074/jbc.M801911200; Hossain MA, 2006, INT J PEPT RES THER, V12, P211, DOI 10.1007/s10989-006-9020-9; Hsu SY, 2002, SCIENCE, V295, P671, DOI 10.1126/science.1065654; HUDSON P, 1984, EMBO J, V3, P2333, DOI 10.1002/j.1460-2075.1984.tb02135.x; HUDSON P, 1983, NATURE, V301, P628, DOI 10.1038/301628a0; Keller R., 2004, COMPUTER AIDED RESON, V1; Kuei C, 2007, J BIOL CHEM, V282, P25425, DOI 10.1074/jbc.M701416200; Kumagai J, 2002, J BIOL CHEM, V277, P31283, DOI 10.1074/jbc.C200398200; Liu CL, 2005, J BIOL CHEM, V280, P292, DOI 10.1074/jbc.M409916200; Liu CL, 2005, MOL PHARMACOL, V67, P231, DOI 10.1124/mol.104.006700; Liu CL, 2003, J BIOL CHEM, V278, P50765, DOI 10.1074/jbc.M308996200; Liu CL, 2003, J BIOL CHEM, V278, P50754, DOI 10.1074/jbc.M308995200; Lok S, 2000, BIOL REPROD, V62, P1593, DOI 10.1095/biolreprod62.6.1593; Ma S, 2007, NEUROSCIENCE, V144, P165, DOI 10.1016/j.neuroscience.2006.08.072; McGowan BMC, 2005, ENDOCRINOLOGY, V146, P3295, DOI 10.1210/en.2004-1532; Rosengren KJ, 2006, J BIOL CHEM, V281, P28287, DOI 10.1074/jbc.M603829200; Rosengren KJ, 2006, J BIOL CHEM, V281, P5845, DOI 10.1074/jbc.M511210200; SCHWABE C, 1977, SCIENCE, V197, P914, DOI 10.1126/science.887933; Sudo S, 2003, J BIOL CHEM, V278, P7855, DOI 10.1074/jbc.M212457200; Sutton SW, 2004, NEUROENDOCRINOLOGY, V80, P298, DOI 10.1159/000083656; Tanaka M, 2005, EUR J NEUROSCI, V21, P1659, DOI 10.1111/j.1460-9568.2005.03980.x; WAGNER G, 1990, PROG NUCL MAG RES SP, V22, P101, DOI 10.1016/0079-6565(90)80003-Z; Wilkinson TN, 2005, BMC EVOL BIOL, V5, DOI 10.1186/1471-2148-5-14; WISHART DS, 1995, J BIOMOL NMR, V5, P67, DOI 10.1007/BF00227471	36	37	39	0	8	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	AUG 29	2008	283	35					23811	23818		10.1074/jbc.M800489200	http://dx.doi.org/10.1074/jbc.M800489200			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	340II	18577524	hybrid, Green Published			2022-12-27	WOS:000258638900035
J	Solis, AS; Peng, R; Crawford, JB; Phillips, JA; Patton, JG				Solis, Amanda S.; Peng, Rui; Crawford, J. Barrett; Phillips, John A., III; Patton, James G.			Growth hormone deficiency and splicing fidelity - Two serine/arginine-rich proteins, ASF/SF2 and SC35, act antagonistically	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							MESSENGER-RNA; SR PROTEINS; 5-SPLICE-SITE RECOGNITION; ENHANCER; INHIBITION; MUTATIONS; MECHANISM; SELECTION; SEQUENCE; ISOFORM	The majority of mutations that cause isolated growth hormone deficiency type II are the result of aberrant splicing of transcripts encoding human growth hormone. Such mutations increase skipping of exon 3 and encode a 17.5- kDa protein that acts as a dominant negative to block secretion of full- length protein produced from unaffected alleles. Previously, we identified a splicing regulatory element in exon 3 ( exonic splicing enhancer 2 ( ESE2)), but we had not determined the molecular mechanism by which this element prevents exon skipping. Here, we show that two members of the serine/ arginine- rich (SR) protein superfamily (ASF/ SF2 and SC35) act antagonistically to regulate exon 3 splicing. ASF/ SF2 activates exon 3 inclusion, but SC35, acting through a region just downstream of ESE2, can block such activation. These findings explain the disease- causing mechanism of a patient mutation in ESE2 that creates a functional SC35- binding site that then acts synergistically with the downstream SC35 site to produce pathological levels of exon 3 skipping. Although the precedent for SR proteins acting as repressors is established, this is the first example of a patient mutation that creates a site through which an SR protein represses splicing.	[Solis, Amanda S.; Peng, Rui; Crawford, J. Barrett; Patton, James G.] Vanderbilt Univ, Dept Biol Sci, Nashville, TN 37235 USA; [Phillips, John A., III] Vanderbilt Univ, Dept Pediat, Nashville, TN 37235 USA	Vanderbilt University; Vanderbilt University	Patton, JG (corresponding author), Vanderbilt Univ, Dept Biol Sci, 2301 Vanderbilt Pl,Stn B,Box 1820, Nashville, TN 37235 USA.	james.g.patton@vanderbilt.edu			NIDDK NIH HHS [DK 35592] Funding Source: Medline; NIGMS NIH HHS [GM 62487 M] Funding Source: Medline; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK035592] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM062487] Funding Source: NIH RePORTER	NIDDK NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		Asada N, 2000, MOL CELL ENDOCRINOL, V162, P121, DOI 10.1016/S0303-7207(00)00202-1; Barnard DC, 2000, MOL CELL BIOL, V20, P3049, DOI 10.1128/MCB.20.9.3049-3057.2000; BIRNEY E, 1993, NUCLEIC ACIDS RES, V21, P5803, DOI 10.1093/nar/21.25.5803; Blencowe BJ, 2000, TRENDS BIOCHEM SCI, V25, P106, DOI 10.1016/S0968-0004(00)01549-8; Buratti E, 2007, NUCLEIC ACIDS RES, V35, P4359, DOI 10.1093/nar/gkm444; Burge CB, 1999, RNA WORLD, P525; Cartegni L, 2002, NAT REV GENET, V3, P285, DOI 10.1038/nrg775; Cogan JD, 1997, HUM MOL GENET, V6, P909, DOI 10.1093/hmg/6.6.909; COGAN JD, 1995, J CLIN ENDOCR METAB, V80, P3591, DOI 10.1210/jc.80.12.3591; Crawford JB, 2006, MOL CELL BIOL, V26, P8791, DOI 10.1128/MCB.01677-06; DENOTO FM, 1981, NUCLEIC ACIDS RES, V9, P3719, DOI 10.1093/nar/9.15.3719; Expert-Bezancon A, 2004, J BIOL CHEM, V279, P38249, DOI 10.1074/jbc.M405377200; FU XD, 1995, RNA, V1, P663; Gallego ME, 1997, EMBO J, V16, P1772, DOI 10.1093/emboj/16.7.1772; JAMISON SF, 1995, NUCLEIC ACIDS RES, V23, P3260, DOI 10.1093/nar/23.16.3260; Jiang ZH, 1998, P NATL ACAD SCI USA, V95, P9155, DOI 10.1073/pnas.95.16.9155; Kan JLC, 1999, GENE DEV, V13, P462, DOI 10.1101/gad.13.4.462; Kanopka A, 1996, NATURE, V381, P535, DOI 10.1038/381535a0; KOHTZ JD, 1994, NATURE, V368, P119, DOI 10.1038/368119a0; LECOMTE CM, 1987, NUCLEIC ACIDS RES, V15, P6331, DOI 10.1093/nar/15.16.6331; MASUDA N, 1988, BIOCHIM BIOPHYS ACTA, V949, P125, DOI 10.1016/0167-4781(88)90062-0; McCarthy EMS, 1998, HUM MOL GENET, V7, P1491, DOI 10.1093/hmg/7.9.1491; Millar DS, 2003, HUM MUTAT, V21, P424, DOI 10.1002/humu.10168; Moseley CT, 2002, J CLIN ENDOCR METAB, V87, P847, DOI 10.1210/jc.87.2.847; PALMETSHOFER A, 1995, MOL CELL ENDOCRINOL, V113, P225, DOI 10.1016/0303-7207(95)03633-I; Procter AM, 1998, HUM GENET, V103, P255, DOI 10.1007/s004390050815; ROBBERSON BL, 1990, MOL CELL BIOL, V10, P84, DOI 10.1128/MCB.10.1.84; Ryther RCC, 2003, HUM GENET, V113, P140, DOI 10.1007/s00439-003-0949-x; Ryther RCC, 2004, ENDOCRINOLOGY, V145, P2988, DOI 10.1210/en.2003-1724; TIAN M, 1994, GENE DEV, V8, P1703, DOI 10.1101/gad.8.14.1703; WANG Z, 1995, RNA, V1, P21; WU JY, 1993, CELL, V75, P1061, DOI 10.1016/0092-8674(93)90316-I; ZAHLER AM, 1992, GENE DEV, V6, P837, DOI 10.1101/gad.6.5.837; Zhu J, 2000, GENE DEV, V14, P3166, DOI 10.1101/gad.189500	34	27	27	0	0	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	AUG 29	2008	283	35					23619	23626		10.1074/jbc.M710175200	http://dx.doi.org/10.1074/jbc.M710175200			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	340II	18586677	Green Published, hybrid			2022-12-27	WOS:000258638900014
J	Hatori, Y; Hirata, A; Toyoshima, C; Lewis, D; Pilankatta, R; Inesi, G				Hatori, Yuta; Hirata, Ayami; Toyoshima, Chikashi; Lewis, David; Pilankatta, Rajendra; Inesi, Giuseppe			Intermediate phosphorylation reactions in the mechanism of ATP utilization by the copper ATPase (CopA) of Thermotoga maritima	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							P-TYPE-ATPASE; WILSONS-DISEASE PROTEIN; HEAVY-METAL TRANSPORT; FULGIDUS CU+-ATPASE; ARCHAEOGLOBUS-FULGIDUS; SARCOPLASMIC-RETICULUM; ESCHERICHIA-COLI; MEMBRANE-VESICLES; PHOSPHATE ANALOG; BINDING DOMAINS	Recombinant and purified Thermotoga maritima CopA sustains ATPase velocity of 1.78-2.73 mu mol/mg/min in the presence of Cu+ (pH 6, 60 degrees C) and 0.03-0.08 mu mol/mg/min in the absence of Cu+. High levels of enzyme phosphorylation are obtained by utilization of [gamma-P-32]ATP in the absence of Cu+. This phosphoenzyme decays at a much slower rate than observed with Cu.E1 similar to P. In fact, the phosphoenzyme is reduced to much lower steady state levels upon addition of Cu+, due to rapid hydrolytic cleavage. Negligible ATPase turnover is sustained by CopA following deletion of its N-metal binding domain (Delta NMBD) or mutation of NMBD cysteines (CXXC). Nevertheless, high levels of phosphoenzyme are obtained by utilization of [gamma-P-32]ATP by the Delta NMBD and CXXC mutants, with no effect of Cu+ either on its formation or hydrolytic cleavage. Phosphoenzyme formation (E2P) can also be obtained by utilization of Pi, and this reaction is inhibited by Cu+ (E2 to E1 transition) even in the Delta NMBD mutant, evidently due to Cu+ binding at a (transport) site other than the NMBD. E2P undergoes hydrolytic cleavage faster in Delta NMBD and slower in CXXC mutant. We propose that Cu+ binding to the NMBD is required to produce an "active" conformation of CopA, whereby additional Cu+ bound to an alternate (transmembrane transport) site initiates faster cycles including formation of Cu.E1 similar to P, followed by the E1 similar to P to E2-P conformational transition and hydrolytic cleavage of phosphate. An H479Q mutation (analogous to one found in Wilson disease) renders CopA unable to utilize ATP, whereas phosphorylation by P-i is retained.	[Hatori, Yuta; Hirata, Ayami; Toyoshima, Chikashi] Univ Tokyo, Inst Mol & Cellular Biosci, Tokyo 1130032, Japan; [Lewis, David; Pilankatta, Rajendra; Inesi, Giuseppe] Calif Pacific Med Ctr, Res Inst, San Francisco, CA 94107 USA	University of Tokyo; California Pacific Medical Center; California Pacific Medical Center Research Institute	Inesi, G (corresponding author), 475 Brannan St, San Francisco, CA 94107 USA.	ginesi@cpmcri.com	Toyoshima, Chikashi/R-4153-2019; Pilankatta, Rajendra/ABC-8821-2021	Pilankatta, Rajendra/0000-0002-8587-8212; Toyoshima, Chikashi/0000-0001-9640-0778	NHLBI NIH HHS [R01 HL069830-08, R01 HL069830] Funding Source: Medline; PHS HHS [R0301-69830] Funding Source: Medline; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL069830] Funding Source: NIH RePORTER	NHLBI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); PHS HHS(United States Department of Health & Human ServicesUnited States Public Health Service); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))		Arguello JM, 2003, J MEMBRANE BIOL, V195, P93, DOI 10.1007/s00232-003-2048-2; Axelsen KB, 1998, J MOL EVOL, V46, P84, DOI 10.1007/PL00006286; BULL PC, 1993, NAT GENET, V5, P327, DOI 10.1038/ng1293-327; BULL PC, 1994, TRENDS GENET, V10, P246, DOI 10.1016/0168-9525(94)90172-4; Burroughs AM, 2006, J MOL BIOL, V361, P1003, DOI 10.1016/j.jmb.2006.06.049; Chintalapati S, 2008, J MOL BIOL, V378, P581, DOI 10.1016/j.jmb.2008.01.094; Cho H, 2001, P NATL ACAD SCI USA, V98, P8525, DOI 10.1073/pnas.131213698; Cobine PA, 2002, BIOCHEMISTRY-US, V41, P5822, DOI 10.1021/bi025515c; de Meis L, 1974, Biochemistry, V13, P5032, DOI 10.1021/bi00721a026; Dmitriev O, 2006, P NATL ACAD SCI USA, V103, P5302, DOI 10.1073/pnas.0507416103; ELETR S, 1972, BIOCHIM BIOPHYS ACTA, V282, P174, DOI 10.1016/0005-2736(72)90321-5; Gonzalez-Guerrero M, 2008, P NATL ACAD SCI USA, V105, P5992, DOI 10.1073/pnas.0711446105; Hatori Y, 2007, J BIOL CHEM, V282, P25213, DOI 10.1074/jbc.M703520200; INESI G, 1967, J BIOL CHEM, V242, P4637; Inesi G, 2008, J BIOL CHEM, V283, P1189, DOI 10.1074/jbc.M707189200; Jensen AML, 2006, EMBO J, V25, P2305, DOI 10.1038/sj.emboj.7601135; LANZETTA PA, 1979, ANAL BIOCHEM, V100, P95, DOI 10.1016/0003-2697(79)90115-5; Lubben M, 2007, J MOL BIOL, V369, P368, DOI 10.1016/j.jmb.2007.03.029; LUTSENKO S, 1995, BIOCHEMISTRY-US, V34, P15607, DOI 10.1021/bi00048a001; Lutsenko S, 2007, PHYSIOL REV, V87, P1011, DOI 10.1152/physrev.00004.2006; MACLENNAN DH, 1985, NATURE, V316, P696, DOI 10.1038/316696a0; Mandal AK, 2003, BIOCHEMISTRY-US, V42, P11040, DOI 10.1021/bi034806y; Mandal AK, 2002, J BIOL CHEM, V277, P7201, DOI 10.1074/jbc.M109964200; MASUDA H, 1973, BIOCHEMISTRY-US, V12, P4581, DOI 10.1021/bi00747a006; Moller JV, 1996, BBA-REV BIOMEMBRANES, V1286, P1, DOI 10.1016/0304-4157(95)00017-8; Multhaup G, 2001, BIOCHEM BIOPH RES CO, V288, P172, DOI 10.1006/bbrc.2001.5757; Nelson KE, 1999, NATURE, V399, P323, DOI 10.1038/20601; Okkeri J, 1999, BIOCHEMISTRY-US, V38, P14109, DOI 10.1021/bi9913956; PEDERSEN PL, 1987, TRENDS BIOCHEM SCI, V12, P146, DOI 10.1016/0968-0004(87)90071-5; Petris MJ, 2000, HUM MOL GENET, V9, P2845, DOI 10.1093/hmg/9.19.2845; PETRUKHIN K, 1994, HUM MOL GENET, V3, P1647, DOI 10.1093/hmg/3.9.1647; Rensing C, 1997, P NATL ACAD SCI USA, V94, P14326, DOI 10.1073/pnas.94.26.14326; Rice WJ, 2006, BIOCHEM BIOPH RES CO, V348, P124, DOI 10.1016/j.bbrc.2006.07.012; Sazinsky MH, 2006, BIOCHEMISTRY-US, V45, P9949, DOI 10.1021/bi0610045; Sazinsky MH, 2006, J BIOL CHEM, V281, P11161, DOI 10.1074/jbc.M510708200; Sharma R, 2000, J BIOL CHEM, V275, P3873, DOI 10.1074/jbc.275.6.3873; Silver S, 1996, GENE, V179, P9, DOI 10.1016/S0378-1119(96)00323-X; Solioz M, 1996, TRENDS BIOCHEM SCI, V21, P237; SOLIOZ M, 1995, J BIOL CHEM, V270, P9217, DOI 10.1074/jbc.270.16.9217; SOLIOZ M, 1996, J BIOL CHEM, V271, P24465; Toyoshima C, 2004, ANNU REV BIOCHEM, V73, P269, DOI 10.1146/annurev.biochem.73.011303.073700; Toyoshima C, 2000, NATURE, V405, P647, DOI 10.1038/35015017; TSAI KJ, 1992, J BACTERIOL, V174, P116, DOI 10.1128/jb.174.1.116-121.1992; Tsivkovskii R, 2003, J BIOL CHEM, V278, P13302, DOI 10.1074/jbc.M300034200; Tsivkovskii R, 2001, J BIOL CHEM, V276, P2234, DOI 10.1074/jbc.M003238200; VULPE C, 1993, NAT GENET, V3, P7, DOI 10.1038/ng0193-7; Walker JM, 2004, J BIOL CHEM, V279, P15376, DOI 10.1074/jbc.M400053200; WEBER K, 1969, J BIOL CHEM, V244, P4406; Williams LE, 2000, BBA-BIOMEMBRANES, V1465, P104, DOI 10.1016/S0005-2736(00)00133-4	49	30	30	0	2	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	AUG 15	2008	283	33					22541	22549		10.1074/jbc.M802735200	http://dx.doi.org/10.1074/jbc.M802735200			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	335VR	18562314	Green Published, hybrid			2022-12-27	WOS:000258321000022
J	Sfondouris, J; Rajagopalan, L; Pereira, FA; Brownell, WE				Sfondouris, John; Rajagopalan, Lavanya; Pereira, Fred A.; Brownell, William E.			Membrane composition modulates prestin-associated charge movement	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							HAIR CELL MOTOR; TEMPERATURE-DEPENDENCE; NONLINEAR CAPACITANCE; VOLTAGE-DEPENDENCE; FORCE GENERATION; LIPID BILAYER; OUTER; CHOLESTEROL; PROTEIN; EXPRESSION	The lateral membrane of the cochlear outer hair cell (OHC) is the site of a membrane-based motor that powers OHC electromotility, enabling amplification and fine-tuning of auditory signals. The OHC membrane protein prestin plays a central role in this process. We have previously shown that membrane cholesterol modulates the peak voltage of prestin-associated nonlinear capacitance in vivo and in vitro. The present study explores the effects of membrane cholesterol and docosahexaenoic acid content on the peak and magnitude of prestin-associated charge movement in a human embryonic kidney (HEK 293) cell model. Increasing membrane cholesterol results in a hyperpolarizing shift in the peak voltage of the nonlinear capacitance (V-pkc) and a decrease in the total charge movement. Both measures depend linearly on membrane cholesterol concentration. Incubation of cholesterol-loaded cells in cholesterol-free media partially restores the V-pkc toward normal values but does not have a compensatory effect on the total charge movement. Decreasing membrane cholesterol results in a depolarizing shift in V-pkc that is restored toward normal values upon incubation in cholesterol-free media. However, cholesterol depletion does not alter the magnitude of charge movement. In contrast, increasing membrane docosahexaenoic acid results in a hyperpolarizing shift in V-pkc that is accompanied by an increase in total charge movement. Our results quantify the relation between membrane cholesterol concentration and prestin-associated charge movement and enhance our understanding of how membrane composition modulates prestin function.	[Sfondouris, John; Rajagopalan, Lavanya; Pereira, Fred A.; Brownell, William E.] Baylor Coll Med, Bobby R Alford Dept Otolaryngol Head & Neck Surg, Houston, TX 77030 USA; [Pereira, Fred A.] Baylor Coll Med, Huffington Ctr Aging, Houston, TX 77030 USA; [Pereira, Fred A.] Baylor Coll Med, Dept Mol & Cellular Biol, Houston, TX 77030 USA; [Rajagopalan, Lavanya] Baylor Coll Med, Keck Ctr Interdisciplinary Biosci Training, Houston, TX 77030 USA	Baylor College of Medicine; Baylor College of Medicine; Baylor College of Medicine; Baylor College of Medicine	Brownell, WE (corresponding author), Baylor Coll Med, Bobby R Alford Dept Otolaryngol Head & Neck Surg, 1 Baylor Plaza, Houston, TX 77030 USA.	brownell@bcm.edu		Pereira, Fred/0000-0003-2100-0280	NATIONAL INSTITUTE ON DEAFNESS AND OTHER COMMUNICATION DISORDERS [R01DC009622, R01DC000354, T32DC007367] Funding Source: NIH RePORTER; NIDCD NIH HHS [T32 DC007367, R01 DC009622, R01 DC00354] Funding Source: Medline	NATIONAL INSTITUTE ON DEAFNESS AND OTHER COMMUNICATION DISORDERS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Deafness & Other Communication Disorders (NIDCD)); NIDCD NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Deafness & Other Communication Disorders (NIDCD))		Abe T, 2007, J MEMBRANE BIOL, V215, P49, DOI 10.1007/s00232-007-9004-5; Adler HJ, 2003, HEARING RES, V184, P27, DOI 10.1016/S0378-5955(03)00192-8; Albert AD, 2005, PROG LIPID RES, V44, P99, DOI 10.1016/j.plipres.2005.02.001; Albert AD, 1996, BBA-PROTEIN STRUCT M, V1297, P77, DOI 10.1016/0167-4838(96)00102-1; Albert AD, 1998, BBA-BIOMEMBRANES, V1368, P52, DOI 10.1016/S0005-2736(97)00200-9; ALBERTS R, 2002, MOL BIOL CELL, P588; Barnett DW, 1997, BIOPHYS J, V72, P1641, DOI 10.1016/S0006-3495(97)78810-6; Belyantseva IA, 2000, J NEUROSCI, V20, part. no.; BOESZEBATTAGLIA K, 1989, J BIOL CHEM, V264, P8151; BOESZEBATTAGLIA K, 1990, J BIOL CHEM, V265, P20727; BOESZEBATTAGLIA K, 1989, EXP EYE RES, V49, P699, DOI 10.1016/S0014-4835(89)80064-8; BROWNELL WE, 1985, SCIENCE, V227, P194, DOI 10.1126/science.3966153; Brownell WE, 2006, SPR HDB AUD, V27, P313; Brownell WE, 2000, CELL AND MOLECULAR BIOLOGY OF THE EAR, P69; Brownell WE, 2001, ANNU REV BIOMED ENG, V3, P169, DOI 10.1146/annurev.bioeng.3.1.169; COOPER GM, 2000, CELL MOL APPROACH, P469; DALLOS P, 1991, NATURE, V350, P155, DOI 10.1038/350155a0; Farrell B, 2006, PHYS REV E, V73, DOI 10.1103/PhysRevE.73.041930; Feller SE, 2002, J AM CHEM SOC, V124, P318, DOI 10.1021/ja0118340; FORGE A, 1991, CELL TISSUE RES, V265, P473, DOI 10.1007/BF00340870; Frank G, 1999, P NATL ACAD SCI USA, V96, P4420, DOI 10.1073/pnas.96.8.4420; GALE JE, 1994, P ROY SOC B-BIOL SCI, V255, P243, DOI 10.1098/rspb.1994.0035; Gale JE, 1997, PFLUG ARCH EUR J PHY, V434, P267, DOI 10.1007/s004240050395; Geleoc GSG, 1999, NAT NEUROSCI, V2, P713, DOI 10.1038/11174; Greeson JN, 2006, BRAIN RES, V1091, P140, DOI 10.1016/j.brainres.2006.02.084; HUANG GJ, 1994, P NATL ACAD SCI USA, V91, P12268, DOI 10.1073/pnas.91.25.12268; Huber T, 2002, J AM CHEM SOC, V124, P298, DOI 10.1021/ja011383j; IWASA KH, 1993, BIOPHYS J, V65, P492, DOI 10.1016/S0006-3495(93)81053-1; KAKEHATA S, 1995, BIOPHYS J, V68, P2190, DOI 10.1016/S0006-3495(95)80401-7; KALINEC F, 1992, P NATL ACAD SCI USA, V89, P8671, DOI 10.1073/pnas.89.18.8671; Liao ZJ, 2005, J ACOUST SOC AM, V118, P3737, DOI 10.1121/1.2118387; Ludwig J, 2001, P NATL ACAD SCI USA, V98, P4178, DOI 10.1073/pnas.071613498; Lue AJC, 2001, OTOLARYNG HEAD NECK, V125, P71, DOI 10.1067/mhn.2001.116446; Meltzer J, 2001, NEUROSCI LETT, V313, P141, DOI 10.1016/S0304-3940(01)02266-2; MITCHELL DC, 1992, BIOCHEMISTRY-US, V31, P662, DOI 10.1021/bi00118a005; Murdock DR, 2005, BIOPHYS J, V89, P4090, DOI 10.1529/biophysj.105.069872; NEEDHAM D, 1990, BIOPHYS J, V58, P997, DOI 10.1016/S0006-3495(90)82444-9; Nguyen TVN, 1998, OTOLARYNG HEAD NECK, V119, P14, DOI 10.1016/S0194-5998(98)70167-6; Oghalai JS, 1998, J NEUROSCI, V18, P48; Oliver D, 2001, SCIENCE, V292, P2340, DOI 10.1126/science.1060939; Oliver D, 1999, J PHYSIOL-LONDON, V519, P791, DOI 10.1111/j.1469-7793.1999.0791n.x; Rajagopalan L, 2007, J BIOL CHEM, V282, P36659, DOI 10.1074/jbc.M705078200; Rajagopalan L, 2006, J NEUROSCI, V26, P12727, DOI 10.1523/JNEUROSCI.2734-06.2006; Rajendran L, 2003, P NATL ACAD SCI USA, V100, P8241, DOI 10.1073/pnas.1331629100; Rawicz W, 2000, BIOPHYS J, V79, P328, DOI 10.1016/S0006-3495(00)76295-3; Reisinger E, 2005, MOL CELL NEUROSCI, V28, P106, DOI 10.1016/j.mcn.2004.08.018; Reversi A, 2006, AM J PHYSIOL-REG I, V291, pR861, DOI 10.1152/ajpregu.00333.2006; Saiz L, 2001, BIOPHYS J, V81, P204, DOI 10.1016/S0006-3495(01)75692-5; SANTI PA, 1994, J HISTOCHEM CYTOCHEM, V42, P705, DOI 10.1177/42.6.8189033; Santos-Sacchi J, 1998, HEARING RES, V116, P99, DOI 10.1016/S0378-5955(97)00204-9; Santos-Sacchi J, 2004, J MEMBRANE BIOL, V200, P83, DOI 10.1007/s00232-004-0699-2; SANTOS-SACCHI J, 1991, J NEUROSCI, V11, P3096, DOI 10.1523/jneurosci.11-10-03096.1991; Santos-Sacchi J, 2001, HEARING RES, V159, P69, DOI 10.1016/S0378-5955(01)00321-5; Santos-Sacchi J, 2001, J PHYSIOL-LONDON, V531, P661, DOI 10.1111/j.1469-7793.2001.0661h.x; Santos-Sacchi J, 1998, J PHYSIOL-LONDON, V510, P225, DOI 10.1111/j.1469-7793.1998.225bz.x; Solsona C, 1998, BIOPHYS J, V74, P1061, DOI 10.1016/S0006-3495(98)74030-5; Sturm AK, 2007, OTOLARYNG HEAD NECK, V136, P434, DOI 10.1016/j.otohns.2006.10.030; Wu M, 1998, J MEMBRANE BIOL, V166, P111, DOI 10.1007/s002329900453; Yu N, 2006, BRAIN RES, V1095, P51, DOI 10.1016/j.brainres.2006.04.017; Zerouga M, 1996, ANTICANCER RES, V16, P2863; Zheng J, 2000, NATURE, V405, P149, DOI 10.1038/35012009	61	32	32	0	0	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	AUG 15	2008	283	33					22473	22481		10.1074/jbc.M803722200	http://dx.doi.org/10.1074/jbc.M803722200			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	335VR	18567583	Green Published, hybrid			2022-12-27	WOS:000258321000015
J	Zhang, WT; Chen, YF; Swift, MR; Tassi, E; Stylianou, DC; Gibby, KA; Riegel, AT; Wellstein, A				Zhang, Wentao; Chen, Yifan; Swift, Matthew R.; Tassi, Elena; Stylianou, Dora C.; Gibby, Krissa A.; Riegel, Anna T.; Wellstein, Anton			Effect of FGF-binding protein 3 on vascular permeability	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							FIBROBLAST-GROWTH-FACTOR; FACTOR-BINDING-PROTEIN; HEPARIN-LIKE MOLECULES; CRYSTAL-STRUCTURE; SKIN CARCINOGENESIS; FACTOR RECEPTORS; STRUCTURAL BASIS; HUMAN CANCER; FGF ACTIVITY; CELL	Fibroblast growth factor-binding protein 1 (FGF-BP1 is BP1) is involved in the regulation of embryonic development, tumor growth, and angiogenesis by mobilizing endogenous FGFs from their extracellular matrix storage. Here we describe a new member of the FGF-BP family, human BP3. We show that the hBP3 protein is secreted from cells, binds to FGF2 in vitro and in intact cells, and inhibits FGF2 binding to heparin. To determine the function of hBP3 in vivo, hBP3 was transiently expressed in chicken embryos and resulted in > 50% lethality within 24 h because of vascular leakage. The onset of vascular permeability was monitored by recording the extravasation kinetics of FITC-labeled 40-kDa dextran microperfused into the vitelline vein of 3-day-old embryos. Vascular permeability increased as early as 8 h after expression of hBP3. The increased vascular permeability caused by hBP3 was prevented by treatment of embryos with PD173074, a selective FGFR kinase inhibitor. Interestingly, a C-terminal 66-amino acid fragment (C66) of hBP3, which contains the predicted FGF binding domain, still inhibited binding of FGF2 to heparin similar to full-length hBP3. However, expression of the C66 fragment did not increase vascular permeability on its own, but required the administration of exogenous FGF2 protein. We conclude that the FGF binding domain and the heparin binding domain are necessary for the hBP3 interaction with endogenous FGF and the activation of FGFR signaling in vivo.	[Zhang, Wentao; Chen, Yifan; Swift, Matthew R.; Tassi, Elena; Stylianou, Dora C.; Gibby, Krissa A.; Riegel, Anna T.; Wellstein, Anton] Georgetown Univ, Lombardi Canc Ctr, Washington, DC 20057 USA	Georgetown University	Wellstein, A (corresponding author), Georgetown Univ, Lombardi Canc Ctr, Res Bldg E311,3970 Reservoir Rd, Washington, DC 20057 USA.	wellstea@georgetown.edu	Stylianou, Dora/J-2697-2016; Stylianou, Dora/AAT-1074-2020; Chen, Yifan/K-1235-2019; Tassi, Enrico/K-3958-2015	Stylianou, Dora/0000-0003-4167-1380; Stylianou, Dora/0000-0003-4167-1380; Chen, Yifan/0000-0003-1388-9200; Wellstein, Anton/0000-0002-0570-4950	National Institutes of Health [R01 CA71508]; NCI [P30 CA51008]; NATIONAL CANCER INSTITUTE [T32CA009686, P30CA051008, R01CA071508] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NCI(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This work was supported, in whole or in part, by National Institutes of Health Grants R01 CA71508 (to A. W.) and P30 CA51008 from the NCI. The costs of publication of this article were defrayed in part by the payment of page charges. This article must therefore be hereby marked "advertisement" in accordance with 18 U. S. C. Section 1734 solely to indicate this fact.	Aigner A, 2000, GROWTH FACTORS, V18, P51, DOI 10.3109/08977190009003233; Aigner A, 2001, INT J CANCER, V92, P510, DOI 10.1002/1097-0215(20010515)92:4<510::AID-IJC1227>3.0.CO;2-H; Ballinger MD, 1999, NAT BIOTECHNOL, V17, P1199, DOI 10.1038/70746; Bansal R, 2003, J NEUROSCI RES, V74, P486, DOI 10.1002/jnr.10773; BASHKIN P, 1989, BIOCHEMISTRY-US, V28, P1737, DOI 10.1021/bi00430a047; Bazzoni G, 2004, PHYSIOL REV, V84, P869, DOI 10.1152/physrev.00035.2003; Beer HD, 2005, ONCOGENE, V24, P5269, DOI 10.1038/sj.onc.1208560; BURGESS WH, 1989, ANNU REV BIOCHEM, V58, P575, DOI 10.1146/annurev.bi.58.070189.003043; Czubayko F, 1997, NAT MED, V3, P1137, DOI 10.1038/nm1097-1137; CZUBAYKO F, 1994, J BIOL CHEM, V269, P28243; Dvorak HF, 2003, AM J PATHOL, V162, P1747, DOI 10.1016/S0002-9440(10)64309-X; Eswarakumar VP, 2005, CYTOKINE GROWTH F R, V16, P139, DOI 10.1016/j.cytogfr.2005.01.001; GOSPODAROWICZ D, 1984, P NATL ACAD SCI-BIOL, V81, P6963, DOI 10.1073/pnas.81.22.6963; Greenman C, 2007, NATURE, V446, P153, DOI 10.1038/nature05610; Grose R, 2005, CYTOKINE GROWTH F R, V16, P179, DOI 10.1016/j.cytogfr.2005.01.003; Kurtz A, 1997, ONCOGENE, V14, P2671, DOI 10.1038/sj.onc.1201117; Kurtz A, 2004, NEOPLASIA, V6, P595, DOI 10.1593/neo.04214; Lametsch R, 2000, J BIOL CHEM, V275, P19469, DOI 10.1074/jbc.M002550200; Mason I, 2007, NAT REV NEUROSCI, V8, P583, DOI 10.1038/nrn2189; McDonnell K, 2005, LAB INVEST, V85, P747, DOI 10.1038/labinvest.3700269; Mohammadi M, 2005, CYTOKINE GROWTH F R, V16, P107, DOI 10.1016/j.cytogfr.2005.01.008; Mohammadi M, 1998, EMBO J, V17, P5896, DOI 10.1093/emboj/17.20.5896; Mongiat M, 2001, J BIOL CHEM, V276, P10263, DOI 10.1074/jbc.M011493200; Mongiat M, 2000, J BIOL CHEM, V275, P7095, DOI 10.1074/jbc.275.10.7095; Ogura K, 1999, J BIOMOL NMR, V13, P11, DOI 10.1023/A:1008330622467; Pellegrini L, 2000, NATURE, V407, P1029, DOI 10.1038/35039551; Pellegrini L, 2001, CURR OPIN STRUC BIOL, V11, P629, DOI 10.1016/S0959-440X(00)00258-X; Plotnikov AN, 1999, CELL, V98, P641, DOI 10.1016/S0092-8674(00)80051-3; Powers CJ, 2000, ENDOCR-RELAT CANCER, V7, P165, DOI 10.1677/erc.0.0070165; Presta M, 2005, CYTOKINE GROWTH F R, V16, P159, DOI 10.1016/j.cytogfr.2005.01.004; Rak J, 1997, NAT MED, V3, P1083, DOI 10.1038/nm1097-1083; Ray PE, 2006, AM J PHYSIOL-REG I, V290, pR105, DOI 10.1152/ajpregu.00492.2005; Ray R, 2003, CANCER RES, V63, P8085; Schlessinger J, 2000, MOL CELL, V6, P743, DOI 10.1016/S1097-2765(00)00073-3; SHING Y, 1984, SCIENCE, V223, P1296, DOI 10.1126/science.6199844; Skaper SD, 2000, J NEUROCHEM, V75, P1520, DOI 10.1046/j.1471-4159.2000.0751520.x; Tassi E, 2006, CANCER RES, V66, P1191, DOI 10.1158/0008-5472.CAN-05-2926; Tassi E, 2001, J BIOL CHEM, V276, P40247, DOI 10.1074/jbc.M104933200; Tassi E, 2007, AM J PHYSIOL-REG I, V293, pR775, DOI 10.1152/ajpregu.00737.2006; VLODAVSKY I, 1991, ANN NY ACAD SCI, V638, P207; Wilkie AOM, 2005, CYTOKINE GROWTH F R, V16, P187, DOI 10.1016/j.cytogfr.2005.03.001; WU DQ, 1991, J BIOL CHEM, V266, P16778; Xie B, 2006, J BIOL CHEM, V281, P1137, DOI 10.1074/jbc.M510754200; YAYON A, 1991, CELL, V64, P841, DOI 10.1016/0092-8674(91)90512-W; Yoneda A, 2000, NAT BIOTECHNOL, V18, P641, DOI 10.1038/76487	45	16	20	0	4	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	OCT 17	2008	283	42					28329	28337		10.1074/jbc.M802144200	http://dx.doi.org/10.1074/jbc.M802144200			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	359EN	18669637	hybrid, Green Published			2022-12-27	WOS:000259969300035
J	Geach, TJ; Dale, L				Geach, Timothy J.; Dale, Leslie			Molecular determinants of Xolloid action in vivo	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							BONE MORPHOGENETIC PROTEIN-1; PROCOLLAGEN C-PROTEINASE; MINIMAL DOMAIN-STRUCTURE; SPEMANN ORGANIZER; TWISTED GASTRULATION; VENTRALIZING FACTOR; DROSOPHILA EMBRYO; CHORDIN; MESODERM; CLEAVAGE	Xld (Xolloid) is a member of the Tolloid family of metalloproteases found in embryos of the frog Xenopus laevis. It cleaves Chordin, an inhibitory binding protein for BMP2/4, releasing fragments with reduced affinity for these important ventralizing signals. As a consequence, increasing Xld activity ventralizes Xenopus embryos. We have used this phenotype as an assay to determine the requirement for the C-terminal, nonprotease component of Xld for in vivo activity. This part of the protein is composed of five complement C1r/C1s-sea urchin epidermal growth factor-BMP1 (CUB) and two epidermal growth factor domains, which are thought to be involved in protein-protein interactions and may confer substrate specificity. Our results show that the protease coupled to CUB1 and CUB2 is the minimum domain structure required to ventralize Xenopus embryos and to block the dorsal axis-inducing activity of Chordin. Xld-CUB1-CUB2 cleaves Chordin, and a protease-inactive version co-precipitates Chordin. Our results indicate that the first and second CUB domains bind Chordin and present it to the protease domain. Protease-inactive Xld blocks the cleavage of Chordin by wild-type Xld and dorsalizes injected Xenopus embryos. We find that protease-inactive Xld-CUB1-CUB2 does not share this activity and that all of the C-terminal domains are required to generate the dorsalized phenotype.	[Geach, Timothy J.; Dale, Leslie] UCL, Dept Anat & Dev Biol, London WC1E 6BT, England	University of London; University College London	Dale, L (corresponding author), UCL, Dept Anat & Dev Biol, Gower St, London WC1E 6BT, England.	l.dale@ucl.ac.uk	Dale, Leslie/C-6709-2008		Biotechnology and Biological Sciences Research Council [BBS/B/0661X]	Biotechnology and Biological Sciences Research Council(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC))	This work was funded by a Biotechnology and Biological Sciences Research Council project Grant BBS/B/0661X. The costs of publication of this article were defrayed in part by the payment of page charges. This article must therefore be hereby marked "advertisement" in accordance with 18 U.S.C. Section 1734 solely to indicate this fact.	Blitz IL, 2000, DEV BIOL, V223, P120, DOI 10.1006/dbio.2000.9740; Canty EG, 2006, J BIOL CHEM, V281, P13258, DOI 10.1074/jbc.M510483200; Chang CB, 2001, NATURE, V410, P483, DOI 10.1038/35068583; CHILDS SR, 1994, DEV BIOL, V162, P209, DOI 10.1006/dbio.1994.1079; Dale L, 1999, SEMIN CELL DEV BIOL, V10, P319, DOI 10.1006/scdb.1999.0308; Dale L, 2002, MECH DEVELOP, V119, P177, DOI 10.1016/S0925-4773(02)00359-3; DALE L, 1992, DEVELOPMENT, V115, P573; De Robertis EM, 2006, NAT REV MOL CELL BIO, V7, P296, DOI 10.1038/nrm1855; Dosch R, 1997, DEVELOPMENT, V124, P2325; Fainsod A, 1997, MECH DEVELOP, V63, P39, DOI 10.1016/S0925-4773(97)00673-4; FINELLI AL, 1994, DEVELOPMENT, V120, P861; Ge Gaoxiang, 2006, Birth Defects Research, V78, P47, DOI 10.1002/bdrc.20060; Ge GX, 2006, J BIOL CHEM, V281, P10786, DOI 10.1074/jbc.M511111200; Goodman SA, 1998, DEV BIOL, V195, P144, DOI 10.1006/dbio.1997.8840; GRAFF JM, 1994, CELL, V79, P169, DOI 10.1016/0092-8674(94)90409-X; Greenspan DS, 2005, TOP CURR CHEM, V247, P149, DOI 10.1007/b103822; Harland R, 1997, ANNU REV CELL DEV BI, V13, P611, DOI 10.1146/annurev.cellbio.13.1.611; Hartigan N, 2003, J BIOL CHEM, V278, P18045, DOI 10.1074/jbc.M211448200; HEMMATIBRIVANLOU A, 1994, CELL, V77, P283, DOI 10.1016/0092-8674(94)90320-4; Hintze V, 2006, BIOCHEMISTRY-US, V45, P6741, DOI 10.1021/bi060228k; JONES CM, 1992, DEVELOPMENT, V115, P639; Khokha MK, 2005, DEV CELL, V8, P401, DOI 10.1016/j.devcel.2005.01.013; Larrain J, 2001, DEVELOPMENT, V128, P4439; Larrain J, 2000, DEVELOPMENT, V127, P821; Lee HX, 2006, CELL, V124, P147, DOI 10.1016/j.cell.2005.12.018; Leighton M, 2003, J BIOL CHEM, V278, P18478, DOI 10.1074/jbc.M213021200; Marques G, 1997, CELL, V91, P417, DOI 10.1016/S0092-8674(00)80425-0; Moali C, 2005, J BIOL CHEM, V280, P24188, DOI 10.1074/jbc.M501486200; O'Connor MB, 2006, DEVELOPMENT, V133, P183; Oelgeschlager M, 2000, NATURE, V405, P757, DOI 10.1038/35015500; Oelgeschlager M, 2003, DEV CELL, V4, P219, DOI 10.1016/S1534-5807(02)00404-5; Petropoulou V, 2005, J BIOL CHEM, V280, P22616, DOI 10.1074/jbc.M413468200; Piccolo S, 1996, CELL, V86, P589, DOI 10.1016/S0092-8674(00)80132-4; Piccolo S, 1997, CELL, V91, P407, DOI 10.1016/S0092-8674(00)80424-9; Reversade B, 2005, DEVELOPMENT, V132, P3381, DOI 10.1242/dev.01901; Reynolds SD, 2000, GENE, V248, P233, DOI 10.1016/S0378-1119(00)00114-1; Ross JJ, 2001, NATURE, V410, P479, DOI 10.1038/35068578; SASAI Y, 1994, CELL, V79, P779, DOI 10.1016/0092-8674(94)90068-X; Scott IC, 1999, DEV BIOL, V213, P283, DOI 10.1006/dbio.1999.9383; Serpe M, 2005, DEVELOPMENT, V132, P2645, DOI 10.1242/dev.01838; Shimmi O, 2003, DEVELOPMENT, V130, P4673, DOI 10.1242/dev.00684; Sive Hazel L., 2000, EARLY DEV XENOPUS LA; SMITH JC, 1983, J EMBRYOL EXP MORPH, V78, P299; SMITH WC, 1992, CELL, V70, P829, DOI 10.1016/0092-8674(92)90316-5; Spemann H., 1938, EMBRYONIC DEV INDUCT; SUZUKI A, 1994, P NATL ACAD SCI USA, V91, P10255, DOI 10.1073/pnas.91.22.10255; Wardle FC, 1999, MECH DEVELOP, V86, P75, DOI 10.1016/S0925-4773(99)00114-8; Wermter C, 2007, BIOL CHEM, V388, P513, DOI 10.1515/BC.2007.054; Zimmerman LB, 1996, CELL, V86, P599, DOI 10.1016/S0092-8674(00)80133-6	49	6	6	0	1	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	OCT 3	2008	283	40					27057	27063		10.1074/jbc.M804232200	http://dx.doi.org/10.1074/jbc.M804232200			7	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	353RT	18664565	hybrid			2022-12-27	WOS:000259586600026
J	Bourd-Boittin, K; Le Pabic, H; Bonnier, D; L'Helgoualc'h, A; Theret, N				Bourd-Boittin, Katia; Le Pabic, Helene; Bonnier, Dominique; L'Helgoualc'h, Annie; Theret, Nathalie			RACK1, a new ADAM12 interacting protein - Contribution to liver fibrogenesis	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							KINASE-C-EPSILON; METALLOPROTEASE DISINTEGRIN ADAM12; EPIDERMAL-GROWTH-FACTOR; CYSTEINE-RICH DOMAIN; 12 MELTRIN ALPHA; EXTRACELLULAR-MATRIX; BINDING-PROTEIN; CELL-ADHESION; TUMOR PROGRESSION; STELLATE CELLS	ADAM12 belongs to a disintegrin-like and metalloproteinase-containing protein family that possesses multidomain structures composed of a pro-domain, a metalloprotease, disintegrin-like, cysteine-rich, epidermal growth factor-like, and transmembrane domains, and a cytoplasmic tail. Overexpression of several ADAMs has been reported in human cancer, and we recently described the involvement of ADAM12 in liver injury (Le Pabic, H., Bonnier, D., Wewer, U. M., Coutand, A., Musso, O., Baffet, G., Clement, B., and Theret, N. (2003) Hepatology 37, 1056 - 1066). In this study, we used a yeast two-hybrid screening of a cDNA library from human hepatocellular carcinoma to analyze binding partners of ADAM12. We identify RACK1, a receptor for activated protein kinase C (PKC), as a new ADAM12 interacting protein. RACK1 is up-regulated in patients with hepatocellular carcinoma and is highly expressed by activated hepatic stellate cells. We demonstrate the involvement of RACK1 in mediating the PKC-dependent translocation of ADAM12 to membranes of activated hepatic stellate cells. In particular, treatment of cells with phorbol esters enhances ADAM12 immunostaining in the membrane fractions and the co-immunoprecipitation of ternary complexes containing RACK1, ADAM12, and PKC. By using RNA interference, we demonstrate that inhibition of RACK1 expression diminishes the phorbol 12-myristate 13-acetate-dependent translocation of ADAM12 to membranes of hepatic stellate cells. Finally, hepatic stellate cells cultured on coated type I collagen induces relocalization of ADAM12 in the membrane, suggesting that this major matrix component in liver cancer and fibrogenesis might stimulate ADAM12 translocation to the cell membrane where its shedding activity takes place.	[Bourd-Boittin, Katia; Le Pabic, Helene; Bonnier, Dominique; L'Helgoualc'h, Annie; Theret, Nathalie] Univ Rennes 1, INSERM, U620, IFR140, F-35000 Rennes, France	Institut National de la Sante et de la Recherche Medicale (Inserm); Universite de Rennes	Theret, N (corresponding author), 2 Av Pr L Bernard, F-35043 Rennes, France.	nathalie.theret@univ-rennes1.fr	theret, nathalie/ABG-6780-2020; Theret, Nathalie/I-2871-2015; le pabic, helene/L-3123-2015	theret, nathalie/0000-0002-5857-7828; Theret, Nathalie/0000-0002-5857-7828; 	INSERM; Region Bretagne PRIR [3193]	INSERM(Institut National de la Sante et de la Recherche Medicale (Inserm)European Commission); Region Bretagne PRIR(Region Bretagne)	This work was supported by INSERM, the Association pour la Recherche contre le Cancer, the Ligue contre le Cancer, and Region Bretagne PRIR Grant 3193. The costs of publication of this article were defrayed in part by the payment of page charges. This article must therefore be hereby marked "advertisement" in accordance with 18 U. S. C. Section 1734 solely to indicate this fact.	Abram CL, 2003, J BIOL CHEM, V278, P16844, DOI 10.1074/jbc.M300267200; Asakura M, 2002, NAT MED, V8, P35, DOI 10.1038/nm0102-35; Atfi A, 2007, J CELL BIOL, V178, P201, DOI 10.1083/jcb.200612046; Bartholin L, 2005, BIOL CELL, V97, P577; Berns H, 2000, FASEB J, V14, P2549, DOI 10.1096/fj.99-1038com; BERRIDGE MJ, 1989, NATURE, V341, P197, DOI 10.1038/341197a0; Besson A, 2002, J BIOL CHEM, V277, P22073, DOI 10.1074/jbc.M111644200; Blobel CP, 2005, NAT REV MOL CELL BIO, V6, P32, DOI 10.1038/nrm1548; Cao Y, 2002, J BIOL CHEM, V277, P26403, DOI 10.1074/jbc.M110814200; Carl-McGrath S, 2005, INT J ONCOL, V26, P17; Carloni V, 1996, GASTROENTEROLOGY, V110, P1127, DOI 10.1053/gast.1996.v110.pm8613002; Chang BY, 2001, J BIOL CHEM, V276, P20346, DOI 10.1074/jbc.M101375200; Chou YC, 1999, BBA-GENE STRUCT EXPR, V1489, P315, DOI 10.1016/S0167-4781(99)00213-4; CLARK EA, 1995, SCIENCE, V268, P233, DOI 10.1126/science.7716514; Csukai M, 1997, J BIOL CHEM, V272, P29200, DOI 10.1074/jbc.272.46.29200; Dyczynska E, 2008, INT J CANCER, V122, P2634, DOI 10.1002/ijc.23405; Dyczynska E, 2007, J BIOL CHEM, V282, P436, DOI 10.1074/jbc.M605451200; Egeblad M, 2002, NAT REV CANCER, V2, P161, DOI 10.1038/nrc745; Eng FJ, 2000, AM J PHYSIOL-GASTR L, V279, pG7, DOI 10.1152/ajpgi.2000.279.1.G7; Eto B, 2000, J BIOL CHEM, V275, P34922, DOI 10.1074/jbc.M001953200; Friedman SL, 2004, NAT CLIN PRACT GASTR, V1, P98, DOI 10.1038/ncpgasthep0055; Galliano MF, 2000, J BIOL CHEM, V275, P13933, DOI 10.1074/jbc.275.18.13933; Hougaard S, 2000, BIOCHEM BIOPH RES CO, V275, P261, DOI 10.1006/bbrc.2000.3295; Hu KL, 2000, AM J PHYSIOL-HEART C, V279, pH2658, DOI 10.1152/ajpheart.2000.279.6.H2658; Huang CC, 2004, J PATHOL, V202, P172, DOI 10.1002/path.1505; Iba K, 1999, AM J PATHOL, V154, P1489, DOI 10.1016/S0002-9440(10)65403-X; Iba K, 2000, J CELL BIOL, V149, P1143, DOI 10.1083/jcb.149.5.1143; Imai K, 2000, CELL STRUCT FUNCT, V25, P329, DOI 10.1247/csf.25.329; Jaken S, 2000, BIOESSAYS, V22, P245, DOI 10.1002/(SICI)1521-1878(200003)22:3<245::AID-BIES6>3.0.CO;2-X; Kadota N, 2000, J BIOCHEM-TOKYO, V128, P941, DOI 10.1093/oxfordjournals.jbchem.a022845; Kawaguchi N, 2003, J CELL SCI, V116, P3893, DOI 10.1242/jcs.00699; Kodama T, 2004, AM J PATHOL, V165, P1743, DOI 10.1016/S0002-9440(10)63429-3; Kveiborg M, 2005, CANCER RES, V65, P4754, DOI 10.1158/0008-5472.CAN-05-0262; Le Pabic H, 2003, HEPATOLOGY, V37, P1056, DOI 10.1053/jhep.2003.50205; Lendeckel U, 2005, J CANCER RES CLIN, V131, P41, DOI 10.1007/s00432-004-0619-y; Liedtke CM, 2002, J BIOL CHEM, V277, P22925, DOI 10.1074/jbc.M201917200; Liliental J, 1998, J BIOL CHEM, V273, P2379, DOI 10.1074/jbc.273.4.2379; Loechel F, 2000, BIOCHEM BIOPH RES CO, V278, P511, DOI 10.1006/bbrc.2000.3835; Loechel F, 1998, J BIOL CHEM, V273, P16993, DOI 10.1074/jbc.273.27.16993; Mackay HJ, 2007, NAT REV CANCER, V7, P554, DOI 10.1038/nrc2168; McCahill A, 2002, MOL PHARMACOL, V62, P1261, DOI 10.1124/mol.62.6.1261; Mochizuki S, 2007, CANCER SCI, V98, P621, DOI 10.1111/j.1349-7006.2007.00434.x; Mochly-Rosen D, 1998, FASEB J, V12, P35; Mori S, 2003, J BIOL CHEM, V278, P46029, DOI 10.1074/jbc.M306393200; Primakoff P, 2000, TRENDS GENET, V16, P83, DOI 10.1016/S0168-9525(99)01926-5; RON D, 1995, J BIOL CHEM, V270, P24180, DOI 10.1074/jbc.270.41.24180; RON D, 1994, P NATL ACAD SCI USA, V91, P839, DOI 10.1073/pnas.91.3.839; Roy R, 2004, J BIOL CHEM, V279, P51323, DOI 10.1074/jbc.M409565200; Schechtman D, 2001, ONCOGENE, V20, P6339, DOI 10.1038/sj.onc.1204778; Seals DF, 2003, GENE DEV, V17, P7, DOI 10.1101/gad.1039703; Shi ZD, 2000, J BIOL CHEM, V275, P18574, DOI 10.1074/jbc.M002172200; Six EM, 2004, J BIOL CHEM, V279, P55818, DOI 10.1074/jbc.M408022200; Sklan EH, 2006, PROG NEUROBIOL, V78, P117, DOI 10.1016/j.pneurobio.2005.12.002; Stawowy P, 2005, CARDIOVASC RES, V67, P50, DOI 10.1016/j.cardiores.2005.03.002; Sundberg C, 2004, J BIOL CHEM, V279, P51601, DOI 10.1074/jbc.M403753200; Suzuki A, 2000, ONCOGENE, V19, P5842, DOI 10.1038/sj.onc.1203986; Theret N, 2001, HEPATOLOGY, V34, P82, DOI 10.1053/jhep.2001.25758; Thodeti CK, 2005, EXP CELL RES, V309, P438, DOI 10.1016/j.yexcr.2005.06.020; Wewer UM, 2006, J BIOL CHEM, V281, P9418, DOI 10.1074/jbc.M513580200; White JM, 2003, CURR OPIN CELL BIOL, V15, P598, DOI 10.1016/j.ceb.2003.08.001; Yam JWP, 2004, BLOOD, V103, P1445, DOI 10.1182/blood-2003-07-2452; Zhang WZ, 2006, MOL CELL BIOL, V26, P413, DOI 10.1128/MCB.26.2.413-424.2006; Zindy P, 2005, FEBS LETT, V579, P95, DOI 10.1016/j.febslet.2004.09.092	63	40	44	0	4	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	SEP 19	2008	283	38					26000	26009		10.1074/jbc.M709829200	http://dx.doi.org/10.1074/jbc.M709829200			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	348GX	18621736	Green Published, hybrid			2022-12-27	WOS:000259200100028
J	Piekna-Przybylska, D; Przybylski, P; Baudin-Baillieu, AS; Rousset, JP; Fournier, MJ				Piekna-Przybylska, Dorota; Przybylski, Piotr; Baudin-Baillieu, Agne S.; Rousset, Jean-Pierre; Fournier, Maurille J.			Ribosome performance is enhanced by a rich cluster of pseudouridines in the A-site finger region of the large subunit	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							SMALL NUCLEOLAR RNAS; SACCHAROMYCES-CEREVISIAE; ANGSTROM RESOLUTION; INTERSUBUNIT BRIDGE; PRERIBOSOMAL RNA; CENTRAL FOLD; MINOR MOTIF; CROSS-LINKS; MUTATIONS; PROTEIN	The large subunit rRNA in eukaryotes contains an unusually dense cluster of 8 - 10 pseudouridine (Psi) modifications located in a three-helix structure (H37-H39) implicated in several functions. This region is dominated by a long flexible helix (H38) known as the "A-site finger" (ASF). The ASF protrudes from the large subunit just above the A-site of tRNA binding, interacts with 5 S rRNA and tRNA, andthroughtheterminalloop, forms a bridge (B1a) with the small subunit. In yeast, the three-helix domain contains 10 Psi s and 6 are concentrated in the ASF helix (3 of the ASF Psi s are conserved among eukaryotes). Here, we show by genetic depletion analysis that the Psi s in the ASF helix and adjoining helices are not crucial for cell viability; however, their presence notably enhances ribosome fitness. Depleting different combinations of Psi s suggest that the modification pattern is important and revealed that loss of multiple Psi s negatively influences ribosome performance. The effects observed include slower cell growth ( reduced rates up to 23% at 30 degrees C and 40-50% at 37 degrees C and 11 degrees C), reduced level of the large subunit ( up to 17%), impaired polysome formation ( appearance of half-mers), reduced translation activity (up to 20% at 30 degrees C and 25% at 11 C), and increased sensitivity to ribosome-based drugs. The results indicate that the Psi s in the three-helix region improve fitness of a eukaryotic ribosome.	[Piekna-Przybylska, Dorota; Przybylski, Piotr; Fournier, Maurille J.] Univ Massachusetts, Dept Biochem & Mol Biol, Amherst, MA 01003 USA; [Baudin-Baillieu, Agne S.; Rousset, Jean-Pierre] Univ Paris 11, Inst Genet & Microbiol, UMR 8621, F-91405 Orsay, France	University of Massachusetts System; University of Massachusetts Amherst; UDICE-French Research Universities; Universite Paris Saclay	Fournier, MJ (corresponding author), Univ Massachusetts, Dept Biochem & Mol Biol, Lederle Grad Res Tower, Amherst, MA 01003 USA.	4nier@biochem.umass.edu			United States Public Health Services [GM19351]; Association Francaise contre les Myopathies [12652]; Association pour la Recherche sur le Cancer [3849]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM019351] Funding Source: NIH RePORTER	United States Public Health Services(United States Department of Health & Human ServicesUnited States Public Health Service); Association Francaise contre les Myopathies(Association Francaise contre les Myopathies); Association pour la Recherche sur le Cancer(Fondation ARC pour la Recherche sur le CancerAustralian Research Council); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported by United States Public Health Services Grant GM19351 (to M.J.F.) and by Association Francaise contre les Myopathies Grant 12652 and Association pour la Recherche sur le Cancer Grant 3849 (to J.P.R.). The costs of publication of this article were defrayed in part by the payment of page charges. This article must therefore be hereby marked "advertisement" in accordance with 18 U.S.C. Section 1734 solely to indicate this fact.	Asano K, 2001, EMBO J, V20, P2326, DOI 10.1093/emboj/20.9.2326; BAKIN A, 1993, BIOCHEMISTRY-US, V32, P9754, DOI 10.1021/bi00088a030; BALAKIN AG, 1993, NUCLEIC ACIDS RES, V21, P5391, DOI 10.1093/nar/21.23.5391; Ban N, 2000, SCIENCE, V289, P905, DOI 10.1126/science.289.5481.905; BARONASLOWELL DM, 1990, MOL CELL BIOL, V10, P5235, DOI 10.1128/MCB.10.10.5235; Bashan A, 2003, MOL CELL, V11, P91, DOI 10.1016/S1097-2765(03)00009-1; Chanfreau G, 1998, EMBO J, V17, P3726, DOI 10.1093/emboj/17.13.3726; Conrad J, 1998, J BIOL CHEM, V273, P18562, DOI 10.1074/jbc.273.29.18562; Culver GM, 1999, SCIENCE, V285, P2133, DOI 10.1126/science.285.5436.2133; Davis DR, 1995, NUCLEIC ACIDS RES, V23, P5020, DOI 10.1093/nar/23.24.5020; Decatur WA, 2002, TRENDS BIOCHEM SCI, V27, P344, DOI 10.1016/S0968-0004(02)02109-6; Decatur WA, 2007, METHOD ENZYMOL, V425, P283, DOI 10.1016/S0076-6879(07)25013-X; Dokudovskaya S, 1996, RNA, V2, P146; Durant PC, 1999, J MOL BIOL, V285, P115, DOI 10.1006/jmbi.1998.2297; Eisinger DP, 1997, MOL CELL BIOL, V17, P5136, DOI 10.1128/MCB.17.9.5136; Frank J, 2003, BIOPOLYMERS, V68, P223, DOI 10.1002/bip.10210; Fredrick K, 2003, SCIENCE, V300, P1159, DOI 10.1126/science.1084571; Gabashvili IS, 2000, CELL, V100, P537, DOI 10.1016/S0092-8674(00)80690-X; Ganot P, 1997, CELL, V89, P799, DOI 10.1016/S0092-8674(00)80263-9; Gerbi S.A., 1996, RIBOSOMAL RNA STRUCT, P71; HELSER TL, 1981, MOL CELL BIOL, V1, P51, DOI 10.1128/MCB.1.1.51; Kaiser Chris, 1994; King TH, 2003, MOL CELL, V11, P425, DOI 10.1016/S1097-2765(03)00040-6; KissLaszlo Z, 1996, CELL, V85, P1077, DOI 10.1016/S0092-8674(00)81308-2; Komoda T, 2006, J BIOL CHEM, V281, P32303, DOI 10.1074/jbc.M607058200; Liang XH, 2007, MOL CELL, V28, P965, DOI 10.1016/j.molcel.2007.10.012; Liiv A, 2006, J BIOL CHEM, V281, P29850, DOI 10.1074/jbc.M603013200; Martz E, 2002, TRENDS BIOCHEM SCI, V27, P107, DOI 10.1016/S0968-0004(01)02008-4; MOAZED D, 1987, BIOCHIMIE, V69, P879, DOI 10.1016/0300-9084(87)90215-X; Ni JW, 1997, CELL, V89, P565, DOI 10.1016/S0092-8674(00)80238-X; Nissen P, 2001, P NATL ACAD SCI USA, V98, P4899, DOI 10.1073/pnas.081082398; Ofengand J, 1997, J MOL BIOL, V266, P246, DOI 10.1006/jmbi.1996.0737; Ofengand J, 2002, FEBS LETT, V514, P17, DOI 10.1016/S0014-5793(02)02305-0; OSSWALD M, 1995, NUCLEIC ACIDS RES, V23, P4635, DOI 10.1093/nar/23.22.4635; PARKER R, 1988, MOL CELL BIOL, V8, P3150, DOI 10.1128/MCB.8.8.3150; PETITJEAN A, 1995, MOL CELL BIOL, V15, P5071; Piekna-Przybylska D, 2008, NUCLEIC ACIDS RES, V36, pD178, DOI 10.1093/nar/gkm855; Piekna-Przybylska D, 2007, RNA, V13, P305, DOI 10.1261/rna.373107; Rakauskaite R, 2006, MOL CELL BIOL, V26, P8992, DOI 10.1128/MCB.01311-06; Razga F, 2005, BIOPHYS J, V88, P3466, DOI 10.1529/biophysj.104.054916; RinkeAppel J, 1995, RNA, V1, P1018; Schuwirth BS, 2005, SCIENCE, V310, P827, DOI 10.1126/science.1117230; Sergiev PV, 2005, J MOL BIOL, V353, P116, DOI 10.1016/j.jmb.2005.08.006; Stark H, 1997, CELL, V88, P19, DOI 10.1016/S0092-8674(00)81854-1; Sumita M, 2005, RNA, V11, P1420, DOI 10.1261/rna.2320605; TOLLERVEY D, 1993, CELL, V72, P443, DOI 10.1016/0092-8674(93)90120-F; Yassin A, 2007, J BIOL CHEM, V282, P24329, DOI 10.1074/jbc.M703106200; Yonath A, 2005, ANNU REV BIOCHEM, V74, P649, DOI 10.1146/annurev.biochem.74.082803.133130; Yusupov MM, 2001, SCIENCE, V292, P883, DOI 10.1126/science.1060089; Zebarjadian Y, 1999, MOL CELL BIOL, V19, P7461	50	51	52	0	2	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	SEP 19	2008	283	38					26026	26036		10.1074/jbc.M803049200	http://dx.doi.org/10.1074/jbc.M803049200			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	348GX	18611858	Green Published, hybrid			2022-12-27	WOS:000259200100031
J	Takeda, Y; He, P; Tachibana, I; Zhou, B; Miyado, K; Kaneko, H; Suzuki, M; Minami, S; Iwasaki, T; Goya, S; Kijima, T; Kumagai, T; Yoshida, M; Osaki, T; Komori, T; Mekada, E; Kawase, I				Takeda, Yoshito; He, Ping; Tachibana, Isao; Zhou, Bo; Miyado, Kenji; Kaneko, Hideshi; Suzuki, Mayumi; Minami, Seigo; Iwasaki, Takeo; Goya, Sho; Kijima, Takashi; Kumagai, Toru; Yoshida, Mitsuhiro; Osaki, Tadashi; Komori, Toshihisa; Mekada, Eisuke; Kawase, Ichiro			Double deficiency of tetraspanins CD9 and CD81 alters cell motility and protease production of macrophages and causes chronic obstructive pulmonary disease-like phenotype in mice	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							MATRIX-METALLOPROTEINASE EXPRESSION; ALVEOLAR MACROPHAGES; HISTONE DEACETYLASE; ANIMAL-MODELS; GROWTH-FACTOR; LACKING CD81; EMPHYSEMA; LUNG; MECHANISMS; MULTIPLE	CD9 and CD81 are closely related tetraspanins that regulate cell motility and signaling by facilitating the organization of multimolecular membrane complexes, including integrins. We show that CD9 and CD81 are down-regulated in smoking-related inflammatory response of a macrophage line, RAW264.7. When functions of CD9 and CD81 were ablated with monoclonal antibody treatment, small interfering RNA transfection, or gene knock-out, macrophages were less motile and produced larger amounts of matrix metalloproteinase (MMP)-2 and MMP-9 than control cells in vitro. In line with this, CD9/CD81 double-knock-out mice spontaneously developed pulmonary emphysema, a major pathological component of chronic obstructive pulmonary disease ( COPD). The mutant lung contained an increased number of alveolar macrophages with elevated activities of MMP-2 and MMP-9 and progressively displayed enlarged airspace and disruption of elastic fibers in the alveoli. Secretory cell metaplasia, a finding similar to goblet cell metaplasia in cigarette smokers, was also observed in the epithelium of terminal bronchioles. With aging, the double-knock-out mice showed extrapulmonary phenotypes, including weight loss, kyphosis, and osteopenia. These results suggest that the tetraspanins CD9 and CD81 regulate cell motility and protease production of macrophages and that their dysfunction may underlie the progression of COPD.	[Takeda, Yoshito; He, Ping; Tachibana, Isao; Zhou, Bo; Suzuki, Mayumi; Minami, Seigo; Iwasaki, Takeo; Goya, Sho; Kijima, Takashi; Kumagai, Toru; Yoshida, Mitsuhiro; Osaki, Tadashi; Komori, Toshihisa; Kawase, Ichiro] Osaka Univ, Grad Sch Med, Dept Resp Med Allergy & Rheumat Dis, Suita, Osaka 5650871, Japan; [He, Ping] Xian Jiaotong Univ, Sch Med, Affiliated Hosp 2, Dept Resp Med, Xian 71004, Peoples R China; [Miyado, Kenji; Mekada, Eisuke] Osaka Univ, Microbial Dis Res Inst, Suita, Osaka 5650871, Japan; [Kaneko, Hideshi] Teijin Pharma Ltd, Pharmaceut Dev Res Labs, Pharmacol & Safety Res Dept, Tokyo 1918512, Japan	Osaka University; Xi'an Jiaotong University; Osaka University; Teijin Pharma Limited	Tachibana, I (corresponding author), Osaka Univ, Grad Sch Med, Dept Resp Med Allergy & Rheumat Dis, 2-2 Yamadaoka, Suita, Osaka 5650871, Japan.	itachi02@imed3.med.osaka-u.ac.jp	MIYADO, KENJI/E-6568-2013	Miyado, Kenji/0000-0002-8339-6738; Mekada, Eisuke/0000-0001-8858-4781	Takeda Science Foundation, Osaka, Japan; "Kansai Biomedical Cluster" Project in Saito, Japan	Takeda Science Foundation, Osaka, Japan(Takeda Science Foundation (TSF)); "Kansai Biomedical Cluster" Project in Saito, Japan	This work was supported by a grant from Takeda Science Foundation, Osaka, Japan (to I.T.), and a grant from "Kansai Biomedical Cluster" Project in Saito, Japan, which is promoted by the Knowledge Cluster Initiative of the Ministry of Education, Culture, Sports, Science and Technology, Japan ( to I.T.). The costs of publication of this article were defrayed in part by the payment of page charges. This article must therefore be hereby marked "advertisement" in accordance with 18 U.S.C. Section 1734 solely to indicate this fact.	Agusti AGN, 2003, EUR RESPIR J, V21, P347, DOI 10.1183/09031936.03.00405703; Agusti Alvar, 2007, Proc Am Thorac Soc, V4, P522, DOI 10.1513/pats.200701-004FM; AMY RWM, 1977, J ANAT, V124, P131; Barnes PJ, 2006, CHEST, V129, P151, DOI 10.1378/chest.129.1.151; Barnes PJ, 2003, EUR RESPIR J, V22, P672, DOI 10.1183/09031936.03.00040703; Brusselle GG, 2006, PULM PHARMACOL THER, V19, P155, DOI 10.1016/j.pupt.2005.06.001; Cawston T, 2001, NOVART FDN SYMP, V234, P205; Chirco R, 2006, CANCER METAST REV, V25, P99, DOI 10.1007/s10555-006-7893-x; Delany AM, 2000, J CLIN INVEST, V105, P915, DOI 10.1172/JCI7039; Finlay GA, 1997, AM J RESP CRIT CARE, V156, P240, DOI 10.1164/ajrccm.156.1.9612018; Finlay GA, 1996, AM J PATHOL, V149, P1405; Greenlee KJ, 2007, PHYSIOL REV, V87, P69, DOI 10.1152/physrev.00022.2006; Gross N J, 2001, Curr Opin Pulm Med, V7, P84, DOI 10.1097/00063198-200103000-00006; Hadjidakis DJ, 2006, ANN NY ACAD SCI, V1092, P385, DOI 10.1196/annals.1365.035; Hemler ME, 2005, NAT REV MOL CELL BIO, V6, P801, DOI 10.1038/nrm1736; Hemler ME, 2003, ANNU REV CELL DEV BI, V19, P397, DOI 10.1146/annurev.cellbio.19.111301.153609; Hoshino S, 2005, BIOCHEM BIOPH RES CO, V329, P58, DOI 10.1016/j.bbrc.2005.01.095; Inoue K, 2006, J BIOL CHEM, V281, P33814, DOI 10.1074/jbc.M607290200; Ito K, 2002, P NATL ACAD SCI USA, V99, P8921, DOI 10.1073/pnas.132556899; Jeffery PK, 2001, AM J RESP CRIT CARE, V164, pS28, DOI 10.1164/ajrccm.164.supplement_2.2106061; Kasahara Y, 2001, AM J RESP CRIT CARE, V163, P737, DOI 10.1164/ajrccm.163.3.2002117; Lind PM, 2001, BONE, V29, P265, DOI 10.1016/S8756-3282(01)00576-2; Liu WG, 2001, J CELL BIOL, V155, P157, DOI 10.1083/jcb.200105052; Lucattelli M, 2003, EUR RESPIR J, V22, P728, DOI 10.1183/09031936.03.00047603; Maecker HT, 1997, J EXP MED, V185, P1505, DOI 10.1084/jem.185.8.1505; MANOLAGAS SC, 1995, NEW ENGL J MED, V332, P305, DOI 10.1056/NEJM199502023320506; Miyado K, 2000, SCIENCE, V287, P321, DOI 10.1126/science.287.5451.321; Miyazaki T, 1997, EMBO J, V16, P4217, DOI 10.1093/emboj/16.14.4217; Nabeshima Y, 2002, AGEING RES REV, V1, P627, DOI 10.1016/S1568-1637(02)00027-2; Nishio M, 2007, NAT CELL BIOL, V9, P36, DOI 10.1038/ncb1515; Ogawa K, 2004, BIOCHEM J, V381, P413, DOI 10.1042/BJ20040058; Ohnishi K, 1998, LAB INVEST, V78, P1077; Ortega N, 2003, ANN NY ACAD SCI, V995, P109, DOI 10.1111/j.1749-6632.2003.tb03214.x; Park GY, 2003, CHEST, V123, P475, DOI 10.1378/chest.123.2.475; Rubinstein E, 2006, DEV BIOL, V290, P351, DOI 10.1016/j.ydbio.2005.11.031; Saito Y, 2006, CANCER RES, V66, P9557, DOI 10.1158/0008-5472.CAN-06-1131; Shapiro SD, 2002, BIOCHEM SOC T, V30, P98, DOI 10.1042/BST0300098; Shibata Y, 2001, BLOOD, V98, P2845, DOI 10.1182/blood.V98.9.2845; Sugiura T, 1999, J CELL BIOL, V146, P1375, DOI 10.1083/jcb.146.6.1375; Takeda Y, 2003, J CELL BIOL, V161, P945, DOI 10.1083/jcb.200212031; Takeda Y, 2007, BLOOD, V109, P1524, DOI 10.1182/blood-2006-08-041970; Tohami T, 2007, FASEB J, V21, P691, DOI 10.1096/fj.06-6610com; Tuder Rubin M, 2006, Proc Am Thorac Soc, V3, P503, DOI 10.1513/pats.200603-054MS; Wang XC, 2005, P NATL ACAD SCI USA, V102, P15791, DOI 10.1073/pnas.0507375102; Wang ZD, 2000, J EXP MED, V192, P1587, DOI 10.1084/jem.192.11.1587; Wright JL, 2002, CHEST, V122, p301S, DOI 10.1378/chest.122.6_suppl.301S; Xu TS, 1998, NAT GENET, V20, P78, DOI 10.1038/1746; Zheng T, 2000, J CLIN INVEST, V106, P1081, DOI 10.1172/JCI10458	48	53	54	2	6	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	SEP 19	2008	283	38					26089	26097		10.1074/jbc.M801902200	http://dx.doi.org/10.1074/jbc.M801902200			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	348GX	18662991	hybrid, Green Published			2022-12-27	WOS:000259200100037
J	Hamilton, BJ; Wang, XW; Collins, J; Bloch, D; Bergeron, A; Henry, B; Terry, BM; Zan, M; Mouland, AJ; Rigby, WFC				Hamilton, B. JoNell; Wang, Xiao-Wei; Collins, Jane; Bloch, Donald; Bergeron, Alan; Henry, Brian; Terry, Benjamin M.; Zan, Moe; Mouland, Andrew J.; Rigby, William F. C.			Separate cis-trans pathways post-transcriptionally regulate murine CD154 (CD40 ligand) expression - A novel function for CA repeats in the 3 '-untranslated region	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							MESSENGER-RNA STABILITY; SYSTEMIC-LUPUS-ERYTHEMATOSUS; TRACT-BINDING-PROTEIN; TNF-ALPHA; HNRNP-L; RHEUMATOID-ARTHRITIS; RICH ELEMENTS; T-CELLS; POLYADENYLATION; GENE	We report a role for CA repeats in the 3'-untranslated region (3'-UTR) in regulating CD154 expression. Human CD154 is encoded by an unstable mRNA; this instability is conferred in cis by a portion of its 3'-UTR that includes a polypyrimidine-rich region and CA dinucleotide repeat. We demonstrate similar instability activity with the murine CD154 3'-UTR. This instability element mapped solely to a conserved 100-base CU-rich region alone, which we call a CU-rich response element. Surprisingly, the CA dinucleotide-rich region also regulated reporter expression but at the level of translation. This activity was associated with poly(A) tail shortening and regulated by heterogeneous nuclear ribonucleoprotein L levels. We conclude that the CD154 3'-UTR contains dual cis-acting elements, one of which defines a novel function for exonic CA dinucleotide repeats. These findings suggest a mechanism for the association of 3'-UTR CA-rich response element polymorphisms with CD154 overexpression and the subsequent risk of autoimmune disease.	[Hamilton, B. JoNell; Wang, Xiao-Wei; Collins, Jane; Henry, Brian; Zan, Moe; Rigby, William F. C.] Dartmouth Hitchcock Med Ctr, Dartmouth Med Sch, Dept Med, Lebanon, NH 03756 USA; [Hamilton, B. JoNell; Wang, Xiao-Wei; Collins, Jane; Henry, Brian; Zan, Moe; Rigby, William F. C.] Dartmouth Hitchcock Med Ctr, Dartmouth Med Sch, Dept Microbiol & Immunol, Lebanon, NH 03756 USA; [Bloch, Donald] Massachusetts Gen Hosp, Div Rheumatol Allergy & Immunol, Boston, MA 02114 USA; [Bloch, Donald] Harvard Univ, Sch Med, Boston, MA 02114 USA; [Terry, Benjamin M.] New York Med Coll, Valhalla, NY 10595 USA; [Mouland, Andrew J.] Sir Mortimer B Davis Jewish Hosp, Lady Davis Inst Med Res, Montreal, PQ H3T 1E2, Canada; [Mouland, Andrew J.] McGill Univ, Montreal, PQ H3T 1E2, Canada	Dartmouth College; Dartmouth College; Harvard University; Massachusetts General Hospital; Harvard University; Harvard Medical School; New York Medical College; Lady Davis Institute; McGill University; McGill University	Rigby, WFC (corresponding author), Dartmouth Hitchcock Med Ctr, Dartmouth Med Sch, Dept Med, Lebanon, NH 03756 USA.	William.Rigby@Dartmouth.edu		Bloch, Donald/0000-0002-6828-4754	National Institutes of Health [R01AR49834, T32AI07363]; American College of Rheumatology Research and Education Foundation; NATIONAL CANCER INSTITUTE [P30CA023108] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [T32AI007363] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES [R01AR049834] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); American College of Rheumatology Research and Education Foundation; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS))	This work was supported, in whole or in part, by National Institutes of Health Grant R01AR49834. This work was also supported by a grant from the American College of Rheumatology Research and Education Foundation. The costs of publication of this article were defrayed in part by the payment of page charges. This article must therefore be hereby marked "advertisement" in accordance with 18 U. S. C. Section 1734 solely to indicate this fact.; Supported as a postdoctoral fellow on National Institutes of Health Training Grant T32AI07363.	Anderson P, 2006, J CELL BIOL, V172, P803, DOI 10.1083/jcb.200512082; Berner B, 2000, ANN RHEUM DIS, V59, P190, DOI 10.1136/ard.59.3.190; Brooks SA, 2002, ARTHRITIS RHEUM, V46, P1362, DOI 10.1002/art.10235; Carballo E, 1998, SCIENCE, V281, P1001, DOI 10.1126/science.281.5379.1001; Castelo-Branco P, 2004, MOL CELL BIOL, V24, P4174, DOI 10.1128/MCB.24.10.4174-4183.2004; Cheli Y, 2006, BLOOD, V107, P4391, DOI 10.1182/blood-2005-12-4822; CHOMCZYNSKI P, 1987, ANAL BIOCHEM, V162, P156, DOI 10.1006/abio.1987.9999; Citores MJ, 2004, ANN RHEUM DIS, V63, P310, DOI 10.1136/ard.2003.006148; Clegg CH, 1997, INT IMMUNOL, V9, P1111, DOI 10.1093/intimm/9.8.1111; DAS GJ, 1998, RNA, V4, P766; de Moor CH, 2005, SEMIN CELL DEV BIOL, V16, P49, DOI 10.1016/j.semcdb.2004.11.007; Dumitru CD, 2000, CELL, V103, P1071, DOI 10.1016/S0092-8674(00)00210-5; Dunn RJ, 1997, J HISTOCHEM CYTOCHEM, V45, P129, DOI 10.1177/002215549704500116; Ford GS, 1999, J IMMUNOL, V162, P4037; Foy TM, 1996, ANNU REV IMMUNOL, V14, P591, DOI 10.1146/annurev.immunol.14.1.591; GOUGH NM, 1988, ANAL BIOCHEM, V173, P93, DOI 10.1016/0003-2697(88)90164-9; Grewal IS, 1998, ANNU REV IMMUNOL, V16, P111, DOI 10.1146/annurev.immunol.16.1.111; Guang SH, 2005, MOL CELL BIOL, V25, P6303, DOI 10.1128/MCB.25.15.6303-6313.2005; Hahn B, 1998, J VIROL, V72, P8782, DOI 10.1128/JVI.72.11.8782-8788.1998; Hamilton BJ, 2003, MOL CELL BIOL, V23, P510, DOI 10.1128/MCB.23.2.510-525.2003; Higuchi T, 2002, J IMMUNOL, V168, P9, DOI 10.4049/jimmunol.168.1.9; HOLLENBAUGH D, 1994, IMMUNOL REV, V138, P23, DOI 10.1111/j.1600-065X.1994.tb00845.x; Hui JY, 2005, EMBO J, V24, P1988, DOI 10.1038/sj.emboj.7600677; Hui JY, 2003, RNA, V9, P931, DOI 10.1261/rna.5660803; Hui JY, 2003, NAT STRUCT BIOL, V10, P33, DOI 10.1038/nsb875; Kim TD, 2005, MOL CELL BIOL, V25, P3232, DOI 10.1128/MCB.25.8.3232-3246.2005; Kontoyiannis D, 1999, IMMUNITY, V10, P387, DOI 10.1016/S1074-7613(00)80038-2; Koshy M, 1996, J CLIN INVEST, V98, P826, DOI 10.1172/JCI118855; Kosinski PA, 2003, J IMMUNOL, V170, P979, DOI 10.4049/jimmunol.170.2.979; Lykke-Andersen J, 2005, GENE DEV, V19, P351, DOI 10.1101/gad.1282305; Martin-Donaire T, 2007, ARTHRITIS RES THER, V9, DOI 10.1186/ar2288; Mehling A, 2001, J EXP MED, V194, P615, DOI 10.1084/jem.194.5.615; Murakami K, 1999, J IMMUNOL, V163, P2667; Nair APK, 1999, MOL CELL BIOL, V19, P889; Natalizio BJ, 2002, J BIOL CHEM, V277, P42733, DOI 10.1074/jbc.M208070200; Noelle RJ, 1996, IMMUNITY, V4, P415, DOI 10.1016/S1074-7613(00)80408-2; NOLAN RD, 1969, EUR J BIOCHEM, V9, P445, DOI 10.1111/j.1432-1033.1969.tb00629.x; Peng J, 2005, RNA, V11, P1131, DOI 10.1261/rna.2470905; Petersen CP, 2006, MOL CELL, V21, P533, DOI 10.1016/j.molcel.2006.01.031; Piecyk M, 2000, EMBO J, V19, P4154, DOI 10.1093/emboj/19.15.4154; PINOLROMA S, 1989, J CELL BIOL, V109, P2575, DOI 10.1083/jcb.109.6.2575; Rigby WFC, 1999, J IMMUNOL, V163, P4199; Salles FJ, 1999, METHODS, V17, P38, DOI 10.1006/meth.1998.0705; Shih SC, 1999, J BIOL CHEM, V274, P1359, DOI 10.1074/jbc.274.3.1359; Singh K, 2004, J IMMUNOL, V173, P976, DOI 10.4049/jimmunol.173.2.976; Suarez A, 1997, EUR J IMMUNOL, V27, P2822, DOI 10.1002/eji.1830271112; Taylor GA, 1996, IMMUNITY, V4, P445, DOI 10.1016/S1074-7613(00)80411-2; Tong A, 2005, J BIOL CHEM, V280, P38297, DOI 10.1074/jbc.M508123200; Waggoner SA, 2003, EXP BIOL MED, V228, P387, DOI 10.1177/153537020322800409; Waterston RH, 2002, NATURE, V420, P520, DOI 10.1038/nature01262; Yu JH, 2005, RNA, V11, P1795, DOI 10.1261/rna.2142405	51	20	20	0	4	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	SEP 12	2008	283	37					25606	25616		10.1074/jbc.M802492200	http://dx.doi.org/10.1074/jbc.M802492200			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	345QZ	18640985	Green Published, hybrid			2022-12-27	WOS:000259012700056
J	Jeong, W; Lee, DY; Park, S; Rhee, SG				Jeong, Woojin; Lee, Duck-Yeon; Park, Sunjoo; Rhee, Sue Goo			ERp16, an endoplasmic reticulum-resident thiol-disulfide oxidoreductase - Biochemical properties and role in apoptosis induced by endoplasmic reticulum stress	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							MEMBRANE-PROTEINS; HUMAN CASPASE-12; QUALITY-CONTROL; ACTIVE-SITE; THIOREDOXIN; ISOMERASE; ER; ACTIVATION; FAMILY; CELLS	We have characterized the properties and putative role of a mammalian thioredoxin-like protein, ERp16 (previously designated ERp18, ERp19, or hTLP19). The predicted amino acid sequence of the 172-residue human protein contains an NH2-terminal signal peptide, a thioredoxin-like domain with an active site motif (CGAC), and a COOH-terminal endoplasmic reticulum (ER) retention sequence (EDEL). Analyses indicated that the mature protein (comprising 146 residues) is generated by cleavage of the 26-residue signal peptide and is localized in the lumen of the ER. Biochemical experiments with the recombinant mature protein revealed it to be a thioldisulfide oxidoreductase. Its redox potential was about -165 mV; its active site cysteine residue Cys(66) was nucleophilic with a pK(a) value of similar to 6.6; it catalyzed the formation, reduction, and isomerization of disulfide bonds, with the unusual CGAC active site motif being responsible for these activities; and it existed as a dimer and underwent a redox-dependent conformational change. The observations that the redox potential of ERp16 (-165 mV) was within the range of that of the ER (-135 to -185 mV) and that ERp16 catalyzed disulfide isomerization of scrambled ribonuclease A suggest a role for ERp16 in protein disulfide isomerization in the ER. Expression of ERp16 in HeLa cells inhibited the induction of apoptosis by agents that elicit ER stress, including brefeldin A, tunicamycin, and dithiothreitol. In contrast, expression of a catalytically inactive mutant of ERp16 potentiated such apoptosis, as did depletion of ERp16 by RNA interference. Our results suggest that ERp16 mediates disulfide bond formation in the ER and plays an important role in cellular defense against prolonged ER stress.	[Jeong, Woojin; Park, Sunjoo; Rhee, Sue Goo] Ewha Womans Univ, Div Life & Pharmaceut Sci, Seoul 120750, South Korea; [Lee, Duck-Yeon] NHLBI, Biochem Lab, NIH, Bethesda, MD 20892 USA	Ewha Womans University; National Institutes of Health (NIH) - USA; NIH National Heart Lung & Blood Institute (NHLBI)	Rhee, SG (corresponding author), Ewha Womans Univ, Div Life & Pharmaceut Sci, 11-1 Daehyun Dong, Seoul 120750, South Korea.	rheesg@ewha.ac.kr			Bio RD Program [M10642040002-07N4204-00210, M10642040001-07N4204-00110]; National Honor Scientist Program [R09-2006-000-10002-0]; National Core Research Center Program [R15-2006-020]; Ministry of Education, Science, and Technology; Brain Korea 21 Scholars Program	Bio RD Program; National Honor Scientist Program(Ministry of Education, Science & Technology (MEST), Republic of Korea); National Core Research Center Program; Ministry of Education, Science, and Technology(Ministry of Education, Science & Technology (MEST), Republic of Korea); Brain Korea 21 Scholars Program(Ministry of Education & Human Resources Development (MOEHRD), Republic of Korea)	This work was authored, in whole or in part, by National Institutes of Health staff. This work was supported by Bio R&D Program Grants M10642040002-07N4204-00210 ( to W.J.) and M10642040001-07N4204-00110 ( to S. G. R.), National Honor Scientist Program Grant R09-2006-000-10002- 0 ( to S. G. R.), and National Core Research Center Program Grant R15-2006-020 ( to W.J.) through the Korea Science and Engineering Foundation funded by the Ministry of Education, Science, and Technology, and by the Brain Korea 21 Scholars Program ( to S. P). The costs of publication of this article were defrayed in part by the payment of page charges. This article must therefore be hereby marked "advertisement" in accordance with 18 U. S. C. Section 1734 solely to indicate this fact.	Alanen HI, 2003, J BIOL CHEM, V278, P28912, DOI 10.1074/jbc.M304598200; AMARCOSTESEC A, 1974, J CELL BIOL, V61, P201, DOI 10.1083/jcb.61.1.201; Aslund F, 1997, J BIOL CHEM, V272, P30780, DOI 10.1074/jbc.272.49.30780; CasciolaRosen L, 1996, J EXP MED, V183, P1957, DOI 10.1084/jem.183.5.1957; Corbett EF, 2000, TRENDS BIOCHEM SCI, V25, P307, DOI 10.1016/S0968-0004(00)01588-7; Donze O, 2002, NUCLEIC ACIDS RES, V30, DOI 10.1093/nar/30.10.e46; Ellgaard L, 2003, NAT REV MOL CELL BIO, V4, P181, DOI 10.1038/nrm1052; Fassio A, 2002, HISTOCHEM CELL BIOL, V117, P151, DOI 10.1007/s00418-001-0364-0; Ferrari DM, 1999, BIOCHEM J, V339, P1, DOI 10.1042/0264-6021:3390001; Ferri KF, 2001, NAT CELL BIOL, V3, pE255, DOI 10.1038/ncb1101-e255; Fischer H, 2002, BIOCHEM BIOPH RES CO, V293, P722, DOI 10.1016/S0006-291X(02)00289-9; Freedman RB, 2002, EMBO REP, V3, P136, DOI 10.1093/embo-reports/kvf035; FREEDMAN RB, 1989, CELL, V57, P1069, DOI 10.1016/0092-8674(89)90043-3; FREEDMAN RB, 1994, TRENDS BIOCHEM SCI, V19, P331, DOI 10.1016/0968-0004(94)90072-8; GRAMINSKI GF, 1989, BIOCHEMISTRY-US, V28, P3562, DOI 10.1021/bi00434a062; HAWKINS HC, 1991, BIOCHEM J, V275, P349, DOI 10.1042/bj2750349; Higo T, 2005, CELL, V120, P85, DOI 10.1016/j.cell.2004.11.048; HJELMELAND LM, 1984, METHOD ENZYMOL, V104, P305; HOLMGREN A, 1985, ANNU REV BIOCHEM, V54, P237, DOI 10.1146/annurev.bi.54.070185.001321; HOLMGREN A, 1972, J BIOL CHEM, V247, P1992; Huber-Wunderlich M, 1998, FOLD DES, V3, P161, DOI 10.1016/S1359-0278(98)00024-8; Jeong W, 2004, J BIOL CHEM, V279, P3151, DOI 10.1074/jbc.M307959200; Jimbo A, 2003, EXP CELL RES, V283, P156, DOI 10.1016/S0014-4827(02)00033-2; Kaufman RJ, 1999, GENE DEV, V13, P1211, DOI 10.1101/gad.13.10.1211; Klappa P, 1998, EMBO J, V17, P927, DOI 10.1093/emboj/17.4.927; Knoblach B, 2003, MOL CELL PROTEOMICS, V2, P1104, DOI 10.1074/mcp.M300053-MCP200; Kobayashi T, 1997, P NATL ACAD SCI USA, V94, P11857, DOI 10.1073/pnas.94.22.11857; KREIBICH G, 1974, J CELL BIOL, V61, P789, DOI 10.1083/jcb.61.3.789; Li Y, 2004, J CELL BIOL, V164, P35, DOI 10.1083/jcb.200307010; Liu F, 2003, GENE, V315, P71, DOI 10.1016/S0378-1119(03)00732-7; LOBELLO M, 1993, J BIOL CHEM, V268, P19033; LUNDSTROM J, 1990, J BIOL CHEM, V265, P9114; Martinon F, 2007, CELL DEATH DIFFER, V14, P10, DOI 10.1038/sj.cdd.4402038; Mori K, 2000, CELL, V101, P451, DOI 10.1016/S0092-8674(00)80855-7; Morishima N, 2002, J BIOL CHEM, V277, P34287, DOI 10.1074/jbc.M204973200; MUNRO S, 1987, CELL, V48, P899, DOI 10.1016/0092-8674(87)90086-9; Nakagawa T, 2000, NATURE, V403, P98, DOI 10.1038/47513; Nakagawa T, 2000, J CELL BIOL, V150, P887, DOI 10.1083/jcb.150.4.887; Nielsen H, 1997, PROTEIN ENG, V10, P1, DOI 10.1093/protein/10.1.1; Noiva R, 1999, SEMIN CELL DEV BIOL, V10, P481, DOI 10.1006/scdb.1999.0319; Saleh M, 2004, NATURE, V429, P75, DOI 10.1038/nature02451; Sevier CS, 2002, NAT REV MOL CELL BIO, V3, P836, DOI 10.1038/nrm954; Stevens FJ, 1999, SEMIN CELL DEV BIOL, V10, P443, DOI 10.1006/scdb.1999.0315; Teasdale RD, 1996, ANNU REV CELL DEV BI, V12, P27, DOI 10.1146/annurev.cellbio.12.1.27; Watson WH, 2003, FEBS LETT, V543, P144, DOI 10.1016/S0014-5793(03)00430-7	45	33	34	0	0	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258			J BIOL CHEM	J. Biol. Chem.	SEP 12	2008	283	37					25557	25566		10.1074/jbc.M803804200	http://dx.doi.org/10.1074/jbc.M803804200			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	345QZ	18628206	Green Published, hybrid			2022-12-27	WOS:000259012700051
J	Kubota, T; Matsuoka, M; Chang, TH; Tailor, P; Sasaki, T; Tashiro, M; Kato, A; Ozato, K				Kubota, Toru; Matsuoka, Mayumi; Chang, Tsung-Hsien; Tailor, Prafullakumar; Sasaki, Tsuguo; Tashiro, Masato; Kato, Atsushi; Ozato, Keiko			Virus infection triggers SUMOylation of IRF3 and IRF7, leading to the negative regulation of type I interferon gene expression	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							IFN-BETA PROMOTER; NF-KAPPA-B; DOUBLE-STRANDED-RNA; TOLL-LIKE RECEPTORS; RIG-I; SUMO-1 MODIFICATION; TRANSCRIPTIONAL REPRESSION; ISG15 CONJUGATION; SIGNALING PATHWAY; UBIQUITIN LIGASE	Viral infection activates Toll-like receptor and RIG-I (retinoic acid-inducible gene I) signaling pathways, leading to phosphorylation of IRF3 (interferon regulatory factor 3) and IRF7 and stimulation of type I interferon (IFN) transcription, a process important for innate immunity. We show that upon vesicular stomatitis virus infection, IRF3 and IRF7 are modified not only by phosphorylation but by the small ubiquitin-related modifiers SUMO1, SUMO2, and SUMO3. SUMOylation of IRF3 and IRF7 was dependent on the activation of Toll-like receptor and RIG-I pathways but not on the IFN-stimulated pathway. However, SUMOylation of IRF3 and IRF7 was not dependent on their phosphorylation, and vice versa. We identified Lys(152) of IRF3 and Lys(406) of IRF7 to be their sole small ubiquitin-related modifier (SUMO) conjugation site. IRF3 and IRF7 mutants defective in SUMOylation led to higher levels of IFN mRNA induction after viral infection, relative to the wild type IRFs, indicating a negative role for SUMOylation in IFN transcription. Together, SUMO modification is an integral part of IRF3 and IRF7 activity that contributes to postactivation attenuation of IFN production.	[Kubota, Toru; Tashiro, Masato; Kato, Atsushi] Natl Inst Infect Dis, Dept Virol 3, Tokyo 2080011, Japan; [Matsuoka, Mayumi; Sasaki, Tsuguo] Natl Inst Infect Dis, Dept Bacterial Pathogenesis & Infect Control, Tokyo 2080011, Japan; [Chang, Tsung-Hsien; Tailor, Prafullakumar; Ozato, Keiko] NICHD, Lab Mol Growth Regulat, Genom Differentiat Program, NIH, Bethesda, MD 20892 USA	National Institute of Infectious Diseases (NIID); National Institute of Infectious Diseases (NIID); National Institutes of Health (NIH) - USA; NIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)	Kubota, T (corresponding author), Natl Inst Infect Dis, Dept Virol 3, Gakuen 4-7-1, Tokyo 2080011, Japan.	kubota@nih.go.jp	Chang, Tsung-Hsien/AAG-9384-2019	Chang, Tsung-Hsien/0000-0003-4806-7864	National Institutes of Health Intramural Research Program; NICHD; Trans-National Institutes of Health Biodefense Program; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT [ZIAHD001310] Funding Source: NIH RePORTER; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT [Z01HD001310] Funding Source: NIH RePORTER	National Institutes of Health Intramural Research Program(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NICHD(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); Trans-National Institutes of Health Biodefense Program; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD))	This work was supported, in whole or in part, by the National Institutes of Health Intramural Research Program, NICHD, and the Trans-National Institutes of Health Biodefense Program. The costs of publication of this article were defrayed in part by the payment of page charges. This article must therefore be hereby marked "advertisement" in accordance with 18 U. S. C. Section 1734 solely to indicate this fact.	Agalioti T, 2000, CELL, V103, P667, DOI 10.1016/S0092-8674(00)00169-0; Akira S, 2006, CELL, V124, P783, DOI 10.1016/j.cell.2006.02.015; Andrejeva J, 2004, P NATL ACAD SCI USA, V101, P17264, DOI 10.1073/pnas.0407639101; Arimoto KI, 2008, MOL IMMUNOL, V45, P1078, DOI 10.1016/j.molimm.2007.07.021; Arimoto KI, 2007, P NATL ACAD SCI USA, V104, P7500, DOI 10.1073/pnas.0611551104; Bossis G, 2005, MOL CELL BIOL, V25, P6964, DOI 10.1128/MCB.25.16.6964-6979.2005; Caillaud A, 2005, J BIOL CHEM, V280, P17671, DOI 10.1074/jbc.M411389200; Cui S, 2008, MOL CELL, V29, P169, DOI 10.1016/j.molcel.2007.10.032; DARNELL JE, 1994, SCIENCE, V264, P1415, DOI 10.1126/science.8197455; David G, 2002, J BIOL CHEM, V277, P23658, DOI 10.1074/jbc.M203690200; Desterro JMP, 1998, MOL CELL, V2, P233, DOI 10.1016/S1097-2765(00)80133-1; Dobreva G, 2003, GENE DEV, V17, P3048, DOI 10.1101/gad.1153003; Durbin JE, 2000, J IMMUNOL, V164, P4220, DOI 10.4049/jimmunol.164.8.4220; Fitzgerald KA, 2003, NAT IMMUNOL, V4, P491, DOI 10.1038/ni921; Gack MU, 2007, NATURE, V446, P916, DOI 10.1038/nature05732; Geiss-Friedlander R, 2007, NAT REV MOL CELL BIO, V8, P947, DOI 10.1038/nrm2293; Gill G, 2004, GENE DEV, V18, P2046, DOI 10.1101/gad.1214604; Gill G, 2005, CURR OPIN GENET DEV, V15, P536, DOI 10.1016/j.gde.2005.07.004; Girdwood D, 2003, MOL CELL, V11, P1043, DOI 10.1016/S1097-2765(03)00141-2; Hay RT, 2005, MOL CELL, V18, P1, DOI 10.1016/j.molcel.2005.03.012; Hengel H, 2005, TRENDS IMMUNOL, V26, P396, DOI 10.1016/j.it.2005.05.004; Hietakangas V, 2006, P NATL ACAD SCI USA, V103, P45, DOI 10.1073/pnas.0503698102; Hodges M, 1998, CURR BIOL, V8, pR749, DOI 10.1016/S0960-9822(07)00477-0; Honda K, 2006, IMMUNITY, V25, P349, DOI 10.1016/j.immuni.2006.08.009; Honda K, 2006, NAT REV IMMUNOL, V6, P644, DOI 10.1038/nri1900; Huang DT, 2004, ONCOGENE, V23, P1958, DOI 10.1038/sj.onc.1207393; Huye LE, 2007, MOL CELL BIOL, V27, P2910, DOI 10.1128/MCB.02256-06; Kawai T, 2005, NAT IMMUNOL, V6, P981, DOI 10.1038/ni1243; Kawai T, 2006, NAT IMMUNOL, V7, P131, DOI 10.1038/ni1303; Kawai T, 2004, NAT IMMUNOL, V5, P1061, DOI 10.1038/ni1118; Kim MJ, 2008, J VIROL, V82, P1474, DOI 10.1128/JVI.01650-07; Kinoshita E, 2006, MOL CELL PROTEOMICS, V5, P749, DOI 10.1074/mcp.T500024-MCP200; LEUNG S, 1995, MOL CELL BIOL, V15, P1312; Levy DE, 2001, CYTOKINE GROWTH F R, V12, P143, DOI 10.1016/S1359-6101(00)00027-7; Lin JY, 2004, FEBS LETT, V573, P15, DOI 10.1016/j.febslet.2004.07.059; Lin RT, 1998, MOL CELL BIOL, V18, P2986, DOI 10.1128/MCB.18.5.2986; LUI B, 2007, CELL, V129, P903; LUI B, 2005, MOL CELL BIOL, V25, P1113; LUI B, 2004, NAT IMMUNOL, V5, P891; Melchior F, 2003, TRENDS BIOCHEM SCI, V28, P612, DOI 10.1016/j.tibs.2003.09.002; Meylan E, 2005, NATURE, V437, P1167, DOI 10.1038/nature04193; Mori M, 2004, J BIOL CHEM, V279, P9698, DOI 10.1074/jbc.M310616200; MULLER M, 1993, EMBO J, V12, P4221, DOI 10.1002/j.1460-2075.1993.tb06106.x; Muller S, 2000, J BIOL CHEM, V275, P13321, DOI 10.1074/jbc.275.18.13321; Nakagawa K, 2002, FEBS LETT, V530, P204, DOI 10.1016/S0014-5793(02)03486-5; O'Shea JJ, 2008, IMMUNITY, V28, P477, DOI 10.1016/j.immuni.2008.03.002; Oshiumi H, 2003, NAT IMMUNOL, V4, P161, DOI 10.1038/ni886; Ozato K, 2007, J BIOL CHEM, V282, P20065, DOI 10.1074/jbc.R700003200; Pascual G, 2005, NATURE, V437, P759, DOI 10.1038/nature03988; Qi BC, 2007, INT J BIOCHEM CELL B, V39, P287, DOI 10.1016/j.biocel.2006.08.016; Rodriguez MS, 2001, J BIOL CHEM, V276, P12654, DOI 10.1074/jbc.M009476200; Ross S, 2002, MOL CELL, V10, P831, DOI 10.1016/S1097-2765(02)00682-2; Roth W, 2004, J IMMUNOL, V173, P6189, DOI 10.4049/jimmunol.173.10.6189; Saitoh T, 2006, NAT IMMUNOL, V7, P598, DOI 10.1038/ni1347; Schwartz DC, 2003, TRENDS BIOCHEM SCI, V28, P321, DOI 10.1016/S0968-0004(03)00113-0; Servant MJ, 2003, J BIOL CHEM, V278, P9441, DOI 10.1074/jbc.M209851200; Seth RB, 2005, CELL, V122, P669, DOI 10.1016/j.cell.2005.08.012; Tahk S, 2007, P NATL ACAD SCI USA, V104, P11643, DOI 10.1073/pnas.0701877104; Thanos D, 1995, CELL, V83, P1091, DOI 10.1016/0092-8674(95)90136-1; Verger A, 2003, EMBO REP, V4, P137, DOI 10.1038/sj.embor.embor738; Xu LG, 2005, MOL CELL, V19, P727, DOI 10.1016/j.molcel.2005.08.014; Yamamoto M, 2002, J IMMUNOL, V169, P6668, DOI 10.4049/jimmunol.169.12.6668; Yang SH, 2004, MOL CELL, V13, P611, DOI 10.1016/S1097-2765(04)00060-7; Yoneyama M, 2004, NAT IMMUNOL, V5, P730, DOI 10.1038/ni1087; Zhao C, 2005, P NATL ACAD SCI USA, V102, P10200, DOI 10.1073/pnas.0504754102	65	126	127	1	18	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	SEP 12	2008	283	37					25660	25670		10.1074/jbc.M804479200	http://dx.doi.org/10.1074/jbc.M804479200			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	345QZ	18635538	hybrid, Green Published			2022-12-27	WOS:000259012700061
J	Miyahara, A; Hirani, TA; Oakes, M; Kereszt, A; Kobe, B; Djordjevic, MA; Gresshoff, PM				Miyahara, Akira; Hirani, Tripty A.; Oakes, Marie; Kereszt, Attila; Kobe, Bostjan; Djordjevic, Michael A.; Gresshoff, Peter M.			Soybean nodule autoregulation receptor kinase phosphorylates two kinase-associated protein phosphatases in vitro	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							GLYCINE-MAX; ARABIDOPSIS-THALIANA; LOTUS-JAPONICUS; GENE ENCODES; MEDICAGO-TRUNCATULA; ROOT DEVELOPMENT; STRUCTURAL BASIS; SHORT-DISTANCE; FHA DOMAIN; CLAVATA1	The NARK (nodule autoregulation receptor kinase) gene, a negative regulator of cell proliferation in nodule primordia in several legumes, encodes a receptor kinase that consists of an extracellular leucine-rich repeat and an intracellular serine/threonine protein kinase domain. The putative catalytic domain of NARK was expressed and purified as a maltose-binding or a glutathione S-transferase fusion protein in Escherichia coli. The recombinant NARK proteins showed autophosphorylation activity in vitro. Several regions of the NARK kinase domain were shown by mass spectrometry to possess phosphoresidues. The kinase-inactive protein K724E failed to autophosphorylate, as did three other proteins corresponding to phenotypically detected mutants defective in whole plant autoregulation of nodulation. A wild-type NARK fusion protein transphosphorylated a kinase-inactive mutant NARK fusion protein, suggesting that it is capable of intermolecular autophosphorylation in vitro. In addition, Ser-861 and Thr-963 in the NARK kinase catalytic domain were identified as phosphorylation sites through site-directed mutagenesis. The genes coding for the kinase-associated protein phosphatases KAPP1 and KAPP2, two putative interacting components of NARK, were isolated. NARK kinase domain phosphorylated recombinant KAPP proteins in vitro. Autophosphorylated NARK kinase domain was, in turn, dephosphorylated by both KAPP1 and KAPP2. Our results suggest a model for signal transduction involving NARK in the control of nodule development.	[Miyahara, Akira; Hirani, Tripty A.; Kereszt, Attila; Gresshoff, Peter M.] Univ Queensland, CILR, Australian Res Council Ctr Excellence Integrat Le, Brisbane, Qld 4072, Australia; [Kobe, Bostjan] Univ Queensland, Sch Microbial & Mol Sci, Brisbane, Qld 4072, Australia; [Kobe, Bostjan] Univ Queensland, Inst Mol Biosci, Brisbane, Qld 4072, Australia; [Oakes, Marie; Djordjevic, Michael A.] Australian Natl Univ, Res Sch Biol Sci, Australian Res Council Ctr Excellence Integrat Le, Canberra, ACT 2601, Australia	University of Queensland; University of Queensland; University of Queensland; Australian National University	Gresshoff, PM (corresponding author), Univ Queensland, CILR, Australian Res Council Ctr Excellence Integrat Le, Brisbane, Qld 4072, Australia.	p.gresshoff@uq.edu.au	Han, Liqi/K-6127-2013; Djordjevic, Michael/C-9945-2009; Kobe, Bostjan/D-1292-2009	Kobe, Bostjan/0000-0001-9413-9166; Djordjevic, Michael/0000-0002-9819-1372; Kereszt, Attila/0000-0002-4421-6554	Australian Research Council Centre for Integrative Legume Research; Queensland State Government Smart State Innovation Scheme; University of Queensland	Australian Research Council Centre for Integrative Legume Research(Australian Research Council); Queensland State Government Smart State Innovation Scheme; University of Queensland(University of Queensland)	This work was supported by the Australian Research Council Centre for Integrative Legume Research, the Queensland State Government Smart State Innovation Scheme, and the University of Queensland. The costs of publication of this article were defrayed in part by the payment of page charges. This article must therefore be hereby marked "advertisement" in accordance with 18 U. S. C. Section 1734 solely to indicate this fact.	Adereth Y, 2005, BIOTECHNIQUES, V38, P864, DOI 10.2144/05386BM03; ALTSCHUL SF, 1990, J MOL BIOL, V215, P403, DOI 10.1006/jmbi.1990.9999; Blom N, 1999, J MOL BIOL, V294, P1351, DOI 10.1006/jmbi.1999.3310; Braun DM, 1997, PLANT J, V12, P83, DOI 10.1046/j.1365-313X.1997.12010083.x; Brinkworth RI, 2003, P NATL ACAD SCI USA, V100, P74, DOI 10.1073/pnas.0134224100; Buzas DM, 2007, J PLANT PHYSIOL, V164, P452, DOI 10.1016/j.jplph.2006.03.006; CARROLL BJ, 1985, P NATL ACAD SCI USA, V82, P4162, DOI 10.1073/pnas.82.12.4162; Clark SE, 1997, CELL, V89, P575, DOI 10.1016/S0092-8674(00)80239-1; Ding Z, 2007, BIOCHEMISTRY-US, V46, P2684, DOI 10.1021/bi061763n; Djordjevic MA, 2003, MOL PLANT MICROBE IN, V16, P508, DOI 10.1094/MPMI.2003.16.6.508; Djordjevic MA, 2007, J PROTEOME RES, V6, P3771, DOI 10.1021/pr0606833; Fletcher JC, 2002, ANNU REV PLANT BIOL, V53, P45, DOI 10.1146/annurev.arplant.53.092701.143332; Fletcher LC, 1999, SCIENCE, V283, P1911, DOI 10.1126/science.283.5409.1911; Gomez-Gomez L, 2001, PLANT CELL, V13, P1155, DOI 10.1105/tpc.13.5.1155; GUAN KL, 1991, ANAL BIOCHEM, V192, P262, DOI 10.1016/0003-2697(91)90534-Z; Guex N, 1997, ELECTROPHORESIS, V18, P2714, DOI 10.1002/elps.1150181505; HANKS SK, 1988, SCIENCE, V241, P42, DOI 10.1126/science.3291115; HORN MA, 1994, BBA-PROTEIN STRUCT M, V1208, P65, DOI 10.1016/0167-4838(94)90160-0; Huse M, 1999, CELL, V96, P425, DOI 10.1016/S0092-8674(00)80555-3; Imaizumi-Anraku H, 2005, NATURE, V433, P527, DOI 10.1038/nature03237; Jeong S, 1999, PLANT CELL, V11, P1925, DOI 10.1105/tpc.11.10.1925; Johnson LN, 1996, CELL, V85, P149, DOI 10.1016/S0092-8674(00)81092-2; Kinkema M, 2006, FUNCT PLANT BIOL, V33, P707, DOI 10.1071/FP06056; KOBE B, 2004, HDB CELL SIGNALING, V1, P539; Krusell L, 2002, NATURE, V420, P422, DOI 10.1038/nature01207; Levy J, 2004, SCIENCE, V303, P1361, DOI 10.1126/science.1093038; Li J, 2000, J CELL SCI, V113, P4143; Li J, 1999, P NATL ACAD SCI USA, V96, P7821, DOI 10.1073/pnas.96.14.7821; Liu GZ, 2002, J BIOL CHEM, V277, P20264, DOI 10.1074/jbc.M110999200; Madsen EB, 2003, NATURE, V425, P637, DOI 10.1038/nature02045; Natera SHA, 2000, MOL PLANT MICROBE IN, V13, P995, DOI 10.1094/MPMI.2000.13.9.995; Nishimura R, 2002, NATURE, V420, P426, DOI 10.1038/nature01231; Nontachalyapoom S, 2007, MOL PLANT MICROBE IN, V20, P769, DOI 10.1094/MPMI-20-7-0769; Nuhse TS, 2004, PLANT CELL, V16, P2394, DOI 10.1105/tpc.104.023150; Oka-Kira E, 2005, PLANT J, V44, P505, DOI 10.1111/j.1365-313X.2005.02543.x; Penmetsa RV, 2003, PLANT PHYSIOL, V131, P998, DOI 10.1104/pp.015677; Radutoiu S, 2003, NATURE, V425, P585, DOI 10.1038/nature02039; Schenk PW, 1999, BBA-MOL CELL RES, V1449, P1, DOI 10.1016/S0167-4889(98)00178-5; Schnabel E, 2005, PLANT MOL BIOL, V58, P809, DOI 10.1007/s11103-005-8102-y; Searle IR, 2003, SCIENCE, V299, P109, DOI 10.1126/science.1077937; Shah K, 2002, GENE DEV, V16, P1707, DOI 10.1101/gad.220402; Shah K, 2001, J BIOL CHEM, V276, P41263, DOI 10.1074/jbc.M102381200; Sharma VK, 2003, P NATL ACAD SCI USA, V100, P11823, DOI 10.1073/pnas.1834206100; Shiu SH, 2001, P NATL ACAD SCI USA, V98, P10763, DOI 10.1073/pnas.181141598; Shoemaker RC, 2006, CURR OPIN PLANT BIOL, V9, P104, DOI 10.1016/j.pbi.2006.01.007; Shoemaker RC, 1996, GENETICS, V144, P329; Skolnick J, 2004, PROTEINS, V56, P502, DOI 10.1002/prot.20106; Stone JM, 1998, PLANT PHYSIOL, V117, P1217, DOI 10.1104/pp.117.4.1217; STONE JM, 1994, SCIENCE, V266, P793, DOI 10.1126/science.7973632; Stracke S, 2002, NATURE, V417, P959, DOI 10.1038/nature00841; THOMPSON JD, 1994, NUCLEIC ACIDS RES, V22, P4673, DOI 10.1093/nar/22.22.4673; van der Knaap E, 1999, PLANT PHYSIOL, V120, P559, DOI 10.1104/pp.120.2.559; Walling JG, 2006, GENETICS, V172, P1893, DOI 10.1534/genetics.105.051466; Wang XF, 2005, PLANT CELL, V17, P1685, DOI 10.1105/tpc.105.031393; Wang XL, 2005, DEV CELL, V8, P855, DOI 10.1016/j.devcel.2005.05.001; Wang ZY, 2006, CELL RES, V16, P427, DOI 10.1038/sj.cr.7310054; Williams RW, 1997, P NATL ACAD SCI USA, V94, P10467, DOI 10.1073/pnas.94.19.10467; Yamamoto E, 2000, BBA-GENE STRUCT EXPR, V1491, P333, DOI 10.1016/S0167-4781(00)00061-0; Yoshida S, 2005, J BIOL CHEM, V280, P9203, DOI 10.1074/jbc.M411665200; Zhang Y, 2004, P NATL ACAD SCI USA, V101, P7594, DOI 10.1073/pnas.0305695101	60	45	47	1	13	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	SEP 12	2008	283	37					25381	25391		10.1074/jbc.M800400200	http://dx.doi.org/10.1074/jbc.M800400200			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	345QZ	18606823	hybrid			2022-12-27	WOS:000259012700033
J	Yen, FT; Roitel, O; Bonnard, L; Notet, V; Pratte, D; Stenger, C; Magueur, E; Bihain, BE				Yen, Frances T.; Roitel, Olivier; Bonnard, Lionel; Notet, Veronique; Pratte, Dagmar; Stenger, Christophe; Magueur, Erwan; Bihain, Bernard E.			Lipolysis stimulated lipoprotein receptor - A novel molecular link between hyperlipidemia, weight gain, and atherosclerosis in mice	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							LOW-DENSITY-LIPOPROTEIN; HEPARAN-SULFATE PROTEOGLYCANS; TRIGLYCERIDE-RICH LIPOPROTEINS; FREE FATTY-ACIDS; LDL-RECEPTOR; CHYLOMICRON REMNANTS; APOLIPOPROTEIN-E; TRANSGENIC MICE; HEPATIC LIPASE; HIGH-AFFINITY	The lipolysis-stimulated lipoprotein receptor, LSR, is a multimeric protein complex in the liver that undergoes conformational changes upon binding of free fatty acids, thereby revealing a binding site(s) that recognizes both apoB and apoE. Complete inactivation of the LSR gene is embryonic lethal in mice. Here we show that removal of a single LSR allele ( LSR-/+) caused statistically significant increases in both plasma triglyceride and cholesterol levels, a 2-fold increase in plasma triglyceride changes during the post-prandial phase, and delayed clearance of lipid emulsions or a high fat meal. The longer postprandial lipoprotein clearance time observed in LSR-/+ mice was further increased in LSR-/+ mice lacking functional low density lipoprotein ( LDL) receptors. LSR-/+ mice placed on a Western-type diet displayed higher plasma triglycerides and cholesterol levels, increased triglyceride-rich lipoproteins and LDL, and increased aorta lipid content, as compared with control mice on the same diet. Furthermore, a direct correlation was observed between the hyperlipidemia and weight gain but only in the LSR-/+ mice. Knockdown of LSR expression by small interfering RNA in mouse Hepa1-6 cells led to decreased internalization of both DiI-labeled cyclohexanedione-LDL and very low density lipoprotein in the presence of oleate. These data led us to conclude that LSR contributes to the physiological clearance of atherogenic triglyceride-rich lipoproteins and LDL. We propose that LSR cooperates with the LDL receptor in the final hepatic processing of apoB-containing lipoproteins and represents a novel therapeutic target for the treatment of hyperlipidemia associated with obesity and atherosclerosis.	[Yen, Frances T.; Stenger, Christophe] Nancy Univ, Inst Natl Polytech Lorraine, Lipidomix JE2482, F-54500 Vandoeuvre Les Nancy, France; [Roitel, Olivier; Bonnard, Lionel; Notet, Veronique; Pratte, Dagmar; Magueur, Erwan; Bihain, Bernard E.] Genclis SAS, F-54500 Vandoeuvre Les Nancy, France	Universite de Lorraine	Yen, FT (corresponding author), Nancy Univ, Inst Natl Polytech Lorraine, Lipidomix JE2482, 15 Rue Bois Champelle, F-54500 Vandoeuvre Les Nancy, France.	frances.yenpotin@mtm.nancy.inserm.fr	Yen, Frances T/G-9175-2014	Yen, Frances T/0000-0001-8740-4304	French Ministry of Higher Education and Research; Region Lorraine; Communaute Urbaine du Grand Nancy; Genclis SAS	French Ministry of Higher Education and Research; Region Lorraine(Region Grand-Est); Communaute Urbaine du Grand Nancy(Region Grand-Est); Genclis SAS	This work was supported by the French Ministry of Higher Education and Research, the Region Lorraine, the Communaute Urbaine du Grand Nancy, and Genclis SAS. The costs of publication of this article were defrayed in part by the payment of page charges. This article must therefore be hereby marked "advertisement" in accordance with 18 U. S. C. Section 1734 solely to indicate this fact.	AALTOSETALA K, 1992, J CLIN INVEST, V90, P1889, DOI 10.1172/JCI116066; ATTIE AD, 1982, HEPATOLOGY, V2, P269; Beigneux AP, 2007, CELL METAB, V5, P279, DOI 10.1016/j.cmet.2007.02.002; Biddinger SB, 2005, DIABETES, V54, P1314, DOI 10.2337/diabetes.54.5.1314; Bihain BE, 1998, CURR OPIN LIPIDOL, V9, P221, DOI 10.1097/00041433-199806000-00006; BIHAIN BE, 1992, BIOCHEMISTRY-US, V31, P4628, DOI 10.1021/bi00134a013; BIHAIN BE, 1989, J BIOL CHEM, V264, P17316; deFaria E, 1996, J LIPID RES, V37, P197; FOLCH J, 1957, J BIOL CHEM, V226, P497; Getz GS, 2006, ARTERIOSCL THROM VAS, V26, P242, DOI 10.1161/01.ATV.0000201071.49029.17; GHOSH RN, 1994, J CELL SCI, V107, P2177; HAVEL RJ, 1995, METABOLIC MOL BASES, V7; HERZ J, 1988, EMBO J, V7, P4119, DOI 10.1002/j.1460-2075.1988.tb03306.x; Hocquette JF, 1998, COMP BIOCHEM PHYS B, V121, P201, DOI 10.1016/S0305-0491(98)10090-1; Hofmann SM, 2007, J CLIN INVEST, V117, P3271, DOI 10.1172/JCI31929; Innerarity T L, 1986, Methods Enzymol, V129, P542; Irigaray P, 2006, FEBS J, V273, P1362, DOI 10.1111/j.1742-4658.2006.05159.x; Ishibashi S, 1996, J BIOL CHEM, V271, P22422, DOI 10.1074/jbc.271.37.22422; ITO Y, 1990, SCIENCE, V249, P790, DOI 10.1126/science.2167514; JI ZS, 1993, J BIOL CHEM, V268, P10160; Ji ZS, 1997, J BIOL CHEM, V272, P31285, DOI 10.1074/jbc.272.50.31285; KITA T, 1982, P NATL ACAD SCI-BIOL, V79, P3623, DOI 10.1073/pnas.79.11.3623; MacArthur JM, 2007, J CLIN INVEST, V117, P153, DOI 10.1172/JCI29154; Mahley RW, 2007, J CLIN INVEST, V117, P94, DOI 10.1172/JCI30889; MAHLEY RW, 1995, METABOLIC MOL BASES, P1953; Mann CJ, 1997, J BIOL CHEM, V272, P31348, DOI 10.1074/jbc.272.50.31348; MANN CJ, 1995, BIOCHEMISTRY-US, V34, P10421, DOI 10.1021/bi00033a014; Markwell M A, 1981, Methods Enzymol, V72, P296; Mesli S, 2004, EUR J BIOCHEM, V271, P3103, DOI 10.1111/j.1432-1033.2004.04223.x; PAIGEN B, 1995, AM J CLIN NUTR, V62, P458; Rohlmann A, 1998, J CLIN INVEST, V101, P689, DOI 10.1172/JCI1240; RUBINSZTEIN DC, 1990, J CLIN INVEST, V86, P1306, DOI 10.1172/JCI114839; Shepherd J, 1986, Methods Enzymol, V129, P566; SHEPHERD J, 1979, J LIPID RES, V20, P999; SHERRILL BC, 1978, J BIOL CHEM, V253, P1859; SIMONS LA, 1975, ATHEROSCLEROSIS, V21, P283, DOI 10.1016/0021-9150(75)90087-8; TABAS I, 1990, J CELL BIOL, V111, P929, DOI 10.1083/jcb.111.3.929; TROUSSARD AA, 1995, J BIOL CHEM, V270, P17068, DOI 10.1074/jbc.270.29.17068; WILLNOW TE, 1994, SCIENCE, V264, P1471, DOI 10.1126/science.7515194; Yen FT, 1999, J BIOL CHEM, V274, P13390, DOI 10.1074/jbc.274.19.13390; YEN FT, 1994, BIOCHEMISTRY-US, V33, P1172, DOI 10.1021/bi00171a017; ZAMBON A, 1993, J LIPID RES, V34, P1021	42	57	57	0	5	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	SEP 12	2008	283	37					25650	25659		10.1074/jbc.M801027200	http://dx.doi.org/10.1074/jbc.M801027200			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	345QZ	18644789	hybrid			2022-12-27	WOS:000259012700060
J	Watson, MR; Lagow, RD; Xu, KX; Zhang, B; Bonini, NM				Watson, Melanie R.; Lagow, Robert D.; Xu, Kexiang; Zhang, Bing; Bonini, Nancy M.			A Drosophila model for amyotrophic lateral sclerosis reveals motor neuron damage by human SOD1	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							CU/ZN-SUPEROXIDE-DISMUTASE; GREEN FLUORESCENT PROTEIN; TRANSGENIC MICE; NEURODEGENERATIVE DISEASE; MOUSE MODEL; AXONAL-TRANSPORT; FAMILIAL ALS; LIFE-SPAN; IN-VITRO; MUTATIONS	Amyotrophic lateral sclerosis (ALS) is a motor neuron disease that leads to loss of motor function and early death. About 5% of cases are inherited, with the majority of identified linkages in the gene encoding copper, zinc-superoxide dismutase (SOD1). Strong evidence indicates that the SOD1 mutations confer dominant toxicity on the protein. To provide new insight into mechanisms of ALS, we have generated and characterized a model for familial ALS in Drosophila with transgenic expression of human SOD1. Expression of wild type or disease-linked (A4V, G85R) mutants of human SOD1 selectively in motor neurons induced progressive climbing deficits. These effects were accompanied by defective neural circuit electrophysiology, focal accumulation of human SOD1 protein in motor neurons, and a stress response in surrounding glia. However, toxicity was not associated with oligomerization of SOD1 and did not lead to neuronal loss. These studies uncover cell-autonomous injury by SOD1 to motor neurons in vivo, as well as non-autonomous effects on glia, and provide the foundation for new insight into injury and protection of motor neurons in ALS.	[Xu, Kexiang; Bonini, Nancy M.] Univ Penn, Howard Hughes Med Inst, Leidy Lab 306, Dept Biol, Philadelphia, PA 19104 USA; [Watson, Melanie R.; Bonini, Nancy M.] Univ Penn, Sch Med, Dept Neurosci, Philadelphia, PA 19104 USA; [Lagow, Robert D.; Zhang, Bing] Univ Oklahoma, Dept Zool, Norman, OK 73019 USA	Howard Hughes Medical Institute; University of Pennsylvania; University of Pennsylvania; University of Oklahoma System; University of Oklahoma - Norman	Bonini, NM (corresponding author), Univ Penn, Howard Hughes Med Inst, Leidy Lab 306, Dept Biol, Philadelphia, PA 19104 USA.	nbonini@sas.upenn.edu		Bonini, Nancy/0000-0003-0226-5291	National Institutes of Health [AG09215]; NIA; NIEHS [ES014441]; Systems and Integrated Biology Training; Developmental Biology Training; David and Lucile Packard Foundation; NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES [R21ES014441] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON AGING [P01AG009215] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NIA(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA)); NIEHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS)); Systems and Integrated Biology Training; Developmental Biology Training; David and Lucile Packard Foundation(The David & Lucile Packard Foundation); NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))	This work was supported, in whole or in part, by National Institutes of Health Grant AG09215 from the NIA ( to N. M. B.) and National Institutes of Health Grant ES014441 from the NIEHS ( to B. Z.). This work was also supported by the Systems and Integrated Biology Training Grant and the Developmental Biology Training Grant ( to M. R. W.) and a grant from the David and Lucile Packard Foundation ( to N. M. B.). The costs of publication of this article were defrayed in part by the payment of page charges. This article must therefore be hereby marked "advertisement" in accordance with 18 U. S. C. Section 1734 solely to indicate this fact.	BENZER S, 1967, P NATL ACAD SCI USA, V58, P1112, DOI 10.1073/pnas.58.3.1112; Bilen J, 2005, ANNU REV GENET, V39, P153, DOI 10.1146/annurev.genet.39.110304.095804; Boillee S, 2006, SCIENCE, V312, P1389, DOI 10.1126/science.1123511; Boillee S, 2006, NEURON, V52, P39, DOI 10.1016/j.neuron.2006.09.018; Borchelt DR, 1998, NEUROBIOL DIS, V5, P27, DOI 10.1006/nbdi.1998.0178; BORCHELT DR, 1994, P NATL ACAD SCI USA, V91, P8292, DOI 10.1073/pnas.91.17.8292; BRADLEY WG, 1987, MUSCLE NERVE, V10, P490, DOI 10.1002/mus.880100603; Bruening W, 1999, J NEUROCHEM, V72, P693, DOI 10.1046/j.1471-4159.1999.0720693.x; Bruijn LI, 1997, NEURON, V18, P327, DOI 10.1016/S0896-6273(00)80272-X; Cassina P, 2005, J NEUROCHEM, V93, P38, DOI 10.1111/j.1471-4159.2004.02984.x; Chan HYE, 2000, HUM MOL GENET, V9, P2811, DOI 10.1093/hmg/9.19.2811; Clement AM, 2003, SCIENCE, V302, P113, DOI 10.1126/science.1086071; de Aguilar JL, 1999, EUR J NEUROSCI, V11, P4179, DOI 10.1046/j.1460-9568.1999.00840.x; Durham HD, 1997, J NEUROPATH EXP NEUR, V56, P523, DOI 10.1097/00005072-199705000-00008; Eaton BA, 2002, NEURON, V34, P729, DOI 10.1016/S0896-6273(02)00721-3; Gifondorwa DJ, 2007, J NEUROSCI, V27, P13173, DOI 10.1523/JNEUROSCI.4057-07.2007; Gong YH, 2000, J NEUROSCI, V20, P660, DOI 10.1523/JNEUROSCI.20-02-00660.2000; Gruzman A, 2007, P NATL ACAD SCI USA, V104, P12524, DOI 10.1073/pnas.0705044104; GURNEY ME, 1994, SCIENCE, V264, P1772, DOI 10.1126/science.8209258; Guzhova I, 2001, BRAIN RES, V914, P66, DOI 10.1016/S0006-8993(01)02774-3; Haass C, 2007, NAT REV MOL CELL BIO, V8, P101, DOI 10.1038/nrm2101; Johnston JA, 2000, P NATL ACAD SCI USA, V97, P12571, DOI 10.1073/pnas.220417997; LaMonte BH, 2002, NEURON, V34, P715, DOI 10.1016/S0896-6273(02)00696-7; Levy JR, 2006, J CELL BIOL, V172, P733, DOI 10.1083/jcb.200511068; Levy JR, 2006, INT J DEV NEUROSCI, V24, P103, DOI 10.1016/j.ijdevneu.2005.11.013; Lino MM, 2002, J NEUROSCI, V22, P4825, DOI 10.1523/JNEUROSCI.22-12-04825.2002; Liu J, 2005, J NEUROCHEM, V93, P875, DOI 10.1111/j.1471-4159.2005.03054.x; Marsh JL, 2006, NEURON, V52, P169, DOI 10.1016/j.neuron.2006.09.025; Martinez VG, 2007, DEV NEUROBIOL, V67, P778, DOI 10.1002/dneu.20388; Marx J, 2005, SCIENCE, V310, P43, DOI 10.1126/science.310.5745.43; Matsumoto G, 2005, J CELL BIOL, V171, P75, DOI 10.1083/jcb.200504050; Mollereau B, 2000, MECH DEVELOP, V93, P151, DOI 10.1016/S0925-4773(00)00287-2; Muchowski PJ, 2005, NAT REV NEUROSCI, V6, P11, DOI 10.1038/nrn1587; Nagai M, 2001, J NEUROSCI, V21, P9246, DOI 10.1523/JNEUROSCI.21-23-09246.2001; Nagai M, 2007, NAT NEUROSCI, V10, P615, DOI 10.1038/nn1876; Nishitoh H, 2008, GENE DEV, V22, P1451, DOI 10.1101/gad.1640108; PARDO CA, 1995, P NATL ACAD SCI USA, V92, P954, DOI 10.1073/pnas.92.4.954; Parkes TL, 1998, NAT GENET, V19, P171, DOI 10.1038/534; Pasinelli P, 1998, P NATL ACAD SCI USA, V95, P15763, DOI 10.1073/pnas.95.26.15763; PHILLIPS JP, 1995, P NATL ACAD SCI USA, V92, P8574, DOI 10.1073/pnas.92.19.8574; Pramatarova A, 2001, J NEUROSCI, V21, P3369, DOI 10.1523/JNEUROSCI.21-10-03369.2001; RABIZADEH S, 1995, P NATL ACAD SCI USA, V92, P3024, DOI 10.1073/pnas.92.7.3024; Rakhit R, 2007, NAT MED, V13, P754, DOI 10.1038/nm1559; RIPPS ME, 1995, P NATL ACAD SCI USA, V92, P689, DOI 10.1073/pnas.92.3.689; Robinson MB, 2005, J NEUROSCI, V25, P9735, DOI 10.1523/JNEUROSCI.1912-05.2005; ROSEN DR, 1994, HUM MOL GENET, V3, P981, DOI 10.1093/hmg/3.6.981; ROSEN DR, 1993, NATURE, V362, P59, DOI 10.1038/362059a0; Ross CA, 2004, NAT MED, V10, pS10, DOI 10.1038/nm1066; Shinder GA, 2001, J BIOL CHEM, V276, P12791, DOI 10.1074/jbc.M010759200; Shulman JM, 2003, CURR OPIN NEUROL, V16, P443, DOI 10.1097/01.wco.0000084220.82329.60; Spencer CC, 2003, AGING CELL, V2, P123, DOI 10.1046/j.1474-9728.2003.00044.x; Stathopulos PB, 2003, P NATL ACAD SCI USA, V100, P7021, DOI 10.1073/pnas.1237797100; Strong MJ, 2005, J NEUROPATH EXP NEUR, V64, P649, DOI 10.1097/01.jnen.0000173889.71434.ea; TANOUYE MA, 1980, J NEUROPHYSIOL, V44, P405, DOI 10.1152/jn.1980.44.2.405; TRIMARCHI JR, 1995, J COMP PHYSIOL A, V176, P355, DOI 10.1007/BF00219061; Turner BJ, 2008, PROG NEUROBIOL, V85, P94, DOI 10.1016/j.pneurobio.2008.01.001; Valentine JS, 2005, ANNU REV BIOCHEM, V74, P563, DOI 10.1146/annurev.biochem.72.121801.161647; Warrick JM, 1999, NAT GENET, V23, P425, DOI 10.1038/70532; Warrick JM, 1998, CELL, V93, P939, DOI 10.1016/S0092-8674(00)81200-3; Watanabe M, 2001, NEUROBIOL DIS, V8, P933, DOI 10.1006/nbdi.2001.0443; WONG PC, 1995, NEURON, V14, P1105, DOI 10.1016/0896-6273(95)90259-7; Wu YR, 2004, HUM GENET, V114, P236, DOI 10.1007/s00439-003-1050-1; YEH E, 1995, P NATL ACAD SCI USA, V92, P7036, DOI 10.1073/pnas.92.15.7036; Zhang B, 1997, J CELL BIOL, V139, P1307, DOI 10.1083/jcb.139.5.1307	64	113	115	1	9	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	SEP 5	2008	283	36					24972	24981		10.1074/jbc.M804817200	http://dx.doi.org/10.1074/jbc.M804817200			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	342YR	18596033	Green Published, hybrid			2022-12-27	WOS:000258820000058
J	Kiyonari, S; Uchimura, M; Shirai, T; Ishino, Y				Kiyonari, Shinichi; Uchimura, Maiko; Shirai, Tsuyoshi; Ishino, Yoshizumi			Physical and functional interactions between uracil-DNA glycosylase and proliferating cell nuclear antigen from the euryarchaeon Pyrococcus furiosus	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							BASE-EXCISION-REPAIR; PYROBACULUM-AEROPHILUM; THERMUS-THERMOPHILUS; CRYSTAL-STRUCTURE; LIGASE-I; REPLICATION; PCNA; POLYMERASES; COMPLEX; BINDING	Uracil-DNA glycosylase (UDG) is an important repair enzyme in all organisms to remove uracil bases from DNA. Recent biochemical studies have revealed that human nuclear UDG (UNG2) forms a multiprotein complex in replication foci and initiates the base excision repair pathway by interacting with proliferating cell nuclear antigen ( PCNA). Here, we show the physical and functional interactions between UDG and PCNA from the hyperthermophilic euryarchaeon, Pyrococcus furiosus. The physical interaction between the two proteins was identified by a surface plasmon resonance analysis. Furthermore, the uracil glycosylase activity of P. furiosus UDG is stimulated by P. furiosus PCNA (PfuPCNA) in vitro. This stimulatory effect was observed only when wild type PfuPCNA, but not a monomeric PCNA mutant, was present in the reaction. Mutational analyses revealed that our predicted PCNA-binding region (AKTLF) in P. furiosus UDG is actually important for the interaction with PfuPCNA. This is the first report describing the functional interaction between archaeal UDG and PCNA.	[Kiyonari, Shinichi; Uchimura, Maiko; Ishino, Yoshizumi] Kyushu Univ, Dept Genet Resources Technol, Fac Agr, Higashi Ku, Fukuoka 8128581, Japan; [Kiyonari, Shinichi; Ishino, Yoshizumi] BIRD Japan Sci & Technol Agcy, Fukuoka 8128581, Japan; [Shirai, Tsuyoshi] Nagahama Inst Biosci & Technol, Dept Biosci, Shiga 5260829, Japan; [Shirai, Tsuyoshi] BIRD Japan Sci & Technol Agcy, Shiga 5260829, Japan	Kyushu University; Japan Science & Technology Agency (JST); Japan Science & Technology Agency (JST)	Ishino, Y (corresponding author), Kyushu Univ, Dept Genet Resources Technol, Fac Agr, Higashi Ku, 6-10-1 Hakozaki, Fukuoka 8128581, Japan.	ishino@agr.kyushu-u.ac.jp	Kiyonari, Shinichi/I-7329-2014	Ishino, Yoshizumi/0000-0001-9419-0826	Ministry of Education, Culture, Sports, Science, and Technology, Japan; Hou-ansha Foundation	Ministry of Education, Culture, Sports, Science, and Technology, Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); Hou-ansha Foundation	This work was supported in part by grants-in-aid from the Ministry of Education, Culture, Sports, Science, and Technology, Japan ( to Y.I.). This work was also supported by the Hou-ansha Foundation. The costs of publication of this article were defrayed in part by the payment of page charges. This article must therefore be hereby marked "advertisement" in accordance with 18 U.S.C. Section 1734 solely to indicate this fact.	Akbari M, 2004, NUCLEIC ACIDS RES, V32, P5486, DOI 10.1093/nar/gkh872; Aravind L., 2000, GENOME BIOL; Barnes DE, 2004, ANNU REV GENET, V38, P445, DOI 10.1146/annurev.genet.38.072902.092448; Berti PJ, 2006, CHEM REV, V106, P506, DOI 10.1021/cr040461t; Cann IKO, 1999, J BACTERIOL, V181, P6591, DOI 10.1128/JB.181.21.6591-6599.1999; Connolly BA, 2003, BIOCHEM SOC T, V31, P699, DOI 10.1042/bst0310699; Dionne I, 2005, BIOCHEM J, V387, P859, DOI 10.1042/BJ20041661; Dou H, 2008, J BIOL CHEM, V283, P3130, DOI 10.1074/jbc.M709186200; Fogg MJ, 2002, NAT STRUCT BIOL, V9, P922, DOI 10.1038/nsb867; Gomes XV, 2000, EMBO J, V19, P3811, DOI 10.1093/emboj/19.14.3811; Greagg MA, 1999, P NATL ACAD SCI USA, V96, P9045, DOI 10.1073/pnas.96.16.9045; Grogan DW, 1998, MOL MICROBIOL, V28, P1043, DOI 10.1046/j.1365-2958.1998.00853.x; Haracska L, 2001, MOL CELL BIOL, V21, P7199, DOI 10.1128/MCB.21.21.7199-7206.2001; Hinks JA, 2002, J BIOL CHEM, V277, P16936, DOI 10.1074/jbc.M200668200; Hoseki J, 2003, J MOL BIOL, V333, P515, DOI 10.1016/j.jmb.2003.08.030; Ishino Y, 2001, GENES CELLS, V6, P699, DOI 10.1046/j.1365-2443.2001.00451.x; JARVIS TC, 1989, J BIOL CHEM, V264, P12709; Kiyonari S, 2007, EXTREMOPHILES, V11, P675, DOI 10.1007/s00792-007-0083-0; Kiyonari S, 2006, J BIOL CHEM, V281, P28023, DOI 10.1074/jbc.M603403200; Klinge S, 2007, NAT STRUCT MOL BIOL, V14, P875, DOI 10.1038/nsmb1288; Ko R, 2005, DNA REPAIR, V4, P1421, DOI 10.1016/j.dnarep.2005.08.006; Komori K, 2000, PROTEIN ENG, V13, P41, DOI 10.1093/protein/13.1.41; Kosaka H, 2007, J MOL BIOL, V373, P839, DOI 10.1016/j.jmb.2007.08.022; Levin DS, 2000, CURR BIOL, V10, P919, DOI 10.1016/S0960-9822(00)00619-9; LINDAHL T, 1993, NATURE, V362, P709, DOI 10.1038/362709a0; LINDAHL T, 1974, BIOCHEMISTRY-US, V13, P3405, DOI 10.1021/bi00713a035; Matsumiya S, 2003, PROTEIN SCI, V12, P823, DOI 10.1110/ps.0234503; Matsumiya S, 2002, GENES CELLS, V7, P911, DOI 10.1046/j.1365-2443.2002.00572.x; Moldovan GL, 2007, CELL, V129, P665, DOI 10.1016/j.cell.2007.05.003; Otterlei M, 1999, EMBO J, V18, P3834, DOI 10.1093/emboj/18.13.3834; Oyama M, 2004, BIOCHEM BIOPH RES CO, V321, P183, DOI 10.1016/j.bbrc.2004.06.136; Parlanti E, 2007, NUCLEIC ACIDS RES, V35, P1569, DOI 10.1093/nar/gkl1159; Pearl LH, 2000, MUTAT RES-DNA REPAIR, V460, P165, DOI 10.1016/S0921-8777(00)00025-2; Rudolf J, 2006, MOL CELL, V23, P801, DOI 10.1016/j.molcel.2006.07.019; Sandigursky M, 2000, J BIOL CHEM, V275, P19146, DOI 10.1074/jbc.M001995200; Sartori AA, 2002, EMBO J, V21, P3182, DOI 10.1093/emboj/cdf309; Sartori AA, 2001, J BIOL CHEM, V276, P29979, DOI 10.1074/jbc.M102985200; SHIRAI T, 2008, PROTEINS IN PRESS; Starkuviene V, 2002, NUCLEIC ACIDS RES, V30, P2097, DOI 10.1093/nar/30.10.2097; Tom S, 2001, J BIOL CHEM, V276, P24817, DOI 10.1074/jbc.M101673200; Tori K, 2007, J BACTERIOL, V189, P5652, DOI 10.1128/JB.00073-07; Xia LQ, 2005, J MOL BIOL, V346, P1259, DOI 10.1016/j.jmb.2005.01.014; Yang HJ, 2002, J BIOL CHEM, V277, P22271, DOI 10.1074/jbc.M201820200	43	25	26	0	1	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	AUG 29	2008	283	35					24185	24193		10.1074/jbc.M802837200	http://dx.doi.org/10.1074/jbc.M802837200			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	340II	18562313	Green Published, hybrid			2022-12-27	WOS:000258638900072
J	Fisk, JC; Ammerman, ML; Presnyak, V; Read, LK				Fisk, John C.; Ammerman, Michelle L.; Presnyak, Vladimir; Read, Laurie K.			TbRGG2, an essential RNA editing accessory factor in two Trypanosoma brucei life cycle stages	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							IN-VIVO ANALYSIS; MESSENGER-RNA; BINDING PROTEIN; ARGININE METHYLATION; GRNA-BINDING; BAND IV; COMPLEX; RBP16; IDENTIFICATION; EDITOSOME	In the mitochondria of kinetoplastid protozoa, including Trypanosoma brucei, RNA editing inserts and/or deletes uridines from pre-mRNAs to produce mature, translatable mRNAs. RNA editing is carried out by several related multiprotein complexes known as editosomes, which contain all of the enzymatic components required for catalysis of editing. In addition, noneditosome accessory factors necessary for editing of specific RNAs have also been described. Here, we report the in vitro and in vivo characterization of the mitochondrial TbRGG2 protein (originally termed TbRGGm) and demonstrate that it acts as an editing accessory factor. TbRGG2 is an RNA-binding protein with a preference for poly(U). TbRGG2 protein levels are up-regulated 10-fold in procyclic form T. brucei compared with bloodstream forms. Nevertheless, the protein is essential for growth in both life cycle stages. TbRGG2 associates with RNase-sensitive and RNase-insensitive mitochondrial complexes, and a small fraction of the protein co-immunoprecipitates with editosomes. RNA interference-mediated depletion of TbRGG2 in both procyclic and bloodstream form T. brucei leads to a dramatic decrease in pan-edited RNAs and in some cases a corresponding increase in the pre-edited RNA. TbRGG2 down-regulation also results in moderate stabilization of never-edited and minimally edited RNAs. Thus, our data are consistent with a model in which TbRGG2 is multifunctional, strongly facilitating the editing of pan-edited RNAs and modestly destabilizing minimally edited and never-edited RNAs. This is the first example of an RNA editing accessory factor that functions in the mammalian infective T. brucei life cycle stage.	[Fisk, John C.; Ammerman, Michelle L.; Presnyak, Vladimir; Read, Laurie K.] SUNY Buffalo, Dept Microbiol & Immunol, Sch Med & Biomed Sci, Buffalo, NY 14214 USA	State University of New York (SUNY) System; State University of New York (SUNY) Buffalo	Read, LK (corresponding author), SUNY Buffalo, Dept Microbiol & Immunol, Sch Med & Biomed Sci, Buffalo, NY 14214 USA.	lread@buffalo.edu		Presnyak, Vladimir/0000-0001-6695-7102; Ammerman, Michelle/0000-0002-4272-5822	National Institutes of Health [AI061580]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI061580] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This work was supported, in whole or in part, by National Institutes of Health Grant AI061580 ( to L. K. R.).	Ammerman ML, 2008, RNA, V14, P1069, DOI 10.1261/rna.982908; Aphasizhev R, 2003, RNA, V9, P62, DOI 10.1261/rna.2134303; BUVOLI M, 1992, NUCLEIC ACIDS RES, V20, P5017, DOI 10.1093/nar/20.19.5017; Carnes J, 2005, P NATL ACAD SCI USA, V102, P16614, DOI 10.1073/pnas.0506133102; Carnes J, 2008, MOL CELL BIOL, V28, P122, DOI 10.1128/MCB.01374-07; El-Shami M, 2007, GENE DEV, V21, P2539, DOI 10.1101/gad.451207; Ernst NL, 2003, MOL CELL, V11, P1525, DOI 10.1016/S1097-2765(03)00185-0; GHISOLFI L, 1992, J BIOL CHEM, V267, P2955; Goulah CC, 2007, J BIOL CHEM, V282, P7181, DOI 10.1074/jbc.M609485200; Goulah CC, 2006, RNA, V12, P1545, DOI 10.1261/rna.90106; Hajduk Steven L., 1997, Nucleic Acids Symposium Series, V36, P15; HARRIS ME, 1990, J BIOL CHEM, V265, P11368; Hayman ML, 1999, J BIOL CHEM, V274, P12067, DOI 10.1074/jbc.274.17.12067; Hitti E, 1998, NUCLEIC ACIDS RES, V26, P4382, DOI 10.1093/nar/26.19.4382; Huang CE, 2002, MOL CELL BIOL, V22, P3194, DOI 10.1128/MCB.22.9.3194-3203.2002; Huang CE, 2001, EMBO J, V20, P4694, DOI 10.1093/emboj/20.17.4694; Kang XD, 2005, P NATL ACAD SCI USA, V102, P1017, DOI 10.1073/pnas.0409275102; KILEDJIAN M, 1992, EMBO J, V11, P2655, DOI 10.1002/j.1460-2075.1992.tb05331.x; KOSLOWSKY DJ, 1992, NATURE, V356, P807, DOI 10.1038/356807a0; Lambert L, 1999, NUCLEIC ACIDS RES, V27, P1429, DOI 10.1093/nar/27.6.1429; Madison-Antenucci S, 1998, EMBO J, V17, P6368, DOI 10.1093/emboj/17.21.6368; Madison-Antenucci S, 2001, MOL CELL, V7, P879, DOI 10.1016/S1097-2765(01)00231-3; Mayer O, 2007, NUCLEIC ACIDS RES, V35, P1257, DOI 10.1093/nar/gkl1143; McManus MT, 2001, RNA, V7, P167, DOI 10.1017/S1355838201002072; Miller MM, 2006, RNA, V12, P1292, DOI 10.1261/rna.2331506; Ouaissi A, 2000, GENE, V253, P271, DOI 10.1016/S0378-1119(00)00253-5; Panigrahi AK, 2003, J AM SOC MASS SPECTR, V14, P728, DOI 10.1016/S1044-0305(03)00126-0; Panigrahi AK, 2003, RNA, V9, P484, DOI 10.1261/rna.2194603; Panigrahi AK, 2008, MOL CELL PROTEOMICS, V7, P534, DOI 10.1074/mcp.M700430-MCP200; Panigrahi AK, 2006, RNA, V12, P1038, DOI 10.1261/rna.45506; Pelletier M, 2005, MOL BIOCHEM PARASIT, V144, P206, DOI 10.1016/j.molbiopara.2005.08.015; Pelletier M, 2003, RNA, V9, P457, DOI 10.1261/rna.2160803; RILEY GR, 1994, J BIOL CHEM, V269, P6101; Ruiz FH, 2000, BIOCHEM BIOPH RES CO, V269, P491, DOI 10.1006/bbrc.2000.2270; Rusche LN, 2001, MOL CELL BIOL, V21, P979, DOI 10.1128/MCB.21.4.979-989.2001; Salavati R, 2006, RNA, V12, P819, DOI 10.1261/rna.2244106; Schnaufer A, 2001, SCIENCE, V291, P2159, DOI 10.1126/science.1058655; Shichijo S, 2003, INT J MOL MED, V12, P895; Trotter JR, 2005, MOL CELL, V20, P403, DOI 10.1016/j.molcel.2005.09.016; Vanhamme L, 1998, J BIOL CHEM, V273, P21825, DOI 10.1074/jbc.273.34.21825; Vondruskova E, 2005, J BIOL CHEM, V280, P2429, DOI 10.1074/jbc.M405933200; Wang BB, 2003, EUKARYOT CELL, V2, P578, DOI 10.1128/EC.2.3.578-587.2003; Wickstead B, 2002, MOL BIOCHEM PARASIT, V125, P211, DOI 10.1016/S0166-6851(02)00238-4; Yamaguchi Y, 2001, J BIOCHEM, V129, P185, DOI 10.1093/oxfordjournals.jbchem.a002842; Yang QS, 2005, BIOCHEMISTRY-US, V44, P13591, DOI 10.1021/bi0508946; Zeiner GM, 2003, EUKARYOT CELL, V2, P222, DOI 10.1128/EC.2.2.222-230.2003	46	59	59	0	3	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	AUG 22	2008	283	34					23016	23025		10.1074/jbc.M801021200	http://dx.doi.org/10.1074/jbc.M801021200			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	337SI	18583347	Green Published, hybrid			2022-12-27	WOS:000258455400014
J	Neet, KE; Thinakaran, G				Neet, Kenneth E.; Thinakaran, Gopal			Thematic Minireview Series on the Molecular Basis of Alzheimer Disease	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Review									[Neet, Kenneth E.] Rosalind Franklin Univ Med & Sci, Chicago Med Sch, Dept Biochem & Mol Biol, N Chicago, IL 60064 USA; [Thinakaran, Gopal] Univ Chicago, Dept Neurobiol, Chicago, IL 60637 USA; [Thinakaran, Gopal] Univ Chicago, Dept Neurol, Chicago, IL 60637 USA; [Thinakaran, Gopal] Univ Chicago, Dept Pathol, Chicago, IL 60637 USA	Chicago Medical School; Rosalind Franklin University Medical & Science; University of Chicago; University of Chicago; University of Chicago	Neet, KE (corresponding author), Rosalind Franklin Univ Med & Sci, Chicago Med Sch, Dept Biochem & Mol Biol, N Chicago, IL 60064 USA.	kenneth.neet@rosalindfranklin.edu			NATIONAL INSTITUTE ON AGING [R01AG019070, R01AG021495] Funding Source: NIH RePORTER; NIA NIH HHS [R01 AG019070, R01 AG021495] Funding Source: Medline	NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA)); NIA NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))		Alzheimer A, 1906, NEUROLOGISCHES CENTR, V23, P1129; Alzheimer A., 1907, Z GESAMTE NEUROL PSY, V18, P177; Stelzma R. A., 1995, CLIN ANAT, V8, P429, DOI [10.1002/ca.980080612, DOI 10.1002/CA.980080612]	3	4	6	0	3	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	OCT 31	2008	283	44					29613	29614		10.1074/jbc.R800051200	http://dx.doi.org/10.1074/jbc.R800051200			2	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	364WS	18650429	Green Published, hybrid			2022-12-27	WOS:000260366900001
J	Yamashita, A; Nijo, N; Pospisil, P; Morita, N; Takenaka, D; Aminaka, R; Yamamoto, Y; Yamamoto, Y				Yamashita, Amu; Nijo, Nobuyoshi; Pospisil, Pavel; Morita, Noriko; Takenaka, Daichi; Aminaka, Ryota; Yamamoto, Yoko; Yamamoto, Yasusi			Quality control of photosystem II - Reactive oxygen species are responsible for the damage to photosystem II under moderate heat stress	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							D1 PROTEIN; THYLAKOID MEMBRANES; SPINACH THYLAKOIDS; SINGLET OXYGEN; ACCEPTOR-SIDE; ANTENNA SIZE; PHOTOINHIBITION; TEMPERATURE; TURNOVER; INACTIVATION	Moderate heat stress (40 degrees C for 30 min) on spinach thylakoid membranes induced cleavage of the reaction center-binding D1 protein of photosystem II, aggregation of the D1 protein with the neighboring polypeptides D2 and CP43, and release of three extrinsic proteins, PsbO, -P, and -Q. These heat-induced events were suppressed under anaerobic conditions or by the addition of sodium ascorbate, a general scavenger of reactive oxygen species. In accordance with this, singlet oxygen and hydroxyl radicals were detected in spinach photosystem II membranes incubated at 40 C for 30 min with electron paramagnetic resonance spin-trapping spectroscopy. The moderate heat stress also induced significant lipid peroxidation under aerobic conditions. We suggest that the reactive oxygen species are generated by heat-induced inactivation of a water-oxidizing manganese complex and through lipid peroxidation. Although occurring in the dark, the damages caused by the moderate heat stress to photosystem II are quite similar to those induced by excessive illumination where reactive oxygen species are involved.	[Yamashita, Amu; Nijo, Nobuyoshi; Morita, Noriko; Takenaka, Daichi; Aminaka, Ryota; Yamamoto, Yasusi] Okayama Univ, Grad Sch Nat Sci & Technol, Okayama 7008530, Japan; [Pospisil, Pavel] Palacky Univ, Biophys Lab, Dept Expt Phys, Fac Sci, Olomouc 77146, Czech Republic; [Yamamoto, Yoko] Okayama Univ, Bioresources Res Inst, Kurashiki, Okayama 7100046, Japan	Okayama University; Palacky University Olomouc; Okayama University	Yamamoto, Y (corresponding author), 3-1-1 Tsushima Naka, Okayama 7008530, Japan.	yasusiya@cc.okayama-u.ac.jp	POSPÍŠIL, Pavel/AAH-4451-2019; Yamamoto, Yasusi/B-2637-2011	POSPÍŠIL, Pavel/0000-0001-9126-2011; 	Ministry of Education, Culture, Sports, Science and Technology of Japan [18570042, 20570039]; Ministry of Education, Youth and Sports of the Czech Republic [6198959215]; Grant Agency of the Czech Republic [522/06/0979]	Ministry of Education, Culture, Sports, Science and Technology of Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); Ministry of Education, Youth and Sports of the Czech Republic(Ministry of Education, Youth & Sports - Czech Republic); Grant Agency of the Czech Republic(Grant Agency of the Czech Republic)	This work was supported by Grants-in-aid for Scientific Research 18570042 and 20570039 from the Ministry of Education, Culture, Sports, Science and Technology of Japan (to Y. Y.), Ministry of Education, Youth and Sports of the Czech Republic Grant MSM 6198959215, and Grant Agency of the Czech Republic Grant 522/06/0979 ( to P. P.). The costs of publication of this article were defrayed in part by the payment of page charges. This article must therefore be hereby marked "advertisement" in accordance with 18 U. S. C. Section 1734 solely to indicate this fact.	Andersson B, 1997, PHYSIOL PLANTARUM, V100, P780, DOI 10.1034/j.1399-3054.1997.1000405.x; ARO EM, 1993, BIOCHIM BIOPHYS ACTA, V1143, P113, DOI 10.1016/0005-2728(93)90134-2; Asada K, 1999, ANNU REV PLANT PHYS, V50, P601, DOI 10.1146/annurev.arplant.50.1.601; Baena-Gonzalez E, 2002, PHILOS T R SOC B, V357, P1451, DOI 10.1098/rstb.2002.1141; BARBER J, 1992, TRENDS BIOCHEM SCI, V17, P61, DOI 10.1016/0968-0004(92)90503-2; Barber J, 1998, BBA-BIOENERGETICS, V1365, P269, DOI 10.1016/S0005-2728(98)00079-6; BERTHOLD DA, 1981, FEBS LETT, V134, P231, DOI 10.1016/0014-5793(81)80608-4; Buchanan B.B., 2000, BIOCH MOL BIOL PLANT; CAO J, 1990, BIOCHIM BIOPHYS ACTA, V1015, P180, DOI 10.1016/0005-2728(90)90018-Y; ENAMI I, 1994, BBA-BIOENERGETICS, V1186, P52, DOI 10.1016/0005-2728(94)90134-1; FORD RC, 1983, FEBS LETT, V160, P159, DOI 10.1016/0014-5793(83)80957-0; Gutteridge J M, 1983, J Appl Biochem, V5, P293; Halliwell B, 1996, ANNU REV NUTR, V16, P33, DOI 10.1146/annurev.nu.16.070196.000341; Henmi T, 2004, PLANT CELL PHYSIOL, V45, P243, DOI 10.1093/pcp/pch027; HIDEG E, 1993, PHOTOCHEM PHOTOBIOL, V58, P280, DOI 10.1111/j.1751-1097.1993.tb09562.x; Ishikawa Y, 1999, BBA-BIOENERGETICS, V1413, P147, DOI 10.1016/S0005-2728(99)00093-6; Komayama K, 2007, BBA-BIOENERGETICS, V1767, P838, DOI 10.1016/j.bbabio.2007.05.001; KYLE DJ, 1984, P NATL ACAD SCI-BIOL, V81, P4070, DOI 10.1073/pnas.81.13.4070; Loll B, 2005, NATURE, V438, P1040, DOI 10.1038/nature04224; Loll B, 2007, BBA-BIOENERGETICS, V1767, P509, DOI 10.1016/j.bbabio.2006.12.009; MACPHERSON AN, 1993, BIOCHIM BIOPHYS ACTA, V1143, P301, DOI 10.1016/0005-2728(93)90201-P; MISHRA NP, 1994, BBA-BIOENERGETICS, V1186, P81, DOI 10.1016/0005-2728(94)90138-4; MISHRA RK, 1992, PLANT PHYSIOL, V99, P1; MIYAO M, 1995, BIOCHEMISTRY-US, V34, P10019, DOI 10.1021/bi00031a025; MIYAO M, 1994, BIOCHEMISTRY-US, V33, P9722, DOI 10.1021/bi00198a043; NASH D, 1985, BIOCHIM BIOPHYS ACTA, V807, P127, DOI 10.1016/0005-2728(85)90115-X; OHAD I, 1984, J CELL BIOL, V270, P14919; Ohira S, 2005, PHOTOSYNTH RES, V84, P29, DOI 10.1007/s11120-004-7310-7; Patzlaff JS, 1996, BIOCHEMISTRY-US, V35, P7802, DOI 10.1021/bi960056z; Pospisil P, 2004, BIOCHEMISTRY-US, V43, P6783, DOI 10.1021/bi036219i; Pospisil P, 2003, BIOPHYS J, V84, P1370, DOI 10.1016/S0006-3495(03)74952-2; Pospisil P, 1999, PHOTOSYNTH RES, V62, P55, DOI 10.1023/A:1006369009170; Pospisil P, 2007, BBA-BIOENERGETICS, V1767, P854, DOI 10.1016/j.bbabio.2007.02.011; Rokka A, 2000, PLANT PHYSIOL, V123, P1525, DOI 10.1104/pp.123.4.1525; SUNDBY C, 1986, BIOCHIM BIOPHYS ACTA, V851, P475, DOI 10.1016/0005-2728(86)90084-8; THOMPSON LK, 1989, BIOCHEMISTRY-US, V28, P6686, DOI 10.1021/bi00442a023; Wydrzynski T, 1996, PHYSIOL PLANTARUM, V96, P342, DOI 10.1111/j.1399-3054.1996.tb00224.x; Yamamoto Y, 2004, METH MOL B, V274, P217; Yamamoto Y, 2001, PLANT CELL PHYSIOL, V42, P121, DOI 10.1093/pcp/pce022; YAMAMOTO Y, 1981, FEBS LETT, V133, P265, DOI 10.1016/0014-5793(81)80520-0; Yamamoto Y, 1998, BIOCHEMISTRY-US, V37, P1565, DOI 10.1021/bi9707640; YAMAMOTO Y, 1995, BIOCHEMISTRY-US, V34, P9038, DOI 10.1021/bi00028a012; YAMAMOTO Y, 1983, OXYGEN EVOLVING SYST, P229; Yamane Y, 1998, PHOTOSYNTH RES, V57, P51, DOI 10.1023/A:1006019102619; Yoshioka M, 2006, J BIOL CHEM, V281, P21660, DOI 10.1074/jbc.M602896200	45	75	81	0	18	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	OCT 17	2008	283	42					28380	28391		10.1074/jbc.M710465200	http://dx.doi.org/10.1074/jbc.M710465200			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	359EN	18664569	Green Published, hybrid			2022-12-27	WOS:000259969300040
J	de la Tour, CB; Amrani, L; Cossard, R; Neuman, KC; Serre, MC; Duguet, M				de la Tour, Claire Bouthier; Amrani, Laila; Cossard, Raynald; Neuman, Keir C.; Serre, Marie Claude; Duguet, Michel			Mutational analysis of the helicase-like domain of Thermotoga maritima reverse gyrase	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							DNA-DEPENDENT ATPASE; TOPOISOMERASE-III; CRYSTAL-STRUCTURE; I TOPOISOMERASE; PROTEIN; SULFOLOBUS; MECHANISM; CLEAVAGE; BINDING; ARCHAEBACTERIA	Reverse gyrase is a unique type IA topoisomerase that is able to introduce positive supercoils into DNA in an ATP-dependent process. ATP is bound to the helicase-like domain of the enzyme that contains most of the conserved motifs found in helicases of the SF1 and SF2 superfamilies. In this paper, we have investigated the role of the conserved helicase motifs I, II, V, VI, and Q by generating mutants of the Thermotoga maritima reverse gyrase. We show that mutations in motifs I, II, V, and VI completely eliminate the supercoiling activity of reverse gyrase and that a mutation in the Qmotif significantly reduces this activity. Further analysis revealed that for most mutants, the DNA binding and cleavage properties are not significantly changed compared with the wild type enzyme, whereas their ATPase activity is impaired. These results clearly show that the helicase motifs are tightly involved in the coupling of ATP hydrolysis to the topoisomerase activity. The zinc finger motif located at the N-terminal end of reverse gyrases was also mutated. Our results indicate that this motif plays an important role in DNA binding.	[de la Tour, Claire Bouthier; Amrani, Laila; Cossard, Raynald; Neuman, Keir C.; Serre, Marie Claude; Duguet, Michel] Univ Paris 11, Inst Genet & Microbiol, UMR8621, F-91405 Orsay, France	UDICE-French Research Universities; Universite Paris Saclay	de la Tour, CB (corresponding author), Univ Paris 11, Inst Genet & Microbiol, UMR8621, Bat 409, F-91405 Orsay, France.	claire.bouthier@igmors.u-psud.fr	Serre, Marie-Claude/B-4159-2008; Neuman, Keir C./F-7400-2011	Neuman, Keir C./0000-0002-0863-5671; SERRE, Marie-Claude/0000-0002-7899-9833	CNRS; Universite Paris-Sud 11 [UMR8621]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [Z01HL001056, ZIAHL001056] Funding Source: NIH RePORTER	CNRS(Centre National de la Recherche Scientifique (CNRS)); Universite Paris-Sud 11; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	This work was supported in part by CNRS and Universite Paris-Sud 11 Grant UMR8621 and by a CNRS grant (Physique et Chimie du Vivant). The costs of publication of this article were defrayed in part by the payment of page charges. This article must therefore be hereby marked "advertisement" in accordance with 18 U.S.C. Section 1734 solely to indicate this fact.	Atomi H, 2004, J BACTERIOL, V186, P4829, DOI 10.1128/JB.186.14.4829-4833.2004; Bennett RJ, 2000, J BIOL CHEM, V275, P26898; Benz J, 1999, STRUCTURE, V7, P671, DOI 10.1016/S0969-2126(99)80088-4; Champoux JJ, 2001, ANNU REV BIOCHEM, V70, P369, DOI 10.1146/annurev.biochem.70.1.369; CONFALONIERI F, 1993, P NATL ACAD SCI USA, V90, P4753, DOI 10.1073/pnas.90.10.4753; De la Tour CB, 1998, J BACTERIOL, V180, P274, DOI 10.1128/JB.180.2.274-281.1998; Declais AC, 2000, J BIOL CHEM, V275, P19498, DOI 10.1074/jbc.M910091199; DELATOUR CB, 1990, J BACTERIOL, V172, P6803, DOI 10.1128/jb.172.12.6803-6808.1990; DELATOUR CB, 1991, J BACTERIOL, V173, P3921, DOI 10.1128/JB.173.12.3921-3923.1991; Duguet M, 1997, J CELL SCI, V110, P1345; Forterre P, 2002, TRENDS GENET, V18, P236, DOI 10.1016/S0168-9525(02)02650-1; FORTERRE P, 1985, EMBO J, V4, P2123, DOI 10.1002/j.1460-2075.1985.tb03902.x; Hall MC, 1999, MOL MICROBIOL, V34, P867, DOI 10.1046/j.1365-2958.1999.01659.x; Harmon FG, 2003, J BIOL CHEM, V278, P42668, DOI 10.1074/jbc.M302994200; HO SN, 1989, GENE, V77, P51, DOI 10.1016/0378-1119(89)90358-2; Hsieh TS, 2006, J BIOL CHEM, V281, P5640, DOI 10.1074/jbc.M513252200; Hsieh TS, 2005, J BIOL CHEM, V280, P20467, DOI 10.1074/jbc.M502739200; JAXEL C, 1989, EMBO J, V8, P3135, DOI 10.1002/j.1460-2075.1989.tb08466.x; Jaxel C, 1999, EUR J BIOCHEM, V260, P103, DOI 10.1046/j.1432-1327.1999.00128.x; Jungblut SP, 2007, J MOL BIOL, V371, P197, DOI 10.1016/j.jmb.2007.05.031; Kampmann M, 2004, NUCLEIC ACIDS RES, V32, P3537, DOI 10.1093/nar/gkh683; KIKUCHI A, 1984, NATURE, V309, P677, DOI 10.1038/309677a0; KOVALSKY OI, 1990, NUCLEIC ACIDS RES, V18, P2801, DOI 10.1093/nar/18.9.2801; Lilley DMJ., 1995, NUCL ACIDS MOL BIOL, P84; Macris MA, 2006, DNA REPAIR, V5, P172, DOI 10.1016/j.dnarep.2005.09.005; NAKASU S, 1985, EMBO J, V4, P2705, DOI 10.1002/j.1460-2075.1985.tb03990.x; Napoli A, 2004, J BIOL CHEM, V279, P33192, DOI 10.1074/jbc.M402619200; OMICHINSKI JG, 1993, SCIENCE, V261, P438, DOI 10.1126/science.8332909; Patel SS, 2006, J BIOL CHEM, V281, P18265, DOI 10.1074/jbc.R600008200; Rodriguez AC, 2002, J BIOL CHEM, V277, P29865, DOI 10.1074/jbc.M202853200; Rodriguez AC, 2002, EMBO J, V21, P418, DOI 10.1093/emboj/21.3.418; SCHAFFNE.W, 1973, ANAL BIOCHEM, V56, P502, DOI 10.1016/0003-2697(73)90217-0; SELBY CP, 1993, SCIENCE, V260, P53, DOI 10.1126/science.8465200; Serre MC, 2003, PROG NUCLEIC ACID RE, V74, P37, DOI 10.1016/S0079-6603(03)01010-9; SHIBATA T, 1987, J BIOL CHEM, V262, P10419; SLESAREV AI, 1990, J BIOMOL STRUCT DYN, V7, P935, DOI 10.1080/07391102.1990.10508533; Swagemakers SMA, 1998, J BIOL CHEM, V273, P28292, DOI 10.1074/jbc.273.43.28292; Tanner NK, 2003, CELL CYCLE, V2, P16, DOI 10.4161/cc.2.1.296; Tanner NK, 2003, MOL CELL, V11, P127, DOI 10.1016/S1097-2765(03)00006-6; Tse-Dinh YC, 1998, BBA-GENE STRUCT EXPR, V1400, P19, DOI 10.1016/S0167-4781(98)00125-0; Tuteja N, 2004, EUR J BIOCHEM, V271, P1849, DOI 10.1111/j.1432-1033.2004.04094.x; Tuteja N, 2004, EUR J BIOCHEM, V271, P1835, DOI 10.1111/j.1432-1033.2004.04093.x; Wang JC, 2002, NAT REV MOL CELL BIO, V3, P430, DOI 10.1038/nrm831	43	12	12	0	3	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	OCT 10	2008	283	41					27395	27402		10.1074/jbc.M800867200	http://dx.doi.org/10.1074/jbc.M800867200			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	355OW	18614530	hybrid			2022-12-27	WOS:000259719200007
J	Hsieh, MCF; Das, D; Sambandam, N; Zhang, MQ; Nahle, Z				Hsieh, Michael C. F.; Das, Debopriya; Sambandam, Nandakumar; Zhang, Michael Q.; Nahle, Zaher			Regulation of the PDK4 isozyme by the Rb-E2F1 complex	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							PYRUVATE-DEHYDROGENASE KINASE; CELL-CYCLE PROGRESSION; GENE-EXPRESSION; RETINOBLASTOMA PROTEIN; CANCER-CELLS; TRANSCRIPTIONAL REGULATION; MUSCLE-CELLS; E2F FAMILY; S-PHASE; INACTIVATION	Loss of the transcription factor E2F1 elicits a complex metabolic phenotype in mice underscored by reduced adiposity and protection from high fat diet-induced diabetes. Here, we demonstrate that E2F1 directly regulates the gene encoding PDK4 (pyruvate dehydrogenase kinase 4), a key nutrient sensor and modulator of glucose homeostasis that is chronically elevated in obesity and diabetes and acutely induced under the metabolic stress of starvation or fasting. We show that loss of E2F1 in vivo blunts PDK4 expression and improves myocardial glucose oxidation. The absence of E2F1 also corresponds to lower blood glucose levels, improved plasma lipid profile, and increased sensitivity to insulin stimulation. Consistently, enforced E2F1 expression up-regulates PDK4 levels and suppresses glucose oxidation in C2C12 myoblasts. Furthermore, inactivation of Rb, the repressor of E2F-dependent transcription, markedly induces PDK4 and triggers the enrichment of E2F1 occupancy onto the PDK4 promoter as detected by chromatin immunoprecipitation analysis. Two overlapping E2F binding sites were identified on this promoter. Transactivation assays later verified E2F1 responsiveness of this promoter element in C2C12 myoblasts and IMR90 fibroblasts, an effect that was completely abrogated following mutation of the E2F sites. Taken together, our data illustrate how the E2F1 mitogen directly regulates PDK4 levels and influences cellular bioenergetics, namely mitochondrial glucose oxidation. These results are relevant to the pathophysiology of chronic diseases like obesity and diabetes, where PDK4 is dysregulated and could have implications pertinent to the etiology of tumor metabolism, especially in cancers with Rb pathway defects.	[Hsieh, Michael C. F.; Sambandam, Nandakumar; Nahle, Zaher] Washington Univ, Dept Med, St Louis, MO 63110 USA; [Das, Debopriya] Ernest O Lawrence Berkeley Natl Lab, Div Life Sci, Berkeley, CA 94270 USA; [Zhang, Michael Q.] Cold Spring Harbor Lab, Cold Spring Harbor, NY 11724 USA	Washington University (WUSTL); United States Department of Energy (DOE); Lawrence Berkeley National Laboratory; Cold Spring Harbor Laboratory	Nahle, Z (corresponding author), Weill Cornell Med Coll, Dept Cardiothorac Surg, Div Thorac Surg, 1300 York Ave,69th St,A Bldg, New York, NY 10065 USA.	znahle@DOM.wustl.edu			American Heart Association [0760028Z]	American Heart Association(American Heart Association)	This work was supported by American Heart Association beginning Grant-in-Aid 0760028Z (to Z.N.). The costs of publication of this article were defrayed in part by the payment of page charges. This article must therefore be hereby marked "advertisement" in accordance with 18 U. S. C. Section 1734 solely to indicate this fact.	Abbot EL, 2005, FEBS J, V272, P3004, DOI 10.1111/j.1742-4658.2005.04713.x; Agah R, 1997, J CLIN INVEST, V100, P2722, DOI 10.1172/JCI119817; Attwooll C, 2004, EMBO J, V23, P4709, DOI 10.1038/sj.emboj.7600481; Bastie CC, 2005, J BIOL CHEM, V280, P14222, DOI 10.1074/jbc.M413625200; Chaussepied M, 2004, MOL CELL, V16, P831, DOI 10.1016/j.molcel.2004.11.003; Dali-Youcef N, 2007, P NATL ACAD SCI USA, V104, P10703, DOI 10.1073/pnas.0611568104; Dang CV, 2006, SEMIN CANCER BIOL, V16, P253, DOI 10.1016/j.semcancer.2006.07.014; Darville MI, 1997, NUCLEIC ACIDS RES, V25, P2759, DOI 10.1093/nar/25.14.2759; DARVILLE MI, 1995, ONCOGENE, V11, P1509; Das D, 2006, MOL SYST BIOL, V2, DOI 10.1038/msb4100067; Dyson N, 1998, GENE DEV, V12, P2245, DOI 10.1101/gad.12.15.2245; Elstrom RL, 2004, CANCER RES, V64, P3892, DOI 10.1158/0008-5472.CAN-03-2904; Fajas L, 2004, J CLIN INVEST, V113, P1288, DOI 10.1172/JCI200418555; Fajas L, 2002, DEV CELL, V3, P39, DOI 10.1016/S1534-5807(02)00190-9; Fantin VR, 2006, CANCER CELL, V9, P425, DOI 10.1016/j.ccr.2006.04.023; Guo K, 1997, J BIOL CHEM, V272, P791, DOI 10.1074/jbc.272.2.791; Harbour JW, 1999, CELL, V98, P859, DOI 10.1016/S0092-8674(00)81519-6; HELIN K, 1993, MOL CELL BIOL, V13, P6501, DOI 10.1128/MCB.13.10.6501; Hernando E, 2004, NATURE, V430, P797, DOI 10.1038/nature02820; Huang BL, 2002, DIABETES, V51, P276, DOI 10.2337/diabetes.51.2.276; Kel AE, 2001, J MOL BIOL, V309, P99, DOI 10.1006/jmbi.2001.4650; Kim JW, 2006, CANCER RES, V66, P8927, DOI 10.1158/0008-5472.CAN-06-1501; Kirshenbaum LA, 1996, DEV BIOL, V179, P402, DOI 10.1006/dbio.1996.0270; Kwon HS, 2004, ADV ENZYME REGUL, V44, P109, DOI 10.1016/j.advenzreg.2003.11.020; Kwon HS, 2006, BBA-GENE STRUCT EXPR, V1759, P141, DOI 10.1016/j.bbaexp.2006.04.005; Liu X, 2007, GENE DEV, V21, P2711, DOI 10.1101/gad.1590607; Nahle Z, 2002, NAT CELL BIOL, V4, P859, DOI 10.1038/ncb868; Nahle Z, 2008, J BIOL CHEM, V283, P14317, DOI 10.1074/jbc.M706478200; Rowles J, 1996, J BIOL CHEM, V271, P22376, DOI 10.1074/jbc.271.37.22376; Sankaran VG, 2008, GENE DEV, V22, P463, DOI 10.1101/gad.1627208; Slansky JE, 1996, BIOESSAYS, V18, P55, DOI 10.1002/bies.950180111; Spriet LL, 2004, J APPL PHYSIOL, V96, P2082, DOI 10.1152/japplphysiol.01318.2003; Storlien L, 2004, P NUTR SOC, V63, P363, DOI 10.1079/PNS2004349; Sugden M. C., 2002, Current Drug Targets - Immune Endocrine and Metabolic Disorders, V2, P151, DOI 10.2174/1568008023340785; Sugden Mary C., 2006, Archives of Physiology and Biochemistry, V112, P139, DOI 10.1080/13813450600935263; Trimarchi JM, 2002, NAT REV MOL CELL BIO, V3, P11, DOI 10.1038/nrm714; Vigo E, 1999, MOL CELL BIOL, V19, P6379; WARBURG O, 1956, SCIENCE, V124, P269; WARBURG O, 1956, SCIENCE, V123, P309, DOI 10.1126/science.123.3191.309; Wende AR, 2005, MOL CELL BIOL, V25, P10684, DOI 10.1128/MCB.25.24.10684-10694.2005; WHYTE P, 1988, NATURE, V334, P124, DOI 10.1038/334124a0; Wu PF, 2000, ARCH BIOCHEM BIOPHYS, V381, P1, DOI 10.1006/abbi.2000.1946; Wu PF, 1998, BIOCHEM J, V329, P197, DOI 10.1042/bj3290197; XUAN Z, 2005, GENOME BIOL, V6; Zhao GX, 2008, AM J PHYSIOL-HEART C, V294, pH936, DOI 10.1152/ajpheart.00870.2007	45	81	83	0	2	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	OCT 10	2008	283	41					27410	27417		10.1074/jbc.M802418200	http://dx.doi.org/10.1074/jbc.M802418200			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	355OW	18667418	hybrid			2022-12-27	WOS:000259719200009
J	Tu, SL; Chen, HC; Ku, LW				Tu, Shih-Long; Chen, Hsiu-Chen; Ku, Li-Wen			Mechanistic studies of the phytochromobilin synthase HY2 from Arabidopsis	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							PHYCOCYANOBILIN-FERREDOXIN OXIDOREDUCTASE; CYANOBACTERIAL PHYCOCYANOBILIN; CHROMOPHORE BIOSYNTHESIS; CRYSTAL-STRUCTURE; BILIVERDIN; BINDING; COMPLEX; DEFICIENT; PCYA; REDUCTION	Phytochromobilin (P Phi B) is an open chain tetrapyrrole molecule that functions as the chromophore of light-sensing phytochromes in plants. Derived from heme, P Phi B is synthesized through an open chain tetrapyrrole intermediate, biliverdin IX alpha (BV), in the biosynthesis pathway. BV is subsequently reduced by the P Phi B synthase HY2 in plants. HY2 is a ferredoxin-dependent bilin reductase that catalyzes the reduction of the A-ring 2,3,3(1),3(2)-diene system to produce an ethylidene group for assembly with apophytochromes. In this study, we sought to determine the catalytic mechanism of HY2. Data from UV-visible and EPR spectroscopy showed that the HY2-catalyzed BV reaction proceeds via a transient radical intermediate. Site-directed mutagenesis showed several ionizable residues that are involved in the catalytic steps. Detailed analysis of these site-directed mutants highlighted a pair of aspartate residues central to proton donation and substrate positioning. A mechanistic prediction for the HY2 reaction is proposed. These results support the hypothesis that ferredoxin-dependent bilin reductases reduce BV through a radical mechanism, but their double bond specificity is decided by strategic placement of different proton-donating residues surrounding the bilin substrate in the active sites.	[Tu, Shih-Long; Chen, Hsiu-Chen; Ku, Li-Wen] Acad Sinica, Inst Plant & Microbial Biol, Taipei 11529, Taiwan	Academia Sinica - Taiwan	Tu, SL (corresponding author), Acad Sinica, Inst Plant & Microbial Biol, Taipei 11529, Taiwan.	tsl@gate.sinica.edu.tw	Tu, Shih-Long/ABF-5446-2021	Tu, Shih-Long/0000-0001-9436-278X	National Science Council [96-2311-B-001019-MY2]; Academia Sinica of Taiwan	National Science Council(Ministry of Science and Technology, Taiwan); Academia Sinica of Taiwan(Academia Sinica - Taiwan)	This work was supported by National Science Council Grant 96-2311-B-001019-MY2 (to S.-L.T.) and Academia Sinica of Taiwan. The costs of publication of this article were defrayed in part by the payment of page charges. This article must therefore be hereby marked "advertisement" in accordance with 18 U.S.C. Section 1734 solely to indicate this fact.	Akashi T, 1999, J BIOL CHEM, V274, P29399, DOI 10.1074/jbc.274.41.29399; CHORY J, 1989, PLANT CELL, V1, P867, DOI 10.1105/tpc.1.9.867; Dammeyer T, 2008, J BIOL CHEM, V283, P27547, DOI 10.1074/jbc.M803765200; Dammeyer T, 2008, CURR BIOL, V18, P442, DOI 10.1016/j.cub.2008.02.067; DEPASCALIS AR, 1993, PROTEIN SCI, V2, P1126, DOI 10.1002/pro.5560020707; Dose MM, 1997, PLANT PHYSIOL, V114, P1047, DOI 10.1104/pp.114.3.1047; ELICH TD, 1989, J BIOL CHEM, V264, P183; Emsley P, 2004, ACTA CRYSTALLOGR D, V60, P2126, DOI 10.1107/S0907444904019158; Falk H., 1989, CHEM LINEAR OLIGOPYR; Frankenberg N, 2003, J BIOL CHEM, V278, P9219, DOI 10.1074/jbc.M211643200; Frankenberg N, 2001, PLANT CELL, V13, P965, DOI 10.1105/tpc.13.4.965; Hagiwara Y, 2006, P NATL ACAD SCI USA, V103, P27, DOI 10.1073/pnas.0507266103; Hagiwara Y, 2006, FEBS LETT, V580, P3823, DOI 10.1016/j.febslet.2006.05.075; Kohchi T, 2001, PLANT CELL, V13, P425, DOI 10.1105/tpc.13.2.425; KROIS D, 1995, MONATSH CHEM, V126, P349, DOI 10.1007/BF00816104; Kurisu G, 2001, NAT STRUCT BIOL, V8, P117, DOI 10.1038/84097; LAGARIAS JC, 1980, J AM CHEM SOC, V102, P4821, DOI 10.1021/ja00534a042; Martinez-Julvez M, 1998, BIOCHEMISTRY-US, V37, P17680, DOI 10.1021/bi981718i; Muramoto T, 1999, PLANT CELL, V11, P335, DOI 10.1105/tpc.11.3.335; PARKS BM, 1991, PLANT CELL, V3, P1177, DOI 10.1105/tpc.3.11.1177; SCHLUCHTER WM, 1994, THESIS PENNSYLVANIA; TERRY MJ, 1991, J BIOL CHEM, V266, P22215; TERRY MJ, 1993, ARCH BIOCHEM BIOPHYS, V306, P1, DOI 10.1006/abbi.1993.1473; Tu SL, 2007, BIOCHEMISTRY-US, V46, P1484, DOI 10.1021/bi062038f; Tu SL, 2006, J BIOL CHEM, V281, P3127, DOI 10.1074/jbc.M510126200; Tu SL, 2004, J AM CHEM SOC, V126, P8682, DOI 10.1021/ja049280z	26	19	19	0	8	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	OCT 10	2008	283	41					27555	27564		10.1074/jbc.M803761200	http://dx.doi.org/10.1074/jbc.M803761200			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	355OW	18658149	hybrid			2022-12-27	WOS:000259719200026
J	Lightcap, CM; Sun, S; Lear, JD; Rodeck, U; Polenova, T; Williams, JC				Lightcap, Christine M.; Sun, Shangjin; Lear, James D.; Rodeck, Ulrich; Polenova, Tatyana; Williams, John C.			Biochemical and structural characterization of the Pak1-LC8 interaction	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							DYNEIN LIGHT-CHAIN; NITRIC-OXIDE SYNTHASE; PROTEIN INHIBITOR; INTRINSIC DISORDER; PHOSPHORYLATION; IDENTIFICATION; LIGHT-CHAIN-1; LOCALIZATION; BINDING; PIN	Pak1 (p21-activated kinase-1) and the dynein light chain, LC8, are overexpressed in breast cancer, and their direct interaction has been proposed to regulate tumor cell survival. These effects have been attributed in part to Pak1-mediated phosphorylation of LC8 at serine 88. However, LC8 is homodimeric, which renders Ser(88) inaccessible. Moreover, Pak1 does not contain a canonical LC8 binding sequence compared with other characterized LC8 binding sequences. Together, these observations raise the question whether the Pak1/LC8 interaction is distinct (i. e. enabled by a unique interface independent of LC8 dimerization). Herein, we present results from biochemical, NMR, and crystallographic studies that show that Pak1 (residues 212-222) binds to LC8 along the same groove as canonical LC8 interaction partners (e. g. nNOS and BimL). Using LC8 point mutants K36P and T67A, we were able to differentiate Pak1 from canonical LC8 binding sequences and identify a key hydrogen bond network that compensates for the loss of the conserved glutamine in the consensus sequence. We also show that the target binding interface formed through LC8 dimerization is required to bind to Pak1 and precludes phosphorylation of LC8 at Ser88. Consistent with this observation, in vitro phosphorylation assays using activated Pak1 fail to phosphorylate LC8. Although these results define structural details of the Pak1/LC8 interaction and suggest a hierarchy of target binding affinities, they do not support the current model whereby Pak1 binds to and subsequently phosphorylates LC8 to promote anchorage-independent growth. Rather, they suggest that LC8 binding modulates Pak1 activity and/or nuclear localization.	[Lightcap, Christine M.; Williams, John C.] Thomas Jefferson Univ, Dept Biochem & Mol Biol, Philadelphia, PA 19107 USA; [Lightcap, Christine M.; Rodeck, Ulrich; Williams, John C.] Thomas Jefferson Univ, Kimmel Canc Ctr, Philadelphia, PA 19107 USA; [Rodeck, Ulrich] Thomas Jefferson Univ, Dept Dermatol, Philadelphia, PA 19107 USA; [Sun, Shangjin; Polenova, Tatyana] Univ Delaware, Dept Chem & Biochem, Newark, DE 19716 USA; [Lear, James D.] Univ Penn, Dept Biochem & Biophys, Philadelphia, PA 19109 USA	Jefferson University; Jefferson University; Jefferson University; University of Delaware; University of Pennsylvania	Williams, JC (corresponding author), Thomas Jefferson Univ, Dept Biochem & Mol Biol, Bluemle Life Sci Bldg,Rm 826,233 S 10th St, Philadelphia, PA 19107 USA.	jwilliam@mail.jci.tju.edu	Sun, Shangjin/E-8054-2012		National Institutes of Health (National Center for Research Resources) [S10-RR022316]; NATIONAL CENTER FOR RESEARCH RESOURCES [S10RR022316] Funding Source: NIH RePORTER	National Institutes of Health (National Center for Research Resources)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR))	This work was supported, in whole or in part, by National Institutes of Health (National Center for Research Resources) Grant S10-RR022316 (to J. C.). The costs of publication of this article were defrayed in part by the payment of page charges. This article must therefore be hereby marked "advertisement" in accordance with 18 U. S. C. Section 1734 solely to indicate this fact.	Arkin M, 2001, ANAL BIOCHEM, V299, P98, DOI 10.1006/abio.2001.5396; BAILEY S, 1994, ACTA CRYSTALLOGR D, V50, P760, DOI 10.1107/s0907444994003112; Barbar E, 2001, BIOCHEMISTRY-US, V40, P1596, DOI 10.1021/bi002278+; Beckwith SM, 1998, J CELL BIOL, V143, P1239, DOI 10.1083/jcb.143.5.1239; Crepieux P, 1997, MOL CELL BIOL, V17, P7375, DOI 10.1128/MCB.17.12.7375; Day CL, 2004, BIOCHEM J, V377, P597, DOI 10.1042/BJ20031251; DELAGLIO F, 1995, J BIOMOL NMR, V6, P277, DOI 10.1007/BF00197809; Dyson HJ, 2005, NAT REV MOL CELL BIO, V6, P197, DOI 10.1038/nrm1589; Emsley P, 2004, ACTA CRYSTALLOGR D, V60, P2126, DOI 10.1107/S0907444904019158; Fan JS, 2001, J MOL BIOL, V306, P97, DOI 10.1006/jmbi.2000.4374; Fan JS, 1998, J BIOL CHEM, V273, P33472, DOI 10.1074/jbc.273.50.33472; GODDARD TD, 2006, SPARKY3; Hodi Z, 2006, BIOCHEMISTRY-US, V45, P12582, DOI 10.1021/bi060991e; Iakoucheva LM, 2004, NUCLEIC ACIDS RES, V32, P1037, DOI 10.1093/nar/gkh253; Jaffrey SR, 1996, SCIENCE, V274, P774, DOI 10.1126/science.274.5288.774; Kaiser FJ, 2003, HUM MOL GENET, V12, P1349, DOI 10.1093/hmg/ddg145; Kharakoz DP, 1997, BIOCHEMISTRY-US, V36, P10276, DOI 10.1021/bi961781c; King SM, 2000, BBA-MOL CELL RES, V1496, P60, DOI 10.1016/S0167-4889(00)00009-4; Lajoix AD, 2004, MOL DIVERS, V8, P281, DOI 10.1023/B:MODI.0000036242.01129.27; Lei M, 2000, CELL, V102, P387, DOI 10.1016/S0092-8674(00)00043-X; Liang J, 1999, NAT STRUCT BIOL, V6, P735; Lovell SC, 2003, PROTEINS, V50, P437, DOI 10.1002/prot.10286; Lu JQ, 2005, BIOCHEM BIOPH RES CO, V331, P153, DOI 10.1016/j.bbrc.2005.03.128; Mammen M, 1998, ANGEW CHEM INT EDIT, V37, P2755; Marley J, 2001, J BIOMOL NMR, V20, P71, DOI 10.1023/A:1011254402785; McCauley SD, 2007, LIFE SCI, V80, P959, DOI 10.1016/j.lfs.2006.11.025; Mccoy AJ, 2007, J APPL CRYSTALLOGR, V40, P658, DOI 10.1107/S0021889807021206; Moseley GW, 2007, MOL BIOL CELL, V18, P3204, DOI 10.1091/mbc.E07-01-0030; Mossessova E, 2000, MOL CELL, V5, P865, DOI 10.1016/S1097-2765(00)80326-3; Murshudov GN, 1997, ACTA CRYSTALLOGR D, V53, P240, DOI 10.1107/S0907444996012255; Navarro-Lerida I, 2004, PROTEOMICS, V4, P339, DOI 10.1002/pmic.200300528; Otwinowski Z, 1997, METHOD ENZYMOL, V276, P307, DOI 10.1016/S0076-6879(97)76066-X; Pirruccello M, 2006, J MOL BIOL, V361, P312, DOI 10.1016/j.jmb.2006.06.017; Rashid T, 2001, J BIOL CHEM, V276, P49043, DOI 10.1074/jbc.M105599200; Rayala SK, 2005, EMBO REP, V6, P538, DOI 10.1038/sj.embor.7400417; Rennefahrt UEE, 2007, J BIOL CHEM, V282, P15667, DOI 10.1074/jbc.M700253200; Rost B, 2003, NUCLEIC ACIDS RES, V31, P3300, DOI 10.1093/nar/gkg508; Sells MA, 2000, J CELL BIOL, V151, P1449, DOI 10.1083/jcb.151.7.1449; Singh RR, 2005, J BIOL CHEM, V280, P18130, DOI 10.1074/jbc.M412607200; Song CY, 2008, J BIOL CHEM, V283, P4004, DOI 10.1074/jbc.M704512200; Song YJ, 2007, J BIOL CHEM, V282, P17272, DOI 10.1074/jbc.M610445200; Sundberg-Smith LJ, 2005, J BIOL CHEM, V280, P2055, DOI 10.1074/jbc.M406013200; Tan GS, 2007, P NATL ACAD SCI USA, V104, P7229, DOI 10.1073/pnas.0701397104; Thiel DA, 2002, CURR BIOL, V12, P1227, DOI 10.1016/S0960-9822(02)00931-4; Uversky VN, 2005, J MOL RECOGNIT, V18, P343, DOI 10.1002/jmr.747; Vadlamudi RK, 2004, CANCER CELL, V5, P575, DOI 10.1016/j.ccr.2004.05.022; Vallee RB, 2004, J NEUROBIOL, V58, P189, DOI 10.1002/neu.10314; Williams JC, 2007, P NATL ACAD SCI USA, V104, P10028, DOI 10.1073/pnas.0703614104; Wu JQ, 2005, SCIENCE, V310, P310, DOI 10.1126/science.1113230; ZWART PH, 2007, CCP4 NEWSLETTER WINT, V7	50	40	41	0	4	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	OCT 3	2008	283	40					27314	27324		10.1074/jbc.M800758200	http://dx.doi.org/10.1074/jbc.M800758200			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	353RT	18650427	Green Published, hybrid			2022-12-27	WOS:000259586600050
J	Chakrabarti, A; Sadler, AJ; Kar, N; Young, HA; Silverman, RH; Williams, BRG				Chakrabarti, Arindam; Sadler, Anthony J.; Kar, Niladri; Young, Howard A.; Silverman, Robert H.; Williams, Bryan R. G.			Protein kinase R-dependent regulation of interleukin-10 in response to double-stranded RNA	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							NF-KAPPA-B; PLASMACYTOID DENDRITIC CELLS; IL-10 GENE-EXPRESSION; NECROSIS-FACTOR-ALPHA; TOLL-LIKE RECEPTOR-3; HUMAN T-CELLS; HUMAN MONOCYTES; RIG-I; ANTIINFLAMMATORY CYTOKINES; TRANSCRIPTION FACTOR	The double-stranded RNA-activated protein kinase R (PKR) is an important component of antiviral defense. PKR participates in different signaling pathways in response to various stimuli to regulate translation via phosphorylation of the eukaryotic initiation factor 2 alpha, and transcription via activating NF-kappa B and IRF-1, to induce pro-inflammatory cytokines. Here we show PKR regulates interleukin-10 induction in response to double-stranded RNA, bacterial lipopolysaccaride, and Sendai virus infection. Using chemical inhibitors, dominant negative constructs, and genetic knockouts, we demonstrate that the PKR-mediated interleukin-10 induction engages JNK and NF-kappa B. Together, our data demonstrate the role of PKR in regulating an anti-inflammatory cytokine. The findings have significance in antiviral as well as broader innate immune responses.	[Sadler, Anthony J.; Williams, Bryan R. G.] Monash Univ, Monash Med Ctr, Monash Inst Med Res, Clayton, Vic 3168, Australia; [Chakrabarti, Arindam; Kar, Niladri; Silverman, Robert H.] Cleveland Clin, Lerner Res Inst, Dept Canc Biol, Cleveland, OH 44195 USA; [Kar, Niladri] Cleveland Clin, Lerner Res Inst, Dept Mol Cardiol, Cleveland, OH 44195 USA; [Young, Howard A.] NCI, Expt Immunol Lab, NIH, Frederick, MD 21702 USA	Monash University; Cleveland Clinic Foundation; Cleveland Clinic Foundation; National Institutes of Health (NIH) - USA; NIH National Cancer Institute (NCI)	Williams, BRG (corresponding author), Monash Univ, Monash Med Ctr, Monash Inst Med Res, 246 Clayton Rd, Clayton, Vic 3168, Australia.	bryan.williams@med.monash.edu.au	sadler, anthony/ABA-5572-2020; Williams, Bryan R. G./A-5021-2009; Young, Howard/R-5140-2019; Young, Howard/A-6350-2008	sadler, anthony/0000-0002-7970-8030; Williams, Bryan R. G./0000-0002-4969-1151; Young, Howard/0000-0002-3118-5111	National Institutes of Health [R01 AI034039, P01 CA062220]; NATIONAL CANCER INSTITUTE [P01CA062220] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI034039] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This work was supported, in whole or in part, by National Institutes of Health Grants R01 AI034039 and P01 CA062220. The costs of publication of this article were defrayed in part by the payment of page charges. This article must therefore be hereby marked "advertisement" in accordance with 18 U. S. C. Section 1734 solely to indicate this fact.	Alexopoulou L, 2001, NATURE, V413, P732, DOI 10.1038/35099560; Asakura Y, 2007, AM J HEMATOL, V82, P640, DOI 10.1002/ajh.20817; Boonstra A, 2006, J IMMUNOL, V177, P7551, DOI 10.4049/jimmunol.177.11.7551; Brightbill HD, 2000, J IMMUNOL, V164, P1940, DOI 10.4049/jimmunol.164.4.1940; Cao SJ, 2006, J BIOL CHEM, V281, P26041, DOI 10.1074/jbc.M602222200; Cao SJ, 2005, J IMMUNOL, V174, P3484, DOI 10.4049/jimmunol.174.6.3484; Chang EY, 2007, J IMMUNOL, V178, P6705, DOI 10.4049/jimmunol.178.11.6705; Cheung BKW, 2005, J IMMUNOL, V175, P7218, DOI 10.4049/jimmunol.175.11.7218; Daftarian PM, 1996, J IMMUNOL, V157, P12; DANDREA A, 1993, J EXP MED, V178, P1041, DOI 10.1084/jem.178.3.1041; Deb A, 2001, EMBO J, V20, P2487, DOI 10.1093/emboj/20.10.2487; Diebold SS, 2003, NATURE, V424, P324, DOI 10.1038/nature01783; Diebold SS, 2004, SCIENCE, V303, P1529, DOI 10.1126/science.1093616; DING L, 1993, J IMMUNOL, V151, P1224; Dummer W, 1996, INT J CANCER, V66, P607, DOI 10.1002/(SICI)1097-0215(19960529)66:5<607::AID-IJC4>3.3.CO;2-B; Elco CP, 2005, J VIROL, V79, P3920, DOI 10.1128/JVI.79.7.3920-3929.2005; Fickenscher H, 2002, TRENDS IMMUNOL, V23, P89, DOI 10.1016/S1471-4906(01)02149-4; FINBLOOM DS, 1995, J IMMUNOL, V155, P1079; GASTL GA, 1993, INT J CANCER, V55, P96, DOI 10.1002/ijc.2910550118; Giambartolomei GH, 1999, INFECT IMMUN, V67, P140, DOI 10.1128/IAI.67.1.140-147.1999; Gil J, 2004, MOL CELL BIOL, V24, P4502, DOI 10.1128/MCB.24.10.4502-4512.2004; Goh KC, 2000, EMBO J, V19, P4292, DOI 10.1093/emboj/19.16.4292; GRABSTEIN KH, 1992, J IMMUNOL, V149, P1524; GRUBER MF, 1994, J IMMUNOL, V152, P1354; Hsu LC, 2004, NATURE, V428, P341, DOI 10.1038/nature02405; Jiang ZF, 2003, J BIOL CHEM, V278, P16713, DOI 10.1074/jbc.M300562200; Kato H, 2006, NATURE, V441, P101, DOI 10.1038/nature04734; Kato H, 2005, IMMUNITY, V23, P19, DOI 10.1016/j.immuni.2005.04.010; KUMAR A, 1994, P NATL ACAD SCI USA, V91, P6288, DOI 10.1073/pnas.91.14.6288; Kumar A, 1997, EMBO J, V16, P406, DOI 10.1093/emboj/16.2.406; Li K, 2005, J BIOL CHEM, V280, P16739, DOI 10.1074/jbc.M414139200; Libraty DH, 1997, J CLIN INVEST, V99, P336, DOI 10.1172/JCI119162; Lopez CB, 2004, J IMMUNOL, V173, P6882, DOI 10.4049/jimmunol.173.11.6882; Lucas M, 2005, J IMMUNOL, V175, P469, DOI 10.4049/jimmunol.175.1.469; MALEFYT RD, 1991, J EXP MED, V174, P915; MALEFYT RD, 1992, CURR OPIN IMMUNOL, V4, P314, DOI 10.1016/0952-7915(92)90082-P; MALEFYT RD, 1993, J IMMUNOL, V151, P6370; Meusel TR, 2002, J IMMUNOL, V168, P6429, DOI 10.4049/jimmunol.168.12.6429; Moore KW, 2001, ANNU REV IMMUNOL, V19, P683, DOI 10.1146/annurev.immunol.19.1.683; Paludan SR, 2001, J VIROL, V75, P8008, DOI 10.1128/JVI.75.17.8008-8015.2001; Scheuner D, 2006, J BIOL CHEM, V281, P21458, DOI 10.1074/jbc.M603784200; Schols D, 1996, J VIROL, V70, P4953, DOI 10.1128/JVI.70.8.4953-4960.1996; Smale ST, 2002, ANNU REV IMMUNOL, V20, P427, DOI 10.1146/annurev.immunol.20.100301.064739; Toshchakov V, 2002, NAT IMMUNOL, V3, P392, DOI 10.1038/ni774; van Furth AM, 1999, INFECT IMMUN, V67, P3714, DOI 10.1128/IAI.67.8.3714-3718.1999; Wang XW, 2003, NUCLEIC ACIDS RES, V31, DOI 10.1093/nar/gng154; Wang ZY, 2005, J IMMUNOL, V174, P2098, DOI 10.4049/jimmunol.174.4.2098; WILLIAMS BR, 2006, UCSD NATURE MOL PAGE, DOI DOI 10.1038/MP.A000792.01; Williams LM, 2004, IMMUNOLOGY, V113, P281, DOI 10.1111/j.1365-2567.2004.01988.x; Yang YL, 1995, EMBO J, V14, P6095, DOI 10.1002/j.1460-2075.1995.tb00300.x; Yoneyama M, 2004, NAT IMMUNOL, V5, P730, DOI 10.1038/ni1087; Zamanian-Daryoush M, 2000, MOL CELL BIOL, V20, P1278, DOI 10.1128/MCB.20.4.1278-1290.2000; Ziegler-Heitbrock L, 2003, J IMMUNOL, V171, P285, DOI 10.4049/jimmunol.171.1.285	53	33	33	1	5	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	SEP 12	2008	283	37					25132	25139		10.1074/jbc.M804770200	http://dx.doi.org/10.1074/jbc.M804770200			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	345QZ	18625702	Green Published, hybrid			2022-12-27	WOS:000259012700005
J	Pavlova, O; Mukhopadhyay, J; Sineva, E; Ebright, RH; Severinov, K				Pavlova, Olga; Mukhopadhyay, Jayanta; Sineva, Elena; Ebright, Richard H.; Severinov, Konstantin			Systematic structure-activity analysis of microcin J25	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							BACTERIAL RNA-POLYMERASE; ESCHERICHIA-COLI; PEPTIDE; TRANSCRIPTION; TAIL	Microcin J25 ( MccJ25) is a 21-residue plasmid-encoded ribosomally synthesized lariat-protoknot antibacterial peptide that targets bacterial RNA polymerase. MccJ25 consists of an 8-residue cycle followed by a 13-residue tail that loops back and threads through the cycle. We have performed systematic mutational scanning of MccJ25, constructing and analyzing more than 380 singly substituted derivatives of MccJ25. The results define residues important for production of MccJ25 ( comprising synthesis of MccJ25 precursor, processing of MccJ25 precursor, export of mature MccJ25, and stability of mature MccJ25), inhibition of RNA polymerase, and inhibition of bacterial growth. The results show that only a small number of residues ( three in the cycle and one in the threaded segment of the tail) are important for MccJ25 production. The results further show that only a small number of additional residues ( two in the cycle and four in the threaded segment of the tail) are important for inhibition of transcription. The results open the way for design and construction of more potent MccJ25-based inhibitors of bacterial growth.	[Pavlova, Olga; Mukhopadhyay, Jayanta; Sineva, Elena; Ebright, Richard H.; Severinov, Konstantin] Waksman Inst Microbiol, Piscataway, NJ 08844 USA; [Pavlova, Olga; Severinov, Konstantin] Russian Acad Sci, Inst Gene Biol, Moscow 119334, Russia; [Mukhopadhyay, Jayanta; Sineva, Elena; Ebright, Richard H.] Rutgers State Univ, Howard Hughes Med Inst, Piscataway, NJ 08904 USA; [Ebright, Richard H.] Rutgers State Univ, Dept Chem, Piscataway, NJ 08904 USA; [Severinov, Konstantin] Rutgers State Univ, Dept Mol Biol & Biochem, Piscataway, NJ 08904 USA	Russian Academy of Sciences; Institute of Gene Biology (IGB) of Russian Academy of Sciences; Howard Hughes Medical Institute; Rutgers State University New Brunswick; Rutgers State University New Brunswick; Rutgers State University New Brunswick	Ebright, RH (corresponding author), Waksman Inst Microbiol, Piscataway, NJ 08844 USA.	ebright@waksman.rutgers.edu; severik@waksman.rutgers.edu	Ebright, Richard/O-3321-2019; Sineva, Elena/A-5267-2008; Severinov, Konstantin/C-8545-2016	Ebright, Richard/0000-0001-8915-7140; Sineva, Elena/0000-0003-2307-0581; 	National Institutes of Health [GM41376, GM64530]; NIAID Northeast Biodefense [U54-AI057158-Lipkin]; Howard Hughes Medical Institute Investigatorship; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [U54AI057158] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM041376, R01GM064530] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NIAID Northeast Biodefense(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); Howard Hughes Medical Institute Investigatorship(Howard Hughes Medical Institute); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported, in whole or in part, by National Institutes of Health Grants GM41376 ( to R. H. E.) and GM64530 ( to K. S.) and by a NIAID Northeast Biodefense center U54-AI057158-Lipkin Grant ( to K. S.). This work was also supported by a Howard Hughes Medical Institute Investigatorship ( to R. H. E.). The costs of publication of this article were defrayed in part by the payment of page charges. This article must therefore be hereby marked "advertisement" in accordance with 18 U. S. C. Section 1734 solely to indicate this fact.	Adelman K, 2004, MOL CELL, V14, P753, DOI 10.1016/j.molcel.2004.05.017; ASENSIO C, 1976, BIOCHEM BIOPH RES CO, V69, P7, DOI 10.1016/S0006-291X(76)80264-1; Bayro MJ, 2003, J AM CHEM SOC, V125, P12382, DOI 10.1021/ja036677e; Blond A, 1999, EUR J BIOCHEM, V259, P747, DOI 10.1046/j.1432-1327.1999.00085.x; Braun V, 2002, BIOCHIMIE, V84, P365, DOI 10.1016/S0300-9084(02)01427-X; Duquesne S, 2007, CHEM BIOL, V14, P793, DOI 10.1016/j.chembiol.2007.06.004; Miller J.H., 1992, SHORT COURSE BACTERI, P150; Mukhopadhyay J, 2004, MOL CELL, V14, P739, DOI 10.1016/j.molcel.2004.06.010; Mukhopadhyay J, 2001, CELL, V106, P453, DOI 10.1016/S0092-8674(01)00464-0; Rosengren KJ, 2004, BIOCHEMISTRY-US, V43, P4696, DOI 10.1021/bi0361261; Rosengren KJ, 2003, J AM CHEM SOC, V125, P12464, DOI 10.1021/JA0367703; SALOMON RA, 1992, J BACTERIOL, V174, P7428, DOI 10.1128/jb.174.22.7428-7435.1992; SALOMON RA, 1993, J BACTERIOL, V175, P7741; SCHLAGECK JG, 1979, J BIOL CHEM, V254, P2074; Semenova E, 2005, J BACTERIOL, V187, P3859, DOI 10.1128/JB.187.11.3859-3863.2005; Severinov K, 2007, MOL MICROBIOL, V65, P1380, DOI 10.1111/j.1365-2958.2007.05874.x; Solbiati JO, 1996, J BACTERIOL, V178, P3661, DOI 10.1128/jb.178.12.3661-3663.1996; Solbiati JO, 1999, J BACTERIOL, V181, P2659, DOI 10.1128/JB.181.8.2659-2662.1999; Wilson KA, 2003, J AM CHEM SOC, V125, P12475, DOI 10.1021/JA036756q; Yuzenkova J, 2002, J BIOL CHEM, V277, P50867, DOI 10.1074/jbc.M209425200	20	93	94	2	18	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	SEP 12	2008	283	37					25589	25595		10.1074/jbc.M803995200	http://dx.doi.org/10.1074/jbc.M803995200			7	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	345QZ	18632663	Green Published, hybrid			2022-12-27	WOS:000259012700054
J	Rayapuram, N; Hagenmuller, J; Grienenberger, JM; Bonnard, G; Giege, P				Rayapuram, Naganand; Hagenmuller, Jeremie; Grienenberger, Jean Michel; Bonnard, Geraldine; Giege, Philippe			The three mitochondrial encoded CcmF proteins form a complex that interacts with CCMH and c-type apocytochromes in Arabidopsis	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							HEME CHAPERONE CCME; PLANT-MITOCHONDRIA; RHODOBACTER-CAPSULATUS; MARCHANTIA-POLYMORPHA; NITRITE REDUCTASE; ESCHERICHIA-COLI; READING FRAMES; GENOME; BIOGENESIS; MATURATION	Three reading frames called ccmF(N1), ccmF(N2), and ccmF(c) are found in the mitochondrial genome of Arabidopsis. These sequences are similar to regions of the bacterial gene ccmF involved in cytochrome c maturation. ccmF genes are always absent from animal and fungi genomes but are found in mitochondrial genomes of land plant and several evolutionary distant eukaryotes. In Arabidopsis, ccmF(N2) despite the absence of a classical initiation codon is not a pseudo gene. The 3 ccmF genes of Arabidopsis are expressed at the protein level. Their products are integral proteins of the mitochondrial inner membrane with in total 11 to 13 predicted transmembrane helices. The conserved WWD domain of CcmF(N2) is localized in the inter membrane space. The 3 CcmF proteins are all detected in a high molecular mass complex of 500 kDa by Blue Native PAGE. Direct interaction between CcmF(N2) and both CcmF(N1) and CcmF(C) is shown with the yeast two-hybrid split ubiquitin system, but no interaction is observed between CcmF(N1) and CcmFC. Similarly, interaction is detected between CcmF(N2) and apocytochrome c but also with apocytochrome c(1). Finally, CcmF(N1) and CcmF(N2) both interact with CCMH previously shown to interact as well with cytochrome c. This strengthens the hypothesis that CcmF and CCMH make a complex that performs the assembly of heme with c-type apocytochromes in plant mitochondria.	[Rayapuram, Naganand; Hagenmuller, Jeremie; Grienenberger, Jean Michel; Bonnard, Geraldine; Giege, Philippe] CNRS, Inst Biol Mol Plantes, F-67084 Strasbourg, France	Centre National de la Recherche Scientifique (CNRS); UDICE-French Research Universities; Universites de Strasbourg Etablissements Associes; Universite de Strasbourg	Giege, P (corresponding author), CNRS, Inst Biol Mol Plantes, 12 Rue Gen Zimmer, F-67084 Strasbourg, France.	Philippe.Giege@ibmp-ulp.u-strasbg.fr		Giege, Philippe/0000-0003-2285-8190	"Centre National de la Recherche Scientifique."	"Centre National de la Recherche Scientifique."(Centre National de la Recherche Scientifique (CNRS))	This work was supported in part by the "Centre National de la Recherche Scientifique." The costs of publication of this article were defrayed in part by the payment of page charges. This article must therefore be hereby marked "advertisement" in accordance with 18 U. S. C. Section 1734 solely to indicate this fact.	Allen JWA, 2006, FEBS LETT, V580, P4827, DOI 10.1016/j.febslet.2006.07.073; ANDERSON S, 1981, NATURE, V290, P457, DOI 10.1038/290457a0; Arai M, 2004, NUCLEIC ACIDS RES, V32, pW390, DOI 10.1093/nar/gkh380; BECKMAN DL, 1992, GENE DEV, V6, P268, DOI 10.1101/gad.6.2.268; BOCK H, 1994, PLANT MOL BIOL, V24, P811, DOI 10.1007/BF00029863; BOWLER C, 1989, P NATL ACAD SCI USA, V86, P3237, DOI 10.1073/pnas.86.9.3237; Budar F, 2001, CR ACAD SCI III-VIE, V324, P543, DOI 10.1016/S0764-4469(01)01324-5; Bullerwell CE, 2004, CURR OPIN MICROBIOL, V7, P528, DOI 10.1016/j.mib.2004.08.008; Chevenet F, 2006, BMC BIOINFORMATICS, V7, DOI 10.1186/1471-2105-7-439; Cinege G, 2004, MOL GENET GENOMICS, V271, P171, DOI 10.1007/s00438-003-0968-2; Dong FG, 1998, CURR GENET, V34, P79, DOI 10.1007/s002940050369; DUMONT ME, 1987, EMBO J, V6, P235, DOI 10.1002/j.1460-2075.1987.tb04744.x; Eaves D, 1998, BIOCHEM SOC T, V26, pS216, DOI 10.1042/bst026s216; Edgar RC, 2004, BMC BIOINFORMATICS, V5, P1, DOI 10.1186/1471-2105-5-113; Forner J, 2007, NUCLEIC ACIDS RES, V35, P3676, DOI 10.1093/nar/gkm270; Giege P, 1998, CURR GENET, V34, P313, DOI 10.1007/s002940050401; Giege P, 2000, EMBO REP, V1, P164, DOI 10.1093/embo-reports/kvd024; Giege P, 2008, MITOCHONDRION, V8, P61, DOI 10.1016/j.mito.2007.10.001; Giege P, 1999, P NATL ACAD SCI USA, V96, P15324, DOI 10.1073/pnas.96.26.15324; Giege P, 2005, PLANT CELL, V17, P1497, DOI 10.1105/tpc.104.030254; Giege P, 2004, FEBS LETT, V563, P165, DOI 10.1016/S0014-5793(04)00291-1; Giege P, 2003, PLANT MOL BIOL REP, V21, P133, DOI 10.1007/BF02774240; Goldman BS, 1998, P NATL ACAD SCI USA, V95, P5003, DOI 10.1073/pnas.95.9.5003; GONZALEZ DH, 1993, CURR GENET, V24, P248, DOI 10.1007/BF00351799; Gray MW, 2004, ANNU REV GENET, V38, P477, DOI 10.1146/annurev.genet.37.110801.142526; Guindon S, 2003, SYST BIOL, V52, P696, DOI 10.1080/10635150390235520; Han D, 2008, PROTEINS, V70, P900, DOI 10.1002/prot.21597; Handa H, 1996, MOL GEN GENET, V252, P292, DOI 10.1007/BF02173775; Hirose T, 1998, FEBS LETT, V430, P257, DOI 10.1016/S0014-5793(98)00673-5; Holec S, 2006, MOL CELL BIOL, V26, P2869, DOI 10.1128/MCB.26.7.2869-2876.2006; KLEIN M, 1994, PLANT J, V6, P447, DOI 10.1046/j.1365-313X.1994.06030447.x; Kranz R, 1998, MOL MICROBIOL, V29, P383, DOI 10.1046/j.1365-2958.1998.00869.x; KRANZ RG, 1989, J BACTERIOL, V171, P456, DOI 10.1128/jb.171.1.456-464.1989; Laloi C, 2001, P NATL ACAD SCI USA, V98, P14144, DOI 10.1073/pnas.241340898; LAMATTINA L, 1993, EUR J BIOCHEM, V217, P831, DOI 10.1111/j.1432-1033.1993.tb18311.x; Lang BF, 1997, NATURE, V387, P493, DOI 10.1038/387493a0; Logan DC, 2006, BBA-MOL CELL RES, V1763, P430, DOI 10.1016/j.bbamcr.2006.01.003; Marienfeld JR, 1997, BIOL CHEM, V378, P859, DOI 10.1515/bchm.1997.378.8.859; Menassa R, 1997, CURR GENET, V31, P70, DOI 10.1007/s002940050178; Merchant SS, 2007, SCIENCE, V318, P245, DOI 10.1126/science.1143609; Meyer EH, 2005, P NATL ACAD SCI USA, V102, P16113, DOI 10.1073/pnas.0503473102; Obrdlik P, 2004, P NATL ACAD SCI USA, V101, P12242, DOI 10.1073/pnas.0404467101; ODA K, 1992, BIOSCI BIOTECH BIOCH, V56, P132, DOI 10.1271/bbb.56.132; ODA K, 1992, NUCLEIC ACIDS RES, V20, P3773, DOI 10.1093/nar/20.14.3773; PAGE MD, 1995, MOL MICROBIOL, V15, P307, DOI 10.1111/j.1365-2958.1995.tb02245.x; Raczynska KD, 2006, FEBS LETT, V580, P5641, DOI 10.1016/j.febslet.2006.09.010; Rayapuram N, 2007, J BIOL CHEM, V282, P21015, DOI 10.1074/jbc.M704091200; Ren Q, 2002, J BIOL CHEM, V277, P7657, DOI 10.1074/jbc.M110979200; Ren Q, 2001, J BIOL CHEM, V276, P32591, DOI 10.1074/jbc.M103058200; Rios-Velazquez C, 2003, J BACTERIOL, V185, P422, DOI 10.1128/JB.185.2.422-431.2003; Sambrook J., 1989, MOL CLONING LAB MANU, V1, P21, DOI DOI 10.51-10.67; Sanders C, 2007, J BACTERIOL, V189, P789, DOI 10.1128/JB.01441-06; SCHAGGER H, 1991, ANAL BIOCHEM, V199, P223, DOI 10.1016/0003-2697(91)90094-A; Schulz H, 2000, MOL MICROBIOL, V37, P1379, DOI 10.1046/j.1365-2958.2000.02083.x; SCHUSTER W, 1993, MOL GEN GENET, V239, P49, DOI 10.1007/BF00281600; Spielewoy N, 2001, J BIOL CHEM, V276, P5491, DOI 10.1074/jbc.M008853200; Talavera G, 2007, SYST BIOL, V56, P564, DOI 10.1080/10635150701472164; Terasawa K, 2007, MOL BIOL EVOL, V24, P699, DOI 10.1093/molbev/msl198; Thaminy Safia, 2004, Methods Mol Biol, V261, P297; Thony-Meyer L, 2002, BIOCHEM SOC T, V30, P633; Thony-Meyer L, 2000, BBA-BIOENERGETICS, V1459, P316, DOI 10.1016/S0005-2728(00)00167-5; Unseld M, 1997, NAT GENET, V15, P57, DOI 10.1038/ng0197-57; VALLON O, 1991, P NATL ACAD SCI USA, V88, P8262, DOI 10.1073/pnas.88.18.8262; WARD BL, 1981, CELL, V25, P793, DOI 10.1016/0092-8674(81)90187-2	64	43	49	0	4	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	SEP 12	2008	283	37					25200	25208		10.1074/jbc.M802621200	http://dx.doi.org/10.1074/jbc.M802621200			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	345QZ	18644794	hybrid, Green Published			2022-12-27	WOS:000259012700012
J	Chan, PM; Lim, L; Manser, E				Chan, Perry M.; Lim, Louis; Manser, Edward			PAK Is Regulated by PI3K, PIX, CDC42, and PP2C alpha and Mediates Focal Adhesion Turnover in the Hyperosmotic Stress-induced p38 Pathway	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							PROTEIN PHOSPHATASE 2C; P21-ACTIVATED KINASE PAK; PHOSPHATIDYLINOSITOL 3-KINASE; GROWTH-FACTOR; ALPHA-PAK; SIGNALING PATHWAY; TYROSINE KINASE; MAP KINASE; SERINE 338; ACTIVATION	Fractionation of brain extracts and functional biochemical assays identified PP2C alpha, a serine/threonine phosphatase, as the major biochemical activity inhibiting PAK1. PP2C alpha dephosphorylated PAK1 and p38, both of which were activated upon hyperosmotic shock with the same kinetics. In comparison to growth factors, hyperosmolality was a more potent activator of PAK1. Therefore we characterize the PAK signaling pathway in the hyperosmotic shock response. Endogenous PAKs were recruited to the p38 kinase complex in a phosphorylation-dependent manner. Overexpression of a PAK inhibitory peptide or dominant negative Cdc42 revealed that p38 activation was dependent on PAK and Cdc42 activities. PAK mutants deficient in binding to Cdc42 or PAK-interacting exchange factor were not activated. Using a panel of kinase inhibitors, we identified PI3K acting upstream of PAK, which correlated with PAK repression by pTEN overexpression. RNA interference knockdown of PAK expression reduced stress-induced p38 activation and conversely, PP2C alpha knockdown increased its activation. Hyperosmotic stress-induced PAK translocation away from focal adhesions to the perinuclear compartment and resulted in disassembly of focal adhesions, which are hallmarks of PAK activation. Inhibition of PAK by overexpression of PP2C alpha or the kinase inhibitory domain prevented sorbitol-induced focal adhesion dissolution. Inhibition of MAPK pathways showed that MEK-ERK signaling but not p38 is required for full PAK activation and focal adhesion turnover. We conclude that 1) PAK plays a required role in hyperosmotic signaling through the PI3K/pTEN/Cdc42/PP2C alpha/p38 pathway, and 2) PAK and PP2C alpha modulate the effects of this pathway on focal adhesion dynamics.	[Chan, Perry M.; Lim, Louis; Manser, Edward] GSK IMCB Grp, Inst Mol & Cell Biol, Singapore 138673, Singapore; [Lim, Louis] UCL, Inst Neurol, Dept Mol Neurosci, London WC1N 1PJ, England	Agency for Science Technology & Research (A*STAR); A*STAR - Institute of Molecular & Cell Biology (IMCB); GlaxoSmithKline; University of London; University College London	Chan, PM (corresponding author), GSK IMCB Grp, Inst Mol & Cell Biol, Proteos Bldg,61 Biopolis Dr, Singapore 138673, Singapore.	perryc@imcb.a-star.edu.sg	Manser, Edward/ABD-2301-2020		GlaxoSmithKline-Singapore Research Fund	GlaxoSmithKline-Singapore Research Fund(GlaxoSmithKline)	This work was supported by the GlaxoSmithKline-Singapore Research Fund (to E. M. and L. L.).	BAGRODIA S, 1995, J BIOL CHEM, V270, P27995; Bain J, 2007, BIOCHEM J, V408, P297, DOI 10.1042/BJ20070797; Bokoch GM, 1998, J BIOL CHEM, V273, P8137, DOI 10.1074/jbc.273.14.8137; Bokoch GM, 2003, ANNU REV BIOCHEM, V72, P743, DOI 10.1146/annurev.biochem.72.121801.161742; Burg MB, 1997, ANNU REV PHYSIOL, V59, P437, DOI 10.1146/annurev.physiol.59.1.437; Chan WH, 1999, J CELL PHYSIOL, V178, P397, DOI 10.1002/(SICI)1097-4652(199903)178:3<397::AID-JCP14>3.3.CO;2-U; Chang PM, 2003, MOL CELL BIOL, V23, P3067, DOI 10.1128/MCB.23.9.3067-3078.2003; Chaudhary A, 2000, CURR BIOL, V10, P551, DOI 10.1016/S0960-9822(00)00475-9; Chong C, 2001, J BIOL CHEM, V276, P17347, DOI 10.1074/jbc.M009316200; Clerk A, 1997, FEBS LETT, V403, P23, DOI 10.1016/S0014-5793(97)00020-3; COHEN P, 1989, ANNU REV BIOCHEM, V58, P453, DOI 10.1146/annurev.bi.58.070189.002321; Cohen P, 1997, FEBS LETT, V410, P3, DOI 10.1016/S0014-5793(97)00490-0; Cotteret S, 2003, MOL CELL BIOL, V23, P5526, DOI 10.1128/MCB.23.16.5526-5539.2003; de Nadal E, 2002, EMBO REP, V3, P735, DOI 10.1093/embo-reports/kvf158; Eblen ST, 2002, MOL CELL BIOL, V22, P6023, DOI 10.1128/MCB.22.17.6023-6033.2002; Frost JA, 1997, EMBO J, V16, P6426, DOI 10.1093/emboj/16.21.6426; Hanada M, 2001, J BIOL CHEM, V276, P5753, DOI 10.1074/jbc.M007773200; Hanada M, 1998, FEBS LETT, V437, P172, DOI 10.1016/S0014-5793(98)01229-0; Kaur R, 2005, J BIOL CHEM, V280, P3323, DOI 10.1074/jbc.M406701200; King AJ, 1998, NATURE, V396, P180, DOI 10.1038/24184; King CC, 2000, J BIOL CHEM, V275, P41201, DOI 10.1074/jbc.M006553200; Kissil JL, 2003, MOL CELL, V12, P841, DOI 10.1016/S1097-2765(03)00382-4; Koh CG, 2002, CURR BIOL, V12, P317, DOI 10.1016/S0960-9822(02)00652-8; Lasa M, 2002, MOL CELL BIOL, V22, P7802, DOI 10.1128/MCB.22.22.7802-7811.2002; Lei M, 2000, CELL, V102, P387, DOI 10.1016/S0092-8674(00)00043-X; Liu ZX, 2002, J BIOL CHEM, V277, P10452, DOI 10.1074/jbc.M107551200; Loo TH, 2004, MOL CELL BIOL, V24, P3849, DOI 10.1128/MCB.24.9.3849-3859.2004; Manser E, 1998, MOL CELL, V1, P183, DOI 10.1016/S1097-2765(00)80019-2; MANSER E, 1995, J BIOL CHEM, V270, P25070, DOI 10.1074/jbc.270.42.25070; Manser E, 1999, Prog Mol Subcell Biol, V22, P115; MANSER E, 1994, NATURE, V367, P40, DOI 10.1038/367040a0; Manser E, 1997, MOL CELL BIOL, V17, P1129, DOI 10.1128/MCB.17.3.1129; Meier R, 1998, EMBO J, V17, P7294, DOI 10.1093/emboj/17.24.7294; Meskiene I, 1998, P NATL ACAD SCI USA, V95, P1938, DOI 10.1073/pnas.95.4.1938; Miah SMS, 2004, MOL CELL BIOL, V24, P71, DOI 10.1128/MCB.24.1.71-83.2004; Mizuno T, 2004, EMBO J, V23, P2226, DOI 10.1038/sj.emboj.7600226; Papakonstanti EA, 2002, MOL BIOL CELL, V13, P2946, DOI 10.1091/mbc.02-01-0599; Park HS, 2004, MOL CELL BIOL, V24, P4384, DOI 10.1128/MCB.24.10.4384-4394.2004; Pollock CB, 2005, CANCER RES, V65, P1244, DOI 10.1158/0008-5472.CAN-04-1911; Price NE, 1999, CURR OPIN NEUROBIOL, V9, P336, DOI 10.1016/S0959-4388(99)80049-X; Raitt DC, 2000, EMBO J, V19, P4623, DOI 10.1093/emboj/19.17.4623; Roig J, 2000, J BIOL CHEM, V275, P16933, DOI 10.1074/jbc.M001627200; Rosette C, 1996, SCIENCE, V274, P1194, DOI 10.1126/science.274.5290.1194; Schurmann A, 2000, MOL CELL BIOL, V20, P453, DOI 10.1128/MCB.20.2.453-461.2000; Sundberg-Smith LJ, 2005, J BIOL CHEM, V280, P2055, DOI 10.1074/jbc.M406013200; Takekawa M, 1998, EMBO J, V17, P4744, DOI 10.1093/emboj/17.16.4744; Uhlik MT, 2003, NAT CELL BIOL, V5, P1104, DOI 10.1038/ncb1071; Vadlamudi RK, 2003, CANCER METAST REV, V22, P385, DOI 10.1023/A:1023729130497; Wang RA, 2002, EMBO J, V21, P5437, DOI 10.1093/emboj/cdf543; Warmka J, 2001, MOL CELL BIOL, V21, P51, DOI 10.1128/MCB.21.1.51-60.2001; Westphal RS, 1999, J BIOL CHEM, V274, P687, DOI 10.1074/jbc.274.2.687; Xia CZ, 2001, P NATL ACAD SCI USA, V98, P6174, DOI 10.1073/pnas.101137298; Yoshii S, 1999, ONCOGENE, V18, P5680, DOI 10.1038/sj.onc.1202936; Zhan Q, 2003, J IMMUNOL, V171, P3785, DOI 10.4049/jimmunol.171.7.3785; Zhang Z, 2000, AM J PHYSIOL-RENAL, V278, pF155, DOI 10.1152/ajprenal.2000.278.1.F155; Zhao ZS, 2000, MOL CELL BIOL, V20, P3906, DOI 10.1128/MCB.20.11.3906-3917.2000; Zhao ZS, 1998, MOL CELL BIOL, V18, P2153, DOI 10.1128/MCB.18.4.2153	57	40	40	0	4	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	SEP 5	2008	283	36					24949	24961		10.1074/jbc.M801728200	http://dx.doi.org/10.1074/jbc.M801728200			13	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	517MA	18586681	Green Published, hybrid			2022-12-27	WOS:000271617300008
J	Mamillapalli, R; VanHouten, J; Zawalich, W; Wysolmerski, J				Mamillapalli, Ramanaiah; VanHouten, Joshua; Zawalich, Walter; Wysolmerski, John			Switching of G-protein usage by the calcium-sensing receptor reverses its effect on parathyroid hormone-related protein secretion in normal versus malignant breast cells	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							EXTRACELLULAR CALCIUM; MAMMARY-GLAND; KINASE-C; MEDIATED PHOSPHORYLATION; CA2+-SENSING RECEPTOR; SIGNAL-TRANSDUCTION; ALPHA-SUBUNITS; EXPRESSION; BINDING; CANCER	The calcium-sensing receptor (CaR) is a G-protein-coupled receptor that signals in response to extracellular calcium and regulates parathyroid hormone secretion. The CaR is also expressed on normal mammary epithelial cells (MMECs), where it has been shown to inhibit secretion of parathyroid hormone-related protein (PTHrP) and participate in the regulation of calcium and bone metabolism during lactation. In contrast to normal breast cells, the CaR has been reported to stimulate PTHrP production by breast cancer cells. In this study, we confirmed that the CaR inhibits PTHrP production by MMECs but stimulates PTHrP production by Comma-D cells (immortalized murine mammary cells) and MCF-7 human breast cancer cells. We found that changes in intracellular cAMP, but not phospholipase C or MAPK signaling, correlated with the opposing effects of the CaR on PTHrP production. Pharmacologic stimulation of cAMP accumulation increased PTHrP production by normal and transformed breast cells. Inhibition of protein kinase A activity mimicked the effects of CaR activation on inhibiting PTHrP secretion by MMECs and blocked the effects of the CaR on stimulating PTHrP production in Comma-D and MCF-7 cells. We found that the CaR coupled to G alpha(i) in MMECs but coupled to G alpha(s) in Comma-D and MCF-7 cells. Thus, the opposing effects of the CaR on PTHrP production are because of alternate G-protein coupling of the receptor in normal versus transformed breast cells. Because PTHrP contributes to hypercalcemia and bone metastases, switching of G-protein usage by the CaR may contribute to the pathogenesis of breast cancer.	[Mamillapalli, Ramanaiah; VanHouten, Joshua; Wysolmerski, John] Yale Univ, Sch Med, Dept Internal Med, Sect Endocrinol & Metab, New Haven, CT 06520 USA; [Zawalich, Walter] Yale Univ, Sch Nursing, New Haven, CT 06520 USA	Yale University; Yale University	Wysolmerski, J (corresponding author), Yale Univ, Sch Med, Dept Internal Med, Sect Endocrinol & Metab, POB 208020, New Haven, CT 06520 USA.	john.wysolmerski@yale.edu	Mamillapalli, Ramanaiah/K-6357-2019	Mamillapalli, Ramanaiah/0000-0002-4022-8910	National Institutes of Health [DK077565, DK69542, DK41230]; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK077565, R01DK041230, R01DK069542] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	This work was supported, in whole or in part, by National Institutes of Health Grants DK077565, DK69542, and DK41230 from the NIDDK.	Abbink W, 2006, J EXP BIOL, V209, P3550, DOI 10.1242/jeb.02399; *APPL BIOS, 1997, US B APPL BIOS, V2; Ardeshirpour L, 2006, BONE, V38, P787, DOI 10.1016/j.bone.2005.11.009; Arthur JM, 1997, AM J PHYSIOL-RENAL, V273, pF129, DOI 10.1152/ajprenal.1997.273.1.F129; Awata H, 2001, J BIOL CHEM, V276, P34871, DOI 10.1074/jbc.M100775200; Baillie GS, 2003, P NATL ACAD SCI USA, V100, P940, DOI 10.1073/pnas.262787199; BANWELL JG, 1970, J CLIN INVEST, V49, P183, DOI 10.1172/JCI106217; BARR AJ, 1999, CRC METH SIG TRANS, P227; Birnbaumer L, 2007, BBA-BIOMEMBRANES, V1768, P772, DOI 10.1016/j.bbamem.2006.12.002; Brown E. M., 2007, V45, P139; BROWN EM, 1993, NATURE, V366, P575, DOI 10.1038/366575a0; Brown EM, 2001, PHYSIOL REV, V81, P239, DOI 10.1152/physrev.2001.81.1.239; Brown Sue A, 2007, Curr Opin Endocrinol Diabetes Obes, V14, P436, DOI 10.1097/MED.0b013e3282f15419; Chattopadhyay N, 2006, AM J PHYSIOL-ENDOC M, V290, pE761, DOI 10.1152/ajpendo.00350.2005; Chattopadhyay N, 2006, MOL GENET METAB, V89, P189, DOI 10.1016/j.ymgme.2006.07.003; Cheng I, 1998, J CLIN ENDOCR METAB, V83, P703, DOI 10.1210/jc.83.2.703; Chilco PJ, 1998, MOL CELL ENDOCRINOL, V138, P173, DOI 10.1016/S0303-7207(97)00239-6; Corbetta S, 2002, J CLIN ENDOCR METAB, V87, P2201, DOI 10.1210/jc.87.5.2201; CRUCIANI RA, 1993, P NATL ACAD SCI USA, V90, P3019, DOI 10.1073/pnas.90.7.3019; Daaka Y, 1997, NATURE, V390, P88, DOI 10.1038/36362; Davies SL, 2007, J BIOL CHEM, V282, P15048, DOI 10.1074/jbc.M607469200; DeMauro S, 2005, J MAMMARY GLAND BIOL, V10, P157, DOI 10.1007/s10911-005-5398-9; Dvorak MM, 2007, ENDOCRINOLOGY, V148, P3156, DOI 10.1210/en.2007-0147; Geibel J, 2006, P NATL ACAD SCI USA, V103, P9390, DOI 10.1073/pnas.0602996103; Harrison C, 2003, LIFE SCI, V74, P489, DOI 10.1016/j.lfs.2003.07.005; Hasseldine ARG, 2003, BRIT J PHARMACOL, V138, P1358, DOI 10.1038/sj.bjp.0705191; Hens JR, 2005, BREAST CANCER RES, V7, P220, DOI 10.1186/bcr1306; Hill SJ, 2003, BRIT J PHARMACOL, V138, P1188, DOI 10.1038/sj.bjp.0705192; Hjalm G, 2001, J BIOL CHEM, V276, P34880, DOI 10.1074/jbc.M100784200; Hofer AM, 2003, NAT REV MOL CELL BIO, V4, P530, DOI 10.1038/nrm1154; Hu JX, 2007, J CELL MOL MED, V11, P908, DOI 10.1111/j.1582-4934.2007.00096.x; Huang C, 2007, J CELL MOL MED, V11, P923, DOI 10.1111/j.1582-4934.2007.00114.x; IKEDA K, 1993, J BIOL CHEM, V268, P1174; Insel PA, 2003, CELL MOL NEUROBIOL, V23, P305, DOI 10.1023/A:1023684503883; Jahnke GD, 1996, J MOL ENDOCRINOL, V17, P247, DOI 10.1677/jme.0.0170247; Jiang YF, 2002, J BIOL CHEM, V277, P50543, DOI 10.1074/jbc.M205798200; KASLOW HR, 1992, FASEB J, V6, P2684, DOI 10.1096/fasebj.6.9.1612292; Kifor O, 2003, J CLIN ENDOCR METAB, V88, P4455, DOI 10.1210/jc.2002-021427; Kifor O, 2001, AM J PHYSIOL-RENAL, V280, pF291, DOI 10.1152/ajprenal.2001.280.2.F291; Kifor O, 1998, J BIOL CHEM, V273, P21708, DOI 10.1074/jbc.273.34.21708; Kovacs CS, 1998, J CLIN INVEST, V101, P2812, DOI 10.1172/JCI2940; Lawler OA, 2001, J BIOL CHEM, V276, P33596, DOI 10.1074/jbc.M104434200; Liao JH, 2006, CANCER RES, V66, P9065, DOI 10.1158/0008-5472.CAN-06-0317; Lorenz S, 2007, ENDOCRINOLOGY, V148, P2398, DOI 10.1210/en.2006-1035; Luo X, 1999, J BIOL CHEM, V274, P17684, DOI 10.1074/jbc.274.25.17684; Mackay HJ, 2003, ENDOCR-RELAT CANCER, V10, P389, DOI 10.1677/erc.0.0100389; Martin NP, 2004, CELL SIGNAL, V16, P1397, DOI 10.1016/j.cellsig.2004.05.002; McNeil L, 1998, AM J OBSTET GYNECOL, V178, P305, DOI 10.1016/S0002-9378(98)80017-3; Morimoto T, 1997, MOL CELL ENDOCRINOL, V129, P91, DOI 10.1016/S0303-7207(97)04044-6; ORourke J, 1997, J BIOL CHEM, V272, P6291, DOI 10.1074/jbc.272.10.6291; Philbrick WM, 1996, PHYSIOL REV, V76, P127, DOI 10.1152/physrev.1996.76.1.127; Quarles LD, 2003, CURR OPIN NEPHROL HY, V12, P349, DOI 10.1097/00041552-200307000-00002; Quinn SJ, 2007, BIOCHEM BIOPH RES CO, V354, P8, DOI 10.1016/j.bbrc.2006.12.160; Robinson GW, 2007, NAT REV GENET, V8, P963, DOI 10.1038/nrg2227; Ryan W L, 1974, Adv Cyclic Nucleotide Res, V4, P81; Sanders JL, 2000, ENDOCRINOLOGY, V141, P4357, DOI 10.1210/en.141.12.4357; Siclari VA, 2006, CANCER METAST REV, V25, P621, DOI 10.1007/s10555-006-9023-1; SIDHU A, 1991, J NEUROCHEM, V57, P1445, DOI 10.1111/j.1471-4159.1991.tb08312.x; Smajilovic S, 2006, BIOCHEM BIOPH RES CO, V348, P1215, DOI 10.1016/j.bbrc.2006.07.192; Smith NJ, 2006, HYPERTENSION, V48, P173, DOI 10.1161/01.HYP.0000232641.84521.92; Sotgia F, 2006, CANCER RES, V66, P10647, DOI 10.1158/0008-5472.CAN-06-2805; Strewler GJ, 2000, NEW ENGL J MED, V342, P177, DOI 10.1056/NEJM200001203420306; Taylor SS, 2005, BBA-PROTEINS PROTEOM, V1754, P25, DOI 10.1016/j.bbapap.2005.08.024; Tfelt-Hansen J, 2005, CRIT REV CL LAB SCI, V42, P35, DOI 10.1080/10408360590886606; Tu CL, 2008, J BIOL CHEM, V283, P3519, DOI 10.1074/jbc.M708318200; VanHouten J, 2004, J CLIN INVEST, V113, P598, DOI 10.1172/JCI200418776; VANHOUTEN J, 2005, J MAMMARY GLAND BIOL, V12, P477; VanHouten JN, 2007, ENDOCRINOLOGY, V148, P5943, DOI 10.1210/en.2007-0850; Wang WH, 1997, AM J PHYSIOL-RENAL, V273, pF421, DOI 10.1152/ajprenal.1997.273.3.F421; Ward DT, 2004, CELL CALCIUM, V35, P217, DOI 10.1016/j.ceca.2003.10.017; Ward DT, 2002, J AM SOC NEPHROL, V13, DOI 10.1097/01.ASN.0000015623.73739.B8; Williams TM, 2004, J BIOL CHEM, V279, P51630, DOI 10.1074/jbc.M409214200; Wysolmerski JJ, 2007, BONEKEY, V4, P209; Xu JK, 2005, J CELL PHYSIOL, V202, P554, DOI 10.1002/jcp.20159; ZAJAC JD, 1989, MOL CELL ENDOCRINOL, V67, P107, DOI 10.1016/0303-7207(89)90236-0; ZAWALICH W, 1987, DIABETES, V36, P426, DOI 10.2337/diabetes.36.4.426; ZAWALICH WS, 1995, ENDOCRINOLOGY, V136, P4903, DOI 10.1210/en.136.11.4903	77	110	112	0	3	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	SEP 5	2008	283	36					24435	24447		10.1074/jbc.M801738200	http://dx.doi.org/10.1074/jbc.M801738200			13	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	342YR	18621740	Green Published, hybrid			2022-12-27	WOS:000258820000019
J	Roca, H; Varsos, Z; Pienta, KJ				Roca, Hernan; Varsos, Zachary; Pienta, Kenneth J.			CCL2 Protects Prostate Cancer PC3 Cells from Autophagic Death via Phosphatidylinositol 3-Kinase/AKT-dependent Survivin Up-regulation	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							MONOCYTE CHEMOATTRACTANT PROTEIN-1; INDUCED APOPTOSIS; MACROPHAGE INFILTRATION; KINASE; PATHWAY; PHOSPHORYLATION; BONE; MACROAUTOPHAGY; AKT/PKB; GROWTH	Resistance to cell death is a hallmark of cancer. Autophagy is a survival mechanism activated in response to nutrient deprivation; however, excessive autophagy will ultimately induce cell death in a nonapoptotic manner. The present study demonstrates that CCL2 protects prostate cancer PC3 cells from autophagic death, allowing prolonged survival in serum-free conditions. Upon serum starvation, CCL2 induced survivin up-regulation in PC3, DU 145, and C4-2B prostate cancer cells. Both cell survival and survivin expression were stunted in CCL2-stimulated PC3 cells when treated either with the phosphatidylinositol 3-kinase inhibitor LY294002 (2 mu M) or the Akt-specific inhibitor-X (Akti-X; 2.5 mu M). Furthermore, CCL2 significantly reduced light chain 3-II (LC3-II) in serum-starved PC3; in contrast, treatment with LY294002 or Akti-X reversed the effect of CCL2 on LC3-II levels, suggesting that CCL2 signaling limits autophagy in these cells. Upon serum deprivation, the analysis of LC3 localization by immunofluorescence revealed a remarkable reduction in LC3 punctate after CCL2 stimulation. CCL2 treatment also resulted in a higher sustained mTORC1 activity as measured by an increase in phospho-p70S6 kinase (Thr(389)). Rapamycin, an inducer of autophagy, both down-regulated survivin and decreased PC3 cell viability in serum-deprived conditions. Treatment with CCL2, however, allowed cells to partially resist rapamycin-induced death, which correlated with survivin protein levels. In two stable transfectants expressing survivin-specific short hairpin RNA, generated from PC3, survivin protein levels controlled both cell viability and LC3 localization in response to CCL2 treatment. Altogether, these findings indicate that CCL2 protects prostate cancer PC3 cells from autophagic death via the phosphatidylinositol 3-kinase/Akt/survivin pathway and reveal survivin as a critical molecule in this survival mechanism.	[Roca, Hernan; Varsos, Zachary; Pienta, Kenneth J.] Univ Michigan, Ctr Comprehens Canc, Dept Urol, Ann Arbor, MI 48109 USA; [Pienta, Kenneth J.] Univ Michigan, Dept Internal Med, Ann Arbor, MI 48109 USA	University of Michigan System; University of Michigan; University of Michigan System; University of Michigan	Roca, H (corresponding author), 1500 E Med Ctr Dr,CCGC Room 7431, Ann Arbor, MI 48109 USA.	rocach@umich.edu	Pienta, Kenneth/E-7679-2015	Pienta, Kenneth/0000-0002-4138-2186	National Institutes of Health, NCI [SPORE CA69568-06A1]; Comprehensive Cancer Center Core [CA 46592-18, PO1 CA093900]; NATIONAL CANCER INSTITUTE [P01CA093900, P50CA069568, P30CA046592] Funding Source: NIH RePORTER	National Institutes of Health, NCI(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); Comprehensive Cancer Center Core; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This work was supported, in whole or in part, by National Institutes of Health, NCI, Grant SPORE CA69568-06A1, Comprehensive Cancer Center Core Grant CA 46592-18, and PO1 CA093900.	Ali SM, 2002, INT J ONCOL, V21, P531; Altieri DC, 2008, NAT REV CANCER, V8, P61, DOI 10.1038/nrc2293; Altieri DC, 2001, TRENDS MOL MED, V7, P542, DOI 10.1016/S1471-4914(01)02243-2; Ambrosini G, 1997, NAT MED, V3, P917, DOI 10.1038/nm0897-917; Arico S, 2001, J BIOL CHEM, V276, P35243, DOI 10.1074/jbc.C100319200; Bar-Shavit Z, 2007, J CELL BIOCHEM, V102, P1130, DOI 10.1002/jcb.21553; Blanc-Brude OP, 2002, NAT MED, V8, P987, DOI 10.1038/nm750; BLOMMAART EFC, 1995, J BIOL CHEM, V270, P2320, DOI 10.1074/jbc.270.5.2320; Boya P, 2005, MOL CELL BIOL, V25, P1025, DOI 10.1128/MCB.25.3.1025-1040.2005; Burnett PE, 1998, P NATL ACAD SCI USA, V95, P1432, DOI 10.1073/pnas.95.4.1432; Charo IF, 2004, CIRC RES, V95, P858, DOI 10.1161/01.RES.0000146672.10582.17; Codogno P, 2005, CELL DEATH DIFFER, V12, P1509, DOI 10.1038/sj.cdd.4401751; Conti I, 2004, SEMIN CANCER BIOL, V14, P149, DOI 10.1016/j.semcancer.2003.10.009; Dasgupta P, 2006, P NATL ACAD SCI USA, V103, P6332, DOI 10.1073/pnas.0509313103; Degenhardt K, 2006, CANCER CELL, V10, P51, DOI 10.1016/j.ccr.2006.06.001; Fornaro M, 2003, J BIOL CHEM, V278, P50402, DOI 10.1074/jbc.M307627200; Inoki K, 2005, NAT GENET, V37, P19, DOI 10.1038/ng1494; Jimenez-Sainz MC, 2003, MOL PHARMACOL, V64, P773, DOI 10.1124/mol.64.3.773; Kabeya Y, 2000, EMBO J, V19, P5720, DOI 10.1093/emboj/19.21.5720; Kamada Y, 2003, CURR TOP MICROBIOL, V279, P73; Klionsky DJ, 2008, AUTOPHAGY, V4, P151, DOI 10.4161/auto.5338; Klionsky DJ, 2007, NAT REV MOL CELL BIO, V8, P931, DOI 10.1038/nrm2245; Klionsky DJ, 2005, AUTOPHAGY, V1, P59, DOI 10.4161/auto.1.1.1536; Kuma A, 2004, NATURE, V432, P1032, DOI 10.1038/nature03029; Leek RD, 1996, CANCER RES, V56, P4625; Levine B, 2004, DEV CELL, V6, P463, DOI 10.1016/S1534-5807(04)00099-1; Levine B, 2008, CELL, V132, P27, DOI 10.1016/j.cell.2007.12.018; Li FZ, 1998, NATURE, V396, P580, DOI 10.1038/25141; Lin JQ, 1999, CANCER RES, V59, P2891; Loberg RD, 2007, CANCER RES, V67, P9417, DOI 10.1158/0008-5472.CAN-07-1286; Loberg RD, 2006, NEOPLASIA, V8, P578, DOI 10.1593/neo.06280; Logothetis CJ, 2005, NAT REV CANCER, V5, P21, DOI 10.1038/nrc1528; Lu Y, 2006, PROSTATE, V66, P1311, DOI 10.1002/pros.20464; Lum JJ, 2005, CELL, V120, P237, DOI 10.1016/j.cell.2004.11.046; Manning BD, 2007, CELL, V129, P1261, DOI 10.1016/j.cell.2007.06.009; Marino M, 2003, MOL BIOL CELL, V14, P2583, DOI 10.1091/mbc.E02-09-0621; Mizushima N, 2007, AUTOPHAGY, V3, P542, DOI 10.4161/auto.4600; Mochizuki T, 2002, J BIOL CHEM, V277, P2790, DOI 10.1074/jbc.M106361200; Nakatogawa H, 2007, CELL, V130, P165, DOI 10.1016/j.cell.2007.05.021; Noda T, 1998, J BIOL CHEM, V273, P3963, DOI 10.1074/jbc.273.7.3963; O'Boyle G, 2007, MOL IMMUNOL, V44, P1944, DOI 10.1016/j.molimm.2006.09.033; Ohta M, 2002, INT J CANCER, V102, P220, DOI 10.1002/ijc.10705; Olie RA, 2000, CANCER RES, V60, P2805; Pattingre S, 2008, BIOCHIMIE, V90, P313, DOI 10.1016/j.biochi.2007.08.014; Pienta Kenneth J, 2005, Clin Prostate Cancer, V4, P24, DOI 10.3816/CGC.2005.n.008; Reiland J, 1999, PROSTATE, V41, P78; Richter R, 2005, J IMMUNOL, V175, P1599, DOI 10.4049/jimmunol.175.3.1599; Sarbassov DD, 2005, SCIENCE, V307, P1098, DOI 10.1126/science.1106148; Song G, 2005, J CELL MOL MED, V9, P59, DOI 10.1111/j.1582-4934.2005.tb00337.x; Takeuchi H, 2005, CANCER RES, V65, P3336, DOI 10.1158/0008-5472.CAN-04-3640; Talmadge JE, 2007, CANCER METAST REV, V26, P373, DOI 10.1007/s10555-007-9072-0; Tamm I, 1998, CANCER RES, V58, P5315; Thelen M, 2001, NAT IMMUNOL, V2, P129, DOI 10.1038/84224; Thimmaiah KN, 2005, J BIOL CHEM, V280, P31924, DOI 10.1074/jbc.M507057200; Vanderkerken K, 2002, CLIN EXP METASTAS, V19, P87, DOI 10.1023/A:1013891205989; Velculescu VE, 1999, NAT GENET, V23, P387, DOI 10.1038/70487; Wu TT, 1998, INT J CANCER, V77, P887, DOI 10.1002/(SICI)1097-0215(19980911)77:6<887::AID-IJC15>3.0.CO;2-Z; Yang CC, 2003, J BIOL CHEM, V278, P25872, DOI 10.1074/jbc.M301744200; Yang SX, 2006, CANCER RES, V66, P4285, DOI 10.1158/0008-5472.CAN-05-4456; Yu L, 2004, SCIENCE, V304, P1500, DOI 10.1126/science.1096645	60	133	141	0	12	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	SEP 5	2008	283	36					25057	25073		10.1074/jbc.M801073200	http://dx.doi.org/10.1074/jbc.M801073200			17	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	517MA	18611860	hybrid, Green Published			2022-12-27	WOS:000271617300012
J	Butkinaree, C; Cheung, WD; Park, S; Park, K; Barber, M; Hart, GW				Butkinaree, Chutikarn; Cheung, Win D.; Park, Sungjin; Park, Kyoungsook; Barber, Megan; Hart, Gerald W.			Characterization of beta-N-acetylglucosaminidase cleavage by caspase-3 during apoptosis	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							O-GLCNAC TRANSFERASE; FAS-INDUCED APOPTOSIS; NUCLEOCYTOPLASMIC PROTEINS; CYTOSOLIC PROTEINS; SUBSTRATE-SPECIFICITY; DYNAMIC INTERPLAY; LINKED GLCNAC; CELL-FUNCTION; GLYCOSYLATION; PHOSPHORYLATION	beta-O-Linked N- acetylglucosamine is a dynamic post- translational modification involved in protein regulation in a manner similar to phosphorylation. Removal of N-acetylglucosamine is regulated by beta-N-acetylglucosaminidase (O-GlcNAcase), which was previously shown to be a substrate of caspase-3 in vitro. Here we show that O- GlcNAcase is cleaved by caspase- 3 into two fragments during apoptosis, an N- terminal fragment containing the O- GlcNAcase active site and a C- terminal fragment containing a region with homology to GCN5 histone acetyltransferases. The caspase- 3 cleavage site of O- GlcNAcase, mapped by Edman sequencing, is a noncanonical recognition site that occurs after Asp- 413 of the SVVD sequence in human O- GlcNAcase. A point mutation, D413A, abrogates cleavage by caspase- 3 both in vitro and in vivo. Finally, we show that O- GlcNAcase activity is not affected by caspase- 3 cleavage because the N- and C- terminal O- GlcNAcase fragments remain associated after the cleavage. Furthermore, when co- expressed simultaneously in the same cell, the N- terminal and C- terminal caspase fragments associate to reconstitute O- GlcNAcase enzymatic activity. These studies support the identification of O- GlcNAcase as a caspase- 3 substrate with a novel caspase- 3 cleavage site and provide insight about O- GlcNAcase regulation during apoptosis.	[Butkinaree, Chutikarn; Cheung, Win D.; Park, Kyoungsook; Barber, Megan; Hart, Gerald W.] Johns Hopkins Univ, Sch Med, Dept Biol Chem, Baltimore, MD 21205 USA; [Park, Sungjin] Johns Hopkins Univ, Sch Med, Dept Neurosci, Baltimore, MD 21205 USA	Johns Hopkins University; Johns Hopkins University	Hart, GW (corresponding author), Johns Hopkins Univ, Sch Med, Dept Biol Chem, 725 N Wolfe St, Baltimore, MD 21205 USA.	gwhart@jhmi.edu		Hart, Gerald/0000-0001-7812-4351	NCI NIH HHS [CA 42486] Funding Source: Medline; NICHD NIH HHS [HD 13563] Funding Source: Medline; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT [R01HD013563, R37HD013563] Funding Source: NIH RePORTER; NATIONAL CANCER INSTITUTE [R01CA042486] Funding Source: NIH RePORTER	NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NICHD NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))		Algeciras-Schimnich A, 2002, MOL CELL BIOL, V22, P207, DOI 10.1128/MCB.22.1.207-220.2002; Boehmelt G, 2000, EMBO J, V19, P5092, DOI 10.1093/emboj/19.19.5092; CasciolaRosen L, 1996, J EXP MED, V183, P1957, DOI 10.1084/jem.183.5.1957; Cetinbas N, 2006, BIOCHEMISTRY-US, V45, P3835, DOI 10.1021/bi052370b; Champattanachai V, 2007, AM J PHYSIOL-CELL PH, V292, pC178, DOI 10.1152/ajpcell.00162.2006; CHOU TY, 1995, J BIOL CHEM, V270, P18961, DOI 10.1074/jbc.270.32.18961; Cohen P, 2001, EUR J BIOCHEM, V268, P5001, DOI 10.1046/j.0014-2956.2001.02473.x; Comer FI, 2001, BIOCHEMISTRY-US, V40, P7845, DOI 10.1021/bi0027480; Comer FI, 2000, J BIOL CHEM, V275, P29179, DOI 10.1074/jbc.R000010200; Comtesse N, 2001, BIOCHEM BIOPH RES CO, V283, P634, DOI 10.1006/bbrc.2001.4815; Danial NN, 2004, CELL, V116, P205, DOI 10.1016/S0092-8674(04)00046-7; DONG DLY, 1994, J BIOL CHEM, V269, P19321; Dumont A, 1999, ONCOGENE, V18, P747, DOI 10.1038/sj.onc.1202325; Dunker AK, 2002, BIOCHEMISTRY-US, V41, P6573, DOI 10.1021/bi012159+; Forsythe ME, 2006, P NATL ACAD SCI USA, V103, P11952, DOI 10.1073/pnas.0601931103; Fulop N, 2007, CARDIOVASC RES, V73, P288, DOI 10.1016/j.cardiores.2006.07.018; Gao Y, 2001, J BIOL CHEM, V276, P9838, DOI 10.1074/jbc.M010420200; Griffith LS, 1999, EUR J BIOCHEM, V262, P824, DOI 10.1046/j.1432-1327.1999.00439.x; Hart GW, 2007, NATURE, V446, P1017, DOI 10.1038/nature05815; Heckel D, 1998, HUM MOL GENET, V7, P1859, DOI 10.1093/hmg/7.12.1859; Hengartner MO, 2000, NATURE, V407, P770, DOI 10.1038/35037710; Iyer SPN, 2003, J BIOL CHEM, V278, P24608, DOI 10.1074/jbc.M300036200; Kamemura K, 2003, PROG NUCLEIC ACID RE, V73, P107, DOI 10.1016/S0079-6603(03)01004-3; Kaufmann SH, 2001, TRENDS CELL BIOL, V11, P526, DOI 10.1016/S0962-8924(01)02173-0; Kipp M, 2000, J BIOL CHEM, V275, P5031, DOI 10.1074/jbc.275.7.5031; Kreppel LK, 1999, J BIOL CHEM, V274, P32015, DOI 10.1074/jbc.274.45.32015; Lefebvre T, 1999, BBA-GEN SUBJECTS, V1472, P71, DOI 10.1016/S0304-4165(99)00105-1; Lubas WA, 2000, J BIOL CHEM, V275, P10983, DOI 10.1074/jbc.275.15.10983; Mukerjee N, 2001, BIOCHEM BIOPH RES CO, V285, P1192, DOI 10.1006/bbrc.2001.5278; NICHOLSON DW, 1995, NATURE, V376, P37, DOI 10.1038/376037a0; O'Donnell N, 2004, MOL CELL BIOL, V24, P1680, DOI 10.1128/MCB.24.4.1680-1690.2004; Prilusky J, 2005, BIOINFORMATICS, V21, P3435, DOI 10.1093/bioinformatics/bti537; Salvesen GS, 1997, CELL, V91, P443, DOI 10.1016/S0092-8674(00)80430-4; Schlegel J, 1996, J BIOL CHEM, V271, P1841, DOI 10.1074/jbc.271.4.1841; Silke J, 2001, EMBO J, V20, P3114, DOI 10.1093/emboj/20.12.3114; Slawson C, 2005, J BIOL CHEM, V280, P32944, DOI 10.1074/jbc.M503396200; Talanian RV, 1997, J BIOL CHEM, V272, P9677; Thornberry NA, 1998, SCIENCE, V281, P1312, DOI 10.1126/science.281.5381.1312; Toleman C, 2004, J BIOL CHEM, V279, P53665, DOI 10.1074/jbc.M410406200; TORRES CR, 1984, J BIOL CHEM, V259, P3308; Ubeda M, 1997, J BIOL CHEM, V272, P19562, DOI 10.1074/jbc.272.31.19562; Van Damme P, 2005, NAT METHODS, V2, P771, DOI 10.1038/NMETH792; Vosseller K, 2002, P NATL ACAD SCI USA, V99, P5313, DOI 10.1073/pnas.072072399; Webb PR, 2000, APOPTOSIS, V5, P451, DOI 10.1023/A:1009601220552; WEIS M, 1995, EXP CELL RES, V219, P699, DOI 10.1006/excr.1995.1281; Wells L, 2004, J BIOL CHEM, V279, P38466, DOI 10.1074/jbc.M406481200; Wells L, 2002, J BIOL CHEM, V277, P1755, DOI 10.1074/jbc.M109656200; Wells L, 2001, SCIENCE, V291, P2376, DOI 10.1126/science.1058714; Whelan SA, 2003, CIRC RES, V93, P1047, DOI 10.1161/01.RES.0000103190.20260.37; Zachara NE, 2004, J BIOL CHEM, V279, P30133, DOI 10.1074/jbc.M403773200; Zachara NE, 2004, BBA-GEN SUBJECTS, V1673, P13, DOI 10.1016/j.bbagen.2004.03.016; Zachara NE, 2004, TRENDS CELL BIOL, V14, P218, DOI 10.1016/j.tcb.2004.03.005; Zachara NE, 2002, CHEM REV, V102, P431, DOI 10.1021/cr000406u; Zhang FX, 2003, CELL, V115, P715, DOI 10.1016/S0092-8674(03)00974-7	54	82	85	0	13	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	AUG 29	2008	283	35					23557	23566		10.1074/jbc.M804116200	http://dx.doi.org/10.1074/jbc.M804116200			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	340II	18586680	Green Published, hybrid			2022-12-27	WOS:000258638900008
J	Koike-Takeshita, A; Yoshida, M; Taguchi, H				Koike-Takeshita, Ayumi; Yoshida, Masasuke; Taguchi, Hideki			Revisiting the GroEL-GroES reaction cycle via the symmetric intermediate implied by novel aspects of the GroEL(D398A) mutant	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							CHAPERONIN GROEL; SUBSTRATE PROTEIN; CRYSTAL-STRUCTURE; ESCHERICHIA-COLI; COMPLEXES; ATP; MECHANISM; POLYPEPTIDE; BINDING; CAVITY	The Escherichia coli chaperonin GroEL is a double-ring chaperone that assists in protein folding with the aid of GroES and ATP. It is believed that GroEL alternates the folding-active rings and that the substrate protein ( and GroES) can bind to the open trans-ring only after ATP in the cis-ring is hydrolyzed. However, we found that a substrate protein prebound to the trans-ring remained bound during the first ATP cycle, and this substrate was assisted by GroEL-GroES when the second cycle began. Moreover, a slow ATP-hydrolyzing GroEL mutant (D398A) in the ATP-bound form bound a substrate protein and GroES to the trans-ring. The apparent discrepancy with the results from an earlier study (Rye, H. S., Roseman, A. M., Chen, S., Furtak, K., Fenton, W. A., Saibil, H. R., and Horwich, A. L.(1999) Cell 97, 325-338) can be explained by the previously unnoticed fact that the ATP-bound form of the D398A mutant exists as a symmetric 1:2 GroEL-GroES complex (the "football"-shaped complex) and that the substrate protein (and GroES) in the medium is incorporated into the complex only after the slow turnover. In light of these results, the current model of the GroEL-GroES reaction cycle via the asymmetric 1:1 GroEL-GroES complex deserves reexamination.	[Koike-Takeshita, Ayumi; Taguchi, Hideki] Univ Tokyo, Grad Sch Frontier Sci, Dept Med Genome Sci, Chiba 2778562, Japan; [Koike-Takeshita, Ayumi; Yoshida, Masasuke] Tokyo Inst Technol, Chem Resources Lab, Midori Ku, Yokohama, Kanagawa 2268503, Japan	University of Tokyo; Tokyo Institute of Technology	Taguchi, H (corresponding author), Univ Tokyo, Grad Sch Frontier Sci, Dept Med Genome Sci, FSB401,5-1-5 Kashiwanoha, Chiba 2778562, Japan.	taguchi@k.u-tokyo.ac.jp	taguchi, hideki/AAM-2663-2021; Taguchi, Hideki/B-6946-2009	taguchi, hideki/0000-0002-6612-9339; Taguchi, Hideki/0000-0002-6612-9339	Ministry of Education, Culture, Sports, Science, and Technology (MEXT), Japan [17049009, 19037007, 19058002]	Ministry of Education, Culture, Sports, Science, and Technology (MEXT), Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT))	This work was supported by Grant-in-aids for Scientific Research on Priority Areas 17049009, 19037007, and 19058002 (to H. T.) from the Ministry of Education, Culture, Sports, Science, and Technology (MEXT), Japan. The costs of publication of this article were defrayed in part by the payment of page charges. This article must therefore be hereby marked "advertisement" in accordance with 18 U.S.C. Section 1734 solely to indicate this fact.	AZEM A, 1994, SCIENCE, V265, P653, DOI 10.1126/science.7913553; Azem A, 1995, P NATL ACAD SCI USA, V92, P12021, DOI 10.1073/pnas.92.26.12021; Ben-Zvi AP, 1998, P NATL ACAD SCI USA, V95, P15275, DOI 10.1073/pnas.95.26.15275; BRAIG K, 1994, NATURE, V371, P578, DOI 10.1038/371578a0; CORRALES FJ, 1995, P NATL ACAD SCI USA, V92, P5326, DOI 10.1073/pnas.92.12.5326; Corrales FJ, 1996, FOLD DES, V1, P265, DOI 10.1016/S1359-0278(96)00040-5; Fujiwara K, 2007, J BACTERIOL, V189, P5860, DOI 10.1128/JB.00493-07; Hartl FU, 2002, SCIENCE, V295, P1852, DOI 10.1126/science.1068408; Hayer-Hartl MK, 1999, BIOL CHEM, V380, P531, DOI 10.1515/BC.1999.068; HISABORI T, 1992, J BIOL CHEM, V267, P4551; Horovitz A, 2005, CURR OPIN STRUC BIOL, V15, P646, DOI 10.1016/j.sbi.2005.10.001; Horowitz PM, 1999, P NATL ACAD SCI USA, V96, P2682, DOI 10.1073/pnas.96.6.2682; Horwich AL, 2007, ANNU REV CELL DEV BI, V23, P115, DOI 10.1146/annurev.cellbio.23.090506.123555; Hunt JF, 1996, NATURE, V379, P37, DOI 10.1038/379037a0; Kerner MJ, 2005, CELL, V122, P209, DOI 10.1016/j.cell.2005.05.028; Koike-Takeshita A, 2006, J BIOL CHEM, V281, P962, DOI 10.1074/jbc.M506298200; Li J, 1999, J BIOL CHEM, V274, P10790, DOI 10.1074/jbc.274.16.10790; LLORCA O, 1994, FEBS LETT, V345, P181, DOI 10.1016/0014-5793(94)00432-3; Lorimer G, 1997, NATURE, V388, P720, DOI 10.1038/41892; Mayhew M, 1996, NATURE, V379, P420, DOI 10.1038/379420a0; McLennan N, 1998, NATURE, V392, P139, DOI 10.1038/32317; Motojima F, 2003, J BIOL CHEM, V278, P26648, DOI 10.1074/jbc.M300806200; Motojima F, 2000, BIOCHEM BIOPH RES CO, V267, P842, DOI 10.1006/bbrc.1999.2020; Rye HS, 1999, CELL, V97, P325, DOI 10.1016/S0092-8674(00)80742-4; Rye HS, 1997, NATURE, V388, P792, DOI 10.1038/42047; Sakikawa C, 1999, J BIOL CHEM, V274, P21251, DOI 10.1074/jbc.274.30.21251; Sameshima T, 2008, J BIOL CHEM, V283, P23765, DOI 10.1074/jbc.M802541200; SCHMIDT M, 1994, SCIENCE, V265, P656, DOI 10.1126/science.7913554; SORBO BH, 1953, ACTA CHEM SCAND, V7, P1129, DOI 10.3891/acta.chem.scand.07-1129; Sparrer H, 1997, P NATL ACAD SCI USA, V94, P1096, DOI 10.1073/pnas.94.4.1096; Taguchi H, 2005, J BIOCHEM, V137, P543, DOI 10.1093/jb/mvi069; Taguchi H, 2004, J BIOL CHEM, V279, P45737, DOI 10.1074/jbc.M406795200; TAGUCHI H, 1995, FEBS LETT, V359, P195, DOI 10.1016/0014-5793(95)00041-7; Taguchi H, 2001, NAT BIOTECHNOL, V19, P861, DOI 10.1038/nbt0901-861; Thirumalai D, 2001, ANNU REV BIOPH BIOM, V30, P245, DOI 10.1146/annurev.biophys.30.1.245; TODD MJ, 1994, SCIENCE, V265, P659, DOI 10.1126/science.7913555; Ueno T, 2004, MOL CELL, V14, P423, DOI 10.1016/S1097-2765(04)00261-8; WEISSMAN JS, 1994, CELL, V78, P693, DOI 10.1016/0092-8674(94)90533-9; WEISSMAN JS, 1995, CELL, V83, P577, DOI 10.1016/0092-8674(95)90098-5; Xu ZH, 1997, NATURE, V388, P741, DOI 10.1038/41944; Young JC, 2004, NAT REV MOL CELL BIO, V5, P781, DOI 10.1038/nrm1492	41	40	41	0	12	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	AUG 29	2008	283	35					23774	23781		10.1074/jbc.M802542200	http://dx.doi.org/10.1074/jbc.M802542200			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	340II	18567584	Green Published, hybrid			2022-12-27	WOS:000258638900031
J	Lee, DH; Jeong, HS; Jeong, HG; Kim, KM; Kim, H; Choi, SH				Lee, Dong Hwan; Jeong, Hye Sook; Jeong, Hee Gon; Kim, Kyung Mo; Kim, Heebal; Choi, Sang Ho			A consensus sequence for binding of SmcR, a Vibrio vulnificus LuxR homologue, and genome-wide identification of the SmcR regulon	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							VIRULENCE GENE-EXPRESSION; HARVEYI-LUXR; RECEPTOR PROTEIN; GLOBAL REGULATOR; CHOLERAE; BACTERIA; HAPR; METALLOPROTEASE; TRANSCRIPTION; RUGOSITY	Quorum sensing has been implicated as an important global regulatory system controlling the expression of numerous virulence factors in bacterial pathogens. In the present study, DNA targets of SmcR, a Vibrio vulnificus LuxR homologue, were selected from a random pool of DNA fragments by using a cycle selection procedure consisting of in vitro DNA- SmcR interaction, purification of SmcR- DNA complexes, and PCR amplification of SmcR- bound DNA. The amplified DNA fragments were cloned and analyzed separately by electrophoretic mobility shift assay to verify the specific binding of SmcR to the DNA. The DNA sequences bound by SmcR were determined by DNase I footprinting, and alignment of the resulting 29 sequences revealed a 22- bp consensus SmcR- binding sequence, 5'- TTATTGATWWRWTWNTNAATAA-3' (where W represents A or T, R is G or A, and N is any nucleotide), with an 8- bp ( TTATTGAT) inverted repeat. The consensus sequence revealed greater efficiency for the binding of SmcR than the SmcR- binding sequence previously identified within PvvpE. Mutational analysis demonstrated that the 9th and 10th bases from the center are the most essential for SmcR binding. A genome- wide search using the consensus sequence predicted that at least 121 genes are under the control of SmcR, and 10 of these newly identified SmcR regulon members were verified as being regulated by SmcR in V. vulnificus as well as in vitro. The consensus sequence and newly identified genes should be of use for elucidating the regulatory mechanism of SmcR and provide further insight into the role of the quorum sensing in V. vulnificus pathogenesis.	[Lee, Dong Hwan; Jeong, Hee Gon; Kim, Kyung Mo; Kim, Heebal; Choi, Sang Ho] Seoul Natl Univ, Dept Agr Biotechnol, Seoul 151921, South Korea; [Lee, Dong Hwan; Jeong, Hye Sook; Jeong, Hee Gon; Choi, Sang Ho] Seoul Natl Univ, Ctr Agr Biomat, Natl Res Lab Mol Microbiol & Toxicol, Seoul 151921, South Korea	Seoul National University (SNU); Seoul National University (SNU)	Choi, SH (corresponding author), Seoul Natl Univ, Dept Agr Biotechnol, Seoul 151921, South Korea.	choish@snu.ac.kr	Kim, Heebal/A-8889-2016	Kim, Heebal/0000-0003-3064-1303; Jeong, Hee Gon/0000-0002-8103-2690; Kim, Kyung Mo/0000-0001-5125-5079; Choi, Sang Ho/0000-0003-3865-1039				Beyhan S, 2007, J BACTERIOL, V189, P388, DOI 10.1128/JB.00981-06; Browning DF, 2004, NAT REV MICROBIOL, V2, P57, DOI 10.1038/nrmicro787; Crooks GE, 2004, GENOME RES, V14, P1188, DOI 10.1101/gr.849004; Croxatto A, 2002, J BACTERIOL, V184, P1617, DOI 10.1128/JB.184.6.1617-1629.2002; de Kievit TR, 2000, INFECT IMMUN, V68, P4839, DOI 10.1128/IAI.68.9.4839-4849.2000; De Silva RS, 2007, J BACTERIOL, V189, P5683, DOI 10.1128/JB.01807-06; Fuqua C, 2002, NAT REV MOL CELL BIO, V3, P685, DOI 10.1038/nrm907; Higgins DA, 2007, NATURE, V450, P883, DOI 10.1038/nature06284; Jeong HG, 2008, J BACTERIOL, V190, P3768, DOI 10.1128/JB.00058-08; Jeong HS, 2003, J BIOL CHEM, V278, P45072, DOI 10.1074/jbc.M308184200; Jobling MG, 1997, MOL MICROBIOL, V26, P1023, DOI 10.1046/j.1365-2958.1997.6402011.x; Karp PD, 2005, NUCLEIC ACIDS RES, V33, P6083, DOI 10.1093/nar/gki892; Kovacikova G, 2002, MOL MICROBIOL, V46, P1135, DOI 10.1046/j.1365-2958.2002.03229.x; Lee BC, 2008, INFECT IMMUN, V76, P1509, DOI 10.1128/IAI.01503-07; Lee JH, 2007, J MICROBIOL, V45, P146; Lee JH, 2007, J MICROBIOL BIOTECHN, V17, P325; Lee JH, 2006, MOL MICROBIOL, V60, P513, DOI 10.1111/j.1365-2958.2006.05115.x; McCarter LL, 1998, J BACTERIOL, V180, P3166, DOI 10.1128/JB.180.12.3166-3173.1998; McDougald D, 2001, J BACTERIOL, V183, P758, DOI 10.1128/JB.183.2.758-762.2001; McDougald D, 2000, GENE, V248, P213, DOI 10.1016/S0378-1119(00)00117-7; McLeod SM, 2001, CURR OPIN MICROBIOL, V4, P152, DOI 10.1016/S1369-5274(00)00181-8; MEKALANOS JJ, 1992, J BACTERIOL, V174, P1; MILLER JF, 1989, SCIENCE, V243, P916, DOI 10.1126/science.2537530; Miller MB, 2001, ANNU REV MICROBIOL, V55, P165, DOI 10.1146/annurev.micro.55.1.165; Ochsner UA, 1996, P NATL ACAD SCI USA, V93, P4409, DOI 10.1073/pnas.93.9.4409; Rhee JE, 2005, J BACTERIOL, V187, P7870, DOI 10.1128/JB.187.22.7870-7875.2005; Roh JB, 2006, J BIOL CHEM, V281, P34775, DOI 10.1074/jbc.M607844200; Sambrook J., 2001, MOL CLONING LAB MANU; Shao CP, 2001, J BACTERIOL, V183, P1369, DOI 10.1128/JB.183.4.1369-1375.2001; SWARTZMAN E, 1993, J BIOL CHEM, V268, P16706; Waters CM, 2006, GENE DEV, V20, P2754, DOI 10.1101/gad.1466506; Waters CM, 2005, ANNU REV CELL DEV BI, V21, P319, DOI 10.1146/annurev.cellbio.21.012704.131001; Yildiz FH, 2004, MOL MICROBIOL, V53, P497, DOI 10.1111/j.1365-2958.2004.04154.x; Zhu J, 2002, P NATL ACAD SCI USA, V99, P3129, DOI 10.1073/pnas.052694299	34	39	39	1	4	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	AUG 29	2008	283	35					23610	23618		10.1074/jbc.M801480200	http://dx.doi.org/10.1074/jbc.M801480200			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	340II	18579523	Green Published, hybrid			2022-12-27	WOS:000258638900013
J	Pagel-Langenickel, I; Bao, JJ; Joseph, JJ; Schwartz, DR; Mantell, BS; Xu, XL; Raghavachari, N; Sack, MN				Pagel-Langenickel, Ines; Bao, Jianjun; Joseph, Joshua J.; Schwartz, Daniel R.; Mantell, Benjamin S.; Xu, Xiuli; Raghavachari, Nalini; Sack, Michael N.			PGC-1 alpha integrates insulin signaling, mitochondrial regulation, and bioenergetic function in skeletal muscle	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							TYPE-2 DIABETES-MELLITUS; ADIPOSE-TISSUE; FATTY-ACID; OXIDATIVE-METABOLISM; GENE-EXPRESSION; GLUCOSE; OVEREXPRESSION; ROSIGLITAZONE; RESISTANCE; PROTECTS	The pathophysiology underlying mitochondrial dysfunction in insulin-resistant skeletal muscle is incompletely characterized. To further delineate this we investigated the interaction between insulin signaling, mitochondrial regulation, and function in C2C12 myotubes and in skeletal muscle. In myotubes elevated insulin and glucose disrupt insulin signaling, mitochondrial biogenesis, and mitochondrial bioenergetics. The insulin-sensitizing thiazolidinedione pioglitazone restores these perturbations in parallel with induction of the mitochondrial biogenesis regulator PGC-1 alpha. Overexpression of PGC-1 alpha rescues insulin signaling and mitochondrial bioenergetics, and its silencing concordantly disrupts insulin signaling and mitochondrial bioenergetics. In primary skeletal myoblasts pioglitazone also up-regulates PGC-1 alpha expression and restores the insulin-resistant mitochondrial bioenergetic profile. In parallel, pioglitazone upregulates PGC-1 alpha in db/db mouse skeletal muscle. Interestingly, the small interfering RNA knockdown of the insulin receptor in C2C12 myotubes down-regulates PGC-1 alpha and attenuates mitochondrial bioenergetics. Concordantly, mitochondrial bioenergetics are blunted in insulin receptor knock-out mouse-derived skeletal myoblasts. Taken together these data demonstrate that elevated glucose and insulin impairs and pioglitazone restores skeletal myotube insulin signaling, mitochondrial regulation, and bioenergetics. Pioglitazone functions in part via the induction of PGC-1 alpha. Moreover, PGC-1 alpha is identified as a bidirectional regulatory link integrating insulin-signaling and mitochondrial homeostasis in skeletal muscle.	[Pagel-Langenickel, Ines; Bao, Jianjun; Joseph, Joshua J.; Schwartz, Daniel R.; Mantell, Benjamin S.; Sack, Michael N.] NHLBI, Natl Inst Hlth, Translat Med Branch, Bethesda, MD 20892 USA; [Xu, Xiuli; Raghavachari, Nalini] NHLBI, Natl Inst Hlth, Genom Core, Bethesda, MD 20892 USA	National Institutes of Health (NIH) - USA; NIH National Heart Lung & Blood Institute (NHLBI); National Institutes of Health (NIH) - USA; NIH National Heart Lung & Blood Institute (NHLBI)	Sack, MN (corresponding author), NHLBI, Natl Inst Hlth, Translat Med Branch, Bldg 10-CRC,Rm 5-3150,10 Ctr Dr, Bethesda, MD 20892 USA.	sackm@nhlbi.nih.gov	Mantell, Benjamin/ABE-2117-2020	Mantell, Benjamin/0000-0002-7700-6975; Joseph, Joshua/0000-0001-9169-8261	Intramural NIH HHS Funding Source: Medline; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [ZICHL006018, ZIAHL005199, Z01HL005199] Funding Source: NIH RePORTER	Intramural NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))		Accili D, 1996, NAT GENET, V12, P106, DOI 10.1038/ng0196-106; Arany Z, 2008, P NATL ACAD SCI USA, V105, P4721, DOI 10.1073/pnas.0800979105; Baur JA, 2006, NATURE, V444, P337, DOI 10.1038/nature05354; Befroy DE, 2007, DIABETES, V56, P1376, DOI 10.2337/db06-0783; Benton CR, 2008, J BIOL CHEM, V283, P4228, DOI 10.1074/jbc.M704332200; Blendea MC, 2005, AM J PHYSIOL-ENDOC M, V288, pE353, DOI 10.1152/ajpendo.00402.2004; Boden G, 2005, DIABETES, V54, P880, DOI 10.2337/diabetes.54.3.880; Bogacka I, 2005, DIABETES, V54, P1392, DOI 10.2337/diabetes.54.5.1392; Choi CS, 2007, J CLIN INVEST, V117, P1995, DOI 10.1172/JCI13579; Deeg MA, 2007, DIABETES CARE, V30, P2458, DOI 10.2337/dc06-1903; Garcia-Martinez C, 2001, FASEB J, V15, P2033, DOI 10.1096/fj.00-0828fje; Gates AC, 2007, CELL METAB, V6, P497, DOI 10.1016/j.cmet.2007.10.010; Gerhart-Hines Z, 2007, EMBO J, V26, P1913, DOI 10.1038/sj.emboj.7601633; Handschin C, 2007, J CLIN INVEST, V117, P3463, DOI 10.1172/JCI31785; Handschin C, 2007, J BIOL CHEM, V282, P30014, DOI 10.1074/jbc.M704817200; Hondares E, 2006, ENDOCRINOLOGY, V147, P2829, DOI 10.1210/en.2006-0070; Karlsson HKR, 2006, DIABETES, V55, P1283, DOI 10.2337/db05-0853; Lagouge M, 2006, CELL, V127, P1109, DOI 10.1016/j.cell.2006.11.013; Liu L, 2007, J CLIN INVEST, V117, P1679, DOI 10.1172/JCI30565; MARTIN BC, 1992, LANCET, V340, P925, DOI 10.1016/0140-6736(92)92814-V; Mensink M, 2007, INT J OBESITY, V31, P1302, DOI 10.1038/sj.ijo.0803567; Milne JC, 2007, NATURE, V450, P712, DOI 10.1038/nature06261; Miura S, 2003, J BIOL CHEM, V278, P31385, DOI 10.1074/jbc.M304312200; Mootha VK, 2003, NAT GENET, V34, P267, DOI 10.1038/ng1180; Morino K, 2005, J CLIN INVEST, V115, P3587, DOI 10.1172/JCI25151; Nissen SE, 2007, NEW ENGL J MED, V356, P2457, DOI 10.1056/NEJMoa072761; Pagel-Langenickel I, 2007, AM J PHYSIOL-HEART C, V293, pH2659, DOI 10.1152/ajpheart.00782.2007; Patti ME, 2003, P NATL ACAD SCI USA, V100, P8466, DOI 10.1073/pnas.1032913100; Petersen KF, 2004, NEW ENGL J MED, V350, P664, DOI 10.1056/NEJMoa031314; Petersen KF, 2007, P NATL ACAD SCI USA, V104, P12587, DOI 10.1073/pnas.0705408104; RANDO TA, 1994, J CELL BIOL, V125, P1275, DOI 10.1083/jcb.125.6.1275; Schuler M, 2006, CELL METAB, V4, P407, DOI 10.1016/j.cmet.2006.10.003; Skov V, 2007, DIABETES, V56, P2349, DOI 10.2337/db07-0275; St-Pierre J, 2003, J BIOL CHEM, V278, P26597, DOI 10.1074/jbc.M301850200; Storgaard H, 2001, DIABETES, V50, P2770, DOI 10.2337/diabetes.50.12.2770; Sun C, 2007, CELL METAB, V6, P307, DOI 10.1016/j.cmet.2007.08.014; Wan YH, 2007, NAT MED, V13, P1496, DOI 10.1038/nm1672; Wei M, 1999, ANN INTERN MED, V130, P89, DOI 10.7326/0003-4819-130-2-199901190-00002; Wende AR, 2007, J BIOL CHEM, V282, P36642, DOI 10.1074/jbc.M707006200; Wilson-Fritch L, 2004, J CLIN INVEST, V114, P1281, DOI 10.1172/JCI200421752; Yaspelkis BB, 2007, AM J PHYSIOL-ENDOC M, V293, pE941, DOI 10.1152/ajpendo.00230.2007	41	92	96	0	8	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	AUG 15	2008	283	33					22464	22472		10.1074/jbc.M800842200	http://dx.doi.org/10.1074/jbc.M800842200			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	335VR	18579525	Green Published, hybrid			2022-12-27	WOS:000258321000014
J	Wang, XM; Fonseca, BD; Tang, H; Liu, R; Elia, A; Clemens, MJ; Bommer, UA; Proud, CG				Wang, Xuemin; Fonseca, Bruno D.; Tang, Hua; Liu, Rui; Elia, Androulla; Clemens, Michael J.; Bommer, Ulrich-Axel; Proud, Christopher G.			Re-evaluating the Roles of Proposed Modulators of Mammalian Target of Rapamycin Complex 1 (mTORC1) Signaling	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							POLYPEPTIDE-CHAIN INITIATION; NUCLEOTIDE-EXCHANGE FACTOR; TRANSFER-RNA-SYNTHETASES; SMALL GTPASE RHEB; AMINO-ACIDS; TRANSLATIONAL CONTROL; S6 KINASE; PROTEIN; PHOSPHORYLATION; FKBP38	Signaling through mammalian target of rapamycin complex 1 (mTORC1) is stimulated by amino acids and insulin. Insulin inactivates TSC1/2, the GTPase-activator complex for Rheb, and Rheb.GTP activates mTORC1. It is not clear how amino acids regulate mTORC1. FKBP38 (immunophilin FK506-binding protein, 38 kDa), was recently reported to exert a negative effect on mTORC1 function that is relieved by its binding to Rheb.GTP. We confirm that Rheb binds wild type FKBP38, but inactive Rheb mutants showed contrasting abilities to bind FKBP38. We were unable to observe any regulation of FKBP38/mTOR binding by amino acids or insulin. Furthermore, FKBP38 did not inhibit mTORC1 signaling. The translationally controlled tumor protein (TCTP) in Drosophila was recently reported to act as the guanine nucleotide-exchange factor for Rheb. We have studied the role of TCTP in mammalian TORC1 signaling and its control by amino acids. Reducing TCTP levels did not reproducibly affect mTORC1 signaling in amino acid-replete/insulin-stimulated cells. Moreover, overexpressing TCTP did not rescue mTORC1 signaling in amino acid-starved cells. In addition, we were unable to see any stable interaction between TCTP and Rheb or mTORC1. Accumulation of uncharged tRNA has been previously proposed to be involved in the inhibition of mTORC1 signaling during amino acid starvation. To test this hypothesis, we used a Chinese hamster ovary cell line containing a temperature-sensitive mutation in leucyl-tRNA synthetase. Leucine deprivation markedly inhibited mTORC1 signaling in these cells, but shifting the cells to the nonpermissive temperature for the synthetase did not. These data indicate that uncharged tRNALeu does not switch off mTORC1 signaling and suggest that mTORC1 is controlled by a distinct pathway that senses the availability of amino acids. Our data also indicate that, in the mammalian cell lines tested here, neither TCTP nor FKBP38 regulates mTORC1 signaling.	[Wang, Xuemin; Fonseca, Bruno D.; Tang, Hua; Liu, Rui; Proud, Christopher G.] Univ British Columbia, Dept Biochem & Mol Biol, Vancouver, BC V6T 1Z3, Canada; [Elia, Androulla] St Georges Univ London, Div Basic Med Sci, London SW17 0RE, England; [Clemens, Michael J.] Univ Sussex, Sch Life Sci, Dept Biochem, Brighton BN1 9QG, E Sussex, England; [Bommer, Ulrich-Axel] Univ Wollongong, Grad Sch Med, Wollongong, NSW 2522, Australia	University of British Columbia; St Georges University London; University of Sussex; University of Wollongong	Proud, CG (corresponding author), Univ British Columbia, Dept Biochem & Mol Biol, 2350 Hlth Sci Mall, Vancouver, BC V6T 1Z3, Canada.	C.G.Proud@soton.ac.uk	Elia, Androulla/AAE-6854-2021; LIU, RUI/P-1991-2019	Proud, Christopher/0000-0003-0704-6442; Bommer, Ulrich/0000-0003-1110-7615	Canadian Institutes of Health Research; Ajinomoto Amino Acid Research Program; University of British Columbia; Wellcome Trust; Ralph Bates Cancer Research Fund	Canadian Institutes of Health Research(Canadian Institutes of Health Research (CIHR)); Ajinomoto Amino Acid Research Program; University of British Columbia; Wellcome Trust(Wellcome TrustEuropean Commission); Ralph Bates Cancer Research Fund	This work was supported by grants from the Canadian Institutes of Health Research, the Ajinomoto Amino Acid Research Program, and the University of British Columbia (to C. G. P.), from the Wellcome Trust (to U. A. B., A. E., and M. J. C.), and from the Ralph Bates Cancer Research Fund (to A. E. and M. J. C.). The costs of publication of this article were defrayed in part by the payment of page charges. This article must therefore be hereby marked "advertisement" in accordance with 18 U. S. C. Section 1734 solely to indicate this fact.	AUSTIN SA, 1986, EUR J BIOCHEM, V157, P39, DOI 10.1111/j.1432-1033.1986.tb09635.x; Avruch J, 2006, ONCOGENE, V25, P6361, DOI 10.1038/sj.onc.1209882; Avruch J, 2001, Prog Mol Subcell Biol, V26, P115; Bai XC, 2007, SCIENCE, V318, P977, DOI 10.1126/science.1147379; Basso AD, 2005, J BIOL CHEM, V280, P31101, DOI 10.1074/jbc.M503763200; Berlanga JJ, 1999, EUR J BIOCHEM, V265, P754, DOI 10.1046/j.1432-1327.1999.00780.x; Beugnet A, 2003, BIOCHEM J, V372, P555, DOI 10.1042/BJ20021266; Bommer UA, 2004, INT J BIOCHEM CELL B, V36, P379, DOI 10.1016/S1357-2725(03)00213-9; Browne GJ, 2004, MOL CELL BIOL, V24, P2986, DOI 10.1128/MCB.24.7.2986-2997.2004; Byfield MP, 2005, J BIOL CHEM, V280, P33076, DOI 10.1074/jbc.M507201200; Cans C, 2003, P NATL ACAD SCI USA, V100, P13892, DOI 10.1073/pnas.2335950100; Castro AF, 2003, J BIOL CHEM, V278, P32493, DOI 10.1074/jbc.C300226200; Chen SH, 2007, MOL BIOL CELL, V18, P2525, DOI 10.1091/mbc.E07-02-0188; CLEMENS MJ, 1987, J BIOL CHEM, V262, P767; Easton JB, 2006, ONCOGENE, V25, P6436, DOI 10.1038/sj.onc.1209886; Edlich F, 2005, EMBO J, V24, P2688, DOI 10.1038/sj.emboj.7600739; Edlich F, 2007, J BIOL CHEM, V282, P36496, DOI 10.1074/jbc.M705061200; Edlich F, 2007, J BIOL CHEM, V282, P15341, DOI 10.1074/jbc.M611594200; Erdmann F, 2007, FEBS LETT, V581, P5709, DOI 10.1016/j.febslet.2007.11.037; Findlay GM, 2007, BIOCHEM J, V403, P13, DOI 10.1042/BJ20061881; Fonseca BD, 2007, J BIOL CHEM, V282, P24514, DOI 10.1074/jbc.M704406200; Gachet Y, 1999, J CELL SCI, V112, P1257; Hsu YC, 2007, NATURE, V445, P785, DOI 10.1038/nature05528; Iiboshi Y, 1999, J BIOL CHEM, V274, P1092, DOI 10.1074/jbc.274.2.1092; Kimball SR, 2006, J NUTR, V136, p227S, DOI 10.1093/jn/136.1.227S; Land SC, 2007, J BIOL CHEM, V282, P20534, DOI 10.1074/jbc.M611782200; Lee CH, 2007, ANNU REV PHARMACOL, V47, P443, DOI 10.1146/annurev.pharmtox.47.120505.105359; Li Y, 2004, MOL CELL BIOL, V24, P7965, DOI 10.1128/MCB.24.18.7965-7975.2004; Long X, 2005, CURR BIOL, V15, P702, DOI 10.1016/j.cub.2005.02.053; Long XM, 2005, J BIOL CHEM, V280, P23433, DOI 10.1074/jbc.C500169200; Manning BD, 2003, TRENDS BIOCHEM SCI, V28, P573, DOI 10.1016/j.tibs.2003.09.003; MOORE PA, 1977, J BIOL CHEM, V252, P7427; Nobukuni T, 2005, P NATL ACAD SCI USA, V102, P14238, DOI 10.1073/pnas.0506925102; OLDFIELD S, 1992, EUR J BIOCHEM, V208, P73, DOI 10.1111/j.1432-1033.1992.tb17160.x; Pham PTT, 2000, J CELL BIOCHEM, V79, P427, DOI 10.1002/1097-4644(20001201)79:3<427::AID-JCB80>3.0.CO;2-0; POLLARD JW, 1989, EUR J BIOCHEM, V182, P1, DOI 10.1111/j.1432-1033.1989.tb14793.x; POLLARD JW, 1979, J CELL PHYSIOL, V98, P571, DOI 10.1002/jcp.1040980315; Proud CG, 2005, SEMIN CELL DEV BIOL, V16, P3, DOI 10.1016/j.semcdb.2004.11.004; Roccio M, 2006, ONCOGENE, V25, P657, DOI 10.1038/sj.onc.1209106; Rosner M, 2003, ONCOGENE, V22, P4786, DOI 10.1038/sj.onc.1206776; Sarbassov DD, 2005, SCIENCE, V307, P1098, DOI 10.1126/science.1106148; Shirane M, 2003, NAT CELL BIOL, V5, P28, DOI 10.1038/ncb894; Smith EM, 2005, J BIOL CHEM, V280, P18717, DOI 10.1074/jbc.M414499200; Sood R, 2000, GENETICS, V154, P787; Tee AR, 2003, CURR BIOL, V13, P1259, DOI 10.1016/S0960-9822(03)00506-2; Thaw P, 2001, NAT STRUCT BIOL, V8, P701, DOI 10.1038/90415; THOMPSON LH, 1973, P NATL ACAD SCI USA, V70, P3094, DOI 10.1073/pnas.70.11.3094; Walker VE, 2007, J BIOL CHEM, V282, P23509, DOI 10.1074/jbc.M701006200; Wang HQ, 2005, HUM MOL GENET, V14, P1889, DOI 10.1093/hmg/ddi195; Wang XM, 2005, MOL CELL BIOL, V25, P2558, DOI 10.1128/MCB.25.7.2558-2572.2005; Wang XM, 1998, BIOCHEM J, V334, P261, DOI 10.1042/bj3340261; Wang XM, 2008, MOL CELL BIOL, V28, P1429, DOI 10.1128/MCB.01512-07; Wang XM, 2006, PHYSIOLOGY, V21, P362, DOI 10.1152/physiol.00024.2006; Wullschleger S, 2006, CELL, V124, P471, DOI 10.1016/j.cell.2006.01.016; Yang Q, 2007, CELL RES, V17, P666, DOI 10.1038/cr.2007.64	55	116	135	0	19	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 7	2008	283	45					30482	30492		10.1074/jbc.M803348200	http://dx.doi.org/10.1074/jbc.M803348200			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	367ID	18676370	Green Published, hybrid			2022-12-27	WOS:000260544800006
J	Pietroni, P; von Hippel, PH				Pietroni, Paola; von Hippel, Peter H.			Multiple ATP binding is required to stabilize the "Activated" (clamp open) clamp loader of the T4 DNA replication complex	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ACCESSORY PROTEIN COMPLEX; POLYMERASE-III HOLOENZYME; CELL NUCLEAR ANTIGEN; ESCHERICHIA-COLI; SLIDING CLAMP; GAMMA-COMPLEX; FACTOR-C; CRYSTAL-STRUCTURE; MECHANISM; SYSTEM	Most DNA replication systems include a sliding clamp that encircles the genomic DNA and links the polymerase to the template to control polymerase processivity. A loading complex is required to open the clamp and place it onto the DNA. In phage T4 this complex consists of a trimeric clamp of gp45 subunits and a pentameric loader assembly of four gp44 and one gp62 subunit(s), with clamp loading driven by ATP binding. We measure this binding as a function of input ligand concentration and show that four ATPs bind to the gp44/62 complex with equal affinity. In contrast, the ATPase rate profile of the clamp-clamp loader complex exhibits a marked peak at an input ATP concentration close to the overall K-d (similar to 30 mu M), with further increases in bound ATP decreasing the ATPase rate to a much lower level. Thus the progressive binding of the four ATPs triggers a conformational change in the complex that markedly inhibits ATPase activity. This inhibition is related to ring opening by using a clamp that is covalently cross-linked across its subunit interfaces and thus rendered incapable of opening. Binding of this clamp abolishes substrate inhibition of the ATPase but leaves ATP binding unchanged. We show that four ATP ligands must bind to the T4 clamp loader before the loader can be fully "activated" and the clamp opened, and that ATP hydrolysis is required only for release of the loader complex after clamp loading onto the replication fork has been completed.	[von Hippel, Peter H.] Univ Oregon, Inst Mol Biol, Eugene, OR 97403 USA; Univ Oregon, Dept Chem, Eugene, OR 97403 USA	University of Oregon; University of Oregon	von Hippel, PH (corresponding author), Univ Oregon, Inst Mol Biol, Eugene, OR 97403 USA.	petevh@molbio.uoregon.edu		von Hippel, Peter H./0000-0003-2512-8097	National Institutes of Health [GM-15792, GM-29158]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM029158, R01GM015792, R37GM015792] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported, in whole or in part, by National Institutes of Health Grants GM-15792 and GM-29158. The costs of publication of this article were defrayed in part by the payment of page charges. This article must therefore be hereby marked "advertisement" in accordance with 18 U. S. C. Section 1734 solely to indicate this fact.	Alley SC, 1999, BIOCHEMISTRY-US, V38, P7696, DOI 10.1021/bi9827971; Bowman GD, 2004, NATURE, V429, P724, DOI 10.1038/nature02585; CULLMANN G, 1995, MOL CELL BIOL, V15, P4661; Davey MJ, 2002, NAT REV MOL CELL BIO, V3, P826, DOI 10.1038/nrm949; Georgescu RE, 2008, CELL, V132, P43, DOI 10.1016/j.cell.2007.11.045; Gomes XV, 2001, J BIOL CHEM, V276, P34776, DOI 10.1074/jbc.M011743200; Gomes XV, 2001, J BIOL CHEM, V276, P34768, DOI 10.1074/jbc.M011631200; Hingorani MM, 2000, CURR BIOL, V10, pR25, DOI 10.1016/S0960-9822(99)00252-3; Hingorani MM, 1998, J BIOL CHEM, V273, P24550, DOI 10.1074/jbc.273.38.24550; HUANG CC, 1981, J BIOL CHEM, V256, P4087; JARVIS TC, 1990, J BIOL CHEM, V265, P15160; JARVIS TC, 1989, J BIOL CHEM, V264, P12717; JARVIS TC, 1989, J BIOL CHEM, V264, P12709; Jeruzalmi D, 2001, CELL, V106, P429, DOI 10.1016/S0092-8674(01)00463-9; Jeruzalmi D, 2001, CELL, V106, P417, DOI 10.1016/S0092-8674(01)00462-7; Johnson A, 2003, J BIOL CHEM, V278, P14406, DOI 10.1074/jbc.M212708200; Johnson A, 2006, J BIOL CHEM, V281, P35531, DOI 10.1074/jbc.M606090200; KABOORD BF, 1995, CURR BIOL, V5, P149, DOI 10.1016/S0960-9822(95)00036-4; Latham GJ, 1999, P NATL ACAD SCI USA, V96, P12448, DOI 10.1073/pnas.96.22.12448; MAKI S, 1988, J BIOL CHEM, V263, P6561; Moarefi I, 2000, J MOL BIOL, V296, P1215, DOI 10.1006/jmbi.1999.3511; Neuwald AF, 1999, GENOME RES, V9, P27; ODONNELL M, 1993, NUCLEIC ACIDS RES, V21, P1, DOI 10.1093/nar/21.1.1; Ogura T, 2001, GENES CELLS, V6, P575, DOI 10.1046/j.1365-2443.2001.00447.x; Pietroni P, 2001, J MOL BIOL, V309, P869, DOI 10.1006/jmbi.2001.4687; RUSH J, 1989, J BIOL CHEM, V264, P10943; Snyder AK, 2004, J BIOL CHEM, V279, P4386, DOI 10.1074/jbc.M310430200; STUKENBERG PT, 1991, J BIOL CHEM, V266, P11328; Turner J, 1999, EMBO J, V18, P771, DOI 10.1093/emboj/18.3.771; von Hippel PH, 2007, ANNU REV BIOPH BIOM, V36, P79, DOI 10.1146/annurev.biophys.34.040204.144521; Williams CR, 2004, J BIOL CHEM, V279, P4376, DOI 10.1074/jbc.M310429200; Young MC, 1996, J MOL BIOL, V264, P440, DOI 10.1006/jmbi.1996.0652	32	19	20	0	0	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	OCT 17	2008	283	42					28338	28353		10.1074/jbc.M804371200	http://dx.doi.org/10.1074/jbc.M804371200			16	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	359EN	18676368	Green Published, hybrid			2022-12-27	WOS:000259969300036
J	Cheng, TF; Hu, XP; Gnatt, A; Brooks, PJ				Cheng, Tsu-Fan; Hu, Xiaopeng; Gnatt, Averell; Brooks, Philip J.			Differential blocking effects of the acetaldehyde-derived DNA lesion N-2-ethyl-2 '-deoxyguanosine on transcription by multisubunit and single subunit RNA polymerases	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							STRUCTURAL BASIS; NUCLEOSIDE TRIPHOSPHATES; TRANSLESION SYNTHESIS; ELONGATION COMPLEXES; ALLOSTERIC BINDING; ADDUCTS; MECHANISM; BACTERIAL; CLEAVAGE; BYPASS	Acetaldehyde, the first metabolite of ethanol, reacts with DNA to form adducts, including N-2-ethyl-2'-deoxyguanosine (N-2-Et-dG). Although the effects of N-2-Et-dG on DNA polymerases have been well studied, nothing is known about possible effects of this lesion on transcription by RNA polymerases (RNAPs). Using primer extension assays in vitro, we found that a single N-2-Et-dG lesion is a strong block to both mammalian RNAPII and two other multisubunit RNAPs, (yeast RNAPII and Escherichia coli RNAP), as well as to T7 RNAP. However, the mechanism of transcription blockage appears to differ between the multisubunit RNAPs and T7 RNAP. Specifically, all three of the multisubunit RNAPs can incorporate a single rNTP residue opposite the lesion, whereas T7 RNAP is essentially unable to do so. Using the mammalian RNAPII, we found that CMP is exclusively incorporated opposite the N-2-Et-dG lesion. In addition, we also show that the accessory transcription factor TFIIS does not act as a lesion bypass factor, as it does for other nonbulky DNA lesions; instead, it stimulates the polymerase to remove the CMP incorporated opposite the lesion by mammalian RNAPII. We also include models of the N-2-Et-dG within the active site of yeast RNAPII, which are compatible with our observations.	[Cheng, Tsu-Fan; Brooks, Philip J.] NIAAA, Mol Neurobiol Sect, Neurogenet Lab, Bethesda, MD 20892 USA; [Hu, Xiaopeng; Gnatt, Averell] Univ Maryland, Sch Med, Dept Pharmacol & Expt Therapeut, Baltimore, MD 21201 USA	National Institutes of Health (NIH) - USA; NIH National Institute on Alcohol Abuse & Alcoholism (NIAAA); University System of Maryland; University of Maryland Baltimore	Brooks, PJ (corresponding author), NIAAA, Mol Neurobiol Sect, Neurogenet Lab, 5625 Fishers Ln,Rm 3S-32, Rockville, MD 20852 USA.	pjbrooks@mail.nih.gov			Division of Clinical and Intramural Research; National Institute on Alcohol Abuse and Alcoholism; NATIONAL INSTITUTE ON ALCOHOL ABUSE AND ALCOHOLISM [Z01AA000083, ZIAAA000083] Funding Source: NIH RePORTER	Division of Clinical and Intramural Research; National Institute on Alcohol Abuse and Alcoholism(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Alcohol Abuse & Alcoholism (NIAAA)); NATIONAL INSTITUTE ON ALCOHOL ABUSE AND ALCOHOLISM(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Alcohol Abuse & Alcoholism (NIAAA))	This work was supported by the Division of Clinical and Intramural Research, National Institute on Alcohol Abuse and Alcoholism. The costs of publication of this article were defrayed in part by the payment of page charges. This article must therefore be hereby marked "advertisement" in accordance with 18 U. S. C. Section 1734 solely to indicate this fact.	Baan R, 2007, LANCET ONCOL, V8, P292, DOI 10.1016/S1470-2045(07)70099-2; Brooks PJ, 2005, ALCOHOL, V35, P187, DOI 10.1016/j.alcohol.2005.03.009; Charlet-Berguerand N, 2006, EMBO J, V25, P5481, DOI 10.1038/sj.emboj.7601403; Chen L, 2007, CHEM RES TOXICOL, V20, P108, DOI 10.1021/tx060232x; Choi JY, 2006, J BIOL CHEM, V281, P21062, DOI 10.1074/jbc.M602246200; Choi JY, 2006, J BIOL CHEM, V281, P12315, DOI 10.1074/jbc.M600112200; Choi JY, 2005, J MOL BIOL, V352, P72, DOI 10.1016/j.jmb.2005.06.079; Crabb DW, 2004, P NUTR SOC, V63, P49, DOI 10.1079/PNS2003327; DELLARCO VL, 1988, MUTAT RES, V195, P1, DOI 10.1016/0165-1110(88)90013-9; Dimitri A, 2008, J MOL BIOL, V375, P353, DOI 10.1016/j.jmb.2007.10.057; DONAHUE BA, 1994, P NATL ACAD SCI USA, V91, P8502, DOI 10.1073/pnas.91.18.8502; FANG JL, 1997, CARCINOGENESIS, V18, P632; Fish RN, 2002, BBA-GENE STRUCT EXPR, V1577, P287, DOI 10.1016/S0167-4781(02)00459-1; Foster JE, 2001, CELL, V106, P243, DOI 10.1016/S0092-8674(01)00420-2; FRAENKELCONRAT H, 1988, P NATL ACAD SCI USA, V85, P3758, DOI 10.1073/pnas.85.11.3758; Gnatt A, 1997, J BIOL CHEM, V272, P30799, DOI 10.1074/jbc.272.49.30799; Hecht SS, 2001, TOXICOLOGY, V166, P31, DOI 10.1016/S0300-483X(01)00436-X; Holmes SF, 2003, J BIOL CHEM, V278, P35597, DOI 10.1074/jbc.M304496200; Hu X, 2006, P NATL ACAD SCI USA, V103, P9506, DOI 10.1073/pnas.0603702103; Inagaki S, 2004, BIOL PHARM BULL, V27, P273, DOI 10.1248/bpb.27.273; IZBAN MG, 1993, J BIOL CHEM, V268, P12874; Kashkina E, 2006, MOL CELL, V24, P257, DOI 10.1016/j.molcel.2006.10.001; Kettenberger H, 2003, CELL, V114, P347, DOI 10.1016/S0092-8674(03)00598-1; Kireeva ML, 2000, J BIOL CHEM, V275, P6530, DOI 10.1074/jbc.275.9.6530; Koivisto P, 2004, J BIOL CHEM, V279, P40470, DOI 10.1074/jbc.M407960200; Komissarova N, 2003, METHOD ENZYMOL, V371, P233; Kuraoka I, 2007, DNA REPAIR, V6, P841, DOI 10.1016/j.dnarep.2007.01.014; MASTERS BS, 1987, CELL, V51, P89, DOI 10.1016/0092-8674(87)90013-4; Matsuda T, 1999, BIOCHEMISTRY-US, V38, P929, DOI 10.1021/bi982134j; Matsuda T, 2006, CHEM RES TOXICOL, V19, P1374, DOI 10.1021/tx060113h; Nedialkov YA, 2003, J BIOL CHEM, V278, P18303, DOI 10.1074/jbc.M301103200; Ogawa H, 2000, INT J BIOCHEM CELL B, V32, P289, DOI 10.1016/S1357-2725(99)00113-2; Perrino FW, 2003, CHEM RES TOXICOL, V16, P1616, DOI 10.1021/tx034164f; Pomerantz RT, 2006, MOL CELL, V24, P245, DOI 10.1016/j.molcel.2006.08.014; Prakash S, 2005, ANNU REV BIOCHEM, V74, P317, DOI 10.1146/annurev.biochem.74.082803.133250; Svetlov V, 2004, J BIOL CHEM, V279, P38087, DOI 10.1074/jbc.C400316200; Temiakov D, 2004, CELL, V116, P381, DOI 10.1016/S0092-8674(04)00059-5; Theruvathu JA, 2005, NUCLEIC ACIDS RES, V33, P3513, DOI 10.1093/nar/gki661; Thomas MJ, 1998, CELL, V93, P627, DOI 10.1016/S0092-8674(00)81191-5; Tornaletti S, 2005, MUTAT RES-FUND MOL M, V577, P131, DOI 10.1016/j.mrfmmm.2005.03.014; Upton DC, 2006, CHEM RES TOXICOL, V19, P960, DOI 10.1021/tx060084a; Upton DC, 2006, MUTAT RES-FUND MOL M, V599, P1, DOI 10.1016/j.mrfmmm.2005.12.014; VACA CE, 1995, CHEM-BIOL INTERACT, V98, P51, DOI 10.1016/0009-2797(95)03632-V; Vassylyev DG, 2007, NATURE, V448, P163, DOI 10.1038/nature05931; VRIEND G, 1990, J MOL GRAPHICS, V8, P52, DOI 10.1016/0263-7855(90)80070-V; Wang D, 2006, CELL, V127, P941, DOI 10.1016/j.cell.2006.11.023; Wang M, 2000, CHEM RES TOXICOL, V13, P1149, DOI 10.1021/tx000118t; Wang MY, 2006, CHEM RES TOXICOL, V19, P319, DOI 10.1021/tx0502948; Westover KD, 2004, CELL, V119, P481, DOI 10.1016/j.cell.2004.10.016; Wind M, 2000, BIOESSAYS, V22, P327, DOI 10.1002/(SICI)1521-1878(200004)22:4<327::AID-BIES3>3.0.CO;2-4; Yin YW, 2004, CELL, V116, P393, DOI 10.1016/S0092-8674(04)00120-5; Zhang CF, 2004, J MOL BIOL, V342, P1085, DOI 10.1016/j.jmb.2004.07.070	52	17	17	0	0	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	OCT 10	2008	283	41					27820	27828		10.1074/jbc.M804086200	http://dx.doi.org/10.1074/jbc.M804086200			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	355OW	18669632	Green Published, hybrid			2022-12-27	WOS:000259719200053
J	Olivier, NB; Imperiali, B				Olivier, Nelson B.; Imperiali, Barbara			Crystal structure and catalytic mechanism of PglD from Campylobacter jejuni	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							N-ACETYLGLUCOSAMINE ACYLTRANSFERASE; GENERAL PROTEIN GLYCOSYLATION; ESCHERICHIA-COLI; ACTIVE-SITE; SERINE ACETYLTRANSFERASE; ANTECEDENT INFECTIONS; LINKED GLYCAN; BETA-HELIX; BIOSYNTHESIS; IDENTIFICATION	The carbohydrate 2,4-diacetamido-2,4,6-trideoxy-alpha-D-glucopyranose (BacAc(2)) is found in a variety of eubacterial pathogens. In Campylobacter jejuni, PglD acetylates the C4 amino group on UDP-2-acetamido-4-amino-2,4,6-trideoxy-alpha-D-glucopyranose (UDP-4-amino-sugar) to form UDP-BacAc2. Sequence analysis predicts PglD to be a member of the left-handed beta helix family of enzymes. However, poor sequence homology between PglD and left-handed beta helix enzymes with existing structural data precludes unambiguous identification of the active site. The co-crystal structures of PglD in the presence of citrate, acetyl coenzyme A, or the UDP-4-amino-sugar were solved. The biological assembly is a trimer with one active site formed between two protomers. Residues lining the active site were identified, and results from functional assays on alanine mutants suggest His-125 is critical for catalysis, whereas His-15 and His-134 are involved in substrate binding. These results are discussed in the context of implications for proteins homologous to PglD in other pathogens.	MIT, Dept Chem, Cambridge, MA 02139 USA; MIT, Dept Biol, Cambridge, MA 02139 USA	Massachusetts Institute of Technology (MIT); Massachusetts Institute of Technology (MIT)	Imperiali, B (corresponding author), MIT, 77 Massachusetts Ave,18-590, Cambridge, MA 02090 USA.	imper@mit.edu		Imperiali, Barbara/0000-0002-5749-7869	National Institutes of Health [F32GM075415, GM39334]; NIGMS; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [F32GM075415, R01GM039334, R29GM039334] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NIGMS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported, in whole or in part, by National Institutes of Health Grant Post-doctoral Fellowship F32GM075415 (NIGMS; to N. B. O.) and Grant GM39334 (to B. I.). The costs of publication of this article were defrayed in part by the payment of page charges. This article must therefore be hereby marked "advertisement" in accordance with 18 U.S.C. Section 1734 solely to indicate this fact.	Aas FE, 2007, MOL MICROBIOL, V65, P607, DOI 10.1111/j.1365-2958.2007.05806.x; ANDERSON MS, 1993, J BIOL CHEM, V268, P19858; Baar C, 2003, P NATL ACAD SCI USA, V100, P11690, DOI 10.1073/pnas.1932838100; BAILEY S, 1994, ACTA CRYSTALLOGR D, V50, P760, DOI 10.1107/s0907444994003112; Beaman TW, 1998, BIOCHEMISTRY-US, V37, P6689, DOI 10.1021/bi980106v; Beaman TW, 1997, BIOCHEMISTRY-US, V36, P489, DOI 10.1021/bi962522q; BOUDAVARI S, 1996, MERCK INDEX, P636; BRUNGER AT, 1993, ACTA CRYSTALLOGR D, V49, P24, DOI 10.1107/S0907444992007352; Brunger AT, 1998, ACTA CRYSTALLOGR D, V54, P905, DOI 10.1107/S0907444998003254; Buetow L, 2007, P NATL ACAD SCI USA, V104, P4321, DOI 10.1073/pnas.0606356104; Chen GQ, 1997, P NATL ACAD SCI USA, V94, P13431, DOI 10.1073/pnas.94.25.13431; DICKER IB, 1992, MOL MICROBIOL, V6, P817, DOI 10.1111/j.1365-2958.1992.tb01532.x; Emsley P, 2004, ACTA CRYSTALLOGR D, V60, P2126, DOI 10.1107/S0907444904019158; Field RA, 2003, BIOCHEMISTRY-US, V42, P7637, DOI 10.1021/bi0345079; FRENCH S, 1978, ACTA CRYSTALLOGR A, V34, P517, DOI 10.1107/S0567739478001114; Guerrero SA, 2001, APPL MICROBIOL BIOT, V56, P718, DOI 10.1007/s002530100690; Hegge FT, 2004, P NATL ACAD SCI USA, V101, P10798, DOI 10.1073/pnas.0402397101; Hendrixson DR, 2004, MOL MICROBIOL, V52, P471, DOI 10.1111/j.1365-2958.2004.03988.x; Jacobs BC, 1998, NEUROLOGY, V51, P1110, DOI 10.1212/WNL.51.4.1110; Johnson CM, 2004, BIOCHEMISTRY-US, V43, P15534, DOI 10.1021/bi048450h; JONES TA, 1991, ACTA CRYSTALLOGR A, V47, P110, DOI 10.1107/S0108767390010224; Kehoe LE, 2003, J BIOL CHEM, V278, P29963, DOI 10.1074/jbc.M303766200; Kelly J, 2006, J BACTERIOL, V188, P2427, DOI 10.1128/JB.188.7.2427-2434.2006; Kisker C, 1996, EMBO J, V15, P2323, DOI 10.1002/j.1460-2075.1996.tb00588.x; Koga M, 2005, NEUROLOGY, V64, P1605, DOI 10.1212/01.WNL.0000160399.08456.7C; Larsen JC, 2004, J BACTERIOL, V186, P6508, DOI 10.1128/JB.186.19.6508-6514.2004; LEWENDON A, 1995, J BIOL CHEM, V270, P26326, DOI 10.1074/jbc.270.44.26326; Lewis AL, 2006, J BIOL CHEM, V281, P11186, DOI 10.1074/jbc.M513772200; MESCHER MF, 1976, J BIOL CHEM, V251, P2005; Murshudov GN, 1997, ACTA CRYSTALLOGR D, V53, P240, DOI 10.1107/S0907444996012255; Olivier NB, 2006, BIOCHEMISTRY-US, V45, P13659, DOI 10.1021/bi061456h; Olsen LR, 2007, PROTEIN SCI, V16, P1230, DOI 10.1110/ps.072779707; Oyston PCF, 2004, NAT REV MICROBIOL, V2, P967, DOI 10.1038/nrmicro1045; Perrakis A, 2001, ACTA CRYSTALLOGR D, V57, P1445, DOI 10.1107/S0907444901014007; Pye VE, 2004, J BIOL CHEM, V279, P40729, DOI 10.1074/jbc.M403751200; RAETZ CRH, 1995, SCIENCE, V270, P997, DOI 10.1126/science.270.5238.997; Rangarajan ES, 2008, BIOCHEMISTRY-US, V47, P1827, DOI 10.1021/bi702032r; REES JH, 1995, NEW ENGL J MED, V333, P1374, DOI 10.1056/NEJM199511233332102; RENDEFOURNIER R, 1993, ANTIMICROB AGENTS CH, V37, P2119, DOI 10.1128/AAC.37.10.2119; Schoenhofen IC, 2006, J BIOL CHEM, V281, P723, DOI 10.1074/jbc.M511021200; Stafford WF, 2004, BIOPHYS CHEM, V108, P231, DOI 10.1016/j.bpc.2003.10.028; Sugantino M, 2002, BIOCHEMISTRY-US, V41, P2209, DOI 10.1021/bi011991b; Sulzenbacher G, 2001, J BIOL CHEM, V276, P11844, DOI 10.1074/jbc.M011225200; Szymanski CM, 1999, MOL MICROBIOL, V32, P1022, DOI 10.1046/j.1365-2958.1999.01415.x; Tian Y, 1997, PROTEINS, V28, P298; VAARA M, 1992, FEMS MICROBIOL LETT, V97, P249, DOI 10.1016/0378-1097(92)90344-N; Wang XG, 2002, STRUCTURE, V10, P581, DOI 10.1016/S0969-2126(02)00741-4; Weerapana E, 2006, GLYCOBIOLOGY, V16, p91R, DOI 10.1093/glycob/cwj099; Young NM, 2002, J BIOL CHEM, V277, P42530, DOI 10.1074/jbc.M206114200; ZEHAVI U, 1973, J BIOL CHEM, V248, P433	50	36	37	0	4	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	OCT 10	2008	283	41					27937	27946		10.1074/jbc.M801207200	http://dx.doi.org/10.1074/jbc.M801207200			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	355OW	18667421	hybrid, Green Published			2022-12-27	WOS:000259719200064
J	Tremp, AZ; Khater, EI; Dessens, JT				Tremp, Annie Z.; Khater, Emad I.; Dessens, Johannes T.			IMC1b is a putative membrane skeleton protein involved in cell shape, mechanical strength, motility, and infectivity of malaria ookinetes	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							PLASMODIUM-BERGHEI; TOXOPLASMA-GONDII; GLIDING MOTILITY; MOSQUITO MIDGUT; PARASITE; INVASION; OOCYST; CTRP; TRANSFORMATION; CYTOSKELETON	Membrane skeletons are cytoskeletal elements that have important roles in cell development, shape, and structural integrity. Malaria parasites encode a conserved family of putative membrane skeleton proteins related to articulins. One member, IMC1a, is expressed in sporozoites and localizes to the pellicle, a unique membrane complex believed to form a scaffold onto which the ligands and glideosome are arranged to mediate parasite motility and invasion. IMC1b is a closely related structural paralogue of IMC1a, fostering speculation that it could be functionally homologous but in a different invasive life stage. Here we have generated genetically modified parasites that express IMC1b tagged with green fluorescent protein, and we show that it is targeted exclusively to the pellicle of ookinetes. Wealso show that IMC1b-deficient ookinetes display abnormal cell shape, reduced gliding motility, decreased mechanical strength, and reduced infectivity. These findings are consistent with a membrane skeletal role of IMC1b and provide strong experimental support for the view that membrane skeletons form an integral part of the pellicle of apicomplexan zoites and function to provide rigidity to the pellicular membrane complex. The similarities observed between the loss-of-function phenotypes of IMC1a and IMC1b show that membrane skeletons of ookinetes and sporozoites function in an overall similar way. However, the fact that ookinetes and sporozoites do not use the same IMC1 protein implies that different mechanical properties are required of their respective membrane skeletons, likely reflecting the distinct environments in which these life stages must operate.	[Tremp, Annie Z.; Dessens, Johannes T.] London Sch Hyg & Trop Med, Dept Infect & Trop Med, London WC1E 7HT, England; [Khater, Emad I.] Ain Shams Univ, Dept Entomol, Cairo 11566, Egypt	University of London; London School of Hygiene & Tropical Medicine; Egyptian Knowledge Bank (EKB); Ain Shams University	Dessens, JT (corresponding author), London Sch Hyg & Trop Med, Dept Infect & Trop Med, London WC1E 7HT, England.	Johannes.Dessens@lshtm.ac.uk	Khater, Emad I. M./D-4248-2009; Khater, Dr, Emad I. M./AAV-7158-2020	Khater, Emad I. M./0000-0002-7510-6294; Khater, Dr, Emad I. M./0000-0002-7510-6294; Dessens, Johannes/0000-0002-2070-6073; Tremp, Annie/0000-0003-4042-9074	Wellcome Trust	Wellcome Trust(Wellcome TrustEuropean Commission)	This work was supported by the Wellcome Trust. The costs of publication of this article were defrayed in part by the payment of page charges. This article must therefore be hereby marked "advertisement" in accordance with 18 U. S. C. Section 1734 solely to indicate this fact.	Arai M, 2001, MOL BIOCHEM PARASIT, V116, P17, DOI 10.1016/S0166-6851(01)00299-7; Carter V, 2008, MOL MICROBIOL, V68, P1560, DOI 10.1111/j.1365-2958.2008.06254.x; Carter V, 2007, INT J PARASITOL, V37, P1221, DOI 10.1016/j.ijpara.2007.03.005; Claudianos C, 2002, MOL MICROBIOL, V45, P1473, DOI 10.1046/j.1365-2958.2002.03118.x; Dessens JT, 2001, INFECT IMMUN, V69, P4041, DOI 10.1128/IAI.69.6.4041-4047.2001; Dessens JT, 1999, EMBO J, V18, P6221, DOI 10.1093/emboj/18.22.6221; Dessens JT, 2003, MOL MICROBIOL, V49, P319, DOI 10.1046/j.1365-2958.2003.03566.x; Dobrowolski JM, 1997, MOL MICROBIOL, V26, P163, DOI 10.1046/j.1365-2958.1997.5671913.x; Dobrowolski JM, 1996, CELL, V84, P933, DOI 10.1016/S0092-8674(00)81071-5; GARNHAM PCC, 1969, T ROY SOC TROP MED H, V63, P187, DOI 10.1016/0035-9203(69)90145-X; Hall N, 2005, SCIENCE, V307, P82, DOI 10.1126/science.1103717; Han YS, 2000, EMBO J, V19, P6030, DOI 10.1093/emboj/19.22.6030; Heintzelman MB, 2003, CURR BIOL, V13, pR57, DOI 10.1016/S0960-9822(02)01428-8; Khater EI, 2004, J CELL BIOL, V167, P425, DOI 10.1083/jcb.200406068; Le Chat L, 2007, MOL BIOCHEM PARASIT, V153, P41, DOI 10.1016/j.molbiopara.2007.01.016; Mann T, 2002, J BIOL CHEM, V277, P41240, DOI 10.1074/jbc.M205056200; Mann T, 2001, MOL BIOCHEM PARASIT, V115, P257, DOI 10.1016/S0166-6851(01)00289-4; Meissner M, 2002, SCIENCE, V298, P837, DOI 10.1126/science.1074553; Menard R, 1997, NATURE, V385, P336, DOI 10.1038/385336a0; MENKE A, 1991, NATURE, V349, P69, DOI 10.1038/349069a0; Morrissette NS, 2002, MICROBIOL MOL BIOL R, V66, P21, DOI 10.1128/MMBR.66.1.21-38.2002; Pumplin David W., 1993, Trends in Cell Biology, V3, P113, DOI 10.1016/0962-8924(93)90173-X; Raibaud A, 2001, J STRUCT BIOL, V135, P47, DOI 10.1006/jsbi.2001.4396; Sachs J, 2002, NATURE, V415, P680, DOI 10.1038/415680a; SINDEN RE, 1985, PARASITOLOGY, V91, P227, DOI 10.1017/S0031182000057334; Soldati D, 2004, CURR OPIN CELL BIOL, V16, P32, DOI 10.1016/j.ceb.2003.11.013; Spaccapelo R, 1997, LANCET, V350, P335, DOI 10.1016/S0140-6736(97)24031-6; Templeton TJ, 2000, MOL MICROBIOL, V36, P1, DOI 10.1046/j.1365-2958.2000.01821.x; Vernick KD, 1999, EXP PARASITOL, V91, P362, DOI 10.1006/expr.1998.4388; Waters AP, 1997, METHODS, V13, P134, DOI 10.1006/meth.1997.0506; Yuda M, 1999, J EXP MED, V190, P1711, DOI 10.1084/jem.190.11.1711	31	47	47	0	1	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	OCT 10	2008	283	41					27604	27611		10.1074/jbc.M801302200	http://dx.doi.org/10.1074/jbc.M801302200			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	355OW	18650444	Green Published, hybrid, Green Accepted			2022-12-27	WOS:000259719200031
J	He, LH; Aleksandrov, AA; Serohijos, AWR; Hegedus, T; Aleksandrov, LA; Cui, L; Dokholyan, NV; Riordan, JR				He, Lihua; Aleksandrov, Andrei A.; Serohijos, Adrian W. R.; Hegedus, Tamas; Aleksandrov, Luba A.; Cui, Liying; Dokholyan, Nikolay V.; Riordan, John R.			Multiple membrane-cytoplasmic domain contacts in the cystic fibrosis transmembrane conductance regulator (CFTR) mediate regulation of channel gating	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							NUCLEOTIDE-BINDING DOMAIN; DISEASE-ASSOCIATED MUTATIONS; MULTIDRUG ABC TRANSPORTER; CHLORIDE CHANNEL; DELTA-F508 MUTATION; CRYSTAL-STRUCTURE; ATP-BINDING; PROTEIN; LOOP; PHOSPHORYLATION	The cystic fibrosis transmembrane conductance regulator (CFTR) is a unique ATP-binding cassette (ABC) ion channel mutated in patients with cystic fibrosis. The most common mutation, deletion of phenylalanine 508 (Delta F508) and many other disease-associated mutations occur in the nucleotide binding domains (NBD) and the cytoplasmic loops (CL) of the membrane-spanning domains (MSD). A recently constructed computational model of the CFTR three-dimensional structure, supported by experimental data (Serohijos, A. W., Hegedus, T., Aleksandrov, A. A., He, L., Cui, L., Dokholyan, N. V., and Riordan, J. R. (2008) Proc. Natl. Acad. Sci. U. S. A. 105, 3256-3261) revealed that several of these mutations including Delta F508 disrupted interfaces between these domains. Here we have used cysteine cross-linking experiments to verify all NBD/CL interfaces predicted by the structural model and observed that their cross-linking has a variety of different effects on channel gating. The interdomain contacts comprise aromatic clusters important for stabilization of the interfaces and also involve the Q-loops and X-loops that are in close proximity to the ATP binding sites. Cross-linking of all domain-swapping contacts between NBDs and MSD cytoplasmic loops in opposite halves of the protein rapidly and reversibly arrest single channel gating while those in the same halves have lesser impact. These results reinforce the idea that mediation of regulatory signals between cytoplasmic- and membrane-integrated domains of the CFTR channel apparently relies on an array of precise but highly dynamic interdomain structural joints.	[He, Lihua; Serohijos, Adrian W. R.; Hegedus, Tamas; Aleksandrov, Luba A.; Cui, Liying; Dokholyan, Nikolay V.; Riordan, John R.] Univ N Carolina, Dept Biochem & Biophys, Chapel Hill, NC 27599 USA; [Aleksandrov, Andrei A.] Univ N Carolina, Dept Biomed Engn, Chapel Hill, NC 27599 USA; [Serohijos, Adrian W. R.] Univ N Carolina, Dept Phys & Astron, Chapel Hill, NC 27599 USA; [Serohijos, Adrian W. R.; Dokholyan, Nikolay V.] Univ N Carolina, Mol & Cellular Phys Program, Chapel Hill, NC 27599 USA; [He, Lihua; Hegedus, Tamas; Aleksandrov, Luba A.; Cui, Liying; Riordan, John R.] Univ N Carolina, Cyst Fibrosis Ctr, Chapel Hill, NC 27599 USA	University of North Carolina; University of North Carolina Chapel Hill; University of North Carolina; University of North Carolina Chapel Hill; University of North Carolina; University of North Carolina Chapel Hill; University of North Carolina; University of North Carolina Chapel Hill; University of North Carolina; University of North Carolina Chapel Hill	Riordan, JR (corresponding author), Univ N Carolina, Dept Biochem & Biophys, Chapel Hill, NC 27599 USA.	jack_riordan@med.unc.edu	Hegedus, Tamas/P-8625-2015; Serohijos, Adrian/G-4607-2011; Dokholyan, Nikolay/D-8081-2018; Dokholyan, Nikolay/B-2238-2009	Hegedus, Tamas/0000-0002-5195-749X; Dokholyan, Nikolay/0000-0002-8225-4025; Dokholyan, Nikolay/0000-0002-8225-4025; Serohijos, Adrian/0000-0001-8369-982X	National Institutes of Health [DK051619]; Cystic Fibrosis Foundation [DOKHOL07I0]; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK051619, R01DK051870] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Cystic Fibrosis Foundation(Italian Cystic Fibrosis Research Foundation); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	This work was supported, in whole or in part, by National Institutes of Health Grant DK051619 (to J. R. R.). This work was also supported by Cystic Fibrosis Foundation Grant DOKHOL07I0 ( to N. V. D.). The costs of publication of this article were defrayed in part by the payment of page charges. This article must therefore be hereby marked "advertisement" in accordance with 18 U. S. C. Section 1734 solely to indicate this fact.	Aleksandrov AA, 2007, PFLUG ARCH EUR J PHY, V453, P693, DOI 10.1007/s00424-006-0140-z; Aleksandrov L, 2002, J BIOL CHEM, V277, P15419, DOI 10.1074/jbc.M111713200; BAKER J, 2006, PEDS PULMONOL S, V29, P97; Callebaut I, 2004, CELL MOL LIFE SCI, V61, P230, DOI 10.1007/s00018-003-3386-z; CHANG XB, 1993, J BIOL CHEM, V268, P11304; Chen EY, 2004, J BIOL CHEM, V279, P39620, DOI 10.1074/jbc.M407887200; CHENG SH, 1990, CELL, V63, P827, DOI 10.1016/0092-8674(90)90148-8; Cui L, 2006, J PHYSIOL-LONDON, V572, P347, DOI 10.1113/jphysiol.2005.099457; Cui LY, 2007, J MOL BIOL, V365, P981, DOI 10.1016/j.jmb.2006.10.086; Dalmas O, 2005, J BIOL CHEM, V280, P36857, DOI 10.1074/jbc.M503266200; Dawson RJP, 2006, NATURE, V443, P180, DOI 10.1038/nature05155; Du K, 2005, NAT STRUCT MOL BIOL, V12, P17, DOI 10.1038/nsmb882; Hollenstein K, 2007, NATURE, V446, P213, DOI 10.1038/nature05626; Hung LW, 1998, NATURE, V396, P703, DOI 10.1038/25393; Joo NS, 2004, J BIOL CHEM, V279, P38854, DOI 10.1074/jbc.M407077200; Lewis HA, 2005, J BIOL CHEM, V280, P1346, DOI 10.1074/jbc.M410968200; Lewis HA, 2004, EMBO J, V23, P282, DOI 10.1038/sj.emboj.7600040; Locher KP, 2002, SCIENCE, V296, P1091, DOI 10.1126/science.1071142; Matsui H, 1998, J CLIN INVEST, V102, P1125, DOI 10.1172/JCI2687; Mense M, 2006, EMBO J, V25, P4728, DOI 10.1038/sj.emboj.7601373; Oldham ML, 2007, NATURE, V450, P515, DOI 10.1038/nature06264; Pinkett HW, 2007, SCIENCE, V315, P373, DOI 10.1126/science.1133488; Quinton PM, 2007, PHYSIOLOGY, V22, P212, DOI 10.1152/physiol.00041.2006; Seibert FS, 1996, J BIOL CHEM, V271, P27493, DOI 10.1074/jbc.271.44.27493; Seibert FS, 1997, BIOCHEMISTRY-US, V36, P11966, DOI 10.1021/bi9712652; Seibert FS, 1996, J BIOL CHEM, V271, P15139, DOI 10.1074/jbc.271.25.15139; Serohijos AWR, 2008, PLOS COMPUT BIOL, V4, DOI 10.1371/journal.pcbi.1000008; Serohijos AWR, 2008, P NATL ACAD SCI USA, V105, P3256, DOI 10.1073/pnas.0800254105; Smith PC, 2002, MOL CELL, V10, P139, DOI 10.1016/S1097-2765(02)00576-2; Tarran R, 2001, MOL CELL, V8, P149, DOI 10.1016/S1097-2765(01)00286-6; THIBODEAU PH, 2004, PED PULMONOL S, V27, P189; Wang Y, 2007, J BIOL CHEM, V282, P33247, DOI 10.1074/jbc.C700175200; Ward A, 2007, P NATL ACAD SCI USA, V104, P19005, DOI 10.1073/pnas.0709388104; WARD CL, 1995, CELL, V83, P121, DOI 10.1016/0092-8674(95)90240-6; Winter MC, 1997, NATURE, V389, P294, DOI 10.1038/38514; Younger JM, 2006, CELL, V126, P571, DOI 10.1016/j.cell.2006.06.041; Zaitseva J, 2005, BIOCHEMISTRY-US, V44, P9680, DOI 10.1021/bi0506122; Zolnerciks JK, 2007, FASEB J, V21, P3937, DOI 10.1096/fj.07-8610com	38	96	98	0	13	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258			J BIOL CHEM	J. Biol. Chem.	SEP 26	2008	283	39					26383	26390		10.1074/jbc.M803894200	http://dx.doi.org/10.1074/jbc.M803894200			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	350GV	18658148	Green Published, hybrid			2022-12-27	WOS:000259341600012
J	Wang, Y; Rogers, PM; Su, C; Varga, G; Stayrook, KR; Burris, TP				Wang, Yongjun; Rogers, Pamela M.; Su, Chen; Varga, Gabor; Stayrook, Keith R.; Burris, Thomas P.			Regulation of cholesterologenesis by the oxysterol receptor, LXR alpha	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							LIVER-X-RECEPTOR; SQUALENE SYNTHASE INHIBITOR; HMG-COA REDUCTASE; RESPONSE ELEMENTS; GENE-EXPRESSION; METABOLISM; PROMOTER; PATHWAY; LANOSTEROL; ACTIVATORS	Cholesterol is required for normal cellular and physiological function, yet dysregulation of cholesterol metabolism is associated with diseases such as atherosclerosis. Cholesterol biosynthesis is regulated by end product negative feedback inhibition where the levels of sterols and oxysterols regulate the expression of cholesterologenic enzymes. Sterol regulatory element-binding protein-2 is responsive to both sterols and oxysterols and has been shown to mediate the transcriptional response of the cholesterologenic enzymes to these lipids. Here, we show that the nuclear hormone receptor for oxysterols, the liver X receptor alpha (LXR alpha), regulates cholesterol biosynthesis by directly silencing the expression of two key cholesterologenic enzymes ( lanosterol 14 alpha-demethylase (CYP51A1), and squalene synthase (farnesyl diphosphate farnesyl transferase 1)) via novel negative LXR DNA response elements (nLXREs) located in each of these genes. Examination of the CYP51A1 gene revealed that both the SRE and nLXRE are required for normal oxysterol-dependent repression of this gene. Thus, these data suggest that LXR alpha plays an important role in the regulation of cholesterol biosynthesis.	[Wang, Yongjun; Rogers, Pamela M.; Burris, Thomas P.] Louisiana State Univ Syst, Pennington Biomed Res Ctr, Nucl Receptor Biol Lab, Baton Rouge, LA 70808 USA; [Su, Chen; Varga, Gabor; Stayrook, Keith R.] Lilly Corp Ctr, Lilly Res Labs, Indianapolis, IN 46285 USA	Louisiana State University System; Louisiana State University; Pennington Biomedical Research Center; Eli Lilly	Burris, TP (corresponding author), Scripps Res Inst, 5353 Parkside Dr, Jupiter, FL 33458 USA.	tburris@scripps.edu	Burris, Thomas P/B-3886-2016; Burris, Thomas/H-5078-2011; Varga, Gábor/O-8858-2017	Burris, Thomas P/0000-0003-2922-4449; 	National Institutes of Health [DK080201]; American Heart Association; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK080201] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); American Heart Association(American Heart Association); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	This work was supported, in whole or in part, by National Institutes of Health Grant DK080201 (to T. P. B.). This work was also supported by an award from the American Heart Association (to T. P. B.). The costs of publication of this article were defrayed in part by the payment of page charges. This article must therefore be hereby marked "advertisement" in accordance with 18 U. S. C. Section 1734 solely to indicate this fact.	Albers M, 2006, J BIOL CHEM, V281, P4920, DOI 10.1074/jbc.M510101200; Amin D, 1997, J PHARMACOL EXP THER, V281, P746; Blaschke F, 2006, CIRC RES, V99, pE88, DOI 10.1161/01.RES.0000252878.34269.06; BURRIS TP, 1995, BIOCHEM BIOPH RES CO, V214, P576, DOI 10.1006/bbrc.1995.2324; Chen WL, 2007, CELL METAB, V5, P73, DOI 10.1016/j.cmet.2006.11.012; Goldstein JL, 2006, CELL, V124, P35, DOI 10.1016/j.cell.2005.12.022; Halder SK, 2002, MOL ENDOCRINOL, V16, P1853, DOI 10.1210/me.2001-0262; Horton JD, 2002, J CLIN INVEST, V109, P1125, DOI 10.1172/JCI200215593; Hu TH, 2005, ENDOCRINOLOGY, V146, P5380, DOI 10.1210/en.2005-0591; Janowski BA, 1996, NATURE, V383, P728, DOI 10.1038/383728a0; Joseph SB, 2003, NAT MED, V9, P213, DOI 10.1038/nm820; Lange Y, 2008, J BIOL CHEM, V283, P1445, DOI 10.1074/jbc.M706967200; Lehmann JM, 1997, J BIOL CHEM, V272, P3137, DOI 10.1074/jbc.272.6.3137; Lepesheva GI, 2004, MOL CELL ENDOCRINOL, V215, P165, DOI 10.1016/j.mce.2003.11.016; Maxfield FR, 2005, NATURE, V438, P612, DOI 10.1038/nature04399; Michael LF, 2005, MINI-REV MED CHEM, V5, P729, DOI 10.2174/1389557054553767; MIETTINEN TA, 1988, J LIPID RES, V29, P43; Sandelin A, 2005, MOL ENDOCRINOL, V19, P595, DOI 10.1210/me.2004-0101; Song BL, 2005, CELL METAB, V1, P179, DOI 10.1016/j.cmet.2005.01.001; Stayrook KR, 2008, MOL PHARMACOL, V73, P607, DOI 10.1124/mol.107.039099; Takahashi S, 1999, J BACTERIOL, V181, P1256, DOI 10.1128/JB.181.4.1256-1263.1999; Ugawa T, 2000, BRIT J PHARMACOL, V131, P63, DOI 10.1038/sj.bjp.0703545; Varga G, 2007, BIODRUGS, V21, P117, DOI 10.2165/00063030-200721020-00006; Wagner BL, 2003, MOL CELL BIOL, V23, P5780, DOI 10.1128/MCB.23.16.5780-5789.2003; Wang H, 2008, MOL CELL BIOL, V28, P2187, DOI 10.1128/MCB.01479-07; Wong J, 2008, J BIOL CHEM, V283, P700, DOI 10.1074/jbc.M706416200; Yoshikawa T, 2003, MOL ENDOCRINOL, V17, P1240, DOI 10.1210/me.2002-0190; Zelcer N, 2006, J CLIN INVEST, V116, P607, DOI 10.1172/JCI27883	28	97	106	0	8	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	SEP 26	2008	283	39					26332	26339		10.1074/jbc.M804808200	http://dx.doi.org/10.1074/jbc.M804808200			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	350GV	18676367	hybrid, Green Published			2022-12-27	WOS:000259341600006
J	Nilsson, SK; Christensen, S; Raarup, MK; Ryan, RO; Nielsen, MS; Olivecrona, G				Nilsson, Stefan K.; Christensen, Stine; Raarup, Merete K.; Ryan, Robert O.; Nielsen, Morten S.; Olivecrona, Gunilla			Endocytosis of apolipoprotein A-V by members of the low density lipoprotein receptor and the Vps10p domain receptor families	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							TRIGLYCERIDE-RICH LIPOPROTEINS; SORTILIN/NEUROTENSIN RECEPTOR-3; BINDS; CHOLESTEROL; SORTILIN; IDENTIFICATION; ASSOCIATION; MICROSCOPY; BRAIN; RISK	Apolipoprotein A-V (apoA-V) is present in low amounts in plasma and has been found to modulate triacylglycerol levels in humans and in animal models. ApoA-V displays affinity for members of the low density lipoprotein receptor (LDL-R) gene family, known as the classical lipoprotein receptors, including LRP1 and SorLA/LR11. In addition to LDL-A binding repeats, the mosaic receptor SorLA/LR11 also possesses a Vps10p domain. Here we show that apoA-V also binds to sortilin, a receptor from the Vsp10p domain gene family that lacks LDL-A repeats. Binding of apoA-V to sortilin was competed by neurotensin, a ligand that binds specifically to the Vps10p domain. To investigate the biological fate of receptor-bound apoA-V, binding experiments were conducted with cultured human embryonic kidney cells transfected with either SorLA/LR11 or sortilin. Compared with nontransfected cells, apoA-V binding to SorLA/LR11-and sortilin-expressing cells was markedly enhanced. Internalization experiments, live imaging studies, and fluorescence resonance energy transfer analyses demonstrated that labeled apoA-V was rapidly internalized, co-localized with receptors in early endosomes, and followed the receptors through endosomes to the trans-Golgi network. The observed decrease of fluorescence signal intensity as a function of time during live imaging experiments suggested ligand uncoupling in endosomes with subsequent delivery to lysosomes for degradation. This interpretation was supported by experiments with I-125-labeled apoA-V, demonstrating clear differences in degradation between transfected and nontransfected cells. We conclude that apoA-V binds to receptors possessing LDL-A repeats and Vsp10p domains and that apoA-V is internalized into cells via these receptors. This could be a mechanism by which apoA-V modulates lipoprotein metabolism in vivo.	[Nilsson, Stefan K.; Olivecrona, Gunilla] Umea Univ, Dept Med Biosci Physiol Chem, SE-90187 Umea, Sweden; [Christensen, Stine; Raarup, Merete K.; Nielsen, Morten S.] Univ Aarhus, MIND Ctr, Dept Med Biochem & Stereol, DK-8000 Aarhus, Denmark; [Christensen, Stine; Raarup, Merete K.; Nielsen, Morten S.] Univ Aarhus, Elect Microscopy Res Lab, DK-8000 Aarhus, Denmark; [Ryan, Robert O.] Childrens Hosp, Oakland Res Inst, Ctr Prevent Obes Diabet & Cardiovasc Dis, Oakland, CA 94609 USA	Umea University; Aarhus University; Aarhus University; Children's Hospital Los Angeles; Children's Hospital Oakland Research Institute	Olivecrona, G (corresponding author), Umea Univ Hosp Area, Bldg 6M,3rd Floor, SE-90187 Umea, Sweden.		Nielsen, Morten Schallburg/G-9498-2016; Nilsson, Stefan/K-5555-2012	Nielsen, Morten Schallburg/0000-0001-9863-9694; 	National Institutes of Health [HL-073061]; Swedish Research Council [12203]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL073061] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Swedish Research Council(Swedish Research CouncilEuropean Commission); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	This work was supported, in whole or in part, by National Institutes of Health Grant HL-073061. This work was also supported by Swedish Research Council Grant 12203 and King Gustav V and Queen Victoria Research Foundation. The MIND-Center is sponsored by The Lundbeck Foundation. The costs of publication of this article were defrayed in part by the payment of page charges. This article must therefore be hereby marked "advertisement" in accordance with 18 U. S. C. Section 1734 solely to indicate this fact.	Andersen OM, 2005, P NATL ACAD SCI USA, V102, P13461, DOI 10.1073/pnas.0503689102; Beckstead JA, 2003, BIOCHEMISTRY-US, V42, P9416, DOI 10.1021/bi034509t; Beigneux AP, 2007, CELL METAB, V5, P279, DOI 10.1016/j.cmet.2007.02.002; BENGTSSONOLIVECRONA G, 1991, METHOD ENZYMOL, V197, P345; Calandra S, 2006, CURR OPIN LIPIDOL, V17, P122, DOI 10.1097/01.mol.0000217892.00618.54; Dallinga-Thie GM, 2006, DIABETOLOGIA, V49, P1505, DOI 10.1007/s00125-006-0261-0; Dichlberger A, 2007, J LIPID RES, V48, P1451, DOI 10.1194/jlr.C600026-JLR200; Elangovan M, 2003, METHODS, V29, P58, DOI 10.1016/S1046-2023(02)00283-9; Fruchart-Najib J, 2004, BIOCHEM BIOPH RES CO, V319, P397, DOI 10.1016/j.bbrc.2004.05.003; Grosskopf I, 2005, ARTERIOSCL THROM VAS, V25, P2573, DOI 10.1161/01.ATV.0000186189.26141.12; Heeren J, 2006, ARTERIOSCL THROM VAS, V26, P442, DOI 10.1161/01.ATV.0000201282.64751.47; Herz J, 2001, J CLIN INVEST, V108, P779, DOI 10.1172/JCI200113992; Huang W, 2006, BIOCHEM BIOPH RES CO, V346, P14, DOI 10.1016/j.bbrc.2006.05.072; Hubacek JA, 2005, CLIN CHEM LAB MED, V43, P897, DOI 10.1515/CCLM.2005.153; Ishihara M, 2005, J LIPID RES, V46, P2015, DOI 10.1194/jlr.D500018-JLR200; Jacobsen L, 1996, J BIOL CHEM, V271, P31379, DOI 10.1074/jbc.271.49.31379; Jansen P, 2007, NAT NEUROSCI, V10, P1449, DOI 10.1038/nn2000; Kathiresan S, 2008, NAT GENET, V40, P189, DOI 10.1038/ng.75; Lookene A, 2005, J BIOL CHEM, V280, P25383, DOI 10.1074/jbc.M501589200; Mari M, 2008, TRAFFIC, V9, P380, DOI 10.1111/j.1600-0854.2007.00686.x; Merkel M, 2005, J CLIN INVEST, V115, P2694, DOI 10.1172/JCI26712; Merkel M, 2005, J BIOL CHEM, V280, P21553, DOI 10.1074/jbc.M411412200; Niculescu LS, 2007, CLIN CHEM LAB MED, V45, P1133, DOI 10.1515/CCLM.2007.257; Nielsen MS, 2007, MOL CELL BIOL, V27, P6842, DOI 10.1128/MCB.00815-07; Nielsen MS, 1999, J BIOL CHEM, V274, P8832, DOI 10.1074/jbc.274.13.8832; Nielsen MS, 2001, EMBO J, V20, P2180, DOI 10.1093/emboj/20.9.2180; Nilsson SK, 2007, BIOCHEMISTRY-US, V46, P3896, DOI 10.1021/bi7000533; Ohwaki K, 2007, ARTERIOSCL THROM VAS, V27, P1050, DOI 10.1161/ATVBAHA.106.137091; Pennacchio LA, 2001, SCIENCE, V294, P169, DOI 10.1126/science.1064852; Petersen CM, 1999, EMBO J, V18, P595, DOI 10.1093/emboj/18.3.595; Petersen CM, 1997, J BIOL CHEM, V272, P3599, DOI 10.1074/jbc.272.6.3599; Samani NJ, 2007, NEW ENGL J MED, V357, P443, DOI 10.1056/NEJMoa072366; Sandhu MS, 2008, LANCET, V371, P483, DOI 10.1016/S0140-6736(08)60208-1; Schaap FG, 2004, J BIOL CHEM, V279, P27941, DOI 10.1074/jbc.M403240200; Shu X, 2007, J LIPID RES, V48, P1445, DOI 10.1194/jlr.C700002-JLR200; Sun GT, 2006, CHEM PHYS LIPIDS, V143, P22, DOI 10.1016/j.chemphyslip.2006.04.004; Talmud PJ, 2002, HUM MOL GENET, V11, P3039, DOI 10.1093/hmg/11.24.3039; Vaessen SFC, 2006, J LIPID RES, V47, P2064, DOI 10.1194/jlr.M600233-JLR200; van Dijk KW, 2004, CURR OPIN LIPIDOL, V15, P239, DOI [10.1097/01.mol.00001300096.77252.1f, 10.1097/00041433-200406000-00002]; Wallrabe H, 2006, MICROSC RES TECHNIQ, V69, P196, DOI 10.1002/jemt.20281; Wallrabe H, 2003, BIOPHYS J, V85, P559, DOI 10.1016/S0006-3495(03)74500-7; Yamada Y, 2007, ATHEROSCLEROSIS, V191, P298, DOI 10.1016/j.atherosclerosis.2006.05.035	42	88	95	0	2	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	SEP 19	2008	283	38					25920	25927		10.1074/jbc.M802721200	http://dx.doi.org/10.1074/jbc.M802721200			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	348GX	18603531	Green Published, hybrid			2022-12-27	WOS:000259200100019
J	Compton, SA; Tolun, G; Kamath-Loeb, AS; Loeb, LA; Griffith, JD				Compton, Sarah A.; Tolun, Goekhan; Kamath-Loeb, Ashwini S.; Loeb, Lawrence A.; Griffith, Jack D.			The Werner syndrome protein binds replication fork and Holliday junction DNAs as an oligomer	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ESCHERICHIA-COLI RECQ; HELICASE; EXONUCLEASE; VISUALIZATION; BLM; COMPLEXES; MECHANISM; DOMAIN; P53; WRN	Werner syndrome is an inherited disease displaying a premature aging phenotype. The gene mutated in Werner syndrome encodes both a 3' -> 35' DNA helicase and a 3' -> 35' DNA exonuclease. Both WRN helicase and exonuclease preferentially utilize DNA substrates containing alternate secondary structures. By virtue of its ability to resolve such DNA structures, WRN is postulated to prevent the stalling and collapse of replication forks that encounter damaged DNA. Using electron microscopy, we visualized the binding of full-length WRN to DNA templates containing replication forks and Holliday junctions, intermediates observed during DNA replication and recombination, respectively. We show that both wild-type WRN and a helicase-defective mutant bind with exceptionally high specificity (> 1000-fold) to DNA secondary structures at the replication fork and at Holliday junctions. Little or no binding is observed elsewhere on the DNA molecules. Calculations of the molecular weight of full-length WRN revealed that, in solution, WRN exists predominantly as a dimer. However, WRN bound to DNA is larger; the mass is consistent with that of a tetramer.	[Compton, Sarah A.; Tolun, Goekhan; Griffith, Jack D.] Univ N Carolina, Lineberger Comprehens Canc Ctr, Chapel Hill, NC 27599 USA; [Kamath-Loeb, Ashwini S.; Loeb, Lawrence A.] Univ Washington, Dept Pathol, Gottstein Mem Canc Res Ctr, Seattle, WA 98195 USA; [Kamath-Loeb, Ashwini S.; Loeb, Lawrence A.] Univ Washington, Dept Biochem, Gottstein Mem Canc Res Ctr, Seattle, WA 98195 USA	University of North Carolina; University of North Carolina Chapel Hill; University of Washington; University of Washington Seattle; University of Washington; University of Washington Seattle	Griffith, JD (corresponding author), Univ N Carolina, Lineberger Comprehens Canc Ctr, Chapel Hill, NC 27599 USA.	jdg@med.unc.edu	TOLUN, Gökhan/D-1971-2012; Tolun, Gokhan/AAG-9606-2021	TOLUN, Gökhan/0000-0001-6166-9451; Tolun, Gokhan/0000-0001-6166-9451	National Institutes of Health [F32 GM077900, GM31819, ES013773]; Glenn foundation; Genome Network Project [PO1 CA077852]; NATIONAL CANCER INSTITUTE [P01CA077852] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES [R01ES013773] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [F32GM077900, R01GM031819] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Glenn foundation; Genome Network Project(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported, in whole or in part, by National Institutes of Health Grants F32 GM077900 (to S.A.C.), GM31819 (to J.D.G.), and ES013773 (to J.D.G.), a Glenn foundation award (to J.D.G.), and Genome Network Project Grant PO1 CA077852 (to L.A.L.).	Allen DJ, 1997, EMBO J, V16, P4467, DOI 10.1093/emboj/16.14.4467; Beresten SF, 1999, PROTEIN EXPRES PURIF, V17, P239, DOI 10.1006/prep.1999.1135; Bianchi A, 1997, EMBO J, V16, P1785, DOI 10.1093/emboj/16.7.1785; Choudhary S, 2004, J BIOL CHEM, V279, P34603, DOI 10.1074/jbc.M401901200; Fouche N, 2006, BIOCHEMISTRY-US, V45, P9624, DOI 10.1021/bi060313s; Fry M, 1999, J BIOL CHEM, V274, P12797, DOI 10.1074/jbc.274.18.12797; Gray MD, 1997, NAT GENET, V17, P100, DOI 10.1038/ng0997-100; GRIFFITH JD, 1995, J MOL BIOL, V246, P576, DOI 10.1016/S0022-2836(05)80107-X; GRIFFITH JD, 1978, ANNU REV BIOPHYS BIO, V7, P19, DOI 10.1146/annurev.bb.07.060178.000315; Hanada K, 2007, CELL MOL LIFE SCI, V64, P2306, DOI 10.1007/s00018-007-7121-z; Harmon FG, 2001, J BIOL CHEM, V276, P232, DOI 10.1074/jbc.M006555200; Huang SR, 2000, NUCLEIC ACIDS RES, V28, P2396, DOI 10.1093/nar/28.12.2396; Huber MD, 2002, NUCLEIC ACIDS RES, V30, P3954, DOI 10.1093/nar/gkf530; Janscak P, 2003, J MOL BIOL, V330, P29, DOI 10.1016/S0022-2836(03)00534-5; Kamath-Loeb AS, 1998, J BIOL CHEM, V273, P34145, DOI 10.1074/jbc.273.51.34145; Kamath-Loeb Ashwini S., 2006, V47, P435; Karow JK, 1999, CURR BIOL, V9, P597, DOI 10.1016/S0960-9822(99)80264-4; LEE S, 1995, CELL, V81, P1013, DOI 10.1016/S0092-8674(05)80006-6; Mohaghegh P, 2001, NUCLEIC ACIDS RES, V29, P2843, DOI 10.1093/nar/29.13.2843; Muzzolini L, 2007, PLOS BIOL, V5, P157, DOI 10.1371/journal.pbio.0050020; Opresko PL, 2001, J BIOL CHEM, V276, P44677, DOI 10.1074/jbc.M107548200; Ozgenc A, 2005, MUTAT RES-FUND MOL M, V577, P237, DOI 10.1016/j.mrfmmm.2005.03.020; Shen JC, 2000, NUCLEIC ACIDS RES, V28, P3260, DOI 10.1093/nar/28.17.3260; Shen JC, 1998, J BIOL CHEM, V273, P34139, DOI 10.1074/jbc.273.51.34139; Singleton MR, 2007, ANNU REV BIOCHEM, V76, P23, DOI 10.1146/annurev.biochem.76.052305.115300; Subramanian D, 2005, J BIOL CHEM, V280, P42568, DOI 10.1074/jbc.M506348200; Tuteja N, 2004, EUR J BIOCHEM, V271, P1835, DOI 10.1111/j.1432-1033.2004.04093.x; Wu L, 2007, DNA REPAIR, V6, P936, DOI 10.1016/j.dnarep.2007.02.007; Xu HQ, 2003, J BIOL CHEM, V278, P34925, DOI 10.1074/jbc.M303581200; Xue Y, 2002, BIOCHEMISTRY-US, V41, P2901, DOI 10.1021/bi0157161; Zhang XD, 2006, J BIOL CHEM, V281, P12655, DOI 10.1074/jbc.M513089200	31	56	57	0	2	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	SEP 5	2008	283	36					24478	24483		10.1074/jbc.M803370200	http://dx.doi.org/10.1074/jbc.M803370200			6	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	342YR	18596042	hybrid, Green Published			2022-12-27	WOS:000258820000022
J	Cunha, FM; Berti, DA; Ferreira, ZS; Klitzke, CF; Markus, RP; Ferro, ES				Cunha, Fernanda M.; Berti, Denise A.; Ferreira, Zulma S.; Klitzke, Clecio F.; Markus, Regina P.; Ferro, Emer S.			Intracellular peptides as natural regulators of cell signaling	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							THIMET OLIGOPEPTIDASE; ENDOPEPTIDASE 24.15; SOLUBLE METALLOENDOPEPTIDASE; ANTIGENIC PEPTIDES; EC 3.4.24.15; PROTEIN; DEGRADATION; RECEPTOR; LOCALIZATION; NEUROLYSIN	Protein degradation by the ubiquitin proteasome system releases large amounts of oligopeptides within cells. To investigate possible functions for these intracellularly generated oligopeptides, we fused them to a cationic transactivator peptide sequence using reversible disulfide bonds, introduced them into cells, and analyzed their effect on G protein-coupled receptor (GPCR) signal transduction. A mixture containing four of these peptides (20-80 mu M) significantly inhibited the increase in the extracellular acidification response triggered by angiotensin II (ang II) in CHO-S cells transfected with the ang II type 1 receptor (AT1R-CHO-S). Subsequently, either alone or in a mixture, these peptides increased luciferase gene transcription in AT1R-CHO-S cells stimulated with ang II and in HEK293 cells treated with isoproterenol. These peptides without transactivator failed to affect GPCR cellular responses. All four functional peptides were shown in vitro to competitively inhibit the degradation of a synthetic substrate by thimet oligopeptidase. Overexpression of thimet oligopeptidase in both CHO-S and HEK293 cells was sufficient to reduce luciferase activation triggered by a specific GPCR agonist. Moreover, using individual peptides as baits in affinity columns, several proteins involved in GPCR signaling were identified, including alpha-adaptin A and dynamin 1. These results suggest that before their complete degradation, intracellular peptides similar to those generated by proteasomes can actively affect cell signaling, probably representing additional bioactive molecules within cells.	[Klitzke, Clecio F.] Butantan Inst, Ctr Appl Toxinol, CAT CEPID, BR-05503900 Sao Paulo, Brazil; [Cunha, Fernanda M.] Univ Fed Sao Paulo, Dept Biochem, BR-04044020 Sao Paulo, Brazil; [Cunha, Fernanda M.; Berti, Denise A.; Ferro, Emer S.] Univ Sao Paulo, Inst Biomed Sci, Dept Physiol, BR-05508900 Sao Paulo, Brazil; [Cunha, Fernanda M.; Berti, Denise A.; Ferro, Emer S.] Univ Sao Paulo, Inst Biomed Sci, Dept Cell Biol & Dev, BR-05508900 Sao Paulo, Brazil	Instituto Butantan; Universidade Federal de Sao Paulo (UNIFESP); Universidade de Sao Paulo; Universidade de Sao Paulo	Ferro, ES (corresponding author), Av Prof Lineu Prestes 1524,Sala 431,Campus Univ, BR-05508900 Sao Paulo, Brazil.	eferro@usp.br	DA CUNHA, FERNANDA MARQUES/AAY-4000-2020; Ferreira, Zulma/D-3200-2012; Markus, Regina P./AAC-1505-2021; Ferro, Emer S/D-3908-2012; Klitzke, Clecio Fernando/A-8920-2010; Markus, Regina P/K-2954-2012; da Cunha, Fernanda M/G-3575-2012	Markus, Regina P./0000-0003-4606-6120; Ferro, Emer S/0000-0003-1651-9192; Klitzke, Clecio Fernando/0000-0001-5973-6088; Markus, Regina P/0000-0003-4606-6120; da Cunha, Fernanda M/0000-0002-1583-5380; Ferreira, Zulma/0000-0001-6571-837X	Sao Paulo State Research Foundation [04/04933-2]; Financiadora de Estudos e Projetos; National Laboratory of Synchrotron Light (Sao Paulo Proteome Network)	Sao Paulo State Research Foundation(Fundacao de Amparo a Pesquisa do Estado de Sao Paulo (FAPESP)); Financiadora de Estudos e Projetos(Financiadora de Inovacao e Pesquisa (Finep)); National Laboratory of Synchrotron Light (Sao Paulo Proteome Network)	This work was supported by Sao Paulo State Research Foundation Grant 04/04933-2 and grants from Financiadora de Estudos e Projetos and the National Laboratory of Synchrotron Light (Sao Paulo Proteome Network).	Akopian TN, 1997, J BIOL CHEM, V272, P1791, DOI 10.1074/jbc.272.3.1791; Altschul SF, 1997, NUCLEIC ACIDS RES, V25, P3389, DOI 10.1093/nar/25.17.3389; Anderson GP, 2006, CLIN REV ALLERG IMMU, V31, P119, DOI 10.1385/CRIAI:31:2:119; Baechle D, 2005, ANAL BIOCHEM, V345, P161, DOI 10.1016/j.ab.2005.06.040; BALL CL, 1995, J CELL SCI, V108, P2865; Band AM, 2001, FEBS LETT, V505, P118, DOI 10.1016/S0014-5793(01)02798-3; Bonny C, 2001, DIABETES, V50, P77, DOI 10.2337/diabetes.50.1.77; Brady AE, 2002, CELL SIGNAL, V14, P297, DOI 10.1016/S0898-6568(01)00239-X; Camargo ACM, 1997, BIOCHEM J, V324, P517, DOI 10.1042/bj3240517; CAMARGO ACM, 1979, J BIOL CHEM, V254, P5304; Carreno FR, 2005, J NEUROCHEM, V93, P10, DOI 10.1111/j.1471-4159.2004.02967.x; Che FY, 2006, J MOL NEUROSCI, V28, P265, DOI 10.1385/JMN:28:3:265; Che FY, 2001, P NATL ACAD SCI USA, V98, P9971, DOI 10.1073/pnas.161542198; Che FY, 2005, MOL CELL PROTEOMICS, V4, P1391, DOI 10.1074/mcp.T500010-MCP200; CHU TG, 1984, BIOCHEMISTRY-US, V23, P3598, DOI 10.1021/bi00311a005; D'Souza KM, 2008, J THORAC CARDIOV SUR, V135, P172, DOI 10.1016/j.jtcvs.2007.08.035; Demasi M, 2008, FREE RADICAL BIO MED, V44, P1180, DOI 10.1016/j.freeradbiomed.2007.12.012; DICKINSON KEJ, 1994, BRIT J PHARMACOL, V113, P179, DOI 10.1111/j.1476-5381.1994.tb16191.x; Dolenc I, 1998, FEBS LETT, V434, P357, DOI 10.1016/S0014-5793(98)01010-2; Ferro ES, 2004, J NEUROCHEM, V91, P769, DOI 10.1111/j.1471-4159.2004.02757.x; Ferro ES, 1999, DNA CELL BIOL, V18, P781, DOI 10.1089/104454999314926; Fitzgerald LR, 1999, ANAL BIOCHEM, V275, P54, DOI 10.1006/abio.1999.4295; Fontenele-Neto JD, 2001, J COMP NEUROL, V438, P399, DOI 10.1002/cne.1323; Friedman J, 2002, MOL PHARMACOL, V62, P1094, DOI 10.1124/mol.62.5.1094; Geier E, 1999, SCIENCE, V283, P978, DOI 10.1126/science.283.5404.978; Goldberg AL, 2003, NATURE, V426, P895, DOI 10.1038/nature02263; Gupta B, 2005, ADV DRUG DELIVER REV, V57, P637, DOI 10.1016/j.addr.2004.10.007; Head BP, 2006, J BIOL CHEM, V281, P26391, DOI 10.1074/jbc.M602577200; HEALY DP, 1992, BRAIN RES, V571, P121, DOI 10.1016/0006-8993(92)90517-D; Heimann AS, 2007, P NATL ACAD SCI USA, V104, P20588, DOI 10.1073/pnas.0706980105; Heimann AS, 2005, PHYSIOL GENOMICS, V20, P173, DOI 10.1152/physiolgenomics.00145.2004; Hershko A, 2000, NAT MED, V6, P1073, DOI 10.1038/80384; Higuchi S, 2007, CLIN SCI, V112, P417, DOI 10.1042/CS20060342; Kaspari A, 1996, BBA-PROTEIN STRUCT M, V1293, P147, DOI 10.1016/0167-4838(95)00238-3; Kelemen BR, 2002, J BIOL CHEM, V277, P8741, DOI 10.1074/jbc.M108459200; Kessler BM, 2002, MOL IMMUNOL, V39, P171, DOI 10.1016/S0161-5890(02)00100-1; Kheifets V, 2006, J BIOL CHEM, V281, P23218, DOI 10.1074/jbc.M602075200; Kim SI, 2003, BIOCHEM J, V375, P111, DOI 10.1042/BJ20030490; Kisselev AF, 2002, J BIOL CHEM, V277, P22260, DOI 10.1074/jbc.M112360200; Kisselev AF, 1998, J BIOL CHEM, V273, P1982, DOI 10.1074/jbc.273.4.1982; Klarlund JK, 1997, SCIENCE, V275, P1927, DOI 10.1126/science.275.5308.1927; Kobilka BK, 2007, TRENDS PHARMACOL SCI, V28, P397, DOI 10.1016/j.tips.2007.06.003; Lim EJ, 2007, J BIOL CHEM, V282, P9722, DOI 10.1074/jbc.M609897200; Machado MFM, 2006, BIOCHEM BIOPH RES CO, V339, P520, DOI 10.1016/j.bbrc.2005.11.041; Massarelli EE, 1999, BRAIN RES, V851, P261, DOI 10.1016/S0006-8993(99)02135-6; MCCONNELL HM, 1992, SCIENCE, V257, P1906, DOI 10.1126/science.1329199; Montiel JL, 1997, J NEUROCHEM, V68, P354; OLIVEIRA EB, 1976, BIOCHEMISTRY-US, V15, P1967, DOI 10.1021/bi00654a026; Oliveira L, 2007, PHYSIOL REV, V87, P565, DOI 10.1152/physrev.00040.2005; Oliveira V, 2001, BIOCHEMISTRY-US, V40, P4417, DOI 10.1021/bi002715k; ORLOWSKI M, 1983, EUR J BIOCHEM, V135, P81, DOI 10.1111/j.1432-1033.1983.tb07620.x; Pawson T, 1997, SCIENCE, V278, P2075, DOI 10.1126/science.278.5346.2075; Pawson T, 2003, SCIENCE, V300, P445, DOI 10.1126/science.1083653; Pickart CM, 2004, CELL, V116, P181, DOI 10.1016/S0092-8674(03)01074-2; PIEROTTI A, 1990, BIOCHEMISTRY-US, V29, P10323, DOI 10.1021/bi00497a006; Pontier SM, 2006, EMBO J, V25, P2698, DOI 10.1038/sj.emboj.7601157; PORTARO FCV, 1999, BIOCHEM BIOPH RES CO, V25, P1292; Ray K, 2004, J BIOL CHEM, V279, P20480, DOI 10.1074/jbc.M400795200; Reits E, 2003, IMMUNITY, V18, P97, DOI 10.1016/S1074-7613(02)00511-3; Rioli V, 2003, J BIOL CHEM, V278, P8547, DOI 10.1074/jbc.M212030200; Romisch K, 2005, ANNU REV CELL DEV BI, V21, P435, DOI 10.1146/annurev.cellbio.21.012704.133250; Saric T, 2004, J BIOL CHEM, V279, P46723, DOI 10.1074/jbc.M406537200; Saric T, 2001, J BIOL CHEM, V276, P36474, DOI 10.1074/jbc.M105517200; Shrimpton CN, 1997, J BIOL CHEM, V272, P17395, DOI 10.1074/jbc.272.28.17395; Silva CL, 1999, BIOCHEM BIOPH RES CO, V255, P591, DOI 10.1006/bbrc.1999.0250; Smart D, 2000, BIOCHEM CELL BIOL, V78, P281, DOI 10.1139/bcb-78-3-281; Soughayer JS, 2004, BIOCHEMISTRY-US, V43, P8528, DOI 10.1021/bi036296d; Tullai JW, 2000, J BIOL CHEM, V275, P36514, DOI 10.1074/jbc.M001843200; UDENFRIEND S, 1972, SCIENCE, V178, P871, DOI 10.1126/science.178.4063.871; WENZEL T, 1994, FEBS LETT, V349, P205, DOI 10.1016/0014-5793(94)00665-2; Wu Y, 2007, EMBO J, V26, P2981, DOI 10.1038/sj.emboj.7601741; YATES JR, 1995, ANAL CHEM, V67, P1426, DOI 10.1021/ac00104a020; York IA, 2003, IMMUNITY, V18, P429, DOI 10.1016/S1074-7613(03)00058-X; Zhang J, 1997, J BIOL CHEM, V272, P27005, DOI 10.1074/jbc.272.43.27005	74	72	73	1	4	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	SEP 5	2008	283	36					24448	24459		10.1074/jbc.M801252200	http://dx.doi.org/10.1074/jbc.M801252200			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	342YR	18617518	Green Published, hybrid			2022-12-27	WOS:000258820000020
J	Freibaum, BD; Counter, CM				Freibaum, Brian D.; Counter, Christopher M.			The protein hSnm1B is stabilized when bound to the telomere-binding protein TRF2	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							DNA-REPAIR; SACCHAROMYCES-CEREVISIAE; COMPLEX; END; POLYADENYLATION; SUSCEPTIBILITY; RECOGNITION; DEGRADATION; PROTEOLYSIS; EXPRESSION	hSnm1B is member of the SNM family of exonucleases involved in DNA processing and is known to be localized to telomeres via binding to the telomere- binding protein TRF2. Here we demonstrate that the C terminus of hSnm1B facilitates the concentration of hSnm1B on telomeres by promoting ubiquitinmediated degradation of hSnm1B that is not localized to telomeres, as well as by blocking protein degradation and fostering localization to telomeres via binding of TRF2. Finally, a mutant of hSnm1B stabilized independently of exogenous TRF2- induced cell death. Taken together, we speculate that sequestering hSnm1B at telomeres by a combination of stabilizing the protein when bound to telomeres and degrading it when not bound to telomeres may be a means to prevent potentially lethal effects of unregulated hSnm1B activity.	Duke Univ, Med Ctr, Dept Pharmacol, Durham, NC 27710 USA; Duke Univ, Med Ctr, Dept Canc Biol & Radial Oncol, Durham, NC 27710 USA; Duke Univ, Med Ctr, Dept Radiat Oncol, Durham, NC 27710 USA	Duke University; Duke University; Duke University	Counter, CM (corresponding author), DUMC 3813, Durham, NC 27710 USA.	count004@mc.duke.edu		Counter, Christopher M/0000-0003-0748-3079	NATIONAL CANCER INSTITUTE [R01CA082481] Funding Source: NIH RePORTER; NCI NIH HHS [CA 082481] Funding Source: Medline	NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))		Ahkter S, 2005, MOL CELL BIOL, V25, P10071, DOI 10.1128/MCB.25.22.10071-10078.2005; ANDERSSON S, 1989, J BIOL CHEM, V264, P8222; Armbruster BN, 2001, MOL CELL BIOL, V21, P7775, DOI 10.1128/MCB.21.22.7775-7786.2001; Blackburn EH, 2001, CELL, V106, P661, DOI 10.1016/S0092-8674(01)00492-5; Bonatto D, 2005, COMPUT BIOL CHEM, V29, P420, DOI 10.1016/j.compbiolchem.2005.09.004; Broccoli D, 1997, NAT GENET, V17, P231, DOI 10.1038/ng1097-231; Cabuy E, 2005, RADIAT RES, V164, P53, DOI 10.1667/RR3376; Chang W, 2003, GENE DEV, V17, P1328, DOI 10.1101/gad.1077103; CHRISTOFORI G, 1988, CELL, V54, P875, DOI 10.1016/S0092-8674(88)91263-9; de Lange T, 2005, GENE DEV, V19, P2100, DOI 10.1101/gad.1346005; Demuth I, 2004, ONCOGENE, V23, P8611, DOI 10.1038/sj.onc.1207895; Dronkert MLG, 2000, MOL CELL BIOL, V20, P4553, DOI 10.1128/MCB.20.13.4553-4561.2000; Freibaum BD, 2006, J BIOL CHEM, V281, P15033, DOI 10.1074/jbc.C600038200; GILMARTIN GM, 1989, GENE DEV, V3, P2180, DOI 10.1101/gad.3.12b.2180; Griffith JD, 1999, CELL, V97, P503, DOI 10.1016/S0092-8674(00)80760-6; HENRIQUES JAP, 1980, GENETICS, V95, P273; HENRIQUES JAP, 1990, CURR GENET, V18, P387, DOI 10.1007/BF00309906; Karlseder J, 1999, SCIENCE, V283, P1321, DOI 10.1126/science.283.5406.1321; Kim JH, 2005, GENE DEV, V19, P776, DOI 10.1101/gad.1289405; KIRCHER M, 1983, CHEM-BIOL INTERACT, V44, P27, DOI 10.1016/0009-2797(83)90127-8; Lee TH, 2006, J BIOL CHEM, V281, P759, DOI 10.1074/jbc.M509855200; Lenain C, 2006, CURR BIOL, V16, P1303, DOI 10.1016/j.cub.2006.05.021; Liu D, 2004, J BIOL CHEM, V279, P51338, DOI 10.1074/jbc.M409293200; Ma YM, 2002, CELL, V108, P781, DOI 10.1016/S0092-8674(02)00671-2; O'Hayer KM, 2006, METHOD ENZYMOL, V407, P637, DOI 10.1016/S0076-6879(05)07050-3; Richie CT, 2002, MOL CELL BIOL, V22, P8635, DOI 10.1128/MCB.22.24.8635-8647.2002; Rooney S, 2003, J EXP MED, V197, P553, DOI 10.1084/jem.20021891; TAKAGAKI Y, 1989, GENE DEV, V3, P1711, DOI 10.1101/gad.3.11.1711; Takaku H, 2003, NUCLEIC ACIDS RES, V31, P2272, DOI 10.1093/nar/gkg337; van Overbeek M, 2006, CURR BIOL, V16, P1295, DOI 10.1016/j.cub.2006.05.022; van Steensel B, 1998, CELL, V92, P401, DOI 10.1016/S0092-8674(00)80932-0; Wilkinson KD, 2000, SEMIN CELL DEV BIOL, V11, P141, DOI 10.1006/scdb.2000.0164; WILSON IA, 1985, P NATL ACAD SCI USA, V82, P5255, DOI 10.1073/pnas.82.16.5255; Zhang XS, 2002, DNA REPAIR, V1, P379, DOI 10.1016/S1568-7864(02)00015-0	34	13	15	0	0	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	AUG 29	2008	283	35					23671	23676		10.1074/jbc.M800388200	http://dx.doi.org/10.1074/jbc.M800388200			6	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	340II	18593705	hybrid, Green Published			2022-12-27	WOS:000258638900020
J	Ren, JG; Li, ZG; Sacks, DB				Ren, Jian-Guo; Li, Zhigang; Sacks, David B.			IQGAP1 integrates Ca2+/calmodulin and B-Raf signaling	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							GROWTH-FACTOR RECEPTOR; PROTEIN-KINASE; ACTIN-BINDING; CELL-ADHESION; MAP KINASE; CALMODULIN; ACTIVATION; CALCIUM; CDC42; CA2+	Ca2+ and calmodulin modulate numerous cellular functions, ranging from muscle contraction to the cell cycle. Accumulating evidence indicates that Ca2+ and calmodulin regulate the MAPK signaling pathway at multiple positions in the cascade, but the molecular mechanism underlying these observations is poorly defined. We previously documented that IQGAP1 is a scaffold in the MAPK cascade. IQGAP1 binds to and regulates the activities of ERK, MEK, and B-Raf. Here we demonstrate that IQGAP1 integrates Ca2+ and calmodulin with B-Raf signaling. In vitro analysis reveals that Ca2+ promotes the direct binding of IQGAP1 to B-Raf. This interaction is inhibited by calmodulin in a Ca2+-regulated manner. Epidermal growth factor (EGF) is unable to stimulate B-Raf activity in fibroblasts treated with the Ca2+ ionophore A23187. In contrast, chelation of intracellular free Ca2+ concentrations ([Ca2+](i)) significantly enhances EGF-stimulated B-Raf activity, an effect that is dependent on IQGAP1. Incubation of cells with EGF augments the association of B-Raf with IQGAP1. Moreover, Ca2+ regulates the association of B-Raf with IQGAP1 in cells. Increasing [Ca2+](i) with Ca2+ ionophores significantly reduces co-immunoprecipitation of B- Raf and IQGAP1, whereas chelation of Ca2+ enhances the interaction. Consistent with these findings, increasing and decreasing [Ca2+](i) increase and decrease, respectively, co-immunoprecipitation of calmodulin with IQGAP1. Collectively, our data identify a previously unrecognized mechanism in which the scaffold protein IQGAP1 couples Ca2+ and calmodulin signaling to B-Raf function.	[Sacks, David B.] Brigham & Womens Hosp, Dept Pathol, Boston, MA 02115 USA; Harvard Univ, Sch Med, Boston, MA 02115 USA	Harvard University; Brigham & Women's Hospital; Harvard University; Harvard Medical School	Sacks, DB (corresponding author), Brigham & Womens Hosp, Dept Pathol, Thorn 530,75 Francis St, Boston, MA 02115 USA.	dsacks@rics.bwh.harvard.edu		Sacks, David/0000-0003-3100-0735	NATIONAL CANCER INSTITUTE [R01CA075205] Funding Source: NIH RePORTER; NCI NIH HHS [R01 CA075205] Funding Source: Medline	NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))		Agell N, 2002, CELL SIGNAL, V14, P649, DOI 10.1016/S0898-6568(02)00007-4; BABU YS, 1985, NATURE, V315, P37, DOI 10.1038/315037a0; Berridge MJ, 2000, NAT REV MOL CELL BIO, V1, P11, DOI 10.1038/35036035; Bosch M, 1998, J BIOL CHEM, V273, P22145, DOI 10.1074/jbc.273.34.22145; Bourguignon LYW, 2005, J BIOL CHEM, V280, P11961, DOI 10.1074/jbc.M411985200; Briggs MW, 2003, EMBO REP, V4, P571, DOI 10.1038/sj.embor.embor867; Briggs MW, 2003, FEBS LETT, V542, P7, DOI 10.1016/S0014-5793(03)00333-8; Briggs MW, 2002, J BIOL CHEM, V277, P7453, DOI 10.1074/jbc.M104315200; Brown MD, 2006, TRENDS CELL BIOL, V16, P242, DOI 10.1016/j.tcb.2006.03.002; Campbell SL, 1998, ONCOGENE, V17, P1395, DOI 10.1038/sj.onc.1202174; Chin D, 2000, TRENDS CELL BIOL, V10, P322, DOI 10.1016/S0962-8924(00)01800-6; Chong H, 2003, CELL SIGNAL, V15, P463, DOI 10.1016/S0898-6568(02)00139-0; CLAPHAM DE, 1995, CELL, V80, P259, DOI 10.1016/0092-8674(95)90408-5; Cook SJ, 1997, J BIOL CHEM, V272, P13309, DOI 10.1074/jbc.272.20.13309; Cullen PJ, 2006, CURR OPIN CELL BIOL, V18, P157, DOI 10.1016/j.ceb.2006.02.012; Downward J, 2001, NATURE, V411, P759, DOI 10.1038/35081138; Egea J, 2000, MOL CELL BIOL, V20, P1931, DOI 10.1128/MCB.20.6.1931-1946.2000; Erickson JW, 1997, J BIOL CHEM, V272, P24443, DOI 10.1074/jbc.272.39.24443; FARNSWORTH CL, 1995, NATURE, V376, P524, DOI 10.1038/376524a0; Fivaz M, 2005, J CELL BIOL, V170, P429, DOI 10.1083/jcb.200409157; Fukata M, 1997, J BIOL CHEM, V272, P29579, DOI 10.1074/jbc.272.47.29579; Grewal SS, 2000, J BIOL CHEM, V275, P3722, DOI 10.1074/jbc.275.5.3722; Hart MJ, 1996, EMBO J, V15, P2997, DOI 10.1002/j.1460-2075.1996.tb00663.x; Ho YD, 1999, J BIOL CHEM, V274, P464, DOI 10.1074/jbc.274.1.464; Jeong HW, 2007, J BIOL CHEM, V282, P20752, DOI 10.1074/jbc.M700487200; Ji QS, 2000, ONCOGENE, V19, P1853, DOI 10.1038/sj.onc.1203517; Jordan JD, 2000, CELL, V103, P193, DOI 10.1016/S0092-8674(00)00112-4; Jorissen RN, 2003, EXP CELL RES, V284, P31, DOI 10.1016/S0014-4827(02)00098-8; Joyal JL, 1997, J BIOL CHEM, V272, P15419, DOI 10.1074/jbc.272.24.15419; Kolch W, 2005, NAT REV MOL CELL BIO, V6, P827, DOI 10.1038/nrm1743; Kuroda S, 1998, SCIENCE, V281, P832, DOI 10.1126/science.281.5378.832; Li ZG, 2003, J BIOL CHEM, V278, P4347, DOI 10.1074/jbc.M208579200; Li ZG, 1999, J BIOL CHEM, V274, P37885, DOI 10.1074/jbc.274.53.37885; Liu Q, 2005, J CELL BIOL, V170, P183, DOI 10.1083/jcb.200504167; Martin-Nieto J, 1998, BIOCHEMISTRY-US, V37, P227, DOI 10.1021/bi971765v; Mateer SC, 2003, CELL MOTIL CYTOSKEL, V55, P147, DOI 10.1002/cm.10118; Mateer SC, 2002, J BIOL CHEM, V277, P12324, DOI 10.1074/jbc.M109535200; Mbele GO, 2002, J BIOL CHEM, V277, P49998, DOI 10.1074/jbc.M205363200; MEDEMA JP, 1994, MOL CELL BIOL, V14, P7078, DOI 10.1128/MCB.14.11.7078; MORGAN AJ, 1994, BIOCHEM J, V300, P665, DOI 10.1042/bj3000665; Morrison DK, 2003, ANNU REV CELL DEV BI, V19, P91, DOI 10.1146/annurev.cellbio.19.111401.091942; Morrison DK, 1997, CURR OPIN CELL BIOL, V9, P174, DOI 10.1016/S0955-0674(97)80060-9; PAWSON T, 1995, NATURE, V373, P573, DOI 10.1038/373573a0; Pearson G, 2001, ENDOCR REV, V22, P153, DOI 10.1210/er.22.2.153; Phillips-Mason PJ, 2006, J BIOL CHEM, V281, P4903, DOI 10.1074/jbc.M506414200; Ren JG, 2005, J BIOL CHEM, V280, P34548, DOI 10.1074/jbc.M507321200; Ren JG, 2007, P NATL ACAD SCI USA, V104, P10465, DOI 10.1073/pnas.0611308104; Ritt DA, 2007, CURR BIOL, V17, P179, DOI 10.1016/j.cub.2006.11.061; ROSEN LB, 1994, NEURON, V12, P1207, DOI 10.1016/0896-6273(94)90438-3; Roux PP, 2004, MICROBIOL MOL BIOL R, V68, P320, DOI 10.1128/MMBR.68.2.320-344.2004; Roy M, 2005, MOL CELL BIOL, V25, P7940, DOI 10.1128/MCB.25.18.7940-7952.2005; Roy M, 2004, J BIOL CHEM, V279, P17329, DOI 10.1074/jbc.M308405200; Sacks DB, 2006, BIOCHEM SOC T, V34, P833, DOI 10.1042/BST0340833; SACKS DB, 1991, ANAL BIOCHEM, V194, P369, DOI 10.1016/0003-2697(91)90243-M; Schrick C, 2007, NEURON, V55, P786, DOI 10.1016/j.neuron.2007.07.034; Swart-Mataraza JM, 2002, J BIOL CHEM, V277, P24753, DOI 10.1074/jbc.M111165200; Tebar F, 2002, MOL BIOL CELL, V13, P2057, DOI 10.1091/mbc.01-12-0571; Terai K, 2006, EMBO J, V25, P3556, DOI 10.1038/sj.emboj.7601241; Thomas GM, 2004, NAT REV NEUROSCI, V5, P173, DOI 10.1038/nrn1346; Villalonga P, 2001, MOL CELL BIOL, V21, P7345, DOI 10.1128/MCB.21.21.7345-7354.2001; Wellbrock C, 2004, NAT REV MOL CELL BIO, V5, P875, DOI 10.1038/nrm1498; Yamaguchi T, 2004, J BIOL CHEM, V279, P40419, DOI 10.1074/jbc.M405079200	62	39	42	0	1	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	AUG 22	2008	283	34					22972	22982		10.1074/jbc.M804626200	http://dx.doi.org/10.1074/jbc.M804626200			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	337SI	18567582	hybrid, Green Accepted			2022-12-27	WOS:000258455400010
J	Goodman, JM				Goodman, Joel M.			The gregarious lipid droplet	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Review							DIFFERENTIATION-RELATED PROTEIN; DOMINANT-NEGATIVE MUTANT; ENDOPLASMIC-RETICULUM; SURFACE-LAYER; BODIES; PERILIPIN; CAVEOLIN; MITOCHONDRIA; CHOLESTEROL; ASSOCIATION	Cytoplasmic lipid droplets were considered until recently to be in the same category as glycogen granules, simple storage sites for energy, waxing and waning as metabolic energy needs dictated, but otherwise inert particles. It has become clear, however, that droplets are much more than isolated storage depots in the cell and that they can skate around on the cytoskeleton, physically interact with several organelles over short or long durations, and be beasts of burden, storing important molecules unrelated to lipids for later use. Although important clues to the panoply of droplet functions have come to light as a result of several proteomics studies, some behavioral qualities of this organelle were apparent from older morphological studies. Droplets are indeed gregarious. In this Minireview, after first considering the basic biochemical properties of lipid droplets, I shall focus on their interactions with other organelles, as manifest by morphological and dynamic studies and hinted at by proteomics. The important functions of droplets in storing and chaperoning proteins are well covered in a recent review (1) and will not be discussed here.	Univ Texas SW Med Sch, Dept Pharmacol, Dallas, TX 75390 USA	University of Texas System; University of Texas Southwestern Medical Center Dallas	Goodman, JM (corresponding author), Univ Texas SW Med Sch, Dept Pharmacol, Dallas, TX 75390 USA.	joel.goodman@utsouthwestern.edu	Goodman, Joel M/A-6376-2012		NIGMS NIH HHS [R01 GM084210] Funding Source: Medline; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM084210] Funding Source: NIH RePORTER	NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		Andersson L, 2006, J CELL SCI, V119, P2246, DOI 10.1242/jcs.02941; Ashrafi Kaveh, 2007, WormBook, P1; Bartz R, 2007, J LIPID RES, V48, P837, DOI 10.1194/jlr.M600413-JLR200; Bartzt R, 2007, J PROTEOME RES, V6, P3256, DOI 10.1021/pr070158j; Bascom RA, 2003, MOL BIOL CELL, V14, P939, DOI 10.1091/mbc.E02-10-0633; Beller M, 2006, MOL CELL PROTEOMICS, V5, P1082, DOI 10.1074/mcp.M600011-MCP200; Binns D, 2006, J CELL BIOL, V173, P719, DOI 10.1083/jcb.200511125; BLANCHETTEMACKIE EJ, 1995, J LIPID RES, V36, P1211; Bostrom P, 2005, ARTERIOSCL THROM VAS, V25, P1945, DOI 10.1161/01.ATV.0000179676.41064.d4; Bostrom P, 2007, NAT CELL BIOL, V9, P1286, DOI 10.1038/ncb1648; Brasaemle DL, 2007, J LIPID RES, V48, P2547, DOI 10.1194/jlr.R700014-JLR200; Capuano F, 2007, BIOTECHNOL ADV, V25, P203, DOI 10.1016/j.biotechadv.2006.11.006; CHAPMAN KD, 1991, J CELL BIOL, V115, P995, DOI 10.1083/jcb.115.4.995; Cocchiaro JL, 2008, P NATL ACAD SCI USA, V105, P9379, DOI 10.1073/pnas.0712241105; Cohen AW, 2004, DIABETES, V53, P1261, DOI 10.2337/diabetes.53.5.1261; Dugail I, 2007, CELL MOL LIFE SCI, V64, P2452, DOI 10.1007/s00018-007-7277-6; GENNIS RB, 1989, BIOMEMBRANES MOL STR, P21; GREENBERG AS, 1991, J BIOL CHEM, V266, P11341; Guo Y, 2008, NATURE, V453, P657, DOI 10.1038/nature06928; Habeler G, 2002, NUCLEIC ACIDS RES, V30, P80, DOI 10.1093/nar/30.1.80; Hayashi Y, 2001, PROTOPLASMA, V218, P83, DOI 10.1007/BF01288364; Hoepfner D, 2005, CELL, V122, P85, DOI 10.1016/j.cell.2005.04.025; Hsieh K, 2005, PLANT J, V43, P889, DOI 10.1111/j.1365-313X.2005.02502.x; KRUIP TAM, 1983, GAMETE RES, V8, P29, DOI 10.1002/mrd.1120080105; LAW JH, 1989, J BIOL CHEM, V264, P16335; Le Lay S, 2006, TRAFFIC, V7, P549, DOI 10.1111/j.1600-0854.2006.00406.x; Liu PS, 2007, BBA-MOL CELL RES, V1773, P784, DOI 10.1016/j.bbamcr.2007.02.004; Marchesan D, 2003, J BIOL CHEM, V278, P27293, DOI 10.1074/jbc.M301430200; Marcinkiewicz A, 2006, J BIOL CHEM, V281, P11901, DOI 10.1074/jbc.M600171200; Martin S, 2005, J BIOL CHEM, V280, P42325, DOI 10.1074/jbc.M506651200; Murphy DJ, 1999, TRENDS BIOCHEM SCI, V24, P109, DOI 10.1016/S0968-0004(98)01349-8; Nagayama M, 2007, J LIPID RES, V48, P9, DOI 10.1194/jlr.M600155-JLR200; NOVIKOFF AB, 1980, J CELL BIOL, V87, P180, DOI 10.1083/jcb.87.1.180; Ozeki S, 2005, J CELL SCI, V118, P2601, DOI 10.1242/jcs.02401; Packter NM, 1995, ARCH MICROBIOL, V164, P420, DOI 10.1007/BF02529740; Pol A, 2005, MOL BIOL CELL, V16, P2091, DOI 10.1091/mbc.E04-08-0737; Pol A, 2001, J CELL BIOL, V152, P1057, DOI 10.1083/jcb.152.5.1057; Pol A, 2004, MOL BIOL CELL, V15, P99, DOI 10.1091/mbc.E03-06-0368; Prattes S, 2000, J CELL SCI, V113, P2977; Rajakumari S, 2008, PROG LIPID RES, V47, P157, DOI 10.1016/j.plipres.2008.01.001; Rizzuto R, 1998, SCIENCE, V280, P1763, DOI 10.1126/science.280.5370.1763; Robenek H, 2005, J LIPID RES, V46, P1331, DOI 10.1194/jlr.M400323-JLR200; Robenek H, 2006, J CELL SCI, V119, P4215, DOI 10.1242/jcs.03191; Schrader M, 2001, J HISTOCHEM CYTOCHEM, V49, P1421, DOI 10.1177/002215540104901110; Shaw CS, 2008, HISTOCHEM CELL BIOL, V129, P65, DOI 10.1007/s00418-007-0349-8; Simmen T, 2005, EMBO J, V24, P717, DOI 10.1038/sj.emboj.7600559; STEMBERGER BH, 1984, CELL TISSUE RES, V236, P471, DOI 10.1007/BF00214252; Sturmey RG, 2006, REPRODUCTION, V132, P829, DOI 10.1530/REP-06-0073; Szymanski KM, 2007, P NATL ACAD SCI USA, V104, P20890, DOI 10.1073/pnas.0704154104; Targett-Adams P, 2003, J BIOL CHEM, V278, P15998, DOI 10.1074/jbc.M211289200; Tarnopolsky MA, 2007, AM J PHYSIOL-REG I, V292, pR1271, DOI 10.1152/ajpregu.00472.2006; Tauchi-Sato K, 2002, J BIOL CHEM, V277, P44507, DOI 10.1074/jbc.M207712200; Valetti C, 1999, MOL BIOL CELL, V10, P4107, DOI 10.1091/mbc.10.12.4107; Vock R, 1996, J EXP BIOL, V199, P1689; Welte MA, 2005, CURR BIOL, V15, P1266, DOI 10.1016/j.cub.2005.06.062; Welte MA, 2007, TRENDS CELL BIOL, V17, P363, DOI 10.1016/j.tcb.2007.06.004; Wolins NE, 2006, FEBS LETT, V580, P5484, DOI 10.1016/j.febslet.2006.08.040	57	194	201	0	92	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	OCT 17	2008	283	42					28005	28009		10.1074/jbc.R800042200	http://dx.doi.org/10.1074/jbc.R800042200			5	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	359EN	18611863	Green Published, hybrid			2022-12-27	WOS:000259969300001
J	Chevallier, J; Chamoun, Z; Jiang, GW; Prestwich, G; Sakai, N; Matile, S; Parton, RG; Gruenberg, J				Chevallier, Julien; Chamoun, Zeina; Jiang, Guowei; Prestwich, Glenn; Sakai, Naomi; Matile, Stefan; Parton, Robert G.; Gruenberg, Jean			Lysobisphosphatidic acid controls endosomal cholesterol levels	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							NIEMANN-PICK-DISEASE; TRANSPORT; BIOGENESIS; VESICLES; ALIX; DEGRADATION; TRAFFICKING; COMPARTMENT; MEMBRANES; PATHWAY	Most cell types acquire cholesterol by endocytosis of circulating low density lipoprotein, but little is known about the mechanisms of intra-endosomal cholesterol transport and about the primary cause of its aberrant accumulation in the cholesterol storage disorder Niemann-Pick type C (NPC). Here we report that lysobisphosphatidic acid (LBPA), an unconventional phospholipid that is only detected in late endosomes, regulates endosomal cholesterol levels under the control of Alix/AlP1, which is an LBPA-interacting protein involved in sorting into multivesicular endosomes. We find that Alix down-expression decreases both LBPA levels and the lumenal vesicle content of late endosomes. Cellular cholesterol levels are also decreased, presumably because the storage capacity of endosomes is affected and thus cholesterol clearance accelerated. Both lumenal membranes and cholesterol can be restored in Alix knockdown cells by exogenously added LBPA. Conversely, we also find that LBPA becomes limiting upon pathological cholesterol accumulation in NPC cells, because the addition of exogenous LBPA, but not of LBPA isoforms or analogues, partially reverts the NPC phenotype. We conclude that LBPA controls the cholesterol capacity of endosomes.	[Chevallier, Julien; Chamoun, Zeina; Gruenberg, Jean] Univ Geneva, Dept Biochem, CH-1211 Geneva 4, Switzerland; [Sakai, Naomi] Univ Geneva, Dept Organ Chem, CH-1211 Geneva 4, Switzerland; [Jiang, Guowei; Prestwich, Glenn; Matile, Stefan] Univ Utah, Dept Med Chem, Salt Lake City, UT 84108 USA; [Parton, Robert G.] Univ Queensland, Inst Mol Biosci, Brisbane, Qld 4072, Australia; [Parton, Robert G.] Univ Queensland, Ctr Microscopy & Microanal, Brisbane, Qld 4072, Australia	University of Geneva; University of Geneva; Utah System of Higher Education; University of Utah; University of Queensland; University of Queensland	Gruenberg, J (corresponding author), Univ Geneva, Dept Biochem, 30 Quai E Ansermet, CH-1211 Geneva 4, Switzerland.	jean.gruenberg@biochem.unige.ch	Parton, Robert G/C-5673-2009; Chevallier, Julien/AAY-9567-2020; Sakai, Naomi/AFN-6204-2022; Matile, Stefan/AFL-7826-2022	Parton, Robert G/0000-0002-7494-5248; Chevallier, Julien/0000-0002-4423-9502; Sakai, Naomi/0000-0002-9460-1944; Matile, Stefan/0000-0002-8537-8349	Swiss National Science Foundation; Telethon; Australian National Health and Medical Research Council	Swiss National Science Foundation(Swiss National Science Foundation (SNSF)European Commission); Telethon(Fondazione Telethon); Australian National Health and Medical Research Council(National Health and Medical Research Council (NHMRC) of Australia)	This work was supported by the Swiss National Science Foundation and the Telethon (to J. G.) and the Australian National Health and Medical Research Council (to R. G. P.). The costs of publication of this article were defrayed in part by the payment of page charges. This article must therefore be hereby marked "advertisement" in accordance with 18 U.S.C. Section 1734 solely to indicate this fact.	Abrami L, 2004, J CELL BIOL, V166, P645, DOI 10.1083/jcb.200312072; ANIENTO F, 1993, J CELL BIOL, V123, P1373, DOI 10.1083/jcb.123.6.1373; Cabezas A, 2005, J CELL SCI, V118, P2625, DOI 10.1242/jcs.02382; Chen CS, 1999, LANCET, V354, P901, DOI 10.1016/S0140-6736(98)10034-X; Chen W, 2001, J BIOL CHEM, V276, P43564, DOI 10.1074/jbc.M107938200; Chevallier J, 2000, ORG LETT, V2, P1859, DOI 10.1021/ol0059246; Cluett EB, 1997, MOL BIOL CELL, V8, P2233, DOI 10.1091/mbc.8.11.2233; Dikic I, 2004, BIOESSAYS, V26, P604, DOI 10.1002/bies.20068; Frolov A, 2001, J BIOL CHEM, V276, P46414, DOI 10.1074/jbc.M108099200; Futerman AH, 2004, NAT REV MOL CELL BIO, V5, P554, DOI 10.1038/nrm1423; Gallegos AM, 2002, CHEM PHYS LIPIDS, V116, P19, DOI 10.1016/S0009-3084(02)00018-X; GAMBLE W, 1978, J LIPID RES, V19, P1068; GRUENBERG J, 1985, EUR J CELL BIOL, V38, P312; GRUENBERG J, 1989, J CELL BIOL, V108, P1301, DOI 10.1083/jcb.108.4.1301; Gruenberg J, 2004, NAT REV MOL CELL BIO, V5, P317, DOI 10.1038/nrm1360; Hao MM, 2002, J BIOL CHEM, V277, P609, DOI 10.1074/jbc.M108861200; Holtta-Vuori M, 2000, CURR BIOL, V10, P95, DOI 10.1016/S0960-9822(99)99991-8; Hurley JH, 2006, ANNU REV BIOPH BIOM, V35, P277, DOI 10.1146/annurev.biophys.35.040405.102126; Ikonen E, 2004, SEMIN CELL DEV BIOL, V15, P445, DOI 10.1016/j.semcdb.2004.03.001; Jiang GW, 2005, ORG LETT, V7, P3837, DOI 10.1021/ol051194w; Ko DC, 2001, MOL BIOL CELL, V12, P601, DOI 10.1091/mbc.12.3.601; Kobayashi T, 1999, NAT CELL BIOL, V1, P113, DOI 10.1038/10084; Kobayashi T, 1998, NATURE, V392, P193, DOI 10.1038/32440; Kobayashi T, 2002, J BIOL CHEM, V277, P32157, DOI 10.1074/jbc.M202838200; Kolter T, 2005, ANNU REV CELL DEV BI, V21, P81, DOI 10.1146/annurev.cellbio.21.122303.120013; KORNFELD S, 1989, ANNU REV CELL BIOL, V5, P483, DOI 10.1146/annurev.cb.05.110189.002411; KREIS TE, 1986, EMBO J, V5, P931, DOI 10.1002/j.1460-2075.1986.tb04306.x; LAEMMLI UK, 1970, NATURE, V227, P680, DOI 10.1038/227680a0; Le Blanc I, 2005, NAT CELL BIOL, V7, P653, DOI 10.1038/ncb1269; Lebrand C, 2002, EMBO J, V21, P1289, DOI 10.1093/emboj/21.6.1289; Liscum L, 2000, TRAFFIC, V1, P218, DOI 10.1034/j.1600-0854.2000.010304.x; LISCUM L, 1989, J BIOL CHEM, V264, P11796; Lusa S, 2001, J CELL SCI, V114, P1893; Matsuo H, 2004, SCIENCE, V303, P531, DOI 10.1126/science.1092425; Maxfield FR, 2005, NATURE, V438, P612, DOI 10.1038/nature04399; Mayran N, 2003, EMBO J, V22, P3242, DOI 10.1093/emboj/cdg321; Mobius W, 2003, TRAFFIC, V4, P222; Narita K, 2005, FASEB J, V19, P1558, DOI 10.1096/fj.04-2714fje; Neufeld EB, 2004, J BIOL CHEM, V279, P15571, DOI 10.1074/jbc.M314160200; Odorizzi G, 2006, J CELL SCI, V119, P3025, DOI 10.1242/jcs.03072; PARTON RG, 1992, J CELL SCI, V103, P335; Puri V, 1999, NAT CELL BIOL, V1, P386, DOI 10.1038/14084; Schmidt MHH, 2004, MOL CELL BIOL, V24, P8981, DOI 10.1128/MCB.24.20.8981-8993.2004; Simons K, 2000, TRENDS CELL BIOL, V10, P459, DOI 10.1016/S0962-8924(00)01847-X; Sobo K, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000851; Sobo K, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000391; Sturley SL, 2004, BBA-MOL CELL BIOL L, V1685, P83, DOI 10.1016/j.bbalip.2004.08.014; Vanier MT, 2003, CLIN GENET, V64, P269, DOI 10.1034/j.1399-0004.2003.00147.x; VANIER MT, 1983, BIOCHIM BIOPHYS ACTA, V750, P178, DOI 10.1016/0005-2760(83)90218-7; Zhang M, 2001, J BIOL CHEM, V276, P3417, DOI 10.1074/jbc.M005393200	51	140	140	3	15	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	OCT 10	2008	283	41					27871	27880		10.1074/jbc.M801463200	http://dx.doi.org/10.1074/jbc.M801463200			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	355OW	18644787	hybrid			2022-12-27	WOS:000259719200058
J	Zimmer, SM; Liu, J; Clayton, JL; Stephens, DS; Snyder, JP				Zimmer, Shanta M.; Liu, Jin; Clayton, Jaime L.; Stephens, David S.; Snyder, James P.			Paclitaxel binding to human and murine MD-2	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							TOLL-LIKE RECEPTOR-4; LIPOPOLYSACCHARIDE MIMETIC ACTION; LIPID-A; SIGNAL-TRANSDUCTION; TLR4-MD-2 COMPLEX; CRYSTAL-STRUCTURE; BETA-TUBULIN; MOUSE MD-2; TAXOL; PROTEIN	Paclitaxel (PTX) is an important cancer chemotherapeutic agent that binds to beta-tubulin and prevents mitosis through microtubule overstabilization. Recent evidence also implicates PTX in the induction of apoptosis of cancer cells via the TLR4 innate immune pathway. The TLR4 accessory protein, MD-2, is an essential component for the species-specific proinflammatory activity of PTX on murine cells. However, whether PTX binds to human MD-2 and how MD-2 and TLR4 interact with PTX are not well defined. Recombinant human MD-2 (rhMD-2) was produced in a Pichia pastoris expression system, and the interaction between rhMD-2 and PTX was assessed by an enzyme-linked immunosorbent assay to show that PTX binds rhMD-2. Formation of the latter complex was found to be dose-dependent and inhibited by anti-MD-2 antibody but not by an isotype control antibody. As measured by human tumor necrosis factor alpha production, human THP-1 monocytes expressing TLR4 and MD-2 were poorly responsive to the addition of PTX, but murine macrophages expressing TLR4 and MD-2 responded in a dose-dependent manner. Human embryonic kidney (HEK293) cells transfected with both human TLR4 and human MD-2 or human MD-2 and murine TLR4 were also poorly responsive to PTX (10 mu M). However, HEK293 cells transfected with murine MD-2 and human TLR4 or murine MD-2 and murine TLR4 were highly responsive to PTX (10 mu M), indicating that the murine MD-2/ PTX interaction is required for TLR4 activation. To further define the structural differences for MD-2/ TLR4 activation, crystal structures of both murine and human MD-2 were subjected to PTX docking by computational methods. These models indicate that PTX binds in the pocket of both human and mouse MD-2 structures. The species-specific difference between human and murine MD-2 activation of TLR4 by PTX can be explained by alterations of surface charge distribution (i.e. electrostatic potential), binding pocket size, and the locus of PTX binding within the MD-2 pocket, which results in reorganization of the 123-130 amino acid loop. In particular, Phe(126) appears to operate as a bridge for TLR4.MD-2 dimerization in the mouse but not the human protein.	[Zimmer, Shanta M.; Stephens, David S.] Emory Univ, Dept Chem, Atlanta, GA 30322 USA; [Liu, Jin; Clayton, Jaime L.; Snyder, James P.] Emory Univ, Sch Med, Div Infect Dis, Atlanta, GA 30322 USA	Emory University; Emory University	Zimmer, SM (corresponding author), Vet Affairs Med Ctr, Res Serv 151, 1670 Clairmont Rd, Decatur, GA 30033 USA.		Stephens, David S/A-8788-2012		National Institutes of Health [K08 AI060966-03, R01 AI033517-10, R01 CA-69571]; NATIONAL CANCER INSTITUTE [R01CA069571] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI033517, K08AI060966] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This work was supported, in whole or in part, by National Institutes of Health Grants K08 AI060966-03 (to S. M. Z.), R01 AI033517-10 (to D. S. S.), and R01 CA-69571 (to J. P. S.). The costs of publication of this article were defrayed in part by the payment of page charges. This article must therefore be hereby marked "advertisement" in accordance with 18 U.S.C. Section 1734 solely to indicate this fact.	Bertoni C, 1997, MAMM GENOME, V8, P90, DOI 10.1007/s003359900364; BRADFORD MM, 1976, ANAL BIOCHEM, V72, P248, DOI 10.1016/0003-2697(76)90527-3; Chow JC, 1999, J BIOL CHEM, V274, P10689, DOI 10.1074/jbc.274.16.10689; CLEVELAND DW, 1977, J BIOL CHEM, V252, P1102; Derewenda U, 2002, J MOL BIOL, V318, P189, DOI 10.1016/S0022-2836(02)00027-X; Dundas J, 2006, NUCLEIC ACIDS RES, V34, pW116, DOI 10.1093/nar/gkl282; Fishman MN, 2006, CLIN CANCER RES, V12, P523, DOI 10.1158/1078-0432.CCR-05-0928; Friedland N, 2003, P NATL ACAD SCI USA, V100, P2512, DOI 10.1073/pnas.0437840100; Ganesh T, 2004, P NATL ACAD SCI USA, V101, P10006, DOI 10.1073/pnas.0403459101; Ganesh T, 2007, J MED CHEM, V50, P713, DOI 10.1021/jm061071x; Gioannini TL, 2004, P NATL ACAD SCI USA, V101, P4186, DOI 10.1073/pnas.0306906101; Gruber A, 2004, J BIOL CHEM, V279, P28475, DOI 10.1074/jbc.M400993200; HORWITZ SB, 1986, ANN NY ACAD SCI, V466, P733, DOI 10.1111/j.1749-6632.1986.tb38455.x; Hung LC, 2007, BIOCHEM PHARMACOL, V73, P1957, DOI 10.1016/j.bcp.2007.03.006; Hyakushima N, 2004, J IMMUNOL, V173, P6949, DOI 10.4049/jimmunol.173.11.6949; Ichikawa S, 2005, J BIOCHEM, V137, P255, DOI 10.1093/jb/mvi039; Inohara N, 2002, TRENDS BIOCHEM SCI, V27, P219, DOI 10.1016/S0968-0004(02)02084-4; Jayaram B, 1998, J PHYS CHEM B, V102, P9571, DOI 10.1021/jp982007x; Kawasaki K, 2003, J ENDOTOXIN RES, V9, P301, DOI 10.1179/096805103225002548; Kawasaki K, 2003, J IMMUNOL, V170, P413, DOI 10.4049/jimmunol.170.1.413; Kawasaki K, 2000, J BIOL CHEM, V275, P2251, DOI 10.1074/jbc.275.4.2251; Kawasaki K, 2001, J ENDOTOXIN RES, V7, P232, DOI 10.1177/09680519010070030701; Kawasaki K, 2001, J IMMUNOL, V166, P11, DOI 10.4049/jimmunol.166.1.11; Kelly MG, 2006, CANCER RES, V66, P3859, DOI 10.1158/0008-5472.CAN-05-3948; Kim HM, 2007, CELL, V130, P906, DOI 10.1016/j.cell.2007.08.002; MANTHEY CL, 1994, J IMMUNOL, V152, P825; MANTHEY CL, 1992, J IMMUNOL, V149, P2459; MANTHEY CL, 1993, J EXP MED, V178, P695, DOI 10.1084/jem.178.2.695; Mata-Haro V, 2007, SCIENCE, V316, P1628, DOI 10.1126/science.1138963; MEDZHITOV R, 1997, NATURE, V388, P397; MIZUSHIMA S, 1990, NUCLEIC ACIDS RES, V18, P5322, DOI 10.1093/nar/18.17.5322; Moses JW, 2005, J AM COLL CARDIOL, V45, P1165, DOI 10.1016/j.jacc.2004.10.074; Muroi M, 2002, INFECT IMMUN, V70, P3546, DOI 10.1128/IAI.70.7.3546-3550.2002; Nishitania C, 2005, BIOCHEM BIOPH RES CO, V328, P586, DOI 10.1016/j.bbrc.2005.01.021; Ohnishi T, 2001, J IMMUNOL, V167, P3354, DOI 10.4049/jimmunol.167.6.3354; Ohto U, 2007, SCIENCE, V316, P1632, DOI 10.1126/science.1139111; Okamoto M, 2003, JNCI-J NATL CANCER I, V95, P316, DOI 10.1093/jnci/95.4.316; Okamoto Masato, 2003, Journal of Medical Investigation, V50, P9; Ozinsky A, 2000, P NATL ACAD SCI USA, V97, P13766, DOI 10.1073/pnas.250476497; Pugin J, 2004, BLOOD, V104, P4071, DOI 10.1182/blood-2003-04-1290; RAETZ CRH, 1985, J BIOL CHEM, V260, P6080; Rahman MM, 1998, CARBOHYD RES, V307, P311; Re F, 2003, J IMMUNOL, V171, P5272, DOI 10.4049/jimmunol.171.10.5272; SCHIFF PB, 1979, NATURE, V277, P665, DOI 10.1038/277665a0; Shimazu R, 1999, J EXP MED, V189, P1777, DOI 10.1084/jem.189.11.1777; Snyder JP, 2000, J AM CHEM SOC, V122, P724, DOI 10.1021/ja9930115; Snyder JP, 2001, P NATL ACAD SCI USA, V98, P5312, DOI 10.1073/pnas.051309398; Viriyakosol S, 2006, J BIOL CHEM, V281, P11955, DOI 10.1074/jbc.M511627200; Viriyakosol S, 2001, J BIOL CHEM, V276, P38044; Visintin A, 2003, J BIOL CHEM, V278, P48313, DOI 10.1074/jbc.M306802200; Visintin A, 2001, P NATL ACAD SCI USA, V98, P12156, DOI 10.1073/pnas.211445098; Vogel S, 2001, J ENDOTOXIN RES, V7, P237, DOI 10.1177/09680519010070030801; VRIEND G, 1990, J MOL GRAPHICS, V8, P52, DOI 10.1016/0263-7855(90)80070-V; Wang J, 2002, BRIT J HAEMATOL, V118, P638, DOI 10.1046/j.1365-2141.2002.03645.x; WANI MC, 1971, J AM CHEM SOC, V93, P2325, DOI 10.1021/ja00738a045; Wright CS, 2003, J MOL BIOL, V331, P951, DOI 10.1016/S0022-2836(03)00794-0; Zaks-Zilberman M, 2001, CYTOKINE, V15, P156, DOI 10.1006/cyto.2001.0935; Zimmer SM, 2007, GLYCOBIOLOGY, V17, P847, DOI 10.1093/glycob/cwm057; Zughaier SM, 2005, INFECT IMMUN, V73, P2940, DOI 10.1128/IAI.73.5.2940-2950.2005; Zughaier SM, 2004, INFECT IMMUN, V72, P371, DOI 10.1128/IAI.72.1.371-380.2004	60	67	70	3	12	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	OCT 10	2008	283	41					27916	27926		10.1074/jbc.M802826200	http://dx.doi.org/10.1074/jbc.M802826200			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	355OW	18650420	Green Published, hybrid			2022-12-27	WOS:000259719200062
J	Beltrami, A; Rossmann, M; Fiorillo, MT; Paladini, F; Sorrentino, R; Saenger, W; Kumar, P; Ziegler, A; Uchanska-Ziegler, B				Beltrami, Alessandra; Rossmann, Maxim; Fiorillo, Maria Teresa; Paladini, Fabiana; Sorrentino, Rosa; Saenger, Wolfram; Kumar, Pravin; Ziegler, Andreas; Uchanska-Ziegler, Barbara			Citrullination-dependent differential presentation of a self-peptide by HLA-B27 subtypes	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							3-DIMENSIONAL STRUCTURE; ANKYLOSING-SPONDYLITIS; CUTTING EDGE; PROTEINS; DISEASE; RECOGNITION; ANTIBODIES; ANTIGEN; AUTOANTIBODIES; CONFORMATION	Inflammatory processes are accompanied by the posttranslational modification of certain arginine residues within proteins to yield citrulline, although it is largely unknown how this modification influences antigen presentation. We employed crystallographic and functional studies to investigate whether the exchange of arginine to citrulline affects the display of a peptide by two human major histocompatibility antigen class I subtypes, HLA-B* 2705 and HLA-B* 2709. Both differ only in residue 116 within the peptide binding groove despite their differential association with ankylosing spondylitis, an inflammatory rheumatic disorder. The crystal structures described here show that a modified self-peptide, pVIPR-U5(RRKWURWHL; U = citrulline), is presented by the two HLA-B27 molecules in distinct conformations. These binding modes differ not only drastically from each other but also from the conformations exhibited by the non-citrullinated peptide in a given subtype. The differential reactivity of HLA-B27-restricted cytotoxic T cells with modified or unmodified pVIPR supports the structural findings and shows that the presentation of citrullinated peptides has the potential to influence immune responses.	[Beltrami, Alessandra; Ziegler, Andreas; Uchanska-Ziegler, Barbara] Free Univ Berlin, Charite Univ Med Berlin, Inst Immungenet, D-14195 Berlin, Germany; [Rossmann, Maxim; Saenger, Wolfram] Free Univ Berlin, Inst Chem & Biochem Kristallog, D-14195 Berlin, Germany; [Fiorillo, Maria Teresa; Paladini, Fabiana; Sorrentino, Rosa] Univ Roma La Sapienza, Dipartimento Biol Cellulare & Sviluppo, I-00185 Rome, Italy	Free University of Berlin; Humboldt University of Berlin; Charite Universitatsmedizin Berlin; Free University of Berlin; Sapienza University Rome	Ziegler, A (corresponding author), Free Univ Berlin, Charite Univ Med Berlin, Inst Immungenet, Campus Benjamin Franklin,Thielallee 73, D-14195 Berlin, Germany.	andreas.ziegler@charite.de	Sorrentino, Rosa/G-5472-2012	Sorrentino, Rosa/0000-0002-9632-2383; Rossmann, Maxim/0000-0001-8811-3277; Paladini, Fabiana/0000-0003-1040-452X; FIORILLO, Maria Teresa/0000-0002-6859-5851	Deutsche Forschungsgemeinschaft [SFB 449]; VolkswagenStiftung [1/79 983]	Deutsche Forschungsgemeinschaft(German Research Foundation (DFG)); VolkswagenStiftung(Volkswagen)	This work was financially supported by Deutsche Forschungsgemeinschaft (SFB 449, B6), VolkswagenStiftung (1/79 983), Berliner Krebsgesellschaft (Ernst von Leyden fellowship to A. B.), Senate of Berlin (NaFoG fellowship to P. K.), Sonnenfeld-Stiftung, Berlin, and Fonds der Chemischen Industrie. The costs of publication of this article were defrayed in part by the payment of page charges. This article must therefore be hereby marked "advertisement" in accordance with 18 U. S. C. Section 1734 solely to indicate this fact.	BAILEY S, 1994, ACTA CRYSTALLOGR D, V50, P760, DOI 10.1107/s0907444994003112; Bizzaro N, 2007, CLIN CHEM LAB MED, V45, P150, DOI 10.1515/CCLM.2007.027; Borbulevych OY, 2007, J MOL BIOL, V372, P1123, DOI 10.1016/j.jmb.2007.07.025; BREWERTON DA, 1973, LANCET, V1, P904; Chapuy-Regaud S, 2005, CLIN EXP IMMUNOL, V139, P542, DOI 10.1111/j.1365-2249.2004.02708.x; DAMATO M, 1995, EUR J IMMUNOL, V25, P3199, DOI 10.1002/eji.1830251133; de Castro JAL, 2004, TISSUE ANTIGENS, V63, P424, DOI 10.1111/j.0001-2815.2004.00220.x; DeLano W, 2002, PYMOL 0 99; Ding YH, 1999, IMMUNITY, V11, P45, DOI 10.1016/S1074-7613(00)80080-1; ELLIS SA, 1982, HUM IMMUNOL, V5, P49, DOI 10.1016/0198-8859(82)90030-1; Emsley P, 2004, ACTA CRYSTALLOGR D, V60, P2126, DOI 10.1107/S0907444904019158; Fearon WR, 1939, BIOCHEM J, V33, P902, DOI 10.1042/bj0330902; Fiorillo MT, 2000, J CLIN INVEST, V106, P47, DOI 10.1172/JCI9295; Fiorillo MT, 2005, J BIOL CHEM, V280, P2962, DOI 10.1074/jbc.M410807200; FIORILLO MT, 2008, MOL MECH SPONDYLOART; GARBOCZI DN, 1992, P NATL ACAD SCI USA, V89, P3429, DOI 10.1073/pnas.89.8.3429; Gyorgy B, 2006, INT J BIOCHEM CELL B, V38, P1662, DOI 10.1016/j.biocel.2006.03.008; HAMMER RE, 1990, CELL, V63, P1099, DOI 10.1016/0092-8674(90)90512-D; Hill JA, 2003, J IMMUNOL, V171, P538, DOI 10.4049/jimmunol.171.2.538; Hillig RC, 2004, J BIOL CHEM, V279, P652, DOI 10.1074/jbc.M307457200; Hulsmeyer M, 2005, J MOL BIOL, V346, P1367, DOI 10.1016/j.jmb.2004.12.047; Hulsmeyer M, 2004, J EXP MED, V199, P271, DOI 10.1084/jem.20031690; Hulsmeyer M, 2002, J BIOL CHEM, V277, P47844, DOI 10.1074/jbc.M206392200; Ireland J, 2006, J IMMUNOL, V177, P1421, DOI 10.4049/jimmunol.177.3.1421; KELLY A, 1992, NATURE, V355, P641, DOI 10.1038/355641a0; Kersh GJ, 2001, J IMMUNOL, V166, P3345, DOI 10.4049/jimmunol.166.5.3345; Khan MA, 2007, AUTOIMMUN REV, V6, P183, DOI 10.1016/j.autrev.2006.11.003; Klareskog L, 2008, ANNU REV IMMUNOL, V26, P651, DOI 10.1146/annurev.immunol.26.021607.090244; LASKOWSKI RA, 1993, J APPL CRYSTALLOGR, V26, P283, DOI 10.1107/S0021889892009944; de Castro JAL, 2007, IMMUNOL LETT, V108, P27, DOI 10.1016/j.imlet.2006.10.004; MADDEN DR, 1992, CELL, V70, P1035, DOI 10.1016/0092-8674(92)90252-8; MADDEN DR, 1995, ANNU REV IMMUNOL, V13, P587, DOI 10.1146/annurev.iy.13.040195.003103; Makrygiannakis D, 2006, ANN RHEUM DIS, V65, P1219, DOI 10.1136/ard.2005.049403; Masson-Bessiere C, 2001, J IMMUNOL, V166, P4177, DOI 10.4049/jimmunol.166.6.4177; Matsuo K, 2006, ARTHRITIS RES THER, V8, DOI 10.1186/ar2085; MCDONALD IK, 1994, J MOL BIOL, V238, P777, DOI 10.1006/jmbi.1994.1334; Miley MJ, 2004, J EXP MED, V200, P1445, DOI 10.1084/jem.20040217; Miller PJ, 2007, J MOL BIOL, V373, P315, DOI 10.1016/j.jmb.2007.07.028; Murshudov GN, 1997, ACTA CRYSTALLOGR D, V53, P240, DOI 10.1107/S0907444996012255; Nielen MMJ, 2005, ANN RHEUM DIS, V64, P1199, DOI 10.1136/ard.2004.029389; Otwinowski Z., 1993, P CCP4 STUD WEEK DAT, P56; Perrakis A, 2001, ACTA CRYSTALLOGR D, V57, P1445, DOI 10.1107/S0907444901014007; Ramos M, 2002, J BIOL CHEM, V277, P28749, DOI 10.1074/jbc.M204155200; Rehm A, 2000, HUM IMMUNOL, V61, P408, DOI 10.1016/S0198-8859(99)00176-7; Ruckert C, 2006, J BIOL CHEM, V281, P2306, DOI 10.1074/jbc.M508528200; SCHLOSSTEIN L, 1973, NEW ENGL J MED, V288, P704, DOI 10.1056/NEJM197304052881403; Schuttelkopf AW, 2004, ACTA CRYSTALLOGR D, V60, P1355, DOI 10.1107/S0907444904011679; Sharma AK, 2001, J BIOL CHEM, V276, P21443, DOI 10.1074/jbc.M010791200; Stewart-Jones GBE, 2005, EUR J IMMUNOL, V35, P341, DOI 10.1002/eji.200425724; Tilleman K, 2008, RHEUMATOLOGY, V47, P597, DOI 10.1093/rheumatology/ken077; Vossenaar ER, 2004, ARTHRITIS RHEUM-US, V50, P3485, DOI 10.1002/art.20584; Vossenaar ER, 2003, ARTHRITIS RHEUM-US, V48, P2489, DOI 10.1002/art.11229; Vossenaar ER., 2004, CLIN APPL IMMUNOL RE, V4, P239, DOI [DOI 10.1016/j.cair.2003.11.001, 10.1016/j.cair.2003.11.001, DOI 10.1016/J.CAIR.2003.11.001]; VRIEND G, 1990, J MOL GRAPHICS, V8, P52, DOI 10.1016/0263-7855(90)80070-V; WALLACE AC, 1995, PROTEIN ENG, V8, P127, DOI 10.1093/protein/8.2.127; YOUNG BJJ, 1979, BRIT MED J, V2, P97, DOI 10.1136/bmj.2.6182.97; ZIEGLER A, 2008, MOL MECH SPONDYLOART	57	24	26	0	1	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	OCT 3	2008	283	40					27189	27199		10.1074/jbc.M802818200	http://dx.doi.org/10.1074/jbc.M802818200			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	353RT	18650441	hybrid			2022-12-27	WOS:000259586600039
J	Iwai, T; Murai, J; Yoshikawa, H; Tsumaki, N				Iwai, Takao; Murai, Junko; Yoshikawa, Hideki; Tsumaki, Noriyuki			Smad7 inhibits chondrocyte differentiation at multiple steps during endochondral bone formation and down-regulates p38 MAPK pathways	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							MORPHOGENETIC PROTEIN; GENE-EXPRESSION; CRE RECOMBINASE; I RECEPTORS; CARTILAGE DEVELOPMENT; GROWTH-PLATE; MOUSE; CHONDROGENESIS; PROLIFERATION; VIVO	Bone morphogenetic proteins (BMPs) play critical roles at various stages in endochondral bone formation. In vitro studies have demonstrated that Smad7 regulates transforming growth factor-beta and BMP signals by inhibiting Smad pathways in chondrocytes. However, the in vivo roles of Smad7 during cartilage development are unknown. To investigate distinct effects of Smad7 at different stages during chondrocyte differentiation, we generated a series of conditional transgenic mice that overexpress Smad7 in chondrocytes at various steps of differentiation by using the Cre/loxP system. Wegenerated Col11a2-lacZ(floxed)-Smad7 transgenic mice and mated them with three types of Cre transgenic mice to obtain Smad7(Prx1), Smad7(11Enh), and Smad7(11Prom) conditional transgenic mice. Smad7(Prx1) mice overexpressing Smad7 in condensing mesenchymal cells showed disturbed mesenchymal condensation associated with decreased Sox9 expression, leading to poor cartilage formation. Smad7(11Enh) mice overexpressing Smad7 in round chondrocytes showed decreased chondrocyte proliferation rates. Smad7(11Prom) mice overexpressing Smad7 in flat chondrocytes showed inhibited maturation of chondrocytes toward hypertrophy. Micromass culture of mesenchymal cells showed that BMP-induced cartilaginous nodule formation was down-regulated by overexpression of Smad7, but not Smad6. Overexpression of Smad7, but not Smad6, down-regulated the phosphorylation of p38 MAPKs. Our data provide in vivo evidence for distinct effects of Smad7 at different stages during chondrocyte differentiation and suggest that Smad7 in prechondrogenic cells inhibits chondrocyte differentiation possibly by down- regulating BMP- activated p38 MAPK pathways.	[Iwai, Takao; Murai, Junko; Tsumaki, Noriyuki] Osaka Univ, Grad Sch Med, Dept Bone & Cartilage Biol, Suita, Osaka 5650871, Japan; [Iwai, Takao; Murai, Junko; Yoshikawa, Hideki] Osaka Univ, Grad Sch Med, Dept Orthopaed Surg, Suita, Osaka 5650871, Japan	Osaka University; Osaka University	Tsumaki, N (corresponding author), Osaka Univ, Grad Sch Med, Dept Bone & Cartilage Biol, 2-2 Yamadaoka, Suita, Osaka 5650871, Japan.	ntsumaki@dbcb.med.osaka-u.ac.jp	Murai, Junko/AAU-9516-2021	Tsumaki, Noriyuki/0000-0002-0520-3654	Ministry of Education, Culture, Sports, Science, and Technology of Japan [18390415, 19659378]; Health and Labor Sciences of Japan	Ministry of Education, Culture, Sports, Science, and Technology of Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); Health and Labor Sciences of Japan	This work was supported in part by Scientific Research Grants 18390415 and 19659378 from the Ministry of Education, Culture, Sports, Science, and Technology of Japan and by Health and Labor Sciences of Japan research grants. The costs of publication of this article were defrayed in part by the payment of page charges. This article must therefore be hereby marked "advertisement" in accordance with 18 U. S. C. Section 1734 solely to indicate this fact.	Akiyama H, 2002, GENE DEV, V16, P2813, DOI 10.1101/gad.1017802; Baffi MO, 2004, DEV BIOL, V276, P124, DOI 10.1016/j.ydbio.2004.08.027; Bauge C, 2007, ARTHRITIS RHEUM, V56, P3020, DOI 10.1002/art.22840; Derynck R, 2003, NATURE, V425, P577, DOI 10.1038/nature02006; Fujii M, 1999, MOL BIOL CELL, V10, P3801, DOI 10.1091/mbc.10.11.3801; Fujimaki R, 2006, J BONE MINER METAB, V24, P191, DOI 10.1007/s00774-005-0671-y; Fujimaki R, 2005, J BONE MINER METAB, V23, P270, DOI 10.1007/s00774-004-0595-y; Fukuda T, 2006, GENESIS, V44, P159, DOI 10.1002/dvg.20201; Goto K, 2007, J BIOL CHEM, V282, P20603, DOI 10.1074/jbc.M702100200; Hoffman LM, 2006, J CELL BIOL, V174, P101, DOI 10.1083/jcb.200604150; Horiki M, 2004, J CELL BIOL, V165, P433, DOI 10.1083/jcb.200311015; Ito Y, 2002, DEV DYNAM, V224, P69, DOI 10.1002/dvdy.10088; Kaiser M, 2004, ARTHRITIS RHEUM-US, V50, P3535, DOI 10.1002/art.20750; Katagiri T, 2002, GENES CELLS, V7, P949, DOI 10.1046/j.1365-2443.2002.00573.x; Kobayashi T, 2005, P NATL ACAD SCI USA, V102, P18023, DOI 10.1073/pnas.0503617102; Korchynskyi O, 2002, J BIOL CHEM, V277, P4883, DOI 10.1074/jbc.M111023200; Kronenberg HM, 2006, ANN NY ACAD SCI, V1068, P1, DOI 10.1196/annals.1346.002; Li RG, 2006, J IMMUNOL, V176, P6777, DOI 10.4049/jimmunol.176.11.6777; Liao P, 2001, P NATL ACAD SCI USA, V98, P12283, DOI 10.1073/pnas.211086598; Logan M, 2002, GENESIS, V33, P77, DOI 10.1002/gene.10092; Luukko K, 2001, MECH DEVELOP, V101, P209, DOI 10.1016/S0925-4773(00)00556-6; Massague J, 2005, GENE DEV, V19, P2783, DOI 10.1101/gad.1350705; Miyazono K, 2001, J CELL PHYSIOL, V187, P265, DOI 10.1002/jcp.1080; Muskhelishvili L, 2003, J HISTOCHEM CYTOCHEM, V51, P1681, DOI 10.1177/002215540305101212; Nakamura K, 1999, EXP CELL RES, V250, P351, DOI 10.1006/excr.1999.4535; Oh CD, 2000, J BIOL CHEM, V275, P5613, DOI 10.1074/jbc.275.8.5613; Olsen BR, 2000, ANNU REV CELL DEV BI, V16, P191, DOI 10.1146/annurev.cellbio.16.1.191; PELTON RW, 1990, DEVELOPMENT, V110, P609; Peters PWJ, 1977, METHODS PRENATAL TOX, P153; Raingeaud J, 1996, MOL CELL BIOL, V16, P1247; Sakai K, 1997, BIOCHEM BIOPH RES CO, V237, P318, DOI 10.1006/bbrc.1997.7111; Sakou T, 1999, J BONE MINER RES, V14, P1145, DOI 10.1359/jbmr.1999.14.7.1145; Scharstuhl A, 2003, OSTEOARTHR CARTILAGE, V11, P773, DOI 10.1016/S1063-4584(03)00165-1; Shukunami C, 1996, J CELL BIOL, V133, P457, DOI 10.1083/jcb.133.2.457; Stanton LA, 2003, DEV BIOL, V263, P165, DOI 10.1016/S0012-1606(03)00321-X; Tsumaki N, 1996, J CELL BIOL, V134, P1573, DOI 10.1083/jcb.134.6.1573; Tsumaki N, 2005, CYTOKINE GROWTH F R, V16, P279, DOI 10.1016/j.cytogfr.2005.04.001; Tsumaki N, 2002, J BONE MINER RES, V17, P898, DOI 10.1359/jbmr.2002.17.5.898; Valcourt U, 2002, J BIOL CHEM, V277, P33545, DOI 10.1074/jbc.M202086200; Wang GY, 2005, J BONE MINER RES, V20, P1022, DOI 10.1359/JBMR.050113; Yanagisawa M, 2001, GENES CELLS, V6, P1091, DOI 10.1046/j.1365-2443.2001.00483.x; Yoon BS, 2005, P NATL ACAD SCI USA, V102, P5062, DOI 10.1073/pnas.0500031102; Yoon BS, 2006, DEVELOPMENT, V133, P4667, DOI 10.1242/dev.02680; Zhang JH, 2005, DEV BIOL, V284, P311, DOI 10.1016/j.ydbio.2005.05.036; Zhang R, 2006, P NATL ACAD SCI USA, V103, P365, DOI 10.1073/pnas.0507979103	45	59	61	0	5	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	OCT 3	2008	283	40					27154	27164		10.1074/jbc.M801175200	http://dx.doi.org/10.1074/jbc.M801175200			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	353RT	18644788	hybrid			2022-12-27	WOS:000259586600036
J	Filipp, D; Moemeni, B; Ferzoco, A; Kathirkamathamby, K; Zhang, J; Ballek, O; Davidson, D; Veillette, A; Julius, M				Filipp, Dominik; Moemeni, Behrouz; Ferzoco, Alessandra; Kathirkamathamby, Kirishanthy; Zhang, Jenny; Ballek, Ondrej; Davidson, Dominique; Veillette, Andre; Julius, Michael			Lck-dependent Fyn activation requires C terminus-dependent targeting of kinase-active Lck to lipid rafts	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							TYROSINE PROTEIN-KINASE; T-CELL-RECEPTOR; SRC-FAMILY KINASES; TCR-ALPHA-BETA; SIGNAL-TRANSDUCTION; SH2 DOMAIN; TRANSMEMBRANE ADAPTER; CRYSTAL-STRUCTURE; ANTIGEN RECEPTOR; HORMONE RECEPTOR	Mechanisms regulating the activation and delivery of function of Lck and Fyn are central to the generation of the most proximal signaling events emanating from the T cell antigen receptor (TcR) complex. Recent results demonstrate that lipid rafts (LR) segregate Lck and Fyn and play a fundamental role in the temporal and spatial coordination of their activation. Specifically, TcR-CD4 co-aggregation-induced Lck activation outside LR results in Lck translocation to LR where the activation of LR-resident Fyn ensues. Here we report a structure-function analysis toward characterizing the mechanism supporting Lck partitioning to LR and its capacity to activate co-localized Fyn. Using NIH 3T3 cells ectopically expressing FynT, we demonstrate that only LR-associated, kinase-active (Y505F)Lck reciprocally co-immunoprecipitates with and activates Fyn. Mutational analyses revealed a profound reduction in the formation of Lck-Fyn complexes and Fyn activation, using kinase domain mutants K273R and Y394F of (Y505F)Lck, both of which have profoundly compromised kinase activity. The only kinase-active Lck mutants tested that revealed impaired physical and enzymatic engagement with Fyn were those involving truncation of the C-terminal sequence YQPQP. Remarkably, sequential truncation of YQPQP resulted in an increasing reduction of kinase-active Lck partitioning to LR, in both fibroblasts and T cells. This in turn correlated with an ablation of the capacity of these truncates to enhance TcR-mediated interleukin-2 production. Thus, Lck-dependent Fyn activation is predicated by proximity-mediated transphosphorylation of the Fyn kinase domain, and targeting kinase-active Lck to LR is dependent on the C-terminal sequence QPQP.	[Filipp, Dominik; Moemeni, Behrouz; Ferzoco, Alessandra; Kathirkamathamby, Kirishanthy; Zhang, Jenny; Julius, Michael] Univ Toronto, Sunnybrook Res Inst, Toronto, ON M4N 3M5, Canada; [Filipp, Dominik; Moemeni, Behrouz; Ferzoco, Alessandra; Kathirkamathamby, Kirishanthy; Zhang, Jenny; Julius, Michael] Univ Toronto, Dept Immunol, Toronto, ON M4N 3M5, Canada; [Filipp, Dominik; Ballek, Ondrej] Inst Mol Genet AS CR, Immunol Lab, Prague 14220 4, Czech Republic; [Davidson, Dominique; Veillette, Andre] Clin Res Inst Montreal, Mol Oncol Lab, Montreal, PQ H2W 1R7, Canada; [Davidson, Dominique; Veillette, Andre] Univ Montreal, Dept Med, Montreal, PQ H3A 1A1, Canada; [Davidson, Dominique; Veillette, Andre] McGill Univ, Dept Med, Montreal, PQ H3T 1J4, Canada	University of Toronto; Sunnybrook Research Institute; University Toronto Affiliates; Sunnybrook Health Science Center; University of Toronto; Czech Academy of Sciences; Institute of Molecular Genetics of the Czech Academy of Sciences; Institut de Recherche Clinique de Montreal (IRCM); Universite de Montreal; Universite de Montreal; McGill University	Julius, M (corresponding author), Univ Toronto, Sunnybrook Res Inst, Rm A3-33,2075 Bayview Ave, Toronto, ON M4N 3M5, Canada.	michael.julius@sri.utoronto.ca	Filipp, Dominik/G-4395-2014	Filipp, Dominik/0000-0003-2506-9330	Canadian Institutes of Health Research [FRN9735]	Canadian Institutes of Health Research(Canadian Institutes of Health Research (CIHR))	This work was supported by Grant FRN9735 from the Canadian Institutes of Health Research. The costs of publication of this article were defrayed in part by the payment of page charges. This article must therefore be hereby marked "advertisement" in accordance with 18 U. S. C. Section 1734 solely to indicate this fact.	ABRAHAM N, 1990, MOL CELL BIOL, V10, P5197, DOI 10.1128/MCB.10.10.5197; ABRAHAM N, 1991, NATURE, V350, P62, DOI 10.1038/350062a0; AMREIN KE, 1988, P NATL ACAD SCI USA, V85, P4247, DOI 10.1073/pnas.85.12.4247; Bonnard M, 1997, CELL IMMUNOL, V175, P1, DOI 10.1006/cimm.1996.1044; Bougeret C, 1996, J BIOL CHEM, V271, P7465, DOI 10.1074/jbc.271.13.7465; Brdicka T, 2000, J EXP MED, V191, P1591, DOI 10.1084/jem.191.9.1591; Brdickova N, 2003, J EXP MED, V198, P1453, DOI 10.1084/jem.20031484; Brown MT, 1996, BBA-REV CANCER, V1287, P121, DOI 10.1016/0304-419X(96)00003-0; CARON L, 1992, MOL CELL BIOL, V12, P2720, DOI 10.1128/MCB.12.6.2720; CARRERA AC, 1993, P NATL ACAD SCI USA, V90, P442, DOI 10.1073/pnas.90.2.442; CARTWRIGHT CA, 1987, CELL, V49, P83, DOI 10.1016/0092-8674(87)90758-6; CHOW LML, 1993, NATURE, V365, P156, DOI 10.1038/365156a0; COOPER JA, 1988, P NATL ACAD SCI USA, V85, P4232, DOI 10.1073/pnas.85.12.4232; Costa MJ, 2004, ENDOCRINOLOGY, V145, P1464, DOI 10.1210/en.2003-1432; Cowan-Jacob SW, 2005, STRUCTURE, V13, P861, DOI 10.1016/j.str.2005.03.012; Davidson D, 2003, MOL CELL BIOL, V23, P2017, DOI 10.1128/MCB.23.6.2017-2028.2003; DAVIDSON D, 1992, J EXP MED, V175, P1483, DOI 10.1084/jem.175.6.1483; DAVIDSON D, 1994, J BIOL CHEM, V269, P10956; Doro U, 1996, MOL CELL BIOL, V16, P4996; Falahati R, 2007, J IMMUNOL, V178, P2056, DOI 10.4049/jimmunol.178.4.2056; Filipp D, 2004, MOL IMMUNOL, V41, P645, DOI 10.1016/j.molimm.2004.04.011; Filipp D, 2004, J IMMUNOL, V172, P4266, DOI 10.4049/jimmunol.172.7.4266; Filipp D, 2003, J EXP MED, V197, P1221, DOI 10.1084/jem.20022112; GAUEN LKT, 1992, MOL CELL BIOL, V12, P5438, DOI 10.1128/MCB.12.12.5438; Harrison SC, 2003, CELL, V112, P737, DOI 10.1016/S0092-8674(03)00196-X; HAUGHN L, 1992, NATURE, V358, P328, DOI 10.1038/358328a0; Haughn L, 1998, J EXP MED, V188, P1575, DOI 10.1084/jem.188.9.1575; Hawash IY, 2002, J BIOL CHEM, V277, P5683, DOI 10.1074/jbc.M110002200; Heck E, 2006, J VIROL, V80, P9934, DOI 10.1128/JVI.01112-06; Hermiston ML, 2002, J CLIN INVEST, V109, P9; Holdorf AD, 2002, NAT IMMUNOL, V3, P259, DOI 10.1038/ni761; Horejsi V, 2003, IMMUNOL REV, V191, P148, DOI 10.1034/j.1600-065X.2003.00001.x; Hubbard SR, 2000, ANNU REV BIOCHEM, V69, P373, DOI 10.1146/annurev.biochem.69.1.373; Irles C, 2003, NAT IMMUNOL, V4, P189, DOI 10.1038/ni877; JULIUS M, 1993, IMMUNOL TODAY, V14, P177; KAMPS MP, 1986, MOL CELL BIOL, V6, P751, DOI 10.1128/MCB.6.3.751; Kesavan KP, 2002, J BIOL CHEM, V277, P14666, DOI 10.1074/jbc.M111911200; Kimura A, 2001, P NATL ACAD SCI USA, V98, P9098, DOI 10.1073/pnas.151252898; Kjellen P, 2002, VIROLOGY, V297, P281, DOI 10.1006/viro.2002.1419; KUBO RT, 1989, J IMMUNOL, V142, P2736; Lallemand-Breitenbach V, 2004, J BIOL CHEM, V279, P41168, DOI 10.1074/jbc.M406482200; Leung BL, 1999, J IMMUNOL, V163, P1334; Lingwood D, 2007, NAT PROTOC, V2, P2159, DOI 10.1038/nprot.2007.294; LOUIE RR, 1988, J VIROL, V62, P4673, DOI 10.1128/JVI.62.12.4673-4679.1988; MAROUN CR, 1994, EUR J IMMUNOL, V24, P959, DOI 10.1002/eji.1830240427; Martin GS, 2001, NAT REV MOL CELL BIO, V2, P467, DOI 10.1038/35073094; Mayer BJ, 1997, CURR BIOL, V7, pR295, DOI 10.1016/S0960-9822(06)00141-2; Mendieta J, 2004, J MOL GRAPH MODEL, V23, P189, DOI 10.1016/j.jmgm.2004.06.001; Miller CE, 2004, BIOPHYS J, V86, P3700, DOI 10.1529/biophysj.103.032508; Mitchell JL, 2007, J MOL BIOL, V366, P1282, DOI 10.1016/j.jmb.2006.12.026; Moarefi I, 1997, NATURE, V385, P650, DOI 10.1038/385650a0; Molon B, 2005, NAT IMMUNOL, V6, P465, DOI 10.1038/ni1191; Morrow IC, 2005, TRAFFIC, V6, P725, DOI 10.1111/j.1600-0854.2005.00318.x; Navratil AM, 2006, BIOL REPROD, V74, P788, DOI 10.1095/biolreprod.105.048157; Palacios EH, 2004, ONCOGENE, V23, P7990, DOI 10.1038/sj.onc.1208074; Park I, 1995, P NATL ACAD SCI USA, V92, P12338, DOI 10.1073/pnas.92.26.12338; Pawson AJ, 2003, ENDOCRINOLOGY, V144, P3860, DOI 10.1210/en.2003-0028; Porter JA, 1996, SCIENCE, V274, P255, DOI 10.1126/science.274.5285.255; Pui JC, 1999, IMMUNITY, V11, P299, DOI 10.1016/S1074-7613(00)80105-3; Resh MD, 2004, SUB CELL BIOCHEM, V37, P217; Resh MD, 1999, BBA-MOL CELL RES, V1451, P1, DOI 10.1016/S0167-4889(99)00075-0; RESH MD, 2006, SCI STKE, pRE14, DOI DOI 10.1126/STKE.3592006RE14; RESKEKUNZ AB, 1985, EUR J IMMUNOL, V15, P1048, DOI 10.1002/eji.1830151017; REYNOLDS AB, 1987, EMBO J, V6, P2359, DOI 10.1002/j.1460-2075.1987.tb02512.x; Roess DA, 2003, BIOL REPROD, V69, P1765, DOI 10.1095/biolreprod.103.018846; SAMELSON LE, 1990, P NATL ACAD SCI USA, V87, P4358, DOI 10.1073/pnas.87.11.4358; Schmedt C, 2001, J EXP MED, V193, P815, DOI 10.1084/jem.193.7.815; Seddon B, 2000, SCIENCE, V290, P127, DOI 10.1126/science.290.5489.127; SHENOYSCARIA AM, 1993, MOL CELL BIOL, V13, P6385, DOI 10.1128/MCB.13.10.6385; Sicheri F, 1997, NATURE, V385, P602, DOI 10.1038/385602a0; Straus DB, 1996, J BIOL CHEM, V271, P9976, DOI 10.1074/jbc.271.17.9976; SUGIMOTO Y, 1985, J BIOL CHEM, V260, P3838; Thomas SM, 1997, ANNU REV CELL DEV BI, V13, P513, DOI 10.1146/annurev.cellbio.13.1.513; TSYGANKOV AY, 1994, J BIOL CHEM, V269, P7792; TURNER JM, 1990, CELL, V60, P755, DOI 10.1016/0092-8674(90)90090-2; VEILLETTE A, 1988, ONCOGENE RES, V2, P385; Viola A, 2007, NAT REV IMMUNOL, V7, P889, DOI 10.1038/nri2193; Webb Y, 2000, J BIOL CHEM, V275, P261, DOI 10.1074/jbc.275.1.261; Werlen G, 2002, CURR OPIN IMMUNOL, V14, P299, DOI 10.1016/S0952-7915(02)00339-4; Xu WQ, 1997, NATURE, V385, P595, DOI 10.1038/385595a0; Yamaguchi H, 1996, NATURE, V384, P484, DOI 10.1038/384484a0; Yeh E T, 1994, Semin Immunol, V6, P73, DOI 10.1006/smim.1994.1011; Zamoyska R, 2003, IMMUNOL REV, V191, P107, DOI 10.1034/j.1600-065X.2003.00015.x	83	18	18	0	6	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	SEP 26	2008	283	39					26409	26422		10.1074/jbc.M710372200	http://dx.doi.org/10.1074/jbc.M710372200			14	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	350GV	18660530	Green Published, hybrid			2022-12-27	WOS:000259341600015
J	Maeda, A; Maeda, T; Golczak, M; Palczewski, K				Maeda, Akiko; Maeda, Tadao; Golczak, Marcin; Palczewski, Krzysztof			Retinopathy in mice induced by disrupted all-trans-retinal clearance	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							COUPLED RECEPTOR RHODOPSIN; MACULAR DEGENERATION; VISUAL CYCLE; PIGMENT EPITHELIUM; STARGARDT-DISEASE; MOUSE MODEL; LIGHT DAMAGE; GENE ABCR; IN-VIVO; A2E	The visual (retinoid) cycle is a fundamental metabolic process in vertebrate retina responsible for production of 11-cis-retinal, the chromophore of rhodopsin and cone pigments. 11-cis-Retinal is bound to opsins, forming visual pigments, and when the resulting visual chromophore 11-cis-retinylidene is photoisomerized to all-trans-retinylidene, all-trans-retinal is released from these receptors. Toxic byproducts of the visual cycle formed from all-trans-retinal often are associated with lipofuscin deposits in the retinal pigmented epithelium (RPE), but it is not clear whether aberrant reactions of the visual cycle participate in RPE atrophy, leading to a rapid onset of retinopathy. Here we report that mice lacking both the ATP-binding cassette transporter 4 (Abca4) and enzyme retinol dehydrogenase 8 (Rdh8), proteins critical for all-trans-retinal clearance from photoreceptors, developed severe RPE/photoreceptor dystrophy at an early age. This phenotype includes lipofuscin, drusen, and basal laminar deposits, Bruch's membrane thickening, and choroidal neovascularization. Importantly, the severity of visual dysfunction and retinopathy was exacerbated by light but attenuated by treatment with retinylamine, a visual cycle inhibitor that slows the flow of all-trans-retinal through the visual cycle. These findings provide direct evidence that aberrant production of toxic condensation byproducts of the visual cycle in mice can lead to rapid, progressive retinal degeneration.	[Maeda, Akiko; Maeda, Tadao; Golczak, Marcin; Palczewski, Krzysztof] Case Western Reserve Univ, Sch Med, Dept Pharmacol, Cleveland, OH 44106 USA; [Maeda, Tadao] Case Western Reserve Univ, Sch Med, Dept Ophthalmol, Cleveland, OH 44106 USA	Case Western Reserve University; Case Western Reserve University	Palczewski, K (corresponding author), Case Western Reserve Univ, Sch Med, Dept Pharmacol, 10900 Euclid Ave, Cleveland, OH 44106 USA.	kxp65@case.edu			National Institutes of Health [EY09339, P30 EY11373, EY08123]; NATIONAL EYE INSTITUTE [R01EY008123, P30EY011373, R01EY009339] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL EYE INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI))	This work was supported, in whole or in part, by National Institutes of Health Grants EY09339, P30 EY11373, and EY08123. The costs of publication of this article were defrayed in part by the payment of page charges. This article must therefore be hereby marked "advertisement" in accordance with 18 U. S. C. Section 1734 solely to indicate this fact.	Allikmets R, 1997, NAT GENET, V15, P236, DOI 10.1038/ng0397-236; Allikmets R, 2000, AM J HUM GENET, V67, P487, DOI 10.1086/303018; Allikmets R, 1997, SCIENCE, V277, P1805, DOI 10.1126/science.277.5333.1805; Ben-Shabat S, 2002, ANGEW CHEM INT EDIT, V41, P814, DOI 10.1002/1521-3773(20020301)41:5<814::AID-ANIE814>3.0.CO;2-2; Ben-Shabat S, 2002, J BIOL CHEM, V277, P7183, DOI 10.1074/jbc.M108981200; Chen J, 1999, INVEST OPHTH VIS SCI, V40, P2978; Chen Y, 2007, J BIOL CHEM, V282, P34420, DOI 10.1074/jbc.M611289200; De S, 2002, J GEN PHYSIOL, V120, P147, DOI 10.1085/jgp.20028566; DELORI FC, 1995, INVEST OPHTH VIS SCI, V36, P2327; ELDRED GE, 1993, NATURE, V364, P396; Evans JR, 2001, PROG RETIN EYE RES, V20, P227, DOI 10.1016/S1350-9462(00)00023-9; Filipek S, 2003, ANNU REV PHYSIOL, V65, P851, DOI 10.1146/annurev.physiol.65.092101.142611; Fishkin NE, 2005, P NATL ACAD SCI USA, V102, P7091, DOI 10.1073/pnas.0501266102; Golczak M, 2005, J BIOL CHEM, V280, P42263, DOI 10.1074/jbc.M509351200; Golczak M, 2005, P NATL ACAD SCI USA, V102, P8162, DOI 10.1073/pnas.0503318102; Golczak M, 2008, J BIOL CHEM, V283, P9543, DOI 10.1074/jbc.M708982200; Haines JL, 2007, P NATL ACAD SCI USA, V104, P16725, DOI 10.1073/pnas.0708151104; Hollyfield JG, 2008, NAT MED, V14, P194, DOI 10.1038/nm1709; Kim SR, 2007, P NATL ACAD SCI USA, V104, P19273, DOI 10.1073/pnas.0708714104; Kim SR, 2004, P NATL ACAD SCI USA, V101, P11668, DOI 10.1073/pnas.0403499101; Liu JH, 2000, J BIOL CHEM, V275, P29354, DOI 10.1074/jbc.M910191199; Maeda A, 2005, J BIOL CHEM, V280, P18822, DOI 10.1074/jbc.M501757200; Maeda A, 2007, P NATL ACAD SCI USA, V104, P19565, DOI 10.1073/pnas.0707477104; Maeda A, 2006, MOL PHARMACOL, V70, P1220, DOI 10.1124/mol.106.026823; Maeda A, 2006, INVEST OPHTH VIS SCI, V47, P4540, DOI 10.1167/iovs.06-0215; Mata NL, 2001, INVEST OPHTH VIS SCI, V42, P1685; Molday RS, 2007, J BIOENERG BIOMEMBR, V39, P507, DOI 10.1007/s10863-007-9118-6; NILSSON SEG, 1977, ACTA OPHTHALMOL, V55, P994; Palczewski K, 2006, ANNU REV BIOCHEM, V75, P743, DOI 10.1146/annurev.biochem.75.103004.142743; Parish CA, 1998, P NATL ACAD SCI USA, V95, P14609, DOI 10.1073/pnas.95.25.14609; Radu RA, 2004, P NATL ACAD SCI USA, V101, P5928, DOI 10.1073/pnas.0308302101; Rattner A, 2000, J BIOL CHEM, V275, P11034, DOI 10.1074/jbc.275.15.11034; Rattner A, 2006, NAT REV NEUROSCI, V7, P860, DOI 10.1038/nrn2007; Shroyer NF, 2001, HUM MOL GENET, V10, P2671, DOI 10.1093/hmg/10.23.2671; Sparrow JR, 2000, INVEST OPHTH VIS SCI, V41, P1981; Travis GH, 2007, ANNU REV PHARMACOL, V47, P469, DOI 10.1146/annurev.pharmtox.47.120505.105225; Verdegem PJE, 1997, TETRAHEDRON LETT, V38, P5355, DOI 10.1016/S0040-4039(97)01171-4; Weng J, 1999, CELL, V98, P13, DOI 10.1016/S0092-8674(00)80602-9; Wenzel A, 2001, J NEUROSCI, V21, P53, DOI 10.1523/JNEUROSCI.21-01-00053.2001; Yannuzzi LA, 2004, AM J OPHTHALMOL, V137, P511, DOI 10.1016/j.ajo.2003.12.035	40	210	216	1	15	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	SEP 26	2008	283	39					26684	26693		10.1074/jbc.M804505200	http://dx.doi.org/10.1074/jbc.M804505200			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	350GV	18658157	Green Published, hybrid			2022-12-27	WOS:000259341600042
J	Rudrabhatla, P; Zheng, YL; Amin, ND; Kesavapany, S; Albers, W; Pant, HC				Rudrabhatla, Parvathi; Zheng, Ya-Li; Amin, Niranjana D.; Kesavapany, Sashi; Albers, Wayne; Pant, Harish C.			Pin1-dependent Prolyl Isomerization Modulates the Stress-induced Phosphorylation of High Molecular Weight Neurofilament Protein	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article								Aberrant phosphorylation of neuronal cytoskeletal proteins is a key pathological event in neurodegenerative disorders such as Alzheimer disease (AD) and amyotrophic lateral sclerosis, but the underlying mechanisms are still unclear. Previous studies have shown that Pin1, a peptidylprolyl cis/trans-isomerase, may be actively involved in the regulation of Tau hyperphosphorylation in AD. Here, we show that Pin1 modulates oxidative stressinduced NF-H phosphorylation. In an in vitro kinase assay, the addition of Pin1 substantially increased phosphorylation of NF-H KSP repeats by proline-directed kinases, Erk1/2, Cdk5/p35, and JNK3 in a concentration-dependent manner. In vivo, dominant-negative (DN) Pin1 and Pin1 small interfering RNA inhibited epidermal growth factor-induced NF-H phosphorylation. Because oxidative stress plays an important role in the pathogenesis of neurodegenerative diseases, we studied the role of Pin1 in stressed cortical neurons and HEK293 cells. Both hydrogen peroxide (H2O2) and heat stresses induce phosphorylation of NF-H in transfected HEK293 cells and primary cortical cultures. Knockdown of Pin1 by transfected Pin1 short interference RNA and DN-Pin1 rescues the effect of stress-induced NF-H phosphorylation. The H2O2 and heat shock induced perikaryal phospho-NF-H accumulations, and neuronal apoptosis was rescued by inhibition of Pin1 in cortical neurons. JNK3, a brain-specific JNK isoform, is activated under oxidative and heat stresses, and inhibition of Pin1 by Pin1 short interference RNA and DN-Pin1 inhibits this pathway. These results implicate Pin1 as a possible modulator of stress-induced NF-H phosphorylation as seen in neurodegenerative disorders likeAD and amyotrophic lateral sclerosis. Thus, Pin1 may be a potential therapeutic target for these diseases.	[Rudrabhatla, Parvathi; Zheng, Ya-Li; Amin, Niranjana D.; Albers, Wayne; Pant, Harish C.] NINDS, Lab Neurochem, NIH, Bethesda, MD 20892 USA; [Kesavapany, Sashi] Natl Univ Singapore, Yong Loo Lin Sch Med, Dept Biochem, Singapore 117697, Singapore	National Institutes of Health (NIH) - USA; NIH National Institute of Neurological Disorders & Stroke (NINDS); National University of Singapore	Pant, HC (corresponding author), NINDS, Cytoskeletal Prot Regulat Sect, Lab Neurochem, NIH, Bldg 49,Rm 2A28, Bethesda, MD 20892 USA.	panth@ninds.nih.gov		Rudrabhatla, Parvathi/0000-0002-7537-3130	National Institutes of Health Intramural Research Programs of the NINDS	National Institutes of Health Intramural Research Programs of the NINDS	This work was supported, in whole or in part, by the National Institutes of Health Intramural Research Programs of the NINDS. The costs of publication of this article were defrayed in part by the payment of page charges. This article must therefore be hereby marked "advertisement" in accordance with 18 U.S.C. Section 1734 solely to indicate this fact.	Barone M. C., 2008, J NEUROCHEM, V274, P5211; Bayer E, 2003, J BIOL CHEM, V278, P26183, DOI 10.1074/jbc.M300721200; Becker EBE, 2006, NEURON, V49, P655, DOI 10.1016/j.neuron.2006.01.034; Brownlees J, 2000, J CELL SCI, V113, P401; Chao SH, 2001, NUCLEIC ACIDS RES, V29, P767, DOI 10.1093/nar/29.3.767; Cleveland DW, 2001, NAT REV NEUROSCI, V2, P806, DOI 10.1038/35097565; Crenshaw DG, 1998, EMBO J, V17, P1315, DOI 10.1093/emboj/17.5.1315; Davis R. J., 1997, NATURE, V389, P865; De Castro E, 2004, FREE RADICAL BIO MED, V37, P139, DOI 10.1016/j.freeradbiomed.2004.04.021; ELHANANY E, 1994, J NEUROCHEM, V63, P2324; FIGLEWICZ DA, 1994, HUM MOL GENET, V3, P1757, DOI 10.1093/hmg/3.10.1757; Giasson BI, 1996, J BIOL CHEM, V271, P30404, DOI 10.1074/jbc.271.48.30404; Guex N, 1997, ELECTROPHORESIS, V18, P2714, DOI 10.1002/elps.1150181505; Hennig L, 1998, BIOCHEMISTRY-US, V37, P5953, DOI 10.1021/bi973162p; Herdegen T, 1997, NEUROSCIENCE, V81, P199, DOI 10.1016/S0306-4522(97)00170-X; HOFFMAN PN, 1975, J CELL BIOL, V66, P351, DOI 10.1083/jcb.66.2.351; Jaffe H, 1998, BIOCHEMISTRY-US, V37, P16211, DOI 10.1021/bi981264p; Jaffe H., 1995, J NEUROCHEM, V64, P2681; Julien JP, 1995, BIOCHEM CELL BIOL, V73, P593, DOI 10.1139/o95-064; JULIEN JP, 1982, J BIOL CHEM, V257, P467; Kesavapany S, 2004, J NEUROSCI, V24, P4421, DOI 10.1523/JNEUROSCI.0690-04.2004; Kesavapany S, 2007, MOL BIOL CELL, V18, P3645, DOI 10.1091/mbc.E07-03-0237; LAEMMLI UK, 1970, NATURE, V227, P680, DOI 10.1038/227680a0; LEE VMY, 1987, J NEUROSCI, V7, P3474; LEE VMY, 1988, P NATL ACAD SCI USA, V85, P1998, DOI 10.1073/pnas.85.6.1998; Liou YC, 2002, P NATL ACAD SCI USA, V99, P1335, DOI 10.1073/pnas.032404099; Lu KP, 2007, NAT REV MOL CELL BIO, V8, P904, DOI 10.1038/nrm2261; Lu PJ, 1999, NATURE, V399, P784; MANETTO V, 1988, J NEUROPATH EXP NEUR, V47, P642, DOI 10.1097/00005072-198811000-00007; Martin JH, 1996, MOL BRAIN RES, V35, P47, DOI 10.1016/0169-328X(95)00181-Q; Masaki R, 2000, J NEUROSCI RES, V62, P75, DOI 10.1002/1097-4547(20001001)62:1<75::AID-JNR8>3.0.CO;2-V; McKeith IG, 2000, ANN NY ACAD SCI, V920, P1; Merritt SE, 1999, J BIOL CHEM, V274, P10195, DOI 10.1074/jbc.274.15.10195; Messenger MM, 2002, J BIOL CHEM, V277, P23054, DOI 10.1074/jbc.M200111200; Monje P, 2005, J BIOL CHEM, V280, P35081, DOI 10.1074/jbc.C500353200; NIXON RA, 1991, TRENDS NEUROSCI, V14, P501, DOI 10.1016/0166-2236(91)90062-Y; NIXON RA, 1994, J CELL BIOL, V126, P1031, DOI 10.1083/jcb.126.4.1031; Pant AC, 1997, BRAIN RES, V765, P259, DOI 10.1016/S0006-8993(97)00561-1; Pant HC, 1995, BIOCHEM CELL BIOL, V73, P575, DOI 10.1139/o95-063; Paulsen MT, 2005, TOXICOL APPL PHARM, V209, P1, DOI 10.1016/j.taap.2005.03.005; Rao MV, 2003, NEUROCHEM RES, V28, P1041, DOI 10.1023/A:1023259207015; Ryo A, 2006, J BIOL CHEM, V281, P4117, DOI 10.1074/jbc.M507026200; SAYLE RA, 1995, TRENDS BIOCHEM SCI, V20, P374, DOI 10.1016/S0968-0004(00)89080-5; SCHILLING K, 1989, J HISTOCHEM CYTOCHEM, V37, P241, DOI 10.1177/37.2.2492046; Shea TB, 2004, J NEUROSCI RES, V76, P795, DOI 10.1002/jnr.20099; SHEA TB, 1989, DEV BRAIN RES, V50, P142, DOI 10.1016/0165-3806(89)90134-X; SIPPL MJ, 1993, PROTEINS, V17, P355, DOI 10.1002/prot.340170404; STERNBERGER LA, 1983, P NATL ACAD SCI-BIOL, V80, P6126, DOI 10.1073/pnas.80.19.6126; van Drogen F, 2006, MOL CELL, V23, P37, DOI 10.1016/j.molcel.2006.05.020; Veeranna, 1998, J NEUROSCI, V18, P4008; Weigum SE, 2003, BMC NEUROSCI, V4, DOI 10.1186/1471-2202-4-6; Wulf GM, 2001, EMBO J, V20, P3459, DOI 10.1093/emboj/20.13.3459; Xu YX, 2003, GENE DEV, V17, P2765, DOI 10.1101/gad.1135503; Yeh E, 2004, NAT CELL BIOL, V6, P308, DOI 10.1038/ncb1110; Yi P, 2005, MOL CELL BIOL, V25, P9687, DOI 10.1128/MCB.25.21.9687-9699.2005; Zhang S, 2007, CELL DEATH DIFFER, V14, P1001, DOI 10.1038/sj.cdd.4402088; Zita MM, 2007, EMBO J, V26, P1761, DOI 10.1038/sj.emboj.7601625	57	29	29	0	1	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	SEP 26	2008	283	39					26737	26747		10.1074/jbc.M801633200	http://dx.doi.org/10.1074/jbc.M801633200			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	VJ1XW	18635547	hybrid, Green Published			2022-12-27	WOS:000551106800001
J	De Leon, DD; Li, C; Delson, MI; Matschinsky, FM; Stanley, CA; Stoffers, DA				De Leon, Diva D.; Li, Changhong; Delson, Madeleine I.; Matschinsky, Franz M.; Stanley, Charles A.; Stoffers, Doris A.			Exendin-(9-39) corrects fasting hypoglycemia in SUR-1(-/-) mice by lowering cAMP in pancreatic beta-cells and inhibiting insulin secretion	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							GLUCAGON-LIKE PEPTIDE-1; INDEPENDENT POTENTIATION; KNOCKOUT MICE; GLUCOSE; RECEPTOR; INCRETIN; HYPERINSULINISM; ANTAGONIST; RELEASE; HUMANS	Congenital hyperinsulinism is a disorder of pancreatic beta-cell function characterized by failure to suppress insulin secretion in the setting of hypoglycemia, resulting in brain damage or death if untreated. Loss-of-function mutations in the K-ATP channel (composed of two subunits: Kir6.2 and SUR-1) are responsible for the most common and severe form of congenital hyperinsulinism. Most patients are unresponsive to available medical therapy and require palliative pancreatectomy. Similar to the human condition, the SUR-1(-/)-mouse is hypoglycemic when fasted and hyperglycemic when glucose-loaded. We have previously reported that the glucagon-like peptide-1 receptor antagonist exendin-(9-39) raises fasting blood glucose in normal mice. Here we examine the effect of exendin-(9-39) on fasting blood glucose in SUR-1(-/)-mice. Mice were randomized to receive exendin-(9-39) or vehicle. Fasting blood glucose levels in SUR-1(-/)-mice treated with exendin-(9-39) were significantly higher than in vehicle-treated mice and not different from wild-type littermates. Exendin-(9-39) did not further worsen glucose tolerance and had no effect on body weight and insulin sensitivity. Isolated islet perifusion studies demonstrated that exendin-(9-39) blocked amino acid-stimulated insulin secretion, which is abnormally increased in SUR-1(-/)-islets. Furthermore, cAMP content in SUR-1(-/)-islets was reduced by exendin-(9-39) both basally and when stimulated by amino acids, whereas cytosolic calcium levels were not affected. These findings suggest that cAMP plays a key role in K-ATP-independent insulin secretion and that the GLP-1 receptor is constitutively active in SUR-1(-/)-beta-cells. Our findings indicate that exendin-(9-39) normalizes fasting hypoglycemia in SUR-1(-/)-mice via a direct effect on insulin secretion, thereby raising exendin-(9-39) as a potential therapeutic agent for K-ATP hyperinsulinism.	[De Leon, Diva D.; Li, Changhong; Delson, Madeleine I.; Stanley, Charles A.] Childrens Hosp Philadelphia, Div Endocrinol Diabet, Dept Pediat, Philadelphia, PA 19104 USA; [De Leon, Diva D.; Matschinsky, Franz M.; Stanley, Charles A.; Stoffers, Doris A.] Univ Penn, Inst Diabet Obes & Metab, Philadelphia, PA 19104 USA; [Stoffers, Doris A.] Univ Penn, Dept Med, Div Endocrinol Diabet & Metab, Philadelphia, PA 19104 USA	University of Pennsylvania; Pennsylvania Medicine; Childrens Hospital of Philadelphia; University of Pennsylvania; University of Pennsylvania	De Leon, DD (corresponding author), Childrens Hosp Philadelphia, Div Endocrinol Diabet, Dept Pediat, 3615 Civic Ctr Blvd, Philadelphia, PA 19104 USA.	deleon@email.chop.edu; stoffers@mail.med.upenn.edu	De Leon, Diva D./V-8626-2019; Stoffers, Doris/H-6157-2012	De Leon, Diva D./0000-0003-1225-8087; STANLEY, CHARLES/0000-0003-4881-9392	American Diabetes Association Career Development Award; Pediatric Endocrine Career Development award in Diabetes Research [K12 DK063682]; Career Development Award [K23-DK073663]; Penn Diabetes Center [P30 DK 019525, R01DK53012]; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [K12DK063682, P30DK019525, K23DK073663, R01DK053012] Funding Source: NIH RePORTER	American Diabetes Association Career Development Award(American Diabetes Association); Pediatric Endocrine Career Development award in Diabetes Research; Career Development Award; Penn Diabetes Center; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	These studies were supported by an American Diabetes Association Career Development Award (to D. A. S.), Pediatric Endocrine Career Development award in Diabetes Research K12 DK063682, Career Development Award K23-DK073663, and a Pilot and Feasibility grant from the Penn Diabetes Center P30 DK 019525 (to D. D. L.) and R01DK53012 (to C. A. S.). The costs of publication of this article were defrayed in part by the payment of page charges. This article must therefore be hereby marked "advertisement" in accordance with 18 U. S. C. Section 1734 solely to indicate this fact.	Aguilar-Bryan L, 1999, ENDOCR REV, V20, P101, DOI 10.1210/er.20.2.101; AMMALA C, 1993, NATURE, V363, P356, DOI 10.1038/363356a0; DAlessio DA, 1996, J CLIN INVEST, V97, P133, DOI 10.1172/JCI118380; De Leon DD, 2006, INT J BIOCHEM CELL B, V38, P845, DOI 10.1016/j.biocel.2005.07.011; De Leon DD, 2003, DIABETES, V52, P365, DOI 10.2337/diabetes.52.2.365; Doliba NM, 2007, AM J PHYSIOL-ENDOC M, V292, pE1507, DOI 10.1152/ajpendo.00282.2006; Doliba NM, 2004, AM J PHYSIOL-ENDOC M, V286, pE834, DOI 10.1152/ajpendo.00292.2003; Dunne MJ, 2004, PHYSIOL REV, V84, P239, DOI 10.1152/physrev.00022.2003; Edwards CMB, 1999, DIABETES, V48, P86, DOI 10.2337/diabetes.48.1.86; Eliasson L, 2003, J GEN PHYSIOL, V121, P181, DOI 10.1085/jgp.20028707; Flamez D, 1999, DIABETES, V48, P1979, DOI 10.2337/diabetes.48.10.1979; Fourtner SH, 2006, J PEDIATR-US, V149, P47, DOI 10.1016/j.jpeds.2006.02.033; Gao Z, 1999, DIABETES, V48, P1535, DOI 10.2337/diabetes.48.8.1535; Gromada J, 1998, PFLUG ARCH EUR J PHY, V435, P583, DOI 10.1007/s004240050558; Henquin JC, 2000, DIABETES, V49, P1751, DOI 10.2337/diabetes.49.11.1751; Holst JJ, 2004, AM J PHYSIOL-ENDOC M, V287, pE199, DOI 10.1152/ajpendo.00545.2003; Kashima Y, 2001, J BIOL CHEM, V276, P46046, DOI 10.1074/jbc.M108378200; KOLLIGS F, 1995, DIABETES, V44, P16, DOI 10.2337/diabetes.44.1.16; Li CH, 2004, J BIOL CHEM, V279, P13393, DOI 10.1074/jbc.M311502200; LOTEN EG, 1978, J BIOL CHEM, V253, P746; LOTEN EG, 1970, BIOCHEM J, V120, P187, DOI 10.1042/bj1200187; Masur K, 2005, MOL ENDOCRINOL, V19, P1373, DOI 10.1210/me.2004-0350; Moens K, 1998, DIABETES, V47, P66, DOI 10.2337/diabetes.47.1.66; Nakazaki M, 2002, DIABETES, V51, P3440, DOI 10.2337/diabetes.51.12.3440; Ozaki N, 2000, NAT CELL BIOL, V2, P805, DOI 10.1038/35041046; PILKIS SJ, 1975, J BIOL CHEM, V250, P6328; Renstrom E, 1997, J PHYSIOL-LONDON, V502, P105, DOI 10.1111/j.1469-7793.1997.105bl.x; Schirra J, 1998, J CLIN INVEST, V101, P1421, DOI 10.1172/JCI1349; Seghers V, 2000, J BIOL CHEM, V275, P9270, DOI 10.1074/jbc.275.13.9270; Seino S, 2003, PROG BIOPHYS MOL BIO, V81, P133, DOI 10.1016/S0079-6107(02)00053-6; Senft G, 1968, Diabetologia, V4, P322, DOI 10.1007/BF01211766; Serre V, 1998, ENDOCRINOLOGY, V139, P4448, DOI 10.1210/en.139.11.4448; Shibasaki T, 2007, P NATL ACAD SCI USA, V104, P19333, DOI 10.1073/pnas.0707054104; Shiota C, 2005, AM J PHYSIOL-ENDOC M, V289, pE570, DOI 10.1152/ajpendo.00102.2005; Shiota C, 2002, J BIOL CHEM, V277, P37176, DOI 10.1074/jbc.M206757200; Stanley CA, 2002, J CLIN ENDOCR METAB, V87, P4857, DOI 10.1210/jc.2002-021403; THORENS B, 1992, P NATL ACAD SCI USA, V89, P8641, DOI 10.1073/pnas.89.18.8641; WANG ZL, 1995, J CLIN INVEST, V95, P417, DOI 10.1172/JCI117671; Yajima H, 1999, DIABETES, V48, P1006, DOI 10.2337/diabetes.48.5.1006	39	56	61	0	1	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	SEP 19	2008	283	38					25786	25793		10.1074/jbc.M804372200	http://dx.doi.org/10.1074/jbc.M804372200			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	348GX	18635551	hybrid, Green Published			2022-12-27	WOS:000259200100004
J	Ma, DZ; Bai, XC; Guo, SG; Jiang, Y				Ma, Dongzhu; Bai, Xiaochun; Guo, Shuguang; Jiang, Yu			The switch I region of Rheb is critical for its interaction with FKBP38	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							MAMMALIAN TARGET; FKBP12-RAPAMYCIN-ASSOCIATED PROTEIN; SIGNALING NETWORK; RAPAMYCIN MTOR; CELL-GROWTH; LOCALIZATION; ACTIVATION; APOPTOSIS; PATHWAY; INSULIN	The Ras-like small GTPase Rheb is an upstream activator of the mammalian target of rapamycin (mTOR). It has recently been shown that Rheb activates mTOR by binding to its endogenous inhibitor FKBP38 and preventing it from association with mTOR. The interaction of Rheb with FKBP38 is controlled by its guanine nucleotide binding states, which are responsive to growth factor and amino acid conditions. In this study, we show that Rheb interacts with FKBP38 through a section within its switch I region that is equivalent to the effector domain of other Ras-like small GTPases. We find that the ability for Rheb to interact with FKBP38 correlates with its activity for mTOR activation. Our findings suggest that FKBP38 is a bona fide effector of Rheb and that the ability to interact with FKBP38 is important for Rheb as an activator of mTOR.	[Ma, Dongzhu; Guo, Shuguang; Jiang, Yu] Univ Pittsburgh, Sch Med, Dept Pharmacol & Chem Biol, Pittsburgh, PA 15213 USA; [Bai, Xiaochun] So Med Univ, Sch Basic Med Sci, Dept Cell Biol, Guangzhou 510515, Peoples R China	Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; Southern Medical University - China	Jiang, Y (corresponding author), Univ Pittsburgh, Sch Med, Dept Pharmacol & Chem Biol, Pittsburgh, PA 15213 USA.	yuj5@pitt.edu			National Institutes of Health [GM068832, CA129821]; NATIONAL CANCER INSTITUTE [R01CA129821] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM068832] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported, in whole by National Institutes of Health Grants GM068832 and CA129821 (to Y.J.). The costs of publication of this article were defrayed in part by the payment of page charges. This article must therefore be hereby marked "advertisement" in accordance with 18 U. S. C. Section 1734 solely to indicate this fact.	Aspuria PJ, 2004, CELL SIGNAL, V16, P1105, DOI 10.1016/j.cellsig.2004.03.019; Avruch J, 2006, ONCOGENE, V25, P6361, DOI 10.1038/sj.onc.1209882; Bai XC, 2007, SCIENCE, V318, P977, DOI 10.1126/science.1147379; Bos JL, 1997, BBA-REV CANCER, V1333, pM19, DOI 10.1016/S0304-419X(97)00015-2; Buerger C, 2006, BIOCHEM BIOPH RES CO, V344, P869, DOI 10.1016/j.bbrc.2006.03.220; Davies TH, 2005, INT J BIOCHEM CELL B, V37, P42, DOI 10.1016/j.biocel.2004.03.013; Desai BN, 2002, P NATL ACAD SCI USA, V99, P4319, DOI 10.1073/pnas.261702698; Drenan RM, 2004, J BIOL CHEM, V279, P772, DOI 10.1074/jbc.M305912200; Fischer G, 1998, FEBS LETT, V426, P17, DOI 10.1016/S0014-5793(98)00242-7; Garami A, 2003, MOL CELL, V11, P1457, DOI 10.1016/S1097-2765(03)00220-X; Harrar Y, 2001, TRENDS PLANT SCI, V6, P426, DOI 10.1016/S1360-1385(01)02044-1; Kim JE, 2000, P NATL ACAD SCI USA, V97, P14340, DOI 10.1073/pnas.011511898; Li Y, 2004, TRENDS BIOCHEM SCI, V29, P32, DOI 10.1016/j.tibs.2003.11.007; Long X, 2005, CURR BIOL, V15, P702, DOI 10.1016/j.cub.2005.02.053; Long XM, 2005, J BIOL CHEM, V280, P23433, DOI 10.1074/jbc.C500169200; Maestre-Martinez M, 2006, J BIOMOL NMR, V34, P197, DOI 10.1007/s10858-006-0018-6; Manning BD, 2003, TRENDS BIOCHEM SCI, V28, P573, DOI 10.1016/j.tibs.2003.09.003; Marshall CJ, 1996, CURR OPIN CELL BIOL, V8, P197, DOI 10.1016/S0955-0674(96)80066-4; Martin DE, 2005, CURR OPIN CELL BIOL, V17, P158, DOI 10.1016/j.ceb.2005.02.008; Nielsen JV, 2004, GENOMICS, V83, P181, DOI 10.1016/j.ygeno.2003.07.001; Nobukuni T, 2005, P NATL ACAD SCI USA, V102, P14238, DOI 10.1073/pnas.0506925102; Pedersen KM, 1999, ELECTROPHORESIS, V20, P249, DOI 10.1002/(SICI)1522-2683(19990201)20:2<249::AID-ELPS249>3.0.CO;2-F; Portier BP, 2006, J BIOL CHEM, V281, P40493, DOI 10.1074/jbc.M606181200; Proud CG, 2007, SCIENCE, V318, P926, DOI 10.1126/science.1150653; Saucedo LJ, 2003, NAT CELL BIOL, V5, P566, DOI 10.1038/ncb996; Schieke SM, 2006, J BIOL CHEM, V281, P27643, DOI 10.1074/jbc.M603536200; Shirane M, 2003, NAT CELL BIOL, V5, P28, DOI 10.1038/ncb894; Stocker H, 2003, NAT CELL BIOL, V5, P559, DOI 10.1038/ncb995; Tabancay AP, 2003, J BIOL CHEM, V278, P39921, DOI 10.1074/jbc.M306553200; Takahashi K, 2005, J BIOL CHEM, V280, P32768, DOI 10.1074/jbc.M506280200; Tee AR, 2005, FEBS LETT, V579, P4763, DOI 10.1016/j.febslet.2005.07.054; Wang HQ, 2005, HUM MOL GENET, V14, P1889, DOI 10.1093/hmg/ddi195; Withers DJ, 1997, BIOCHEM BIOPH RES CO, V241, P704, DOI 10.1006/bbrc.1997.7878; Wittinghofer A, 1996, TRENDS BIOCHEM SCI, V21, P488, DOI 10.1016/S0968-0004(96)10064-5; Zhang XW, 2002, J BIOL CHEM, V277, P28127, DOI 10.1074/jbc.M202625200; Zhang Y, 2003, NAT CELL BIOL, V5, P578, DOI 10.1038/ncb999	36	50	52	0	5	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	SEP 19	2008	283	38					25963	25970		10.1074/jbc.M802356200	http://dx.doi.org/10.1074/jbc.M802356200			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	348GX	18658153	Green Published, hybrid			2022-12-27	WOS:000259200100024
J	Tomita, T; Kido, T; Kurotani, R; Iemura, SI; Sterneck, E; Natsume, T; Vinson, C; Kimura, S				Tomita, Takeshi; Kido, Taketomo; Kurotani, Reiko; Iemura, Shun-ichiro; Sterneck, Esta; Natsume, Tohru; Vinson, Charles; Kimura, Shioko			CAATT/enhancer-binding proteins alpha and delta interact with NKX2-1 to synergistically activate mouse secretoglobin 3A2 gene expression	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							TRANSCRIPTION FACTOR-I; HEPATOCYTE NUCLEAR FACTOR-3; SP-A GENE; C/EBP-ALPHA; REGULATES EXPRESSION; EPITHELIAL-CELLS; LUNG DEVELOPMENT; B PROMOTER; RAT LUNG; SURFACTANT	Secretoglobin (SCGB) 3A2 is a small molecular weight secreted protein predominantly expressed in lung airways. We previously demonstrated that the expression of SCGB3A2 is regulated by homeodomain transcription factor NKX2-1. Here we show that CCAAT/enhancer-binding proteins, C/EBP alpha and C/EBP delta, regulate mouse Scgb3a2 gene transcription in vivo and in vitro by binding to specific sites located in the Scgb3a2 promoter and the activity is synergistically enhanced through cooperative interaction with NKX2-1. Six C/EBP binding sites lie within 500 bp of the Scgb3a2 gene promoter, of which two sites, located at -44 to -54 bp and -192 to -201 bp, appear to be critical for the synergistic activation of Scgb3a2 gene transcription with NKX2-1. All three transcription factors, C/EBP alpha, C/EBP delta, and NKX2-1, are expressed in the epithelial cells of airways, particularly the bronchus, where high expression of SCGB3A2 is found. The expression of these transcription factors markedly increases toward the end of gestation, which coincides with the marked increase of SCGB3A2, suggesting the importance of C/EBP alpha and C/EBP delta, and their synergistic interaction with NKX2-1 in mouse Scgb3a2 gene transcription and lung development.	[Tomita, Takeshi; Kido, Taketomo; Kurotani, Reiko; Vinson, Charles; Kimura, Shioko] NCI, Lab Metab, NIH, Bethesda, MD 20892 USA; [Kurotani, Reiko] Yokohama City Univ, Cardiovasc Res Inst, Yokohama, Kanagawa 2360006, Japan; [Iemura, Shun-ichiro; Natsume, Tohru] Natl Inst Adv Ind Sci & Technol, Biol Informat Res Ctr, Tokyo 1350064, Japan; [Sterneck, Esta] NCI, Lab Cell & Dev Signaling, Frederick, MD 21702 USA	National Institutes of Health (NIH) - USA; NIH National Cancer Institute (NCI); Yokohama City University; National Institute of Advanced Industrial Science & Technology (AIST); National Institutes of Health (NIH) - USA; NIH National Cancer Institute (NCI)	Kimura, S (corresponding author), NCI, Lab Metab, NIH, Bldg 37,Rm 3112B, Bethesda, MD 20892 USA.	kimuras@mail.nih.gov	Natsume, Tohru/M-7627-2018	Natsume, Tohru/0000-0002-1510-2582; Sterneck, Esta/0000-0001-7716-8766; Tomita, Takeshi/0000-0001-6815-2244; Kido, Taketomo/0000-0001-9790-0862	National Cancer Institute, Center for Cancer Research; New Energy and Industrial Technology Development Organization; NATIONAL CANCER INSTITUTE [ZIABC010307, ZIABC005271, ZIABC010449] Funding Source: NIH RePORTER	National Cancer Institute, Center for Cancer Research(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); New Energy and Industrial Technology Development Organization(New Energy and Industrial Technology Development Organization (NEDO)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This work was authored, in whole or in part, by National Institutes of Health staff. This work was supported by the Intramural Research Program of the National Cancer Institute, Center for Cancer Research, and in part by the New Energy and Industrial Technology Development Organization ( to T. N.). The costs of publication of this article were defrayed in part by the payment of page charges. This article must therefore be hereby marked "advertisement" in accordance with 18 U.S.C. Section 1734 solely to indicate this fact.	Bachurski CJ, 2003, MOL CELL BIOL, V23, P9014, DOI 10.1128/MCB.23.24.9014-9024.2003; Berg T, 2006, AM J PHYSIOL-LUNG C, V291, pL683, DOI 10.1152/ajplung.00497.2005; BOHINSKI RJ, 1994, MOL CELL BIOL, V14, P5671, DOI 10.1128/MCB.14.9.5671; BRUNO MD, 1995, J BIOL CHEM, V270, P6531, DOI 10.1074/jbc.270.12.6531; CAO ZD, 1991, GENE DEV, V5, P1538, DOI 10.1101/gad.5.9.1538; Cassel TN, 2003, AM J PHYSIOL-LUNG C, V285, pL773, DOI 10.1152/ajplung.00023.2003; Cassel TN, 2002, J BIOL CHEM, V277, P36970, DOI 10.1074/jbc.M201293200; Cassel TN, 2000, AM J RESP CELL MOL, V22, P469, DOI 10.1165/ajrcmb.22.4.3916; Chiba Y, 2006, AM J RESP CRIT CARE, V173, P958, DOI 10.1164/rccm.200503-456OC; Costa RH, 2001, AM J PHYSIOL-LUNG C, V280, pL823, DOI 10.1152/ajplung.2001.280.5.L823; He YC, 2002, J BIOL CHEM, V277, P19530, DOI 10.1074/jbc.M201126200; Henson MC, 2004, REPRODUCTION, V127, P87, DOI 10.1530/rep.1.00037; Horster M, 2000, AM J PHYSIOL-RENAL, V279, pF982, DOI 10.1152/ajprenal.2000.279.6.F982; Ikeda K, 1996, MOL CELL BIOL, V16, P3626; Kelly SE, 1996, J BIOL CHEM, V271, P6881, DOI 10.1074/jbc.271.12.6881; Kimura S, 1996, GENE DEV, V10, P60, DOI 10.1101/gad.10.1.60; Klug J, 2000, ANN NY ACAD SCI, V923, P348; Maeda Y, 2006, J BIOL CHEM, V281, P9600, DOI 10.1074/jbc.M510435200; Magdaleno SM, 1997, AM J PHYSIOL-LUNG C, V272, pL1142, DOI 10.1152/ajplung.1997.272.6.L1142; Mandal AK, 2004, J EXP MED, V199, P1317, DOI 10.1084/jem.20031666; Martis PC, 2006, DEVELOPMENT, V133, P1155, DOI 10.1242/dev.02273; Matlapudi A, 2002, BBA-GENE STRUCT EXPR, V1575, P91, DOI 10.1016/S0167-4781(02)00288-9; Minoo P, 2007, MOL CELL BIOL, V27, P2155, DOI 10.1128/MCB.01133-06; Naltner A, 2000, J BIOL CHEM, V275, P56, DOI 10.1074/jbc.275.1.56; Natsume T, 2002, ANAL CHEM, V74, P4725, DOI 10.1021/ac020018n; Niimi T, 2001, MOL ENDOCRINOL, V15, P2021, DOI 10.1210/me.15.11.2021; OGASAWARA Y, 1991, BIOCHIM BIOPHYS ACTA, V1083, P252, DOI 10.1016/0005-2760(91)90079-W; Oh WJ, 2007, CANCER RES, V67, P1867, DOI 10.1158/0008-5472.CAN-06-2746; Pabst T, 2001, NAT GENET, V27, P263, DOI 10.1038/85820; Park KS, 2004, J BIOL CHEM, V279, P17384, DOI 10.1074/jbc.M312569200; Perl AKT, 2002, TRANSGENIC RES, V11, P21, DOI 10.1023/A:1013986627504; Perrone L, 1999, J BIOL CHEM, V274, P4640, DOI 10.1074/jbc.274.8.4640; Ramji DP, 2002, BIOCHEM J, V365, P561, DOI 10.1042/bj20020508; Ray MK, 1996, MOL CELL BIOL, V16, P2056; Rivas M, 2004, J BIOL CHEM, V279, P33114, DOI 10.1074/jbc.M403526200; Rosenberg E, 2002, BBA-GENE STRUCT EXPR, V1575, P82, DOI 10.1016/S0167-4781(02)00287-7; SAWAYA PL, 1993, MOL CELL BIOL, V13, P3860, DOI 10.1128/MCB.13.7.3860; SHIMIZU H, 1991, BIOCHIM BIOPHYS ACTA, V1081, P53, DOI 10.1016/0005-2760(91)90249-H; Singh G, 1997, AM J RESP CELL MOL, V17, P141, DOI 10.1165/ajrcmb.17.2.f138; Sterneck E, 1998, P NATL ACAD SCI USA, V95, P10908, DOI 10.1073/pnas.95.18.10908; Vinson C, 2002, MOL CELL BIOL, V22, P6321, DOI 10.1128/MCB.22.18.6321-6335.2002; WIKENHEISER KA, 1993, P NATL ACAD SCI USA, V90, P11029, DOI 10.1073/pnas.90.23.11029; Yang YS, 2001, AM J RESP CELL MOL, V24, P30, DOI 10.1165/ajrcmb.24.1.4050; Yi M, 2002, J BIOL CHEM, V277, P2997, DOI 10.1074/jbc.M109793200; Yuan BB, 2000, DEV DYNAM, V217, P180, DOI 10.1002/(SICI)1097-0177(200002)217:2<180::AID-DVDY5>3.0.CO;2-3; Zhang YZ, 2007, DEVELOPMENT, V134, P189, DOI 10.1242/dev.02720	46	17	19	0	4	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	SEP 12	2008	283	37					25617	25627		10.1074/jbc.M805140200	http://dx.doi.org/10.1074/jbc.M805140200			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	345QZ	18632661	Green Published, hybrid			2022-12-27	WOS:000259012700057
J	Buscarlet, M; Perin, A; Laing, A; Brickman, JM; Stifani, S				Buscarlet, Manuel; Perin, Alessandro; Laing, Adam; Brickman, Joshua Mark; Stifani, Stefano			Inhibition of cortical neuron differentiation by Groucho/TLE1 requires interaction with WRPW, but not Eh1, repressor peptides	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							TRANSDUCIN-LIKE-ENHANCER; LOOP-HELIX FACTORS; TRANSCRIPTIONAL REPRESSION; ASTROCYTE DIFFERENTIATION; PROMOTES NEUROGENESIS; CEREBRAL HEMISPHERES; DROSOPHILA GROUCHO; CRYSTAL-STRUCTURE; SPECIFICITY GENE; NERVOUS-SYSTEM	In both invertebrates and vertebrates, transcriptional co-repressors of the Groucho/transducin-like Enhancer of split (Gro/TLE) family regulate a number of developmental mechanisms, including neuronal differentiation. The pleiotropic activity of Gro/TLE depends on context-specific interactions with a variety of DNA-binding proteins. Most of those factors engage Gro/TLE through two different types of short peptide motifs, the WRP(W/Y) tetrapeptide and the Engrailed homology 1 (Eh1) sequence (FXIXXIL). The aim of this study was to elucidate the contribution of WRP(W/Y) and Eh1 motifs to mammalian Gro/TLE anti-neurogenic activity. Here we describe point mutations within the C-terminal WD40 repeat domain of Gro/TLE1 that do not perturb protein folding but disrupt the ability of Gro/TLE1 to inhibit the differentiation of cerebral cortex neural progenitor cells into neurons. One of those mutations, L743F, selectively blocks binding to Hes1, an anti-neurogenic basic helix-loop-helix protein that harbors a WRPW motif. In contrast, the L743F mutation does not disrupt binding to Engrailed1 and FoxG1, which both contain Eh1 motifs, nor to Tcf3, which binds to the Gro/TLE N terminus. These results demonstrate that the recruitment of transcription factors harboring WRP(W/Y) tetrapeptides is essential to the antineurogenic function of Gro/TLE1.	[Buscarlet, Manuel; Perin, Alessandro; Stifani, Stefano] McGill Univ, Montreal Neurol Inst, Ctr Neuronal Survival, Montreal, PQ H3A 2B4, Canada; [Laing, Adam; Brickman, Joshua Mark] MRC Ctr Regenerat Med, Inst Stem Cell Res, Edinburgh EH9 3JQ, Midlothian, Scotland	McGill University; University of Edinburgh	Stifani, S (corresponding author), McGill Univ, Montreal Neurol Inst, Ctr Neuronal Survival, 3801 Univ St, Montreal, PQ H3A 2B4, Canada.	stefano.stifani@mcgill.ca	Perin, Alessandro/AAM-6299-2021; Perin, Alessandro/AAC-1316-2019	Perin, Alessandro/0000-0002-6697-9835; Stifani, Stefano/0000-0002-2376-7701; Brickman, Joshua/0000-0003-1580-7491	University of Padova ( Neurosurgical Unit, Treviso Hospital, Treviso, Italy); MRC; Trust and Scottish Funding Council; Canadian Institutes of Health Research [MOP-13957]; Medical Research Council [G0700711B] Funding Source: researchfish	University of Padova ( Neurosurgical Unit, Treviso Hospital, Treviso, Italy); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Trust and Scottish Funding Council; Canadian Institutes of Health Research(Canadian Institutes of Health Research (CIHR)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission)	This work was supported in part by a Residency Fellowship from the University of Padova ( Neurosurgical Unit, Treviso Hospital, Treviso, Italy) (to A.P.), an MRC Studentship ( to A. L.), by grants from the Wellcome Trust and Scottish Funding Council ( to J.M.B.), and the Canadian Institutes of Health Research (MOP-13957) ( to S. S.). The costs of publication of this article were defrayed in part by the payment of page charges. This article must therefore be hereby marked "advertisement" in accordance with 18 U.S.C. Section 1734 solely to indicate this fact.	Appolloni I, 2008, CEREB CORTEX, V18, P553, DOI 10.1093/cercor/bhm092; Belanger-Jasmin S, 2007, J NEUROCHEM, V103, P2022, DOI 10.1111/j.1471-4159.2007.04902.x; Benes FM, 2007, P NATL ACAD SCI USA, V104, P10164, DOI 10.1073/pnas.0703806104; Brantjes H, 2001, NUCLEIC ACIDS RES, V29, P1410, DOI 10.1093/nar/29.7.1410; Bray SJ, 2006, NAT REV MOL CELL BIO, V7, P678, DOI 10.1038/nrm2009; Buscarlet M, 2007, TRENDS CELL BIOL, V17, P353, DOI 10.1016/j.tcb.2007.07.002; Chen GQ, 2000, GENE, V249, P1, DOI 10.1016/S0378-1119(00)00161-X; Courey AJ, 2001, GENE DEV, V15, P2786; DEHNI G, 1995, MECH DEVELOP, V53, P369, DOI 10.1016/0925-4773(95)00452-1; Fisher AL, 1996, MOL CELL BIOL, V16, P2670; Friocourt G, 2008, J NEUROSCI, V28, P5794, DOI 10.1523/JNEUROSCI.1067-08.2008; Gasperowicz M, 2005, J CELL BIOCHEM, V95, P670, DOI 10.1002/jcb.20476; GHOSH A, 1995, NEURON, V15, P89, DOI 10.1016/0896-6273(95)90067-5; Giagtzoglou N, 2003, DEVELOPMENT, V130, P259, DOI 10.1242/dev.00206; Grbavec D, 1998, EUR J BIOCHEM, V258, P339, DOI 10.1046/j.1432-1327.1998.2580339.x; Hasson P, 2006, BRIT J CANCER, V94, P771, DOI 10.1038/sj.bjc.6603019; Heitzler P, 1996, DEVELOPMENT, V122, P161; Hirata H, 2000, J BIOL CHEM, V275, P19083, DOI 10.1074/jbc.M001075200; ISHIBASHI M, 1994, EMBO J, V13, P1799, DOI 10.1002/j.1460-2075.1994.tb06448.x; Ishibashi M, 1995, GENE DEV, V9, P3136, DOI 10.1101/gad.9.24.3136; Jennings BH, 2006, MOL CELL, V22, P645, DOI 10.1016/j.molcel.2006.04.024; Jepsen K, 2007, NATURE, V450, P415, DOI 10.1038/nature06270; Jhas S, 2006, J NEUROSCI, V26, P11061, DOI 10.1523/JNEUROSCI.1358-06.2006; Jimenez G, 1997, GENE DEV, V11, P3072, DOI 10.1101/gad.11.22.3072; Ju BG, 2004, CELL, V119, P815, DOI 10.1016/j.cell.2004.11.017; Kobayashi M, 2001, DEV BIOL, V232, P315, DOI 10.1006/dbio.2001.0185; Komachi K, 1997, MOL CELL BIOL, V17, P6023, DOI 10.1128/MCB.17.10.6023; Leon C, 1997, DEV DYNAM, V208, P11, DOI 10.1002/(SICI)1097-0177(199701)208:1<11::AID-AJA2>3.0.CO;2-4; Marcal N, 2005, MOL CELL BIOL, V25, P10916, DOI 10.1128/MCB.25.24.10916-10929.2005; Menard C, 2002, NEURON, V36, P597, DOI 10.1016/S0896-6273(02)01026-7; MILLER DM, 1993, GENETICS, V135, P741; Nuthall HN, 2004, MOL CELL BIOL, V24, P8395, DOI 10.1128/MCB.24.19.8395-8407.2004; Nuthall HN, 2002, MOL CELL BIOL, V22, P389, DOI 10.1128/MCB.22.2.389-399.2002; Ohtsuka T, 2001, J BIOL CHEM, V276, P30467, DOI 10.1074/jbc.M102420200; Ohtsuka T, 1999, EMBO J, V18, P2196, DOI 10.1093/emboj/18.8.2196; Panto MR, 2004, EUR J NEUROSCI, V19, P2893, DOI 10.1111/j.0953-816X.2004.03326.x; PAROUSH Z, 1994, CELL, V79, P805, DOI 10.1016/0092-8674(94)90070-1; Pflugrad A, 1997, DEVELOPMENT, V124, P1699; Pickles LM, 2002, STRUCTURE, V10, P751, DOI 10.1016/S0969-2126(02)00768-2; SASAI Y, 1992, GENE DEV, V6, P2620, DOI 10.1101/gad.6.12b.2620; Shen Q, 2006, NAT NEUROSCI, V9, P743, DOI 10.1038/nn1694; Sondek J, 1996, NATURE, V379, P369, DOI 10.1038/379369a0; Sonderegger CK, 2003, ONCOGENE, V22, P1749, DOI 10.1038/sj.onc.1206308; Sprague ER, 2000, EMBO J, V19, P3016, DOI 10.1093/emboj/19.12.3016; Sun Y, 2001, CELL, V104, P365, DOI 10.1016/S0092-8674(01)00224-0; Toma JG, 2000, J NEUROSCI, V20, P7648; WALL MA, 1995, CELL, V83, P1047, DOI 10.1016/0092-8674(95)90220-1; Wu G, 2003, MOL CELL, V11, P1445, DOI 10.1016/S1097-2765(03)00234-X; XUAN SH, 1995, NEURON, V14, P1141, DOI 10.1016/0896-6273(95)90262-7; Yao J, 1998, DEV GROWTH DIFFER, V40, P133; Yao J, 2001, MOL CELL BIOL, V21, P1962, DOI 10.1128/MCB.21.6.1962-1972.2001; Yao J, 2000, MECH DEVELOP, V93, P105, DOI 10.1016/S0925-4773(00)00278-1; Zamparini AL, 2006, DEVELOPMENT, V133, P3709, DOI 10.1242/dev.02516	53	30	31	0	5	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	SEP 5	2008	283	36					24881	24888		10.1074/jbc.M800722200	http://dx.doi.org/10.1074/jbc.M800722200			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	342YR	18611861	Green Published, hybrid			2022-12-27	WOS:000258820000053
J	Koszelak-Rosenblum, M; Krol, AC; Simmons, DM; Goulah, CC; Wroblewski, L; Malkowski, MG				Koszelak-Rosenblum, Mary; Krol, Adam C.; Simmons, Danielle M.; Goulah, Christopher C.; Wroblewski, Liliana; Malkowski, Michael G.			His-311 and Arg-559 are key residues involved in fatty acid oxygenation in pathogen-inducible oxygenase	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							CYCLOOXYGENASE ACTIVE-SITE; ENDOPEROXIDE-H SYNTHASE-1; FUNGUS GAEUMANNOMYCES-GRAMINIS; THERMAL SHIFT ASSAYS; ARACHIDONIC-ACID; ALPHA-DIOXYGENASE; HYDROPEROXIDE ISOMERASE; PROTEIN-STABILITY; CRYSTAL-STRUCTURE; DRUG DISCOVERY	Pathogen-inducible oxygenase ( PIOX) oxygenates fatty acids into 2R-hydroperoxides. PIOX belongs to the fatty acid alpha-dioxygenase family, which exhibits homology to cyclooxygenase enzymes (COX-1 and COX-2). Although these enzymes share common catalytic features, including the use of a tyrosine radical during catalysis, little is known about other residues involved in the dioxygenase reaction of PIOX. We generated a model of linoleic acid ( LA) bound to PIOX based on computational sequence alignment and secondary structure predictions with COX-1 and experimental observations that governed the placement of carbon-2 of LA below the catalytic Tyr-379. Examination of the model identified His-311, Arg-558, and Arg-559 as potential molecular determinants of the dioxygenase reaction. Substitutions at His-311 and Arg-559 resulted in mutant constructs that retained virtually no oxygenase activity, whereas substitutions of Arg-558 caused only moderate decreases in activity. Arg-559 mutant constructs exhibited increases of greater than 140-fold in K-m, whereas no substantial change in Km was observed for His-311 or Arg-558 mutant constructs. Thermal shift assays used to measure ligand binding affinity show that the binding of LA is significantly reduced in a Y379F/R559A mutant construct compared with that observed for Y379F/R558A construct. Although Oryza sativa PIOX exhibited oxygenase activity against a variety of 14-20-carbon fatty acids, the enzyme did not oxygenate substrates containing modifications at the carboxylate, carbon-1, or carbon-2. Taken together, these data suggest that Arg-559 is required for high affinity binding of substrates to PIOX, whereas His-311 is involved in optimally aligning carbon-2 below Tyr-379 for catalysis.	[Koszelak-Rosenblum, Mary; Krol, Adam C.; Simmons, Danielle M.; Goulah, Christopher C.; Malkowski, Michael G.] SUNY Buffalo, Hauptman Woodward Med Res Inst, Buffalo, NY 14203 USA; [Simmons, Danielle M.; Wroblewski, Liliana; Malkowski, Michael G.] SUNY Buffalo, Dept Biol Struct, Buffalo, NY 14203 USA	Hauptman Woodward Medical Research Institute; State University of New York (SUNY) System; State University of New York (SUNY) Buffalo; State University of New York (SUNY) System; State University of New York (SUNY) Buffalo	Malkowski, MG (corresponding author), 700 Ellicott St, Buffalo, NY 14221 USA.	malkowski@hwi.buffalo.edu	Malkowski, Michael G/G-4939-2011	Malkowski, Michael G/0000-0003-1025-0014; Malkowski, Michael/0000-0002-1203-7463	National Institutes of Health [R01GM077176]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM077176] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported, in whole or in part, by National Institutes of Health Grant R01GM077176. The costs of publication of this article were defrayed in part by the payment of page charges. This article must therefore be hereby marked "advertisement" in accordance with 18 U.S.C. Section 1734 solely to indicate this fact.	Bhattacharyya DK, 1996, J BIOL CHEM, V271, P2179, DOI 10.1074/jbc.271.4.2179; BRODOWSKY ID, 1992, J BIOL CHEM, V267, P14738; Case DA, 2005, J COMPUT CHEM, V26, P1668, DOI 10.1002/jcc.20290; Creelman RA, 1997, ANNU REV PLANT PHYS, V48, P355, DOI 10.1146/annurev.arplant.48.1.355; Daiyasu H, 2000, J MOL EVOL, V51, P433, DOI 10.1007/s002390010106; Garavito RM, 2002, PROSTAG OTH LIPID M, V68-9, P129; Gerritse G, 1998, J BIOTECHNOL, V64, P23, DOI 10.1016/S0168-1656(98)00101-1; Ginalski K, 2003, BIOINFORMATICS, V19, P1015, DOI 10.1093/bioinformatics/btg124; Hamberg M, 1999, J BIOL CHEM, V274, P24503, DOI 10.1074/jbc.274.35.24503; Hamberg M, 2002, INT CONGR SER, V1233, P307, DOI 10.1016/S0531-5131(02)00158-9; Hamberg M, 2002, PROSTAG OTH LIPID M, V68-9, P363, DOI 10.1016/S0090-6980(02)00040-0; HammondKosack KE, 1996, PLANT CELL, V8, P1773, DOI 10.1105/tpc.8.10.1773; Harman CA, 2004, J BIOL CHEM, V279, P42929, DOI 10.1074/jbc.M403013200; Hermsmeier D, 2001, PLANT PHYSIOL, V125, P683, DOI 10.1104/pp.125.2.683; Jones DT, 1999, J MOL BIOL, V292, P195, DOI 10.1006/jmbi.1999.3091; Kim YC, 2002, J EXP BOT, V53, P383, DOI 10.1093/jexbot/53.367.383; Koeduka T, 2002, J BIOL CHEM, V277, P22648, DOI 10.1074/jbc.M110420200; Kozak KR, 2003, BIOCHEMISTRY-US, V42, P9041, DOI 10.1021/bi034471k; Kozak KR, 2001, J BIOL CHEM, V276, P30072, DOI 10.1074/jbc.M104467200; Liu W, 2006, PLANT PHYSIOL BIOCH, V44, P284, DOI 10.1016/j.plaphy.2006.06.013; Liu W, 2004, J BIOL CHEM, V279, P29805, DOI 10.1074/jbc.M401779200; Lloyd T, 2006, ACTA CRYSTALLOGR F, V62, P365, DOI 10.1107/S1744309106007305; Lo MC, 2004, ANAL BIOCHEM, V332, P153, DOI 10.1016/j.ab.2004.04.031; Malkowski MG, 2000, SCIENCE, V289, P1933, DOI 10.1126/science.289.5486.1933; Malkowski MG, 2001, J BIOL CHEM, V276, P37547, DOI 10.1074/jbc.M105982200; Matulis D, 2005, BIOCHEMISTRY-US, V44, P5258, DOI 10.1021/bi048135v; McGuffin LJ, 2000, BIOINFORMATICS, V16, P404, DOI 10.1093/bioinformatics/16.4.404; Pantoliano MW, 2001, J BIOMOL SCREEN, V6, P429, DOI 10.1089/108705701753364922; PICOT D, 1994, NATURE, V367, P243, DOI 10.1038/367243a0; Rowlinson SW, 2000, J BIOL CHEM, V275, P6586, DOI 10.1074/jbc.275.9.6586; Rowlinson SW, 1999, J BIOL CHEM, V274, P23305, DOI 10.1074/jbc.274.33.23305; SALI A, 1993, J MOL BIOL, V234, P779, DOI 10.1006/jmbi.1993.1626; Sanz A, 1998, PLANT CELL, V10, P1523, DOI 10.1105/tpc.10.9.1523; Schneider C, 2004, J BIOL CHEM, V279, P4404, DOI 10.1074/jbc.M307431200; Schneider C, 2002, J BIOL CHEM, V277, P478, DOI 10.1074/jbc.M107471200; Su C, 1998, J BIOL CHEM, V273, P20744, DOI 10.1074/jbc.273.33.20744; Su C, 1996, J BIOL CHEM, V271, P14112, DOI 10.1074/jbc.271.24.14112; THOMPSON JD, 1994, NUCLEIC ACIDS RES, V22, P4673, DOI 10.1093/nar/22.22.4673; Thuresson ED, 2001, J BIOL CHEM, V276, P10358, DOI 10.1074/jbc.M009378200; Thuresson ED, 2001, J BIOL CHEM, V276, P10347, DOI 10.1074/jbc.M009377200; Tirajoh A, 2005, J EXP BOT, V56, P713, DOI 10.1093/jxb/eri038; Vedadi M, 2006, P NATL ACAD SCI USA, V103, P15835, DOI 10.1073/pnas.0605224103; Yeh AP, 2006, ACTA CRYSTALLOGR D, V62, P451, DOI 10.1107/S0907444906005233	43	21	23	0	5	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	SEP 5	2008	283	36					24962	24971		10.1074/jbc.M804358200	http://dx.doi.org/10.1074/jbc.M804358200			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	342YR	18596034	hybrid, Green Published			2022-12-27	WOS:000258820000057
J	Suzuki, M; Ueno, T; Iizuka, R; Miura, T; Zako, T; Akahori, R; Miyake, T; Shimamoto, N; Aoki, M; Tanii, T; Ohdomari, I; Funatsu, T				Suzuki, Mihoko; Ueno, Taro; Iizuka, Ryo; Miura, Takahiro; Zako, Tamotsu; Akahori, Rena; Miyake, Takeo; Shimamoto, Naonobu; Aoki, Mutsuko; Tanii, Takashi; Ohdomari, Iwao; Funatsu, Takashi			Effect of the C-terminal truncation on the functional cycle of chaperonin GroEL - Implication that the C-terminal region facilitates the transition from the folding-arrested to the folding-competent state	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							PROTEIN-PROTEIN INTERACTIONS; HYDROPHILIC RESIDUES; CRYSTAL-STRUCTURE; CENTRAL CAVITY; SUBSTRATE; POLYPEPTIDE; MECHANISM; ATP; MICROSCOPY; SEQUENCES	To elucidate the exact role of the C-terminal region of GroEL in its functional cycle, the C-terminal 20-amino acid truncated mutant of GroEL was constructed. The steady-state ATPase rate and duration of GroES binding showed that the functional cycle of the truncated GroEL is extended by similar to 2 s in comparison with that of the wild type, without interfering with the basic functions of GroEL. We have proposed a model for the functional cycle of GroEL, which consists of two rate-limiting steps of similar to 3- and similar to 5-s duration (Ueno, T., Taguchi, H., Tadakuma, H., Yoshida, M., and Funatsu, T. (2004) Mol. Cell 14, 423-434). According to the model, detailed kinetic studies were performed. We found that a 20-residue truncation of the C terminus extends the time until inorganic phosphate is generated and the time for arresting protein folding in the central cavity, i.e. the lifetime of the first rate-limiting step in the functional cycle, to an similar to 5-s duration. These results suggest that the integrity of the C-terminal region facilitates the transition from the first to the second rate-limiting state.	[Suzuki, Mihoko; Ueno, Taro; Iizuka, Ryo; Funatsu, Takashi] Univ Tokyo, Grad Sch Pharmaceut Sci, Bunkyo Ku, Tokyo 1130033, Japan; [Miura, Takahiro; Akahori, Rena; Miyake, Takeo; Aoki, Mutsuko; Tanii, Takashi; Ohdomari, Iwao] Waseda Univ, Fac Sci & Engn, Shinjuku Ku, Tokyo 1698555, Japan; [Zako, Tamotsu] RIKEN, Bioengn Lab, Saitama 3510198, Japan; [Shimamoto, Naonobu; Tanii, Takashi; Ohdomari, Iwao] Waseda Univ, Nanotechnol Res Ctr, Shinjuku Ku, Tokyo 1620041, Japan; [Funatsu, Takashi] Univ Tokyo, Ctr NanoBio Integrat, Bunkyo Ku, Tokyo 1138656, Japan	University of Tokyo; Waseda University; RIKEN; Waseda University; University of Tokyo	Funatsu, T (corresponding author), Univ Tokyo, Grad Sch Pharmaceut Sci, Bunkyo Ku, 7-3-1 Hongo, Tokyo 1130033, Japan.	funatsu@mail.ecc.u-tokyo.ac.jp	Zako, Tamotsu/C-3004-2012; Shimamoto, Naonobu/AGP-3424-2022; Miyake, Takeo/AAU-1388-2020; Shimamoto, Naonobu/D-6708-2012; Funatsu, Takashi/Q-1404-2015	Miyake, Takeo/0000-0002-7445-633X; Funatsu, Takashi/0000-0002-9656-8308; Iizuka, Ryo/0000-0002-9328-5628	Takeda Science Foundation; Ministry of Education, Science, Sports and Culture of Japan [18031008];  [17201031];  [18770126]; Grants-in-Aid for Scientific Research [20310069] Funding Source: KAKEN	Takeda Science Foundation(Takeda Science Foundation (TSF)); Ministry of Education, Science, Sports and Culture of Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); ; ; Grants-in-Aid for Scientific Research(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))	This work was supported in part by Takeda Science Foundation (to T. F.), Grant-in-aid for Scientific Research (A) 17201031 (to T. F.), Grant-in-aid for Young Scientists 18770126 (to T. U.), and Grant-in-aid for Scientific Research on Priority Areas 18031008 (to T. U.) from the Ministry of Education, Science, Sports and Culture of Japan. The costs of publication of this article were defrayed in part by the payment of page charges. This article must therefore be hereby marked "advertisement" in accordance with 18 U.S.C. Section 1734 solely to indicate this fact.	Aoki K, 1997, J BIOL CHEM, V272, P32158, DOI 10.1074/jbc.272.51.32158; Aoki K, 2000, J BIOL CHEM, V275, P13755, DOI 10.1074/jbc.275.18.13755; BRAIG K, 1994, NATURE, V371, P578, DOI 10.1038/371578a0; Brocchieri L, 2000, PROTEIN SCI, V9, P476; BURNETT BP, 1994, J BACTERIOL, V176, P6980, DOI 10.1128/JB.176.22.6980-6985.1994; BURSTON SG, 1995, J MOL BIOL, V249, P138, DOI 10.1006/jmbi.1995.0285; CHEN S, 1994, NATURE, V371, P261, DOI 10.1038/371261a0; Cliff MJ, 2006, J BIOL CHEM, V281, P21266, DOI 10.1074/jbc.M601605200; Elad N, 2007, MOL CELL, V26, P415, DOI 10.1016/j.molcel.2007.04.004; Farr GW, 2007, P NATL ACAD SCI USA, V104, P5342, DOI 10.1073/pnas.0700820104; Hartl FU, 2002, SCIENCE, V295, P1852, DOI 10.1126/science.1068408; HEIM R, 1995, NATURE, V373, P663, DOI 10.1038/373663b0; Horwich AL, 2007, ANNU REV CELL DEV BI, V23, P115, DOI 10.1146/annurev.cellbio.23.090506.123555; LANGER T, 1992, EMBO J, V11, P4757, DOI 10.1002/j.1460-2075.1992.tb05581.x; Levene MJ, 2003, SCIENCE, V299, P682, DOI 10.1126/science.1079700; Machida K, 2008, J BIOL CHEM, V283, P6886, DOI 10.1074/jbc.M708002200; Makino Y, 1997, J BIOL CHEM, V272, P12468, DOI 10.1074/jbc.272.19.12468; MARTIN J, 1991, NATURE, V352, P36, DOI 10.1038/352036a0; MCLENNAN NF, 1994, MOL MICROBIOL, V14, P309, DOI 10.1111/j.1365-2958.1994.tb01292.x; MCLENNAN NF, 1993, MOL MICROBIOL, V7, P49, DOI 10.1111/j.1365-2958.1993.tb01096.x; MCPHIE P, 1989, BIOCHEM BIOPH RES CO, V158, P115, DOI 10.1016/S0006-291X(89)80185-8; MIYAKE T, 2008, ANAL CHEM IN PRESS; Motojima F, 2003, J BIOL CHEM, V278, P26648, DOI 10.1074/jbc.M300806200; Motojima F, 2000, BIOCHEM BIOPH RES CO, V267, P842, DOI 10.1006/bbrc.1999.2020; Murai N, 1996, J BIOL CHEM, V271, P28229, DOI 10.1074/jbc.271.45.28229; Rye HS, 1999, CELL, V97, P325, DOI 10.1016/S0092-8674(00)80742-4; Sakikawa C, 1999, J BIOL CHEM, V274, P21251, DOI 10.1074/jbc.274.30.21251; Taguchi H, 2001, NAT BIOTECHNOL, V19, P861, DOI 10.1038/nbt0901-861; Tang YC, 2008, EMBO J, V27, P1458, DOI 10.1038/emboj.2008.77; Tang YC, 2006, CELL, V125, P903, DOI 10.1016/j.cell.2006.04.027; Thiyagarajan P, 1996, STRUCTURE, V4, P79, DOI 10.1016/S0969-2126(96)00011-1; Ueno T, 2004, MOL CELL, V14, P423, DOI 10.1016/S1097-2765(04)00261-8; Viani MB, 2000, NAT STRUCT BIOL, V7, P644, DOI 10.1038/77936; Xu ZH, 1997, NATURE, V388, P741, DOI 10.1038/41944; Yokokawa M, 2006, EMBO J, V25, P4567, DOI 10.1038/sj.emboj.7601326	35	26	26	0	2	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	AUG 29	2008	283	35					23931	23939		10.1074/jbc.M804090200	http://dx.doi.org/10.1074/jbc.M804090200			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	340II	18583344	Green Published, hybrid			2022-12-27	WOS:000258638900048
J	Guo, R; Yamashita, M; Zhang, Q; Zhou, Q; Chen, D; Reynolds, DG; Awad, HA; Yanoso, L; Zhao, L; Schwarz, EM; Zhang, YE; Boyce, BF; Xing, LP				Guo, Ruolin; Yamashita, Motozo; Zhang, Qian; Zhou, Quan; Chen, Di; Reynolds, David G.; Awad, Hani A.; Yanoso, Laura; Zhao, Lan; Schwarz, Edward M.; Zhang, Ying E.; Boyce, Brendan F.; Xing, Lianping			Ubiquitin ligase Smurf1 mediates tumor necrosis factor-induced systemic bone loss by promoting proteasomal degradation of bone morphogenetic signaling proteins	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							NF-KAPPA-B; MURINE CLONAL OSTEOBLASTS; FACTOR-ALPHA; TNF-ALPHA; RHEUMATOID-ARTHRITIS; RUNX2 DEGRADATION; DIFFERENTIATION; EXPRESSION; APOPTOSIS; RECEPTOR	Chronic inflammatory disorders, such as rheumatoid arthritis, are often accompanied by systemic bone loss, which is thought to occur through inflammatory cytokine-mediated stimulation of osteoclast resorption and inhibition of osteoblast function. However, the mechanisms involved in osteoblast inhibition remain poorly understood. Here we test the hypothesis that increased Smad ubiquitin regulatory factor 1 (Smurf1)-mediated degradation of the bone morphogenetic protein pathway signaling proteins mediates reduced bone formation in inflammatory disorders. Osteoblasts derived from bone marrow or long bone samples of adult tumor necrosis factor (TNF) transgenic (TNF-Tg) mice were used in this study. TNF decreased the steady-state levels of Smad1 and Runx2 protein similarly to those in long bones of TNF-Tg mice. In the presence of the proteasome inhibitor MG132, TNF increased accumulation of ubiquitinated Smad1 protein. TNF administration over calvarial bones caused decreases in Smad1 and Runx2 protein levels and mRNA expression of osteoblast marker genes in wild-type, but not in Smurf1(-/-) mice. Vertebral bone volume and strength of TNF-Tg/Smurf1(-/-) mice were examined by a combination of micro-CT, bone histomorphometry, and biomechanical testing and compared with those from TNF-Tg littermates. TNF-Tg mice had significantly decreased bone volume and biomechanical properties, which were partially rescued in TNF-Tg/Smurf1(-/-) mice. We conclude that in chronic inflammatory disorders where TNF is increased, TNF induces the expression of ubiquitin ligase Smurf1 and promotes ubiquitination and proteasomal degradation of Smad1 and Runx2, leading to systemic bone loss. Inhibition of ubiquitin-mediated Smad1 and Runx2 degradation in osteoblasts could help to treat inflammation-induced osteoporosis.	[Guo, Ruolin; Zhang, Qian; Zhou, Quan; Zhao, Lan; Boyce, Brendan F.; Xing, Lianping] Univ Rochester, Med Ctr, Dept Pathol & Lab Med, Rochester, NY 14642 USA; [Chen, Di; Reynolds, David G.; Awad, Hani A.; Yanoso, Laura; Schwarz, Edward M.; Boyce, Brendan F.; Xing, Lianping] Univ Rochester, Med Ctr, Ctr Musculoskeletal Res, Rochester, NY 14642 USA; [Yamashita, Motozo; Zhang, Ying E.] NCI, Cellular & Mol Biol Lab, Ctr Canc Res, NIH, Bethesda, MD 20892 USA	University of Rochester; University of Rochester; National Institutes of Health (NIH) - USA; NIH National Cancer Institute (NCI)	Xing, LP (corresponding author), Univ Rochester, Med Ctr, Dept Pathol & Lab Med, Rochester, NY 14642 USA.	Lianping_xing@urmc.rochester.edu	Zhang, Ying E/G-3657-2015; Awad, Hani A/G-6976-2014; Mostafa, Taymour/H-6834-2019	Zhang, Ying E/0000-0003-2753-7601; Awad, Hani A/0000-0003-2197-2610; Mostafa, Taymour/0000-0003-3627-0662	National Institutes of Health [AR48697, AR53586, AR43510]; NATIONAL CANCER INSTITUTE [ZIABC011168, ZIABC010419] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES [R01AR054465, R01AR043510, R21AR053586, R01AR051189, K02AR052411, R01AR048697] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS))	This work was supported, in whole or in part, by National Institutes of Health Grants AR48697 and AR53586 ( to L. X.) and AR43510 ( to B. F. B.).	Abbas S, 2003, CYTOKINE, V22, P33, DOI 10.1016/S1043-4666(03)00106-6; Bodine SC, 2001, SCIENCE, V294, P1704, DOI 10.1126/science.1065874; Chen D, 2004, GROWTH FACTORS, V22, P233, DOI 10.1080/08977190412331279890; Cuevas BD, 2005, ONCOGENE, V24, P801, DOI 10.1038/sj.onc.1208239; Datto M, 2005, CELL, V121, P2, DOI 10.1016/j.cell.2005.03.017; Di Comite G, 2006, ANN NY ACAD SCI, V1069, P428, DOI 10.1196/annals.1351.041; Eigler A, 1997, Z GASTROENTEROL, V35, P899; Franzoso G, 1997, GENE DEV, V11, P3482, DOI 10.1101/gad.11.24.3482; Gallagher E, 2006, P NATL ACAD SCI USA, V103, P1717, DOI 10.1073/pnas.0510664103; Gao M, 2005, MOL CELL, V19, P581, DOI 10.1016/j.molcel.2005.08.017; Gilbert L, 2000, ENDOCRINOLOGY, V141, P3956, DOI 10.1210/en.141.11.3956; Gilbert L, 2002, J BIOL CHEM, V277, P2695, DOI 10.1074/jbc.M106339200; Gilbert LC, 2005, AM J PHYSIOL-ENDOC M, V288, pE1011, DOI 10.1152/ajpendo.00534.2004; Glass DJ, 2003, NAT CELL BIOL, V5, P87, DOI 10.1038/ncb0203-87; Goldring SR, 2003, CALCIFIED TISSUE INT, V73, P97, DOI 10.1007/s00223-002-1049-y; Goldring SR, 2003, RHEUMATOLOGY, V42, P11, DOI 10.1093/rheumatology/keg327; Guo ZJ, 2002, MOL CELL BIOL, V22, P5761, DOI 10.1128/MCB.22.16.5761-5768.2002; Ito H, 2004, GENE THER, V11, P34, DOI 10.1038/sj.gt.3302102; Izzi L, 2004, ONCOGENE, V23, P2071, DOI 10.1038/sj.onc.1207412; Jilka RL, 1998, J BONE MINER RES, V13, P793, DOI 10.1359/jbmr.1998.13.5.793; Kaneki H, 2006, J BIOL CHEM, V281, P4326, DOI 10.1074/jbc.M509430200; Kitajima I, 1996, J BONE MINER RES, V11, P200; Kitajima I, 1996, BONE, V19, P263, DOI 10.1016/8756-3282(96)00181-0; Li P, 2004, ARTHRITIS RHEUM, V50, P265, DOI 10.1002/art.11419; Li Y, 2007, J BONE MINER RES, V22, P646, DOI 10.1359/JBMR.070121; LI YP, 1992, J IMMUNOL, V148, P788; Mimura T, 2001, EXP EYE RES, V72, P71, DOI 10.1006/exer.2000.0925; Mukai T, 2007, BIOCHEM BIOPH RES CO, V356, P1004, DOI 10.1016/j.bbrc.2007.03.099; Nair SP, 2000, RHEUMATOLOGY, V39, P821, DOI 10.1093/rheumatology/39.8.821; Nakayama Hisanori, 2007, Clin Calcium, V17, P1607; Sangadala S, 2006, J BIOL CHEM, V281, P17212, DOI 10.1074/jbc.M511013200; Sapkota G, 2007, MOL CELL, V25, P441, DOI 10.1016/j.molcel.2007.01.006; Shen R, 2006, J BIOL CHEM, V281, P3569, DOI 10.1074/jbc.M506761200; Silva MJ, 2004, BONE, V35, P425, DOI 10.1016/j.bone.2004.03.027; Srivastava S, 1999, J CLIN INVEST, V104, P503, DOI 10.1172/JCI7094; TAICHMAN RS, 1992, INFLAMMATION, V16, P587, DOI 10.1007/BF00919342; Wiesner S, 2007, CELL, V130, P651, DOI 10.1016/j.cell.2007.06.050; Yamashita M, 2005, CELL, V121, P101, DOI 10.1016/j.cell.2005.01.035; Yang C, 2006, MOL CELL, V21, P135, DOI 10.1016/j.molcel.2005.11.014; Zhao M, 2004, J BIOL CHEM, V279, P12854, DOI 10.1074/jbc.M313294200; Zhao M, 2003, J BIOL CHEM, V278, P27939, DOI 10.1074/jbc.M304132200; Zhu HT, 1999, NATURE, V400, P687, DOI 10.1038/23293	42	106	112	1	11	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	AUG 22	2008	283	34					23084	23092		10.1074/jbc.M709848200	http://dx.doi.org/10.1074/jbc.M709848200			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	337SI	18567580	Green Published, hybrid			2022-12-27	WOS:000258455400021
J	Wang, J; Zhang, H; Iyer, D; Feng, XH; Schwartz, RJ				Wang, Jun; Zhang, Hua; Iyer, Dinakar; Feng, Xin-Hua; Schwartz, Robert J.			Regulation of cardiac specific nkx2.5 gene activity by small ubiquitin-like modifier	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							SERUM RESPONSE FACTOR; DNA-BINDING TARGETS; KAPPA-B ACTIVATION; SUMO-1 MODIFICATION; IN-VIVO; TRANSCRIPTION FACTOR; PROTEIN INHIBITOR; HEART DEVELOPMENT; TINMAN HOMOLOG; SUMOYLATION	The cardiac specific homeobox gene nkx2.5, a member of the nk-2 class family, plays a central role in cardiogenesis and is a target of the small ubiquitin-like modifier (SUMO). Nkx2.5 was modified by SUMO on its 51st amino acid, a lysine residue conserved across species but absent in other nk-2 members. Conversion of this lysine to an arginine (K51R) substantially reduced Nkx2.5 DNA binding and also its transcriptional activity. Unexpectedly, mutant K51R was targeted by ubiquitin. E3 ligase PIAS proteins PIAS1, PIASx, and PIASy, but not PIAS3, enhanced SUMO-1 attachment to Nkx2.5 on the primary SUMO acceptor site. SUMO-2 linkage to Nkx2.5 was catalyzed only by PIASx and not by other PIAS proteins. SUMO conjugation stabilized the formation of Nkx2.5-containing complexes that led to robust transcriptional activation. Thus, SUMO modification serves as a positive regulator for Nkx2.5 transcriptional activity.	[Wang, Jun; Zhang, Hua; Schwartz, Robert J.] Texas A&M Univ, Inst Biosci & Technol, Houston, TX 77030 USA; [Iyer, Dinakar] Baylor Coll Med, Dept Med, Houston, TX 77030 USA; [Feng, Xin-Hua] Baylor Coll Med, Dept Mol & Cell Biol, Houston, TX 77030 USA	Texas A&M University System; Baylor College of Medicine; Baylor College of Medicine	Wang, J (corresponding author), 2121 W Holcombe Blvd, Houston, TX 77030 USA.	junwang@ibt.tamhsc.edu						AZPIAZU N, 1993, GENE DEV, V7, P1325, DOI 10.1101/gad.7.7b.1325; Azuma Y, 2005, EMBO J, V24, P2172, DOI 10.1038/sj.emboj.7600700; Belaguli NS, 2000, MOL CELL BIOL, V20, P7550, DOI 10.1128/MCB.20.20.7550-7558.2000; BODMER R, 1993, DEVELOPMENT, V118, P719; BOURBON HM, 1995, J BIOL CHEM, V270, P11130, DOI 10.1074/jbc.270.19.11130; CHEN CY, 1995, J BIOL CHEM, V270, P15628, DOI 10.1074/jbc.270.26.15628; Chen CY, 1996, DEV GENET, V19, P119, DOI 10.1002/(SICI)1520-6408(1996)19:2<119::AID-DVG3>3.0.CO;2-C; Chen CY, 1996, MOL CELL BIOL, V16, P6372; Chen RM, 2004, J BIOL CHEM, V279, P21883, DOI 10.1074/jbc.M402074200; Desterro JMP, 1998, MOL CELL, V2, P233, DOI 10.1016/S1097-2765(00)80133-1; Dohmen RJ, 2004, BBA-MOL CELL RES, V1695, P113, DOI 10.1016/j.bbamcr.2004.09.021; Durocher D, 1996, MOL CELL BIOL, V16, P4648, DOI 10.1128/mcb.16.9.4648; Durocher D, 1997, EMBO J, V16, P5687, DOI 10.1093/emboj/16.18.5687; Garg V, 2003, NATURE, V424, P443, DOI 10.1038/nature01827; Goodson ML, 2001, J BIOL CHEM, V276, P18513, DOI 10.1074/jbc.M008066200; Harvey RP, 1996, DEV BIOL, V178, P203, DOI 10.1006/dbio.1996.0212; Hay RT, 2005, MOL CELL, V18, P1, DOI 10.1016/j.molcel.2005.03.012; Herrmann J, 2007, CIRC RES, V100, P1276, DOI 10.1161/01.RES.0000264500.11888.f0; Iniguez-Lluhi JA, 2006, ACS CHEM BIOL, V1, P204, DOI 10.1021/cb600188m; Iyer D, 2006, P NATL ACAD SCI USA, V103, P4516, DOI 10.1073/pnas.0505338103; Kasahara H, 1999, MOL CELL BIOL, V19, P526; Kasahara H, 2001, J BIOL CHEM, V276, P4570, DOI 10.1074/jbc.M004995200; KOMURO I, 1993, P NATL ACAD SCI USA, V90, P8145, DOI 10.1073/pnas.90.17.8145; Lee Y, 2007, J CEREBR BLOOD F MET, V27, P950, DOI 10.1038/sj.jcbfm.9600395; Liang M, 2004, J BIOL CHEM, V279, P22857, DOI 10.1074/jbc.M401554200; Lin X, 2003, J BIOL CHEM, V278, P31043, DOI 10.1074/jbc.C300112200; Lin X, 2003, MOL CELL, V11, P1389, DOI 10.1016/S1097-2765(03)00175-8; LINTS TJ, 1993, DEVELOPMENT, V119, P419; LYONS I, 1995, GENE DEV, V9, P1654, DOI 10.1101/gad.9.13.1654; Mabb AM, 2006, NAT CELL BIOL, V8, P986, DOI 10.1038/ncb1458; Matsuura T, 2005, EXP CELL RES, V308, P65, DOI 10.1016/j.yexcr.2005.04.022; Matsuzaki K, 2003, BIOCHEM BIOPH RES CO, V306, P32, DOI 10.1016/S0006-291X(03)00910-0; Nakagawa K, 2002, FEBS LETT, V530, P204, DOI 10.1016/S0014-5793(02)03486-5; Nathan D, 2006, GENE DEV, V20, P966, DOI 10.1101/gad.1404206; Nguyen HV, 2006, AM J PATHOL, V168, P1452, DOI 10.2353/ajpath.2006.050782; Nishida T, 2002, J BIOL CHEM, V277, P41311, DOI 10.1074/jbc.M206741200; Rodriguez MS, 1999, EMBO J, V18, P6455, DOI 10.1093/emboj/18.22.6455; Rodriguez MS, 2001, J BIOL CHEM, V276, P12654, DOI 10.1074/jbc.M009476200; Saitoh H, 2000, J BIOL CHEM, V275, P6252, DOI 10.1074/jbc.275.9.6252; Santti H, 2005, J MOL ENDOCRINOL, V34, P645, DOI 10.1677/jme.1.01666; Sepulveda JL, 1998, MOL CELL BIOL, V18, P3405, DOI 10.1128/MCB.18.6.3405; Shao RJ, 2004, FEBS LETT, V569, P293, DOI 10.1016/j.febslet.2004.05.079; Steffan JS, 2004, SCIENCE, V304, P100, DOI 10.1126/science.1092194; Tanaka M, 1999, DEVELOPMENT, V126, P1269; TREIER M, 1994, CELL, V78, P787, DOI 10.1016/S0092-8674(94)90502-9; Wang J, 2005, MOL CELL BIOL, V25, P9829, DOI 10.1128/MCB.25.22.9829-9844.2005; Wang J, 2004, J BIOL CHEM, V279, P49091, DOI 10.1074/jbc.M407494200; Wang J, 2007, MOL CELL BIOL, V27, P622, DOI 10.1128/MCB.01160-06; Willis MS, 2006, J MOL CELL CARDIOL, V41, P567, DOI 10.1016/j.yjmcc.2006.07.015; Wong KA, 2004, MOL CELL BIOL, V24, P5577, DOI 10.1128/MCB.24.12.5577-5586.2004	50	43	45	0	4	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	AUG 22	2008	283	34					23235	23243		10.1074/jbc.M709748200	http://dx.doi.org/10.1074/jbc.M709748200			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	337SI	18579533	hybrid, Green Published			2022-12-27	WOS:000258455400037
J	Kol, S; Nouwen, N; Driessen, AJM				Kol, Stefan; Nouwen, Nico; Driessen, Arnold J. M.			Mechanisms of YidC-mediated Insertion and Assembly of Multimeric Membrane Protein Complexes	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Review							F1F0 ATP SYNTHASE; RECOGNITION PARTICLE RECEPTOR; ESCHERICHIA-COLI YIDC; INNER MEMBRANE; SUBUNIT-C; TARGETING PATHWAY; SEC-TRANSLOCASE; M13 PROCOAT; BIOGENESIS; REQUIREMENTS	The YidC protein fulfills a dual and essential role in the assembly of inner membrane proteins in Escherichia coli. Besides interacting with transmembrane segments of newly synthesized membrane proteins that insert into the membrane via the SecYEG complex, YidC also functions as an independent membrane protein insertase and assists in membrane protein folding. Here, we discuss the mechanisms of YidC substrate recognition and membrane insertion with emphasis on its role in the assembly of multimeric membrane protein complexes such as the F1F0-ATP synthase.	[Kol, Stefan; Driessen, Arnold J. M.] Univ Groningen, Dept Mol Microbiol, Groningen Biomol Sci & Biotechnol Inst, Zernike Inst Adv Mat, NL-9751 NN Haren, Netherlands; [Kol, Stefan; Driessen, Arnold J. M.] Univ Groningen, Kluyver Ctr Genom Ind Microorganisms, NL-9751 NN Haren, Netherlands; [Nouwen, Nico] Lab Symbiosis Trop & Mediterraneennes, F-34398 Montpellier 5, France	University of Groningen; University of Groningen; Universite de Montpellier	Driessen, AJM (corresponding author), Univ Groningen, Dept Mol Microbiol, Groningen Biomol Sci & Biotechnol Inst, Zernike Inst Adv Mat, NL-9751 NN Haren, Netherlands.	a.j.m.driessen@rug.nl	Driessen, Arnold J.M./D-1876-2012; Institute, Zernike/W-7033-2019	Kol, Stefan/0000-0002-1992-8242; Driessen, Arnold J.M./0000-0001-9258-9104	Earth and Life Science Foundation; Netherlands Organization for Scientific Research; European Community [LSHG-CT-2004-504601]	Earth and Life Science Foundation; Netherlands Organization for Scientific Research(Netherlands Organization for Scientific Research (NWO)); European Community(European Commission)	This work was supported by the Earth and Life Science Foundation, subsidized by the Netherlands Organization for Scientific Research, and by European Community Grant LSHG-CT-2004-504601 (European Membrane Protein Consortium). This minireview will be reprinted in the 2008 Minireview Compendium, which will be available in January, 2009.	Ackerman SH, 2005, PROG NUCLEIC ACID RE, V80, P95, DOI 10.1016/S0079-6603(05)80003-0; Akiyama Y, 1996, FEBS LETT, V399, P26, DOI 10.1016/S0014-5793(96)01283-5; Angelini S, 2006, J CELL BIOL, V174, P715, DOI 10.1083/jcb.200606093; Beck K, 2001, EMBO REP, V2, P709, DOI 10.1093/embo-reports/kve154; Bernstein HD, 2000, CURR OPIN MICROBIOL, V3, P203, DOI 10.1016/S1369-5274(00)00076-X; Bernstein KD, 2001, J BACTERIOL, V183, P2187, DOI 10.1128/JB.183.7.2187-2197.2001; Blattner FR, 1997, SCIENCE, V277, P1453, DOI 10.1126/science.277.5331.1453; Celebi N, 2006, J MOL BIOL, V357, P1428, DOI 10.1016/j.jmb.2006.01.030; Celebi N, 2008, J MOL BIOL, V375, P1282, DOI 10.1016/j.jmb.2007.11.054; Chen MY, 2003, J BIOL CHEM, V278, P23295, DOI 10.1074/jbc.M301008200; Chen MY, 2002, J BIOL CHEM, V277, P7670, DOI 10.1074/jbc.M110644200; Cristobal S, 1999, J BIOL CHEM, V274, P20068, DOI 10.1074/jbc.274.29.20068; Dalbey RE, 2000, ANNU REV CELL DEV BI, V16, P51, DOI 10.1146/annurev.cellbio.16.1.51; de Gier JWL, 1998, P NATL ACAD SCI USA, V95, P14646, DOI 10.1073/pnas.95.25.14646; du Plessis DJF, 2006, J BIOL CHEM, V281, P12248, DOI 10.1074/jbc.M600048200; Facey SJ, 2007, J MOL BIOL, V365, P995, DOI 10.1016/j.jmb.2006.10.083; Froderberg L, 2003, MOL MICROBIOL, V47, P1015, DOI 10.1046/j.1365-2958.2003.03346.x; GAY NJ, 1984, J BACTERIOL, V158, P820, DOI 10.1128/JB.158.3.820-825.1984; Herrmann JM, 2004, J BIOL CHEM, V279, P2507, DOI 10.1074/jbc.M310468200; Herskovits AA, 2002, J CELL BIOL, V159, P403, DOI 10.1083/jcb.200204144; Houstek J, 2006, BBA-BIOENERGETICS, V1757, P1400, DOI 10.1016/j.bbabio.2006.04.006; Jia LX, 2007, MOL BIOL CELL, V18, P1897, DOI 10.1091/mbc.E06-10-0925; Jiang FL, 2003, J BIOL CHEM, V278, P48965, DOI 10.1074/jbc.M307362200; Kol S, 2008, J BIOL CHEM, V283, P9871, DOI 10.1074/jbc.M709408200; Kol S, 2006, J BIOL CHEM, V281, P29762, DOI 10.1074/jbc.M605317200; Krebstakies T, 2005, J BIOL CHEM, V280, P33338, DOI 10.1074/jbc.M506251200; Lefebvre-Legendre L, 2001, J BIOL CHEM, V276, P6789, DOI 10.1074/jbc.M009557200; Lemaire C, 2000, J BIOL CHEM, V275, P23471, DOI 10.1074/jbc.M002045200; Lotz M, 2008, J MOL BIOL, V375, P901, DOI 10.1016/j.jmb.2007.10.089; Nagamori S, 2004, J CELL BIOL, V165, P53, DOI 10.1083/jcb.200402067; Oliver DC, 2008, J BIOL CHEM, V283, P5208, DOI 10.1074/jbc.M708936200; Ono S, 2004, J BIOL CHEM, V279, P33409, DOI 10.1074/jbc.M404993200; Price CE, 2008, J BIOL CHEM, V283, P26921, DOI 10.1074/jbc.M804490200; Samuelson JC, 2000, NATURE, V406, P637, DOI 10.1038/35020586; Samuelson JC, 2001, J BIOL CHEM, V276, P34847, DOI 10.1074/jbc.M105793200; Scotti PA, 2000, EMBO J, V19, P542, DOI 10.1093/emboj/19.4.542; Serek J, 2004, EMBO J, V23, P294, DOI 10.1038/sj.emboj.7600063; STEFFENS K, 1984, EUR J BIOCHEM, V138, P617, DOI 10.1111/j.1432-1033.1984.tb07959.x; Suzuki T, 2007, P NATL ACAD SCI USA, V104, P20776, DOI 10.1073/pnas.0708075105; Urbanus ML, 2001, EMBO REP, V2, P524, DOI 10.1093/embo-reports/kve108; VALENT QA, 1995, EMBO J, V14, P5494, DOI 10.1002/j.1460-2075.1995.tb00236.x; van Bloois E, 2006, J BIOL CHEM, V281, P10002, DOI 10.1074/jbc.M511357200; van Bloois E, 2004, FEBS LETT, V576, P97, DOI 10.1016/j.febslet.2004.08.069; van Bloois E, 2008, FEBS LETT, V582, P1419, DOI 10.1016/j.febslet.2008.02.082; van der Laan M, 2005, CURR OPIN MICROBIOL, V8, P182, DOI 10.1016/j.mib.2005.02.004; van der Laan M, 2004, J CELL BIOL, V165, P213, DOI 10.1083/jcb.200402100; van der Laan M, 2004, J BIOL CHEM, V279, P1659, DOI 10.1074/jbc.M306527200; van der Laan M, 2003, P NATL ACAD SCI USA, V100, P5801, DOI 10.1073/pnas.0636761100; VIK SB, 1987, J BIOL CHEM, V262, P8340; Wagner S, 2008, J BIOL CHEM, V283, P17881, DOI 10.1074/jbc.M801481200; Xie K, 2007, BIOCHEMISTRY-US, V46, P15153, DOI 10.1021/bi701398y; Yi L, 2003, BIOCHEMISTRY-US, V42, P10537, DOI 10.1021/bi034309h; Yi L, 2004, J BIOL CHEM, V279, P39260, DOI 10.1074/jbc.M405490200; Zeng XM, 2007, MOL BIOL CELL, V18, P617, DOI 10.1091/mbc.E06-09-0801	54	49	50	0	4	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 14	2008	283	46					31269	31273		10.1074/jbc.R800029200	http://dx.doi.org/10.1074/jbc.R800029200			5	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	370KJ	18658156	Green Submitted, Green Published, hybrid			2022-12-27	WOS:000260760800001
J	Lopez-Otin, C; Bond, JS				Lopez-Otin, Carlos; Bond, Judith S.			Proteases: Multifunctional Enzymes in Life and Disease	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Review							SERINE PROTEASES; GENOMIC ANALYSIS; GENE FAMILIES; PROTEOLYSIS; METALLOPROTEINASES; ARABIDOPSIS; COMPLEXITY; EXPRESSION; INHIBITORS; VIRULENCE		[Bond, Judith S.] Penn State Univ, Coll Med, Dept Biochem & Mol Biol, Hershey, PA 17033 USA; [Lopez-Otin, Carlos] Univ Oviedo, Fac Med, Inst Univ Oncol, Dept Bioquim & Biol Mol, E-33006 Oviedo, Spain	Pennsylvania Commonwealth System of Higher Education (PCSHE); Pennsylvania State University; Penn State Health; University of Oviedo; Instituto Universitario de Oncologia de Asturias	Bond, JS (corresponding author), Penn State Univ, Coll Med, Dept Biochem & Mol Biol, Hershey, PA 17033 USA.	jbond@psu.edu	López-Otín, Carlos/AAB-2106-2020	López-Otín, Carlos/0000-0001-6964-1904	National Institutes of Health [DK-19691]; Pennsylvania Department of Health Tobacco Settlement; Ministerio de Educacion y Ciencia; European Union; Fundacion M. Botin; Fundacion Lilly; Obra Social Cajastur-Asturias, Spain; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK019691, R56DK019691, R37DK019691] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Pennsylvania Department of Health Tobacco Settlement; Ministerio de Educacion y Ciencia(Spanish Government); European Union(European Commission); Fundacion M. Botin; Fundacion Lilly; Obra Social Cajastur-Asturias, Spain; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	This work was supported, in whole or in part, by National Institutes of Health Grant DK-19691 and the Pennsylvania Department of Health Tobacco Settlement Funds (to J. S. B.). This work was also supported by grants from the Ministerio de Educacion y Ciencia, European Union, Fundacion M. Botin, and Fundacion Lilly (to C. L.-O.). The work performed at the Instituto Universitario de Oncologia was supported by the Obra Social Cajastur-Asturias, Spain. This is the first article of a mini review series on proteases to be published in future issues of the Journal. This minireview will be reprinted in the 2008 Minireview Compendium, which will be available in January, 2009.	Barrett A. J., 1998, HDB PROTEOLYTIC ENZY; Bertenshaw GP, 2003, J BIOL CHEM, V278, P2522, DOI 10.1074/jbc.M208808200; Beynon R.J., 2001, PROTEOLYTIC ENZYMES; Bode W, 2000, BBA-PROTEIN STRUCT M, V1477, P241, DOI 10.1016/S0167-4838(99)00276-9; Cal S, 2007, FRONT BIOSCI-LANDMRK, V12, P4661, DOI 10.2741/2415; Chauhan D, 2008, BLOOD, V111, P1654, DOI 10.1182/blood-2006-10-050476; Ciechanover A, 2005, NAT REV MOL CELL BIO, V6, P79, DOI 10.1038/nrm1552; Deacon CF, 2008, FRONT BIOSCI-LANDMRK, V13, P1780, DOI 10.2741/2799; Eagle ARR, 2005, HUM GENET, V118, P12, DOI 10.1007/s00439-005-0019-7; Ehrmann M, 2004, ANNU REV GENET, V38, P709, DOI 10.1146/annurev.genet.38.072902.093416; FREIJE JMP, 1994, J BIOL CHEM, V269, P16766; Garcia-Lorenzo M, 2006, BMC PLANT BIOL, V6, DOI 10.1186/1471-2229-6-30; Kang SH, 2007, J BIOL CHEM, V282, P5256, DOI 10.1074/jbc.M610590200; Kaur R, 2007, P NATL ACAD SCI USA, V104, P7628, DOI 10.1073/pnas.0611195104; Kayagaki N, 2007, SCIENCE, V318, P1628, DOI 10.1126/science.1145918; Keller UAD, 2007, BIOL CHEM, V388, P1159, DOI 10.1515/BC.2007.146; Levene PA, 1905, J BIOL CHEM, V1, P45; Lopez-Otin C, 2002, NAT REV MOL CELL BIO, V3, P509, DOI 10.1038/nrm858; Lopez-Otin C, 2007, NAT REV CANCER, V7, P800, DOI 10.1038/nrc2228; Makinoshima H, 2005, NATURE, V436, P406, DOI 10.1038/nature03713; Marino G, 2003, J BIOL CHEM, V278, P3671, DOI 10.1074/jbc.M208247200; Mason RW, 2008, PLACENTA, V29, P385, DOI 10.1016/j.placenta.2008.02.006; Masson E, 2008, CLIN GASTROENTEROL H, V6, P82, DOI 10.1016/j.cgh.2007.10.004; McKerrow JH, 2006, ANNU REV PATHOL-MECH, V1, P497, DOI 10.1146/annurev.pathol.1.110304.100151; Mitsui S, 2008, FRONT BIOSCI-LANDMRK, V13, P1991, DOI 10.2741/2818; Oikonomopoulou K, 2006, BIOL CHEM, V387, P677, DOI 10.1515/BC.2006.086; Ordonez GR, 2008, GENOME BIOL, V9, DOI 10.1186/gb-2008-9-5-r81; Overall CM, 2007, NAT REV MOL CELL BIO, V8, P245, DOI 10.1038/nrm2120; Overall CM, 2002, NAT REV CANCER, V2, P657, DOI 10.1038/nrc884; Page-McCaw A, 2007, NAT REV MOL CELL BIO, V8, P221, DOI 10.1038/nrm2125; Pampalakis G, 2007, BBA-REV CANCER, V1776, P22, DOI 10.1016/j.bbcan.2007.06.001; Porter S, 2005, BIOCHEM J, V386, P15, DOI 10.1042/BJ20040424; Puente XS, 2005, GENOMICS, V86, P638, DOI 10.1016/j.ygeno.2005.07.009; Puente XS, 2005, BIOCHEM SOC T, V33, P331, DOI 10.1042/BST0330331; Puente XS, 2004, GENOME RES, V14, P609, DOI 10.1101/gr.1946304; Puente XS, 2003, NAT REV GENET, V4, P544, DOI 10.1038/nrg1111; Riedl SJ, 2007, NAT REV MOL CELL BIO, V8, P405, DOI 10.1038/nrm2153; Saeki K, 2007, J BIOSCI BIOENG, V103, P501, DOI 10.1263/jbb.103.501; Sauer RT, 2004, CELL, V119, P9, DOI 10.1016/j.cell.2004.09.020; Shah PK, 2008, GENE, V407, P199, DOI 10.1016/j.gene.2007.10.012; Siegel RM, 2006, NAT REV IMMUNOL, V6, P308, DOI 10.1038/nri1809; Szabo R, 2008, INT J BIOCHEM CELL B, V40, P1297, DOI 10.1016/j.biocel.2007.11.013; Tripathi LP, 2006, BMC GENOMICS, V7, DOI 10.1186/1471-2164-7-200; Turk B, 2006, NAT REV DRUG DISCOV, V5, P785, DOI 10.1038/nrd2092; Urban S, 2006, GENE DEV, V20, P3054, DOI 10.1101/gad.1488606; Versteeg HH, 2006, SEMIN THROMB HEMOST, V32, P24, DOI 10.1055/s-2006-933337; Yan CH, 2007, J CELL PHYSIOL, V211, P19, DOI 10.1002/jcp.20948	47	528	549	4	71	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 7	2008	283	45					30433	30437		10.1074/jbc.R800035200	http://dx.doi.org/10.1074/jbc.R800035200			5	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	367ID	18650443	hybrid, Green Published			2022-12-27	WOS:000260544800001
J	Kirkland, SC; Ying, HJ				Kirkland, Susan C.; Ying, Huijun			alpha 2 beta 1 integrin regulates lineage commitment in multipotent human colorectal cancer cells	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							STEM-CELLS; EXTRACELLULAR-MATRIX; MULTILINEAGE DIFFERENTIATION; INTEGRIN ALPHA-2-BETA-1; SIGNALING PATHWAYS; I COLLAGEN; ADHESION; GROWTH; RECEPTOR; BETA-1-INTEGRINS	The human colorectal epithelium is maintained by multipotent stem cells that give rise to absorptive, mucous, and endocrine lineages. Recent evidence suggests that human colorectal cancers are likewise maintained by a minority population of so-called cancer stem cells. We have previously established a human colorectal cancer cell line with multipotent characteristics (HRA-19) and developed a serum-free medium that induces endocrine, mucous and absorptive lineage commitment by HRA-19 cells in vitro. In this study, we investigate the role of the beta 1 integrin family of cell surface extracellular matrix receptors in multilineage differentiation by these multipotent human colorectal cancer cells. We show that endocrine and mucous lineage commitment is blocked in the presence of function-blocking antibodies to beta 1 integrin. Function-blocking antibodies to alpha 2 integrin also blocked both HRA-19 endocrine lineage commitment and enterocytic differentiation by Caco-2 human colon cancer cells; both effects being abrogated by the MEK inhibitor, PD98059, suggesting a role for ERK signaling in alpha 2-mediated regulation of colorectal cancer cell differentiation. To further explore the role of alpha 2 integrin in multilineage differentiation, we established multipotent cells expressing high levels of wild-type alpha 2 integrin or a non-signaling chimeric alpha 2 integrin. Overexpression of wild-type alpha 2 integrin in HRA-19 cells significantly enhanced endocrine and mucous lineage commitment, while cells expressing the non-signaling chimeric alpha 2 integrin had negligible ability for either endocrine or mucous lineage commitment. This study indicates that the collagen receptor alpha 2 beta 1 integrin is a regulator of cell fate in human multipotent colorectal cancer cells.	[Kirkland, Susan C.] Univ London Imperial Coll Sci Technol & Med, Dept Histopathol, Fac Med, London W12 ONN, England	Imperial College London	Kirkland, SC (corresponding author), Univ London Imperial Coll Sci Technol & Med, Dept Histopathol, Fac Med, DuCane Rd, London W12 ONN, England.	s.kirkland@imperial.ac.uk			The Wellcome Trust [060688]	The Wellcome Trust(Wellcome TrustEuropean Commission)	This work was supported by Grant 060688 from The Wellcome Trust. The costs of publication of this article were defrayed in part by the payment of page charges. This article must therefore be hereby marked "advertisement" in accordance with 18 U. S. C. Section 1734 solely to indicate this fact.	Brittan M, 2004, GUT, V53, P899, DOI 10.1136/gut.2003.025478; Campos LS, 2004, DEVELOPMENT, V131, P3433, DOI 10.1242/dev.01199; Chen SS, 2007, STEM CELLS, V25, P553, DOI 10.1634/stemcells.2006-0419; Collins AT, 2005, CANCER RES, V65, P10946, DOI 10.1158/0008-5472.CAN-05-2018; Collins AT, 2001, J CELL SCI, V114, P3865; Comoglio PM, 2003, CURR OPIN CELL BIOL, V15, P565, DOI 10.1016/S0955-0674(03)00096-6; Crook MF, 2002, J VASC RES, V39, P221, DOI 10.1159/000063687; Dalerba P, 2007, P NATL ACAD SCI USA, V104, P10158, DOI 10.1073/pnas.0703478104; Dalerba P, 2007, ANNU REV MED, V58, P267, DOI 10.1146/annurev.med.58.062105.204854; Ding QM, 2001, BIOCHEM BIOPH RES CO, V284, P282, DOI 10.1006/bbrc.2001.4969; Fabbri M, 1996, TISSUE ANTIGENS, V48, P47, DOI 10.1111/j.1399-0039.1996.tb02604.x; Fang JY, 2005, LANCET ONCOL, V6, P322, DOI 10.1016/S1470-2045(05)70168-6; Flaim CJ, 2005, NAT METHODS, V2, P119, DOI 10.1038/NMETH736; Fujimoto K, 2002, GASTROENTEROLOGY, V123, P1941, DOI 10.1053/gast.2002.37065; Grzesiak JJ, 2006, BRIT J CANCER, V94, P1311, DOI 10.1038/sj.bjc.6603088; Hall CL, 2006, CANCER RES, V66, P8648, DOI 10.1158/0008-5472.CAN-06-1544; HEINO J, 1989, J BIOL CHEM, V264, P380; Heino J, 2000, MATRIX BIOL, V19, P319, DOI 10.1016/S0945-053X(00)00076-7; Henderson K, 1996, DIFFERENTIATION, V60, P259, DOI 10.1046/j.1432-0436.1996.6040259.x; Hers I, 2000, EUR J BIOCHEM, V267, P2088, DOI 10.1046/j.1432-1327.2000.01214.x; Hill RP, 2006, CANCER RES, V66, P1891, DOI 10.1158/0008-5472.CAN-05-3450; HYNES RO, 1992, CELL, V69, P11, DOI 10.1016/0092-8674(92)90115-S; Hynes RO, 2002, CELL, V110, P673, DOI 10.1016/S0092-8674(02)00971-6; Ivaska J, 1999, J CELL BIOL, V147, P401, DOI 10.1083/jcb.147.2.401; Jiang FX, 2001, MOL MED, V7, P107, DOI 10.1007/BF03401944; JONES PH, 1995, CELL, V80, P83, DOI 10.1016/0092-8674(95)90453-0; Jones RG, 2006, J CELL BIOL, V175, P505, DOI 10.1083/jcb.200602160; Jordan CT, 2006, NEW ENGL J MED, V355, P1253, DOI 10.1056/NEJMra061808; KIRKLAND SC, 1988, CANCER, V61, P1359, DOI 10.1002/1097-0142(19880401)61:7<1359::AID-CNCR2820610714>3.0.CO;2-0; Kirkland SC, 2001, J CELL SCI, V114, P2055; Klekotka PA, 2001, J BIOL CHEM, V276, P32353, DOI 10.1074/jbc.M101921200; Leone DP, 2005, J CELL SCI, V118, P2589, DOI 10.1242/jcs.02396; Lussier C, 2000, MICROSC RES TECHNIQ, V51, P169; Matsubara T, 2004, BIOCHEM BIOPH RES CO, V313, P503, DOI 10.1016/j.bbrc.2003.11.143; Miranti CK, 2002, NAT CELL BIOL, V4, pE83, DOI 10.1038/ncb0402-e83; Moore KA, 2006, SCIENCE, V311, P1880, DOI 10.1126/science.1110542; Ni HY, 1998, CELL ADHES COMMUN, V5, P257, DOI 10.3109/15419069809040296; Ning Y, 2007, J BIOL CHEM, V282, P6380, DOI 10.1074/jbc.M610915200; O'Brien CA, 2007, NATURE, V445, P106, DOI 10.1038/nature05372; Ohlstein B, 2004, CURR OPIN CELL BIOL, V16, P693, DOI 10.1016/j.ceb.2004.09.003; Radel C, 2005, AM J PHYSIOL-HEART C, V288, pH936, DOI 10.1152/ajpheart.00519.2004; Reya T, 2005, NATURE, V434, P843, DOI 10.1038/nature03319; Ricci-Vitiani L, 2007, NATURE, V445, P111, DOI 10.1038/nature05384; Rohwedel J, 1998, DEV BIOL, V201, P167, DOI 10.1006/dbio.1998.9002; Sancho E, 2004, ANNU REV CELL DEV BI, V20, P695, DOI 10.1146/annurev.cellbio.20.010403.092805; Sawhney RS, 2003, J BIOL CHEM, V278, P19861, DOI 10.1074/jbc.M213162200; Scartozzi M, 2006, EXPERT OPIN THER TAR, V10, P281, DOI 10.1517/14728222.10.2.281; Stappenbeck TS, 2003, P NATL ACAD SCI USA, V100, P1004, DOI 10.1073/pnas.242735899; Taupin D, 1999, GASTROENTEROLOGY, V116, P1072, DOI 10.1016/S0016-5085(99)70010-7; WAYNER EA, 1988, J CELL BIOL, V107, P1881, DOI 10.1083/jcb.107.5.1881; WAYNER EA, 1991, J CELL BIOL, V113, P919, DOI 10.1083/jcb.113.4.919; Whittard JD, 2002, MATRIX BIOL, V21, P525, DOI 10.1016/S0945-053X(02)00037-9; Yu X, 2000, J CELL SCI, V113, P2139; Zhu AJ, 1999, P NATL ACAD SCI USA, V96, P6728, DOI 10.1073/pnas.96.12.6728	54	27	30	0	4	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	OCT 10	2008	283	41					27612	27619		10.1074/jbc.M802932200	http://dx.doi.org/10.1074/jbc.M802932200			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	355OW	18664572	Green Published, hybrid			2022-12-27	WOS:000259719200032
J	Price, CE; Driessen, AJM				Price, Claire E.; Driessen, Arnold J. M.			YidC is involved in the biogenesis of anaerobic respiratory complexes in the inner membrane of Escherichia coli	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							TWIN-ARGININE TRANSLOCASE; SEC-INDEPENDENT PROTEIN; FUMARATE REDUCTASE; NITRATE REDUCTASE; STRESS-RESPONSE; ATP SYNTHASE; NUCLEAR GENE; SUBUNIT-C; INSERTION; PATHWAY	YidC of Escherichia coli belongs to the evolutionarily conserved Oxa1/Alb3/YidC family. Members of this family have all been implicated in membrane protein biogenesis of aerobic respiratory and energy-transducing proteins. YidC is essential for the insertion of subunit c of the F1F0-ATP synthase and subunit a of cytochrome o oxidase. The aim of this study was to investigate whether YidC plays a role during anaerobic growth of Escherichia coli, specifically when either nitrate or fumarate are used as terminal electron acceptors or under fermentative conditions. The effect of YidC depletion on the growth, enzyme activities, and protein levels in the inner membrane was determined. YidC is essential for all anaerobic growth conditions tested, and this is not because of the decreased levels of F1F0-ATP synthase in the inner membrane only. The results suggest a role for YidC in the membrane biogenesis of integral membrane parts of the anaerobic respiratory chain.	Univ Groningen, Dept Mol Microbiol, Groningen Biomol Sci & Biotechnol Inst, Zernike Inst Adv Mat, NL-9751 NN Haren, Netherlands; Univ Groningen, Kluyver Ctr Genom Ind Microorganisms, NL-9751 NN Haren, Netherlands	University of Groningen; University of Groningen	Driessen, AJM (corresponding author), Univ Groningen, Dept Microbiol, Kerklaan 30, NL-9751 NN Haren, Netherlands.	a.j.m.driessen@rug.nl	Institute, Zernike/W-7033-2019; Driessen, Arnold J.M./D-1876-2012	Driessen, Arnold J.M./0000-0001-9258-9104	Netherlands Proteomics Centre; European Community [LSHG-CT-2004-504601]	Netherlands Proteomics Centre; European Community(European Commission)	This work was supported by a grant from the Netherlands Proteomics Centre and by European Community Grant LSHG-CT-2004-504601. The costs of publication of this article were defrayed in part by the payment of page charges. This article must therefore be hereby marked "advertisement" in accordance with 18 U. S. C. Section 1734 solely to indicate this fact.	AMANN E, 1985, GENE, V40, P183, DOI 10.1016/0378-1119(85)90041-1; BAUER M, 1994, MOL GEN GENET, V245, P272, DOI 10.1007/BF00290106; Bertero MG, 2003, NAT STRUCT BIOL, V10, P681, DOI 10.1038/nsb969; BONNEFOY N, 1994, J MOL BIOL, V239, P201, DOI 10.1006/jmbi.1994.1363; Cecchini G, 2002, BBA-BIOENERGETICS, V1553, P140, DOI 10.1016/S0005-2728(01)00238-9; Chan CS, 2006, BIOCHEM BIOPH RES CO, V343, P244, DOI 10.1016/j.bbrc.2006.02.133; Darwin AJ, 2005, MOL MICROBIOL, V57, P621, DOI 10.1111/j.1365-2958.2005.04694.x; de Gier JW, 2001, MOL MICROBIOL, V40, P314, DOI 10.1046/j.1365-2958.2001.02392.x; du Plessis DJF, 2006, J BIOL CHEM, V281, P12248, DOI 10.1074/jbc.M600048200; Dubini A, 2003, FEBS LETT, V549, P141, DOI 10.1016/S0014-5793(03)00802-0; Emanuelsson O, 2007, NAT PROTOC, V2, P953, DOI 10.1038/nprot.2007.131; Facey SJ, 2007, J MOL BIOL, V365, P995, DOI 10.1016/j.jmb.2006.10.083; GARLAND PB, 1975, BIOCHEM J, V152, P547, DOI 10.1042/bj1520547; Hatzixanthis K, 2003, MOL MICROBIOL, V49, P1377, DOI 10.1046/j.1365-2958.2003.03642.x; Iverson TM, 1999, SCIENCE, V284, P1961, DOI 10.1126/science.284.5422.1961; Jovanovic G, 2006, J BIOL CHEM, V281, P21147, DOI 10.1074/jbc.M602323200; Kao MC, 2005, BIOCHEMISTRY-US, V44, P9545, DOI 10.1021/bi050708w; Kaufmann A, 1999, BIOCHEMISTRY-US, V38, P9115, DOI 10.1021/bi990539d; LAEMMLI UK, 1970, NATURE, V227, P680, DOI 10.1038/227680a0; LANZETTA PA, 1979, ANAL BIOCHEM, V100, P95, DOI 10.1016/0003-2697(79)90115-5; LATOUR DJ, 1989, BIOCHEM CELL BIOL, V67, P251, DOI 10.1139/o89-038; LESTER RL, 1971, J BACTERIOL, V105, P1006, DOI 10.1128/JB.105.3.1006-1014.1971; Lin E., 1987, ESCHERICHIA COLI SAL, P201; Lloyd LJ, 2004, J BIOL CHEM, V279, P55707, DOI 10.1074/jbc.M408994200; MALONEY PC, 1987, ESCHERICHIA COLI SAL, P222; MCCORMICK KA, 1993, J BIOL CHEM, V268, P24683; Moore M, 2000, J BIOL CHEM, V275, P1529, DOI 10.1074/jbc.275.3.1529; Nagamori S, 2004, J CELL BIOL, V165, P53, DOI 10.1083/jcb.200402067; Nouwen N, 2001, FEBS LETT, V508, P103, DOI 10.1016/S0014-5793(01)03033-2; Potter LC, 1999, BIOCHEM J, V344, P77, DOI 10.1042/0264-6021:3440077; Rose RW, 2002, MOL MICROBIOL, V45, P943, DOI 10.1046/j.1365-2958.2002.03090.x; Rothery RA, 1998, BIOCHEM J, V332, P35, DOI 10.1042/bj3320035; Sambasivarao D, 2001, J BIOL CHEM, V276, P20167, DOI 10.1074/jbc.M010369200; Samuelson JC, 2000, NATURE, V406, P637, DOI 10.1038/35020586; Sargent F, 1999, J BIOL CHEM, V274, P36073, DOI 10.1074/jbc.274.51.36073; Seo J, 2007, MOL MICROBIOL, V65, P714, DOI 10.1111/j.1365-2958.2007.05821.x; Stiburek L, 2007, J MOL BIOL, V374, P506, DOI 10.1016/j.jmb.2007.09.044; TOWBIN H, 1979, P NATL ACAD SCI USA, V76, P4350, DOI 10.1073/pnas.76.9.4350; Tran QH, 1997, EUR J BIOCHEM, V244, P155, DOI 10.1111/j.1432-1033.1997.00155.x; Turner RJ, 2004, CAN J MICROBIOL, V50, P225, DOI 10.1139/W03-117; van Bloois E, 2006, J BIOL CHEM, V281, P10002, DOI 10.1074/jbc.M511357200; van Bloois E, 2008, FEBS LETT, V582, P1419, DOI 10.1016/j.febslet.2008.02.082; van der Laan M, 2004, J CELL BIOL, V165, P213, DOI 10.1083/jcb.200402100; van der Laan M, 2003, P NATL ACAD SCI USA, V100, P5801, DOI 10.1073/pnas.0636761100; van der Laan M, 2001, EMBO REP, V2, P519, DOI 10.1093/embo-reports/kve106; Weber A, 2006, J BACTERIOL, V188, P7165, DOI 10.1128/JB.00508-06; Yi L, 2003, BIOCHEMISTRY-US, V42, P10537, DOI 10.1021/bi034309h	47	26	26	0	3	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	OCT 3	2008	283	40					26921	26927		10.1074/jbc.M804490200	http://dx.doi.org/10.1074/jbc.M804490200			7	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	353RT	18635537	hybrid, Green Published			2022-12-27	WOS:000259586600012
J	Wright, NT; Prosser, BL; Varney, KM; Zimmer, DB; Schneider, MF; Weber, DJ				Wright, Nathan T.; Prosser, Benjamin L.; Varney, Kristen M.; Zimmer, Danna B.; Schneider, Martin F.; Weber, David J.			S100A1 and calmodulin compete for the same binding site on ryanodine receptor	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							CA2+ RELEASE CHANNEL; 3-DIMENSIONAL SOLUTION STRUCTURE; CA2+-BINDING PROTEIN S100A1; DIPOLAR COUPLINGS; REGULATORY DOMAIN; NMR STRUCTURE; APOCALMODULIN; COMPLEX; ACTIVATION; REGION	In heart and skeletal muscle an S100 protein family member, S100A1, binds to the ryanodine receptor (RyR) and promotes Ca2+ release. Using competition binding assays, we further characterized this system in skeletal muscle and showed that Ca2+-S100A1 competes with Ca2+-calmodulin (CaM) for the same binding site on RyR1. In addition, the NMR structure was determined for Ca2+-S100A1 bound to a peptide derived from this CaM/S100A1 binding domain, a region conserved in RyR1 and RyR2 and termed RyRP12 (residues 3616-3627 in human RyR1). Examination of the S100A1-RyRP12 complex revealed residues of the helical RyRP12 peptide (Lys-3616, Trp-3620, Lys-3622, Leu-3623, Leu-3624, and Lys-3626) that are involved in favorable hydrophobic and electrostatic interactions with Ca2+-S100A1. These same residues were shown previously to be important for RyR1 binding to Ca2+-CaM. A model for regulating muscle contraction is presented in which Ca2+-S100A1 and Ca2+-CaM compete directly for the same binding site on the ryanodine receptor.	[Wright, Nathan T.; Prosser, Benjamin L.; Varney, Kristen M.; Schneider, Martin F.; Weber, David J.] Univ Maryland, Sch Med, Dept Biochem & Mol Biol, Baltimore, MD 21201 USA; [Zimmer, Danna B.] Texas A&M Univ, Coll Vet Med, Dept Vet Pathobiol, College Stn, TX 77843 USA	University System of Maryland; University of Maryland Baltimore; Texas A&M University System; Texas A&M University College Station	Weber, DJ (corresponding author), 108 N Greene St, Baltimore, MD 21201 USA.	dweber@umaryland.edu	Weber, David J/B-5349-2011; Tuluc, Petronel/C-2527-2011	Weber, David J/0000-0002-8824-1110; Wright, Nathan/0000-0003-0177-6129; Prosser, Benjamin/0000-0003-3696-9131	National Institutes of Health [GM58888, CA107331, AR055099]; Shared Instrumentation [S10 RR10441, S10 RR15741, S10 RR16812, S10 RR23447]; National Institutes of Health; DBI [0115795]; National Science Foundation; NATIONAL CANCER INSTITUTE [R01CA107331] Funding Source: NIH RePORTER; NATIONAL CENTER FOR RESEARCH RESOURCES [S10RR016812, S10RR031729, S10RR015741, S10RR010441, S10RR023447] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES [R37AR055099, R01AR055099] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM058888] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Shared Instrumentation; National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); DBI; National Science Foundation(National Science Foundation (NSF)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported, in whole or in part, by National Institutes of Health Grants GM58888 and CA107331 (to D. J. W.) and AR055099 (to M. F. S.). The NMR spectrometers used in these studies were purchased, in part, by Shared Instrumentation Grants S10 RR10441, S10 RR15741, S10 RR16812, and S10 RR23447 (to D. J. W.) from the National Institutes of Health and DBI 0115795 from the National Science Foundation (to D. J. W.). The costs of publication of this article were defrayed in part by the payment of page charges. This article must therefore be hereby marked "advertisement" in accordance with 18 U. S. C. Section 1734 solely to indicate this fact.	BAX A, 1994, J MAGN RESON SER A, V106, P269, DOI 10.1006/jmra.1994.1038; Bhattacharya S, 2003, BIOCHEMISTRY-US, V42, P14416, DOI 10.1021/bi035089a; BRUNGER AT, 1993, X PLOR VERSION 3 1; Donato R, 2001, INT J BIOCHEM CELL B, V33, P637, DOI 10.1016/S1357-2725(01)00046-2; Drohat AC, 1998, BIOCHEMISTRY-US, V37, P2729, DOI 10.1021/bi972635p; Drohat AC, 1999, PROTEIN SCI, V8, P800; Du XJ, 2002, MOL CELL BIOL, V22, P2821, DOI 10.1128/MCB.22.8.2821-2829.2002; Fill M, 2002, PHYSIOL REV, V82, P893, DOI 10.1152/physrev.00013.2002; Inman KG, 2002, J MOL BIOL, V324, P1003, DOI 10.1016/S0022-2836(02)01152-X; Lipsitz RS, 2004, ANNU REV BIOPH BIOM, V33, P387, DOI 10.1146/annurev.biophys.33.110502.140306; Maximciuc AA, 2006, STRUCTURE, V14, P1547, DOI 10.1016/j.str.2006.08.011; McClintock KA, 2003, J BIOL CHEM, V278, P6251, DOI 10.1074/jbc.M210622200; MEISSNER G, 1994, ANNU REV PHYSIOL, V56, P485, DOI 10.1146/annurev.ph.56.030194.002413; Moore CP, 1999, BIOCHEMISTRY-US, V38, P8532, DOI 10.1021/bi9907431; Most P, 2004, J CLIN INVEST, V114, P1550, DOI 10.1172/JCI200421454; Most P, 2003, J BIOL CHEM, V278, P33809, DOI 10.1074/jbc.M301788200; Most P, 2003, J BIOL CHEM, V278, P26356, DOI 10.1074/jbc.M303338200; ODriscoll S, 1996, BIOCHEM J, V319, P421, DOI 10.1042/bj3190421; Ottiger M, 1998, J MAGN RESON, V131, P373, DOI 10.1006/jmre.1998.1361; Prosser BL, 2008, J BIOL CHEM, V283, P5046, DOI 10.1074/jbc.M709231200; Rodney GG, 2003, BIOPHYS J, V85, P921, DOI 10.1016/S0006-3495(03)74531-7; Rodney GG, 2001, J BIOL CHEM, V276, P2069, DOI 10.1074/jbc.M008891200; RODNEY GG, 2008, AM J PHYSIOL, V294, P1288; Rustandi RR, 2000, NAT STRUCT BIOL, V7, P570; Rustandi RR, 2002, BIOCHEMISTRY-US, V41, P788, DOI 10.1021/bi0118308; Samso M, 2002, J BIOL CHEM, V277, P1349, DOI 10.1074/jbc.M109196200; Santamaria-Kisiel L, 2006, BIOCHEM J, V396, P201, DOI 10.1042/BJ20060195; Tjandra N, 1997, NAT STRUCT BIOL, V4, P732, DOI 10.1038/nsb0997-732; Treves S, 1997, BIOCHEMISTRY-US, V36, P11496, DOI 10.1021/bi970160w; TRIPATHY A, 1995, BIOPHYS J, V69, P106, DOI 10.1016/S0006-3495(95)79880-0; VUISTER GW, 1994, NAT STRUCT BIOL, V1, P605, DOI 10.1038/nsb0994-605; WESTERBLAD H, 1991, J GEN PHYSIOL, V98, P615, DOI 10.1085/jgp.98.3.615; WISHART DS, 1992, BIOCHEMISTRY-US, V31, P1647, DOI 10.1021/bi00121a010; Wright NT, 2005, J MOL BIOL, V353, P410, DOI 10.1016/j.jmb.2005.08.027; Yamaguchi N, 2003, J BIOL CHEM, V278, P23480, DOI 10.1074/jbc.M301125200; Yamaguchi N, 2001, J BIOL CHEM, V276, P22579, DOI 10.1074/jbc.M102729200; Zhang HW, 2003, J BIOL CHEM, V278, P8348, DOI 10.1074/jbc.M209565200; Zimmer DB, 2003, MICROSC RES TECHNIQ, V60, P552, DOI 10.1002/jemt.10297	38	90	98	0	8	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	SEP 26	2008	283	39					26676	26683		10.1074/jbc.M804432200	http://dx.doi.org/10.1074/jbc.M804432200			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	350GV	18650434	hybrid, Green Published			2022-12-27	WOS:000259341600041
J	Saegusa, J; Akakura, N; Wu, CY; Hoogland, C; Ma, Z; Lam, KS; Liu, FT; Takada, YK; Takada, Y				Saegusa, Jun; Akakura, Nobuaki; Wu, Chun-Yi; Hoogland, Case; Ma, Zi; Lam, Kit S.; Liu, Fu-Tong; Takada, Yoko K.; Takada, Yoshikazu			Pro-inflammatory secretory phospholipase a2 type IIA binds to integrins alpha v beta 3 and alpha 4 beta 1 and induces proliferation of monocytic cells in an integrin-dependent manner	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							AUTOMATED DOCKING; MEMBRANE-RECEPTOR; CRYSTAL-STRUCTURE; ONCOGENIC ACTION; PROSTATE-CANCER; MOLECULAR-BASIS; LIGAND-BINDING; A(2); ALPHA(V)BETA(3); PROTEINS	Secretory phospholipase A2 group IIA (sPLA2-IIA) plays an important role in the pathogenesis of inflammatory diseases. Catalytic activity of this enzyme that generates arachidonic acid is a major target for development of anti-inflammatory agents. Independent of its catalytic activity, sPLA2-IIA induces pro-inflammatory signals in a receptor-mediated mechanism (e. g. through the M-type receptor). However, the M-type receptor is species-specific: sPLA2-IIA binds to the M-type receptor in rodents and rabbits, but not in human. Thus sPLA2-IIA receptors in human have not been established. Here we demonstrated that sPLA2-IIA bound to integrin alpha v beta 3 at a high affinity (K-D= 2 x 10(-7) M). We identified amino acid residues in sPLA2-IIA (Arg-74 and Arg-100) that are critical for integrin binding using docking simulation and mutagenesis. The integrin-binding site did not include the catalytic center or the M-type receptor-binding site. sPLA2-IIA also bound to alpha 4 beta 1. We showed that sPLA2-IIA competed with VCAM-1 for binding to alpha 4 beta 1, and bound to a site close to those for VCAM-1 and CS-1 in the alpha 4 subunit. Wild type and the catalytically inactive H47Q mutant of sPLA2-IIA induced cell proliferation and ERK1/2 activation in monocytic cells, but the integrin binding-defective R74E/R100E mutant did not. This indicates that integrin binding is required, but catalytic activity is not required, for sPLA2-IIA-induced proliferative signaling. These results suggest that integrins alpha v beta 3 and alpha 4 beta 1 may serve as receptors for sPLA2-IIA and mediate pro-inflammatory action of sPLA2-IIA, and that integrin sPLA2-IIA interaction is a novel therapeutic target.	[Saegusa, Jun; Akakura, Nobuaki; Hoogland, Case; Ma, Zi; Liu, Fu-Tong; Takada, Yoko K.; Takada, Yoshikazu] Univ Calif Davis, Sch Med, Dept Dermatol, Sacramento, CA 95817 USA; [Wu, Chun-Yi; Lam, Kit S.] Univ Calif Davis, Sch Med, Dept Hematol Oncol, Sacramento, CA 95817 USA	University of California System; University of California Davis; University of California System; University of California Davis	Takada, Y (corresponding author), Res 3 Suite 3300,4645 2nd Ave, Sacramento, CA 95817 USA.	ytakada@ucdavis.edu	Liu, FU-TONG/A-5749-2019	Liu, FU-TONG/0000-0002-3354-1001; takada, yoshikazu/0000-0001-5481-9589	National Institutes of Health [AG027350]; American Heart Association [0555102Y]; NATIONAL INSTITUTE ON AGING [R21AG027350] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); American Heart Association(American Heart Association); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))	This work was supported, in whole or in part, by National Institutes of Health Grant AG027350 (to Y.T.). This work was also supported by American Heart Association Grant-in-aid 0555102Y. The costs of publication of this article were defrayed in part by the payment of page charges. This article must therefore be hereby marked "advertisement" in accordance with 18 U.S.C. Section 1734 solely to indicate this fact.	Antonov AS, 2004, AM J PATHOL, V165, P247, DOI 10.1016/S0002-9440(10)63293-2; BLYSTONE SD, 1994, J CELL BIOL, V127, P1129, DOI 10.1083/jcb.127.4.1129; Boilard E, 2003, FASEB J, V17, P1068, DOI 10.1096/fj.02-0938com; Bowton DL, 2005, J ASTHMA, V42, P65, DOI 10.1081/JAS-200044748; Bradley JD, 2005, J RHEUMATOL, V32, P417; Byzova TV, 1998, THROMB HAEMOSTASIS, V80, P726; Cupillard L, 1999, J BIOL CHEM, V274, P7043, DOI 10.1074/jbc.274.11.7043; Dong QH, 2006, CANCER LETT, V240, P9, DOI 10.1016/j.canlet.2005.08.012; Eliceiri BP, 1999, J CLIN INVEST, V103, P1227, DOI 10.1172/JCI6869; ESKO JD, 1985, P NATL ACAD SCI USA, V82, P3197, DOI 10.1073/pnas.82.10.3197; Eto K, 2002, J BIOL CHEM, V277, P17804, DOI 10.1074/jbc.M200086200; Fleming FE, 2007, ARCH VIROL, V152, P1087, DOI 10.1007/s00705-007-0937-x; Fuentes L, 2002, FEBS LETT, V531, P7, DOI 10.1016/S0014-5793(02)03401-4; Gelb MH, 1999, CURR OPIN STRUC BIOL, V9, P428, DOI 10.1016/S0959-440X(99)80059-1; Gelb MH, 2000, J BIOL CHEM, V275, P39823, DOI 10.1074/jbc.C000671200; GOODSELL DS, 1990, PROTEINS, V8, P195, DOI 10.1002/prot.340080302; HEMLER ME, 1987, J BIOL CHEM, V262, P11478; Humphries JD, 2000, J BIOL CHEM, V275, P20337, DOI 10.1074/jbc.M000568200; Hynes RO, 2002, CELL, V110, P673, DOI 10.1016/S0092-8674(02)00971-6; IRIE A, 1995, EMBO J, V14, P5550, DOI 10.1002/j.1460-2075.1995.tb00242.x; Jaross W, 2002, EUR J CLIN INVEST, V32, P383, DOI 10.1046/j.1365-2362.2002.01000.x; Jiang JZ, 2002, AM J PATHOL, V160, P667, DOI 10.1016/S0002-9440(10)64886-9; LAMBEAU G, 1995, J BIOL CHEM, V270, P5534, DOI 10.1074/jbc.270.10.5534; LAMBEAU G, 1994, J BIOL CHEM, V269, P1575; Mori S, 2008, J BIOL CHEM, V283, P18066, DOI 10.1074/jbc.M801213200; Morris GM, 1996, J COMPUT AID MOL DES, V10, P293, DOI 10.1007/BF00124499; Morris GM, 1998, J COMPUT CHEM, V19, P1639, DOI 10.1002/(SICI)1096-987X(19981115)19:14<1639::AID-JCC10>3.0.CO;2-B; Murakami M, 1999, J BIOL CHEM, V274, P29927, DOI 10.1074/jbc.274.42.29927; Nath D, 1999, J CELL SCI, V112, P579; NICOLAS JP, 1995, J BIOL CHEM, V270, P28869, DOI 10.1074/jbc.270.48.28869; Niessen HWM, 2003, CARDIOVASC RES, V60, P68, DOI 10.1016/S0008-6363(03)00324-9; Peng L, 2006, NAT CHEM BIOL, V2, P381, DOI 10.1038/nchembio798; PRATER CA, 1991, J CELL BIOL, V112, P1031, DOI 10.1083/jcb.112.5.1031; REYNOLDS LJ, 1994, ANAL BIOCHEM, V217, P25, DOI 10.1006/abio.1994.1079; Saphire EO, 2001, SCIENCE, V293, P1155, DOI 10.1126/science.1061692; Sartipy P, 2000, CIRC RES, V86, P707, DOI 10.1161/01.RES.86.6.707; Shimaoka M, 2003, NAT REV DRUG DISCOV, V2, P703, DOI 10.1038/nrd1174; Six DA, 2000, BBA-MOL CELL BIOL L, V1488, P1, DOI 10.1016/S1388-1981(00)00105-0; Sved P, 2004, CANCER RES, V64, P6934, DOI 10.1158/0008-5472.CAN-03-3018; Tada K, 1998, J IMMUNOL, V161, P5008; Takada Y, 2007, GENOME BIOL, V8, DOI 10.1186/gb-2007-8-5-215; Takagi J, 1997, J BIOCHEM, V121, P914; Takagi J, 2001, NAT STRUCT BIOL, V8, P412, DOI 10.1038/87569; Tarui T, 2001, J BIOL CHEM, V276, P39562, DOI 10.1074/jbc.M101815200; Tatulian SA, 2001, BIOPHYS J, V80, P789, DOI 10.1016/S0006-3495(01)76058-4; Triggiani M, 2003, J IMMUNOL, V170, P3279, DOI 10.4049/jimmunol.170.6.3279; Valentin E, 2000, BBA-MOL CELL BIOL L, V1488, P59, DOI 10.1016/S1388-1981(00)00110-4; Wang WY, 1999, BIOTECHNIQUES, V26, P680, DOI 10.2144/99264st03; Wu PL, 2006, J BIOL CHEM, V281, P7937, DOI 10.1074/jbc.M513035200; Xiong JP, 2002, SCIENCE, V296, P151, DOI 10.1126/science.1069040; Zhang HC, 2001, J MED CHEM, V44, P1021, DOI 10.1021/jm000506s; Zhang XP, 1998, J BIOL CHEM, V273, P7345, DOI 10.1074/jbc.273.13.7345; Zhang YP, 1999, J BIOL CHEM, V274, P27726, DOI 10.1074/jbc.274.39.27726	53	70	78	0	5	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	SEP 19	2008	283	38					26107	26115		10.1074/jbc.M804835200	http://dx.doi.org/10.1074/jbc.M804835200			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	348GX	18635536	Green Published, hybrid			2022-12-27	WOS:000259200100039
J	Roberts, PJ; Mitin, N; Keller, PJ; Chenette, EJ; Madigan, JP; Currin, RO; Cox, AD; Wilson, O; Kirschmeier, P; Der, CJ				Roberts, Patrick J.; Mitin, Natalia; Keller, Patricia J.; Chenette, Emily J.; Madigan, James P.; Currin, Rachel O.; Cox, Adrienne D.; Wilson, Oswald; Kirschmeier, Paul; Der, Channing J.			Rho family GTPase modification and dependence on CAAX motif-signaled posttranslational modification	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							GERANYLGERANYLTRANSFERASE-I INHIBITORS; FARNESYL-PROTEIN TRANSFERASE; FARNESYLTRANSFERASE INHIBITORS; ALTERNATIVE PRENYLATION; RAS SUPERFAMILY; HA-RAS; K-RAS; N-RAS; PALMITOYLATION; LOCALIZATION	Rho GTPases (20 human members) comprise a major branch of the Ras superfamily of small GTPases, and aberrant Rho GTPase function has been implicated in oncogenesis and other human diseases. Although many of our current concepts of Rho GTPases are based on the three classical members (RhoA, Rac1, and Cdc42), recent studies have revealed the diversity of biological functions mediated by other family members. A key basis for the functional diversity of Rho GTPases is their association with distinct subcellular compartments, which is dictated in part by three posttranslational modifications signaled by their carboxylterminal CAAX( where C represents cysteine, A is an aliphatic amino acid, and X is a terminal amino acid) tetrapeptide motifs. CAAX motifs are substrates for the prenyltransferase-catalyzed addition of either farnesyl or geranylgeranyl isoprenoid lipids, Rce1-catalyzed endoproteolytic cleavage of the AAX amino acids, and Icmt-catalyzed carboxyl methylation of the isoprenylcysteine. We utilized pharmacologic, biochemical, and genetic approaches to determine the sequence requirements and roles of CAAX signal modifications in dictating the subcellular locations and functions of the Rho GTPase family. Although the classical Rho GTPases are modified by geranylgeranylation, we found that a majority of the other Rho GTPases are substrates for farnesyltransferase. We found that the membrane association and/or function of Rho GTPases are differentially dependent on Rce1-and Icmt-mediated modifications. Our results further delineate the sequence requirements for prenyltransferase specificity and functional roles for protein prenylation in Rho GTPase function. We conclude that a majority of Rho GTPases are targets for pharmacologic inhibitors of farnesyltransferase, Rce1, and Icmt.	[Roberts, Patrick J.; Mitin, Natalia; Currin, Rachel O.; Cox, Adrienne D.; Der, Channing J.] Univ N Carolina, Lineberger Comprehens Canc Ctr, Chapel Hill, NC 27599 USA; [Roberts, Patrick J.] Univ N Carolina, Div Pharmacol & Expt Therapeut, Chapel Hill, NC 27599 USA; [Mitin, Natalia; Keller, Patricia J.; Cox, Adrienne D.; Der, Channing J.] Univ N Carolina, Dept Pharmacol, Chapel Hill, NC 27599 USA; [Keller, Patricia J.; Madigan, James P.; Cox, Adrienne D.] Univ N Carolina, Dept Radiat Oncol, Chapel Hill, NC 27599 USA; [Chenette, Emily J.; Madigan, James P.; Cox, Adrienne D.; Der, Channing J.] Univ N Carolina, Curriculum Genet & Mol Biol, Chapel Hill, NC 27599 USA; [Wilson, Oswald; Kirschmeier, Paul] Schering Plough Res Inst, Kenilworth, NJ 07033 USA	University of North Carolina; University of North Carolina Chapel Hill; University of North Carolina; University of North Carolina Chapel Hill; University of North Carolina; University of North Carolina Chapel Hill; University of North Carolina; University of North Carolina Chapel Hill; University of North Carolina; University of North Carolina Chapel Hill; Merck & Company; Schering-Plough Research Institute	Der, CJ (corresponding author), Univ N Carolina, Lineberger Comprehens Canc Ctr, 450 W Dr,CB 7295, Chapel Hill, NC 27599 USA.	cjder@med.unc.edu	Mitin, Natalia/E-8043-2012	Chenette, Emily/0000-0003-0393-395X; Der, Channing/0000-0002-7751-2747; Cox, Adrienne D./0000-0002-4901-2454	National Institutes of Health [CA063071, CA67771, CA92240, CA109550]; NATIONAL CANCER INSTITUTE [U19CA067771, R01CA109550, R01CA063071, R01CA092240] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This work was supported, in whole or in part, by National Institutes of Health Grants CA063071, CA67771, and CA92240 (to C. J. D.) and CA063071, CA67771, and CA109550 (to A. D. C.). The costs of publication of this article were defrayed in part by the payment of page charges. This article must therefore be hereby marked "advertisement" in accordance with 18 U. S. C. Section 1734 solely to indicate this fact.	ADAMSON P, 1992, J BIOL CHEM, V267, P20033; Aspenstrom P, 2004, BIOCHEM J, V377, P327, DOI 10.1042/BJ20031041; Backlund PS, 1997, J BIOL CHEM, V272, P33175, DOI 10.1074/jbc.272.52.33175; Bergo MO, 2004, J CLIN INVEST, V113, P539, DOI 10.1172/JCI200418829; Bergo MO, 2002, MOL CELL BIOL, V22, P171, DOI 10.1128/MCB.22.1.171-181.2002; Bergo MO, 2001, J BIOL CHEM, V276, P5841, DOI 10.1074/jbc.C000831200; Bernards A, 2004, TRENDS CELL BIOL, V14, P377, DOI 10.1016/j.tcb.2004.05.003; Berzat AC, 2005, J BIOL CHEM, V280, P33055, DOI 10.1074/jbc.M507362200; Berzat AC, 2006, METHOD ENZYMOL, V407, P575, DOI 10.1016/S0076-6879(05)07046-1; CARBONI JM, 1995, ONCOGENE, V10, P1905; Chardin P, 2006, NAT REV MOL CELL BIO, V7, P54, DOI 10.1038/nrm1788; Chenette EJ, 2005, J BIOL CHEM, V280, P13784, DOI 10.1074/jbc.M411300200; Choy E, 1999, CELL, V98, P69, DOI 10.1016/S0092-8674(00)80607-8; Colicelli John, 2004, Sci STKE, V2004, pRE13, DOI 10.1126/stke.2502004re13; Cox Adrienne D., 1992, Current Opinion in Cell Biology, V4, P1008, DOI 10.1016/0955-0674(92)90133-W; Drisdel RC, 2004, BIOTECHNIQUES, V36, P276, DOI 10.2144/04362RR02; El Oualid F, 2006, CURR MED CHEM, V13, P2385, DOI 10.2174/092986706777935078; Ellis S, 2000, CURR BIOL, V10, P1387, DOI 10.1016/S0960-9822(00)00777-6; Etienne-Manneville S, 2002, NATURE, V420, P629, DOI 10.1038/nature01148; Falsetti SC, 2007, MOL CELL BIOL, V27, P8003, DOI 10.1128/MCB.00057-07; Fiordalisi JJ, 2003, J BIOL CHEM, V278, P41718, DOI 10.1074/jbc.M305733200; Foster R, 1996, MOL CELL BIOL, V16, P2689; HANCOCK JF, 1990, CELL, V63, P133, DOI 10.1016/0092-8674(90)90294-O; Heo WD, 2003, CELL, V113, P315; JAMES GL, 1995, J BIOL CHEM, V270, P6221, DOI 10.1074/jbc.270.11.6221; Joyce PL, 2003, CANCER RES, V63, P7959; KATAYAMA M, 1991, J BIOL CHEM, V266, P12639; KATO K, 1992, P NATL ACAD SCI USA, V89, P6403, DOI 10.1073/pnas.89.14.6403; Keller PJ, 2005, METHODS, V37, P131, DOI 10.1016/j.ymeth.2005.05.023; KINSELLA BT, 1991, P NATL ACAD SCI USA, V88, P8934, DOI 10.1073/pnas.88.20.8934; Klein RM, 2008, MOL BIOL CELL, V19, P498, DOI 10.1091/mbc.E07-09-0895; Lebowitz PF, 1997, J BIOL CHEM, V272, P15591, DOI 10.1074/jbc.272.25.15591; Linder ME, 2003, BIOCHEMISTRY-US, V42, P4311, DOI 10.1021/bi034159a; Lu Q, 2004, CIRC RES, V94, P306, DOI 10.1161/01.RES.0000113923.85084.C1; Michaelson D, 2001, J CELL BIOL, V152, P111, DOI 10.1083/jcb.152.1.111; Michaelson D, 2005, MOL BIOL CELL, V16, P1606, DOI 10.1091/mbc.e04-11-0960; MOORES SL, 1991, J BIOL CHEM, V266, P14603; Nadolski MJ, 2007, FEBS J, V274, P5202, DOI 10.1111/j.1742-4658.2007.06056.x; OHYA Y, 1993, MOL BIOL CELL, V4, P1017, DOI 10.1091/mbc.4.10.1017; Papaharalambus C, 2005, J BIOL CHEM, V280, P18790, DOI 10.1074/jbc.M410081200; Parton RG, 2004, TRENDS CELL BIOL, V14, P141, DOI 10.1016/j.tcb.2004.02.001; Prendergast GC, 2000, CURR OPIN CELL BIOL, V12, P166, DOI 10.1016/S0955-0674(99)00072-1; Quatela SE, 2006, CURR OPIN CELL BIOL, V18, P162, DOI 10.1016/j.ceb.2006.02.004; Reid TS, 2004, J MOL BIOL, V343, P417, DOI 10.1016/j.jmb.2004.08.056; Ridley AJ, 2006, TRENDS CELL BIOL, V16, P522, DOI 10.1016/j.tcb.2006.08.006; Roskoski R, 1998, ARCH BIOCHEM BIOPHYS, V356, P167, DOI 10.1006/abbi.1998.0768; Rowell CA, 1997, J BIOL CHEM, V272, P14093, DOI 10.1074/jbc.272.22.14093; Sahai E, 2002, NAT REV CANCER, V2, P133, DOI 10.1038/nrc725; Schmidt A, 2002, GENE DEV, V16, P1587, DOI 10.1101/gad.1003302; Sebti SM, 2000, ONCOGENE, V19, P6584, DOI 10.1038/sj.onc.1204146; Sebti SM, 2003, NAT REV CANCER, V3, P945, DOI 10.1038/nrc1234; Shields JM, 2007, CANCER RES, V67, P1502, DOI 10.1158/0008-5472.CAN-06-3311; Shutes A, 2006, METHOD ENZYMOL, V406, P11, DOI 10.1016/S0076-6879(06)06002-2; SILVIUS JR, 1994, BIOCHEMISTRY-US, V33, P3014, DOI 10.1021/bi00176a034; Sjogren AKM, 2007, J CLIN INVEST, V117, P1294, DOI 10.1172/JCI30868; Sun JZ, 2003, CANCER RES, V63, P8922; Sun JZ, 1999, CANCER RES, V59, P4919; Vega FM, 2007, CELL, V129, P1430, DOI 10.1016/j.cell.2007.06.021; Veit M, 2001, EMBO J, V20, P3145, DOI 10.1093/emboj/20.12.3145; Webb Y, 2000, J BIOL CHEM, V275, P261, DOI 10.1074/jbc.275.1.261; Wennerberg K, 2005, J CELL SCI, V118, P843, DOI 10.1242/jcs.01660; Wennerberg K, 2004, J CELL SCI, V117, P1301, DOI 10.1242/jcs.01118; Wherlock M, 2004, J CELL SCI, V117, P3221, DOI 10.1242/jcs.01193; Whyte DB, 1997, J BIOL CHEM, V272, P14459, DOI 10.1074/jbc.272.22.14459; Willumsen BM, 1996, ONCOGENE, V13, P1901; Winter-Vann AM, 2005, NAT REV CANCER, V5, P405, DOI 10.1038/nrc1612; Zhang FL, 1997, J BIOL CHEM, V272, P10232	67	227	228	0	25	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	SEP 12	2008	283	37					25150	25163		10.1074/jbc.M800882200	http://dx.doi.org/10.1074/jbc.M800882200			14	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	345QZ	18614539	Green Published, hybrid			2022-12-27	WOS:000259012700007
J	Weinbaum, JS; Broekelmann, TJ; Pierce, RA; Werneck, CC; Segade, F; Craft, CS; Knutsen, RH; Mecham, RP				Weinbaum, Justin S.; Broekelmann, Thomas J.; Pierce, Richard A.; Werneck, Claudio C.; Segade, Fernando; Craft, Clarissa S.; Knutsen, Russell H.; Mecham, Robert P.			Deficiency in microfibril-associated glycoprotein-1 leads to complex phenotypes in multiple organ systems	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							FIBRILLIN-CONTAINING MICROFIBRILS; CARBOXYL-TERMINAL DOMAIN; EXTRACELLULAR-MATRIX; IN-VIVO; NONELASTIC TISSUES; RICH MICROFIBRILS; PROTEINS MAGP-1; TERNARY COMPLEX; MARFAN-SYNDROME; CELL-ADHESION	Microfibril-associated glycoprotein-1 (MAGP-1) is a small molecular weight component of the fibrillin-rich microfibril. Gene-targeted inactivation of MAGP-1 reveals a complex phenotype that includes increased body weight and size due to excess body fat, an altered wound healing response in bone and skin, and a bleeding diathesis. Elastic tissues rich in MAGP-1-containing microfibrils develop normally and show normal function. The penetrance of MAGP-1-null phenotypes is highly variable and mouse strain-dependent, suggesting the influence of modifier genes. MAGP-1 was found to bind active transforming growth factor-beta(TGF-beta) and BMP-7 with high affinity, suggesting that it may be an important modulator of microfibril-mediated growth factor signaling. Many of the phenotypic traits observed in MAGP-1-deficient mice are consistent with loss of TGF-beta function and are generally opposite those associated with mutations in fibrillin-1 that result in enhanced TGF-beta signaling. Increased body size and fat deposition in MAGP-1-mutant animals are particularly intriguing given the localization of obesity traits in humans to the region on chromosome 1 containing the MAGP-1 gene.	[Weinbaum, Justin S.; Broekelmann, Thomas J.; Craft, Clarissa S.; Knutsen, Russell H.; Mecham, Robert P.] Washington Univ, Sch Med, Dept Cell Biol & Physiol, St Louis, MO 63110 USA; [Pierce, Richard A.] Washington Univ, Sch Med, Dept Med, St Louis, MO 63110 USA; [Werneck, Claudio C.] Univ Estadual Campinas, Dept Bioquim, BR-13084225 Campinas, SP, Brazil; [Segade, Fernando] Univ Penn, Sch Dent Med, Dept Anat & Cell Biol, Philadelphia, PA 19104 USA	Washington University (WUSTL); Washington University (WUSTL); Universidade Estadual de Campinas; University of Pennsylvania	Mecham, RP (corresponding author), Washington Univ, Sch Med, Dept Cell Biol & Physiol, Campus Box 8228,660 S Euclid Ave, St Louis, MO 63110 USA.	bmecham@wustl.edu	Werneck, Claudio C/C-7568-2012; Weinbaum, Justin S/C-3192-2009	Werneck, Claudio C/0000-0002-9413-0572; Weinbaum, Justin S/0000-0002-0626-6083	National Institutes of Health [HL53325, HL71960, HL74138, HL54049, T32 HL007873]; National Science Foundation; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL053325, R01HL074138, R01HL071960, R29HL054049, R37HL053325, T32HL007873, R01HL054049] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); National Science Foundation(National Science Foundation (NSF)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	This work was supported, in whole or in part, by National Institutes of Health Grants HL53325, HL71960, HL74138 ( to R. P. M.), HL54049 ( to R. A. P.), and T32 HL007873 ( to J.S.W.). The costs of publication of this article were defrayed in part by the payment of page charges. This article must therefore be hereby marked "advertisement" in accordance with 18 U. S. C. Section 1734 solely to indicate this fact.; Recipient of a National Science Foundation graduate research fellowship.	Agah A, 2002, AM J PATHOL, V161, P831, DOI 10.1016/S0002-9440(10)64243-5; Arteaga-Solis E, 2001, J CELL BIOL, V154, P275, DOI 10.1083/jcb.200105046; Blakytny R, 2004, J CELL PHYSIOL, V199, P67, DOI 10.1002/jcp.10454; Bradshaw AD, 2001, J CLIN INVEST, V107, P1049, DOI 10.1172/JCI12939; Broekelmann TJ, 2005, J BIOL CHEM, V280, P40939, DOI 10.1074/jbc.M507309200; BROWNAUGSBURGER P, 1994, J BIOL CHEM, V269, P28443; BrownAugsburger P, 1996, BIOCHEM J, V318, P149, DOI 10.1042/bj3180149; Brunner G, 2004, THROMB HAEMOSTASIS, V92, P253, DOI 10.1160/TH04-05-0324; Carta L, 2006, J BIOL CHEM, V281, P8016, DOI 10.1074/jbc.M511599200; Charbonneau Noe L, 2004, Birth Defects Res C Embryo Today, V72, P37, DOI 10.1002/bdrc.20000; Chaudhry SS, 2007, J CELL BIOL, V176, P355, DOI 10.1083/jcb.200608167; Chen E, 2006, BLOOD, V107, P4364, DOI 10.1182/blood-2005-02-0789; CHEN YP, 1993, J BIOL CHEM, V268, P27381; Choy L, 2003, J BIOL CHEM, V278, P9609, DOI 10.1074/jbc.M212259200; Cohn RD, 2007, NAT MED, V13, P204, DOI 10.1038/nm1536; Dallas SL, 2000, J BONE MINER RES, V15, P68, DOI 10.1359/jbmr.2000.15.1.68; DAVIS EC, 1993, LAB INVEST, V68, P89; Finnis ML, 1997, J BIOL CHEM, V272, P22817, DOI 10.1074/jbc.272.36.22817; GIBSON MA, 1986, J BIOL CHEM, V261, P1429; Gibson MA, 1998, J HISTOCHEM CYTOCHEM, V46, P871, DOI 10.1177/002215549804600802; GIBSON MA, 1989, J BIOL CHEM, V264, P4590; GIBSON MA, 1987, IMMUNOL CELL BIOL, V65, P345, DOI 10.1038/icb.1987.39; Gregory KE, 2005, J BIOL CHEM, V280, P27970, DOI 10.1074/jbc.M504270200; Hanssen E, 2004, J BIOL CHEM, V279, P29185, DOI 10.1074/jbc.M313672200; Isogai Z, 2003, J BIOL CHEM, V278, P2750, DOI 10.1074/jbc.M209256200; Jensen SA, 2001, J BIOL CHEM, V276, P39661, DOI 10.1074/jbc.M104533200; Judge DP, 2005, LANCET, V366, P1965, DOI 10.1016/S0140-6736(05)67789-6; Karonen T, 1997, BRIT J DERMATOL, V137, P51, DOI 10.1046/j.1365-2133.1997.17671859.x; Kielty CM, 2002, J MUSCLE RES CELL M, V23, P581, DOI 10.1023/A:1023479010889; Kozel BA, 2003, J BIOL CHEM, V278, P18491, DOI 10.1074/jbc.M212715200; Kyriakides TR, 1998, J CELL BIOL, V140, P419, DOI 10.1083/jcb.140.2.419; Kyriakides TR, 2003, BLOOD, V101, P3915, DOI 10.1182/blood.V101.10.3915; Lee SJ, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000789; Liu YJ, 2004, J CLIN ENDOCR METAB, V89, P875, DOI 10.1210/jc.2003-030774; Miyamoto A, 2006, J BIOL CHEM, V281, P10089, DOI 10.1074/jbc.M600298200; Morris BJ, 2005, HYPERTENSION, V46, P1256, DOI 10.1161/01.HYP.0000188055.13764.dc; Neptune ER, 2003, NAT GENET, V33, P407, DOI 10.1038/ng1116; Ng CM, 2004, J CLIN INVEST, V114, P1586, DOI 10.1172/JCI22715; Pausova Z, 2005, HYPERTENSION, V46, P1280, DOI 10.1161/01.HYP.0000188049.23233.fb; Pereira L, 1999, P NATL ACAD SCI USA, V96, P3819, DOI 10.1073/pnas.96.7.3819; Pfaff M, 1996, FEBS LETT, V384, P247, DOI 10.1016/0014-5793(96)00325-0; Pogue R, 2006, CURR TOP DEV BIOL, V76, P1, DOI 10.1016/S0070-2153(06)76001-X; Puolakkainen PA, 2005, J HISTOCHEM CYTOCHEM, V53, P571, DOI 10.1369/jhc.4A6425.2005; Ramirez F, 2007, J CELL PHYSIOL, V213, P326, DOI 10.1002/jcp.21189; Reinboth B, 2002, J BIOL CHEM, V277, P3950, DOI 10.1074/jbc.M109540200; Ritty TM, 1999, J BIOL CHEM, V274, P8933, DOI 10.1074/jbc.274.13.8933; SAKAI LY, 1986, J CELL BIOL, V103, P2499, DOI 10.1083/jcb.103.6.2499; Sakamoto H, 1996, J BIOL CHEM, V271, P4916; Segade F, 2005, BBA-GENE STRUCT EXPR, V1731, P215, DOI 10.1016/j.bbaexp.2005.10.007; Segade F, 2002, J BIOL CHEM, V277, P11050, DOI 10.1074/jbc.M110347200; Segade F, 2000, MATRIX BIOL, V19, P671, DOI 10.1016/S0945-053X(00)00115-3; Segade F, 2007, INT J BIOCHEM CELL B, V39, P2303, DOI 10.1016/j.biocel.2007.06.017; Sengle G, 2008, J BIOL CHEM, V283, P13874, DOI 10.1074/jbc.M707820200; Speakman JR, 2004, J NUTR, V134, p2090S, DOI 10.1093/jn/134.8.2090S; STARCHER B, 1995, RESPIRATION, V62, P252; Trask BC, 2000, MOL BIOL CELL, V11, P1499, DOI 10.1091/mbc.11.5.1499; Trask BC, 2001, BIOCHEMISTRY-US, V40, P4372, DOI 10.1021/bi002738z; Trask TM, 2000, J BIOL CHEM, V275, P24400, DOI 10.1074/jbc.M003665200; Wagenseil JE, 2005, AM J PHYSIOL-HEART C, V289, pH1209, DOI 10.1152/ajpheart.00046.2005; Werneck CC, 2004, J BIOL CHEM, V279, P23045, DOI 10.1074/jbc.M402656200; Werneck CC, 2008, BLOOD, V111, P4137, DOI 10.1182/blood-2007-07-101733; WITHERS AP, 1994, J MED GENET, V31, P174; Zacchigna L, 2006, CELL, V124, P929, DOI 10.1016/j.cell.2005.12.035	63	72	76	0	4	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	SEP 12	2008	283	37					25533	25543		10.1074/jbc.M709962200	http://dx.doi.org/10.1074/jbc.M709962200			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	345QZ	18625713	Green Published, hybrid			2022-12-27	WOS:000259012700049
J	Gilbert, M; Jung, SR; Reed, BJ; Sweet, IR				Gilbert, Merle; Jung, Seung-Ryoung; Reed, Benjamin J.; Sweet, Ian R.			Islet oxygen consumption and insulin secretion tightly coupled to calcium derived from L-type calcium channels but not from the endoplasmic reticulum	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							PANCREATIC BETA-CELLS; PROTEIN-KINASE-C; GLYCEROL-PHOSPHATE DEHYDROGENASE; CA2+ CHANNELS; B-CELLS; DEPENDENT MOBILIZATION; MITOCHONDRIAL CALCIUM; CYTOPLASMIC CA2+; CHROMAFFIN CELLS; HIT-T15 CELLS	The aim of the study was to test whether the source of intracellular calcium (Ca2+) is a determinant of beta cell function. We hypothesized that elevations in cytosolic Ca2+ caused by the release of Ca2+ from the endoplasmic reticulum (ER) have little physiologic impact on oxygen consumption and insulin secretion. Ca2+ release from the ER was induced in isolated rat islets by acetylcholine and response of oxygen consumption rate (OCR), NAD(P) H, cytosolic Ca2+, and insulin secretory rate (ISR) were measured. Glucose increased all four parameters, and thereafter acetylcholine further increased cytosolic Ca2+, OCR, and ISR. To assess the contribution of Ca2+ release from the ER in mediating the effects of acetylcholine, ER Ca2+ stores were first emptied by inhibiting the sarcoendoplasmic reticulum Ca2+-ATPase, which subsequently reduced the effect of acetylcholine on cytosolic Ca2+ but not its effects on OCR or ISR. As predicted, OCR and ISR were acutely sensitive to changes in L-type Ca2+ channel activity; nimodipine completely inhibited glucose-stimulated ISR and suppressed OCR by 36%, despite only inhibiting cytosolic Ca2+ by 46%. Moreover, in the presence of nimodipine and high glucose, acetylcholine still elevated cytosolic Ca2+ levels above those observed in the presence of high glucose alone but did not significantly stimulate ISR. In conclusion, Ca2+ flux through L-type Ca2+ channels was tightly coupled to changes in OCR and ISR. In contrast, the results obtained support the notion that Ca2+ release from the ER has little or no access to the intracellular machinery that regulates OCR and ISR.	[Gilbert, Merle; Jung, Seung-Ryoung; Reed, Benjamin J.; Sweet, Ian R.] Univ Washington, Dept Med, Seattle, WA 98195 USA	University of Washington; University of Washington Seattle	Sweet, IR (corresponding author), Univ Washington, Dept Med, Box 358055, Seattle, WA 98195 USA.	isweet@u.washington.edu		Gilbert, Merle/0000-0001-8147-3958	National Institutes of Health [DK17047, DK063986]; National Science Foundation [IIP-0750508]; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R21DK063986, P30DK017047] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); National Science Foundation(National Science Foundation (NSF)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	This work was supported, in whole or in part, by National Institutes of Health Grants DK17047 and DK063986. This work was also supported by National Science Foundation Grant IIP-0750508.	AcevedoDuncan M, 1997, NEUROCHEM RES, V22, P775, DOI 10.1023/A:1022071407268; Arredouani A, 2002, AM J PHYSIOL-ENDOC M, V282, pE982, DOI 10.1152/ajpendo.00347.2001; Barg S, 2002, DIABETES, V51, pS74, DOI 10.2337/diabetes.51.2007.S74; BOKVIST K, 1995, EMBO J, V14, P50, DOI 10.1002/j.1460-2075.1995.tb06974.x; BROWN GC, 1992, BIOCHEM J, V284, P1; Detimary P, 1998, BIOCHEM J, V333, P269, DOI 10.1042/bj3330269; Doliba NM, 2006, AM J PHYSIOL-ENDOC M, V291, pE525, DOI 10.1152/ajpendo.00579.2005; GAO ZY, 1994, ENDOCRINOLOGY, V135, P191, DOI 10.1210/en.135.1.191; Gilon P, 2001, ENDOCR REV, V22, P565, DOI 10.1210/er.22.5.565; GILON P, 1995, BIOCHEM J, V311, P259, DOI 10.1042/bj3110259; Gromada J, 1999, J PHYSIOL-LONDON, V518, P745, DOI 10.1111/j.1469-7793.1999.0745p.x; HAMAKAWA N, 1995, CELL CALCIUM, V17, P21, DOI 10.1016/0143-4160(95)90099-3; HANSFORD RG, 1985, REV PHYSIOL BIOCH P, V102, P1, DOI 10.1007/BFb0034084; HENQUIN JC, 1988, ENDOCRINOLOGY, V122, P2134, DOI 10.1210/endo-122-5-2134; Henquin JC, 2003, EUR J CLIN INVEST, V33, P742, DOI 10.1046/j.1365-2362.2003.01207.x; Jamme I, 1997, BRAIN RES, V774, P123, DOI 10.1016/S0006-8993(97)81695-2; Kajikawa M, 2002, DIABETES, V51, P2522, DOI 10.2337/diabetes.51.8.2522; Kennedy ED, 1998, DIABETES METAB, V24, P15; KOBAYASHI K, 1979, CIRC RES, V44, P166, DOI 10.1161/01.RES.44.2.166; MacDonald MJ, 1996, ARCH BIOCHEM BIOPHYS, V326, P79, DOI 10.1006/abbi.1996.0049; MacMurray AJ, 2002, GENOME RES, V12, P1029, DOI 10.1101/gr.412702; Matsumoto S, 1999, TRANSPLANTATION, V67, pS220, DOI 10.1097/00007890-199904150-00880; MCCORMACK JG, 1990, BIOCHEM J, V267, P527, DOI 10.1042/bj2670527; Mears D, 2004, J MEMBRANE BIOL, V200, P57, DOI 10.1007/s00232-004-0692-9; Mears D, 2004, J MEMBRANE BIOL, V197, P59, DOI 10.1007/s00232-003-0642-y; Naraghi M, 1998, BIOPHYS J, V75, P1635, DOI 10.1016/S0006-3495(98)77606-4; Niswender CM, 2005, GENESIS, V43, P109, DOI 10.1002/gene.20159; Niwa T, 1998, DIABETES, V47, P1699, DOI 10.2337/diabetes.47.11.1699; Rolland JF, 2002, J BIOL CHEM, V277, P38373, DOI 10.1074/jbc.M203888200; RUTTER GA, 1992, BIOCHIM BIOPHYS ACTA, V1175, P107, DOI 10.1016/0167-4889(92)90016-5; Rutter GA, 2006, CELL CALCIUM, V40, P539, DOI 10.1016/j.ceca.2006.08.015; SATIN LS, 1995, ENDOCRINOLOGY, V136, P4589, DOI 10.1210/en.136.10.4589; Satin LS, 2000, ENDOCRINE, V13, P251, DOI 10.1385/ENDO:13:3:251; Schulla V, 2003, EMBO J, V22, P3844, DOI 10.1093/emboj/cdg389; Sweet IR, 2006, DIABETES, V55, P3509, DOI 10.2337/db06-0400; Sweet Ian R, 2002, Diabetes Technol Ther, V4, P661, DOI 10.1089/152091502320798303; Sweet Ian R, 2002, Diabetes Technol Ther, V4, P67, DOI 10.1089/15209150252924111; Sweet IR, 2004, DIABETES, V53, P401, DOI 10.2337/diabetes.53.2.401; Sweet IR, 1996, AM J PHYSIOL-ENDOC M, V271, pE606, DOI 10.1152/ajpendo.1996.271.3.E606; Trus M, 2007, BIOCHEMISTRY-US, V46, P14461, DOI 10.1021/bi7016816; WENG L, 1993, CELL SIGNAL, V5, P777, DOI 10.1016/0898-6568(93)90038-N; WOLF BA, 1988, AM J PHYSIOL, V254, pE121, DOI 10.1152/ajpendo.1988.254.2.E121; WOLLHEIM CB, 1981, PHYSIOL REV, V61, P914, DOI 10.1152/physrev.1981.61.4.914; WORLEY JF, 1994, J BIOL CHEM, V269, P14359; Yanagita T, 1999, J NEUROCHEM, V73, P1749, DOI 10.1046/j.1471-4159.1999.731749.x	45	25	26	0	1	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	SEP 5	2008	283	36					24334	24342		10.1074/jbc.M802097200	http://dx.doi.org/10.1074/jbc.M802097200			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	342YR	18593707	hybrid, Green Published			2022-12-27	WOS:000258820000008
J	Munirajan, AK; Ando, K; Mukai, A; Takahashi, M; Suenaga, Y; Ohira, M; Koda, T; Hirota, T; Ozaki, T; Nakagawara, A				Munirajan, Arasambattu K.; Ando, Kiyohiro; Mukai, Akira; Takahashi, Masato; Suenaga, Yusuke; Ohira, Miki; Koda, Tadayuki; Hirota, Toru; Ozaki, Toshinori; Nakagawara, Akira			KIF1B beta functions as a haploinsufficient tumor suppressor gene mapped to chromosome 1p36.2 by inducing apoptotic cell death	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							HOMOZYGOUSLY DELETED REGION; HUMAN NEUROBLASTOMA; COILED-COIL; KINESIN; IDENTIFICATION; PROTEIN; INSTABILITY; EXPRESSION; PRINCIPLES; TRANSPORT	Deletion of the distal region of chromosome 1 frequently occurs in a variety of human cancers, including aggressive neuroblastoma. Previously, we have identified a 500-kb homozygously deleted region at chromosome 1p36.2 harboring at least six genes in a neuroblastoma-derived cell line NB1/C201. Among them, only KIF1B beta, a member of the kinesin superfamily proteins, induced apoptotic cell death. These results prompted us to address whether KIF1B beta could be a tumor suppressor gene mapped to chromosome 1p36 in neuroblastoma. Hemizygous deletion of KIF1B beta in primary neuroblastomas was significantly correlated with advanced stages (p = 0.0013) and MYCN amplification (p < 0.001), whereas the mutation rate of the KIF1B beta gene was infrequent. Although KIF1B beta allelic loss was significantly associated with a decrease in KIF1B beta mRNA levels, its promoter region was not hypermethylated. Additionally, expression of KIF1B beta was markedly down-regulated in advanced stages of tumors (p < 0.001). Enforced expression of KIF1B beta resulted in an induction of apoptotic cell death in association with an increase in the number of cells entered into the G(2)/M phase of the cell cycle, whereas its knockdown by either short interfering RNA or by a genetic suppressor element led to an accelerated cell proliferation or enhanced tumor formation in nude mice, respectively. Furthermore, we demonstrated that the rod region unique to KIF1B beta is critical for the induction of apoptotic cell death in a p53-independent manner. Thus, KIF1B beta may act as a haploinsufficient tumor suppressor, and its allelic loss may be involved in the pathogenesis of neuroblastoma and other cancers.	[Munirajan, Arasambattu K.; Ando, Kiyohiro; Mukai, Akira; Takahashi, Masato; Suenaga, Yusuke; Ohira, Miki; Ozaki, Toshinori; Nakagawara, Akira] Chiba Canc Ctr, Res Inst, Div Biochem, Chuo Ku, Chiba 2608717, Japan; [Munirajan, Arasambattu K.; Koda, Tadayuki] Hisamitsu Pharmaceut Co Inc, Res Ctr Funct Genom, Tokyo 1418577, Japan; [Munirajan, Arasambattu K.] Univ Madras, Dr ALM PG Inst Basic Med Sci, Dept Genet, Madras 600113, Tamil Nadu, India; [Hirota, Toru] Inst Canc Res, Dept Expt Pathol, Tokyo 1358550, Japan	Chiba Cancer Center; Hisamitsu Pharmaceutical Co Ltd; University of Madras; Japanese Foundation for Cancer Research	Nakagawara, A (corresponding author), Chiba Canc Ctr, Res Inst, Div Biochem, Chuo Ku, 666-2 Nitona, Chiba 2608717, Japan.	akiranak@chiba-cc.jp	Munirajan, Arasambattu/S-1096-2019; MUNIRAJAN, A K/P-5953-2019	MUNIRAJAN, A K/0000-0003-1337-9008; Suenaga, Yusuke/0000-0001-6902-5386	Ministry of Education, Culture, Sports, Science and Technology of Japan; Ministry of Health, Labor and Welfare of Japan	Ministry of Education, Culture, Sports, Science and Technology of Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); Ministry of Health, Labor and Welfare of Japan(Ministry of Health, Labour and Welfare, Japan)	This work was supported by the Ministry of Education, Culture, Sports, Science and Technology of Japan and the Ministry of Health, Labor and Welfare of Japan.	BADER SA, 1991, CELL GROWTH DIFFER, V2, P245; Bagchi A, 2007, CELL, V128, P459, DOI 10.1016/j.cell.2006.11.052; Bauer A, 2001, GENE CHROMOSOME CANC, V31, P228, DOI 10.1002/gcc.1139; Bharadwaj R, 2004, ONCOGENE, V23, P2016, DOI 10.1038/sj.onc.1207374; Blain SW, 2003, CANCER CELL, V3, P111, DOI 10.1016/S1535-6108(03)00026-6; BRODEUR GM, 1984, SCIENCE, V224, P1121, DOI 10.1126/science.6719137; Brodeur GM, 2003, NAT REV CANCER, V3, P203, DOI 10.1038/nrc1014; CARON H, 1995, MED PEDIATR ONCOL, V24, P215, DOI 10.1002/mpo.2950240402; Caron H, 2001, GENE CHROMOSOME CANC, V30, P168, DOI 10.1002/1098-2264(200102)30:2<168::AID-GCC1072>3.0.CO;2-E; Chen YZ, 2001, GENE CHROMOSOME CANC, V31, P326, DOI 10.1002/gcc.1151; Cook WD, 2000, ONCOGENE, V19, P3434, DOI 10.1038/sj.onc.1203653; Dutta K, 2003, PROTEIN SCI, V12, P257, DOI 10.1110/ps.0223903; Ejeskar K, 2001, MED PEDIATR ONCOL, V36, P61, DOI 10.1002/1096-911X(20010101)36:1<61::AID-MPO1016>3.0.CO;2-0; Endow SA, 1999, EUR J BIOCHEM, V262, P12, DOI 10.1046/j.1432-1327.1999.00339.x; Fero ML, 1998, NATURE, V396, P177, DOI 10.1038/24179; Fodde R, 2002, SCIENCE, V298, P761, DOI 10.1126/science.1077707; Garkavtsev I, 1996, NAT GENET, V14, P415, DOI 10.1038/ng1296-415; GEHRING M, 1995, CANCER RES, V55, P5366; Goldstein LSB, 1999, ANNU REV CELL DEV BI, V15, P141, DOI 10.1146/annurev.cellbio.15.1.141; Gong TWL, 1999, GENE, V239, P117, DOI 10.1016/S0378-1119(99)00370-4; Herman JG, 1996, P NATL ACAD SCI USA, V93, P9821, DOI 10.1073/pnas.93.18.9821; Hirokawa N, 1998, SCIENCE, V279, P519, DOI 10.1126/science.279.5350.519; Hogarty MD, 2000, MED PEDIATR ONCOL, V35, P512, DOI 10.1002/1096-911X(20001201)35:6<512::AID-MPO2>3.0.CO;2-D; Ichimiya S, 2001, MED PEDIATR ONCOL, V36, P42, DOI 10.1002/1096-911X(20010101)36:1<42::AID-MPO1011>3.0.CO;2-K; Joshi B, 2003, BIOCHEM BIOPH RES CO, V312, P459, DOI 10.1016/j.bbrc.2003.10.148; Lawrence CJ, 2004, J CELL BIOL, V167, P19, DOI 10.1083/jcb.200408113; MARTINSSON T, 1995, CANCER RES, V55, P5681; Midorikawa R, 2006, CELL, V125, P371, DOI 10.1016/j.cell.2006.02.039; Mizuguchi H, 1998, HUM GENE THER, V9, P2577, DOI 10.1089/hum.1998.9.17-2577; MOLL UM, 1995, P NATL ACAD SCI USA, V92, P4407, DOI 10.1073/pnas.92.10.4407; Mosse YP, 2005, GENE CHROMOSOME CANC, V43, P390, DOI 10.1002/gcc.20198; Nagai M, 2000, INT J ONCOL, V16, P907; NAKAGAWARA A, 1993, NEW ENGL J MED, V328, P847, DOI 10.1056/NEJM199303253281205; Nakagawara A, 2000, MED PEDIATR ONCOL, V35, P516, DOI 10.1002/1096-911X(20001201)35:6<516::AID-MPO3>3.0.CO;2-Z; Nakagawara A, 1998, MED PEDIATR ONCOL, V31, P113, DOI 10.1002/(SICI)1096-911X(199808)31:2<113::AID-MPO14>3.0.CO;2-O; NANGAKU M, 1994, CELL, V79, P1209, DOI 10.1016/0092-8674(94)90012-4; Ohira M, 2000, ONCOGENE, V19, P4302, DOI 10.1038/sj.onc.1203786; Schwab M, 2003, LANCET ONCOL, V4, P472, DOI 10.1016/S1470-2045(03)01166-5; Schwab M, 1996, GENE CHROMOSOME CANC, V16, P211, DOI 10.1002/(SICI)1098-2264(199608)16:4<211::AID-GCC1>3.0.CO;2-0; Sells SF, 1997, MOL CELL BIOL, V17, P3823, DOI 10.1128/MCB.17.7.3823; Sherr CJ, 2004, CELL, V116, P235, DOI 10.1016/S0092-8674(03)01075-4; Tomioka N, 2008, ONCOGENE, V27, P441, DOI 10.1038/sj.onc.1210661; Westermann F, 2002, CANCER LETT, V184, P127, DOI 10.1016/S0304-3835(02)00199-4; White PS, 2005, ONCOGENE, V24, P2684, DOI 10.1038/sj.onc.1208306; White PS, 2001, MED PEDIATR ONCOL, V36, P37, DOI 10.1002/1096-911X(20010101)36:1<37::AID-MPO1010>3.0.CO;2-L; WHITE PS, 1995, P NATL ACAD SCI USA, V92, P5520, DOI 10.1073/pnas.92.12.5520; Zhao C, 2001, CELL, V105, P587, DOI 10.1016/S0092-8674(01)00363-4	47	80	82	0	10	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	SEP 5	2008	283	36					24426	24434		10.1074/jbc.M802316200	http://dx.doi.org/10.1074/jbc.M802316200			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	342YR	18614535	Green Published, hybrid			2022-12-27	WOS:000258820000018
J	Pontier, SM; Percherancier, Y; Galandrin, S; Breit, A; Gales, C; Bouvier, M				Pontier, Stephanie M.; Percherancier, Yann; Galandrin, Segolene; Breit, Andreas; Gales, Celine; Bouvier, Michel			Cholesterol-dependent Separation of the beta(2)-Adrenergic Receptor from Its Partners Determines Signaling Efficacy INSIGHT INTO NANOSCALE ORGANIZATION OF SIGNAL TRANSDUCTION	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							BETA-ADRENERGIC-RECEPTOR; METABOTROPIC GLUTAMATE-RECEPTOR; HETEROTRIMERIC G-PROTEINS; RESONANCE ENERGY-TRANSFER; LIVING CELL-MEMBRANES; GPI-ANCHORED PROTEINS; LIPID RAFTS; ADENYLYL-CYCLASE; PLASMA-MEMBRANE; CARDIAC MYOCYTES	Determining the role of lipid raft nanodomains in G protein-coupled receptor signaling remains fraught by the lack of assays directly monitoring rafts in native membranes. We thus combined extensive biochemical and pharmacological approaches to a nanoscale strategy based on bioluminescence resonance energy transfer (BRET) to assess the spatial and functional influence of cholesterol-rich liquid-ordered lipid nanodomains on beta(2) adrenergic receptor (beta(2)AR) signaling. The data revealed that whereas beta(2)AR did not partition within liquid-ordered lipid phase, a pool of G protein and adenylyl cyclase (AC) were sequestered in these domains. Destabilization of the liquid-ordered phase by cholesterol depletion led to a lateral redistribution of G alpha(s) and AC that favored interactions between the receptor and its signaling partners as assessed by BRET. This resulted in an increased basal and agonist-promoted beta(2)AR-stimulated cAMP production that was partially dampened as a result of constitutive protein kinase A-dependent phosphorylation and desensitization of the receptor. This restraining influence of nanodomains on beta(2)AR signaling was further substantiated by showing that liquid-ordered lipid phase stabilization using caveolin overexpression or increasing membrane cholesterol amount led to an inhibition of beta(2)AR-associated signaling. Given the emerging concept that clustering of receptors and effectors into signaling platforms contributes to the efficacy and selectivity of signal transduction, our results support a model whereby cholesterol-promoted liquid-ordered lipid phase-embedding G(s) and AC allows their lateral separation from the receptor, thus restraining the basal activity and controlling responsiveness of beta(2)AR signaling machinery within larger signaling platforms.	[Bouvier, Michel] Univ Montreal, Inst Rech Immunol & Cancerol, Dept Biochim, Montreal, PQ H3C 3J7, Canada; Univ Montreal, Grp Rech Univ Medicament, Montreal, PQ H3C 3J7, Canada	Universite de Montreal; Universite de Montreal	Bouvier, M (corresponding author), Univ Montreal, Inst Rech Immunol & Cancerol, Dept Biochim, CP 6128 Succursale Ctr Ville, Montreal, PQ H3C 3J7, Canada.	michel.bouvier@umontreal.ca	Pontier, Stéphanie/A-3836-2015; Bouvier, Michel/H-2758-2014	Pontier, Stéphanie/0000-0002-9124-9228; Bouvier, Michel/0000-0003-1128-0100; percherancier, yann/0000-0002-2410-5806; GALES, Celine/0000-0002-4938-1583	Institut National de la Sante et de la Recherche Medicale (INSERM, France); CIHR	Institut National de la Sante et de la Recherche Medicale (INSERM, France)(Institut National de la Sante et de la Recherche Medicale (Inserm)); CIHR(Canadian Institutes of Health Research (CIHR))	Recipient of a fellowship from the Institut National de la Sante et de la Recherche Medicale (INSERM, France) and a postdoctoral fellowship from the CIHR.	Allen JA, 2005, MOL PHARMACOL, V67, P1493, DOI 10.1124/mol.104.008342; ALOUSI AA, 1991, FASEB J, V5, P2300, DOI 10.1096/fasebj.5.9.1650314; Balijepalli RC, 2006, P NATL ACAD SCI USA, V103, P7500, DOI 10.1073/pnas.0503465103; Becher A, 2001, J NEUROCHEM, V79, P787, DOI 10.1046/j.1471-4159.2001.00614.x; BOUVIER M, 1988, NATURE, V333, P370, DOI 10.1038/333370a0; BOUVIER M, 1991, FEBS LETT, V279, P243, DOI 10.1016/0014-5793(91)80159-Z; Bouvier M, 2001, NAT REV NEUROSCI, V2, P274, DOI 10.1038/35067575; BRADFORD MM, 1976, ANAL BIOCHEM, V72, P248, DOI 10.1016/0003-2697(76)90527-3; Brown DA, 1998, ANNU REV CELL DEV BI, V14, P111, DOI 10.1146/annurev.cellbio.14.1.111; BROWN DA, 1992, CELL, V68, P533, DOI 10.1016/0092-8674(92)90189-J; Bunemann M, 2003, P NATL ACAD SCI USA, V100, P16077, DOI 10.1073/pnas.2536719100; CARON MG, 1990, G PROTEINS, P295; Chidiac P, 1996, MOL PHARMACOL, V50, P662; DELEAN A, 1980, J BIOL CHEM, V255, P7108; Douglass AD, 2005, CELL, V121, P937, DOI 10.1016/j.cell.2005.04.009; Dupre DJ, 2007, CELL SIGNAL, V19, P481, DOI 10.1016/j.cellsig.2006.07.021; Dupre DJ, 2006, J BIOL CHEM, V281, P34561, DOI 10.1074/jbc.M605012200; Eroglu C, 2003, P NATL ACAD SCI USA, V100, P10219, DOI 10.1073/pnas.1737042100; Fotiadis D, 2003, NATURE, V421, P127, DOI 10.1038/421127a; Gales C, 2005, NAT METHODS, V2, P177, DOI 10.1038/NMETH743; Gales C, 2006, NAT STRUCT MOL BIOL, V13, P778, DOI 10.1038/nsmb1134; Gao MH, 1998, P NATL ACAD SCI USA, V95, P1038, DOI 10.1073/pnas.95.3.1038; Gimpl G, 1997, BIOCHEMISTRY-US, V36, P10959, DOI 10.1021/bi963138w; Glebov OO, 2004, NAT CELL BIOL, V6, P238, DOI 10.1038/ncb1103; Gomez-Mouton C, 2004, J CELL BIOL, V164, P759, DOI 10.1083/jcb.200309101; Goodwin JS, 2005, BIOPHYS J, V89, P1398, DOI 10.1529/biophysj.104.055640; Hao MM, 2001, P NATL ACAD SCI USA, V98, P13072, DOI 10.1073/pnas.231377398; Harder T, 1998, J CELL BIOL, V141, P929, DOI 10.1083/jcb.141.4.929; Harder T, 1997, CURR OPIN CELL BIOL, V9, P534, DOI 10.1016/S0955-0674(97)80030-0; Harikumar KG, 2005, J BIOL CHEM, V280, P2176, DOI 10.1074/jbc.M410385200; HAUSDORFF WP, 1990, FASEB J, V4, P2881, DOI 10.1096/fasebj.4.11.2165947; Ianoul A, 2005, NAT CHEM BIOL, V1, P196, DOI 10.1038/nchembio726; Jiao XM, 2005, MOL CELL BIOL, V25, P5752, DOI 10.1128/MCB.25.13.5752-5762.2005; Kenworthy AK, 1998, J CELL BIOL, V142, P69, DOI 10.1083/jcb.142.1.69; Klein S, 2000, P NATL ACAD SCI USA, V97, P3219, DOI 10.1073/pnas.050015797; KLEIN U, 1995, BIOCHEMISTRY-US, V34, P13784, DOI 10.1021/bi00042a009; Krawczyk C, 2000, IMMUNITY, V13, P463, DOI 10.1016/S1074-7613(00)00046-7; Krumins AM, 1997, BIOCHEM PHARMACOL, V54, P61, DOI 10.1016/S0006-2952(97)00147-0; Kukkonen JP, 2001, TRENDS PHARMACOL SCI, V22, P616, DOI 10.1016/S0165-6147(00)01864-2; Lagane B, 2000, J BIOL CHEM, V275, P33197, DOI 10.1074/jbc.C000576200; Lavoie C, 2002, J BIOL CHEM, V277, P35402, DOI 10.1074/jbc.M204163200; Levitzki A, 2002, CHEMBIOCHEM, V3, P815, DOI 10.1002/1439-7633(20020902)3:9<815::AID-CBIC815>3.0.CO;2-E; Macdonald JL, 2005, J LIPID RES, V46, P1061, DOI 10.1194/jlr.D400041-JLR200; Madore N, 1999, EMBO J, V18, P6917, DOI 10.1093/emboj/18.24.6917; Mayor S, 2004, TRAFFIC, V5, P231, DOI 10.1111/j.1600-0854.2004.00172.x; McCabe JB, 2001, MOL BIOL CELL, V12, P3601, DOI 10.1091/mbc.12.11.3601; Mercier JF, 2002, J BIOL CHEM, V277, P44925, DOI 10.1074/jbc.M205767200; Mishra S, 2007, J NEUROCHEM, V103, P135, DOI 10.1111/j.1471-4159.2007.04720.x; Miura Y, 2001, BIOCHEMISTRY-US, V40, P15418, DOI 10.1021/bi015574a; NEUBIG RR, 1994, FASEB J, V8, P939, DOI 10.1096/fasebj.8.12.8088459; Nichols BJ, 2003, CURR BIOL, V13, P686, DOI 10.1016/S0960-9822(03)00209-4; OCONNOR SW, 1984, BIOCHIM BIOPHYS ACTA, V778, P497, DOI 10.1016/0005-2736(84)90399-7; Oh P, 2001, MOL BIOL CELL, V12, P685, DOI 10.1091/mbc.12.3.685; Ostrom RS, 2000, J PHARMACOL EXP THER, V294, P407; Ostrom RS, 2000, MOL PHARMACOL, V57, P1075; Ostrom RS, 2001, J BIOL CHEM, V276, P42063, DOI 10.1074/jbc.M105348200; Pang L, 1999, BIOCHEMISTRY-US, V38, P12003, DOI 10.1021/bi990227a; Percherancier Y, 2003, J BIOL CHEM, V278, P3153, DOI 10.1074/jbc.M207371200; Pierini L, 1996, J CELL BIOL, V134, P1427, DOI 10.1083/jcb.134.6.1427; PRIETO JC, 1990, GEN PHARMACOL-VASC S, V21, P931, DOI 10.1016/0306-3623(90)90457-W; Rebois RV, 2006, J CELL SCI, V119, P2807, DOI 10.1242/jcs.03021; Rybin VO, 2000, J BIOL CHEM, V275, P41447, DOI 10.1074/jbc.M006951200; Salahpour A, 2004, J BIOL CHEM, V279, P33390, DOI 10.1074/jbc.M403363200; SALOMON Y, 1974, ANAL BIOCHEM, V58, P541, DOI 10.1016/0003-2697(74)90222-X; SCARPACE PJ, 1985, BIOCHIM BIOPHYS ACTA, V845, P520, DOI 10.1016/0167-4889(85)90220-4; Seveau S, 2001, MOL BIOL CELL, V12, P3550, DOI 10.1091/mbc.12.11.3550; Sharma P, 2004, CELL, V116, P577, DOI 10.1016/S0092-8674(04)00167-9; SMART EJ, 1995, P NATL ACAD SCI USA, V92, P10104, DOI 10.1073/pnas.92.22.10104; Smart EJ, 1996, J BIOL CHEM, V271, P29427, DOI 10.1074/jbc.271.46.29427; Song KS, 1996, J BIOL CHEM, V271, P9690, DOI 10.1074/jbc.271.16.9690; Tepe NM, 1999, BIOCHEMISTRY-US, V38, P16706, DOI 10.1021/bi991619k; THOMAS JL, 1994, J CELL BIOL, V125, P795, DOI 10.1083/jcb.125.4.795; Tran TM, 2004, MOL PHARMACOL, V65, P196, DOI 10.1124/mol.65.1.196; Uittenbogaard A, 2000, J BIOL CHEM, V275, P25595, DOI 10.1074/jbc.M003401200; Uittenbogaard A, 2000, J BIOL CHEM, V275, P11278, DOI 10.1074/jbc.275.15.11278; Uittenbogaard A, 1998, J BIOL CHEM, V273, P6525, DOI 10.1074/jbc.273.11.6525; Vidalain PO, 2000, EMBO J, V19, P3304, DOI 10.1093/emboj/19.13.3304; White JH, 1998, NATURE, V396, P679, DOI 10.1038/25354; Xiang Y, 2002, J BIOL CHEM, V277, P34280, DOI 10.1074/jbc.M201644200	79	100	102	0	14	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	SEP 5	2008	283	36					24659	24672		10.1074/jbc.M800778200	http://dx.doi.org/10.1074/jbc.M800778200			14	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	517MA	18566454	hybrid, Green Published			2022-12-27	WOS:000271617300002
J	Vargas, KJ; Terunuma, M; Tello, JA; Pangalos, MN; Moss, SJ; Couve, A				Vargas, Karina J.; Terunuma, Miho; Tello, Judith A.; Pangalos, Menelas N.; Moss, Stephen J.; Couve, Andres			The Availability of Surface GABA(B) Receptors Is Independent of gamma-Aminobutyric Acid but Controlled by Glutamate in Central Neurons	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							DEPENDENT PROTEIN-KINASE; SUBCELLULAR-LOCALIZATION; SYNAPTIC SITES; B RECEPTORS; TRAFFICKING; ENDOCYTOSIS; PATHWAY; PHOSPHORYLATION; SUBUNITS; DESENSITIZATION	The efficacy of synaptic transmission depends on the availability of ionotropic and metabotropic neurotransmitter receptors at the plasma membrane, but the contribution of the endocytic and recycling pathways in the regulation of gamma-aminobutyric acid type B (GABA(B)) receptors remains controversial. To understand the mechanisms that regulate the abundance of GABA(B) receptors, we have studied their turnover combining surface biotin labeling and a microscopic immunoendocytosis assay in hippocampal and cortical neurons. We report that internalization of GABA(B) receptors is agonist-independent. We also demonstrate that receptors endocytose in the cell body and dendrites but not in axons. Additionally, we show that GABA(B) receptors endocytose as heterodimers via clathrin- and dynamin-1-dependent mechanisms and that they recycle to the plasma membrane after endocytosis. More importantly, we show that glutamate decreases the levels of cell surface receptors in a manner dependent on an intact proteasome pathway. These observations indicate that glutamate and not GABA controls the abundance of surface GABA(B) receptors in central neurons, consistent with their enrichment at glutamatergic synapses.	[Vargas, Karina J.; Tello, Judith A.; Couve, Andres] Univ Chile, Fac Med, ICBM, Santiago, Chile; [Vargas, Karina J.] Univ Austral Chile, Valdivia, Chile; [Terunuma, Miho; Moss, Stephen J.] Univ Penn, Sch Med, Dept Neurosci, Philadelphia, PA 19104 USA; [Pangalos, Menelas N.] Wyeth Ayerst Res, Neurosci Discovery, Princeton, NJ 08543 USA; [Moss, Stephen J.] UCL, Dept Pharmacol, London WC1E 6BT, England	Universidad de Chile; Universidad Austral de Chile; University of Pennsylvania; Pfizer; University of London; University College London	Couve, A (corresponding author), Univ Chile, Fac Med, ICBM, Independencia 1027, Santiago, Chile.	andres@neuro.med.uchile.cl	couve, andres/I-2249-2013	couve, andres/0000-0003-4216-8672; Terunuma, Miho/0000-0003-1876-9726	FONDECYT [1071001]; Iniciativa Cientifica Milenio;  [ICM-P04-068-F]; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS051195, R01NS048045, R01NS081986, R21NS080064] Funding Source: NIH RePORTER	FONDECYT(Comision Nacional de Investigacion Cientifica y Tecnologica (CONICYT)CONICYT FONDECYT); Iniciativa Cientifica Milenio; ; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	Supported byFONDECYT 1071001 and Iniciativa Cientifica Milenio ICM-P04- 068-F.	Bayer N, 2001, J BIOL CHEM, V276, P3952, DOI 10.1074/jbc.M004722200; Bettler B, 2004, PHYSIOL REV, V84, P835, DOI 10.1152/physrev.00036.2003; Bettler B, 2006, PHARMACOL THERAPEUT, V110, P533, DOI 10.1016/j.pharmthera.2006.03.006; Clem RL, 2006, NEURON, V49, P663, DOI 10.1016/j.neuron.2006.01.019; Collingridge GL, 2004, NAT REV NEUROSCI, V5, P952, DOI 10.1038/nrn1556; Correa SAL, 2004, NEUROPHARMACOLOGY, V47, P475, DOI 10.1016/j.neuropharm.2004.04.021; Cousins MS, 2002, DRUG ALCOHOL DEPEN, V65, P209, DOI 10.1016/S0376-8716(01)00163-6; Couve A, 2004, BIOCHEM PHARMACOL, V68, P1527, DOI 10.1016/j.bcp.2004.06.036; Couve A, 1998, J BIOL CHEM, V273, P26361, DOI 10.1074/jbc.273.41.26361; Couve A, 2002, NAT NEUROSCI, V5, P415, DOI 10.1038/nn833; Ehlers MD, 2000, NEURON, V28, P511, DOI 10.1016/S0896-6273(00)00129-X; Fairfax BP, 2004, J BIOL CHEM, V279, P12565, DOI 10.1074/jbc.M311389200; Fourgeaud L, 2003, J BIOL CHEM, V278, P12222, DOI 10.1074/jbc.M205663200; Gonzalez-Maeso J, 2003, EUR J PHARMACOL, V481, P15, DOI 10.1016/j.ejphar.2003.09.002; Goslin K., 1991, CULTURING NERVE CELL, P251; Grampp T, 2007, J BIOL CHEM, V282, P24157, DOI 10.1074/jbc.M702626200; Gray NW, 2003, CURR BIOL, V13, P510, DOI 10.1016/S0960-9822(03)00136-2; Hawrot E, 1998, FEBS LETT, V432, P103, DOI 10.1016/S0014-5793(98)00794-7; HERSKOVITS JS, 1993, J CELL BIOL, V122, P565, DOI 10.1083/jcb.122.3.565; Inoue A, 2003, CURR OPIN NEUROBIOL, V13, P332, DOI 10.1016/S0959-4388(03)00077-1; Jiang M, 2006, NAT PROTOC, V1, P695, DOI 10.1038/nprot.2006.86; Kulik A, 2003, J NEUROSCI, V23, P11026; Kulik A, 2002, EUR J NEUROSCI, V15, P291, DOI 10.1046/j.0953-816x.2001.01855.x; Kuramoto N, 2007, NEURON, V53, P233, DOI 10.1016/j.neuron.2006.12.015; Laffray S, 2007, EUR J NEUROSCI, V25, P1402, DOI 10.1111/j.1460-9568.2007.05398.x; Lenferink AEG, 1998, EMBO J, V17, P3385, DOI 10.1093/emboj/17.12.3385; Lujan R, 2006, EUR J NEUROSCI, V23, P1479, DOI 10.1111/j.1460-9568.2006.04669.x; Margeta-Mitrovic M, 2000, NEURON, V27, P97, DOI 10.1016/S0896-6273(00)00012-X; Melikova MS, 2006, CELL BIOL INT, V30, P31, DOI 10.1016/j.cellbi.2005.09.003; MOLLENHAUER HH, 1990, BIOCHIM BIOPHYS ACTA, V1031, P225, DOI 10.1016/0304-4157(90)90008-Z; Moss SJ, 2001, NAT REV NEUROSCI, V2, P240, DOI 10.1038/35067500; Perroy J, 2003, EMBO J, V22, P3816, DOI 10.1093/emboj/cdg383; Pin JP, 2004, BIOCHEM PHARMACOL, V68, P1565, DOI 10.1016/j.bcp.2004.06.035; Praefcke GJK, 2004, NAT REV MOL CELL BIO, V5, P133, DOI 10.1038/nrm1313; Ramoino P, 2006, J CELL SCI, V119, P2056, DOI 10.1242/jcs.02931; Restituito S, 2005, MOL CELL NEUROSCI, V28, P747, DOI 10.1016/j.mcn.2004.12.006; Sakaba T, 2003, NATURE, V424, P775, DOI 10.1038/nature01859; Seachrist JL, 2003, LIFE SCI, V74, P225, DOI 10.1016/j.lfs.2003.09.009; Vigot R, 2006, NEURON, V50, P589, DOI 10.1016/j.neuron.2006.04.014	39	45	46	0	3	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258			J BIOL CHEM	J. Biol. Chem.	SEP 5	2008	283	36					24641	24648		10.1074/jbc.M802419200	http://dx.doi.org/10.1074/jbc.M802419200			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	342YR	18579521	hybrid, Green Published			2022-12-27	WOS:000258820000068
J	Clerc, I; Polakowski, N; Andre-Arpin, C; Cook, P; Barbeau, B; Mesnard, JM; Lemasson, I				Clerc, Isabelle; Polakowski, Nicholas; Andre-Arpin, Charlotte; Cook, Pamela; Barbeau, Benoit; Mesnard, Jean-Michel; Lemasson, Isabelle			An interaction between the human T cell leukemia virus type 1 basic leucine zipper factor (HBZ) and the KIX domain of p300/CBP contributes to the down-regulation of tax-dependent viral transcription by HBZ	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							CREB-BINDING-PROTEIN; BZIP FACTOR HBZ; NUCLEAR-RECEPTOR; MOLECULAR-INTERACTIONS; ENHANCE TRANSCRIPTION; HTLV-1 TRANSCRIPTION; 21-BASE-PAIR REPEATS; COACTIVATOR CBP; ACTIVATION; GENE	Activation of human T cell leukemia virus type 1 (HTLV-1) transcription is established through the formation of protein complexes on the viral promoter that are essentially composed of the cellular basic leucine zipper (bZIP) transcription factor cAMP-response element-binding protein (CREB (or certain other members of the ATF/CREB family), the HTLV-1-encoded transactivator Tax, and the pleiotropic cellular coactivators p300/CBP. HTLV-1 bZIP factor (HBZ) is a protein encoded by HTLV-1 that contains a bZIP domain and functions to repress HTLV-1 transcription. HBZ has been shown to repress viral transcription by dimerizing with CREB, which occurs specifically through the bZIP domain in each protein, and preventing CREB from binding to the DNA. However, we previously found that HBZ causes only partial removal of CREB from a chromosomally integrated viral promoter, and more importantly, an HBZ mutant lacking the COOH-terminal bZIP domain retains the ability to repress viral transcription. These results suggest that an additional mechanism contributes to HBZ-mediated repression of HTLV-1 transcription. In this study, we show that HBZ binds directly to the p300 and CBP coactivators. Two LXXLL-like motifs located within the NH2-terminal region of HBZ are important for this interaction and specifically mediate binding to the KIX domain of p300/CBP. We provide evidence that this interaction interferes with the ability of Tax to bind p300/CBP and thereby inhibits the association of the coactivators with the viral promoter. Our findings demonstrate that HBZ utilizes a bipartite mechanism to repress viral transcription.	[Polakowski, Nicholas; Cook, Pamela; Lemasson, Isabelle] E Carolina Univ, Brody Sch Med, Dept Microbiol & Immunol, Greenville, NC 27834 USA; [Clerc, Isabelle; Andre-Arpin, Charlotte; Mesnard, Jean-Michel] CPBS, Inst Biol, CNRS, UMR 5236, F-34965 Montpellier 2, France; [Clerc, Isabelle; Andre-Arpin, Charlotte; Mesnard, Jean-Michel] Univ Montpellier 1, F-34965 Montpellier, France; [Barbeau, Benoit] Univ Quebec, Dept Sci Biol, Montreal, PQ H2X 3X8, Canada; [Clerc, Isabelle; Andre-Arpin, Charlotte; Mesnard, Jean-Michel] Univ Montpellier 2, CPBS, F-34095 Montpellier, France	University of North Carolina; East Carolina University; Centre National de la Recherche Scientifique (CNRS); Universite de Montpellier; University of Quebec; University of Quebec Montreal; Universite de Montpellier	Mesnard, JM (corresponding author), CPBS, Inst Biol, CNRS, UMR 5236, CS 69033,4 Bd Henri 4, F-34965 Montpellier 2, France.	jean-michel.mesnard@univ-montp1.fr; lemassoni@ecu.edu	Lemasson, Isabelle/N-1355-2013; Barbeau, Benoit/A-1174-2010	Barbeau, Benoit/0000-0002-4108-8155; Mesnard, Jean-Michel/0000-0003-3344-5367; Clerc, Isabelle/0000-0002-7140-7049; polakowski, Nicholas/0000-0003-4949-5799	East Carolina University; CNRS; Universite Montpellier 1; Association pour la Recherche sur le Cancer [3606]; Fondation Recherche Medicale (Comite Languedoc); Ligue Contre le Cancer (Comite de l'Herault)	East Carolina University; CNRS(Centre National de la Recherche Scientifique (CNRS)); Universite Montpellier 1; Association pour la Recherche sur le Cancer(Fondation ARC pour la Recherche sur le CancerAustralian Research Council); Fondation Recherche Medicale (Comite Languedoc); Ligue Contre le Cancer (Comite de l'Herault)	This work was supported by a Research Development Grant Program Award from East Carolina University (to I. C.) and by institutional grants from CNRS and the Universite Montpellier 1 (UM 1) and grants from the Association pour la Recherche sur le Cancer (Grant 3606), the Fondation Recherche Medicale (Comite Languedoc), and the Ligue Contre le Cancer (Comite de l'Herault) (to J. M. M.). The costs of publication of this article were defrayed in part by the payment of page charges. This article must therefore be hereby marked "advertisement" in accordance with 18 U.S.C. Section 1734 solely to indicate this fact.	Arnold J, 2006, BLOOD, V107, P3976, DOI 10.1182/blood-2005-11-4551; Arpin-Andre C, 2007, J BIOL CHEM, V282, P33132, DOI 10.1074/jbc.M702279200; Barbeau B, 2007, INT REV IMMUNOL, V26, P283, DOI 10.1080/08830180701690843; Basbous J, 2003, J VIROL, V77, P13028, DOI 10.1128/JVI.77.24.13028-13035.2003; Basbous J, 2003, J BIOL CHEM, V278, P43620, DOI 10.1074/jbc.M307275200; Bayly R, 2004, J BIOL CHEM, V279, P55362, DOI 10.1074/jbc.M408654200; Bayly R, 2006, MOL CELL BIOL, V26, P6442, DOI 10.1128/MCB.02025-05; Cavanagh MH, 2006, RETROVIROLOGY, V3, DOI 10.1186/1742-4690-3-15; Chan HM, 2001, J CELL SCI, V114, P2363; Ching YP, 2006, NAT CELL BIOL, V8, P717, DOI 10.1038/ncb1432; ECKNER R, 1994, GENE DEV, V8, P869, DOI 10.1101/gad.8.8.869; Eckner R, 1996, MOL CELL BIOL, V16, P3454; Frangioni JV, 2000, NAT BIOTECHNOL, V18, P1080, DOI 10.1038/80280; Frank SR, 2001, GENE DEV, V15, P2069, DOI 10.1101/gad.906601; Gachon F, 2002, VIROLOGY, V299, P271, DOI 10.1006/viro.2002.1501; Gachon F, 2001, FEBS LETT, V502, P57, DOI 10.1016/S0014-5793(01)02646-1; Gachon F, 1998, J VIROL, V72, P8332, DOI 10.1128/JVI.72.10.8332-8337.1998; Gachon F, 2000, MOL CELL BIOL, V20, P3470, DOI 10.1128/MCB.20.10.3470-3481.2000; Gaudray G, 2002, J VIROL, V76, P12813, DOI 10.1128/JVI.76.24.12813-12822.2002; Georges SA, 2002, MOL CELL BIOL, V22, P127, DOI 10.1128/MCB.22.1.127-137.2002; Giebler HA, 1997, MOL CELL BIOL, V17, P5156, DOI 10.1128/MCB.17.9.5156; Goodman RH, 2000, GENE DEV, V14, P1553; Gwack Y, 2001, J VIROL, V75, P1909, DOI 10.1128/JVI.75.4.1909-1917.2001; Harrod R, 1998, MOL CELL BIOL, V18, P5052, DOI 10.1128/MCB.18.9.5052; Hebbar PB, 2008, J BIOL CHEM, V283, P4595, DOI 10.1074/jbc.M709121200; Heery DM, 1997, NATURE, V387, P733, DOI 10.1038/42750; Hivin P, 2005, J CELL SCI, V118, P1355, DOI 10.1242/jcs.01727; Hivin P, 2007, RETROVIROLOGY, V4, DOI 10.1186/1742-4690-4-14; Hivin P, 2006, NUCLEIC ACIDS RES, V34, P2761, DOI 10.1093/nar/gkl375; Iyer NG, 2004, ONCOGENE, V23, P4225, DOI 10.1038/sj.onc.1207118; Kashanchi F, 2005, ONCOGENE, V24, P5938, DOI 10.1038/sj.onc.1208973; Kimzey AL, 1998, J BIOL CHEM, V273, P13768, DOI 10.1074/jbc.273.22.13768; Ko L, 2000, P NATL ACAD SCI USA, V97, P6212, DOI 10.1073/pnas.97.11.6212; Kraus WL, 1999, MOL CELL BIOL, V19, P8123; Kuhlmann AS, 2007, RETROVIROLOGY, V4, DOI 10.1186/1742-4690-4-92; Kwok RPS, 1996, NATURE, V380, P642, DOI 10.1038/380642a0; Langlois M, 2004, VIROLOGY, V329, P395, DOI 10.1016/j.virol.2004.09.003; LAROCCA D, 1989, BIOCHEM BIOPH RES CO, V163, P1006, DOI 10.1016/0006-291X(89)92322-X; Lemasson I, 2006, J BIOL CHEM, V281, P13075, DOI 10.1074/jbc.M512193200; Lemasson I, 2001, J BIOL CHEM, V276, P15720, DOI 10.1074/jbc.M100131200; Lemasson I, 2002, J BIOL CHEM, V277, P49459, DOI 10.1074/jbc.M209566200; Lemasson I, 2007, J VIROL, V81, P1543, DOI 10.1128/JVI.00480-06; Lenzmeier BA, 1998, MOL CELL BIOL, V18, P721, DOI 10.1128/MCB.18.2.721; Li M, 2007, J VIROL METHODS, V142, P159, DOI 10.1016/j.jviromet.2007.01.023; Lu HX, 2002, MOL CELL BIOL, V22, P4450, DOI 10.1128/MCB.22.13.4450-4462.2002; Lundblad JR, 1998, J BIOL CHEM, V273, P19251, DOI 10.1074/jbc.273.30.19251; Matsuoka M, 2007, NAT REV CANCER, V7, P270, DOI 10.1038/nrc2111; McInerney EM, 1998, GENE DEV, V12, P3357, DOI 10.1101/gad.12.21.3357; McManus KJ, 2001, BIOCHEM CELL BIOL, V79, P253, DOI 10.1139/bcb-79-3-253; Mesnard JM, 2006, BLOOD, V108, P3979, DOI 10.1182/blood-2006-03-007732; Murata K, 2006, J VIROL, V80, P2495, DOI 10.1128/JVI.80.5.2495-2505.2006; Okada M, 2002, J VIROL, V76, P12564, DOI 10.1128/JVI.76.24.12564-12573.2002; Patel D, 1999, EMBO J, V18, P5061, DOI 10.1093/emboj/18.18.5061; Peloponese JM, 2005, P NATL ACAD SCI USA, V102, P18974, DOI 10.1073/pnas.0506659103; Satou Y, 2006, P NATL ACAD SCI USA, V103, P720, DOI 10.1073/pnas.0507631103; Scoggin KES, 2001, MOL CELL BIOL, V21, P5520, DOI 10.1128/MCB.21.16.5520-5530.2001; Suzuki T, 1999, ONCOGENE, V18, P5967, DOI 10.1038/sj.onc.1203008; Takeda S, 2004, INT J CANCER, V109, P559, DOI 10.1002/ijc.20007; Thebault S, 2000, J BIOL CHEM, V275, P4848, DOI 10.1074/jbc.275.7.4848; Tie F, 1996, J VIROL, V70, P8368, DOI 10.1128/JVI.70.12.8368-8374.1996; Westin S, 1998, NATURE, V395, P199, DOI 10.1038/26040; Yan JP, 1998, J MOL BIOL, V281, P395, DOI 10.1006/jmbi.1998.1951; Yin MJ, 1996, MOL CELL BIOL, V16, P3156; ZHAO LJ, 1992, P NATL ACAD SCI USA, V89, P7070, DOI 10.1073/pnas.89.15.7070; Zor T, 2004, J MOL BIOL, V337, P521, DOI 10.1016/j.jmb.2004.01.038	65	106	109	0	1	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258			J BIOL CHEM	J. Biol. Chem.	AUG 29	2008	283	35					23903	23913		10.1074/jbc.M803116200	http://dx.doi.org/10.1074/jbc.M803116200			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	340II	18599479	Green Published, hybrid			2022-12-27	WOS:000258638900045
J	Coulthurst, SJ; Lilley, KS; Hedley, PE; Liu, H; Toth, IK; Salmond, GPC				Coulthurst, Sarah J.; Lilley, Kathryn S.; Hedley, Peter E.; Liu, Hui; Toth, Ian K.; Salmond, George P. C.			DsbA plays a critical and multifaceted role in the production of secreted virulence factors by the phytopathogen Erwinia carotovora subsp atroseptica	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							DISULFIDE BOND FORMATION; GRAM-NEGATIVE BACTERIA; ESCHERICHIA-COLI; PSEUDOMONAS-AERUGINOSA; PULLULANASE SECRETION; ENTERIC PHYTOPATHOGEN; PROTEIN SECRETION; ISOMERASE DSBC; CHRYSANTHEMI; PATHOGENESIS	Erwinia carotovora subsp. atroseptica is an enterobacterial phytopathogen causing economically significant soft rot disease. Pathogenesis is mediated by multiple secreted virulence factors, many of which are secreted by the type II (Out) secretion system. DsbA catalyzes the introduction of disulfide bonds into periplasmic and secreted proteins. In this study, the extracellular proteome (secretome) of wild type E. carotovora subsp. atroseptica SCRI1043, and dsbA and out mutants, was analyzed by spectral counting mass spectrometry. This revealed that dsbA inactivation had a huge impact on the secretome and identified diverse DsbA- and Out-dependent secreted proteins, representing known, predicted, and novel candidate virulence factors. Further characterization of the dsbA mutant showed that secreted enzyme activities, motility, production of the quorum-sensing signal, and virulence were absent or substantially reduced. The impact of DsbA on secreted virulence factor production was mediated at multiple levels, including impacting on the Out secretion system and the virulence gene regulatory network. Transcriptome analyses revealed that the abundance of a broad, but defined, set of transcripts, including many virulence factors, was altered in the dsbA mutant, identifying a new virulence regulon responsive to extracytoplasmic conditions. In conclusion, DsbA plays a crucial, multifaceted role in the pathogenesis of E. carotovora subsp. atroseptica.	[Coulthurst, Sarah J.; Lilley, Kathryn S.; Salmond, George P. C.] Univ Cambridge, Dept Biochem, Cambridge CB2 1QW, England; [Lilley, Kathryn S.] Univ Cambridge, Cambridge Syst Biol Inst, Cambridge CB2 1QR, England; [Hedley, Peter E.; Liu, Hui; Toth, Ian K.] Invergowrie, Scottish Crop Res Inst, Dundee DD2 5DA, Scotland	University of Cambridge; University of Cambridge; James Hutton Institute	Salmond, GPC (corresponding author), Univ Cambridge, Dept Biochem, Tennis Court Rd, Cambridge CB2 1QW, England.	gpcs@mole.bio.cam.ac.uk	Hedley, Peter/F-1149-2011; Lilley, Kathryn/ABF-5787-2020	Hedley, Peter/0000-0003-0866-324X; Lilley, Kathryn/0000-0003-0594-6543; Coulthurst, Sarah/0000-0002-0808-1875	Biotechnology and Biological Sciences Research Council	Biotechnology and Biological Sciences Research Council(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC))	This work was supported by the Biotechnology and Biological Sciences Research Council. The costs of publication of this article were defrayed in part by the payment of page charges. This article must therefore be hereby marked "advertisement" in accordance with 18 U.S.C. Section 1734 solely to indicate this fact.	Agudo D, 2004, PROTEOMICS, V4, P355, DOI 10.1002/pmic.200300554; Aldridge P, 2002, CURR OPIN MICROBIOL, V5, P160, DOI 10.1016/S1369-5274(02)00302-8; Bell KS, 2004, P NATL ACAD SCI USA, V101, P11105, DOI 10.1073/pnas.0402424101; Berg HC, 2003, ANNU REV BIOCHEM, V72, P19, DOI 10.1146/annurev.biochem.72.121801.161737; Burr T, 2006, MOL MICROBIOL, V59, P113, DOI 10.1111/j.1365-2958.2005.04939.x; CHATTERJEE A, 1991, J BACTERIOL, V173, P1765, DOI 10.1128/jb.173.5.1765-1769.1991; Corbett M, 2005, MOL PLANT MICROBE IN, V18, P334, DOI 10.1094/MPMI-18-0334; Coulthurst SJ, 2006, MOL PLANT PATHOL, V7, P31, DOI 10.1111/J.1364-3703.2005.00314.X; DAILEY FE, 1993, P NATL ACAD SCI USA, V90, P1043, DOI 10.1073/pnas.90.3.1043; Delepelaire P, 2004, BBA-MOL CELL RES, V1694, P149, DOI 10.1016/j.bbamcr.2004.05.001; Duguay AR, 2004, BBA-MOL CELL RES, V1694, P121, DOI 10.1016/j.bbamcr.2004.04.012; Filloux A, 2004, BBA-MOL CELL RES, V1694, P163, DOI 10.1016/j.bbamcr.2004.05.003; Ha UH, 2003, INFECT IMMUN, V71, P1590, DOI 10.1128/IAI.71.3.1590-1595.2003; Harris SJ, 1998, MOL MICROBIOL, V28, P705, DOI 10.1046/j.1365-2958.1998.00825.x; Hiniker A, 2005, J BIOL CHEM, V280, P33785, DOI 10.1074/jbc.M505742200; Hiniker A, 2004, J BIOL CHEM, V279, P12967, DOI 10.1074/jbc.M311391200; Holeva MC, 2004, MOL PLANT MICROBE IN, V17, P943, DOI 10.1094/MPMI.2004.17.9.943; Kadokura H, 2003, ANNU REV BIOCHEM, V72, P111, DOI 10.1146/annurev.biochem.72.121801.161459; KANIGA K, 1991, GENE, V109, P137, DOI 10.1016/0378-1119(91)90599-7; Kazemi-Pour N, 2004, PROTEOMICS, V4, P3177, DOI 10.1002/pmic.200300814; Laatu M, 2003, J BACTERIOL, V185, P1642, DOI 10.1128/JB.185.5.1642-1649.2003; Lasica AM, 2007, FEMS MICROBIOL REV, V31, P626, DOI 10.1111/j.1574-6976.2007.00081.x; Liu HB, 2004, ANAL CHEM, V76, P4193, DOI 10.1021/ac0498563; Liu H, 2008, PLOS PATHOG, V4, DOI 10.1371/journal.ppat.1000093; Macnab RM, 2004, BBA-MOL CELL RES, V1694, P207, DOI 10.1016/j.bbamcr.2004.04.005; Mattinen L, 2007, PROTEOMICS, V7, P3527, DOI 10.1002/pmic.200600759; McCarter LL, 2006, CURR OPIN MICROBIOL, V9, P180, DOI 10.1016/j.mib.2006.02.001; Nakamoto H, 2004, BBA-MOL CELL RES, V1694, P111, DOI 10.1016/j.bbamcr.2004.02.012; Pemberton CL, 2005, MOL PLANT MICROBE IN, V18, P343, DOI 10.1094/MPMI-18-0343; Perombelon MCM, 2002, PLANT PATHOL, V51, P1, DOI 10.1046/j.0032-0862.2001.Short title.doc.x; Pugsley AP, 2001, J BACTERIOL, V183, P1312, DOI 10.1128/JB.183.4.1312-1319.2001; Raivio TL, 2005, MOL MICROBIOL, V56, P1119, DOI 10.1111/j.1365-2958.2005.04625.x; REEVES PJ, 1993, MOL MICROBIOL, V8, P443, DOI 10.1111/j.1365-2958.1993.tb01589.x; Rojas CM, 2002, P NATL ACAD SCI USA, V99, P13142, DOI 10.1073/pnas.202358699; Sandkvist M, 2001, INFECT IMMUN, V69, P3523, DOI 10.1128/IAI.69.6.3523-3535.2001; Sauvonnet N, 1998, MOL MICROBIOL, V27, P661, DOI 10.1046/j.1365-2958.1998.00722.x; SHEVCHIK VE, 1995, MOL MICROBIOL, V16, P745, DOI 10.1111/j.1365-2958.1995.tb02435.x; Thomson NR, 1999, METHOD MICROBIOL, V29, P347; TOTH I, 1993, J GEN MICROBIOL, V139, P2705, DOI 10.1099/00221287-139-11-2705; Toth IK, 2005, CURR OPIN PLANT BIOL, V8, P424, DOI 10.1016/j.pbi.2005.04.001; Toth IK, 2003, MOL PLANT PATHOL, V4, P17, DOI 10.1046/j.1364-3703.2003.00149.x; Venkatesh B, 2006, J BACTERIOL, V188, P3088, DOI 10.1128/JB.188.8.3088-3098.2006; Vertommen D, 2008, MOL MICROBIOL, V67, P336, DOI 10.1111/j.1365-2958.2007.06030.x; Vincent-Sealy LV, 1999, MICROBIOL-SGM, V145, P1945, DOI 10.1099/13500872-145-8-1945; WALKER DS, 1994, MOL PLANT MICROBE IN, V7, P425, DOI 10.1094/MPMI-7-0425; Whitehead NA, 2002, ANTON LEEUW INT J G, V81, P223, DOI 10.1023/A:1020570802717; Whitehead NA, 2001, FEMS MICROBIOL REV, V25, P365, DOI 10.1111/j.1574-6976.2001.tb00583.x; Winson MK, 1998, FEMS MICROBIOL LETT, V163, P185, DOI 10.1111/j.1574-6968.1998.tb13044.x; Yu J, 1999, MICROBES INFECT, V1, P1221, DOI 10.1016/S1286-4579(99)00239-7	50	39	42	0	8	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	AUG 29	2008	283	35					23739	23753		10.1074/jbc.M801829200	http://dx.doi.org/10.1074/jbc.M801829200			15	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	340II	18562317	Green Published, hybrid			2022-12-27	WOS:000258638900028
J	Guo, Q; Jureller, JE; Warren, JT; Solomaha, E; Florian, J; Tang, WJ				Guo, Qing; Jureller, Justin E.; Warren, Julia T.; Solomaha, Elena; Florian, Jan; Tang, Wei-Jen			Protein-protein docking and analysis reveal that two homologous bacterial adenylyl cyclase toxins interact with calmodulin differently	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							FREE-ENERGY CALCULATIONS; BINDING FREE-ENERGIES; ANTHRAX EDEMA FACTOR; MOLECULAR-DYNAMICS; TARGET RECOGNITION; CRYSTAL-STRUCTURE; STRUCTURAL BASIS; PEPTIDE COMPLEX; APO-CALMODULIN; HIV PROTEASE	Calmodulin (CaM), a eukaryotic calcium sensor that regulates diverse biological activities, consists of N- and C-terminal globular domains (N-CaM and C-CaM, respectively). CaM serves as the activator of CyaA, a 188-kDa adenylyl cyclase toxin secreted by Bordetella pertussis, which is the etiologic agent for whooping cough. Upon insertion of the N-terminal adenylyl cyclase domain (ACD) of CyaA to its targeted eukaryotic cells, CaM binds to this domain tightly (similar to 200 pM affinity). This interaction activates the adenylyl cyclase activity of CyaA, leading to a rise in intracellular cAMP levels to disrupt normal cellular signaling. We recently solved the structure of CyaA-ACD in complex with C-CaM to elucidate the mechanism of catalytic activation. However, the structure of the interface between N-CaM and CyaA, the formation of which contributes a 400-fold increase of binding affinity between CyaA and CaM, remains elusive. Here, we used site-directed mutations and molecular dynamic simulations to generate several working models of CaM-bound CyaA-ACD. The validity of these models was evaluated by disulfide bond cross-linking, point mutations, and fluorescence resonance energy transfer experiments. Our study reveals that a beta-hairpin region (amino acids 259-273) of CyaA-ACD likely makes contacts with the second calcium binding motif of the extended CaM. This mode of interaction differs from the interaction of N-CaM with anthrax edema factor, which binds N-CaM via its helical domain. Thus, two structurally conserved, bacterial adenylyl cyclase toxins have evolved to utilize distinct binding surfaces and modes of activation in their interaction with CaM, a highly conserved eukaryotic signaling protein.	[Jureller, Justin E.] Univ Chicago, Inst Biophys Dynam, NanoBiol Facil, Chicago, IL 60637 USA; [Warren, Julia T.] Univ Chicago, Biol Sci Collegiate Div, Chicago, IL 60637 USA; [Solomaha, Elena] Univ Chicago, Biophys Core Facil, Chicago, IL 60637 USA; [Florian, Jan] Loyola Univ Chicago, Dept Chem, Chicago, IL 60626 USA; [Guo, Qing; Tang, Wei-Jen] Univ Chicago, Ben May Dept Canc Biol, Chicago, IL 60637 USA	University of Chicago; University of Chicago; University of Chicago; Loyola University Chicago; University of Chicago	Tang, WJ (corresponding author), Univ Chicago, Ben May Dept Canc Res, 929 E 57th St, Chicago, IL 60637 USA.	wtang@uchicago.edu	Florian, Jan/E-1554-2012	Florian, Jan/0000-0003-2669-4293; Warren, Julia/0000-0003-2017-6444; Tang, Wei-Jen/0000-0002-8267-8995	National Institutes of Health [GM62548]; Howard Hughes Medical Institute Undergraduate Research Fellowship; Institute for Biophysical Dynamics Yen Postdoctoral Fellowship; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM062548] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Howard Hughes Medical Institute Undergraduate Research Fellowship(Howard Hughes Medical Institute); Institute for Biophysical Dynamics Yen Postdoctoral Fellowship; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported, in whole or in part, by National Institutes of Health Grant GM62548 (to W.-J.T.). This work was also supported by a Howard Hughes Medical Institute Undergraduate Research Fellowship (to J. T. W.) and an Institute for Biophysical Dynamics Yen Postdoctoral Fellowship (to J. E. J.). The costs of publication of this article were defrayed in part by the payment of page charges. This article must therefore be hereby marked "advertisement" in accordance with 18 U.S.C. Section 1734 solely to indicate this fact.	Almlof M, 2006, BIOPHYS J, V90, P433, DOI 10.1529/biophysj.105.073239; Aqvist J, 2002, ACCOUNTS CHEM RES, V35, P358, DOI 10.1021/ar010014p; AQVIST J, 1994, PROTEIN ENG, V7, P385, DOI 10.1093/protein/7.3.385; BABU YS, 1985, NATURE, V315, P37, DOI 10.1038/315037a0; Becker W, 2005, ADV TIME CORRELATED; Bertini I, 2004, P NATL ACAD SCI USA, V101, P6841, DOI 10.1073/pnas.0308641101; Bhattacharya S, 2004, BBA-MOL CELL RES, V1742, P69, DOI 10.1016/j.bbamcr.2004.09.002; Bonvin AM, 2006, CURR OPIN STRUC BIOL, V16, P194, DOI 10.1016/j.sbi.2006.02.002; Brandsdal BO, 2001, PROTEIN SCI, V10, P1584, DOI 10.1110/ps.940101; CHATTOPADHYAYA R, 1992, J MOL BIOL, V228, P1177, DOI 10.1016/0022-2836(92)90324-D; Chen R, 2003, PROTEINS, V52, P80, DOI 10.1002/prot.10389; CORNELL SJ, 1995, PHYS REV LETT, V75, P2250, DOI 10.1103/PhysRevLett.75.2250; Dombkowski AA, 2003, BIOINFORMATICS, V19, P1852, DOI 10.1093/bioinformatics/btg231; Drum CL, 2002, NATURE, V415, P396, DOI 10.1038/415396a; Eldik LV, 1998, CALMODULIN SIGNAL TR; Fallon JL, 2003, STRUCTURE, V11, P1303, DOI 10.1016/j.str.2003.09.004; FARRAR YJK, 1993, J BIOL CHEM, V268, P4120; FINN BE, 1995, NAT STRUCT BIOL, V2, P777, DOI 10.1038/nsb0995-777; Florian J, 2002, J PHYS CHEM B, V106, P5739, DOI 10.1021/jp020790u; Grabarek Z, 2005, J MOL BIOL, V346, P1351, DOI 10.1016/j.jmb.2005.01.004; Gray JJ, 2003, J MOL BIOL, V331, P281, DOI 10.1016/S0022-2836(03)00670-3; Guo Q, 2005, EMBO J, V24, P3190, DOI 10.1038/sj.emboj.7600800; Guo Q, 2004, J BIOL CHEM, V279, P29427, DOI 10.1074/jbc.M402689200; Hansson T, 1998, J COMPUT AID MOL DES, V12, P27, DOI 10.1023/A:1007930623000; Hayashi N, 2000, PROTEIN SCI, V9, P1905, DOI 10.1110/ps.9.10.1905; Heifetz A, 2007, PROTEINS, V69, P816, DOI 10.1002/prot.21734; Hoeflich KP, 2002, CELL, V108, P739, DOI 10.1016/S0092-8674(02)00682-7; Houdusse A, 2006, P NATL ACAD SCI USA, V103, P19326, DOI 10.1073/pnas.0609436103; HUDSON EN, 1973, BIOCHEMISTRY-US, V12, P4154, DOI 10.1021/bi00745a019; Humphrey W, 1996, J MOL GRAPH MODEL, V14, P33, DOI 10.1016/0263-7855(96)00018-5; Ishikita H, 2008, ANGEW CHEM INT EDIT, V47, P697, DOI 10.1002/anie.200704178; Johnson KA, 2006, EMBO J, V25, P1977, DOI 10.1038/sj.emboj.7601080; JORGENSEN WL, 1983, J CHEM PHYS, V79, P926, DOI 10.1063/1.445869; Krueger JK, 2001, J BIOL CHEM, V276, P4535, DOI 10.1074/jbc.C000857200; KUBONIWA H, 1995, NAT STRUCT BIOL, V2, P768, DOI 10.1038/nsb0995-768; Lacy DB, 2005, P NATL ACAD SCI USA, V102, P16409, DOI 10.1073/pnas.0508259102; Ladant D, 1999, TRENDS MICROBIOL, V7, P172, DOI 10.1016/S0966-842X(99)01468-7; Lakowicz J.R., 2006, PRINCIPLES FLUORESCE; LEE FS, 1992, PROTEIN ENG, V5, P215, DOI 10.1093/protein/5.3.215; LEE SY, 1992, BRIT J MATH STAT PSY, V45, P93, DOI 10.1111/j.2044-8317.1992.tb00979.x; Marelius J, 1998, J MOL GRAPH MODEL, V16, P213, DOI 10.1016/S1093-3263(99)00012-1; MEADOR WE, 1993, SCIENCE, V262, P1718, DOI 10.1126/science.8259515; MEADOR WE, 1992, SCIENCE, V257, P1251, DOI 10.1126/science.1519061; Moens PDJ, 2005, BIOCHEMISTRY-US, V44, P3298, DOI 10.1021/bi048015n; Morris GM, 1998, J COMPUT CHEM, V19, P1639, DOI 10.1002/(SICI)1096-987X(19981115)19:14<1639::AID-JCC10>3.0.CO;2-B; Osawa M, 1999, NAT STRUCT BIOL, V6, P819; Remenyi A, 2006, CURR OPIN STRUC BIOL, V16, P676, DOI 10.1016/j.sbi.2006.10.008; Schneidman-Duhovny D, 2005, PROTEINS, V60, P224, DOI 10.1002/prot.20562; Schumacher MA, 2001, NATURE, V410, P1120, DOI 10.1038/35074145; Sham YY, 2000, PROTEINS, V39, P393, DOI 10.1002/(SICI)1097-0134(20000601)39:4<393::AID-PROT120>3.3.CO;2-8; Shen YQ, 2005, EMBO J, V24, P929, DOI 10.1038/sj.emboj.7600574; Shen YQ, 2002, EMBO J, V21, P6721, DOI 10.1093/emboj/cdf681; Shen YQ, 2006, NATURE, V443, P870, DOI 10.1038/nature05143; TREWHELLA J, 1992, CELL CALCIUM, V13, P377, DOI 10.1016/0143-4160(92)90051-S; Ulmer TS, 2003, J BIOL CHEM, V278, P29261, DOI 10.1074/jbc.M302837200; Van Petegem F, 2005, NAT STRUCT MOL BIOL, V12, P1108, DOI 10.1038/nsmb1027; Wang EZ, 1997, BIOCHEMISTRY-US, V36, P15026, DOI 10.1021/bi963075h; Warren JT, 2007, J MOL BIOL, V374, P517, DOI 10.1016/j.jmb.2007.09.048; Wilson MA, 2000, J MOL BIOL, V301, P1237, DOI 10.1006/jmbi.2000.4029; ZHANG M, 1995, NAT STRUCT BIOL, V2, P758, DOI 10.1038/nsb0995-758	60	24	24	0	1	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	AUG 29	2008	283	35					23836	23845		10.1074/jbc.M802168200	http://dx.doi.org/10.1074/jbc.M802168200			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	340II	18583346	Green Published, hybrid			2022-12-27	WOS:000258638900038
J	Lucero, HA; Ravid, K; Grimsby, JL; Rich, CB; DiCamillo, SJ; Maki, JM; Myllyharju, J; Kagan, HM				Lucero, Hector A.; Ravid, Katya; Grimsby, Jessica L.; Rich, Celeste B.; DiCamillo, Sandra J.; Maki, Joni M.; Myllyharju, Johanna; Kagan, Herbert M.			Lysyl oxidase oxidizes cell membrane proteins and enhances the chemotactic response of vascular smooth muscle cells	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							BETA-AMINOPROPIONITRILE; SIGNAL-TRANSDUCTION; BIOLOGICAL SAMPLES; FIBROGENIC CELLS; MESSENGER-RNA; CROSS-LINKING; MIGRATION; OXIDATION; ADHESION; COLLAGEN	Lysyl oxidase (LOX) is a potent chemokine inducing the migration of varied cell types. Here we demonstrate that inhibition of LOX activity by beta-aminopropionitrile ( BAPN) in cultured rat aortic smooth muscle cells (SMCs) reduced the chemotactic response and sensitivity of these cells toward LOX and toward PDGF-BB. The chemotactic activity of PDGF-BB was significantly enhanced in the presence of a non-chemotactic concentration of LOX. We considered the possibility that extracellular LOX may oxidize cell surface proteins, including the PDGF receptor-beta (PDGFR-beta), to affect PDGF-BB-induced chemotaxis. Plasma membranes purified from control SMC contained oxidized PDGFR-beta. The oxidation of this receptor and other membrane proteins was largely prevented in cells preincubated with BAPN. Addition of purified LOX to these cells restored the profile of oxidized proteins toward that of control cells. The high affinity and capacity for the binding of PDGF-BB by cells containing oxidized PDGFR-beta was diminished by similar to 2-fold when compared with cells in which oxidation by LOX was prevented by BAPN. Phosphorylated members of the PDGFR-beta dependent signal transduction pathway, including PDGFR-beta, SHP2, AKT1, and ERK1/ERK2 (p44/42 MAPK), turned over faster in BAPN-treated than in control SMCs. LOX knock-out mouse embryonic fibroblasts mirrored the effect obtained with SMCs treated with BAPN. These novel findings suggest that LOX activity is essential to generate optimal chemotactic sensitivity of cells to chemoattractants by oxidizing specific cell surface proteins, such as PDGFR-beta.	[Lucero, Hector A.; Ravid, Katya; Grimsby, Jessica L.; Rich, Celeste B.; DiCamillo, Sandra J.; Kagan, Herbert M.] Boston Univ, Dept Biochem, Sch Med, Boston, MA 02118 USA; [Maki, Joni M.; Myllyharju, Johanna] Univ Oulu, Collagen Res Unit, Bioctr Oulu, FIN-90014 Oulu, Finland; [Maki, Joni M.; Myllyharju, Johanna] Univ Oulu, Dept Med Biochem & Mol Biol, FIN-90014 Oulu, Finland	Boston University; University of Oulu; University of Oulu	Lucero, HA (corresponding author), Boston Univ, Dept Biochem, Sch Med, 715 Albany St, Boston, MA 02118 USA.	hlucero@bu.edu		Ravid, Katya/0000-0002-9918-3024	National Institutes of Health [HL13262-31]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [P01HL013262] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	This work was supported, in whole or in part, by National Institutes of Health Grant HL13262-31 ( to H. K. and K. R.). The costs of publication of this article were defrayed in part by the payment of page charges. This article must therefore be hereby marked "advertisement" in accordance with 18 U. S. C. Section 1734 solely to indicate this fact.	Bardwell AJ, 2001, J BIOL CHEM, V276, P10374, DOI 10.1074/jbc.M010271200; BOLTON AE, 1973, BIOCHEM J, V133, P529, DOI 10.1042/bj1330529; Bouez C, 2006, CLIN CANCER RES, V12, P1463, DOI 10.1158/1078-0432.CCR-05-1456; Bulut T, 2004, J INVEST SURG, V17, P211, DOI 10.1080/08941930490472028; Csiszar K, 2001, PROG NUCLEIC ACID RE, V70, P1, DOI 10.1016/S0079-6603(01)70012-8; Davies KJA, 2001, BIOCHIMIE, V83, P301, DOI 10.1016/S0300-9084(01)01250-0; Dean RT, 1997, BIOCHEM J, V324, P1; Erler JT, 2006, NATURE, V440, P1222, DOI 10.1038/nature04695; Farjanel J, 2005, OSTEOARTHR CARTILAGE, V13, P120, DOI 10.1016/j.joca.2004.06.015; Franke TF, 1997, SCIENCE, V275, P665, DOI 10.1126/science.275.5300.665; Genestra M, 2007, CELL SIGNAL, V19, P1807, DOI 10.1016/j.cellsig.2007.04.009; Giampuzzi M, 2000, J BIOL CHEM, V275, P36341, DOI 10.1074/jbc.M003362200; Giampuzzi M, 2003, BBA-PROTEINS PROTEOM, V1647, P239, DOI 10.1016/S1570-9639(03)00058-X; Gilad GM, 2001, EUR J PHARMACOL, V430, P69, DOI 10.1016/S0014-2999(01)01354-1; Heldin CH, 1998, BBA-REV CANCER, V1378, pF79, DOI 10.1016/S0304-419X(98)00015-8; Jeay S, 2003, MOL CELL BIOL, V23, P2251, DOI 10.1128/MCB.23.7.2251-2263.2003; KAGAN HM, 1995, METHOD ENZYMOL, V258, P122; KAGAN HM, 1984, J BIOL CHEM, V259, P1203; KAGAN HM, 1981, ARTERIOSCLEROSIS, V1, P287, DOI 10.1161/01.ATV.1.4.287; Karlsson S, 2006, MOL BIOL CELL, V17, P4846, DOI 10.1091/mbc.E06-04-0306; KENYON K, 1991, SCIENCE, V253, P802, DOI 10.1126/science.1678898; Kirschmann DA, 2002, CANCER RES, V62, P4478; Klippel A, 1997, MOL CELL BIOL, V17, P338, DOI 10.1128/MCB.17.1.338; Laczko R, 2007, NEUROPATH APPL NEURO, V33, P631, DOI 10.1111/j.1365-2990.2007.00858.x; Lazarus HM, 1995, MATRIX BIOL, V14, P727, DOI 10.1016/S0945-053X(05)80015-0; Leskovac V, 2005, INT J BIOCHEM CELL B, V37, P731, DOI 10.1016/j.biocel.2004.10.014; Li WD, 2000, J CELL BIOCHEM, V78, P550, DOI 10.1002/1097-4644(20000915)78:4<550::AID-JCB4>3.3.CO;2-#; Li WD, 1997, P NATL ACAD SCI USA, V94, P12817, DOI 10.1073/pnas.94.24.12817; Liu XQ, 2004, NAT GENET, V36, P178, DOI 10.1038/ng1297; Lucero HA, 2006, CELL MOL LIFE SCI, V63, P2304, DOI 10.1007/s00018-006-6149-9; Maki JM, 2005, AM J PATHOL, V167, P927, DOI 10.1016/S0002-9440(10)61183-2; Maki JM, 2002, CIRCULATION, V106, P2503, DOI 10.1161/01.CIR.0000038109.84500.1E; NAGAN N, 1994, J BIOL CHEM, V269, P22366; Nellaiappan K, 2000, J CELL BIOCHEM, V79, P576, DOI 10.1002/1097-4644(20001215)79:4<576::AID-JCB60>3.0.CO;2-A; NELSON JM, 1988, P SOC EXP BIOL MED, V188, P346; Palamakumbura AH, 2002, ANAL BIOCHEM, V300, P245, DOI 10.1006/abio.2001.5464; Panchenko MV, 1996, J BIOL CHEM, V271, P7113, DOI 10.1074/jbc.271.12.7113; Payne SL, 2005, CANCER RES, V65, P11429, DOI 10.1158/0008-5472.CAN-05-1274; Payne SL, 2007, J CELL BIOCHEM, V101, P1338, DOI 10.1002/jcb.21371; PINNELL SR, 1968, P NATL ACAD SCI USA, V61, P708, DOI 10.1073/pnas.61.2.708; Ronnstrand L, 2001, INT J CANCER, V91, P757, DOI 10.1002/1097-0215(200002)9999:9999<::AID-IJC1136>3.0.CO;2-J; SCHREIBER BM, 1988, ATHEROSCLEROSIS, V69, P69, DOI 10.1016/0021-9150(88)90290-0; Shacter E, 2000, DRUG METAB REV, V32, P307, DOI 10.1081/DMR-100102336; Shimokado K, 1997, ANN NY ACAD SCI, V811, P130, DOI 10.1111/j.1749-6632.1997.tb51995.x; Stadtman ER, 2006, FREE RADICAL RES, V40, P1250, DOI 10.1080/10715760600918142; SUNDARESAN M, 1995, SCIENCE, V270, P296, DOI 10.1126/science.270.5234.296; TANG SS, 1983, J BIOL CHEM, V258, P4331; TANG SS, 1989, CONNECT TISSUE RES, V19, P93, DOI 10.3109/03008208909016817; Thomassin L, 2005, J BIOL CHEM, V280, P42848, DOI 10.1074/jbc.M506832200; TOSELLI P, 1992, MATRIX, V12, P321, DOI 10.1016/S0934-8832(11)80084-3; Veal EA, 2007, MOL CELL, V26, P1, DOI 10.1016/j.molcel.2007.03.016; Vogel W, 1996, CELL GROWTH DIFFER, V7, P1589; Wang SX, 1996, SCIENCE, V273, P1078, DOI 10.1126/science.273.5278.1078; WOLFE LB, 1993, J BIOL CHEM, V268, P12418	54	66	70	1	9	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	AUG 29	2008	283	35					24103	24117		10.1074/jbc.M709897200	http://dx.doi.org/10.1074/jbc.M709897200			15	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	340II	18586678	Green Published, hybrid			2022-12-27	WOS:000258638900064
J	Wallander, ML; Zumbrennen, KB; Rodansky, ES; Romney, SJ; Leibold, EA				Wallander, Michelle L.; Zumbrennen, Kimberly B.; Rodansky, Eva S.; Romney, S. Joshua; Leibold, Elizabeth A.			Iron-independent phosphorylation of iron regulatory protein 2 regulates ferritin during the cell cycle	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ELEMENT-BINDING-PROTEIN; RESPONSIVE ELEMENT; TRANSFERRIN RECEPTORS; TARGETED DELETION; PHOSPHATASE CDC14; MOLECULAR CONTROL; RNA-BINDING; EXPRESSION; IDENTIFICATION; DEGRADATION	Iron regulatory protein 2 (IRP2) is a key iron sensor that post-transcriptionally regulates mammalian iron homeostasis by binding to iron- responsive elements ( IREs) in mRNAs that encode proteins involved in iron metabolism ( e. g. ferritin and transferrin receptor 1). During iron deficiency, IRP2 binds IREs to regulate mRNA translation or stability, whereas during iron sufficiency IRP2 is degraded by the proteasome. Here, we identify an iron- independent IRP2 phosphorylation site that is regulated by the cell cycle. IRP2 Ser- 157 is phosphorylated by Cdk1/ cyclin B1 during G2/ M and is dephosphorylated during mitotic exit by the phosphatase Cdc14A. Ser- 157 phosphorylation during G2/ M reduces IRP2 RNA- binding activity and increases ferritin synthesis, whereas Ser- 157 dephosphorylation during mitotic exit restores IRP2 RNA- binding activity and represses ferritin synthesis. These data show that reversible phosphorylation of IRP2 during G2/ M has a role in modulating the iron- independent expression of ferritin and other IRE- containing mRNAs during the cell cycle.	[Rodansky, Eva S.; Romney, S. Joshua; Leibold, Elizabeth A.] Univ Utah, Eccles Program Human Mol Biol & Genet, Salt Lake City, UT 84112 USA; [Wallander, Michelle L.; Zumbrennen, Kimberly B.; Leibold, Elizabeth A.] Univ Utah, Dept Oncol Sci, Salt Lake City, UT 84112 USA; [Leibold, Elizabeth A.] Univ Utah, Dept Med, Salt Lake City, UT 84112 USA	Utah System of Higher Education; University of Utah; Utah System of Higher Education; University of Utah; Utah System of Higher Education; University of Utah	Leibold, EA (corresponding author), Univ Utah, Eccles Program Human Mol Biol & Genet, 15 N 2030 E,Rm 3240A, Salt Lake City, UT 84112 USA.	betty.leibold@genetics.utah.edu			NATIONAL CANCER INSTITUTE [P30CA042014] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [T32DK007115] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM045201] Funding Source: NIH RePORTER; NCI NIH HHS [2P30 CA 42014] Funding Source: Medline; NIDDK NIH HHS [2T32 DK 007115] Funding Source: Medline; NIGMS NIH HHS [R01 GM 045201] Funding Source: Medline	NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NIDDK NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		Bembenek J, 2001, J BIOL CHEM, V276, P48237, DOI 10.1074/jbc.M108126200; Blethrow JD, 2008, P NATL ACAD SCI USA, V105, P1442, DOI 10.1073/pnas.0708966105; Boucrot E, 2007, P NATL ACAD SCI USA, V104, P7939, DOI 10.1073/pnas.0702511104; Bourdon E, 2003, BLOOD CELL MOL DIS, V31, P247, DOI 10.1016/S1079-9796(03)00161-X; Brown NM, 1998, P NATL ACAD SCI USA, V95, P15235, DOI 10.1073/pnas.95.26.15235; Buss JL, 2003, CURR MED CHEM, V10, P1021, DOI 10.2174/0929867033457638; CHITAMBAR CR, 1983, J CLIN INVEST, V72, P1314, DOI 10.1172/JCI111087; Cho HP, 2005, MOL CELL BIOL, V25, P4541, DOI 10.1128/MCB.25.11.4541-4551.2005; Clarke SL, 2006, EMBO J, V25, P544, DOI 10.1038/sj.emboj.7600954; Cmejla R, 2006, BIOCHEM BIOPH RES CO, V341, P158, DOI 10.1016/j.bbrc.2005.12.155; Cooperman SS, 2005, BLOOD, V106, P1084, DOI 10.1182/blood-2004-12-4703; COX TC, 1991, EMBO J, V10, P1891, DOI 10.1002/j.1460-2075.1991.tb07715.x; Cozzi A, 2000, J BIOL CHEM, V275, P25122, DOI 10.1074/jbc.M003797200; Dunn LL, 2007, TRENDS CELL BIOL, V17, P93, DOI 10.1016/j.tcb.2006.12.003; EISENSTEIN RS, 1993, J BIOL CHEM, V268, P27363; FRAZIER JL, 1982, J CLIN INVEST, V69, P853, DOI 10.1172/JCI110525; Fu D, 2007, BLOOD, V110, P752, DOI 10.1182/blood-2007-03-076737; GALBRAITH RM, 1981, IMMUNOLOGY, V44, P703; Galy B, 2005, BLOOD, V106, P2580, DOI 10.1182/blood-2005-04-1365; Gao J, 2001, BLOOD, V98, P842, DOI 10.1182/blood.V98.3.842; Goto H, 1999, J BIOL CHEM, V274, P25543, DOI 10.1074/jbc.274.36.25543; Gottesfeld JM, 1997, TRENDS BIOCHEM SCI, V22, P197, DOI 10.1016/S0968-0004(97)01045-1; Gray NK, 1996, P NATL ACAD SCI USA, V93, P4925, DOI 10.1073/pnas.93.10.4925; GUO B, 1994, J BIOL CHEM, V269, P24252; HAILE DJ, 1992, P NATL ACAD SCI USA, V89, P7536, DOI 10.1073/pnas.89.16.7536; Hanson ES, 1999, J BIOL CHEM, V274, P5047, DOI 10.1074/jbc.274.8.5047; Hanson ES, 1998, J BIOL CHEM, V273, P7588, DOI 10.1074/jbc.273.13.7588; Hanson ES, 2003, J BIOL CHEM, V278, P40337, DOI 10.1074/jbc.M302798200; Hentze MW, 2004, CELL, V117, P285, DOI 10.1016/S0092-8674(04)00343-5; IWAI K, 1995, EMBO J, V14, P5350, DOI 10.1002/j.1460-2075.1995.tb00219.x; Kaiser BK, 2002, MOL BIOL CELL, V13, P2289, DOI 10.1091/mbc.01-11-0535; Kakhlon O, 2001, BLOOD, V97, P2863, DOI 10.1182/blood.V97.9.2863; Kulp KS, 1996, EXP CELL RES, V229, P60, DOI 10.1006/excr.1996.0343; Lanzetti L, 2007, J BIOL CHEM, V282, P15258, DOI 10.1074/jbc.M700914200; LARRICK JW, 1979, J SUPRAMOL STR CELL, V11, P579, DOI 10.1002/jss.400110415; LaVaute T, 2001, NAT GENET, V27, P209, DOI 10.1038/84859; Le NTV, 2002, BBA-REV CANCER, V1603, P31, DOI 10.1016/S0304-419X(02)00068-9; LEIBOLD EA, 1988, P NATL ACAD SCI USA, V85, P2171, DOI 10.1073/pnas.85.7.2171; Li LW, 1997, J BIOL CHEM, V272, P29403, DOI 10.1074/jbc.272.47.29403; MacDonald JA, 2002, MOL CELL PROTEOMICS, V1, P314, DOI 10.1074/mcp.M200002-MCP200; Mackey AJ, 2003, NUCLEIC ACIDS RES, V31, P3859, DOI 10.1093/nar/gkg513; Mailand N, 2002, NAT CELL BIOL, V4, P317, DOI 10.1038/ncb777; Malumbres M, 2005, TRENDS BIOCHEM SCI, V30, P630, DOI 10.1016/j.tibs.2005.09.005; Meyron-Holtz EG, 2004, SCIENCE, V306, P2087, DOI 10.1126/science.1103786; Meyron-Holtz EG, 2004, EMBO J, V23, P386, DOI 10.1038/sj.emboj.7600041; Nie GJ, 2006, BLOOD, V108, P2428, DOI 10.1182/blood-2006-04-018341; Nigg EA, 2001, NAT REV MOL CELL BIO, V2, P21, DOI 10.1038/35048096; NYHOLM S, 1993, J BIOL CHEM, V268, P26200; O'Donnell KA, 2006, MOL CELL BIOL, V26, P2373, DOI 10.1128/MCB.26.6.2373-2386.2006; Paulsen MT, 2006, MOL CANCER, V5, DOI 10.1186/1476-4598-5-25; Phillips JD, 1996, BIOCHEMISTRY-US, V35, P15704, DOI 10.1021/bi960653l; Pitula JS, 2004, P NATL ACAD SCI USA, V101, P10907, DOI 10.1073/pnas.0404308101; Rieder CL, 2004, DEV CELL, V7, P637, DOI 10.1016/j.devcel.2004.09.002; Rouault TA, 2006, NAT CHEM BIOL, V2, P406, DOI 10.1038/nchembio807; Sanchez M, 2007, NAT STRUCT MOL BIOL, V14, P420, DOI 10.1038/nsmb1222; Sanchez M, 2006, J BIOL CHEM, V281, P22865, DOI 10.1074/jbc.M603876200; Schalinske KL, 1996, J BIOL CHEM, V271, P7168, DOI 10.1074/jbc.271.12.7168; Schneider BD, 2003, BLOOD, V102, P3404, DOI 10.1182/blood-2003-02-0433; Schweitzer JK, 2005, J BIOL CHEM, V280, P41628, DOI 10.1074/jbc.M504497200; Shou WY, 1999, CELL, V97, P233, DOI 10.1016/S0092-8674(00)80733-3; Van Der Geer P., 1993, PROTEIN PHOSPHORYLAT, P31; Vazquez-Novelle MD, 2005, J BIOL CHEM, V280, P29144, DOI 10.1074/jbc.M413328200; Visintin R, 1998, MOL CELL, V2, P709, DOI 10.1016/S1097-2765(00)80286-5; Wallander ML, 2006, BBA-MOL CELL RES, V1763, P668, DOI 10.1016/j.bbamcr.2006.05.004; Wang J, 2004, MOL CELL BIOL, V24, P954, DOI 10.1128/MCB.24.3.954-965.2004; WARREN G, 1984, EMBO J, V3, P2217, DOI 10.1002/j.1460-2075.1984.tb02119.x; Yu Y, 2007, CELL CYCLE, V6, P1982, DOI 10.4161/cc.6.16.4603; Yu Y, 2006, CLIN CANCER RES, V12, P6876, DOI 10.1158/1078-0432.CCR-06-1954; Yuan K, 2007, J BIOL CHEM, V282, P27414, DOI 10.1074/jbc.M703555200	69	16	18	0	5	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	AUG 29	2008	283	35					23589	23598		10.1074/jbc.M803005200	http://dx.doi.org/10.1074/jbc.M803005200			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	340II	18574241	Green Published, hybrid			2022-12-27	WOS:000258638900011
J	Derangeon, M; Bourmeyster, N; Plaisance, I; Pinet-Charvet, C; Chen, Q; Duthe, F; Popoff, MR; Sarrouilhe, D; Herve, JC				Derangeon, Mickael; Bourmeyster, Nicolas; Plaisance, Isabelle; Pinet-Charvet, Caroline; Chen, Qian; Duthe, Fabien; Popoff, Michel R.; Sarrouilhe, Denis; Herve, Jean-Claude			RhoA GTPase and F-actin Dynamically Regulate the Permeability of Cx43-made Channels in Rat Cardiac Myocytes	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							GAP JUNCTIONAL COMMUNICATION; PROTEIN-KINASE; VENTRICULAR MYOCYTES; ZONULA OCCLUDENS-1; PLASMA-MEMBRANE; CULTURED ASTROCYTES; EPITHELIAL BARRIER; OSTEOBLASTIC CELLS; CA2+ CURRENT; CONNEXIN43	Gap junctions are clusters of transmembrane channels allowing a passive diffusion of ions and small molecules between adjacent cells. Connexin43, the main channel-forming protein expressed in ventricular myocytes, can associate with zonula occludens-1, a scaffolding protein linked to the actin cytoskeleton and to signal transduction molecules. The possible influence of Rho GTPases, major regulators of cellular junctions and of the actin cytoskeleton, in the modulation of gap junctional intercellular communication ( GJIC) was examined. The activation of RhoA by cytoxic necrotizing factor 1 markedly enhanced GJIC, whereas its specific inhibition by the Clostridium botulinum C3 exoenzyme significantly reduced it. RhoA activity affects GJIC without major cellular redistribution of junctional plaques or changes in the Cx43 phosphorylation pattern. As these GTPases frequently act via the cortical cytoskeleton, the importance of F-actin in the modulation of GJIC was investigated by means of agents interfering with actin polymerization. Cytoskeleton stabilization by phalloidin slowed down the kinetics of channel rundown in the absence of ATP, whereas its disruption by cytochalasin D rapidly and markedly reduced GJIC despite ATP presence. Cytoskeleton stabilization by phalloidin markedly reduced the consequences of RhoA activation or inactivation. This mechanism appears to be the first described capable to both up- or down-regulate GJIC through RhoA activation or, conversely, inhibition. The inhibition of Rho downstream kinase effectors had no effect on GJIC. The present results provide further insight into the gating and regulation of junctional channels and identify a new downstream target for the small G-protein RhoA.	[Derangeon, Mickael; Bourmeyster, Nicolas; Plaisance, Isabelle; Pinet-Charvet, Caroline; Chen, Qian; Duthe, Fabien; Sarrouilhe, Denis; Herve, Jean-Claude] Univ Poitiers, CNRS, Inst Physiol & Biol Cellulaires, UMR 6187, F-86022 Poitiers, France; [Popoff, Michel R.] Inst Pasteur, Unite Bacteries Anaerobies & Toxines, F-75724 Paris 15, France	Centre National de la Recherche Scientifique (CNRS); Universite de Poitiers; Le Reseau International des Instituts Pasteur (RIIP); Institut Pasteur Paris	Herve, JC (corresponding author), Univ Poitiers, CNRS, Inst Physiol & Biol Cellulaires, UMR 6187, 40 Ave Recteur Pineau, F-86022 Poitiers, France.	Jean.Claude.Herve@univ-poitiers.fr	derangeon, mickael/D-3606-2015	pinet, caroline/0000-0002-8440-0292; Bourmeyster, Nicolas/0000-0002-9563-5142	European Community Research and Technological Development Action [QLG1-CT-1999-00516]	European Community Research and Technological Development Action	This work was supported in part by grants from the European Community Research and Technological Development Action QLG1-CT-1999-00516. The costs of publication of this article were defrayed in part by the payment of page charges. This article must therefore be hereby marked " advertisement" in accordance with 18 U. S. C. Section 1734 solely to indicate this fact.	Akoyev V, 2007, CELL SIGNAL, V19, P958, DOI 10.1016/j.cellsig.2006.11.007; Anderson JM, 1996, CURR BIOL, V6, P382, DOI 10.1016/S0960-9822(02)00501-8; Anderson SC, 2002, INVEST OPHTH VIS SCI, V43, P978; Aoki H, 1998, CIRC RES, V82, P666, DOI 10.1161/01.RES.82.6.666; Barker RJ, 2001, CELL COMMUN ADHES, V8, P205, DOI 10.3109/15419060109080724; Barker RJ, 2002, CIRC RES, V90, P317, DOI 10.1161/hh0302.104471; Bishop AL, 2000, BIOCHEM J, V348, P241, DOI 10.1042/0264-6021:3480241; BOURMEYSTER N, 1992, BIOCHEMISTRY-US, V31, P12863, DOI 10.1021/bi00166a022; Bruewer M, 2004, AM J PHYSIOL-CELL PH, V287, pC327, DOI 10.1152/ajpcell.00087.2004; Butkevich E, 2004, CURR BIOL, V14, P650, DOI 10.1016/j.cub.2004.03.063; COOPER JA, 1987, J CELL BIOL, V105, P1473, DOI 10.1083/jcb.105.4.1473; Czyz J, 2005, INT J DEV BIOL, V49, P33, DOI 10.1387/ijdb.041835jc; Dabiri GA, 1997, P NATL ACAD SCI USA, V94, P9493, DOI 10.1073/pnas.94.17.9493; Deleze J, 2001, METH MOL B, V154, P313; DERANGEON M, 2007, ARCH MAL COEUR VAISS, V100, P313; Duthe F, 2001, AM J PHYSIOL-CELL PH, V281, pC1648, DOI 10.1152/ajpcell.2001.281.5.C1648; Etienne-Manneville S, 2002, NATURE, V420, P629, DOI 10.1038/nature01148; Fanning AS, 1998, J BIOL CHEM, V273, P29745, DOI 10.1074/jbc.273.45.29745; Giepmans BNG, 2001, CURR BIOL, V11, P1364, DOI 10.1016/S0960-9822(01)00424-9; Giepmans BNG, 1998, CURR BIOL, V8, P931, DOI 10.1016/S0960-9822(07)00375-2; Grounds HR, 2005, J CELL BIOCHEM, V95, P529, DOI 10.1002/jcb.20441; HALL A, 1994, ANNU REV CELL BIOL, V10, P31, DOI 10.1146/annurev.cb.10.110194.000335; Hartsock A, 2008, BBA-BIOMEMBRANES, V1778, P660, DOI 10.1016/j.bbamem.2007.07.012; Herve JC, 2006, PROG BIOPHYS MOL BIO, V90, P225, DOI 10.1016/j.pbiomolbio.2005.06.005; Herve JC, 2007, PROG BIOPHYS MOL BIO, V94, P29, DOI 10.1016/j.pbiomolbio.2007.03.010; Hirose M, 1998, J CELL BIOL, V141, P1625, DOI 10.1083/jcb.141.7.1625; Hopkins AM, 2003, J CELL SCI, V116, P725, DOI 10.1242/jcs.00300; HUANG KP, 1982, J BIOL CHEM, V257, P3236; Hughes BA, 1998, AM J PHYSIOL-CELL PH, V275, pC1372, DOI 10.1152/ajpcell.1998.275.5.C1372; Hunter AW, 2005, MOL BIOL CELL, V16, P5686, DOI 10.1091/mbc.E05-08-0737; Ishizaki T, 2000, MOL PHARMACOL, V57, P976; Kamouchi M, 1997, J PHYSIOL-LONDON, V504, P545, DOI 10.1111/j.1469-7793.1997.545bd.x; KANTER HL, 1992, CIRC RES, V70, P438, DOI 10.1161/01.RES.70.2.438; Kim JH, 2007, BIOCHEM BIOPH RES CO, V352, P503, DOI 10.1016/j.bbrc.2006.11.051; Kostetskii I, 2005, CIRC RES, V96, P346, DOI 10.1161/01.RES.0000156274.72390.2c; Lader AS, 1999, AM J PHYSIOL-CELL PH, V277, pC1277, DOI 10.1152/ajpcell.1999.277.6.C1277; LAEMMLI UK, 1970, NATURE, V227, P680, DOI 10.1038/227680a0; Laing JG, 2007, CARDIOVASC PATHOL, V16, P159, DOI 10.1016/j.carpath.2007.01.004; Laing JG, 2005, J CELL SCI, V118, P2167, DOI 10.1242/jcs.02329; Laing JG, 2001, J BIOL CHEM, V276, P23051, DOI 10.1074/jbc.M100303200; Lampe PD, 2001, AM J PHYSIOL-CELL PH, V281, pC1211, DOI 10.1152/ajpcell.2001.281.4.C1211; Lerm M, 2002, INFECT IMMUN, V70, P4053, DOI 10.1128/IAI.70.8.4053-4058.2002; Li JF, 2005, CIRC RES, V97, P474, DOI 10.1161/01.RES.0000181132.11393.18; Luo Y, 2003, J CELL SCI, V116, P1471, DOI 10.1242/jcs.00339; Maass K, 2007, CIRC RES, V101, P1283, DOI 10.1161/CIRCRESAHA.107.162818; Marvaud JC, 2002, J BIOL CHEM, V277, P43659, DOI 10.1074/jbc.M207828200; Matsuda T, 2006, J MOL CELL CARDIOL, V40, P495, DOI 10.1016/j.yjmcc.2005.12.010; MCNICHOLAS CM, 1994, P NATL ACAD SCI USA, V91, P8077, DOI 10.1073/pnas.91.17.8077; Mironov SL, 1999, EUR J NEUROSCI, V11, P1831, DOI 10.1046/j.1460-9568.1999.00584.x; Nagy JI, 1997, EXP CELL RES, V236, P127, DOI 10.1006/excr.1997.3716; Piccoli G, 2004, J NEUROSCI, V24, P10918, DOI 10.1523/JNEUROSCI.4020-04.2004; Plaisance I, 2003, PFLUG ARCH EUR J PHY, V447, P181, DOI 10.1007/s00424-003-1158-0; Postma FR, 1998, J CELL BIOL, V140, P1199, DOI 10.1083/jcb.140.5.1199; Rajashree R, 2005, AM J PHYSIOL-HEART C, V289, pH1736, DOI 10.1152/ajpheart.00318.2004; Rouach N, 2006, EUR J NEUROSCI, V23, P1453, DOI 10.1111/j.1460-9568.2006.04671.x; Sarrouilhe D, 1998, BBA-MOL CELL RES, V1403, P199, DOI 10.1016/S0167-4889(98)00038-X; Sezgin M, 2004, J ELECTRON IMAGING, V13, P146, DOI 10.1117/1.1631315; Shumilina EV, 2003, FEBS LETT, V547, P27, DOI 10.1016/S0014-5793(03)00663-X; SUGIURA H, 1990, CIRC RES, V66, P1095, DOI 10.1161/01.RES.66.4.1095; TADVALKAR G, 1983, J CELL BIOL, V96, P1279, DOI 10.1083/jcb.96.5.1279; Tamkun MM, 2007, J CELL SCI, V120, P2413, DOI 10.1242/jcs.007351; Theiss C, 2002, EXP CELL RES, V281, P197, DOI 10.1006/excr.2002.5652; Thorburn J, 1997, EMBO J, V16, P1888, DOI 10.1093/emboj/16.8.1888; Toyofuku T, 1998, J BIOL CHEM, V273, P12725, DOI 10.1074/jbc.273.21.12725; Uehata M, 1997, NATURE, V389, P990, DOI 10.1038/40187; van Zeijl L, 2007, J CELL BIOL, V177, P881, DOI 10.1083/jcb.200610144; Verrecchia F, 1997, PFLUG ARCH EUR J PHY, V434, P113, DOI 10.1007/s004240050370; Verrecchia F, 1999, J PHYSIOL-LONDON, V516, P447, DOI 10.1111/j.1469-7793.1999.0447v.x; Verrecchia F, 1997, AM J PHYSIOL-CELL PH, V272, pC875, DOI 10.1152/ajpcell.1997.272.3.C875; WADE MH, 1986, SCIENCE, V232, P525, DOI 10.1126/science.3961495; WANG YJ, 1995, J CELL SCI, V108, P3501; Wang ZR, 2004, AM J PHYSIOL-HEART C, V286, pH749, DOI 10.1152/ajpheart.00398.2003; Wheelock MJ, 2003, CURR OPIN CELL BIOL, V15, P509, DOI 10.1016/S0955-0674(03)00101-7; Wherlock M, 2002, J CELL SCI, V115, P239; Yamane Y, 2002, NEUROSCIENCE, V112, P593, DOI 10.1016/S0306-4522(02)00095-7; Yatani A, 2005, AM J PHYSIOL-HEART C, V288, pH650, DOI 10.1152/ajpheart.00268.2004; Yin XY, 2000, J BIOL CHEM, V275, P6850, DOI 10.1074/jbc.275.10.6850; ZANDOMENI R, 1984, J BIOL CHEM, V259, P4804; Zhao ZS, 2005, BIOCHEM J, V386, P201, DOI 10.1042/BJ20041638; Zhu C, 2005, MICROSC MICROANAL, V11, P244, DOI 10.1017/S143192760505049X	80	39	39	0	5	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 7	2008	283	45					30754	30765		10.1074/jbc.M801556200	http://dx.doi.org/10.1074/jbc.M801556200			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	367ID	18667438	Green Published, hybrid			2022-12-27	WOS:000260544800030
J	Joshi, MC; Sharma, A; Kant, S; Birah, A; Gupta, GP; Khan, SR; Bhatnagar, R; Banerjee, N				Joshi, Mohan Chandra; Sharma, Animesh; Kant, Sashi; Birah, Ajanta; Gupta, Gorakh Prasad; Khan, Sharik R.; Bhatnagar, Rakesh; Banerjee, Nirupama			An insecticidal GroEL protein with chitin binding activity from Xenorhabdus nematophila	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							CHAPERONIN GROEL; MOLECULAR-BIOLOGY; CRYSTAL-STRUCTURE; ESCHERICHIA-COLI; PILIN SUBUNIT; RECOGNITION; STABILITY; MEMBRANE; RESIDUES; GROWTH	Xenorhabdus nematophila secretes insecticidal proteins to kill its larval prey. We have isolated an similar to 58-kDa GroEL homolog, secreted in the culture medium through outer membrane vesicles. The protein was orally insecticidal to the major crop pest Helicoverpa armigera with an LC50 of similar to 3.6 mu g/g diet. For optimal insecticidal activity all three domains of the protein, apical, intermediate, and equatorial, were necessary. The apical domain alone was able to bind to the larval gut membranes and manifest low level insecticidal activity. At equimolar concentrations, the apical domain contained approximately one-third and the apical-intermediate domain approximately one-half bioactivity of that of the full-length protein. Interaction of the protein with the larval gut membrane was specifically inhibited by N-acetylglucosamine and chito-oligosaccharides. Treatment of the larval gut membranes with chitinase abolished protein binding. Based on the three-dimensional structural model, mutational analysis demonstrated that surface-exposed residues Thr-347 and Ser-356 in the apical domain were crucial for both binding to the gut epithelium and insecticidal activity. Double mutant T347A,S356A was 80% less toxic (p < 0.001) than the wild type protein. The GroEL homolog showed alpha-chitin binding activity with K-d similar to 0.64 mu M and B-max similar to 4.68 mu mol/g chitin. The variation in chitin binding activity of the mutant proteins was in good agreement with membrane binding characteristics and insecticidal activity. The less toxic double mutant XnGroEL showed an similar to 8-fold increase of K-d in chitin binding assay. Our results demonstrate that X. nematophila secretes an insecticidal GroEL protein with chitin binding activity.	[Joshi, Mohan Chandra; Kant, Sashi; Khan, Sharik R.; Banerjee, Nirupama] Int Ctr Genet Engn & Biotechnol, New Delhi 110067, India; [Sharma, Animesh] Fuzzylife, Open Source Bioinformat Educ, New Delhi 110091, India; [Birah, Ajanta; Gupta, Gorakh Prasad] Indian Agr Res Inst, Div Entomol, New Delhi 110012, India; [Joshi, Mohan Chandra; Bhatnagar, Rakesh] Jawaharlal Nehru Univ, Sch Biotechnol, New Delhi 110067, India	Department of Biotechnology (DBT) India; International Center for Genetic Engineering & Biotechnology (ICGEB); International Center for Genetic Engineering & Biotechnology (ICGEB), New Delhi; Indian Council of Agricultural Research (ICAR); ICAR - Indian Agricultural Research Institute; Jawaharlal Nehru University, New Delhi	Banerjee, N (corresponding author), Int Ctr Genet Engn & Biotechnol, New Delhi 110067, India.		Kant, Sashi/V-3864-2019	Kant, Sashi/0000-0002-9015-8383; Joshi, Mohan/0000-0002-1808-771X	Department of Biotechnology, Government of India	Department of Biotechnology, Government of India(Department of Biotechnology (DBT) India)	This work was supported in part by the Department of Biotechnology, Government of India. The costs of publication of this article were defrayed in part by the payment of page charges. This article must therefore be hereby marked "advertisement" in accordance with 18 U.S.C. Section 1734 solely to indicate this fact.	Akhurst R., 2012, PARASITES PATHOGENS, P1; Altschul SF, 1997, NUCLEIC ACIDS RES, V25, P3389, DOI 10.1093/nar/25.17.3389; Bochkareva E, 1999, J BIOL CHEM, V274, P20756, DOI 10.1074/jbc.274.30.20756; Boisvert DC, 1996, NAT STRUCT BIOL, V3, P170, DOI 10.1038/nsb0296-170; Bonet J, 2006, PROTEINS, V63, P65, DOI 10.1002/prot.20791; Braig K, 1998, CURR OPIN STRUC BIOL, V8, P159, DOI 10.1016/S0959-440X(98)80033-X; Bukau B, 1998, CELL, V92, P351, DOI 10.1016/S0092-8674(00)80928-9; CIOFFI M, 1983, TISSUE CELL, V15, P781, DOI 10.1016/0040-8166(83)90050-2; CLARKE AR, 1985, BIOCHIM BIOPHYS ACTA, V829, P397, DOI 10.1016/0167-4838(85)90250-X; Dukan S, 1999, J BIOL CHEM, V274, P26027, DOI 10.1074/jbc.274.37.26027; Fares MA, 2002, MOL BIOL EVOL, V19, P1162, DOI 10.1093/oxfordjournals.molbev.a004174; FAYET O, 1989, J BACTERIOL, V171, P1379, DOI 10.1128/JB.171.3.1379-1385.1989; FENTON WA, 1994, NATURE, V371, P614, DOI 10.1038/371614a0; Fink AL, 1999, PHYSIOL REV, V79, P425, DOI 10.1152/physrev.1999.79.2.425; Forst S, 1996, MICROBIOL REV, V60, P21, DOI 10.1128/MMBR.60.1.21-43.1996; GOLDSTEIN MA, 1993, J BACTERIOL, V175, P5762, DOI 10.1128/JB.175.18.5762-5768.1993; Guo XF, 2002, J CARBOHYD CHEM, V21, P149, DOI 10.1081/CAR-120003746; Herbert EE, 2007, NAT REV MICROBIOL, V5, P634, DOI 10.1038/nrmicro1706; HOROVITZ A, 1993, J BIOL CHEM, V268, P9957; Jurat-Fuentes JL, 2004, EUR J BIOCHEM, V271, P3127, DOI 10.1111/j.1432-1033.2004.04238.x; Khandelwal P, 2004, BIOCHEM BIOPH RES CO, V314, P943, DOI 10.1016/j.bbrc.2003.12.187; Khandelwal P, 2004, J BACTERIOL, V186, P6465, DOI 10.1128/JB.186.19.6465-6476.2004; Khandelwal P, 2003, APPL ENVIRON MICROB, V69, P2032, DOI 10.1128/AEM.69.4.2032-2037.2003; KONI PA, 1994, MICROBIOL-SGM, V140, P1869, DOI 10.1099/13500872-140-8-1869; Merzendorfer H, 2003, J EXP BIOL, V206, P4393, DOI 10.1242/jeb.00709; Motojima F, 2004, P NATL ACAD SCI USA, V101, P15005, DOI 10.1073/pnas.0406132101; Pettersen EF, 2004, J COMPUT CHEM, V25, P1605, DOI 10.1002/jcc.20084; Phillips JC, 2005, J COMPUT CHEM, V26, P1781, DOI 10.1002/jcc.20289; Pigott CR, 2007, MICROBIOL MOL BIOL R, V71, P255, DOI 10.1128/MMBR.00034-06; Ranford JC, 2002, J CLIN PATHOL-MOL PA, V55, P209, DOI 10.1136/mp.55.4.209; Rice P, 2000, TRENDS GENET, V16, P276, DOI 10.1016/S0168-9525(00)02024-2; Schwede T, 2003, NUCLEIC ACIDS RES, V31, P3381, DOI 10.1093/nar/gkg520; Sicard M, 2004, APPL ENVIRON MICROB, V70, P6473, DOI 10.1128/AEM.70.11.6473-6480.2004; Sigler PB, 1998, ANNU REV BIOCHEM, V67, P581, DOI 10.1146/annurev.biochem.67.1.581; SIGLER PB, 1995, PHILOS T ROY SOC B, V348, P113, DOI 10.1098/rstb.1995.0052; Singh J, 1998, PROTEIN SCI, V7, P1124, DOI 10.1002/pro.5560070506; Surin AK, 1999, BIOORG KHIM+, V25, P358; THOMPSON JD, 1994, NUCLEIC ACIDS RES, V22, P4673, DOI 10.1093/nar/22.22.4673; Vaaje-Kolstad G, 2005, J BIOL CHEM, V280, P11313, DOI 10.1074/jbc.M407175200; Vashisht AA, 2005, PLANT J, V44, P76, DOI 10.1111/j.1365-313X.2005.02511.x; Wai SN, 2003, CELL, V115, P25, DOI 10.1016/S0092-8674(03)00754-2; Wan SZ, 2005, J IMMUNOL, V175, P1715, DOI 10.4049/jimmunol.175.3.1715; WARD ES, 1988, J MOL BIOL, V202, P527, DOI 10.1016/0022-2836(88)90283-5; Yoshida N, 2001, NATURE, V411, P44, DOI 10.1038/35075148; Zeltins A, 1997, EUR J BIOCHEM, V246, P557, DOI 10.1111/j.1432-1033.1997.t01-1-00557.x; Zhang SX, 2007, J COMPUT AID MOL DES, V21, P97, DOI 10.1007/s10822-007-9102-6	46	38	43	0	3	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	OCT 17	2008	283	42					28287	28296		10.1074/jbc.M804416200	http://dx.doi.org/10.1074/jbc.M804416200			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	359EN	18667427	Green Published, hybrid			2022-12-27	WOS:000259969300030
J	Rougemaille, M; Shankar, S; Braun, S; Rowley, M; Madhani, HD				Rougemaille, Mathieu; Shankar, Smita; Braun, Sigurd; Rowley, Margot; Madhani, Hiten D.			Ers1, a rapidly diverging protein essential for RNA interference-dependent heterochromatic silencing in Schizosaccharomyces pombe	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							FISSION YEAST; RITS; LOCALIZATION; METHYLATION	Centromeric silencing and heterochromatin formation in Schizosaccharomyces pombe require the RNA interference (RNAi) machinery. Three factors that mediate this mechanism have been identified: 1) the RNA-dependent RNA polymerase complex RdRC, 2) the Argonaute-containing RITS (RNA-induced initiation of transcriptional silencing) complex, and 3) the endoribonuclease Dicer ortholog Dcr1. S. pombe mutants lacking a new factor described here, Ers1, are completely defective in RNAi-dependent silencing of centromeric regions but, importantly, not in RNAi-independent silencing at the mat3M or tel2R loci. ers1 Delta cells likewise fail to convert centromeric pre-small interfering RNA transcripts into small interfering RNAs, are defective in histone H3Lys(9) methylation, and are unable to recruit the RITS complex to centromeric sequences. Surprisingly, Ers1 lacks obvious orthologs outside of the genus Schizosaccharomyces. Within this group, it is diverging rapidly, raising the possibility that it is coevolving with target RNA elements.	[Rougemaille, Mathieu; Shankar, Smita; Braun, Sigurd; Rowley, Margot; Madhani, Hiten D.] Univ Calif San Francisco, Dept Biochem & Biophys, San Francisco, CA 94143 USA	University of California System; University of California San Francisco	Madhani, HD (corresponding author), Univ Calif San Francisco, Dept Biochem & Biophys, San Francisco, CA 94143 USA.	hiten@biochem.ucsf.edu		Braun, Sigurd/0000-0001-6399-8574; Rougemaille, Mathieu/0000-0002-9675-3888; Madhani, Hiten/0000-0001-7400-6657	National Institutes of Health [R01GM063670]; Sandler Foundation; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM063670] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Sandler Foundation; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported, in whole or in part, by National Institutes of Health Grant R01GM063670 (to H. D. M.). This work was also supported by an Opportunity grant from the Sandler Foundation (to H. D. M.). The costs of publication of this article were defrayed in part by the payment of page charges. This article must therefore be hereby marked "advertisement" in accordance with 18 U. S. C. Section 1734 solely to indicate this fact.	Appelgren H, 2003, J CELL SCI, V116, P4035, DOI 10.1242/jcs.00707; Buhler M, 2007, CELL, V129, P707, DOI 10.1016/j.cell.2007.03.038; Deshpande G, 2005, GENE DEV, V19, P1680, DOI 10.1101/gad.1316805; LUMBSCH HT, 2007, MYCONET, V13, P1403; Matsuyama A, 2006, NAT BIOTECHNOL, V24, P841, DOI 10.1038/nbt1222; Mette MF, 2000, EMBO J, V19, P5194, DOI 10.1093/emboj/19.19.5194; Motamedi MR, 2004, CELL, V119, P789, DOI 10.1016/j.cell.2004.11.034; Noma K, 2004, NAT GENET, V36, P1174, DOI 10.1038/ng1452; Obbard DJ, 2006, CURR BIOL, V16, P580, DOI 10.1016/j.cub.2006.01.065; Pal-Bhadra M, 2004, SCIENCE, V303, P669, DOI 10.1126/science.1092653; Sadaie M, 2004, EMBO J, V23, P3825, DOI 10.1038/sj.emboj.7600401; UZAWA S, 1992, J CELL SCI, V101, P267; Verdel A, 2004, SCIENCE, V303, P672, DOI 10.1126/science.1093686; Volpe TA, 2002, SCIENCE, V297, P1833, DOI 10.1126/science.1074973	14	14	15	0	1	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	SEP 19	2008	283	38					25770	25773		10.1074/jbc.C800140200	http://dx.doi.org/10.1074/jbc.C800140200			4	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	348GX	18658154	Green Published, hybrid			2022-12-27	WOS:000259200100002
J	Wang, WH; Hullinger, RL; Andrisani, OM				Wang, Wen-Horng; Hullinger, Ronald L.; Andrisani, Ourania M.			Hepatitis B virus X protein via the p38MAPK pathway induces E2F1 release and ATR kinase activation mediating p53 apoptosis	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							DAMAGE-INDUCED PHOSPHORYLATION; TUMOR-SUPPRESSOR GENE; DNA-DAMAGE; CELL-LINES; HEPATOCELLULAR-CARCINOMA; MOLECULAR PATHOGENESIS; TARGET GENES; CHECKPOINT; EXPRESSION; TRANSCRIPTION	Hepatitis B virus (HBV) X protein (pX) is implicated in hepatocellular carcinoma (HCC) pathogenesis by an unknown mechanism. Deletions or mutations of genes involved in the p53 pathway are often associated with HBV-mediated HCC, indicating rescue from p53 apoptosis is a likely mechanism in HBV-HCC pathogenesis. Herein, we determined the mechanism by which pX sensitizes hepatocytes to p53-mediated apoptosis. Although it is well established that the Rb/E2F/ARF pathway stabilizes p53, and the DNA damage-activated ATM/ATR kinases activate p53, the mechanism that coordinates these two pathways has not been determined. We demonstrate that the p38MAPK pathway activated by pX serves this role in p53 apoptosis. Specifically, the activated p38MAPK pathway stabilizes p53 via E2F1-mediated ARF expression, and also activates the transcriptional function of p53 by activating ATR. Knockdown of p53, E2F1, ATR, or p38MAPK alpha abrogates pX-mediated apoptosis, demonstrating that E2F1, ATR, and p38MAPK alpha are all essential in p53 apoptosis in response to pX. Specifically, in response to pX expression, the p38MAPK pathway activates Cdk4 and Cdk2, leading to phosphorylation of Rb, release of E2F1, and transcription of ARF. The p38MAPK pathway also activates ATR, leading to phosphorylation of p53 on Ser-18 and Ser-23, transcription of pro-apoptotic genes Bax, Fas, and Noxa, and apoptosis. In conclusion, pX sensitizes hepatocytes to p53 apoptosis via activation of the p38MAPK pathway, which couples p53 stabilization and p53 activation, by E2F1 induction and ATR activation, respectively.	[Wang, Wen-Horng; Hullinger, Ronald L.; Andrisani, Ourania M.] Purdue Univ, Dept Basic Med Sci, W Lafayette, IN 47907 USA	Purdue University System; Purdue University; Purdue University West Lafayette Campus	Andrisani, OM (corresponding author), Purdue Univ, Dept Basic Med Sci, 625 Harrison St, W Lafayette, IN 47907 USA.	andrisao@purdue.edu		Andrisani, Ourania/0000-0002-6230-0303	National Institutes of Health [044533]; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R29DK044533, R01DK044533] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	This work was supported, in whole or in part, by National Institutes of Health Grant NIDDK 044533 (to O.M.A.). The costs of publication of this article were defrayed in part by the payment of page charges. This article must therefore be hereby marked "advertisement" in accordance with 18 U. S. C. Section 1734 solely to indicate this fact.	Andrisani OM, 1999, INT J ONCOL, V15, P373; Banin S, 1998, SCIENCE, V281, P1674, DOI 10.1126/science.281.5383.1674; Bates S, 1998, NATURE, V395, P124, DOI 10.1038/25867; Benjanirut C, 2006, J BIOL CHEM, V281, P2969, DOI 10.1074/jbc.M503939200; BENN J, 1995, P NATL ACAD SCI USA, V92, P11215, DOI 10.1073/pnas.92.24.11215; Bouchard MJ, 2004, J VIROL, V78, P12725, DOI 10.1128/JVI.78.23.12725-12734.2004; Brown EJ, 2000, GENE DEV, V14, P397; Buendia MA, 2000, SEMIN CANCER BIOL, V10, P185; Bulavin DV, 2002, NAT GENET, V31, P210, DOI 10.1038/ng894; Bulavin DV, 2001, NATURE, V411, P102, DOI 10.1038/35075107; Canman CE, 1998, SCIENCE, V281, P1677, DOI 10.1126/science.281.5383.1677; Cerrato JA, 2004, INT J ONCOL, V24, P409; Chirillo P, 1997, P NATL ACAD SCI USA, V94, P8162, DOI 10.1073/pnas.94.15.8162; de Stanchina E, 1998, GENE DEV, V12, P2434, DOI 10.1101/gad.12.15.2434; Dirac AMG, 2003, J BIOL CHEM, V278, P11731, DOI 10.1074/jbc.C300023200; Fogal V, 2005, CELL DEATH DIFFER, V12, P369, DOI 10.1038/sj.cdd.4401562; Giaccia AJ, 1998, GENE DEV, V12, P2973, DOI 10.1101/gad.12.19.2973; Ginsberg D, 2002, FEBS LETT, V529, P122, DOI 10.1016/S0014-5793(02)03270-2; GREENBLATT MS, 1994, CANCER RES, V54, P4855; Gu W, 1997, CELL, V90, P595, DOI 10.1016/S0092-8674(00)80521-8; Hainaut P, 1998, NUCLEIC ACIDS RES, V26, P205, DOI 10.1093/nar/26.1.205; Haupt Y, 1997, NATURE, V387, P296, DOI 10.1038/387296a0; HERMEKING H, 1994, SCIENCE, V265, P2091, DOI 10.1126/science.8091232; Hershko T, 2005, CELL DEATH DIFFER, V12, P377, DOI 10.1038/sj.cdd.4401575; HUNTER T, 1995, CELL, V80, P225, DOI 10.1016/0092-8674(95)90405-0; Kastan MB, 2000, NAT REV MOL CELL BIO, V1, P179, DOI 10.1038/35043058; Kinzler KW, 1997, NATURE, V386, P763; Lee C, 2004, NATURE, V430, P913, DOI 10.1038/nature02813; Lee S, 2002, J BIOL CHEM, V277, P8730, DOI 10.1074/jbc.M108025200; Liu QH, 2000, GENE DEV, V14, P1448; LOWE SW, 1993, GENE DEV, V7, P535, DOI 10.1101/gad.7.4.535; Meek DW, 1999, ONCOGENE, V18, P7666, DOI 10.1038/sj.onc.1202951; Moon NS, 2005, DEV CELL, V9, P463, DOI 10.1016/j.devcel.2005.08.015; MORGAN DO, 1995, NATURE, V374, P131, DOI 10.1038/374131a0; Murphy PJM, 2004, J BIOL CHEM, V279, P30195, DOI 10.1074/jbc.M403539200; Paris M, 2006, MOL CELL BIOL, V26, P8826, DOI 10.1128/MCB.00575-06; Parkin DM, 2001, EUR J CANCER, V37, pS4, DOI 10.1016/S0959-8049(01)00267-2; Pediconi N, 2003, NAT CELL BIOL, V5, P552, DOI 10.1038/ncb998; Pomerantz J, 1998, CELL, V92, P713, DOI 10.1016/S0092-8674(00)81400-2; Pusapati RV, 2006, P NATL ACAD SCI USA, V103, P1446, DOI 10.1073/pnas.0507367103; Rogoff HA, 2004, MOL CELL BIOL, V24, P2968, DOI 10.1128/MCB.24.7.2968-2977.2004; Seger YR, 2002, CANCER CELL, V2, P401, DOI 10.1016/S1535-6108(02)00183-6; Su Q, 1998, HEPATOLOGY, V27, P1109, DOI 10.1002/hep.510270428; Tang Y, 2006, MOL CELL, V24, P827, DOI 10.1016/j.molcel.2006.11.021; Tarn C, 1999, J BIOL CHEM, V274, P2327, DOI 10.1074/jbc.274.4.2327; Thorgeirsson SS, 2002, NAT GENET, V31, P339, DOI 10.1038/ng0802-339; Tibbetts RS, 1999, GENE DEV, V13, P152, DOI 10.1101/gad.13.2.152; Tibbetts RS, 2000, GENE DEV, V14, P2989, DOI 10.1101/gad.851000; Wang WH, 2004, MOL CELL BIOL, V24, P10352, DOI 10.1128/MCB.24.23.10352-10365.2004; Wells J, 2002, P NATL ACAD SCI USA, V99, P3890, DOI 10.1073/pnas.062047499; Zhang YP, 2001, SCIENCE, V292, P1910, DOI 10.1126/science.1058637	51	69	74	0	12	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	SEP 12	2008	283	37					25455	25467		10.1074/jbc.M801934200	http://dx.doi.org/10.1074/jbc.M801934200			13	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	345QZ	18606816	hybrid, Green Published			2022-12-27	WOS:000259012700041
J	Liu, JY; Versaw, WK; Pumplin, N; Gomez, SK; Blaylock, LA; Harrison, MJ				Liu, Jinyuan; Versaw, Wayne K.; Pumplin, Nathan; Gomez, S. Karen; Blaylock, Laura A.; Harrison, Maria J.			Closely related members of the Medicago truncatula PHT1 phosphate transporter gene family encode phosphate transporters with distinct biochemical activities	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							FUNCTIONAL-ANALYSIS; PLASMA-MEMBRANE; PLANT; EXPRESSION; ARABIDOPSIS; IDENTIFICATION; CLONING; MICRORNA399; REVEALS; PATHWAY	Phosphorus is one of the essential mineral nutrients required by all living cells. Plants assimilate phosphate (P-i) from the soil, and their root systems encounter tremendous variation in P-i concentration, both temporally and spatially. Genome sequence data indicate that plant genomes contain large numbers of genes predicted to encode P-i transporters, the functions of which are largely unexplored. Here we present a comparative analysis of four very closely related P-i transporters of the PHT1 family of Medicago truncatula. Based on their sequence similarity and locations in the genome, these four genes probably arose via recent gene duplication events, and they form a small subfamily within the PHT1 family. The four genes are expressed in roots with partially overlapping but distinct spatial expression patterns, responses to P-i and expression during arbuscular mycorrhizal symbiosis. The proteins are located in the plasma membrane. Three members of the subfamily, MtPT1, MtPT2, and MtPT3, show low affinities for P-i. MtPT5 shares 84% amino acid identity with MtPT1, MtPT2, and MtPT3 but shows a high affinity for P-i with an apparent Km in yeast of 13 mu M. Sequence comparisons and protein modeling suggest that amino acid residues that differ substantially between MtPT5 and the other three transporters are clustered in two regions of the protein. The data provide the first clues as to amino acid residues that impact transport activity of plant P-i transporter proteins.	[Liu, Jinyuan; Pumplin, Nathan; Gomez, S. Karen; Blaylock, Laura A.; Harrison, Maria J.] Cornell Univ, Boyce Thompson Inst Plant Res, Ithaca, NY 14853 USA; [Versaw, Wayne K.] Texas A&M Univ, Dept Biol, College Stn, TX 77843 USA	Cornell University; Boyce Thompson Institute for Plant Research; Texas A&M University System; Texas A&M University College Station	Harrison, MJ (corresponding author), Tower Rd, Ithaca, NY 14853 USA.	mjh78@cornell.edu	Pumplin, Nathan/F-5539-2016	Pumplin, Nathan/0000-0003-4492-5358; Harrison, Maria J/0000-0001-8716-1875	United States National Science Foundation [IBN-0343975]; Samuel Roberts Noble Foundation; National Science Foundation [DBI-0618969]	United States National Science Foundation(National Science Foundation (NSF)); Samuel Roberts Noble Foundation; National Science Foundation(National Science Foundation (NSF))	The work was supported by United States National Science Foundation Grant IBN-0343975 and The Samuel Roberts Noble Foundation. Microscopy analyses were carried out in the BTI Plant Cell Imaging Center using instrumentation purchased with an award from National Science Foundation Grant DBI-0618969. The costs of publication of this article were defrayed in part by the payment of page charges. This article must therefore be hereby marked "advertisement" in accordance with 18 U. S. C. Section 1734 solely to indicate this fact.	Ames B.N., 1966, METHOD ENZYMOL, V8, P115, DOI [10.1016/0076-6879(66)08014-5, DOI 10.1016/0076-6879(66)08014-5]; Aung K, 2006, PLANT PHYSIOL, V141, P1000, DOI 10.1104/pp.106.078063; Balestrini R, 2007, MOL PLANT MICROBE IN, V20, P1055, DOI 10.1094/MPMI-20-9-1055; Bari R, 2006, PLANT PHYSIOL, V141, P988, DOI 10.1104/pp.106.079707; Boisson-Dernier A, 2001, MOL PLANT MICROBE IN, V14, P695, DOI 10.1094/MPMI.2001.14.6.695; Bucher M, 2007, NEW PHYTOL, V173, P11, DOI 10.1111/j.1469-8137.2006.01935.x; BUN YM, 1991, MOL CELL BIOL, V11, P3229; Chen AQ, 2007, NEW PHYTOL, V173, P817, DOI 10.1111/j.1469-8137.2006.01962.x; Chiou TJ, 2001, PLANT J, V25, P281, DOI 10.1046/j.1365-313x.2001.00963.x; Chiu WL, 1996, CURR BIOL, V6, P325, DOI 10.1016/S0960-9822(02)00483-9; Daram P, 1998, PLANTA, V206, P225, DOI 10.1007/s004250050394; Froissard Marine, 2006, Biotechnology Journal, V1, P308, DOI 10.1002/biot.200500034; Glassop D, 2005, PLANTA, V222, P688, DOI 10.1007/s00425-005-0015-0; Guo B, 2008, NEW PHYTOL, V177, P889, DOI 10.1111/j.1469-8137.2007.02331.x; Harrison MJ, 2005, ANNU REV MICROBIOL, V59, P19, DOI 10.1146/annurev.micro.58.030603.123749; Harrison MJ, 2002, PLANT CELL, V14, P2413, DOI 10.1105/tpc.004861; Hong X, 2006, MOL BIOL EVOL, V23, P2392, DOI 10.1093/molbev/msl111; Javot H, 2007, P NATL ACAD SCI USA, V104, P1720, DOI 10.1073/pnas.0608136104; Javot H, 2007, PLANT CELL ENVIRON, V30, P310, DOI 10.1111/j.1365-3040.2006.01617.x; Kai M, 2002, PLANT SCI, V163, P837, DOI 10.1016/S0168-9452(02)00233-9; Karandashov V, 2005, TRENDS PLANT SCI, V10, P22, DOI 10.1016/j.tplants.2004.12.003; Knappe S, 2003, PLANT PHYSIOL, V131, P1178, DOI 10.1104/pp.016519; Lang I, 2004, PROTOPLASMA, V224, P231, DOI 10.1007/s00709-004-0062-6; Lang-Pauluzzi I, 2000, J MICROSC-OXFORD, V198, P188, DOI 10.1046/j.1365-2818.2000.00677.x; Leggewie G, 1997, PLANT CELL, V9, P381, DOI 10.1105/tpc.9.3.381; Liu CM, 1998, PLANT PHYSIOL, V116, P91, DOI 10.1104/pp.116.1.91; Liu H, 1998, MOL PLANT MICROBE IN, V11, P14, DOI 10.1094/MPMI.1998.11.1.14; Liu JY, 2004, CAN J BOT, V82, P1177, DOI [10.1139/b04-048, 10.1139/B04-048]; Liu JY, 2003, PLANT CELL, V15, P2106, DOI 10.1105/tpc.014183; Lynch M, 2000, GENETICS, V154, P459; Martinez P, 1998, MOL GEN GENET, V258, P628, DOI 10.1007/s004380050776; Mitsukawa N, 1997, P NATL ACAD SCI USA, V94, P7098, DOI 10.1073/pnas.94.13.7098; Muchhal US, 1996, P NATL ACAD SCI USA, V93, P10519, DOI 10.1073/pnas.93.19.10519; Mudge SR, 2002, PLANT J, V31, P341, DOI 10.1046/j.1365-313X.2002.01356.x; Nagy R, 2006, PLANT BIOLOGY, V8, P186, DOI 10.1055/s-2005-873052; Nagy R, 2005, PLANT J, V42, P236, DOI 10.1111/j.1365-313X.2005.02364.x; Okumura S, 1998, DNA Res, V5, P261, DOI 10.1093/dnares/5.5.261; Paszkowski U, 2002, P NATL ACAD SCI USA, V99, P13324, DOI 10.1073/pnas.202474599; Picault N, 2004, TRENDS PLANT SCI, V9, P138, DOI 10.1016/j.tplants.2004.01.007; Rae AL, 2003, PLANT MOL BIOL, V53, P27, DOI 10.1023/B:PLAN.0000009259.75314.15; Raghothama KG, 1999, ANNU REV PLANT PHYS, V50, P665, DOI 10.1146/annurev.arplant.50.1.665; Rausch C, 2002, PLANTA, V216, P23, DOI 10.1007/s00425-002-0921-3; Rausch C, 2001, NATURE, V414, P462, DOI 10.1038/35106601; Saier M H Jr, 1999, J Mol Microbiol Biotechnol, V1, P257; Schachtman DP, 1998, PLANT PHYSIOL, V116, P447, DOI 10.1104/pp.116.2.447; Scott A, 1999, BIOTECHNIQUES, V26, P1125, DOI 10.2144/99266st04; Shin H, 2004, PLANT J, V39, P629, DOI 10.1111/j.1365-313X.2004.02161.x; Smith FW, 1997, PLANT J, V11, P83, DOI 10.1046/j.1365-313X.1997.11010083.x; Smith S., 1997, MYCORRHIZAL SYMBIOSI, V2nd Edn; Versaw WK, 2002, PLANT CELL, V14, P1751, DOI 10.1105/tpc.002220; VERSAW WK, 1995, GENE, V153, P135, DOI 10.1016/0378-1119(94)00814-9; Xiao K, 2006, PLANT BIOLOGY, V8, P439, DOI 10.1055/s-2005-873053; Yang J, 2007, PLANTA, V226, P169, DOI 10.1007/s00425-007-0478-2; Zhao LM, 2003, NEW PHYTOL, V157, P291, DOI 10.1046/j.1469-8137.2003.00677.x	54	70	84	1	28	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	SEP 5	2008	283	36					24673	24681		10.1074/jbc.M802695200	http://dx.doi.org/10.1074/jbc.M802695200			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	342YR	18596039	Green Published, hybrid			2022-12-27	WOS:000258820000037
J	Loo, TW; Bartlett, MC; Clarke, DM				Loo, Tip W.; Bartlett, M. Claire; Clarke, David M.			Arginines in the first transmembrane segment promote maturation of a P-glycoprotein processing mutant by hydrogen bond interactions with tyrosines in transmembrane segment 11	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							AMINO-ACID SUBSTITUTIONS; DRUG-BINDING DOMAIN; DISRUPTS PACKING; ATP HYDROLYSIS; MUTATIONS; TRANSPORT; MEMBRANE; DELTA-F508; RHODAMINE; RESIDUES	A key goal is to correct defective folding of mutant ATP binding cassette (ABC) transporters, as they cause diseases such as cystic fibrosis. P-glycoprotein (ABCB1) is a useful model system because introduction of an arginine at position 65 of the first transmembrane (TM) segment could repair folding defects. To determine the mechanism of arginine rescue, we first tested the effects of introducing arginines at other positions in TM1 ( residues 52-72) of a P-glycoprotein processing mutant (G251V) that is defective in folding and trafficking to the cell surface (20% maturation efficiency). We found that arginines introduced into one face of the TM1 helix ( positions 52, 55, 56, 59, 60, 62, 63, 66, and 67) inhibited maturation, whereas arginines on the opposite face of the helix promoted ( positions 64, 65, 68, and 71) or had little effect ( positions 61, and 69) on maturation. Arginines at positions 61, 64, 65, and 68 appeared to lie close to the drug binding sites as they reduced the apparent affinity for drug substrates such as vinblastine and verapamil. Therefore, arginines that promoted maturation may face an aqueous drug translocation pathway, whereas those that inhibited maturation may face the lipid bilayer. The highest maturation efficiencies (60-85%) were observed with the Arg-65 and Arg-68 mutants. Mutations that removed hydrogen bond acceptors (Y950F/Y950A or Y953F/Y953A) in TM11 predicted to lie close to Arg-65 or Arg- 68 inhibited maturation but did not affect maturation of the G251V parent. Therefore, arginine may rescue defective folding by promoting packing of the TM segments through hydrogen bond interactions.	[Clarke, David M.] Univ Toronto, Dept Med, Toronto, ON M5S 1A8, Canada; Univ Toronto, Dept Biochem, Toronto, ON M5S 1A8, Canada	University of Toronto; University of Toronto	Clarke, DM (corresponding author), Univ Toronto, Dept Med, 1 Kings Coll Circle,Rm 7342,Med Sci Bldg, Toronto, ON M5S 1A8, Canada.	david.clarke@utoronto.ca	Clarke, David M./A-1112-2008	Clarke, David M./0000-0003-4335-7184; Loo, Tip W/0000-0003-2108-0188	National Cancer Institute of Canada; Canadian Institutes of Health Research [62832, 25043]; Cystic Fibrosis Foundation [CLARKE-08GO]	National Cancer Institute of Canada(Canadian Cancer Society (CCS)); Canadian Institutes of Health Research(Canadian Institutes of Health Research (CIHR)); Cystic Fibrosis Foundation(Italian Cystic Fibrosis Research Foundation)	This work was supported by grants from the National Cancer Institute of Canada through the Canadian Cancer Society, Canadian Institutes of Health Research Grants 62832 and 25043, and Cystic Fibrosis Foundation Grant CLARKE-08GO. The costs of publication of this article were defrayed in part by the payment of page charges. This article must therefore be hereby marked "advertisement" in accordance with 18 U.S.C. Section 1734 solely to indicate this fact.	Ambudkar SV, 1997, J BIOL CHEM, V272, P21160, DOI 10.1074/jbc.272.34.21160; Chamberlain AK, 2004, J MOL BIOL, V339, P471, DOI 10.1016/j.jmb.2004.03.072; CHEN CJ, 1986, CELL, V47, P381, DOI 10.1016/0092-8674(86)90595-7; Chen EY, 2004, J BIOL CHEM, V279, P39620, DOI 10.1074/jbc.M407887200; Chen Y, 2001, CANCER RES, V61, P7763; Choi MY, 2004, BIOCHEMISTRY-US, V43, P8077, DOI 10.1021/bi0494525; Cymes GD, 2005, NATURE, V438, P975, DOI 10.1038/nature04293; Dawson RJP, 2006, NATURE, V443, P180, DOI 10.1038/nature05155; Dey S, 1997, P NATL ACAD SCI USA, V94, P10594, DOI 10.1073/pnas.94.20.10594; Dorairaj S, 2007, P NATL ACAD SCI USA, V104, P4943, DOI 10.1073/pnas.0610470104; Gallivan JP, 1999, P NATL ACAD SCI USA, V96, P9459, DOI 10.1073/pnas.96.17.9459; HOOF T, 1994, J BIOL CHEM, V269, P20575; Li L, 2008, BIOPHYS J, V94, pL11, DOI 10.1529/biophysj.107.121566; Loo TW, 2007, J BIOL CHEM, V282, P32043, DOI 10.1074/jbc.M706175200; Loo TW, 2006, J BIOL CHEM, V281, P29436, DOI 10.1074/jbc.C600209200; Loo TW, 2006, BIOCHEM J, V399, P351, DOI 10.1042/BJ20060715; Loo TW, 2006, BIOCHEM J, V396, P537, DOI 10.1042/BJ20060012; Loo TW, 1997, J BIOL CHEM, V272, P709, DOI 10.1074/jbc.272.2.709; Loo TW, 2005, BIOCHEMISTRY-US, V44, P10250, DOI 10.1021/bi050705j; Loo TW, 2004, BIOCHEMISTRY-US, V43, P12081, DOI 10.1021/bi049045t; Loo TW, 2004, J BIOL CHEM, V279, P18232, DOI 10.1074/jbc.M400229200; Loo TW, 2004, J BIOL CHEM, V279, P7692, DOI 10.1074/jbc.M311825200; Loo TW, 2003, J BIOL CHEM, V278, P50136, DOI 10.1074/jbc.M310448200; Loo TW, 1999, FASEB J, V13, P1724, DOI 10.1096/fasebj.13.13.1724; Loo TW, 2003, J BIOL CHEM, V278, P20449, DOI 10.1074/jbc.C300154200; Loo TW, 1999, J BIOL CHEM, V274, P35388, DOI 10.1074/jbc.274.50.35388; Loo TW, 1999, J BIOL CHEM, V274, P24759, DOI 10.1074/jbc.274.35.24759; Loo TW, 2000, J BIOL CHEM, V275, P5253, DOI 10.1074/jbc.275.8.5253; Loo TW, 2002, J BIOL CHEM, V277, P27585, DOI 10.1074/jbc.C200330200; LOO TW, 1994, J BIOL CHEM, V269, P7243; Loo TW, 2002, J BIOL CHEM, V277, P44332, DOI 10.1074/jbc.M208433200; Loo TW, 1998, J BIOL CHEM, V273, P14671, DOI 10.1074/jbc.273.24.14671; Loo TW, 2002, P NATL ACAD SCI USA, V99, P3511, DOI 10.1073/pnas.022049799; Loo TW, 2001, J BIOL CHEM, V276, P36877, DOI 10.1074/jbc.C100467200; LOO TW, 1994, BIOCHEMISTRY-US, V33, P14049, DOI 10.1021/bi00251a013; LOO TW, 1995, J BIOL CHEM, V270, P21449, DOI 10.1074/jbc.270.37.21449; LOO TW, 1995, J BIOL CHEM, V270, P21839, DOI 10.1074/jbc.270.37.21839; LOO TW, 1994, J BIOL CHEM, V269, P28683; Ng PC, 2006, ANNU REV GENOM HUM G, V7, P61, DOI 10.1146/annurev.genom.7.080505.115630; Pedemonte N, 2005, J CLIN INVEST, V115, P2564, DOI 10.1172/JCI24898; Rosenberg MF, 2001, EMBO J, V20, P5615, DOI 10.1093/emboj/20.20.5615; Rowe SM, 2005, NEW ENGL J MED, V352, P1992, DOI 10.1056/NEJMra043184; Sanders CR, 2004, ANNU REV BIOPH BIOM, V33, P25, DOI 10.1146/annurev.biophys.33.110502.140348; SANGER F, 1977, P NATL ACAD SCI USA, V74, P5463, DOI 10.1073/pnas.74.12.5463; Taguchi Y, 1997, FEBS LETT, V413, P142, DOI 10.1016/S0014-5793(97)00899-5; Therien AG, 2001, NAT STRUCT BIOL, V8, P597, DOI 10.1038/89631; Van Goor F, 2006, AM J PHYSIOL-LUNG C, V290, pL1117, DOI 10.1152/ajplung.00169.2005; Wang Y, 2007, MOL PHARMACOL, V71, P751, DOI 10.1124/mol.106.029926; Wang Y, 2006, MOL PHARMACOL, V70, P297, DOI 10.1124/mol.106.023994; Ward A, 2007, P NATL ACAD SCI USA, V104, P19005, DOI 10.1073/pnas.0709388104; Zolnerciks JK, 2007, FASEB J, V21, P3937, DOI 10.1096/fj.07-8610com	51	25	25	0	1	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	SEP 5	2008	283	36					24860	24870		10.1074/jbc.M803351200	http://dx.doi.org/10.1074/jbc.M803351200			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	342YR	18596043	Green Published, hybrid			2022-12-27	WOS:000258820000052
J	Luo, YQ; Lathia, J; Mughal, M; Mattson, MP				Luo, Yongquan; Lathia, Justin; Mughal, Mohammed; Mattson, Mark P.			SDF1 alpha/CXCR4 Signaling, via ERKs and the Transcription Factor Egr1, Induces Expression of a 67-kDa Form of Glutamic Acid Decarboxylase in Embryonic Hippocampal Neurons	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							CHEMOKINE RECEPTOR CXCR4; CELL-DERIVED FACTOR-1; CENTRAL-NERVOUS-SYSTEM; DENTATE GRANULE CELLS; GENE-EXPRESSION; STEM-CELLS; PROGENITOR CELLS; RAT HIPPOCAMPUS; MESSENGER-RNAS; NEURAL STEM	Stromal cell-derived factor alpha(SDF1 alpha) and its cognate receptor CXCR4 play an important role in neuronal development in the hippocampus, but the genes directly regulated by SDF1 alpha/CXCR4 signaling are unknown. To study the role of CXCR4 targeted genes in neuronal development, we used neuronal cultures established from embryonic day 18 rats. Hippocampal neurons express CXCR4 receptor proteins and are stimulated by SDF1 alpha resulting in activation of extracellular signal-regulated kinase (ERK) 1/2 and the transcription factor cAMP-response element-binding protein. SDF1 alpha rapidly induces the expression of the early growth response gene Egr1, a transcription factor involved in activity-dependent neuronal responses, in a concentration-dependent manner. Gel-shift analysis showed that SDF1 alpha enhances DNA binding activity to the Egr1-containing promoter for GAD67. Chromatin immunoprecipitation analysis using an Egr1 antibody indicated that SDF1 alpha stimulation increases binding of Egr1 to a GAD67 promoter DNA sequence. SDF1 alpha stimulation increases the expression of GAD67 at both them RNA and protein levels, and increases the amount and neurite localization of gamma-aminobutyric acid (GABA) in neurons already expressing GABA. SDF1 alpha-induced Egr1/GAD67 expression is mediated by the G protein-coupled CXCR4 receptor and activation of the ERK pathway. Reduction of Egr1 gene expression using small interfering RNA technology lowers the level of GAD67 transcripts and inhibits SDF1 alpha-induced GABA production. Inhibition of CXCR4 activation in the developing mouse brain in utero greatly reduced Egr1 and GAD67 mRNA levels and GAD67 protein levels, suggesting a pivotal role for CXCR4 signaling in the development of GABAergic neurons in vivo. Our data suggest that SDF1 alpha/CXCR4/G protein/ERK signaling induces the expression of the GAD67 system via Egr1 activation, a mechanism that may promote the maturation of GABAergic neurons during development.	[Luo, Yongquan; Lathia, Justin; Mughal, Mohammed; Mattson, Mark P.] NIA, Neurosci Lab, Intramural Res Program, NIH, Baltimore, MD 21224 USA	National Institutes of Health (NIH) - USA; NIH National Institute on Aging (NIA)	Mattson, MP (corresponding author), Rm 4F01,5600 Nathan Shock Dr, Baltimore, MD 21224 USA.	mattsonm@grc.nia.nih.gov	Mattson, Mark P/F-6038-2012; Lathia, Justin/AHB-8296-2022		NIA, Intramural Research Program; NATIONAL INSTITUTE ON AGING [ZIAAG000324, Z01AG000324] Funding Source: NIH RePORTER	NIA, Intramural Research Program(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))	This work was supported, in whole or in part, by a National Institutes of Health grant from the NIA, Intramural Research Program.	Arakawa Y, 2003, J CELL BIOL, V161, P381, DOI 10.1083/jcb.200210149; Bagri A, 2002, DEVELOPMENT, V129, P4249; Bajetto A, 1999, J NEUROCHEM, V73, P2348, DOI 10.1046/j.1471-4159.1999.0732348.x; Barbero S, 2002, ANN NY ACAD SCI, V973, P60, DOI 10.1111/j.1749-6632.2002.tb04607.x; Behar TN, 2000, CEREB CORTEX, V10, P899, DOI 10.1093/cercor/10.9.899; Belmadani A, 2005, J NEUROSCI, V25, P3995, DOI 10.1523/JNEUROSCI.4631-04.2005; Ben-Ari Y, 2002, NAT REV NEUROSCI, V3, P728, DOI 10.1038/nrn920; Benes FM, 2007, P NATL ACAD SCI USA, V104, P10164, DOI 10.1073/pnas.0703806104; Berger EA, 1999, ANNU REV IMMUNOL, V17, P657, DOI 10.1146/annurev.immunol.17.1.657; BOND RW, 1990, P NATL ACAD SCI USA, V87, P8771, DOI 10.1073/pnas.87.22.8771; Bozon B, 2003, PHILOS T R SOC B, V358, P805, DOI 10.1098/rstb.2002.1224; CAO XM, 1990, MOL CELL BIOL, V10, P1931, DOI 10.1128/MCB.10.5.1931; Chalasani SH, 2003, J NEUROSCI, V23, P1360, DOI 10.1523/JNEUROSCI.23-04-01360.2003; Cheng AW, 2007, J NEUROCHEM, V100, P1515, DOI 10.1111/j.1471-4159.2006.07337.x; Dent G, 2007, BRAIN RES, V1138, P1, DOI 10.1016/j.brainres.2006.04.082; Dziembowska M, 2005, GLIA, V50, P258, DOI 10.1002/glia.20170; Earnheart JC, 2007, J NEUROSCI, V27, P3845, DOI 10.1523/JNEUROSCI.3609-06.2007; Elmariah SB, 2005, J NEUROSCI, V25, P3638, DOI 10.1523/JNEUROSCI.3980-04.2005; ERLANDER MG, 1991, NEURON, V7, P91, DOI 10.1016/0896-6273(91)90077-D; Ge SY, 2006, NATURE, V439, P589, DOI 10.1038/nature04404; Hatse S, 2002, FEBS LETT, V527, P255, DOI 10.1016/S0014-5793(02)03143-5; Herdegen T, 1998, BRAIN RES REV, V28, P370, DOI 10.1016/S0165-0173(98)00018-6; Ishikawa H, 2007, J MOL ENDOCRINOL, V39, P333, DOI 10.1677/JME-06-0069; Kasyanov A, 2006, EUR J NEUROSCI, V23, P1120, DOI 10.1111/j.1460-9568.2006.04646.x; Kinney JW, 2006, J NEUROSCI, V26, P1604, DOI 10.1523/JNEUROSCI.4722-05.2006; Klein RS, 2001, DEVELOPMENT, V128, P1971; Knapska E, 2004, PROG NEUROBIOL, V74, P183, DOI 10.1016/j.pneurobio.2004.05.007; Lazarini F, 2003, GLIA, V42, P139, DOI 10.1002/glia.10139; LEMAIRE P, 1988, P NATL ACAD SCI USA, V85, P4691, DOI 10.1073/pnas.85.13.4691; LoTurco JJ, 1995, NEURON, V15, P1287, DOI 10.1016/0896-6273(95)90008-X; Lu M, 2002, P NATL ACAD SCI USA, V99, P7090, DOI 10.1073/pnas.092013799; Luo YQ, 2006, NEUROSCI LETT, V398, P291, DOI 10.1016/j.neulet.2006.01.024; Luo YQ, 2005, J NEUROCHEM, V93, P452, DOI 10.1111/j.1471-4159.2005.03049.x; Luo YQ, 2002, J NEUROCHEM, V83, P1481, DOI 10.1046/j.1471-4159.2002.01260.x; Ma Q, 1998, P NATL ACAD SCI USA, V95, P9448, DOI 10.1073/pnas.95.16.9448; MARTIN DL, 1993, J NEUROCHEM, V60, P395, DOI 10.1111/j.1471-4159.1993.tb03165.x; MATTSON MP, 1992, J NEUROSCI, V12, P376, DOI 10.1523/jneurosci.12-02-00376.1992; MATTSON MP, 1989, BRAIN RES, V490, P110, DOI 10.1016/0006-8993(89)90436-8; MayerProschel M, 1997, NEURON, V19, P773, DOI 10.1016/S0896-6273(00)80960-5; MILBRANDT J, 1987, SCIENCE, V238, P797, DOI 10.1126/science.3672127; Nakamura NH, 2004, NEUROENDOCRINOLOGY, V80, P308, DOI 10.1159/000083657; Oberlin E, 1996, NATURE, V382, P833, DOI 10.1038/382833a0; Odemis V, 2005, MOL CELL NEUROSCI, V30, P494, DOI 10.1016/j.mcn.2005.07.019; Ohba S, 2005, CEREB CORTEX, V15, P291, DOI 10.1093/cercor/bhh130; Pedersen AA, 2001, DNA SEQUENCE, V11, P485, DOI 10.3109/10425170109041332; PETERSOHN D, 1995, J BIOL CHEM, V270, P24361, DOI 10.1074/jbc.270.41.24361; Raychowdhury R, 2002, MOL ENDOCRINOL, V16, P2802, DOI 10.1210/me.2001-0292; Reiss K, 2002, NEUROSCIENCE, V115, P295, DOI 10.1016/S0306-4522(02)00307-X; Rossi D, 2000, ANNU REV IMMUNOL, V18, P217, DOI 10.1146/annurev.immunol.18.1.217; Sgambato V, 1998, J NEUROSCI, V18, P8814; Sloviter RS, 1996, J COMP NEUROL, V373, P593; SOMOGYI R, 1995, J NEUROSCI, V15, P2575; SZABO G, 1994, MOL CELL BIOL, V14, P7535, DOI 10.1128/MCB.14.11.7535; Szabo G, 1996, DNA CELL BIOL, V15, P1081, DOI 10.1089/dna.1996.15.1081; Szabo G, 2000, NEUROSCIENCE, V100, P287, DOI 10.1016/S0306-4522(00)00275-X; Tham TN, 2001, EUR J NEUROSCI, V13, P845, DOI 10.1046/j.0953-816x.2000.01451.x; THIEL G, 1994, J BIOL CHEM, V269, P15294; Tran PB, 2003, NAT REV NEUROSCI, V4, P444, DOI 10.1038/nrn1116; Varju P, 2001, CELL TISSUE RES, V305, P239, DOI 10.1007/s004410100356; Wadiche LO, 2005, J NEUROPHYSIOL, V94, P4528, DOI 10.1152/jn.00633.2005; WORLEY PF, 1993, J NEUROSCI, V13, P4776; Yanagawa Y, 1997, BIOCHEM J, V326, P573, DOI 10.1042/bj3260573; Yau JLW, 1996, MOL BRAIN RES, V42, P354, DOI 10.1016/S0169-328X(96)00220-3; Zhang WB, 2002, J BIOL CHEM, V277, P24515, DOI 10.1074/jbc.M200889200; Zhu Y, 2002, NAT NEUROSCI, V5, P719, DOI 10.1038/nn881	65	55	57	0	1	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	SEP 5	2008	283	36					24789	24800		10.1074/jbc.M800649200	http://dx.doi.org/10.1074/jbc.M800649200			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	517MA	18606818	Green Published, hybrid			2022-12-27	WOS:000271617300005
J	Okumura, F; Lenschow, DJ; Zhang, DE				Okumura, Fumihiko; Lenschow, Deborah J.; Zhang, Dong-Er			Nitrosylation of ISG15 prevents the disulfide bond-mediated dimerization of ISG15 and contributes to effective ISGylation	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							UBIQUITIN-LIKE PROTEIN; NITRIC-OXIDE SYNTHASE; EIF4E COGNATE 4EHP; VIRAL REPLICATION; MESSENGER-RNA; E2 ENZYME; INTERFERON; LIGASE; VIRUS; CELLS	The expression of the ubiquitin-like molecule ISG15 (UCRP) and protein modification by ISG15 (ISGylation) are strongly activated by interferon, genotoxic stress, and pathogen infection, suggesting that ISG15 plays an important role in innate immune responses. Inducible nitric-oxide synthase (iNOS) is induced by the similar stimuli as ISG15 and enhances the production of nitric oxide (NO), a pleiotropic free radical with anti-pathogen activity. Here, we report that cysteine residues (Cys-76 and -143 in mouse, Cys-78 in human) of ISG15 can be modified by NO, and the NO modification of ISG15 decreases the dimerization of ISG15. The mutation of the cysteine residue of ISG15 to serine improves total ISGylation. The NO synthase inhibitor S-ethylisothiourea reduces endogenous ISGylation. Furthermore, ectopic expression of iNOS enhanced total ISGylation. Together, these results suggest that nitrosylation of ISG15 enhances target protein ISGylation. This is the first report of a relationship between ISGylation and nitrosylation.	[Zhang, Dong-Er] Univ Calif San Diego, Div Biol Sci, San Diego, CA 92093 USA; [Zhang, Dong-Er] Univ Calif San Diego, Moores Canc Ctr, Dept Pathol, San Diego, CA 92093 USA; [Lenschow, Deborah J.] Washington Univ, Sch Med, Dept Internal Med, St Louis, MO 63110 USA; [Lenschow, Deborah J.] Washington Univ, Sch Med, Dept Pathol, St Louis, MO 63110 USA; [Lenschow, Deborah J.] Washington Univ, Sch Med, Dept Immunol, St Louis, MO 63110 USA; [Okumura, Fumihiko; Zhang, Dong-Er] Scripps Res Inst, Dept Mol & Expt Med, La Jolla, CA 92037 USA	University of California System; University of California San Diego; University of California System; University of California San Diego; Washington University (WUSTL); Washington University (WUSTL); Washington University (WUSTL); Scripps Research Institute	Zhang, DE (corresponding author), Univ Calif San Diego, Moores Canc Ctr, Dept Pathol, Mail Stop 0815,Rm 5328,3855 Hlth Sci Dr, San Diego, CA 92093 USA.	d7zhang@ucsd.edu			National Institutes of Health [GM66955, CA102625]; Uehara Memorial Foundation; NATIONAL CANCER INSTITUTE [R01CA102625] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM066955] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Uehara Memorial Foundation(Uehara Memorial Foundation); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported, in whole or in part, by National Institutes of Health Grants GM66955 and CA102625 (to D.-E.Z.). This work was also supported by a Uehara Memorial Foundation postdoctoral fellowship (to F.O.). This is manuscript 19193 from The Scripps Research Institute.	BENZ D, 2002, MED SCI MONITOR, V8, P1; Cho PF, 2005, CELL, V121, P411, DOI 10.1016/j.cell.2005.02.024; Dastur A, 2006, J BIOL CHEM, V281, P4334, DOI 10.1074/jbc.M512830200; DCunha J, 1996, J IMMUNOL, V157, P4100; Fang FC, 1997, J CLIN INVEST, V99, P2818, DOI 10.1172/JCI119473; FARRELL PJ, 1979, NATURE, V279, P523, DOI 10.1038/279523a0; Fernandez JA, 2000, VIRAL IMMUNOL, V13, P287, DOI 10.1089/08828240050144626; Garcia-Sastre A, 2006, SCIENCE, V312, P879, DOI 10.1126/science.1125676; HAAS AL, 1987, J BIOL CHEM, V262, P11315; Hess DT, 2005, NAT REV MOL CELL BIO, V6, P150, DOI 10.1038/nrm1569; Jaffrey S R, 2001, Sci STKE, V2001, ppl1, DOI 10.1126/stke.2001.86.pl1; Kaisho T, 2006, J ALLERGY CLIN IMMUN, V117, P979, DOI 10.1016/j.jaci.2006.02.023; Kim KI, 2004, MOL CELL BIOL, V24, P9592, DOI 10.1128/MCB.24.21.9592-9600.2004; Kim KI, 2006, MOL CELL BIOL, V26, P472, DOI 10.1128/MCB.26.2.472-479.2006; KNIGHT E, 1991, J IMMUNOL, V146, P2280; KOK K, 1993, P NATL ACAD SCI USA, V90, P6071, DOI 10.1073/pnas.90.13.6071; KORANT BD, 1984, J BIOL CHEM, V259, P4835; LEI SZ, 1992, NEURON, V8, P1087, DOI 10.1016/0896-6273(92)90130-6; Lenschow DJ, 2007, P NATL ACAD SCI USA, V104, P1371, DOI 10.1073/pnas.0607038104; LOEB KR, 1992, J BIOL CHEM, V267, P7806; Lowenstein CJ, 1996, J CLIN INVEST, V97, P1837, DOI 10.1172/JCI118613; Lowenstein CJ, 2004, J CELL SCI, V117, P2865, DOI 10.1242/jcs.01166; MacLean A, 1998, J GEN VIROL, V79, P825, DOI 10.1099/0022-1317-79-4-825; Malakhova OA, 2003, GENE DEV, V17, P455, DOI 10.1101/gad.1056303; Nathan C, 2000, P NATL ACAD SCI USA, V97, P8841, DOI 10.1073/pnas.97.16.8841; Okumura A, 2006, P NATL ACAD SCI USA, V103, P1440, DOI 10.1073/pnas.0510518103; Okumura F, 2004, J BIOL CHEM, V279, P53533, DOI 10.1074/jbc.M402916200; Okumura F, 2007, GENE DEV, V21, P255, DOI 10.1101/gad.1521607; Osiak A, 2005, MOL CELL BIOL, V25, P6338, DOI 10.1128/MCB.25.15.6338-6345.2005; Owhashi M, 2003, BIOCHEM BIOPH RES CO, V309, P533, DOI 10.1016/j.bbrc.2003.08.038; Payabvash S, 2006, FREE RADICAL BIO MED, V41, P1817, DOI 10.1016/j.freeradbiomed.2006.09.010; RECHT M, 1991, J IMMUNOL, V147, P2617; Reiss CS, 1998, J VIROL, V72, P4547, DOI 10.1128/JVI.72.6.4547-4551.1998; Sorensen CM, 2007, BIOCHEMISTRY-US, V46, P772, DOI 10.1021/bi061408x; Takeuchi T, 2005, J BIOCHEM, V138, P711, DOI 10.1093/jb/mvi172; Uehara T, 2006, NATURE, V441, P513, DOI 10.1038/nature04782; Wong JJY, 2006, P NATL ACAD SCI USA, V103, P10735, DOI 10.1073/pnas.0600397103; Zaragoza C, 1999, J IMMUNOL, V163, P5497; Zaragoza C, 1998, P NATL ACAD SCI USA, V95, P2469, DOI 10.1073/pnas.95.5.2469; Zhao C, 2004, P NATL ACAD SCI USA, V101, P7578, DOI 10.1073/pnas.0402528101; Zou WG, 2006, J BIOL CHEM, V281, P3989, DOI 10.1074/jbc.M510787200	42	17	19	0	2	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	SEP 5	2008	283	36					24484	24488		10.1074/jbc.M803795200	http://dx.doi.org/10.1074/jbc.M803795200			5	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	342YR	18606809	hybrid, Green Published			2022-12-27	WOS:000258820000023
J	Westbye, MP; Feyzi, E; Aas, PA; Vagbo, CB; Talstad, VA; Kavli, B; Hagen, L; Sundheim, O; Akbari, M; Liabakk, NB; Slupphaug, G; Otterlei, M; Krokan, HE				Westbye, Marianne Pedersen; Feyzi, Emadoldin; Aas, Per Arne; Vagbo, Cathrine Broberg; Talstad, Vivi Anita; Kavli, Bodil; Hagen, Lars; Sundheim, Ottar; Akbari, Mansour; Liabakk, Nina-Beate; Slupphaug, Geir; Otterlei, Marit; Krokan, Hans Einar			Human AlkB homolog 1 is a mitochondrial protein that demethylates 3-methylcytosine in DNA and RNA	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							BASE EXCISION-REPAIR; ESCHERICHIA-COLI; ALKYLATION DAMAGE; OXIDATIVE DEMETHYLATION; ENZYME ALKB; METHYLATION DAMAGE; UNG GENE; NUCLEAR; URACIL; CELLS	The Escherichia coli AlkB protein and human homologs hABH2 and hABH3 are 2-oxoglutarate (2OG)/Fe(II)-dependent DNA/RNA demethylases that repair 1-methyladenine and 3-methylcytosine residues. Surprisingly, hABH1, which displays the strongest homology to AlkB, failed to show repair activity in two independent studies. Here, we show that hABH1 is a mitochondrial protein, as demonstrated using fluorescent fusion protein expression, immunocytochemistry, and Western blot analysis. A fraction is apparently nuclear and this fraction increases strongly if the fluorescent tag is placed at the N-terminal end of the protein, thus interfering with mitochondrial targeting. Molecular modeling of hABH1 based upon the sequence and known structures of AlkB and hABH3 suggested an active site almost identical to these enzymes. hABH1 decarboxylates 2OG in the absence of a prime substrate, and the activity is stimulated by methylated nucleotides. Employing three different methods we demonstrate that hABH1 demethylates 3-methylcytosine in single-stranded DNA and RNA in vitro. Site-specific mutagenesis confirmed that the putative Fe( II) and 2OG binding residues are essential for activity. In conclusion, hABH1 is a functional mitochondrial AlkB homolog that repairs 3-methylcytosine in single-stranded DNA and RNA.	[Westbye, Marianne Pedersen; Feyzi, Emadoldin; Aas, Per Arne; Vagbo, Cathrine Broberg; Talstad, Vivi Anita; Kavli, Bodil; Hagen, Lars; Sundheim, Ottar; Akbari, Mansour; Liabakk, Nina-Beate; Slupphaug, Geir; Otterlei, Marit; Krokan, Hans Einar] Norwegian Univ Sci & Technol, Dept Canc Res & Mol Med, N-7489 Trondheim, Norway	Norwegian University of Science & Technology (NTNU)	Krokan, HE (corresponding author), Erling Skjalgssons Gt 1, NO-7489 Trondheim, Norway.	Hans.Krokan@ntnu.no	kavli, bodil/ABC-8889-2020; Vågbø, Cathrine Broberg/N-3226-2017; Slupphaug, Geir/AAN-3794-2020	Vågbø, Cathrine Broberg/0000-0003-3959-7409; Monsen, Vivi Talstad/0000-0003-2821-5145; Akbari, Mansour/0000-0002-6490-7766; Otterlei, Marit/0000-0002-5232-1186; Slupphaug, Geir/0000-0002-7498-3500	National Programme for Research in Functional Genomics in Norway (FUGE); European Community [LSHG-CT-2005-512113]; Norwegian Cancer Association; Olav's Hospital, Trondheim; Svanhild and Arne Must Fund for Medical Research	National Programme for Research in Functional Genomics in Norway (FUGE)(Research Council of Norway); European Community(European Commission); Norwegian Cancer Association; Olav's Hospital, Trondheim; Svanhild and Arne Must Fund for Medical Research	This work was supported by the National Programme for Research in Functional Genomics in Norway (FUGE) in the Research Council of Norway, European Community Integrated Project DNA Repair Grant LSHG-CT-2005-512113, The Norwegian Cancer Association, The Cancer Fund at St. Olav's Hospital, Trondheim, and the Svanhild and Arne Must Fund for Medical Research. The costs of publication of this article were defrayed in part by the payment of page charges. This article must therefore be hereby marked "advertisement" in accordance with 18 U. S. C. Section 1734 solely to indicate this fact.	Aas PA, 2003, NATURE, V421, P859, DOI 10.1038/nature01363; Akbari M, 2007, NEUROSCIENCE, V145, P1201, DOI 10.1016/j.neuroscience.2006.10.010; Akbari M, 2004, NUCLEIC ACIDS RES, V32, P5486, DOI 10.1093/nar/gkh872; ARAVIND L, 2001, GENOME BIOL, V2, DOI DOI 10.1186/gb-2001-2-3-research0007; Bannister AJ, 2005, NATURE, V436, P1103, DOI 10.1038/nature04048; Bratlie MS, 2005, BMC GENOMICS, V6, DOI 10.1186/1471-2164-6-1; Chang BS, 2007, SCIENCE, V318, P444, DOI 10.1126/science.1145801; Clamp M, 2004, BIOINFORMATICS, V20, P426, DOI 10.1093/bioinformatics/btg430; Cuff JA, 2000, PROTEINS, V40, P502, DOI 10.1002/1097-0134(20000815)40:3<502::AID-PROT170>3.0.CO;2-Q; Delaney JC, 2004, P NATL ACAD SCI USA, V101, P14051, DOI 10.1073/pnas.0403489101; Drablos F, 2004, DNA REPAIR, V3, P1389, DOI 10.1016/j.dnarep.2004.05.004; Duncan T, 2002, P NATL ACAD SCI USA, V99, P16660, DOI 10.1073/pnas.262589799; Falnes PO, 2002, NATURE, V419, P178, DOI 10.1038/nature01048; Gerken T, 2007, SCIENCE, V318, P1469, DOI 10.1126/science.1151710; Harrison JF, 2007, GLIA, V55, P1416, DOI 10.1002/glia.20556; Hatchell EC, 2006, MOL CELL, V22, P657, DOI 10.1016/j.molcel.2006.05.024; Hausinger RP, 2004, CRIT REV BIOCHEM MOL, V39, P21, DOI 10.1080/10409230490440541; Henshaw TF, 2004, J INORG BIOCHEM, V98, P856, DOI 10.1016/j.jinorgbio.2003.10.021; KATAOKA H, 1983, J BACTERIOL, V153, P1301, DOI 10.1128/JB.153.3.1301-1307.1983; Kurowski MA, 2003, BMC GENOMICS, V4, DOI 10.1186/1471-2164-4-48; Lambert AJ, 2007, AGING CELL, V6, P417, DOI 10.1111/j.1474-9726.2007.00316.x; LeDoux SP, 2007, NEUROSCIENCE, V145, P1249, DOI 10.1016/j.neuroscience.2006.10.002; LEDOUX SP, 1992, CARCINOGENESIS, V13, P1967, DOI 10.1093/carcin/13.11.1967; Lee DH, 2005, J BIOL CHEM, V280, P39448, DOI 10.1074/jbc.M509881200; Mishina Y, 2004, J AM CHEM SOC, V126, P16930, DOI 10.1021/ja045066z; Nilsen H, 2000, NUCLEIC ACIDS RES, V28, P2277, DOI 10.1093/nar/28.12.2277; Nilsen H, 1997, NUCLEIC ACIDS RES, V25, P750, DOI 10.1093/nar/25.4.750; Ougland R, 2004, MOL CELL, V16, P107, DOI 10.1016/j.molcel.2004.09.002; Pan ZS, 2008, DEV DYNAM, V237, P316, DOI 10.1002/dvdy.21418; Ringvoll J, 2006, EMBO J, V25, P2189, DOI 10.1038/sj.emboj.7601109; Rozenski J, 1999, NUCLEIC ACIDS RES, V27, P196, DOI 10.1093/nar/27.1.196; SABOURIN PJ, 1982, J BIOL CHEM, V257, P7468; Sawyer DE, 1999, MUTAT RES-DNA REPAIR, V434, P161, DOI 10.1016/S0921-8777(99)00027-0; Schwede T, 2003, NUCLEIC ACIDS RES, V31, P3381, DOI 10.1093/nar/gkg520; Sedgwick B, 2004, NAT REV MOL CELL BIO, V5, P148, DOI 10.1038/nrm1312; Sedgwick B, 2002, ONCOGENE, V21, P8886, DOI 10.1038/sj.onc.1205998; Singer B., 1983, MOL BIOL MUTAGENS CA; Sundheim O, 2006, EMBO J, V25, P3389, DOI 10.1038/sj.emboj.7601219; Thompson JD, 1997, NUCLEIC ACIDS RES, V25, P4876, DOI 10.1093/nar/25.24.4876; Trewick SC, 2002, NATURE, V419, P174, DOI 10.1038/nature00908; Tsujikawa K, 2007, J CELL MOL MED, V11, P1105, DOI 10.1111/j.1582-4934.2007.00094.x; Wei YF, 1996, NUCLEIC ACIDS RES, V24, P931, DOI 10.1093/nar/24.5.931; Welford RWD, 2003, J BIOL CHEM, V278, P10157, DOI 10.1074/jbc.M211058200; Wilson DM, 2007, DNA REPAIR, V6, P544, DOI 10.1016/j.dnarep.2006.10.017; Yang Y, 2007, P NATL ACAD SCI USA, V104, P7253, DOI 10.1073/pnas.0611506104; Yu B, 2006, NATURE, V439, P879, DOI 10.1038/nature04561	46	132	136	1	20	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	SEP 5	2008	283	36					25046	25056		10.1074/jbc.M803776200	http://dx.doi.org/10.1074/jbc.M803776200			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	342YR	18603530	Green Published, hybrid			2022-12-27	WOS:000258820000062
J	Yu, Y; Ge, NL; Xie, M; Sun, WJ; Burlingame, S; Pass, AK; Nuchtern, JG; Zhang, DK; Fu, SB; Schneider, MD; Fan, J; Yang, JH				Yu, Yang; Ge, Ningling; Xie, Min; Sun, Wenjing; Burlingame, Susan; Pass, Amy K.; Nuchtern, Jed G.; Zhang, Dekai; Fu, Songbin; Schneider, Michael D.; Fan, Jia; Yang, Jianhua			Phosphorylation of Thr-178 and Thr-184 in the TAK1 T-loop Is Required for Interleukin (IL)-1-mediated Optimal NF kappa B and AP-1 Activation as Well as IL-6 Gene Expression	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							KINASE KINASE KINASE; BETA SIGNAL-TRANSDUCTION; INNATE IMMUNE-RESPONSES; MAP KINASE; CHARACTERIZING PHOSPHOPROTEINS; MASS-SPECTROMETRY; STRUCTURAL BASIS; PROTEIN TAB1; PATHWAY; DROSOPHILA	TAK1 (transforming growth factor-beta-activated kinase 1), a mitogen-activated protein kinase kinase kinase, is activated by various cytokines, including interleukin-1 (IL-1). However, the precise regulation for TAK1 activation at the molecular level is still not fully understood. Here we report that dual phosphorylation of Thr-178 and Thr-184 residues within the kinase activation loop of TAK1 is essential for TAK1-mediated NF kappa B and AP-1 activation. Once co-overexpressed with TAB1, TAK1 mutant with alanine substitution of these two residues fails to activate IKK beta-mediated NF kappa B and JNK-mediated AP-1, whereas TAK1 mutant with replacement of these two sites with acidic residues acts like the TAK1 wild type. Consistently, TAK1 mutant with alanine substitution of these two residues severely inhibits IL-1-induced NF kappa B and AP-1 activities, whereas TAK1 mutant with replacement of these two sites with acidic residues slightly enhances IL-1-induced NF kappa B and AP-1 activities compared with theTAK1 wild-type. IL-1 induces the phosphorylation of endogenous TAK1 at Thr-178 and Thr-184. Reconstitution of TAK1-deficient mouse embryo fibroblast cells with wild-type TAK1 or a TAK1 mutant containing threonine 178 and 184 to alanine mutations revealed the importance of these two sites in IL-1-mediated IKK-NF kappa B and JNK-AP-1 activation as well as IL-1-induced IL-6 gene expression. Our finding is the first report that substitution of key serine/threonine residues with acidic residues mimics the phosphorylated state of TAK1 and renders TAK1 active during its induced activation.	[Yu, Yang; Ge, Ningling; Sun, Wenjing; Pass, Amy K.; Yang, Jianhua] Baylor Coll Med, Texas Childrens Canc Ctr, Dept Pediat, Houston, TX 77030 USA; [Xie, Min; Schneider, Michael D.] Baylor Coll Med, Ctr Cardiovasc Dev, Dept Med, Houston, TX 77030 USA; [Burlingame, Susan; Nuchtern, Jed G.] Baylor Coll Med, Dan L Duncan Canc Ctr, Michael E DeBakey Dept Surg, Houston, TX 77030 USA; [Zhang, Dekai] Texas A&M Univ, Inst Biosci & Technol, Ctr Extracellular Matrix Biol, Houston, TX 77030 USA; [Ge, Ningling; Fan, Jia] Fudan Univ, Zhongshan Hosp, Liver Canc Inst, Shanghai 200032, Peoples R China; [Yu, Yang; Fu, Songbin] Harbin Med Univ, Lab Med Genet, Harbin 150081, Peoples R China	Baylor College of Medicine; Texas Children's Cancer Center; Baylor College of Medicine; Baylor College of Medicine; Texas A&M University System; Fudan University; Harbin Medical University	Yang, JH (corresponding author), Baylor Coll Med, Texas Childrens Canc Ctr, Dept Pediat, Houston, TX 77030 USA.	jianhuay@bcm.tmc.edu	Xie, Min/AAY-3426-2020; Fan, Jia/C-6689-2017	Xie, Min/0000-0002-2967-3490; Schneider, Michael/0000-0001-9645-1938	National Institutes of Health [1R21CA106513-01A2]; American Cancer Society [RSG-06-070-01-TBE]; NCI; T32 Training [1T32CA115303-01A1]; NATIONAL CANCER INSTITUTE [T32CA115303, R21CA106513] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); American Cancer Society(American Cancer Society); NCI(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); T32 Training; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This work was supported, in whole or in part, by National Institutes of Health Grant 1R21CA106513-01A2 (to J. Y.). This work was also supported by American Cancer Society Grant RSG-06-070-01-TBE (to J. Y.).; Supported by NCI, National Institutes of Health, T32 Training Grant 1T32CA115303-01A1.	ALESSI DR, 1994, EMBO J, V13, P1610, DOI 10.1002/j.1460-2075.1994.tb06424.x; Arend WR, 2002, CYTOKINE GROWTH F R, V13, P323, DOI 10.1016/S1359-6101(02)00020-5; BAEUERLE PA, 1994, ANNU REV IMMUNOL, V12, P141, DOI 10.1146/annurev.immunol.12.1.141; Baud V, 2001, TRENDS CELL BIOL, V11, P372, DOI 10.1016/S0962-8924(01)02064-5; Beutler B, 2004, NATURE, V430, P257, DOI 10.1038/nature02761; Boutros M, 2002, DEV CELL, V3, P711, DOI 10.1016/S1534-5807(02)00325-8; Brown K, 2005, J MOL BIOL, V354, P1013, DOI 10.1016/j.jmb.2005.09.098; Cheung PCF, 2004, BIOCHEM J, V378, P27, DOI 10.1042/BJ20031794; Conner SH, 2006, BIOCHEM J, V399, P427, DOI 10.1042/BJ20061077; Davis RJ, 2000, CELL, V103, P239, DOI 10.1016/S0092-8674(00)00116-1; DAVIS RJ, 1994, BIOCH SOC S, V64, P1; Delhase M, 1999, SCIENCE, V284, P309, DOI 10.1126/science.284.5412.309; DINARELLO CA, 1984, REV INFECT DIS, V6, P51, DOI 10.1016/S1359-6101(97)00023-3; Gafken PR, 2006, CELL COMMUN ADHES, V13, P249, DOI 10.1080/15419060601077917; Goshe Michael B., 2006, Briefings in Functional Genomics & Proteomics, V4, P363, DOI 10.1093/bfgp/eli007; Irie T, 2000, FEBS LETT, V467, P160, DOI 10.1016/S0014-5793(00)01146-7; Ishitani T, 2003, EMBO J, V22, P6277, DOI 10.1093/emboj/cdg605; Johnson LN, 1996, CELL, V85, P149, DOI 10.1016/S0092-8674(00)81092-2; Karin M, 1997, CURR OPIN CELL BIOL, V9, P240, DOI 10.1016/S0955-0674(97)80068-3; Karin M, 2000, ANNU REV IMMUNOL, V18, P621, DOI 10.1146/annurev.immunol.18.1.621; Kishimoto K, 2000, J BIOL CHEM, V275, P7359, DOI 10.1074/jbc.275.10.7359; Liu HH, 2006, P NATL ACAD SCI USA, V103, P11677, DOI 10.1073/pnas.0603089103; Mendoza H, 2008, BIOCHEM J, V409, P711, DOI 10.1042/BJ20071149; Mercurio F, 1997, SCIENCE, V278, P860, DOI 10.1126/science.278.5339.860; Ninomiya-Tsuji J, 1999, NATURE, V398, P252, DOI 10.1038/18465; O'Neill LAJ, 1998, J LEUKOCYTE BIOL, V63, P650, DOI 10.1002/jlb.63.6.650; Park JM, 2004, GENE DEV, V18, P584, DOI 10.1101/gad.1168104; PAYNE DM, 1991, EMBO J, V10, P885, DOI 10.1002/j.1460-2075.1991.tb08021.x; Qin JZ, 2004, J BIOL CHEM, V279, P26748, DOI 10.1074/jbc.M400785200; RESING KA, 1995, BIOCHEMISTRY-US, V34, P2610, DOI 10.1021/bi00008a027; Sakurai H, 2002, BIOCHEM BIOPH RES CO, V297, P1277, DOI 10.1016/S0006-291X(02)02379-3; Sakurai H, 1999, J BIOL CHEM, V274, P10641, DOI 10.1074/jbc.274.15.10641; Sakurai H, 2000, FEBS LETT, V474, P141, DOI 10.1016/S0014-5793(00)01588-X; Sato S, 2005, NAT IMMUNOL, V6, P1087, DOI 10.1038/ni1255; Shibuya H, 1996, SCIENCE, V272, P1179, DOI 10.1126/science.272.5265.1179; Shim JH, 2005, GENE DEV, V19, P2668, DOI 10.1101/gad.1360605; Silverman N, 2003, J BIOL CHEM, V278, P48928, DOI 10.1074/jbc.M304802200; Singhirunnusorn P, 2005, J BIOL CHEM, V280, P7359, DOI 10.1074/jbc.M407537200; Takaesu G, 2003, J MOL BIOL, V326, P105, DOI 10.1016/S0022-2836(02)01404-3; Takaesu G, 2000, MOL CELL, V5, P649, DOI 10.1016/S1097-2765(00)80244-0; Vidal S, 2001, GENE DEV, V15, P1900, DOI 10.1101/gad.203301; Wan J, 2004, MOL CELL BIOL, V24, P192, DOI 10.1128/MCB.24.1.192-199.2004; Wan YSY, 2006, NAT IMMUNOL, V7, P851, DOI 10.1038/ni1355; Wang C, 2001, NATURE, V412, P346, DOI 10.1038/35085597; Weston CR, 2002, SCIENCE, V296, P2345, DOI 10.1126/science.1073344; Xie M, 2006, P NATL ACAD SCI USA, V103, P17378, DOI 10.1073/pnas.0604708103; YAMAGUCHI K, 1995, SCIENCE, V270, P2008, DOI 10.1126/science.270.5244.2008; ZHENG CF, 1994, EMBO J, V13, P1123, DOI 10.1002/j.1460-2075.1994.tb06361.x	48	81	83	0	4	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	SEP 5	2008	283	36					24497	24505		10.1074/jbc.M802825200	http://dx.doi.org/10.1074/jbc.M802825200			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	342YR	18617512	Green Published, hybrid			2022-12-27	WOS:000258820000069
J	Davies, MN; O'Callaghan, BL; Towle, HC				Davies, Michael N.; O'Callaghan, Brennon L.; Towle, Howard C.			Glucose activates ChREBP by increasing its rate of nuclear entry and relieving repression of its transcriptional activity	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							CARBOHYDRATE-RESPONSE ELEMENT; PYRUVATE-KINASE GENE; LIPOGENIC ENZYME GENES; FATTY-ACID SYNTHASE; WILLIAMS-BEUREN-SYNDROME; BINDING PROTEIN CHREBP; CENTER-DOT-MLX; C-MYC; POSTTRANSCRIPTIONAL REGULATION; REGULATED TRANSCRIPTION	Carbohydrate response element-binding protein (ChREBP) is a glucose-responsive transcription factor that activates genes involved in de novo lipogenesis in mammals. The current model for glucose activation of ChREBP proposes that increased glucose metabolism triggers a cytoplasmic to nuclear translocation of ChREBP that is critical for activation. However, we find that ChREBP actively shuttles between the cytoplasm and nucleus in both low and high glucose in the glucose-sensitive beta cell-derived line, 832/13. Glucose stimulates a 3-fold increase in the rate of ChREBP nuclear entry, but trapping ChREBP in the nucleus by mutagenesis or with a nuclear export inhibitor does not lead to constitutive activation. In fact, mutational studies targeting the nuclear export signal of ChREBP also identified a distinct function essential for glucose-dependent transcriptional activation. From this, we conclude that an additional event independent of nuclear translocation is required for activation. The N-terminal segment of ChREBP ( amino acids 1-298) has previously been shown to repress activity under basal conditions. This segment has five highly conserved regions, Mondo conserved regions 1-5 (MCR1 to -5). Based on activating mutations in MCR2 and MCR5, we propose that these two regions act coordinately to repress ChREBP in low glucose. In addition, other mutations in MCR2 and mutations in MCR3 were found to prevent glucose activation. Hence, we conclude that both relief of repression and adoption of an activating form are required for ChREBP activation.	[Davies, Michael N.; O'Callaghan, Brennon L.; Towle, Howard C.] Univ Minnesota, Dept Biochem Mol Biol & Biophys, Minneapolis, MN 55455 USA	University of Minnesota System; University of Minnesota Twin Cities	Towle, HC (corresponding author), 321 Church St SE,6-155 Jackson Hall, Minneapolis, MN 55455 USA.	towle001@umn.edu		O'Callaghan, Brennon L/0000-0002-0800-5856	National Institutes of Health [DK26919, P30 DK50456]; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK026919, P30DK050456] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	This work was supported, in whole or in part, by National Institutes of Health Grants DK26919 and P30 DK50456 (to the Minnesota Obesity Center). The costs of publication of this article were defrayed in part by the payment of page charges. This article must therefore be hereby marked "advertisement" in accordance with 18 U.S.C. Section 1734 solely to indicate this fact.	BERGOT MO, 1992, NUCLEIC ACIDS RES, V20, P1871, DOI 10.1093/nar/20.8.1871; Billin AN, 1999, J BIOL CHEM, V274, P36344, DOI 10.1074/jbc.274.51.36344; Billin AN, 2000, MOL CELL BIOL, V20, P8845, DOI 10.1128/MCB.20.23.8845-8854.2000; Burgess SC, 2008, J BIOL CHEM, V283, P1670, DOI 10.1074/jbc.M706540200; Collier JJ, 2007, AM J PHYSIOL-ENDOC M, V293, pE48, DOI 10.1152/ajpendo.00357.2006; Collier JJ, 2003, J BIOL CHEM, V278, P6588, DOI 10.1074/jbc.M208011200; de Luis O, 2000, EUR J HUM GENET, V8, P215, DOI 10.1038/sj.ejhg.5200435; Dentin R, 2005, BIOCHIMIE, V87, P81, DOI 10.1016/j.biochi.2004.11.008; Dentin R, 2004, J BIOL CHEM, V279, P20314, DOI 10.1074/jbc.M312475200; Dentin R, 2006, DIABETES, V55, P2159, DOI 10.2337/db06-0200; Eilers AL, 2002, MOL CELL BIOL, V22, P8514, DOI 10.1128/MCB.22.24.8514-8526.2002; Foretz M, 1999, P NATL ACAD SCI USA, V96, P12737, DOI 10.1073/pnas.96.22.12737; He ZB, 2004, AM J PHYSIOL-ENDOC M, V287, pE424, DOI 10.1152/ajpendo.00568.2003; Hohmeier HE, 2000, DIABETES, V49, P424, DOI 10.2337/diabetes.49.3.424; Horton JD, 1998, P NATL ACAD SCI USA, V95, P5987, DOI 10.1073/pnas.95.11.5987; Iizuka K, 2004, P NATL ACAD SCI USA, V101, P7281, DOI 10.1073/pnas.0401516101; Iizuka K, 2006, AM J PHYSIOL-ENDOC M, V291, pE358, DOI 10.1152/ajpendo.00027.2006; Ishii S, 2004, P NATL ACAD SCI USA, V101, P15597, DOI 10.1073/pnas.0405238101; Kabashima T, 2003, P NATL ACAD SCI USA, V100, P5107, DOI 10.1073/pnas.0730817100; KATSURADA A, 1989, BIOCHIM BIOPHYS ACTA, V1004, P103, DOI 10.1016/0005-2760(89)90219-1; KATSURADA A, 1990, EUR J BIOCHEM, V190, P427, DOI 10.1111/j.1432-1033.1990.tb15592.x; Kawaguchi T, 2001, P NATL ACAD SCI USA, V98, P13710, DOI 10.1073/pnas.231370798; Koo SH, 2001, J BIOL CHEM, V276, P9437, DOI 10.1074/jbc.M010029200; Li MV, 2008, MOL ENDOCRINOL, V22, P1658, DOI 10.1210/me.2007-0560; Li MV, 2006, DIABETES, V55, P1179, DOI 10.2337/db05-0822; LIU ZR, 1993, J BIOL CHEM, V268, P12787; Lodige I, 2005, J BIOL CHEM, V280, P43087, DOI 10.1074/jbc.M509180200; Ma L, 2005, J BIOL CHEM, V280, P12019, DOI 10.1074/jbc.M413063200; Ma L, 2007, NUCLEIC ACIDS RES, V35, P35, DOI 10.1093/nar/gkl987; Ma L, 2006, J BIOL CHEM, V281, P28721, DOI 10.1074/jbc.M601576200; Merla G, 2002, HUM GENET, V110, P429, DOI 10.1007/s00439-002-0710-x; Meyer T, 2004, EUR J BIOCHEM, V271, P4606, DOI 10.1111/j.1432-1033.2004.04423.x; NTAMBI JM, 1992, J BIOL CHEM, V267, P10925; O'Callaghan BL, 2001, J BIOL CHEM, V276, P16033, DOI 10.1074/jbc.M101557200; Osborne TF, 2000, J BIOL CHEM, V275, P32379, DOI 10.1074/jbc.R000017200; Pierreux CE, 2000, MOL CELL BIOL, V20, P9041, DOI 10.1128/MCB.20.23.9041-9054.2000; Rufo C, 2001, J BIOL CHEM, V276, P21969, DOI 10.1074/jbc.M100461200; Schmierer B, 2008, P NATL ACAD SCI USA, V105, P6608, DOI 10.1073/pnas.0710134105; SHIH HM, 1994, J BIOL CHEM, V269, P9380; Shimano H, 1999, J BIOL CHEM, V274, P35832, DOI 10.1074/jbc.274.50.35832; Stoeckman AK, 2004, J BIOL CHEM, V279, P15662, DOI 10.1074/jbc.M311301200; Towle HC, 2005, TRENDS ENDOCRIN MET, V16, P489, DOI 10.1016/j.tem.2005.10.003; Tsatsos NG, 2006, BIOCHEM BIOPH RES CO, V340, P449, DOI 10.1016/j.bbrc.2005.12.029; Tsatsos NG, 2008, BIOCHEM J, V411, P261, DOI 10.1042/BJ20071156; Uyeda K, 2006, CELL METAB, V4, P107, DOI 10.1016/j.cmet.2006.06.008; Vaulont S, 2000, J BIOL CHEM, V275, P31555, DOI 10.1074/jbc.R000016200; VAULONT S, 1986, J BIOL CHEM, V261, P7621; Wang HY, 2002, J BIOL CHEM, V277, P32746, DOI 10.1074/jbc.M201635200; Xavier GD, 2006, J LIPID RES, V47, P2482, DOI 10.1194/jlr.M600289-JLR200; Yamashita H, 2001, P NATL ACAD SCI USA, V98, P9116, DOI 10.1073/pnas.161284298	50	77	81	1	3	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	AUG 29	2008	283	35					24029	24038		10.1074/jbc.M801539200	http://dx.doi.org/10.1074/jbc.M801539200			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	340II	18591247	Green Published, hybrid			2022-12-27	WOS:000258638900058
J	Okamoto, K; Iwano, T; Tachibana, M; Shinkai, Y				Okamoto, Keiji; Iwano, Tomohiko; Tachibana, Makoto; Shinkai, Yoichi			Distinct roles of TRF1 in the regulation of telomere structure and lengthening	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ABERRANT HOMOLOGOUS RECOMBINATION; MAMMALIAN TELOMERES; DNA-DAMAGE; IN-VITRO; COMPLEX; POT1; END; PROTEIN; TIN2; LOCALIZATION	The telomere is a functional chromatin structure that consists of G-rich repetitive sequences and various associated proteins. Telomeres protect chromosomal ends from degradation, provide escape from the DNA damage response, and regulate telomere lengthening by telomerase. Multiple proteins that localize at telomeres form a complex called shelterin/telosome. One component, TRF1, is a double-stranded telomeric DNA binding protein. Inactivation of TRF1 disrupts telomeric localization of other shelterin components and induces chromosomal instability. Here, we examined how the telomeric localization of shelterin components is crucial for TRF1-mediated telomere-associated functions. We found that many of the mTRF1 deficient phenotypes, including chromosomal instability, growth defects, and dysfunctional telomere damage response, were suppressed by the telomere localization of shelterin components in the absence of functional mTRF1. However, abnormal telomere signals and telomere elongation phenotypes were either not rescued or only partially rescued, respectively. These data suggest that TRF1 regulates telomere length and function by at least two mechanisms; in one TRF1 acts through the recruiting/tethering of other shelterin components to telomeres, and in the other TRF1 seems to play a more direct role.	[Shinkai, Yoichi] Kyoto Univ, Inst Virus Res, Expt Res Ctr Infect Dis, Sakyo Ku, Kawara, Kyoto 6068507, Japan; Kyoto Univ, Grad Sch Biostudies, Sakyo Ku, Kawara, Kyoto 6068507, Japan	Kyoto University; Kyoto University	Shinkai, Y (corresponding author), Kyoto Univ, Inst Virus Res, Expt Res Ctr Infect Dis, Sakyo Ku, 53 Shogoin, Kawara, Kyoto 6068507, Japan.	yshinkai@virus.kyoto-u.ac.jp	Shinkai, Yoichi/N-3909-2014	Shinkai, Yoichi/0000-0002-6051-2484	Ministry of Education, Science, Technology, and Culture of Japan; Ministry of Education, Culture, Sports, Science, and Technology; Kyoto University; Institute for Virus Research	Ministry of Education, Science, Technology, and Culture of Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); Ministry of Education, Culture, Sports, Science, and Technology(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); Kyoto University; Institute for Virus Research	This work was supported by a grant-in-aid from the Ministry of Education, Science, Technology, and Culture of Japan (to Y.S. and M.T.) and by the 21st Century COE Program of the Ministry of Education, Culture, Sports, Science, and Technology to Graduate School of Biostudies and Institute for Virus Research, Kyoto University (to K.O. and T.I.). The costs of publication of this article were defrayed in part by the payment of page charges. This article must therefore be hereby marked "advertisement" in accordance with 18 U.S.C. Section 1734 solely to indicate this fact.	Bae NS, 2007, MOL CELL, V26, P323, DOI 10.1016/j.molcel.2007.03.023; Baumann P, 2001, SCIENCE, V292, P1171, DOI 10.1126/science.1060036; Bianchi A, 1997, EMBO J, V16, P1785, DOI 10.1093/emboj/16.7.1785; Blasco MA, 2007, NAT REV GENET, V8, P299, DOI 10.1038/nrg2047; Broccoli D, 1997, NAT GENET, V17, P231, DOI 10.1038/ng1097-231; Celli GB, 2005, NAT CELL BIOL, V7, P712, DOI 10.1038/ncb1275; DADDA DF, 2003, NATURE, V426, P194, DOI DOI 10.1038/NATURE02118; de Lange T, 2005, GENE DEV, V19, P2100, DOI 10.1101/gad.1346005; Grant JD, 2001, BIOTECHNIQUES, V31, P1314, DOI 10.2144/01316bc02; Griffith JD, 1999, CELL, V97, P503, DOI 10.1016/S0092-8674(00)80760-6; He H, 2006, EMBO J, V25, P5180, DOI 10.1038/sj.emboj.7601294; Hockemeyer D, 2006, CELL, V126, P63, DOI 10.1016/j.cell.2006.04.044; Houghtaling BR, 2004, CURR BIOL, V14, P1621, DOI 10.1016/j.cub.2004.08.052; Iwano T, 2004, J BIOL CHEM, V279, P1442, DOI 10.1074/jbc.M309138200; Karlseder J, 2002, SCIENCE, V295, P2446, DOI 10.1126/science.1069523; Kelleher C, 2005, MOL CELL BIOL, V25, P808, DOI 10.1128/MCB.25.2.808-818.2005; Kim S, 2004, J BIOL CHEM, V279, P43799, DOI 10.1074/jbc.M408650200; Kim SH, 1999, NAT GENET, V23, P405, DOI 10.1038/70508; Kim SH, 2003, EMBO REP, V4, P685, DOI 10.1038/sj.embor.embor872; Liu D, 2004, J BIOL CHEM, V279, P51338, DOI 10.1074/jbc.M409293200; Liu D, 2004, NAT CELL BIOL, V6, P673, DOI 10.1038/ncb1142; Loayza D, 2003, NATURE, V423, P1013, DOI 10.1038/nature01688; Munoz P, 2005, NAT GENET, V37, P1063, DOI 10.1038/ng1633; NANDA I, 1994, CYTOGENET CELL GENET, V65, P190, DOI 10.1159/000133630; O'Connor MS, 2006, P NATL ACAD SCI USA, V103, P11874, DOI 10.1073/pnas.0605303103; Riha K, 2006, ANNU REV GENET, V40, P237, DOI 10.1146/annurev.genet.39.110304.095755; Schoeftner S, 2008, NAT CELL BIOL, V10, P228, DOI 10.1038/ncb1685; Smogorzewska A, 2004, ANNU REV BIOCHEM, V73, P177, DOI 10.1146/annurev.biochem.73.071403.160049; Smogorzewska A, 2000, MOL CELL BIOL, V20, P1659, DOI 10.1128/MCB.20.5.1659-1668.2000; Takai H, 2003, CURR BIOL, V13, P1549, DOI 10.1016/S0960-9822(03)00542-6; vanSteensel B, 1997, NATURE, V385, P740, DOI 10.1038/385740a0; Wu L, 2006, CELL, V126, P49, DOI 10.1016/j.cell.2006.05.037; Wu YL, 2007, DNA REPAIR, V6, P157, DOI 10.1016/j.dnarep.2006.09.005; Ye JZS, 2004, J BIOL CHEM, V279, P47264, DOI 10.1074/jbc.M409047200; Ye JZS, 2004, GENE DEV, V18, P1649, DOI 10.1101/gad.1215404; Zhong ZH, 2007, J BIOL CHEM, V282, P29314, DOI 10.1074/jbc.M701413200	36	39	39	0	1	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	AUG 29	2008	283	35					23981	23988		10.1074/jbc.M802395200	http://dx.doi.org/10.1074/jbc.M802395200			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	340II	18587156	Green Published, hybrid			2022-12-27	WOS:000258638900054
J	Yoshikawa, D; Yamaguchi, N; Ishibashi, D; Yamanaka, H; Okimura, N; Yamaguchi, Y; Mori, T; Miyata, H; Shigematsu, K; Katamine, S; Sakaguchi, S				Yoshikawa, Daisuke; Yamaguchi, Naohiro; Ishibashi, Daisuke; Yamanaka, Hitoki; Okimura, Nobuhiko; Yamaguchi, Yoshitaka; Mori, Tsuyoshi; Miyata, Hironori; Shigematsu, Kazuto; Katamine, Shigeru; Sakaguchi, Suehiro			Dominant-negative effects of the N-terminal half of prion protein on neurotoxicity of prion protein-like protein/doppel in mice	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							PRP-LIKE PROTEIN; PURKINJE-CELL DEGENERATION; TRANSGENIC MICE; SUPEROXIDE-DISMUTASE; ECTOPIC EXPRESSION; DEFICIENT MICE; TRUNCATED PRP; UP-REGULATION; BRAIN-DAMAGE; DOPPEL	Prion protein-like protein/doppel is neurotoxic, causing ataxia and Purkinje cell degeneration in mice, whereas prion protein antagonizes doppel-induced neurodegeneration. Doppel is homologous to the C-terminal half of prion protein but lacks the amino acid sequences corresponding to the N-terminal half of prion protein. We show here that transgenic mice expressing a fusion protein consisting of the N-terminal half, corresponding to residues 1-124, of prion protein and doppel in neurons failed to develop any neurological signs for up to 730 days in a background devoid of prion protein. In addition, the fusion protein prolonged the onset of ataxia in mice expressing exogenous doppel. These results suggested that the N-terminal part of prion protein has a neuroprotective potential acting both cis and trans on doppel. We also show that prion protein lacking the pre-octapeptide repeat (Delta 25-50) or octapeptide repeat (Delta 51-90) region alone could not impair the antagonistic function against doppel.	[Yamaguchi, Yoshitaka; Mori, Tsuyoshi; Sakaguchi, Suehiro] Univ Tokushima, Inst Enzyme Res, Div Mol Neurobiol, Tokushima 7708503, Japan; [Yoshikawa, Daisuke; Yamaguchi, Naohiro; Ishibashi, Daisuke; Okimura, Nobuhiko; Katamine, Shigeru; Sakaguchi, Suehiro] Nagasaki Univ, Dept Mol Microbiol & Immunol, Grad Sch Biomed Sci, Nagasaki 8528523, Japan; [Yamanaka, Hitoki; Sakaguchi, Suehiro] PRESTO Japan Sci & Technol Agcy, Saitama 3320012, Japan; [Miyata, Hironori] Univ Occupat & Environm Hlth, Anim Res Ctr, Kitakyushu, Fukuoka 8078555, Japan; [Shigematsu, Kazuto] Nagasaki Univ, Dept Pathol, Grad Sch Biomed Sci, Nagasaki 8528523, Japan	Tokushima University; Nagasaki University; Japan Science & Technology Agency (JST); University of Occupational & Environmental Health - Japan; Nagasaki University	Sakaguchi, S (corresponding author), Univ Tokushima, Inst Enzyme Res, Div Mol Cytol, 3-18-15 Kuramoto Cho, Tokushima 7708503, Japan.	sakaguch@ier.tokushima-u.ac.jp	Yamaguchi, Yoshitaka/ABD-2499-2020		Ministry of Health, Labor and Welfare, Japan	Ministry of Health, Labor and Welfare, Japan(Ministry of Health, Labour and Welfare, Japan)	This study was supported in part by a Research on Specific Diseases grant from the Ministry of Health, Labor and Welfare, Japan. The costs of publication of this article were defrayed in part by the payment of page charges. This article must therefore be hereby marked "advertisement" in accordance with 18 U.S.C. Section 1734 solely to indicate this fact.	Anderson L, 2004, P NATL ACAD SCI USA, V101, P3644, DOI 10.1073/pnas.0308681101; Atarashi R, 2003, J BIOL CHEM, V278, P28944, DOI 10.1074/jbc.M303655200; Barmada S, 2004, NEUROBIOL DIS, V16, P527, DOI 10.1016/j.nbd.2004.05.005; Baumann F, 2007, EMBO J, V26, P538, DOI 10.1038/sj.emboj.7601510; Behrens A, 2002, TRENDS NEUROSCI, V25, P150, DOI 10.1016/S0166-2236(00)02089-0; Bounhar Y, 2001, J BIOL CHEM, V276, P39145, DOI 10.1074/jbc.C100443200; BRINSTER RL, 1985, P NATL ACAD SCI USA, V82, P4438, DOI 10.1073/pnas.82.13.4438; Brown DR, 1997, NATURE, V390, P684, DOI 10.1038/37733; Brown DR, 1997, EXP NEUROL, V146, P104, DOI 10.1006/exnr.1997.6505; Brown DR, 2002, J NEUROSCI RES, V67, P211, DOI 10.1002/jnr.10118; BUELER H, 1992, NATURE, V356, P577, DOI 10.1038/356577a0; Drisaldi B, 2004, J BIOL CHEM, V279, P55443, DOI 10.1074/jbc.M404794200; Flechsig E, 2003, EMBO J, V22, P3095, DOI 10.1093/emboj/cdg285; Haigh CL, 2006, J NEUROCHEM, V98, P677, DOI 10.1111/j.1471-4159.2006.03906.x; Hoshino S, 2003, ACT NEUR S, V86, P297; Jackson GS, 2001, P NATL ACAD SCI USA, V98, P8531, DOI 10.1073/pnas.151038498; Kuwahara C, 1999, NATURE, V400, P225, DOI 10.1038/22241; Li AM, 2007, EMBO J, V26, P548, DOI 10.1038/sj.emboj.7601507; Li AM, 2000, CELL MOL NEUROBIOL, V20, P553, DOI 10.1023/A:1007059827541; Li AM, 2000, AM J PATHOL, V157, P1447, DOI 10.1016/S0002-9440(10)64782-7; Liu T, 2001, BRAIN RES, V896, P118, DOI 10.1016/S0006-8993(01)02050-9; McLennan NF, 2004, AM J PATHOL, V165, P227, DOI 10.1016/S0002-9440(10)63291-9; Mo HP, 2001, P NATL ACAD SCI USA, V98, P2352, DOI 10.1073/pnas.051627998; Moore RC, 1999, J MOL BIOL, V292, P797, DOI 10.1006/jmbi.1999.3108; Moore RC, 2001, P NATL ACAD SCI USA, V98, P15288, DOI 10.1073/pnas.251550798; Nunziante M, 2003, J BIOL CHEM, V278, P3726, DOI 10.1074/jbc.M206313200; OESCH B, 1985, CELL, V40, P735, DOI 10.1016/0092-8674(85)90333-2; Pauly PC, 1998, J BIOL CHEM, V273, P33107, DOI 10.1074/jbc.273.50.33107; Prusiner SB, 1997, SCIENCE, V278, P245, DOI 10.1126/science.278.5336.245; Prusiner SB, 1998, P NATL ACAD SCI USA, V95, P13363, DOI 10.1073/pnas.95.23.13363; Rossi D, 2001, EMBO J, V20, P694, DOI 10.1093/emboj/20.4.694; Sakaguchi S, 1996, NATURE, V380, P528, DOI 10.1038/380528a0; Sakudo A, 2005, BIOCHEM BIOPH RES CO, V326, P600, DOI 10.1016/j.bbrc.2004.11.092; Sakudo A, 2003, BIOCHEM BIOPH RES CO, V308, P660, DOI 10.1016/S0006-291X(03)01459-1; Sakurai-Yamashita Y, 2005, NEUROSCIENCE, V136, P281, DOI 10.1016/j.neuroscience.2005.06.095; Santuccione A, 2005, J CELL BIOL, V169, P341, DOI 10.1083/jcb.200409127; SCOTT MR, 1992, PROTEIN SCI, V1, P986, DOI 10.1002/pro.5560010804; Shmerling D, 1998, CELL, V93, P203, DOI 10.1016/S0092-8674(00)81572-X; SHYNG SL, 1995, J BIOL CHEM, V270, P14793, DOI 10.1074/jbc.270.24.14793; Taylor DR, 2005, J CELL SCI, V118, P5141, DOI 10.1242/jcs.02627; Walmsley AR, 2003, J BIOL CHEM, V278, P37241, DOI 10.1074/jbc.M302036200; Watts JC, 2007, EMBO J, V26, P4038, DOI 10.1038/sj.emboj.7601830; Weise J, 2004, NEUROSCI LETT, V372, P146, DOI 10.1016/j.neulet.2004.09.030; Weissmann C, 1999, SCIENCE, V286, P914, DOI 10.1126/science.286.5441.914; WILMUT I, 1991, J REPROD FERTIL, V92, P245, DOI 10.1530/jrf.0.0920245; Yamaguchi N, 2004, BIOCHEM BIOPH RES CO, V319, P1247, DOI 10.1016/j.bbrc.2004.05.115	46	22	22	0	3	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	AUG 29	2008	283	35					24202	24211		10.1074/jbc.M804212200	http://dx.doi.org/10.1074/jbc.M804212200			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	340II	18562311	hybrid, Green Published			2022-12-27	WOS:000258638900074
J	Orth, JHC; Fester, I; Preuss, I; Agnoletto, L; Wilson, BA; Aktories, K				Orth, Joachim H. C.; Fester, Ines; Preuss, Inga; Agnoletto, Laura; Wilson, Brenda A.; Aktories, Klaus			Activation of G alpha(i) and subsequent uncoupling of receptor-G alpha(i) signaling by Pasteurella multocida toxin	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							PERTUSSIS-TOXIN; ADP-RIBOSYLATION; ADENYLATE-CYCLASE; SWISS 3T3-CELLS; MITOGENIC TOXIN; POTENT MITOGEN; G-PROTEINS; BINDING; INVOLVEMENT; CELLS	Bacterial protein toxins are powerful tools for elucidating signaling mechanisms in eukaryotic cells. A number of bacterial protein toxins, e. g. cholera toxin, pertussis toxin (PTx), or Pasteurella multocida toxin (PMT), target heterotrimeric G proteins and have been used to stimulate or block specific signaling pathways or to demonstrate the contribution of their target proteins in cellular effects. PMT is a major virulence factor of P. multocida causing pasteurellosis in man and animals and is responsible for atrophic rhinitis in pigs. PMT modulates various signaling pathways, including phospholipase C beta and RhoA, by acting on the heterotrimeric G proteins G alpha(q) and G alpha(12/13), respectively. Here we report that PMT is a powerful activator of G(i) protein. We show that PMT decreases basal isoproterenol and forskolin-stimulated cAMP accumulation in intact Swiss 3T3 cells, inhibits adenylyl cyclase activity in cell membrane preparations, and enhances the inhibition of cAMP accumulation caused by lysophosphatidic acid via endothelial differentiation gene receptors. PMT-mediated inhibition of cAMP production is independent of toxin activation of G alpha(q) and/or G alpha(12/13). Although the effects of PMT are not inhibited by PTx, PMT blocks PTx-catalyzed ADP-ribosylation of Gi. PMT also inhibits steady-state GTPase activity and GTP binding of G(i) in Swiss 3T3 cell membranes stimulated by lysophosphatidic acid. The data indicate that PMT is a novel activator of G(i), modulating its GTPase activity and converting it into a PTx-insensitive state.	[Orth, Joachim H. C.; Fester, Ines; Preuss, Inga; Agnoletto, Laura; Aktories, Klaus] Univ Freiburg, Inst Expt & Klin Pharmacol & Toxicol, D-79104 Freiburg, Germany; [Wilson, Brenda A.] Univ Illinois, Dept Microbiol, Urbana, IL 61801 USA	University of Freiburg; University of Illinois System; University of Illinois Urbana-Champaign	Aktories, K (corresponding author), Univ Freiburg, Inst Expt & Klin Pharmacol & Toxicol, D-79104 Freiburg, Germany.	Klaus.Aktories@pharmakol.uni-freiburg.de	Aktories, Klaus/CAJ-5682-2022	Aktories, Klaus/0000-0002-5397-0436; Agnoletto, Laura/0000-0002-6236-362X	NIAID NIH HHS [R01 AI038396] Funding Source: Medline; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI038396] Funding Source: NIH RePORTER	NIAID NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))		Akam EC, 1997, BRIT J PHARMACOL, V121, P1203, DOI 10.1038/sj.bjp.0701238; Aminova LR, 2008, PROTEIN SCI, V17, P945, DOI 10.1110/ps.083445408; Busch C, 2001, INFECT IMMUN, V69, P3628, DOI 10.1128/IAI.69.6.3628-3634.2001; CASEY PJ, 1988, J BIOL CHEM, V263, P2577; GIL J, 1991, J CELL BIOL, V113, P943, DOI 10.1083/jcb.113.4.943; Gill D M, 1977, Adv Cyclic Nucleotide Res, V8, P85; HEPLER JR, 1992, TRENDS BIOCHEM SCI, V17, P383, DOI 10.1016/0968-0004(92)90005-T; HIGASHIJIMA T, 1988, J BIOL CHEM, V263, P6491; JOHNSON RA, 1994, METHOD ENZYMOL, V238, P31; KATADA T, 1986, J BIOL CHEM, V261, P8182; KATADA T, 1982, P NATL ACAD SCI-BIOL, V79, P3129, DOI 10.1073/pnas.79.10.3129; Kitadokoro K, 2007, P NATL ACAD SCI USA, V104, P5139, DOI 10.1073/pnas.0608197104; Lax AJ, 2001, INT J MED MICROBIOL, V291, P261, DOI 10.1078/1438-4221-00129; Milligan G, 2003, TRENDS PHARMACOL SCI, V24, P87, DOI 10.1016/S0165-6147(02)00027-5; Mullan PB, 1996, INFECT IMMUN, V64, P959, DOI 10.1128/IAI.64.3.959-965.1996; MURAYAMA T, 1983, J BIOL CHEM, V258, P3319; Nurnberg B, 1997, BACTERIAL TOXINS TOO, P47; Offermanns S, 1998, EMBO J, V17, P4304, DOI 10.1093/emboj/17.15.4304; Orth JHC, 2005, J BIOL CHEM, V280, P36701, DOI 10.1074/jbc.M507203200; Orth JHC, 2004, J BIOL CHEM, V279, P34150, DOI 10.1074/jbc.M405353200; Orth JHC, 2003, BIOCHEMISTRY-US, V42, P4971, DOI 10.1021/bi0272959; Orth JHC, 2007, CELL SIGNAL, V19, P2174, DOI 10.1016/j.cellsig.2007.06.016; Orth JHC, 2007, J BIOL CHEM, V282, P3050, DOI 10.1074/jbc.M609018200; Pullinger GD, 2001, INFECT IMMUN, V69, P7839, DOI 10.1128/IAI.69.12.7839-7850.2001; ROZENGURT E, 1990, P NATL ACAD SCI USA, V87, P123, DOI 10.1073/pnas.87.1.123; SEIFERT R, 1992, EUR J BIOCHEM, V203, P143, DOI 10.1111/j.1432-1033.1992.tb19839.x; SPICHER K, 1994, BIOCHEM BIOPH RES CO, V198, P906, DOI 10.1006/bbrc.1994.1129; STADDON JM, 1991, J BIOL CHEM, V266, P4840; Takasaki J, 2004, J BIOL CHEM, V279, P47438, DOI 10.1074/jbc.M408846200; TOYOSHIGE M, 1994, BIOCHEMISTRY-US, V33, P4865, DOI 10.1021/bi00182a014; UI M, 1990, ADP RIBOSYLATING TOX, P45; Vogt S, 2003, J BIOL CHEM, V278, P28743, DOI 10.1074/jbc.M304570200; Ward PN, 1998, INFECT IMMUN, V66, P5636, DOI 10.1128/IAI.66.12.5636-5642.1998; Wilson BA, 2000, INFECT IMMUN, V68, P4531, DOI 10.1128/IAI.68.8.4531-4538.2000; Wilson BA, 2005, REV PHYSIOL BIOCH P, V152, P93, DOI 10.1007/s10254-004-0032-6; Wilson BA, 1997, J BIOL CHEM, V272, P1268, DOI 10.1074/jbc.272.20.12961; Wilson BA, 2005, COMPREHENSIVE SOURCE, P430; Zywietz A, 2001, J BIOL CHEM, V276, P3840, DOI 10.1074/jbc.M007819200	38	38	39	0	2	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	AUG 22	2008	283	34					23288	23294		10.1074/jbc.M803435200	http://dx.doi.org/10.1074/jbc.M803435200			7	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	337SI	18583341	hybrid			2022-12-27	WOS:000258455400041
J	Rabu, C; Wipf, P; Brodsky, JL; High, S				Rabu, Catherine; Wipf, Peter; Brodsky, Jeffrey L.; High, Stephen			A precursor-specific role for Hsp40/Hsc70 during tail-anchored protein integration at the endoplasmic reticulum	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							SIGNAL-RECOGNITION PARTICLE; MOLECULAR CHAPERONES; MEMBRANE INSERTION; ATPASE ACTIVITY; TRANSLOCATION; PATHWAY; YEAST; IDENTIFICATION; MECHANISMS; INHIBITOR	Tail-anchored (TA) protein synthesis at the endoplasmic reticulum (ER) represents a distinct and novel process that provides a paradigm for understanding post-translational membrane insertion in eukaryotes. The major route for delivering TA proteins to the ER requires both ATP and one or more cytosolic factors that facilitate efficient membrane insertion. Until recently, the identity of these cytosolic components was elusive, but two candidates have now been suggested to promote ATP-dependent TA protein integration. The first is the cytosolic chaperone complex of Hsp40/Hsc70, and the second is a novel ATPase denoted Asna-1 or TRC40. In this study we focus on the role of the Hsp40/Hsc70 complex in promoting TA protein biogenesis at the ER. We show that the membrane integration of most TA proteins is stimulated by Hsp40/Hsc70 when using purified components and a reconstituted system. In contrast, when both Hsp40/Hsc70 and Asna-1/TRC40 are provided as a complete system, small molecule inhibition of Hsp40/Hsc70 indicates that only a subset of TA proteins are obligatory clients for this chaperone-mediated delivery route. We show that the hydrophobicity of the TA region dictates whether a precursor is delivered to the ER via the Hsp40/Hsc70 or Asna-1/TRC40-dependent route, and we conclude that these distinct cytosolic ATPases are responsible for two different ATP-dependent pathways of TA protein biogenesis.	[Rabu, Catherine; High, Stephen] Univ Manchester, Fac Life Sci, Manchester M13 9PT, Lancs, England; [Wipf, Peter] Univ Pittsburgh, Dept Chem, Pittsburgh, PA 15260 USA; [Brodsky, Jeffrey L.] Univ Pittsburgh, Dept Biol Sci, Pittsburgh, PA 15260 USA	University of Manchester; Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh	High, S (corresponding author), Univ Manchester, Fac Life Sci, Michael Smith Bldg,Oxford Rd, Manchester M13 9PT, Lancs, England.	stephen.high@manchester.ac.uk	Rabu, Catherine/K-7369-2015; Wipf, Peter/AAG-1771-2021	Rabu, Catherine/0000-0001-8405-2809; Wipf, Peter/0000-0001-7693-5863; High, Stephen/0000-0002-4532-8152	National Institutes of Health [P50-GM067082]; Biotechnology and Biological Sciences Research Council; Biotechnology and Biological Sciences Research Council [BB/D007879/1] Funding Source: researchfish; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [P50GM067082] Funding Source: NIH RePORTER; BBSRC [BB/D007879/1] Funding Source: UKRI	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Biotechnology and Biological Sciences Research Council(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); Biotechnology and Biological Sciences Research Council(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); BBSRC(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC))	This work was supported, in whole or in part, by National Institutes of Health Grant P50-GM067082 from the NIGMS for support of the P50 Chemical Methodologies and Library Development Program at the University of Pittsburgh (to P. W.). This work was also supported by a Biotechnology and Biological Sciences Research Council project grant (to S. H.). The costs of publication of this article were defrayed in part by the payment of page charges. This article must therefore be hereby marked "advertisement" in accordance with 18 U. S. C. Section 1734 solely to indicate this fact.	Abell BM, 2007, J CELL SCI, V120, P1743, DOI 10.1242/jcs.002410; Abell BM, 2003, J BIOL CHEM, V278, P5669, DOI 10.1074/jbc.M209968200; Abell BM, 2004, EMBO J, V23, P2755, DOI 10.1038/sj.emboj.7600281; ANDERSON DJ, 1983, P NATL ACAD SCI-BIOL, V80, P7249, DOI 10.1073/pnas.80.23.7249; Auld KL, 2006, GENETICS, V174, P215, DOI 10.1534/genetics.106.058362; Borgese N, 2003, J CELL BIOL, V161, P1013, DOI 10.1083/jcb.200303069; Borgese N, 2003, BIOCHEM SOC T, V31, P1238; Borgese N, 2007, CURR OPIN CELL BIOL, V19, P368, DOI 10.1016/j.ceb.2007.04.019; Brambillasca S, 2006, J CELL BIOL, V175, P767, DOI 10.1083/jcb.200608101; Chang YW, 2008, J BIOL CHEM, V283, P15502, DOI 10.1074/jbc.M708992200; Egea PF, 2005, CURR OPIN STRUC BIOL, V15, P213, DOI 10.1016/j.sbi.2005.03.007; Favaloro V, 2008, J CELL SCI, V121, P1832, DOI 10.1242/jcs.020321; Fewell SW, 2004, J BIOL CHEM, V279, P51131, DOI 10.1074/jbc.M404857200; Fewell SW, 2001, J BIOL CHEM, V276, P910, DOI 10.1074/jbc.M008535200; FRYDMAN J, 1994, NATURE, V370, P111, DOI 10.1038/370111a0; GILMORE R, 1993, CELL, V75, P589, DOI 10.1016/0092-8674(93)90476-7; High S, 2004, BIOCHEM SOC T, V32, P659, DOI 10.1042/BST0320659; Kalbfleisch T, 2007, TRAFFIC, V8, P1687, DOI 10.1111/j.1600-0854.2007.00661.x; Kao G, 2007, CELL, V128, P577, DOI 10.1016/j.cell.2006.12.031; Kim PK, 1997, BIOCHEMISTRY-US, V36, P8873, DOI 10.1021/bi970090t; King C, 1999, BIOCHEMISTRY-US, V38, P12452, DOI 10.1021/bi9902788; KUTAY U, 1995, EMBO J, V14, P217, DOI 10.1002/j.1460-2075.1995.tb06994.x; Kutay Ulrike, 1993, Trends in Cell Biology, V3, P72, DOI 10.1016/0962-8924(93)90066-A; Lee MJ, 2008, CURR BIOL, V18, P211, DOI 10.1016/j.cub.2008.01.007; Mukhopadhyay R, 2006, FEBS LETT, V580, P3889, DOI 10.1016/j.febslet.2006.06.017; Mutka SC, 2001, MOL BIOL CELL, V12, P577, DOI 10.1091/mbc.12.3.577; Ng DTW, 1996, J CELL BIOL, V134, P269, DOI 10.1083/jcb.134.2.269; Ngosuwan J, 2003, J BIOL CHEM, V278, P7034, DOI 10.1074/jbc.M210544200; NILSSON I, 1993, J BIOL CHEM, V268, P5798; Rabu C, 2007, CURR BIOL, V17, pR472, DOI 10.1016/j.cub.2007.04.031; Rodina A, 2007, NAT CHEM BIOL, V3, P498, DOI 10.1038/nchembio.2007.10; Schuldiner M, 2005, CELL, V123, P507, DOI 10.1016/j.cell.2005.08.031; Setoguchi K, 2006, EMBO J, V25, P5635, DOI 10.1038/sj.emboj.7601438; Stefanovic S, 2007, CELL, V128, P1147, DOI 10.1016/j.cell.2007.01.036; Wattenberg BW, 2007, BIOSCIENCE REP, V27, P385, DOI 10.1007/s10540-007-9061-0; Wilson CM, 2007, J CELL SCI, V120, P648, DOI 10.1242/jcs.000729; Wright CM, 2008, BIOORGAN MED CHEM, V16, P3291, DOI 10.1016/j.bmc.2007.12.014; Yabal M, 2003, J BIOL CHEM, V278, P3489, DOI 10.1074/jbc.M210253200	38	88	89	0	4	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	OCT 10	2008	283	41					27504	27513		10.1074/jbc.M804591200	http://dx.doi.org/10.1074/jbc.M804591200			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	355OW	18667436	Green Accepted, hybrid, Green Published			2022-12-27	WOS:000259719200021
J	Hegde, ML; Theriot, CA; Das, A; Hegde, PM; Guo, ZG; Gary, RK; Hazra, TK; Shen, BH; Mitra, S				Hegde, Muralidhar L.; Theriot, Corey A.; Das, Aditi; Hegde, Pavana M.; Guo, Zhigang; Gary, Ronald K.; Hazra, Tapas K.; Shen, Binghui; Mitra, Sankar			Physical and functional interaction between human oxidized base-specific DNA glycosylase NEIL1 and flap endonuclease 1	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							CELL NUCLEAR ANTIGEN; PURIFIED HUMAN PROTEINS; EXCISION-REPAIR; MAMMALIAN-CELLS; REPLICATION FORK; STRUCTURAL BASIS; POLYMERASE-BETA; WRN HELICASE; FEN-1; PCNA	The S phase-specific activation of NEIL1 and not of the other DNA glycosylases responsible for repairing oxidatively damaged bases in mammalian genomes and the activation of NEIL1 by proliferating cell nuclear antigen (PCNA) suggested preferential action by NEIL1 in oxidized base repair during DNA replication. Here we show that NEIL1 interacts with flap endonuclease 1 (FEN-1), an essential component of the DNA replication. FEN-1 is present in the NEIL1 immunocomplex isolated from human cell extracts, and the two proteins colocalize in the nucleus. FEN-1 stimulates the activity of NEIL1 in vitro in excising 5-hydroxyuracil from duplex, bubble, forked, and single-stranded DNA substrates by up to 5-fold. The disordered region near the C terminus of NEIL1, which is dispensable for activity, is necessary and sufficient for high affinity binding to FEN-1 (K-D congruent to 0.2 mu M). The interacting interface of FEN-1 is localized in its disordered C-terminal region uniquely present in mammalian orthologs. Fine structure mapping identified several Lys and Arg residues in this region that form salt bridges with Asp and Glu residues in NEIL1. NEIL1 was previously shown to initiate single nucleotide excision repair, which does not require FEN-1 or PCNA. The present study shows that NEIL1 could also participate in strand displacement repair synthesis (long patch repair (LP-BER)) mediated by FEN-1 and stimulated by PCNA. Interaction between NEIL1 and FEN-1 is essential for efficient NEIL1-initiated LP-BER. These studies strongly implicate NEIL1 in a distinct subpathway of LP-BER in replicating genomes.	[Hegde, Muralidhar L.; Theriot, Corey A.; Das, Aditi; Hegde, Pavana M.; Hazra, Tapas K.; Mitra, Sankar] Univ Texas Med Branch, Dept Biochem & Mol Biol, Galveston, TX 77555 USA; [Guo, Zhigang; Shen, Binghui] City Hope Natl Med Ctr, Dept Radiat Biol, Duarte, CA 91010 USA; [Guo, Zhigang; Shen, Binghui] Beckman Res Inst, Duarte, CA 91010 USA; [Gary, Ronald K.] Univ Nevada, Dept Chem, Las Vegas, NV 89154 USA	University of Texas System; University of Texas Medical Branch Galveston; City of Hope; City of Hope; Beckman Research Institute of City of Hope; Nevada System of Higher Education (NSHE); University of Nevada Las Vegas	Mitra, S (corresponding author), Univ Texas Med Branch, Dept Biochem & Mol Biol, 6-136 Med Res Bldg,Route 1079, Galveston, TX 77555 USA.	samitra@utmb.edu	Classen, Scott/AAY-8176-2020; Gary, Ronald K/A-8650-2008	Gary, Ronald K/0000-0001-5079-1953; Shen, Binghui/0000-0002-4408-407X; Hegde, Muralidhar/0000-0001-7333-8123; Dixit, Pavana/0000-0003-0811-3942	National Institutes of Health United States Public Health Service Research [P01 CA092584, R01 CA81063, R01 CA53791, P30 ES06676, R01 CA102271, R01 CA073764]; NATIONAL CANCER INSTITUTE [R01CA081063, R01CA073764, P01CA092584, R01CA102271, R01CA053791] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES [P30ES006676] Funding Source: NIH RePORTER	National Institutes of Health United States Public Health Service Research(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS))	This work was supported, in whole or in part, by National Institutes of Health United States Public Health Service Research Grants P01 CA092584, R01 CA81063, R01 CA53791, and P30 ES06676 (to S. M.); R01 CA102271 (to T. K. H.); and R01 CA073764 (to B. H. S.). The costs of publication of this article were defrayed in part by the payment of page charges. This article must therefore be hereby marked "advertisement" in accordance with 18 U. S. C. Section 1734 solely to indicate this fact.	AMES BN, 1993, P NATL ACAD SCI USA, V90, P7915, DOI 10.1073/pnas.90.17.7915; Bandaru V, 2002, DNA REPAIR, V1, P517, DOI 10.1016/S1568-7864(02)00036-8; Bhakat KK, 2006, MOL CELL BIOL, V26, P1654, DOI 10.1128/MCB.26.5.1654-1665.2006; Cadet JL, 1998, NEUROCHEM INT, V32, P117, DOI 10.1016/S0197-0186(97)00031-4; Chapados BR, 2004, CELL, V116, P39, DOI 10.1016/S0092-8674(03)01036-5; Das A, 2007, J BIOL CHEM, V282, DOI 10.1074/jbc.M703343200; Das A, 2006, DNA REPAIR, V5, P1439, DOI 10.1016/j.dnarep.2006.07.003; Das S, 2007, J BIOL CHEM, V282, P28474, DOI 10.1074/jbc.M704672200; Dianova II, 2001, BIOCHEMISTRY-US, V40, P12639, DOI 10.1021/bi011117i; Dizdaroglu M, 2002, FREE RADICAL BIO MED, V32, P1102, DOI 10.1016/S0891-5849(02)00826-2; Dou H, 2003, J BIOL CHEM, V278, P49679, DOI 10.1074/jbc.M308658200; Dou H, 2008, J BIOL CHEM, V283, P3130, DOI 10.1074/jbc.M709186200; Fortini P, 1998, BIOCHEMISTRY-US, V37, P3575, DOI 10.1021/bi972999h; Frosina G, 1996, J BIOL CHEM, V271, P9573, DOI 10.1074/jbc.271.16.9573; Gary R, 1997, J BIOL CHEM, V272, P24522, DOI 10.1074/jbc.272.39.24522; GRISHAM MB, 1986, AM J PHYSIOL, V251, pG567, DOI 10.1152/ajpgi.1986.251.4.G567; Guan X, 2007, NUCLEIC ACIDS RES, V35, P2463, DOI 10.1093/nar/gkm075; Guo ZG, 2008, J MOL BIOL, V377, P679, DOI 10.1016/j.jmb.2007.10.074; Hazra TK, 2002, J BIOL CHEM, V277, P30417, DOI 10.1074/jbc.C200355200; Hazra TK, 2002, P NATL ACAD SCI USA, V99, P3523, DOI 10.1073/pnas.062053799; Hegde ML, 2008, CELL RES, V18, P27, DOI 10.1038/cr.2008.8; Heller RC, 2006, NATURE, V439, P557, DOI 10.1038/nature04329; Heller RC, 2006, NAT REV MOL CELL BIO, V7, P932, DOI 10.1038/nrm2058; Hilser VJ, 2007, P NATL ACAD SCI USA, V104, P8311, DOI 10.1073/pnas.0700329104; Ikeda S, 1998, J BIOL CHEM, V273, P21585, DOI 10.1074/jbc.273.34.21585; Jayaraman L, 1998, GENE DEV, V12, P462, DOI 10.1101/gad.12.4.462; Kedar PS, 2002, J BIOL CHEM, V277, P31115, DOI 10.1074/jbc.M201497200; Klungland A, 1997, EMBO J, V16, P3341, DOI 10.1093/emboj/16.11.3341; Krokan HE, 2000, FEBS LETT, V476, P73, DOI 10.1016/S0014-5793(00)01674-4; Leppard JB, 2003, MOL CELL BIOL, V23, P5919, DOI 10.1128/MCB.23.16.5919-5927.2003; Lieber MR, 1997, BIOESSAYS, V19, P233, DOI 10.1002/bies.950190309; Liu R, 2006, NUCLEIC ACIDS RES, V34, P1772, DOI 10.1093/nar/gkl106; Liu Y, 2004, ANNU REV BIOCHEM, V73, P589, DOI 10.1146/annurev.biochem.73.012803.092453; Matsumoto Y, 1999, J BIOL CHEM, V274, P33703, DOI 10.1074/jbc.274.47.33703; Morland I, 2002, NUCLEIC ACIDS RES, V30, P4926, DOI 10.1093/nar/gkf618; Pascucci B, 1999, J BIOL CHEM, V274, P33696, DOI 10.1074/jbc.274.47.33696; Podlutsky AJ, 2001, EMBO J, V20, P1477, DOI 10.1093/emboj/20.6.1477; Radicella JP, 1997, P NATL ACAD SCI USA, V94, P8010, DOI 10.1073/pnas.94.15.8010; Sakurai S, 2005, EMBO J, V24, P683, DOI 10.1038/sj.emboj.7600519; Sharma S, 2005, NUCLEIC ACIDS RES, V33, P6769, DOI 10.1093/nar/gki1002; Sharma S, 2004, MOL BIOL CELL, V15, P734, DOI 10.1091/mbc.E03-08-0567; Shen BH, 2005, BIOESSAYS, V27, P717, DOI 10.1002/bies.20255; Takao M, 2002, EMBO J, V21, P3486, DOI 10.1093/emboj/cdf350; Wiederhold L, 2004, MOL CELL, V15, P209, DOI 10.1016/j.molcel.2004.06.003; Zharkov DO, 2003, DNA REPAIR, V2, P839, DOI 10.1016/S1568-7864(03)00084-3	45	80	82	0	5	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	OCT 3	2008	283	40					27028	27037		10.1074/jbc.M802712200	http://dx.doi.org/10.1074/jbc.M802712200			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	353RT	18662981	Green Published, hybrid			2022-12-27	WOS:000259586600023
J	Zahn, C; Jaschke, A; Weiske, J; Hommel, A; Hesse, D; Augustin, R; Lu, L; Hong, WJ; Florian, S; Scheepers, A; Joost, HG; Huber, O; Schurmann, A				Zahn, Claudia; Jaschke, Alexander; Weiske, Joerg; Hommel, Angela; Hesse, Deike; Augustin, Robert; Lu, Lei; Hong, Wanjin; Florian, Simone; Scheepers, Andrea; Joost, Hans-Georg; Huber, Otmar; Schuermann, Annette			ADP-ribosylation factor-like GTPase ARFRP1 is required for trans-golgi to plasma membrane trafficking of E-cadherin	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ADHERENS JUNCTIONS; CELL-ADHESION; N-CADHERIN; GENE-EXPRESSION; PROTEIN SYS1P; MOUSE EMBRYOS; GRIP DOMAINS; BETA-CATENIN; COMPLEX; FAMILY	ADP-ribosylation factor-related protein 1 (ARFRP1) plays a specific role in Golgi function controlling recruitment of GRIP domain proteins and ARL1 to the trans-Golgi. Deletion of the mouse Arfrp1 gene causes embryonic lethality during early gastrulation, because epiblast cells detach from the ectodermal cell layer and do not differentiate to mesodermal tissue. Here we show that in Arfrp1(-/-) embryos E-cadherin is mistargeted to intracellular compartments, whereas in control embryos it is present at the cell surface of trophectodermal and ectodermal cells. In enterocytes of intestine-specific Arfrp1 null mutants (Arfrp1vil(-/-)), E-cadherin is associated with intracellular membranes, partially colocalizing with the cis-Golgi marker GM130 or with punctae close to the cell surface. In contrast, in control enterocytes E-cadherin is exclusively located in the lateral membranes. In addition, ARL1 is dislocated from Golgi membranes to the cytosol of Arfrp1vil(-/-) enterocytes. Depletion of endogenous ARFRP1 by RNA interference leads to a dislocation of E-cadherin from the cell surface in HeLa cells and to a reduced cell aggregation in Ltk(-) Ecad cells. ARFRP1 was coimmunoprecipitated in a complex with E-cadherin, alpha-catenin, beta-catenin, gamma-catenin, and p120(ctn) from lysates of Madin-Darby canine kidney cells stably expressing myc-ARFRP1. These data indicate that knock-out of Arfrp1 disrupts the trafficking of E-cadherin through the Golgi and suggest an essential role of the GTPase in trans-Golgi network function.	[Zahn, Claudia; Jaschke, Alexander; Hommel, Angela; Hesse, Deike; Augustin, Robert; Scheepers, Andrea; Joost, Hans-Georg; Schuermann, Annette] German Inst Human Nutr Potsdam Rehbrucke, Dept Pharmacol, D-14558 Nuthetal, Germany; [Weiske, Joerg; Huber, Otmar] Charite Univ Med Berlin, Cent Dept, Lab Med & Pathobiochem, D-12200 Berlin, Germany; [Lu, Lei; Hong, Wanjin] Inst Mol & Cell Biol, Membrane Biol Lab, Singapore 138673, Singapore; [Florian, Simone] German Inst Human Nutr Potsdam Rehbrucke, Dept Toxicol, D-14558 Nuthetal, Germany	Deutsches Institut fur Ernahrungsforschung Potsdam-Rehbrucke (DIfE); Free University of Berlin; Humboldt University of Berlin; Charite Universitatsmedizin Berlin; Agency for Science Technology & Research (A*STAR); A*STAR - Institute of Molecular & Cell Biology (IMCB); Deutsches Institut fur Ernahrungsforschung Potsdam-Rehbrucke (DIfE)	Schurmann, A (corresponding author), German Inst Human Nutr Potsdam Rehbrucke, Dept Pharmacol, Arthur Scheunert Allee 114-116, D-14558 Nuthetal, Germany.	schuermann@dife.de	Hesse, Deike/F-5716-2018; Huber, Otmar/AAA-4548-2021; Joost, Hans-Georg/J-4462-2013; HONG, Wanjin/E-9927-2010; Lu, Lei/A-2225-2011	Hesse, Deike/0000-0001-5915-8003; Huber, Otmar/0000-0003-4359-1747; Joost, Hans-Georg/0000-0002-5860-606X; Lu, Lei/0000-0002-8192-1471; Schurmann, Annette/0000-0002-4113-4377	Deutsche Forschungsgemeinschaft [750/5-2, 750/5-3]	Deutsche Forschungsgemeinschaft(German Research Foundation (DFG))	This work was supported by the Deutsche Forschungsgemeinschaft Grants Schu 750/5-2 and Schu 750/5-3 (to A.S.) and the Sonnenfeld-Stiftung (to O.H.). The costs of publication of this article were defrayed in part by the payment of page charges. This article must therefore be hereby marked "advertisement" in accordance with 18 U.S.C. Section 1734 solely to indicate this fact.	Abe K, 2008, P NATL ACAD SCI USA, V105, P13, DOI 10.1073/pnas.0710504105; Angres B, 2001, DEV DYNAM, V221, P182, DOI 10.1002/dvdy.1146; Angst BD, 2001, J CELL SCI, V114, P625; Barth AIM, 1997, J CELL BIOL, V136, P693, DOI 10.1083/jcb.136.3.693; Behnia R, 2004, NAT CELL BIOL, V6, P405, DOI 10.1038/ncb1120; Bryant DM, 2004, TRENDS CELL BIOL, V14, P427, DOI 10.1016/j.tcb.2004.07.007; Buchmann J, 2007, ENDOCRINOLOGY, V148, P1561, DOI 10.1210/en.2006-1244; Chen XY, 2003, J CELL BIOL, V163, P547, DOI 10.1083/jcb.200305137; D'Souza-Schorey C, 2005, TRENDS CELL BIOL, V15, P19, DOI 10.1016/j.tcb.2004.11.002; Davis MA, 2003, J CELL BIOL, V163, P525, DOI 10.1083/jcb.200307111; Drees F, 2005, CELL, V123, P903, DOI 10.1016/j.cell.2005.09.021; DUBAND JL, 1988, DEVELOPMENT, V103, P325; Fukata M, 2001, NAT REV MOL CELL BIO, V2, P887, DOI 10.1038/35103068; HATTA K, 1986, NATURE, V320, P447, DOI 10.1038/320447a0; HATTA K, 1987, DEV BIOL, V120, P215, DOI 10.1016/0012-1606(87)90119-9; Huber O, 1999, J CELL SCI, V112, P4415; Kahn RA, 2006, J CELL BIOL, V172, P645, DOI 10.1083/jcb.200512057; KAHN RA, 2003, PROTEINS CELL REGULA; Kamei T, 1999, ONCOGENE, V18, P6776, DOI 10.1038/sj.onc.1203114; KASPER M, 1995, HISTOCHEM CELL BIOL, V104, P383, DOI 10.1007/BF01458132; KLINOWSKA TCM, 1994, DIFFERENTIATION, V57, P7, DOI 10.1046/j.1432-0436.1994.5710007.x; Leckband D, 2002, STRUCTURE, V10, P739, DOI 10.1016/S0969-2126(02)00783-9; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; Lock JG, 2005, TRAFFIC, V6, P1142, DOI 10.1111/j.1600-0854.2005.00349.x; Lowe SL, 1996, J CELL SCI, V109, P209; Lu L, 2003, MOL BIOL CELL, V14, P3767, DOI 10.1091/mbc.E03-01-0864; Lussier C, 2000, MICROSC RES TECHNIQ, V51, P169; Madison BB, 2002, J BIOL CHEM, V277, P33275, DOI 10.1074/jbc.M204935200; Mueller AG, 2002, MOL CELL BIOL, V22, P1488, DOI 10.1128/MCB.22.5.1488-1494.2002; NAGAFUCHI A, 1988, EMBO J, V7, P3679, DOI 10.1002/j.1460-2075.1988.tb03249.x; Palacios F, 2002, NAT CELL BIOL, V4, P929, DOI 10.1038/ncb881; Panic B, 2003, MOL CELL, V12, P863, DOI 10.1016/S1097-2765(03)00356-3; Panic B, 2003, CURR BIOL, V13, P405, DOI 10.1016/S0960-9822(03)00091-5; Perez-Moreno M, 2003, CELL, V112, P535, DOI 10.1016/S0092-8674(03)00108-9; Pujuguet P, 2003, MOL BIOL CELL, V14, P2181, DOI 10.1091/mbc.E02-07-0410; Radice GL, 1997, DEV BIOL, V181, P64, DOI 10.1006/dbio.1996.8443; Schurmann A, 1999, J BIOL CHEM, V274, P9744, DOI 10.1074/jbc.274.14.9744; Schurmann A, 1995, J BIOL CHEM, V270, P30657, DOI 10.1074/jbc.270.51.30657; Setty SRG, 2004, NAT CELL BIOL, V6, P414, DOI 10.1038/ncb1121; Setty SRG, 2003, CURR BIOL, V13, P401, DOI 10.1016/S0960-9822(03)00089-7; Shin HW, 2005, J CELL SCI, V118, P4039, DOI 10.1242/jcs.02524; Vleminckx K, 1999, BIOESSAYS, V21, P211, DOI 10.1002/(SICI)1521-1878(199903)21:3<211::AID-BIES5>3.3.CO;2-G; Wang B, 2005, AM J PHYSIOL-CELL PH, V288, pC1411, DOI 10.1152/ajpcell.00533.2004; WEILAND M, 1990, BIOCHEM J, V270, P331, DOI 10.1042/bj2700331; Weiske J, 2005, J CELL SCI, V118, P3117, DOI 10.1242/jcs.02437; Weiske J, 2001, J BIOL CHEM, V276, P41175, DOI 10.1074/jbc.M105769200; Wheelock MJ, 2003, ANNU REV CELL DEV BI, V19, P207, DOI 10.1146/annurev.cellbio.19.011102.111135; Xiao KY, 2005, MOL BIOL CELL, V16, P5141, DOI 10.1091/mbc.E05-05-0440; Xiao KY, 2003, J CELL BIOL, V163, P535, DOI 10.1083/jcb.200306001; Yamada S, 2005, CELL, V123, P889, DOI 10.1016/j.cell.2005.09.020; Yap AS, 1998, J CELL BIOL, V141, P779, DOI 10.1083/jcb.141.3.779; Zahn C, 2006, MOL MEMBR BIOL, V23, P475, DOI 10.1080/09687860600840100; Zbar AP, 2004, J GASTROENTEROL, V39, P413, DOI 10.1007/s00535-004-1335-8	53	28	29	1	3	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	OCT 3	2008	283	40					27179	27188		10.1074/jbc.M802108200	http://dx.doi.org/10.1074/jbc.M802108200			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	353RT	18662990	hybrid			2022-12-27	WOS:000259586600038
J	Harada, K; Ogai, A; Takahashi, T; Kitakaze, M; Matsubara, H; Oh, H				Harada, Koichiro; Ogai, Akiko; Takahashi, Tomosaburo; Kitakaze, Masafumi; Matsubara, Hiroaki; Oh, Hidemasa			Crossveinless-2 controls bone morphogenetic protein signaling during early cardiomyocyte differentiation in P19 cells	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							EARLY CARDIOMYOGENESIS; BMP INDUCTION; MESODERM; ENDODERM; HEART; GASTRULATION; INHIBITION; EXPRESSION; GROWTH; PLAYS	Increasing evidence indicates that bone morphogenetic proteins (BMPs) are crucial for cardiac induction, specification, and development. Although signaling of BMPs is tightly regulated through soluble BMP-binding proteins, how they regulate BMP signaling during cardiac differentiation remains unknown. To identify molecules responsible for BMP signaling during early cardiomyocyte differentiation of P19 cells, cDNA subtraction was performed. We found a bimodal expression of the BMP-binding protein Crossveinless-2 (Cv2) during cardiomyocyte differentiation; Cv2 is temporally expressed earlier than cardiac transcription factors such as Nkx2.5 and Tbx5 and acts as a suppressor for BMP signaling in P19 cells. We established a P19 clonal cell line harboring a cardiac alpha-myosin heavy chain promoter-driven enhanced green fluorescent protein gene to monitor cardiac differentiation by flow cytometry. Treatment with BMP2 during the first 2 days of differentiation suppressed cardiomyocyte differentiation through activation of downstream targets Smad1/5/8 protein and Id1 gene, whereas treatment with Cv2 conversely inhibited Smad1/5/8 activation and Id1 expression, leading to increased generation of cardiac cells. RNA interference-mediated knockdown (KD) of endogenous Cv2 showed increased Smad1/5/8 activation and impaired cardiomyocyte differentiation. Expression of cardiac mesoderm markers was reduced, whereas expression of Id1 and endoderm markers such as Sox7, Hnf4, and E-cadherin was induced in Cv2-kinase dead cells. These phenotypes were rescued by the addition of Cv2 protein to the culture media during the first 2 days of differentiation or co-culture with parental cells. These data suggest that Cv2 may specify cardiac mesodermal lineage through inhibition of BMP signaling at early stage of cardiogenesis.	[Harada, Koichiro; Takahashi, Tomosaburo; Matsubara, Hiroaki; Oh, Hidemasa] Kyoto Univ Hosp, Translat Res Ctr, Dept Expt Therapeut, Kyoto 6068507, Japan; [Takahashi, Tomosaburo; Matsubara, Hiroaki] Kyoto Prefectural Univ Med, Dept Cardiovasc Med, Kyoto 6028566, Japan; [Harada, Koichiro; Kitakaze, Masafumi] Natl Cardiovasc Ctr, Osaka 5658565, Japan; [Ogai, Akiko] Natl Cardiovasc Ctr, Res Inst, Dept Epidemiol, Osaka 5658565, Japan	Kyoto University; Kyoto Prefectural University of Medicine; National Cerebral & Cardiovascular Center - Japan; National Cerebral & Cardiovascular Center - Japan	Harada, K (corresponding author), 5-7-1 Fujishiro Dai, Osaka 5658565, Japan.	kharada_kuhp@yahoo.co.jp			Japan Cardiovascular Research Foundation; Ministry of Education, Culture, Sports, Science, and Technology of Japan; Ministry of Health, Labor, and Welfare of Japan	Japan Cardiovascular Research Foundation; Ministry of Education, Culture, Sports, Science, and Technology of Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); Ministry of Health, Labor, and Welfare of Japan(Ministry of Health, Labour and Welfare, Japan)	This work was supported by grants from Japan Cardiovascular Research Foundation, grants-in-aid from the Ministry of Education, Culture, Sports, Science, and Technology of Japan, and grants-in-aid from the Ministry of Health, Labor, and Welfare of Japan. The costs of publication of this article were defrayed in part by the payment of page charges. This article must therefore be hereby marked "advertisement" in accordance with 18 U. S. C. Section 1734 solely to indicate this fact.	Andree B, 1998, MECH DEVELOP, V70, P119, DOI 10.1016/S0925-4773(97)00186-X; Angello JC, 2006, DEV DYNAM, V235, P2122, DOI 10.1002/dvdy.20863; Binnerts ME, 2004, BIOCHEM BIOPH RES CO, V315, P272, DOI 10.1016/j.bbrc.2004.01.048; Buckingham M, 2005, NAT REV GENET, V6, P826, DOI 10.1038/nrg1710; Coffinier C, 2002, MECH DEVELOP, V119, pS179, DOI 10.1016/S0925-4773(03)00113-8; Coles E, 2004, DEVELOPMENT, V131, P5309, DOI 10.1242/dev.01419; Conley CA, 2000, DEVELOPMENT, V127, P3947; Coucouvanis E, 1999, DEVELOPMENT, V126, P535; De Robertis EM, 2004, ANNU REV CELL DEV BI, V20, P285, DOI 10.1146/annurev.cellbio.20.011403.154124; Dosch R, 1997, DEVELOPMENT, V124, P2325; Hogan BLM, 1996, GENE DEV, V10, P1580, DOI 10.1101/gad.10.13.1580; Ikeya M, 2006, DEVELOPMENT, V133, P4463, DOI 10.1242/dev.02647; Kamimura M, 2004, DEV DYNAM, V230, P434, DOI 10.1002/dvdy.20069; Katagiri T, 2002, GENES CELLS, V7, P949, DOI 10.1046/j.1365-2443.2002.00573.x; Ladd AN, 1998, DEV BIOL, V204, P407, DOI 10.1006/dbio.1998.9094; Lough J, 2000, DEV DYNAM, V217, P327, DOI 10.1002/(SICI)1097-0177(200004)217:4<327::AID-DVDY1>3.3.CO;2-B; McMahon JA, 1998, GENE DEV, V12, P1438, DOI 10.1101/gad.12.10.1438; Mishina Y, 1995, GENE DEV, V9, P3027, DOI 10.1101/gad.9.24.3027; Miura S, 2006, DEVELOPMENT, V133, P3767, DOI 10.1242/dev.02552; Monzen K, 2001, J CELL BIOL, V153, P687, DOI 10.1083/jcb.153.4.687; Moser M, 2003, MOL CELL BIOL, V23, P5664, DOI 10.1128/MCB.23.16.5664-5679.2003; Naito AT, 2005, CIRC RES, V97, P144, DOI 10.1161/01.RES.0000175241.92285.f8; Norton JD, 2000, J CELL SCI, V113, P3897; PARAMESWARAN M, 1995, DEV GENET, V17, P16, DOI 10.1002/dvg.1020170104; Rentzsch F, 2006, DEVELOPMENT, V133, P801, DOI 10.1242/dev.02250; Runnicki M.A., 1987, TERATOCARCINOMAS EMB, P19; Saga Y, 1996, DEVELOPMENT, V122, P2769; SATER AK, 1989, DEVELOPMENT, V105, P821; Schultheiss TM, 1997, GENE DEV, V11, P451, DOI 10.1101/gad.11.4.451; Srivastava D, 2000, NATURE, V407, P221, DOI 10.1038/35025190; Stary M, 2005, EXP CELL RES, V310, P331, DOI 10.1016/j.yexcr.2005.07.013; Tada S, 2005, DEVELOPMENT, V132, P4363, DOI 10.1242/dev.02005; Takahashi T, 2003, CIRCULATION, V107, P1912, DOI 10.1161/01.CIR.0000064899.53876.A3; van Wijk B, 2007, CARDIOVASC RES, V74, P244, DOI 10.1016/j.cardiores.2006.11.022; WILKINSON DG, 1990, NATURE, V343, P657, DOI 10.1038/343657a0; Ying QL, 2003, CELL, V115, P281, DOI 10.1016/S0092-8674(03)00847-X; Yuasa S, 2005, NAT BIOTECHNOL, V23, P607, DOI 10.1038/nbt1093; Zhang HB, 1996, DEVELOPMENT, V122, P2977	38	13	13	0	2	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	SEP 26	2008	283	39					26705	26713		10.1074/jbc.M801485200	http://dx.doi.org/10.1074/jbc.M801485200			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	350GV	18662983	Green Published, hybrid			2022-12-27	WOS:000259341600044
J	Tsai, CY; Chou, CK; Yang, CW; Lai, YC; Liang, CC; Chen, CM; Tsai, TF				Tsai, Ching-Yen; Chou, Chen-Kung; Yang, Chu-Wen; Lai, Yi-Chen; Liang, Chih-Chia; Chen, Chun-Ming; Tsai, Ting-Fen			Hurp deficiency in mice leads to female infertility caused by an implantation defect	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							EMBRYO IMPLANTATION; SPINDLE CHECKPOINT; MOUSE MODELS; AURORA-A; KINETOCHORE; RAN; RECEPTOR	First revealed in cancer studies, HURP ( hepatoma up-regulated protein) is a cell cycle-associated gene with elevated expression in the G(2)/M phase. Cell culture studies have revealed that HURP is an essential factor required for spindle formation and chromosome congression during mitosis. However, the function of HURP in an in vivo context has not been explored. Wegenerated a Hurp knock-out (Hurp(-/-)) mouse to investigate the role of HURP in development under normal physiological conditions. Hurp(-/-) mice develop normally and are indistinguishable from their wild-type littermates. Interestingly, breeding experiments revealed that Hurp(-/-) females are completely infertile, whereas the males reproduce normally. Ovulation, fertilization, and pre-implantation embryo development are normal; however, the Hurp(-/-) females are unable to form implantation sites due to an inability to undergo the decidual reaction. This is caused by a defect in endometrial stromal proliferation that leads to implantation failure. Additionally, HURP expression in the uterus coincides with the implantation stage and can be induced by estrogen treatment. Our results demonstrate for the first time that HURP affects endometrial stromal proliferation during implantation but is dispensable during normal development in mice; specifically, HURP has an essential function in uterine biology.	[Tsai, Ching-Yen; Lai, Yi-Chen; Liang, Chih-Chia; Chen, Chun-Ming; Tsai, Ting-Fen] Natl Yang Ming Univ, Dept Life Sci, Taipei 112, Taiwan; [Tsai, Ching-Yen; Lai, Yi-Chen; Liang, Chih-Chia; Chen, Chun-Ming; Tsai, Ting-Fen] Natl Yang Ming Univ, Inst Genome Sci, Taipei 112, Taiwan; [Chou, Chen-Kung] Chang Gung Univ, Dept Life Sci, Tao Yuan 333, Taiwan; [Yang, Chu-Wen] Soochow Univ, Dept Microbiol, Taipei 111, Taiwan; [Tsai, Ting-Fen] Natl Hlth Res Inst, Div Mol & Genom Med, Zhunan 350, Taiwan	National Yang Ming Chiao Tung University; National Yang Ming Chiao Tung University; Chang Gung University; Soochow University; National Health Research Institutes - Taiwan	Tsai, TF (corresponding author), Natl Yang Ming Univ, Dept Life Sci, 155 Li Nong St,Sec 2, Taipei 112, Taiwan.	tftsai@ym.edu.tw	Tsai, Ching-Yen/AEX-9366-2022	Tsai, Ching-Yen/0000-0001-7964-6661; Chen, Chun-Ming/0000-0001-8873-7602	National Research Program for Genomic Medicine [95HC007, NSC96-2752-B-010-004-PAE, CMRPD160471]; National Science Council [NSC96-2320-B-031-001-MY2]; Ministry of Education "Aim for the Top University Plan."; National Yang-Ming University Genome Research Center; National Science Council	National Research Program for Genomic Medicine(Ministry of Science and Technology, Taiwan); National Science Council(Ministry of Science and Technology, Taiwan); Ministry of Education "Aim for the Top University Plan."(Ministry of Education, Taiwan); National Yang-Ming University Genome Research Center; National Science Council(Ministry of Science and Technology, Taiwan)	This work was supported by National Research Program for Genomic Medicine Grants 95HC007 and NSC96-2752-B-010-004-PAE (to T.-F.T.), CMRPD160471 (to C.-K.C.), and NSC96-2320-B-031-001-MY2 (to C.-W.Y.) from the National Science Council and by a grant from the Ministry of Education "Aim for the Top University Plan." Work performed in the Microarray and Gene Expression Analysis Core Facility of the National Yang-Ming University Genome Research Center was supported by the National Research Program for Genomic Medicine, National Science Council. The costs of publication of this article were defrayed in part by the payment of page charges. This article must therefore be hereby marked "advertisement" in accordance with 18 U. S. C. Section 1734 solely to indicate this fact.	Bao L, 2007, ENDOCRINOLOGY, V148, P2326, DOI 10.1210/en.2006-1643; Bassal S, 2001, GENOMICS, V77, P5, DOI 10.1006/geno.2001.6570; Bole-Feysot C, 1998, ENDOCR REV, V19, P225, DOI 10.1210/edrv.19.3.0334; Chen RH, 2007, J BIOMED SCI, V14, P475, DOI 10.1007/s11373-007-9157-3; Dey SK, 2004, ENDOCR REV, V25, P341, DOI 10.1210/er.2003-0020; Fausto N, 2006, HEPATOLOGY, V43, pS45, DOI 10.1002/hep.20969; Greene AK, 2003, J INVEST SURG, V16, P99, DOI 10.1080/08941930390194424; Hewitt SC, 2003, MOL ENDOCRINOL, V17, P2070, DOI 10.1210/me.2003-0146; Hogan B, 1994, MANIPULATING MOUSE E; Koffa MD, 2006, CURR BIOL, V16, P743, DOI 10.1016/j.cub.2006.03.056; Lee KY, 2007, TRENDS ENDOCRIN MET, V18, P234, DOI 10.1016/j.tem.2007.06.002; Lee KY, 2007, MOL CELL BIOL, V27, P5468, DOI 10.1128/MCB.00342-07; Lim H, 1997, CELL, V91, P197, DOI 10.1016/S0092-8674(00)80402-X; Matsumoto H, 2002, J BIOL CHEM, V277, P29260, DOI 10.1074/jbc.M203996200; Sanderson HS, 2006, CURR BIOL, V16, pR466, DOI 10.1016/j.cub.2006.05.032; Sillje HHW, 2006, CURR BIOL, V16, P731, DOI 10.1016/j.cub.2006.02.070; Tranguch S, 2005, P NATL ACAD SCI USA, V102, P14326, DOI 10.1073/pnas.0505775102; Tsou AP, 2003, ONCOGENE, V22, P298, DOI 10.1038/sj.onc.1206129; Wang HB, 2006, NAT REV GENET, V7, P185, DOI 10.1038/nrg1808; Wilde A, 2006, J CELL BIOL, V173, P829, DOI 10.1083/jcb.200605150; Wong J, 2008, MOL BIOL CELL, V19, P2083, DOI 10.1091/mbc.E07-10-1088; Wong J, 2006, J CELL BIOL, V173, P879, DOI 10.1083/jcb.200511132; Yu CTR, 2005, MOL CELL BIOL, V25, P5789, DOI 10.1128/MCB.25.14.5789-5800.2005; Yu HT, 2006, J CELL BIOL, V173, P153, DOI 10.1083/jcb.200601172	24	17	18	0	3	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	SEP 26	2008	283	39					26302	26306		10.1074/jbc.C800117200	http://dx.doi.org/10.1074/jbc.C800117200			5	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	350GV	18676373	Green Published, hybrid			2022-12-27	WOS:000259341600002
J	Castelle, C; Guiral, M; Malarte, G; Ledgham, F; Leroy, G; Brugna, M; Giudici-Orticoni, MT				Castelle, Cindy; Guiral, Marianne; Malarte, Guillaume; Ledgham, Fouzia; Leroy, Gisele; Brugna, Myriam; Giudici-Orticoni, Marie-Therese			A new iron-oxidizing/O-2-reducing supercomplex spanning both inner and outer membranes, isolated from the extreme acidophile Acidithiobacillus ferrooxidans	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							BACTERIUM THIOBACILLUS-FERROOXIDANS; ELECTRON-TRANSFER; AQUIFEX-AEOLICUS; BC(1) COMPLEXES; IRON OXIDATION; PROTEIN; OXIDASE; PROKARYOTES	The iron respiratory chain of the acidophilic bacterium Acidithiobacillus ferrooxidans involves various metalloenzymes. Here we demonstrate that the oxygen reduction pathway from ferrous iron (named downhill pathway) is organized as a super-complex constituted of proteins located in the outer and inner membranes as well as in the periplasm. For the first time, the outer membrane-bound cytochrome c Cyc2 was purified, and we showed that it is responsible for iron oxidation and determined that its redox potential is the highest measured to date for a cytochrome c. The organization of metalloproteins inside the supramolecular structure was specified by protein-protein interaction experiments. The isolated complex spanning the two membranes had iron oxidase as well as oxygen reductase activities, indicating functional electron transfer between the first iron electron acceptor, Cyc2, and the Cu-A center of cytochrome c oxidase aa3. This is the first characterization of a respirasome from an acidophilic bacterium. In Acidithiobacillus ferrooxidans, O-2 reduction from ferrous iron must be coupled to the energy-consuming reduction of NAD(+)(P) from ferrous iron (uphill pathway) required for CO2 fixation and other anabolic processes. Besides the proteins involved in the O-2 reduction, there were additional proteins in the supercomplex, involved in uphill pathway (bc complex and cytochrome Cyc(42)), suggesting a possible physical link between these two pathways.	[Castelle, Cindy; Guiral, Marianne; Malarte, Guillaume; Ledgham, Fouzia; Leroy, Gisele; Brugna, Myriam; Giudici-Orticoni, Marie-Therese] IBSM CNRS, Lab Bioengn & Ingn Prot, F-13402 Marseille 20, France	Centre National de la Recherche Scientifique (CNRS); UDICE-French Research Universities; Aix-Marseille Universite	Giudici-Orticoni, MT (corresponding author), IBSM CNRS, Lab Bioengn & Ingn Prot, 31 Chemin Joseph Aiguier, F-13402 Marseille 20, France.	giudici@ibsm.cnrs-mrs.fr		Castelle, Cindy/0000-0002-0751-9804				Appia-Ayme C, 1999, APPL ENVIRON MICROB, V65, P4781; Arnesano F, 2003, P NATL ACAD SCI USA, V100, P3814, DOI 10.1073/pnas.0636904100; ARREDONDO R, 1994, APPL ENVIRON MICROB, V60, P2846, DOI 10.1128/AEM.60.8.2846-2851.1994; Baker-Austin C, 2007, TRENDS MICROBIOL, V15, P165, DOI 10.1016/j.tim.2007.02.005; Brasseur G, 2004, BBA-BIOENERGETICS, V1656, P114, DOI 10.1016/j.bbabio.2004.02.008; Brasseur G, 2002, BBA-BIOENERGETICS, V1555, P37, DOI 10.1016/S0005-2728(02)00251-7; Brugna-Guiral M, 2003, EXTREMOPHILES, V7, P145, DOI 10.1007/s00792-002-0306-3; Bruscella P, 2007, MICROBIOL-SGM, V153, P102, DOI 10.1099/mic.0.2006/000067-0; Chen FP, 2007, J REPROD MED, V52, P317; CROAL LR, 2007, ANNU REV GENET, V38, P175; Dutton P L, 1978, Methods Enzymol, V54, P411; EDMONSO DG, 1993, CURRENT PROTOCOLS MO, P1; Elbehti A, 2000, J BACTERIOL, V182, P3602, DOI 10.1128/JB.182.12.3602-3606.2000; Elbehti A, 1999, J BIOL CHEM, V274, P16760, DOI 10.1074/jbc.274.24.16760; Giudici-Orticoni MT, 2000, BIOCHEMISTRY-US, V39, P7205, DOI 10.1021/bi992846p; Guiral M, 2005, J BIOL CHEM, V280, P42004, DOI 10.1074/jbc.M508034200; Jeans C, 2008, ISME J, V2, P542, DOI 10.1038/ismej.2008.17; Malarte G, 2005, BIOCHEMISTRY-US, V44, P6471, DOI 10.1021/bi048425b; Marlovits TC, 2004, SCIENCE, V306, P1040, DOI 10.1126/science.1102610; Marshall MJ, 2006, PLOS BIOL, V4, P1324, DOI 10.1371/journal.pbio.0040268; Mick DU, 2007, EMBO J, V26, P4347, DOI 10.1038/sj.emboj.7601862; Myllykallio H, 2000, TRENDS MICROBIOL, V8, P493, DOI 10.1016/S0966-842X(00)01831-X; Poyau A, 1999, FEBS LETT, V462, P416, DOI 10.1016/S0014-5793(99)01571-9; Quaranta D, 2007, J BACTERIOL, V189, P5361, DOI 10.1128/JB.00377-07; Rohwerder T, 2003, APPL MICROBIOL BIOT, V63, P239, DOI 10.1007/s00253-003-1448-7; Schagger H, 2001, IUBMB LIFE, V52, P119, DOI 10.1080/15216540152845911; Schulke N, 1999, J BIOL CHEM, V274, P22847, DOI 10.1074/jbc.274.32.22847; Stroh A, 2004, J BIOL CHEM, V279, P5000, DOI 10.1074/jbc.M309505200; THOMAS PE, 1976, ANAL BIOCHEM, V75, P168, DOI 10.1016/0003-2697(76)90067-1; Weber KA, 2006, NAT REV MICROBIOL, V4, P752, DOI 10.1038/nrmicro1490; Wittig I, 2007, METHOD CELL BIOL, V80, P723, DOI 10.1016/S0091-679X(06)80033-6; YEATES TO, 2007, BIOCHEM SOC T, V35	32	129	133	2	43	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	SEP 19	2008	283	38					25803	25811		10.1074/jbc.M802496200	http://dx.doi.org/10.1074/jbc.M802496200			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	348GX	18632666	Green Published, hybrid			2022-12-27	WOS:000259200100006
J	De-La-Pena, C; Lei, Z; Watson, BS; Sumner, LW; Vivanco, JM				De-la-Pena, Clelia; Lei, Zhentian; Watson, Bonnie S.; Sumner, Lloyd W.; Vivanco, Jorge M.			Root-microbe communication through protein secretion	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							PV. TOMATO DC3000; MEDICAGO-TRUNCATULA; EXTRACELLULAR PROTEINS; 2-DIMENSIONAL ELECTROPHORESIS; SINORHIZOBIUM-MELILOTI; ANTIMICROBIAL PROTEINS; GENE-EXPRESSION; ALFALFA SEEDS; NOD GENES; RHIZOBIUM	Biotic interactions in the rhizosphere are biologically important, and although many of those interactions have been well studied, the role of secreted proteins in the cross-talk between microbes and roots has not been investigated. Here, protein secretion was studied during the communication between the roots of two plants (Medicago sativa and Arabidopsis thaliana) and the bacterial symbiont of one of these species (Sinorhizobium meliloti strain Rm1021) and an opportunistic bacterial pathogen of A. thaliana (Pseudomonas syringae pv. tomato DC3000) using a proteomic approach. It was found that protein exudation in the M. sativa-S. meliloti interaction caused an increase in the secretion of seven plant proteins, such as hydrolases, peptidases, and peroxidases among others in two or more time points compared with the plant control. In addition, four proteins, all of bacterial origin, were increased 1.5-fold more in this interaction compared with S. meliloti alone. However, these proteins were not induced when M. sativa was inoculated with P. syringae DC3000. The interaction between A. thaliana and P. syringae DC3000 highly induced the secretion of several plant proteins related to defense soon after initial contact with P. syringae, but these proteins were not secreted in the incompatible interaction with S. meliloti. The results of this study reveal a specific, protein level cross-talk between roots and microbes. These results suggest that secreted proteins may be a critical component in the process of signaling and recognition that occurs between compatible and incompatible interactions.	[De-la-Pena, Clelia; Vivanco, Jorge M.] Colorado State Univ, Ctr Rhizosphere Biol, Ft Collins, CO 80523 USA; [De-la-Pena, Clelia; Vivanco, Jorge M.] Colorado State Univ, Dept Hort & Landscape Architecture, Ft Collins, CO 80523 USA; [Lei, Zhentian; Watson, Bonnie S.; Sumner, Lloyd W.] Samuel Roberts Noble Fdn Inc, Ardmore, OK 73401 USA	Colorado State University; Colorado State University; Noble Research Institute	Vivanco, JM (corresponding author), Colorado State Univ, Ctr Rhizosphere Biol, 217 Shepardson Bldg, Ft Collins, CO 80523 USA.	j.vivanco@colostate.edu	Sumner, Lloyd W/A-3270-2013	Sumner, Lloyd W/0000-0002-4086-663X; De-la-Pena, Clelia/0000-0002-9093-9489; Watson, Bonnie/0000-0003-2222-8156	National Science Foundation [MCB-0542642]	National Science Foundation(National Science Foundation (NSF))	These studies were supported by National Science Foundation Grant MCB-0542642 (to J. M. V.). The costs of publication of this article were defrayed in part by the payment of page charges. This article must therefore be hereby marked "advertisement" in accordance with 18 U. S. C. Section 1734 solely to indicate this fact.	Akiyama K, 2005, NATURE, V435, P824, DOI 10.1038/nature03608; Ampe F, 2003, GENOME BIOL, V4, DOI 10.1186/gb-2003-4-2-r15; ANTELMANN H, 2006, MICROBIAL PROTEOMICS; Badri DV, 2008, PLANT PHYSIOL, V146, P762, DOI 10.1104/pp.107.109587; Bais HP, 2006, ANNU REV PLANT BIOL, V57, P233, DOI 10.1146/annurev.arplant.57.032905.105159; Bais HP, 2004, TRENDS PLANT SCI, V9, P26, DOI 10.1016/j.tplants.2003.11.008; Barea JM, 2005, J EXP BOT, V56, P1761, DOI 10.1093/jxb/eri197; BARON C, 1995, TRENDS BIOTECHNOL, V13, P356, DOI 10.1016/S0167-7799(00)88981-7; BLUM H, 1987, ELECTROPHORESIS, V8, P93, DOI 10.1002/elps.1150080203; Boekhorst J, 2006, MICROBIOL-SGM, V152, P3175, DOI 10.1099/mic.0.29217-0; BOHLOOL BB, 1974, SCIENCE, V185, P269, DOI 10.1126/science.185.4147.269; BRADFORD MM, 1976, ANAL BIOCHEM, V72, P248, DOI 10.1016/0003-2697(76)90527-3; Buell CR, 2003, P NATL ACAD SCI USA, V100, P10181, DOI 10.1073/pnas.1731982100; Bueno P, 2001, NEW PHYTOL, V152, P91, DOI 10.1046/j.0028-646x.2001.00246.x; Butler JL, 2003, APPL ENVIRON MICROB, V69, P6793, DOI 10.1128/AEM.69.11.6793-6800.2003; Chinchilla D, 2007, NATURE, V448, P497, DOI 10.1038/nature05999; COOK D, 1995, PLANT CELL, V7, P43, DOI 10.1105/tpc.7.1.43; Creasy DM, 2002, PROTEOMICS, V2, P1426, DOI 10.1002/1615-9861(200210)2:10<1426::AID-PROT1426>3.0.CO;2-5; CURRIER WW, 1976, PLANT PHYSIOL, V57, P820, DOI 10.1104/pp.57.5.820; Den Herder J, 2007, PLANT PHYSIOL, V144, P717, DOI 10.1104/pp.107.098764; EGELHOFF TT, 1985, J BACTERIOL, V164, P591, DOI 10.1128/JB.164.2.591-599.1985; ESNAULT R, 1993, MOL PLANT MICROBE IN, V6, P655, DOI 10.1094/MPMI-6-655; Fedorova M, 2002, PLANT PHYSIOL, V130, P519, DOI 10.1104/pp.006833; Fraysse N, 2003, EUR J BIOCHEM, V270, P1365, DOI 10.1046/j.1432-1033.2003.03492.x; Fritig B, 1998, CURR OPIN IMMUNOL, V10, P16, DOI 10.1016/S0952-7915(98)80025-3; Galibert F, 2001, SCIENCE, V293, P668, DOI 10.1126/science.1060966; Gamas P, 1998, MOL PLANT MICROBE IN, V11, P393, DOI 10.1094/MPMI.1998.11.5.393; Gilois N, 2007, PROTEOMICS, V7, P1719, DOI 10.1002/pmic.200600502; Giraud E, 2007, SCIENCE, V316, P1307, DOI 10.1126/science.1139548; Goormachtig S, 1998, PLANT CELL, V10, P905, DOI 10.1105/tpc.10.6.905; Gramss G, 1998, NEW PHYTOL, V138, P401, DOI 10.1046/j.1469-8137.1998.00128.x; HALVERSON LJ, 1984, PLANT PHYSIOL, V74, P84, DOI 10.1104/pp.74.1.84; Hammond-Kosack KE, 2003, CURR OPIN BIOTECH, V14, P177, DOI 10.1016/S0958-1669(03)00035-1; Harrison MJ, 2005, ANNU REV MICROBIOL, V59, P19, DOI 10.1146/annurev.micro.58.030603.123749; HARTWIG UA, 1991, PLANT PHYSIOL, V95, P797, DOI 10.1104/pp.95.3.797; HARTWIG UA, 1989, PLANT PHYSIOL, V91, P1138, DOI 10.1104/pp.91.3.1138; Hause B, 2007, PHYTOCHEMISTRY, V68, P101, DOI 10.1016/j.phytochem.2006.09.025; He YW, 2004, NAT IMMUNOL, V5, P88, DOI 10.1038/ni1021; HUNGRIA M, 1991, PLANT PHYSIOL, V97, P759, DOI 10.1104/pp.97.2.759; Jones KM, 2008, P NATL ACAD SCI USA, V105, P704, DOI 10.1073/pnas.0709338105; Kasprzewska A, 2003, CELL MOL BIOL LETT, V8, P809; Keith RC, 2003, MICROBIOL-SGM, V149, P1127, DOI 10.1099/mic.0.26109-0; Kiely PD, 2006, MICROB ECOL, V51, P257, DOI 10.1007/s00248-006-9019-y; Kim ST, 2003, PROTEOMICS, V3, P2368, DOI 10.1002/pmic.200300577; Kourtev PS, 2003, SOIL BIOL BIOCHEM, V35, P895, DOI 10.1016/S0038-0717(03)00120-2; Kunze G, 2004, PLANT CELL, V16, P3496, DOI 10.1105/tpc.104.026765; Lei Z, 2005, MOL CELL PROTEOMICS, V4, P1812, DOI 10.1074/mcp.D500005-MCP200; Lin CC, 1999, BIOL FERT SOILS, V30, P83, DOI 10.1007/s003740050591; Long SR, 1996, PLANT CELL, V8, P1885, DOI 10.1105/tpc.8.10.1885; Loyola-Vargas VM, 2007, PLANTA, V225, P301, DOI 10.1007/s00425-006-0349-2; Mathesius U, 2003, P NATL ACAD SCI USA, V100, P1444, DOI 10.1073/pnas.262672599; MAXWELL CA, 1989, PLANT PHYSIOL, V91, P842, DOI 10.1104/pp.91.3.842; MEADE HM, 1982, J BACTERIOL, V149, P114, DOI 10.1128/JB.149.1.114-122.1982; MOORE RA, 1989, CAN J MICROBIOL, V35, P910, DOI 10.1139/m89-151; Morgan JAW, 2005, J EXP BOT, V56, P1729, DOI 10.1093/jxb/eri205; MURASHIGE T, 1962, PHYSIOL PLANTARUM, V15, P473, DOI 10.1111/j.1399-3054.1962.tb08052.x; Neumann G, 2002, TRENDS PLANT SCI, V7, P162, DOI 10.1016/S1360-1385(02)02241-0; Nobrega FM, 2005, PLANT SOIL, V272, P223, DOI 10.1007/s11104-004-4954-1; OFARRELL PH, 1975, J BIOL CHEM, V250, P4007; Oldroyd GED, 2007, SCIENCE, V315, P52, DOI 10.1126/science.1137588; Perkins DN, 1999, ELECTROPHORESIS, V20, P3551, DOI 10.1002/(SICI)1522-2683(19991201)20:18<3551::AID-ELPS3551>3.0.CO;2-2; Perret X, 2000, MICROBIOL MOL BIOL R, V64, P180, DOI 10.1128/MMBR.64.1.180-201.2000; PETERS NK, 1986, SCIENCE, V233, P977, DOI 10.1126/science.3738520; Prayitno J, 2006, J PROTEOME RES, V5, P3084, DOI 10.1021/pr0602646; Rodriguez-Navarro DN, 2007, FEMS MICROBIOL LETT, V272, P127, DOI 10.1111/j.1574-6968.2007.00761.x; SAMAC DA, 1990, PLANT PHYSIOL, V93, P907, DOI 10.1104/pp.93.3.907; Santos R, 2000, MOL MICROBIOL, V38, P750, DOI 10.1046/j.1365-2958.2000.02178.x; Shaw LJ, 2006, ENVIRON MICROBIOL, V8, P1867, DOI 10.1111/j.1462-2920.2006.01141.x; Singh BK, 2004, TRENDS MICROBIOL, V12, P386, DOI 10.1016/j.tim.2004.06.008; Smolka MB, 2003, PROTEOMICS, V3, P224, DOI 10.1002/pmic.200390031; STAEHELIN C, 1995, PLANT PHYSIOL, V108, P1607, DOI 10.1104/pp.108.4.1607; Steenhoudt O, 2000, FEMS MICROBIOL REV, V24, P487, DOI 10.1111/j.1574-6976.2000.tb00552.x; Sumner LW, 2002, RAPID COMMUN MASS SP, V16, P160, DOI 10.1002/rcm.555; Takeda N, 2007, PHYTOCHEMISTRY, V68, P111, DOI 10.1016/j.phytochem.2006.09.022; Tamasloukht M, 2003, PLANT PHYSIOL, V131, P1468, DOI 10.1104/pp.012898; Taylor CB, 1998, PLANT CELL, V10, P873; Teplitski M, 2000, MOL PLANT MICROBE IN, V13, P637, DOI 10.1094/MPMI.2000.13.6.637; Thilmony R, 2006, PLANT J, V46, P34, DOI 10.1111/j.1365-313X.2006.02725.x; Thomma BPHJ, 1998, P NATL ACAD SCI USA, V95, P15107, DOI 10.1073/pnas.95.25.15107; Turrini A, 2004, NEW PHYTOL, V163, P393, DOI 10.1111/j.1469-8137.2004.01107.x; van Loon LC, 2006, ANNU REV PHYTOPATHOL, V44, P135, DOI 10.1146/annurev.phyto.44.070505.143425; von Bodman SB, 2003, ANNU REV PHYTOPATHOL, V41, P455, DOI 10.1146/annurev.phyto.41.052002.095652; Wardle DA, 2006, ECOL LETT, V9, P870, DOI 10.1111/j.1461-0248.2006.00931.x; Watt M, 2006, ANN BOT-LONDON, V97, P839, DOI 10.1093/aob/mcl028; Weis VM, 1996, P NATL ACAD SCI USA, V93, P13683, DOI 10.1073/pnas.93.24.13683; Wen FS, 2007, PLANT PHYSIOL, V143, P773, DOI 10.1104/pp.106.091637; WHALEN MC, 1991, PLANT CELL, V3, P49, DOI 10.1105/tpc.3.1.49; Xie ZP, 1999, J EXP BOT, V50, P327, DOI 10.1093/jexbot/50.332.327; Yazaki K, 2006, FEBS LETT, V580, P1183, DOI 10.1016/j.febslet.2005.12.009; Zipfel C, 2004, NATURE, V428, P764, DOI 10.1038/nature02485	90	110	113	0	55	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	SEP 12	2008	283	37					25247	25255		10.1074/jbc.M801967200	http://dx.doi.org/10.1074/jbc.M801967200			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	345QZ	18635546	hybrid			2022-12-27	WOS:000259012700017
J	Dutta, D; Ray, S; Vivian, JL; Paul, S				Dutta, Debasree; Ray, Soma; Vivian, Jay L.; Paul, Soumen			Activation of the VEGFR1 chromatin domain - An angiogenic signal-ETS1/HIF-2 alpha regulatory axis	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ENDOTHELIAL GROWTH-FACTOR; HYPOXIA-INDUCIBLE FACTOR-2-ALPHA; ETS TRANSCRIPTION FACTORS; TYROSINE KINASE; FACTOR RECEPTOR; BONE-MARROW; VASCULAR DEVELOPMENT; TUMOR ANGIOGENESIS; HUMAN GLIOMAS; FLT-1	Angiogenesis is induced by multiple growth factors including vascular endothelial growth factor (VEGF) and fibroblast growth factor 2 (FGF2). In vascular endothelium VEGF signals through two receptor-tyrosine kinases, VEGFR1 and VEGFR2. The VEGFR1 gene encodes both a receptor-tyrosine kinase and a secreted splice variant, soluble VEGFR1. Whereas VEGFR1 is essential for vascular development, mechanisms that regulate VEGFR1 expression in endothelial cells are poorly understood. We demonstrate here that in endothelial cells, FGF2 and epidermal growth factor (EGF) signaling induce VEGFR1 mRNA expression in a combinatorial fashion. EGF/FGF2-mediated VEGFR1 induction is mediated via functional interaction of transcription factors ETS1 and HIF-2 alpha. Mechanistic analyses revealed that in endothelial cells EGF/FGF2 signaling induces ETS1 expression, increases HIF-2 alpha protein level in absence of hypoxia, and recruits both ETS1 and HIF-2 alpha to the VEGFR1 chromatin domain. Knockdown of ETS1 and HIF-2 alpha by RNA interference inhibits EGF/FGF2-induced VEGFR1 expression, and loss of expression is associated with impaired RNA-polymerase II recruitment and histone modifications at the VEGFR1 promoter region. In addition, using a mouse embryonic stem cell in vitro differentiation system, we found that induction of VEGFR1 in embryoid bodies is also associated with ETS1 and HIF-2 alpha recruitment to the VEGFR1 locus. These results establish an angiogenic signal-ETS1/HIF-2 alpha axis that regulates the VEGFR1 chromatin domain to induce VEGFR1 transcription in endothelial cells and in differentiating embryonic stem cells.	[Paul, Soumen] Univ Kansas, Med Ctr, Dept Pathol & Lab Med, Inst Maternal Fetal Biol, Kansas City, KS 66160 USA; Univ Kansas, Med Ctr, Dept Pathol & Lab Med, Div Canc & Dev Biol, Kansas City, KS 66160 USA	University of Kansas; University of Kansas Medical Center; University of Kansas; University of Kansas Medical Center	Paul, S (corresponding author), Univ Kansas, Med Ctr, Dept Pathol & Lab Med, Inst Maternal Fetal Biol, Kansas City, KS 66160 USA.	spaul2@kumc.edu			National Institutes of Health [P20 RR16475]; University of Kansas Cancer Center; NATIONAL CENTER FOR RESEARCH RESOURCES [P20RR016475, P20RR024214] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); University of Kansas Cancer Center; NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR))	This work was supported, in whole or in part, by National Institutes of Health Grant P20 RR16475 (Kansas INBRE). This work was also supported by the University of Kansas Cancer Center. The costs of publication of this article were defrayed in part by the payment of page charges. This article must therefore be hereby marked "advertisement" in accordance with 18 U. S. C. Section 1734 solely to indicate this fact.	Aprelikova O, 2006, CANCER RES, V66, P5641, DOI 10.1158/0008-5472.CAN-05-3345; Autiero M, 2003, NAT MED, V9, P936, DOI 10.1038/nm884; Barleon B, 1997, CANCER RES, V57, P5421; Barleon B, 1996, BLOOD, V87, P3336, DOI 10.1182/blood.V87.8.3336.bloodjournal8783336; BORIES JC, 1995, NATURE, V377, P635, DOI 10.1038/377635a0; Botella LM, 2001, J BIOL CHEM, V276, P34486, DOI 10.1074/jbc.M011611200; Carmeliet P, 2001, NAT MED, V7, P575, DOI 10.1038/87904; Cox CM, 2000, DEV DYNAM, V218, P371, DOI 10.1002/(SICI)1097-0177(200006)218:2<371::AID-DVDY10>3.3.CO;2-Q; Cuenda A, 2000, METH MOL B, V99, P161; Czuwara-Ladykowska J, 2002, J BIOL CHEM, V277, P20399, DOI 10.1074/jbc.M200206200; Duan LJ, 2005, CIRCULATION, V111, P2227, DOI 10.1161/01.CIR.0000163580.98098.A3; Dube A, 1999, CIRC RES, V84, P1177, DOI 10.1161/01.RES.84.10.1177; Elvert G, 2003, J BIOL CHEM, V278, P7520, DOI 10.1074/jbc.M211298200; Ferrara N, 2003, NAT MED, V9, P669, DOI 10.1038/nm0603-669; Ferrara N, 1996, NATURE, V380, P439, DOI 10.1038/380439a0; FOLKMAN J, 1995, NAT MED, V1, P27, DOI 10.1038/nm0195-27; FONG GH, 1995, NATURE, V376, P66, DOI 10.1038/376066a0; FRIESEL RE, 1995, FASEB J, V9, P919, DOI 10.1096/fasebj.9.10.7542215; Gerber HP, 1997, J BIOL CHEM, V272, P23659, DOI 10.1074/jbc.272.38.23659; GOLDMAN CK, 1993, MOL BIOL CELL, V4, P121, DOI 10.1091/mbc.4.1.121; Grass JA, 2003, P NATL ACAD SCI USA, V100, P8811, DOI 10.1073/pnas.1432147100; Hanahan D, 1996, CELL, V86, P353, DOI 10.1016/S0092-8674(00)80108-7; Hiratsuka S, 1998, P NATL ACAD SCI USA, V95, P9349, DOI 10.1073/pnas.95.16.9349; Huang L, 2008, J BIOL CHEM, V283, P7616, DOI 10.1074/jbc.M705839200; Im Hogune, 2004, Methods Mol Biol, V284, P129; Jorissen RN, 2003, EXP CELL RES, V284, P31, DOI 10.1016/S0014-4827(02)00098-8; Kaplan RN, 2005, NATURE, V438, P820, DOI 10.1038/nature04186; Kappas NC, 2008, J CELL BIOL, V181, P847, DOI 10.1083/jcb.200709114; Kearney JB, 2004, BLOOD, V103, P4527, DOI 10.1182/blood-2003-07-2315; KENDALL RL, 1993, P NATL ACAD SCI USA, V90, P10705, DOI 10.1073/pnas.90.22.10705; Le Bras A, 2007, ONCOGENE, V26, P7480, DOI 10.1038/sj.onc.1210566; Lyden D, 2001, NAT MED, V7, P1194, DOI 10.1038/nm1101-1194; MAROULAKOU IG, 1994, ONCOGENE, V9, P1551; MARTINYBARON G, 1993, J BIOL CHEM, V268, P9194; MORISHITA K, 1995, J BIOL CHEM, V270, P27948, DOI 10.1074/jbc.270.46.27948; Nishimoto S, 2006, EMBO REP, V7, P782, DOI 10.1038/sj.embor.7400755; Olsson AK, 2006, NAT REV MOL CELL BIO, V7, P359, DOI 10.1038/nrm1911; Pal S, 2006, J CELL BIOL, V174, P1047, DOI 10.1083/jcb.200603152; Patel SA, 2008, CELL DEATH DIFFER, V15, P628, DOI 10.1038/cdd.2008.17; Peng J, 2000, P NATL ACAD SCI USA, V97, P8386, DOI 10.1073/pnas.140087397; PLATE KH, 1992, NATURE, V359, P845, DOI 10.1038/359845a0; Rahimi N, 2006, FRONT BIOSCI-LANDMRK, V11, P818; Reyes M, 2002, J CLIN INVEST, V109, P337, DOI 10.1172/JCI200214327; Rodriguez-Pascual F, 2003, CIRC RES, V92, P1288, DOI 10.1161/01.RES.0000078491.79697.7F; Sato Y, 2001, CELL STRUCT FUNCT, V26, P19, DOI 10.1247/csf.26.19; Scortegagna M, 2003, NAT GENET, V35, P331, DOI 10.1038/ng1266; Seghezzi G, 1998, J CELL BIOL, V141, P1659, DOI 10.1083/jcb.141.7.1659; SHALABY F, 1995, NATURE, V376, P62, DOI 10.1038/376062a0; Simon MC, 2008, ANNU REV PHYSIOL, V70, P51, DOI 10.1146/annurev.physiol.70.113006.100526; Takeda N, 2004, CIRC RES, V95, P146, DOI 10.1161/01.RES.0000134920.10128.b4; Tanaka K, 1998, J CELL PHYSIOL, V176, P235, DOI 10.1002/(SICI)1097-4652(199808)176:2<235::AID-JCP2>3.0.CO;2-P; Tian H, 1997, GENE DEV, V11, P72, DOI 10.1101/gad.11.1.72; Tian H, 1998, GENE DEV, V12, P3320, DOI 10.1101/gad.12.21.3320; Valter MM, 1999, CANCER RES, V59, P5608; VANDENBUNDER B, 1989, DEVELOPMENT, V107, P265; vanderValk P, 1997, ANN ONCOL, V8, P1023, DOI 10.1023/A:1008265905505; Wakiya K, 1996, J BIOL CHEM, V271, P30823, DOI 10.1074/jbc.271.48.30823; WERNERT N, 1992, AM J PATHOL, V140, P119; Yang C, 1998, MOL CELL BIOL, V18, P2218, DOI 10.1128/MCB.18.4.2218	59	46	48	0	8	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	SEP 12	2008	283	37					25404	25413		10.1074/jbc.M804349200	http://dx.doi.org/10.1074/jbc.M804349200			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	345QZ	18625704	hybrid, Green Published			2022-12-27	WOS:000259012700035
J	Islam, A; Jones, H; Hiroi, T; Lam, J; Zhang, J; Moss, J; Vaughan, M; Levine, SJ				Islam, Aminul; Jones, Heather; Hiroi, Toyoko; Lam, Jonathan; Zhang, Jing; Moss, Joel; Vaughan, Martha; Levine, Stewart J.			cAMP-dependent protein kinase a (PKA) signaling induces TNFR1 exosome-like vesicle release via anchoring of PKA regulatory subunit RII beta to BIG2	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							TUMOR-NECROSIS-FACTOR; FACTOR-BINDING-PROTEIN; CELL-DERIVED-EXOSOMES; BREFELDIN-A; MULTIVESICULAR BODY; FACTOR RECEPTOR; AKAP BINDING; PATHWAY; SPECIFICITY; MECHANISM	The 55-kDa TNFR1 (type I tumor necrosis factor receptor) can be released to the extracellular space by two mechanisms, the proteolytic cleavage and shedding of soluble receptor ectodomains and the release of full-length receptors within exosome-like vesicles. We have shown that the brefeldin A-inhibited guanine nucleotide exchange protein BIG2 associates with TNFR1 and selectively modulates the release of TNFR1 exosome-like vesicles via an ARF1- and ARF3-dependent mechanism. Here, we assessed the role of BIG2 A kinase-anchoring protein (AKAP) domains in the regulation of TNFR1 exosome-like vesicle release from human vascular endothelial cells. We show that 8-bromo-cyclic AMP induced the release of full-length, 55-kDa TNFR1 within exosome-like vesicles via a protein kinase A (PKA)-dependent mechanism. Using RNA interference to decrease specifically the levels of individual PKA regulatory subunits, we demonstrate that RII beta modulates both the constitutive and cAMP-induced release of TNFR1 exosome-like vesicles. Consistent with its AKAP function, BIG2 was required for the cAMP-induced PKA-dependent release of TNFR1 exosome-like vesicles via a mechanism that involved the binding of RII beta to BIG2 AKAP domains B and C. We conclude that both the constitutive and cAMP-induced release of TNFR1 exosome-like vesicles occur via PKA-dependent pathways that are regulated by the anchoring of RII beta to BIG2 via AKAP domains B and C. Thus, BIG2 regulates TNFR1 exosome-like vesicle release by two distinct mechanisms, as a guanine nucleotide exchange protein that activates class I ADP-ribosylation factors and as an AKAP for RII beta that localizes PKA signaling within cellular TNFR1 trafficking pathways.	[Islam, Aminul; Lam, Jonathan; Zhang, Jing; Levine, Stewart J.] NHLBI, Pulm & Vasc Med Branch, Natl Inst Hlth, Bethesda, MD 20892 USA; [Jones, Heather; Hiroi, Toyoko; Moss, Joel; Vaughan, Martha] NHLBI, Translat Med Branch, Natl Inst Hlth, Bethesda, MD 20892 USA	National Institutes of Health (NIH) - USA; NIH National Heart Lung & Blood Institute (NHLBI); National Institutes of Health (NIH) - USA; NIH National Heart Lung & Blood Institute (NHLBI)	Levine, SJ (corresponding author), NHLBI, Pulm & Vasc Med Branch, Natl Inst Hlth, Bldg 10,Rm 6D03,MSC 1590, Bethesda, MD 20892 USA.	levines@nhlbi.nih.gov			Division of Intramural Research; NHLBI; National Institutes of Health; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [Z01HL002544, ZIAHL000627, Z01HL000627, ZIAHL002544] Funding Source: NIH RePORTER	Division of Intramural Research(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NHLBI(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	This work was supported, in whole or in part, by the Division of Intramural Research, NHLBI, National Institutes of Health. The costs of publication of this article were defrayed in part by the payment of page charges. This article must therefore be hereby marked "advertisement" in accordance with 18 U.S.C. Section 1734 solely to indicate this fact.	Alto NM, 2003, P NATL ACAD SCI USA, V100, P4445, DOI 10.1073/pnas.0330734100; BRAKEBUSCH C, 1994, J BIOL CHEM, V269, P32488; Burns-Hamuro LL, 2003, P NATL ACAD SCI USA, V100, P4072, DOI 10.1073/pnas.2628038100; Calzolari A, 2006, J CELL SCI, V119, P4486, DOI 10.1242/jcs.03228; CARR DW, 1991, J BIOL CHEM, V266, P14188; Chaput N, 2006, J LEUKOCYTE BIOL, V80, P471, DOI 10.1189/jlb.0206094; Chen GQ, 2002, SCIENCE, V296, P1634, DOI 10.1126/science.1071924; Cui XL, 2002, J CLIN INVEST, V110, P515, DOI 10.1172/JCI200213847; de Gassart A, 2003, BLOOD, V102, P4336, DOI 10.1182/blood-2003-03-0871; de Rooij J, 1998, NATURE, V396, P474, DOI 10.1038/24884; Delghandi MP, 2005, CELL SIGNAL, V17, P1343, DOI 10.1016/j.cellsig.2005.02.003; Denzer K, 2000, J CELL SCI, V113, P3365; ENGELMANN H, 1989, J BIOL CHEM, V264, P11974; Fevrier B, 2005, TRAFFIC, V6, P10, DOI 10.1111/j.1600-0854.2004.00247.x; Fevrier B, 2004, CURR OPIN CELL BIOL, V16, P415, DOI 10.1016/j.ceb.2004.06.003; Gold MG, 2006, MOL CELL, V24, P383, DOI 10.1016/j.molcel.2006.09.006; Gomez MI, 2007, EMBO J, V26, P701, DOI 10.1038/sj.emboj.7601554; Guan HC, 2005, J BIOL CHEM, V280, P9957, DOI 10.1074/jbc.M412180200; Hawari FI, 2004, P NATL ACAD SCI USA, V101, P1297, DOI 10.1073/pnas.0307981100; Herberg FW, 2000, J MOL BIOL, V298, P329, DOI 10.1006/jmbi.2000.3662; Islam A, 2006, J BIOL CHEM, V281, P6860, DOI 10.1074/jbc.M509397200; Islam A, 2007, J BIOL CHEM, V282, P9591, DOI 10.1074/jbc.M607122200; Kawasaki H, 1998, SCIENCE, V282, P2275, DOI 10.1126/science.282.5397.2275; Kinderman FS, 2006, MOL CELL, V24, P397, DOI 10.1016/j.molcel.2006.09.015; Li HW, 2003, P NATL ACAD SCI USA, V100, P1627, DOI 10.1073/pnas.0337678100; LIPPINCOTTSCHWARTZ J, 1989, CELL, V56, P801, DOI 10.1016/0092-8674(89)90685-5; Locksley RM, 2001, CELL, V104, P487, DOI 10.1016/S0092-8674(01)00237-9; MISUMI Y, 1986, J BIOL CHEM, V261, P1398; Moss J, 1998, J BIOL CHEM, V273, P21431, DOI 10.1074/jbc.273.34.21431; NOPHAR Y, 1990, EMBO J, V9, P3269, DOI 10.1002/j.1460-2075.1990.tb07526.x; OLSSON I, 1989, EUR J HAEMATOL, V42, P270, DOI 10.1111/j.1600-0609.1989.tb00111.x; Raposo G, 1996, J EXP MED, V183, P1161, DOI 10.1084/jem.183.3.1161; Reddy P, 2000, J BIOL CHEM, V275, P14608, DOI 10.1074/jbc.275.19.14608; SCHALL TJ, 1990, CELL, V61, P361, DOI 10.1016/0092-8674(90)90816-W; SECKINGER P, 1989, J BIOL CHEM, V264, P11966; Seino S, 2005, PHYSIOL REV, V85, P1303, DOI 10.1152/physrev.00001.2005; TAYLOR SS, 1990, ANNU REV BIOCHEM, V59, P971, DOI 10.1146/annurev.bi.59.070190.004543; Thery C, 2002, NAT REV IMMUNOL, V2, P569, DOI 10.1038/nri855; Wajant H, 2003, CELL DEATH DIFFER, V10, P45, DOI 10.1038/sj.cdd.4401189; Wallach D, 1999, ANNU REV IMMUNOL, V17, P331, DOI 10.1146/annurev.immunol.17.1.331; WALLACH D, 1991, TUMOR NECROSIS FACTO; WALSH DA, 1968, J BIOL CHEM, V243, P3763; Wang J, 2003, J BIOL CHEM, V278, P21751, DOI 10.1074/jbc.M212662200; Wong W, 2004, NAT REV MOL CELL BIO, V5, P959, DOI 10.1038/nrm1527; Wubbolts R, 2003, J BIOL CHEM, V278, P10963, DOI 10.1074/jbc.M207550200	46	20	22	0	5	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	SEP 12	2008	283	37					25364	25371		10.1074/jbc.M804966200	http://dx.doi.org/10.1074/jbc.M804966200			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	345QZ	18625701	hybrid, Green Published			2022-12-27	WOS:000259012700031
J	Novgorodov, SA; Gudz, TI; Obeid, LM				Novgorodov, Sergei A.; Gudz, Tatyana I.; Obeid, Lina M.			Long-chain ceramide is a potent inhibitor of the mitochondrial permeability transition pore	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Review							NECROSIS-FACTOR-ALPHA; CYTOCHROME-C RELEASE; RAT-LIVER MITOCHONDRIA; APOPTOTIC CELL-DEATH; ADENINE-NUCLEOTIDE TRANSLOCASE; DEPENDENT ANION CHANNEL; 2 SEPARATE SITES; CYCLOPHILIN-D; PROTEIN PHOSPHATASE; CYCLOSPORINE-A	The sphingolipid ceramide has been implicated in mediating cell death that is accompanied by mitochondrial functional alterations. Moreover, ceramide has been shown to accumulate in mitochondria upon induction of apoptotic processes. In this study, we sought to evaluate the effects of natural, highly hydrophobic long-chain ceramides on mitochondrial function in vitro. Ceramide in a dodecane/ethanol delivery system inhibited the opening of the mitochondrial permeability transition pore (PTP) induced by either oxidative stress, SH group cross-linking, or high Ca2+ load, suggesting that the inhibitory point is at a level at which major PTP regulatory pathways converge. Moreover, ceramide had no effect on well known mitochondrial components that modulate PTP activity, such as cyclophilin D, voltage-dependent anion channel, adenine nucleotide transporter, and ATP synthase. The inhibitory effect of ceramide on PTP was not stereospecific, nor was there a preference for ceramide over dihydroceramide. However, the effect of ceramide on PTP was significantly influenced by the fatty acid moiety chain length. These studies are the first to show that long-chain ceramide can influence PTP at physiologically relevant concentrations, suggesting that it is the only known potent natural inhibitor of PTP. These results suggest a novel mechanism of ceramide regulation of mitochondrial function.	[Novgorodov, Sergei A.; Obeid, Lina M.] Med Univ S Carolina, Dept Med, Charleston, SC 29425 USA; [Gudz, Tatyana I.] Med Univ S Carolina, Dept Neurosci, Charleston, SC 29425 USA; [Novgorodov, Sergei A.] Med Univ S Carolina, Dept Biochem & Mol Biol, Charleston, SC 29425 USA; [Gudz, Tatyana I.; Obeid, Lina M.] Ralph H Johnson Vet Affairs Med Ctr, Charleston, SC 29401 USA	Medical University of South Carolina; Medical University of South Carolina; Medical University of South Carolina; US Department of Veterans Affairs; Veterans Health Administration (VHA); Ralph H Johnson VA Medical Center	Obeid, LM (corresponding author), Med Univ S Carolina, Dept Med, 114 Doughty St,POB 250779, Charleston, SC 29425 USA.	obeidl@musc.edu		obeid, lina/0000-0002-0734-0847	National Institutes of Health [AG16583, P20 RR 17677-04, CO6 RR018823]; Veterans Affairs Merit Awards; NATIONAL CENTER FOR RESEARCH RESOURCES [P20RR017677, C06RR018823] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON AGING [R01AG016583] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Veterans Affairs Merit Awards(US Department of Veterans Affairs); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))	This work was supported, in whole or in part, by National Institutes of Health Grant AG16583 (to L. M. O.), National Institutes of Health Grant P20 RR 17677-04 (to T. I. G.), and National Institutes of Health Grant CO6 RR018823. This work was also supported by Veterans Affairs Merit Awards (to T. I. G. and L. M. O.). The costs of publication of this article were defrayed in part by the payment of page charges. This article must therefore be hereby marked "advertisement" in accordance with 18 U. S. C. Section 1734 solely to indicate this fact.	Aoyama M, 1998, BIOCHEM J, V336, P727, DOI 10.1042/bj3360727; Ardail D, 2002, BBA-MOL CELL BIOL L, V1583, P305, DOI 10.1016/S1388-1981(02)00252-4; Ardail D, 2001, FEBS LETT, V488, P160, DOI 10.1016/S0014-5793(00)02332-2; Armstrong JS, 2006, BIOESSAYS, V28, P253, DOI 10.1002/bies.20370; Arora AS, 1997, HEPATOLOGY, V25, P958, DOI 10.1002/hep.510250428; Atlante A, 2005, BBA-BIOENERGETICS, V1708, P50, DOI 10.1016/j.bbabio.2005.01.009; Azoulay-Zohar H, 2004, BIOCHEM J, V377, P347, DOI 10.1042/BJ20031465; Baines CP, 2007, NAT CELL BIOL, V9, P550, DOI 10.1038/ncb1575; Baines CP, 2005, NATURE, V434, P658, DOI 10.1038/nature03434; Bidere N, 2003, J BIOL CHEM, V278, P31401, DOI 10.1074/jbc.M301911200; BIELAWSKA A, 1993, J BIOL CHEM, V268, P26226; Bielawski J, 2006, METHODS, V39, P82, DOI 10.1016/j.ymeth.2006.05.004; Birbes H, 2005, BIOCHEM J, V386, P445, DOI 10.1042/BJ20041627; Birbes H, 2001, FASEB J, V15, P2669, DOI 10.1096/fj.01-0539com; CAMPO ML, 1992, J BIOL CHEM, V267, P8123; Chalfant CE, 1999, J BIOL CHEM, V274, P20313, DOI 10.1074/jbc.274.29.20313; Chalfant CE, 2004, J LIPID RES, V45, P496, DOI 10.1194/jlr.M300347-JLR200; Chen Quan, 2003, Korean Journal of Biological Sciences, V7, P1; Chernyak BV, 1996, EUR J BIOCHEM, V238, P623, DOI 10.1111/j.1432-1033.1996.0623w.x; Chiang CW, 2003, MOL CELL BIOL, V23, P6350, DOI 10.1128/MCB.23.18.6350-6362.2003; Chiang CW, 2001, BLOOD, V97, P1289, DOI 10.1182/blood.V97.5.1289; Corda S, 2001, AM J RESP CELL MOL, V24, P762, DOI 10.1165/ajrcmb.24.6.4228; Costantini P, 1996, J BIOL CHEM, V271, P6746, DOI 10.1074/jbc.271.12.6746; Crompton M, 1999, BIOCHEM J, V341, P233, DOI 10.1042/0264-6021:3410233; Crompton M, 2000, J PHYSIOL-LONDON, V529, P11, DOI 10.1111/j.1469-7793.2000.00011.x; Curtin JF, 2002, J IMMUNOL METHODS, V265, P49, DOI 10.1016/S0022-1759(02)00070-4; Dai Q, 2004, ONCOGENE, V23, P3650, DOI 10.1038/sj.onc.1207430; Datta SR, 1997, CELL, V91, P231, DOI 10.1016/S0092-8674(00)80405-5; Dbaibo GS, 2001, FEBS LETT, V503, P7, DOI 10.1016/S0014-5793(01)02625-4; Di Paola M, 2000, BIOCHEMISTRY-US, V39, P6660, DOI 10.1021/bi9924415; Di Paola M, 2004, J BIOENERG BIOMEMBR, V36, P165, DOI 10.1023/B:JOBB.0000023619.97392.0c; DOBROWSKY RT, 1993, J BIOL CHEM, V268, P15523; Ferraro C, 2000, CELL DEATH DIFFER, V7, P197, DOI 10.1038/sj.cdd.4400595; Fontaine E, 1998, J BIOL CHEM, V273, P25734, DOI 10.1074/jbc.273.40.25734; Frezza C, 2007, NAT PROTOC, V2, P287, DOI 10.1038/nprot.2006.478; Gamard CJ, 1997, J BIOL CHEM, V272, P16474, DOI 10.1074/jbc.272.26.16474; GARCIAECHEVERRIA C, 1993, BIOCHEM BIOPH RES CO, V191, P70, DOI 10.1006/bbrc.1993.1185; GarciaRuiz C, 1997, J BIOL CHEM, V272, P11369; Ghafourifar P, 1999, J BIOL CHEM, V274, P6080, DOI 10.1074/jbc.274.10.6080; Gogvadze V, 2001, J BIOL CHEM, V276, P19066, DOI 10.1074/jbc.M100614200; Grabowski DR, 1998, BIOCHEM PHARMACOL, V56, P345, DOI 10.1016/S0006-2952(98)00159-2; GRAHAM JM, 1999, CURRENT PROTOCOLS CE; Gudz T, 1997, ARCH BIOCHEM BIOPHYS, V342, P143, DOI 10.1006/abbi.1997.0113; Gudz TI, 1997, J BIOL CHEM, V272, P24154, DOI 10.1074/jbc.272.39.24154; HALESTRAP AP, 1990, BIOCHEM J, V268, P153, DOI 10.1042/bj2680153; Hampton MB, 1996, FEBS LETT, V399, P277, DOI 10.1016/S0014-5793(96)01341-5; HAWORTH RA, 1979, ARCH BIOCHEM BIOPHYS, V195, P460, DOI 10.1016/0003-9861(79)90372-2; HAWORTH RA, 1980, J MEMBRANE BIOL, V54, P231, DOI 10.1007/BF01870239; He LH, 2002, FEBS LETT, V512, P1, DOI 10.1016/S0014-5793(01)03314-2; Heinrich M, 2004, CELL DEATH DIFFER, V11, P550, DOI 10.1038/sj.cdd.4401382; Hoppel CL, 1998, J BIOL CHEM, V273, P23495, DOI 10.1074/jbc.273.36.23495; JI L, 1995, FEBS LETT, V358, P211, DOI 10.1016/0014-5793(94)01428-4; KAMO N, 1979, J MEMBRANE BIOL, V49, P105, DOI 10.1007/BF01868720; Kashkar H, 2005, J BIOL CHEM, V280, P20804, DOI 10.1074/jbc.M410869200; Khaled AR, 2001, J BIOL CHEM, V276, P6453, DOI 10.1074/jbc.M006391200; KINNALLY KW, 1993, P NATL ACAD SCI USA, V90, P1374, DOI 10.1073/pnas.90.4.1374; Kokoszka JE, 2004, NATURE, V427, P461, DOI 10.1038/nature02229; Kolesnick RN, 1998, ANNU REV PHYSIOL, V60, P643, DOI 10.1146/annurev.physiol.60.1.643; Krauskopf A, 2006, BBA-BIOENERGETICS, V1757, P590, DOI 10.1016/j.bbabio.2006.02.007; Kristal BS, 1999, J BIOL CHEM, V274, P23169, DOI 10.1074/jbc.274.33.23169; Kroemer G, 2007, PHYSIOL REV, V87, P99, DOI 10.1152/physrev.00013.2006; LENARTOWICZ E, 1991, J BIOENERG BIOMEMBR, V23, P679, DOI 10.1007/BF00785817; Li YM, 2004, BIOCHEM J, V383, P101, DOI 10.1042/BJ20040669; Lin CF, 2004, J BIOL CHEM, V279, P40755, DOI 10.1074/jbc.M404726200; Lin DT, 2002, J BIOL CHEM, V277, P31134, DOI 10.1074/jbc.M112035200; Martinou JC, 2001, NAT REV MOL CELL BIO, V2, P63, DOI 10.1038/35048069; Matsko CM, 2001, BIOCHEM BIOPH RES CO, V287, P1112, DOI 10.1006/bbrc.2001.5696; McFarlane SM, 2000, MOL CELL BIOCHEM, V211, P19, DOI 10.1023/A:1007189911897; McStay GP, 2002, BIOCHEM J, V367, P541, DOI 10.1042/BJ20011672; Mimeault M, 2002, FEBS LETT, V530, P9, DOI 10.1016/S0014-5793(02)03432-4; Montes LR, 2002, J BIOL CHEM, V277, P11788, DOI 10.1074/jbc.M111568200; Mootha VK, 2001, EMBO J, V20, P661, DOI 10.1093/emboj/20.4.661; Nakagawa T, 2005, NATURE, V434, P652, DOI 10.1038/nature03317; Narita M, 1998, P NATL ACAD SCI USA, V95, P14681, DOI 10.1073/pnas.95.25.14681; Novgorodov SA, 2005, J BIOL CHEM, V280, P16096, DOI 10.1074/jbc.M411707200; NOVGORODOV SA, 1989, FEBS LETT, V247, P255, DOI 10.1016/0014-5793(89)81347-X; NOVGORODOV SA, 1994, ARCH BIOCHEM BIOPHYS, V311, P219, DOI 10.1006/abbi.1994.1230; Osawa Y, 2005, J BIOL CHEM, V280, P27879, DOI 10.1074/jbc.M503002200; Pacher P, 2001, EMBO J, V20, P4107, DOI 10.1093/emboj/20.15.4107; Paris F, 2001, J BIOL CHEM, V276, P8297, DOI 10.1074/jbc.M008732200; Pastorino JG, 1999, J BIOL CHEM, V274, P31734, DOI 10.1074/jbc.274.44.31734; Pastorino JG, 1996, J BIOL CHEM, V271, P29792, DOI 10.1074/jbc.271.47.29792; Petit PX, 2001, BIOCHEM J, V353, P357, DOI 10.1042/0264-6021:3530357; Pettus BJ, 2002, BBA-MOL CELL BIOL L, V1585, P114, DOI 10.1016/S1388-1981(02)00331-1; Pinton P, 2001, EMBO J, V20, P2690, DOI 10.1093/emboj/20.11.2690; Rabkin SW, 2002, CELL BIOL INT, V26, P433, DOI 10.1006/cbir.2002.0876; Rasola A, 2007, APOPTOSIS, V12, P815, DOI 10.1007/s10495-007-0723-y; Ricci JE, 2003, J CELL BIOL, V160, P65, DOI 10.1083/jcb.200208089; Ruvolo PP, 1999, J BIOL CHEM, V274, P20296, DOI 10.1074/jbc.274.29.20296; SanchezAlcazar JA, 1997, J BIOL CHEM, V272, P30167, DOI 10.1074/jbc.272.48.30167; Sawada N, 2000, CELL DEATH DIFFER, V7, P761, DOI 10.1038/sj.cdd.4400711; Schinzel AC, 2005, P NATL ACAD SCI USA, V102, P12005, DOI 10.1073/pnas.0505294102; Scorrano L, 2003, BIOCHEM BIOPH RES CO, V304, P437, DOI 10.1016/S0006-291X(03)00615-6; Scorrano L, 2003, SCIENCE, V300, P135, DOI 10.1126/science.1081208; Shimizu S, 2001, J CELL BIOL, V152, P237, DOI 10.1083/jcb.152.2.237; Simon CG, 1998, BIOCHEMISTRY-US, V37, P2059, DOI 10.1021/bi9710636; Siskind LJ, 2008, J BIOL CHEM, V283, P6622, DOI 10.1074/jbc.M706115200; Siskind LJ, 2006, MITOCHONDRION, V6, P118, DOI 10.1016/j.mito.2006.03.002; Siskind LJ, 2002, J BIOL CHEM, V277, P26796, DOI 10.1074/jbc.M200754200; Siskind LJ, 2000, J BIOL CHEM, V275, P38640, DOI 10.1074/jbc.C000587200; SMITH PK, 1985, ANAL BIOCHEM, V150, P76, DOI 10.1016/0003-2697(85)90442-7; Soriano ME, 2004, J BIOL CHEM, V279, P36803, DOI 10.1074/jbc.M405297200; Stoica BA, 2003, MOL CELL NEUROSCI, V22, P365, DOI 10.1016/S1044-7431(02)00028-3; Szalai G, 1999, EMBO J, V18, P6349, DOI 10.1093/emboj/18.22.6349; Taha TA, 2006, BBA-BIOMEMBRANES, V1758, P2027, DOI 10.1016/j.bbamem.2006.10.018; Tepper AD, 1999, J CLIN INVEST, V103, P971, DOI 10.1172/JCI5457; Tserng KY, 2003, ANAL BIOCHEM, V323, P84, DOI 10.1016/j.ab.2003.08.026; VanderHeiden MG, 1997, CELL, V91, P627, DOI 10.1016/S0092-8674(00)80450-X; Walter L, 2002, FREE RADICAL RES, V36, P405, DOI 10.1080/10715760290021252; Walter L, 2000, J BIOL CHEM, V275, P29521, DOI 10.1074/jbc.M004128200; Wiesner DA, 1996, J NEUROCHEM, V66, P1418; WOLFF RA, 1994, J BIOL CHEM, V269, P19605; Xin MG, 2006, J BIOL CHEM, V281, P18859, DOI 10.1074/jbc.M512543200; Yuan H, 2003, MITOCHONDRION, V2, P237, DOI 10.1016/S1567-7249(02)00106-X; Zamzami N, 2005, CELL DEATH DIFFER, V12, P1478, DOI 10.1038/sj.cdd.4401682	115	33	34	0	5	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	SEP 5	2008	283	36					24707	24717		10.1074/jbc.M801810200	http://dx.doi.org/10.1074/jbc.M801810200			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	342YR	18596045	Green Published, hybrid			2022-12-27	WOS:000258820000040
J	Sakiyama, H; Wynn, RM; Lee, WR; Fukasawa, M; Mizuguchi, H; Gardner, KH; Repa, JJ; Uyeda, K				Sakiyama, Haruhiko; Wynn, R. Max; Lee, Wan-Ru; Fukasawa, Masashi; Mizuguchi, Hiroyuki; Gardner, Kevin H.; Repa, Joyce J.; Uyeda, Kosaku			Regulation of Nuclear Import/Export of Carbohydrate Response Element-binding Protein (ChREBP) INTERACTION OF AN alpha-HELIX OF ChREBP WITH THE 14-3-3 PROTEINS AND REGULATION BY PHOSPHORYLATION	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							TRANSCRIPTION FACTOR; IMPORTIN-BETA; GLUCOSE; METABOLISM; MLX; LOCALIZATION; INVOLVEMENT; ACTIVATION; PREDICTION; MECHANISM	Carbohydrate response element-binding protein (ChREBP) is a glucose-responsive transcription factor that plays a critical role in the glucose-mediated induction of gene products involved in hepatic glycolysis and lipogenesis. Glucose affects the activity of ChREBP largely through post-translational mechanisms involving phosphorylation-dependent cellular localization. In this work we show that the N-terminal region of ChREBP (residues 1-251) regulates its subcellular localization via an interaction with 14-3-3. 14-3-3 binds an alpha-helix in this region (residues 125-135) to retain ChREBP in the cytosol, and binding of 14-3-3 is facilitated by phosphorylation of nearby Ser-140 and Ser-196. Phosphorylation of ChREBP at these sites was essential for its interaction with CRM1 for export to the cytosol, whereas nuclear import of ChREBP requires dephosphorylated ChREBP to interact with importin alpha. Notably, 14-3-3 appears to compete with importin alpha for ChREBP binding. 14-3-3 beta bound to a synthetic peptide spanning residues 125-144 and bearing a phosphate at Ser-140 with a dissociation constant of 1.1 mu M, as determined by isothermal calorimetry. The interaction caused a shift in the fluorescence maximum of the tryptophan residues of the peptide. The corresponding unphosphorylated peptide failed to bind 14-3-3 beta. These results suggest that interactions with importin alpha and 14-3-3 regulate movement of ChREBP into and out of the nucleus, respectively, and that these interactions are regulated by the ChREBP phosphorylation status.	[Sakiyama, Haruhiko; Wynn, R. Max; Lee, Wan-Ru; Fukasawa, Masashi; Gardner, Kevin H.; Uyeda, Kosaku] Univ Texas SW Med Ctr, Dept Biochem, Dallas, TX 75390 USA; [Gardner, Kevin H.] Univ Texas SW Med Ctr, Dept Pharmacol, Dallas, TX 75390 USA; [Repa, Joyce J.] Univ Texas SW Med Ctr, Dept Physiol, Dallas, TX 75390 USA; [Mizuguchi, Hiroyuki] Univ Tokushima, Dept Pharmaceut Sci, Tokushima, Japan; [Uyeda, Kosaku] Dallas Vet Affairs Med Ctr, Dallas, TX 75216 USA	University of Texas System; University of Texas Southwestern Medical Center Dallas; University of Texas System; University of Texas Southwestern Medical Center Dallas; University of Texas System; University of Texas Southwestern Medical Center Dallas; Tokushima University	Uyeda, K (corresponding author), Univ Texas SW Med Ctr, Dept Biochem, Dallas, TX 75390 USA.	Kosaku.Uyeda@utsouthwestern.edu	Gardner, Kevin H./K-7802-2012; Mizuguchi, Hiroyuki/B-5676-2013; Gardner, Kevin/K-5493-2019	Gardner, Kevin H./0000-0002-8671-2556; Mizuguchi, Hiroyuki/0000-0001-7055-316X; Wynn, Richard/0000-0002-1879-2136				Bodnar RJ, 1999, J BIOL CHEM, V274, P33474, DOI 10.1074/jbc.274.47.33474; Bridges D, 2004, SCI STKE, pre10; C elegans Sequencing Consortium, 1998, SCIENCE, V282, P2012, DOI 10.1126/science.282.5396.2012; Canbay A, 2007, Z GASTROENTEROL, V45, P35, DOI 10.1055/s-2006-927368; Cingolani G, 1999, NATURE, V399, P221, DOI 10.1038/20367; Cuff JA, 1998, BIOINFORMATICS, V14, P892, DOI 10.1093/bioinformatics/14.10.892; Gorlich D, 1996, EMBO J, V15, P1810, DOI 10.1002/j.1460-2075.1996.tb00530.x; Grozinger CM, 2000, P NATL ACAD SCI USA, V97, P7835, DOI 10.1073/pnas.140199597; HATTORI M, 1990, DNA CELL BIOL, V9, P777, DOI 10.1089/dna.1990.9.777; Iizuka K, 2006, AM J PHYSIOL-ENDOC M, V291, pE358, DOI 10.1152/ajpendo.00027.2006; Kabashima T, 2003, P NATL ACAD SCI USA, V100, P5107, DOI 10.1073/pnas.0730817100; Kawaguchi T, 2002, J BIOL CHEM, V277, P3829, DOI 10.1074/jbc.M107895200; Kawaguchi T, 2001, P NATL ACAD SCI USA, V98, P13710, DOI 10.1073/pnas.231370798; Lacroix E, 1998, J MOL BIOL, V284, P173, DOI 10.1006/jmbi.1998.2145; Li MV, 2006, DIABETES, V55, P1179, DOI 10.2337/db05-0822; LIU D, 1995, NATURE, V376, P191, DOI 10.1038/376191a0; Liu YQ, 1996, BIOCHEM BIOPH RES CO, V221, P554, DOI 10.1006/bbrc.1996.0634; Ma L, 2005, J BIOL CHEM, V280, P12019, DOI 10.1074/jbc.M413063200; Masters SC, 1999, BIOCHEMISTRY-US, V38, P5216, DOI 10.1021/bi982492m; Mattaj IW, 1998, ANNU REV BIOCHEM, V67, P265, DOI 10.1146/annurev.biochem.67.1.265; Merla G, 2004, HUM MOL GENET, V13, P1505, DOI 10.1093/hmg/ddh163; Meroni G, 2000, ONCOGENE, V19, P3266, DOI 10.1038/sj.onc.1203634; Nagoshi E, 1999, MOL BIOL CELL, V10, P2221, DOI 10.1091/mbc.10.7.2221; NISHIMURA M, 1994, J BIOL CHEM, V269, P26100; Pemberton LF, 2005, TRAFFIC, V6, P187, DOI 10.1111/j.1600-0854.2005.00270.x; Rubio MP, 2004, BIOCHEM J, V379, P395, DOI 10.1042/bj20031797; Seimiya H, 2000, EMBO J, V19, P2652, DOI 10.1093/emboj/19.11.2652; Stewart M, 1998, J MOL BIOL, V284, P1517, DOI 10.1006/jmbi.1998.2204; Stoeckman AK, 2004, J BIOL CHEM, V279, P15662, DOI 10.1074/jbc.M311301200; Tsatsos NG, 2006, BIOCHEM BIOPH RES CO, V340, P449, DOI 10.1016/j.bbrc.2005.12.029; Wang BC, 1999, BIOCHEMISTRY-US, V38, P12499, DOI 10.1021/bi991353h; Yamashita H, 2001, P NATL ACAD SCI USA, V98, P9116, DOI 10.1073/pnas.161284298; Yang XW, 2006, P NATL ACAD SCI USA, V103, P17237, DOI 10.1073/pnas.0605779103	33	75	77	0	5	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	SEP 5	2008	283	36					24899	24908		10.1074/jbc.M804308200	http://dx.doi.org/10.1074/jbc.M804308200			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	342YR	18606808	Green Published, hybrid			2022-12-27	WOS:000258820000074
J	Kondas, K; Szlama, G; Trexler, M; Patthy, L				Kondas, Katalin; Szlama, Gyoergy; Trexler, Maria; Patthy, Laszlo			Both WFIKKN1 and WFIKKN2 have high affinity for growth and differentiation factors 8 and 11	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							PROTEASE INHIBITOR DOMAIN; BETA SUPERFAMILY; MYOSTATIN GENE; EXPRESSION ANALYSIS; MULTIPLE TYPES; MUSCLE; GDF11; CARDIOMYOCYTES; PROTEINS; ADIPOGENESIS	WFIKKN1 and WFIKKN2 are large extracellular multidomain proteins consisting of a WAP, a follistatin, an immunoglobulin, two Kunitz- type protease inhibitor domains, and an NTR domain. Recent experiments have shown that WFIKKN2 protein binds mature GDF8/ myostatin and myostatin propeptide and inhibits the biological activity of myostatin ( Hill, J. J., Qiu, Y., Hewick, R. M., and Wolfman, N. M. ( 2003) Mol. Endocrinol. 17, 1144 - 1154). Here we show that the paralogue of this protein, WFIKKN1, also binds to both myostatin and myostatin propeptide and that both WFIKKN1 and WFIKKN2 bind GDF11, the growth and differentiation factor most closely related to myostatin, with high affinity. Structure- function studies onWFIKKN1have revealed that the follistatin domain is primarily responsible for the binding of mature growth factor, whereas the NTR domain contributes most significantly to the interaction with myostatin propeptide. Analysis of the evolutionary histories of WFIKKN1/ WFIKKN2 and GDF8/ GDF11 proteins indicates that the functional association of an ancestral WFIKKNprotein with an ancestor of GDF8/ 11 may date back to cephalochordates/ urochordates. Although duplication of the corresponding genes gave rise to WFIKKN1/ WFIKKN2 and GDF8/ GDF11 in early vertebrates, the data presented here suggest that there is significant functional overlap of the paralogous proteins.	[Kondas, Katalin; Szlama, Gyoergy; Trexler, Maria; Patthy, Laszlo] Hungarian Acad Sci, Biol Res Ctr, Inst Enzymol, H-1113 Budapest, Hungary	Eotvos Lorand Research Network; Hungarian Academy of Sciences; Hungarian Biological Research Center; Hungarian Research Centre for Natural Sciences	Patthy, L (corresponding author), Hungarian Acad Sci, Biol Res Ctr, Inst Enzymol, H-1113 Budapest, Hungary.	patthy@enzim.hu	Patthy, Laszlo/Q-6058-2019; Patthy, Laszlo/A-2353-2013					Andersson O, 2006, EMBO REP, V7, P831, DOI 10.1038/sj.embor.7400752; Artaza JN, 2005, ENDOCRINOLOGY, V146, P3547, DOI 10.1210/en.2005-0362; Banyai L, 1999, PROTEIN SCI, V8, P1636, DOI 10.1110/ps.8.8.1636; Biga PR, 2005, COMP BIOCHEM PHYS B, V141, P218, DOI 10.1016/j.cbpc.2005.03.004; Delsuc F, 2006, NATURE, V439, P965, DOI 10.1038/nature04336; Dichmann DS, 2006, DEV DYNAM, V235, P3016, DOI 10.1002/dvdy.20953; Esquela AF, 2003, DEV BIOL, V257, P356, DOI 10.1016/S0012-1606(03)00100-3; Feldman BJ, 2006, P NATL ACAD SCI USA, V103, P15675, DOI 10.1073/pnas.0607501103; Gamer LW, 2001, DEV BIOL, V229, P407, DOI 10.1006/dbio.2000.9981; Gamer LW, 1999, DEV BIOL, V208, P222, DOI 10.1006/dbio.1998.9191; Garikipati DK, 2007, ENDOCRINOLOGY, V148, P2106, DOI 10.1210/en.2006-1299; Garikipati DK, 2006, J ENDOCRINOL, V190, P879, DOI 10.1677/joe.1.06866; Ge GX, 2005, MOL CELL BIOL, V25, P5846, DOI 10.1128/MCB.25.14.5846-5858.2005; Gonzalez-Cadavid NF, 1998, P NATL ACAD SCI USA, V95, P14938, DOI 10.1073/pnas.95.25.14938; Hamrick MW, 2007, BONE, V40, P1544, DOI 10.1016/j.bone.2007.02.012; Harmon EB, 2004, DEVELOPMENT, V131, P6163, DOI 10.1242/dev.01535; Helterline DLI, 2007, GEN COMP ENDOCR, V151, P90, DOI 10.1016/j.ygcen.2006.12.023; Hill JJ, 2002, J BIOL CHEM, V277, P40735, DOI 10.1074/jbc.M206379200; Hill JJ, 2003, MOL ENDOCRINOL, V17, P1144, DOI 10.1210/me.2002-0366; Ji SQ, 1998, AM J PHYSIOL-REG I, V275, pR1265, DOI 10.1152/ajpregu.1998.275.4.R1265; Kocabas AM, 2002, BBA-GENE STRUCT EXPR, V1575, P99, DOI 10.1016/S0167-4781(02)00289-0; Kubota K, 2007, COMP BIOCHEM PHYS A, V148, P550, DOI 10.1016/j.cbpa.2007.07.004; Lee SJ, 1999, CURR OPIN GENET DEV, V9, P604, DOI 10.1016/S0959-437X(99)00004-0; Lee SJ, 2001, P NATL ACAD SCI USA, V98, P9306, DOI 10.1073/pnas.151270098; Liepinsh E, 2006, J BIOMOL NMR, V35, P73, DOI 10.1007/s10858-006-9013-1; Lin X, 2006, INT J MOL MED, V17, P833; Liu JP, 2006, DEVELOPMENT, V133, P2865, DOI 10.1242/dev.02478; Mckoy G, 2007, CARDIOVASC RES, V74, P304, DOI 10.1016/j.cardiores.2007.02.023; McPherron AC, 1997, NATURE, V387, P83, DOI 10.1038/387083a0; McPherron AC, 1999, NAT GENET, V22, P260, DOI 10.1038/10320; McPherron AC, 1997, P NATL ACAD SCI USA, V94, P12457, DOI 10.1073/pnas.94.23.12457; Nagy A, 2003, EUR J BIOCHEM, V270, P2101, DOI 10.1046/j.1432-1033.2003.03593.x; Nakashima M, 1999, MECH DEVELOP, V80, P185, DOI 10.1016/S0925-4773(98)00205-6; Nomura T, 2008, BIOCHEM BIOPH RES CO, V365, P863, DOI 10.1016/j.bbrc.2007.11.087; Oh SP, 2002, GENE DEV, V16, P2749, DOI 10.1101/gad.1021802; Ostbye TK, 2001, EUR J BIOCHEM, V268, P5249, DOI 10.1046/j.0014-2956.2001.02456.x; Rawlings ND, 2008, NUCLEIC ACIDS RES, V36, pD320, DOI 10.1093/nar/gkm954; Rebbapragada A, 2003, MOL CELL BIOL, V23, P7230, DOI 10.1128/MCB.23.20.7230-7242.2003; Roberts SB, 2003, MOL CELL ENDOCRINOL, V210, P9, DOI 10.1016/j.mce.2003.09.002; Roberts SB, 2001, FEBS LETT, V491, P212, DOI 10.1016/S0014-5793(01)02196-2; Sharma M, 1999, J CELL PHYSIOL, V180, P1; Sundaresan NR, 2008, RES VET SCI, V85, P86, DOI 10.1016/j.rvsc.2007.09.014; Thies RS, 2001, GROWTH FACTORS, V18, P251; Trexler M, 2002, BIOL CHEM, V383, P223, DOI 10.1515/BC.2002.023; Trexler M, 2001, P NATL ACAD SCI USA, V98, P3705, DOI 10.1073/pnas.061028398; Wolfman NM, 2003, P NATL ACAD SCI USA, V100, P15842, DOI 10.1073/pnas.2534946100; Wu HH, 2003, NEURON, V37, P197, DOI 10.1016/S0896-6273(02)01172-8; Xing F, 2007, DEV GENES EVOL, V217, P549, DOI 10.1007/s00427-007-0162-3; Ye HQ, 2007, MAR BIOTECHNOL, V9, P262, DOI 10.1007/s10126-006-6093-6; Zimmers TA, 2002, SCIENCE, V296, P1486, DOI 10.1126/science.1069525	50	51	57	0	40	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	AUG 29	2008	283	35					23677	23684		10.1074/jbc.M803025200	http://dx.doi.org/10.1074/jbc.M803025200			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	340II	18596030	hybrid, Green Published			2022-12-27	WOS:000258638900021
J	Czyzyk, J; Chen, HC; Bottomly, K; Flavell, RA				Czyzyk, Jan; Chen, Hui-Chen; Bottomly, Kim; Flavell, Richard A.			p21 Ras/impedes mitogenic signal propagation regulates cytokine production and migration in CD4 T cells	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							MAP KINASE ACTIVATION; SPHINGOSINE-1-PHOSPHATE RECEPTOR-1; NEGATIVE SELECTION; ANTIGEN RECEPTOR; HA-RAS; PROTEIN; DIFFERENTIATION; THYMOCYTES; EXPRESSION; ERK	The propensity of T cells to generate coordinated cytokine responses is critical for the host to develop resistance to pathogens while maintaining the state of immunotolerance to self-antigens. The exact mechanisms responsible for preventing the overproduction of proinflammatory cytokines including interferon (IFN)-gamma are not fully understood, however. In this study, we examined the role of a recently described Ras GTPase effector and repressor of the Raf/MEK/ERK cascade called impedes mitogenic signal propagation ( Imp) in limiting the induction of T-cell cytokines. We found that stimulation of the T cell receptor complex leads to the rapid development of a physical association between Ras and Imp. Consistent with the hypothesis that Imp inhibits signal transduction, we also found that disengagement of this molecule by the Ras(V12G37) effector loop mutant or RNA interference markedly enhances the activation of the NFAT transcription factor and IFN-gamma secretion. A strong output of IFN-gamma is responsible for the distinct lymphocyte traffic pattern observed in vivo because the transgenic or retroviral expression of Ras(V12G37) caused T cells to accumulate preferentially in the lymph nodes and delayed their escape from the lymphoid tissue, respectively. Together, our results describe a hitherto unrecognized negative regulatory role for Imp in the production of IFN-gamma in T cells and point to Ras-Imp binding as an attractive target for therapeutic interventions in conditions involving the production of this inflammatory cytokine.	[Czyzyk, Jan] Yale Univ, Sch Med, Dept Pathol, New Haven, CT 06520 USA; [Czyzyk, Jan; Chen, Hui-Chen; Bottomly, Kim; Flavell, Richard A.] Yale Univ, Sch Med, Dept Immunobiol, New Haven, CT 06520 USA; [Flavell, Richard A.] Yale Univ, Sch Med, Howard Hughes Med Inst, New Haven, CT 06520 USA	Yale University; Yale University; Howard Hughes Medical Institute; Yale University	Czyzyk, J (corresponding author), 300 Cedar St,TAC S546, New Haven, CT 06519 USA.	jan.czyzyk@yale.edu	Chen, Hui-Chen/L-8149-2013	Chen, Hui-Chen/0000-0001-9751-5729	National Institutes of Health [R01 5R37A1026791-18]; American Cancer Society Research Scholar	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); American Cancer Society Research Scholar(American Cancer Society)	This work was supported, in whole or in part, by National Institutes of Health Grant R01 5R37A1026791-18 (to K. B.). This work was also supported by an American Cancer Society Research Scholar Grant (to J.C.).	Alberola-Ila J, 2003, IMMUNOL REV, V191, P79, DOI 10.1034/j.1600-065X.2003.00012.x; ALBEROLAILA J, 1995, NATURE, V373, P620, DOI 10.1038/373620a0; Asada M, 2004, MOL CELL BIOL, V24, P8236, DOI 10.1128/MCB.24.18.8236-8243.2004; BALDARI CT, 1993, J BIOL CHEM, V268, P2693; BALDARI CT, 1992, J BIOL CHEM, V267, P4289; Bivona TG, 2006, MOL CELL, V21, P481, DOI 10.1016/j.molcel.2006.01.012; Bivona TG, 2003, NATURE, V424, P694, DOI 10.1038/nature01806; BOGUSKI MS, 1993, NATURE, V366, P643, DOI 10.1038/366643a0; BOS JL, 1997, CELL, V129, P865; Campbell SL, 1998, ONCOGENE, V17, P1395, DOI 10.1038/sj.onc.1202174; Chi HB, 2005, J IMMUNOL, V174, P2485, DOI 10.4049/jimmunol.174.5.2485; Chiu VK, 2002, NAT CELL BIOL, V4, P343, DOI 10.1038/ncb783; CLARK GJ, 1993, P NATL ACAD SCI USA, V90, P4887, DOI 10.1073/pnas.90.11.4887; Cristofano A. D., 2001, J EXP MED, V194, P275; Czyzyk J, 2003, P NATL ACAD SCI USA, V100, P6003, DOI 10.1073/pnas.1031494100; Czyzyk J, 2000, MOL CELL BIOL, V20, P8740, DOI 10.1128/MCB.20.23.8740-8747.2000; Daniels MA, 2006, NATURE, V444, P724, DOI 10.1038/nature05269; DOWNWARD J, 1990, NATURE, V346, P719, DOI 10.1038/346719a0; Fields PE, 1996, SCIENCE, V271, P1276, DOI 10.1126/science.271.5253.1276; FRANKLIN RA, 1994, J CLIN INVEST, V93, P2134, DOI 10.1172/JCI117209; Hanafusa H, 2002, NAT CELL BIOL, V4, P850, DOI 10.1038/ncb867; IZQUIERDO M, 1994, J EXP MED, V180, P401, DOI 10.1084/jem.180.1.401; Jorritsma PJ, 2003, J IMMUNOL, V170, P2427, DOI 10.4049/jimmunol.170.5.2427; Kent SC, 2005, NATURE, V435, P224, DOI 10.1038/nature03625; Kinashi T, 2000, J BIOL CHEM, V275, P22590, DOI 10.1074/jbc.M000633200; Li QJ, 2007, CELL, V129, P147, DOI 10.1016/j.cell.2007.03.008; Li S, 1998, J BIOL CHEM, V273, P6183, DOI 10.1074/jbc.273.11.6183; Li W, 1996, SCIENCE, V271, P1272, DOI 10.1126/science.271.5253.1272; Lo CG, 2005, J EXP MED, V201, P291, DOI 10.1084/jem.20041509; Matheny SA, 2004, NATURE, V427, P256, DOI 10.1038/nature02237; Matloubian M, 2004, NATURE, V427, P355, DOI 10.1038/nature02284; McCarty N, 2005, NAT IMMUNOL, V6, P65, DOI 10.1038/ni1145; Mor A, 2006, ANNU REV IMMUNOL, V24, P771, DOI 10.1146/annurev.immunol.24.021605.090723; Morrison DK, 2003, ANNU REV CELL DEV BI, V19, P91, DOI 10.1146/annurev.cellbio.19.111401.091942; Murphy, 2003, FUNDAMENTAL IMMUNOLO, P801; Nguyen A, 2002, MOL CELL BIOL, V22, P3035, DOI 10.1128/MCB.22.9.3035-3045.2002; Olenchock BA, 2006, NAT IMMUNOL, V7, P1174, DOI 10.1038/ni1400; Olsen NJ, 2004, ARTHRITIS RES THER, V6, P120, DOI 10.1186/ar1190; Ory S, 2004, CURR BIOL, V14, pR277, DOI 10.1016/j.cub.2004.03.023; OWAKI H, 1993, EMBO J, V12, P4367, DOI 10.1002/j.1460-2075.1993.tb06121.x; RAYTER SI, 1992, EMBO J, V11, P4549, DOI 10.1002/j.1460-2075.1992.tb05556.x; Remans PHJ, 2004, J IMMUNOL, V173, P920, DOI 10.4049/jimmunol.173.2.920; Rosen H, 2005, NAT REV IMMUNOL, V5, P560, DOI 10.1038/nri1650; Rubio CA, 2003, EUR J CLIN INVEST, V33, P406, DOI 10.1046/j.1365-2362.2003.01151.x; Sasaki A, 2003, NAT CELL BIOL, V5, P427, DOI 10.1038/ncb978; Schneider H, 2006, SCIENCE, V313, P1972, DOI 10.1126/science.1131078; Stefanova I, 2003, NAT IMMUNOL, V4, P248, DOI 10.1038/ni895; STOKOE D, 1994, SCIENCE, V264, P1463, DOI 10.1126/science.7811320; SWAN KA, 1995, EMBO J, V14, P276, DOI 10.1002/j.1460-2075.1995.tb07001.x; Swat W, 1996, P NATL ACAD SCI USA, V93, P4683, DOI 10.1073/pnas.93.10.4683; Torii S, 2004, DEV CELL, V7, P33, DOI 10.1016/j.devcel.2004.05.019; VOJTEK AB, 1993, CELL, V74, P205, DOI 10.1016/0092-8674(93)90307-C; WHITE MA, 1995, CELL, V80, P533, DOI 10.1016/0092-8674(95)90507-3; Yamanashi Y, 2000, GENE DEV, V14, P11; Yan F, 2004, J CLIN INVEST, V114, P1272, DOI 10.1172/JCI200421022; Zha YY, 2006, NAT IMMUNOL, V7, P1166, DOI 10.1038/ni1394; Zhao MM, 2001, J EXP MED, V194, P265, DOI 10.1084/jem.194.3.265; Zhong XP, 2003, NAT IMMUNOL, V4, P882, DOI 10.1038/ni958	58	11	12	0	0	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	AUG 22	2008	283	34					23004	23015		10.1074/jbc.M804084200	http://dx.doi.org/10.1074/jbc.M804084200			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	337SI	18577512	Green Published, hybrid			2022-12-27	WOS:000258455400013
J	Hebenstreit, D; Giaisi, M; Treiber, MK; Zhang, XB; Mi, HF; Horejs-Hoeck, J; Andersen, KG; Krammer, PH; Duschl, A; Li-Weber, M				Hebenstreit, Daniel; Giaisi, Marco; Treiber, Monika K.; Zhang, Xiao-Bin; Mi, Huai-Feng; Horejs-Hoeck, Jutta; Andersen, Kristian G.; Krammer, Peter H.; Duschl, Albert; Li-Weber, Min			LEF-1 negatively controls interleukin-4 expression through a proximal promoter regulatory element	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							GENE-EXPRESSION; T-CELLS; TRANSCRIPTION; TCF-1; PROTEIN; INVOLVEMENT; ACTIVATION	Lymphoid enhancer-binding factor 1 (LEF-1) and T cell factor (TCF-1) are downstream effectors of the Wnt signaling pathway and are involved in the regulation of T cell development in the thymus. LEF-1 and TCF-1 are also expressed in mature peripheral primary T cells, but their expression is down-regulated following T cell activation. Although the decisive roles of LEF-1 and TCF-1 in the early stages of T cell development are well documented, the functions of these factors in mature peripheral T cells are largely unknown. Recently, LEF-1 was shown to suppress Th2 cytokines interleukin-4 (IL-4), -5, and -13 expression from the developing Th2 cells that overexpress LEF-1 through retrovirus gene transduction. In this study, we further investigated the expression and functions of LEF-1 and TCF-1 in peripheral CD4(+) T cells and revealed that LEF-1 is dominantly expressed in Th1 but not in Th2 cells. We identified a high affinity LEF-1-binding site in the negative regulatory element of the IL-4 promoter. Knockdown LEF-1 expression by LEF-1-specific small interfering RNA resulted in an increase in the IL-4 mRNA expression. This study further confirms a negative regulatory role of LEF-1 in mature peripheral T cells. Furthermore, we found that IL-4 stimulation possesses a negative effect on the expressions of LEF-1 and TCF-1 in primary T cells, suggesting a positive feedback effect of IL-4 on IL-4 gene expression.	[Hebenstreit, Daniel; Horejs-Hoeck, Jutta; Duschl, Albert] Salzburg Univ, Dept Mol Biol, A-5020 Salzburg, Austria; [Giaisi, Marco; Treiber, Monika K.; Krammer, Peter H.; Li-Weber, Min] German Canc Res Ctr, Tumorimmunol Program, D-69120 Heidelberg, Germany; [Zhang, Xiao-Bin; Mi, Huai-Feng] Nankai Univ, Inst Polymer Chem, Tianjin 300071, Peoples R China; [Hebenstreit, Daniel; Andersen, Kristian G.] MRC, Mol Biol Lab, Cambridge CB2 0QH, England	Salzburg University; Helmholtz Association; German Cancer Research Center (DKFZ); Nankai University; MRC Laboratory Molecular Biology	Li-Weber, M (corresponding author), Deutsch Krebsforschungszentrum, German Canc Res Ctr, Tumor Immunol Program D030, Neuenheimer Feld 280, D-69120 Heidelberg, Germany.	m.li-weber@dkfz-heidelberg.de	Horejs-Hoeck, Jutta/E-5010-2011; hebenstreit, daniel/GWZ-2082-2022; Andersen, Kristian/D-5006-2009; Horejs-Hoeck, Jutta/AAF-1735-2019; Duschl, Albert/E-5872-2011	Horejs-Hoeck, Jutta/0000-0002-0984-204X; hebenstreit, daniel/0000-0003-0144-6728; Andersen, Kristian/0000-0001-6431-5982; Horejs-Hoeck, Jutta/0000-0002-0984-204X; Duschl, Albert/0000-0002-7034-9860	MRC [MC_U105184296] Funding Source: UKRI; Austrian Science Fund FWF [P 18409] Funding Source: Medline; Medical Research Council [MC_U105184296] Funding Source: Medline	MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Austrian Science Fund FWF(Austrian Science Fund (FWF)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC))		Brannon M, 1997, GENE DEV, V11, P2359, DOI 10.1101/gad.11.18.2359; Cavallo RA, 1998, NATURE, V395, P604, DOI 10.1038/26982; Chung EJ, 2002, BLOOD, V100, P982, DOI 10.1182/blood.V100.3.982; Dorfman DM, 2003, AM J PATHOL, V162, P1539, DOI 10.1016/S0002-9440(10)64287-3; Galceran J, 1999, GENE DEV, V13, P709, DOI 10.1101/gad.13.6.709; Hattori N, 1996, J EXP MED, V184, P1137, DOI 10.1084/jem.184.3.1137; Ho IC, 2002, CELL, V109, pS109, DOI 10.1016/S0092-8674(02)00705-5; HOSSAIN MB, 2008, IMMUNOLOGY IN PRESS; Hurlstone A, 2002, EMBO J, V21, P2303, DOI 10.1093/emboj/21.10.2303; Ioannidis V, 2001, NAT IMMUNOL, V2, P691, DOI 10.1038/90623; KRAMMER PH, 1983, IMMUNOL REV, V76, P5, DOI 10.1111/j.1600-065X.1983.tb01095.x; Li-Weber M, 2003, NAT REV IMMUNOL, V3, P534, DOI 10.1038/nri1128; Li-Weber M, 2002, EUR J IMMUNOL, V32, P3587, DOI 10.1002/1521-4141(200212)32:12<3587::AID-IMMU3587>3.0.CO;2-E; LIWEBER M, 1993, J IMMUNOL, V151, P1371; Lu BF, 2004, P NATL ACAD SCI USA, V101, P3023, DOI 10.1073/pnas.0307743100; Moon RT, 2002, SCIENCE, V296, P1644, DOI 10.1126/science.1071549; Moon RT, 2004, NAT REV GENET, V5, P689, DOI 10.1038/nrg1427; Nusse R, 2005, CELL RES, V15, P28, DOI 10.1038/sj.cr.7290260; Okamura RM, 1998, IMMUNITY, V8, P11, DOI 10.1016/S1074-7613(00)80454-9; Prieve MG, 1999, MOL CELL BIOL, V19, P4503; Reya T, 2005, NATURE, V434, P843, DOI 10.1038/nature03319; Roose J, 1998, NATURE, V395, P608, DOI 10.1038/26989; Schilham MW, 1998, J IMMUNOL, V161, P3984; Staal FJT, 2005, NAT REV IMMUNOL, V5, P21, DOI 10.1038/nri1529; Staal FJT, 2003, CURR OPIN IMMUNOL, V15, P204, DOI 10.1016/S0952-7915(03)00003-7; TRAVIS A, 1991, GENE DEV, V5, P880, DOI 10.1101/gad.5.5.880; vandeWetering M, 1996, MOL CELL BIOL, V16, P745; VANDEWETERING M, 1991, EMBO J, V10, P123, DOI 10.1002/j.1460-2075.1991.tb07928.x; VANGENDEREN C, 1994, GENE DEV, V8, P2691, DOI 10.1101/gad.8.22.2691; VERBEEK S, 1995, NATURE, V374, P70, DOI 10.1038/374070a0; WATERMAN ML, 1991, GENE DEV, V5, P656, DOI 10.1101/gad.5.4.656; Weerkamp F, 2006, TRENDS IMMUNOL, V27, P125, DOI 10.1016/j.it.2006.01.006; Willinger T, 2006, J IMMUNOL, V176, P1439, DOI 10.4049/jimmunol.176.3.1439; Wirnsberger G, 2006, EUR J IMMUNOL, V36, P1882, DOI 10.1002/eji.200635972; Xu YY, 2003, NAT IMMUNOL, V4, P1177, DOI 10.1038/ni1008	35	22	23	0	3	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	AUG 15	2008	283	33					22490	22497		10.1074/jbc.M804096200	http://dx.doi.org/10.1074/jbc.M804096200			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	335VR	18579517	hybrid, Green Accepted			2022-12-27	WOS:000258321000017
J	Choi, CL; Claridge, SA; Garner, EC; Alivisatos, AP; Mullins, RD				Choi, Charina L.; Claridge, Shelley A.; Garner, Ethan C.; Alivisatos, A. Paul; Mullins, R. Dyche			Protein-nanocrystal conjugates support a single filament polymerization model in R1 plasmid segregation	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							DNA SEGREGATION; GOLD; NANOPARTICLE; COMPLEX	To ensure inheritance by daughter cells, many low-copy number bacterial plasmids, including the R1 drug-resistance plasmid, encode their own DNA segregation systems. The par operon of plasmid R1 directs construction of a simple spindle structure that converts free energy of polymerization of an actin-like protein, ParM, into work required to move sister plasmids to opposite poles of rod-shaped cells. The structures of individual components have been solved, but little is known about the ultrastructure of the R1 spindle. To determine the number of ParM filaments in a minimal R1 spindle, we used DNA-gold nanocrystal conjugates as mimics of the R1 plasmid. We found that each end of a single polar ParM filament binds to a single ParR/parC-gold complex, consistent with the idea that ParM filaments bind in the hollow core of the ParR/parC ring complex. Our results further suggest that multifilament spindles observed in vivo are associated with clusters of plasmids segregating as a unit.	[Garner, Ethan C.; Mullins, R. Dyche] Univ Calif San Francisco, Dept Cellular & Mol Pharmacol, San Francisco, CA 94143 USA; [Choi, Charina L.; Claridge, Shelley A.; Alivisatos, A. Paul] Univ Calif Berkeley, Dept Chem, Berkeley, CA 94720 USA; [Choi, Charina L.; Claridge, Shelley A.; Alivisatos, A. Paul] Univ Calif Berkeley, Lawrence Berkeley Lab, Div Mat Sci, Berkeley, CA 94720 USA	University of California System; University of California San Francisco; University of California System; University of California Berkeley; United States Department of Energy (DOE); Lawrence Berkeley National Laboratory; University of California System; University of California Berkeley	Mullins, RD (corresponding author), Univ Calif San Francisco, Dept Cellular & Mol Pharmacol, 600 16th St, San Francisco, CA 94143 USA.	dyche@mullinslab.ucsf.edu	Garner, Ethan/J-4025-2014; Alivisatos, Paul/N-8863-2015	Garner, Ethan/0000-0003-0141-3555; Alivisatos, Paul/0000-0001-6895-9048	National Institutes of Health [PN2 EY016546, 5R01GM079556-03]; University of California San Francisco/University of California Berkeley Nanomedicine Development Center; University of California San Francisco; Sandler Family Supporting Foundation; Office of Science, Office of Basic Energy Sciences, of the United States Department of Energy [DE-AC02-05CH11231]; NATIONAL EYE INSTITUTE [PN2EY016546] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM079556, R01GM061010] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); University of California San Francisco/University of California Berkeley Nanomedicine Development Center; University of California San Francisco(University of California System); Sandler Family Supporting Foundation; Office of Science, Office of Basic Energy Sciences, of the United States Department of Energy(United States Department of Energy (DOE)); NATIONAL EYE INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported, in whole or in part, by National Institutes of Health Grant PN2 EY016546 to the University of California San Francisco/University of California Berkeley Nanomedicine Development Center as administered through the University of California San Francisco. This work was also supported by grants from the Sandler Family Supporting Foundation, National Institutes of Health Grant 5R01GM079556-03, and the Director, Office of Science, Office of Basic Energy Sciences, of the United States Department of Energy under Contract DE-AC02-05CH11231 (to R. D. M.). The costs of publication of this article were defrayed in part by the payment of page charges. This article must therefore be hereby marked "advertisement" in accordance with 18 U. S. C. Section 1734 solely to indicate this fact.	Asbury CL, 2006, P NATL ACAD SCI USA, V103, P9873, DOI 10.1073/pnas.0602249103; Becker E, 2006, EMBO J, V25, P5919, DOI 10.1038/sj.emboj.7601443; Campbell CS, 2007, J CELL BIOL, V179, P1059, DOI 10.1083/jcb.200708206; Claridge SA, 2005, CHEM MATER, V17, P1628, DOI 10.1021/cm0484089; Claridge SA, 2008, NANO LETT, V8, P1202, DOI 10.1021/nl0802032; Dye NA, 2007, TRENDS CELL BIOL, V17, P239, DOI 10.1016/j.tcb.2007.03.005; Garner EC, 2004, SCIENCE, V306, P1021, DOI 10.1126/science.1101313; Garner EC, 2007, SCIENCE, V315, P1270, DOI 10.1126/science.1138527; Gerdes K, 2000, MOL MICROBIOL, V37, P455, DOI 10.1046/j.1365-2958.2000.01975.x; Giardini PA, 2003, P NATL ACAD SCI USA, V100, P6493, DOI 10.1073/pnas.1031670100; Larsen RA, 2007, GENE DEV, V21, P1340, DOI 10.1101/gad.1546107; Loweth CJ, 1999, ANGEW CHEM INT EDIT, V38, P1808, DOI 10.1002/(SICI)1521-3773(19990614)38:12<1808::AID-ANIE1808>3.0.CO;2-C; Moller-Jensen J, 2002, EMBO J, V21, P3119, DOI 10.1093/emboj/cdf320; Moller-Jensen J, 2007, EMBO J, V26, P4413, DOI 10.1038/sj.emboj.7601864; NORDSTROM K, 1972, J BACTERIOL, V110, P562; Orlova A, 2007, NAT STRUCT MOL BIOL, V14, P921, DOI 10.1038/nsmb1300; Pogliano J, 2001, P NATL ACAD SCI USA, V98, P4486, DOI 10.1073/pnas.081075798; Schumacher MA, 2007, NATURE, V450, P1268, DOI 10.1038/nature06392; Sonnichsen C, 2005, NAT BIOTECHNOL, V23, P741, DOI 10.1038/nbt1100; van den Ent F, 2002, EMBO J, V21, P6935, DOI 10.1093/emboj/cdf672; Westermann S, 2006, NATURE, V440, P565, DOI 10.1038/nature04409; Zanchet D, 2001, NANO LETT, V1, P32, DOI 10.1021/nl005508e	22	15	15	0	13	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	OCT 17	2008	283	42					28081	28086		10.1074/jbc.M803833200	http://dx.doi.org/10.1074/jbc.M803833200			6	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	359EN	18658133	Green Submitted, hybrid, Green Published			2022-12-27	WOS:000259969300010
J	Bezin, S; Charpentier, G; Lee, HC; Baux, G; Fossier, P; Cancela, JM				Bezin, Stephanie; Charpentier, Gilles; Lee, Hon Cheung; Baux, Gerard; Fossier, Philippe; Cancela, Jose-Manuel			Regulation of nuclear Ca2+ signaling by translocation of the Ca2+ messenger synthesizing enzyme ADP-ribosyl cyclase during neuronal depolarization	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ADENINE-DINUCLEOTIDE PHOSPHATE; CALCIUM-MOBILIZING METABOLITE; PANCREATIC-ACINAR-CELLS; ELEMENT-BINDING PROTEIN; INOSITOL TRISPHOSPHATE; NUCLEOPLASMIC RETICULUM; RYANODINE RECEPTORS; GENE-EXPRESSION; NEUROTRANSMITTER RELEASE; ENDOPLASMIC-RETICULUM	In neurons, voltage-gated Ca2+ channels and nuclear Ca2+ signaling play important roles, such as in the regulation of gene expression. However, the link between electrical activity and biochemical cascade activation involved in the generation of the nuclear Ca2+ signaling is poorly understood. Here we show that depolarization of Aplysia neurons induces the translocation of ADP-ribosyl cyclase, a Ca2+ messenger synthesizing enzyme, from the cytosol into the nucleus. The translocation is dependent on Ca2+ influx mainly through the voltage-dependent L-type Ca2+ channels. We report also that specific nucleoplasmic Ca2+ signals can be induced by three different calcium messengers, cyclic ADP-ribose, nicotinic acid adenine dinucleotide phosphate (NAADP), both produced by the ADP-ribosyl cyclase, and inositol 1,4,5-trisphosphate (IP3). Moreover, our pharmacological data show that NAADP acts on its own receptor, which cooperates with the IP3 and the ryanodine receptors to generate nucleoplasmic Ca2+ oscillations. We propose a new model where voltage-dependent L-type Ca2+ channel-induced nuclear translocation of the cytosolic cyclase is a crucial step in the fine tuning of nuclear Ca2+ signals in neurons.	[Bezin, Stephanie; Charpentier, Gilles; Baux, Gerard; Fossier, Philippe; Cancela, Jose-Manuel] CNRS, Neurobiol Cellulaire & Mol Lab, UPR 9040, F-91198 Gif Sur Yvette, France; [Charpentier, Gilles] Univ Bordeaux 1, Lab DMPFCS, IECB, F-33607 Pessac, France; [Lee, Hon Cheung] Univ Hong Kong, Dept Physiol, Hong Kong, Hong Kong, Peoples R China	Centre National de la Recherche Scientifique (CNRS); UDICE-French Research Universities; Universite Paris Saclay; UDICE-French Research Universities; Universite de Bordeaux; University of Hong Kong	Cancela, JM (corresponding author), CNRS, Neurobiol Cellulaire & Mol Lab, UPR 9040, 1 Ave Terrasse, F-91198 Gif Sur Yvette, France.	jose.cancela@nbcm.cnrs-gif.fr	Lee, Hon Cheung/C-4329-2009	Cancela, Jose-Manuel/0000-0002-6234-1500	Association Francaise contre les Myopathies and the Association pour la Recherche sur le Cancer	Association Francaise contre les Myopathies and the Association pour la Recherche sur le Cancer	The work was supported by grants from the Association Francaise contre les Myopathies and the Association pour la Recherche sur le Cancer (to J.-M. C.). The costs of publication of this article were defrayed in part by the payment of page charges. This article must therefore be hereby marked "advertisement" in accordance with 18 U.S.C. Section 1734 solely to indicate this fact.	Aarhus R, 1995, J BIOL CHEM, V270, P30327, DOI 10.1074/jbc.270.51.30327; Adebanjo OA, 1999, NAT CELL BIOL, V1, P409, DOI 10.1038/15640; Albrieux M, 1998, J BIOL CHEM, V273, P14566, DOI 10.1074/jbc.273.23.14566; Alonso MT, 2006, CELL CALCIUM, V40, P513, DOI 10.1016/j.ceca.2006.08.013; Antonov I, 2003, NEURON, V37, P135, DOI 10.1016/S0896-6273(02)01129-7; Bach G, 2001, MOL GENET METAB, V73, P197, DOI 10.1006/mgme.2001.3195; Barco A, 2006, J NEUROCHEM, V97, P1520, DOI 10.1111/j.1471-4159.2006.03870.x; Berridge MJ, 2003, NAT REV MOL CELL BIO, V4, P517, DOI 10.1038/nrm1155; Bezin S, 2008, PFLUG ARCH EUR J PHY, V456, P581, DOI 10.1007/s00424-007-0435-8; Bezin S, 2006, J PHYSIOLOGY-PARIS, V99, P111, DOI 10.1016/j.jphysparis.2005.12.007; Borodinsky LN, 2004, NATURE, V429, P523, DOI 10.1038/nature02518; BRINI M, 1993, EMBO J, V12, P4813, DOI 10.1002/j.1460-2075.1993.tb06170.x; Cancela JM, 2003, PFLUG ARCH EUR J PHY, V446, P322, DOI 10.1007/s00424-003-1035-x; Cancela JM, 2002, EMBO J, V21, P909, DOI 10.1093/emboj/21.5.909; Cancela JM, 2001, ANNU REV PHYSIOL, V63, P99, DOI 10.1146/annurev.physiol.63.1.99; Cancela JM, 1999, NATURE, V398, P74, DOI 10.1038/18032; Cancela JM, 2000, EMBO J, V19, P2549, DOI 10.1093/emboj/19.11.2549; Cardenas C, 2005, J CELL SCI, V118, P3131, DOI 10.1242/jcs.02446; Cardenas C, 2004, J BIOL CHEM, V279, P39122, DOI 10.1074/jbc.M401044200; Carrion AM, 1999, NATURE, V398, P80, DOI 10.1038/18044; Ceni C, 2003, J BIOL CHEM, V278, P40670, DOI 10.1074/jbc.M301196200; Chameau P, 2001, PFLUG ARCH EUR J PHY, V443, P289, DOI 10.1007/s004240100691; Chamero P, 2002, J BIOL CHEM, V277, P50226, DOI 10.1074/jbc.C200522200; Chawla S, 2002, EUR J PHARMACOL, V447, P131, DOI 10.1016/S0014-2999(02)01837-X; Churamani D, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000797; Churchill GC, 2002, CELL, V111, P703, DOI 10.1016/S0092-8674(02)01082-6; Dammermann W, 2005, J BIOL CHEM, V280, P21394, DOI 10.1074/jbc.M413085200; De Flora A, 2004, ANN NY ACAD SCI, V1028, P176, DOI 10.1196/annals.1322.021; De Koninck P, 1998, SCIENCE, V279, P227, DOI 10.1126/science.279.5348.227; DIVECHA N, 1993, CELL, V74, P405, DOI 10.1016/0092-8674(93)80041-C; Dolmetsch RE, 2001, SCIENCE, V294, P333, DOI 10.1126/science.1063395; Dolmetsch RE, 1998, NATURE, V392, P933, DOI 10.1038/31960; Echevarria W, 2003, NAT CELL BIOL, V5, P440, DOI 10.1038/ncb980; Fliegert R, 2007, BIOCHEM SOC T, V35, P109, DOI 10.1042/BST0350109; Fossier P, 1999, TRENDS NEUROSCI, V22, P161, DOI 10.1016/S0166-2236(98)01307-1; Galione A, 2005, MOL INTERV, V5, P73, DOI 10.1124/mi.5.2.4; Gerasimenko JV, 2003, J CELL BIOL, V163, P271, DOI 10.1083/jcb.200306134; Gerasimenko JV, 2006, J CELL SCI, V119, P226, DOI 10.1242/jcs.02721; GERASIMENKO OV, 1995, CELL, V80, P439, DOI 10.1016/0092-8674(95)90494-8; Gomes DA, 2006, CAN J PHYSIOL PHARM, V84, P325, DOI 10.1139/Y05-117; Gomez-Ospina N, 2006, CELL, V127, P591, DOI 10.1016/j.cell.2006.10.017; Hawkins RD, 2006, BIOL BULL-US, V210, P174, DOI 10.2307/4134556; HELLMICH MR, 1991, CELL REGUL, V2, P193, DOI 10.1091/mbc.2.3.193; Hong EJ, 2005, CURR OPIN NEUROBIOL, V15, P21, DOI 10.1016/j.conb.2005.01.002; HOWARD M, 1993, SCIENCE, V262, P1056, DOI 10.1126/science.8235624; Jin I, 2003, J NEUROSCI, V23, P7288; Jong YJI, 2005, J BIOL CHEM, V280, P30469, DOI 10.1074/jbc.M501775200; Khoo KM, 2000, J BIOL CHEM, V275, P24807, DOI 10.1074/jbc.M908231199; Knot HJ, 2005, MOL INTERV, V5, P112, DOI 10.1124/mi.5.2.8; Langhorst MF, 2004, CELL SIGNAL, V16, P1283, DOI 10.1016/j.cellsig.2004.03.013; Ledo F, 2002, EMBO J, V21, P4583, DOI 10.1093/emboj/cdf440; LEE HC, 1991, CELL REGUL, V2, P203, DOI 10.1091/mbc.2.3.203; Lee HC, 2003, CURR BIOL, V13, pR186, DOI 10.1016/S0960-9822(03)00120-9; LEE HC, 1995, J BIOL CHEM, V270, P2152, DOI 10.1074/jbc.270.5.2152; Lee HC, 2005, J BIOL CHEM, V280, P33693, DOI 10.1074/jbc.R500012200; Leite MF, 2003, P NATL ACAD SCI USA, V100, P2975, DOI 10.1073/pnas.0536590100; Li WH, 1998, NATURE, V392, P936, DOI 10.1038/31965; Lipp P, 1997, EMBO J, V16, P7166, DOI 10.1093/emboj/16.23.7166; Malavasi F, 2006, MOL MED, V12, P334, DOI 10.2119/2006-00094.Malavasi; MALVIYA AN, 1990, P NATL ACAD SCI USA, V87, P9270, DOI 10.1073/pnas.87.23.9270; Marius P, 2006, CELL CALCIUM, V39, P65, DOI 10.1016/j.ceca.2005.09.010; Masgrau R, 2003, CURR BIOL, V13, P247, DOI 10.1016/S0960-9822(03)00041-1; Menteyne A, 2006, CURR BIOL, V16, P1931, DOI 10.1016/j.cub.2006.07.070; Moccia F, 2003, FASEB J, V17, P1907, DOI 10.1096/fj.03-0178fje; Mothet JP, 1998, J PHYSIOL-LONDON, V507, P405, DOI 10.1111/j.1469-7793.1998.405bt.x; Munshi C, 1999, J BIOL CHEM, V274, P30770, DOI 10.1074/jbc.274.43.30770; O'Callaghan DW, 2005, BIOCHEM J, V391, P231, DOI 10.1042/BJ20051001; O'Callaghan DW, 2003, BIOCHEM SOC T, V31, P963; O'Callaghan DW, 2002, J BIOL CHEM, V277, P14227, DOI 10.1074/jbc.M111750200; Parekh AB, 2005, PHYSIOL REV, V85, P757, DOI 10.1152/physrev.00057.2003; Park MK, 2001, EMBO J, V20, P1863, DOI 10.1093/emboj/20.8.1863; Rizzuto R, 2006, PHYSIOL REV, V86, P369, DOI 10.1152/physrev.00004.2005; Santella L, 1997, CELL CALCIUM, V22, P11, DOI 10.1016/S0143-4160(97)90085-3; Soares S, 2007, AM J PHYSIOL-CELL PH, V292, pC227, DOI 10.1152/ajpcell.00638.2005; Tomida T, 2003, EMBO J, V22, P3825, DOI 10.1093/emboj/cdg381; Verkhratsky A, 2005, PHYSIOL REV, V85, P201, DOI 10.1152/physrev.00004.2004; Walseth TF, 2005, P NATL ACAD SCI USA, V102, P14941, DOI 10.1073/pnas.0507258102; Yamasaki M, 2005, CURR BIOL, V15, P874, DOI 10.1016/j.cub.2005.04.033; Yamasaki M, 2004, J BIOL CHEM, V279, P7234, DOI 10.1074/jbc.M311088200; Zhang F, 2007, J BIOL CHEM, V282, P25259, DOI 10.1074/jbc.M701614200	80	37	37	0	1	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	OCT 10	2008	283	41					27859	27870		10.1074/jbc.M804701200	http://dx.doi.org/10.1074/jbc.M804701200			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	355OW	18632662	hybrid			2022-12-27	WOS:000259719200057
J	Dammeyer, T; Hofmann, E; Frankenberg-Dinkel, N				Dammeyer, Thorben; Hofmann, Eckhard; Frankenberg-Dinkel, Nicole			Phycoerythrobilin synthase (PebS) of a marine virus - Crystal structures of the biliverdin complex and the substrate-free form	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							PHYCOCYANOBILIN-FERREDOXIN OXIDOREDUCTASE; CYANOBACTERIAL PHYCOCYANOBILIN; PHYTOCHROMOBILIN SYNTHASE; DIFFRACTION DATA; BIOSYNTHESIS; BILIN; PCYA; REDUCTION; FAMILY; HY2	The reddish purple open chain tetrapyrrole pigment phycoerythrobilin (PEB; A(lambda max) similar to 550nm) is an essential chromophore of the light-harvesting phycobiliproteins of most cyanobacteria, red algae, and cryptomonads. The enzyme phycoerythrobilin synthase (PebS), recently discovered in a marine virus infecting oceanic cyanobacteria of the genus Prochlorococcus (cyanophage PSSM-2), is a new member of the ferredoxin-dependent bilin reductase (FDBR) family. In a formal four-electron reduction, the substrate biliverdin IX alpha is reduced to yield 3Z-PEB, a reaction that commonly requires the action of two individual FDBRs. The first reaction catalyzed by PebS is the reduction of the 15,16-methine bridge of the biliverdin IX alpha tetrapyrrole system. This reaction is exclusive to PEB biosynthetic enzymes. The second reduction site is the A-ring 2,3,3(1),3(2)-diene system, the most common target of FDBRs. Here, we present the first crystal structures of a PEB biosynthetic enzyme. Structures of the substrate complex were solved at 1.8- and 2.1-angstrom resolution and of the substrate-free form at 1.55-angstrom resolution. The overall folding revealed an alpha/beta/alpha-sandwich with similarity to the structure of phycocyanobilin: ferredoxin oxidoreductase (PcyA). The substrate-binding site is located between the central beta-sheet and C-terminal alpha-helices. Eight refined molecules with bound substrate, from two different crystal forms, revealed a high flexibility of the substrate-binding pocket. The substrate was found to be either in a planar porphyrin-like conformation or in a helical conformation and is coordinated by a conserved aspartate/asparagine pair from the beta-sheet side. From the alpha-helix side, a conserved highly flexible aspartate/proline pair is involved in substrate binding and presumably catalysis.	[Dammeyer, Thorben; Hofmann, Eckhard; Frankenberg-Dinkel, Nicole] Ruhr Univ Bochum, Dept Biol & Biotechnol, D-44780 Bochum, Germany	Ruhr University Bochum	Hofmann, E (corresponding author), Ruhr Univ Bochum, Dept Biol & Biotechnol, Univ Str 150, D-44780 Bochum, Germany.	eckhard.hofmann@bph.rub.de; nicole.frankenberg@rub.de	Frankenberg-Dinkel, Nicole/C-1058-2011; Hofmann, Eckhard/GPF-5024-2022	Frankenberg-Dinkel, Nicole/0000-0002-7757-6839; Hofmann, Eckhard/0000-0003-4874-372X; Dammeyer, Thorben/0000-0002-3542-1273	Deutsche Forschungsgemeinschaft [Teilprojekt C6, Teilprojekt C8]	Deutsche Forschungsgemeinschaft(German Research Foundation (DFG))	This work was supported by Sonderforschungsbereich 480 from the Deutsche Forschungsgemeinschaft (Teilprojekt C6 and C8; to E. H. and N. F.-D.). The costs of publication of this article were defrayed in part by the payment of page charges. This article must therefore be hereby marked "advertisement" in accordance with 18 U. S. C. Section 1734 solely to indicate this fact.	BAILEY S, 1994, ACTA CRYSTALLOGR D, V50, P760, DOI 10.1107/s0907444994003112; Blankenship RE, 2001, NAT STRUCT BIOL, V8, P94, DOI 10.1038/84191; Cornejo J, 1998, PLANT J, V15, P99, DOI 10.1046/j.1365-313X.1998.00186.x; Dammeyer T, 2008, CURR BIOL, V18, P442, DOI 10.1016/j.cub.2008.02.067; Dammeyer T, 2007, FEMS MICROBIOL LETT, V271, P251, DOI 10.1111/j.1574-6968.2007.00715.x; Dammeyer T, 2006, J BIOL CHEM, V281, P27081, DOI 10.1074/jbc.M605154200; DeLano W.L, PYMOL MOL GRAPHICS S; Diederichs K, 1997, NAT STRUCT BIOL, V4, P269, DOI 10.1038/nsb0497-269; Emsley P, 2004, ACTA CRYSTALLOGR D, V60, P2126, DOI 10.1107/S0907444904019158; Frankenberg N, 2003, J BIOL CHEM, V278, P9219, DOI 10.1074/jbc.M211643200; Frankenberg N, 2001, PLANT CELL, V13, P965, DOI 10.1105/tpc.13.4.965; GILL SC, 1989, ANAL BIOCHEM, V182, P319, DOI 10.1016/0003-2697(89)90602-7; GLAZER AN, 1994, J APPL PHYCOL, V6, P105, DOI 10.1007/BF02186064; Hagiwara Y, 2006, P NATL ACAD SCI USA, V103, P27, DOI 10.1073/pnas.0507266103; Hagiwara Y, 2006, FEBS LETT, V580, P3823, DOI 10.1016/j.febslet.2006.05.075; KABSCH W, 1993, J APPL CRYSTALLOGR, V26, P795, DOI 10.1107/S0021889893005588; KROIS D, 1995, MONATSH CHEM, V126, P349, DOI 10.1007/BF00816104; KROIS D, 1991, MONATSH CHEM, V122, P495, DOI 10.1007/BF00809802; KRONICK MN, 1983, CLIN CHEM, V29, P1582; LASKOWSKI R, 1993, B ENVIRON CONTAM TOX, V50, P232, DOI 10.1007/BF00191727; McCoy AJ, 2005, ACTA CRYSTALLOGR D, V61, P458, DOI 10.1107/S0907444905001617; McDowell MT, 2001, PLANT PHYSIOL, V126, P1546, DOI 10.1104/pp.126.4.1546; Morris RJ, 2002, ACTA CRYSTALLOGR D, V58, P968, DOI 10.1107/S0907444902005462; Murshudov GN, 1997, ACTA CRYSTALLOGR D, V53, P240, DOI 10.1107/S0907444996012255; ONG LJ, 1991, J BIOL CHEM, V266, P9515; ONG LJ, 1987, J BIOL CHEM, V262, P6323; Pape T, 2004, J APPL CRYSTALLOGR, V37, P843, DOI 10.1107/S0021889804018047; PASTORE A, 1989, EUR BIOPHYS J BIOPHY, V16, P363, DOI 10.1007/BF00257885; Ri Y, 1999, BIOPHYS J, V76, P2887, DOI 10.1016/S0006-3495(99)77444-8; Ritter S, 1999, J STRUCT BIOL, V126, P86, DOI 10.1006/jsbi.1999.4106; RUDIGER W, 1980, Z NATURFORSCH C, V35, P763; Schneider TR, 2002, ACTA CRYSTALLOGR D, V58, P1772, DOI 10.1107/S0907444902011678; Sheldrick GM, 2008, ACTA CRYSTALLOGR A, V64, P112, DOI 10.1107/S0108767307043930; TERRY MJ, 1995, J BIOL CHEM, V270, P11111, DOI 10.1074/jbc.270.19.11111; Tu SL, 2008, J BIOL CHEM, V283, P27555, DOI 10.1074/jbc.M803761200; Tu SL, 2007, BIOCHEMISTRY-US, V46, P1484, DOI 10.1021/bi062038f; Tu SL, 2006, J BIOL CHEM, V281, P3127, DOI 10.1074/jbc.M510126200; Tu SL, 2004, J AM CHEM SOC, V126, P8682, DOI 10.1021/ja049280z; VANDUYNE GD, 1993, J MOL BIOL, V229, P105, DOI 10.1006/jmbi.1993.1012; WELLER JP, 1980, CHEM BER-RECL, V113, P1603, DOI 10.1002/cber.19801130439	40	36	37	0	8	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	OCT 10	2008	283	41					27547	27554		10.1074/jbc.M803765200	http://dx.doi.org/10.1074/jbc.M803765200			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	355OW	18662988	hybrid, Green Published			2022-12-27	WOS:000259719200025
J	Taft, MH; Hartmann, FK; Rump, A; Keller, H; Chizhov, I; Manstein, DJ; Tsiavaliaris, G				Taft, Manuel H.; Hartmann, Falk K.; Rump, Agrani; Keller, Heiko; Chizhov, Igor; Manstein, Dietmar J.; Tsiavaliaris, Georgios			Dictyostelium myosin-5b is a conditional processive motor	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							LOW DUTY RATIO; UNCONVENTIONAL MYOSIN; KINETIC MECHANISM; MOLECULAR MOTOR; BINDING DOMAIN; ACTIN; DISCOIDEUM; MAGNESIUM; PROTEIN; TRAFFICKING	Dictyostelium myosin-5b is the gene product of myoJ and one of two closely related myosin-5 isoenzymes produced in Dictyostelium discoideum. Here we report a detailed investigation of the kinetic and functional properties of the protein. In standard assay buffer conditions, Dictyostelium myosin-5b displays high actin affinity in the presence of ADP, fast ATP hydrolysis, and a high steady-state ATPase activity in the presence of actin that is rate limited by ADP release. These properties are typical for a processive motor that can move over long distances along actin filaments without dissociating. Our results show that a physiological decrease in the concentration of free Mg2+-ions leads to an increased rate of ADP release and shortening of the fraction of time the motor spends in the strong actin binding states. Consistently, the ability of the motor to efficiently translocate actin filaments at very low surface densities decreases with decreasing concentrations of free Mg2+-ions. In addition, we provide evidence that the observed changes in Ddmyosin-5b motor activity are of physiological relevance and propose a mechanism by which this molecular motor can switch between processive and non-processive movement.	[Taft, Manuel H.; Hartmann, Falk K.; Rump, Agrani; Keller, Heiko; Chizhov, Igor; Manstein, Dietmar J.; Tsiavaliaris, Georgios] Hannover Med Sch, Inst Biophys Chem, D-30625 Hannover, Germany	Hannover Medical School	Tsiavaliaris, G (corresponding author), Hannover Med Sch, Inst Biophys Chem, OE 4350,Carl Neuberg Str 1, D-30625 Hannover, Germany.	gtsiaval@bpc.mh-hannover.de	Manstein, Dietmar J. J/M-1034-2013; Taft, Manuel/O-1396-2019; Taft, Manuel H/T-2508-2017; Manstein, Dietmar J./AAG-2640-2019	Manstein, Dietmar J. J/0000-0003-0763-0147; Taft, Manuel/0000-0001-5853-8629; Taft, Manuel H/0000-0001-5853-8629; Manstein, Dietmar J./0000-0003-0763-0147	Deutsche Forschungsgemeinschaft [TS 169/3-1, MA 1081/11]	Deutsche Forschungsgemeinschaft(German Research Foundation (DFG))	The work was supported by Deutsche Forschungsgemeinschaft Grants TS 169/3-1 (to G.T.) and MA 1081/11 (to D.J.M.). The costs of publication of this article were defrayed in part by the payment of page charges. This article must therefore be hereby marked "advertisement" in accordance with 18 U. S. C. Section 1734 solely to indicate this fact.	Anson M, 1996, EMBO J, V15, P6069, DOI 10.1002/j.1460-2075.1996.tb00995.x; BAGSHAW CR, 1975, FEBS LETT, V58, P197, DOI 10.1016/0014-5793(75)80258-4; Baker JE, 2004, P NATL ACAD SCI USA, V101, P5542, DOI 10.1073/pnas.0307247101; Boldogh IR, 2005, GENE, V354, P28, DOI 10.1016/j.gene.2005.03.049; Burgess S, 2002, J CELL BIOL, V159, P983, DOI 10.1083/jcb.200208172; Burgess SA, 2007, J MOL BIOL, V372, P1165, DOI 10.1016/j.jmb.2007.07.014; Coureux PD, 2004, EMBO J, V23, P4527, DOI 10.1038/sj.emboj.7600458; CRIDDLE AH, 1985, BIOCHEM J, V232, P343, DOI 10.1042/bj2320343; De La Cruz EM, 1999, P NATL ACAD SCI USA, V96, P13726, DOI 10.1073/pnas.96.24.13726; Desnos C, 2007, J NEUROSCI, V27, P10636, DOI 10.1523/JNEUROSCI.1228-07.2007; Desnos C, 2007, BIOL CELL, V99, P411, DOI 10.1042/BC20070021; Dunn BD, 2007, J CELL BIOL, V178, P1193, DOI 10.1083/jcb.200707080; Durrwang U, 2006, J CELL SCI, V119, P550, DOI 10.1242/jcs.02774; EGELHOFF TT, 1991, METHOD ENZYMOL, V196, P319; Evans LL, 1998, J CELL SCI, V111, P2055; Farruggia G, 2006, J AM CHEM SOC, V128, P344, DOI 10.1021/ja056523u; Foth BJ, 2006, P NATL ACAD SCI USA, V103, P3681, DOI 10.1073/pnas.0506307103; Fujita-Becker S, 2005, J BIOL CHEM, V280, P6064, DOI 10.1074/jbc.M412473200; Furch M, 1999, J MOL BIOL, V290, P797, DOI 10.1006/jmbi.1999.2921; Gabriel D, 1999, J CELL SCI, V112, P3995; Gerisch G, 2002, CELL BIOL INT, V26, P845, DOI 10.1006/cbir.2002.0938; Hammer JA, 1996, J BIOL CHEM, V271, P7120, DOI 10.1074/jbc.271.12.7120; Hancock WO, 1998, J CELL BIOL, V140, P1395, DOI 10.1083/jcb.140.6.1395; Kim HM, 2007, J ORG CHEM, V72, P2088, DOI 10.1021/jo062341m; Knetsch MLW, 2002, J MUSCLE RES CELL M, V23, P605, DOI 10.1023/A:1024498805771; Kollmar M, 2006, BMC GENOMICS, V7, DOI 10.1186/1471-2164-7-183; Komatsu H, 2004, J AM CHEM SOC, V126, P16353, DOI 10.1021/ja049624l; Kurzawa SE, 1997, BIOCHEMISTRY-US, V36, P317, DOI 10.1021/bi962166b; LEHRER SS, 1972, BIOCHEMISTRY-US, V11, P1211, DOI 10.1021/bi00757a015; LEVI V, 2006, BIOPHYS J, V90; Lise MF, 2006, J BIOL CHEM, V281, P3669, DOI 10.1074/jbc.M511725200; MANSTEIN DJ, 1995, J MUSCLE RES CELL M, V16, P325, DOI 10.1007/BF00121141; Mehta AD, 1999, NATURE, V400, P590, DOI 10.1038/23072; Peterson MD, 1996, J MUSCLE RES CELL M, V17, P411, DOI 10.1007/BF00123358; Reck-Peterson SL, 2001, J CELL BIOL, V153, P1121, DOI 10.1083/jcb.153.5.1121; Rock RS, 2001, P NATL ACAD SCI USA, V98, P13655, DOI 10.1073/pnas.191512398; Rosenfeld SS, 2005, J BIOL CHEM, V280, P6072, DOI 10.1074/jbc.M412717200; Suzuki Y, 2002, ANAL CHEM, V74, P1423, DOI 10.1021/ac010914j; Takagi Y, 2008, J BIOL CHEM, V283, P8527, DOI 10.1074/jbc.M709150200; Terrak M, 2005, P NATL ACAD SCI USA, V102, P12718, DOI 10.1073/pnas.0503899102; Thirumurugan K, 2006, NATURE, V442, P212, DOI 10.1038/nature04865; Toth J, 2005, J BIOL CHEM, V280, P30594, DOI 10.1074/jbc.M505209200; Trybus KM, 2007, J BIOL CHEM, V282, P23316, DOI 10.1074/jbc.M701636200; Trybus KM, 1999, J BIOL CHEM, V274, P27448, DOI 10.1074/jbc.274.39.27448; Varadi A, 2005, MOL BIOL CELL, V16, P2670, DOI 10.1091/mbc.e04-11-1001; Walker ML, 2000, NATURE, V405, P804, DOI 10.1038/35015592; Watanabe S, 2006, BIOCHEMISTRY-US, V45, P2729, DOI 10.1021/bi051682b; Watanabe S, 2008, J BIOL CHEM, V283, P10581, DOI 10.1074/jbc.M707657200; Yildiz A, 2003, SCIENCE, V300, P2061, DOI 10.1126/science.1084398; Yoshimura A, 2006, CURR BIOL, V16, P2345, DOI 10.1016/j.cub.2006.10.024	50	30	32	0	5	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	OCT 3	2008	283	40					26902	26910		10.1074/jbc.M802957200	http://dx.doi.org/10.1074/jbc.M802957200			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	353RT	18650439	hybrid			2022-12-27	WOS:000259586600010
J	Xie, JJ; Reverdatto, S; Frolov, A; Hoffmann, R; Burz, DS; Shekhtman, A				Xie, Jingjing; Reverdatto, Sergey; Frolov, Andrej; Hoffmann, Ralf; Burz, David S.; Shekhtman, Alexander			Structural basis for pattern recognition by the receptor for advanced glycation end products (RAGE)	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							PROTEIN-PROTEIN INTERACTIONS; CELL-SURFACE RECEPTOR; DIPOLAR COUPLINGS; NMR-SPECTROSCOPY; GLYCOSYLATION; MECHANISM; ACTIVATION; LIGANDS; BINDING; IDENTIFICATION	The receptor for advanced glycated end products ( RAGE) is a multiligand receptor that is implicated in the pathogenesis of various diseases, including diabetic complications, neurodegenerative disorders, and inflammatory responses. The ability of RAGE to recognize advanced glycated end products (AGEs) formed by nonenzymatic glycoxidation of cellular proteins places RAGE in the category of pattern recognition receptors. The structural mechanism of AGE recognition was an enigma due to the diversity of chemical structures found in AGE-modified proteins. Here, using NMR spectroscopy we showed that the immunoglobulin V-type domain of RAGE is responsible for recognizing various classes of AGEs. Three distinct surfaces of the V domain were identified to mediate AGE-V domain interactions. They are located in the positively charged areas of the V domain. The first interaction surface consists of strand C and loop CC', the second interaction surface consists of strand C', strand F, and loop FG, and the third interaction surface consists of strand A' and loop EF. The secondary structure elements of the interaction surfaces exhibit significant flexibility on the ms-mu s time scale. Despite highly specific AGE-V domain interactions, the binding affinity of AGEs for an isolated V domain is low, similar to 10 mu M. Using in-cell fluorescence resonance energy transfer we show that RAGE is a constitutive oligomer on the plasma membrane. We propose that constitutive oligomerization of RAGE is responsible for recognizing patterns of AGE-modified proteins with affinities less than 100 nM.	[Xie, Jingjing; Reverdatto, Sergey; Burz, David S.; Shekhtman, Alexander] SUNY Albany, Dept Chem, Albany, NY 12222 USA; [Frolov, Andrej; Hoffmann, Ralf] Univ Leipzig, Dept Chem & Mineral, Inst Bioanalyt Chem, D-14103 Leipzig, Germany	State University of New York (SUNY) System; State University of New York (SUNY) Albany; Leipzig University	Shekhtman, A (corresponding author), SUNY Albany, Dept Chem, 1400 Washington Ave, Albany, NY 12222 USA.	ashekhta@albany.edu	Frolov, Andrej A/V-5550-2018; xie, jing/GRY-1689-2022; Hoffmann, Ralf/ABD-8779-2020	Shekhtman, Alexander/0000-0003-2649-2675	American Diabetes Association Career Development [1-06-CD-23]	American Diabetes Association Career Development(American Diabetes Association)	This work was supported by American Diabetes Association Career Development Award 1-06-CD-23 (to A. S.). The costs of publication of this article were defrayed in part by the payment of page charges. This article must therefore be hereby marked "advertisement" in accordance with 18 U. S. C. Section 1734 solely to indicate this fact.	Anderson MM, 1999, J CLIN INVEST, V104, P103, DOI 10.1172/JCI3042; Bastiaens PIH, 1996, EMBO J, V15, P4246, DOI 10.1002/j.1460-2075.1996.tb00799.x; Bax A, 2001, METHOD ENZYMOL, V339, P127, DOI 10.1016/S0076-6879(01)39313-8; BROWNLEE M, 1995, ANNU REV MED, V46, P223, DOI 10.1146/annurev.med.46.1.223; Buetler TM, 2008, MOL NUTR FOOD RES, V52, P370, DOI 10.1002/mnfr.200700101; Burz DS, 2006, NAT PROTOC, V1, P146, DOI 10.1038/nprot.2006.23; Burz DS, 2006, NAT METHODS, V3, P91, DOI 10.1038/NMETH851; Chothia C, 1997, ANNU REV BIOCHEM, V66, P823, DOI 10.1146/annurev.biochem.66.1.823; Chou JJ, 2001, J BIOMOL NMR, V21, P377, DOI 10.1023/A:1013336502594; Dattilo BM, 2007, BIOCHEMISTRY-US, V46, P6957, DOI 10.1021/bi7003735; DOMINICZAK MH, 1991, DIABETIC MED, V8, P505, DOI 10.1111/j.1464-5491.1991.tb01643.x; Eghbalnia HR, 2005, J BIOMOL NMR, V32, P71, DOI 10.1007/s10858-005-5705-1; FARROW NA, 1995, BIOCHEMISTRY-US, V34, P868, DOI 10.1021/bi00003a021; Frolov A, 2007, J PEPT SCI, V13, P862, DOI 10.1002/psc.901; GLOMB MA, 1995, J BIOL CHEM, V270, P10017, DOI 10.1074/jbc.270.17.10017; Gruber P, 2005, J PEPT RES, V66, P111, DOI 10.1111/j.1399-3011.2005.00279.x; Guex N, 1997, ELECTROPHORESIS, V18, P2714, DOI 10.1002/elps.1150181505; Hanford LE, 2004, J BIOL CHEM, V279, P50019, DOI 10.1074/jbc.M409782200; Hawkins CL, 1998, BIOCHEM J, V332, P617, DOI 10.1042/bj3320617; Heizmann CW, 2007, MOL NUTR FOOD RES, V51, P1116, DOI 10.1002/mnfr.200600284; Herrick-Davis K, 2005, J BIOL CHEM, V280, P40144, DOI 10.1074/jbc.M507396200; Hinton DJS, 2006, AMINO ACIDS, V30, P425, DOI 10.1007/s00726-006-0269-2; Hofmann MA, 2002, GENES IMMUN, V3, P123, DOI 10.1038/sj.gene.6363861; Hofmann MA, 1999, CELL, V97, P889, DOI 10.1016/S0092-8674(00)80801-6; JENCKS WP, 1981, P NATL ACAD SCI-BIOL, V78, P4046, DOI 10.1073/pnas.78.7.4046; Kenworthy AK, 1998, J CELL BIOL, V142, P69, DOI 10.1083/jcb.142.1.69; Kislinger T, 1999, J BIOL CHEM, V274, P31740, DOI 10.1074/jbc.274.44.31740; Kislinger T, 2001, ARTERIOSCL THROM VAS, V21, P905, DOI 10.1161/01.ATV.21.6.905; Kostrewa D, 2001, EMBO J, V20, P4391, DOI 10.1093/emboj/20.16.4391; Lakowicz J. R., 2006, PRINCIPLES FLUORESCE, V3rd, P443, DOI DOI 10.1007/978-0-387-46312-4_13; LANE AN, 1994, METHOD ENZYMOL, V239, P596; Laskowski RA, 1996, J BIOMOL NMR, V8, P477, DOI 10.1007/BF00228148; Leclerc E, 2007, J BIOL CHEM, V282, P31317, DOI 10.1074/jbc.M703951200; Liliensiek B, 2004, J CLIN INVEST, V113, P1641, DOI 10.1172/JCI200418704; Lin L, 2006, CELL MOL IMMUNOL, V3, P351; Loria JP, 1999, J BIOMOL NMR, V15, P151, DOI 10.1023/A:1008355631073; Losonczi JA, 1999, J MAGN RESON, V138, P334, DOI 10.1006/jmre.1999.1754; Lutterloh EC, 2007, CRIT CARE, V11, DOI 10.1186/cc6184; Marsche G, 2007, FASEB J, V21, P1145, DOI 10.1096/fj.06-7439com; Masse JE, 2005, J MAGN RESON, V174, P133, DOI 10.1016/j.jmr.2005.01.017; Matsuo H, 1999, J AM CHEM SOC, V121, P9903, DOI 10.1021/ja991881g; McInnes C, 2000, PROTEIN ENG, V13, P143, DOI 10.1093/protein/13.3.143; Medzhitov R, 1997, CELL, V91, P295, DOI 10.1016/S0092-8674(00)80412-2; NEEPER M, 1992, J BIOL CHEM, V267, P14998; Osawa M, 2007, BBA-GEN SUBJECTS, V1770, P1468, DOI 10.1016/j.bbagen.2007.07.003; Ostendorp T, 2007, EMBO J, V26, P3868, DOI 10.1038/sj.emboj.7601805; Reddy MA, 2006, J BIOL CHEM, V281, P13685, DOI 10.1074/jbc.M511425200; Schalkwijk CG, 2004, DIABETES-METAB RES, V20, P369, DOI 10.1002/dmrr.488; Schmidt AM, 2001, J CLIN INVEST, V108, P949, DOI 10.1172/JCI200114002; Schmitt A, 2005, ANAL BIOCHEM, V338, P201, DOI 10.1016/j.ab.2004.12.003; Shekhtman A, 2001, J MOL BIOL, V314, P129, DOI 10.1006/jmbi.2001.5126; Srikrishna G, 2002, J NEUROCHEM, V80, P998, DOI 10.1046/j.0022-3042.2002.00796.x; Stahl PD, 1998, CURR OPIN IMMUNOL, V10, P50, DOI 10.1016/S0952-7915(98)80031-9; SUGAYA K, 1994, GENOMICS, V23, P408, DOI 10.1006/geno.1994.1517; Taguchi A, 2000, NATURE, V405, P354, DOI 10.1038/35012626; TAYLOR ME, 1993, J BIOL CHEM, V268, P399; Thornalley PJ, 2003, BIOCHEM J, V375, P581, DOI 10.1042/BJ20030763; Thornalley PJ, 1998, CELL MOL BIOL, V44, P1013; THORNALLEY PJ, 1999, CLIN LAB, V45, P263; Valencia JV, 2004, DIABETES, V53, P743, DOI 10.2337/diabetes.53.3.743; Valencia JV, 2004, ANAL BIOCHEM, V324, P68, DOI 10.1016/j.ab.2003.09.013; Wallrabe H, 2003, BIOPHYS J, V85, P559, DOI 10.1016/S0006-3495(03)74500-7; Walters KJ, 1999, P NATL ACAD SCI USA, V96, P7877, DOI 10.1073/pnas.96.14.7877; Walters KJ, 2001, METHOD ENZYMOL, V339, P238, DOI 10.1016/S0076-6879(01)39316-3; WELLSKNECHT KJ, 1995, BIOCHEMISTRY-US, V34, P3702, DOI 10.1021/bi00011a027; WISHART DS, 1994, J BIOMOL NMR, V4, P171; Xie J, 2007, J BIOL CHEM, V282, P4218, DOI 10.1074/jbc.M608888200; Yan SD, 1996, NATURE, V382, P685, DOI 10.1038/382685a0; Yeh CH, 2001, DIABETES, V50, P1495, DOI 10.2337/diabetes.50.6.1495; Zacharias DA, 2002, SCIENCE, V296, P913, DOI 10.1126/science.1068539; Zuiderweg ERP, 2002, BIOCHEMISTRY-US, V41, P1, DOI 10.1021/bi011870b; Zweckstetter M, 2000, J AM CHEM SOC, V122, P3791, DOI 10.1021/ja0000908; [No title captured]; [No title captured]; [No title captured]; [No title captured]	76	178	184	0	20	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	OCT 3	2008	283	40					27255	27269		10.1074/jbc.M801622200	http://dx.doi.org/10.1074/jbc.M801622200			15	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	353RT	18667420	hybrid			2022-12-27	WOS:000259586600045
J	Chen, S; Tong, X; Woodard, RW; Du, GC; Wu, J; Chen, J				Chen, Sheng; Tong, Xing; Woodard, Ronald W.; Du, Guocheng; Wu, Jing; Chen, Jian			Identification and characterization of bacterial cutinase	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							FRUCTICOLA WINT. HONEY; SOLANI-PISI CUTINASE; POLYETHYLENE TEREPHTHALATE; INTERFACIAL ACTIVATION; THERMOMONOSPORA-FUSCA; ANGSTROM RESOLUTION; CRYSTAL-STRUCTURE; LIPASE; PURIFICATION; ENZYME	Cutinase, which exists in both fungi and bacteria, catalyzes the cleavage of the ester bonds of cutin. Fungal cutinases have been extensively studied, however, reports on bacterial cutinases have been limited due to the lack of knowledge concerning the identity of their open reading frames. In the present study, the cutinase from Thermobifida fusca was induced by cutin and purified to homogeneity by following p-nitrophenyl butyrate hydrolyzing activity. Peptide mass fingerprinting analysis of the wild-type enzyme matched two proteins, Tfu_0883 and Tfu_0882, which are 93% identical in sequence. Both proteins were cloned and overexpressed in their mature form. Recombinant Tfu_0883 and Tfu_0882 display very similar enzymatic properties and were confirmed to be cutinases by their capability to hydrolyze the ester bonds of cutin. Comparative characterization of Fusarium solani pisi and T. fusca cutinases indicated that they have similar substrate specificity and catalytic properties except that the T. fusca enzymes are thermally more stable. Homology modeling revealed that T. fusca cutinases adopt an alpha/beta-hydrolase fold that exhibits both similarities and variations from the fungal cutinase structure. A serine hydrolase catalytic mechanism involving a Ser(170)-His(248)-Asp(216) (Tfu_0883 numbering) catalytic triad was supported by active site-directed inhibition studies and mutational analyses. This is the first report of cutinase encoding genes from bacterial sources.	[Chen, Sheng; Tong, Xing; Du, Guocheng; Wu, Jing; Chen, Jian] Jiangnan Univ, State Key Lab Food Sci & Technol, Wuxi 214122, Jiangsu, Peoples R China; [Chen, Sheng; Tong, Xing; Du, Guocheng; Wu, Jing; Chen, Jian] Jiangnan Univ, Minist Educ, Sch Biotechnol, Wuxi 214122, Jiangsu, Peoples R China; [Chen, Sheng; Tong, Xing; Du, Guocheng; Wu, Jing; Chen, Jian] Jiangnan Univ, Minist Educ, Key Lab Ind Biotechnol, Wuxi 214122, Jiangsu, Peoples R China; [Woodard, Ronald W.] Univ Michigan, Dept Med Chem, Ann Arbor, MI 48109 USA	Jiangnan University; Jiangnan University; Jiangnan University; University of Michigan System; University of Michigan	Wu, J (corresponding author), Jiangnan Univ, State Key Lab Food Sci & Technol, 1800 Lihu Ave, Wuxi 214122, Jiangsu, Peoples R China.	jingwu@jiangnan.edu.cn; jchen@jiangnan.edu.cn	Wu, Jing/GZK-5063-2022	Woodard, Ronald/0000-0002-7472-3653	Program for New Century Excellent Talents in University [NCET-06-0486]; National Science Fund for Distinguished Young Scholars of China [20625619]; 111 Project [11-2-06]; Research Program of State Key Laboratory of Food Science and Technology [SKLF-MB-200802]	Program for New Century Excellent Talents in University(Program for New Century Excellent Talents in University (NCET)); National Science Fund for Distinguished Young Scholars of China(National Natural Science Foundation of China (NSFC)National Science Fund for Distinguished Young Scholars); 111 Project(Ministry of Education, China - 111 Project); Research Program of State Key Laboratory of Food Science and Technology	This work was supported by Program for New Century Excellent Talents in University Grant NCET-06-0486, National Science Fund for Distinguished Young Scholars of China Grant 20625619, 111 Project Grant 11-2-06, and Research Program of State Key Laboratory of Food Science and Technology Grant SKLF-MB-200802. The costs of publication of this article were defrayed in part by the payment of page charges. This article must therefore be hereby marked "advertisement" in accordance with 18 U. S. C. Section 1734 solely to indicate this fact.	Alisch-Mark M, 2006, BIOTECHNOL LETT, V28, P681, DOI 10.1007/s10529-006-9041-7; Angkawidjaja C, 2007, FEBS LETT, V581, P5060, DOI 10.1016/j.febslet.2007.09.048; Araujo R, 2007, J BIOTECHNOL, V128, P849, DOI 10.1016/j.jbiotec.2006.12.028; BRZOZOWSKI AM, 1991, NATURE, V351, P491, DOI 10.1038/351491a0; Brzozowski AM, 2000, BIOCHEMISTRY-US, V39, P15071, DOI 10.1021/bi0013905; Carvalho CML, 1999, BIOTECHNOL BIOENG, V66, P17, DOI [10.1002/(SICI)1097-0290(1999)66:1<17::AID-BIT2>3.0.CO;2-F, 10.1002/(SICI)1097-0290(1999)66:1&lt;17::AID-BIT2&gt;3.0.CO;2-F]; Cunha MT, 2003, J BIOTECHNOL, V100, P55, DOI 10.1016/S0168-1656(02)00225-0; Degani O, 2002, APPL BIOCHEM BIOTECH, V102, P277, DOI 10.1385/ABAB:102-103:1-6:277; Dodson G, 1998, TRENDS BIOCHEM SCI, V23, P347, DOI 10.1016/S0968-0004(98)01254-7; Egmond MR, 2000, BIOCHIMIE, V82, P1015, DOI 10.1016/S0300-9084(00)01183-4; Ferreira BS, 2003, APPL MICROBIOL BIOT, V61, P69, DOI 10.1007/s00253-002-1196-0; Fett WF, 1999, J APPL MICROBIOL, V86, P561, DOI 10.1046/j.1365-2672.1999.00690.x; FETT WF, 1992, CURR MICROBIOL, V25, P165, DOI 10.1007/BF01571025; FETT WF, 1992, APPL ENVIRON MICROB, V58, P2123, DOI 10.1128/AEM.58.7.2123-2130.1992; GERARD HC, 1992, PHYTOCHEM ANALYSIS, V3, P139, DOI 10.1002/pca.2800030310; Gindro K, 1999, FEMS MICROBIOL LETT, V171, P239, DOI 10.1111/j.1574-6968.1999.tb13438.x; Holmquist M, 2000, CURR PROTEIN PEPT SC, V1, P209, DOI 10.2174/1389203003381405; JAEGER KE, 1994, FEMS MICROBIOL REV, V15, P29, DOI 10.1016/0168-6445(94)90025-6; Kleeberg I, 2005, BIOMACROMOLECULES, V6, P262, DOI 10.1021/bm049582t; Lang D, 1996, J MOL BIOL, V259, P704, DOI 10.1006/jmbi.1996.0352; LIN TS, 1980, PHYSIOL PLANT PATHOL, V17, P1, DOI 10.1016/0048-4059(80)90002-8; Longhi S, 1999, BBA-MOL CELL BIOL L, V1441, P185, DOI 10.1016/S1388-1981(99)00159-6; Maeda H, 2005, APPL MICROBIOL BIOT, V67, P778, DOI 10.1007/s00253-004-1853-6; Nardini M, 1999, CURR OPIN STRUC BIOL, V9, P732, DOI 10.1016/S0959-440X(99)00037-8; Osman SF, 1999, J AGR FOOD CHEM, V47, P799, DOI 10.1021/jf980693r; Price MN, 2005, NUCLEIC ACIDS RES, V33, P880, DOI 10.1093/nar/gki232; PURDY RE, 1973, ARCH BIOCHEM BIOPHYS, V159, P61, DOI 10.1016/0003-9861(73)90429-3; Schwede T, 2003, NUCLEIC ACIDS RES, V31, P3381, DOI 10.1093/nar/gkg520; SEBASTIAN J, 1988, ARCH BIOCHEM BIOPHYS, V263, P77, DOI 10.1016/0003-9861(88)90615-7; SEBASTIAN J, 1987, J BACTERIOL, V169, P131, DOI 10.1128/jb.169.1.131-136.1987; Vertommen MAME, 2005, J BIOTECHNOL, V120, P376, DOI 10.1016/j.jbiotec.2005.06.015; WALTON TJ, 1972, BIOCHEMISTRY-US, V11, P1885, DOI 10.1021/bi00760a025; Wang GY, 2000, ARCH BIOCHEM BIOPHYS, V382, P31, DOI 10.1006/abbi.2000.1995; Wang GY, 2002, FUNGAL GENET BIOL, V35, P261, DOI 10.1006/fgbi.2001.1320; Wei YY, 1998, STRUCTURE, V6, P511, DOI 10.1016/S0969-2126(98)00052-5	35	150	177	9	73	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	SEP 19	2008	283	38					25854	25862		10.1074/jbc.M800848200	http://dx.doi.org/10.1074/jbc.M800848200			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	348GX	18658138	hybrid, Green Published			2022-12-27	WOS:000259200100012
J	Cho, C; Reck-Peterson, SL; Vale, RD				Cho, Carol; Reck-Peterson, Samara L.; Vale, Ronald D.			Regulatory ATPase sites of cytoplasmic dynein affect processivity and force generation	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							SINGLE KINESIN MOLECULES; HAND-OVER-HAND; NUCLEOTIDE-BINDING; HEAVY-CHAIN; MOTOR; HYDROLYSIS; DOMAINS; COMMUNICATION; COMPLEXES; PROTEINS	The heavy chain of cytoplasmic dynein contains four nucleotide-binding domains referred to as AAA1-AAA4, with the first domain (AAA1) being the main ATP hydrolytic site. Although previous studies have proposed regulatory roles for AAA3 and AAA4, the role of ATP hydrolysis at these sites remains elusive. Here, we have analyzed the single molecule motility properties of yeast cytoplasmic dynein mutants bearing mutations that prevent ATP hydrolysis at AAA3 or AAA4. Both mutants remain processive, but the AAA4 mutant exhibits a surprising increase in processivity due to its tighter affinity for microtubules. In addition to changes in motility characteristics, AAA3 and AAA4 mutants produce less maximal force than wild-type dynein. These results indicate that the nucleotide binding state at AAA3 and AAA4 can allosterically modulate microtubule binding affinity and affect dynein processivity and force production.	[Cho, Carol; Reck-Peterson, Samara L.; Vale, Ronald D.] Univ Calif San Francisco, Howard Hughes Med Inst, San Francisco, CA 94158 USA; [Cho, Carol; Reck-Peterson, Samara L.; Vale, Ronald D.] Univ Calif San Francisco, Dept Cellular & Mol Pharmacol, San Francisco, CA 94158 USA	Howard Hughes Medical Institute; University of California System; University of California San Francisco; University of California System; University of California San Francisco	Vale, RD (corresponding author), MC 2200,Rm N312E,600 16th St, San Francisco, CA 94158 USA.	vale@cmp.ucsf.edu		Reck-Peterson, Samara/0000-0002-1553-465X; Cho, Carol/0000-0003-4070-6561	National Institutes of Health [T32 GM07810]; Howard Hughes Medical Institute; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [T32GM007810, R01GM097312] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Howard Hughes Medical Institute(Howard Hughes Medical Institute); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported, in whole or in part, by National Institutes of Health Grant T32 GM07810 (to C. C.). This work was also supported by the Howard Hughes Medical Institute (to R. D. V.). The costs of publication of this article were defrayed in part by the payment of page charges. This article must therefore be hereby marked "advertisement" in accordance with 18 U. S. C. Section 1734 solely to indicate this fact.	BLOCK SM, 1990, NATURE, V348, P348, DOI 10.1038/348348a0; Burgess SA, 2003, NATURE, V421, P715, DOI 10.1038/nature01377; DeLaBarre B, 2003, NAT STRUCT BIOL, V10, P856, DOI 10.1038/nsb972; Enemark EJ, 2006, NATURE, V442, P270, DOI 10.1038/nature04943; Erzberger JP, 2006, ANNU REV BIOPH BIOM, V35, P93, DOI 10.1146/annurev.biophys.35.040405.101933; Farrell CM, 2002, J BIOL CHEM, V277, P17079, DOI 10.1074/jbc.M108793200; Gennerich A, 2007, CELL, V131, P952, DOI 10.1016/j.cell.2007.10.016; GIBBONS BH, 1987, J BIOL CHEM, V262, P8354; GIBBONS IR, 1991, NATURE, V352, P640, DOI 10.1038/352640a0; Hattendorf DA, 2002, EMBO J, V21, P12, DOI 10.1093/emboj/21.1.12; Huyton T, 2003, J STRUCT BIOL, V144, P337, DOI 10.1016/j.jsb.2003.10.007; Kon T, 2005, NAT STRUCT MOL BIOL, V12, P513, DOI 10.1038/nsmb930; Kon T, 2004, BIOCHEMISTRY-US, V43, P11266, DOI 10.1021/bi048985a; Martin A, 2005, NATURE, V437, P1115, DOI 10.1038/nature04031; Mizuno N, 2007, P NATL ACAD SCI USA, V104, P20832, DOI 10.1073/pnas.0710406105; Neuwald AF, 1999, GENOME RES, V9, P27; OGAWA K, 1995, MOL BIOL CELL, V6, P685, DOI 10.1091/mbc.6.6.685; Ogura T, 2001, GENES CELLS, V6, P575, DOI 10.1046/j.1365-2443.2001.00447.x; Reck-Peterson SL, 2006, CELL, V126, P335, DOI 10.1016/j.cell.2006.05.046; Reck-Peterson SL, 2004, P NATL ACAD SCI USA, V101, P1491, DOI 10.1073/pnas.2637011100; Ross JL, 2006, NAT CELL BIOL, V8, P562, DOI 10.1038/ncb1421; Samso M, 1998, J MOL BIOL, V276, P927, DOI 10.1006/jmbi.1997.1584; Schwacha A, 2001, MOL CELL, V8, P1093, DOI 10.1016/S1097-2765(01)00389-6; Silvanovich A, 2003, MOL BIOL CELL, V14, P1355, DOI 10.1091/mbc.E02-10-0675; SVOBODA K, 1994, CELL, V77, P773, DOI 10.1016/0092-8674(94)90060-4; Takahashi Y, 2004, P NATL ACAD SCI USA, V101, P12865, DOI 10.1073/pnas.0403429101; Thorn KS, 2000, J CELL BIOL, V151, P1093, DOI 10.1083/jcb.151.5.1093; Tomishige M, 2002, SCIENCE, V297, P2263, DOI 10.1126/science.1073386; Vale RD, 2000, J CELL BIOL, V150, pF13, DOI 10.1083/jcb.150.1.F13; Vallee RB, 2004, J NEUROBIOL, V58, P189, DOI 10.1002/neu.10314; Yildiz A, 2004, SCIENCE, V303, P676, DOI 10.1126/science.1093753; Yildiz A, 2003, SCIENCE, V300, P2061, DOI 10.1126/science.1084398; Zhang XD, 2000, MOL CELL, V6, P1473, DOI 10.1016/S1097-2765(00)00143-X	33	102	102	0	10	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	SEP 19	2008	283	38					25839	25845		10.1074/jbc.M802951200	http://dx.doi.org/10.1074/jbc.M802951200			7	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	348GX	18650442	Green Published, hybrid			2022-12-27	WOS:000259200100010
J	Klaavuniemi, T; Yamashiro, S; Ono, S				Klaavuniemi, Tuula; Yamashiro, Sawako; Ono, Shoichiro			Caenorhabditis elegans gelsolin-like protein 1 is a novel actin filament-severing protein with four gelsolin-like repeats	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							DEPOLYMERIZING FACTOR/COFILIN PROTEINS; PLASMA-GELSOLIN; INTERACTING PROTEIN-1; BINDING PROTEIN; F-ACTIN; ESCHERICHIA-COLI; SKELETAL-MUSCLE; ATP-ACTIN; ADP-ACTIN; GENE	The gelsolin family of proteins is a major class of actin regulatory proteins that sever, cap, and nucleate actin filaments in a calcium-dependent manner and are involved in various cellular processes. Typically, gelsolin-related proteins have three or six repeats of gelsolin-like (G) domain, and each domain plays a distinct role in severing, capping, and nucleation. The Caenorhabditis elegans gelsolin-like protein-1 (gsnl-1) gene encodes an unconventional gelsolin-related protein with four G domains. Sequence alignment suggests that GSNL-1 lacks two G domains that are equivalent to fourth and fifth G domains of gelsolin. In vitro, GSNL-1 severed actin filaments and capped the barbed end in a calcium-dependent manner. However, unlike gelsolin, GSNL-1 remained bound to the side of F-actin with a submicromolar affinity and did not nucleate actin polymerization, although it bound to G-actin with high affinity. These results indicate that GSNL-1 is a novel member of the gelsolin family of actin regulatory proteins and provide new insight into functional diversity and evolution of gelsolin-related proteins.	[Klaavuniemi, Tuula; Yamashiro, Sawako; Ono, Shoichiro] Emory Univ, Dept Pathol, Atlanta, GA 30322 USA	Emory University	Ono, S (corresponding author), Emory Univ, Dept Pathol, 615 Michael St,Whitehead Res Bldg,Rm 105N, Atlanta, GA 30322 USA.	sono@emory.edu	Ono, Shoichiro/A-6475-2015	Ono, Shoichiro/0000-0002-4763-0398; Yamashiro, Sawako/0000-0002-5980-0470	National Institutes of Health [R01 AR48615]; NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES [R01AR048615] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS))	This work was supported, in whole or in part, by National Institutes of Health Grant R01 AR48615. The costs of publication of this article were defrayed in part by the payment of page charges. This article must therefore be hereby marked "advertisement" in accordance with 18 U.S.C. Section 1734 solely to indicate this fact.	Agrawal PB, 2007, AM J HUM GENET, V80, P162, DOI 10.1086/510402; Allen PG, 1996, J BIOL CHEM, V271, P4665; BROWN SS, 1982, J CELL BIOL, V93, P205, DOI 10.1083/jcb.93.1.205; BRYAN J, 1986, J CELL BIOL, V102, P1439, DOI 10.1083/jcb.102.4.1439; Burtnick LD, 1997, CELL, V90, P661, DOI 10.1016/S0092-8674(00)80527-9; CAMPBELL HD, 1993, P NATL ACAD SCI USA, V90, P11386, DOI 10.1073/pnas.90.23.11386; CARLIER MF, 1988, J BIOL CHEM, V263, P817; Carlier MF, 1997, J CELL BIOL, V136, P1307, DOI 10.1083/jcb.136.6.1307; CASELLA JF, 1987, J CELL BIOL, V105, P371, DOI 10.1083/jcb.105.1.371; CASELLA JF, 1986, J BIOL CHEM, V261, P915; Deng H, 2007, GENETICS, V177, P847, DOI 10.1534/genetics.107.078964; DISSMANN E, 1994, EUR J CELL BIOL, V63, P336; DITSCH A, 1994, EUR J BIOCHEM, V224, P223, DOI 10.1111/j.1432-1033.1994.tb20015.x; DOI Y, 1984, J BIOL CHEM, V259, P1868; Fox RM, 2007, GENOME BIOL, V8, DOI 10.1186/gb-2007-8-9-r188; Fujita H, 1997, EUR J BIOCHEM, V248, P834, DOI 10.1111/j.1432-1033.1997.00834.x; Gloss A, 2003, MOL BIOL CELL, V14, P2716, DOI 10.1091/mbc.E02-12-0827; Goshima M, 1999, BIOCHEM BIOPH RES CO, V257, P111, DOI 10.1006/bbrc.1999.0420; HARRIS HE, 1984, FEBS LETT, V177, P184, DOI 10.1016/0014-5793(84)81280-6; Hunt-Newbury R, 2007, PLOS BIOL, V5, P1981, DOI 10.1371/journal.pbio.0050237; Ichetovkin I, 2000, CELL MOTIL CYTOSKEL, V45, P293, DOI 10.1002/(SICI)1097-0169(200004)45:4<293::AID-CM5>3.0.CO;2-1; Kamath RS, 2003, NATURE, V421, P231, DOI 10.1038/nature01278; Kawamoto S, 2002, FEBS LETT, V516, P234, DOI 10.1016/S0014-5793(02)02540-1; KOUYAMA T, 1981, EUR J BIOCHEM, V114, P33; KUROKAWA H, 1990, BIOCHEM BIOPH RES CO, V168, P451, DOI 10.1016/0006-291X(90)92342-W; KWIATKOWSKI DJ, 1989, J CELL BIOL, V108, P1717, DOI 10.1083/jcb.108.5.1717; Larkin MA, 2007, BIOINFORMATICS, V23, P2947, DOI 10.1093/bioinformatics/btm404; Mariol MC, 2001, CURR BIOL, V11, P1691, DOI 10.1016/S0960-9822(01)00528-0; McArdle K, 1998, J CELL BIOL, V143, P1201, DOI 10.1083/jcb.143.5.1201; McGough AM, 2003, FEBS LETT, V552, P75, DOI 10.1016/S0014-5793(03)00932-3; MIKLOS GLG, 1990, J NEUROGENET, V6, P133, DOI 10.3109/01677069009107106; Mohri K, 2006, MOL BIOL CELL, V17, P2190, DOI 10.1091/mbc.E05-11-1016; OHTSUKA Y, 1994, ZOOL SCI, V11, P407; Ohtsuka Y, 1998, BBA-PROTEIN STRUCT M, V1383, P219, DOI 10.1016/S0167-4838(97)00211-2; Ono K, 2003, J CELL SCI, V116, P2073, DOI 10.1242/jcs.00421; Ono S, 2004, J BIOL CHEM, V279, P14207, DOI 10.1074/jbc.M313418200; Ono S, 1999, J CELL BIOL, V145, P491, DOI 10.1083/jcb.145.3.491; Ono S, 1998, J BIOL CHEM, V273, P3778, DOI 10.1074/jbc.273.6.3778; Ono S, 2001, J CELL BIOL, V152, P1313, DOI 10.1083/jcb.152.6.1313; ONO S, 1994, J BIOL CHEM, V269, P15280; Ono S, 2007, INT REV CYTOL, V258, P1, DOI 10.1016/S0074-7696(07)58001-0; PARDEE JD, 1982, METHOD ENZYMOL, V85, P164; POLLARD TD, 1986, J CELL BIOL, V103, P2747, DOI 10.1083/jcb.103.6.2747; PORTE F, 1986, EUR J BIOCHEM, V154, P87, DOI 10.1111/j.1432-1033.1986.tb09362.x; SAFER D, 1989, ANAL BIOCHEM, V178, P32, DOI 10.1016/0003-2697(89)90351-5; Schultz J, 1998, P NATL ACAD SCI USA, V95, P5857, DOI 10.1073/pnas.95.11.5857; Selden LA, 1998, BIOPHYS J, V75, P3092, DOI 10.1016/S0006-3495(98)77750-1; Silacci P, 2004, CELL MOL LIFE SCI, V61, P2614, DOI 10.1007/s00018-004-4225-6; Soeno Y, 1998, J MUSCLE RES CELL M, V19, P639, DOI 10.1023/A:1005329114263; Southwick FS, 2000, P NATL ACAD SCI USA, V97, P6936, DOI 10.1073/pnas.97.13.6936; SOUTHWICK FS, 1995, J BIOL CHEM, V270, P45, DOI 10.1074/jbc.270.1.45; Sun HQ, 1999, J BIOL CHEM, V274, P33179, DOI 10.1074/jbc.274.47.33179; Vartiainen MK, 2002, MOL BIOL CELL, V13, P183, DOI 10.1091/mbc.01-07-0331; WAY M, 1989, J CELL BIOL, V109, P593, DOI 10.1083/jcb.109.2.593; Xiang Y, 2007, PLANT CELL, V19, P1930, DOI 10.1105/tpc.106.048413; Yamashiro S, 2005, BIOCHEMISTRY-US, V44, P14238, DOI 10.1021/bi050933d; Yamashiro S, 2007, J CELL SCI, V120, P3022, DOI 10.1242/jcs.013516; YIN HL, 1981, J BIOL CHEM, V256, P9693; YIN HL, 1981, J CELL BIOL, V91, P901, DOI 10.1083/jcb.91.3.901; YIN HL, 1990, FEBS LETT, V264, P78, DOI 10.1016/0014-5793(90)80769-F	60	21	23	0	1	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	SEP 19	2008	283	38					26071	26080		10.1074/jbc.M803618200	http://dx.doi.org/10.1074/jbc.M803618200			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	348GX	18640981	Green Published, hybrid			2022-12-27	WOS:000259200100035
J	Guo, H; Mi, Z; Kuo, PC				Guo, Hongtao; Mi, Zhiyong; Kuo, Paul C.			Characterization of short range DNA looping in endotoxin-mediated transcription of the murine inducible nitric-oxide synthase (iNOS) gene	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							NF-KAPPA-B; INTERFERON-GAMMA; IFN-GAMMA; EXPRESSION; LIPOPOLYSACCHARIDE; INHIBITION; INDUCTION; COMPLEX; BINDING; RESPIRATION	The local structural properties and spatial conformations of chromosomes are intimately associated with gene expression. The spatial associations of critical genomic elements in inducible nitric-oxide synthase (iNOS) transcription have not been previously examined. In this regard, the murine iNOS promoter contains 2 NF-kappa B binding sites (nt-86 and nt-972) that are essential for maximal transactivation of iNOS by LPS. Although AP-1 is commonly listed as an essential transcription factor for LPS-mediated iNOS transactivation, the relationship between AP-1 and NF-kappa B in this setting is not well studied. In this study using a model of LPS-stimulated ANA-1 murine macrophages, we demonstrate that short range DNA looping occurs at the iNOS promoter. This looping requires the presence of AP-1, c-Jun, NF-kappa B p65, and p300-associated acetyltransferase activity. The distal AP-1 binding site interacts via p300 with the proximal NF-kappa B binding site to create this DNA loop to participate in iNOS transcription. Other geographically distant AP-1 and NF-kappa B sites are certainly occupied, but selected sites are critical for iNOS transcription and the formation of the c-Jun, p65, and p300 transcriptional complex. In this "simplified" model of murine iNOS promoter, numerous transcription factors recognize and bind to various response elements, but these locales do not equally contribute to iNOS gene transcription.	[Guo, Hongtao; Mi, Zhiyong; Kuo, Paul C.] Duke Univ, Med Ctr, Dept Surg, Durham, NC 27710 USA	Duke University	Kuo, PC (corresponding author), 110 Bell Bldg,DUMC 3522, Durham, NC 27710 USA.	kuo00004@mc.duke.edu			National Institutes of Health [AI44629, DK070642, GM65113]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R29AI044629, R01AI044629] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R21DK070642] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM065113, R56GM065113] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported, in whole or in part, by National Institutes of Health Grants AI44629, DK070642, and GM65113 (to P. C. K.). The costs of publication of this article were defrayed in part by the payment of page charges. This article must therefore be hereby marked "advertisement" in accordance with 18 U. S. C. Section 1734 solely to indicate this fact.	Babu DA, 2008, J BIOL CHEM, V283, P8164, DOI 10.1074/jbc.M800336200; Beltran B, 2000, P NATL ACAD SCI USA, V97, P14602, DOI 10.1073/pnas.97.26.14602; Brendeford EM, 1998, FEBS LETT, V425, P52, DOI 10.1016/S0014-5793(98)00196-3; Brockmann D, 1999, GENE EXPRESSION, V8, P1; Brookes PS, 2001, J MOL CELL CARDIOL, V33, P69, DOI 10.1006/jmcc.2000.1276; Cao WS, 2003, P NATL ACAD SCI USA, V100, P7773, DOI 10.1073/pnas.1337185100; Dekker J, 2002, SCIENCE, V295, P1306, DOI 10.1126/science.1067799; Doursout MF, 2000, J CRIT CARE, V15, P22, DOI 10.1053/jcrc.2000.0150022; Ganster RW, 2005, J INTERF CYTOK RES, V25, P707, DOI 10.1089/jir.2005.25.707; Ganster RW, 2001, P NATL ACAD SCI USA, V98, P8638, DOI 10.1073/pnas.151239498; Gao JJ, 1997, J BIOL CHEM, V272, P1226, DOI 10.1074/jbc.272.2.1226; Guidarelli A, 1998, BRIT J PHARMACOL, V123, P1311, DOI 10.1038/sj.bjp.0701683; Kilbourn R G, 1997, Dis Mon, V43, P277; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; LOWENSTEIN CJ, 1993, P NATL ACAD SCI USA, V90, P9730, DOI 10.1073/pnas.90.20.9730; Matthews JR, 1996, NUCLEIC ACIDS RES, V24, P2236, DOI 10.1093/nar/24.12.2236; Mellott JK, 2001, AM J PHYSIOL-LUNG C, V280, pL390, DOI 10.1152/ajplung.2001.280.3.L390; Nathan C, 1997, J CLIN INVEST, V100, P2417, DOI 10.1172/JCI119782; NATHAN C, 1994, J BIOL CHEM, V269, P13725; ODDIS CV, 1994, BIOCHEM BIOPH RES CO, V205, P992, DOI 10.1006/bbrc.1994.2764; Stempelj M, 2007, J BIOL CHEM, V282, P9797, DOI 10.1074/jbc.M609426200; SUSICK L, 2007, J CELL MOL IN PRESS; Taylor BS, 1998, J BIOL CHEM, V273, P15148, DOI 10.1074/jbc.273.24.15148; Taylor BS, 2000, SHOCK, V13, P413, DOI 10.1097/00024382-200006000-00001; Teng XW, 2002, AM J PHYSIOL-CELL PH, V282, pC144, DOI 10.1152/ajpcell.2002.282.1.C144; Togashi H, 1997, P NATL ACAD SCI USA, V94, P2676, DOI 10.1073/pnas.94.6.2676; Vakoc CR, 2005, MOL CELL, V17, P453, DOI 10.1016/j.molcel.2004.12.028; Vo N, 2001, J BIOL CHEM, V276, P13505, DOI 10.1074/jbc.R000025200; Wang TH, 2001, BIOCHEM J, V358, P747, DOI 10.1042/0264-6021:3580747; XIE QW, 1994, J LEUKOCYTE BIOL, V56, P576, DOI 10.1002/jlb.56.5.576; XIE QW, 1993, J EXP MED, V177, P1779, DOI 10.1084/jem.177.6.1779	31	17	17	0	4	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	SEP 12	2008	283	37					25209	25217		10.1074/jbc.M804062200	http://dx.doi.org/10.1074/jbc.M804062200			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	345QZ	18596035	hybrid, Green Published			2022-12-27	WOS:000259012700013
J	Marelja, Z; Stocklein, W; Nimtz, M; Leimkuhler, S				Marelja, Zvonimir; Stoecklein, Walter; Nimtz, Manfred; Leimkuehler, Silke			A novel role for human Nfs1 in the cytoplasm - Nfs1 acts as a sulfur donor for MOCS3, a protein involved in molybdenum cofactor biosynthesis	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							RHODANESE-LIKE DOMAIN; MOLYBDOPTERIN SYNTHASE; CYSTEINE DESULFURASE; CLUSTER BIOGENESIS; ESCHERICHIA-COLI; IRON; ISD11; GENE; ISCU; NIFS	The human MOCS3 gene encodes a protein involved in activation and sulfuration of the C terminus of MOCS2A, the smaller subunit of the molybdopterin (MPT) synthase. MPT synthase catalyzes the formation of the dithiolene group ofMPT that is required for the coordination of the molybdenum atom in the last step of molybdenum cofactor (Moco) biosynthesis. The two-domain proteinMOCS3catalyzes both the adenylation and the subsequent generation of a thiocarboxylate group at the C terminus of MOCS2A by its C-terminal rhodanese-like domain (RLD). The low activity of MOCS3-RLD with thiosulfate as sulfur donor and detailed mutagenesis studies showed that thiosulfate is most likely not the physiological sulfur source for Moco biosynthesis in eukaryotes. It was suggested that an L-cysteine desulfurase might be involved in the sulfuration of MOCS3 in vivo. In this report, we investigated the involvement of the human L-cysteine desulfurase Nfs1 in sulfur transfer to MOCS3-RLD. A variant of Nfs1 was purified in conjunction with Isd11 in a heterologous expression system in Escherichia coli, and the kinetic parameters of the purified protein were determined. By studying direct protein-protein interactions, we were able to show that Nfs1 interacted specifically with MOCS3-RLD and that sulfur is transferred from L-cysteine to MOCS3-RLD via an Nfs1-bound persulfide intermediate. Because MOCS3 was shown to be located in the cytosol, our results suggest that cytosolic Nfs1 has an important role in sulfur transfer for the biosynthesis of Moco.	[Marelja, Zvonimir; Stoecklein, Walter; Leimkuehler, Silke] Univ Potsdam, Inst Biochem & Biol, D-14476 Potsdam, Germany; [Nimtz, Manfred] Helmholtz Ctr Infect Res, D-38124 Braunschweig, Germany	University of Potsdam; Helmholtz Association; Helmholtz-Center for Infection Research	Leimkuhler, S (corresponding author), Univ Potsdam, Inst Biochem & Biol, D-14476 Potsdam, Germany.	sleim@uni-potsdam.de	Marelja, Zvonimir/AAL-3557-2020	Leimkuhler, Silke/0000-0003-3238-2122; Marelja, Zvonimir/0000-0002-3702-7528	Deutsche Forschungsgemeinschaft [LE1171/5-3]; Fonds der Chemischen Industrie	Deutsche Forschungsgemeinschaft(German Research Foundation (DFG)); Fonds der Chemischen Industrie(Fonds der Chemischen IndustrieEuropean Commission)	This work was supported in part by Deutsche Forschungsgemeinschaft Grant LE1171/5-3 and the Fonds der Chemischen Industrie. The costs of publication of this article were defrayed in part by the payment of page charges. This article must therefore be hereby marked "advertisement" in accordance with 18 U. S. C. Section 1734 solely to indicate this fact.	Adam AC, 2006, EMBO J, V25, P174, DOI 10.1038/sj.emboj.7600905; Biederbick A, 2006, MOL CELL BIOL, V26, P5675, DOI 10.1128/MCB.00112-06; Bordo D, 2002, EMBO REP, V3, P741, DOI 10.1093/embo-reports/kvf150; Duran M, 1996, INT PEDIAT, V11, P334; FOGO JK, 1949, ANAL CHEM, V21, P732, DOI 10.1021/ac60030a028; Frazzon J, 2003, CURR OPIN CHEM BIOL, V7, P166, DOI 10.1016/S1367-5931(03)00021-8; Hille R, 1996, CHEM REV, V96, P2757, DOI 10.1021/cr950061t; Johnson JL., 2001, METABOLIC MOL BASES, P3163; Krepinsky K, 2007, FEBS J, V274, P2778, DOI 10.1111/j.1742-4658.2007.05811.x; Lake MW, 2001, NATURE, V414, P325, DOI 10.1038/35104586; Land T, 1998, MOL CELL, V2, P807, DOI 10.1016/S1097-2765(00)80295-6; Lauhon CT, 2000, J BIOL CHEM, V275, P20096, DOI 10.1074/jbc.M002680200; Leimkuhler S, 2003, J BIOL CHEM, V278, P26127, DOI 10.1074/jbc.M303092200; Leimkuhler S, 2001, J BIOL CHEM, V276, P34695, DOI 10.1074/jbc.M102787200; Leimkuhler S, 2001, J BIOL CHEM, V276, P22024, DOI 10.1074/jbc.M102072200; Li KY, 2006, J BIOL CHEM, V281, P12344, DOI 10.1074/jbc.M600582200; Lill R, 2008, ANNU REV BIOCHEM, V77, P669, DOI 10.1146/annurev.biochem.76.052705.162653; Lill R, 2006, ANNU REV CELL DEV BI, V22, P457, DOI 10.1146/annurev.cellbio.22.010305.104538; Lill R, 2006, BBA-MOL CELL RES, V1763, P652, DOI 10.1016/j.bbamcr.2006.05.011; Loiseau L, 2005, J BIOL CHEM, V280, P26760, DOI 10.1074/jbc.M504067200; Marquet A, 2001, CURR OPIN CHEM BIOL, V5, P541, DOI 10.1016/S1367-5931(00)00249-0; Matthies A, 2005, BIOCHEMISTRY-US, V44, P7912, DOI 10.1021/bi0503448; Matthies A, 2004, P NATL ACAD SCI USA, V101, P5946, DOI 10.1073/pnas.0308191101; Mihara H, 2002, APPL MICROBIOL BIOT, V60, P12, DOI 10.1007/s00253-002-1107-4; Mueller EG, 2006, NAT CHEM BIOL, V2, P185, DOI 10.1038/nchembio779; Muhlenhoff U, 2004, J BIOL CHEM, V279, P36906, DOI 10.1074/jbc.M406516200; Nakai Y, 2007, MOL CELL BIOL, V27, P2841, DOI 10.1128/MCB.01321-06; Neumann M, 2006, J BIOL CHEM, V281, P15701, DOI 10.1074/jbc.M601617200; PETERSON EA, 1954, J AM CHEM SOC, V76, P169, DOI 10.1021/ja01630a045; RAJAGOPALAN KV, 1982, FED PROC, V41, P2608; RAJAGOPALAN KV, 1996, ESCHERICHIA COLI SAL, P674; Reiss J, 2000, HUM GENET, V106, P157, DOI 10.1007/s004390051023; Reiss J, 2003, HUM MUTAT, V21, P569, DOI 10.1002/humu.10223; Richards TA, 2006, MOL BIOL EVOL, V23, P1341, DOI 10.1093/molbev/msl001; Rouault TA, 2005, NAT REV MOL CELL BIO, V6, P345, DOI 10.1038/nrm1620; Schmitz J, 2008, BIOCHEMISTRY-US, V47, P6479, DOI 10.1021/bi800477u; Shan YX, 2007, HUM MOL GENET, V16, P929, DOI 10.1093/hmg/ddm038; SORBO B, 1957, BIOCHIM BIOPHYS ACTA, V23, P412, DOI 10.1016/0006-3002(57)90346-3; Takahashi Y, 2002, J BIOL CHEM, V277, P28380, DOI 10.1074/jbc.C200365200; Tong WH, 2000, EMBO J, V19, P5692, DOI 10.1093/emboj/19.21.5692; Tong WH, 2006, CELL METAB, V3, P199, DOI 10.1016/j.cmet.2006.02.003; Urbina HD, 2001, J BIOL CHEM, V276, P44521, DOI 10.1074/jbc.M106907200; Wiedemann N, 2006, EMBO J, V25, P184, DOI 10.1038/sj.emboj.7600906; Wuebbens MM, 2003, J BIOL CHEM, V278, P14523, DOI 10.1074/jbc.M300453200; Zhang Y, 2008, J MOL BIOL, V379, P881, DOI 10.1016/j.jmb.2008.03.051; ZHENG LM, 1993, P NATL ACAD SCI USA, V90, P2754, DOI 10.1073/pnas.90.7.2754; ZHENG LM, 1994, BIOCHEMISTRY-US, V33, P4714, DOI 10.1021/bi00181a031; Zheng LM, 1998, J BIOL CHEM, V273, P13264, DOI 10.1074/jbc.273.21.13264	48	97	103	1	10	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	SEP 12	2008	283	37					25178	25185		10.1074/jbc.M804064200	http://dx.doi.org/10.1074/jbc.M804064200			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	345QZ	18650437	hybrid			2022-12-27	WOS:000259012700010
J	Wang, JR; Lian, HQ; Zhao, Y; Kauss, MA; Spindel, S				Wang, Jianrong; Lian, Huiqin; Zhao, Ying; Kauss, Mara A.; Spindel, Samantha			Vitamin D3 induces autophagy of human myeloid leukemia cells	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							MONOCYTIC DIFFERENTIATION; BH3-LIKE DOMAIN; RETINOIC ACID; CANCER-CELLS; APOPTOSIS; DEATH; INDUCTION; BCL-2; PHOSPHORYLATION; MATURATION	Vitamin D3 causes potent suppression of various cancer cells; however, significant supraphysiological concentrations of this compound are required for antineoplastic effects. Current combinatorial therapies with vitamin D3 are restricted to differentiation effects. It remains uncertain if autophagy is involved in vitamin D3 inhibition on leukemia cells. Here we show that besides triggering differentiation and inhibiting apoptosis, which was previously known, vitamin D3 triggers autophagic death in human myeloid leukemia cells. Inhibiting differentiation does not efficiently diminish vitamin D3 suppression on leukemia cells. Vitamin D3 up-regulates Beclin1, which binds to class III phosphatidylinositol 3-kinase to trigger autophagy. Vitamin D3 phosphorylates Bad in its BH3 domain, resulting in disassociation of the apoptotic Bad-Bcl-xL complex and association of Bcl-xL with Beclin1 and ultimate suppression of apoptotic signaling. Knockdown of Beclin1 eliminates vitamin D3-induced autophagy and inhibits differentiation but activates apoptosis, suggesting that Beclin1 is required for both autophagy and differentiation, and autophagy cooperates with differentiation but excludes apoptosis, in which Beclin1 acts as an interface for these three different cascades. Moreover, additional up-regulation of autophagy, but not apoptosis, dramatically improves vitamin D3 inhibition on leukemia cells. These findings extend our understanding of the action of vitamin D3 in antineoplastic effects and the role of Beclin1 in regulating multiple cellular cascades and suggest a potentially promising strategy with a significantly better antileukemia effect.	[Wang, Jianrong; Lian, Huiqin] Cornell Univ, Dept Mol Biol & Genet, Ithaca, NY 14853 USA; [Wang, Jianrong; Lian, Huiqin] Treman Res Inst, Ithaca, NY 14850 USA; [Zhao, Ying; Kauss, Mara A.; Spindel, Samantha] Cornell Univ, Dept Biomed Sci, Ithaca, NY 14853 USA	Cornell University; Cornell University	Wang, JR (corresponding author), Cornell Univ, Dept Mol Biol & Genet, Ithaca, NY 14853 USA.	jw99@cornell.edu			Unimed Foundation	Unimed Foundation	This work was supported in part by a grant from the Unimed Foundation. The costs of publication of this article were defrayed in part by the payment of page charges. This article must therefore be hereby marked "advertisement" in accordance with 18 U. S. C. Section 1734 solely to indicate this fact.	ABE E, 1981, P NATL ACAD SCI-BIOL, V78, P4990, DOI 10.1073/pnas.78.8.4990; BEER TM, 2003, J CLIN ONCOL, V28, P8; Beer TM, 2007, J CLIN ONCOL, V25, P669, DOI 10.1200/JCO.2006.06.8197; BRACKMAN D, 1995, J LEUKOCYTE BIOL, V58, P547, DOI 10.1002/jlb.58.5.547; Breitkreutz I, 2007, BRIT J HAEMATOL, V139, P55, DOI 10.1111/j.1365-2141.2007.06747.x; Bursch W, 2000, J CELL SCI, V113, P1189; Capiati DA, 2004, J CELL BIOCHEM, V93, P384, DOI 10.1002/jcb.20165; Danilenko M, 2001, JNCI-J NATL CANCER I, V93, P1224, DOI 10.1093/jnci/93.16.1224; Datta SR, 1997, CELL, V91, P231, DOI 10.1016/S0092-8674(00)80405-5; Drenou B, 1999, J IMMUNOL, V163, P4115; ELSTNER E, 1994, BLOOD, V84, P1960; Flanagan L, 2003, J STEROID BIOCHEM, V84, P181, DOI 10.1016/S0960-0760(03)00028-1; GAVRIELI Y, 1992, J CELL BIOL, V119, P493, DOI 10.1083/jcb.119.3.493; Guertin DA, 2005, TRENDS MOL MED, V11, P353, DOI 10.1016/j.molmed.2005.06.007; Guyton KZ, 2003, NUTR REV, V61, P227, DOI 10.1301/nr.2003.jul.227-238; Guzey M, 2002, MOL CANCER THER, V1, P667; Hoyer-Hansen M, 2005, CELL DEATH DIFFER, V12, P1297, DOI 10.1038/sj.cdd.4401651; Iguchi T, 2005, INT J ONCOL, V27, P893; Inbal B, 2002, J CELL BIOL, V157, P455, DOI 10.1083/jcb.200109094; James SY, 1996, J STEROID BIOCHEM, V58, P395, DOI 10.1016/0960-0760(96)00048-9; Johnson CS, 2002, UROLOGY, V60, P123, DOI 10.1016/S0090-4295(02)01591-1; Kabeya Y, 2000, EMBO J, V19, P5720, DOI 10.1093/emboj/19.21.5720; Kihara A, 2001, EMBO REP, V2, P330, DOI 10.1093/embo-reports/kve061; Liang XH, 1999, NATURE, V402, P672, DOI 10.1038/45257; Loewith R, 2002, MOL CELL, V10, P457, DOI 10.1016/S1097-2765(02)00636-6; Maiuri MC, 2007, EMBO J, V26, P2527, DOI 10.1038/sj.emboj.7601689; MANGELSDORF DJ, 1984, J CELL BIOL, V98, P391, DOI 10.1083/jcb.98.2.391; MARTIN SJ, 1995, CELL, V82, P349, DOI 10.1016/0092-8674(95)90422-0; Marx J, 2006, SCIENCE, V312, P1160, DOI 10.1126/science.312.5777.1160; Mathiasen IS, 1999, CANCER RES, V59, P4848; Mizushima N, 2001, J CELL BIOL, V152, P657, DOI 10.1083/jcb.152.4.657; Mizushima N, 2007, AUTOPHAGY, V3, P542, DOI 10.4161/auto.4600; OBERG F, 1993, J IMMUNOL, V150, P3487; Oberstein A, 2007, J BIOL CHEM, V282, P13123, DOI 10.1074/jbc.M700492200; Oltersdorf T, 2005, NATURE, V435, P677, DOI 10.1038/nature03579; Paglin S, 2001, CANCER RES, V61, P439; Pattingre S, 2005, CELL, V122, P927, DOI 10.1016/j.cell.2005.07.002; Pepper C, 2003, BLOOD, V101, P2454, DOI 10.1182/blood-2002-07-1984; Reggiori F, 2002, EUKARYOT CELL, V1, P11, DOI 10.1128/EC.01.1.11-21.2002; Sarbassov DD, 2005, CURR OPIN CELL BIOL, V17, P596, DOI 10.1016/j.ceb.2005.09.009; Schwende H, 1996, J LEUKOCYTE BIOL, V59, P555, DOI 10.1002/jlb.59.4.555; Shintani T, 2004, SCIENCE, V306, P990, DOI 10.1126/science.1099993; Tan KO, 1999, J BIOL CHEM, V274, P23687, DOI 10.1074/jbc.274.34.23687; Tan Y, 2000, J BIOL CHEM, V275, P25865, DOI 10.1074/jbc.M004199200; Wagner N, 2003, EXP EYE RES, V77, P1, DOI 10.1016/s0014-4835(03)00108-8; WANG J, 2008, EUR J CELL IN PRESS; Wang JR, 2008, J BIOL CHEM, V283, P4375, DOI 10.1074/jbc.M708471200; Wang XN, 2006, J CELL PHYSIOL, V209, P253, DOI 10.1002/jcp.20731; Yamamoto A, 1998, CELL STRUCT FUNCT, V23, P33, DOI 10.1247/csf.23.33; YAN J, 2004, CANCER RES, V64, P370; Yu L, 2004, SCIENCE, V304, P1500, DOI 10.1126/science.1096645; Zha JP, 1996, CELL, V87, P619, DOI 10.1016/S0092-8674(00)81382-3; Zhang YY, 2006, CELL CYCLE, V5, P447, DOI 10.4161/cc.5.4.2467; Zhu JH, 2007, AM J PATHOL, V170, P75, DOI 10.2353/ajpath.2007.060524	54	106	111	0	3	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	SEP 12	2008	283	37					25596	25605		10.1074/jbc.M801716200	http://dx.doi.org/10.1074/jbc.M801716200			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	345QZ	18628207	hybrid			2022-12-27	WOS:000259012700055
J	Hu, B; Kong, LL; Matthews, RT; Viapiano, MS				Hu, Bin; Kong, Leopold L.; Matthews, Russell T.; Viapiano, Mariano S.			The proteoglycan brevican binds to fibronectin after proteolytic cleavage and promotes glioma cell motility	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ENRICHED HYALURONAN-BINDING; CHONDROITIN SULFATE PROTEOGLYCANS; GROWTH-FACTOR RECEPTOR; INVASION IN-VIVO; EXTRACELLULAR-MATRIX; GENE-EXPRESSION; MALIGNANT GLIOMAS; PG-M/VERSICAN; UP-REGULATION; BRAIN	The adult neural parenchyma contains a distinctive extracellular matrix that acts as a barrier to cell and neurite motility. Nonneural tumors that metastasize to the central nervous system almost never infiltrate it and instead displace the neural tissue as they grow. In contrast, invasive gliomas disrupt the extracellular matrix and disperse within the neural tissue. A major inhibitory component of the neural matrix is the lectican family of chondroitin sulfate proteoglycans, of which brevican is the most abundant member in the adult brain. Interestingly, brevican is also highly up-regulated in gliomas and promotes glioma dispersion by unknown mechanisms. Here we show that brevican secreted by glioma cells enhances cell adhesion and motility only after proteolytic cleavage. At the molecular level, brevican promotes epidermal growth factor receptor activation, increases the expression of cell adhesion molecules, and promotes the secretion of fibronectin and accumulation of fibronectin microfibrils on the cell surface. Moreover, the N-terminal cleavage product of brevican, but not the full-length protein, associates with fibronectin in cultured cells and in surgical samples of glioma. Taken together, our results provide the first evidence of the cellular and molecular mechanisms that may underlie the motility-promoting role of brevican in primary brain tumors. In addition, these results underscore the important functional implications of brevican processing in glioma progression.	[Hu, Bin; Viapiano, Mariano S.] Ohio State Univ, Ctr Mol Neurobiol, Ctr Med, Columbus, OH 43210 USA; [Viapiano, Mariano S.] Ohio State Univ, Dept Neurol Surg, Ctr Med, Columbus, OH 43210 USA; James Comprehens Canc Ctr, Columbus, OH 43210 USA; [Kong, Leopold L.] Yale Univ, Coll Med, Dept Neurobiol, New Haven, CT 06510 USA; [Matthews, Russell T.] SUNY Stony Brook, Sch Med, Dept Physiol & Neurosci, Syracuse, NY 13210 USA	University System of Ohio; Ohio State University; University System of Ohio; Ohio State University; James Cancer Hospital & Solove Research Institute; University System of Ohio; Ohio State University; Yale University; State University of New York (SUNY) System; State University of New York (SUNY) Stony Brook	Viapiano, MS (corresponding author), Ohio State Univ, Ctr Mol Neurobiol, Ctr Med, 226B Rightmire Hall,1060 Carmack Rd, Columbus, OH 43210 USA.	viapiano.1@osu.edu	Viapiano, Mariano/AAE-5787-2019; Viapiano, Mariano/B-8095-2009; Hu, Bin/H-8804-2013	Viapiano, Mariano/0000-0002-8756-388X; Kong, Leopold/0000-0001-7456-1773	Accelerate Brain Cancer Cure Foundation; American Brain Tumor Association; Dardinger Center	Accelerate Brain Cancer Cure Foundation; American Brain Tumor Association; Dardinger Center	This work was supported by research grants from the Accelerate Brain Cancer Cure Foundation ( to R.T.M.), the American Brain Tumor Association ( Butler Family Foundation Fellowship to M. S. V. and Joel A. Gringras J. Fellowship to B. H.) and the Dardinger Center Fund for Neuro-Oncology Research at the Ohio State University Medical Center ( to M. S. V.). The costs of publication of this article were defrayed in part by the payment of page charges. This article must therefore be hereby marked "advertisement" in accordance with 18 U.S.C. Section 1734 solely to indicate this fact.	Abdollahi A, 2005, CLIN CANCER RES, V11, P6270, DOI 10.1158/1078-0432.CCR-04-1223; Bandtlow CE, 2000, PHYSIOL REV, V80, P1267, DOI 10.1152/physrev.2000.80.4.1267; Barami Kaveh, 2006, Neurosurg Focus, V21, pE13; Bellail AC, 2004, INT J BIOCHEM CELL B, V36, P1046, DOI 10.1016/j.biocel.2004.01.013; Bello L, 2003, NEUROSURGERY, V52, P177, DOI 10.1097/00006123-200301000-00023; Binder DK, 2002, J NEURO-ONCOL, V56, P149, DOI 10.1023/A:1014566604005; Boon K, 2004, BMC CANCER, V4, DOI 10.1186/1471-2407-4-39; Cattaruzza S, 2005, MATRIX BIOL, V24, P400, DOI 10.1016/j.matbio.2005.06.005; D'Abaco GM, 2007, J CLIN NEUROSCI, V14, P1041, DOI 10.1016/j.jocn.2007.06.019; Freije WA, 2004, CANCER RES, V64, P6503, DOI 10.1158/0008-5472.CAN-04-0452; Gaggioli C, 2005, ONCOGENE, V24, P1423, DOI 10.1038/sj.onc.1208318; Gladson CL, 1999, J NEUROPATH EXP NEUR, V58, P1029, DOI 10.1097/00005072-199910000-00001; Glass R, 2005, J NEUROSCI, V25, P2637, DOI 10.1523/JNEUROSCI.5118-04.2005; Goldbrunner RH, 1999, ACTA NEUROCHIR, V141, P295, DOI 10.1007/s007010050301; Heron PM, 2007, J NEUROSCI METH, V159, P203, DOI 10.1016/j.jneumeth.2006.07.013; Hocking DC, 2003, AM J PHYSIOL-LUNG C, V285, pL169, DOI 10.1152/ajplung.00371.2002; Iwamoto H, 1999, J LAB CLIN MED, V134, P83, DOI 10.1016/S0022-2143(99)90057-4; Jaworski DM, 2000, J NEUROSCI RES, V61, P396, DOI 10.1002/1097-4547(20000815)61:4<396::AID-JNR6>3.0.CO;2-S; Jaworski DM, 1996, CANCER RES, V56, P2293; JAWORSKI DM, 1994, J CELL BIOL, V125, P495, DOI 10.1083/jcb.125.2.495; Jaworski DM, 1999, EXP NEUROL, V157, P327, DOI 10.1006/exnr.1999.7062; KUENG W, 1989, ANAL BIOCHEM, V182, P16, DOI 10.1016/0003-2697(89)90710-0; Larsen M, 2006, CURR OPIN CELL BIOL, V18, P463, DOI 10.1016/j.ceb.2006.08.009; Li HD, 2000, J CELL BIOL, V149, P1275, DOI 10.1083/jcb.149.6.1275; Liang Y, 2005, P NATL ACAD SCI USA, V102, P5814, DOI 10.1073/pnas.0402870102; Louis DN, 2006, ANNU REV PATHOL-MECH, V1, P97, DOI 10.1146/annurev.pathol.1.110304.100043; Margolis RK, 1996, PERSPECT DEV NEUROBI, V3, P273; Massey JM, 2008, EXP NEUROL, V209, P426, DOI 10.1016/j.expneurol.2007.03.029; Matthews RT, 2000, J BIOL CHEM, V275, P22695, DOI 10.1074/jbc.M909764199; Mercuri FA, 2000, J BIOL CHEM, V275, P33038, DOI 10.1074/jbc.275.42.33038; Morgenstern DA, 2002, PROG BRAIN RES, V137, P313; MORLA A, 1994, NATURE, V367, P193, DOI 10.1038/367193a0; Nakamura H, 2000, J BIOL CHEM, V275, P38885, DOI 10.1074/jbc.M003875200; NAKAMURA M, 1994, J CELL PHYSIOL, V159, P415, DOI 10.1002/jcp.1041590305; Novak U, 2000, J CLIN NEUROSCI, V7, P280, DOI 10.1054/jocn.1999.0212; Nutt CL, 2001, NEUROSCIENTIST, V7, P113, DOI 10.1177/107385840100700206; Nutt CL, 2001, CANCER RES, V61, P7056; Ohnishi T, 1998, CLIN EXP METASTAS, V16, P729, DOI 10.1023/A:1006532812408; Paulus W, 1996, J NEUROPATH EXP NEUR, V55, P528, DOI 10.1097/00005072-199605000-00005; Pearlman A L, 1996, Prog Brain Res, V108, P117; Phillips HS, 2006, CANCER CELL, V9, P157, DOI 10.1016/j.ccr.2006.02.019; Pilkington GJ, 1997, ANTICANCER RES, V17, P4103; Properzi F, 2004, NEWS PHYSIOL SCI, V19, P33, DOI 10.1152/nips.01449.2003; Rao JS, 2003, NAT REV CANCER, V3, P489, DOI 10.1038/nrc1121; Rauch U, 2004, CELL MOL LIFE SCI, V61, P2031, DOI 10.1007/s00018-004-4043-x; Ruoslahti E, 1996, GLYCOBIOLOGY, V6, P489, DOI 10.1093/glycob/6.5.489; Schwarzbauer JE, 1999, CURR OPIN CELL BIOL, V11, P622, DOI 10.1016/S0955-0674(99)00017-4; Sheng W, 2005, MOL BIOL CELL, V16, P1330, DOI 10.1091/mbc.e04-04-0295; Subramanian A, 2002, LANCET ONCOL, V3, P498, DOI 10.1016/S1470-2045(02)00819-7; Tatenhorst L, 2005, BRAIN PATHOL, V15, P46; Thon N, 2000, EUR J NEUROSCI, V12, P2547, DOI 10.1046/j.1460-9568.2000.00109.x; Tiscornia G, 2006, NAT PROTOC, V1, P241, DOI 10.1038/nprot.2006.37; TORP SH, 1995, J CLIN PATHOL-CL MOL, V48, pM191; Tso CL, 2006, MOL CANCER RES, V4, P607, DOI 10.1158/1541-7786.MCR-06-0005; Tucker Gordon C, 2006, Curr Oncol Rep, V8, P96, DOI 10.1007/s11912-006-0043-3; Uchiyama-Tanaka Y, 2002, KIDNEY INT, V62, P799, DOI 10.1046/j.1523-1755.2002.00537.x; Viapiano MS, 2006, TRENDS MOL MED, V12, P488, DOI 10.1016/j.molmed.2006.08.007; Viapiano MS, 2008, J NEURO-ONCOL, V88, P261, DOI 10.1007/s11060-008-9575-8; Viapiano MS, 2005, CANCER RES, V65, P6726, DOI 10.1158/0008-5472.CAN-05-0585; Viapiano MS, 2003, J BIOL CHEM, V278, P33239, DOI 10.1074/jbc.M303480200; Wu YJ, 2005, CELL RES, V15, P483, DOI 10.1038/sj.cr.7290318; Wu YJ, 2004, J CELL SCI, V117, P2227, DOI 10.1242/jcs.01057; Wu YJ, 2004, MOL BIOL CELL, V15, P2093, DOI 10.1091/mbc.E03-09-0667; Wu YJ, 2002, J BIOL CHEM, V277, P12294, DOI 10.1074/jbc.M110748200; Xi XD, 2003, J CELL BIOL, V162, P329, DOI 10.1083/jcb.200303120; Xi XD, 2006, J BIOL CHEM, V281, P29426, DOI 10.1074/jbc.C600039200; Xiang YY, 2006, J BIOL CHEM, V281, P19358, DOI 10.1074/jbc.M512980200; YAMADA KM, 1980, J BIOL CHEM, V255, P6055; Zhang H, 1998, J NEUROSCI, V18, P2370; Zhang J, 2005, J PATHOL, V207, P402, DOI 10.1002/path.1846; Zheng PS, 2004, FASEB J, V18, P754, DOI 10.1096/fj.03-0545fje	71	67	73	0	4	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	SEP 5	2008	283	36					24848	24859		10.1074/jbc.M801433200	http://dx.doi.org/10.1074/jbc.M801433200			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	342YR	18611854	Green Published, hybrid			2022-12-27	WOS:000258820000051
J	Rallabhandi, P; Nhu, QM; Toshchakov, VY; Piao, W; Medvedev, AE; Hollenberg, MD; Fasano, A; Vogel, SN				Rallabhandi, Prasad; Nhu, Quan M.; Toshchakov, Vladimir Y.; Piao, Wenji; Medvedev, Andrei E.; Hollenberg, Morley D.; Fasano, Alessio; Vogel, Stefanie N.			Analysis of proteinase-activated receptor 2 and TLR4 signal transduction - A novel paradigm for receptor cooperativity	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							PROTEINASE-ACTIVATED RECEPTORS; TOLL-LIKE RECEPTORS; NF-KAPPA-B; LUNG EPITHELIAL-CELLS; INFLAMMATORY RESPONSES; ENDOGENOUS LIGANDS; ENDOTHELIAL-CELLS; IMMUNE-RESPONSE; INNATE IMMUNITY; MAJOR ROLE	Proteinase-activated receptor 2 (PAR(2)), a seven-transmembrane G protein-coupled receptor, is activated at inflammatory sites by proteolytic cleavage of its extracellular N terminus by trypsin-like enzymes, exposing a tethered, receptor-activating ligand. Synthetic agonist peptides (AP) that share the tethered ligand sequence also activate PAR(2), often measured by Ca2+ release. PAR(2) contributes to inflammation through activation of NF-kappa B-regulated genes; however, the mechanism by which this occurs is unknown. Overexpression of human PAR(2) in HEK293T cells resulted in concentration-dependent, PAR(2) AP-inducible NF-kappa B reporter activation that was protein synthesis-independent, yet blocked by inhibitors that uncouple G(i) proteins or sequester intracellular Ca2+. Because previous studies described synergistic PAR(2)- and TLR4-mediated cytokine production, we hypothesized that PAR(2) and TLR4 might interact at the level of signaling. In the absence of TLR4, PAR(2)-induced NF-kappa B activity was inhibited by dominant negative (DN)-TRIF or DN-TRAM constructs, but not by DN-MyD88, findings confirmed using cell-permeable, adapter-specific BB loop blocking peptides. Co-expression of TLR4/MD-2/CD14 with PAR(2) in HEK293T cells led to a synergistic increase in AP-induced NF-kappa B signaling that was MyD88-dependent and required a functional TLR4, despite the fact that AP exhibited no TLR4 agonist activity. Co-immunoprecipitation of PAR(2) and TLR4 revealed a physical association that was AP-dependent. The response to AP or lipopolysaccharide was significantly diminished in TLR4(-/-) and PAR(2)(-/)-macrophages, respectively, and SW620 colonic epithelial cells exhibited synergistic responses to co-stimulation with AP and lipopolysaccharide. Our data suggest a unique interaction between two distinct innate immune response receptors and support a novel paradigm of receptor cooperativity in inflammatory responses.	[Rallabhandi, Prasad; Nhu, Quan M.; Toshchakov, Vladimir Y.; Piao, Wenji; Medvedev, Andrei E.; Vogel, Stefanie N.] Univ Maryland, Dept Microbiol & Immunol, Baltimore, MD 21201 USA; [Fasano, Alessio] Univ Maryland, Dept Pediat, Baltimore, MD 21201 USA; [Fasano, Alessio] Univ Maryland, Mucosal Biol Res Ctr, Baltimore, MD 21201 USA; [Hollenberg, Morley D.] Univ Calgary, Dept Pharmacol & Therapeut, Calgary, AB T2N 4N1, Canada; [Hollenberg, Morley D.] Univ Calgary, Dept Med, Calgary, AB T2N 4N1, Canada	University System of Maryland; University of Maryland Baltimore; University System of Maryland; University of Maryland Baltimore; University System of Maryland; University of Maryland Baltimore; University of Calgary; University of Calgary	Vogel, SN (corresponding author), Univ Maryland, Dept Microbiol & Immunol, 660 W Redwood St,Rm 324, Baltimore, MD 21201 USA.	svogel@som.umaryland.edu	Hollenberg, Morley/AFV-6966-2022; Fasano, Alessio/K-5486-2016; Toshchakov, Vladimir/C-2798-2014	Fasano, Alessio/0000-0002-2134-0261; Toshchakov, Vladimir/0000-0002-7942-2294	National Institutes of Health [R37 AI-18797, R01 AI-059524, R01 DK048373, T32 AI-07540]; Canadian Institutes of Health Research; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI059524, R37AI018797, T32AI007540] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK048373] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Canadian Institutes of Health Research(Canadian Institutes of Health Research (CIHR)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	This work was supported, in whole or in part, by National Institutes of Health Grants R37 AI-18797 (to S. N. V.), R01 AI-059524 (to A. E. M.), R01 DK048373 (to A. F.), and T32 AI-07540 (to Q. M. N.), and a Canadian Institutes of Health Research operating grant (to M. H.).	Adachi O, 1998, IMMUNITY, V9, P143, DOI 10.1016/S1074-7613(00)80596-8; Adam E, 2006, J BIOL CHEM, V281, P6910, DOI 10.1074/jbc.M507140200; Akira S, 2004, NAT REV IMMUNOL, V4, P499, DOI 10.1038/nri1391; Al-Ani B, 1999, J PHARMACOL EXP THER, V290, P753; Antalis TM, 2007, NAT CLIN PRACT GASTR, V4, P393, DOI 10.1038/ncpgasthep0846; Arora P, 2007, J CELL SCI, V120, P921, DOI 10.1242/jcs.03409; Bianchi ME, 2007, J LEUKOCYTE BIOL, V81, P1, DOI 10.1189/jlb.0306164; Bushell T, 2007, J PHYSIOL-LONDON, V581, P7, DOI 10.1113/jphysiol.2007.129577; Cario E, 2006, J IMMUNOL, V176, P4258, DOI 10.4049/jimmunol.176.7.4258; Chi LQ, 2001, J INTERF CYTOK RES, V21, P231, DOI 10.1089/107999001750169871; Chignard M, 2006, AM J RESP CELL MOL, V34, P394, DOI 10.1165/rcmb.2005-0250TR; Chow JC, 1999, J BIOL CHEM, V274, P10689, DOI 10.1074/jbc.274.16.10689; Chung WO, 2004, J IMMUNOL, V173, P5165, DOI 10.4049/jimmunol.173.8.5165; Cicala C, 1999, CIRCULATION, V99, P2590, DOI 10.1161/01.CIR.99.19.2590; Cocks TM, 2001, PULM PHARMACOL THER, V14, P183, DOI 10.1006/pupt.2001.0285; Cocks TM, 2000, TRENDS PHARMACOL SCI, V21, P103, DOI 10.1016/S0165-6147(99)01440-6; Compton SJ, 2002, BIOCHEM J, V368, P495, DOI 10.1042/BJ20020706; Compton SJ, 2000, J BIOL CHEM, V275, P39207, DOI 10.1074/jbc.M007215200; Devaney JM, 2003, FEBS LETT, V544, P129, DOI 10.1016/S0014-5793(03)00482-4; Devlin MG, 2007, PARASITOL RES, V101, P105, DOI 10.1007/s00436-007-0467-1; Doyle SL, 2006, BIOCHEM PHARMACOL, V72, P1102, DOI 10.1016/j.bcp.2006.07.010; Dulon S, 2005, AM J RESP CELL MOL, V32, P411, DOI 10.1165/rcmb.2004-0274OC; Dunne A, 2003, J BIOL CHEM, V278, P41443, DOI 10.1074/jbc.M301742200; Fitzgerald KA, 2003, J EXP MED, V198, P1043, DOI 10.1084/jem.20031023; Fukata M, 2007, BIOCHEM SOC T, V35, P1473, DOI 10.1042/BST0351473; Gantner BN, 2003, J EXP MED, V197, P1107, DOI 10.1084/jem.20021787; Hamilton JR, 2001, CIRC RES, V89, P92, DOI 10.1161/hh1301.092661; Hansen KK, 2005, P NATL ACAD SCI USA, V102, P8363, DOI 10.1073/pnas.0409535102; Hietaranta A, 2004, BIOCHEM BIOPH RES CO, V323, P192, DOI 10.1016/j.bbrc.2004.08.077; Hollenberg MD, 2002, PHARMACOL REV, V54, P203, DOI 10.1124/pr.54.2.203; Hollenberg MD, 1997, CAN J PHYSIOL PHARM, V75, P832, DOI 10.1139/cjpp-75-7-832; Holzhausen M, 2006, AM J PATHOL, V168, P1189, DOI 10.2353/ajpath.2006.050658; Johansson U, 2005, J LEUKOCYTE BIOL, V78, P967, DOI 10.1189/jlb.0704422; Johnson GB, 2004, J IMMUNOL, V172, P20, DOI 10.4049/jimmunol.172.1.20; Kagan JC, 2008, NAT IMMUNOL, V9, P361, DOI 10.1038/ni1569; Kawabata A, 2005, J PHARMACOL SCI, V97, P20, DOI 10.1254/jphs.FMJ04005X4; Kawabata A, 1999, J PHARMACOL EXP THER, V288, P358; Kawagoe J, 2002, JPN J PHARMACOL, V88, P77, DOI 10.1254/jjp.88.77; Kelso EB, 2006, J PHARMACOL EXP THER, V316, P1017, DOI 10.1124/jpet.105.093807; Khan MA, 2006, INFECT IMMUN, V74, P2522, DOI 10.1128/IAI.74.5.2522-2536.2006; Kida Y, 2007, INFECT IMMUN, V75, P164, DOI 10.1128/IAI.01239-06; Lindner JR, 2000, J IMMUNOL, V165, P6504, DOI 10.4049/jimmunol.165.11.6504; Macfarlane SR, 2001, PHARMACOL REV, V53, P245; MCINTIRE FC, 1967, BIOCHEMISTRY-US, V6, P2363, DOI 10.1021/bi00860a011; McIntosh KA, 2007, CURR OPIN PHARMACOL, V7, P334, DOI 10.1016/j.coph.2007.01.002; Means TK, 2001, J IMMUNOL, V166, P4074, DOI 10.4049/jimmunol.166.6.4074; Medvedev AE, 2007, J BIOL CHEM, V282, P16042, DOI 10.1074/jbc.M606781200; Medzhitov R, 1997, CELL, V91, P295, DOI 10.1016/S0092-8674(00)80412-2; Mitcham JL, 1996, J BIOL CHEM, V271, P5777, DOI 10.1074/jbc.271.10.5777; Mollen KP, 2006, SHOCK, V26, P430, DOI 10.1097/01.shk.0000228797.41044.08; Moretti S, 2008, MUCOSAL IMMUNOL, V1, P156, DOI 10.1038/mi.2007.13; Munford RS, 2006, PLOS PATHOG, V2, P467, DOI 10.1371/journal.ppat.0020067; Neurath H, 1999, P NATL ACAD SCI USA, V96, P10962, DOI 10.1073/pnas.96.20.10962; Nhu QM, 2006, J ENDOTOXIN RES, V12, P285, DOI 10.1179/096805106X118834; Noorbakhsh F, 2006, J EXP MED, V203, P425, DOI 10.1084/jem.20052148; Nystedt S, 1996, J BIOL CHEM, V271, P14910, DOI 10.1074/jbc.271.25.14910; O'Neill LAJ, 2007, NAT REV IMMUNOL, V7, P353, DOI 10.1038/nri2079; Ossovskaya VS, 2004, PHYSIOL REV, V84, P579, DOI 10.1152/physrev.00028.2003; Rallabhandi P, 2006, J IMMUNOL, V177, P322, DOI 10.4049/jimmunol.177.1.322; Ramachandran R, 2008, BRIT J PHARMACOL, V153, pS263, DOI 10.1038/sj.bjp.0707507; Reed CE, 2004, J ALLERGY CLIN IMMUN, V114, P997, DOI 10.1016/j.jaci.2004.07.060; Rifkin IR, 2005, IMMUNOL REV, V204, P27, DOI 10.1111/j.0105-2896.2005.00239.x; Rogers NC, 2005, IMMUNITY, V22, P507, DOI 10.1016/j.immuni.2005.03.004; Roosterman D, 2003, AM J PHYSIOL-CELL PH, V284, pC1319, DOI 10.1152/ajpcell.00540.2002; Sansonetti PJ, 2006, NAT IMMUNOL, V7, P1237, DOI 10.1038/ni1420; Sato S, 2003, J IMMUNOL, V171, P4304, DOI 10.4049/jimmunol.171.8.4304; Schmidlin F, 2002, J IMMUNOL, V169, P5315, DOI 10.4049/jimmunol.169.9.5315; Soreide K, 2006, J PATHOL, V209, P147, DOI 10.1002/path.1999; Steinhoff M, 2005, ENDOCR REV, V26, P1, DOI 10.1210/er.2003-0025; Sun DX, 2006, NAT IMMUNOL, V7, P375, DOI 10.1038/ni1308; Sun G, 2001, J IMMUNOL, V167, P1014, DOI 10.4049/jimmunol.167.2.1014; Toshchakov VU, 2005, J IMMUNOL, V175, P494, DOI 10.4049/jimmunol.175.1.494; Turk B, 2006, NAT REV DRUG DISCOV, V5, P785, DOI 10.1038/nrd2092; Vergnolle N, 1999, J IMMUNOL, V163, P5064; Vergnolle N, 2000, ALIMENT PHARM THER, V14, P257; Visintin A, 2006, IMMUNOBIOLOGY, V211, P437, DOI 10.1016/j.imbio.2006.05.010; Wesche H, 1997, IMMUNITY, V7, P837, DOI 10.1016/S1074-7613(00)80402-1; Yamamoto M, 2003, SCIENCE, V301, P640, DOI 10.1126/science.1087262; Zhang Z, 2006, CELL MOL LIFE SCI, V63, P2901, DOI 10.1007/s00018-006-6189-1	80	112	117	0	10	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	SEP 5	2008	283	36					24314	24325		10.1074/jbc.M804800200	http://dx.doi.org/10.1074/jbc.M804800200			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	342YR	18622013	Green Published, hybrid			2022-12-27	WOS:000258820000006
J	Rubio, A; Rambla, JL; Santaella, M; Gomez, MD; Orzaez, D; Granell, A; Gomez-Gomez, L				Rubio, Angela; Rambla, Jose Luis; Santaella, Marcella; Gomez, M. Dolores; Orzaez, Diego; Granell, Antonio; Gomez-Gomez, Lourdes			Cytosolic and plastoglobule-targeted carotenoid dioxygenases from Crocus sativus are both involved in beta-ionone release	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ABSCISIC-ACID BIOSYNTHESIS; CLEAVAGE DIOXYGENASE; FUNCTIONAL-CHARACTERIZATION; RAIN-FOREST; ARABIDOPSIS; GENES; IDENTIFICATION; VOLATILE; TOMATO; ACCUMULATION	Saffron, the processed stigma of Crocus sativus, is characterized by the presence of several apocarotenoids that contribute to the color, flavor, and aroma of the spice. However, little is known about the synthesis of aroma compounds during the development of the C. sativus stigma. The developing stigma is nearly odorless, but before and at anthesis, the aromatic compound beta-ionone becomes the principal norisoprenoid volatile in the stigma. In this study, four carotenoid cleavage dioxygenase (CCD) genes, CsCCD1a, CsCCD1b, CsCCD4a, and CsCCD4b, were isolated from C. sativus. Expression analysis showed that CsCCD1a was constitutively expressed, CsCCD1b was unique to the stigma tissue, but only CsCCD4a and -b had expression patterns consistent with the highest levels of beta-carotene and emission of beta-ionone derived during the stigma development. The CsCCD4 enzymes were localized in plastids and more specifically were present in the plastoglobules. The enzymatic activities of CsCCD1a, CsCCD1b, and CsCCD4 enzymes were determined by Escherichia coli expression, and subsequent analysis of the volatile products was generated by GC/MS. The four CCDs fell in two phylogenetically divergent dioxygenase classes, but all could cleave beta-carotene at the 9,10(9', 10') positions to yield beta-ionone. The data obtained suggest that all four C. sativus CCD enzymes may contribute in different ways to the production of beta-ionone. In addition, the location and precise timing of beta-ionone synthesis, together with its known activity as a fragrance and insect attractant, suggest that this volatile may have a role in Crocus pollination.	[Rubio, Angela; Santaella, Marcella; Gomez-Gomez, Lourdes] Univ Castilla La Mancha, ETSIA, Inst Desarrollo Reg, Secc Biotecnol, Albacete 02071, Spain; [Rambla, Jose Luis; Gomez, M. Dolores; Orzaez, Diego; Granell, Antonio] Univ Politecn Valencia, CSIC, Inst Biol Mol & Celular Plantas, Valencia 46022, Spain	Universidad de Castilla-La Mancha; Consejo Superior de Investigaciones Cientificas (CSIC); Universitat Politecnica de Valencia; CSIC-UPV - Instituto de Biologia Molecular y Celular de Plantas (IBMCP)	Gomez-Gomez, L (corresponding author), Univ Castilla La Mancha, ETSIA, Inst Desarrollo Reg, Secc Biotecnol, Campus Univ S-N, Albacete 02071, Spain.	marialourdes.gomez@uclm.es	Gomez/K-8775-2014; Rubio, Angel/M-7387-2019; Granell, Antonio/G-3664-2010; Orzaez, Diego/H-3457-2012; Rambla, José L./B-5881-2011; Gomez-Gomez, Lourdes/AAF-2371-2020; ORZAEZ, DIEGO/X-2915-2019	Gomez/0000-0001-9445-2056; Rubio, Angel/0000-0002-3274-2450; Orzaez, Diego/0000-0003-1662-5403; Rambla, José L./0000-0003-4704-2534; Gomez-Gomez, Lourdes/0000-0003-2586-4457; ORZAEZ, DIEGO/0000-0003-1662-5403; Rubio-Moraga, Angela/0000-0002-2162-2314	Ministerio de Educacio n y Ciencia [BIO2003-05259, BIO2006-00841]	Ministerio de Educacio n y Ciencia(Spanish GovernmentEuropean Commission)	This work was supported by Ministerio de Educacio n y Ciencia Grants BIO2003-05259 and BIO2006-00841. The costs of publication of this article were defrayed in part by the payment of page charges. This article must therefore be hereby marked "advertisement" in accordance with 18 U. S. C. Section 1734 solely to indicate this fact.	Auldridge ME, 2006, PLANT J, V45, P982, DOI 10.1111/j.1365-313X.2006.02666.x; Auldridge ME, 2006, CURR OPIN PLANT BIOL, V9, P315, DOI 10.1016/j.pbi.2006.03.005; Baldermann S, 2005, FOOD RES INT, V38, P833, DOI 10.1016/j.foodres.2005.02.009; Beveridge CA, 2006, CURR OPIN PLANT BIOL, V9, P35, DOI 10.1016/j.pbi.2005.11.006; Bondada BR, 2003, TREE PHYSIOL, V23, P553, DOI 10.1093/treephys/23.8.553; Booker J, 2004, CURR BIOL, V14, P1232, DOI 10.1016/j.cub.2004.06.061; Bouvier F, 2005, TRENDS PLANT SCI, V10, P187, DOI 10.1016/j.tplants.2005.02.007; Bouvier F, 2003, PLANT CELL, V15, P47, DOI 10.1105/tpc.006536; Castillo R, 2005, PLANT PHYSIOL, V139, P674, DOI 10.1104/pp.105.067827; Chernys JT, 2000, PLANT PHYSIOL, V124, P343, DOI 10.1104/pp.124.1.343; Chichiricco G, 1999, GRANA, V38, P31, DOI 10.1080/001731300750044681; Clough SJ, 1998, PLANT J, V16, P735, DOI 10.1046/j.1365-313x.1998.00343.x; Cunningham FX, 1996, PLANT CELL, V8, P1613, DOI 10.1105/tpc.8.9.1613; D'Auria M, 2006, J CHROMATOGR SCI, V44, P18, DOI 10.1093/chromsci/44.1.18; Cancino AD, 2007, PLANT SPEC BIOL, V22, P129, DOI 10.1111/j.1442-1984.2007.00185.x; DERUERE J, 1994, PLANT CELL, V6, P119, DOI 10.1105/tpc.6.1.119; Galpaz N, 2006, PLANT CELL, V18, P1947, DOI 10.1105/tpc.105.039966; Grilli M, 2004, PLANT BIOSYST, V138, P43, DOI DOI 10.1080/11263500410001684116; GRILLICAIOLA M, 1999, SAFFRON, P31; Hammack L, 2001, J CHEM ECOL, V27, P1373, DOI 10.1023/A:1010365225957; HESLOPHARRISON Y, 1977, ANN BOT-LONDON, V41, P913, DOI 10.1093/oxfordjournals.aob.a085387; Ibdah M, 2006, PHYTOCHEMISTRY, V67, P1579, DOI 10.1016/j.phytochem.2006.02.009; Kanakis CD, 2004, J AGR FOOD CHEM, V52, P4515, DOI 10.1021/jf049808j; KATONOGUCHI H, 1993, PHYSIOL PLANTARUM, V89, P423, DOI 10.1111/j.1399-3054.1993.tb05193.x; Kaup MT, 2002, PLANT PHYSIOL, V129, P1616, DOI 10.1104/pp.003087; Kirk J., 1978, PLASTIDS THEIR CHEM, P217; Kloer DP, 2006, CELL MOL LIFE SCI, V63, P2291, DOI 10.1007/s00018-006-6176-6; Lewinsohn E, 2005, J AGR FOOD CHEM, V53, P3142, DOI 10.1021/jf047927t; LICHTENTHALER HK, 1968, ENDEAVOUR, V27, P144; Locy RD, 1996, PLANT PHYSIOL, V110, P321, DOI 10.1104/pp.110.1.321; Lohmann A, 2006, J BIOL CHEM, V281, P40461, DOI 10.1074/jbc.M609412200; MATHEW B, 1999, REPROD BIOL SAFFRON, P19; Mathieu S, 2005, J EXP BOT, V56, P2721, DOI 10.1093/jxb/eri265; McKee J, 1998, BOT J LINN SOC, V128, P369; MIKHLIN E D, 1983, Prikladnaya Biokhimiya i Mikrobiologiya, V19, P795; Milet-Pinheiro P, 2005, REV BRAS ZOOL, V22, P853, DOI 10.1590/S0101-81752005000400008; Moise AR, 2005, TRENDS PLANT SCI, V10, P178, DOI 10.1016/j.tplants.2005.02.006; Moraga A, 2004, PLANTA, V219, P955, DOI 10.1007/s00425-004-1299-1; Munne-Bosch S, 2004, FUNCT PLANT BIOL, V31, P203, DOI 10.1071/FP03236; Naested H, 2004, J CELL SCI, V117, P4807, DOI 10.1242/jcs.01360; Nakagawa T, 2007, J BIOSCI BIOENG, V104, P34, DOI 10.1263/jbb.104.34; Negbi M., 1999, SAFFRON CROCUS SATIV, DOI [10.1201/9780203303665, DOI 10.1201/9780203303665]; Nemesio A, 2006, NEOTROP ENTOMOL, V35, P313, DOI 10.1590/S1519-566X2006000300004; Nielsen H, 1997, PROTEIN ENG, V10, P1, DOI 10.1093/protein/10.1.1; Ohmiya A, 2006, PLANT PHYSIOL, V142, P1193, DOI 10.1104/pp.106.087130; Pichersky E, 2000, TRENDS PLANT SCI, V5, P439, DOI 10.1016/S1360-1385(00)01741-6; Rey P, 2000, PLANT J, V21, P483, DOI 10.1046/j.1365-313x.2000.00699.x; Schwartz SH, 2004, J BIOL CHEM, V279, P46940, DOI 10.1074/jbc.M409004200; Schwartz SH, 2001, J BIOL CHEM, V276, P25208, DOI 10.1074/jbc.M102146200; Schwartz SH, 1997, SCIENCE, V276, P1872, DOI 10.1126/science.276.5320.1872; Siddique MA, 2006, PLANT CELL PHYSIOL, V47, P1663, DOI 10.1093/pcp/pcl033; Simkin AJ, 2004, PLANT J, V40, P882, DOI 10.1111/j.1365-313X.2004.02263.x; Simkin AJ, 2004, PLANT PHYSIOL, V136, P3504, DOI 10.1104/pp.104.049718; Sitte P, 1980, PIGMENTS PLANTS, P117; Sorefan K, 2003, GENE DEV, V17, P1469, DOI 10.1101/gad.256603; Sun ZR, 1996, J BIOL CHEM, V271, P24349, DOI 10.1074/jbc.271.40.24349; Tan BC, 1997, P NATL ACAD SCI USA, V94, P12235, DOI 10.1073/pnas.94.22.12235; TARANTILIS PA, 1994, J CHROMATOGR A, V664, P55, DOI 10.1016/0021-9673(94)80628-4; Tarantilis PA, 1997, J AGR FOOD CHEM, V45, P459, DOI 10.1021/jf960105e; TEVINI M, 1985, PLANTA, V163, P91, DOI 10.1007/BF00395902; Tieman DM, 2006, J EXP BOT, V57, P887, DOI 10.1093/jxb/erj074; Vidi PA, 2006, J BIOL CHEM, V281, P11225, DOI 10.1074/jbc.M511939200; Vishnevetsky M, 1999, TRENDS PLANT SCI, V4, P232, DOI 10.1016/S1360-1385(99)01414-4; Vogel JT, 2008, J BIOL CHEM, V283, P11364, DOI 10.1074/jbc.M710106200; von Lintig J, 2000, J BIOL CHEM, V275, P11915, DOI 10.1074/jbc.275.16.11915; Winterhalter P, 2000, FOOD REV INT, V16, P39, DOI 10.1081/FRI-100100281; Wrischer Mercedes, 2007, Acta Botanica Croatica, V66, P81; Ytterberg AJ, 2006, PLANT PHYSIOL, V140, P984, DOI 10.1104/pp.105.076083	68	196	211	2	38	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	SEP 5	2008	283	36					24816	24825		10.1074/jbc.M804000200	http://dx.doi.org/10.1074/jbc.M804000200			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	342YR	18611853	Green Published, hybrid			2022-12-27	WOS:000258820000048
J	Sprouse, RO; Shcherbakova, I; Cheng, HY; Jamison, E; Brenowitz, M; Auble, DT				Sprouse, Rebekka O.; Shcherbakova, Inna; Cheng, Huiyong; Jamison, Elizabeth; Brenowitz, Michael; Auble, David T.			Function and structural organization of Mot1 bound to a natural target promoter	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							TATA-BINDING PROTEIN; RNA-POLYMERASE-II; TRANSCRIPTION IN-VIVO; SACCHAROMYCES-CEREVISIAE; DNA-BINDING; GENE-EXPRESSION; REPRESSES TRANSCRIPTION; FOOTPRINTING ANALYSIS; BASAL TRANSCRIPTION; YEAST	Mot1 is an essential, conserved TATA-binding protein (TBP)-associated factor in Saccharomyces cerevisiae and a member of the Snf2/Swi2 ATPase family. Mot1 uses ATP hydrolysis to displace TBP from DNA, an activity that can be readily reconciled with its global role in gene repression. Less well understood is how Mot1 directly activates gene expression. It has been suggested that Mot1-mediated activation can occur by displacement of inactive TBP-containing complexes from promoters, thereby permitting assembly of functional transcription complexes. Mot1 may also activate transcription by other mechanisms that have not yet been defined. A gap in our understanding has been the absence of biochemical information related to the activity of Mot1 on natural target genes. Using URA1 as a model Mot1-activated promoter, we show striking differences in the way that both TBP and Mot1 interact with DNA compared with other model DNA substrates analyzed previously. These differences are due at least in part to the propensity of TBP alone to bind to the URA1 promoter in the wrong orientation to direct appropriate assembly of the URA1 preinitiation complex. The results suggest that Mot1-mediated activation of URA1 transcription involves at least two steps, one of which is the removal of TBP bound to the promoter in the opposite orientation required for URA1 transcription.	[Sprouse, Rebekka O.; Auble, David T.] Univ Virginia Hlth Syst, Dept Biochem & Mol Genet, Charlottesville, VA 22908 USA; [Shcherbakova, Inna; Cheng, Huiyong; Jamison, Elizabeth; Brenowitz, Michael] Albert Einstein Coll Med, Dept Biochem, Bronx, NY 10461 USA	University of Virginia; Yeshiva University; Albert Einstein College of Medicine	Auble, DT (corresponding author), 1340 Jefferson Pk Ave,Rm 6213, Charlottesville, VA 22908 USA.	dta4n@virginia.edu			National Institutes of Health [GM55763, GM39929]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM055763, R01GM039929, R29GM039929] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported, in whole or in part, by National Institutes of Health Grants GM55763 ( to D. T. A.) and GM39929 ( to M. B.). The costs of publication of this article were defrayed in part by the payment of page charges. This article must therefore be hereby marked "advertisement" in accordance with 18 U. S. C. Section 1734 solely to indicate this fact.	Albert I, 2007, NATURE, V446, P572, DOI 10.1038/nature05632; Andrau JC, 2002, EMBO J, V21, P5173, DOI 10.1093/emboj/cdf485; AUBLE DT, 1994, GENE DEV, V8, P1920, DOI 10.1101/gad.8.16.1920; Auble DT, 1997, MOL CELL BIOL, V17, P4842, DOI 10.1128/MCB.17.8.4842; Basehoar AD, 2004, CELL, V116, P699, DOI 10.1016/S0092-8674(04)00205-3; BRENOWITZ M, 1993, FOOTPRINTING TECHNIQ, P1; BURATOWSKI S, 1989, CELL, V56, P549, DOI 10.1016/0092-8674(89)90578-3; Chitikila C, 2002, MOL CELL, V10, P871, DOI 10.1016/S1097-2765(02)00683-4; Cox JM, 1997, P NATL ACAD SCI USA, V94, P13475, DOI 10.1073/pnas.94.25.13475; Darst RP, 2003, J BIOL CHEM, V278, P13216, DOI 10.1074/jbc.M211445200; Darst RP, 2001, EMBO J, V20, P2028, DOI 10.1093/emboj/20.8.2028; Das R, 2005, RNA, V11, P344, DOI 10.1261/rna.7214405; Dasgupta A, 2005, EMBO J, V24, P1717, DOI 10.1038/sj.emboj.7600646; Dasgupta A, 2002, P NATL ACAD SCI USA, V99, P2666, DOI 10.1073/pnas.052397899; DAVIS JL, 1992, MOL CELL BIOL, V12, P1879, DOI 10.1128/MCB.12.4.1879; Durr H, 2005, CELL, V121, P363, DOI 10.1016/j.cell.2005.03.026; EISEN JA, 1995, NUCLEIC ACIDS RES, V23, P2715, DOI 10.1093/nar/23.14.2715; Faiger H, 2006, NUCLEIC ACIDS RES, V34, P104, DOI 10.1093/nar/gkj414; Fenton H., 1894, J CHEM SOC T, V65, P899, DOI [10.1039/CT8946500899, DOI 10.1039/CT8946500899]; Geisberg JV, 2002, MOL CELL BIOL, V22, P8122, DOI 10.1128/MCB.22.23.8122-8134.2002; Geisberg JV, 2001, MOL CELL BIOL, V21, P2736, DOI 10.1128/MCB.21.8.2736-2742.2001; Gupta S, 2007, BIOCHEMISTRY-US, V46, P9886, DOI 10.1021/bi7003608; Hahn S, 2004, NAT STRUCT MOL BIOL, V11, P394, DOI 10.1038/nsmb763; HOOPES BC, 1992, J BIOL CHEM, V267, P11539; Hsieh M, 1996, METHOD ENZYMOL, V274, P478; KIM JL, 1993, NATURE, V365, P520, DOI 10.1038/365520a0; Lee TI, 1998, GENE DEV, V12, P1398, DOI 10.1101/gad.12.10.1398; Li B, 2007, CELL, V128, P707, DOI 10.1016/j.cell.2007.01.015; Li Fusheng, 2002, Methods Mol Biol, V182, P19; Liang SD, 1996, MOL CELL BIOL, V16, P3773; Liu YC, 2001, BIOCHEMISTRY-US, V40, P6257, DOI 10.1021/bi0019794; LOSSON R, 1985, J MOL BIOL, V185, P65, DOI 10.1016/0022-2836(85)90183-4; Matangkasombut O, 2004, ADV PROTEIN CHEM, V67, P67; MEISTERERNST M, 1991, CELL, V67, P557, DOI 10.1016/0092-8674(91)90530-C; Muller F, 2007, J BIOL CHEM, V282, P14685, DOI 10.1074/jbc.R700012200; Pastor N, 2000, J MOL BIOL, V304, P55, DOI 10.1006/jmbi.2000.4173; Patikoglou GA, 1999, GENE DEV, V13, P3217, DOI 10.1101/gad.13.24.3217; Pereira LA, 2003, GENE, V315, P1, DOI 10.1016/S0378-1119(03)00714-5; Pereira LA, 2001, MOL CELL BIOL, V21, P7523, DOI 10.1128/MCB.21.21.7523-7534.2001; Prelich G, 1997, MOL CELL BIOL, V17, P2057, DOI 10.1128/MCB.17.4.2057; Pugh BF, 2000, GENE, V255, P1, DOI 10.1016/S0378-1119(00)00288-2; RANISH JA, 1992, SCIENCE, V255, P1127, DOI 10.1126/science.1546313; Ranish JA, 1996, CURR OPIN GENET DEV, V6, P151, DOI 10.1016/S0959-437X(96)80044-X; Reese JC, 2003, CURR OPIN GENET DEV, V13, P114, DOI 10.1016/S0959-437X(03)00013-3; ROY A, 1990, MOL CELL BIOL, V10, P5257, DOI 10.1128/MCB.10.10.5257; Schluesche P, 2007, NAT STRUCT MOL BIOL, V14, P1196, DOI 10.1038/nsmb1328; SCHMITT ME, 1990, NUCLEIC ACIDS RES, V18, P3091, DOI 10.1093/nar/18.10.3091; SIKORSKI RS, 1989, GENETICS, V122, P19; Spencer JV, 2002, MOL CELL BIOL, V22, P8744, DOI 10.1128/MCB.22.24.8744-8755.2002; Sprouse RO, 2006, EMBO J, V25, P1492, DOI 10.1038/sj.emboj.7601050; Storici F, 2001, NAT BIOTECHNOL, V19, P773, DOI 10.1038/90837; STRUBIN M, 1992, CELL, V68, P721, DOI 10.1016/0092-8674(92)90147-5; Takamoto K, 2004, NUCLEIC ACIDS RES, V32, DOI 10.1093/nar/gnh117; Willy PJ, 2000, SCIENCE, V290, P982, DOI 10.1126/science.290.5493.982	54	12	12	0	2	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	SEP 5	2008	283	36					24935	24948		10.1074/jbc.M803749200	http://dx.doi.org/10.1074/jbc.M803749200			14	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	342YR	18606810	Green Published, hybrid			2022-12-27	WOS:000258820000056
J	Wu, Z; Zhang, W; Chen, GB; Cheng, L; Liao, J; Jia, N; Gao, Y; Dai, HM; Yuan, JD; Cheng, LZ; Xiao, L				Wu, Zhao; Zhang, Wei; Chen, Guibin; Cheng, Lu; Liao, Jing; Jia, Nannan; Gao, Yuan; Dai, Huiming; Yuan, Jinduo; Cheng, Linzhao; Xiao, Lei			Combinatorial signals of Activin/Nodal and bone morphogenic protein regulate the early lineage segregation of human embryonic stem cells	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							FIBROBLAST-GROWTH-FACTOR; SELF-RENEWAL; HUMAN BLASTOCYSTS; MOUSE EMBRYO; IN-VITRO; DIFFERENTIATION; PLURIPOTENCY; TROPHOBLAST; INHIBITION; MAINTAINS	Cell fate commitment of pre-implantation blastocysts, to either the inner cell mass or trophoblast, is the first step in cell lineage segregation of the developing human embryo. However, the intercellular signals that control fate determination of these cells remain obscure. Human embryonic stem cells (hESCs) provide a unique model for studying human early embryonic development. We have previously shown that Activin/Nodal signaling contributes to maintaining pluripotency of hESCs, which are derivatives of the inner cell mass. Here we further demonstrate that the inhibition of Activin/Nodal signaling results in the loss of hESC pluripotency and trophoblast differentiation, similar to BMP4-induced trophoblast differentiation from hESCs. We also show that the trophoblast induction effect of BMP4 correlates with and depends on the inhibition of Activin/Nodal signaling. However, the activation of BMP signaling is still required for trophoblast differentiation when Activin/Nodal signaling is inhibited. These data reveal that the early lineage segregation of hESCs is determined by the combinatorial signals of Activin/Nodal and BMP.	[Wu, Zhao; Zhang, Wei; Cheng, Lu; Liao, Jing; Jia, Nannan; Gao, Yuan; Dai, Huiming; Xiao, Lei] Chinese Acad Sci, Mol Cell Biol Lab, Key Lab Stem Cell Biol,Shanghai Inst Biol Sci, Inst Biochem & Cell Biol,Cell Bank Stem Cell Bank, Shanghai 200031, Peoples R China; [Zhang, Wei; Yuan, Jinduo] Shandong Normal Univ, Dept Biotechnol, Coll Life Sci, Jinan 250014, Peoples R China; [Chen, Guibin; Cheng, Linzhao] Johns Hopkins Univ, Sch Med, Stem Cell Program, Inst Cell Engn, Baltimore, MD 21205 USA; [Chen, Guibin; Cheng, Linzhao] Johns Hopkins Univ, Sch Med, Dept Gynecol & Obstet, Baltimore, MD 21205 USA	Chinese Academy of Sciences; Shanghai Institutes for Biological Sciences, CAS; Shandong Normal University; Johns Hopkins University; Johns Hopkins University	Xiao, L (corresponding author), 320 Yue Yang Rd,Bldg 41,Rm 625, Shanghai 200031, Peoples R China.	leixiao@sibs.ac.cn	Liao, Jing/J-4620-2014		Ministry of Science and Technology [2007CB947100, 2006CB943900]; National Natural Science Foundation of China [30600306]; Shanghai Institutes for Biological Sciences [2007KIP101]	Ministry of Science and Technology(Ministry of Science, ICT & Future Planning, Republic of Korea); National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Shanghai Institutes for Biological Sciences(Chinese Academy of Sciences)	This work was supported by Ministry of Science and Technology Grants 2007CB947100 and 2006CB943900, National Natural Science Foundation of China Grant 30600306, and Shanghai Institutes for Biological Sciences Grant 2007KIP101. The costs of publication of this article were defrayed in part by the payment of page charges. This article must therefore be hereby marked "advertisement" in accordance with 18 U. S. C. Section 1734 solely to indicate this fact.	Beattie GM, 2005, STEM CELLS, V23, P489, DOI 10.1634/stemcells.2004-0279; Brennan J, 2001, NATURE, V411, P965, DOI 10.1038/35082103; Brons IGM, 2007, NATURE, V448, P191, DOI 10.1038/nature05950; Cai LH, 2007, CELL RES, V17, P62, DOI 10.1038/sj.cr.7310138; Chen GB, 2008, CELL STEM CELL, V2, P345, DOI 10.1016/j.stem.2008.02.004; Cheng LZ, 2006, NATURE, V440, P992, DOI 10.1038/440992b; Cowan CA, 2004, NEW ENGL J MED, V350, P1353, DOI 10.1056/NEJMsr040330; Cross JC, 2003, PLACENTA, V24, P123, DOI 10.1053/plac.2002.0887; D'Amour KA, 2006, NAT BIOTECHNOL, V24, P1392, DOI 10.1038/nbt1259; Dolnikov K, 2006, STEM CELLS, V24, P236, DOI 10.1634/stemcells.2005-0036; Dravid G, 2005, STEM CELLS, V23, P1489, DOI 10.1634/stemcells.2005-0034; Gerami-Naini B, 2004, ENDOCRINOLOGY, V145, P1517, DOI 10.1210/en.2003-1241; Inman GJ, 2002, MOL PHARMACOL, V62, P65, DOI 10.1124/mol.62.1.65; James D, 2005, DEVELOPMENT, V132, P1273, DOI 10.1242/dev.01706; Kaufman DS, 2001, P NATL ACAD SCI USA, V98, P10716, DOI 10.1073/pnas.191362598; Laping NJ, 2002, MOL PHARMACOL, V62, P58, DOI 10.1124/mol.62.1.58; Lu CC, 2001, CURR OPIN GENET DEV, V11, P384, DOI 10.1016/S0959-437X(00)00208-2; NAKAMURA T, 1990, SCIENCE, V247, P836, DOI 10.1126/science.2106159; Ogawa K, 2007, J CELL SCI, V120, P55, DOI 10.1242/jcs.03296; Pera MF, 2004, J CELL SCI, V117, P1269, DOI 10.1242/jcs.00970; Reppel M, 2004, CELL PHYSIOL BIOCHEM, V14, P187, DOI 10.1159/000080326; Rossant J, 2001, NAT REV GENET, V2, P538, DOI 10.1038/35080570; Rossant J, 2001, STEM CELLS, V19, P477, DOI 10.1634/stemcells.19-6-477; Russ AP, 2000, NATURE, V404, P95, DOI 10.1038/35003601; Ryan K, 1996, CELL, V87, P989, DOI 10.1016/S0092-8674(00)81794-8; Sato N, 2004, NAT MED, V10, P55, DOI 10.1038/nm979; Schenke-Layland K, 2007, STEM CELLS, V25, P1529, DOI 10.1634/stemcells.2006-0729; Schuldiner M, 2000, P NATL ACAD SCI USA, V97, P11307, DOI 10.1073/pnas.97.21.11307; Smith AG, 2001, ANNU REV CELL DEV BI, V17, P435, DOI 10.1146/annurev.cellbio.17.1.435; SMITH AG, 1988, NATURE, V336, P688, DOI 10.1038/336688a0; Smith JR, 2008, DEV BIOL, V313, P107, DOI 10.1016/j.ydbio.2007.10.003; Strumpf D, 2005, DEVELOPMENT, V132, P2093, DOI 10.1242/dev.01801; TEN DP, 2004, TRENDS BIOCHEM SCI, V29, P265; Thomson JA, 1998, SCIENCE, V282, P1145, DOI 10.1126/science.282.5391.1145; Vallier L, 2005, J CELL SCI, V118, P4495, DOI 10.1242/jcs.02553; Wang D, 2007, P NATL ACAD SCI USA, V104, P4449, DOI 10.1073/pnas.0700052104; WILLIAMS RL, 1988, NATURE, V336, P684, DOI 10.1038/336684a0; Xiao L, 2006, STEM CELLS, V24, P1476, DOI 10.1634/stemcells.2005-0299; Xu CH, 2005, STEM CELLS, V23, P315, DOI 10.1634/stemcells.2004-0211; Xu CH, 2001, NAT BIOTECHNOL, V19, P971, DOI 10.1038/nbt1001-971; Xu RH, 2002, NAT BIOTECHNOL, V20, P1261, DOI 10.1038/nbt761; Xu RH, 2005, NAT METHODS, V2, P185, DOI 10.1038/NMETH744; Ying QL, 2003, CELL, V115, P281, DOI 10.1016/S0092-8674(03)00847-X; Zhan XC, 2004, LANCET, V364, P163, DOI 10.1016/S0140-6736(04)16629-4; Zhang SC, 2001, NAT BIOTECHNOL, V19, P1129, DOI 10.1038/nbt1201-1129	45	75	80	1	10	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	SEP 5	2008	283	36					24991	25002		10.1074/jbc.M803893200	http://dx.doi.org/10.1074/jbc.M803893200			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	342YR	18596037	hybrid, Green Published			2022-12-27	WOS:000258820000059
J	Dicker, IB; Terry, B; Lin, ZY; Li, ZF; Bollini, S; Samanta, HK; Gali, V; Walker, MA; Krystal, MR				Dicker, Ira B.; Terry, Brian; Lin, Zeyu; Li, Zhufang; Bollini, Sagarika; Samanta, Himadri K.; Gali, Volodymyr; Walker, Michael A.; Krystal, Mark R.			Biochemical analysis of HIV-1 integrase variants resistant to strand transfer inhibitors	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							IMMUNODEFICIENCY-VIRUS TYPE-1; TERMINAL REPEAT; DNA INTEGRATION; DIKETO ACID; PROTEIN; RECOGNITION; MUTATIONS; MECHANISM; BINDING; ACCUMULATION	In this study, eight different HIV-1 integrase proteins containing mutations observed in strand transfer inhibitor- resistant viruses were expressed, purified, and used for detailed enzymatic analyses. All the variants examined were impaired for strand transfer activity compared with the wild type enzyme, with relative catalytic efficiencies ( kp/ Km) ranging from 0.6 to 50% of wild type. The origin of the reduced strand transfer efficiencies of the variant enzymes was predominantly because of poorer catalytic turnover ( kp) values. However, smaller secondorder effects were caused by up to 4- fold increases in Km values for target DNA utilization in some of the variants. All the variants were less efficient than the wild type enzyme in assembling on the viral long terminal repeat, as each variant required more protein than wild type to attain maximal activity. In addition, the variant integrases displayed up to 8- fold reductions in their catalytic efficiencies for 3'-processing. The Q148R variant was the most defective enzyme. The molecular basis for resistance of these enzymes was shown to be due to lower affinity binding of the strand transfer inhibitor to the integrase complex, a consequence of faster dissociation rates. In the case of the Q148R variant, the origin of reduced compound affinity lies in alterations to the active site that reduce the binding of a catalytically essential magnesium ion. Finally, except for T66I, variant viruses harboring the the resistance-inducing substitutions were defective for viral integration.	[Dicker, Ira B.; Terry, Brian; Lin, Zeyu; Li, Zhufang; Bollini, Sagarika; Samanta, Himadri K.; Gali, Volodymyr; Krystal, Mark R.] Bristol Myers Squibb Res & Dev, Dept Virol, Wallingford, CT 06492 USA; [Walker, Michael A.] Bristol Myers Squibb Res & Dev, Dept Med Chem, Wallingford, CT 06492 USA	Bristol-Myers Squibb; Bristol-Myers Squibb	Dicker, IB (corresponding author), Bristol Myers Squibb Co, Dept Virol, 5 Res Pkwy, Wallingford, CT 06492 USA.	Ira.Dicker@BMS.com						Asante-Appiah E, 1999, ADV VIRUS RES, V52, P351, DOI 10.1016/S0065-3527(08)60306-1; Bartz SR, 1996, J VIROL, V70, P2324, DOI 10.1128/JVI.70.4.2324-2331.1996; BLAIR W, 2003, Patent No. 2003001378; Bugreev DV, 2003, BIOCHEMISTRY-US, V42, P9235, DOI 10.1021/bi0300480; BUSHMAN FD, 1991, P NATL ACAD SCI USA, V88, P1339, DOI 10.1073/pnas.88.4.1339; Butler SL, 2002, J VIROL, V76, P3739, DOI 10.1128/JVI.76.8.3739-3747.2002; Cheng HC, 2004, PHARMACOL RES, V50, P21, DOI 10.1016/j.phrs.2003.11.007; Cherepanov P, 2003, J BIOL CHEM, V278, P372, DOI 10.1074/jbc.M209278200; Chiu TK, 2004, CURR TOP MED CHEM, V4, P965, DOI 10.2174/1568026043388547; COOPER D, 2007, 14 C RETR OPP INF LO; CRAIGIE R, 1990, CELL, V62, P829, DOI 10.1016/0092-8674(90)90126-Y; Deprez E, 2000, BIOCHEMISTRY-US, V39, P9275, DOI 10.1021/bi000397j; Deprez E, 2004, MOL PHARMACOL, V65, P85, DOI 10.1124/mol.65.1.85; Deprez E, 2001, P NATL ACAD SCI USA, V98, P10090, DOI 10.1073/pnas.181024498; Dicker IB, 2007, J BIOL CHEM, V282, P31186, DOI 10.1074/jbc.M704935200; ENGELMAN A, 1991, CELL, V67, P1211, DOI 10.1016/0092-8674(91)90297-C; Espeseth AS, 2000, P NATL ACAD SCI USA, V97, P11244, DOI 10.1073/pnas.200139397; Faure A, 2005, NUCLEIC ACIDS RES, V33, P977, DOI 10.1093/nar/gki241; Fikkert V, 2004, AIDS, V18, P2019, DOI 10.1097/00002030-200410210-00006; Fikkert V, 2003, J VIROL, V77, P11459, DOI 10.1128/JVI.77.21.11459-11470.2003; FRANSEN S, 2008, 17 HIV DRUG RES WORK; Gao K, 2001, EMBO J, V20, P3565, DOI 10.1093/emboj/20.13.3565; Gerton JL, 1998, J VIROL, V72, P5046, DOI 10.1128/JVI.72.6.5046-5055.1998; Hazuda DJ, 2004, P NATL ACAD SCI USA, V101, P11233, DOI 10.1073/pnas.0402357101; Hazuda DJ, 2000, SCIENCE, V287, P646, DOI 10.1126/science.287.5453.646; HAZUDA DJ, 2007, 16 INT HIV RES WORKS; JONES G, 2007, 14 C RETR OPP INF LO; JONES KS, 1992, J BIOL CHEM, V267, P16037; KATZ RA, 1990, CELL, V63, P87, DOI 10.1016/0092-8674(90)90290-U; Kehlenbeck S, 2006, J VIROL, V80, P6883, DOI 10.1128/JVI.00306-06; Lee DJ, 2006, ANTIMICROB AGENTS CH, V50, P134, DOI 10.1128/AAC.50.1.134-142.2006; Lee DJ, 2004, J VIROL, V78, P5835, DOI 10.1128/JVI.78.11.5835-5847.2004; Li M, 2006, EMBO J, V25, P1295, DOI 10.1038/sj.emboj.7601005; MCCOLL DJ, 2007, 16 INT HIV RES WORKS; MILLER M, 2008, 17 INT HIV DRUG RES; Neamati N, 2002, EXPERT OPIN THER PAT, V12, P709, DOI 10.1517/13543776.12.5.709; O'Doherty U, 2000, J VIROL, V74, P10074, DOI 10.1128/JVI.74.21.10074-10080.2000; O'Doherty U, 2002, J VIROL, V76, P10942, DOI 10.1128/JVI.76.21.10942-10950.2002; Pommier Y, 2005, NAT REV DRUG DISCOV, V4, P236, DOI 10.1038/nrd1660; REN C, 2007, 16 INT HIV RES WORKS; SEGEL IH, 1975, ENZYME KINETICS, P19; SHERMAN PA, 1990, P NATL ACAD SCI USA, V87, P5119, DOI 10.1073/pnas.87.13.5119; Shimura K, 2008, J VIROL, V82, P764, DOI 10.1128/JVI.01534-07; Smolov M, 2006, FEBS J, V273, P1137, DOI 10.1111/j.1742-4658.2006.05139.x; VINCENT KA, 1990, NUCLEIC ACIDS RES, V18, P6045, DOI 10.1093/nar/18.20.6045; VINK C, 1991, J VIROL, V65, P4636, DOI 10.1128/JVI.65.9.4636-4644.1991; VINK C, 1993, TRENDS GENET, V9, P433, DOI 10.1016/0168-9525(93)90107-S; Wang LD, 2005, BIOCHEM BIOPH RES CO, V337, P313, DOI 10.1016/j.bbrc.2005.08.274; WISKERCHEN M, 1995, J VIROL, V69, P376, DOI 10.1128/JVI.69.1.376-386.1995; Yi JZ, 1999, BIOCHEMISTRY-US, V38, P8458, DOI 10.1021/bi982870n; YOSHINAGA T, 2008, 15 C RETR OPP INF BO	51	28	28	0	1	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	AUG 29	2008	283	35					23599	23609		10.1074/jbc.M804213200	http://dx.doi.org/10.1074/jbc.M804213200			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	340II	18577511	Green Published, hybrid			2022-12-27	WOS:000258638900012
J	Hayashi, H; Sano, H; Seo, S; Kume, T				Hayashi, Hisaki; Sano, Hideto; Seo, Seungwoon; Kume, Tsutomu			The Foxc2 transcription factor regulates angiogenesis via induction of integrin beta 3 expression	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							LYMPHEDEMA-DISTICHIASIS SYNDROME; INHIBITS TUMOR-GROWTH; VASCULAR DEVELOPMENT; CARDIOVASCULAR DEVELOPMENT; PATHOLOGICAL ANGIOGENESIS; ENDOTHELIAL-CELLS; MICE LACKING; MIGRATION; RECEPTOR; LETHALITY	Forkhead transcription factor Foxc2 is an essential regulator of the cardiovascular system in development and disease. However, the cellular and molecular functions of Foxc2 in vascular endothelial cells are still not fully understood. Here, through gene expression profiling in endothelial cells, we identified molecules associated with cell-extracellular matrix interactions, integrin beta 3 (Itgb3), integrin beta 5 (Itgb5), and fibronectin, as downstream targets of Foxc2. We found that Itgb3 expression is directly regulated by Foxc2 through multiple Forkhead-binding elements within two high homology regions in the Itgb3 promoter. Because Itgb3 is known to regulate angiogenesis, we further tested whether Foxc2 is directly involved in angiogenesis by regulating Itgb3 expression by in vitro experiments. Overexpression of Foxc2 significantly enhanced endothelial cell migration and adhesion, whereas this effect was strongly inhibited by Itgb3 neutralization antibody. In accordance with these results, pulmonary microvascular endothelial cells isolated from Foxc2 heterozygous mutant mice showed a marked reduction in Itgb3 expression and cell migration. Finally, ex vivo aortic ring assay to test the sprouting and microvessel formation revealed enhanced microvessel outgrowth by Foxc2 overexpression. Conversely, microvessel outgrowth from aortas of Foxc2 heterozygous mutant mice was reduced. Taken together, these results suggest that Foxc2 directly induces Itgb3 expression and regulates angiogenesis by Itgb3-mediated endothelial cell adhesion and migration.	[Hayashi, Hisaki; Sano, Hideto; Seo, Seungwoon; Kume, Tsutomu] Vanderbilt Univ, Med Ctr, Dept Med, Div Cardiovasc Med, Nashville, TN 37232 USA	Vanderbilt University	Kume, T (corresponding author), Vanderbilt Univ, Med Ctr, Dept Med, Div Cardiovasc Med, 2220 Pierce Ave, Nashville, TN 37232 USA.	tsutomu.kume@vanderbilt.edu	Sano, Hideto/GZM-5074-2022	Sano, Hideto/0000-0002-4185-3224	National Institutes of Health [HL067105, DK068547, HL074121]; NATIONAL EYE INSTITUTE [R01EY019484] Funding Source: NIH RePORTER; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [P01HL067105, R01HL074121] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R21DK068547] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL EYE INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	This work was supported, in whole or in part, by National Institutes of Health Grants HL067105, DK068547, and HL074121 ( to T. K.). The costs of publication of this article were defrayed in part by the payment of page charges. This article must therefore be hereby marked "advertisement" in accordance with 18 U.S.C. Section 1734 solely to indicate this fact.	Bader BL, 1998, CELL, V95, P507, DOI 10.1016/S0092-8674(00)81618-9; Borges E, 2000, J BIOL CHEM, V275, P39867, DOI 10.1074/jbc.M007040200; Carmeliet P, 2005, NATURE, V438, P932, DOI 10.1038/nature04478; Dagenais SL, 2004, GENE EXPR PATTERNS, V4, P611, DOI 10.1016/j.modgep.2004.07.004; Davis GE, 2005, CIRC RES, V97, P1093, DOI 10.1161/01.RES.0000191547.64391.e3; Duarte A, 2004, GENE DEV, V18, P2474, DOI 10.1101/gad.1239004; Gale NW, 2004, P NATL ACAD SCI USA, V101, P15949, DOI 10.1073/pnas.0407290101; Goumans MJ, 2002, EMBO J, V21, P1743, DOI 10.1093/emboj/21.7.1743; Harrington LS, 2008, MICROVASC RES, V75, P144, DOI 10.1016/j.mvr.2007.06.006; Hayashi H, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002401; Hayashi H, 2008, BIOCHEM BIOPH RES CO, V367, P584, DOI 10.1016/j.bbrc.2007.12.183; He TC, 1998, P NATL ACAD SCI USA, V95, P2509, DOI 10.1073/pnas.95.5.2509; Hynes RO, 2007, J THROMB HAEMOST, V5, P32, DOI 10.1111/j.1538-7836.2007.02569.x; Hynes RO, 2002, NAT MED, V8, P918, DOI 10.1038/nm0902-918; Iida K, 1997, DEVELOPMENT, V124, P4627; Kamiyama M, 2006, ONCOGENE, V25, P7019, DOI 10.1038/sj.onc.1209694; Krebs LT, 2004, GENE DEV, V18, P2469, DOI 10.1101/gad.1239204; Kriederman BM, 2003, HUM MOL GENET, V12, P1179, DOI 10.1093/hmg/ddg123; Kume T, 2001, GENE DEV, V15, P2470, DOI 10.1101/gad.907301; Lamalice L, 2007, CIRC RES, V100, P782, DOI 10.1161/01.RES.0000259593.07661.1e; Mahabeleshwar GH, 2007, CIRC RES, V101, P570, DOI 10.1161/CIRCRESAHA.107.155655; Mahabeleshwar GH, 2006, J EXP MED, V203, P2495, DOI 10.1084/jem.20060807; Malin D, 2007, MOL CELL BIOL, V27, P2486, DOI 10.1128/MCB.01736-06; Mani SA, 2007, P NATL ACAD SCI USA, V104, P10069, DOI 10.1073/pnas.0703900104; Mellor RH, 2007, CIRCULATION, V115, P1912, DOI 10.1161/CIRCULATIONAHA.106.675348; Mulgrew K, 2006, MOL CANCER THER, V5, P3122, DOI 10.1158/1535-7163.MCT-06-0356; Myatt SS, 2007, NAT REV CANCER, V7, P847, DOI 10.1038/nrc2223; Noguera-Troise I, 2006, NATURE, V444, P1032, DOI 10.1038/nature05355; Petrova TV, 2004, NAT MED, V10, P974, DOI 10.1038/nm1094; Reynolds LE, 2002, NAT MED, V8, P27, DOI 10.1038/nm0102-27; Ridgway J, 2006, NATURE, V444, P1083, DOI 10.1038/nature05313; Rolli M, 2003, P NATL ACAD SCI USA, V100, P9482, DOI 10.1073/pnas.1633689100; Rupp PA, 2001, CIRC RES, V89, P566, DOI 10.1161/hh1901.097747; Scehnet JS, 2007, BLOOD, V109, P4753, DOI 10.1182/blood-2006-12-063933; Seo S, 2006, DEV BIOL, V296, P421, DOI 10.1016/j.ydbio.2006.06.012; Seo S, 2006, DEV BIOL, V294, P458, DOI 10.1016/j.ydbio.2006.03.035; Serini G, 2006, EXP CELL RES, V312, P651, DOI 10.1016/j.yexcr.2005.10.020; Wierstra I, 2007, BIOCHEM BIOPH RES CO, V352, P61, DOI 10.1016/j.bbrc.2006.10.151; Wilkinson-Berka JL, 2006, INVEST OPHTH VIS SCI, V47, P1600, DOI 10.1167/iovs.05-1314; Winnier GE, 1999, DEV BIOL, V213, P418, DOI 10.1006/dbio.1999.9382; Zhang HM, 2007, AM J PATHOL, V171, P1113, DOI 10.2353/ajpath.2007.070226	41	69	71	0	5	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	AUG 29	2008	283	35					23791	23800		10.1074/jbc.M800190200	http://dx.doi.org/10.1074/jbc.M800190200			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	340II	18579532	Green Published, hybrid			2022-12-27	WOS:000258638900033
J	Sameshima, T; Ueno, T; Iizuka, R; Ishii, N; Terada, N; Okabe, K; Funatsu, T				Sameshima, Tomoya; Ueno, Taro; Iizuka, Ryo; Ishii, Noriyuki; Terada, Naofumi; Okabe, Kohki; Funatsu, Takashi			Football- and bullet-shaped GroEL-GroES complexes coexist during the reaction cycle	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							CHAPERONIN GROEL; ATP HYDROLYSIS; PROTEIN; GROEL(14)(GROES(7))(2); POLYPEPTIDE; COOPERATIVITY; TRANSITION; MICROSCOPY; CATALYSIS; ADP	GroEL is an Escherichia coli chaperonin that is composed of two heptameric rings stacked back-to-back. GroEL assists protein folding with its cochaperonin GroES in an ATP-dependent manner in vitro and in vivo. However, it is still unclear whether GroES binds to both rings of GroEL simultaneously under physiological conditions. In this study, we monitored the GroEL-GroES interaction in the reaction cycle using fluorescence resonance energy transfer. We found that nearly equivalent amounts of symmetric GroEL-(GroES)(2) (football-shaped) complex and asymmetric GroEL-GroES (bullet-shaped) complex coexist during the functional reaction cycle. We also found that D398A, an ATP hydrolysis defective mutant of GroEL, forms a football-shaped complex with ATP bound to the two rings. Furthermore, we showed that ADP prevents the association of ATP to the trans-ring of GroEL, and as a consequence, the second GroES cannot bind to GroEL. Considering the concentrations of ADP and ATP in E. coli, ADP is expected to have a small effect on the inhibition of GroES binding to the trans-ring of GroEL in vivo. These results suggest that we should reconsider the chaperonin-mediated protein-folding mechanism that involves the football-shaped complex.	[Sameshima, Tomoya; Ueno, Taro; Iizuka, Ryo; Terada, Naofumi; Okabe, Kohki; Funatsu, Takashi] Univ Tokyo, Grad Sch Pharmaceut Sci, Lab Bio Analyt Chem, Bunkyo Ku, Tokyo 1130033, Japan; [Ishii, Noriyuki] Natl Inst Adv Ind Sci & Technol, Biol Informat Res Ctr, Tsukuba, Ibaraki 3058566, Japan; [Funatsu, Takashi] Univ Tokyo, Ctr NanoBio Integrat, Bunkyo Ku, Tokyo 1138656, Japan	University of Tokyo; National Institute of Advanced Industrial Science & Technology (AIST); University of Tokyo	Funatsu, T (corresponding author), Univ Tokyo, Grad Sch Pharmaceut Sci, Lab Bio Analyt Chem, Bunkyo Ku, 7-3-1 Hongo, Tokyo 1130033, Japan.	funatsu@mail.ecc.u-tokyo.ac.jp	Funatsu, Takashi/Q-1404-2015; Ishii, Noriyuki/E-5661-2011	Funatsu, Takashi/0000-0002-9656-8308; Ishii, Noriyuki/0000-0002-4120-6203; Iizuka, Ryo/0000-0002-9328-5628	Mitsubishi Foundation; Ministry of Education, Culture, Sports, Science and Technology of Japan [17201031]	Mitsubishi Foundation; Ministry of Education, Culture, Sports, Science and Technology of Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT))	This work was supported by a grant from the Mitsubishi Foundation (to T. F.) and by Grant-in-Aid for Scientific Research (A) 17201031 (to T. F.) from the Ministry of Education, Culture, Sports, Science and Technology of Japan. The costs of publication of this article were defrayed in part by the payment of pagecharges. This article must therefore be hereby marked "advertisement" in accordance with 18 U.S.C. Section 1734 solely to indicate this fact.	AZEM A, 1994, SCIENCE, V265, P653, DOI 10.1126/science.7913553; Azem A, 1995, P NATL ACAD SCI USA, V92, P12021, DOI 10.1073/pnas.92.26.12021; Beissinger M, 1999, J MOL BIOL, V289, P1075, DOI 10.1006/jmbi.1999.2780; BOCHKAREVA ES, 1992, J BIOL CHEM, V267, P6796; Bukau B, 1998, CELL, V92, P351, DOI 10.1016/S0092-8674(00)80928-9; CHABRE M, 1990, TRENDS BIOCHEM SCI, V15, P6, DOI 10.1016/0968-0004(90)90117-T; Cliff MJ, 1999, J MOL BIOL, V293, P667, DOI 10.1006/jmbi.1999.3138; Danziger O, 2003, P NATL ACAD SCI USA, V100, P13797, DOI 10.1073/pnas.2333925100; ENGEL A, 1995, SCIENCE, V269, P832, DOI 10.1126/science.7638600; Gorovits BM, 1997, J BIOL CHEM, V272, P26999, DOI 10.1074/jbc.272.43.26999; Hartl FU, 2002, SCIENCE, V295, P1852, DOI 10.1126/science.1068408; HAYERHARTL MK, 1995, SCIENCE, V269, P836, DOI 10.1126/science.7638601; Horwich AL, 2006, CHEM REV, V106, P1917, DOI 10.1021/cr040435v; Iizuka R, 2005, J BIOL CHEM, V280, P40375, DOI 10.1074/jbc.M506785200; Inobe T, 2008, BIOPHYS J, V94, P1392, DOI 10.1529/biophysj.107.114710; LEHNINGER AL, 1993, PRINCIPLES BIOCH, P364; Lorimer GH, 1996, FASEB J, V10, P5, DOI 10.1096/fasebj.10.1.8566548; LOWRY OH, 1951, J BIOL CHEM, V193, P265; Meyer AS, 2003, CELL, V113, P369, DOI 10.1016/S0092-8674(03)00307-6; Motojima F, 2003, J BIOL CHEM, V278, P26648, DOI 10.1074/jbc.M300806200; Motojima F, 2000, BIOCHEM BIOPH RES CO, V267, P842, DOI 10.1006/bbrc.1999.2020; Murai N, 1996, J BIOL CHEM, V271, P28229, DOI 10.1074/jbc.271.45.28229; Ranson NA, 2006, NAT STRUCT MOL BIOL, V13, P147, DOI 10.1038/nsmb1046; Ranson NA, 2001, CELL, V107, P869, DOI 10.1016/S0092-8674(01)00617-1; Rye HS, 1999, CELL, V97, P325, DOI 10.1016/S0092-8674(00)80742-4; Rye HS, 1997, NATURE, V388, P792, DOI 10.1038/42047; Rye HS, 2001, METHODS, V24, P278, DOI 10.1006/meth.2001.1188; SCHMIDT M, 1994, SCIENCE, V265, P656, DOI 10.1126/science.7913554; Sparrer H, 1997, P NATL ACAD SCI USA, V94, P1096, DOI 10.1073/pnas.94.4.1096; Taguchi H, 2004, J BIOL CHEM, V279, P45737, DOI 10.1074/jbc.M406795200; Taguchi H, 2001, NAT BIOTECHNOL, V19, P861, DOI 10.1038/nbt0901-861; TODD MJ, 1994, SCIENCE, V265, P659, DOI 10.1126/science.7913555; Torok Z, 1996, J BIOL CHEM, V271, P16180, DOI 10.1074/jbc.271.27.16180; Ueno T, 2004, MOL CELL, V14, P423, DOI 10.1016/S1097-2765(04)00261-8; Walter S, 2002, CELL MOL LIFE SCI, V59, P1589, DOI 10.1007/PL00012485; YIFRACH O, 1995, BIOCHEMISTRY-US, V34, P5303, DOI 10.1021/bi00016a001; Yokokawa M, 2006, EMBO J, V25, P4567, DOI 10.1038/sj.emboj.7601326	37	37	38	0	9	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	AUG 29	2008	283	35					23765	23773		10.1074/jbc.M802541200	http://dx.doi.org/10.1074/jbc.M802541200			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	340II	18567585	Green Published, hybrid			2022-12-27	WOS:000258638900030
J	Fujiwara, S; Wang, L; Han, LQ; Suh, SS; Salome, PA; McClung, CR; Somers, DE				Fujiwara, Sumire; Wang, Lei; Han, Linqu; Suh, Sung-Suk; Salome, Patrice A.; McClung, C. Robertson; Somers, David E.			Post-translational regulation of the Arabidopsis circadian clock through selective proteolysis and phosphorylation of pseudo-response regulator proteins	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							PLAY ESSENTIAL ROLES; APRR1/TOC1 QUINTET; EARLY PHOTOMORPHOGENESIS; TARGETED DEGRADATION; ABERRANT EXPRESSION; GENE-EXPRESSION; FLOWERING TIME; SCFZTL COMPLEX; KINASE CK2; THALIANA	The circadian clock controls the period, phasing, and amplitude of processes that oscillate with a near 24-h rhythm. One core group of clock components in Arabidopsis that controls the pace of the central oscillator is comprised of five PRR (pseudo-response regulator) proteins whose biochemical function in the clock remains unclear. Peak expression of TOC1 (timing of cab expression 1)/PRR1, PRR3, PRR5, PRR7, and PRR9 are each phased differently over the course of the day and loss of any PRR protein alters period. Here we show that, together with TOC1, PRR5 is the only other likely proteolytic substrate of the E3 ubiquitin ligase SCFZTL within this PRR family. We further demonstrate a functional significance for the phosphorylated forms of PRR5, TOC1, and PRR3. Each PRR protein examined is nuclear-localized and is differentially phosphorylated over the circadian cycle. The more highly phosphorylated forms of PRR5 and TOC1 interact best with the F-box protein ZTL (ZEITLUPE), suggesting a mechanism to modulate their proteolysis. In vivo degradation of both PRR5 and ZTL is inhibited by blue light, likely the result of blue light photoperception by ZTL. TOC1 and PRR3 interact in vivo and phosphorylation of both is necessary for their optimal binding in vitro. Additionally, because PRR3 and ZTL both interact with TOC1 in vivo via the TOC1 N terminus, taken together these data suggest that the TOC1/PRR3 phosphorylation-dependent interaction may protect TOC1 from ZTL-mediated degradation, resulting in an enhanced amplitude of TOC1 cycling.	[Fujiwara, Sumire; Wang, Lei; Han, Linqu; Suh, Sung-Suk; Somers, David E.] Ohio State Univ, Dept Plant Cellular & Mol Biol, Ctr Plant Biotechnol, Columbus, OH 43210 USA; [Salome, Patrice A.; McClung, C. Robertson] Dartmouth Coll, Dept Biol Sci, Hanover, NH 03755 USA	University System of Ohio; Ohio State University; Dartmouth College	Somers, DE (corresponding author), 054 Rightmire Hall,1060 Carmack Rd, Columbus, OH 43210 USA.	somers.24@osu.edu	Salome, Patrice/E-5702-2017; Somers, David E/A-9209-2010	McClung, C. Robertson/0000-0002-7875-3614; WANG, LEI/0000-0002-4912-5387; Salome, Patrice/0000-0003-4452-9064	National Science Foundation [MCB-0343887];  [IBN-0344377];  [MCB-0544137]	National Science Foundation(National Science Foundation (NSF)); ; 	This work was supported in part by National Science Foundation Grants MCB-0343887 (to C.R.M.) and IBN-0344377 and MCB-0544137 ( to D. E. S.).	Alabadi D, 2001, SCIENCE, V293, P880, DOI 10.1126/science.1061320; BECHTOLD N, 1993, CR ACAD SCI III-VIE, V316, P1194; Bell-Pedersen D, 2005, NAT REV GENET, V6, P544, DOI 10.1038/nrg1633; Brunner M, 2006, GENE DEV, V20, P1061, DOI 10.1101/gad.1410406; Curtis MD, 2003, PLANT PHYSIOL, V133, P462, DOI 10.1104/pp.103.027979; Daniel X, 2004, P NATL ACAD SCI USA, V101, P3292, DOI 10.1073/pnas.0400163101; David KM, 2006, FEBS LETT, V580, P1193, DOI 10.1016/j.febslet.2006.01.016; Dharmasiri N, 2003, CURR BIOL, V13, P1418, DOI 10.1016/S0960-9822(03)00536-0; Ding ZJ, 2007, GENETICS, V176, P1501, DOI 10.1534/genetics.107.072769; Dodd AN, 2005, SCIENCE, V309, P630, DOI 10.1126/science.1115581; Eriksson ME, 2003, PLANTA, V218, P159, DOI 10.1007/s00425-003-1106-4; Fang YS, 2007, GENE DEV, V21, P1506, DOI 10.1101/gad.1541607; Farre EM, 2005, CURR BIOL, V15, P47, DOI 10.1016/j.cub.2004.12.067; Farre EM, 2007, PLANT J, V52, P548, DOI 10.1111/j.1365-313X.2007.03258.x; Godinho SIH, 2007, SCIENCE, V316, P897, DOI 10.1126/science.1141138; Green RM, 2002, PLANT PHYSIOL, V129, P576, DOI 10.1104/pp.004374; Guo FQ, 2001, PLANT CELL, V13, P1761, DOI 10.1105/tpc.13.8.1761; Han LQ, 2004, PLANT J, V40, P291, DOI 10.1111/j.1365-313X.2004.02207.x; Harmer SL, 2001, ANNU REV CELL DEV BI, V17, P215, DOI 10.1146/annurev.cellbio.17.1.215; Ito S, 2003, PLANT CELL PHYSIOL, V44, P1237, DOI 10.1093/pcp/pcg136; Ito S, 2008, PLANT CELL PHYSIOL, V49, P201, DOI 10.1093/pcp/pcm178; Ito S, 2007, PLANT CELL PHYSIOL, V48, P1644, DOI 10.1093/pcp/pcm122; Itoh H, 2005, PLANT CELL PHYSIOL, V46, P1392, DOI 10.1093/pcp/pci152; Johnson CH, 2005, ANNU PLANT REV, V21, P237; Kaczorowski KA, 2003, PLANT CELL, V15, P2654, DOI 10.1105/tpc.015065; Kevei E, 2006, PLANT PHYSIOL, V140, P933, DOI 10.1104/pp.105.074864; Kiba T, 2007, PLANT CELL, V19, P2516, DOI 10.1105/tpc.107.053033; Kim WY, 2007, NATURE, V449, P356, DOI 10.1038/nature06132; Kim WY, 2003, P NATL ACAD SCI USA, V100, P4933, DOI 10.1073/pnas.0736949100; Ko HW, 2002, NATURE, V420, P673, DOI 10.1038/nature01272; Liu Y, 2005, METHOD ENZYMOL, V393, P379, DOI 10.1016/S0076-6879(05)93017-6; Locke JCW, 2006, MOL SYST BIOL, V2, DOI 10.1038/msb4100102; Makino S, 2002, PLANT CELL PHYSIOL, V43, P58, DOI 10.1093/pcp/pcf005; Mas P, 2003, NATURE, V426, P567, DOI 10.1038/nature02163; Matsushika A, 2000, PLANT CELL PHYSIOL, V41, P1002, DOI 10.1093/pcp/pcd043; Matsushika A, 2002, PLANT CELL PHYSIOL, V43, P833, DOI 10.1093/pcp/pcf118; Matsushika A, 2007, BIOSCI BIOTECH BIOCH, V71, P527, DOI 10.1271/bbb.60583; Matsushika A, 2007, BIOSCI BIOTECH BIOCH, V71, P535, DOI 10.1271/bbb.60584; McClung CR, 2006, PLANT CELL, V18, P792, DOI 10.1105/tpc.106.040980; Michael TP, 2003, SCIENCE, V302, P1049, DOI 10.1126/science.1082971; Mizuno T, 2005, PLANT CELL PHYSIOL, V46, P677, DOI 10.1093/pcp/pci087; Nakamichi N, 2005, PLANT CELL PHYSIOL, V46, P686, DOI 10.1093/pcp/pci086; Nakamichi N, 2005, PLANT CELL PHYSIOL, V46, P609, DOI 10.1093/pcp/pci061; Para A, 2007, PLANT CELL, V19, P3462, DOI 10.1105/tpc.107.054775; Perales M, 2006, PLANT J, V46, P849, DOI 10.1111/j.1365-313X.2006.02744.x; Salome PA, 2005, PLANT CELL, V17, P791, DOI 10.1105/tpc.104.029504; Sato E, 2002, PLANT CELL PHYSIOL, V43, P1374, DOI 10.1093/pcp/pcf166; Siepka SM, 2007, CELL, V129, P1011, DOI 10.1016/j.cell.2007.04.030; Smalle J, 2004, ANNU REV PLANT BIOL, V55, P555, DOI 10.1146/annurev.arplant.55.031903.141801; Somers DE, 2000, CELL, V101, P319, DOI 10.1016/S0092-8674(00)80841-7; Somers DE, 2004, PLANT CELL, V16, P769, DOI 10.1105/tpc.016808; Song HR, 2005, PLANT MOL BIOL, V57, P761, DOI 10.1007/s11103-005-3096-z; Strayer C, 2000, SCIENCE, V289, P768, DOI 10.1126/science.289.5480.768; Sugano S, 1999, P NATL ACAD SCI USA, V96, P12362, DOI 10.1073/pnas.96.22.12362; Sugano S, 1998, P NATL ACAD SCI USA, V95, P11020, DOI 10.1073/pnas.95.18.11020; Ueguchi-Tanaka M, 2007, ANNU REV PLANT BIOL, V58, P183, DOI 10.1146/annurev.arplant.58.032806.103830; Willems AR, 2004, BBA-MOL CELL RES, V1695, P133, DOI 10.1016/j.bbamcr.2004.09.027; Yamamoto Y, 2003, PLANT CELL PHYSIOL, V44, P1119, DOI 10.1093/pcp/pcg148; Zachgo S, 2000, PLANT J, V23, P697, DOI 10.1046/j.1365-313x.2000.00826.x; Zeilinger MN, 2006, MOL SYST BIOL, V2, DOI 10.1038/msb4100101	60	160	172	3	30	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	AUG 22	2008	283	34					23073	23083		10.1074/jbc.M803471200	http://dx.doi.org/10.1074/jbc.M803471200			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	337SI	18562312	hybrid			2022-12-27	WOS:000258455400020
J	Zhang, YY; Mei, ZQ; Wu, JW; Wang, ZX				Zhang, Yuan-Yuan; Mei, Zi-Qing; Wu, Jia-Wei; Wang, Zhi-Xin			Enzymatic activity and substrate specificity of mitogen-activated protein kinase p38 alpha in different phosphorylation states	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							SIGNAL-REGULATED KINASE-2; CONTINUOUS SPECTROPHOTOMETRIC ASSAY; MAP-KINASE; TYROSINE-PHOSPHATASE; KINETIC-MECHANISM; STRESS; P38; PATHWAYS; DEPHOSPHORYLATION; INACTIVATION	The mitogen-activated protein (MAP) kinases are essential signaling molecules that mediate many cellular effects of growth factors, cytokines, and stress stimuli. Full activation of the MAP kinases requires dual phosphorylation of the Thr and Tyr residues in the TXY motif of the activation loop by MAP kinase kinases. Down-regulation of MAP kinase activity can be initiated by multiple serine/threonine phosphatases, tyrosine-specific phosphatases, and dual specificity phosphatases (MAP kinase phosphatases). This would inevitably lead to the formation of monophosphorylated MAP kinases. However, the biological functions of these monophosphorylated MAP kinases are currently not clear. In this study, we have prepared MAP kinase p38 alpha, a member of the MAP kinase family, in all phosphorylated forms and characterized their biochemical properties. Our results indicated the following: (i) p38 alpha phosphorylated at both Thr-180 and Tyr-182 was 10-20-fold more active than p38 alpha phosphorylated at Thr-180 only, whereas p38 alpha phosphorylated at Tyr-182 alone was inactive; (ii) the dual-specific MKP5, the tyrosine-specific hematopoietic protein-tyrosine phosphatase, and the serine/threonine-specific PP2C alpha are all highly specific for the dephosphorylation of p38 alpha, and the dephosphorylation rates were significantly affected by different phosphorylated states of p38 alpha; (iii) the N-terminal domain of MPK5 has no effect on enzyme catalysis, whereas deletion of the MAP kinase-binding domain in MKP5 leads to a 370-fold decrease in kcat/Km for the dephosphorylation of p38 alpha. This study has thus revealed the quantitative contributions of phosphorylation of Thr, Tyr, or both to the activation of p38 alpha and to the substrate specificity for various phosphatases.	[Zhang, Yuan-Yuan; Mei, Zi-Qing; Wu, Jia-Wei; Wang, Zhi-Xin] Tsinghua Univ, Dept Biol Sci & Biotechnol, Minist Educ Bioinformat, Key Lab, Beijing 100084, Peoples R China; [Wang, Zhi-Xin] Acad Sinica, Natl Lab Biomacromol, Inst Biophys, Beijing 100101, Peoples R China	Tsinghua University; Chinese Academy of Sciences; Institute of Biophysics, CAS	Wu, JW (corresponding author), Tsinghua Univ, Dept Biol Sci & Biotechnol, Minist Educ Bioinformat, Key Lab, Beijing 100084, Peoples R China.	jiaweiwu@mail.tsinghua.edu.cn; zhixinwang@mail.tsinghua.edu.cn	wang, zhixin/GZH-2500-2022		Ministry of Science and Technology of China [2006CB503900-2007CB914400]; National Natural Science Foundation of China [30425005-30770476]	Ministry of Science and Technology of China(Ministry of Science and Technology, China); National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC))	This work was supported in part by Grants 2006CB503900-2007CB914400 from the Ministry of Science and Technology of China and Grants 30425005-30770476 from National Natural Science Foundation of China. The costs of publication of this article were defrayed in part by the payment of page charges. This article must therefore be hereby marked "advertisement" in accordance with 18 U. S. C. Section 1734 solely to indicate this fact.	AHN NG, 1991, J BIOL CHEM, V266, P4220; Avdi NJ, 2002, J BIOL CHEM, V277, P40687, DOI 10.1074/jbc.M204455200; Barford D, 1996, TRENDS BIOCHEM SCI, V21, P407, DOI 10.1016/S0968-0004(96)10060-8; Camps M, 2000, FASEB J, V14, P6, DOI 10.1096/fasebj.14.1.6; Canagarajah BJ, 1997, CELL, V90, P859, DOI 10.1016/S0092-8674(00)80351-7; Cha HJ, 2001, J CELL BIOL, V153, P1355, DOI 10.1083/jcb.153.7.1355; Chen GJ, 2000, BIOCHEMISTRY-US, V39, P2079, DOI 10.1021/bi9919495; CHENG Q, 1995, ANAL BIOCHEM, V226, P68, DOI 10.1006/abio.1995.1192; Cobb MH, 1999, PROG BIOPHYS MOL BIO, V71, P479, DOI 10.1016/S0079-6107(98)00056-X; Farooq A, 2004, CELL SIGNAL, V16, P769, DOI 10.1016/j.cellsig.2003.12.008; GILL SC, 1989, ANAL BIOCHEM, V182, P319, DOI 10.1016/0003-2697(89)90602-7; Graves JD, 1999, PHARMACOL THERAPEUT, V82, P111, DOI 10.1016/S0163-7258(98)00056-4; Gronda M, 2001, MOL CELL BIOL, V21, P6851, DOI 10.1128/MCB.21.20.6851-6858.2001; Groom LA, 1996, EMBO J, V15, P3621, DOI 10.1002/j.1460-2075.1996.tb00731.x; Johnson LN, 1996, CELL, V85, P149, DOI 10.1016/S0092-8674(00)81092-2; Keyse SM, 2000, CURR OPIN CELL BIOL, V12, P186, DOI 10.1016/S0955-0674(99)00075-7; Killilea SD, 1998, METH MOL B, V93, P23; Kyriakis JM, 2001, PHYSIOL REV, V81, P807, DOI 10.1152/physrev.2001.81.2.807; Lewis TS, 1998, ADV CANCER RES, V74, P49, DOI 10.1016/S0065-230X(08)60765-4; MCCLURE WR, 1969, BIOCHEMISTRY-US, V8, P2782, DOI 10.1021/bi00835a014; Muda M, 1996, J BIOL CHEM, V271, P27205, DOI 10.1074/jbc.271.44.27205; Muda M, 1996, J BIOL CHEM, V271, P4319; Munoz JJ, 2003, BIOCHEM J, V372, P193, DOI 10.1042/BJ20021941; Nguyen AN, 1999, GENE DEV, V13, P1653, DOI 10.1101/gad.13.13.1653; Ogata M, 1999, BIOCHEM BIOPH RES CO, V256, P52, DOI 10.1006/bbrc.1999.0278; PAYNE DM, 1991, EMBO J, V10, P885, DOI 10.1002/j.1460-2075.1991.tb08021.x; Pearson G, 2001, ENDOCR REV, V22, P153, DOI 10.1210/er.22.2.153; Pettiford SM, 2000, ONCOGENE, V19, P858, DOI 10.1038/sj.onc.1203408; RAINGEAUD J, 1995, J BIOL CHEM, V270, P7420, DOI 10.1074/jbc.270.13.7420; ROMANI A, 1992, ARCH BIOCHEM BIOPHYS, V298, P1, DOI 10.1016/0003-9861(92)90086-C; ROSKOSKI R, 1983, METHOD ENZYMOL, V99, P3; Roux PP, 2004, MICROBIOL MOL BIOL R, V68, P320, DOI 10.1128/MMBR.68.2.320-344.2004; Saxena M, 1999, J BIOL CHEM, V274, P11693, DOI 10.1074/jbc.274.17.11693; Saxena M, 1999, NAT CELL BIOL, V1, P305, DOI 10.1038/13024; SEGEL IH, 1975, ENZYME KINETICS, P73; SEGER R, 1995, FASEB J, V9, P726, DOI 10.1096/fasebj.9.9.7601337; SERGIENKO EA, 1994, ANAL BIOCHEM, V221, P348, DOI 10.1006/abio.1994.1424; Szafranska AE, 2005, FEBS J, V272, P4631, DOI 10.1111/j.1742-4658.2005.04827.x; Takekawa M, 1998, EMBO J, V17, P4744, DOI 10.1093/emboj/17.16.4744; Tanoue T, 1999, J BIOL CHEM, V274, P19949, DOI 10.1074/jbc.274.28.19949; WARD Y, 1994, NATURE, V367, P651, DOI 10.1038/367651a0; WEBB MR, 1992, P NATL ACAD SCI USA, V89, P4884, DOI 10.1073/pnas.89.11.4884; Widmann C, 1999, PHYSIOL REV, V79, P143, DOI 10.1152/physrev.1999.79.1.143; Yao Z, 2000, FEBS LETT, V468, P37, DOI 10.1016/S0014-5793(00)01191-1; Zanke BW, 1996, J BIOL CHEM, V271, P29876, DOI 10.1074/jbc.271.47.29876; Zhang HM, 1999, TRANSPORT RES B-METH, V33, P1, DOI 10.1016/S0191-2615(98)00022-8; Zhao Y, 2001, J BIOL CHEM, V276, P32382, DOI 10.1074/jbc.M103369200; ZHENG CF, 1993, J BIOL CHEM, V268, P11435; Zhou B, 1999, J BIOL CHEM, V274, P35526, DOI 10.1074/jbc.274.50.35526; Zhou B, 2002, J BIOL CHEM, V277, P31818, DOI 10.1074/jbc.M203969200; Zhou B, 2002, J BIOL CHEM, V277, P13889, DOI 10.1074/jbc.M200377200	51	63	65	0	12	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	SEP 26	2008	283	39					26591	26601		10.1074/jbc.M801703200	http://dx.doi.org/10.1074/jbc.M801703200			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	350GV	18669639	Green Published, hybrid			2022-12-27	WOS:000259341600035
J	Sobotka, R; Duerhring, U; Komenda, J; Peter, E; Gardian, Z; Tichy, M; Grimm, B; Wilde, A				Sobotka, Roman; Duerhring, Ulf; Komenda, Josef; Peter, Enrico; Gardian, Zdenko; Tichy, Martin; Grimm, Bernhard; Wilde, Annegret			Importance of the cyanobacterial GUN4 protein for chlorophyll metabolism and assembly of photosynthetic complexes	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							SYNECHOCYSTIS SP PCC-6803; SP. PCC 6803; PHOTOSYSTEM-II; TETRAPYRROLE BIOSYNTHESIS; SIGNAL-TRANSDUCTION; GENE-EXPRESSION; IN-VIVO; MUTANT; LIGHT; FERROCHELATASE	Gun4 is a porphyrin-binding protein that activates magnesium chelatase, a multimeric enzyme catalyzing the first committed step in chlorophyll biosynthesis. In plants, GUN4 has been implicated in plastid-to-nucleus retrograde signaling processes that coordinate both photosystem II and photosystem I nuclear gene expression with chloroplast function. In this work we present the functional analysis of Gun4 from the cyanobacterium Synechocystis sp. PCC 6803. Affinity co-purification of the FLAG-tagged Gun4 with the ChlH subunit of the magnesium chelatase confirmed the association of Gun4 with the enzyme in cyanobacteria. Inactivation of the gun4 gene abolished photoautotrophic growth of the resulting gun4 mutant strain that exhibited a decreased activity of magnesium chelatase. Consequently, the cellular content of chlorophyll-binding proteins was highly inadequate, especially that of proteins of photosystem II. Immunoblot analyses, blue native polyacrylamide gel electrophoresis, and radiolabeling of the membrane protein complexes suggested that the availability of the photosystem II antenna protein CP47 is a limiting factor for the photosystem II assembly in the gun4 mutant.	[Sobotka, Roman; Komenda, Josef; Tichy, Martin] Univ S Bohemia, Inst Phys Biol, Nove Hrady 37333, Czech Republic; [Sobotka, Roman; Komenda, Josef; Tichy, Martin] Inst Microbiol, Dept Autotroph Microorg, Trebon 37971, Czech Republic; [Grimm, Bernhard; Wilde, Annegret] Humboldt Univ, Inst Biol, D-10115 Berlin, Germany; [Gardian, Zdenko] Inst Plant Mol Biol, Ceske Budejovice 37005, Czech Republic	University of South Bohemia Ceske Budejovice; Czech Academy of Sciences; Institute of Microbiology of the Czech Academy of Sciences; Humboldt University of Berlin	Wilde, A (corresponding author), Univ Giessen, Inst Microbiol & Mol Biol, Heinrich Buff Ring 26-32, D-35392 Giessen, Germany.	Annegret.Wilde@mikro.bio.uni-giessen.de	Sobotka, Roman/J-3077-2014; Komenda, Josef/H-4083-2014; Gardian, Zdenko/G-9476-2014; Tichy, Martin/B-6545-2008; Gardian, Zdeno/AAU-7904-2020	Sobotka, Roman/0000-0001-5909-3879; Komenda, Josef/0000-0003-4588-0382; Tichy, Martin/0000-0003-2814-1959; Gardian, Zdeno/0000-0003-1578-2773	Deutsche Forschungsgemeinschaft [SFB429, TPA8]; Institutional Research Concept [AV0Z50200510]; Ministry of Education of the Czech Republic project [MSM6007665808]; Grant Agency of the Czech Academy of Sciences [IAA500200713]	Deutsche Forschungsgemeinschaft(German Research Foundation (DFG)); Institutional Research Concept; Ministry of Education of the Czech Republic project(Ministry of Education, Youth & Sports - Czech Republic); Grant Agency of the Czech Academy of Sciences(Grant Agency of the Czech Republic)	This work was supported by Deutsche Forschungsgemeinschaft Grants SFB429 and TPA8 (to A. W. and B. G.), by Institutional Research Concept AV0Z50200510, by Ministry of Education of the Czech Republic project MSM6007665808 (to J.K.), and by Grant Agency of the Czech Academy of Sciences project IAA500200713 (to R. S. and M. T.). The costs of publication of this article were defrayed in part by the payment of page charges. This article must therefore be hereby marked "advertisement" in accordance with 18 U. S. C. Section 1734 solely to indicate this fact.	Beale SI, 2005, TRENDS PLANT SCI, V10, P309, DOI 10.1016/j.tplants.2005.05.005; Brusslan JA, 2002, PHOTOSYNTH RES, V71, P185, DOI 10.1023/A:1015539109209; Davison PA, 2005, BIOCHEMISTRY-US, V44, P7603, DOI 10.1021/bi050240x; Dobakova M, 2007, PLANT PHYSIOL, V145, P1681, DOI 10.1104/pp.107.107805; Duhring U, 2006, BBA-BIOENERGETICS, V1757, P3, DOI 10.1016/j.bbabio.2005.11.001; EATONRYE JJ, 1991, PLANT MOL BIOL, V17, P1165, DOI 10.1007/BF00028733; Grossman AR, 2004, ANNU REV GENET, V38, P119, DOI 10.1146/annurev.genet.38.072902.092328; He QF, 1998, EUR J BIOCHEM, V253, P161, DOI 10.1046/j.1432-1327.1998.2530161.x; He QF, 1998, P NATL ACAD SCI USA, V95, P5830, DOI 10.1073/pnas.95.10.5830; HERRIN DL, 1992, J BIOL CHEM, V267, P8260; Jansch L, 1996, PLANT J, V9, P357, DOI 10.1046/j.1365-313X.1996.09030357.x; Kada S, 2003, PLANT MOL BIOL, V51, P225, DOI 10.1023/A:1021195226978; Komenda J, 2004, J BIOL CHEM, V279, P48620, DOI 10.1074/jbc.M405725200; Komenda J, 2002, EUR J BIOCHEM, V269, P610, DOI 10.1046/j.0014-2956.2001.02693.x; Larkin RM, 2003, SCIENCE, V299, P902, DOI 10.1126/science.1079978; Mochizuki N, 2001, P NATL ACAD SCI USA, V98, P2053, DOI 10.1073/pnas.98.4.2053; Papenbrock J, 2001, PLANTA, V213, P667, DOI 10.1007/s004250100593; Papenbrock J, 1999, PLANTA, V208, P264, DOI 10.1007/s004250050558; PLUMLEY FG, 1995, PLANT CELL, V7, P689, DOI 10.2307/3870172; PORRA RJ, 1989, BIOCHIM BIOPHYS ACTA, V975, P384, DOI 10.1016/S0005-2728(89)80347-0; RIPPKA R, 1979, J GEN MICROBIOL, V11, P419; SCHAGGER H, 1991, ANAL BIOCHEM, V199, P223, DOI 10.1016/0003-2697(91)90094-A; SHEN GZ, 1994, J BIOL CHEM, V269, P13904; Sobotka R, 2005, J BIOL CHEM, V280, P31595, DOI 10.1074/jbc.M505976200; Sobotka R, 2008, J BACTERIOL, V190, P2086, DOI 10.1128/JB.01678-07; SUSEK RE, 1993, CELL, V74, P787, DOI 10.1016/0092-8674(93)90459-4; Tous C, 2001, J BIOL CHEM, V276, P29059, DOI 10.1074/jbc.M103418200; Vavilin D, 2007, BBA-BIOENERGETICS, V1767, P920, DOI 10.1016/j.bbabio.2007.03.010; Vavilin DV, 2002, PHYSIOL PLANTARUM, V115, P9, DOI 10.1034/j.1399-3054.2002.1150102.x; Verdecia MA, 2005, PLOS BIOL, V3, P777, DOI 10.1371/journal.pbio.0030151; Wilde A, 2004, FEBS LETT, V571, P119, DOI 10.1016/j.febslet.2004.06.063; YANG HJ, 1995, P NATL ACAD SCI USA, V92, P7332, DOI 10.1073/pnas.92.16.7332	32	61	63	0	16	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	SEP 19	2008	283	38					25794	25802		10.1074/jbc.M803787200	http://dx.doi.org/10.1074/jbc.M803787200			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	348GX	18625715	hybrid, Green Published			2022-12-27	WOS:000259200100005
J	Borodina, I; Siebring, J; Zhang, J; Smith, CP; van Keulen, G; Dijkhuizen, L; Nielsen, J				Borodina, Irina; Siebring, Jeroen; Zhang, Jie; Smith, Colin P.; van Keulen, Geertje; Dijkhuizen, Lubbert; Nielsen, Jens			Antibiotic overproduction in Streptomyces coelicolor A3(2) mediated by phosphofructokinase deletion	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							MYCOBACTERIUM-TUBERCULOSIS H37RV; SECONDARY METABOLISM; ESCHERICHIA-COLI; SACCHAROMYCES-CEREVISIAE; GENOME SEQUENCE; MORPHOLOGICAL-DIFFERENTIATION; GLYCOLYTIC PATHWAY; LIVIDANS TK24; RECX GENE; IN-VIVO	Streptomycetes are exploited for production of a wide range of secondary metabolites, and there is much interest in enhancing the level of production of these metabolites. Secondary metabolites are synthesized in dedicated biosynthetic routes, but precursors and co-factors are derived from the primary metabolism. High level production of antibiotics in streptomycetes therefore requires engineering of the primary metabolism. Here we demonstrate this by targeting a key enzyme in glycolysis, phosphofructokinase, leading to improved antibiotic production in Streptomyces coelicolor A3(2). Deletion of pfkA2 (SCO5426), one of three annotated pfkA homologues in S. coelicolor A3(2), resulted in a higher production of the pigmented antibiotics actinorhodin and undecylprodigiosin. The pfkA2 deletion strain had an increased carbon flux through the pentose phosphate pathway, as measured by C-13 metabolic flux analysis, establishing the ATP-dependent PfkA2 as a key player in determining the carbon flux distribution. The increased pentose phosphate pathway flux appeared largely because of accumulation of glucose 6-phosphate and fructose 6-phosphate, as experimentally observed in the mutant strain. Through genome-scale metabolic model simulations, we predicted that decreased phosphofructokinase activity leads to an increase in pentose phosphate pathway flux and in flux to pigmented antibiotics and pyruvate. Integrated analysis of gene expression data using a genome-scale metabolic model further revealed transcriptional changes in genes encoding redox co-factor-dependent enzymes as well as those encoding pentose phosphate pathway enzymes and enzymes involved in storage carbohydrate biosynthesis.	[Borodina, Irina; Zhang, Jie; Nielsen, Jens] Tech Univ Denmark, BioCtr, Ctr Microbial Biotechnol, DK-2800 Lyngby, Denmark; [Siebring, Jeroen; Dijkhuizen, Lubbert] Univ Groningen, Dept Microbiol, Groningen Biotechnol & Biomol Sci Inst, NL-9750 AA Haren, Netherlands; [Smith, Colin P.] Univ Surrey, Fac Sci Hlth & Med Sci, Funct Genom Lab, Guildford GU2 7XH, Surrey, England; [van Keulen, Geertje] Univ Coll Swansea, Sch Environm & Soc, Swansea SA2 8PP, W Glam, Wales	Technical University of Denmark; University of Groningen; University of Surrey; Swansea University	Nielsen, J (corresponding author), Tech Univ Denmark, BioCtr, Ctr Microbial Biotechnol, DK-2800 Lyngby, Denmark.	jn@biocentrum.dtu.dk	Dijkhuizen, Lubbert/E-9454-2014; Dijkhuizen, Lubbert/K-3539-2019; Borodina, Irina/G-5587-2013; Smith, Colin/AAL-4507-2021; Nielsen, Jens/Q-1347-2017	Dijkhuizen, Lubbert/0000-0003-2312-7162; Nielsen, Jens/0000-0002-9955-6003; Borodina, Irina/0000-0002-8452-1393; Zhang, Jie/0000-0003-4119-9442	European Union 6FP ActinoGEN Project [LSHM-CT-2004-005224]; Biotechnology and Biological Sciences Research Council [G18886] Funding Source: researchfish	European Union 6FP ActinoGEN Project(European Commission); Biotechnology and Biological Sciences Research Council(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC))	This work was sponsored in part by European Union 6FP ActinoGEN Project (Contract LSHM-CT-2004-005224). The costs of publication of this article were defrayed in part by the payment of page charges. This article must therefore be hereby marked "advertisement" in accordance with 18 U. S. C. Section 1734 solely to indicate this fact.	Alper H, 2005, METAB ENG, V7, P155, DOI 10.1016/j.ymben.2004.12.003; Alper H, 2005, NAT BIOTECHNOL, V23, P612, DOI 10.1038/nbt1083; Alves AMCR, 1997, APPL ENVIRON MICROB, V63, P956, DOI 10.1128/AEM.63.3.956-961.1997; Bentley SD, 2002, NATURE, V417, P141, DOI 10.1038/417141a; Bibb MJ, 2005, CURR OPIN MICROBIOL, V8, P208, DOI 10.1016/j.mib.2005.02.016; Borodina I, 2005, GENOME RES, V15, P820, DOI 10.1101/gr.3364705; BRUTON CJ, 1995, MOL MICROBIOL, V18, P89, DOI 10.1111/j.1365-2958.1995.mmi_18010089.x; Butler MJ, 2002, APPL ENVIRON MICROB, V68, P4731, DOI 10.1128/AEM.68.10.4731-4739.2002; Bystrykh LV, 1996, J BACTERIOL, V178, P2238, DOI 10.1128/jb.178.8.2238-2244.1996; Camus JC, 2002, MICROBIOL-SGM, V148, P2967, DOI 10.1099/00221287-148-10-2967; Chouayekh H, 2002, MOL MICROBIOL, V43, P919, DOI 10.1046/j.1365-2958.2002.02557.x; Christensen B, 1999, METAB ENG, V1, P282, DOI 10.1006/mben.1999.0117; Cole ST, 1998, NOVART FDN SYMP, V217, P160, DOI 10.1002/0470846526.ch12; DAVIDSON A, 1992, THESIS U GLASGOW GLA; DEKONING W, 1992, ANAL BIOCHEM, V204, P118, DOI 10.1016/0003-2697(92)90149-2; Galvao CW, 2003, CAN J MICROBIOL, V49, P145, DOI [10.1139/w03-010, 10.1139/W03-010]; Ghorbel S, 2006, J BACTERIOL, V188, P677, DOI 10.1128/JB.188.2.677-686.2006; Ghorbel S, 2006, J BACTERIOL, V188, P6269, DOI 10.1128/JB.00202-06; Gunnarsson N, 2004, ADV BIOCHEM ENG BIOT, V88, P137, DOI 10.1007/b992690; Gust B, 2003, P NATL ACAD SCI USA, V100, P1541, DOI 10.1073/pnas.0337542100; HEATH EC, 1958, J BIOL CHEM, V231, P1009; HEINISCH J, 1986, CURR GENET, V11, P227, DOI 10.1007/BF00420611; Hesketh AR, 2002, MOL MICROBIOL, V46, P917, DOI 10.1046/j.1365-2958.2002.03219.x; Kalinowski J, 2003, J BIOTECHNOL, V104, P5, DOI 10.1016/S0168-1656(03)00154-8; Karandikar A, 1997, MICROBIOL-SGM, V143, P3581, DOI 10.1099/00221287-143-11-3581; Kerr MK, 2000, J COMPUT BIOL, V7, P819, DOI 10.1089/10665270050514954; Kieser T., 2000, PRACTICAL STREPTOMYC, P408; LAMPEN JO, 1951, J BACTERIOL, V61, P97, DOI 10.1128/JB.61.1.97-98.1951; LESSIE TG, 1972, J BACTERIOL, V110, P1107, DOI 10.1128/JB.110.3.1107-1117.1972; Li RF, 2006, METAB ENG, V8, P240, DOI 10.1016/j.ymben.2006.01.003; Meile L, 2001, J BACTERIOL, V183, P2929, DOI 10.1128/JB.183.9.2929-2936.2001; MORRIS DL, 1948, SCIENCE, V107, P254, DOI 10.1126/science.107.2775.254; Natsume R, 2003, ACTA CRYSTALLOGR D, V59, P2313, DOI 10.1107/S0907444903020766; OLUKOSHI ER, 1994, MICROBIOL-SGM, V140, P931, DOI 10.1099/00221287-140-4-931; OLUKOSHI ER, 1992, BIOCHEM SOC T, V20, P99; Onaka H, 1998, MOL MICROBIOL, V28, P743, DOI 10.1046/j.1365-2958.1998.00832.x; Orban JI, 2000, J MICROBIOL METH, V40, P221, DOI 10.1016/S0167-7012(00)00133-0; Packter NM, 1995, ARCH MICROBIOL, V164, P420, DOI 10.1007/BF02529740; Pages V, 2003, DNA REPAIR, V2, P273, DOI 10.1016/S1568-7864(02)00217-3; Paget MSB, 1998, EMBO J, V17, P5776, DOI 10.1093/emboj/17.19.5776; Patil KR, 2005, BMC BIOINFORMATICS, V6, DOI 10.1186/1471-2105-6-308; Patil KR, 2005, P NATL ACAD SCI USA, V102, P2685, DOI 10.1073/pnas.0406811102; Redenbach M, 1996, MOL MICROBIOL, V21, P77, DOI 10.1046/j.1365-2958.1996.6191336.x; ROLLIN C, 1995, EUR J BIOCHEM, V227, P488, DOI 10.1111/j.1432-1033.1995.tb20414.x; Rossa CA, 2002, METAB ENG, V4, P138, DOI 10.1006/mben.2001.0217; Ryu YG, 2006, APPL ENVIRON MICROB, V72, P7132, DOI 10.1128/AEM.01308-06; Segre D, 2002, P NATL ACAD SCI USA, V99, P15112, DOI 10.1073/pnas.232349399; Sheng DH, 2005, DNA REPAIR, V4, P671, DOI 10.1016/j.dnarep.2005.02.006; Sonderegger M, 2004, APPL ENVIRON MICROB, V70, P2892, DOI 10.1128/AEM.70.5.2892-2897.2004; Stohl EA, 2003, J BIOL CHEM, V278, P2278, DOI 10.1074/jbc.M210496200; Thompson JD, 1997, NUCLEIC ACIDS RES, V25, P4876, DOI 10.1093/nar/25.24.4876; TSAO SW, 1985, J ANTIBIOT, V38, P128, DOI 10.7164/antibiotics.38.128; van Keulen G, 2004, J MICROBIOL METH, V58, P139, DOI 10.1016/j.mimet.2004.03.014; Vierling S, 2000, J BACTERIOL, V182, P4005, DOI 10.1128/JB.182.14.4005-4011.2000; Vinciotti V, 2005, BIOINFORMATICS, V21, P492, DOI 10.1093/bioinformatics/bti022; VINING LC, 1992, GENE, V115, P135, DOI 10.1016/0378-1119(92)90551-Y; Viollier PH, 2001, J BACTERIOL, V183, P3193, DOI 10.1128/JB.183.10.3193-3203.2001; Viollier PH, 2001, J BACTERIOL, V183, P3184, DOI 10.1128/JB.183.10.3184-3192.2001; Wiechert W, 2001, METAB ENG, V3, P265, DOI 10.1006/mben.2001.0188; Wilson WA, 2002, MOL CELL PROTEOMICS, V1, P232, DOI 10.1074/mcp.M100024-MCP200; Wittmann C, 2004, ANAL BIOCHEM, V327, P135, DOI 10.1016/j.ab.2004.01.002; YANG YH, 2001, P SPIE, V4266	63	113	122	1	23	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	SEP 12	2008	283	37					25186	25199		10.1074/jbc.M803105200	http://dx.doi.org/10.1074/jbc.M803105200			14	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	345QZ	18606812	Green Submitted, hybrid, Green Published			2022-12-27	WOS:000259012700011
J	Carattino, MD; Hughey, RP; Kleyman, TR				Carattino, Marcelo D.; Hughey, Rebecca P.; Kleyman, Thomas R.			Proteolytic processing of the epithelial sodium channel gamma subunit has a dominant role in channel activation	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							NA+ CHANNELS; XENOPUS-OOCYTES; ELASTASE ACTIVATION; MEMBRANE TOPOLOGY; FURIN; ENAC; TRANSPORT; CLEAVAGE; PEPTIDE; MCAP2	Maturation of the epithelial sodium channel (ENaC) involves furin-dependent cleavage at two extracellular sites within the alpha subunit and at a single extracellular site within the gamma subunit. Channels lacking furin processing of the alpha subunit have very low activity. We recently identified a prostasin-dependent cleavage site (RKRK186) in the gamma subunit. We also demonstrated that the tract alpha D206-R231, between the two furin cleavage sites in the alpha subunit, as well as the tract gamma E144-K186, between the furin and prostasin cleavage sites in the gamma subunit, are inhibitory domains. ENaC cleavage by furin, and subsequently by prostasin, leads to a stepwise increase in the open probability of the channel as a result of release of the alpha and gamma subunit inhibitory tracts, respectively. We examined whether release of either the alpha or gamma inhibitory tract has a dominant role in activating the channel. Co-expression of prostasin and either wild type channels or mutant channels lacking furin cleavage of the alpha subunit (alpha R205A, R208A, R231A beta gamma) in Xenopus laevis oocytes led to increases in whole cell currents to similar levels. In an analogous manner and independent of the proteolytic processing of the alpha subunit, amiloride-sensitive currents in oocytes expressing channels carrying gamma subunits with both a mutation in the furin cleavage site and a deletion of the inhibitory tract (alpha beta gamma R143A, Delta E144-K186 and alpha R205A, R208A, R231A beta gamma R143A, Delta E144-K186) were significantly higher than those from oocytes expressing wild type ENaC. When channels lacked the alpha and gamma subunitinhibitorytracts, alpha subunitcleavage was required for channels to be fully active. Channels lacking both furin cleavage and the inhibitory tract in the gamma subunit(alpha beta gamma R143A, Delta E144-K186) showed a significant reduction in the efficacy of block by the synthetic alpha-26 inhibitory peptide representing the tract alpha D206-R231. Our data indicate that removal of the inhibitory tract from the gamma subunit, in the absence of alpha subunit cleavage, results in nearly full activation of the channel.	[Carattino, Marcelo D.; Hughey, Rebecca P.; Kleyman, Thomas R.] Univ Pittsburgh, Renal Electrolyte Div, Dept Med, Pittsburgh, PA 15261 USA; [Hughey, Rebecca P.; Kleyman, Thomas R.] Univ Pittsburgh, Dept Cell Biol & Physiol, Pittsburgh, PA 15261 USA	Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh	Hughey, RP (corresponding author), Univ Pittsburgh, Renal Electrolyte Div, Dept Med, S933 Scaife Hall, Pittsburgh, PA 15261 USA.	hugheyr@pitt.edu			National Institutes of Health [R01/R56 DK065161, P30 DK079307]; Cystic Fibrosis Foundation [R883CR02, Kleyma08P0]; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK065161, P30DK079307] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Cystic Fibrosis Foundation(Italian Cystic Fibrosis Research Foundation); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	This work was supported, in whole or in part, by National Institutes of Health Grants R01/R56 DK065161 and P30 DK079307. This work was also supported by the Cystic Fibrosis Foundation (R883CR02 and Kleyma08P0). The costs of publication of this article were defrayed in part by the payment of page charges. This article must therefore be hereby marked "advertisement" in accordance with 18 U. S. C. Section 1734 solely to indicate this fact.	Adams CM, 1997, J BIOL CHEM, V272, P27295, DOI 10.1074/jbc.272.43.27295; Adebamiro A, 2007, J GEN PHYSIOL, V130, P611, DOI 10.1085/jgp.200709781; Andreasen D, 2006, J AM SOC NEPHROL, V17, P968, DOI 10.1681/ASN.2005060637; Bruns JB, 2007, J BIOL CHEM, V282, P6153, DOI 10.1074/jbc.M610636200; Caldwell RA, 2005, AM J PHYSIOL-LUNG C, V288, pL813, DOI 10.1152/ajplung.00435.2004; Caldwell RA, 2004, AM J PHYSIOL-CELL PH, V286, pC190, DOI 10.1152/ajpcell.00342.2003; CANESSA CM, 1994, NATURE, V367, P463, DOI 10.1038/367463a0; Carattino MD, 2006, J BIOL CHEM, V281, P18901, DOI 10.1074/jbc.M604109200; Chraibi A, 1998, J GEN PHYSIOL, V111, P127, DOI 10.1085/jgp.111.1.127; Harris M, 2007, J BIOL CHEM, V282, P58, DOI 10.1074/jbc.M605125200; Hughey RP, 2004, J BIOL CHEM, V279, P48491, DOI 10.1074/jbc.C400460200; Hughey RP, 2004, J BIOL CHEM, V279, P18111, DOI 10.1074/jbc.C400080200; Jasti J, 2007, NATURE, V449, P316, DOI 10.1038/nature06163; Kabra R, 2008, J BIOL CHEM, V283, P6033, DOI 10.1074/jbc.M708555200; Picard N, 2008, J BIOL CHEM, V283, P4602, DOI 10.1074/jbc.M705664200; RENARD S, 1994, J BIOL CHEM, V269, P12981; Sheng S, 2006, AM J PHYSIOL-RENAL, V290, pF1488, DOI 10.1152/ajprenal.00439.2005; SNYDER PM, 1994, J BIOL CHEM, V269, P24379; Vallet V, 1997, NATURE, V389, P607, DOI 10.1038/39329; Vuagniaux G, 2002, J GEN PHYSIOL, V120, P191, DOI 10.1085/jgp.20028598	20	96	99	0	1	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	SEP 12	2008	283	37					25290	25295		10.1074/jbc.M803931200	http://dx.doi.org/10.1074/jbc.M803931200			6	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	345QZ	18650438	Green Published, hybrid			2022-12-27	WOS:000259012700022
J	Nieto, FL; Pescio, LG; Favale, NO; Adamo, AM; Sterin-Speziale, NB				Nieto, Francisco Leocata; Pescio, Lucila G.; Favale, Nicolas O.; Adamo, Ana M.; Sterin-Speziale, Norma B.			Sphingolipid metabolism is a crucial determinant of cellular fate in nonstimulated proliferating Madin-Darby canine kidney (MDCK) cells	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							SERINE PALMITOYLTRANSFERASE; SPHINGOSINE KINASE; INDUCED APOPTOSIS; CERAMIDE; SPHINGOSINE-1-PHOSPHATE; PATHWAY; DIFFERENTIATION; BIOSYNTHESIS; 1-PHOSPHATE; INHIBITION	The present report was addressed to study the influence of sphingolipid metabolism in determining cellular fate. In non-stimulated proliferating Madin-Darby canine kidney ( MDCK) cells, sphingolipid de novo synthesis is branched mainly to a production of sphingomyelin and ceramide, with a minor production of sphingosylphosphocholine, ceramide 1-phosphate, and sphingosine 1-phosphate. Experiments with P-32 as a radioactive precursor showed that sphingosine 1-phosphate is produced mainly by a de novo independent pathway. Enzymatic inhibition of the de novo pathway and ceramide synthesis affected cell number and viability only slightly, without changing sphingosine 1-phosphate production. By contrast, inhibition of sphingosine kinase-1 activity provoked a significant reduction in both cell number and viability in a dose-dependent manner. When sphingolipid metabolism was studied, an increase in de novo formed ceramide was found, which correlated with the concentration of enzyme inhibitor and the reduction in cell number and viability. Knockdown of sphingosine kinase-1 expression also induced an accumulation of de novo synthesized ceramide, provoking a slight reduction in cell number and viability similar to that induced by a low concentration of the sphingosine kinase inhibitor. Taken together, our results indicate that the level of de novo formed ceramide is controlled by the synthesis of sphingosine 1-phosphate, which appears to occur through a de novo synthesis-independent pathway, most probably the salvage pathway, that is responsible for the MDCK cell fate, suggesting that under proliferating conditions, a dynamic interplay exists between the de novo synthesis and the salvage pathway.	[Nieto, Francisco Leocata; Pescio, Lucila G.; Favale, Nicolas O.; Sterin-Speziale, Norma B.] Univ Buenos Aires, Dept Cell Biol, Sch Pharm & Biochem, RA-1113 Buenos Aires, DF, Argentina; [Nieto, Francisco Leocata; Pescio, Lucila G.; Favale, Nicolas O.; Adamo, Ana M.; Sterin-Speziale, Norma B.] Consejo Nacl Invest Cient & Tecn, Inst Quim & Fisioquim Biol, Buenos Aires, DF, Argentina; [Nieto, Francisco Leocata; Pescio, Lucila G.; Favale, Nicolas O.; Sterin-Speziale, Norma B.] Univ Buenos Aires, Dept Biol Chem, Sch Pharm & Biochem, RA-1113 Buenos Aires, DF, Argentina	University of Buenos Aires; Consejo Nacional de Investigaciones Cientificas y Tecnicas (CONICET); University of Buenos Aires	Sterin-Speziale, NB (corresponding author), Univ Buenos Aires, Dept Cell Biol, Sch Pharm & Biochem, Junin 956,1er Piso, RA-1113 Buenos Aires, DF, Argentina.	speziale@ffyb.uba.ar	Adamo, Ana M/U-7961-2019		University of Buenos Aires [UBACyT TB068]; Conseyo Nacional de Investigaciones Cientificas y Tecnicas (CONICET) [PIP 5557]; Agencia Nacional de Promocion Cientifica y Tecnologica [PICT 33154]	University of Buenos Aires(University of Buenos Aires); Conseyo Nacional de Investigaciones Cientificas y Tecnicas (CONICET)(Consejo Nacional de Investigaciones Cientificas y Tecnicas (CONICET)); Agencia Nacional de Promocion Cientifica y Tecnologica(ANPCyT)	This work was supported by Grants UBACyT TB068 from the University of Buenos Aires, PIP 5557 from Conseyo Nacional de Investigaciones Cientificas y Tecnicas (CONICET), and PICT 33154 from Agencia Nacional de Promocion Cientifica y Tecnologica. The costs of publication of this article were defrayed in part by the payment of page charges. This article must therefore be hereby marked "advertisement" in accordance with 18 U. S. C. Section 1734 solely to indicate this fact.	Cuvillier O, 2002, BBA-MOL CELL BIOL L, V1585, P153, DOI 10.1016/S1388-1981(02)00336-0; DBAIBO GS, 1995, P NATL ACAD SCI USA, V92, P1347, DOI 10.1073/pnas.92.5.1347; Edsall L, 2000, METHOD ENZYMOL, V312, P9; Facchinetti MM, 2003, BIOL NEONATE, V84, P243, DOI 10.1159/000072308; Furuya S, 1998, J NEUROCHEM, V71, P366; Futerman AH, 2004, EMBO REP, V5, P777, DOI 10.1038/sj.embor.7400208; Gomez-Munoz A, 2005, FEBS LETT, V579, P3744, DOI 10.1016/j.febslet.2005.05.067; Hanada K, 2003, BBA-MOL CELL BIOL L, V1632, P16, DOI 10.1016/S1388-1981(03)00059-3; Hannun YA, 2002, J BIOL CHEM, V277, P25847, DOI 10.1074/jbc.R200008200; Hannun YA, 2000, TRENDS CELL BIOL, V10, P73, DOI 10.1016/S0962-8924(99)01694-3; Jung EM, 1998, J INVEST DERMATOL, V110, P318, DOI 10.1046/j.1523-1747.1998.00137.x; Kitatani K, 2008, CELL SIGNAL, V20, P1010, DOI 10.1016/j.cellsig.2007.12.006; Kolesnick R, 1999, TRENDS BIOCHEM SCI, V24, P224, DOI 10.1016/S0968-0004(99)01408-5; Laviad EL, 2008, J BIOL CHEM, V283, P5677, DOI 10.1074/jbc.M707386200; Le Stunff H, 2002, J CELL BIOL, V158, P1039, DOI 10.1083/jcb.200203123; Lee JY, 1998, BIOCHEM J, V334, P457, DOI 10.1042/bj3340457; LOWRY OH, 1951, J BIOL CHEM, V193, P265; Maceyka M, 2002, BBA-MOL CELL BIOL L, V1585, P193, DOI 10.1016/S1388-1981(02)00341-4; MERRILL AH, 1985, J LIPID RES, V26, P617; Ogretmen B, 2004, NAT REV CANCER, V4, P604, DOI 10.1038/nrc1411; OLIVERA A, 1993, NATURE, V365, P557, DOI 10.1038/365557a0; Olivera A, 2000, METHOD ENZYMOL, V311, P215; Perry DK, 2000, J BIOL CHEM, V275, P9078, DOI 10.1074/jbc.275.12.9078; Perry DK, 2000, METHOD ENZYMOL, V312, P22; Signorelli P, 2002, METHOD ENZYMOL, V345, P275; Spiegel S, 2003, NAT REV MOL CELL BIO, V4, P397, DOI 10.1038/nrm1103; Taha TA, 2005, FASEB J, V19, P482, DOI 10.1096/fj.05-4412fje; Uchida Y, 2003, J INVEST DERMATOL, V120, P662, DOI 10.1046/j.1523-1747.2003.12098.x; vanEchtenDeckert G, 1997, J BIOL CHEM, V272, P15825, DOI 10.1074/jbc.272.25.15825; Venable ME, 1995, J BIOL CHEM, V270, P30701, DOI 10.1074/jbc.270.51.30701; WANG E, 1991, J BIOL CHEM, V266, P14486; Zheng W, 2006, BBA-BIOMEMBRANES, V1758, P1864, DOI 10.1016/j.bbamem.2006.08.009; Zhu XF, 2003, CANCER LETT, V193, P149, DOI 10.1016/S0304-3835(03)00050-8	33	9	9	0	6	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	SEP 12	2008	283	37					25682	25691		10.1074/jbc.M804437200	http://dx.doi.org/10.1074/jbc.M804437200			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	345QZ	18625703	hybrid			2022-12-27	WOS:000259012700063
J	Cox, JM; Li, H; Wood, EA; Chitteni-Pattu, S; Inman, RB; Cox, MM				Cox, Julia M.; Li, Hao; Wood, Elizabeth A.; Chitteni-Pattu, Sindhu; Inman, Ross B.; Cox, Michael M.			Defective dissociation of a "Slow" RecA mutant protein imparts an Escherichia coli growth defect	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							DNA STRAND EXCHANGE; ATP HYDROLYSIS; CRYSTAL-STRUCTURE; REPLICATION FORKS; NUCLEOSIDE TRIPHOSPHATE; GENETIC-RECOMBINATION; BINDING-PROTEIN; NTP HYDROLYSIS; IN-VIVO; REPAIR	The RecA and some related proteins possess a simple motif, called (KR)X(KR), that ( in RecA) consists of two lysine residues at positions 248 and 250 at the subunit-subunit interface. This study and previous work implicate this RecA motif in the following: (a)catalyzing ATP hydrolysis in trans, (b) coordinating the ATP hydrolytic cycles of adjacent subunits, ( c) governing the rate of ATP hydrolysis, and (d) coupling the ATP hydrolysis to work ( in this case DNA strand exchange). The conservative K250R mutation leaves RecA nucleoprotein filament formation largely intact. However, ATP hydrolysis is slowed to less than 15% of the wild-type rate. DNA strand exchange is also slowed commensurate with the rate of ATP hydrolysis. The results reinforce the idea of a tight coupling between ATP hydrolysis and DNA strand exchange. When a plasmid-borne RecA K250R protein is expressed in a cell otherwise lacking RecA protein, the growth of the cells is severely curtailed. The slow growth defect is alleviated in cells lacking RecFOR function, suggesting that the defect reflects loading of RecA at stalled replication forks. Suppressors occur as recA gene alterations, and their properties indicate that limited dissociation by RecA K250R confers the slow growth phenotype. Overall, the results suggest that recombinational DNA repair is a common occurrence in cells. RecA protein plays a sufficiently intimate role in the bacterial cell cycle that its properties can limit the growth rate of a bacterial culture.	[Cox, Julia M.; Li, Hao; Wood, Elizabeth A.; Chitteni-Pattu, Sindhu; Inman, Ross B.; Cox, Michael M.] Univ Wisconsin, Dept Biochem, Madison, WI 53706 USA	University of Wisconsin System; University of Wisconsin Madison	Cox, JM (corresponding author), Univ Wisconsin, Dept Biochem, 433 Babcock Dr, Madison, WI 53706 USA.	cox@biochem.wisc.edu	Li, Hao/AAS-9804-2020	Li, Hao/0000-0002-6652-4793	National Institutes of Health [GM32335]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM032335] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported, in whole or in part, by National Institutes of Health Grant GM32335. The costs of publication of this article were defrayed in part by the payment of page charges. This article must therefore be hereby marked "advertisement" in accordance with 18 U. S. C. Section 1734 solely to indicate this fact.	Anderson DG, 1999, J BIOL CHEM, V274, P27139, DOI 10.1074/jbc.274.38.27139; Arnold DA, 2000, J BIOL CHEM, V275, P12261, DOI 10.1074/jbc.275.16.12261; Bedale WA, 1996, J BIOL CHEM, V271, P5725, DOI 10.1074/jbc.271.10.5725; BRENNER SL, 1987, J BIOL CHEM, V262, P4011; Campbell MJ, 1999, J MOL BIOL, V286, P437, DOI 10.1006/jmbi.1998.2457; Campbell MJ, 1999, J MOL BIOL, V286, P417, DOI 10.1006/jmbi.1998.2456; Chen ZC, 2008, NATURE, V453, P489, DOI 10.1038/nature06971; Churchill JJ, 2000, J MOL BIOL, V297, P537, DOI 10.1006/jmbi.2000.3590; Conway AB, 2004, NAT STRUCT MOL BIOL, V11, P791, DOI 10.1038/nsmb795; Cox JM, 2006, J BIOL CHEM, V281, P12968, DOI 10.1074/jbc.M513736200; Cox JM, 2005, PLOS BIOL, V3, P231, DOI 10.1371/journal.pbio.0030052; Cox M.M., 2007, TOPICS CURRENT GENET, P53; Cox Michael M., 2005, P369; Cox MM, 2007, CRIT REV BIOCHEM MOL, V42, P41, DOI 10.1080/10409230701260258; Cox MM, 2007, NAT REV MOL CELL BIO, V8, P127, DOI 10.1038/nrm2099; Cox MM, 2000, NATURE, V404, P37, DOI 10.1038/35003501; Cox MM, 2003, ANNU REV MICROBIOL, V57, P551, DOI 10.1146/annurev.micro.57.030502.090953; Cox MM, 2001, P NATL ACAD SCI USA, V98, P8173, DOI 10.1073/pnas.131004998; CRAIG NL, 1981, J BIOL CHEM, V256, P8039; Crampton DJ, 2004, P NATL ACAD SCI USA, V101, P4373, DOI 10.1073/pnas.0400968101; Drees JC, 2004, MOL CELL, V15, P789, DOI 10.1016/j.molcel.2004.08.026; Haruta N, 2003, J BIOL CHEM, V278, P52710, DOI 10.1074/jbc.M308563200; Heller RC, 2006, NATURE, V439, P557, DOI 10.1038/nature04329; Hobbs MD, 2007, J BIOL CHEM, V282, P11058, DOI 10.1074/jbc.M611007200; JAIN SK, 1994, J BIOL CHEM, V269, P20653; KIM JI, 1992, J BIOL CHEM, V267, P16444; KIM JI, 1992, J BIOL CHEM, V267, P16438; Kowalczykowski SC, 2000, TRENDS BIOCHEM SCI, V25, P156, DOI 10.1016/S0968-0004(00)01569-3; Kuzminov A, 1999, MICROBIOL MOL BIOL R, V63, P751, DOI 10.1128/MMBR.63.4.751-813.1999; Leipe DD, 2000, GENOME RES, V10, P5; LINDSLEY JE, 1990, J BIOL CHEM, V265, P9043; LOHMAN TM, 1985, J BIOL CHEM, V260, P3594; Lusetti SL, 2002, ANNU REV BIOCHEM, V71, P71, DOI 10.1146/annurev.biochem.71.083101.133940; Lusetti SL, 2003, J BIOL CHEM, V278, P16372, DOI 10.1074/jbc.M212917200; MacFarland KJ, 1997, J BIOL CHEM, V272, P17675, DOI 10.1074/jbc.272.28.17675; Michel B, 2004, P NATL ACAD SCI USA, V101, P12783, DOI 10.1073/pnas.0401586101; Michel B, 2001, P NATL ACAD SCI USA, V98, P8181, DOI 10.1073/pnas.111008798; Michel B, 2007, DNA REPAIR, V6, P967, DOI 10.1016/j.dnarep.2007.02.016; Morimatsu K, 2003, MOL CELL, V11, P1337, DOI 10.1016/S1097-2765(03)00188-6; MORRICAL SW, 1986, BIOCHEMISTRY-US, V25, P1482, DOI 10.1021/bi00355a003; Nayak S, 1999, J BIOL CHEM, V274, P25979, DOI 10.1074/jbc.274.37.25979; NEUENDORF SK, 1986, J BIOL CHEM, V261, P8276; NGUYEN TT, 1993, J BIOL CHEM, V268, P3107; Pennington JM, 2007, NAT GENET, V39, P797, DOI 10.1038/ng2051; REHRAUER WM, 1993, J BIOL CHEM, V268, P1292; Robu ME, 2004, J BIOL CHEM, V279, P10973, DOI 10.1074/jbc.M312184200; Robu ME, 2001, P NATL ACAD SCI USA, V98, P8211, DOI 10.1073/pnas.131022698; Rothstein R, 2000, GENE DEV, V14, P1; Rudolph CJ, 2007, GENE DEV, V21, P668, DOI 10.1101/gad.417607; Sawaya MR, 1999, CELL, V99, P167, DOI 10.1016/S0092-8674(00)81648-7; Scheffzek K, 1996, NATURE, V384, P591, DOI 10.1038/384591a0; Schlacher K, 2006, NATURE, V442, P883, DOI 10.1038/nature05042; Schnos M, 2000, MOL BIOTECHNOL, V16, P77, DOI 10.1385/MB:16:1:77; SCHUTTE BC, 1987, BIOCHEMISTRY-US, V26, P5616, DOI 10.1021/bi00392a006; Shan Q, 1997, J MOL BIOL, V265, P519, DOI 10.1006/jmbi.1996.0748; Shan Q, 1997, J BIOL CHEM, V272, P11063; Shan Q, 1998, MOL CELL, V1, P309, DOI 10.1016/S1097-2765(00)80031-3; Shan Q, 1996, J BIOL CHEM, V271, P5712, DOI 10.1074/jbc.271.10.5712; Singleton MR, 2000, CELL, V101, P589, DOI 10.1016/S0092-8674(00)80871-5; Spies M, 2006, MOL CELL, V21, P573, DOI 10.1016/j.molcel.2006.01.007; STORY RM, 1992, NATURE, V355, P374, DOI 10.1038/355374a0; STORY RM, 1992, NATURE, V355, P318, DOI 10.1038/355318a0; UMEZU K, 1994, J BIOL CHEM, V269, P30005; UZEST M, 1995, MOL MICROBIOL, V17, P1177, DOI 10.1111/j.1365-2958.1995.mmi_17061177.x; VanLoock MS, 2003, STRUCTURE, V11, P187, DOI 10.1016/S0969-2126(03)00003-0; Vilenchik MM, 2003, P NATL ACAD SCI USA, V100, P12871, DOI 10.1073/pnas.2135498100; Wu Y, 2004, MOL CELL, V15, P423, DOI 10.1016/j.molcel.2004.07.014; Ye JQ, 2004, BBA-BIOENERGETICS, V1659, P1, DOI 10.1016/j.bbabio.2004.06.003	68	17	17	0	6	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	SEP 5	2008	283	36					24909	24921		10.1074/jbc.M803934200	http://dx.doi.org/10.1074/jbc.M803934200			13	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	342YR	18603529	Green Published, hybrid			2022-12-27	WOS:000258820000054
J	Dordelmann, C; Telgmann, R; Brand, E; Hagedorn, C; Schroer, B; Hasenkamp, S; Baumgart, P; Kleine-Katthofer, P; Paul, M; Brand-Herrmann, SM				Doerdelmann, Corinna; Telgmann, Ralph; Brand, Eva; Hagedorn, Claudia; Schroeer, Bianca; Hasenkamp, Sandra; Baumgart, Peter; Kleine-Katthoefer, Peter; Paul, Martin; Brand-Herrmann, Stefan-Martin			Functional and structural profiling of the human thrombopoietin gene promoter	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							CHROMOSOMAL LOCALIZATION; TRANSCRIPTION FACTOR; EXPRESSION; BINDING; CELLS; ASSOCIATION; MECHANISM; PROTEINS; DISEASES; CLONING	Human thrombopoietin (TPO) is involved in cardiovascular disease as it regulates megakaryocyte development and enhances platelet adhesion/aggregation. The THPO promoter structure is still controversial. By reverse transcription-PCR, we confirm that THPO transcription is cell line-dependently initiated at two alternative promoters, which we newly designated P1a and P1. We subsequently electrophoretically scanned and resequenced these portions in 95 and 57 patients with cardiovascular disease, respectively, and identified seven variants (-1450/del58bp, C-920T [rs2855306], A-622G, C-413T [rs885838], C+ 5A, G+ 115A, and C+ 135T). After subcloning of 1032 bp of THPO P1 in pGL3-basic vector, five molecular haplotypes (MolHaps1-5) were observed: [A(-622)-C-413-C+5-G(+115); wild type (wt)], [A(-622)-T-413-C+5-G(+115)], [G(-622)-T-413-C+5-G(+115)], [A(-622)-C-413-A(+5)-G(-115)], [A(-622)-C-413-C+5-A(+115)], and analyzed in reporter gene assays in HEK293T and HepG2 cells. MolHaps 2, 4, and 5 were significantly more active than wt (all p values <= 0.01) in HEK293T cells, MolHap3 exerted a substantial loss of promoter activity (p < 0.0001 in HEK293T and p < 0.01 in HepG2, compared with wt). Electrophoretic mobility shift assays revealed that A-622G and C-413T individually differed from MolHaps in their DNA-protein interaction patterns. Supershift and chromatin immunoprecipitation assays identified CCAAT/enhancer-binding protein delta as the binding protein exclusively for the -622A allelic portion.	[Doerdelmann, Corinna; Telgmann, Ralph; Hagedorn, Claudia; Schroeer, Bianca; Brand-Herrmann, Stefan-Martin] Univ Munster, Dept Mol Genet Cardiovasc Dis, Leibniz Inst Arteriosclerosis Res, D-48149 Munster, Germany; [Brand, Eva; Hasenkamp, Sandra] Univ Hosp Munster, Dept Internal Med Nephrol & Hypertens, D-48149 Munster, Germany; [Baumgart, Peter] Clemenshosp GmbH Munster, D-48145 Munster, Germany; [Kleine-Katthoefer, Peter] St Franziskus Hosp Munster, D-48145 Munster, Germany; [Paul, Martin] Charite Univ Med Berlin, Inst Clin Pharmacol & Toxicol, D-10117 Berlin, Germany	University of Munster; University of Munster; St. Franziskus-Hospital; Free University of Berlin; Humboldt University of Berlin; Charite Universitatsmedizin Berlin	Brand-Herrmann, SM (corresponding author), Univ Munster, Dept Mol Genet Cardiovasc Dis, Leibniz Inst Arteriosclerosis Res, Domagkstr 3, D-48149 Munster, Germany.	brandher@unimuenster.de			German Ministry for Education and Science (BMBF); National Genome Research Network for Cardiovascular Disease; Bio-Profile-Project [BMBF 0313040C]; European Union Project Network of Excellence [FP6-2005-LIFESCI-HEALTH-6]; InGenious HyperCare [037093]; Information and Communication Technologies (ICT) [FP7-ICT-2007-2, 224635]; Virtual Pathological Heart of the Virtual Physiological Human [VPH2]	German Ministry for Education and Science (BMBF)(Federal Ministry of Education & Research (BMBF)); National Genome Research Network for Cardiovascular Disease; Bio-Profile-Project; European Union Project Network of Excellence(European Commission); InGenious HyperCare(European Commission); Information and Communication Technologies (ICT); Virtual Pathological Heart of the Virtual Physiological Human	This work has been supported by grants from the German Ministry for Education and Science (BMBF; to M. P. in the National Genome Research Network for Cardiovascular Disease and to E. B., S.-M. B.-H., and R. T. in Bio-Profile-Project BMBF 0313040C). This study was also supported by European Union Project Network of Excellence Grant FP6-2005-LIFESCI-HEALTH-6, Integrating Genomics, Clinical Research and Care in Hypertension, InGenious HyperCare proposal 037093 (to E. B. and S.-M. B.-H. (support of R. T.), and an Information and Communication Technologies (ICT) in FP7-ICT-2007-2, project 224635, VPH2 (Virtual Pathological Heart of the Virtual Physiological Human; S.-M. B.-H.).	Anderson MK, 2001, P NATL ACAD SCI USA, V98, P553, DOI 10.1073/pnas.021478998; Boyd KE, 1998, P NATL ACAD SCI USA, V95, P13887, DOI 10.1073/pnas.95.23.13887; Burton PR, 2007, NATURE, V447, P661, DOI 10.1038/nature05911; CAMBIEN F, 1992, NATURE, V359, P641, DOI 10.1038/359641a0; CAO ZD, 1991, GENE DEV, V5, P1538, DOI 10.1101/gad.5.9.1538; CHANG MS, 1995, J BIOL CHEM, V270, P511, DOI 10.1074/jbc.270.2.511; Cotton JM, 2003, THROMB HAEMOSTASIS, V89, P538, DOI 10.1055/s-0037-1613385; DIMATTIA GE, 1990, J BIOL CHEM, V265, P16412; FOSTER DC, 1994, P NATL ACAD SCI USA, V91, P13023, DOI 10.1073/pnas.91.26.13023; GARDINERGARDEN M, 1987, J MOL BIOL, V196, P261, DOI 10.1016/0022-2836(87)90689-9; Garner C, 2006, EUR J HUM GENET, V14, P101, DOI 10.1038/sj.ejhg.5201499; GELLERSEN B, 1994, MOL ENDOCRINOL, V8, P356, DOI 10.1210/me.8.3.356; Ghilardi N, 1998, BLOOD, V92, P4023, DOI 10.1182/blood.V92.11.4023.423k54_4023_4030; Grabe N., 2002, SILICO BIOL, V2, P1; GREVIN D, 1993, INT J DEV BIOL, V37, P519; Herrmann SM, 2001, ARTERIOSCL THROM VAS, V21, P1538, DOI 10.1161/hq0901.095555; Kamura T, 1997, J BIOL CHEM, V272, P11361; Kaushansky K, 2005, J CLIN INVEST, V115, P3339, DOI 10.1172/JCI26674; Kaushansky K, 1998, NEW ENGL J MED, V339, P746, DOI 10.1056/NEJM199809103391107; Kojima H, 2001, EXP HEMATOL, V29, P616, DOI 10.1016/S0301-472X(01)00623-3; Liu SH, 2000, J BIOL CHEM, V275, P41364, DOI 10.1074/jbc.M004172200; MAEKAWA T, 1989, EMBO J, V8, P2023, DOI 10.1002/j.1460-2075.1989.tb03610.x; McPherson R, 2007, SCIENCE, V316, P1488, DOI 10.1126/science.1142447; MILLER SA, 1988, NUCLEIC ACIDS RES, V16, P1215, DOI 10.1093/nar/16.3.1215; Murone MM, 1998, STEM CELLS, V16, P1, DOI 10.1002/stem.160001; Oda A, 1996, BLOOD, V87, P4664, DOI 10.1182/blood.V87.11.4664.bloodjournal87114664; Pasquet JM, 2000, BLOOD, V95, P3429, DOI 10.1182/blood.V95.11.3429.011k22_3429_3434; SCHREIBER E, 1989, NUCLEIC ACIDS RES, V17, P6419, DOI 10.1093/nar/17.15.6419; SOHMA Y, 1994, FEBS LETT, V353, P57, DOI 10.1016/0014-5793(94)01008-0; Sungaran R, 1997, BLOOD, V89, P101, DOI 10.1182/blood.V89.1.101; van Os E, 2003, BRIT J HAEMATOL, V121, P482, DOI 10.1046/j.1365-2141.2003.04292.x; Wiestner A, 1998, NAT GENET, V18, P49, DOI 10.1038/ng0198-49	32	8	8	0	4	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	SEP 5	2008	283	36					24382	24391		10.1074/jbc.M802198200	http://dx.doi.org/10.1074/jbc.M802198200			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	342YR	18617523	Green Published, hybrid			2022-12-27	WOS:000258820000012
J	Kaufmann, AM; Krise, JP				Kaufmann, Allyn M.; Krise, Jeffrey P.			Niemann-Pick C1 functions in regulating lysosomal amine content	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							LIPOPROTEIN-DERIVED CHOLESTEROL; HAMSTER OVARY CELLS; DISEASE-TYPE-C; INTRACELLULAR-TRANSPORT; GANGLIOSIDE STORAGE; POLYAMINE TRANSPORT; ALDEHYDE LOAD; LIVING CELLS; PROTEIN; ACCUMULATION	Mutations in the late endosomal/lysosomal membrane protein Niemann-Pick C1 (NPC1) are known to cause a generalized block in retrograde vesicle-mediated transport, resulting in the hyper-accumulation of multiple lysosomal cargos. An important, yet often overlooked, category of lysosomal cargo includes the vast array of small molecular weight amine-containing molecules that are substrates for ion trapping in the highly acidic organelle lumen. We show here that the introduction of amine-containing molecules in lysosomes can significantly stimulate NPC1-mediated late endosome/lysosome fusion, and subsequently the secretion of lysosomal cargo. To illustrate the physiological importance of this NPC1-mediated transport pathway, we show that NPC1-deficient cells are more susceptible to the toxic effects of a lysosomotropic polyamine metabolite 3-aminopropanal. Moreover, NPC fibroblasts are shown to have higher levels of polyamine oxidase, an enzyme involved in the formation of 3-aminopropanal. Collectively, these findings provide strong support for a novel functional role for NPC1 and may also provide clues toward understanding NPC disease progression.	[Kaufmann, Allyn M.; Krise, Jeffrey P.] Univ Kansas, Dept Pharmaceut Chem, Sch Pharm, Lawrence, KS 66047 USA	University of Kansas	Krise, JP (corresponding author), Univ Kansas, Dept Pharmaceut Chem, Sch Pharm, 2095 Constant Ave, Lawrence, KS 66047 USA.	krise@ku.edu			NATIONAL CANCER INSTITUTE [R01CA106655] Funding Source: NIH RePORTER; NCI NIH HHS [R01 CA106655] Funding Source: Medline	NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))		Andrews N. W., 2005, SCI STKE, ppe19; Andrews NW, 2000, TRENDS CELL BIOL, V10, P316, DOI 10.1016/S0962-8924(00)01794-3; BACHRACH U, 1966, ANAL BIOCHEM, V17, P38, DOI 10.1016/0003-2697(66)90005-4; Bernstein HG, 1999, PROG NEUROBIOL, V57, P485, DOI 10.1016/S0301-0082(98)00065-3; BOLHUIS PA, 1987, NEUROLOGY, V37, P75, DOI 10.1212/WNL.37.1.75; Bright NA, 2005, CURR BIOL, V15, P360, DOI 10.1016/j.cub.2005.01.049; Bright NA, 2001, TRAFFIC, V2, P631, DOI 10.1034/j.1600-0854.2001.20906.x; BULYCHEV A, 1978, EXP CELL RES, V115, P343, DOI 10.1016/0014-4827(78)90288-4; Chen CS, 1998, P NATL ACAD SCI USA, V95, P6373, DOI 10.1073/pnas.95.11.6373; Cullis PM, 1999, CHEM BIOL, V6, P717, DOI 10.1016/S1074-5521(00)80019-8; Dai HQ, 1999, CANCER RES, V59, P4944; Davies JP, 2000, SCIENCE, V290, P2295, DOI 10.1126/science.290.5500.2295; DAVIS BA, 1989, J CHROMATOGR, V466, P89, DOI 10.1016/S0021-9673(01)84617-3; DEDUVE C, 1974, BIOCHEM PHARMACOL, V23, P2495, DOI 10.1016/0006-2952(74)90174-9; Diettrich O, 1998, FEBS LETT, V441, P369, DOI 10.1016/S0014-5793(98)01578-6; Duvvuri M, 2005, BIOCHEMISTRY-US, V44, P15743, DOI 10.1021/bi051759w; Duvvuri M, 2004, J BIOL CHEM, V279, P32367, DOI 10.1074/jbc.M400735200; Duvvuri M, 2004, PHARM RES-DORDR, V21, P26, DOI 10.1023/B:PHAM.0000012148.12516.3f; Duvvuri M, 2005, MOL PHARMACEUT, V2, P440, DOI 10.1021/mp050043s; Erickson RP, 2000, J INHERIT METAB DIS, V23, P54, DOI 10.1023/A:1005650930330; Ferri KF, 2001, NAT CELL BIOL, V3, pE255, DOI 10.1038/ncb1101-e255; FINNIN BC, 1969, J PHARM PHARMACOL, V21, P114, DOI 10.1111/j.2042-7158.1969.tb08207.x; Ganley IG, 2006, J BIOL CHEM, V281, P17890, DOI 10.1074/jbc.M601679200; Garver William S., 2002, Current Molecular Medicine (Hilversum), V2, P485, DOI 10.2174/1566524023362375; GOLDIN E, 1992, BIOCHIM BIOPHYS ACTA, V1127, P303, DOI 10.1016/0005-2760(92)90236-O; Gong YP, 2006, J PHARMACOL EXP THER, V316, P242, DOI 10.1124/jpet.105.089482; Griffiths G, 2002, SEMIN CELL DEV BIOL, V13, P279, DOI 10.1016/S1084-9521(02)00057-5; Ioannou YA, 2005, TRENDS BIOCHEM SCI, V30, P498, DOI 10.1016/j.tibs.2005.07.007; Ivanova S, 1998, J EXP MED, V188, P327, DOI 10.1084/jem.188.2.327; JAHRAUS A, 1994, J CELL SCI, V107, P145; Janne J, 2004, EUR J BIOCHEM, V271, P877, DOI 10.1111/j.1432-1033.2004.04009.x; Ko DC, 2001, MOL BIOL CELL, V12, P601, DOI 10.1091/mbc.12.3.601; Konig G, 2008, MONATSH CHEM, V139, P401, DOI 10.1007/s00706-007-0819-7; LISCUM L, 1990, BIOCHIM BIOPHYS ACTA, V1045, P40, DOI 10.1016/0005-2760(90)90201-8; LISCUM L, 1989, J BIOL CHEM, V264, P11796; Liu YJ, 2000, HUM MOL GENET, V9, P1087, DOI 10.1093/hmg/9.7.1087; Luzio JP, 2007, NAT REV MOL CELL BIO, V8, P622, DOI 10.1038/nrm2217; Luzio JP, 2003, MOL MEMBR BIOL, V20, P141, DOI 10.1080/0968768031000089546; Masuko T, 2003, J NEUROCHEM, V84, P610, DOI 10.1046/j.1471-4159.2003.01558.x; Morissette G, 2004, J PHARMACOL EXP THER, V310, P395, DOI 10.1124/jpet.104.066084; MORRISON LD, 1995, NEUROSCI LETT, V197, P5, DOI 10.1016/0304-3940(95)11881-V; Mukhejee S, 2004, BBA-MOL CELL BIOL L, V1685, P28, DOI 10.1016/j.bbalip.2004.08.009; Neufeld EB, 1999, J BIOL CHEM, V274, P9627, DOI 10.1074/jbc.274.14.9627; OHKUMA S, 1978, P NATL ACAD SCI USA, V75, P3327, DOI 10.1073/pnas.75.7.3327; Passeggio J, 2005, J BIOL CHEM, V280, P10333, DOI 10.1074/jbc.M413657200; Patterson MC, 2004, BBA-MOL CELL BIOL L, V1685, P77, DOI 10.1016/j.bbalip.2004.08.013; PATTERSON MC, 1993, NEUROLOGY, V43, P61, DOI 10.1212/WNL.43.1_Part_1.61; Pentchev PG, 2004, BBA-MOL CELL BIOL L, V1685, P3, DOI 10.1016/j.bbalip.2004.08.005; RABINOWITZ S, 1992, J CELL BIOL, V116, P95, DOI 10.1083/jcb.116.1.95; Reddy A, 2001, CELL, V106, P157, DOI 10.1016/S0092-8674(01)00421-4; Rodriguez A, 1997, J CELL BIOL, V137, P93, DOI 10.1083/jcb.137.1.93; ROFF CF, 1991, DEV NEUROSCI-BASEL, V13, P315, DOI 10.1159/000112179; SOLHEIM AE, 1983, BIOCHIM BIOPHYS ACTA, V763, P284, DOI 10.1016/0167-4889(83)90136-2; Somers KL, 2001, J INHERIT METAB DIS, V24, P427, DOI 10.1023/A:1010588112003; Soulet D, 2004, J BIOL CHEM, V279, P49355, DOI 10.1074/jbc.M401287200; Sturley SL, 2004, BBA-MOL CELL BIOL L, V1685, P83, DOI 10.1016/j.bbalip.2004.08.014; Tseng Tsai-Tien, 1999, Journal of Molecular Microbiology and Biotechnology, V1, P107; Vincent I, 2003, CURR OPIN NEUROL, V16, P155, DOI 10.1097/00019052-200304000-00006; Virgili M, 2006, NEUROCHEM INT, V48, P201, DOI 10.1016/j.neuint.2005.10.004; Wood PL, 2007, BRAIN RES, V1145, P150, DOI 10.1016/j.brainres.2006.10.004; Wood PL, 2006, BRAIN RES, V1095, P190, DOI 10.1016/j.brainres.2006.04.038; YANG WCT, 1965, EXP CELL RES, V38, P495, DOI 10.1016/0014-4827(65)90373-3; Yu ZQ, 2004, BRAIN RES, V1016, P163, DOI 10.1016/j.brainres.2004.04.075; Zhang M, 2001, P NATL ACAD SCI USA, V98, P4466, DOI 10.1073/pnas.081070898	64	42	42	0	1	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	SEP 5	2008	283	36					24584	24593		10.1074/jbc.M803715200	http://dx.doi.org/10.1074/jbc.M803715200			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	342YR	18591242	hybrid, Green Published			2022-12-27	WOS:000258820000030
J	Manfredi, C; Carrasco, B; Ayora, S; Alonso, JC				Manfredi, Candela; Carrasco, Begona; Ayora, Silvia; Alonso, Juan C.			Bacillus subtilis RecO nucleates RecA onto SsbA-coated single-stranded DNA	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							HOLLIDAY-JUNCTION RESOLVASE; ESCHERICHIA-COLI RECF; REPLICATION PROTEIN-A; BINDING PROTEIN; BREAK REPAIR; HOMOLOGOUS RECOMBINATION; GENETIC-RECOMBINATION; RAD51 RECOMBINASE; FILAMENTS; SSDNA	Subsaturating amounts of Bacillus subtilis SsbA, independently of the order of addition, partially inhibit the single-stranded DNA-dependent dATPase activity of RecA. This negative effect is fully overcome when a substoichiometric amount of RecO is added. SsbA added prior to RecA does not stimulate the dATP-dependent DNA strand exchange activity; however, added after RecA it enhances the extent of strand exchange. The addition of RecO stimulates RecA-mediated joint molecule formation, although it limits the accumulation of final recombination products. Thus we suggest that RecO has a dual activity: RecO acts as a RecA mediator enabling RecA to utilize SsbA-coated single-stranded DNA as a polymerization substrate and controls RecA-mediated DNA strand exchange by limiting its extent. We herein discuss the possible mechanisms of RecO involvement in the regulation of double strand break repair and genetic transformation.	[Manfredi, Candela; Carrasco, Begona; Ayora, Silvia; Alonso, Juan C.] CSIC, Ctr Nacl Biotecnol, Dept Microbiol Biotechnol, E-28049 Madrid, Spain	Consejo Superior de Investigaciones Cientificas (CSIC); CSIC - Centro Nacional de Biotecnologia (CNB)	Alonso, JC (corresponding author), CSIC, Ctr Nacl Biotecnol, Dept Microbiol Biotechnol, C Darwin 3,Campus Univ Autonoma Madrid, E-28049 Madrid, Spain.	jcalonso@cnb.csic.es	Ayora, Silvia/D-2552-2009; Alonso, Juan Carlos/D-2595-2009	Ayora, Silvia/0000-0003-3121-1786; Alonso, Juan Carlos/0000-0002-5178-7179; Carrasco, Begona/0000-0002-5671-1296	Ministerio de Ciencia e Innovacio n (MCI); Direccio n General de Investigacio n (DGI) [BFU2006-01062]; MCI-DGI [BFU2006-02907]	Ministerio de Ciencia e Innovacio n (MCI)(Ministry of Science and Innovation, Spain (MICINN)Spanish Government); Direccio n General de Investigacio n (DGI)(Spanish Government); MCI-DGI	This work was supported by Ministerio de Ciencia e Innovacio n (MCI), Direccio n General de Investigacio n (DGI) Grant BFU2006-01062 (to J. C. A.) and BFU2006-02907 from MCI-DGI (to S. A.). The costs of publication of this article were defrayed in part by the payment of page charges. This article must therefore be hereby marked "advertisement" in accordance with 18 U. S. C. Section 1734 solely to indicate this fact.	ALONSO JC, 1993, J BIOL CHEM, V268, P1424; ALONSO JC, 1991, BIOCHIMIE, V73, P277, DOI 10.1016/0300-9084(91)90213-K; Anantha RW, 2007, J BIOL CHEM, V282, P35910, DOI 10.1074/jbc.M704645200; Ayora S, 2004, P NATL ACAD SCI USA, V101, P452, DOI 10.1073/pnas.2533829100; Ayora S, 2002, NUCLEIC ACIDS RES, V30, P2280, DOI 10.1093/nar/30.11.2280; Ayora S, 2002, J BIOL CHEM, V277, P35969, DOI 10.1074/jbc.M204467200; Ayora S, 2002, J MOL BIOL, V316, P35, DOI 10.1006/jmbi.2001.5336; Ayora S, 1997, MOL GEN GENET, V254, P54, DOI 10.1007/s004380050390; Ayora S, 1997, MOL MICROBIOL, V23, P639, DOI 10.1046/j.1365-2958.1997.2431611.x; Beernink HTH, 1999, TRENDS BIOCHEM SCI, V24, P385, DOI 10.1016/S0968-0004(99)01451-6; Bianco P R, 1998, Front Biosci, V3, pD570; Bork JM, 2001, EMBO J, V20, P7313, DOI 10.1093/emboj/20.24.7313; BRENNER SL, 1990, J MOL BIOL, V216, P949, DOI 10.1016/S0022-2836(99)80013-8; CANOSI U, 1978, MOL GEN GENET, V166, P259, DOI 10.1007/BF00267617; Carrasco B, 2005, NUCLEIC ACIDS RES, V33, P3942, DOI 10.1093/nar/gki713; Carrasco B, 2001, J BACTERIOL, V183, P5772, DOI 10.1128/JB.183.19.5772-5777.2001; Carrasco B, 2008, DNA REPAIR, V7, P990, DOI 10.1016/j.dnarep.2008.03.019; Cox MM, 2007, CRIT REV BIOCHEM MOL, V42, P41, DOI 10.1080/10409230701260258; Cox MM, 2007, NAT REV MOL CELL BIO, V8, P127, DOI 10.1038/nrm2099; Fernandez S, 1999, MOL GEN GENET, V261, P567, DOI 10.1007/s004380051002; Filippo JS, 2008, ANNU REV BIOCHEM, V77, P229, DOI 10.1146/annurev.biochem.77.061306.125255; Galletto R, 2007, CURR BIOL, V17, pR395, DOI 10.1016/j.cub.2007.03.009; GASSEL M, 1989, MOL MICROBIOL, V3, P1269, DOI 10.1111/j.1365-2958.1989.tb00277.x; Hobbs MD, 2007, J BIOL CHEM, V282, P11058, DOI 10.1074/jbc.M611007200; Inoue J, 2008, NUCLEIC ACIDS RES, V36, P94, DOI 10.1093/nar/gkm1004; Kantake N, 2002, P NATL ACAD SCI USA, V99, P15327, DOI 10.1073/pnas.252633399; Kidane D, 2004, MOL MICROBIOL, V52, P1627, DOI 10.1111/j.1365-2958.2004.04102.x; Kidane D, 2005, J CELL BIOL, V170, P357, DOI 10.1083/jcb.200412090; KOWALCZYKOWSKI SC, 1994, MICROBIOL REV, V58, P401, DOI 10.1128/MMBR.58.3.401-465.1994; Lee BI, 2004, EMBO J, V23, P2029, DOI 10.1038/sj.emboj.7600222; Leiros I, 2005, EMBO J, V24, P906, DOI 10.1038/sj.emboj.7600582; Lindner C, 2004, J BACTERIOL, V186, P1097, DOI 10.1128/JB.186.4.1097-1105.2004; LOVETT CM, 1985, J BIOL CHEM, V260, P3305; LUISIDELUCA C, 1995, J BACTERIOL, V177, P566, DOI 10.1128/jb.177.3.566-572.1995; Makharashvili N, 2004, STRUCTURE, V12, P1881, DOI 10.1016/j.str.2004.08.006; Mijakovic I, 2006, NUCLEIC ACIDS RES, V34, P1588, DOI 10.1093/nar/gkj514; MORRICAL SW, 1985, BIOCHEMISTRY-US, V24, P760, DOI 10.1021/bi00324a034; Petranovic D, 2007, MOL MICROBIOL, V63, P1797, DOI 10.1111/j.1365-2958.2007.05625.x; Sanchez H, 2005, GENETICS, V171, P873, DOI 10.1534/genetics.105.045906; SANCHEZ H, 2007, TOP CURR GENET, V17, P27; Sanchez H, 2007, DYNAMICS DNA DOUBLE; Shan Q, 1997, J MOL BIOL, V265, P519, DOI 10.1006/jmbi.1996.0748; Song BW, 2000, J BIOL CHEM, V275, P15895, DOI 10.1074/jbc.M910244199; Spies M, 2006, MOL CELL, V21, P573, DOI 10.1016/j.molcel.2006.01.007; Steffen SE, 2002, J BIOL CHEM, V277, P14493, DOI 10.1074/jbc.M112444200; Steffen SE, 1999, J BIOL CHEM, V274, P25990, DOI 10.1074/jbc.274.37.25990; Sugiyama T, 2002, J BIOL CHEM, V277, P31663, DOI 10.1074/jbc.M203494200; Sugiyama T, 2006, EMBO J, V25, P5539, DOI 10.1038/sj.emboj.7601412; Sung P, 2003, J BIOL CHEM, V278, P42729, DOI 10.1074/jbc.R300027200; Sung P, 2006, NAT REV MOL CELL BIO, V7, P739, DOI 10.1038/nrm2008; UMEZU K, 1993, P NATL ACAD SCI USA, V90, P3875, DOI 10.1073/pnas.90.9.3875; UMEZU K, 1994, J BIOL CHEM, V269, P30005; WANG TCV, 1993, MUTAT RES, V294, P157, DOI 10.1016/0921-8777(93)90024-B; Webb BL, 1995, J BIOL CHEM, V270, P31397, DOI 10.1074/jbc.270.52.31397; WEISE F, 1994, VIROLOGY, V202, P1046, DOI 10.1006/viro.1994.1436; West SC, 2003, NAT REV MOL CELL BIO, V4, P435, DOI 10.1038/nrm1127; Yang HJ, 2005, NATURE, V433, P653, DOI 10.1038/nature03234	57	40	40	0	9	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	SEP 5	2008	283	36					24837	24847		10.1074/jbc.M802002200	http://dx.doi.org/10.1074/jbc.M802002200			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	342YR	18599486	hybrid, Green Published			2022-12-27	WOS:000258820000050
J	Masuda-Sasa, T; Polaczek, P; Peng, XP; Chen, L; Campbell, JL				Masuda-Sasa, Taro; Polaczek, Piotr; Peng, Xiao P.; Chen, Lu; Campbell, Judith L.			Processing of G4 DNA by Dna2 helicase/nuclease and replication protein a (RPA) provides insights into the mechanism of Dna2/RPA substrate recognition	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							OKAZAKI FRAGMENT MATURATION; TELOMERIC G-QUADRUPLEXES; SACCHAROMYCES-CEREVISIAE; IN-VIVO; ENZYMATIC-PROPERTIES; SYNDROME HELICASE; BINDING PROTEIN; YEAST; ENDONUCLEASE; FLAP	The polyguanine-rich DNA sequences commonly found at telomeres and in rDNA arrays have been shown to assemble into structures known as G quadruplexes, or G4 DNA, stabilized by base-stacked G quartets, an arrangement of four hydrogen-bonded guanines. G4 DNA structures are resistant to the many helicases and nucleases that process intermediates arising in the course of DNA replication and repair. The lagging strand DNA replication protein, Dna2, has demonstrated a unique localization to telomeres and a role in de novo telomere biogenesis, prompting us to study the activities of Dna2 on G4 DNA-containing substrates. We find that yeast Dna2 binds with 25-fold higher affinity to G4 DNA formed from yeast telomere repeats than to single-stranded DNA of the same sequence. Human Dna2 also binds G4 DNAs. The helicase activities of both yeast and human Dna2 are effective in unwinding G4 DNAs. On the other hand, the nuclease activities of both yeast and human Dna2 are attenuated by the formation of G4 DNA, with the extent of inhibition depending on the topology of the G4 structure. This inhibition can be overcome by replication protein A. Replication protein A is known to stimulate the 5'- to 3'-nuclease activity of Dna2; however, we go on to show that this same protein inhibits the 3'- to 5'-exo/endonuclease activity of Dna2. These observations are discussed in terms of possible roles for Dna2 in resolving G4 secondary structures that arise during Okazaki fragment processing and telomere lengthening.	[Masuda-Sasa, Taro; Polaczek, Piotr; Peng, Xiao P.; Chen, Lu; Campbell, Judith L.] CALTECH, Braun Labs 147 75, Pasadena, CA 91125 USA	California Institute of Technology	Campbell, JL (corresponding author), CALTECH, Braun Labs 147 75, Pasadena, CA 91125 USA.	jcampbel@its.caltech.edu			National Institutes of Health [GM087666]; Philip Morris External Research Program	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Philip Morris External Research Program	This work was supported, in whole or in part, by National Institutes of Health Grant GM087666 from the USPHS and a research grant from the Philip Morris External Research Program.	Bae KH, 2003, NUCLEIC ACIDS RES, V31, P3006, DOI 10.1093/nar/gkg422; Bae SH, 2001, NATURE, V412, P456, DOI 10.1038/35086609; Bae SH, 2000, J BIOL CHEM, V275, P38022, DOI 10.1074/jbc.M006513200; Budd ME, 2005, PLOS GENET, V1, P634, DOI 10.1371/journal.pgen.0010061; Budd ME, 2006, MOL CELL BIOL, V26, P2490, DOI 10.1128/MCB.26.7.2490-2500.2006; BUDD ME, 1995, P NATL ACAD SCI USA, V92, P7642, DOI 10.1073/pnas.92.17.7642; BUDD ME, 1995, J BIOL CHEM, V270, P26766, DOI 10.1074/jbc.270.45.26766; Choe W, 2002, MOL CELL BIOL, V22, P4202, DOI 10.1128/MCB.22.12.4202-4217.2002; de Laat WL, 1998, GENE DEV, V12, P2598, DOI 10.1101/gad.12.16.2598; Fry M, 1999, J BIOL CHEM, V274, P12797, DOI 10.1074/jbc.274.18.12797; Ghosal G, 2005, NUCLEIC ACIDS RES, V33, P4692, DOI 10.1093/nar/gki777; GIRALDO R, 1994, EMBO J, V13, P2411, DOI 10.1002/j.1460-2075.1994.tb06526.x; Huber MD, 2002, NUCLEIC ACIDS RES, V30, P3954, DOI 10.1093/nar/gkf530; Huber MD, 2006, J MOL BIOL, V358, P1071, DOI 10.1016/j.jmb.2006.01.077; Imamura O, 2003, P NATL ACAD SCI USA, V100, P8193, DOI 10.1073/pnas.1431624100; Ivessa AS, 2002, GENE DEV, V16, P1383, DOI 10.1101/gad.982902; Kao HI, 2004, J BIOL CHEM, V279, P50840, DOI 10.1074/jbc.M409231200; Kao HI, 2004, J BIOL CHEM, V279, P15014, DOI 10.1074/jbc.M313216200; Kao KI, 2002, J BIOL CHEM, V277, P14379, DOI 10.1074/jbc.M110662200; Kim JH, 2006, NUCLEIC ACIDS RES, V34, P1854, DOI 10.1093/nar/gkl102; Li J, 2005, NUCLEIC ACIDS RES, V33, P4649, DOI 10.1093/nar/gki782; LIU ZP, 1994, CELL, V77, P1083, DOI 10.1016/0092-8674(94)90447-2; LIU ZP, 1993, P NATL ACAD SCI USA, V90, P3157, DOI 10.1073/pnas.90.8.3157; Lopes M, 2006, MOL CELL, V21, P15, DOI 10.1016/j.molcel.2005.11.015; Lyonnais S, 2002, NUCLEIC ACIDS RES, V30, P5276, DOI 10.1093/nar/gkf644; Maizels N, 2006, NAT STRUCT MOL BIOL, V13, P1055, DOI 10.1038/nsmb1171; Majka J, 2006, J BIOL CHEM, V281, P27855, DOI 10.1074/jbc.M605176200; Masuda-Sasa T, 2006, NUCLEIC ACIDS RES, V34, P1865, DOI 10.1093/nar/gkl070; Masuda-Sasa T, 2006, J BIOL CHEM, V281, P38555, DOI 10.1074/jbc.M604925200; Miller KM, 2006, NATURE, V440, P824, DOI 10.1038/nature04638; Mohaghegh P, 2001, NUCLEIC ACIDS RES, V29, P2843, DOI 10.1093/nar/29.13.2843; Muniyappa K, 2000, MOL CELL BIOL, V20, P1361, DOI 10.1128/MCB.20.4.1361-1369.2000; Parkinson GN, 2002, NATURE, V417, P876, DOI 10.1038/nature755; Salas TR, 2006, NUCLEIC ACIDS RES, V34, P4857, DOI 10.1093/nar/gkl564; Sambrook J., 1989, MOL CLONING LAB MANU, V1, P21, DOI DOI 10.51-10.67; SEN D, 1992, BIOCHEMISTRY-US, V31, P65, DOI 10.1021/bi00116a011; SEN D, 1990, NATURE, V344, P410, DOI 10.1038/344410a0; Sharma S, 2004, HUM MOL GENET, V13, P2247, DOI 10.1093/hmg/ddh234; Singer MS, 1998, GENETICS, V150, P613; Stewart JA, 2006, J BIOL CHEM, V281, P38565, DOI 10.1074/jbc.M606884200; Sun H, 1998, J BIOL CHEM, V273, P27587, DOI 10.1074/jbc.273.42.27587; Sun H, 1999, NUCLEIC ACIDS RES, V27, P1978, DOI 10.1093/nar/27.9.1978; Sun H, 2001, P NATL ACAD SCI USA, V98, P12444, DOI 10.1073/pnas.231479198; WANG Y, 1993, STRUCTURE, V1, P263, DOI 10.1016/0969-2126(93)90015-9; Weitao T, 2003, MUTAT RES-FUND MOL M, V532, P157, DOI 10.1016/j.mrfmmm.2003.08.015; ZAHLER AM, 1991, NATURE, V350, P718, DOI 10.1038/350718a0; Zaug AJ, 2005, P NATL ACAD SCI USA, V102, P10864, DOI 10.1073/pnas.0504744102	47	64	68	0	5	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	SEP 5	2008	283	36					24359	24373		10.1074/jbc.M802244200	http://dx.doi.org/10.1074/jbc.M802244200			15	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	342YR	18593712	hybrid, Green Accepted, Green Published			2022-12-27	WOS:000258820000010
J	Bricker, TM; Frankel, LK				Bricker, Terry M.; Frankel, Laurie K.			The psbo1 Mutant of Arabidopsis Cannot Efficiently Use Calcium in Support of Oxygen Evolution by Photosystem II	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							MANGANESE-STABILIZING PROTEIN; KDA EXTRINSIC PROTEIN; 33-KDA; BINDING; CHLORIDE; LACKING; SYSTEM; THERMOLUMINESCENCE; ASSEMBLY/STABILITY; PHOTOAUTOTROPHY	The Arabidopsis thaliana mutant psbo1 contains a point mutation in the psbO-1 gene (At5g66570) leading to the loss of expression of the PsbO-1 protein and overexpression of the PsbO-2 protein (Murakami, R., Ifuku, K., Takabayashi, A., Shikanai, T., Endo, T., and Sato, F. (2002) FEBS Lett. 523, 138-142). Previous characterization of fluorescence induction and decay kinetics by our laboratory documented defects on both the oxidizing and reducing sides of Photosystem II. Additionally, anomalous flash oxygen yield patterns indicated that the mutant contains a defective oxygen-evolving complex that appears to exhibit anomalously long-lived S-2 and S-3 oxidation states (Liu, H., Frankel, L. K., and Bricker, T. M. (2007) Biochemistry 46, 7607-7613). In this study, we have documented that the S-2 and S-3 states in psbo1 thylakoids decay very slowly. The total flash oxygen yield of the psbo1 mutant was also significantly reduced, as was its stability. Incubation of psbo1 thylakoids at high NaCl concentrations did not increase the rate of S-2 and S-3 state decay. The oxygen-evolving complexes of the mutant did, however, exhibit somewhat enhanced stability following this treatment. Incubation with CaCl2 had a significantly more dramatic effect. Under this condition, both the S-2 and S-3 states of the mutant decayed at nearly the same rate as the wild type, and the total oxygen yield and its stability following CaCl2 treatment were indistinguishable from that of the wild type. These results strongly suggest that the principal defect in the psbo1 mutant is an inability to effectively utilize the calcium associated with Photosystem II. We hypothesize that the PsbO-2 protein cannot effectively sequester calcium at the oxygen-evolving site.	[Bricker, Terry M.; Frankel, Laurie K.] Louisiana State Univ, Dept Biol Sci, Biochem & Mol Biol Sect, Baton Rouge, LA 70803 USA	Louisiana State University System; Louisiana State University	Bricker, TM (corresponding author), Louisiana State Univ, Dept Biol Sci, Biochem & Mol Biol Sect, Baton Rouge, LA 70803 USA.	btbric@lsu.edu			National Science Foundation and the Department of Energy	National Science Foundation and the Department of Energy	This work was supported by grants from the National Science Foundation and the Department of Energy (to T. M. B. and L. K. F.). The costs of publication of this article were defrayed in part by the payment of page charges. This article must therefore be hereby marked "advertisement" in accordance with 18 U. S. C. Section 1734 solely to indicate this fact.	ANDERSSON B, 1984, BIOCHIM BIOPHYS ACTA, V766, P21, DOI 10.1016/0005-2728(84)90212-3; ARNON DI, 1949, PLANT PHYSIOL, V24, P1, DOI 10.1104/pp.24.1.1; Betts SD, 1997, BIOCHEMISTRY-US, V36, P4047, DOI 10.1021/bi962413b; Bricker TM, 2005, ADV PHOTO RESPIRAT, V22, P95; Bricker TM, 2003, BIOCHEMISTRY-US, V42, P2056, DOI 10.1021/bi020652v; BRICKER TM, 1992, BIOCHEMISTRY-US, V31, P4623, DOI 10.1021/bi00134a012; Bricker TM, 1998, PHOTOSYNTH RES, V56, P157, DOI 10.1023/A:1006068615220; Bricker TM, 2001, BIOCHEMISTRY-US, V40, P11483, DOI 10.1021/bi010906x; BRICKER TM, 1996, OXYGENIC PHOTOSYNTHE, P113; BURNAP RL, 1992, BIOCHEMISTRY-US, V31, P7404, DOI 10.1021/bi00147a027; ENGELS DH, 1994, PHOTOSYNTH RES, V42, P227, DOI 10.1007/BF00018265; KAVELAKI K, 1991, PHOTOSYNTH RES, V29, P149, DOI 10.1007/BF00036218; Liu HJ, 2007, BIOCHEMISTRY-US, V46, P7607, DOI 10.1021/bi700107w; MESSINGER J, 1993, BIOCHEMISTRY-US, V32, P7658, DOI 10.1021/bi00081a009; MEUNIER PC, 1993, PHOTOSYNTH RES, V36, P111, DOI 10.1007/BF00016276; Miqyass M, 2007, PHOTOSYNTH RES, V92, P275, DOI 10.1007/s11120-006-9124-2; MIYAO M, 1984, FEBS LETT, V170, P350, DOI 10.1016/0014-5793(84)81342-3; MIYAO M, 1987, BIOCHIM BIOPHYS ACTA, V890, P151, DOI 10.1016/0005-2728(87)90016-8; Murakami R, 2005, FEBS J, V272, P2165, DOI 10.1111/j.1742-4658.2005.04636.x; Murakami R, 2002, FEBS LETT, V523, P138, DOI 10.1016/S0014-5793(02)02963-0; MURATA N, 1984, BIOCHIM BIOPHYS ACTA, V765, P363, DOI 10.1016/0005-2728(84)90177-4; ONO T, 1985, BIOCHIM BIOPHYS ACTA, V806, P331, DOI 10.1016/0005-2728(85)90240-3; PHILBRICK JB, 1991, J BIOL CHEM, V266, P13370; Popelkova H, 2006, BIOCHEMISTRY-US, V45, P3107, DOI 10.1021/bi0523759; Popelkova H, 2007, PHOTOSYNTH RES, V93, P111, DOI 10.1007/s11120-006-9121-5; PutnamEvans C, 1996, BIOCHEMISTRY-US, V35, P4046, DOI 10.1021/bi952661s; Seidler A, 1996, BBA-BIOENERGETICS, V1277, P35, DOI 10.1016/S0005-2728(96)00102-8; VASS I, 1992, BIOCHIM BIOPHYS ACTA, V1102, P195, DOI 10.1016/0005-2728(92)90100-G; Yi XP, 2007, J BIOL CHEM, V282, P24833, DOI 10.1074/jbc.M705011200; Yi XP, 2005, J BIOL CHEM, V280, P16170, DOI 10.1074/jbc.M501550200	30	23	24	0	3	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	OCT 24	2008	283	43					29022	29027		10.1074/jbc.M805122200	http://dx.doi.org/10.1074/jbc.M805122200			6	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	362EB	18667416	Green Published, hybrid			2022-12-27	WOS:000260179900028
J	Karpurapu, M; Wang, D; Singh, NK; Li, QY; Rao, GN				Karpurapu, Manjula; Wang, Dong; Singh, Nikhlesh K.; Li, Quanyi; Rao, Gadiparthi N.			NFATc1 targets cyclin a in the regulation of vascular smooth muscle cell multiplication during restenosis	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ACTIVATED T-CELLS; DEPENDENT KINASE INHIBITOR; RECEPTOR TYROSINE KINASE; NUCLEAR FACTOR; TRANSCRIPTION FACTOR; NEOINTIMA FORMATION; IN-VITRO; NF-ATC; PROTEIN; GROWTH	Platelet-derived growth factor BB (PDGF-BB) induced cyclin A expression and CDK2 activity in vascular smooth muscle cells (VSMC). Inhibition of nuclear factors of activated T cell (NFAT) activation by cyclosporin A (CsA) and VIVIT suppressed PDGF-BB-induced cyclin A expression and CDK2 activity, resulting in blockade of VSMC in the G(1) phase. In addition, CsA- and VIVIT-mediated inhibition of NFATs and small interfering RNA-targeted down-regulation of cyclin A levels suppressed PDGF-BB-induced VSMC DNA synthesis. PDGF-BB also induced cyclin A mRNA levels in VSMC in an NFAT-dependent manner. Cloning and bioinformatic analysis of rat cyclin A promoter revealed the presence of NFAT-binding elements, and PDGF-BB induced the binding of NFATs to these regulatory sequences in a CsA- and VIVIT-sensitive manner. Chromatin immunoprecipitation analysis showed that NFATc1 binds to the cyclin A promoter in response to PDGF-BB in a VIVIT-sensitive manner. Furthermore, PDGF-BB induced cyclin A promoter-luciferase reporter gene activity in VSMC, and it was inhibited by both CsA and VIVIT. Balloon injury induced cyclin A expression and CDK2 activity in rat carotid arteries, and these responses were also blocked by VIVIT. In addition, VIVIT attenuated balloon injury-induced SMC proliferation, resulting in reduced restenosis. Down-regulation of NFATc1 by its small interfering RNA inhibited PDGF-BB-induced cyclin A expression and DNA synthesis both in rat and human VSMC. Together, these findings demonstrate that the cyclin A-CDK2 complex may be a potential effector of NFATs, specifically NFATc1, in mediating SMC multiplication leading to neointima formation. Therefore, NFATs may be used as target molecules for the development of therapeutic agents against vascular diseases such as restenosis.	[Karpurapu, Manjula; Wang, Dong; Singh, Nikhlesh K.; Li, Quanyi; Rao, Gadiparthi N.] Univ Tennessee, Hlth Sci Ctr, Dept Physiol, Memphis, TN 38163 USA	University of Tennessee System; University of Tennessee Health Science Center	Rao, GN (corresponding author), Univ Tennessee, Hlth Sci Ctr, Dept Physiol, 894 Union Ave, Memphis, TN 38163 USA.	grao@physio1.utmem.edu	Singh, Nikhlesh/AAA-4253-2020	Singh, Nikhlesh/0000-0002-3665-6023	National Institutes of Health [HL069908]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL069908] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	This work was supported, in whole or in part, by National Institutes of Health Grant HL069908 (to G. N. R.). The costs of publication of this article were defrayed in part by the payment of page charges. This article must therefore be hereby marked " advertisement" in accordance with 18 U. S. C. Section 1734 solely to indicate this fact.	Aramburu J, 1999, SCIENCE, V285, P2129, DOI 10.1126/science.285.5436.2129; Baksh S, 2002, MOL CELL, V10, P1071, DOI 10.1016/S1097-2765(02)00701-3; Beier F, 2000, J BIOL CHEM, V275, P12948, DOI 10.1074/jbc.275.17.12948; Berthet C, 2006, DEV CELL, V10, P563, DOI 10.1016/j.devcel.2006.03.004; BOISE LH, 1993, MOL CELL BIOL, V13, P1911, DOI 10.1128/MCB.13.3.1911; Boss V, 1998, J BIOL CHEM, V273, P19664, DOI 10.1074/jbc.273.31.19664; Caetano MS, 2002, FASEB J, V16, P1940, DOI 10.1096/fj.02-0282fje; Carvalho LDS, 2007, CELL CYCLE, V6, P1789, DOI 10.4161/cc.6.14.4473; CHANG MW, 1995, J CLIN INVEST, V96, P2260, DOI 10.1172/JCI118281; Chen DH, 1997, J CLIN INVEST, V99, P2334, DOI 10.1172/JCI119414; Chen W, 2004, CANCER RES, V64, P3949, DOI 10.1158/0008-5472.CAN-03-3906; Cheng RK, 2007, CIRC RES, V100, P1741, DOI 10.1161/CIRCRESAHA.107.153544; de la Pompa JL, 1998, NATURE, V392, P182, DOI 10.1038/32419; Decker EL, 1998, J BIOL CHEM, V273, P26923, DOI 10.1074/jbc.273.41.26923; Gondeau C, 2005, J BIOL CHEM, V280, P13793, DOI 10.1074/jbc.M413690200; Graef IA, 2001, CELL, V105, P863, DOI 10.1016/S0092-8674(01)00396-8; HARPER JW, 1993, CELL, V75, P805; Heit JJ, 2006, NATURE, V443, P345, DOI 10.1038/nature05097; Hengst L, 1998, GENE DEV, V12, P3882, DOI 10.1101/gad.12.24.3882; Hogan PG, 2003, GENE DEV, V17, P2205, DOI 10.1101/gad.1102703; Horsley V, 2001, J CELL BIOL, V153, P329, DOI 10.1083/jcb.153.2.329; Ishida N, 2002, J BIOL CHEM, V277, P41147, DOI 10.1074/jbc.M205063200; Jauliac S, 2002, NAT CELL BIOL, V4, P540, DOI 10.1038/ncb816; Johnson BV, 2004, MOL CELL BIOL, V24, P7914, DOI 10.1128/MCB.24.18.7914-7930.2004; JOHNSON DG, 1993, NATURE, V365, P349, DOI 10.1038/365349a0; Johnson EN, 2003, J BIOL CHEM, V278, P1686, DOI 10.1074/jbc.M210250200; Katabami M, 2005, J BIOL CHEM, V280, P16728, DOI 10.1074/jbc.M413892200; KATO J, 1993, GENE DEV, V7, P331; KATO JY, 1994, CELL, V79, P487, DOI 10.1016/0092-8674(94)90257-7; KOFF A, 1992, SCIENCE, V257, P1689, DOI 10.1126/science.1388288; Kozar K, 2004, CELL, V118, P477, DOI 10.1016/j.cell.2004.07.025; Liu ZM, 2005, J BIOL CHEM, V280, P14700, DOI 10.1074/jbc.M500322200; Liu ZM, 2004, J BIOL CHEM, V279, P41218, DOI 10.1074/jbc.M406917200; Moldovan GL, 2007, CELL, V129, P665, DOI 10.1016/j.cell.2007.05.003; Molkentin JD, 1998, CELL, V93, P215, DOI 10.1016/S0092-8674(00)81573-1; MORGAN DO, 1995, NATURE, V374, P131, DOI 10.1038/374131a0; Murray AW, 2004, CELL, V116, P221, DOI 10.1016/S0092-8674(03)01080-8; Neal JW, 2003, J BIOL CHEM, V278, P17246, DOI 10.1074/jbc.M300528200; NIGG EA, 1995, BIOESSAYS, V17, P471, DOI 10.1002/bies.950170603; NURSE P, 1994, CELL, V79, P547, DOI 10.1016/0092-8674(94)90539-8; OHTSUBO M, 1993, SCIENCE, V259, P1908, DOI 10.1126/science.8384376; Pavletich NP, 1999, J MOL BIOL, V287, P821, DOI 10.1006/jmbi.1999.2640; Ranger AM, 1998, NATURE, V392, P186, DOI 10.1038/32426; Ravnik SE, 1999, DEV BIOL, V207, P408, DOI 10.1006/dbio.1998.9156; Santini MP, 2001, P NATL ACAD SCI USA, V98, P9575, DOI 10.1073/pnas.161299698; Sever-Chroneos Z, 2001, MOL CELL BIOL, V21, P4032, DOI 10.1128/MCB.21.12.4032-4045.2001; Sherr CJ, 2004, GENE DEV, V18, P2699, DOI 10.1101/gad.1256504; SHERR CJ, 1995, GENE DEV, V9, P1149, DOI 10.1101/gad.9.10.1149; SHERR CJ, 1993, CELL, V73, P1059, DOI 10.1016/0092-8674(93)90636-5; Shimizu M, 1998, EXP CELL RES, V239, P93, DOI 10.1006/excr.1997.3884; Sunters A, 2004, J BIOL CHEM, V279, P9882, DOI 10.1074/jbc.M310184200; TOYOSHIMA H, 1994, CELL, V78, P67, DOI 10.1016/0092-8674(94)90573-8; WAGA S, 1994, NATURE, V369, P574, DOI 10.1038/369574a0; WEINBERG RA, 1995, CELL, V81, P323, DOI 10.1016/0092-8674(95)90385-2; XIONG Y, 1993, NATURE, V366, P701, DOI 10.1038/366701a0; Yang R, 1997, CANCER RES, V57, P913; Yang ZY, 1996, P NATL ACAD SCI USA, V93, P7905, DOI 10.1073/pnas.93.15.7905; Yellaturu CR, 2002, BIOCHEM J, V368, P183, DOI 10.1042/BJ20020347; Yu HX, 2006, ARTERIOSCL THROM VAS, V26, P1531, DOI 10.1161/01.ATV.0000225286.30710.af	59	32	38	1	2	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	SEP 26	2008	283	39					26577	26590		10.1074/jbc.M800423200	http://dx.doi.org/10.1074/jbc.M800423200			14	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	350GV	18667424	Green Published, hybrid			2022-12-27	WOS:000259341600034
J	Uemura, T; Yerushalmi, HF; Tsaprailis, G; Stringer, DE; Pastorian, KE; Hawel, L; Byus, CV; Gerner, EW				Uemura, Takeshi; Yerushalmi, Hagit F.; Tsaprailis, George; Stringer, David E.; Pastorian, Kirk E.; Hawel, Leo, III; Byus, Craig V.; Gerner, Eugene W.			Identification and characterization of a diamine exporter in colon epithelial cells	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							PUTRESCINE TRANSPORT-SYSTEM; HAMSTER OVARY CELLS; ACTIVATED KI-RAS; ESCHERICHIA-COLI; SACCHAROMYCES-CEREVISIAE; POLYAMINE UPTAKE; MAMMALIAN-CELLS; ORNITHINE-DECARBOXYLASE; VACUOLAR MEMBRANE; MASS-SPECTROMETRY	SLC3A2, a member of the solute carrier family, was identified by proteomics methods as a component of a transporter capable of exporting the diamine putrescine in the Chinese hamster ovary (CHO) cells selected for resistance to growth inhibition by high exogenous concentrations of putrescine. Putrescine transport was increased in inverted plasma membrane vesicles prepared from cells resistant to growth inhibition by putrescine compared with transport in inverted vesicles prepared from non-selected cells. Knockdown of SLC3A2 in human cells, using short hairpin RNA, caused an increase in putrescine uptake and a decrease in arginine uptake activity. SLC3A2 knockdown cells accumulated higher polyamine levels and grew faster than control cells. The growth of SLC3A2 knockdown cells was inhibited by high concentrations of putrescine. Knockdown of SLC3A2 reduced export of polyamines from cells. Expression of SLC3A2 was suppressed in human HCT116 colon cancer cells, which have an activated K-RAS, compared with their isogenic clone, Hkh2 cells, which lack an activated K-RAS allele. Spermidine/spermine N1-acetyltransferase (SAT1) was co-immunoprecipitated by an anti-SLC3A2 antibody as was SLC3A2 with an anti-SAT1 antibody. SLC3A2 and SAT1 colocalized on the plasma membrane. These data provide the first molecular characterization of a polyamine exporter in animal cells and indicate that the diamine putrescine is exported by an arginine transporter containing SLC3A2, whose expression is negatively regulated by K-RAS. The interaction between SLC3A2 and SAT1 suggests that these proteins may facilitate excretion of acetylated polyamines.	[Uemura, Takeshi; Stringer, David E.; Gerner, Eugene W.] Univ Arizona, Arizona Canc Ctr, Tucson, AZ 85724 USA; [Yerushalmi, Hagit F.] Technion Israel Inst Technol, Fac Med, IL-31096 Haifa, Israel; [Tsaprailis, George] Coll Pharm, Ctr Toxicol, Tucson, AZ 85721 USA; [Pastorian, Kirk E.; Hawel, Leo, III; Byus, Craig V.] Univ Calif Riverside, Dept Biomed Sci, Riverside, CA 92521 USA	Arizona Center Cancer Care; University of Arizona; Technion Israel Institute of Technology; Rappaport Faculty of Medicine; University of California System; University of California Riverside	Gerner, EW (corresponding author), Univ Arizona, Arizona Canc Ctr, 1515 N Campbell Ave, Tucson, AZ 85724 USA.	egerner@azcc.arizona.edu		Tsaprailis, George/0000-0003-1239-2358	National Institutes of Health [CA123065]; NATIONAL CANCER INSTITUTE [R01CA123065, P50CA095060, P30CA023074, P01CA072008] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES [P30ES006694] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS))	This work was supported, in whole or in part, by National Institutes of Health Grant CA123065. The costs of publication of this article were defrayed in part by the payment of page charges. This article must therefore be hereby marked "advertisement" in accordance with 18 U. S. C. Section 1734 solely to indicate this fact.	Andon NL, 2002, PROTEOMICS, V2, P1156, DOI 10.1002/1615-9861(200209)2:9<1156::AID-PROT1156>3.0.CO;2-4; Aouida M, 2005, J BIOL CHEM, V280, P24267, DOI 10.1074/jbc.M503071200; BACHRACH U, 1970, ANN NY ACAD SCI, V171, P939, DOI 10.1111/j.1749-6632.1970.tb39400.x; Belting M, 2003, J BIOL CHEM, V278, P47181, DOI 10.1074/jbc.M308325200; Chen C, 2004, J CELL BIOL, V167, P161, DOI 10.1083/jcb.200312166; Cohen S.S., 1998, GUIDE POLYAMINES, V1st ed.; Cooper B, 2003, J AM SOC MASS SPECTR, V14, P736, DOI 10.1016/S1044-0305(03)00125-9; ENG JK, 1994, J AM SOC MASS SPECTR, V5, P976, DOI 10.1016/1044-0305(94)80016-2; Feral CC, 2007, J CELL BIOL, V178, P701, DOI 10.1083/jcb.200705090; FURUCHI T, 1991, J BIOL CHEM, V266, P20928; Gerner EW, 2007, BIOCHEM SOC T, V35, P322, DOI 10.1042/BST0350322; Hasne MP, 2005, J BIOL CHEM, V280, P15188, DOI 10.1074/jbc.M411331200; HAWEL L, 1994, J BIOL CHEM, V269, P7412; HAWEL L, 1994, BBA-MOL CELL RES, V1222, P15, DOI 10.1016/0167-4889(94)90020-5; Heiskala M, 1999, EMBO J, V18, P1214, DOI 10.1093/emboj/18.5.1214; HESSELS J, 1989, INT J CANCER, V43, P1155, DOI 10.1002/ijc.2910430632; Higashi K, 2008, J BACTERIOL, V190, P872, DOI 10.1128/JB.01505-07; Igarashi K, 2000, BIOCHEM BIOPH RES CO, V271, P559, DOI 10.1006/bbrc.2000.2601; Ignatenko NA, 2004, MOL CARCINOGEN, V39, P91, DOI 10.1002/mc.10166; Ignatenko NA, 2006, NUTR CANCER, V56, P172, DOI 10.1207/s15327914nc5602_8; Ignaternko NA, 2004, MOL CARCINOGEN, V39, P221, DOI 10.1002/mc.20008; KAKINUMA Y, 1988, EUR J BIOCHEM, V176, P409, DOI 10.1111/j.1432-1033.1988.tb14297.x; KASHIWAGI K, 1990, J BIOL CHEM, V265, P20893; KASHIWAGI K, 1992, P NATL ACAD SCI USA, V89, P4529, DOI 10.1073/pnas.89.10.4529; Kurihara S, 2005, J BIOL CHEM, V280, P4602, DOI 10.1074/jbc.M411114200; Linsalata M, 2004, SCAND J GASTROENTERO, V39, P470, DOI 10.1080/0036552031008755; Loser C, 1999, GUT, V44, P12, DOI 10.1136/gut.44.1.12; Mariadason JM, 2003, CANCER RES, V63, P8791; Pastorian KE, 1997, EXP CELL RES, V231, P284, DOI 10.1006/excr.1996.3467; PEGG AE, 1988, CANCER RES, V48, P759; PISTOCCHI R, 1993, J BIOL CHEM, V268, P146; Roy UKB, 2008, MOL CARCINOGEN, V47, P538, DOI 10.1002/mc.20414; Sala R, 2002, AM J PHYSIOL-CELL PH, V282, pC134, DOI 10.1152/ajpcell.2002.282.1.C134; SAXENA M, 1995, J BIOL CHEM, V270, P5312, DOI 10.1074/jbc.270.10.5312; SCHAUB T, 1991, FEBS LETT, V279, P83, DOI 10.1016/0014-5793(91)80256-3; SEILER N, 1980, J CHROMATOGR, V221, P227, DOI 10.1016/S0378-4347(00)84307-8; Shevchenko A, 1996, ANAL CHEM, V68, P850, DOI 10.1021/ac950914h; SHIRASAWA S, 1993, SCIENCE, V260, P85, DOI 10.1126/science.8465203; Soksawatmaekhin W, 2004, MOL MICROBIOL, V51, P1401, DOI 10.1046/j.1365-2958.2003.03913.x; Tachihara K, 2005, J BIOL CHEM, V280, P12637, DOI 10.1074/jbc.M410778200; Tahara H, 2006, DRUG METAB DISPOS, V34, P743, DOI 10.1124/dmd.105.008375; TJANDRAWINATA RR, 1994, BIOCHEM PHARMACOL, V48, P2237, DOI 10.1016/0006-2952(94)00420-X; TJANDRAWINATA RR, 1994, J IMMUNOL, V152, P3039; TOME ME, 1994, J CELL PHYSIOL, V158, P237, DOI 10.1002/jcp.1041580205; Tomitori H, 1999, J BIOL CHEM, V274, P3265, DOI 10.1074/jbc.274.6.3265; Tomitori H, 2001, BIOCHEM J, V353, P681, DOI 10.1042/0264-6021:3530681; Torrents D, 1998, J BIOL CHEM, V273, P32437, DOI 10.1074/jbc.273.49.32437; Uemura T, 2005, J BIOL CHEM, V280, P9646, DOI 10.1074/jbc.M410274200; Uemura T, 2005, BIOCHEM BIOPH RES CO, V328, P1028, DOI 10.1016/j.bbrc.2005.01.064; Uemura T, 2004, BIOCHEM BIOPH RES CO, V315, P1082, DOI 10.1016/j.bbrc.2004.01.162; Uemura T, 2007, J BIOL CHEM, V282, P7733, DOI 10.1074/jbc.M611105200; Wang XJ, 2004, J BIOL CHEM, V279, P51370, DOI 10.1074/jbc.M410471200; Woolridge DP, 1997, J BIOL CHEM, V272, P8864; Xie XZ, 1997, J BIOL CHEM, V272, P20484, DOI 10.1074/jbc.272.33.20484	54	68	70	0	4	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	SEP 26	2008	283	39					26428	26435		10.1074/jbc.M804714200	http://dx.doi.org/10.1074/jbc.M804714200			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	350GV	18660501	Green Published, hybrid			2022-12-27	WOS:000259341600017
J	Gross, J; Grass, S; Davis, AE; Gilmore-Erdmann, P; Townsend, RR; Geme, JWS				Gross, Julia; Grass, Susan; Davis, Alan E.; Gilmore-Erdmann, Petra; Townsend, R. Reid; Geme, Joseph W. St., III			The haemophilus influenzae HMW1 adhesin is a glycoprotein with an unusual N-linked carbohydrate modification	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							POST-SOURCE-DECAY; PROTEIN-PHOSPHORYLATION; METASTABLE DECAY; SURFACE-LAYER; IDENTIFICATION; GLYCOSYLATION; GENES; ATTACHMENT; SECRETION; PATHOGENS	The Haemophilus influenzae HMW1 adhesin mediates adherence to respiratory epithelial cells, a critical early step in the pathogenesis of H. influenzae disease. In recent work, we demonstrated that HMW1 undergoes glycosylation. In addition, we observed that glycosylation of HMW1 is essential for HMW1 tethering to the bacterial surface, a prerequisite for HMW1-mediated adherence to host epithelium. In this study, we examined HMW1 proteolytic fragments by mass spectrometry, achieved 89% amino acid sequence coverage, and identified 31 novel modification sites. All of the modified sites were asparagine residues, in all but one case in the conventional consensus sequence of N-linked glycans, viz. NX(S/T). Liquid chromatography-tandem mass spectrometry analysis using a hybrid linear quadrupole ion trap Fourier transform ion cyclotron mass spectrometer, accurate mass measurements, and deuterium exchange studies established that the modifying glycan structures were mono- or dihexoses rather than the N-acetylated chitobiosyl core that is characteristic of N-glycosylation. This unusual carbohydrate modification suggests that HMW1 glycosylation requires a glycosyltransferase with a novel activity.	[Geme, Joseph W. St., III] Duke Univ, Med Ctr, Dept Pediat, Childrens Hlth Ctr, Durham, NC 27710 USA; [Grass, Susan; Geme, Joseph W. St., III] Duke Univ, Med Ctr, Dept Mol Genet & Microbiol, Durham, NC 27710 USA; [Gross, Julia; Davis, Alan E.; Gilmore-Erdmann, Petra; Townsend, R. Reid] Washington Univ, Sch Med, Dept Med, St Louis, MO 63110 USA; [Townsend, R. Reid] Washington Univ, Sch Med, Dept Cell Biol & Physiol, St Louis, MO 63110 USA	Duke University; Duke University; Washington University (WUSTL); Washington University (WUSTL)	Geme, JWS (corresponding author), Duke Univ, Med Ctr, Dept Pediat, Childrens Hlth Ctr, Rm T901, Durham, NC 27710 USA.	j.stgeme@duke.edu			United States Public Health Service [DC-02873]; University of Georgia [2-P41-RR05351]; Washington University Mass Spectrometry Resource [P41-RR00954]; William M. Keck Foundation; NATIONAL CENTER FOR RESEARCH RESOURCES [P41RR000954, P41RR005351] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON DEAFNESS AND OTHER COMMUNICATION DISORDERS [R01DC002873] Funding Source: NIH RePORTER	United States Public Health Service(United States Department of Health & Human ServicesUnited States Public Health Service); University of Georgia; Washington University Mass Spectrometry Resource; William M. Keck Foundation(W.M. Keck Foundation); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL INSTITUTE ON DEAFNESS AND OTHER COMMUNICATION DISORDERS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Deafness & Other Communication Disorders (NIDCD))	This work was supported by United States Public Health Service Grants RO1 DC-02873 (to J.W.S.), 2-P41-RR05351 (to the University of Georgia Complex Carbohydrate Research Center), and P41-RR00954 (to the Washington University Mass Spectrometry Resource) and by the William M. Keck Foundation. The costs of publication of this article were defrayed in part by the payment of page charges. This article must therefore be hereby marked "advertisement" in accordance with 18 U.S.C. Section 1734 solely to indicate this fact.	BARENKAMP SJ, 1994, INFECT IMMUN, V62, P3320, DOI 10.1128/IAI.62.8.3320-3328.1994; Barenkamp SJ, 1996, INFECT IMMUN, V64, P1246, DOI 10.1128/IAI.64.4.1246-1251.1996; BARENKAMP SJ, 1992, INFECT IMMUN, V60, P1302, DOI 10.1128/IAI.60.4.1302-1313.1992; Benz I, 2001, MOL MICROBIOL, V40, P1403, DOI 10.1046/j.1365-2958.2001.02487.x; Brimer CD, 1998, J BACTERIOL, V180, P3209, DOI 10.1128/JB.180.12.3209-3217.1998; Buscher AZ, 2004, J BACTERIOL, V186, P4209, DOI 10.1128/JB.186.13.4209-4217.2004; CASTRIC P, 1995, MICROBIOL-UK, V141, P1247, DOI 10.1099/13500872-141-5-1247; Doig P, 1996, MOL MICROBIOL, V19, P379, DOI 10.1046/j.1365-2958.1996.370890.x; Geme JWS, 1998, MOL MICROBIOL, V27, P617; Grass S, 2000, MOL MICROBIOL, V36, P55, DOI 10.1046/j.1365-2958.2000.01812.x; Grass S, 2003, MOL MICROBIOL, V48, P737, DOI 10.1046/j.1365-2958.2003.03450.x; Gross J, 1998, J AM SOC MASS SPECTR, V9, P866, DOI 10.1016/S1044-0305(98)00058-0; Gross J, 2001, J AM SOC MASS SPECTR, V12, P180, DOI 10.1016/S1044-0305(00)00209-9; Jacob-Dubuisson F, 2001, MOL MICROBIOL, V40, P306, DOI 10.1046/j.1365-2958.2001.02278.x; King JB, 2006, ANAL CHEM, V78, P2171, DOI 10.1021/ac051520l; King JB, 2007, RAPID COMMUN MASS SP, V21, P3443, DOI 10.1002/rcm.3223; Kowarik M, 2006, EMBO J, V25, P1957, DOI 10.1038/sj.emboj.7601087; Kuo CC, 1996, J CLIN INVEST, V98, P2813, DOI 10.1172/JCI119109; KUPCU Z, 1984, FEBS LETT, V173, P185, DOI 10.1016/0014-5793(84)81043-1; Lindenthal C, 1999, INFECT IMMUN, V67, P4084, DOI 10.1128/IAI.67.8.4084-4091.1999; MESSNER P, 1988, FEBS LETT, V228, P317, DOI 10.1016/0014-5793(88)80023-1; Schmidt MA, 2003, TRENDS MICROBIOL, V11, P554, DOI 10.1016/j.tim.2003.10.004; St Geme JW, 1998, INFECT IMMUN, V66, P364; STGEME JW, 1993, P NATL ACAD SCI USA, V90, P2875, DOI 10.1073/pnas.90.7.2875; Surana NK, 2004, P NATL ACAD SCI USA, V101, P14497, DOI 10.1073/pnas.0404679101; Szymanski CM, 2005, NAT REV MICROBIOL, V3, P225, DOI 10.1038/nrmicro1100; Virji M, 1997, GENE, V192, P141, DOI 10.1016/S0378-1119(97)00082-6	27	83	84	0	12	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	SEP 19	2008	283	38					26010	26015		10.1074/jbc.M801819200	http://dx.doi.org/10.1074/jbc.M801819200			6	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	348GX	18621734	Green Published, hybrid			2022-12-27	WOS:000259200100029
J	MacFarlane, AJ; Liu, XW; Perry, CA; Flodby, P; Allen, RH; Stabler, SP; Stover, PJ				MacFarlane, Amanda J.; Liu, Xiaowen; Perry, Cheryll A.; Flodby, Per; Allen, Robert H.; Stabler, Sally P.; Stover, Patrick J.			Cytoplasmic serine hydroxymethyltransferase regulates the metabolic partitioning of methylenetetrahydrofolate but is not essential in mice	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ONE-CARBON METABOLISM; FOLATE-DEFICIENCY; GENE; COBALAMIN; MAMMALS	The hydroxymethyl group of serine is a primary source of tetrahydrofolate (THF)-activated one-carbon units that are required for the synthesis of purines and thymidylate and for S-adenosylmethionine (AdoMet)-dependent methylation reactions. Serine hydroxylmethyltransferase (SHMT) catalyzes the reversible and THF-dependent conversion of serine to glycine and 5,10-methylene-THF. SHMT is present in eukaryotic cells as mitochondrial SHMT and cytoplasmic (cSHMT) isozymes that are encoded by distinct genes. In this study, the essentiality of cSHMT-derived THF-activated one-carbons was investigated by gene disruption in the mouse germ line. Mice lacking cSHMT are viable and fertile, demonstrating that cSHMT is not an essential source of THF-activated one-carbon units. cSHMT-deficient mice exhibit altered hepatic AdoMet levels and uracil content in DNA, validating previous in vitro studies that indicated this enzyme regulates the partitioning of methylenetetrahydrofolate between the thymidylate and homocysteine remethylation pathways. This study suggests that mitochondrial SHMT-derived one-carbon units are essential for folate-mediated one-carbon metabolism in the cytoplasm.	[MacFarlane, Amanda J.; Liu, Xiaowen; Perry, Cheryll A.; Flodby, Per; Stover, Patrick J.] Cornell Univ, Div Nutr Sci, Ithaca, NY 14853 USA; [Allen, Robert H.; Stabler, Sally P.] Univ Colorado, Hlth Sci Ctr, Dept Med, Denver, CO 80262 USA; [Allen, Robert H.; Stabler, Sally P.] Univ Colorado, Hlth Sci Ctr, Div Hematol, Denver, CO 80262 USA	Cornell University; University of Colorado System; University of Colorado Anschutz Medical Campus; University of Colorado Denver; University of Colorado System; University of Colorado Anschutz Medical Campus; University of Colorado Denver	Stover, PJ (corresponding author), Cornell Univ, Div Nutr Sci, 315 Savage Hall, Ithaca, NY 14853 USA.	pjs13@cornell.edu			National Institutes of Health [DK58144]; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R37DK058144, R01DK058144] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	This work was supported, in whole or in part, by National Institutes of Health Grant DK58144 from the USPHS. The costs of publication of this article were defrayed in part by the payment of page charges. This article must therefore be hereby marked "advertisement" in accordance with 18 U. S. C. Section 1734 solely to indicate this fact.	ALLEN RH, 1993, METABOLISM, V42, P1448, DOI 10.1016/0026-0495(93)90198-W; Anderson DD, 2007, CLIN CHEM LAB MED, V45, P1760, DOI 10.1515/CCLM.2007.355; APPLING DR, 1991, FASEB J, V5, P2645, DOI 10.1096/fasebj.5.12.1916088; BENSADOUN A, 1976, ANAL BIOCHEM, V70, P241, DOI 10.1016/S0003-2697(76)80064-4; Christensen KE, 2006, BIOESSAYS, V28, P595, DOI 10.1002/bies.20420; Finkelstein JD, 2000, SEMIN THROMB HEMOST, V26, P219, DOI 10.1055/s-2000-8466; Girgis S, 1998, GENE, V210, P315, DOI 10.1016/S0378-1119(98)00085-7; Herbig K, 2002, J BIOL CHEM, V277, P38381, DOI 10.1074/jbc.M205000200; Liu XW, 2001, BIOCHEMISTRY-US, V40, P4932, DOI 10.1021/bi002598t; MOUNTFORD P, 1994, P NATL ACAD SCI USA, V91, P4303, DOI 10.1073/pnas.91.10.4303; STABLER SP, 1993, BLOOD, V81, P3404; Stover PJ, 2004, NUTR REV, V62, pS3, DOI 10.1111/j.1753-4887.2004.tb00070.x; Stover PJ, 1997, J BIOL CHEM, V272, P1842, DOI 10.1074/jbc.272.3.1842; Szebenyi DME, 2000, BIOCHEMISTRY-US, V39, P13313, DOI 10.1021/bi000635a; Townsend JH, 2004, AM J PHYSIOL-GASTR L, V286, pG588, DOI 10.1152/ajpgi.00454.2003; Vatcher GP, 1998, J BIOL CHEM, V273, P6066, DOI 10.1074/jbc.273.11.6066; Woeller CF, 2007, J BIOL CHEM, V282, P17623, DOI 10.1074/jbc.M702526200	17	106	111	0	3	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	SEP 19	2008	283	38					25846	25853		10.1074/jbc.M802671200	http://dx.doi.org/10.1074/jbc.M802671200			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	348GX	18644786	hybrid, Green Published			2022-12-27	WOS:000259200100011
J	Amir-Moazami, O; Alexia, C; Charles, N; Launay, P; Monteiro, RC; Benhamou, M				Amir-Moazami, Omid; Alexia, Catherine; Charles, Nicolas; Launay, Pierre; Monteiro, Renato C.; Benhamou, Marc			Phospholipid scramblase 1 modulates a selected set of IgE receptor-mediated mast cell responses through LAT-dependent pathway	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							PROTEIN-TYROSINE KINASE; MEMBRANE PHOSPHOLIPID SCRAMBLASE-1; BASOPHILIC LEUKEMIA-CELLS; HIGH-AFFINITY RECEPTOR; GROWTH-FACTOR RECEPTOR; PLASMA-MEMBRANE; BETA-HEXOSAMINIDASE; NEGATIVE REGULATION; CYTOKINE PRODUCTION; FYN KINASE	Engagement of the IgE receptor (Fc epsilon RI) on mast cells leads to the release of preformed and newly formed mediators as well as of cytokines. The signaling pathways responsible for these responses involve tyrosine phosphorylation of multiple proteins. We previously reported the phosphorylation on tyrosine of phospholipid scramblase 1 (PLSCR1) after Fc epsilon RI aggregation. Here, PLSCR1 expression was knocked down in the RBL-2H3 mast cell line using short hairpin RNA. Knocking down PLSCR1 expression resulted in significantly impaired degranulation responses after Fc epsilon RI aggregation and release of vascular endothelial growth factor, whereas release of MCP-1 was minimally affected. The release of neither leukotriene C4 nor prostaglandin D2 was altered by knocking down of PLSCR1. Analysis of Fc epsilon RI-dependent signaling pathways revealed that whereas tyrosine phosphorylation of ERK and Akt was unaffected, tyrosine phosphorylation of LAT was significantly reduced in PLSCR1 knocked down cells. Tyrosine phosphorylation of phospholipase C gamma 1 and consequently the mobilization of calcium were also significantly reduced in these cells. In nonactivated mast cells, PLSCR1 was found in part in lipid rafts where it was further recruited after cell activation and was constitutively associated with Lyn and Syk but not with LAT or Fyn. Altogether, these data identify PLSCR1 as a novel amplifier of Fc epsilon RI signaling that acts selectively on the Lyn-initiated LAT/phospholipase C gamma 1/calcium axis, resulting in potentiation of a selected set of mast cell responses.	[Amir-Moazami, Omid; Alexia, Catherine; Charles, Nicolas; Launay, Pierre; Monteiro, Renato C.; Benhamou, Marc] Univ Paris 07, INSERM, Fac Med Xavier Bichat, U699, F-75018 Paris, France	Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Bichat-Claude Bernard - APHP; Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universite Paris Cite	Benhamou, M (corresponding author), Univ Paris 07, INSERM, Fac Med Xavier Bichat, U699, 16 Rue Henri Huchard, F-75018 Paris, France.	Marc.Benhamou@inserm.fr	CHARLES, Nicolas/S-2214-2019; Monteiro, Renato C/U-8633-2017; CHARLES, Nicolas/P-5430-2014; Launay, Pierre/AAH-7076-2019	CHARLES, Nicolas/0000-0002-5416-5834; Monteiro, Renato C/0000-0001-5202-5646; CHARLES, Nicolas/0000-0002-5416-5834; Benhamou, Marc/0000-0001-7763-3795	Association pour l'Utilisation du Rein Artificie; Fondation de France [2002004544]; Ministere de l' Enseignement Superieur et de la Recherche	Association pour l'Utilisation du Rein Artificie; Fondation de France(Fondation de France); Ministere de l' Enseignement Superieur et de la Recherche	This work was supported in part by Association pour l'Utilisation du Rein Artificiel and by Grant 2002004544 (to M. B.) from the Fondation de France. The costs of publication of this article were defrayed in part by the payment of page charges. This article must therefore be hereby marked" advertisement" in accordance with 18 U. S. C. Section 1734 solely to indicate this fact.; Supported by a Ministere de l' Enseignement Superieur et de la Recherche grant.	Ali K, 2004, NATURE, V431, P1007, DOI 10.1038/nature02991; Ben-Efraim I, 2004, BIOCHEMISTRY-US, V43, P3518, DOI 10.1021/bi0356911; BENHAMOU M, 1992, J BIOL CHEM, V267, P7310; BENHAMOU M, 1990, P NATL ACAD SCI USA, V87, P5327, DOI 10.1073/pnas.87.14.5327; BENHAMOU M, 1993, J BIOL CHEM, V268, P23318; BENHAMOU M, 1986, J IMMUNOL, V136, P1385; Brdicka T, 2002, J EXP MED, V196, P1617, DOI 10.1084/jem.20021405; Charles N, 2004, J BIOL CHEM, V279, P12312, DOI 10.1074/jbc.M309456200; Choi OH, 1996, NATURE, V380, P634; Delacour D, 2006, CURR BIOL, V16, P408, DOI 10.1016/j.cub.2005.12.046; Delacour D, 2007, TRAFFIC, V8, P379, DOI 10.1111/j.1600-0854.2007.00539.x; Dong BH, 2004, J VIROL, V78, P8983, DOI 10.1128/JVI.78.17.8983-8993.2004; EISEMAN E, 1992, NATURE, V355, P78; Gomez G, 2005, J IMMUNOL, V175, P7602, DOI 10.4049/jimmunol.175.11.7602; Gonzalez-Espinosa C, 2003, J EXP MED, V197, P1453, DOI 10.1084/jem.20021806; GRYNKIEWICZ G, 1985, J BIOL CHEM, V260, P3440; Hernandez-Hansen V, 2005, J IMMUNOL, V175, P7880, DOI 10.4049/jimmunol.175.12.7880; HIRASAWA N, 1995, J IMMUNOL, V154, P5391; Holowka D, 2005, BBA-MOL CELL RES, V1746, P252, DOI 10.1016/j.bbamcr.2005.06.007; Huber M, 1998, P NATL ACAD SCI USA, V95, P11330, DOI 10.1073/pnas.95.19.11330; Kantari C, 2007, BLOOD, V110, P4086, DOI 10.1182/blood-2007-03-080457; Kato N, 2002, BIOCHEMISTRY-US, V41, P8068, DOI 10.1021/bi016022v; Kraft S, 2004, INT ARCH ALLERGY IMM, V135, P62, DOI 10.1159/000080231; Kraft S, 2007, NAT REV IMMUNOL, V7, P365, DOI 10.1038/nri2072; Launay P, 1998, J LEUKOCYTE BIOL, V63, P636, DOI 10.1002/jlb.63.5.636; Leung WH, 2007, J IMMUNOL, V179, P95, DOI 10.4049/jimmunol.179.1.95; Malaviya R, 2001, IMMUNOL REV, V179, P16, DOI 10.1034/j.1600-065X.2001.790102.x; Malbec O, 2004, J IMMUNOL, V173, P5086, DOI 10.4049/jimmunol.173.8.5086; Martin S, 2000, INT ARCH ALLERGY IMM, V123, P249, DOI 10.1159/000024451; METZGER H, 1991, CLIN EXP ALLERGY, V21, P269, DOI 10.1111/j.1365-2222.1991.tb01658.x; MINOGUCHI K, 1994, J BIOL CHEM, V269, P16902; Nanjundan M, 2003, J BIOL CHEM, V278, P37413, DOI 10.1074/jbc.M306182200; Olivera A, 2006, J BIOL CHEM, V281, P2515, DOI 10.1074/jbc.M508931200; Olivera A, 2007, IMMUNITY, V26, P287, DOI 10.1016/j.immuni.2007.02.008; PAOLINI R, 1991, NATURE, V353, P855, DOI 10.1038/353855a0; Parravicini V, 2002, NAT IMMUNOL, V3, P741, DOI 10.1038/ni817; Pastorelli C, 2001, J BIOL CHEM, V276, P20407, DOI 10.1074/jbc.M100790200; Pennock JL, 2006, CHEM IMMUNOL ALLERGY, V90, P128, DOI 10.1159/000088885; Pombo I, 2003, FEBS LETT, V550, P144, DOI 10.1016/S0014-5793(03)00864-0; RAZIN E, 1983, J EXP MED, V157, P189, DOI 10.1084/jem.157.1.189; Rivera J, 2001, INT ARCH ALLERGY IMM, V124, P137, DOI 10.1159/000053692; Saitoh S, 2000, IMMUNITY, V12, P525, DOI 10.1016/S1074-7613(00)80204-6; Saitoh S, 2003, J EXP MED, V198, P831, DOI 10.1084/jem.20030574; Smrz D, 2008, J BIOL CHEM, V283, P10904, DOI 10.1074/jbc.M710386200; STEINHOFF MM, 1980, BIOCHIM BIOPHYS ACTA, V618, P28, DOI 10.1016/0005-2760(80)90050-8; Sun J, 2002, BIOCHEMISTRY-US, V41, P6338, DOI 10.1021/bi025610l; TOLONE G, 1978, BRIT J EXP PATHOL, V59, P105; Volna P, 2004, J EXP MED, V200, P1001, DOI 10.1084/jem.20041213; Wen RR, 2002, J IMMUNOL, V169, P6743, DOI 10.4049/jimmunol.169.12.6743; Wiedmer T, 2000, BBA-BIOMEMBRANES, V1467, P244, DOI 10.1016/S0005-2736(00)00236-4; Wiedmer T, 2004, P NATL ACAD SCI USA, V101, P13296, DOI 10.1073/pnas.0405354101; Wiedmer T, 2003, BIOCHEMISTRY-US, V42, P1227, DOI 10.1021/bi026679w; YAMASHITA T, 1994, P NATL ACAD SCI USA, V91, P11251, DOI 10.1073/pnas.91.23.11251; Zhang J, 2002, MOL CELL BIOL, V22, P8144, DOI 10.1128/MCB.22.23.8144-8154.2002; Zhou QS, 2005, J BIOL CHEM, V280, P35062, DOI 10.1074/jbc.M504821200; Zhou QS, 2002, BLOOD, V99, P4030, DOI 10.1182/blood-2001-12-0271; Zhou QS, 1997, J BIOL CHEM, V272, P18240, DOI 10.1074/jbc.272.29.18240; Zhu MH, 2004, J EXP MED, V200, P991, DOI 10.1084/jem.20041223	58	27	28	1	3	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	SEP 12	2008	283	37					25514	25523		10.1074/jbc.M705320200	http://dx.doi.org/10.1074/jbc.M705320200			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	345QZ	18579528	hybrid			2022-12-27	WOS:000259012700047
J	Hall, JR; Lee, HO; Bunker, BD; Dorn, ES; Rogers, GC; Duronio, RJ; Cook, JG				Hall, Jonathan R.; Lee, Hyun O.; Bunker, Brandon D.; Dorn, Elizabeth S.; Rogers, Greg C.; Duronio, Robert J.; Cook, Jeanette Gowen			Cdt1 and Cdc6 are destabilized by rereplication-induced DNA damage	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							RE-REPLICATION; MAMMALIAN-CELLS; PREVENTS REREPLICATION; MULTIPLE MECHANISMS; G(2)/M CHECKPOINT; EUKARYOTIC CELLS; GEMININ; DEGRADATION; STABILITY; PATHWAY	The replication factors Cdt1 and Cdc6 are essential for origin licensing, a prerequisite for DNA replication initiation. Mechanisms to ensure that metazoan origins initiate once per cell cycle include degradation of Cdt1 during S phase and inhibition of Cdt1 by the geminin protein. Geminin depletion or overexpression of Cdt1 or Cdc6 in human cells causes rereplication, a form of endogenous DNA damage. Rereplication induced by these manipulations is however uneven and incomplete, suggesting that one or more mechanisms restrain rereplication once it begins. We find that both Cdt1 and Cdc6 are degraded in geminin-depleted cells. We further show that Cdt1 degradation in cells that have rereplicated requires the PCNA binding site of Cdt1 and the Cu14(DDB1) ubiquitin ligase, and Cdt1 can induce its own degradation when overproduced. Cdc6 degradation in geminin-depleted cells requires Huwe1, the ubiquitin ligase that regulates Cdc6 after DNA damage. Moreover, perturbations that specifically disrupt Cdt1 and Cdc6 degradation in response to DNA damage exacerbate rereplication when combined with geminin depletion, and this enhanced rereplication occurs in both human cells and in Drosophila melanogaster cells. We conclude that rereplication-associated DNA damage triggers Cdt1 and Cdc6 ubiquitination and destruction, and propose that this pathway represents an evolutionarily conserved mechanism that minimizes the extent of rereplication.	[Hall, Jonathan R.; Bunker, Brandon D.; Dorn, Elizabeth S.; Cook, Jeanette Gowen] Univ N Carolina, Dept Biochem & Biophys, Chapel Hill, NC 27599 USA; [Lee, Hyun O.; Duronio, Robert J.; Cook, Jeanette Gowen] Univ N Carolina, Curriculum Genet & Mol Biol, Chapel Hill, NC 27599 USA; [Rogers, Greg C.; Duronio, Robert J.] Univ N Carolina, Dept Biol, Chapel Hill, NC 27599 USA; [Duronio, Robert J.; Cook, Jeanette Gowen] Univ N Carolina, Lineberger Comprehens Canc Ctr, Chapel Hill, NC 27599 USA	University of North Carolina; University of North Carolina Chapel Hill; University of North Carolina; University of North Carolina Chapel Hill; University of North Carolina; University of North Carolina Chapel Hill; University of North Carolina; University of North Carolina Chapel Hill	Cook, JG (corresponding author), Univ N Carolina, Dept Biochem & Biophys, Campus Box 7260, Chapel Hill, NC 27599 USA.	jean_cook@med.unc.edu		Duronio, Robert/0000-0001-6469-6965; Cook, Jeanette/0000-0003-0849-7405	NATIONAL CANCER INSTITUTE [K01CA094907] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM083024] Funding Source: NIH RePORTER; NCI NIH HHS [K01 CA094907, K01 CA 094907, K01 CA094907-04, K01 CA094907-05] Funding Source: Medline; NIGMS NIH HHS [R01 GM083024] Funding Source: Medline	NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		Archambault V, 2005, MOL CELL BIOL, V25, P6707, DOI 10.1128/MCB.25.15.6707-6721.2005; Arentson E, 2002, ONCOGENE, V21, P1150, DOI 10.1038/sj.onc.1205175; Arias EE, 2006, NAT CELL BIOL, V8, P84, DOI 10.1038/ncb1346; Arias EE, 2007, GENE DEV, V21, P497, DOI 10.1101/gad.1508907; Ballabeni A, 2004, EMBO J, V23, P3122, DOI 10.1038/sj.emboj.7600314; Bell SP, 2002, ANNU REV BIOCHEM, V71, P333, DOI 10.1146/annurev.biochem.71.110601.135425; Blanchard F, 2002, MOL BIOL CELL, V13, P1536, DOI 10.1091/mbc.02-02-0010; Blow JJ, 2005, NAT REV MOL CELL BIO, V6, P476, DOI 10.1038/nrm1663; Braden WA, 2006, MOL CELL BIOL, V26, P7667, DOI 10.1128/MCB.00045-06; Cook JG, 2004, J BIOL CHEM, V279, P9625, DOI 10.1074/jbc.M311933200; Davidson IF, 2006, MOL CELL, V24, P433, DOI 10.1016/j.molcel.2006.09.010; Diffley JFX, 2004, CURR BIOL, V14, pR778, DOI 10.1016/j.cub.2004.09.019; Duursma A, 2005, MOL CELL BIOL, V25, P6937, DOI 10.1128/MCB.25.16.6937-6947.2005; Ferenbach A, 2005, NUCLEIC ACIDS RES, V33, P316, DOI 10.1093/nar/gki176; Fujita M, 2006, CELL DIV, V1, DOI 10.1186/1747-1028-1-22; Hall JR, 2007, MOL BIOL CELL, V18, P3340, DOI 10.1091/mbc.E07-02-0173; Heffernan TP, 2007, J BIOL CHEM, V282, P9458, DOI 10.1074/jbc.M611292200; Higa LAA, 2003, NAT CELL BIOL, V5, P1008, DOI 10.1038/ncb1061; Hochegger H, 2007, J CELL BIOL, V178, P257, DOI 10.1083/jcb.200702034; Hu J, 2004, NAT CELL BIOL, V6, P1003, DOI 10.1038/ncb1172; Kondo T, 2004, J BIOL CHEM, V279, P27315, DOI 10.1074/jbc.M314023200; Lee AYL, 2007, J BIOL CHEM, V282, P32243, DOI 10.1074/jbc.M705486200; Lin JJ, 2007, J BIOL CHEM, V282, P30357, DOI 10.1074/jbc.M705178200; Liontos M, 2007, CANCER RES, V67, P10899, DOI 10.1158/0008-5472.CAN-07-2837; Liu EB, 2004, J BIOL CHEM, V279, P17283, DOI 10.1074/jbc.C300549200; Liu E, 2007, J CELL BIOL, V179, P643, DOI 10.1083/jcb.200704138; Lovejoy CA, 2006, MOL CELL BIOL, V26, P7977, DOI 10.1128/MCB.00819-06; Machida YJ, 2005, CELL, V123, P13, DOI 10.1016/j.cell.2005.09.019; McGarry TJ, 2002, MOL BIOL CELL, V13, P3662, DOI 10.1091/mbc.E02-04-0199; Melixetian M, 2004, J CELL BIOL, V165, P473, DOI 10.1083/jcb.200403106; Mihaylov IS, 2002, MOL CELL BIOL, V22, P1868, DOI 10.1128/MCB.22.6.1868-1880.2002; Nguyen VQ, 2001, NATURE, V411, P1068, DOI 10.1038/35082600; Nishitani H, 2006, EMBO J, V25, P1126, DOI 10.1038/sj.emboj.7601002; Rogers SL, 2002, J CELL BIOL, V158, P873, DOI 10.1083/jcb.200202032; Saxena S, 2005, MUTAT RES-FUND MOL M, V569, P111, DOI 10.1016/j.mrfmmm.2004.05.026; Saxena S, 2003, CELL CYCLE, V2, P283, DOI 10.4161/cc.2.4.443; Schrofelbauer B, 2007, P NATL ACAD SCI USA, V104, P4130, DOI 10.1073/pnas.0610167104; Sclafani RA, 2007, ANNU REV GENET, V41, P237, DOI 10.1146/annurev.genet.41.110306.130308; Senga T, 2006, J BIOL CHEM, V281, P6246, DOI 10.1074/jbc.M512705200; Tatsumi Y, 2006, J CELL SCI, V119, P3128, DOI 10.1242/jcs.03031; Thomer M, 2004, DEVELOPMENT, V131, P4807, DOI 10.1242/dev.01348; Vaziri C, 2003, MOL CELL, V11, P997, DOI 10.1016/S1097-2765(03)00099-6; Xouri G, 2004, EUR J BIOCHEM, V271, P3368, DOI 10.1111/j.1432-1033.2004.04271.x; Zhu WG, 2004, MOL CELL BIOL, V24, P7140, DOI 10.1128/MCB.24.16.7140-7150.2004	44	35	35	0	0	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	SEP 12	2008	283	37					25356	25363		10.1074/jbc.M802667200	http://dx.doi.org/10.1074/jbc.M802667200			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	345QZ	18617514	hybrid, Green Published			2022-12-27	WOS:000259012700030
J	Tang, ML; Vararattanavech, A; Tan, SM				Tang, Man-Li; Vararattanavech, Ardcharaporn; Tan, Suet-Mien			Urokinase-type plasminogen activator receptor induces conformational changes in the integrin alpha(M)beta(2) headpiece and reorientation of its transmembrane domains	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							INTEGRIN ALPHA(M)BETA(2); MONOCLONAL-ANTIBODY; I-DOMAIN; COMPLEMENT RECEPTOR-TYPE-3; CRYSTAL-STRUCTURE; STRUCTURAL BASIS; LIGAND-BINDING; DEFICIENT MICE; A-DOMAIN; MAC-1	The glycosylphosphatidylinositol-linked urokinase- type plasminogen activator receptor (uPAR) interacts with the heterodimer cell adhesion molecules integrins to modulate cell adhesion and migration. Devoid of a cytoplasmic domain, uPAR triggers intracellular signaling via its associated molecules that contain cytoplasmic domains. Interestingly, uPAR changes the ectodomain conformation of one of its partner molecules, integrin alpha(5)beta(1), and elicits cytoplasmic signaling. The separation or reorientation of integrin transmembrane domains and cytoplasmic tails are required for integrin outside-in signaling. However, there is a lack of direct evidence showing these conformational changes of an integrin that interacts with uPAR. In this investigation we used reporter monoclonal antibodies and fluorescence resonance energy transfer analyses to show conformational changes in the alpha(M)beta(2) headpiece and reorientation of its transmembrane domains when alpha(M)beta(2) interacts with uPAR.	[Tang, Man-Li; Vararattanavech, Ardcharaporn; Tan, Suet-Mien] Nanyang Technol Univ, Sch Biol Sci, Div Cell & Mol Biol, Singapore 637551, Singapore	Nanyang Technological University & National Institute of Education (NIE) Singapore; Nanyang Technological University	Tan, SM (corresponding author), Nanyang Technol Univ, Sch Biol Sci, Div Cell & Mol Biol, 60 Nanyang Dr, Singapore 637551, Singapore.	smtan@ntu.edu.sg	Tan, Suet/A-2224-2011	Tan, Suet-Mien/0000-0003-2371-8739	Singapore A*STAR BMRC [04/1/22/19/358]	Singapore A*STAR BMRC(Agency for Science Technology & Research (A*STAR))	This work was supported by Singapore A*STAR BMRC Grant 04/1/22/19/358. The costs of publication of this article were defrayed in part by the payment of page charges. This article must therefore be hereby marked "advertisement" in accordance with 18 U. S. C. Section 1734 solely to indicate this fact.	Adair BD, 2005, J CELL BIOL, V168, P1109, DOI 10.1083/jcb.200410068; ALTIERI DC, 1991, J IMMUNOL, V147, P1891; ANDREW D, 1993, EUR J IMMUNOL, V23, P2217, DOI 10.1002/eji.1830230925; Andrew DP, 1998, EUR J IMMUNOL, V28, P1959, DOI 10.1002/(SICI)1521-4141(199806)28:06<1959::AID-IMMU1959>3.0.CO;2-4; Annenkov A, 1996, EUR J IMMUNOL, V26, P207, DOI 10.1002/eji.1830260132; Arnaout MA, 2007, CURR OPIN CELL BIOL, V19, P495, DOI 10.1016/j.ceb.2007.08.002; Arnaout MA, 2005, ANNU REV CELL DEV BI, V21, P381, DOI 10.1146/annurev.cellbio.21.090704.151217; Baldwin ET, 1998, STRUCTURE, V6, P923, DOI 10.1016/S0969-2126(98)00093-8; BARCLAY AN, 1997, LEUKOCYTE FACTS BOOK, P158; BAZZONI G, 1995, J BIOL CHEM, V270, P25570, DOI 10.1074/jbc.270.43.25570; Beglova N, 2002, NAT STRUCT BIOL, V9, P282, DOI 10.1038/nsb779; Behrens EM, 2007, J IMMUNOL, V178, P6268, DOI 10.4049/jimmunol.178.10.6268; Blasi F, 2002, NAT REV MOL CELL BIO, V3, P932, DOI 10.1038/nrm977; BOHUSLAV J, 1995, J EXP MED, V181, P1381, DOI 10.1084/jem.181.4.1381; CAO DR, 1995, J IMMUNOL, V154, P1817; Cheng M, 2007, J BIOL CHEM, V282, P18225, DOI 10.1074/jbc.M701386200; Chigaev A, 2001, J BIOL CHEM, V276, P48670, DOI 10.1074/jbc.M103194200; Cunningham O, 2003, EMBO J, V22, P5994, DOI 10.1093/emboj/cdg588; Cywes C, 1996, INFECT IMMUN, V64, P5373, DOI 10.1128/IAI.64.12.5373-5383.1996; DAVIS GE, 1992, EXP CELL RES, V200, P242, DOI 10.1016/0014-4827(92)90170-D; Ehlers MRW, 2000, MICROBES INFECT, V2, P289, DOI 10.1016/S1286-4579(00)00299-9; Forsyth CB, 1998, J IMMUNOL, V161, P6198; Fu G, 2006, BIOCHEM BIOPH RES CO, V346, P986, DOI 10.1016/j.bbrc.2006.06.015; Gyetko MR, 2000, J IMMUNOL, V165, P1513, DOI 10.4049/jimmunol.165.3.1513; Gyetko MR, 2004, J LEUKOCYTE BIOL, V76, P648, DOI 10.1189/jlb.0104023; Huai Q, 2006, SCIENCE, V311, P656, DOI 10.1126/science.1121143; Juffermans NP, 2001, INFECT IMMUN, V69, P5182, DOI 10.1128/IAI.69.8.5182-5185.2001; Kim M, 2003, SCIENCE, V301, P1720, DOI 10.1126/science.1084174; Larson RS, 2005, BIOCHEMISTRY-US, V44, P4322, DOI 10.1021/bi048187k; Lau TL, 2008, J BIOL CHEM, V283, P16162, DOI 10.1074/jbc.M801748200; Lau TL, 2008, BIOCHEMISTRY-US, V47, P4008, DOI 10.1021/bi800107a; Lim J, 2007, MOL BIOL CELL, V18, P976, DOI 10.1091/mbc.E06-09-0813; Llinas P, 2005, EMBO J, V24, P1655, DOI 10.1038/sj.emboj.7600635; Lu CF, 2001, J IMMUNOL, V166, P5629, DOI 10.4049/jimmunol.166.9.5629; Lu HF, 1997, J CLIN INVEST, V99, P1340, DOI 10.1172/JCI119293; Luo BH, 2004, PLOS BIOL, V2, P776, DOI 10.1371/journal.pbio.0020153; Luo BH, 2007, ANNU REV IMMUNOL, V25, P619, DOI 10.1146/annurev.immunol.25.022106.141618; Luque A, 1996, J BIOL CHEM, V271, P11067, DOI 10.1074/jbc.271.19.11067; Mould AP, 2003, J BIOL CHEM, V278, P17028, DOI 10.1074/jbc.M213139200; Nishida N, 2006, IMMUNITY, V25, P583, DOI 10.1016/j.immuni.2006.07.016; Plow EF, 2000, J BIOL CHEM, V275, P21785, DOI 10.1074/jbc.R000003200; Plow EF, 1997, J CLIN INVEST, V99, P1145, DOI 10.1172/JCI119267; Pluskota E, 2004, J BIOL CHEM, V279, P18063, DOI 10.1074/jbc.M310462200; Pluskota E, 2003, BLOOD, V101, P1582, DOI 10.1182/blood-2002-06-1842; Rosenkranz AR, 1998, J IMMUNOL, V161, P6463; Shaw JM, 2001, CLIN EXP IMMUNOL, V126, P311, DOI 10.1046/j.1365-2249.2001.01661.x; Shi ML, 2007, J BIOL CHEM, V282, P30198, DOI 10.1074/jbc.M701670200; Simon DI, 2000, J BIOL CHEM, V275, P10228, DOI 10.1074/jbc.275.14.10228; Simon DI, 1996, BLOOD, V88, P3185, DOI 10.1182/blood.V88.8.3185.bloodjournal8883185; Skoberne M, 2006, BLOOD, V108, P947, DOI 10.1182/blood-2005-12-4812; Spijkers PPEM, 2005, BLOOD, V105, P170, DOI 10.1182/blood-2004-02-0498; Stephens P, 1995, CELL ADHES COMMUN, V3, P375, DOI 10.3109/15419069509081292; Takagi J, 2003, EMBO J, V22, P4607, DOI 10.1093/emboj/cdg445; Tang ML, 2006, BIOCHEM BIOPH RES CO, V348, P1184, DOI 10.1016/j.bbrc.2006.07.179; Tang RH, 2005, J BIOL CHEM, V280, P29208, DOI 10.1074/jbc.M503239200; Tarui T, 2001, J BIOL CHEM, V276, P3983, DOI 10.1074/jbc.M008220200; UCIECHOWSKI P, 1989, CLUSTER REPORT CD11; Vararattanavech A, 2008, BIOCHEM J, V410, P495, DOI 10.1042/BJ20071218; VIOLETTE SM, 1995, J IMMUNOL, V155, P3092; Wei Y, 2005, J CELL BIOL, V168, P501, DOI 10.1083/jcb.200404112; Wei Y, 2007, J BIOL CHEM, V282, P3929, DOI 10.1074/jbc.M607989200; Xiao T, 2004, NATURE, V432, P59, DOI 10.1038/nature02976; Xiong JP, 2002, SCIENCE, V296, P151, DOI 10.1126/science.1069040; Xue W, 1997, CANCER RES, V57, P1682; XUE W, 1994, J IMMUNOL, V152, P4630; Zhang H, 2003, INFLAMM RES, V52, P86, DOI 10.1007/s000110300006; ZHOU MJ, 1993, J IMMUNOL, V150, P3030; Zhu JQ, 2007, BLOOD, V110, P2475, DOI 10.1182/blood-2007-03-080077	68	16	16	0	2	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	SEP 12	2008	283	37					25392	25403		10.1074/jbc.M802311200	http://dx.doi.org/10.1074/jbc.M802311200			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	345QZ	18644795	hybrid			2022-12-27	WOS:000259012700034
J	Landgraf, P; Wahle, P; Pape, HC; Gundelfinger, ED; Kreutz, MR				Landgraf, Peter; Wahle, Petra; Pape, Hans-Christian; Gundelfinger, Eckart D.; Kreutz, Michael R.			The Survival-promoting Peptide Y-P30 Enhances Binding of Pleiotrophin to Syndecan-2 and-3 and Supports Its Neuritogenic Activity	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							PROTEOLYSIS-INDUCING FACTOR; GROWTH-ASSOCIATED MOLECULE; NF-KAPPA-B; HEPARAN-SULFATE PROTEOGLYCANS; MUSCLE PROTEIN-DEGRADATION; CANCER CACHECTIC FACTOR; HB-GAM; NEURITE OUTGROWTH; BREAST-CANCER; RAT-BRAIN	Y-P30 is a polypeptide produced by peripheral blood mononuclear cells of the maternal immune system during pregnancy. The peptide passes the blood-placenta barrier and accumulates in neurons of the developing infant brain, where it enhances survival of thalamic neurons and displays neuritogenic activities. In this study, we identify pleiotrophin (PTN) and syndecan-2 and -3 as direct binding partners of Y-P30. PTN is known to promote neurite outgrowth of thalamic neurons due to its association with the proteoglycan syndecan-3. Via spontaneous oligomerization Y-P30 can capture large macromolecular complexes containing PTN and potentially syndecans. Accordingly, the neuritogenic activity of Y-P30 in thalamic primary cultures requires the presence of PTN in the media and binding to syndecans. Thus, we propose that the neurite outgrowth promoting actions of Y-P30 during brain development are essentially based on its association with the PTN/syndecan signaling complex. This identifies a new mechanism of communication between the nervous and the immune system that might directly affect the wiring of the brain during development.	[Landgraf, Peter; Kreutz, Michael R.] Leibniz Inst Neurobiol, Project Grp Neuroplast, D-39118 Magdeburg, Germany; [Gundelfinger, Eckart D.] Leibniz Inst Neurobiol, Dept Nueorchem Mol Biol, D-39118 Magdeburg, Germany; [Wahle, Petra] Ruhr Univ Bochum, Fac Biol, AG Dev Biol, D-44780 Bochum, Germany; [Pape, Hans-Christian] Univ Munster, Inst Physiol, D-48149 Munster, Germany	Leibniz Institut fur Neurobiologie (LIN); Leibniz Institut fur Neurobiologie (LIN); Ruhr University Bochum; University of Munster	Kreutz, MR (corresponding author), Leibniz Inst Neurobiol, Project Grp Neuroplast, Brenneckestr 6, D-39118 Magdeburg, Germany.	Kreutz@ifn-magdeburg.de			Bundes ministerium fur Bildung und Forschung [01GA0505]; Deutsche Forschungsgemeinschaft [SFB 779 TPB8]; Leibniz-Society; Land Sachsen-Anhalt [N1/TP4/MRK, N2/TP5]; Schram Foundation; Fonds der Chemischen Industrie	Bundes ministerium fur Bildung und Forschung(Federal Ministry of Education & Research (BMBF)); Deutsche Forschungsgemeinschaft(German Research Foundation (DFG)); Leibniz-Society; Land Sachsen-Anhalt; Schram Foundation; Fonds der Chemischen Industrie(Fonds der Chemischen IndustrieEuropean Commission)	This work was supported by grants from the Bundes ministerium fur Bildung und Forschung (Grant 01GA0505 to M. R. K. and E. D. G.), Deutsche Forschungsgemeinschaft (Grant SFB 779 TPB8), Leibniz-Society (Pakt fur Forschung to M. R. K.), Land Sachsen-Anhalt (Grants N1/TP4/MRK and N2/TP5 to M. R. K. and E. D. G.), the Schram Foundation (to M. R. K.), and Fonds der Chemischen Industrie (to E. D. G.).	Bao XF, 2005, J BIOL CHEM, V280, P35318, DOI 10.1074/jbc.M507304200; Bao XF, 2005, J BIOL CHEM, V280, P9180, DOI 10.1074/jbc.M413423200; Bernard-Pierrot I, 1999, BIOCHEM BIOPH RES CO, V266, P437, DOI 10.1006/bbrc.1999.1835; BLOCH B, 1992, DEV BRAIN RES, V70, P267, DOI 10.1016/0165-3806(92)90206-C; Cabal-Manzano R, 2001, BRIT J CANCER, V84, P1599, DOI 10.1054/bjoc.2001.1830; Chang YC, 2007, P NATL ACAD SCI USA, V104, P10888, DOI 10.1073/pnas.0704366104; Cunningham TJ, 1998, J NEUROSCI, V18, P7047; Cunningham TJ, 2000, EXP NEUROL, V163, P457, DOI 10.1006/exnr.2000.7390; Deans DAC, 2006, BRIT J CANCER, V94, P731, DOI 10.1038/sj.bjc.6602989; Dieterich DC, 2008, PLOS BIOL, V6, P286, DOI 10.1371/journal.pbio.0060034; Helmuth M, 2001, ANAL BIOCHEM, V293, P149, DOI 10.1006/abio.2001.5107; Hida H, 2003, EUR J NEUROSCI, V17, P2127, DOI 10.1046/j.1460-9568.2003.02661.x; Hsueh YP, 1999, J NEUROSCI, V19, P7415, DOI 10.1523/JNEUROSCI.19-17-07415.1999; Kinnunen A, 1998, EUR J NEUROSCI, V10, P635, DOI 10.1046/j.1460-9568.1998.00082.x; Kinnunen A, 1999, EUR J NEUROSCI, V11, P491, DOI 10.1046/j.1460-9568.1999.00457.x; Kinnunen T, 1996, J BIOL CHEM, V271, P2243, DOI 10.1074/jbc.271.4.2243; Kinnunen T, 1998, J BIOL CHEM, V273, P10702, DOI 10.1074/jbc.273.17.10702; Landgraf P, 2004, FASEB J, V18, P225, DOI 10.1096/fj.04-1789fje; LI YS, 1990, SCIENCE, V250, P1690, DOI 10.1126/science.2270483; Lorite MJ, 1998, BRIT J CANCER, V78, P850, DOI 10.1038/bjc.1998.592; Maeda N, 1996, J BIOL CHEM, V271, P21446, DOI 10.1074/jbc.271.35.21446; MERENMIES J, 1990, J BIOL CHEM, V265, P16721; Mi RF, 2007, P NATL ACAD SCI USA, V104, P4664, DOI 10.1073/pnas.0603243104; Perez-Pinera P, 2007, CELL CYCLE, V6, P2877, DOI 10.4161/cc.6.23.5090; Porter D, 2003, P NATL ACAD SCI USA, V100, P10931, DOI 10.1073/pnas.1932980100; RAULO E, 1994, J BIOL CHEM, V269, P12999; Raulo E, 2005, J BIOL CHEM, V280, P41576, DOI 10.1074/jbc.M506457200; RAULO E, 1992, J BIOL CHEM, V267, P11408; Russell ST, 2008, BIOCHEM J, V409, P751, DOI 10.1042/BJ20070688; Sanderson RD, 2004, MATRIX BIOL, V23, P341, DOI 10.1016/j.matbio.2004.08.004; Schittek B, 2001, NAT IMMUNOL, V2, P1133, DOI 10.1038/ni732; Schulz JG, 2003, J BIOL CHEM, V278, P48651, DOI 10.1074/jbc.M308424200; Smith HJ, 2003, BRIT J CANCER, V89, P1783, DOI 10.1038/sj.bjc.6601328; Stoica GE, 2001, J BIOL CHEM, V276, P16772, DOI 10.1074/jbc.M010660200; Todorov P, 1996, NATURE, V379, P739, DOI 10.1038/379739a0; Todorov PT, 1999, BRIT J CANCER, V80, P1734, DOI 10.1038/sj.bjc.6690590; WANAKA A, 1993, DEV BRAIN RES, V72, P133, DOI 10.1016/0165-3806(93)90166-8; Watchorn TM, 2002, AM J PHYSIOL-ENDOC M, V282, pE763, DOI 10.1152/ajpendo.00408.2001; Watchorn TM, 2001, FASEB J, V15, P562; Whitehouse AS, 2003, BRIT J CANCER, V89, P1116, DOI 10.1038/sj.bjc.6601132; Wyke SM, 2005, BRIT J CANCER, V92, P711, DOI 10.1038/sj.bjc.6602402; Zhang N, 1997, J BIOL CHEM, V272, P16733, DOI 10.1074/jbc.272.27.16733	42	29	29	0	1	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	SEP 5	2008	283	36					25036	25045		10.1074/jbc.M800963200	http://dx.doi.org/10.1074/jbc.M800963200			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	517MA	18599487	hybrid, Green Published			2022-12-27	WOS:000271617300011
J	Jung, YY; Kim, HJ; Min, SH; Rhee, SG; Jeong, WJ				Jung, Yuyeon; Kim, Hojin; Min, Sun Hee; Rhee, Sue Goo; Jeong, Woojin			Dynein light chain LC8 negatively regulates NF-kappa B through the redox-dependent interaction with I kappa B alpha	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							NECROSIS-FACTOR-ALPHA; NADPH OXIDASE; TYROSINE PHOSPHORYLATION; TRANSCRIPTION FACTOR; CYTOPLASMIC DYNEIN; INDUCED ACTIVATION; TNF-ALPHA; PROTEIN; INHIBITOR; INDUCTION	Redox regulation of nuclear factor kappa B (NF-kappa B) has been described, but the molecular mechanism underlying such regulation has remained unclear. We recently showed that a novel disulfide reductase, TRP14, inhibits tumor necrosis factor alpha (TNF alpha)-induced NF-kappa B activation, and we identified the dynein light chain LC8, which interacts with the NF-kappa B inhibitor I kappa B alpha, as a potential substrate of TRP14. We now show the molecular mechanism by which NF-kappa B activation is redox-dependently regulated through LC8. LC8 inhibited TNF alpha-induced NF-kappa B activation in HeLa cells by interacting with I kappa B alpha and thereby preventing its phosphorylation by I kappa B kinase (IKK), without affecting the activity of IKK itself. TNF alpha induced the production of reactive oxygen species, which oxidized LC8 to a homodimer linked by the reversible formation of a disulfide bond between the Cys(2) residues of each subunit and thereby resulted in its dissociation from I kappa B alpha. Butylated hydroxyanisol, an antioxidant, and diphenyleneiodonium, an inhibitor of NADPH oxidase, attenuated the phosphorylation and degradation of I kappa B alpha by TNF alpha stimulation. In addition LC8 inhibited NF-kappa B activation by other stimuli including interleukin-1 beta and lipopolysaccharide, both of which generated reactive oxygen species. Furthermore, TRP14 catalyzed reduction of oxidized LC8. Together, our results indicate that LC8 binds I kappa B alpha in a redox-dependent manner and thereby prevents its phosphorylation by IKK. TRP14 contributes to this inhibitory activity by maintaining LC8 in a reduced state.	[Rhee, Sue Goo] Ewha Womans Univ, Div Life & Pharmaceut Sci, Dept Life Sci, Seoul 120750, South Korea; Ewha Womans Univ, Ctr Cell Signaling & Drug Discovery Res, Seoul 120750, South Korea	Ewha Womans University; Ewha Womans University	Rhee, SG (corresponding author), Ewha Womans Univ, Div Life & Pharmaceut Sci, Dept Life Sci, Sci Bldg C,Rm 102,11-1 Daehyun Dong, Seoul 120750, South Korea.	rheesg@ewha.ac.kr; jeongw@ewha.ac.kr			Korean government (the Ministry of Education and Human Resources Development) [KRF-2006-311C00414]; Ewha Womans University Research; Bio R D Program [M10642040002-07N4204-00210]; National Core Research Center Program [R15-2006-020]; Korea Science and Engineering Foundation; Brain Korea 21 Scholars Program; Ministry of Education, Science and Technology	Korean government (the Ministry of Education and Human Resources Development)(Korean Government); Ewha Womans University Research; Bio R D Program; National Core Research Center Program; Korea Science and Engineering Foundation(Korea Science and Engineering Foundation); Brain Korea 21 Scholars Program(Ministry of Education & Human Resources Development (MOEHRD), Republic of Korea); Ministry of Education, Science and Technology(Ministry of Education, Science & Technology (MEST), Republic of Korea)	This work was supported by Korea Research Foundation Grant KRF-2006-311C00414 from the Korean government (the Ministry of Education and Human Resources Development), a Ewha Womans University Research Grant of 2005, Bio R & D Program Grant M10642040002-07N4204-00210 (to S.G.R.) and M10642040002-07N4204-00210 ( to W. J.), National Core Research Center Program Grant R15-2006-020 through the Korea Science and Engineering Foundation funded by the Ministry of Education, Science and Technology, and funds from the Brain Korea 21 Scholars Program (to Y. J. and S. H. M.). The costs of publication of this article were defrayed in part by the payment of page charges. This article must therefore be hereby marked "advertisement" in accordance with 18 U. S. C. Section 1734 solely to indicate this fact.	Asehnoune K, 2004, J IMMUNOL, V172, P2522, DOI 10.4049/jimmunol.172.4.2522; Baldwin AS, 1996, ANNU REV IMMUNOL, V14, P649, DOI 10.1146/annurev.immunol.14.1.649; Barnes PJ, 1997, NEW ENGL J MED, V336, P1066, DOI 10.1056/NEJM199704103361506; Benashski SE, 1997, J BIOL CHEM, V272, P20929, DOI 10.1074/jbc.272.33.20929; Bowie A, 2000, BIOCHEM PHARMACOL, V59, P13, DOI 10.1016/S0006-2952(99)00296-8; Brigelius-Flohe R, 2004, ARCH BIOCHEM BIOPHYS, V423, P66, DOI 10.1016/j.abb.2003.12.008; Crepieux P, 1997, MOL CELL BIOL, V17, P7375, DOI 10.1128/MCB.17.12.7375; Dang PMC, 2006, J CLIN INVEST, V116, P2033, DOI 10.1172/JCI27544; Dewas C, 2003, J IMMUNOL, V171, P4392, DOI 10.4049/jimmunol.171.8.4392; Dick T, 1996, MOL CELL BIOL, V16, P1966; Donze O, 2002, NUCLEIC ACIDS RES, V30, DOI 10.1093/nar/30.10.e46; Fan CG, 2003, J BIOL CHEM, V278, P2072, DOI 10.1074/jbc.M206718200; Fan JS, 2001, J MOL BIOL, V306, P97, DOI 10.1006/jmbi.2000.4374; Fenwick C, 2000, SCIENCE, V287, P869, DOI 10.1126/science.287.5454.869; Frey RS, 2002, CIRC RES, V90, P1012, DOI 10.1161/01.RES.0000017631.28815.8E; Garg AK, 2002, MOL IMMUNOL, V39, P509, DOI 10.1016/S0161-5890(02)00207-9; Gloire G, 2006, BIOCHEM PHARMACOL, V72, P1493, DOI 10.1016/j.bcp.2006.04.011; Hayakawa M, 2003, EMBO J, V22, P3356, DOI 10.1093/emboj/cdg332; HAYASHI T, 1993, J BIOL CHEM, V268, P11380; Hayden MS, 2004, GENE DEV, V18, P2195, DOI 10.1101/gad.1228704; Huxford T, 2006, METHOD ENZYMOL, V407, P527, DOI 10.1016/S0076-6879(05)07042-4; Imbert V, 1996, CELL, V86, P787, DOI 10.1016/S0092-8674(00)80153-1; Jaffrey SR, 1996, SCIENCE, V274, P774, DOI 10.1126/science.274.5288.774; Jeong W, 2004, J BIOL CHEM, V279, P3151, DOI 10.1074/jbc.M307959200; Jimi E, 2004, NAT MED, V10, P617, DOI 10.1038/nm1054; Kaltschmidt B, 1997, P NATL ACAD SCI USA, V94, P2642, DOI 10.1073/pnas.94.6.2642; Kato T, 2003, MOL CELL, V12, P829, DOI 10.1016/S1097-2765(03)00358-7; Kim YS, 2007, MOL CELL, V26, P675, DOI 10.1016/j.molcel.2007.04.021; King SM, 2000, BBA-MOL CELL RES, V1496, P60, DOI 10.1016/S0167-4889(00)00009-4; King SM, 1996, J BIOL CHEM, V271, P19358, DOI 10.1074/jbc.271.32.19358; KING SM, 1995, J BIOL CHEM, V270, P11445, DOI 10.1074/jbc.270.19.11445; Kutuk O, 2003, TRENDS MOL MED, V9, P549, DOI 10.1016/j.molmed.2003.10.007; Li NX, 1998, P NATL ACAD SCI USA, V95, P13012, DOI 10.1073/pnas.95.22.13012; Li QA, 2006, MOL CELL BIOL, V26, P140, DOI 10.1128/MCB.26.1.140-154.2006; Li Q, 2006, J BIOL CHEM, V281, P37566, DOI 10.1074/jbc.M603643200; Liang J, 1999, NAT STRUCT BIOL, V6, P735; Lo KWH, 2005, J BIOL CHEM, V280, P8172, DOI 10.1074/jbc.M411408200; Lu JQ, 2005, BIOCHEM BIOPH RES CO, V331, P153, DOI 10.1016/j.bbrc.2005.03.128; McIntyre KW, 2003, ARTHRITIS RHEUM-US, V48, P2652, DOI 10.1002/art.11131; Mezghrani A, 2001, EMBO J, V20, P6288, DOI 10.1093/emboj/20.22.6288; Pahl HL, 1999, ONCOGENE, V18, P6853, DOI 10.1038/sj.onc.1203239; Park HS, 2004, J IMMUNOL, V173, P3589, DOI 10.4049/jimmunol.173.6.3589; Phillis R, 1996, DEVELOPMENT, V122, P2955; Puthalakath H, 2002, CELL DEATH DIFFER, V9, P505, DOI 10.1038/sj.cdd.4400998; Puthalakath H, 2001, SCIENCE, V293, P1829, DOI 10.1126/science.1062257; Puthalakath H, 1999, MOL CELL, V3, P287, DOI 10.1016/S1097-2765(00)80456-6; Saitoh M, 1998, EMBO J, V17, P2596, DOI 10.1093/emboj/17.9.2596; Sanlioglu S, 2001, J BIOL CHEM, V276, P30188, DOI 10.1074/jbc.M102061200; Shishodia S, 2004, BIOCHEM PHARMACOL, V68, P1071, DOI 10.1016/j.bcp.2004.04.026; Tateishi Y, 2008, BIOCHEM BIOPH RES CO, V366, P301, DOI 10.1016/j.bbrc.2007.11.039; Tobiume K, 2002, J CELL PHYSIOL, V191, P95, DOI 10.1002/jcp.10080; Vadlamudi RK, 2004, CANCER CELL, V5, P575, DOI 10.1016/j.ccr.2004.05.022; Vlahopoulos S, 1999, BLOOD, V94, P1878, DOI 10.1182/blood.V94.6.1878; Wilson MJ, 2001, CELL MOTIL CYTOSKEL, V49, P229, DOI 10.1002/cm.1036; Witherow DS, 2004, P NATL ACAD SCI USA, V101, P8603, DOI 10.1073/pnas.0402851101; Xu Y, 1999, DNA CELL BIOL, V18, P709, DOI 10.1089/104454999314999	56	74	76	0	3	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	AUG 29	2008	283	35					23863	23871		10.1074/jbc.M803072200	http://dx.doi.org/10.1074/jbc.M803072200			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	340II	18579519	Green Published, hybrid			2022-12-27	WOS:000258638900041
J	Chen, CA; Druhan, LJ; Varadharaj, S; Chen, YR; Zweier, JL				Chen, Chun-An; Druhan, Lawrence J.; Varadharaj, Saradhadevi; Chen, Yeong-Renn; Zweier, Jay L.			Phosphorylation of endothelial nitric-oxide synthase regulates superoxide generation from the enzyme	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							FREE-RADICAL GENERATION; PROTEIN-KINASE-C; SPHINGOSINE 1-PHOSPHATE; ESCHERICHIA-COLI; L-ARGININE; ACTIVATION; MECHANISM; PEROXYNITRITE; IDENTIFICATION; CALMODULIN	In the vasculature, nitric oxide (NO) is generated by endothelial NO synthase (eNOS) in a calcium/calmodulin-dependent reaction. With oxidative stress, the critical cofactor BH4 is depleted, and NADPH oxidation is uncoupled from NO generation, leading to production of (O-2(center dot) over bar). Although phosphorylation of eNOS regulates in vivo NO generation, the effects of phosphorylation on eNOS coupling and O-2(center dot) over bar generation are unknown. Therefore, we phosphorylated recombinant BH4- free eNOS in vitro using native kinases and determined O2 (center dot) over bar generation using EPR spin trapping. Phosphorylation of Ser-1177 by Akt led to an increase (> 50%) in maximal O-2(center dot) over bar generation from eNOS. Moreover, Ser-1177 phosphorylation greatly altered the Ca2+ sensitivity of eNOS, such that O-2(center dot) over bar generation became largely Ca2+-independent. In contrast, phosphorylation of eNOS at Thr-495 by protein kinase C alpha(PKC alpha) had no effect on maximum activity or calcium sensitivity but decreased calmodulin binding and increased association with caveolin. In endothelial cells, eNOS-dependent O-2(center dot) over bar generation was stimulated by vascular endothelial growth factor that induced phosphorylation of Ser-1177. With PKC activation that led to phosphorylation of Thr-495, no inhibition of O-2(center dot) over bar generation occurred. As such, phosphorylation of eNOS at Ser- 1177 is pivotal in the direct regulation of O-2(center dot) over bar and NO generation, altering both the Ca2+ sensitivity of the enzyme and rate of product formation, whereas phosphorylation of Thr-495 indirectly affects this process through regulation of the calmodulin and caveolin interaction. Thus, Akt-mediated phosphorylation modulates eNOS uncoupling and greatly increases O-2(center dot) over bar generation from the enzyme at low Ca2+ concentrations, and PKC alpha-mediated phosphorylation alters the sensitivity of the enzyme to other negative regulatory signals.	[Zweier, Jay L.] Ohio State Univ, Coll Med, Davis Heart & Lung Res Inst, Columbus, OH 43210 USA; Ohio State Univ, Coll Med, Dept Internal Med, Div Cardiovasc Med, Columbus, OH 43210 USA	Ohio State University; Ohio State University	Zweier, JL (corresponding author), Ohio State Univ, Coll Med, Davis Heart & Lung Res Inst, 473 W 12th Ave, Columbus, OH 43210 USA.	Jay.Zweier@osumc.edu	Druhan, Lawrence/E-2994-2011		National Institutes of Health [HL63744, HL65608, HL38324, HL83237]; American Heart Association; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL083237, R01HL038324, R01HL063744, P01HL065608, R29HL038324] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); American Heart Association(American Heart Association); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	This work was supported, in whole or in part, by National Institutes of Health Grants HL63744, HL65608, and HL38324 (to J.L.Z.) and HL83237 (Y.-R.C.). This work was also supported by an American Heart Association postdoctoral fellowship (to C.-A. C.). The costs of publication of this article were defrayed in part by the payment of page charges. This article must therefore be hereby marked "advertisement" in accordance with 18 U. S. C. Section 1734 solely to indicate this fact.	Andrews DA, 2002, BLOOD, V100, P3392, DOI 10.1182/blood.V100.9.3392; Berka V, 2004, J BIOL CHEM, V279, P32243, DOI 10.1074/jbc.M404044200; Berka V, 1998, BIOCHEMISTRY-US, V37, P6136, DOI 10.1021/bi980133l; BERS DM, 1994, METHOD CELL BIOL, V40, P3; Bucci M, 2000, NAT MED, V6, P1362, DOI 10.1038/82176; Cardounel AJ, 2005, J BIOL CHEM, V280, P7540, DOI 10.1074/jbc.M410241200; Chen PF, 2000, J BIOL CHEM, V275, P13155, DOI 10.1074/jbc.275.17.13155; Chen PF, 2003, J BIOL CHEM, V278, P52392, DOI 10.1074/jbc.M305469200; Chen YR, 2006, J BIOL CHEM, V281, P13159, DOI 10.1074/jbc.M513627200; Delgado-Esteban M, 2002, J NEUROCHEM, V82, P1148, DOI 10.1046/j.1471-4159.2002.01055.x; Dimmeler S, 1999, NATURE, V399, P601, DOI 10.1038/21224; Dumitrescu C, 2007, P NATL ACAD SCI USA, V104, P15081, DOI 10.1073/pnas.0702986104; Fleming I, 2005, CARDIOVASC RES, V65, P897, DOI 10.1016/j.cardiores.2004.11.003; Fleming I, 2001, CIRC RES, V88, pE68, DOI 10.1161/hh1101.092677; Fulton D, 2001, J PHARMACOL EXP THER, V299, P818; Fulton D, 1999, NATURE, V399, P597, DOI 10.1038/21218; Gallis B, 1999, J BIOL CHEM, V274, P30101, DOI 10.1074/jbc.274.42.30101; GERBER NC, 1995, J BIOL CHEM, V270, P17791, DOI 10.1074/jbc.270.30.17791; Greif DM, 2002, BIOCHEMISTRY-US, V41, P15845, DOI 10.1021/bi026732g; GRIFFITH OW, 1995, ANNU REV PHYSIOL, V57, P707, DOI 10.1146/annurev.ph.57.030195.003423; Haque MM, 2007, P NATL ACAD SCI USA, V104, P9254, DOI 10.1073/pnas.0700332104; Harris MB, 2001, J BIOL CHEM, V276, P16587, DOI 10.1074/jbc.M100229200; Igarashi J, 2001, J BIOL CHEM, V276, P36281, DOI 10.1074/jbc.M105628200; Ju H, 1997, J BIOL CHEM, V272, P18522, DOI 10.1074/jbc.272.30.18522; Kone BC, 2003, AM J PHYSIOL-RENAL, V285, pF178, DOI 10.1152/ajprenal.00048.2003; Lane P, 2002, J BIOL CHEM, V277, P19087, DOI 10.1074/jbc.M200258200; Lim EJ, 2007, AM J PHYSIOL-HEART C, V293, pH3340, DOI 10.1152/ajpheart.00921.2007; Lin MI, 2003, J BIOL CHEM, V278, P44719, DOI 10.1074/jbc.M302836200; Maniatis NA, 2006, CIRC RES, V99, P870, DOI 10.1161/01.RES.0000245187.08026.47; McCabe TJ, 2000, J BIOL CHEM, V275, P6123, DOI 10.1074/jbc.275.9.6123; Michel JB, 1997, J BIOL CHEM, V272, P15583, DOI 10.1074/jbc.272.25.15583; Michell BJ, 2001, J BIOL CHEM, V276, P17625, DOI 10.1074/jbc.C100122200; Michell BJ, 2002, J BIOL CHEM, V277, P42344, DOI 10.1074/jbc.M205144200; Michell BJ, 1999, CURR BIOL, V9, P845, DOI 10.1016/S0960-9822(99)80371-6; Morales-Ruiz M, 2001, J BIOL CHEM, V276, P19672, DOI 10.1074/jbc.M009993200; Muscoli C, 2003, BRIT J PHARMACOL, V140, P445, DOI 10.1038/sj.bjp.0705430; Nagata D, 2006, HYPERTENSION, V48, P165, DOI 10.1161/01.HYP.0000226054.53527.bb; NATHAN C, 1994, CELL, V78, P915, DOI 10.1016/0092-8674(94)90266-6; Niki I, 1996, J BIOCHEM, V120, P685; Nishida CR, 1999, J BIOL CHEM, V274, P14692, DOI 10.1074/jbc.274.21.14692; Pacher P, 2007, PHYSIOL REV, V87, P315, DOI 10.1152/physrev.00029.2006; Partovian C, 2005, CIRC RES, V97, P482, DOI 10.1161/01.RES.0000179775.04114.45; Patton C, 2004, CELL CALCIUM, V35, P427, DOI 10.1016/j.ceca.2003.10.006; POU S, 1992, J BIOL CHEM, V267, P24173; RodriguezCrespo I, 1996, ARCH BIOCHEM BIOPHYS, V336, P151, DOI 10.1006/abbi.1996.0543; Sessa WC, 2004, J CELL SCI, V117, P2427, DOI 10.1242/jcs.01165; Simoncini T, 2000, NATURE, V407, P538, DOI 10.1038/35035131; Stuehr DJ, 2004, J BIOL CHEM, V279, P36167, DOI 10.1074/jbc.R400017200; Sun J, 2008, ARCH BIOCHEM BIOPHYS, V471, P126, DOI 10.1016/j.abb.2008.01.003; Szabo C, 2003, TOXICOL LETT, V140, P105, DOI 10.1016/S0378-4274(02)00507-6; Vasquez-Vivar J, 1998, P NATL ACAD SCI USA, V95, P9220, DOI 10.1073/pnas.95.16.9220; Whitsett J, 2006, FREE RADICAL BIO MED, V40, P2056, DOI 10.1016/j.freeradbiomed.2006.02.001; Xia Y, 2004, J AM COLL CARDIOL, V43, p294A, DOI 10.1016/S0735-1097(04)91245-4; Xia Y, 1998, J BIOL CHEM, V273, P25804, DOI 10.1074/jbc.273.40.25804; Xia Y, 1996, P NATL ACAD SCI USA, V93, P6770, DOI 10.1073/pnas.93.13.6770; Xia Y, 1998, J BIOL CHEM, V273, P22635, DOI 10.1074/jbc.273.35.22635; Xia Y, 1997, P NATL ACAD SCI USA, V94, P6954, DOI 10.1073/pnas.94.13.6954; ZWEIER JL, 1987, P NATL ACAD SCI USA, V84, P1404, DOI 10.1073/pnas.84.5.1404; ZWEIER JL, 1988, J BIOL CHEM, V263, P1353; Zweier JL, 1998, TRANSPL P, V30, P4228, DOI 10.1016/S0041-1345(98)01399-2; ZWEIER JL, 1988, P NATL ACAD SCI USA, V85, P4046, DOI 10.1073/pnas.85.11.4046; ZWEIER JL, 1989, J BIOL CHEM, V264, P18890	62	133	136	0	4	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	OCT 3	2008	283	40					27038	27047		10.1074/jbc.M802269200	http://dx.doi.org/10.1074/jbc.M802269200			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	353RT	18622039	hybrid, Green Published			2022-12-27	WOS:000259586600024
J	Conn, EM; Madsen, MA; Cravatt, BF; Ruf, W; Deryugina, EI; Quigley, JP				Conn, Erin M.; Madsen, Mark A.; Cravatt, Benjamin F.; Ruf, Wolfram; Deryugina, Elena I.; Quigley, James P.			Cell surface proteomics identifies molecules functionally linked to tumor cell intravasation	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							JUNCTIONAL ADHESION MOLECULE; TISSUE-FACTOR; CANCER METASTASIS; TRANSENDOTHELIAL MIGRATION; MATRIX METALLOPROTEINASES; DOWN-REGULATION; MELANOMA-CELLS; FACTOR-VIIA; IN-VIVO; PROTEIN	In order to better understand the molecular and cellular determinants of tumor cell intravasation, our laboratory has generated a pair of congenic human HT-1080 fibrosarcoma variants (i.e. HT-hi/diss and HT-lo/diss) differing 50-100-fold in their ability to intravasate and disseminate. To investigate the molecular differences underlying the distinct dissemination capacities of these HT-1080 variants, we performed a comparative analysis of the cell surface proteomes of HT-hi/diss and HT-lo/diss. Cell membrane proteins were enriched by biotinylation and avidin precipitation and analyzed by tandem mass spectrometry employing multidimensional protein identification technology. By this approach, 47 cell surface-associated molecules were identified as differentially expressed between the HT-1080 intravasation variants. From these candidates, four targets (i.e. TIMP-2, NCAM-1, JAM-C, and tissue factor (TF)) were selected for further biochemical validation and in vivo functional verification. Western blot analysis of the cell surface enriched fractions confirmed the proteomic array data, demonstrating that, in vitro, TIMP-2 protein was increased in the HT-lo/diss variant, whereas NCAM-1, JAM-C, and TF levels were increased in the HT-hi/diss variant. Corresponding in vivo differences in levels of TIMP-2, JAM-C, and TF were demonstrated in primary tumors grown in the chick embryo. Finally, functional inhibition of one selected protein (i.e. TF) by small interfering RNA silencing or ligation with a function-blocking antibody significantly reduced HT-hi/diss intravasation, thus clearly implicating TF in the early steps of tumor cell dissemination. Overall, our cell surface proteomic analysis provides a powerful tool for identification of specific cell membrane molecules that contribute functionally to intravasation and metastasis in vivo.	[Conn, Erin M.; Madsen, Mark A.; Cravatt, Benjamin F.; Deryugina, Elena I.; Quigley, James P.] Scripps Res Inst, Dept Cell Biol, La Jolla, CA 92037 USA; [Ruf, Wolfram] Scripps Res Inst, Dept Immunol, La Jolla, CA 92037 USA	Scripps Research Institute; Scripps Research Institute	Quigley, JP (corresponding author), Scripps Res Inst, Dept Cell Biol, 10550 N Torrey Pines Rd, La Jolla, CA 92037 USA.	jquigley@scripps.edu			National Institutes of Health [CA55852, CA105412]; National Institutes of Health, NCI [2 T32CA77109- 08]; NATIONAL CANCER INSTITUTE [R01CA055852, R01CA105412, T32CA077109] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); National Institutes of Health, NCI(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This work was supported, in whole or in part, by National Institutes of Health Grants CA55852 and CA105412 ( to J. P. Q.) and National Institutes of Health, NCI, Grant 2 T32CA77109- 08 ( to E. M. C.). The costs of publication of this article were defrayed in part by the payment of page charges. This article must therefore be hereby marked "advertisement" in accordance with 18 U. S. C. Section 1734 solely to indicate this fact.	Belting M, 2005, ARTERIOSCL THROM VAS, V25, P1545, DOI 10.1161/01.ATV.0000171155.05809.bf; Blavier L, 1999, ANN NY ACAD SCI, V878, P108, DOI 10.1111/j.1749-6632.1999.tb07677.x; Bogenrieder T, 2003, ONCOGENE, V22, P6524, DOI 10.1038/sj.onc.1206757; Bradfield PF, 2007, BLOOD, V110, P2545, DOI 10.1182/blood-2007-03-078733; Bromberg ME, 2001, THROMB HAEMOSTASIS, V86, P1210; Chambers AF, 2002, NAT REV CANCER, V2, P563, DOI 10.1038/nrc865; Chavakis T, 2004, J BIOL CHEM, V279, P55602, DOI 10.1074/jbc.M404676200; CUNNINGHAM BA, 1987, SCIENCE, V236, P799, DOI 10.1126/science.3576199; Cunningham SA, 2000, J BIOL CHEM, V275, P34750, DOI 10.1074/jbc.M002718200; DAVIE EW, 1991, BIOCHEMISTRY-US, V30, P10363, DOI 10.1021/bi00107a001; Deryugina EI, 2005, CANCER RES, V65, P10959, DOI 10.1158/0008-5472.CAN-05-2228; ENG JK, 1994, J AM SOC MASS SPECTR, V5, P976, DOI 10.1016/1044-0305(94)80016-2; ESUMI N, 1991, CANCER RES, V51, P4549; Fidler IJ, 2003, NAT REV CANCER, V3, P453, DOI 10.1038/nrc1098; Fuse C, 2007, J BIOL CHEM, V282, P8276, DOI 10.1074/jbc.M608836200; Gupta GP, 2006, CELL, V127, P679, DOI 10.1016/j.cell.2006.11.001; Hastie C, 2005, ONCOGENE, V24, P5905, DOI 10.1038/sj.onc.1208747; Holen T, 2002, NUCLEIC ACIDS RES, V30, P1757, DOI 10.1093/nar/30.8.1757; Jang JH, 2003, PROTEOMICS, V3, P1947, DOI 10.1002/pmic.200300563; Jiang X, 2004, J THROMB HAEMOST, V2, P93, DOI 10.1111/j.1538-7836.2004.00545.x; Kim J, 1998, CELL, V94, P353, DOI 10.1016/S0092-8674(00)81478-6; Koizume S, 2006, CANCER RES, V66, P9453, DOI 10.1158/0008-5472.CAN-06-1803; Lee J, 2006, CANCER CELL, V9, P391, DOI 10.1016/j.ccr.2006.03.030; Link AJ, 1999, NAT BIOTECHNOL, V17, P676, DOI 10.1038/10890; LIU H, 2002, BIOTECHNIQUES, V32, P902; Liu HB, 2002, BIOTECHNIQUES, V32, P898, DOI 10.2144/02324pt01; Liu HB, 2004, ANAL CHEM, V76, P4193, DOI 10.1021/ac0498563; Liu YS, 1999, P NATL ACAD SCI USA, V96, P14694, DOI 10.1073/pnas.96.26.14694; MACKMAN N, 1989, BIOCHEMISTRY-US, V28, P1755, DOI 10.1021/bi00430a050; Madsen MA, 2006, J BIOL CHEM, V281, P15997, DOI 10.1074/jbc.M601223200; Mueller BM, 1998, J CLIN INVEST, V101, P1372, DOI 10.1172/JCI930; MUELLER BM, 1992, P NATL ACAD SCI USA, V89, P11832, DOI 10.1073/pnas.89.24.11832; Pang JX, 2002, J PROTEOME RES, V1, P161, DOI 10.1021/pr015518w; Pantel K, 2004, NAT REV CANCER, V4, P448, DOI 10.1038/nrc1370; Partridge JJ, 2007, J BIOL CHEM, V282, P35964, DOI 10.1074/jbc.M705993200; RAO LVM, 1992, CANCER METAST REV, V11, P249; RUF W, 1994, FASEB J, V8, P385, DOI 10.1096/fasebj.8.6.8168689; Ruf W, 2006, SEMIN THROMB HEMOST, V32, P61, DOI 10.1055/s-2006-939555; Santoso S, 2005, J BIOL CHEM, V280, P36326, DOI 10.1074/jbc.M505059200; Scheurer SB, 2005, PROTEOMICS, V5, P3035, DOI 10.1002/pmic.200402069; Shin BK, 2003, J BIOL CHEM, V278, P7607, DOI 10.1074/jbc.M210455200; STRONGIN AY, 1995, J BIOL CHEM, V270, P5331, DOI 10.1074/jbc.270.10.5331; Versteeg HH, 2008, BLOOD, V111, P190, DOI 10.1182/blood-2007-07-101048; Versteeg HH, 2004, MOL MED, V10, P6, DOI 10.2119/2003-00047.Versteeg; Voigtlander C, 2002, J CELL BIOCHEM, V85, P54, DOI 10.1002/jcb.10099; Wang WG, 2005, TRENDS CELL BIOL, V15, P138, DOI 10.1016/j.tcb.2005.01.003; Wang XL, 2004, INT J CANCER, V112, P994, DOI 10.1002/ijc.20527; Washburn MP, 2001, NAT BIOTECHNOL, V19, P242, DOI 10.1038/85686; Zhang W, 2003, ELECTROPHORESIS, V24, P2855, DOI 10.1002/elps.200305569; Zijlstra A, 2002, CANCER RES, V62, P7083; Zijlstra A, 2008, CANCER CELL, V13, P221, DOI 10.1016/j.ccr.2008.01.031; Zucker S, 1998, J BIOL CHEM, V273, P1216, DOI 10.1074/jbc.273.2.1216	52	43	44	1	5	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	SEP 26	2008	283	39					26518	26527		10.1074/jbc.M803337200	http://dx.doi.org/10.1074/jbc.M803337200			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	350GV	18658134	Green Published, hybrid			2022-12-27	WOS:000259341600028
J	Sai, JQ; Raman, D; Liu, YX; Wikswo, J; Richmond, A				Sai, Jiqing; Raman, Dayanidhi; Liu, Yuxin; Wikswo, John; Richmond, Ann			Parallel phosphatidylinositol 3-kinase (PI3K)-dependent and Src-dependent pathways lead to CXCL8-mediated Rac2 activation and chemotaxis	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							NUCLEOTIDE EXCHANGE ACTIVITY; NEUTROPHIL CHEMOTAXIS; FAMILY; PI3K-GAMMA; PROTEINS; POLARITY; DOCK180; CELLS; DICTYOSTELIUM; ELMO1	The requirement for phosphatidylinositol 3-kinase (PI3K) in the establishment of cell polarity and motility in a number of cell types has recently come into question. In this study, we demonstrate that inhibition of PI3K by wortmannin in neutrophil-like differentiated HL60 cells expressing CXCR2 resulted in reduced cell motility but normal chemotaxis in response to a gradient of CXCL8. However, wortmannin inhibition of PI3K did impair the ability of cells to re-orient their polarity and respond quickly to a change in the direction of the CXCL8 gradient. We hypothesized that Src-regulated ELMO-Dock2-Rac2 activation mediates chemotaxis in the absence of PI3K activity. Inhibition of Src with the small molecule inhibitor, PP2, or inhibition of Dock2 by shRNA knockdown confirmed the functional role of Src and Dock2 in regulating chemotaxis when PI3K was inhibited. Moreover, neutrophils isolated from bone marrow of hck(-/-) fgr(-/-) lyn(-/-) mice exhibited much more severe inhibition of chemotaxis when PI3K was blocked with wortmannin as compared with neutrophils isolated from bone marrow of wild-type mice. Thus, PI3K and Src-ELMO-Dock2 pathways work in parallel to activate Rac2 and modulate chemotaxis in response to a CXCL8 gradient in neutrophils.	[Sai, Jiqing; Raman, Dayanidhi; Richmond, Ann] Vanderbilt Univ, Sch Med, Dept Canc Biol, Nashville, TN 37232 USA; [Richmond, Ann] Vanderbilt Univ, Sch Med, Dept Vet Affairs, Nashville, TN 37232 USA; [Liu, Yuxin; Wikswo, John] Vanderbilt Univ, Sch Engn, VIIBRE & Biomed Engn, Nashville, TN 37212 USA	Vanderbilt University; Vanderbilt University; Vanderbilt University	Richmond, A (corresponding author), Vanderbilt Univ, Sch Med, Dept Canc Biol, 221 Kirkland Hall, Nashville, TN 37232 USA.	ann.richmond@vanderbilt.edu	Richmond, Ann/A-3048-2014; liu, yuxin/GRY-3592-2022	RICHMOND, ANN/0000-0002-9580-900X	National Institutes of Health [CA34590]; NCI [U54CA113007]; Department of Veterans Affairs; Vanderbilt Academic Venture Capital Fund; Vanderbilt Ingram-Cancer Center [CA68485]; NATIONAL CANCER INSTITUTE [R23CA034590, R01CA034590, U54CA113007, P30CA068485] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NCI(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); Department of Veterans Affairs(US Department of Veterans Affairs); Vanderbilt Academic Venture Capital Fund; Vanderbilt Ingram-Cancer Center; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This work was supported, in whole or in part by National Institutes of Health Grants CA34590 (to A. R.) and NCI U54CA113007 (to Vito Quaranta). This work was also supported by a Senior Research Career Scientist Award from the Department of Veterans Affairs (to A. R.), the Vanderbilt Institute for Integrative Biosystems Research and Education and the Vanderbilt Academic Venture Capital Fund (to J. W.), and the Vanderbilt Ingram-Cancer Center Grant CA68485 (to Jennifer Pietenpol). The costs of publication of this article were defrayed in part by the payment of page charges. This article must therefore be hereby marked "advertisement" in accordance with 18 U. S. C. Section 1734 solely to indicate this fact.	Andrew N, 2007, NAT CELL BIOL, V9, P193, DOI 10.1038/ncb1536; Benard V, 1999, J BIOL CHEM, V274, P13198, DOI 10.1074/jbc.274.19.13198; Boxio R, 2004, J LEUKOCYTE BIOL, V75, P604, DOI 10.1189/jlb.0703340; Camps M, 2005, NAT MED, V11, P936, DOI 10.1038/nm1284; Chen LF, 2007, DEV CELL, V12, P603, DOI 10.1016/j.devcel.2007.03.005; Cote JF, 2006, METHOD ENZYMOL, V406, P41, DOI 10.1016/S0076-6879(06)06004-6; Cote JF, 2005, NAT CELL BIOL, V7, P797, DOI 10.1038/ncb1280; Cote JF, 2002, J CELL SCI, V115, P4901, DOI 10.1242/jcs.00219; DeBakker CD, 2004, CURR BIOL, V14, P2208, DOI 10.1016/j.cub.2004.12.029; Fergus GJ, 2007, NAT CELL BIOL, V9, P86, DOI 10.1038/ncb1517; Filippi MD, 2004, NAT IMMUNOL, V5, P744, DOI 10.1038/ni1081; Grimsley CM, 2004, J BIOL CHEM, V279, P6087, DOI 10.1074/jbc.M307087200; Gu Y, 2001, J BIOL CHEM, V276, P15929, DOI 10.1074/jbc.M010445200; Gumienny TL, 2001, CELL, V107, P27, DOI 10.1016/S0092-8674(01)00520-7; Hasegawa H, 1996, MOL CELL BIOL, V16, P1770; Heit B, 2008, NAT IMMUNOL, V9, P743, DOI 10.1038/ni.1623; Heit B, 2008, J CELL SCI, V121, P205, DOI 10.1242/jcs.020412; Hirsch E, 2000, SCIENCE, V287, P1049, DOI 10.1126/science.287.5455.1049; Hoeller O, 2007, CURR BIOL, V17, P813, DOI 10.1016/j.cub.2007.04.004; Katoh H, 2003, NATURE, V424, P461, DOI 10.1038/nature01817; Kunisaki Y, 2006, J CELL BIOL, V174, P647, DOI 10.1083/jcb.200602142; Li SJ, 2002, J IMMUNOL, V169, P5043, DOI 10.4049/jimmunol.169.9.5043; Li Z, 2000, SCIENCE, V287, P1046, DOI 10.1126/science.287.5455.1046; Liu YX, 2008, BIOMED MICRODEVICES, V10, P499, DOI 10.1007/s10544-007-9158-z; Loovers HM, 2006, MOL BIOL CELL, V17, P1503, DOI 10.1091/mbc.E05-09-0825; LOWELL CA, 1994, GENE DEV, V8, P387, DOI 10.1101/gad.8.4.387; Lu MJ, 2006, METHOD ENZYMOL, V406, P388, DOI 10.1016/S0076-6879(06)06028-9; Lu MJ, 2005, CURR BIOL, V15, P371, DOI 10.1016/j.cub.2005.01.050; Ma YC, 2000, CELL, V102, P635, DOI 10.1016/S0092-8674(00)00086-6; Meller N, 2005, J CELL SCI, V118, P4937, DOI 10.1242/jcs.02671; Neel NF, 2007, J CELL SCI, V120, P1559, DOI 10.1242/jcs.03437; Nishihara H, 2002, BLOOD, V100, P3968, DOI 10.1182/blood-2001-11-0032; Nombela-Arrieta C, 2004, IMMUNITY, V21, P429, DOI 10.1016/j.immuni.2004.07.012; Parente CA, 1998, CELL, V95, P81, DOI 10.1016/S0092-8674(00)81784-5; Roberts AW, 1999, IMMUNITY, V10, P183, DOI 10.1016/S1074-7613(00)80019-9; Sai JQ, 2006, J BIOL CHEM, V281, P35931, DOI 10.1074/jbc.M605883200; Sanui T, 2003, BLOOD, V102, P2948, DOI 10.1182/blood-2003-01-0173; Sasaki T, 2000, SCIENCE, V287, P1040, DOI 10.1126/science.287.5455.1040; Servant G, 2000, SCIENCE, V287, P1037, DOI 10.1126/science.287.5455.1037; Shinohara M, 2002, NATURE, V416, P759, DOI 10.1038/416759a; Smith LD, 2007, CELL SIGNAL, V19, P2528, DOI 10.1016/j.cellsig.2007.08.006; Takeda K, 2007, J BIOL CHEM, V282, P11874, DOI 10.1074/jbc.M610984200; van Haastert PJM, 2007, J CELL BIOL, V177, P809, DOI 10.1083/jcb.200701134; Wang F, 2002, NAT CELL BIOL, V4, P513, DOI 10.1038/ncb810; Weiner OD, 2002, NAT CELL BIOL, V4, P509, DOI 10.1038/ncb811; Welch HCE, 2002, CELL, V108, P809, DOI 10.1016/S0092-8674(02)00663-3; Yokoyama N, 2005, BIOCHEMISTRY-US, V44, P8841, DOI 10.1021/bi0500832	47	55	57	0	8	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	SEP 26	2008	283	39					26538	26547		10.1074/jbc.M805611200	http://dx.doi.org/10.1074/jbc.M805611200			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	350GV	18662984	Green Published, hybrid			2022-12-27	WOS:000259341600030
J	Martinez, SE; Heikaus, CC; Klevit, RE; Beavo, JA				Martinez, Sergio E.; Heikaus, Clemens C.; Klevit, Rachel E.; Beavo, Joseph A.			The structure of the GAF A domain from phosphodiesterase 6C reveals determinants of cGMP binding, a conserved binding surface, and a large cGMP-dependent conformational change	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							INHIBITORY GAMMA-SUBUNIT; CONE PHOTORECEPTOR PHOSPHODIESTERASE; MOLECULAR-GRAPHICS PROJECT; ESCHERICHIA-COLI; CYCLIC-GMP; ROD CGMP-PHOSPHODIESTERASE-6; VISUAL TRANSDUCTION; BACKBONE DYNAMICS; DIMERIZATION; PROTEINS	The photoreceptor phosphodiesterase (PDE6) regulates the intracellular levels of the second messenger cGMP in the outer segments of cone and rod photoreceptor cells. PDE6 contains two regulatory GAF domains, of which one (GAF A) binds cGMP and regulates the activity of the PDE6 holoenzyme. To increase our understanding of this allosteric regulation mechanism, we present the 2.6 angstrom crystal structure of the cGMP-bound GAF A domain of chicken cone PDE6. Nucleotide specificity appears to be provided in part by the orientation of Asn-116, which makes two hydrogen bonds to the guanine ring of cGMP but is not strictly conserved among PDE6 isoforms. The isolated PDE6C GAF A domain is monomeric and does not contain sufficient structural determinants to form a homodimer as found in full-length PDE6C. A highly conserved surface patch on GAF A indicates a potential binding site for the inhibitory subunit P gamma. NMR studies reveal that the apo-PDE6C GAF A domain is structured but adopts a significantly altered structural state indicating a large conformational change with rearrangement of secondary structure elements upon cGMP binding. The presented crystal structure will help to define the cGMP-dependent regulation mechanism of the PDE6 holoenzyme and its inhibition through P gamma binding.	[Martinez, Sergio E.; Beavo, Joseph A.] Univ Washington, Dept Pharmacol, Seattle, WA 98195 USA; [Heikaus, Clemens C.; Klevit, Rachel E.] Univ Washington, Dept Biochem, Seattle, WA 98195 USA	University of Washington; University of Washington Seattle; University of Washington; University of Washington Seattle	Beavo, JA (corresponding author), Univ Washington, Dept Pharmacol, Box 357280, Seattle, WA 98195 USA.	beavo@u.washington.edu	Klevit, Rachel/AAI-7038-2021	Klevit, Rachel/0000-0002-3476-969X	National Institutes of Health [R01 DK21723, P01 HL44948]; Boehringer Ingelheim Fonds Ph. D. scholarship; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [P01HL044948] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK021723] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Boehringer Ingelheim Fonds Ph. D. scholarship(Boehringer Ingelheim); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	This work was supported, in whole or in part, by National Institutes of Health Grants R01 DK21723 (to J.A.B.) and P01 HL44948 (to J.A.B. and R.E K.) and by a Boehringer Ingelheim Fonds Ph. D. scholarship (to C.C.H.). The costs of publication of this article were defrayed in part by the payment of page charges. This article must therefore be hereby marked "advertisement" in accordance with 18 U. S. C. Section 1734 solely to indicate this fact.	Anantharaman V, 2001, J MOL BIOL, V307, P1271, DOI 10.1006/jmbi.2001.4508; Aravind L, 1997, TRENDS BIOCHEM SCI, V22, P458, DOI 10.1016/S0968-0004(97)01148-1; Arshavsky VY, 2002, ANNU REV PHYSIOL, V64, P153, DOI 10.1146/annurev.physiol.64.082701.102229; Artemyev NO, 1996, J BIOL CHEM, V271, P25382, DOI 10.1074/jbc.271.41.25382; Brunger AT, 1998, ACTA CRYSTALLOGR D, V54, P905, DOI 10.1107/S0907444998003254; Cann M, 2007, MOL MICROBIOL, V64, P461, DOI 10.1111/j.1365-2958.2007.05669.x; Chappie TA, 2007, J MED CHEM, V50, P182, DOI 10.1021/jm060653b; Corbin JD, 2003, MOL PHARMACOL, V63, P1364, DOI 10.1124/mol.63.6.1364; COTE RH, 1994, P NATL ACAD SCI USA, V91, P4845, DOI 10.1073/pnas.91.11.4845; Cote RH, 2007, CYCLIC NUCLEOTIDE PH, P165; DELAGLIO F, 1995, J BIOMOL NMR, V6, P277, DOI 10.1007/BF00197809; Emsley P, 2004, ACTA CRYSTALLOGR D, V60, P2126, DOI 10.1107/S0907444904019158; FARROW NA, 1994, BIOCHEMISTRY-US, V33, P5984, DOI 10.1021/bi00185a040; GILLESPIE PG, 1988, J BIOL CHEM, V263, P8133; Guo LW, 2006, J BIOL CHEM, V281, P15412, DOI 10.1074/jbc.M600595200; Handa N, 2008, J BIOL CHEM, V283, P19657, DOI 10.1074/jbc.M800595200; Heikaus CC, 2008, J BIOL CHEM, V283, P22749, DOI 10.1074/jbc.M801577200; Huang DM, 2004, J BIOL CHEM, V279, P48143, DOI 10.1074/jbc.M404338200; Iffland A, 2005, BIOCHEMISTRY-US, V44, P8312, DOI 10.1021/bi047313h; JOHNSON BA, 1994, J BIOMOL NMR, V4, P603, DOI 10.1007/BF00404272; Kajimura N, 2002, J STRUCT BIOL, V139, P27, DOI 10.1016/S1047-8477(02)00502-6; Lin ZD, 2007, P NATL ACAD SCI USA, V104, P9597, DOI 10.1073/pnas.0703774104; MANDEL AM, 1995, J MOL BIOL, V246, P144, DOI 10.1006/jmbi.1994.0073; Martinez SE, 2005, P NATL ACAD SCI USA, V102, P3082, DOI 10.1073/pnas.0409913102; Martinez SE, 2002, P NATL ACAD SCI USA, V99, P13260, DOI 10.1073/pnas.192374899; Martinez Sergio E, 2002, Mol Interv, V2, P317, DOI 10.1124/mi.2.5.317; MARTINS TJ, 1982, J BIOL CHEM, V257, P1973; Miroux B, 1996, J MOL BIOL, V260, P289, DOI 10.1006/jmbi.1996.0399; Mou HM, 2001, J BIOL CHEM, V276, P27527, DOI 10.1074/jbc.M103316200; Muradov H, 2004, VISION RES, V44, P2437, DOI 10.1016/j.visres.2004.05.013; Muradov KG, 2003, J BIOL CHEM, V278, P10594, DOI 10.1074/jbc.M208456200; Muradov KG, 2002, BIOCHEMISTRY-US, V41, P3884, DOI 10.1021/bi015935m; Murshudov GN, 1997, ACTA CRYSTALLOGR D, V53, P240, DOI 10.1107/S0907444996012255; Potterton E, 2002, ACTA CRYSTALLOGR D, V58, P1955, DOI 10.1107/S0907444902015391; Potterton L, 2004, ACTA CRYSTALLOGR D, V60, P2288, DOI 10.1107/S0907444904023716; PUGH EN, 1986, VISION RES, V26, P1613, DOI 10.1016/0042-6989(86)90051-9; Song J, 2008, P NATL ACAD SCI USA, V105, P1505, DOI 10.1073/pnas.0709558105; Sung BJ, 2003, NATURE, V425, P98, DOI 10.1038/nature01914; Tcheudji JFK, 2001, J MOL BIOL, V310, P781, DOI 10.1006/jmbi.2001.4813; Terwilliger TC, 1999, ACTA CRYSTALLOGR D, V55, P849, DOI 10.1107/S0907444999000839; Terwilliger TC, 2000, ACTA CRYSTALLOGR D, V56, P965, DOI 10.1107/S0907444900005072; THOMPSON JD, 1994, NUCLEIC ACIDS RES, V22, P4673, DOI 10.1093/nar/22.22.4673; VANDUYNE GD, 1993, J MOL BIOL, V229, P105, DOI 10.1006/jmbi.1993.1012; Wagner JR, 2005, NATURE, V438, P325, DOI 10.1038/nature04118; Wang HC, 2006, J BIOL CHEM, V281, P21469, DOI 10.1074/jbc.M512527200; Wu AY, 2004, J BIOL CHEM, V279, P37928, DOI 10.1074/jbc.M404287200; Yamazaki M, 2002, J BIOL CHEM, V277, P40675, DOI 10.1074/jbc.M203469200; Zoraghi R, 2004, MOL PHARMACOL, V65, P267, DOI 10.1124/mol.65.2.267; Zoraghi R, 2005, J BIOL CHEM, V280, P12051, DOI 10.1074/jbc.M413611200	49	38	39	0	12	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	SEP 19	2008	283	38					25913	25919		10.1074/jbc.M802891200	http://dx.doi.org/10.1074/jbc.M802891200			7	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	348GX	18614542	Green Published, hybrid			2022-12-27	WOS:000259200100018
J	Grespin, ME; Bonamy, GMC; Roggero, VR; Cameron, NG; Adam, LE; Atchison, AP; Fratto, VM; Allison, LA				Grespin, Matthew E.; Bonamy, Ghislain M. C.; Roggero, Vincent R.; Cameron, Nicole G.; Adam, Lindsay E.; Atchison, Andrew P.; Fratto, Victoria M.; Allison, Lizabeth A.			Thyroid hormone receptor alpha 1 follows a cooperative CRM1/calreticulin-mediated nuclear export pathway	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ONCOPROTEIN V-ERBA; GLUCOCORTICOID-RECEPTOR; NUCLEOCYTOPLASMIC TRANSPORT; SUBCELLULAR-LOCALIZATION; HORMONE-RECEPTORS; RIBOSOMAL-SUBUNIT; BINDING-PROTEIN; CALRETICULIN; EXPRESSION; SIGNALS	The thyroid hormone receptor alpha 1 (TR alpha) exhibits a dual role as an activator or repressor of its target genes in response to thyroid hormone (T-3) .Previously, we have shown that TR alpha, formerly thought to reside solely in the nucleus bound to DNA, actually shuttles rapidly between the nucleus and cytoplasm. An important aspect of the shuttling activity of TR alpha is its ability to exit the nucleus through the nuclear pore complex. TR alpha export is not sensitive to treatment with the CRM1-specific inhibitor leptomycin B ( LMB) in heterokaryon assays, suggesting a role for an export receptor other than CRM1. Here, we have used a combined approach of in vivo fluorescence recovery after photobleaching experiments, in vitro permeabilized cell nuclear export assays, and glutathione S-transferase pull-down assays to investigate the export pathway used by TR alpha. We show that, in addition to shuttling in heterokaryons, TR alpha shuttles rapidly in an unfused monokaryon system as well. Furthermore, our data show that TR alpha directly interacts with calreticulin, and point to the intriguing possibility that TR alpha follows a cooperative export pathway in which both calreticulin and CRM1 play a role in facilitating efficient translocation of TR alpha from the nucleus to cytoplasm.	[Grespin, Matthew E.; Bonamy, Ghislain M. C.; Roggero, Vincent R.; Cameron, Nicole G.; Adam, Lindsay E.; Atchison, Andrew P.; Fratto, Victoria M.; Allison, Lizabeth A.] Coll William & Mary, Dept Biol, Williamsburg, VA 23187 USA	William & Mary	Allison, LA (corresponding author), POB 8795,Millington Hall 116, Williamsburg, VA 23187 USA.	laalli@wm.edu		Bonamy, Ghislain/0000-0002-2826-5225	National Institutes of Health [2R15 DK058028-02]; National Science Foundation [MCB-0646506]; Howard Hughes Medical Institute; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R15DK058028] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); National Science Foundation(National Science Foundation (NSF)); Howard Hughes Medical Institute(Howard Hughes Medical Institute); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	This work was supported, in whole or in part, by National Institutes of Health Grant 2R15 DK058028-02 and National Science Foundation Grant MCB-0646506 ( to L. A. A.). This work was also supported by a Howard Hughes Medical Institute grant through the Undergraduate Biological Sciences Education Program to the College of William & Mary ( to N. G. C., L. E. A., and A. P. A.). The costs of publication of this article were defrayed in part by the payment of page charges. This article must therefore be hereby marked "advertisement"in accordance with 18 U. S. C. Section 1734 solely to indicate this fact.	ADAM SA, 1990, J CELL BIOL, V111, P807, DOI 10.1083/jcb.111.3.807; Afshar N, 2005, MOL CELL BIOL, V25, P8844, DOI 10.1128/MCB.25.20.8844-8853.2005; Amazit L, 2003, J BIOL CHEM, V278, P32195, DOI 10.1074/jbc.M300730200; Andrin C, 1998, BIOCHEMISTRY-US, V37, P10386, DOI 10.1021/bi980595z; Black BE, 2001, CURR BIOL, V11, P1749, DOI 10.1016/S0960-9822(01)00537-1; Bohlson SS, 2007, MOL IMMUNOL, V44, P33, DOI 10.1016/j.molimm.2006.06.021; Bonamy Ghislain M C, 2006, Nucl Recept Signal, V4, pe008; Bonamy GMC, 2005, MOL ENDOCRINOL, V19, P1213, DOI 10.1210/me.2004-0204; Bunn CF, 2001, MOL ENDOCRINOL, V15, P512, DOI 10.1210/mend.15.4.0619; BURNS K, 1994, NATURE, V367, P476, DOI 10.1038/367476a0; CHANDRAN UR, 1992, MOL ENDOCRINOL, V6, P837, DOI 10.1210/me.6.5.837; Cheng SY, 2003, MOL CELL ENDOCRINOL, V213, P23, DOI 10.1016/j.mce.2003.10.051; Cook A, 2007, ANNU REV BIOCHEM, V76, P647, DOI 10.1146/annurev.biochem.76.052705.161529; Coppolino MG, 1997, NATURE, V386, P843, DOI 10.1038/386843a0; Corbett EF, 2000, J BIOL CHEM, V275, P27177; DEDHAR S, 1994, NATURE, V367, P480, DOI 10.1038/367480a0; DEDHAR S, 2001, J CELL BIOL, V152, P127; DeLong LJ, 2004, J BIOL CHEM, V279, P15356, DOI 10.1074/jbc.M308214200; Donnelly S, 2006, ARTHRITIS RHEUM-US, V54, P1543, DOI 10.1002/art.21783; Englmeier L, 2001, EMBO REP, V2, P926, DOI 10.1093/embo-reports/kve200; Freedman DA, 1998, MOL CELL BIOL, V18, P7288, DOI 10.1128/MCB.18.12.7288; Fried H, 2003, CELL MOL LIFE SCI, V60, P1659, DOI 10.1007/s00018-003-3070-3; Gonzalez-Sancho JM, 2003, CANCER LETT, V192, P121, DOI 10.1016/S0304-3835(02)00614-6; Guo L, 2002, J BIOL CHEM, V277, P50776, DOI 10.1074/jbc.M209900200; Hache RJG, 1999, J BIOL CHEM, V274, P1432, DOI 10.1074/jbc.274.3.1432; Hattori K, 2007, MOL GENET METAB, V91, P285, DOI 10.1016/j.ymgme.2007.02.003; Hedges J, 2006, J BIOL CHEM, V281, P36579, DOI 10.1074/jbc.M606798200; Holaska JM, 2002, MOL CELL BIOL, V22, P6286, DOI 10.1128/MCB.22.17.6286-6297.2002; Holaska JM, 1998, P NATL ACAD SCI USA, V95, P14739, DOI 10.1073/pnas.95.25.14739; Itoh M, 2002, MOL ENDOCRINOL, V16, P2382, DOI 10.1210/me.2002-0144; Jethmalani SM, 1997, J CELL BIOCHEM, V66, P98; Kobayashi S, 2006, CYTOGENET GENOME RES, V115, P10, DOI 10.1159/000094795; Krause KH, 1997, CELL, V88, P439, DOI 10.1016/S0092-8674(00)81884-X; Kudo N, 1999, P NATL ACAD SCI USA, V96, P9112, DOI 10.1073/pnas.96.16.9112; Kutay U, 2005, TRENDS CELL BIOL, V15, P121, DOI 10.1016/j.tcb.2005.01.005; la Cour T, 2004, PROTEIN ENG DES SEL, V17, P527, DOI 10.1093/protein/gzh062; la Cour T, 2003, NUCLEIC ACIDS RES, V31, P393, DOI 10.1093/nar/gkg101; Lain S, 1999, EXP CELL RES, V253, P315, DOI 10.1006/excr.1999.4672; LEUNGHAGESTEIJN CY, 1994, J CELL SCI, V107, P589; Li SS, 2005, J IMMUNOL, V174, P654, DOI 10.4049/jimmunol.174.2.654; Lindsay ME, 2001, J CELL BIOL, V153, P1391, DOI 10.1083/jcb.153.7.1391; Lozyk MD, 2006, BMC DEV BIOL, V6, DOI 10.1186/1471-213X-6-54; MADAN AP, 1993, P NATL ACAD SCI USA, V90, P3588, DOI 10.1073/pnas.90.8.3588; Maruvada P, 2003, J BIOL CHEM, V278, P12425, DOI 10.1074/jbc.M202752200; Mery L, 1996, J BIOL CHEM, V271, P9332, DOI 10.1074/jbc.271.16.9332; Mesaeli N, 2004, MOL BIOL CELL, V15, P1862, DOI 10.1091/mbc.E03-04-0251; Mesaeli N, 1999, J CELL BIOL, V144, P857, DOI 10.1083/jcb.144.5.857; Pemberton LF, 2005, TRAFFIC, V6, P187, DOI 10.1111/j.1600-0854.2005.00270.x; Prufer K, 2002, MOL ENDOCRINOL, V16, P1738, DOI 10.1210/me.2001-0345; Rittinger K, 1999, MOL CELL, V4, P153, DOI 10.1016/S1097-2765(00)80363-9; Savory JGA, 1999, MOL CELL BIOL, V19, P1025; Seiser RM, 2006, GENETICS, V174, P679, DOI 10.1534/genetics.106.062117; Shank LC, 2005, CRIT REV EUKAR GENE, V15, P49, DOI 10.1615/CritRevEukaryotGeneExpr.v15.i1.40; Sharma A, 2004, PLANT CELL PHYSIOL, V45, P684, DOI 10.1093/pcp/pch077; Stommel JM, 1999, EMBO J, V18, P1660, DOI 10.1093/emboj/18.6.1660; Walther RF, 2003, J BIOL CHEM, V278, P37858, DOI 10.1074/jbc.M306356200; Weis K, 2003, CELL, V112, P441, DOI 10.1016/S0092-8674(03)00082-5; West M, 2007, J BIOL CHEM, V282, P14028, DOI 10.1074/jbc.M700256200	58	28	30	0	2	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	SEP 12	2008	283	37					25576	25588		10.1074/jbc.M710482200	http://dx.doi.org/10.1074/jbc.M710482200			13	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	345QZ	18641393	Green Published, hybrid			2022-12-27	WOS:000259012700053
J	Im, JS; Lee, JK				Im, Jun-Sub; Lee, Joon-Kyu			ATR-dependent activation of p38 MAP kinase is responsible for apoptotic cell death in cells depleted of Cdc7	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							DNA-REPLICATION CHECKPOINT; S-PHASE; CARCINOMA-CELLS; IN-VIVO; PROTEIN; DAMAGE; P53; INITIATION; CISPLATIN; PATHWAY	Cdc7 is a serine/threonine kinase that plays essential roles in the initiation of eukaryotic DNA replication and checkpoint response. In previous studies, depletion of Cdc7 by small interfering RNA was shown to induce an abortive S phase that led to the cell cycle arrest in normal human fibroblasts and apoptotic cell death in various cancer cells. Here we report that stress-activated p38 MAP kinase was activated and responsible for apoptotic cell death in Cdc7-depleted HeLa cells. The activation of p38 MAP kinase in the Cdc7-depleted cells was shown to depend on ATR, a major sensor kinase for checkpoint or DNA damage responses. Only the p38 MAP kinase, and not the other stress-activated kinases such as JNK or ERK, was activated, and both caspase 8 and caspase 9 were activated for the induction of apoptosis. Activation of apoptosis in Cdc7-depleted cells was completely abolished in cells treated with small interfering RNA or an inhibitor of the p38 MAP kinase, suggesting that p38 MAP kinase activation was responsible for apoptotic cell death. Taken together, we suggest that the ATR-dependent activation of the p38 MAP kinase is a major signaling pathway that induces apoptotic cell death after depletion of Cdc7 in cancer cells.	[Im, Jun-Sub; Lee, Joon-Kyu] Seoul Natl Univ, Dept Biol Educ, Seoul 151748, South Korea	Seoul National University (SNU)	Lee, JK (corresponding author), Seoul Natl Univ, Dept Biol Educ, Seoul 151748, South Korea.	joonlee@snu.ac.kr			Cancer Control, Ministry of Health & Welfare, Republic of Korea [0620260]; Korean Government (MOST) [R01-2007-000-20380-0]	Cancer Control, Ministry of Health & Welfare, Republic of Korea(Ministry of Health & Welfare (MOHW), Republic of Korea); Korean Government (MOST)(Ministry of Science & Technology (MOST), Republic of KoreaKorean Government)	This work was supported by a grant of the National R&D Program for Cancer Control, Ministry of Health & Welfare, Republic of Korea (0620260), and the Korea Science and Engineering Foundation (KOSEF) grant funded by the Korean Government (MOST) (R01-2007-000-20380-0). The costs of publication of this article were defrayed in part by the payment of page charges.	Appella E, 2001, EUR J BIOCHEM, V268, P2764, DOI 10.1046/j.1432-1327.2001.02225.x; Bartek J, 2001, CURR OPIN CELL BIOL, V13, P738, DOI 10.1016/S0955-0674(00)00280-5; Bartek J, 2004, NAT REV MOL CELL BIO, V5, P792, DOI 10.1038/nrm1493; Bell SP, 2002, ANNU REV BIOCHEM, V71, P333, DOI 10.1146/annurev.biochem.71.110601.135425; Brancho D, 2003, GENE DEV, V17, P1969, DOI 10.1101/gad.1107303; Brozovic A, 2004, INT J CANCER, V112, P974, DOI 10.1002/ijc.20522; Bulavin DV, 2001, NATURE, V411, P102, DOI 10.1038/35075107; Carrassa L, 2004, CELL CYCLE, V3, P1177; Costanzo V, 2003, MOL CELL, V11, P203, DOI 10.1016/S1097-2765(02)00799-2; Cuenda A, 2007, BBA-MOL CELL RES, V1773, P1358, DOI 10.1016/j.bbamcr.2007.03.010; Dohrmann PR, 1999, GENETICS, V151, P965; DOWELL SJ, 1994, SCIENCE, V265, P1243, DOI 10.1126/science.8066465; Enslen H, 2000, EMBO J, V19, P1301, DOI 10.1093/emboj/19.6.1301; Fridman JS, 2003, ONCOGENE, V22, P9030, DOI 10.1038/sj.onc.1207116; Heffernan TP, 2007, J BIOL CHEM, V282, P9458, DOI 10.1074/jbc.M611292200; Jiang W, 1999, EMBO J, V18, P5703, DOI 10.1093/emboj/18.20.5703; Kastan MB, 2004, NATURE, V432, P316, DOI 10.1038/nature03097; Kim JM, 2008, ONCOGENE, V27, P3475, DOI 10.1038/sj.onc.1210994; Kim JM, 2002, EMBO J, V21, P2168, DOI 10.1093/emboj/21.9.2168; Kinzel B, 2002, CANCER, V94, P1808, DOI 10.1002/cncr.10383; Kyriakis JM, 2001, PHYSIOL REV, V81, P807, DOI 10.1152/physrev.2001.81.2.807; Lemaire M, 2006, CELL CYCLE, V5, P1649, DOI 10.4161/cc.5.15.3006; Manke IA, 2005, MOL CELL, V17, P37, DOI 10.1016/j.molcel.2004.11.021; Mansouri A, 2003, J BIOL CHEM, V278, P19245, DOI 10.1074/jbc.M208134200; Montagnoli A, 2004, CANCER RES, V64, P7110, DOI 10.1158/0008-5472.CAN-04-1547; Nebreda AR, 2000, TRENDS BIOCHEM SCI, V25, P257, DOI 10.1016/S0968-0004(00)01595-4; Nyberg KA, 2002, ANNU REV GENET, V36, P617, DOI 10.1146/annurev.genet.36.060402.113540; Porras A, 2004, MOL BIOL CELL, V15, P922, DOI 10.1091/mbc.E03-08-0592; Reinhardt HC, 2007, CANCER CELL, V11, P175, DOI 10.1016/j.ccr.2006.11.024; Rodriguez-Bravo V, 2006, CANCER RES, V66, P8672, DOI 10.1158/0008-5472.CAN-05-4443; Roos WP, 2006, TRENDS MOL MED, V12, P440, DOI 10.1016/j.molmed.2006.07.007; Sclafani RA, 2007, ANNU REV GENET, V41, P237, DOI 10.1146/annurev.genet.41.110306.130308; Silva T, 2006, J BIOL CHEM, V281, P11569, DOI 10.1074/jbc.M510278200; Vogelstein B, 2000, NATURE, V408, P307, DOI 10.1038/35042675; Vousden KH, 2002, BBA-REV CANCER, V1602, P47, DOI 10.1016/S0304-419X(02)00035-5; Weinreich M, 1999, EMBO J, V18, P5334, DOI 10.1093/emboj/18.19.5334	36	40	44	0	4	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	SEP 12	2008	283	37					25171	25177		10.1074/jbc.M802851200	http://dx.doi.org/10.1074/jbc.M802851200			7	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	345QZ	18625709	hybrid			2022-12-27	WOS:000259012700009
J	Teillet, F; Gaboriaud, C; Lacroix, M; Martin, L; Arlaud, GJ; Thielens, NM				Teillet, Florence; Gaboriaud, Christine; Lacroix, Monique; Martin, Lydie; Arlaud, Gerard J.; Thielens, Nicole M.			Crystal structure of the CUB1-EGF-CUB2 domain of human MASP-1/3 and identification of its interaction sites with mannan-binding lectin and ficolins	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							NATURALLY-OCCURRING MUTATIONS; SERINE PROTEASES-1 AND-2; ELECTRON-DENSITY MAPS; X-RAY-STRUCTURE; COMPLEMENT PATHWAY; ACTIVATES COMPLEMENT; SERUM LECTIN; PROTEIN; REGION; LOCALIZATION	MASP-1 and MASP-3 are homologous proteases arising from alternative splicing of the MASP1/3 gene. They include an identical CUB1-EGF-CUB2-CCP1-CCP2 module array prolonged by different serine protease domains at the C-terminal end. The x-ray structure of the CUB1-EGF-CUB2 domain of human MASP-1/3, responsible for interaction of MASP-1 and -3 with their partner proteins mannan-binding lectin (MBL) and ficolins, was solved to a resolution of 2.3 angstrom. The structure shows a head-to-tail homodimer mainly stabilized by hydrophobic interactions between the CUB1 module of one monomer and the epidermal growth factor (EGF) module of its counterpart. A Ca2+ ion bound primarily to both EGF modules stabilizes the intra- and inter-monomer CUB1-EGF interfaces. Additional Ca2+ ions are bound to each CUB1 and CUB2 module through six ligands contributed by Glu(49), Asp(57), Asp(102), and Ser(104) (CUB1) and their counterparts Glu(216), Asp(226), Asp(263), and Ser(265) (CUB2), plus one and two water molecules, respectively. To identify the residues involved in interaction of MASP-1 and -3 with MBL and L- and H-ficolins, 27 point mutants of human MASP-3 were generated, and their binding properties were analyzed using surface plasmon resonance spectroscopy. These mutations map two homologous binding sites contributed by modules CUB1 and CUB2, located in close vicinity of their Ca2+-binding sites and stabilized by the Ca2+ ion. This information allows us to propose a model of the MBL-MASP-1/3 interaction, involving a major electrostatic interaction between two acidic Ca2+ ligands of MASP-1/3 and a conserved lysine of MBL. Based on these and other data, a schematic model of a MBL.MASP complex is proposed.	[Teillet, Florence; Lacroix, Monique; Arlaud, Gerard J.; Thielens, Nicole M.] UJF, CEA, CNRS,Lab Enzymol Mol, Inst Biol Struct Jean Pierre Ebel,UMR 5075, F-38027 Grenoble 1, France; [Teillet, Florence; Lacroix, Monique; Arlaud, Gerard J.; Thielens, Nicole M.] UJF, CEA, CNRS,Lab Cristallog & Cristallogenese Proteines, Inst Biol Struct Jean Pierre Ebel,UMR 5075, F-38027 Grenoble 1, France	Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Biology (INSB); UDICE-French Research Universities; Communaute Universite Grenoble Alpes; Universite Grenoble Alpes (UGA); CEA; UDICE-French Research Universities; Communaute Universite Grenoble Alpes; Universite Grenoble Alpes (UGA); CEA; Centre National de la Recherche Scientifique (CNRS)	Thielens, NM (corresponding author), UJF, CEA, CNRS,Lab Enzymol Mol, Inst Biol Struct Jean Pierre Ebel,UMR 5075, 41 Rue Jules Horowitz, F-38027 Grenoble 1, France.	nicole.thielens@ibs.fr	Thielens, Nicole M/F-2512-2013	Thielens, Nicole M/0000-0002-7354-0302	Commissariat a l'Energie Atomique; CNRS; Universite Joseph Fourier, Grenoble, France	Commissariat a l'Energie Atomique(French Atomic Energy Commission); CNRS(Centre National de la Recherche Scientifique (CNRS)); Universite Joseph Fourier, Grenoble, France	This work was supported by the Commissariat a l'Energie Atomique, the CNRS, and the Universite Joseph Fourier, Grenoble, France. The costs of publication of this article were defrayed in part by the payment of page charges. This article must therefore be hereby marked "advertisement" in accordance with 18 U. S. C. Section 1734 solely to indicate this fact.	Arlaud GJ, 2007, MOL IMMUNOL, V44, P3809, DOI 10.1016/j.molimm.2007.06.147; Bersch B, 1998, BIOCHEMISTRY-US, V37, P1204, DOI 10.1021/bi971851v; Brunger AT, 1998, ACTA CRYSTALLOGR D, V54, P905, DOI 10.1107/S0907444998003254; BUSBY TF, 1990, BIOCHEMISTRY-US, V29, P4613, DOI 10.1021/bi00471a016; CAMPBELL ID, 1993, CURR OPIN STRUC BIOL, V3, P385, DOI 10.1016/S0959-440X(05)80111-3; Chen CB, 2001, J BIOL CHEM, V276, P25894, DOI 10.1074/jbc.M103539200; Cseh S, 2002, J IMMUNOL, V169, P5735, DOI 10.4049/jimmunol.169.10.5735; Dahl MR, 2001, IMMUNITY, V15, P127, DOI 10.1016/S1074-7613(01)00161-3; Endo Y, 2006, ADV EXP MED BIOL, V586, P265; Feinberg H, 2003, EMBO J, V22, P2348, DOI 10.1093/emboj/cdg236; Gal P, 2005, J BIOL CHEM, V280, P33435, DOI 10.1074/jbc.M506051200; GILL SC, 1989, ANAL BIOCHEM, V182, P319, DOI 10.1016/0003-2697(89)90602-7; Girija UV, 2007, J IMMUNOL, V179, P455, DOI 10.4049/jimmunol.179.1.455; Gregory LA, 2004, J BIOL CHEM, V279, P29391, DOI 10.1074/jbc.M402687200; Gregory LA, 2003, J BIOL CHEM, V278, P32157, DOI 10.1074/jbc.M305175200; Harding MM, 1999, ACTA CRYSTALLOGR D, V55, P1432, DOI 10.1107/S0907444999007374; Holmskov U, 2003, ANNU REV IMMUNOL, V21, P547, DOI 10.1146/annurev.immunol.21.120601.140954; IKEDA K, 1987, J BIOL CHEM, V262, P7451; JONES TA, 1991, ACTA CRYSTALLOGR A, V47, P110, DOI 10.1107/S0108767390010224; KABSCH W, 1993, J APPL CRYSTALLOGR, V26, P795, DOI 10.1107/S0021889893005588; Krarup A, 2004, J BIOL CHEM, V279, P47513, DOI 10.1074/jbc.M407161200; Lacroix M, 1997, BIOCHEMISTRY-US, V36, P6270, DOI 10.1021/bi962719i; Lacroix M, 2007, MOL IMMUNOL, V44, P3930, DOI 10.1016/j.molimm.2007.06.054; Liu Y, 2005, J IMMUNOL, V175, P3150, DOI 10.4049/jimmunol.175.5.3150; Matsushita M, 1996, J BIOL CHEM, V271, P2448, DOI 10.1074/jbc.271.5.2448; Matsushita M, 2000, J IMMUNOL, V164, P2281, DOI 10.4049/jimmunol.164.5.2281; MATSUSHITA M, 1992, J EXP MED, V176, P1497, DOI 10.1084/jem.176.6.1497; Matsushita M, 2002, J IMMUNOL, V168, P3502, DOI 10.4049/jimmunol.168.7.3502; Morris RJ, 2003, METHOD ENZYMOL, V374, P229, DOI 10.1016/S0076-6879(03)74011-7; Murshudov GN, 1997, ACTA CRYSTALLOGR D, V53, P240, DOI 10.1107/S0907444996012255; Navaza J, 2001, ACTA CRYSTALLOGR D, V57, P1367, DOI 10.1107/S0907444901012422; Romao MJ, 1997, J MOL BIOL, V274, P650, DOI 10.1006/jmbi.1997.1423; Rossi V, 2001, J BIOL CHEM, V276, P40880, DOI 10.1074/jbc.M105934200; Stengaard-Pedersen K, 2003, NEW ENGL J MED, V349, P554, DOI 10.1056/NEJMoa022836; Stover CM, 1999, J IMMUNOL, V162, P3481; Takahashi M, 1999, INT IMMUNOL, V11, P859, DOI 10.1093/intimm/11.5.859; Takahashi M, 2008, J IMMUNOL, V180, P6132, DOI 10.4049/jimmunol.180.9.6132; Teillet F, 2005, J IMMUNOL, V174, P2870, DOI 10.4049/jimmunol.174.5.2870; Teillet F, 2007, J IMMUNOL, V178, P5710, DOI 10.4049/jimmunol.178.9.5710; Thiel S, 1997, NATURE, V386, P506, DOI 10.1038/386506a0; Thielens NM, 2001, J IMMUNOL, V166, P5068, DOI 10.4049/jimmunol.166.8.5068; THIELENS NM, 1990, J BIOL CHEM, V265, P14469; Wallis R, 2004, J BIOL CHEM, V279, P14065, DOI 10.1074/jbc.M400171200; Wallis R, 2000, J BIOL CHEM, V275, P30962, DOI 10.1074/jbc.M004030200; Zundel S, 2004, J IMMUNOL, V172, P4342, DOI 10.4049/jimmunol.172.7.4342	45	66	73	0	4	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	SEP 12	2008	283	37					25715	25724		10.1074/jbc.M803551200	http://dx.doi.org/10.1074/jbc.M803551200			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	345QZ	18596036	hybrid			2022-12-27	WOS:000259012700066
J	Wang, Y; Tandan, S; Cheng, J; Yang, C; Nguyen, L; Sugianto, J; Johnstone, JL; Sun, Y; Hill, JA				Wang, Yanggan; Tandan, Samvit; Cheng, Jun; Yang, Chunmei; Nguyen, Lan; Sugianto, Jessica; Johnstone, Janet L.; Sun, Yuyang; Hill, Joseph A.			Ca2+/calmodulin-dependent protein kinase II-dependent remodeling of Ca2+ current in pressure overload heart failure	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							INDUCED CARDIAC-HYPERTROPHY; CALMODULIN KINASE; VENTRICULAR MYOCYTES; CALCIUM-CHANNELS; SARCOPLASMIC-RETICULUM; HUMAN MYOCARDIUM; FACILITATION; CAMKII; PHOSPHORYLATION; CALCINEURIN	Ca2+/calmodulin-dependent protein kinase II (CaMKII) activity is increased in heart failure (HF), a syndrome characterized by markedly increased risk of arrhythmia. Activation of CaMKII increases peak L-type Ca2+ current (I-Ca) and slows ICa inactivation. Whether these events are linked mechanistically is unknown. ICa was recorded in acutely dissociated subepicardial and subendocardial murine left ventricular (LV) myocytes using the whole cell patch clamp method. Pressure overload heart failure was induced by surgical constriction of the thoracic aorta. ICa density was significantly larger in subepicardial myocytes than in subendocardial/myocytes. Similar patterns were observed in the cell surface expression of alpha 1c, the channel pore-forming subunit. In failing LV, ICa density was increased proportionately in both cell types, and the time course of ICa inactivation was slowed. This typical pattern of changes suggested a role of CaMKII. Consistent with this, measurements of CaMKII activity revealed a 2-3-fold increase (p < 0.05) in failing LV. To test for a causal link, we measured frequency-dependent I-Ca facilitation. In HF myocytes, this CaMKII-dependent process could not be induced, suggesting already maximal activation. Internal application of active CaMKII in failing myocytes did not elicit changes in ICa. Finally, CaMKII inhibition by internal diffusion of a specific peptide inhibitor reduced I-Ca density and inactivation time course to similar levels in control and HF myocytes. ICa density manifests a significant transmural gradient, and this gradient is preserved in heart failure. Activation of CaMKII, a known pro-arrhythmic molecule, is a major contributor to ICa remodeling in load-induced heart failure.	[Wang, Yanggan; Tandan, Samvit; Cheng, Jun; Yang, Chunmei; Nguyen, Lan; Sugianto, Jessica; Johnstone, Janet L.; Hill, Joseph A.] Univ Texas SW Med Ctr Dallas, Dept Internal Med Cardiol, Dallas, TX 75390 USA; [Hill, Joseph A.] Univ Texas SW Med Ctr Dallas, Dept Biol Mol, Dallas, TX 75390 USA; [Sun, Yuyang] Emory Univ, Dept Pediat, Atlanta, GA 30322 USA	University of Texas System; University of Texas Southwestern Medical Center Dallas; University of Texas System; University of Texas Southwestern Medical Center Dallas; Emory University	Hill, JA (corresponding author), Univ Texas SW Med Ctr Dallas, Dept Internal Med, Div Cardiol, Dallas, TX 75390 USA.	joseph.hill@utsouthwestern.edu			National Institutes of Health [HL-075173, HL-080144, T35-DK066141, HL-088168]; Donald W. Reynolds Cardiovascular Clinical Research Center; American Heart Association [0665178Y, 0640084N]; National Heart Foundation [H2007-019]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R21HL088168, R01HL075173, R01HL080144] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [T35DK066141] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Donald W. Reynolds Cardiovascular Clinical Research Center; American Heart Association(American Heart Association); National Heart Foundation(National Heart Foundation of Australia); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	This work was supported, in whole or in part, by National Institutes of Health Grants HL-075173 (to J.A.H.), HL-080144 (to J.A.H.), T35-DK066141 (to L.N. and J.S.), and HL-088168 (to Y.W.). This work was also supported by grants from the Donald W. Reynolds Cardiovascular Clinical Research Center (to J.A.H.), American Heart Association Grants 0665178Y (to Y.W.) and 0640084N (to J.A.H.), National Heart Foundation Grant H2007-019 (to Y.W.), The costs of publication of this article were defrayed in part by the payment of page charges. This article must therefore be hereby marked "advertisement" in accordance with 18 U. S. C. Section 1734 solely to indicate this fact.	Ai X, 2005, CIRC RES, V97, P1314, DOI 10.1161/01.RES.0000194329.41863.89; Akar FG, 2005, ANN MED, V37, P44, DOI 10.1080/07853890510007214; Alden KJ, 2002, AM J PHYSIOL-CELL PH, V282, pC768, DOI 10.1152/ajpcell.00494.2001; Anderson ME, 2007, CARDIOVASC RES, V73, P657, DOI 10.1016/j.cardiores.2006.12.009; Anderson ME, 2004, TRENDS CARDIOVAS MED, V14, P152, DOI 10.1016/j.tcm.2004.02.005; ANDERSON ME, 1994, CIRC RES, V75, P854, DOI 10.1161/01.RES.75.5.854; Antzelevitch C, 2007, AM J PHYSIOL-HEART C, V293, pH2024, DOI 10.1152/ajpheart.00355.2007; BEUCKELMANN DJ, 1992, BASIC RES CARDIOL, V87, P235; BRAUN AP, 1995, ANNU REV PHYSIOL, V57, P417, DOI 10.1146/annurev.ph.57.030195.002221; Bryant SM, 1997, CARDIOVASC RES, V35, P315, DOI 10.1016/S0008-6363(97)00111-9; Colomer JM, 2003, MOL ENDOCRINOL, V17, P183, DOI 10.1210/me.2002-0350; Currie S, 1999, FEBS LETT, V459, P244, DOI 10.1016/S0014-5793(99)01254-5; Dzhura I, 2002, J PHYSIOL-LONDON, V545, P399, DOI 10.1113/jphysiol.2002.021881; Erxleben C, 2006, P NATL ACAD SCI USA, V103, P3932, DOI 10.1073/pnas.0511322103; Gaborit N, 2007, J PHYSIOL-LONDON, V582, P675, DOI 10.1113/jphysiol.2006.126714; Gao L, 2006, BIOCHEM BIOPH RES CO, V345, P1606, DOI 10.1016/j.bbrc.2006.05.066; Gong YF, 2007, CIRCULATION, V115, P2094, DOI 10.1161/CIRCULATIONAHA.106.656504; Grueter CE, 2006, MOL CELL, V23, P641, DOI 10.1016/j.molcel.2006.07.006; Guo JQ, 2006, J PHYSIOL-LONDON, V574, P509, DOI 10.1113/jphysiol.2006.109199; Hagemann D, 2001, MOL CELL BIOCHEM, V220, P69, DOI 10.1023/A:1010899724222; Hasenfuss G, 1998, CARDIOVASC RES, V39, P60, DOI 10.1016/S0008-6363(98)00110-2; Heineke J, 2006, NAT REV MOL CELL BIO, V7, P589, DOI 10.1038/nrm1983; Hill JA, 2008, NEW ENGL J MED, V358, P1370, DOI 10.1056/NEJMra072139; Hoch B, 1999, CIRC RES, V84, P713, DOI 10.1161/01.RES.84.6.713; Hudmon A, 2002, BIOCHEM J, V364, P593, DOI 10.1042/BJ20020228; Hudmon A, 2005, J CELL BIOL, V171, P537, DOI 10.1083/jcb.200505155; ISHIDA A, 1995, BIOCHEM BIOPH RES CO, V212, P806, DOI 10.1006/bbrc.1995.2040; Janse MJ, 2004, CARDIOVASC RES, V61, P208, DOI 10.1016/j.cardiores.2003.11.018; Khoo MSC, 2006, CIRCULATION, V114, P1352, DOI 10.1161/CIRCULATIONAHA.106.644583; Kohlhaas M, 2006, CIRC RES, V98, P235, DOI 10.1161/01.RES.0000200739.90811.9f; Ledoux J, 1999, J PHARMACOL EXP THER, V290, P1165; Lee TS, 2006, J BIOL CHEM, V281, P25560, DOI 10.1074/jbc.M508661200; Maier LS, 2007, CARDIOVASC RES, V73, P631, DOI 10.1016/j.cardiores.2006.11.005; Maier LS, 2007, CARDIOVASC RES, V73, P629, DOI 10.1016/j.cardiores.2007.01.005; MEWES T, 1994, J MOL CELL CARDIOL, V26, P1307, DOI 10.1006/jmcc.1994.1149; OUADID H, 1995, J CARDIOVASC PHARM, V25, P282, DOI 10.1097/00005344-199502000-00014; Pandit SV, 2001, BIOPHYS J, V81, P3029, DOI 10.1016/S0006-3495(01)75943-7; ROSSNER KL, 1991, AM J PHYSIOL, V260, pH1179, DOI 10.1152/ajpheart.1991.260.4.H1179; Rothermel BA, 2005, PHYSIOL GENOMICS, V23, P18, DOI 10.1152/physiolgenomics.00061.2005; Saito T, 2003, J MOL CELL CARDIOL, V35, P1153, DOI 10.1016/S0022-2828(03)00234-7; Schroder F, 1998, CIRCULATION, V98, P969, DOI 10.1161/01.CIR.98.10.969; SUMI M, 1991, BIOCHEM BIOPH RES CO, V181, P968, DOI 10.1016/0006-291X(91)92031-E; Tanskanen AJ, 2005, BIOPHYS J, V88, P85, DOI 10.1529/biophysj.104.051508; Toscano CD, 2005, BRAIN RES, V1044, P51, DOI 10.1016/j.brainres.2005.02.076; VanCoppenolle F, 1997, MOL CELL BIOCHEM, V168, P155; Wang HS, 2003, J PHYSIOL-LONDON, V547, P825, DOI 10.1113/jphysiol.2002.035410; Wang W, 2004, CIRC RES, V95, P798, DOI 10.1161/01.RES.0000145361.50017.aa; Wang YG, 2000, CARDIOVASC RES, V48, P310, DOI 10.1016/S0008-6363(00)00178-4; Wang YG, 2006, CIRCULATION, V113, P1849, DOI 10.1161/CIRCULATIONAHA.106.615682; Wang YG, 2006, J CARDIOVASC ELECTR, V17, P298, DOI 10.1111/j.1540-8167.2006.00362.x; Wang ZY, 2001, CIRCULATION, V104, P1657, DOI 10.1161/hc3901.095766; Wu YJ, 2002, CIRCULATION, V106, P1288, DOI 10.1161/01.CIR.0000027583.73268.E7; Wu YJ, 1999, CIRC RES, V84, P906; Wu YJ, 1999, AM J PHYSIOL-HEART C, V276, pH2168, DOI 10.1152/ajpheart.1999.276.6.H2168; Yatani A, 2001, J MOL CELL CARDIOL, V33, P249, DOI 10.1006/jmcc.2000.1296; YUAN WL, 1994, AM J PHYSIOL, V267, pH982, DOI 10.1152/ajpheart.1994.267.3.H982; Zhang R, 2005, NAT MED, V11, P409, DOI 10.1038/nm1215; Zhang T, 2003, CIRC RES, V92, P912, DOI 10.1161/01.RES.0000069686.31472.C5	58	44	47	0	5	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	SEP 12	2008	283	37					25524	25532		10.1074/jbc.M803043200	http://dx.doi.org/10.1074/jbc.M803043200			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	345QZ	18622016	Green Published, hybrid			2022-12-27	WOS:000259012700048
J	Sarewicz, M; Borek, A; Daldal, F; Froncisz, W; Osyczka, A				Sarewicz, Marcin; Borek, Arkadiusz; Daldal, Fevzi; Froncisz, Wojciech; Osyczka, Artur			Demonstration of short-lived complexes of cytochrome c with cytochrome bc(1) by EPR spectroscopy - Implications for the mechanism of interprotein electron transfer	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							PROTEIN-PROTEIN ASSOCIATION; RHODOBACTER-CAPSULATUS; PHOTOSYNTHETIC GROWTH; TRANSITION-STATE; BINDING-SITES; DOUBLE-MUTANT; SPIN; MEMBRANE; C(2); MITOCHONDRIAL	One of the steps of a common pathway for biological energy conversion involves electron transfer between cytochrome c and cytochrome bc(1). To clarify the mechanism of this reaction, we examined the structural association of those two proteins using the electron transfer-independent electron paramagnetic resonance (EPR) techniques. Drawing on the differences in the continuous wave EPR spectra and saturation recoveries of spin-labeled bacterial and mitochondrial cytochromes c recorded in the absence and presence of bacterial cytochrome bc(1), we have exposed a time scale of dynamic equilibrium between the bound and the free state of cytochrome c at various ionic strengths. Our data show a successive decrease of the bound cytochrome c fraction as the ionic strength increases, with a limit of similar to 120 mM NaCl above which essentially no bound cytochrome c can be detected by EPR. This limit does not apply to all of the interactions of cytochrome c with cytochrome bc(1) because the cytochrome bc(1) enzymatic activity remained high over a much wider range of ionic strengths. We concluded that EPR monitors just the tightly bound state of the association and that an averaged lifetime of this state decreases from over 100 mu s at low ionic strength to less than 400 ns at an ionic strength above 120 mM. This suggests that at physiological ionic strength, the tightly bound complex on average lasts less than the time needed for a single electron exchange between hemes c and c(1), indicating that productive electron transfer requires several collisions of the two molecules. This is consistent with an early idea of diffusion-coupled reactions that link the soluble electron carriers with the membranous complexes, which, we believe, provides a robust means of regulating electron flow through these complexes.	[Sarewicz, Marcin; Borek, Arkadiusz; Froncisz, Wojciech; Osyczka, Artur] Jagiellonian Univ, Fac Biochem Biophys & Biotechnol, Dept Biophys, PL-30387 Krakow, Poland; [Daldal, Fevzi] Univ Penn, Dept Biol, Inst Plant Sci, Philadelphia, PA 19104 USA	Jagiellonian University; University of Pennsylvania	Osyczka, A (corresponding author), Jagiellonian Univ, Fac Biochem Biophys & Biotechnol, Dept Biophys, PL-30387 Krakow, Poland.	osyczkaa@biotka.mol.uj.edu.pl	Froncisz, Wojciech/U-9828-2018; Kumar, Rishabh/P-4667-2017	Froncisz, Wojciech/0000-0002-0287-0988; Borek, Arkadiusz/0000-0003-3195-3579; Sarewicz, Marcin/0000-0001-6813-5997; Osyczka, Artur/0000-0002-1637-2365	NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM038237] Funding Source: NIH RePORTER; NIGMS NIH HHS [R01 GM038237, GM 38237] Funding Source: Medline; Wellcome Trust [076488] Funding Source: Medline	NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); Wellcome Trust(Wellcome TrustEuropean Commission)		Altenbach C, 2005, BIOPHYS J, V89, P2103, DOI 10.1529/biophysj.105.059063; ALTENBACH C, 1994, P NATL ACAD SCI USA, V91, P1667, DOI 10.1073/pnas.91.5.1667; ATTAASAFOADJEI E, 1991, P NATL ACAD SCI USA, V88, P492, DOI 10.1073/pnas.88.2.492; Axelrod HL, 2005, PHOTOSYNTH RES, V85, P101, DOI 10.1007/s11120-005-1368-8; Bartsch R. G., 1971, METHODS ENZYMOL, V23, P344, DOI [10.1016/S0076-6879(71)23110-4, DOI 10.1016/S0076-6879(71)23110-4]; BENNING MM, 1991, J MOL BIOL, V220, P673, DOI 10.1016/0022-2836(91)90109-J; BERLINER LJ, 1982, ANAL BIOCHEM, V119, P450, DOI 10.1016/0003-2697(82)90612-1; Berry EA, 2004, PHOTOSYNTH RES, V81, P251, DOI 10.1023/B:PRES.0000036888.18223.0e; Biswas Roopa, 2001, Science Progress, V84, P45, DOI 10.3184/003685001783239050; BLOCH F, 1946, PHYS REV, V70, P460, DOI 10.1103/PhysRev.70.460; CAFFREY M, 1992, ARCH BIOCHEM BIOPHYS, V292, P419, DOI 10.1016/0003-9861(92)90011-K; Ciurli S, 2005, PHOTOSYNTH RES, V85, P115, DOI 10.1007/s11120-004-6556-4; Columbus L, 2002, TRENDS BIOCHEM SCI, V27, P288, DOI 10.1016/S0968-0004(02)02095-9; Daldal F, 2003, PHOTOSYNTH RES, V76, P127, DOI 10.1023/A:1024999101226; Darrouzet E, 1999, BIOCHEMISTRY-US, V38, P7908, DOI 10.1021/bi990211k; DeLano W.L, PYMOL MOL GRAPHICS S; Devanathan S, 2007, BIOCHEMISTRY-US, V46, P7138, DOI 10.1021/bi602649u; Diaz-Moreno I, 2005, BIOCHEMISTRY-US, V44, P3176, DOI 10.1021/bi047855z; Engstrom G, 2003, BIOCHEMISTRY-US, V42, P2816, DOI 10.1021/bi027213g; FEIX JB, 1998, BIO MAGN RE, V14, P251; FRONCISZ W, 1982, J MAGN RESON, V47, P515, DOI 10.1016/0022-2364(82)90221-9; GUNER S, 1993, BIOCHEMISTRY-US, V32, P4793, DOI 10.1021/bi00069a014; GUPTE S, 1984, P NATL ACAD SCI-BIOL, V81, P2606, DOI 10.1073/pnas.81.9.2606; HACKENBROCK CR, 1986, J BIOENERG BIOMEMBR, V18, P331, DOI 10.1007/BF00743010; HAEHNEL W, 1984, ANNU REV PLANT PHYS, V35, P659, DOI 10.1146/annurev.pp.35.060184.003303; HALL J, 1987, BIOCHEMISTRY-US, V26, P4501, DOI 10.1021/bi00388a049; HALL J, 1987, J BIOL CHEM, V262, P14005; Hansen DF, 2003, J MAGN RESON, V163, P215, DOI 10.1016/S1090-7807(03)00062-4; Harel M, 2007, J MOL BIOL, V371, P180, DOI 10.1016/j.jmb.2007.05.032; HECKERT NA, 2003, NIST HDB, V148; Hunte C, 2002, BBA-BIOENERGETICS, V1555, P21, DOI 10.1016/S0005-2728(02)00249-9; ILNICKI J, 1994, MOLECUL PHYS REP, V5, P203; JENNEY FE, 1993, EMBO J, V12, P1283, DOI 10.1002/j.1460-2075.1993.tb05773.x; Kerfeld CA, 1998, ANNU REV PLANT PHYS, V49, P397, DOI 10.1146/annurev.arplant.49.1.397; Kooser R. G., 1992, CONCEPT MAGNETIC RES, V4, P145; Kostrzewa A, 2000, BIOCHEMISTRY-US, V39, P6066, DOI 10.1021/bi992559l; Lange C, 2002, P NATL ACAD SCI USA, V99, P2800, DOI 10.1073/pnas.052704699; Mailer C, 2005, J PHYS CHEM A, V109, P4049, DOI 10.1021/jp044671l; Maneg O, 2004, BBA-BIOENERGETICS, V1655, P274, DOI 10.1016/j.bbabio.2003.10.010; MARGOLIASH E, 1959, BIOCHEM J, V71, P570, DOI 10.1042/bj0710570; MCCONNELL HM, 1958, J CHEM PHYS, V28, P430, DOI 10.1063/1.1744152; Meyer TE, 2003, PHOTOSYNTH RES, V76, P111, DOI 10.1023/A:1024910323089; MEYER TE, 1993, BIOCHEMISTRY-US, V32, P4552, DOI 10.1021/bi00068a010; Meyers R. A., 2000, ENCY ANAL CHEM, P5725; Millett F, 2004, PHOTOSYNTH RES, V82, P1, DOI 10.1023/B:PRES.0000040434.77061.ca; Miyashita O, 2004, P NATL ACAD SCI USA, V101, P16174, DOI 10.1073/pnas.0405745101; Moore G. R., 1990, CYTOCHROMES C EVOLUT; MOSER CC, 1992, NATURE, V355, P796, DOI 10.1038/355796a0; Myllykallio H, 1999, P NATL ACAD SCI USA, V96, P4348, DOI 10.1073/pnas.96.8.4348; Myllykallio H, 1997, J BACTERIOL, V179, P2623, DOI 10.1128/jb.179.8.2623-2631.1997; Nelson N, 2004, NAT REV MOL CELL BIO, V5, P971, DOI 10.1038/nrm1525; Nicholls D., 2002, BIOENERGETICS, V3; Osyczka A, 1999, BIOCHEMISTRY-US, V38, P15779, DOI 10.1021/bi990907d; Osyczka A, 2001, J BIOL CHEM, V276, P24108, DOI 10.1074/jbc.M101141200; Page CC, 1999, NATURE, V402, P47, DOI 10.1038/46972; Rich PR, 2003, BIOCHEM SOC T, V31, P1095; RIEDER R, 1980, J BIOL CHEM, V255, P4732; Sarewicz M, 2008, EUR BIOPHYS J BIOPHY, V37, P483, DOI 10.1007/s00249-007-0240-5; Selzer T, 2001, PROTEINS, V45, P190, DOI 10.1002/prot.1139; Tetreault M, 2002, BIOCHEMISTRY-US, V41, P5807, DOI 10.1021/bi012053e; Tian H, 2000, J BIOL CHEM, V275, P9587, DOI 10.1074/jbc.275.13.9587; Turyna B, 1998, BBA-PROTEIN STRUCT M, V1386, P50, DOI 10.1016/S0167-4838(98)00059-4; Valkova-Valchanova MB, 1998, BIOCHEMISTRY-US, V37, P16242, DOI 10.1021/bi981651z; ZHOU HX, 1993, BIOPHYS J, V64, P1711, DOI 10.1016/S0006-3495(93)81543-1	64	34	34	0	12	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	SEP 5	2008	283	36					24826	24836		10.1074/jbc.M802174200	http://dx.doi.org/10.1074/jbc.M802174200			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	342YR	18617515	Green Published, hybrid			2022-12-27	WOS:000258820000049
J	Scragg, JL; Dallas, ML; Wilkinson, JA; Varadi, G; Peers, C				Scragg, Jason L.; Dallas, Mark L.; Wilkinson, Jenny A.; Varadi, Gyula; Peers, Chris			Carbon monoxide inhibits L-type Ca2+ channels via redox modulation of key cysteine residues by mitochondrial reactive oxygen species	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							HEME OXYGENASE-1; SMOOTH-MUSCLE; RAT-HEART; HYPOXIA; EXPRESSION; MICE; HYPERTENSION; INFARCTION; MOLECULES; MECHANISM	Conditions of stress, such as myocardial infarction, stimulate up-regulation of heme oxygenase (HO-1) to provide cardioprotection. Here, we show that CO, a product of heme catabolism by HO-1, directly inhibits native rat cardiomyocyte L-type Ca2+ currents and the recombinant alpha(1C) subunit of the human cardiac L-type Ca2+ channel. CO (applied via a recognized CO donor molecule or as the dissolved gas) caused reversible, voltage-independent channel inhibition, which was dependent on the presence of a spliced insert in the cytoplasmic C-terminal region of the channel. Sequential molecular dissection and point mutagenesis identified three key cysteine residues within the proximal 31 amino acids of the splice insert required for CO sensitivity. CO-mediated inhibition was independent of nitric oxide and protein kinase G but was prevented by antioxidants and the reducing agent, dithiothreitol. Inhibition of NADPH oxidase and xanthine oxidase did not affect the inhibitory actions of CO. Instead, inhibitors of complex III (but not complex I) of the mitochondrial electron transport chain and a mitochondrially targeted antioxidant (Mito Q) fully prevented the effects of CO. Our data indicate that the cardioprotective effects of HO-1 activity may be attributable to an inhibitory action of CO on cardiac L-type Ca2+ channels. Inhibition arises from the ability of CO to promote generation of reactive oxygen species from complex III of mitochondria. This in turn leads to redox modulation of any or all of three critical cysteine residues in the channel's cytoplasmic C-terminal tail, resulting in channel inhibition.	[Scragg, Jason L.; Dallas, Mark L.; Wilkinson, Jenny A.; Peers, Chris] Univ Leeds, Div Cardiovasc & Neuronal Remodelling, Leeds Inst Genet Hlth & Therapeut, Leeds LS2 9JT, W Yorkshire, England; [Varadi, Gyula] RMD Inc, Watertown, MA 02472 USA	University of Leeds	Scragg, JL (corresponding author), Univ Leeds, Div Cardiovasc & Neuronal Remodelling, Leeds Inst Genet Hlth & Therapeut, Level 10,Worsley Bldg, Leeds LS2 9JT, W Yorkshire, England.	J.Scragg@leeds.ac.uk; c.s.peers@leeds.ac.uk	Dallas, Mark/Q-6117-2019; Dallas, Mark L/A-6654-2013	Dallas, Mark/0000-0002-5190-0522; Peers, Chris/0000-0002-8354-346X	British Heart Foundation	British Heart Foundation(British Heart Foundation)	This work was supported by the British Heart Foundation.	Boczkowski J, 2006, TRENDS BIOCHEM SCI, V31, P614, DOI 10.1016/j.tibs.2006.09.001; Bodi I, 2005, J CLIN INVEST, V115, P3306, DOI 10.1172/JCI27167; Chatterjee PK, 2007, BRIT J PHARMACOL, V150, P961, DOI 10.1038/sj.bjp.0707185; Christou H, 2000, CIRC RES, V86, P1224, DOI 10.1161/01.RES.86.12.1224; Clark JE, 2003, CIRC RES, V93, pE2, DOI 10.1161/01.RES.0000084381.86567.08; D'Amico G, 2006, J CELL SCI, V119, P2291, DOI 10.1242/jcs.02914; Dallas ML, 2008, NEUROREPORT, V19, P345, DOI 10.1097/WNR.0b013e3282f51045; Davis MJ, 1999, PHYSIOL REV, V79, P387, DOI 10.1152/physrev.1999.79.2.387; Durante W, 2002, VASC MED, V7, P195, DOI 10.1191/1358863x02vm424ra; Durante W, 2006, J CELL MOL MED, V10, P672, DOI 10.1111/j.1582-4934.2006.tb00427.x; EWING JF, 1994, J PHARMACOL EXP THER, V271, P408; Fearon IM, 2000, CIRC RES, V87, P537, DOI 10.1161/01.RES.87.7.537; Fearon IM, 1999, J PHYSIOL-LONDON, V514, P629, DOI 10.1111/j.1469-7793.1999.629ad.x; Fearon IM, 1997, J PHYSIOL-LONDON, V500, P551, DOI 10.1113/jphysiol.1997.sp022041; Grilli A, 2003, ANN CLIN LAB SCI, V33, P208; Jauslin ML, 2003, FASEB J, V17, P1972, DOI 10.1096/fj.03-0240fje; Kim HP, 2006, ANNU REV PHARMACOL, V46, P411, DOI 10.1146/annurev.pharmtox.46.120604.141053; KING MP, 1989, SCIENCE, V246, P500, DOI 10.1126/science.2814477; Klockner U, 1997, AM J PHYSIOL-HEART C, V272, pH1372, DOI 10.1152/ajpheart.1997.272.3.H1372; Lakkisto P, 2002, J MOL CELL CARDIOL, V34, P1357, DOI 10.1006/jmcc.2002.2094; Lim I, 2005, AM J PHYSIOL-GASTR L, V288, pG7, DOI 10.1152/ajpgi.00205.2004; MCFAUL SJ, 1987, TOXICOL APPL PHARM, V87, P464, DOI 10.1016/0041-008X(87)90252-3; MCGRATH JJ, 1984, PHARMACOL BIOCHEM BE, V21, P99, DOI 10.1016/0091-3057(84)90171-0; MCGRATH JJ, 1984, P SOC EXP BIOL MED, V177, P132; Moens AL, 2005, INT J CARDIOL, V100, P179, DOI 10.1016/j.ijcard.2004.04.013; Motterlini R, 2002, CIRC RES, V90, pE17, DOI 10.1161/hh0202.104530; PEPINE CJ, 1995, EUR HEART J, V16, P19, DOI 10.1093/eurheartj/16.suppl_H.19; Ravens U, 1999, PHARMACOL RES, V39, P167, DOI 10.1006/phrs.1998.0416; Ryter SW, 2006, PHYSIOL REV, V86, P583, DOI 10.1152/physrev.00011.2005; Scragg JL, 2004, METHOD ENZYMOL, V381, P290; SYLVESTER JT, 1978, CIRC RES, V43, P429, DOI 10.1161/01.RES.43.3.429; Taille C, 2005, J BIOL CHEM, V280, P25350, DOI 10.1074/jbc.M503512200; Turrens JF, 2003, J PHYSIOL-LONDON, V552, P335, DOI 10.1113/jphysiol.2003.049478; Uemura K, 2005, BIOCHEM BIOPH RES CO, V334, P661, DOI 10.1016/j.bbrc.2005.06.142; Wiesel P, 2001, CIRC RES, V88, P1088, DOI 10.1161/hh1001.091521; Williams SEJ, 2004, SCIENCE, V306, P2093, DOI 10.1126/science.1105010; Wu LY, 2005, PHARMACOL REV, V57, P585, DOI 10.1124/pr.57.4.3; Yang LM, 2004, HYPERTENSION, V43, P1221, DOI 10.1161/01.HYP.0000126287.62060.e6; Yet SF, 1999, J CLIN INVEST, V103, pR23, DOI 10.1172/JCI6163; Yet SF, 2001, CIRC RES, V89, P168, DOI 10.1161/hh1401.093314; Zuckerbraun BS, 2007, FASEB J, V21, P1099, DOI 10.1096/fj.06-6644com	41	108	112	0	7	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	SEP 5	2008	283	36					24412	24419		10.1074/jbc.M803037200	http://dx.doi.org/10.1074/jbc.M803037200			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	342YR	18596041	hybrid, Green Published			2022-12-27	WOS:000258820000016
J	Shinoda, Y; Ogata, N; Higashikawa, A; Manabe, I; Shindo, T; Yamada, T; Kugimiya, F; Ikeda, T; Kawamura, N; Kawasaki, Y; Tsushima, K; Takeda, N; Nagai, R; Hoshi, K; Nakamura, K; Chung, UI; Kawaguchi, H				Shinoda, Yusuke; Ogata, Naoshi; Higashikawa, Akiro; Manabe, Ichiro; Shindo, Takayuki; Yamada, Takashi; Kugimiya, Fumitaka; Ikeda, Toshiyuki; Kawamura, Naohiro; Kawasaki, Yosuke; Tsushima, Kensuke; Takeda, Norifumi; Nagai, Ryozo; Hoshi, Kazuto; Nakamura, Kozo; Chung, Ung-il; Kawaguchi, Hiroshi			Kruppel-like factor 5 causes cartilage degradation through transactivation of matrix metalloproteinase 9	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ENDOTHELIAL GROWTH-FACTOR; ENDOCHONDRAL BONE-FORMATION; TRANSCRIPTION FACTOR KLF5; DEVELOPING LONG BONES; MONOCLONAL-ANTIBODIES; KEY REGULATOR; MICE LACKING; II COLLAGEN; KAPPA-B; OSSIFICATION	Although degradation of cartilage matrix has been suggested to be a rate-limiting step for endochondral ossification during skeletal development, little is known about the transcriptional regulation. This study investigated the involvement of KLF5 (Kruppel-like factor 5), an Sp/KLF family member, in the skeletal development. KLF5 was expressed in chondrocytes and osteoblasts but not in osteoclasts. The heterozygous deficient (KLF5(+/-)) mice exhibited skeletal growth retardation in the perinatal period. Although chondrocyte proliferation and differentiation were normal, cartilage matrix degradation was impaired in KLF5(+/-) mice, causing delay in replacement of cartilage with bone at the primary ossification center in the embryonic limbs and elongation of hypertrophic chondrocyte layer in the neonatal growth plates. Microarray analyses identified MMP9 (matrix metalloproteinase 9) as a transcriptional target, since it was strongly up-regulated by adenoviral transfection of KLF5 in chondrogenic cell line OUMS27. The KLF5 overexpression caused gelatin degradation by stimulating promoter activity of MMP9 without affecting chondrocyte differentiation or vascular endothelial growth factor expression in the culture of chondrogenic cells; however, in osteoclast precursors, it affected neither MMP9 expression nor osteoclastic differentiation. KLF5 dysfunction by genetic heterodeficiency or RNA interference was confirmed to cause reduction of MMP9 expression in cultured chondrogenic cells. MMP9 expression was decreased in the limbs of KLF5(+/-) embryos, which was correlated with suppression of matrix degradation, calcification, and vascularization. We conclude that KLF5 causes cartilage matrix degradation through transcriptional induction of MMP9, providing the first evidence that transcriptional regulation of a proteinase contributes to endochondral ossification and skeletal development.	[Shinoda, Yusuke; Ogata, Naoshi; Higashikawa, Akiro; Manabe, Ichiro; Shindo, Takayuki; Yamada, Takashi; Kugimiya, Fumitaka; Ikeda, Toshiyuki; Kawamura, Naohiro; Kawasaki, Yosuke; Tsushima, Kensuke; Takeda, Norifumi; Nagai, Ryozo; Hoshi, Kazuto; Nakamura, Kozo; Chung, Ung-il; Kawaguchi, Hiroshi] Univ Tokyo, Tokyo 1138655, Japan	University of Tokyo	Kawaguchi, H (corresponding author), Univ Tokyo, Tokyo 1138655, Japan.	kawaguchi-ort@h.u-tokyo.ac.jp	Manabe, Ichiro/E-1529-2014; Ikeda, Toshiyuki/GVS-5588-2022; Manabe, Ichiro/AAE-5105-2021; Kawamura, Naohiro/J-8372-2019	TAKEDA, NORIFUMI/0000-0003-4818-3347; Tsushima, Kensuke/0000-0001-7338-7849				Aizawa K, 2004, J BIOL CHEM, V279, P70, DOI 10.1074/jbc.M306621200; Bieker JJ, 2001, J BIOL CHEM, V276, P34355, DOI 10.1074/jbc.R100043200; Bluteau G, 2007, BONE, V40, P568, DOI 10.1016/j.bone.2006.09.024; Colnot C, 2003, DEVELOPMENT, V130, P4123, DOI 10.1242/dev.00559; Colnot C, 2001, DEV BIOL, V229, P203, DOI 10.1006/dbio.2000.9933; Conkright MD, 1999, NUCLEIC ACIDS RES, V27, P1263, DOI 10.1093/nar/27.5.1263; Engsig MT, 2000, J CELL BIOL, V151, P879, DOI 10.1083/jcb.151.4.879; Gerber HP, 1999, NAT MED, V5, P623, DOI 10.1038/9467; Gollner H, 2001, MECH DEVELOP, V106, P77, DOI 10.1016/S0925-4773(01)00420-8; Haeusler G, 2005, CALCIFIED TISSUE INT, V76, P326, DOI 10.1007/s00223-004-0161-6; Holmbeck K, 1999, CELL, V99, P81, DOI 10.1016/S0092-8674(00)80064-1; Inada M, 2004, P NATL ACAD SCI USA, V101, P17192, DOI 10.1073/pnas.0407788101; JINGUSHI S, 1995, J ORTHOPAED RES, V13, P761, DOI 10.1002/jor.1100130516; Kaczynski J, 2003, GENOME BIOL, V4, DOI 10.1186/gb-2003-4-2-206; Karsenty G, 2002, DEV CELL, V2, P389, DOI 10.1016/S1534-5807(02)00157-0; Kobayashi K, 2000, J EXP MED, V191, P275, DOI 10.1084/jem.191.2.275; Kobielak A, 2006, P NATL ACAD SCI USA, V103, P2322, DOI 10.1073/pnas.0510422103; Kosaki N, 2007, BIOCHEM BIOPH RES CO, V354, P846, DOI 10.1016/j.bbrc.2006.12.234; Kronenberg HM, 2003, NATURE, V423, P332, DOI 10.1038/nature01657; Lee ER, 1999, DEV DYNAM, V215, P190, DOI 10.1002/(SICI)1097-0177(199907)215:3<190::AID-AJA2>3.0.CO;2-B; LEFEBVRE V, 1994, MATRIX BIOL, V14, P329, DOI 10.1016/0945-053X(94)90199-6; Maes C, 2002, MECH DEVELOP, V111, P61, DOI 10.1016/S0925-4773(01)00601-3; Milner Jennifer M., 2005, Current Drug Targets - Inflammation and Allergy, V4, P363, DOI 10.2174/1568010054022141; Nakashima K, 2002, CELL, V108, P17, DOI 10.1016/s0092-8674(01)00622-5; NALDINI L, 1995, J BIOL CHEM, V270, P603, DOI 10.1074/jbc.270.2.603; Ohnishi S, 2000, DEV DYNAM, V217, P421, DOI 10.1002/(SICI)1097-0177(200004)217:4<421::AID-DVDY9>3.0.CO;2-1; Oishi Y, 2005, CELL METAB, V1, P27, DOI 10.1016/j.cmet.2004.11.005; Ortega N, 2003, ANN NY ACAD SCI, V995, P109, DOI 10.1111/j.1749-6632.2003.tb03214.x; Perez-Moreno M, 2006, DEV CELL, V11, P601, DOI 10.1016/j.devcel.2006.10.010; Pratta MA, 2003, J BIOL CHEM, V278, P45539, DOI 10.1074/jbc.M303737200; REPONEN P, 1994, ANN NY ACAD SCI, V732, P472, DOI 10.1111/j.1749-6632.1994.tb24789.x; Shimoaka T, 2004, J BIOL CHEM, V279, P15314, DOI 10.1074/jbc.M312525200; Shindo T, 2002, NAT MED, V8, P856, DOI 10.1038/nm738; Stickens D, 2004, DEVELOPMENT, V131, P5883, DOI 10.1242/dev.01461; TERATO K, 1992, J IMMUNOL, V148, P2103; Terato K, 1995, AUTOIMMUNITY, V22, P137, DOI 10.3109/08916939508995311; Torres M, 1997, P NATL ACAD SCI USA, V94, P901, DOI 10.1073/pnas.94.3.901; Tortorella MD, 1999, SCIENCE, V284, P1664, DOI 10.1126/science.284.5420.1664; van Vliet J, 2006, GENOMICS, V87, P474, DOI 10.1016/j.ygeno.2005.12.011; Vu TH, 1998, CELL, V93, P411, DOI 10.1016/S0092-8674(00)81169-1; Watanabe N, 1999, CIRC RES, V85, P182, DOI 10.1161/01.RES.85.2.182; Werb Z, 1997, CELL, V91, P439, DOI 10.1016/S0092-8674(00)80429-8; Whitelock JM, 1996, J BIOL CHEM, V271, P10079, DOI 10.1074/jbc.271.17.10079; Yamada T, 2006, NAT MED, V12, P665, DOI 10.1038/nm1409; Zelzer E, 2002, DEVELOPMENT, V129, P1893; Zelzer E, 2004, DEVELOPMENT, V131, P2161, DOI 10.1242/dev.01053; Zhou ZJ, 2000, P NATL ACAD SCI USA, V97, P4052, DOI 10.1073/pnas.060037197	47	42	48	0	5	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	SEP 5	2008	283	36					24682	24689		10.1074/jbc.M709857200	http://dx.doi.org/10.1074/jbc.M709857200			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	342YR	18617520	hybrid, Green Published			2022-12-27	WOS:000258820000038
J	Varfolomeev, E; Goncharov, T; Fedorova, AV; Dynek, JN; Zobel, K; Deshayes, K; Fairbrother, WJ; Vucic, D				Varfolomeev, Eugene; Goncharov, Tatiana; Fedorova, Anna V.; Dynek, Jasmin N.; Zobel, Kerry; Deshayes, Kurt; Fairbrother, Wayne J.; Vucic, Domagoj			c-IAP1 and c-IAP2 are critical mediators of tumor necrosis factor alpha (TNF alpha)-induced NF-kappa B activation	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							APOPTOSIS PROTEINS; CELLULAR INHIBITOR; DEPENDENT APOPTOSIS; KINASE-ACTIVITY; C-IAPS; UBIQUITINATION; PATHWAY; TRAF2; SIGNALS; BINDING	The inhibitor of apoptosis (IAP) proteins are a family of antiapoptotic regulators found in viruses and metazoans. c-IAP1 and c-IAP2 are recruited to tumor necrosis factor receptor 1 (TNFR1)-associated complexes where they can regulate receptor-mediated signaling. Both c-IAP1 and c-IAP2 have been implicated in TNF alpha-stimulated NF-kappa B activation. However, individual c-IAP1 and c-IAP2 gene knock-outs in mice did not reveal changes in TNF signaling pathways, and the phenotype of a combined deficiency of c-IAPs has yet to be reported. Here we investigate the role of c-IAP1 and c-IAP2 in TNF alpha-stimulated activation of NF-kappa B. We demonstrate that TNF alpha-induced NF-kappa B activation is severely diminished in the absence of both c-IAP proteins. In addition, combined absence of c-IAP1 and c-IAP2 rendered cells sensitive to TNF alpha-induced cell death. Using cells with genetic ablation of c-IAP1 or cells where the c-IAP proteins were eliminated using IAP antagonists, we show that TNF alpha-induced RIP1 ubiquitination is abrogated in the absence of c-IAPs. Furthermore, we reconstitute the ubiquitination process with purified components in vitro and demonstrate that c-IAP1, in collaboration with the ubiquitin conjugating enzyme (E2) enzyme UbcH5a, mediates polymerization of Lys-63-linked chains on RIP1. Therefore, c-IAP1 and c-IAP2 are required for TNF alpha-stimulated RIP1 ubiquitination and NF-kappa B activation.	[Varfolomeev, Eugene; Goncharov, Tatiana; Fedorova, Anna V.; Dynek, Jasmin N.; Zobel, Kerry; Deshayes, Kurt; Fairbrother, Wayne J.; Vucic, Domagoj] Genentech Inc, Dept Prot Engn, San Francisco, CA 94080 USA	Roche Holding; Genentech	Vucic, D (corresponding author), Genentech Inc, Dept Prot Engn, 460 Point San Bruno Blvd, San Francisco, CA 94080 USA.	domagoj@gene.com						Baud V, 2001, TRENDS CELL BIOL, V11, P372, DOI 10.1016/S0962-8924(01)02064-5; Chen GQ, 2002, SCIENCE, V296, P1634, DOI 10.1126/science.1071924; Chen ZJ, 1996, CELL, V84, P853, DOI 10.1016/S0092-8674(00)81064-8; Chen ZJJ, 2005, NAT CELL BIOL, V7, P758, DOI 10.1038/ncb0805-758; Chu ZL, 1997, P NATL ACAD SCI USA, V94, P10057, DOI 10.1073/pnas.94.19.10057; Conte D, 2006, MOL CELL BIOL, V26, P699, DOI 10.1128/MCB.26.2.699-708.2006; Conze DB, 2005, MOL CELL BIOL, V25, P3348, DOI 10.1128/MCB.25.8.3348-3356.2005; Ea CK, 2006, MOL CELL, V22, P245, DOI 10.1016/j.molcel.2006.03.026; HSU HL, 1995, CELL, V81, P495, DOI 10.1016/0092-8674(95)90070-5; Hu SM, 2003, J BIOL CHEM, V278, P10055, DOI 10.1074/jbc.M207197200; Hunter AM, 2007, APOPTOSIS, V12, P1543, DOI 10.1007/s10495-007-0087-3; Kanayama A, 2004, MOL CELL, V15, P535, DOI 10.1016/j.molcel.2004.08.008; Kelliher MA, 1998, IMMUNITY, V8, P297, DOI 10.1016/S1074-7613(00)80535-X; Lee TH, 2004, J BIOL CHEM, V279, P33185, DOI 10.1074/jbc.M404206200; Li XM, 2002, NATURE, V416, P345, DOI 10.1038/416345a; Micheau O, 2001, MOL CELL BIOL, V21, P5299, DOI 10.1128/MCB.21.16.5299-5305.2001; Park SM, 2004, FEBS LETT, V566, P151, DOI 10.1016/j.feblset.2004.04.021; Pineda G, 2007, ADV EXP MED BIOL, V597, P80; Rothe M, 1995, CELL, V83, P1243, DOI 10.1016/0092-8674(95)90149-3; Samuel T, 2006, J BIOL CHEM, V281, P1080, DOI 10.1074/jbc.M509381200; Santoro MM, 2007, NAT GENET, V39, P1397, DOI 10.1038/ng.2007.8; Scheidereit C, 2006, ONCOGENE, V25, P6685, DOI 10.1038/sj.onc.1209934; Terzic J, 2007, BIOCHEM SOC T, V35, P942, DOI 10.1042/BST0350942; Varfolomeev E, 2005, J BIOL CHEM, V280, P40599, DOI 10.1074/jbc.M509560200; Varfolomeev E, 2008, CELL CYCLE, V7, P1511, DOI 10.4161/cc.7.11.5959; Varfolomeev E, 2007, CELL, V131, P669, DOI 10.1016/j.cell.2007.10.030; Varfolomeev E, 2006, J BIOL CHEM, V281, P29022, DOI 10.1074/jbc.M605116200; Vince JE, 2007, CELL, V131, P682, DOI 10.1016/j.cell.2007.10.037; Vucic D, 2005, BIOCHEM J, V385, P11, DOI 10.1042/BJ20041108; Wang CY, 1998, SCIENCE, V281, P1680, DOI 10.1126/science.281.5383.1680; Wertz IE, 2004, NATURE, V430, P694, DOI 10.1038/nature02794; Wu CJ, 2006, NAT CELL BIOL, V8, P398, DOI 10.1038/ncb1384; Yamamoto M, 2006, NAT IMMUNOL, V7, P962, DOI 10.1038/ni1367; Yang Y, 2000, SCIENCE, V288, P874, DOI 10.1126/science.288.5467.874; Ying SM, 2008, MICROBES INFECT, V10, P97, DOI 10.1016/j.micinf.2007.10.005	35	415	430	0	12	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	SEP 5	2008	283	36					24295	24299		10.1074/jbc.C800128200	http://dx.doi.org/10.1074/jbc.C800128200			5	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	342YR	18621737	Green Published, hybrid			2022-12-27	WOS:000258820000003
J	Verbitskiy, D; van der Merwe, JA; Zehrmann, A; Brennicke, A; Takenaka, M				Verbitskiy, Daniil; van der Merwe, Johannes A.; Zehrmann, Anja; Brennicke, Axel; Takenaka, Mizuki			Multiple specificity recognition motifs enhance plant mitochondrial RNA editing in vitro	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							PENTATRICOPEPTIDE REPEAT PROTEIN; SITE RECOGNITION; CHLOROPLAST TRANSCRIPTS; ELEMENTS; INVOLVEMENT; SEQUENCE; GENOME	Analysis of RNA editing in plant mitochondria has at least in vitro been hampered by very low activity. Consequently, none of the trans-acting factors involved has yet been identified. We here report that in vitro RNA editing increases dramatically when additional cognate recognition motifs are introduced into the template RNA molecule. Substrate RNAs with tandemly repeated recognition elements enhance in vitro RNA editing from 2-3% to 50-80%. The stimulation is not influenced by the editing status of a respective RNA editing site, suggesting that specific recognition of a site can be independent of the edited nucleotide itself. In vivo, attachment of the editing complex may thus be analogously initiated at sequence similarities in the vicinity of bona fide editing sites. This cis-acting enhancement decreases with increasing distance between the duplicated specificity signals; a cooperative effect is detectable up to similar to 200 nucleotides. Such repeated template constructs promise to be powerful tools for the RNA affinity identification of the as yet unknown trans-factors of plant mitochondrial RNA editing.	[Verbitskiy, Daniil; van der Merwe, Johannes A.; Zehrmann, Anja; Brennicke, Axel; Takenaka, Mizuki] Univ Ulm, Inst Mol Bot, D-89069 Ulm, Germany	Ulm University	Takenaka, M (corresponding author), Univ Ulm, Inst Mol Bot, D-89069 Ulm, Germany.	mizuki.takenaka@uni-ulm.de	Takenaka, Mizuki/B-2636-2013; Takenaka, Mizuki/AAK-9884-2020	Takenaka, Mizuki/0000-0002-3242-5092; Takenaka, Mizuki/0000-0002-3242-5092	Deutsche Forschungsgemeinschaft	Deutsche Forschungsgemeinschaft(German Research Foundation (DFG))	This work was supported by grants from the Deutsche Forschungsgemeinschaft.	Bolle N, 2006, FEBS LETT, V580, P4443, DOI 10.1016/j.febslet.2006.07.011; Choury D, 2004, NUCLEIC ACIDS RES, V32, P6397, DOI 10.1093/nar/gkh969; Choury D, 2006, CURR GENET, V50, P405, DOI 10.1007/s00294-006-0100-3; Farre JC, 2001, MOL CELL BIOL, V21, P6731, DOI 10.1128/MCB.21.20.6731-6737.2001; Gagliardi D., 2007, PLANT MITOCHONDRIA, P50, DOI DOI 10.1002/9780470986592.CH3; Giege P, 1999, P NATL ACAD SCI USA, V96, P15324, DOI 10.1073/pnas.96.26.15324; Handa H, 2003, NUCLEIC ACIDS RES, V31, P5907, DOI 10.1093/nar/gkg795; Hegeman CE, 2005, PLANT J, V42, P124, DOI 10.1111/j.1365-313X.2005.02360.x; Heller WP, 2008, J BIOL CHEM, V283, P7314, DOI 10.1074/jbc.M709595200; Hirose T, 2001, EMBO J, V20, P1144, DOI 10.1093/emboj/20.5.1144; Kobayashi Y, 2008, NUCLEIC ACIDS RES, V36, P311, DOI 10.1093/nar/gkm1026; Kotera E, 2005, NATURE, V433, P326, DOI 10.1038/nature03229; Lurin C, 2004, PLANT CELL, V16, P2089, DOI 10.1105/tpc.104.022236; Miyamoto T, 2002, MOL CELL BIOL, V22, P6726, DOI 10.1128/MCB.22.19.6726-6734.2002; Nakajima Y, 2005, J PLANT PHYSIOL, V162, P1347, DOI 10.1016/j.jplph.2005.02.009; Neuwirt J, 2005, RNA, V11, P1563, DOI 10.1261/rna.2740905; Okuda K, 2007, P NATL ACAD SCI USA, V104, P8178, DOI 10.1073/pnas.0700865104; Okuda K, 2006, J BIOL CHEM, V281, P37661, DOI 10.1074/jbc.M608184200; Sasaki T, 2006, PLANT J, V47, P802, DOI 10.1111/j.1365-313X.2006.02825.x; Shikanai T, 2006, CELL MOL LIFE SCI, V63, P698, DOI 10.1007/s00018-005-5449-9; Takenaka M, 2004, NUCLEIC ACIDS RES, V32, P4137, DOI 10.1093/nar/gkh763; Takenaka M, 2003, J BIOL CHEM, V278, P47526, DOI 10.1074/jbc.M305341200; Takenaka M, 2008, MITOCHONDRION, V8, P35, DOI 10.1016/j.mito.2007.09.004; Takenaka M, 2007, METHOD ENZYMOL, V424, P439, DOI 10.1016/S0076-6879(07)24020-0; Takenaka M, 2007, FEBS LETT, V581, P2743, DOI 10.1016/j.febslet.2007.05.025; van der Merwe JA, 2006, FEBS LETT, V580, P268, DOI 10.1016/j.febslet.2005.12.011; Verbitskiy D, 2006, PLANT J, V47, P408, DOI 10.1111/j.1365-313X.2006.02794.x; WISSINGER B, 1992, TRENDS GENET, V8, P322, DOI 10.1016/0168-9525(92)90265-6	28	18	20	0	1	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	SEP 5	2008	283	36					24374	24381		10.1074/jbc.M803292200	http://dx.doi.org/10.1074/jbc.M803292200			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	342YR	18596040	hybrid, Green Published			2022-12-27	WOS:000258820000011
J	Zhang, G; Park, MA; Mitchell, C; Walker, T; Hamed, H; Studer, E; Graf, M; Rahmani, M; Gupta, S; Hylemon, PB; Fisher, PB; Grant, S; Dent, P				Zhang, Guo; Park, Margaret A.; Mitchell, Clint; Walker, Teneille; Hamed, Hossein; Studer, Elaine; Graf, Martin; Rahmani, Mohamed; Gupta, Seema; Hylemon, Philip B.; Fisher, Paul B.; Grant, Steven; Dent, Paul			Multiple cyclin kinase inhibitors promote bile acid-induced apoptosis and autophagy in primary hepatocytes via p53-CD95-dependent signaling	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							DNA-DAMAGE; CELL-DEATH; RAT HEPATOCYTES; FAS RECEPTOR; P53; ACTIVATION; MDM2; PHOSPHORYLATION; PATHWAYS; ROLES	Previously, using primary hepatocytes residing in early G(1) phase, we demonstrated that expression of the cyclin-dependent kinase (CDK) inhibitor protein p21(Cip-1/WAF1/mda6) (p21) enhanced the toxicity of deoxycholic acid (DCA) + MEK1/2 inhibitor. This study examined the mechanisms regulating this apoptotic process. Overexpression of p21 or p27(Kip-1) (p27) enhanced DCA + MEK1/2 inhibitor toxicity in primary hepatocytes that was dependent on expression of acidic sphingomyelinase and CD95. Overexpression of p21 suppressed MDM2, elevated p53 levels, and enhanced CD95, BAX, NOXA, and PUMA expression; knockdown of BAX/NOXA/PUMA reduced CDK inhibitor-stimulated cell killing. Parallel to cell death processes, overexpression of p21 or p27 profoundly enhanced DCA + MEK1/2 inhibitor-induced expression of ATG5 and GRP78/BiP and phosphorylation of PKR-like endoplasmic reticulum kinase (PERK) and eIF2 alpha, and it increased the numbers of vesicles containing a transfected LC3-GFP construct. Incubation of cells with 3-methyladenine or knockdown of ATG5 suppressed DCA + MEK1/2 inhibitor-induced LC3-GFP vesicularization and enhanced DCA + MEK1/2 inhibitor-induced toxicity. Expression of dominant negative PERK blocked DCA + MEK1/2 inhibitor-induced expression of ATG5, GRP78/BiP, and eIF2 + phosphorylation and prevented LC3-GFP vesicularization. Knock-out or knockdown of p53 or CD95 abolished DCA + MEK1/2 inhibitor-induced PERK phosphorylation and prevented LC3-GFP vesicularization. Thus, CDK inhibitors suppress MDM2 levels and enhance p53 expression that facilitates bile acid-induced, ceramide-dependent CD95 activation to induce both apoptosis and autophagy in primary hepatocytes.	[Zhang, Guo; Park, Margaret A.; Mitchell, Clint; Walker, Teneille; Hamed, Hossein; Rahmani, Mohamed; Dent, Paul] Virginia Commonwealth Univ, Dept Biochem, Richmond, VA 23298 USA; [Grant, Steven] Virginia Commonwealth Univ, Dept Mol Biol Hematol Oncol, Richmond, VA 23298 USA; [Studer, Elaine; Gupta, Seema; Hylemon, Philip B.] Virginia Commonwealth Univ, Dept Microbiol & Immunol, Richmond, VA 23298 USA; [Graf, Martin] Virginia Commonwealth Univ, Dept Neurosurg, Richmond, VA 23298 USA; [Fisher, Paul B.] Virginia Commonwealth Univ, Dept Human & Mol Genet, Richmond, VA 23298 USA; [Fisher, Paul B.; Grant, Steven; Dent, Paul] Virginia Commonwealth Univ, Inst Mol Med, Richmond, VA 23298 USA	Virginia Commonwealth University; Virginia Commonwealth University; Virginia Commonwealth University; Virginia Commonwealth University; Virginia Commonwealth University; Virginia Commonwealth University	Dent, P (corresponding author), Virginia Commonwealth Univ, Dept Biochem & Mol Biol, Med Coll Virginia, 401 Coll St, Richmond, VA 23298 USA.	pdent@vcu.edu		Rahmani, Mohamed/0000-0002-3992-8039; ZHANG, GUO/0000-0001-7755-443X	National Institutes of Health [R01-DK52825, P01-CA104177, R01-CA108520]; USPHS [R01-CA63753, R01-CA77141]; Department of Defense Award [DAMD17-03-1-0262]; V Foundation; Leukemia Society of America [6405-97]; NATIONAL CANCER INSTITUTE [P01CA104177, R01CA108520, R01CA063753] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK052825] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); USPHS(United States Department of Health & Human ServicesUnited States Public Health Service); Department of Defense Award(United States Department of Defense); V Foundation; Leukemia Society of America(Leukemia and Lymphoma Society); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	This work was supported, in whole or in part, by National Institutes of Health Grants R01-DK52825, P01-CA104177, and R01-CA108520 (to P. D.) and R01-CA63753 and R01-CA77141 (to S. G.) from the USPHS, Department of Defense Award DAMD17-03-1-0262, The V Foundation, and a Leukemia Society of America Grant 6405-97.	Abida WM, 2008, CANCER RES, V68, P352, DOI 10.1158/0008-5472.CAN-07-2069; BENAGE D, 1990, J CLIN GASTROENTEROL, V12, P192, DOI 10.1097/00004836-199004000-00017; BLOOMER JR, 1976, ARCH INTERN MED, V136, P57, DOI 10.1001/archinte.136.1.57; Chehab NH, 1999, P NATL ACAD SCI USA, V96, P13777, DOI 10.1073/pnas.96.24.13777; Coqueret O, 2003, TRENDS CELL BIOL, V13, P65, DOI 10.1016/S0962-8924(02)00043-0; Crighton D, 2007, CELL DEATH DIFFER, V14, P1071, DOI 10.1038/sj.cdd.4402108; Crighton D, 2006, CELL, V126, P121, DOI 10.1016/j.cell.2006.05.034; Fang YW, 2004, HEPATOLOGY, V40, P961, DOI 10.1002/hep.20385; Faubion WA, 1999, J CLIN INVEST, V103, P137, DOI 10.1172/JCI4765; Feng ZH, 2005, P NATL ACAD SCI USA, V102, P8204, DOI 10.1073/pnas.0502857102; Fujiwara K, 2008, J BIOL CHEM, V283, P388, DOI 10.1074/jbc.M611043200; Gupta S, 2001, J BIOL CHEM, V276, P15816, DOI 10.1074/jbc.M010878200; Gupta S, 2004, J BIOL CHEM, V279, P5821, DOI 10.1074/jbc.M310979200; Haupt Y, 1997, NATURE, V387, P296, DOI 10.1038/387296a0; HOLT PR, 1972, ARCH INTERN MED, V130, P574, DOI 10.1001/archinte.130.4.574; Honda R, 1997, FEBS LETT, V420, P25, DOI 10.1016/S0014-5793(97)01480-4; Koeppel TA, 1997, HEPATOLOGY, V26, P1085; Kubbutat MHG, 1997, NATURE, V387, P299, DOI 10.1038/387299a0; Labi V, 2006, CELL DEATH DIFFER, V13, P1325, DOI 10.1038/sj.cdd.4401940; Maki CG, 1999, J BIOL CHEM, V274, P16531, DOI 10.1074/jbc.274.23.16531; Maya R, 2001, GENE DEV, V15, P1067, DOI 10.1101/gad.886901; Noto H, 1998, ARTIF ORGANS, V22, P300, DOI 10.1046/j.1525-1594.1998.05071.x; PARK MA, 2008, CANC BIOL T IN PRESS; Park MA, 2008, MOL PHARMACOL, V73, P1168, DOI 10.1124/mol.107.042697; Poupon R, 2000, J HEPATOL, V32, P129, DOI 10.1016/S0168-8278(00)80421-3; Pyo JO, 2005, J BIOL CHEM, V280, P20722, DOI 10.1074/jbc.M413934200; Qiao D, 2001, CARCINOGENESIS, V22, P35, DOI 10.1093/carcin/22.1.35; Qiao L, 2002, HEPATOLOGY, V35, P779, DOI 10.1053/jhep.2002.32533; Qiao L, 2002, HEPATOLOGY, V36, P39, DOI 10.1053/jhep.2002.33899; Qiao L, 2001, MOL BIOL CELL, V12, P2629, DOI 10.1091/mbc.12.9.2629; Roberts MS, 2002, CLIN PHARMACOKINET, V41, P751, DOI 10.2165/00003088-200241100-00005; Saporita AJ, 2007, CURR MED CHEM, V14, P1815; Shieh SY, 1997, CELL, V91, P325, DOI 10.1016/S0092-8674(00)80416-X; Tao WK, 1999, P NATL ACAD SCI USA, V96, P3077, DOI 10.1073/pnas.96.6.3077; Wang W, 2008, CURR OPIN ONCOL, V20, P90, DOI 10.1097/CCO.0b013e3282f31d6f; Werneburg NW, 2003, AM J PHYSIOL-GASTR L, V285, pG31, DOI 10.1152/ajpgi.00536.2002; Yacoub A, 2008, MOL CANCER THER, V7, P297, DOI 10.1158/1535-7163.MCT-07-2166; Yu J, 2003, CANCER CELL, V4, P248, DOI 10.1016/S1535-6108(03)00249-6; ZHANG G, 2008, CLIN CANC R IN PRESS; Zhang Z, 2004, CLIN CANCER RES, V10, P1263, DOI 10.1158/1078-0432.CCR-0245-03	40	39	39	0	3	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	SEP 5	2008	283	36					24343	24358		10.1074/jbc.M803444200	http://dx.doi.org/10.1074/jbc.M803444200			16	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	342YR	18614532	Green Published, hybrid			2022-12-27	WOS:000258820000009
J	Hunter, GA; Sampson, MP; Ferreira, GC				Hunter, Gregory A.; Sampson, Matthew P.; Ferreira, Gloria C.			Metal ion substrate inhibition of ferrochelatase	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							SACCHAROMYCES-CEREVISIAE FERROCHELATASE; BACILLUS-SUBTILIS FERROCHELATASE; ACTIVE-SITE RESIDUES; IRON-SULFUR CLUSTER; MAMMALIAN FERROCHELATASE; HEME-BIOSYNTHESIS; 2FE-2S CLUSTER; PORPHYRIN METALATION; DIRECTED MUTAGENESIS; PROTOPORPHYRIN-IX	Ferrochelatase catalyzes the insertion of ferrous iron into protoporphyrin IX to form heme. Robust kinetic analyses of the reaction mechanism are complicated by the instability of ferrous iron in aqueous solution, particularly at alkaline pH values. At pH 7.00 the half-life for spontaneous oxidation of ferrous ion is approximately 2 min in the absence of metal complexing additives, which is sufficient for direct comparisons of alternative metal ion substrates with iron. These analyses reveal that purified recombinant ferrochelatase from both murine and yeast sources inserts not only ferrous iron but also divalent cobalt, zinc, nickel, and copper into protoporphyrin IX to form the corresponding metalloporphyrins but with considerable mechanistic variability. Ferrous iron is the preferred metal ion substrate in terms of apparent kcat and is also the only metal ion substrate not subject to severe substrate inhibition. Substrate inhibition occurs in the order Cu2+ > Zn2+ > Co2+ > Ni2+ and can be alleviated by the addition of metal complexing agents such as beta-mercaptoethanol or imidazole to the reaction buffer. These data indicate the presence of two catalytically significant metal ion binding sites that may coordinately regulate a selective processivity for the various potential metal ion substrates.	[Hunter, Gregory A.; Sampson, Matthew P.; Ferreira, Gloria C.] Univ S Florida, Coll Med, Dept Mol Med, Tampa, FL 33612 USA; [Ferreira, Gloria C.] Univ S Florida, H Lee Moffit Canc Ctr & Res Inst, Tampa, FL 33612 USA	State University System of Florida; University of South Florida; State University System of Florida; University of South Florida	Hunter, GA (corresponding author), Univ S Florida, Coll Med, Dept Mol Med, MDC 7, Tampa, FL 33612 USA.	ghunter@health.usf.edu; gferreir@health.usf.edu	Ferreira, Gloria C/A-4709-2012	Ferreira, Gloria C/0000-0001-9279-2217	NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM080270] Funding Source: NIH RePORTER; NIGMS NIH HHS [R01 GM080270, GM 080270] Funding Source: Medline	NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		Al-Karadaghi S, 2006, TRENDS BIOCHEM SCI, V31, P135, DOI 10.1016/j.tibs.2006.01.001; Al-Karadaghi S, 1997, STRUCTURE, V5, P1501, DOI 10.1016/S0969-2126(97)00299-2; Bencze KZ, 2007, CHEM COMMUN, P1798, DOI 10.1039/b703195e; BOTTOMLEY SS, 2004, PORPHYRIA, P1057; Brindley AA, 2003, J BIOL CHEM, V278, P22388, DOI 10.1074/jbc.M302468200; BROWN SB, 1976, BIOCHEM J, V153, P279, DOI 10.1042/bj1530279; COCHRAN AG, 1990, SCIENCE, V249, P781, DOI 10.1126/science.2389144; Conn MM, 1996, J AM CHEM SOC, V118, P7012, DOI 10.1021/ja961249c; Crichton RR, 2002, J INORG BIOCHEM, V91, P9, DOI 10.1016/S0162-0134(02)00461-0; Crouse BR, 1996, BIOCHEMISTRY-US, V35, P16222, DOI 10.1021/bi9620114; DAILEY HA, 1994, BIOCHEMISTRY-US, V33, P403, DOI 10.1021/bi00168a003; Dailey HA, 2000, CELL MOL LIFE SCI, V57, P1909, DOI 10.1007/PL00000672; Dailey TA, 2002, J BACTERIOL, V184, P2460, DOI 10.1128/JB.184.9.2460-2464.2002; Ferreira GC, 1999, INT J BIOCHEM CELL B, V31, P995, DOI 10.1016/S1357-2725(99)00066-7; FERREIRA GC, 1994, J BIOL CHEM, V269, P7062; FERREIRA GC, 1994, J BIOL CHEM, V269, P4396; FISCHER BE, 1979, EUR J BIOCHEM, V94, P523, DOI 10.1111/j.1432-1033.1979.tb12921.x; FRANCO R, 1995, J BIOL CHEM, V270, P26352, DOI 10.1074/jbc.270.44.26352; FURUKAWA T, 1995, BIOCHEM J, V310, P533, DOI 10.1042/bj3100533; Gora M, 1996, J BIOL CHEM, V271, P11810, DOI 10.1074/jbc.271.20.11810; GUNTER EW, 1989, CLIN CHEM, V35, P1601; HANSON JW, 1984, BIOCHEM J, V222, P695, DOI 10.1042/bj2220695; HANSSON M, 1994, EUR J BIOCHEM, V220, P201, DOI 10.1111/j.1432-1033.1994.tb18615.x; Hansson MD, 2007, BIOCHEMISTRY-US, V46, P87, DOI 10.1021/bi061760a; He YN, 2004, BIOCHEMISTRY-US, V43, P16254, DOI 10.1021/bi0488193; Hoggins M, 2007, BIOCHEMISTRY-US, V46, P8121, DOI 10.1021/bi602418e; JONES MS, 1970, BIOCHEM J, V119, P453, DOI 10.1042/bj1190453; Karlberg T, 2002, BIOCHEMISTRY-US, V41, P13499, DOI 10.1021/bi0260785; Karlberg T, 2008, J MOL BIOL, V378, P1074, DOI 10.1016/j.jmb.2008.03.040; Kuchar J, 2004, CHEM REV, V104, P509, DOI 10.1021/cr020613p; Kuzmic P, 1996, ANAL BIOCHEM, V237, P260, DOI 10.1006/abio.1996.0238; Labbe RF, 1999, CLIN CHEM, V45, P2060; Lecerof D, 2003, J BIOL INORG CHEM, V8, P452, DOI 10.1007/s00775-002-0436-1; Li YF, 1997, BIOCHEMISTRY-US, V36, P5589, DOI 10.1021/bi962694n; Lloyd SG, 1996, J AM CHEM SOC, V118, P9892, DOI 10.1021/ja954000o; MARGALIT R, 1984, BIOCHEM J, V219, P445, DOI 10.1042/bj2190445; Mash HE, 2003, ANAL CHEM, V75, P671, DOI 10.1021/ac0261101; Medlock AE, 2007, J MOL BIOL, V373, P1006, DOI 10.1016/j.jmb.2007.08.040; Najahi-Missaoui W, 2005, BLOOD, V106, P1098, DOI 10.1182/blood-2004-12-4661; Nakayama K, 2000, ARCH BIOCHEM BIOPHYS, V375, P240, DOI 10.1006/abbi.1999.1641; O'Neill HA, 2005, BIOCHEMISTRY-US, V44, P537, DOI 10.1021/bi048459j; OKUDA M, 1994, BBA-GEN SUBJECTS, V1200, P123, DOI 10.1016/0304-4165(94)90126-0; Park S, 2003, J BIOL CHEM, V278, P31340, DOI 10.1074/jbc.M303158200; PORRA RJ, 1967, BIOCHEM J, V104, P321, DOI 10.1042/bj1040321; Schneider-Yin X, 2000, BLOOD, V96, P1545, DOI 10.1182/blood.V96.4.1545.h8001545_1545_1549; Schubert HL, 1999, BIOCHEMISTRY-US, V38, P10660, DOI 10.1021/bi9906773; Sellers VM, 1996, BIOCHEMISTRY-US, V35, P2699, DOI 10.1021/bi952631p; Sellers VM, 2001, BIOCHEMISTRY-US, V40, P9821, DOI 10.1021/bi010012c; Shaw GC, 2006, NATURE, V440, P96, DOI 10.1038/nature04512; Shepherd M, 2006, BIOCHEM J, V397, P47, DOI 10.1042/BJ20051967; Shi Z, 2004, J BIOL CHEM, V279, P19977, DOI 10.1074/jbc.M313821200; STUMM W, 1961, IND ENG CHEM, V53, P143, DOI 10.1021/ie50614a030; SUNG W, 1980, ENVIRON SCI TECHNOL, V14, P561, DOI 10.1021/es60165a006; Suzuki T, 2000, PLANT CELL PHYSIOL, V41, P192, DOI 10.1093/pcp/41.2.192; TAKETANI S, 1982, EUR J BIOCHEM, V127, P443; Wu CK, 2001, NAT STRUCT BIOL, V8, P156, DOI 10.1038/84152; Yin Jiang, 2006, Journal of Structural and Functional Genomics, V7, P37, DOI 10.1007/s10969-006-9008-x; Yoon T, 2004, J BIOL CHEM, V279, P25943, DOI 10.1074/jbc.C400107200; Yu QY, 1997, ANAL BIOCHEM, V253, P50, DOI 10.1006/abio.1997.2349; ZUMDAHL SS, 2004, CHEM PRINCIPLES, P891	60	42	42	2	17	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	AUG 29	2008	283	35					23685	23691		10.1074/jbc.M803372200	http://dx.doi.org/10.1074/jbc.M803372200			7	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	340II	18593702	Green Published, hybrid			2022-12-27	WOS:000258638900022
J	Kagawa, W; Kagawa, A; Saito, K; Ikawa, S; Shibata, T; Kurumizaka, H; Yokoyama, S				Kagawa, Wataru; Kagawa, Ako; Saito, Kengo; Ikawa, Shukuko; Shibata, Takehiko; Kurumizaka, Hitoshi; Yokoyama, Shigeyuki			Identification of a second DNA binding site in the human Rad52 protein	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							SINGLE-STRANDED-DNA; HOMOLOGOUS RECOMBINATION; RECA-PROTEIN; GENETIC-RECOMBINATION; YEAST; REPLICATION; EXCHANGE; REPAIR; RECOGNITION; MEDIATOR	Rad52 plays essential roles in homology-dependent double-strand break repair. Various studies have established the functions of Rad52 in Rad51-dependent and Rad51-independent repair processes. However, the precise molecular mechanisms of Rad52 in these processes remain unknown. In the present study we have identified a novel DNA binding site within Rad52 by a structure-based alanine scan mutagenesis. This site is closely aligned with the putative single-stranded DNA binding site determined previously. Mutations in this site impaired the ability of the Rad52-single-stranded DNA complex to form a ternary complex with double-stranded DNA and subsequently catalyze the formation of D-loops. We found that Rad52 introduces positive supercoils into double-stranded DNA and that the second DNA binding site is essential for this activity. Our findings suggest that Rad52 aligns two recombining DNA molecules within the first and second DNA binding sites to stimulate the homology search and strand invasion processes.	[Saito, Kengo; Kurumizaka, Hitoshi] Waseda Univ, Dept Elect Engn & Biosci, Grad Sch Adv Sci & Engn, Struct Biol Lab,Shinjuku Ku, Tokyo 1628480, Japan; [Kagawa, Wataru; Kagawa, Ako; Saito, Kengo; Kurumizaka, Hitoshi; Yokoyama, Shigeyuki] RIKEN, Syst & Struct Biol Ctr, Yokohama, Kanagawa 2300045, Japan; [Ikawa, Shukuko; Shibata, Takehiko] RIKEN, Adv Sci Inst, Wako, Saitama 3510198, Japan; [Shibata, Takehiko] Yokohama City Univ, Int Grad Sch Arts & Sci, Yokohama, Kanagawa 2300045, Japan; [Yokoyama, Shigeyuki] Univ Tokyo, Grad Sch Sci, Dept Biophys & Biochem, Bunkyo Ku, Tokyo 1130033, Japan	Waseda University; RIKEN; RIKEN; Yokohama City University; University of Tokyo	Yokoyama, S (corresponding author), Waseda Univ, Dept Elect Engn & Biosci, Grad Sch Adv Sci & Engn, Struct Biol Lab,Shinjuku Ku, 2-2 Wakamatsu Cho, Tokyo 1628480, Japan.	kurumizaka@waseda.jp; yokoyama@biochem.s.u-tokyo.ac.jp	Yokoyama, Shigeyuki/N-6911-2015	Yokoyama, Shigeyuki/0000-0003-3133-7338; Kurumizaka, Hitoshi/0000-0001-7412-3722; Kagawa, Wataru/0000-0002-8801-6589; SAITO, Kengo/0000-0002-8714-6285	Targeted Proteins Research Program; RIKEN Structural Genomics/Proteomics Initiative of the National Project on Protein Structural Functional Analyses; Ministry of Education, Culture, Sports, Science, and Technology of Japan	Targeted Proteins Research Program(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); RIKEN Structural Genomics/Proteomics Initiative of the National Project on Protein Structural Functional Analyses; Ministry of Education, Culture, Sports, Science, and Technology of Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT))	This work was supported by the Targeted Proteins Research Program and the RIKEN Structural Genomics/Proteomics Initiative of the National Project on Protein Structural and Functional Analyses, Ministry of Education, Culture, Sports, Science, and Technology of Japan. The costs of publication of this article were defrayed in part by the payment of page charges. This article must therefore be hereby marked "advertisement" in accordance with 18 U. S. C. Section 1734 solely to indicate this fact.	Baynton K, 2003, J BIOL CHEM, V278, P36476, DOI 10.1074/jbc.M303885200; Benson FE, 1998, NATURE, V391, P401, DOI 10.1038/34937; Bi BY, 2004, P NATL ACAD SCI USA, V101, P9568, DOI 10.1073/pnas.0403205101; Daley JM, 2005, ANNU REV GENET, V39, P431, DOI 10.1146/annurev.genet.39.073003.113340; Doe CL, 2004, NUCLEIC ACIDS RES, V32, P5570, DOI 10.1093/nar/gkh853; Doherty AJ, 1996, NUCLEIC ACIDS RES, V24, P2488, DOI 10.1093/nar/24.13.2488; Feng Q, 2007, DNA REPAIR, V6, P27, DOI 10.1016/j.dnarep.2006.08.007; Folta-Stogniew E, 2004, MOL CELL, V15, P965, DOI 10.1016/j.molcel.2004.08.017; Iyer LM, 2002, BMC GENOMICS, V3, DOI 10.1186/1471-2164-3-8; Kagawa W, 2002, MOL CELL, V10, P359, DOI 10.1016/S1097-2765(02)00587-7; Kagawa W, 2001, J BIOL CHEM, V276, P35201, DOI 10.1074/jbc.M104938200; Kito K, 1999, BBA-GENE STRUCT EXPR, V1489, P303, DOI 10.1016/S0167-4781(99)00214-6; Kraus E, 2001, P NATL ACAD SCI USA, V98, P8255, DOI 10.1073/pnas.151008198; Kumar JK, 2004, P NATL ACAD SCI USA, V101, P9562, DOI 10.1073/pnas.0403416101; Lloyd JA, 2005, J MOL BIOL, V345, P239, DOI 10.1016/j.jmb.2004.10.065; Macke TJ, 1998, ACS SYM SER, V682, P379; Mazin AV, 1996, P NATL ACAD SCI USA, V93, P10673, DOI 10.1073/pnas.93.20.10673; Mortensen UH, 1996, P NATL ACAD SCI USA, V93, P10729, DOI 10.1073/pnas.93.20.10729; New JH, 1998, NATURE, V391, P407, DOI 10.1038/34950; Nishinaka T, 1998, P NATL ACAD SCI USA, V95, P11071, DOI 10.1073/pnas.95.19.11071; Noirot P, 2003, EMBO J, V22, P324, DOI 10.1093/emboj/cdg027; Park MS, 1996, J BIOL CHEM, V271, P18996, DOI 10.1074/jbc.271.31.18996; Parsons CA, 2000, EMBO J, V19, P4175, DOI 10.1093/emboj/19.15.4175; Ranatunga W, 2001, J BIOL CHEM, V276, P15876, DOI 10.1074/jbc.M011747200; Reddy G, 1997, MUTAT RES-FUND MOL M, V377, P53, DOI 10.1016/S0027-5107(97)00057-2; Shao XG, 2000, NUCLEIC ACIDS RES, V28, P2643, DOI 10.1093/nar/28.14.2643; SHIBATA T, 1979, P NATL ACAD SCI USA, V76, P5100, DOI 10.1073/pnas.76.10.5100; Shinohara A, 1998, NATURE, V391, P404, DOI 10.1038/34943; Singleton MR, 2002, P NATL ACAD SCI USA, V99, P13492, DOI 10.1073/pnas.212449899; SNOUNOU G, 1983, J MOL BIOL, V167, P211, DOI 10.1016/S0022-2836(83)80043-6; Song BW, 2000, J BIOL CHEM, V275, P15895, DOI 10.1074/jbc.M910244199; Stasiak AZ, 2000, CURR BIOL, V10, P337, DOI 10.1016/S0960-9822(00)00385-7; STORL K, 1993, FEBS LETT, V334, P49, DOI 10.1016/0014-5793(93)81678-S; Sugiyama T, 2002, J BIOL CHEM, V277, P31663, DOI 10.1074/jbc.M203494200; Sugiyama T, 1998, P NATL ACAD SCI USA, V95, P6049, DOI 10.1073/pnas.95.11.6049; Sung P, 1997, J BIOL CHEM, V272, P28194, DOI 10.1074/jbc.272.45.28194; Sung P, 2006, NAT REV MOL CELL BIO, V7, P739, DOI 10.1038/nrm2008; Symington LS, 2002, MICROBIOL MOL BIOL R, V66, P630, DOI 10.1128/MMBR.66.4.630-670.2002; Thorpe PH, 2006, MOL CELL BIOL, V26, P3752, DOI 10.1128/MCB.26.10.3752-3763.2006; Van Dyck E, 1998, J MOL BIOL, V284, P1027, DOI 10.1006/jmbi.1998.2203	40	53	54	0	6	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	AUG 29	2008	283	35					24264	24273		10.1074/jbc.M802204200	http://dx.doi.org/10.1074/jbc.M802204200			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	340II	18593704	Green Published, hybrid			2022-12-27	WOS:000258638900080
J	Mambole, AS; Baruch, D; Nusbaum, P; Bigot, S; Suzuki, M; Lesavre, P; Fukuda, M; Halbwachs-Mecarelli, L				Mambole, Agne S.; Baruch, Dominique; Nusbaum, Patrick; Bigot, Sylvain; Suzuki, Misa; Lesavre, Philippe; Fukuda, Minoru; Halbwachs-Mecarelli, Lise			The cleavage of neutrophil leukosialin (CD43) by cathepsin G releases its extracellular domain and triggers its intramembrane proteolysis by presenilin/gamma-secretase	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							SELECTIN GLYCOPROTEIN LIGAND-1; CELL-SURFACE EXPRESSION; SIALOPHORIN CD43; DOWN-REGULATION; ALPHA-1-PROTEASE INHIBITOR; ENDOTHELIAL-CELLS; SERINE PROTEASES; GAMMA-SECRETASE; MOLECULE CD43; T-CELLS	The highly negatively charged membrane sialoglycoprotein leukosialin, CD43, is shed during neutrophil activation. This is generally thought to enhance cell adhesion. We here describe two novel consequences of this shedding, during neutrophil activation by phorbol esters or by chemoattractants after TNF- priming. CD43 proteolysis was investigated by Western blotting, using a polyclonal antibody to CD43 intracellular domain. Our data emphasize the importance of a juxtamembranous cleavage of about 50% of membrane CD43 molecules by cathepsin G. Indeed, it is inhibited by alpha 1- antichymotrypsin and cathepsinGinhibitor I and is reproduced by exogenous purified cathepsin G. The resulting membrane- anchored C- terminal fragment, CD43- CTF, becomes susceptible to presenilin/gamma-secretase, which releases CD43 intracytoplasmic domain: preincubation with three different gamma-secretase inhibitors, before PMNtreatment by agonists or by purified cathepsin G, results in the accumulation of CD43-CTF. Because CD43 binds E- selectin, we also investigated the effect of the soluble extracellular domain CD43s, released by cathepsin G juxtamembranous cleavage, on neutrophil adhesion to endothelial cells. A recombinant CD43s- Fc fusion protein inhibited neutrophil E selectindependent adhesion to endothelial cells under flow conditions, while it had no effect on neutrophil static adhesion. We thus propose that, in addition to its potential pro- adhesive role, CD43 proteolysis results in: (i) the release, by cathepsin G, of CD43 extracellular domain, able to inhibit the adhesion of flowing neutrophils on endothelial cells and thus to participate to the natural control of inflammation; (ii) the release and/or the clearance, by presenilin/gamma-secretase, of CD43 intracellular domain, thereby regulating CD43- mediated signaling.	[Mambole, Agne S.; Nusbaum, Patrick; Bigot, Sylvain; Lesavre, Philippe; Halbwachs-Mecarelli, Lise] Hop Necker Enfants Malad, INSERM, U 845, F-75015 Paris, France; [Mambole, Agne S.; Baruch, Dominique; Nusbaum, Patrick; Bigot, Sylvain; Lesavre, Philippe; Halbwachs-Mecarelli, Lise] Univ Paris 05, F-75015 Paris, France; [Baruch, Dominique] INSERM, U765, F-75006 Paris, France; [Suzuki, Misa; Fukuda, Minoru] Burnham Inst Med Res, Canc Res Ctr, La Jolla, CA 92037 USA	Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Necker-Enfants Malades - APHP; Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universite Paris Cite; UDICE-French Research Universities; Universite Paris Cite; Institut National de la Sante et de la Recherche Medicale (Inserm); Sanford Burnham Prebys Medical Discovery Institute	Halbwachs-Mecarelli, L (corresponding author), Hop Necker Enfants Malad, INSERM, U 845, 161 Rue Sevres, F-75015 Paris, France.	lise.halbwachs@inserm.fr	baruch, dominique/F-8189-2013; Baruch, Dominique/ABA-1791-2020	Baruch, Dominique/0000-0003-2835-5500	NATIONAL CANCER INSTITUTE [R37CA033000, R01CA033000] Funding Source: NIH RePORTER; NCI NIH HHS [CA 33000, R01 CA033000] Funding Source: Medline	NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))		ALVAREZ V, 1991, KIDNEY INT, V40, P899, DOI 10.1038/ki.1991.291; Andersson CX, 2005, BIOCHEM J, V387, P377, DOI 10.1042/BJ20041387; Andersson CX, 2004, BIOCHEM BIOPH RES CO, V316, P12, DOI 10.1016/j.bbrc.2004.02.011; BAZIL V, 1994, J IMMUNOL, V152, P1314; BIERHUIZEN MFA, 1994, J BIOL CHEM, V269, P4473; CAMPANERO MR, 1991, EUR J IMMUNOL, V21, P3045, DOI 10.1002/eji.1830211222; Fernandez-Rodriguez J, 2002, TUMOR BIOL, V23, P193, DOI 10.1159/000067252; Fuhlbrigge RC, 2006, BLOOD, V107, P1421, DOI 10.1182/blood-2005-05-2112; Gardiner EE, 2001, BLOOD, V98, P1440, DOI 10.1182/blood.V98.5.1440; Garton KJ, 2006, J LEUKOCYTE BIOL, V79, P1105, DOI 10.1189/jlb.0106038; HalbwachsMecarelli L, 1996, BLOOD, V87, P1200, DOI 10.1182/blood.V87.3.1200.bloodjournal8731200; JAFFE EA, 1973, J CLIN INVEST, V52, P2745, DOI 10.1172/JCI107470; Kopan R, 2004, NAT REV MOL CELL BIO, V5, P499, DOI 10.1038/nrm1406; Korkmaz B, 2005, AM J RESP CELL MOL, V32, P553, DOI 10.1165/rcmb.2004-0374OC; KUIJPERS TW, 1992, J IMMUNOL, V149, P998; Legendre P, 2006, J THROMB HAEMOST, V4, P236, DOI 10.1111/j.1538-7836.2005.01653.x; LOPEZ S, 1995, CLIN EXP IMMUNOL, V101, P25; Lopez S, 1998, CELL ADHES COMMUN, V5, P151, DOI 10.3109/15419069809040288; MANJUNATH N, 1995, NATURE, V377, P535, DOI 10.1038/377535a0; Marambaud P, 2002, EMBO J, V21, P1948, DOI 10.1093/emboj/21.8.1948; Matsumoto M, 2005, J IMMUNOL, V175, P8042, DOI 10.4049/jimmunol.175.12.8042; Mirnics ZK, 2002, BLOOD CELL MOL DIS, V28, P28, DOI 10.1006/bcmd.2002.0486; Mody PD, 2007, BLOOD, V110, P2974, DOI 10.1182/blood-2007-01-065276; NAKAJIMA K, 1979, J BIOL CHEM, V254, P4027; NATHAN C, 1993, J CELL BIOL, V122, P243, DOI 10.1083/jcb.122.1.243; Nie J, 2004, EXP CELL RES, V296, P145, DOI 10.1016/j.yexcr.2004.02.008; Nusbaum P, 2005, J BIOL CHEM, V280, P5843, DOI 10.1074/jbc.M413405200; Owen CA, 2004, J IMMUNOL, V172, P7791, DOI 10.4049/jimmunol.172.12.7791; Park HY, 2006, INT IMMUNOPHARMACOL, V6, P1061, DOI 10.1016/j.intimp.2006.01.019; Pham CTN, 2006, NAT REV IMMUNOL, V6, P541, DOI 10.1038/nri1841; Radford DJ, 2001, ARTHRITIS RHEUM, V44, P2851, DOI 10.1002/1529-0131(200112)44:12<2851::AID-ART473>3.0.CO;2-2; REMOLDODONNELL E, 1995, BLOOD, V86, P2395, DOI 10.1182/blood.V86.6.2395.bloodjournal8662395; REMOLDODONNELL E, 1994, J IMMUNOL, V152, P3595; RENESTO P, 1994, J IMMUNOL, V152, P4612; Ridger VC, 2005, AM J PATHOL, V166, P945, DOI 10.1016/S0002-9440(10)62314-0; RIEU P, 1992, EUR J IMMUNOL, V22, P3021, DOI 10.1002/eji.1830221138; SANCHEZMATEOS P, 1995, BLOOD, V86, P2228, DOI 10.1182/blood.V86.6.2228.bloodjournal8662228; SAWADA R, 1994, J BIOL CHEM, V269, P1425; SCHMID K, 1992, P NATL ACAD SCI USA, V89, P663, DOI 10.1073/pnas.89.2.663; Selkoe DJ, 2007, CELL, V131, P215, DOI 10.1016/j.cell.2007.10.012; Seveau S, 2000, BLOOD, V95, P2462; SHELLEY CS, 1989, P NATL ACAD SCI USA, V86, P2819, DOI 10.1073/pnas.86.8.2819; Sikut R, 1997, BIOCHEM BIOPH RES CO, V238, P612, DOI 10.1006/bbrc.1997.7334; TRAVIS J, 1983, ANNU REV BIOCHEM, V52, P655, DOI 10.1146/annurev.bi.52.070183.003255; Tsuboi S, 2001, BIOESSAYS, V23, P46, DOI 10.1002/1521-1878(200101)23:1<46::AID-BIES1006>3.3.CO;2-V; Walker J, 1999, J IMMUNOL, V162, P4109	46	25	27	0	0	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	AUG 29	2008	283	35					23627	23635		10.1074/jbc.M710286200	http://dx.doi.org/10.1074/jbc.M710286200			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	340II	18586676	hybrid, Green Published			2022-12-27	WOS:000258638900015
J	Zhang, SS; Park, CG; Zhang, P; Bartra, SS; Plano, GV; Klena, JD; Skurnik, M; Hinnebusch, BJ; Chen, T				Zhang, Shu-sheng; Park, Chae Gyu; Zhang, Pei; Bartra, Sara Schesser; Plano, Gregory V.; Klena, John D.; Skurnik, Mikael; Hinnebusch, B. Joseph; Chen, Tie			Plasminogen Activator Pla of Yersinia pestis Utilizes Murine DEC-205 (CD205) as a Receptor to Promote Dissemination	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							PRIMARY PNEUMONIC PLAGUE; DENDRITIC CELL SUBSETS; ANTIGEN GENE-CLUSTER; DC-SIGN CD209; O-ANTIGEN; MYCOBACTERIUM-TUBERCULOSIS; CORE LIPOPOLYSACCHARIDE; NEISSERIA-GONORRHOEAE; NONINTEGRIN CD209; ESCHERICHIA-COLI	Yersinia pestis, a Gram-negative bacterium that causes bubonic and pneumonic plague, is able to rapidly disseminate to other parts of its mammalian hosts. Y. pestis expresses plasminogen activator (PLA) on its surface, which has been suggested to play a role in bacterial dissemination. It has been speculated that Y. pestis hijacks antigen-presenting cells, such as macrophages (M phi s) and dendritic cells, to be delivered to lymph nodes to initiate dissemination and infection. Both alveolar M phi s and pulmonary dendritic cells express a C-type lectin receptor, DEC-205 (CD205), which mediates antigen uptake and presentation. However, no ligand has been identified for DEC-205. In this study, we show that the invasion of alveolar M phi s by Y. pestis depends both in vitro and in vivo on the expression of PLA. DEC-205-expressing M phi s and transfectants, but not their negative counterparts, phagocytosed PLA-expressing Y. pestis and Escherichia coli K12 more efficiently than PLA-negative controls. The interactions between PLA-expressing bacteria and DEC-205-expressing transfectants or alveolar M phi s could be inhibited by an anti-DEC-205 antibody. Importantly, the blockage of the PLA-DEC-205 interaction reduced the dissemination of Y. pestis in mice. In conclusion, murine DEC-205 is a receptor for PLA of Y. pestis, and this host-pathogen interaction appears to play a key role in promoting bacterial dissemination.	[Zhang, Shu-sheng; Zhang, Pei; Chen, Tie] Univ Illinois, Coll Med Rockford, Dept Biomed Sci, Rockford, IL 61107 USA; [Park, Chae Gyu] Rockefeller Univ, Chris Browne Ctr Immunol & Immune Dis, Lab Cellular Physiol & Immunol, New York, NY 10065 USA; [Bartra, Sara Schesser; Plano, Gregory V.] Univ Miami, Miller Sch Med, Dept Microbiol & Immunol, Miami, FL 33101 USA; [Klena, John D.] Univ Canterbury, Sch Biol Sci, Christchurch 1, New Zealand; [Bartra, Sara Schesser] Umea Univ, Dept Mol Biol, SE-90187 Umea, Sweden; [Hinnebusch, B. Joseph] NIAID, Lab Zoonot Pathogens, Rocky Mt Labs, NIH, Hamilton, MN 59840 USA; [Skurnik, Mikael] Univ Helsinki, Haartman Inst, Dept Bacteriol & Immunol, FIN-00014 Helsinki, Finland; [Skurnik, Mikael] Univ Helsinki, Cent Hosp Lab Diagnost, FIN-00014 Helsinki, Finland	University of Illinois System; University of Illinois Chicago; University of Illinois Rockford; Rockefeller University; University of Miami; University of Canterbury; Umea University; National Institutes of Health (NIH) - USA; NIH National Institute of Allergy & Infectious Diseases (NIAID); University of Helsinki; University of Helsinki	Chen, T (corresponding author), Univ Illinois, Coll Med Rockford, Dept Biomed Sci, 1601 Parkview Ave, Rockford, IL 61107 USA.	tiechen@uic.edu	Zhang, Shusheng/GRO-2963-2022; Skurnik, Mikael/I-8477-2019	Skurnik, Mikael/0000-0001-8791-9260; Park, Chae Gyu/0000-0003-1906-1308	National Institutes of Health [AI 057158]; University of Illinois, College of Medicine, Rockford; Academy of Finland [114075];  [Northeast Biodefense Center]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [U54AI057158, Z01AI000919] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); University of Illinois, College of Medicine, Rockford; Academy of Finland(Academy of Finland); ; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This work was supported, in whole or in part, by National Institutes of Health grants (USPHS). This work was also supported in part by a grant from the University of Illinois, College of Medicine, Rockford (to T. C.), and work in the Skurnik laboratory was supported by Academy of Finland Grant 114075. The costs of publication of this article were defrayed in part by the payment of page charges. This article must therefore be hereby marked "advertisement" in accordance with 18 U. S. C. Section 1734 solely to indicate this fact.; Supported by National Institutes of Health Grant AI 057158 (Northeast Biodefense Center).	Achtman M, 1999, P NATL ACAD SCI USA, V96, P14043, DOI 10.1073/pnas.96.24.14043; Achtman M, 2004, P NATL ACAD SCI USA, V101, P17837, DOI 10.1073/pnas.0408026101; Bartra SS, 2008, INFECT IMMUN, V76, P612, DOI 10.1128/IAI.01125-07; Bearden SW, 1999, MOL MICROBIOL, V32, P403, DOI 10.1046/j.1365-2958.1999.01360.x; Bonifaz L, 2002, J EXP MED, V196, P1627, DOI 10.1084/jem.20021598; Bonifaz LC, 2004, J EXP MED, V199, P815, DOI 10.1084/jem.20032220; Bozzacco L, 2007, P NATL ACAD SCI USA, V104, P1289, DOI 10.1073/pnas.0610383104; BRUBAKER RR, 1983, REV INFECT DIS, V5, pS748; CHEN T, 1995, J EXP MED, V182, P511, DOI 10.1084/jem.182.2.511; Chen T, 1997, J EXP MED, V185, P1557, DOI 10.1084/jem.185.9.1557; Chen T, 2001, J BIOL CHEM, V276, P17413, DOI 10.1074/jbc.M010609200; Chen T, 1996, P NATL ACAD SCI USA, V93, P14851, DOI 10.1073/pnas.93.25.14851; Cornelis GR, 1997, MOL MICROBIOL, V23, P861, DOI 10.1046/j.1365-2958.1997.2731623.x; Do Y, 2008, EUR J IMMUNOL, V38, P20, DOI 10.1002/eji.200737799; Du YD, 2002, INFECT IMMUN, V70, P1453, DOI 10.1128/IAI.70.3.1453-1460.2002; Dudziak D, 2007, SCIENCE, V315, P107, DOI 10.1126/science.1136080; Elvin SJ, 2004, NATURE, V430, P417, DOI 10.1038/nature02822; Engering A, 2002, BLOOD, V100, P1780, DOI 10.1182/blood-2001-12-0179; Fetherston JD, 1999, MOL MICROBIOL, V32, P289, DOI 10.1046/j.1365-2958.1999.01348.x; FETHERSTON JD, 1992, MOL MICROBIOL, V6, P2693, DOI 10.1111/j.1365-2958.1992.tb01446.x; Geijtenbeek TBH, 2000, CELL, V100, P587, DOI 10.1016/S0092-8674(00)80694-7; Granelli-Piperno A, 2005, J IMMUNOL, V175, P4265, DOI 10.4049/jimmunol.175.7.4265; Hammad H, 2007, ADV IMMUNOL, V93, P265, DOI 10.1016/S0065-2776(06)93007-7; Hao XL, 2008, J VIROL, V82, P4908, DOI 10.1128/JVI.02367-07; Hemmila E, 2004, J VIROL, V78, P10156, DOI 10.1128/JVI.78.18.10156-10165.2004; Hinnebusch BJ, 2002, SCIENCE, V296, P733, DOI 10.1126/science.1069972; ISBERG RR, 1990, CELL, V60, P861, DOI 10.1016/0092-8674(90)90099-Z; Isberg RR, 2001, J CELL SCI, V114, P21; Kang YS, 2003, INT IMMUNOL, V15, P177, DOI 10.1093/intimm/dxg019; KARLYSHEV AV, 1992, FEBS LETT, V297, P77, DOI 10.1016/0014-5793(92)80331-A; Kato M, 2006, INT IMMUNOL, V18, P857, DOI 10.1093/intimm/dxl022; Klena J, 2005, J BACTERIOL, V187, P1710, DOI 10.1128/JB.187.5.1710-1715.2005; KLENA JD, 1992, J BACTERIOL, V174, P7297, DOI 10.1128/jb.174.22.7297-7307.1992; KLENA JD, 1993, MOL MICROBIOL, V9, P393, DOI 10.1111/j.1365-2958.1993.tb01700.x; Kolodziejek AM, 2007, MICROBIOL-SGM, V153, P2941, DOI 10.1099/mic.0.2006/005694-0; Kukkonen M, 2004, MOL MICROBIOL, V51, P215, DOI 10.1046/j.1365-2958.2003.03817.x; Lahteenmaki K, 1998, INFECT IMMUN, V66, P5755; Lahteenmaki K, 2001, FEBS LETT, V504, P69, DOI 10.1016/S0014-5793(01)02775-2; Lathem WW, 2005, P NATL ACAD SCI USA, V102, P17786, DOI 10.1073/pnas.0506840102; Lathem WW, 2007, SCIENCE, V315, P509, DOI 10.1126/science.1137195; Legge KL, 2005, IMMUNITY, V23, P649, DOI 10.1016/j.immuni.2005.11.006; McDonald D, 2003, SCIENCE, V300, P1295, DOI 10.1126/science.1084238; Mecsas J, 2004, NATURE, V427, P606, DOI 10.1038/427606a; Medzhitov R, 1997, NATURE, V388, P394, DOI 10.1038/41131; Ordway D, 2006, J IMMUNOL, V176, P4931, DOI 10.4049/jimmunol.176.8.4931; Overheim KA, 2005, INFECT IMMUN, V73, P5152, DOI 10.1128/IAI.73.8.5152-5159.2005; Oyston PCF, 2003, J MED MICROBIOL, V52, P289, DOI 10.1099/jmm.0.05044-0; Pack M, 2008, IMMUNOLOGY, V123, P438, DOI 10.1111/j.1365-2567.2007.02710.x; PERROW C, 1997, ORG ENV, V10, P66, DOI DOI 10.1177/0921810697101009; PORTNOY DA, 1985, CURR TOP MICROBIOL, V118, P29; Prior JL, 2001, FEMS MICROBIOL LETT, V197, P229, DOI 10.1111/j.1574-6968.2001.tb10608.x; Pujol C, 2005, P NATL ACAD SCI USA, V102, P12909, DOI 10.1073/pnas.0502849102; ROSQVIST R, 1988, NATURE, V334, P522, DOI 10.1038/334522a0; SCHNAITMAN CA, 1993, MICROBIOL REV, V57, P655, DOI 10.1128/MMBR.57.3.655-682.1993; Sebbane F, 2006, P NATL ACAD SCI USA, V103, P5526, DOI 10.1073/pnas.0509544103; SIKKEMA DJ, 1987, INFECT IMMUN, V55, P572, DOI 10.1128/IAI.55.3.572-578.1987; SKURNIK M, 1989, MOL MICROBIOL, V3, P517, DOI 10.1111/j.1365-2958.1989.tb00198.x; Skurnik M, 2000, MOL MICROBIOL, V37, P316, DOI 10.1046/j.1365-2958.2000.01993.x; Takahara K, 2004, INT IMMUNOL, V16, P819, DOI 10.1093/intimm/dxh084; Takeda K, 2003, ANNU REV IMMUNOL, V21, P335, DOI 10.1146/annurev.immunol.21.120601.141126; Tan KM, 2002, EMBO J, V21, P2076, DOI 10.1093/emboj/21.9.2076; Trumpfheller C, 2006, J EXP MED, V203, P607, DOI 10.1084/jem.20052005; Vazquez-Torres A, 2000, CURR OPIN MICROBIOL, V3, P54, DOI 10.1016/S1369-5274(99)00051-X; Viboud GI, 2005, ANNU REV MICROBIOL, V59, P69, DOI 10.1146/annurev.micro.59.030804.121320; Weeks S, 2002, MICROB PATHOGENESIS, V32, P227, DOI 10.1006/mpat.2002.0498; Welkos S, 2002, VACCINE, V20, P2206, DOI 10.1016/S0264-410X(02)00119-6; Wieland CW, 2007, MICROBES INFECT, V9, P134, DOI 10.1016/j.micinf.2006.10.018; Zhang P, 2008, INFECT IMMUN, V76, P2070, DOI 10.1128/IAI.01246-07; Zhang P, 2006, J IMMUNOL, V177, P4002, DOI 10.4049/jimmunol.177.6.4002; Zhang P, 2006, J LEUKOCYTE BIOL, V79, P731, DOI 10.1189/jlb.0405184	70	54	56	0	6	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 14	2008	283	46					31511	31521		10.1074/jbc.M804646200	http://dx.doi.org/10.1074/jbc.M804646200			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	370KJ	18650418	Green Published, hybrid			2022-12-27	WOS:000260760800030
J	Arolas, JL; Pantoja-Uceda, D; Ventura, S; Blanco, FJ; Aviles, FX				Arolas, Joan L.; Pantoja-Uceda, David; Ventura, Salvador; Blanco, Francisco J.; Aviles, Francesc X.			The NMR structures of the major intermediates of the two-domain tick carboxypeptidase inhibitor reveal symmetry in its folding and unfolding pathways	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							PANCREATIC TRYPSIN-INHIBITOR; TORSION ANGLE DYNAMICS; PROTEIN STRUCTURES; DISULFIDE; PROGRAM; STATE; LYSOZYME; BINDING; ANALOG; RATES	There is a lack of experimental structural information about folding intermediates of multidomain proteins. Tick carboxypeptidase inhibitor (TCI) is a small, disulfide-rich protein consisting of two domains that fold and unfold autonomously through the formation of two major intermediates, IIIa and IIIb. Each intermediate contains three native disulfide bonds in one domain and six free cysteines in the other domain. Here we have determined the NMR structures of these two intermediates trapped and isolated at acidic pH in which they are stable and compared their structures with that of the native protein analyzed under the same conditions. Both IIIa and IIIb were found to contain a folded region that corresponds to the N- and C-terminal domains of TCI, respectively, with structures very similar to the corresponding regions of the native protein. The remainder of the polypeptide chains of the intermediates was shown to be unfolded in a random coil conformation. Solvent exchange measurements further indicated that the two protein domains are not completely independent, but affect each other in terms of dynamics and stability, in agreement with reported inhibitory activity data. The derived results provide structural evidence for symmetric TCI folding and unfolding mechanisms that converge in IIIa and IIIb and reveal the structural basis that accounts for the strong and simultaneous accumulation of both intermediates. Altogether, this work has important implications for a better understanding of the folding mechanisms of multidomain, disulfide-rich proteins.	[Arolas, Joan L.; Ventura, Salvador; Aviles, Francesc X.] Univ Autonoma Barcelona, Inst Biotecnol & Biomed, Bellaterra 08193, Spain; [Arolas, Joan L.; Ventura, Salvador; Aviles, Francesc X.] Univ Autonoma Barcelona, Dept Bioquim & Biol Mol, Bellaterra 08193, Spain; [Pantoja-Uceda, David] CSIC, Inst Quim Fis Rocasolano, Dept Espect & Estruct Mol, E-28006 Madrid, Spain; [Blanco, Francisco J.] CIC bioGUNE, Struct Biol Unit, Derio 48160, Spain	Autonomous University of Barcelona; Autonomous University of Barcelona; Consejo Superior de Investigaciones Cientificas (CSIC); CSIC - Instituto de Quimica Fisica Rocasolano (IQFR); CIC bioGUNE	Aviles, FX (corresponding author), Univ Autonoma Barcelona, Inst Biotecnol & Biomed, Bellaterra 08193, Spain.	fblanco@cicbiogune.es; francescxavier.aviles@uab.es	cancer, biogune/H-7276-2012; Pantoja-Uceda, David/J-8097-2014; Avilés, Francesc Xavier/A-2664-2015; Ventura, Salvador/AAY-3170-2021; Ventura, Salvador/C-7021-2008; Blanco, Francisco J/D-4401-2009; Aviles, Francesc Xavier/F-3482-2019	Avilés, Francesc Xavier/0000-0002-1399-6789; Ventura, Salvador/0000-0002-9652-6351; Ventura, Salvador/0000-0002-9652-6351; Blanco, Francisco J/0000-0003-2545-4319; Aviles, Francesc Xavier/0000-0002-1399-6789; Lopez Arolas, Joan/0000-0002-4198-5016; Pantoja-Uceda, David/0000-0003-4390-6972	Ministerio de Educacion y Ciencia, Spain [BIO2007-68046, GEN2003-20642-C09-05]; EU-Grant 3D repertoire [LSHG-CT-2005-512028]	Ministerio de Educacion y Ciencia, Spain(Spanish Government); EU-Grant 3D repertoire	This work was supported in part by the Ministerio de Educacion y Ciencia, Spain, Grants BIO2007-68046 (to F.X.A.) and GEN2003-20642-C09-05 (to F.J.B. and F.X.A.) and by EU-Grant 3D repertoire, Contract LSHG-CT-2005-512028 (to F.J.B.). The costs of publication of this article were defrayed in part by the payment of page charges. This article must therefore be hereby marked "advertisement" in accordance with 18 U.S.C. Section 1734 solely to indicate this fact.	Arolas JL, 2005, STRUCTURE, V13, P1193, DOI 10.1016/j.str.2005.05.008; Arolas JL, 2005, J MOL BIOL, V350, P489, DOI 10.1016/j.jmb.2005.05.015; Arolas JL, 2005, J BIOL CHEM, V280, P3441, DOI 10.1074/jbc.M411086200; Arolas JL, 2007, CURR PHARM DESIGN, V13, P349, DOI 10.2174/138161207780162980; Arolas JL, 2006, J BIOL CHEM, V281, P22906, DOI 10.1074/jbc.M602301200; Arolas JL, 2006, TRENDS BIOCHEM SCI, V31, P292, DOI 10.1016/j.tibs.2006.03.005; Batey S, 2006, P NATL ACAD SCI USA, V103, P18113, DOI 10.1073/pnas.0604580103; Bulaj G, 2008, ANTIOXID REDOX SIGN, V10, P141, DOI 10.1089/ars.2007.1856; Case DA, 2005, J COMPUT CHEM, V26, P1668, DOI 10.1002/jcc.20290; Cemazar M, 2006, J BIOL CHEM, V281, P8224, DOI 10.1074/jbc.M513399200; Cemazar M, 2008, STRUCTURE, V16, P842, DOI 10.1016/j.str.2008.02.023; Chang JY, 2004, BIOCHEMISTRY-US, V43, P4522, DOI 10.1021/bi0360354; CHANG JY, 1995, J BIOL CHEM, V270, P11992, DOI 10.1074/jbc.270.20.11992; Chang JY, 1996, BIOCHEMISTRY-US, V35, P11702, DOI 10.1021/bi9606915; Cheng Y, 2006, TRENDS BIOTECHNOL, V24, P435, DOI 10.1016/j.tibtech.2006.07.005; Creighton TE, 1997, BIOL CHEM, V378, P731; Creighton TE, 1996, FASEB J, V10, P110, DOI 10.1096/fasebj.10.1.8566531; Daly NL, 2003, J BIOL CHEM, V278, P6314, DOI 10.1074/jbc.M210492200; DARBY NJ, 1995, J MOL BIOL, V249, P463, DOI 10.1006/jmbi.1995.0309; DELAGLIO F, 1995, J BIOMOL NMR, V6, P277, DOI 10.1007/BF00197809; Guntert P, 1997, J MOL BIOL, V273, P283, DOI 10.1006/jmbi.1997.1284; GUNTERT P, 1991, J MOL BIOL, V217, P517, DOI 10.1016/0022-2836(91)90754-T; Guntert Peter, 2004, Methods Mol Biol, V278, P353; Guo ZY, 2008, ANTIOXID REDOX SIGN, V10, P127, DOI 10.1089/ars.2007.1860; Han JH, 2007, NAT REV MOL CELL BIO, V8, P319, DOI 10.1038/nrm2144; Herrmann T, 2002, J MOL BIOL, V319, P209, DOI 10.1016/S0022-2836(02)00241-3; HVIDT AASE, 1966, ADVANCE PROTEIN CHEM, V21, P287, DOI 10.1016/S0065-3233(08)60129-1; Jee JunGoo, 2003, Journal of Structural and Functional Genomics, V4, P179, DOI 10.1023/A:1026122726574; JOHNSON BA, 1994, J BIOMOL NMR, V4, P603, DOI 10.1007/BF00404272; Johnson Bruce A, 2004, Methods Mol Biol, V278, P313; Koradi R, 1996, J MOL GRAPHICS, V14, P51, DOI 10.1016/0263-7855(96)00009-4; Kortemme T, 1996, J MOL BIOL, V257, P188, DOI 10.1006/jmbi.1996.0155; Laity JH, 1997, BIOCHEMISTRY-US, V36, P12683, DOI 10.1021/bi970878b; Laskowski RA, 1996, J BIOMOL NMR, V8, P477, DOI 10.1007/BF00228148; LINDERSTROMLANG KU, 1955, CHEM SOC SPEC PUBL, V2, P1; Mukherjee S, 2007, BIOCHEMISTRY-US, V46, P9911, DOI 10.1021/bi700477h; NARDETZKY O, 1996, CHEMTRACTS BIOCH MOL, V6, P1; Noda Y, 2002, BIOCHEMISTRY-US, V41, P2130, DOI 10.1021/bi0113418; Pantoja-Uceda D, 2005, PROTEIN SCI, V14, P224, DOI 10.1110/ps.041138705; Pantoja-Uceda D, 2008, BIOCHEMISTRY-US, V47, P7066, DOI 10.1021/bi800403m; Plaxco KW, 1998, J MOL BIOL, V277, P985, DOI 10.1006/jmbi.1998.1645; Religa TL, 2005, NATURE, V437, P1053, DOI 10.1038/nature04054; Ross CA, 2004, NAT MED, V10, pS10, DOI 10.1038/nm1066; Sanglas L, 2008, MOL CELL, V31, P598, DOI 10.1016/j.molcel.2008.05.031; Sato A, 2000, J PEPT RES, V56, P218, DOI 10.1034/j.1399-3011.2000.00769.x; Shimotakahara S, 1997, BIOCHEMISTRY-US, V36, P6915, DOI 10.1021/bi963024k; van den Berg B, 1999, J MOL BIOL, V290, P781, DOI 10.1006/jmbi.1999.2915; VANMIERLO CPM, 1994, J MOL BIOL, V235, P1044, DOI 10.1006/jmbi.1994.1056; Wedemeyer WJ, 2000, BIOCHEMISTRY-US, V39, P4207, DOI 10.1021/bi992922o; WEISSMAN JS, 1991, SCIENCE, V253, P1386, DOI 10.1126/science.1716783; Welker E, 2001, P NATL ACAD SCI USA, V98, P2312, DOI 10.1073/pnas.041615798; WUTHRICH K, 1983, J MOL BIOL, V169, P949, DOI 10.1016/S0022-2836(83)80144-2; Wuthrich K, 1986, NMR PROTEINS NUCL AC, P117; Yokota A, 2004, BIOCHEMISTRY-US, V43, P6663, DOI 10.1021/bi049967w	54	9	9	0	0	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	OCT 3	2008	283	40					27110	27120		10.1074/jbc.M803978200	http://dx.doi.org/10.1074/jbc.M803978200			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	353RT	18640980	hybrid, Green Published			2022-12-27	WOS:000259586600032
J	Burgess, NK; Dao, TP; Stanley, AM; Fleming, KG				Burgess, Nancy K.; Dao, Thuy P.; Stanley, Ann Marie; Fleming, Karen G.			beta-barrel proteins that reside in the Escherichia coli outer membrane in vivo demonstrate varied folding behavior in vitro	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							LIPID-BILAYER; SALMONELLA-TYPHIMURIUM; DODECYL-SULFATE; CHANNEL; INSERTION; MECHANISM; OMPA; ENVELOPE; FORMS; PHOSPHATIDYLCHOLINE	Little is known about the dynamic process of membrane protein folding, and few models exist to explore it. In this study we doubled the number of Escherichia coli outer membrane proteins (OMPs) for which folding into lipid bilayers has been systematically investigated. We cloned, expressed, and folded nine OMPs: outer membrane protein X (OmpX), OmpW, OmpA, the crcA gene product (PagP), OmpT, outer membrane phospholipase A (OmpLa), the fadl gene product (FadL), the yaet gene product (Omp85), and OmpF. These proteins fold into the same bilayer in vivo and share a transmembrane beta-barrel motif but vary in sequence and barrel size. We quantified the ability of these OMPs to fold into a matrix of bilayer environments. Several trends emerged from these experiments: higher pH values, thinner bilayers, and increased bilayer curvature promote folding of all OMPs. Increasing the incubation temperature promoted folding of several OMPs but inhibited folding of others. We discovered that OMPs do not have the same ability to fold into any single bilayer environment. This suggests that although environmental factors influence folding, OMPs also have intrinsic qualities that profoundly modulate their folding. To rationalize the differences in folding efficiency, we performed kinetic and thermal denaturation experiments, the results of which demonstrated that OMPs employ different strategies to achieve the observed folding efficiency.	[Burgess, Nancy K.; Dao, Thuy P.; Stanley, Ann Marie; Fleming, Karen G.] Johns Hopkins Univ, TC Jenkins Dept Biophys, Baltimore, MD 21218 USA	Johns Hopkins University	Fleming, KG (corresponding author), 3400 N Charles St, Baltimore, MD 21218 USA.	karen.fleming@jhu.edu	Fleming, Karen/E-7892-2011		National Science Foundation [MCB0423807]	National Science Foundation(National Science Foundation (NSF))	This work was supported by Grant MCB0423807 from the National Science Foundation. The costs of publication of this article were defrayed in part by the payment of page charges. This article must therefore be hereby marked "advertisement" in accordance with 18 U. S. C. Section 1734 solely to indicate this fact.	Arora A, 2000, J BIOL CHEM, V275, P1594, DOI 10.1074/jbc.275.3.1594; Basle A, 2004, BBA-BIOMEMBRANES, V1664, P100, DOI 10.1016/j.bbamem.2004.04.009; BLACK PN, 1987, J BIOL CHEM, V262, P1412; Blattner FR, 1997, SCIENCE, V277, P1453, DOI 10.1126/science.277.5331.1453; Bolter B, 1998, P NATL ACAD SCI USA, V95, P15831, DOI 10.1073/pnas.95.26.15831; Bos MP, 2007, ANNU REV MICROBIOL, V61, P191, DOI 10.1146/annurev.micro.61.080706.093245; Casadio R, 2002, FEBS LETT, V520, P1, DOI 10.1016/S0014-5793(02)02758-8; COLBEAU A, 1971, BIOCHIM BIOPHYS ACTA, V249, P462, DOI 10.1016/0005-2736(71)90123-4; DEKKER N, 1995, EUR J BIOCHEM, V232, P214, DOI 10.1111/j.1432-1033.1995.tb20801.x; ENGELMAN DM, 1981, CELL, V23, P411, DOI 10.1016/0092-8674(81)90136-7; Gentle I, 2004, J CELL BIOL, V164, P19, DOI 10.1083/jcb.200310092; Hessa T, 2005, SCIENCE, V307, P1427, DOI 10.1126/science.1109176; Hill K, 1998, NATURE, V395, P516, DOI 10.1038/26780; Hong HD, 2006, J BIOL CHEM, V281, P7568, DOI 10.1074/jbc.M512365200; Hong HD, 2004, P NATL ACAD SCI USA, V101, P4065, DOI 10.1073/pnas.0400358101; Hong HD, 2007, J AM CHEM SOC, V129, P8320, DOI 10.1021/ja068849o; Hong H, 2006, NAT CHEM BIOL, V2, P627, DOI 10.1038/nchembio827; Huysmans GHM, 2007, J MOL BIOL, V373, P529, DOI 10.1016/j.jmb.2007.07.072; INOUYE M, 1973, J BACTERIOL, V113, P304, DOI 10.1128/JB.113.1.304-312.1973; KAMIO Y, 1976, BIOCHEMISTRY-US, V15, P2561, DOI 10.1021/bi00657a012; KHALID S, 2007, BIOCH BIOPHYS ACTA; KLEFFEL B, 1985, EMBO J, V4, P1589, DOI 10.1002/j.1460-2075.1985.tb03821.x; Kleinschmidt JH, 2002, J MOL BIOL, V324, P319, DOI 10.1016/S0022-2836(02)01071-9; Kleinschmidt JH, 1999, BIOCHEMISTRY-US, V38, P4996, DOI 10.1021/bi9824644; Kleinschmidt JH, 1999, BIOCHEMISTRY-US, V38, P5006, DOI 10.1021/bi982465w; Kleinschmidt JH, 1996, BIOCHEMISTRY-US, V35, P12993, DOI 10.1021/bi961478b; Kramer RA, 2000, EUR J BIOCHEM, V267, P885, DOI 10.1046/j.1432-1327.2000.01073.x; Laue T.M., 1992, ANAL ULTRACENTRIFUGA, P90; LEWIS BA, 1983, J MOL BIOL, V166, P211, DOI 10.1016/S0022-2836(83)80007-2; Lomize AL, 2006, PROTEIN SCI, V15, P1318, DOI 10.1110/ps.062126106; Lomize MA, 2006, BIOINFORMATICS, V22, P623, DOI 10.1093/bioinformatics/btk023; Mahalakshmi R, 2007, BBA-BIOMEMBRANES, V1768, P3216, DOI 10.1016/j.bbamem.2007.08.008; Meindl-Beinker NM, 2006, EMBO REP, V7, P1111, DOI 10.1038/sj.embor.7400818; MONCELLI MR, 1994, BIOPHYS J, V66, P1969, DOI 10.1016/S0006-3495(94)80990-7; NAKAMURA K, 1976, J BIOCHEM, V80, P1411, DOI 10.1093/oxfordjournals.jbchem.a131414; OSBORN MJ, 1972, J BIOL CHEM, V247, P3962; Pautsch A, 1999, PROTEINS, V34, P167, DOI 10.1002/(SICI)1097-0134(19990201)34:2<167::AID-PROT2>3.3.CO;2-8; Pilsl H, 1999, J BACTERIOL, V181, P3578, DOI 10.1128/JB.181.11.3578-3581.1999; Pocanschi CL, 2006, J MOL BIOL, V355, P548, DOI 10.1016/j.jmb.2005.10.060; Pocanschi CL, 2006, BIOPHYS J, V91, pL75, DOI 10.1529/biophysj.106.091439; Reumann S, 1999, P NATL ACAD SCI USA, V96, P784, DOI 10.1073/pnas.96.2.784; Robert V, 2006, PLOS BIOL, V4, P1984, DOI 10.1371/journal.pbio.0040377; Sambrook J., 1989, MOL CLONING LAB MANU, V1, P21, DOI DOI 10.51-10.67; Schleiff E, 2003, PROTEIN SCI, V12, P748, DOI 10.1110/ps.0237503; SEYDEL U, 1989, J MEMBRANE BIOL, V109, P95, DOI 10.1007/BF01870848; Shanmugavadivu B, 2007, J MOL BIOL, V368, P66, DOI 10.1016/j.jmb.2007.01.066; Stanley AM, 2008, ARCH BIOCHEM BIOPHYS, V469, P46, DOI 10.1016/j.abb.2007.09.024; Stegmeier JF, 2006, J BIOCHEM, V140, P275, DOI 10.1093/jb/mvj147; SURREY T, 1995, J BIOL CHEM, V270, P28199; Surrey T, 1996, BIOCHEMISTRY-US, V35, P2283, DOI 10.1021/bi951216u; SURREY T, 1992, P NATL ACAD SCI USA, V89, P7457, DOI 10.1073/pnas.89.16.7457; Tamm LK, 2004, BBA-BIOMEMBRANES, V1666, P250, DOI 10.1016/j.bbamem.2004.06.011; White SH, 2004, PROTEIN SCI, V13, P1948, DOI 10.1110/ps.04712004; Wilks JC, 2007, J BACTERIOL, V189, P5601, DOI 10.1128/JB.00615-07	54	172	176	1	24	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	SEP 26	2008	283	39					26748	26758		10.1074/jbc.M802754200	http://dx.doi.org/10.1074/jbc.M802754200			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	350GV	18641391	Green Published, hybrid			2022-12-27	WOS:000259341600047
J	Leung, AWC; Varanyuwatana, P; Halestrap, AP				Leung, Anna W. C.; Varanyuwatana, Pinadda; Halestrap, Andrew P.			The mitochondrial phosphate carrier interacts with cyclophilin D and may play a key role in the permeability transition	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ADENINE-NUCLEOTIDE TRANSLOCASE; DEPENDENT ANION CHANNEL; RAT-HEART MITOCHONDRIA; CELL-DEATH; OXIDATIVE STRESS; INORGANIC-PHOSPHATE; ADP/ATP CARRIER; MATRIX VOLUME; UBIQUINONE ANALOGS; REPERFUSION INJURY	The mitochondrial permeability transition pore (MPTP) plays a key role in cell death, yet its molecular identity remains uncertain. Although knock-out studies have confirmed critical roles for both cyclophilin-D (CyP-D) and the adenine nucleotide translocase (ANT), given a strong enough stimulus MPTP opening can occur in the absence of either. Here we provide evidence that the mitochondrial phosphate carrier (PiC) may also be a critical component of the MPTP. Phenylarsine oxide (PAO) was found to activate MPTP opening in the presence of carboxyatractyloside (CAT) that prevents ANT binding to immobilized PAO. Only four proteins from solubilized CAT-treated beef heart inner mitochondrial membranes bound to immobilized PAO, one of which was the PiC. GST-CyP-D pull-down and co-immunoprecipitation studies revealed CsA-sensitive binding of PiC to CyP-D; this increased following diamide treatment. Co-immunoprecipitation of the ANT with the PiC was also observed but was insensitive to CsA treatment. N-ethylmaleimide and ubiquinone analogues (UQ(0) and Ro 68-3400) inhibited phosphate transport into rat liver mitochondria with the same concentration dependence as their inhibition of MPTP opening. UQ(0) and Ro 68-3400 also induced the "m" conformation of the ANT, as does NEM, and reduced the binding of both the PiC and ANT to the PAO column. We propose a model for the MPTP in which a calcium-triggered conformational change of the PiC, facilitated by CyP-D, induces pore opening. An interaction of the PiC with the ANT may enable agents that bind to either transporter to modulate pore opening.	[Halestrap, Andrew P.] Univ Bristol, Dept Biochem, Sch Med Sci, Bristol BS8 1TD, Avon, England; Univ Bristol, Bristol Heart Inst, Sch Med Sci, Bristol BS8 1TD, Avon, England	University of Bristol; University of Bristol	Halestrap, AP (corresponding author), Univ Bristol, Dept Biochem, Sch Med Sci, Bristol BS8 1TD, Avon, England.	a.halestrap@bristol.ac.uk	Halestrap, Andrew P/G-7275-2011	Halestrap, Andrew/0000-0001-5374-2778	British Heart Foundation [FS/04/043];  [RG/03/002]	British Heart Foundation(British Heart Foundation); 	This work was supported in part by a Research Studentship (FS/04/043) from the British Heart Foundation (to A. W. C. L.) and Programme Grant support (RG/03/002). The costs of publication of this article were defrayed in part by the payment of page charges. This article must therefore be hereby marked "advertisement" in accordance with 18 U. S. C. Section 1734 solely to indicate this fact.	Alcala S, 2008, ONCOGENE, V27, P44, DOI 10.1038/sj.onc.1210600; AQUILA H, 1982, EUR J BIOCHEM, V122, P141, DOI 10.1111/j.1432-1033.1982.tb05859.x; Baines CP, 2007, NAT CELL BIOL, V9, P550, DOI 10.1038/ncb1575; Baines CP, 2005, NATURE, V434, P658, DOI 10.1038/nature03434; Basso E, 2005, J BIOL CHEM, V280, P18558, DOI 10.1074/jbc.C500089200; Bernardi P, 2006, FEBS J, V273, P2077, DOI 10.1111/j.1742-4658.2006.05213.x; Brustovetsky N, 2002, BIOCHEMISTRY-US, V41, P11804, DOI 10.1021/bi0200110; Brustovetsky N, 1996, BIOCHEMISTRY-US, V35, P8483, DOI 10.1021/bi960833v; CARPENTER L, 1994, BIOCHEM J, V304, P751, DOI 10.1042/bj3040751; Cesura AM, 2003, J BIOL CHEM, V278, P49812, DOI 10.1074/jbc.M304748200; Chen C, 2004, J BIOL CHEM, V279, P31761, DOI 10.1074/jbc.M401353200; Chernyak BV, 1996, EUR J BIOCHEM, V238, P623, DOI 10.1111/j.1432-1033.1996.0623w.x; Clarke SJ, 2008, CIRC RES, V102, P1082, DOI 10.1161/CIRCRESAHA.107.167072; Crompton M, 1999, BIOCHEM J, V341, P233, DOI 10.1042/0264-6021:3410233; CROMPTON M, 1988, EUR J BIOCHEM, V178, P489, DOI 10.1111/j.1432-1033.1988.tb14475.x; CROMPTON M, 1988, BIOCHEM J, V255, P357; Crompton M, 1998, EUR J BIOCHEM, V258, P729, DOI 10.1046/j.1432-1327.1998.2580729.x; Da Cruz S, 2003, J BIOL CHEM, V278, P41566, DOI 10.1074/jbc.M304940200; Das M, 2003, J PHYSIOL-LONDON, V547, P893, DOI 10.1113/jphysiol.2002.035006; DOUSSIERE J, 1984, BIOCHIM BIOPHYS ACTA, V766, P492, DOI 10.1016/0005-2728(84)90265-2; Fiermonte G, 1998, J BIOL CHEM, V273, P22782, DOI 10.1074/jbc.273.35.22782; Fontaine E, 1998, J BIOL CHEM, V273, P25734, DOI 10.1074/jbc.273.40.25734; GORNALL AG, 1949, J BIOL CHEM, V177, P751; GRIFFITHS EJ, 1991, BIOCHEM J, V274, P611, DOI 10.1042/bj2740611; GUERIN B, 1990, J BIOL CHEM, V265, P19736; Halestrap AP, 2004, CARDIOVASC RES, V61, P372, DOI 10.1016/S0008-6363(03)00533-9; Halestrap AP, 2006, BIOCHEM SOC T, V34, P232, DOI 10.1042/BST0340232; Halestrap AP, 1997, J BIOL CHEM, V272, P3346, DOI 10.1074/jbc.272.6.3346; Halestrap AP, 2002, BIOCHIMIE, V84, P153, DOI 10.1016/S0300-9084(02)01375-5; Halestrap AP, 2000, BIOCHEM SOC T, V28, P170, DOI 10.1042/bst0280170; Halestrap AP, 2004, NATURE, V430, DOI 10.1038/nature02816; HALESTRAP AP, 1990, BIOCHEM J, V268, P153, DOI 10.1042/bj2680153; Halestrap AP, 2003, CURR MED CHEM, V10, P1507, DOI 10.2174/0929867033457278; Halestrap AP, 1998, BBA-BIOENERGETICS, V1366, P79, DOI 10.1016/S0005-2728(98)00122-4; HALESTRAP AP, 1987, BIOCHEM J, V244, P159, DOI 10.1042/bj2440159; HALESTRAP AP, 1986, BIOCHEM J, V239, P559, DOI 10.1042/bj2390559; He LH, 2002, FEBS LETT, V512, P1, DOI 10.1016/S0014-5793(01)03314-2; Hildyard JCW, 2005, BBA-BIOENERGETICS, V1707, P221, DOI 10.1016/j.bbabio.2004.12.005; HUGHES WA, 1981, BIOCHEM J, V196, P459, DOI 10.1042/bj1960459; HUNTER DR, 1979, ARCH BIOCHEM BIOPHYS, V195, P453, DOI 10.1016/0003-9861(79)90371-0; KLINGENBERG M, 1971, FEBS LETT, V16, P253, DOI 10.1016/0014-5793(71)80363-0; KLINGENBERG M, 2008, BIOCH BIOPH IN PRESS; Ko YH, 2003, J BIOL CHEM, V278, P12305, DOI 10.1074/jbc.C200703200; Kokoszka JE, 2004, NATURE, V427, P461, DOI 10.1038/nature02229; Kramer R, 1998, EXP PHYSIOL, V83, P259, DOI 10.1113/expphysiol.1998.sp004111; Krauskopf A, 2006, BBA-BIOENERGETICS, V1757, P590, DOI 10.1016/j.bbabio.2006.02.007; Kroemer G, 2007, PHYSIOL REV, V87, P99, DOI 10.1152/physrev.00013.2006; LEQUOC K, 1988, ARCH BIOCHEM BIOPHYS, V265, P249, DOI 10.1016/0003-9861(88)90125-7; McStay GP, 2002, BIOCHEM J, V367, P541, DOI 10.1042/BJ20011672; Nakagawa T, 2005, NATURE, V434, P652, DOI 10.1038/nature03317; Owen MR, 2000, BIOCHEM J, V348, P607, DOI 10.1042/0264-6021:3480607; Palmieri F, 2004, PFLUG ARCH EUR J PHY, V447, P689, DOI 10.1007/s00424-003-1099-7; PEYROULA EP, 2003, NATURE, V426, P39; Phelps A, 2004, BIOCHEMISTRY-US, V43, P6200, DOI 10.1021/bi036148n; ROJO M, 1994, BBA-BIOENERGETICS, V1187, P360, DOI 10.1016/0005-2728(94)90010-8; Smith, 1967, METHOD ENZYMOL, V10, P81, DOI DOI 10.1016/0076-6879(67)10016-5; Smith VR, 2003, BIOCHEM J, V376, P757, DOI 10.1042/BJ20030942; STONER CD, 1973, J CELL BIOL, V56, P65, DOI 10.1083/jcb.56.1.65; Tafani M, 2001, CANCER RES, V61, P2459; Walter L, 2002, FREE RADICAL RES, V36, P405, DOI 10.1080/10715760290021252; Walter L, 2000, J BIOL CHEM, V275, P29521, DOI 10.1074/jbc.M004128200; WOHLRAB H, 1986, BIOCHIM BIOPHYS ACTA, V853, P115, DOI 10.1016/0304-4173(86)90007-8; Woodfield K, 1998, BIOCHEM J, V336, P287, DOI 10.1042/bj3360287	63	251	260	1	13	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	SEP 26	2008	283	39					26312	26323		10.1074/jbc.M805235200	http://dx.doi.org/10.1074/jbc.M805235200			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	350GV	18667415	Green Published, hybrid			2022-12-27	WOS:000259341600004
J	Huang, QQ; Hossain, MM; Wu, K; Parai, K; Pope, RM; Jin, JP				Huang, Qi-Quan; Hossain, M. Moazzem; Wu, Kaichun; Parai, Kakoli; Pope, Richard M.; Jin, Jian-Ping			Role of h2-calponin in regulating macrophage motility and phagocytosis	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							SMOOTH-MUSCLE CONTRACTION; STRUCTURAL ORGANIZATION; RHEUMATOID-ARTHRITIS; STEM-CELLS; IN-VITRO; CALPONIN; EXPRESSION; ACTIN; GENE; PHOSPHORYLATION	The actin cytoskeleton plays a major role in cell motility that is essential for the function of phagocytes. Calponin is an actin-associated regulatory protein. Here we report the finding of significant levels of the h2 isoform of calponin in peripheral blood cells of myeloid lineage. To study the functional significance, h2-calponin gene (Cnn2) interrupted mice were constructed. Germ line transmission of the Cnn2-flox-neo allele was obtained in chimeras from two independent clones of targeted embryonic stem cells. The insertion of the neo(R) cassette into intron 2 of the Cnn2 gene resulted in a significant knockdown of h2-calponin expression. Removing the frt-flanked neo(R) cassette by FLP1 recombinase rescued the knockdown effect. Cre recombinase-induced deletion of the loxP-flanked exon 2 eliminated the expression of h2-calponin protein. H2-calponin-free mice showed reduced numbers of peripheral blood neutrophils and monocytes. H2-calponin-free macrophages demonstrated a higher rate of proliferation and faster migration than that of h2-calponin-positive cells, consistent with a faster diapedesis of peripheral monocytes and neutrophils. H2-calponin-free macrophages showed reduced spreading in adhesion culture together with decreased tropomyosin in the actin cytoskeleton. The lack of h2-calponin also significantly increased macrophage phagocytotic activity, suggesting a novel mechanism to regulate phagocyte functions.	[Huang, Qi-Quan; Hossain, M. Moazzem; Wu, Kaichun; Parai, Kakoli; Pope, Richard M.; Jin, Jian-Ping] Northwestern Univ, Feinberg Sch Med, Dept Med, Chicago, IL 60611 USA	Northwestern University; Feinberg School of Medicine	Jin, JP (corresponding author), Evanston NW Healthcare, Sect Mol Cardiol, Evanston, IL 60201 USA.	jpjin@northwestern.edu	Jin, Jian-Ping/AAD-1149-2020	Jin, JP/0000-0001-9932-1063; Pope, Richard M./0000-0003-2416-8660	National Institutes of Health [HL-086720, AR-049217, AR048269]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL086720] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES [R01AR049217, R01AR048269] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS))	This work was supported, in whole or in part, by National Institutes of Health Grants HL-086720 (to J.-P.J.) and AR-049217 and AR048269 ( to R. M. P.). The costs of publication of this article were defrayed in part by the payment of page charges. This article must therefore be hereby marked "advertisement" in accordance with 18 U. S. C. Section 1734 solely to indicate this fact.	ABE M, 1990, J BIOCHEM-TOKYO, V108, P835, DOI 10.1093/oxfordjournals.jbchem.a123289; ALLEN BG, 1994, TRENDS BIOCHEM SCI, V19, P362, DOI 10.1016/0968-0004(94)90112-0; APPLEGATE D, 1994, J BIOL CHEM, V269, P10683; Aziz A, 2006, MOL CELL BIOL, V26, P6808, DOI 10.1128/MCB.00245-06; Beningo KA, 2002, J CELL SCI, V115, P849; COLLINS SJ, 1978, P NATL ACAD SCI USA, V75, P2458, DOI 10.1073/pnas.75.5.2458; Conrad M, 2003, BIOTECHNIQUES, V34, P1136, DOI 10.2144/03346bm03; Davies John Q, 2005, Methods Mol Biol, V290, P91; Discher DE, 2005, SCIENCE, V310, P1139, DOI 10.1126/science.1116995; Gao JM, 1996, BIOCHEM BIOPH RES CO, V218, P292, DOI 10.1006/bbrc.1996.0051; Gordon S, 2007, EUR J IMMUNOL, V37, pS9, DOI 10.1002/eji.200737638; HAEBERLE JR, 1994, J BIOL CHEM, V269, P12424; HORIUCHI KY, 1991, BIOCHEM BIOPH RES CO, V176, P1487, DOI 10.1016/0006-291X(91)90455-G; Hossain MM, 2006, BIOCHEMISTRY-US, V45, P15670, DOI 10.1021/bi061718f; Hossain MM, 2005, J BIOL CHEM, V280, P42442, DOI 10.1074/jbc.M509952200; Hossain MM, 2003, AM J PHYSIOL-CELL PH, V284, pC156, DOI 10.1152/ajpcell.00233.2002; Huang QQ, 2007, ARTHRITIS RHEUM-US, V56, P2192, DOI 10.1002/art.22707; Huang QQ, 1999, GENE, V229, P1, DOI 10.1016/S0378-1119(99)00051-7; Jin JP, 1996, BIOCHEM CELL BIOL, V74, P187, DOI 10.1139/o96-019; Jones GE, 2000, J LEUKOCYTE BIOL, V68, P593; LE JM, 1988, LYMPHOKINE RES, V7, P99; Ley K, 2007, NAT REV IMMUNOL, V7, P678, DOI 10.1038/nri2156; Lin J J, 1997, Int Rev Cytol, V170, P1, DOI 10.1016/S0074-7696(08)61619-8; LIN JJC, 1985, HYBRIDOMA, V4, P223, DOI 10.1089/hyb.1985.4.223; Liu C, 2008, NAT HIST, V117, P70; Liu HT, 2005, J IMMUNOL, V175, P8337, DOI 10.4049/jimmunol.175.12.8337; Liu HT, 2003, BLOOD, V102, P344, DOI 10.1182/blood-2002-11-3396; Liu HT, 2001, J EXP MED, V194, P113, DOI 10.1084/jem.194.2.113; Ma YY, 2004, NAT IMMUNOL, V5, P380, DOI 10.1038/ni1054; Meyers EN, 1998, NAT GENET, V18, P136, DOI 10.1038/ng0298-136; Miyado K, 1996, BIOCHEM BIOPH RES CO, V225, P427, DOI 10.1006/bbrc.1996.1190; NAKAMURA Y, 1995, CELL MOTIL CYTOSKEL, V31, P273, DOI 10.1002/cm.970310404; Nigam R, 1998, J MUSCLE RES CELL M, V19, P695, DOI 10.1023/A:1005389300151; NISHIDA W, 1993, GENE, V130, P297, DOI 10.1016/0378-1119(93)90435-6; ODA T, 1986, J IMMUNOL METHODS, V88, P175; Pagliari LJ, 2000, MOL CELL BIOL, V20, P8855, DOI 10.1128/MCB.20.23.8855-8865.2000; Perlman H, 1999, J EXP MED, V190, P1679, DOI 10.1084/jem.190.11.1679; RASCHKE WC, 1978, CELL, V15, P261, DOI 10.1016/0092-8674(78)90101-0; Scott RS, 2001, NATURE, V411, P207, DOI 10.1038/35075603; SHIRINSKY VP, 1992, J BIOL CHEM, V267, P15886; STRASSER P, 1993, FEBS LETT, V330, P13, DOI 10.1016/0014-5793(93)80909-E; Tacke F, 2006, IMMUNOBIOLOGY, V211, P609, DOI 10.1016/j.imbio.2006.05.025; TAKAHASHI K, 1986, BIOCHEM BIOPH RES CO, V141, P20, DOI 10.1016/S0006-291X(86)80328-X; TAKAHASHI K, 1991, J BIOL CHEM, V266, P13284; Tang J, 2006, J BIOL CHEM, V281, P6664, DOI 10.1074/jbc.M506991200; THOMAS KR, 1987, CELL, V51, P503, DOI 10.1016/0092-8674(87)90646-5; TRABELSITERZIDIS H, 1995, BIOCHEM J, V306, P211, DOI 10.1042/bj3060211; WALSH MP, 1991, BIOCHEM CELL BIOL, V69, P771, DOI 10.1139/o91-119; WARREN KS, 1995, J CELL BIOL, V129, P697, DOI 10.1083/jcb.129.3.697; WILKINSON PC, 1982, IMMUNOBIOLOGY, V161, P376, DOI 10.1016/S0171-2985(82)80095-8; WILKINSON PC, 1980, MONONUCLEAR PHAGOCYT, P475; WINDER SJ, 1993, BIOCHEM J, V296, P827, DOI 10.1042/bj2960827; WINDER SJ, 1990, J BIOL CHEM, V265, P10148; YEH MY, 1979, P NATL ACAD SCI USA, V76, P2927, DOI 10.1073/pnas.76.6.2927	54	46	50	0	2	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	SEP 19	2008	283	38					25887	25899		10.1074/jbc.M801163200	http://dx.doi.org/10.1074/jbc.M801163200			13	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	348GX	18617524	hybrid, Green Published			2022-12-27	WOS:000259200100016
J	Oguchi, Y; Takeda, K; Watanabe, S; Yokota, N; Miki, K; Tokuda, H				Oguchi, Yuki; Takeda, Kazuki; Watanabe, Shoji; Yokota, Naoko; Miki, Kunio; Tokuda, Hajime			Opening and closing of the hydrophobic cavity of LolA coupled to lipoprotein binding and release	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ESCHERICHIA-COLI; OUTER-MEMBRANE; MOLECULAR CHAPERONE; CRYSTAL-STRUCTURE; TRANSPORTER; PROTEINS; LOCALIZATION; VIOLACEIN; VIOE; RSEB	Outer membrane-specific lipoproteins of Escherichia coli are released from the inner membrane through the action of Lol-CDE, which leads to the formation of a complex between the lipoprotein and LolA, a periplasmic chaperone. LolA then transfers lipoproteins to LolB, a receptor in the outer membrane. The structures of LolA and LolB are very similar, having an incomplete beta-barrel covered with an alpha-helical lid forming a hydrophobic cavity inside. The cavity of LolA, but not that of LolB, is closed and thus inaccessible to the bulk solvent. Previous studies suggested that Arg at position 43 of LolA is critical for maintaining this closed structure. We show here, through a crystallo-graphic study, that the cavity of the LolA(R43L) mutant, in which Leu replaces Arg-43, is indeed open to the external milieu. We then found that the binding of a fluorescence probe distinguishes the open/close state of the cavity. Furthermore, it was revealed that the hydrophobic cavity of LolA opens upon the binding of lipoproteins. Such a liganded LolA was found to be inactive in the release of lipoproteins from the inner membrane. On the other hand, the liganded LolA became fully functional when lipoproteins were removed from LolA by detergent treatment or transferred to LolB. Free LolA thus formed was inaccessible to a fluorescence probe. These results, taken together, reveal the LolA cycle, in which the hydrophobic cavity undergoes opening and closing upon the binding and release of lipoproteins, respectively.	[Oguchi, Yuki; Watanabe, Shoji; Yokota, Naoko; Tokuda, Hajime] Univ Tokyo, Inst Mol & Cellular Biosci, Bunkyo Ku, Tokyo 1130032, Japan; [Takeda, Kazuki; Miki, Kunio] Harima Inst, Spring Ctr 8, RIKEN, Mikazuki, Hyogo 6795148, Japan; [Takeda, Kazuki; Miki, Kunio] Kyoto Univ, Grad Sch Sci, Dept Chem, Kyoto 6068502, Japan	University of Tokyo; RIKEN; Kyoto University	Tokuda, H (corresponding author), Univ Tokyo, Inst Mol & Cellular Biosci, Bunkyo Ku, 1-1-1 Yayoi, Tokyo 1130032, Japan.	htokuda@iam.u-tokyo.ac.jp	Takeda, Kazuki/AAQ-9238-2021	Takeda, Kazuki/0000-0002-4094-6816	Ministry of Education, Science, Sports and Culture of Japan	Ministry of Education, Science, Sports and Culture of Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT))	This work was supported by grants from the Ministry of Education, Science, Sports and Culture of Japan (to H. T.). The costs of publication of this article were defrayed in part by the payment of page charges. This article must therefore be hereby marked "advertisement" in accordance with 18 U. S. C. Section 1734 solely to indicate this fact.	CASADABAN MJ, 1976, J MOL BIOL, V104, P541, DOI 10.1016/0022-2836(76)90119-4; Hirano S, 2008, J BIOL CHEM, V283, P6459, DOI 10.1074/jbc.M708109200; HUSSAIN M, 1982, J BIOL CHEM, V257, P5177; Kim DY, 2007, P NATL ACAD SCI USA, V104, P8779, DOI 10.1073/pnas.0703117104; LAEMMLI UK, 1970, NATURE, V227, P680, DOI 10.1038/227680a0; MATSUYAMA S, 1995, EMBO J, V14, P3365, DOI 10.1002/j.1460-2075.1995.tb07342.x; Matsuyama S, 1997, EMBO J, V16, P6947, DOI 10.1093/emboj/16.23.6947; Miyamoto A, 2001, BIOCHEM BIOPH RES CO, V287, P1125, DOI 10.1006/bbrc.2001.5705; Narita S, 2004, ARCH MICROBIOL, V182, P1, DOI 10.1007/s00203-004-0682-4; Osborn M J, 1974, Methods Enzymol, V31, P642; Pastukhov AV, 2003, PROTEINS, V53, P607, DOI 10.1002/prot.10401; Ryan KS, 2008, J BIOL CHEM, V283, P6467, DOI 10.1074/jbc.M708573200; Sambrook J., 1989, MOL CLONING LAB MANU; Sulzenbacher G, 2006, EMBO J, V25, P1436, DOI 10.1038/sj.emboj.7601048; Takeda K, 2003, EMBO J, V22, P3199, DOI 10.1093/emboj/cdg324; Taniguchi N, 2005, J BIOL CHEM, V280, P34481, DOI 10.1074/jbc.M507388200; Taniguchi N, 2008, J BIOL CHEM, V283, P8538, DOI 10.1074/jbc.M800026200; Tokuda H, 2004, BBA-MOL CELL RES, V1693, P5, DOI 10.1016/j.bbamcr.2004.02.005; Watanabe S, 2006, J BIOL CHEM, V281, P3335, DOI 10.1074/jbc.M509596200; Watanabe S, 2007, PROTEIN SCI, V16, P2741, DOI 10.1110/ps.073101307; Wollmann P, 2007, J MOL BIOL, V372, P927, DOI 10.1016/j.jmb.2007.06.039; Yakushi T, 2000, NAT CELL BIOL, V2, P212, DOI 10.1038/35008635	22	30	32	0	3	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	SEP 12	2008	283	37					25414	25420		10.1074/jbc.M804736200	http://dx.doi.org/10.1074/jbc.M804736200			7	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	345QZ	18617521	hybrid			2022-12-27	WOS:000259012700036
J	Wu, ZQ; Yang, XM; Weber, G; Liu, XQ				Wu, Zhao-Qiu; Yang, Xiaoming; Weber, Gregory; Liu, Xiaoqi			Plk1 phosphorylation of TRF1 is essential for its binding to telomeres	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							POLO-LIKE KINASE; PROTEIN PIN2/TRF1; CELLS; END; COMPLEX; LENGTH; DNA; LOCALIZATION; REPLICATION; APOPTOSIS	In a search for Polo-like kinase 1 (Plk1) interaction proteins, we have identified TRF1 (telomeric repeat binding factor 1) as a potential Plk1 target. In this communication we report further characterization of the interaction. We show that Plk1 associates with TRF1, and Plk1 phosphorylates TRF1 at Ser-435 in vivo. Moreover, Cdk1, serving as a priming kinase, phosphorylates TRF1 to generate a docking site for Plk1 toward TRF1. In the presence of nocodazole, ectopic expression of wild type TRF1 but not TRF1 with alanine mutation in the Plk1 phosphorylation site induces apoptosis in cells containing short telomeres but not in cells containing long telomeres. Unexpectedly, down-regulation of TRF1 by RNA interference affects cell proliferation and results in obvious apoptosis in cells with short telomeres but not in cells with long telomeres. Importantly, we observe that telomeric DNA binding ability of TRF1 is cell cycle-regulated and reaches a peak during mitosis. Upon phosphorylation by Plk1 in vivo and in vitro, the ability of TRF1 to bind telomeric DNA is dramatically increased. These results demonstrate that Plk1 interacts with and phosphorylates TRF1 and suggest that Plk1-mediated phosphorylation is involved in both TRF1 overexpression-induced apoptosis and its telomeric DNA binding ability.	[Wu, Zhao-Qiu; Weber, Gregory; Liu, Xiaoqi] Purdue Univ, Dept Biochem, W Lafayette, IN 47907 USA; [Wu, Zhao-Qiu; Weber, Gregory; Liu, Xiaoqi] Purdue Univ, Ctr Canc, W Lafayette, IN 47907 USA; [Yang, Xiaoming] Sichuan Univ, Coll Chem, Chengdu 610064, Peoples R China	Purdue University System; Purdue University; Purdue University West Lafayette Campus; Purdue University System; Purdue University; Purdue University West Lafayette Campus; Sichuan University	Liu, XQ (corresponding author), Purdue Univ, Dept Biochem, 175 S Univ St, W Lafayette, IN 47907 USA.	liu8@purdue.Edu			National Institutes of Health [K01 CA114401]; NATIONAL CANCER INSTITUTE [K01CA114401] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This work was supported, in whole or in part, by National Institutes of Health Grant K01 CA114401 (a Howard Temin Award ( to X. L.)). The costs of publication of this article were defrayed in part by the payment of page charges. This article must therefore be hereby marked "advertisement" in accordance with 18 U. S. C. Section 1734 solely to indicate this fact.	Barr FA, 2004, NAT REV MOL CELL BIO, V5, P429, DOI 10.1038/nrm1401; Baumann C, 2007, CELL, V128, P101, DOI 10.1016/j.cell.2006.11.041; Bianchi A, 1997, EMBO J, V16, P1785, DOI 10.1093/emboj/16.7.1785; Bilaud T, 1997, NAT GENET, V17, P236, DOI 10.1038/ng1097-236; Blackburn EH, 2000, NATURE, V408, P53, DOI 10.1038/35040500; Blasco MA, 1997, CELL, V91, P25, DOI 10.1016/S0092-8674(01)80006-4; Brennan IM, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000409; Cech TR, 2004, CELL, V116, P273, DOI 10.1016/S0092-8674(04)00038-8; Chan SRWL, 2004, PHILOS T R SOC B, V359, P109, DOI 10.1098/rstb.2003.1370; CHONG L, 1995, SCIENCE, V270, P1663, DOI 10.1126/science.270.5242.1663; de Lange T, 2005, GENE DEV, V19, P2100, DOI 10.1101/gad.1346005; DELANGE T, 1992, EMBO J, V11, P717, DOI 10.1002/j.1460-2075.1992.tb05104.x; Eckerdt F, 2005, ONCOGENE, V24, P267, DOI 10.1038/sj.onc.1208273; Elia AEH, 2003, CELL, V115, P83, DOI 10.1016/S0092-8674(03)00725-6; Elia AEH, 2003, SCIENCE, V299, P1228, DOI 10.1126/science.1079079; GOLSTEYN RM, 1994, J CELL SCI, V107, P1509; Griffith JD, 1999, CELL, V97, P503, DOI 10.1016/S0092-8674(00)80760-6; Iwano T, 2004, J BIOL CHEM, V279, P1442, DOI 10.1074/jbc.M309138200; Karlseder J, 1999, SCIENCE, V283, P1321, DOI 10.1126/science.283.5406.1321; Karlseder J, 2003, MOL CELL BIOL, V23, P6533, DOI 10.1128/MCB.23.18.6533-6541.2003; Kim MK, 2008, J BIOL CHEM, V283, P14144, DOI 10.1074/jbc.M710065200; Kishi S, 2001, ONCOGENE, V20, P1497, DOI 10.1038/sj.onc.1204229; Kishi S, 2001, J BIOL CHEM, V276, P29282, DOI 10.1074/jbc.M011534200; Lin CY, 2000, P NATL ACAD SCI USA, V97, P12589, DOI 10.1073/pnas.220423497; LINGNER J, 1995, SCIENCE, V269, P1533, DOI 10.1126/science.7545310; Liu XQ, 2006, MOL CELL BIOL, V26, P2093, DOI 10.1128/MCB.26.6.2093-2108.2006; Loayza D, 2003, NATURE, V423, P1013, DOI 10.1038/nature01688; Nakajima H, 2003, J BIOL CHEM, V278, P25277, DOI 10.1074/jbc.C300126200; Nishiyama A, 2006, EMBO J, V25, P575, DOI 10.1038/sj.emboj.7600964; O'Connor MS, 2006, P NATL ACAD SCI USA, V103, P11874, DOI 10.1073/pnas.0605303103; Shen MH, 1997, P NATL ACAD SCI USA, V94, P13618, DOI 10.1073/pnas.94.25.13618; Smith S, 1998, SCIENCE, V282, P1484, DOI 10.1126/science.282.5393.1484; Smogorzewska A, 2004, ANNU REV BIOCHEM, V73, P177, DOI 10.1146/annurev.biochem.73.071403.160049; Stewart SA, 2006, ANNU REV CELL DEV BI, V22, P531, DOI 10.1146/annurev.cellbio.22.010305.104518; van Steensel B, 1998, CELL, V92, P401, DOI 10.1016/S0092-8674(00)80932-0; van Vugt MATM, 2005, ONCOGENE, V24, P2844, DOI 10.1038/sj.onc.1208617; vanSteensel B, 1997, NATURE, V385, P740, DOI 10.1038/385740a0; Winkles JA, 2005, ONCOGENE, V24, P260, DOI 10.1038/sj.onc.1208219; Wu ZQ, 2008, P NATL ACAD SCI USA, V105, P1919, DOI 10.1073/pnas.0712063105; Ye JZS, 2004, J BIOL CHEM, V279, P47264, DOI 10.1074/jbc.M409047200; ZHONG Z, 1992, MOL CELL BIOL, V12, P4834, DOI 10.1128/MCB.12.11.4834; ZHOU SY, 1994, CURR BIOL, V4, P973, DOI 10.1016/S0960-9822(00)00221-9	42	36	37	0	8	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	SEP 12	2008	283	37					25503	25513		10.1074/jbc.M803304200	http://dx.doi.org/10.1074/jbc.M803304200			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	345QZ	18625707	Green Published, hybrid			2022-12-27	WOS:000259012700046
J	Kortlever, RM; Nijwening, JH; Bernards, R				Kortlever, Roderik M.; Nijwening, Jeroen H.; Bernards, Rene			Transforming growth factor-beta requires its target plasminogen activator inhibitor-1 for cytostatic activity	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							TGF-BETA; MESENCHYMAL TRANSITION; CANCER; SUPPRESSION; PHOSPHORYLATION; P27(KIP1); SMAD4; P53	The cytokine transforming growth factor beta(TGF beta) has strong antiproliferative activity in most normal cells but contributes to tumor progression in the later stages of oncogenesis. It is not fully understood which TGF beta target genes are causally involved in mediating its cytostatic activity. We report here that suppression of the TGF beta target gene encoding plasminogen activator inhibitor-1 (PAI-1) by RNA interference leads to escape from the cytostatic activity of TGF beta both in human keratinocytes (HaCaTs) and primary mouse embryo fibroblasts. Consistent with this, PAI-1 knock-out mouse embryo fibroblasts are also resistant to TGF beta growth arrest. Conversely, we show that ectopic expression of PAI-1 in proliferating HaCaT cells induces a growth arrest. PAI-1 knockdown does not interfere with canonical TGF beta signaling as judged by SMAD phosphorylation and induction of bona fide TGF beta target genes. Instead, knockdown of PAI-1 results in sustained activation of protein kinase B. Significantly, we find that constitutive protein kinase B activity leads to evasion of the growth-inhibitory action of TGF beta. Our data are consistent with a model in which induction of PAI-1 by TGF beta is critical for the induction of proliferation arrest.	Netherlands Canc Inst, Div Mol Carcinogenesis, Ctr Canc Genom, NL-1066 CX Amsterdam, Netherlands; Netherlands Canc Inst, Div Mol Carcinogenesis, Ctr Biomed Genet, NL-1066 CX Amsterdam, Netherlands	Netherlands Cancer Institute; Netherlands Cancer Institute	Bernards, R (corresponding author), Plesmanlaan 121, NL-1066 CX Amsterdam, Netherlands.	r.bernards@nki.nl	Kortlever, Roderik/AAY-9220-2020	Bernards, Rene/0000-0001-8677-3423; Kortlever, Roderik/0000-0001-5558-2851	European Union 6th Framework (INTACT); Center for Cancer Genomics	European Union 6th Framework (INTACT)(European Commission); Center for Cancer Genomics	This work was supported by a grant from the European Union 6th Framework (INTACT) and by the Center for Cancer Genomics.	Akhurst RJ, 2001, TRENDS CELL BIOL, V11, pS44, DOI 10.1016/S0962-8924(01)82259-5; Andreasen PA, 2000, CELL MOL LIFE SCI, V57, P25, DOI 10.1007/s000180050497; Bierie B, 2006, CYTOKINE GROWTH F R, V17, P29, DOI 10.1016/j.cytogfr.2005.09.006; Brummelkamp TR, 2002, CANCER CELL, V2, P243, DOI 10.1016/S1535-6108(02)00122-8; Choong PFM, 2003, CLIN ORTHOP RELAT R, pS46, DOI 10.1097/01.blo.0000093845.72468.bd; Cordenonsi M, 2003, CELL, V113, P301, DOI 10.1016/S0092-8674(03)00308-8; Deckers M, 2006, CANCER RES, V66, P2202, DOI 10.1158/0008-5472.CAN-05-3560; Derynck R, 2001, NAT GENET, V29, P117, DOI 10.1038/ng1001-117; Derynck R, 2007, NAT CELL BIOL, V9, P1000, DOI 10.1038/ncb434; Feng XH, 2005, ANNU REV CELL DEV BI, V21, P659, DOI 10.1146/annurev.cellbio.21.022404.142018; HANNON GJ, 1994, NATURE, V371, P257, DOI 10.1038/371257a0; Herrera RE, 1996, MOL BIOL CELL, V7, P1335, DOI 10.1091/mbc.7.9.1335; Kortlever RM, 2006, NAT CELL BIOL, V8, P877, DOI 10.1038/ncb1448; LAIHO M, 1990, CELL, V62, P175, DOI 10.1016/0092-8674(90)90251-9; Levy L, 2005, MOL CELL BIOL, V25, P8108, DOI 10.1128/MCB.25.18.8108-8125.2005; Liang J, 2002, NAT MED, V8, P1153, DOI 10.1038/nm761; Look M, 2003, THROMB HAEMOSTASIS, V90, P538, DOI 10.1160/TH-02-11-0264; Massague J, 2000, NAT REV MOL CELL BIO, V1, P169, DOI 10.1038/35043051; Parsons R, 2004, SEMIN CELL DEV BIOL, V15, P171, DOI 10.1016/j.semcdb.2003.12.021; Shin I, 2002, NAT MED, V8, P1145, DOI 10.1038/nm759; Siegel PM, 2003, NAT REV CANCER, V3, P807, DOI 10.1038/nrc1208; Stover DG, 2007, J CELL BIOCHEM, V101, P851, DOI 10.1002/jcb.21149; Viglietto G, 2002, NAT MED, V8, P1136, DOI 10.1038/nm762; WIKNER NE, 1990, J INVEST DERMATOL, V95, P607, DOI 10.1111/1523-1747.ep12505603	24	42	44	0	0	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	SEP 5	2008	283	36					24308	24313		10.1074/jbc.M803341200	http://dx.doi.org/10.1074/jbc.M803341200			6	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	342YR	18614541	hybrid, Green Published			2022-12-27	WOS:000258820000005
J	Durfee, LA; Kelley, ML; Huibregtse, JM				Durfee, Larissa A.; Kelley, Melissa L.; Huibregtse, Jon M.			The basis for selective E1-E2 interactions in the ISG15 conjugation system	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							UBIQUITIN-PROTEIN LIGASE; HUMAN-CELLS; E2 ENZYME; IDENTIFICATION; E1; DEGRADATION; TARGETS; PARKIN; DETERMINANTS; RECRUITMENT	E1 and E2 enzymes coordinate the first steps in conjugation of ubiquitin (Ub) and ubiquitin-like proteins (Ubls). ISG15 is an interferon-alpha/beta-induced Ubl, and the E1 and E2 enzymes for ISG15 conjugation are Ube1L and UbcH8, respectively. UbcH7 is the most closely related E2 to UbcH8, yet it does not function in ISG15 conjugation in vivo, while both UbcH7 and UbcH8 have been reported to function in Ub conjugation. Kinetic analyses of wild-type and chimeric E2s were performed to determine the basis for preferential activation of UbcH8 by Ube1L and to determine whether UbcH8 is activated equally well by Ube1L and E1(Ub) (Ube1). K-m determinations confirmed the strong preference of Ube1L for UbcH8 over UbcH7 (a 29-fold K-m difference), similar to the preference of E1(Ub) for UbcH7 over UbcH8 (a 36- fold K-m difference). Thioester assays of chimeric E2s identified two structural elements within residues 1-39 of UbcH8 that play a major role in defining Ube1L-UbcH8 specificity: the alpha 1-helix and the beta 1-beta 2 region. The C-terminal ubiquitin fold domain (UFD) of Ube1L was required for transfer of ISG15 to UbcH8 and for binding of Ube1L to UbcH8. Replacement of the Ube1L UFD with that from E1(Ub) resulted in preferential transfer of ISG15 to UbcH7. Together, these results indicate that Ube1L discriminates between UbcH8 and closely related Ub E2s based on specific interactions between the Ube1L UFD and determinants within the N-terminal region of UbcH8.	[Durfee, Larissa A.; Kelley, Melissa L.; Huibregtse, Jon M.] Univ Texas Austin, Inst Cellular & Mol Biol, Sect Mol Genet & Microbiol, Austin, TX 78712 USA	University of Texas System; University of Texas Austin	Huibregtse, JM (corresponding author), Univ Texas Austin, Inst Cellular & Mol Biol, Sect Mol Genet & Microbiol, 2500 Speedway, Austin, TX 78712 USA.	huibreg@mail.utexas.edu			NCI [CA072943]; NATIONAL CANCER INSTITUTE [R01CA072943] Funding Source: NIH RePORTER	NCI(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This work was supported, in whole or in part, by National Institutes of Health Grant CA072943 (to J.M.H.) from NCI. The costs of publication of this article were defrayed in part by the payment of page charges. This article must therefore be hereby marked "advertisement" in accordance with 18 U.S.C. Section 1734 solely to indicate this fact.	Beaudenon S, 2005, METHOD ENZYMOL, V398, P3, DOI 10.1016/S0076-6879(05)98001-4; Bencsath KP, 2002, J BIOL CHEM, V277, P47938, DOI 10.1074/jbc.M207442200; Chin LS, 2002, J BIOL CHEM, V277, P35071, DOI 10.1074/jbc.M203300200; Chiu YH, 2007, MOL CELL, V27, P1014, DOI 10.1016/j.molcel.2007.08.020; Dastur A, 2006, J BIOL CHEM, V281, P4334, DOI 10.1074/jbc.M512830200; Fortier JM, 2006, J IMMUNOL, V176, P6454, DOI 10.4049/jimmunol.176.11.6454; Giannakopoulos NV, 2005, BIOCHEM BIOPH RES CO, V336, P496, DOI 10.1016/j.bbrc.2005.08.132; Groettrup M, 2008, TRENDS BIOCHEM SCI, V33, P230, DOI 10.1016/j.tibs.2008.01.005; HAAS AL, 2006, PROTEIN DEGRADATION, P103; Huang DT, 2008, NAT STRUCT MOL BIOL, V15, P280, DOI 10.1038/nsmb.1387; Huang DT, 2007, NATURE, V445, P394, DOI 10.1038/nature05490; Huang DT, 2005, MOL CELL, V17, P341, DOI 10.1016/j.molcel.2004.12.020; Huang DT, 2004, NAT STRUCT MOL BIOL, V11, P927, DOI 10.1038/nsmb826; Huang J, 2006, FEBS LETT, V580, P940, DOI 10.1016/j.febslet.2005.09.105; Huang L, 1999, SCIENCE, V286, P1321, DOI 10.1126/science.286.5443.1321; Imai Y, 2000, J BIOL CHEM, V275, P35661, DOI 10.1074/jbc.C000447200; Jin JP, 2007, NATURE, V447, P1135, DOI 10.1038/nature05902; Kerscher O, 2006, ANNU REV CELL DEV BI, V22, P159, DOI 10.1146/annurev.cellbio.22.010605.093503; Kim KI, 2004, MOL CELL BIOL, V24, P9592, DOI 10.1128/MCB.24.21.9592-9600.2004; Kumar S, 1997, J BIOL CHEM, V272, P13548, DOI 10.1074/jbc.272.21.13548; Lois LM, 2005, EMBO J, V24, P439, DOI 10.1038/sj.emboj.7600552; Melchior F, 2000, ANNU REV CELL DEV BI, V16, P591, DOI 10.1146/annurev.cellbio.16.1.591; Moynihan TP, 1996, MAMM GENOME, V7, P520, DOI 10.1007/s003359900155; Moynihan TP, 1999, J BIOL CHEM, V274, P30963, DOI 10.1074/jbc.274.43.30963; Niwa J, 2001, BIOCHEM BIOPH RES CO, V281, P706, DOI 10.1006/bbrc.2001.4414; Pickart CM, 2001, ANNU REV BIOCHEM, V70, P503, DOI 10.1146/annurev.biochem.70.1.503; PITLUK ZW, 1995, MOL CELL BIOL, V15, P1210; SCHEFFNER M, 1995, NATURE, V373, P81, DOI 10.1038/373081a0; Shimura H, 2000, NAT GENET, V25, P302, DOI 10.1038/77060; Su AI, 2002, P NATL ACAD SCI USA, V99, P4465, DOI 10.1073/pnas.012025199; SULLIVAN ML, 1991, J BIOL CHEM, V266, P23878; Urano T, 2002, NATURE, V417, P871, DOI 10.1038/nature00826; Wheeler TC, 2002, J BIOL CHEM, V277, P10273, DOI 10.1074/jbc.M107857200; Winn PJ, 2004, STRUCTURE, V12, P1563, DOI 10.1016/j.str.2004.06.017; Yuan WM, 2001, EMBO J, V20, P362, DOI 10.1093/emboj/20.3.362; Zhang Y, 2000, P NATL ACAD SCI USA, V97, P13354, DOI 10.1073/pnas.240347797; Zhao C, 2004, P NATL ACAD SCI USA, V101, P7578, DOI 10.1073/pnas.0402528101; Zhao C, 2005, P NATL ACAD SCI USA, V102, P10200, DOI 10.1073/pnas.0504754102; Zheng N, 2000, CELL, V102, P533, DOI 10.1016/S0092-8674(00)00057-X	39	39	40	0	3	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	AUG 29	2008	283	35					23895	23902		10.1074/jbc.M804069200	http://dx.doi.org/10.1074/jbc.M804069200			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	340II	18583345	hybrid, Green Published			2022-12-27	WOS:000258638900044
J	Haggie, PM; Verkman, AS				Haggie, Peter M.; Verkman, A. S.			Monomeric CFTR in plasma membranes in live cells revealed by single molecule fluorescence imaging	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							TRANSMEMBRANE CONDUCTANCE REGULATOR; CYSTIC-FIBROSIS; CHLORIDE CHANNEL; DRUG DISCOVERY; PROTEIN; MECHANISM; DOMAIN; STOICHIOMETRY; ACTIVATORS; THERAPY	The cystic fibrosis transmembrane conductance regulator (CFTR) is a cAMP-regulated chloride channel. There is indirect and conflicting evidence about whether CFTR exists in cell membranes as monomers, dimers, or higher order oligomers. We measured fluorescence intensities and photobleaching dynamics of distinct fluorescent spots in cells expressing functional CFTR- green fluorescent protein (GFP) chimeras. Intensity analysis of GFP- labeled CFTR in live cells showed singlecomponent distributions with mean intensity equal to that of purified monomeric GFP, indicating monomeric CFTR in cell membranes. Fluorescent spots showed single- step photobleaching, independently verifying that CFTR is monomeric. Results did not depend on whether GFP was added to the CFTR N terminus or fourth extracellular loop or on whether CFTR chloride conductance was stimulated by cAMP agonists. Control measurements with a CFTR chimera containing two GFPs showed two- step photobleaching and a single- component intensity distribution with mean intensity twice that of monomeric GFP. These results provide direct evidence for monomeric CFTR in live cells.	[Haggie, Peter M.] Univ Calif San Francisco, Dept Med, San Francisco, CA 94143 USA; Univ Calif San Francisco, Dept Physiol, San Francisco, CA 94143 USA	University of California System; University of California San Francisco; University of California System; University of California San Francisco	Haggie, PM (corresponding author), Univ Calif San Francisco, Dept Med, San Francisco, CA 94143 USA.	peter.haggie@ucsf.edu			NATIONAL EYE INSTITUTE [R01EY013574] Funding Source: NIH RePORTER; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL059198, R01HL073856] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF BIOMEDICAL IMAGING AND BIOENGINEERING [R37EB000415, R01EB000415] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R37DK035124, P30DK072517, R01DK035124, R01DK081355] Funding Source: NIH RePORTER; NEI NIH HHS [EY 13574] Funding Source: Medline; NHLBI NIH HHS [HL 59198, HL 73856] Funding Source: Medline; NIBIB NIH HHS [EB 00415] Funding Source: Medline; NIDDK NIH HHS [DK 72517, DK 35124, DK 081355, R01 DK081355] Funding Source: Medline	NATIONAL EYE INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF BIOMEDICAL IMAGING AND BIOENGINEERING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Biomedical Imaging & Bioengineering (NIBIB)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NEI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI)); NHLBI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NIBIB NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Biomedical Imaging & Bioengineering (NIBIB)); NIDDK NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))		Chen JH, 2002, J MEMBRANE BIOL, V188, P55, DOI 10.1007/s00232-001-0174-2; Dickson RM, 1997, NATURE, V388, P355, DOI 10.1038/41048; Eskandari S, 1998, P NATL ACAD SCI USA, V95, P11235, DOI 10.1073/pnas.95.19.11235; Gadsby DC, 2006, NATURE, V440, P477, DOI 10.1038/nature04712; Galietta LJV, 2001, J BIOL CHEM, V276, P19723, DOI 10.1074/jbc.M101892200; Haggie PM, 2006, MOL BIOL CELL, V17, P4937, DOI 10.1091/mbc.E06-08-0670; Haggie PM, 2004, J BIOL CHEM, V279, P5494, DOI 10.1074/jbc.M312445200; Haupts U, 1998, P NATL ACAD SCI USA, V95, P13573, DOI 10.1073/pnas.95.23.13573; Hollenstein K, 2007, CURR OPIN STRUC BIOL, V17, P412, DOI 10.1016/j.sbi.2007.07.003; Kunzelmann K, 2002, PHYSIOL REV, V82, P245, DOI 10.1152/physrev.00026.2001; Leake MC, 2006, NATURE, V443, P355, DOI 10.1038/nature05135; Li CY, 2004, J BIOL CHEM, V279, P24673, DOI 10.1074/jbc.M400688200; Lukacs GL, 1997, BIOCHEM J, V328, P353; MARSHALL J, 1994, J BIOL CHEM, V269, P2987; Moyer BD, 1998, J BIOL CHEM, V273, P21759, DOI 10.1074/jbc.273.34.21759; Moyer BD, 1999, J CLIN INVEST, V104, P1353, DOI 10.1172/JCI7453; Raghuram V, 2001, P NATL ACAD SCI USA, V98, P1300, DOI 10.1073/pnas.031538898; Raghuram V, 2003, P NATL ACAD SCI USA, V100, P9620, DOI 10.1073/pnas.1633250100; Ramjeesingh M, 2003, BIOCHEM J, V374, P793, DOI 10.1042/BJ20030683; Ramjeesingh M, 2001, BIOCHEMISTRY-US, V40, P10700, DOI 10.1021/bi0108195; Rosenberg MF, 2004, J BIOL CHEM, V279, P39051, DOI 10.1074/jbc.M407434200; Rowe SM, 2005, NEW ENGL J MED, V352, P1992, DOI 10.1056/NEJMra043184; Schillers H, 2004, CELL PHYSIOL BIOCHEM, V14, P1, DOI 10.1159/000076921; Sharma M, 2004, J CELL BIOL, V164, P923, DOI 10.1083/jcb.200312018; Steyer JA, 2001, NAT REV MOL CELL BIO, V2, P268, DOI 10.1038/35067069; Sugiyama Y, 2005, NAT METHODS, V2, P677, DOI 10.1038/NMETH783; Thiagarajah JR, 2005, TRENDS PHARMACOL SCI, V26, P172, DOI 10.1016/j.tips.2005.02.003; Thiagarajah JR, 2003, CURR OPIN PHARMACOL, V3, P594, DOI 10.1016/j.coph.2003.06.012; Ulbrich MH, 2007, NAT METHODS, V4, P319, DOI 10.1038/NMETH1024; Verkman AS, 2006, CURR PHARM DESIGN, V12, P2235, DOI 10.2174/138161206777585148; Verkman AS, 2004, CURR OPIN NEPHROL HY, V13, P563, DOI 10.1097/00041552-200409000-00013; Wang SS, 2000, CELL, V103, P169, DOI 10.1016/S0092-8674(00)00096-9; Zerhusen B, 1999, J BIOL CHEM, V274, P7627, DOI 10.1074/jbc.274.12.7627	33	31	33	0	8	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	AUG 29	2008	283	35					23510	23513		10.1074/jbc.C800100200	http://dx.doi.org/10.1074/jbc.C800100200			4	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	340II	18617526	Green Published, hybrid			2022-12-27	WOS:000258638900003
J	Segura, JM; Guillaume, P; Mark, S; Dojcinovic, D; Johannsen, A; Bosshard, G; Angelov, G; Legler, DF; Vogel, H; Luescher, IF				Segura, Jean-Manuel; Guillaume, Philippe; Mark, Silke; Dojcinovic, Danijel; Johannsen, Alexandre; Bosshard, Giovanna; Angelov, Georgi; Legler, Daniel F.; Vogel, Horst; Luescher, Immanuel F.			Increased mobility of major histocompatibility complex I-peptide complexes decreases the sensitivity of antigen recognition	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							CYTOTOXIC T-LYMPHOCYTES; SINGLE-PARTICLE TRACKING; SUPRAMOLECULAR ACTIVATION CLUSTER; CELL-RECEPTOR MICROCLUSTERS; RESONANCE ENERGY-TRANSFER; IMMUNOLOGICAL SYNAPSE; ENDOPLASMIC-RETICULUM; TARGET-CELLS; ANOMALOUS DIFFUSION; MEMBRANE-PROTEINS	CD8(+) cytotoxic T lymphocytes (CTL) can recognize and kill target cells expressing only a few cognate major histocompatibility complex (MHC) I-peptide complexes. This high sensitivity requires efficient scanning of a vast number of highly diverse MHC I-peptide complexes by the T cell receptor in the contact site of transient conjugates formed mainly by nonspecific interactions of ICAM-1 and LFA-1. Tracking of single H-2K(d) molecules loaded with fluorescent peptides on target cells and nascent conjugates with CTL showed dynamic transitions between states of free diffusion and immobility. The immobilizations were explained by association of MHC I-peptide complexes with ICAM-1 and strongly increased their local concentration in cell adhesion sites and hence their scanning by T cell receptor. In nascent immunological synapses cognate complexes became immobile, whereas noncognate ones diffused out again. Interfering with this mobility modulation-based concentration and sorting of MHC I-peptide complexes strongly impaired the sensitivity of antigen recognition by CTL, demonstrating that it constitutes a new basic aspect of antigen presentation by MHCI molecules.	[Segura, Jean-Manuel; Guillaume, Philippe; Mark, Silke; Dojcinovic, Danijel; Johannsen, Alexandre; Bosshard, Giovanna; Angelov, Georgi; Luescher, Immanuel F.] Univ Lausanne, Ludwig Inst Canc Res, Lausanne Branch, CH-1066 Epalinges, Switzerland; [Segura, Jean-Manuel; Vogel, Horst] Ecole Polytech Fed Lausanne, Inst Sci & Ingn Chim, CH-1015 Lausanne, Switzerland; [Legler, Daniel F.] Univ Konstanz, Biotechnol Inst Thurgau, CH-8280 Kreuzlingen, Switzerland	Ludwig Institute for Cancer Research; University of Lausanne; Swiss Federal Institutes of Technology Domain; Ecole Polytechnique Federale de Lausanne	Luescher, IF (corresponding author), Univ Lausanne, Ludwig Inst Canc Res, Lausanne Branch, CH-1066 Epalinges, Switzerland.	Immanuel.Luescher@licr.unil.ch	Vogel, Horst/AAJ-5490-2021	Legler, Daniel F./0000-0001-8610-4764	Swiss National Foundation [310000-108251]; internal Ecole Polytechnique Federale de Lausanne	Swiss National Foundation(Swiss National Science Foundation (SNSF)); internal Ecole Polytechnique Federale de Lausanne	This work was supported in part by Grant 310000-108251 from Swiss National Foundation (to I. F. L.) and internal Ecole Polytechnique Federale de Lausanne grants (to H. V.). The costs of publication of this article were defrayed in part by the payment of page charges. This article must therefore be hereby marked "advertisement" in accordance with 18 U. S. C. Section 1734 solely to indicate this fact.	Angelov GS, 2006, J IMMUNOL, V176, P3356, DOI 10.4049/jimmunol.176.6.3356; Bacso Z, 2002, BIOCHEM BIOPH RES CO, V290, P635, DOI 10.1006/bbrc.2001.6246; Bodnar A, 2003, INT IMMUNOL, V15, P331, DOI 10.1093/intimm/dxg042; Campi G, 2005, J EXP MED, V202, P1031, DOI 10.1084/jem.20051182; Capps GG, 2004, BIOPHYS J, V86, P2896, DOI 10.1016/S0006-3495(04)74341-6; CARPEN O, 1992, J CELL BIOL, V118, P1223, DOI 10.1083/jcb.118.5.1223; Cebecauer M, 2005, J BIOL CHEM, V280, P23820, DOI 10.1074/jbc.M500654200; Damjanovich S, 1998, CYTOMETRY, V33, P225, DOI 10.1002/(SICI)1097-0320(19981001)33:2<225::AID-CYTO18>3.0.CO;2-W; Diedrich G, 2001, J IMMUNOL, V166, P1703, DOI 10.4049/jimmunol.166.3.1703; EDIDIN M, 1994, P NATL ACAD SCI USA, V91, P3378, DOI 10.1073/pnas.91.8.3378; GAO XM, 1993, EUR J IMMUNOL, V23, P653, DOI 10.1002/eji.1830230312; Gaspar R, 2001, J IMMUNOL, V166, P5078, DOI 10.4049/jimmunol.166.8.5078; Georgiou G, 2002, BIOPHYS J, V82, P1828, DOI 10.1016/S0006-3495(02)75533-1; HUANG JH, 1994, IMMUNITY, V1, P607, DOI 10.1016/1074-7613(94)90050-7; Jacquier V, 2006, P NATL ACAD SCI USA, V103, P14325, DOI 10.1073/pnas.0603942103; JAULIN C, 1992, J IMMUNOL, V149, P3990; Kaizuka Y, 2007, P NATL ACAD SCI USA, V104, P20296, DOI 10.1073/pnas.0710258105; Krogsgaard M, 2005, NATURE, V434, P238, DOI 10.1038/nature03391; Kwik J, 2003, P NATL ACAD SCI USA, V100, P13964, DOI 10.1073/pnas.2336102100; Lebedeva T, 2005, CURR OPIN IMMUNOL, V17, P251, DOI 10.1016/j.coi.2005.04.008; Lebedeva T, 2004, IMMUNOLOGY, V113, P460, DOI 10.1111/j.1365-2567.2004.01985.x; Legler DF, 2004, FASEB J, V18, P73, DOI 10.1096/fj.03-1338fje; Legler DF, 2001, FASEB J, V15, P1601, DOI 10.1096/fj.00-0841fje; LOPEZ JA, 1992, J IMMUNOL, V149, P3827; LUESCHER IF, 1995, IMMUNITY, V3, P51, DOI 10.1016/1074-7613(95)90158-2; MANN DW, 1989, J IMMUNOL, V142, P318; Marwali MR, 2004, J IMMUNOL, V173, P2960, DOI 10.4049/jimmunol.173.5.2960; Naldini L, 1996, SCIENCE, V272, P263, DOI 10.1126/science.272.5259.263; O'Keefe JP, 2005, J IMMUNOL, V175, P5581, DOI 10.4049/jimmunol.175.9.5581; Pentcheva T, 2001, J IMMUNOL, V166, P6625, DOI 10.4049/jimmunol.166.11.6625; Perez JB, 2006, J MOL BIOL, V363, P918, DOI 10.1016/j.jmb.2006.08.036; Potter TA, 2001, P NATL ACAD SCI USA, V98, P12624, DOI 10.1073/pnas.221458898; Purbhoo MA, 2004, NAT IMMUNOL, V5, P524, DOI 10.1038/ni1058; Saito T, 2006, CURR OPIN IMMUNOL, V18, P305, DOI 10.1016/j.coi.2006.03.014; Saxton MJ, 1996, BIOPHYS J, V70, P1250, DOI 10.1016/S0006-3495(96)79682-0; Saxton MJ, 1997, ANNU REV BIOPH BIOM, V26, P373, DOI 10.1146/annurev.biophys.26.1.373; SIMPSON E, 1994, IMMUNOLOGY, V81, P132; SIMSON R, 1995, BIOPHYS J, V69, P989, DOI 10.1016/S0006-3495(95)79972-6; Smith PR, 1999, BIOPHYS J, V76, P3331, DOI 10.1016/S0006-3495(99)77486-2; Somersalo K, 2004, J CLIN INVEST, V113, P49, DOI 10.1172/JCI200419337; Suzuki J, 2007, BLOOD, V109, P168, DOI 10.1182/blood-2005-12-020164; Sykulev Y, 1996, IMMUNITY, V4, P565, DOI 10.1016/S1074-7613(00)80483-5; Tang Q, 2003, BIOPHYS J, V84, P400, DOI 10.1016/S0006-3495(03)74860-7; Umemura YM, 2008, BIOPHYS J, V95, P435, DOI 10.1529/biophysj.107.123018; Varma R, 2006, IMMUNITY, V25, P117, DOI 10.1016/j.immuni.2006.04.010; Vrljic M, 2002, BIOPHYS J, V83, P2681, DOI 10.1016/S0006-3495(02)75277-6; Yachi PP, 2007, J EXP MED, V204, P2747, DOI 10.1084/jem.20062610; Yachi PP, 2005, NAT IMMUNOL, V6, P785, DOI 10.1038/ni1220; Yokosuka T, 2005, NAT IMMUNOL, V6, P1253, DOI 10.1038/ni1272; Zamoyska R, 1996, INT IMMUNOL, V8, P551, DOI 10.1093/intimm/8.4.551; Zhang YN, 2006, IMMUNOL RES, V35, P151, DOI 10.1385/IR:35:1:151	51	20	22	0	2	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	AUG 29	2008	283	35					24254	24263		10.1074/jbc.M803549200	http://dx.doi.org/10.1074/jbc.M803549200			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	340II	18579518	hybrid, Green Published			2022-12-27	WOS:000258638900079
J	Vogiatzi, T; Xilouri, M; Vekrellis, K; Stefanis, L				Vogiatzi, Tereza; Xilouri, Maria; Vekrellis, Kostas; Stefanis, Leonidas			Wild type alpha-synuclein is degraded by chaperone-mediated autophagy and macroautophagy in neuronal cells	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							PARKINSONS-DISEASE; CORTICAL-NEURONS; PROTEIN-DEGRADATION; RNA INTERFERENCE; PC12 CELLS; DEATH; PROTEASOME; GENE; AGGREGATION; INHIBITOR	alpha-Synuclein ( ASYN) is crucial in Parkinson disease ( PD) pathogenesis. Increased levels of wild type ( WT) ASYN expression are sufficient to cause PD in humans. The manner of posttranscriptional regulation of ASYN levels is controversial. Previously, we had shown that WT ASYN can be degraded by chaperone- mediated autophagy ( CMA) in isolated liver lysosomes. Whether this occurs in a cellular and, in particular, in a neuronal cell context is unclear. Using a mutantASYNform that lacks the CMA recognition motif and RNA interference against the rate- limiting step in the CMA pathway, Lamp2a, we show here that CMA is indeed involved in WT ASYN degradation in PC12 and SH- SY5Y cells, and in primary cortical and midbrain neurons. However, the extent of involvement varies between cell types, potentially because of differences in compensatory mechanisms. CMA inhibition leads to an accumulation of soluble high molecular weight and detergent- insoluble species of ASYN, suggesting that CMA dysfunction may play a role in the generation of such aberrant species in PD. ASYN and Lamp2a are developmentally regulated in parallel in cortical neuron cultures and in vivo in the central nervous system, and they physically interact as indicated by co- immunoprecipitation. In contrast to previous reports, inhibition of macroautophagy, but not the proteasome, also leads toWTASYN accumulation, suggesting that this lysosomal pathway is also involved in normal ASYN turnover. These results indicate thatCMAand macroautophagy are important pathways for WT ASYN degradation in neurons and underline the importance of CMA as degradation machinery in the nervous system.	[Vogiatzi, Tereza; Xilouri, Maria; Vekrellis, Kostas; Stefanis, Leonidas] Acad Athens, Biomed Res Fdn, Div Basic Neurosci, Athens 11527, Greece; [Stefanis, Leonidas] Univ Athens, Sch Med, Attikon Hosp, Dept Neurol 2, Athens 12462, Greece	Academy of Athens; Athens Medical School; National & Kapodistrian University of Athens; University Hospital Attikon	Stefanis, L (corresponding author), Acad Athens, Biomed Res Fdn, Div Basic Neurosci, 4 Soranou Efesiou St, Athens 11527, Greece.	lstefanis@bioacademy.gr	Stefanis, Leonidas/AAD-7192-2019	Xilouri, Maria/0000-0001-7038-0780	NINDS NIH HHS [R21 NS 055693] Funding Source: Medline; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R21NS055693] Funding Source: NIH RePORTER	NINDS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))		Ancolio K, 2000, NEUROSCI LETT, V285, P79, DOI 10.1016/S0304-3940(00)01049-1; Bennett MC, 1999, J BIOL CHEM, V274, P33855, DOI 10.1074/jbc.274.48.33855; Clough RL, 2007, FASEB J, V21, P596, DOI 10.1096/fj.06-7111com; Cuervo AM, 2000, J BIOL CHEM, V275, P31505, DOI 10.1074/jbc.M002102200; Cuervo AM, 2004, SCIENCE, V305, P1292, DOI 10.1126/science.1101738; Cuervo AM, 2000, J CELL SCI, V113, P4441; Cuervo AM, 1996, SCIENCE, V273, P501, DOI 10.1126/science.273.5274.501; Dietrich P, 2003, MOL CELL NEUROSCI, V24, P430, DOI 10.1016/S1044-7431(03)00201-X; Dull T, 1998, J VIROL, V72, P8463, DOI 10.1128/JVI.72.11.8463-8471.1998; Elbashir SM, 2001, NATURE, V411, P494, DOI 10.1038/35078107; Franklin JL, 1998, J CELL BIOL, V142, P1313, DOI 10.1083/jcb.142.5.1313; Furuta K, 1999, ARCH BIOCHEM BIOPHYS, V365, P75, DOI 10.1006/abbi.1999.1147; Giasson BI, 2002, NEURON, V34, P521, DOI 10.1016/S0896-6273(02)00682-7; HART PD, 1991, J EXP MED, V174, P881, DOI 10.1084/jem.174.4.881; Imai Y, 2000, J BIOL CHEM, V275, P35661, DOI 10.1074/jbc.C000447200; Kiffin R, 2007, J CELL SCI, V120, P782, DOI 10.1242/jcs.001073; KONECKI DS, 1995, BIOCHEM BIOPH RES CO, V215, P757, DOI 10.1006/bbrc.1995.2528; Kruger R, 1998, NAT GENET, V18, P106, DOI 10.1038/ng0298-106; Lee DH, 1998, TRENDS CELL BIOL, V8, P397, DOI 10.1016/S0962-8924(98)01346-4; Levine B, 2004, DEV CELL, V6, P463, DOI 10.1016/S1534-5807(04)00099-1; Majeski AE, 2004, INT J BIOCHEM CELL B, V36, P2435, DOI 10.1016/j.biocel.2004.02.013; Maraganore DM, 2006, JAMA-J AM MED ASSOC, V296, P661, DOI 10.1001/jama.296.6.661; Martin LJ, 2006, J NEUROSCI, V26, P41, DOI 10.1523/JNEUROSCI.4308-05.2006; Martinez-Vicente M, 2008, J CLIN INVEST, V118, P777, DOI 10.1172/JCI32806; Massey A, 2004, INT J BIOCHEM CELL B, V36, P2420, DOI 10.1016/j.biocel.2004.04.010; Massey AC, 2006, P NATL ACAD SCI USA, V103, P5805, DOI 10.1073/pnas.0507436103; Muller O, 2000, J CELL BIOL, V151, P519, DOI 10.1083/jcb.151.3.519; Paxinou E, 2001, J NEUROSCI, V21, P8053, DOI 10.1523/JNEUROSCI.21-20-08053.2001; Polymeropoulos MH, 1997, SCIENCE, V276, P2045, DOI 10.1126/science.276.5321.2045; Reynolds A, 2004, NAT BIOTECHNOL, V22, P326, DOI 10.1038/nbt936; Rideout HJ, 2003, J NEUROCHEM, V84, P803, DOI 10.1046/j.1471-4159.2003.01574.x; Rideout HJ, 2002, MOL CELL NEUROSCI, V21, P223, DOI 10.1006/mcne.2002.1173; Rideout HJ, 2001, J NEUROCHEM, V78, P899, DOI 10.1046/j.1471-4159.2001.00474.x; Rubio CA, 2003, EUR J CLIN INVEST, V33, P406, DOI 10.1046/j.1365-2362.2003.01151.x; SEGLEN PO, 1982, P NATL ACAD SCI-BIOL, V79, P1889, DOI 10.1073/pnas.79.6.1889; Shintani T, 2004, SCIENCE, V306, P990, DOI 10.1126/science.1099993; Singleton A, 2004, LANCET, V364, P1105, DOI 10.1016/S0140-6736(04)17117-1; Stefanis L, 2001, J NEUROSCI, V21, P9549, DOI 10.1523/JNEUROSCI.21-24-09549.2001; Stefanis L, 1999, J NEUROSCI, V19, P6235; Tofaris GK, 2001, FEBS LETT, V509, P22, DOI 10.1016/S0014-5793(01)03115-5; Trojanowski JQ, 1998, CELL DEATH DIFFER, V5, P832, DOI 10.1038/sj.cdd.4400432; Webb JL, 2003, J BIOL CHEM, V278, P25009, DOI 10.1074/jbc.M300227200	42	476	485	0	45	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	AUG 29	2008	283	35					23542	23556		10.1074/jbc.M801992200	http://dx.doi.org/10.1074/jbc.M801992200			15	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	340II	18566453	hybrid, Green Published			2022-12-27	WOS:000258638900007
J	Suzuki, T; Nakaya, T				Suzuki, Toshiharu; Nakaya, Tadashi			Regulation of Amyloid beta-Protein Precursor by Phosphorylation and Protein Interactions	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Review							ALZHEIMERS-DISEASE; CYTOPLASMIC DOMAIN; SCAFFOLD PROTEINS; DEPENDENT REGULATION; APP PHOSPHORYLATION; MEMBRANE-PROTEINS; CLEAVAGE; FE65; METABOLISM; FAMILY	Amyloid beta-protein precursor (APP), a type I membrane protein, is cleaved by primary alpha- or beta-secretase and secondary gamma-secretase. Cleavage of APP by beta- and gamma-secretases generates amyloid beta-protein, the main constituent of the cerebrovascular amyloid that accompanies Alzheimer disease. The generation and aggregation of amyloid beta-protein in the brain are believed to be a primary cause of Alzheimer disease pathogenesis, and indeed, early onset Alzheimer disease is genetically linked to APP and also to presenilins 1 and 2, which are components of gamma-secretase. Proteolytic cleavage of APP has been investigated as a candidate target for Alzheimer disease therapy, but the mechanisms regulating APP metabolism are still unclear. APP is a type I membrane protein with a short cytoplasmic region consisting of 47 amino acids. Recent research has elucidated the significance of the cytoplasmic region in the metabolism, trafficking, and physiological function of APP. The structure and function of the APP cytoplasmic domain can be modified by phosphorylation and through interaction with cytoplasmic proteins. This minireview summarizes a large body of recent information on the regulation of APP by phosphorylation and protein interaction, along with some of the physiological functions of APP. Recent findings regarding the regulation of APP processing contribute to the development of novel drugs and/or therapies for Alzheimer disease.	[Suzuki, Toshiharu; Nakaya, Tadashi] Hokkaido Univ, Neurosci Lab, Grad Sch Pharmaceut Sci, Kita Ku, Sapporo, Hokkaido 0600812, Japan	Hokkaido University	Suzuki, T (corresponding author), Hokkaido Univ, Neurosci Lab, Grad Sch Pharmaceut Sci, Kita Ku, Sapporo, Hokkaido 0600812, Japan.	tsuzuki@pharm.hokudai.ac.jp	Suzuki, Toshiharu/B-5342-2013		Ministry of Education, Culture, Sports, Science, and Technology, Japan [20390018, 20023001, 207900049]	Ministry of Education, Culture, Sports, Science, and Technology, Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT))	This work was supported in part by Grants-in-aid for Scientific Research 20390018 and 20023001 (to T.S.) and 207900049 (to T.N.) from the Ministry of Education, Culture, Sports, Science, and Technology, Japan. This minireview will be reprinted in the 2008 Minireview Compendium, which will be available in January, 2009. This is the fourth article of eleven in the Thematic Minireview Series on the Molecular Basis of Alzheimer Disease.	Ando K, 2001, J BIOL CHEM, V276, P40353, DOI 10.1074/jbc.M104059200; Ando K, 1999, J NEUROSCI, V19, P4421; Aplin AE, 1996, J NEUROCHEM, V67, P699; Araki Y, 2004, J BIOL CHEM, V279, P24343, DOI 10.1074/jbc.M401925200; Araki Y, 2003, J BIOL CHEM, V278, P49448, DOI 10.1074/jbc.M306024200; Araki Y, 2007, EMBO J, V26, P1475, DOI 10.1038/sj.emboj.7601609; Borg JP, 1998, J BIOL CHEM, V273, P14761, DOI 10.1074/jbc.273.24.14761; Buxbaum JD, 1998, J NEUROSCI, V18, P9629; Cao XW, 2001, SCIENCE, V293, P115, DOI 10.1126/science.1058783; Cao XW, 2004, J BIOL CHEM, V279, P24601, DOI 10.1074/jbc.M402248200; CHEN WJ, 1990, J BIOL CHEM, V265, P3116; Dickens M, 1997, SCIENCE, V277, P693, DOI 10.1126/science.277.5326.693; GANDY S, 1988, P NATL ACAD SCI USA, V85, P6218, DOI 10.1073/pnas.85.16.6218; Gervais FG, 1999, CELL, V97, P395, DOI 10.1016/S0092-8674(00)80748-5; Ho A, 2003, P NATL ACAD SCI USA, V100, P1409, DOI 10.1073/pnas.252774899; Hoe HS, 2008, J BIOL CHEM, V283, P6288, DOI 10.1074/jbc.M704140200; HUNG AY, 1994, EMBO J, V13, P534, DOI 10.1002/j.1460-2075.1994.tb06291.x; Iijima K, 2000, J NEUROCHEM, V75, P1085, DOI 10.1046/j.1471-4159.2000.0751085.x; Inomata H, 2003, J BIOL CHEM, V278, P22946, DOI 10.1074/jbc.M212160200; Kimberly WT, 2005, J NEUROSCI, V25, P5533, DOI 10.1523/JNEUROSCI.4883-04.2005; KNOPS J, 1993, BIOCHEM BIOPH RES CO, V197, P380, DOI 10.1006/bbrc.1993.2490; Lee JH, 2004, J BIOL CHEM, V279, P49099, DOI 10.1074/jbc.M405602200; Lee JH, 2003, J BIOL CHEM, V278, P47025, DOI 10.1074/jbc.M300503200; Lee MS, 2003, J CELL BIOL, V163, P83, DOI 10.1083/jcb.200301115; Liu F, 2003, FEBS LETT, V547, P193, DOI 10.1016/S0014-5793(03)00714-2; Liu KN, 2002, BIOCHEMISTRY-US, V41, P3128, DOI 10.1021/bi015800g; McLoughlin DM, 1999, EUR J NEUROSCI, V11, P1988, DOI 10.1046/j.1460-9568.1999.00610.x; Miller CCJ, 2006, TRENDS NEUROSCI, V29, P280, DOI 10.1016/j.tins.2006.03.001; Minopoli G, 2001, J BIOL CHEM, V276, P6545, DOI 10.1074/jbc.M007340200; Minopoli G, 2007, J BIOL CHEM, V282, P831, DOI 10.1074/jbc.C600276200; Muresan Z, 2005, J NEUROSCI, V25, P3741, DOI 10.1523/JNEUROSCI.0152-05.2005; Nakaya T, 2008, J BIOL CHEM, V283, P19119, DOI 10.1074/jbc.M801827200; Nakaya T, 2006, GENES CELLS, V11, P633, DOI 10.1111/j.1365-2443.2006.00968.x; NORSTEDT C, 1993, J BIOL CHEM, V268, P608; Oishi M, 1997, MOL MED, V3, P111, DOI 10.1007/BF03401803; OLTERSDORF T, 1990, J BIOL CHEM, V265, P4492; Pastorino L, 2006, NATURE, V440, P528, DOI 10.1038/nature04543; Qi-Takahara Y, 2005, J NEUROSCI, V25, P436, DOI 10.1523/JNEUROSCI.1575-04.2005; Ramelot TA, 2001, J MOL BIOL, V307, P871, DOI 10.1006/jmbi.2001.4535; Ramelot TA, 2000, BIOCHEMISTRY-US, V39, P2714, DOI 10.1021/bi992580m; Saito Y, 2003, J BIOL CHEM, V278, P39428, DOI 10.1074/jbc.M305542200; Sano Y, 2006, PLOS ONE, V1, DOI 10.1371/journal.pone.0000051; Sano Y, 2006, J BIOL CHEM, V281, P37853, DOI 10.1074/jbc.M609312200; Sastre M, 2001, EMBO REP, V2, P835, DOI 10.1093/embo-reports/kve180; Selkoe DJ, 2001, PHYSIOL REV, V81, P741, DOI 10.1152/physrev.2001.81.2.741; Small SA, 2006, NEURON, V52, P15, DOI 10.1016/j.neuron.2006.09.001; Standen CL, 2001, J NEUROCHEM, V76, P316, DOI 10.1046/j.1471-4159.2001.00102.x; Stokin GB, 2005, SCIENCE, V307, P1282, DOI 10.1126/science.1105681; Sumioka A, 2008, EXP CELL RES, V314, P1155, DOI 10.1016/j.yexcr.2007.12.006; SUZUKI T, 1994, EMBO J, V13, P1114, DOI 10.1002/j.1460-2075.1994.tb06360.x; Suzuki T, 2006, J BIOCHEM, V139, P949, DOI 10.1093/jb/mvj121; Tanahashi H, 1999, BIOCHEM BIOPH RES CO, V255, P663, DOI 10.1006/bbrc.1999.0265; Taru H, 2004, FEBS LETT, V567, P248, DOI 10.1016/j.febslet.2004.04.077; Taru H, 2004, J BIOL CHEM, V279, P21628, DOI 10.1074/jbc.M312007200; Taru H, 2002, J BIOL CHEM, V277, P20070, DOI 10.1074/jbc.M108372200; Taru H, 2002, J BIOL CHEM, V277, P27567, DOI 10.1074/jbc.M203713200; Tomita S, 1999, J BIOL CHEM, V274, P2243, DOI 10.1074/jbc.274.4.2243; Tomita S, 1998, J BIOL CHEM, V273, P6277, DOI 10.1074/jbc.273.11.6277; Verhey KJ, 2001, J CELL BIOL, V152, P959, DOI 10.1083/jcb.152.5.959; Vingtdeux V, 2005, NEUROBIOL DIS, V20, P625, DOI 10.1016/j.nbd.2005.05.004; Weidemann A, 2002, BIOCHEMISTRY-US, V41, P2825, DOI 10.1021/bi015794o; Zambrano N, 2001, J BIOL CHEM, V276, P19787, DOI 10.1074/jbc.M100792200	62	90	91	0	10	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	OCT 31	2008	283	44					29633	29637		10.1074/jbc.R800003200	http://dx.doi.org/10.1074/jbc.R800003200			5	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	364WS	18650433	Green Published, hybrid			2022-12-27	WOS:000260366900005
J	de Agostini, AI; Dong, JC; Arrighi, CD; Ramus, MA; Dentand-Quadri, I; Thalmann, S; Ventura, P; Ibecheole, V; Monge, F; Fischer, AM; HajMohammadi, S; Shworak, NW; Zhang, LJ; Zhang, Z; Linhardt, RJ				de Agostini, Ariane I.; Dong, Ji-Cui; Arrighi, Corinne de Vantery; Ramus, Marie-Andree; Dentand-Quadri, Isabelle; Thalmann, Sebastien; Ventura, Patricia; Ibecheole, Victoria; Monge, Felicia; Fischer, Anne-Marie; HajMohammadi, Sassan; Shworak, Nicholas W.; Zhang, Lijuan; Zhang, Zhenqing; Linhardt, Robert J.			Human follicular fluid heparan sulfate contains abundant 3-O-sulfated chains with anticoagulant activity	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							D-GLUCOSAMINYL 3-O-SULFOTRANSFERASE; ENDOTHELIAL-CELLS; ANTITHROMBIN-BINDING; THROMBIN GENERATION; OVARIAN-FOLLICLES; GRANULOSA-CELLS; RAT OVARY; PROTEOGLYCANS; EXPRESSION; MODULATION	Anticoagulant heparan sulfate proteoglycans bind and activate antithrombin by virtue of a specific 3-O-sulfated pentasaccharide. They not only occur in the vascular wall but also in extravascular tissues, such as the ovary, where their functions remain unknown. The rupture of the ovarian follicle at ovulation is one of the most striking examples of tissue remodeling in adult mammals. It involves tightly controlled inflammation, proteolysis, and fibrin deposition. We hypothesized that ovarian heparan sulfates may modulate these processes through interactions with effector proteins. Our previous work has shown that anticoagulant heparan sulfates are synthesized by rodent ovarian granulosa cells, and we now have set out to characterize heparan sulfates from human follicular fluid. Here we report the first anticoagulant heparan sulfate purified from a natural human extravascular source. Heparan sulfate chains were fractionated according to their affinity for antithrombin, and their structure was analyzed by H-1 NMR and MS/MS. We find that human follicular fluid is a rich source of anticoagulant heparan sulfate, comprising 50.4% of total heparan sulfate. These antithrombin-binding chains contain more than 6% 3-O-sulfated glucosamine residues, convey an anticoagulant activity of 2.5 IU/ml to human follicular fluid, and have an anti-Factor Xa specific activity of 167 IU/mg. The heparan sulfate chains that do not bind antithrombin surprisingly exhibit an extremely high content in 3-O-sulfated glucosamine residues, which suggest that they may exhibit biological activities through interactions with other proteins.	[de Agostini, Ariane I.; Dong, Ji-Cui; Arrighi, Corinne de Vantery; Ramus, Marie-Andree; Dentand-Quadri, Isabelle; Thalmann, Sebastien; Ventura, Patricia; Ibecheole, Victoria] Univ Hosp Geneva, Dept Obstet & Gynaecol, Geneva 14, Switzerland; [de Agostini, Ariane I.; Dong, Ji-Cui; Arrighi, Corinne de Vantery; Ramus, Marie-Andree; Dentand-Quadri, Isabelle; Thalmann, Sebastien; Ventura, Patricia; Ibecheole, Victoria] Univ Geneva, Geneva 14, Switzerland; [Monge, Felicia; Fischer, Anne-Marie] Univ Paris 05, Fac Med, F-75014 Paris, France; [Monge, Felicia; Fischer, Anne-Marie] INSERM, U765, F-75006 Paris, France; [Monge, Felicia; Fischer, Anne-Marie] Hop Europeen Georges Pompidou, Serv Hematol Biol, AP HP, F-75015 Paris, France; [HajMohammadi, Sassan; Shworak, Nicholas W.] Dartmouth Med Sch, Dept Med, Cardiol Sect, Hanover, NH 03756 USA; [Zhang, Lijuan] Washington Univ, Sch Med, Dept Pathol & Immunol, St Louis, MO 63110 USA; [Zhang, Zhenqing; Linhardt, Robert J.] Rensselaer Polytech Inst, Ctr Biotechnol & Interdisciplinary Studies, Dept Chem & Chem Biol, Troy, NY 12180 USA	University of Geneva; University of Geneva; UDICE-French Research Universities; Universite Paris Cite; Institut National de la Sante et de la Recherche Medicale (Inserm); Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Europeen Georges-Pompidou - APHP; UDICE-French Research Universities; Universite Paris Cite; Dartmouth College; Washington University (WUSTL); Rensselaer Polytechnic Institute	de Agostini, AI (corresponding author), Fdn Rech Med, CH-1205 Geneva, Switzerland.	Ariane.Deagostini@medecine.unige.ch	Shworak, Nicholas/AAJ-6770-2020	Shworak, Nicholas/0000-0001-7783-4634	National Institutes of Health [GM38060]; Swiss National Foundation [3200B0-102148/1]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM038060] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON AGING [R01AG023590] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Swiss National Foundation(Swiss National Science Foundation (SNSF)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))	This work was supported, in whole or in part, by National Institutes of Health Grant GM38060 (to R. J. L.). This work was also supported by Swiss National Foundation Grant 3200B0-102148/1 (to A. d. A.). The costs of publication of this article were defrayed in part by the payment of page charges. This article must therefore be hereby marked "advertisement" in accordance with 18 U. S. C. Section 1734 solely to indicate this fact.	Bjornsson S, 1998, ANAL BIOCHEM, V256, P229, DOI 10.1006/abio.1997.2494; Bungay SD, 2006, B MATH BIOL, V68, P2283, DOI 10.1007/s11538-006-9115-7; Carrell R, 1997, THROMB HAEMOSTASIS, V78, P516; Daniels RJ, 2001, HUM MOL GENET, V10, P339, DOI 10.1093/hmg/10.4.339; de Agostini AI, 2006, SWISS MED WKLY, V136, P583; DEAGOSTINI AI, 1994, J CELL BIOCHEM, V54, P174, DOI 10.1002/jcb.240540206; DEAGOSTINI AI, 1990, J CELL BIOL, V111, P1293, DOI 10.1083/jcb.111.3.1293; ENGLAND BG, 1974, J CLIN ENDOCR METAB, V38, P42, DOI 10.1210/jcem-38-1-42; Eriksen GV, 1999, BIOCHEM J, V340, P613, DOI 10.1042/0264-6021:3400613; Eriksen GV, 1997, FERTIL STERIL, V68, P791, DOI 10.1016/S0015-0282(97)00326-9; Gentry PA, 2000, FERTIL STERIL, V73, P848, DOI 10.1016/S0015-0282(99)00635-4; Girardin EP, 2005, J BIOL CHEM, V280, P38059, DOI 10.1074/jbc.M507997200; Gong F, 2003, J BIOL CHEM, V278, P35152, DOI 10.1074/jbc.M300925200; Haimov-Kochman R, 2005, BIOL REPROD, V73, P20, DOI 10.1095/biolreprod.104.036780; HajMohammadi S, 2003, J CLIN INVEST, V111, P989, DOI 10.1172/JCI200315809; Hasan S, 2002, BIOL REPROD, V66, P144, DOI 10.1095/biolreprod66.1.144; Hosseini G, 1996, J BIOL CHEM, V271, P22090, DOI 10.1074/jbc.271.36.22090; KAMAT BR, 1995, AM J PATHOL, V146, P157; KOJIMA T, 1992, J BIOL CHEM, V267, P4859; Lawrence R, 2007, MATRIX BIOL, V26, P442, DOI 10.1016/j.matbio.2007.03.002; Liu JA, 1999, J BIOL CHEM, V274, P38155, DOI 10.1074/jbc.274.53.38155; Liu JA, 1999, J BIOL CHEM, V274, P5185, DOI 10.1074/jbc.274.8.5185; MARCUM JA, 1986, J BIOL CHEM, V261, P7507; McArthur ME, 2000, BIOL REPROD, V63, P913, DOI 10.1095/biolreprod63.3.913; Okada Y, 2002, J BIOL CHEM, V277, P42488, DOI 10.1074/jbc.M206510200; PEJLER G, 1987, J BIOL CHEM, V262, P5036; Princivalle M, 2001, GLYCOBIOLOGY, V11, P183, DOI 10.1093/glycob/11.3.183; Roach LE, 2002, BIOL REPROD, V66, P1350, DOI 10.1095/biolreprod66.5.1350; Rosenberg RD, 1997, J CLIN INVEST, V99, P2062, DOI 10.1172/JCI119377; Shimada H, 2001, BIOL REPROD, V64, P1739, DOI 10.1095/biolreprod64.6.1739; Shriver Z, 2000, P NATL ACAD SCI USA, V97, P10365, DOI 10.1073/pnas.97.19.10365; SHWORAK NW, 1994, J BIOL CHEM, V269, P21204; Shworak NW, 1999, J BIOL CHEM, V274, P5170, DOI 10.1074/jbc.274.8.5170; SHWORAK NW, 1994, J BIOL CHEM, V269, P24941; Therien I, 2005, MOL REPROD DEV, V71, P97, DOI 10.1002/mrd.20287; Vongchan P, 2005, BBA-GEN SUBJECTS, V1721, P1, DOI 10.1016/j.bbagen.2004.09.007; Warda M, 2006, GLYCOCONJUGATE J, V23, P555, DOI 10.1007/s10719-006-7668-1; Xia GQ, 2002, J BIOL CHEM, V277, P37912, DOI 10.1074/jbc.M204209200; Yabe T, 2001, BIOCHEM J, V359, P235, DOI 10.1042/0264-6021:3590235; Ye S, 2001, BIOCHEMISTRY-US, V40, P14429, DOI 10.1021/bi011000u; Zhang LJ, 1999, J BIOL CHEM, V274, P5681, DOI 10.1074/jbc.274.9.5681	41	53	54	0	5	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	OCT 17	2008	283	42					28115	28124		10.1074/jbc.M805338200	http://dx.doi.org/10.1074/jbc.M805338200			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	359EN	18669628	Green Accepted, Green Published, hybrid			2022-12-27	WOS:000259969300014
J	Chai, SC; Wang, WL; Ye, QZ				Chai, Sergio C.; Wang, Wen-Long; Ye, Qi-Zhuang			Fe(II) is the native cofactor for Escherichia coli methionine aminopeptidase	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							METALLOFORM-SELECTIVE INHIBITION; PEPTIDE DEFORMYLASE; SACCHAROMYCES-CEREVISIAE; RECOMBINANT PROLIDASE; SUBSTRATE-SPECIFICITY; STRUCTURAL-ANALYSIS; OUTER-MEMBRANE; DRUG DISCOVERY; CELL-GROWTH; PROTEINS	Divalent metal ions play a critical role in the removal of N-terminal methionine from nascent proteins by methionine aminopeptidase (MetAP). Being an essential enzyme for bacteria, MetAP is an appealing target for the development of novel antibacterial drugs. Although purified enzyme can be activated by several divalent metal ions, the exact metal ion used by MetAP in cells is unknown. Many MetAP inhibitors are highly potent on purified enzyme, but they fail to show significant inhibition of bacterial growth. One possibility for the failure is a disparity of the metal used in activation of purified MetAP and the metal actually used by MetAP inside bacterial cells. Therefore, the challenge is to elucidate the physiologically relevant metal for MetAP and discover MetAP inhibitors that can effectively inhibit cellular MetAP. We have recently discovered MetAP inhibitors with selectivity toward different metalloforms of Escherichia coli MetAP, and with these unique inhibitors, we characterized their inhibition of MetAP enzyme activity in a cellular environment. We observed that only inhibitors that are selective for the Fe(II)-form of MetAP were potent in this assay. Further, we found that only these Fe(II)-form selective inhibitors showed significant inhibition of growth of five E. coli strains and two Bacillus strains. We confirmed their cellular target as MetAP by analysis of N-terminal processed and unprocessed recombinant glutathione S-transferase proteins. Therefore, we conclude that Fe(II) is the likely metal used by MetAP in E. coli and other bacterial cells.	[Chai, Sergio C.; Wang, Wen-Long; Ye, Qi-Zhuang] Indiana Univ, Sch Med, Dept Biochem & Mol Biol, Indianapolis, IN 46202 USA	Indiana University System; Indiana University-Purdue University Indianapolis	Ye, QZ (corresponding author), Indiana Univ, Sch Med, Dept Biochem & Mol Biol, 635 Barnhill Dr, Indianapolis, IN 46202 USA.	yeq@iupui.edu	Ye, Qizhuang/B-3147-2009	Chai, Sergio/0000-0002-8257-8599	National Institutes of Health [AI065898]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R56AI065898, R01AI065898] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This work was supported, in whole or in part by National Institutes of Health Grant AI065898 (to Q.-Z.Y.). The costs of publication of this article were defrayed in part by the payment of page charges. This article must therefore be hereby marked "advertisement" in accordance with 18 U. S. C. Section 1734 solely to indicate this fact.	Bradshaw RA, 1998, TRENDS BIOCHEM SCI, V23, P263, DOI 10.1016/S0968-0004(98)01227-4; BRASS JM, 1981, J BACTERIOL, V146, P10, DOI 10.1128/JB.146.1.10-17.1981; Chandu D, 2003, MICROBIOL-SGM, V149, P3437, DOI 10.1099/mic.0.26518-0; CHANG SYP, 1989, J BACTERIOL, V171, P4071, DOI 10.1128/jb.171.7.4071-4072.1989; Copik AJ, 2003, BIOCHEMISTRY-US, V42, P6283, DOI 10.1021/bi027327s; Cottrell GS, 2000, BIOCHEMISTRY-US, V39, P15121, DOI 10.1021/bi001585c; D'souza VM, 2000, BIOCHEMISTRY-US, V39, P3817, DOI 10.1021/bi9925827; D'souza VM, 1999, BIOCHEMISTRY-US, V38, P11079, DOI 10.1021/bi990872h; D'souza VM, 2002, BIOCHEMISTRY-US, V41, P13096, DOI 10.1021/bi020395u; DAGERT M, 1979, GENE, V6, P23, DOI 10.1016/0378-1119(79)90082-9; Douangamath A, 2004, J MED CHEM, V47, P1325, DOI 10.1021/jm034188j; Ghose AK, 1999, J COMB CHEM, V1, P55, DOI 10.1021/cc9800071; Giglione C, 2004, CELL MOL LIFE SCI, V61, P1455, DOI 10.1007/s00018-004-3466-8; Giglione C, 2000, MOL MICROBIOL, V36, P1197, DOI 10.1046/j.1365-2958.2000.01908.x; Golich FC, 2006, PROTEIN EXPRES PURIF, V47, P634, DOI 10.1016/j.pep.2005.11.012; Graham SC, 2005, BIOCHEMISTRY-US, V44, P13820, DOI 10.1021/bi0512849; Griffith EC, 1998, P NATL ACAD SCI USA, V95, P15183, DOI 10.1073/pnas.95.26.15183; Griffith EC, 1997, CHEM BIOL, V4, P461, DOI 10.1016/S1074-5521(97)90198-8; Hanzlik RP, 1976, INORGANIC ASPECTS BI; HOOPER NM, 1992, HYPERTENSION, V19, P281, DOI 10.1161/01.HYP.19.3.281; Huang M, 2006, BIOCHEM BIOPH RES CO, V339, P506, DOI 10.1016/j.bbrc.2005.11.042; Huang M, 2007, J MED CHEM, V50, P5735, DOI 10.1021/jm700930k; Huang QQ, 2005, BIOORG MED CHEM LETT, V15, P5386, DOI 10.1016/j.bmcl.2005.09.019; IRVIN RT, 1981, J BACTERIOL, V145, P1397, DOI 10.1128/JB.145.3.1397-1403.1981; Kobayashi M, 1999, EUR J BIOCHEM, V261, P1, DOI 10.1046/j.1432-1327.1999.00186.x; Kobayashi M, 1998, NAT BIOTECHNOL, V16, P733, DOI 10.1038/nbt0898-733; LATHE R, 1980, P NATL ACAD SCI-BIOL, V77, P3548, DOI 10.1073/pnas.77.6.3548; Leopoldini M, 2007, J AM CHEM SOC, V129, P7776, DOI 10.1021/ja068168t; Li JY, 2003, BIOCHEM BIOPH RES CO, V307, P172, DOI 10.1016/S0006-291X(03)01144-6; Li X, 1995, P NATL ACAD SCI USA, V92, P12357, DOI 10.1073/pnas.92.26.12357; Lipinski CA, 2001, ADV DRUG DELIVER REV, V46, P3, DOI 10.1016/S0169-409X(00)00129-0; Liu LF, 1997, BIOCHEM J, V327, P593, DOI 10.1042/bj3270593; Liu SP, 1998, SCIENCE, V282, P1324, DOI 10.1126/science.282.5392.1324; Lowther WT, 1999, BIOCHEMISTRY-US, V38, P14810, DOI 10.1021/bi991711g; Lowther WT, 2000, BBA-PROTEIN STRUCT M, V1477, P157, DOI 10.1016/S0167-4838(99)00271-X; Lowther WT, 1999, BIOCHEMISTRY-US, V38, P7678, DOI 10.1021/bi990684r; Lowther WT, 2002, CHEM REV, V102, P4581, DOI 10.1021/cr0101757; Luo QL, 2003, J MED CHEM, V46, P2631, DOI 10.1021/jm0300532; Lupi A, 2006, FEBS J, V273, P5466, DOI 10.1111/j.1742-4658.2006.05538.x; Maher MJ, 2004, BIOCHEMISTRY-US, V43, P2771, DOI 10.1021/bi0356451; MEINNEL T, 1995, J MOL BIOL, V254, P175, DOI 10.1006/jmbi.1995.0609; MILLER CG, 1989, J BACTERIOL, V171, P5215, DOI 10.1128/jb.171.9.5215-5217.1989; Molinaro G, 2005, BIOCHEM J, V385, P389, DOI 10.1042/BJ20040849; National Committee for Clinical Laboratory Standards, 2000, M7A4 NAT COMM CLIN L; NORMARK S, 1969, J BACTERIOL, V97, P1334, DOI 10.1128/JB.97.3.1334-1342.1969; Oefner C, 2003, J MOL BIOL, V332, P13, DOI 10.1016/S0022-2836(03)00862-3; Outten CE, 2001, SCIENCE, V292, P2488, DOI 10.1126/science.1060331; Rajagopalan PTR, 1997, BIOCHEMISTRY-US, V36, P13910, DOI 10.1021/bi971155v; Sarker SD, 2007, METHODS, V42, P321, DOI 10.1016/j.ymeth.2007.01.006; Schiffmann R, 2005, ANGEW CHEM INT EDIT, V44, P3620, DOI 10.1002/anie.200500592; Tetko IV, 2005, J COMPUT AID MOL DES, V19, P453, DOI 10.1007/s10822-005-8694-y; Towbin H, 2003, J BIOL CHEM, V278, P52964, DOI 10.1074/jbc.M309039200; Vaughan MD, 2002, CURR MED CHEM, V9, P385, DOI 10.2174/0929867023371102; Walker KW, 1998, PROTEIN SCI, V7, P2684, DOI 10.1002/pro.5560071224; Wang JY, 2003, BIOCHEMISTRY-US, V42, P5035, DOI 10.1021/bi020670c; Watt RK, 1999, CELL MOL LIFE SCI, V56, P604, DOI 10.1007/s000180050456; Wilce MCJ, 1998, P NATL ACAD SCI USA, V95, P3472, DOI 10.1073/pnas.95.7.3472; Xie SX, 2006, ACTA CRYSTALLOGR D, V62, P425, DOI 10.1107/S0907444906003878; Yang SI, 2008, FEBS J, V275, P271, DOI 10.1111/j.1742-4658.2007.06197.x; Ye OZ, 2004, J AM CHEM SOC, V126, P13940, DOI 10.1021/ja045864; Ye QZ, 2006, P NATL ACAD SCI USA, V103, P9470, DOI 10.1073/pnas.0602433103; Yocum CF, 1999, CURR OPIN CHEM BIOL, V3, P182, DOI 10.1016/S1367-5931(99)80031-3; You CH, 2005, BMC MICROBIOL, V5, DOI 10.1186/1471-2180-5-57; Zhang ZQ, 1998, J AM SOC MASS SPECTR, V9, P225, DOI 10.1016/S1044-0305(97)00284-5; ZORZOPULOS J, 1989, FEMS MICROBIOL LETT, V61, P23	65	46	46	0	7	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	OCT 3	2008	283	40					26879	26885		10.1074/jbc.M804345200	http://dx.doi.org/10.1074/jbc.M804345200			7	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	353RT	18669631	Green Published, hybrid			2022-12-27	WOS:000259586600007
J	Solaro, RJ				Solaro, R. John			Multiplex kinase signaling modifies cardiac function at the level of sarcomeric proteins	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Review							TROPONIN-I; DEPENDENT PHOSPHORYLATION; ACTIVATION MECHANISMS; C PHOSPHORYLATION; HEART-FAILURE; PKC; SITES; DYSFUNCTION; EXPRESSION; TITIN		[Solaro, R. John] Univ Illinois, Dept Physiol & Biophys, Chicago, IL 60612 USA; [Solaro, R. John] Univ Illinois, Cardiovasc Res Ctr, Chicago, IL 60612 USA	University of Illinois System; University of Illinois Chicago; University of Illinois Chicago Hospital; University of Illinois System; University of Illinois Chicago; University of Illinois Chicago Hospital	Solaro, RJ (corresponding author), Univ Illinois, Dept Physiol & Biophys, Chicago, IL 60612 USA.	solarorj@uic.edu			National Institutes of Health [HL 62426, HL 64035, HL 22231]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL022231, R37HL022231, P01HL062426, R01HL064035] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	This work was supported, in whole or in part, by National Institutes of Health Grants HL 62426, HL 64035, and HL 22231. This minireview will be reprinted in the 2008 Minireview Compendium, which will be available in January, 2009.	Andersen GO, 2002, AM J PHYSIOL-HEART C, V283, pH1471, DOI 10.1152/ajpheart.00232.2002; Angelone T, 2008, ACTA PHYSIOL, V193, P229, DOI 10.1111/j.1748-1716.2008.01838.x; Avkiran M, 2008, CIRC RES, V102, P157, DOI 10.1161/CIRCRESAHA.107.168211; Belin RJ, 2007, CIRC RES, V101, P195, DOI 10.1161/CIRCRESAHA.107.148288; Bers DM, 2001, EXCITATION CONTRACTI; Bowling N, 1999, CIRCULATION, V99, P384, DOI 10.1161/01.CIR.99.3.384; Burkart EM, 2003, J BIOL CHEM, V278, P11265, DOI 10.1074/jbc.M210712200; Cazorla O, 2006, CARDIOVASC RES, V69, P370, DOI 10.1016/j.cardiores.2005.11.009; Chen L, 2001, P NATL ACAD SCI USA, V98, P11114, DOI 10.1073/pnas.191369098; Decker RS, 2005, CIRCULATION, V111, P906, DOI 10.1161/01.CIR.0000155609.95618.75; Flashman E, 2004, CIRC RES, V94, P1279, DOI 10.1161/01.RES.0000127175.21818.C2; Granzier H, 2007, MUSCLE NERVE, V36, P740, DOI 10.1002/mus.20886; Hamdani N, 2008, CARDIOVASC RES, V77, P649, DOI 10.1093/cvr/cvm079; Hinken AC, 2007, PHYSIOLOGY, V22, P73, DOI 10.1152/physiol.00043.2006; Hirai T, 2003, J BIOCHEM, V133, P1, DOI 10.1093/jb/mvg017; Hoshijima M, 2006, AM J PHYSIOL-HEART C, V290, pH1313, DOI 10.1152/ajpheart.00816.2005; Huang L, 2001, AM J PHYSIOL-CELL PH, V280, pC1114, DOI 10.1152/ajpcell.2001.280.5.C1114; Itoh S, 2005, J BIOL CHEM, V280, P24135, DOI 10.1074/jbc.M413015200; Kentish JC, 2001, CIRC RES, V88, P1059, DOI 10.1161/hh1001.091640; Kobayashi T, 2005, ANNU REV PHYSIOL, V67, P39, DOI 10.1146/annurev.physiol.67.040403.114025; Linke WA, 2008, CARDIOVASC RES, V77, P637, DOI 10.1016/j.cardiores.2007.03.029; Luiken JJFP, 2008, CELL SIGNAL, V20, P543, DOI 10.1016/j.cellsig.2007.11.007; Metzger JM, 2004, CIRC RES, V94, P146, DOI 10.1161/01.RES.0000110083.17024.60; Moss RL, 2006, CIRC RES, V99, P225, DOI 10.1161/01.RES.0000236793.88131.dc; Mudd JO, 2008, NATURE, V451, P919, DOI 10.1038/nature06798; NOLAND TA, 1995, J BIOL CHEM, V270, P25445, DOI 10.1074/jbc.270.43.25445; Noland TA, 1996, BIOCHEMISTRY-US, V35, P14923, DOI 10.1021/bi9616357; Pyle WG, 2004, CIRC RES, V94, P296, DOI 10.1161/01.RES.0000116143.74830.A9; Roman BB, 2004, AM J PHYSIOL-HEART C, V286, pH2089, DOI 10.1152/ajpheart.00582.2003; Sadayappan S, 2006, P NATL ACAD SCI USA, V103, P16918, DOI 10.1073/pnas.0607069103; Scruggs SB, 2006, J MOL CELL CARDIOL, V40, P465, DOI 10.1016/j.yjmcc.2005.12.009; Sheehan KA, 2007, AM J PHYSIOL-REG I, V293, pR963, DOI 10.1152/ajpregu.00253.2007; Shin HG, 2000, CARDIOVASC RES, V48, P285, DOI 10.1016/S0008-6363(00)00185-1; Solaro RJ, 2008, CARDIOVASC RES, V77, P616, DOI 10.1093/cvr/cvn004; SOLARO RJ, 2001, HDB PHYSL 2, V1, P264; Steinberg SF, 2004, BIOCHEM J, V384, P449, DOI 10.1042/BJ20040704; Stelzer JE, 2007, CIRC RES, V101, P503, DOI 10.1161/CIRCRESAHA.107.153650; Sumandea MP, 2008, J BIOL CHEM, V283, P22680, DOI 10.1074/jbc.M802396200; Sumandea MP, 2003, J BIOL CHEM, V278, P35135, DOI 10.1074/jbc.M306325200; Takeishi Y, 1998, J CLIN INVEST, V102, P72, DOI 10.1172/JCI2709; Vahebi S, 2005, CIRC RES, V96, P740, DOI 10.1161/01.RES.0000162457.56568.7d; Vahebi S, 2007, CIRC RES, V100, P408, DOI 10.1161/01.RES.0000258116.60404.ad; Vega RB, 2004, MOL CELL BIOL, V24, P8374, DOI 10.1128/MCB.24.19.8374-8385.2004; Vila-Petroff MG, 1999, CIRC RES, V84, P1020, DOI 10.1161/01.RES.84.9.1020; Wang GY, 2006, AM J PHYSIOL-HEART C, V291, pH2013, DOI 10.1152/ajpheart.00167.2006; Wang H, 2006, J MOL CELL CARDIOL, V41, P823, DOI 10.1016/j.yjmcc.2006.08.016; Wang JW, 2003, AM J PHYSIOL-HEART C, V284, pH2277, DOI 10.1152/ajpheart.00142.2002; Westfall MV, 2005, J BIOL CHEM, V280, P41324, DOI 10.1074/jbc.M506043200; Wu SC, 2007, J BIOL CHEM, V282, P30691, DOI 10.1074/jbc.M703670200; Yuan C, 2006, PROTEOMICS, V6, P4176, DOI 10.1002/pmic.200500894	50	81	81	0	5	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	OCT 3	2008	283	40					26829	26833		10.1074/jbc.R800037200	http://dx.doi.org/10.1074/jbc.R800037200			5	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	353RT	18567577	hybrid, Green Published			2022-12-27	WOS:000259586600001
J	Lavrik, IN; Mock, T; Golks, A; Hoffmann, JC; Baumann, S; Krammer, PH				Lavrik, Inna N.; Mock, Thomas; Golks, Alexander; Hoffmann, Julia C.; Baumann, Simone; Krammer, Peter H.			CD95 stimulation results in the formation of a novel death effector domain protein-containing complex	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							NF-KAPPA-B; RECEPTOR-INDUCED APOPTOSIS; INDUCED-PROXIMITY MODEL; SIGNALING COMPLEX; CASPASE-8 ACTIVATION; LIGAND; FLICE; FADD; DISC; TRAIL	Stimulation of CD95(APO-1/Fas) by its natural ligand CD95L (APO-1L/FasL) leads to the formation of the death-inducing signaling complex. Here we report that upon CD95 stimulation in several T and B cell lines, a novel signaling complex is formed, which we term complex II. Complex II is composed of the death effector domain proteins as follows: procaspase-8a/b, three isoforms of c-FLIP (c-FLIPL, c-FLIPS, c-FLIPR), and FADD. Notably, complex II does not contain CD95. Based on our findings we suggest that CD95 signaling includes two steps. The first step involves formation of the death-inducing signaling complex at the cell membrane. The second step involves formation of the cytosolic death effector domain protein-containing complex that may play an important role in amplification of caspase activation.	[Lavrik, Inna N.; Mock, Thomas; Golks, Alexander; Hoffmann, Julia C.; Baumann, Simone; Krammer, Peter H.] German Canc Res Ctr, Tumor Immunol Program, Div Immunogenet, D-69120 Heidelberg, Germany	Helmholtz Association; German Cancer Research Center (DKFZ)	Krammer, PH (corresponding author), German Canc Res Ctr, Tumor Immunol Program, Div Immunogenet, Neuenheimer Feld 280, D-69120 Heidelberg, Germany.	p.krammer@dkfz.de	Lavrik, Inna N/C-1700-2009	Lavrik, Inna N/0000-0002-9324-309X	Wilhelm Sander Stiftung, SB Cancer and Tumorzentrum, Heidelberg/Mannheim, Germany [SB 405]	Wilhelm Sander Stiftung, SB Cancer and Tumorzentrum, Heidelberg/Mannheim, Germany	This work was supported by Grant SB 405 from Wilhelm Sander Stiftung, SB Cancer and Tumorzentrum, Heidelberg/Mannheim, Germany. The costs of publication of this article were defrayed in part by the payment of page charges. This article must therefore be hereby marked "advertisement" in accordance with 18 U. S. C. Section 1734 solely to indicate this fact.	Algeciras-Schimnich A, 2002, MOL CELL BIOL, V22, P207, DOI 10.1128/MCB.22.1.207-220.2002; Ashkenazi A, 1998, SCIENCE, V281, P1305, DOI 10.1126/science.281.5381.1305; Carrington PE, 2006, MOL CELL, V22, P599, DOI 10.1016/j.molcel.2006.04.018; Feig C, 2007, EMBO J, V26, P221, DOI 10.1038/sj.emboj.7601460; Golks A, 2006, CELL DEATH DIFFER, V13, P489, DOI 10.1038/sj.cdd.4401766; Golks A, 2005, J BIOL CHEM, V280, P14507, DOI 10.1074/jbc.M414425200; Jin ZY, 2006, MOL CELL BIOL, V26, P8136, DOI 10.1128/MCB.00257-06; KISCHKEL FC, 1995, EMBO J, V14, P5579, DOI 10.1002/j.1460-2075.1995.tb00245.x; Krammer PH, 2000, NATURE, V407, P789, DOI 10.1038/35037728; Kreuz S, 2004, J CELL BIOL, V166, P369, DOI 10.1083/jcb.200401036; Krueger A, 2001, J BIOL CHEM, V276, P20633, DOI 10.1074/jbc.M101780200; Lavrik I, 2003, CELL DEATH DIFFER, V10, P144, DOI 10.1038/sj.cdd.4401156; Lavrik I, 2005, J CELL SCI, V118, P265, DOI 10.1242/jcs.01610; Lavrik IN, 2005, J CLIN INVEST, V115, P2665, DOI 10.1172/JCI26252; Lee KH, 2006, EMBO J, V25, P1009, DOI 10.1038/sj.emboj.7601016; Medema JP, 1997, EMBO J, V16, P2794, DOI 10.1093/emboj/16.10.2794; Micheau O, 2003, CELL, V114, P181, DOI 10.1016/S0092-8674(03)00521-X; Muzio M, 1998, J BIOL CHEM, V273, P2926, DOI 10.1074/jbc.273.5.2926; Muzio M, 1996, CELL, V85, P817, DOI 10.1016/S0092-8674(00)81266-0; Peter ME, 2003, CELL DEATH DIFFER, V10, P26, DOI 10.1038/sj.cdd.4401186; Rebe C, 2007, BLOOD, V109, P1442, DOI 10.1182/blood-2006-03-011585; Salvesen GS, 1999, P NATL ACAD SCI USA, V96, P10964, DOI 10.1073/pnas.96.20.10964; Sandu C, 2006, CELL DEATH DIFFER, V13, P2052, DOI 10.1038/sj.cdd.4401966; Scaffidi C, 1999, J BIOL CHEM, V274, P1541, DOI 10.1074/jbc.274.3.1541; Scaffidi C, 2000, J IMMUNOL, V164, P1236, DOI 10.4049/jimmunol.164.3.1236; Scaffidi C, 1997, J BIOL CHEM, V272, P26953, DOI 10.1074/jbc.272.43.26953; Scaffidi C, 1998, EMBO J, V17, P1675, DOI 10.1093/emboj/17.6.1675; Schmitz I, 1999, CELL DEATH DIFFER, V6, P821, DOI 10.1038/sj.cdd.4400569; Siegel RM, 2004, J CELL BIOL, V167, P735, DOI 10.1083/jcb.200406101; Siegmund D, 2007, CELL SIGNAL, V19, P1172, DOI 10.1016/j.cellsig.2006.12.008; Sprick MR, 2002, EMBO J, V21, P4520, DOI 10.1093/emboj/cdf441; Stennicke HR, 1998, J BIOL CHEM, V273, P27084, DOI 10.1074/jbc.273.42.27084; Su H, 2005, SCIENCE, V307, P1465, DOI 10.1126/science.1104765; SUDA T, 1993, CELL, V75, P1169, DOI 10.1016/0092-8674(93)90326-L; TEWARI M, 1995, CELL, V81, P801, DOI 10.1016/0092-8674(95)90541-3; TRAUTH BC, 1989, SCIENCE, V245, P301, DOI 10.1126/science.2787530; Varfolomeev E, 2005, J BIOL CHEM, V280, P40599, DOI 10.1074/jbc.M509560200; Walczak H, 1999, NAT MED, V5, P157, DOI 10.1038/5517	38	39	42	0	2	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	SEP 26	2008	283	39					26401	26408		10.1074/jbc.M800823200	http://dx.doi.org/10.1074/jbc.M800823200			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	350GV	18635548	hybrid, Green Published			2022-12-27	WOS:000259341600014
J	Sohet, F; Colin, Y; Genetet, S; Ripoche, P; Metral, S; Le Van Kim, C; Lopez, C				Sohet, Fabien; Colin, Yves; Genetet, Sandrine; Ripoche, Pierre; Metral, Sylvain; Le Van Kim, Caroline; Lopez, Claude			Phosphorylation and ankyrin-G binding of the C-terminal domain regulate targeting and function of the ammonium transporter RhBG	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							TUBULAR-ACIDOSIS DRTA; BLOOD-GROUP SYSTEM; TYROSINE PHOSPHORYLATION; RHC GLYCOPROTEIN; INOSITOL 1,4,5-TRISPHOSPHATE; NEONATAL CARDIOMYOCYTES; CRYSTAL-STRUCTURE; INITIAL SEGMENTS; EPITHELIAL-CELLS; CHANNEL ACTIVITY	RhBG, a human member of the Amt/Mep/Rh/superfamily of ammonium transporters, has been shown to facilitate NH3 transport and to be anchored to the basolateral plasma membrane of kidney epithelial cells, via ankyrin-G. We showed here that triple alanine substitution of the (FLD421)-F-419 sequence, which links the cytoplasmic C-terminal domain of RhBG to ankyrin-G, not only disrupted the interaction of RhBG with the spectrin-based skeleton but also delayed its cell surface expression, decreased its plasma membrane stability, and abolished its NH3 transport function in epithelial cell lines. Similarly, we demonstrated that both anchoring to the membrane skeleton and ammonium transport activity are regulated by the phosphorylation status of the C-terminal tail of RhBG. Tyrosine 429, which belongs to the previously reported YED basolateral targeting signal of RhBG, was demonstrated to be phosphorylated in vitro using purified Src and Syk kinases and ex vivo by analyzing the effect of pervanadate treatment on wild-type RhBG or Y429A mutants. Then, we showed that Y429D and Y429E mutations, mimicking constitutive phosphorylation, abolished NH3 transport and enhanced Triton X-100 solubilization of RhBG from the cell membrane. In contrast, the nonphosphorylated/nonphosphorylatable Y429A and Y429F mutants behaved the same as wild-type RhBG. Conversely, Y/A or Y/F but not Y/E or Y/D mutations of residue 429 abolished the exclusive basolateral localization of RhBG in polarized epithelial cells. All these results led to a model in which targeting and ammonium transport function of RhBG are regulated by both phosphorylation and membrane skeleton binding of the C-terminal cytoplasmic domain.	[Colin, Yves] INSERM, U665, F-75015 Paris, France; Inst Natl Transfus Sanguine, F-75015 Paris, France; Univ Paris 07, F-75005 Paris, France	Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universite Paris Cite	Colin, Y (corresponding author), INSERM, U665, F-75015 Paris, France.	yves.colin@inserm.fr	colin, yves/O-1910-2017; METRAL, Sylvain/P-5833-2017; le van kim, caroline/O-7030-2017	colin, yves/0000-0001-5196-4254; METRAL, Sylvain/0000-0001-6244-8546; GENETET, Sandrine/0000-0001-8497-0087; le van kim, caroline/0000-0002-3251-1310	Institut National de la Transfusion Sanguine, INSERM; Universite Paris Diderot- Paris 7	Institut National de la Transfusion Sanguine, INSERM(Institut National de la Sante et de la Recherche Medicale (Inserm)); Universite Paris Diderot- Paris 7	This investigation was supported in part by the Institut National de la Transfusion Sanguine, INSERM, and the Universite Paris Diderot- Paris 7. The costs of publication of this article were defrayed in part by the payment of page charges. This article must therefore be hereby marked "advertisement" in accordance with 18 U. S. C. Section 1734 solely to indicate this fact.	Andrade SLA, 2005, P NATL ACAD SCI USA, V102, P14994, DOI 10.1073/pnas.0506254102; Avent ND, 2000, BLOOD, V95, P375, DOI 10.1182/blood.V95.2.375; Bakouh N, 2004, J BIOL CHEM, V279, P15975, DOI 10.1074/jbc.M308528200; Benjelloun F, 2005, PFLUG ARCH EUR J PHY, V450, P155, DOI 10.1007/s00424-005-1381-y; Bennett V, 2001, PHYSIOL REV, V81, P1353, DOI 10.1152/physrev.2001.81.3.1353; Biswas K, 2005, MOL MICROBIOL, V56, P649, DOI 10.1111/j.1365-2958.2005.04576.x; Bonifacino JS, 1999, J CELL BIOL, V145, P923, DOI 10.1083/jcb.145.5.923; Bruce LJ, 2003, BLOOD, V101, P4180, DOI 10.1182/blood-2002-09-2824; Callebaut I, 2006, TRANSFUS CLIN BIOL, V13, P70, DOI 10.1016/j.tracli.2006.02.001; Cartron JP, 1999, BEST PRACT RES CL HA, V12, P655, DOI 10.1053/beha.1999.0047; Conroy MJ, 2005, BRIT J HAEMATOL, V131, P543, DOI 10.1111/j.1365-2141.2005.05786.x; Cunha SR, 2007, J BIOL CHEM, V282, P4875, DOI 10.1074/jbc.M607096200; Garver TD, 1997, J CELL BIOL, V137, P703, DOI 10.1083/jcb.137.3.703; Hall RA, 1998, NATURE, V392, P626, DOI 10.1038/33458; Handlogten ME, 2005, AM J PHYSIOL-GASTR L, V288, pG1036, DOI 10.1152/ajpgi.00418.2004; Hisatsune C, 2004, J BIOL CHEM, V279, P18887, DOI 10.1074/jbc.M311274200; Huang CH, 2001, BLOOD CELL MOL DIS, V27, P90, DOI 10.1006/bcmd.2000.0355; Huang CH, 2005, P NATL ACAD SCI USA, V102, P15512, DOI 10.1073/pnas.0507886102; Jenkins SM, 2001, J CELL BIOL, V155, P739, DOI 10.1083/jcb.200109026; Khademi S, 2004, SCIENCE, V305, P1587, DOI 10.1126/science.1101952; LAEMMLI UK, 1970, NATURE, V227, P680, DOI 10.1038/227680a0; Le Van Kim C, 2006, BLOOD REV, V20, P93, DOI 10.1016/j.blre.2005.04.002; Li X, 2007, P NATL ACAD SCI USA, V104, P19279, DOI 10.1073/pnas.0709710104; Lin DH, 2008, J BIOL CHEM, V283, P7674, DOI 10.1074/jbc.M705574200; Liu Z, 2001, J BIOL CHEM, V276, P1424, DOI 10.1074/jbc.M007528200; Lopez C, 2005, J BIOL CHEM, V280, P8221, DOI 10.1074/jbc.M413351200; Loque D, 2007, NATURE, V446, P195, DOI 10.1038/nature05579; Lowe JS, 2008, J CELL BIOL, V180, P173, DOI 10.1083/jcb.200710107; Ludewig U, 2004, J PHYSIOL-LONDON, V559, P751, DOI 10.1113/jphysiol.2004.067728; Ludewig U, 2003, J BIOL CHEM, V278, P45603, DOI 10.1074/jbc.M307424200; Lupo D, 2007, P NATL ACAD SCI USA, V104, P19303, DOI 10.1073/pnas.0706563104; Malhotra JD, 2002, J BIOL CHEM, V277, P26681, DOI 10.1074/jbc.M202354200; Marini AM, 1997, TRENDS BIOCHEM SCI, V22, P460, DOI 10.1016/S0968-0004(97)01132-8; Marini AM, 2000, NAT GENET, V26, P341, DOI 10.1038/81656; Mayer M, 2006, J GEN PHYSIOL, V127, P133, DOI 10.1085/jgp.200509369; Mellman I, 1996, ANNU REV CELL DEV BI, V12, P575, DOI 10.1146/annurev.cellbio.12.1.575; Mohler PJ, 2005, PLOS BIOL, V3, P2158, DOI 10.1371/journal.pbio.0030423; Mohler PJ, 2005, FRONT BIOSCI, V10, P2832, DOI 10.2741/1739; Mohler PJ, 2004, P NATL ACAD SCI USA, V101, P17533, DOI 10.1073/pnas.0403711101; Mohler PJ, 2004, J BIOL CHEM, V279, P12980, DOI 10.1074/jbc.M313979200; Mohler PJ, 2002, J BIOL CHEM, V277, P10599, DOI 10.1074/jbc.M110958200; Monahan BJ, 2002, FUNGAL GENET BIOL, V36, P35, DOI 10.1016/S1087-1845(02)00004-X; Nakhoul NL, 2005, AM J PHYSIOL-RENAL, V288, pF170, DOI 10.1152/ajprenal.00419.2003; Neuhauser B, 2007, PLANT PHYSIOL, V143, P1651, DOI 10.1104/pp.106.094243; Nicolas V, 2006, TRANSFUS CLIN BIOL, V13, P23, DOI 10.1016/j.tracli.2006.02.019; Nicolas V, 2003, J BIOL CHEM, V278, P25526, DOI 10.1074/jbc.M302816200; Odell AF, 2005, J BIOL CHEM, V280, P37974, DOI 10.1074/jbc.M503646200; Pan ZM, 2006, J NEUROSCI, V26, P2599, DOI 10.1523/JNEUROSCI.4314-05.2006; Quentin F, 2003, J AM SOC NEPHROL, V14, P545, DOI 10.1097/01.ASN.0000050413.43662.55; Raghuram V, 2001, P NATL ACAD SCI USA, V98, P1300, DOI 10.1073/pnas.031538898; Ripoche P, 2004, P NATL ACAD SCI USA, V101, P17222, DOI 10.1073/pnas.0403704101; Scotland P, 1998, J CELL BIOL, V143, P1305, DOI 10.1083/jcb.143.5.1305; Sheng M, 2001, ANNU REV NEUROSCI, V24, P1, DOI 10.1146/annurev.neuro.24.1.1; Shirahata E, 2006, J NEUROPHYSIOL, V96, P1347, DOI 10.1152/jn.01264.2005; Songyang Z, 1997, SCIENCE, V275, P73, DOI 10.1126/science.275.5296.73; Stephens DJ, 1997, FEBS LETT, V416, P27, DOI 10.1016/S0014-5793(97)01165-4; Toye AM, 2005, BIOCHEM SOC SYMP, V72, P47, DOI 10.1042/bss0720047; Toye AM, 2004, J CELL SCI, V117, P1399, DOI 10.1242/jcs.00974; Tuvia S, 1999, J CELL BIOL, V147, P995, DOI 10.1083/jcb.147.5.995; Tuvia S, 1997, P NATL ACAD SCI USA, V94, P12957, DOI 10.1073/pnas.94.24.12957; Vela J, 2007, AM J PHYSIOL-CELL PH, V293, pC951, DOI 10.1152/ajpcell.00429.2006; Verlander JW, 2003, AM J PHYSIOL-RENAL, V284, pF323, DOI 10.1152/ajprenal.00050.2002; Wang SS, 2000, CELL, V103, P169, DOI 10.1016/S0092-8674(00)00096-9; Weiner ID, 2003, ACTA PHYSIOL SCAND, V179, P331, DOI 10.1046/j.0001-6772.2003.01210.x; Westhoff CM, 2002, J BIOL CHEM, V277, P12499, DOI 10.1074/jbc.C200060200; Wu HY, 2003, J BIOL CHEM, V278, P40425, DOI 10.1074/jbc.C300225200; Xia ZQ, 2003, J BIOL CHEM, V278, P21901, DOI 10.1074/jbc.M301905200; Zheng L, 2004, P NATL ACAD SCI USA, V101, P17090, DOI 10.1073/pnas.0406475101; Zhou DX, 1998, J CELL BIOL, V143, P1295, DOI 10.1083/jcb.143.5.1295; Zidi-Yahiaoui N, 2006, TRANSFUS CLIN BIOL, V13, P128, DOI 10.1016/j.tracli.2006.02.025; Zidi-Yahiaoui N, 2005, BIOCHEM J, V391, P33, DOI 10.1042/BJ20050657	71	15	16	0	5	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	SEP 26	2008	283	39					26557	26567		10.1074/jbc.M803120200	http://dx.doi.org/10.1074/jbc.M803120200			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	350GV	18635543	Green Submitted, Green Published, hybrid			2022-12-27	WOS:000259341600032
J	Soragni, E; Kassavetis, GA				Soragni, Elisabetta; Kassavetis, George A.			Absolute gene occupancies by RNA polymerase III, TFIIIB, and TFIIIC in Saccharomyces cerevisiae	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							INITIATION-FACTOR TFIIIB; TRANSCRIPTION COMPLEXES; IN-VITRO; YEAST; MAF1; PROMOTER; REPRESSION; PROTEIN; MACHINERY; DEPHOSPHORYLATION	A major limitation of chromatin immunoprecipitation lies in the challenge of measuring the immunoprecipitation effectiveness of different proteins and antibodies and the resultant inability to compare the occupancies of different DNA-binding proteins. Here we present the implementation of a quantitative chromatin immunoprecipitation assay in the RNA polymerase III (pol III) system that allowed us to measure the absolute in vivo occupancy of pol III and its two transcription factors, TFIIIC and TFIIIB, on a subset of pol III genes. The crucial point of our analysis was devising a method that allows the accurate determination of the immunoprecipitation efficiency for each protein. We achieved this by spiking every immunoprecipitation reaction with the formaldehyde cross-linked in vitro counterparts of TFIIIB-, TFIIIC-, and pol III-DNA complexes, measuring the in vitro occupancies of the corresponding factors on a DNA probe and determining probe recovery by quantitative PCR. Analysis of nine pol III-transcribed genes with diverse sequence characteristics showed a very high occupancy by TFIIIB and pol III ( pol III occupancy being generally similar to 70% of TFIIIB occupancy) and a TFIIIC occupancy that ranged between similar to 5 and 25%. Current data suggest that TFIIIC is released during transcription in vitro, and it has been proposed that TFIIIB suffices for pol III recruitment in vivo. Our findings point to the transient nature of the TFIIIC- DNA interaction in vivo, with no significant counter-correlation between pol III and TFIIIC occupancy and instead to a dependence of TFIIIB- DNA and TFIIIC- DNA complex maintenance in vivo on pol III function.	Univ Calif San Diego, Div Biol Sci, La Jolla, CA 92093 USA; Univ Calif San Diego, Ctr Mol Genet, La Jolla, CA 92093 USA	University of California System; University of California San Diego; University of California System; University of California San Diego	Soragni, E (corresponding author), Scripps Res Inst, Dept Mol Biol, 10550 N Torrey Pines Rd,MB-27, La Jolla, CA 92037 USA.	soragni@scripps.edu; gak@biomail.ucsd.edu			National Institutes of Health [GM018386]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM018386, R37GM018386] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported, in whole or in part, by National Institutes of Health Grant GM018386. The costs of publication of this article were defrayed in part by the payment of page charges. This article must therefore be hereby marked "advertisement" in accordance with 18 U. S. C. Section 1734 solely to indicate this fact.	Andrau JC, 2001, EUR J BIOCHEM, V268, P5167, DOI 10.1046/j.0014-2956.2001.02445.x; BAKER RE, 1986, J BIOL CHEM, V261, P5275; BARDELEBEN C, 1994, J MOL BIOL, V235, P1193, DOI 10.1006/jmbi.1994.1073; BARFORD JP, 1976, EXP CELL RES, V102, P276, DOI 10.1016/0014-4827(76)90043-4; BARTHOLOMEW B, 1990, EMBO J, V9, P2197, DOI 10.1002/j.1460-2075.1990.tb07389.x; BRAUN BR, 1989, P NATL ACAD SCI USA, V86, P2530, DOI 10.1073/pnas.86.8.2530; BURNOL AF, 1993, NATURE, V362, P475, DOI 10.1038/362475a0; Chedin S, 1998, COLD SPRING HARB SYM, V63, P381, DOI 10.1101/sqb.1998.63.381; Ciesla M, 2007, MOL CELL BIOL, V27, P7693, DOI 10.1128/MCB.01051-07; Costanzo G, 2001, MOL CELL BIOL, V21, P3166, DOI 10.1128/MCB.21.9.3166-3178.2001; Dieci G, 2000, J MOL BIOL, V299, P601, DOI 10.1006/jmbi.2000.3783; Dieci G, 2002, J BIOL CHEM, V277, P6903, DOI 10.1074/jbc.M105036200; Dieci G, 2007, TRENDS GENET, V23, P614, DOI 10.1016/j.tig.2007.09.001; Dumay-Odelot H, 2007, J BIOL CHEM, V282, P17179, DOI 10.1074/jbc.M611542200; ESCHENLAUER JB, 1993, MOL CELL BIOL, V13, P3015, DOI 10.1128/MCB.13.5.3015; FELICI F, 1989, MOL CELL BIOL, V9, P3260, DOI 10.1128/MCB.9.8.3260; Ferrari R, 2004, P NATL ACAD SCI USA, V101, P13442, DOI 10.1073/pnas.0403851101; French SL, 2008, MOL CELL BIOL, V28, P4576, DOI 10.1128/MCB.00127-08; Geiduschek EP, 2001, J MOL BIOL, V310, P1, DOI 10.1006/jmbi.2001.4732; Giuliodori S, 2003, J MOL BIOL, V333, P1, DOI 10.1016/j.jmb.2003.08.016; Goodfellow SJ, 2008, J MOL BIOL, V378, P481, DOI 10.1016/j.jmb.2008.02.060; Guffanti E, 2006, J BIOL CHEM, V281, P29155, DOI 10.1074/jbc.M600387200; Harismendy O, 2003, EMBO J, V22, P4738, DOI 10.1093/emboj/cdg466; Harlow E., 1999, USING ANTIBODIES LAB; Hiley SL, 2005, NUCLEIC ACIDS RES, V33, P3048, DOI 10.1093/nar/gki608; Joazeiro CAP, 1996, GENE DEV, V10, P725, DOI 10.1101/gad.10.6.725; Johnson SS, 2007, MOL CELL, V26, P367, DOI 10.1016/j.molcel.2007.03.021; KASSAVETIS GA, 1991, P NATL ACAD SCI USA, V88, P7308, DOI 10.1073/pnas.88.16.7308; Kassavetis GA, 1998, MOL CELL BIOL, V18, P5587, DOI 10.1128/MCB.18.9.5587; Kassavetis GA, 2006, J BIOL CHEM, V281, P7445, DOI 10.1074/jbc.M512810200; KASSAVETIS GA, 1989, MOL CELL BIOL, V9, P2551, DOI 10.1128/MCB.9.6.2551; KASSAVETIS GA, 1990, CELL, V60, P235, DOI 10.1016/0092-8674(90)90739-2; Kassavetis GA, 2001, EMBO J, V20, P2823, DOI 10.1093/emboj/20.11.2823; Li Y, 2000, MOL CELL BIOL, V20, P3843, DOI 10.1128/MCB.20.11.3843-3851.2000; Longtine MS, 1998, YEAST, V14, P953, DOI 10.1002/(SICI)1097-0061(199807)14:10<953::AID-YEA293>3.3.CO;2-L; MARSOLIER MC, 1995, GENE DEV, V9, P410, DOI 10.1101/gad.9.4.410; MOENNE A, 1990, EMBO J, V9, P271, DOI 10.1002/j.1460-2075.1990.tb08105.x; Moir RD, 2004, ADV PROTEIN CHEM, V67, P93; Moir RD, 2006, P NATL ACAD SCI USA, V103, P15044, DOI 10.1073/pnas.0607129103; Moqtaderi Z, 2004, MOL CELL BIOL, V24, P4118, DOI 10.1128/MCB.24.10.4118-4127.2004; Nechaev S, 2006, EMBO J, V25, P1700, DOI 10.1038/sj.emboj.7601069; Oficjalska-Pham D, 2006, MOL CELL, V22, P623, DOI 10.1016/j.molcel.2006.04.008; Pluta K, 2001, MOL CELL BIOL, V21, P5031, DOI 10.1128/MCB.21.15.5031-5040.2001; Reina JH, 2006, PLOS ONE, V1, DOI 10.1371/journal.pone.0000134; Roberts DN, 2003, P NATL ACAD SCI USA, V100, P14695, DOI 10.1073/pnas.2435566100; Roberts DN, 2006, MOL CELL, V22, P633, DOI 10.1016/j.molcel.2006.04.009; Rollins J, 2007, INT J BIOL SCI, V3, P292; Schramm L, 2000, GENE DEV, V14, P2650, DOI 10.1101/gad.836400; StrahlBolsinger S, 1997, GENE DEV, V11, P83, DOI 10.1101/gad.11.1.83; Svejstrup JQ, 2007, TRENDS BIOCHEM SCI, V32, P165, DOI 10.1016/j.tibs.2007.02.005; Teichmann M, 2000, P NATL ACAD SCI USA, V97, P14200, DOI 10.1073/pnas.97.26.14200; Thompson M, 2003, SCIENCE, V302, P1399, DOI 10.1126/science.1089814; Upadhya R, 2002, MOL CELL, V10, P1489, DOI 10.1016/S1097-2765(02)00787-6; Willis IM, 2004, PROG NUCLEIC ACID RE, V77, P323, DOI 10.1016/S0079-6603(04)77009-9; Zecherle GN, 1996, MOL CELL BIOL, V16, P5801	55	20	20	0	0	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	SEP 26	2008	283	39					26568	26576		10.1074/jbc.M803769200	http://dx.doi.org/10.1074/jbc.M803769200			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	350GV	18667429	Green Published, hybrid			2022-12-27	WOS:000259341600033
J	Sabbatini, ME; Chen, X; Ernst, SA; Williams, JA				Sabbatini, Maria E.; Chen, Xuequn; Ernst, Stephen A.; Williams, John A.			Rap1 activation plays a regulatory role in pancreatic amylase secretion	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							DEPENDENT PROTEIN-KINASE; NUCLEOTIDE-RELEASING PROTEIN; CA2+-INDUCED CA2+ RELEASE; CYCLIC-AMP; SELECTIVE INHIBITOR; BINDING PROTEINS; CAMP; EPAC; CELL; CALCIUM	Rap1 is a member of the Ras superfamily of small GTP-binding proteins and is localized on pancreatic zymogen granules. The current study was designed to determine whether GTP-Rap1 is involved in the regulation of amylase secretion. Rap1A/B and the two Rap1 guanine nucleotide exchange factors, Epac1 and CalDAG-GEF III, were identified in mouse pancreatic acini. A fraction of both Rap1 and Epac1 colocalized with amylase in zymogen granules, but only Rap1 was integral to the zymogen granule membranes. Stimulation with cholecystokinin (CCK), carbachol, and vasoactive intestinal peptide all induced Rap1 activation, as did calcium ionophore A23187, phorbol ester, forskolin, 8-bromo-cyclic AMP, and the Epac-specific cAMP analog 8-pCPT-2'-O-Me-cAMP. The phospholipase C inhibitor U-73122 abolished carbachol- but not forskolin-induced Rap1 activation. Co-stimulation with carbachol and 8-pCPT-2'-O-Me-cAMP led to an additive effect on Rap1 activation, whereas a synergistic effect was seen on amylase release. Although the protein kinase A inhibitor H-89 abolished forskolin-stimulated CREB phosphorylation, it did not modify forskolin-induced GTP-Rap1 levels, excluding PKA participation. Overexpression of Rap1 GTPase-activating protein, which blocked Rap1 activation, reduced the effect of 8-bromo-cyclic AMP, 8-pCPT-2'-O-Me-cAMP, and vasoactive intestinal peptide on amylase release by 60% and reduced CCK-as well as carbachol-stimulated pancreatic amylase release by 40%. These findings indicate that GTP-Rap1 is required for pancreatic amylase release. Rap1 activation not only mediates the cAMP-evoked response via Epac1 but is also involved in CCK- and carbachol-induced amylase release, with their action most likely mediated by CalDAG-GEF III.	[Sabbatini, Maria E.; Chen, Xuequn; Williams, John A.] Univ Michigan, Dept Mol & Integrat Physiol, Ann Arbor, MI 48109 USA; [Ernst, Stephen A.] Univ Michigan, Dept Cell & Dev Biol, Ann Arbor, MI 48109 USA	University of Michigan System; University of Michigan; University of Michigan System; University of Michigan	Sabbatini, ME (corresponding author), 7744 Med Sci Bldg 2,1150 W Med Ctr Dr, Ann Arbor, MI 48109 USA.	mesabba@umich.edu		Williams, John/0000-0002-6063-7615; Sabbatini, Maria Eugenia/0000-0001-7100-2482	National Institutes of Health [DK-41128]; Michigan Gastrointestinal Peptide Center [P30 DK-34933]; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [P30DK034933, R01DK041128] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Michigan Gastrointestinal Peptide Center; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	This work was supported, in whole or in part, by National Institutes of Health Grant DK-41128 (to J.A.W.). This work was also supported by Michigan Gastrointestinal Peptide Center Grant P30 DK-34933. The costs of publication of this article were defrayed in part by the payment of page charges. This article must therefore be hereby marked "advertisement" in accordance with 18 U.S.C. Section 1734 solely to indicate this fact.	Amano R, 2007, J REPROD DEVELOP, V53, P127, DOI 10.1262/jrd.18077; Bi Y, 2005, AM J PHYSIOL-CELL PH, V289, pC22, DOI 10.1152/ajpcell.00395.2004; Bos JL, 2005, CURR OPIN CELL BIOL, V17, P123, DOI 10.1016/j.ceb.2005.02.009; Branham MAT, 2006, J BIOL CHEM, V281, P8656, DOI 10.1074/jbc.M508854200; BURNHAM DB, 1988, BIOCHIM BIOPHYS ACTA, V969, P33, DOI 10.1016/0167-4889(88)90085-7; BURNHAM DB, 1984, AM J PHYSIOL, V246, pG500, DOI 10.1152/ajpgi.1984.246.5.G500; BURNHAM DB, 1984, J PHYSIOL-LONDON, V349, P475, DOI 10.1113/jphysiol.1984.sp015168; Chaudhuri A, 2007, AM J PHYSIOL-GASTR L, V292, pG1403, DOI 10.1152/ajpgi.00478.2005; Chen XQ, 2002, J BIOL CHEM, V277, P18002, DOI 10.1074/jbc.M201248200; Chen XQ, 2006, MOL CELL PROTEOMICS, V5, P306, DOI 10.1074/mcp.M500172-MCP200; Chen XQ, 2004, BIOCHEM BIOPH RES CO, V323, P1157, DOI 10.1016/j.bbrc.2004.08.212; Chen XQ, 2003, J BIOL CHEM, V278, P50053, DOI 10.1074/jbc.M309910200; CHIJIWA T, 1990, J BIOL CHEM, V265, P5267; Crittenden JR, 2004, NAT MED, V10, P982, DOI 10.1038/nm1098; D'Silva NJ, 1998, AM J PHYSIOL-CELL PH, V274, pC1667, DOI 10.1152/ajpcell.1998.274.6.C1667; de Rooij J, 1998, NATURE, V396, P474, DOI 10.1038/24884; Dremier S, 2007, ENDOCRINOLOGY, V148, P4612, DOI 10.1210/en.2007-0540; Ebinu JO, 1998, SCIENCE, V280, P1082, DOI 10.1126/science.280.5366.1082; Eliasson L, 2003, J GEN PHYSIOL, V121, P181, DOI 10.1085/jgp.20028707; Enserink JM, 2004, J BIOL CHEM, V279, P44889, DOI 10.1074/jbc.M404599200; Enserink JM, 2002, NAT CELL BIOL, V4, P901, DOI 10.1038/ncb874; FISCHER TH, 1990, J BIOL CHEM, V265, P19405; Franke B, 1997, EMBO J, V16, P252, DOI 10.1093/emboj/16.2.252; Fujimoto K, 2002, J BIOL CHEM, V277, P50497, DOI 10.1074/jbc.M210146200; GOKE B, 1992, AM J PHYSIOL, V262, pC493, DOI 10.1152/ajpcell.1992.262.2.C493; Guo FF, 2001, J BIOL CHEM, V276, P25568, DOI 10.1074/jbc.M101277200; Gupta M, 2005, J BIOL CHEM, V280, P8109, DOI 10.1074/jbc.M413697200; HEISLER S, 1983, CAN J PHYSIOL PHARM, V61, P1168, DOI 10.1139/y83-174; JAMIESON JD, 1967, J CELL BIOL, V34, P597, DOI 10.1083/jcb.34.2.597; Kang GX, 2005, J PHYSIOL-LONDON, V566, P173, DOI 10.1113/jphysiol.2005.087510; Kang GX, 2003, J BIOL CHEM, V278, P8279, DOI 10.1074/jbc.M211682200; Kashima Y, 2001, J BIOL CHEM, V276, P46046, DOI 10.1074/jbc.M108378200; Kawasaki H, 1998, SCIENCE, V282, P2275, DOI 10.1126/science.282.5397.2275; Kooistra MRH, 2005, FEBS LETT, V579, P4966, DOI 10.1016/j.febslet.2005.07.080; LEROSEY I, 1991, BIOCHEM BIOPH RES CO, V175, P430, DOI 10.1016/0006-291X(91)91582-W; Li J, 2007, MOL ENDOCRINOL, V21, P159, DOI 10.1210/me.2006-0340; M'Rabet L, 1998, BLOOD, V92, P2133, DOI 10.1182/blood.V92.6.2133.418k19_2133_2140; McLeod SJ, 1998, J BIOL CHEM, V273, P29218, DOI 10.1074/jbc.273.44.29218; Mochizuki N, 1999, NATURE, V400, P891, DOI 10.1038/23738; NAGATA K, 1995, BRIT J HAEMATOL, V90, P180; Pinxteren JA, 2000, BIOCHIMIE, V82, P385, DOI 10.1016/S0300-9084(00)00197-8; QUILLIAM LA, 1991, J IMMUNOL, V147, P1628; Sabbatini ME, 2003, AM J PHYSIOL-GASTR L, V285, pG929, DOI 10.1152/ajpgi.00010.2003; Savina A, 2005, TRAFFIC, V6, P131, DOI 10.1111/j.1600-0854.2004.00257.x; Seino S, 2005, PHYSIOL REV, V85, P1303, DOI 10.1152/physrev.00001.2005; Shibasaki T, 2007, P NATL ACAD SCI USA, V104, P19333, DOI 10.1073/pnas.0707054104; Shimomura H, 2004, ARCH BIOCHEM BIOPHYS, V431, P124, DOI 10.1016/j.abb.2004.07.021; Takai Y, 2001, PHYSIOL REV, V81, P153, DOI 10.1152/physrev.2001.81.1.153; TOULLEC D, 1991, J BIOL CHEM, V266, P15771; Tsygankova OM, 2001, MOL CELL BIOL, V21, P1921, DOI 10.1128/MCB.21.6.1921-1929.2001; Wang ZP, 2006, MOL CELL BIOL, V26, P2130, DOI 10.1128/MCB.26.6.2130-2145.2006; WILLIAMS JA, 1978, AM J PHYSIOL, V235, pE517, DOI 10.1152/ajpendo.1978.235.5.E517; Williams JA, 2006, PHYSIOLOGY OF THE GASTROINTESTINAL TRACT, VOLS 1 AND 2, 4TH EDITION, P1337; Wittchen ES, 2005, J BIOL CHEM, V280, P11675, DOI 10.1074/jbc.M412595200; Yamashita S, 2000, J BIOL CHEM, V275, P25488, DOI 10.1074/jbc.M003414200; Yang Y, 2002, J BIOL CHEM, V277, P25756, DOI 10.1074/jbc.M202575200; Zwartkruis FJT, 1999, EXP CELL RES, V253, P157, DOI 10.1006/excr.1999.4695	57	35	37	0	3	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	AUG 29	2008	283	35					23884	23894		10.1074/jbc.M800754200	http://dx.doi.org/10.1074/jbc.M800754200			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	340II	18577515	Green Published, hybrid			2022-12-27	WOS:000258638900043
J	Pellistri, F; Bucciantini, M; Relini, A; Nosi, D; Gliozzi, A; Robello, M; Stefani, M				Pellistri, Francesca; Bucciantini, Monica; Relini, Annalisa; Nosi, Daniele; Gliozzi, Alessandra; Robello, Mauro; Stefani, Massimo			Nonspecific Interaction of Prefibrillar Amyloid Aggregates with Glutamatergic Receptors Results in Ca2+ Increase in Primary Neuronal Cells	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							PROTEIN MISFOLDING DISEASES; HIPPOCAMPAL-NEURONS; CALCIUM-CHANNELS; OXIDATIVE DAMAGE; COMMON MECHANISM; MAMMALIAN-CELLS; PRION PROTEIN; IN-VITRO; HYPF-N; BETA	It is widely reported that the Ca2+ increase following nonspecific cell membrane permeabilization is among the earliest biochemical modifications in cells exposed to toxic amyloid aggregates. However, more recently receptors with Ca2+ channel activity such as alpha-amino-3-hydroxy-5-methylisoxazole-4-propionic acid (AMPA), N-methyl D-aspartate (NMDA), ryanodine, and inositol 1,4,5-trisphosphate receptors have been proposed as mediators of the Ca2+ increase in neuronal cells challenged with beta-amyloid peptides. We previously showed that prefibrillar aggregates of proteins not associated with amyloid diseases are toxic to exposed cells similarly to comparable aggregates of disease-associated proteins. In particular, prefibrillar aggregates of the prokaryotic HypF-N were shown to be toxic to different cultured cell lines by eliciting Ca2+ and reactive oxygen species increases. This study was aimed at assessing whether NMDA and AMPA receptor activations could be considered a generic feature of cell interaction with amyloid aggregates rather than a specific effect of some aggregated protein. Therefore, we investigated whether NMDA and AMPA receptors were involved in the Ca2+ increase following exposure of rat cerebellar granule cells to HypF-N prefibrillar aggregates. We found that the intracellular Ca2+ increase was associated with the early activation of NMDA and AMPA receptors, although some nonspecific membrane permeabilization was also observed at longer times of exposure. This result matched a significant co-localization of the aggregates with both receptors on the plasma membrane. Our data support the possibility that glutamatergic channels are generic sites of interaction with the cell membrane of prefibrillar aggregates of different peptides and proteins as well as the key structures responsible for the resulting early membrane permeabilization to Ca2+.	[Pellistri, Francesca; Relini, Annalisa; Gliozzi, Alessandra; Robello, Mauro] Univ Genoa, Dept Phys, I-16146 Genoa, Italy; [Pellistri, Francesca; Bucciantini, Monica; Relini, Annalisa; Gliozzi, Alessandra; Robello, Mauro; Stefani, Massimo] Univ Florence, Res Ctr Mol Basis Neurodegenerat, I-50134 Florence, Italy; [Bucciantini, Monica; Stefani, Massimo] Univ Florence, Dept Biochem Sci, I-50134 Florence, Italy; [Nosi, Daniele] Univ Florence, Dept Anat Histol & Forens Med, I-50134 Florence, Italy	University of Genoa; University of Florence; University of Florence; University of Florence	Robello, M (corresponding author), Univ Genoa, Dept Phys, Via Dodecaneso 33, I-16146 Genoa, Italy.	robello@fisica.unige.it	Relini, Annalisa/AHC-3105-2022	RELINI, ANNALISA/0000-0002-4040-9279; STEFANI, MASSIMO/0000-0002-4490-1922; bucciantini, monica/0000-0002-5243-9301	Italian MUR [2005053998_001, _005]; Fondazione CARIGE; Ente Cassa di Risparmio di Firenze	Italian MUR(Ministry of Education, Universities and Research (MIUR)); Fondazione CARIGE(Fondazione Carige); Ente Cassa di Risparmio di Firenze(Fondazione Cassa Risparmio Firenze)	This work was supported by Italian MUR Grants 2005053998_001 and _005, Fondazione CARIGE, and Ente Cassa di Risparmio di Firenze. The costs of publication of this article were defrayed in part by the payment of page charges. This article must therefore be hereby marked "advertisement" in accordance with 18 U. S. C. Section 1734 solely to indicate this fact.	AMICO C, 1995, J NEUROSCI, V15, P2839; Baglioni S, 2006, J NEUROSCI, V26, P8160, DOI 10.1523/JNEUROSCI.4809-05.2006; Bucciantini M, 2004, J BIOL CHEM, V279, P31374, DOI 10.1074/jbc.M400348200; Bucciantini M, 2002, NATURE, V416, P507, DOI 10.1038/416507a; Butterfield DA, 2001, TRENDS MOL MED, V7, P548, DOI 10.1016/S1471-4914(01)02173-6; Calamai M, 2003, BIOCHEMISTRY-US, V42, P15078, DOI 10.1021/bi030135s; Canale C, 2006, BIOPHYS J, V91, P4575, DOI 10.1529/biophysj.106.089482; Carulla N, 2005, NATURE, V436, P554, DOI 10.1038/nature03986; Casagrande S, 2007, NEUROSCI LETT, V414, P273, DOI 10.1016/j.neulet.2006.12.024; Chiti F, 1999, P NATL ACAD SCI USA, V96, P3590, DOI 10.1073/pnas.96.7.3590; Chiti F, 2001, PROTEIN SCI, V10, P2541, DOI 10.1110/ps.ps.10201; Costes SV, 2004, BIOPHYS J, V86, P3993, DOI [10.1529/biophysj.103.038422, 10.1529/biophysi.103.038422]; De Felice FG, 2007, J BIOL CHEM, V282, P11590, DOI 10.1074/jbc.M607483200; Demuro A, 2005, J BIOL CHEM, V280, P17294, DOI 10.1074/jbc.M500997200; Dorningues A, 2007, NEUROCHEM INT, V50, P872, DOI 10.1016/j.neuint.2007.03.001; Gharibyan AL, 2007, J MOL BIOL, V365, P1337, DOI 10.1016/j.jmb.2006.10.101; Giovannini MG, 2002, NEUROBIOL DIS, V11, P257, DOI 10.1006/nbdi.2002.0538; Grooms SY, 2006, J NEUROSCI, V26, P8339, DOI 10.1523/JNEUROSCI.0472-06.2006; Hou X, 2007, J NEUROCHEM, V100, P446, DOI 10.1111/j.1471-4159.2006.04210.x; Hsieh H, 2006, NEURON, V52, P831, DOI 10.1016/j.neuron.2006.10.035; Hyun DH, 2002, J BIOL CHEM, V277, P28572, DOI 10.1074/jbc.M200666200; Infanger DW, 2006, ANTIOXID REDOX SIGN, V8, P1583, DOI 10.1089/ars.2006.8.1583; Kayed R, 2004, J BIOL CHEM, V279, P46363, DOI 10.1074/jbc.C400260200; Kayed R, 2003, SCIENCE, V300, P486, DOI 10.1126/science.1079469; Kelly BL, 2006, J BIOL CHEM, V281, P28079, DOI 10.1074/jbc.M605081200; Kourie JI, 2001, CELL MOL NEUROBIOL, V21, P173, DOI 10.1023/A:1010932603406; Kranenburg O, 2003, FEBS LETT, V539, P149, DOI 10.1016/S0014-5793(03)00218-7; Kwak S, 2006, CURR OPIN NEUROBIOL, V16, P281, DOI 10.1016/j.conb.2006.05.004; Liu SJ, 2007, TRENDS NEUROSCI, V30, P126, DOI 10.1016/j.tins.2007.01.006; Milhavet O, 2002, BRAIN RES REV, V38, P328, DOI 10.1016/S0165-0173(01)00150-3; Novitskaya V, 2006, J BIOL CHEM, V281, P13828, DOI 10.1074/jbc.M511174200; Parsons CG, 2007, NEUROPHARMACOLOGY, V53, P699, DOI 10.1016/j.neuropharm.2007.07.013; Pieri L, 2006, J BIOL CHEM, V281, P15337, DOI 10.1074/jbc.M511647200; Relini A, 2004, J MOL BIOL, V338, P943, DOI 10.1016/j.jmb.2004.03.054; Resende R, 2007, BRAIN RES, V1143, P11, DOI 10.1016/j.brainres.2007.01.071; Smith JF, 2006, P NATL ACAD SCI USA, V103, P15806, DOI 10.1073/pnas.0604035103; Snyder EM, 2005, NAT NEUROSCI, V8, P1051, DOI 10.1038/nn1503; Stefani M, 2003, J MOL MED, V81, P678, DOI 10.1007/s00109-003-0464-5; Stefani M, 2004, BBA-MOL BASIS DIS, V1739, P5, DOI 10.1016/j.bbadis.2004.08.004; Taddei N, 1996, BIOCHEMISTRY-US, V35, P7077, DOI 10.1021/bi952900b; Walsh DM, 2004, PROTEIN PEPTIDE LETT, V11, P213, DOI 10.2174/0929866043407174; Yang W, 2002, HUM MOL GENET, V11, P2905, DOI 10.1093/hmg/11.23.2905; Zhu YJ, 2000, FASEB J, V14, P1244, DOI 10.1096/fasebj.14.9.1244	44	43	46	0	4	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	OCT 31	2008	283	44					29950	29960		10.1074/jbc.M803992200	http://dx.doi.org/10.1074/jbc.M803992200			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	364WS	18676369	Green Published, hybrid			2022-12-27	WOS:000260366900040
J	Qi, Z; Shi, WG; Xue, N; Pan, CG; Jing, WG; Liu, KL; Jiang, SB				Qi, Zhi; Shi, Weiguo; Xue, Na; Pan, Chungen; Jing, Weiguo; Liu, Keliang; Jiang, Shibo			Rationally Designed Anti-HIV Peptides Containing Multifunctional Domains as Molecule Probes for Studying the Mechanisms of Action of the First and Second Generation HIV Fusion Inhibitors	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							TERMINAL COILED-COIL; TRANSMEMBRANE GLYCOPROTEIN; ENVELOPE GLYCOPROTEIN; MONOCLONAL-ANTIBODY; ATOMIC-STRUCTURE; CORE STRUCTURE; TYPE-1 GP41; VIRUS; ENTRY; PROTEIN	We have previously shown that the first generation human immunodeficiency virus (HIV) fusion inhibitor T20 (Fuzeon) contains a critical lipid-binding domain (LBD), whereas C34, another anti-HIV peptide derived from the gp41 C-terminal heptad repeat, consists of an important pocket-binding domain (PBD), and both share a common 4-3 heptad repeat (HR) sequence (Liu, S., Jing, W., Cheung, B., Lu, H., Sun, J., Yan, X., Niu, J., Farmar, J., Wu, S., and Jiang, S. (2007) J. Biol. Chem. 282, 9612-9620). T1249, the second generation HIV fusion inhibitor, has both LBD and PBD but a different HR sequence, suggesting that these three anti-HIV peptides may have distinct mechanisms of action. Here we rationally designed a set of peptides that contain multiple copies of a predicted HR sequence (5HR) or the HR sequence plus either LBD (4HR-LBD) or PBD (PBD-4HR) or both (PBD-3HR-LBD), and we compared their anti-HIV-1 activity and biophysical properties. We found that the peptide 5HR exhibited low-to-moderate inhibitory activity on HIV-1-mediated cell-cell fusion, whereas addition of LBD and/or PBD to the HR sequence resulted in a significant increase of the anti-HIV-1 activity. The peptides containing PBD, including PBD-4HR and PBD-3HR-LBD, could form a stable six-helix bundle with the N-peptide N46 and effectively blocked the gp41 core formation, whereas the peptides containing LBD, e. g. 4HR-LBD and PBD-3HR-LBD, could interact with the lipid vehicles. These results suggest that the HR sequence in these anti-HIV peptides acts as a structure domain and is responsible for its interaction with the HR sequence in N-terminal heptad repeat, whereas PBD and LBD are critical for interactions with their corresponding targets. T20, C34, and T1249 may function like 4HR-LBD, PBD-4HR, and PBD-3HR-LBD, respectively, to interact with different target sites for inhibiting HIV fusion and entry. Therefore, this study provides important information for understanding the mechanisms of action of the peptic HIV-1 fusion inhibitors and for rational design of novel antiviral peptides against HIV and other viruses with class I fusion proteins.	[Shi, Weiguo; Liu, Keliang] Beijing Inst Pharmacol & Toxicol, Beijing 100850, Peoples R China; [Qi, Zhi; Xue, Na; Pan, Chungen; Jing, Weiguo; Jiang, Shibo] New York Blood Ctr, Lindsley F Kimball Res Inst, New York, NY 10065 USA; [Pan, Chungen] Peking Univ, Coll Life Sci, Beijing 100871, Peoples R China	Academy of Military Medical Sciences - China; New York Blood Center; Peking University	Liu, KL (corresponding author), Beijing Inst Pharmacol & Toxicol, Beijing 100850, Peoples R China.	keliangliu@yahoo.com; sjiang@nybloodcenter.org	Jiang, Shibo/L-4500-2014	Jiang, Shibo/0000-0001-8283-7135	National Institutes of Health [AI46221]; China Postdoctoral Science Foundation [20070410511]; Outstanding Overseas Chinese Scholars Fund of Chinese Academy of Sciences [2005-2-6]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R21AI046221, R01AI046221] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); China Postdoctoral Science Foundation(China Postdoctoral Science Foundation); Outstanding Overseas Chinese Scholars Fund of Chinese Academy of Sciences(Chinese Academy of Sciences); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This work was supported, in whole or in part, by National Institutes of Health Grant AI46221 (to S. J.). This work was also supported by China Postdoctoral Science Foundation Grant 20070410511 (to W. S.) and Outstanding Overseas Chinese Scholars Fund of Chinese Academy of Sciences Grant 2005-2-6. The costs of publication of this article were defrayed in part by the payment of page charges. This article must therefore be hereby marked "advertisement" in accordance with 18 U. S. C. Section 1734 solely to indicate this fact.	Chan DC, 1997, CELL, V89, P263, DOI 10.1016/S0092-8674(00)80205-6; Chan DC, 1998, P NATL ACAD SCI USA, V95, P15613, DOI 10.1073/pnas.95.26.15613; Chan DC, 1998, CELL, V93, P681, DOI 10.1016/S0092-8674(00)81430-0; Chinnadurai R, 2007, J VIROL, V81, P6563, DOI 10.1128/JVI.02546-06; Combet C, 2000, TRENDS BIOCHEM SCI, V25, P147, DOI 10.1016/S0968-0004(99)01540-6; Dwyer JJ, 2003, BIOCHEMISTRY-US, V42, P4945, DOI 10.1021/bi027283n; Dwyer JJ, 2007, P NATL ACAD SCI USA, V104, P12772, DOI 10.1073/pnas.0701478104; GALLAHER WR, 1989, AIDS RES HUM RETROV, V5, P431, DOI 10.1089/aid.1989.5.431; GEOURJON C, 1994, PROTEIN ENG, V7, P157, DOI 10.1093/protein/7.2.157; He YX, 2007, J BIOL CHEM, V282, P25631, DOI 10.1074/jbc.M703781200; Ji H, 1999, J VIROL, V73, P8578, DOI 10.1128/JVI.73.10.8578-8586.1999; Jiang S, 1998, J VIROL, V72, P10213, DOI 10.1128/JVI.72.12.10213-10217.1998; JIANG S, 2000, P SOC PHOTO-OPT INS, V3926, P212, DOI DOI 10.1117/12.380514; JIANG SB, 1993, NATURE, V365, P113, DOI 10.1038/365113a0; Jiang SB, 1999, J VIROL METHODS, V80, P85, DOI 10.1016/S0166-0934(99)00041-5; Jiang SB, 2000, BIOCHEM BIOPH RES CO, V270, P153, DOI 10.1006/bbrc.2000.2411; Jiang SB, 2000, BIOCHEM BIOPH RES CO, V269, P641, DOI 10.1006/bbrc.1999.1972; KYTE J, 1982, J MOL BIOL, V157, P105, DOI 10.1016/0022-2836(82)90515-0; LaBranche CC, 2001, ANTIVIR RES, V50, P95, DOI 10.1016/S0166-3542(01)00130-9; Lazzarin A, 2005, EXPERT OPIN PHARMACO, V6, P453, DOI 10.1517/14656566.6.3.453; Liu SW, 2007, J BIOL CHEM, V282, P9612, DOI 10.1074/jbc.M609148200; Liu SW, 2004, LANCET, V363, P938, DOI 10.1016/S0140-6736(04)15788-7; Liu SW, 2005, J BIOL CHEM, V280, P11259, DOI 10.1074/jbc.M411141200; Liu SW, 2003, PEPTIDES, V24, P1303, DOI 10.1016/j.peptides.2003.07.013; Lu M, 1997, J BIOMOL STRUCT DYN, V15, P465, DOI 10.1080/07391102.1997.10508958; LU M, 1995, NAT STRUCT BIOL, V2, P1075, DOI 10.1038/nsb1295-1075; Matthews T, 2004, NAT REV DRUG DISCOV, V3, P215, DOI 10.1038/nrd1331; Otaka A, 2002, ANGEW CHEM INT EDIT, V41, P2938, DOI 10.1002/1521-3773(20020816)41:16<2937::AID-ANIE2937>3.0.CO;2-J; Tan KM, 1997, P NATL ACAD SCI USA, V94, P12303, DOI 10.1073/pnas.94.23.12303; Weissenhorn W, 1997, NATURE, V387, P426, DOI 10.1038/387426a0; WILD C, 1992, P NATL ACAD SCI USA, V89, P10537, DOI 10.1073/pnas.89.21.10537; WILD CT, 1994, P NATL ACAD SCI USA, V91, P9770, DOI 10.1073/pnas.91.21.9770	32	48	56	0	14	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	OCT 31	2008	283	44					30376	30384		10.1074/jbc.M804672200	http://dx.doi.org/10.1074/jbc.M804672200			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	364WS	18662985	Green Published, hybrid			2022-12-27	WOS:000260366900081
J	Steiner, H; Fluhrer, R; Haass, C				Steiner, Harald; Fluhrer, Regina; Haass, Christian			Intramembrane Proteolysis by gamma-Secretase	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Review							AMYLOID-BETA-PROTEIN; ALZHEIMERS-DISEASE; IN-VIVO; COMPLEX COMPONENT; PRESENILIN 2; A-BETA; PRECURSOR; NICASTRIN; NOTCH; APP	gamma-Secretase mediates the final proteolytic cleavage, which liberates amyloid beta-peptide (A beta), the major component of senile plaques in the brains of Alzheimer disease patients. Therefore, gamma-secretase is a prime target for A beta-lowering therapeutic strategies. gamma-Secretase is a protein complex composed of four different subunits, presenilin (PS), APH-1, nicastrin, and PEN-2, which are most likely present in a 1:1:1:1 stoichiometry. PS harbors the catalytically active site, which is critically required for the aspartyl protease activity of gamma-secretase. Moreover, numerous familial Alzheimer disease-associated mutations within the PSs increase the production of the aggregation-prone and neurotoxic 42- amino acid A beta. Nicastrin may serve as a substrate receptor, although this has recently been challenged. PEN-2 is required to stabilize PS within the gamma-secretase complex. No particular function has so far been assigned to APH-1. The four components are sufficient and required for gamma-secretase activity. At least six different gamma-secretase complexes exist that are composed of different variants of PS and APH-1. All gamma-secretase complexes can exert pathological A beta production. Assembly of the gamma-secretase complex occurs within the endoplasmic reticulum, and only fully assembled and functional gamma-secretase complexes are transported to the plasma membrane. Structural analysis by electron microscopy and chemical cross-linking reveals a water-containing cavity, which allows intramembrane proteolysis. Specific and highly sensitive gamma-secretase inhibitors have been developed; however, they interfere with the physiological function of gamma-secretase in Notch signaling and thus cause rather significant side effects in human trials. Modulators of gamma-secretase, which selectively affect the production of the pathological 42- amino acid A beta, do not inhibit Notch signaling.	[Steiner, Harald] Univ Munich, Ctr Integrated Prot Sci Munich, D-80336 Munich, Germany; Univ Munich, Adolf Butenandt Inst, Dept Biochem, Lab Neurodegenerat Dis Res, D-80336 Munich, Germany	University of Munich; University of Munich	Steiner, H (corresponding author), Univ Munich, Ctr Integrated Prot Sci Munich, D-80336 Munich, Germany.	harald.steiner@med.uni-muenchen.de; christian.haass@med.uni-muenchen.de	Fluhrer, Regina/F-2642-2011		Deutsche Forschungsgemeinschaft (Gottfried Wilhelm Leibniz Award); Collaborative Research Center [SFB596]; Federal Ministry of Education and Research; Hans and Ilse Breuer Foundation; LMUexcellent Program;  [HA 1737-11]	Deutsche Forschungsgemeinschaft (Gottfried Wilhelm Leibniz Award)(German Research Foundation (DFG)); Collaborative Research Center; Federal Ministry of Education and Research(Federal Ministry of Education & Research (BMBF)); Hans and Ilse Breuer Foundation; LMUexcellent Program; 	This work was supported by the Deutsche Forschungsgemeinschaft (Gottfried Wilhelm Leibniz Award (to C. H.), Collaborative Research Center (Grant SFB596) "Molecular Mechanisms of Neurodegeneration" (to H. S. and C. H.), and Grant HA 1737-11 (to C. H. and R. F.)), the Federal Ministry of Education and Research ("Degenerative Dementias: Target Identification, Validation and Translation into Treatment Strategies" (to C. H. and H. S.)), the Alzheimer Research Award of the Hans and Ilse Breuer Foundation (to H. S.), and an LMUexcellent Program research professorship (to C. H.). This is the third article of eleven in the Thematic Minireview Series on the Molecular Basis of Alzheimer Disease. This minireview will be reprinted in the 2008 Minireview Compendium, which will be available in January, 2009.	Bentahir M, 2006, J NEUROCHEM, V96, P732, DOI 10.1111/j.1471-4159.2005.03578.x; Brown MS, 2000, CELL, V100, P391, DOI 10.1016/S0092-8674(00)80675-3; BUSCIGLIO J, 1993, P NATL ACAD SCI USA, V90, P2092, DOI 10.1073/pnas.90.5.2092; Chavez-Gutierrez L, 2008, J BIOL CHEM, V283, P20096, DOI 10.1074/jbc.M803040200; Chen FS, 2006, NATURE, V440, P1208, DOI 10.1038/nature04667; Churcher I, 2005, CURR PHARM DESIGN, V11, P3363, DOI 10.2174/138161205774370771; Cole SL, 2008, J BIOL CHEM, V283, P29621, DOI 10.1074/jbc.R800015200; Czirr E, 2007, J BIOL CHEM, V282, P24504, DOI 10.1074/jbc.M700618200; De Strooper B, 1998, NATURE, V391, P387, DOI 10.1038/34910; Edbauer D, 2002, P NATL ACAD SCI USA, V99, P8666, DOI 10.1073/pnas.132277899; Edbauer D, 2002, J BIOL CHEM, V277, P13389, DOI 10.1074/jbc.M111571200; Edbauer D, 2003, NAT CELL BIOL, V5, P486, DOI 10.1038/ncb960; Francis R, 2002, DEV CELL, V3, P85, DOI 10.1016/S1534-5807(02)00189-2; Geling A, 2002, EMBO REP, V3, P688, DOI 10.1093/embo-reports/kvf124; Goutte C, 2002, P NATL ACAD SCI USA, V99, P775, DOI 10.1073/pnas.022523499; HAASS C, 1992, NATURE, V359, P322, DOI 10.1038/359322a0; Haass C, 2004, EMBO J, V23, P483, DOI 10.1038/sj.emboj.7600061; Haass C, 2002, TRENDS CELL BIOL, V12, P556, DOI 10.1016/S0962-8924(02)02394-2; Haass C, 2007, NAT REV MOL CELL BIO, V8, P101, DOI 10.1038/nrm2101; Hardy J, 2002, SCIENCE, V297, P353, DOI 10.1126/science.1072994; Hasegawa H, 2004, J BIOL CHEM, V279, P46455, DOI 10.1074/jbc.M406289200; Hebert SS, 2004, NEUROBIOL DIS, V17, P260, DOI 10.1016/j.nbd.2004.08.002; Herreman A, 2000, NAT CELL BIOL, V2, P461, DOI 10.1038/35017105; Herreman A, 1999, P NATL ACAD SCI USA, V96, P11872, DOI 10.1073/pnas.96.21.11872; Iwata N, 2001, SCIENCE, V292, P1550, DOI 10.1126/science.1059946; Kaether C, 2007, EMBO REP, V8, P743, DOI 10.1038/sj.embor.7401027; Kaether C, 2006, NEURODEGENER DIS, V3, P275, DOI 10.1159/000095267; KANG J, 1987, NATURE, V325, P733, DOI 10.1038/325733a0; Kopan R, 2004, NAT REV MOL CELL BIO, V5, P499, DOI 10.1038/nrm1406; Kornilova AY, 2005, P NATL ACAD SCI USA, V102, P3230, DOI 10.1073/pnas.0407640102; Lai MT, 2003, J BIOL CHEM, V278, P22475, DOI 10.1074/jbc.M300974200; Lazarov VK, 2006, P NATL ACAD SCI USA, V103, P6889, DOI 10.1073/pnas.0602321103; Munter LM, 2007, EMBO J, V26, P1702, DOI 10.1038/sj.emboj.7601616; Prokop S, 2004, J BIOL CHEM, V279, P23255, DOI 10.1074/jbc.M401789200; Qi-Takahara Y, 2005, J NEUROSCI, V25, P436, DOI 10.1523/JNEUROSCI.1575-04.2005; Ren Z, 2007, J BIOL CHEM, V282, P35350, DOI 10.1074/jbc.M702739200; Sato C, 2006, J NEUROSCI, V26, P12081, DOI 10.1523/JNEUROSCI.3614-06.2006; Sato T, 2007, J BIOL CHEM, V282, P33985, DOI 10.1074/jbc.M705248200; Scheuner D, 1996, NAT MED, V2, P864, DOI 10.1038/nm0896-864; Schroeter EH, 2003, P NATL ACAD SCI USA, V100, P13075, DOI 10.1073/pnas.1735338100; Selkoe D, 2003, ANNU REV NEUROSCI, V26, P565, DOI 10.1146/annurev.neuro.26.041002.131334; Serneels L, 2005, P NATL ACAD SCI USA, V102, P1719, DOI 10.1073/pnas.0408901102; Shah S, 2005, CELL, V122, P435, DOI 10.1016/j.cell.2005.05.022; Sherrington R, 1996, HUM MOL GENET, V5, P985, DOI 10.1093/hmg/5.7.985; Shirotani K, 2004, J BIOL CHEM, V279, P41340, DOI 10.1074/jbc.M405768200; Shirotani K, 2007, NEUROBIOL DIS, V27, P102, DOI 10.1016/j.nbd.2007.04.011; SHOJI M, 1992, SCIENCE, V258, P126, DOI 10.1126/science.1439760; Spasic D, 2007, J CELL BIOL, V176, P629, DOI 10.1083/jcb.200609180; Steiner H, 2000, NAT CELL BIOL, V2, P848, DOI 10.1038/35041097; Steiner H, 1999, BIOCHEMISTRY-US, V38, P14600, DOI 10.1021/bi9914210; Steiner H, 2008, CURR ALZHEIMER RES, V5, P147, DOI 10.2174/156720508783954677; Struhl G, 2000, MOL CELL, V6, P625, DOI 10.1016/S1097-2765(00)00061-7; Thinakaran G, 1996, NEURON, V17, P181, DOI 10.1016/S0896-6273(00)80291-3; Tolia A, 2008, J BIOL CHEM, V283, P19793, DOI 10.1074/jbc.M802461200; Tolia A, 2006, J BIOL CHEM, V281, P27633, DOI 10.1074/jbc.M604997200; Vetrivel KS, 2008, J BIOL CHEM, V283, P19489, DOI 10.1074/jbc.M801037200; Weggen S, 2001, NATURE, V414, P212, DOI 10.1038/35102591; Wolfe MS, 2004, SCIENCE, V305, P1119, DOI 10.1126/science.1096187; Wolfe MS, 1999, NATURE, V398, P513, DOI 10.1038/19077; Yamasaki A, 2006, J NEUROSCI, V26, P3821, DOI 10.1523/JNEUROSCI.5354-05.2006; Yu G, 2000, NATURE, V407, P48, DOI 10.1038/35024009; Zhang ZH, 2000, NAT CELL BIOL, V2, P463, DOI 10.1038/35017108; Zhou SX, 2005, P NATL ACAD SCI USA, V102, P7499, DOI 10.1073/pnas.0502768102	64	172	175	0	15	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	OCT 31	2008	283	44					29627	29631		10.1074/jbc.R800010200	http://dx.doi.org/10.1074/jbc.R800010200			5	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	364WS	18650432	Green Published, hybrid			2022-12-27	WOS:000260366900004
J	Fulton, Z; McAlister, A; Wilce, MCJ; Brammananth, R; Zaker-Tabrizi, L; Perugini, MA; Bottomley, SP; Coppel, RL; Crellin, PK; Rossjohn, J; Beddoe, T				Fulton, Zara; McAlister, Adrian; Wilce, Matthew C. J.; Brammananth, Rajini; Zaker-Tabrizi, Leyla; Perugini, Matthew A.; Bottomley, Stephen P.; Coppel, Ross L.; Crellin, Paul K.; Rossjohn, Jamie; Beddoe, Travis			Crystal structure of a UDP-glucose-specific glycosyltransferase from a Mycobacterium Species	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							SEDIMENTATION-VELOCITY; COMPLEX; ULTRACENTRIFUGATION; RECOGNITION; ALIGNMENT; DONOR; SPSA	Glycosyltransferases (GTs) are a large and ubiquitous family of enzymes that specifically transfer sugar moieties to a range of substrates. Mycobacterium tuberculosis contains a large number of GTs, many of which are implicated in cell wall synthesis, yet the majority of these GTs remain poorly characterized. Here, we report the high resolution crystal structures of an essential GT (MAP2569c) from Mycobacterium avium subsp. paratuberculosis (a close homologue of Rv1208 from M. tuberculosis) in its apo- and ligand-bound forms. The structure adopted the GT-A fold and possessed the characteristic DXD motif that coordinated an Mn2+ ion. Atypical of most GTs characterized to date, MAP2569c exhibited specificity toward the donor substrate, UDP-glucose. The structure of this ligated complex revealed an induced fit binding mechanism and provided a basis for this unique specificity. Collectively, the structural features suggested that MAP2569c may adopt a "retaining" enzymatic mechanism, which has implications for the classification of other GTs in this large superfamily.	[Fulton, Zara; McAlister, Adrian; Wilce, Matthew C. J.; Zaker-Tabrizi, Leyla; Rossjohn, Jamie; Beddoe, Travis] Monash Univ, Prot Crystallog Unit, Sch Biomed Sci, Dept Biochem & Mol Biol, Clayton, Vic 3800, Australia; [Fulton, Zara; Brammananth, Rajini; Zaker-Tabrizi, Leyla; Coppel, Ross L.; Crellin, Paul K.; Rossjohn, Jamie; Beddoe, Travis] Monash Univ, Australian Res Council Ctr Excellence Struct & Fu, Clayton, Vic 3800, Australia; [Brammananth, Rajini; Coppel, Ross L.; Crellin, Paul K.] Monash Univ, Dept Microbiol, Sch Biomed Sci, Clayton, Vic 3800, Australia; [Perugini, Matthew A.] Univ Melbourne, Mol Sci & Biotechnol Inst Bio21, Parkville, Vic 3010, Australia; [Bottomley, Stephen P.] Monash Univ, Dept Biochem & Mol Biol, Sch Biomed Sci, Clayton, Vic 3800, Australia	Monash University; Monash University; Monash University; University of Melbourne; Monash University	Beddoe, T (corresponding author), Monash Univ, Prot Crystallog Unit, Sch Biomed Sci, Dept Biochem & Mol Biol, Clayton, Vic 3800, Australia.	travis.beddoe@med.monash.edu.au	Rossjohn, Jamie/F-9032-2013; Coppel, Ross L/A-6626-2008; Beddoe, Travis/F-3415-2014	Rossjohn, Jamie/0000-0002-2020-7522; Coppel, Ross L/0000-0002-4476-9124; Beddoe, Travis/0000-0003-4550-2277; Crellin, Paul K/0000-0002-2017-4935	Australian Research Council (ARC) Centre of Excellence in Structural and Functional Microbial Genomics; National Health and Medical Research Council (NHMRC) of Australia	Australian Research Council (ARC) Centre of Excellence in Structural and Functional Microbial Genomics(Australian Research Council); National Health and Medical Research Council (NHMRC) of Australia(National Health and Medical Research Council (NHMRC) of Australia)	This work was supported by the Australian Research Council (ARC) Centre of Excellence in Structural and Functional Microbial Genomics and the National Health and Medical Research Council (NHMRC) of Australia. The costs of publication of this article were defrayed in part by the payment of page charges. This article must therefore be hereby marked "advertisement" in accordance with 18 U.S.C. Section 1734 solely to indicate this fact.	BAILEY S, 1994, ACTA CRYSTALLOGR D, V50, P760, DOI 10.1107/s0907444994003112; Berg S, 2007, GLYCOBIOLOGY, V17, p35R, DOI 10.1093/glycob/cwm010; Campbell JA, 1997, BIOCHEM J, V326, P929, DOI 10.1042/bj3260929u; Charnock SJ, 1999, BIOCHEMISTRY-US, V38, P6380, DOI 10.1021/bi990270y; Chenna R, 2003, NUCLEIC ACIDS RES, V31, P3497, DOI 10.1093/nar/gkg500; Cole JL, 2008, METHOD CELL BIOL, V84, P143, DOI 10.1016/S0091-679X(07)84006-4; Cowtan K., 1994, JOINT CCP4 ESF EACBM, V31, P34; Crick DC, 2001, GLYCOBIOLOGY, V11, p107R, DOI 10.1093/glycob/11.9.107R; Daffe M, 1998, ADV MICROB PHYSIOL, V39, P131; DeLano W.L, PYMOL MOL GRAPHICS S; Empadinhas N, 2008, FEMS MICROBIOL LETT, V280, P195, DOI 10.1111/j.1574-6968.2007.01064.x; Emsley P, 2004, ACTA CRYSTALLOGR D, V60, P2126, DOI 10.1107/S0907444904019158; Flint J, 2005, NAT STRUCT MOL BIOL, V12, P608, DOI 10.1038/nsmb950; Fritz TA, 2004, P NATL ACAD SCI USA, V101, P15307, DOI 10.1073/pnas.0405657101; Fulton Z, 2008, ACTA CRYSTALLOGR F, V64, P428, DOI 10.1107/S1744309108011196; Gordon RD, 2006, J MOL BIOL, V360, P67, DOI 10.1016/j.jmb.2006.04.058; GOSSELIN S, 1994, ANAL BIOCHEM, V220, P92, DOI 10.1006/abio.1994.1303; HOLM L, 1993, J MOL BIOL, V233, P123, DOI 10.1006/jmbi.1993.1489; KABSCH W, 1983, BIOPOLYMERS, V22, P2577, DOI 10.1002/bip.360221211; Martinez-Fleites C, 2006, CHEM BIOL, V13, P1143, DOI 10.1016/j.chembiol.2006.09.005; Murshudov GN, 1997, ACTA CRYSTALLOGR D, V53, P240, DOI 10.1107/S0907444996012255; Perrakis A, 1999, NAT STRUCT BIOL, V6, P458, DOI 10.1038/8263; Persson K, 2001, NAT STRUCT BIOL, V8, P166, DOI 10.1038/84168; Qasba PK, 2005, TRENDS BIOCHEM SCI, V30, P53, DOI 10.1016/j.tibs.2004.11.005; Ramakrishnan B, 2004, CURR OPIN STRUC BIOL, V14, P593, DOI 10.1016/j.sbi.2004.09.006; Ramakrishnan B, 2002, J MOL BIOL, V318, P491, DOI 10.1016/S0022-2836(02)00020-7; ROSSMANN MG, 1974, NATURE, V250, P194, DOI 10.1038/250194a0; Sassetti CM, 2003, MOL MICROBIOL, V48, P77, DOI 10.1046/j.1365-2958.2003.03425.x; Schuck P, 2000, BIOPHYS J, V78, P1606, DOI 10.1016/S0006-3495(00)76713-0; Studier FW, 2005, PROTEIN EXPRES PURIF, V41, P207, DOI 10.1016/j.pep.2005.01.016; Tarbouriech N, 2001, J MOL BIOL, V314, P655, DOI 10.1006/jmbi.2001.5159; Weeks CM, 2002, Z KRISTALLOGR, V217, P686, DOI 10.1524/zkri.217.12.686.20659; Wiggins CAR, 1998, P NATL ACAD SCI USA, V95, P7945, DOI 10.1073/pnas.95.14.7945; Wimmerova M, 2003, BIOCHIMIE, V85, P691, DOI 10.1016/S0300-9084(03)00120-2; Zhang Y, 2007, STRUCTURE, V15, P1031, DOI 10.1016/j.str.2007.07.006	35	21	23	0	4	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	OCT 10	2008	283	41					27881	27890		10.1074/jbc.M801853200	http://dx.doi.org/10.1074/jbc.M801853200			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	355OW	18667419	hybrid			2022-12-27	WOS:000259719200059
J	Liao, H; Huang, WH; Schachner, M; Guan, Y; Guo, JJ; Yan, J; Qin, J; Bai, XS; Zhang, LY				Liao, Hong; Huang, Wenhui; Schachner, Melitta; Guan, Yue; Guo, Jingjing; Yan, Jun; Qin, Jing; Bai, Xianshu; Zhang, Luyong			beta 1 integrin-mediated effects of tenascin-R domains EGFL and FN6-8 on neural stem/progenitor cell proliferation and differentiation in vitro	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							EXTRACELLULAR-MATRIX GLYCOPROTEIN; SUBVENTRICULAR ZONE; MICE DEFICIENT; MESSENGER-RNA; STEM-CELLS; ADHESION; NEUROGENESIS; J1-160/180; MIGRATION; JANUSIN	Neural stem/progenitor cells (NSCs) have the capacity for self-renewal and differentiation into major classes of central nervous system cell types, such as neurons, astrocytes, and oligodendrocytes. The determination of fate of NSCs appears to be regulated by both intrinsic and extrinsic factors. Mounting evidence has shown that extracellular matrix molecules contribute to NSC proliferation and differentiation as extrinsic factors. Here we explore the effects of the epidermal growth factor-like (EGFL) and fibronectin type III homologous domains 6-8 (FN6-8) of the extracellular matrix molecule tenascin-R on NSC proliferation and differentiation. Our results show that domain FN6-8 inhibited NSC proliferation and promoted NSCs differentiation into astrocytes and less into oligodendrocytes or neurons. The EGFL domain did not affect NSC proliferation, but promoted NSC differentiation into neurons and reduced NSC differentiation into astrocytes and oligodendrocytes. Treatment of NSCs with beta 1 integrin function-blocking antibody resulted in attenuation of inhibition of the effect of FN6-8 on NSC proliferation. The influence of EGFL or FN6-8 on NSCs differentiation was inhibited by beta 1 integrin antibody application, implicating beta 1 integrin in proliferation and differentiation induced by EGFL and FN6-8 mediated triggering of NSCs.	[Liao, Hong; Huang, Wenhui; Guan, Yue; Guo, Jingjing; Yan, Jun; Qin, Jing; Bai, Xianshu] China Pharmaceut Univ, Neurobiol Lab, New Drug Screening Ctr, Nanjing 210038, Peoples R China; [Zhang, Luyong] China Pharmaceut Univ, Jiangsu Ctr Pharmacodynam Res & Evaluat, Nanjing 210038, Peoples R China; [Huang, Wenhui; Schachner, Melitta] Univ Hamburg, Zentrum Mol Biol, D-20251 Hamburg, Germany; [Schachner, Melitta] Rutgers State Univ, Keck Ctr Collaborat Neurosci, Piscataway, NJ 08854 USA; [Schachner, Melitta] Rutgers State Univ, Dept Cell Biol & Neurosci, Piscataway, NJ 08854 USA	China Pharmaceutical University; China Pharmaceutical University; University of Hamburg; Rutgers State University New Brunswick; Rutgers State University New Brunswick	Liao, H (corresponding author), 1 Shen Nong Rd, Nanjing 210038, Peoples R China.	liaohong56@hotmail.com; lyzhang@cpu.edu.cn	Huang, Wenhui/M-6227-2013; Bai, Xianshu/ABY-7478-2022	Huang, Wenhui/0000-0001-9865-0375; Bai, Xianshu/0000-0002-4758-1645	National Natural Science Foundation of China [30670793]; Natural Science Foundation of Jiang Su Province [BK2006150]; International Coorperation Projects of Jiang Su Province [BZ2006050]; Pharmacodynamics Research and Evaluation Fund of Jiang Su Province; Initial Fund of China Pharmaceutical University	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Natural Science Foundation of Jiang Su Province(Natural Science Foundation of Jiangsu Province); International Coorperation Projects of Jiang Su Province; Pharmacodynamics Research and Evaluation Fund of Jiang Su Province; Initial Fund of China Pharmaceutical University	This work was supported by grants from the National Natural Science Foundation of China (30670793), Natural Science Foundation of Jiang Su Province (BK2006150), International Coorperation Projects of Jiang Su Province (BZ2006050), Pharmacodynamics Research and Evaluation Fund of Jiang Su Province, and Initial Fund of China Pharmaceutical University (to H. L.). The costs of publication of this article were defrayed in part by the payment of page charges. This article must therefore be hereby marked " advertisement" in accordance with 18 U.S.C. Section 1734 solely to indicate this fact.	Alvarez-Buylla A, 2002, J NEUROSCI, V22, P629, DOI 10.1523/JNEUROSCI.22-03-00629.2002; Apostolova I, 2006, J NEUROSCI, V26, P7849, DOI 10.1523/JNEUROSCI.1526-06.2006; BARTSCH U, 1993, GLIA, V9, P57, DOI 10.1002/glia.440090108; Bruckner G, 2000, J COMP NEUROL, V428, P616, DOI 10.1002/1096-9861(20001225)428:4<616::AID-CNE3>3.0.CO;2-K; Dityatev A, 2007, DEV NEUROBIOL, V67, P570, DOI 10.1002/dneu.20361; Dityatev A, 2006, CELL TISSUE RES, V326, P647, DOI 10.1007/s00441-006-0217-1; FUSS B, 1993, J CELL BIOL, V120, P1237, DOI 10.1083/jcb.120.5.1237; Gage FH, 2000, SCIENCE, V287, P1433, DOI 10.1126/science.287.5457.1433; Garcion E, 2004, DEVELOPMENT, V131, P3423, DOI 10.1242/dev.01202; Garcion E, 2001, DEVELOPMENT, V128, P2485; Gurevicius K, 2004, MOL CELL NEUROSCI, V25, P515, DOI 10.1016/j.mcn.2003.12.001; Hargus G, 2008, STEM CELLS, V26, P1973, DOI 10.1634/stemcells.2007-0929; HUSMANN K, 1992, J CELL BIOL, V116, P1475, DOI 10.1083/jcb.116.6.1475; Jankovski A, 1996, J COMP NEUROL, V371, P376; Jones FS, 2000, DEV DYNAM, V218, P235, DOI 10.1002/(SICI)1097-0177(200006)218:2<235::AID-DVDY2>3.3.CO;2-7; LAEMMLI UK, 1970, NATURE, V227, P680, DOI 10.1038/227680a0; Li LH, 2005, ANNU REV CELL DEV BI, V21, P605, DOI 10.1146/annurev.cellbio.21.012704.131525; Liao H, 2005, J BIOL CHEM, V280, P8316, DOI 10.1074/jbc.M412730200; LOCHTER A, 1993, J NEUROSCI, V13, P3986; LOCHTER A, 1991, J CELL BIOL, V113, P1159, DOI 10.1083/jcb.113.5.1159; LOIS C, 1994, SCIENCE, V264, P1145, DOI 10.1126/science.8178174; LUSKIN MB, 1993, NEURON, V11, P173, DOI 10.1016/0896-6273(93)90281-U; Magavi SS, 2000, NATURE, V405, P951, DOI 10.1038/35016083; Moore KA, 2006, SCIENCE, V311, P1880, DOI 10.1126/science.1110542; MORGANTI MC, 1990, EXP NEUROL, V109, P98, DOI 10.1016/S0014-4886(05)80012-3; Norenberg U, 1996, INT J DEV NEUROSCI, V14, P217, DOI 10.1016/0736-5748(96)00009-3; Pencea V, 2001, EXP NEUROL, V172, P1, DOI 10.1006/exnr.2001.7768; PESHEVA P, 1994, J CELL SCI, V107, P2323; PESHEVA P, 1989, J CELL BIOL, V109, P1765, DOI 10.1083/jcb.109.4.1765; Pesheva P, 1997, J NEUROSCI, V17, P4642; PESHEVA P, 1993, NEURON, V10, P69, DOI 10.1016/0896-6273(93)90243-K; Probstmeier R, 1999, EUR J NEUROSCI, V11, P2474, DOI 10.1046/j.1460-9568.1999.00670.x; RichterLandsberg C, 1996, J NEUROSCI RES, V45, P161, DOI 10.1002/(SICI)1097-4547(19960715)45:2<161::AID-JNR8>3.0.CO;2-8; Saghatelyan A, 2004, NAT NEUROSCI, V7, P347, DOI 10.1038/nn1211; Saghatelyan AK, 2001, MOL CELL NEUROSCI, V17, P226, DOI 10.1006/mcne.2000.0922; SCHACHNER M, 1994, PERSPECT DEV NEUROBI, V2, P33; Scheffler B, 1999, TRENDS NEUROSCI, V22, P348, DOI 10.1016/S0166-2236(99)01416-2; Srinivasan J, 1998, P NATL ACAD SCI USA, V95, P15753, DOI 10.1073/pnas.95.26.15753; Steindler DA, 1996, PROG BRAIN RES, V108, P349, DOI 10.1016/S0079-6123(08)62551-0; TAYLOR J, 1993, J NEUROSCI RES, V35, P347, DOI 10.1002/jnr.490350402; van Meeteren ME, 2005, DEV BRAIN RES, V156, P78, DOI 10.1016/j.devbrainres.2005.02.005; WINTERGERST ES, 1993, EUR J NEUROSCI, V5, P299, DOI 10.1111/j.1460-9568.1993.tb00497.x; Xiao ZC, 1997, J NEUROSCI RES, V49, P698, DOI 10.1002/(SICI)1097-4547(19970915)49:6<698::AID-JNR4>3.0.CO;2-2; Xiao ZC, 1996, EUR J NEUROSCI, V8, P766, DOI 10.1111/j.1460-9568.1996.tb01262.x	44	23	23	0	8	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	OCT 10	2008	283	41					27927	27936		10.1074/jbc.M804764200	http://dx.doi.org/10.1074/jbc.M804764200			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	355OW	18658130	hybrid			2022-12-27	WOS:000259719200063
J	Oka, T; Mazack, V; Sudol, M				Oka, Tsutomu; Mazack, Virginia; Sudol, Marius			Mst2 and lats kinases regulate apoptotic function of Yes kinase-associated protein (YAP)	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							TUMOR-SUPPRESSOR PATHWAY; WARTS-HIPPO PATHWAY; CELL-CYCLE EXIT; WW DOMAIN; ORGAN SIZE; PROMOTES APOPTOSIS; TEAD/TEF FAMILY; PROLIFERATION; DROSOPHILA; GROWTH	The Hippo pathway in Drosophila controls the size and shape of organs. In the fly, activation of this pathway conveys growth-inhibitory signals and promotes apoptosis in epithelial cells. We "reconstituted" the Hippo pathway in a human epithelial cell line and showed that, in contrast to flies, the activation of this pathway results in anti-apoptotic signals. We have shown that in human embryonic kidney (HEK) 293 cells, the complex formation between transcriptional co-activators YAPs (Yes kinase-associated proteins) and Lats kinases requires the intact WW domains of YAPs, as well as intact Pro-Pro-AA-Tyr (where AA is any amino acid) motifs in Lats kinases. These kinases cooperate with the upstream Mst2 kinase to phosphorylate YAPs at Ser127. Overexpression of YAP2 in HEK293 cells promoted apoptosis, whereas the Mst2/Lats1-induced phosphorylation of YAP partially rescued the cells from apoptotic death. Apoptotic signaling of YAP2 was mediated via stabilization of p73, which formed a complex with YAP2. All components of the Hippo pathway that we studied were localized in the cytoplasm, with the exception of YAP, which also localized in the nucleus. The localization of YAP2 in the nucleus was negatively controlled by the Lats1 kinase. Our apoptotic "readout" of the Hippo pathway in embryonic kidney cells represents a useful experimental system for the identification of the putative upstream receptor, membrane protein, or extracellular factor that initiates an entire signaling cascade and ultimately controls the size of organs.	[Oka, Tsutomu; Mazack, Virginia; Sudol, Marius] Weis Ctr Res, Geisinger Clin, Lab Signal Transduct & Prote Profiling, Danville, PA 17822 USA; [Sudol, Marius] Mt Sinai Sch Med, Dept Med, New York, NY 10029 USA	Icahn School of Medicine at Mount Sinai	Sudol, M (corresponding author), 100 N Acad Ave, Danville, PA 17822 USA.	msudol1@geisinger.edu			Breast Cancer Coalition	Breast Cancer Coalition	This work was supported by two Breast Cancer Coalition grants from the Pennsylvania Department of Health (to M. S.). The costs of publication of this article were defrayed in part by the payment of page charges. This article must therefore be hereby marked "advertisement" in accordance with 18 U. S. C. Section 1734 solely to indicate this fact.	Bandura JL, 2008, DEV CELL, V14, P315, DOI 10.1016/j.devcel.2008.02.010; Basu S, 2003, MOL CELL, V11, P11, DOI 10.1016/S1097-2765(02)00776-1; Beausoleil SA, 2004, P NATL ACAD SCI USA, V101, P12130, DOI 10.1073/pnas.0404720101; Bennett FC, 2006, CURR BIOL, V16, P2101, DOI 10.1016/j.cub.2006.09.045; BORK P, 1994, TRENDS BIOCHEM SCI, V19, P531, DOI 10.1016/0968-0004(94)90053-1; Bothos J, 2005, CANCER RES, V65, P6568, DOI 10.1158/0008-5472.CAN-05-0862; Camargo FD, 2007, CURR BIOL, V17, P2054, DOI 10.1016/j.cub.2007.10.039; Chan EH, 2005, ONCOGENE, V24, P2076, DOI 10.1038/sj.onc.1208445; Chen HI, 1997, J BIOL CHEM, V272, P17070, DOI 10.1074/jbc.272.27.17070; CHEN HI, 1995, P NATL ACAD SCI USA, V92, P7819, DOI 10.1073/pnas.92.17.7819; Danovi SA, 2008, CELL DEATH DIFFER, V15, P217, DOI 10.1038/sj.cdd.4402226; Debnath J, 2003, METHODS, V30, P256, DOI 10.1016/S1046-2023(03)00032-X; Deng Y, 2003, J BIOL CHEM, V278, P11760, DOI 10.1074/jbc.M211085200; Dong JX, 2007, CELL, V130, P1120, DOI 10.1016/j.cell.2007.07.019; Edgar BA, 2006, CELL, V124, P267, DOI 10.1016/j.cell.2006.01.005; Espanel X, 1999, J BIOL CHEM, V274, P17284, DOI 10.1074/jbc.274.24.17284; Goulev Y, 2008, CURR BIOL, V18, P435, DOI 10.1016/j.cub.2008.02.034; Graves JD, 1998, EMBO J, V17, P2224, DOI 10.1093/emboj/17.8.2224; Hamaratoglu F, 2006, NAT CELL BIOL, V8, P27, DOI 10.1038/ncb1339; Hao YW, 2008, J BIOL CHEM, V283, P5496, DOI 10.1074/jbc.M709037200; Harvey KF, 2003, CELL, V114, P457, DOI 10.1016/S0092-8674(03)00557-9; Harvey K, 2007, NAT REV CANCER, V7, P182, DOI 10.1038/nrc2070; Hoshino M, 2006, J CELL BIOL, V172, P589, DOI 10.1083/jcb.200509132; Hu H, 2004, PROTEOMICS, V4, P643, DOI 10.1002/pmic.200300632; Huang JB, 2005, CELL, V122, P421, DOI 10.1016/j.cell.2005.06.007; Jia JH, 2003, GENE DEV, V17, P2514, DOI 10.1101/gad.1134003; Komuro A, 2003, J BIOL CHEM, V278, P33334, DOI 10.1074/jbc.M305597200; Leevers SJ, 2005, CURR OPIN CELL BIOL, V17, P604, DOI 10.1016/j.ceb.2005.09.008; Levy D, 2007, CELL DEATH DIFFER, V14, P743, DOI 10.1038/sj.cdd.4402063; Levy D, 2008, MOL CELL, V29, P350, DOI 10.1016/j.molcel.2007.12.022; Matallanas D, 2008, CELL CYCLE, V7, P879, DOI 10.4161/cc.7.7.5630; Matallanas D, 2007, MOL CELL, V27, P962, DOI 10.1016/j.molcel.2007.08.008; McPherson JP, 2004, EMBO J, V23, P3677, DOI 10.1038/sj.emboj.7600371; Meignin C, 2007, CURR BIOL, V17, P1871, DOI 10.1016/j.cub.2007.09.062; Nguyen JT, 1998, SCIENCE, V282, P2088, DOI 10.1126/science.282.5396.2088; O'Neill E, 2004, SCIENCE, V306, P2267, DOI 10.1126/science.1103233; O'Neill EE, 2005, CANCER RES, V65, P5485, DOI 10.1158/0008-5472.CAN-05-1453; Overholtzer M, 2006, P NATL ACAD SCI USA, V103, P12405, DOI 10.1073/pnas.0605579103; Pan DJ, 2007, GENE DEV, V21, P886, DOI 10.1101/gad.1536007; Pantalacci S, 2003, NAT CELL BIOL, V5, P921, DOI 10.1038/ncb1051; Rocco JW, 2006, CANCER CELL, V9, P45, DOI 10.1016/j.ccr.2005.12.013; Ryoo HD, 2003, NAT CELL BIOL, V5, P853, DOI 10.1038/ncb1003-853; Saucedo LJ, 2007, NAT REV MOL CELL BIO, V8, P613, DOI 10.1038/nrm2221; Silva E, 2006, CURR BIOL, V16, P2081, DOI 10.1016/j.cub.2006.09.004; Sotgia F, 2001, BIOCHEMISTRY-US, V40, P14585, DOI 10.1021/bi011247r; St John MAR, 1999, NAT GENET, V21, P182, DOI 10.1038/5965; Strano S, 2005, MOL CELL, V18, P447, DOI 10.1016/j.molcel.2005.04.008; Strano S, 2001, J BIOL CHEM, V276, P15164, DOI 10.1074/jbc.M010484200; SUDOL M, 1995, J BIOL CHEM, V270, P14733, DOI 10.1074/jbc.270.24.14733; Sudol M, 2000, CELL, V103, P1001, DOI 10.1016/S0092-8674(00)00203-8; Sun SG, 2008, DEV DYNAM, V237, P270, DOI 10.1002/dvdy.21411; Takahashi Y, 2005, CLIN CANCER RES, V11, P1380, DOI 10.1158/1078-0432.CCR-04-1773; Tapon N, 2002, CELL, V110, P467, DOI 10.1016/S0092-8674(02)00824-3; Udan RS, 2003, NAT CELL BIOL, V5, P914, DOI 10.1038/ncb1050; Vassilev A, 2001, GENE DEV, V15, P1229, DOI 10.1101/gad.888601; Vidal M, 2006, CURR OPIN GENET DEV, V16, P10, DOI 10.1016/j.gde.2005.12.004; Vitolol MI, 2007, CANCER BIOL THER, V6, P856, DOI 10.4161/cbt.6.6.4241; Vogelstein B, 2004, NAT MED, V10, P789, DOI 10.1038/nm1087; Willecke M, 2006, CURR BIOL, V16, P2090, DOI 10.1016/j.cub.2006.09.005; Wu S, 2003, CELL, V114, P445, DOI 10.1016/S0092-8674(03)00549-X; Wu S, 2008, DEV CELL, V14, P388, DOI 10.1016/j.devcel.2008.01.007; Yagi R, 1999, EMBO J, V18, P2551, DOI 10.1093/emboj/18.9.2551; Zender L, 2006, CELL, V125, P1253, DOI 10.1016/j.cell.2006.05.030; Zhang JM, 2008, CANCER RES, V68, P2789, DOI 10.1158/0008-5472.CAN-07-6205; Zhang L, 2008, DEV CELL, V14, P377, DOI 10.1016/j.devcel.2008.01.006; Zhao B, 2007, GENE DEV, V21, P2747, DOI 10.1101/gad.1602907	66	269	276	0	17	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	OCT 10	2008	283	41					27534	27546		10.1074/jbc.M804380200	http://dx.doi.org/10.1074/jbc.M804380200			13	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	355OW	18640976	hybrid			2022-12-27	WOS:000259719200024
J	Cain, SA; Baldwin, AK; Mahalingam, Y; Raynal, B; Jowitt, TA; Shuttleworth, CA; Couchman, JR; Kielty, CM				Cain, Stuart A.; Baldwin, Andrew K.; Mahalingam, Yashithra; Raynal, Bertrand; Jowitt, Thomas A.; Shuttleworth, C. Adrian; Couchman, John R.; Kielty, Cay M.			Heparan sulfate regulates fibrillin-1 N- and C-terminal interactions	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							FOCAL ADHESION FORMATION; MARFAN-SYNDROME; CALCIUM DETERMINES; HUMAN TROPOELASTIN; RICH MICROFIBRILS; CELL-ADHESION; ORGANIZATION; MOLECULES; PROTEINS; DOMAINS	Fibrillin-1 N- and C-terminal heparin binding sites have been characterized. An unprocessed monomeric N- terminal fragment (PF1) induced a very high heparin binding response, indicating heparin-mediated multimerization. Using PF1 deletion and short fragments, a heparin binding site was localized within the domain encoded by exon 7 after the first hybrid domain. Rodent embryonic fibroblasts adhered to PF1 and deletion fragments, and, when cells were plated on fibrillin-1 or fibronectin Arg-Gly-Asp cell-binding fragments, cells showed heparin-dependent spreading and focal contact formation in response to soluble PF1. Within domains encoded by exons 59 - 62 near the fibrillin-1 C terminus are novel conformation-dependent high affinity heparin and tropoelastin binding sites. Heparin disrupted tropoelastin binding but did not disrupt N- and C-terminal fibrillin-1 interactions. Thus, fibrillin-1 N- terminal interactions with heparin/heparan sulfate directly influence cell behavior, whereas C-terminal interactions with heparin/heparan sulfate regulate elastin deposition. These data highlight how heparin/heparan sulfate controls fibrillin-1 interactions.	[Cain, Stuart A.; Baldwin, Andrew K.; Raynal, Bertrand; Jowitt, Thomas A.; Shuttleworth, C. Adrian; Kielty, Cay M.] Univ Manchester, Fac Life Sci, Wellcome Trust Ctr Cell Matrix Res, Manchester M13 9PT, Lancs, England; [Mahalingam, Yashithra] Univ London Imperial Coll Sci Technol & Med, Div Biomed Sci, London SW7 2AZ, England; [Couchman, John R.] Univ Copenhagen, Inst Biomed, Bioctr, DK-2200 Copenhagen, Denmark; [Raynal, Bertrand] Inst Pasteur, F-75724 Paris 15, France	University of Manchester; Imperial College London; University of Copenhagen; Le Reseau International des Instituts Pasteur (RIIP); Institut Pasteur Paris	Kielty, CM (corresponding author), Univ Manchester, Fac Life Sci, Wellcome Trust Ctr Cell Matrix Res, Michael Smith Bldg,Oxford Rd, Manchester M13 9PT, Lancs, England.	cay.kielty@manchester.ac.uk	Cain, Stuart A/G-2836-2017	Jowitt, Thomas/0000-0002-4045-0933; Baldwin, Andrew/0000-0002-8331-6769; Cain, Stuart/0000-0001-8417-1058; raynal, Bertrand/0000-0001-5634-0408	British Heart Foundation [PG/04/052/17027]; Wellcome Trust [081930]; Medical Research Council [0200246]; European Union [LSHM-CT-2005-018960]; Medical Research Council [G0200246] Funding Source: researchfish; MRC [G0200246] Funding Source: UKRI	British Heart Foundation(British Heart Foundation); Wellcome Trust(Wellcome Trust); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); European Union(European Commission); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC))	This work was funded by British Heart Foundation Grant PG/04/052/17027, Wellcome Trust Grant 081930, Medical Research Council Grant G0200246, and European Union Grant LSHM-CT-2005-018960. The costs of publication of this article were defrayed in part by the payment of page charges. This article must therefore be hereby marked "advertisement" in accordance with 18 U. S. C. Section 1734 solely to indicate this fact.	Baldock C, 2006, P NATL ACAD SCI USA, V103, P11922, DOI 10.1073/pnas.0601609103; Bax DV, 2007, J CELL SCI, V120, P1383, DOI 10.1242/jcs.003954; Bax DV, 2003, J BIOL CHEM, V278, P34605, DOI 10.1074/jbc.M303159200; BLOOMFIE.V, 1967, BIOPOLYMERS, V5, P135, DOI 10.1002/bip.1967.360050202; Cain SA, 2006, PROTEOMICS, V6, P111, DOI 10.1002/pmic.200401340; Cain SA, 2005, J BIOL CHEM, V280, P30526, DOI 10.1074/jbc.M501390200; Cain SA, 2008, METHODS, V45, P42, DOI 10.1016/j.ymeth.2008.01.005; de la Torre JG, 2000, BIOPHYS J, V78, P719, DOI 10.1016/S0006-3495(00)76630-6; Dovas A, 2006, J CELL SCI, V119, P2837, DOI 10.1242/jcs.03020; Downing AK, 1996, CELL, V85, P597, DOI 10.1016/S0092-8674(00)81259-3; Higashiyama S, 2008, CANCER SCI, V99, P214, DOI 10.1111/j.1349-7006.2007.00676.x; Hubmacher D, 2006, CURR TOP DEV BIOL, V75, P93, DOI 10.1016/S0070-2153(06)75004-9; Jensen SA, 2001, J BIOL CHEM, V276, P39661, DOI 10.1074/jbc.M104533200; Kielty Cay M., 2006, Expert Reviews in Molecular Medicine, V8, P1, DOI 10.1017/S146239940600007X; Marson A, 2005, J BIOL CHEM, V280, P5013, DOI 10.1074/jbc.M409029200; MARTIN SL, 1995, GENE, V154, P159, DOI 10.1016/0378-1119(94)00848-M; Mellody KT, 2006, J BIOL CHEM, V281, P31854, DOI 10.1074/jbc.M602743200; Nardella C, 2004, ANAL BIOCHEM, V332, P368, DOI 10.1016/j.ab.2004.05.050; Osmond RIW, 2002, ANAL BIOCHEM, V310, P199, DOI 10.1016/S0003-2697(02)00396-2; PEREIRA L, 1993, HUM MOL GENET, V2, P961, DOI 10.1093/hmg/2.7.961; Reinhardt DP, 1997, J BIOL CHEM, V272, P7368, DOI 10.1074/jbc.272.11.7368; Ritty TM, 2003, BIOCHEM J, V375, P425, DOI 10.1042/BJ20030649; Rock MJ, 2004, J BIOL CHEM, V279, P23748, DOI 10.1074/jbc.M400212200; SAKAI LY, 1991, J BIOL CHEM, V266, P14763; Schuck P, 2002, BIOPHYS J, V82, P1096, DOI 10.1016/S0006-3495(02)75469-6; Smallridge RS, 2003, J BIOL CHEM, V278, P12199, DOI 10.1074/jbc.M208266200; Tiedemann K, 2005, J BIOL CHEM, V280, P11404, DOI 10.1074/jbc.M409882200; Tiedemann K, 2001, J BIOL CHEM, V276, P36035, DOI 10.1074/jbc.M104985200; Toonkool P, 2001, J BIOL CHEM, V276, P44575, DOI 10.1074/jbc.M107920200; Wagenseil Jessica E., 2007, Birth Defects Research, V81, P229, DOI 10.1002/bdrc.20111; Wallis DD, 2003, J CELL BIOCHEM, V90, P641, DOI 10.1002/jcb.10657; Wess TJ, 1998, J CELL BIOL, V141, P829, DOI 10.1083/jcb.141.3.829	32	47	47	0	5	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258			J BIOL CHEM	J. Biol. Chem.	OCT 3	2008	283	40					27017	27027		10.1074/jbc.M803373200	http://dx.doi.org/10.1074/jbc.M803373200			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	353RT	18669635	hybrid			2022-12-27	WOS:000259586600022
J	Oshima, Y; Akiyama, T; Hikita, A; Iwasawa, M; Nagase, Y; Nakamura, M; Wakeyama, H; Kawamura, N; Ikeda, T; Chung, U; Hennighausen, L; Kawaguchi, H; Nakamura, K; Tanaka, S				Oshima, Yasushi; Akiyama, Toru; Hikita, Atsuhiko; Iwasawa, Mitsuyasu; Nagase, Yuichi; Nakamura, Masaki; Wakeyama, Hidetoshi; Kawamura, Naohiro; Ikeda, Toshiyuki; Chung, Ung-il; Hennighausen, Lothar; Kawaguchi, Hiroshi; Nakamura, Kozo; Tanaka, Sakae			Pivotal role of Bcl-2 family proteins in the regulation of chondrocyte apoptosis	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							HORMONE-RELATED PEPTIDE; AVIAN GROWTH-PLATE; CELL-DEATH; ENDOCHONDRAL OSSIFICATION; CONDITIONAL DELETION; EXTRACELLULAR-MATRIX; X GENE; BNIP3; MICE; EXPRESSION	During endochondral ossification, chondrocytes undergo hypertrophic differentiation and die by apoptosis. The level of inorganic phosphate (P-i) elevates at the site of cartilage mineralization, and when chondrocytes were treated with P-i, they underwent rapid apoptosis. Gene silencing of the proapoptotic Bcl-2 homology 3-only molecule bnip3 significantly suppressed P-i-induced apoptosis. Conversely, overexpression of Bcl-xL suppressed, and its knockdown promoted, the apoptosis of chondrocytes. Bnip3 was associated with Bcl-xL in chondrocytes stimulated with Pi. Bcl-xL was expressed uniformly in the growth plate chondrocytes, whereas Bnip3 expression was exclusively localized in the hypertrophic chondrocytes. Finally, we generated chondrocyte-specific bcl-x knock-out mice using the Cre-loxP recombination system, and we provided evidence that the hypertrophic chondrocyte layer was shortened in those mice because of an increased apoptosis of prehypertrophic and hypertrophic chondrocytes, with the mice afflicted with dwarfism as a result. These results suggest the pivotal role of Bcl-2 family members in the regulation of chondrocyte apoptosis.	[Oshima, Yasushi; Akiyama, Toru; Iwasawa, Mitsuyasu; Nagase, Yuichi; Nakamura, Masaki; Wakeyama, Hidetoshi; Kawamura, Naohiro; Ikeda, Toshiyuki; Kawaguchi, Hiroshi; Nakamura, Kozo; Tanaka, Sakae] Univ Tokyo, Fac Med, Dept Orthopaed Surg, Bunkyo Ku, Tokyo 1130033, Japan; [Hikita, Atsuhiko] Sagamihara Hosp, Natl Hosp Org, Clin Res Ctr, Dept Pathomech, Kanagawa 2288522, Japan; [Chung, Ung-il] Univ Tokyo, Ctr Dis Biol & Integrat Med, Bunkyo Ku, Tokyo 1130033, Japan; [Hennighausen, Lothar] NIH, Lab Genet & Physiol, Bethesda, MD 20892 USA	University of Tokyo; University of Tokyo; National Institutes of Health (NIH) - USA	Tanaka, S (corresponding author), Univ Tokyo, Fac Med, Dept Orthopaed Surg, Bunkyo Ku, Hongo 7-3-1, Tokyo 1130033, Japan.	TANAKAS-ORT@h.u-tokyo.ac.jp	Kawamura, Naohiro/J-8372-2019; Akiyama, Toru/AAA-5887-2020; Tanaka, Sakae/Y-3061-2019; Ikeda, Toshiyuki/GVS-5588-2022	Akiyama, Toru/0000-0001-9493-4768; Tanaka, Sakae/0000-0001-9210-9414; Hennighausen, Lothar/0000-0001-8319-9841	Ministry of Education, Culture, Sports, Science, and Technology of Japan; Ministry of Health, Labor, and Welfare of Japan; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [ZIADK061000, Z01DK061000] Funding Source: NIH RePORTER	Ministry of Education, Culture, Sports, Science, and Technology of Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); Ministry of Health, Labor, and Welfare of Japan(Ministry of Health, Labour and Welfare, Japan); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	This work was authored, in whole or in part, by National Institutes of Health staff. This work was supported in part by grants-in-aid from the Ministry of Education, Culture, Sports, Science, and Technology of Japan and health science research grants from the Ministry of Health, Labor, and Welfare of Japan (to S. T.). The costs of publication of this article were defrayed in part by the payment of page charges. This article must therefore be hereby marked "advertisement" in accordance with 18 U. S. C. Section 1734 solely to indicate this fact.	Amizuka N, 1996, ENDOCRINOLOGY, V137, P5055, DOI 10.1210/en.137.11.5055; Amling M, 1997, J CELL BIOL, V136, P205, DOI 10.1083/jcb.136.1.205; ANDERSON HC, 1975, AM J PATHOL, V79, P237; BOYDE A, 1980, HISTOCHEMISTRY, V69, P85, DOI 10.1007/BF00508369; Colnot C, 2001, DEV BIOL, V229, P203, DOI 10.1006/dbio.2000.9933; Diwan A, 2007, J CLIN INVEST, V117, P2825, DOI 10.1172/JCI32490; FARNUM CE, 1987, ANAT REC, V219, P221, DOI 10.1002/ar.1092190303; GIBSON GJ, 1995, DEV DYNAM, V203, P468, DOI 10.1002/aja.1002030409; Gross A, 1999, GENE DEV, V13, P1899, DOI 10.1101/gad.13.15.1899; Hamacher-Brady A, 2007, CELL DEATH DIFFER, V14, P146, DOI 10.1038/sj.cdd.4401936; Hamacher-Brady A, 2006, AUTOPHAGY, V2, P307, DOI 10.4161/auto.2947; HATORI M, 1995, J BONE MINER RES, V10, P1960, DOI 10.1002/jbmr.5650101216; Hon H, 2004, J IMMUNOL, V173, P4425, DOI 10.4049/jimmunol.173.7.4425; Huang DCS, 2000, CELL, V103, P839, DOI 10.1016/S0092-8674(00)00187-2; Ikeda T, 2004, ARTHRITIS RHEUM-US, V50, P3561, DOI 10.1002/art.20611; Inada M, 1999, DEV DYNAM, V214, P279, DOI 10.1002/(SICI)1097-0177(199904)214:4<279::AID-AJA1>3.0.CO;2-W; KERR JFR, 1972, BRIT J CANCER, V26, P239, DOI 10.1038/bjc.1972.33; Kitamura T, 1998, INT J HEMATOL, V67, P351; Kronenberg HM, 2003, NATURE, V423, P332, DOI 10.1038/nature01657; Kubl DA, 2007, BIOCHEM J, V405, P407, DOI 10.1042/BJ20070319; Lee H, 2006, MOL CELLS, V21, P1; Magne D, 2003, J BONE MINER RES, V18, P1430, DOI 10.1359/jbmr.2003.18.8.1430; Mansfield K, 1999, J CELL PHYSIOL, V179, P276, DOI 10.1002/(SICI)1097-4652(199906)179:3<276::AID-JCP5>3.0.CO;2-#; Mansfield K, 2001, BONE, V28, P1, DOI 10.1016/S8756-3282(00)00409-9; Miyagishi Makoto, 2004, Methods Mol Biol, V252, P483; Morita S, 2000, GENE THER, V7, P1063, DOI 10.1038/sj.gt.3301206; Mwale F, 2002, J BONE MINER RES, V17, P275, DOI 10.1359/jbmr.2002.17.2.275; Nagata S, 1997, CELL, V88, P355, DOI 10.1016/S0092-8674(00)81874-7; Newton K, 1998, EMBO J, V17, P706, DOI 10.1093/emboj/17.3.706; Okami J, 2004, CANCER RES, V64, P5338, DOI 10.1158/0008-5472.CAN-04-0089; Ovchinnikov DA, 2000, GENESIS, V26, P145, DOI 10.1002/(SICI)1526-968X(200002)26:2<145::AID-GENE14>3.0.CO;2-C; Park M, 2007, NAT CELL BIOL, V9, P287, DOI 10.1038/ncb1538; Ray R, 2000, J BIOL CHEM, V275, P1439, DOI 10.1074/jbc.275.2.1439; Riedlinger G, 2002, BIOL REPROD, V66, P438, DOI 10.1095/biolreprod66.2.438; Rucker EB, 2000, MOL ENDOCRINOL, V14, P1038, DOI 10.1210/me.14.7.1038; Sabbagh Y, 2005, P NATL ACAD SCI USA, V102, P9637, DOI 10.1073/pnas.0502249102; Savitt JM, 2005, J NEUROSCI, V25, P6721, DOI 10.1523/JNEUROSCI.0760-05.2005; Schipani E, 2006, ANN NY ACAD SCI, V1068, P66, DOI 10.1196/annals.1346.009; Shukunami C, 1996, J CELL BIOL, V133, P457, DOI 10.1083/jcb.133.2.457; Srinivas V, 2006, AUTOPHAGY, V2, P215, DOI 10.4161/auto.2649; Strasser A, 2000, ANNU REV BIOCHEM, V69, P217, DOI 10.1146/annurev.biochem.69.1.217; THOMPSON CB, 1995, SCIENCE, V267, P1456, DOI 10.1126/science.7878464; Wagner KU, 2000, DEVELOPMENT, V127, P4949; Walton KD, 2001, MECH DEVELOP, V109, P281, DOI 10.1016/S0925-4773(01)00549-4; WU LNY, 1995, J CELL BIOCHEM, V57, P218, DOI 10.1002/jcb.240570206; Yoshida CA, 2004, GENE DEV, V18, P952, DOI 10.1101/gad.1174704	46	31	37	0	3	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	SEP 26	2008	283	39					26499	26508		10.1074/jbc.M800933200	http://dx.doi.org/10.1074/jbc.M800933200			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	350GV	18632667	hybrid, Green Published			2022-12-27	WOS:000259341600026
J	Prasad, A; Paruchuri, V; Preet, A; Latif, F; Ganju, RK				Prasad, Anil; Paruchuri, Vikram; Preet, Anju; Latif, Farida; Ganju, Ramesh K.			Slit-2 induces a tumor-suppressive effect by regulating beta-catenin in breast cancer cells	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							OLFACTORY-BULB AXONS; COLORECTAL-CANCER; ROBO RECEPTORS; EPIGENETIC INACTIVATION; EXPRESSION PATTERNS; SIGNALING PATHWAYS; LUNG DEVELOPMENT; VERTEBRATE SLIT; CARCINOMA CELLS; WNT PATHWAY	SLIT-2 is considered as a candidate tumor suppressor gene, because it is frequently inactivated in various cancers due to hypermethylation of its promoter region and allelic loss. However, the exact mechanism of its tumor-suppressive effect has not been elucidated. Here, we observed that Slit-2-overexpressing breast cancer cells exhibited decreased proliferation and migration capabilities compared with control cells under in vitro conditions. These results were confirmed in vivo in mouse model systems. Mice injected with MCF-7/Slit-2 cells showed a 60-70% reduction in tumor size compared with mice injected with MCF-7/VC cells both in the absence and presence of estrogen. Upon further elucidation, we observed that Slit-2 mediates the tumor-suppressive effect via a coordinated regulation of the beta-catenin and PI3K signaling pathways and by enhancing beta-catenin/E-cadherin-mediated cell-cell adhesion. Our study for the first time reveals that Slit-2-overexpressing breast cancer cells exhibit tumor suppressor capabilities through the novel mechanism of beta-catenin modulation.	[Prasad, Anil; Paruchuri, Vikram; Preet, Anju; Ganju, Ramesh K.] Harvard Univ, Sch Med, Beth Israel Deaconess Med Ctr, Div Expt Med, Boston, MA 02115 USA; [Latif, Farida] Univ Birmingham, Inst Biomed Res, Div Reprod & Child Hlth, Birmingham B15 2TT, W Midlands, England	Harvard University; Beth Israel Deaconess Medical Center; Harvard Medical School; University of Birmingham	Prasad, A (corresponding author), Harvard Univ, Sch Med, Beth Israel Deaconess Med Ctr, Div Expt Med, HIM 342, Boston, MA 02115 USA.	abailugu@bidmc.harvard.edu	Thomson, Axel/A-7893-2013		National Institutes of Health [CA109527]; NATIONAL CANCER INSTITUTE [R01CA109527] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This work was supported, in whole or in part, by National Institutes of Health Grant CA109527. This work was also supported by the Susan G. Komen Breast Cancer Foundation (to R. K. G.). The costs of publication of this article were defrayed in part by the payment of page charges. This article must therefore be hereby marked "advertisement" in accordance with 18 U. S. C. Section 1734 solely to indicate this fact.	Amit S, 2002, GENE DEV, V16, P1066, DOI 10.1101/gad.230302; Anselmo MA, 2003, GENE EXPR PATTERNS, V3, P13, DOI 10.1016/S1567-133X(02)00095-9; Astuti D, 2004, BRIT J CANCER, V90, P515, DOI 10.1038/sj.bjc.6601447; Bashaw GJ, 1999, CELL, V97, P917, DOI 10.1016/S0092-8674(00)80803-X; Battye R, 2001, J NEUROSCI, V21, P4290, DOI 10.1523/JNEUROSCI.21-12-04290.2001; Brabletz T, 1999, AM J PATHOL, V155, P1033, DOI 10.1016/S0002-9440(10)65204-2; Brose K, 1999, CELL, V96, P795, DOI 10.1016/S0092-8674(00)80590-5; Bukholm IK, 1998, J PATHOL, V185, P262, DOI 10.1002/(SICI)1096-9896(199807)185:3<262::AID-PATH97>3.0.CO;2-Y; Chen JH, 2001, J NEUROSCI, V21, P1548, DOI 10.1523/JNEUROSCI.21-05-01548.2001; Conacci-Sorrell M, 2002, J CLIN INVEST, V109, P987, DOI 10.1172/JCI200215429; Cowin P, 2005, CURR OPIN CELL BIOL, V17, P499, DOI 10.1016/j.ceb.2005.08.014; Crawford HC, 1999, ONCOGENE, V18, P2883, DOI 10.1038/sj.onc.1202627; CROSS DAE, 1995, NATURE, V378, P785, DOI 10.1038/378785a0; Dallol A, 2003, ONCOGENE, V22, P4611, DOI 10.1038/sj.onc.1206687; Dallol A, 2003, CANCER RES, V63, P1054; Dallol A, 2002, CANCER RES, V62, P5874; Dickinson RE, 2004, BRIT J CANCER, V91, P2071, DOI 10.1038/sj.bjc.6602222; Duffy MJ, 2000, BREAST CANCER RES, V2, P252, DOI 10.1186/bcr65; Fang DX, 2007, J BIOL CHEM, V282, P11221, DOI 10.1074/jbc.M611871200; Fang XJ, 2000, P NATL ACAD SCI USA, V97, P11960, DOI 10.1073/pnas.220413597; Fearon ER, 2000, JNCI-J NATL CANCER I, V92, P515, DOI 10.1093/jnci/92.7.515; Fujiwara M, 2006, VASC MED, V11, P115, DOI 10.1191/1358863x06vm658ra; Georgas K, 1999, CYTOGENET CELL GENET, V86, P246, DOI 10.1159/000015351; Gilles C, 2003, CANCER RES, V63, P2658; Grieshammer U, 2004, DEV CELL, V6, P709, DOI 10.1016/S1534-5807(04)00108-X; Grone J, 2006, ONCOL REP, V15, P1437; Guan HB, 2003, J IMMUNOL, V171, P6519, DOI 10.4049/jimmunol.171.12.6519; Hatsell S, 2003, J MAMMARY GLAND BIOL, V8, P145, DOI 10.1023/A:1025944723047; He TC, 1998, SCIENCE, V281, P1509, DOI 10.1126/science.281.5382.1509; Howitt JA, 2004, EMBO J, V23, P4406, DOI 10.1038/sj.emboj.7600446; Katoh Y, 2005, ONCOL REP, V14, P1351; Kidd T, 1999, CELL, V96, P785, DOI 10.1016/S0092-8674(00)80589-9; Kramer SG, 2001, SCIENCE, V292, P737, DOI 10.1126/science.1058766; Li HS, 1999, CELL, V96, P807, DOI 10.1016/S0092-8674(00)80591-7; Mestdagt M, 2006, INT J CANCER, V118, P35, DOI 10.1002/ijc.21291; Mhashilkar AM, 2003, MOL THER, V8, P207, DOI 10.1016/S1525-0016(03)00170-9; Nagafuchi A, 2001, CURR OPIN CELL BIOL, V13, P600, DOI 10.1016/S0955-0674(00)00257-X; Papkoff J, 1996, MOL CELL BIOL, V16, P2128; Piper M, 2000, MECH DEVELOP, V94, P213, DOI 10.1016/S0925-4773(00)00313-0; Prasad A, 2004, J BIOL CHEM, V279, P9115, DOI 10.1074/jbc.M308083200; Rajagopalan S, 2000, NEURON, V28, P767, DOI 10.1016/S0896-6273(00)00152-5; Ray G, 2005, ONCOL REP, V13, P445; Rhee J, 2002, NAT CELL BIOL, V4, P798, DOI 10.1038/ncb858; Rhee J, 2007, NAT CELL BIOL, V9, P883, DOI 10.1038/ncb1614; Rubinfeld B, 1996, SCIENCE, V272, P1023, DOI 10.1126/science.272.5264.1023; Santiago-Martinez E, 2006, P NATL ACAD SCI USA, V103, P12441, DOI 10.1073/pnas.0605284103; Seth P, 2005, BIOCHEM BIOPH RES CO, V332, P533, DOI 10.1016/j.bbrc.2005.03.250; Simpson JH, 2000, NEURON, V28, P753, DOI 10.1016/S0896-6273(00)00151-3; Stuart RO, 2003, KIDNEY INT, V64, P1997, DOI 10.1046/j.1523-1755.2003.00383.x; Sundaresan V, 1998, ONCOGENE, V17, P1723, DOI 10.1038/sj.onc.1202103; TAKEICHI M, 1991, SCIENCE, V251, P1451, DOI 10.1126/science.2006419; Tetsu O, 1999, NATURE, V398, P422, DOI 10.1038/18884; Van Aken E, 2001, VIRCHOWS ARCH, V439, P725, DOI 10.1007/S004280100516; Vasioukhin V, 2001, CURR OPIN CELL BIOL, V13, P76, DOI 10.1016/S0955-0674(00)00177-0; Wang KH, 1999, CELL, V96, P771, DOI 10.1016/S0092-8674(00)80588-7; Watson PH, 1996, CURR TOP MICROBIOL, V213, P267; Werbowetski-Ogilvie TE, 2006, ONCOGENE, V25, P5103, DOI 10.1038/sj.onc.1209524; Weston CR, 2001, SCIENCE, V292, P2439, DOI 10.1126/science.1063279; Wielenga VJM, 1999, AM J PATHOL, V154, P515, DOI 10.1016/S0002-9440(10)65297-2; Wong K, 2002, CURR OPIN GENET DEV, V12, P583, DOI 10.1016/S0959-437X(02)00343-X; Xian J, 2001, P NATL ACAD SCI USA, V98, P15062, DOI 10.1073/pnas.251407098; Yuan WL, 1999, DEV BIOL, V212, P290, DOI 10.1006/dbio.1999.9371; Zlotnik A, 2006, INT J CANCER, V119, P2026, DOI 10.1002/ijc.22024	63	87	93	0	4	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	SEP 26	2008	283	39					26624	26633		10.1074/jbc.M800679200	http://dx.doi.org/10.1074/jbc.M800679200			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	350GV	18611862	hybrid, Green Published			2022-12-27	WOS:000259341600038
J	Jing, XF; Zhao, DM; Waldschmidt, TJ; Xue, HH				Jing, Xuefang; Zhao, Dong-Mei; Waldschmidt, Thomas J.; Xue, Hai-Hui			GABP beta 2 is dispensible for normal lymphocyte development but moderately affects B cell responses	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							GA-BINDING-PROTEIN; TRANSCRIPTION FACTOR GABP; TOLL-LIKE RECEPTORS; GENE-EXPRESSION; NEUROMUSCULAR-JUNCTION; GERMINAL CENTER; T-CELLS; ALPHA; PROMOTER; COMPLEX	GA-binding protein (GABP) is the only Ets family transcription factor that functions as a heterodimer. The GABP alpha subunit binds to DNA, and the GABP beta subunit possesses the ability to transactivate target genes. Inactivation of GABP alpha caused embryonic lethality and defective lymphocyte development and immune responses. There are 3 isoforms of the GABP beta subunit, but whether they have distinct functions has not been addressed. In this study, we selectively ablated the expression of GABP beta 2 using a gene trap strategy. GABP beta 2-deficient mice were viable and had normal T and B cell development, suggesting that loss of GABP beta 2 is compensated for by other GABP beta isoforms during these processes. GABP beta 2-deficient T cells can be activated and proliferate similarly to wild-type controls. In contrast, B cells lacking GABP beta 2 showed 2-3-fold increases in proliferation in response to B cell receptor stimulation. In addition, GABP beta 2-deficient mice exhibited moderately increased antibody production and germinal center responses when challenged with T-dependent antigens. These results indicate that albeit GABP beta isoforms are redundant in lymphocyte development, GABP beta 2 has a distinct role in restraining B cell expansion and humoral responses.	[Waldschmidt, Thomas J.] Univ Iowa, Carver Coll Med, Dept Pathol, Iowa City, IA 52242 USA; [Jing, Xuefang; Zhao, Dong-Mei; Xue, Hai-Hui] Univ Iowa, Carver Coll Med, Dept Microbiol, Iowa City, IA 52242 USA	University of Iowa; University of Iowa	Xue, HH (corresponding author), 51 Newton Rd BSB 3-710, Iowa City, IA 52246 USA.	hai-huixue@uiowa.edu		Waldschmidt, Thomas/0000-0001-6147-6991; Xue, Hai-Hui/0000-0002-9163-7669				Avots A, 1997, MOL CELL BIOL, V17, P4381, DOI 10.1128/MCB.17.8.4381; Bannert N, 1999, P NATL ACAD SCI USA, V96, P1541, DOI 10.1073/pnas.96.4.1541; Batchelor AH, 1998, SCIENCE, V279, P1037, DOI 10.1126/science.279.5353.1037; Bernasconi NL, 2003, BLOOD, V101, P4500, DOI 10.1182/blood-2002-11-3569; BROWN TA, 1992, GENE DEV, V6, P2502, DOI 10.1101/gad.6.12b.2502; Camacho SA, 1998, IMMUNOL TODAY, V19, P511, DOI 10.1016/S0167-5699(98)01327-9; de Vinuesa CG, 1999, EUR J IMMUNOL, V29, P1314; DeKoter RP, 2007, J BIOL CHEM, V282, P14194, DOI 10.1074/jbc.M700377200; DELABROUSSE FC, 1994, GENE DEV, V8, P1853, DOI 10.1101/gad.8.15.1853; Gallant S, 2006, ARCH IMMUNOL THER EX, V54, P149, DOI 10.1007/s00005-006-0017-z; Hardy RR, 2001, ANNU REV IMMUNOL, V19, P595, DOI 10.1146/annurev.immunol.19.1.595; Hauck L, 2002, MOL CELL BIOL, V22, P2147, DOI 10.1128/MCB.22.7.2147-2158.2002; Iwasaki A, 2004, NAT IMMUNOL, V5, P987, DOI 10.1038/ni1112; Li XR, 1999, J BIOL CHEM, V274, P35203, DOI 10.1074/jbc.274.49.35203; Loder F, 1999, J EXP MED, V190, P75, DOI 10.1084/jem.190.1.75; Niiro H, 2002, NAT REV IMMUNOL, V2, P945, DOI 10.1038/nri955; O'Leary DA, 2007, MOL CELL BIOL, V27, P3470, DOI 10.1128/MCB.00659-06; Ravel-Chapuis A, 2007, EMBO J, V26, P1117, DOI 10.1038/sj.emboj.7601572; Ristevski S, 2004, MOL CELL BIOL, V24, P5844, DOI 10.1128/MCB.24.13.5844-5849.2004; Rosmarin  AG, 2004, BLOOD CELL MOL DIS, V32, P143, DOI 10.1016/j.bcmd.2003.09.005; Rothenberg EV, 2005, ANNU REV IMMUNOL, V23, P601, DOI 10.1146/annurev.immunol.23.021704.115737; SAWADA J, 1994, EMBO J, V13, P1396, DOI 10.1002/j.1460-2075.1994.tb06393.x; Sharrocks AD, 2001, NAT REV MOL CELL BIO, V2, P827, DOI 10.1038/35099076; Shiio Y, 1996, ONCOGENE, V12, P1837; Shinall SM, 2000, J IMMUNOL, V164, P5729, DOI 10.4049/jimmunol.164.11.5729; Sowa Y, 1997, CANCER RES, V57, P3145; Suzuki F, 1998, J BIOL CHEM, V273, P29302, DOI 10.1074/jbc.273.45.29302; Takeda K, 2003, ANNU REV IMMUNOL, V21, P335, DOI 10.1146/annurev.immunol.21.120601.141126; THOMPSON CC, 1991, SCIENCE, V253, P762, DOI 10.1126/science.1876833; Xue HH, 2008, MOL CELL BIOL, V28, P4300, DOI 10.1128/MCB.01855-07; Xue HH, 2007, IMMUNITY, V26, P421, DOI 10.1016/j.immuni.2007.03.010; Xue HH, 2004, NAT IMMUNOL, V5, P1036, DOI 10.1038/ni1117; Xue HH, 2002, INT IMMUNOL, V14, P1263, DOI 10.1093/intimm/dxf101; Yang ZF, 2007, NAT CELL BIOL, V9, P339, DOI 10.1038/ncb1548	34	9	9	0	0	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	SEP 5	2008	283	36					24326	24333		10.1074/jbc.M804487200	http://dx.doi.org/10.1074/jbc.M804487200			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	342YR	18628204	hybrid, Green Published			2022-12-27	WOS:000258820000007
J	Rossi, MJ; Mazin, AV				Rossi, Matthew J.; Mazin, Alexander V.			Rad51 protein stimulates the branch migration activity of Rad54 protein	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							RECOMBINATION FACTORS RAD51; DNA STRAND EXCHANGE; HOMOLOGOUS RECOMBINATION; NUCLEOPROTEIN FILAMENT; ATPASE ACTIVITY; RAD51-DSDNA FILAMENT; HOLLIDAY JUNCTIONS; CHROMATIN; YEAST; BINDING	The Rad51 and Rad54 proteins play important roles during homologous recombination in eukaryotes. Rad51 forms a nucleoprotein filament on single-stranded DNA and performs the initial steps of double strand break repair. Rad54 belongs to the Swi2/Snf2 family of ATP-dependent DNA translocases. We previously showed that Rad54 promotes branch migration of Holliday junctions. Here we find that human Rad51 (hRad51) significantly stimulates the branch migration activity of hRad54. The stimulation appears to be evolutionarily conserved, as yeast Rad51 also stimulates the branch migration activity of yeast Rad54. We further investigated the mechanism of this stimulation. Our results demonstrate that the stimulation of hRad54-promoted branch migration by hRad51 is driven by specific protein-protein interactions, and the active form of the hRad51 filament is more stimulatory than the inactive one. The current results support the hypothesis that the hRad51 conformation state has a strong effect on interaction with hRad54 and ultimately on the function of hRad54 in homologous recombination.	[Rossi, Matthew J.; Mazin, Alexander V.] Drexel Univ, Coll Med, Dept Biochem & Mol Biol, Philadelphia, PA 19102 USA	Drexel University	Mazin, AV (corresponding author), Drexel Univ, Coll Med, Dept Biochem & Mol Biol, 245 N 15th St,NCB,Rm 10103, Philadelphia, PA 19102 USA.	amazin@drexelmed.edu		Rossi, Matthew/0000-0002-7796-919X	National Institutes of Health [CA100839, MH084119]; Leukemia and Lymphoma Society [1054-09]; NATIONAL CANCER INSTITUTE [R01CA100839, R56CA100839] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF MENTAL HEALTH [R03MH084119] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Leukemia and Lymphoma Society(Leukemia and Lymphoma Society); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH))	This work was supported, in whole or in part, by National Institutes of Health Grants CA100839 and MH084119. This work was also supported by the Leukemia and Lymphoma Society Scholar Award 1054-09 (to A. V. M.). The costs of publication of this article were defrayed in part by the payment of page charges. This article must therefore be hereby marked "advertisement" in accordance with 18 U. S. C. Section 1734 solely to indicate this fact.	Alexeev A, 2003, NAT STRUCT BIOL, V10, P182, DOI 10.1038/nsb901; Alexiadis V, 2004, J BIOL CHEM, V279, P27824, DOI 10.1074/jbc.M402648200; Bugreev DV, 2007, NAT STRUCT MOL BIOL, V14, P746, DOI 10.1038/nsmb1268; Bugreev DV, 2006, NATURE, V442, P590, DOI 10.1038/nature04889; Bugreev DV, 2004, P NATL ACAD SCI USA, V101, P9988, DOI 10.1073/pnas.0402105101; BUGREEV DV, 2006, NAT PROTOCOLS; Busygina V, 2008, GENE DEV, V22, P786, DOI 10.1101/gad.1638708; Chi P, 2006, DNA REPAIR, V5, P381, DOI 10.1016/j.dnarep.2005.11.005; Clever B, 1997, EMBO J, V16, P2535, DOI 10.1093/emboj/16.9.2535; Golub EI, 1997, NUCLEIC ACIDS RES, V25, P4106, DOI 10.1093/nar/25.20.4106; Heyer WD, 2006, NUCLEIC ACIDS RES, V34, P4115, DOI 10.1093/nar/gkl481; Jaskelioff M, 2003, J BIOL CHEM, V278, P9212, DOI 10.1074/jbc.M211545200; Kiianitsa K, 2002, J BIOL CHEM, V277, P46205, DOI 10.1074/jbc.M207967200; Kiianitsa K, 2006, P NATL ACAD SCI USA, V103, P9767, DOI 10.1073/pnas.0604240103; KOWALCZYKOWSKI SC, 1987, J MOL BIOL, V193, P97, DOI 10.1016/0022-2836(87)90630-9; Krogh BO, 2004, ANNU REV GENET, V38, P233, DOI 10.1146/annurev.genet.38.072902.091500; Li X, 2007, NUCLEIC ACIDS RES, V35, P4124, DOI 10.1093/nar/gkm412; Mazin AV, 2000, MOL CELL, V6, P583, DOI 10.1016/S1097-2765(00)00057-5; Mazin AV, 2003, J BIOL CHEM, V278, P14029, DOI 10.1074/jbc.M212779200; Mazina OM, 2007, J BIOL CHEM, V282, P21068, DOI 10.1074/jbc.M701992200; Mazina OM, 2004, J BIOL CHEM, V279, P52042, DOI 10.1074/jbc.M410244200; Murayama Y, 2008, NATURE, V451, P1018, DOI 10.1038/nature06609; Muzzolini L, 2007, PLOS BIOL, V5, P157, DOI 10.1371/journal.pbio.0050020; Paques F, 1999, MICROBIOL MOL BIOL R, V63, P349; Petukhova G, 1998, NATURE, V393, P91, DOI 10.1038/30037; RADDING CM, 1993, CURR BIOL, V3, P358, DOI 10.1016/0960-9822(93)90200-8; Raschle M, 2004, J BIOL CHEM, V279, P51973, DOI 10.1074/jbc.M410101200; Sigurdsson S, 2002, J BIOL CHEM, V277, P42790, DOI 10.1074/jbc.M208004200; Sigurdsson S, 2001, J BIOL CHEM, V276, P8798, DOI 10.1074/jbc.M010011200; Sung P, 2003, J BIOL CHEM, V278, P42729, DOI 10.1074/jbc.R300027200; Tan TLR, 2003, DNA REPAIR, V2, P787, DOI 10.1016/S1568-7864(03)00070-3; Thoma NH, 2005, NAT STRUCT MOL BIOL, V12, P350, DOI 10.1038/nsmb919; Van Komen S, 2000, MOL CELL, V6, P563, DOI 10.1016/S1097-2765(00)00055-1; West SC, 2003, NAT REV MOL CELL BIO, V4, P435, DOI 10.1038/nrm1127; Wyman C, 2004, DNA REPAIR, V3, P827, DOI 10.1016/j.dnarep.2004.03.037; Zhang ZQ, 2007, NAT STRUCT MOL BIOL, V14, P397, DOI 10.1038/nsmb1223	36	19	19	0	3	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	SEP 5	2008	283	36					24698	24706		10.1074/jbc.M800839200	http://dx.doi.org/10.1074/jbc.M800839200			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	342YR	18617519	hybrid, Green Published			2022-12-27	WOS:000258820000039
J	Koyama, T; Nakaoka, Y; Fujio, Y; Hirota, H; Nishida, K; Sugiyama, S; Okamoto, K; Yamauchi-Takihara, K; Yoshimura, M; Mochizuki, S; Hori, M; Hiran, T; Mochizuki, N				Koyama, Tatsuya; Nakaoka, Yoshikazu; Fujio, Yasushi; Hirota, Hisao; Nishida, Keigo; Sugiyama, Shoko; Okamoto, Kitaro; Yamauchi-Takihara, Keiko; Yoshimura, Michihiro; Mochizuki, Seibu; Hori, Masatsugu; Hiran, Toshio; Mochizuki, Naoki			Interaction of scaffolding adaptor protein Gab1 with tyrosine phosphatase SHP2 negatively regulates IGF-I-dependent myogenic differentiation via the ERK1/2 signaling pathway	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ENDOTHELIAL GROWTH-FACTOR; PHOSPHATIDYLINOSITOL 3-KINASE; DOCKING PROTEIN; C-MET; ACTIVATION; KINASE; CYTOKINE; EGF; BINDING; PROLIFERATION	Grb2-associated binder 1 (Gab1) coordinates various receptor tyrosine kinase signaling pathways. Although skeletal muscle differentiation is regulated by some growth factors, it remains elusive whether Gab1 coordinates myogenic signals. Here, we examined the molecular mechanism of insulin-like growth factor-I (IGF-I)-mediated myogenic differentiation, focusing on Gab1 and its downstream signaling. Gab1 underwent tyrosine phosphorylation and subsequent complex formation with protein-tyrosine phosphatase SHP2 upon IGF-I stimulation in C2C12 myoblasts. On the other hand, Gab1 constitutively associated with phosphatidylinositol 3-kinase regulatory subunit p85. To delineate the role of Gab1 in IGF-I-dependent signaling, we examined the effect of adenovirus-mediated forced expression of wild-type Gab1 (Gab1(WT)), mutated Gab1 that is unable to bind SHP2 (Gab1(Delta SHP2)), or mutated Gab1 that is unable to bind p85 (Gab1(Delta p85)), on the differentiation of C2C12 myoblasts. IGF-I-induced myogenic differentiation was enhanced in myoblasts overexpressing Gab1(Delta SHP2), but inhibited in those overexpressing either Gab1WT or Gab1(Delta p85). Conversely, IGF-I-induced extracellular signal-regulated kinase 1/2 (ERK1/2) activation was significantly repressed in myoblasts overexpressing Gab1(Delta SHP2) but enhanced in those overexpressing either Gab1WT or Gab1(Delta p85). Furthermore, small interference RNA-mediated Gab1 knockdown enhanced myogenic differentiation. Overexpression of catalytic-inactive SHP2 modulated IGF-I-induced myogenic differentiation and ERK1/2 activation similarly to that of Gab1(Delta SHP2), suggesting that Gab1-SHP2 complex inhibits IGF-I-dependent myogenesis through ERK1/2. Consistently, the blockade of ERK1/2 pathway reversed the inhibitory effect of Gab1(WT) overexpression on myogenic differentiation, and constitutive activation of the ERK1/2 pathway suppressed the enhanced myogenic differentiation by overexpression of Gab1(Delta SHP2). Collectively, these data suggest that the Gab1-SHP2-ERK1/2 signaling pathway comprises an inhibitory axis for IGF-I-dependent myogenic differentiation.	[Nakaoka, Yoshikazu; Hirota, Hisao; Sugiyama, Shoko; Okamoto, Kitaro; Yamauchi-Takihara, Keiko; Hori, Masatsugu] Osaka Univ, Dept Cardiovasc Med, Grad Sch Med, Osaka 5650871, Japan; [Koyama, Tatsuya; Nakaoka, Yoshikazu; Mochizuki, Naoki] Natl Cardiovasc Ctr, Res Inst, Dept Struct Anal, Osaka 5658565, Japan; [Fujio, Yasushi] Osaka Univ, Dept Clin Pharmacol & Pharmacogenom, Grad Sch Pharmaceut Sci, Osaka 5650871, Japan; [Nishida, Keigo; Hiran, Toshio] RIKEN, Res Ctr Allergy & Immunol, Lab Cytokine Signaling, Tsurumi Ku, Yokohama, Kanagawa 2300045, Japan; [Koyama, Tatsuya; Yoshimura, Michihiro; Mochizuki, Seibu] Jikei Univ, Sch Med, Div Cardiol, Dept Internal Med,Minato Ku, Tokyo 1058461, Japan; [Hiran, Toshio] Osaka Univ, Grad Sch Frontier Biosci, Lab Dev Immunol, Osaka 5650871, Japan; [Hiran, Toshio] Osaka Univ, Grad Sch Med, Lab Dev Immunol, Osaka 5650871, Japan	Osaka University; National Cerebral & Cardiovascular Center - Japan; Osaka University; RIKEN; Jikei University; Osaka University; Osaka University	Nakaoka, Y (corresponding author), Osaka Univ, Dept Cardiovasc Med, Grad Sch Med, Osaka 5650871, Japan.	ynakaoka@imed3.med.osaka-u.ac.jp	Fujio, Yasushi/H-3421-2017; Hirano, Toshio/C-8194-2009	Fujio, Yasushi/0000-0003-0828-2930; 	Ministry of Education, Science, Sports and Culture of Japan; Ministry of Health, Labour, and Welfare of Japan; National Institute of Biomedical Innovation; Takeda Medical Research Foundation; Uehara Memorial Foundation; Japan Heart Foundation Young Investigator's Research; Suzuken Memorial Foundation; Astellas Foundation for Research on Metabolic Disorders; Senri Life Science Foundation; Miyata Cardiology Research Promotion Funds	Ministry of Education, Science, Sports and Culture of Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); Ministry of Health, Labour, and Welfare of Japan(Ministry of Health, Labour and Welfare, Japan); National Institute of Biomedical Innovation(National Institute of Biomedical Innovation); Takeda Medical Research Foundation; Uehara Memorial Foundation(Uehara Memorial Foundation); Japan Heart Foundation Young Investigator's Research; Suzuken Memorial Foundation; Astellas Foundation for Research on Metabolic Disorders; Senri Life Science Foundation; Miyata Cardiology Research Promotion Funds	This work was supported by grants from the Ministry of Education, Science, Sports and Culture of Japan (to Y. N., K. Y.- T., and N. M.); the Ministry of Health, Labour, and Welfare of Japan (to N. M.); the Program for the Promotion of Fundamental Studies in Health Sciences of the National Institute of Biomedical Innovation (to N. M.); the Takeda Medical Research Foundation (to N. M.); The Uehara Memorial Foundation (to Y. N.); the Japan Heart Foundation Young Investigator's Research Grant (to Y. N.); the Suzuken Memorial Foundation (to Y. N.); the Astellas Foundation for Research on Metabolic Disorders (to Y. N.); the Senri Life Science Foundation (to Y. N.); and the Miyata Cardiology Research Promotion Funds (to Y. N.). The costs of publication of this article were defrayed in part by the payment of page charges. This article must therefore be hereby marked "advertisement" in accordance with 18 U. S. C. Section 1734 solely to indicate this fact.	BACH LA, 1995, ENDOCRINOLOGY, V136, P5061, DOI 10.1210/en.136.11.5061; Bard-Chapeau EA, 2005, NAT MED, V11, P567, DOI 10.1038/nm1227; BECKER TC, 1994, METHOD CELL BIOL, V43, P161; Bennett AM, 1997, SCIENCE, V278, P1288, DOI 10.1126/science.278.5341.1288; Coolican SA, 1997, J BIOL CHEM, V272, P6653, DOI 10.1074/jbc.272.10.6653; Cunnick JM, 2000, J BIOL CHEM, V275, P13842, DOI 10.1074/jbc.275.18.13842; Cunnick JM, 2002, J BIOL CHEM, V277, P9498, DOI 10.1074/jbc.M110547200; Cunnick JM, 2001, J BIOL CHEM, V276, P24380, DOI 10.1074/jbc.M010275200; Dance M, 2006, J BIOL CHEM, V281, P23285, DOI 10.1074/jbc.M600987200; de Alvaro C, 2005, MOL BIOL CELL, V16, P4454, DOI 10.1091/mbc.E05-05-0419; Deng XB, 2003, J BIOL CHEM, V278, P41347, DOI 10.1074/jbc.M306780200; EWTON DZ, 1994, J CELL PHYSIOL, V161, P277, DOI 10.1002/jcp.1041610212; Florini JR, 1996, ENDOCR REV, V17, P481, DOI 10.1210/edrv-17-5-481; Gu HH, 2003, TRENDS CELL BIOL, V13, P122, DOI 10.1016/S0962-8924(03)00002-3; HolgadoMadruga M, 1996, NATURE, V379, P560, DOI 10.1038/379560a0; Itoh M, 2000, MOL CELL BIOL, V20, P3695, DOI 10.1128/MCB.20.10.3695-3704.2000; Jiang BH, 2000, P NATL ACAD SCI USA, V97, P1749, DOI 10.1073/pnas.040560897; Jiang BH, 1999, P NATL ACAD SCI USA, V96, P2077, DOI 10.1073/pnas.96.5.2077; Jiang BH, 1998, P NATL ACAD SCI USA, V95, P14179, DOI 10.1073/pnas.95.24.14179; Jin ZG, 2005, J BIOL CHEM, V280, P12305, DOI 10.1074/jbc.M500294200; Kaliman P, 1998, MOL ENDOCRINOL, V12, P66, DOI 10.1210/mend.12.1.0047; Kaliman P, 1996, J BIOL CHEM, V271, P19146, DOI 10.1074/jbc.271.32.19146; Kontaridis MI, 2002, MOL CELL BIOL, V22, P3875, DOI 10.1128/MCB.22.11.3875-3891.2002; Kontaridis MI, 2001, J CELL SCI, V114, P2187; Laramee M, 2007, J BIOL CHEM, V282, P7758, DOI 10.1074/jbc.M611327200; Mattoon DR, 2004, BMC BIOL, V2, DOI 10.1186/1741-7007-2-24; Meng SS, 2005, BIOCHEM J, V391, P143, DOI 10.1042/BJ20050229; Montagner A, 2005, J BIOL CHEM, V280, P5350, DOI 10.1074/jbc.M410012200; Nakaoka Y, 2003, CIRC RES, V93, P221, DOI 10.1161/01.RES.0000085562.48906.4A; Nakaoka Y, 2007, J CLIN INVEST, V117, P1771, DOI 10.1172/JCI30651; Neel BG, 2003, TRENDS BIOCHEM SCI, V28, P284, DOI 10.1016/S0968-0004(03)00091-4; Nishida K, 2003, CANCER SCI, V94, P1029, DOI 10.1111/j.1349-7006.2003.tb01396.x; Nishida K, 1999, BLOOD, V93, P1809, DOI 10.1182/blood.V93.6.1809.406k35_1809_1816; Rodrigues GA, 2000, MOL CELL BIOL, V20, P1448, DOI 10.1128/MCB.20.4.1448-1459.2000; Sachs M, 2000, J CELL BIOL, V150, P1375, DOI 10.1083/jcb.150.6.1375; Sarbassov DD, 1998, MOL ENDOCRINOL, V12, P1870, DOI 10.1210/me.12.12.1870; Schaeper U, 2000, J CELL BIOL, V149, P1419, DOI 10.1083/jcb.149.7.1419; Schaeper U, 2007, P NATL ACAD SCI USA, V104, P15376, DOI 10.1073/pnas.0702555104; Shi ZQ, 2000, MOL CELL BIOL, V20, P1526, DOI 10.1128/MCB.20.5.1526-1536.2000; Shi ZQ, 1998, J BIOL CHEM, V273, P4904, DOI 10.1074/jbc.273.9.4904; Takahashi-Tezuka M, 1998, MOL CELL BIOL, V18, P4109, DOI 10.1128/MCB.18.7.4109; Tiganis T, 2007, BIOCHEM J, V402, P1, DOI 10.1042/BJ20061548; Tortorella LL, 2001, J BIOL CHEM, V276, P13709, DOI 10.1074/jbc.M100091200; Ueyama T, 2000, J MOL CELL CARDIOL, V32, P947, DOI 10.1006/jmcc.2000.1135; Weidner KM, 1996, NATURE, V384, P173, DOI 10.1038/384173a0; White MF, 2003, SCIENCE, V302, P1710, DOI 10.1126/science.1092952; Yamasaki S, 2003, ONCOGENE, V22, P1546, DOI 10.1038/sj.onc.1206284; Yamasaki S, 2001, J BIOL CHEM, V276, P45175, DOI 10.1074/jbc.M105384200; Zhang SQ, 2002, MOL CELL BIOL, V22, P4062, DOI 10.1128/MCB.22.12.4062-4072.2002; Zito CI, 2004, J CELL PHYSIOL, V199, P227, DOI 10.1002/jcp.10446	50	22	23	0	0	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	AUG 29	2008	283	35					24234	24244		10.1074/jbc.M803907200	http://dx.doi.org/10.1074/jbc.M803907200			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	340II	18577518	Green Published, hybrid			2022-12-27	WOS:000258638900077
J	Yuan, BF; Wang, YS				Yuan, Bifeng; Wang, Yinsheng			Mutagenic and cytotoxic properties of 6-thioguanine, S-6-methylthioguanine, and guanine-S-6-sulfonic acid	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ACUTE LYMPHOBLASTIC-LEUKEMIA; ESCHERICHIA-COLI; MISMATCH REPAIR; DNA-POLYMERASES; IN-VIVO; ORGAN-TRANSPLANTATION; SKIN-CANCER; UVA LIGHT; REPLICATION; METHYLATION	Thiopurine drugs, including 6- thioguanine ( SG), 6- mercaptopurine, and azathioprine, are widely employed anticancer agents and immunosuppressants. The formation of SG nucleotides from the thiopurine prodrugs and their subsequent incorporation into nucleic acids are important for the drugs to exert their cytotoxic effects. SG in DNA can be methylated by S- adenosylL- methionine to give S6- methylthioguanine ( S6mG) and oxidized by UVA light to render guanine- S6- sulfonic acid ( SO3HG). Here, we constructed single- stranded M13 shuttle vectors carrying a SG, S6mG, or SO3HG at a unique site and allowed the vectors to propagate in wild- type and bypass polymerasedeficient Escherichia coli cells. Analysis of the replication products by using the competitive replication and adduct bypass and a slightly modified restriction enzyme digestion and post- labeling assays revealed that, although none of the three thionucleosides considerably blocked DNA replication in all transfected E. coli cells, both S6mG and SO3HG were highly mutagenic, which resulted in G3A mutation at frequencies of 94 and 77%, respectively, in wild- type E. coli cells. Deficiency in bypass polymerases does not result in alteration of mutation frequencies of these two lesions. In contrast to what was found from previous steady- state kinetic analysis, our data demonstrated that 6- thioguanine is mutagenic, with G3A transition occurring at a frequency of similar to 10%. The mutagenic properties of 6- thioguanine and its derivatives revealed in the present study offered important knowledge about the biological implications of these thionucleosides.	[Yuan, Bifeng; Wang, Yinsheng] Univ Calif Riverside, Dept Chem, Riverside, CA 92521 USA	University of California System; University of California Riverside	Wang, YS (corresponding author), Univ Calif Riverside, Dept Chem 027, Riverside, CA 92521 USA.	yinsheng.wang@ucr.edu	Yuan, Bi-Feng/K-5803-2013	Yuan, Bi-Feng/0000-0001-5223-4659	NATIONAL CANCER INSTITUTE [R01CA101864] Funding Source: NIH RePORTER; NCI NIH HHS [R01 CA 101864] Funding Source: Medline	NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))		Apffel A, 1997, ANAL CHEM, V69, P1320, DOI 10.1021/ac960916h; AQUILINA G, 1989, CARCINOGENESIS, V10, P1219, DOI 10.1093/carcin/10.7.1219; Delaney JC, 2006, METHOD ENZYMOL, V408, P1, DOI 10.1016/S0076-6879(06)08001-3; Delaney JC, 1999, CHEM BIOL, V6, P743, DOI 10.1016/S1074-5521(00)80021-6; Delaney JC, 2004, P NATL ACAD SCI USA, V101, P14051, DOI 10.1073/pnas.0403489101; ELION GB, 1989, SCIENCE, V244, P41, DOI 10.1126/science.2649979; Euvrard S, 2003, NEW ENGL J MED, V348, P1681, DOI 10.1056/NEJMra022137; GREEN MHL, 1989, CARCINOGENESIS, V10, P893, DOI 10.1093/carcin/10.5.893; GRIFFIN S, 1994, BIOCHEMISTRY-US, V33, P4787, DOI 10.1021/bi00182a006; Gu CN, 2007, NUCLEIC ACIDS RES, V35, P3693, DOI 10.1093/nar/gkm247; Gunnarsdottir S, 2003, DRUG METAB DISPOS, V31, P718, DOI 10.1124/dmd.31.6.718; Hong HZ, 2007, NUCLEIC ACIDS RES, V35, P7118, DOI 10.1093/nar/gkm851; Jarosz DF, 2007, TRENDS MICROBIOL, V15, P70, DOI 10.1016/j.tim.2006.12.004; JONES M, 1981, MOL GEN GENET, V184, P562, DOI 10.1007/BF00352542; KARRAN P, 1994, BIOESSAYS, V16, P833, DOI 10.1002/bies.950161110; Kroplin T, 2000, EUR J CLIN PHARMACOL, V56, P343, DOI 10.1007/s002280000137; Krynetski EY, 2001, MOL PHARMACOL, V59, P367, DOI 10.1124/mol.59.2.367; LENNARD L, 1992, EUR J CLIN PHARMACOL, V43, P329, DOI 10.1007/BF02220605; LEPAGE GA, 1963, CANCER RES, V23, P1202; Lindelof B, 2000, BRIT J DERMATOL, V143, P513, DOI 10.1046/j.1365-2133.2000.03703.x; Maga G, 2007, NATURE, V447, P606, DOI 10.1038/nature05843; O'Donovan P, 2005, SCIENCE, V309, P1871, DOI 10.1126/science.1114233; PENN I, 1994, CANCER DETECT PREV, V18, P241; PODOLSKY DK, 1991, NEW ENGL J MED, V325, P928, DOI 10.1056/NEJM199109263251306; PRESENT DH, 1980, NEW ENGL J MED, V302, P981, DOI 10.1056/NEJM198005013021801; Pui CH, 1998, NEW ENGL J MED, V339, P605, DOI 10.1056/NEJM199808273390907; Pui CH, 2007, NAT REV DRUG DISCOV, V6, P149, DOI 10.1038/nrd2240; Ramsay HM, 2002, BRIT J DERMATOL, V147, P950, DOI 10.1046/j.1365-2133.2002.04976.x; RAPPAPORT HP, 1993, BIOCHEMISTRY-US, V32, P3047, DOI 10.1021/bi00063a016; Spratt TE, 1997, NUCLEIC ACIDS RES, V25, P3354, DOI 10.1093/nar/25.16.3354; Sutton MD, 2001, P NATL ACAD SCI USA, V98, P8342, DOI 10.1073/pnas.111036998; Swann PF, 1996, SCIENCE, V273, P1109, DOI 10.1126/science.273.5278.1109; Waters TR, 1997, BIOCHEMISTRY-US, V36, P2501, DOI 10.1021/bi9621573; Xu YZ, 1996, TETRAHEDRON, V52, P10737, DOI 10.1016/0040-4020(96)00596-0; Yuan BF, 2008, P NATL ACAD SCI USA, V105, P8679, DOI 10.1073/pnas.0711546105; Zhang XH, 2007, DNA REPAIR, V6, P344, DOI 10.1016/j.dnarep.2006.11.003	36	34	34	0	12	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	AUG 29	2008	283	35					23665	23670		10.1074/jbc.M804047200	http://dx.doi.org/10.1074/jbc.M804047200			6	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	340II	18591241	Green Published, hybrid			2022-12-27	WOS:000258638900019
J	Crawford, DK; Perkins, DI; Trudell, JR; Bertaccini, EJ; Davies, DL; Alkana, RL				Crawford, Daniel K.; Perkins, Daya I.; Trudell, James R.; Bertaccini, Edward J.; Davies, Daryl L.; Alkana, Ronald L.			Roles for Loop 2 residues of alpha 1 glycine receptors in agonist activation	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							GATED ION-CHANNEL; NICOTINIC ACETYLCHOLINE-RECEPTOR; SIGNATURE DISULFIDE LOOP; EXTRACELLULAR DOMAIN; CRYSTAL-STRUCTURE; CHARGED RESIDUES; LIGAND-BINDING; A RECEPTOR; SUBUNIT; GABA(A)	The present study tested the hypothesis that several residues in Loop 2 of alpha 1 glycine receptors (GlyRs) play important roles in mediating the transduction of agonist activation to channel gating. This was accomplished by investigating the effect of cysteine point mutations at positions 50 - 60 on glycine responses in alpha 1GlyRs using two-electrode voltage clamp of Xenopus oocytes. Cysteine substitutions produced position-specific changes in glycine sensitivity that were consistent with a beta-turn structure of Loop 2, with odd-numbered residues in the beta-turn interacting with other agonist-activation elements at the interface between extracellular and transmembrane domains. We also tested the hypothesis that the charge at position 53 is important for agonist activation by measuring the glycine response of wild type (WT) and E53C GlyRs exposed to methanethiosulfonate reagents. As earlier, E53C GlyRs have a significantly higher EC50 thanWTGlyRs. Exposing E53C GlyRs to the negatively charged 2-sulfonatoethyl methanethiosulfonate, but not neutral 2-hydroxyethyl methanethiosulfonate, positively charged 2-aminoethyl methanethiosulfonate, or 2-trimethyl-ammonioethyl methanethiosulfonate, decreased the glycine EC50 to resemble WT GlyR responses. Exposure to these reagents did not significantly alter the glycine EC50 for WT GlyRs. The latter findings suggest that the negative charge at position 53 is important for activation of GlyRs through its interaction with positive charge(s) in other neighboring agonist activation elements. Collectively, the findings provide the basis for a refined molecular model of alpha 1GlyRs based on the recent x-ray structure of a prokaryotic pentameric ligand-gated ion channel and offer insight into the structure-function relationships in GlyRs and possibly other ligand-gated ion channels.	[Davies, Daryl L.] Univ So Calif, Sch Pharm, Alcohol & Brain Res Lab, Dept Pharmacol & Pharmaceut Sci, Los Angeles, CA 90089 USA; [Crawford, Daniel K.; Alkana, Ronald L.] Univ So Calif, Grad Program Neurosci, Los Angeles, CA 90089 USA; [Trudell, James R.; Bertaccini, Edward J.] Stanford Sch Med, Dept Anesthesia, Stanford, CA 94305 USA; [Trudell, James R.; Bertaccini, Edward J.] Stanford Sch Med, Beckman Program Mol & Genet Med, Stanford, CA 94305 USA; [Bertaccini, Edward J.] Palo Alto Vet Affairs Hlth Care Syst, Dept Anesthesia, Palo Alto, CA 94304 USA	University of Southern California; University of Southern California; Stanford University; Stanford University	Davies, DL (corresponding author), Univ So Calif, Sch Pharm, Alcohol & Brain Res Lab, Dept Pharmacol & Pharmaceut Sci, 1985 Zonal Ave PSC 500, Los Angeles, CA 90089 USA.	ddavies@usc.edu	Davies, Daryl L/P-1137-2016	Davies, Daryl L/0000-0003-2940-7739; Crawford, Daniel/0000-0002-0169-8645; Bertaccini, Edward/0000-0002-9062-0566	National Institutes of Health, NIAAA [AA03972, AA013890, AA013922, AA013378]; University of Southern California School of Pharmacy; NATIONAL INSTITUTE ON ALCOHOL ABUSE AND ALCOHOLISM [R01AA013922, R01AA003972, R01AA013378, R21AA013890] Funding Source: NIH RePORTER	National Institutes of Health, NIAAA(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Alcohol Abuse & Alcoholism (NIAAA)); University of Southern California School of Pharmacy; NATIONAL INSTITUTE ON ALCOHOL ABUSE AND ALCOHOLISM(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Alcohol Abuse & Alcoholism (NIAAA))	This work was supported, in whole or in part, by National Institutes of Health, NIAAA, Grants AA03972 (to R. L. A.), AA013890 (to D. L. D.), AA013922 (to D. L. D.), and AA013378 (to J. R. T.) and the University of Southern California School of Pharmacy. This work was conducted as partial fulfillment of the requirements for the Ph. D. degree in Neuroscience, University of Southern California (D. K. C.). Portions of these findings were presented at the Annual Meeting of the Society for Neuroscience in Atlanta, GA (Program 233.7/D32, 2006 Neuroscience Meeting Planner, Atlanta, GA, Society for Neuroscience). The costs of publication of this article were defrayed in part by the payment of page charges. This article must therefore be hereby marked "advertisement" in accordance with 18 U. S. C. Section 1734 solely to indicate this fact.	Absalom NL, 2003, J BIOL CHEM, V278, P50151, DOI 10.1074/jbc.M305357200; AKABAS MH, 1992, SCIENCE, V258, P307, DOI 10.1126/science.1384130; Asgary MP, 2007, BIOINFORMATICS, V23, P3125, DOI 10.1093/bioinformatics/btm324; Bertaccini E, 2002, PROTEIN ENG, V15, P443, DOI 10.1093/protein/15.6.443; Bocquet N, 2007, NATURE, V445, P116, DOI 10.1038/nature05371; Brejc K, 2001, NATURE, V411, P269, DOI 10.1038/35077011; Castaldo P, 2004, J BIOL CHEM, V279, P25598, DOI 10.1074/jbc.M311021200; Chakrapani S, 2004, J GEN PHYSIOL, V123, P341, DOI 10.1085/jgp.200309004; Chen ZW, 2005, MOL PHARMACOL, V68, P152, DOI 10.1124/mol.104.009878; Crawford DK, 2007, J NEUROCHEM, V102, P2097, DOI 10.1111/j.1471-4159.2007.04680.x; Davies DL, 2004, J NEUROCHEM, V89, P1175, DOI 10.1111/j.1471-4159.2004.02390.x; Davies DL, 2003, ALCOHOL CLIN EXP RES, V27, P743, DOI 10.1097/01.ALC.0000065722.31109.A1; Dellisanti CD, 2007, NAT NEUROSCI, V10, P953, DOI 10.1038/nn1942; Hales TG, 2006, J BIOL CHEM, V281, P17034, DOI 10.1074/jbc.M603599200; Hilf RJC, 2008, NATURE, V452, P375, DOI 10.1038/nature06717; HUTCHINSON EG, 1994, PROTEIN SCI, V3, P2207, DOI 10.1002/pro.5560031206; Kash TL, 2004, NEUROSCI LETT, V371, P230, DOI 10.1016/j.neulet.2004.09.002; Kash TL, 2003, NATURE, V421, P272, DOI 10.1038/nature01280; Keramidas A, 2000, BIOPHYS J, V79, P247, DOI 10.1016/S0006-3495(00)76287-4; Lynch JW, 2004, PHYSIOL REV, V84, P1051, DOI 10.1152/physrev.00042.2003; Mascia MP, 1996, BRIT J PHARMACOL, V119, P1331, DOI 10.1111/j.1476-5381.1996.tb16042.x; Mascia MP, 1996, MOL PHARMACOL, V50, P402; McLaughlin JT, 2007, MOL PHARMACOL, V71, P1312, DOI 10.1124/mol.106.033092; Mercado J, 2006, J NEUROSCI, V26, P2031, DOI 10.1523/JNEUROSCI.4555-05.2006; Miller PS, 2004, BRIT J PHARMACOL, V143, P19, DOI 10.1038/sj.bjp.0705875; O'Mara M, 2005, BIOPHYS J, V88, P3286, DOI 10.1529/biophysj.104.051664; O'Mara M, 2003, P NATL ACAD SCI USA, V100, P4310, DOI 10.1073/pnas.0630652100; Ortells MO, 1997, PROTEIN ENG, V10, P511, DOI 10.1093/protein/10.5.511; ORTELLS MO, 1995, TRENDS NEUROSCI, V18, P121, DOI 10.1016/0166-2236(95)93887-4; Price KL, 2007, J BIOL CHEM, V282, P25623, DOI 10.1074/jbc.M702524200; Rajendra S, 1997, PHARMACOL THERAPEUT, V73, P121, DOI 10.1016/S0163-7258(96)00163-5; Reeves DC, 2005, J NEUROSCI, V25, P9358, DOI 10.1523/JNEUROSCI.1045-05.2005; RYAN SG, 1994, NAT GENET, V7, P131, DOI 10.1038/ng0694-131; Sala F, 2005, J BIOL CHEM, V280, P6642, DOI 10.1074/jbc.M411048200; SAUL B, 1994, FEBS LETT, V350, P71, DOI 10.1016/0014-5793(94)00736-5; Schofield CM, 2004, BIOCHEMISTRY-US, V43, P10058, DOI 10.1021/bi036159g; Schofield CM, 2003, J BIOL CHEM, V278, P34079, DOI 10.1074/jbc.M302416200; Sine SM, 2006, NATURE, V440, P448, DOI 10.1038/nature04708; Tang P, 2002, BIOPHYS J, V83, P252, DOI 10.1016/S0006-3495(02)75166-7; THEUSCH CM, 2005, SOC NEUR ABSTR; Trudell JR, 2004, J MOL GRAPH MODEL, V23, P39, DOI 10.1016/j.jmgm.2004.03.004; Trudell JR, 2002, BBA-BIOMEMBRANES, V1565, P91, DOI 10.1016/S0005-2736(02)00512-6; Unwin N, 2005, J MOL BIOL, V346, P967, DOI 10.1016/j.jmb.2004.12.031; Wang J, 2007, J BIOL CHEM, V282, P26210, DOI 10.1074/jbc.M702314200; Wilson GG, 2000, J GEN PHYSIOL, V115, P93, DOI 10.1085/jgp.115.2.93; Xiu XN, 2005, J BIOL CHEM, V280, P41655, DOI 10.1074/jbc.M508635200; Yoshimura K, 2001, BIOPHYS J, V80, P2198, DOI 10.1016/S0006-3495(01)76192-9	47	18	17	0	2	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	OCT 10	2008	283	41					27698	27706		10.1074/jbc.M802384200	http://dx.doi.org/10.1074/jbc.M802384200			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	355OW	18658152	Green Published, hybrid			2022-12-27	WOS:000259719200041
J	Knight, KK; Wentzlaff, DM; Snyder, PM				Knight, Kristin K.; Wentzlaff, Danielle M.; Snyder, Peter M.			Intracellular sodium regulates proteolytic activation of the epithelial sodium channel	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							NA+ SELF-INHIBITION; FEEDBACK INHIBITION; CYTOSOLIC NA+; FROG-SKIN; RAT CCT; EXPRESSION; TRANSPORT; FURIN; MEMBRANE; CLEAVAGE	Na+ transport across epithelia is mediated in part by the epithelial Na+ channel ENaC. Previous work indicates that Na+ is an important regulator of ENaC, providing a negative feedback mechanism to maintain Na+ homeostasis. ENaC is synthesized as an inactive precursor, which is activated by proteolytic cleavage of the extracellular domains of the alpha and gamma subunits. Here we found that Na+ regulates ENaC in part by altering proteolytic activation of the channel. When the Na+ concentration was low, we found that the majority of ENaC at the cell surface was in the cleaved/active state. As Na+ increased, there was a dose-dependent decrease in ENaC cleavage and, hence, ENaC activity. This Na+ effect was dependent on Na+ permeation; cleavage was increased by the ENaC blocker amiloride and by a mutation that decreases ENaC activity (alpha(H69A)) and was reduced by a mutation that activates ENaC (beta(S520K)). Moreover, the Na+ ionophore monensin reversed the effect of the inactivating mutation (alpha(H69A)) on ENaC cleavage, suggesting that intracellular Na+ regulates cleavage. Na+ did not alter activity of Nedd4-2, an E3 ubiquitin ligase that modulates ENaC cleavage, but Na+ reduced ENaC cleavage by exogenous trypsin. Our findings support a model in which intracellular Na+ regulates cleavage by altering accessibility of ENaC cleavage sites to proteases and provide a molecular explanation for the earlier observation that intracellular Na+ inhibits Na+ transport via ENaC (Na+ feedback inhibition).	[Snyder, Peter M.] Univ Iowa, Dept Internal Med, Roy J & Lucille A Carver Coll Med, Iowa City, IA 52242 USA; Univ Iowa, Dept Mol Physiol & Biophys, Roy J & Lucille A Carver Coll Med, Iowa City, IA 52242 USA	University of Iowa; University of Iowa	Snyder, PM (corresponding author), Univ Iowa, Dept Internal Med, Roy J & Lucille A Carver Coll Med, 371 EMRB, Iowa City, IA 52242 USA.	peter-snyder@uiowa.edu			National Institutes of Health	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA)	This work was supported, in whole or in part, by the National Institutes of Health. The costs of publication of this article were defrayed in part by the payment of page charges. This article must therefore be hereby marked "advertisement" in accordance with 18 U. S. C. Section 1734 solely to indicate this fact.; 1 Supported by the National Institutes of Health.	Abriel H, 1999, J PHYSIOL-LONDON, V516, P31, DOI 10.1111/j.1469-7793.1999.031aa.x; Anantharam A, 2006, J PHYSIOL-LONDON, V574, P333, DOI 10.1113/jphysiol.2006.109173; Awayda MS, 1999, AM J PHYSIOL-CELL PH, V277, pC216, DOI 10.1152/ajpcell.1999.277.2.C216; Bengrine A, 2007, FASEB J, V21, P1189, DOI 10.1096/fj.06-6046com; Bruns JB, 2007, J BIOL CHEM, V282, P6153, DOI 10.1074/jbc.M610636200; Caldwell RA, 2005, AM J PHYSIOL-LUNG C, V288, pL813, DOI 10.1152/ajplung.00435.2004; Caldwell RA, 2004, AM J PHYSIOL-CELL PH, V286, pC190, DOI 10.1152/ajpcell.00342.2003; CANESSA CM, 1994, NATURE, V367, P463, DOI 10.1038/367463a0; CANESSA CM, 1993, NATURE, V361, P467, DOI 10.1038/361467a0; Chraibi A, 2002, J GEN PHYSIOL, V120, P133, DOI 10.1085/jgp.20028612; Dinudom A, 1998, P NATL ACAD SCI USA, V95, P7169, DOI 10.1073/pnas.95.12.7169; FRINDT G, 1993, AM J PHYSIOL, V264, pF565, DOI 10.1152/ajprenal.1993.264.3.F565; Garty H, 1997, PHYSIOL REV, V77, P359, DOI 10.1152/physrev.1997.77.2.359; Grunder S, 1999, PFLUG ARCH EUR J PHY, V438, P709, DOI 10.1007/s004240051097; HARVEY BJ, 1988, J GEN PHYSIOL, V92, P767, DOI 10.1085/jgp.92.6.767; Hughey RP, 2004, J BIOL CHEM, V279, P48491, DOI 10.1074/jbc.C400460200; Hughey RP, 2004, J BIOL CHEM, V279, P18111, DOI 10.1074/jbc.C400080200; Kabra R, 2008, J BIOL CHEM, V283, P6033, DOI 10.1074/jbc.M708555200; Kellenberger S, 1998, J CLIN INVEST, V101, P2741, DOI 10.1172/JCI2837; Knight KK, 2006, P NATL ACAD SCI USA, V103, P2805, DOI 10.1073/pnas.0511184103; Komwatana P, 1996, P NATL ACAD SCI USA, V93, P8107, DOI 10.1073/pnas.93.15.8107; Lifton RP, 1996, SCIENCE, V272, P676, DOI 10.1126/science.272.5262.676; MACROBBIE E, 1961, ACTA PHYSIOL SCAND, V53, P348, DOI 10.1111/j.1748-1716.1961.tb02293.x; MCDONALD FJ, 1994, AM J PHYSIOL, V266, pL728, DOI 10.1152/ajplung.1994.266.6.L728; MCDONALD FJ, 1995, AM J PHYSIOL-CELL PH, V268, pC1157, DOI 10.1152/ajpcell.1995.268.5.C1157; PALMER LG, 1986, AM J PHYSIOL, V250, pF273, DOI 10.1152/ajprenal.1986.250.2.F273; Pineda AO, 2004, J BIOL CHEM, V279, P31842, DOI 10.1074/jbc.M401756200; ROSE BD, 1984, CLIN PHYSL ACID BASE, P125; Schild L, 2004, REV PHYSIOL BIOCH P, V151, P93, DOI 10.1007/s10254-004-0023-7; Sheng S, 2006, AM J PHYSIOL-RENAL, V290, pF1488, DOI 10.1152/ajprenal.00439.2005; Sheng SH, 2004, J BIOL CHEM, V279, P9743, DOI 10.1074/jbc.M311952200; SILVER RB, 1993, AM J PHYSIOL, V264, pF557, DOI 10.1152/ajprenal.1993.264.3.F557; Snyder PM, 2005, ENDOCRINOLOGY, V146, P5079, DOI 10.1210/en.2005-0894; Snyder PM, 2002, J BIOL CHEM, V277, P5, DOI 10.1074/jbc.C100623200; Snyder PM, 2000, J GEN PHYSIOL, V116, P781, DOI 10.1085/jgp.116.6.781; Vallet V, 1997, NATURE, V389, P607, DOI 10.1038/39329	36	35	35	1	7	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	OCT 10	2008	283	41					27477	27482		10.1074/jbc.M804176200	http://dx.doi.org/10.1074/jbc.M804176200			6	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	355OW	18662987	hybrid, Green Published			2022-12-27	WOS:000259719200018
J	Nomachi, A; Nishita, M; Inaba, D; Enomoto, M; Hamasaki, M; Minami, Y				Nomachi, Akira; Nishita, Michiru; Inaba, Daisuke; Enomoto, Masahiro; Hamasaki, Mayumi; Minami, Yasuhiro			Receptor tyrosine kinase Ror2 mediates Wnt5a-induced polarized cell migration by activating c-Jun N-terminal kinase via actin-binding protein filamin A	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							JNK SIGNALING PATHWAY; EXPRESSION; MOTILITY; CDC42; PROLIFERATION; STABILIZATION; DROSOPHILA; MOVEMENTS; EXTENSION; MELANOMA	The receptor tyrosine kinase Ror2 has recently been shown to act as an alternative receptor or coreceptor for Wnt5a and to mediate Wnt5a-induced migration of cultured cells. However, little is known about the molecular mechanism underlying this migratory process. Here we show by wound-healing assays that Ror2 plays critical roles in Wnt5a-induced cell migration by regulating formation of lamellipodia and reorientation of microtubule-organizing center (MTOC). Wnt5a stimulation induces activation of the c-Jun N-terminal kinase JNK at the wound edge in a Ror2-dependent manner, and inhibiting JNK activity abrogates Wnt5a-induced lamellipodia formation and MTOC reorientation. Additionally, the association of Ror2 with the actin-binding protein filamin A is required for Wnt5a-induced JNK activation and polarized cell migration. We further show that Wnt5a-induced JNK activation and MTOC reorientation can be suppressed by inhibiting PKC zeta. Taken together, our findings indicate that Wnt5a/Ror2 activates JNK, through a process involving filamin A and PKC zeta, to regulate polarized cell migration.	[Nomachi, Akira; Nishita, Michiru; Inaba, Daisuke; Enomoto, Masahiro; Hamasaki, Mayumi; Minami, Yasuhiro] Kobe Univ, Dept Physiol & Cell Biol, Grad Sch Med, Chuo Ku, Kobe, Hyogo 6500017, Japan; [Enomoto, Masahiro] Kobe Univ, Dept Pediat, Grad Sch Med, Chuo Ku, Kobe, Hyogo 6500017, Japan	Kobe University; Kobe University	Nishita, M (corresponding author), Kobe Univ, Dept Physiol & Cell Biol, Grad Sch Med, Chuo Ku, 7-5-1 Kusunoki Cho, Kobe, Hyogo 6500017, Japan.	nishita@med.kobe-u.ac.jp; minami@kobe-u.ac.jp			Ministry of Education, Culture, Sports, Science, and Technology, Japan; Uehara Memorial Foundation; Naito Foundation; Hyogo Science and Technology Association; Astellas Foundation for Research on Metabolic Disorders	Ministry of Education, Culture, Sports, Science, and Technology, Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); Uehara Memorial Foundation(Uehara Memorial Foundation); Naito Foundation(Naito Memorial Foundation); Hyogo Science and Technology Association; Astellas Foundation for Research on Metabolic Disorders	This work was supported in part by a Grant-in-Aid for Scientific Research in Priority Areas, a Grant-in-Aid for Scientific Research (B), and a Grant-in-Aid for Young Scientists (B) from the Ministry of Education, Culture, Sports, Science, and Technology, Japan, the Uehara Memorial Foundation, the Naito Foundation, the Hyogo Science and Technology Association, and the Astellas Foundation for Research on Metabolic Disorders. The costs of publication of this article were defrayed in part by the payment of page charges. This article must therefore be hereby marked "advertisement" in accordance with 18 U.S.C. Section 1734 solely to indicate this fact.	Bosch M, 2005, DEV BIOL, V280, P73, DOI 10.1016/j.ydbio.2005.01.002; CUNNINGHAM CC, 1992, SCIENCE, V255, P325, DOI 10.1126/science.1549777; DeChiara TM, 2000, NAT GENET, V24, P271, DOI 10.1038/73488; Etienne-Manneville S, 2001, CELL, V106, P489, DOI 10.1016/S0092-8674(01)00471-8; Forrester WC, 1999, NATURE, V400, P881, DOI 10.1038/23722; Franz CM, 2002, DEV CELL, V2, P153, DOI 10.1016/S1534-5807(02)00120-X; Gundersen GG, 2002, NAT REV MOL CELL BIO, V3, P296, DOI 10.1038/nrm777; Hikasa H, 2002, DEVELOPMENT, V129, P5227; Huang C, 2003, NATURE, V424, P219, DOI 10.1038/nature01745; Jaeschke A, 2006, MOL CELL, V23, P899, DOI 10.1016/j.molcel.2006.07.028; Javelaud D, 2003, J BIOL CHEM, V278, P24624, DOI 10.1074/jbc.M301942200; Kani S, 2004, J BIOL CHEM, V279, P50102, DOI 10.1074/jbc.M409039200; Kodama A, 2004, J CELL BIOL, V167, P203, DOI 10.1083/jcb.200408047; Kurayoshi M, 2006, CANCER RES, V66, P10439, DOI 10.1158/0008-5472.CAN-06-2359; Lallemand D, 1998, EMBO J, V17, P5615, DOI 10.1093/emboj/17.19.5615; Leonardi A, 2000, J BIOL CHEM, V275, P271, DOI 10.1074/jbc.275.1.271; Mammoto A, 2007, J CELL SCI, V120, P456, DOI 10.1242/jcs.03353; Marti A, 1997, J BIOL CHEM, V272, P2620, DOI 10.1074/jbc.272.5.2620; Masckauchan TNH, 2006, MOL BIOL CELL, V17, P5163, DOI 10.1091/mbc.E06-04-0320; Matsubayashi Y, 2004, CURR BIOL, V14, P731, DOI 10.1016/j.cub.2004.03.060; Matsuda T, 2001, MECH DEVELOP, V105, P153, DOI 10.1016/S0925-4773(01)00383-5; Mikels AJ, 2006, PLOS BIOL, V4, P570, DOI 10.1371/journal.pbio.0040115; Nishita M, 2006, J CELL BIOL, V175, P555, DOI 10.1083/jcb.200607127; Oishi I, 2003, GENES CELLS, V8, P645, DOI 10.1046/j.1365-2443.2003.00662.x; Paganoni S, 2005, J CELL SCI, V118, P433, DOI 10.1242/jcs.01622; Palazzo AF, 2001, CURR BIOL, V11, P1536, DOI 10.1016/S0960-9822(01)00475-4; Pollard TD, 2003, CELL, V112, P453, DOI 10.1016/S0092-8674(03)00120-X; Ramet M, 2002, DEV BIOL, V241, P145, DOI 10.1006/dbio.2001.0502; Schambony A, 2007, DEV CELL, V12, P779, DOI 10.1016/j.devcel.2007.02.016; Schlessinger K, 2007, J CELL BIOL, V178, P355, DOI 10.1083/jcb.200701083; Sharma GD, 2003, J BIOL CHEM, V278, P21989, DOI 10.1074/jbc.M302650200; Takada R, 2005, GENES CELLS, V10, P919, DOI 10.1111/j.1365-2443.2005.00889.x; Takeuchi S, 2000, GENES CELLS, V5, P71, DOI 10.1046/j.1365-2443.2000.00300.x; Weeraratna AT, 2002, CANCER CELL, V1, P279, DOI 10.1016/S1535-6108(02)00045-4; Yamamoto S, 2008, DEV CELL, V15, P23, DOI 10.1016/j.devcel.2008.05.007; Yamanaka H, 2002, EMBO REP, V3, P69, DOI 10.1093/embo-reports/kvf008; Yoda A, 2003, J RECEPT SIG TRANSD, V23, P1, DOI 10.1081/RRS-120018757	37	150	156	0	5	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	OCT 10	2008	283	41					27973	27981		10.1074/jbc.M802325200	http://dx.doi.org/10.1074/jbc.M802325200			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	355OW	18667433	hybrid			2022-12-27	WOS:000259719200067
J	Nye, CK; Hanson, RW; Kalhan, SC				Nye, Colleen K.; Hanson, Richard W.; Kalhan, Satish C.			Glyceroneogenesis is the dominant pathway for triglyceride glycerol synthesis in vivo in the rat	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							PHOSPHOENOLPYRUVATE CARBOXYKINASE GTP; RESPONSIVE GLUCOSE-TRANSPORTER; ADIPOSE-TISSUE; SKELETAL-MUSCLE; ACID CYCLE; INSULIN-RESISTANCE; FATTY-ACIDS; TRIACYLGLYCEROL SYNTHESIS; TRITIATED-WATER; CYTOSOLIC FORM	Triglyceride synthesis in mammalian tissues requires glycerol 3-phosphate as the source of triglyceride glycerol. In this study the relative contribution of glyceroneogenesis and glycolysis to triglyceride glycerol synthesis was quantified in vivo in adipose tissue, skeletal muscle, and liver of the rat in response to a chow diet (controls), 48-h fast, and lipogenic (high sucrose) diet. The rate of glyceroneogenesis was quantified using the tritium ([H-3(2)]O) labeling of body water, and the contribution of glucose, via glycolysis, was determined using a [U-C-14] glucose tracer. In epididymal and mesenteric adipose tissue of control rats, glyceroneogenesis accounted for similar to 90% of triglyceride glycerol synthesis. Fasting for 48 h did not alter glyceroneogenesis in adipose tissue, whereas the contribution of glucose was negligible. In response to sucrose feeding, the synthesis of triglyceride glycerol via both glyceroneogenesis and glycolysis nearly doubled (versus controls); however, glyceroneogenesis remained quantitatively higher as compared with the contribution of glucose. Enhancement of triglyceride-fatty acid cycling by epinephrine infusion resulted in a higher rate of glyceroneogenesis in adipose tissue, as compared with controls, whereas the contribution of glucose via glycolysis was not measurable. Glyceroneogenesis provided the majority of triglyceride glycerol in the gastrocnemius and soleus. In the liver the fractional contribution of glyceroneogenesis remained constant (similar to 60%) under all conditions and was higher than that of glucose. Thus, glyceroneogenesis, in contrast to glucose, via glycolysis, is quantitatively the predominant source of triglyceride glycerol in adipose tissue, skeletal muscle, and liver of the rat during fasting and high sucrose feeding.	[Nye, Colleen K.; Hanson, Richard W.] Case Western Reserve Univ, Dept Biochem, Cleveland, OH 44106 USA; [Kalhan, Satish C.] Case Western Reserve Univ, Lerner Coll Med, Cleveland Clin, Dept Med, Cleveland, OH 44106 USA; [Nye, Colleen K.; Hanson, Richard W.; Kalhan, Satish C.] Cleveland Clin, Dept Gastroenterol, Cleveland, OH 44195 USA; [Nye, Colleen K.; Hanson, Richard W.; Kalhan, Satish C.] Cleveland Clin, Dept Pathobiol, Cleveland, OH 44195 USA	Case Western Reserve University; Case Western Reserve University; Cleveland Clinic Foundation; Cleveland Clinic Foundation; Cleveland Clinic Foundation	Kalhan, SC (corresponding author), Lerner Res Inst, Dept Pathobiol, 9500 Euclid Ave,NE40, Cleveland, OH 44195 USA.	satish.kalhan@case.edu		Kalhan, Satish/0000-0002-8012-4171	National Institutes of Health [DK-58620, DK-25541, HD-11089, HD-042154]; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT [R01HD042154, P01HD011089, P50HD011089] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK021859, R37DK021859, R01DK058620, R01DK025541] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	This work was supported, in whole or in part, by National Institutes of Health Grants DK-58620 and DK-25541 (to R. W. H.) and HD-11089 and HD-042154 (to S. C. K.). The costs of publication of this article were defrayed in part by the payment of page charges. This article must therefore be hereby marked "advertisement" in accordance with 18 U. S. C. Section 1734 solely to indicate this fact.	Abel ED, 2001, NATURE, V409, P729, DOI 10.1038/35055575; BALLARD FJ, 1967, BIOCHEM J, V104, P866, DOI 10.1042/bj1040866; BALLARD FJ, 1967, J BIOL CHEM, V242, P2746; BAY U, 1986, MOL CELL ENDOCRINOL, V47, P217, DOI 10.1016/0303-7207(86)90115-2; Bederman IR, 2006, AM J PHYSIOL-ENDOC M, V290, pE1048, DOI 10.1152/ajpendo.00340.2005; BERGE RK, 1983, INT J BIOCHEM, V15, P205, DOI 10.1016/0020-711X(83)90066-6; BERGER J, 1989, NATURE, V340, P70, DOI 10.1038/340070a0; Bonen A, 2006, APPL PHYSIOL NUTR ME, V31, P31, DOI 10.1139/H05-002; Botion LM, 1998, METABOLISM, V47, P1217, DOI 10.1016/S0026-0495(98)90326-2; Burgess SC, 2004, J BIOL CHEM, V279, P48941, DOI 10.1074/jbc.M407120200; Cadoudal T, 2008, M S-MED SCI, V24, P407, DOI 10.1051/medsci/2008244407; Carrasco S, 2004, MOL BIOL CELL, V15, P2932, DOI 10.1091/mbc.E03-11-0844; Chaves VE, 2006, J NUTR, V136, P2475, DOI 10.1093/jn/136.10.2475; Chen JL, 2005, J BIOL CHEM, V280, P25396, DOI 10.1074/jbc.M413948200; DEFRONZO RA, 1981, DIABETES, V30, P1000, DOI 10.2337/diab.30.12.1000; Ezaki O, 1997, BIOCHEM BIOPH RES CO, V241, P1, DOI 10.1006/bbrc.1997.7587; FOLCH J, 1957, J BIOL CHEM, V226, P497; Franckhauser S, 2006, DIABETES, V55, P273, DOI 10.2337/diabetes.55.02.06.db05-0482; Franckhauser S, 2002, DIABETES, V51, P624, DOI 10.2337/diabetes.51.3.624; Franckhauser S, 2007, DIABETES, V56, pA458; FRAYN KN, 1994, AM J PHYSIOL, V266, pE308, DOI 10.1152/ajpendo.1994.266.3.E308; Goodpaster BH, 2001, J CLIN ENDOCR METAB, V86, P5755, DOI 10.1210/jc.86.12.5755; Guo ZK, 1998, J APPL PHYSIOL, V84, P1674, DOI 10.1152/jappl.1998.84.5.1674; Guo ZK, 1999, J BIOL CHEM, V274, P23702, DOI 10.1074/jbc.274.34.23702; Gutmann I, 1974, METHOD ENZYMAT AN, P1464; Hakimi P, 2007, J BIOL CHEM, V282, P32844, DOI 10.1074/jbc.M706127200; Hanson RW, 1997, ANNU REV BIOCHEM, V66, P581, DOI 10.1146/annurev.biochem.66.1.581; HETENYI G, 1982, FED PROC, V41, P104; JAMES DE, 1988, NATURE, V333, P183, DOI 10.1038/333183a0; JANSSON PA, 1994, J CLIN INVEST, V93, P240, DOI 10.1172/JCI116951; Kalhan SC, 2008, METABOLISM, V57, P305, DOI 10.1016/j.metabol.2007.10.003; Kalhan SC, 2001, J BIOL CHEM, V276, P12928, DOI 10.1074/jbc.M006186200; Karbowska J, 2001, METABOLISM, V50, P734, DOI 10.1053/meta.2001.23309; KASHIWAGI A, 1983, J BIOL CHEM, V258, P3685; KATZ J, 1966, J BIOL CHEM, V241, P3600; Kotani K, 2004, J CLIN INVEST, V114, P1666, DOI 10.1172/JCI200421341; Kowalski TJ, 1997, AM J PHYSIOL-ENDOC M, V273, pE613, DOI 10.1152/ajpendo.1997.273.3.E613; Krssak M, 1999, DIABETOLOGIA, V42, P113, DOI 10.1007/s001250051123; Newsholme E A, 1976, Biochem Soc Symp, P61; NEWSHOLME EA, 1969, BIOCHEM J, V112, P465, DOI 10.1042/bj1120465; NEWSHOLME P, 1987, BIOCHEM J, V242, P631, DOI 10.1042/bj2420631; NEWSHOLME P, 1986, BIOCHEM J, V239, P121, DOI 10.1042/bj2390121; Olswang Y, 2002, P NATL ACAD SCI USA, V99, P625, DOI 10.1073/pnas.022616299; Owen OE, 2002, J BIOL CHEM, V277, P30409, DOI 10.1074/jbc.R200006200; POSTLE AD, 1980, BIOCHEM J, V192, P65, DOI 10.1042/bj1920065; REEVES RE, 1941, J AM CHEM SOC, V63, P1476; RESHEF L, 1972, ISRAEL J MED SCI, V8, P372; RESHEF L, 1967, J LIPID RES, V8, P688; Reshef L, 2003, J BIOL CHEM, V278, P30413, DOI 10.1074/jbc.R300017200; ROBINSON J, 1967, BIOCHEM J, V104, P2; ROGNSTAD R, 1974, EUR J BIOCHEM, V47, P383, DOI 10.1111/j.1432-1033.1974.tb03703.x; SCHNEIBLE PA, 1981, J BIOL CHEM, V256, P4888; Schwarz JM, 1995, J CLIN INVEST, V96, P2735, DOI 10.1172/JCI118342; SHRAGO E, 1971, METABOLISM, V20, P54, DOI 10.1016/0026-0495(71)90059-X; Smith SA, 2003, BIOCHIMIE, V85, P1219, DOI 10.1016/j.biochi.2003.10.010; STAINSBY WN, 1984, J APPL PHYSIOL, V57, P321, DOI 10.1152/jappl.1984.57.2.321; STEELE R, 1956, AM J PHYSIOL, V187, P15, DOI 10.1152/ajplegacy.1956.187.1.15; TAGLIAFERRO AR, 1990, INT J OBESITY, V14, P957; Tchkonia T, 2005, AM J PHYSIOL-ENDOC M, V288, pE267, DOI 10.1152/ajpendo.00265.2004; TONTONOZ P, 1995, MOL CELL BIOL, V15, P351, DOI 10.1128/MCB.15.1.351; WIELAND O, 1974, METHOD ENZYMAT AN, P1404; WOLFE RR, 1987, AM J PHYSIOL, V252, pE189, DOI 10.1152/ajpendo.1987.252.2.E189; WOLFE RR, 1987, AM J PHYSIOL, V252, pE218, DOI 10.1152/ajpendo.1987.252.2.E218	63	118	119	0	11	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	OCT 10	2008	283	41					27565	27574		10.1074/jbc.M804393200	http://dx.doi.org/10.1074/jbc.M804393200			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	355OW	18662986	Green Published, hybrid			2022-12-27	WOS:000259719200027
J	Becker, D; Woltersdorf, R; Boldt, W; Schmitz, S; Braam, U; Schmalzing, G; Markwardt, F				Becker, Daniel; Woltersdorf, Ronja; Boldt, Wolfgang; Schmitz, Stephan; Braam, Ursula; Schmalzing, Gurnther; Markwardt, Fritz			The P2X(7) carboxyl tail is a regulatory module of P2X(7) receptor channel activity	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							BLUE NATIVE ELECTROPHORESIS; MEMBRANE-PROTEIN COMPLEXES; C-TERMINAL DOMAIN; NUCLEOTIDE RECEPTOR; FUNCTIONAL EVIDENCE; CYTOLYTIC PORE; GATING RING; K+ CHANNEL; ATP; ACTIVATION	P2X(7) receptors are ATP-gated cation channels composed of three identical subunits, each having intracellular amino and carboxyl termini and two transmembrane segments connected by a large ectodomain. Within the P2X family, P2X(7) subunits are unique in possessing an extended carboxyl tail. We expressed the human P2X(7) subunit as two complementary fragments, a carboxyl tail-truncated receptor channel core ( residues 1-436 or 1-505) and a tail extension ( residues 434-595) in Xenopus laevis oocytes. P2X(7) channel core subunits efficiently assembled as homotrimers that appeared abundantly at the oocyte surface, yet produced only similar to 5% of the full-length P2X(7) receptor current. Co- assembly of channel core subunits with full-length P2X(7) subunits inhibited channel current, indicating that the lack of a single carboxyl tail domain is dominant-negative for P2X(7) receptor activity. Co- expression of the tail extension as a discrete protein increased ATP-gated current amplitudes of P2X(7) channel cores 10-20-fold, fully reconstituting the wild type electrophysiological phenotype of the P2X(7) receptor. Chemical cross-linking revealed that the discrete tail extension bound with unity stoichiometry to the carboxyl tail of the P2X(7) channel core. We conclude that a non-covalent association of crucial functional importance exists between the carboxyl tail of the channel core and the tail extension. Using a slightly shorter P2X(7) subunit core and subfragments of the tail extension, this association could be narrowed down to include residues 409-436 and 434-494 of the split receptor. Together, these results identify the tail extension as a regulatory gating module, potentially making P2X(7) channel gating sensitive to intracellular regulation.	[Becker, Daniel; Boldt, Wolfgang; Markwardt, Fritz] Univ Halle Wittenberg, Julius Bernstein Inst Physiol, D-06097 Halle, Germany; [Woltersdorf, Ronja; Schmitz, Stephan; Braam, Ursula; Schmalzing, Gurnther] Univ Aachen, Rhein Westfal TH Aachen, Dept Mol Pharmacol, D-52074 Aachen, Germany	Martin Luther University Halle Wittenberg; RWTH Aachen University	Schmalzing, G (corresponding author), Univ Halle Wittenberg, Julius Bernstein Inst Physiol, Magdeburger Str 6, D-06097 Halle, Germany.	gschmalzing@ukaachen.de; Fritz.Markwardt@medizin.uni-halle.de	Markwardt, Fritz/F-7693-2013	Markwardt, Fritz/0000-0001-6761-2923	Deutsche Forschungsgemeinschaft [Ma1581/12-1, Schm536/6-3, SFB 542]; Medical Faculty of the Martin-Luther-University Roux Program [5/09, 10/01, 13/07]	Deutsche Forschungsgemeinschaft(German Research Foundation (DFG)); Medical Faculty of the Martin-Luther-University Roux Program	This work was supported by Deutsche Forschungsgemeinschaft Grants Ma1581/12-1 ( to F. M.), Schm536/6-3 and SFB 542 ( to G. S.), and Medical Faculty of the Martin-Luther-University Roux Program Grants 5/09, 10/01, and 13/07 ( to F. M.). The costs of publication of this article were defrayed in part by the payment of page charges. This article must therefore be hereby marked "advertisement" in accordance with 18 U. S. C. Section 1734 solely to indicate this fact.	Aschrafi A, 2004, J MOL BIOL, V342, P333, DOI 10.1016/j.jmb.2004.06.092; Cheewatrakoolpong B, 2005, BIOCHEM BIOPH RES CO, V332, P17, DOI 10.1016/j.bbrc.2005.04.087; Cushman SJ, 2000, NAT STRUCT BIOL, V7, P403; Denlinger LC, 2003, J IMMUNOL, V171, P1304, DOI 10.4049/jimmunol.171.3.1304; Denlinger LC, 2001, J IMMUNOL, V167, P1871, DOI 10.4049/jimmunol.167.4.1871; Duckwitz W, 2006, J BIOL CHEM, V281, P39561, DOI 10.1074/jbc.M606113200; Eickhorst AN, 2002, J GEN PHYSIOL, V120, P119, DOI 10.1085/jgp.20028535; Faria RX, 2005, AM J PHYSIOL-CELL PH, V288, pC260, DOI 10.1152/ajpcell.00215.2004; Feng YH, 2006, J BIOL CHEM, V281, P17228, DOI 10.1074/jbc.M602999200; Ferrari D, 2006, J IMMUNOL, V176, P3877, DOI 10.4049/jimmunol.176.7.3877; Fisher JA, 2004, J NEUROSCI, V24, P10475, DOI 10.1523/JNEUROSCI.3250-04.2004; Fujiwara Y, 2006, J PHYSIOL-LONDON, V576, P135, DOI 10.1113/jphysiol.2006.115246; GLOOR S, 1995, GENE, V160, P213, DOI 10.1016/0378-1119(95)00226-V; HORN R, 1987, BIOPHYS J, V51, P255, DOI 10.1016/S0006-3495(87)83331-3; Hulme JT, 2005, P NATL ACAD SCI USA, V102, P5274, DOI 10.1073/pnas.0409885102; Johnson JP, 2005, P NATL ACAD SCI USA, V102, P2742, DOI 10.1073/pnas.0408323102; Jones DT, 2007, BIOINFORMATICS, V23, P538, DOI 10.1093/bioinformatics/btl677; Khakh BS, 2006, NATURE, V442, P527, DOI 10.1038/nature04886; Kim M, 2001, EMBO J, V20, P6347, DOI 10.1093/emboj/20.22.6347; Klapperstuck M, 2001, J PHYSIOL-LONDON, V534, P25, DOI 10.1111/j.1469-7793.2001.00025.x; Klapperstuck M, 2000, BBA-BIOMEMBRANES, V1467, P444, DOI 10.1016/S0005-2736(00)00245-5; Koshimizu T, 1999, J BIOL CHEM, V274, P37651, DOI 10.1074/jbc.274.53.37651; Loukin SH, 2002, P NATL ACAD SCI USA, V99, P1926, DOI 10.1073/pnas.042538599; Maingret F, 2000, EMBO J, V19, P2483, DOI 10.1093/emboj/19.11.2483; Nicke A, 1998, EMBO J, V17, P3016, DOI 10.1093/emboj/17.11.3016; North RA, 2002, PHYSIOL REV, V82, P1013, DOI 10.1152/physrev.00015.2002; Pelegrin P, 2006, EMBO J, V25, P5071, DOI 10.1038/sj.emboj.7601378; Qu Y, 2007, J IMMUNOL, V179, P1913, DOI 10.4049/jimmunol.179.3.1913; Rassendren F, 1997, J BIOL CHEM, V272, P5482, DOI 10.1074/jbc.272.9.5482; Riedel T, 2007, BIOPHYS J, V93, P846, DOI 10.1529/biophysj.106.103614; Riedel T, 2007, BIOPHYS J, V92, P2377, DOI 10.1529/biophysj.106.091413; SCHAGGER H, 1994, ANAL BIOCHEM, V217, P220, DOI 10.1006/abio.1994.1112; SCHAGGER H, 1991, ANAL BIOCHEM, V199, P223, DOI 10.1016/0003-2697(91)90094-A; Schilling WP, 1999, AM J PHYSIOL-CELL PH, V277, pC755, DOI 10.1152/ajpcell.1999.277.4.C755; Scholl U, 2006, P NATL ACAD SCI USA, V103, P11411, DOI 10.1073/pnas.0601631103; Silberberg SD, 2005, J GEN PHYSIOL, V125, P347, DOI 10.1085/jgp.200409221; Smart ML, 2003, J BIOL CHEM, V278, P8853, DOI 10.1074/jbc.M211094200; Surprenant A, 1996, SCIENCE, V272, P735, DOI 10.1126/science.272.5262.735; Torres GE, 1999, J BIOL CHEM, V274, P22359, DOI 10.1074/jbc.274.32.22359; Virginio C, 1999, J PHYSIOL-LONDON, V519, P335, DOI 10.1111/j.1469-7793.1999.0335m.x; Watters JJ, 2001, DRUG DEVELOP RES, V53, P91, DOI 10.1002/ddr.1176; Wilson HL, 2002, J BIOL CHEM, V277, P34017, DOI 10.1074/jbc.M205120200; Ye S, 2006, CELL, V126, P1161, DOI 10.1016/j.cell.2006.08.029	43	49	50	0	3	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	SEP 12	2008	283	37					25725	25734		10.1074/jbc.M803855200	http://dx.doi.org/10.1074/jbc.M803855200			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	345QZ	18617511	hybrid			2022-12-27	WOS:000259012700067
J	Hu, ZL; Chen, J; Wei, Q; Xia, Y				Hu, Zhuangli; Chen, Juan; Wei, Qin; Xia, Yong			Bidirectional actions of hydrogen peroxide on endothelial nitric-oxide synthase phosphorylation and function - Co-commitment and interplay of Akt and AMPK	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ACTIVATED PROTEIN-KINASE; DEPENDENT PHOSPHORYLATION; PHOSPHATASE 2A; DYSFUNCTION; DEPHOSPHORYLATION; MECHANISMS; STRESS; CELLS	Endothelial NO synthase (eNOS) is critically modulated by kinases via the phosphorylation of its Ser(1179) (bovine) or Ser(1177) (human) residue. Reactive oxygen species such as H2O2 was reported to activate Akt, leading to increased eNOS Ser(1179) phosphorylation and activity. But reactive oxygen species are also known to attenuate eNOS function in cardiovascular diseases. Prior studies showing H2O2-stimulated eNOS phosphorylation were performed on serum-starved cells, and only the short term effect of H2O2 was examined. Here we found that the effects of H2O2 on eNOS Ser(1179) phosphorylation and function were bidirectional. With endothelial cells cultured with serum, H2O2 initially raised eNOSSer(1179) phosphorylation and activity. However, after the peak increase at 30 min, eNOS Ser(1179) phosphorylation dramatically declined. Parallel to the alterations of eNOS Ser(1179) phosphorylation, Akt was transiently activated by H2O2 and subsequently became dormant. In contrast, AMP-activated protein kinase (AMPK) was progressively activated in H2O2-treated cells. Blocking Akt activation abolished the initial rise of eNOS Ser(1179) phosphorylation after H2O2 treatment. In long term H2O2-treated cells where Akt was deactivated, significant amounts of Ser(1179)-phosphorylated eNOS remained. AMPK inhibition eradicated the remaining eNOS Ser(1179) phosphorylation. Taken together, these studies revealed that Akt and AMPK orchestrated a bidirectional action on eNOS Ser(1179) phosphorylation in H2O2-treated cells. Long term H2O2 exposure decreased eNOS Ser(1179) phosphorylation, and this might account for the loss of eNOS function in cardiovascular diseases where chronic oxidative injury occurs.	[Hu, Zhuangli; Chen, Juan; Wei, Qin; Xia, Yong] Ohio State Univ, Dept Mol & Cellular Biochem, Div Cardiovasc Med, Davis Heart & Lung Res Inst, Columbus, OH 43210 USA	University System of Ohio; Ohio State University	Xia, Y (corresponding author), Ohio State Univ, Davis Heart & Lung Res Inst 605, 473 W 12th Ave, Columbus, OH 43210 USA.	yong.xia@osumc.edu			National Institutes of Health [HL77575, HL86965]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL077575, R01HL086965] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	This work was supported, in whole or in part, by National Institutes of Health Grants HL77575 and HL86965. The costs of publication of this article were defrayed in part by the payment of page charges. This article must therefore be hereby marked "advertisement" in accordance with 18 U. S. C. Section 1734 solely to indicate this fact.	BREDT DS, 1989, P NATL ACAD SCI USA, V86, P9030, DOI 10.1073/pnas.86.22.9030; BREDT DS, 1994, ANNU REV BIOCHEM, V63, P175, DOI 10.1146/annurev.bi.63.070194.001135; Cai H, 2000, CIRC RES, V87, P840, DOI 10.1161/01.RES.87.10.840; Cai H, 2003, MOL PHARMACOL, V63, P325, DOI 10.1124/mol.63.2.325; Choi SL, 2001, BIOCHEM BIOPH RES CO, V287, P92, DOI 10.1006/bbrc.2001.5544; Dimmeler S, 1999, NATURE, V399, P601, DOI 10.1038/21224; Du XL, 2001, J CLIN INVEST, V108, P1341, DOI 10.1172/JCI11235; Feletou M, 2006, AM J PHYSIOL-HEART C, V291, pH985, DOI 10.1152/ajpheart.00292.2006; Fleming I, 2003, AM J PHYSIOL-REG I, V284, pR1, DOI 10.1152/ajpregu.00323.2002; Fontana J, 2002, CIRC RES, V90, P866, DOI 10.1161/01.RES.0000016837.26733.BE; Fulton D, 2001, J PHARMACOL EXP THER, V299, P818; Fulton D, 1999, NATURE, V399, P597, DOI 10.1038/21218; Greif DM, 2002, BIOCHEMISTRY-US, V41, P15845, DOI 10.1021/bi026732g; GRIFFITH OW, 1995, ANNU REV PHYSIOL, V57, P707, DOI 10.1146/annurev.ph.57.030195.003423; Inoki K, 2003, CELL, V115, P577, DOI 10.1016/S0092-8674(03)00929-2; Kim EK, 2004, J BIOL CHEM, V279, P19970, DOI 10.1074/jbc.M402165200; Kovacic S, 2003, J BIOL CHEM, V278, P39422, DOI 10.1074/jbc.M305371200; Liu SL, 2005, NAT MED, V11, P952, DOI 10.1038/nm1289; Michell BJ, 2001, J BIOL CHEM, V276, P17625, DOI 10.1074/jbc.C100122200; Millward TA, 1999, TRENDS BIOCHEM SCI, V24, P186, DOI 10.1016/S0968-0004(99)01375-4; MONCADA S, 1991, PHARMACOL REV, V43, P109; Musicki B, 2005, P NATL ACAD SCI USA, V102, P11870, DOI 10.1073/pnas.0502488102; Papaharalambus CA, 2007, TRENDS CARDIOVAS MED, V17, P48, DOI 10.1016/j.tcm.2006.11.005; Shiojima I, 2002, CIRC RES, V90, P1243, DOI 10.1161/01.RES.0000022200.71892.9F; Thomas SR, 2002, J BIOL CHEM, V277, P6017, DOI 10.1074/jbc.M109107200; Wei Q, 2005, J BIOL CHEM, V280, P18081, DOI 10.1074/jbc.M413607200; Wei Q, 2006, J BIOL CHEM, V281, P21652, DOI 10.1074/jbc.M602105200; Xia Y, 1997, P NATL ACAD SCI USA, V94, P12705, DOI 10.1073/pnas.94.23.12705; Zhang M, 2008, CIRC RES, V102, P328, DOI 10.1161/CIRCRESAHA.107.163253; Zhou GC, 2001, J CLIN INVEST, V108, P1167, DOI 10.1172/JCI13505	30	52	55	0	3	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	SEP 12	2008	283	37					25256	25263		10.1074/jbc.M802455200	http://dx.doi.org/10.1074/jbc.M802455200			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	345QZ	18617528	Green Published, hybrid			2022-12-27	WOS:000259012700018
J	Simoneau, M; Boulanger, J; Coulombe, G; Renaud, MA; Duchesne, C; Rivard, N				Simoneau, Melanie; Boulanger, Jim; Coulombe, Genevieve; Renaud, Marc-Andre; Duchesne, Cathia; Rivard, Nathalie			Activation of Cdk2 stimulates proteasome-dependent truncation of tyrosine phosphatase SHP-1 in human proliferating intestinal epithelial cells	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							PHOSPHOTYROSINE PHOSPHATASE; NEGATIVE REGULATION; ANTIGEN RECEPTOR; MESSENGER-RNAS; PROTEIN-KINASE; CYCLIN E-CDK2; MOTH-EATEN; C-KIT; PHOSPHORYLATION; EXPRESSION	SHP-1 is expressed in the nuclei of intestinal epithelial cells (IECs). Increased SHP-1 expression and phosphatase activity coincide with cell cycle arrest and differentiation in these cells. Suspecting the tumor-suppressive properties of SHP-1, a yeast two-hybrid screen of an IEC cDNA library was conducted using the full-length SHP-1 as bait. Characterization of many positive clones revealed sequences identical to a segment of the Cdk2 cDNA sequence. Interaction between SHP-1 and Cdk2 was confirmed by co-immunoprecipitations whereby co-precipitated Cdk2 phosphorylated SHP- 1 protein. Inhibition of Cdk2 (roscovitine) or proteasome (MG132) was associated with an enhanced nuclear punctuate distribution of SHP-1. Double labeling localization studies with signature proteins of subnuclear domains revealed a co-localization between the splicing factor SC35 and SHP-1 in bright nucleoplasmic foci. Using Western blot analyses with the anti-SHP-1 antibody recognizing the C terminus, a lower molecular mass species of 45 kDa was observed in addition to the full-length 64-65-kDa SHP-1 protein. Treatment with MG132 led to an increase in expression of the full-length SHP- 1 protein while concomitantly leading to a decrease in the levels of the lower mass 45-kDa molecular species. Further Western blots revealed that the 45-kDa protein corresponds to the C-terminal portion of SHP- 1 generated from proteasome activity. Mutational analysis of Tyr(208) and Ser(591) (a Cdk2 phosphorylation site) residues on SHP- 1 abolished the expression of the amino-truncated 45-kDa SHP-1 protein. In conclusion, our results indicate that Cdk2-associated complexes, by targeting SHP-1 for proteolysis, counteract the ability of SHP-1 to block cell cycle progression of IECs.	[Simoneau, Melanie; Boulanger, Jim; Coulombe, Genevieve; Renaud, Marc-Andre; Duchesne, Cathia; Rivard, Nathalie] Univ Sherbrooke, Fac Med & Sci Sante, Dept Anat & Biol Cellulaire, Sherbrooke, PQ J1H 5N4, Canada	University of Sherbrooke	Rivard, N (corresponding author), Univ Sherbrooke, Fac Med, Dept Anat & Biol Cellulaire, Sherbrooke, PQ J1H 5N4, Canada.	Nathalie.Rivard@USherbrooke.ca			Natural Sciences and Engineering Research Council of Canada	Natural Sciences and Engineering Research Council of Canada(Natural Sciences and Engineering Research Council of Canada (NSERC)CGIAR)	This work was supported by a grant from the Natural Sciences and Engineering Research Council of Canada (to N.R.). The costs of publication of this article were defrayed in part by the payment of page charges. This article must therefore be hereby marked "advertisement" in accordance with 18 U. S. C. Section 1734 solely to indicate this fact.; Student scholar from the Natural Sciences and Engineering Research Council of Canada. Student scholar from the Fonds pour la Recherche en Sante du Quebec.	BANVILLE D, 1995, GENOMICS, V27, P165, DOI 10.1006/geno.1995.1020; Baugh JM, 2004, MOL CELL, V16, P575, DOI 10.1016/j.molcel.2004.10.017; BEAULIEU JF, 1991, BIOCHEM J, V280, P599, DOI 10.1042/bj2800599; Bhasin M, 2005, NUCLEIC ACIDS RES, V33, pW202, DOI 10.1093/nar/gki587; Boulanger J, 2005, J BIOL CHEM, V280, P18095, DOI 10.1074/jbc.M502184200; Brown NR, 2007, CELL CYCLE, V6, P1350, DOI 10.4161/cc.6.11.4278; BURRIDGE K, 1995, ANAL BIOCHEM, V232, P56, DOI 10.1006/abio.1995.9961; Chen HE, 1996, MOL CELL BIOL, V16, P3685, DOI 10.1128/mcb.16.7.3685; Chen M, 2002, MOL BIOL CELL, V13, P3576, DOI 10.1091/mbc.02-05-0083; Colwill K, 1996, EMBO J, V15, P265, DOI 10.1002/j.1460-2075.1996.tb00357.x; Craggs G, 2001, J BIOL CHEM, V276, P23719, DOI 10.1074/jbc.M102846200; DAVID M, 1995, MOL CELL BIOL, V15, P7050; Delibrias CC, 1997, J EXP MED, V186, P1575, DOI 10.1084/jem.186.9.1575; Deschenes C, 2001, GASTROENTEROLOGY, V120, P423, DOI 10.1053/gast.2001.21199; Duchesne C, 2003, J BIOL CHEM, V278, P14274, DOI 10.1074/jbc.M300425200; Fabunmi RP, 2001, J CELL SCI, V114, P29; FENG GS, 1993, SCIENCE, V259, P1607, DOI 10.1126/science.8096088; GU Y, 1992, EMBO J, V11, P3995, DOI 10.1002/j.1460-2075.1992.tb05493.x; He DD, 2005, J CELL BIOCHEM, V94, P944, DOI 10.1002/jcb.20307; HUANG S, 1991, Genes and Development, V5, P2288, DOI 10.1101/gad.5.12a.2288; Johnson C, 2000, J CELL BIOL, V150, P417, DOI 10.1083/jcb.150.3.417; Jones ML, 2004, J BIOL CHEM, V279, P40475, DOI 10.1074/jbc.M402970200; Keilhack H, 2001, J CELL BIOL, V152, P325, DOI 10.1083/jcb.152.2.325; Keilhack H, 2000, J BIOL CHEM, V275, P26376, DOI 10.1074/jbc.M001315200; KLINGMULLER U, 1995, CELL, V80, P729, DOI 10.1016/0092-8674(95)90351-8; Ko TK, 2001, J CELL SCI, V114, P2591; Kojima T, 2001, J BIOL CHEM, V276, P32247, DOI 10.1074/jbc.M103790200; Lamond AI, 2003, NAT REV MOL CELL BIO, V4, P605, DOI 10.1038/nrm1172; Leon F, 2002, LEUKEMIA, V16, P1470, DOI 10.1038/sj.leu.2402546; Liu EB, 2004, J BIOL CHEM, V279, P17283, DOI 10.1074/jbc.C300549200; Liu Y, 2007, J LEUKOCYTE BIOL, V82, P742, DOI 10.1189/jlb.1206736; Marengere LEM, 1996, SCIENCE, V272, P1170, DOI 10.1126/science.272.5265.1170; McClue SJ, 2002, INT J CANCER, V102, P463, DOI 10.1002/ijc.10738; MICHALIK J, 1981, LIFE SCI, V28, P1371, DOI 10.1016/0024-3205(81)90411-2; Migone TS, 1998, P NATL ACAD SCI USA, V95, P3845, DOI 10.1073/pnas.95.7.3845; Neel BG, 1997, CURR OPIN CELL BIOL, V9, P193, DOI 10.1016/S0955-0674(97)80063-4; Oka T, 2001, AM J PATHOL, V159, P1495, DOI 10.1016/S0002-9440(10)62535-7; Pani G, 1996, J EXP MED, V184, P839, DOI 10.1084/jem.184.3.839; Park CS, 2004, J BIOL CHEM, V279, P19592, DOI 10.1074/jbc.M314208200; PEI DH, 1993, P NATL ACAD SCI USA, V90, P1092, DOI 10.1073/pnas.90.3.1092; Perreault N, 1996, EXP CELL RES, V224, P354, DOI 10.1006/excr.1996.0145; PETERSON GL, 1977, ANAL BIOCHEM, V83, P346, DOI 10.1016/0003-2697(77)90043-4; Plas DR, 1996, SCIENCE, V272, P1173, DOI 10.1126/science.272.5265.1173; Qu CK, 2000, CELL RES, V10, P279, DOI 10.1038/sj.cr.7290055; Rape M, 2002, NAT CELL BIOL, V4, pE113, DOI 10.1038/ncb0502-e113; RIVARD N, 1995, J BIOL CHEM, V270, P11017, DOI 10.1074/jbc.270.18.11017; Rockel TD, 2005, J CELL SCI, V118, P5231, DOI 10.1242/jcs.02642; Rockel TD, 2002, J STRUCT BIOL, V140, P189; Sacco-Bubulya P, 2002, J CELL BIOL, V156, P425, DOI 10.1083/jcb.200107017; Sato S, 2005, GASTROENTEROLOGY, V129, P1225, DOI 10.1053/j.gastro.2005.07.025; Sheaff RJ, 1997, GENE DEV, V11, P1464, DOI 10.1101/gad.11.11.1464; SHULTZ LD, 1993, CELL, V73, P1445, DOI 10.1016/0092-8674(93)90369-2; Smith KP, 1999, J CELL BIOL, V144, P617, DOI 10.1083/jcb.144.4.617; Sorokin AV, 2005, EMBO J, V24, P3602, DOI 10.1038/sj.emboj.7600830; Stefanova I, 2003, NAT IMMUNOL, V4, P248, DOI 10.1038/ni895; Takeda DY, 2001, J BIOL CHEM, V276, P1993, DOI 10.1074/jbc.M005719200; Tamir I, 2000, CURR OPIN IMMUNOL, V12, P307, DOI 10.1016/S0952-7915(00)00092-3; TAUCHI T, 1995, J BIOL CHEM, V270, P5631, DOI 10.1074/jbc.270.10.5631; TAUCHI T, 1994, J BIOL CHEM, V269, P25206; Tintignac LA, 2000, EXP CELL RES, V259, P300, DOI 10.1006/excr.2000.4973; TOWNLEY R, 1993, BIOCHEMISTRY-US, V32, P13414, DOI 10.1021/bi00212a006; Trinkle-Mulcahy L, 1999, J CELL SCI, V112, P157; TSUI HW, 1993, NAT GENET, V4, P124, DOI 10.1038/ng0693-124; Uesugi Y, 1999, EUR J HAEMATOL, V62, P239; Unkeless JC, 1997, CURR OPIN IMMUNOL, V9, P338, DOI 10.1016/S0952-7915(97)80079-9; VAMBUTAS V, 1995, J BIOL CHEM, V270, P25629, DOI 10.1074/jbc.270.43.25629; WANSINK DG, 1993, J CELL BIOL, V122, P283, DOI 10.1083/jcb.122.2.283; Welcker M, 2003, MOL CELL, V12, P381, DOI 10.1016/S1097-2765(03)00287-9; Wu CY, 2003, GENE, V306, P1, DOI 10.1016/S0378-1119(03)00400-1; Xing YG, 1995, J CELL BIOL, V131, P1635, DOI 10.1083/jcb.131.6.1635; Yang J, 2003, J BIOL CHEM, V278, P6516, DOI 10.1074/jbc.M210430200; YI TL, 1993, MOL CELL BIOL, V13, P7577, DOI 10.1128/MCB.13.12.7577; YI TL, 1993, MOL CELL BIOL, V13, P3350, DOI 10.1128/MCB.13.6.3350; Zhang JY, 2000, SEMIN IMMUNOL, V12, P361, DOI 10.1006/smim.2000.0223; Zhang Q, 2000, AM J PATHOL, V157, P1137, DOI 10.1016/S0002-9440(10)64629-9; ZHAO ZZ, 1993, J BIOL CHEM, V268, P2816	76	16	16	0	1	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	SEP 12	2008	283	37					25544	25556		10.1074/jbc.M804177200	http://dx.doi.org/10.1074/jbc.M804177200			13	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	345QZ	18617527	hybrid			2022-12-27	WOS:000259012700050
J	Talior-Volodarsky, I; Randhawa, VK; Zaid, H; Klip, A				Talior-Volodarsky, Ilana; Randhawa, Varinder K.; Zaid, Hilal; Klip, Amira			alpha-actinin-4 is selectively required for insulin-induced GLUT4 translocation	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							GLUCOSE-TRANSPORT; PHOSPHATIDYLINOSITOL 3-KINASE; ALPHA-ACTININ; GLUCOSE-TRANSPORTER-4 GLUT4; MOUSE MACROPHAGES; PLASMA-MEMBRANE; SKELETAL-MUSCLE; PROTEIN COMPLEX; CROSS-LINKING; AMINO-ACIDS	Insulin induces GLUT4 translocation to the muscle cell surface. Using differential amino acid labeling and mass spectrometry, we observed insulin-dependent co-precipitation of actinin-4 (ACTN4) with GLUT4 (Foster, L. J., Rudich, A., Talior, I., Patel, N., Huang, X., Furtado, L. M., Bilan, P. J., Mann, M., and Klip, A. (2006) J. Proteome Res. 5, 64 -75). ACTN4 links F-actin to membrane proteins, and actin dynamics are essential for GLUT4 translocation. We hypothesized that ACTN4 may contribute to insulin-regulated GLUT4 traffic. In L6 muscle cells insulin, but not platelet-derived growth factor, increased co-precipitation of ACTN4 with GLUT4. Small interfering RNA-mediated ACTN4 knockdown abolished the gain in surface-exposed GLUT4 elicited by insulin but not by platelet-derived growth factor, membrane depolarization, or mitochondrial uncoupling. In contrast, knockdown of alpha-actinin-1 (ACTN1) did not prevent GLUT4 translocation by insulin. GLUT4 colocalized with ACTN4 along the insulin-induced cortical actin mesh and ACTN4 knockdown prevented GLUT4-actin colocalization without impeding actin remodeling or Akt phosphorylation, maintaining GLUT4 in a tight perinuclear location. We propose that ACTN4 contributes to GLUT4 traffic, likely by tethering GLUT4 vesicles to the cortical actin cytoskeleton.	[Talior-Volodarsky, Ilana; Randhawa, Varinder K.; Zaid, Hilal; Klip, Amira] Hosp Sick Children, Cell Biol Program, Toronto, ON M5G 1X8, Canada; [Randhawa, Varinder K.; Klip, Amira] Univ Toronto, Dept Biochem, Toronto, ON M5S 1A8, Canada	University of Toronto; University Toronto Affiliates; Hospital for Sick Children (SickKids); University of Toronto	Klip, A (corresponding author), Hosp Sick Children, Cell Biol Program, 555 Univ Ave, Toronto, ON M5G 1X8, Canada.	amira@sickkids.ca			Canadian Institutes of Health Research [MT 7307]; Banting and Best Diabetes Center; Hospital for Sick Children Research Training Centre; Canadian Institutes of Health Research, Banting and Best Diabetes Center; Research Training Centre	Canadian Institutes of Health Research(Canadian Institutes of Health Research (CIHR)); Banting and Best Diabetes Center; Hospital for Sick Children Research Training Centre; Canadian Institutes of Health Research, Banting and Best Diabetes Center(Canadian Institutes of Health Research (CIHR)); Research Training Centre	This work was supported by Canadian Institutes of Health Research Grant MT 7307 (to A. K.). The costs of publication of this article were defrayed in part by the payment of page charges. This article must therefore be hereby marked "advertisement" in accordance with 18 U. S. C. Section 1734 solely to indicate this fact.; 1. Supported by research fellowship awards from the Banting and Best Diabetes Center and the Hospital for Sick Children Research Training Centre.; 2 Supported by doctoral awards from Canadian Institutes of Health Research, Banting and Best Diabetes Center, Research Training Centre, and Ontario Graduate Scholarship.	Antonescu CN, 2008, TRAFFIC, V9, P1173, DOI 10.1111/j.1600-0854.2008.00755.x; Araki N, 2000, J CELL SCI, V113, P3329; Bai L, 2007, CELL METAB, V5, P47, DOI 10.1016/j.cmet.2006.11.013; Bose A, 2002, NATURE, V420, P821, DOI 10.1038/nature01246; Bryant NJ, 2002, NAT REV MOL CELL BIO, V3, P267, DOI 10.1038/nrm782; CARTEE GD, 1991, J APPL PHYSIOL, V70, P1593, DOI 10.1152/jappl.1991.70.4.1593; CHUNQIU HJ, 2003, MOL BIOL CELL, V14, P3578; Daniliuc S, 2003, J IMMUNOL, V171, P3225, DOI 10.4049/jimmunol.171.6.3225; Ding ZY, 2006, P NATL ACAD SCI USA, V103, P15014, DOI 10.1073/pnas.0606917103; Djinovic-Carugo K, 1999, CELL, V98, P537, DOI 10.1016/S0092-8674(00)81981-9; DOHM GL, 1991, AM J PHYSIOL, V260, pE459, DOI 10.1152/ajpendo.1991.260.3.E459; Dugani CB, 2005, EMBO REP, V6, P1137, DOI 10.1038/sj.embor.7400584; Dugani CB, 2008, EUR J CELL BIOL, V87, P337, DOI 10.1016/j.ejcb.2008.02.009; El-Husseini AED, 2000, BIOCHEM BIOPH RES CO, V267, P906, DOI 10.1006/bbrc.1999.2045; Falasca M, 2007, J BIOL CHEM, V282, P28226, DOI 10.1074/jbc.M704357200; Foster LJ, 2006, J PROTEOME RES, V5, P64, DOI 10.1021/pr0502626; Foster LJ, 2001, J BIOL CHEM, V276, P44212, DOI 10.1074/jbc.M102964200; FUKAMI K, 1992, NATURE, V359, P150, DOI 10.1038/359150a0; Geiger PC, 2006, AM J PHYSIOL-ENDOC M, V291, pE1258, DOI 10.1152/ajpendo.00273.2006; Gonzalez E, 2006, MOL BIOL CELL, V17, P4484, DOI 10.1091/mbc.E06-07-0585; Goode NP, 2004, NEPHROL DIAL TRANSPL, V19, P844, DOI 10.1093/ndt/gfg620; Hara T, 2007, MOL CELL PROTEOMICS, V6, P479, DOI 10.1074/mcp.M600129-MCP200; Hegmans JPJJ, 2004, AM J PATHOL, V164, P1807, DOI 10.1016/S0002-9440(10)63739-X; Herman MA, 2006, J CLIN INVEST, V116, P1767, DOI 10.1172/JCI29027; Honda K, 1998, J CELL BIOL, V140, P1383, DOI 10.1083/jcb.140.6.1383; Honda K, 2004, ONCOGENE, V23, P5257, DOI 10.1038/sj.onc.1207652; IMAMURA M, 1994, EUR J BIOCHEM, V223, P395, DOI 10.1111/j.1432-1033.1994.tb19006.x; IMAMURA M, 1992, J BIOL CHEM, V267, P25927; Ishiki M, 2005, J BIOL CHEM, V280, P28792, DOI 10.1074/jbc.M500501200; Ishiki M, 2005, ENDOCRINOLOGY, V146, P5071, DOI 10.1210/en.2005-0850; Joost HG, 2002, AM J PHYSIOL-ENDOC M, V282, pE974, DOI 10.1152/ajpendo.00407.2001; KANAI F, 1993, J BIOL CHEM, V268, P14523; Kanzaki M, 2001, J BIOL CHEM, V276, P42436, DOI 10.1074/jbc.M108297200; Karlsson HKR, 2007, CELL BIOCHEM BIOPHYS, V48, P103, DOI 10.1007/s12013-007-0030-9; Khayat ZA, 1998, AM J PHYSIOL-CELL PH, V275, pC1487, DOI 10.1152/ajpcell.1998.275.6.C1487; Khayat ZA, 2000, J CELL SCI, V113, P279; Khayat ZA, 2002, CAN J APPL PHYSIOL, V27, P129, DOI 10.1139/h02-010; Kim JH, 2002, J BIOL CHEM, V277, P23714, DOI 10.1074/jbc.M200835200; KLIP A, 1990, BIOCHEM BIOPH RES CO, V172, P728, DOI 10.1016/0006-291X(90)90735-6; Koumanov F, 2005, CELL METAB, V2, P179, DOI 10.1016/j.cmet.2005.08.007; Lanzetti L, 2004, NATURE, V429, P309, DOI 10.1038/nature02542; Li DL, 2001, J BIOL CHEM, V276, P22883, DOI 10.1074/jbc.M010143200; Lizunov VA, 2005, J CELL BIOL, V169, P481, DOI 10.1083/jcb.200412069; MATSUDAIRA P, 1991, TRENDS BIOCHEM SCI, V16, P87, DOI 10.1016/0968-0004(91)90039-X; Niu WY, 2003, J BIOL CHEM, V278, P17953, DOI 10.1074/jbc.M211136200; Omata W, 2000, BIOCHEM J, V346, P321, DOI 10.1042/0264-6021:3460321; Ong SE, 2006, NAT PROTOC, V1, P2650, DOI 10.1038/nprot.2006.427; OTTO JJ, 1994, CURR OPIN CELL BIOL, V6, P105, DOI 10.1016/0955-0674(94)90123-6; Pascual J, 1997, BIOESSAYS, V19, P811, DOI 10.1002/bies.950190911; Patel N, 2003, MOL CELL BIOL, V23, P4611, DOI 10.1128/MCB.23.13.4611-4626.2003; Patrie KM, 2002, J BIOL CHEM, V277, P30183, DOI 10.1074/jbc.M203072200; Randhawa VK, 2000, MOL BIOL CELL, V11, P2403, DOI 10.1091/mbc.11.7.2403; Rudich A, 2003, ACTA PHYSIOL SCAND, V178, P297, DOI 10.1046/j.1365-201X.2003.01163.x; Rudich A, 2003, DIABETOLOGIA, V46, P649, DOI 10.1007/s00125-003-1080-1; Semiz S, 2003, EMBO J, V22, P2387, DOI 10.1093/emboj/cdg237; Taha C, 1997, AM J PHYSIOL-ENDOC M, V273, pE68, DOI 10.1152/ajpendo.1997.273.1.E68; Thong FSL, 2007, DIABETES, V56, P414, DOI 10.2337/db06-0900; Thong FSL, 2005, PHYSIOLOGY, V20, P271, DOI 10.1152/physiol.00017.2005; Tong P, 2001, J CLIN INVEST, V108, P371, DOI 10.1172/JCI12348; Torok D, 2004, J CELL SCI, V117, P5447, DOI 10.1242/jcs.01421; TSAKIRIDIS T, 1995, BIOCHEM J, V309, P1; TSAKIRIDIS T, 1994, J BIOL CHEM, V269, P29934; Tsao TS, 1999, DIABETES, V48, P775, DOI 10.2337/diabetes.48.4.775; Ueyama A, 1999, AM J PHYSIOL-ENDOC M, V277, pE572, DOI 10.1152/ajpendo.1999.277.3.E572; van Dam EM, 2005, MOL ENDOCRINOL, V19, P1067, DOI 10.1210/me.2004-0413; Wang QH, 1998, FEBS LETT, V427, P193, DOI 10.1016/S0014-5793(98)00423-2; Watson RT, 2007, CELL SIGNAL, V19, P2209, DOI 10.1016/j.cellsig.2007.06.003; Watson RT, 2004, ENDOCR REV, V25, P177, DOI 10.1210/er.2003-0011; Wijesekara N, 2006, AM J PHYSIOL-ENDOC M, V290, pE1276, DOI 10.1152/ajpendo.00573.2005; Williams D, 2008, J CELL BIOL, V180, P375, DOI 10.1083/jcb.200709108; Yan Q, 2005, MOL BIOL CELL, V16, P2470, DOI 10.1091/mbc.e04-11-1014; Yang J, 2005, J BIOL CHEM, V280, P4070, DOI 10.1074/jbc.M410213200; Yeung T, 2006, SCIENCE, V313, P347, DOI 10.1126/science.1129551; Zimmet P, 2001, NATURE, V414, P782, DOI 10.1038/414782a	74	36	37	0	6	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	SEP 12	2008	283	37					25115	25123		10.1074/jbc.M801750200	http://dx.doi.org/10.1074/jbc.M801750200			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	345QZ	18617516	hybrid			2022-12-27	WOS:000259012700003
J	Arachiche, A; Augereau, O; Decossas, M; Pertuiset, C; Gontier, E; Letellier, T; Dachary-Prigent, J				Arachiche, Amal; Augereau, Olivier; Decossas, Marion; Pertuiset, Claire; Gontier, Etienne; Letellier, Thierry; Dachary-Prigent, Jeanne			Localization of PTP-1B, SHP-2, and Src exclusively in rat brain mitochondria and functional consequences	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							DEPENDENT TYROSINE PHOSPHORYLATION; OXIDATIVE-PHOSPHORYLATION; PROTEIN-KINASE; COMPLEX-I; CAMP; PHOSPHATASE; HEART; IDENTIFICATION	An immunodetection study of protein tyrosine phosphatase 1B (PTP-1B), SHP-2, and Src in isolated mitochondria from different rat tissues (brain, muscle, heart, liver, and kidney) revealed their exclusive localization in the brain. Given this result, we sought whether mitochondria respond to ATP and to the general tyrosine phosphatase inhibitor orthovanadate and found little or no change in the tyrosine phosphorylation profile of mitochondria from muscle, heart, liver, and kidney. In contrast, ATP induced an enhancement in the tyrosine-phosphorylated protein profile of brain mitochondria, which was further greatly enhanced with orthovanadate and which disappeared when Src was inhibited with two inhibitors: PP2 and PP1. Importantly, we found that in brain mitochondria, ATP addition induced Src autophosphorylation at Tyr-416 in its catalytic site, leading to its activation, whereas the regulatory Tyr-527 site remained unphosphorylated. Functional implications were addressed by measurements of the enzymatic activity of each of the oxidative phosphorylation complexes in brain mitochondria in the presence of ATP. We found an increase in complex I, III, and IV activity and a decrease in complex V activity, partially reversed by Src inhibition, demonstrating that the complexes are Src substrates. These results complemented and reinforced our initial study showing that respiration of brain mitochondria was partially dependent on tyrosine phosphorylation. Therefore, the present data suggest a possible control point in the regulation of respiration by tyrosine phosphorylation of the complexes mediated by Src auto-activation.	[Arachiche, Amal; Augereau, Olivier; Pertuiset, Claire; Letellier, Thierry; Dachary-Prigent, Jeanne] Univ Bordeaux 2, INSERM Physiopathol Mitochondriale U688, F-33076 Bordeaux, France; [Decossas, Marion; Gontier, Etienne] Univ Bordeaux 2, Pole Microscopie Elect, Serv Commun Microscopie, F-33076 Bordeaux, France	Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universite de Bordeaux; UDICE-French Research Universities; Universite de Bordeaux	Dachary-Prigent, J (corresponding author), Univ Bordeaux 2, INSERM Physiopathol Mitochondriale U688, 146 Rue Leo Saignat, F-33076 Bordeaux, France.	jeanne.dachary@u-bordeaux2.fr		decossas, marion/0000-0003-0810-4309	INSERM; Universite Victor Segalen-Bordeaux 2; Fondation de France	INSERM(Institut National de la Sante et de la Recherche Medicale (Inserm)European Commission); Universite Victor Segalen-Bordeaux 2; Fondation de France(Fondation de France)	This work was supported in part by grants from INSERM, the Universite Victor Segalen-Bordeaux 2, and the Fondation de France.	Alonso A, 2004, CELL, V117, P699, DOI 10.1016/j.cell.2004.05.018; Augereau O, 2005, CELL MOL LIFE SCI, V62, P1478, DOI 10.1007/s00018-005-5005-7; Bain J, 2003, BIOCHEM J, V371, P199, DOI 10.1042/BJ20021535; Benard G, 2008, INT J BIOCHEM CELL B, V40, P1543, DOI 10.1016/j.biocel.2007.11.023; Benard G, 2006, AM J PHYSIOL-CELL PH, V291, pC1172, DOI 10.1152/ajpcell.00195.2006; BIRCHMACHIN MA, 1989, PEDIATR RES, V25, P553, DOI 10.1203/00006450-198905000-00025; Cardone L, 2004, MOL CELL BIOL, V24, P4613, DOI 10.1128/MCB.24.11.4613-4626.2004; Chen RM, 2004, J BIOL CHEM, V279, P26036, DOI 10.1074/jbc.M402710200; CLARK JB, 1970, J BIOL CHEM, V245, P4724; Devin A, 2007, AM J PHYSIOL-CELL PH, V292, pC52, DOI 10.1152/ajpcell.00208.2006; Di Pancrazio F, 2006, PROTEOMICS, V6, P921, DOI 10.1002/pmic.200500077; Gnaiger E, 1998, J EXP BIOL, V201, P1129; Huttemann M, 2007, BBA-MOL CELL RES, V1773, P1701, DOI 10.1016/j.bbamcr.2007.10.001; JOHNSON D, 1958, NATURE, V181, P701, DOI 10.1038/181701a0; JUMELLELACLAU M, 1993, BIOCHIM BIOPHYS ACTA, V1141, P90, DOI 10.1016/0005-2728(93)90193-J; Kipp JL, 2001, ENDOCRINE, V15, P165, DOI 10.1385/ENDO:15:2:165; Lee I, 2005, J BIOL CHEM, V280, P6094, DOI 10.1074/jbc.M411335200; Lewandrowski U, 2008, FEBS LETT, V582, P1104, DOI 10.1016/j.febslet.2008.02.077; Livigni A, 2006, MOL BIOL CELL, V17, P263, DOI 10.1091/mbc.e05-09-0827; Miyazaki T, 2003, J CELL BIOL, V160, P709, DOI 10.1083/jcb.200209098; MORGANHUGHES JA, 1990, BIOCHIM BIOPHYS ACTA, V1018, P217, DOI 10.1016/0005-2728(90)90252-Y; Pagliarini DJ, 2006, TRENDS BIOCHEM SCI, V31, P26, DOI 10.1016/j.tibs.2005.11.005; Pagliarini DJ, 2005, MOL CELL, V19, P197, DOI 10.1016/j.molcel.2005.06.008; Papa S, 2002, BIOSCIENCE REP, V22, P3, DOI 10.1023/A:1016004921277; RIMOLDI M, 1982, J NEUROL, V227, P201, DOI 10.1007/BF00313387; Roskoski R, 2004, BIOCHEM BIOPH RES CO, V324, P1155, DOI 10.1016/j.bbrc.2004.09.171; Rossignol R, 2000, BIOCHEM J, V347, P45, DOI 10.1042/0264-6021:3470045; Salvi M, 2005, FREE RADICAL BIO MED, V38, P1267, DOI 10.1016/j.freeradbiomed.2005.02.006; Salvi M, 2004, CELL MOL LIFE SCI, V61, P2393, DOI 10.1007/s00018-004-4211-z; Salvi M, 2002, BBA-MOL CELL RES, V1589, P181, DOI 10.1016/S0167-4889(02)00174-X; Sardanelli AM, 1995, FEBS LETT, V377, P470, DOI 10.1016/0014-5793(95)01407-1; SOLAINI G, 1993, EUR J BIOCHEM, V214, P729, DOI 10.1111/j.1432-1033.1993.tb17974.x; Sun GQ, 1998, ONCOGENE, V17, P1587, DOI 10.1038/sj.onc.1202076; TECHNIKOVADOBROVA Z, 1994, FEBS LETT, V350, P187, DOI 10.1016/0014-5793(94)00760-8	34	59	61	0	3	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	SEP 5	2008	283	36					24406	24411		10.1074/jbc.M709217200	http://dx.doi.org/10.1074/jbc.M709217200			6	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	342YR	18583343	hybrid, Green Published			2022-12-27	WOS:000258820000015
J	Argraves, KM; Gazzolo, PJ; Groh, EM; Wilkerson, BA; Matsuura, BS; Twal, WO; Hammad, SM; Argraves, WS				Argraves, Kelley M.; Gazzolo, Patrick J.; Groh, Eric M.; Wilkerson, Brent A.; Matsuura, Bryan S.; Twal, Waleed O.; Hammad, Samar M.; Argraves, W. Scott			High density lipoprotein-associated sphingosine 1-phosphate promotes endothelial barrier function	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							PROTEIN-KINASE PATHWAY; COUPLED RECEPTOR EDG-1; MAMMALIAN-CELLS; LUNG INJURY; IN-VIVO; INTEGRITY; ENDOTOXIN; SPHINGOSINE-1-PHOSPHATE; PHOSPHORYLATION; ACTIVATION	High density lipoproteins (HDL) are major plasma carriers of sphingosine 1-phosphate (S1P). Here we show that HDL increases endothelial barrier integrity as measured by electric cell substrate impedance sensing. S1P was implicated as the mediator in this process through findings showing that pertussis toxin, an inhibitor of G(i)-coupled S1P receptors, as well as antagonists of the S1P receptor, S1P1, inhibited barrier enhancement by HDL. Additional findings show that HDL stimulates endothelial cell activation of Erk1/2 and Akt, signaling pathway intermediates that have been implicated in S1P-dependent endothelial barrier activity. HDL was also found to promote endothelial cell motility, a process that may also relate to endothelial barrier function in the context of a vascular injury response. The effects of HDL on endothelial cell Erk1/2 and Akt activation and motility were suppressed by pertussis toxin and S1P1 antagonists. However, both HDL-induced barrier enhancement and HDL-induced motility showed a greater dependence on Akt activation as compared with Erk1/2 activation. Together, the findings indicate that HDL has endothelial barrier promoting activities, which are attributable to its S1P component and signaling through the S1P1/Akt pathway.	[Argraves, Kelley M.; Gazzolo, Patrick J.; Groh, Eric M.; Wilkerson, Brent A.; Matsuura, Bryan S.; Twal, Waleed O.; Hammad, Samar M.; Argraves, W. Scott] Med Univ S Carolina, Dept Anat & Cell Biol, Charleston, SC 29425 USA	Medical University of South Carolina	Argraves, KM (corresponding author), Med Univ S Carolina, Dept Anat & Cell Biol, 171 Ashley Ave, Charleston, SC 29425 USA.	argravek@musc.edu		Wilkerson, Brent/0000-0002-3532-3075; Hammad, Samar/0000-0002-1313-2542	National Institutes of Health [HL80404, RR107677, HL52813, HL079274]; American Heart Association-Jon DeHaan Foundation Scientist Development [0230245N]; NATIONAL CENTER FOR RESEARCH RESOURCES [C06RR018823] Funding Source: NIH RePORTER; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL079274, P01HL052813, R01HL080404] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); American Heart Association-Jon DeHaan Foundation Scientist Development(American Heart Association); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	This work was supported, in whole or in part, by National Institutes of Health Grants HL80404 and RR107677 ( to K. M. A.), HL52813 ( to W. S. A.), and HL079274 ( to S. M. H.). This work was also supported by American Heart Association-Jon DeHaan Foundation Scientist Development Grant in Angiogenesis 0230245N ( to K. M. A.). The costs of publication of this article were defrayed in part by the payment of page charges. This article must therefore be hereby marked "advertisement" in accordance with 18 U. S. C. Section 1734 solely to indicate this fact.	Argraves KM, 2007, J LIPID RES, V48, P2325, DOI 10.1194/jlr.R700011-JLR200; Bielawski J, 2006, METHODS, V39, P82, DOI 10.1016/j.ymeth.2006.05.004; Bohm SK, 1997, BIOCHEM J, V322, P1; COCKERILL GW, 1995, ARTERIOSCL THROM VAS, V15, P1987, DOI 10.1161/01.ATV.15.11.1987; Cockerill GW, 2001, FASEB J, V15, P1941, DOI 10.1096/fj.01-0075com; EMANCIPATOR K, 1992, INFECT IMMUN, V60, P596, DOI 10.1128/IAI.60.2.596-601.1992; Garcia JGN, 2001, J CLIN INVEST, V108, P689, DOI 10.1172/JCI12450; GIAEVER I, 1993, NATURE, V366, P591, DOI 10.1038/366591a0; GIAEVER I, 1991, P NATL ACAD SCI USA, V88, P7896, DOI 10.1073/pnas.88.17.7896; HUBSCH AP, 1995, J LAB CLIN MED, V126, P548; Jo EJ, 2005, CHEM BIOL, V12, P703, DOI 10.1016/j.chembiol.2005.04.019; Kataoka N, 2002, P NATL ACAD SCI USA, V99, P15638, DOI 10.1073/pnas.242590799; Lee JF, 2006, J BIOL CHEM, V281, P29190, DOI 10.1074/jbc.M604310200; Lee MJ, 1996, J BIOL CHEM, V271, P11272, DOI 10.1074/jbc.271.19.11272; Lee MJ, 1999, CELL, V99, P301, DOI 10.1016/S0092-8674(00)81661-X; Lee MJ, 2001, MOL CELL, V8, P693, DOI 10.1016/S1097-2765(01)00324-0; LEVINE DM, 1993, P NATL ACAD SCI USA, V90, P12040, DOI 10.1073/pnas.90.24.12040; McVerry BJ, 2004, AM J RESP CRIT CARE, V170, P987, DOI 10.1164/rccm.200405-684oc; Murata N, 2000, BIOCHEM J, V352, P809, DOI 10.1042/0264-6021:3520809; NORDESTGAARD BG, 1995, ARTERIOSCL THROM VAS, V15, P534, DOI 10.1161/01.ATV.15.4.534; Osinde M, 2007, NEUROPHARMACOLOGY, V52, P1210, DOI 10.1016/j.neuropharm.2006.11.010; Park KS, 2007, BIOCHEM BIOPH RES CO, V356, P239, DOI 10.1016/j.bbrc.2007.02.112; Peng XQ, 2004, AM J RESP CRIT CARE, V169, P1245, DOI 10.1164/rccm.200309-1258OC; Schaphorst KL, 2003, AM J PHYSIOL-LUNG C, V285, pL258, DOI 10.1152/ajplung.00311.2002; Taha TA, 2004, BBA-MOL CELL BIOL L, V1682, P48, DOI 10.1016/S1388-1981(04)00023-X; Thiemermann C, 2003, J AM SOC NEPHROL, V14, P1833, DOI 10.1097/01.ASN.0000075552.97794.8C; Vogel C, 2007, J CELL PHYSIOL, V212, P236, DOI 10.1002/jcp.21022; Wachtel M, 2002, BIOCHEM J, V367, P873, DOI 10.1042/BJ20020746; WU J, 1995, J BIOL CHEM, V270, P11484, DOI 10.1074/jbc.270.19.11484; XU M, 2007, AM J PHYSIOL, V4, pC1309	30	91	98	0	4	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	SEP 5	2008	283	36					25074	25081		10.1074/jbc.M801214200	http://dx.doi.org/10.1074/jbc.M801214200			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	342YR	18606817	Green Published, hybrid			2022-12-27	WOS:000258820000063
J	He, YW; Hryciw, DH; Carroll, ML; Myers, SA; Whitbread, AK; Kumar, S; Poronnik, P; Hooper, JD				He, Yaowu; Hryciw, Deanne H.; Carroll, Melanie L.; Myers, Stephen A.; Whitbread, Astrid K.; Kumar, Sharad; Poronnik, Philip; Hooper, John D.			The ubiquitin-protein ligase Nedd4-2 differentially interacts with and regulates members of the Tweety family of chloride ion channels	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							EPITHELIAL NA+ CHANNEL; MELANOGASTER GENE TWEETY; SODIUM-CHANNEL; ALBUMIN UPTAKE; HUMAN HOMOLOG; WW DOMAINS; ENAC; CELLS; DEGRADATION; ENDOCYTOSIS	The Tweety proteins comprise a family of chloride ion channels with three members identified in humans (TTYH1-3) and orthologues in fly and murine species. In humans, increased TTYH2 expression is associated with cancer progression, whereas fly Tweety is associated with developmental processes. Structurally, Tweety proteins are characterized by five membranespanning domains and N-glycan modifications important for trafficking to the plasma membrane, where these proteins are oriented with the amino terminus located extracellularly and the carboxyl terminus cytoplasmically. In addition to N-glycosylation, ubiquitination mediated by the HECT type E3 ubiquitin ligase Nedd4-2 is a post-translation modification important in regulating membrane proteins. In the present study, we performed a comprehensive analysis of the ability of each of TTYH1-3 to interact with Nedd4-2 and to be ubiquitinated and regulated by this ligase. Our data indicate that Nedd4-2 binds to two family members, TTYH2 and TTYH3, which contain consensus PY ((L/P)PXY) binding sites for HECT type E3 ubiquitin ligases, but not to TTYH1, which lacks this motif. Consistently, Nedd4-2 ubiquitinates both TTYH2 and TTYH3. Importantly, we have shown that endogenous TTYH2 and Nedd4-2 are binding partners and demonstrated that the TTYH2PY motif is essential for these interactions. We have also shown that Nedd4-2-mediated ubiquitination of TTYH2 is a critical regulator of cell surface and total cellular levels of this protein. These data, indicating that Nedd4-2 differentially interacts with and regulates TTYH1-3, will be important for understanding mechanisms controlling Tweety proteins in physiology and disease.	[He, Yaowu; Carroll, Melanie L.; Myers, Stephen A.; Whitbread, Astrid K.; Hooper, John D.] Queensland Univ Technol, Inst Hlth & Biomed Innovat, Kelvin Grove, Qld 4059, Australia; [He, Yaowu; Carroll, Melanie L.; Myers, Stephen A.; Whitbread, Astrid K.; Hooper, John D.] Queensland Univ Technol, Sch Life Sci, Kelvin Grove, Qld 4059, Australia; [Hryciw, Deanne H.; Poronnik, Philip] Univ Queensland, Sch Biomed Sci, Brisbane, Qld 4072, Australia; [Kumar, Sharad] Inst Med & Vet Sci, Hanson Inst, Adelaide, SA 5000, Australia	Queensland University of Technology (QUT); Queensland University of Technology (QUT); University of Queensland; Hanson Institute; Institute Medical & Veterinary Science Australia	Hooper, JD (corresponding author), Queensland Univ Technol, Inst Hlth & Biomed Innovat, Corner Musk Ave & Blamey St, Kelvin Grove, Qld 4059, Australia.	jd.hooper@qut.edu.au	Hooper, John/C-1481-2016; Kumar, Sharad/AAX-7787-2020; Hryciw, Deanne/P-2642-2019	Hooper, John/0000-0003-1054-8486; Kumar, Sharad/0000-0001-7126-9814; Hryciw, Deanne/0000-0003-1697-8890; Whitbread, Astrid/0000-0003-2307-9252; HE, Yaowu/0000-0002-7828-263X; Poronnik, Philip/0000-0002-6246-528X; Myers, Stephen/0000-0003-4793-3820	National Health and Medical Research Council of Australia; Australian Research Council	National Health and Medical Research Council of Australia(National Health and Medical Research Council (NHMRC) of Australia); Australian Research Council(Australian Research Council)	This work was supported by National Health and Medical Research Council of Australia grants (to J.D.H., P.P., and S.K.) and a fellowship (to J.D.H.) and Australian Research Council grants ( to P. P. and S. K.). The costs of publication of this article were defrayed in part by the payment of page charges. This article must therefore be hereby marked "advertisement" in accordance with 18 U.S.C. Section 1734 solely to indicate this fact.	Campbell HD, 2000, GENOMICS, V68, P89, DOI 10.1006/geno.2000.6259; CAMPBELL HD, 1993, P NATL ACAD SCI USA, V90, P11386, DOI 10.1073/pnas.90.23.11386; d'Azzo A, 2005, TRAFFIC, V6, P429, DOI 10.1111/j.1600-0854.2005.00294.x; Devuyst Olivier, 2005, Nephron Physiology, V99, P69; DiAntonio A, 2004, ANNU REV NEUROSCI, V27, P223, DOI 10.1146/annurev.neuro.27.070203.144317; Ekberg J, 2007, J BIOL CHEM, V282, P12135, DOI 10.1074/jbc.M609385200; Fotia AB, 2004, J BIOL CHEM, V279, P28930, DOI 10.1074/jbc.M402820200; Harvey KF, 1999, TRENDS CELL BIOL, V9, P166, DOI 10.1016/S0962-8924(99)01541-X; Hatanaka T, 2006, J BIOL CHEM, V281, P35922, DOI 10.1074/jbc.M606577200; He YW, 2008, BIOCHEM J, V412, P45, DOI 10.1042/BJ20071722; Hooper JD, 1999, CANCER RES, V59, P3199; Hryciw DH, 2006, INT J BIOCHEM CELL B, V38, P1036, DOI 10.1016/j.biocel.2005.09.009; Hryciw DH, 2003, J BIOL CHEM, V278, P40169, DOI 10.1074/jbc.M307890200; Hryciw DH, 2004, J BIOL CHEM, V279, P54996, DOI 10.1074/jbc.M411491200; Jespersen T, 2007, CARDIOVASC RES, V74, P64, DOI 10.1016/j.cardiores.2007.01.008; Kee Y, 2007, BIOCHEM BIOPH RES CO, V354, P329, DOI 10.1016/j.bbrc.2007.01.025; Konstas AA, 2002, J BIOL CHEM, V277, P29406, DOI 10.1074/jbc.M203018200; Kumar S, 1997, GENOMICS, V40, P435, DOI 10.1006/geno.1996.4582; Liu YC, 2004, ANNU REV IMMUNOL, V22, P81, DOI 10.1146/annurev.immunol.22.012703.104813; Lu C, 2007, TRAFFIC, V8, P1246, DOI 10.1111/j.1600-0854.2007.00602.x; Maleszka R, 1996, P NATL ACAD SCI USA, V93, P447, DOI 10.1073/pnas.93.1.447; Malik B, 2001, J BIOL CHEM, V276, P12903, DOI 10.1074/jbc.M010626200; Miller JH, 2003, BIOPHYS J, V84, P2781, DOI 10.1016/S0006-3495(03)75082-6; Mukhopadhyay D, 2007, SCIENCE, V315, P201, DOI 10.1126/science.1127085; Muratani M, 2003, NAT REV MOL CELL BIO, V4, P192, DOI 10.1038/nrm1049; Nath D, 1999, J CELL SCI, V112, P579; Otte L, 2003, PROTEIN SCI, V12, P491, DOI 10.1110/ps.0233203; Pickart CM, 2004, BBA-MOL CELL RES, V1695, P55, DOI 10.1016/j.bbamcr.2004.09.019; Rae FK, 2001, GENOMICS, V77, P200, DOI 10.1006/geno.2001.6629; Rotin D, 2000, J MEMBRANE BIOL, V176, P1; Schnell JD, 2003, J BIOL CHEM, V278, P35857, DOI 10.1074/jbc.R300018200; Schwartz DC, 2003, TRENDS BIOCHEM SCI, V28, P321, DOI 10.1016/S0968-0004(03)00113-0; Simon P, 2007, CELL PHYSIOL BIOCHEM, V20, P715, DOI 10.1159/000110432; Snyder PM, 2004, J BIOL CHEM, V279, P5042, DOI 10.1074/jbc.M312477200; Snyder PM, 2002, J BIOL CHEM, V277, P5, DOI 10.1074/jbc.C100623200; Staub O, 1996, EMBO J, V15, P2371, DOI 10.1002/j.1460-2075.1996.tb00593.x; Staub O, 1997, EMBO J, V16, P6325, DOI 10.1093/emboj/16.21.6325; Staub O, 2006, PHYSIOL REV, V86, P669, DOI 10.1152/physrev.00020.2005; Sudol M, 2000, CELL, V103, P1001, DOI 10.1016/S0092-8674(00)00203-8; Sullivan M, 2007, NAT REV MOL CELL BIO, V8, P894, DOI 10.1038/nrm2276; Suzuki M, 2004, J BIOL CHEM, V279, P22461, DOI 10.1074/jbc.M313813200; SWERDLOW PS, 1986, ANAL BIOCHEM, V156, P147, DOI 10.1016/0003-2697(86)90166-1; Toiyama Y, 2007, WORLD J GASTROENTERO, V13, P2717, DOI 10.3748/wjg.v13.i19.2717; van Bemmelen MX, 2004, CIRC RES, V95, P284, DOI 10.1161/01.RES.0000136816.05109.89; Verdecia MA, 2000, NAT STRUCT BIOL, V7, P639, DOI 10.1038/77929; Yip PM, 1998, MOL BIOL CELL, V9, P277, DOI 10.1091/mbc.9.2.277; Zhou RF, 2007, J BIOL CHEM, V282, P20207, DOI 10.1074/jbc.M611329200	47	29	29	0	5	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	AUG 29	2008	283	35					24000	24010		10.1074/jbc.M803361200	http://dx.doi.org/10.1074/jbc.M803361200			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	340II	18577513	Green Published, hybrid			2022-12-27	WOS:000258638900056
J	Pyarajan, S; Matejovic, G; Pratt, JC; Baksh, S; Burakoff, SJ				Pyarajan, Saiju; Matejovic, Gabriel; Pratt, Joanne C.; Baksh, Shairaz; Burakoff, Steven J.			Interleukin-3 (IL-3)-induced c-fos activation is modulated by gab2-calcineurin interaction	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							SCAFFOLDING ADAPTER GAB2; BINDING-PROTEINS; HEMATOPOIETIC-CELLS; DOCKING PROTEIN; BREAST-CANCER; CA2+ INFLUX; CALCINEURIN; PATHWAY; PROLIFERATION; EXPRESSION	Interleukin-3 (IL-3) regulates cell growth by affecting various processes such as cell death, survival, and proliferation. Cues from the external environment are sensed by surface receptors, and complex signaling mechanisms arise within the cells, leading to specific functional outcomes. In this study, we demonstrate that the cytokine IL-3 induces the activation of the Ca2+-dependent phosphatase, calcineurin (Cn). Furthermore Cn dephosphorylates Gab2, resulting in c-fos activation and cell proliferation. We also report that there is a direct interaction between Cn and Gab2 upon IL-3 stimulation, and Akt can regulate this interaction.	[Pyarajan, Saiju; Matejovic, Gabriel; Burakoff, Steven J.] NYU, Sch Med, Inst Canc, New York, NY 10016 USA; [Baksh, Shairaz] Univ Alberta, Dept Pediat, Edmonton, AB T6G 2N8, Canada	New York University; University of Alberta	Pyarajan, S (corresponding author), Mt Sinai Sch Med, 1 Gustave L Levy Pl,Box 1130, New York, NY 10029 USA.	saiju.pyarajan@mssm.edu	Baksh, Shairaz/GRX-2106-2022					Baksh S, 2000, SEMIN IMMUNOL, V12, P405, DOI 10.1006/smim.2000.0221; Baksh S, 2000, ONCOGENE, V19, P2820, DOI 10.1038/sj.onc.1203585; Baksh S, 2002, MOL CELL, V10, P1071, DOI 10.1016/S1097-2765(02)00701-3; Bentires-Alj M, 2006, NAT MED, V12, P114, DOI 10.1038/nm1341; Berridge MJ, 2000, NAT REV MOL CELL BIO, V1, P11, DOI 10.1038/35036035; Brummer T, 2006, J BIOL CHEM, V281, P626, DOI 10.1074/jbc.M509567200; CAMERON AM, 1995, CELL, V83, P463, DOI 10.1016/0092-8674(95)90124-8; Chaussepied M, 2004, MOL CELL, V16, P831, DOI 10.1016/j.molcel.2004.11.003; Daly RJ, 2002, ONCOGENE, V21, P5175, DOI 10.1038/sj.onc.1205522; Dorsey JF, 2002, BLOOD, V99, P1388, DOI 10.1182/blood.V99.4.1388; Frey N, 2000, P NATL ACAD SCI USA, V97, P14632, DOI 10.1073/pnas.260501097; Gu HH, 1997, J BIOL CHEM, V272, P16421, DOI 10.1074/jbc.272.26.16421; Gu HH, 2001, NATURE, V412, P186, DOI 10.1038/35084076; Gu HH, 1998, MOL CELL, V2, P729, DOI 10.1016/S1097-2765(00)80288-9; Li SL, 1996, J MOL ENDOCRINOL, V16, P229, DOI 10.1677/jme.0.0160229; Liu JO, 2003, BIOCHEM BIOPH RES CO, V311, P1103, DOI 10.1016/j.bbrc.2003.10.020; Lynch DK, 2002, EMBO J, V21, P72, DOI 10.1093/emboj/21.1.72; Maurer U, 2006, MOL CELL, V21, P749, DOI 10.1016/j.molcel.2006.02.009; Miyakawa Y, 2001, J BIOL CHEM, V276, P2494, DOI 10.1074/jbc.M002633200; Oliveria SF, 2003, J CELL BIOL, V160, P101, DOI 10.1083/jcb.200209127; Palaga T, 2004, INT IMMUNOPHARMACOL, V4, P953, DOI 10.1016/j.intimp.2004.04.006; Pratt JC, 2000, J IMMUNOL, V165, P4158, DOI 10.4049/jimmunol.165.8.4158; Sattler M, 2002, CANCER CELL, V1, P479, DOI 10.1016/S1535-6108(02)00074-0; Timms JF, 1998, MOL CELL BIOL, V18, P3838, DOI 10.1128/MCB.18.7.3838; Wada T, 2005, NAT MED, V11, P394, DOI 10.1038/nm1203; Yano S, 1998, NATURE, V396, P584, DOI 10.1038/25147; Yao XQ, 1999, LIFE SCI, V65, P55, DOI 10.1016/S0024-3205(99)00218-0; Yu M, 2006, J BIOL CHEM, V281, P28615, DOI 10.1074/jbc.M603742200; Zhang Y, 2007, BLOOD, V110, P116, DOI 10.1182/blood-2006-11-060707	29	5	5	0	1	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	AUG 29	2008	283	35					23505	23509		10.1074/jbc.C800087200	http://dx.doi.org/10.1074/jbc.C800087200			5	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	340II	18586679	hybrid, Green Published			2022-12-27	WOS:000258638900002
J	Rodius, S; Chaloin, O; Moes, M; Schaffner-Reckinger, E; Landrieu, I; Lippens, G; Lin, MH; Zhang, J; Kieffer, N				Rodius, Sophie; Chaloin, Olivier; Moes, Michele; Schaffner-Reckinger, Elisabeth; Landrieu, Isabelle; Lippens, Guy; Lin, Minghui; Zhang, Ji; Kieffer, Nelly			The Talin rod IBS2 alpha-helix interacts with the beta 3 integrin cytoplasmic tail membrane-proximal helix by establishing charge complementary salt bridges	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							VINCULIN-BINDING-SITE; TYROSINE PHOSPHORYLATION; FOCAL ADHESIONS; ACTININ BINDING; DOMAIN; ACTIVATION; PROTEINS; IDENTIFICATION; BETA(3); ALPHA(IIB)BETA(3)	Talin establishes a major link between integrins and actin filaments and contains two distinct integrin binding sites: one, IBS1, located in the talin head domain and involved in integrin activation and a second, IBS2, that maps to helix 50 of the talin rod domain and is essential for linking integrin beta subunits to the cytoskeleton (Moes, M., Rodius, S., Coleman, S. J., Monkley, S. J., Goormaghtigh, E., Tremuth, L., Kox, C., van der Holst, P. P., Critchley, D. R., and Kieffer, N. ( 2007) J. Biol. Chem. 282, 17280 17288). Through the combined approach of mutational analysis of the beta 3 integrin cytoplasmic tail and the talin rod IBS2 site, SPR binding studies, as well as site-specific antibody inhibition experiments, we provide evidence that the integrin beta 3-talin rod interaction relies on a helix-helix association between alpha-helix 50 of the talin rod domain and the membrane-proximal alpha-helix of the beta 3 integrin cytoplasmic tail. Moreover, charge complementarity between the highly conserved talin rod IBS2 lysine residues and integrin beta 3 glutamic acid residues is necessary for this interaction. Our results support a model in which talin IBS2 binds to the same face of the beta 3 subunit cytoplasmic helix as the integrin alpha IIb cytoplasmic tail helix, suggesting that IBS2 can only interact with the beta 3 subunit following integrin activation.	[Lin, Minghui; Zhang, Ji; Kieffer, Nelly] Shanghai Jiao Tong Univ, CNRS LIS124, RuiJin Hosp, French Chinese Res Ctr Life Sci & Genom, Shanghai 200025, Peoples R China; [Rodius, Sophie; Moes, Michele; Schaffner-Reckinger, Elisabeth; Kieffer, Nelly] Univ Luxembourg, CNRS, GDRE ITI, Lab Biol & Physiol Integree, L-1511 Luxembourg, Luxembourg; [Chaloin, Olivier] Inst Biol Mol & Cellulaire, CNRS, UPR 9021, F-67084 Strasbourg, France; [Landrieu, Isabelle; Lippens, Guy] Univ Lille 1, Unite Glycobiol Struct & Fonct, CNRS, UMR 8576, F-59655 Villeneuve Dascq, France	Shanghai Jiao Tong University; University of Luxembourg; Centre National de la Recherche Scientifique (CNRS); UDICE-French Research Universities; Universites de Strasbourg Etablissements Associes; Universite de Strasbourg; Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Biology (INSB); Universite de Lille - ISITE; Universite de Lille	Kieffer, N (corresponding author), Shanghai Jiao Tong Univ, CNRS LIS124, RuiJin Hosp, French Chinese Res Ctr Life Sci & Genom, Shanghai 200025, Peoples R China.	nkieffer@pt.lu	Landrieu, Isabelle/AAF-8495-2019	Landrieu, Isabelle/0000-0002-4883-2637; Lippens, Guy/0000-0002-8236-0901	EU Marie Curie Research Training Network; HPRN-CT-2002-00253; Fondation Luxembourgeoise contre le Cancer ( Luxembourg); University of Luxembourg	EU Marie Curie Research Training Network(European Commission); HPRN-CT-2002-00253; Fondation Luxembourgeoise contre le Cancer ( Luxembourg); University of Luxembourg	This work was supported in part by funds from the EU Marie Curie Research Training Network (EC project HPRN-CT-2002-00253), the Fondation Luxembourgeoise contre le Cancer ( Luxembourg), and the University of Luxembourg. The costs of publication of this article were defrayed in part by the payment of page charges. This article must therefore be hereby marked "advertisement" in accordance with 18 U.S.C. Section 1734 solely to indicate this fact.	Altmann SM, 2002, STRUCTURE, V10, P1085, DOI 10.1016/S0969-2126(02)00808-0; Bass MD, 2002, BIOCHEM J, V362, P761, DOI 10.1042/0264-6021:3620761; Bodeau AL, 2001, J CELL SCI, V114, P2795; Brett TJ, 2006, NAT STRUCT MOL BIOL, V13, P121, DOI 10.1038/nsmb1043; Broderick MJF, 2002, J STRUCT BIOL, V137, P184, DOI 10.1006/jsbi.2002.4465; BURRIDGE K, 1983, CELL MOTIL CYTOSKEL, V3, P405, DOI 10.1002/cm.970030509; Chen H, 2006, J BIOL CHEM, V281, P40389, DOI 10.1074/jbc.M607324200; Craig SW, 1996, CURR OPIN CELL BIOL, V8, P74, DOI 10.1016/S0955-0674(96)80051-2; Djinovic-Carugo K, 2002, FEBS LETT, V513, P119, DOI 10.1016/S0014-5793(01)03304-X; Fillingham I, 2005, STRUCTURE, V13, P65, DOI 10.1016/j.str.2004.11.006; Giancotti FG, 2000, NAT CELL BIOL, V2, pE13, DOI 10.1038/71397; Gingras AR, 2006, BIOCHEMISTRY-US, V45, P1805, DOI 10.1021/bi052136l; Gingras AR, 2005, J BIOL CHEM, V280, P37217, DOI 10.1074/jbc.M508060200; Hoellerer MK, 2003, STRUCTURE, V11, P1207, DOI 10.1016/j.str.2003.08.010; Hughes PE, 1996, J BIOL CHEM, V271, P6571, DOI 10.1074/jbc.271.12.6571; Hynes RO, 2002, CELL, V110, P673, DOI 10.1016/S0092-8674(02)00971-6; Jockusch BM, 1995, ANNU REV CELL DEV BI, V11, P379, DOI 10.1146/annurev.cellbio.11.1.379; Kiema T, 2006, MOL CELL, V21, P337, DOI 10.1016/j.molcel.2006.01.011; Kim M, 2004, J CELL BIOL, V167, P1241, DOI 10.1083/jcb.200404160; KROEMKER M, 1994, FEBS LETT, V355, P259, DOI 10.1016/0014-5793(94)01216-4; Law DA, 1996, J BIOL CHEM, V271, P10811, DOI 10.1074/jbc.271.18.10811; Liu SC, 2000, J CELL SCI, V113, P3563; Ma YQ, 2006, BIOCHEMISTRY-US, V45, P6656, DOI 10.1021/bi060279h; MCGREGOR A, 1994, BIOCHEM J, V301, P225, DOI 10.1042/bj3010225; Moes M, 2007, J BIOL CHEM, V282, P17280, DOI 10.1074/jbc.M611846200; OTEY CA, 1993, J BIOL CHEM, V268, P21193; Otey CA, 2004, CELL MOTIL CYTOSKEL, V58, P104, DOI 10.1002/cm.20007; Papagrigoriou E, 2004, EMBO J, V23, P2942, DOI 10.1038/sj.emboj.7600285; Pierce MM, 2005, BIOCHEMISTRY-US, V44, P321, DOI 10.1021/bi047964d; Reddy KB, 1998, J BIOL CHEM, V273, P35039, DOI 10.1074/jbc.273.52.35039; Schaffner-Reckinger E, 1998, J BIOL CHEM, V273, P12623, DOI 10.1074/jbc.273.20.12623; Tanentzapf G, 2006, NAT CELL BIOL, V8, P601, DOI 10.1038/ncb1411; Tremuth L, 2004, J BIOL CHEM, V279, P22258, DOI 10.1074/jbc.M400947200; Ulmer TS, 2003, BIOCHEMISTRY-US, V42, P8307, DOI 10.1021/bi034384s; Vallar L, 1999, J BIOL CHEM, V274, P17257, DOI 10.1074/jbc.274.24.17257; Vinogradova O, 2004, P NATL ACAD SCI USA, V101, P4094, DOI 10.1073/pnas.0400742101; Vinogradova O, 2002, CELL, V110, P587, DOI 10.1016/S0092-8674(02)00906-6; Wegener KL, 2007, CELL, V128, P171, DOI 10.1016/j.cell.2006.10.048; Woodside DG, 2002, J BIOL CHEM, V277, P39401, DOI 10.1074/jbc.M207657200; Yan B, 2001, J BIOL CHEM, V276, P28164, DOI 10.1074/jbc.M104161200; Ylanne J, 2001, STRUCTURE, V9, P597, DOI 10.1016/S0969-2126(01)00619-0; Ylanne Jari, 2001, Cell Mol Biol Lett, V6, P234; Zhao RY, 2004, ARCH IMMUNOL THER EX, V52, P348	43	46	49	0	2	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	AUG 29	2008	283	35					24212	24223		10.1074/jbc.M709704200	http://dx.doi.org/10.1074/jbc.M709704200			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	340II	18577523	hybrid, Green Published			2022-12-27	WOS:000258638900075
J	Yahi, H; Fritsch, L; Philipot, O; Guasconi, V; Souidi, M; Robin, P; Polesskaya, A; Losson, R; Harel-Bellan, A; Ait-Si-Ali, S				Yahi, Hakima; Fritsch, Lauriane; Philipot, Ophelie; Guasconi, Valentina; Souidi, Mouloud; Robin, Philippe; Polesskaya, Anna; Losson, Regine; Harel-Bellan, Annick; Ait-Si-Ali, Slimane			Differential cooperation between heterochromatin protein HP1 isoforms and MyoD in myoblasts	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							SKELETAL-MUSCLE DIFFERENTIATION; H3 LYSINE-9 METHYLATION; HISTONE H3; MYOGENIC DIFFERENTIATION; MAMMALIAN-CELLS; TERMINAL DIFFERENTIATION; CHROMATIN-STRUCTURE; GENE ACTIVITY; STEM-CELLS; BINDING	Mechanisms of transcriptional repression are important during cell differentiation. Mammalian heterochromatin protein 1 isoforms HP1 alpha, HP1 beta, and HP1 gamma play important roles in the regulation of chromatin structure and function. We explored the possibility of different roles for the three HP1 isoforms in an integrated system, skeletalmuscleterminaldifferentiation. Inthissystem, terminal differentiation is initiated by the transcription factor MyoD, whose target genes remain mainly silent until myoblasts are induced to differentiate. Here we show that HP1 beta and HP1 gamma isoforms, but not HP1 alpha, interact withMyoDin myoblasts. This interaction is direct, as shown using recombinant proteins in vitro. A gene reporter assay revealed that HP1 alpha and HP1 beta, but not HP1 gamma, inhibit MyoD transcriptional activity, suggesting a model in which MyoD could serve as a bridge between nucleosomes and chromatinbinding proteins such as HDACs and HP1. Chromatin immunoprecipitationassaysshowapreferentialrecruitmentofHP1proteins on MyoD target genes in proliferating myoblasts. Finally, modulation ofHP1protein level impairsMyoDtarget gene expression and muscle terminal differentiation. Together, our data show a nonconventional interaction between HP1 and a tissue- specific transcription factor, MyoD. In addition, they strongly suggest that HP1 isoforms play important roles during muscle terminal differentiation in an isoform- dependent manner.	[Yahi, Hakima; Fritsch, Lauriane; Philipot, Ophelie; Guasconi, Valentina; Souidi, Mouloud; Robin, Philippe; Polesskaya, Anna; Harel-Bellan, Annick; Ait-Si-Ali, Slimane] Univ Paris Sud, CNRS, FRE 2944, Inst Andre Lwoff, F-94801 Villejuif, France; [Losson, Regine] Univ Strasbourg 1, Coll France, Inst Genet & Biol Mol & Cellulaire, CNRS,UMR 7104, F-67404 Illkirch Graffenstaden, France; [Losson, Regine] Univ Strasbourg 1, Coll France, INSERM, U 596, F-67404 Illkirch Graffenstaden, France	Centre National de la Recherche Scientifique (CNRS); UDICE-French Research Universities; Universite Paris Saclay; Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Biology (INSB); Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; PSL Research University Paris; College de France; Universites de Strasbourg Etablissements Associes; Universite de Strasbourg; Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; PSL Research University Paris; College de France; Universites de Strasbourg Etablissements Associes; Universite de Strasbourg	Ait-Si-Ali, S (corresponding author), Univ Paris Sud, CNRS, FRE 2944, Inst Andre Lwoff, 7 Rue Guy Moquet,94800 Villejuif, F-94801 Villejuif, France.	aitsiali@vjf.cnrs.fr	Harel-Bellan, Annick/M-9795-2015; SOUIDI, Mouloud/ABI-1444-2020	Harel-Bellan, Annick/0000-0002-2339-153X				Aagaard L, 1999, EMBO J, V18, P1923, DOI 10.1093/emboj/18.7.1923; Agarwal N, 2007, NUCLEIC ACIDS RES, V35, P5402, DOI 10.1093/nar/gkm599; Ait-Si-Ali S, 2004, EMBO J, V23, P605, DOI 10.1038/sj.emboj.7600074; Bannister AJ, 2001, NATURE, V410, P120, DOI 10.1038/35065138; Brero A, 2005, J CELL BIOL, V169, P733, DOI 10.1083/jcb.200502062; Buckingham M, 1996, BIOCHEM SOC T, V24, P506, DOI 10.1042/bst0240506; Cammas F, 2004, GENE DEV, V18, P2147, DOI 10.1101/gad.302904; Cammas F, 2002, J CELL SCI, V115, P3439; Caretti G, 2004, GENE DEV, V18, P2627, DOI 10.1101/gad.1241904; Cavalli G, 1998, CURR OPIN CELL BIOL, V10, P354, DOI 10.1016/S0955-0674(98)80011-2; Czvitkovich S, 2001, MECH DEVELOP, V107, P141, DOI 10.1016/S0925-4773(01)00464-6; de la Serna IL, 2001, NAT GENET, V27, P187, DOI 10.1038/84826; Demarco IA, 2006, NAT METHODS, V3, P519, DOI 10.1038/NMETH889; Dialynas GK, 2007, J CELL SCI, V120, P3415, DOI 10.1242/jcs.012914; EISSENBERG JC, 1990, P NATL ACAD SCI USA, V87, P9923, DOI 10.1073/pnas.87.24.9923; Francastel C, 2000, NAT REV MOL CELL BIO, V1, P137, DOI 10.1038/35040083; Fulco M, 2003, MOL CELL, V12, P51, DOI 10.1016/S1097-2765(03)00226-0; Guasconi V, 2005, CANCER BIOL THER, V4, P134; Hediger F, 2006, CURR OPIN GENET DEV, V16, P143, DOI 10.1016/j.gde.2006.02.013; Ito H, 2001, EXP CELL RES, V266, P213, DOI 10.1006/excr.2001.5220; Lachner M, 2001, NATURE, V410, P116, DOI 10.1038/35065132; Lechner MS, 2005, BIOCHEM BIOPH RES CO, V331, P929, DOI 10.1016/j.bbrc.2005.04.016; Lomberk G, 2006, GENOME BIOL, V7, DOI 10.1186/gb-2006-7-7-228; Mal A, 2003, P NATL ACAD SCI USA, V100, P1735, DOI 10.1073/pnas.0437843100; Mal A, 2001, EMBO J, V20, P1739, DOI 10.1093/emboj/20.7.1739; Mal AK, 2006, EMBO J, V25, P3323, DOI 10.1038/sj.emboj.7601229; Meshorer E, 2006, DEV CELL, V10, P105, DOI 10.1016/j.devcel.2005.10.017; Meshorer E, 2006, NAT REV MOL CELL BIO, V7, P540, DOI 10.1038/nrm1938; Minc E, 1999, CHROMOSOMA, V108, P220, DOI 10.1007/s004120050372; Minc E, 2000, CYTOGENET CELL GENET, V90, P279, DOI 10.1159/000056789; Minc E., 2001, Methods in Cell Science, V23, P171, DOI 10.1023/A:1013168323754; Moen PT, 2004, MOL BIOL CELL, V15, P197, DOI 10.1091/mbc.e03-06-0388; Narita M, 2003, CELL, V113, P703, DOI 10.1016/S0092-8674(03)00401-X; Nielsen AL, 1999, EMBO J, V18, P6385, DOI 10.1093/emboj/18.22.6385; Nielsen AL, 2001, MOL CELL, V7, P729, DOI 10.1016/S1097-2765(01)00218-0; Nielsen AL, 2002, EMBO J, V21, P5797, DOI 10.1093/emboj/cdf560; Nielsen SJ, 2001, NATURE, V412, P561, DOI 10.1038/35087620; Ohkawa Y, 2006, EMBO J, V25, P490, DOI 10.1038/sj.emboj.7600943; Panteleeva I, 2007, EMBO J, V26, P3616, DOI 10.1038/sj.emboj.7601789; Polesskaya A, 2000, J BIOL CHEM, V275, P34359, DOI 10.1074/jbc.M003815200; Robin P, 2007, GENOME BIOL, V8, DOI 10.1186/gb-2007-8-12-r270; Sharma GG, 2003, MOL CELL BIOL, V23, P8363, DOI 10.1128/MCB.23.22.8363-8376.2003; Stewart MD, 2005, MOL CELL BIOL, V25, P2525, DOI 10.1128/MCB.25.7.2525-2538.2005; Stopka T, 2005, EMBO J, V24, P3712, DOI 10.1038/sj.emboj.7600834; Vakoc CR, 2005, MOL CELL, V19, P381, DOI 10.1016/j.molcel.2005.06.011; Vassallo MF, 2002, P NATL ACAD SCI USA, V99, P5919, DOI 10.1073/pnas.092025499; Viens A, 2004, ANAL BIOCHEM, V325, P68, DOI 10.1016/j.ab.2003.10.015; Walsh K, 1997, CURR OPIN GENET DEV, V7, P597, DOI 10.1016/S0959-437X(97)80005-6; Zhang CL, 2002, MOL CELL BIOL, V22, P7302, DOI 10.1128/MCB.22.20.7302-7312.2002	49	25	25	0	3	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	AUG 29	2008	283	35					23692	23700		10.1074/jbc.M802647200	http://dx.doi.org/10.1074/jbc.M802647200			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	340II	18599480	Green Published, hybrid			2022-12-27	WOS:000258638900023
J	Camacho, M; Machado, JD; Alvarez, J; Borges, R				Camacho, Marcial; Machado, Jose D.; Alvarez, Javier; Borges, Ricardo			Intravesicular calcium release mediates the motion and exocytosis of secretory organelles - A study with adrenal chromaffin cells	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							PLASMA-MEMBRANE; H+-ATPASE; GRANULES; VESICLES; CATECHOLAMINES; INHIBITORS; BINDING; STORAGE; CHROMOGRANINS; BAFILOMYCINS	Secretory vesicles of sympathetic neurons and chromaffin granules maintain a pH gradient toward the cytosol (pH 5.5 versus 7.2) promoted by the V-ATPase activity. This gradient of pH is also responsible for the accumulation of amines and Ca2+ because their transporters use H+ as the counter ion. We have recently shown that alkalinization of secretory vesicles slowed down exocytosis, whereas acidification caused the opposite effect. In this paper, we measure the alkalinization of vesicular pH, caused by the V-ATPase inhibitor bafilomycin A1, by total internal reflection fluorescence microscopy in cells overexpressing the enhanced green fluorescent protein-labeled synaptobrevin (VAMP2-EGFP) protein. The disruption of the vesicular gradient of pH caused the leak of Ca2+, measured with fura-2. Fluorimetric measurements, using the dye Oregon green BAPTA-2, showed that bafilomycin directly released Ca2+ from freshly isolated vesicles. The Ca2+ released from vesicles to the cytosol dramatically increased the granule motion of chromaffin- or PC12-derived granules and triggered exocytosis (measured by amperometry). We conclude that the gradient of pH of secretory vesicles might be involved in the homeostatic regulation of cytosolic Ca2+ and in two of the major functions of secretory cells, vesicle motion and exocytosis.	[Camacho, Marcial; Machado, Jose D.; Borges, Ricardo] Univ La Laguna, Unidad Farmacol, Fac Med, E-38071 San Cristobal la Laguna, Spain; [Alvarez, Javier] Inst Biol & Genet Mol, E-47005 Valladolid, Spain	Universidad de la Laguna; Consejo Superior de Investigaciones Cientificas (CSIC); CSIC-UVA - Instituto de Biologia y Genetica Molecular (IBGM)	Machado, JD (corresponding author), Univ La Laguna, Unidad Farmacol, Fac Med, E-38071 San Cristobal la Laguna, Spain.	jdmacha@ull.es	Machado, José David/N-5210-2014; Borges, Ricardo/N-3250-2014; Alvarez, Javier/K-8210-2014	Machado, José David/0000-0003-3531-7051; Borges, Ricardo/0000-0003-3413-4392; Alvarez, Javier/0000-0003-0636-5521; Camacho Perez, Marcial/0000-0002-2367-1259				Albillos A, 1997, NATURE, V389, P509, DOI 10.1038/39081; Allersma MW, 2006, MOL BIOL CELL, V17, P2424, DOI 10.1091/mbc.E05-10-0938; Allersma MW, 2004, MOL BIOL CELL, V15, P4658, DOI 10.1091/mbc.E04-02-0149; BOROWITZ JL, 1967, J CELL PHYSIOL, V69, P311, DOI 10.1002/jcp.1040690307; BOWMAN EJ, 1988, P NATL ACAD SCI USA, V85, P7972, DOI 10.1073/pnas.85.21.7972; Buchanan CM, 2001, BIOCHEM J, V360, P431, DOI 10.1042/0264-6021:3600431; BULENDA D, 1985, BIOCHEMISTRY-US, V24, P7760, DOI 10.1021/bi00347a039; Camacho M, 2006, J NEUROCHEM, V96, P324, DOI 10.1111/j.1471-4159.2005.03526.x; Drose S, 1997, J EXP BIOL, V200, P1; Gagliardi S, 1998, J MED CHEM, V41, P1883, DOI 10.1021/jm9707838; Garcia AG, 2006, PHYSIOL REV, V86, P1093, DOI 10.1152/physrev.00039.2005; GRYNKIEWICZ G, 1985, J BIOL CHEM, V260, P3440; HAIGH JR, 1993, NEUROREPORT, V4, P571, DOI 10.1097/00001756-199305000-00028; HAIGH JR, 1989, BIOCHEM J, V259, P485, DOI 10.1042/bj2590485; HARTREE EF, 1972, ANAL BIOCHEM, V48, P422, DOI 10.1016/0003-2697(72)90094-2; Haynes CL, 2006, BIOPHYS CHEM, V123, P20, DOI 10.1016/j.bpc.2006.04.005; HELLE KB, 1985, ACTA PHYSIOL SCAND, V123, P21, DOI 10.1111/j.1748-1716.1985.tb07556.x; JANKOWSKI JA, 1993, J BIOL CHEM, V268, P14694; JOHANNES L, 1994, EMBO J, V13, P2029, DOI 10.1002/j.1460-2075.1994.tb06476.x; KAWAGOE KT, 1993, J NEUROSCI METH, V48, P225, DOI 10.1016/0165-0270(93)90094-8; Machado JD, 2000, J BIOL CHEM, V275, P20274, DOI 10.1074/jbc.M000930200; Machado JD, 2002, CIRC RES, V91, P830, DOI 10.1161/01.RES.0000039530.30495.6F; Mahapatra NR, 2004, J BIOL CHEM, V279, P51107, DOI 10.1074/jbc.M408742200; Moreno A, 2005, CELL CALCIUM, V37, P555, DOI 10.1016/j.ceca.2005.02.002; Mundorf ML, 1999, J NEUROCHEM, V73, P2397, DOI 10.1046/j.1471-4159.1999.0732397.x; Mundorf ML, 2000, J BIOL CHEM, V275, P9136, DOI 10.1074/jbc.275.13.9136; Nelson N, 1999, PHYSIOL REV, V79, P361, DOI 10.1152/physrev.1999.79.2.361; Plattner H, 1997, J CELL BIOL, V139, P1709, DOI 10.1083/jcb.139.7.1709; SALA F, 1990, BIOPHYS J, V57, P313, DOI 10.1016/S0006-3495(90)82533-9; Segura F, 2000, J NEUROSCI METH, V103, P151, DOI 10.1016/S0165-0270(00)00309-5; SMITH AD, 1967, BIOCHEM J, V103, P480, DOI 10.1042/bj1030480; Steyer JA, 1999, BIOPHYS J, V76, P2262, DOI 10.1016/S0006-3495(99)77382-0; Taraska JW, 2003, P NATL ACAD SCI USA, V100, P2070, DOI 10.1073/pnas.0337526100; Taupenot L, 2005, J BIOL CHEM, V280, P3885, DOI 10.1074/jbc.M408197200; VIDEEN JS, 1992, J BIOL CHEM, V267, P3066; VONRUDEN L, 1993, SCIENCE, V262, P1061, DOI 10.1126/science.8235626; WILSON SP, 1995, ANAL BIOCHEM, V226, P212, DOI 10.1006/abio.1995.1216; WINKLER H, 1980, NEUROSCIENCE, V5, P1803, DOI 10.1016/0306-4522(80)90031-7; WINKLER H, 1993, J ANAT, V183, P237; YOO SH, 1991, J BIOL CHEM, V266, P7740	40	43	43	0	8	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	AUG 15	2008	283	33					22383	22389		10.1074/jbc.M800552200	http://dx.doi.org/10.1074/jbc.M800552200			7	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	335VR	18562320	hybrid			2022-12-27	WOS:000258321000006
J	Garst, AD; Heroux, A; Rambo, RP; Batey, RT				Garst, Andrew D.; Heroux, Annie; Rambo, Robert P.; Batey, Robert T.			Crystal structure of the lysine riboswitch regulatory mRNA element	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							GENE-EXPRESSION; RECOGNITION; MOTIF; BIOSYNTHESIS; MECHANISMS; SCATTERING; BACTERIA; ANALOGS; TARGETS; LIGAND	Riboswitches are metabolite-sensitive elements found in mRNAs that control gene expression through a regulatory secondary structural switch. Along with regulation of lysine biosynthetic genes, mutations within the lysine-responsive riboswitch (L-box) play a role in the acquisition of resistance to antimicrobiallysine analogs. To understand the structural basis for lysine binding, we have determined the 2.8 angstrom resolution crystal structure of lysine bound to the Thermotoga maritima asd lysine riboswitch ligand-binding domain. The structure reveals a complex architecture scaffolding a binding pocket completely enveloping lysine. Mutations conferring antimicrobial resistance cluster around this site as well as highly conserved long range interactions, indicating that they disrupt lysine binding or proper folding of the RNA. Comparison of the free and bound forms by x-ray crystallography, small angle x-ray scattering, and chemical probing reveals almost identical structures, indicating that lysine induces only limited and local conformational changes upon binding.	[Garst, Andrew D.; Batey, Robert T.] Univ Colorado, Dept Chem & Biochem, Boulder, CO 80309 USA; [Heroux, Annie] Brookhaven Natl Lab, Dept Biol, Upton, NY 11973 USA; [Rambo, Robert P.] Univ Calif Berkeley, Lawrence Berkeley Lab, Div Life Sci, Berkeley, CA 94720 USA	University of Colorado System; University of Colorado Boulder; United States Department of Energy (DOE); Brookhaven National Laboratory; United States Department of Energy (DOE); Lawrence Berkeley National Laboratory; University of California System; University of California Berkeley	Batey, RT (corresponding author), Univ Colorado, Dept Chem & Biochem, Campus Box 215, Boulder, CO 80309 USA.	robert.batey@colorado.edu	Batey, Robert/A-8265-2009	Batey, Robert/0000-0002-1384-6625	NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM073850] Funding Source: NIH RePORTER; NIGMS NIH HHS [GM073850] Funding Source: Medline	NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		Adams PD, 2002, ACTA CRYSTALLOGR D, V58, P1948, DOI 10.1107/S0907444902016657; Ataide SF, 2007, ACS CHEM BIOL, V2, P819, DOI 10.1021/cb7002253; Barrick JE, 2007, GENOME BIOL, V8, DOI 10.1186/gb-2007-8-11-r239; Blouin S, 2007, RNA, V13, P1256, DOI 10.1261/rna.560307; Blount KF, 2007, NAT CHEM BIOL, V3, P44, DOI 10.1038/nchembio842; Blount KF, 2006, NAT BIOTECHNOL, V24, P1558, DOI 10.1038/nbt1268; Cheah MT, 2007, NATURE, V447, P497, DOI 10.1038/nature05769; Correll CC, 1998, P NATL ACAD SCI USA, V95, P13436, DOI 10.1073/pnas.95.23.13436; DeLano W.L, PYMOL MOL GRAPHICS S; Edwards TE, 2006, STRUCTURE, V14, P1459, DOI 10.1016/j.str.2006.07.008; Emsley P, 2004, ACTA CRYSTALLOGR D, V60, P2126, DOI 10.1107/S0907444904019158; FAMULOK M, 1994, J AM CHEM SOC, V116, P1698, DOI 10.1021/ja00084a010; Grundy FJ, 2003, P NATL ACAD SCI USA, V100, P12057, DOI 10.1073/pnas.2133705100; Guinier A., 1955, SMALL ANGLE SCATTERI; Guo F, 2006, RNA, V12, P387, DOI 10.1261/rna.2198206; Irnov AK, 2006, COLD SH Q B, V71, P239, DOI 10.1101/sqb.2006.71.021; Klein DJ, 2001, EMBO J, V20, P4214, DOI 10.1093/emboj/20.15.4214; Laederach A, 2007, RNA, V13, P643, DOI 10.1261/rna.381407; Leontis NB, 2001, RNA, V7, P499, DOI 10.1017/S1355838201002515; Leontis NB, 2006, CURR OPIN STRUC BIOL, V16, P279, DOI 10.1016/j.sbi.2006.05.009; Lipfert J, 2007, ANNU REV BIOPH BIOM, V36, P307, DOI 10.1146/annurev.biophys.36.040306.132655; LU Y, 1992, FEMS MICROBIOL LETT, V92, P23, DOI 10.1016/0378-1097(92)90536-W; Montange RK, 2006, NATURE, V441, P1172, DOI 10.1038/nature04819; Mulhbacher J, 2007, NUCLEIC ACIDS RES, V35, P5568, DOI 10.1093/nar/gkm572; Nissen P, 2001, P NATL ACAD SCI USA, V98, P4899, DOI 10.1073/pnas.081082398; Otwinowski Z, 1997, METHOD ENZYMOL, V276, P307, DOI 10.1016/S0076-6879(97)76066-X; Patte JC, 1998, FEMS MICROBIOL LETT, V169, P165, DOI 10.1016/S0378-1097(98)00479-0; Pflugrath JW, 1999, ACTA CRYSTALLOGR D, V55, P1718, DOI 10.1107/S090744499900935X; Putnam CD, 2007, Q REV BIOPHYS, V40, P191, DOI 10.1017/S0033583507004635; Rodionov DA, 2003, NUCLEIC ACIDS RES, V31, P6748, DOI 10.1093/nar/gkg900; Russell R, 2002, P NATL ACAD SCI USA, V99, P4266, DOI 10.1073/pnas.072589599; Schneider TR, 2002, ACTA CRYSTALLOGR D, V58, P1772, DOI 10.1107/S0907444902011678; Serganov A, 2006, NATURE, V441, P1167, DOI 10.1038/nature04740; Sheldrick GM, 2002, Z KRISTALLOGR, V217, P644, DOI 10.1524/zkri.217.12.644.20662; Sudarsan N, 2003, GENE DEV, V17, P2688, DOI 10.1101/gad.1140003; SVERGUN DI, 1992, J APPL CRYSTALLOGR, V25, P495, DOI 10.1107/S0021889892001663; Thore S, 2006, SCIENCE, V312, P1208, DOI 10.1126/science.1128451; Wachter A, 2007, PLANT CELL, V19, P3437, DOI 10.1105/tpc.107.053645; Wickiser JK, 2005, MOL CELL, V18, P49, DOI 10.1016/j.molcel.2005.02.032; Wilkinson KA, 2006, NAT PROTOC, V1, P1610, DOI 10.1038/nprot.2006.249; Wilson DS, 1999, ANNU REV BIOCHEM, V68, P611, DOI 10.1146/annurev.biochem.68.1.611; Winkler WC, 2005, ANNU REV MICROBIOL, V59, P487, DOI 10.1146/annurev.micro.59.030804.121336	42	147	149	0	20	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	AUG 15	2008	283	33					22347	22351		10.1074/jbc.C800120200	http://dx.doi.org/10.1074/jbc.C800120200			5	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	335VR	18593706	hybrid, Green Published			2022-12-27	WOS:000258321000002
J	Kota, S; Sabbah, A; Chang, TH; Harnack, R; Xiang, Y; Meng, X; Bose, S				Kota, Srikanth; Sabbah, Ahmed; Chang, Te Hung; Harnack, Rosalinda; Xiang, Yan; Meng, Xiangzhi; Bose, Santanu			Role of human beta-defensin-2 during tumor necrosis factor-alpha/NF-kappa B- mediated innate antiviral response against human respiratory syncytial virus	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							LUNG EPITHELIAL-CELLS; MULTIPLE SIGNALING PATHWAYS; INFECTION IN-VITRO; GENE-EXPRESSION; BETA-DEFENSINS; TYPE-3 INFECTION; TRANSCRIPTIONAL REGULATION; ALVEOLAR MACROPHAGES; HEPARAN-SULFATE; RNA VIRUSES	Human respiratory syncytial virus (RSV) constitutes a highly pathogenic virus that infects lung epithelial cells to cause a wide spectrum of respiratory diseases. Our recent studies have revealed the existence of an interferon-alpha/beta-independent, innate antiviral response against RSV that was dependent on activation of NF-kappa B. We demonstrated that NF-kappa B inducing pro-inflammatory cytokines like tumor necrosis factor-alpha(TNF) confers potent antiviral function against RSV in an NF-kappa B-dependent fashion, independent of interferon-alpha/beta. During our efforts to study this pathway, we identified HBD2 (human beta-defensin-2), a soluble secreted cationic protein as an antiviral factor induced during NF-kappa B-dependent innate antiviral activity in human lung epithelial cells. Our results demonstrated that HBD2 is induced by TNF and RSV in an NF-kappa B-dependent manner. Induction of HBD2 in infected cells was mediated by the paracrine/autocrine action of TNF produced upon RSV infection. HBD2 plays a critical role during host defense, because purified HBD2 drastically inhibited RSV infection. We also show that the antiviral mechanism of HBD2 involves blocking of viral cellular entry possibly because of destabilization/disintegration of the viral envelope. The important role of HBD2 in the innate response was also evident from loss of antiviral activity of TNF upon HBD2 silencing by short interfering RNA. The in vivo physiological relevance of HBD2 in host defense was apparent from induction of murine beta-defensin-4 (murine counterpart of HBD2) in lung tissues of RSV-infected mice. Thus, HBD2 functions as an antiviral molecule during NF-kappa B-dependent innate antiviral immunity mediated by the autocrine/paracrine action of TNF.	[Kota, Srikanth; Sabbah, Ahmed; Chang, Te Hung; Harnack, Rosalinda; Xiang, Yan; Meng, Xiangzhi; Bose, Santanu] Univ Texas Hlth Sci Ctr San Antonio, Dept Microbiol & Immunol, San Antonio, TX 78229 USA	University of Texas System; University of Texas Health San Antonio	Bose, S (corresponding author), Univ Texas Hlth Sci Ctr San Antonio, Dept Microbiol & Immunol, 7703 Floyd Curl Dr,MC-7758, San Antonio, TX 78229 USA.	bose@uthscsa.edu		Xiang, Yan/0000-0002-7633-1629	NCI NIH HHS [CA129246] Funding Source: Medline; NIAID NIH HHS [AI069062] Funding Source: Medline; NIDCR NIH HHS [T32-DE14318] Funding Source: Medline; NATIONAL CANCER INSTITUTE [R21CA129246] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R21AI069062] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DENTAL & CRANIOFACIAL RESEARCH [T32DE014318] Funding Source: NIH RePORTER	NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NIAID NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NIDCR NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Dental & Craniofacial Research (NIDCR)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF DENTAL & CRANIOFACIAL RESEARCH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Dental & Craniofacial Research (NIDCR))		Arns CW, 2003, BRAZ J MED BIOL RES, V36, P213, DOI 10.1590/S0100-879X2003000200008; Atreya PL, 1999, VIROLOGY, V261, P227, DOI 10.1006/viro.1999.9835; Bals R, 1999, INFECT IMMUN, V67, P3542, DOI 10.1128/IAI.67.7.3542-3547.1999; Basu M, 2006, J GEN VIROL, V87, P2653, DOI 10.1099/vir.0.82039-0; BECKER S, 1991, J IMMUNOL, V147, P4307; Biermer M, 2003, J VIROL, V77, P4033, DOI 10.1128/JVI.77.7.4033-4042.2003; Bitko V, 2005, NAT MED, V11, P50, DOI 10.1038/nm1164; Bitko V, 2001, BMC Microbiol, V1, P34, DOI 10.1186/1471-2180-1-34; Bitko V, 1997, VIROLOGY, V232, P369, DOI 10.1006/viro.1997.8582; Bohling A, 2006, BIOCHEMISTRY-US, V45, P5663, DOI 10.1021/bi052026e; Bose S, 2004, J VIROL, V78, P8146, DOI 10.1128/JVI.78.15.8146-8158.2004; Bose S, 2003, J INTERF CYTOK RES, V23, P401, DOI 10.1089/107999003322277810; Bose S, 2003, P NATL ACAD SCI USA, V100, P10890, DOI 10.1073/pnas.1832775100; Bose S, 2002, VIROLOGY, V298, P73, DOI 10.1006/viro.2002.1484; Bose S, 2001, J VIROL, V75, P1984, DOI 10.1128/JVI.75.4.1984-1989.2001; Brasier AR, 1998, J BIOL CHEM, V273, P3551, DOI 10.1074/jbc.273.6.3551; Brown G, 2002, J GEN VIROL, V83, P611, DOI 10.1099/0022-1317-83-3-611; Brown HJ, 2003, J VIROL, V77, P8532, DOI 10.1128/JVI.77.15.8532-8540.2003; CAMERINIOTERO RD, 1975, EUR J BIOCHEM, V53, P343, DOI 10.1111/j.1432-1033.1975.tb04074.x; Carpenter LR, 2002, BMC INFECT DIS, V2, DOI 10.1186/1471-2334-2-5; Chavez-Bueno S, 2005, VIROL J, V2, DOI 10.1186/1743-422X-2-46; Chen Christiane I-U, 2004, J Cyst Fibros, V3, P45, DOI 10.1016/j.jcf.2003.12.008; CHIPPS BE, 1993, PEDIATR INFECT DIS J, V12, P653, DOI 10.1097/00006454-199308000-00006; Choudhary S, 2005, J VIROL, V79, P8948, DOI 10.1128/JVI.79.14.8948-8959.2005; COLLINS PL, 2001, FIELDS VIROLOGY, P1443; Falsey AR, 2005, NEW ENGL J MED, V352, P1749, DOI 10.1056/NEJMoa043951; Feldman SA, 2000, J VIROL, V74, P6442, DOI 10.1128/JVI.74.14.6442-6447.2000; Feng Z, 2006, J IMMUNOL, V177, P782, DOI 10.4049/jimmunol.177.2.782; FRANKEULLMANN G, 1995, J IMMUNOL, V154, P268; Garofalo RP, 2000, AM J RESP CELL MOL, V23, P581, DOI 10.1165/ajrcmb.23.5.f204; Garofalo RP, 2001, J INFECT DIS, V184, P393, DOI 10.1086/322788; Hallak LK, 2000, VIROLOGY, V271, P264, DOI 10.1006/viro.2000.0293; Hao HN, 2001, J NEUROCHEM, V77, P1027, DOI 10.1046/j.1471-4159.2001.00305.x; Harder J, 2001, J BIOL CHEM, V276, P5707, DOI 10.1074/jbc.M008557200; Hazrati E, 2006, J IMMUNOL, V177, P8658, DOI 10.4049/jimmunol.177.12.8658; Hiratsuka T, 1998, BIOCHEM BIOPH RES CO, V249, P943, DOI 10.1006/bbrc.1998.9239; Jia HP, 2000, J BIOL CHEM, V275, P33314, DOI 10.1074/jbc.M006603200; Krisanaprakornkit S, 2000, INFECT IMMUN, V68, P2907, DOI 10.1128/IAI.68.5.2907-2915.2000; Krisanaprakornkit S, 1998, INFECT IMMUN, V66, P4222; LEHRER RI, 1993, ANNU REV IMMUNOL, V11, P105, DOI 10.1146/annurev.iy.11.040193.000541; LICHTENSTEIN AK, 1988, J IMMUNOL, V140, P2686; McDermott AM, 2003, INVEST OPHTH VIS SCI, V44, P1859, DOI 10.1167/iovs.02-0787; McNamara PS, 2004, EUR RESPIR J, V23, P106, DOI 10.1183/09031936.03.00048103; Mejias A, 2005, ANTIMICROB AGENTS CH, V49, P4700, DOI 10.1128/AAC.49.11.4700-4707.2005; Meng XZ, 2006, VIROLOGY, V353, P220, DOI 10.1016/j.virol.2006.05.032; MEROLLA R, 1995, AM J RESP CRIT CARE, V152, P1358, DOI 10.1164/ajrccm.152.4.7551395; MIDULLA F, 1993, J INFECT DIS, V168, P1515, DOI 10.1093/infdis/168.6.1515; Mineshiba J, 2005, FEMS IMMUNOL MED MIC, V45, P37, DOI 10.1016/j.femsim.2005.01.008; Morrison TG, 2003, BBA-BIOMEMBRANES, V1614, P73, DOI 10.1016/S0005-2736(03)00164-0; Munk C, 2003, AIDS RES HUM RETROV, V19, P875, DOI 10.1089/088922203322493049; Neuzil KM, 1996, AM J MED SCI, V311, P201, DOI 10.1097/00000441-199605000-00001; O'Neil DA, 1999, J IMMUNOL, V163, P6718; PANUSKA JR, 1990, AM J PHYSIOL, V259, pL396, DOI 10.1152/ajplung.1990.259.6.L396; Pebernard S, 2004, DIFFERENTIATION, V72, P103, DOI 10.1111/j.1432-0436.2004.07202001.x; Proud D, 2004, J IMMUNOL, V172, P4637, DOI 10.4049/jimmunol.172.7.4637; Quinones-Mateu ME, 2003, AIDS, V17, pF39, DOI [10.1097/00002030-200311070-00001, 10.1097/01.aids.0000096878.73209.4f]; Raj PA, 2002, FEMS MICROBIOL LETT, V206, P9, DOI 10.1111/j.1574-6968.2002.tb10979.x; Rivas-Santiago B, 2005, INFECT IMMUN, V73, P4505, DOI 10.1128/IAI.73.8.4505-4511.2005; Ross DJ, 2004, TRANSPLANTATION, V78, P1222, DOI 10.1097/01.TP.0000137265.18491.75; Sakai S, 1997, J MED VIROL, V53, P145, DOI 10.1002/(SICI)1096-9071(199710)53:2<145::AID-JMV6>3.0.CO;2-9; Schaefer TM, 2005, J IMMUNOL, V174, P992, DOI 10.4049/jimmunol.174.2.992; Schaller-Bals S, 2002, AM J RESP CRIT CARE, V165, P992, DOI 10.1164/ajrccm.165.7.200110-020; Schutte BC, 2002, ANNU REV PHYSIOL, V64, P709, DOI 10.1146/annurev.physiol.64.081501.134340; Sen GC, 2001, ANNU REV MICROBIOL, V55, P255, DOI 10.1146/annurev.micro.55.1.255; Seo SH, 2002, J VIROL, V76, P1071, DOI 10.1128/JVI.76.3.1071-1076.2002; Seo SH, 2002, NAT MED, V8, P950, DOI 10.1038/nm757; Sheeran P, 1999, PEDIATR INFECT DIS J, V18, P115, DOI 10.1097/00006454-199902000-00007; Shiba H, 2003, BIOCHEM BIOPH RES CO, V306, P867, DOI 10.1016/S0006-291X(03)01075-1; Singh PK, 1998, P NATL ACAD SCI USA, V95, P14961, DOI 10.1073/pnas.95.25.14961; Sinha S, 2003, ANTIMICROB AGENTS CH, V47, P494, DOI 10.1128/AAC.47.2.494-500.2003; Soukup JM, 2003, CLIN IMMUNOL, V107, P178, DOI 10.1016/S1521-6616(03)00038-X; Spann KM, 2005, J VIROL, V79, P5353, DOI 10.1128/JVI.79.9.5353-5362.2005; Stark GR, 1998, ANNU REV BIOCHEM, V67, P227, DOI 10.1146/annurev.biochem.67.1.227; Sun LL, 2005, J VIROL, V79, P14318, DOI 10.1128/JVI.79.22.14318-14329.2005; Tamura M, 2000, J VIROL, V74, P11589, DOI 10.1128/JVI.74.24.11589-11597.2000; Tomita T, 2002, RESPIROLOGY, V7, P305, DOI 10.1046/j.1440-1843.2002.00415.x; Tsutsumi H, 1999, J LEUKOCYTE BIOL, V66, P99, DOI 10.1002/jlb.66.1.99; Tsutsumi-Ishii Y, 2002, J LEUKOCYTE BIOL, V71, P154; UEBA O, 1978, ACTA MED OKAYAMA, V32, P265; Veldhuizen EJA, 2008, MOL IMMUNOL, V45, P386, DOI 10.1016/j.molimm.2007.06.001; Wietek C, 2007, TRENDS BIOCHEM SCI, V32, P311, DOI 10.1016/j.tibs.2007.05.003; Zhang LQ, 2002, SCIENCE, V298, P995, DOI 10.1126/science.1076185	82	96	106	0	9	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	AUG 15	2008	283	33					22417	22429		10.1074/jbc.M710415200	http://dx.doi.org/10.1074/jbc.M710415200			13	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	335VR	18567888	Green Published, hybrid			2022-12-27	WOS:000258321000010
J	Smerdel-Ramoya, A; Zanotti, S; Deregowski, V; Canalis, E				Smerdel-Ramoya, Anna; Zanotti, Stefano; Deregowski, Valerie; Canalis, Ernesto			Connective tissue growth factor enhances osteoblastogenesis in vitro	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							BONE-MORPHOGENETIC-PROTEIN; TARGET GENE HES-1; TWISTED-GASTRULATION; INHIBITS OSTEOBLASTOGENESIS; SIGNALING PATHWAYS; RNA INTERFERENCE; FACTOR CTGF; DIFFERENTIATION; NOTCH; WNT	Connective tissue growth factor (CTGF), a member of the CCN family of proteins, is expressed by osteoblasts, but its function in cells of the osteoblastic lineage has not been established. We investigated the effects of CTGF overexpression by transducing murine ST-2 stromal cells with a retroviral vector, where CTGF is under the control of the cytomegalovirus promoter. Overexpression of CTGF in ST-2 cells increased alkaline phosphatase activity, osteocalcin and alkaline phosphatase mRNA levels, and mineralized nodule formation. CTGF overexpression decreased the effect of bone morphogenetic protein-2 on Smad 1/5/8 phosphorylation and of Wnt 3 on cytosolic beta-catenin,indicating that the stimulatory effect on osteoblastogenesis was unrelated to BMP and Wnt signaling. CTGF overexpression suppressed Notch signaling and induced the transcription of hairy and E (spl)-1 (HES)-1, by Notch-independent mechanisms. CTGF induced nuclear factor of activated T cells (NFAT) transactivation by a calcineurin-dependent mechanism. Down-regulation of CTGF enhanced Notch signaling and decreased HES-1 transcription and NFAT transactivation. Similar effects were observed following forced CTGF overexpression, the addition of CTGF protein, or the transduction of ST-2 cells with a retroviral vector expressing HES-1. In conclusion, CTGF enhances osteoblastogenesis, possibly by inhibiting Notch signaling and inducing HES-1 transcription and NFAT transactivation.	[Smerdel-Ramoya, Anna; Zanotti, Stefano; Deregowski, Valerie; Canalis, Ernesto] St Francis Hosp & Med Ctr, Dept Res, Hartford, CT 06105 USA; [Canalis, Ernesto] Univ Connecticut, Sch Med, Farmington, CT 06030 USA	Saint Francis Hospital & Medical Center; University of Connecticut	Canalis, E (corresponding author), St Francis Hosp & Med Ctr, Dept Res, 114 Woodland St, Hartford, CT 06105 USA.	ecanalis@stfranciscare.org	Zanotti, Stefano/C-6006-2009		NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES [R01AR021707, R37AR021707] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK045227, R01DK042424] Funding Source: NIH RePORTER; NIAMS NIH HHS [AR21707, R01 AR021707] Funding Source: Medline; NIDDK NIH HHS [DK42424, R01 DK042424, DK45227] Funding Source: Medline	NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NIAMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS)); NIDDK NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))		Abreu JG, 2002, GENE, V287, P39, DOI 10.1016/S0378-1119(01)00827-7; Abreu JG, 2002, NAT CELL BIOL, V4, P599, DOI 10.1038/ncb826; Bianco P, 2000, J CLIN INVEST, V105, P1663, DOI 10.1172/JCI10413; Billiard J, 2005, MOL ENDOCRINOL, V19, P90, DOI 10.1210/me.2004-0153; Brigstock DR, 2003, J CLIN PATHOL-MOL PA, V56, P127, DOI 10.1136/mp.56.2.127; Brigstock DR, 2003, J ENDOCRINOL, V178, P169, DOI 10.1677/joe.0.1780169; Chang CB, 2001, NATURE, V410, P483, DOI 10.1038/35068583; Curry CL, 2006, LAB INVEST, V86, P842, DOI 10.1038/labinvest.3700442; DAHL LK, 1952, P SOC EXP BIOL MED, V80, P474, DOI 10.3181/00379727-80-19661; Dai YS, 2005, MOL CELL BIOL, V25, P9936, DOI 10.1128/MCB.25.22.9936-9948.2005; Deregowski V, 2006, J BIOL CHEM, V281, P6203, DOI 10.1074/jbc.M508370200; Elbashir SM, 2001, NATURE, V411, P494, DOI 10.1038/35078107; Gazzerro E, 2005, ENDOCRINOLOGY, V146, P655, DOI 10.1210/en.2004-0766; Gazzerro E, 2005, ENDOCRINOLOGY, V146, P3875, DOI 10.1210/en.2005-0053; Gazzerro E, 2006, BONE, V39, P1252, DOI 10.1016/j.bone.2006.06.028; Ghosh-Choudhury Nandini, 1994, Critical Reviews in Eukaryotic Gene Expression, V4, P345; Graef IA, 2001, CURR OPIN GENET DEV, V11, P505, DOI 10.1016/S0959-437X(00)00225-2; Ishisaki A, 1999, J BIOL CHEM, V274, P13637, DOI 10.1074/jbc.274.19.13637; Iso T, 2003, J CELL PHYSIOL, V194, P237, DOI 10.1002/jcp.10208; Iso T, 2001, MOL CELL BIOL, V21, P6071, DOI 10.1128/MCB.21.17.6071-6079.2001; Ivkovic S, 2003, DEVELOPMENT, V130, P2779, DOI 10.1242/dev.00505; Kawaki H, 2008, BIOCHEM BIOPH RES CO, V366, P450, DOI 10.1016/j.bbrc.2007.11.155; Koga T, 2005, NAT MED, V11, P880, DOI 10.1038/nm1270; LAEMMLI UK, 1970, NATURE, V227, P680, DOI 10.1038/227680a0; LARDELLI M, 1993, EXP CELL RES, V204, P364, DOI 10.1006/excr.1993.1044; Latinkic BV, 2003, DEVELOPMENT, V130, P2429, DOI 10.1242/dev.00449; LIAN J, 1989, P NATL ACAD SCI USA, V86, P1143, DOI 10.1073/pnas.86.4.1143; Luo Q, 2004, J BIOL CHEM, V279, P55958, DOI 10.1074/jbc.M407810200; Mammucari C, 2005, DEV CELL, V8, P665, DOI 10.1016/j.devcel.2005.02.016; Mercurio S, 2004, DEVELOPMENT, V131, P2137, DOI 10.1242/dev.01045; Nam Y, 2006, CELL, V124, P973, DOI 10.1016/j.cell.2005.12.037; Nazarenko I, 2002, NUCLEIC ACIDS RES, V30, DOI 10.1093/nar/30.9.e37; Nazarenko I, 2002, NUCLEIC ACIDS RES, V30, P2089, DOI 10.1093/nar/30.9.2089; Nishida T, 2000, J CELL PHYSIOL, V184, P197, DOI 10.1002/1097-4652(200008)184:2<197::AID-JCP7>3.0.CO;2-R; Nofziger D, 1999, DEVELOPMENT, V126, P1689; Nosaka T, 2003, MOL CELL BIOL, V23, P2969, DOI 10.1128/MCB.23.8.2969-2980.2003; Otsuka E, 1999, AM J PHYSIOL-CELL PH, V277, pC132, DOI 10.1152/ajpcell.1999.277.1.C132; Parisi MS, 2006, BONE, V38, P671, DOI 10.1016/j.bone.2005.10.005; Pereira RC, 2004, ENDOCRINOLOGY, V145, P1952, DOI 10.1210/en.2003-0868; Pereira RC, 2000, AM J PHYSIOL-ENDOC M, V279, pE570, DOI 10.1152/ajpendo.2000.279.3.E570; Persson U, 1998, FEBS LETT, V434, P83, DOI 10.1016/S0014-5793(98)00954-5; Ross DA, 2004, MOL CELL BIOL, V24, P3505, DOI 10.1128/MCB.24.8.3505-3513.2004; Ross JJ, 2001, NATURE, V410, P479, DOI 10.1038/35068578; Rydziel S, 2007, J BIOL CHEM, V282, P19762, DOI 10.1074/jbc.M700212200; Safadi FF, 2003, J CELL PHYSIOL, V196, P51, DOI 10.1002/jcp.10319; SCHREIBER E, 1989, NUCLEIC ACIDS RES, V17, P6419, DOI 10.1093/nar/17.15.6419; Sciaudone M, 2003, ENDOCRINOLOGY, V144, P5631, DOI 10.1210/en.2003-0463; Sharp PA, 2001, GENE DEV, V15, P485, DOI 10.1101/gad.880001; Smerdel-Ramoya A, 2007, J BONE MINER RES, V22, pS51; Stockhausen MT, 2005, EXP CELL RES, V310, P218, DOI 10.1016/j.yexcr.2005.07.011; Strobl LJ, 1997, IMMUNOBIOLOGY, V198, P299, DOI 10.1016/S0171-2985(97)80050-2; Strom A, 1997, GENE DEV, V11, P3168, DOI 10.1101/gad.11.23.3168; SUDO H, 1983, J CELL BIOL, V96, P191, DOI 10.1083/jcb.96.1.191; Sun L, 2005, P NATL ACAD SCI USA, V102, P17130, DOI 10.1073/pnas.0508480102; THIES RS, 1992, ENDOCRINOLOGY, V130, P1318, DOI 10.1210/en.130.3.1318; TSO JY, 1985, NUCLEIC ACIDS RES, V13, P2485, DOI 10.1093/nar/13.7.2485; Westendorf JJ, 2004, GENE, V341, P19, DOI 10.1016/j.gene.2004.06.044; Wilson JJ, 2006, CELL, V124, P985, DOI 10.1016/j.cell.2006.01.035; Young CS, 1998, MOL CELL BIOL, V18, P2474, DOI 10.1128/MCB.18.5.2474; Zamurovic N, 2004, J BIOL CHEM, V279, P37704, DOI 10.1074/jbc.M403813200; Zhao M, 2004, J BIOL CHEM, V279, P12854, DOI 10.1074/jbc.M313294200	61	41	47	0	3	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	AUG 15	2008	283	33					22690	22699		10.1074/jbc.M710140200	http://dx.doi.org/10.1074/jbc.M710140200			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	335VR	18583340	Green Published, hybrid			2022-12-27	WOS:000258321000038
J	White, UA; Stewart, WC; Mynatt, RL; Stephens, JM				White, Ursula A.; Stewart, William C.; Mynatt, Randall L.; Stephens, Jacqueline M.			Neuropoietin attenuates adipogenesis and induces insulin resistance in adipocytes	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							CILIARY NEUROTROPHIC FACTOR; LEUKEMIA INHIBITORY FACTOR; NECROSIS-FACTOR-ALPHA; CYTOKINE SIGNAL TRANSDUCER; RECEPTOR OB-R; ONCOSTATIN-M; 3T3-L1 ADIPOCYTES; CNTF RECEPTOR; LEPTIN RECEPTOR; TRANSCRIPTIONAL REPRESSION	Recent findings have implicated gp 130 receptor ligands, particularly ciliary neurotrophic factor (CNTF), as potential antiobesity therapeutics. Neuropoietin (NP) is a recently discovered cytokine in the gp130 family that shares functional and structural features with CNTF and signals via the CNTF receptor tripartite complex comprised of CNTFR alpha, LIF receptor, and gp130. NP plays a role in the development of the nervous system, but the effects of NP on adipocytes have not been previously examined. Because CNTF exerts anti-obesogenic effects in adipocytes and NP shares the same receptor complex, we investigated the effects of NP on adipocyte development and insulin action. Using cultured 3T3-L1 adipocytes, we observed that NP has the ability to block adipogenesis in a dose- and time-dependent manner. We also observed that cultured adipocytes, as well as murine adipose tissue, are highly responsive to acute NP treatment. Rodents injected with NP had a substantial increase in STAT3 tyrosine phosphorylation and ERK 1 and 2 activation. We also observed the induction of SOCS-3 mRNA in 3T3-L1 adipocytes following NP treatment. Unlike CNTF, our studies have revealed that NP also substantially attenuates insulin-stimulated glucose uptake in 3T3-L1 adipocytes. In addition, NP blocks insulin action in adipose tissue in vivo. These observations are supported by data demonstrating that NP impairs insulin signaling via decreased activation of both IRS-1 and Akt. In summary, we have observed that both adipocytes in vitro and in vivo are highly responsive to NP, and this cytokine has the ability to affect insulin signaling in fat cells. These novel observations suggest that NP, unlike CNTF, may not be a viable obesity therapeutic.	[White, Ursula A.; Stephens, Jacqueline M.] Louisiana State Univ, Dept Biol Sci, Baton Rouge, LA 70803 USA; [Stewart, William C.] Middle Tennessee State Univ, Murfreesboro, TN 37132 USA; [Mynatt, Randall L.] Pennington Biomed Res Ctr, Baton Rouge, LA 70808 USA	Louisiana State University System; Louisiana State University; Middle Tennessee State University; Louisiana State University System; Louisiana State University; Pennington Biomedical Research Center	Stephens, JM (corresponding author), Louisiana State Univ, Dept Biol Sci, Baton Rouge, LA 70803 USA.	jsteph1@lsu.edu	Stephens, Jacqueline M/R-5217-2018; White, Ursula/N-1997-2017; Mynatt, Randall L/N-1980-2017	Mynatt, Randall L/0000-0003-4399-0019	NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [P30DK072476, R01DK052968] Funding Source: NIH RePORTER; NIDDK NIH HHS [P30 DK072476, R01DK52968] Funding Source: Medline	NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NIDDK NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))		Adams TE, 1998, J BIOL CHEM, V273, P1285, DOI 10.1074/jbc.273.3.1285; Auernhammer CJ, 2003, ENDOCRINOLOGY, V144, P1202, DOI 10.1210/en.2002-220933; Bjorbaek C, 1999, ENDOCRINOLOGY, V140, P2035, DOI 10.1210/en.140.5.2035; Bjorbaek C, 1999, J BIOL CHEM, V274, P30059, DOI 10.1074/jbc.274.42.30059; Bjorbaek C, 1998, MOL CELL, V1, P619, DOI 10.1016/S1097-2765(00)80062-3; Blanchard F, 2001, J BIOL CHEM, V276, P47038, DOI 10.1074/jbc.M107971200; BOULTON TG, 1994, J BIOL CHEM, V269, P11648; Bousquet C, 1999, J CLIN INVEST, V104, P1277, DOI 10.1172/JCI7924; Ceresa BP, 1996, J BIOL CHEM, V271, P12121, DOI 10.1074/jbc.271.21.12121; Cohen B, 1996, SCIENCE, V274, P1185, DOI 10.1126/science.274.5290.1185; Considine RV, 1996, NEW ENGL J MED, V334, P292, DOI 10.1056/NEJM199602013340503; Cota D, 2006, SCIENCE, V312, P927, DOI 10.1126/science.1124147; DAVIS S, 1993, SCIENCE, V260, P1805, DOI 10.1126/science.8390097; DAVIS S, 1993, SCIENCE, V259, P1736, DOI 10.1126/science.7681218; DECHIARA TM, 1995, CELL, V83, P313, DOI 10.1016/0092-8674(95)90172-8; Derouet D, 2004, P NATL ACAD SCI USA, V101, P4827, DOI 10.1073/pnas.0306178101; Elson GCA, 2000, NAT NEUROSCI, V3, P867, DOI 10.1038/78765; Emanuelli B, 2000, J BIOL CHEM, V275, P15985, DOI 10.1074/jbc.275.21.15985; Emanuelli B, 2001, J BIOL CHEM, V276, P47944, DOI 10.1074/jbc.M104602200; Febbraio MA, 2007, J CLIN INVEST, V117, P841, DOI 10.1172/JCI30453; Flier JS, 2004, CELL, V116, P337, DOI 10.1016/S0092-8674(03)01081-X; Gloaguen I, 1997, P NATL ACAD SCI USA, V94, P6456, DOI 10.1073/pnas.94.12.6456; Harp JB, 2001, BIOCHEM BIOPH RES CO, V281, P907, DOI 10.1006/bbrc.2001.4460; Heinrich PC, 2003, BIOCHEM J, V374, P1, DOI 10.1042/BJ20030407; Hogan JC, 2005, J ENDOCRINOL, V185, P485, DOI 10.1677/joe.1.05980; LAEMMLI UK, 1970, NATURE, V227, P680, DOI 10.1038/227680a0; Lambert PD, 2001, P NATL ACAD SCI USA, V98, P4652, DOI 10.1073/pnas.061034298; Magrangeas F, 2001, BIOCHEM J, V353, P223, DOI 10.1042/0264-6021:3530223; MASU Y, 1993, NATURE, V365, P27, DOI 10.1038/365027a0; Miller RG, 1996, NEUROLOGY, V47, P1329, DOI 10.1212/WNL.47.5.1329; Miyaoka Y, 2006, J BIOL CHEM, V281, P37913, DOI 10.1074/jbc.M606089200; Nakashima K, 1997, FEBS LETT, V401, P49, DOI 10.1016/S0014-5793(96)01430-5; Nakashima K, 1997, FEBS LETT, V403, P79, DOI 10.1016/S0014-5793(97)00013-6; Oh H, 1998, J BIOL CHEM, V273, P9703, DOI 10.1074/jbc.273.16.9703; Pflanz S, 2004, J IMMUNOL, V172, P2225, DOI 10.4049/jimmunol.172.4.2225; Robledo O, 1997, J BIOL CHEM, V272, P4855, DOI 10.1074/jbc.272.8.4855; Sleeman M W, 2000, Pharm Acta Helv, V74, P265, DOI 10.1016/S0031-6865(99)00050-3; SMITH PJ, 1988, J BIOL CHEM, V263, P9402; Song HY, 2007, INT J BIOCHEM CELL B, V39, P439, DOI 10.1016/j.biocel.2006.07.014; Starr R, 1997, NATURE, V387, P917, DOI 10.1038/43206; STEPHENS JM, 1991, J BIOL CHEM, V266, P21839; STEPHENS JM, 1992, J BIOL CHEM, V267, P13580; Stephens JM, 1998, J BIOL CHEM, V273, P31408, DOI 10.1074/jbc.273.47.31408; Stephens JM, 1996, J BIOL CHEM, V271, P10441, DOI 10.1074/jbc.271.18.10441; Stewart WC, 1999, BBA-MOL CELL RES, V1452, P188, DOI 10.1016/S0167-4889(99)00129-9; TAGA T, 1989, CELL, V58, P573, DOI 10.1016/0092-8674(89)90438-8; Tartaglia LA, 1995, CELL, V83, P1263, DOI 10.1016/0092-8674(95)90151-5; Villarino AV, 2006, J IMMUNOL, V176, P237, DOI 10.4049/jimmunol.176.1.237; Watt MJ, 2006, NAT MED, V12, P541, DOI 10.1038/nm1383; Zvonic S, 2004, J BIOL CHEM, V279, P47572, DOI 10.1074/jbc.M403998200; Zvonic S, 2003, J BIOL CHEM, V278, P2228, DOI 10.1074/jbc.M205871200	51	19	20	1	1	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	AUG 15	2008	283	33					22505	22512		10.1074/jbc.M710462200	http://dx.doi.org/10.1074/jbc.M710462200			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	335VR	18562323	Green Published, hybrid			2022-12-27	WOS:000258321000019
J	Gellerich, FN; Gizatullina, Z; Nguyen, HP; Trumbeckaite, S; Vielhaber, S; Seppet, E; Zierz, S; Landwehrmeyer, B; Riess, O; von Horsten, S; Striggow, F				Gellerich, Frank N.; Gizatullina, Zemfira; Nguyen, Huu P.; Trumbeckaite, Sonata; Vielhaber, Stefan; Seppet, Enn; Zierz, Stephan; Landwehrmeyer, Bernhard; Riess, Olaf; von Hoersten, Stephan; Striggow, Frank			Impaired Regulation of Brain Mitochondria by Extramitochondrial Ca2+ in Transgenic Huntington Disease Rats	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							PERMEABILITY TRANSITION PORE; CYCLOSPORINE-A; SUBCELLULAR-LOCALIZATION; MEMBRANE; LIVER; IDENTIFICATION; EXPRESSION; GENE; BIOENERGETICS; SENSITIVITY	Huntington disease ( HD) is characterized by polyglutamine expansions of huntingtin (htt), but the underlying pathomechanisms have remained unclear. We studied brain mitochondria of transgenic HD rats with 51 glutamine repeats (htt(51Q)), modeling the adult form of HD. Ca-free(2+) up to 2 mu M activated state 3 respiration of wild type mitochondria with glutamate/malate or pyruvate/malate as substrates. Ca-free(2+) above 2 mu M inhibited respiration via cyclosporin A-dependent permeability transition (PT). Ruthenium red, an inhibitor of the mitochondrial Ca2+ uniporter, did not affect the Ca2+ -dependent activation of respiration but reduced Ca2+ -induced inhibition. Thus, Ca2+ activation was mediated exclusively by extramitochondrial Ca2+, whereas inhibition was promoted also by intramitochondrial Ca2+. In contrast, htt(51Q) mitochondria showed a deficient state 3 respiration, a lower sensitivity to Ca2+ activation, and a higher susceptibility to Ca2+ -dependent inhibition. Furthermore htt(51Q) mitochondria exhibited a diminished membrane potential stability in response to Ca2+, lower capacities and rates of Ca2+ accumulation, and a decreased Ca2+ threshold for PT in a substrate-independent but cyclosporin A-sensitive manner. Compared with wild type, Ca2+ -induced inhibition of respiration of htt(51Q) mitochondria was less sensitive to ruthenium red, indicating the involvement of extramitochondrial Ca2+. In conclusion, we demonstrate a novel mechanism of mitochondrial regulation by extramitochondrial Ca2+. We suggest that specific regulatory Ca2+ binding sites on the mitochondrial surface, e. g. the glutamate/aspartate carrier (aralar), mediate this regulation. Interactions between htt(51Q) and distinct targets such as aralar and/or the PT pore may underlie mitochondrial dysregulation leading to energetic depression, cell death, and tissue atrophy in HD.	[Gellerich, Frank N.; Gizatullina, Zemfira; Striggow, Frank] KeyNeurotek Pharmaceut AG, D-39120 Magdeburg, Germany; [Nguyen, Huu P.; Riess, Olaf] Univ Tubingen, Dept Med Genet, D-72076 Tubingen, Germany; [Trumbeckaite, Sonata] Kaunas Univ Med, Inst Biomed Res, LT-50009 Kaunas, Lithuania; [Vielhaber, Stefan] Otto VonGuericke Univ Magdegurg, Dept Neurol, D-39120 Magdeburg, Germany; [Seppet, Enn] Univ Tartu, Ctr Mol & Clin Med, Dept Pathophysiol, EE-50411 Tartu, Estonia; [Zierz, Stephan] Univ Halle Wittenberg, Dept Neurol, D-06120 Halle, Saale, Germany; [Landwehrmeyer, Bernhard] Univ Ulm, Dept Neurol, D-89081 Ulm, Germany; [von Hoersten, Stephan] Univ Erlangen Nurnberg, Franz Penzoldt Ctr, D-91054 Erlangen, Germany	Eberhard Karls University of Tubingen; Lithuanian University of Health Sciences; Otto von Guericke University; University of Tartu; Martin Luther University Halle Wittenberg; Ulm University; University of Erlangen Nuremberg	Gellerich, FN (corresponding author), KeyNeurotek Pharmaceut AG, ZENIT Technol Pk,Leipziger Str 44, D-39120 Magdeburg, Germany.	gellerich@keyneurotek.de	von Hörsten, Stephan/G-9005-2015; Nguyen, Huu Phuc/HDO-3462-2022; Nguyen, Huu Phuc/F-5390-2015	von Hörsten, Stephan/0000-0001-6409-0664; Nguyen, Huu Phuc/0000-0001-6139-788X; Nguyen, Huu Phuc/0000-0001-6139-788X; Landwehrmeyer, Georg Bernhard/0000-0003-3375-790X	European Huntington network; Deutsche Forschungsgemeinschaft [Ge 664/11-2]; Estonian Science Foundation [7117]; European Community [MTKD-CT-2004517176]; HighQ	European Huntington network; Deutsche Forschungsgemeinschaft(German Research Foundation (DFG)); Estonian Science Foundation; European Community(European Commission); HighQ	This work was supported by the European Huntington network, Deutsche Forschungsgemeinschaft Grant Ge 664/11-2, Estonian Science Foundation Grant 7117 (to E. S.), European Community Contract MTKD-CT-2004517176 ( to (E. S.), and by HighQ (to S. v. H. and O. R.). The costs of publication of this article were defrayed in part by the payment of page charges. This article must therefore be hereby marked " advertisement" in accordance with 18 U. S. C. Section 1734 solely to indicate this fact.	AKERMAN KEO, 1976, FEBS LETT, V68, P191, DOI 10.1016/0014-5793(76)80434-6; AMBROSE CM, 1994, SOMAT CELL MOLEC GEN, V20, P27, DOI 10.1007/BF02257483; Bathori G, 2006, J BIOL CHEM, V281, P17347, DOI 10.1074/jbc.M600906200; BERNARDI P, 1993, J BIOL CHEM, V268, P1005; BERNARDI P, 1992, J BIOL CHEM, V267, P8834; Bezprozvanny I, 2004, BIOCHEM BIOPH RES CO, V322, P1310, DOI 10.1016/j.bbrc.2004.08.035; Browne SE, 2004, NEUROCHEM RES, V29, P531, DOI 10.1023/B:NERE.0000014824.04728.dd; Brustovetsky N, 2005, J NEUROCHEM, V93, P1361, DOI 10.1111/j.1471-4159.2005.03036.x; Brustovetsky N, 2000, J NEUROSCI, V20, P8229, DOI 10.1523/JNEUROSCI.20-22-08229.2000; Choo YS, 2004, HUM MOL GENET, V13, P1407, DOI 10.1093/hmg/ddh162; del Arco A, 2004, J BIOL CHEM, V279, P24701, DOI 10.1074/jbc.M401417200; Fiermonte G, 2004, J BIOL CHEM, V279, P30722, DOI 10.1074/jbc.M400445200; Gellerich FN, 2004, MOL CELL BIOCHEM, V256, P391, DOI 10.1023/B:MCBI.0000009885.34498.e6; Gizatullina ZZ, 2006, ANN NEUROL, V59, P407, DOI 10.1002/ana.20754; Gizatullina ZZ, 2005, BBA-BIOENERGETICS, V1706, P98, DOI 10.1016/j.bbabio.2004.09.013; Gnaiger E, 2001, RESP PHYSIOL, V128, P277, DOI 10.1016/S0034-5687(01)00307-3; GRODEN DL, 1991, CELL CALCIUM, V12, P279, DOI 10.1016/0143-4160(91)90002-V; Hagen T, 2003, AM J PHYSIOL-GASTR L, V285, pG274, DOI 10.1152/ajpgi.00052.2003; Hansford RG, 1998, MOL CELL BIOCHEM, V184, P359, DOI 10.1023/A:1006893903113; Harjes P, 2003, TRENDS BIOCHEM SCI, V28, P425, DOI 10.1016/S0968-0004(03)00168-3; HOEK JB, 1983, J BIOL CHEM, V258, P54; IGBAVBOA U, 1988, J BIOL CHEM, V263, P1405; Kosinski CM, 2007, MOVEMENT DISORD, V22, P1637, DOI 10.1002/mds.21550; Kowaltowski AJ, 1997, BBA-BIOENERGETICS, V1322, P221, DOI 10.1016/S0005-2728(97)00078-9; Kudin AP, 2004, J BIOL CHEM, V279, P4127, DOI 10.1074/jbc.M310341200; Langbehn DR, 2004, CLIN GENET, V65, P267, DOI 10.1111/j.1399-0004.2004.00241.x; LI SH, 1993, NEURON, V11, P985, DOI 10.1016/0896-6273(93)90127-D; Litsky ML, 1997, BIOCHEMISTRY-US, V36, P7071, DOI 10.1021/bi970180y; Mangiarini L, 1996, CELL, V87, P493, DOI 10.1016/S0092-8674(00)81369-0; Mayr JA, 2007, AM J HUM GENET, V80, P478, DOI 10.1086/511788; Milakovic T, 2006, J BIOL CHEM, V281, P34785, DOI 10.1074/jbc.M603845200; Naga KK, 2007, J NEUROSCI, V27, P7469, DOI 10.1523/JNEUROSCI.0646-07.2007; NOSEK MT, 1990, J BIOL CHEM, V265, P8444; NOVGORODOV SA, 1994, ARCH BIOCHEM BIOPHYS, V311, P219, DOI 10.1006/abbi.1994.1230; Oliveira JMA, 2007, J NEUROCHEM, V101, P241, DOI 10.1111/j.1471-4159.2006.04361.x; Palmieri L, 2001, EMBO J, V20, P5060, DOI 10.1093/emboj/20.18.5060; Panov AV, 2004, ARCH BIOCHEM BIOPHYS, V424, P44, DOI 10.1016/j.abb.2004.01.013; Panov AV, 2002, NAT NEUROSCI, V5, P731, DOI 10.1038/nn884; Panov AV, 2003, ARCH BIOCHEM BIOPHYS, V410, P1, DOI 10.1016/S0003-9861(02)00585-4; Pardo B, 2006, J BIOL CHEM, V281, P1039, DOI 10.1074/jbc.M507270200; Petrasch-Parwez E, 2007, J COMP NEUROL, V501, P716, DOI 10.1002/cne.21272; Rockabrand E, 2007, HUM MOL GENET, V16, P61, DOI 10.1093/hmg/ddl440; Roesch K, 2004, HUM MOL GENET, V13, P2101, DOI 10.1093/hmg/ddh217; SCHOOLWERTH AC, 1980, INT J BIOCHEM, V12, P145, DOI 10.1016/0020-711X(80)90058-0; SCHOOLWERTH AC, 1978, J BIOL CHEM, V253, P6177; SEPPET E, 2007, MOL SYSTEM BIOENERGE, P479, DOI DOI 10.1002/9783527621095.CH15; Tang TS, 2005, P NATL ACAD SCI USA, V102, P2602, DOI 10.1073/pnas.0409402102; UTO A, 1991, CELL CALCIUM, V12, P29, DOI 10.1016/0143-4160(91)90082-P; von Horsten S, 2003, HUM MOL GENET, V12, P617, DOI 10.1093/hmg/ddg075; WIECHELMAN KJ, 1988, ANAL BIOCHEM, V175, P231, DOI 10.1016/0003-2697(88)90383-1	50	69	70	0	2	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 7	2008	283	45					30715	30724		10.1074/jbc.M709555200	http://dx.doi.org/10.1074/jbc.M709555200			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	367ID	18606820	Green Published, hybrid			2022-12-27	WOS:000260544800027
J	Anand, K; Pallares, I; Valnickova, Z; Christensen, T; Vendrell, J; Wendt, KU; Schreuder, HA; Enghild, JJ; Aviles, FX				Anand, Kanchan; Pallares, Irantzu; Valnickova, Zuzana; Christensen, Trine; Vendrell, Josep; Wendt, K. Ulrich; Schreuder, Herman A.; Enghild, Jan J.; Aviles, Francesc X.			The Crystal Structure of Thrombin-activable Fibrinolysis Inhibitor (TAFI) Provides the Structural Basis for Its Intrinsic Activity and the Short Half-life of TAFIa	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							PLASMA PROCARBOXYPEPTIDASE-B; 3-DIMENSIONAL STRUCTURE; CARBOXYPEPTIDASE-B; THERMAL-STABILITY; U TAFI; ACTIVATION; INACTIVATION; PURIFICATION; INSTABILITY; VARIANTS	Mature thrombin-activable fibrinolysis inhibitor (TAFIa) is a highly unstable metallocarboxypeptidase that stabilizes blood clots by clipping C-terminal lysine residues from partially degraded fibrin. In accordance with its in vitro antifibrinolytic activity, animal studies have reported that inhibition of mature TAFI aids in the prevention of thrombosis. The level of TAFI activity is stringently regulated through (i) controlled proteolytic truncation of the zymogen (TAFI), generating the mature enzyme, TAFIa, and (ii) the short half-life of TAFIa. TAFI itself exhibits an intrinsic enzymatic activity, which is likely required to provide a baseline level of antifibrinolytic activity. The novel crystal structure presented here reveals that the active site of TAFI is accessible, providing the structural explanation for the its intrinsic activity. It also supports the notion that an "instability region" exists, in agreement with site-directed mutagenesis studies. Sulfate ions, bound to this region, point toward a potential heparin-binding site and could explain how heparin stabilizes TAFIa.	[Anand, Kanchan; Wendt, K. Ulrich; Schreuder, Herman A.] Sanofi Aventis Pharma Deutschland GmbH, D-65926 Frankfurt, Germany; [Pallares, Irantzu; Vendrell, Josep; Aviles, Francesc X.] Univ Autonoma Barcelona, Inst Biotecnol Biomed, E-08193 Barcelona, Spain; [Valnickova, Zuzana; Christensen, Trine; Enghild, Jan J.] Aarhus Univ, Dept Mol Biol, Ctr Insoluble Prot Struct inSPIN, DK-8000 Aarhus C, Denmark; [Valnickova, Zuzana; Christensen, Trine; Enghild, Jan J.] Aarhus Univ, Dept Mol Biol, Interdisciplinary Nanosci Ctr iNANO, DK-8000 Aarhus C, Denmark	Sanofi-Aventis; Autonomous University of Barcelona; Aarhus University; Aarhus University	Schreuder, HA (corresponding author), Sanofi Aventis Pharma Deutschland GmbH, Bldg G877,Ind Pk Hochst, D-65926 Frankfurt, Germany.	herman.schreuder@sanofi-aventis.com; jje@mb.au.dk	Aviles, Francesc Xavier/F-3482-2019; Avilés, Francesc Xavier/A-2664-2015; Pallares, Irantzu/N-3687-2014; Vendrell, Josep/A-6731-2010	Aviles, Francesc Xavier/0000-0002-1399-6789; Avilés, Francesc Xavier/0000-0002-1399-6789; Pallares, Irantzu/0000-0002-8205-2060; Vendrell, Josep/0000-0002-9378-4742; Schreuder, Herman/0000-0003-2249-2782; Enghild, Jan Johannes/0000-0001-9292-9172	EC-European Commission [LSHG 2006-18830-CAMP]; Ministry of Education and Science of Spain (for Universitat Autonoma de Barcelona) [BIO2007-68046]; Danish Natural Science Research Council	EC-European Commission(European CommissionEuropean Commission Joint Research Centre); Ministry of Education and Science of Spain (for Universitat Autonoma de Barcelona)(Spanish Government); Danish Natural Science Research Council(Danish Natural Science Research Council)	This work was supported by Grants LSHG 2006-18830-CAMP from the EC-European Commission, Directorate F, Grant BIO2007-68046 from Ministry of Education and Science of Spain (for Universitat Autonoma de Barcelona), and a grant from the Danish Natural Science Research Council (for Aarhus University). H. A. S. and K. U. W. are employed by Sanofi-Aventis, a publicly held pharmaceutical company. The costs of publication of this article were defrayed in part by the payment of page charges. This article must therefore be hereby marked "advertisement" in accordance with 18 U. S. C. Section 1734 solely to indicate this fact.	Arolas JL, 2007, CURR PHARM DESIGN, V13, P349, DOI 10.2174/138161207780162980; BAJZAR L, 1995, J BIOL CHEM, V270, P14477, DOI 10.1074/jbc.270.24.14477; Boffa MB, 1998, J BIOL CHEM, V273, P2127, DOI 10.1074/jbc.273.4.2127; Boffa MB, 2000, J BIOL CHEM, V275, P12868, DOI 10.1074/jbc.275.17.12868; Bouma BN, 2001, THROMB RES, V101, P329, DOI 10.1016/S0049-3848(00)00411-4; Brunger AT, 1998, ACTA CRYSTALLOGR D, V54, P905, DOI 10.1107/S0907444998003254; Campbell W, 2001, IMMUNOL REV, V180, P162, DOI 10.1034/j.1600-065X.2001.1800114.x; Ceresa E, 2007, J THROMB HAEMOST, V5, P2105, DOI 10.1111/j.1538-7836.2007.02720.x; Ceresa E, 2006, J BIOL CHEM, V281, P15878, DOI 10.1074/jbc.M509839200; COLL M, 1991, EMBO J, V10, P1; Davis IW, 2007, NUCLEIC ACIDS RES, V35, pW375, DOI 10.1093/nar/gkm216; EATON DL, 1991, J BIOL CHEM, V266, P21833; Garcia-Saez I, 1997, EMBO J, V16, P6906, DOI 10.1093/emboj/16.23.6906; HENDRIKS D, 1990, BIOCHIM BIOPHYS ACTA, V1034, P86, DOI 10.1016/0304-4165(90)90157-R; KABSCH W, 1993, J APPL CRYSTALLOGR, V26, P795, DOI 10.1107/S0021889893005588; Knecht W, 2006, FEBS J, V273, P778, DOI 10.1111/j.1742-4658.2006.05110.x; Mao SS, 1999, J BIOL CHEM, V274, P35046, DOI 10.1074/jbc.274.49.35046; Marx PF, 2000, J BIOL CHEM, V275, P12410, DOI 10.1074/jbc.275.17.12410; Marx PF, 2002, BIOCHEMISTRY-US, V41, P1211, DOI 10.1021/bi0115683; Murshudov GN, 1997, ACTA CRYSTALLOGR D, V53, P240, DOI 10.1107/S0907444996012255; Nesheim M, 2003, CHEST, V124, p33S, DOI 10.1378/chest.124.3_suppl.33S; Rawlings ND, 2006, NUCLEIC ACIDS RES, V34, pD270, DOI 10.1093/nar/gkj089; Redlitz A, 1996, CIRCULATION, V93, P1328, DOI 10.1161/01.CIR.93.7.1328; Schneider M, 2002, J BIOL CHEM, V277, P1021, DOI 10.1074/jbc.M104444200; Storoni LC, 2004, ACTA CRYSTALLOGR D, V60, P432, DOI 10.1107/S0907444903028956; SUENSON E, 1984, EUR J BIOCHEM, V140, P513, DOI 10.1111/j.1432-1033.1984.tb08132.x; Valnickova Z, 2006, BIOCHEMISTRY-US, V45, P1525, DOI 10.1021/bi051956v; Valnickova Z, 1996, J BIOL CHEM, V271, P12937, DOI 10.1074/jbc.271.22.12937; Valnickova Z, 2007, J BIOL CHEM, V282, P3066, DOI 10.1074/jbc.M606559200; VENDRELL J, 2000, BIOCHIM BIOPHYS ACTA, V1477, P2884; WANG W, 1994, J BIOL CHEM, V269, P15937; Willemse JL, 2007, FRONT BIOSCI-LANDMRK, V12, P1973, DOI 10.2741/2203; Willemse JL, 2006, ANAL BIOCHEM, V356, P157, DOI 10.1016/j.ab.2006.05.020; Zirlik A, 2004, THROMB HAEMOSTASIS, V91, P420	34	29	30	0	3	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	OCT 24	2008	283	43					29416	29423		10.1074/jbc.M804003200	http://dx.doi.org/10.1074/jbc.M804003200			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	362EB	18669641	Green Published, hybrid			2022-12-27	WOS:000260179900068
J	Gubern, A; Casas, J; Barcelo-Torns, M; Barneda, D; de la Rosa, X; Masgrau, R; Picatoste, F; Balsinde, J; Balboa, MA; Claro, E				Gubern, Albert; Casas, Javier; Barcelo-Torns, Miquel; Barneda, David; de la Rosa, Xavier; Masgrau, Roser; Picatoste, Fernando; Balsinde, Jesus; Balboa, Maria A.; Claro, Enrique			Group IVA phospholipase A(2) is necessary for the biogenesis of lipid droplets	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							DIFFERENTIATION-RELATED PROTEIN; NUCLEAR-MAGNETIC-RESONANCE; VISIBLE LIPIDS; CELLULAR-REGULATION; BODY FORMATION; C6 CELLS; NILE RED; A(2); MEMBRANE; INHIBITION	Lipid droplets (LD) are organelles present in all cell types, consisting of a hydrophobic core of triacylglycerols and cholesteryl esters, surrounded by a monolayer of phospholipids and cholesterol. This work shows that LD biogenesis induced by serum, by long-chain fatty acids, or the combination of both in CHO-K1 cells was prevented by phospholipase A(2) inhibitors with a pharmacological profile consistent with the implication of group IVA cytosolic phospholipase A(2) (cPLA(2)alpha). Knocking down cPLA(2)alpha expression with short interfering RNA was similar to pharmacological inhibition in terms of enzyme activity and LD biogenesis. A Chinese hamster ovary cell clone stably expressing an enhanced green fluorescent protein-cPLA(2)alpha fusion protein (EGFP-cPLA(2)) displayed higher LD occurrence under basal conditions and upon LD induction. Induction of LD took place with concurrent phosphorylation of cPLA(2)alpha at Ser(505). Transfection of a S505A mutant cPLA(2)alpha showed that phosphorylation at Ser(505) is key for enzyme activity and LD formation. cPLA(2)alpha contribution to LD biogenesis was not because of the generation of arachidonic acid, nor was it related to neutral lipid synthesis. cPLA(2)alpha inhibition in cells induced to form LD resulted in the appearance of tubulo-vesicular profiles of the smooth endoplasmic reticulum, compatible with a role of cPLA(2)alpha in the formation of nascent LD from the endoplasmic reticulum.	[Gubern, Albert; Barcelo-Torns, Miquel; Barneda, David; de la Rosa, Xavier; Masgrau, Roser; Picatoste, Fernando; Claro, Enrique] Univ Autonoma Barcelona, Inst Neurociencies, E-08193 Barcelona, Spain; [Gubern, Albert; Barcelo-Torns, Miquel; Barneda, David; de la Rosa, Xavier; Masgrau, Roser; Picatoste, Fernando; Claro, Enrique] Univ Autonoma Barcelona, Dept Bioquim & Biol Mol, E-08193 Barcelona, Spain; [Casas, Javier; Balsinde, Jesus; Balboa, Maria A.] CSIC, Inst Biol & Genet Mol, E-47003 Valladolid, Spain; [Casas, Javier; Balsinde, Jesus; Balboa, Maria A.] Ctr Invest Biomed Red Diabet & Enfermedades Metab, E-47003 Valladolid, Spain	Autonomous University of Barcelona; Autonomous University of Barcelona; Consejo Superior de Investigaciones Cientificas (CSIC); CSIC-UVA - Instituto de Biologia y Genetica Molecular (IBGM); CIBER - Centro de Investigacion Biomedica en Red; CIBERDEM	Claro, E (corresponding author), Univ Autonoma Barcelona, Inst Neurociencies, Edifici M2,Campus Univ Autonoma Barcelona, E-08193 Barcelona, Spain.	enrique.claro@uab.es	Gubern, Albert/C-9902-2011; Balsinde, Jesús/C-7833-2018; Balboa, María A./V-9493-2018; Masgrau, Roser/D-3047-2011; Casas, Javier/K-7190-2015; Claro, Enrique/D-5612-2009	Gubern, Albert/0000-0001-6458-1498; Balsinde, Jesús/0000-0002-4157-6714; Balboa, María A./0000-0002-2130-5298; Masgrau, Roser/0000-0002-6722-5939; Casas, Javier/0000-0002-6413-8127; Claro, Enrique/0000-0002-7592-7906; Barneda, David/0000-0002-4436-4100	Spanish Ministry of Education and Science [SAF 2004-01698, SAF 200760055]; Spanish Ministry of Health [PI03/0528]	Spanish Ministry of Education and Science(Spanish Government); Spanish Ministry of Health(Instituto de Salud Carlos IIISpanish Government)	This work was supported in part by Grants SAF 2004-01698 and SAF 200760055 from the Spanish Ministry of Education and Science and Grant PI03/0528 from the Spanish Ministry of Health. The costs of publication of this article were defrayed in part by the payment of page charges. This article must therefore be hereby marked "advertisement" in accordance with 18 U. S. C. Section 1734 solely to indicate this fact.	Al-Saffar NMS, 2002, BRIT J CANCER, V86, P963, DOI 10.1038/sj/bjc/6600188; Andersson L, 2006, J CELL SCI, V119, P2246, DOI 10.1242/jcs.02941; Balsinde J, 2005, CELL SIGNAL, V17, P1052, DOI 10.1016/j.cellsig.2005.03.002; Balsinde J, 2000, J IMMUNOL, V164, P5398, DOI 10.4049/jimmunol.164.10.5398; Balsinde J, 1999, ANNU REV PHARMACOL, V39, P175, DOI 10.1146/annurev.pharmtox.39.1.175; Balsinde J, 2002, BIOCHEM J, V364, P695, DOI 10.1042/BJ20020142; Barba I, 1999, CANCER RES, V59, P1861; Barba I, 2001, NMR BIOMED, V14, P33, DOI 10.1002/nbm.688; BLIGH EG, 1959, CAN J BIOCHEM PHYS, V37, P911; Bostrom P, 2005, ARTERIOSCL THROM VAS, V25, P1945, DOI 10.1161/01.ATV.0000179676.41064.d4; Bostrom P, 2007, NAT CELL BIOL, V9, P1286, DOI 10.1038/ncb1648; Bozza PT, 1996, P NATL ACAD SCI USA, V93, P11091, DOI 10.1073/pnas.93.20.11091; Bozza PT, 2001, PROSTAG LEUKOTR ESS, V64, P227, DOI 10.1054/plef.2001.0264; Brasaemle DL, 2004, J BIOL CHEM, V279, P46835, DOI 10.1074/jbc.M409340200; Brasaemle DL, 1997, J LIPID RES, V38, P2249; Brasaemle DL, 2000, J BIOL CHEM, V275, P38486, DOI 10.1074/jbc.M007322200; Brown WJ, 2003, TRAFFIC, V4, P214, DOI 10.1034/j.1600-0854.2003.00078.x; CADIGAN KM, 1989, J CELL BIOL, V108, P2201, DOI 10.1083/jcb.108.6.2201; Casas J, 2006, J BIOL CHEM, V281, P6106, DOI 10.1074/jbc.M505230200; Casas J, 2006, MOL BIOL CELL, V17, P155, DOI 10.1091/mbc.e05-06-0545; Cermelli S, 2006, CURR BIOL, V16, P1783, DOI 10.1016/j.cub.2006.07.062; Chalfant CE, 2005, J CELL SCI, V118, P4605, DOI 10.1242/jcs.02637; Chang TY, 2001, J LIPID RES, V42, P1933; Cole NB, 2002, J BIOL CHEM, V277, P6344, DOI 10.1074/jbc.M108414200; Coleman RA, 2004, PROG LIPID RES, V43, P134, DOI 10.1016/S0163-7827(03)00051-1; Das S, 2003, J BIOL CHEM, V278, P41431, DOI 10.1074/jbc.M304897200; Di Vito M, 2001, BBA-MOL CELL BIOL L, V1530, P47, DOI 10.1016/S1388-1981(00)00165-7; FIGUEIREDO PD, 2001, J BIOL CHEM, V276, P47361; Fujimoto T, 2006, ANN NY ACAD SCI, V1086, P104, DOI 10.1196/annals.1377.010; Fujimoto Y, 2004, BBA-MOL CELL RES, V1644, P47, DOI 10.1016/j.bbamcr.2003.10.018; Fukumoto S, 2002, HISTOCHEM CELL BIOL, V118, P423, DOI 10.1007/s00418-002-0462-7; Ghosh M, 2007, J BIOL CHEM, V282, P11676, DOI 10.1074/jbc.M608458200; Ghosh M, 2006, PROG LIPID RES, V45, P487, DOI 10.1016/j.plipres.2006.05.003; GREENSPAN P, 1985, J LIPID RES, V26, P781; GREENSPAN P, 1985, J CELL BIOL, V100, P965, DOI 10.1083/jcb.100.3.965; Grimmer S, 2005, TRAFFIC, V6, P144, DOI 10.1111/j.1600-0854.2005.00258.x; Hakumaki JM, 2003, TRENDS PHARMACOL SCI, V24, P146, DOI 10.1016/S0165-6147(03)00032-4; Hakumaki JM, 2000, TRENDS BIOCHEM SCI, V25, P357, DOI 10.1016/S0968-0004(00)01614-5; Hutter-Paier B, 2004, NEURON, V44, P227, DOI 10.1016/j.neuron.2004.08.043; Iorio E, 2003, BBA-MOL CELL BIOL L, V1634, P1, DOI 10.1016/j.bbalip.2003.07.001; Lennartz MR, 1997, J CELL SCI, V110, P2041; Listenberger LL, 2007, CURR PROTOC CELL BIO, DOI [DOI 10.1002/0471143030.CB2402S35, 10.1002/0471143030.cb2402s35]; Liu PS, 2004, J BIOL CHEM, V279, P3787, DOI 10.1074/jbc.M311945200; Marchesan D, 2003, J BIOL CHEM, V278, P27293, DOI 10.1074/jbc.M301430200; Martin S, 2006, NAT REV MOL CELL BIO, V7, P373, DOI 10.1038/nrm1912; MAYORGA LS, 1993, P NATL ACAD SCI USA, V90, P10255, DOI 10.1073/pnas.90.21.10255; Meadows JW, 2005, J CLIN ENDOCR METAB, V90, P2344, DOI 10.1210/jc.2004-1199; Miura S, 2002, J BIOL CHEM, V277, P32253, DOI 10.1074/jbc.M204410200; Murphy DJ, 2001, PROG LIPID RES, V40, P325, DOI 10.1016/S0163-7827(01)00013-3; Nakamura N, 2005, BIOCHEM BIOPH RES CO, V335, P117, DOI 10.1016/j.bbrc.2005.07.050; Ohsaki Y, 2006, MOL BIOL CELL, V17, P2674, DOI 10.1091/mbc.E05-07-0659; Pardo R, 2003, J NEUROCHEM, V87, P417, DOI 10.1046/j.1471-4159.2003.02015.x; Quintero M, 2007, BBA-MOL CELL BIOL L, V1771, P31, DOI 10.1016/j.bbalip.2006.10.003; Robenek H, 2006, J CELL SCI, V119, P4215, DOI 10.1242/jcs.03191; Schaloske RH, 2006, BBA-MOL CELL BIOL L, V1761, P1246, DOI 10.1016/j.bbalip.2006.07.011; Schmitz JE, 2005, MAGN RESON MED, V54, P43, DOI 10.1002/mrm.20529; Seno K, 2000, J MED CHEM, V43, P1041, DOI 10.1021/jm9905155; SPECTOR AA, 1980, PROG LIPID RES, V19, P155; Staneva G, 2004, CHEM PHYS LIPIDS, V129, P53, DOI 10.1016/j.chemphyslip.2003.11.005; Tobin KAR, 2006, J LIPID RES, V47, P815, DOI 10.1194/jlr.M500527-JLR200; Wolins NE, 2006, FEBS LETT, V580, P5484, DOI 10.1016/j.febslet.2006.08.040; Wolins NE, 2005, J BIOL CHEM, V280, P19146, DOI 10.1074/jbc.M500978200; Wolins NE, 2001, J BIOL CHEM, V276, P5101, DOI 10.1074/jbc.M006775200; Yasugi E, 2006, DEV GROWTH DIFFER, V48, P177, DOI 10.1111/j.1440-169x.2006.00855.x; Yu WG, 1998, AM J PATHOL, V152, P759	65	70	71	1	12	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	OCT 10	2008	283	41					27369	27382		10.1074/jbc.M800696200	http://dx.doi.org/10.1074/jbc.M800696200			14	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	355OW	18632668	hybrid, Green Published			2022-12-27	WOS:000259719200005
J	Sam, KA; Strampraad, MJF; de Vries, S; Ferguson, SJ				Sam, Katharine A.; Strampraad, Marc J. F.; de Vries, Simon; Ferguson, Stuart J.			Very early reaction intermediates detected by microsecond time scale kinetics of cytochrome cd(1)-catalyzed reduction of nitrite	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							CD(1) NITRITE; PARACOCCUS-PANTOTROPHUS; THIOSPHAERA-PANTOTROPHA; DISSIMILATORY NITRITE; ELECTRON-TRANSFER; OXIDASE REACTION; HEME; ENZYME; DENITRIFICANS; PSEUDOAZURIN	Paracoccus pantotrophus cytochrome cd(1) is a nitrite reductase found in the periplasm of many denitrifying bacteria. It catalyzes the reduction of nitrite to nitric oxide during the denitrification part of the biological nitrogen cycle. Previous studies of early millisecond intermediates in the nitrite reduction reaction have shown, by comparison with pH 7.0, that at the optimum pH, approximately pH 6, the earliest intermediates were lost in the dead time of the instrument. Access to early time points (similar to 100 mu s) through use of an ultra-rapid mixing device has identified a spectroscopically novel intermediate, assigned as the Michaelis complex, formed from reaction of fully reduced enzyme with nitrite. Spectroscopic observation of the subsequent transformation of this species has provided data that demand reappraisal of the general belief that the two subunits of the enzyme function independently.	[Sam, Katharine A.; Ferguson, Stuart J.] Univ Oxford, Dept Biochem, Oxford OX1 3QU, England; [Strampraad, Marc J. F.; de Vries, Simon] Delft Univ Technol, NL-2628 BC Delft, Netherlands	University of Oxford; Delft University of Technology	Ferguson, SJ (corresponding author), Univ Oxford, Dept Biochem, S Parks Rd, Oxford OX1 3QU, England.	stuart.ferguson@bioch.ox.ac.uk			Biotechnology and Biological Sciences Research Council [C19430]; Foundation for Fundamental Research on Matter [D-26]; Netherlands Foundation for Research NWO [700-50-025]	Biotechnology and Biological Sciences Research Council(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); Foundation for Fundamental Research on Matter(FOM (The Netherlands)); Netherlands Foundation for Research NWO(Netherlands Organization for Scientific Research (NWO))	This work was supported by Biotechnology and Biological Sciences Research Council Grant C19430 (to S.J.F.), a studentship (to K. A. S.), the Foundation for Fundamental Research on Matter Grant D-26 (to S.d.V.), and the Netherlands Foundation for Research NWO Grant 700-50-025. The costs of publication of this article were defrayed in part by the payment of page charges. This article must therefore be hereby marked "advertisement" in accordance with 18 U. S. C. Section 1734 solely to indicate this fact.	Allen JWA, 2002, BIOCHEM J, V366, P883, DOI 10.1042/BJ20020795; ALLEN JWA, 2001, HDB METALLOPROTEINS, P424; Averill BA, 1996, CHEM REV, V96, P2951, DOI 10.1021/cr950056p; Berks BC, 1995, BBA-BIOENERGETICS, V1232, P97, DOI 10.1016/0005-2728(95)00092-5; Cherepanov AV, 2004, BBA-BIOENERGETICS, V1656, P1, DOI 10.1016/j.bbabio.2004.02.006; Das TK, 2001, BIOCHEMISTRY-US, V40, P10774, DOI 10.1021/bi002327i; Farver O, 2003, P NATL ACAD SCI USA, V100, P7622, DOI 10.1073/pnas.0932693100; FULOP V, 1995, CELL, V81, P369, DOI 10.1016/0092-8674(95)90390-9; George SJ, 2000, J BIOL CHEM, V275, P33231, DOI 10.1074/jbc.M005033200; Jafferji A, 2000, J BIOL CHEM, V275, P25089, DOI 10.1074/jbc.M001377200; Kharitonov VG, 1997, BIOCHEMISTRY-US, V36, P6814, DOI 10.1021/bi970201o; KIM CH, 1984, J BIOL CHEM, V259, P2092; Kobayashi K, 1997, BIOCHEMISTRY-US, V36, P13611, DOI 10.1021/bi971045o; Koppenhofer A, 2000, BIOCHEMISTRY-US, V39, P4028, DOI 10.1021/bi991912k; KUKIMOTO M, 1994, BIOCHEMISTRY-US, V33, P5246, DOI 10.1021/bi00183a030; MOIR JWB, 1993, EUR J BIOCHEM, V212, P377, DOI 10.1111/j.1432-1033.1993.tb17672.x; NEWTON N, 1967, BIOCHEM J, V105, pC21, DOI 10.1042/bj1050021C; Pearson IV, 2003, J BACTERIOL, V185, P6308, DOI 10.1128/JB.185.21.6308-6315.2003; RIBEIRO JMC, 1993, SCIENCE, V260, P539, DOI 10.1126/science.8386393; Richter CD, 2002, J BIOL CHEM, V277, P3093, DOI 10.1074/jbc.M108944200; Rinaldo S, 2007, BIOCHEM BIOPH RES CO, V363, P662, DOI 10.1016/j.bbrc.2007.09.036; Rinaldo S, 2007, J BIOL CHEM, V282, P14761, DOI 10.1074/jbc.M700933200; Sam KA, 2008, BIOCHEM BIOPH RES CO, V371, P719, DOI 10.1016/j.bbrc.2008.04.149; Sam KA, 2008, J BIOL CHEM, V283, P12555, DOI 10.1074/jbc.M800954200; Sjogren T, 2001, J BIOL CHEM, V276, P13072, DOI 10.1074/jbc.M011312200; van Wonderen JH, 2007, J BIOL CHEM, V282, P28207, DOI 10.1074/jbc.M701242200; Wiertz FGM, 2007, J BIOL CHEM, V282, P31580, DOI 10.1074/jbc.M705520200; Williams PA, 1997, NATURE, V389, P406, DOI 10.1038/38775; YAMANAKA T, 1963, BIOCHIM BIOPHYS ACTA, V67, P407	29	13	14	0	7	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	OCT 10	2008	283	41					27403	27409		10.1074/jbc.M804493200	http://dx.doi.org/10.1074/jbc.M804493200			7	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	355OW	18669629	hybrid			2022-12-27	WOS:000259719200008
J	Trivedi, CM; Lu, MM; Wang, QH; Epstein, JA				Trivedi, Chinmay M.; Lu, Min Min; Wang, Qiaohong; Epstein, Jonathan A.			Transgenic overexpression of Hdac3 in the heart produces increased postnatal cardiac myocyte proliferation but does not induce hypertrophy	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							HISTONE DEACETYLASE INHIBITORS; CELL-CYCLE; TRANSCRIPTIONAL REPRESSION; COMPLEX; GROWTH; EXPRESSION; DELETION; FAMILY; CANCER; ROLES	Class I and II histone deacetylases (HDACs) play vital roles in regulating cardiac development, morphogenesis, and hypertrophic responses. Although the roles of Hdac1 and Hdac2, class I HDACs, in cardiac hyperplasia, growth, and hypertrophic responsiveness have been reported, the role in the heart of Hdac3, another class I HDAC, has been less well explored. Here we report that myocyte-specific overexpression of Hdac3 in mice results in cardiac abnormalities at birth. Hdac3 overexpression produces thickening of ventricular myocardium, especially the interventricular septum, and reduction of both ventricular cavities in newborn hearts. Our data suggest that increased thickness of myocardium in Hdac3-transgenic (Hdac3-Tg) mice is due to increased cardiomyocyte hyperplasia without hypertrophy. Hdac3 overexpression inhibits several cyclin-dependent kinase inhibitors, including Cdkn1a, Cdkn1b, Cdkn1c, Cdkn2b, and Cdkn2c. Hdac3-Tg mice did not develop cardiac hypertrophy at 3 months of age, unlike previously reported Hdac2-Tg mice. Further, Hdac3 overexpression did not augment isoproterenol-induced cardiac hypertrophy when compared with wild-type littermates. These findings identify Hdac3 as a novel regulator of cardiac myocyte proliferation during cardiac development.	[Trivedi, Chinmay M.; Wang, Qiaohong; Epstein, Jonathan A.] Univ Penn, Dept Cell & Dev Biol, Philadelphia, PA 19104 USA; [Trivedi, Chinmay M.; Lu, Min Min; Epstein, Jonathan A.] Univ Penn, Penn Cardiovasc Inst, Philadelphia, PA 19104 USA	University of Pennsylvania; University of Pennsylvania	Epstein, JA (corresponding author), 1154 BRB 2,421 Curie Blvd, Philadelphia, PA 19104 USA.	epsteinj@mail.med.upenn.edu	Riddoch, Jane/F-7968-2010; Trivedi, Chinmay M/ABA-4097-2021	Epstein, Jonathan/0000-0001-8637-4465; Trivedi, Chinmay/0000-0002-3544-0474	National Institutes of Health [RO1HL071546]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL071546] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	This work was supported, in whole or in part, by National Institutes of Health Grant RO1HL071546 (to J. A. E.). The costs of publication of this article were defrayed in part by the payment of page charges. This article must therefore be hereby marked "advertisement" in accordance with 18 U. S. C. Section 1734 solely to indicate this fact.	Ahringer J, 2000, TRENDS GENET, V16, P351, DOI 10.1016/S0168-9525(00)02066-7; Ahuja P, 2007, PHYSIOL REV, V87, P521, DOI 10.1152/physrev.00032.2006; Antos CL, 2003, J BIOL CHEM, V278, P28930, DOI 10.1074/jbc.M303113200; Backs J, 2006, CIRC RES, V98, P15, DOI 10.1161/01.RES.0000197782.21444.8f; Bhaskara S, 2008, MOL CELL, V30, P61, DOI 10.1016/j.molcel.2008.02.030; Bicknell KA, 2007, J MOL CELL CARDIOL, V42, P706, DOI 10.1016/j.yjmcc.2007.01.006; Bolden JE, 2006, NAT REV DRUG DISCOV, V5, P769, DOI 10.1038/nrd2133; Chang SR, 2006, CELL, V126, P321, DOI 10.1016/j.cell.2006.05.040; Chang SR, 2004, MOL CELL BIOL, V24, P8467, DOI 10.1128/MCB.24.19.8467-8476.2004; Chen F, 2002, CELL, V110, P713, DOI 10.1016/S0092-8674(02)00932-7; De Ruijter AJM, 2003, BIOCHEM J, V370, P737, DOI 10.1042/BJ20021321; Ekwall K, 2005, TRENDS GENET, V21, P608, DOI 10.1016/j.tig.2005.08.009; Evans-Anderson HJ, 2008, CIRC RES, V102, P686, DOI 10.1161/CIRCRESAHA.107.163428; Fischle W, 2002, MOL CELL, V9, P45, DOI 10.1016/S1097-2765(01)00429-4; Garber K, 2007, NAT BIOTECHNOL, V25, P17, DOI 10.1038/nbt0107-17; Gregoretti IV, 2004, J MOL BIOL, V338, P17, DOI 10.1016/j.jmb.2004.02.006; Guenther MG, 2000, GENE DEV, V14, P1048; Hassig CA, 1997, CELL, V89, P341, DOI 10.1016/S0092-8674(00)80214-7; Huang WF, 2006, BIOCHEM BIOPH RES CO, V339, P165, DOI 10.1016/j.bbrc.2005.11.010; Kee HJ, 2006, CIRCULATION, V113, P51, DOI 10.1161/CIRCULATIONAHA.105.559724; Knutson SK, 2008, EMBO J, V27, P1017, DOI 10.1038/emboj.2008.51; Kong YL, 2006, CIRCULATION, V113, P2579, DOI 10.1161/CIRCULATIONAHA.106.625467; Kook H, 2003, J CLIN INVEST, V112, P863, DOI 10.1172/JCI200319137; Lagger G, 2002, EMBO J, V21, P2672, DOI 10.1093/emboj/21.11.2672; Marks PA, 2001, NAT REV CANCER, V1, P194, DOI 10.1038/35106079; Montgomery RL, 2007, GENE DEV, V21, P1790, DOI 10.1101/gad.1563807; Narlikar GJ, 2002, CELL, V108, P475, DOI 10.1016/S0092-8674(02)00654-2; Poolman RA, 1999, CIRC RES, V85, P117, DOI 10.1161/01.RES.85.2.117; Thiagalingam S, 2003, ANN NY ACAD SCI, V983, P84, DOI 10.1111/j.1749-6632.2003.tb05964.x; Trivedi CM, 2007, ATHEROSCLEROSIS, V195, pE50, DOI 10.1016/j.atherosclerosis.2007.04.055; Trivedi CM, 2007, NAT MED, V13, P324, DOI 10.1038/nm1552; Wilson AJ, 2006, J BIOL CHEM, V281, P13548, DOI 10.1074/jbc.M510023200; Wolffe AP, 1996, SCIENCE, V272, P371, DOI 10.1126/science.272.5260.371; Xu WS, 2007, ONCOGENE, V26, P5541, DOI 10.1038/sj.onc.1210620; You A, 2001, P NATL ACAD SCI USA, V98, P1454, DOI 10.1073/pnas.98.4.1454; Zhang CL, 2002, CELL, V110, P479, DOI 10.1016/S0092-8674(02)00861-9	36	80	89	0	2	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	SEP 26	2008	283	39					26484	26489		10.1074/jbc.M803686200	http://dx.doi.org/10.1074/jbc.M803686200			6	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	350GV	18625706	hybrid, Green Published			2022-12-27	WOS:000259341600024
J	Hewavitharana, T; Deng, XX; Wang, YJ; Ritchie, MF; Girish, GV; Soboloff, J; Gill, DL				Hewavitharana, Thamara; Deng, Xiaoxiang; Wang, Youjun; Ritchie, Michael F.; Girish, Gannareddy V.; Soboloff, Jonathan; Gill, Donald L.			Location and function of STIM1 in the activation of Ca2+ entry signals	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							INOSITOL TRISPHOSPHATE RECEPTOR; INTERACTION MOLECULE-1 STIM1; ENDOPLASMIC-RETICULUM; PLASMA-MEMBRANE; CRAC CHANNEL; STORE DEPLETION; CALCIUM INFLUX; ORAI1; PROTEINS; SENSOR	Store-operated channels (SOCs) mediate Ca2+ entry signals in response to endoplasmic reticulum (ER) Ca2+ depletion in most cells. STIM1 senses decreased ER luminal Ca2+ through its EF-hand Ca2+-binding motif and aggregates in near-plasma membrane (PM) ER junctions to activate PM Orai1, the functional SOC. STIM1 is also present in the PM, although its role there is unknown. STIM1-mediated coupling was examined using the stable EF20 HEK293 cell line expressing the STIM1-D76A/E87A EF-hand mutant (STIM1(EF)) deficient in Ca2+ binding. EF20 cells were viable despite constitutive Ca2+ entry, allowing study of SOC activation without depleting ER Ca2+. STIM1(EF) was exclusively in stable near-PM junctions, 3.5-fold larger than formed with STIM1(WT). STIMEF-expressing cells had normal ER Ca2+ levels but substantially reduced ER Ca2+ leak. Expression of antiapoptotic Bcl-2 proteins (BCl-2, MCL-1, BCL-XL) were increased 2-fold in EF20 cells, probably reflecting survival of EF20 cells but not accounting for decreased ER Ca2+ leak. Surface biotinylation and streptavidin pull-down of cells expressing STIM1(WT) or STIM1(EF) revealed strong PM interactions of both proteins. Although surface expression of STIM1(WT) was clearly detectable, STIM1(EF) was undetectable at the cell surface. Thus, the Ca2+ binding-defective STIM1(EF) mutant exists exclusively in aggregates within near-PM junctions but, unlike STIM1WT, is not trafficked to the PM. Although not inserted in the PM, external application of a monoclonal anti-N-terminal STIM1 antibody blocked constitutive STIMEF-mediated Ca2+ entry, but only in cells expressing endogenous STIM1(WT) and not in DT40 STIM1 knock-out cells devoid of STIMWT. This suggests that PM-STIM1 may play a regulatory role in SOC activation.	[Hewavitharana, Thamara; Deng, Xiaoxiang; Wang, Youjun; Ritchie, Michael F.; Girish, Gannareddy V.; Soboloff, Jonathan; Gill, Donald L.] Temple Univ, Sch Med, Dept Biochem, Philadelphia, PA 19140 USA	Pennsylvania Commonwealth System of Higher Education (PCSHE); Temple University	Soboloff, J (corresponding author), Temple Univ, Sch Med, Dept Biochem, 3400 N Broad St, Philadelphia, PA 19140 USA.	soboloff@temple.edu; dgill@temple.edu	Wang, Youjun/H-4016-2013; Soboloff, Jonathan/I-6995-2012	Wang, Youjun/0000-0003-0961-1716; Soboloff, Jonathan/0000-0001-5192-1297	National Institutes of Health [HL55426, AI058173]; American Heart Association; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL055426] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI058173] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); American Heart Association(American Heart Association); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This work was supported in whole or in part, by National Institutes of Health Grants HL55426 (to D. L. G.) AI058173 (to D. L. G.). This work was also supported by the American Heart Association (to J. S.). The costs of publication of this article were defrayed in part by the payment of page charges. This article must therefore be hereby marked "advertisement" in accordance with 18 U. S. C. Section 1734 solely to indicate this fact.	Baba Y, 2006, P NATL ACAD SCI USA, V103, P16704, DOI 10.1073/pnas.0608358103; Berridge MJ, 2003, NAT REV MOL CELL BIO, V4, P517, DOI 10.1038/nrm1155; Berridge MJ, 2000, NAT REV MOL CELL BIO, V1, P11, DOI 10.1038/35036035; Berridge MJ, 2002, CELL CALCIUM, V32, P235, DOI 10.1016/S0143416002001823; Camello C, 2002, CELL CALCIUM, V32, P355, DOI 10.1016/S0143416002001926; CHOMCZYNSKI P, 1993, BIOTECHNIQUES, V15, P532; Chu X, 2002, J BIOL CHEM, V277, P34375, DOI 10.1074/jbc.M205541200; Dziadek MA, 2007, CELL CALCIUM, V42, P123, DOI 10.1016/j.ceca.2007.02.006; Feske S, 2006, NATURE, V441, P179, DOI 10.1038/nature04702; GRYNKIEWICZ G, 1985, J BIOL CHEM, V260, P3440; Hauser CT, 2007, P NATL ACAD SCI USA, V104, P3693, DOI 10.1073/pnas.0611713104; Liou J, 2005, CURR BIOL, V15, P1235, DOI 10.1016/j.cub.2005.05.055; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; Lomax RB, 2002, J BIOL CHEM, V277, P26479, DOI 10.1074/jbc.M201845200; Luik RM, 2006, J CELL BIOL, V174, P815, DOI 10.1083/jcb.200604015; Ma HT, 2000, SCIENCE, V287, P1647, DOI 10.1126/science.287.5458.1647; Ma HT, 2002, J BIOL CHEM, V277, P6915, DOI 10.1074/jbc.M107755200; Ma HT, 2001, J BIOL CHEM, V276, P18888, DOI 10.1074/jbc.M100944200; Manji SSM, 2000, BBA-PROTEIN STRUCT M, V1481, P147, DOI 10.1016/S0167-4838(00)00105-9; Marchant JS, 2005, CURR BIOL, V15, pR493, DOI 10.1016/j.cub.2005.06.035; Mercer JC, 2006, J BIOL CHEM, V281, P24979, DOI 10.1074/jbc.M604589200; Oakes SA, 2005, P NATL ACAD SCI USA, V102, P105, DOI 10.1073/pnas.0408352102; Oritani K, 1996, J CELL BIOL, V134, P771, DOI 10.1083/jcb.134.3.771; Palmer AE, 2004, P NATL ACAD SCI USA, V101, P17404, DOI 10.1073/pnas.0408030101; Palmer AE, 2006, NAT PROTOC, V1, P1057, DOI 10.1038/nprot.2006.172; Parekh AB, 1997, PHYSIOL REV, V77, P901, DOI 10.1152/physrev.1997.77.4.901; Parekh AB, 2005, PHYSIOL REV, V85, P757, DOI 10.1152/physrev.00057.2003; Peinelt C, 2006, NAT CELL BIOL, V8, P771, DOI 10.1038/ncb1435; Pinton P, 2000, J CELL BIOL, V148, P857, DOI 10.1083/jcb.148.5.857; Prakriya M, 2006, NATURE, V443, P230, DOI 10.1038/nature05122; Roos J, 2005, J CELL BIOL, V169, P435, DOI 10.1083/jcb.200502019; Soboloff J, 2005, J BIOL CHEM, V280, P39786, DOI 10.1074/jbc.M506064200; Soboloff J, 2006, BBA-MOL CELL RES, V1763, P1161, DOI 10.1016/j.bbamcr.2006.09.023; Soboloff J, 2006, CURR BIOL, V16, P1465, DOI 10.1016/j.cub.2006.05.051; Soboloff J, 2006, J BIOL CHEM, V281, P20661, DOI 10.1074/jbc.C600126200; Spassova MA, 2006, P NATL ACAD SCI USA, V103, P4040, DOI 10.1073/pnas.0510050103; Stathopulos PB, 2006, J BIOL CHEM, V281, P35855, DOI 10.1074/jbc.M608247200; Tu HP, 2006, CELL, V126, P981, DOI 10.1016/j.cell.2006.06.059; Van Coppenolle F, 2004, J CELL SCI, V117, P4135, DOI 10.1242/jcs.01274; Varnai P, 2007, J BIOL CHEM, V282, P29678, DOI 10.1074/jbc.M704339200; Venkatachalam K, 2002, NAT CELL BIOL, V4, pE263, DOI 10.1038/ncb1102-e263; Vig M, 2006, SCIENCE, V312, P1220, DOI 10.1126/science.1127883; Vig M, 2006, CURR BIOL, V16, P2073, DOI 10.1016/j.cub.2006.08.085; White C, 2005, NAT CELL BIOL, V7, P1021, DOI 10.1038/ncb1302; Williams RT, 2002, BBA-PROTEIN STRUCT M, V1596, P131, DOI 10.1016/S0167-4838(02)00211-X; Williams RT, 2001, BIOCHEM J, V357, P673, DOI 10.1042/0264-6021:3570673; Wu MM, 2006, J CELL BIOL, V174, P803, DOI 10.1083/jcb.200604014; Yeromin AV, 2006, NATURE, V443, P226, DOI 10.1038/nature05108; Youle RJ, 2008, NAT REV MOL CELL BIO, V9, P47, DOI 10.1038/nrm2308; Zhang SL, 2006, P NATL ACAD SCI USA, V103, P9357, DOI 10.1073/pnas.0603161103; Zhang SYL, 2005, NATURE, V437, P902, DOI 10.1038/nature04147	51	40	41	0	3	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	SEP 19	2008	283	38					26252	26262		10.1074/jbc.M802239200	http://dx.doi.org/10.1074/jbc.M802239200			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	348GX	18635545	Green Published, hybrid			2022-12-27	WOS:000259200100053
J	Hewitson, KS; Holmes, SL; Ehrismann, D; Hardy, AP; Chowdhury, R; Schofield, CJ; McDonough, MA				Hewitson, Kirsty S.; Holmes, Samantha L.; Ehrismann, Dominic; Hardy, Adam P.; Chowdhury, Rasheduzzaman; Schofield, Christopher J.; McDonough, Michael A.			Evidence that two enzyme-derived histidine ligands are sufficient for iron binding and catalysis by factor inhibiting HIF (FIH)	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							HYPOXIA-INDUCIBLE-FACTOR; TAURINE/ALPHA-KETOGLUTARATE DIOXYGENASE; VON-HIPPEL-LINDAU; ASPARAGINYL HYDROXYLASE; 2-OXOGLUTARATE OXYGENASES; PROLYL 4-HYDROXYLASE; FAMILY; HALOGENASE; ASCORBATE; SITES	A 2-His-1-carboxylate triad of iron binding residues is present in many non-heme iron oxygenases including the Fe(II) and 2-oxoglutarate (2OG)-dependent dioxygenases. Three variants (D201A, D201E, and D201G) of the iron binding Asp-201 residue of an asparaginyl hydroxylase, factor inhibiting HIF (FIH), were made and analyzed. FIH-D201A and FIH-D201E did not catalyze asparaginyl hydroxylation, but in the presence of a reducing agent, they displayed enhanced 2OG turnover when compared with wild-type FIH. Turnover of 2OG by FIH-D201A was significantly stimulated by the addition of HIF-1 alpha(786-826) peptide. Like FIH-D201A and D201E, the D201G variant enhanced 2OG turnover but rather unexpectedly catalyzed asparaginyl hydroxylation. Crystal structures of the FIH-D201A and D201G variants in complex with Fe(II)/Zn(II), 2OG, and HIF-1 alpha(786-826/788-806) implied that only two FIH-based residues (His-199 and His-279) are required for metal binding. The results indicate that variation of 2OG-dependent dioxygenase iron-ligating residues as a means of functional assignment should be treated with caution. The results are of mechanistic interest in the light of recent biochemical and structural analyses of non-heme iron and 2OG-dependent halogenases that are similar to the FIH-D201A/G variants in that they use only two His-residues to ligate iron.	[Hewitson, Kirsty S.; Holmes, Samantha L.; Ehrismann, Dominic; Hardy, Adam P.; Chowdhury, Rasheduzzaman; Schofield, Christopher J.; McDonough, Michael A.] Univ Oxford, Dept Chem, Chem Res Lab, Oxford OX1 3TA, England	University of Oxford	Schofield, CJ (corresponding author), Univ Oxford, Dept Chem, Chem Res Lab, Mansfield Rd, Oxford OX1 3TA, England.	christopher.schofield@chem.ox.ac.uk; michael.mcdonough@chem.ox.ac.uk	Chowdhury, Rashed/I-7697-2014; McDonough, Michael/N-8913-2019; McDonough, Michael A/G-2744-2013	Chowdhury, Rashed/0000-0002-8058-6149; McDonough, Michael/0000-0003-4664-6942; McDonough, Michael A/0000-0003-4664-6942; Schofield, Christopher/0000-0002-0290-6565	Wellcome Trust; Engineering and Physical Sciences Research Council; Biotechnology and Biological Sciences Research Council; Medical Research Council [G0500367] Funding Source: researchfish; MRC [G0500367] Funding Source: UKRI	Wellcome Trust(Wellcome TrustEuropean Commission); Engineering and Physical Sciences Research Council(UK Research & Innovation (UKRI)Engineering & Physical Sciences Research Council (EPSRC)); Biotechnology and Biological Sciences Research Council(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC))	This work was supported by grants from the Wellcome Trust, the Engineering and Physical Sciences Research Council, and the Biotechnology and Biological Sciences Research Council for funding. The costs of publication of this article were defrayed in part by the payment of page charges. This article must therefore be hereby marked "advertisement" in accordance with 18 U. S. C. Section 1734 solely to indicate this fact.	Blasiak LC, 2006, NATURE, V440, P368, DOI 10.1038/nature04544; Bruick RK, 2001, SCIENCE, V294, P1337, DOI 10.1126/science.1066373; Brunger AT, 1998, ACTA CRYSTALLOGR D, V54, P905, DOI 10.1107/S0907444998003254; Chen ZZ, 2006, CELL, V125, P691, DOI 10.1016/j.cell.2006.04.024; Clifton IJ, 2006, J INORG BIOCHEM, V100, P644, DOI 10.1016/j.jinorgbio.2006.01.024; Cockman ME, 2006, P NATL ACAD SCI USA, V103, P14767, DOI 10.1073/pnas.0606877103; Costas M, 2004, CHEM REV, V104, P939, DOI 10.1021/cr020628n; Dann CE, 2002, P NATL ACAD SCI USA, V99, P15351, DOI 10.1073/pnas.202614999; Ehrismann D, 2007, BIOCHEM J, V401, P227, DOI 10.1042/BJ20061151; Elkins JM, 2003, J BIOL CHEM, V278, P1802, DOI 10.1074/jbc.C200644200; Emsley P, 2004, ACTA CRYSTALLOGR D, V60, P2126, DOI 10.1107/S0907444904019158; Epstein ACR, 2001, CELL, V107, P43, DOI 10.1016/S0092-8674(01)00507-4; Galonic DP, 2007, NAT CHEM BIOL, V3, P113, DOI 10.1038/nchembio856; Gaspard S, 1997, BIOCHEMISTRY-US, V36, P4852, DOI 10.1021/bi9616864; Hausinger RP, 2004, CRIT REV BIOCHEM MOL, V39, P21, DOI 10.1080/10409230490440541; Hewitson KS, 2005, PHILOS T R SOC A, V363, P807, DOI 10.1098/rsta.2004.1540; Hewitson KS, 2002, J BIOL CHEM, V277, P26351, DOI 10.1074/jbc.C200273200; Kaelin WG, 2004, CLIN CANCER RES, V10, p6290S, DOI 10.1158/1078-0432.CCR-sup-040025; Knowles HJ, 2003, CANCER RES, V63, P1764; Lancaster DE, 2004, BIOCHEM SOC T, V32, P943, DOI 10.1042/BST0320943; Lancaster DE, 2004, BIOCHEM J, V383, P429, DOI 10.1042/BJ20040735; Lando D, 2002, GENE DEV, V16, P1466, DOI 10.1101/gad.991402; Lando D, 2002, SCIENCE, V295, P858, DOI 10.1126/science.1068592; Lange SJ, 1998, CURR OPIN CHEM BIOL, V2, P159, DOI 10.1016/S1367-5931(98)80057-4; LASKOWSKI RA, 1993, J APPL CRYSTALLOGR, V26, P283, DOI 10.1107/S0021889892009944; Lee C, 2003, J BIOL CHEM, V278, P7558, DOI 10.1074/jbc.M210385200; Myllyharju J, 1997, EMBO J, V16, P1173, DOI 10.1093/emboj/16.6.1173; MYLLYLA R, 1984, J BIOL CHEM, V259, P5403; Neidig ML, 2007, J AM CHEM SOC, V129, P14224, DOI 10.1021/ja074557r; Neidig ML, 2005, CHEM COMMUN, P5843, DOI 10.1039/b510233m; Otwinowski Z, 1997, METHOD ENZYMOL, V276, P307, DOI 10.1016/S0076-6879(97)76066-X; Price JC, 2003, BIOCHEMISTRY-US, V42, P7497, DOI 10.1021/bi030011f; Proshlyakov DA, 2004, J AM CHEM SOC, V126, P1022, DOI 10.1021/ja039113j; Sim J, 2000, BIOSCI BIOTECH BIOCH, V64, P828, DOI 10.1271/bbb.64.828; Trewick SC, 2007, EMBO J, V26, P4670, DOI 10.1038/sj.emboj.7601892; Trewick SC, 2005, EMBO REP, V6, P315, DOI 10.1038/sj.embor.7400379; Vaillancourt FH, 2005, P NATL ACAD SCI USA, V102, P10111, DOI 10.1073/pnas.0504412102; VRIEND G, 1990, J MOL GRAPHICS, V8, P52, DOI 10.1016/0263-7855(90)80070-V; Zhang ZH, 2000, NAT STRUCT BIOL, V7, P127	39	41	42	0	14	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	SEP 19	2008	283	38					25971	25978		10.1074/jbc.M804999200	http://dx.doi.org/10.1074/jbc.M804999200			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	348GX	18611856	hybrid, Green Published			2022-12-27	WOS:000259200100025
J	Nakamaru-Ogiso, E; Matsuno-Yagi, A; Yoshikawa, S; Yagi, T; Ohnishi, T				Nakamaru-Ogiso, Eiko; Matsuno-Yagi, Akemi; Yoshikawa, Shinya; Yagi, Takao; Ohnishi, Tomoko			Iron-sulfur cluster N5 is coordinated by an HXXXCXXCXXXXXC motif in the NuoG subunit of Escherichia coli NADH : quinone oxidoreductase (complex I)	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							BOVINE HEART-MITOCHONDRIA; UBIQUINONE OXIDOREDUCTASE; DEHYDROGENASE FRAGMENT; THERMUS-THERMOPHILUS; YARROWIA-LIPOLYTICA; PYROCOCCUS-FURIOSUS; NITRATE REDUCTASE; RESPIRATORY-CHAIN; 4FE-4S CLUSTER; FE4S4 CLUSTER	NADH:quinone oxidoreductase (complex I) plays a central role in cellular energy metabolism, and its dysfunction is found in numerous human mitochondrial diseases. Although the understanding of its structure and function has been limited, the x-ray crystal structure of the hydrophilic part of Thermus thermophilus complex I recently became available. It revealed the localization of all redox centers, including 9 iron-sulfur clusters and their coordinating ligands, and confirmed the predictions mostly made by Ohnishi et al. (Ohnishi, T., and Nakamaru-Ogiso, E. (2008) Biochim. Biophys. Acta 1777, 703-710) based on various EPR studies. Recently, Yakovlev et al. (Yakovlev, G., Reda, T., and Hirst, J. (2007) Proc. Natl. Acad. Sci. U.S.A. 104, 12720-12725) claimed that the EPR signals from clusters N4, N5, and N6b were misassigned. Here we identified and characterized cluster N5 in the Escherichia coli complex I whose EPR signals had never been detected by any group. Using homologous recombination, we constructed mutant strains of H101A, H101C, H101A/C114A, and cluster N5 knock-out. Although mutant NuoEFG subcomplexes were dissociated from complex I, we successfully recovered these mutant NuoCDEFG subcomplexes by expressing the His-tagged NuoCD subunit, which had a high affinity to NuoG. The W221A mutant was used as a control subcomplex carrying wild-type clusters. By lowering temperatures to around 3 K, we finally succeeded in detecting cluster N5 signals in the control for the first time. However, no cluster N5 signals were found in any of the N5 mutants, whereas EPR signals from all other clusters were detected. These data confirmed that, contrary to the misassignment claim, cluster N5 has a unique coordination with His(Cys)(3) ligands in NuoG.	[Nakamaru-Ogiso, Eiko; Ohnishi, Tomoko] Univ Penn, Sch Med, Dept Biochem & Biophys, Philadelphia, PA 19104 USA; [Matsuno-Yagi, Akemi; Yagi, Takao] Scripps Res Inst, Div Biochem, Dept Mol & Expt Med, La Jolla, CA 92037 USA; [Yoshikawa, Shinya] Univ Hyogo, Dept Life Sci, Kamigohri Akoh, Hyogo 6781297, Japan	University of Pennsylvania; Scripps Research Institute; University of Hyogo	Nakamaru-Ogiso, E (corresponding author), 215 Anat Chem Bldg,36th & Hamilton Walk, Philadelphia, PA 19104 USA.	eikoo@mail.med.upenn.edu			Sam and Rose Stein Endowment Fund; National Institutes of Health [R01GM30736]; United States Public Health Service [R01GM33712]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM033712, R01GM030736] Funding Source: NIH RePORTER	Sam and Rose Stein Endowment Fund; National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); United States Public Health Service(United States Department of Health & Human ServicesUnited States Public Health Service); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	We thank Dr. S. Tsuyoshi Ohnishi for assistance. Synthesis of oligonucleotides and DNA sequencing were supported in part by the Sam and Rose Stein Endowment Fund.; This work was supported, in whole or in part, by National Institutes of Health Grants R01GM30736 (to T.O.) and R01GM33712 (to T.Y.) from the United States Public Health Service. The costs of publication of this article were defrayed in part by the payment of page charges. This article must therefore be hereby marked "advertisement" in accordance with 18 U. S. C. Section 1734 solely to indicate this fact.	AASA R, 1975, BIOCHIM BIOPHYS ACTA, V391, P259, DOI 10.1016/0005-2744(75)90249-1; BEINERT H, 1983, ANAL BIOCHEM, V131, P373, DOI 10.1016/0003-2697(83)90186-0; BEINERT H, 1982, BIOCHIM BIOPHYS ACTA, V683, P245, DOI 10.1016/0304-4173(82)90003-9; BRADFORD MM, 1976, ANAL BIOCHEM, V72, P248, DOI 10.1016/0003-2697(76)90527-3; Brandt U, 2006, ANNU REV BIOCHEM, V75, P69, DOI 10.1146/annurev.biochem.75.103004.142539; Braun M, 1998, BIOCHEMISTRY-US, V37, P1861, DOI 10.1021/bi971176p; Brereton PS, 1999, BIOCHEMISTRY-US, V38, P10594, DOI 10.1021/bi990671d; Bungert S, 1999, FEBS LETT, V460, P207, DOI 10.1016/S0014-5793(99)01341-1; CALZOLAI L, 1995, BIOCHEMISTRY-US, V34, P11373, DOI 10.1021/bi00036a010; Carroll J, 2003, MOL CELL PROTEOMICS, V2, P117, DOI 10.1074/mcp.M300014-MCP200; CASADABAN MJ, 1976, J MOL BIOL, V104, P541, DOI 10.1016/0022-2836(76)90119-4; Dementin S, 2006, J AM CHEM SOC, V128, P5209, DOI 10.1021/ja060233b; Djafarzadeh R, 2000, BBA-BIOENERGETICS, V1459, P230, DOI 10.1016/S0005-2728(00)00154-7; DOEG KA, 1962, ARCH BIOCHEM BIOPHYS, V97, P37, DOI 10.1016/0003-9861(62)90041-3; HEKMAN C, 1991, J BIOL CHEM, V266, P13564; LAEMMLI UK, 1970, NATURE, V227, P680, DOI 10.1038/227680a0; Lanciano P, 2007, J PHYS CHEM B, V111, P13632, DOI 10.1021/jp075243t; LEIF H, 1995, EUR J BIOCHEM, V230, P538, DOI 10.1111/j.1432-1033.1995.tb20594.x; Link AJ, 1997, J BACTERIOL, V179, P6228, DOI 10.1128/jb.179.20.6228-6237.1997; LOWRY OH, 1951, J BIOL CHEM, V193, P265; Nakamaru-Ogiso E, 2005, J BIOL CHEM, V280, P301, DOI 10.1074/jbc.M410377200; Nakamaru-Ogiso E, 2002, J BIOL CHEM, V277, P1680, DOI 10.1074/jbc.M108796200; Nakashima Y, 2002, J BIOENERG BIOMEMBR, V34, P11, DOI 10.1023/A:1013862502185; OHNISHI T, 1993, J BIOENERG BIOMEMBR, V25, P325, DOI 10.1007/BF00762457; Ohnishi T, 1998, BBA-BIOENERGETICS, V1364, P186, DOI 10.1016/S0005-2728(98)00027-9; OHNISHI T, 1975, BIOCHIM BIOPHYS ACTA, V387, P475, DOI 10.1016/0005-2728(75)90087-0; Ohnishi T., 1979, MEMBRANE PROTEINS EN, P1; Ohnishi T, 2008, BBA-BIOENERGETICS, V1777, P703, DOI 10.1016/j.bbabio.2008.04.032; Peters JW, 1998, SCIENCE, V282, P1853, DOI 10.1126/science.282.5395.1853; Pohl T, 2007, BIOCHEMISTRY-US, V46, P10694, DOI 10.1021/bi701057t; Pohl T, 2007, BIOCHEMISTRY-US, V46, P6588, DOI 10.1021/bi700371c; Rothery RA, 2004, BIOCHEMISTRY-US, V43, P5324, DOI 10.1021/bi049938l; RUPP H, 1978, BIOCHIM BIOPHYS ACTA, V537, P255, DOI 10.1016/0005-2795(78)90509-3; Sazanov LA, 2006, SCIENCE, V311, P1430, DOI 10.1126/science.1123809; Schagger H, 1995, METHOD ENZYMOL, V260, P190, DOI 10.1016/0076-6879(95)60137-6; SLED VD, 1993, J BIOENERG BIOMEMBR, V25, P347, DOI 10.1007/BF00762460; TRANBETCKE A, 1990, J BACTERIOL, V172, P2920, DOI 10.1128/jb.172.6.2920-2929.1990; VINOGRADOV AD, 1995, FEBS LETT, V370, P83, DOI 10.1016/0014-5793(95)00803-H; Waletko A, 2005, J BIOL CHEM, V280, P5622, DOI 10.1074/jbc.M411488200; WALKER JE, 1992, Q REV BIOPHYS, V25, P253, DOI 10.1017/S003358350000425X; Yagi T, 2003, BIOCHEMISTRY-US, V42, P2266, DOI 10.1021/bi027158b; Yagi T, 1998, BBA-BIOENERGETICS, V1364, P125, DOI 10.1016/S0005-2728(98)00023-1; Yakovlev G, 2007, P NATL ACAD SCI USA, V104, P12720, DOI 10.1073/pnas.0705593104; Yano T, 2003, J BIOL CHEM, V278, P15514, DOI 10.1074/jbc.M212275200; Zickermann V, 2007, BBA-BIOENERGETICS, V1767, P393, DOI 10.1016/j.bbabio.2007.03.005	45	19	19	0	7	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	SEP 19	2008	283	38					25979	25987		10.1074/jbc.M804015200	http://dx.doi.org/10.1074/jbc.M804015200			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	348GX	18603533	Green Published, hybrid			2022-12-27	WOS:000259200100026
J	Park, HS; Betzenhauser, MJ; Won, JH; Chen, J; Yule, DI				Park, Hyung Seo; Betzenhauser, Matthew J.; Won, Jong Hak; Chen, Ju; Yule, David I.			The type 2 inositol (1,4,5)-trisphosphate (InsP(3)) receptor determines the sensitivity of InsP(3)-induced Ca2+ release to ATP in pancreatic acinar cells	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							DEPENDENT PROTEIN-KINASE; LIGAND-BINDING AFFINITY; SALIVARY-GLAND CELLS; 1,4,5-TRISPHOSPHATE RECEPTORS; TRISPHOSPHATE RECEPTORS; ADENINE-NUCLEOTIDES; FUNCTIONAL-CHARACTERIZATION; POLARIZED EXPRESSION; RYANODINE-RECEPTORS; EXOCRINE PANCREAS	Calcium release through inositol (1,4,5)-trisphosphate receptors (InsP(3)R) is the primary signal driving digestive enzyme and fluid secretion from pancreatic acinar cells. The type 2 (InsP(3)R2) and type 3 (InsP(3)R3) InsP(3)R are the predominant isoforms expressed in acinar cells and are required for proper exocrine gland function. Both InsP3R2 and InsP3R3 are positively regulated by cytosolic ATP, but InsP(3)R(2) is 10-fold more sensitive than InsP3R3 to this form of modulation. In this study, we examined the role of InsP3R2 in setting the sensitivity of InsP(3)-induced Ca2+ release (IICR) to ATP in pancreatic acinar cells. IICR was measured in permeabilized acinar cells from wild-type (WT) and InsP(3)R2 knock-out (KO) mice. ATP augmented IICR from WT pancreatic cells with an EC50 of 38 mu M. However, the EC50 was 10-fold higher in acinar cells isolated from InsP(3)R2-KO mice, indicating a role for InsP3R2 in setting the sensitivity of IICR to ATP. Consistent with this idea, heterologous expression of InsP(3)R2 in RinM5F cells, which natively express predominately InsP3R3, increased the sensitivity of IICR to ATP. Depletion of ATP attenuated agonist-induced Ca2+ signaling in WT pancreatic acinar cells. This effect was more profound in acinar cells prepared from InsP(3)R2-KO mice. These data suggest that the sensitivity of IICR to ATP depletion is regulated by the particular complement of InsP3R expressed in an individual cell. The effects of metabolic stress on intracellular Ca2+ signals can therefore be determined by the relative amount of InsP(3)R2 expressed in cells.	[Park, Hyung Seo; Betzenhauser, Matthew J.; Won, Jong Hak; Yule, David I.] Univ Rochester, Sch Med & Dent, Dept Physiol & Pharmacol, Med Ctr, Rochester, NY 14642 USA; [Park, Hyung Seo] Konyang Univ, Coll Med, Dept Physiol, Taejon 302718, South Korea; [Chen, Ju] Univ Calif San Diego, Dept Med, La Jolla, CA 92093 USA	University of Rochester; Konyang University; Konyang University Hospital; University of California System; University of California San Diego	Betzenhauser, MJ (corresponding author), Univ Rochester, Sch Med & Dent, Dept Physiol & Pharmacol, Med Ctr, 601 Elmwood Ave,Box 711, Rochester, NY 14642 USA.	Matthew_Betzenhauser@urmc.rochester.edu	Chen, Ju/E-5579-2011		National Institutes of Health [T32-DE07202, RO1-DK054568, RO1-DE016999]; NATIONAL INSTITUTE OF DENTAL &CRANIOFACIAL RESEARCH [R01DE016999, T32DE007202] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK054568] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF DENTAL &CRANIOFACIAL RESEARCH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Dental & Craniofacial Research (NIDCR)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	This work was supported, in whole or in part, by National Institutes of Health Training Grant T32-DE07202 from NIDCR (to M.J.B.), National Institutes of Health Grants RO1-DK054568 and RO1-DE016999 (to D.I.Y.), and a National Institutes of Health grant (to J.C). The costs of publication of this article were defrayed in part by the payment of page charges. This article must therefore be hereby marked "advertisement" in accordance with 18 U.S.C. Section 1734 solely to indicate this fact.	Ashby MC, 2002, PHYSIOL REV, V82, P701, DOI 10.1152/physrev.00006.2002; Bare DJ, 2005, J BIOL CHEM, V280, P15912, DOI 10.1074/jbc.M414212200; Barrow SL, 2008, PFLUG ARCH EUR J PHY, V455, P1025, DOI 10.1007/s00424-007-0360-x; Betzenhauser MJ, 2008, J BIOL CHEM, V283, P21579, DOI 10.1074/jbc.M801680200; BEZPROZVANNY I, 1993, NEURON, V10, P1175, DOI 10.1016/0896-6273(93)90065-Y; Bezprozvanny I, 2005, CELL CALCIUM, V38, P261, DOI 10.1016/j.ceca.2005.06.030; BLONDEL O, 1993, J BIOL CHEM, V268, P11356; Caron AZ, 2007, CELL CALCIUM, V42, P323, DOI 10.1016/j.ceca.2007.01.002; Criddle DN, 2006, GASTROENTEROLOGY, V130, P781, DOI 10.1053/j.gastro.2005.12.031; Csordas G, 2006, J CELL BIOL, V174, P915, DOI 10.1083/jcb.200604016; FERRIS CD, 1990, P NATL ACAD SCI USA, V87, P2147, DOI 10.1073/pnas.87.6.2147; Foskett JK, 2007, PHYSIOL REV, V87, P593, DOI 10.1152/physrev.00035.2006; Futatsugi A, 2005, SCIENCE, V309, P2232, DOI 10.1126/science.1114110; Higo T, 2005, CELL, V120, P85, DOI 10.1016/j.cell.2004.11.048; HIROSE K, 1994, NATURE, V372, P791; Holtzclaw LA, 2002, GLIA, V39, P69, DOI 10.1002/glia.10085; IINO M, 1991, J GEN PHYSIOL, V98, P681, DOI 10.1085/jgp.98.4.681; Iwai M, 2005, J BIOL CHEM, V280, P10305, DOI 10.1074/jbc.M413824200; Iwai M, 2007, J BIOL CHEM, V282, P12755, DOI 10.1074/jbc.M609833200; Jayaraman T, 1996, SCIENCE, V272, P1492, DOI 10.1126/science.272.5267.1492; Joseph SK, 2000, J BIOL CHEM, V275, P16084, DOI 10.1074/jbc.M000506200; JOSEPH SK, 1995, J BIOL CHEM, V270, P23310, DOI 10.1074/jbc.270.40.23310; Kargacin ME, 1997, AM J PHYSIOL-CELL PH, V273, pC1416; KASAI H, 1993, CELL, V74, P669, DOI 10.1016/0092-8674(93)90514-Q; KASAI H, 1990, NATURE, V348, P735, DOI 10.1038/348735a0; Khan MT, 2006, J BIOL CHEM, V281, P3731, DOI 10.1074/jbc.M509262200; LeBeau AP, 1999, J GEN PHYSIOL, V113, P851, DOI 10.1085/jgp.113.6.851; Lee MG, 1997, J BIOL CHEM, V272, P15765, DOI 10.1074/jbc.272.25.15765; Lee MG, 1997, J BIOL CHEM, V272, P15771, DOI 10.1074/jbc.272.25.15771; Leite MF, 2002, GASTROENTEROLOGY, V122, P415, DOI 10.1053/gast.2002.30982; Li XD, 2005, CIRC RES, V96, P1274, DOI 10.1161/01.RES.0000172556.05576.4c; Maes K, 2000, CELL CALCIUM, V27, P257, DOI 10.1054/ceca.2000.0121; Mak DOD, 1999, J BIOL CHEM, V274, P22231, DOI 10.1074/jbc.274.32.22231; Missiaen L, 1997, BIOCHEM J, V325, P661, DOI 10.1042/bj3250661; Miyakawa T, 1999, EMBO J, V18, P1303, DOI 10.1093/emboj/18.5.1303; NATHANSON MH, 1994, J BIOL CHEM, V269, P4693; Padfield PJ, 1998, PFLUG ARCH EUR J PHY, V436, P782, DOI 10.1007/s004240050702; Patel S, 1999, CELL CALCIUM, V25, P247, DOI 10.1054/ceca.1999.0021; Patterson RL, 2004, ANNU REV BIOCHEM, V73, P437, DOI 10.1146/annurev.biochem.73.071403.161303; Petravicz J, 2008, J NEUROSCI, V28, P4967, DOI 10.1523/JNEUROSCI.5572-07.2008; ROSS CA, 1992, P NATL ACAD SCI USA, V89, P4265, DOI 10.1073/pnas.89.10.4265; Straub SV, 2000, J GEN PHYSIOL, V116, P547, DOI 10.1085/jgp.116.4.547; Straub SV, 2002, J BIOL CHEM, V277, P31949, DOI 10.1074/jbc.M204318200; Szabadkai G, 2006, J CELL BIOL, V175, P901, DOI 10.1083/jcb.200608073; Tu HP, 2005, BIOPHYS J, V88, P1046, DOI 10.1529/biophysj.104.049593; Tu HP, 2004, J BIOL CHEM, V279, P19375, DOI 10.1074/jbc.M313476200; Tu HP, 2003, BIOPHYS J, V85, P290, DOI 10.1016/S0006-3495(03)74474-9; Wagner LE, 2006, J BIOL CHEM, V281, P17410, DOI 10.1074/jbc.M601340200; Williams JA, 2006, PHYSIOLOGY OF THE GASTROINTESTINAL TRACT, VOLS 1 AND 2, 4TH EDITION, P1337; WOJCIKIEWICZ RJH, 1995, J BIOL CHEM, V270, P11678, DOI 10.1074/jbc.270.19.11678; Wojcikiewicz RJH, 1998, MOL PHARMACOL, V53, P656, DOI 10.1124/mol.53.4.656; Wojcikiewicz RJH, 1998, J BIOL CHEM, V273, P5670, DOI 10.1074/jbc.273.10.5670; WOJCIKIEWICZ RJH, 1995, BIOCHEM BIOPH RES CO, V213, P334, DOI 10.1006/bbrc.1995.2134; Yule DI, 1997, J BIOL CHEM, V272, P9093	54	32	32	0	1	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	SEP 19	2008	283	38					26081	26088		10.1074/jbc.M804184200	http://dx.doi.org/10.1074/jbc.M804184200			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	348GX	18658132	hybrid, Green Published			2022-12-27	WOS:000259200100036
J	Tokarska-Schlattner, M; Boissan, M; Munier, A; Borot, C; Mailleau, C; Speer, O; Schlattner, U; Lacombe, ML				Tokarska-Schlattner, Malgorzata; Boissan, Mathieu; Munier, Annie; Borot, Caroline; Mailleau, Christiane; Speer, Oliver; Schlattner, Uwe; Lacombe, Marie-Lise			The nucleoside diphosphate kinase D (NM23-H4) binds the inner mitochondrial membrane with high affinity to cardiolipin and couples nucleotide transfer with respiration	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							CREATINE-KINASE; CONTACT SITES; INTERMEMBRANE SPACE; OUTER-MEMBRANE; LOCALIZATION; MATRIX; GENES; PHOSPHORYLATION; DIPHOSPHOKINASE; CARCINOMA	Nucleoside diphosphate kinase (NDPK/Nm23), responsible for intracellular di- and triphosphonucleoside homeostasis, plays multiple roles in cellular energetics, signaling, proliferation, differentiation and tumor invasion. The only human NDPK with a mitochondrial targeting sequence is NDPK-D, the NME4 gene product, which is a peripheral protein of mitochondrial membranes. Subfractionation of rat liver and HEK 293 cell mitochondria revealed that NDPK-D is essentially bound to the inner membrane. Surface plasmon resonance analysis of the interaction using recombinant NDPK-D and model liposomes showed that NDPK-D interacts electrostatically with anionic phospholipids, with highest affinity observed for cardiolipin. Mutation of the central arginine (Arg-90) in a surface-exposed basic RRK motif unique to NDPK-D strongly reduced interaction with anionic phospholipids. Due to its symmetrical hexameric structure, NDPK-D was able to cross-link anionic phospholipid-containing liposomes, suggesting that NDPK-D could promote intermembrane contacts. Latency assays with isolated mitochondria and antibody binding to mitoplasts indicated a dual orientation for NDPK-D. In HeLa cells, stable expression of wild type but not of the R90D mutant led to membrane-bound enzyme in vivo. Respiration was significantly stimulated by the NDPK substrate TDP in mitochondria containing wild-type NDPK-D, but not in those expressing the R90D mutant, which is catalytically equally active. This indicates local ADP regeneration in the mitochondrial intermembrane space and a tight functional coupling of NDPK-D with oxidative phosphorylation that depends on its membrane-bound state.	[Tokarska-Schlattner, Malgorzata; Schlattner, Uwe] Univ Grenoble 1, INSERM, U884, Lab Bioenerget Fondamentale & Appl, F-38041 Grenoble, France; [Boissan, Mathieu; Munier, Annie; Mailleau, Christiane; Lacombe, Marie-Lise] Univ Paris 06, UMPC, INSERM, UMRS 893,CdR St Antoine, F-75012 Paris, France; [Borot, Caroline] Univ Denis Diderot Paris 07, EA 3106, Lab Biol & Biochim Cellulaire Viellissement, F-75005 Paris, France; [Speer, Oliver; Schlattner, Uwe] ETH, Inst Cell Biol, CH-8093 Zurich, Switzerland	Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Communaute Universite Grenoble Alpes; Universite Grenoble Alpes (UGA); Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Saint-Antoine - APHP; Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Sorbonne Universite; UDICE-French Research Universities; Universite Paris Cite; Swiss Federal Institutes of Technology Domain; ETH Zurich	Schlattner, U (corresponding author), Univ Grenoble 1, INSERM, U884, Lab Bioenerget Fondamentale & Appl, BP 53, F-38041 Grenoble, France.	uwe.schlattner@ujf-grenoble.fr; Lacombe@inserm.fr	Schlattner, Uwe/D-1267-2009	Schlattner, Uwe/0000-0003-1159-5911; Tokarska-Schlattner, Malgorzata/0000-0003-4401-7050	Germaine de Stael Program for Franco-Swiss collaboration; Agence Nationale de la Recherche; European Community; INSERM; Groupement des Entreprises Francaises contre le Cancer; Association pour la Recherche contre le Cancer	Germaine de Stael Program for Franco-Swiss collaboration; Agence Nationale de la Recherche(French National Research Agency (ANR)); European Community(European Commission); INSERM(Institut National de la Sante et de la Recherche Medicale (Inserm)European Commission); Groupement des Entreprises Francaises contre le Cancer; Association pour la Recherche contre le Cancer(Fondation ARC pour la Recherche sur le Cancer)	This work was supported by the Germaine de Stael Program for Franco-Swiss collaboration (to U.S. and M.-L.L.), the Agence Nationale de la Recherche (Chaire d'Excellence (to U.S.)), the Marie Curie Intraeuropean Fellowship of the European Community (to M.T.-S.), INSERM, and grants from the Groupement des Entreprises Francaises contre le Cancer and from the Association pour la Recherche contre le Cancer (to M.-L.L.). The costs of publication of this article were defrayed in part by the payment of page charges. This article must therefore be hereby marked "advertisement" in accordance with 18 U.S.C. Section 1734 solely to indicate this fact.	Agarwal R P, 1978, Methods Enzymol, V51, P376; Amutha B, 2003, BIOCHEM J, V370, P805, DOI 10.1042/BJ20021415; Anderca MI, 2002, PLANT CELL PHYSIOL, V43, P1276, DOI 10.1093/pcp/pcf155; Boissan M, 2005, JNCI-J NATL CANCER I, V97, P836, DOI 10.1093/jnci/dji143; BRDICZKA D, 1991, BIOCHIM BIOPHYS ACTA, V1071, P291, DOI 10.1016/0304-4157(91)90018-R; Brdiczka D, 1998, BIOFACTORS, V8, P235, DOI 10.1002/biof.5520080311; Chan DC, 2006, ANNU REV CELL DEV BI, V22, P79, DOI 10.1146/annurev.cellbio.22.010305.104638; CHERRADI N, 1994, ENDOCRINOLOGY, V134, P1358, DOI 10.1210/en.134.3.1358; Dzeja PP, 2003, J EXP BIOL, V206, P2039, DOI 10.1242/jeb.00426; Ellington WR, 2001, ANNU REV PHYSIOL, V63, P289, DOI 10.1146/annurev.physiol.63.1.289; Epand RF, 2007, J MOL BIOL, V365, P968, DOI 10.1016/j.jmb.2006.10.028; Epand RF, 2007, BIOPHYS J, V92, P126, DOI 10.1529/biophysj.106.092353; Erent M, 2001, EUR J BIOCHEM, V268, P1972, DOI 10.1046/j.1432-1327.2001.2076.doc.x; Eskes R, 2000, MOL CELL BIOL, V20, P929, DOI 10.1128/MCB.20.3.929-935.2000; Galvis MLE, 1999, BIOCHIMIE, V81, P1089, DOI 10.1016/S0300-9084(99)00353-3; Gordon DM, 2006, BIOCHEM J, V400, P163, DOI 10.1042/BJ20060904; Hayer J, 2001, ANTICANCER RES, V21, P2821; HOVIUS R, 1990, BIOCHIM BIOPHYS ACTA, V1021, P217, DOI 10.1016/0005-2736(90)90036-N; JACOBUS WE, 1977, J BIOL CHEM, V252, P4232; Janin J, 2000, J BIOENERG BIOMEMBR, V32, P215, DOI 10.1023/A:1005528811303; Knorpp C, 2003, FEBS LETT, V555, P363, DOI 10.1016/S0014-5793(03)01288-2; Kowluru A, 2002, ARCH BIOCHEM BIOPHYS, V398, P160, DOI 10.1006/abbi.2001.2710; KREBS HA, 1978, BIOCHEM J, V174, P297, DOI 10.1042/bj1740297; Lacombe ML, 2000, J BIOENERG BIOMEMBR, V32, P247, DOI 10.1023/A:1005584929050; Lambeth David O, 2002, IUBMB Life, V54, P143; Lambeth DO, 1997, J BIOL CHEM, V272, P24604, DOI 10.1074/jbc.272.39.24604; Lambeth DO, 2004, J BIOL CHEM, V279, P36621, DOI 10.1074/jbc.M406884200; Lascu I, 2000, J BIOENERG BIOMEMBR, V32, P237, DOI 10.1023/A:1005532912212; Lascu I, 2000, J BIOENERG BIOMEMBR, V32, P227, DOI 10.1023/A:1005580828141; Liu JH, 2005, BIOCHEM BIOPH RES CO, V330, P865, DOI 10.1016/j.bbrc.2005.03.048; Masse K, 2002, GENE, V296, P87, DOI 10.1016/S0378-1119(02)00836-3; Milon L, 2000, J BIOL CHEM, V275, P14264, DOI 10.1074/jbc.275.19.14264; Milon L, 1997, HUM GENET, V99, P550, DOI 10.1007/s004390050405; MUHONEN WW, 1995, COMP BIOCHEM PHYS B, V110, P211, DOI 10.1016/0305-0491(94)00123-C; Olichon A, 2007, CELL DEATH DIFFER, V14, P682, DOI 10.1038/sj.cdd.4402048; Olichon A, 2002, FEBS LETT, V523, P171, DOI 10.1016/S0014-5793(02)02985-X; PEDERSEN PL, 1973, J BIOL CHEM, V248, P3956; Pfanner N, 2001, NAT REV MOL CELL BIO, V2, P339, DOI 10.1038/35073006; Pfeiffer K, 2003, J BIOL CHEM, V278, P52873, DOI 10.1074/jbc.M308366200; Pinon VPB, 1999, EXP CELL RES, V246, P355, DOI 10.1006/excr.1998.4318; ROBINSON JB, 1985, J BIOL CHEM, V260, P800; RYTOMAA M, 1995, J BIOL CHEM, V270, P3197, DOI 10.1074/jbc.270.7.3197; Sadek CM, 2003, J BIOL CHEM, V278, P13133, DOI 10.1074/jbc.M300369200; SAKS VA, 1980, J BIOL CHEM, V255, P755; Schlame M, 2000, PROG LIPID RES, V39, P257, DOI 10.1016/S0163-7827(00)00005-9; Schlattner U, 2000, J BIOENERG BIOMEMBR, V32, P123, DOI 10.1023/A:1005576831968; Schlattner U, 2006, BBA-MOL BASIS DIS, V1762, P164, DOI 10.1016/j.bbadis.2005.09.004; Schlattner U, 2004, J BIOL CHEM, V279, P24334, DOI 10.1074/jbc.M314158200; Schlattner U, 2004, ENCY BIOL CHEM, P646; Sorice M, 2004, CELL DEATH DIFFER, V11, P1133, DOI 10.1038/sj.cdd.4401457; Speer O, 2005, BIOCHEM J, V385, P445, DOI 10.1042/BJ20040386; Stachowiak O, 1996, BIOCHEMISTRY-US, V35, P15522, DOI 10.1021/bi961838v; STEEG PS, 1988, J NATL CANCER I, V80, P200, DOI 10.1093/jnci/80.3.200; Sweetlove LJ, 2001, FEBS LETT, V508, P272, DOI 10.1016/S0014-5793(01)03069-1; TROLL H, 1993, J BIOL CHEM, V268, P25469; Walzel B, 2002, J BIOL CHEM, V277, P37503, DOI 10.1074/jbc.M201168200; Zhang M, 2002, J BIOL CHEM, V277, P43553, DOI 10.1074/jbc.C200551200	57	68	69	1	11	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	SEP 19	2008	283	38					26198	26207		10.1074/jbc.M803132200	http://dx.doi.org/10.1074/jbc.M803132200			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	348GX	18635542	hybrid, Green Published, Green Accepted			2022-12-27	WOS:000259200100048
J	Duncan, RE; Sarkadi-Nagy, E; Jaworski, K; Ahmadian, M; Sul, HS				Duncan, Robin E.; Sarkadi-Nagy, Eszter; Jaworski, Kathy; Ahmadian, Maryam; Sul, Hei Sook			Identification and functional characterization of adipose-specific phospholipase A(2) (AdPLA)	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							II TUMOR-SUPPRESSOR; LECITHIN-RETINOL ACYLTRANSFERASE; ACTIVATED RECEPTOR-GAMMA; ADIPOCYTE DIFFERENTIATION; INHIBITORS; EXPRESSION; MECHANISM; H-REV107; FAMILY; CELLS	Phospholipases A(2) (PLA(2)s) catalyze hydrolysis of fatty acids from the sn-2 position of phospholipids. Here we report the identification and characterization of a membrane-associated intracellular calcium-dependent, adipose-specific PLA(2) that we named AdPLA (adipose-specific phospholipase A(2)). We found that AdPLA was highly expressed specifically in white adipose tissue and was induced during preadipocyte differentiation into adipocytes. Clearance of AdPLA by immunoprecipitation significantly decreased PLA activity in white adipose tissue lysates but had no effect on liver lysates, where expression was hardly detectable. In characterizing AdPLA, we employed radiochemical assays with TLC analysis of the enzyme activity of lysates from COS-7 cells overexpressing AdPLA. For kinetic studies, we produced purified recombinant AdPLA for use in a lipoxidase-coupled spectrophotometric assay. AdPLA generated free fatty acid and lysophospholipid from phosphatidylcholine with a preference for hydrolysis at the sn-2 position. Although we found low but detectable lysophospholipase activity, AdPLA showed no significant activity against a variety of other lipid substrates. Calcium was found to activate AdPLA but was not essential for activity. Studies with known phospholipase inhibitors, including bromoenolactone, methyl arachidonyl fluorophosphate, AACOCF(3), 7,7-dimethyl-5,8-eicosadienoic acid, and thioetheramide, supported that AdPLA is a phospholipase. Mutational studies showed that His-23 and Cys-113 are critical for activity of AdPLA and suggested that AdPLA is likely a His/Cys PLA(2). Overall, although AdPLA is similar to other histidine phospholipases in pH and calcium dependence, AdPLA showed different characteristics in many regards, including predicted catalytic mechanism. AdPLA may therefore represent the first member of a new group of PLA(2)s, group XVI.	[Duncan, Robin E.; Sarkadi-Nagy, Eszter; Jaworski, Kathy; Ahmadian, Maryam; Sul, Hei Sook] Univ Calif Berkeley, Dept Nutr Sci & Toxicol, Berkeley, CA 94720 USA	University of California System; University of California Berkeley	Sul, HS (corresponding author), Univ Calif Berkeley, Dept Nutr Sci & Toxicol, 219 Morgan Hall, Berkeley, CA 94720 USA.	hsul@nature.berkeley.edu	Han, Zaiqi/AAI-2233-2019; Duncan, Robin/AAH-7465-2021	Jaworski, Kathy/0000-0001-6014-5066	National Institutes of Health [DK075682]; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK075682, T32DK061918] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	This work was supported, in whole or in part, by National Institutes of Health Grant DK075682 (to H. S. S.). The costs of publication of this article were defrayed in part by the payment of page charges. This article must therefore be hereby marked "advertisement" in accordance with 18 U. S. C. Section 1734 solely to indicate this fact.	Aubert J, 2000, MOL CELL ENDOCRINOL, V160, P149, DOI 10.1016/S0303-7207(99)00210-5; BLIGH EG, 1959, CAN J BIOCHEM PHYS, V37, P911; COHENLURIA R, 1992, CELL SIGNAL, V4, P331, DOI 10.1016/0898-6568(92)90073-H; DECARVALHO MGS, 1995, J BIOL CHEM, V270, P20439, DOI 10.1074/jbc.270.35.20439; DePetrocellis L, 1997, BIOCHEM BIOPH RES CO, V231, P82, DOI 10.1006/bbrc.1997.6000; Diaz BL, 2003, PROSTAG LEUKOTR ESS, V69, P87, DOI 10.1016/S0952-3278(03)00069-3; DIEZ E, 1992, J BIOL CHEM, V267, P18342; Fain JN, 2000, J LIPID RES, V41, P1689; Fajas L, 2003, J LIPID RES, V44, P1652, DOI 10.1194/jlr.M300248-JLR200; FORMAN BM, 1995, CELL, V83, P803, DOI 10.1016/0092-8674(95)90193-0; Ghosh M, 2006, PROG LIPID RES, V45, P487, DOI 10.1016/j.plipres.2006.05.003; HAZEN SL, 1991, J BIOL CHEM, V266, P7227; Hirabayashi T, 2004, BIOL PHARM BULL, V27, P1168, DOI 10.1248/bpb.27.1168; Jahng WJ, 2003, BIOCHEMISTRY-US, V42, P12805, DOI 10.1021/bi035370p; Jenkins CM, 2004, J BIOL CHEM, V279, P48968, DOI 10.1074/jbc.M407841200; Jimenez M, 2003, ANAL BIOCHEM, V319, P131, DOI 10.1016/S0003-2697(03)00331-2; KATHER H, 1979, J CLIN INVEST, V64, P609, DOI 10.1172/JCI109500; Kim KM, 2001, J BIOL CHEM, V276, P37409, DOI 10.1074/jbc.M106728200; Lambeau G, 2008, ANNU REV BIOCHEM, V77, P495, DOI 10.1146/annurev.biochem.76.062405.154007; Lucas KK, 2005, PROSTAG OTH LIPID M, V77, P235, DOI 10.1016/j.prostaglandins.2005.02.004; Marblestone JG, 2006, PROTEIN SCI, V15, P182, DOI 10.1110/ps.051812706; Nazarenko I, 2007, J CELL SCI, V120, P1393, DOI 10.1242/jcs.000018; Nazarenko I, 2006, AM J PATHOL, V169, P1427, DOI 10.2353/ajpath.2006.051341; Nugent C, 2001, J BIOL CHEM, V276, P9149, DOI 10.1074/jbc.M009817200; Reginato MJ, 1998, J BIOL CHEM, V273, P1855, DOI 10.1074/jbc.273.4.1855; Roder K, 2002, BIOCHEM BIOPH RES CO, V293, P793, DOI 10.1016/S0006-291X(02)00274-7; Roder K, 2002, J BIOL CHEM, V277, P30543, DOI 10.1074/jbc.M111891200; Roer K, 2002, BIOCHEM BIOPH RES CO, V294, P63, DOI 10.1016/S0006-291X(02)00440-0; Schaloske RH, 2006, BBA-MOL CELL BIOL L, V1761, P1246, DOI 10.1016/j.bbalip.2006.07.011; Sers C, 1997, J CELL BIOL, V136, P935, DOI 10.1083/jcb.136.4.935; Six DA, 2000, BBA-MOL CELL BIOL L, V1488, P1, DOI 10.1016/S1388-1981(00)00105-0; STREET IP, 1993, BIOCHEMISTRY-US, V32, P5935, DOI 10.1021/bi00074a003; Villena JA, 2004, J BIOL CHEM, V279, P47066, DOI 10.1074/jbc.M403855200; Xue LL, 2004, BIOCHEMISTRY-US, V43, P6120, DOI 10.1021/bi049556f; Yan HY, 2003, J LIPID RES, V44, P424, DOI 10.1194/jlr.M200357-JLR200; YU L, 1990, J BIOL CHEM, V265, P2657; Yuan C, 2006, P NATL ACAD SCI USA, V103, P6142, DOI 10.1073/pnas.0601805103	37	114	123	0	8	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	SEP 12	2008	283	37					25428	25436		10.1074/jbc.M804146200	http://dx.doi.org/10.1074/jbc.M804146200			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	345QZ	18614531	hybrid, Green Published			2022-12-27	WOS:000259012700038
J	Fan, TC; Fang, SL; Hwang, CS; Hsu, CY; Lu, XA; Hung, SC; Lin, SC; Chang, MDT				Fan, Tan-Chi; Fang, Shun-Lung; Hwang, Chi-Shin; Hsu, Chih-Yen; Lu, Xin-an; Hung, Shang-cheng; Lin, Shu-Chuan; Chang, Margaret Dah-Tsyr			Characterization of molecular interactions between eosinophil cationic protein and heparin	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							GLYCOSAMINOGLYCAN INTERACTIONS; HIV-1 TAT; IN-VITRO; RNASE 3; SULFATE; PROLIFERATION; MEMBRANE; GROWTH; DOMAIN; ELECTROPHORESIS	Eosinophil cationic protein (ECP) is currently used as a biomarker for airway inflammation. It is a heparin-binding ribonuclease released by activated eosinophils. Its cytotoxicity toward cancer cell lines is blocked by heparin. The objective of this study was to locate the heparin binding site of ECP by site-directed mutagenesis and construction of a synthetic peptide derived from this region. Synthetic heparin with >= 5 monosaccharide units showed strong inhibition of ECP binding to the cell surface. Analysis of ECP mt1 (R34A/W35A/R36A/K38A) showed that these charged and aromatic residues were involved in ECP binding to heparin and the cell surface. A potential binding motif is located in the loop L3 region between helix alpha 2 and strand beta 1, outside the RNA binding domain. The synthetic peptide derived from the loop L3 region displayed strong pentasaccharide binding affinity and blocked ECP binding to cells. In addition, ECP mt1 showed reduced cytotoxicity. Thus, the tight interaction between ECP and heparin acts as the primary step for ECP endocytosis. These results provide new insights into the structure and function of ECP for anti-asthma therapy.	[Fan, Tan-Chi; Fang, Shun-Lung; Hwang, Chi-Shin; Hsu, Chih-Yen; Lin, Shu-Chuan; Chang, Margaret Dah-Tsyr] Natl Tsing Hua Univ, Inst Mol & Cellular Biol, Hsinchu 30013, Taiwan; [Fan, Tan-Chi; Fang, Shun-Lung; Hwang, Chi-Shin; Hsu, Chih-Yen; Lin, Shu-Chuan; Chang, Margaret Dah-Tsyr] Natl Tsing Hua Univ, Dept Life Sci, Hsinchu 30013, Taiwan; [Hwang, Chi-Shin] Taipei City Hosp, Dept Neurol, Zhong Xiao Branch, Taipei 10341, Taiwan; [Hung, Shang-cheng] Acad Sinica, Genom Res Ctr, Taipei 11529, Taiwan; [Lu, Xin-an; Hung, Shang-cheng] Natl Tsing Hua Univ, Dept Chem, Hsinchu 30013, Taiwan	National Tsing Hua University; National Tsing Hua University; Taipei City Hospital; Academia Sinica - Taiwan; National Tsing Hua University	Chang, MDT (corresponding author), Natl Tsing Hua Univ, Inst Mol & Cellular Biol, 101 Sect 2,Kuang Fu Rd, Hsinchu 30013, Taiwan.	dtchang@life.nthu.edu.tw						Boix E, 1999, J BIOL CHEM, V274, P15605, DOI 10.1074/jbc.274.22.15605; Calabro A, 2000, GLYCOBIOLOGY, V10, P273, DOI 10.1093/glycob/10.3.273; Capila I, 2002, ANGEW CHEM INT EDIT, V41, P391; CARDIN AD, 1989, ARTERIOSCLEROSIS, V9, P21, DOI 10.1161/01.ATV.9.1.21; Carreras E, 2003, BIOCHEMISTRY-US, V42, P6636, DOI 10.1021/bi0273011; Carreras E, 2005, MOL CELL BIOCHEM, V272, P1, DOI 10.1007/s11010-005-4777-2; Domachowske JB, 1998, NUCLEIC ACIDS RES, V26, P3358, DOI 10.1093/nar/26.14.3358; Fan TC, 2007, TRAFFIC, V8, P1778, DOI 10.1111/j.1600-0854.2007.00650.x; Ferro V, 2002, CARBOHYD RES, V337, P139, DOI 10.1016/S0008-6215(01)00300-7; GLEICH GJ, 1986, P NATL ACAD SCI USA, V83, P3146, DOI 10.1073/pnas.83.10.3146; Gleich GJ, 2000, J ALLERGY CLIN IMMUN, V105, P651, DOI 10.1067/mai.2000.105712; GUIMOND S, 1993, J BIOL CHEM, V268, P23906; Hileman RE, 1998, BIOESSAYS, V20, P156, DOI 10.1002/(SICI)1521-1878(199802)20:2<156::AID-BIES8>3.3.CO;2-#; Holmes O, 2007, J MOL BIOL, V367, P395, DOI 10.1016/j.jmb.2006.12.061; Joyce JA, 2005, ONCOGENE, V24, P4037, DOI 10.1038/sj.onc.1208602; KIMATA H, 1992, CELL IMMUNOL, V141, P422, DOI 10.1016/0008-8749(92)90160-Q; Lau EK, 2004, J BIOL CHEM, V279, P22294, DOI 10.1074/jbc.M311224200; Ledin J, 2004, J BIOL CHEM, V279, P42732, DOI 10.1074/jbc.M405382200; Lee JC, 2004, J AM CHEM SOC, V126, P476, DOI 10.1021/ja038244h; LEHRER RI, 1989, J IMMUNOL, V142, P4428; Liang CT, 2007, J COMP PATHOL, V136, P57, DOI 10.1016/j.jcpa.2006.11.002; Maccarana M, 1996, J BIOL CHEM, V271, P17804, DOI 10.1074/jbc.271.30.17804; Maeda T, 2002, EUR J BIOCHEM, V269, P307, DOI 10.1046/j.0014-2956.2001.02653.x; Mallorqui-Fernandez G, 2000, J MOL BIOL, V300, P1297, DOI 10.1006/jmbi.2000.3939; MOLINA HA, 1988, AM J TROP MED HYG, V38, P327, DOI 10.4269/ajtmh.1988.38.327; Parish CR, 1999, CANCER RES, V59, P3433; PETERSON CGB, 1986, IMMUNOBIOLOGY, V171, P1; Raman R, 2005, CHEM BIOL, V12, P267, DOI 10.1016/j.chembiol.2004.11.020; Tumova S, 2000, INT J BIOCHEM CELL B, V32, P269, DOI 10.1016/S1357-2725(99)00116-8; Venge P, 1998, INT J BIOCHEM CELL B, V30, P433, DOI 10.1016/S1357-2725(97)00127-1; Vives E, 1997, J BIOL CHEM, V272, P16010, DOI 10.1074/jbc.272.25.16010; YOUNG JD, 1986, NATURE, V321, P613, DOI 10.1038/321613a0; Yu GL, 2002, EUR J MED CHEM, V37, P783, DOI 10.1016/S0223-5234(02)01347-8; Ziegler A, 2004, BIOPHYS J, V86, P254, DOI 10.1016/S0006-3495(04)74101-6	34	40	41	0	9	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	SEP 12	2008	283	37					25468	25474		10.1074/jbc.M803516200	http://dx.doi.org/10.1074/jbc.M803516200			7	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	345QZ	18593710	hybrid			2022-12-27	WOS:000259012700042
J	Gregori, C; Schurller, C; Frohner, IE; Ammerer, G; Kuchler, K				Gregori, Christa; Schuerller, Christoph; Frohner, Ingrid E.; Ammerer, Gustav; Kuchler, Karl			Weak organic acids trigger conformational changes of the yeast transcription factor War1 in vivo to elicit stress adaptation	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							PROLINE UTILIZATION PATHWAY; SACCHAROMYCES-CEREVISIAE; MULTIDRUG-RESISTANCE; ABC TRANSPORTER; AMINO-ACID; FUNCTIONAL DISSECTION; PHENOTYPIC ANALYSIS; REGULATORY GENE; ACTIVATION; BINDING	The Saccharomyces cerevisiae zinc cluster regulator War1 mediates an essential transcriptional and adaptive response to weak organic acid stress. Here we investigate the mechanism of War1 activation upon weak acid stress. We identified several gain-of-function WAR1 alleles mapping to the central War1 region. These mutations constitutively increase levels of the plasma membrane ABC transporter Pdr12, the main War1 target mediating stress adaptation. Functional analysis of War1 reveals that the central region and its C-terminal activation domain are required for function. Notably, the native DNA-binding and dimerization domains appear dispensable for War1 activity, because they can be replaced by a LexA DNA-binding domain. Chromatin immunoprecipitation demonstrates elevated promoter affinity of activated War1, because its PDR12 promoter association increases upon stress. Hyperactive WAR1 alleles have constitutively high PDR12 promoter association. Furthermore, fluorescence resonance energy transfer of functional CFP-War1-YFP proteins also demonstrates conformational changes of stress-activated War1 in vivo. Our results suggest a mechanism whereby War1 activation is accompanied by conformational changes enhancing promoter association, thus initiating the adaptation process.	[Gregori, Christa; Frohner, Ingrid E.; Kuchler, Karl] Med Univ Vienna, Max F Perutz Labs, A-1030 Vienna, Austria; [Schuerller, Christoph; Ammerer, Gustav] Univ Vienna, Max F Perutz Labs, A-1030 Vienna, Austria	Medical University of Vienna; University of Vienna; Vienna Biocenter (VBC); Max F. Perutz Laboratories (MFPL); Medical University of Vienna; University of Vienna; Vienna Biocenter (VBC); Max F. Perutz Laboratories (MFPL)	Schurller, C (corresponding author), Med Univ Vienna, Max F Perutz Labs, A-1030 Vienna, Austria.	Christoph.Schueller@univie.ac.at; karl.kuchler@meduniwien.ac.at	kuchler, karl/AAL-6937-2020	kuchler, karl/0000-0003-2719-5955; Schuller, Christoph/0000-0002-1649-1217; Frohner, Ingrid/0000-0002-0200-449X	Austrian Science Foundation [P-15934-B08]; Vienna Biocenter [SFB35-04]; Austrian Science Fund (FWF) [F 3504] Funding Source: researchfish	Austrian Science Foundation(Austrian Science Fund (FWF)); Vienna Biocenter; Austrian Science Fund (FWF)(Austrian Science Fund (FWF))	This work was supported in part by Austrian Science Foundation Grant P-15934-B08 and in part by Grant SFB35-04 ( to K. K.) and by Vienna Biocenter Ph.D. program grant ( to I. F.). The costs of publication of this article were defrayed in part by the payment of page charges. This article must therefore be hereby marked "advertisement" in accordance with 18 U. S. C. Section 1734 solely to indicate this fact.	Alepuz PM, 2001, MOL CELL, V7, P767, DOI 10.1016/S1097-2765(01)00221-0; AXELROD JD, 1991, MOL CELL BIOL, V11, P564, DOI 10.1128/MCB.11.1.564; Bhaumik SR, 2004, GENE DEV, V18, P333, DOI 10.1101/gad.1148404; Damelin M, 2000, MOL CELL, V5, P133, DOI 10.1016/S1097-2765(00)80409-8; DELAVEAU T, 1994, MOL GEN GENET, V244, P501, DOI 10.1007/BF00583901; des Etages SAG, 2001, MOL MICROBIOL, V40, P890, DOI 10.1046/j.1365-2958.2001.02432.x; desEtages SAG, 1996, GENETICS, V142, P1069; El Alami M, 2002, MOL MICROBIOL, V43, P1629; Fardeau V, 2007, J BIOL CHEM, V282, P5063, DOI 10.1074/jbc.M610197200; Flynn PJ, 1999, MOL CELL BIOL, V19, P882; FRIDEN P, 1989, MOL CELL BIOL, V9, P4056, DOI 10.1128/MCB.9.9.4056; Giepmans BNG, 2006, SCIENCE, V312, P217, DOI 10.1126/science.1124618; Gordon GW, 1998, BIOPHYS J, V74, P2702, DOI 10.1016/S0006-3495(98)77976-7; Gorner W, 1998, GENE DEV, V12, P586, DOI 10.1101/gad.12.4.586; Gregori C, 2007, FEBS J, V274, P3094, DOI 10.1111/j.1742-4658.2007.05837.x; Hallstrom TC, 2001, J BIOL CHEM, V276, P23674, DOI 10.1074/jbc.M101568200; Hatzixanthis K, 2003, YEAST, V20, P575, DOI 10.1002/yea.981; Hazelwood LA, 2006, FEMS YEAST RES, V6, P937, DOI 10.1111/j.1567-1364.2006.00094.x; Holyoak CD, 1999, J BACTERIOL, V181, P4644, DOI 10.1128/JB.181.15.4644-4652.1999; Huang HL, 2000, MOL CELL BIOL, V20, P892, DOI 10.1128/MCB.20.3.892-899.2000; Kaiser C., 1994, METHODS YEAST GENETI; KIRKPATRICK CR, 1995, MOL CELL BIOL, V15, P4021; Kolaczkowska A, 2002, MOL GENET GENOMICS, V267, P96, DOI 10.1007/s00438-002-0642-0; Kolaczkowska A, 1999, DRUG RESIST UPDATE, V2, P403, DOI 10.1054/drup.1999.0113; KREBS HA, 1983, BIOCHEM J, V214, P657, DOI 10.1042/bj2140657; Kren A, 2003, MOL CELL BIOL, V23, P1775, DOI 10.1128/MCB.23.5.1775-1785.2003; Lebel K, 2006, YEAST, V23, P249, DOI 10.1002/yea.1346; MacPherson S, 2006, MICROBIOL MOL BIOL R, V70, P583, DOI 10.1128/MMBR.00015-06; Mamnun YM, 2004, FEBS LETT, V559, P111, DOI 10.1016/S0014-5793(04)00046-8; MARCZAK JE, 1989, MOL CELL BIOL, V9, P4696, DOI 10.1128/MCB.9.11.4696; MARCZAK JE, 1991, MOL CELL BIOL, V11, P2609, DOI 10.1128/MCB.11.5.2609; Peng G, 2002, P NATL ACAD SCI USA, V99, P8548, DOI 10.1073/pnas.142100099; PFEIFER K, 1989, CELL, V56, P291, DOI 10.1016/0092-8674(89)90903-3; Piper P, 2001, MICROBIOL-SGM, V147, P2635, DOI 10.1099/00221287-147-10-2635; Piper P, 1998, EMBO J, V17, P4257, DOI 10.1093/emboj/17.15.4257; Reece RJ, 2006, BIOCHEM SOC SYMP, V73, P85; ROSE MD, 1987, CELL, V48, P1047, DOI 10.1016/0092-8674(87)90712-4; ROTHSTEIN RJ, 1983, METHOD ENZYMOL, V101, P202; Schjerling P, 1996, NUCLEIC ACIDS RES, V24, P4599, DOI 10.1093/nar/24.23.4599; Schuller C, 2004, MOL BIOL CELL, V15, P706, DOI 10.1091/mbc.E03-05-0322; Sellick CA, 2005, TRENDS BIOCHEM SCI, V30, P405, DOI 10.1016/j.tibs.2005.05.007; Sellick CA, 2003, EMBO J, V22, P5147, DOI 10.1093/emboj/cdg480; SIKORSKI RS, 1989, GENETICS, V122, P19; SZE JY, 1992, SCIENCE, V258, P1143, DOI 10.1126/science.1439822; Thakur JK, 2008, NATURE, V452, P604, DOI 10.1038/nature06836; Todd RB, 1997, FUNGAL GENET BIOL, V21, P388, DOI 10.1006/fgbi.1997.0993; Wang D, 1999, J BIOL CHEM, V274, P19017, DOI 10.1074/jbc.274.27.19017; Wang D, 1997, J BIOL CHEM, V272, P19383, DOI 10.1074/jbc.272.31.19383; ZHOU KM, 1990, NUCLEIC ACIDS RES, V18, P291, DOI 10.1093/nar/18.2.291	49	26	29	0	8	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	SEP 12	2008	283	37					25752	25764		10.1074/jbc.M803095200	http://dx.doi.org/10.1074/jbc.M803095200			13	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	345QZ	18621731	Green Published, hybrid			2022-12-27	WOS:000259012700069
J	Wynn, RM; Kato, M; ChuangO, JL; Tso, SC; Li, J; Chuang, DT				Wynn, R. Max; Kato, Masato; ChuangO, Jacinta L.; Tso, Shih-Chia; Li, Jun; Chuang, David T.			Pyruvate dehydrogenase kinase-4 structures reveal a metastable open conformation fostering robust core-free basal activity	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							LIPOYL-BEARING DOMAIN; CRYSTAL-STRUCTURE; PROTEIN-KINASE; RAT-HEART; DIHYDROLIPOYL ACETYLTRANSFERASE; PHOSPHORYLATION SITES; MAXIMUM-LIKELIHOOD; BLOOD-GLUCOSE; COMPLEX; BINDING	Human pyruvate dehydrogenase complex (PDC) is down-regulated by pyruvate dehydrogenase kinase (PDK) isoforms 1 -4. PDK4 is overexpressed in skeletal muscle in type 2 diabetes, resulting in impaired glucose utilization. Here we show that human PDK4 has robust core-free basal activity, which is considerably higher than activity levels of other PDK isoforms stimulated by thePDCcore. PDK4 binds the L3 lipoyl domain, but its activity is not significantly stimulated by any individual lipoyl domains or the core of PDC. The 2.0-A crystal structures of the PDK4 dimer with bound ADP reveal an open conformation with a wider active-site cleft, compared with that in the closed conformation epitomized by the PDK2-ADP structure. The open conformation in PDK4 shows partially ordered C-terminal cross-tails, in which the conserved DW (Asp(394) -Trp(395)) motif from one subunit anchors to the N-terminal domain of the other subunit. The open conformation fosters a reduced binding affinity for ADP, facilitating the efficient removal of product inhibition by this nucleotide. Alteration or deletion of the DW-motif disrupts the C-terminal cross-tail anchor, resulting in the closed conformation and the nearly complete inactivation of PDK4. Fluorescence quenching and enzyme activity data suggest that compounds AZD7545 and dichloroacetate lock PDK4 in the open and the closed conformational states, respectively. We propose that PDK4 with bound ADP exists in equilibrium between the open and the closed conformations. The favored metastable open conformation is responsible for the robust basal activity of PDK4 in the absence of the PDC core.	[Wynn, R. Max; ChuangO, Jacinta L.; Tso, Shih-Chia; Li, Jun; Chuang, David T.] Univ Texas SW Med Ctr Dallas, Dept Biochem, Dallas, TX 75390 USA; [Wynn, R. Max; Kato, Masato; Chuang, David T.] Univ Texas SW Med Ctr Dallas, Dept Internal Med, Dallas, TX 75390 USA	University of Texas System; University of Texas Southwestern Medical Center Dallas; University of Texas System; University of Texas Southwestern Medical Center Dallas	Chuang, DT (corresponding author), Univ Texas SW Med Ctr Dallas, Dept Biochem, Dallas, TX 75390 USA.	Chuang@UTSouthwestern.edu		Wynn, Richard/0000-0002-1879-2136	National Institutes of Health [DK62306]; Welch Foundation. [Grant I-1286]; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK062306, R56DK062306] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Welch Foundation.(The Welch Foundation); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	This work was supported, in whole or in part, by National Institutes of Health Grant DK62306. This work was also supported by Grant I-1286 from the Welch Foundation. The costs of publication of this article were defrayed in part by the payment of page charges. This article must therefore be hereby marked "advertisement" in accordance with 18 U. S. C. Section 1734 solely to indicate this fact.	Aicher TD, 1999, J MED CHEM, V42, P2741, DOI 10.1021/jm9902584; ALEX LA, 1994, TRENDS GENET, V10, P133, DOI 10.1016/0168-9525(94)90215-1; Baker JC, 2000, J BIOL CHEM, V275, P15773, DOI 10.1074/jbc.M909488199; Ban C, 1999, CELL, V97, P85, DOI 10.1016/S0092-8674(00)80717-5; Bao HY, 2004, BIOCHEMISTRY-US, V43, P13442, DOI 10.1021/bi0494875; Bao HY, 2004, BIOCHEMISTRY-US, V43, P13432, DOI 10.1021/bi049488x; Bergerat A, 1997, NATURE, V386, P414, DOI 10.1038/386414a0; Bowker-Kinley MM, 1998, BIOCHEM J, V329, P191, DOI 10.1042/bj3290191; Brautigam CA, 2005, J MOL BIOL, V350, P543, DOI 10.1016/j.jmb.2005.05.014; Collaborative Computational Project, 1994, ACTA CRYSTALLOGR D, V50, P760, DOI DOI 10.1107/S0907444994003112; Cowtan KD, 1996, ACTA CRYSTALLOGR D, V52, P43, DOI 10.1107/S090744499500761X; DONG J, 2001, THESIS KANSAS STATE; Dutta R, 2000, TRENDS BIOCHEM SCI, V25, P24, DOI 10.1016/S0968-0004(99)01503-0; Gouet P, 1999, BIOINFORMATICS, V15, P305, DOI 10.1093/bioinformatics/15.4.305; Green T, 2008, J BIOL CHEM, V283, P15789, DOI 10.1074/jbc.M800311200; HANKS SK, 1988, SCIENCE, V241, P42, DOI 10.1126/science.3291115; Harris RA, 1997, J BIOL CHEM, V272, P19746, DOI 10.1074/jbc.272.32.19746; Harris RA, 2001, ADV ENZYME REGUL, V41, P269, DOI 10.1016/S0065-2571(00)00020-0; Hawes JW, 2000, METHOD ENZYMOL, V324, P200; Hiromasa Y, 2006, J BIOL CHEM, V281, P12568, DOI 10.1074/jbc.M513514200; Hiromasa Y, 2004, J BIOL CHEM, V279, P6921, DOI 10.1074/jbc.M308172200; Hiromasa Y, 2008, BIOCHEMISTRY-US, V47, P2312, DOI 10.1021/bi7014772; Hiromasa Y, 2008, BIOCHEMISTRY-US, V47, P2298, DOI 10.1021/bi701475f; Holness MJ, 2003, BIOCHEM SOC T, V31, P1143; Huang BL, 2002, DIABETES, V51, P276, DOI 10.2337/diabetes.51.2.276; Jeoung NH, 2008, AM J PHYSIOL-ENDOC M, V295, pE46, DOI 10.1152/ajpendo.00536.2007; Kato M, 2005, EMBO J, V24, P1763, DOI 10.1038/sj.emboj.7600663; Kato M, 2007, STRUCTURE, V15, P992, DOI 10.1016/j.str.2007.07.001; Klyuyeva A, 2005, BIOCHEMISTRY-US, V44, P13573, DOI 10.1021/bi0505868; Knoechel TR, 2006, BIOCHEMISTRY-US, V45, P402, DOI 10.1021/bi051402s; Kolobova E, 2001, BIOCHEM J, V358, P69, DOI 10.1042/0264-6021:3580069; KOROTCHKINA LG, 1995, J BIOL CHEM, V270, P14297, DOI 10.1074/jbc.270.24.14297; Korotchkina LG, 2001, J BIOL CHEM, V276, P5731, DOI 10.1074/jbc.M007558200; Li J, 2007, J BIOL CHEM, V282, P11904, DOI 10.1074/jbc.M610843200; LIU SJ, 1995, J BIOL CHEM, V270, P793, DOI 10.1074/jbc.270.2.793; Liu XL, 1998, AM J PHYSIOL-REG I, V274, pR1212, DOI 10.1152/ajpregu.1998.274.5.R1212; Machius M, 2001, P NATL ACAD SCI USA, V98, P11218, DOI 10.1073/pnas.201220098; Majer M, 1998, MOL GENET METAB, V65, P181, DOI 10.1006/mgme.1998.2748; Mayers RM, 2005, BIOCHEM SOC T, V33, P367, DOI 10.1042/BST0330367; MONOD J, 1965, J MOL BIOL, V12, P88, DOI 10.1016/S0022-2836(65)80285-6; Muoio DM, 2002, J BIOL CHEM, V277, P26089, DOI 10.1074/jbc.M203997200; Murshudov GN, 1997, ACTA CRYSTALLOGR D, V53, P240, DOI 10.1107/S0907444996012255; Otwinowski Z, 1997, METHOD ENZYMOL, V276, P307, DOI 10.1016/S0076-6879(97)76066-X; PATEL MS, 1990, FASEB J, V4, P3224, DOI 10.1096/fasebj.4.14.2227213; Popov KM, 1997, ADV SEC MESS PHOSPH, V31, P105; RADKE GA, 1993, BIOCHEM BIOPH RES CO, V190, P982, DOI 10.1006/bbrc.1993.1146; Read RJ, 2001, ACTA CRYSTALLOGR D, V57, P1373, DOI 10.1107/S0907444901012471; Reed LJ, 2001, J BIOL CHEM, V276, P38329, DOI 10.1074/jbc.R100026200; Roche TE, 2007, CELL MOL LIFE SCI, V64, P830, DOI 10.1007/s00018-007-6380-z; Roche TE, 2003, EUR J BIOCHEM, V270, P1050, DOI 10.1046/j.1432-1033.2003.03468.x; Rowles J, 1996, J BIOL CHEM, V271, P22376, DOI 10.1074/jbc.271.37.22376; SALE GJ, 1981, BIOCHEM J, V193, P935, DOI 10.1042/bj1930935; Schwede T, 2003, NUCLEIC ACIDS RES, V31, P3381, DOI 10.1093/nar/gkg520; Shroads AL, 2008, J PHARMACOL EXP THER, V324, P1163, DOI 10.1124/jpet.107.134593; Smirnova IN, 1998, FEBS LETT, V431, P309, DOI 10.1016/S0014-5793(98)00760-1; Steussy CN, 2001, J BIOL CHEM, V276, P37443, DOI 10.1074/jbc.M104285200; TEAGUE WM, 1979, BIOCHEM BIOPH RES CO, V87, P244, DOI 10.1016/0006-291X(79)91672-3; THOMPSON JD, 1994, NUCLEIC ACIDS RES, V22, P4673, DOI 10.1093/nar/22.22.4673; Tso SC, 2006, J BIOL CHEM, V281, P27197, DOI 10.1074/jbc.M604339200; Tuganova A, 2002, BIOCHEM J, V366, P129, DOI 10.1042/BJ20020301; Tuganova A, 2007, BIOCHEMISTRY-US, V46, P8592, DOI 10.1021/bi700650k; WHITEHOUSE S, 1973, BIOCHEM J, V134, P651, DOI 10.1042/bj1340651; WIGLEY DB, 1991, NATURE, V351, P624, DOI 10.1038/351624a0; Wu PF, 1998, BIOCHEM J, V329, P197, DOI 10.1042/bj3290197; YEAMAN SJ, 1978, BIOCHEMISTRY-US, V17, P2364, DOI 10.1021/bi00605a017; Yu XK, 2008, STRUCTURE, V16, P104, DOI 10.1016/j.str.2007.10.024	66	54	57	0	9	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	SEP 12	2008	283	37					25305	25315		10.1074/jbc.M802249200	http://dx.doi.org/10.1074/jbc.M802249200			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	345QZ	18658136	Green Published, hybrid			2022-12-27	WOS:000259012700024
J	Meiss, E; Konno, H; Groth, G; Hisabori, T				Meiss, Erik; Konno, Hiroki; Groth, Georg; Hisabori, Toru			Molecular processes of inhibition and stimulation of ATP synthase caused by the phytotoxin tentoxin	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							CHLOROPLAST COUPLING FACTOR-1; CATALYTIC SITE; NUCLEOTIDE-BINDING; ADENOSINE-TRIPHOSPHATASE; SPINACH CHLOROPLAST; KINETIC-ANALYSIS; F-1 MOTOR; F-1-ATPASE; F1-ATPASE; ROTATION	F-1-ATPase is the smallest mechanical motor known. Tentoxin, a cyclic peptide produced by phytopathogenic fungi, inactivates the F-1 motor in sensitive plants at nanomolar to micromolar concentrations, whereas higher concentrations surpass the natural activity of the enzyme. Single molecule studies now have clarified the molecular steps involved in both processes. Inactivation delays the dwell time of a single step in the complete 360 turn and results in an asymmetric rotation of the central rotor subunit. In contrast, rotation in the stimulated F-1 particle is smooth and accompanied by strongly reduced ADP inhibition. Our study provides for the first time the direct observation of a noncompetitively inhibited state of the enzyme and directly visualizes the regulation of the molecular motor by an external natural compound. In addition, the ADP release step during catalysis was revealed by analysis of the single molecule rotation behavior. Hence, tentoxin is a sophisticated molecular tool to mark and control certain catalytic steps within the reaction pathway of the molecular F-1 motor.	[Meiss, Erik; Konno, Hiroki; Hisabori, Toru] Tokyo Inst Technol, Chem Resources Lab, Midori Ku, Yokohama, Kanagawa 2268503, Japan; [Meiss, Erik; Groth, Georg] Univ Dusseldorf, Inst Biochem Pflanzen, D-40225 Dusseldorf, Germany	Tokyo Institute of Technology; Heinrich Heine University Dusseldorf	Hisabori, T (corresponding author), Tokyo Inst Technol, Chem Resources Lab, Midori Ku, Nagatsuta 4259-R1-8, Yokohama, Kanagawa 2268503, Japan.	thisabor@res.titech.ac.jp	Hisabori, Toru/E-5205-2014	Hisabori, Toru/0000-0003-2046-0277				ABRAHAMS JP, 1994, NATURE, V370, P621, DOI 10.1038/370621a0; Adachi K, 2007, CELL, V130, P309, DOI 10.1016/j.cell.2007.05.020; Ariga T, 2007, NAT STRUCT MOL BIOL, V14, P841, DOI 10.1038/nsmb1296; AVNI A, 1992, SCIENCE, V257, P1245, DOI 10.1126/science.1387730; Bowler MW, 2006, P NATL ACAD SCI USA, V103, P8646, DOI 10.1073/pnas.0602915103; BOYER PD, 1993, BIOCHIM BIOPHYS ACTA, V1140, P215, DOI 10.1016/0005-2728(93)90063-L; CARLIER MF, 1979, BIOCHEMISTRY-US, V18, P3446, DOI 10.1021/bi00583a002; DAHSE I, 1994, J PLANT PHYSIOL, V143, P615, DOI 10.1016/S0176-1617(11)81147-8; Groth G, 2002, P NATL ACAD SCI USA, V99, P3464, DOI 10.1073/pnas.052546099; Groth G, 2002, J BIOL CHEM, V277, P20117, DOI 10.1074/jbc.C200168200; GUERRERO KJ, 1990, J BIOL CHEM, V265, P16280; Hirono-Hara Y, 2001, P NATL ACAD SCI USA, V98, P13649, DOI 10.1073/pnas.241365698; HISABORI T, 1993, J BIOCHEM-TOKYO, V114, P808, DOI 10.1093/oxfordjournals.jbchem.a124260; HISABORI T, 1992, J BIOL CHEM, V267, P4551; HU NM, 1993, J BIOL CHEM, V268, P8536; Jault JM, 1995, BIOCHEMISTRY-US, V34, P16412, DOI 10.1021/bi00050a023; Konno H, 2006, EMBO J, V25, P4596, DOI 10.1038/sj.emboj.7601348; LANDT O, 1990, GENE, V96, P125, DOI 10.1016/0378-1119(90)90351-Q; Mao HZ, 2007, P NATL ACAD SCI USA, V104, P18478, DOI 10.1073/pnas.0709322104; MILGROM YM, 1990, BIOCHIM BIOPHYS ACTA, V1020, P43, DOI 10.1016/0005-2728(90)90091-H; Mitome N, 2002, EUR J BIOCHEM, V269, P53, DOI 10.1046/j.0014-2956.2002.02623.x; Mochimaru M, 1997, FEBS LETT, V419, P23, DOI 10.1016/S0014-5793(97)01421-X; Nishizaka T, 2004, NAT STRUCT MOL BIOL, V11, P142, DOI 10.1038/nsmb721; Noji H, 1997, NATURE, V386, P299, DOI 10.1038/386299a0; OHTA S, 1980, J BIOCHEM-TOKYO, V87, P1609, DOI 10.1093/oxfordjournals.jbchem.a132904; OHTA Y, 1993, PLANT CELL PHYSIOL, V34, P523; Pavlova P, 2004, J BIOL CHEM, V279, P9685, DOI 10.1074/jbc.C400014200; Sakaki N, 2005, BIOPHYS J, V88, P2047, DOI 10.1529/biophysj.104.054668; Santolini J, 1999, J BIOL CHEM, V274, P849, DOI 10.1074/jbc.274.2.849; Shimabukuro K, 2003, P NATL ACAD SCI USA, V100, P14731, DOI 10.1073/pnas.2434983100; SHOSHAN V, 1978, BIOCHIM BIOPHYS ACTA, V504, P108, DOI 10.1016/0005-2728(78)90010-5; STEELE JA, 1976, P NATL ACAD SCI USA, V73, P2245, DOI 10.1073/pnas.73.7.2245; Stiggall D L, 1979, Methods Enzymol, V55, P308; TAUSSKY HH, 1953, J BIOL CHEM, V202, P675; Tucker WC, 2001, BIOCHEMISTRY-US, V40, P7542, DOI 10.1021/bi0105227; VASILYEVA EA, 1982, BIOCHEM J, V202, P15, DOI 10.1042/bj2020015; Yasuda R, 2001, NATURE, V410, P898, DOI 10.1038/35073513; Yasuda R, 1998, CELL, V93, P1117, DOI 10.1016/S0092-8674(00)81456-7; YOSHIDA M, 1983, J BIOL CHEM, V258, P4407; Yoshida M, 2001, NAT REV MOL CELL BIO, V2, P669, DOI 10.1038/35089509	40	27	28	2	14	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	SEP 5	2008	283	36					24594	24599		10.1074/jbc.M802574200	http://dx.doi.org/10.1074/jbc.M802574200			6	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	342YR	18579520	Green Published, hybrid			2022-12-27	WOS:000258820000031
J	Box, JA; Bunch, JT; Zappulla, DC; Glynn, EF; Baumann, P				Box, Jessica A.; Bunch, Jeremy T.; Zappulla, David C.; Glynn, Earl F.; Baumann, Peter			A flexible template boundary element in the RNA subunit of fission yeast telomerase	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							SACCHAROMYCES-CEREVISIAE TELOMERASE; DOMINANT DYSKERATOSIS-CONGENITA; SECONDARY STRUCTURE; SCHIZOSACCHAROMYCES-POMBE; REVERSE-TRANSCRIPTASE; TETRAHYMENA TELOMERASE; APLASTIC-ANEMIA; DNA; RECOGNITION; MUTATIONS	Telomerase adds telomeric repeat sequences to chromosome ends using a short region of its RNA subunit as a template. Telomerase RNA subunits are phylogenetically highly divergent, and different strategies have evolved to demarcate the boundary of the template region. The recent identification of the gene encoding telomerase RNA in the fission yeast Schizosaccharomyces pombe (ter1(+)) has opened the door for structure-function analyses in a model that shares many features with the telomere maintenance machinery of higher eukaryotes. Here we describe a structural element in TER1 that defines the 5' boundary of the template. Disruption of a predicted long range base pairing interaction between template-adjacent nucleotides and a sequence further upstream resulted in reverse transcription beyond the template region and caused telomere shortening. Normal telomere length was restored by combining complementary nucleotide substitutions in both elements, showing that base pairing, not a specific sequence, limits reverse transcription beyond the template. The template boundary described here resembles that of budding yeasts and some mammalian telomerases. However, unlike any previously characterized boundary element, part of the paired region overlaps with the template itself, thus necessitating disruption of these interactions during most reverse transcription cycles. We show that changes in the paired region directly affect the length of individual telomeric repeat units. Our data further illustrate that marginal alignment of the telomeric 3' end with RNA sequences downstream of the template is responsible for primer slippage, causing incorporation of strings of guanosines at the start of a subset of repeats.	[Box, Jessica A.; Bunch, Jeremy T.; Glynn, Earl F.; Baumann, Peter] Stowers Inst Med Res, Kansas City, MO USA; [Box, Jessica A.; Bunch, Jeremy T.; Glynn, Earl F.; Baumann, Peter] Univ Colorado, Dept Chem & Biochem, Howard Hughes Med Inst, Boulder, CO 80309 USA; [Baumann, Peter] Univ Kansas, Med Ctr, Dept Biochem & Mol Biol, Kansas City, KS 66160 USA	Stowers Institute for Medical Research; Howard Hughes Medical Institute; University of Colorado System; University of Colorado Boulder; University of Kansas; University of Kansas Medical Center	Baumann, P (corresponding author), Stowers Inst, 1000 E 50th St, Kansas City, MO 64110 USA.	peb@stowers-institute.org	Zappulla, David/C-7818-2009	Zappulla, David/0000-0001-8242-3493; Baumann, Peter/0000-0003-4892-1485	National Institutes of Health [K99GM80400]; Stowers Institute for Medical Research; Pew Scholars in the Biomedical Sciences Award; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [K99GM080400, R00GM080400] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Stowers Institute for Medical Research; Pew Scholars in the Biomedical Sciences Award; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported, in whole or in part, by National Institutes of Health Grant K99GM80400 (to D. C. Z.). This work was also supported by the Stowers Institute for Medical Research and a Pew Scholars in the Biomedical Sciences Award (to P. B.). The costs of publication of this article were defrayed in part by the payment of page charges. This article must therefore be hereby marked "advertisement" in accordance with 18 U. S. C. Section 1734 solely to indicate this fact.	Ares M, 2008, NAT STRUCT MOL BIOL, V15, P18, DOI 10.1038/nsmb0108-18; Armanios M, 2005, P NATL ACAD SCI USA, V102, P15960, DOI 10.1073/pnas.0508124102; AUTEXIER C, 1995, GENE DEV, V9, P2227, DOI 10.1101/gad.9.18.2227; Baumann P, 2000, MOL BIOL CELL, V11, P3265, DOI 10.1091/mbc.11.10.3265; Bunch JT, 2005, MOL CELL BIOL, V25, P5567, DOI 10.1128/mcb.25.13.5567-5578.2005; Cech TR, 2004, CELL, V116, P273, DOI 10.1016/S0092-8674(04)00038-8; Chen JL, 2004, TRENDS BIOCHEM SCI, V29, P183, DOI 10.1016/j.tibs.2004.02.003; Chen JL, 2003, GENE DEV, V17, P2747, DOI 10.1101/gad.1140303; Chen JL, 2000, CELL, V100, P503, DOI 10.1016/S0092-8674(00)80687-X; Cohn M, 1998, CURR GENET, V33, P83, DOI 10.1007/s002940050312; Collins K, 1999, ANNU REV BIOCHEM, V68, P187, DOI 10.1146/annurev.biochem.68.1.187; Collins K, 2006, NAT REV MOL CELL BIO, V7, P484, DOI 10.1038/nrm1961; Croy JE, 2006, J MOL BIOL, V361, P80, DOI 10.1016/j.jmb.2006.06.002; Dandjinou AT, 2004, CURR BIOL, V14, P1148, DOI 10.1016/j.cub.2004.05.054; Forstemann K, 2001, MOL CELL BIOL, V21, P7277, DOI 10.1128/MCB.21.21.7277-7286.2001; Haering CH, 2000, P NATL ACAD SCI USA, V97, P6367, DOI 10.1073/pnas.130187397; Hiraoka Y, 1998, TRENDS BIOCHEM SCI, V23, P126, DOI 10.1016/S0968-0004(98)01176-1; Konig P, 1997, TRENDS BIOCHEM SCI, V22, P43, DOI 10.1016/S0968-0004(97)01008-6; Lai CK, 2002, GENE DEV, V16, P415, DOI 10.1101/gad.962602; Leonardi J, 2008, NAT STRUCT MOL BIOL, V15, P26, DOI 10.1038/nsmb1343; Lin J, 2004, P NATL ACAD SCI USA, V101, P14713, DOI 10.1073/pnas.0405879101; LINGNER J, 1994, GENE DEV, V8, P1984, DOI 10.1101/gad.8.16.1984; McCormickGraham M, 1997, EMBO J, V16, P3233, DOI 10.1093/emboj/16.11.3233; MCCORMICKGRAHAM M, 1995, NUCLEIC ACIDS RES, V23, P1091, DOI 10.1093/nar/23.7.1091; MCEACHERN MJ, 1995, NATURE, V376, P403, DOI 10.1038/376403a0; Mitchell JR, 1999, NATURE, V402, P551, DOI 10.1038/990141; ROMERO DP, 1991, CELL, V67, P343, DOI 10.1016/0092-8674(91)90186-3; Seto AG, 2003, RNA, V9, P1323, DOI 10.1261/rna.5570803; SINGER MS, 1994, SCIENCE, V266, P404, DOI 10.1126/science.7545955; Theimer CA, 2006, CURR OPIN STRUC BIOL, V16, P307, DOI 10.1016/j.sbi.2006.05.005; Trujillo KM, 2005, J BIOL CHEM, V280, P9119, DOI 10.1074/jbc.M414511200; Tzfati Y, 2000, SCIENCE, V288, P863, DOI 10.1126/science.288.5467.863; Vulliamy T, 2001, NATURE, V413, P432, DOI 10.1038/35096585; Vulliamy T, 2002, LANCET, V359, P2168, DOI 10.1016/S0140-6736(02)09087-6; Webb CJ, 2008, NAT STRUCT MOL BIOL, V15, P34, DOI 10.1038/nsmb1354; Wellinger RJ, 1997, EUR J CANCER, V33, P735, DOI 10.1016/S0959-8049(97)00067-1; Yamaguchi H, 2005, NEW ENGL J MED, V352, P1413, DOI 10.1056/NEJMoa042980; ZAKIAN VA, 1995, SCIENCE, V270, P1601, DOI 10.1126/science.270.5242.1601; Zappulla DC, 2004, P NATL ACAD SCI USA, V101, P10024, DOI 10.1073/pnas.0403641101	39	29	30	0	4	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	AUG 29	2008	283	35					24224	24233		10.1074/jbc.M802043200	http://dx.doi.org/10.1074/jbc.M802043200			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	340II	18574244	Green Published, hybrid			2022-12-27	WOS:000258638900076
J	Haraguchi, M; Okubo, T; Miyashita, Y; Miyamoto, Y; Hayashi, M; Crotti, TN; McHugh, KP; Ozawa, M				Haraguchi, Misako; Okubo, Tadashi; Miyashita, Yayoi; Miyamoto, Yasunori; Hayashi, Masao; Crotti, Tania N.; McHugh, Kevin P.; Ozawa, Masayuki			Snail regulates cell-matrix adhesion by regulation of the expression of integrins and basement membrane proteins	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							E-CADHERIN; MESENCHYMAL TRANSITIONS; COLORECTAL-CANCER; TUMOR-REGRESSION; SUPPRESSION; GENE; ACTIVATION; PROMOTER; SURVIVAL; CONFERS	Snail, a transcriptional repressor of E-cadherin expression, plays a role in the process of epithelial-mesenchymal transition. However, the molecular basis of the role of snail in epithelial-mesenchymal transition has not been fully clarified. Here we show that the expression of snail in epithelial Madin-Darby canine kidney (MDCK) and A431 cells enhances both cell detachment and attachment. Snail did not confer resistance to anoikis induced by loss of contact but instead enhanced cell attachment to extracellular matrices such as fibronectin. This attachment was inhibited by Arg-Gly-Asp (RGD) peptides. Up-regulation of the promoter activity of integrin V was observed in snail-expressing MDCK (MDCK/snail) cells. Snail also enhanced MDCK cell migration toward osteopontin that is a ligand for integrin V 3. We confirmed the reduction of basement membrane proteins such as laminin (LN) alpha 3, beta 3, and gamma 2 (laminin-5/LN-5) and of receptors for LN-5 such as integrins alpha 3, alpha 6, or alpha 4 in MDCK/snail or in snail-expressing A431 (A431/snail) cells. Nevertheless, suppression of LN-gamma 3 chain by transient transfection of small interference RNAs resulted in no enhancement of cell detachment. We also found an induction of matrix metalloproteinase-3 in MDCK/snail and A431/snailcells. However, the inhibition of matrix metalloproteinase-3 showed no significant effect on the detachment of MDCK/snail cells. These results suggest that snail enhances cell detachment by multiple mechanism and leads to cell migration and reattachment at a second site, at least in part, by changing the expression of integrins in the cells.	[Haraguchi, Misako; Okubo, Tadashi; Miyashita, Yayoi; Ozawa, Masayuki] Kagoshima Univ, Grad Sch Med & Dent Sci, Dept Biochem & Mol Biol, Kagoshima 8908544, Japan; [Miyamoto, Yasunori; Hayashi, Masao] Ochanomizu Univ, Dept Biol, Tokyo 1128610, Japan; [Crotti, Tania N.; McHugh, Kevin P.] Harvard Univ, Sch Med, Beth Israel Deaconess Med Ctr, Div Rheumatol, Boston, MA 02115 USA	Kagoshima University; Ochanomizu University; Harvard University; Beth Israel Deaconess Medical Center; Harvard Medical School	Haraguchi, M (corresponding author), Kagoshima Univ, Grad Sch Med & Dent Sci, Dept Biochem & Mol Biol, 8-35-1 Sakuragaoka, Kagoshima 8908544, Japan.	haraguci@m3.kufm.kagoshima-u.ac.jp	Miyamoto, Yasunori/M-4825-2019	Miyamoto, Yasunori/0000-0001-9192-4281; Crotti, Tania/0000-0002-5422-3758				Bandow K, 2007, J CELL PHYSIOL, V211, P392, DOI 10.1002/jcp.20944; Barrallo-Gimeno A, 2005, DEVELOPMENT, V132, P3151, DOI 10.1242/dev.01907; BIRCHMEIER C, 1996, ACTA ANAT, V156, P17; Blanco MJ, 2002, ONCOGENE, V21, P3241, DOI 10.1038/sj.onc.1205416; Bogenrieder T, 2003, ONCOGENE, V22, P6524, DOI 10.1038/sj.onc.1206757; Bolos V, 2003, J CELL SCI, V116, P499, DOI 10.1242/jcs.00224; BROOKS PC, 1994, CELL, V79, P1157, DOI 10.1016/0092-8674(94)90007-8; Cano A, 2000, NAT CELL BIOL, V2, P76, DOI 10.1038/35000025; Chambers AF, 2002, NAT REV CANCER, V2, P563, DOI 10.1038/nrc865; Christofori G, 1999, TRENDS BIOCHEM SCI, V24, P73, DOI 10.1016/S0968-0004(98)01343-7; Haraguchi M, 2000, J EXP MED, V191, P1709, DOI 10.1084/jem.191.10.1709; HAVENITH MG, 1988, CANCER-AM CANCER SOC, V62, P2207, DOI 10.1002/1097-0142(19881115)62:10<2207::AID-CNCR2820621023>3.0.CO;2-L; Heilshorn SC, 2003, BIOMATERIALS, V24, P4245, DOI 10.1016/S0142-9612(03)00294-1; Hood JD, 2002, SCIENCE, V296, P2404, DOI 10.1126/science.1070200; Ikeda K, 2006, AM J PATHOL, V168, P856, DOI 10.2353/ajpath.2006.050384; Jorda M, 2005, J CELL SCI, V118, P3371, DOI 10.1242/jcs.02465; Kajita M, 2004, MOL CELL BIOL, V24, P7559, DOI 10.1128/MCB.24.17.7559-7566.2004; Kambe M, 1998, BBA-GENE STRUCT EXPR, V1395, P209, DOI 10.1016/S0167-4781(97)00152-8; Kang HG, 2007, CANCER RES, V67, P3094, DOI 10.1158/0008-5472.CAN-06-3259; Kiemer AK, 2001, ONCOGENE, V20, P6679, DOI 10.1038/sj.onc.1204872; Kolachala VL, 2007, J BIOL CHEM, V282, P32965, DOI 10.1074/jbc.M704388200; Mak GZ, 2006, MOL BIOL CELL, V17, P3664, DOI 10.1091/mbc.E05-11-1070; Ohkubo T, 2004, J CELL SCI, V117, P1675, DOI 10.1242/jcs.01004; Pecheur I, 2002, FASEB J, V16, P1266, DOI 10.1096/fj.01-0911fje; Peinado H, 2004, J CELL SCI, V117, P2827, DOI 10.1242/jcs.01145; Peinado HC, 2004, INT J DEV BIOL, V48, P365, DOI 10.1387/ijdb.041794hp; Pulyaeva H, 1997, CLIN EXP METASTAS, V15, P111, DOI 10.1023/A:1018444609098; Ryan MC, 1999, J CELL BIOL, V145, P1309, DOI 10.1083/jcb.145.6.1309; Sloan EK, 2006, BREAST CANCER RES, V8, DOI 10.1186/bcr1398; Sugimachi K, 2003, CLIN CANCER RES, V9, P2657; Takeichi M, 1993, CURR OPIN CELL BIOL, V5, P806, DOI 10.1016/0955-0674(93)90029-P; Takkunen M, 2006, J HISTOCHEM CYTOCHEM, V54, P1263, DOI 10.1369/jhc.6A6958.2006; Uchimiya H, 2002, CANCER RES, V62, P2834; Vega S, 2004, GENE DEV, V18, P1131, DOI 10.1101/gad.294104; Yang J, 2004, CELL, V117, P927, DOI 10.1016/j.cell.2004.06.006	35	79	80	0	7	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	AUG 29	2008	283	35					23514	23523		10.1074/jbc.M801125200	http://dx.doi.org/10.1074/jbc.M801125200			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	340II	18593711	Green Published, hybrid			2022-12-27	WOS:000258638900004
J	Kitajima-Ihara, T; Furutani, Y; Suzuki, D; Ihara, K; Kandori, H; Homma, M; Sudo, Y				Kitajima-Ihara, Tomomi; Furutani, Yuji; Suzuki, Daisuke; Ihara, Kunio; Kandori, Hideki; Homma, Michio; Sudo, Yuki			Salinibacter sensory rhodopsin - Sensory rhodopsin I-like protein from a eubacterium	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							PHARAONIS PHOBORHODOPSIN; NATRONOBACTERIUM-PHARAONIS; STRUCTURAL-CHANGES; HALOBACTERIAL TRANSDUCER; COGNATE TRANSDUCER; TRANSIENT MOVEMENT; MUTATION ANALYSIS; CHARGED RESIDUES; PROTON PUMP; HELIX F	Halobacterium salinarum sensory rhodopsin I ( HsSRI), a dual receptor regulating both negative and positive phototaxis in haloarchaea, transmits light signals through changes in proteinprotein interactions with its transducer, halobacterial transducer protein I ( HtrI). Haloarchaea also have another sensor pigment, sensory rhodopsin II ( SRII), which functions as a receptor regulating negative phototaxis. Compared with HsSRI, the signal relay mechanism of SRII is well characterized because SRII from Natronomonus pharaonis ( NpSRII) is much more stable than HsSRI and HsSRII, especially in dilute salt solutions and is much more resistant to detergents. Two genes encoding SRI homologs were identified from the genome sequence of the eubacterium Salinibacter ruber. Those sequences are distantly related to HsSRI (similar to 40% identity) and contain most of the amino acid residues identified as necessary for its function. To determine whether those genes encode functional protein( s), we cloned and expressed them in Escherichia coli. One of them ( SrSRI) was expressed well as a recombinant protein having alltrans retinal as a chromophore. UV- Vis, low- temperature UVVis, pH- titration, and flash photolysis experiments revealed that the photochemical properties of SrSRI are similar to those of HsSRI. In addition to the expression system, the high stability of SrSRI makes it possible to prepare large amounts of protein and enables studies of mutant proteins that will allow new approaches to investigate the photosignaling process of SRI- HtrI.	[Kitajima-Ihara, Tomomi; Suzuki, Daisuke; Homma, Michio; Sudo, Yuki] Nagoya Univ, Grad Sch Sci, Div Biol Sci, Chikusa Ku, Nagoya, Aichi 4648602, Japan; [Ihara, Kunio] Nagoya Univ, Ctr Gene Res, Chikusa Ku, Nagoya, Aichi 4648602, Japan; [Furutani, Yuji; Kandori, Hideki] Nagoya Inst Technol, Dept Mat Sci & Engn, Showa Ku, Nagoya, Aichi 4668555, Japan	Nagoya University; Nagoya University; Nagoya Institute of Technology	Sudo, Y (corresponding author), Nagoya Univ, Grad Sch Sci, Div Biol Sci, Chikusa Ku, Nagoya, Aichi 4648602, Japan.	4sudo@bunshi4.bio.nagoya-u.ac.jp	Sudo, Yuki/AGY-0493-2022; IHARA, Kunio/D-1952-2011; Furutani, Yuji/J-8337-2019	Sudo, Yuki/0000-0001-8155-9356; Furutani, Yuji/0000-0001-5284-8773				Balashov SP, 2005, SCIENCE, V309, P2061, DOI 10.1126/science.1118046; BOGOMOLNI RA, 1982, P NATL ACAD SCI-BIOL, V79, P6250, DOI 10.1073/pnas.79.20.6250; Chizhov I, 1998, BIOPHYS J, V75, P999, DOI 10.1016/S0006-3495(98)77588-5; Gordeliy VI, 2002, NATURE, V419, P484, DOI 10.1038/nature01109; HAZEMOTO N, 1983, BIOPHYS J, V44, P59, DOI 10.1016/S0006-3495(83)84277-5; Hippler-Mreyen S, 2003, J MOL BIOL, V330, P1203, DOI 10.1016/S0022-2836(03)00656-9; Hoff WD, 1997, ANNU REV BIOPH BIOM, V26, P223, DOI 10.1146/annurev.biophys.26.1.223; IMAMOTO Y, 1992, BIOCHEMISTRY-US, V31, P2523, DOI 10.1021/bi00124a012; Iwata T, 2003, BIOCHEMISTRY-US, V42, P8183, DOI 10.1021/bi0345135; Jung KH, 1998, J BACTERIOL, V180, P2033, DOI 10.1128/JB.180.8.2033-2042.1998; KAMO N, 1985, ARCH BIOCHEM BIOPHYS, V238, P90, DOI 10.1016/0003-9861(85)90144-4; Kandori H, 2002, J PHYS CHEM A, V106, P2091, DOI 10.1021/jp012447f; Kandori H, 2001, BIOCHEMISTRY-US, V40, P9238, DOI 10.1021/bi0103819; Luecke H, 2001, SCIENCE, V293, P1499, DOI 10.1126/science.1062977; Luecke H, 1999, J MOL BIOL, V291, P899, DOI 10.1006/jmbi.1999.3027; MARMUR J, 1961, J MOL BIOL, V3, P208, DOI 10.1016/S0022-2836(61)80047-8; Mongodin EF, 2005, P NATL ACAD SCI USA, V102, P18147, DOI 10.1073/pnas.0509073102; Moukhametzianov R, 2006, NATURE, V440, P115, DOI 10.1038/nature04520; OLSON KD, 1992, PHOTOCHEM PHOTOBIOL, V56, P1181, DOI 10.1111/j.1751-1097.1992.tb09743.x; OLSON KD, 1995, P NATL ACAD SCI USA, V92, P3185, DOI 10.1073/pnas.92.8.3185; PebayPeyroula E, 1997, SCIENCE, V277, P1676, DOI 10.1126/science.277.5332.1676; PETTEI MJ, 1977, BIOCHEMISTRY-US, V16, P1955, DOI 10.1021/bi00628a031; RUDOLPH J, 1995, EMBO J, V14, P4249, DOI 10.1002/j.1460-2075.1995.tb00099.x; SASAKI J, 2008, PHOTOCHEM P IN PRESS; Sasaki J, 2007, MOL MICROBIOL, V66, P1321, DOI 10.1111/j.1365-2958.2007.05983.x; Sasaki J, 2007, BIOPHYS J, V92, P4045, DOI 10.1529/biophysj.106.101121; SCHARF B, 1992, BIOCHEMISTRY-US, V31, P12486, DOI 10.1021/bi00164a027; SEIDEL R, 1995, P NATL ACAD SCI USA, V92, P3036, DOI 10.1073/pnas.92.7.3036; Shimono K, 2003, J BIOL CHEM, V278, P23882, DOI 10.1074/jbc.M301200200; Shimono K, 2001, BBA-BIOMEMBRANES, V1515, P92, DOI 10.1016/S0005-2736(01)00394-7; SPUDICH EN, 1982, P NATL ACAD SCI-BIOL, V79, P4308, DOI 10.1073/pnas.79.14.4308; Spudich JL, 1996, CURR OPIN CELL BIOL, V8, P452, DOI 10.1016/S0955-0674(96)80020-2; Spudich JL, 2002, CURR OPIN STRUC BIOL, V12, P540, DOI 10.1016/S0959-440X(02)00359-7; SPUDICH JL, 1984, NATURE, V312, P509, DOI 10.1038/312509a0; SPUDICH JL, 1995, BIOPHYS CHEM, V56, P165, DOI 10.1016/0301-4622(95)00029-W; Spudich JL, 2006, TRENDS MICROBIOL, V14, P480, DOI 10.1016/j.tim.2006.09.005; Sudo Y, 2006, J MOL BIOL, V357, P1274, DOI 10.1016/j.jmb.2006.01.061; Sudo Y, 2005, J AM CHEM SOC, V127, P16036, DOI 10.1021/ja056203a; Sudo Y, 2005, BIOCHEMISTRY-US, V44, P6144, DOI 10.1021/bi047573z; Sudo Y, 2004, BIOCHEMISTRY-US, V43, P13748, DOI 10.1021/bi048803c; Sudo Y, 2003, BIOCHEMISTRY-US, V42, P14166, DOI 10.1021/bi035678g; Sudo Y, 2003, PHOTOCHEM PHOTOBIOL, V78, P511, DOI 10.1562/0031-8655(2003)078<0511:IONPPS>2.0.CO;2; Sudo Y, 2002, BIOPHYS J, V83, P427, DOI 10.1016/S0006-3495(02)75180-1; Sudo Y, 2001, BIOPHYS J, V80, P916, DOI 10.1016/S0006-3495(01)76070-5; Sudo Y, 2007, J BIOL CHEM, V282, P15550, DOI 10.1074/jbc.M701271200; Sudo Y, 2006, P NATL ACAD SCI USA, V103, P16129, DOI 10.1073/pnas.0607467103; Sudo Y, 2006, J BIOL CHEM, V281, P34239, DOI 10.1074/jbc.M605907200; TAKAHASHI T, 1990, BIOCHEMISTRY-US, V29, P8467, DOI 10.1021/bi00488a038; Trivedi VD, 2003, BIOCHEMISTRY-US, V42, P13887, DOI 10.1021/bi034399q; TSUDA M, 1982, BIOCHEM BIOPH RES CO, V108, P970; Wegener AA, 2000, J MOL BIOL, V301, P881, DOI 10.1006/jmbi.2000.4008; Wegener AA, 2001, EMBO J, V20, P5312, DOI 10.1093/emboj/20.19.5312; YAN B, 1990, BIOPHYS J, V57, P807, DOI 10.1016/S0006-3495(90)82600-X; YAO VJ, 1992, P NATL ACAD SCI USA, V89, P11915, DOI 10.1073/pnas.89.24.11915; Yoshida H, 2004, PHOTOCH PHOTOBIO SCI, V3, P537, DOI 10.1039/b315454h; Zhang XN, 1997, BIOPHYS J, V73, P1516, DOI 10.1016/S0006-3495(97)78183-9	56	47	49	0	3	ELSEVIER	AMSTERDAM	RADARWEG 29, 1043 NX AMSTERDAM, NETHERLANDS		1083-351X		J BIOL CHEM	J. Biol. Chem.	AUG 29	2008	283	35					23533	23541		10.1074/jbc.M802990200	http://dx.doi.org/10.1074/jbc.M802990200			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	340II	18566451	Green Published, hybrid			2022-12-27	WOS:000258638900006
J	Matsushima, Y; Farr, CL; Fan, L; Kaguni, LS				Matsushima, Yuichi; Farr, Carol L.; Fan, Li; Kaguni, Laurie S.			Physiological and biochemical defects in carboxyl-terminal mutants of mitochondrial DNA helicase	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							PROGRESSIVE EXTERNAL OPHTHALMOPLEGIA; REPLICATIVE HELICASE; CRYSTAL-STRUCTURE; MULTIPLE DELETIONS; BACTERIOPHAGE T7; GENE-4 HELICASE; BINDING PROTEIN; COPY NUMBER; TWINKLE; DOMAIN	Mitochondrial DNA helicase, also called Twinkle, is essential for mtDNA maintenance. Its helicase domain shares high homology with helicases from superfamily 4. Structural analyses of helicases from this family indicate that carboxyl-terminal residues contribute to NTP hydrolysis required for translocation and DNA unwinding, yet genetic and biochemical information is very limited. Here, we evaluate the effects of overexpression in Drosophila cell culture of variants carrying a series of deletion and alanine substitution mutations in the carboxyl terminus and identify critical residues between amino acids 572 and 596 of the 613 amino acid polypeptide that are essential for mitochondrial DNA helicase function in vivo. Likewise, amino acid substitution mutants K574A, R576A, Y577A, F588A, and F595A show dose-dependent dominant-negative phenotypes. Arg-576 and Phe-588 are analogous to the arginine finger and base stack of other helicases, including the bacteriophage T7 gene 4 protein and bacterial DnaB helicase, respectively. We show here that representative human recombinant proteins that are analogous to the alanine substitution mutants exhibit defects in nucleotide hydrolysis. Our findings may be applicable to understand the role of the carboxyl-terminal region in superfamily 4 DNA helicases in general.	[Matsushima, Yuichi; Farr, Carol L.; Kaguni, Laurie S.] Michigan State Univ, Dept Biochem & Mol Biol, E Lansing, MI 48824 USA; [Fan, Li] Scripps Res Inst, Dept Mol Biol, La Jolla, CA 92037 USA	Michigan State University; Scripps Research Institute	Kaguni, LS (corresponding author), Michigan State Univ, Dept Biochem & Mol Biol, E Lansing, MI 48824 USA.	lskaguni@msu.edu	Classen, Scott/AAY-8176-2020		National Institutes of Health [GM45295, RO1 CA112093, PO1 CA92584]; NATIONAL CANCER INSTITUTE [R01CA112093, P01CA092584] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM045295] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported, in whole or in part, by National Institutes of Health Grants GM45295 (to L.S.K.) and RO1 CA112093 and PO1 CA92584 (NCI; to John A. Tainer in support of L. F.). The costs of publication of this article were defrayed in part by the payment of page charges. This article must therefore be hereby marked "advertisement" in accordance with 18 U. S. C. Section 1734 solely to indicate this fact.	Bailey S, 2007, SCIENCE, V318, P459, DOI 10.1126/science.1147353; Bailey S, 2007, NUCLEIC ACIDS RES, V35, P4728, DOI 10.1093/nar/gkm507; Copeland WC, 2008, ANNU REV MED, V59, P131, DOI 10.1146/annurev.med.59.053006.104646; Crampton DJ, 2006, MOL CELL, V21, P165, DOI 10.1016/j.molcel.2005.11.027; Crampton DJ, 2004, P NATL ACAD SCI USA, V101, P4373, DOI 10.1073/pnas.0400968101; Donmez I, 2006, NUCLEIC ACIDS RES, V34, P4216, DOI 10.1093/nar/gkl508; Farge G, 2008, NUCLEIC ACIDS RES, V36, P393, DOI 10.1093/nar/gkm1025; Hakonen AH, 2007, BRAIN, V130, P3032, DOI 10.1093/brain/awm242; Hamdan SM, 2007, MOL CELL, V27, P539, DOI 10.1016/j.molcel.2007.06.020; Hamdan SM, 2005, P NATL ACAD SCI USA, V102, P5096, DOI 10.1073/pnas.0501637102; Kaguni LS, 2004, ANNU REV BIOCHEM, V73, P293, DOI 10.1146/annurev.biochem.72.121801.161455; Kong DC, 1998, J BIOL CHEM, V273, P6556, DOI 10.1074/jbc.273.11.6556; Korhonen JA, 2008, J MOL BIOL, V377, P691, DOI 10.1016/j.jmb.2008.01.035; Lee SJ, 2006, J BIOL CHEM, V281, P25841, DOI 10.1074/jbc.M604602200; Leipe DD, 2000, GENOME RES, V10, P5; Matsushima Y, 2005, J BIOL CHEM, V280, P16815, DOI 10.1074/jbc.M500569200; Matsushima Y, 2004, J BIOL CHEM, V279, P26900, DOI 10.1074/jbc.M401643200; Matsushima Y, 2007, J BIOL CHEM, V282, P9436, DOI 10.1074/jbc.M610550200; McRee DE, 1999, J STRUCT BIOL, V125, P156, DOI 10.1006/jsbi.1999.4094; Niedenzu T, 2001, J MOL BIOL, V306, P479, DOI 10.1006/jmbi.2000.4398; Notarnicola SM, 1997, J BIOL CHEM, V272, P18425, DOI 10.1074/jbc.272.29.18425; Patel SS, 2000, ANNU REV BIOCHEM, V69, P651, DOI 10.1146/annurev.biochem.69.1.651; Sarzi E, 2007, ANN NEUROL, V62, P579, DOI 10.1002/ana.21207; Sawaya MR, 1999, CELL, V99, P167, DOI 10.1016/S0092-8674(00)81648-7; Singleton MR, 2007, ANNU REV BIOCHEM, V76, P23, DOI 10.1146/annurev.biochem.76.052305.115300; Singleton MR, 2000, CELL, V101, P589, DOI 10.1016/S0092-8674(00)80871-5; Spelbrink JN, 2001, NAT GENET, V28, P223, DOI 10.1038/90058; Spinazzola A, 2005, GENE, V354, P162, DOI 10.1016/j.gene.2005.03.025; Suomalainen A, 1997, NEUROLOGY, V48, P1244, DOI 10.1212/WNL.48.5.1244; SUOMALAINEN A, 1992, J CLIN INVEST, V90, P61, DOI 10.1172/JCI115856; Wang G, 2008, NAT STRUCT MOL BIOL, V15, P94, DOI 10.1038/nsmb1356; Wanrooij S, 2007, NUCLEIC ACIDS RES, V35, P3238, DOI 10.1093/nar/gkm215; ZEVIANI M, 1989, NATURE, V339, P309, DOI 10.1038/339309a0; Ziebarth TD, 2007, J MOL BIOL, V367, P1382, DOI 10.1016/j.jmb.2007.01.079; Ziegelin G, 2003, NUCLEIC ACIDS RES, V31, P5917, DOI 10.1093/nar/gkg790	35	19	19	0	4	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	AUG 29	2008	283	35					23964	23971		10.1074/jbc.M803674200	http://dx.doi.org/10.1074/jbc.M803674200			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	340II	18593709	hybrid, Green Published			2022-12-27	WOS:000258638900052
J	Mouillet-Richard, S; Nishida, N; Pradines, E; Laude, H; Schneider, B; Feraudet, C; Grassi, J; Launay, JM; Lehmann, S; Kellermann, O				Mouillet-Richard, Sophie; Nishida, Noriyuki; Pradines, Elodie; Laude, Hubert; Schneider, Benoit; Feraudet, Cecile; Grassi, Jacques; Launay, Jean-Marie; Lehmann, Sylvain; Kellermann, Odile			Prions impair bioaminergic functions through serotonin- or catecholamine-derived neurotoxins in neuronal cells	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							POSSIBLE RELEVANCE; SCRAPIE INFECTION; OXIDATIVE STRESS; PROTEIN PRPC; BRAIN; DISEASE; TRANSPORTERS; TRANSMISSION; HYDROXYLASE; RESISTANT	The conversion of the cellular prion protein, PrPC, to an abnormal isoform, PrPSc, is a central event leading to neurodegeneration in prion diseases. Deciphering the molecular and cellular changes imparted by PrPSc accumulation remains an arduous task due to the small number of cell lines supporting prion replication. Here we introduce the 1C11 cell line as a new in vitro model to investigate prion pathogenesis. This cell line is a committed neuroectodermal progenitor able to differentiate into fully functional serotonergic or catecholaminergic neurons. 1C11 cells, which naturally express PrPC from the undifferentiated state, can be chronically infected with various prion strains. Prion infection does not promote any noticeable phenotypic change in the progenitor cells nor prevent the onset of the serotonergic and catecholaminergic differentiation programs. Pathogenic prions, however, deviate the overall neurotransmitter-metabolism in both pathways by decreasing bioamine synthesis, storage, and transport, and enhancing catabolism. Noteworthy, oxidized derivatives of both serotonin and catecholamines are selectively detected in the differentiated progenies of infected cells and contribute to irreversible impairment in bioamine synthesis. Finally, the level of PrPSc accumulation, that of infectivity, and the extent of all prion-induced changes in infected cells appear to be correlated. The report of such specific effects of infection on neuronal functions provides a foundation for dissecting the events underlying loss of neuronal homeostasis in prion diseases.	[Mouillet-Richard, Sophie; Pradines, Elodie; Schneider, Benoit; Kellermann, Odile] CNRS, Inst Pasteur, INSERM, U747,FRE 2937, F-94801 Villejuif, France; [Nishida, Noriyuki; Lehmann, Sylvain] CNRS, Inst Human Genet, UPR 1142, F-34396 Montpellier 5, France; [Laude, Hubert] INRA, Unite Virol & Immunol Mol, F-78350 Jouy En Josas, France; [Feraudet, Cecile; Grassi, Jacques] CEA Saclay, Serv Pharmacol & Immunoanalyse, iBiTecS, F-91191 Gif Sur Yvette, France; [Launay, Jean-Marie] Hoffmann Roche AG, Pharma Res Dept, CH-4070 Basel, Switzerland; [Launay, Jean-Marie] Hop Lariboisiere, Serv Biochim, EA3621, F-75009 Paris, France	Centre National de la Recherche Scientifique (CNRS); Institut National de la Sante et de la Recherche Medicale (Inserm); Centre National de la Recherche Scientifique (CNRS); Universite de Montpellier; INRAE; UDICE-French Research Universities; Universite Paris Saclay; CEA; UDICE-French Research Universities; Universite Paris Saclay; Roche Holding; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Lariboisiere-Fernand-Widal - APHP; UDICE-French Research Universities; Universite Paris Cite	Mouillet-Richard, S (corresponding author), CNRS, Inst Pasteur, INSERM, U747,FRE 2937, 7 Rue Guy Moquet, F-94801 Villejuif, France.	mouillet@vjf.cnrs.fr	Mouillet, Sophie/E-4960-2017; Lehmann, Sylvain/P-1301-2017; Schneider, Benoit/AAF-3850-2019	Mouillet, Sophie/0000-0002-8950-1949; Lehmann, Sylvain/0000-0001-6117-562X; Schneider, Benoit/0000-0002-1377-2670	Groupement d'interet scientifique Infections a prions; CNRS; Fondation de la Recherche Medicale; European Community [TSE Biotech BIO4CT98-6064, Neuroprion FOOD-CT-2004-506579]	Groupement d'interet scientifique Infections a prions; CNRS(Centre National de la Recherche Scientifique (CNRS)); Fondation de la Recherche Medicale(Fondation pour la Recherche Medicale); European Community(European Commission)	This work was supported by grants from the Groupement d'interet scientifique "Infections a prions," the CNRS, the Fondation de la Recherche Medicale, and the European Community (TSE Biotech BIO4CT98-6064, Neuroprion FOOD-CT-2004-506579). The costs of publication of this article were defrayed in part by the payment of page charges. This article must therefore be hereby marked "advertisement" in accordance with 18 U. S. C. Section 1734 solely to indicate this fact.	Baumgarten HG, 2004, NEUROTOX RES, V6, P589, DOI 10.1007/BF03033455; Brandner S, 1996, P NATL ACAD SCI USA, V93, P13148, DOI 10.1073/pnas.93.23.13148; BUELER H, 1993, CELL, V73, P1339, DOI 10.1016/0092-8674(93)90360-3; CHEN JC, 1989, J PHARMACOL EXP THER, V250, P141; Chesebro B, 2005, SCIENCE, V308, P1435, DOI 10.1126/science.1110837; Cronier S, 2004, P NATL ACAD SCI USA, V101, P12271, DOI 10.1073/pnas.0402725101; Feraudet C, 2005, J BIOL CHEM, V280, P11247, DOI 10.1074/jbc.M407006200; Fleckenstein AE, 2000, EUR J PHARMACOL, V406, P1, DOI 10.1016/S0014-2999(00)00639-7; Giri RK, 2006, P NATL ACAD SCI USA, V103, P3875, DOI 10.1073/pnas.0510902103; Klohn PC, 2003, P NATL ACAD SCI USA, V100, P11666, DOI 10.1073/pnas.1834432100; Kloppel S, 2002, J NEURAL TRANSM, V109, P1105, DOI 10.1007/s007020200093; Kocisko DA, 2004, J GEN VIROL, V85, P2479, DOI 10.1099/vir.0.80082-0; Kuhn DM, 1999, J NEUROCHEM, V73, P1309, DOI 10.1046/j.1471-4159.1999.0731309.x; Larsen KE, 2002, J NEUROSCI, V22, P8951; Launay JM, 2006, FASEB J, V20, P1843, DOI 10.1096/fj.06-5724com; Ledoux JM, 2005, MED HYPOTHESES, V64, P910, DOI 10.1016/j.mehy.2004.11.020; LEVINE RA, 1984, ANAL BIOCHEM, V143, P205, DOI 10.1016/0003-2697(84)90577-3; LIN PYT, 1984, J LIQ CHROMATOGR, V7, P509, DOI 10.1080/01483918408073983; Mallucci G, 2005, NAT REV NEUROSCI, V6, P23, DOI 10.1038/nrn1584; Mallucci G, 2003, SCIENCE, V302, P871, DOI 10.1126/science.1090187; Milhavet O, 2000, P NATL ACAD SCI USA, V97, P13937, DOI 10.1073/pnas.250289197; Milhavet O, 2002, BRAIN RES REV, V38, P328, DOI 10.1016/S0165-0173(01)00150-3; Milhavet O, 2006, STEM CELLS, V24, P2284, DOI 10.1634/stemcells.2006-0088; Mouillet-Richard S, 2000, SCIENCE, V289, P1925, DOI 10.1126/science.289.5486.1925; Mouillet-Richard S, 2005, J BIOL CHEM, V280, P4592, DOI 10.1074/jbc.M406199200; Mouillet-Richard S, 2000, J BIOL CHEM, V275, P9186, DOI 10.1074/jbc.275.13.9186; Nishida N, 2000, J VIROL, V74, P320, DOI 10.1128/JVI.74.1.320-325.2000; Pietri M, 2006, J BIOL CHEM, V281, P28470, DOI 10.1074/jbc.M602774200; Prusiner SB, 1998, P NATL ACAD SCI USA, V95, P13363, DOI 10.1073/pnas.95.23.13363; RACE RE, 1987, J GEN VIROL, V68, P1391, DOI 10.1099/0022-1317-68-5-1391; RIDDLES PW, 1983, METHOD ENZYMOL, V91, P49; ROSA LFBPC, 1995, BIOCHEM J, V310, P709, DOI 10.1042/bj3100709; RUBENSTEIN R, 1991, J GEN VIROL, V72, P1279, DOI 10.1099/0022-1317-72-6-1279; Schatzl HM, 1997, J VIROL, V71, P8821; Schneider B, 2003, P NATL ACAD SCI USA, V100, P13326, DOI 10.1073/pnas.2235648100; Steele AD, 2006, P NATL ACAD SCI USA, V103, P3416, DOI 10.1073/pnas.0511290103; TATEISHI J, 1984, ACTA NEUROPATHOL, V64, P85, DOI 10.1007/BF00695613; Thiriot DS, 2001, J BIOL CHEM, V276, P27304, DOI 10.1074/jbc.M103947200; Vilette D, 2001, P NATL ACAD SCI USA, V98, P4055, DOI 10.1073/pnas.061337998; Vilette D, 2008, VET RES, V39, DOI 10.1051/vetres:2007049; WOLF WA, 1988, J NEUROCHEM, V50, P534, DOI 10.1111/j.1471-4159.1988.tb02944.x; WOLF WA, 1985, EUR J PHARMACOL, V109, P381, DOI 10.1016/0014-2999(85)90399-1; Wong BS, 2001, J NEUROCHEM, V79, P689, DOI 10.1046/j.1471-4159.2001.00625.x; WRONA MZ, 1995, J NEUROCHEM, V64, P1390; Wrona MZ, 2001, CHEM RES TOXICOL, V14, P1184, DOI 10.1021/tx010037c; Yun SW, 2006, EXP NEUROL, V201, P90, DOI 10.1016/j.expneurol.2006.03.025; Zeidler M, 1997, LANCET, V350, P908, DOI 10.1016/S0140-6736(97)03148-6	47	21	21	0	0	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	AUG 29	2008	283	35					23782	23790		10.1074/jbc.M802433200	http://dx.doi.org/10.1074/jbc.M802433200			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	340II	18617522	Green Published, hybrid			2022-12-27	WOS:000258638900032
J	Burton, CR; Meredith, JE; Barten, DM; Goldstein, ME; Krause, CM; Kieras, CJ; Sisk, L; Iben, LG; Polson, C; Thompson, MW; Lin, XA; Corsa, J; Fiedler, T; Pierdomenico, M; Cao, Y; Roach, AH; Cantone, JL; Ford, MJ; Drexler, DM; Olson, RE; Yang, MG; Bergstrom, CP; McElhone, KE; Bronson, JJ; Macor, JE; Blat, Y; Grafstrom, RH; Stern, AM; Seiffert, DA; Zaczek, R; Albright, CF; Toyn, JH				Burton, Catherine R.; Meredith, Jere E.; Barten, Donna M.; Goldstein, Margi E.; Krause, Carol M.; Kieras, Cathy J.; Sisk, Lisa; Iben, Lawrence G.; Polson, Craig; Thompson, Mark W.; Lin, Xu-Alan; Corsa, Jason; Fiedler, Tracey; Pierdomenico, Maria; Cao, Yang; Roach, Arthur H.; Cantone, Joseph L.; Ford, Michael J.; Drexler, Dieter M.; Olson, Richard E.; Yang, Michael G.; Bergstrom, Carl P.; McElhone, Kate E.; Bronson, Joanne J.; Macor, John E.; Blat, Yuval; Grafstrom, Robert H.; Stern, Andrew M.; Seiffert, Dietmar A.; Zaczek, Robert; Albright, Charles F.; Toyn, Jeremy H.			The amyloid-beta rise and gamma-secretase inhibitor potency depend on the level of substrate expression	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							PRECURSOR-PROTEIN; ALZHEIMERS-DISEASE; INTRAMEMBRANE CLEAVAGE; ZETA-CLEAVAGE; A-BETA; PRESENILIN; IDENTIFICATION; MUTATIONS; MECHANISM; BINDING	The amyloid-beta(A beta) peptide, which likely plays a key role in Alzheimer disease, is derived from the amyloid-beta precursor protein (APP) through consecutive proteolytic cleavages by beta-site APP-cleaving enzyme and gamma-secretase. Unexpectedly gamma-secretase inhibitors can increase the secretion of A beta peptides under some circumstances. This "A beta rise" phenomenon, the same inhibitor causing an increase in A beta at low concentrations but inhibition at higher concentrations, has been widely observed. Here we show that the A beta rise depends on the beta-secretase-derived C-terminal fragment of APP (beta CTF) or C99 levels with low levels causing rises. In contrast, the N-terminally truncated form of A beta, known as "p3," formed by alpha-secretase cleavage, did not exhibit a rise. In addition to the A beta rise, low beta CTF or C99 expression decreased gamma-secretase inhibitor potency. This " potency shift" may be explained by the relatively high enzyme to substrate ratio under conditions of low substrate because increased concentrations of inhibitor would be necessary to affect substrate turnover. Consistent with this hypothesis, gamma-secretase inhibitor radioligand occupancy studies showed that a high level of occupancy was correlated with inhibition of A beta under conditions of low substrate expression. The A beta rise was also observed in rat brain after dosing with the gamma-secretase inhibitor BMS-299897. The A beta rise and potency shift are therefore relevant factors in the development of gamma-secretase inhibitors and can be evaluated using appropriate choices of animal and cell culture models. Hypothetical mechanisms for the A beta rise, including the "incomplete processing" and endocytic models, are discussed.	[Burton, Catherine R.; Meredith, Jere E.; Barten, Donna M.; Goldstein, Margi E.; Krause, Carol M.; Kieras, Cathy J.; Sisk, Lisa; Iben, Lawrence G.; Polson, Craig; Thompson, Mark W.; Lin, Xu-Alan; Corsa, Jason; Fiedler, Tracey; Pierdomenico, Maria; Cao, Yang; Roach, Arthur H.; Zaczek, Robert; Albright, Charles F.; Toyn, Jeremy H.] Bristol Myers Squibb Co, Neurosci Biol, Wallingford, CT 06492 USA; [Cantone, Joseph L.; Ford, Michael J.; Drexler, Dieter M.] Bristol Myers Squibb Co, Discovery Analyt Sci, Wallingford, CT 06492 USA; [Olson, Richard E.; Yang, Michael G.; Bergstrom, Carl P.; McElhone, Kate E.; Bronson, Joanne J.; Macor, John E.] Bristol Myers Squibb Co, Discovery Chem, Wallingford, CT 06492 USA; [Blat, Yuval; Grafstrom, Robert H.; Stern, Andrew M.; Seiffert, Dietmar A.] Bristol Myers Squibb Co, Res & Dev, Chem Enzymol, Pennington, NJ 08534 USA	Bristol-Myers Squibb; Bristol-Myers Squibb; Bristol-Myers Squibb; Bristol-Myers Squibb	Toyn, JH (corresponding author), Bristol Myers Squibb Co, Neurosci Biol, 5 Res Pkwy, Wallingford, CT 06492 USA.	jeremy.toyn@bms.com	Grafström, Roland C/N-7217-2016	Drexler, Dieter/0000-0003-2877-7973; Stern, Andrew/0000-0002-8437-2957				Barten DM, 2005, J PHARMACOL EXP THER, V312, P635, DOI 10.1124/jpet.104.075408; Barten Donna M, 2006, Drugs R D, V7, P87, DOI 10.2165/00126839-200607020-00003; Bateman RJ, 2007, J AM SOC MASS SPECTR, V18, P997, DOI 10.1016/j.jasms.2007.02.009; Bentahir M, 2006, J NEUROCHEM, V96, P732, DOI 10.1111/j.1471-4159.2005.03578.x; Berezovska O, 2005, J NEUROSCI, V25, P3009, DOI 10.1523/JNEUROSCI.0364-05.2005; Citron M, 1996, P NATL ACAD SCI USA, V93, P13170, DOI 10.1073/pnas.93.23.13170; Clarke EE, 2006, J BIOL CHEM, V281, P31279, DOI 10.1074/jbc.M605051200; Dong YZ, 2006, FASEB J, V20, P331, DOI 10.1096/fj.05-4524fje; Dovey HF, 2001, J NEUROCHEM, V76, P173, DOI 10.1046/j.1471-4159.2001.00012.x; Durkin JT, 1999, J BIOL CHEM, V274, P20499, DOI 10.1074/jbc.274.29.20499; Funamoto S, 2004, BIOCHEMISTRY-US, V43, P13532, DOI 10.1021/bi049399k; Goldstein ME, 2007, J PHARMACOL EXP THER, V323, P102, DOI 10.1124/jpet.107.125492; HAASS C, 1995, NAT MED, V1, P1291, DOI 10.1038/nm1295-1291; Hardy J, 2002, SCIENCE, V297, P353, DOI 10.1126/science.1072994; Herreman A, 2000, NAT CELL BIOL, V2, P461, DOI 10.1038/35017105; Higaki JN, 1999, J MED CHEM, V42, P3889, DOI 10.1021/jm990009f; HUNG AY, 1993, J BIOL CHEM, V268, P22959; Iben LG, 2007, J BIOL CHEM, V282, P36829, DOI 10.1074/jbc.M707002200; Kaether C, 2004, J CELL BIOL, V167, P809, DOI 10.1083/jcb.200410090; Kakuda N, 2006, J BIOL CHEM, V281, P14776, DOI 10.1074/jbc.M513453200; Klafki HW, 1996, J BIOL CHEM, V271, P28655, DOI 10.1074/jbc.271.45.28655; Koo EH, 1996, J CELL SCI, V109, P991; KOO EH, 1994, J BIOL CHEM, V269, P17386; KUENTZEL SL, 1993, BIOCHEM J, V295, P367, DOI 10.1042/bj2950367; Lanz TA, 2006, J PHARMACOL EXP THER, V319, P924, DOI 10.1124/jpet.106.110700; Li YM, 2000, NATURE, V405, P689, DOI 10.1038/35015085; Lleo A, 2004, NAT MED, V10, P1065, DOI 10.1038/nm1112; Moore CL, 2000, ANN NY ACAD SCI, V920, P197; Prasad CVC, 2007, BIOORG MED CHEM LETT, V17, P4006, DOI 10.1016/j.bmcl.2007.04.082; Qi-Takahara Y, 2005, J NEUROSCI, V25, P436, DOI 10.1523/JNEUROSCI.1575-04.2005; Sato T, 2005, FEBS LETT, V579, P2907, DOI 10.1016/j.febslet.2005.04.037; Seiffert D, 2000, J BIOL CHEM, V275, P34086, DOI 10.1074/jbc.M005430200; Selkoe DJ, 2003, ANNU REV PHARMACOL, V43, P545, DOI 10.1146/annurev.pharmtox.43.100901.140248; SELKOE DJ, 1988, P NATL ACAD SCI USA, V85, P7341, DOI 10.1073/pnas.85.19.7341; Siemers E, 2005, CLIN NEUROPHARMACOL, V28, P126, DOI 10.1097/01.wnf.0000167360.27670.29; Steinhilb ML, 2002, J NEUROCHEM, V80, P1019, DOI 10.1046/j.0022-3042.2002.00764.x; Thinakaran G, 1996, J BIOL CHEM, V271, P9390, DOI 10.1074/jbc.271.16.9390; Tian GC, 2003, J BIOL CHEM, V278, P28968, DOI 10.1074/jbc.M300905200; Tian GC, 2002, J BIOL CHEM, V277, P31499, DOI 10.1074/jbc.M112328200; Wahrle S, 2002, NEUROBIOL DIS, V9, P11, DOI 10.1006/nbdi.2001.0470; Wolfe MS, 2007, EMBO REP, V8, P136, DOI 10.1038/sj.embor.7400896; Wolfe MS, 1998, J MED CHEM, V41, P6, DOI 10.1021/jm970621b; Wolfe MS, 1999, BIOCHEMISTRY-US, V38, P4720, DOI 10.1021/bi982562p; Yagishita S, 2006, BIOCHEMISTRY-US, V45, P3952, DOI 10.1021/bi0521846; Yamazaki T, 1997, BIOCHEMISTRY-US, V36, P8377, DOI 10.1021/bi970209y; Yang MG, 2007, BIOORG MED CHEM LETT, V17, P3910, DOI 10.1016/j.bmcl.2007.04.102; Zhang LL, 1999, J BIOL CHEM, V274, P8966, DOI 10.1074/jbc.274.13.8966; Zhang LL, 2001, BIOCHEMISTRY-US, V40, P5049, DOI 10.1021/bi0028800; Zhang M, 2006, FASEB J, V20, P1176, DOI 10.1096/fj.05-5531fje; Zhang ZH, 2000, NAT CELL BIOL, V2, P463, DOI 10.1038/35017108; Zhao GJ, 2005, J BIOL CHEM, V280, P37689, DOI 10.1074/jbc.M507993200; Zhao GJ, 2004, J BIOL CHEM, V279, P50647, DOI 10.1074/jbc.C400473200; Zhao GJ, 2007, J NEUROCHEM, V100, P1234, DOI 10.1111/j.1471-4159.2006.04302.x	53	53	53	0	1	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	AUG 22	2008	283	34					22992	23003		10.1074/jbc.M804175200	http://dx.doi.org/10.1074/jbc.M804175200			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	337SI	18574238	hybrid			2022-12-27	WOS:000258455400012
J	Engel, R; Westphal, AH; Huberts, DHEW; Nabuurs, SM; Lindhoud, S; Visser, AJWG; van Mierlo, CPM				Engel, Ruchira; Westphal, Adrie H.; Huberts, Daphne H. E. W.; Nabuurs, Sanne M.; Lindhoud, Simon; Visser, Antonie J. W. G.; van Mierlo, Carlo P. M.			Macromolecular crowding compacts unfolded apoflavodoxin and causes severe aggregation of the off-pathway intermediate during apoflavodoxin folding	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							FLUORESCENCE CORRELATION SPECTROSCOPY; AZOTOBACTER-VINELANDII APOFLAVODOXIN; INCLUSION-BODY FORMATION; PROTEIN STABILITY; HYDROGEN-EXCHANGE; ESCHERICHIA-COLI; MOLECULAR CHAPERONES; REFRACTIVE-INDEX; SELF-ASSOCIATION; CREATINE-KINASE	To understand how proteins fold in vivo, it is important to investigate the effects of macromolecular crowding on protein folding. Here, the influence of crowding on in vitro apoflavodoxin folding, which involves a relatively stable off-pathway intermediate with molten globule characteristics, is reported. To mimic crowded conditions in cells, dextran 20 at 30% (w/v) is used, and its effects are measured by a diverse combination of optical spectroscopic techniques. Fluorescence correlation spectroscopy shows that unfolded apoflavodoxin has a hydrodynamic radius of 37 +/- 3 angstrom at 3M guanidine hydrochloride. Forster resonance energy transfer measurements reveal that subsequent addition of dextran 20 leads to a decrease in protein volume of about 29%, which corresponds to an increase in protein stability of maximally 1.1 kcal mol(-1). The compaction observed is accompanied by increased secondary structure, as far-UV CD spectroscopy shows. Due to the addition of crowding agent, the midpoint of thermal unfolding of native apoflavodoxin rises by 2.9 degrees C. Although the stabilization observed is rather limited, concomitant compaction of unfolded apoflavodoxin restricts the conformational space sampled by the unfolded state, and this could affect kinetic folding of apoflavodoxin. Most importantly, crowding causes severe aggregation of the off-pathway folding intermediate during apoflavodoxin folding in vitro. However, apoflavodoxin can be over expressed in the cytoplasm of Escherichia coli, where it efficiently folds to its functional native form at high yield without noticeable problems. Apparently, in the cell, apoflavodoxin requires the help of chaperones like Trigger Factor and the DnaK system for efficient folding.	[Engel, Ruchira; Westphal, Adrie H.; Huberts, Daphne H. E. W.; Nabuurs, Sanne M.; Lindhoud, Simon; van Mierlo, Carlo P. M.] Univ Wageningen & Res Ctr, Biochem Lab, MicroSpect Ctr, NL-6703 HA Wageningen, Netherlands; [Visser, Antonie J. W. G.] Vrije Univ Amsterdam, Inst Mol Cell Biol, Dept Biol Struct, NL-1081 HV Amsterdam, Netherlands	Wageningen University & Research; Vrije Universiteit Amsterdam	van Mierlo, CPM (corresponding author), Univ Wageningen & Res Ctr, Biochem Lab, MicroSpect Ctr, Dreijenlaan 3, NL-6703 HA Wageningen, Netherlands.	carlo.vanmierlo@wur.nl	vanMierlo, Carlo p/B-4491-2016; Engel, Ruchira/A-5394-2010; Westphal, Adrie Herman/L-3517-2019	vanMierlo, Carlo p/0000-0002-5358-8392; Westphal, Adrie Herman/0000-0003-4264-6267; Engel, Ruchira/0000-0002-0630-5767	Netherlands Organization for Scientific Research	Netherlands Organization for Scientific Research(Netherlands Organization for Scientific Research (NWO))	This work was supported by the Netherlands Organization for Scientific Research "From Molecule to Cell" program. The costs of publication of this article were defrayed in part by the payment of page charges. This article must therefore be hereby marked "advertisement" in accordance with 18 U.S.C. Section 1734 solely to indicate this fact.	Alagaratnam S, 2005, PROTEIN SCI, V14, P2284, DOI 10.1110/ps.051582605; ANFINSEN CB, 1973, SCIENCE, V181, P223, DOI 10.1126/science.181.4096.223; BABUL J, 1969, ANAL BIOCHEM, V28, P216, DOI 10.1016/0003-2697(69)90172-9; Betts S, 1997, ADV PROTEIN CHEM, V50, P243, DOI 10.1016/S0065-3233(08)60323-X; Bollen YJM, 2006, P NATL ACAD SCI USA, V103, P4095, DOI 10.1073/pnas.0509133103; Bollen YJM, 2005, BIOPHYS CHEM, V114, P181, DOI 10.1016/j.bpc.2004.12.005; Bollen YJM, 2005, J BIOL CHEM, V280, P7836, DOI 10.1074/jbc.M412871200; Bollen YJM, 2004, BIOCHEMISTRY-US, V43, P10475, DOI 10.1021/bi049545m; Chattopadhyay K, 2005, BIOPHYS J, V88, P1413, DOI 10.1529/biophysj.104.053199; Cheung MS, 2005, P NATL ACAD SCI USA, V102, P4753, DOI 10.1073/pnas.0409630102; del Pino IMP, 2000, PROTEINS, V40, P58, DOI 10.1002/(SICI)1097-0134(20000701)40:1<58::AID-PROT80>3.0.CO;2-M; Despa F, 2005, ANN NY ACAD SCI, V1066, P54, DOI 10.1196/annals.1363.005; Du F, 2006, J MOL BIOL, V364, P469, DOI 10.1016/j.jmb.2006.09.018; Duy C, 2006, BIOPHYS J, V90, P3704, DOI 10.1529/biophysj.105.078980; Duy C, 2005, J BIOL CHEM, V280, P37360, DOI 10.1074/jbc.M507530200; Ellis RJ, 2006, BIOL CHEM, V387, P485, DOI 10.1515/BC.2006.064; Ellis R. John, 1999, Current Opinion in Structural Biology, V9, P102, DOI 10.1016/S0959-440X(99)80013-X; Ellis RJ, 2001, TRENDS BIOCHEM SCI, V26, P597, DOI 10.1016/S0968-0004(01)01938-7; Ellis RJ, 2001, CURR OPIN STRUC BIOL, V11, P114, DOI 10.1016/S0959-440X(00)00172-X; Frydman J, 2001, ANNU REV BIOCHEM, V70, P603, DOI 10.1146/annurev.biochem.70.1.603; Gellerich FN, 1998, EUR J BIOCHEM, V254, P172, DOI 10.1046/j.1432-1327.1998.2540172.x; Hall D, 2006, FEBS LETT, V580, P2584, DOI 10.1016/j.febslet.2006.04.005; Hartl FU, 2002, SCIENCE, V295, P1852, DOI 10.1126/science.1068408; Hatters DM, 2002, J BIOL CHEM, V277, P7824, DOI 10.1074/jbc.M110429200; Hess ST, 2002, BIOCHEMISTRY-US, V41, P697, DOI 10.1021/bi0118512; Hink MA, 2003, METHOD ENZYMOL, V361, P93; Hoffmann A, 2007, P NATL ACAD SCI USA, V104, P105, DOI 10.1073/pnas.0604353104; Jaenicke R, 1997, ADV PROTEIN CHEM, V50, P1, DOI 10.1016/S0065-3233(08)60318-6; JARVIS TC, 1990, J BIOL CHEM, V265, P15160; Kaiser CM, 2006, NATURE, V444, P455, DOI 10.1038/nature05225; Kerner MJ, 2005, CELL, V122, P209, DOI 10.1016/j.cell.2005.05.028; Knox RS, 2002, J PHYS CHEM B, V106, P5289, DOI 10.1021/jp013927+; Lakowicz JR, 1999, PRINCIPLES FLUORESCE; Langdon GM, 2001, PROTEINS, V43, P476, DOI 10.1002/prot.1059; LAURENT TC, 1964, J CHROMATOGR, V14, P317, DOI 10.1016/S0021-9673(00)86637-6; LAURENT TC, 1963, BIOCHEM J, V89, P253, DOI 10.1042/bj0890253; LINDNER R, 1995, BIOPHYS CHEM, V57, P15, DOI 10.1016/0301-4622(95)00063-4; Lindner RA, 1997, BIOPHYS CHEM, V66, P57, DOI 10.1016/S0301-4622(97)00011-2; LONDON J, 1974, EUR J BIOCHEM, V47, P409, DOI 10.1111/j.1432-1033.1974.tb03707.x; Luby-Phelps K, 2000, INT REV CYTOL, V192, P189; Martin J, 2002, BIOCHEMISTRY-US, V41, P5050, DOI 10.1021/bi015925l; McPhie P, 2006, J MOL BIOL, V361, P7, DOI 10.1016/j.jmb.2006.05.075; Minton AP, 2006, J CELL SCI, V119, P2863, DOI 10.1242/jcs.03063; Minton AP, 2005, J PHARM SCI-US, V94, P1668, DOI 10.1002/jps.20417; Minton AP, 2000, CURR OPIN STRUC BIOL, V10, P34, DOI 10.1016/S0959-440X(99)00045-7; Minton AP, 2005, BIOPHYS J, V88, P971, DOI 10.1529/biophysj.104.050351; Muralidhara BK, 2004, BIOCHEMISTRY-US, V43, P12855, DOI 10.1021/bi048944e; Nienhaus GU, 2006, MACROMOL BIOSCI, V6, P907, DOI 10.1002/mabi.200600158; OGSTON AG, 1958, T FARADAY SOC, V54, P1754, DOI 10.1039/tf9585401754; Qu YX, 2002, BIOPHYS CHEM, V101, P155, DOI 10.1016/S0301-4622(02)00148-5; Rajan RS, 2001, P NATL ACAD SCI USA, V98, P13060, DOI 10.1073/pnas.181479798; Rivas G, 1999, BIOCHEMISTRY-US, V38, P9379, DOI 10.1021/bi990355z; Rudiger S, 1997, EMBO J, V16, P1501, DOI 10.1093/emboj/16.7.1501; Sancho J, 2006, CELL MOL LIFE SCI, V63, P855, DOI 10.1007/s00018-005-5514-4; Sasahara K, 2003, J MOL BIOL, V326, P1227, DOI 10.1016/S0022-2836(02)01443-2; Skakun VV, 2005, EUR BIOPHYS J BIOPHY, V34, P323, DOI 10.1007/s00249-004-0453-9; Speed MA, 1996, NAT BIOTECHNOL, V14, P1283, DOI 10.1038/nbt1096-1283; Spencer DS, 2005, J MOL BIOL, V351, P219, DOI 10.1016/j.jmb.2005.05.029; Stagg L, 2007, P NATL ACAD SCI USA, V104, P18976, DOI 10.1073/pnas.0705127104; Steensma E, 1998, PROTEIN SCI, V7, P306; Steensma E, 1996, EUR J BIOCHEM, V235, P167, DOI 10.1111/j.1432-1033.1996.00167.x; Steensma E, 1998, J MOL BIOL, V282, P653, DOI 10.1006/jmbi.1998.2045; Tokuriki N, 2004, PROTEIN SCI, V13, P125, DOI 10.1110/ps.03288104; Toptygin D, 2002, J PHYS CHEM B, V106, P3724, DOI 10.1021/jp0133889; van den Berg B, 2000, EMBO J, V19, P3870, DOI 10.1093/emboj/19.15.3870; van den Berg B, 1999, EMBO J, V18, P6927, DOI 10.1093/emboj/18.24.6927; van Mierlo CPM, 2000, J BIOTECHNOL, V79, P281, DOI 10.1016/S0168-1656(00)00244-3; Van Mierlo CPM, 2000, PROTEIN SCI, V9, P145; Van Mierlo CPM, 1998, PROTEIN SCI, V7, P2331, DOI 10.1002/pro.5560071110; Wilkins DK, 1999, BIOCHEMISTRY-US, V38, P16424, DOI 10.1021/bi991765q; ZIMMERMAN SB, 1991, J MOL BIOL, V222, P599, DOI 10.1016/0022-2836(91)90499-V; ZIMMERMAN SB, 1987, P NATL ACAD SCI USA, V84, P1871, DOI 10.1073/pnas.84.7.1871; ZIMMERMAN SB, 1993, ANNU REV BIOPH BIOM, V22, P27, DOI 10.1146/annurev.bb.22.060193.000331; ZIMMERMAN SB, 1988, BIOCHIM BIOPHYS ACTA, V949, P297, DOI 10.1016/0167-4781(88)90155-8	74	62	62	0	18	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	OCT 10	2008	283	41					27383	27394		10.1074/jbc.M802393200	http://dx.doi.org/10.1074/jbc.M802393200			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	355OW	18640986	Green Published, hybrid			2022-12-27	WOS:000259719200006
J	Bottomley, MJ; Lo Surdo, P; Di Giovine, P; Cirillo, A; Scarpelli, R; Ferrigno, F; Jones, P; Neddermann, P; De Francesco, R; Steinkuhler, C; Gallinari, P; Carfi, A				Bottomley, Matthew J.; Lo Surdo, Paola; Di Giovine, Paolo; Cirillo, Agostino; Scarpelli, Rita; Ferrigno, Federica; Jones, Philip; Neddermann, Petra; De Francesco, Raffaele; Steinkuhler, Christian; Gallinari, Paola; Carfi, Andrea			Structural and functional analysis of the human HDAC4 catalytic domain reveals a regulatory structural zinc-binding domain	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							CONTROLS CHONDROCYTE HYPERTROPHY; HISTONE DEACETYLASE HOMOLOG; CRYSTAL-STRUCTURE; CLASS IIHDACS; TRANSCRIPTION; ACETYLATION; INSIGHTS; COMPLEX	Histone deacetylases (HDACs) regulate chromatin status and gene expression, and their inhibition is of significant therapeutic interest. To date, no biological substrate for class IIa HDACs has been identified, and only low activity on acetylated lysines has been demonstrated. Here, we describe inhibitor-bound and inhibitor-free structures of the histone deacetylase-4 catalytic domain (HDAC4cd) and of an HDAC4cd active site mutant with enhanced enzymatic activity toward acetylated lysines. The structures presented, coupled with activity data, provide the molecular basis for the intrinsically low enzymatic activity of class IIa HDACs toward acetylated lysines and reveal active site features that may guide the design of class-specific inhibitors. In addition, these structures reveal a conformationally flexible structural zinc-binding domain conserved in all class IIa enzymes. Importantly, either the mutation of residues coordinating the structural zinc ion or the binding of a class IIa selective inhibitor prevented the association of HDAC4 with the N-CoR center dot HDAC3 repressor complex. Together, these data suggest a key role of the structural zinc-binding domain in the regulation of class IIa HDAC functions.	[Bottomley, Matthew J.; Lo Surdo, Paola; Di Giovine, Paolo; Cirillo, Agostino; Scarpelli, Rita; Ferrigno, Federica; Jones, Philip; Neddermann, Petra; De Francesco, Raffaele; Steinkuhler, Christian; Gallinari, Paola; Carfi, Andrea] Ist Ric Biol Mol P Angeletti, Merck Res Labs, I-00040 Rome, Italy	Merck & Company	Carfi, A (corresponding author), Ist Ric Biol Mol P Angeletti, Merck Res Labs, Via Pontina Km 30-600, I-00040 Rome, Italy.		Gallinari, Paola/ABE-8238-2021; Scarpelli, Rita/A-2985-2012; De Francesco, Raffaele/J-6003-2012	De Francesco, Raffaele/0000-0001-8754-5123				Ago T, 2008, CELL, V133, P978, DOI 10.1016/j.cell.2008.04.041; Arnold MA, 2007, DEV CELL, V12, P377, DOI 10.1016/j.devcel.2007.02.004; BAILEY S, 1994, ACTA CRYSTALLOGR D, V50, P760, DOI 10.1107/s0907444994003112; Bolden JE, 2006, NAT REV DRUG DISCOV, V5, P769, DOI 10.1038/nrd2133; Chen LF, 2001, SCIENCE, V293, P1653, DOI 10.1126/science.1062374; Cress WD, 2000, J CELL PHYSIOL, V184, P1, DOI 10.1002/(SICI)1097-4652(200007)184:1<1::AID-JCP1>3.0.CO;2-7; De Ruijter AJM, 2003, BIOCHEM J, V370, P737, DOI 10.1042/BJ20021321; Emsley P, 2004, ACTA CRYSTALLOGR D, V60, P2126, DOI 10.1107/S0907444904019158; Finnin MS, 1999, NATURE, V401, P188, DOI 10.1038/43710; Fischle W, 2002, MOL CELL, V9, P45, DOI 10.1016/S1097-2765(01)00429-4; Gallinari P, 2007, CELL RES, V17, P195, DOI 10.1038/sj.cr.7310149; Glozak MA, 2005, GENE, V363, P15, DOI 10.1016/j.gene.2005.09.010; Guo L, 2007, P NATL ACAD SCI USA, V104, P4297, DOI 10.1073/pnas.0608041104; Illi B, 2007, CIRC RES, V101, P1205; Ito A, 2002, EMBO J, V21, P6236, DOI 10.1093/emboj/cdf616; Jeon EJ, 2006, J BIOL CHEM, V281, P16502, DOI 10.1074/jbc.M512494200; Jones P, 2008, BIOORG MED CHEM LETT, V18, P3456, DOI 10.1016/j.bmcl.2008.02.026; Lahm A, 2007, P NATL ACAD SCI USA, V104, P17335, DOI 10.1073/pnas.0706487104; Leslie AGW, 1992, JOINT CCP4 ESF EAMCB, V26; Martin M, 2007, ONCOGENE, V26, P5450, DOI 10.1038/sj.onc.1210613; McKinsey TA, 2007, NAT REV DRUG DISCOV, V6, P617, DOI 10.1038/nrd2193; Moreth K, 2007, BIOCHEM J, V401, P659, DOI 10.1042/BJ20061239; Nielsen TK, 2007, ACTA CRYSTALLOGR F, V63, P270, DOI 10.1107/S1744309107012377; Nielsen TK, 2005, J MOL BIOL, V354, P107, DOI 10.1016/j.jmb.2005.09.065; Perrakis A, 2001, ACTA CRYSTALLOGR D, V57, P1445, DOI 10.1107/S0907444901014007; Schuetz A, 2008, J BIOL CHEM, V283, P11355, DOI 10.1074/jbc.M707362200; Somoza JR, 2004, STRUCTURE, V12, P1325, DOI 10.1016/j.str.2004.04.012; van den Berg S, 2006, J BIOTECHNOL, V121, P291, DOI 10.1016/j.jbiotec.2005.08.006; Vannini A, 2004, P NATL ACAD SCI USA, V101, P15064, DOI 10.1073/pnas.0404603101; Vannini A, 2007, EMBO REP, V8, P879, DOI 10.1038/sj.embor.7401047; Vega RB, 2004, CELL, V119, P555, DOI 10.1016/j.cell.2004.10.024; Verdin E, 2003, TRENDS GENET, V19, P286, DOI 10.1016/S0168-9525(03)00073-8; Yang XJ, 2005, MOL CELL BIOL, V25, P2873, DOI 10.1128/MCB.25.8.2873-2884.2005; Yuan ZL, 2005, SCIENCE, V307, P269, DOI 10.1126/science.1105166	35	233	254	1	26	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	SEP 26	2008	283	39					26694	26704		10.1074/jbc.M803514200	http://dx.doi.org/10.1074/jbc.M803514200			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	350GV	18614528	hybrid, Green Published			2022-12-27	WOS:000259341600043
J	Demirci, H; Gregory, ST; Dahlberg, AE; Jogl, G				Demirci, Hasan; Gregory, Steven T.; Dahlberg, Albert E.; Jogl, Gerwald			Crystal structure of the Thermus thermophilus 16 S rRNA methyltransferase RsmC in complex with cofactor and substrate guanosine	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							LEVEL STREPTOMYCIN RESISTANCE; ESCHERICHIA-COLI; DEPENDENT METHYLTRANSFERASE; THERMUS-THERMOPHILUS; STRUCTURE ALIGNMENT; MUTATIONS; FOLD; CONTRIBUTES; RECOGNITION; SELECTIVITY	Post-transcriptional modification is a ubiquitous feature of ribosomal-RNA in all kingdoms of life. Modified nucleotides are generally clustered in functionally important regions of the ribosome, but the functional contribution to protein synthesis is not well understood. Here we describe high resolution crystal structures for the N-2-guanine methyltransferase RsmC that modifies residue G1207 in 16 S rRNA near the decoding site of the 30 S ribosomal subunit. RsmC is a class I S-adenosyl-L-methionine-dependent methyltransferase composed of two methyltransferase domains. However, only one S-adenosyl-L-methionine molecule and one substrate molecule, guanosine, bind in the ternary complex. The N-terminal domain does not bind any cofactor. Two structures with bound S-adenosyl-L-methionine and S-adenosyl-L-homocysteine confirm that the cofactor binding mode is highly similar to other class I methyltransferases. Secondary structure elements of the N-terminal domain contribute to cofactor-binding interactions and restrict access to the cofactor-binding site. The orientation of guanosine in the active site reveals that G1207 has to disengage from its Watson-Crick base pairing interaction with C1051 in the 16 S rRNA and flip out into the active site prior to its modification. Inspection of the 30 S crystal structure indicates that access to G1207 by RsmC is incompatible with the native subunit structure, consistent with previous suggestions that this enzyme recognizes a subunit assembly intermediate.	[Demirci, Hasan; Gregory, Steven T.; Dahlberg, Albert E.; Jogl, Gerwald] Brown Univ, Dept Mol Biol Cell Biol & Biochem, Providence, RI 02912 USA	Brown University	Jogl, G (corresponding author), Brown Univ, Dept Mol Biol Cell Biol & Biochem, Box G-E129, Providence, RI 02912 USA.	Gerwald_Jogl@brown.edu	Jogl, Gerwald/AAJ-5783-2021	Jogl, Gerwald/0000-0002-5465-5315; Demirci, Hasan/0000-0002-9135-5397	National Institutes of Health [GM19756]; Brown University	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Brown University	This work was supported, in whole or in part, by National Institutes of Health Grant GM19756 (to A. E. D.). This work was also supported by Brown University (to G. J.). The costs of publication of this article were defrayed in part by the payment of page charges. This article must therefore be hereby marked "advertisement" in accordance with 18 U. S. C. Section 1734 solely to indicate this fact.	Alian A, 2008, P NATL ACAD SCI USA, V105, P6876, DOI 10.1073/pnas.0802247105; [Anonymous], [No title captured]; BAILEY S, 1994, ACTA CRYSTALLOGR D, V50, P760, DOI 10.1107/s0907444994003112; Bujnicki JM, 2000, FASEB J, V14, P2365, DOI 10.1096/fj.00-0076com; BUJNICKI JM, 2002, BMC BIOINFORMATICS, V3; Clamp M, 2004, BIOINFORMATICS, V20, P426, DOI 10.1093/bioinformatics/btg430; Cohen SX, 2004, ACTA CRYSTALLOGR D, V60, P2222, DOI 10.1107/S0907444904027556; CUSACK S, 1998, MANY FACES RNA, P55; Decatur WA, 2002, TRENDS BIOCHEM SCI, V27, P344, DOI 10.1016/S0968-0004(02)02109-6; DeLano WL, 2004, PYMOL MOL GRAPHICS S; Demirci H, 2007, EMBO J, V26, P567, DOI 10.1038/sj.emboj.7601508; Emsley P, 2004, ACTA CRYSTALLOGR D, V60, P2126, DOI 10.1107/S0907444904019158; Goedecke K, 2001, NAT STRUCT BIOL, V8, P121, DOI 10.1038/84104; GORINGER HU, 1991, P NATL ACAD SCI USA, V88, P6603, DOI 10.1073/pnas.88.15.6603; GREGORY ST, 1995, NUCLEIC ACIDS RES, V23, P4234, DOI 10.1093/nar/23.21.4234; Guymon R, 2006, BIOCHEMISTRY-US, V45, P4888, DOI 10.1021/bi052579p; HENDRICKSON WA, 1990, EMBO J, V9, P1665, DOI 10.1002/j.1460-2075.1990.tb08287.x; Hoang C, 2001, CELL, V107, P929, DOI 10.1016/S0092-8674(01)00618-3; JEMIOLO DK, 1991, NUCLEIC ACIDS RES, V19, P4259, DOI 10.1093/nar/19.15.4259; KOZBIAL PZ, 2005, BMC STRUCT BIOL, P5; Krissinel E, 2004, ACTA CRYSTALLOGR D, V60, P2256, DOI 10.1107/S0907444904026460; Larkin MA, 2007, BIOINFORMATICS, V23, P2947, DOI 10.1093/bioinformatics/btm404; LASKOWSKI RA, 1993, J APPL CRYSTALLOGR, V26, P283, DOI 10.1107/S0021889892009944; Lee TT, 2005, CELL, V120, P599, DOI 10.1016/j.cell.2004.12.037; Lenz T, 2007, J AM CHEM SOC, V129, P6240, DOI 10.1021/ja069366n; Martin JL, 2002, CURR OPIN STRUC BIOL, V12, P783, DOI 10.1016/S0959-440X(02)00391-3; Mengel-Jorgensen J, 2006, J BIOL CHEM, V281, P22108, DOI 10.1074/jbc.M600377200; MOINE H, 1994, J MOL BIOL, V243, P402, DOI 10.1006/jmbi.1994.1668; Murshudov GN, 1997, ACTA CRYSTALLOGR D, V53, P240, DOI 10.1107/S0907444996012255; Nishimura K, 2007, J BACTERIOL, V189, P6068, DOI 10.1128/JB.00558-07; Nishimura K, 2007, J BACTERIOL, V189, P3876, DOI 10.1128/JB.01776-06; Ogle JM, 2002, CELL, V111, P721, DOI 10.1016/S0092-8674(02)01086-3; Ogle JM, 2001, SCIENCE, V292, P897, DOI 10.1126/science.1060612; Okamoto S, 2007, MOL MICROBIOL, V63, P1096, DOI 10.1111/j.1365-2958.2006.05585.x; Otwinowski Z, 1997, METHOD ENZYMOL, V276, P307, DOI 10.1016/S0076-6879(97)76066-X; Perrakis A, 1999, NAT STRUCT BIOL, V6, P458, DOI 10.1038/8263; Schubert HL, 2003, TRENDS BIOCHEM SCI, V28, P329, DOI 10.1016/S0968-0004(03)00090-2; Schubert HL, 2003, BIOCHEMISTRY-US, V42, P5592, DOI 10.1021/bi034026p; Sergiev PV, 2007, NUCLEIC ACIDS RES, V35, P2295, DOI 10.1093/nar/gkm104; Shatsky M, 2006, PROTEINS, V62, P209, DOI 10.1002/prot.20665; Shieh FK, 2006, J MOL BIOL, V362, P516, DOI 10.1016/j.jmb.2006.07.030; Sunita S, 2007, NUCLEIC ACIDS RES, V35, P4264, DOI 10.1093/nar/gkm411; Terwilliger TC, 1999, ACTA CRYSTALLOGR D, V55, P849, DOI 10.1107/S0907444999000839; Terwilliger TC, 2000, ACTA CRYSTALLOGR D, V56, P965, DOI 10.1107/S0907444900005072; Tscherne JS, 1999, J BIOL CHEM, V274, P924, DOI 10.1074/jbc.274.2.924; Wimberly BT, 2000, NATURE, V407, P327, DOI 10.1038/35030006; Xu Z, 2008, NAT STRUCT MOL BIOL, V15, P534, DOI 10.1038/nsmb.1408	47	17	17	0	1	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	SEP 26	2008	283	39					26548	26556		10.1074/jbc.M804005200	http://dx.doi.org/10.1074/jbc.M804005200			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	350GV	18667428	hybrid, Green Published			2022-12-27	WOS:000259341600031
J	Guerrini, M; Guglieri, S; Casu, B; Torri, G; Mourier, P; Boudier, C; Viskov, C				Guerrini, Marco; Guglieri, Sara; Casu, Benito; Torri, Giangiacomo; Mourier, Pierre; Boudier, Christian; Viskov, Christian			Antithrombin-binding octasaccharides and role of extensions of the active pentasaccharide sequence in the specificity and strength of interaction - Evidence for very high affinity induced by an unusual Glucuronic acid residue	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							MOLECULAR-WEIGHT HEPARINS; TRANSFER DIFFERENCE NMR; FACTOR XA; MECHANISM; ACTIVATION; LIGAND; OLIGOSACCHARIDES; ACCELERATION; CONFORMATION; SPECTROSCOPY	The antithrombotic activity of low molecular weight heparins (LMWHs) is largely associated with the antithrombin ( AT)binding pentasaccharide sequence AGA*IA (GlcN(NAc/NS),(6S)-GlcA-GlcN(NS),(3,6S)-IdoUA(2S)-GlcN(NS,6S)). The location of the AGA*IA sequences along the LMWH chains is also expected to influence binding to AT. This study was aimed at investigating the role of the structure and molecular conformation of different disaccharide extensions on both sides of the AGA*IA sequence in modulating the affinity for AT. Four high purity octasaccharides isolated by size exclusion chromatography, high pressure liquid chromatography, and AT-affinity chromatography from the LMWH enoxaparin were selected for the study. All the four octasaccharides terminate at their nonreducing end with 4,5-unsaturated uronic acid residues (Delta U). In two octasaccharides, AGA*IA was elongated at the reducing end by units IdoUA(2S)-GlcN(NS,6S) (OCTA- 1) or IdoUA-GlcN(NAc),(6S) (OCTA-2). In the other two octasaccharides (OCTA-3 and OCTA-4), AGA*IA was elongated at the nonreducing side by units GlcN(NS),(6S)-IdoUA and GlcN(NS),(6S)-GlcA, respectively. Extensions increased the affinity for AT of octasaccharides with respect to pentasaccharide AGA*IA, as also confirmed by fluorescence titration. Two- dimensional NMR and docking studies clearly indicated that, although elongation of the AGA*IA sequence does not substantially modify the bound conformation of the AGA*IA segment, extensions promote additional contacts with the protein. It should be noted that, as not previously reported, the unusual GlcA residue that precedes the AGA*IA sequence in OCTA-4 induced an unexpected 1 order of magnitude increase in the affinity to AT with respect to its IdoUA- containing homolog OCTA-3. Such a residue was found to orientate its two hydroxyl groups at close distance to residues of the protein. Besides the well established ionic interactions, nonionic interactions may thus contribute to strengthen oligosaccharideAT complexes.	[Guerrini, Marco; Guglieri, Sara; Casu, Benito; Torri, Giangiacomo] G Ronzoni Inst Chem & Biochem Res, I-20133 Milan, Italy; [Mourier, Pierre; Viskov, Christian] Sanofi Aventis, F-94403 Vitry Sur Seine, France; [Boudier, Christian] Univ Strasbourg 1, Fac Pharm, Dept Physicochim & Pharmacochim Interact Mol & Ce, CNRS,UMR 7175, F-67401 Illkirch Graffenstaden, France	Sanofi-Aventis; Centre National de la Recherche Scientifique (CNRS); UDICE-French Research Universities; Universites de Strasbourg Etablissements Associes; Universite de Strasbourg	Guerrini, M (corresponding author), G Ronzoni Inst Chem & Biochem Res, Via G Colombo 81, I-20133 Milan, Italy.	guerrini@ronzoni.it; Christian.Viskov@sanofi-aventis.com	Boudier, Christian/N-3841-2018	Boudier, Christian/0000-0002-5534-6389; Torri, Giangiacomo/0000-0002-2077-1203; Guerrini, Marco/0000-0001-7246-9113				Angulo J, 2005, GLYCOBIOLOGY, V15, P1008, DOI 10.1093/glycob/cwi091; Belzar KJ, 2000, J BIOL CHEM, V275, P8733, DOI 10.1074/jbc.275.12.8733; Boudier C, 2001, BIOCHEMISTRY-US, V40, P9962, DOI 10.1021/bi010701o; Casu B, 2001, ADV CARBOHYD CHEM BI, V57, P159, DOI 10.1016/S0065-2318(01)57017-1; Casu B, 1999, SEMIN THROMB HEMOST, V25, P17; Casu B., 2005, CHEM BIOL HEPARIN HE, P1, DOI DOI 10.1016/B978-008044859-6/50002-2; de Kort M, 2005, DRUG DISCOV TODAY, V10, P769, DOI 10.1016/S1359-6446(05)03457-4; Desai UR, 1998, J BIOL CHEM, V273, P7478, DOI 10.1074/jbc.273.13.7478; Guerrini M, 2007, SEMIN THROMB HEMOST, V33, P478, DOI 10.1055/s-2007-982078; Guerrini M, 2006, BIOCHEM J, V399, P191, DOI 10.1042/BJ20060656; Hileman RE, 1998, BIOCHEMISTRY-US, V37, P15231, DOI 10.1021/bi980212x; Hjelm R, 2007, BIOCHEMISTRY-US, V46, P3378, DOI 10.1021/bi6024929; HOOK M, 1976, FEBS LETT, V66, P90, DOI 10.1016/0014-5793(76)80592-3; Hoppensteadt D., 2005, CHEM BIOL HEPARIN HE, P583; Hricovini M, 2001, BIOCHEM J, V359, P265, DOI 10.1042/0264-6021:3590265; Huntington JA, 1996, BIOCHEMISTRY-US, V35, P8495, DOI 10.1021/bi9604643; Jin L, 1997, P NATL ACAD SCI USA, V94, P14683, DOI 10.1073/pnas.94.26.14683; Johnson DJD, 2006, EMBO J, V25, P2029, DOI 10.1038/sj.emboj.7601089; Li W, 2004, NAT STRUCT MOL BIOL, V11, P857, DOI 10.1038/nsmb811; Lin PH, 2001, BBA-GEN SUBJECTS, V1526, P105, DOI 10.1016/S0304-4165(01)00117-9; Linhardt RJ, 1999, SEMIN THROMB HEMOST, V25, P5; LOGANATHAN D, 1990, BIOCHEMISTRY-US, V29, P4362, DOI 10.1021/bi00470a015; Mayer M, 1999, ANGEW CHEM INT EDIT, V38, P1784, DOI 10.1002/(SICI)1521-3773(19990614)38:12<1784::AID-ANIE1784>3.0.CO;2-Q; Mayer M, 2001, J AM CHEM SOC, V123, P6108, DOI 10.1021/ja0100120; Morris GM, 1998, J COMPUT CHEM, V19, P1639, DOI 10.1002/(SICI)1096-987X(19981115)19:14<1639::AID-JCC10>3.0.CO;2-B; MOSELEY HNB, 1995, J MAGN RESON SER B, V108, P243, DOI 10.1006/jmrb.1995.1129; Mourier PAJ, 2004, ANAL BIOCHEM, V332, P299, DOI 10.1016/j.ab.2004.06.020; OLSON ST, 1992, J BIOL CHEM, V267, P12528; OLSON ST, 1991, J BIOL CHEM, V266, P6342; OLSON ST, 1991, J BIOL CHEM, V266, P6353; OLSON ST, 1981, J BIOL CHEM, V256, P1065; Petitou M, 2004, ANGEW CHEM INT EDIT, V43, P3118, DOI 10.1002/anie.200300640; RAGAZZI M, 1993, J CARBOHYD CHEM, V12, P523, DOI 10.1080/07328309308019405; RAGAZZI M, 1986, J COMPUT CHEM, V7, P105, DOI 10.1002/jcc.540070203; RECORD MT, 1976, J MOL BIOL, V107, P145, DOI 10.1016/S0022-2836(76)80023-X; Seyrek E, 2007, BIOPOLYMERS, V86, P249, DOI 10.1002/bip.20731; THOMPSON LD, 1994, BIOCHEMISTRY-US, V33, P3831, DOI 10.1021/bi00179a006; THUNBERG L, 1982, CARBOHYD RES, V100, P393, DOI 10.1016/S0008-6215(00)81050-2; Toida T, 1996, J BIOL CHEM, V271, P32040, DOI 10.1074/jbc.271.50.32040; VERLI H, 1997, J MOL GRAPH MODEL, V15, P18	40	72	81	0	9	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	SEP 26	2008	283	39					26662	26675		10.1074/jbc.M801102200	http://dx.doi.org/10.1074/jbc.M801102200			14	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	350GV	18640975	hybrid, Green Published			2022-12-27	WOS:000259341600040
J	Sawada, T; Nishiyama, C; Kishi, T; Sasazuki, T; Komazawa-Sakon, S; Xue, X; Piao, JH; Ogata, H; Nakayama, J; Taki, T; Hayashi, Y; Watanabe, M; Yagita, H; Okumura, K; Nakano, H				Sawada, Taisuke; Nishiyama, Chiharu; Kishi, Takuma; Sasazuki, Tomonari; Komazawa-Sakon, Sachiko; Xue, Xin; Piao, Jiang-Hu; Ogata, Hideko; Nakayama, Jun-ichi; Taki, Tomohiko; Hayashi, Yasuhide; Watanabe, Mamoru; Yagita, Hideo; Okumura, Ko; Nakano, Hiroyasu			Fusion of OTT to BSAC results in aberrant up-regulation of transcriptional activity	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							SERUM RESPONSE FACTOR; MEGAKARYOBLASTIC LEUKEMIA; HISTONE DEACETYLASES; GENE-EXPRESSION; ACTIVATION; MYOCARDIN; CLONING; ALPHA; DIFFERENTIATION; COACTIVATOR	OTT/RBM15-BSAC/MAL/MKL1/MRTF-A was identified as a fusion transcript generated by t(1; 22)(p13; q13) in acute megakaryoblastic leukemia. Previous studies have shown that BSAC (basic, SAP, and coiled-coil domain) activates the promoters containing CArG boxes via interaction with serum response factor, and OTT (one twenty-two) negatively regulates the development of megakaryocytes and myeloid cells. However, the mechanism by which OTT-BSAC promotes leukemia is largely unknown. Here we show that OTT-BSAC, but not BSAC or OTT strongly activates several promoters containing a transcription factor Yin Yang 1-binding sequence. In addition, although BSAC predominantly localizes in the cytoplasm and its nuclear translocation is considered to be regulated by the Rho-actin signaling pathway, OTT-BSAC exclusively localizes in the nucleus. Moreover, OTT interacts with histone deacetylase 3, but this interaction is abolished in OTT-BSAC. Collectively, these functional and spatial changes of OTT and BSAC caused by the fusion might perturb their functions, culminating in the development of acute megakaryoblastic leukemia.	[Sawada, Taisuke; Kishi, Takuma; Sasazuki, Tomonari; Komazawa-Sakon, Sachiko; Xue, Xin; Piao, Jiang-Hu; Ogata, Hideko; Okumura, Ko; Nakano, Hiroyasu] Juntendo Univ, Sch Med, Dept Immunol, Bunkyo Ku, Tokyo 1138421, Japan; [Nishiyama, Chiharu] Juntendo Univ, Sch Med, Atopy Allergy Res Ctr, Bunkyo Ku, Tokyo 1138421, Japan; [Piao, Jiang-Hu] Juntendo Univ, Sch Med, Sportol Ctr, Bunkyo Ku, Tokyo 1138421, Japan; [Piao, Jiang-Hu] Ningxia Med Coll, Sch Basic Med Sci, Dept Immunol, Xingqing Qu 750004, Yinchuan, Peoples R China; [Nakayama, Jun-ichi] RIKEN, Ctr Dev Biol, Lab Chromatin Dynam, Chuo Ku, Kobe, Hyogo 6500047, Japan; [Taki, Tomohiko] Kyoto Prefectural Univ Med, Grad Sch Med Sci, Dept Mol Lab Med, Kamigyo Ku, Kyoto 6028566, Japan; [Hayashi, Yasuhide] Gunma Childrens Med Ctr, Gunma 3778577, Japan; [Watanabe, Mamoru] Tokyo Med & Dent Univ, Dept Gastroenterol & Hepatol, Bunkyo Ku, Tokyo 1138519, Japan	Juntendo University; Juntendo University; Juntendo University; Ningxia Medical University; RIKEN; Kyoto Prefectural University of Medicine; Gunma Children's Medical Centre; Tokyo Medical & Dental University (TMDU)	Nakano, H (corresponding author), Juntendo Univ, Sch Med, Dept Immunol, Bunkyo Ku, 2-1-1 Hongo, Tokyo 1138421, Japan.	hnakano@juntendo.ac.jp	Nishiyama, Chiharu/GPW-9372-2022; Nakayama, Jun-ichi/C-6003-2011; Watanabe, Mamoru/AHE-0489-2022	Nakayama, Jun-ichi/0000-0002-5597-8239; Nakano, Hiroyasu/0000-0003-4843-1427; Komazawa-Sakon, Sachiko/0000-0002-6244-1974	Grant-in-Aid for a " High-Tech Research Center"; Ministry of Education, Culture, Sports, Science and Technology; Scientific Research (B) and (C) from Japan Society for the Promotion of Science; NOVARTIS Foundation (Japan) for the Promotion of Science; Takeda Science Foundation; Mitsubishi Pharma Foundation; Tokyo Biochemical Research Foundation	Grant-in-Aid for a " High-Tech Research Center"; Ministry of Education, Culture, Sports, Science and Technology(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); Scientific Research (B) and (C) from Japan Society for the Promotion of Science(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI)); NOVARTIS Foundation (Japan) for the Promotion of Science(Novartis); Takeda Science Foundation(Takeda Science Foundation (TSF)); Mitsubishi Pharma Foundation; Tokyo Biochemical Research Foundation	This work was supported in part by a Grant-in-Aid for a " High-Tech Research Center" Project for Private Universities, matching fund subsidy from the Ministry of Education, Culture, Sports, Science and Technology, and Scientific Research (B) and (C) from Japan Society for the Promotion of Science, and grants from the NOVARTIS Foundation (Japan) for the Promotion of Science, the Takeda Science Foundation, the Mitsubishi Pharma Foundation, and the Tokyo Biochemical Research Foundation. The costs of publication of this article were defrayed in part by the payment of page charges. This article must therefore be hereby marked " advertisement" in accordance with 18 U. S. C. Section 1734 solely to indicate this fact.	Ariyoshi M, 2003, GENE DEV, V17, P1909, DOI 10.1101/gad.266203; Cen B, 2003, MOL CELL BIOL, V23, P6597, DOI 10.1128/MCB.23.18.6597-6608.2003; Donohoe ME, 1999, MOL CELL BIOL, V19, P7237; Erkeland SJ, 2003, BLOOD, V101, P1111, DOI 10.1182/blood-2002-04-1207; Holmes ML, 2002, J BIOL CHEM, V277, P48333, DOI 10.1074/jbc.M206127200; Jepsen K, 2002, J CELL SCI, V115, P689; Kanada S, 2008, J IMMUNOL, V180, P8204, DOI 10.4049/jimmunol.180.12.8204; Li SJ, 2006, MOL CELL BIOL, V26, P5797, DOI 10.1128/MCB.00211-06; Ma XY, 2007, MOL CELL BIOL, V27, P3056, DOI 10.1128/MCB.01339-06; Ma ZG, 2001, NAT GENET, V28, P220, DOI 10.1038/90054; Mercher T, 2001, P NATL ACAD SCI USA, V98, P5776, DOI 10.1073/pnas.101001498; Miralles F, 2003, CELL, V113, P329, DOI 10.1016/S0092-8674(03)00278-2; MURAOKA O, 1993, IMMUNOL LETT, V37, P159, DOI 10.1016/0165-2478(93)90026-X; Nakano H, 1998, P NATL ACAD SCI USA, V95, P3537, DOI 10.1073/pnas.95.7.3537; Ng HH, 2000, TRENDS BIOCHEM SCI, V25, P121; Nguyen N, 2004, J BIOL CHEM, V279, P25927, DOI 10.1074/jbc.M402525200; Nishiyama C, 2002, J IMMUNOL, V168, P4546, DOI 10.4049/jimmunol.168.9.4546; OGURA M, 1985, BLOOD, V66, P1384; Raffel GD, 2007, P NATL ACAD SCI USA, V104, P6001, DOI 10.1073/pnas.0609041104; Sasazuki T, 2002, J BIOL CHEM, V277, P28853, DOI 10.1074/jbc.M203190200; SHI Y, 1997, BIOCHIM BIOPHYS ACTA, V1332, P49; Shi YH, 2001, GENE DEV, V15, P1140, DOI 10.1101/gad.871201; Struhl K, 1998, GENE DEV, V12, P599, DOI 10.1101/gad.12.5.599; Sun Y, 2006, MOL CELL BIOL, V26, P5809, DOI 10.1128/MCB.00024-06; Thomas MJ, 1999, GENE, V236, P197, DOI 10.1016/S0378-1119(99)00261-9; Wang DZ, 2002, P NATL ACAD SCI USA, V99, P14855, DOI 10.1073/pnas.222561499; Wang DZ, 2001, CELL, V105, P851, DOI 10.1016/S0092-8674(01)00404-4; Yang XJ, 2005, MOL CELL BIOL, V25, P2873, DOI 10.1128/MCB.25.8.2873-2884.2005	28	14	15	0	0	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	SEP 26	2008	283	39					26820	26828		10.1074/jbc.M802315200	http://dx.doi.org/10.1074/jbc.M802315200			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	350GV	18667423	Green Published, hybrid			2022-12-27	WOS:000259341600053
J	Siller-Jackson, AJ; Burra, S; Gu, SM; Xia, XC; Bonewald, LF; Sprague, E; Jiang, JX				Siller-Jackson, Arlene J.; Burra, Sirisha; Gu, Sumin; Xia, Xuechun; Bonewald, Lynda F.; Sprague, Eugene; Jiang, Jean X.			Adaptation of connexin 43-hemichannel prostaglandin release to mechanical loading	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							GAP-JUNCTION HEMICHANNELS; FLUID-FLOW; OSTEOCLAST FORMATION; ATP RELEASE; BONE MASS; OSTEOCYTES; EXPRESSION; INHIBITION; CARTILAGE; PROTEINS	Bone tissues respond to mechanical loading/unloading regimens to accommodate (re) modeling requirements; however, the underlying molecular mechanism responsible for these responses is largely unknown. Previously, we reported that connexin (Cx) 43 hemichannels in mechanosensing osteocytes mediate the release of prostaglandin, PGE(2), a crucial factor for bone formation in response to anabolic loading. We show here that the opening of hemichannels and release of PGE(2) by shear stress were significantly inhibited by a potent antibody we developed that specifically blocks Cx43-hemichannels, but not gap junctions or other channels. The opening of hemichannels and release of PGE(2) are magnitude-dependent on the level of shear stress. Insertion of a rest period between stress enhances this response. Hemichannels gradually close after 24 h of continuous shear stress corresponding with reduced Cx43 expression on the cell surface, thereby reducing any potential negative effects of channels staying open for extended periods. These data suggest that Cx43-hemichannel activity associated with PGE(2) release is adaptively regulated by mechanical loading to provide an effective means of regulating levels of extracellular signaling molecules responsible for initiation of bone (re) modeling.	[Siller-Jackson, Arlene J.; Burra, Sirisha; Gu, Sumin; Xia, Xuechun; Jiang, Jean X.] Univ Texas Hlth Sci Ctr San Antonio, Dept Biochem, San Antonio, TX 78229 USA; [Sprague, Eugene] Univ Texas Hlth Sci Ctr San Antonio, Dept Radiol, San Antonio, TX 78229 USA; [Bonewald, Lynda F.] Univ Missouri, Sch Dent, Dept Oral Biol, Kansas City, MO 64108 USA	University of Texas System; University of Texas Health San Antonio; University of Texas System; University of Texas Health San Antonio; University of Missouri System; University of Missouri Kansas City	Jiang, JX (corresponding author), Univ Texas Hlth Sci Ctr San Antonio, Dept Biochem, 7703 Floyd Curl Dr, San Antonio, TX 78229 USA.	jiangj@uthscsa.edu	Bonewald, Lynda/Q-3638-2019; burra, sirisha/H-2014-2011	Jiang, Jean/0000-0002-2185-5716	National Institutes of Health [F31 AR053468, P01 AR46798]; Welch Foundation [AQ-1507]; NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES [F31AR053468, P01AR046798] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Welch Foundation(The Welch Foundation); NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS))	This work was supported, in whole or in part, by National Institutes of Health Grants F31 AR053468 (to A. J. S.-J.) and P01 AR46798 (to J. X. J., L. F. B., and E. S.). This work was also supported by the Welch Foundation Grant AQ-1507 (to J. X. J.). The costs of publication of this article were defrayed in part by the payment of page charges. This article must therefore be hereby marked "advertisement" in accordance with 18 U. S. C. Section 1734 solely to indicate this fact.	AARDEN EM, 1994, J CELL BIOCHEM, V55, P287, DOI 10.1002/jcb.240550304; Ajubi NE, 1996, BIOCHEM BIOPH RES CO, V225, P62, DOI 10.1006/bbrc.1996.1131; Boucher S, 2003, J NEUROSCI RES, V72, P393, DOI 10.1002/jnr.10575; Braet K, 2003, CELL CALCIUM, V33, P37, DOI 10.1016/S0143-4160(02)00180-X; Burger EH, 1999, FASEB J, V13, pS101, DOI 10.1096/fasebj.13.9001.s101; Chaytor AT, 1997, J PHYSIOL-LONDON, V503, P99, DOI 10.1111/j.1469-7793.1997.099bi.x; Cheng BX, 2001, J BONE MINER RES, V16, P249, DOI 10.1359/jbmr.2001.16.2.249; Cherian PP, 2005, MOL BIOL CELL, V16, P3100, DOI 10.1091/mbc.E04-10-0912; Chung DJ, 2006, J CELL SCI, V119, P4187, DOI 10.1242/jcs.03162; CIVITELLI R, 1993, J CLIN INVEST, V91, P1888, DOI 10.1172/JCI116406; COLLINS DA, 1992, J BONE MINER RES, V7, P555; COLLINS DA, 1991, J BONE MINER RES, V6, P157; Contreras JE, 2003, P NATL ACAD SCI USA, V100, P11388, DOI 10.1073/pnas.1434298100; COWIN SC, 1991, J BIOMECH ENG-T ASME, V113, P191, DOI 10.1115/1.2891234; DAHL G, 1994, BIOPHYS J, V67, P1816, DOI 10.1016/S0006-3495(94)80663-0; Daniels GM, 1998, METHOD ENZYMOL, V296, P307; DONAHUE HJ, 1995, J BONE MINER RES, V10, P1359; ELFOULY MH, 1987, EXP CELL RES, V168, P422, DOI 10.1016/0014-4827(87)90014-0; Evans WH, 2006, BIOCHEM J, V397, P1, DOI 10.1042/BJ20060175; Forwood MR, 1996, J BONE MINER RES, V11, P1688; Genetos DC, 2007, J CELL PHYSIOL, V212, P207, DOI 10.1002/jcp.21021; Goodenough DA, 2003, NAT REV MOL CELL BIO, V4, P285, DOI 10.1038/nrm1072; He DS, 1999, P NATL ACAD SCI USA, V96, P6495, DOI 10.1073/pnas.96.11.6495; Hofer A, 1998, GLIA, V24, P141, DOI 10.1002/(SICI)1098-1136(199809)24:1<141::AID-GLIA13>3.0.CO;2-R; Jacobs CR, 1998, J BIOMECH, V31, P969, DOI 10.1016/S0021-9290(98)00114-6; Jee WSS, 1997, BONE, V21, P297, DOI 10.1016/S8756-3282(97)00147-6; John S, 2003, ACTA PHYSIOL SCAND, V179, P23, DOI 10.1046/j.1365-201X.2003.01197.x; Kato Y, 1997, J BONE MINER RES, V12, P2014, DOI 10.1359/jbmr.1997.12.12.2014; Klein-Nulend J, 2005, PATHOL BIOL, V53, P576, DOI 10.1016/j.patbio.2004.12.005; KLEINNULEND J, 1995, FASEB J, V9, P441, DOI 10.1096/fasebj.9.5.7896017; Kondo RP, 2000, J MOL CELL CARDIOL, V32, P1859, DOI 10.1006/jmcc.2000.1220; LANYON LE, 1984, J BIOMECH, V17, P897, DOI 10.1016/0021-9290(84)90003-4; Li JL, 2005, J BIOL CHEM, V280, P42952, DOI 10.1074/jbc.M506415200; Mason DJ, 1996, J BONE MINER RES, V11, P350; Pelegrin P, 2006, EMBO J, V25, P5071, DOI 10.1038/sj.emboj.7601378; Plotkin LI, 2002, J BIOL CHEM, V277, P8648, DOI 10.1074/jbc.M108625200; PRASAD ARS, 1993, CIRC RES, V72, P827, DOI 10.1161/01.RES.72.4.827; Presley CA, 2005, CELL COMMUN ADHES, V12, P307, DOI 10.1080/15419060500514200; Raisz LG, 1999, OSTEOARTHR CARTILAGE, V7, P419, DOI 10.1053/joca.1998.0230; Raisz LG, 2005, J CLIN INVEST, V115, P3318, DOI 10.1172/JCI27071; Robling AG, 2000, J BONE MINER RES, V15, P1596, DOI 10.1359/jbmr.2000.15.8.1596; Romanello M, 2001, J BONE MINER RES, V16, P1465, DOI 10.1359/jbmr.2001.16.8.1465; RUBIN CT, 1985, CALCIFIED TISSUE INT, V37, P411, DOI 10.1007/BF02553711; RUBIN CT, 1987, J ORTHOPAED RES, V5, P300, DOI 10.1002/jor.1100050217; Saez JC, 2003, ACTA PHYSIOL SCAND, V179, P9, DOI 10.1046/j.1365-201X.2003.01196.x; SCHIRRMACHER K, 1992, CALCIFIED TISSUE INT, V51, P285, DOI 10.1007/BF00334489; Schwab W, 1998, HISTOCHEM J, V30, P413, DOI 10.1023/A:1003220225670; Skerry T. M., 2006, Journal of Musculoskeletal & Neuronal Interactions, V6, P122; Srinivasan S, 2002, J BONE MINER RES, V17, P1613, DOI 10.1359/jbmr.2002.17.9.1613; Tanaka K, 1995, J BONE MINER METAB, V13, P61, DOI DOI 10.1007/BF01771319; Tate MLK, 2003, J BIOMECH, V36, P1409, DOI 10.1016/S0021-9290(03)00123-4; Thi MM, 2003, AM J PHYSIOL-CELL PH, V284, pC389, DOI 10.1152/ajpcell.00052.2002; THOMPSON DD, 1988, J BONE MINER RES, V3, P409; Wang LY, 2003, J BIOMECH, V36, P1439, DOI 10.1016/S0021-9290(03)00241-0; ZENG Y, 1994, ANN BIOMED ENG, V22, P280, DOI 10.1007/BF02368235	55	120	124	0	9	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	SEP 26	2008	283	39					26374	26382		10.1074/jbc.M803136200	http://dx.doi.org/10.1074/jbc.M803136200			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	350GV	18676366	Green Published, hybrid			2022-12-27	WOS:000259341600011
J	Marcellino, D; Ferre, S; Casado, V; Cortes, A; Le Foll, B; Mazzola, C; Drago, F; Saur, O; Stark, H; Soriano, A; Barnes, C; Goldberg, SR; Lluis, C; Fuxe, K; Franco, R				Marcellino, Daniel; Ferre, Sergi; Casado, Vicent; Cortes, Antonio; Le Foll, Bernard; Mazzola, Carmen; Drago, Filippo; Saur, Oliver; Stark, Holger; Soriano, Aroa; Barnes, Chanel; Goldberg, Steven R.; Lluis, Carme; Fuxe, Kjell; Franco, Rafael			Identification of dopamine D-1-D-3 receptor heteromers - Indications for a role of synergistic D-1-D-3 receptor interactions in the striatum	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							MEDIUM SPINY NEURONS; LOCOMOTOR-ACTIVITY; CELL-MEMBRANE; D-2 RECEPTORS; MICE; D1; RAT; 7-OH-DPAT; GENE; NEUROTRANSMISSION	The function of dopamine D-3 receptors present in the striatum has remained elusive. In the present study evidence is provided for the existence of dopamine D-1-D-3 receptor heteromers and for an intramembrane D-1-D-3 receptor cross-talk in living cells and in the striatum. The formation of D-1-D-3 receptor heteromers was demonstrated by fluorescence resonance energy transfer and bioluminescence resonance energy transfer techniques in transfected mammalian cells. In membrane preparations from these cells, a synergistic D-1-D-3 intramembrane receptor-receptor interaction was observed, by which D3 receptor stimulation enhances D-1 receptor agonist affinity, indicating that the D-1-D-3 intramembrane receptor-receptor interaction is a biochemical characteristic of the D-1-D-3 receptor heteromer. The same biochemical characteristic was also observed in membrane preparations from brain striatum, demonstrating the striatal co-localization and heteromerization of D-1 and D-3 receptors. According to the synergistic D-1-D-3 intramembrane receptor-receptor interaction, experiments in reserpinized mice showed that D-3 receptor stimulation potentiates D-1 receptor-mediated behavioral effects by a different mechanism than D-2 receptor stimulation. The present study shows that a main functional significance of the D3 receptor is to obtain a stronger dopaminergic response in the striatal neurons that co-express the two receptors.	[Marcellino, Daniel; Fuxe, Kjell] Karolinska Inst, Dept Neurosci, Stockholm 17177, Sweden; [Ferre, Sergi; Barnes, Chanel; Goldberg, Steven R.] Natl Inst Drug Abuse, Behav Neurosci Branch, Intramural Res Program, Dept Hlth & Human Serv, Baltimore, MD 21224 USA; [Casado, Vicent; Cortes, Antonio; Soriano, Aroa; Lluis, Carme; Franco, Rafael] Univ Barcelona, Dept Biochem & Mol Biol, E-08028 Barcelona, Spain; [Casado, Vicent; Cortes, Antonio; Soriano, Aroa; Lluis, Carme; Franco, Rafael] Univ Barcelona, Inst Invest Biomed August Pi i Sunyer, E-08028 Barcelona, Spain; [Le Foll, Bernard] Univ Toronto, Ctr Addict & Mental Hlth, Translat Addict Res Lab, Toronto, ON M5S 2S1, Canada; [Mazzola, Carmen; Drago, Filippo] Univ Catania, Sch Med, Dept Expt & Clin Pharmacol, I-95125 Catania, Italy; [Saur, Oliver; Stark, Holger] Univ Frankfurt, Inst Chem Pharmacol, D-60438 Frankfurt, Germany	Karolinska Institutet; National Institutes of Health (NIH) - USA; NIH National Institute on Drug Abuse (NIDA); University of Barcelona; University of Barcelona; Hospital Clinic de Barcelona; IDIBAPS; University of Toronto; University Toronto Affiliates; Centre for Addiction & Mental Health - Canada; University of Catania; Goethe University Frankfurt	Ferre, S (corresponding author), Natl Inst Drug Abuse, Behav Neurosci Branch, Intramural Res Program, Dept Hlth & Human Serv, 251 Bayview Blvd, Baltimore, MD 21224 USA.	sferre@intra.nida.nih.gov	Le Foll, Bernard/K-2952-2014; Drago, Filippo/AAC-5090-2022; Marcellino, Daniel/HDM-8433-2022; Drago, Francesco/H-7563-2019; Stark, Holger/A-4235-2009; Ferre, Sergi/K-6115-2014; Franco, Rafael/C-3694-2015; Casadó, Vicent/K-1660-2014; Soriano, Aroa/J-9105-2016; Drago, Filippo/K-5619-2018	Le Foll, Bernard/0000-0002-6406-4973; Marcellino, Daniel/0000-0002-4618-7267; Stark, Holger/0000-0003-3336-1710; Ferre, Sergi/0000-0002-1747-1779; Franco, Rafael/0000-0003-2549-4919; Casadó, Vicent/0000-0002-1764-3825; Soriano, Aroa/0000-0001-9659-1471; Drago, Filippo/0000-0003-2887-5223; Fuxe, Kjell/0000-0001-8491-4288	National Institute on Drug Abuse; Ministerio de Ciencia y Tecnologia [SAF2006-00170]; NATIONAL INSTITUTE ON DRUG ABUSE [Z02DA000001, Z01DA000493, Z01DA000001, ZIFDA000001, ZIADA000001, ZIADA000493] Funding Source: NIH RePORTER	National Institute on Drug Abuse(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)European Commission); Ministerio de Ciencia y Tecnologia(Ministry of Science and Innovation, Spain (MICINN)Spanish Government); NATIONAL INSTITUTE ON DRUG ABUSE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)European Commission)	This work was supported, in whole or in part, by the National Institutes of Health Intramural Research Program, National Institute on Drug Abuse, Dept. of Health and Human Services. This work was also supported by the Ministerio de Ciencia y Tecnologia (Grants SAF2006-00170). The costs of publication of this article were defrayed in part by the payment of page charges. This article must therefore be hereby marked "advertisement" in accordance with 18 U. S. C. Section 1734 solely to indicate this fact.	Accili D, 1996, P NATL ACAD SCI USA, V93, P1945, DOI 10.1073/pnas.93.5.1945; Agnati LF, 2003, PHARMACOL REV, V55, P509, DOI 10.1124/pr.55.3.2; Aizman O, 2000, NAT NEUROSCI, V3, P226, DOI 10.1038/72929; ALBIN RL, 1989, TRENDS NEUROSCI, V12, P366, DOI 10.1016/0166-2236(89)90074-X; ALEXANDER GE, 1990, TRENDS NEUROSCI, V13, P266, DOI 10.1016/0166-2236(90)90107-L; Bezard E, 2003, NAT MED, V9, P762, DOI 10.1038/nm875; Bordet R, 1997, P NATL ACAD SCI USA, V94, P3363, DOI 10.1073/pnas.94.7.3363; Canals M, 2003, J BIOL CHEM, V278, P46741, DOI 10.1074/jbc.M306451200; CASADO V, 1990, J NEUROSCI RES, V26, P461, DOI 10.1002/jnr.490260409; CHENG Y, 1973, BIOCHEM PHARMACOL, V22, P3099; Ciruela F, 2006, J NEUROSCI, V26, P2080, DOI 10.1523/JNEUROSCI.3574-05.2006; Ferre S, 1996, EUR J NEUROSCI, V8, P1545, DOI 10.1111/j.1460-9568.1996.tb01617.x; FERRE S, 1994, EUR J PHARMACOL, V255, P203, DOI 10.1016/0014-2999(94)90099-X; FERRE S, 1993, J NEUROSCI, V13, P5402, DOI 10.1523/JNEUROSCI.13-12-05402.1993; Ferre S, 2007, TRENDS NEUROSCI, V30, P440, DOI 10.1016/j.tins.2007.07.001; Fiorentini C, 2008, MOL PHARMACOL, V74, P59, DOI 10.1124/mol.107.043885; Franco R, 2003, TRENDS BIOCHEM SCI, V28, P238, DOI 10.1016/S0968-0004(03)00065-3; Gerfen C. R., 2004, RAT NERVOUS SYSTEM, P445; GERFEN CR, 1990, SCIENCE, V250, P1429, DOI 10.1126/science.2147780; GERFEN CR, 1992, TRENDS NEUROSCI, V15, P133, DOI 10.1016/0166-2236(92)90355-C; Jordan M, 1996, NUCLEIC ACIDS RES, V24, P596, DOI 10.1093/nar/24.4.596; Lee SP, 2004, J BIOL CHEM, V279, P35671, DOI 10.1074/jbc.M401923200; LEMOINE C, 1991, P NATL ACAD SCI USA, V88, P4205, DOI 10.1073/pnas.88.10.4205; Millan MJ, 2000, J PHARMACOL EXP THER, V293, P1063; Millan MJ, 2004, PSYCHOPHARMACOLOGY, V174, P341, DOI 10.1007/s00213-003-1770-x; Missale C, 1998, PHYSIOL REV, V78, P189, DOI 10.1152/physrev.1998.78.1.189; Mori T, 1997, JPN J PHARMACOL, V73, P251, DOI 10.1254/jjp.73.251; Neve KA, 2004, J RECEPT SIG TRANSD, V24, P165, DOI 10.1081/LRST-200029981; Pritchard LM, 2003, NEUROPSYCHOPHARMACOL, V28, P100, DOI 10.1038/sj.npp.1300018; Pugsley TA, 1995, J PHARMACOL EXP THER, V275, P1355; Rashid AJ, 2007, P NATL ACAD SCI USA, V104, P654, DOI 10.1073/pnas.0604049104; Ridray S, 1998, EUR J NEUROSCI, V10, P1676, DOI 10.1046/j.1460-9568.1998.00173.x; RUBINSTEIN M, 1988, EUR J PHARMACOL, V148, P419, DOI 10.1016/0014-2999(88)90121-5; Sarrio S, 2000, MOL CELL BIOL, V20, P5164, DOI 10.1128/MCB.20.14.5164-5174.2000; SCHOEMAKER H, 1993, EUR J PHARMACOL, V242, pR1, DOI 10.1016/0014-2999(93)90259-K; Schwartz JC, 1998, BRAIN RES REV, V26, P236, DOI 10.1016/S0165-0173(97)00046-5; Sokoloff P., 2006, CNS & Neurological Disorders-Drug Targets, V5, P25, DOI 10.2174/187152706784111551; STARR MS, 1989, PHARMACOL BIOCHEM BE, V33, P41, DOI 10.1016/0091-3057(89)90426-7; Surmeier DJ, 2007, TRENDS NEUROSCI, V30, P228, DOI 10.1016/j.tins.2007.03.008; SURMEIER DJ, 1992, P NATL ACAD SCI USA, V89, P10178, DOI 10.1073/pnas.89.21.10178; SURMEIER DJ, 1993, TRENDS NEUROSCI, V16, P299, DOI 10.1016/0166-2236(93)90103-S; Surmeier DJ, 1996, J NEUROSCI, V16, P6579, DOI 10.1523/jneurosci.16-20-06579.1996; Zimmermann T, 2002, FEBS LETT, V531, P245, DOI 10.1016/S0014-5793(02)03508-1	43	182	184	0	7	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	SEP 19	2008	283	38					26016	26025		10.1074/jbc.M710349200	http://dx.doi.org/10.1074/jbc.M710349200			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	348GX	18644790	Green Published, hybrid			2022-12-27	WOS:000259200100030
J	Wen, WY; Liu, W; Yan, J; Zhang, MJ				Wen, Wenyu; Liu, Wei; Yan, Jing; Zhang, Mingjie			Structure basis and unconventional lipid membrane binding properties of the PH-C1 tandem of Rho kinases	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							MYOTONIC-DYSTROPHY KINASE; PLECKSTRIN HOMOLOGY DOMAIN; CDC42-BINDING KINASE; PROTEIN-KINASE; TARGET BINDING; PH DOMAINS; MYOSIN-II; ROCK-I; PHOSPHOLIPASE-C-GAMMA-1; COMPLEX	Rho kinase (ROCK), a downstream effector of Rho GTPase, is a serine/threonine protein kinase that regulates many crucial cellular processes via control of cytoskeletal structures. The C-terminal PH-C1 tandem of ROCKs has been implicated to play an autoinhibitory role by sequestering the N-terminal kinase domain and reducing its kinase activity. The binding of lipids to the pleckstrin homology (PH) domain not only regulates the localization of the protein but also releases the kinase domain from the close conformation and thereby activates its kinase activity. However, the molecular mechanism governing the ROCK PH-C1 tandem-mediated lipid membrane interaction is not known. In this study, we demonstrate that ROCK is a new member of the split PH domain family of proteins. The ROCK split PH domain folds into a canonical PH domain structure. The insertion of the atypical C1 domain in the middle does not alter the structure of the PH domain. We further show that the C1 domain of ROCK lacks the diacylglycerol/phorbol ester binding pocket seen in other canonical C1 domains. Instead, the inserted C1 domain and the PH domain function cooperatively in binding to membrane bilayers via the unconventional positively charged surfaces on each domain. Finally, the analysis of all split PH domains with known structures indicates that split PH domains represent a unique class of tandem protein modules, each possessing distinct structural and functional features.	[Wen, Wenyu; Liu, Wei; Yan, Jing; Zhang, Mingjie] Hong Kong Univ Sci & Technol, Dept Biochem, Mol Neurosci Ctr, Kowloon, Hong Kong, Peoples R China	Hong Kong University of Science & Technology	Zhang, MJ (corresponding author), Hong Kong Univ Sci & Technol, Dept Biochem, Mol Neurosci Ctr, Kowloon, Hong Kong, Peoples R China.	mzhang@ust.hk	liu, weicheng/D-4173-2013; Yan, Jing/C-3163-2012	Liu, Wei/0000-0001-8250-2562; Zhang, Mingjie/0000-0001-9404-0190	Research Grants Council of Hong Kong [HKUST6419/05M, 6442/06M, 663407, CA07/08.SC01, AoE/B-15/01-II]	Research Grants Council of Hong Kong(Hong Kong Research Grants Council)	This work was supported by the Research Grants Council of Hong Kong Grants HKUST6419/05M, 6442/06M, 663407, CA07/08.SC01, and AoE/B-15/01-II (to M. Z.). The costs of publication of this article were defrayed in part by the payment of page charges. This article must therefore be hereby marked "advertisement" in accordance with 18 U. S. C. Section 1734 solely to indicate this fact.	Alam SL, 2006, NAT STRUCT MOL BIOL, V13, P1029, DOI 10.1038/nsmb1160; Amano M, 1999, J BIOL CHEM, V274, P32418, DOI 10.1074/jbc.274.45.32418; Aroul-Selvam R, 2004, J MOL BIOL, V338, P633, DOI 10.1016/j.jmb.2004.03.039; Brunger AT, 1998, ACTA CRYSTALLOGR D, V54, P905, DOI 10.1107/S0907444998003254; Cavanagh J., 1996, PROTEIN NMR SPECTROS; Chen XQ, 1999, J BIOL CHEM, V274, P19901, DOI 10.1074/jbc.274.28.19901; Choi SH, 2008, J BIOL CHEM, V283, P10543, DOI 10.1074/jbc.M707463200; Cornilescu G, 1999, J BIOMOL NMR, V13, P289, DOI 10.1023/A:1008392405740; Cronin TC, 2004, EMBO J, V23, P3711, DOI 10.1038/sj.emboj.7600388; DeBell K, 2007, MOL CELL BIOL, V27, P854, DOI 10.1128/MCB.01400-06; Di Cunto F, 1998, J BIOL CHEM, V273, P29706, DOI 10.1074/jbc.273.45.29706; Feng JH, 1999, J BIOL CHEM, V274, P3744, DOI 10.1074/jbc.274.6.3744; Feng W, 2003, NAT STRUCT BIOL, V10, P972, DOI 10.1038/nsb992; Ferguson KM, 2000, MOL CELL, V6, P373, DOI 10.1016/S1097-2765(00)00037-X; FERGUSON KM, 1995, CELL, V83, P1037, DOI 10.1016/0092-8674(95)90219-8; Ishizaki T, 1997, FEBS LETT, V404, P118, DOI 10.1016/S0014-5793(97)00107-5; Ishizaki T, 1996, EMBO J, V15, P1885, DOI 10.1002/j.1460-2075.1996.tb00539.x; Koradi R, 1996, J MOL GRAPHICS, V14, P51, DOI 10.1016/0263-7855(96)00009-4; Laskowski RA, 1996, J BIOMOL NMR, V8, P477, DOI 10.1007/BF00228148; Lemmon MA, 2005, CELL, V120, P574, DOI 10.1016/j.cell.2005.02.023; Lemmon MA, 2000, BIOCHEM J, V350, P1, DOI 10.1042/0264-6021:3500001; Leung T, 1996, MOL CELL BIOL, V16, P5313; Leung T, 1998, MOL CELL BIOL, V18, P130, DOI 10.1128/MCB.18.1.130; Long JF, 2003, J MOL BIOL, V327, P203, DOI 10.1016/S0022-2836(03)00113-X; Long JF, 2008, J MOL BIOL, V375, P1457, DOI 10.1016/j.jmb.2007.11.088; Madaule P, 1995, FEBS LETT, V377, P243, DOI 10.1016/0014-5793(95)01351-2; Nakagawa O, 1996, FEBS LETT, V392, P189, DOI 10.1016/0014-5793(96)00811-3; Ng Y, 2004, J BIOL CHEM, V279, P34156, DOI 10.1074/jbc.M405252200; NICHOLLS A, 1991, PROTEINS, V11, P281, DOI 10.1002/prot.340110407; Poulin B, 2005, P NATL ACAD SCI USA, V102, P4276, DOI 10.1073/pnas.0409590102; Riento K, 2003, NAT REV MOL CELL BIO, V4, P446, DOI 10.1038/nrm1128; Sebbagh M, 2001, NAT CELL BIOL, V3, P346, DOI 10.1038/35070019; Selvam RA, 2004, NUCLEIC ACIDS RES, V32, pD193, DOI 10.1093/nar/gkh047; Tan I, 2001, MOL CELL BIOL, V21, P2767, DOI 10.1128/MCB.21.8.2767-2778.2001; Teo HL, 2006, CELL, V125, P99, DOI 10.1016/j.cell.2006.01.047; Thomas CC, 2002, CURR BIOL, V12, P1256, DOI 10.1016/S0960-9822(02)00972-7; VAN AL, 1997, GENE DEV, V11, P2295; van Rossum DB, 2005, NATURE, V434, P99, DOI 10.1038/nature03340; Wen WY, 2006, J BIOL CHEM, V281, P12060, DOI 10.1074/jbc.M600336200; Wuthrich K, 1986, NMR PROTEINS NUCL AC; Yamashiro S, 2003, MOL BIOL CELL, V14, P1745, DOI 10.1091/mbc.E02-07-0427; Yan J, 2005, EMBO J, V24, P3985, DOI 10.1038/sj.emboj.7600858; Yan J, 2008, J MOL BIOL, V378, P425, DOI 10.1016/j.jmb.2008.02.052; Yoneda A, 2005, J CELL BIOL, V170, P443, DOI 10.1083/jcb.200412043; ZHANG GG, 1995, CELL, V81, P917, DOI 10.1016/0092-8674(95)90011-X	45	29	31	0	10	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	SEP 19	2008	283	38					26263	26273		10.1074/jbc.M803417200	http://dx.doi.org/10.1074/jbc.M803417200			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	348GX	18640982	Green Published, hybrid			2022-12-27	WOS:000259200100054
J	Kan, H; Kim, CH; Kwon, HM; Park, JW; Roh, KB; Lee, H; Park, BJ; Zhang, R; Zhang, J; Soederhall, K; Ha, NC; Lee, BL				Kan, Hongnan; Kim, Chan-Hee; Kwon, Hyun-Mi; Park, Ji-Won; Roh, Kyung-Baeg; Lee, Hanna; Park, Bum-Joon; Zhang, Rong; Zhang, Jinghai; Soederhall, Kenneth; Ha, Nam-Chul; Lee, Bok Luel			Molecular control of phenoloxidase-induced melanin synthesis in an insect	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							HOLOTRICHIA-DIOMPHALIA LARVAE; TENEBRIO-MOLITOR LARVAE; PROPHENOLOXIDASE-ACTIVATING ENZYME; PATTERN-RECOGNITION PROTEIN; MASQUERADE-LIKE PROTEIN; FRESH-WATER CRAYFISH; SERINE-PROTEASE; COLEOPTERAN INSECT; ANOPHELES-GAMBIAE; MANDUCA-SEXTA	The melanization reaction induced by activated phenoloxidase in arthropods must be tightly controlled because of excessive formation of quinones and excessive systemic melanization damage to the hosts. However, the molecular mechanism by which phenoloxidase-induced melanin synthesis is regulated in vivo is largely unknown. It is known that the Spatzle-processing enzyme is a key enzyme in the production of cleaved Spatzle from pro-Spatzle in the Drosophila Toll pathway. Here, we provide biochemical evidence that the Tenebrio molitor Spatzle processing enzyme converts both the 79-kDa Tenebrio prophenoloxidase and Tenebrio clip-domain SPH1 zymogen to an active melanization complex. This complex, consisting of the 76-kDa Tenebrio phenoloxidase and an active form of Tenebrio clip-domain SPH1, efficiently produces melanin on the surface of bacteria, and this activity has a strong bactericidal effect. Interestingly, we found the phenoloxidase- induced melanization reaction to be tightly regulated by Tenebrio prophenoloxidase, which functions as a competitive inhibitor of melanization complex formation. These results demonstrate that the Tenebrio Toll pathway and the melanization reaction share a common serine protease for the regulation of these two major innate immune responses.	[Kan, Hongnan; Kim, Chan-Hee; Kwon, Hyun-Mi; Park, Ji-Won; Roh, Kyung-Baeg; Lee, Hanna; Ha, Nam-Chul; Lee, Bok Luel] Pusan Natl Univ, Coll Pharm, Natl Res Lab Def Prot, Pusan 609735, South Korea; [Kan, Hongnan; Zhang, Rong; Zhang, Jinghai] Shenyang Pharmaceut Univ, Sch Life Sci & Biopharmaceut, Shenyang 110016, Peoples R China; [Soederhall, Kenneth] Uppsala Univ, Evolutionary Biol Ctr, Dept Comparat Physiol, Ctr Biol, SE-75236 Uppsala, Sweden; [Park, Bum-Joon] Pusan Natl Univ, Coll Nat Sci, Dept Mol Biol, Pusan 609735, South Korea	Pusan National University; Shenyang Pharmaceutical University; Uppsala University; Pusan National University	Lee, BL (corresponding author), Pusan Natl Univ, Coll Pharm, Natl Res Lab Def Prot, Pusan 609735, South Korea.	brlee@pusan.ac.kr	Kim, Chan-Hee/C-6849-2016	Kim, Chan-Hee/0000-0002-5315-4981	National Research Laboratory [M10400000028-04J0000-02]; Ministry of Science and Technology/ Korea Science and Engineering Foundation; Pusan National University	National Research Laboratory(Korea Science and Engineering Foundation); Ministry of Science and Technology/ Korea Science and Engineering Foundation(Korea Science and Engineering Foundation); Pusan National University(Pusan National University)	This work was supported by programs of the National Research Laboratory (Grant M10400000028-04J0000-02) of the Ministry of Science and Technology/ Korea Science and Engineering Foundation and in part by the BK21 Program and a 2007 Pusan National University postdoctoral fellowship grant (to C.-H. K.). The costs of publication of this article were defrayed in part by the payment of page charges. This article must therefore be hereby marked "advertisement" in accordance with 18 U. S. C. Section 1734 solely to indicate this fact.	Anderson A F, 2000, Am J Knee Surg, V13, P19; Barillas-Mury C, 2007, TRENDS PARASITOL, V23, P297, DOI 10.1016/j.pt.2007.05.001; Cerenius L, 2004, IMMUNOL REV, V198, P116, DOI 10.1111/j.0105-2896.2004.00116.x; Ferrandon D, 2007, NAT REV IMMUNOL, V7, P862, DOI 10.1038/nri2194; Galko MJ, 2004, PLOS BIOL, V2, P1114, DOI 10.1371/journal.pbio.0020239; Gillespie JP, 1997, ANNU REV ENTOMOL, V42, P611, DOI 10.1146/annurev.ento.42.1.611; Gupta S, 2005, INSECT BIOCHEM MOLEC, V35, P241, DOI 10.1016/j.ibmb.2004.12.003; Jang IH, 2006, DEV CELL, V10, P45, DOI 10.1016/j.devcel.2005.11.013; Jiang HB, 1998, P NATL ACAD SCI USA, V95, P12220, DOI 10.1073/pnas.95.21.12220; Kim CH, 2008, J BIOL CHEM, V283, P7599, DOI 10.1074/jbc.M710216200; Kim MS, 2002, J BIOL CHEM, V277, P39999, DOI 10.1074/jbc.M205508200; Kumar S, 2003, P NATL ACAD SCI USA, V100, P14139, DOI 10.1073/pnas.2036262100; Kwon TH, 2000, EUR J BIOCHEM, V267, P6188, DOI 10.1046/j.1432-1327.2000.01695.x; Lee HS, 1999, FEBS LETT, V444, P255, DOI 10.1016/S0014-5793(99)00067-8; Lee KM, 2000, EUR J BIOCHEM, V267, P3695, DOI 10.1046/j.1432-1327.2000.01402.x; Lee KY, 2002, EUR J BIOCHEM, V269, P4375, DOI 10.1046/j.1432-1033.2002.03155.x; Lee SY, 1998, EUR J BIOCHEM, V257, P615, DOI 10.1046/j.1432-1327.1998.2570615.x; Lee SY, 2001, J IMMUNOL, V166, P7319, DOI 10.4049/jimmunol.166.12.7319; Lemaitre B, 1996, CELL, V86, P973, DOI 10.1016/S0092-8674(00)80172-5; Lemaitre B, 2007, ANNU REV IMMUNOL, V25, P697, DOI 10.1146/annurev.immunol.25.022106.141615; Ligoxygakis P, 2002, EMBO J, V21, P6330, DOI 10.1093/emboj/cdf661; Matarese G, 2008, TRENDS IMMUNOL, V29, P12, DOI 10.1016/j.it.2007.10.006; MOON HJ, 1994, J BIOCHEM-TOKYO, V116, P53, DOI 10.1093/oxfordjournals.jbchem.a124502; Nappi AJ, 2000, BIOESSAYS, V22, P469, DOI 10.1002/(SICI)1521-1878(200005)22:5<469::AID-BIES9>3.3.CO;2-W; Nappi AJ, 1998, J PARASITOL, V84, P1150, DOI 10.2307/3284664; Nappi AJ, 2005, INSECT BIOCHEM MOLEC, V35, P443, DOI 10.1016/j.ibmb.2005.01.014; OBRIEN PJ, 1991, CHEM-BIOL INTERACT, V80, P1, DOI 10.1016/0009-2797(91)90029-7; Park JW, 2007, P NATL ACAD SCI USA, V104, P6602, DOI 10.1073/pnas.0610924104; Piao S, 2005, EMBO J, V24, P4404, DOI 10.1038/sj.emboj.7600891; Piao SF, 2007, J BIOL CHEM, V282, P10783, DOI 10.1074/jbc.M611556200; Satoh D, 1999, J BIOL CHEM, V274, P7441, DOI 10.1074/jbc.274.11.7441; Schnitger AKD, 2007, J BIOL CHEM, V282, P21884, DOI 10.1074/jbc.M701635200; Shin SW, 2005, J BIOL CHEM, V280, P16499, DOI 10.1074/jbc.M500711200; Tang HP, 2006, J BIOL CHEM, V281, P28097, DOI 10.1074/jbc.M601642200; Wang RG, 2001, EUR J BIOCHEM, V268, P895, DOI 10.1046/j.1432-1327.2001.01945.x; Yu XQ, 2003, INSECT BIOCHEM MOLEC, V33, P197, DOI 10.1016/S0965-1748(02)00191-1; Zhang R, 2003, J BIOL CHEM, V278, P42072, DOI 10.1074/jbc.M307475200	38	172	182	1	49	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	SEP 12	2008	283	37					25316	25323		10.1074/jbc.M804364200	http://dx.doi.org/10.1074/jbc.M804364200			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	345QZ	18628205	hybrid			2022-12-27	WOS:000259012700025
J	Prahst, C; Heroult, M; Lanahan, AA; Uziel, N; Kessler, O; Shraga-Heled, N; Simons, M; Neufeld, G; Augustin, HG				Prahst, Claudia; Heroult, Melanie; Lanahan, Anthony A.; Uziel, Noa; Kessler, Ofra; Shraga-Heled, Niva; Simons, Michael; Neufeld, Gera; Augustin, Hellmut G.			Neuropilin-1-VEGFR-2 complexing requires the PDZ-binding domain of neuropilin-1	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ENDOTHELIAL GROWTH-FACTOR; NERVOUS-SYSTEM; C-TERMINUS; CONTAINING PROTEIN; KINASE-ACTIVITY; CRUCIAL ROLE; RGS-GAIP; EXPRESSION; RECEPTOR; CELLS	Vascular endothelial growth factor (VEGF) acts as a hierarchically high switch of the angiogenic cascade by interacting with its high affinity VEGF receptors and with neuropilin co-receptors. VEGF(165) binds to both Neuropilin-1 (NP-1) and VEGFR-2, and it is believed that ligand binding forms an extracellular bridge between both molecules. This leads to complex formation, thereby enhancing VEGFR-2 phosphorylation and subsequent signaling. We found that inhibition of VEGF receptor (VEGFR) phosphorylation reduced complex formation between NP-1 and VEGFR-2, suggesting a functional role of the cytoplasmic domain of VEGFR-2 for complex formation. Correspondingly, deleting the PDZ-binding domain of NP-1 decreased complex formation, indicating that extracellular VEGF165 binding is not sufficient for VEGFR-2-NP-1 interaction. Synectin is an NP-1 PDZ-binding domain-interacting molecule. Experiments in Synectin-deficient endothelial cells revealed reduced VEGFR-2-NP-1 complex formation, suggesting a role for Synectin in VEGFR-2-NP-1 signaling. Taken together, the experiments have identified a novel mechanism of NP-1 interaction with VEGFR-2, which involves the cytoplasmic domain of NP-1.	[Prahst, Claudia; Heroult, Melanie; Augustin, Hellmut G.] Univ Heidelberg, Med Fac Mannheim CBTM, Joint Res Div Vasc Biol, D-69120 Heidelberg, Germany; [Prahst, Claudia; Heroult, Melanie; Augustin, Hellmut G.] DKFZ, D-69120 Heidelberg, Germany; [Lanahan, Anthony A.; Simons, Michael] Dartmouth Med Sch, Dept Med, Angiogenesis Res Ctr, Lebanon, NH 03756 USA; [Lanahan, Anthony A.; Simons, Michael] Dartmouth Med Sch, Dept Med, Cardiol Sect, Lebanon, NH 03756 USA; [Uziel, Noa; Kessler, Ofra; Shraga-Heled, Niva; Neufeld, Gera] Technion Israel Inst Technol, Bruce Rappaport Fac Med, Rappaport Res Inst Med Sci, Canc & Vasc Biol Res Ctr, IL-31096 Haifa, Israel	Ruprecht Karls University Heidelberg; Helmholtz Association; German Cancer Research Center (DKFZ); Dartmouth College; Dartmouth College; Technion Israel Institute of Technology; Rappaport Faculty of Medicine	Augustin, HG (corresponding author), Univ Heidelberg, Med Fac Mannheim CBTM, Joint Res Div Vasc Biol, Neuenheimer Feld 581, D-69120 Heidelberg, Germany.	augustin@angiogenese.de	Augustin, Hellmut/AAA-5246-2020; Neufeld, Gera/F-1524-2019; Simons, Michael/G-8553-2014	Augustin, Hellmut/0000-0002-7173-4242; Simons, Michael/0000-0003-0348-7734	Deutsche Forschungsgemeinschaft [SPP1190]; German-Israel-Foundation; National Institutes of Health [HL084619]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL084619] Funding Source: NIH RePORTER	Deutsche Forschungsgemeinschaft(German Research Foundation (DFG)); German-Israel-Foundation(German-Israeli Foundation for Scientific Research and Development); National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	This work was supported by Deutsche Forschungsgemeinschaft Grant SPP1190 (Au83/9-1; to H. G. A.), the German-Israel-Foundation (to G. N. and H. G. A.), and National Institutes of Health Grant HL084619 (to M. S.). The costs of publication of this article were defrayed in part by the payment of page charges. This article must therefore be hereby marked "advertisement" in accordance with 18 U. S. C. Section 1734 solely to indicate this fact.	Becker PM, 2005, CIRC RES, V96, P1257, DOI 10.1161/01.RES.0000171756.13554.49; Cai HB, 1999, J NEUROSCI, V19, P6519; Chittenden TW, 2006, DEV CELL, V10, P783, DOI 10.1016/j.devcel.2006.03.012; De Vries L, 1998, P NATL ACAD SCI USA, V95, P12340, DOI 10.1073/pnas.95.21.12340; Dougher M, 1999, ONCOGENE, V18, P1619, DOI 10.1038/sj.onc.1202478; El Mourabit H, 2002, MATRIX BIOL, V21, P207, DOI 10.1016/S0945-053X(01)00198-6; Ewan LC, 2006, TRAFFIC, V7, P1270, DOI 10.1111/j.1600-0854.2006.00462.x; Fiedler U, 2006, NAT MED, V12, P235, DOI 10.1038/nm1351; Fujisawa H, 1998, CURR OPIN NEUROBIOL, V8, P587, DOI 10.1016/S0959-4388(98)80085-8; Herzog Y, 2001, MECH DEVELOP, V109, P115, DOI 10.1016/S0925-4773(01)00518-4; Kato H, 2004, FEBS LETT, V572, P123, DOI 10.1016/j.febslet.2004.07.017; Kawakami A, 1996, J NEUROBIOL, V29, P1, DOI 10.1002/(SICI)1097-4695(199601)29:1<1::AID-NEU1>3.0.CO;2-F; Kawasaki T, 1999, DEVELOPMENT, V126, P4895; Kitsukawa T, 1997, NEURON, V19, P995, DOI 10.1016/S0896-6273(00)80392-X; Kitsukawa T, 1995, DEVELOPMENT, V121, P4309; Kobayashi S, 2004, FASEB J, V18, P929, DOI 10.1096/fj.03-0767fje; Lou XJ, 2001, MOL BIOL CELL, V12, P615, DOI 10.1091/mbc.12.3.615; Moyon D, 2001, DEVELOPMENT, V128, P3359; Muders MH, 2006, CANCER RES, V66, P10264, DOI 10.1158/0008-5472.CAN-06-2321; Pan Q, 2007, J BIOL CHEM, V282, P24049, DOI 10.1074/jbc.M703554200; Risau W, 1997, NATURE, V386, P671, DOI 10.1038/386671a0; Shraga-Heled N, 2007, FASEB J, V21, P915, DOI 10.1096/fj.06-6277com; Soker S, 1998, CELL, V92, P735, DOI 10.1016/S0092-8674(00)81402-6; Soker S, 2002, J CELL BIOCHEM, V85, P357, DOI 10.1002/jcb.10140; TAKAGI S, 1995, DEV BIOL, V170, P207, DOI 10.1006/dbio.1995.1208; Wang L, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0001161; Wang L, 2006, FASEB J, V20, P1513, DOI 10.1096/fj.05-5504fje; Wood JM, 2000, CANCER RES, V60, P2178	28	102	109	0	5	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	SEP 12	2008	283	37					25110	25114		10.1074/jbc.C800137200	http://dx.doi.org/10.1074/jbc.C800137200			5	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	345QZ	18628209	Green Published, hybrid			2022-12-27	WOS:000259012700002
J	Watanabe, S; Oguchi, Y; Takeda, K; Miki, K; Tokuda, H				Watanabe, Shoji; Oguchi, Yuki; Takeda, Kazuki; Miki, Kunio; Tokuda, Hajime			Introduction of a lethal redox switch that controls the opening and closing of the hydrophobic cavity in LolA	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							OUTER-MEMBRANE LIPOPROTEIN; ESCHERICHIA-COLI LIPOPROTEINS; BINDING CASSETTE TRANSPORTER; MOLECULAR CHAPERONE; INNER MEMBRANE; LOCALIZATION; PROTEIN; RELEASE; LOLCDE	LolA plays a critical role in the outer membrane sorting of Escherichia coli lipoproteins because it carries a hydrophobic lipoprotein from the inner membrane through the hydrophilic periplasm to the outer membrane receptor LolB. LolA has an incomplete beta-barrel structure composed of 11 beta-strands with an alpha-helical lid forming a hydrophobic cavity inside. The accompanying study revealed that the hydrophobic cavity opens and closes upon the binding and release of lipoproteins, respectively. Ile(93) in the alpha-helix and Phe(140) in the beta-strand are located close to each other in the hydrophobic cavity. These two residues were replaced by Cys to construct the I93C/F140C derivative. Expression of I93C/F140C immediately arrested growth whether wild-type LolA was present or not. However, this dominant negative phenotype was abolished by reducing agents, indicating that the intramolecular disulfide bonding between the two Cys residues is lethal. I93C/F140C was unstable, and its periplasmic level was lower than that of wild-type LolA or its single Cys derivative. Reduction of I93C/F140C was essential for the release of lipoproteins from the inner membrane. Moreover, treatment of I93C/F140C with divalent cross-linkers having different side chain lengths revealed that opening of the lid for a sufficient distance is required for the release activity. The binding of a fluorescent probe to the hydrophobic cavity of I93C/F140C also depended on reducing agents. Taken together, these results indicate that the two Cys residues introduced into LolA function as a redox switch, which regulates the opening and closing of the hydrophobic cavity.	[Watanabe, Shoji; Oguchi, Yuki; Tokuda, Hajime] Univ Tokyo, Inst Mol & Cellular Biosci, Bunkyo Ku, Tokyo 1130032, Japan; [Takeda, Kazuki; Miki, Kunio] Harima Inst, Spring Ctr 8, RIKEN, Mikazuki, Hyogo 6795148, Japan; [Takeda, Kazuki; Miki, Kunio] Kyoto Univ, Grad Sch Sci, Dept Chem, Kyoto 6068502, Japan	University of Tokyo; RIKEN; Kyoto University	Tokuda, H (corresponding author), Univ Tokyo, Inst Mol & Cellular Biosci, Bunkyo Ku, 1-1-1 Yayoi, Tokyo 1130032, Japan.	htokuda@iam.u-tokyo.ac.jp	Takeda, Kazuki/AAQ-9238-2021	Takeda, Kazuki/0000-0002-4094-6816	Ministry of Education, Science, Sports and Culture of Japan	Ministry of Education, Science, Sports and Culture of Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT))	This work was supported by grants from the Ministry of Education, Science, Sports and Culture of Japan (to H. T.). The costs of publication of this article were defrayed in part by the payment of page charges. This article must therefore be hereby marked "advertisement" in accordance with 18 U. S. C. Section 1734 solely to indicate this fact.	BRAUN V, 1975, BIOCHIM BIOPHYS ACTA, V415, P335, DOI 10.1016/0304-4157(75)90013-1; CAREAGA CL, 1992, J MOL BIOL, V226, P1219, DOI 10.1016/0022-2836(92)91063-U; HUSSAIN M, 1982, J BIOL CHEM, V257, P5177; Kaufmann A, 1999, BIOCHEMISTRY-US, V38, P9115, DOI 10.1021/bi990539d; LAEMMLI UK, 1970, NATURE, V227, P680, DOI 10.1038/227680a0; MATSUYAMA S, 1995, EMBO J, V14, P3365, DOI 10.1002/j.1460-2075.1995.tb07342.x; Matsuyama S, 1997, EMBO J, V16, P6947, DOI 10.1093/emboj/16.23.6947; Miyamoto A, 2001, BIOCHEM BIOPH RES CO, V287, P1125, DOI 10.1006/bbrc.2001.5705; MIZUSHIMA S, 1984, MOL CELL BIOCHEM, V60, P5; Narita S, 2004, ARCH MICROBIOL, V182, P1, DOI 10.1007/s00203-004-0682-4; Narita S, 2002, J BACTERIOL, V184, P1417, DOI 10.1128/JB.184.5.1417-1422.2002; Oguchi Y, 2008, J BIOL CHEM, V283, P25414, DOI 10.1074/jbc.M804736200; OLIVER DB, 1990, P NATL ACAD SCI USA, V87, P8227, DOI 10.1073/pnas.87.21.8227; Sambrook J., 1989, MOL CLONING LAB MANU; Sorgen PL, 2002, P NATL ACAD SCI USA, V99, P14037, DOI 10.1073/pnas.182552199; SOWDHAMINI R, 1989, PROTEIN ENG, V3, P95, DOI 10.1093/protein/3.2.95; Tajima T, 1998, FEBS LETT, V439, P51, DOI 10.1016/S0014-5793(98)01334-9; Takeda K, 2003, EMBO J, V22, P3199, DOI 10.1093/emboj/cdg324; Tanaka K, 2001, J BACTERIOL, V183, P6538, DOI 10.1128/JB.183.22.6538-6542.2001; Taniguchi N, 2005, J BIOL CHEM, V280, P34481, DOI 10.1074/jbc.M507388200; Taniguchi N, 2008, J BIOL CHEM, V283, P8538, DOI 10.1074/jbc.M800026200; Terada M, 2001, J BIOL CHEM, V276, P47690, DOI 10.1074/jbc.M109307200; Tokuda H, 2004, BBA-MOL CELL RES, V1693, P5, DOI 10.1016/j.bbamcr.2004.02.005; Watanabe S, 2006, J BIOL CHEM, V281, P3335, DOI 10.1074/jbc.M509596200; Watanabe S, 2007, PROTEIN SCI, V16, P2741, DOI 10.1110/ps.073101307; Yakushi T, 1998, J BIOL CHEM, V273, P32576, DOI 10.1074/jbc.273.49.32576; Yakushi T, 2000, NAT CELL BIOL, V2, P212, DOI 10.1038/35008635; Yakushi T, 1997, J BACTERIOL, V179, P2857, DOI 10.1128/jb.179.9.2857-2862.1997	28	14	16	0	3	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	SEP 12	2008	283	37					25421	25427		10.1074/jbc.M804737200	http://dx.doi.org/10.1074/jbc.M804737200			7	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	345QZ	18621730	hybrid			2022-12-27	WOS:000259012700037
J	Magnone, M; Basile, G; Bruzzese, D; Guida, L; Signorello, MG; Chothi, MP; Bruzzone, S; Millo, E; Qi, AD; Nicholas, RA; Kassack, MU; Leoncini, G; Zocchi, E				Magnone, Mirko; Basile, Giovanna; Bruzzese, Debora; Guida, Lucrezia; Signorello, Maria Grazia; Chothi, Madhu Parakkottil; Bruzzone, Santina; Millo, Enrico; Qi, Ai-Dong; Nicholas, Robert A.; Kassack, Matthias U.; Leoncini, Giuliana; Zocchi, Elena			Adenylic Dinucleotides Produced by CD38 Are Negative Endogenous Modulators of Platelet Aggregation	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							NITRIC-OXIDE INSUFFICIENCY; RIBOSE-SYNTHESIZING CD38; P2Y(11) RECEPTOR; P2 RECEPTORS; CYCLIC-AMP; DIADENOSINE PHOSPHATES; PHOSPHOLIPASE-C; BLOOD-PLATELETS; ADP; ACTIVATION	Diadenosine 5',5'''-P1,P2-diphosphate (Ap2A) is one of the adenylic dinucleotides stored in platelet granules. Along with proaggregant ADP, it is released upon platelet activation and is known to stimulate myocyte proliferation. We have previously demonstrated synthesis of Ap2A and of two isomers thereof, called P18 and P24, from their high pressure liquid chromatography retention time, by the ADP-ribosyl cyclase CD38 in mammalian cells. Here we show that Ap2A and its isomers are present in resting human platelets and are released during thrombin-induced platelet activation. The three adenylic dinucleotides were identified by high pressure liquid chromatography through a comparison with the retention times and the absorption spectra of purified standards. Ap2A, P18, and P24 had no direct effect on platelet aggregation, but they inhibited platelet aggregation induced by physiological agonists (thrombin, ADP, and collagen), with mean IC50 values ranging between 5 and 15 mu M. Moreover, the three dinucleotides did not modify the intracellular calcium concentration in resting platelets, whereas they significantly reduced the thrombin-induced intracellular calcium increase. Through binding to the purinergic receptor P2Y(11), exogenously applied Ap2A, P18, and P24 increased the intracellular cAMP concentration and stimulated platelet production of nitric oxide, the most important endogenous antiaggregant. The presence of Ap2A, P18, and P24 in resting platelets and their release during thrombin-induced platelet activation at concentrations equal to or higher than the respective IC50 value on platelet aggregation suggest a role of these dinucleotides as endogenous negative modulators of aggregation.	[Magnone, Mirko; Basile, Giovanna; Bruzzese, Debora; Guida, Lucrezia; Signorello, Maria Grazia; Chothi, Madhu Parakkottil; Bruzzone, Santina; Millo, Enrico; Leoncini, Giuliana; Zocchi, Elena] Univ Genoa, Dept Expt Med, Biochem Sect, I-16132 Genoa, Italy; [Magnone, Mirko; Basile, Giovanna; Bruzzese, Debora; Guida, Lucrezia; Signorello, Maria Grazia; Chothi, Madhu Parakkottil; Bruzzone, Santina; Millo, Enrico; Leoncini, Giuliana; Zocchi, Elena] Univ Genoa, Ctr Excellence Biomed Res, I-16132 Genoa, Italy; [Guida, Lucrezia; Bruzzone, Santina; Zocchi, Elena] Adv Biotechnol Ctr, I-16132 Genoa, Italy; [Qi, Ai-Dong; Nicholas, Robert A.] Univ N Carolina, Dept Pharmacol, Chapel Hill, NC 27599 USA; [Kassack, Matthias U.] Univ Dusseldorf, Inst Pharmaceut & Med Chem, D-40225 Dusseldorf, Germany	University of Genoa; University of Genoa; University of North Carolina; University of North Carolina Chapel Hill; Heinrich Heine University Dusseldorf	Zocchi, E (corresponding author), Univ Genoa, Dept Expt Med, Biochem Sect, Viale Benedetto 15,1, I-16132 Genoa, Italy.	ezocchi@unige.it	Madhu, Parakkottil Chothi/AAF-8251-2021; Bruzzone, Santina/A-4264-2015; Signorello, Maria Grazia/AGN-4399-2022; Millo, Enrico/K-3218-2018	Madhu, Parakkottil Chothi/0000-0002-3138-1075; Bruzzone, Santina/0000-0003-2034-3716; Signorello, Maria Grazia/0000-0001-5042-6614; Millo, Enrico/0000-0002-4019-0051	Associazione Italiana per la Ricerca sul Cancro; Italian Ministry of Education, University, and Scientific Research [MIUR-PRIN 2003, MIUR FIRB RBAUO19A3C, MIUR FIRB RBNE01ERXR, MIUR FIRB RBLA039LSF]; University of Genova and Fondazione Cassa di Risparmio di Genova e Imperia; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL071131] Funding Source: NIH RePORTER	Associazione Italiana per la Ricerca sul Cancro(Fondazione AIRC per la ricerca sul cancro); Italian Ministry of Education, University, and Scientific Research(Ministry of Education, Universities and Research (MIUR)); University of Genova and Fondazione Cassa di Risparmio di Genova e Imperia; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	This work was supported in part by grants from the Associazione Italiana per la Ricerca sul Cancro; from the Italian Ministry of Education, University, and Scientific Research (MIUR-PRIN 2003, MIUR FIRB RBAUO19A3C, MIUR FIRB RBNE01ERXR and MIUR FIRB RBLA039LSF); and from the University of Genova and Fondazione Cassa di Risparmio di Genova e Imperia. The costs of publication of this article were defrayed in part by the payment of page charges. This article must therefore be hereby marked "advertisement" in accordance with 18 U.S.C. Section 1734 solely to indicate this fact.	Anfossi G, 2002, THROMB RES, V105, P71, DOI 10.1016/S0049-3848(01)00412-1; Basile G, 2005, P NATL ACAD SCI USA, V102, P14509, DOI 10.1073/pnas.0503691102; Bohme E, 1974, Methods Enzymol, V38, P199; BORN GVR, 1962, NATURE, V194, P927, DOI 10.1038/194927b0; Bruzzone S, 2007, J BIOL CHEM, V282, P5045, DOI 10.1074/jbc.M609802200; Chen Y, 2004, J LEUKOCYTE BIOL, V76, P245, DOI 10.1189/jlb.0204066; COLE B, 1971, ANN NY ACAD SCI, V185, P477; Communi D, 1997, J BIOL CHEM, V272, P31969, DOI 10.1074/jbc.272.51.31969; Coward P, 1999, ANAL BIOCHEM, V270, P242, DOI 10.1006/abio.1999.4061; DEGRAAF JC, 1992, CIRCULATION, V85, P2284, DOI 10.1161/01.CIR.85.6.2284; Gachet C, 2005, SEMIN THROMB HEMOST, V31, P162, DOI 10.1055/s-2005-869521; Gkaliagkousi E, 2007, CIRC RES, V101, P654, DOI 10.1161/CIRCRESAHA.107.158410; Graeff R, 2002, BIOCHEM J, V367, P163, DOI 10.1042/BJ20020644; Granger DL, 1996, METHOD ENZYMOL, V268, P142; GREEN LC, 1982, ANAL BIOCHEM, V126, P131, DOI 10.1016/0003-2697(82)90118-X; Haslam RJ, 1999, THROMB HAEMOSTASIS, V82, P412; Hechler B, 2005, SEMIN THROMB HEMOST, V31, P150, DOI 10.1055/s-2005-869520; Houston D, 2006, BRIT J PHARMACOL, V147, P459, DOI 10.1038/sj.bjp.0706453; Jankowski J, 2001, J BIOL CHEM, V276, P8904, DOI 10.1074/jbc.M009527200; Keeble JE, 2002, BRIT J PHARMACOL, V137, P295, DOI 10.1038/sj.bjp.0704876; LEE HC, 2002, CYCLIC ADP RIBOSE NA; Leoncini G, 2002, BIOCHEM PHARMACOL, V64, P277, DOI 10.1016/S0006-2952(02)01108-5; LEONCINI G, 1990, EUR J HAEMATOL, V44, P115; Loscalzo J, 2001, CIRC RES, V88, P756, DOI 10.1161/hh0801.089861; Luo J, 1999, FASEB J, V13, P695, DOI 10.1096/fasebj.13.6.695; MALINSKI T, 1993, BIOCHEM BIOPH RES CO, V194, P960, DOI 10.1006/bbrc.1993.1914; Marjanovic JA, 2005, J BIOL CHEM, V280, P37430, DOI 10.1074/jbc.M506518200; Moreschi I, 2008, CELL CALCIUM, V43, P344, DOI 10.1016/j.ceca.2007.06.006; Moreschi I, 2006, J BIOL CHEM, V281, P31419, DOI 10.1074/jbc.M606625200; MURUGANANDAM A, 1994, BBA-GEN SUBJECTS, V1200, P1, DOI 10.1016/0304-4165(94)90019-1; NAKAHATA N, 1987, BIOCHEM J, V241, P337, DOI 10.1042/bj2410337; Nylander S, 2003, THROMB RES, V111, P65, DOI 10.1016/j.thromres.2003.08.021; Ohlmann P, 1998, BIOCHEM J, V331, P431, DOI 10.1042/bj3310431; Qi AD, 2001, BRIT J PHARMACOL, V132, P318, DOI 10.1038/sj.bjp.0703788; RADOMSKI MW, 1990, P NATL ACAD SCI USA, V87, P5193, DOI 10.1073/pnas.87.13.5193; RADOMSKI MW, 1990, BRIT J PHARMACOL, V101, P325, DOI 10.1111/j.1476-5381.1990.tb12709.x; RADOMSKI MW, 1993, ADV EXP MED BIOL, V344, P251; Ramaschi G, 1996, BLOOD, V87, P2308, DOI 10.1182/blood.V87.6.2308.bloodjournal8762308; Rao Gundu H. R., 1993, Indian Journal of Physiology and Pharmacology, V37, P263; Riddell DR, 1999, VITAM HORM, V57, P25; Rossi L, 1998, AIDS RES HUM RETROV, V14, P435, DOI 10.1089/aid.1998.14.435; Sage SO, 1997, PROSTAG LEUKOTR ESS, V57, P435, DOI 10.1016/S0952-3278(97)90424-5; SALZMAN EW, 1972, ADV CYCL NUCL RES<D>, V1, P231; Schluter H, 1996, J AUTON PHARMACOL, V16, P357, DOI 10.1111/j.1474-8673.1996.tb00053.x; Tertyshnikova S, 1998, P NATL ACAD SCI USA, V95, P1613, DOI 10.1073/pnas.95.4.1613; TOHMATSU T, 1989, BIOCHIM BIOPHYS ACTA, V1013, P190, DOI 10.1016/0167-4889(89)90048-7; Torti M, 1998, FEBS LETT, V428, P200, DOI 10.1016/S0014-5793(98)00516-X; Ullmann H, 2005, J MED CHEM, V48, P7040, DOI 10.1021/jm050301p; vanderGiet M, 1997, BRIT J PHARMACOL, V120, P1453, DOI 10.1038/sj.bjp.0701074; Vaughan KR, 2007, J IMMUNOL, V179, P8544, DOI 10.4049/jimmunol.179.12.8544; Voetsch B, 2004, HISTOCHEM CELL BIOL, V122, P353, DOI 10.1007/s00418-004-0675-z; Wang L, 2003, J THROMB HAEMOST, V1, P330, DOI 10.1046/j.1538-7836.2003.00070.x	52	8	8	0	0	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	SEP 5	2008	283	36					24460	24468		10.1074/jbc.M710568200	http://dx.doi.org/10.1074/jbc.M710568200			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	342YR	18606819	Green Published, hybrid			2022-12-27	WOS:000258820000070
J	Mao, HZ; Abraham, CG; Krishnakumar, AM; Weber, J				Mao, Hui Z.; Abraham, Christopher G.; Krishnakumar, Arathianand M.; Weber, Joachim			A functionally important hydrogen-bonding network at the beta(DP)/alpha(DP) interface of ATP synthase	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ESCHERICHIA-COLI F-1-ATPASE; 3 CATALYTIC SITES; NUCLEOTIDE-BINDING; REGULATORY PROTEIN; BETA-SUBUNIT; EPSILON-SUBUNIT; DELTA-SUBUNIT; F1-ATPASE; HYDROLYSIS; IDENTIFICATION	ATP synthase uses a unique rotary mechanism to couple ATP synthesis and hydrolysis to transmembrane proton translocation. The F-1 subcomplex has three catalytic nucleotide binding sites, one on each beta subunit, at the interface to the adjacent alpha subunit. In the x-ray structure of F1 (Abrahams, J. P., Leslie, A. G. W., Lutter, R., and Walker, J. E. (1994) Nature 370, 621 628), the three catalytic beta/alpha interfaces differ in the extent of inter-subunit interactions between the C termini of the beta and alpha subunits. At the closed beta(DP)/alpha(DP) interface, a hydrogen-bonding network is formed between both subunits, which is absent at the more open beta(TP)/alpha(TP) interface and at the wide open beta(E)/alpha(E) interface. The hydrogen-bonding network reaches from beta L328 (Escherichia coli numbering) and beta Q441 via alpha Q399, eta R398, and alpha E402 to beta R394, and ends in a cation/pi interaction between beta R394 and alpha F406. Using mutational analysis in E. coli ATP synthase, the functional importance of the beta(DP)/alpha(DP) hydrogen-bonding network is demonstrated. Its elimination results in a severely impaired enzyme but has no pronounced effect on the binding affinities of the catalytic sites. A possible role for the hydrogen-bonding network in coupling of ATP synthesis/hydrolysis and rotation will be discussed.	[Mao, Hui Z.; Abraham, Christopher G.; Krishnakumar, Arathianand M.; Weber, Joachim] Texas Tech Univ, Dept Chem & Biochem, Lubbock, TX 79409 USA	Texas Tech University System; Texas Tech University	Weber, J (corresponding author), Texas Tech Univ, Dept Chem & Biochem, Box 41061, Lubbock, TX 79409 USA.	joachim.weber@ttuhsc.edu			National Institutes of Health Grant [GM071462]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM071462] Funding Source: NIH RePORTER	National Institutes of Health Grant(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported, in whole or in part, by National Institutes of Health Grant GM071462 (to J. W.). The costs of publication of this article were defrayed in part by the payment of page charges. This article must therefore be hereby marked "advertisement" in accordance with 18 U. S. C. Section 1734 solely to indicate this fact.	ABRAHAMS JP, 1994, NATURE, V370, P621, DOI 10.1038/370621a0; Ahmad Z, 2004, J BIOL CHEM, V279, P31505, DOI 10.1074/jbc.M404621200; Altschul SF, 1997, NUCLEIC ACIDS RES, V25, P3389, DOI 10.1093/nar/25.17.3389; Bowler MW, 2007, J BIOL CHEM, V282, P14238, DOI 10.1074/jbc.M700203200; Bowler MW, 2006, P NATL ACAD SCI USA, V103, P8646, DOI 10.1073/pnas.0602915103; Cabezon E, 2003, NAT STRUCT BIOL, V10, P744, DOI 10.1038/nsb966; Clark-Walker GD, 2000, BBA-PROTEIN STRUCT M, V1478, P125, DOI 10.1016/S0167-4838(00)00003-0; Dimroth P, 2006, EMBO REP, V7, P276, DOI 10.1038/sj.embor.7400646; Gao YQ, 2005, CELL, V123, P195, DOI 10.1016/j.cell.2005.10.001; Gao YQ, 2003, P NATL ACAD SCI USA, V100, P11339, DOI 10.1073/pnas.1334188100; Gledhill JR, 2007, P NATL ACAD SCI USA, V104, P15671, DOI 10.1073/pnas.0707326104; HICKS DB, 1990, J BIOL CHEM, V265, P20547; Ichikawa N, 2005, J BIOCHEM, V138, P201, DOI 10.1093/jb/mvi116; Kabaleeswaran V, 2006, EMBO J, V25, P5433, DOI 10.1038/sj.emboj.7601410; Ketchum CJ, 1998, BIOCHEM J, V330, P707; KLIONSKY DJ, 1984, J BACTERIOL, V160, P1055, DOI 10.1128/JB.160.3.1055-1060.1984; LEE RSF, 1989, FEBS LETT, V253, P269, DOI 10.1016/0014-5793(89)80973-1; LEE RSF, 1991, BIOCHEMISTRY-US, V30, P6842, DOI 10.1021/bi00242a006; Leslie AGW, 2000, PHILOS T ROY SOC B, V355, P465, DOI 10.1098/rstb.2000.0588; Lobau S, 1998, BIOCHEMISTRY-US, V37, P10846, DOI 10.1021/bi9807153; Mao HZ, 2007, P NATL ACAD SCI USA, V104, P18478, DOI 10.1073/pnas.0709322104; Menz RI, 2001, CELL, V106, P331, DOI 10.1016/S0092-8674(01)00452-4; Nadanaciva S, 2000, BIOCHEMISTRY-US, V39, P9583, DOI 10.1021/bi000941o; Nadanaciva S, 1999, J BIOL CHEM, V274, P7052, DOI 10.1074/jbc.274.11.7052; Nishizaka T, 2004, NAT STRUCT MOL BIOL, V11, P142, DOI 10.1038/nsmb721; Noji H, 2001, J BIOL CHEM, V276, P1665, DOI 10.1074/jbc.R000021200; PERLIN DS, 1983, J BIOL CHEM, V258, P9793; Pu JZ, 2008, P NATL ACAD SCI USA, V105, P1192, DOI 10.1073/pnas.0708746105; RAO R, 1988, J BIOL CHEM, V263, P5569; Scanlon JAB, 2007, BIOCHEMISTRY-US, V46, P8785, DOI 10.1021/bi700610m; SENIOR AE, 1983, BIOCHEM J, V210, P395, DOI 10.1042/bj2100395; SENIOR AE, 1984, ARCH BIOCHEM BIOPHYS, V228, P49, DOI 10.1016/0003-9861(84)90045-6; Stocker A, 2007, STRUCTURE, V15, P904, DOI 10.1016/j.str.2007.06.009; TAUSSKY HH, 1953, J BIOL CHEM, V202, P675; vanRaaij MJ, 1996, P NATL ACAD SCI USA, V93, P6913, DOI 10.1073/pnas.93.14.6913; VANVELDHOVEN PP, 1987, ANAL BIOCHEM, V161, P45, DOI 10.1016/0003-2697(87)90649-X; Wang YM, 2007, J BIOL CHEM, V282, P8228, DOI 10.1074/jbc.M609635200; Weber J, 2003, J BIOL CHEM, V278, P13409, DOI 10.1074/jbc.M212037200; Weber J, 2002, J BIOL CHEM, V277, P18390, DOI 10.1074/jbc.M201047200; Weber J, 2004, METHOD ENZYMOL, V380, P132; WEBER J, 1992, BIOCHEMISTRY-US, V31, P5112, DOI 10.1021/bi00137a004; Weber J, 2003, FEBS LETT, V545, P61, DOI 10.1016/S0014-5793(03)00394-6; WEBER J, 1993, J BIOL CHEM, V268, P20126; Weber J, 1999, J BIOL CHEM, V274, P19124, DOI 10.1074/jbc.274.27.19124; Weber J, 1996, J BIOL CHEM, V271, P18711, DOI 10.1074/jbc.271.31.18711; Weber J, 2001, J BIOL CHEM, V276, P35422, DOI 10.1074/jbc.M104946200; Weber J, 2006, BBA-BIOENERGETICS, V1757, P1162, DOI 10.1016/j.bbabio.2006.04.007; Wilkens S, 2005, ADV PROTEIN CHEM, V71, P345, DOI 10.1016/S0065-3233(04)71009-8; Yasuda R, 2001, NATURE, V410, P898, DOI 10.1038/35073513	49	8	8	0	1	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	SEP 5	2008	283	36					24781	24788		10.1074/jbc.M804142200	http://dx.doi.org/10.1074/jbc.M804142200			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	342YR	18579516	Green Published, hybrid			2022-12-27	WOS:000258820000046
J	Otero, JE; Dai, S; Foglia, D; Alhawagri, M; Vacher, J; Pasparakis, M; Abu-Amer, Y				Otero, Jesse E.; Dai, Simon; Foglia, Domenica; Alhawagri, Muhammad; Vacher, Jean; Pasparakis, Manolis; Abu-Amer, Yousef			Defective Osteoclastogenesis by IKK beta-null Precursors Is a Result of Receptor Activator of NF-kappa B Ligand (RANKL)-induced JNK-dependent Apoptosis and Impaired Differentiation	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							C-JUN; KINASE PHOSPHATASE; ALPHA; MICE; INHIBITOR; SUBUNIT; PHOSPHORYLATION; OSTEOPETROSIS; PEPTIDE; PATHWAY		[Otero, Jesse E.; Dai, Simon; Foglia, Domenica; Alhawagri, Muhammad; Abu-Amer, Yousef] Washington Univ, Sch Med, Dept Orthopaed Surg, St Louis, MO 63110 USA; [Abu-Amer, Yousef] Washington Univ, Sch Med, Dept Cell Biol & Physiol, St Louis, MO 63110 USA; [Vacher, Jean] Inst Rech Clin Montreal, Montreal, PQ H2W 1R7, Canada; [Pasparakis, Manolis] Univ Cologne, D-50674 Cologne, Germany	Washington University (WUSTL); Washington University (WUSTL); Institut de Recherche Clinique de Montreal (IRCM); Universite de Montreal; University of Cologne	Abu-Amer, Y (corresponding author), Washington Univ, Sch Med, Dept Orthopaed Surg, 1 Barnes Jewish Hosp Plaza,Suite 11300,Box 8233, St Louis, MO 63110 USA.	abuamery@wudosis.wustl.edu	Pasparakis, Manolis/N-4350-2019; Pasparakis, Manolis/H-9292-2017	Pasparakis, Manolis/0000-0002-9870-0966; Pasparakis, Manolis/0000-0002-9870-0966	National Institutes of health [AR049192, AR054326]; Ruth L. Kirschstein Predoctoral National Research Service Award [AR055392-01]; Shriners Hospital for Children [8510, 8570]; NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES [R01AR054326, R01AR049192, R01AR047443, F31AR055392] Funding Source: NIH RePORTER	National Institutes of health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Ruth L. Kirschstein Predoctoral National Research Service Award(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Shriners Hospital for Children; NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS))	This work was supported, in whole or in part, by National Institutes of Health Grants AR049192 and AR054326 (to Y. A.-A.). This work was also supported by Ruth L. Kirschstein Predoctoral National Research Service Award AR055392-01 (to J. E. O.) and Shriners Hospital for Children Grants 8510 and 8570 (to Y. A.-A).	Abbas S, 2003, J BIOL CHEM, V278, P20077, DOI 10.1074/jbc.M208619200; Anderson DM, 1997, NATURE, V390, P175, DOI 10.1038/36593; Barr RK, 2002, J BIOL CHEM, V277, P10987, DOI 10.1074/jbc.M107565200; Bharti AC, 2004, J BIOL CHEM, V279, P6065, DOI 10.1074/jbc.M308062200; Chaisson ML, 2004, J BIOL CHEM, V279, P54841, DOI 10.1074/jbc.M406392200; Dai S, 2004, J BIOL CHEM, V279, P37219, DOI 10.1074/jbc.C400258200; David JP, 2002, J CELL SCI, V115, P4317, DOI 10.1242/jcs.00082; Deng YB, 2003, CELL, V115, P61, DOI 10.1016/S0092-8674(03)00757-8; Ferron M, 2005, GENESIS, V41, P138, DOI 10.1002/gene.20108; Ikeda F, 2004, J CLIN INVEST, V114, P475, DOI 10.1172/JCI200419657; Iotsova V, 1997, NAT MED, V3, P1285, DOI 10.1038/nm1197-1285; Kong YY, 1999, NATURE, V397, P315, DOI 10.1038/16852; Lee SH, 2006, NAT MED, V12, P1403, DOI 10.1038/nm1514; Li ZW, 1999, J EXP MED, V189, P1839, DOI 10.1084/jem.189.11.1839; LIU YS, 1995, J BIOL CHEM, V270, P8377, DOI 10.1074/jbc.270.15.8377; Papa S, 2004, NAT CELL BIOL, V6, P146, DOI 10.1038/ncb1093; Pasparakis M, 2002, NATURE, V417, P861, DOI 10.1038/nature00820; Perkins ND, 2007, NAT REV MOL CELL BIO, V8, P49, DOI 10.1038/nrm2083; Ruocco MG, 2005, J EXP MED, V201, P1677, DOI 10.1084/jem.20042081; Senftleben U, 2001, SCIENCE, V293, P1495, DOI 10.1126/science.1062677; Shishodia S, 2002, J BIOCHEM MOL BIOL, V35, P28; Tang GL, 2001, NATURE, V414, P313, DOI 10.1038/35104568; Teitelbaum SL, 2004, J CLIN INVEST, V114, P463, DOI 10.1172/JCI200422644; Theodosiou A, 1999, ONCOGENE, V18, P6981, DOI 10.1038/sj.onc.1203185; Vaira S, 2008, P NATL ACAD SCI USA, V105, P3897, DOI 10.1073/pnas.0708576105; Yagi M, 2005, J EXP MED, V202, P345, DOI 10.1084/jem.20050645; Yamashita T, 2007, J BIOL CHEM, V282, P18245, DOI 10.1074/jbc.M610701200; YOSHIDA H, 1990, NATURE, V345, P442, DOI 10.1038/345442a0; Zandi E, 1997, CELL, V91, P243, DOI 10.1016/S0092-8674(00)80406-7	29	33	35	0	0	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	SEP 5	2008	283	36					24546	24553		10.1074/jbc.M800434200	http://dx.doi.org/10.1074/jbc.M800434200			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	342YR	18567579	hybrid, Green Published			2022-12-27	WOS:000258820000071
J	Ozawa, Y; Nakao, K; Kurihara, T; Shimazaki, T; Shimmura, S; Ishida, S; Yoshimura, A; Tsubota, K; Okano, H				Ozawa, Yoko; Nakao, Keiko; Kurihara, Toshihide; Shimazaki, Takuya; Shimmura, Shigeto; Ishida, Susumu; Yoshimura, Akihiko; Tsubota, Kazuo; Okano, Hideyuki			Roles of STAT3/SOCS3 pathway in regulating the visual function and ubiquitin-proteasome-dependent degradation of rhodopsin during retinal inflammation	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							CILIARY NEUROTROPHIC FACTOR; ENDOTOXIN-INDUCED UVEITIS; II TYPE-1 RECEPTOR; STAT3 ACTIVATION; PHOTORECEPTOR DIFFERENTIATION; CYTOKINE SIGNALING-3; IN-VIVO; SOCS3; ROD; CELLS	Inflammatory cytokines cause tissue dysfunction. We previously reported that retinal inflammation down-regulates rhodopsin expression and impairs visual function by an unknown mechanism. Here, we demonstrate that rhodopsin levels were preserved by suppressor of cytokine signaling 3 (SOCS3), a negative feedback regulator of STAT3 activation. SOCS3 was expressed mainly in photoreceptor cells in the retina. In the SOCS3-deficient retinas, rhodopsin protein levels dropped sooner, and the reduction was more profound than in the wild type. Visual dysfunction, measured by electroretinogram, was prolonged in retina-specific SOCS3 conditional knockout mice. Visual dysfunction and decreased rhodopsin levels both correlated with increased STAT3 activation enhanced by SOCS3 deficiency. Interleukin 6, one of the inflammatory cytokines found during retinal inflammation, activated STAT3 and decreased rhodopsin protein in adult retinal explants. This was enhanced by inhibiting SOCS3 function in vitro, indicating that rhodopsin reduction was not a secondary effect in the mutant mice. Interestingly, in the inflamed SOCS3-deficient adult retina, rhodopsin decreased post-transcriptionally at least partly through ubiquitin-proteasome-dependent degradation accelerated by STAT3 activation and not transcriptionally as in the developing retina, on which we reported previously. A STAT3-dependent E3 ubiquitin ligase, Ubr1, was responsible for rhodopsin degradation and was up-regulated in the inflamed SOCS3-deficient retinas. These results indicate that in wild-type animals, a decrease in rhodopsin during inflammation is minimized by endogenous SOCS3. However, when STAT3 activation exceeds some threshold beyond the compensatory activity of endogenous SOCS3, rhodopsin levels decrease. These findings suggest SOCS3 as a potential therapeutic target molecule for protecting photoreceptor cell function during inflammation.	[Ozawa, Yoko; Kurihara, Toshihide; Shimmura, Shigeto; Ishida, Susumu; Tsubota, Kazuo] Keio Univ, Sch Med, Dept Ophthalmol, Tokyo 1608582, Japan; [Ozawa, Yoko; Nakao, Keiko; Kurihara, Toshihide; Shimazaki, Takuya; Okano, Hideyuki] Keio Univ, Sch Med, Dept Physiol, Tokyo 1608582, Japan; [Nakao, Keiko] Saitama Med Univ, Fac Med, Dept Physiol, Saitama 3500495, Japan; [Yoshimura, Akihiko] Keio Univ, Sch Med, Dept Microbiol & Immunol, Tokyo 1608582, Japan; [Yoshimura, Akihiko] Kyushu Univ, Med Inst Bioregulat, Div Mol & Cellular Immunol, Fukuoka 8128582, Japan; [Okano, Hideyuki] Japan Sci & Technol Corp, CREST, Kawaguchi, Saitama 3320012, Japan; [Okano, Hideyuki] Japan Sci & Technol Corp, SORST, Kawaguchi, Saitama 3320012, Japan	Keio University; Keio University; Saitama Medical University; Keio University; Kyushu University; Japan Science & Technology Agency (JST); Japan Science & Technology Agency (JST)	Okano, H (corresponding author), 35 Shinanomachi,Shinjuku Ku, Tokyo 1608582, Japan.	hidokano@sc.itc.keio.ac.jp	Shimazaki, Takuya/L-1159-2013; Yoshimura, Akihiko/K-5515-2013; Shimmura, Shigeto/J-4678-2013; Kurihara, Toshihide/ABA-7058-2020; Ozawa, Yoko/AAH-9888-2020; Okano, Hideyuki/I-7584-2019	Shimazaki, Takuya/0000-0002-3936-2098; Kurihara, Toshihide/0000-0002-5457-2720; 				Adegoke OAJ, 2002, AM J PHYSIOL-ENDOC M, V283, pE482, DOI 10.1152/ajpendo.00097.2002; Babon JJ, 2006, MOL CELL, V22, P205, DOI 10.1016/j.molcel.2006.03.024; Do Rhee K, 2007, INVEST OPHTH VIS SCI, V48, P1389, DOI 10.1167/iovs.06-0677; Ezzeddine ZD, 1997, DEVELOPMENT, V124, P1055; Furukawa A, 2002, J NEUROSCI, V22, P1640, DOI 10.1523/JNEUROSCI.22-05-01640.2002; Furukawa T, 1997, CELL, V91, P531, DOI 10.1016/S0092-8674(00)80439-0; Furukawa T, 1999, NAT GENET, V23, P466, DOI 10.1038/70591; Hanada T, 2001, J BIOL CHEM, V276, P40746, DOI 10.1074/jbc.M106139200; Illing ME, 2002, J BIOL CHEM, V277, P34150, DOI 10.1074/jbc.M204955200; Jo D, 2005, NAT MED, V11, P892, DOI 10.1038/nm1269; Koizumi K, 2003, INVEST OPHTH VIS SCI, V44, P2184, DOI 10.1167/iovs.02-0589; Kopito RR, 2000, TRENDS CELL BIOL, V10, P524, DOI 10.1016/S0962-8924(00)01852-3; KURIHARA T, 2008, DIABETES IN PRESS; Kurihara T, 2006, INVEST OPHTH VIS SCI, V47, P5545, DOI 10.1167/iovs.06-0478; Lebel E, 2000, ENDOCRINOLOGY, V141, P3749, DOI 10.1210/en.141.10.3749; Marquardt T, 2001, CELL, V105, P43, DOI 10.1016/S0092-8674(01)00295-1; Minami M, 1996, P NATL ACAD SCI USA, V93, P3963, DOI 10.1073/pnas.93.9.3963; Mori H, 2004, NAT MED, V10, P739, DOI 10.1038/nm1071; Nagai N, 2005, INVEST OPHTH VIS SCI, V46, P2925, DOI 10.1167/iovs.04-1476; Nakajima K, 1996, EMBO J, V15, P3651, DOI 10.1002/j.1460-2075.1996.tb00734.x; Ndubuisi MI, 1999, J BIOL CHEM, V274, P25499, DOI 10.1074/jbc.274.36.25499; Neophytou C, 1997, DEVELOPMENT, V124, P2345; Ng DCH, 2006, J CELL BIOL, V172, P245, DOI 10.1083/jcb.200503021; NIWA H, 1991, GENE, V108, P193, DOI 10.1016/0378-1119(91)90434-D; Obin MS, 1996, J BIOL CHEM, V271, P14473, DOI 10.1074/jbc.271.24.14473; Okada S, 2006, NAT MED, V12, P829, DOI 10.1038/nm1425; Ozawa Y, 2004, MOL CELL NEUROSCI, V26, P258, DOI 10.1016/j.mcn.2004.02.001; Ozawa Y, 2007, DEV BIOL, V303, P591, DOI 10.1016/j.ydbio.2006.11.032; Peng GH, 2005, HUM MOL GENET, V14, P747, DOI 10.1093/hmg/ddi070; Reich NC, 2006, NAT REV IMMUNOL, V6, P602, DOI 10.1038/nri1885; Reme CE, 1999, INVEST OPHTH VIS SCI, V40, P2398; Rhee KD, 2004, J NEUROSCI, V24, P9779, DOI 10.1523/JNEUROSCI.1785-04.2004; Roberts AW, 2001, P NATL ACAD SCI USA, V98, P9324, DOI 10.1073/pnas.161271798; Saliba RS, 2002, J CELL SCI, V115, P2907; Samardzija M, 2006, FASEB J, V20, P2411, DOI 10.1096/fj.06-5895fje; Sasaki A, 2003, J BIOL CHEM, V278, P2432, DOI 10.1074/jbc.C200608200; Sasaki T, 2006, MOL CELL, V24, P63, DOI 10.1016/j.molcel.2006.08.005; Schulz-Key S, 2002, INVEST OPHTH VIS SCI, V43, P3099; Shah M, 2006, J BIOL CHEM, V281, P7302, DOI 10.1074/jbc.M508527200; Shouda T, 2001, J CLIN INVEST, V108, P1781, DOI 10.1172/JCI200113568; Sieving PA, 2006, P NATL ACAD SCI USA, V103, P3896, DOI 10.1073/pnas.0600236103; STRYER L, 1991, J BIOL CHEM, V266, P10711; Suzuki A, 2001, J EXP MED, V193, P471, DOI 10.1084/jem.193.4.471; SUZUKI K, 1994, JPN J PHARMACOL, V64, P97, DOI 10.1254/jjp.64.97; Tomita K, 1996, NEURON, V16, P723, DOI 10.1016/S0896-6273(00)80093-8; Wen R, 2006, J NEUROSCI, V26, P13523, DOI 10.1523/JNEUROSCI.4021-06.2006; Yang XP, 2005, J HEPATOL, V43, P704, DOI 10.1016/j.jhep.2005.02.048; Yasukawa H, 2003, NAT IMMUNOL, V4, P551, DOI 10.1038/ni938	48	52	53	0	4	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	SEP 5	2008	283	36					24561	24570		10.1074/jbc.M802238200	http://dx.doi.org/10.1074/jbc.M802238200			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	342YR	18614536	hybrid, Green Published			2022-12-27	WOS:000258820000029
J	Piubelli, L; Pedotti, M; Molla, G; Feindler-Boeckh, S; Ghisla, S; Pilone, MS; Pollegioni, L				Piubelli, Luciano; Pedotti, Mattia; Molla, Gianluca; Feindler-Boeckh, Susanne; Ghisla, Sandro; Pilone, Mirella S.; Pollegioni, Loredano			On the oxygen reactivity of flavoprotein oxidases - An oxygen access tunnel and gate in Brevibacterium sterolicum cholesterol oxidase	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							DESULFOVIBRIO-VULGARIS HILDENBOROUGH; RHODOCOCCUS-EQUI; CRYSTAL-STRUCTURE; STREPTOMYCES-HYGROSCOPICUS; OXIDATION-REDUCTION; ACTIVE-SITE; C-OXIDASE; MECHANISM; FLAVINYLATION; FLAVODOXIN	The flavoprotein cholesterol oxidase from Brevibacterium sterolicum (BCO) possesses a narrow channel that links the active center containing the flavin to the outside solvent. This channel has been proposed to serve for the access of dioxygen; it contains at its "bottom" a Glu-Arg pair (Glu-475-Arg-477) that was found by crystallographic studies to exist in two forms named "open" and "closed," which in turn was suggested to constitute a gate functioning in the control of oxygen access. Most mutations of residues that flank the channel have minor effects on the oxygen reactivity. Mutations of Glu-311, however, cause a switch in the basic kinetic mechanism of the reaction of reduced BCO with dioxygen; wild-type BCO and most mutants show a saturation behavior with increasing oxygen concentration, whereas for Glu-311 mutants a linear dependence is found that is assumed to reflect a "simple" second order process. This is taken as support for the assumption that residue Glu-311 finely tunes the Glu-475-Arg-477 pair, forming a gate that functions in modulating the access/reactivity of dioxygen.	[Piubelli, Luciano; Pedotti, Mattia; Molla, Gianluca; Pilone, Mirella S.; Pollegioni, Loredano] Univ Insubria, Dept Biotechnol & Mol Sci, I-21100 Varese, Italy; [Feindler-Boeckh, Susanne; Ghisla, Sandro] Univ Konstanz, Fachbereich Biol, D-7857 Constance, Germany	University of Insubria; University of Konstanz	Pollegioni, L (corresponding author), Univ Insubria, Dept Biotechnol & Mol Sci, Via JH Dunant 3, I-21100 Varese, Italy.	loredano.pollegioni@uninsubria.it		POLLEGIONI, LOREDANO/0000-0003-1733-7243; PIUBELLI, LUCIANO/0000-0003-0805-5121; Molla, Gianluca/0000-0003-3688-3397				Brunori M, 2000, BIOPHYS CHEM, V86, P221, DOI 10.1016/S0301-4622(00)00142-3; Corbin DR, 2001, PLANT PHYSIOL, V126, P1116, DOI 10.1104/pp.126.3.1116; Coulombe R, 2001, J BIOL CHEM, V276, P30435, DOI 10.1074/jbc.M104103200; Deng PC, 2007, GENE, V398, P208, DOI 10.1016/j.gene.2007.01.037; Draghi F, 2002, J BIOL CHEM, V277, P7509, DOI 10.1074/jbc.M109206200; Edmondson DE, 2001, ANTIOXID REDOX SIGN, V3, P789, DOI 10.1089/15230860152664984; Fuhrmann H, 2002, J VET MED B, V49, P310, DOI 10.1046/j.1439-0450.2002.00555.x; Gadda G, 1997, EUR J BIOCHEM, V250, P369, DOI 10.1111/j.1432-1033.1997.0369a.x; GIBSON QH, 1964, J BIOL CHEM, V239, P3927; Hofacker I, 1998, PROTEINS, V30, P100, DOI 10.1002/(SICI)1097-0134(199801)30:1<100::AID-PROT9>3.0.CO;2-S; Ladron N, 2003, J CLIN MICROBIOL, V41, P3241, DOI 10.1128/JCM.41.7.3241-3245.2003; Lario PI, 2003, J MOL BIOL, V326, P1635, DOI 10.1016/S0022-2836(03)00054-8; LI JY, 1993, BIOCHEMISTRY-US, V32, P11507, DOI 10.1021/bi00094a006; Lim L, 2006, BIOCHEM J, V400, P13, DOI 10.1042/BJ20060664; MACHANGU RS, 1991, CAN J VET RES, V55, P332; MacLachlan J, 2000, J STEROID BIOCHEM, V72, P169, DOI 10.1016/S0960-0760(00)00044-3; MASSEY V, 1978, BIOCHEMISTRY-US, V17, P9, DOI 10.1021/bi00594a002; Massey V, 1980, BIOCHEM SOC T, V8, P246, DOI 10.1042/bst0080246; Motteran L, 2001, J BIOL CHEM, V276, P18024, DOI 10.1074/jbc.M010953200; MULLER F, 1973, BIOCHEMISTRY-US, V12, P4654; Pei YL, 2006, VET MICROBIOL, V118, P240, DOI 10.1016/j.vetmic.2006.08.006; Pollegioni L, 1999, EUR J BIOCHEM, V264, P140, DOI 10.1046/j.1432-1327.1999.00586.x; PURCELL JP, 1993, BIOCHEM BIOPH RES CO, V196, P1406, DOI 10.1006/bbrc.1993.2409; Sambrook J., 1989, MOL CLONING LAB MANU, V1, P21, DOI DOI 10.51-10.67; Sampson NS, 2001, ANTIOXID REDOX SIGN, V3, P839, DOI 10.1089/15230860152665019; SCHOPFER LM, 1988, BIOCHEMISTRY-US, V27, P6599, DOI 10.1021/bi00417a059; Soulimane T, 2000, EMBO J, V19, P1766, DOI 10.1093/emboj/19.8.1766; STRICKLAND S, 1975, J BIOL CHEM, V250, P4048; VRIELINK A, 1991, J MOL BIOL, V219, P533, DOI 10.1016/0022-2836(91)90192-9; WHITBY LG, 1954, BIOCHIM BIOPHYS ACTA, V15, P148, DOI 10.1016/0006-3002(54)90111-0; Zhou ZM, 1996, BIOCHEMISTRY-US, V35, P15980, DOI 10.1021/bi962124n; ZHOU ZM, 1995, BIOCHEMISTRY-US, V34, P3183, DOI 10.1021/bi00010a007	32	39	39	2	10	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	SEP 5	2008	283	36					24738	24747		10.1074/jbc.M802321200	http://dx.doi.org/10.1074/jbc.M802321200			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	342YR	18614534	Green Published, hybrid			2022-12-27	WOS:000258820000042
J	Footer, MJ; Lyo, JK; Theriot, JA				Footer, Matthew J.; Lyo, John K.; Theriot, Julie A.			Close packing of Listeria monocytogenes ActA, a natively unfolded protein, enhances F-actin assembly without dimerization	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							VASODILATOR-STIMULATED PHOSPHOPROTEIN; ARP2/3 COMPLEX; N-WASP; SHIGELLA-FLEXNERI; SURFACE; MOTILITY; BINDING; NUCLEATION; DOMAIN; ACTIVATION	Studies of the biochemistry of Listeria monocytogenes virulence protein ActA have typically focused on the behavior of bacteria in complex systems or on the characterization of the protein after expression and purification. Although prior in vivo work has proposed that ActA forms dimers on the surface of L. monocytogenes, dimerization has not been demonstrated in vitro, and little consideration has been given to the surface environment where ActA performs its pivotal role in bacterial actin-based motility. We have synthesized and characterized an ActA dimer and provide evidence that the two ActA molecules do not interact with each other even when tethered together. However, we also demonstrate that artificial dimers provide superior activation of actin nucleation by the Arp2/3 complex compared with monomers and that increased activation of the Arp2/3 complex by dimers may be a general property of Arp2/3 activators. It appears that the close packing (similar to 19 nm) of ActA molecules on the surface of L. monocytogenes is so dense that the kinetics of actin nucleation mimic that of synthetic ActA dimers. We also present observations indicating that ActA is a natively unfolded protein, largely random coil that is responsible for many of the unique physical properties of ActA including its extended structure, aberrant mobility during SDS-PAGE, and ability to resist irreversible denaturation upon heating.	[Theriot, Julie A.] Stanford Univ, Sch Med, Dept Microbiol & Immunol, Stanford, CA 94305 USA; [Footer, Matthew J.; Lyo, John K.; Theriot, Julie A.] Stanford Univ, Sch Med, Dept Biochem, Stanford, CA 94305 USA; [Lyo, John K.] Cornell Univ, Weill Med Coll, New York, NY 10021 USA	Stanford University; Stanford University; Cornell University	Footer, MJ (corresponding author), 279 Campus Dr,B477, Stanford, CA 94305 USA.	footer@stanford.edu	Theriot, Julie/HHN-2034-2022	Footer, Matthew/0000-0002-3365-2916; Theriot, Julie/0000-0002-2334-2535	National Institutes of Health [R01-AI36929]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R37AI036929, R01AI036929] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This work was supported, in whole or in part, by National Institutes of Health Grant R01-AI36929. The costs of publication of this article were defrayed in part by the payment of page charges. This article must therefore be hereby marked "advertisement" in accordance with 18 U.S.C. Section 1734 solely to indicate this fact.	Adler A J, 1973, Methods Enzymol, V27, P675; Auerbuch V, 2003, MOL MICROBIOL, V49, P1361, DOI 10.1046/j.1365-2958.2003.03639.x; Bachmann C, 1999, J BIOL CHEM, V274, P23549, DOI 10.1074/jbc.274.33.23549; Bailly M, 2001, CURR BIOL, V11, P620, DOI 10.1016/S0960-9822(01)00152-X; BELYI YF, 1992, MED MICROBIOL IMMUN, V181, P283, DOI 10.1007/BF00198848; Bernheim-Groswasser A, 2002, NATURE, V417, P308, DOI 10.1038/417308a; BRUNDAGE RA, 1993, P NATL ACAD SCI USA, V90, P11890, DOI 10.1073/pnas.90.24.11890; Cameron LA, 1999, P NATL ACAD SCI USA, V96, P4908, DOI 10.1073/pnas.96.9.4908; Cameron LA, 2004, MOL BIOL CELL, V15, P2312, DOI 10.1091/mbc.E03-12-0913; CHAKRABORTY T, 1995, EMBO J, V14, P1314, DOI 10.1002/j.1460-2075.1995.tb07117.x; Cicchetti G, 1999, J BIOL CHEM, V274, P33616, DOI 10.1074/jbc.274.47.33616; Cohn E., 1943, PROTEINS AMINO ACIDS, P157; Correia I, 1999, J CELL BIOL, V146, P831, DOI 10.1083/jcb.146.4.831; CREIGHTON TE, 1993, PROTEINS STRUCTURES, P177; DURCHSCHLAG H, 1986, THERMODYNAMIC DATA B, P45; EDELHOCH H, 1967, BIOCHEMISTRY-US, V6, P1948, DOI 10.1021/bi00859a010; Egile C, 1999, J CELL BIOL, V146, P1319, DOI 10.1083/jcb.146.6.1319; FARBER JM, 1991, MICROBIOL REV, V55, P476, DOI 10.1128/MMBR.55.3.476-511.1991; Gertler FB, 1996, CELL, V87, P227, DOI 10.1016/S0092-8674(00)81341-0; Higgs HN, 2000, J CELL BIOL, V150, P1311, DOI 10.1083/jcb.150.6.1311; Higgs HN, 1999, BIOCHEMISTRY-US, V38, P15212, DOI 10.1021/bi991843+; Hufner K, 2001, J BIOL CHEM, V276, P35761, DOI 10.1074/jbc.M106520200; KOCKS C, 1993, J CELL SCI, V105, P699; KOCKS C, 1992, CELL, V68, P521, DOI 10.1016/0092-8674(92)90188-I; KOCKS C, 1995, MOL MICROBIOL, V18, P413, DOI 10.1111/j.1365-2958.1995.mmi_18030413.x; LAEMMLI UK, 1970, NATURE, V227, P680, DOI 10.1038/227680a0; Laue T.M., 1992, ANAL ULTRACENTRIFUGA, P90; Lauer P, 2001, MOL MICROBIOL, V42, P1163, DOI 10.1046/j.1365-2958.2001.02677.x; Lecuit M, 2001, SCIENCE, V292, P1722, DOI 10.1126/science.1059852; Lide D. R., 2008, CRC HDB CHEM PHYS, P4; Lo Conte L, 1999, J MOL BIOL, V285, P2177; Loessner MJ, 1996, APPL ENVIRON MICROB, V62, P3057, DOI 10.1128/AEM.62.8.3057-3060.1996; Machner MP, 2001, J BIOL CHEM, V276, P40096, DOI 10.1074/jbc.M104279200; MAKAROV AA, 1994, BIOPOLYMERS, V34, P1123, DOI 10.1002/bip.360340816; Marienfeld S, 1997, ANTON LEEUW INT J G, V72, P291, DOI 10.1023/A:1000578811089; Matias VRF, 2006, J BACTERIOL, V188, P1011, DOI 10.1128/JB.188.3.1011-1021.2006; Matias VRF, 2005, MOL MICROBIOL, V56, P240, DOI 10.1111/j.1365-2958.2005.04535.x; Mendelson R, 1997, P NATL ACAD SCI USA, V94, P8533, DOI 10.1073/pnas.94.16.8533; Miki H, 1996, EMBO J, V15, P5326, DOI 10.1002/j.1460-2075.1996.tb00917.x; Mourrain P, 1997, P NATL ACAD SCI USA, V94, P10034, DOI 10.1073/pnas.94.19.10034; Murray CL, 2008, J VIROL, V82, P1294, DOI 10.1128/JVI.01815-07; Nielsen MM, 2007, BIOPHYS J, V92, P3674, DOI 10.1529/biophysj.106.101238; Nooren IMA, 2003, J MOL BIOL, V325, P991, DOI 10.1016/S0022-2836(02)01281-0; Obradovic Z, 2005, PROTEINS, V61, P176, DOI 10.1002/prot.20735; PARKER W, 1992, BIOPHYS J, V61, P1435, DOI 10.1016/S0006-3495(92)81949-5; Pentecost M, 2006, PLOS PATHOG, V2, P29, DOI 10.1371/journal.ppat.0020003; PISTOR S, 1994, EMBO J, V13, P758, DOI 10.1002/j.1460-2075.1994.tb06318.x; PISTOR S, 1995, CURR BIOL, V5, P517, DOI 10.1016/S0960-9822(95)00104-7; Pistor S, 2000, J CELL SCI, V113, P3277; Portnoy DA, 2002, J CELL BIOL, V158, P409, DOI 10.1083/jcb.200205009; RADIVOJAC P, 2008, PAC S BIOCOMPUT, V8, P216; Rafelski SM, 2006, MOL MICROBIOL, V59, P1262, DOI 10.1111/j.1365-2958.2006.05025.x; Rafelski SM, 2005, BIOPHYS J, V89, P2146, DOI 10.1529/biophysj.105.061168; REYNOLDS JA, 1970, P NATL ACAD SCI USA, V66, P1002, DOI 10.1073/pnas.66.3.1002; Robinson RC, 2001, SCIENCE, V294, P1679, DOI 10.1126/science.1066333; Romero P, 2001, PROTEINS, V42, P38, DOI 10.1002/1097-0134(20010101)42:1<38::AID-PROT50>3.0.CO;2-3; ROMERO P, 1997, P IEEE INT C NEUR NE; Rucker AL, 2002, PROTEIN SCI, V11, P980, DOI 10.1110/ps.4550102; Ruzza P, 2004, J PEPT SCI, V10, P423, DOI 10.1002/psc.558; Samarin S, 2003, J CELL BIOL, V163, P131, DOI 10.1083/jcb.200303191; SCHUTT CE, 1993, NATURE, V365, P810, DOI 10.1038/365810a0; Shetron-Rama LM, 2002, INFECT IMMUN, V70, P1087, DOI 10.1128/IAI.70.3.1087-1096.2002; Skoble J, 2000, J CELL BIOL, V150, P527, DOI 10.1083/jcb.150.3.527; SMITH GA, 1995, MOL MICROBIOL, V17, P945, DOI 10.1111/j.1365-2958.1995.mmi_17050945.x; Smith GA, 1996, J CELL BIOL, V135, P647, DOI 10.1083/jcb.135.3.647; SPUDICH JA, 1971, J BIOL CHEM, V246, P4866; Steffen P, 2000, CELL MOTIL CYTOSKEL, V45, P58; Tarini M, 2006, IEEE T VIS COMPUT GR, V12, P1237, DOI 10.1109/TVCG.2006.115; Theriot JA, 1998, METHOD ENZYMOL, V298, P114, DOI 10.1016/S0076-6879(98)98013-2; TIFFANY ML, 1973, BIOPOLYMERS, V12, P575, DOI 10.1002/bip.1973.360120310; TILNEY LG, 1989, J CELL BIOL, V109, P1597, DOI 10.1083/jcb.109.4.1597; Upadhyaya A, 2003, P NATL ACAD SCI USA, V100, P4521, DOI 10.1073/pnas.0837027100; Volkman BF, 2002, CELL, V111, P565, DOI 10.1016/S0092-8674(02)01076-0; Welch MD, 1997, NATURE, V385, P265, DOI 10.1038/385265a0; Welch MD, 1998, SCIENCE, V281, P105, DOI 10.1126/science.281.5373.105; Werten MWT, 2001, PROTEIN ENG, V14, P447, DOI 10.1093/protein/14.6.447; Zalevsky J, 2001, J BIOL CHEM, V276, P3468, DOI 10.1074/jbc.M006407200	77	25	25	0	5	ELSEVIER	AMSTERDAM	RADARWEG 29, 1043 NX AMSTERDAM, NETHERLANDS		1083-351X		J BIOL CHEM	J. Biol. Chem.	AUG 29	2008	283	35					23852	23862		10.1074/jbc.M803448200	http://dx.doi.org/10.1074/jbc.M803448200			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	340II	18577520	Green Published, hybrid			2022-12-27	WOS:000258638900040
J	Neidt, EM; Skau, CT; Kovar, DR				Neidt, Erin M.; Skau, Colleen T.; Kovar, David R.			The cytokinesis formins from the nematode worm and fission yeast differentially mediate actin filament assembly	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							SCHIZOSACCHAROMYCES-POMBE; CELL-DIVISION; CONTRACTILE RING; CAPPING PROTEIN; HOMOLOGY-2 DOMAIN; C-ELEGANS; BUNDLING ACTIVITY; ARP2/3 COMPLEX; ADP-ACTIN; PROFILIN	Formins drive actin filament assembly for diverse cellular processes including motility, establishing polarity, and cell division. To investigate the mechanism of contractile ring assembly in animal cells, we directly compared the actin assembly properties of formins required for cytokinesis in the nematode worm early embryo (CYK-1) and fission yeast (Cdc12p). Like Cdc12p and most other formins, CYK-1 nucleates actin filament assembly and remains processively associated with the elongating barbed end while facilitating the addition of profilin-actin above the theoretical diffusion-limited rate. However, specific properties differ significantly between Cdc12p and CYK-1. Cdc12p efficiently nucleates filaments that in the presence of profilin elongate at approximately the same rate as control filaments without formin (similar to 10.0 subunits/s). CYK-1 is an inefficient nucleator but allows filaments to elongate profilin-actin 6-fold faster than Cdc12p (similar to 60 subunits/s). Both Cdc12p and CYK-1 bind to pre-assembled actin filaments with low nanomolar affinity, but CYK-1 dissociates 2 orders of magnitude more quickly. However, CYK-1 rapidly re-associates with free barbed ends. Cdc12p allows barbed ends to elongate in the presence of excess capping protein, whereas capping protein inhibits CYK-1-mediated actin assembly. Therefore, these evolutionarily diverse formins can drive contractile ring assembly by a generally similar mechanism, but cells with unique dimensions and physical parameters might require proteins with carefully tuned actin assembly properties.	[Neidt, Erin M.; Skau, Colleen T.; Kovar, David R.] Univ Chicago, Dept Mol Genet & Cell Biol, Chicago, IL 60637 USA; [Kovar, David R.] Univ Chicago, Dept Biochem & Mol Biol, Chicago, IL 60637 USA	University of Chicago; University of Chicago	Kovar, DR (corresponding author), 920 E 58th St,Suite 915 E, Chicago, IL 60637 USA.	drkovar@uchicago.edu			National Institutes of Health [GM-079265]; Edward Mallinckrodt, Jr. Foundation; Cancer Research Foundation; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM079265] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Edward Mallinckrodt, Jr. Foundation; Cancer Research Foundation; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported, in whole or in part, by National Institutes of Health Grant GM-079265. This work was also supported by an Edward Mallinckrodt, Jr. Foundation grant and a Cancer Research Foundation grant (to D.R.K.). The costs of publication of this article were defrayed in part by the payment of page charges. This article must therefore be hereby marked "advertisement" in accordance with 18 U.S.C. Section 1734 solely to indicate this fact.	Andrianantoandro E, 2001, J MOL BIOL, V312, P721, DOI 10.1006/jmbi.2001.5005; Bahler J, 1998, J CELL BIOL, V143, P1603, DOI 10.1083/jcb.143.6.1603; Balasubramanian MK, 2004, CURR BIOL, V14, pR806, DOI 10.1016/j.cub.2004.09.022; BALASUBRAMANIAN MK, 1994, J CELL BIOL, V125, P1289, DOI 10.1083/jcb.125.6.1289; Balasubramanian MK, 1998, GENETICS, V149, P1265; Blanchoin L, 2000, NATURE, V404, P1007, DOI 10.1038/35010008; Bringmann H, 2005, NATURE, V436, P731, DOI 10.1038/nature03823; Chang F, 1996, J CELL SCI, V109, P131; Chang F, 1999, CURR BIOL, V9, P849, DOI 10.1016/S0960-9822(99)80372-8; Chang F, 1997, J CELL BIOL, V137, P169, DOI 10.1083/jcb.137.1.169; COOPER JA, 1983, J MUSCLE RES CELL M, V4, P253, DOI 10.1007/BF00712034; Dechant R, 2003, DEV CELL, V4, P333, DOI 10.1016/S1534-5807(03)00057-1; Faix J, 2006, DEV CELL, V10, P693, DOI 10.1016/j.devcel.2006.05.001; Feierbach B, 2001, CURR BIOL, V11, P1656, DOI 10.1016/S0960-9822(01)00525-5; Glotzer M, 2005, SCIENCE, V307, P1735, DOI 10.1126/science.1096896; Harris ES, 2006, J BIOL CHEM, V281, P14383, DOI 10.1074/jbc.M510923200; Harris ES, 2004, J BIOL CHEM, V279, P20076, DOI 10.1074/jbc.M312718200; Higgs HN, 2005, MOL BIOL CELL, V16, P1, DOI 10.1091/mbc.E04-07-0565; Higgs HN, 2005, TRENDS BIOCHEM SCI, V30, P342, DOI 10.1016/j.tibs.2005.04.014; HOUK TW, 1974, ANAL BIOCHEM, V62, P66, DOI 10.1016/0003-2697(74)90367-4; Kitayama C, 1997, J CELL BIOL, V137, P1309, DOI 10.1083/jcb.137.6.1309; Kovar DR, 2003, J CELL BIOL, V161, P875, DOI 10.1083/jcb.200211078; Kovar DR, 2006, CURR OPIN CELL BIOL, V18, P11, DOI 10.1016/J.CEB.2005.12.011; Kovar DR, 2006, CELL, V124, P423, DOI 10.1016/j.cell.2005.11.038; Kovar DR, 2005, MOL BIOL CELL, V16, P2313, DOI 10.1091/mbc.E04-09-0781; Kovar DR, 2004, P NATL ACAD SCI USA, V101, P14725, DOI 10.1073/pnas.0405902101; Kuhn JR, 2005, BIOPHYS J, V88, P1387, DOI 10.1529/biophysj.104.047399; Lord M, 2004, J CELL BIOL, V167, P315, DOI 10.1083/jcb.200404045; Lu J, 2001, MOL BIOL CELL, V12, P1161, DOI 10.1091/mbc.12.4.1161; May KM, 1997, CELL MOTIL CYTOSKEL, V38, P385, DOI 10.1002/(SICI)1097-0169(1997)38:4<385::AID-CM8>3.0.CO;2-2; McCollum D, 1996, EMBO J, V15, P6438, DOI 10.1002/j.1460-2075.1996.tb01035.x; Michelot A, 2005, PLANT CELL, V17, P2296, DOI 10.1105/tpc.105.030908; Michelot A, 2006, CURR BIOL, V16, P1924, DOI 10.1016/j.cub.2006.07.054; Morrell JL, 1999, MOL BIOL CELL, V10, P4201, DOI 10.1091/mbc.10.12.4201; Moseley JB, 2005, J BIOL CHEM, V280, P28023, DOI 10.1074/jbc.M503094200; Moseley JB, 2004, MOL BIOL CELL, V15, P896, DOI 10.1091/mbc.E03-08-0621; Munro E, 2004, DEV CELL, V7, P413, DOI 10.1016/j.devcel.2004.08.001; Oegema Karen, 2006, WormBook, P1, DOI 10.1895/wormbook.1.72.1; Otomo T, 2005, NATURE, V433, P488, DOI 10.1038/nature03251; Palmgren S, 2001, J CELL BIOL, V155, P251, DOI 10.1083/jcb.200106157; Paoletti A, 2000, MOL BIOL CELL, V11, P2757, DOI 10.1091/mbc.11.8.2757; Paul A, 2008, CURR BIOL, V18, P9, DOI 10.1016/j.cub.2007.11.062; Petersen J, 1998, J CELL BIOL, V141, P1217, DOI 10.1083/jcb.141.5.1217; Polet D, 2006, CELL MOTIL CYTOSKEL, V63, P14, DOI 10.1002/cm.20102; Romero S, 2004, CELL, V119, P419, DOI 10.1016/j.cell.2004.09.039; Sagot I, 2002, NAT CELL BIOL, V4, P626, DOI 10.1038/ncb834; Severson AF, 2002, CURR BIOL, V12, P2066, DOI 10.1016/S0960-9822(02)01355-6; Sohrmann M, 1996, GENE DEV, V10, P2707, DOI 10.1101/gad.10.21.2707; SPUDICH JA, 1971, J BIOL CHEM, V246, P4866; Svitkina TM, 2003, J CELL BIOL, V160, P409, DOI 10.1083/jcb.200210174; Swan KA, 1998, J CELL SCI, V111, P2017; Takaine M, 2007, J BIOL CHEM, V282, P21683, DOI 10.1074/jbc.M611371200; Vavylonis D, 2006, MOL CELL, V21, P455, DOI 10.1016/j.molcel.2006.01.016; Vavylonis D, 2008, SCIENCE, V319, P97, DOI 10.1126/science.1151086; Wallar BJ, 2003, TRENDS CELL BIOL, V13, P435, DOI 10.1016/S0962-8924(03)00153-3; Werner M, 2007, CURR BIOL, V17, P1286, DOI 10.1016/j.cub.2007.06.070; Wu JQ, 2006, J CELL BIOL, V174, P391, DOI 10.1083/jcb.200602032; Wu JQ, 2003, DEV CELL, V5, P723, DOI 10.1016/S1534-5807(03)00324-1; Xu YW, 2004, CELL, V116, P711, DOI 10.1016/S0092-8674(04)00210-7; Yonetani A, 2008, MOL BIOL CELL, V19, P2208, DOI 10.1091/mbc.E07-07-0731; Zigmond SH, 2003, CURR BIOL, V13, P1820, DOI 10.1016/j.cub.2003.09.057	61	50	50	0	2	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	AUG 29	2008	283	35					23872	23883		10.1074/jbc.M803734200	http://dx.doi.org/10.1074/jbc.M803734200			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	340II	18577519	hybrid, Green Published			2022-12-27	WOS:000258638900042
J	Balogi, Z; Cheregi, O; Giese, KC; Juhasz, K; Vierling, E; Vass, I; Vigh, L; Horvath, I				Balogi, Zsolt; Cheregi, Ottilia; Giese, Kim C.; Juhasz, Kata; Vierling, Elizabeth; Vass, Imre; Vigh, Laszlo; Horvath, Ibolya			A mutant small heat shock protein with increased thylakoid association provides an elevated resistance against UV-B damage in Synechocystis 6803	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							PHOTOSYSTEM-II; IN-VIVO; ALPHA-CRYSTALLIN; D1 PROTEIN; MEMBRANE; LIPIDS; CYANOBACTERIUM; EXPRESSION; REPAIR; SITE	Besides acting as molecular chaperones, the amphitropic small heat shock proteins (sHsps) are suggested to play an additional role in membrane quality control. We investigated sHsp membrane function in the model cyanobacterium Synechocystis sp. PPC 6803 using mutants of the single sHsp from this organism, Hsp17. We examined mutants in the N-terminal arm, L9P and Q16R, for altered interaction with thylakoid and lipid membranes and examined the effects of these mutations on thylakoid functions. These mutants are unusual in that they retain their oligomeric state and chaperone activity in vitro but fail to confer thermotolerance in vivo. We found that both mutant proteins had dramatically altered membrane/lipid interaction properties. Whereas L9P showed strongly reduced binding to thylakoid and model membranes, Q16R was almost exclusively membrane-associated, properties that may be the cause of reduced heat tolerance of cells carrying these mutations. Among the lipid classes tested, Q16R displayed the highest interaction with negatively charged SQDG. In Q16R cells a specific alteration of the thylakoid-embedded Photosystem II ( PSII) complex was observed. Namely, the binding of plastoquinone and quinone analogue acceptors to the Q(B) site was modified. In addition, the presence of Q16R dramatically reduced UV-B damage of PSII activity because of enhanced PSII repair. We suggest these effects occur at least partly because of increased interaction of Q16R with SQDG in the PSII complex. Our findings further support the model that membrane association is a functional property of sHsps and suggest sHsps as a possible biotechnological tool to enhance UV protection of photosynthetic organisms.	[Balogi, Zsolt; Juhasz, Kata; Vigh, Laszlo; Horvath, Ibolya] Hungarian Acad Sci, Biol Res Ctr, Inst Biochem, H-6701 Szeged, Hungary; [Cheregi, Ottilia; Vass, Imre] Hungarian Acad Sci, Biol Res Ctr, Dept Plant Biol, H-6701 Szeged, Hungary; [Giese, Kim C.; Vierling, Elizabeth] Univ Arizona, Dept Biochem & Mol Biophys, Tucson, AZ 85721 USA	Eotvos Lorand Research Network; Hungarian Academy of Sciences; Hungarian Biological Research Center; Eotvos Lorand Research Network; Hungarian Academy of Sciences; Hungarian Biological Research Center; University of Arizona	Horvath, I (corresponding author), Hungarian Acad Sci, Biol Res Ctr, Inst Biochem, POB 521, H-6701 Szeged, Hungary.	hibi@brc.hu	Multhoff, Gabriele/AAW-9796-2021; Juhasz, Kata/ABB-9246-2020; Vass, Imre/AAS-6171-2021	Multhoff, Gabriele/0000-0002-2616-3137; Vass, Imre/0000-0003-4987-7842; Vierling, Elizabeth/0000-0002-0066-4881	National Institutes of Health [1 R03 TW006154-01A1]; European Union [SOLAR-H2, 212508]; FOGARTY INTERNATIONAL CENTER [R03TW006154] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); European Union(European Commission); FOGARTY INTERNATIONAL CENTER(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Fogarty International Center (FIC))	This work was supported, in whole or in part, by National Institutes of Health Grant 1 R03 TW006154-01A1 (to E.V. and L.V.). This work was also supported by European Union Grant SOLAR-H2, 212508 (to O.C. and I.V.).	Ahn YJ, 2006, PLANT CELL ENVIRON, V29, P95, DOI 10.1111/j.1365-3040.2005.01403.x; Allahverdiyeva Y, 2004, EUR J BIOCHEM, V271, P3523, DOI 10.1111/j.0014-2956.2004.04287.x; Balogi Z, 2005, ARCH BIOCHEM BIOPHYS, V436, P346, DOI 10.1016/j.abb.2005.02.018; BARBATO R, 1992, J CELL BIOL, V119, P325, DOI 10.1083/jcb.119.2.325; Basha E, 2004, J BIOL CHEM, V279, P7566, DOI 10.1074/jbc.M310684200; BERRY J, 1980, ANNU REV PLANT PHYS, V31, P491, DOI 10.1146/annurev.pp.31.060180.002423; Cheregi O, 2007, BBA-BIOENERGETICS, V1767, P820, DOI 10.1016/j.bbabio.2006.11.016; Chowdary TK, 2007, BIOCHEM J, V401, P437, DOI 10.1042/BJ20061046; de Jong WW, 1998, INT J BIOL MACROMOL, V22, P151, DOI 10.1016/S0141-8130(98)00013-0; Giese KC, 2004, J BIOL CHEM, V279, P32674, DOI 10.1074/jbc.M404455200; Giese KC, 2005, P NATL ACAD SCI USA, V102, P18896, DOI 10.1073/pnas.0506169103; Giese KC, 2002, J BIOL CHEM, V277, P46310, DOI 10.1074/jbc.M208926200; Glatz A, 1999, PLANT PHYSIOL BIOCH, V37, P1, DOI 10.1016/S0981-9428(99)80061-8; Horvath I, 1998, P NATL ACAD SCI USA, V95, P3513, DOI 10.1073/pnas.95.7.3513; Huang LX, 2002, J BACTERIOL, V184, P6845, DOI 10.1128/JB.184.24.6845-6858.2002; JOLIOT A, 1964, CR HEBD ACAD SCI, V258, P4622; KANERVO E, 1995, FEBS LETT, V364, P239, DOI 10.1016/0014-5793(95)00404-W; Kanervo E, 1997, PLANT PHYSIOL, V114, P841, DOI 10.1104/pp.114.3.841; KOMENDA J, 1995, BIOCHEMISTRY-US, V34, P9625, DOI 10.1021/bi00029a040; Lee AG, 2005, MOL BIOSYST, V1, P203, DOI 10.1039/b504527d; Lee GJ, 2000, PLANT PHYSIOL, V122, P189, DOI 10.1104/pp.122.1.189; Lee S, 2000, CURR MICROBIOL, V40, P283, DOI 10.1007/s002849910056; Li Y, 2004, RAPID COMMUN MASS SP, V18, P135, DOI 10.1002/rcm.1288; Loll B, 2005, NATURE, V438, P1040, DOI 10.1038/nature04224; Loll B, 2007, BBA-BIOENERGETICS, V1767, P509, DOI 10.1016/j.bbabio.2006.12.009; Nakamoto H, 2000, FEBS LETT, V483, P169, DOI 10.1016/S0014-5793(00)02097-4; Nakamoto H, 2007, CELL MOL LIFE SCI, V64, P294, DOI 10.1007/s00018-006-6321-2; Rhee KH, 1997, NATURE, V389, P522, DOI 10.1038/39103; Sass L, 1997, PHOTOSYNTH RES, V54, P55, DOI 10.1023/A:1005895924892; SATOH K, 1995, PLANT CELL PHYSIOL, V36, P597; Silva P, 2003, PLANT CELL, V15, P2152, DOI 10.1105/tpc.012609; SKINNER MK, 1983, BIOCHEM J, V209, P281, DOI 10.1042/bj2090281; Stamler R, 2005, J MOL BIOL, V353, P68, DOI 10.1016/j.jmb.2005.08.025; Torok Z, 1997, P NATL ACAD SCI USA, V94, P2192, DOI 10.1073/pnas.94.6.2192; Torok Z, 2001, P NATL ACAD SCI USA, V98, P3098, DOI 10.1073/pnas.051619498; Tsvetkova NM, 2002, P NATL ACAD SCI USA, V99, P13504, DOI 10.1073/pnas.192468399; van Montfort RLM, 2001, NAT STRUCT BIOL, V8, P1025, DOI 10.1038/nsb722; Vass I, 1999, BIOCHEMISTRY-US, V38, P12786, DOI 10.1021/bi991094w; VASS I, 1996, HDB PHOTOSYNTHESIS, P931; Vass I, 2007, COMPR SER PHOTOCH, V8, P393; VIGH L, 1993, P NATL ACAD SCI USA, V90, P9090, DOI 10.1073/pnas.90.19.9090; Waters ER, 1996, J EXP BOT, V47, P325, DOI 10.1093/jxb/47.3.325	42	45	45	0	8	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	AUG 22	2008	283	34					22983	22991		10.1074/jbc.M710400200	http://dx.doi.org/10.1074/jbc.M710400200			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	337SI	18574246	hybrid, Green Published			2022-12-27	WOS:000258455400011
J	Kwon, MS; Do Lee, S; Kim, JA; Colla, E; Choi, YJ; Suh, PG; Kwon, HM				Kwon, Min Seong; Do Lee, Sang; Kim, Jeong-Ah; Colla, Emanuela; Choi, Yu Jeong; Suh, Pann-Ghil; Kwon, H. Moo			Novel nuclear localization signal regulated by ambient tonicity in vertebrates	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ENHANCER-BINDING PROTEIN; TRANSCRIPTION FACTOR TONEBP; SYSTEMIC HYPERTONICITY; DOWN-REGULATION; OSMOTIC-STRESS; EXPRESSION; KINASE; EXPORT; PHOSPHORYLATION; DIMERIZATION	TonEBP is a Rel domain-containing transcription factor implicated in adaptive immunity, viral replication, and cancer. In the mammalian kidney, TonEBP is a central regulator of water homeostasis. Animals deficient in TonEBP suffer from life-threatening dehydration due to renal water loss. Ambient tonicity (effective osmolality) is the prominent signal for TonEBP in a bidirectional manner; TonEBP activity decreases in hypotonicity, whereas it increases in hypertonicity. Here we found that TonEBP displayed nuclear export in response to hypotonicity and nuclear import in response to hypertonicity. The nuclear export of TonEBP was not mediated by the nuclear export receptor CRM1 or discrete nuclear export signal. In contrast, a dominant nuclear localization signal (NLS) was found in a small region of 16 amino acid residues. When short peptides containing the NLS were fused to constitutively cytoplasmic proteins, the fusion proteins displayed tonicity-dependent nucleocytoplasmic trafficking like TonEBP. Thus, tonicity-dependent activation of the NLS is crucial in the nucleocytoplasmic trafficking of TonEBP. The novel NLS is present only in the vertebrates, indicating that it developed late in evolution.	[Kwon, Min Seong; Do Lee, Sang; Kim, Jeong-Ah; Colla, Emanuela; Kwon, H. Moo] Univ Maryland, Dept Med, Baltimore, MD 21201 USA; [Choi, Yu Jeong; Suh, Pann-Ghil] Pohang Univ Sci & Technol, Dept Life Sci, Pohang 790784, South Korea	University System of Maryland; University of Maryland Baltimore; Pohang University of Science & Technology (POSTECH)	Kwon, HM (corresponding author), 22 S Greene St,Suite N3W143, Baltimore, MD 21201 USA.	mkwon@medicine.umaryland.edu	Suh, Pann-Ghill/F-3610-2010; Lee-Kwon, Whaseon/D-6021-2011; Colla, Emanuela/H-2483-2013	Colla, Emanuela/0000-0002-4755-7450	NIDDK NIH HHS [DK61677] Funding Source: Medline; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK061677] Funding Source: NIH RePORTER	NIDDK NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))		Beals CR, 1997, GENE DEV, V11, P824, DOI 10.1101/gad.11.7.824; BEG AA, 1993, GENE DEV, V7, P2064, DOI 10.1101/gad.7.11.2064; Cha JH, 2001, J AM SOC NEPHROL, V12, P2221, DOI 10.1681/ASN.V12112221; Dahl SC, 2001, AM J PHYSIOL-CELL PH, V280, pC248, DOI 10.1152/ajpcell.2001.280.2.C248; Go WY, 2004, P NATL ACAD SCI USA, V101, P10673, DOI 10.1073/pnas.0403139101; Graef IA, 2001, P NATL ACAD SCI USA, V98, P5740, DOI 10.1073/pnas.101602398; Ha H, 2003, J BIOL CHEM, V278, P18573, DOI 10.1074/jbc.M212626200; Hasler U, 2006, J AM SOC NEPHROL, V17, P1521, DOI 10.1681/ASN.2005121317; Henderson BR, 2000, EXP CELL RES, V256, P213, DOI 10.1006/excr.2000.4825; Huxford T, 1998, CELL, V95, P759, DOI 10.1016/S0092-8674(00)81699-2; Jauliac S, 2002, NAT CELL BIOL, V4, P540, DOI 10.1038/ncb816; Jeon US, 2006, ACTA PHYSIOL, V187, P241, DOI 10.1111/j.1748-1716.2006.01551.x; Jeon US, 2007, AM J PHYSIOL-RENAL, V293, pF408, DOI 10.1152/ajprenal.00502.2006; KALDERON D, 1984, CELL, V39, P499, DOI 10.1016/0092-8674(84)90457-4; Lam AKM, 2004, J BIOL CHEM, V279, P48048, DOI 10.1074/jbc.M407224200; Lee SD, 2002, BIOCHEM BIOPH RES CO, V294, P968, DOI 10.1016/S0006-291X(02)00572-7; Lim SW, 2007, J AM SOC NEPHROL, V18, P421, DOI 10.1681/ASN.2006060664; Lopez-Rodriguez C, 2004, P NATL ACAD SCI USA, V101, P2392, DOI 10.1073/pnas.0308703100; Lopez-Rodriguez C, 2001, IMMUNITY, V15, P47, DOI 10.1016/S1074-7613(01)00165-0; Loyher ML, 2004, NEUROSCIENCE, V124, P89, DOI 10.1016/j.neuroscience.2003.10.025; Maallem S, 2006, NEUROSCIENCE, V137, P51, DOI 10.1016/j.neuroscience.2005.07.037; Maouyo D, 2002, AM J PHYSIOL-RENAL, V282, pF802, DOI 10.1152/ajprenal.00123.2001; Mattaj IW, 1998, ANNU REV BIOCHEM, V67, P265, DOI 10.1146/annurev.biochem.67.1.265; Miyakawa H, 1999, P NATL ACAD SCI USA, V96, P2538, DOI 10.1073/pnas.96.5.2538; Nakahara S, 2006, CANCER RES, V66, P9995, DOI 10.1158/0008-5472.CAN-06-1772; Nakayama Y, 2000, J BIOL CHEM, V275, P38275, DOI 10.1074/jbc.M004678200; Nakielny S, 1999, CELL, V99, P677, DOI 10.1016/S0092-8674(00)81666-9; OssarehNazari B, 1997, SCIENCE, V278, P141, DOI 10.1126/science.278.5335.141; Posas F, 1996, CELL, V86, P865, DOI 10.1016/S0092-8674(00)80162-2; Ranjbar S, 2006, PLOS PATHOG, V2, P1176, DOI 10.1371/journal.ppat.0020130; Stroud JC, 2002, NAT STRUCT BIOL, V9, P90, DOI 10.1038/nsb749; Tong EHY, 2006, J BIOL CHEM, V281, P23870, DOI 10.1074/jbc.M602556200; Woo SK, 2000, AM J PHYSIOL-RENAL, V278, pF1006; Yoshida T, 2006, J BIOL CHEM, V281, P17114, DOI 10.1074/jbc.M602112200; Zhang Z, 2005, AM J PHYSIOL-RENAL, V289, pF506, DOI 10.1152/ajprenal.00417.2004; Zhu JY, 1999, NATURE, V398, P256, DOI 10.1038/18473; Zhu JY, 1998, CELL, V93, P851, DOI 10.1016/S0092-8674(00)81445-2	37	12	12	0	2	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	AUG 15	2008	283	33					22400	22409		10.1074/jbc.M710550200	http://dx.doi.org/10.1074/jbc.M710550200			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	335VR	18579527	hybrid, Green Published			2022-12-27	WOS:000258321000008
J	Mckeown, L; Burnham, MP; Hodson, C; Jones, OT				Mckeown, Lynn; Burnham, Matthew P.; Hodson, Charlotte; Jones, Owen T.			Identification of an Evolutionarily Conserved Extracellular Threonine Residue Critical for Surface Expression and Its Potential Coupling of Adjacent Voltage-sensing and Gating Domains in Voltage-gated Potassium Channels	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							SHAKER K+ CHANNEL; ION-CHANNEL; MOLECULAR RELATIONSHIPS; ENDOPLASMIC-RETICULUM; SLOW INACTIVATION; MEMBRANE-PROTEINS; CRYSTAL-STRUCTURE; MAMMALIAN BRAIN; HEK-293 CELLS; ER EXPORT	The dynamic expression of voltage-gated potassium channels (Kvs) at the cell surface is a fundamental factor controlling membrane excitability. In exploring possible mechanisms controlling Kv surface expression, we identified a region in the extracellular linker between the first and second of the six (S1-S6) transmembrane-spanning domains of the Kv1.4 channel, which we hypothesized to be critical for its biogenesis. Using immunofluorescence microscopy, flow cytometry, patch clamp electrophysiology, and mutagenesis, we identified a single threonine residue at position 330 within the Kv1.4 S1-S2 linker that is absolutely required for cell surface expression. Mutation of Thr-330 to an alanine, aspartate, or lysine prevented surface expression. However, surface expression occurred upon co-expression of mutant and wild type Kv1.4 subunits or mutation of Thr-330 to a serine. Mutation of the corresponding residue (Thr-211) in Kv3.1 to alanine also caused intracellular retention, suggesting that the conserved threonine plays a generalized role in surface expression. In support of this idea, sequence comparisons showed conservation of the critical threonine in all Kv families and in organisms across the evolutionary spectrum. Based upon the Kv1.2 crystal structure, further mutagenesis, and the partial restoration of surface expression in an electrostatic T330K bridging mutant, we suggest that Thr-330 hydrogen bonds to equally conserved outer pore residues, which may include a glutamate at position 502 that is also critical for surface expression. We propose that Thr-330 serves to interlock the voltage-sensing and gating domains of adjacent monomers, thereby yielding a structure competent for the surface expression of functional tetramers.	[Mckeown, Lynn; Burnham, Matthew P.; Hodson, Charlotte; Jones, Owen T.] Univ Manchester, Fac Life Sci, Manchester M13 9PN, Lancs, England	University of Manchester	Jones, OT (corresponding author), Univ Manchester, Fac Life Sci, 2-25 CTF Bldg,46 Grafton St, Manchester M13 9PN, Lancs, England.	owen.t.jones@manchester.ac.uk	McKeown, Lynn/AAC-6037-2020	McKeown, Lynn/0000-0003-2326-7595; Burnham, Matthew/0000-0001-9136-937X				ARMSTRONG CM, 1977, J GEN PHYSIOL, V70, P567, DOI 10.1085/jgp.70.5.567; Brooks NL, 2006, FEBS J, V273, P3287, DOI 10.1111/j.1742-4658.2006.05339.x; Burke NA, 1999, J GEN PHYSIOL, V113, P71, DOI 10.1085/jgp.113.1.71; CRITZ SD, 1993, J NEUROCHEM, V60, P1175, DOI 10.1111/j.1471-4159.1993.tb03273.x; Delisle BP, 2004, CIRC RES, V94, P1418, DOI 10.1161/01.RES.0000128561.28701.ea; Deutsch C, 2003, NEURON, V40, P265, DOI 10.1016/S0896-6273(03)00506-3; Eduljee C, 2007, AM J PHYSIOL-CELL PH, V292, pC1041, DOI 10.1152/ajpcell.00274.2006; Goder V, 2000, EMBO J, V19, P6704, DOI 10.1093/emboj/19.24.6704; Granseth E, 2005, J MOL BIOL, V346, P377, DOI 10.1016/j.jmb.2004.11.036; Gutman GA, 2005, PHARMACOL REV, V57, P473, DOI 10.1124/pr.57.4.10; Hong KH, 2000, J GEN PHYSIOL, V115, P51, DOI 10.1085/jgp.115.1.51; HOSHI T, 1990, SCIENCE, V250, P533, DOI 10.1126/science.2122519; HOSHI T, 1991, NEURON, V7, P547, DOI 10.1016/0896-6273(91)90367-9; Jones HM, 2005, J BIOL CHEM, V280, P37257, DOI 10.1074/jbc.M508601200; Jones VC, 2008, BMC NEUROSCI, V9, DOI 10.1186/1471-2202-9-10; Jugloff DGM, 2000, J BIOL CHEM, V275, P1357, DOI 10.1074/jbc.275.2.1357; Kreusch A, 1998, NATURE, V392, P945, DOI 10.1038/31978; Kupper J, 1998, EUR J NEUROSCI, V10, P3908; Lai HC, 2006, NAT REV NEUROSCI, V7, P548, DOI 10.1038/nrn1938; Larsson HP, 2000, NEURON, V27, P573, DOI 10.1016/S0896-6273(00)00067-2; Li DQ, 2000, J BIOL CHEM, V275, P11597, DOI 10.1074/jbc.275.16.11597; Li-Smerin YY, 2000, J GEN PHYSIOL, V115, P33, DOI 10.1085/jgp.115.1.33; Long SB, 2005, SCIENCE, V309, P897, DOI 10.1126/science.1116269; Long SB, 2005, SCIENCE, V309, P903, DOI 10.1126/science.1116270; Long SB, 2007, NATURE, V450, P376, DOI 10.1038/nature06265; Ma DK, 2001, SCIENCE, V291, P316, DOI 10.1126/science.291.5502.316; Manganas LN, 2001, P NATL ACAD SCI USA, V98, P14055, DOI 10.1073/pnas.241403898; Manganas LN, 2001, J BIOL CHEM, V276, P49427, DOI 10.1074/jbc.M109325200; Marks MS, 1996, J CELL BIOL, V135, P341, DOI 10.1083/jcb.135.2.341; McKeown L, 2006, BMC BIOTECHNOL, V6, DOI 10.1186/1472-6750-6-15; Misonou H, 2004, CRIT REV BIOCHEM MOL, V39, P125, DOI 10.1080/10409230490475417; Mohapatra DP, 2006, J NEUROSCI, V26, P685, DOI 10.1523/JNEUROSCI.4620-05.2006; Mura CV, 2004, J MEMBRANE BIOL, V201, P157, DOI 10.1007/s00232-004-0713-8; Ortega-Saenz P, 2000, J GEN PHYSIOL, V116, P181, DOI 10.1085/jgp.116.2.181; Ottschytsch N, 2002, P NATL ACAD SCI USA, V99, P7986, DOI 10.1073/pnas.122617999; Pathak MM, 2007, NEURON, V56, P124, DOI 10.1016/j.neuron.2007.09.023; PFAFFINGER PJ, 1995, J BIOL CHEM, V270, P28595, DOI 10.1074/jbc.270.48.28595; Schmidt D, 2006, NATURE, V444, P775, DOI 10.1038/nature05416; Shaw G, 2002, FASEB J, V16, P869, DOI 10.1096/fj.01-0995fje; Shi G, 1999, J MEMBRANE BIOL, V168, P265, DOI 10.1007/s002329900515; Shih TM, 1997, J CELL BIOL, V136, P1037, DOI 10.1083/jcb.136.5.1037; Stockklausner C, 2001, FEBS LETT, V493, P129, DOI 10.1016/S0014-5793(01)02286-4; STUHMER W, 1989, EMBO J, V8, P3235, DOI 10.1002/j.1460-2075.1989.tb08483.x; Tombola F, 2006, ANNU REV CELL DEV BI, V22, P23, DOI 10.1146/annurev.cellbio.21.020404.145837; Trimmer JS, 1998, METHOD ENZYMOL, V293, P32; Tu L, 2000, BIOCHEMISTRY-US, V39, P824, DOI 10.1021/bi991740r; Watanabe I, 2004, J BIOL CHEM, V279, P8879, DOI 10.1074/jbc.M309802200; Watanabe I, 2007, BRAIN RES, V1144, P1, DOI 10.1016/j.brainres.2007.01.092; Yu FH, 2005, PHARMACOL REV, V57, P387, DOI 10.1124/pr.57.4.13; Zhu J, 2003, BIOCHEM J, V375, P769, DOI 10.1042/BJ20030517; Zhu J, 2003, J BIOL CHEM, V278, P25558, DOI 10.1074/jbc.M207984200	51	10	10	0	2	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	OCT 31	2008	283	44					30421	30432		10.1074/jbc.M708921200	http://dx.doi.org/10.1074/jbc.M708921200			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	364WS	18640987	Green Published, hybrid			2022-12-27	WOS:000260366900084
J	Paumi, CM; Chuk, M; Chevelev, I; Stagljar, I; Michaelis, S				Paumi, Christian M.; Chuk, Matthew; Chevelev, Igor; Stagljar, Igor; Michaelis, Susan			Negative regulation of the yeast ABC transporter Ycf1p by phosphorylation within its N-terminal extension	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							MULTIDRUG-RESISTANCE PROTEIN-1; BINDING CASSETTE TRANSPORTER; MEMBRANE-SPANNING DOMAIN; CASEIN KINASE-II; SACCHAROMYCES-CEREVISIAE; R-DOMAIN; SUBSTRATE-SPECIFICITY; CONJUGATE PUMP; CFTR; CADMIUM	The yeast vacuolar membrane protein Ycf1p and its mammalian counterpart, MRP1, belong to the ABCC subfamily of ATP-binding cassette (ABC) transporters that rid cells of toxic endogenous and xenobiotic compounds. Like most members of the ABCC subfamily, Ycf1p contains an N-terminal extension in addition to its ABC "core" domain and transports substrates in the form of glutathione conjugates. Ycf1p is subject to complex regulation to ensure its optimal function. Previous studies showed that Ycf1p activity is stimulated by a guanine nucleotide exchange factor, Tus1p, and is positively regulated by phosphorylation in its ABC core domain at residues Ser-908 and Thr-911. Here we provide evidence that phosphorylation of Ser-251 in the Ycf1p N-terminal extension negatively regulates activity. Mutant Ycf1p- S251A exhibits increased resistance to cadmium in vivo and increased Ycf1p-dependent transport of [H-3] estradiol- beta-17-glucuronide in vitro as compared with wild-type Ycf1p. Activity is restored to the wild-type level for Ycf1-S251E. To identify kinase(s) that negatively regulate Ycf1p function, we conducted an integrated membrane yeast two-hybrid (iMYTH) screen and identified two kinase genes, CKA1 and HAL5, deletion of which increases Ycf1p function. Genetic evidence suggests that Cka1p may regulate Ycf1p function through phosphorylation of Ser 251 either directly or indirectly. Overall, this study provides compelling evidence that negative, as well as positive, regulation of Ycf1p is mediated by phosphorylation.	[Chuk, Matthew; Chevelev, Igor; Stagljar, Igor] Univ Toronto, Dept Biochem, Terrence Donnelly Ctr Cellular & Biomol Res, Toronto, ON M5S 3E1, Canada; [Chuk, Matthew; Chevelev, Igor; Stagljar, Igor] Univ Toronto, Dept Mol Genet, Toronto, ON M5S 3E1, Canada; [Paumi, Christian M.; Michaelis, Susan] Johns Hopkins Sch Med, Dept Cell Biol, Baltimore, MD 21205 USA	University of Toronto; University of Toronto; Johns Hopkins University; Johns Hopkins Medicine	Stagljar, I (corresponding author), Univ Toronto, Dept Biochem, Terrence Donnelly Ctr Cellular & Biomol Res, Toronto, ON M5S 3E1, Canada.	igor.stagljar@utoronto.ca; michaelis@jhmi.edu			National Institutes of Health [GM51508, GM077024]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM051508, F32GM077024] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported, in whole or in part, by National Institutes of Health Grant GM51508 (to S. M.) and National Institutes of Health Postdoctoral Award GM077024 (to C. P.). The costs of publication of this article were defrayed in part by the payment of page charges. This article must therefore be hereby marked "advertisement" in accordance with 18 U.S.C. Section 1734 solely to indicate this fact.	Bakos E, 2000, J CELL SCI, V113, P4451; Borst P, 2002, ANNU REV BIOCHEM, V71, P537, DOI 10.1146/annurev.biochem.71.102301.093055; Burke D., 2000, METHODS YEAST GENETI; Chappe V, 2005, EMBO J, V24, P2730, DOI 10.1038/sj.emboj.7600747; Chappe V, 2003, J PHYSIOL-LONDON, V548, P39, DOI 10.1113/jphysiol.2002.035790; Chaudhuri B, 1997, GENETICS, V145, P75; CHENG SH, 1991, CELL, V66, P1027, DOI 10.1016/0092-8674(91)90446-6; CHENWU JLP, 1988, MOL CELL BIOL, V8, P4981, DOI 10.1128/MCB.8.11.4981; Chi A, 2007, P NATL ACAD SCI USA, V104, P2193, DOI 10.1073/pnas.0607084104; COLE SPC, 1992, SCIENCE, V258, P1650, DOI 10.1126/science.1360704; Cole SPC, 2006, TRENDS PHARMACOL SCI, V27, P438, DOI 10.1016/j.tips.2006.06.008; Csanady L, 2005, J GEN PHYSIOL, V125, P171, DOI 10.1085/jgp.200409076; Dean M, 2005, METHOD ENZYMOL, V400, P409, DOI 10.1016/S0076-6879(05)00024-8; Eraso P, 2004, FEBS LETT, V577, P322, DOI 10.1016/j.febslet.2004.10.030; Fernandez SBM, 2002, J BIOL CHEM, V277, P31048, DOI 10.1074/jbc.M204267200; Ghosh M, 1999, P NATL ACAD SCI USA, V96, P5001, DOI 10.1073/pnas.96.9.5001; Glover CVC, 1998, PROG NUCLEIC ACID RE, V59, P95; Gottesman MM, 2001, J BIOENERG BIOMEMBR, V33, P453, DOI 10.1023/A:1012866803188; Gueldry O, 2003, EUR J BIOCHEM, V270, P2486, DOI 10.1046/j.1432-1033.2003.03620.x; Haimeur A, 2004, CURR DRUG METAB, V5, P21, DOI 10.2174/1389200043489199; Higgins CF, 2001, RES MICROBIOL, V152, P205, DOI 10.1016/S0923-2508(01)01193-7; Howell LD, 2004, BIOCHEM J, V378, P151, DOI 10.1042/BJ20021428; IYER K, 2005, SCI STKE, P13; Jungwirth H, 2006, FEBS LETT, V580, P1131, DOI 10.1016/j.febslet.2005.12.050; Karwatsky J. M., 2004, Current Medicinal Chemistry - Anti-Cancer Agents, V4, P19, DOI 10.2174/1568011043482133; Kelm KB, 2004, TRAFFIC, V5, P165, DOI 10.1111/j.1600-0854.2004.00168.x; King SA, 2000, BIOCHEMISTRY-US, V39, P9868, DOI 10.1021/bi992807d; Li X, 2007, J PROTEOME RES, V6, P1190, DOI 10.1021/pr060559j; Li ZS, 1996, J BIOL CHEM, V271, P6509, DOI 10.1074/jbc.271.11.6509; Li ZS, 1997, P NATL ACAD SCI USA, V94, P42, DOI 10.1073/pnas.94.1.42; Mason DL, 2002, MOL BIOL CELL, V13, P4443, DOI 10.1091/mbc.E02-07-0405; Mason DL, 2003, EUKARYOT CELL, V2, P588, DOI 10.1128/EC.2.3.588-598.2003; Mulet JM, 2004, YEAST, V21, P569, DOI 10.1002/yea.1126; Mulet JM, 1999, MOL CELL BIOL, V19, P3328; Obenauer JC, 2003, NUCLEIC ACIDS RES, V31, P3635, DOI 10.1093/nar/gkg584; Obenauer John C, 2004, Methods Mol Biol, V261, P445; Pascolo L, 2001, BIOCHEM BIOPH RES CO, V282, P60, DOI 10.1006/bbrc.2001.4318; Paumi CM, 2007, MOL CELL, V26, P15, DOI 10.1016/j.molcel.2007.03.011; Pfendner EG, 2007, J MED GENET, V44, P621, DOI 10.1136/jmg.2007.051094; Qian YM, 2002, J BIOL CHEM, V277, P35225, DOI 10.1074/jbc.M206058200; Ren XQ, 2006, J BIOCHEM, V140, P313, DOI 10.1093/jb/mvj155; Ren XQ, 2001, J BIOL CHEM, V276, P23197, DOI 10.1074/jbc.M101554200; ROBERTS CJ, 1991, METHOD ENZYMOL, V194, P644; Sharma KG, 2002, EUKARYOT CELL, V1, P391, DOI 10.1128/EC.1.3.391-400.2002; Smolka MB, 2007, P NATL ACAD SCI USA, V104, P10364, DOI 10.1073/pnas.0701622104; Song WY, 2003, NAT BIOTECHNOL, V21, P914, DOI 10.1038/nbt850; Stagljar I, 2002, TRENDS BIOCHEM SCI, V27, P559, DOI 10.1016/S0968-0004(02)02197-7; SZCZYPKA MS, 1994, J BIOL CHEM, V269, P22853; Taglicht D, 1998, METHOD ENZYMOL, V292, P130; Tommasini R, 1996, P NATL ACAD SCI USA, V93, P6743, DOI 10.1073/pnas.93.13.6743; WEMMIE JA, 1994, J BIOL CHEM, V269, P32592; Wemmie JA, 1997, MOL MICROBIOL, V25, P683, DOI 10.1046/j.1365-2958.1997.5061868.x; Westlake CJ, 2005, MOL BIOL CELL, V16, P2483, DOI 10.1091/mbc.E04-12-1113; Westlake CJ, 2003, BIOCHEMISTRY-US, V42, P14099, DOI 10.1021/bi035333y; Xue Y, 2005, NUCLEIC ACIDS RES, V33, pW184, DOI 10.1093/nar/gki393; Yang YY, 2007, J BIOL CHEM, V282, P8821, DOI 10.1074/jbc.M700152200; Zhou FF, 2004, BIOCHEM BIOPH RES CO, V325, P1443, DOI 10.1016/j.bbrc.2004.11.001	57	40	40	0	4	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	OCT 3	2008	283	40					27079	27088		10.1074/jbc.M802569200	http://dx.doi.org/10.1074/jbc.M802569200			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	353RT	18667437	Green Published, hybrid			2022-12-27	WOS:000259586600029
J	Fenouillet, E; Lavillette, D; Loureiro, S; Krashias, G; Maurin, G; Cosset, FL; Jones, IM; Barbouche, R				Fenouillet, Emmanuel; Lavillette, Dimitri; Loureiro, Silvia; Krashias, George; Maurin, Guillemette; Cosset, Francois-Loic; Jones, Ian M.; Barbouche, Rym			Contribution of redox status to hepatitis C virus E2 envelope protein function and antigenicity	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							B TYPE-I; CELL ENTRY; HYPERVARIABLE REGION-1; NEUTRALIZING ANTIBODIES; DISULFIDE BONDS; CD81; GLYCOPROTEIN; BINDING; RECEPTOR; ACTIVATION	Disulfide bonding contributes to the function and antigenicity of many viral envelope glycoproteins. We assessed here its significance for the hepatitis C virus E2 envelope protein and a counterpart deleted for hypervariable region-1 (HVR1). All 18 cysteine residues of the antigens were involved in disulfides. Chemical reduction of up to half of these disulfides was compatible with anti-E2 monoclonal antibody reaction, CD81 receptor binding, and viral entry, whereas complete reduction abrogated these properties. The addition of 5,5'-dithiobis-2-nitrobenzoic acid had no effect on viral entry. Thus, E2 function is only weakly dependent on its redox status, and cell entry does not require redox catalysts, in contrast to a number of enveloped viruses. Because E2 is a major neutralizing antibody target, we examined the effect of disulfide bonding on E2 antigenicity. We show that reduction of three disulfides, as well as deletion of HVR1, improved antibody binding for half of the patient sera tested, whereas it had no effect on the remainder. Small scale immunization of mice with reduced E2 antigens greatly improved serum reactivity with reduced forms of E2 when compared with immunization using native E2, whereas deletion of HVR1 only marginally affected the ability of the serum to bind the redox intermediates. Immunization with reduced E2 also showed an improved neutralizing antibody response, suggesting that potential epitopes are masked on the disulfide-bonded antigen and that mild reduction may increase the breadth of the antibody response. Although E2 function is surprisingly independent of its redox status, its disulfide bonds mask antigenic domains. E2 redox manipulation may contribute to improved vaccine design.	[Fenouillet, Emmanuel; Barbouche, Rym] Univ Aix Marseille 2, CNRS, UMR 6184, F-13015 Marseille, France; [Lavillette, Dimitri] Univ Lyon, F-69000 Lyon, France; [Lavillette, Dimitri; Maurin, Guillemette; Cosset, Francois-Loic] Univ Lyon 1, IFR128, INSERM, Ecole Normale Super Lyon,U758, F-69007 Lyon, France; [Loureiro, Silvia; Krashias, George; Jones, Ian M.] Univ Reading, Sch Biol Sci, Reading RG6 6AJ, Berks, England	Centre National de la Recherche Scientifique (CNRS); UDICE-French Research Universities; Aix-Marseille Universite; Ecole Normale Superieure de Lyon (ENS de LYON); Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universite Claude Bernard Lyon 1; University of Reading	Fenouillet, E (corresponding author), Fac Med Nord, Bd Dramard, F-13015 Marseille, France.	emmanuel.fenouillet@univmed.fr	Cosset, François-Loïc/M-5862-2019; Jones, Ian/AAF-4986-2019	Cosset, François-Loïc/0000-0001-8842-3726; Jones, Ian/0000-0002-7738-2516; Lavillette, Dimitri/0000-0002-4706-1519	Agence Nationale de Recherche sur le SIDA (ANRS) [HCV 2006-2007]; Ligue Nationale Contre le Cancer; European Union [LSHB-CT-2004-005246]; Wellcome Trust	Agence Nationale de Recherche sur le SIDA (ANRS)(ANRSFrench National Research Agency (ANR)); Ligue Nationale Contre le Cancer(Ligue nationale contre le cancer); European Union(European Commission); Wellcome Trust(Wellcome TrustEuropean Commission)	This work was supported by Agence Nationale de Recherche sur le SIDA (ANRS) Grant HCV 2006-2007 (to E. F. and R. B. (sole support), and I. M. J., and F. L. C.), a grant from the Ligue Nationale Contre le Cancer (to F. L. C.), European Union Grant LSHB-CT-2004-005246 (to F. L. C.), and funds from the Wellcome Trust (to I. M. J.). The costs of publication of this article were defrayed in part by the payment of page charges. This article must therefore be hereby marked "advertisement" in accordance with 18 U. S. C. Section 1734 solely to indicate this fact.	Barbouche R, 2005, MOL PHARMACOL, V67, P1111, DOI 10.1124/mol.104.008276; Barbouche R, 2003, J BIOL CHEM, V278, P3131, DOI 10.1074/jbc.M205467200; Barth H, 2006, J VIROL, V80, P10579, DOI 10.1128/JVI.00941-06; Bartosch B, 2006, VIROLOGY, V348, P1, DOI 10.1016/j.virol.2005.12.027; Bartosch B, 2005, J VIROL, V79, P8217, DOI 10.1128/JVI.79.13.8217-8229.2005; Benham AM, 2005, ANTIOXID REDOX SIGN, V7, P835, DOI 10.1089/ars.2005.7.835; BETZ SF, 1993, PROTEIN SCI, V2, P1551, DOI 10.1002/pro.5560021002; Chan-Fook C, 2000, VIROLOGY, V273, P60, DOI 10.1006/viro.2000.0407; Chen HY, 2007, RETROVIROLOGY, V4, DOI 10.1186/1742-4690-4-33; Diedrich G, 2006, FEBS J, V273, P3871, DOI 10.1111/j.1742-4658.2006.05379.x; Dreux M, 2006, J BIOL CHEM, V281, P18285, DOI 10.1074/jbc.M602706200; Evans MJ, 2007, NATURE, V446, P801, DOI 10.1038/nature05654; Falkowska E, 2007, J VIROL, V81, P8072, DOI 10.1128/JVI.00459-07; Fenouillet E, 2007, ANTIOXID REDOX SIGN, V9, P1009, DOI 10.1089/ars.2007.1639; Ferrari DM, 1999, BIOCHEM J, V339, P1, DOI 10.1042/0264-6021:3390001; Flint M, 2006, J VIROL, V80, P11331, DOI 10.1128/JVI.00104-06; Forns X, 2000, P NATL ACAD SCI USA, V97, P13318, DOI 10.1073/pnas.230453597; Garry RF, 2003, VIROLOGY, V307, P255, DOI 10.1016/S0042-6822(02)00065-X; Grollo L, 2006, ANTIVIR THER, V11, P1005; Hofmann WP, 2003, J INFECT DIS, V187, P982, DOI 10.1086/368221; Hogg PJ, 2003, TRENDS BIOCHEM SCI, V28, P210, DOI 10.1016/S0968-0004(03)00057-4; JENSEN PE, 1995, SEMIN IMMUNOL, V7, P345; Jessop CE, 2004, BIOCHEM SOC T, V32, P655, DOI 10.1042/BST0320655; Keck ZY, 2004, J VIROL, V78, P9224, DOI 10.1128/JVI.78.17.9224-9232.2004; Koutsoudakis G, 2007, J VIROL, V81, P588, DOI 10.1128/JVI.01534-06; Krey T, 2005, J VIROL, V79, P4191, DOI 10.1128/JVI.79.7.4191-4200.2005; Lavillette D, 2006, J BIOL CHEM, V281, P9200, DOI 10.1074/jbc.M512529200; Lavillette D, 2005, HEPATOLOGY, V41, P265, DOI 10.1002/hep.20542; Law M, 2008, NAT MED, V14, P25, DOI 10.1038/nm1698; McCaffrey K, 2007, J VIROL, V81, P9584, DOI 10.1128/JVI.02782-06; Meertens L, 2006, J VIROL, V80, P11571, DOI 10.1128/JVI.01717-06; Mondelli MU, 2001, ANTIVIR RES, V52, P153, DOI 10.1016/S0166-3542(01)00180-2; Navas S, 1998, J VIROL, V72, P1640, DOI 10.1128/JVI.72.2.1640-1646.1998; Owsianka A, 2001, J GEN VIROL, V82, P1877, DOI 10.1099/0022-1317-82-8-1877; Owsianka AM, 2008, J GEN VIROL, V89, P653, DOI 10.1099/vir.0.83386-0; Poumbourios Pantelis, 2007, Antiviral Chemistry & Chemotherapy, V18, P169; Roccasecca R, 2003, J VIROL, V77, P1856, DOI 10.1128/JVI.77.3.1856-1867.2003; Scarselli E, 2002, EMBO J, V21, P5017, DOI 10.1093/emboj/cdf529; Tani H, 2007, J VIROL, V81, P8601, DOI 10.1128/JVI.00608-07; Tscherne DM, 2006, J VIROL, V80, P1734, DOI 10.1128/JVI.80.4.1734-1741.2006; von Hahn T, 2008, J BIOL CHEM, V283, P3689, DOI 10.1074/jbc.R700024200; Wallin M, 2004, EMBO J, V23, P54, DOI 10.1038/sj.emboj.7600012; YOO BJ, 1995, J VIROL, V69, P32, DOI 10.1128/JVI.69.1.32-38.1995; Youn JW, 2005, HEPATOLOGY, V42, P1429, DOI 10.1002/hep.20934; Zeisel MB, 2007, HEPATOLOGY, V46, P1722, DOI 10.1002/hep.21994; Zhang P, 2007, P NATL ACAD SCI USA, V104, P8449, DOI 10.1073/pnas.0703039104; Zheng AH, 2007, J VIROL, V81, P12465, DOI 10.1128/JVI.01457-07	47	14	20	0	6	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	SEP 26	2008	283	39					26340	26348		10.1074/jbc.M805221200	http://dx.doi.org/10.1074/jbc.M805221200			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	350GV	18667425	Green Published, hybrid			2022-12-27	WOS:000259341600007
J	Brown, CR; Wolfe, AB; Cui, DY; Chiang, HL				Brown, C. Randell; Wolfe, Allison B.; Cui, Dongying; Chiang, Hui-Ling			The vacuolar import and degradation pathway merges with the endocytic pathway to deliver fructose-1,6-bisphosphatase to the vacuole for degradation	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							TO-GOLGI TRANSPORT; PROTEIN-TRANSPORT; BETA-COP; CATABOLITE DEGRADATION; CYTOSOLIC PROTEIN; COATED VESICLES; YEAST; COATOMER; ER; ENDOSOME	The gluconeogenic enzyme fructose-1,6-bisphosphatase (FBPase) is degraded in the vacuole when glucose is added to glucose-starved cells. Before it is delivered to the vacuole, however, FBPase is imported into intermediate carriers called Vid ( vacuole import and degradation) vesicles. Here, using biochemical and genetic approaches, we identified a requirement for SEC28 in FBPase degradation. SEC28 encodes the alpha-COP subunit of COPI ( coat protein complex I) coatomer proteins. When SEC28 and other coatomer genes were mutated, FBPase degradation was defective and FBPase association with Vid vesicles was impaired. Coatomer proteins were identified as components of Vid vesicles, and they formed a protein complex with a Vid vesicle-specific protein, Vid24p. Furthermore, Vid24p association with Vid vesicles was impaired when coatomer genes were mutated. Kinetic studies indicated that Sec28p traffics to multiple locations. Sec28p was in Vid vesicles, endocytic compartments, and the vacuolar membrane in various mutants that block the FBPase degradation pathway. Sec28p was also found in vesicles adjacent to the vacuolar membrane in the ret2-1 coatomer mutant. We propose that Sec28p resides in Vid vesicles, and these vesicles converge with the endocytic pathway. After fusion, Sec28p is distributed on the vacuolar membrane, where it concentrates on vesicles that pinch off from this organelle. FBPase also utilizes the endocytic pathway for transport to the vacuole, as demonstrated by its presence in endocytic compartments in the Delta vph1 mutant. Taken together, our results indicate a strong connection between the Vid trafficking pathway and the endocytic pathway.	[Brown, C. Randell; Wolfe, Allison B.; Cui, Dongying; Chiang, Hui-Ling] Penn State Univ, Coll Med, Dept Cellular & Mol Physiol, Hershey, PA 17033 USA	Pennsylvania Commonwealth System of Higher Education (PCSHE); Pennsylvania State University; Penn State Health	Chiang, HL (corresponding author), 500 Univ Dr, Hershey, PA 17033 USA.	hlchiang@psu.edu			National Institutes of Health [RO1GM59480]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM059480] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported, in whole or in part, by National Institutes of Health Grant RO1GM59480 (to H.-L.C.). The costs of publication of this article were defrayed in part by the payment of page charges. This article must therefore be hereby marked "advertisement" in accordance with 18 U.S.C. Section 1734 solely to indicate this fact.	Aniento F, 1996, J CELL BIOL, V133, P29, DOI 10.1083/jcb.133.1.29; Barlowe C, 2003, TRENDS CELL BIOL, V13, P295, DOI 10.1016/S0962-8924(03)00082-5; Bednarek SY, 1996, TRENDS CELL BIOL, V6, P468, DOI 10.1016/0962-8924(96)84943-9; Bowers K, 2005, BBA-MOL CELL RES, V1744, P438, DOI 10.1016/j.bbamcr.2005.04.004; BOWSER R, 1992, J CELL BIOL, V118, P1041, DOI 10.1083/jcb.118.5.1041; Brown CR, 2001, J BIOL CHEM, V276, P48017, DOI 10.1074/jbc.M109222200; Brown CR, 2003, J BIOL CHEM, V278, P25688, DOI 10.1074/jbc.M210549200; Brown CR, 2002, J CELL SCI, V115, P655; Brown CR, 2000, J CELL BIOL, V150, P65, DOI 10.1083/jcb.150.1.65; CHIANG HL, 1991, NATURE, V350, P313, DOI 10.1038/350313a0; Chiang MC, 1998, J CELL BIOL, V140, P1347, DOI 10.1083/jcb.140.6.1347; Daro E, 1997, J CELL BIOL, V139, P1747, DOI 10.1083/jcb.139.7.1747; DUDEN R, 1991, CELL, V64, P649, DOI 10.1016/0092-8674(91)90248-W; Duden R, 1998, EMBO J, V17, P985, DOI 10.1093/emboj/17.4.985; Eugster A, 2004, MOL BIOL CELL, V15, P1011, DOI 10.1091/mbc.E03-10-0724; Faulstich D, 1996, J CELL BIOL, V135, P53, DOI 10.1083/jcb.135.1.53; Gabriely G, 2007, MOL CELL BIOL, V27, P526, DOI 10.1128/MCB.00577-06; Gaynor EC, 1998, MOL BIOL CELL, V9, P653, DOI 10.1091/mbc.9.3.653; Gu F, 1997, J CELL BIOL, V139, P1183, DOI 10.1083/jcb.139.5.1183; Hammerle M, 1998, J BIOL CHEM, V273, P25000, DOI 10.1074/jbc.273.39.25000; Haucke V, 2003, TRENDS CELL BIOL, V13, P59, DOI 10.1016/S0962-8924(02)00011-9; Hoffman M, 1996, GENETICS, V143, P1555; HOSOBUCHI M, 1992, NATURE, V360, P603, DOI 10.1038/360603a0; Huang PH, 1997, J CELL BIOL, V136, P803, DOI 10.1083/jcb.136.4.803; Hung GC, 2004, J BIOL CHEM, V279, P49138, DOI 10.1074/jbc.M404544200; Hurley JH, 2006, ANNU REV BIOPH BIOM, V35, P277, DOI 10.1146/annurev.biophys.35.040405.102126; Kamada Y, 2003, CURR TOP MICROBIOL, V279, P73; Kimata Y, 2000, J BIOL CHEM, V275, P10655, DOI 10.1074/jbc.275.14.10655; Lee MCS, 2004, ANNU REV CELL DEV BI, V20, P87, DOI 10.1146/annurev.cellbio.20.010403.105307; Liu JJ, 2005, AUTOPHAGY, V1, P146, DOI 10.4161/auto.1.3.2036; Longtine MS, 1998, YEAST, V14, P953, DOI 10.1002/(SICI)1097-0061(199807)14:10<953::AID-YEA293>3.3.CO;2-L; ORCI L, 1994, P NATL ACAD SCI USA, V91, P11924, DOI 10.1073/pnas.91.25.11924; Owen DJ, 2004, BIOCHEM SOC T, V32, P1, DOI 10.1042/BST0320001; Owen DJ, 2004, ANNU REV CELL DEV BI, V20, P153, DOI 10.1146/annurev.cellbio.20.010403.104543; Palmer KJ, 2004, TRENDS CELL BIOL, V14, P57, DOI 10.1016/j.tcb.2003.12.001; Piguet V, 1999, CELL, V97, P63, DOI 10.1016/S0092-8674(00)80715-1; RAYMOND CK, 1992, MOL BIOL CELL, V3, P1389, DOI 10.1091/mbc.3.12.1389; Regelmann J, 2003, MOL BIOL CELL, V14, P1652, DOI 10.1091/mbc.E02-08-0456; SCHORK SM, 1994, FEBS LETT, V349, P270, DOI 10.1016/0014-5793(94)00668-7; Seeley ES, 2002, MOL BIOL CELL, V13, P782, DOI 10.1091/mbc.01-10-0512; SERAFINI T, 1991, CELL, V67, P239, DOI 10.1016/0092-8674(91)90176-Y; Shieh HL, 1998, J BIOL CHEM, V273, P3381, DOI 10.1074/jbc.273.6.3381; Shieh HL, 2001, J BIOL CHEM, V276, P10398, DOI 10.1074/jbc.M001767200; VIDA TA, 1995, J CELL BIOL, V128, P779, DOI 10.1083/jcb.128.5.779; WATERS MG, 1991, NATURE, V349, P248, DOI 10.1038/349248a0; WHITNEY JA, 1995, CELL, V83, P703; Wieland F, 1999, CURR OPIN CELL BIOL, V11, P440, DOI 10.1016/S0955-0674(99)80063-5; Yahara N, 2001, MOL BIOL CELL, V12, P221, DOI 10.1091/mbc.12.1.221; Yorimitsu T, 2005, CELL DEATH DIFFER, V12, P1542, DOI 10.1038/sj.cdd.4401765	50	34	34	0	2	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	SEP 19	2008	283	38					26116	26127		10.1074/jbc.M709922200	http://dx.doi.org/10.1074/jbc.M709922200			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	348GX	18660504	Green Published, hybrid			2022-12-27	WOS:000259200100040
J	Machesky, NJ; Zhang, G; Raghavan, B; Zimmerman, P; Kelly, SL; Merrill, AH; Waldman, WJ; Van Brocklyn, JR; Trgovcich, J				Machesky, Nicholas J.; Zhang, Guojuan; Raghavan, Bindu; Zimmerman, Pete; Kelly, Samuel L.; Merrill, Alfred H.; Waldman, W. James; Van Brocklyn, James R.; Trgovcich, Joanne			Human cytomegalovirus regulates bioactive sphingolipids	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							PROTEIN-COUPLED RECEPTORS; SIMPLEX VIRUS TYPE-1; SPHINGOSINE KINASE; ENDOTHELIAL-CELLS; MOLECULAR-CLONING; SPHINGOSINE-1-PHOSPHATE RECEPTORS; FUNCTIONAL-CHARACTERIZATION; CALCIUM MOBILIZATION; SIGNAL-TRANSDUCTION; DISTINCT PATHWAYS	Sphingolipids are present in membranes of all eukaryotic cells. Bioactive sphingolipids also function as signaling molecules that regulate cellular processes such as proliferation, migration, and apoptosis. Human cytomegalovirus ( HCMV) exploits a variety of cellular signaling pathways to promote its own replication. However, whether HCMV modulates lipid signaling pathways is an essentially unexplored area of research in virus-host cell interactions. In this study, we examined the accumulation of the bioactive sphingolipids and the enzymes responsible for the biosynthesis and degradation of these lipids. HCMV infection results in increased accumulation and activity of sphingosine kinase (SphK), the enzyme that generates sphingosine 1-phosphate (S1P) and dihydrosphingosine 1-phosphate (dhS1P). We also utilized a mass spectrometry approach to generate a sphingolipidomic profile of HCMV-infected cells. We show that HCMV infection results in increased levels of dhS1P and ceramide at 24 h, suggesting an enhancement of de novo sphingolipid synthesis. Subsequently dihydrosphingosine and dhS1P decrease at 48 h consistent with attenuation of de novo sphingolipid synthesis. Finally, we present evidence that de novo sphingolipid synthesis and sphingosine kinase activity directly impact virus gene expression and virus growth. Together, these findings demonstrate that host cell sphingolipids are dynamically regulated upon infection with a herpes virus in a manner that impacts virus replication.	[Machesky, Nicholas J.; Zhang, Guojuan; Raghavan, Bindu; Zimmerman, Pete; Waldman, W. James; Van Brocklyn, James R.; Trgovcich, Joanne] Ohio State Univ, Dept Pathol, Columbus, OH 43210 USA; [Kelly, Samuel L.; Merrill, Alfred H.] Georgia Inst Technol, Sch Biol, Atlanta, GA 30332 USA	Ohio State University; University System of Georgia; Georgia Institute of Technology	Trgovcich, J (corresponding author), 4162 Graves Hall,333 W 10th Ave, Columbus, OH 43210 USA.	Joanne.Trgovcich@osumc.edu	Van Brocklyn, Jim/A-9733-2010	Merrill, Alfred/0000-0002-6673-968X	National Institutes of Health NINDS [R01 NS41517, AI51411, GM069338]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI051411] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [U54GM069338] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS041517] Funding Source: NIH RePORTER	National Institutes of Health NINDS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	This work was supported, in whole or in part, by National Institutes of Health NINDS Grants R01 NS41517 (to J.R.V.B.), AI51411 (to J.T.), and GM069338 (LipidMAPSConsortium) ( to A. H. M.). The costs of publication of this article were defrayed in part by the payment of page charges. This article must therefore be hereby marked "advertisement" in accordance with 18 U. S. C. Section 1734 solely to indicate this fact.	Allan-Yorke J, 1998, J VIROL, V72, P2316, DOI 10.1128/JVI.72.3.2316-2322.1998; Anliker B, 2004, SEMIN CELL DEV BIOL, V15, P457, DOI 10.1016/j.semcdb.2004.05.005; Berdyshev EV, 2006, CELL SIGNAL, V18, P1779, DOI 10.1016/j.cellsig.2006.01.018; Billstrom MA, 1998, J VIROL, V72, P5535, DOI 10.1128/JVI.72.7.5535-5544.1998; Boyle KA, 1999, MOL CELL BIOL, V19, P3607; Browne EP, 2001, J VIROL, V75, P12319, DOI 10.1128/JVI.75.24.12319-12330.2001; Bu Shizhong, 2006, FASEB J, V20, P184; Choi OH, 1996, NATURE, V380, P634; Cobbs CS, 2002, CANCER RES, V62, P3347; Cuvillier O, 1996, NATURE, V381, P800, DOI 10.1038/381800a0; Cyster JG, 2005, ANNU REV IMMUNOL, V23, P127, DOI 10.1146/annurev.immunol.23.021704.115628; English D, 2000, FASEB J, V14, P2255, DOI 10.1096/fj.00-0134com; Goparaju SK, 2005, MOL CELL BIOL, V25, P4237, DOI 10.1128/MCB.25.10.4237-4249.2005; Greaves RF, 1998, J VIROL, V72, P366, DOI 10.1128/JVI.72.1.366-379.1998; Harkins L, 2002, LANCET, V360, P1557, DOI 10.1016/S0140-6736(02)11524-8; Hla T, 2003, PHARMACOL RES, V47, P401, DOI 10.1016/S1043-6618(03)00046-X; Hobson JP, 2001, SCIENCE, V291, P1800, DOI 10.1126/science.1057559; Horvath R, 2000, J CLIN VIROL, V16, P17, DOI 10.1016/S1386-6532(99)00064-5; JAULT FM, 1995, J VIROL, V69, P6697, DOI 10.1128/JVI.69.11.6697-6704.1995; Johnson RA, 2000, J VIROL, V74, P1158, DOI 10.1128/JVI.74.3.1158-1167.2000; Johnson RA, 2001, J GEN VIROL, V82, P493, DOI 10.1099/0022-1317-82-3-493; Jolly PS, 2004, J EXP MED, V199, P959, DOI 10.1084/jem.20030680; JONES NL, 1986, EUR J CELL BIOL, V41, P304; Kohama T, 1998, J BIOL CHEM, V273, P23722, DOI 10.1074/jbc.273.37.23722; Lee MJ, 1999, CELL, V99, P301, DOI 10.1016/S0092-8674(00)81661-X; Liu H, 2000, J BIOL CHEM, V275, P19513, DOI 10.1074/jbc.M002759200; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; Maceyka M, 2005, J BIOL CHEM, V280, P37118, DOI 10.1074/jbc.M502207200; Maceyka M, 2002, BBA-MOL CELL BIOL L, V1585, P193, DOI 10.1016/S1388-1981(02)00341-4; Maceyka M, 2007, METHOD ENZYMOL, V434, P243, DOI 10.1016/S0076-6879(07)34013-5; McVerry BJ, 2005, CELL SIGNAL, V17, P131, DOI 10.1016/j.cellsig.2004.08.006; Melendez A, 1998, J BIOL CHEM, V273, P9393, DOI 10.1074/jbc.273.16.9393; Merrill AH, 2005, METHODS, V36, P207, DOI 10.1016/j.ymeth.2005.01.009; Miller DM, 2000, TRANSPLANTATION, V69, P687, DOI 10.1097/00007890-200002270-00040; Miller DM, 1999, J IMMUNOL, V162, P6107; Miller DM, 1998, J EXP MED, V187, P675, DOI 10.1084/jem.187.5.675; Mocarski ES, 1996, P NATL ACAD SCI USA, V93, P11321, DOI 10.1073/pnas.93.21.11321; Monick MM, 2004, AM J RESP CELL MOL, V30, P844, DOI 10.1165/rcmb.2003-0424OC; Navarro L, 1998, MOL CELL BIOL, V18, P3796, DOI 10.1128/MCB.18.7.3796; Nokta MA, 1996, J CLIN INVEST, V97, P2635, DOI 10.1172/JCI118713; Ogawa-Goto K, 2003, J VIROL, V77, P8541, DOI 10.1128/JVI.77.15.8541-8547.2003; Okada T, 2005, J BIOL CHEM, V280, P36318, DOI 10.1074/jbc.M504507200; OLIVERA A, 1993, NATURE, V365, P557, DOI 10.1038/365557a0; Olivera A, 1999, J CELL BIOL, V147, P545, DOI 10.1083/jcb.147.3.545; Oskouian B, 2004, SEMIN CELL DEV BIOL, V15, P529, DOI 10.1016/j.semcdb.2004.05.009; Payne SG, 2004, SEMIN CELL DEV BIOL, V15, P521, DOI 10.1016/j.semcdb.2004.05.008; Pitson SM, 2000, J BIOL CHEM, V275, P33945, DOI 10.1074/jbc.M006176200; Pitson SM, 2000, BIOCHEM J, V350, P429, DOI 10.1042/0264-6021:3500429; Preston CM, 2001, J VIROL, V75, P8909, DOI 10.1128/JVI.75.19.8909-8916.2001; RADSAK K, 1984, VIROLOGY, V138, P300, DOI 10.1016/0042-6822(84)90353-2; Rodems SM, 1998, J VIROL, V72, P9173, DOI 10.1128/JVI.72.11.9173-9180.1998; Rosen H, 2005, NAT REV IMMUNOL, V5, P560, DOI 10.1038/nri1650; Samanta M, 2003, J UROLOGY, V170, P998, DOI 10.1097/01.ju.0000080263.46164.97; SEDMAK DD, 1990, TRANSPLANTATION, V49, P458, DOI 10.1097/00007890-199002000-00043; SPEIR E, 1994, SCIENCE, V265, P391, DOI 10.1126/science.8023160; Spiegel S, 2003, NAT REV MOL CELL BIO, V4, P397, DOI 10.1038/nrm1103; Spiegel S, 2003, BIOCHEM SOC T, V31, P1216; STEINHART WL, 1984, INTERVIROLOGY, V21, P70, DOI 10.1159/000149504; Stenberg RM, 1996, INTERVIROLOGY, V39, P343, DOI 10.1159/000150505; Stropes MPM, 2004, BIOCHEM CELL BIOL, V82, P636, DOI 10.1139/O04-115; Taha TA, 2004, BBA-MOL CELL BIOL L, V1682, P48, DOI 10.1016/S1388-1981(04)00023-X; Tamama K, 2001, BIOCHEM J, V353, P139, DOI 10.1042/bj3530139; Van Brocklyn JR, 2005, J NEUROPATH EXP NEUR, V64, P695, DOI 10.1097/01.jnen.0000175329.59092.2c; Van Brocklyn JR, 1998, J CELL BIOL, V142, P229, DOI 10.1083/jcb.142.1.229; Venkataraman K, 2006, BIOCHEM J, V397, P461, DOI 10.1042/BJ20060251; WALDMAN WJ, 1991, ARCH VIROL, V117, P143, DOI 10.1007/BF01310761; WALDMAN WJ, 1992, TRANSPLANTATION, V54, P887, DOI 10.1097/00007890-199211000-00024; Wang X, 2005, NAT MED, V11, P515, DOI 10.1038/nm1236; Wang X, 2003, NATURE, V424, P456, DOI 10.1038/nature01818; WENTHWOR.BB, 1970, P SOC EXP BIOL MED, V135, P253, DOI 10.3181/00379727-135-35031; Xia P, 2000, CURR BIOL, V10, P1527, DOI 10.1016/S0960-9822(00)00834-4; Young N, 2006, THESCIENTIFICWORLDJO, V6, P946, DOI 10.1100/tsw.2006.182; Zhu H, 2002, P NATL ACAD SCI USA, V99, P3932, DOI 10.1073/pnas.052713799; ZUHERINGDORF DM, 1998, EMBO J, V17, P2830	74	45	45	0	3	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	SEP 19	2008	283	38					26148	26160		10.1074/jbc.M710181200	http://dx.doi.org/10.1074/jbc.M710181200			13	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	348GX	18644793	hybrid, Green Published			2022-12-27	WOS:000259200100043
J	Song, LN; Gelmann, EP				Song, Liang-Nian; Gelmann, Edward P.			Silencing mediator for retinoid and thyroid hormone receptor and nuclear receptor corepressor attenuate transcriptional activation by the beta-catenin-TCF4 complex	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							COLON-CANCER CELLS; PLZF-RAR-ALPHA; NF-KAPPA-B; BETA-CATENIN; ANDROGEN RECEPTOR; HISTONE DEACETYLASE; GENE-EXPRESSION; REGULATED TRANSCRIPTION; COLORECTAL-CANCER; TERMINAL DOMAIN	beta-Catenin is a multifunctional mediator of cellular signaling and an oncogene. Nuclear beta-catenin, when complexed with members of the T-cell factor (TCF)/leukocyte enhancer factor family of DNA-binding proteins, mediates transcriptional activation important for embryonic development and adult cell homeostasis. Deregulation of intracellular levels of beta-catenin is an early event in the development of a variety of cancers. We observed that the proteins silencing mediator for retinoid and thyroid hormone receptor (SMRT) and the nuclear receptor corepressor (NCoR) are negative regulators of transcription induced by the beta-catenin-TCF4 complex. Overexpression of SMRT and NCoR attenuated the transcription of beta-catenin-TCF4-specific reporter gene and of CCND1, an endogenous beta-catenin target gene. Knockdown of endogenous SMRT or NCoR by short interfering RNA augmented the beta-catenin-TCF4-mediated reporter gene expression. Glutathione S-transferase pulldown experiments showed there was a direct physical association of SMRT and NCoR with both beta-catenin and TCF4. DNA-protein interaction studies revealed that the interactions between either SMRT or NCoR and beta-catenin or TCF4 occurred at the promoter regions of CCND1 and other target genes. These findings demonstrate an important role for corepressors SMRT and NCoR in the regulation of beta-catenin-TCF4-mediated gene transcription.	[Song, Liang-Nian; Gelmann, Edward P.] Columbia Univ, Med Ctr, Herbert Irving Comprehens Canc Ctr, Dept Med, New York, NY 10032 USA	Columbia University	Gelmann, EP (corresponding author), Columbia Univ, Med Ctr, Herbert Irving Comprehens Canc Ctr, Dept Med, MHB 6N-435, New York, NY 10032 USA.	gelmanne@columbia.edu			National Institutes of Health [CA96854]; NATIONAL CANCER INSTITUTE [R01CA096854] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This work was supported, in whole or in part, by National Institutes of Health Grant CA96854 from the USPHS (to E. P. G.). The costs of publication of this article were defrayed in part by the payment of page charges. This article must therefore be hereby marked "advertisement" in accordance with 18 U. S. C. Section 1734 solely to indicate this fact.	Asahara H, 1999, MOL CELL BIOL, V19, P8219; Baek SH, 2002, CELL, V110, P55, DOI 10.1016/S0092-8674(02)00809-7; Barker N, 2001, EMBO J, V20, P4935, DOI 10.1093/emboj/20.17.4935; Bienz M, 2000, CELL, V103, P311, DOI 10.1016/S0092-8674(00)00122-7; Billin AN, 2000, MOL CELL BIOL, V20, P6882, DOI 10.1128/MCB.20.18.6882-6890.2000; Brantjes H, 2001, NUCLEIC ACIDS RES, V29, P1410, DOI 10.1093/nar/29.7.1410; Chakladar A, 2005, BIOCHEM BIOPH RES CO, V336, P190, DOI 10.1016/j.bbrc.2005.08.061; Chakrabarti SR, 1999, BIOCHEM BIOPH RES CO, V264, P871, DOI 10.1006/bbrc.1999.1605; CHEN JD, 1995, NATURE, V377, P454, DOI 10.1038/377454a0; Clevers H, 1997, TRENDS GENET, V13, P485, DOI 10.1016/S0168-9525(97)01305-X; Clevers H, 2006, CELL, V127, P469, DOI 10.1016/j.cell.2006.10.018; Eger A, 2004, ONCOGENE, V23, P2672, DOI 10.1038/sj.onc.1207416; Essers MAG, 2005, SCIENCE, V308, P1181, DOI 10.1126/science.1109083; EVANS RM, 1988, SCIENCE, V240, P889, DOI 10.1126/science.3283939; Fernandez-Majada V, 2007, P NATL ACAD SCI USA, V104, P276, DOI 10.1073/pnas.0606476104; Fernandez-Majada V, 2007, CELL CYCLE, V6, P1748, DOI 10.4161/cc.6.14.4429; Guenther MG, 2000, GENE DEV, V14, P1048; Guenther MG, 2001, MOL CELL BIOL, V21, P6091, DOI 10.1128/MCB.21.18.6091-6101.2001; Guidez F, 2000, BLOOD, V96, P2557; He LZ, 1998, NAT GENET, V18, P126, DOI 10.1038/ng0298-126; Hecht A, 2000, EMBO J, V19, P1839, DOI 10.1093/emboj/19.8.1839; Hecht A, 1999, J BIOL CHEM, V274, P18017, DOI 10.1074/jbc.274.25.18017; Heinzel T, 1997, NATURE, V387, P43, DOI 10.1038/387043a0; Hodgson MC, 2005, J BIOL CHEM, V280, P6511, DOI 10.1074/jbc.M408972200; Hoffmans R, 2005, CURR BIOL, V15, P1207, DOI 10.1016/j.cub.2005.05.054; Hong SH, 1997, P NATL ACAD SCI USA, V94, P9028, DOI 10.1073/pnas.94.17.9028; Hu X, 2001, MOL CELL BIOL, V21, P1747, DOI 10.1128/MCB.21.5.1747-1758.2001; Hu X, 1999, NATURE, V402, P93, DOI 10.1038/47069; Huang EY, 2000, GENE DEV, V14, P45; Ishizuka T, 2003, MOL CELL BIOL, V23, P5122, DOI 10.1128/MCB.23.15.5122-5131.2003; Jepsen K, 2000, CELL, V102, P753, DOI 10.1016/S0092-8674(00)00064-7; Kang ZG, 2002, J BIOL CHEM, V277, P48366, DOI 10.1074/jbc.M209074200; Kao HY, 2000, GENE DEV, V14, P55; Kao HY, 1998, GENE DEV, V12, P2269, DOI 10.1101/gad.12.15.2269; Lee SK, 2000, J BIOL CHEM, V275, P12470, DOI 10.1074/jbc.275.17.12470; Levy L, 2002, J BIOL CHEM, V277, P42386, DOI 10.1074/jbc.M207418200; Li HW, 2004, J BIOL CHEM, V279, P4212, DOI 10.1074/jbc.M311374200; Li JW, 2000, EMBO J, V19, P4342, DOI 10.1093/emboj/19.16.4342; Lutterbach B, 1998, MOL CELL BIOL, V18, P7176, DOI 10.1128/MCB.18.12.7176; Ma H, 2005, ONCOGENE, V24, P3619, DOI 10.1038/sj.onc.1208433; Moon RT, 2002, SCIENCE, V296, P1644, DOI 10.1126/science.1071549; Nagy L, 1997, CELL, V89, P373, DOI 10.1016/S0092-8674(00)80218-4; Nelson WJ, 2004, SCIENCE, V303, P1483, DOI 10.1126/science.1094291; Nissen RM, 2000, GENE DEV, V14, P2314, DOI 10.1101/gad.827900; Nusse R, 2005, CELL RES, V15, P28, DOI 10.1038/sj.cr.7290260; Ordentlich P, 1999, P NATL ACAD SCI USA, V96, P2639, DOI 10.1073/pnas.96.6.2639; Perissi V, 2004, CELL, V116, P511, DOI 10.1016/S0092-8674(04)00133-3; Polakis P, 2000, GENE DEV, V14, P1837; Reya T, 2005, NATURE, V434, P843, DOI 10.1038/nature03319; Roh H, 2001, CANCER RES, V61, P6563; Roose J, 1998, NATURE, V395, P608, DOI 10.1038/26989; Rosenfeld MG, 2006, GENE DEV, V20, P1405, DOI 10.1101/gad.1424806; Saleh M, 2000, MOL CELL BIOL, V20, P8623, DOI 10.1128/MCB.20.22.8623-8633.2000; Shi YH, 2001, GENE DEV, V15, P1140, DOI 10.1101/gad.871201; Smith CL, 1997, MOL ENDOCRINOL, V11, P657, DOI 10.1210/me.11.6.657; Smith CL, 2004, ENDOCR REV, V25, P45, DOI 10.1210/er.2003-0023; Song LN, 2005, J BIOL CHEM, V280, P37853, DOI 10.1074/jbc.M503850200; Song LN, 2004, MOL ENDOCRINOL, V18, P70, DOI 10.1210/me.2003-0189; Song LN, 2003, MOL CELL BIOL, V23, P1674, DOI 10.1128/MCB.23.5.1674-1687.2003; Song LN, 2001, J BIOL CHEM, V276, P24806, DOI 10.1074/jbc.M102610200; Toualbi K, 2007, ONCOGENE, V26, P3492, DOI 10.1038/sj.onc.1210133; Truica CI, 2000, CANCER RES, V60, P4709; Verma UN, 2003, CLIN CANCER RES, V9, P1291; Wagner BL, 1998, MOL CELL BIOL, V18, P1369, DOI 10.1128/MCB.18.3.1369; Wang DQ, 2005, MOL ENDOCRINOL, V19, P1483, DOI 10.1210/me.2005-0012; Wang JX, 1998, P NATL ACAD SCI USA, V95, P10860, DOI 10.1073/pnas.95.18.10860; Wu XY, 2001, J BIOL CHEM, V276, P24177, DOI 10.1074/jbc.M100412200; Xu L, 1999, CURR OPIN GENET DEV, V9, P140, DOI 10.1016/S0959-437X(99)80021-5; Xu L, 1998, NATURE, V395, P301, DOI 10.1038/26270; Yang FJ, 2002, J BIOL CHEM, V277, P11336, DOI 10.1074/jbc.M111962200; Yoon HG, 2006, MOL ENDOCRINOL, V20, P1048, DOI 10.1210/me.2005-0324; Zhang JS, 2002, MOL CELL, V9, P611, DOI 10.1016/S1097-2765(02)00468-9	72	17	17	0	3	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	SEP 19	2008	283	38					25988	25999		10.1074/jbc.M800325200	http://dx.doi.org/10.1074/jbc.M800325200			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	348GX	18632669	Green Published, hybrid			2022-12-27	WOS:000259200100027
J	Verhamme, IM; Bock, PE				Verhamme, Ingrid M.; Bock, Paul E.			Rapid-reaction kinetic characterization of the pathway of streptokinase-plasmin catalytic complex formation	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							PEPTIDE CHLOROMETHYL KETONES; BLOOD-COAGULATION PROTEINASES; LYSINE-BINDING SITES; ACTIVE-SITE; FLUORESCENCE PROBES; CONFORMATIONAL ACTIVATION; EQUIMOLAR COMPLEXES; KRINGLE DOMAINS; GLU-PLASMINOGEN; HIGH-AFFINITY	Binding of the fibrinolytic proteinase plasmin (Pm) to streptokinase (SK) in a tight stoichiometric complex transforms Pm into a potent proteolytic activator of plasminogen. SK binding to the catalytic domain of Pm, with a dissociation constant of 12 pM, is assisted by SK Lys(414) binding to a Pm kringle, which accounts for a 11-20-fold affinity decrease when Pm lysine binding sites are blocked by 6-aminohexanoic acid (6-AHA) or benzamidine. The pathway of SK center dot Pm catalytic complex formation was characterized by stopped-flow kinetics of SK and the Lys(414) deletion mutant (SK Delta K414) binding to Pm labeled at the active site with 5-fluorescein ([5F]FFR-Pm) and the reverse reactions by competitive displacement of [5F]FFR-Pm with active site-blocked Pm. The rate constants for the biexponential fluorescence quenching caused by SK and SK Delta K414 binding to [5F]FFR-Pm were saturable as a function of SK concentration, reporting encounter complex affinities of 62-110 nM in the absence of lysine analogs and 4900 - 6500 and 1430 - 2200 nM in the presence of 6-AHA and benzamidine, respectively. The encounter complex with SK Delta K414 was similar to 10-fold weaker in the absence of lysine analogs but indistinguishable from that of native SK in the presence of 6-AHA and benzamidine. The studies delineate for the first time the sequence of molecular events in the formation of the SK center dot Pm catalytic complex and its regulation by kringle ligands. Analysis of the forward and reverse reactions supports a binding mechanism in which SK Lys414 binding to a Pm kringle accompanies near-diffusion-limited encounter complex formation followed by two slower, tightening conformational changes.	[Verhamme, Ingrid M.; Bock, Paul E.] Vanderbilt Univ, Sch Med, Dept Pathol, Nashville, TN 37232 USA	Vanderbilt University	Bock, PE (corresponding author), C3321A Med Ctr N, Nashville, TN 37232 USA.	paul.bock@vanderbilt.edu			National Institutes of Health [RO1 HL056181, RO1 HL 080018]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL080018, R01HL056181] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	This work was supported, in whole or in part, by National Institutes of Health Grant RO1 HL056181 (NHLBI) (to P.E.B.) and RO1 HL 080018 (to I.M.V.). The costs of publication of this article were defrayed in part by the payment of page charges. This article must therefore be hereby marked "advertisement" in accordance with 18 U. S. C. Section 1734 solely to indicate this fact.	BAJAJ SP, 1977, J BIOL CHEM, V252, P492; Bean RR, 2005, J BIOL CHEM, V280, P7504, DOI 10.1074/jbc.M411637200; BOCK PE, 1993, METHOD ENZYMOL, V222, P478; Bock PE, 1996, J BIOL CHEM, V271, P1072, DOI 10.1074/jbc.271.2.1072; Bock PE, 1997, J BIOL CHEM, V272, P19837, DOI 10.1074/jbc.272.32.19837; BOCK PE, 1992, J BIOL CHEM, V267, P14963; BOCK PE, 1992, J BIOL CHEM, V267, P14974; BOCK PE, 1989, ARCH BIOCHEM BIOPHYS, V273, P375, DOI 10.1016/0003-9861(89)90496-7; BOK RA, 1985, BIOCHEMISTRY-US, V24, P3279, DOI 10.1021/bi00334a031; Boxrud PD, 2000, J BIOL CHEM, V275, P14579, DOI 10.1074/jbc.275.19.14579; Boxrud PD, 2000, BIOCHEMISTRY-US, V39, P13974, DOI 10.1021/bi000594i; Boxrud PD, 2004, J BIOL CHEM, V279, P36633, DOI 10.1074/jbc.M405264200; Boxrud PD, 2004, J BIOL CHEM, V279, P36642, DOI 10.1074/jbc.M405265200; Boxrud PD, 2001, J BIOL CHEM, V276, P26084, DOI 10.1074/jbc.M101966200; CASTELLINO FJ, 1981, METHOD ENZYMOL, V80, P365; Castellino FJ, 1997, CIBA F SYMP, V212, P46; CHRISTENSEN U, 1985, FEBS LETT, V182, P43, DOI 10.1016/0014-5793(85)81150-9; CHRISTENSEN U, 1992, BIOCHEM J, V285, P419, DOI 10.1042/bj2850419; CLEMMENSEN I, 1986, EUR J BIOCHEM, V156, P327, DOI 10.1111/j.1432-1033.1986.tb09586.x; Cockell CS, 1998, BIOCHEM J, V333, P99, DOI 10.1042/bj3330099; DAMASCHUN G, 1992, EUR BIOPHYS J BIOPHY, V20, P355; DAVIDSON DJ, 1990, BIOCHEMISTRY-US, V29, P3585, DOI 10.1021/bi00466a023; DEUTSCH DG, 1970, SCIENCE, V170, P1095, DOI 10.1126/science.170.3962.1095; HENKIN J, 1991, PROG CARDIOVASC DIS, V34, P135, DOI 10.1016/0033-0620(91)90010-J; HOYLAERTS M, 1982, J BIOL CHEM, V257, P2912; JACKSON KW, 1982, BIOCHEMISTRY-US, V21, P6620, DOI 10.1021/bi00269a001; Kuzmic P, 1996, ANAL BIOCHEM, V237, P260, DOI 10.1006/abio.1996.0238; LERCH PG, 1980, EUR J BIOCHEM, V107, P7, DOI 10.1111/j.1432-1033.1980.tb04617.x; LINDAHL P, 1991, BIOCHEM J, V276, P387, DOI 10.1042/bj2760387; LUCAS MA, 1983, J BIOL CHEM, V258, P4249; MANGEL WF, 1990, SCIENCE, V248, P69, DOI 10.1126/science.2108500; MARKUS G, 1978, J BIOL CHEM, V253, P727; MARSHALL JM, 1994, BIOCHEMISTRY-US, V33, P3599, DOI 10.1021/bi00178a017; Marti DN, 1997, BIOCHEMISTRY-US, V36, P11591, DOI 10.1021/bi971316v; MCCANCE SG, 1995, BIOCHEMISTRY-US, V34, P9581, DOI 10.1021/bi00029a035; MCCLINTOCK DK, 1971, BIOCHEM BIOPH RES CO, V43, P694, DOI 10.1016/0006-291X(71)90670-X; OLSON ST, 1991, ARCH BIOCHEM BIOPHYS, V286, P533, DOI 10.1016/0003-9861(91)90076-U; Panizzi P, 2006, J BIOL CHEM, V281, P26774, DOI 10.1074/jbc.C600171200; PONTING CP, 1992, BIOCHIM BIOPHYS ACTA, V1159, P155, DOI 10.1016/0167-4838(92)90020-E; PONTING CP, 1992, BLOOD COAGUL FIBRIN, V3, P605, DOI 10.1097/00001721-199210000-00012; REDDY KNN, 1972, J BIOL CHEM, V247, P1683; SCHICK LA, 1974, BIOCHEM BIOPH RES CO, V57, P47, DOI 10.1016/S0006-291X(74)80355-4; TAYLOR FB, 1968, BIOCHEMISTRY-US, V7, P232, DOI 10.1021/bi00841a028; THEWES T, 1990, J BIOL CHEM, V265, P3906; Tsodikov OV, 1999, BIOPHYS J, V76, P1320, DOI 10.1016/S0006-3495(99)77294-2; VARADI A, 1981, BIOCHEM BIOPH RES CO, V103, P97, DOI 10.1016/0006-291X(81)91665-X; VIOLAND BN, 1976, J BIOL CHEM, V251, P3906; VIOLAND BN, 1978, J BIOL CHEM, V253, P5395; Wang SG, 1999, BIOCHEMISTRY-US, V38, P5232, DOI 10.1021/bi981915h; Wang SG, 2000, EUR J BIOCHEM, V267, P3994, DOI 10.1046/j.1432-1327.2000.01434.x; Wang XQ, 1998, SCIENCE, V281, P1662, DOI 10.1126/science.281.5383.1662; WIMAN B, 1979, BIOCHIM BIOPHYS ACTA, V579, P142, DOI 10.1016/0005-2795(79)90094-1; WOHL RC, 1980, J BIOL CHEM, V255, P2005; WOHL RC, 1978, J BIOL CHEM, V253, P1402; [No title captured]	55	9	9	0	4	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	SEP 19	2008	283	38					26137	26147		10.1074/jbc.M804038200	http://dx.doi.org/10.1074/jbc.M804038200			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	348GX	18658146	Green Published, hybrid			2022-12-27	WOS:000259200100042
J	Zhai, P; Stanworth, C; Liu, S; Silberg, JJ				Zhai, Peng; Stanworth, Crystal; Liu, Shirley; Silberg, Jonathan J.			The human escort protein hep binds to the ATPase domain of mitochondrial Hsp70 and regulates ATP hydrolysis	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							MOLECULAR CHAPERONE SYSTEM; ESCHERICHIA-COLI; KINETIC CHARACTERIZATION; EXTINCTION COEFFICIENTS; IMPORT MOTOR; IRON; ISCU; CYCLE; HSC66; DNAK	Hsp70 escort proteins (Hep) have been implicated as essential for maintaining the function of yeast mitochondrial hsp70 molecular chaperones (mtHsp70), but the role that escort proteins play in regulating mammalian chaperone folding and function has not been established. We present evidence that human mtHsp70 exhibits limited solubility due to aggregation mediated by its ATPase domain and show that human Hep directly enhances chaperone solubility through interactions with this domain. In the absence of Hep, mtHsp70 was insoluble when expressed in Escherichia coli, as was its isolated ATPase domain and a chimera having this domain fused to the peptide-binding domain of HscA, a soluble monomeric chaperone. In contrast, these proteins all exhibited increased solubility when expressed in the presence of Hep. In vitro studies further revealed that purified Hep regulates the interaction of mtHsp70 with nucleotides. Full-length mtHsp70 exhibited slow intrinsic ATPhydrolysis activity (6.8 +/- 0.2 x 10(-4) s(-1)) at 25 degrees C, which was stimulated up to 49-fold by Hep. Hep also stimulated the activity of the isolated ATPase domain, albeit to a lower maximal extent (11.5-fold). In addition, gel-filtration studies showed that formation of chaperone-escort protein complexes inhibited mtHsp70 self-association, and they revealed that Hep binding to full-length mtHsp70 and its isolated ATPase domain is strongest in the absence of nucleotides. These findings provide evidence that metazoan escort proteins regulate the catalytic activity and solubility of their cognate chaperones, and they indicate that both forms of regulation arise from interactions with the mtHsp70 ATPase domain.	[Zhai, Peng; Stanworth, Crystal; Liu, Shirley; Silberg, Jonathan J.] Rice Univ, Dept Biochem & Cell Biol, Houston, TX 77251 USA	Rice University	Silberg, JJ (corresponding author), Rice Univ, Dept Biochem & Cell Biol, 6100 Main St,POB 1892,209 Keck Hall, Houston, TX 77251 USA.	joff@rice.edu	Silberg, Jonathan J/A-3817-2010		Robert A. Welch Foundation [C-1614]	Robert A. Welch Foundation(The Welch Foundation)	This work was supported by the Robert A. Welch Foundation (Grant C-1614 to J.J.S.). The costs of publication of this article were defrayed in part by the payment of page charges. This article must therefore be hereby marked "advertisement" in accordance with 18 U.S.C. Section 1734 solely to indicate this fact.	BHATTACHARYYA T, 1995, J BIOL CHEM, V270, P1705, DOI 10.1074/jbc.270.4.1705; Borges JC, 2003, J BIOL CHEM, V278, P35337, DOI 10.1074/jbc.M305083200; Burri L, 2004, J BIOL CHEM, V279, P50243, DOI 10.1074/jbc.M409194200; Claros MG, 1996, EUR J BIOCHEM, V241, P779, DOI 10.1111/j.1432-1033.1996.00779.x; Cupp-Vickery JR, 2004, J MOL BIOL, V342, P1265, DOI 10.1016/j.jmb.2004.07.025; Daugaard M, 2007, FEBS LETT, V581, P3702, DOI 10.1016/j.febsiet.2007.05.039; Dutkiewicz R, 2006, J BIOL CHEM, V281, P7801, DOI 10.1074/jbc.M513301200; Dutkiewicz R, 2003, J BIOL CHEM, V278, P29719, DOI 10.1074/jbc.M303527200; GILL SC, 1989, ANAL BIOCHEM, V182, P319, DOI 10.1016/0003-2697(89)90602-7; Hoff KG, 2002, J BIOL CHEM, V277, P27353, DOI 10.1074/jbc.M202814200; Hoff KG, 2000, P NATL ACAD SCI USA, V97, P7790, DOI 10.1073/pnas.130201997; HORTON RM, 1989, GENE, V77, P61, DOI 10.1016/0378-1119(89)90359-4; Kanai M, 2007, GENES CELLS, V12, P797, DOI 10.1111/j.1365-2443.2007.01091.x; KANG PJ, 1990, NATURE, V348, P137, DOI 10.1038/348137a0; Kaul SC, 2007, EXP GERONTOL, V42, P263, DOI 10.1016/j.exger.2006.10.020; LIBEREK K, 1991, P NATL ACAD SCI USA, V88, P2874, DOI 10.1073/pnas.88.7.2874; MACH H, 1992, ANAL BIOCHEM, V200, P74, DOI 10.1016/0003-2697(92)90279-G; Matouschek A, 2000, EMBO REP, V1, P404, DOI 10.1093/embo-reports/kvd093; Mayer MP, 2005, CELL MOL LIFE SCI, V62, P670, DOI 10.1007/s00018-004-4464-6; MCCARTY JS, 1995, J MOL BIOL, V249, P126, DOI 10.1006/jmbi.1995.0284; Misselwitz B, 1998, MOL CELL, V2, P593, DOI 10.1016/S1097-2765(00)80158-6; Momose T, 2007, EMBO REP, V8, P664, DOI 10.1038/sj.embor.7400990; Muhlenhoff U, 2003, EMBO J, V22, P4815, DOI 10.1093/emboj/cdg446; Muhlenhoff U, 2002, J BIOL CHEM, V277, P29810, DOI 10.1074/jbc.M204675200; Neupert W, 2002, NAT REV MOL CELL BIO, V3, P555, DOI 10.1038/nrm878; Oliveira CLP, 2006, ARCH BIOCHEM BIOPHYS, V449, P77, DOI 10.1016/j.abb.2006.02.015; PACE CN, 1995, PROTEIN SCI, V4, P2411, DOI 10.1002/pro.5560041120; PALLEROS DR, 1993, NATURE, V365, P664, DOI 10.1038/365664a0; Qiu XB, 2006, CELL MOL LIFE SCI, V63, P2560, DOI 10.1007/s00018-006-6192-6; Russell R, 1998, BIOCHEMISTRY-US, V37, P596, DOI 10.1021/bi972025p; Schilke B, 2006, CURR BIOL, V16, P1660, DOI 10.1016/j.cub.2006.06.069; SCHMID D, 1994, SCIENCE, V263, P971, DOI 10.1126/science.8310296; SCHNEIDER HC, 1994, NATURE, V371, P768, DOI 10.1038/371768a0; Sichting M, 2005, EMBO J, V24, P1046, DOI 10.1038/sj.emboj.7600580; Silberg JJ, 1998, J BACTERIOL, V180, P6617, DOI 10.1128/JB.180.24.6617-6624.1998; Silberg JJ, 2004, J BIOL CHEM, V279, P53924, DOI 10.1074/jbc.M410117200; Silberg JJ, 2001, J BIOL CHEM, V276, P1696, DOI 10.1074/jbc.M009542200; Silberg JJ, 2000, J BIOL CHEM, V275, P7779, DOI 10.1074/jbc.275.11.7779; Szklarz LKS, 2005, J MOL BIOL, V351, P206, DOI 10.1016/j.jmb.2005.05.068; Takeda S, 1996, BIOCHEMISTRY-US, V35, P4636, DOI 10.1021/bi952903o; Tong WH, 2000, EMBO J, V19, P5692, DOI 10.1093/emboj/19.21.5692; Vickery LE, 2007, CRIT REV BIOCHEM MOL, V42, P95, DOI 10.1080/10409230701322298; Vickery LE, 1997, PROTEIN SCI, V6, P1047, DOI 10.1002/pro.5560060511; Willmund F, 2008, J BIOL CHEM, V283, P16363, DOI 10.1074/jbc.M708431200; Yamamoto H, 2005, FEBS LETT, V579, P507, DOI 10.1016/j.febslet.2004.12.018; Young JC, 2004, NAT REV MOL CELL BIO, V5, P781, DOI 10.1038/nrm1492	46	27	27	2	8	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	SEP 19	2008	283	38					26098	26106		10.1074/jbc.M803475200	http://dx.doi.org/10.1074/jbc.M803475200			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	348GX	18632665	Green Published, hybrid			2022-12-27	WOS:000259200100038
J	Berthelmann, F; Mehner, D; Richter, S; Lindenstrauss, U; Lunsdorf, H; Hause, G; Bruser, T				Berthelmann, Felix; Mehner, Denise; Richter, Silke; Lindenstrauss, Ute; Luensdorf, Heinrich; Hause, Gerd; Brueser, Thomas			Recombinant expression of tatABC and tatAC results in the formation of interacting cytoplasmic TatA tubes in Escherichia coli	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							PROTEIN-TRANSPORT SYSTEM; TWIN-ARGININE TRANSLOCASE; BACILLUS-SUBTILIS; MEMBRANE INSERTION; PATHWAY; COMPLEXES; COMPONENTS; SUBUNITS; BACTERIA; BINDING	The twin-arginine translocation (Tat) system of bacteria and plant plastids serves to translocate folded proteins across energized biological membranes. In Escherichia coli, the three components TatA, TatB, and TatC mediate this membrane passage. Here we demonstrate that TatA can assemble to form clusters of tube-like structures in vivo. While the presence of TatC is essential for their formation, TatB is not required. The TatA tubes have uniform outer and inner diameters of about 11.5 nm and 6.7 nm, respectively. They align to form a crystalline-like structure in which each tube is surrounded by six TatA tubes. The tube structures become easily detectable even at only a 15-fold overexpression of the tatABC genes. The TatA tubes could also be visualized by fluorescence when untagged TatA was mixed with low amounts of TatA-GFP. The structures were often found in contact with the cell poles. Because TatC is most likely polar in E. coli, as demonstrated by a RR-dependent targeting of translocation-incompatible Tat substrates to the cell poles, and because TatC is required for the formation of aligned TatA tubes, it is proposed that the TatA tubes are initiated at polarly localized TatC.	[Berthelmann, Felix; Mehner, Denise; Richter, Silke; Lindenstrauss, Ute; Brueser, Thomas] Univ Halle Wittenberg, Inst Biol Microbiol, D-06120 Halle, Germany; [Luensdorf, Heinrich] Helmholtz Ctr Infect Res, Div Vaccinol, D-38124 Braunschweig, Germany; [Hause, Gerd] Univ Halle Wittenberg, Bioctr, D-06120 Halle, Germany	Martin Luther University Halle Wittenberg; Helmholtz Association; Helmholtz-Center for Infection Research; Martin Luther University Halle Wittenberg	Bruser, T (corresponding author), Univ Halle Wittenberg, Inst Biol Microbiol, Kurt Mothes Str 3, D-06120 Halle, Germany.	t.brueser@mikrobiologie.uni-halle.de	Berthelmann, Felix/GQP-2587-2022	Bruser, Thomas/0000-0002-5889-8306; Mehner-Breitfeld, Denise/0000-0002-6785-898X	Deutsche Forschungsgemeinschaft [BR2285/2-2]	Deutsche Forschungsgemeinschaft(German Research Foundation (DFG))	This work was supported in part by a grant from the Deutsche Forschungsgemeinschaft (BR2285/2-2) ( to T. B.). The costs of publication of this article were defrayed in part by the payment of page charges. This article must therefore be hereby marked "advertisement" in accordance with 18 U. S. C. Section 1734 solely to indicate this fact.	Behrendt J, 2007, FEBS LETT, V581, P4085, DOI 10.1016/j.febslet.2007.07.045; Berthelmann F, 2004, FEBS LETT, V569, P82, DOI 10.1016/j.febslet.2004.05.054; Bruser T, 1998, FEMS MICROBIOL LETT, V164, P329; Bruser T, 2003, EUR J BIOCHEM, V270, P1211, DOI 10.1046/j.1432-1033.2003.03481.x; CASADABAN MJ, 1976, J MOL BIOL, V104, P541, DOI 10.1016/0022-2836(76)90119-4; Chan CS, 2007, BIOCHEMISTRY-US, V46, P7396, DOI 10.1021/bi7005288; Cline K, 2001, J CELL BIOL, V154, P719, DOI 10.1083/jcb.200105149; Cline K, 2007, EMBO J, V26, P3039, DOI 10.1038/sj.emboj.7601759; Dabney-Smith C, 2006, J BIOL CHEM, V281, P5476, DOI 10.1074/jbc.M512453200; De Keersmaeker S, 2007, MICROBIOL-SGM, V153, P1087, DOI 10.1099/mic.0.2006/003053-0; De Leeuw E, 2001, FEBS LETT, V506, P143, DOI 10.1016/S0014-5793(01)02904-0; Gerard F, 2006, J BIOL CHEM, V281, P6130, DOI 10.1074/jbc.M512733200; Gohlke U, 2005, P NATL ACAD SCI USA, V102, P10482, DOI 10.1073/pnas.0503558102; Gouffi K, 2004, J BIOL CHEM, V279, P11608, DOI 10.1074/jbc.M313187200; Hicks MG, 2005, J BACTERIOL, V187, P2920, DOI 10.1128/JB.187.8.2920-2925.2005; Hou B, 2006, J MOL BIOL, V355, P957, DOI 10.1016/j.jmb.2005.11.029; Jack RL, 2001, J BACTERIOL, V183, P1801, DOI 10.1128/JB.183.5.1801-1804.2001; Jongbloed JDH, 2006, TRENDS MICROBIOL, V14, P2, DOI 10.1016/j.tim.2005.11.001; LAEMMLI UK, 1970, NATURE, V227, P680, DOI 10.1038/227680a0; LOWRY OH, 1951, J BIOL CHEM, V193, P265; Moor H., 1987, CRYOTECHNIQUES BIOL, P175, DOI [10.1007/978-3-642-72815-0_8, DOI 10.1007/978-3-642-72815-0_8]; MULLER D, 1984, SCI BIOL SPECIMEN PR, P131; Muller M, 2005, MOL MEMBR BIOL, V22, P113, DOI 10.1080/09687860500041809; Oates J, 2005, J MOL BIOL, V346, P295, DOI 10.1016/j.jmb.2004.11.047; Pop O, 2002, J BIOL CHEM, V277, P3268, DOI 10.1074/jbc.M110829200; Pop OI, 2003, J BIOL CHEM, V278, P38428, DOI 10.1074/jbc.M306516200; Porcelli I, 2002, BIOCHEMISTRY-US, V41, P13690, DOI 10.1021/bi026142i; Ray N, 2005, J BIOL CHEM, V280, P17961, DOI 10.1074/jbc.M413521200; Richter S, 2005, J BIOL CHEM, V280, P42723, DOI 10.1074/jbc.M509570200; Richter S, 2007, J BIOL CHEM, V282, P33257, DOI 10.1074/jbc.M703303200; Rosch J, 2004, SCIENCE, V304, P1513, DOI 10.1126/science.1097404; Saier MH, 2006, J MEMBRANE BIOL, V214, P75, DOI 10.1007/s00232-006-0049-7; Sargent F, 2002, ARCH MICROBIOL, V178, P77, DOI 10.1007/s00203-002-0434-2; Sargent F, 2001, EUR J BIOCHEM, V268, P3361, DOI 10.1046/j.1432-1327.2001.02263.x; Schreiber S, 2006, J BIOL CHEM, V281, P19977, DOI 10.1074/jbc.M513900200; Shanmugham A, 2006, BIOCHEMISTRY-US, V45, P2243, DOI 10.1021/bi052188a; Westermann M, 2006, BBA-BIOMEMBRANES, V1758, P443, DOI 10.1016/j.bbamem.2006.03.018; Wexler M, 2000, J BIOL CHEM, V275, P16717, DOI 10.1074/jbc.M000800200; Wilms B, 2001, BIOTECHNOL BIOENG, V73, P95, DOI 10.1002/bit.1041; Winkler J, 1996, J STRUCT BIOL, V116, P270, DOI 10.1006/jsbi.1996.0042	40	30	31	0	3	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	SEP 12	2008	283	37					25281	25289		10.1074/jbc.M707757200	http://dx.doi.org/10.1074/jbc.M707757200			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	345QZ	18644791	hybrid			2022-12-27	WOS:000259012700021
J	Lin, YP; Raman, R; Sharma, Y; Chang, YF				Lin, Yi-Pin; Raman, Rajeev; Sharma, Yogendra; Chang, Yung-Fu			Calcium binds to leptospiral immunoglobulin-like protein, LigB, and modulates fibronectin binding	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							GAMMA-CRYSTALLIN DOMAIN; ESCHERICHIA-COLI; INTERROGANS; MEMBRANE; CA2+; DYE; INVOLVEMENT; ATTACHMENT; EXPRESSION; STABILITY	Pathogenic Leptospira spp. express immunoglobulin-like proteins, LigA and LigB, which serve as adhesins to bind to extracellular matrices and mediate their attachment on host cells. However, nothing is known about the mechanism by which these proteins are involved in pathogenesis. We demonstrate that LigBCen2 binds Ca2+, as evidenced by inductively coupled plasma optical emission spectrometry, energy dispersive spectrometry, Ca-45 overlay, and mass spectrometry, although there is no known motif for Ca2+ binding. LigBCen2 binds four Ca2+ as determined by matrix-assisted laser desorption ionization time-of-flight mass spectrometry. The dissociation constant, K-D, for Ca2+ binding is 7 mu M, as measured by isothermal titration calorimetry and calcium competition experiments. The nature of the Ca2+-binding site in LigB is possibly similar to that seen in the beta gamma-crystallin superfamily, since structurally, both families of proteins possess the Greek key type fold. The conformation of LigBCen2 was significantly influenced by Ca2+ binding as shown by far-and near-UV CD and by fluorescence spectroscopy. In the apo form, the protein appears to be partially unfolded, as seen in the far-UV CD spectrum, and upon Ca2+ binding, the protein acquires significant beta-sheet conformation. Ca2+ binding stabilizes the protein as monitored by thermal unfolding by CD (50.7-54.8 degrees C) and by differential scanning calorimetry (50.0-55.7 degrees C). Ca2+ significantly assists the binding of LigBCen2 to the N-terminal domain of fibronectin and perturbs the secondary structure, suggesting the involvement of Ca2+ in adhesion. We demonstrate that LigB is a novel bacterial Ca2+-binding protein and suggest that Ca2+ binding plays a pivotal role in the pathogenesis of leptospirosis.	[Lin, Yi-Pin; Chang, Yung-Fu] Cornell Univ, Coll Vet Med, Dept Populat Med & Diagnost Sci, Ithaca, NY 14853 USA; [Raman, Rajeev; Sharma, Yogendra] Ctr Cellular & Mol Biol, Council Sci & Ind Res, Hyderabad 500007, Andhra Pradesh, India	Cornell University; Council of Scientific & Industrial Research (CSIR) - India; CSIR - Centre for Cellular & Molecular Biology (CCMB)	Chang, YF (corresponding author), Cornell Univ, Coll Vet Med, Dept Populat Med & Diagnost Sci, Ithaca, NY 14853 USA.	yc42@cornell.edu			Harry M. Zweig Memorial Fund; New York State Science and Technology Foundation; Biotechnology Research and Development Corporation; Department of Science and Technology, Government of India	Harry M. Zweig Memorial Fund; New York State Science and Technology Foundation; Biotechnology Research and Development Corporation; Department of Science and Technology, Government of India(Department of Science & Technology (India))	This work was supported in part by the Harry M. Zweig Memorial Fund for Equine Research, the New York State Science and Technology Foundation (to C. A. T.), the Biotechnology Research and Development Corporation (to Y. F. C.), and the Department of Science and Technology, Government of India (to Y. S.). The costs of publication of this article were defrayed in part by the payment of page charges. This article must therefore be hereby marked "advertisement" in accordance with 18 U. S. C. Section 1734 solely to indicate this fact.	BAGBY S, 1994, P NATL ACAD SCI USA, V91, P4308, DOI 10.1073/pnas.91.10.4308; Barbosa AS, 2006, INFECT IMMUN, V74, P6356, DOI 10.1128/IAI.00460-06; Bulach DM, 2006, P NATL ACAD SCI USA, V103, P14560, DOI 10.1073/pnas.0603979103; CADAY CG, 1986, BIOPOLYMERS, V25, P1579, DOI 10.1002/bip.360250814; CADAY CG, 1985, J BIOL CHEM, V260, P5985; CHANG YF, 1993, DNA CELL BIOL, V12, P351, DOI 10.1089/dna.1993.12.351; CHENG Y, 1973, BIOCHEM PHARMACOL, V22, P3099; Choy HA, 2007, INFECT IMMUN, V75, P2441, DOI 10.1128/IAI.01635-06; Clout NJ, 2001, STRUCTURE, V9, P115, DOI 10.1016/S0969-2126(01)00573-1; CRUZ WT, 1990, MOL MICROBIOL, V4, P1933, DOI 10.1111/j.1365-2958.1990.tb02042.x; Dardanelli M, 2003, CAN J MICROBIOL, V49, P399, DOI 10.1139/w03-054; Faine S, 1999, LEPTOSPIRA LEPTOSPIR, V2nd; Faisal SM, 2008, VACCINE, V26, P277, DOI 10.1016/j.vaccine.2007.10.029; GOODE D, 1995, COMPUT CHEM, V19, P65, DOI 10.1016/0097-8485(95)00027-P; Gopalan V, 1997, J MOL BIOL, V267, P818, DOI 10.1006/jmbi.1997.0906; ISBERG RR, 1987, CELL, V50, P769, DOI 10.1016/0092-8674(87)90335-7; Izutsu KT, 1996, FEMS MICROBIOL LETT, V144, P145, DOI 10.1111/j.1574-6968.1996.tb08521.x; Jeromin A, 2004, J BIOL CHEM, V279, P27158, DOI 10.1074/jbc.M312172200; JERSE AE, 1990, P NATL ACAD SCI USA, V87, P7839, DOI 10.1073/pnas.87.20.7839; Jobby MK, 2007, BIOCHEMISTRY-US, V46, P12298, DOI 10.1021/bi700843q; Jobby MK, 2007, FEBS J, V274, P4135, DOI 10.1111/j.1742-4658.2007.05941.x; Jobby MK, 2005, J BIOL CHEM, V280, P1209, DOI 10.1074/jbc.M409253200; JOHNSON RC, 1963, J BACTERIOL, V85, P983, DOI 10.1128/JB.85.5.983-985.1963; Levett PN, 2001, CLIN MICROBIOL REV, V14, P296, DOI 10.1128/CMR.14.2.296-326.2001; Lin XP, 2008, J VET SCI, V9, P133; Lin YP, 2007, BIOCHEM BIOPH RES CO, V362, P443, DOI 10.1016/j.bbrc.2007.07.196; MARUYAMA K, 1984, J BIOCHEM-TOKYO, V95, P511, DOI 10.1093/oxfordjournals.jbchem.a134633; Matsunaga J, 2003, MOL MICROBIOL, V49, P929, DOI 10.1046/j.1365-2958.2003.03619.x; Matsunaga J, 2007, INFECT IMMUN, V75, P2864, DOI 10.1128/IAI.01619-06; Michiels J, 2002, TRENDS MICROBIOL, V10, P87, DOI 10.1016/S0966-842X(01)02284-3; O'Connell DP, 1998, J BIOL CHEM, V273, P6821, DOI 10.1074/jbc.273.12.6821; Palaniappan RUM, 2006, INFECT IMMUN, V74, P1745, DOI 10.1128/IAI.74.3.1745-1750.2006; Palaniappan RUM, 2004, J MED MICROBIOL, V53, P975, DOI 10.1099/jmm.0.45568-0; Palaniappan RUM, 2002, INFECT IMMUN, V70, P5924, DOI 10.1128/IAI.70.11.5924-5930.2002; PIATIGORSKY J, 1984, MOL CELL BIOCHEM, V59, P33; Rajini B, 2003, BIOCHEMISTRY-US, V42, P4552, DOI 10.1021/bi027384l; Rajini B, 2001, J BIOL CHEM, V276, P38464, DOI 10.1074/jbc.M102164200; Ristow P, 2007, PLOS PATHOG, V3, P894, DOI 10.1371/journal.ppat.0030097; Segura ER, 2005, CLIN INFECT DIS, V40, P343, DOI 10.1086/427110; SHARMA Y, 1989, J BIOL CHEM, V264, P20923; Stevenson B, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0001188; STRALEY SC, 1993, MOL MICROBIOL, V8, P1005, DOI 10.1111/j.1365-2958.1993.tb01644.x; TISA LS, 1995, P NATL ACAD SCI USA, V92, P10777, DOI 10.1073/pnas.92.23.10777; TISA LS, 1992, P NATL ACAD SCI USA, V89, P11804, DOI 10.1073/pnas.89.24.11804; TROMBE MC, 1994, J BACTERIOL, V176, P1992, DOI 10.1128/jb.176.7.1992-1996.1994; Verma A, 2006, INFECT IMMUN, V74, P2659, DOI 10.1128/IAI.74.5.2659-2666.2006; Werthen M, 2001, J BIOL CHEM, V276, P6468, DOI 10.1074/jbc.M009223200; Werts C, 2001, NAT IMMUNOL, V2, P346, DOI 10.1038/86354; Yang CW, 2002, J AM SOC NEPHROL, V13, P2037, DOI 10.1097/01.ASN.0000022007.91733.62; Yu XC, 1997, EMBO J, V16, P5455, DOI 10.1093/emboj/16.17.5455	50	53	53	0	2	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	SEP 12	2008	283	37					25140	25149		10.1074/jbc.M801350200	http://dx.doi.org/10.1074/jbc.M801350200			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	345QZ	18625711	hybrid			2022-12-27	WOS:000259012700006
J	Hurd, TR; Requejo, R; Filipovska, A; Brown, S; Prime, TA; Robinson, AJ; Fearnley, IM; Murphy, MP				Hurd, Thomas R.; Requejo, Raquel; Filipovska, Aleksandra; Brown, Stephanie; Prime, Tracy A.; Robinson, Alan J.; Fearnley, Ian M.; Murphy, Michael P.			Complex I within oxidatively stressed bovine heart mitochondria is glutathionylated on Cys-531 and Cys-704 of the 75-kDa subunit - Potential role of Cys residues in decreasing oxidative damage	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							HUMAN GLUTAREDOXIN THIOLTRANSFERASE; NITRIC-OXIDE; PARKINSONS-DISEASE; UBIQUINONE OXIDOREDUCTASE; S-GLUTATHIONYLATION; MASS-SPECTROMETRY; NATIVE ELECTROPHORESIS; HYDROPHILIC DOMAIN; HYDROGEN-PEROXIDE; PROTEIN COMPLEXES	Complex I has reactive thiols on its surface that interact with the mitochondrial glutathione pool and are implicated in oxidative damage in many pathologies. However, the Cys residues and the thiol modifications involved are not known. Here we investigate complex I thiol modification within oxidatively stressed mammalian mitochondria, containing physiological levels of glutathione and glutaredoxin 2. In mitochondria incubated with the thiol oxidant diamide, complex I is only glutathionylated on the 75-kDa subunit. Of the 17 Cys residues on the 75-kDa subunit, 6 are not involved in iron-sulfur centers, making them plausible candidates for glutathionylation. Mass spectrometry of complex I from oxidatively stressed bovine heart mitochondria showed that only Cys-531 and Cys-704 were glutathionylated. The other four non-iron-sulfur center Cys residues remained as free thiols. Complex I glutathionylation also occurred in response to relatively mild oxidative stress caused by increased superoxide production from the respiratory chain. Although complex I glutathionylation within oxidatively stressed mitochondria correlated with loss of activity, it did not increase superoxide formation, and reversal of glutathionylation did not restore complex I activity. Comparison with the known structure of the 75-kDa ortholog Nqo3 from Thermus thermophilus complex I suggested that Cys-531 and Cys-704 are on the surface of mammalian complex I, exposed to the mitochondrial glutathione pool. These findings suggest that Cys-531 and Cys-704 may be important in preventing oxidative damage to complex I by reacting with free radicals and other damaging species, with subsequent glutathionylation recycling the thiyl radicals and sulfenic acids formed on the Cys residues back to free thiols.	[Hurd, Thomas R.; Requejo, Raquel; Filipovska, Aleksandra; Brown, Stephanie; Prime, Tracy A.; Robinson, Alan J.; Fearnley, Ian M.; Murphy, Michael P.] MRC, Dunn Human Nutr Unit, Cambridge CB2 0XY, England	UK Research & Innovation (UKRI); Medical Research Council UK (MRC); MRC Human Nutrition Research	Murphy, MP (corresponding author), MRC, Dunn Human Nutr Unit, Wellcome Trust,MRC Bldg,Hills Rd, Cambridge CB2 0XY, England.	mpm@mrc-dunn.cam.ac.uk	Murphy, Michael P/C-2120-2009; Robinson, Alan/A-9956-2009; Requejo-Aguilar, Raquel/M-2360-2014	Murphy, Michael P/0000-0003-1115-9618; Requejo-Aguilar, Raquel/0000-0002-0532-7630; Filipovska, Aleksandra/0000-0002-6998-8403	Medical Research Council (UK); Natural Sciences and Engineering Council of Canada; Medical Research Council [MC_U105663148, MC_U105663142, MC_U105674181] Funding Source: researchfish; MRC [MC_U105674181, MC_U105663148, MC_U105663142] Funding Source: UKRI	Medical Research Council (UK)(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Natural Sciences and Engineering Council of Canada(Natural Sciences and Engineering Research Council of Canada (NSERC)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC))	This work was supported by the Medical Research Council (UK) and by a postgraduate research scholarship (to T. R. H.) from the Natural Sciences and Engineering Council of Canada. The costs of publication of this article were defrayed in part by the payment of page charges. This article must therefore be hereby marked "advertisement" in accordance with 18 U. S. C. Section 1734 solely to indicate this fact.	Akerboom T P, 1981, Methods Enzymol, V77, P373; ALTSCHUL SF, 1997, NUCLEIC ACIDS RES, V25, P3402; ANDERSON ME, 1985, METHOD ENZYMOL, V113, P548; Beer SM, 2004, J BIOL CHEM, V279, P47939, DOI 10.1074/jbc.M408011200; Bharath S, 2005, ANTIOXID REDOX SIGN, V7, P900, DOI 10.1089/ars.2005.7.900; Bonini MG, 2001, J BIOL CHEM, V276, P9749, DOI 10.1074/jbc.M008456200; Brandt U, 2006, ANNU REV BIOCHEM, V75, P69, DOI 10.1146/annurev.biochem.75.103004.142539; Brown GC, 2004, BBA-BIOENERGETICS, V1658, P44, DOI 10.1016/j.bbabio.2004.03.016; Burwell LS, 2008, ANTIOXID REDOX SIGN, V10, P579, DOI 10.1089/ars.2007.1845; Burwell LS, 2006, BIOCHEM J, V394, P627, DOI 10.1042/BJ20051435; Carroll J, 2003, MOL CELL PROTEOMICS, V2, P117, DOI 10.1074/mcp.M300014-MCP200; Carroll J, 2002, J BIOL CHEM, V277, P50311, DOI 10.1074/jbc.M209166200; Carroll J, 2006, J BIOL CHEM, V281, P32724, DOI 10.1074/jbc.M607135200; Chen CL, 2007, BIOCHEMISTRY-US, V46, P5754, DOI 10.1021/bi602580c; Chinta SJ, 2007, J NEUROSCI, V27, P13997, DOI 10.1523/JNEUROSCI.3885-07.2007; Chinta SJ, 2006, FREE RADICAL BIO MED, V41, P1442, DOI 10.1016/j.freeradbiomed.2006.08.002; Clementi E, 1998, P NATL ACAD SCI USA, V95, P7631, DOI 10.1073/pnas.95.13.7631; Cocheme HM, 2008, J BIOL CHEM, V283, P1786, DOI 10.1074/jbc.M708597200; Costa NJ, 2003, ANTIOXID REDOX SIGN, V5, P291, DOI 10.1089/152308603322110878; Dahm CC, 2006, J BIOL CHEM, V281, P10056, DOI 10.1074/jbc.M512203200; Dalle-Donne I, 2008, ANTIOXID REDOX SIGN, V10, P445, DOI 10.1089/ars.2007.1716; Enoksson M, 2005, BIOCHEM BIOPH RES CO, V327, P774, DOI 10.1016/j.bbrc.2004.12.067; Ford E, 2002, FREE RADICAL BIO MED, V32, P1314, DOI 10.1016/S0891-5849(02)00850-X; Fratelli M, 2002, P NATL ACAD SCI USA, V99, P3505, DOI 10.1073/pnas.052592699; Galkin A, 2007, J BIOL CHEM, V282, P37448, DOI 10.1074/jbc.M707543200; Gavrikova EV, 1999, FEBS LETT, V455, P36, DOI 10.1016/S0014-5793(99)00850-9; Giustarini D, 2004, J CELL MOL MED, V8, P201, DOI 10.1111/j.1582-4934.2004.tb00275.x; Gladyshev VN, 2001, J BIOL CHEM, V276, P30374, DOI 10.1074/jbc.M100020200; Han D, 2003, MOL PHARMACOL, V64, P1136, DOI 10.1124/mol.64.5.1136; Hansen RE, 2005, BIOCHEMISTRY-US, V44, P5899, DOI 10.1021/bi0500372; Hirst J, 2003, BBA-BIOENERGETICS, V1604, P135, DOI 10.1016/S0005-2728(03)00059-8; Hsu M, 2005, J NEUROCHEM, V92, P1091, DOI 10.1111/j.1471-4159.2004.02929.x; Hurd TR, 2007, J BIOL CHEM, V282, P22040, DOI 10.1074/jbc.M703591200; Hurd TR, 2005, ANTIOXID REDOX SIGN, V7, P999, DOI 10.1089/ars.2005.7.999; James AM, 1996, BIOCHEM J, V318, P401, DOI 10.1042/bj3180401; Jao SC, 2006, BIOCHEMISTRY-US, V45, P4785, DOI 10.1021/bi0516327; Jha N, 2000, J BIOL CHEM, V275, P26096, DOI 10.1074/jbc.M000120200; Johansson C, 2004, J BIOL CHEM, V279, P7537, DOI 10.1074/jbc.M312719200; Kenchappa RS, 2003, FASEB J, V17, P717, DOI 10.1096/fj.02-0771fje; Lillig CH, 2005, P NATL ACAD SCI USA, V102, P8168, DOI 10.1073/pnas.0500735102; Lillig CH, 2004, P NATL ACAD SCI USA, V101, P13227, DOI 10.1073/pnas.0401896101; Lin TK, 2002, J BIOL CHEM, V277, P17048, DOI 10.1074/jbc.M110797200; LUCAS M, 1992, ANAL BIOCHEM, V206, P273, DOI 10.1016/0003-2697(92)90366-F; Lundberg M, 2001, J BIOL CHEM, V276, P26269, DOI 10.1074/jbc.M011605200; MCKERNAN TB, 1991, ARCH BIOCHEM BIOPHYS, V288, P653, DOI 10.1016/0003-9861(91)90248-H; Perkins DN, 1999, ELECTROPHORESIS, V20, P3551, DOI 10.1002/(SICI)1522-2683(19991201)20:18<3551::AID-ELPS3551>3.0.CO;2-2; Raha S, 2000, TRENDS BIOCHEM SCI, V25, P502, DOI 10.1016/S0968-0004(00)01674-1; Reddy S, 2000, BIOCHEM J, V347, P821, DOI 10.1042/0264-6021:3470821; Rubino FM, 2006, J MASS SPECTROM, V41, P1578, DOI 10.1002/jms.1143; RUNSWICK MJ, 1989, BIOCHEMISTRY-US, V28, P9452, DOI 10.1021/bi00450a031; SALI A, 1993, J MOL BIOL, V234, P779, DOI 10.1006/jmbi.1993.1626; Sazanov LA, 2006, SCIENCE, V311, P1430, DOI 10.1126/science.1123809; Sazanov LA, 2007, BIOCHEMISTRY-US, V46, P2275, DOI 10.1021/bi602508x; Scarlett JL, 1996, BIOCHEM PHARMACOL, V52, P1047, DOI 10.1016/0006-2952(96)99426-5; Schagger H, 1995, METHOD ENZYMOL, V260, P190, DOI 10.1016/0076-6879(95)60137-6; SCHAGGER H, 1991, ANAL BIOCHEM, V199, P223, DOI 10.1016/0003-2697(91)90094-A; Sharpley MS, 2006, BIOCHEMISTRY-US, V45, P241, DOI 10.1021/bi051809x; Smith, 1967, METHOD ENZYMOL, V10, P81, DOI DOI 10.1016/0076-6879(67)10016-5; SMITH PK, 1985, ANAL BIOCHEM, V150, P76, DOI 10.1016/0003-2697(85)90442-7; Sriram K, 1998, J NEUROSCI, V18, P10287; Starke DW, 2003, J BIOL CHEM, V278, P14607, DOI 10.1074/jbc.M210434200; Taylor ER, 2003, J BIOL CHEM, V278, P19603, DOI 10.1074/jbc.M209359200; THOMAS JA, 1995, ARCH BIOCHEM BIOPHYS, V319, P1, DOI 10.1006/abbi.1995.1261; THOMPSON JD, 1994, NUCLEIC ACIDS RES, V22, P4673, DOI 10.1093/nar/22.22.4673; Walker JE, 1995, METHOD ENZYMOL, V260, P14, DOI 10.1016/0076-6879(95)60127-9; WALKER JE, 1992, Q REV BIOPHYS, V25, P253, DOI 10.1017/S003358350000425X; Wilm M, 1996, NATURE, V379, P466, DOI 10.1038/379466a0; Winterbourn CC, 1999, FREE RADICAL BIO MED, V27, P322, DOI 10.1016/S0891-5849(99)00051-9; WINTERBOURN CC, 1993, FREE RADICAL BIO MED, V14, P85, DOI 10.1016/0891-5849(93)90512-S; Winterbourn CC, 2008, NAT CHEM BIOL, V4, P278, DOI 10.1038/nchembio.85; Zhao HT, 2003, FREE RADICAL BIO MED, V34, P1359, DOI 10.1016/S0891-5849(03)00142-4; Zhao HT, 2005, P NATL ACAD SCI USA, V102, P5727, DOI 10.1073/pnas.0501719102	72	157	158	0	12	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	SEP 5	2008	283	36					24801	24815		10.1074/jbc.M803432200	http://dx.doi.org/10.1074/jbc.M803432200			15	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	342YR	18611857	Green Published, hybrid			2022-12-27	WOS:000258820000047
J	Imanishi, Y; Sun, WY; Maeda, T; Maeda, A; Palczewski, K				Imanishi, Yoshikazu; Sun, Wenyu; Maeda, Tadao; Maeda, Akiko; Palczewski, Krzysztof			Retinyl ester homeostasis in the adipose differentiation-related protein-deficient retina	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							LIPID DROPLET FORMATION; LIGHT-INDUCED DEGENERATION; GATED ION CHANNELS; VISUAL CYCLE; PIGMENT EPITHELIUM; DARK-ADAPTATION; IN-VIVO; MICE; TIP47; RPE65	The retinal pigmented epithelium (RPE) plays an essential role in vision, including storing and converting retinyl esters of the visual chromophore, 11-cis-retinal. Retinyl ester storage structures (RESTs), specialized lipid droplets within the RPE, take up retinyl esters synthesized in the endoplasmic reticulum. Here we report studies of mice lacking exons 2 and 3 of the gene encoding adipose differentiation-related protein (Adfp), a structural component of RESTs. We found that dark adaptation was slower in Adfp(Delta 2-3/Delta 2-3) than in Adfp(+/+) mice and that Adfp(Delta 2-3/Delta 2-3) mice had consistently delayed clearances of all-trans-retinal and all-trans-retinol from rod photoreceptor cells. Two-photon microscopy revealed aberrant trafficking of all-trans-retinyl esters in the RPE of Adfp(Delta 2-3/Delta 2-3) mice, a problem caused by abnormal maintenance of RESTs in the dark-adapted state. Retinyl ester accumulation was also reduced in Adfp(Delta 2-3/Delta 2-3) as compared with Adfp(+/+) mice. These observations suggest that Adfp plays a unique role in vision by maintaining proper storage and trafficking of retinoids within the eye.	[Imanishi, Yoshikazu; Sun, Wenyu; Maeda, Tadao; Maeda, Akiko; Palczewski, Krzysztof] Case Western Reserve Univ, Sch Med, Dept Pharmacol, Cleveland, OH 44106 USA; [Maeda, Tadao] Case Western Reserve Univ, Dept Ophthalmol, Cleveland, OH 44106 USA	Case Western Reserve University; Case Western Reserve University	Palczewski, K (corresponding author), Case Western Reserve Univ, Sch Med, Dept Pharmacol, 10900 Euclid Ave, Cleveland, OH 44106 USA.	kxp65@case.edu	Imanishi, Yoshikazu/E-8178-2010	Imanishi, Yoshikazu/0000-0003-4696-4836	National Institutes of Health [EY009339, P30 EY11373]; Klaus Tschira Foundation; European Life Scientist Organization; Amgen Inc; NATIONAL EYE INSTITUTE [R01EY009339, P30EY011373] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Klaus Tschira Foundation; European Life Scientist Organization; Amgen Inc(Amgen); NATIONAL EYE INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI))	This work was supported, in whole or in part, by National Institutes of Health Grants EY009339 and P30 EY11373. This work was also supported by the Klaus Tschira Foundation, the European Life Scientist Organization, and by an unrestricted grant from Amgen Inc. The costs of publication of this article were defrayed in part by the payment of page charges. This article must therefore be hereby marked "advertisement" in accordance with 18 U. S. C. Section 1734 solely to indicate this fact.	Batten ML, 2004, J BIOL CHEM, V279, P10422, DOI 10.1074/jbc.M312410200; BLANCHETTEMACKIE EJ, 1995, J LIPID RES, V36, P1211; Bostrom P, 2005, ARTERIOSCL THROM VAS, V25, P1945, DOI 10.1161/01.ATV.0000179676.41064.d4; Brasaemle DL, 2004, J BIOL CHEM, V279, P46835, DOI 10.1074/jbc.M409340200; Brasaemle DL, 1997, J LIPID RES, V38, P2249; Buczylko J, 1996, J BIOL CHEM, V271, P20621, DOI 10.1074/jbc.271.34.20621; Chang BHJ, 2006, MOL CELL BIOL, V26, P1063, DOI 10.1128/MCB.26.3.1063-1076.2006; Dalen KT, 2007, BBA-MOL CELL BIOL L, V1771, P210, DOI 10.1016/j.bbalip.2006.11.011; Dean DM, 2002, P NATL ACAD SCI USA, V99, P8372, DOI 10.1073/pnas.122681899; Diaz E, 1998, CELL, V93, P433, DOI 10.1016/S0092-8674(00)81171-X; Fukushima M, 2005, IN VITRO CELL DEV-AN, V41, P321; Gao J, 1999, J BIOL CHEM, V274, P16825, DOI 10.1074/jbc.274.24.16825; GREENBERG AS, 1993, P NATL ACAD SCI USA, V90, P12035, DOI 10.1073/pnas.90.24.12035; Heid HW, 1996, BIOCHEM J, V320, P1025, DOI 10.1042/bj3201025; Heid HW, 1998, CELL TISSUE RES, V294, P309, DOI 10.1007/s004410051181; Imamura M, 2002, AM J PHYSIOL-ENDOC M, V283, pE775, DOI 10.1152/ajpendo.00040.2002; Imanishi Y, 2004, J CELL BIOL, V166, P447, DOI 10.1083/jcb.200405110; Imanishi Y, 2004, J CELL BIOL, V164, P373, DOI 10.1083/jcb.200311079; Imanishi Y, 2007, BIOCHEMISTRY-US, V46, P9674, DOI 10.1021/bi701055g; Isken A, 2007, J BIOL CHEM, V282, P1144, DOI 10.1074/jbc.M609109200; JIANG HP, 1992, P NATL ACAD SCI USA, V89, P7856, DOI 10.1073/pnas.89.17.7856; Jin MH, 2005, CELL, V122, P449, DOI 10.1016/j.cell.2005.06.042; Kim TS, 2005, J BIOL CHEM, V280, P8694, DOI 10.1074/jbc.M413172200; Lamb TD, 2004, PROG RETIN EYE RES, V23, P307, DOI 10.1016/j.preteyeres.2004.03.001; Listenberger LL, 2007, J LIPID RES, V48, P2751, DOI 10.1194/jlr.M700359-JLR200; Liu PS, 2004, J BIOL CHEM, V279, P3787, DOI 10.1074/jbc.M311945200; Maeda A, 2005, J BIOL CHEM, V280, P18822, DOI 10.1074/jbc.M501757200; Maeda A, 2006, J BIOL CHEM, V281, P37697, DOI 10.1074/jbc.M608375200; Martin S, 2006, NAT REV MOL CELL BIO, V7, P373, DOI 10.1038/nrm1912; McBee JK, 2001, PROG RETIN EYE RES, V20, P469, DOI 10.1016/S1350-9462(01)00002-7; McCabe SL, 2004, J GEN PHYSIOL, V123, P521, DOI 10.1085/jgp.200409011; Miura S, 2002, J BIOL CHEM, V277, P32253, DOI 10.1074/jbc.M204410200; Moise AR, 2007, J BIOL CHEM, V282, P2081, DOI 10.1074/jbc.M608315200; Moiseyev G, 2005, P NATL ACAD SCI USA, V102, P12413, DOI 10.1073/pnas.0503460102; O'Byrne SM, 2005, J BIOL CHEM, V280, P35647, DOI 10.1074/jbc.M507924200; Palczewski K, 2006, ANNU REV BIOCHEM, V75, P743, DOI 10.1146/annurev.biochem.75.103004.142743; Redmond TM, 1998, NAT GENET, V20, P344, DOI 10.1038/3813; Redmond TM, 2005, P NATL ACAD SCI USA, V102, P13658, DOI 10.1073/pnas.0504167102; Russell TD, 2008, J LIPID RES, V49, P206, DOI 10.1194/jlr.M700396-JLR200; Serrero G, 2000, BBA-MOL CELL BIOL L, V1488, P245, DOI 10.1016/S1388-1981(00)00128-1; SERVETNICK DA, 1995, J BIOL CHEM, V270, P16970, DOI 10.1074/jbc.270.28.16970; Surya A, 1998, EXP EYE RES, V66, P599, DOI 10.1006/exer.1997.0453; Sztalryd C, 2006, J BIOL CHEM, V281, P34341, DOI 10.1074/jbc.M602497200; Travis GH, 2007, ANNU REV PHARMACOL, V47, P469, DOI 10.1146/annurev.pharmtox.47.120505.105225; TREHAN A, 1990, BIOCHEMISTRY-US, V29, P309, DOI 10.1021/bi00454a001; Tsuiki E, 2007, INVEST OPHTH VIS SCI, V48, P2858, DOI 10.1167/iovs.06-0768; Welte MA, 2005, CURR BIOL, V15, P1266, DOI 10.1016/j.cub.2005.06.062; Weng J, 1999, CELL, V98, P13, DOI 10.1016/S0092-8674(00)80602-9; Wenzel A, 2001, J NEUROSCI, V21, P53, DOI 10.1523/JNEUROSCI.21-01-00053.2001; Wolins NE, 2001, J BIOL CHEM, V276, P5101, DOI 10.1074/jbc.M006775200; Wolins NE, 2003, J BIOL CHEM, V278, P37713, DOI 10.1074/jbc.M304025200; Xu GH, 2005, J BIOL CHEM, V280, P42841, DOI 10.1074/jbc.M506569200; Yamaguchi T, 2006, J BIOL CHEM, V281, P14232, DOI 10.1074/jbc.M601682200	53	23	24	0	2	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	SEP 5	2008	283	36					25091	25102		10.1074/jbc.M802981200	http://dx.doi.org/10.1074/jbc.M802981200			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	342YR	18606814	Green Published, hybrid			2022-12-27	WOS:000258820000064
J	Fu, Y; Buryanovskyy, L; Zhang, Z				Fu, Yue; Buryanovskyy, Leonid; Zhang, Zhongtao			Quinone reductase 2 is a catechol quinone reductase	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							NICOTINAMIDE-N-METHYLTRANSFERASE; IDIOPATHIC PARKINSONS-DISEASE; REDOX-CYCLING QUINOPROTEIN; DT-DIAPHORASE; NQO2 GENE; CRYSTAL-STRUCTURE; OXIDOREDUCTASE-2 NQO2; TYROSINE-HYDROXYLASE; ENZYMATIC OXIDATION; POLYMORPHISM	The functions of quinone reductase 2 have eluded researchers for decades even though a genetic polymorphism is associated with various neurological disorders. Employing enzymatic studies using adrenochrome as a substrate, we show that quinone reductase 2 is specific for the reduction of adrenochrome, whereas quinone reductase 1 shows no activity. We also solved the crystal structure of quinone reductase 2 in complexes with dopamine and adrenochrome, two compounds that are structurally related to catecholamine quinones. Detailed structural analyses delineate the mechanism of quinone reductase 2 specificity toward catechol quinones in comparison with quinone reductase 1; a side-chain rotational difference between quinone reductase 1 and quinone reductase 2 of a single residue, phenylalanine 106, determines the specificity of enzymatic activities. These results infer functional differences between two homologous enzymes and indicate that quinone reductase 2 could play important roles in the regulation of catecholamine oxidation processes that may be involved in the etiology of Parkinson disease.	[Fu, Yue; Buryanovskyy, Leonid; Zhang, Zhongtao] New York Med Coll, Dept Biochem & Mol Biol, Valhalla, NY 10595 USA	New York Medical College	Zhang, Z (corresponding author), New York Med Coll, Dept Biochem & Mol Biol, Valhalla, NY 10595 USA.	Zhongtao_zhang@nymc.edu		zhang, zhongtao/0000-0002-1910-4753	National Institutes of Health (NINDS) [R01 NS051548]; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS051548] Funding Source: NIH RePORTER	National Institutes of Health (NINDS)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	This work was supported, in whole or in part, by National Institutes of Health Grant R01 NS051548 (NINDS). The costs of publication of this article were defrayed in part by the payment of page charges. This article must therefore be hereby marked "advertisement" in accordance with 18 U.S.C. Section 1734 solely to indicate this fact.	AKSOY S, 1994, J BIOL CHEM, V269, P14835; Aoyama K, 2001, NEUROSCI LETT, V298, P78, DOI 10.1016/S0304-3940(00)01723-7; Asanuma M, 2006, EXPERT REV NEUROTHER, V6, P1313, DOI 10.1586/14737175.6.9.1313; BACQ ZM, 1950, ARCH INT PHYS BIOCH, V57, P271, DOI 10.3109/13813455009144910; BAEZ S, 1995, BIOCHEM MOL MED, V56, P37, DOI 10.1006/bmme.1995.1054; Baez S, 1997, BIOCHEM J, V324, P25, DOI 10.1042/bj3240025; Bergamaschi E, 2001, AM J RESP CRIT CARE, V163, P1426, DOI 10.1164/ajrccm.163.6.2006056; Bianchet MA, 2008, VITAM HORM, V78, P63, DOI 10.1016/S0083-6729(07)00004-0; Bieganowski P, 2004, CELL, V117, P495, DOI 10.1016/S0092-8674(04)00416-7; Brunger AT, 1998, ACTA CRYSTALLOGR D, V54, P905, DOI 10.1107/S0907444998003254; Buryanovskyy L, 2004, BIOCHEMISTRY-US, V43, P11417, DOI 10.1021/bi049162o; Calamini B, 2008, BIOCHEM J, V413, P81, DOI 10.1042/BJ20071373; Cavalieri EL, 2004, ANN NY ACAD SCI, V1028, P247, DOI 10.1196/annals.1322.029; CHEN HH, 1992, BIOCHEM J, V284, P855, DOI 10.1042/bj2840855; Chen S, 2000, FREE RADICAL BIO MED, V29, P276, DOI 10.1016/S0891-5849(00)00308-7; Clairmont A, 1999, CARCINOGENESIS, V20, P1235, DOI 10.1093/carcin/20.7.1235; Dinkova-Kostova LT, 2000, FREE RADICAL BIO MED, V29, P231, DOI 10.1016/S0891-5849(00)00300-2; Faig M, 2000, P NATL ACAD SCI USA, V97, P3177, DOI 10.1073/pnas.050585797; Fleming RA, 2002, PHARMACOGENETICS, V12, P31, DOI 10.1097/00008571-200201000-00005; Foster CE, 2000, FREE RADICAL BIO MED, V29, P241, DOI 10.1016/S0891-5849(00)00299-9; Foster CE, 1999, BIOCHEMISTRY-US, V38, P9881, DOI 10.1021/bi990799v; Fu Y, 2005, BIOCHEM BIOPH RES CO, V336, P332, DOI 10.1016/j.bbrc.2005.08.081; GRAHAM DG, 1978, MOL PHARMACOL, V14, P633; Haque ME, 2003, BBA-GEN SUBJECTS, V1619, P39, DOI 10.1016/S0304-4165(02)00440-3; Harada S, 2003, PSYCHIAT GENET, V13, P205, DOI 10.1097/00041444-200312000-00003; Harada S, 2001, BIOCHEM BIOPH RES CO, V288, P887, DOI 10.1006/bbrc.2001.5868; Hastings TG, 1996, ADV EXP MED BIOL, V387, P97; HASTINGS TG, 1995, J NEUROCHEM, V64, P919; Hastings TG, 1996, P NATL ACAD SCI USA, V93, P1956, DOI 10.1073/pnas.93.5.1956; Iskander K, 2006, J BIOL CHEM, V281, P30917, DOI 10.1074/jbc.M605809200; JAISWAL AK, 1990, BIOCHEMISTRY-US, V29, P1899, DOI 10.1021/bi00459a034; Jiang Xiao-hua, 2004, Zhonghua Yi Xue Yi Chuan Xue Za Zhi, V21, P120; Kang YH, 2004, METHOD ENZYMOL, V382, P380; Kiyohara C, 2005, GENET MED, V7, P463, DOI 10.1097/01.GIM.0000177530.55043.c1; Knox RJ, 2000, CANCER RES, V60, P4179; Krajinovic M, 2002, INT J CANCER, V97, P230, DOI 10.1002/ijc.1589; Kuhn DM, 1998, J NEUROSCI, V18, P7111; Kuhn DM, 1999, J NEUROCHEM, V73, P1309, DOI 10.1046/j.1471-4159.1999.0731309.x; LaVoie MJ, 2005, NAT MED, V11, P1214, DOI 10.1038/nm1314; LI RB, 1995, P NATL ACAD SCI USA, V92, P8846, DOI 10.1073/pnas.92.19.8846; LIAO S, 1961, BIOCHEM BIOPH RES CO, V4, P208, DOI 10.1016/0006-291X(61)90272-8; LIAO S, 1962, J BIOL CHEM, V237, P2981; Long DJ, 2002, J BIOL CHEM, V277, P46131, DOI 10.1074/jbc.M208675200; Ohgake S, 2005, ADDICT BIOL, V10, P145, DOI 10.1080/13556210500123423; Okada S, 2005, NEUROSCI LETT, V375, P178, DOI 10.1016/j.neulet.2004.11.009; Okubo T, 2003, ALCOHOL CLIN EXP RES, V27, p68S, DOI 10.1097/01.ALC.0000078616.63296.41; Ostrousky O, 2003, TISSUE ANTIGENS, V62, P483, DOI 10.1046/j.1399-0039.2003.00133.x; Otwinowski Z, 1997, METHOD ENZYMOL, V276, P307, DOI 10.1016/S0076-6879(97)76066-X; Parsons RB, 2003, NEUROSCI LETT, V342, P13, DOI 10.1016/S0304-3940(03)00218-0; Ross D, 2004, METHOD ENZYMOL, V382, P115; Shao M, 2001, Zhonghua Yi Xue Yi Chuan Xue Za Zhi, V18, P122; Smith MT, 1999, P NATL ACAD SCI USA, V96, P7624, DOI 10.1073/pnas.96.14.7624; Smythies J, 1998, BBA-GEN SUBJECTS, V1380, P159, DOI 10.1016/S0304-4165(97)00131-1; Spencer JPE, 1998, J NEUROCHEM, V71, P2112; Sulzer D, 1999, NEUROTOX RES, V1, P181, DOI 10.1007/BF03033289; Takagi S, 2002, ANTICANCER RES, V22, P2749; van Muiswinkel FL, 2004, NEUROBIOL AGING, V25, P1253, DOI 10.1016/j.neurobiolaging.2003.12.010; Wang W, 2004, FREE RADICAL BIO MED, V37, P1231, DOI 10.1016/j.freeradbiomed.2004.06.042; Wang W, 2008, J GERONTOL A-BIOL, V63, P127, DOI 10.1093/gerona/63.2.127; Whitehead RE, 2001, J NEUROCHEM, V76, P1242, DOI 10.1046/j.1471-4159.2001.00125.x; Wu KB, 1997, ARCH BIOCHEM BIOPHYS, V347, P221, DOI 10.1006/abbi.1997.0344; Xu YM, 1998, J NEUROSCI RES, V54, P691, DOI 10.1002/(SICI)1097-4547(19981201)54:5<691::AID-JNR14>3.0.CO;2-F; Zafar KS, 2006, MOL PHARMACOL, V70, P1079, DOI 10.1124/mol.106.024703; Zhang JH, 2003, WORLD J GASTROENTERO, V9, P1390, DOI 10.3748/wjg.v9.i7.1390; Zhao QJ, 1997, P NATL ACAD SCI USA, V94, P1669, DOI 10.1073/pnas.94.5.1669	65	41	52	0	4	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	AUG 29	2008	283	35					23829	23835		10.1074/jbc.M801371200	http://dx.doi.org/10.1074/jbc.M801371200			7	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	340II	18579530	Green Published, hybrid			2022-12-27	WOS:000258638900037
J	Nikonov, A; Juronen, E; Ustav, M				Nikonov, Andrei; Juronen, Erkki; Ustav, Mart			Functional characterization of fingers subdomain-specific monoclonal antibodies inhibiting the hepatitis C virus RNA-dependent RNA polymerase	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							CRYSTAL-STRUCTURE; DE-NOVO; BINDING-SITE; IDENTIFICATION; REPLICATION; INITIATION; NS5B; COMPLEX; CLEAVAGE; REGION	The hepatitis C virus (HCV) RNA-dependent RNA polymerase (RdRp), encoded by nonstructural protein 5B (NS5B), is absolutely essential for the viral replication. Here we describe the development, characterization, and functional properties of the panel of monoclonal antibodies (mAbs) and specifically describe the mechanism of action of two mAbs inhibiting the NS5B RdRp activity. These mAbs recognize and bind to distinct linear epitopes in the fingers subdomain of NS5B. The mAb 8B2 binds the N-terminal epitope of the NS5B and inhibits both primer-dependent and de novo RNA synthesis. mAb 8B2 selectively inhibits elongation of RNA chains and enhances the RNA template binding by NS5B. In contrast, mAb 7G8 binds the epitope that contains motif G conserved in viral RdRps and inhibits only primer-dependent RNA synthesis by specifically targeting the initiation of RNA synthesis, while not interfering with the binding of template RNA by NS5B. To reveal the importance of the residues of mAb 7G8 epitope for the initiation of RNA synthesis, we performed site-directed mutagenesis and extensively characterized the functionality of the HCV RdRp motif G. Comparison of the mutation effects in both in vitro primer-dependent RdRp assay and cellular transient replication assay suggested that mAb7G8 epitope amino acid residues are involved in the interaction of template-primer or template with HCV RdRp. The data presented here allowed us to describe the functionality of the epitopes of mAbs 8B2 and 7G8 in the HCV RdRp activity and suggest that the epitopes recognized by these mAbs may be useful targets for antiviral drugs.	[Nikonov, Andrei; Ustav, Mart] Univ Tartu, Dept Biomed Technol, Inst Technol, EE-50411 Tartu, Estonia; [Juronen, Erkki; Ustav, Mart] Univ Tartu, Inst Gen & Mol Pathol, Lab Mol Pathol, EE-50411 Tartu, Estonia	University of Tartu; University of Tartu	Ustav, M (corresponding author), Univ Tartu, Dept Biomed Technol, Inst Technol, Nooruse 1, EE-50411 Tartu, Estonia.	mart.ustav@ut.ee	Nikonov, Andrei/G-3421-2015; Ustav, Mart/G-6484-2017	Nikonov, Andrei/0000-0003-2121-8984; 	Estonian Science Foundation [5998, 5999]; Basic Science Committee [SF0182566]	Estonian Science Foundation; Basic Science Committee	This work was supported by Grants 5998 and 5999 from Estonian Science Foundation and by Target Financial Project SF0182566 from Basic Science Committee. The costs of publication of this article were defrayed in part by the payment of page charges. This article must therefore be hereby marked "advertisement" in accordance with 18 U. S. C. Section 1734 solely to indicate this fact.	Ago H, 1999, STRUCTURE, V7, P1417, DOI 10.1016/S0969-2126(00)80031-3; AKAIKE H, 1992, No To Hattatsu, V24, P127; Andreotti AH, 2003, BIOCHEMISTRY-US, V42, P9515, DOI 10.1021/bi0350710; BARTENSCHLAGER R, 1993, J VIROL, V67, P3835, DOI 10.1128/JVI.67.7.3835-3844.1993; Bartenschlager R, 2000, J GEN VIROL, V81, P1631, DOI 10.1099/0022-1317-81-7-1631; Binder M, 2007, J VIROL, V81, P5270, DOI 10.1128/JVI.00032-07; Biswal BK, 2005, J BIOL CHEM, V280, P18202, DOI 10.1074/jbc.M413410200; BORDO D, 1991, J MOL BIOL, V217, P721, DOI 10.1016/0022-2836(91)90528-E; BORMAN AM, 1994, EMBO J, V13, P3149, DOI 10.1002/j.1460-2075.1994.tb06613.x; BRADFORD MM, 1976, ANAL BIOCHEM, V72, P248, DOI 10.1016/0003-2697(76)90527-3; Bradrick SS, 2006, NUCLEIC ACIDS RES, V34, P1293, DOI 10.1093/nar/gkl019; Bressanelli S, 1999, P NATL ACAD SCI USA, V96, P13034, DOI 10.1073/pnas.96.23.13034; Bressanelli S, 2002, J VIROL, V76, P3482, DOI 10.1128/JVI.76.7.3482-3492.2002; Butcher SJ, 2001, NATURE, V410, P235, DOI 10.1038/35065653; Carroll SS, 2003, J BIOL CHEM, V278, P11979, DOI 10.1074/jbc.M210914200; CHOO QL, 1989, SCIENCE, V244, P359, DOI 10.1126/science.2523562; Combet C, 2007, NUCLEIC ACIDS RES, V35, pD363, DOI 10.1093/nar/gkl970; Deval J, 2007, J BIOL CHEM, V282, P16907, DOI 10.1074/jbc.M701973200; Dhanak D, 2002, J BIOL CHEM, V277, P38322, DOI 10.1074/jbc.M205566200; Di Marco S, 2005, J BIOL CHEM, V280, P29765, DOI 10.1074/jbc.M505423200; Dutartre H, 2005, J BIOL CHEM, V280, P6359, DOI 10.1074/jbc.M410191200; Friebe P, 2005, J VIROL, V79, P380, DOI 10.1128/JVI.79.1.380-392.2005; Gorbalenya AE, 2002, J MOL BIOL, V324, P47, DOI 10.1016/S0022-2836(02)01033-1; GRAKOUI A, 1993, J VIROL, V67, P2832, DOI 10.1128/JVI.67.5.2832-2843.1993; GRAKOUI A, 1993, J VIROL, V67, P1385, DOI 10.1128/JVI.67.3.1385-1395.1993; Gu BH, 2003, J BIOL CHEM, V278, P16602, DOI 10.1074/jbc.M210891200; Hansen JL, 1997, STRUCTURE, V5, P1109, DOI 10.1016/S0969-2126(97)00261-X; Hoofnagle JH, 2002, HEPATOLOGY, V36, pS21, DOI 10.1053/jhep.2002.36227; Huang HF, 1998, SCIENCE, V282, P1669, DOI 10.1126/science.282.5394.1669; Imbert I, 2006, EMBO J, V25, P4933, DOI 10.1038/sj.emboj.7601368; JURONEN E, 1991, J IMMUNOL METHODS, V136, P103, DOI 10.1016/0022-1759(91)90255-E; Juronen E, 1996, HYBRIDOMA, V15, P77, DOI 10.1089/hyb.1996.15.77; Kaldalu N, 2000, BIOTECHNIQUES, V28, P456, DOI 10.2144/00283st02; Kang SM, 2008, J VIRAL HEPATITIS, V15, P305, DOI 10.1111/j.1365-2893.2007.00945.x; Kao CC, 2000, J VIROL, V74, P11121, DOI 10.1128/JVI.74.23.11121-11128.2000; Kim YC, 2005, J BIOL CHEM, V280, P38011, DOI 10.1074/jbc.M508145200; Koch Uwe, 2006, Infectious Disorders - Drug Targets, V6, P31, DOI 10.2174/187152606776056724; Krieger N, 2001, J VIROL, V75, P4614, DOI 10.1128/JVI.75.10.4614-4624.2001; Lesburg CA, 1999, NAT STRUCT BIOL, V6, P937; Lohmann V, 2003, J VIROL, V77, P3007, DOI 10.1128/JVI.77.5.3007-3019.2003; Lohmann V, 1999, SCIENCE, V285, P110, DOI 10.1126/science.285.5424.110; Lohmann V, 1997, J VIROL, V71, P8416, DOI 10.1128/JVI.71.11.8416-8428.1997; Love RA, 2003, J VIROL, V77, P7575, DOI 10.1128/JVI.77.13.7575-7581.2003; Luo GX, 2000, J VIROL, V74, P851, DOI 10.1128/JVI.74.2.851-863.2000; MIKAELIAN I, 1992, NUCLEIC ACIDS RES, V20, P376, DOI 10.1093/nar/20.2.376; Moradpour D, 2002, J BIOL CHEM, V277, P593, DOI 10.1074/jbc.M108748200; O'Farrell D, 2003, J MOL BIOL, V326, P1025, DOI 10.1016/S0022-2836(02)01439-0; Oh JW, 2000, J BIOL CHEM, V275, P17710, DOI 10.1074/jbc.M908781199; Pauwels F, 2007, J VIROL, V81, P6909, DOI 10.1128/JVI.01543-06; PERZ JP, 2004, 425 ANN M INF DIS SO, P214; Pestova TV, 1998, GENE DEV, V12, P67, DOI 10.1101/gad.12.1.67; Pettersen EF, 2004, J COMPUT CHEM, V25, P1605, DOI 10.1002/jcc.20084; PFAFF E, 1982, EMBO J, V1, P869, DOI 10.1002/j.1460-2075.1982.tb01262.x; PILIPENKO EV, 1989, NUCLEIC ACIDS RES, V17, P5701, DOI 10.1093/nar/17.14.5701; Qin WP, 2002, J BIOL CHEM, V277, P2132, DOI 10.1074/jbc.M106880200; Qin WP, 2001, HEPATOLOGY, V33, P728, DOI 10.1053/jhep.2001.22765; Quinkert D, 2005, J VIROL, V79, P13594, DOI 10.1128/JVI.79.21.13594-13605.2005; Sanner MF, 1996, BIOPOLYMERS, V38, P305, DOI 10.1002/(SICI)1097-0282(199603)38:3<305::AID-BIP4>3.3.CO;2-8; SELBY MJ, 1994, VIROLOGY, V204, P114, DOI 10.1006/viro.1994.1515; Tao YZ, 2002, CELL, V111, P733, DOI 10.1016/S0092-8674(02)01110-8; Thompson AA, 2004, EMBO J, V23, P3462, DOI 10.1038/sj.emboj.7600357; Thompson AA, 2007, J MOL BIOL, V366, P1459, DOI 10.1016/j.jmb.2006.11.070; VANDENHOFF MJB, 1992, NUCLEIC ACIDS RES, V20, P2902, DOI 10.1093/nar/20.11.2902; Wang MT, 2003, J BIOL CHEM, V278, P9489, DOI 10.1074/jbc.M209397200; Watashi K, 2005, MOL CELL, V19, P111, DOI 10.1016/j.molcel.2005.05.014; Windisch MP, 2005, J VIROL, V79, P13778, DOI 10.1128/JVI.79.21.13778-13793.2005	66	6	7	0	1	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	AUG 29	2008	283	35					24089	24102		10.1074/jbc.M803422200	http://dx.doi.org/10.1074/jbc.M803422200			14	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	340II	18574240	hybrid, Green Published			2022-12-27	WOS:000258638900063
J	Obara, K; Sekito, T; Niimi, K; Ohsumi, Y				Obara, Keisuke; Sekito, Takayuki; Niimi, Kaori; Ohsumi, Yoshinori			The Atg18-Atg2 complex is recruited to autophagic membranes via phosphatidylinositol 3-phosphate and exerts an essential function	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							SACCHAROMYCES-CEREVISIAE; FLUORESCENT PROTEIN; MAMMALIAN-CELLS; YEAST; TRANSPORT; 3-KINASE; MUTANTS; VACUOLE; 3,5-BISPHOSPHATE; LOCALIZATION	Atg18 is essential for both autophagy and the regulation of vacuolar morphology. The latter process is mediated by phosphatidylinositol 3,5-bisphosphate binding, which is dispensable for autophagy. Atg18 also binds to phosphatidylinositol 3-phosphate ( PtdIns( 3) P) in vitro. Here, we investigate the relationship between PtdIns( 3) P-binding of Atg18 and autophagy. Using an Atg18 variant, Atg18(FTTG), which is unable to bind phosphoinositides, we found that PtdIns( 3) P binding of Atg18 is essential for full activity in both selective and nonselective autophagy. Atg18( FTTG) formed a complex with Atg2 in a normal manner, and Atg18-Atg2 complex formation occurred in cells in the absence of PtdIns( 3) P, indicating that Atg18-Atg2 complex formation is independent of PtdIns(3)P-binding of Atg18. Atg18 localized to endosomes, the vacuolar membrane, and autophagic membranes, whereas Atg18( FTTG) did not localize to these structures. The localization of Atg2 to autophagic membranes was also lost in Atg18( FTTG) cells. These data indicate that PtdIns( 3) P-binding of Atg18 is involved in directing the Atg18-Atg2 complex to autophagic membranes. Connection of a 2 x FYVE domain, a specific PtdIns(3)P-binding domain, to the C terminus of Atg18( FTTG) restored the localization of Atg18-Atg2 to autophagic membranes and full autophagic activity, indicating that PtdIns(3)P-binding by Atg18 is dispensable for the function of the Atg18-Atg2 complex but is required for its localization. This also suggests that PtdIns( 3) P does not act allosterically on Atg18. Taken together, Atg18 forms a complex with Atg2 irrespective of PtdIns( 3) P binding, associates tightly to autophagic membranes by interacting with PtdIns( 3) P, and plays an essential role.	[Obara, Keisuke; Niimi, Kaori; Ohsumi, Yoshinori] Natl Inst Basic Biol, Dept Cell Biol, Okazaki, Aichi 4448585, Japan; [Sekito, Takayuki] Ehime Univ, Dept Appl Biosci, Fac Agr, Matsuyama, Ehime 7908566, Japan	National Institutes of Natural Sciences (NINS) - Japan; National Institute for Basic Biology (NIBB); Ehime University	Ohsumi, Y (corresponding author), Natl Inst Basic Biol, Dept Cell Biol, Nishigonaka 38,Myodaiji Cho, Okazaki, Aichi 4448585, Japan.	yohsumi@nibb.ac.jp	Obara, Keisuke/A-3824-2012; Ohsumi, Yoshinori/C-6449-2009	Ohsumi, Yoshinori/0000-0003-2384-2166	Ministry of Education, Culture, Sports, Science, and Technology of Japan [15002012]	Ministry of Education, Culture, Sports, Science, and Technology of Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT))	This work was supported in part by Grant-in-aid for Scientific Research 15002012 from the Ministry of Education, Culture, Sports, Science, and Technology of Japan. The costs of publication of this article were defrayed in part by the payment of page charges. This article must therefore be hereby marked "advertisement" in accordance with 18 U. S. C. Section 1734 solely to indicate this fact.	BABA M, 1994, J CELL BIOL, V124, P903, DOI 10.1083/jcb.124.6.903; BROWN WJ, 1995, J CELL BIOL, V130, P781, DOI 10.1083/jcb.130.4.781; Campbell RE, 2002, P NATL ACAD SCI USA, V99, P7877, DOI 10.1073/pnas.082243699; DAVIDSON HW, 1995, J CELL BIOL, V130, P797, DOI 10.1083/jcb.130.4.797; Dove SK, 2004, EMBO J, V23, P1922, DOI 10.1038/sj.emboj.7600203; Efe JA, 2007, MOL BIOL CELL, V18, P4232, DOI 10.1091/mbc.E07-04-0301; Gillooly DJ, 2000, EMBO J, V19, P4577, DOI 10.1093/emboj/19.17.4577; Kaiser C., 1994, METHODS YEAST GENETI; Kihara A, 2001, J CELL BIOL, V152, P519, DOI 10.1083/jcb.152.3.519; Kirisako T, 1999, J CELL BIOL, V147, P435, DOI 10.1083/jcb.147.2.435; Klionsky DJ, 2003, DEV CELL, V5, P539, DOI 10.1016/S1534-5807(03)00296-X; Krick R, 2006, FEBS LETT, V580, P4632, DOI 10.1016/j.febslet.2006.07.041; Mizushima N, 2001, J CELL BIOL, V152, P657, DOI 10.1083/jcb.152.4.657; Mizushima N, 2007, GENE DEV, V21, P2861, DOI 10.1101/gad.1599207; NODA T, 1995, BIOCHEM BIOPH RES CO, V210, P126, DOI 10.1006/bbrc.1995.1636; Obara K, 2006, MOL BIOL CELL, V17, P1527, DOI 10.1091/mbc.E05-09-0841; Obara K, 2008, GENES CELLS, V13, P537, DOI 10.1111/j.1365-2443.2008.01188.x; Ohsumi Y, 2001, NAT REV MOL CELL BIO, V2, P211, DOI 10.1038/35056522; Petiot A, 2000, J BIOL CHEM, V275, P992, DOI 10.1074/jbc.275.2.992; Reggiori F, 2004, DEV CELL, V6, P79, DOI 10.1016/S1534-5807(03)00402-7; ROBINSON JS, 1988, MOL CELL BIOL, V8, P4936, DOI 10.1128/MCB.8.11.4936; Shintani T, 2001, J BIOL CHEM, V276, P30452, DOI 10.1074/jbc.M102346200; STACK JH, 1995, J CELL BIOL, V129, P321, DOI 10.1083/jcb.129.2.321; Stromhaug PE, 2004, MOL BIOL CELL, V15, P3553, DOI 10.1091/mbc.E04-02-0147; Suzuki K, 2001, EMBO J, V20, P5971, DOI 10.1093/emboj/20.21.5971; Suzuki K, 2007, GENES CELLS, V12, P209, DOI 10.1111/j.1365-2443.2007.01050.x; Takenawa T, 2001, J CELL SCI, V114, P1801; TAKESHIGE K, 1992, J CELL BIOL, V119, P301, DOI 10.1083/jcb.119.2.301; THUMM M, 1994, FEBS LETT, V349, P275, DOI 10.1016/0014-5793(94)00672-5; TSUKADA M, 1993, FEBS LETT, V333, P169, DOI 10.1016/0014-5793(93)80398-E; Wang CW, 2001, J BIOL CHEM, V276, P30442, DOI 10.1074/jbc.M102342200; Yang F, 1996, NAT BIOTECHNOL, V14, P1246, DOI 10.1038/nbt1096-1246; Zacharias DA, 2002, SCIENCE, V296, P913, DOI 10.1126/science.1068539	33	209	217	0	17	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	AUG 29	2008	283	35					23972	23980		10.1074/jbc.M803180200	http://dx.doi.org/10.1074/jbc.M803180200			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	340II	18586673	Green Published, hybrid			2022-12-27	WOS:000258638900053
J	Mori, M; Yoneda-Kato, N; Yoshida, A; Kato, JY				Mori, Masaaki; Yoneda-Kato, Noriko; Yoshida, Akihiro; Kato, Jun-ya			Stable Form of JAB1 Enhances Proliferation and Maintenance of Hematopoietic Progenitors	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							BINDING PROTEIN-1 EXPRESSION; CYCLE INHIBITOR P27(KIP1); COP9 SIGNALOSOME; PROGNOSTIC-SIGNIFICANCE; PANCREATIC-CANCER; UBIQUITIN LIGASES; TUMOR SUPPRESSION; BREAST-CANCER; DEGRADATION; P27	Overexpression of JAB1 is observed in a variety of human cancers, but how JAB1 is involved in tumor development remained to be investigated. Here we analyzed mice with modified Jab1 expression. Mice ectopically expressing a more stable form of JAB1 protein under the control of a constitutive promoter were rescued from the embryonic lethality caused by the Jab1(-/-) allele and developed a myeloproliferative disorder in a gene dosage-dependent manner. Hematopoietic cells from the bone marrow of Jab1 transgenic mice had a significantly larger stem cell population and exhibited higher and transplantable proliferative potential. In contrast, Jab1(-/-) mice, which express similar to 70% as much JAB1 protein as their wild-type littermates, showed inefficient hematopoiesis. Expression of the tumor suppressor p16(INK4a) was inversely correlated with that of JAB1, and the oncoprotein SMYD3, a newly identified JAB1 interactor, suppressed transcription of p16 in cooperation with JAB1. Thus, the expression and function of JAB1 are critical for the proliferation and maintenance of hematopoietic progenitors.	[Mori, Masaaki; Yoneda-Kato, Noriko; Yoshida, Akihiro; Kato, Jun-ya] Nara Inst Sci & Technol, Grad Sch Biol Sci, Nara 6300101, Japan	Nara Institute of Science & Technology	Kato, JY (corresponding author), Nara Inst Sci & Technol, Grad Sch Biol Sci, 8916-5 Takayama, Nara 6300101, Japan.	jkata@bs.naist.jp			Ministry of Education, Science, and Culture of Japan	Ministry of Education, Science, and Culture of Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT))	This work was partly supported by grants-in-aid for scientific research and for cancer research from the Ministry of Education, Science, and Culture of Japan. The costs of publication of this article were defrayed in part by the payment of page charges. This article must therefore be hereby marked "advertisement" in accordance with 18 U. S. C. Section 1734 solely to indicate this fact.	Adler AS, 2006, NAT GENET, V38, P421, DOI 10.1038/ng1752; Bech-Otschir D, 2001, EMBO J, V20, P1630, DOI 10.1093/emboj/20.7.1630; Bech-Otschir D, 2002, J CELL SCI, V115, P467; Bounpheng MA, 2000, GENE, V242, P41, DOI 10.1016/S0378-1119(99)00525-9; Chamovitz DA, 2002, CURR BIOL, V12, pR232, DOI 10.1016/S0960-9822(02)00775-3; Chamovitz DA, 2001, EMBO REP, V2, P96, DOI 10.1093/embo-reports/kve028; CHEN C, 1987, MOL CELL BIOL, V7, P2745, DOI 10.1128/MCB.7.8.2745; Claret FX, 1996, NATURE, V383, P453, DOI 10.1038/383453a0; Cope GA, 2003, CELL, V114, P663, DOI 10.1016/S0092-8674(03)00722-0; Dong YY, 2005, CLIN CANCER RES, V11, P259; Esteva FJ, 2003, CLIN CANCER RES, V9, P5652; Fukumoto A, 2004, ONCOL REP, V11, P277; Fukumoto A, 2006, FEBS LETT, V580, P5836, DOI 10.1016/j.febslet.2006.09.042; Gil J, 2006, NAT REV MOL CELL BIO, V7, P667, DOI 10.1038/nrm1987; Goto A, 2004, PATHOL INT, V54, P675, DOI 10.1111/j.1440-1827.2004.01679.x; Hallstrom TC, 2006, GENE DEV, V20, P613, DOI 10.1101/gad.1345006; Hamamoto R, 2004, NAT CELL BIOL, V6, P731, DOI 10.1038/ncb1151; Ito Y, 2003, ANTICANCER RES, V23, P4121; Ito Y, 2003, CANCER LETT, V196, P87, DOI 10.1016/S0304-3835(03)00129-0; Ivan D, 2004, MODERN PATHOL, V17, P811, DOI 10.1038/modpathol.3800123; Janzen V, 2006, NATURE, V443, P421, DOI 10.1038/nature05159; Kim WY, 2006, CELL, V127, P265, DOI 10.1016/j.cell.2006.10.003; Kouvaraki MA, 2003, CANCER RES, V63, P2977; Leal JFM, 2008, ONCOGENE, V27, P1961, DOI 10.1038/sj.onc.1210846; Lowe SW, 2003, CURR OPIN GENET DEV, V13, P77, DOI 10.1016/S0959-437X(02)00013-8; Matsumoto N, 2000, LEUKEMIA, V14, P1757, DOI 10.1038/sj.leu.2401897; Osoegawa A, 2004, J CLIN ONCOL, V22, P4165, DOI 10.1200/JCO.2004.01.035; Patil MA, 2005, CARCINOGENESIS, V26, P2050, DOI 10.1093/carcin/bgi178; Seeger M, 1998, FASEB J, V12, P469, DOI 10.1096/fasebj.12.6.469; Seeger M, 2001, CURR BIOL, V11, pR643, DOI 10.1016/S0960-9822(01)00382-7; Serrano M, 1996, CELL, V85, P27, DOI 10.1016/S0092-8674(00)81079-X; Sui L, 2001, CLIN CANCER RES, V7, P4130; Tomoda K, 1999, NATURE, V398, P160, DOI 10.1038/18230; Tomoda K, 2005, BLOOD, V105, P775, DOI 10.1182/blood-2004-04-1242; Tomoda K, 2004, J BIOL CHEM, V279, P43013, DOI 10.1074/jbc.M406559200; Wei N, 2003, ANNU REV CELL DEV BI, V19, P261, DOI 10.1146/annurev.cellbio.19.111301.112449; Wolf DA, 2003, NAT CELL BIOL, V5, P1029, DOI 10.1038/ncb1203-1029; Yoneda-Kato N, 2005, EMBO J, V24, P1739, DOI 10.1038/sj.emboj.7600656	38	25	25	0	0	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	OCT 24	2008	283	43					29011	29021		10.1074/jbc.M804539200	http://dx.doi.org/10.1074/jbc.M804539200			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	362EB	18667426	hybrid, Green Published			2022-12-27	WOS:000260179900027
J	Schimmel, P				Schimmel, Paul			An Editing Activity That Prevents Mistranslation and Connection to Disease	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							TRANSFER-RNA-SYNTHETASE; RIBONUCLEIC-ACID SYNTHETASE; AMINOACYLATION; DEACYLATION; SIEVE; COLI		Scripps Res Inst, Skaggs Inst Chem Biol, La Jolla, CA 92037 USA	Scripps Research Institute	Schimmel, P (corresponding author), Scripps Res Inst, Skaggs Inst Chem Biol, La Jolla, CA 92037 USA.	schimmel@scripps.edu			National Institutes of Health; National Foundation for Cancer Research; The Skaggs Foundation	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); National Foundation for Cancer Research; The Skaggs Foundation	The work on editing activity has been supported over the years by grants from the National Institutes of Health, by a fellowship from the National Foundation for Cancer Research, and by The Skaggs Foundation.	BALDWIN AN, 1966, J BIOL CHEM, V241, P831; Beebe K, 2008, NATURE, V451, P90, DOI 10.1038/nature06454; ELDRED EW, 1972, J BIOL CHEM, V247, P2961; GIEGE R, 1971, FEBS LETT, V15, P281, DOI 10.1016/0014-5793(71)80638-5; Lee JW, 2006, NATURE, V443, P50, DOI 10.1038/nature05096; Lin L, 1996, NATURE, V384, P33, DOI 10.1038/384033b0; Nangle LA, 2006, CHEM BIOL, V13, P1091, DOI 10.1016/j.chembiol.2006.08.011; Nureki O, 1998, SCIENCE, V280, P578, DOI 10.1126/science.280.5363.578; PAULING L, 1958, FESTSCHRIFT FUER A S; SCHIMMEL P, 1995, TRENDS BIOCHEM SCI, V20, P1, DOI 10.1016/S0968-0004(00)88937-9; SCHMIDT E, 1994, SCIENCE, V264, P265, DOI 10.1126/science.8146659; SCHREIER AA, 1972, BIOCHEMISTRY-US, V11, P1582, DOI 10.1021/bi00759a006; STARZYK RM, 1987, SCIENCE, V237, P1614, DOI 10.1126/science.3306924; YARUS M, 1972, P NATL ACAD SCI USA, V69, P1915, DOI 10.1073/pnas.69.7.1915	14	5	5	0	0	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	OCT 24	2008	283	43					28777	28782		10.1074/jbc.X800007200	http://dx.doi.org/10.1074/jbc.X800007200			6	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	362EB	18640977	hybrid, Green Published			2022-12-27	WOS:000260179900001
J	MacLaine, NJ; Oster, B; Bundgaard, B; Fraser, JA; Buckner, C; Lazo, PA; Meek, DW; Hollsberg, P; Hupp, TR				MacLaine, Nicola J.; Oster, Bodil; Bundgaard, Bettina; Fraser, Jennifer A.; Buckner, Carolyn; Lazo, Pedro A.; Meek, David W.; Hoellsberg, Per; Hupp, Ted R.			A central role for CK1 in catalyzing phosphorylation of the p53 transactivation domain at serine 20 after HHV-6B viral infection	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							DNA-DEPENDENT ACETYLATION; C VIRUS NS5A; COACTIVATOR P300; POINT MUTATION; KINASE; HYPERPHOSPHORYLATION; BINDING; DAMAGE; CELLS; SITE	The tumor suppressor protein p53 is activated by distinct cellular stresses including radiation, hypoxia, type I interferon, and DNA/RNA virus infection. The transactivation domain of p53 contains a phosphorylation site at Ser(20) whose modification stabilizes the binding of the transcriptional co-activator p300 and whose mutation in murine transgenics induces B-cell lymphoma. Although the checkpoint kinase CHK2 is implicated in promoting Ser(20) site phosphorylation after irradiation, the enzyme that triggers this phosphorylation after DNA viral infection is undefined. Using human herpesvirus 6B (HHV-6B) as a virus that induces Ser(20) site phosphorylation of p53 in T-cells, we sought to identify the kinase responsible for this virus-induced p53 modification. The p53 Ser(20) kinase was fractionated and purified using cation, anion, and dye-ligand exchange chromatography. Mass spectrometry identified casein kinase 1 (CK1) and vaccinia-related kinase 1 (VRK1) as enzymes that coeluted with virus-induced Ser(20) site kinase activity. Immunodepletion of CK1 but not VRK1 removed the kinase activity from the peak fraction, and bacterially expressed CK1 exhibited Ser(20) site kinase activity equivalent to that of the virus-induced native CK1. CK1 modified p53 in a docking-dependent manner, which is similar to other known Ser(20) site p53 kinases. Low levels of the CK1 inhibitor D4476 selectively inhibited HHV-6B-induced Ser(20) site phosphorylation of p53. However, x-ray-induced Ser(20) site phosphorylation of p53 was not blocked by D4476. These data highlight a central role for CK1 as the Ser(20) site kinase for p53 in DNA virus-infected cells but also suggest that distinct stresses may selectively trigger different protein kinases to modify the transactivation domain of p53 at Ser(20).	[MacLaine, Nicola J.; Fraser, Jennifer A.; Buckner, Carolyn; Hupp, Ted R.] Univ Edinburgh, Edinburgh EH4 2XR, Midlothian, Scotland; [Oster, Bodil; Bundgaard, Bettina; Hoellsberg, Per] Univ Aarhus, Inst Med Microbiol & Immunol, DK-800 Aarhus, Denmark; [Lazo, Pedro A.] Univ Salamanca, Consejo Super Invest Cient, Ctr Invest Canc, Inst Biol Mol & Celular Canc,Programa Oncol Trans, Salamanca 37071, Spain; [Meek, David W.] Univ Dundee, Ninewells Hosp & Med Sch, Biomed Res Ctr, Dundee DD1 4HN, Scotland	University of Edinburgh; Aarhus University; Consejo Superior de Investigaciones Cientificas (CSIC); CSIC - Centro de Investigacion del Cancer (CIC); CSIC-USAL - Instituto de Biologia Molecular y Celular del Cancer de Salamanca (IBMCC); University of Salamanca; University of Dundee	Hupp, TR (corresponding author), Univ Edinburgh, Crewe Rd S, Edinburgh EH4 2XR, Midlothian, Scotland.	ted.hupp@ed.ac.uk	Lazo, Pedro A./M-6435-2014; 2008, Ibsal/A-1268-2012; RASOR, Scotland/A-3274-2011	Lazo, Pedro A./0000-0001-8997-3025; Fraser, Jennifer/0000-0001-5546-3916	Biotechnology and Biological Sciences Research Council; Radical Solutions for Researching the Proteome (RASOR); Interdisciplinary Research Collaboration in Proteomic Technologies; Lundbeck Foundation; University of Aarhus, Denmark; Cancer Research UK	Biotechnology and Biological Sciences Research Council(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); Radical Solutions for Researching the Proteome (RASOR); Interdisciplinary Research Collaboration in Proteomic Technologies; Lundbeck Foundation(Lundbeckfonden); University of Aarhus, Denmark; Cancer Research UK(Cancer Research UK)	Supported by the Biotechnology and Biological Sciences Research Council-Radical Solutions for Researching the Proteome ( RASOR) Interdisciplinary Research Collaboration in Proteomic Technologies. 2 Supported by grants from the Lundbeck Foundation, Edith Stern, and the Faculty of Health Science ( Program on Molecular Medicine), University of Aarhus, Denmark. 3 Supported by Cancer Research UK.	Ahn JW, 2003, J BIOL CHEM, V278, P20480, DOI 10.1074/jbc.M213185200; Alsheich-Bartok O, 2008, ONCOGENE, V27, P3653, DOI 10.1038/sj.onc.1211036; Boutell C, 2004, J VIROL, V78, P8068, DOI 10.1128/JVI.78.15.8068-8077.2004; Bruins W, 2004, MOL CELL BIOL, V24, P8884, DOI 10.1128/mcb.24.20.8884-8894.2004; Bruins W, 2007, CARCINOGENESIS, V28, P1814, DOI 10.1093/carcin/bgm041; Campagna M, 2007, J GEN VIROL, V88, P2800, DOI 10.1099/vir.0.82922-0; Craig A, 2003, EMBO REP, V4, P787, DOI 10.1038/sj.embor.embor901; Craig AL, 2007, MOL CELL BIOL, V27, P3542, DOI 10.1128/MCB.01595-06; Craig Ashley L, 2003, Methods Mol Biol, V234, P171; Dornan D, 2003, J BIOL CHEM, V278, P13431, DOI 10.1074/jbc.M211460200; Dornan D, 2003, MOL CELL BIOL, V23, P8846, DOI 10.1128/MCB.23.23.8846-8861.2003; Dumaz N, 1999, FEBS LETT, V463, P312, DOI 10.1016/S0014-5793(99)01647-6; Hupp TR, 2007, NAT STRUCT MOL BIOL, V14, P885, DOI 10.1038/nsmb1007-885; HUPP TR, 1995, CELL, V83, P237, DOI 10.1016/0092-8674(95)90165-5; Levine AJ, 2006, CELL DEATH DIFFER, V13, P1027, DOI 10.1038/sj.cdd.4401910; Lin PY, 2006, APOPTOSIS, V11, P2179, DOI 10.1007/s10495-006-0291-6; MacPherson D, 2004, EMBO J, V23, P3689, DOI 10.1038/sj.emboj.7600363; Oster B, 2008, J GEN VIROL, V89, P87, DOI 10.1099/vir.0.83136-0; Oster B, 2005, J VIROL, V79, P1961, DOI 10.1128/JVI.79.3.1961-1965.2005; Pedersen SM, 2006, VIROLOGY, V356, P1, DOI 10.1016/j.virol.2006.07.028; Polley S, 2008, J MOL BIOL, V376, P8, DOI 10.1016/j.jmb.2007.11.082; Quintavalle M, 2007, J BIOL CHEM, V282, P5536, DOI 10.1074/jbc.M610486200; Quintavalle M, 2006, J VIROL, V80, P11305, DOI 10.1128/JVI.01465-06; Rena G, 2004, EMBO REP, V5, P60, DOI 10.1038/sj.embor.7400048; Shieh SY, 2000, GENE DEV, V14, P289; Sun YP, 2005, J BIOL CHEM, V280, P15561, DOI 10.1074/jbc.m412630200; Takaoka A, 2003, NATURE, V424, P516, DOI 10.1038/nature01850; Teufel DP, 2007, P NATL ACAD SCI USA, V104, P7009, DOI 10.1073/pnas.0702010104; Valbuena A, 2007, ARCH BIOCHEM BIOPHYS, V465, P219, DOI 10.1016/j.abb.2007.06.005; Vega FM, 2004, MOL CELL BIOL, V24, P10366, DOI 10.1128/MCB.24.23.10366-10380.2004; Wallace M, 2006, MOL CELL, V23, P251, DOI 10.1016/j.molcel.2006.05.029	31	29	29	0	0	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	OCT 17	2008	283	42					28563	28573		10.1074/jbc.M804433200	http://dx.doi.org/10.1074/jbc.M804433200			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	359EN	18669630	hybrid, Green Published			2022-12-27	WOS:000259969300059
J	Del Favero, M; Mazzantini, E; Briani, F; Zangrossi, S; Tortora, P; Deho, G				Del Favero, Marta; Mazzantini, Elisa; Briani, Federica; Zangrossi, Sandro; Tortora, Paolo; Deho, Gianni			Regulation of Escherichia coli polynucleotide phosphorylase by ATP	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							MESSENGER-RNA DEGRADATION; PHOSPHOROLYSIS REACTIONS; BACILLUS-SUBTILIS; LOW-TEMPERATURE; BINDING DOMAIN; ENERGY CHARGE; GENE; DEGRADOSOME; PROTEIN; EXPRESSION	Polynucleotide phosphorylase ( PNPase), an enzyme conserved in bacteria and eukaryotic organelles, processively catalyzes the phosphorolysis of RNA, releasing nucleotide diphosphates, and the reverse polymerization reaction. In Escherichia coli, both reactions are implicated in RNA decay, as addition of either poly( A) or heteropolymeric tails targets RNA to degradation. PNPase may also be associated with the RNA degradosome, a heteromultimeric protein machine that can degrade highly structured RNA. Here, we report that ATP binds to PNPase and allosterically inhibits both its phosphorolytic and polymerization activities. Our data suggest that PNPase-dependent RNA tailing and degradation occur mainly at low ATP concentrations, whereas other enzymes may play a more significant role at high energy charge. These findings connect RNA turnover with the energy charge of the cell and highlight unforeseen metabolic roles of PNPase.	[Briani, Federica; Deho, Gianni] Univ Milan, Dipartimento Sci Biomol & Biotecnol, I-20133 Milan, Italy; [Del Favero, Marta; Mazzantini, Elisa; Tortora, Paolo] Univ Milano Bicocca, Dipartimento Biotecnol & Biosci, I-20126 Milan, Italy; [Zangrossi, Sandro] Ctr Studio Consiglio Nazl Ric Biol Cellulare & Mo, I-20133 Milan, Italy	University of Milan; University of Milano-Bicocca	Deho, G (corresponding author), Univ Milan, Dipartimento Sci Biomol & Biotecnol, Via Celoria 26, I-20133 Milan, Italy.	gianni.deho@unimi.it	Briani, Federica/AAM-5213-2020; BRIANI, FEDERICA/B-4596-2017	Briani, Federica/0000-0002-5876-4463; BRIANI, FEDERICA/0000-0002-5876-4463; Tortora, Paolo/0000-0001-5234-601X; DEHO', GIOVANNI/0000-0001-5492-7766	Ministero dell'Universita e della Ricerca; Universita degli Studi di Milano [PRIN 2006]	Ministero dell'Universita e della Ricerca(Ministry of Education, Universities and Research (MIUR)); Universita degli Studi di Milano	This work was supported in part by joint grants from the Ministero dell'Universita e della Ricerca and the Universita degli Studi di Milano (PRIN 2006). The costs of publication of this article were defrayed in part by the payment of page charges. This article must therefore be hereby marked "advertisement" in accordance with 18 U. S. C. Section 1734 solely to indicate this fact.	Andrade JM, 2006, MOL MICROBIOL, V60, P219, DOI 10.1111/j.1365-2958.2006.05092.x; ATKINSON DE, 1968, BIOCHEMISTRY-US, V7, P4030, DOI 10.1021/bi00851a033; Bermudez-Cruz RM, 2005, BIOCHIMIE, V87, P737, DOI 10.1016/j.biochi.2005.03.005; Briani F, 2007, BIOCHIMIE, V89, P145, DOI 10.1016/j.biochi.2006.09.020; Bycroft M, 1997, CELL, V88, P235, DOI 10.1016/S0092-8674(00)81844-9; Carpousis AJ, 2007, ANNU REV MICROBIOL, V61, P71, DOI 10.1146/annurev.micro.61.080706.093440; Chen HW, 2007, TRENDS CELL BIOL, V17, P600, DOI 10.1016/j.tcb.2007.09.006; Clements MO, 2002, P NATL ACAD SCI USA, V99, P8784, DOI 10.1073/pnas.132047099; Danchin A, 1997, DNA Res, V4, P9, DOI 10.1093/dnares/4.1.9; Deutscher MP, 2006, NUCLEIC ACIDS RES, V34, P659, DOI 10.1093/nar/gkj472; DEUTSCHER MP, 1991, P NATL ACAD SCI USA, V88, P3277, DOI 10.1073/pnas.88.8.3277; Fontanella L, 1999, ANAL BIOCHEM, V269, P353, DOI 10.1006/abio.1999.4042; GODEFROY T, 1970, EUR J BIOCHEM, V14, P222, DOI 10.1111/j.1432-1033.1970.tb00281.x; GODEFROY T, 1970, EUR J BIOCHEM, V12, P236, DOI 10.1111/j.1432-1033.1970.tb00843.x; Goverde RLJ, 1998, MOL MICROBIOL, V28, P555, DOI 10.1046/j.1365-2958.1998.00816.x; GRUNBERGMANAGO M, 1967, BIOCHEM J, V103, pP62; GRUNBERGMANAGO M, 1955, SCIENCE, V122, P907, DOI 10.1126/science.122.3176.907; Gualerzi CO, 2003, J MOL BIOL, V331, P527, DOI 10.1016/S0022-2836(03)00732-0; Hurwitz J, 2005, J BIOL CHEM, V280, P42477, DOI 10.1074/jbc.X500006200; KIMHI Y, 1967, BIOCHEMISTRY-US, V6, P2066, DOI 10.1021/bi00859a025; Leszczyniecka M, 2004, MOL PHYLOGENET EVOL, V31, P123, DOI 10.1016/j.ympev.2003.07.012; Lin PH, 2005, P NATL ACAD SCI USA, V102, P16590, DOI 10.1073/pnas.0500994102; Lin-Chao S, 2007, J BIOMED SCI, V14, P523, DOI 10.1007/s11373-007-9178-y; Liou GG, 2001, P NATL ACAD SCI USA, V98, P63, DOI 10.1073/pnas.011535498; Luttinger A, 1996, MOL MICROBIOL, V19, P343, DOI 10.1046/j.1365-2958.1996.380907.x; Mackie GA, 2001, METHOD ENZYMOL, V342, P346, DOI 10.1016/S0076-6879(01)42557-2; Matus-Ortega ME, 2007, BBA-GENE STRUCT EXPR, V1769, P194, DOI 10.1016/j.bbaexp.2007.01.008; Miczak A, 1996, P NATL ACAD SCI USA, V93, P3865, DOI 10.1073/pnas.93.9.3865; Mohanty BK, 2006, NUCLEIC ACIDS RES, V34, P5695, DOI 10.1093/nar/gkl684; Mohanty BK, 2000, P NATL ACAD SCI USA, V97, P11966, DOI 10.1073/pnas.220295997; Ochoa S., 1959, NOBEL LECT; Piazza F, 1996, J BACTERIOL, V178, P5513, DOI 10.1128/jb.178.18.5513-5521.1996; PORTIER C, 1975, FEBS LETT, V50, P79, DOI 10.1016/0014-5793(75)81045-3; PY B, 1994, MOL MICROBIOL, V14, P717, DOI 10.1111/j.1365-2958.1994.tb01309.x; Py B, 1996, NATURE, V381, P169, DOI 10.1038/381169a0; REGNIER P, 1987, J BIOL CHEM, V262, P63; Regonesi ME, 2006, BIOCHIMIE, V88, P151, DOI 10.1016/j.biochi.2005.07.012; Regonesi ME, 2004, NUCLEIC ACIDS RES, V32, P1006, DOI 10.1093/nar/gkh268; Rosenzweig JA, 2007, FEMS MICROBIOL LETT, V270, P255, DOI 10.1111/j.1574-6968.2007.00689.x; Sarkar D, 2006, PHARMACOL THERAPEUT, V112, P243, DOI 10.1016/j.pharmthera.2006.04.003; Segel I.H., 1975, ENZYME KINETICS; SHEN LC, 1970, J BIOL CHEM, V245, P5974; SIOMI H, 1993, CELL, V74, P291, DOI 10.1016/0092-8674(93)90420-U; Slomovic S, 2006, CRIT REV PLANT SCI, V25, P65, DOI 10.1080/07352680500391337; Symmons MF, 2000, STRUCTURE, V8, P1215, DOI 10.1016/S0969-2126(00)00521-9; THANG MN, 1967, J MOL BIOL, V26, P403, DOI 10.1016/0022-2836(67)90312-9; WEBB MR, 1992, P NATL ACAD SCI USA, V89, P4884, DOI 10.1073/pnas.89.11.4884; Zuker M, 2003, NUCLEIC ACIDS RES, V31, P3406, DOI 10.1093/nar/gkg595	48	28	28	0	1	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	OCT 10	2008	283	41					27355	27359		10.1074/jbc.C800113200	http://dx.doi.org/10.1074/jbc.C800113200			5	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	355OW	18650428	hybrid			2022-12-27	WOS:000259719200003
J	Nakai, Y; Nakai, M; Hayashi, H				Nakai, Yumi; Nakai, Masato; Hayashi, Hideyuki			Thio-modification of yeast cytosolic tRNA requires a ubiquitin-related system that resembles bacterial sulfur transfer systems	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ESCHERICHIA-COLI; PROTEIN CONJUGATION; ELONGATOR COMPLEX; BIOSYNTHESIS; MITOCHONDRIAL; THIAMIN; LOCALIZATION; NFS1P; BIOGENESIS; ACTIVATION	The wobble uridine in yeast cytosolic tRN(UUU)(ALys2) and tRNA(UUC)(Glu3) undergoes a thio- modification at the second position (s(2) modification) and a methoxycarbonylmethyl modification at the fifth position (mcm(5) modification). We previously demonstrated that the cytosolic and mitochondrial iron- sulfur (Fe/S) cluster assembly machineries termed CIA and ISC, including a cysteine desulfurase called Nfs1, were essential for the s(2) modification. However, the cytosolic component that directly participates in this process remains unclear. Wefound that ubiquitinlike protein Urm1 and ubiquitin- activating enzyme- like protein Uba4, as well as Tuc1 and Tuc2, were strictly required for the s(2) modification. The carboxyl- terminal glycine residue of Urm1 was critical for the s(2) modification, indicating direct involvement of the unique ubiquitin- related system in this process. We also demonstrated that the s(2) and mcm(5) modifications in cytosolic tRNAs influence each other's efficiency. Taken together, our data indicate that the s(2) modification of cytosolic tRNAs is a more complex process that requires additional unidentified components.	[Nakai, Yumi; Hayashi, Hideyuki] Osaka Med Coll, Dept Biochem, Takatsuki, Osaka 5698686, Japan; [Nakai, Masato] Osaka Univ, Inst Prot Res, Suita, Osaka 5650871, Japan	Osaka Medical College; Osaka University	Nakai, Y (corresponding author), Osaka Med Coll, Dept Biochem, 2-7 Daigaku Cho, Takatsuki, Osaka 5698686, Japan.	med004@art.osaka-med.ac.jp			Japan Society for the Promotion of Science [19570140]	Japan Society for the Promotion of Science(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science)	This work was supported by Grant- in-aid for Scientific Research 19570140 from the Japan Society for the Promotion of Science (to Y.N.). The costs of publication of this article were defrayed in part by the payment of page charges. This article must therefore be hereby marked "advertisement" in accordance with 18 U. S. C. Section 1734 solely to indicate this fact.	Agris PF, 2007, J MOL BIOL, V366, P1, DOI 10.1016/j.jmb.2006.11.046; Bjork GR, 2007, RNA, V13, P1245, DOI 10.1261/rna.558707; BORK P, 1994, PROTEINS, V20, P347, DOI 10.1002/prot.340200407; CVRCKOVA F, 1995, GENE DEV, V9, P1817, DOI 10.1101/gad.9.15.1817; Dewez M, 2008, P NATL ACAD SCI USA, V105, P5459, DOI 10.1073/pnas.0709404105; Dorrestein PC, 2004, CHEM BIOL, V11, P1373, DOI 10.1016/j.chembiol.2004.08.009; Esberg A, 2006, MOL CELL, V24, P139, DOI 10.1016/j.molcel.2006.07.031; Fichtner L, 2002, MOL MICROBIOL, V44, P865, DOI 10.1046/j.1365-2958.2002.02928.x; Furukawa K, 2000, J BIOL CHEM, V275, P7462, DOI 10.1074/jbc.275.11.7462; Goehring AS, 2003, MOL BIOL CELL, V14, P1501, DOI 10.1091/mbc.E02-06-0348; Goehring AS, 2003, MOL BIOL CELL, V14, P4329, DOI 10.1091/mbc.e03-02-0079; Huang B, 2005, RNA, V11, P424, DOI 10.1261/rna.7247705; Kalhor HR, 2003, MOL CELL BIOL, V23, P9283, DOI 10.1128/MCB.23.24.9283-9292.2003; Kerscher O, 2006, ANNU REV CELL DEV BI, V22, P159, DOI 10.1146/annurev.cellbio.22.010605.093503; Kispal G, 1999, EMBO J, V18, P3981, DOI 10.1093/emboj/18.14.3981; Lauhon CT, 2000, J BIOL CHEM, V275, P20096, DOI 10.1074/jbc.M002680200; Lehmann C, 2006, BIOCHEMISTRY-US, V45, P11, DOI 10.1021/bi051502y; Lill R, 2006, ANNU REV CELL DEV BI, V22, P457, DOI 10.1146/annurev.cellbio.22.010305.104538; Nakai Y, 2004, J BIOL CHEM, V279, P12363, DOI 10.1074/jbc.M312448200; Nakai Y, 1998, FEBS LETT, V433, P143, DOI 10.1016/S0014-5793(98)00897-7; Nakai Y, 2001, J BIOL CHEM, V276, P8314, DOI 10.1074/jbc.M007878200; Nakai Y, 2007, MOL CELL BIOL, V27, P2841, DOI 10.1128/MCB.01321-06; Nakanishi K, 2005, P NATL ACAD SCI USA, V102, P7487, DOI 10.1073/pnas.0501003102; Numata T, 2006, NATURE, V442, P419, DOI 10.1038/nature04896; Paraskevopoulou C, 2006, MOL MICROBIOL, V59, P795, DOI 10.1111/j.1365-2958.2005.04989.x; Schmitz J, 2008, BIOCHEMISTRY-US, V47, P6479, DOI 10.1021/bi800477u; Singh S, 2005, PROTEIN SCI, V14, P2095, DOI 10.1110/ps.051577605; Umeda N, 2005, J BIOL CHEM, V280, P1613, DOI 10.1074/jbc.M409306200; Xi J, 2001, P NATL ACAD SCI USA, V98, P8513, DOI 10.1073/pnas.141226698; Xu JJ, 2006, P NATL ACAD SCI USA, V103, P11625, DOI 10.1073/pnas.0604876103	30	97	103	0	3	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	OCT 10	2008	283	41					27469	27476		10.1074/jbc.M804043200	http://dx.doi.org/10.1074/jbc.M804043200			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	355OW	18664566	hybrid			2022-12-27	WOS:000259719200017
J	Singh, PK; Behrens, ME; Eggers, JP; Cerny, RL; Bailey, JM; Shanmugam, K; Gendler, SJ; Bennett, EP; Hollingsworth, MA				Singh, Pankaj K.; Behrens, Michelle E.; Eggers, John P.; Cerny, Ronald L.; Bailey, Jennifer M.; Shanmugam, Kandavel; Gendler, Sandra J.; Bennett, Eric P.; Hollingsworth, Michael A.			Phosphorylation of MUC1 by met modulates interaction with p53 and MMP1 expression	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							HEPATOCYTE GROWTH-FACTOR; HUMAN PANCREATIC-CANCER; CARCINOMA-ASSOCIATED ANTIGEN; MATRIX METALLOPROTEINASE-1; CELL-LINE; BETA-CATENIN; CYTOPLASMIC TAIL; FACTOR RECEPTOR; METASTATIC PROPERTIES; ADENOCARCINOMA CELLS	MUC1, a transmembrane mucin, is a key modulator of several signaling pathways that affect oncogenesis, motility, and cell morphology. The interaction of MUC1 cytoplasmic tail (MUC1CT) with signal transducers and its nuclear translocation and subsequent biological responses are believed to be regulated by phosphorylation status, but the precise mechanisms by which this occurs remain poorly defined. We detected a novel association between the Met receptor tyrosine kinase and the MUC1CT. Met catalyzed phosphorylation of tyrosine at YHPM in the MUC1CT. Stimulation of S2-013.MUC1F pancreatic cancer cells with hepatocyte growth factor facilitated nuclear localization of MUC1CT, as determined by real time confocal imaging analysis. MUC1 overexpression also facilitated faster turnover of Met. Phosphorylation of MUC1CT by Met enhanced its interaction with p53, which led to suppression of AP1 transcription factor activity through interactions at the MMP1 promoter, ultimately leading to reduced transcription of MMP1. This correlated with a decrease in hepatocyte growth factor-induced invasiveness when MUC1 was overexpressed. The results demonstrate that MUC1 modulates Met-mediated oncogenic signaling in cancer.	[Singh, Pankaj K.; Eggers, John P.; Bailey, Jennifer M.; Hollingsworth, Michael A.] Univ Nebraska Med Ctr, Eppley Inst Res Canc & Allied Dis, Omaha, NE 68198 USA; [Singh, Pankaj K.; Behrens, Michelle E.; Hollingsworth, Michael A.] Univ Nebraska Med Ctr, Dept Biochem & Mol Biol, Omaha, NE 68198 USA; [Cerny, Ronald L.] Univ Nebraska, Lincoln, NE 68588 USA; [Shanmugam, Kandavel; Gendler, Sandra J.] Mayo Clin, Coll Med, Program Mol Biol, Dept Biochem, Scottsdale, AZ 85259 USA; [Bennett, Eric P.] Univ Copenhagen, Dept Odontol, Sch Dent, DK-2200 Copenhagen N, Denmark	University of Nebraska System; University of Nebraska Medical Center; University of Nebraska System; University of Nebraska Medical Center; University of Nebraska System; University of Nebraska Lincoln; Mayo Clinic; Mayo Clinic Phoenix; University of Copenhagen	Hollingsworth, MA (corresponding author), Univ Nebraska Med Ctr, Eppley Inst Res Canc & Allied Dis, 986805 NE Med Ctr, Omaha, NE 68198 USA.	mahollin@unmc.edu		Bennett, Eric Paul/0000-0002-4976-0647; Singh, Pankaj/0000-0001-8903-0131; Bailey-Lundberg, Jennifer/0000-0002-4750-106X	National Institutes of Health [R01 CA57362, U01 CA111294, CA09476, P20 RR15635]; NCI Cancer Center [P30 CA36727]; Nebraska Research Initiative; Danish National Research Council; NATIONAL CANCER INSTITUTE [U01CA111294, T32CA009476, P30CA036727, R01CA057362] Funding Source: NIH RePORTER; NATIONAL CENTER FOR RESEARCH RESOURCES [P20RR015635] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NCI Cancer Center(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); Nebraska Research Initiative; Danish National Research Council(Danmarks Grundforskningsfond); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR))	This work was supported, in whole or in part, by National Institutes of Health Grants R01 CA57362, U01 CA111294, CA09476 (training), P20 RR15635 from the COBRE Program of the NCRR, and P30 CA36727 from the NCI Cancer Center. This work was also supported by graduate studies assistantships (to P.K.S., J.P.E., and J.M.B.), the Nebraska Research Initiative, and the Danish National Research Council. The costs of publication of this article were defrayed in part by the payment of page charges. This article must therefore be hereby marked "advertisement" in accordance with 18 U. S. C. Section 1734 solely to indicate this fact.	BATRA SK, 1991, J CELL SCI, V100, P841; Beum PV, 1999, J BIOL CHEM, V274, P24641, DOI 10.1074/jbc.274.35.24641; Bian JH, 1997, MOL CELL BIOL, V17, P6330, DOI 10.1128/MCB.17.11.6330; Bolanos-Garcia VM, 2005, MOL CELL BIOCHEM, V276, P149, DOI 10.1007/s11010-005-3696-6; Burdick MD, 1997, J BIOL CHEM, V272, P24198, DOI 10.1074/jbc.272.39.24198; Corso S, 2005, TRENDS MOL MED, V11, P284, DOI 10.1016/j.molmed.2005.04.005; DIRENZO MF, 1995, CANCER RES, V55, P1129; Fuchs B, 2003, FEBS LETT, V553, P104, DOI 10.1016/S0014-5793(03)00984-0; FURUKAWA T, 1995, AM J PATHOL, V147, P889; GALIMI F, 1993, STEM CELLS, V11, P22; Gao CF, 2005, CELL RES, V15, P49, DOI 10.1038/sj.cr.7290264; GRAEVE L, 1989, J CELL BIOL, V109, P2809, DOI 10.1083/jcb.109.6.2809; Higuchi T, 2004, MOL CELL BIOL, V24, P7456, DOI 10.1128/MCB.24.17.7456-7468.2004; Hinoda Y, 2003, J GASTROENTEROL, V38, P1162, DOI 10.1007/s00535-003-1224-6; IWAMURA T, 1992, J GASTROEN HEPATOL, V7, P512, DOI 10.1111/j.1440-1746.1992.tb01030.x; Jinnin M, 2005, NUCLEIC ACIDS RES, V33, P3540, DOI 10.1093/nar/gki648; Jinnin M, 2005, J INVEST DERMATOL, V124, P324, DOI 10.1111/j.0022-202X.2004.23601.x; KIM YW, 1989, PANCREAS, V4, P353, DOI 10.1097/00006676-198906000-00013; Kohlgraf KG, 2003, CANCER RES, V63, P5011; LACROIX M, 2008, CANC CHEMOT IN PRESS; Leng YM, 2007, J BIOL CHEM, V282, P19321, DOI 10.1074/jbc.M703222200; Li YQ, 1998, MOL CELL BIOL, V18, P7216, DOI 10.1128/MCB.18.12.7216; Li YQ, 2001, J BIOL CHEM, V276, P35239, DOI 10.1074/jbc.C100359200; Li YQ, 2001, J BIOL CHEM, V276, P6061, DOI 10.1074/jbc.C000754200; McDermott KM, 2001, INT J CANCER, V94, P783, DOI 10.1002/ijc.1554; METZGAR RS, 1982, CANCER RES, V42, P601; Parry S, 2001, BIOCHEM BIOPH RES CO, V283, P715, DOI 10.1006/bbrc.2001.4775; Rae JM, 2007, BREAST CANCER RES TR, V104, P13, DOI 10.1007/s10549-006-9392-8; Satoh S, 2000, INT J CANCER, V88, P507, DOI 10.1002/1097-0215(20001115)88:4<507::AID-IJC1>3.0.CO;2-0; Singh PK, 2007, CANCER RES, V67, P5201, DOI 10.1158/0008-5472.CAN-06-4647; Singh PK, 2006, TRENDS CELL BIOL, V16, P467, DOI 10.1016/j.tcb.2006.07.006; Sun YB, 1999, ANN NY ACAD SCI, V878, P638, DOI 10.1111/j.1749-6632.1999.tb07749.x; Sun YB, 2004, J CELL BIOCHEM, V92, P258, DOI 10.1002/jcb.20044; Sun YB, 1999, J BIOL CHEM, V274, P11535, DOI 10.1074/jbc.274.17.11535; Thompson EJ, 2006, MOL CANCER RES, V4, P489, DOI 10.1158/1541-7786.MCR-06-0038; TISHLER RB, 1993, CANCER RES, V53, P2212; Wei XL, 2005, CANCER CELL, V7, P167, DOI 10.1016/j.ccr.2005.01.008; Wen YF, 2003, J BIOL CHEM, V278, P38029, DOI 10.1074/jbc.M304333200	38	73	75	1	8	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	OCT 3	2008	283	40					26985	26995		10.1074/jbc.M805036200	http://dx.doi.org/10.1074/jbc.M805036200			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	353RT	18625714	hybrid, Green Published			2022-12-27	WOS:000259586600019
J	Kao, LY; Sassani, P; Azimov, R; Pushkin, A; Abuladze, N; Peti-Peterdi, J; Liu, WX; Newman, D; Kurtz, I				Kao, Liyo; Sassani, Pakan; Azimov, Rustam; Pushkin, Alexander; Abuladze, Natalia; Peti-Peterdi, Janos; Liu, Weixin; Newman, Debra; Kurtz, Ira			Oligomeric structure and minimal functional unit of the electrogenic sodium bicarbonate cotransporter NBCe1-A	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							RENAL TUBULAR-ACIDOSIS; DISULFIDE BOND FORMATION; ERYTHROCYTE ANION-EXCHANGER; CYSTEINE RESIDUES; BAND-3 PROTEIN; AUTOSOMAL-DOMINANT; SLC4A11 MUTATIONS; TRANSPORT PROTEIN; LACTOSE PERMEASE; SELF-ASSOCIATION	The electrogenic sodium bicarbonate cotransporter NBCe1-A mediates the basolateral absorption of sodium and bicarbonate in the proximal tubule. In this study the oligomeric state and minimal functional unit of NBCe1-A were investigated. Wildtype (wt) NBCe1-A isolated from mouse kidney or heterologously expressed in HEK293 cells was predominantly in a dimeric state as was shown using fluorescence energy transfer, pulldown, immunoprecipitation, cross-linking experiments, and nondenaturing perfluorooctanoate-PAGE. NBCe1-A monomers were found to be covalently linked by S-S bonds. When each of the 15 native cysteine residues were individually removed on a wt-NBCe1-A backbone, dimerization of the cotransporter was not affected. In experiments involving multiple native cysteine residue removal, both Cys(630) and Cys(642) in extracellular loop 3 were shown to mediate S-S bond formation between NBCe1-A monomers. When native NBCe1-A cysteine residues were individually reintroduced into a cysteineless NBCe1-A mutant backbone, the finding that a Cys(992) construct that lacked S-S bonds functioned normally indicated that stable covalent linkage of NBCe1-A monomers was not a necessary requirement for functional activity of the cotransporter. Studies using concatameric constructs of wt-NBCe1-A, whose activity is resistant to methanesulfonate reagents, and an NBCe1-A(T442C) mutant, whose activity is completely inhibited by methanesulfonate reagents, confirmed that NBCe1-A monomers are functional. Our results demonstrate that wt-NBCe1-A is predominantly a homodimer, dependent on S-S bond formation that is composed of functionally active monomers.	[Kao, Liyo; Sassani, Pakan; Azimov, Rustam; Pushkin, Alexander; Abuladze, Natalia; Liu, Weixin; Newman, Debra; Kurtz, Ira] Univ Calif Los Angeles, Div Nephrol, David Geffen Sch Med, Los Angeles, CA 90095 USA; [Peti-Peterdi, Janos] Univ So Calif, Keck Sch Med, Zilkha Neurogenet Inst, Dept Physiol, Los Angeles, CA 90033 USA; [Peti-Peterdi, Janos] Univ So Calif, Keck Sch Med, Zilkha Neurogenet Inst, Dept Biophys & Med, Los Angeles, CA 90033 USA	University of California System; University of California Los Angeles; University of California Los Angeles Medical Center; David Geffen School of Medicine at UCLA; University of Southern California; University of Southern California	Kurtz, I (corresponding author), Univ Calif Los Angeles, Div Nephrol, David Geffen Sch Med, 10833 Le Conte Ave,Rm 7-155 Factor Bldg, Los Angeles, CA 90095 USA.	ikurtz@mednet.ucla.edu			National Institutes of Health [DK077162, DK058563, DK063125, ES12935, DK64324, DK74754]; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK058563, R01DK077162, R01DK063125, R01DK074754, R01DK064324] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES [R01ES012935] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS))	This work was supported, in whole or in part, by National Institutes of Health Grants DK077162, DK058563, DK063125, ES12935, DK64324, and DK74754. The costs of publication of this article were defrayed in part by the payment of page charges. This article must therefore be hereby marked "advertisement" in accordance with 18 U. S. C. Section 1734 solely to indicate this fact.	AbdAlla S, 2004, CELL, V119, P343, DOI 10.1016/j.cell.2004.10.006; Aldave AJ, 2007, CORNEA, V26, P896, DOI 10.1097/ICO.0b013e318074bb01; Azimov R, 2007, FASEB J, V21, pA1283; Barkley RA, 2004, HYPERTENSION, V43, P477, DOI 10.1161/01.HYP.0000111585.76299.f7; Bok D, 2003, NAT GENET, V34, P313, DOI 10.1038/ng1176; Bok D, 2001, AM J PHYSIOL-RENAL, V281, pF920, DOI 10.1152/ajprenal.2001.281.5.F920; Boron WF, 2006, J AM SOC NEPHROL, V17, P2368, DOI 10.1681/ASN.2006060620; Bossi E, 2007, AM J PHYSIOL-CELL PH, V292, pC1379, DOI 10.1152/ajpcell.00473.2006; Bruce LJ, 1997, J CLIN INVEST, V100, P1693, DOI 10.1172/JCI119694; CASEY JR, 1989, METHOD ENZYMOL, V173, P494; CASEY JR, 1991, J BIOL CHEM, V266, P15726; CASEY JR, 1995, J BIOL CHEM, V270, P8521, DOI 10.1074/jbc.270.15.8521; Chang MH, 2007, FASEB J, V21, pA1282; Chen JG, 1997, BIOCHEMISTRY-US, V36, P1479, DOI 10.1021/bi962256g; Choi I, 2003, AM J PHYSIOL-RENAL, V284, pF1199, DOI 10.1152/ajprenal.00131.2002; CLARKE S, 1975, J BIOL CHEM, V250, P5459; Desir J, 2007, J MED GENET, V44, P322, DOI 10.1136/jmg.2006.046904; DOLDER M, 1993, J MOL BIOL, V231, P119, DOI 10.1006/jmbi.1993.1261; DONCKERWOLCKE RA, 1970, ARCH DIS CHILD, V45, P769, DOI 10.1136/adc.45.244.769; Ducoudret O, 2001, PFLUG ARCH EUR J PHY, V442, P709, DOI 10.1007/s004240100594; Ellgaard L, 1999, SCIENCE, V286, P1882, DOI 10.1126/science.286.5446.1882; EMERICK MC, 1993, J BIOL CHEM, V268, P23455; Gagnon DG, 2006, J GEN PHYSIOL, V127, P145, DOI 10.1085/jgp.200509439; Gawenis LR, 2007, J BIOL CHEM, V282, P9042, DOI 10.1074/jbc.M607041200; Gill HS, 2006, ACTA CRYSTALLOGR F, V62, P534, DOI 10.1107/S1744309106015181; Graveleau C, 2005, J BIOL CHEM, V280, P31679, DOI 10.1074/jbc.M504008200; Hentschke M, 2006, MOL CELL BIOL, V26, P182, DOI 10.1128/MCB.26.1.182-191.2006; Igarashi T, 1999, NAT GENET, V23, P264, DOI 10.1038/15440; IGARASHI T, 1994, PEDIATR NEPHROL, V8, P70, DOI 10.1007/BF00868266; ISACOFF EY, 1990, NATURE, V345, P530, DOI 10.1038/345530a0; Ito D, 2006, J CELL SCI, V119, P3602, DOI 10.1242/jcs.03101; Jarolim P, 1998, J BIOL CHEM, V273, P6380, DOI 10.1074/jbc.273.11.6380; Jha BK, 2002, EUR J BIOCHEM, V269, P298, DOI 10.1046/j.0014-2956.2001.02654.x; Karet FE, 1998, P NATL ACAD SCI USA, V95, P6337, DOI 10.1073/pnas.95.11.6337; Kedei N, 2001, J BIOL CHEM, V276, P28613, DOI 10.1074/jbc.M103272200; Kittanakom S, 2004, J BIOL CHEM, V279, P40960, DOI 10.1074/jbc.M405356200; Kohler K, 2000, J BIOL CHEM, V275, P26113, DOI 10.1074/jbc.M003564200; Kohler K, 2003, PFLUG ARCH EUR J PHY, V446, P203, DOI 10.1007/s00424-003-1039-6; KURTZ I, 1994, J CLIN INVEST, V94, P173, DOI 10.1172/JCI117304; Lambert G, 2000, J MEMBRANE BIOL, V176, P133, DOI 10.1007/s002320001082; Lambert G, 2001, J GEN PHYSIOL, V117, P533, DOI 10.1085/jgp.117.6.533; Lemann J, 2000, KIDNEY INT, V58, P1267, DOI 10.1046/j.1523-1755.2000.00282.x; LINDENTHAL S, 1991, P NATL ACAD SCI USA, V88, P6540, DOI 10.1073/pnas.88.15.6540; Makagiansar IT, 2002, J BIOL CHEM, V277, P16002, DOI 10.1074/jbc.M200916200; Mathai JC, 1999, BIOCHEMISTRY-US, V38, P923, DOI 10.1021/bi9823683; Mitic LL, 2003, PROTEIN SCI, V12, P218, DOI 10.1110/ps.0233903; Mottamal M, 2006, PROTEINS, V62, P996, DOI 10.1002/prot.20844; Nicke A, 2003, MOL PHARMACOL, V63, P243, DOI 10.1124/mol.63.1.243; Pajor AM, 1999, BIOCHEM J, V344, P205, DOI 10.1042/0264-6021:3440205; PAPPERT G, 1983, BIOCHIM BIOPHYS ACTA, V730, P32, DOI 10.1016/0005-2736(83)90313-9; Pushkin A, 2006, AM J PHYSIOL-RENAL, V290, pF580, DOI 10.1152/ajprenal.00252.2005; Pushkin Alexander, 2001, Journal of the American Society of Nephrology, V12, p8A; Pushkin AV, 2000, IUBMB LIFE, V50, P397, DOI 10.1080/713803739; Ramjeesingh M, 1999, BIOCHEM J, V342, P119, DOI 10.1042/0264-6021:3420119; Rettig MP, 2001, BBA-BIOMEMBRANES, V1515, P72, DOI 10.1016/S0005-2736(01)00397-2; Rizzo MA, 2004, NAT BIOTECHNOL, V22, P445, DOI 10.1038/nbt945; Romero MF, 1997, NATURE, V387, P409, DOI 10.1038/387409a0; SAHINTOTH M, 1994, PROTEIN SCI, V3, P2302, DOI 10.1002/pro.5560031215; SAHINTOTH M, 1994, P NATL ACAD SCI USA, V91, P5421, DOI 10.1073/pnas.91.12.5421; Sander T, 2002, EPILEPSY RES, V51, P249, DOI 10.1016/S0920-1211(02)00152-3; Sassani P, 2002, AM J PHYSIOL-CELL PH, V282, pC408, DOI 10.1152/ajpcell.00409.2001; SCHUBERT D, 1988, MOL ASPECTS MED, V10, P233, DOI 10.1016/0098-2997(88)90009-X; SHEPHERD FH, 1995, ANAL BIOCHEM, V224, P21, DOI 10.1006/abio.1995.1003; Sitte HH, 2004, MOL INTERV, V4, P38, DOI 10.1124/mi.4.1.38; Starremans PGJF, 2003, J AM SOC NEPHROL, V14, P3039, DOI 10.1097/01.ASN.0000097370.29737.5B; Sulistijo ES, 2006, J MOL BIOL, V364, P974, DOI 10.1016/j.jmb.2006.09.065; Sur C, 1997, BIOCHEM BIOPH RES CO, V241, P68, DOI 10.1006/bbrc.1997.7771; Tanaka K, 2004, BIOCHEM J, V380, P283, DOI 10.1042/BJ20031724; Tatishchev S, 2003, BIOCHEMISTRY-US, V42, P755, DOI 10.1021/bi026826q; van Rheenen J, 2004, BIOPHYS J, V86, P2517, DOI 10.1016/S0006-3495(04)74307-6; Vince JW, 1997, BBA-BIOMEMBRANES, V1326, P295, DOI 10.1016/S0005-2736(97)00033-3; Vithana EN, 2008, HUM MOL GENET, V17, P656, DOI 10.1093/hmg/ddm337; Vithana EN, 2006, NAT GENET, V38, P755, DOI 10.1038/ng1824; WANG DN, 1993, EMBO J, V12, P2233, DOI 10.1002/j.1460-2075.1993.tb05876.x; WANG DN, 1994, EMBO J, V13, P3230, DOI 10.1002/j.1460-2075.1994.tb06624.x; WINSNES A, 1979, ACTA PAEDIATR SCAND, V68, P861; Wittrup K. Dane, 1995, Current Opinion in Biotechnology, V6, P203, DOI 10.1016/0958-1669(95)80033-6; Xu JK, 2004, J BIOL CHEM, V279, P19781, DOI 10.1074/jbc.M310785200; Zheng J, 2006, J BIOL CHEM, V281, P19916, DOI 10.1074/jbc.M513854200; Zhu QS, 2004, J BIOL CHEM, V279, P23565, DOI 10.1074/jbc.M401380200	80	50	50	0	0	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	SEP 26	2008	283	39					26782	26794		10.1074/jbc.M804006200	http://dx.doi.org/10.1074/jbc.M804006200			13	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	350GV	18658147	hybrid, Green Published			2022-12-27	WOS:000259341600050
J	Esteban, R; Vega, L; Fujimura, T				Esteban, Rosa; Vega, Lorena; Fujimura, Tsutomu			20S RNA narnavirus defies the antiviral activity of SKI1/XRN1 in Saccharomyces cerevisiae	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							DOUBLE-STRANDED-RNA; MESSENGER-RNA; L-A; IN-VIVO; YEAST; VIRUS; REPLICATION; EXORIBONUCLEASE; POLYMERASE; MUTATIONS	20S RNA virus is a persistent positive strand RNA virus found in Saccharomyces cerevisiae. We previously observed that the virus generated in vivo from a launching vector possessed the correct RNA termini without extra sequences. Here we present evidence that the SKI1/XRN1 5'-exonuclease plays a major role in the elimination of the non-viral upstream sequences from the primary transcripts. The virus, once generated, however, is fairly unaffected by overexpression or deletion of SKI1/XRN1. By contrast, the copy number of the L-A double-stranded RNA virus in the same host is greatly increased by the deletion of SKI1/XRN1, and overexpression of the gene cured L-A virus from the cells at a high frequency. 20S RNA virus, unlike L-A virus, has a strong secondary structure at its 5'-end: the first four nucleotides are G, and they are buried at the bottom of a long stem structure, features known to inhibit the SKI1/XRN1 5'-exonuclease progression. Mutations that weakened the 5'-stem structure made 20S RNA virus vulnerable to SKI1/XRN1. These results, together with the data on L-A virus, indicate a strong anti-RNA virus activity of SKI1/XRN1. Given that 20S RNA virus resides and replicates in the cytoplasm without a protective capsid, our results suggest that the strong secondary structure at the 5'-end is crucial for the 20S RNA virus to evade the host SKI1/XRN1 defense.	[Esteban, Rosa; Vega, Lorena; Fujimura, Tsutomu] Univ Salamanca, Inst Microbiol Bioquim, CSIC, Dept Genet & Microbiol, Salamanca 37007, Spain	Consejo Superior de Investigaciones Cientificas (CSIC); CSIC-USAL - Instituto de Biologia Funcional y Genomica (IBFG); University of Salamanca	Esteban, R (corresponding author), Univ Salamanca, Inst Microbiol Bioquim, CSIC, Dept Genet & Microbiol, Avda Campo Charro S-N, Salamanca 37007, Spain.	mrosa@usal.es	Esteban, Rosa/K-4356-2014; Fujimura, Tsutomu/K-5807-2014	Esteban, Rosa/0000-0001-6804-7209; Fujimura, Tsutomu/0000-0002-9457-6769	Spanish Ministry of Education and Science [BFU2004-00373, BFU2007-60057]	Spanish Ministry of Education and Science(Spanish Government)	This work was supported in part by Grants BFU2004-00373 and BFU2007-60057 from the Spanish Ministry of Education and Science. The costs of publication of this article were defrayed in part by the payment of page charges. This article must therefore be hereby marked "advertisement" in accordance with 18 U. S. C. Section 1734 solely to indicate this fact.	Anderson JSJ, 1998, EMBO J, V17, P1497, DOI 10.1093/emboj/17.5.1497; BALL SG, 1984, GENETICS, V107, P199; Bonnerot C, 2000, MOL CELL BIOL, V20, P5939, DOI 10.1128/MCB.20.16.5939-5946.2000; Caston JR, 1997, J CELL BIOL, V138, P975, DOI 10.1083/jcb.138.5.975; CHENG RH, 1994, J MOL BIOL, V244, P255, DOI 10.1006/jmbi.1994.1726; Coller JM, 2001, RNA, V7, P1717, DOI 10.1017/S135583820101994X; CONDE J, 1976, P NATL ACAD SCI USA, V73, P3651, DOI 10.1073/pnas.73.10.3651; DECKER CJ, 1993, GENE DEV, V7, P1632, DOI 10.1101/gad.7.8.1632; ESTEBAN R, 1989, EMBO J, V8, P947, DOI 10.1002/j.1460-2075.1989.tb03456.x; Esteban R, 2005, J BIOL CHEM, V280, P33725, DOI 10.1074/jbc.M506546200; Esteban R, 2003, P NATL ACAD SCI USA, V100, P2568, DOI 10.1073/pnas.0530167100; Fekete Z, 2008, J BIOL CHEM, V283, P3767, DOI 10.1074/jbc.M709617200; Fischer N, 2002, EMBO J, V21, P2788, DOI 10.1093/emboj/21.11.2788; FUJIMURA T, 1990, CELL, V62, P819, DOI 10.1016/0092-8674(90)90125-X; Fujimura T, 2007, J BIOL CHEM, V282, P19011, DOI 10.1074/jbc.M702432200; GARCIACUELLAR MP, 1995, J BIOL CHEM, V270, P20084, DOI 10.1074/jbc.270.34.20084; JOHNSON AW, 1995, MOL CELL BIOL, V15, P2719; Johnson AW, 1997, MOL CELL BIOL, V17, P6122, DOI 10.1128/MCB.17.10.6122; MANIATIS T, 1993, MOL CLONING LAB MANU, P202; MATSUMOTO Y, 1991, J BIOL CHEM, V266, P12779; Mitchell P, 1997, CELL, V91, P457, DOI 10.1016/S0092-8674(00)80432-8; Mortimer R K, 1975, Methods Cell Biol, V11, P221, DOI 10.1016/S0091-679X(08)60325-8; NEMEROFF ME, 1987, J BIOL CHEM, V262, P6785; Parker R, 2004, NAT STRUCT MOL BIOL, V11, P121, DOI 10.1038/nsmb724; RIDLEY SP, 1984, MOL CELL BIOL, V4, P761, DOI 10.1128/MCB.4.4.761; Rodriguez-Cousino N, 1998, J BIOL CHEM, V273, P20363, DOI 10.1074/jbc.273.32.20363; RODRIGUEZCOUSINO N, 1991, J BIOL CHEM, V266, P12772; SIKORSKI RS, 1989, GENETICS, V122, P19; Solinger JA, 1999, MOL CELL BIOL, V19, P5930; Solorzano A, 2000, J BIOL CHEM, V275, P26428, DOI 10.1074/jbc.M002281200; STEVENS A, 1980, J BIOL CHEM, V255, P3080; Stevens A, 2001, METHOD ENZYMOL, V342, P251, DOI 10.1016/S0076-6879(01)42549-3; TOHE A, 1978, J BACTERIOL, V136, P1002, DOI 10.1128/JB.136.3.1002-1007.1978; Tucker M, 2000, ANNU REV BIOCHEM, V69, P571, DOI 10.1146/annurev.biochem.69.1.571; VARSHNEY U, 1991, J BIOL CHEM, V266, P24712; WEJKSNORA PJ, 1978, J BACTERIOL, V134, P246, DOI 10.1128/JB.134.1.246-260.1978; WICKNER RB, 1991, J VIROL, V65, P155, DOI 10.1128/JVI.65.1.155-161.1991; WICKNER RB, 1986, ANNU REV BIOCHEM, V55, P373, DOI 10.1146/annurev.bi.55.070186.002105; WICKNER RB, 1980, CELL, V21, P217, DOI 10.1016/0092-8674(80)90129-4; WIDNER WR, 1991, MOL CELL BIOL, V11, P2905, DOI 10.1128/MCB.11.5.2905; Wilusz CJ, 2001, NAT REV MOL CELL BIO, V2, P237, DOI 10.1038/35067025	41	28	30	0	9	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	SEP 19	2008	283	38					25812	25820		10.1074/jbc.M804400200	http://dx.doi.org/10.1074/jbc.M804400200			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	348GX	18640978	Green Published, hybrid, Green Submitted			2022-12-27	WOS:000259200100007
J	Noble, CG; Dong, JM; Manser, E; Song, HW				Noble, Christian G.; Dong, Jing-Ming; Manser, Edward; Song, Haiwei			Bcl-x(L) and UVRAG cause a monomer-dimer switch in Beclin1	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							BCL-X-L; TUMOR-SUPPRESSOR FUNCTION; CELL-DEATH; AUTOPHAGY GENE; DOMAIN; PROTEINS; TUMORIGENESIS; DIMERIZATION; COMPLEX; FAMILY	Beclin1 has a key regulatory role in the initiation of autophagy and is a tumor suppressor. We have examined the interplay between viral or human Bcl-2-like proteins and UVRAG and their opposite effects on Beclin1. We show that Beclin1 forms a dimer in solution via its coiled-coil domain both in vivo and in vitro. Viral Bcl-2 binds independently to two sites on the Beclin1 dimer, one with high affinity and one with lower affinity, whereas human Bcl-x(L) binds both sites equally with relatively low affinity. UVRAG disrupts the Beclin1-dimer interface, forming a heterodimer with Beclin1, suggesting that this is how UVRAG causes its effects on Beclin1 to activate autophagy. Both Bcl-2-like proteins reduce the affinity of UVRAG for Beclin1 similar to 4-fold, suggesting that they stabilize the Beclin1 dimer. Moreover, coimmunoprecipitation assays show that UVRAG substantially reduces Beclin1 dimerization in vivo. These data explain the concentration-dependent interplay between Bcl-2, UVRAG, and Beclin1, as both tumor suppressors, UVRAG and Beclin1, have single-copy mutations in human cancers. Furthermore, our data suggest that an alternative strategy for developing anti-cancer compounds would be to disrupt the Beclin1-dimer interface.	[Noble, Christian G.; Dong, Jing-Ming; Manser, Edward; Song, Haiwei] Inst Mol & Cell Biol, Singapore 138673, Singapore	Agency for Science Technology & Research (A*STAR); A*STAR - Institute of Molecular & Cell Biology (IMCB)	Song, HW (corresponding author), Inst Mol & Cell Biol, 61 Biopolis Dr, Singapore 138673, Singapore.	haiwei@imcb.a-star.edu.sg	song, haiwei/H-6082-2011; Manser, Edward/ABD-2301-2020		A*STAR; GlaxoSmithKline-IMCB (GSK-IMCB) Singapore	A*STAR(Agency for Science Technology & Research (A*STAR)); GlaxoSmithKline-IMCB (GSK-IMCB) Singapore(GlaxoSmithKline)	This work was supported by the Biomedical Research Council of A*STAR (Agency for Science, Technology and Research) (to H. S.). The costs of publication of this article were defrayed in part by the payment of page charges. This article must therefore be hereby marked "advertisement" in accordance with 18 U. S. C. Section 1734 solely to indicate this fact.; Supported by the GlaxoSmithKline-IMCB (GSK-IMCB) Singapore fund.	Aita VM, 1999, GENOMICS, V59, P59, DOI 10.1006/geno.1999.5851; Bouillet P, 2001, DEV CELL, V1, P645, DOI 10.1016/S1534-5807(01)00083-1; Cory S, 2002, NAT REV CANCER, V2, P647, DOI 10.1038/nrc883; Denisov AY, 2007, BIOCHEMISTRY-US, V46, P734, DOI 10.1021/bi062080a; Feng W, 2007, J MOL BIOL, V372, P223, DOI 10.1016/j.jmb.2007.06.069; Furuya N, 2005, AUTOPHAGY, V1, P46, DOI 10.4161/auto.1.1.1542; Huang QL, 2002, P NATL ACAD SCI USA, V99, P3428, DOI 10.1073/pnas.062525799; Ionov Y, 2004, ONCOGENE, V23, P639, DOI 10.1038/sj.onc.1207178; Levine B, 2005, J CLIN INVEST, V115, P2679, DOI 10.1172/JCI26390; Liang C, 2006, NAT CELL BIOL, V8, P688, DOI 10.1038/ncb1426; Liang XH, 1998, J VIROL, V72, P8586, DOI 10.1128/JVI.72.11.8586-8596.1998; Liang XH, 1999, NATURE, V402, P672, DOI 10.1038/45257; Liang XH, 2001, CANCER RES, V61, P3443; Maiuri MC, 2007, EMBO J, V26, P2527, DOI 10.1038/sj.emboj.7601689; Manser E, 1997, MOL CELL BIOL, V17, P1129, DOI 10.1128/MCB.17.3.1129; Nguyen AW, 2005, NAT BIOTECHNOL, V23, P355, DOI 10.1038/nbt1066; O'Neill JW, 2006, J MOL BIOL, V356, P367, DOI 10.1016/j.jmb.2005.11.032; Oberstein A, 2007, J BIOL CHEM, V282, P13123, DOI 10.1074/jbc.M700492200; Pattingre S, 2005, CELL, V122, P927, DOI 10.1016/j.cell.2005.07.002; Qu XP, 2003, J CLIN INVEST, V112, P1809, DOI 10.1172/JCI200320039; Schuck P, 2000, BIOPHYS J, V78, P1606, DOI 10.1016/S0006-3495(00)76713-0; Shimizu S, 2004, NAT CELL BIOL, V6, P1221, DOI 10.1038/ncb1192; Thuduppathy GR, 2006, PROTEIN SCI, V15, P248, DOI 10.1110/ps.051807706; Yu L, 2004, SCIENCE, V304, P1500, DOI 10.1126/science.1096645; Yue ZY, 2003, P NATL ACAD SCI USA, V100, P15077, DOI 10.1073/pnas.2436255100	25	76	79	1	4	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	SEP 19	2008	283	38					26274	26282		10.1074/jbc.M804723200	http://dx.doi.org/10.1074/jbc.M804723200			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	348GX	18641390	Green Published, hybrid			2022-12-27	WOS:000259200100055
J	Jaitovich, A; Mehta, S; Na, N; Ciechanover, A; Goldman, RD; Ridge, KM				Jaitovich, Ariel; Mehta, Semil; Na, Ni; Ciechanover, Aaron; Goldman, Robert D.; Ridge, Karen M.			Ubiquitin-proteasome-mediated degradation of keratin intermediate filaments in mechanically stimulated A549 cells	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							MALLORY BODIES; INCLUSION-BODIES; PHOSPHORYLATION; CYTOSKELETON; CYTOKERATIN; MECHANISMS; LIVER; IDENTIFICATION; DISPLACEMENT; ORGANIZATION	We previously reported that shear stress induces phosphorylation and disassembly of keratin intermediate filaments (IFs). Shear stress also induces a time- and strain-dependent degradation of keratin IFs, and the current study examines the mechanisms involved in degradation of keratin proteins in human A549 cells exposed to 0-24 h of shear stress (7.5-30 dynes/ cm(2)). Ubiquitin was found to be covalently associated with keratin proteins immunoprecipitated from shear-stressed cells, and pretreatment with the proteasomal inhibitor MG132 prevented the degradation of the keratin IF network. Importantly, phosphorylation of K8 Ser-73 is required for the shear stress-mediated ubiquitination, disassembly, and degradation of the keratin IF network. Immunofluorescence microscopy revealed that shear stress caused the thin array of keratin fibrils observed in control cells to be reorganized into a perinuclear aggregate, known as an aggresome, and that ubiquitin was also associated with this structure. Finally, the E2 enzymes, UbcH5b, -c, and Ubc3, but not E2-25K are required for the shear stress-mediated ubiquitin-proteasomal degradation of keratin proteins. These data suggest that shear stress promotes the disassembly and degradation of the keratin IF network via phosphorylation and the ubiquitin- proteasome pathway.	[Jaitovich, Ariel; Mehta, Semil; Na, Ni; Goldman, Robert D.; Ridge, Karen M.] Northwestern Univ, Sch Med, Div Pulm & Crit Care Med, Chicago, IL 60611 USA; [Goldman, Robert D.; Ridge, Karen M.] Northwestern Univ, Sch Med, Dept Cell & Mol Biol, Chicago, IL 60611 USA; [Ciechanover, Aaron] Technion Israel Inst Technol, Res Inst, IL-31096 Haifa, Israel; [Ciechanover, Aaron] Technion Israel Inst Technol, Rappaport Fac Med, IL-31096 Haifa, Israel	Northwestern University; Northwestern University; Technion Israel Institute of Technology; Technion Israel Institute of Technology; Rappaport Faculty of Medicine	Ridge, KM (corresponding author), Northwestern Univ, Sch Med, Div Pulm & Crit Care Med, 240 E Huron,McGaw M328, Chicago, IL 60611 USA.	kridge@northwestern.edu	Ciechanover, Aaron J/C-9166-2017		National Institutes of Health [P01-HL71643, R01-HL079190, GM 36806]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL079190, P01HL071643] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R37GM036806, R01GM036806] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported, in whole or in part, by National Institutes of Health Grants P01-HL71643 (to R. G. D. and K. M. R.), R01-HL079190 (to K. M. R.), and GM 36806 (to R. G. D.). The costs of publication of this article were defrayed in part by the payment of page charges. This article must therefore be hereby marked "advertisement" in accordance with 18 U. S. C. Section 1734 solely to indicate this fact.	Bilek AM, 2003, J APPL PHYSIOL, V94, P770, DOI 10.1152/japplphysiol.00764.2002; CADRIN M, 1991, EXP MOL PATHOL, V55, P170, DOI 10.1016/0014-4800(91)90050-8; Cadrin M, 1995, BIOCHEM CELL BIOL, V73, P627, DOI 10.1139/o95-069; CADRIN M, 1995, LAB INVEST, V72, P453; Chang L, 2004, NAT REV MOL CELL BIO, V5, P601, DOI 10.1038/nrm1438; Ciechanover A, 2000, J CELL BIOCHEM, P40; Coulombe PA, 2002, CURR OPIN CELL BIOL, V14, P110, DOI 10.1016/S0955-0674(01)00301-5; HAZAN R, 1986, LAB INVEST, V54, P543; Helmke BP, 2001, BIOPHYS J, V80, P184, DOI 10.1016/S0006-3495(01)76006-7; Helmke BP, 2000, CIRC RES, V86, P745, DOI 10.1161/01.RES.86.7.745; Herrmann H, 2000, CURR OPIN CELL BIOL, V12, P79, DOI 10.1016/S0955-0674(99)00060-5; Hershko A, 1998, ANNU REV BIOCHEM, V67, P425, DOI 10.1146/annurev.biochem.67.1.425; JELLINGER K, 1990, ADV NEUROL, V53, P1; Jensen JP, 1995, J BIOL CHEM, V270, P30408, DOI 10.1074/jbc.270.51.30408; Johnston JA, 1998, J CELL BIOL, V143, P1883, DOI 10.1083/jcb.143.7.1883; Julien JP, 1997, TRENDS CELL BIOL, V7, P243, DOI 10.1016/S0962-8924(97)01049-0; Kopito RR, 2000, TRENDS CELL BIOL, V10, P524, DOI 10.1016/S0962-8924(00)01852-3; Ku NO, 1996, CANCER METAST REV, V15, P429, DOI 10.1007/BF00054011; Ku NO, 2000, J CELL BIOL, V149, P547, DOI 10.1083/jcb.149.3.547; Ku NO, 1997, J BIOL CHEM, V272, P7556, DOI 10.1074/jbc.272.11.7556; Ku NO, 1999, AM J PHYSIOL-GASTR L, V277, pG1108, DOI 10.1152/ajpgi.1999.277.6.G1108; Ku NO, 1996, J CLIN INVEST, V98, P1034, DOI 10.1172/JCI118864; LAEMMLI UK, 1970, NATURE, V227, P680, DOI 10.1038/227680a0; Lecuona E, 1999, AM J RESP CRIT CARE, V159, P603, DOI 10.1164/ajrccm.159.2.9805050; Lee JC, 2002, J CELL BIOL, V158, P1051, DOI 10.1083/jcb.200112124; LOWE J, 1988, J PATHOL, V155, P9, DOI 10.1002/path.1711550105; MICHEL RP, 1982, HUM PATHOL, V13, P81, DOI 10.1016/S0046-8177(82)80143-3; NONOMURA A, 1986, ACTA PATHOL JAPON, V36, P1669; NONOMURA A, 1986, ACTA PATHOL JAPON, V36, P869; OHTA M, 1988, LAB INVEST, V59, P848; Omary MB, 2006, TRENDS BIOCHEM SCI, V31, P383, DOI 10.1016/j.tibs.2006.05.008; Omary MB, 2004, NEW ENGL J MED, V351, P2087, DOI 10.1056/NEJMra040319; PAINE R, 1988, DEV BIOL, V129, P505, DOI 10.1016/0012-1606(88)90396-X; Pickart CM, 2001, ANNU REV BIOCHEM, V70, P503, DOI 10.1146/annurev.biochem.70.1.503; PREISEGGER KH, 1992, LAB INVEST, V66, P193; Ridge KM, 2005, J BIOL CHEM, V280, P30400, DOI 10.1074/jbc.M504239200; SALMHOFER H, 1994, HEPATOLOGY, V20, P731, DOI 10.1016/0270-9139(94)90111-2; SCHEFFNER M, 1994, P NATL ACAD SCI USA, V91, P8797, DOI 10.1073/pnas.91.19.8797; Schweizer J, 2006, J CELL BIOL, V174, P169, DOI 10.1083/jcb.200603161; Shang F, 1997, J BIOL CHEM, V272, P23086, DOI 10.1074/jbc.272.37.23086; SHIMIZU S, 1986, ACTA PATHOL JAPON, V36, P105; Sivaramakrishnan S, 2008, P NATL ACAD SCI USA, V105, P889, DOI 10.1073/pnas.0710728105; Sznajder JI, 1998, LUNG BIOL HEALTH DIS, V116, P413; Toivola DM, 1997, J CELL SCI, V110, P23; WOODCOCKMITCHELL J, 1989, AM REV RESPIR DIS, V139, P343, DOI 10.1164/ajrccm/139.2.343; Yoon KH, 2001, J CELL BIOL, V153, P503, DOI 10.1083/jcb.153.3.503; Yoon M, 1998, J CELL BIOL, V143, P147, DOI 10.1083/jcb.143.1.147; ZATLOUKAL K, 1990, HEPATOLOGY, V11, P652, DOI 10.1002/hep.1840110419; ZATLOUKAL K, 1990, LAB INVEST, V62, P427; ZATLOUKAL K, 1992, LAB INVEST, V66, P774; Zatloukal K, 2007, EXP CELL RES, V313, P2033, DOI 10.1016/j.yexcr.2007.04.024	51	43	43	1	3	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	SEP 12	2008	283	37					25348	25355		10.1074/jbc.M801635200	http://dx.doi.org/10.1074/jbc.M801635200			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	345QZ	18617517	hybrid, Green Published			2022-12-27	WOS:000259012700029
J	Jardin, I; Lopez, JJ; Salido, GM; Rosado, JA				Jardin, Isaac; Lopez, Jose J.; Salido, Gines M.; Rosado, Juan A.			Orai1 mediates the interaction between STIM1 and hTRPC1 and regulates the mode of activation of hTRPC1-forming Ca2+ channels	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							CAPACITATIVE CALCIUM-ENTRY; STORE-OPERATED CHANNEL; HUMAN PLATELETS; ACTIN CYTOSKELETON; PHOSPHOLIPASE-C; PLASMA-MEMBRANE; CRAC CHANNEL; CELLS; RECEPTOR; INFLUX	Orai1 and hTRPC1 have been presented as essential components of store-operated channels mediating highly Ca2+ selective I-CRAC and relatively Ca2+ selective I-SOC, respectively. STIM1 has been proposed to communicate the Ca2+ content of the intracellular Ca2+ stores to the plasma membrane storeoperated Ca2+ channels. Here we present evidence for the dynamic interaction between endogenously expressed Orai1 and both STIM1 and hTRPC1 regulated by depletion of the intracellular Ca2+ stores, using the pharmacological tools thapsigargin plus ionomycin, or by the physiological agonist thrombin, independently of extracellular Ca2+. In addition we report that Orai1 mediates the communication between STIM1 and hTRPC1, which is essential for the mode of activation of hTRPC1-forming Ca2+ permeable channels. Electrotransjection of cells with anti-Orai1 antibody, directed toward the C-terminal region that mediates the interaction with STIM1, and stabilization of an actin cortical barrier with jasplakinolide prevented the interaction between STIM1 and hTRPC1. Under these conditions hTRPC1 was no longer involved in store-operated calcium entry but in diacylglycerol-activated non-capacitative Ca2+ entry. These findings support the functional role of the STIM1-Orai1-hTRPC1 complex in the activation of store-operated Ca2+ entry.	[Jardin, Isaac; Lopez, Jose J.; Salido, Gines M.; Rosado, Juan A.] Univ Extremadura, Cellular Physiol Res Grp, Dept Physiol, Caceres 10071, Spain	Universidad de Extremadura	Rosado, JA (corresponding author), Univ Extremadura, Cellular Physiol Res Grp, Dept Physiol, Caceres 10071, Spain.	jarosado@unex.es	Lopez, Jose Javier/F-4602-2016; Salido, Gines M./A-4292-2009; rosado, juan/H-3488-2015	Lopez, Jose Javier/0000-0002-5234-1478; Salido, Gines M./0000-0002-8687-2445; rosado, juan/0000-0002-9749-2325; Jardin, Isaac/0000-0003-4575-8264	Spanish Ministry of Education and Science [BFU2007-60104]	Spanish Ministry of Education and Science(Spanish Government)	This work was supported in part by Spanish Ministry of Education and Science Grant BFU2007-60104. The costs of publication of this article were defrayed in part by the payment of page charges. This article must therefore be hereby marked "advertisement" in accordance with 18 U. S. C. Section 1734 solely to indicate this fact.	Ambudkar IS, 2007, CELL CALCIUM, V42, P213, DOI 10.1016/j.ceca.2007.01.013; Boulay G, 1999, P NATL ACAD SCI USA, V96, P14955, DOI 10.1073/pnas.96.26.14955; Brownlow SL, 2005, THROMB HAEMOSTASIS, V94, P839, DOI 10.1160/TH05-06-0391; BUBB MR, 1994, J BIOL CHEM, V269, P14869; CHAKRABARTI R, 1989, J BIOL CHEM, V264, P15494; Cheng KT, 2008, J BIOL CHEM, V283, P12935, DOI 10.1074/jbc.C800008200; den Dekker E, 2001, BBA-MOL CELL RES, V1539, P243, DOI 10.1016/S0167-4889(01)00112-4; DHAR A, 1994, J BIOL CHEM, V269, P9123; Feske S, 2006, NATURE, V441, P179, DOI 10.1038/nature04702; Flemming PK, 2006, J BIOL CHEM, V281, P4977, DOI 10.1074/jbc.M510301200; GRYNKIEWICZ G, 1985, J BIOL CHEM, V260, P3440; Gwack Y, 2007, J BIOL CHEM, V282, P16232, DOI 10.1074/jbc.M609630200; Hassock SR, 2002, BLOOD, V100, P2801, DOI 10.1182/blood-2002-03-0723; Hofmann T, 1999, NATURE, V397, P259, DOI 10.1038/16711; Huang GN, 2006, NAT CELL BIOL, V8, P1003, DOI 10.1038/ncb1454; Jardin I, 2008, BBA-MOL CELL RES, V1783, P84, DOI 10.1016/j.bbamcr.2007.07.007; Jardin I, 2008, CELL SIGNAL, V20, P737, DOI 10.1016/j.cellsig.2007.12.010; Juska A, 2005, BIOCHEM BIOPH RES CO, V334, P779, DOI 10.1016/j.bbrc.2005.07.040; Leung PC, 2006, J VASC RES, V43, P367, DOI 10.1159/000094096; Liao Y, 2008, P NATL ACAD SCI USA, V105, P2895, DOI 10.1073/pnas.0712288105; Liao Y, 2007, P NATL ACAD SCI USA, V104, P4682, DOI 10.1073/pnas.0611692104; Lievremont JP, 2004, AM J PHYSIOL-CELL PH, V287, pC1709, DOI 10.1152/ajpcell.00350.2004; Liou J, 2005, CURR BIOL, V15, P1235, DOI 10.1016/j.cub.2005.05.055; Lopez JJ, 2005, BIOCHEM J, V390, P243, DOI 10.1042/BJ20050168; Lopez JJ, 2006, J BIOL CHEM, V281, P28254, DOI 10.1074/jbc.M604272200; Moneer Z, 2005, BIOCHEM J, V389, P821, DOI 10.1042/BJ20050145; Muik M, 2008, J BIOL CHEM, V283, P8014, DOI 10.1074/jbc.M708898200; Ong HL, 2007, J BIOL CHEM, V282, P9105, DOI 10.1074/jbc.M608942200; Parekh AB, 2005, PHYSIOL REV, V85, P757, DOI 10.1152/physrev.00057.2003; Putney JW, 2005, J CELL BIOL, V169, P381, DOI 10.1083/jcb.200503161; Putney JW, 2001, J CELL SCI, V114, P2223; Redondo PC, 2003, BIOCHEM J, V370, P255, DOI 10.1042/BJ20021505; Redondo PC, 2008, BBA-MOL CELL RES, V1783, P1163, DOI 10.1016/j.bbamcr.2007.12.008; Roos J, 2005, J CELL BIOL, V169, P435, DOI 10.1083/jcb.200502019; Rosado JA, 2000, J PHYSIOL-LONDON, V526, P221, DOI 10.1111/j.1469-7793.2000.t01-2-00221.x; Rosado JA, 2000, J BIOL CHEM, V275, P7527, DOI 10.1074/jbc.275.11.7527; Rosado JA, 2000, BIOCHEM J, V347, P183, DOI 10.1042/0264-6021:3470183; Rosado JA, 2002, J BIOL CHEM, V277, P42157, DOI 10.1074/jbc.M207320200; Shurety W, 1998, MOL BIOL CELL, V9, P957, DOI 10.1091/mbc.9.4.957; Stathopulos PB, 2006, J BIOL CHEM, V281, P35855, DOI 10.1074/jbc.M608247200; Vazquez G, 2003, J BIOL CHEM, V278, P21649, DOI 10.1074/jbc.M302162200; Vig M, 2006, SCIENCE, V312, P1220, DOI 10.1126/science.1127883; Vig M, 2006, CURR BIOL, V16, P2073, DOI 10.1016/j.cub.2006.08.085; WES PD, 1995, P NATL ACAD SCI USA, V92, P9652, DOI 10.1073/pnas.92.21.9652; Xu SZ, 2006, CIRC RES, V98, P1381, DOI 10.1161/01.RES.0000225284.36490.a2; Xu SZ, 2001, CIRC RES, V88, P84, DOI 10.1161/01.RES.88.1.84; Yuan JP, 2003, CELL, V114, P777, DOI 10.1016/S0092-8674(03)00716-5; Zhang SL, 2006, P NATL ACAD SCI USA, V103, P9357, DOI 10.1073/pnas.0603161103; Zhang SYL, 2005, NATURE, V437, P902, DOI 10.1038/nature04147; Zhu X, 1996, CELL, V85, P661, DOI 10.1016/S0092-8674(00)81233-7	50	133	140	0	7	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	SEP 12	2008	283	37					25296	25304		10.1074/jbc.M802904200	http://dx.doi.org/10.1074/jbc.M802904200			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	345QZ	18644792	hybrid			2022-12-27	WOS:000259012700023
J	Jo, OD; Martin, J; Bernath, A; Masri, J; Lichtenstein, A; Gera, J				Jo, Oak D.; Martin, Jheralyn; Bernath, Andrew; Masri, Janine; Lichtenstein, Alan; Gera, Joseph			Heterogeneous nuclear ribonucleoprotein A1 regulates cyclin D1 and c-myc internal ribosome entry site function through Akt signaling	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							RNA-BINDING-PROTEINS; FORKHEAD TRANSCRIPTION FACTOR; STRAND ANNEALING ACTIVITY; TRANS-ACTING FACTORS; MESSENGER-RNA; HNRNP A1; GLYCERALDEHYDE-3-PHOSPHATE DEHYDROGENASE; SUBCELLULAR-DISTRIBUTION; TRANSLATIONAL CONTROL; MEDIATED TRANSLATION	The translation of the cyclin D1 and c-myc mRNAs occurs via internal ribosome entry site (IRES)-mediated initiation under conditions of reduced eIF-4F complex formation and Akt activity. Here we identify hnRNP A1 as an IRES trans-acting factor that regulates cyclin D1 and c-myc IRES activity, depending on the Akt status of the cell. hnRNP A1 binds both IRESs in vitro and in intact cells and enhances in vitro IRES-dependent reporter expression. Akt regulates this IRES activity by inducing phosphorylation of hnRNP A1 on serine 199. Serine 199-phosphorylated hnRNP A1 binds to the IRESs normally but is unable to support IRES activity in vitro. Reducing expression levels of hnRNP A1 or overexpressing a dominant negative version of the protein markedly inhibits rapamycin-stimulated IRES activity in cells and correlated with redistribution of cyclin D1 and c-myc transcripts from heavy polysomes to monosomes. Importantly, knockdown of hnRNP A1 also renders quiescent Akt-containing cells sensitive to rapamycin-induced G(1) arrest. These results support a role for hnRNP A1 in mediating rapamycin-induced alterations of cyclin D1 and c-myc IRES activity in an Akt-dependent manner and provide the first direct link between Akt and the regulation of IRES activity.	[Jo, Oak D.; Martin, Jheralyn; Bernath, Andrew; Masri, Janine; Lichtenstein, Alan; Gera, Joseph] Greater Los Angeles Vet Affairs Healthcare Syst, Dept Res & Dev, Los Angeles, CA 91343 USA; [Lichtenstein, Alan; Gera, Joseph] David Geffen Sch Med, Dept Med, Los Angeles, CA 90048 USA; [Lichtenstein, Alan] Univ Calif Los Angeles, Jonsson Comprehens Canc Ctr, Los Angeles, CA 90048 USA	US Department of Veterans Affairs; Veterans Health Administration (VHA); VA Greater Los Angeles Healthcare System; University of California System; University of California Los Angeles; University of California Los Angeles Medical Center; David Geffen School of Medicine at UCLA; UCLA Jonsson Comprehensive Cancer Center; University of California System; University of California Los Angeles	Gera, J (corresponding author), Univ Calif Los Angeles, Dept Res & Dev, Med Ctr, 16111 Plummer St 151,Bldg 1,Rm C111A, Los Angeles, CA 91343 USA.	gera@ucla.edu		Gera, Joseph/0000-0002-2908-6894	NCI NIH HHS [R01CA109312, P30 CA016042, R01CA111448, CA-16042] Funding Source: Medline; NIAID NIH HHS [P30 AI028697, AI-28697] Funding Source: Medline; NATIONAL CANCER INSTITUTE [R01CA111448, R01CA109312, P30CA016042] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [P30AI028697] Funding Source: NIH RePORTER	NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NIAID NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))		Andjelkovic M, 1997, J BIOL CHEM, V272, P31515, DOI 10.1074/jbc.272.50.31515; Baird SD, 2006, RNA, V12, P1755, DOI 10.1261/rna.157806; Bonnal S, 2005, J BIOL CHEM, V280, P4144, DOI 10.1074/jbc.M411492200; Brownawell AM, 2001, MOL CELL BIOL, V21, P3534, DOI 10.1128/MCB.21.10.3534-3546.2001; Brunet A, 1999, CELL, V96, P857, DOI 10.1016/S0092-8674(00)80595-4; BURD CG, 1994, EMBO J, V13, P1197, DOI 10.1002/j.1460-2075.1994.tb06369.x; Buxade M, 2005, IMMUNITY, V23, P177, DOI 10.1016/j.immuni.2005.06.009; COBIANCHI F, 1993, NUCLEIC ACIDS RES, V21, P949, DOI 10.1093/nar/21.4.949; Dreyfuss G, 2002, NAT REV MOL CELL BIO, V3, P195, DOI 10.1038/nrm760; Gera JF, 2002, METHOD ENZYMOL, V350, P499, DOI 10.1016/S0076-6879(02)50981-2; Guil S, 2006, MOL CELL BIOL, V26, P5744, DOI 10.1128/MCB.00224-06; HAMILTON BJ, 1993, J BIOL CHEM, V268, P8881; Hay DC, 2001, MOL CELL BIOL, V21, P3482, DOI 10.1128/MCB.21.10.3482-3490.2001; Hellen CUT, 2001, GENE DEV, V15, P1593, DOI 10.1101/gad.891101; HENICS T, 1994, J BIOL CHEM, V269, P5377; Holcik M, 2003, MOL CELL BIOL, V23, P280, DOI 10.1128/MCB.23.1.280-288.2003; Holcik M, 2005, NAT REV MOL CELL BIO, V6, P318, DOI 10.1038/nrm1618; Hsieh AC, 2004, NUCLEIC ACIDS RES, V32, P893, DOI 10.1093/nar/gkh238; Hsu JH, 2001, BLOOD, V98, P2853, DOI 10.1182/blood.V98.9.2853; IDRISS H, 1994, BIOCHEMISTRY-US, V33, P11382, DOI 10.1021/bi00203a037; Iervolino A, 2002, MOL CELL BIOL, V22, P2255, DOI 10.1128/MCB.22.7.2255-2266.2002; Komar AA, 2005, J BIOL CHEM, V280, P23425, DOI 10.1074/jbc.R400041200; Konishi H, 1996, P NATL ACAD SCI USA, V93, P7639, DOI 10.1073/pnas.93.15.7639; Kress E, 2005, RETROVIROLOGY, V2, DOI 10.1186/1742-4690-2-8; Kullmann M, 2002, GENE DEV, V16, P3087, DOI 10.1101/gad.248902; Le Quesne JPC, 2001, J MOL BIOL, V310, P111, DOI 10.1006/jmbi.2001.4745; Lewis SM, 2007, MOL BIOL CELL, V18, P1302, DOI 10.1091/mbc.E06-06-0515; Mamane Y, 2006, ONCOGENE, V25, P6416, DOI 10.1038/sj.onc.1209888; Marderosian M, 2006, ONCOGENE, V25, P6277, DOI 10.1038/sj.onc.1209645; MICHAEL WM, 1995, CELL, V83, P415; Mitchell SA, 2005, GENE DEV, V19, P1556, DOI 10.1101/gad.339105; Mitchell SA, 2001, MOL CELL BIOL, V21, P3364, DOI 10.1128/MCB.21.10.3364-3374.2001; Pekarsky Y, 2000, P NATL ACAD SCI USA, V97, P3028, DOI 10.1073/pnas.040557697; PINOLROMA S, 1991, SCIENCE, V253, P312, DOI 10.1126/science.1857966; PINOLROMA S, 1992, NATURE, V355, P730, DOI 10.1038/355730a0; Powell DW, 2002, J BIOL CHEM, V277, P21639, DOI 10.1074/jbc.M203167200; Ramaswamy S, 1999, P NATL ACAD SCI USA, V96, P2110, DOI 10.1073/pnas.96.5.2110; Ruggero D, 2005, ONCOGENE, V24, P7426, DOI 10.1038/sj.onc.1209098; Schultz DE, 1996, J BIOL CHEM, V271, P14134, DOI 10.1074/jbc.271.24.14134; SenGupta DJ, 1996, P NATL ACAD SCI USA, V93, P8496, DOI 10.1073/pnas.93.16.8496; Sharma A, 2007, J BIOL CHEM, V282, P9505, DOI 10.1074/jbc.M608874200; Sherman F, 2002, METHOD ENZYMOL, V350, P3, DOI 10.1016/S0076-6879(02)50954-X; Shi YJ, 2005, J BIOL CHEM, V280, P10964, DOI 10.1074/jbc.M407874200; Spriggs KA, 2005, CELL DEATH DIFFER, V12, P585, DOI 10.1038/sj.cdd.4401642; Stoneley M, 2004, ONCOGENE, V23, P3200, DOI 10.1038/sj.onc.1207551; Svitkin YV, 1996, EMBO J, V15, P7147, DOI 10.1002/j.1460-2075.1996.tb01106.x; Takagi M, 2005, CELL, V123, P49, DOI 10.1016/j.cell.2005.07.034; Tenenbaum SA, 2002, METHODS, V26, P191, DOI 10.1016/S1046-2023(02)00022-1; Vagner S, 2001, EMBO REP, V2, P893, DOI 10.1093/embo-reports/kve208; van Oordt WV, 2000, J CELL BIOL, V149, P307, DOI 10.1083/jcb.149.2.307; Wang RW, 2006, CELL SIGNAL, V18, P1722, DOI 10.1016/j.cellsig.2006.01.020; Wang X, 2006, CELL DEATH DIFFER, V13, P2099, DOI 10.1038/sj.cdd.4401969; Wilker EW, 2007, NATURE, V446, P329, DOI 10.1038/nature05584; Yaffe MB, 2001, NAT BIOTECHNOL, V19, P348, DOI 10.1038/86737; Yi MY, 2000, J VIROL, V74, P6459, DOI 10.1128/JVI.74.14.6459-6468.2000	55	83	87	1	3	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	AUG 22	2008	283	34					23274	23287		10.1074/jbc.M801185200	http://dx.doi.org/10.1074/jbc.M801185200			14	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	337SI	18562319	Green Published, hybrid			2022-12-27	WOS:000258455400040
J	Lu, ZP; Sack, MN				Lu, Zhongping; Sack, Michael N.			ATF-1 is a hypoxia-responsive transcriptional activator of skeletal muscle mitochondrial-uncoupling protein 3	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							INDUCIBLE FACTOR-I; OXIDATIVE STRESS; BINDING-PROTEIN; PROMOTER REGION; FACTOR CREB; FATTY-ACID; GENE; UCP3; OVEREXPRESSION; EXPRESSION	Hypoxia induces oxidative damage in skeletal muscle. Uncoupling protein 3 (UCP3) is the skeletal muscle enriched uncoupling protein and has previously been shown to confer resistance against oxidative stress. We show that hypoxia robustly up-regulates skeletal muscle UCP3 and that the absence of UCP3 in primary skeletal myocytes exacerbates hypoxia-induced reactive oxygen species generation. In this context, we reasoned that the investigation of the regulation of UCP3 may identify novel hypoxia-responsive regulatory pathways that modulate intrinsic anti-oxidant defenses. By screening a transcription factor array of 704 full-length cDNAs in murine C2C12 myoblasts following cotransfection of a murine UCP3 promoter-luciferase construct and myoD we identified numerous candidate regulatory factors that up-regulate UCP3. Active transcription factor-1 (ATF-1) was identified, and as this transcription factor is a known component of a multiprotein hypoxia-induced regulatory complex, we explored its role in hypoxia-mediated UCP3 up-regulation. Site-directed mutagenesis and chromatin immunoprecipitation assays identify a 10-bp region required for ATF-1 induction of UCP3 promoter activity. Hypoxia promotes the phosphorylation of ATF-1, and the knockdown of ATF-1 by shRNA prevents hypoxia-mediated up-regulation of UCP3. Pharmacologic inhibition of p38 MAP kinase prevents both hypoxia-mediated ATF-1 phosphorylation and UCP3 up-regulation. PKA signaling does not modulate hypoxia-induced UCP3 up-regulation and neither does HIF-1 alpha activation by cobalt chloride. In conclusion, ATF-1, via p38 MAP kinase activation, functions as a novel regulatory pathway driving UCP3 expression. These data reinforce the role of ATF-1 as a hypoxia-responsive trans-activator and identifies a novel regulatory program that may modulate cellular responses to oxygen-deficit.	[Lu, Zhongping; Sack, Michael N.] NHLBI, Translat Med Branch, NIH, Bethesda, MD 20892 USA	National Institutes of Health (NIH) - USA; NIH National Heart Lung & Blood Institute (NHLBI)	Sack, MN (corresponding author), NHLBI, Translat Med Branch, NIH, Bldg 10 CRC,Rm 5-3150,10 Ctr Dr, Bethesda, MD 20892 USA.	sackm@nhlbi.nih.gov			Intramural NIH HHS Funding Source: Medline; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [Z01HL005199, ZIAHL005199] Funding Source: NIH RePORTER	Intramural NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))		Anderson EJ, 2007, J BIOL CHEM, V282, P31257, DOI 10.1074/jbc.M706129200; Beitner-Johnson D, 2001, CELL SIGNAL, V13, P23, DOI 10.1016/S0898-6568(00)00128-5; Bleckmann SC, 2002, MOL CELL BIOL, V22, P1919, DOI 10.1128/MCB.22.6.1919-1925.2002; BONNI A, 1995, MOL CELL NEUROSCI, V6, P168, DOI 10.1006/mcne.1995.1015; Brand MD, 2005, CELL METAB, V2, P85, DOI 10.1016/j.cmet.2005.06.002; BRINDLE P, 1995, P NATL ACAD SCI USA, V92, P10521, DOI 10.1073/pnas.92.23.10521; Choi CS, 2007, J CLIN INVEST, V117, P1995, DOI 10.1172/JCI13579; Clanton TL, 2007, J APPL PHYSIOL, V102, P2379, DOI 10.1152/japplphysiol.01298.2006; Costford SR, 2006, AM J PHYSIOL-ENDOC M, V290, pE1304, DOI 10.1152/ajpendo.00401.2005; Ebert BL, 1998, MOL CELL BIOL, V18, P4089, DOI 10.1128/MCB.18.7.4089; Echtay KS, 2003, EMBO J, V22, P4103, DOI 10.1093/emboj/cdg412; Echtay KS, 2002, NATURE, V415, P96, DOI 10.1038/415096a; Flandin P, 2005, FEBS LETT, V579, P3411, DOI 10.1016/j.febslet.2005.04.084; Fujimura Y, 2001, ONCOGENE, V20, P6653, DOI 10.1038/sj.onc.1204684; Garcia-Martinez C, 2001, FASEB J, V15, P2033, DOI 10.1096/fj.00-0828fje; Jean D, 2000, ONCOGENE, V19, P2721, DOI 10.1038/sj.onc.1203569; Kim DH, 2007, J BIOCHEM MOL BIOL, V40, P921; Kitagawa K, 2007, FEBS J, V274, P3210, DOI 10.1111/j.1742-4658.2007.05890.x; Koechlin C, 2005, THORAX, V60, P834, DOI 10.1136/thx.2004.037531; KVIETIKOVA I, 1995, NUCLEIC ACIDS RES, V23, P4542, DOI 10.1093/nar/23.22.4542; Magalhaes J, 2005, J APPL PHYSIOL, V99, P1247, DOI 10.1152/japplphysiol.01324.2004; Mayr B, 2001, NAT REV MOL CELL BIO, V2, P599, DOI 10.1038/35085068; McLeod CJ, 2005, J BIOL CHEM, V280, P33470, DOI 10.1074/jbc.M505258200; Nissen SE, 2007, NEW ENGL J MED, V356, P2457, DOI 10.1056/NEJMoa072761; PONGUBALA JMR, 1995, J BIOL CHEM, V270, P10304, DOI 10.1074/jbc.270.17.10304; RANDO TA, 1994, J CELL BIOL, V125, P1275, DOI 10.1083/jcb.125.6.1275; Rosenberg D, 2002, ANN NY ACAD SCI, V968, P65, DOI 10.1111/j.1749-6632.2002.tb04327.x; Sack MN, 2006, CARDIOVASC RES, V72, P210, DOI 10.1016/j.cardiores.2006.07.010; Semenza GL, 2007, BIOCHEM J, V405, P1, DOI 10.1042/BJ20070389; Sen CK, 2006, CARDIOVASC RES, V71, P280, DOI 10.1016/j.cardiores.2006.01.003; Shimokawa T, 1998, BIOCHEM BIOPH RES CO, V246, P287, DOI 10.1006/bbrc.1998.8600; Solanes G, 2000, FASEB J, V14, P2141; Solanes G, 2005, BIOCHEM J, V386, P505, DOI 10.1042/BJ20041073; Solanes G, 2003, MOL ENDOCRINOL, V17, P1944, DOI 10.1210/me.2002-0395; Talbot DA, 2005, BBA-BIOENERGETICS, V1709, P150, DOI 10.1016/j.bbabio.2005.07.001; Taylor CT, 2008, BIOCHEM J, V409, P19, DOI 10.1042/BJ20071249; Tu N, 2000, LIFE SCI, V67, P2267, DOI 10.1016/S0024-3205(00)00802-X; Vidal-Puig AJ, 2000, J BIOL CHEM, V275, P16258, DOI 10.1074/jbc.M910179199; Wan YH, 2007, NAT MED, V13, P1496, DOI 10.1038/nm1672; WANG GL, 1995, J BIOL CHEM, V270, P1230, DOI 10.1074/jbc.270.3.1230; Zhou M, 2000, AM J PHYSIOL-ENDOC M, V279, pE622, DOI 10.1152/ajpendo.2000.279.3.E622	41	25	27	0	3	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	AUG 22	2008	283	34					23410	23418		10.1074/jbc.M801236200	http://dx.doi.org/10.1074/jbc.M801236200			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	337SI	18579531	Green Published, hybrid			2022-12-27	WOS:000258455400050
J	Rodriguez-Almazan, C; Arreola, R; Rodriguez-Larrea, D; Aguirre-Lopez, B; de Gomez-Puyou, MT; Perez-Montfort, R; Costas, M; Gomez-Puyou, A; Torres-Larios, A				Rodriguez-Almazan, Claudia; Arreola, Rodrigo; Rodriguez-Larrea, David; Aguirre-Lopez, Beatrice; de Gomez-Puyou, Marietta Tuena; Perez-Montfort, Ruy; Costas, Miguel; Gomez-Puyou, Armando; Torres-Larios, Alfredo			Structural basis of human triosephosphate isomerase deficiency: Mutation E104D is related to alterations of a conserved water network at the dimer interface	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							TRIOSE-PHOSPHATE ISOMERASE; CRYSTAL-STRUCTURE; PROTEIN; RESOLUTION; TIM; NEURODEGENERATION; ASSOCIATION; GLYCOLYSIS; INSIGHTS; FORM	Human triosephosphate isomerase deficiency is a rare autosomal disease that causes premature death of homozygous individuals. The most frequent mutation that leads to this illness is in position 104, which involves a conservative change of a Glu for Asp. Despite the extensive work that has been carried out on the E104D mutant enzyme in hemolysates and whole cells, the molecular basis of this disease is poorly understood. Here, we show that the purified, recombinant mutant enzyme E104D, while exhibiting normal catalytic activity, shows impairments in the formation of active dimers and low thermostability and monomerizes under conditions in which the wild type retains its dimeric form. The crystal structure of the E104D mutant at 1.85 angstrom resolution showed that its global structure was similar to that of the wild type; however, residue 104 is part of a conserved cluster of 10 residues, five from each subunit. An analysis of the available high resolution structures of TIM dimers revealed that this cluster forms a cavity that possesses an elaborate conserved network of buried water molecules that bridge the two subunits. In the E104D mutant, a disruption of contacts of the amino acid side chains in the conserved cluster leads to a perturbation of the water network in which the water-protein and water-water interactions that join the two monomers are significantly weakened and diminished. Thus, the disruption of this solvent system would stand as the underlying cause of the deficiency.	[Rodriguez-Almazan, Claudia; Arreola, Rodrigo; Aguirre-Lopez, Beatrice; de Gomez-Puyou, Marietta Tuena; Perez-Montfort, Ruy; Gomez-Puyou, Armando; Torres-Larios, Alfredo] Univ Nacl Autonoma Mexico, Dept Bioquim, Inst Fisiol Celular, Mexico City 04510, DF, Mexico; [Rodriguez-Larrea, David; Costas, Miguel] Univ Granada, Fac Ciencias, Dept Quim Fis, Granada 18071, Spain	Universidad Nacional Autonoma de Mexico; University of Granada	Torres-Larios, A (corresponding author), Univ Nacl Autonoma Mexico, Dept Bioquim, Inst Fisiol Celular, Ciudad Univ,Apartado Postal 70-243, Mexico City 04510, DF, Mexico.	torres@ifc.unam.mx	Rodriguez-Larrea, David/ABH-3171-2020	Rodriguez-Larrea, David/0000-0002-5580-7413; Perez-Montfort, Ruy/0000-0003-0810-1159; Arreola, Rodrigo/0000-0003-2417-418X; Costas, Miguel/0000-0001-8604-6381; Torres-Larios, Alfredo/0000-0002-0702-350X	Consejo Nacional de Ciencia y Tecnologia [60127-Q, 41328-Q, 49872]; Programa de Apoyo a Proyectos de Investigacione Innovacion Tecnologica; Ministerio de Educacion y Ciencia de Espana; DGAPAUNAM; United States Department of Energy, Office of Science, Office of Basic Energy Sciences [W-31-109-Eng-38]	Consejo Nacional de Ciencia y Tecnologia(Consejo Nacional de Ciencia y Tecnologia (CONACyT)); Programa de Apoyo a Proyectos de Investigacione Innovacion Tecnologica(Programa de Apoyo a Proyectos de Investigacion e Innovacion Tecnologica (PAPIIT)); Ministerio de Educacion y Ciencia de Espana(Spanish Government); DGAPAUNAM(Universidad Nacional Autonoma de Mexico); United States Department of Energy, Office of Science, Office of Basic Energy Sciences(United States Department of Energy (DOE))	This work was supported by Consejo Nacional de Ciencia y Tecnologia Grants 60127-Q, 41328-Q, and 49872 and Programa de Apoyo a Proyectos de Investigacione Innovacion Tecnologica, Universidad Nacional Autonoma de Mexico, Grant IN200507.; Supported by the Ministerio de Educacion y Ciencia de Espana and DGAPAUNAM;; Data were collected at the SE Regional Collaborative Access Team (SER-CAT) 22-ID beamline at the Advanced Photon Source, Argonne National Laboratory. Use of the Advanced Photon Source was supported by the United States Department of Energy, Office of Science, Office of Basic Energy Sciences, under Contract W-31-109-Eng-38. The critical reading of Anne-Catherine Dock-Bregeon, Alfonso Mondragon, Kerren Swinger, Andrew Swinger, and Jonathan Ipsaro is greatly acknowledged. The technical assistance of Nallely Cabrera and Anita Vega-Miranda is kindly appreciated.	Ahmed N, 2003, BBA-MOL BASIS DIS, V1639, P121, DOI 10.1016/j.bbadis.2003.08.002; ALBERY WJ, 1976, BIOCHEMISTRY-US, V15, P5631, DOI 10.1021/bi00670a032; Ationu A, 1999, BLOOD, V94, P3193, DOI 10.1182/blood.V94.9.3193.421k26_3193_3198; BAILEY S, 1994, ACTA CRYSTALLOGR D, V50, P760, DOI 10.1107/s0907444994003112; Brunger AT, 1998, ACTA CRYSTALLOGR D, V54, P905, DOI 10.1107/S0907444998003254; DAAR IO, 1986, P NATL ACAD SCI USA, V83, P7903, DOI 10.1073/pnas.83.20.7903; Dundas J, 2006, NUCLEIC ACIDS RES, V34, pW116, DOI 10.1093/nar/gkl282; Emsley P, 2004, ACTA CRYSTALLOGR D, V60, P2126, DOI 10.1107/S0907444904019158; Gayathri P, 2007, ACTA CRYSTALLOGR D, V63, P206, DOI 10.1107/S0907444906046488; Gnerer JP, 2006, P NATL ACAD SCI USA, V103, P14987, DOI 10.1073/pnas.0606887103; Hollan S, 1997, P NATL ACAD SCI USA, V94, P10362, DOI 10.1073/pnas.94.19.10362; Hough MA, 2004, P NATL ACAD SCI USA, V101, P5976, DOI 10.1073/pnas.0305143101; Kapust RB, 1999, PROTEIN SCI, V8, P1668, DOI 10.1110/ps.8.8.1668; Kinoshita T, 2005, ACTA CRYSTALLOGR F, V61, P346, DOI 10.1107/S1744309105008341; KNOWLES JR, 1991, NATURE, V350, P121, DOI 10.1038/350121a0; Krissinel E, 2007, J MOL BIOL, V372, P774, DOI 10.1016/j.jmb.2007.05.022; Leslie AGW, 1992, JOINT CCP4 ESF EAMCB, V26; Levy Y, 2006, ANNU REV BIOPH BIOM, V35, P389, DOI 10.1146/annurev.biophys.35.040405.102134; Maier T, 2003, J MOL BIOL, V328, P669, DOI 10.1016/S0022-2836(03)00311-5; Mainfroid V, 1996, J MOL BIOL, V257, P441, DOI 10.1006/jmbi.1996.0174; MANDE SC, 1994, PROTEIN SCI, V3, P810, DOI 10.1002/pro.5560030510; Mccoy AJ, 2007, J APPL CRYSTALLOGR, V40, P658, DOI 10.1107/S0021889807021206; Nangle LA, 2007, P NATL ACAD SCI USA, V104, P11239, DOI 10.1073/pnas.0705055104; Olah J, 2005, BIOCHEM J, V392, P675, DOI 10.1042/BJ20050993; Orosz F, 2000, P NATL ACAD SCI USA, V97, P1026, DOI 10.1073/pnas.97.3.1026; Orosz F, 2001, BLOOD, V98, P3106, DOI 10.1182/blood.V98.10.3106; Orosz F, 1996, J THEOR BIOL, V182, P437, DOI 10.1006/jtbi.1996.0184; Ovadi J, 2004, MOL CELL BIOCHEM, V256, P83, DOI 10.1023/B:MCBI.0000009860.86969.72; Ralser M, 2006, PLOS ONE, V1, DOI 10.1371/journal.pone.0000030; Raschke TM, 2006, CURR OPIN STRUC BIOL, V16, P152, DOI 10.1016/j.sbi.2006.03.002; Repiso Ada, 2002, Haematologica, V87, pECR12; Rodier F, 2005, PROTEINS, V60, P36, DOI 10.1002/prot.20478; Schneider AS, 2000, BEST PRACT RES CL HA, V13, P119, DOI 10.1053/beha.2000.0061; Shanthi V., 2003, Journal of Applied Crystallography, V36, P167, DOI 10.1107/S0021889802019489; Shi YH, 2005, J BIOL CHEM, V280, P41805, DOI 10.1074/jbc.M505181200; Sumathi K, 2006, NUCLEIC ACIDS RES, V34, pW128, DOI 10.1093/nar/gkl036; Walden H, 2001, J MOL BIOL, V306, P745, DOI 10.1006/jmbi.2000.4433; WALEY SG, 1973, BIOCHEM J, V135, P165, DOI 10.1042/bj1350165; Wang Wenyan, 2002, Methods Mol Biol, V182, P37; Wilson MA, 2003, P NATL ACAD SCI USA, V100, P9256, DOI 10.1073/pnas.1133288100; ZABORI S, 1980, Z NATURFORSCH C, V35, P999; Zomosa-Signoret V, 2003, BIOCHEMISTRY-US, V42, P3311, DOI 10.1021/bi0206560	43	63	65	0	7	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	AUG 22	2008	283	34					23254	23263		10.1074/jbc.M802145200	http://dx.doi.org/10.1074/jbc.M802145200			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	337SI	18562316	hybrid			2022-12-27	WOS:000258455400058
J	Lockridge, O; Xue, WH; Gaydess, A; Grigoryan, H; Ding, SJ; Schopfer, LM; Hinrichs, SH; Masson, P				Lockridge, Oksana; Xue, Weihua; Gaydess, Andrea; Grigoryan, Hasmik; Ding, Shi-Jian; Schopfer, Lawrence M.; Hinrichs, Steven H.; Masson, Patrick			Pseudo-esterase activity of human albumin - Slow turnover on tyrosine 411 and stable acetylation of 82 residues including 59 lysines	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							HUMAN-SERUM-ALBUMIN; ARYL ACYLAMIDASE ACTIVITY; PARA-NITROPHENYL ACETATE; EPSILON-N-ACETYLLYSINE; ACETYLSALICYLIC-ACID; CRYSTAL-STRUCTURE; HUMAN PLASMA; ASPIRIN; BINDING; PROTEIN	Human albumin is thought to hydrolyze esters because multiple equivalents of product are formed for each equivalent of albumin. Esterase activity with p-nitrophenyl acetate has been attributed to turnover at tyrosine 411. However, p-nitrophenyl acetate creates multiple, stable, acetylated adducts, a property contrary to turnover. Our goal was to identify residues that become acetylated by p-nitrophenyl acetate and determine the relationship between stable adduct formation and turnover. Fatty acid-free human albumin was treated with 0.5mM p-nitrophenyl acetate for 5 min to 2 weeks, or with 10mMp-nitrophenyl acetate for 48 h to 2 weeks. Aliquots were digested with pepsin, trypsin, or GluC and analyzed by mass spectrometry to identify labeled residues. Only Tyr-411 was acetylated within the first 5 min of reaction with 0.5 mM p-nitrophenyl acetate. After 0.5 -6 h there was partial acetylation of 16 -17 residues including Asp-1, Lys-4, Lys-12, Tyr-411, Lys-413, and Lys-414. Treatment with 10 mM p-nitrophenyl acetate resulted in acetylation of 59 lysines, 10 serines, 8 threonines, 4 tyrosines, and Asp-1. When Tyr-411 was blocked with diisopropylfluorophosphate or chlorpyrifos oxon, albumin had normal esterase activity with beta-naphthyl acetate as visualized on a nondenaturing gel. However, after 82 residues had been acetylated, esterase activity was almost completely inhibited. The half-life for deacetylation of Tyr-411 at pH 8.0, 22 degrees C was 61 +/- 4 h. Acetylated lysines formed adducts that were even more stable. In conclusion, the pseudo-esterase activity of albumin is the result of irreversible acetylation of 82 residues and is not the result of turnover.	[Lockridge, Oksana; Xue, Weihua; Grigoryan, Hasmik; Schopfer, Lawrence M.] Univ Nebraska, Med Ctr, Eppley Inst, Omaha, NE 68198 USA; [Ding, Shi-Jian; Hinrichs, Steven H.] Univ Nebraska, Med Ctr, Dept Pathol & Microbiol, Omaha, NE 68198 USA; [Masson, Patrick] Ctr Rech, Serv Sante Armees, Unite Enzymol, F-38702 La Tronche, France	University of Nebraska System; University of Nebraska Medical Center; University of Nebraska System; University of Nebraska Medical Center	Masson, P (corresponding author), Univ Nebraska, Med Ctr, Eppley Inst, Omaha, NE 68198 USA.	olockrid@unmc.edu	Grigoryan, Hasmik/G-6996-2014; Masson, Patrick YM/J-3964-2013; Masson, Patrick/AAA-7213-2019	Masson, Patrick YM/0000-0002-7837-3662; Masson, Patrick/0000-0002-7837-3662	NATIONAL CANCER INSTITUTE [P30CA036727] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [U01NS058056] Funding Source: NIH RePORTER; NCI NIH HHS [P30CA36727] Funding Source: Medline; NINDS NIH HHS [U01 NS058056-02] Funding Source: Medline	NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NINDS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))		ALLFREY VG, 1984, METHOD ENZYMOL, V107, P224; Brunmark P, 1997, CHEM RES TOXICOL, V10, P880, DOI 10.1021/tx9700782; CASIDA JE, 1959, BIOCHIM BIOPHYS ACTA, V36, P411, DOI 10.1016/0006-3002(59)90184-2; De Vriese C, 2007, ENDOCRINOLOGY, V148, P2355, DOI 10.1210/en.2006-1281; DUBOISPRESLE N, 1995, MOL PHARMACOL, V47, P647; Geer LY, 2004, J PROTEOME RES, V3, P958, DOI 10.1021/pr0499491; Georges H, 2000, CHIRALITY, V12, P53; GERSHEY EL, 1968, J BIOL CHEM, V243, P5018; HAWKINS D, 1968, SCIENCE, V160, P780, DOI 10.1126/science.160.3829.780; Jiao KS, 2001, ANAL BIOCHEM, V293, P43, DOI 10.1006/abio.2001.5118; KWON CH, 1987, CANCER RES, V47, P1505; Lapko VN, 2001, PROTEIN SCI, V10, P1130, DOI 10.1110/ps.40901; Li B, 2005, BIOCHEM PHARMACOL, V70, P1673, DOI 10.1016/j.bcp.2005.09.002; Li B, 2008, CHEM RES TOXICOL, V21, P421, DOI 10.1021/tx700339m; Li B, 2007, ANAL BIOCHEM, V361, P263, DOI 10.1016/j.ab.2006.11.018; Macdonald JM, 1999, BIOCHEM PHARMACOL, V57, P1233, DOI 10.1016/S0006-2952(99)00039-8; Manoharan I, 2006, ARCH BIOCHEM BIOPHYS, V452, P186, DOI 10.1016/j.abb.2006.06.003; Masson P, 2007, J ENZYM INHIB MED CH, V22, P463, DOI 10.1080/14756360701383932; MEANS GE, 1975, BIOCHEMISTRY-US, V14, P4989, DOI 10.1021/bi00693a031; MEANS GE, 1979, ARCH BIOCHEM BIOPHYS, V194, P526, DOI 10.1016/0003-9861(79)90647-7; MORIKAWA M, 1979, JPN J PHARMACOL, V29, P581, DOI 10.1254/jjp.29.581; Nachon F, 2005, BIOCHEMISTRY-US, V44, P1154, DOI 10.1021/bi048238d; OIKAWA A, 1967, BIOCHEM J, V104, P947, DOI 10.1042/bj1040947; Perkins DN, 1999, ELECTROPHORESIS, V20, P3551, DOI 10.1002/(SICI)1522-2683(19991201)20:18<3551::AID-ELPS3551>3.0.CO;2-2; RAINSFORD KD, 1980, EUR J CLIN INVEST, V10, P413, DOI 10.1111/j.1365-2362.1980.tb00054.x; Riordan J F, 1972, Methods Enzymol, V25, P500, DOI 10.1016/S0076-6879(72)25046-7; ROTH GJ, 1978, J BIOL CHEM, V253, P3782; Sakurai Y, 2004, PHARM RES-DORDR, V21, P285, DOI 10.1023/B:PHAM.0000016241.84630.06; Salvi A, 1997, DRUG METAB DISPOS, V25, P395; SANGER F, 1945, BIOCHEM J, V39, P507, DOI 10.1042/bj0390507; Sanger F., 1963, P CHEM SOC, V5, P76; Sogorb MA, 2004, ARCH TOXICOL, V78, P629, DOI 10.1007/s00204-004-0584-x; Sogorb MA, 1998, ARCH TOXICOL, V72, P219, DOI 10.1007/s002040050492; Sugio S, 1999, PROTEIN ENG, V12, P439, DOI 10.1093/protein/12.6.439; TILDON JT, 1972, J BIOL CHEM, V247, P1265; TOVE SB, 1962, BIOCHIM BIOPHYS ACTA, V57, P230, DOI 10.1016/0006-3002(62)91115-0; VIOLAND BN, 1994, PROTEIN SCI, V3, P1089, DOI 10.1002/pro.5560030712; WALKER JE, 1976, FEBS LETT, V66, P173, DOI 10.1016/0014-5793(76)80496-6; Watanabe H, 2000, BIOCHEM J, V349, P813, DOI 10.1042/bj3490813; Williams NH, 2007, ARCH TOXICOL, V81, P627, DOI 10.1007/s00204-007-0191-8; Yang F, 2007, J STRUCT BIOL, V157, P348, DOI 10.1016/j.jsb.2006.08.015	41	89	95	1	22	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	AUG 15	2008	283	33					22582	22590		10.1074/jbc.M802555200	http://dx.doi.org/10.1074/jbc.M802555200			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	335VR	18577514	Green Published			2022-12-27	WOS:000258321000027
J	Trapp, T; Kogler, G; El-Khattouti, A; Sorg, RV; Besselmann, M; Focking, M; Buhrle, CP; Trompeter, I; Fischer, JC; Wernet, P				Trapp, Thorsten; Koegler, Gesine; El-Khattouti, Abdelouahid; Sorg, Ruediger V.; Besselmann, Michael; Foecking, Melanie; Buehrle, Christian P.; Trompeter, Ingo; Fischer, Johannes C.; Wernet, Peter			Hepatocyte Growth Factor/c-MET Axis-mediated Tropism of Cord Blood-derived Unrestricted Somatic Stem Cells for Neuronal Injury	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							CEREBRAL-ARTERY OCCLUSION; CENTRAL-NERVOUS-SYSTEM; BONE-MARROW; IN-VITRO; C-MET; BEHAVIORAL DEFICITS; EXPERIMENTAL STROKE; NEUROTROPHIC FACTOR; MOUSE MODEL; RAT-BRAIN	An under-agarose chemotaxis assay was used to investigate whether unrestricted somatic stem cells (USSC) that were recently characterized in human cord blood are attracted by neuronal injury in vitro. USSC migrated toward extracts of post-ischemic brain tissue of mice in which stroke had been induced. Moreover, apoptotic neurons secrete factors that strongly attracted USSC, whereas necrotic and healthy neurons did not. Investigating the expression of growth factors and chemokines in lesioned brain tissue and neurons and of their respective receptors in USSC revealed expression of hepatocyte growth factor (HGF) in post-ischemic brain and in apoptotic but not in necrotic neurons and of the HGF receptor c-MET in USSC. Neuronal lesion-triggered migration was observed in vitro and in vivo only when c-MET was expressed at a high level in USSC. Neutralization of the bioactivity of HGF with an antibody inhibited migration of USSC toward neuronal injury. This, together with the finding that human recombinant HGF attracts USSC, document that HGF signaling is necessary for the tropism of USSC for neuronal injury. Our data demonstrate that USSC have the capacity to migrate toward apoptotic neurons and injured brain. Together with their neural differentiation potential, this suggests a neuroregenerative potential of USSC. Moreover, we provide evidence for a hitherto unrecognized pivotal role of the HGF/c-MET axis in guiding stem cells toward brain injury, which may partly account for the capability of HGF to improve function in the diseased central nervous system.	[Trapp, Thorsten; Koegler, Gesine; El-Khattouti, Abdelouahid; Sorg, Ruediger V.; Trompeter, Ingo; Fischer, Johannes C.; Wernet, Peter] Univ Dusseldorf, Med Ctr, Lab Neuroregenerat, Inst Transplantat Diagnost & Cell Therapeut,ITZ, D-40225 Dusseldorf, Germany; [Trapp, Thorsten; Foecking, Melanie] Univ Med Ctr Munster, European Grad Sch Neurosci, D-48129 Munster, Germany; [Foecking, Melanie] Beaumont Hosp, Royal Coll Surg Ireland, Educ & Res Ctr, Dept Psychiat, Dublin 2, Ireland; [Buehrle, Christian P.] Univ Cologne, Dept Stereotaxy & Funct Neurosurg, D-50924 Cologne, Germany; [Besselmann, Michael] Univ Med Ctr Munster, Dept Neurol, D-48129 Munster, Germany	Heinrich Heine University Dusseldorf; University of Munster; Royal College of Surgeons - Ireland; University of Cologne; University of Munster	Trapp, T (corresponding author), Univ Dusseldorf, Med Ctr, Lab Neuroregenerat, Inst Transplantat Diagnost & Cell Therapeut,ITZ, Moorenstr 5,Bldg 14-80, D-40225 Dusseldorf, Germany.	trapp@itz.uni-duesseldorf.de	Foecking, Melanie/G-9491-2011	Foecking, Melanie/0000-0002-6299-2952; Fischer, Johannes/0000-0002-2079-1845	European Community [BIO4-CT98-0293, QLG3-CT-2000-00934, QLK6-CT-2000-60042]	European Community(European Commission)	This work was supported by European Community Grants BIO4-CT98-0293, QLG3-CT-2000-00934, and QLK6-CT-2000-60042 (to the Trapp laboratory). The costs of publication of this article were defrayed in part by the payment of page charges. This article must therefore be hereby marked "advertisement" in accordance with 18 U. S. C. Section 1734 solely to indicate this fact.	Abounader R, 2005, NEURO-ONCOLOGY, V7, P436, DOI 10.1215/S1152851705000050; BACKHAUSS C, 1992, J PHARMACOL TOXICOL, V27, P27, DOI 10.1016/1056-8719(92)90017-U; Bang OY, 2005, ANN NEUROL, V57, P874, DOI 10.1002/ana.20501; Boccaccio C, 2006, NAT REV CANCER, V6, P637, DOI 10.1038/nrc1912; Bolanos-Garcia VM, 2005, MOL CELL BIOCHEM, V276, P149, DOI 10.1007/s11010-005-3696-6; Bowers DC, 2000, CANCER RES, V60, P4277; Buzanska L, 2002, J CELL SCI, V115, P2131; Chen JL, 2001, STROKE, V32, P2682, DOI 10.1161/hs1101.098367; Chen N, 2005, STEM CELLS, V23, P1560, DOI 10.1634/stemcells.2004-0284; Date I, 2004, J NEUROSCI RES, V78, P442, DOI 10.1002/jnr.20263; Date I, 2004, BIOCHEM BIOPH RES CO, V319, P1152, DOI 10.1016/j.bbrc.2004.05.100; DAVIS JB, 1994, BRAIN RES, V652, P169, DOI 10.1016/0006-8993(94)90334-4; Erdo F, 2003, J CEREBR BLOOD F MET, V23, P780, DOI 10.1097/01.WCB.0000071886.63724.FB; Ferraro D, 2006, ONCOGENE, V25, P3689, DOI 10.1038/sj.onc.1209409; Giacobini P, 2007, J NEUROSCI, V27, P431, DOI 10.1523/JNEUROSCI.4979-06.2007; Goldman S, 2005, NAT BIOTECHNOL, V23, P862, DOI 10.1038/nbt1119; Haas S, 2005, CURR OPIN NEUROL, V18, P59, DOI 10.1097/00019052-200502000-00012; Hara H, 1996, J CEREBR BLOOD F MET, V16, P605, DOI 10.1097/00004647-199607000-00010; Hata R, 1998, J CEREBR BLOOD F MET, V18, P367, DOI 10.1097/00004647-199804000-00004; Hayashi T, 1998, BRAIN RES, V799, P311, DOI 10.1016/S0006-8993(98)00391-6; Hermann A, 2004, J CELL SCI, V117, P4411, DOI 10.1242/jcs.01307; Hill WD, 2004, J NEUROPATH EXP NEUR, V63, P84, DOI 10.1093/jnen/63.1.84; Hoehn M, 2002, P NATL ACAD SCI USA, V99, P16267, DOI 10.1073/pnas.242435499; HONDA S, 1995, MOL BRAIN RES, V32, P197, DOI 10.1016/0169-328X(95)00075-4; Jaiswal N, 1997, J CELL BIOCHEM, V64, P295, DOI 10.1002/(SICI)1097-4644(199702)64:2<295::AID-JCB12>3.0.CO;2-I; Kelly S, 2004, P NATL ACAD SCI USA, V101, P11839, DOI 10.1073/pnas.0404474101; Kobayashi H, 2006, BLOOD, V108, P1260, DOI 10.1182/blood-2005-09-012807; Kobayashi T, 2006, STROKE, V37, P2361, DOI 10.1161/01.STR.0000236025.44089.e1; Kogler G, 2004, J EXP MED, V200, P123, DOI 10.1084/jem.20040440; Laevsky G, 2001, BIOTECHNIQUES, V31, P1140, DOI 10.2144/01315rr03; Li YQ, 2005, CANCER RES, V65, P9355, DOI 10.1158/0008-5472.CAN-05-1946; Lindvall O, 2006, NATURE, V441, P1094, DOI 10.1038/nature04960; Mazzone M, 2006, FASEB J, V20, P1611, DOI 10.1096/fj.06-5947rev; MIES G, 1991, J CEREBR BLOOD F MET, V11, P753, DOI 10.1038/jcbfm.1991.132; Munoz JR, 2005, P NATL ACAD SCI USA, V102, P18171, DOI 10.1073/pnas.0508945102; Neuss S, 2004, STEM CELLS, V22, P405, DOI 10.1634/stemcells.22-3-405; Newman MB, 2006, EXP NEUROL, V199, P201, DOI 10.1016/j.expneurol.2006.04.001; Oshima K, 2004, FASEB J, V18, P212, DOI 10.1096/fj.03-0567fje; Peterson DA, 2004, J CLIN INVEST, V114, P312, DOI 10.1172/jc1200422540; Robin AM, 2006, J CEREBR BLOOD F MET, V26, P125, DOI 10.1038/sj.jcbfm.9600172; Rosu-Myles M, 2005, J CELL SCI, V118, P4343, DOI 10.1242/jcs.02555; Shimamura M, 2004, CIRCULATION, V109, P424, DOI 10.1161/01.CIR.0000109496.82683.49; Son BR, 2006, STEM CELLS, V24, P1254, DOI 10.1634/stemcells.2005-0271; Sun W, 2005, STEM CELLS, V23, P931, DOI 10.1634/stemcells.2004-0316; Taguchi A, 2004, J CLIN INVEST, V114, P330, DOI 10.1172/jci200420622; Trapp T, 2003, MOL CELL NEUROSCI, V23, P302, DOI 10.1016/S1044-7431(03)00013-7; Trapp T, 1996, J BIOL CHEM, V271, P9879, DOI 10.1074/jbc.271.17.9879; Trapp T, 2001, MOL CELL NEUROSCI, V17, P883, DOI 10.1006/mcne.2001.0971; Varming T, 1996, J NEUROSCI RES, V44, P40, DOI 10.1002/(SICI)1097-4547(19960401)44:1<40::AID-JNR5>3.0.CO;2-I; Vendrame M, 2004, STROKE, V35, P2390, DOI 10.1161/01.STR.0000141681.06735.9b; WARBURTON PE, 1991, GENOMICS, V11, P324, DOI 10.1016/0888-7543(91)90139-6	51	28	38	0	4	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 21	2008	283	47					32244	32253		10.1074/jbc.M800862200	http://dx.doi.org/10.1074/jbc.M800862200			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	372HW	18628208	hybrid			2022-12-27	WOS:000260893700011
J	Langston, LD; O'Donnell, M				Langston, Lance D.; O'Donnell, Mike			DNA Polymerase delta Is Highly Processive with Proliferating Cell Nuclear Antigen and Undergoes Collision Release upon Completing DNA	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							REPLICATION-FACTOR-C; LAGGING-STRAND POLYMERASE; ESCHERICHIA-COLI; III HOLOENZYME; SACCHAROMYCES-CEREVISIAE; SLIDING CLAMPS; IN-VITRO; LEADING-STRAND; FORK; EPSILON	In most cells, 100-1000 Okazaki fragments are produced for each replicative DNA polymerase present in the cell. For fast-growing cells, this necessitates rapid recycling of DNA polymerase on the lagging strand. Bacteria produce long Okazaki fragments (1-2 kb) and utilize a highly processive DNA polymerase III (pol III), which is held to DNA by a circular sliding clamp. In contrast, Okazaki fragments in eukaryotes are quite short, 100 250 bp, and thus the eukaryotic lagging strand polymerase does not require a high degree of processivity. The lagging strand polymerase in eukaryotes, polymerase delta (pol delta), functions with the proliferating cell nuclear antigen ( PCNA) sliding clamp. In this report, Saccharomyces cerevisiae pol delta is examined on model substrates to gain insight into the mechanism of lagging strand replication in eukaryotes. Surprisingly, we find pol delta is highly processive with PCNA, over at least 5 kb, on Replication Protein A (RPA)-coated primed single strand DNA. The high processivity of pol delta observed in this report contrasts with its role in synthesis of short lagging strand fragments, which require it to rapidly dissociate from DNA at the end of each Okazaki fragment. We find that this dilemma is solved by a "collision release" process in which pol delta ejects from PCNA upon extending a DNA template to completion and running into the downstream duplex. The released pol delta transfers to a new primed site, provided the new site contains a PCNA clamp. Additional results indicate that the collision release mechanism is intrinsic to the pol3/pol31 subunits of the pol delta heterotrimer.	[Langston, Lance D.; O'Donnell, Mike] Rockefeller Univ, Howard Hughes Med Inst, New York, NY 10065 USA	Howard Hughes Medical Institute; Rockefeller University	O'Donnell, M (corresponding author), 1230 York Ave,Box 288, New York, NY 10065 USA.	odonnel@mail.rockefeller.edu		O'Donnell, Michael/0000-0001-9002-4214; Langston, Lance/0000-0002-2736-9284	National Institutes of Health [GM38839]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R37GM038839, R01GM038839] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported, in whole or in part, by National Institutes of Health Grant GM38839. The costs of publication of this article were defrayed in part by the payment of page charges. This article must therefore be hereby marked "advertisement" in accordance with 18 U. S. C. Section 1734 solely to indicate this fact.	AYYAGARI R, 1995, MOL CELL BIOL, V15, P4420; BAUER GA, 1988, P NATL ACAD SCI USA, V85, P7506, DOI 10.1073/pnas.85.20.7506; Bauerschmidt C, 2007, GENES CELLS, V12, P745, DOI 10.1111/j.1365-2443.2007.01090.x; Bielinsky AK, 1998, SCIENCE, V279, P95, DOI 10.1126/science.279.5347.95; BURGERS PMJ, 1991, J BIOL CHEM, V266, P22698; BURGERS PMJ, 1993, J BIOL CHEM, V268, P19923; Chilkova O, 2007, NUCLEIC ACIDS RES, V35, P6588, DOI 10.1093/nar/gkm741; CONAWAY RC, 1982, P NATL ACAD SCI-BIOL, V79, P4585, DOI 10.1073/pnas.79.15.4585; DEPAMPHILIS ML, 1980, ANNU REV BIOCHEM, V49, P627, DOI 10.1146/annurev.bi.49.070180.003211; Dua R, 1999, J BIOL CHEM, V274, P22283, DOI 10.1074/jbc.274.32.22283; FAY PJ, 1981, J BIOL CHEM, V256, P976; Finkelstein J, 2003, ANAL BIOCHEM, V319, P78, DOI 10.1016/S0003-2697(03)00273-2; Garg P, 2005, CRIT REV BIOCHEM MOL, V40, P115, DOI 10.1080/10409230590935433; Gerik KJ, 1998, J BIOL CHEM, V273, P19747, DOI 10.1074/jbc.273.31.19747; Glover BP, 1998, J BIOL CHEM, V273, P23476, DOI 10.1074/jbc.273.36.23476; Higuchi K, 2003, GENES CELLS, V8, P437, DOI 10.1046/j.1365-2443.2003.00646.x; Johansson E, 2004, J BIOL CHEM, V279, P1907, DOI 10.1074/jbc.M310362200; Johnson A, 2006, J BIOL CHEM, V281, P35531, DOI 10.1074/jbc.M606090200; Kelman Z, 1998, EMBO J, V17, P2436, DOI 10.1093/emboj/17.8.2436; Kesti T, 1999, MOL CELL, V3, P679, DOI 10.1016/S1097-2765(00)80361-5; Kim S, 1996, J BIOL CHEM, V271, P21406, DOI 10.1074/jbc.271.35.21406; Labib K, 2000, SCIENCE, V288, P1643, DOI 10.1126/science.288.5471.1643; LEE SH, 1989, P NATL ACAD SCI USA, V86, P7361, DOI 10.1073/pnas.86.19.7361; Leu FP, 2003, MOL CELL, V11, P315, DOI 10.1016/S1097-2765(03)00042-X; LEU FP, 2002, THESIS CORNELL MED C; Li XJ, 2000, J BIOL CHEM, V275, P34757, DOI 10.1074/jbc.M006556200; MAKI S, 1988, J BIOL CHEM, V263, P6555; Masuda Y, 2007, NUCLEIC ACIDS RES, V35, P6904, DOI 10.1093/nar/gkm822; McElhinny SAN, 2008, MOL CELL, V30, P137, DOI 10.1016/j.molcel.2008.02.022; McInerney P, 2004, J BIOL CHEM, V279, P21543, DOI 10.1074/jbc.M401649200; MORRISON A, 1992, NUCLEIC ACIDS RES, V20, P375, DOI 10.1093/nar/20.2.375; O'Donnell M, 2006, J BIOL CHEM, V281, P10653, DOI 10.1074/jbc.R500028200; ODONNELL ME, 1987, J BIOL CHEM, V262, P16558; ODONNELL ME, 1985, J BIOL CHEM, V260, P2884; ONRUST R, 1995, J BIOL CHEM, V270, P13348, DOI 10.1074/jbc.270.22.13348; Pages V, 2003, SCIENCE, V300, P1300, DOI 10.1126/science.1083964; PAN ZQ, 1993, P NATL ACAD SCI USA, V90, P6, DOI 10.1073/pnas.90.1.6; PODUST LM, 1995, MOL CELL BIOL, V15, P3072; PODUST VN, 1995, BIOCHEMISTRY-US, V34, P5003, DOI 10.1021/bi00015a011; Podust VN, 1998, J BIOL CHEM, V273, P31992, DOI 10.1074/jbc.273.48.31992; PRELICH G, 1987, NATURE, V326, P517, DOI 10.1038/326517a0; Pursell ZF, 2007, SCIENCE, V317, P127, DOI 10.1126/science.1144067; Raghuraman MK, 2001, SCIENCE, V294, P115, DOI 10.1126/science.294.5540.115; Stillman B, 2008, MOL CELL, V30, P259, DOI 10.1016/j.molcel.2008.04.011; STUDWELLVAUGHAN PS, 1991, J BIOL CHEM, V266, P19833; STUKENBERG PT, 1994, CELL, V78, P877, DOI 10.1016/S0092-8674(94)90662-9; TSUCHIHASHI Z, 1989, J BIOL CHEM, V264, P17790; TSURIMOTO T, 1991, J BIOL CHEM, V266, P1961; Turner J, 1995, METHOD ENZYMOL, V262, P442; Uhlmann F, 1997, J BIOL CHEM, V272, P10058; WAGA S, 1994, NATURE, V369, P207, DOI 10.1038/369207a0; WEINBERG DH, 1990, P NATL ACAD SCI USA, V87, P8692, DOI 10.1073/pnas.87.22.8692; Yang JS, 2006, MOL CELL, V21, P153, DOI 10.1016/j.molcel.2005.11.029; Yao N, 1996, GENES CELLS, V1, P101, DOI 10.1046/j.1365-2443.1996.07007.x; Yao N, 2000, J BIOL CHEM, V275, P1421, DOI 10.1074/jbc.275.2.1421; Yuzhakov A, 1999, EMBO J, V18, P6189, DOI 10.1093/emboj/18.21.6189	56	56	56	0	4	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	OCT 24	2008	283	43					29522	29531		10.1074/jbc.M804488200	http://dx.doi.org/10.1074/jbc.M804488200			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	362EB	18635534	hybrid, Green Published			2022-12-27	WOS:000260179900078
J	Muryoi, N; Tiedemann, MT; Pluym, M; Cheung, J; Heinrichs, DE; Stillman, MJ				Muryoi, Naomi; Tiedemann, Michael T.; Pluym, Mark; Cheung, Johnson; Heinrichs, David E.; Stillman, Martin J.			Demonstration of the iron-regulated surface determinant (Isd) heme transfer pathway in Staphylococcus aureus	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							BINDING PROPERTIES; UPTAKE SYSTEM; PROTEIN; HEMOGLOBIN; PATHOGENESIS; HAPTOGLOBIN; EXPRESSION; HEMOPHORES; RESISTANCE; SPECTRA	In this study, we report experimental results that provide the first complete challenge of a proposed model for heme acquisition by Staphylococcus aureus via the Isd pathway first put forth by Mazmanian, S. K., Skaar, E. P., Gaspar, A. H., Humayun, M., Gornicki, P., Jelenska, J., Joachmiak, A., Missiakas, D. M., and Schneewind, O. (2003) Science 299, 906-909. The heme-binding NEAT domains of Isd proteins IsdA, IsdB (domain 2), IsdC, and HarA/IsdH (domain 3), and the heme-binding IsdE protein, were overexpressed and purified in apo (heme-free) form. Absorption and magnetic circular dichroism spectral data, together with electrospray ionization mass spectrometry were used to unambiguously identify that heme transfers from NEAT-A through NEAT-C to IsdE. Heme transfer was demonstrated to occur in a unidirectional fashion in the sequence NEAT-B -> NEAT-A -> NEAT-C -> IsdE or, alternatively, initiating from NEAT-H3 instead of NEAT-B2: NEAT-H3 -> NEAT- A -> NEAT-C -> IsdE. Under the conditions of our experiments, only NEAT-H3 and NEAT-B2 could transfer bidirectionally, which is in the reverse direction as well, and only with each other. Whereas apo-IsdE readily accepted heme from holo-NEAT-C, it would not accept heme from holo-NEAT-A. Heme transfer to IsdE requires the presence of holo-NEAT-C, in agreement with the proposal that IsdC serves as the central conduit of the heme transfer pathway. These experimental findings corroborate the heme transfer model first proposed by the Schneewind group. Our data show that heme transport from the wall-anchored IsdH/IsdB proteins proceeds directly to IsdE at the membrane and, for this to occur, we propose that specific protein-protein interactions must take place.	[Muryoi, Naomi; Cheung, Johnson; Heinrichs, David E.] Univ Western Ontario, Dept Microbiol & Immunol, London, ON N6A 5C1, Canada; [Tiedemann, Michael T.; Pluym, Mark; Stillman, Martin J.] Univ Western Ontario, Dept Chem, London, ON N6A 5B7, Canada	Western University (University of Western Ontario); Western University (University of Western Ontario)	Heinrichs, DE (corresponding author), Univ Western Ontario, Dept Microbiol & Immunol, London, ON N6A 5C1, Canada.	deh@uwo.ca; martin.stillman@uwo.ca	Stillman, Martin/O-3191-2016; Heinrichs, David/ABD-5702-2021	Stillman, Martin/0000-0001-6799-7560; Heinrichs, David/0000-0002-7217-2456	Canadian Institutes of Health Research; Natural Sciences and Engineering Research Council; Ontario Graduate Scholarship program	Canadian Institutes of Health Research(Canadian Institutes of Health Research (CIHR)); Natural Sciences and Engineering Research Council(Natural Sciences and Engineering Research Council of Canada (NSERC)); Ontario Graduate Scholarship program(Ontario Graduate Scholarship)	This work was supported by a Canadian Institutes of Health Research operating grant (to D. E. H.), operating and equipment grants from the Natural Sciences and Engineering Research Council (NSERC) of Canada (to M. J. S.), the NSERC Postgraduate Scholarship program (to M. P.), and the Ontario Graduate Scholarship program (to M. T. T.). The costs of publication of this article were defrayed in part by the payment of page charges. This article must therefore be hereby marked "advertisement" in accordance with 18 U. S. C. Section 1734 solely to indicate this fact.	BERRY EA, 1987, ANAL BIOCHEM, V161, P1, DOI 10.1016/0003-2697(87)90643-9; CHEEK J, 2000, MAGNETIC CIRCULAR DI; Clarke SR, 2008, INFECT IMMUN, V76, P1518, DOI 10.1128/IAI.01530-07; Clarke SR, 2007, CELL HOST MICROBE, V1, P199, DOI 10.1016/j.chom.2007.04.005; Clarke SR, 2004, MOL MICROBIOL, V51, P1509, DOI 10.1111/j.1365-2958.2003.03938.x; Dryla A, 2003, MOL MICROBIOL, V49, P37, DOI 10.1046/j.1365-2958.2003.03542.x; Dryla A, 2007, J BACTERIOL, V189, P254, DOI 10.1128/JB.01366-06; Eakanunkul S, 2005, BIOCHEMISTRY-US, V44, P13179, DOI 10.1021/bi050422r; Genco CA, 2001, MOL MICROBIOL, V39, P1, DOI 10.1046/j.1365-2958.2001.02231.x; Gordon RJ, 2008, CLIN INFECT DIS, V46, pS350, DOI 10.1086/533591; Grigg JC, 2007, J BIOL CHEM, V282, P28815, DOI 10.1074/jbc.M704602200; Grigg JC, 2007, MOL MICROBIOL, V63, P139, DOI 10.1111/j.1365-2958.2006.05502.x; GUZMAN LM, 1995, J BACTERIOL, V177, P4121, DOI 10.1128/jb.177.14.4121-4130.1995; LI JM, 1988, J BACTERIOL, V170, P1021, DOI 10.1128/jb.170.2.1021-1025.1988; Liu MY, 2008, J BIOL CHEM, V283, P6668, DOI 10.1074/jbc.M708372200; Mack J, 2004, BIOCHEM BIOPH RES CO, V320, P781, DOI 10.1016/j.bbrc.2004.06.025; Mazmanian SK, 2002, P NATL ACAD SCI USA, V99, P2293, DOI 10.1073/pnas.032523999; Mazmanian SK, 2003, SCIENCE, V299, P906, DOI 10.1126/science.1081147; McGowan JE, 2004, NAT REV MICROBIOL, V2, P251, DOI 10.1038/nrmicro845; Morrissey JA, 2002, INFECT IMMUN, V70, P2399, DOI 10.1128/IAI.70.5.2399-2407.2002; Pluym M, 2008, J INORG BIOCHEM, V102, P480, DOI 10.1016/j.jinorgbio.2007.11.011; Pluym M, 2007, J PORPHYR PHTHALOCYA, V11, P165, DOI 10.1142/S1088424607000217; Pluym M, 2007, BIOCHEMISTRY-US, V46, P12777, DOI 10.1021/bi7009585; Reniere ML, 2007, BIOMETALS, V20, P333, DOI 10.1007/s10534-006-9032-0; Sharp KH, 2007, J BIOL CHEM, V282, P10625, DOI 10.1074/jbc.M700234200; Skaar EP, 2004, MICROBES INFECT, V6, P390, DOI 10.1016/j.micinf.2003.12.008; Skaar EP, 2004, J BIOL CHEM, V279, P436, DOI 10.1074/jbc.M307952200; SPRINGALL J, 1976, BIOCHIM BIOPHYS ACTA, V453, P494, DOI 10.1016/0005-2795(76)90145-8; Taylor JM, 2002, MOL MICROBIOL, V43, P1603, DOI 10.1046/j.1365-2958.2002.02850.x; Torres VJ, 2006, J BACTERIOL, V188, P8421, DOI 10.1128/JB.01335-06; Vermeiren CL, 2006, BIOCHEMISTRY-US, V45, P12867, DOI 10.1021/bi0607711; Wandersman C, 2000, CURR OPIN MICROBIOL, V3, P215, DOI 10.1016/S1369-5274(00)00078-3; Wandersman C, 2004, ANNU REV MICROBIOL, V58, P611, DOI 10.1146/annurev.micro.58.030603.123811; Zhu H, 2008, J BIOL CHEM, V283, P18450, DOI 10.1074/jbc.M801466200	34	124	130	1	24	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	OCT 17	2008	283	42					28125	28136		10.1074/jbc.M802171200	http://dx.doi.org/10.1074/jbc.M802171200			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	359EN	18676371	Green Published, hybrid			2022-12-27	WOS:000259969300015
J	Shimamoto, S; Takata, M; Tokuda, M; Oohira, F; Tokumitsu, H; Kobayashi, R				Shimamoto, Seiko; Takata, Maki; Tokuda, Masaaki; Oohira, Fumikazu; Tokumitsu, Hiroshi; Kobayashi, Ryoji			Interactions of S100A2 and S100A6 with the tetratricopeptide repeat proteins, Hsp90/Hsp70-organizing protein and kinesin light chain	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							MOLECULAR CHAPERONE; ANTIALLERGIC DRUGS; SCAFFOLD PROTEIN; BINDING; HSP90; IDENTIFICATION; MECHANISMS; TARGET; CARGO; HSP70	S100A2 and S100A6 interact with several target proteins in a Ca2+-regulated manner. However, the exact intracellular roles of the S100 proteins are unclear. In this study we identified Hsp70/Hsp90-organizing protein (Hop) and kinesin light chain (KLC) as novel targets of S100A2 and S100A6. Hop directly associates with Hsp70 and Hsp90 through the tetratricopeptide (TPR) domains andregulates Hop-Hsp70 and Hop-Hsp90 complex formation. We have found that S100A2 and S100A6 bind to the TPR domain of Hop, resulting in inhibition of the Hop-Hsp70 and Hop-Hsp90 interactions in vitro. Although endogenous Hsp70 and Hsp90 interact with Hop in resting Cos-7 cells, but not with S100A6, stimulation of these cells with ionomycin caused a Hop-S100A6 interaction, resulting in the dissociation of Hsp70 and Hsp90 from Hop. Similarly, glutathione S-transferase pulldown and co-immunoprecipitation experiments revealed that S100A6 binds to the TPR domain of KLC, resulting in inhibition of the KLC-c-Jun N-terminal kinase (JNK)-interacting protein 1 (JIP-1) interaction in vitro. The transiently expressed JIP-1 interacts with KLC in resting Cos-7 cells but not with S100A6. Stimulation of these cells with ionomycin also caused a KLC-S100A6 interaction, resulting in dissociation of JIP- 1 from KLC. These results strongly suggest that the S100 proteins modulate Hsp70-Hop-Hsp90 multichaperone complex formation and KLC-cargo interaction via Ca2+-dependent S100 protein-TPR protein complex formation in vivo as well as in vitro. Moreover, we have shown that S100A2 and S100A6 interact with another TPR protein Tom70 and regulate the Tom70-ligand interaction in vitro. Thus, our findings suggest a new intracellular Ca2+-signaling pathway via S100 proteins-TPR motif interactions.	[Shimamoto, Seiko; Takata, Maki; Tokumitsu, Hiroshi; Kobayashi, Ryoji] Kagawa Univ, Fac Med, Dept Signal Transduct Sci, Miki, Kagawa 7610793, Japan; [Tokuda, Masaaki] Kagawa Univ, Fac Med, Dept Cell Physiol, Miki, Kagawa 7610793, Japan; [Shimamoto, Seiko; Oohira, Fumikazu] Kagawa Univ, Fac Engn, Dept Intelligent Mech Syst Engn, Takamatsu, Kagawa 7610396, Japan	Kagawa University; Kagawa University; Kagawa University	Kobayashi, R (corresponding author), Kagawa Univ, Fac Med, Dept Signal Transduct Sci, 1750-1 Ikenobe, Miki, Kagawa 7610793, Japan.	ryoji@med.kagawa-u.ac.jp	Tokumitsu, Hiroshi/M-3978-2015	Tokumitsu, Hiroshi/0000-0002-2193-6794	Ministry of Education, Culture, Sports, Science, and Technology of Japan [18300123]	Ministry of Education, Culture, Sports, Science, and Technology of Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT))	This work was supported in part by grants-in aid for Scientific Research 18300123 from the Ministry of Education, Culture, Sports, Science, and Technology of Japan. The costs of publication of this article were defrayed in part by the payment of page charges. This article must therefore be hereby marked "advertisement" in accordance with 18 U.S.C. Section 1734 solely to indicate this fact.	Adio S, 2006, J MUSCLE RES CELL M, V27, P153, DOI 10.1007/s10974-005-9054-1; Ballinger CA, 1999, MOL CELL BIOL, V19, P4535; Bhattacharya S, 2004, BBA-MOL CELL RES, V1742, P69, DOI 10.1016/j.bbamcr.2004.09.002; Blatch GL, 1999, BIOESSAYS, V21, P932, DOI 10.1002/(SICI)1521-1878(199911)21:11<932::AID-BIES5>3.0.CO;2-N; Carrigan PE, 2004, J BIOL CHEM, V279, P16185, DOI 10.1074/jbc.M314130200; Chen SY, 1998, J BIOL CHEM, V273, P35194, DOI 10.1074/jbc.273.52.35194; Donato R, 1999, BBA-MOL CELL RES, V1450, P191, DOI 10.1016/S0167-4889(99)00058-0; Donato R, 2003, MICROSC RES TECHNIQ, V60, P540, DOI 10.1002/jemt.10296; Hernandez MP, 2002, J BIOL CHEM, V277, P38294, DOI 10.1074/jbc.M206566200; Hirokawa N, 2005, NAT REV NEUROSCI, V6, P201, DOI 10.1038/nrn1624; Kamm C, 2004, J BIOL CHEM, V279, P19882, DOI 10.1074/jbc.M401332200; Kelkar N, 2005, MOL CELL BIOL, V25, P2733, DOI 10.1128/MCB.25.7.2733-2743.2005; Konecna A, 2006, MOL BIOL CELL, V17, P3651, DOI 10.1091/mbc.E06-02-0112; LASSLE M, 1998, J BIOL CHEM, V273, P3679; Lazarov O, 2005, J NEUROSCI, V25, P2386, DOI 10.1523/JNEUROSCI.3089-04.2005; Matsuda S, 2003, J BIOL CHEM, V278, P38601, DOI 10.1074/jbc.M304379200; McGuire JR, 2006, J BIOL CHEM, V281, P3552, DOI 10.1074/jbc.M509806200; Murphy PJM, 2001, J BIOL CHEM, V276, P30092, DOI 10.1074/jbc.M103773200; Nguyen Q, 2005, J BIOL CHEM, V280, P30185, DOI 10.1074/jbc.M505499200; Odunuga OO, 2003, J BIOL CHEM, V278, P6896, DOI 10.1074/jbc.M206867200; Okada M, 2004, J BIOL CHEM, V279, P4221, DOI 10.1074/jbc.M309014200; Okada M, 2003, BIOCHEM J, V374, P433, DOI 10.1042/BJ20030351; Okada M, 2002, BIOCHEM BIOPH RES CO, V292, P1023, DOI 10.1006/bbrc.2002.6761; Prodromou C, 1999, EMBO J, V18, P754, DOI 10.1093/emboj/18.3.754; Santamaria-Kisiel L, 2006, BIOCHEM J, V396, P201, DOI 10.1042/BJ20060195; Scheufler C, 2000, CELL, V101, P199, DOI 10.1016/S0092-8674(00)80830-2; Siligardi G, 2004, J BIOL CHEM, V279, P51989, DOI 10.1074/jbc.M410562200; SMITH DF, 1993, MOL CELL BIOL, V13, P869, DOI 10.1128/MCB.13.2.869; Tomas A, 2003, J BIOL CHEM, V278, P20210, DOI 10.1074/jbc.M212669200; van der Spuy J, 2000, BIOCHEM J, V345, P645, DOI 10.1042/0264-6021:3450645; Verhey KJ, 2001, TRENDS BIOCHEM SCI, V26, P545, DOI 10.1016/S0968-0004(01)01931-4; Verhey KJ, 2001, J CELL BIOL, V152, P959, DOI 10.1083/jcb.152.5.959; Yamashita K, 1999, PROTEIN EXPRES PURIF, V16, P47, DOI 10.1006/prep.1998.1026; Young JC, 2003, CELL, V112, P41, DOI 10.1016/S0092-8674(02)01250-3	34	37	39	0	2	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	OCT 17	2008	283	42					28246	28258		10.1074/jbc.M801473200	http://dx.doi.org/10.1074/jbc.M801473200			13	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	359EN	18669640	Green Published, hybrid			2022-12-27	WOS:000259969300026
J	Nadanaka, S; Ishida, M; Ikegami, M; Kitagawa, H				Nadanaka, Satomi; Ishida, Miho; Ikegami, Masami; Kitagawa, Hiroshi			Chondroitin 4-O-sulfotransferase-1 modulates Wnt-3a signaling through control of E disaccharide expression of chondroitin sulfate	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							HERPES-SIMPLEX-VIRUS; WNT/BETA-CATENIN; HEPARAN-SULFATE; CROSS-TALK; TGF-BETA; DEVELOPMENTAL REGULATION; MOLECULAR-CLONING; GROWTH-FACTORS; PATHWAYS; PROTEOGLYCANS	Wnt-3a is a ligand that activates the beta-catenin-dependent pathway in Wnt signaling, which is implicated in numerous physiological events such as morphogenesis. So far, heparan sulfate (HS) proteoglycans have been highlighted as a low affinity receptor for morphogens containing Wnts. Here we show the importance of chondroitin sulfate (CS) proteoglycans in the efficient signaling of Wnt-3a and the structural features of CS required for the regulation of Wnt-3a signaling. Wnt-3a signaling was depressed in a mouse L cell mutant, called sog9, which is defective in the EXT1 gene encoding the HS-synthesizing enzyme and the chondroitin 4-O-sulfotransferase (C4ST-1) gene compared with parental L cells. The transfection of sog9 cells with C4ST-1 resulted in the recovery of Wnt-3a signaling, whereas the expression of EXT1 in sog9 cells could not restore Wnt-3a signaling. In addition, the expression level of introduced C4ST-1 correlated with the recovery of Wnt-3a signaling accompanied by the increased expression of the E disaccharide unit of CS. Interestingly, molecular interaction analyses using Biacore revealed that squid CS-E (rich in the E disaccharide unit) bound strongly to Wnt-3a (K-d = 13.2 nM) to the same extent as heparin from bovine lung (K-d = 8.43 nM). In contrast, other CS isoforms as well as HS isolated from bovine kidney showed little binding activity to Wnt-3a. Moreover, exogenously added CS-E potently inhibited the accumulation of beta-catenin induced by Wnt-3a. These results suggest that CS-E-like structures synthesized by C4ST-1 participate in Wnt-3a signaling and modulate the physiological events caused by Wnt-3a signals.	[Nadanaka, Satomi; Ishida, Miho; Ikegami, Masami; Kitagawa, Hiroshi] Kobe Pharmaceut Univ, Dept Biochem, Higashinada Ku, Kobe, Hyogo 6588558, Japan; [Kitagawa, Hiroshi] Japan Sci & Technol Agcy, CREST, Kawaguchi, Saitama 3320012, Japan	Kobe Pharmaceutical University; Japan Science & Technology Agency (JST)	Kitagawa, H (corresponding author), Kobe Pharmaceut Univ, Dept Biochem, Higashinada Ku, 4-19-1 Motoyamakita Machi, Kobe, Hyogo 6588558, Japan.	kitagawa@kobepharma-u.ac.jp	Kitagawa, Hiroshi/AAJ-1344-2020	Kitagawa, Hiroshi/0000-0002-9307-7079	Japan Private School Promotion Foundation; Core Research for Evolutional Science and Technology of the Japan Science and Technology Corp; the Takeda Science Foundation; MEXT, Japan	Japan Private School Promotion Foundation; Core Research for Evolutional Science and Technology of the Japan Science and Technology Corp(Core Research for Evolutional Science and Technology (CREST)); the Takeda Science Foundation(Takeda Science Foundation (TSF)); MEXT, Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT))	This work was supported in part by a scientific research promotion fund from the Japan Private School Promotion Foundation, Core Research for Evolutional Science and Technology of the Japan Science and Technology Corp. (to H. K.), the Takeda Science Foundation (to H. K.), and Grant-in-aid for Scientific Research-B 19390025 (to H. K.) from MEXT, Japan. The costs of publication of this article were defrayed in part by the payment of page charges. This article must therefore be hereby marked " advertisement" in accordance with 18 U. S. C. Section 1734 solely to indicate this fact.	BANFIELD BW, 1995, J VIROL, V69, P3290, DOI 10.1128/JVI.69.6.3290-3298.1995; Boutros M, 1998, CELL, V94, P109, DOI 10.1016/S0092-8674(00)81226-X; Bulow HE, 2004, NEURON, V41, P723, DOI 10.1016/S0896-6273(04)00084-4; Dao DY, 2007, ANN NY ACAD SCI, V1116, P82, DOI 10.1196/annals.1402.082; Deepa SS, 2002, J BIOL CHEM, V277, P43707, DOI 10.1074/jbc.M207105200; Duncan G, 2001, J CLIN INVEST, V108, P511, DOI 10.1172/JCI200113737; Forsberg E, 1999, NATURE, V400, P773, DOI 10.1038/23488; Gurdon JB, 2001, NATURE, V413, P797, DOI 10.1038/35101500; Hiraoka N, 2000, J BIOL CHEM, V275, P20188, DOI 10.1074/jbc.M002443200; Jiao XY, 2007, J BIOL CHEM, V282, P1080, DOI 10.1074/jbc.M513414200; Mak KK, 2006, DEVELOPMENT, V133, P3695, DOI 10.1242/dev.02546; Kitagawa H, 1997, J BIOL CHEM, V272, P31377, DOI 10.1074/jbc.272.50.31377; KITAGAWA H, 1995, ANAL BIOCHEM, V232, P114, DOI 10.1006/abio.1995.9952; Kleber M, 2005, J CELL BIOL, V169, P309, DOI 10.1083/jcb.200411095; Kluppel M, 2005, DEVELOPMENT, V132, P3989, DOI 10.1242/dev.01948; Kuhl M, 2000, TRENDS GENET, V16, P279, DOI 10.1016/s0168-9525(00)02028-x; Logan CY, 2004, ANNU REV CELL DEV BI, V20, P781, DOI 10.1146/annurev.cellbio.20.010403.113126; Maiti A, 1998, SCIENCE, V282, P941, DOI 10.1126/science.282.5390.941; Meyer K, 1941, J BIOL CHEM, V138, P491; Molenaar M, 1996, CELL, V86, P391, DOI 10.1016/S0092-8674(00)80112-9; Moon RT, 2002, SCIENCE, V296, P1644, DOI 10.1126/science.1071549; Nakashima A, 2005, J BIOL CHEM, V280, P37660, DOI 10.1074/jbc.M504612200; Nandini CD, 2004, J BIOL CHEM, V279, P50799, DOI 10.1074/jbc.M404746200; Nishita M, 2000, NATURE, V403, P781, DOI 10.1038/35001602; Plotnikov AN, 1999, CELL, V98, P641, DOI 10.1016/S0092-8674(00)80051-3; Reichsman F, 1996, J CELL BIOL, V135, P819, DOI 10.1083/jcb.135.3.819; Reinhold MI, 2006, J BIOL CHEM, V281, P1381, DOI 10.1074/jbc.M504875200; Sambrook J., 1989, MOL CLONING LAB MANU, V1, P21, DOI DOI 10.51-10.67; SCHILLER S, 1961, J BIOL CHEM, V236, P983; Schlessinger J, 2000, MOL CELL, V6, P743, DOI 10.1016/S1097-2765(00)00073-3; Schmidt HH, 2004, ONCOGENE, V23, P6991, DOI 10.1038/sj.onc.1207934; Shibamoto S, 1998, GENES CELLS, V3, P659; Shortkroff S, 2007, OSTEOARTHR CARTILAGE, V15, P147, DOI 10.1016/j.joca.2006.07.004; Sugahara K, 2003, CURR OPIN STRUC BIOL, V13, P612, DOI 10.1016/j.sbi.2003.09.011; Takada R, 2005, GENES CELLS, V10, P919, DOI 10.1111/j.1365-2443.2005.00889.x; Tamamura Y, 2005, J BIOL CHEM, V280, P19185, DOI 10.1074/jbc.M414275200; Theocharis AD, 2003, INT J BIOCHEM CELL B, V35, P376, DOI 10.1016/S1357-2725(02)00264-9; Thiele H, 2004, P NATL ACAD SCI USA, V101, P10155, DOI 10.1073/pnas.0400334101; Tsara ME, 2002, ANTICANCER RES, V22, P2893; Tuli R, 2003, J BIOL CHEM, V278, P41227, DOI 10.1074/jbc.M305312200; Uyama T, 2006, J BIOL CHEM, V281, P38668, DOI 10.1074/jbc.M609320200; Wodarz A, 1998, ANNU REV CELL DEV BI, V14, P59, DOI 10.1146/annurev.cellbio.14.1.59; Yamauchi S, 2000, J BIOL CHEM, V275, P8975, DOI 10.1074/jbc.275.12.8975; Zhu WD, 2008, NATURE, V454, P345, DOI 10.1038/nature07027; Zorn AM, 1999, DEV BIOL, V209, P282, DOI 10.1006/dbio.1999.9257	45	70	70	0	10	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	OCT 3	2008	283	40					27333	27343		10.1074/jbc.M802997200	http://dx.doi.org/10.1074/jbc.M802997200			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	353RT	18667431	hybrid			2022-12-27	WOS:000259586600052
J	Ram, N; Weiss, N; Texier-Nogues, I; Aroui, S; Andreotti, N; Pirollet, F; Ronjat, M; Sabatier, JM; Darbon, H; Jacquemond, V; De Waard, M				Ram, Narendra; Weiss, Norbert; Texier-Nogues, Isabelle; Aroui, Sonia; Andreotti, Nicolas; Pirollet, Fabienne; Ronjat, Michel; Sabatier, Jean-Marc; Darbon, Herve; Jacquemond, Vincent; De Waard, Michel			Design of a disulfide-less, pharmacologically inert, and chemically competent analog of maurocalcine for the efficient transport of impermeant compounds into cells	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							SKELETAL-MUSCLE FIBERS; AMINO-ACID-RESIDUES; RYANODINE RECEPTOR; SCORPION TOXINS; CA2+ RELEASE; PEPTIDE; PENETRATION; MAUROTOXIN; BINDING; DEPOLARIZATION	Maurocalcine is a 33-mer peptide initially isolated from the venom of a Tunisian scorpion. It has proved itself valuable as a pharmacological activator of the ryanodine receptor and has helped the understanding of the molecular basis underlying excitation-contraction coupling in skeletal muscles. Because of its positively charged nature, it is also an innovative vector for the cell penetration of various compounds. We report a novel maurocalcine analog with improved properties: (i) the complete loss of pharmacological activity, (ii) preservation of the potent ability to carry cargo molecules into cells, and (iii) coupling chemistries not affected by the presence of internal cysteine residues of maurocalcine. We did this by replacing the six internal cysteine residues of maurocalcine by isosteric 2-aminobutyric acid residues and by adding an additional N-terminal biotinylated lysine (for a proof of concept analog) or an N-terminal cysteine residue (for a chemically competent coupling analogue). Additional replacement of a glutamate residue by alanyl at position 12 further improves the potency of these analogues. Coupling to several cargo molecules or nanoparticles are presented to illustrate the cell penetration potency and usefulness of these pharmacologically inactive analogs.	[Ram, Narendra; Aroui, Sonia; Pirollet, Fabienne; Ronjat, Michel; De Waard, Michel] Univ Grenoble 1, Grenoble Inst Neurosci, U836, Res Grp Calcium Channels Funct & Pathol 3, F-38042 Grenoble 09, France; [Weiss, Norbert; Jacquemond, Vincent] Univ Lyon 1, CNRS, UMR Physiol Integrat Cellulaire & Mol 5123, F-69622 Villeurbanne, France; [Texier-Nogues, Isabelle] CEA Grenoble LETI DTBS, F-38054 Grenoble, France; [Andreotti, Nicolas; Sabatier, Jean-Marc] Univ Mediterannee Ambrillia Biopharm, Fac Med Nord ERT62, Marseille 20, France; [Darbon, Herve] Univ Aix Marseille, CNRS, AFMB, UMR 6098, F-13288 Marseille 09, France	UDICE-French Research Universities; Communaute Universite Grenoble Alpes; Universite Grenoble Alpes (UGA); Centre National de la Recherche Scientifique (CNRS); UDICE-French Research Universities; Universite Claude Bernard Lyon 1; CEA; UDICE-French Research Universities; Aix-Marseille Universite; Centre National de la Recherche Scientifique (CNRS); UDICE-French Research Universities; Aix-Marseille Universite	De Waard, M (corresponding author), Univ Grenoble 1, Grenoble Inst Neurosci, U836, Res Grp Calcium Channels Funct & Pathol 3, BP 170, F-38042 Grenoble 09, France.	michel.dewaard@ujf-grenoble.fr	Weiss, Norbert/G-5330-2014; De Waard, Michel/G-7406-2014; Pirollet, Fabienne/L-3088-2013	Weiss, Norbert/0000-0002-0040-1109; De Waard, Michel/0000-0002-2782-9615; Jacquemond, Vincent/0000-0003-4944-270X; SABATIER, Jean-Marc/0000-0002-9040-5647; Texier, Isabelle/0000-0002-8859-8283; Ronjat, Michel/0000-0002-9728-6425	INSERM; CEA	INSERM(Institut National de la Sante et de la Recherche Medicale (Inserm)European Commission); CEA(French Atomic Energy Commission)	This work was supported in part by INSERM and the Fonds de Valorisation of the CEA. The costs of publication of this article were defrayed in part by the payment of page charges. This article must therefore be hereby marked "advertisement" in accordance with 18 U. S. C. Section 1734 solely to indicate this fact.	Altafaj X, 2005, J BIOL CHEM, V280, P4013, DOI 10.1074/jbc.C400433200; Boisseau S, 2006, BBA-BIOMEMBRANES, V1758, P308, DOI 10.1016/j.bbamem.2006.02.007; Cai WB, 2006, NANO LETT, V6, P669, DOI 10.1021/nl052405t; Collet C, 1999, J PHYSIOL-LONDON, V520, P417, DOI 10.1111/j.1469-7793.1999.00417.x; Csernoch L, 1998, BIOPHYS J, V75, P957, DOI 10.1016/S0006-3495(98)77584-8; Davidson TJ, 2004, J NEUROSCI, V24, P10040, DOI 10.1523/JNEUROSCI.3643-04.2004; di Luccio E, 2002, BIOCHEM J, V361, P409, DOI 10.1042/0264-6021:3610409; ELHAYEK R, 1995, J BIOL CHEM, V270, P28696, DOI 10.1074/jbc.270.48.28696; Esteve E, 2005, J BIOL CHEM, V280, P12833, DOI 10.1074/jbc.M412521200; Esteve E, 2003, J BIOL CHEM, V278, P37822, DOI 10.1074/jbc.M305798200; Fajloun Z, 2000, J BIOL CHEM, V275, P39394, DOI 10.1074/jbc.M006810200; Fajloun Z, 2000, J BIOL CHEM, V275, P13605, DOI 10.1074/jbc.275.18.13605; GALLO V, 1987, J NEUROSCI, V7, P2203; Jacquemond V, 1997, BIOPHYS J, V73, P920, DOI 10.1016/S0006-3495(97)78124-4; KIM DH, 1983, J BIOL CHEM, V258, P9662; Liang JF, 2005, BIOORG MED CHEM LETT, V15, P5071, DOI 10.1016/j.bmcl.2005.07.087; Mabrouk K, 2007, BBA-BIOMEMBRANES, V1768, P2528, DOI 10.1016/j.bbamem.2007.06.030; Mosbah A, 2000, PROTEINS, V40, P436, DOI 10.1002/1097-0134(20000815)40:3&lt;436::AID-PROT90&gt;3.0.CO;2-9; Nascimento FD, 2007, J BIOL CHEM, V282, P21349, DOI 10.1074/jbc.M604876200; Pouvreau S, 2006, BIOPHYS J, V91, P2206, DOI 10.1529/biophysj.105.078089; Ram N, 2008, J BIOL CHEM, V283, P24274, DOI 10.1074/jbc.M709971200; Shahbazzadeh D, 2007, BIOCHEM J, V404, P89, DOI 10.1042/BJ20061404; Zhu SY, 2003, FASEB J, V17, P1765, DOI 10.1096/fj.02-1044fje	23	27	27	0	5	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	OCT 3	2008	283	40					27048	27056		10.1074/jbc.M804727200	http://dx.doi.org/10.1074/jbc.M804727200			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	353RT	18621738	Green Submitted, Green Accepted, hybrid			2022-12-27	WOS:000259586600025
J	Jin, JF; Hou, Q; Mullen, TD; Zeidan, YH; Bielawski, J; Kraveka, JM; Bielawska, A; Obeid, LM; Hannun, YA; Hsu, YT				Jin, Junfei; Hou, Qi; Mullen, Thomas D.; Zeidan, Youssef H.; Bielawski, Jacek; Kraveka, Jacqueline M.; Bielawska, Alicja; Obeid, Lina M.; Hannun, Yusuf A.; Hsu, Yi-Te			Ceramide generated by sphingomyelin hydrolysis and the salvage pathway is involved in hypoxia/reoxygenation-induced bax redistribution to mitochondria in NT-2 cells	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							PERMEABILITY TRANSITION PORE; DELTA-MEDIATED PHOSPHORYLATION; CYTOCHROME-C RELEASE; ACID SPHINGOMYELINASE; CONFORMATIONAL-CHANGE; TNF-ALPHA; NEURONAL APOPTOSIS; CEREBRAL-ISCHEMIA; SIGNALS APOPTOSIS; HL-60 CELLS	Ceramide functions as an important second messenger in apoptosis signaling pathways. In this report, we show that treatment of NT-2 neuronal precursor cells with hypoxia/reoxygenation (H/R) resulted in ceramide up-regulation. This elevation in ceramide was primarily due to the actions of acid sphingomyelinase and ceramide synthase LASS 5, demonstrating the action of the salvage pathway. Hypoxia/reoxygenation treatment led to Bax translocation from the cytoplasm to mitochondria and cytochrome c release from mitochondria. Down-regulation of either acid sphingomyelinase or LASS 5-attenuated ceramide accumulation and H/R-induced Bax translocation to mitochondria. Overall, we have demonstrated that ceramide upregulation following H/R is pertinent to Bax activation to promote cell death.	[Jin, Junfei; Hou, Qi; Zeidan, Youssef H.; Bielawski, Jacek; Bielawska, Alicja; Hannun, Yusuf A.; Hsu, Yi-Te] Med Univ S Carolina, Dept Biochem & Mol Biol, Div Hematol Oncol, Charleston, SC 29425 USA; [Mullen, Thomas D.; Obeid, Lina M.] Med Univ S Carolina, Dept Med, Div Hematol Oncol, Charleston, SC 29425 USA; [Kraveka, Jacqueline M.] Med Univ S Carolina, Dept Pediat, Div Hematol Oncol, Charleston, SC 29425 USA; [Hou, Qi] Peking Union Med Coll, Inst Mat Med, Dept Pharmacol, Beijing 100050, Peoples R China; [Hou, Qi] Chinese Acad Med Sci, Beijing 100050, Peoples R China; [Obeid, Lina M.] Ralph H Johnson Vet Affairs Med Ctr, Charleston, SC 29401 USA	Medical University of South Carolina; Medical University of South Carolina; Medical University of South Carolina; Chinese Academy of Medical Sciences - Peking Union Medical College; Institute of Materia Medica - CAMS; Peking Union Medical College; Chinese Academy of Medical Sciences - Peking Union Medical College; US Department of Veterans Affairs; Veterans Health Administration (VHA); Ralph H Johnson VA Medical Center	Hsu, YT (corresponding author), Med Univ S Carolina, Dept Biochem & Mol Biol, Div Hematol Oncol, 173 Ashley Ave,POB 250509, Charleston, SC 29425 USA.	hsuy@musc.edu	Zeidan, Youssef H./H-7578-2019	Zeidan, Youssef H./0000-0002-1951-8585; Jin, Junfei/0000-0002-9237-9024; obeid, lina/0000-0002-0734-0847	National Institutes of Health [NS40932, CA97132]; NATIONAL CANCER INSTITUTE [P01CA097132, K01CA100767] Funding Source: NIH RePORTER; NATIONAL CENTER FOR RESEARCH RESOURCES [P20RR017677] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS040932] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	This work was supported, in whole or in part, by National Institutes of Health Grants NS40932 (to Y.-T. H.) and CA97132 ( to Y. A. H.). The costs of publication of this article were defrayed in part by the payment of page charges. This article must therefore be hereby marked "advertisement" in accordance with 18 U. S. C. Section 1734 solely to indicate this fact.	Antonsson B, 2001, J BIOL CHEM, V276, P11615, DOI 10.1074/jbc.M010810200; Bidere N, 2003, J BIOL CHEM, V278, P31401, DOI 10.1074/jbc.M301911200; Bielawski J, 2006, METHODS, V39, P82, DOI 10.1016/j.ymeth.2006.05.004; Birbes H, 2005, BIOCHEM J, V386, P445, DOI 10.1042/BJ20041627; BOSE R, 1995, CELL, V82, P405, DOI 10.1016/0092-8674(95)90429-8; Cheng W, 1996, EXP CELL RES, V226, P316, DOI 10.1006/excr.1996.0232; Daum G, 1997, PROG LIPID RES, V36, P103, DOI 10.1016/S0163-7827(97)00006-4; De Giorgi F, 2002, FASEB J, V16, P607, DOI 10.1096/fj.01-0269fje; Desagher S, 1999, J CELL BIOL, V144, P891, DOI 10.1083/jcb.144.5.891; DMELLO NP, 1994, J BIOL CHEM, V269, P15451; Eskes R, 1998, J CELL BIOL, V143, P217, DOI 10.1083/jcb.143.1.217; Eskes R, 2000, MOL CELL BIOL, V20, P929, DOI 10.1128/MCB.20.3.929-935.2000; Garzotto M, 1998, CANCER RES, V58, P2260; Ginis I, 1999, AM J PHYSIOL-CELL PH, V276, pC1171, DOI 10.1152/ajpcell.1999.276.5.C1171; Goni FM, 2002, FEBS LETT, V531, P38, DOI 10.1016/S0014-5793(02)03482-8; Gross A, 1998, EMBO J, V17, P3878, DOI 10.1093/emboj/17.14.3878; Gulbins Erich, 2002, Subcell Biochem, V36, P229; Hannun YA, 2002, J BIOL CHEM, V277, P25847, DOI 10.1074/jbc.R200008200; Heinrich M, 1999, EMBO J, V18, P5252, DOI 10.1093/emboj/18.19.5252; Hou Q, 2005, AM J PHYSIOL-HEART C, V289, pH477, DOI 10.1152/ajpheart.00879.2004; Hsu YT, 1997, P NATL ACAD SCI USA, V94, P3668, DOI 10.1073/pnas.94.8.3668; Hsu YT, 1997, J BIOL CHEM, V272, P13829, DOI 10.1074/jbc.272.21.13829; Hsu YT, 1998, J BIOL CHEM, V273, P10777, DOI 10.1074/jbc.273.17.10777; Kashkar H, 2005, J BIOL CHEM, V280, P20804, DOI 10.1074/jbc.M410869200; Kim HJ, 2001, FEBS LETT, V505, P264, DOI 10.1016/S0014-5793(01)02836-8; Kim WH, 2000, CANCER LETT, V151, P39; KNUDSON CM, 1995, SCIENCE, V270, P96, DOI 10.1126/science.270.5233.96; KRAJEWSKI S, 1995, J NEUROSCI, V15, P6364; Kubota M, 1996, NEUROL RES, V18, P337; Larsen EC, 2007, NEUROSCIENCE, V146, P946, DOI 10.1016/j.neuroscience.2007.02.022; Lee M, 2003, J BIOL CHEM, V278, P39653, DOI 10.1074/jbc.M306104200; Levade T, 1999, BBA-MOL CELL BIOL L, V1438, P1, DOI 10.1016/S1388-1981(99)00038-4; Li P, 1997, CELL, V91, P479, DOI 10.1016/S0092-8674(00)80434-1; Manon S, 1997, FEBS LETT, V415, P29, DOI 10.1016/S0014-5793(97)01087-9; Marchesini N, 2004, BIOCHEM CELL BIOL, V82, P27, DOI 10.1139/o03-091; Marchesini N, 2003, J BIOL CHEM, V278, P13775, DOI 10.1074/jbc.M212262200; MERRILL AH, 1990, BIOCHIM BIOPHYS ACTA, V1044, P1, DOI 10.1016/0005-2760(90)90211-F; Michel C, 1997, J BIOL CHEM, V272, P22432, DOI 10.1074/jbc.272.36.22432; Mikhailov V, 2001, J BIOL CHEM, V276, P18361, DOI 10.1074/jbc.M100655200; Misao J, 1996, CIRCULATION, V94, P1506, DOI 10.1161/01.CIR.94.7.1506; Mizutani Y, 2005, BIOCHEM J, V390, P263, DOI 10.1042/BJ20050291; Nakane M, 2000, NEUROSCI LETT, V296, P89, DOI 10.1016/S0304-3940(00)01655-4; Northington FJ, 2001, J NEUROSCI, V21, P1931, DOI 10.1523/JNEUROSCI.21-06-01931.2001; O'Brien NW, 2003, CIRC RES, V92, P589, DOI 10.1161/01.RES.0000066290.29715.67; Oh HL, 2006, NEUROTOXICOLOGY, V27, P31, DOI 10.1016/j.neuro.2005.05.008; OLTVAI ZN, 1993, CELL, V74, P609, DOI 10.1016/0092-8674(93)90509-O; Pastorino JG, 1999, J BIOL CHEM, V274, P31734, DOI 10.1074/jbc.274.44.31734; Perez D, 2000, MOL CELL, V6, P53, DOI 10.1016/S1097-2765(00)00007-1; Perry DK, 2002, BBA-MOL CELL BIOL L, V1585, P146, DOI 10.1016/S1388-1981(02)00335-9; PICKETT CB, 1980, EXP CELL RES, V128, P343, DOI 10.1016/0014-4827(80)90070-1; Print CG, 2000, BIOESSAYS, V22, P423, DOI 10.1002/(SICI)1521-1878(200005)22:5&lt;423::AID-BIES4&gt;3.0.CO;2-0; Putcha GV, 2002, J CELL BIOL, V157, P441, DOI 10.1083/jcb.200110108; Roth KA, 2001, MENT RETARD DEV D R, V7, P261, DOI 10.1002/mrdd.1036; Ruvolo PP, 2003, PHARMACOL RES, V47, P383, DOI 10.1016/S1043-6618(03)00050-1; Sawada N, 2000, CELL DEATH DIFFER, V7, P761, DOI 10.1038/sj.cdd.4400711; Schulz A, 2006, J BIOL CHEM, V281, P2784, DOI 10.1074/jbc.M509483200; Smaili SS, 2001, CELL DEATH DIFFER, V8, P909, DOI 10.1038/sj.cdd.4400889; Spassieva S, 2006, J BIOL CHEM, V281, P33931, DOI 10.1074/jbc.M608092200; Ternes P, 2002, J BIOL CHEM, V277, P25512, DOI 10.1074/jbc.M202947200; Voelker DR, 2005, TRENDS BIOCHEM SCI, V30, P396, DOI 10.1016/j.tibs.2005.05.008; von Haefen C, 2002, ONCOGENE, V21, P4009, DOI 10.1038/sj.onc.1205497; Wang E, 2000, METHOD ENZYMOL, V311, P15; WIEGMANN K, 1994, CELL, V78, P1005, DOI 10.1016/0092-8674(94)90275-5; Wolter KG, 1997, J CELL BIOL, V139, P1281, DOI 10.1083/jcb.139.5.1281; Yu J, 2007, J BIOL CHEM, V282, P25940, DOI 10.1074/jbc.M701812200; Yu ZF, 2000, J MOL NEUROSCI, V15, P85, DOI 10.1385/JMN:15:2:85; Zeidan YH, 2008, FASEB J, V22, P183, DOI 10.1096/fj.07-8967com; Zeidan YH, 2007, J BIOL CHEM, V282, P11549, DOI 10.1074/jbc.M609424200; Zeidan YH, 2006, J BIOL CHEM, V281, P24695, DOI 10.1074/jbc.M604713200; Zhou HL, 2000, J CELL BIOL, V151, P483, DOI 10.1083/jcb.151.3.483; Zhou HL, 1998, J BIOL CHEM, V273, P16568, DOI 10.1074/jbc.273.26.16568	71	60	60	0	9	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	SEP 26	2008	283	39					26509	26517		10.1074/jbc.M801597200	http://dx.doi.org/10.1074/jbc.M801597200			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	350GV	18676372	hybrid, Green Published			2022-12-27	WOS:000259341600027
J	Li, Y; Reddy, MA; Miao, F; Shanmugam, N; Yee, JK; Hawkins, D; Ren, B; Natarajan, R				Li, Yan; Reddy, Marpadga A.; Miao, Feng; Shanmugam, Narkunaraja; Yee, Jiing-Kuan; Hawkins, David; Ren, Bing; Natarajan, Rama			Role of the histone H3 lysine 4 methyltransferase, SET7/9, in the regulation of NF-kappa B-dependent inflammatory genes - Relevance to diabetes and inflammation	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							SMOOTH-MUSCLE-CELLS; RNA-POLYMERASE-II; GLYCATION END-PRODUCTS; CHROMATIN MODIFICATIONS; LINKS INFLAMMATION; INSULIN-RESISTANCE; STRUCTURAL BASIS; IKK-BETA; METHYLATION; TRANSCRIPTION	Nuclear factor kappa-B (NF-kappa B)-regulated inflammatory genes, such as TNF-alpha(tumor necrosis factor-alpha), play key roles in the pathogenesis of inflammatory diseases, including diabetes and the metabolic syndrome. However, the nuclear chromatin mechanisms are unclear. We report here that the chromatin histone H3-lysine 4 methyltransferase, SET7/9, is a novel coactivator of NF-kappa B. Gene silencing of SET7/9 with small interfering RNAs in monocytes significantly inhibited TNF-alpha-induced inflammatory genes and histone H3-lysine 4 methylation on these promoters, as well as monocyte adhesion to endothelial or smooth muscle cells. Chromatin immunoprecipitation revealed that SET7/9 small interfering RNA could reduce TNF-alpha-induced recruitment of NF-kappa B p65 to inflammatory gene promoters. Inflammatory gene induction by ligands of the receptor for advanced glycation end products was also attenuated in SET7/9 knockdown monocytes. In addition, we also observed increased inflammatory gene expression and SET7/9 recruitment in macrophages from diabetic mice. Microarray profiling revealed that, in TNF-alpha-stimulated monocytes, the induction of 25% NF-kappa B downstream genes, including the histone H3-lysine 27 demethylase JMJD3, was attenuated by SET7/9 depletion. These results demonstrate a novel role for SET7/9 in inflammation and diabetes.	[Li, Yan; Natarajan, Rama] Beckman Res Inst City Hope, Grad Sch Biol Sci, Duarte, CA 91010 USA; [Yee, Jiing-Kuan] Beckman Res Inst City Hope, Div Virol, Duarte, CA 91010 USA; [Hawkins, David; Ren, Bing] Univ Calif San Diego, Ludwig Inst Canc Res, La Jolla, CA 92037 USA; [Li, Yan; Reddy, Marpadga A.; Miao, Feng; Shanmugam, Narkunaraja; Natarajan, Rama] Beckman Res Inst City Hope, Dept Diabet, Gonda Diabet Ctr, Duarte, CA 91010 USA	City of Hope; Beckman Research Institute of City of Hope; City of Hope; Beckman Research Institute of City of Hope; Ludwig Institute for Cancer Research; University of California System; University of California San Diego; City of Hope; Beckman Research Institute of City of Hope	Natarajan, R (corresponding author), Beckman Res Inst City Hope, Dept Diabet, Gonda Diabet Ctr, 1500 E Duarte Rd, Duarte, CA 91010 USA.	RNatarajan@coh.org		Reddy, Marpadga A/0000-0001-9259-7243	National Institutes of Health [R01 DK065073, R01 HL87864]; Juvenile Diabetes Research Foundation; American Heart Association, Western States; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL087864] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK065073] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Juvenile Diabetes Research Foundation(Juvenile Diabetes Research Foundation); American Heart Association, Western States(American Heart Association); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	This work was supported, in whole or in part, by National Institutes of Health Grants R01 DK065073 and R01 HL87864. This work was also supported by the Juvenile Diabetes Research Foundation (to R. N.) and a Predoctoral fellowship from the American Heart Association, Western States Affiliate (to Y. L.). The costs of publication of this article were defrayed in part by the payment of page charges. This article must therefore be hereby marked "advertisement" in accordance with 18 U. S. C. Section 1734 solely to indicate this fact.	Arkan MC, 2005, NAT MED, V11, P191, DOI 10.1038/nm1185; Berger SL, 2007, NATURE, V447, P407, DOI 10.1038/nature05915; Cai DS, 2005, NAT MED, V11, P183, DOI 10.1038/nm1166; Cai QK, 2004, AM J PHYSIOL-CELL PH, V287, pC707, DOI 10.1152/ajpcell.00170.2004; Chuikov S, 2004, NATURE, V432, P353, DOI 10.1038/nature03117; Couture JF, 2006, NAT STRUCT MOL BIOL, V13, P140, DOI 10.1038/nsmb1045; Covic M, 2005, EMBO J, V24, P85, DOI 10.1038/sj.emboj.7600500; Dandona P, 2005, CIRCULATION, V111, P1448, DOI 10.1161/01.CIR.0000158483.13093.9D; De Santa F, 2007, CELL, V130, P1083, DOI 10.1016/j.cell.2007.08.019; de Winther MPJ, 2005, ARTERIOSCL THROM VAS, V25, P904, DOI 10.1161/01.ATV.0000160340.72641.87; Dillon SC, 2005, GENOME BIOL, V6, DOI 10.1186/gb-2005-6-8-227; Doran AC, 2008, ARTERIOSCL THROM VAS, V28, P812, DOI 10.1161/ATVBAHA.107.159327; Francis J, 2005, J BIOL CHEM, V280, P36244, DOI 10.1074/jbc.M505741200; Gerber M, 2003, J BIOL CHEM, V278, P26303, DOI 10.1074/jbc.R300014200; Ghosh S, 1998, ANNU REV IMMUNOL, V16, P225, DOI 10.1146/annurev.immunol.16.1.225; Hampsey M, 2003, CELL, V113, P429, DOI 10.1016/S0092-8674(03)00360-X; Hayden MS, 2008, CELL, V132, P344, DOI 10.1016/j.cell.2008.01.020; Heintzman ND, 2007, NAT GENET, V39, P311, DOI 10.1038/ng1966; Hofmann MA, 1999, CELL, V97, P889, DOI 10.1016/S0092-8674(00)80801-6; Hu P, 2006, J AM CHEM SOC, V128, P1272, DOI 10.1021/ja056153+; Jenuwein T, 2001, SCIENCE, V293, P1074, DOI 10.1126/science.1063127; Kouskouti A, 2004, MOL CELL, V14, P175, DOI 10.1016/S1097-2765(04)00182-0; Kouzarides T, 2007, CELL, V128, P693, DOI 10.1016/j.cell.2007.02.005; LENARDO MJ, 1989, CELL, V58, P227, DOI 10.1016/0092-8674(89)90833-7; Li SL, 2006, DIABETES, V55, P2611, DOI 10.2337/db06-0164; Lusis AJ, 2000, NATURE, V407, P233, DOI 10.1038/35025203; Martin C, 2005, NAT REV MOL CELL BIO, V6, P838, DOI 10.1038/nrm1761; Miao F, 2004, J BIOL CHEM, V279, P18091, DOI 10.1074/jbc.M311786200; Miao F, 2007, J BIOL CHEM, V282, P13854, DOI 10.1074/jbc.M609446200; Miao F, 2006, MOL ENDOCRINOL, V20, P1562, DOI 10.1210/me.2005-0365; Nishioka K, 2002, GENE DEV, V16, P479, DOI 10.1101/gad.967202; Raines EW, 2005, J LIPID RES, V46, P1081, DOI 10.1194/jlr.R500004-JLR200; Reddy MA, 2006, J BIOL CHEM, V281, P13685, DOI 10.1074/jbc.M511425200; Ross R, 1999, NEW ENGL J MED, V340, P115, DOI 10.1056/NEJM199901143400207; Ruthenburg AJ, 2007, NAT REV MOL CELL BIO, V8, P983, DOI 10.1038/nrm2298; Shanmugam N, 2003, J BIOL CHEM, V278, P34834, DOI 10.1074/jbc.M302828200; Tachibana M, 2005, GENE DEV, V19, P815, DOI 10.1101/gad.1284005; Wang HB, 2001, MOL CELL, V8, P1207, DOI 10.1016/S1097-2765(01)00405-1; Wilson JR, 2002, CELL, V111, P105, DOI 10.1016/S0092-8674(02)00964-9; Yam P, 2006, MOL THER, V14, P236, DOI 10.1016/j.ymthe.2006.02.017; Zhang X, 2003, MOL CELL, V12, P177, DOI 10.1016/S1097-2765(03)00224-7; Zhong HH, 1998, MOL CELL, V1, P661, DOI 10.1016/S1097-2765(00)80066-0	42	261	273	5	26	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	SEP 26	2008	283	39					26771	26781		10.1074/jbc.M802800200	http://dx.doi.org/10.1074/jbc.M802800200			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	350GV	18650421	hybrid, Green Published			2022-12-27	WOS:000259341600049
J	Wang, FS; Xia, P; Wu, F; Wang, DM; Wang, W; Ward, T; Liu, Y; Aikhionbare, F; Guo, Z; Powell, M; Liu, BY; Bi, F; Shaw, A; Zhu, ZG; Elmoselhi, A; Fan, DM; Cover, TL; Ding, X; Yao, XB				Wang, Fengsong; Xia, Peng; Wu, Fang; Wang, Dongmei; Wang, Wei; Ward, Tarsha; Liu, Ya; Aikhionbare, Felix; Guo, Zhen; Powell, Michael; Liu, Bingya; Bi, Feng; Shaw, Andrew; Zhu, Zhenggang; Elmoselhi, Adel; Fan, Daiming; Cover, Timothy L.; Ding, Xia; Yao, Xuebiao			Helicobacter pylori VacA disrupts apical membrane-cytoskeletal interactions in gastric parietal cells	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ACID-SECRETION; TOXIN VACA; EZRIN; INFECTION; PROTEIN; PHOSPHORYLATION; CYTOTOXIN; IDENTIFICATION; CANCER	Helicobacter pylori persistently colonize the human stomach and have been linked to atrophic gastritis and gastric carcinoma. Although it is well known that H. pylori infection can result in hypochlorhydria, the molecular mechanisms underlying this phenomenon remain poorly understood. Here we show that VacA permeabilizes the apical membrane of gastric parietal cells and induces hypochlorhydria. The functional consequences of VacA infection on parietal cell physiology were studied using freshly isolated rabbit gastric glands and cultured parietal cells. Secretory activity of parietal cells was judged by an aminopyrine uptake assay and confocal microscopic examination. VacA permeabilization induces an influx of extracellular calcium, followed by activation of calpain and subsequent proteolysis of ezrin at Met(469) -Thr(470), which results in the liberation of ezrin from the apical membrane of the parietal cells. VacA treatment inhibits acid secretion by preventing the recruitment of H, K-ATPase-containing tubulovesicles to the apical membrane of gastric parietal cells. Electron microscopic examination revealed that VacA treatment disrupts the radial arrangement of actin filaments in apical microvilli due to the loss of ezrin integrity in parietal cells. Significantly, expression of calpain-resistant ezrin restored the functional activity of parietal cells in the presence of VacA. Proteolysis of ezrin in VacA-infected parietal cells is a novel mechanism underlying H. pylori-induced inhibition of acid secretion. Our results indicate that VacA disrupts the apical membrane-cytoskeletal interactions in gastric parietal cells and thereby causes hypochlorhydria.	[Wang, Wei; Ding, Xia] Beijing Univ Chinese Med, Beijing 100029, Peoples R China; [Wang, Fengsong; Xia, Peng; Wu, Fang; Wang, Dongmei; Guo, Zhen; Yao, Xuebiao] Univ Sci & Technol China, Div Cellular Dynam, Hefei 230027, Peoples R China; [Wang, Fengsong; Xia, Peng; Wu, Fang; Wang, Dongmei; Guo, Zhen; Yao, Xuebiao] Hefei Natl Lab Phys Sci Nanoscale, Hefei 230027, Peoples R China; [Wang, Fengsong; Ward, Tarsha; Liu, Ya; Aikhionbare, Felix; Guo, Zhen; Powell, Michael; Shaw, Andrew; Elmoselhi, Adel] Morehouse Sch Med, Atlanta, GA 30310 USA; [Bi, Feng] Sichuan Univ, W China Hosp, Dept Abdominal Canc, Chengdu 610041, Peoples R China; [Fan, Daiming] Fourth Mil Med Univ, Key Lab Canc Biol, Xian 710032, Shanxi, Peoples R China; [Cover, Timothy L.] Vanderbilt Univ, Sch Med, Dept Med, Nashville, TN 37232 USA; [Cover, Timothy L.] Vanderbilt Univ, Sch Med, Dept Microbiol & Immunol, Nashville, TN 37232 USA; [Cover, Timothy L.] Vet Affairs Tennessee Valley Healthcare Syst, Nashville, TN 37232 USA; [Liu, Bingya; Zhu, Zhenggang] Shanghai Jiao Tong Univ, Inst Digest Surg, Shanghai 210026, Peoples R China	Beijing University of Chinese Medicine; Chinese Academy of Sciences; University of Science & Technology of China, CAS; Morehouse School of Medicine; Sichuan University; Air Force Military Medical University; Vanderbilt University; Vanderbilt University; US Department of Veterans Affairs; Veterans Health Administration (VHA); VA Tennessee Valley Healthcare System; Shanghai Jiao Tong University	Ding, X (corresponding author), Beijing Univ Chinese Med, Beijing 100029, Peoples R China.	xding@bucm.edu.cn; yaoxb@ustc.edu.cn	Cover, Timothy/I-3814-2015; Yao, Xuebiao/P-5771-2014; Elmoselhi, Adel B/AAI-3478-2020; Liu, Bingya/GMW-5655-2022	Cover, Timothy/0000-0001-8503-002X; Elmoselhi, Adel B/0000-0003-2152-6629; Xia, Peng/0000-0002-5419-7756	National Institutes of Health [DK56292, CA89019, CA132389, AI39657, DK53623, G-12RR03034]; Chinese Academy of Science [KSCX1-YW-R65, KSCX2-YW-H-10]; Chinese 973 [2002CB713700, 2007CB914503, 2006CB943603]; Chinese Natural Science Foundation [30270654, 39925018, 30500183, 30570926]; Chinese 863 Project [2001AA215331, 2006AA02A247]; Chinese Minister of Education [200203580851]; NATIONAL CANCER INSTITUTE [P20CA132389, P50CA089019] Funding Source: NIH RePORTER; NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES [UL1TR000454] Funding Source: NIH RePORTER; NATIONAL CENTER FOR RESEARCH RESOURCES [G12RR003034] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI039657] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK056292, R01DK053623] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Chinese Academy of Science(Chinese Academy of Sciences); Chinese 973(National Basic Research Program of China); Chinese Natural Science Foundation(National Natural Science Foundation of China (NSFC)); Chinese 863 Project(National High Technology Research and Development Program of China); Chinese Minister of Education; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Advancing Translational Sciences (NCATS)); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	This work was supported, in whole or in part, by National Institutes of Health Grants DK56292, CA89019, CA132389, AI39657, DK53623, and G-12RR03034. This work was also supported by Chinese Academy of Science Grants KSCX1-YW-R65 and KSCX2-YW-H-10; Chinese 973 project Grants 2002CB713700, 2007CB914503, and 2006CB943603; Chinese Natural Science Foundation Grants 30270654, 39925018, 30500183, and 30570926; Chinese 863 Project Grants 2001AA215331 and 2006AA02A247; Chinese Minister of Education Grant 200203580851 (to X. Y.); 111 Project 07007 (to X. D.); and the Department of Veterans Affairs. The costs of publication of this article were defrayed in part by the payment of page charges. This article must therefore be hereby marked " advertisement" in accordance with 18 U. S. C. Section 1734 solely to indicate this fact.	Adrian M, 2002, J MOL BIOL, V318, P121, DOI 10.1016/S0022-2836(02)00047-5; Agnew BJ, 1999, J CELL SCI, V112, P2639; Ammar DA, 2002, AM J PHYSIOL-GASTR L, V282, pG23, DOI 10.1152/ajpgi.00277.2002; BLACK JA, 1981, GASTROENTEROLOGY, V81, P509; Bretscher A, 2002, NAT REV MOL CELL BIO, V3, P586, DOI 10.1038/nrm882; CORREA P, 1992, CANCER RES, V52, P6735; Cover TL, 2005, NAT REV MICROBIOL, V3, P320, DOI 10.1038/nrmicro1095; Cover TL, 1997, J CELL BIOL, V138, P759, DOI 10.1083/jcb.138.4.759; COVER TL, 2001, PRINCIPLES BACTERIAL, P510; de Bernard M, 2004, INT J MED MICROBIOL, V293, P589, DOI 10.1078/1438-4221-00299; deBernard M, 1997, MOL MICROBIOL, V26, P665, DOI 10.1046/j.1365-2958.1997.5881952.x; El-Omar EM, 2000, NATURE, V404, P398, DOI 10.1038/35006081; ElOmar EM, 1997, GASTROENTEROLOGY, V113, P15, DOI 10.1016/S0016-5085(97)70075-1; ELOMAR EM, 1995, GASTROENTEROLOGY, V109, P681, DOI 10.1016/0016-5085(95)90374-7; Fang ZY, 2006, MOL CELL PROTEOMICS, V5, P1437, DOI 10.1074/mcp.M600050-MCP200; Forte JG, 1996, TRENDS CELL BIOL, V6, P45, DOI 10.1016/0962-8924(96)81009-9; Furuta T, 2002, GASTROENTEROLOGY, V123, P92, DOI 10.1053/gast.2002.34156; Furuta T, 1998, SCAND J GASTROENTERO, V33, P357, DOI 10.1080/00365529850170973; Gauthier NC, 2005, MOL BIOL CELL, V16, P4852, DOI 10.1091/mbc.E05-05-0398; HANZEL DK, 1989, AM J PHYSIOL, V256, pG1082, DOI 10.1152/ajpgi.1989.256.6.G1082; Hasson LE, 1996, NEW ENGL J MED, V335, P242; Jin CJ, 2006, BIOCHEM BIOPH RES CO, V341, P784, DOI 10.1016/j.bbrc.2006.01.023; Marlink KL, 2003, AM J PHYSIOL-GASTR L, V285, pG163, DOI 10.1152/ajpgi.00257.2002; MORRIS A, 1987, AM J GASTROENTEROL, V82, P192; Necchi V, 2007, GASTROENTEROLOGY, V132, P1009, DOI 10.1053/j.gastro.2007.01.049; Peek RM, 2002, NAT REV CANCER, V2, P28, DOI 10.1038/nrc703; Schraw W, 2002, J BIOL CHEM, V277, P34642, DOI 10.1074/jbc.M203466200; Szabo I, 1999, EMBO J, V18, P5517, DOI 10.1093/emboj/18.20.5517; Takahashi A, 1999, PHYSIOL REV, V79, P1089, DOI 10.1152/physrev.1999.79.4.1089; Tamura A, 2005, J CELL BIOL, V169, P21, DOI 10.1083/jcb.200410083; Uemura N, 2001, NEW ENGL J MED, V345, P784, DOI 10.1056/NEJMoa001999; URUSHIDANI T, 1999, AM J PHYSIOL, V256, pG1070; WANG KKW, 1999, CALPAIN PHARM TOXICO, P77; YAO X, 1994, MOL CELLULAR MECH H; Yao XB, 1997, J CELL BIOL, V139, P435, DOI 10.1083/jcb.139.2.435; Yao XB, 2003, ANNU REV PHYSIOL, V65, P103, DOI 10.1146/annurev.physiol.65.072302.114200; YAO XB, 1993, AM J PHYSIOL, V265, pC36, DOI 10.1152/ajpcell.1993.265.1.C36; Yao XB, 1996, J BIOL CHEM, V271, P7224, DOI 10.1074/jbc.271.12.7224; YAO XB, 1995, MOL BIOL CELL, V6, P541, DOI 10.1091/mbc.6.5.541; Ye D, 1999, J BIOL CHEM, V274, P9277, DOI 10.1074/jbc.274.14.9277; Zhou RH, 2005, J CELL SCI, V118, P4381, DOI 10.1242/jcs.02559; Zhou RH, 2003, J BIOL CHEM, V278, P35651, DOI 10.1074/jbc.M303416200; Zhou RH, 2003, MOL BIOL CELL, V14, P1097, DOI 10.1091/mbc.E02-07-0425	43	50	53	1	19	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	SEP 26	2008	283	39					26714	26725		10.1074/jbc.M800527200	http://dx.doi.org/10.1074/jbc.M800527200			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	350GV	18625712	hybrid, Green Published			2022-12-27	WOS:000259341600045
J	Lapointe, J; Hekimi, S				Lapointe, Jerome; Hekimi, Siegfried			Early mitochondrial dysfunction in long-lived Mclk1(+/-) mice	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ALPHA-KETOGLUTARATE DEHYDROGENASE; CYTOCHROME-C-REDUCTASE; CAENORHABDITIS-ELEGANS; OXIDATIVE STRESS; LIFE-SPAN; HYDROGEN-PEROXIDE; CALORIC RESTRICTION; HEART-MITOCHONDRIA; RADICAL GENERATION; ELECTRON-TRANSPORT	Reduced activity of CLK-1/MCLK1 (also known as COQ7), a mitochondrial enzyme that is necessary for ubiquinone biosynthesis, prolongs the lifespan of nematodes and mice by a mechanism that is distinct from that of the insulin signaling pathway. Here we show that 2-fold reduction of MCLK1 expression in mice reveals an additional function for the protein, as this level of reduction does not affect ubiquinone levels yet affects mitochondrial function substantially. Indeed, we observe that the phenotype of young Mclk1(+/-) mutants includes a severe reduction of mitochondrial electron transport, ATP synthesis, and total nicotinamide adenine dinucleotide (NAD(tot)) pool size as well as an alteration in the activity of key enzymes of the tricarboxylic acid cycle. Surprisingly, we also find that Mclk1 heterozygosity leads to a dramatic increase in mitochondrial oxidative stress by a variety of measures. Furthermore, we find that the mitochondrial dysfunction is accompanied by a decrease in oxidative damage to cytosolic proteins as well as by a decrease in plasma isoprostanes, a systemic biomarker of oxidative stress and aging. We propose a mechanism for the conjunction of low ATP levels, high mitochondrial oxidative stress, and low non-mitochondrial oxidative damage in a long-lived mutant. Our model helps to clarify the relationship between energy metabolism and the aging process and suggests the need for a reformulation of the mitochondrial oxidative stress theory of aging.	[Lapointe, Jerome; Hekimi, Siegfried] McGill Univ, Dept Biol, Montreal, PQ H3A 1B1, Canada	McGill University	Hekimi, S (corresponding author), McGill Univ, Dept Biol, 1205 Doctor Penfield Ave, Montreal, PQ H3A 1B1, Canada.	Siegfried.Hekimi@McGill.ca			National Science and Engineering Research Council of Canada	National Science and Engineering Research Council of Canada(Natural Sciences and Engineering Research Council of Canada (NSERC))	This study was funded in part by a grant from the National Science and Engineering Research Council of Canada. The costs of publication of this article were defrayed in part by the payment of page charges. This article must therefore be hereby marked "advertisement" in accordance with 18 U.S.C. Section 1734 solely to indicate this fact.	Aguilaniu H, 2005, GENE DEV, V19, P2399, DOI 10.1101/gad.1366505; Andziak B, 2006, AGING CELL, V5, P463, DOI 10.1111/j.1474-9726.2006.00237.x; [Anonymous], 1922, BIOL DEATH; AUSTIN J, 1984, J BIOL CHEM, V259, P154; Ballard JWO, 2007, ANN NY ACAD SCI, V1114, P93, DOI 10.1196/annals.1396.011; Bedard K, 2007, PHYSIOL REV, V87, P245, DOI 10.1152/physrev.00044.2005; Berger F, 2004, TRENDS BIOCHEM SCI, V29, P111, DOI 10.1016/j.tibs.2004.01.007; Branicky R, 2006, MOL CELL BIOL, V26, P3976, DOI 10.1128/MCB.26.10.3976-3985.2006; Brys K, 2007, EXP GERONTOL, V42, P845, DOI 10.1016/j.exger.2007.02.004; Cadenas E, 2000, FREE RADICAL BIO MED, V29, P222, DOI 10.1016/S0891-5849(00)00317-8; CADENAS E, 1977, ARCH BIOCHEM BIOPHYS, V180, P248, DOI 10.1016/0003-9861(77)90035-2; Chiou CC, 2003, CLIN CHIM ACTA, V334, P87, DOI 10.1016/S0009-8981(03)00191-8; CRINSON M, 1992, BIOCHEM CELL BIOL, V70, P301, DOI 10.1139/o92-047; Dillin A, 2002, SCIENCE, V298, P2398, DOI 10.1126/science.1077780; Drew B, 2003, AM J PHYSIOL-REG I, V285, pR1259, DOI 10.1152/ajpregu.00264.2003; Ellard JP, 2007, MOL CELL ENDOCRINOL, V264, P90, DOI 10.1016/j.mce.2006.10.008; Feng JL, 2001, DEV CELL, V1, P633, DOI 10.1016/S1534-5807(01)00071-5; Finkel T, 2000, NATURE, V408, P239, DOI 10.1038/35041687; FLOHE L, 1984, METHOD ENZYMOL, V105, P114; Franco AA, 1999, FREE RADICAL BIO MED, V27, P1122, DOI 10.1016/S0891-5849(99)00166-5; GARDNER PR, 1995, J BIOL CHEM, V270, P13399, DOI 10.1074/jbc.270.22.13399; HARMAN D, 1972, J AM GERIATR SOC, V20, P145, DOI 10.1111/j.1532-5415.1972.tb00787.x; Hekimi S, 2003, SCIENCE, V299, P1351, DOI 10.1126/science.1082358; Hekimi S, 2006, NAT GENET, V38, P985, DOI 10.1038/ng1881; Hihi AK, 2003, J BIOL CHEM, V278, P41013, DOI 10.1074/jbc.M305034200; Jo SH, 2001, J BIOL CHEM, V276, P16168, DOI 10.1074/jbc.M010120200; Jonassen T, 2001, P NATL ACAD SCI USA, V98, P421, DOI 10.1073/pnas.021337498; Kayser EB, 2004, J BIOL CHEM, V279, P54479, DOI 10.1074/jbc.M403066200; Kenyon C, 2005, CELL, V120, P449, DOI 10.1016/j.cell.2005.02.002; Kevork HA, 2004, EXP GERONTOL, V39, P1145, DOI 10.1016/j.exger.2004.04.009; Kowaltowski AJ, 1999, FREE RADICAL BIO MED, V26, P463, DOI 10.1016/S0891-5849(98)00216-0; Kwong LK, 2000, ARCH BIOCHEM BIOPHYS, V373, P16, DOI 10.1006/abbi.1999.1495; Kwong LK, 1998, ARCH BIOCHEM BIOPHYS, V350, P118, DOI 10.1006/abbi.1997.0489; Lakowski B, 1998, P NATL ACAD SCI USA, V95, P13091, DOI 10.1073/pnas.95.22.13091; Lakowski B, 1996, SCIENCE, V272, P1010, DOI 10.1126/science.272.5264.1010; Lee SS, 2003, NAT GENET, V33, P40, DOI 10.1038/ng1056; Lerner F, 2001, BIOCHEM BIOPH RES CO, V288, P69, DOI 10.1006/bbrc.2001.5735; Levavasseur F, 2001, J BIOL CHEM, V276, P46160, DOI 10.1074/jbc.M108980200; Liu XX, 2005, GENE DEV, V19, P2424, DOI 10.1101/gad.1352905; Lopez-Torres M, 2002, FREE RADICAL BIO MED, V32, P882, DOI 10.1016/S0891-5849(02)00773-6; Magni G, 1999, ADV ENZYMOL RAMB, V73, P135, DOI 10.1002/9780470123195.ch5; Maia L, 2005, FREE RADICAL RES, V39, P979, DOI 10.1080/10715760500210962; MCCARTER RJ, 1989, AM J PHYSIOL, V257, pE175, DOI 10.1152/ajpendo.1989.257.2.E175; Morrow JD, 2000, DRUG METAB REV, V32, P377, DOI 10.1081/DMR-100102340; Muller FL, 2004, J BIOL CHEM, V279, P49064, DOI 10.1074/jbc.M407715200; Nakai D, 2001, BIOCHEM BIOPH RES CO, V289, P463, DOI 10.1006/bbrc.2001.5977; Nulton-Persson AC, 2001, J BIOL CHEM, V276, P23357, DOI 10.1074/jbc.M100320200; Ran Q, 2007, J GERONTOL A-BIOL, V62, P932, DOI 10.1093/gerona/62.9.932; Schuh RA, 2005, TOXICOL SCI, V88, P495, DOI 10.1093/toxsci/kfi334; Schulz TJ, 2007, CELL METAB, V6, P280, DOI 10.1016/j.cmet.2007.08.011; SHIGENAGA MK, 1994, P NATL ACAD SCI USA, V91, P10771, DOI 10.1073/pnas.91.23.10771; SOHAL RS, 1994, MECH AGEING DEV, V74, P121, DOI 10.1016/0047-6374(94)90104-X; Sohal RS, 2002, FREE RADICAL BIO MED, V33, P573, DOI 10.1016/S0891-5849(02)00885-7; Sone H, 2004, BIOCHEM BIOPH RES CO, V314, P824, DOI 10.1016/j.bbrc.2003.12.164; Speakman JR, 2005, J EXP BIOL, V208, P1717, DOI 10.1242/jeb.01556; Sreekumar R, 2002, AM J PHYSIOL-ENDOC M, V283, pE38, DOI 10.1152/ajpendo.00387.2001; Starkov AA, 2004, J NEUROSCI, V24, P7779, DOI 10.1523/JNEUROSCI.1899-04.2004; Taguchi A, 2007, SCIENCE, V317, P369, DOI 10.1126/science.1142179; Takahashi M, 2008, MECH AGEING DEV, V129, P291, DOI 10.1016/j.mad.2008.01.008; Temple MD, 2005, TRENDS CELL BIOL, V15, P319, DOI 10.1016/j.tcb.2005.04.003; Tretter L, 2005, PHILOS T R SOC B, V360, P2335, DOI 10.1098/rstb.2005.1764; TURRENS JF, 1980, BIOCHEM J, V191, P421, DOI 10.1042/bj1910421; TURRENS JF, 1985, ARCH BIOCHEM BIOPHYS, V237, P408, DOI 10.1016/0003-9861(85)90293-0; Williams MD, 1998, J BIOL CHEM, V273, P28510, DOI 10.1074/jbc.273.43.28510; WONG A, 1995, GENETICS, V139, P1247; Yang W, 2007, GENETICS, V177, P2063, DOI 10.1534/genetics.107.080788; Ying WH, 2008, ANTIOXID REDOX SIGN, V10, P179, DOI 10.1089/ars.2007.1672; YU L, 1982, J BIOL CHEM, V257, P2016; Zini R, 2007, FREE RADICAL RES, V41, P1159, DOI 10.1080/10715760701635074	69	158	160	0	6	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	SEP 19	2008	283	38					26217	26227		10.1074/jbc.M803287200	http://dx.doi.org/10.1074/jbc.M803287200			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	348GX	18635541	Green Published, hybrid			2022-12-27	WOS:000259200100050
J	Lauer, ME; Erzurum, SC; Mukhopadhyay, D; Vasanji, A; Drazba, J; Wang, AM; Fulop, C; Hascall, VC				Lauer, Mark E.; Erzurum, Serpil C.; Mukhopadhyay, Durba; Vasanji, Amit; Drazba, Judith; Wang, Aimin; Fulop, Csaba; Hascall, Vincent C.			Differentiated murine airway epithelial cells synthesize a leukocyte-adhesive hyaluronan matrix in response to endoplasmic reticulum stress	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							FACTOR RECEPTOR ACTIVATION; BRONCHOALVEOLAR LAVAGE; EXPRESSION; ASTHMA; GROWTH; CD44; LUNG; ER; SECRETIONS; ACID	In this report, we describe a novel method for culturing murine trachea epithelial cells on a native basement membrane at an air-liquid interface to produce a pseudostratified, differentiated airway epithelium composed of ciliated and nonciliated cells. This model was used to examine hyaluronan synthesis by the airway epithelial cells (AECs) in response to poly(I, C) and tunicamycin. The former induces a response similar to viral infection, and the latter is a bacterial toxin known to induce endoplasmic reticulum (ER) stress. We found significant accumulation of hyaluronan on the apical surface of the AECs in response to ER stress, but, unlike previously reported results with smooth muscle cells, no increase in hyaluronan was observed in response to poly(I, C). Monocytic U937 cells adhered at 4 degrees C to the apical surface of the AECs subjected to ER stress by a mechanism almost entirely mediated by hyaluronan. The U937 cells spontaneously released themselves from the abnormal hyaluronan matrix when their metabolism was restored by shifting the temperature from 4 to 37 degrees C in a custom-made flow chamber. Time lapse confocal microscopy permitted live imaging of this interaction between the U937 cells and the hyaluronan matrix and their subsequent response at 37 degrees C. Within 45 min, we observed dynamic protrusions of the U937 cell plasma membrane into nearby hyaluronan matrix, resulting in the degradation of this matrix. Simultaneously, we observed some reorganization of the hyaluronan matrix, from a generalized, apical distribution to localized regions around the AEC tight junctions. We discuss the implications these results might have for the airway epithelium and its relation to airway inflammation and hyperresponsiveness associated with asthma and other airway diseases.	[Lauer, Mark E.; Mukhopadhyay, Durba; Vasanji, Amit; Wang, Aimin; Fulop, Csaba; Hascall, Vincent C.] Cleveland Clin, Dept Biomed Engn, Lerner Res Inst, Cleveland, OH 44195 USA; [Erzurum, Serpil C.] Cleveland Clin, Dept Pathobiol, Lerner Res Inst, Cleveland, OH 44195 USA; [Drazba, Judith] Cleveland Clin, Dept Imaging Core, Lerner Res Inst, Cleveland, OH 44195 USA	Cleveland Clinic Foundation; Cleveland Clinic Foundation; Cleveland Clinic Foundation	Hascall, VC (corresponding author), Cleveland Clin, Dept Biomed Engn ND20, Cleveland, OH 44195 USA.	hascalv@ccf.org			National Institutes of Health [PO1 HL081064]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [P01HL081064] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	This work was supported, in whole or in part, by National Institutes of Health Grant PO1 HL081064 Pathology of Asthma. The costs of publication of this article were defrayed in part by the payment of page charges. This article must therefore be hereby marked "advertisement" in accordance with 18 U. S. C. Section 1734 solely to indicate this fact.	Bals Robert, 2004, J Cyst Fibros, V3 Suppl 2, P49, DOI 10.1016/j.jcf.2004.05.010; Boodoo S, 2006, AM J PHYSIOL-LUNG C, V291, pL479, DOI 10.1152/ajplung.00518.2005; Casalino-Matsuda SM, 2006, AM J RESP CELL MOL, V34, P581, DOI 10.1165/rcmb.2005-0386OC; Casalino-Matsuda SM, 2004, J BIOL CHEM, V279, P21606, DOI 10.1074/jbc.M309950200; de la Motte CA, 1999, J BIOL CHEM, V274, P30747, DOI 10.1074/jbc.274.43.30747; Dimcheff DE, 2004, J BIOL CHEM, V279, P33782, DOI 10.1074/jbc.M403304200; Forteza R, 2001, FASEB J, V15, P2179, DOI 10.1096/fj.01-0036com; HAINES DS, 1991, J CELL BIOCHEM, V46, P9, DOI 10.1002/jcb.240460104; HALLGREN R, 1989, AM REV RESPIR DIS, V139, P682; Jiang D, 2007, ANNU REV CELL DEV BI, V23, P435, DOI 10.1146/annurev.cellbio.23.090506.123337; Jorgensen MM, 2003, APMIS, V111, P86; Kincaid MM, 2007, ANTIOXID REDOX SIGN, V9, P2373, DOI 10.1089/ars.2007.1817; Koff JL, 2008, AM J PHYSIOL-LUNG C, V294, pL1068, DOI 10.1152/ajplung.00025.2008; Lackie PM, 1997, AM J RESP CELL MOL, V16, P14, DOI 10.1165/ajrcmb.16.1.8998074; LAITINEN A, 1994, AM J RESP CRIT CARE, V150, pS14, DOI 10.1164/ajrccm/150.5_Pt_2.S14; Majors AK, 2003, J BIOL CHEM, V278, P47223, DOI 10.1074/jbc.M304871200; Manzanares D, 2007, AM J RESP CELL MOL, V37, P160, DOI 10.1165/rcmb.2006-0413OC; Matsukura S, 2007, INT ARCH ALLERGY IMM, V143, P80, DOI 10.1159/000101411; MCCARTHY KJ, 2008, J MICROSC RES TECH, V71, P335; Monzon ME, 2006, AM J RESP CELL MOL, V34, P135, DOI 10.1165/rcmb.2005-0256OC; MUNRO S, 1987, CELL, V48, P899, DOI 10.1016/0092-8674(87)90086-9; Pahl HL, 1999, PHYSIOL REV, V79, P683, DOI 10.1152/physrev.1999.79.3.683; Pirinen RT, 1998, INT J CANCER, V79, P251, DOI 10.1002/(SICI)1097-0215(19980619)79:3<251::AID-IJC7>3.0.CO;2-O; Proud D, 2006, AM J RESP CELL MOL, V35, P513, DOI 10.1165/rcmb.2006-0199TR; Reynolds HY, 2000, LUNG, V178, P271, DOI 10.1007/s004080000032; SAHU S, 1978, BIOCHEM J, V173, P565, DOI 10.1042/bj1730565; Sahu S, 1978, Inflammation, V3, P149, DOI 10.1007/BF00910736; Selbi W, 2004, J AM SOC NEPHROL, V15, P1199, DOI 10.1097/01.ASN.0000125619.27422.8E; Shi T, 2006, MOL PHARMACOL, V70, P129, DOI 10.1124/mol.105.020735; SMITH DL, 1993, AM REV RESPIR DIS, V148, P523, DOI 10.1164/ajrccm/148.2.523; Stern R, 2007, BIOTECHNOL ADV, V25, P537, DOI 10.1016/j.biotechadv.2007.07.001; Stern R, 2006, EUR J CELL BIOL, V85, P699, DOI 10.1016/j.ejcb.2006.05.009; SUNDSTROM C, 1976, INT J CANCER, V17, P565, DOI 10.1002/ijc.2910170504; Tammi R, 2001, J BIOL CHEM, V276, P35111, DOI 10.1074/jbc.M103481200; Tammi RH, 2000, HISTOCHEM CELL BIOL, V113, P265, DOI 10.1007/s004180000128; Teder P, 2002, SCIENCE, V296, P155, DOI 10.1126/science.1069659; Wang AM, 2004, J BIOL CHEM, V279, P10279, DOI 10.1074/jbc.M312045200; Weigel PH, 1997, J BIOL CHEM, V272, P13997, DOI 10.1074/jbc.272.22.13997; You YJ, 2002, AM J PHYSIOL-LUNG C, V283, pL1315, DOI 10.1152/ajplung.00169.2002	39	37	38	0	5	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	SEP 19	2008	283	38					26283	26296		10.1074/jbc.M803350200	http://dx.doi.org/10.1074/jbc.M803350200			14	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	348GX	18644783	Green Published, hybrid			2022-12-27	WOS:000259200100056
J	Pastorino, JG; Shulga, N				Pastorino, John G.; Shulga, Nataly			Tumor necrosis factor-alpha can provoke cleavage and activation of sterol regulatory element-binding protein in ethanol-exposed cells via a caspase-dependent pathway that is cholesterol insensitive	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ENDOPLASMIC-RETICULUM STRESS; ALCOHOLIC LIVER-DISEASE; MOLECULAR-MECHANISMS; HEPATIC STEATOSIS; EXPRESSION; SREBP; METABOLISM; APOPTOSIS; INVIVO; INJURY	Ethanol induces the development of hepatic steatosis, increasingly recognized as causing vulnerability to subsequent liver injury. Ethanol has been shown to activate SREBP-1 ( sterol regulatory element-binding protein) processing through the conventional cholesterol-sensitive pathway ( 1). The present study demonstrates that ethanol can also bring about SREBP-1 cleavage and activation through a novel pathway dependent on the endoplasmic reticulum-localized caspases-4 and -12. Evidence is presented that tumor necrosis factor can stimulate caspase-4 and -12 activation in ethanol-exposed cells, which cleaves SREBP-1 to a transcriptionally active form to induce the synthesis of lipogenic enzymes and triglycerides. Moreover, the caspase-4 and -12-dependent activation of SREBP-1 is insensitive to the normal negative feedback exerted by cholesterol and is mediated by the translocation of the scaffolding protein, TRAF-2, to the endoplasmic reticulum.	[Pastorino, John G.; Shulga, Nataly] Univ Med & Dent New Jersey, Sch Osteopath Med, Dept Mol Biol, Ctr Sci, Stratford, NJ 08084 USA	Rowan University; Rowan University School of Osteopathic Medicine; Rutgers State University New Brunswick; Rutgers State University Medical Center	Pastorino, JG (corresponding author), Univ Med & Dent New Jersey, Sch Osteopath Med, Dept Mol Biol, Ctr Sci, Rm 316,2 Med Ctr Dr, Stratford, NJ 08084 USA.	pastorjg@umdnj.edu			National Institutes of Health [R01CA118356, R01AA012897]; NATIONAL CANCER INSTITUTE [R01CA118356] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON ALCOHOL ABUSE AND ALCOHOLISM [R01AA012897] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE ON ALCOHOL ABUSE AND ALCOHOLISM(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Alcohol Abuse & Alcoholism (NIAAA))	This work was supported, in whole or in part, by National Institutes of Health Grants R01CA118356 and R01AA012897. The costs of publication of this article were defrayed in part by the payment of page charges. This article must therefore be hereby marked "advertisement" in accordance with 18 U. S. C. Section 1734 solely to indicate this fact.	Arch RH, 2000, BIOCHEM BIOPH RES CO, V272, P936, DOI 10.1006/bbrc.2000.2873; Bradley JR, 2001, ONCOGENE, V20, P6482, DOI 10.1038/sj.onc.1204788; Colgan SM, 2007, INT J BIOCHEM CELL B, V39, P1843, DOI 10.1016/j.biocel.2007.05.002; Crabb DW, 2006, J GASTROEN HEPATOL, V21, pS56, DOI 10.1111/j.1440-1746.2006.04582.x; Diehl AM, 1999, ALCOHOL CLIN EXP RES, V23, P1419, DOI 10.1097/00000374-199909000-00001; Donohue TM, 2007, WORLD J GASTROENTERO, V13, P4974; Endo M, 2007, EXP BIOL MED, V232, P614; Enomoto N, 1999, HEPATOLOGY, V29, P1680, DOI 10.1002/hep.510290633; Esfandiari F, 2005, AM J PHYSIOL-GASTR L, V289, pG54, DOI 10.1152/ajpgi.00542.2004; FEINGOLD KR, 1987, J CLIN INVEST, V80, P184, DOI 10.1172/JCI113046; GRUNFELD C, 1988, J LIPID RES, V29, P1327; Hetz C, 2006, SCIENCE, V312, P572, DOI 10.1126/science.1123480; Higgins ME, 2001, J LIPID RES, V42, P1939; Hoek JB, 2004, SEMIN LIVER DIS, V24, P257, DOI 10.1055/s-2004-832939; Horton JD, 2002, COLD SPRING HARB SYM, V67, P491, DOI 10.1101/sqb.2002.67.491; Hu P, 2006, MOL CELL BIOL, V26, P3071, DOI 10.1128/MCB.26.8.3071-3084.2006; Ji C, 2003, GASTROENTEROLOGY, V124, P1488, DOI 10.1016/S0016-5085(03)00276-2; Ji C, 2006, J HEPATOL, V45, P717, DOI 10.1016/j.jhep.2006.05.009; Ji C, 2004, WORLD J GASTROENTERO, V10, P1699; Kalai M, 2003, J CELL BIOL, V162, P457, DOI 10.1083/jcb.200303157; Kamada S, 1997, ONCOGENE, V15, P285, DOI 10.1038/sj.onc.1201192; Kaplowitz N, 2006, J GASTROEN HEPATOL, V21, pS7, DOI 10.1111/j.1440-1746.2006.04581.x; Lakshmanan U, 2007, J IMMUNOL, V179, P8480, DOI 10.4049/jimmunol.179.12.8480; Lawler JF, 1998, J BIOL CHEM, V273, P5053, DOI 10.1074/jbc.273.9.5053; Lieber CS, 1997, CLIN CHIM ACTA, V257, P59, DOI 10.1016/S0009-8981(96)06434-0; Nishitoh H, 1998, MOL CELL, V2, P389, DOI 10.1016/S1097-2765(00)80283-X; Pelletier N, 2006, J IMMUNOL, V176, P1340, DOI 10.4049/jimmunol.176.3.1340; Pennington HL, 1997, J GASTROEN HEPATOL, V12, P305, DOI 10.1111/j.1440-1746.1997.tb00426.x; Rawson RB, 2003, NAT REV MOL CELL BIO, V4, P631, DOI 10.1038/nrm1174; Schroder M, 2005, ANNU REV BIOCHEM, V74, P739, DOI 10.1146/annurev.biochem.73.011303.074134; Urano F, 2000, J CELL SCI, V113, P3697; Urano F, 2000, SCIENCE, V287, P664, DOI 10.1126/science.287.5453.664; Wang XD, 1996, EMBO J, V15, P1012, DOI 10.1002/j.1460-2075.1996.tb00438.x; WANG XD, 1995, J BIOL CHEM, V270, P18044, DOI 10.1074/jbc.270.30.18044; Yoneda T, 2001, J BIOL CHEM, V276, P13935, DOI 10.1074/jbc.M010677200; You M, 2004, ALCOHOL, V34, P39, DOI 10.1016/j.alcohol.2004.07.004; You M, 2002, J BIOL CHEM, V277, P29342, DOI 10.1074/jbc.M202411200	37	19	20	0	0	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	SEP 12	2008	283	37					25638	25649		10.1074/jbc.M800237200	http://dx.doi.org/10.1074/jbc.M800237200			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	345QZ	18635549	Green Published, hybrid			2022-12-27	WOS:000259012700059
J	You, ZY; Masai, H				You, Zhiying; Masai, Hisao			Cdt1 forms a complex with the minichromosome maintenance protein (MCM) and activates its helicase activity	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							EUKARYOTIC DNA-REPLICATION; ESCHERICHIA-COLI DNAB; MCM4/6/7 HELICASE; CHROMOSOMAL DNA; BUDDING YEAST; S-PHASE; INITIATION; GEMININ; BINDING; CHROMATIN	Mcm4/6/7 forms a complex possessing DNA helicase activity, suggesting that Mcm may be a central component for the replicative helicase. Although Cdt1 is known to be essential for loading of Mcm onto the chromatin, its precise role in pre-RC formation and replication initiation is unknown. Using purified proteins, we show that Cdt1 forms a complex with Mcm4/6/7, Mcm2/3/4/5/6/7, and Mcm2/4/6/7 in glycerol gradient fractionation through interaction with Mcm2 and Mcm4/6. In the glycerol gradient fractionation, Mcm4/6/7-Cdt1 forms a complex (speculated to be a (Mcm4/6/7)(2)-Cdt1(3) assembly) in the presence of ATP, which is significantly larger than the Mcm4/6/7-Cdt1 complex generated in its absence. Furthermore, DNA binding and helicase activities of Mcm4/6/7 are significantly stimulated by Cdt1 protein in vitro. We generated a Cdt1 mutant, which fails to stimulate DNA binding and helicase activities of Mcm4/6/7. This mutant Cdt1 showed reduced interaction with Mcm and is deficient in the formation of a high molecular weight complex with Mcm. Thus, a productive interaction between Cdt1 and MCM appears to be essential for efficient loading of MCM onto template DNA, as well as for the efficient unwinding reaction.	[You, Zhiying; Masai, Hisao] Tokyo Metropolitan Inst Med Sci, Genome Dynam Project, Bunkyo Ku, Tokyo 1138613, Japan	Tokyo Metropolitan Institute of Medical Science	Masai, H (corresponding author), Tokyo Metropolitan Inst Med Sci, Genome Dynam Project, Bunkyo Ku, 18-22 Honkomagome 3-Chome, Tokyo 1138613, Japan.	masai-hs@igakuken.or.jp						Ballabeni A, 2004, EMBO J, V23, P3122, DOI 10.1038/sj.emboj.7600314; Barcena M, 2001, EMBO J, V20, P1462, DOI 10.1093/emboj/20.6.1462; Bell SP, 2002, ANNU REV BIOCHEM, V71, P333, DOI 10.1146/annurev.biochem.71.110601.135425; BELL SP, 1995, CELL, V83, P563, DOI 10.1016/0092-8674(95)90096-9; Blow JJ, 2005, NAT REV MOL CELL BIO, V6, P476, DOI 10.1038/nrm1663; BRAMHILL D, 1988, CELL, V52, P743, DOI 10.1016/0092-8674(88)90412-6; Chen S, 2007, GENE DEV, V21, P2897, DOI 10.1101/gad.1596807; Cocker JH, 1996, NATURE, V379, P180, DOI 10.1038/379180a0; Cook JG, 2004, J BIOL CHEM, V279, P9625, DOI 10.1074/jbc.M311933200; Costa A, 2008, BIOCHEM SOC T, V36, P136, DOI 10.1042/BST0360136; Davey MJ, 2002, EMBO J, V21, P3148, DOI 10.1093/emboj/cdf308; Galletto R, 2003, J MOL BIOL, V329, P441, DOI 10.1016/S0022-2836(03)00435-2; Ishimi Y, 1997, J BIOL CHEM, V272, P24508, DOI 10.1074/jbc.272.39.24508; KOBORI JA, 1982, J BIOL CHEM, V257, P13770; KOONIN EV, 1993, NUCLEIC ACIDS RES, V21, P2541, DOI 10.1093/nar/21.11.2541; Labib K, 2000, SCIENCE, V288, P1643, DOI 10.1126/science.288.5471.1643; LANKA E, 1983, NUCLEIC ACIDS RES, V11, P987, DOI 10.1093/nar/11.4.987; Lee DG, 2000, CURR OPIN CELL BIOL, V12, P280, DOI 10.1016/S0955-0674(00)00089-2; Lee JK, 2001, P NATL ACAD SCI USA, V98, P54, DOI 10.1073/pnas.98.1.54; Li SS, 2005, HISTOPATHOLOGY, V46, P307, DOI 10.1111/j.1365-2559.2005.02069.x; Lutzmann M, 2006, EMBO J, V25, P5764, DOI 10.1038/sj.emboj.7601436; Machida YJ, 2005, CELL, V123, P13, DOI 10.1016/j.cell.2005.09.019; Maiorano D, 2000, J BIOL CHEM, V275, P8426, DOI 10.1074/jbc.275.12.8426; Mendez J, 2003, BIOESSAYS, V25, P1158, DOI 10.1002/bies.10370; Mihaylov IS, 2002, MOL CELL BIOL, V22, P1868, DOI 10.1128/MCB.22.6.1868-1880.2002; Nishitani H, 2000, NATURE, V404, P625, DOI 10.1038/35007110; Nishitani H, 2001, J BIOL CHEM, V276, P44905, DOI 10.1074/jbc.M105406200; SEUFERT W, 1987, CELL, V48, P73, DOI 10.1016/0092-8674(87)90357-6; Speck C, 2005, NAT STRUCT MOL BIOL, V12, P965, DOI 10.1038/nsmb1002; SPECK C, 2007, J BIOL CHEM; Tanaka S, 2002, NAT CELL BIOL, V4, P198, DOI 10.1038/ncb757; Tye BK, 1999, ANNU REV BIOCHEM, V68, P649, DOI 10.1146/annurev.biochem.68.1.649; Velten M, 2003, MOL CELL, V11, P1009, DOI 10.1016/S1097-2765(03)00130-8; WAHLE E, 1989, J BIOL CHEM, V264, P2469; WAHLE E, 1989, J BIOL CHEM, V264, P2463; Walter J, 1998, MOL CELL, V1, P519, DOI 10.1016/S1097-2765(00)80052-0; WICKNER S, 1975, P NATL ACAD SCI USA, V72, P921, DOI 10.1073/pnas.72.3.921; Wohlschlegel JA, 2000, SCIENCE, V290, P2309, DOI 10.1126/science.290.5500.2309; Wuarin J, 2002, CELL, V111, P419, DOI 10.1016/S0092-8674(02)01042-5; Xouri G, 2007, EMBO J, V26, P1303, DOI 10.1038/sj.emboj.7601597; Yanagi K, 2002, J BIOL CHEM, V277, P40871, DOI 10.1074/jbc.M206202200; You Z, 2005, NUCLEIC ACIDS RES, V33, P3033, DOI 10.1093/nar/gki607; You ZY, 2002, J BIOL CHEM, V277, P42471, DOI 10.1074/jbc.M205769200; You ZY, 2003, EMBO J, V22, P6148, DOI 10.1093/emboj/cdg576; You ZY, 1999, MOL CELL BIOL, V19, P8003	45	26	26	0	2	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	SEP 5	2008	283	36					24469	24477		10.1074/jbc.M803212200	http://dx.doi.org/10.1074/jbc.M803212200			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	342YR	18606811	Green Published, hybrid			2022-12-27	WOS:000258820000021
J	Choi, JY; Guengerich, FP				Choi, Jeong-Yun; Guengerich, F. Peter			Kinetic analysis of translesion synthesis opposite bulky N-2- and O-6-alkylguanine DNA adducts by human DNA polymerase REV1	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							HIV-1 REVERSE-TRANSCRIPTASE; STEADY-STATE KINETICS; YEAST REV1; ESCHERICHIA-COLI; PROTEIN-TEMPLATE; BIOCHEMICAL BASIS; KLENOW FRAGMENT; REPLICATION; FIDELITY; O-6-METHYLGUANINE	REV1, a Y family DNA polymerase ( pol), is involved in replicative bypass past DNA lesions, so- called translesion DNA synthesis. In addition to a structural role as a scaffold protein, REV1 has been proposed to play a catalytic role as a dCTP transferase in translesion DNA synthesis past abasic and guanine lesions in eukaryotes. To better understand the catalytic function of REV1 in guanine lesion bypass, purified recombinant human REV1 was studied with two series of guanine lesions, N2- alkylG adducts (in oligonucleotides) ranging in size from methyl ( Me) to CH2(6- benzo[ a] pyrenyl) (BP) and O-6- alkylG adducts ranging from Me to 4- oxo- 4-( 3- pyridyl) butyl ( Pob). REV1 readily produced 1- base incorporation oppositeGand allGadducts except for O6- PobG, which caused almost complete blockage. Steadystate kinetic parameters ( kcat/ Km) were similar for insertion of dCTP opposite G and N2- G adducts but were severely reduced opposite the O-6-G adducts. REV1 showed apparent pre- steadystate burst kinetics for dCTP incorporation only opposite N2- BPG and little, if any, opposite G, N2- benzyl (Bz) G, or O6- BzG. The maximal polymerization rate ( kpol 0.9 s-1) opposite N2-BPG was almost the same as opposite G, with only slightly decreased binding affinity to dCTP (2.5-fold). REV1 boundN2- BPG- adductedDNA3- fold more tightly than unmodified G- containing DNA. These results and the lack of an elemental effect ((Sp)- 2'- deoxycytidine 5'-O-( 1- thiotriphosphate)) suggest that the late steps after product formation ( possibly product release) become rate- limiting in catalysis opposite N2-BPG. Weconclude that human REV1, apparently the slowest Y family polymerase, is kinetically highly tolerant to N2- adduct at G but not to O-6-adducts.	[Choi, Jeong-Yun] Ewha Womans Univ, Sch Med, Dept Pharmacol, Seoul 158710, South Korea; [Guengerich, F. Peter] Vanderbilt Univ, Sch Med, Dept Biochem, Nashville, TN 37232 USA; [Guengerich, F. Peter] Vanderbilt Univ, Sch Med, Ctr Mol Toxicol, Nashville, TN 37232 USA	Ewha Womans University; Vanderbilt University; Vanderbilt University	Choi, JY (corresponding author), Ewha Womans Univ, Sch Med, Dept Pharmacol, 911-1 Mok 6 Dong, Seoul 158710, South Korea.	jychoi@ewha.ac.kr			NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES [P30ES000267, R01ES010375] Funding Source: NIH RePORTER; NIEHS NIH HHS [P30 ES 000267, R01 ES 010375] Funding Source: Medline	NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS)); NIEHS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS))		BORER PN, 1975, HDB BIOCH MOL BIOL, P589; Choi JY, 2006, J BIOL CHEM, V281, P38244, DOI 10.1074/jbc.M608369200; Choi JY, 2006, CHEM RES TOXICOL, V19, P879, DOI 10.1021/tx060051v; Choi JY, 2006, J BIOL CHEM, V281, P25297, DOI 10.1074/jbc.M605699200; Choi JY, 2006, J BIOL CHEM, V281, P21062, DOI 10.1074/jbc.M602246200; Choi JY, 2006, J BIOL CHEM, V281, P12315, DOI 10.1074/jbc.M600112200; Choi JY, 2005, J MOL BIOL, V352, P72, DOI 10.1016/j.jmb.2005.06.079; Choi JY, 2004, J BIOL CHEM, V279, P19217, DOI 10.1074/jbc.M313759200; CONNOLLY ML, 1993, J MOL GRAPH MODEL, V11, P139, DOI 10.1016/0263-7855(93)87010-3; Eoff RL, 2007, J BIOL CHEM, V282, P19831, DOI 10.1074/jbc.M702290200; Eoff RL, 2007, J BIOL CHEM, V282, P1456, DOI 10.1074/jbc.M609661200; Friedberg E. C., 2006, DNA REPAIR MUTAGENES; Furge LL, 1997, BIOCHEMISTRY-US, V36, P6475, DOI 10.1021/bi9627267; Furge LL, 1999, BIOCHEMISTRY-US, V38, P4818, DOI 10.1021/bi982163u; Goodman MF, 2002, ANNU REV BIOCHEM, V71, P17, DOI 10.1146/annurev.biochem.71.083101.124707; GOODMAN MF, 1993, CRIT REV BIOCHEM MOL, V28, P83, DOI 10.3109/10409239309086792; GOTH R, 1974, P NATL ACAD SCI USA, V71, P639, DOI 10.1073/pnas.71.3.639; Guengerich FP, 2006, CHEM REV, V106, P420, DOI 10.1021/cr0404693; Guo CX, 2006, MOL CELL BIOL, V26, P8892, DOI 10.1128/MCB.01118-06; Guo CX, 2006, MOL CELL, V23, P265, DOI 10.1016/j.molcel.2006.05.038; Guo CX, 2003, EMBO J, V22, P6621, DOI 10.1093/emboj/cdg626; Guo DY, 2004, NUCLEIC ACIDS RES, V32, P1122, DOI 10.1093/nar/gkh279; Haracska L, 2002, J BIOL CHEM, V277, P15546, DOI 10.1074/jbc.M112146200; Hellman LM, 2007, NAT PROTOC, V2, P1849, DOI 10.1038/nprot.2007.249; HERSCHLAG D, 1991, BIOCHEMISTRY-US, V30, P4844, DOI 10.1021/bi00234a003; Howell CA, 2007, BIOCHEMISTRY-US, V46, P13451, DOI 10.1021/bi701429v; JOHNSON KA, 1993, ANNU REV BIOCHEM, V62, P685, DOI 10.1146/annurev.bi.62.070193.003345; JOHNSON KA, 1995, METHOD ENZYMOL, V249, P38; Johnson RE, 2005, P NATL ACAD SCI USA, V102, P10466, DOI 10.1073/pnas.0503859102; Lin WS, 1999, NUCLEIC ACIDS RES, V27, P4468, DOI 10.1093/nar/27.22.4468; LOVELESS A, 1969, NATURE, V223, P206, DOI 10.1038/223206a0; MEEHAN T, 1979, NATURE, V277, P410, DOI 10.1038/277410a0; Moriya M, 1996, BIOCHEMISTRY-US, V35, P16646, DOI 10.1021/bi9608875; Nair DT, 2008, STRUCTURE, V16, P239, DOI 10.1016/j.str.2007.12.009; Nair DT, 2005, SCIENCE, V309, P2219, DOI 10.1126/science.1116336; Nelson JR, 1996, NATURE, V382, P729, DOI 10.1038/382729a0; Ohmori H, 2001, MOL CELL, V8, P7, DOI 10.1016/S1097-2765(01)00278-7; PACE CN, 1995, PROTEIN SCI, V4, P2411, DOI 10.1002/pro.5560041120; PATEL SS, 1991, BIOCHEMISTRY-US, V30, P511, DOI 10.1021/bi00216a029; Pauly GT, 2002, CHEM RES TOXICOL, V15, P165, DOI 10.1021/tx0101245; Prakash S, 2005, ANNU REV BIOCHEM, V74, P317, DOI 10.1146/annurev.biochem.74.082803.133250; Suo ZC, 1999, BIOCHEMISTRY-US, V38, P715, DOI 10.1021/bi981854n; Terashima I, 2001, BIOCHEMISTRY-US, V40, P4106, DOI 10.1021/bi002719p; TURESKY RJ, 1994, CHEM RES TOXICOL, V7, P752, DOI 10.1021/tx00042a007; Upton DC, 2006, CHEM RES TOXICOL, V19, P960, DOI 10.1021/tx060084a; Upton DC, 2006, MUTAT RES-FUND MOL M, V599, P1, DOI 10.1016/j.mrfmmm.2005.12.014; Vaisman A, 2005, EMBO J, V24, P2957, DOI 10.1038/sj.emboj.7600786; van Holde K. E., 1998, PRINCIPLES PHYS BIOC, P587; Wang LJ, 1997, CHEM RES TOXICOL, V10, P562, DOI 10.1021/tx9602067; Washington MT, 2004, MOL CELL BIOL, V24, P6900, DOI 10.1128/MCB.24.16.6900-6906.2004; Washington MT, 2003, MOL CELL BIOL, V23, P5107, DOI 10.1128/MCB.23.14.5107-5112.2003; Wolfle WT, 2005, MOL CELL BIOL, V25, P7137, DOI 10.1128/MCB.25.16.7137-7143.2005; Woodside AM, 2002, BIOCHEMISTRY-US, V41, P1027, DOI 10.1021/bi011495n; Woodside AM, 2002, BIOCHEMISTRY-US, V41, P1039, DOI 10.1021/bi011496f; Yasui M, 2001, NUCLEIC ACIDS RES, V29, P1994, DOI 10.1093/nar/29.9.1994; Zhang YB, 2002, NUCLEIC ACIDS RES, V30, P1630, DOI 10.1093/nar/30.7.1630	56	55	57	0	5	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	AUG 29	2008	283	35					23645	23655		10.1074/jbc.M801686200	http://dx.doi.org/10.1074/jbc.M801686200			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	340II	18591245	hybrid, Green Published			2022-12-27	WOS:000258638900017
J	Malanovic, N; Streith, I; Wolinski, H; Rechberger, G; Kohlwein, SD; Tehlivets, O				Malanovic, Nermina; Streith, Ingo; Wolinski, Heimo; Rechberger, Gerald; Kohlwein, Sepp D.; Tehlivets, Oksana			S-Adenosyl-L-homocysteine hydrolase, key enzyme of methylation metabolism, regulates phosphatidylcholine synthesis and triacylglycerol homeostasis in yeast - Implications for homocysteine as a risk factor of atherosclerosis	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							SACCHAROMYCES-CEREVISIAE; TRANSCRIPTIONAL REGULATION; PHOSPHOLIPID-METABOLISM; GENE-EXPRESSION; FUNCTIONAL-CHARACTERIZATION; SULFUR ASSIMILATION; ADENOSYLHOMOCYSTEINE; ADENOSYLMETHIONINE; DEFICIENCY; METHYLTRANSFERASE	In eukaryotes, S-adenosyl-L-homocysteine hydrolase (Sah1) offers a single way for degradation of S-adenosyl-L-homocysteine, a product and potent competitive inhibitor of S-adenosyl-L-methionine (AdoMet)-dependent methyltransferases. Denovophosphatidylcholine(PC)synthesisrequiresthreeAdoMet-dependent methylation steps. Here we show that down-regulation of SAH1 expression in yeast leads to accumulation of S-ad-enosyl-L-homocysteine and decreased de novo PC synthesis in vivo. This decrease is accompanied by an increase in triacylglycerol (TG) levels, demonstrating that Sah1-regulated methylation has a major impact on cellular lipid homeostasis. TG accumulation is also observed in cho2 and opi3 mutants defective in methylation of phosphatidylethanolamine to PC, confirming that PC de novo synthesis and TG synthesis are metabolically coupled through the efficiency of the phospholipid methylation reaction. Indeed, because both types of lipids share phosphatidic acid as a precursor, we find in cells with down-regulated Sah1 activity major alterations in the expression of the INO1 gene as well as in the localization of Opi1, a negative regulatory factor of phospholipid synthesis, which binds and is retained in the endoplasmic reticulum membrane by phosphatidic acid in conjunction with VAMP/synaptobrevin-associated protein, Scs2. The addition of homocysteine, by the reversal of the Sah1-catalyzed reaction, also leads to TG accumulation in yeast, providing an attractive model for the role of homocysteine as a risk factor of atherosclerosis in humans.	[Malanovic, Nermina; Streith, Ingo; Wolinski, Heimo; Rechberger, Gerald; Kohlwein, Sepp D.; Tehlivets, Oksana] Graz Univ, Inst Mol Biosci, A-8010 Graz, Austria	University of Graz	Tehlivets, O (corresponding author), Graz Univ, Inst Mol Biosci, Humboldtstr 50-2, A-8010 Graz, Austria.	oksana.tehlivets@uni-graz.at	; Malanovic, Nermina/ACF-9103-2022	Tehlivets, Oksana/0000-0003-1650-5014; Rechberger, Gerald N./0000-0002-0071-317X; Kohlwein, Sepp Dieter/0000-0002-1030-0598; Wolinski, Heimo/0000-0002-1583-6092; Malanovic, Nermina/0000-0002-2903-9369	Austrian Science Fund FWF [P18094-B14, F3005]; Austrian Science Fund (FWF) [F 3005] Funding Source: researchfish	Austrian Science Fund FWF(Austrian Science Fund (FWF)); Austrian Science Fund (FWF)(Austrian Science Fund (FWF))	This work was supported by the Austrian Science Fund FWF, Project P18094-B14 (to O.T.) and Project SFB Lipotox (F3005) ( to S. D. K.). The costs of publication of this article were defrayed in part by the payment of page charges. This article must therefore be hereby marked "advertisement" in accordance with 18 U.S.C. Section 1734 solely to indicate this fact.	BACHHAWAT N, 1995, J BIOL CHEM, V270, P25087, DOI 10.1074/jbc.270.42.25087; Baric I, 2005, J INHERIT METAB DIS, V28, P885, DOI 10.1007/s10545-005-0192-9; Baric I, 2004, P NATL ACAD SCI USA, V101, P4234, DOI 10.1073/pnas.0400658101; BRETON A, 1977, J BACTERIOL, V132, P224, DOI 10.1128/JB.132.1.224-232.1977; Buist NRM, 2006, J INHERIT METAB DIS, V29, P538, DOI 10.1007/s10545-006-0240-0; Carman GM, 2007, J BIOL CHEM, V282, P37293, DOI 10.1074/jbc.R700038200; Castro R, 2003, CLIN CHEM, V49, P1292, DOI 10.1373/49.8.1292; Chen M, 2007, BBA-MOL CELL BIOL L, V1771, P310, DOI 10.1016/j.bbalip.2006.05.017; Chen ZT, 2001, HUM MOL GENET, V10, P433, DOI 10.1093/hmg/10.5.433; Chiang PK, 1996, FASEB J, V10, P471, DOI 10.1096/fasebj.10.4.8647346; Christopher SA, 2002, MOL GENET METAB, V75, P335, DOI 10.1016/S1096-7192(02)00003-3; Davis CD, 2007, NUTR REV, V65, P88, DOI [10.1111/j.1753-4887.2007.tb00285.x, 10.1301/nr.2007.feb.88-94]; Dayal S, 2001, CIRC RES, V88, P1203, DOI 10.1161/hh1101.092180; de Kroon AIPM, 2007, BBA-MOL CELL BIOL L, V1771, P343, DOI 10.1016/j.bbalip.2006.07.010; DELAHABA G, 1959, J BIOL CHEM, V234, P603; Detich N, 2003, J BIOL CHEM, V278, P20812, DOI 10.1074/jbc.M211813200; Finkelstein JD, 2006, J NUTR, V136, p1750S, DOI 10.1093/jn/136.6.1750S; FOLCH J, 1957, J BIOL CHEM, V226, P497; Gaspar ML, 2007, BBA-MOL CELL BIOL L, V1771, P241, DOI 10.1016/j.bbalip.2006.06.011; GAYNOR PM, 1990, BIOCHIM BIOPHYS ACTA, V1045, P156, DOI 10.1016/0005-2760(90)90145-N; Gellekink H, 2005, CLIN CHEM, V51, P1487, DOI 10.1373/clinchem.2004.046995; GIETZ RD, 1995, YEAST, V11, P355, DOI 10.1002/yea.320110408; GREENBERG ML, 1982, MOL GEN GENET, V186, P157, DOI 10.1007/BF00331845; Hansen J, 2000, MOL GEN GENET, V263, P535, DOI 10.1007/s004380051199; Hartz CS, 2006, J NUTR, V136, P3005, DOI 10.1093/jn/136.12.3005; Henry SA, 1998, PROG NUCLEIC ACID RE, V61, P133, DOI 10.1016/S0079-6603(08)60826-0; HOFFMAN DR, 1980, J BIOL CHEM, V255, P822; Isa Y, 2006, J NUTR SCI VITAMINOL, V52, P479, DOI 10.3177/jnsv.52.479; Jesch SA, 2005, J BIOL CHEM, V280, P9106, DOI 10.1074/jbc.M411770200; Jesch SA, 2006, J BIOL CHEM, V281, P24070, DOI 10.1074/jbc.M604541200; Kerins DM, 2001, AM J CLIN NUTR, V74, P723; Kharbanda KK, 2007, WORLD J GASTROENTERO, V13, P4947, DOI 10.3748/wjg.v13.i37.4947; Kurat CF, 2006, J BIOL CHEM, V281, P491, DOI 10.1074/jbc.M508414200; Lee H, 1998, BIOL REPROD, V58, P1437, DOI 10.1095/biolreprod58.6.1437; Li ZY, 2006, CELL METAB, V3, P321, DOI 10.1016/j.cmet.2006.03.007; Lindsay H, 1996, BIOCHEM J, V320, P473, DOI 10.1042/bj3200473; Loehrer FMT, 2001, ATHEROSCLEROSIS, V154, P147, DOI 10.1016/S0021-9150(00)00449-4; Loewen CJR, 2004, SCIENCE, V304, P1644, DOI 10.1126/science.1096083; MCGEE TP, 1994, J BACTERIOL, V176, P6861, DOI 10.1128/JB.176.22.6861-6868.1994; MCGRAW P, 1989, GENETICS, V122, P317; Mendoza-Cozatl D, 2005, FEMS MICROBIOL REV, V29, P653, DOI 10.1016/j.femsre.2004.09.004; MILLER MW, 1994, EMBO J, V13, P1806, DOI 10.1002/j.1460-2075.1994.tb06449.x; Mizunuma M, 2004, P NATL ACAD SCI USA, V101, P6086, DOI 10.1073/pnas.0308314101; Moffatt BA, 2002, PLANT PHYSIOL, V128, P812, DOI 10.1104/pp.010880; Mushegian AR, 1998, GENOME RES, V8, P590, DOI 10.1101/gr.8.6.590; Niedenthal RK, 1996, YEAST, V12, P773, DOI 10.1002/(SICI)1097-0061(19960630)12:8<773::AID-YEA972>3.3.CO;2-C; Pan HJ, 2006, FEBS LETT, V580, P5953, DOI 10.1016/j.febslet.2006.09.066; Sas B, 1999, J CHROMATOGR A, V864, P179, DOI 10.1016/S0021-9673(99)01025-0; Schneiter Roger, 2006, Methods Mol Biol, V313, P75; Stead LM, 2006, AM J CLIN NUTR, V83, P5; Strahl BD, 2002, MOL CELL BIOL, V22, P1298, DOI 10.1128/MCB.22.5.1298-1306.2002; Tehlivets O, 2004, FEBS LETT, V577, P501, DOI 10.1016/j.febslet.2004.10.057; Thomas D, 1997, MICROBIOL MOL BIOL R, V61, P503, DOI 10.1128/.61.4.503-532.1997; THOMAS D, 1990, J BIOL CHEM, V265, P15518; Vance DE, 2006, FEBS LETT, V580, P5430, DOI 10.1016/j.febslet.2006.06.025; Vance JE, 2004, BIOCHEM CELL BIOL, V82, P113, DOI 10.1139/o03-073; Vollset SE, 2001, AM J CLIN NUTR, V74, P130; Werstuck GH, 2001, J CLIN INVEST, V107, P1263, DOI 10.1172/JCI11596; Winzeler EA, 1999, SCIENCE, V285, P901, DOI 10.1126/science.285.5429.901; WOLFE MS, 1991, J MED CHEM, V34, P1521, DOI 10.1021/jm00109a001; Wolinski Heimo, 2008, V457, P151, DOI 10.1007/978-1-59745-261-8_11; Zaina S, 2005, J NUTR, V135, P5, DOI 10.1093/jn/135.1.5	62	58	61	1	10	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	AUG 29	2008	283	35					23989	23999		10.1074/jbc.M800830200	http://dx.doi.org/10.1074/jbc.M800830200			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	340II	18591246	Green Published, hybrid			2022-12-27	WOS:000258638900055
J	Nikaido, E; Yamaguchi, A; Nishino, K				Nikaido, Eiji; Yamaguchi, Akihito; Nishino, Kunihiko			AcrAB multidrug efflux pump regulation in Salmonella enterica serovar typhimurium by RamA in response to environmental signals	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							MULTIPLE ANTIBIOTIC-RESISTANCE; LEVEL FLUOROQUINOLONE RESISTANCE; RAW-MILK CHEESE; ESCHERICHIA-COLI; DRUG-RESISTANCE; FATTY-ACIDS; BILE-SALTS; EXPRESSION; GENES; TRANSPORTER	Salmonella enterica serovar Typhimurium has at least nine multidrug efflux pumps. Among these pumps, AcrAB is effective in generating drug resistance and has wide substrate specificity. Here we report that indole, bile, and an Escherichia coli conditioned medium induced the AcrAB pump in Salmonella through a specific regulator, RamA. The RamA-binding sites were located in the upstream regions of acrAB and tolC. RamA was required for indole induction of acrAB. Other regulators of acrAB such as MarA, SoxS, Rob, SdiA, and AcrR did not contribute to acrAB induction by indole in Salmonella. Indole activated ramA transcription, and overproduction of RamA caused increased acrAB expression. In contrast, induction of ramA was not required for induction of acrAB by bile. Cholic acid binds to RamA, and we suggest that bile acts by altering pre-existing RamA. This points to two different AcrAB regulatory modes through RamA. Our results suggest that RamA controls the Salmonella AcrAB-TolC multidrug efflux system through dual regulatory modes in response to environmental signals.	[Nikaido, Eiji; Yamaguchi, Akihito; Nishino, Kunihiko] Osaka Univ, Dept Cell Membrane Biol, Inst Sci & Ind Res, Osaka 5670047, Japan; [Nikaido, Eiji; Yamaguchi, Akihito; Nishino, Kunihiko] Osaka Univ, Grad Sch Pharmaceut Sci, Osaka 5670047, Japan; [Nishino, Kunihiko] Japan Sci & Technol Corp, PRESTO, Tokyo 1020075, Japan	Osaka University; Osaka University; Japan Science & Technology Agency (JST)	Yamaguchi, A (corresponding author), Osaka Univ, Dept Cell Membrane Biol, Inst Sci & Ind Res, Osaka 5670047, Japan.	akihito@sanken.osaka-u.ac.jp; nishino@sanken.osaka-u.ac.jp			Takeda Science Foundation; Inamori Foundation; Japan Science and Technology Agency; Fundamental Studies in Health Sciences of the National Institute of Biomedical Innovation; Ministry of Education, Culture, Sports, Science and Technology of Japan; Japan Society for the Promotion of Science	Takeda Science Foundation(Takeda Science Foundation (TSF)); Inamori Foundation; Japan Science and Technology Agency(Japan Science & Technology Agency (JST)); Fundamental Studies in Health Sciences of the National Institute of Biomedical Innovation(National Institute of Biomedical Innovation); Ministry of Education, Culture, Sports, Science and Technology of Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); Japan Society for the Promotion of Science(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science)	This work was supported in part by Takeda Science Foundation, Inamori Foundation, the PRESTO program of the Japan Science and Technology Agency (to K. N.), the Program for Promotion of Fundamental Studies in Health Sciences of the National Institute of Biomedical Innovation, and by grants from the Ministry of Education, Culture, Sports, Science and Technology of Japan, Japan Society for the Promotion of Science (to A. Y. and K. N.). The costs of publication of this article were defrayed in part by the payment of page charges. This article must therefore be hereby marked "advertisement" in accordance with 18 U. S. C. Section 1734 solely to indicate this fact.	Abouzeed YM, 2008, ANTIMICROB AGENTS CH, V52, P2428, DOI 10.1128/AAC.00084-08; AHMED M, 1994, J BIOL CHEM, V269, P28506; Baca-DeLancey RR, 1999, P NATL ACAD SCI USA, V96, P4610, DOI 10.1073/pnas.96.8.4610; Batta AK, 2002, J CHROMATOGR B, V775, P153, DOI 10.1016/S1570-0232(02)00289-1; Baucheron S, 2004, J ANTIMICROB CHEMOTH, V53, P657, DOI 10.1093/jac/dkh122; Baucheron S, 2002, MICROB DRUG RESIST, V8, P281, DOI 10.1089/10766290260469543; Brown MH, 1999, MOL MICROBIOL, V31, P394, DOI 10.1046/j.1365-2958.1999.01162.x; Chollet R, 2004, ANTIMICROB AGENTS CH, V48, P2518, DOI 10.1128/AAC.48.7.2518-2523.2004; Cloeckaert A, 2001, VET RES, V32, P291, DOI 10.1051/vetres:2001105; Cody SH, 1999, JAMA-J AM MED ASSOC, V281, P1805, DOI 10.1001/jama.281.19.1805; Datsenko KA, 2000, P NATL ACAD SCI USA, V97, P6640, DOI 10.1073/pnas.120163297; Davies A, 1996, Commun Dis Rep CDR Rev, V6, pR159; DAVIS RW, 1980, ADV BACTERIAL GENET, P100; Eaves DJ, 2004, ANTIMICROB AGENTS CH, V48, P1145, DOI 10.1128/AAC.48.4.1145-1150.2004; ELLEDGE SJ, 1989, GENE DEV, V3, P185, DOI 10.1101/gad.3.2.185; FIELDS PI, 1986, P NATL ACAD SCI USA, V83, P5189, DOI 10.1073/pnas.83.14.5189; Grein T, 1999, IRISH MED J, V92, P238; Grkovic S, 2002, MICROBIOL MOL BIOL R, V66, P671, DOI 10.1128/MMBR.66.4.671-701.2002; Hernandez-Urzua E, 2007, ARCH MICROBIOL, V187, P67, DOI 10.1007/s00203-006-0175-8; Hirakawa H, 2005, MOL MICROBIOL, V55, P1113, DOI 10.1111/j.1365-2958.2004.04449.x; Hosek G., 1997, Morbidity and Mortality Weekly Report, V46, P308; Kobayashi A, 2006, J BACTERIOL, V188, P5693, DOI 10.1128/JB.00217-06; KOMATSU T, 1990, J BACTERIOL, V172, P4082, DOI 10.1128/jb.172.7.4082-4089.1990; Lacroix FJC, 1996, FEMS MICROBIOL LETT, V135, P161, DOI 10.1016/0378-1097(95)00443-2; Li XZ, 2004, DRUGS, V64, P159, DOI 10.2165/00003495-200464020-00004; LOMOVSKAYA O, 1995, J BACTERIOL, V177, P2328, DOI 10.1128/jb.177.9.2328-2334.1995; Ma D, 1996, MOL MICROBIOL, V19, P101, DOI 10.1046/j.1365-2958.1996.357881.x; MA D, 1995, MOL MICROBIOL, V16, P45, DOI 10.1111/j.1365-2958.1995.tb02390.x; Martin RG, 2002, MOL MICROBIOL, V44, P1611, DOI 10.1046/j.1365-2958.2002.02985.x; McClelland M, 2001, NATURE, V413, P852, DOI 10.1038/35101614; Miller J. H, 1972, EXPT MOL GENETICS; Molbak K, 1999, NEW ENGL J MED, V341, P1420, DOI 10.1056/NEJM199911043411902; Murakami S, 2002, NATURE, V419, P587, DOI 10.1038/nature01050; Murakami S, 2006, NATURE, V443, P173, DOI 10.1038/nature05076; Ng LK, 1999, ANTIMICROB AGENTS CH, V43, P3018, DOI 10.1128/AAC.43.12.3018; Nikaido H, 1996, J BACTERIOL, V178, P5853, DOI 10.1128/jb.178.20.5853-5859.1996; Nishino K, 2006, MOL MICROBIOL, V59, P126, DOI 10.1111/j.1365-2958.2005.04940.x; Nishino K, 2007, J BACTERIOL, V189, P9066, DOI 10.1128/JB.01045-07; Olliver A, 2005, ANTIMICROB AGENTS CH, V49, P289, DOI 10.1128/AAC.49.1.289-301.2005; Olliver A, 2004, FEMS MICROBIOL LETT, V238, P267, DOI 10.1016/j.femsle.2004.07.046; Paulsen IT, 2001, J MOL MICROB BIOTECH, V3, P145; Piddock LJV, 2002, FEMS MICROBIOL REV, V26, P3, DOI 10.1016/S0168-6445(01)00076-6; Prouty AM, 2004, MICROBIOL-SGM, V150, P775, DOI 10.1099/mic.0.26769-0; Putman M, 2000, MICROBIOL MOL BIOL R, V64, P672, DOI 10.1128/MMBR.64.4.672-693.2000; Randall LP, 2002, RES VET SCI, V72, P87, DOI 10.1053/rvsc.2001.0537; Rosenberg EY, 2003, MOL MICROBIOL, V48, P1609, DOI 10.1046/j.1365-2958.2003.03531.x; Scherer CA, 2001, PRINCIPLES BACTERIAL, P266; Schneiders T, 2003, ANTIMICROB AGENTS CH, V47, P2831, DOI 10.1128/AAC.47.9.2831-2837.2003; Schuldiner S, 2006, NATURE, V443, P156, DOI 10.1038/443156b; SONNENWIRTH AC, 1980, ENTERIC BACTERIA BAC, P645; Thanassi DG, 1997, J BACTERIOL, V179, P2512, DOI 10.1128/jb.179.8.2512-2518.1997; Threlfall EJ, 1997, MICROB DRUG RESIST, V3, P263, DOI 10.1089/mdr.1997.3.263; Threlfall EJ, 1996, LANCET, V347, P1053, DOI 10.1016/S0140-6736(96)90199-3; van der Straaten T, 2004, INFECT IMMUN, V72, P996, DOI 10.1128/IAI.72.2.996-1003.2004; van der Straaten T, 2004, ANTIMICROB AGENTS CH, V48, P2292, DOI 10.1128/AAC.48.6.2292-2294.2004; Villar RG, 1999, JAMA-J AM MED ASSOC, V281, P1811, DOI 10.1001/jama.281.19.1811; YANOFSKY C, 1991, J BACTERIOL, V173, P6009, DOI 10.1128/jb.173.19.6009-6017.1991; Yassien MA, 2002, ANTIMICROB AGENTS CH, V46, P360, DOI 10.1128/AAC.46.2.360-366.2002; Yu EW, 2003, J BACTERIOL, V185, P5657, DOI 10.1128/JB.185.19.5657-5664.2003; Zgurskaya HI, 2000, MOL MICROBIOL, V37, P219, DOI 10.1046/j.1365-2958.2000.01926.x	60	156	164	0	27	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	AUG 29	2008	283	35					24245	24253		10.1074/jbc.M804544200	http://dx.doi.org/10.1074/jbc.M804544200			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	340II	18577510	Green Published, hybrid			2022-12-27	WOS:000258638900078
J	Signorell, A; Rauch, M; Jelk, J; Ferguson, MAJ; Butikofer, P				Signorell, Aita; Rauch, Monika; Jelk, Jennifer; Ferguson, Michael A. J.; Buetikofer, Peter			Phosphatidylethanolamine in Trypanosoma brucei is organized in two separate pools and is synthesized exclusively by the Kennedy pathway	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							YEAST SACCHAROMYCES-CEREVISIAE; PROCYCLIC CULTURE FORMS; PHOSPHOLIPID BIOSYNTHESIS; MAMMALIAN-CELLS; BLOOD-STREAM; FATTY-ACID; PHOSPHATIDYLSERINE; SPECIFICITY; METABOLISM; LIPIDS	Phosphatidylethanolamine is a major phospholipid class of all eukaryotic cells. It can be synthesized via the CDP-ethanolamine branch of the Kennedy pathway, by decarboxylation of phosphatidylserine, or by base exchange with phosphatidylserine. The contributions of these pathways to total phosphatidylethanolamine synthesis have remained unclear. Although Trypanosoma brucei, the causative agent of human and animal trypanosomiasis, has served as a model organism to elucidate the entire reaction sequence for glycosylphosphatidylinositol biosynthesis, the pathways for the synthesis of the major phospholipid classes have received little attention. Wenowshow that disruption of the CDP- ethanolamine branch of the Kennedy pathway using RNA interference results in dramatic changes in phosphatidylethanolamine, phosphatidylserine, and phosphatidylcholine. By targeting individual enzymes of the pathway, we demonstrate that de novo phosphatidylethanolamine synthesis in T. brucei procyclic forms is strictly dependent on the CDPethanolamine route. Interestingly, the last step in the Kennedy pathway can be mediated by two separate activities leading to two distinct pools of phosphatidylethanolamine, consisting of predominantly alk- 1- enyl- acyl- or diacyl- type molecular species. In addition, we show that phosphatidylserine in T. brucei procyclic forms is synthesized exclusively by base exchange with phosphatidylethanolamine.	[Signorell, Aita; Rauch, Monika; Jelk, Jennifer; Buetikofer, Peter] Univ Bern, Inst Biochem & Mol Med, CH-3012 Bern, Switzerland; [Ferguson, Michael A. J.] Univ Dundee, Div Biol Chem & Drug Discovery, Wellcome Trust Bioctr, Dundee DD1 5EH, Scotland	University of Bern; University of Dundee	Butikofer, P (corresponding author), Univ Bern, Inst Biochem & Mol Med, Buhlstr 28, CH-3012 Bern, Switzerland.	peter.buetikofer@mci.unibe.ch		Ferguson, Michael/0000-0003-1321-8714	Wellcome Trust [071463] Funding Source: Medline	Wellcome Trust(Wellcome TrustEuropean Commission)		Arikketh D, 2008, J BIOL CHEM, V283, P12888, DOI 10.1074/jbc.M800714200; Bakovic M, 2007, BIOCHEM CELL BIOL, V85, P283, DOI 10.1139/O07-006; Birner R, 2003, INT REV CYTOL, V225, P273, DOI 10.1016/S0074-7696(05)25007-6; Bleijerveld OB, 2007, J BIOL CHEM, V282, P28362, DOI 10.1074/jbc.M703786200; Bochud-Allemann N, 2002, J BIOL CHEM, V277, P32849, DOI 10.1074/jbc.M205776200; BRUN R, 1979, ACTA TROP, V36, P289; Burgermeister M, 2004, BBA-MOL CELL BIOL L, V1686, P148, DOI 10.1016/j.bbalip.2004.09.005; Butikofer P, 1997, BIOCHEM J, V326, P415; BUTIKOFER P, 1989, BLOOD, V73, P1699; Carman GM, 1999, PROG LIPID RES, V38, P361, DOI 10.1016/S0163-7827(99)00010-7; Chomczynski P, 2006, NAT PROTOC, V1, P581, DOI 10.1038/nprot.2006.83; De Matteis MA, 2004, NAT CELL BIOL, V6, P487, DOI 10.1038/ncb0604-487; DIXON H, 1970, COMP BIOCHEM PHYSIOL, V33, P111, DOI 10.1016/0010-406X(70)90487-1; Dowhan W, 1997, ANNU REV BIOCHEM, V66, P199, DOI 10.1146/annurev.biochem.66.1.199; Ferguson MAJ, 1999, J CELL SCI, V112, P2799; Ferguson MAJ, 2000, P NATL ACAD SCI USA, V97, P10673, DOI 10.1073/pnas.97.20.10673; Ford DA, 2003, J LIPID RES, V44, P554, DOI 10.1194/jlr.M200426-JLR200; Guler JL, 2008, MOL MICROBIOL, V67, P1125, DOI 10.1111/j.1365-2958.2008.06112.x; Henneberry AL, 2002, MOL BIOL CELL, V13, P3148, DOI 10.1091/mbc.01-11-0540; Horibata Y, 2007, J LIPID RES, V48, P503, DOI 10.1194/jlr.C600019-JLR200; KANFER J, 1964, J BIOL CHEM, V239, P1720; KENNEDY EP, 1956, J BIOL CHEM, V222, P193; Martin KL, 2006, MOL MICROBIOL, V61, P89, DOI 10.1111/j.1365-2958.2006.05216.x; Martin KL, 2006, BIOCHEM J, V396, P287, DOI 10.1042/BJ20051825; MENON AK, 1993, EMBO J, V12, P1907, DOI 10.1002/j.1460-2075.1993.tb05839.x; Munro S, 2004, NAT CELL BIOL, V6, P469, DOI 10.1038/ncb0604-469; NIKAWA J, 1981, BIOCHIM BIOPHYS ACTA, V665, P420, DOI 10.1016/0005-2760(81)90254-X; OPPERDOES FR, 1984, FEBS LETT, V169, P35, DOI 10.1016/0014-5793(84)80284-7; Orlean P, 2007, J LIPID RES, V48, P993, DOI 10.1194/jlr.R700002-JLR200; PATNAIK PK, 1993, MOL BIOCHEM PARASIT, V58, P97, DOI 10.1016/0166-6851(93)90094-E; Pessi G, 2005, J BIOL CHEM, V280, P12461, DOI 10.1074/jbc.M414626200; RIFKIN MR, 1995, J BIOL CHEM, V270, P16160, DOI 10.1074/jbc.270.27.16160; ROUSER G, 1970, LIPIDS, V5, P494, DOI 10.1007/BF02531316; Signorell A, 2008, J BIOL CHEM, V283, P20320, DOI 10.1074/jbc.M802430200; Tillman TS, 2003, CELL BIOCHEM BIOPHYS, V38, P161, DOI 10.1385/CBB:38:2:161; van Hellemond JJ, 2006, FEBS LETT, V580, P5552, DOI 10.1016/j.febslet.2006.07.056; Vance JE, 2004, BIOCHEM CELL BIOL, V82, P113, DOI 10.1139/o03-073; Vance JE, 2008, J LIPID RES, V49, P1377, DOI 10.1194/jlr.R700020-JLR200; Vial HJ, 2003, MOL BIOCHEM PARASIT, V126, P143, DOI 10.1016/S0166-6851(02)00281-5; VOELKER DR, 1984, P NATL ACAD SCI-BIOL, V81, P2669, DOI 10.1073/pnas.81.9.2669; Voelker DR, 2003, J LIPID RES, V44, P441, DOI 10.1194/jlr.R200020-JLR200; Wang XM, 2006, PROG LIPID RES, V45, P250, DOI 10.1016/j.plipres.2006.01.005; Wirtz E, 1999, MOL BIOCHEM PARASIT, V99, P89, DOI 10.1016/S0166-6851(99)00002-X	43	46	46	0	4	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	AUG 29	2008	283	35					23636	23644		10.1074/jbc.M803600200	http://dx.doi.org/10.1074/jbc.M803600200			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	340II	18587155	hybrid, Green Published			2022-12-27	WOS:000258638900016
J	Xia, ZX; Webster, A; Du, FY; Piatkov, K; Ghislain, M; Varshavsky, A				Xia, Zanxian; Webster, Ailsa; Du, Fangyong; Piatkov, Konstantin; Ghislain, Michel; Varshavsky, Alexander			Substrate-binding sites of UBR1, the ubiquitin ligase of the N-end rule pathway	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							RNA-PROTEIN TRANSFERASE; MICE LACKING; TRANSCRIPTIONAL REPRESSION; RECOGNITION COMPONENT; MEDIATED DEGRADATION; ESCHERICHIA-COLI; COHESIN SUBUNIT; SHUTTLE VECTORS; SPECIFICITY; YEAST	Substrates of a ubiquitin-dependent proteolytic system called the N-end rule pathway include proteins with destabilizing N-terminal residues. N-recognins, the pathway's ubiquitin ligases, contain three substrate-binding sites. The type-1 site is specific for basic N-terminal residues (Arg, Lys, and His). The type-2 site is specific for bulky hydrophobic N-terminal residues (Trp, Phe, Tyr, Leu, and Ile). We show here that the type-1/2 sites of UBR1, the sole N-recognin of the yeast Saccharomyces cerevisiae, are located in the first similar to 700 residues of the 1,950-residue UBR1. These sites are distinct in that they can be selectively inactivated by mutations, identified through a genetic screen. Mutations inactivating the type-1 site are in the previously delineated similar to 70-residue UBR motif characteristic of N-recognins. Fluorescence polarization and surface plasmon resonance were used to determine that UBR1 binds, with a K-d of similar to 1 mu M, to either type-1 or type-2 destabilizing N-terminal residues of reporter peptides but does not bind to a stabilizing N-terminal residue such as Gly. A third substrate-binding site of UBR1 targets an internal degron of CUP9, a transcriptional repressor of peptide import. We show that the previously demonstrated in vivo dependence of CUP9 ubiquitylation on the binding of cognate dipeptides to the type-1/2 sites of UBR1 can be reconstituted in a completely defined in vitro system. We also found that purified UBR1 and CUP9 interact nonspecifically and that specific binding ( which involves, in particular, the binding by cognate dipeptides to the UBR1 type-1/2 sites) can be restored either by a chaperone such as EF1A or through macromolecular crowding.	[Xia, Zanxian; Piatkov, Konstantin; Varshavsky, Alexander] CALTECH, Div Biol, Pasadena, CA 91125 USA; [Webster, Ailsa] Celltech R&D, Slough SL1 4EN, Berks, England; [Du, Fangyong] Yale Univ, Dept Microbial Pathogenesis, New Haven, CT 06536 USA; [Ghislain, Michel] Univ Louvain, Grp Physiol Biochem, B-1348 Louvain, Belgium	California Institute of Technology; Celltech Group Ltd; Yale University	Varshavsky, A (corresponding author), CALTECH, Div Biol, Pasadena, CA 91125 USA.	avarsh@caltech.edu			National Institutes of Health [DK39520, GM31530]; Ellison Medical Foundation; Sandler Program for Asthma Research; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R37DK039520, R01DK039520, R56DK039520] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM031530] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Ellison Medical Foundation(Lawrence Ellison Foundation); Sandler Program for Asthma Research; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported, in whole or in part, by National Institutes of Health Grants DK39520 and GM31530 (to A.V.). This work was also supported by the Ellison Medical Foundation and the Sandler Program for Asthma Research. The costs of publication of this article were defrayed in part by the payment of page charges. This article must therefore be hereby marked "advertisement" in accordance with 18 U.S.C. Section 1734 solely to indicate this fact.	ALAGRAMAM K, 1995, MOL MICROBIOL, V15, P225, DOI 10.1111/j.1365-2958.1995.tb02237.x; An JY, 2006, P NATL ACAD SCI USA, V103, P6212, DOI 10.1073/pnas.0601700103; Ausubel F.M., 2006, CURRENT PROTOCOLS MO; BACHMAIR A, 1989, CELL, V56, P1019, DOI 10.1016/0092-8674(89)90635-1; BACHMAIR A, 1986, SCIENCE, V234, P179, DOI 10.1126/science.3018930; BAKER RT, 1995, J BIOL CHEM, V270, P12065, DOI 10.1074/jbc.270.20.12065; BAKER RT, 1991, P NATL ACAD SCI USA, V87, P2374; BARRAL Y, 1995, GENE DEV, V9, P399, DOI 10.1101/gad.9.4.399; BARTEL B, 1990, EMBO J, V9, P3179, DOI 10.1002/j.1460-2075.1990.tb07516.x; Byrd C, 1998, EMBO J, V17, P269, DOI 10.1093/emboj/17.1.269; Catic A, 2007, EMBO J, V26, P3474, DOI 10.1038/sj.emboj.7601772; Chuang SM, 2005, MOL CELL BIOL, V25, P403, DOI 10.1128/MCB.25.1.403-413.2005; DEGROOT RJ, 1991, P NATL ACAD SCI USA, V88, P8967, DOI 10.1073/pnas.88.20.8967; DELTITO BJD, 1995, J BACTERIOL, V177, P7086, DOI 10.1128/jb.177.24.7086-7091.1995; Ditzel M, 2003, NAT CELL BIOL, V5, P467, DOI 10.1038/ncb984; Dong XS, 2007, PROTEIN SCI, V16, P528, DOI 10.1110/ps.062616107; DU F, 2001, THESIS CALIFORNIA I; Du FY, 2002, P NATL ACAD SCI USA, V99, P14110, DOI 10.1073/pnas.172527399; Ellis RJ, 2003, NATURE, V425, P27, DOI 10.1038/425027a; Erbse A, 2006, NATURE, V439, P753, DOI 10.1038/nature04412; Feldman RMR, 1997, CELL, V91, P221, DOI 10.1016/S0092-8674(00)80404-3; Garzon M, 2007, FEBS LETT, V581, P3189, DOI 10.1016/j.febslet.2007.06.005; Ghislain M, 1996, EMBO J, V15, P4884, DOI 10.1002/j.1460-2075.1996.tb00869.x; GIETZ RD, 1988, GENE, V74, P527, DOI 10.1016/0378-1119(88)90185-0; GONDA DK, 1989, J BIOL CHEM, V264, P16700; Graciet E, 2006, P NATL ACAD SCI USA, V103, P3078, DOI 10.1073/pnas.0511224103; Halaris A, 2007, CNS DRUGS, V21, P885, DOI 10.2165/00023210-200721110-00002; Hou JY, 2008, NAT STRUCT MOL BIOL, V15, P288, DOI 10.1038/nsmb.1392; Hu RG, 2005, NATURE, V437, P981, DOI 10.1038/nature04027; Hu RG, 2008, P NATL ACAD SCI USA, V105, P76, DOI 10.1073/pnas.0710568105; Hu RG, 2006, J BIOL CHEM, V281, P32559, DOI 10.1074/jbc.M604355200; Inobe T, 2008, CURR OPIN STRUC BIOL, V18, P43, DOI 10.1016/j.sbi.2007.12.014; JARVIS TC, 1990, J BIOL CHEM, V265, P15160; JOHNSON ES, 1990, NATURE, V346, P287, DOI 10.1038/346287a0; JOHNSON ES, 1995, J BIOL CHEM, V270, P17442, DOI 10.1074/jbc.270.29.17442; Ju DD, 2007, BBA-MOL CELL RES, V1773, P1672, DOI 10.1016/j.bbamcr.2007.04.012; Kwak KS, 2004, CANCER RES, V64, P8193, DOI 10.1158/0008-5472.CAN-04-2102; Kwon YT, 2003, MOL CELL BIOL, V23, P8255, DOI 10.1128/MCB.23.22.8255-8271.2003; Kwon YT, 2000, MOL CELL BIOL, V20, P4135, DOI 10.1128/MCB.20.11.4135-4148.2000; Kwon YT, 1999, MOL CELL BIOL, V19, P182; Kwon YT, 2002, SCIENCE, V297, P96, DOI 10.1126/science.1069531; Kwon YT, 2001, MOL CELL BIOL, V21, P8007, DOI 10.1128/MCB.21.23.8007-8021.2001; Lee MJ, 2005, P NATL ACAD SCI USA, V102, P15030, DOI 10.1073/pnas.0507533102; Levy F, 1996, P NATL ACAD SCI USA, V93, P4907, DOI 10.1073/pnas.93.10.4907; Lloyd AG, 2007, VIROLOGY, V360, P129, DOI 10.1016/j.virol.2006.10.007; Lupas AN, 2003, J STRUCT BIOL, V141, P77, DOI 10.1016/S1047-8477(02)00582-8; Lynch M, 2007, ORIGINS GENOME ARCHI; Maeda H, 2007, J BIOL CHEM, V282, P26956, DOI 10.1074/jbc.M703436200; Malave TM, 2006, BIOCHEM CELL BIOL, V84, P437, DOI 10.1139/O06-073; Minton AP, 2001, J BIOL CHEM, V276, P10577, DOI 10.1074/jbc.R100005200; Mogk A, 2007, TRENDS CELL BIOL, V17, P165, DOI 10.1016/j.tcb.2007.02.001; Moore JMR, 2004, J BIOL CHEM, V279, P27584, DOI 10.1074/jbc.M403453200; Morton TA, 1998, METHOD ENZYMOL, V295, P268; Myszka DG, 1998, TRENDS BIOCHEM SCI, V23, P149, DOI 10.1016/S0968-0004(98)01183-9; Prakash S, 2004, NAT STRUCT MOL BIOL, V11, P830, DOI 10.1038/nsmb814; Rao H, 2001, NATURE, V410, P955, DOI 10.1038/35073627; Redd MJ, 1997, J BIOL CHEM, V272, P11193; Sasaki T, 2006, MOL CELL, V24, P63, DOI 10.1016/j.molcel.2006.08.005; Seeliger MA, 2003, NAT STRUCT BIOL, V10, P718, DOI 10.1038/nsb962; SHERMAN F, 1991, METHOD ENZYMOL, V194, P3; SHRADER TE, 1993, J BACTERIOL, V175, P4364, DOI 10.1128/JB.175.14.4364-4374.1993; Siepmann TJ, 2003, J BIOL CHEM, V278, P9448, DOI 10.1074/jbc.M211240200; SIKORSKI RS, 1989, GENETICS, V122, P19; Smith RL, 2000, TRENDS BIOCHEM SCI, V25, P325, DOI 10.1016/S0968-0004(00)01592-9; Stary S, 2003, PLANT PHYSIOL, V133, P1360, DOI 10.1104/pp.103.029272; Stevens SW, 2000, METHOD ENZYMOL, V318, P385; Suto K, 2006, EMBO J, V25, P5942, DOI 10.1038/sj.emboj.7601433; Suzuki T, 1999, EMBO J, V18, P6017, DOI 10.1093/emboj/18.21.6017; Tasaki T, 2005, MOL CELL BIOL, V25, P7120, DOI 10.1128/MCB.25.16.7120-7136.2005; Tasaki T, 2007, TRENDS BIOCHEM SCI, V32, P520, DOI 10.1016/j.tibs.2007.08.010; Tasaki T, 2007, J BIOL CHEM, V282, P18510, DOI 10.1074/jbc.M701894200; TOBIAS JW, 1991, SCIENCE, V254, P1374, DOI 10.1126/science.1962196; Turner GC, 2000, NATURE, V405, P579, DOI 10.1038/35014629; Uhlmann F, 1999, NATURE, V400, P37, DOI 10.1038/21831; Van Regenmortel M H V, 2003, Dev Biol (Basel), V112, P141; Varshavsky A, 2003, NAT CELL BIOL, V5, P373, DOI 10.1038/ncb0503-373; Varshavsky A, 1996, P NATL ACAD SCI USA, V93, P12142, DOI 10.1073/pnas.93.22.12142; Varshavsky A, 2005, METHOD ENZYMOL, V399, P777, DOI 10.1016/S0076-6879(05)99051-4; Varshavsky A, 2004, CURR BIOL, V14, pR181, DOI 10.1016/j.cub.2004.02.014; Wang KH, 2007, GENE DEV, V21, P403, DOI 10.1101/gad.1511907; Watanabe K, 2007, NATURE, V449, P867, DOI 10.1038/nature06167; Xie YM, 2000, P NATL ACAD SCI USA, V97, P2497, DOI 10.1073/pnas.060025497; Xie YM, 1999, EMBO J, V18, P6832, DOI 10.1093/emboj/18.23.6832; Xie YM, 2001, P NATL ACAD SCI USA, V98, P3056, DOI 10.1073/pnas.071022298; Yoshida S, 2002, PLANT J, V32, P129, DOI 10.1046/j.1365-313X.2002.01407.x; Zenker M, 2005, NAT GENET, V37, P1345, DOI 10.1038/ng1681	86	77	78	0	8	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	AUG 29	2008	283	35					24011	24028		10.1074/jbc.M802583200	http://dx.doi.org/10.1074/jbc.M802583200			18	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	340II	18566452	Green Accepted, hybrid, Green Published			2022-12-27	WOS:000258638900057
J	Kim, Y; Lee, YS; Choe, J; Lee, H; Kim, YM; Jeoung, D				Kim, Youngmi; Lee, Yun-Sil; Choe, Jongseon; Lee, Hansoo; Kim, Young-Myeong; Jeoung, Dooil			CD44-epidermal growth factor receptor interaction mediates hyaluronic acid-promoted cell motility by activating protein kinase C signaling involving Akt, Rac1, Phox, reactive oxygen species, focal adhesion kinase, and MMP-2	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							NF-KAPPA-B; NADPH OXIDASE ACTIVATION; BREAST-CANCER CELLS; HYALURONAN-CD44 INTERACTION; MATRIX METALLOPROTEINASE-2; MESENCHYMAL TRANSITION; ENDOTHELIAL-CELLS; EPITHELIAL-CELLS; CYTOSKELETON FUNCTION; EGF RECEPTOR	Hyaluronic acid ( HA) is known to play an important role in motility of tumor cells. However, the molecular mechanisms associated with HA-promoted melanoma cell motility are not fully understood. Treatment of cells with HA was shown to increase the production of reactive oxygen species (ROS) in a CD44-dependent manner. Antioxidants, such asN-acetyl-L-cysteine and seleno-L-methionine, prevented HA from enhancing cell motility. Protein kinase C (PKC)-alpha and PKC delta were responsible for increased Rac1 activity, production of ROS, and mediated HA-promoted cell motility. HA increased Rac1 activity via CD44, PKC alpha, and PKC delta. Transfection with dominant negative and constitutive active Rac1 mutants demonstrated that Rac1 was responsible for the increased production of ROS and cell motility by HA. Inhibition of NADPH oxidase by diphenylene iodonium and down-regulation of p47(Phox) and p67(Phox) decreased the ROS level, suggesting that NADPH oxidase is the main source of ROS production. Rac1 increased phosphorylation of FAK. FAK functions downstream of and is necessary for HA-promoted cell motility. Secretion and expression of MMP-2 were increased by treatment with HA via the action of PKC alpha, PKC delta, and Rac1 and the production of ROS and FAK. Ilomastat, an inhibitor of MMP-2, exerted a negative effect on HA-promoted cell motility. HA increased interaction between CD44 and epidermal growth factor receptor ( EGFR). AG1478, an inhibitor of EGFR, decreased phosphorylation of PKC alpha, PKC delta, and Rac1 activity and suppressed induction of p47Phox and p67Phox. These results suggest that CD44-EGFR interaction is necessary for HA-promoted cell motility by regulating PKC signaling. EGFR-Akt interaction promoted by HA was responsible for the increased production of ROS and HA-promoted cell motility. In summary, HA promotes CD44-EGFR interaction, which in turn activates PKC signaling, involving Akt, Rac1, Phox, and the production of ROS, FAK, and MMP-2, to enhance melanoma cell motility.	[Kim, Youngmi; Lee, Hansoo; Jeoung, Dooil] Kangwon Natl Univ, Sch Biol Sci, Coll Nat Sci, Chunchon 200701, South Korea; [Lee, Yun-Sil] Korea Inst Radiol & Med Sci, Lab Radiat Effect, Div Radiat Biol, Seoul 139706, South Korea; [Choe, Jongseon; Kim, Young-Myeong] Kangwon Natl Univ, Sch Med, Chunchon 200701, South Korea	Kangwon National University; Korea Institute of Radiological & Medical Sciences; Kangwon National University	Jeoung, D (corresponding author), Kangwon Natl Univ, Sch Biol Sci, Coll Nat Sci, Chunchon 200701, South Korea.	jeoungd@kangwon.ac.kr	Lee, Yun-Sil/AAP-1378-2020	Lee, Yun-Sil/0000-0002-7538-8850				Aye MM, 2004, INT J CANCER, V112, P738, DOI 10.1002/ijc.20497; BARTOLAZZI A, 1994, J EXP MED, V180, P53, DOI 10.1084/jem.180.1.53; Bourguignon LYW, 2007, J NEUROCHEM, V101, P1002, DOI 10.1111/j.1471-4159.2007.04485.x; Bourguignon LYW, 2006, J BIOL CHEM, V281, P14026, DOI 10.1074/jbc.M507734200; Bourguignon LYW, 2005, J BIOL CHEM, V280, P11961, DOI 10.1074/jbc.M411985200; Bourguignon LYW, 2004, J BIOL CHEM, V279, P29654, DOI 10.1074/jbc.M403608200; Bourguignon LYW, 2001, J BIOL CHEM, V276, P48679, DOI 10.1074/jbc.M106759200; Bourguignon LYW, 2000, J BIOL CHEM, V275, P1829, DOI 10.1074/jbc.275.3.1829; Boyer B, 2000, BIOCHEM PHARMACOL, V60, P1091, DOI 10.1016/S0006-2952(00)00427-5; Cary LA, 1996, J CELL SCI, V109, P1787; Cavallaro U, 2004, NAT REV CANCER, V4, P118, DOI 10.1038/nrc1276; Chang EJ, 2007, J CELL SCI, V120, P166, DOI 10.1242/jcs.03310; Chang FM, 2007, MOL BIOL CELL, V18, P253, DOI 10.1091/mbc.E06-03-0207; Chaturvedi LS, 2007, J BIOL CHEM, V282, P14, DOI 10.1074/jbc.M605817200; Cheng GZ, 2007, CANCER RES, V67, P1979, DOI 10.1158/0008-5472.CAN-06-1479; Cheng G, 2006, J BIOL CHEM, V281, P17718, DOI 10.1074/jbc.M512751200; Cho HJ, 2007, BIOCHEM BIOPH RES CO, V353, P337, DOI 10.1016/j.bbrc.2006.12.035; Cook AC, 2006, J BIOL CHEM, V281, P24381, DOI 10.1074/jbc.M602694200; Denning MF, 1996, J BIOL CHEM, V271, P5325, DOI 10.1074/jbc.271.10.5325; DerMardirossian C, 2006, MOL BIOL CELL, V17, P4760, DOI 10.1091/mbc.E06-06-0533; Dissanayake SK, 2007, J BIOL CHEM, V282, P17259, DOI 10.1074/jbc.M700075200; DOCHERTY NG, 2006, AM J PHYSIOL, V290, pR1202; Ellis IR, 2007, EXP CELL RES, V313, P732, DOI 10.1016/j.yexcr.2006.11.016; Fan CY, 2005, BIOCHEM J, V390, P761, DOI 10.1042/BJ20050287; Felty Q, 2005, BIOCHEMISTRY-US, V44, P6900, DOI 10.1021/bi047629p; Fitzgerald KA, 2000, J IMMUNOL, V164, P2053, DOI 10.4049/jimmunol.164.4.2053; Frey RS, 2006, J BIOL CHEM, V281, P16128, DOI 10.1074/jbc.M508810200; Galli A, 2005, HEPATOLOGY, V41, P1074, DOI 10.1002/hep.20683; Gomes JAP, 2004, BRIT J OPHTHALMOL, V88, P821, DOI 10.1136/bjo.2003.027573; GUO Y, 1994, CANCER RES, V154, P1561; Hamilton SR, 2007, J BIOL CHEM, V282, P16667, DOI 10.1074/jbc.M702078200; Han DC, 1999, J BIOL CHEM, V274, P24425, DOI 10.1074/jbc.274.34.24425; Hu B, 2006, CANCER RES, V66, P775, DOI 10.1158/0008-5472.CAN-05-1149; HU T, 2005, AM J PHYSIOL, V289, pR816; Ikeda S, 2005, ARTERIOSCL THROM VAS, V25, P2295, DOI 10.1161/01.ATV.0000187472.55437.af; Kim HR, 2004, CANCER RES, V64, P4569, DOI 10.1158/0008-5472.CAN-04-0202; Kim HJ, 2007, MOL CELL BIOL, V27, P3165, DOI 10.1128/MCB.01315-06; Kim KH, 2007, FEBS LETT, V581, P3303, DOI 10.1016/j.febslet.2007.06.012; Kim MS, 2005, INT J ONCOL, V27, P839; Mahrouf M, 2006, BIOCHEM PHARMACOL, V72, P176, DOI 10.1016/j.bcp.2006.04.027; Migita K, 2005, FEBS LETT, V579, P3119, DOI 10.1016/j.febslet.2005.04.071; Misra S, 2006, J BIOL CHEM, V281, P34936, DOI 10.1074/jbc.C600138200; Miyoshi A, 2004, BRIT J CANCER, V90, P1265, DOI 10.1038/sj.bjc.6601685; Moldovan L, 2006, CARDIOVASC RES, V71, P236, DOI 10.1016/j.cardiores.2006.05.003; Mountain DJH, 2007, AM J PHYSIOL-CELL PH, V292, pC867, DOI 10.1152/ajpcell.00161.2006; Mummert ME, 2003, MOL CANCER THER, V2, P295; Munoz-Najar UM, 2006, ONCOGENE, V25, P2379, DOI 10.1038/sj.onc.1209273; Murai T, 2006, BIOCHEM J, V395, P65, DOI 10.1042/BJ20050582; Nedvetzki S, 2004, P NATL ACAD SCI USA, V101, P18081, DOI 10.1073/pnas.0407378102; Pan J, 2005, J CELL PHYSIOL, V202, P536, DOI 10.1002/jcp.20151; Park MJ, 2002, CANCER RES, V62, P6318; Radisky DC, 2005, NATURE, V436, P123, DOI 10.1038/nature03688; Sangrar W, 2007, MOL CELL BIOL, V27, P6140, DOI 10.1128/MCB.01744-06; SCHLAEPFER DD, 1994, NATURE, V372, P786; Schroder K, 2007, ARTERIOSCL THROM VAS, V27, P1736, DOI 10.1161/ATVBAHA.107.142117; Singh R, 2007, MOL THER, V15, P369, DOI 10.1038/sj.mt.6300050; Sohara Y, 2001, MOL BIOL CELL, V12, P1859, DOI 10.1091/mbc.12.6.1859; Spallarossa P, 2006, CARDIOVASC RES, V69, P736, DOI 10.1016/j.cardiores.2005.08.009; SPHENOY NG, 2003, J IMMUNOL, V171, P3734; Takahashi T, 2004, J ORAL PATHOL MED, V33, P224, DOI 10.1111/j.0904-2512.2004.00024.x; Tamura M, 1998, SCIENCE, V280, P1614, DOI 10.1126/science.280.5369.1614; Thiery JP, 2002, NAT REV CANCER, V2, P442, DOI 10.1038/nrc822; Thomson S, 2005, CANCER RES, V65, P9455, DOI 10.1158/0008-5472.CAN-05-1058; Udabage L, 2005, CANCER RES, V65, P6139, DOI 10.1158/0008-5472.CAN-04-1622; Ugolev Y, 2006, J BIOL CHEM, V281, P19204, DOI 10.1074/jbc.M600042200; Wang HH, 2007, CANCER RES, V67, P2922, DOI 10.1158/0008-5472.CAN-06-3598; Wang L, 2006, J NEUROSCI, V26, P5996, DOI 10.1523/JNEUROSCI.5380-05.2006; Wei YZ, 2006, J BIOL CHEM, V281, P35137, DOI 10.1074/jbc.M601320200; Yamaoka-Tojo M, 2004, CIRC RES, V95, P276, DOI 10.1161/01.RES.0000136522.58649.60; Zhang QG, 2006, J NEUROCHEM, V98, P1886, DOI 10.1111/j.1471-4159.2006.04020.x; Zhang X, 1999, P NATL ACAD SCI USA, V96, P9021, DOI 10.1073/pnas.96.16.9021	71	105	106	1	15	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	AUG 15	2008	283	33					22513	22528		10.1074/jbc.M708319200	http://dx.doi.org/10.1074/jbc.M708319200			16	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	335VR	18577517	hybrid			2022-12-27	WOS:000258321000020
J	Watanabe, M; Tanaka, Y; Suenaga, A; Kuroda, M; Yao, M; Watanabe, N; Arisaka, F; Ohta, T; Tanaka, I; Tsumoto, K				Watanabe, Masato; Tanaka, Yoshikazu; Suenaga, Ayuko; Kuroda, Makoto; Yao, Min; Watanabe, Nobuhisa; Arisaka, Fumio; Ohta, Toshiko; Tanaka, Isao; Tsumoto, Kouhei			Structural basis for multimeric heme complexation through a specific protein-heme interaction - The case of the third neat domain of IsdH from Staphylococcus aureus	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							SIZE-DISTRIBUTION ANALYSIS; HEMOGLOBIN RECEPTOR; CRYSTAL-STRUCTURE; IRON; ULTRACENTRIFUGATION; REFINEMENT; METABOLISM; SOFTWARE; SEQUENCE; VACCINE	To elucidate the heme acquisition system in pathogenic bacteria, we investigated the heme-binding properties of the third NEAT domain of IsdH (IsdH-NEAT3), a receptor for heme located on the surfaces of pathogenic bacterial cells, by using x-ray crystallography, isothermal titration calorimetry, examination of absorbance spectra, mutation analysis, size-exclusion chromatography, and analytical ultracentrifugation. We found the following: 1) IsdH-NEAT3 can bind with multiple heme molecules by two modes; 2) heme was bound at the surface of IsdH-NEAT3; 3) candidate residues proposed from the crystal structure were not essential for binding with heme; and 4) IsdH-NEAT3 was associated into a multimeric heme complex by the addition of excess heme. From these observations, we propose a heme-binding mechanism for IsdH-NEAT3 that involves multimerization and discuss the biological importance of this mechanism.	[Watanabe, Masato; Tanaka, Yoshikazu; Suenaga, Ayuko; Tsumoto, Kouhei] Univ Tokyo, Grad Sch Frontier Sci, Dept Med Genome Sci, Tokyo 2778562, Japan; [Tanaka, Yoshikazu] Hokkaido Univ, Creat Res Initiat Sousei, Sapporo, Hokkaido 0010021, Japan; [Tanaka, Yoshikazu; Yao, Min; Watanabe, Nobuhisa; Tanaka, Isao] Hokkaido Univ, Fac Adv Life Sci, Sapporo, Hokkaido 0600810, Japan; [Kuroda, Makoto; Ohta, Toshiko] Univ Tsukuba, Inst Basic Med Sci, Grad Sch Comprehens Human Sci, Dept Microbiol, Tsukuba, Ibaraki 3058575, Japan; [Arisaka, Fumio] Tokyo Inst Technol, Grad Sch Biosci & Biotechnol, Yokohama, Kanagawa 2268501, Japan	University of Tokyo; Hokkaido University; Hokkaido University; University of Tsukuba; Tokyo Institute of Technology	Tanaka, Y (corresponding author), Univ Tokyo, Grad Sch Frontier Sci, Dept Med Genome Sci, Tokyo 2778562, Japan.	tanaka@cris.hokudai.ac.jp; tsumoto@k.u-tokyo.ac.jp	Tanaka, Yoshikazu/B-7056-2009; Watanabe, Masato/J-5256-2013; Watanabe, Nobuhisa/B-1187-2008; yao, min/F-5287-2011	Watanabe, Nobuhisa/0000-0002-0118-5815; yao, min/0000-0003-1687-5904	National Project on Protein Structural and Functional Analyses; Ministry of Education, Culture, Sports, Science, and Technology of Japan	National Project on Protein Structural and Functional Analyses(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); Ministry of Education, Culture, Sports, Science, and Technology of Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT))	This work was supported in part by the National Project on Protein Structural and Functional Analyses, Ministry of Education, Culture, Sports, Science, and Technology of Japan, and by grants-in-aid for younger scientists ( to Y. T.) and general research ( to K. T.) from the Ministry of Education, Science, Sports, and Culture of Japan. The costs of publication of this article were defrayed in part by the payment of page charges. This article must therefore be hereby marked "advertisement" in accordance with 18 U. S. C. Section 1734 solely to indicate this fact.	Andrade MA, 2002, GENOME BIOL, V3; Aranda R, 2007, J MOL BIOL, V374, P374, DOI 10.1016/j.jmb.2007.08.058; Brunger AT, 1998, ACTA CRYSTALLOGR D, V54, P905, DOI 10.1107/S0907444998003254; de Villiers KA, 2007, J BIOL INORG CHEM, V12, P101, DOI 10.1007/s00775-006-0170-1; Dinges MM, 2000, CLIN MICROBIOL REV, V13, P16, DOI 10.1128/CMR.13.1.16-34.2000; Dryla A, 2007, J BACTERIOL, V189, P254, DOI 10.1128/JB.01366-06; GILLAM EMJ, 1995, ARCH BIOCHEM BIOPHYS, V319, P540, DOI 10.1006/abbi.1995.1329; Grigg JC, 2007, MOL MICROBIOL, V63, P139, DOI 10.1111/j.1365-2958.2006.05502.x; Hiramatsu K, 1997, LANCET, V350, P1670, DOI 10.1016/S0140-6736(97)07324-8; Kuklin NA, 2006, INFECT IMMUN, V74, P2215, DOI 10.1128/IAI.74.4.2215-2223.2006; Kuroda M, 2005, P NATL ACAD SCI USA, V102, P13272, DOI 10.1073/pnas.0502950102; LASKOWSKI RA, 1993, J APPL CRYSTALLOGR, V26, P283, DOI 10.1107/S0021889892009944; Laue T.M., 1992, ANAL ULTRACENTRIFUGA, P90; Maresso AW, 2006, BIOMETALS, V19, P193, DOI 10.1007/s10534-005-4863-7; Mazmanian SK, 2003, SCIENCE, V299, P906, DOI 10.1126/science.1081147; Montano GA, 2003, BIOPHYS J, V85, P2560, DOI 10.1016/S0006-3495(03)74678-5; Murshudov GN, 1997, ACTA CRYSTALLOGR D, V53, P240, DOI 10.1107/S0907444996012255; Otwinowski Z, 1997, METHOD ENZYMOL, V276, P307, DOI 10.1016/S0076-6879(97)76066-X; Pagola S, 2000, NATURE, V404, P307, DOI 10.1038/35005132; Pilpa RM, 2006, J MOL BIOL, V360, P435, DOI 10.1016/j.jmb.2006.05.019; Ratledge C, 2000, ANNU REV MICROBIOL, V54, P881, DOI 10.1146/annurev.micro.54.1.881; Reniere ML, 2007, BIOMETALS, V20, P333, DOI 10.1007/s10534-006-9032-0; Riggs A., 1981, Methods in Enzymology, V76, P5; SCHNEEWIND O, 1992, CELL, V70, P267, DOI 10.1016/0092-8674(92)90101-H; Schuck P, 2002, BIOPHYS J, V82, P1096, DOI 10.1016/S0006-3495(02)75469-6; Schuck P, 2000, BIOPHYS J, V78, P1606, DOI 10.1016/S0006-3495(00)76713-0; Sharp KH, 2007, J BIOL CHEM, V282, P10625, DOI 10.1074/jbc.M700234200; Skaar EP, 2004, J BIOL CHEM, V279, P436, DOI 10.1074/jbc.M307952200; Stojiljkovic I, 2002, DNA CELL BIOL, V21, P281, DOI 10.1089/104454902753759708; Stranger-Jones YK, 2006, P NATL ACAD SCI USA, V103, P16942, DOI 10.1073/pnas.0606863103; Tanaka Y, 2007, J BIOL CHEM, V282, P5770, DOI 10.1074/jbc.M607340200; Terwilliger TC, 1999, ACTA CRYSTALLOGR D, V55, P1872, DOI 10.1107/S090744499901029X; Terwilliger TC, 2003, ACTA CRYSTALLOGR D, V59, P45, DOI 10.1107/S0907444902018048; Terwilliger TC, 1999, ACTA CRYSTALLOGR D, V55, P849, DOI 10.1107/S0907444999000839; Terwilliger TC, 2003, ACTA CRYSTALLOGR D, V59, P38, DOI 10.1107/S0907444902018036; Terwilliger TC, 2000, ACTA CRYSTALLOGR D, V56, P965, DOI 10.1107/S0907444900005072; Torres VJ, 2006, J BACTERIOL, V188, P8421, DOI 10.1128/JB.01335-06; Vagin A, 1997, J APPL CRYSTALLOGR, V30, P1022, DOI 10.1107/S0021889897006766; Yao M, 2006, ACTA CRYSTALLOGR D, V62, P189, DOI 10.1107/S0907444905038965	39	75	75	1	8	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	OCT 17	2008	283	42					28649	28659		10.1074/jbc.M803383200	http://dx.doi.org/10.1074/jbc.M803383200			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	359EN	18667422	hybrid, Green Published			2022-12-27	WOS:000259969300067
J	Schack, VR; Morth, JP; Toustrup-Jensen, MS; Anthonisen, AN; Nissen, P; Andersen, JP; Vilsen, B				Schack, Vivien Rodacker; Morth, Jens Preben; Toustrup-Jensen, Mads S.; Anthonisen, Anne Nyholm; Nissen, Poul; Andersen, Jens Peter; Vilsen, Bente			Identification and function of a cytoplasmic K+ site of the Na+,K+-ATPase	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							TRANSMEMBRANE SEGMENT M1; CATION-BINDING; SARCOPLASMIC-RETICULUM; CONFORMATIONAL-CHANGES; ATP HYDROLYSIS; ALPHA-SUBUNIT; SODIUM-PUMP; POTASSIUM; NA+; TRANSPORT	A cytoplasmic nontransport K+/Rb+ site in the P-domain of the Na+, K+ -ATPase has been identified by anomalous difference Fourier map analysis of crystals of the [Rb-2] center dot E-2 center dot MgF42-form of the enzyme. The functional roles of this third K+/Rb+ binding site were studied by site-directed mutagenesis, replacing the side chain of Asp(742) donating oxygen ligand(s) to the site with alanine, glutamate, and lysine. Unlike the wild-type Na+, K+ -ATPase, the mutants display a biphasic K+ concentration dependence of E2P dephosphorylation, indicating that the cytoplasmic K+ site is involved in activation of dephosphorylation. The affinity of the site is lowered significantly (30-200-fold) by the mutations, the lysine mutation being most disruptive. Moreover, the mutations accelerate the E-2 to E-1 conformational transition, again with the lysine substitution resulting in the largest effect. Hence, occupation of the cytoplasmic K+/Rb+ site not only enhances E2P dephosphorylation but also stabilizes the E-2 dephosphoenzyme. These characteristics of the previously unrecognized nontransport site make it possible to account for the hitherto poorly understood trans-effects of cytoplasmic K+ by the consecutive transport model, without implicating a simultaneous exposure of the transport sites toward the cytoplasmic and extracellular sides of the membrane. The cytoplasmic K+/Rb+ site appears to be conserved among Na+, K+ -ATPases and P-type ATPases in general, and its mode of operation may be associated with stabilizing the loop structure at the C-terminal end of the P6 helix of the P-domain, thereby affecting the function of highly conserved catalytic residues and promoting helix-helix interactions between the P- and A-domains in the E-2 state.	[Schack, Vivien Rodacker; Toustrup-Jensen, Mads S.; Anthonisen, Anne Nyholm; Andersen, Jens Peter; Vilsen, Bente] Univ Aarhus, Inst Physiol & Biophys, DK-8000 Aarhus C, Denmark; [Morth, Jens Preben; Nissen, Poul] Univ Aarhus, Dept Mol Biol, DK-8000 Aarhus C, Denmark; [Schack, Vivien Rodacker; Morth, Jens Preben; Toustrup-Jensen, Mads S.; Anthonisen, Anne Nyholm; Nissen, Poul; Andersen, Jens Peter; Vilsen, Bente] Univ Aarhus, Ctr Membrane Pumps Cells & Dis PUMPKIN, Danish Natl Res Fdn, DK-8000 Aarhus C, Denmark	Aarhus University; Aarhus University; Aarhus University; Danmarks Grundforskningsfond	Vilsen, B (corresponding author), Univ Aarhus, Inst Physiol & Biophys, Ole Worms Alle 1185, DK-8000 Aarhus C, Denmark.	bv@fi.au.dk	Morth, Jens Preben/AAP-7834-2021; Morth, Jens Preben/G-4450-2013; Nissen, Poul/D-5774-2014	Morth, Jens Preben/0000-0003-4077-0192; Morth, Jens Preben/0000-0003-4077-0192; Nissen, Poul/0000-0003-0948-6628; Schack, Vivien/0000-0002-1365-3938; Andersen, Jens Peter/0000-0003-0654-4300; Toustrup-Jensen, Mads Schak/0000-0003-2064-5861; Vilsen, Bente/0000-0002-4727-9382	Lundbeck Foundation, Denmark; Danish Medical Research Council; Novo Nordisk Foundation, Denmark; Danish National Research Foundation (PUMPKIN Centre)	Lundbeck Foundation, Denmark(Lundbeckfonden); Danish Medical Research Council(Danish Medical Research CouncilUK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Novo Nordisk Foundation, Denmark(Novo Nordisk Foundation); Danish National Research Foundation (PUMPKIN Centre)(Danmarks Grundforskningsfond)	This study was funded in part by grants from the Lundbeck Foundation, Denmark, the Danish Medical Research Council, the Novo Nordisk Foundation, Denmark, and the Danish National Research Foundation (PUMPKIN Centre). The costs of publication of this article were defrayed in part by the payment of page charges. This article must therefore be hereby marked "advertisement" in accordance with 18 U.S.C. Section 1734 solely to indicate this fact.	ARGUELLO JM, 1994, J BIOL CHEM, V269, P6892; BEAUGE LA, 1980, J PHYSIOL-LONDON, V299, P367, DOI 10.1113/jphysiol.1980.sp013130; Blostein R, 1997, J BIOL CHEM, V272, P24987, DOI 10.1074/jbc.272.40.24987; BLOSTEIN R, 1977, J BIOL CHEM, V252, P3035; Brunger AT, 1998, ACTA CRYSTALLOGR D, V54, P905, DOI 10.1107/S0907444998003254; Buch-Pedersen MJ, 2006, J BIOL CHEM, V281, P38285, DOI 10.1074/jbc.M604781200; CANTLEY LC, 1978, J BIOL CHEM, V253, P7361; CORNELIUS F, 1991, BIOCHIM BIOPHYS ACTA, V1071, P19, DOI 10.1016/0304-4157(91)90011-K; CORNELIUS F, 1991, BIOCHIM BIOPHYS ACTA, V1067, P227, DOI 10.1016/0005-2736(91)90048-D; Einholm AP, 2007, J BIOL CHEM, V282, P23854, DOI 10.1074/jbc.M702259200; Einholm AP, 2005, P NATL ACAD SCI USA, V102, P11254, DOI 10.1073/pnas.0501201102; GARAY RP, 1973, J PHYSIOL-LONDON, V231, P297, DOI 10.1113/jphysiol.1973.sp010234; GLYNN IM, 1993, J PHYSIOL-LONDON, V462, P1; Gropp T, 1998, BBA-BIOMEMBRANES, V1368, P184, DOI 10.1016/S0005-2736(97)00162-4; HOFFMAN PG, 1971, J GEN PHYSIOL, V58, P438, DOI 10.1085/jgp.58.4.438; JEWELL EA, 1991, J BIOL CHEM, V266, P16925; Jorgensen PL, 2003, ANNU REV PHYSIOL, V65, P817, DOI 10.1146/annurev.physiol.65.092101.142558; KABSCH W, 1993, J APPL CRYSTALLOGR, V26, P795, DOI 10.1107/S0021889893005588; Kaplan JH, 2002, ANNU REV BIOCHEM, V71, P511, DOI 10.1146/annurev.biochem.71.102201.141218; KARLISH SJD, 1980, J BIOENERG BIOMEMBR, V12, P111, DOI 10.1007/BF00744678; LINGREL JB, 1994, J BIOL CHEM, V269, P19659; Morth JP, 2007, NATURE, V450, P1043, DOI 10.1038/nature06419; Ogawa H, 2002, P NATL ACAD SCI USA, V99, P15977, DOI 10.1073/pnas.202622299; Olesen C, 2004, SCIENCE, V306, P2251, DOI 10.1126/science.1106289; Olesen C, 2007, NATURE, V450, P1036, DOI 10.1038/nature06418; POST RL, 1972, J BIOL CHEM, V247, P6530; Rodacker V, 2006, J BIOL CHEM, V281, P18539, DOI 10.1074/jbc.M601780200; SACHS JR, 1981, J PHYSIOL-LONDON, V319, P515, DOI 10.1113/jphysiol.1981.sp013923; SACHS JR, 1991, SOC GEN PHY, V46, P249; SHIGEKAWA M, 1978, J BIOL CHEM, V253, P1451; SKOU JC, 1985, SODIUM PUMP, P575; Sorensen TLM, 2004, SCIENCE, V304, P1672, DOI 10.1126/science.1099366; Sorensen TLM, 2004, J BIOL CHEM, V279, P46355, DOI 10.1074/jbc.C400414200; Toustrup-Jensen M, 2005, J BIOL CHEM, V280, P10210, DOI 10.1074/jbc.M411214200; Toustrup-Jensen M, 2001, BIOCHEMISTRY-US, V40, P5521, DOI 10.1021/bi002367m; Toyoshima C, 2004, NATURE, V432, P361, DOI 10.1038/nature02981; Toyoshima C, 2000, NATURE, V405, P647, DOI 10.1038/35015017; Toyoshima C, 2002, NATURE, V418, P605, DOI 10.1038/nature00944; VARA F, 1982, J BIOL CHEM, V257, P2826; Vilsen B, 1998, BIOCHEMISTRY-US, V37, P10961, DOI 10.1021/bi9802925; VILSEN B, 1995, BIOCHEMISTRY-US, V34, P1455, DOI 10.1021/bi00004a041; VILSEN B, 1992, FEBS LETT, V314, P301, DOI 10.1016/0014-5793(92)81494-7; WALL SM, 1994, AM J PHYSIOL-RENAL, V267, pF660, DOI 10.1152/ajprenal.1994.267.4.F660; YODA A, 1988, J BIOL CHEM, V263, P10320	44	29	30	0	5	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	OCT 10	2008	283	41					27982	27990		10.1074/jbc.M803506200	http://dx.doi.org/10.1074/jbc.M803506200			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	355OW	18669634	hybrid, Green Published			2022-12-27	WOS:000259719200068
J	Baljuls, A; Schmitz, W; Mueller, T; Zahedi, RP; Sickmann, A; Hekman, M; Rapp, UR				Baljuls, Angela; Schmitz, Werner; Mueller, Thomas; Zahedi, Rene P.; Sickmann, Albert; Hekman, Mirko; Rapp, Ulf R.			Positive regulation of A-RAF by phosphorylation of isoform-specific hinge segment and identification of novel phosphorylation sites	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							B-RAF; C-RAF; KINASE-ACTIVITY; NEGATIVE REGULATION; PROTEIN-KINASE; FEEDBACK PHOSPHORYLATION; DIFFERENTIAL REGULATION; BINDING-SPECIFICITY; POLYACRYLAMIDE-GELS; BIOLOGICAL-ACTIVITY	In mammals the RAF family of serine/threonine kinases consists of three members, A-, B-, and C- RAF. Activation of RAF kinases involves a complex series of phosphorylations. Although the most prominent phosphorylation sites of B-and C-RAF are well characterized, little is known about regulatory phosphorylation of A-RAF. Using mass spectrometry, we identified here a number of novel in vivo phosphorylation sites in A-RAF. In particular, we found that Ser-432 participates in MEK binding and is indispensable for A-RAF signaling. On the other hand, phosphorylation within the activation segment does not contribute to epidermal growth factor-mediated activation. Furthermore, we show that the potential 14-3-3 binding domains in A-RAF are phosphorylated independently of its activation status. Of importance, we identified a novel regulatory domain in A-RAF (referred to as IH-segment) positioned between amino acids 248 and 267 that contains seven putative phosphorylation sites. Three of these sites, serines 257, 262, and 264, regulate A-RAF activation in a stimulatory manner. The spatial model of the A-RAF fragment, including residues between Ser-246 and Glu-277, revealed a switch of charge at the molecular surface of the IH-region upon phosphorylation, suggesting a mechanism in which the high accumulation of negative charges may lead to an electrostatic destabilization of protein-membrane interaction resulting in depletion of A-RAF from the plasma membrane. Together, we provide here for the first time a detailed analysis of in vivo A-RAF phosphorylation status and demonstrate that regulation of A-RAF by phosphorylation exhibits unique features compared with B-and C-RAF.	[Baljuls, Angela; Hekman, Mirko; Rapp, Ulf R.] Univ Wurzburg, Inst Med Radiat & Cell Res, D-97078 Wurzburg, Germany; [Schmitz, Werner] Univ Wurzburg, Inst Physiol Chem, D-97078 Wurzburg, Germany; [Mueller, Thomas] Univ Wurzburg, Julius von Sachs Inst Biosci, D-97078 Wurzburg, Germany; [Zahedi, Rene P.; Sickmann, Albert] Univ Wurzburg, Rudolf Virchow Ctr, Deutsch Forsch Gemeinschaft Res Ctr Expt Biomed, D-97078 Wurzburg, Germany	University of Wurzburg; University of Wurzburg; University of Wurzburg; University of Wurzburg	Rapp, UR (corresponding author), Univ Wurzburg, Inst Med Radiat & Cell Res, Versbacher Str 5, D-97078 Wurzburg, Germany.	rappur@mail.uni-wuerzburg.de	Zahedi, René/A-9148-2012; Sickmann, Albert/A-1010-2011; Zahedi, Rene/HGU-5710-2022	Zahedi, René/0000-0002-4960-5460; Sickmann, Albert/0000-0002-2388-5265; Mueller, Thomas/0000-0003-1862-7357	Deutsche Forschungsgemeinschaft [SFB 487]	Deutsche Forschungsgemeinschaft(German Research Foundation (DFG))	This work was supported by Deutsche Forschungsgemeinschaft Grant SFB 487, projects C3 and B2. The costs of publication of this article were defrayed in part by the payment of page charges. This article must therefore be hereby marked "advertisement" in accordance with 18 U. S. C. Section 1734 solely to indicate this fact.	ALESSI DR, 1994, EMBO J, V13, P1610, DOI 10.1002/j.1460-2075.1994.tb06424.x; APP H, 1991, MOL CELL BIOL, V11, P913, DOI 10.1128/MCB.11.2.913; Baker NA, 2001, P NATL ACAD SCI USA, V98, P10037, DOI 10.1073/pnas.181342398; Balan V, 2006, MOL BIOL CELL, V17, P1141, DOI 10.1091/mbc.E04-12-1123; Baljuls A, 2007, J BIOL CHEM, V282, DOI 10.1074/jbc.M702429200; Barnard D, 1998, ONCOGENE, V17, P1539, DOI 10.1038/sj.onc.1202061; BONNER TI, 1985, MOL CELL BIOL, V5, P1400, DOI 10.1128/MCB.5.6.1400; Brummer T, 2006, ONCOGENE, V25, P6262, DOI 10.1038/sj.onc.1209640; Brummer T, 2003, ONCOGENE, V22, P8823, DOI 10.1038/sj.onc.1207185; Chong H, 2001, EMBO J, V20, P3716, DOI 10.1093/emboj/20.14.3716; Cuff JA, 1998, BIOINFORMATICS, V14, P892, DOI 10.1093/bioinformatics/14.10.892; DAUM G, 1994, TRENDS BIOCHEM SCI, V19, P474, DOI 10.1016/0968-0004(94)90133-3; Davies H, 2002, NATURE, V417, P949, DOI 10.1038/nature00766; Dhillon AS, 2002, ARCH BIOCHEM BIOPHYS, V404, P3, DOI 10.1016/S0003-9861(02)00244-8; Dhillon AS, 2002, MOL CELL BIOL, V22, P3237, DOI 10.1128/MCB.22.10.3237-3246.2002; Diaz B, 1997, MOL CELL BIOL, V17, P4509, DOI 10.1128/MCB.17.8.4509; Dougherty MK, 2004, J CELL SCI, V117, P1875, DOI 10.1242/jcs.01171; Dougherty MK, 2005, MOL CELL, V17, P215, DOI 10.1016/j.molcel.2004.11.055; Dumaz N, 2002, MOL CELL BIOL, V22, P3717, DOI 10.1128/MCB.22.11.3717-3728.2002; Emuss V, 2005, CANCER RES, V65, P9719, DOI 10.1158/0008-5472.CAN-05-1683; Fischer A, 2007, J BIOL CHEM, V282, DOI 10.1074/jbc.M607458200; Garnett MJ, 2005, MOL CELL, V20, P963, DOI 10.1016/j.molcel.2005.10.022; Garnett MJ, 2004, CANCER CELL, V6, P313, DOI 10.1016/j.ccr.2004.09.022; Ghosh S, 1996, J BIOL CHEM, V271, P8472, DOI 10.1074/jbc.271.14.8472; GHOSH SJ, 1994, J BIOL CHEM, V269, P10000; Guan KL, 2000, J BIOL CHEM, V275, P27354; Hagemann C, 1999, EXP CELL RES, V253, P34, DOI 10.1006/excr.1999.4689; HAN M, 1993, NATURE, V363, P133, DOI 10.1038/363133a0; Hekman M, 2002, J BIOL CHEM, V277, P24090, DOI 10.1074/jbc.M200576200; Hekman M, 2005, FEBS LETT, V579, P464, DOI 10.1016/j.febslet.2004.11.105; Hekman M, 2004, J BIOL CHEM, V279, P14074, DOI 10.1074/jbc.M309620200; Homeyer N, 2006, J MOL MODEL, V12, P281, DOI 10.1007/s00894-005-0028-4; Houben Roland, 2004, J Carcinog, V3, P6, DOI 10.1186/1477-3163-3-6; HULEIHEL M, 1986, MOL CELL BIOL, V6, P2655, DOI 10.1128/MCB.6.7.2655; IKAWA S, 1988, MOL CELL BIOL, V8, P2651, DOI 10.1128/MCB.8.6.2651; Improta-Brears T, 1999, MOL CELL BIOCHEM, V198, P171, DOI 10.1023/A:1006981411691; Johnson LM, 2005, BIOCHEMISTRY-US, V44, P3432, DOI 10.1021/bi0487692; KIEBER JJ, 1993, CELL, V72, P427, DOI 10.1016/0092-8674(93)90119-B; Kubicek M, 2002, J BIOL CHEM, V277, P7913, DOI 10.1074/jbc.M108733200; Marais R, 1997, J BIOL CHEM, V272, P4378, DOI 10.1074/jbc.272.7.4378; MARK GE, 1987, MOL CELL BIOL, V7, P2134, DOI 10.1128/MCB.7.6.2134; Mason CS, 1999, EMBO J, V18, P2137, DOI 10.1093/emboj/18.8.2137; Mazurek S, 2007, ANTICANCER RES, V27, P3963; Mischak H, 1996, MOL CELL BIOL, V16, P5409; Moelling K, 2002, J BIOL CHEM, V277, P31099, DOI 10.1074/jbc.M111974200; MORRISON DK, 1993, J BIOL CHEM, V268, P17309; NEUHOFF V, 1988, ELECTROPHORESIS, V9, P255, DOI 10.1002/elps.1150090603; PAYNE DM, 1991, EMBO J, V10, P885, DOI 10.1002/j.1460-2075.1991.tb08021.x; Pelkmans L, 2005, NATURE, V436, P128, DOI 10.1038/nature03866; Rapp UR, 2006, CANCER CELL, V9, P9, DOI 10.1016/j.ccr.2005.12.022; RAPP UR, 1983, P NATL ACAD SCI-BIOL, V80, P4218, DOI 10.1073/pnas.80.14.4218; Reinders J, 2007, MOL CELL PROTEOMICS, V6, P1896, DOI 10.1074/mcp.M700098-MCP200; Reusch HP, 2001, J BIOL CHEM, V276, P33630, DOI 10.1074/jbc.M105322200; Rizzo MA, 2000, J BIOL CHEM, V275, P23911, DOI 10.1074/jbc.M001553200; Rizzo MA, 2001, J BIOL CHEM, V276, P34928, DOI 10.1074/jbc.M105918200; Rost B, 2003, NUCLEIC ACIDS RES, V31, P3300, DOI 10.1093/nar/gkg508; Rushworth LK, 2006, MOL CELL BIOL, V26, P2262, DOI 10.1128/MCB.26.6.2262-2272.2006; STEPHENS RM, 1992, MOL CELL BIOL, V12, P3733, DOI 10.1128/MCB.12.9.3733; SUEN KL, 1995, ONCOGENE, V11, P825; Tzivion G, 1998, NATURE, V394, P88, DOI 10.1038/27938; Tzivion G, 2002, J BIOL CHEM, V277, P3061, DOI 10.1074/jbc.R100059200; Wan PTC, 2004, CELL, V116, P855, DOI 10.1016/S0092-8674(04)00215-6; Wartmann M, 1997, J BIOL CHEM, V272, P3915, DOI 10.1074/jbc.272.7.3915; Weber CK, 2001, CANCER RES, V61, P3595; Wellbrock C, 2004, NAT REV MOL CELL BIO, V5, P875, DOI 10.1038/nrm1498; Wilm M, 1996, NATURE, V379, P466, DOI 10.1038/379466a0; Wixler V, 1996, FEBS LETT, V385, P131, DOI 10.1016/0014-5793(96)00363-8; Xia F, 2008, PLOS BIOL, V6, P1115, DOI 10.1371/journal.pbio.0060128; Xing HR, 2001, J BIOL CHEM, V276, P9733, DOI 10.1074/jbc.M008096200; Yaffe MB, 1997, CELL, V91, P961, DOI 10.1016/S0092-8674(00)80487-0; Yip-Schneider MT, 2000, BIOCHEM J, V351, P151, DOI 10.1042/0264-6021:3510151; Yuryev A, 2003, GENOMICS, V81, P112, DOI 10.1016/S0888-7543(02)00008-3; Zahedi RP, 2008, J PROTEOME RES, V7, P526, DOI 10.1021/pr0704130; Zhang BH, 2000, EMBO J, V19, P5429, DOI 10.1093/emboj/19.20.5429; Zhu J, 2005, MOL BIOL CELL, V16, P4733, DOI 10.1091/mbc.E05-02-0090	75	23	24	0	2	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	OCT 3	2008	283	40					27239	27254		10.1074/jbc.M801782200	http://dx.doi.org/10.1074/jbc.M801782200			16	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	353RT	18662992	hybrid			2022-12-27	WOS:000259586600044
J	Collard, F; Zhang, J; Nemet, I; Qanungo, KR; Monnier, VM; Yee, VC				Collard, Francois; Zhang, Jianye; Nemet, Ina; Qanungo, Kaustubha R.; Monnier, Vincent M.; Yee, Vivien C.			Crystal structure of the deglycating enzyme fructosamine oxidase (Amadoriase II)	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							AMINO-ACID OXIDASE; MONOMERIC SARCOSINE OXIDASE; PROTEIN CROSS-LINK; EC 1.5.3; EXTRACELLULAR-MATRIX; FUNCTIONAL-ANALYSIS; ASPERGILLUS-ORYZAE; MOLECULAR-CLONING; MAILLARD REACTION; EXPRESSION	Fructosamine oxidases (FAOX) catalyze the oxidative deglycation of low molecular weight fructosamines (Amadori products). These proteins are of interest in developing an enzyme to deglycate proteins implicated in diabetic complications. We report here the crystal structures of FAOX-II from the fungi Aspergillus fumigatus, in free form and in complex with the inhibitor fructosyl-thioacetate, at 1.75 and 1.6 angstrom resolution, respectively. FAOX-II is a two domain FAD-enzyme with an overall topology that is most similar to that of monomeric sarcosine oxidase. Active site residues Tyr-60, Arg-112 and Lys-368 bind the carboxylic portion of the fructosamine, whereas Glu-280 and Arg-411 bind the fructosyl portion. From structure-guided sequence comparison, Glu-280 was identified as a signature residue for FAOX activity. Two flexible surface loops become ordered upon binding of the inhibitor in a catalytic site that is about 12 A deep, providing an explanation for the very low activity of FAOX enzymes toward protein-bound fructosamines, which would have difficulty accessing the active site. Structure-based mutagenesis showed that substitution of Glu-280 and Arg-411 eliminates enzyme activity. In contrast, modification of other active site residues or of amino acids in the flexible active site loops has little effect, highlighting these regions as potential targets in designing an enzyme that will accept larger substrates.	[Collard, Francois; Zhang, Jianye; Nemet, Ina; Monnier, Vincent M.] Case Western Reserve Univ, Dept Pathol, Cleveland, OH 44106 USA; [Qanungo, Kaustubha R.; Monnier, Vincent M.; Yee, Vivien C.] Case Western Reserve Univ, Dept Biochem, Cleveland, OH 44106 USA; [Zhang, Jianye] Case Western Reserve Univ, Dept Chem, Cleveland, OH 44106 USA	Case Western Reserve University; Case Western Reserve University; Case Western Reserve University	Monnier, VM (corresponding author), Case Western Reserve Univ, Dept Pathol, 2103 Cornell Rd, Cleveland, OH 44106 USA.	vmm3@cwru.edu	Nemet, Ina/ABG-2855-2021; Monnier, Vincent M/B-1371-2009	Nemet, Ina/0000-0002-0657-7121	National Institutes of Health [AG 18436, EY07099, DK075897]; NATIONAL EYE INSTITUTE [R01EY007099] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF BIOMEDICAL IMAGING AND BIOENGINEERING [P30EB009998] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK075897] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON AGING [R01AG018436] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL EYE INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI)); NATIONAL INSTITUTE OF BIOMEDICAL IMAGING AND BIOENGINEERING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Biomedical Imaging & Bioengineering (NIBIB)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))	This work was supported, in whole or in part, by National Institutes of Health Grants AG 18436 and EY07099 (to V. M. M.) and DK075897 (to V.C.Y.). The costs of publication of this article were defrayed in part by the payment of page charges. This article must therefore be hereby marked "advertisement" in accordance with 18 U. S. C. Section 1734 solely to indicate this fact.	Akazawa S, 2004, APPL ENVIRON MICROB, V70, P5882, DOI 10.1128/AEM.70.10.5882-5890.2004; Beksan E, 2003, J AGR FOOD CHEM, V51, P5428, DOI 10.1021/jf0344441; Davidek T, 2005, ANAL CHEM, V77, P140, DOI 10.1021/ac048925a; Davis IW, 2007, NUCLEIC ACIDS RES, V35, pW375, DOI 10.1093/nar/gkm216; DeLano W.L, PYMOL MOL GRAPHICS S; Delpierre G, 2000, DIABETES, V49, P1627, DOI 10.2337/diabetes.49.10.1627; Emsley P, 2004, ACTA CRYSTALLOGR D, V60, P2126, DOI 10.1107/S0907444904019158; Ferri S, 2004, MAR BIOTECHNOL, V6, P625, DOI 10.1007/s10126-004-0001-8; Fujiwara M, 2006, J BIOSCI BIOENG, V102, P241, DOI 10.1263/jbb.102.241; GRANDHEE SK, 1991, J BIOL CHEM, V266, P11649; Hirokawa K, 2003, BIOCHEM BIOPH RES CO, V311, P104, DOI 10.1016/j.bbrc.2003.09.169; HORIUCHI T, 1989, AGR BIOL CHEM TOKYO, V53, P103, DOI 10.1080/00021369.1989.10869245; KOYAMA Y, 1991, AGR BIOL CHEM TOKYO, V55, P1259, DOI 10.1080/00021369.1991.10870758; Krissinel E, 2004, ACTA CRYSTALLOGR D, V60, P2256, DOI 10.1107/S0907444904026460; LASKOWSKI RA, 1993, J APPL CRYSTALLOGR, V26, P283, DOI 10.1107/S0021889892009944; Miura S, 2008, PROTEIN ENG DES SEL, V21, P233, DOI 10.1093/protein/gzm047; Monnier VM, 2005, ANN NY ACAD SCI, V1043, P533, DOI 10.1196/annals.1333.061; Murshudov GN, 1997, ACTA CRYSTALLOGR D, V53, P240, DOI 10.1107/S0907444996012255; Otwinowski Z, 1997, METHOD ENZYMOL, V276, P307, DOI 10.1016/S0076-6879(97)76066-X; ROPER H, 1983, CARBOHYD RES, V116, P183, DOI 10.1016/0008-6215(83)88108-7; Saxena AK, 1996, J BIOL CHEM, V271, P32803, DOI 10.1074/jbc.271.51.32803; Sell DR, 2005, J BIOL CHEM, V280, P12310, DOI 10.1074/jbc.M500733200; Tagami U, 2000, J MASS SPECTROM, V35, P131, DOI 10.1002/(SICI)1096-9888(200002)35:2<131::AID-JMS920>3.0.CO;2-0; Takahashi M, 1997, J BIOL CHEM, V272, P12505, DOI 10.1074/jbc.272.19.12505; Takahashi M, 1997, J BIOL CHEM, V272, P3437, DOI 10.1074/jbc.272.6.3437; Terwilliger TC, 1999, ACTA CRYSTALLOGR D, V55, P849, DOI 10.1107/S0907444999000839; Terwilliger TC, 2003, ACTA CRYSTALLOGR D, V59, P38, DOI 10.1107/S0907444902018036; Terwilliger TC, 2000, ACTA CRYSTALLOGR D, V56, P965, DOI 10.1107/S0907444900005072; Thornalley PJ, 1999, BIOCHEM J, V344, P109, DOI 10.1042/0264-6021:3440109; Trickey P, 1999, STRUCTURE, V7, P331, DOI 10.1016/S0969-2126(99)80043-4; Wagner MA, 2000, BIOCHEMISTRY-US, V39, P8813, DOI 10.1021/bi000349z; Wendt T, 2003, J AM SOC NEPHROL, V14, P1383, DOI 10.1097/01.ASN.0000065100.17349.CA; Wiame E, 2002, J BIOL CHEM, V277, P42523, DOI 10.1074/jbc.M200863200; Wu XL, 2002, BIOCHEMISTRY-US, V41, P4453, DOI 10.1021/bi025539j; Wu XL, 2000, BIOCHEMISTRY-US, V39, P1515, DOI 10.1021/bi992031g; Yoshida N, 2005, FEMS MICROBIOL LETT, V248, P141, DOI 10.1016/j.femsle.2005.05.035; Yoshida N, 2004, J BIOSCI BIOENG, V97, P278, DOI 10.1263/jbb.97.278; Yoshida N, 1996, EUR J BIOCHEM, V242, P499, DOI 10.1111/j.1432-1033.1996.0499r.x; Yoshida N, 2007, J BIOSCI BIOENG, V104, P424, DOI 10.1263/jbb.104.424; Zhao GH, 2002, BIOCHEMISTRY-US, V41, P9751, DOI 10.1021/bi020286f	40	41	43	0	9	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	OCT 3	2008	283	40					27007	27016		10.1074/jbc.M804885200	http://dx.doi.org/10.1074/jbc.M804885200			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	353RT	18667417	Green Published, hybrid			2022-12-27	WOS:000259586600021
J	Bendz, H; Marincek, BC; Momburg, F; Ellwart, JW; Issels, RD; Nelson, PJ; Noessner, E				Bendz, Henriette; Marincek, Boris-Christian; Momburg, Frank; Ellwart, Joachim W.; Issels, Rolf D.; Nelson, Peter J.; Noessner, Elfriede			Calcium signaling in dendritic cells by human or mycobacterial Hsp70 is caused by contamination and is not required for Hsp70-mediated enhancement of cross-presentation	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							HEAT-SHOCK PROTEINS; INNATE IMMUNE-SYSTEM; CD8(+) T-CELLS; CHEMOKINE RECEPTORS; ANTIGEN DELIVERY; STRESS-PROTEINS; HEAT-SHOCK-PROTEIN-70; PATHWAY; BINDING; CCR5	Extracellular heat shock proteins (HSPs) can stimulate antigen-specific immune responses. Using recombinant human (rhu) Hsp70, we previously demonstrated that through complex formation with exogenous antigenic peptides, rhuHsp70 can enhance cross-presentation by antigen-presenting cells (APCs) resulting in stronger T cell stimulation. T cell stimulatory activity has also been described for mycobacterial (myc) Hsp70. MycHsp70-assisted T cell activation has been reported to act through the binding of mycHsp70 to chemokine receptor 5 (CCR5), calcium signaling, phenotypic maturation, and cytokine secretion by dendritic cells (DCs). We report that highly purified rhuHsp70 and mycHsp70 proteins both strongly enhance cross-presentation of exogenous antigens. Augmentation of cross-presentation was seen for different APCs, irrespective of CCR5 expression. Moreover, neither of the purified Hsp70 proteins induced calcium signals in APCs. Instead, calcium signaling activity was found to be caused by contaminating nucleotides present in Hsp70 protein preparations. These results refute the hypothesis that mycHsp70 proteins require CCR5 expression and calcium signaling by APCs for enhanced antigen cross-presentation for T cell stimulation.	[Bendz, Henriette; Ellwart, Joachim W.; Issels, Rolf D.; Noessner, Elfriede] Helmholtz Zentrum Munchen, German Res Ctr Environm Hlth, Inst Mol Immunol, D-81377 Munich, Germany; [Bendz, Henriette; Issels, Rolf D.] Univ Munich, Clin Cooperat Grp Hyperthermia, Dept Internal Med 3, Klinikum Grosshadern, D-81377 Munich, Germany; [Marincek, Boris-Christian; Momburg, Frank] German Canc Res Ctr, Div Mol Immunol, D-69120 Heidelberg, Germany; [Nelson, Peter J.] Univ Munich, Med Poliklin, D-80336 Munich, Germany	Helmholtz Association; Helmholtz-Center Munich - German Research Center for Environmental Health; University of Munich; Helmholtz Association; German Cancer Research Center (DKFZ); University of Munich	Noessner, E (corresponding author), Helmholtz Zentrum Munchen, German Res Ctr Environm Hlth, Inst Mol Immunol, Marchioninistr 25, D-81377 Munich, Germany.	noessner@helmholtz-muenchen.de		Issels, Rolf/0000-0002-3494-6561	Deutsche Forschungsgemeinschaft [SFB455, SFB-TR36]; EU	Deutsche Forschungsgemeinschaft(German Research Foundation (DFG)); EU(European Commission)	This work was supported in part by Grants SFB455 (to E. N. and R. D. I.) and SFB-TR36 (to P. J. N.) from the Deutsche Forschungsgemeinschaft and EU Grant INNOCHEM (to P. J. N.). The costs of publication of this article were defrayed in part by the payment of page charges. This article must therefore be hereby marked "advertisement" in accordance with 18 U. S. C. Section 1734 solely to indicate this fact.	Asea A, 2000, NAT MED, V6, P435, DOI 10.1038/74697; Asea A, 2007, J BIOSCIENCES, V32, P579, DOI 10.1007/s12038-007-0057-5; Basu S, 2000, INT IMMUNOL, V12, P1539, DOI 10.1093/intimm/12.11.1539; Basu S, 2001, IMMUNITY, V14, P303, DOI 10.1016/S1074-7613(01)00111-X; Bausinger H, 2002, EUR J IMMUNOL, V32, P3708, DOI 10.1002/1521-4141(200212)32:12<3708::AID-IMMU3708>3.0.CO;2-C; Bausinger H, 2002, TRENDS IMMUNOL, V23, P342, DOI 10.1016/S1471-4906(02)02249-4; Becker T, 2002, J CELL BIOL, V158, P1277, DOI 10.1083/jcb.200208083; Bendz H, 2007, J BIOL CHEM, V282, P31688, DOI 10.1074/jbc.M704129200; Binder RJ, 2004, TISSUE ANTIGENS, V64, P442, DOI 10.1111/j.1399-0039.2004.00299.x; BUCHBERGER A, 1994, NAT STRUCT BIOL, V1, P95, DOI 10.1038/nsb0294-95; Calderwood SK, 2005, EUR J IMMUNOL, V35, P2518, DOI 10.1002/eji.200535002; Calderwood SK, 2007, FEBS LETT, V581, P3689, DOI 10.1016/j.febslet.2007.04.044; Castellino F, 2006, NATURE, V440, P890, DOI 10.1038/nature04651; Floto RA, 2006, SCIENCE, V314, P454, DOI 10.1126/science.1133515; Habich C, 2005, J IMMUNOL, V174, P1298, DOI 10.4049/jimmunol.174.3.1298; Javid B, 2007, J IMMUNOL, V179, P2035, DOI 10.4049/jimmunol.179.4.2035; Kim CH, 2003, J IMMUNOL, V171, P152, DOI 10.4049/jimmunol.171.1.152; la Sala A, 2001, J IMMUNOL, V166, P1611, DOI 10.4049/jimmunol.166.3.1611; Lancaster GI, 2005, J BIOL CHEM, V280, P23349, DOI 10.1074/jbc.M502017200; Lang A, 2005, J AM SOC NEPHROL, V16, P383, DOI 10.1681/ASN.2004040276; MacAry PA, 2004, IMMUNITY, V20, P95, DOI 10.1016/S1074-7613(03)00357-1; Mack M, 2000, NAT MED, V6, P769, DOI 10.1038/77498; Marteau F, 2004, J LEUKOCYTE BIOL, V76, P796, DOI 10.1189/jlb.0104032; Mayer MP, 2005, CELL MOL LIFE SCI, V62, P670, DOI 10.1007/s00018-004-4464-6; Means TK, 2003, J IMMUNOL, V170, P5165, DOI 10.4049/jimmunol.170.10.5165; Noessner E, 2002, J IMMUNOL, V169, P5424, DOI 10.4049/jimmunol.169.10.5424; Pockley AG, 2008, TRENDS BIOCHEM SCI, V33, P71, DOI 10.1016/j.tibs.2007.10.005; Schnurr M, 2005, BLOOD, V105, P1582, DOI 10.1182/blood-2004-05-1718; Tesniere A, 2008, CELL DEATH DIFFER, V15, P3, DOI 10.1038/sj.cdd.4402269; Tobian AAR, 2005, J IMMUNOL, V174, P5209, DOI 10.4049/jimmunol.174.9.5209; Tobian AAR, 2004, J IMMUNOL, V172, P5277, DOI 10.4049/jimmunol.172.9.5277; Triantafilou M, 2002, TRENDS IMMUNOL, V23, P301, DOI 10.1016/S1471-4906(02)02233-0; Tsan MF, 2004, J LEUKOCYTE BIOL, V76, P514, DOI 10.1189/jlb.0304127; Udono H, 2004, METHODS, V32, P21, DOI 10.1016/S1046-2023(03)00182-8; Vega VL, 2008, J IMMUNOL, V180, P4299, DOI 10.4049/jimmunol.180.6.4299; Wallin RPA, 2002, TRENDS IMMUNOL, V23, P130, DOI 10.1016/S1471-4906(01)02168-8; Weber C, 2001, BLOOD, V97, P1144, DOI 10.1182/blood.V97.4.1144; Whittall T, 2006, EUR J IMMUNOL, V36, P2304, DOI 10.1002/eji.200635953; Ye ZY, 2007, J BIOL CHEM, V282, P4479, DOI 10.1074/jbc.M606802200	39	32	33	0	3	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	SEP 26	2008	283	39					26477	26483		10.1074/jbc.M803310200	http://dx.doi.org/10.1074/jbc.M803310200			7	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	350GV	18658155	Green Published, hybrid			2022-12-27	WOS:000259341600023
J	Newberry, KJ; Huffman, JL; Miller, MC; Vazquez-Laslop, N; Neyfakh, AA; Brennan, RG				Newberry, Kate J.; Huffman, Joy L.; Miller, Marshall C.; Vazquez-Laslop, Nora; Neyfakh, Alex A.; Brennan, Richard G.			Structures of BmrR-Drug complexes reveal a rigid multidrug binding pocket and transcription activation through tyrosine expulsion	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							CRYSTAL-STRUCTURE; MOLECULAR-MECHANISMS; LIGAND-BINDING; EFFLUX PUMPS; MERR FAMILY; DNA; PROTEIN; REGULATOR; TRANSPORTER; RECOGNITION	BmrR is a member of the MerR family and a multidrug binding transcription factor that up-regulates the expression of the bmr multidrug efflux transporter gene in response to myriad lipophilic cationic compounds. The structural mechanism by which BmrR binds these chemically and structurally different drugs and subsequently activates transcription is poorly understood. Here, we describe the crystal structures of BmrR bound to rhodamine 6G (R6G) orberberine(Ber) and cognate DNA. These structures reveal each drug stacks against multiple aromatic residues with their positive charges most proximal to the carboxylate group of Glu-253 and that, unlike other multidrug binding pockets, that of BmrR is rigid. Substitution of Glu-253 with either alanine (E253A) or glutamine (E253Q) results in unpredictable binding affinities for R6G, Ber, and tetraphenylphosphonium. Moreover, these drug binding studies reveal that the negative charge of Glu-253 is not important for high affinity binding to Ber and tetraphenylphosphonium but plays a more significant, but unpredictable, role in R6G binding. In vitro transcription data show that E253A and E253Q are constitutively active, and structures of the drug-free E253A-DNA and E253Q-DNA complexes support a transcription activation mechanism requiring the expulsion of Tyr152 from the multidrug binding pocket. In sum, these data delineate the mechanism by which BmrR binds lipophilic, monovalent cationic compounds and suggest the importance of the redundant negative electrostatic nature of this rigid drug binding pocket that can be used to discriminate against molecules that are not substrates of the Bmr multidrug efflux pump.	[Newberry, Kate J.; Brennan, Richard G.] Univ Texas MD Anderson Canc Ctr, Dept Biochem & Mol Biol, Houston, TX 77030 USA; [Huffman, Joy L.; Miller, Marshall C.] Oregon Hlth & Sci Univ, Dept Biochem & Mol Biol, Portland, OR 97239 USA; [Vazquez-Laslop, Nora; Neyfakh, Alex A.] Univ Illinois, Ctr Pharmaceut Biotechnol, Chicago, IL 60607 USA	University of Texas System; UTMD Anderson Cancer Center; Oregon Health & Science University; University of Illinois System; University of Illinois Chicago; University of Illinois Chicago Hospital	Brennan, RG (corresponding author), Univ Texas MD Anderson Canc Ctr, Dept Biochem & Mol Biol, 1515 Holcombe Blvd, Houston, TX 77030 USA.	rgbrenna@mdanderson.org		Brennan, Richard/0000-0001-7647-485X	National Institutes of Health [A1048593]; National Science Foundation [MCB- 9816983]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI048593] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); National Science Foundation(National Science Foundation (NSF)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This work was supported, in whole or in part, by National Institutes of Health Grant A1048593 (to R. G. B.). This work was also supported by National Science Foundation Grant MCB- 9816983 (to A. A. N.). The costs of publication of this article were defrayed in part by the payment of page charges. This article must therefore be hereby marked "advertisement" in accordance with 18 U. S. C. Section 1734 solely to indicate this fact.	AHMED M, 1994, J BIOL CHEM, V269, P28506; Alekshun MN, 2007, CELL, V128, P1037, DOI 10.1016/j.cell.2007.03.004; Alguel Y, 2007, J MOL BIOL, V369, P829, DOI 10.1016/j.jmb.2007.03.062; ANSARI AZ, 1992, NATURE, V355, P87, DOI 10.1038/355087a0; ANSARI AZ, 1995, NATURE, V374, P371; BAILEY S, 1994, ACTA CRYSTALLOGR D, V50, P760, DOI 10.1107/s0907444994003112; Brown NL, 2003, FEMS MICROBIOL REV, V27, P145, DOI 10.1016/S0168-6445(03)00051-2; Brunger AT, 1998, ACTA CRYSTALLOGR D, V54, P905, DOI 10.1107/S0907444998003254; Edgar R, 1999, EMBO J, V18, P822, DOI 10.1093/emboj/18.4.822; Grkovic S, 2002, MICROBIOL MOL BIOL R, V66, P671, DOI 10.1128/MMBR.66.4.671-701.2002; Gu RY, 2007, J MOL BIOL, V372, P583, DOI 10.1016/j.jmb.2007.06.072; Heldwein EEZ, 2001, NATURE, V409, P378, DOI 10.1038/35053138; HELMANN JD, 1988, ANNU REV BIOCHEM, V57, P839, DOI 10.1146/annurev.bi.57.070188.004203; Hidalgo E, 1998, EMBO J, V17, P2629, DOI 10.1093/emboj/17.9.2629; Higgins CF, 2007, NATURE, V446, P749, DOI 10.1038/nature05630; Leslie A. G. W., 1992, JOINT CCP4 ESF EAMCB; Murray DS, 2004, J BIOL CHEM, V279, P14365, DOI 10.1074/jbc.M313870200; Muth TR, 2000, EMBO J, V19, P234, DOI 10.1093/emboj/19.2.234; Newberry KJ, 2004, J BIOL CHEM, V279, P20356, DOI 10.1074/jbc.M400960200; OHALLORAN TV, 1989, CELL, V56, P119, DOI 10.1016/0092-8674(89)90990-2; Outten CE, 1999, J BIOL CHEM, V274, P37517, DOI 10.1074/jbc.274.53.37517; PARKHILL J, 1990, NUCLEIC ACIDS RES, V18, P5157, DOI 10.1093/nar/18.17.5157; Piddock LJV, 2006, NAT REV MICROBIOL, V4, P629, DOI 10.1038/nrmicro1464; Poole K, 2007, ANN MED, V39, P162, DOI 10.1080/07853890701195262; Rajan SS, 2006, PROTEINS, V65, P255, DOI 10.1002/prot.21073; SCHULZ GE, 1979, PRINCIPLES PROTEIN S, P30; Schumacher MA, 2002, EMBO J, V21, P1210, DOI 10.1093/emboj/21.5.1210; Schumacher MA, 2001, SCIENCE, V294, P2158, DOI 10.1126/science.1066020; Schumacher MA, 2004, EMBO J, V23, P2923, DOI 10.1038/sj.emboj.7600288; SUMMERS AO, 1992, J BACTERIOL, V174, P3097, DOI 10.1128/jb.174.10.3097-3101.1992; Vazquez-Laslop N, 1999, BIOCHEMISTRY-US, V38, P16925, DOI 10.1021/bi991988g; Watanabe S, 2008, P NATL ACAD SCI USA, V105, P4121, DOI 10.1073/pnas.0709188105; Zheleznova EE, 1999, CELL, V96, P353, DOI 10.1016/S0092-8674(00)80548-6	34	37	38	0	5	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	SEP 26	2008	283	39					26795	26804		10.1074/jbc.M804191200	http://dx.doi.org/10.1074/jbc.M804191200			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	350GV	18658145	Green Published, hybrid			2022-12-27	WOS:000259341600051
J	Qu, SG; Kanner, BI				Qu, Shaogang; Kanner, Baruch I.			Substrates and non-transportable analogues induce structural rearrangements at the extracellular entrance of the glial glutamate transporter GLT-1/EAAT2	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							PAIRED CYSTEINE MUTAGENESIS; RAT-BRAIN; ACID TRANSPORTER; INDIVIDUAL SUBUNITS; MEMBRANE-VESICLES; REENTRANT LOOP; GLT-1; SODIUM; PORE; RESIDUES	To explore rearrangements of the reentrant loop HP2 relative to transmembrane domains (TMs) 7 and 8 during transport by the glial glutamate transporter GLT-1/EAAT2, cysteine pairs were introduced at the extracellular ends of these structural elements. The pairs were introduced around 10-15 angstrom "above" the residues, which make contact with substrate in the related archaeal homologue Glt(Ph). Transport by the double mutants M449C/L466C (HP2/TM 8), L453C/I463C (HP2/TM 8), and I411C/I463C (TM 7/TM 8) was inhibited by copper(II)(1,10-phenanthroline) (3) (CuPh) and by Cd2+. Inhibition was only observed when the two cysteines were present in the same construct, but not with the respective single cysteine mutants or when only one cysteine was paired with a mutation to another residue. Glutamate and potassium, both expected to increase the proportion of inward-facing transporters, significantly protected against the inhibition of transport activity of M449C/L466C by CuPh. The non-transportable analogues kainate and D,L-threo-beta-benzyloxyaspartate are expected to stabilize an outward-facing conformation, but only the latter potentiated the effect of CuPh on M449C/L466C. However, both analogues increased the aqueous accessibility of the cysteines introduced at positions 449 and 466 to a membrane-impermeant sulfhydryl reagent. Inhibition of L453C/I463C by CuPh was protected not only by glutamate but also by the two analogues. In contrast, these ligands had very little effect on the inhibition of I411C/I463C by CuPh. Our results are consistent with the proposal that HP2 serves as the extracellular gate of the transporter and indicate that glutamate and the two analogues induce distinct conformations of HP2.	[Qu, Shaogang; Kanner, Baruch I.] Hebrew Univ Jerusalem, Hadassah Med Sch, Dept Biochem, IL-91120 Jerusalem, Israel	Hebrew University of Jerusalem	Kanner, BI (corresponding author), Hebrew Univ Jerusalem, Hadassah Med Sch, Dept Biochem, IL-91120 Jerusalem, Israel.	kannerb@cc.huji.ac.il			NINDS, National Institutes of Health [NS16708]; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R56NS016708, R01NS016708] Funding Source: NIH RePORTER	NINDS, National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	This work was supported, in whole or in part, by NINDS, National Institutes of Health Grant NS16708. The costs of publication of this article were defrayed in part by the payment of page charges. This article must therefore be hereby marked "advertisement" in accordance with 18 U. S. C. Section 1734 solely to indicate this fact.	ARRIZA JL, 1994, J NEUROSCI, V14, P5559; Bendahan A, 2000, J BIOL CHEM, V275, P37436, DOI 10.1074/jbc.M006536200; Benitah JP, 1996, P NATL ACAD SCI USA, V93, P7392, DOI 10.1073/pnas.93.14.7392; Borre L, 2001, J BIOL CHEM, V276, P40396, DOI 10.1074/jbc.M104926200; Boudker O, 2007, NATURE, V445, P387, DOI 10.1038/nature05455; BREW H, 1987, NATURE, V327, P707, DOI 10.1038/327707a0; Brocke L, 2002, J BIOL CHEM, V277, P3985, DOI 10.1074/jbc.M107735200; FUERST TR, 1986, P NATL ACAD SCI USA, V83, P8122, DOI 10.1073/pnas.83.21.8122; GLUSKER JP, 1991, ADV PROTEIN CHEM, V42, P1; Grewer C, 2005, BIOCHEMISTRY-US, V44, P11913, DOI 10.1021/bi050987n; Grunewald M, 2002, J BIOL CHEM, V277, P26074, DOI 10.1074/jbc.M202248200; Grunewald M, 1998, NEURON, V21, P623, DOI 10.1016/S0896-6273(00)80572-3; Grunewald M, 2000, J BIOL CHEM, V275, P9684, DOI 10.1074/jbc.275.13.9684; Huang ZJ, 2008, BIOPHYS J, V95, P2292, DOI 10.1529/biophysj.108.133421; KANNER BI, 1978, BIOCHEMISTRY-US, V17, P3949, DOI 10.1021/bi00612a011; KANNER BI, 1982, BIOCHEMISTRY-US, V21, P6327, DOI 10.1021/bi00267a044; Kavanaugh MP, 1997, J BIOL CHEM, V272, P1703, DOI 10.1074/jbc.272.3.1703; KLEINBERGERDORON N, 1994, J BIOL CHEM, V269, P3063; Koch HP, 2007, J BIOL CHEM, V282, P24547, DOI 10.1074/jbc.M704087200; Koch HP, 2007, J NEUROSCI, V27, P2943, DOI 10.1523/JNEUROSCI.0118-07.2007; Koch HP, 2005, J NEUROSCI, V25, P1730, DOI 10.1523/JNEUROSCI.4138-04.2005; KUNKEL TA, 1987, METHOD ENZYMOL, V154, P367; Leary GP, 2007, J NEUROSCI, V27, P2938, DOI 10.1523/JNEUROSCI.4851-06.2007; Leighton BH, 2006, J BIOL CHEM, V281, P29788, DOI 10.1074/jbc.M604991200; Levy LM, 1998, J NEUROSCI, V18, P9620, DOI 10.1523/jneurosci.18-23-09620.1998; PerezGarcia MT, 1996, P NATL ACAD SCI USA, V93, P300, DOI 10.1073/pnas.93.1.300; PINES G, 1995, J BIOL CHEM, V270, P17093, DOI 10.1074/jbc.270.29.17093; PINES G, 1990, BIOCHEMISTRY-US, V29, P11209, DOI 10.1021/bi00503a008; PINES G, 1992, NATURE, V360, P464, DOI 10.1038/360464a0; Slotboom DJ, 1999, P NATL ACAD SCI USA, V96, P14282, DOI 10.1073/pnas.96.25.14282; SZATKOWSKI M, 1990, NATURE, V348, P443, DOI 10.1038/348443a0; Teichman S, 2007, J GEN PHYSIOL, V129, P527, DOI 10.1085/jgp.200609707; WADICHE JI, 1995, NEURON, V14, P1019, DOI 10.1016/0896-6273(95)90340-2; Yernool D, 2004, NATURE, V431, P811, DOI 10.1038/nature03018; Zerangue N, 1996, NATURE, V383, P634, DOI 10.1038/383634a0; Zhang YM, 1999, P NATL ACAD SCI USA, V96, P1710, DOI 10.1073/pnas.96.4.1710; Zhang YM, 1998, P NATL ACAD SCI USA, V95, P751, DOI 10.1073/pnas.95.2.751; Zomot E, 2005, J BIOL CHEM, V280, P25512, DOI 10.1074/jbc.M503864200	38	29	30	0	3	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	SEP 26	2008	283	39					26391	26400		10.1074/jbc.M802401200	http://dx.doi.org/10.1074/jbc.M802401200			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	350GV	18658151	Green Published, hybrid			2022-12-27	WOS:000259341600013
J	Yang, Y; Wu, F; Ward, T; Yan, F; Wu, Q; Wang, ZY; McGlothen, T; Peng, W; You, TP; Sun, MK; Cui, TX; Hu, RM; Dou, Z; Zhu, JD; Xie, W; Rao, ZH; Ding, X; Yao, XB				Yang, Yong; Wu, Fang; Ward, Tarsha; Yan, Feng; Wu, Quan; Wang, Zhaoyang; McGlothen, Tanisha; Peng, Wei; You, Tianpa; Sun, Mingkuan; Cui, Taixing; Hu, Renming; Dou, Zhen; Zhu, Jingde; Xie, Wei; Rao, Zihe; Ding, Xia; Yao, Xuebiao			Phosphorylation of HsMis13 by aurora B kinase is essential for assembly of functional kinetochore	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							CENP-E; MICROTUBULE ATTACHMENT; MOLECULAR ANALYSIS; PROTEIN E; CENTROMERES; CHECKPOINT; ANAPHASE; COMPLEX; MIS12; NUF2	Chromosome movements in mitosis are orchestrated by dynamic interactions between spindle microtubules and the kinetochore, a multiprotein complex assembled onto centro-meric DNA of the chromosome. Here we show that phosphorylation of human HsMis13 by Aurora B kinase is required for functional kinetochore assembly in HeLa cells. Aurora B interacts with HsMis13 in vitro and in vivo. HsMis13 is a cognate substrate of Aurora B, and the phosphorylation sites were mapped to Ser-100 and Ser-109. Suppression of Aurora B kinase by either small interfering RNA or chemical inhibitors abrogates the localization of HsMis13 but not HsMis12 to the kinetochore. In addition, non-phosphorylatable but not wild type and phospho-mimicking HsMis13 failed to localize to the kinetochore, demonstrating the requirement of phosphorylation by Aurora B for the assembly of HsMis13 to kinetochore. In fact, localization of HsMis13 to the kinetochore is spatiotemporally regulated by Aurora B kinase, which is essential for recruiting outer kinetochore components such as Ndc80 components and CENP-E for functional kinetochore assembly. Importantly, phospho-mimicking mutant HsMis13 restores the assembly of CENP-E to the kinetochore, and tension developed across the sister kinetochores in Aurora B-inhibited cells. Thus, we reason that HsMis13 phosphorylation by Aurora B is required for organizing a stable bi-oriented microtubule kinetochore attachment that is essential for faithful chromosome segregation in mitosis.	[Yang, Yong; Ward, Tarsha; Yan, Feng; Wu, Quan; McGlothen, Tanisha; Sun, Mingkuan; Dou, Zhen; Ding, Xia] Morehouse Sch Med, Canc Biol Program, Atlanta, GA 30310 USA; [Yang, Yong; Wu, Fang; Yan, Feng; Wu, Quan; Wang, Zhaoyang; You, Tianpa; Cui, Taixing; Dou, Zhen; Zhu, Jingde; Ding, Xia; Yao, Xuebiao] Hefei Natl Lab Phys Sci Microscale, Hefei 230027, Peoples R China; [Yang, Yong; Wu, Fang; Yan, Feng; Wu, Quan; Wang, Zhaoyang; You, Tianpa; Cui, Taixing; Dou, Zhen; Zhu, Jingde; Ding, Xia; Yao, Xuebiao] Univ Sci & Technol China, Hefei 230027, Peoples R China; [Hu, Renming] Fudan Univ, Huashan Hosp, Dept Endocrinol & Metab, Shanghai 200040, Peoples R China; [Sun, Mingkuan; Xie, Wei] Southeast Univ, Sch Med, MOE Key Lab Dev Genes & Human Dis, Nanjing 210009, Peoples R China; [Sun, Mingkuan; Xie, Wei] Beijing Univ Chinese Med, Dept Med, Beijing 100029, Peoples R China; [Peng, Wei; Rao, Zihe] Chinese Acad Sci, Inst Biophys, Beijing 100101, Peoples R China	Morehouse School of Medicine; Chinese Academy of Sciences; University of Science & Technology of China, CAS; Fudan University; Southeast University - China; Beijing University of Chinese Medicine; Chinese Academy of Sciences; Institute of Biophysics, CAS	Ding, X (corresponding author), Morehouse Sch Med, Canc Biol Program, Atlanta, GA 30310 USA.	xding@bucm.edu.cn; yaoxb@ustc.edu.cn	Yang, Yong/U-4781-2019; Sun, Mingkuan/H-6191-2019; Yao, Xuebiao/P-5771-2014; Rao, Zihe/HCH-6944-2022; DOU, ZHEN/N-2022-2013; SUN, Mingkuan/I-7186-2016; Yang, Yong/P-8322-2018	Sun, Mingkuan/0000-0002-4511-5894; SUN, Mingkuan/0000-0002-4511-5894; DOU, ZHEN/0000-0003-3303-9393	National Institutes of Health [DK56292, CA132389, CA92080]; Chinese 973 Project [2002CB713700, 2006CB943603, 2007CB914503]; Chinese Academy of Sciences [KSCX1-YW-R65, KSCX2-YW-H10]; Chinese 863 Project [2006AA02A247]; Chinese Ministry of Education [20020358051, 20050358061]; 111 Project [B07007]; Chinese Natural Science Foundation [90508002, 30121001, 30500183, 30600321]; American Cancer Society [RPG 99-173-1]; Atlanta Clinical and Translational Science Award Chemical Biology; NATIONAL CANCER INSTITUTE [P20CA132389] Funding Source: NIH RePORTER; NATIONAL CENTER FOR RESEARCH RESOURCES [G12RR003034] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK056292] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Chinese 973 Project(National Basic Research Program of China); Chinese Academy of Sciences(Chinese Academy of Sciences); Chinese 863 Project(National High Technology Research and Development Program of China); Chinese Ministry of Education(Ministry of Education, China); 111 Project(Ministry of Education, China - 111 Project); Chinese Natural Science Foundation(National Natural Science Foundation of China (NSFC)); American Cancer Society(American Cancer Society); Atlanta Clinical and Translational Science Award Chemical Biology; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	This work was supported, in whole or in part, by National Institutes of Health Grants DK56292, CA132389, and CA92080. This work was also supported by grants from Chinese 973 Project (2002CB713700, 2006CB943603, and 2007CB914503), Chinese Academy of Sciences (KSCX1-YW-R65 and KSCX2-YW-H10), Chinese 863 Project (2006AA02A247), Chinese Ministry of Education (20020358051 and 20050358061 and 111 Project B07007 (to X. D.), Chinese Natural Science Foundation (90508002 and 30121001 (to X. Y.), 30500183 (to X. D.), and 30600321 (to Z. D.)), American Cancer Society (RPG 99-173-1), and an Atlanta Clinical and Translational Science Award Chemical Biology grant (to X. Y.). The costs of publication of this article were defrayed in part by the payment of page charges. This article must therefore be hereby marked "advertisement" in accordance with 18 U. S. C. Section 1734 solely to indicate this fact.	Betzig E, 2006, SCIENCE, V313, P1642, DOI 10.1126/science.1127344; Cao XW, 2005, J BIOL CHEM, V280, P13584, DOI 10.1074/jbc.M411941200; Cheeseman IM, 2006, CELL, V127, P983, DOI 10.1016/j.cell.2006.09.039; Cheeseman IM, 2004, GENE DEV, V18, P2255, DOI 10.1101/gad.1234104; Cleveland DW, 2003, CELL, V112, P407, DOI 10.1016/S0092-8674(03)00115-6; DeLuca JG, 2006, CELL, V127, P969, DOI 10.1016/j.cell.2006.09.047; DeLuca JG, 2005, MOL BIOL CELL, V16, P519, DOI 10.1091/mbc.E04-09-0852; Ditchfield C, 2003, J CELL BIOL, V161, P267, DOI 10.1083/jcb.200208091; Fu GS, 2007, CELL RES, V17, P608, DOI 10.1038/cr.2007.55; Fuller BG, 2008, NATURE, V453, P1132, DOI 10.1038/nature06923; Goshima G, 1999, GENE DEV, V13, P1664, DOI 10.1101/gad.13.13.1664; Goshima G, 2003, J CELL BIOL, V160, P25, DOI 10.1083/jcb.200210005; Harrington EA, 2004, NAT MED, V10, P262, DOI 10.1038/nm1003; He XW, 2001, CELL, V106, P195, DOI 10.1016/S0092-8674(01)00438-X; Jansen LET, 2007, J CELL BIOL, V176, P795, DOI 10.1083/jcb.200701066; Johnson VL, 2004, J CELL SCI, V117, P1577, DOI 10.1242/jcs.01006; Ke YW, 2003, CELL RES, V13, P69, DOI 10.1038/sj.cr.7290152; Kline SL, 2006, J CELL BIOL, V173, P9, DOI 10.1083/jcb.200509158; Lampson MA, 2004, NAT CELL BIOL, V6, P232, DOI 10.1038/ncb1102; Liu D, 2007, J BIOL CHEM, V282, P21415, DOI 10.1074/jbc.M609026200; Liu XK, 2005, EMBO J, V24, P2919, DOI 10.1038/sj.emboj.7600762; Murata-Hori M, 2002, CURR BIOL, V12, P894, DOI 10.1016/S0960-9822(02)00848-5; Musacchio A, 2007, NAT REV MOL CELL BIO, V8, P379, DOI 10.1038/nrm2163; Nigg EA, 2001, NAT REV MOL CELL BIO, V2, P21, DOI 10.1038/35048096; Obuse C, 2004, NAT CELL BIOL, V6, P1135, DOI 10.1038/ncb1187; TAKAHASHI K, 1994, MOL BIOL CELL, V5, P1145, DOI 10.1091/mbc.5.10.1145; Tanaka TU, 2005, PHILOS T R SOC B, V360, P581, DOI 10.1098/rstb.2004.1612; Xue Y, 2005, NUCLEIC ACIDS RES, V33, pW184, DOI 10.1093/nar/gki393; Yao XB, 2000, NAT CELL BIOL, V2, P484, DOI 10.1038/35019518; Yao XB, 1997, J CELL BIOL, V139, P435, DOI 10.1083/jcb.139.2.435	30	57	59	0	9	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	SEP 26	2008	283	39					26726	26736		10.1074/jbc.M804207200	http://dx.doi.org/10.1074/jbc.M804207200			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	350GV	18640974	Green Published, hybrid			2022-12-27	WOS:000259341600046
J	Mahoney, DJ; Mikecz, K; Ali, T; Mabilleau, G; Benayahu, D; Plaas, A; Milner, CM; Day, AJ; Sabokbar, A				Mahoney, David J.; Mikecz, Katalin; Ali, Tariq; Mabilleau, Guillaume; Benayahu, Dafna; Plaas, Anna; Milner, Caroline M.; Day, Anthony J.; Sabokbar, Afsaneh			TSG-6 regulates bone remodeling through inhibition of osteoblastogenesis and osteoclast activation	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							NECROSIS-FACTOR-ALPHA; FACTOR-STIMULATED GENE-6; MORPHOGENETIC PROTEIN ANTAGONIST; HYALURONAN-BINDING PROTEIN; COLLAGEN-INDUCED ARTHRITIS; LINK MODULE; EXTRACELLULAR-MATRIX; IN-VITRO; OSTEOPROTEGERIN LIGAND; DIFFERENTIATION FACTOR	TSG-6 is an inflammation-induced protein that is produced at pathological sites, including arthritic joints. In animal models of arthritis, TSG-6 protects against joint damage; this has been attributed to its inhibitory effects on neutrophil migration and plasmin activity. Here we investigated whether TSG-6 can directly influence bone erosion. Our data reveal that TSG-6 inhibits RANKL-induced osteoclast differentiation/activation from human and murine precursor cells, where elevated dentine erosion by osteoclasts derived from TSG-6(-/)-mice is consistent with the very severe arthritis seen in these animals. However, the long bones from unchallenged TSG-6(-/)-mice were found to have higher trabecular mass than controls, suggesting that in the absence of inflammation TSG-6 has a role in bone homeostasis; we have detected expression of the TSG-6 protein in the bone marrow of unchallenged wild type mice. Furthermore, we have observed that TSG-6 can inhibit bone morphogenetic protein-2 (BMP-2)-mediated osteoblast differentiation. Interaction analysis revealed that TSG-6 binds directly to RANKL and to BMP-2 (as well as other osteogenic BMPs but not BMP-3) via composite surfaces involving its Link and CUB modules. Consistent with this, the full-length protein is required for maximal inhibition of osteoblast differentiation and osteoclast activation, although the isolated Link module retains significant activity in the latter case. We hypothesize that TSG-6 has dual roles in bone remodeling; one protective, where it inhibits RANKL-induced bone erosion in inflammatory diseases such as arthritis, and the other homeostatic, where its interactions with BMP-2 and RANKL help to balance mineralization by osteoblasts and bone resorption by osteoclasts.	[Ali, Tariq; Milner, Caroline M.; Day, Anthony J.] Univ Manchester, Fac Life Sci, Wellcome Trust Ctr Cell Matrix Res, Manchester M13 9PT, Lancs, England; [Mahoney, David J.; Mabilleau, Guillaume; Plaas, Anna; Sabokbar, Afsaneh] Univ Oxford, Nuffield Dept Orthopaed Surg, Botnar Res Ctr, Oxford OX3 7LD, England; [Mahoney, David J.; Ali, Tariq; Milner, Caroline M.; Day, Anthony J.] Univ Oxford, Dept Biochem, MRC Immunochem Unit, Oxford OX1 3QU, England; [Mikecz, Katalin] Rush Univ, Med Ctr, Dept Orthoped Surg, Chicago, IL 60612 USA; [Benayahu, Dafna] Tel Aviv Univ, Sackler Sch Med, Dept Cell & Dev Biol, IL-69978 Tel Aviv, Israel; [Plaas, Anna] Rush Univ, Med Ctr, Dept Biochem, Chicago, IL 60612 USA	University of Manchester; University of Oxford; University of Oxford; Rush University; Tel Aviv University; Sackler Faculty of Medicine; Rush University	Milner, CM (corresponding author), Univ Manchester, Fac Life Sci, Wellcome Trust Ctr Cell Matrix Res, Michael Smith Bldg,Oxford Rd, Manchester M13 9PT, Lancs, England.	caroline.milner@manchester.ac.uk; anthony.day@mancheste.ac.uk; afsie.sabokbar@ndos.ox.ac.uk	Day, Anthony/O-1658-2015; Milner, Caroline M/P-5526-2015; Mabilleau, Guillaume/M-8261-2018	Day, Anthony/0000-0002-1415-3134; Milner, Caroline M/0000-0001-7355-9655; Mabilleau, Guillaume/0000-0003-1445-329X; Mikecz, Katalin/0000-0003-1506-4296	Arthritis and Research Campaign [16539, 17950]; ISIS Innovation [POC 228]; National Institutes of Health NIAMS [AR051163]; CellProm Project, FP6th of the European Community [NMP4CT-2004-500039]; NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES [R01AR051163] Funding Source: NIH RePORTER	Arthritis and Research Campaign(Versus Arthritis); ISIS Innovation; National Institutes of Health NIAMS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS)); CellProm Project, FP6th of the European Community; NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS))	This work was supported by Arthritis and Research Campaign Grants 16539 and 17950 (to A. J. D. and C. M. M. and to A. S., A. J. D., and C. M. M., respectively) and ISIS Innovation, Oxford Grant POC 228 (to A. S. and A. J. D.). This work was also supported by National Institutes of Health NIAMS Grant AR051163 (to K. M.). Funding was also received from the CellProm Project, FP6th of the European Community (NMP4CT-2004-500039 (to D. B.)). The costs of publication of this article were defrayed in part by the payment of page charges. This article must therefore be hereby marked "advertisement" in accordance with 18 U. S. C. Section 1734 solely to indicate this fact.	Asagiri M, 2007, BONE, V40, P251, DOI 10.1016/j.bone.2006.09.023; Bandyopadhyay A, 2006, PLOS GENET, V2, P2116, DOI 10.1371/journal.pgen.0020216; Bardos T, 2001, AM J PATHOL, V159, P1711, DOI 10.1016/S0002-9440(10)63018-0; Bayliss MT, 2001, OSTEOARTHR CARTILAGE, V9, P42, DOI 10.1053/joca.2000.0348; Benayahu D, 1996, CALCIFIED TISSUE INT, V59, P254, DOI 10.1007/s002239900119; BENAYAHU D, 1994, J CELL BIOCHEM, V56, P62, DOI 10.1002/jcb.240560111; BENAYAHU D, 1995, BIOCHEM BIOPH RES CO, V210, P197, DOI 10.1006/bbrc.1995.1646; Blundell CD, 2005, J BIOL CHEM, V280, P18189, DOI 10.1074/jbc.M414343200; Blundell CD, 2003, J BIOL CHEM, V278, P49261, DOI 10.1074/jbc.M309623200; Bonucci E, 2001, MARC MALPIG SYMP SER, V7, P129; Cao TV, 2004, MICROCIRCULATION, V11, P615, DOI 10.1080/10739680490503438; Chen D, 2004, GROWTH FACTORS, V22, P233, DOI 10.1080/08977190412331279890; Cheng HW, 2003, J BONE JOINT SURG AM, V85A, P1544, DOI 10.2106/00004623-200308000-00017; Daluiski A, 2001, NAT GENET, V27, P84, DOI 10.1038/83810; Davidson ENB, 2006, ANN RHEUM DIS, V65, P1414, DOI 10.1136/ard.2005.045971; Davidson ENB, 2007, ARTHRITIS RES THER, V9, DOI 10.1186/ar2305; Day AJ, 1996, PROTEIN EXPRES PURIF, V8, P1, DOI 10.1006/prep.1996.0068; Forteza R, 2007, AM J RESP CELL MOL, V36, P20, DOI 10.1165/rcmb.2006-0018OC; Fried A, 1996, J CELL BIOCHEM, V62, P476, DOI 10.1002/(SICI)1097-4644(19960915)62:4<476::AID-JCB5>3.0.CO;2-J; Fujimoto T, 2002, AM J PATHOL, V160, P1495, DOI 10.1016/S0002-9440(10)62575-8; Fulop C, 2003, DEVELOPMENT, V130, P2253, DOI 10.1242/dev.00422; Gazzerro E, 2005, ENDOCRINOLOGY, V146, P655, DOI 10.1210/en.2004-0766; Getting SJ, 2002, J BIOL CHEM, V277, P51068, DOI 10.1074/jbc.M205121200; Glant TT, 2002, ARTHRITIS RHEUM-US, V46, P2207, DOI 10.1002/art.10555; Higman VA, 2007, J MOL BIOL, V371, P669, DOI 10.1016/j.jmb.2007.05.073; Inoue I, 2006, J PHARMACOL SCI, V100, P205, DOI 10.1254/jphs.FMJ05004X5; Itonaga I, 2000, ANN RHEUM DIS, V59, P26, DOI 10.1136/ard.59.1.26; Kahmann JD, 1997, PROTEIN EXPRES PURIF, V9, P315, DOI 10.1006/prep.1996.0694; Kang Q, 2004, GENE THER, V11, P1312, DOI 10.1038/sj.gt.3302298; Kehlen A, 2003, ARTHRITIS RES THER, V5, pR186, DOI 10.1186/ar762; Kingsley D M, 2001, Novartis Found Symp, V232, P213; Kohda D, 1996, CELL, V86, P767, DOI 10.1016/S0092-8674(00)80151-8; Koike N, 2007, J BIOL CHEM, V282, P15843, DOI 10.1074/jbc.M701570200; Kondo Y, 2001, J BONE MINER METAB, V19, P352, DOI 10.1007/s007740170004; Kong YY, 1999, NATURE, V402, P304, DOI 10.1038/35005552; Kong YY, 1999, NATURE, V397, P315, DOI 10.1038/16852; Kusu N, 2003, J BIOL CHEM, V278, P24113, DOI 10.1074/jbc.M301716200; Kuznetsova SA, 2005, J BIOL CHEM, V280, P30899, DOI 10.1074/jbc.M500701200; Kuznetsova SA, 2008, MATRIX BIOL, V27, P201, DOI 10.1016/j.matbio.2007.10.003; Kuznetsova SA, 2006, J CELL SCI, V119, P4499, DOI 10.1242/jcs.03171; Lacey DL, 1998, CELL, V93, P165, DOI 10.1016/S0092-8674(00)81569-X; LEE TH, 1992, J CELL BIOL, V116, P545, DOI 10.1083/jcb.116.2.545; Lesley J, 2002, J BIOL CHEM, V277, P26600, DOI 10.1074/jbc.M201068200; Levine AJ, 2006, CELL CYCLE, V5, P1069, DOI 10.4161/cc.5.10.2771; Lorensen W.E., 1987, COMPUT GRAPH, V21, P163, DOI [10.1145/37401.37422, DOI 10.1145/37401.37422]; Mahoney DJ, 2005, J BIOL CHEM, V280, P27044, DOI 10.1074/jbc.M502068200; Mahoney DJ, 2004, ANAL BIOCHEM, V330, P123, DOI 10.1016/j.ab.2004.03.055; Mahoney DJ, 2001, J BIOL CHEM, V276, P22764, DOI 10.1074/jbc.M100666200; Maier R, 1996, ARTHRITIS RHEUM, V39, P552, DOI 10.1002/art.1780390403; Margerie D, 1997, OSTEOARTHR CARTILAGE, V5, P129, DOI 10.1016/S1063-4584(97)80006-4; Milner CM, 2006, BIOCHEM SOC T, V34, P446, DOI 10.1042/BST0340446; Milner CM, 2003, J CELL SCI, V116, P1863, DOI 10.1242/jcs.00407; Mindrescu C, 2002, ARTHRITIS RHEUM, V46, P2453, DOI 10.1002/art.10503; Mindrescu C, 2000, ARTHRITIS RHEUM, V43, P2668, DOI 10.1002/1529-0131(200012)43:12<2668::AID-ANR6>3.0.CO;2-E; Nakagawa N, 1998, BIOCHEM BIOPH RES CO, V253, P395, DOI 10.1006/bbrc.1998.9788; Nakamura A, 2007, BONE, V40, P305, DOI 10.1016/j.bone.2006.09.001; Nentwich HA, 2002, J BIOL CHEM, V277, P15354, DOI 10.1074/jbc.M110765200; Ochsner SA, 2003, ENDOCRINOLOGY, V144, P4376, DOI 10.1210/en.2003-0487; Ohazama A, 2005, J DENT RES, V84, P603, DOI 10.1177/154405910508400704; Page G, 2005, ARTHRITIS RHEUM-US, V52, P2307, DOI 10.1002/art.21211; PARFITT AM, 1987, J BONE MINER RES, V2, P595, DOI 10.1002/jbmr.5650020617; Parkar AA, 1998, FEBS LETT, V428, P171, DOI 10.1016/S0014-5793(98)00523-7; Parkar AA, 1997, FEBS LETT, V410, P413, DOI 10.1016/S0014-5793(97)00621-2; PARTRIDGE NC, 1980, FEBS LETT, V115, P139, DOI 10.1016/0014-5793(80)80744-7; Plaas A, 2007, OSTEOARTHR CARTILAGE, V15, P719, DOI 10.1016/j.joca.2006.12.008; Quinn JMW, 1998, ENDOCRINOLOGY, V139, P4424, DOI 10.1210/endo.139.10.6331; Reddi AH, 2001, ARTHRITIS RES, V3, P1; Rugg MS, 2005, J BIOL CHEM, V280, P25674, DOI 10.1074/jbc.M501332200; Rydziel S, 2007, J BIOL CHEM, V282, P19762, DOI 10.1074/jbc.M700212200; Sabokbar A, 2003, METH MOLEC MED, V80, P101; Salustri A, 2004, DEVELOPMENT, V131, P1577, DOI 10.1242/dev.01056; Sanggaard KW, 2005, J BIOL CHEM, V280, P11936, DOI 10.1074/jbc.M409016200; Schneeweis LA, 2005, J BIOL CHEM, V280, P41155, DOI 10.1074/jbc.M506366200; Simonet WS, 1997, CELL, V89, P309, DOI 10.1016/S0092-8674(00)80209-3; Suda T, 1999, ENDOCR REV, V20, P345, DOI 10.1210/er.20.3.345; SUDO H, 1983, J CELL BIOL, V96, P191, DOI 10.1083/jcb.96.1.191; Szanto S, 2004, ARTHRITIS RHEUM-US, V50, P3012, DOI 10.1002/art.20655; TAKEUCHI Y, 1993, J BONE MINER RES, V8, P823; Tanaka S, 2005, IMMUNOL REV, V208, P30, DOI 10.1111/j.0105-2896.2005.00327.x; Tsuji K, 2006, NAT GENET, V38, P1424, DOI 10.1038/ng1916; TSUKAHARA S, 2006, BIOCHEM J, V15, P595; Wan DC, 2007, J BIOL CHEM, V282, P26450, DOI 10.1074/jbc.M703282200; Wani MR, 1999, ENDOCRINOLOGY, V140, P1927, DOI 10.1210/en.140.4.1927; Wisniewski HG, 2004, CYTOKINE GROWTH F R, V15, P129, DOI 10.1016/j.cytogfr.2004.01.005; WISNIEWSKI HG, 1993, J IMMUNOL, V151, P6593; WISNIEWSKI HG, 1994, BIOCHEMISTRY-US, V33, P7423, DOI 10.1021/bi00189a049; Wisniewski HG, 1996, J IMMUNOL, V156, P1609; Yamada S, 2007, J BIOL CHEM, V282, P23070, DOI 10.1074/jbc.M611181200; Zhu WQ, 2007, J CRANIO MAXILL SURG, V35, P103, DOI 10.1016/j.jcms.2006.12.001	89	39	40	0	5	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	SEP 19	2008	283	38					25952	25962		10.1074/jbc.M802138200	http://dx.doi.org/10.1074/jbc.M802138200			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	348GX	18586671	Green Published, hybrid			2022-12-27	WOS:000259200100023
J	Sastre, AP; Grossmann, S; Reusch, HP; Schaefer, M				Sastre, Alejandra Perez; Grossmann, Solveig; Reusch, H. Peter; Schaefer, Michael			Requirement of an intermediate gene expression for biphasic ERK1/2 activation in thrombin-stimulated vascular smooth muscle cells	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							PROTEIN-KINASE ACTIVATION; EARLY RESPONSE GENE; GROWTH-FACTOR; TRANSCRIPTION FACTOR; RECEPTOR TRANSACTIVATION; ANGIOTENSIN-II; MAP KINASES; PROHB-EGF; IN-VIVO; HB-EGF	The expression of contractile proteins in vascular smooth muscle cells is controlled by still poorly defined mechanisms. A thrombin-inducible expression of smooth muscle-specific alpha-actin and myosin heavy chain requires transactivation of the epidermal growth factor (EGF) receptor and a biphasic activation of ERK1/2. Here we demonstrate that the sustained second phase of ERK1/2 phosphorylation requires de novo RNA and protein synthesis. Depolymerization of the actin cytoskeleton by cytochalasin D or disruption of transit between the endoplasmic reticulum and the Golgi apparatus by brefeldin A prevented the second phase of ERK1/2 phosphorylation. We thus conclude that synthesis and trafficking of a plasma membrane-resident protein may be critical intermediates. Analysis of the expression of protease-activated receptor 1, heparin-binding EGF (HB-EGF), and the EGF receptor revealed that pro-HB-EGF is significantly up-regulated upon thrombin stimulation. The kinetic of HB-EGF expression closely matched that of the second phase of ERK1/2 phosphorylation. Because inhibition of matrix metalloproteases or of the EGF receptor strongly attenuated the late phase of ERK1/2 phosphorylation, the second phase of ERK1/2 activation is primarily relayed by shedding of EGF receptor ligands. The small interfering RNA-mediated knockdown of HB-EGF expression confirmed an important role of HB-EGF expression in triggering the second phase of ERK1/2 activation. Confocal imaging of a yellow fluorescent protein-tagged HB-EGF construct demonstrates the rapid plasma membrane integration of the newly synthesized protein. These data imply that the hormonal control of contractile protein expression relies on an intermediate HB-EGF expression to sustain the signaling strength within the Ras/Raf/MEK/ERK cascade.	[Sastre, Alejandra Perez; Grossmann, Solveig; Schaefer, Michael] Charite, Div Mol Pharmacol & Cell Biol, D-14195 Berlin, Germany; [Reusch, H. Peter] Ruhr Univ Bochum, Klin Pharmakol Abt, D-44780 Bochum, Germany	Free University of Berlin; Humboldt University of Berlin; Charite Universitatsmedizin Berlin; Ruhr University Bochum	Schaefer, M (corresponding author), Univ Leipzig, Rudolf Boehm Inst Pharm & Toxikol, Hartelstr 16-18, D-04107 Leipzig, Germany.	michael.schaefer@medizin.uni-leipzig.de			Deutsche Forschungsgemeinschaft [GRK865, Scha941/2-1]	Deutsche Forschungsgemeinschaft(German Research Foundation (DFG))	This work was supported by Grants GRK865 and Scha941/2-1 from Deutsche Forschungsgemeinschaft (to A. P. S., S. G., and M. S.). The costs of publication of this article were defrayed in part by the payment of page charges. This article must therefore be hereby marked "advertisement" in accordance with 18 U. S. C. Section 1734 solely to indicate this fact.	BEAUCHAMP RD, 1991, CANCER RES, V51, P5253; Berk BC, 2001, PHYSIOL REV, V81, P999, DOI 10.1152/physrev.2001.81.3.999; Delaney J, 2008, NEUROCHEM RES, V33, P545, DOI 10.1007/s11064-007-9474-y; Eferl R, 2003, NAT REV CANCER, V3, P859, DOI 10.1038/nrc1209; Eguchi S, 1998, J BIOL CHEM, V273, P8890, DOI 10.1074/jbc.273.15.8890; Gerits N, 2007, TRANSGENIC RES, V16, P281, DOI 10.1007/s11248-006-9052-0; Goetze S, 2001, ATHEROSCLEROSIS, V159, P93, DOI 10.1016/S0021-9150(01)00497-X; Hirano K, 2007, ARTERIOSCL THROM VAS, V27, P27, DOI 10.1161/01.ATV.0000251995.73307.2d; HultgardhNilsson A, 1996, CIRC RES, V78, P589, DOI 10.1161/01.RES.78.4.589; Hungerford JE, 1999, J VASC RES, V36, P2, DOI 10.1159/000025622; IVES HE, 1978, J EXP MED, V148, P1400, DOI 10.1084/jem.148.5.1400; Iwamoto R, 2000, CYTOKINE GROWTH F R, V11, P335, DOI 10.1016/S1359-6101(00)00013-7; Kaperonis EA, 2006, EUR J VASC ENDOVASC, V31, P386, DOI 10.1016/j.ejvs.2005.11.001; Koh YH, 2001, J BIOCHEM-TOKYO, V130, P351, DOI 10.1093/oxfordjournals.jbchem.a002993; Kolch W, 2005, NAT REV MOL CELL BIO, V6, P827, DOI 10.1038/nrm1743; Liu AY, 1997, PROSTATE, V30, P145, DOI 10.1002/(SICI)1097-0045(19970215)30:3<145::AID-PROS1>3.0.CO;2-L; Lusis AJ, 2000, NATURE, V407, P233, DOI 10.1038/35025203; MARSHALL CJ, 1995, CELL, V80, P179, DOI 10.1016/0092-8674(95)90401-8; McCarthy SA, 1997, MOL CELL BIOL, V17, P2401, DOI 10.1128/MCB.17.5.2401; Miyamoto S, 2006, CANCER SCI, V97, P341, DOI 10.1111/j.1349-7006.2006.00188.x; Naito S, 1998, AM J PHYSIOL-CELL PH, V274, pC472, DOI 10.1152/ajpcell.1998.274.2.C472; Nanba D, 2003, J CELL BIOL, V163, P489, DOI 10.1083/jcb.200303017; Oettgen P, 2006, CIRC RES, V99, P1159, DOI 10.1161/01.RES.0000251056.85990.db; Owens GK, 2004, PHYSIOL REV, V84, P767, DOI 10.1152/physrev.00041.2003; Park JM, 1999, AM J PHYSIOL-CELL PH, V277, pC294, DOI 10.1152/ajpcell.1999.277.2.C294; Prenzel N, 1999, NATURE, V402, P884, DOI 10.1038/47260; Redlich K, 2001, ARTHRITIS RHEUM, V44, P266, DOI 10.1002/1529-0131(200102)44:2<266::AID-ANR43>3.3.CO;2-7; Reusch HP, 2001, J BIOL CHEM, V276, P19540, DOI 10.1074/jbc.M101963200; Reusch HP, 2001, J BIOL CHEM, V276, P33630, DOI 10.1074/jbc.M105322200; ROTHMAN A, 1994, J BIOL CHEM, V269, P6399; Roy J, 2001, DIFFERENTIATION, V67, P50, DOI 10.1046/j.1432-0436.2001.067001050.x; Santiago FS, 2004, CIRC RES, V95, P479, DOI 10.1161/01.RES.0000141135.36279.67; Schauwienold D, 2003, HYPERTENSION, V41, P546, DOI 10.1161/01.HYP.0000054213.37471.84; Sherer Y, 2006, NAT CLIN PRACT RHEUM, V2, P99, DOI 10.1038/ncprheum0092; Soyensen BS, 2006, EXP CELL RES, V312, P3651, DOI 10.1016/j.yexcr.2006.08.007; Stegemann JP, 2005, J APPL PHYSIOL, V98, P2321, DOI 10.1152/japplphysiol.01114.2004; Torii S, 2004, J BIOCHEM, V136, P557, DOI 10.1093/jb/mvh159; Wang F, 2007, ONCOGENE, V26, P2006, DOI 10.1038/sj.onc.1209999; *WHO, 1985, TECH REP SERV, V143, P1; Zhan YM, 2005, J CLIN INVEST, V115, P2508, DOI 10.1172/JCI24403	40	8	8	0	1	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	SEP 19	2008	283	38					25871	25878		10.1074/jbc.M800949200	http://dx.doi.org/10.1074/jbc.M800949200			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	348GX	18650426	hybrid, Green Published			2022-12-27	WOS:000259200100014
J	Scanlon, JAB; Al-Shawi, MK; Nakamoto, RK				Scanlon, Joanne A. Baylis; Al-Shawi, Marwan K.; Nakamoto, Robert K.			A rotor-stator cross-link in the F-1-ATPase blocks the rate-limiting step of rotational catalysis	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ESCHERICHIA-COLI F1-ATPASE; F0F1 ATP SYNTHASE; HEART MITOCHONDRIAL ATPASE; GAMMA-SUBUNIT; BETA-SUBUNIT; INORGANIC-PHOSPHATE; ADENOSINE-TRIPHOSPHATASE; DIRECTED MUTAGENESIS; UNCOUPLING MUTATION; NUCLEOTIDE-BINDING	The F0F1-ATP synthase couples the functions of H+ transport and ATP synthesis/hydrolysis through the efficient transmission of energy mediated by rotation of the centrally located gamma, epsilon, and c subunits. To understand the gamma subunit role in the catalytic mechanism, we previously determined the partial rate constants and devised a minimal kinetic model for the rotational hydrolytic mode of the F-1-ATPase enzyme that uniquely fits the pre-steady state and steady state data (Baylis Scanlon, J. A., Al-Shawi, M. K., Le, N. P., and Nakamoto, R. K. (2007) Biochemistry 46, 8785-8797). Here we directly test the model using two single cysteine mutants, beta D380C and beta E381C, which can be used to reversibly inhibit rotation upon formation of a cross-link with the conserved gamma Cys-87. In the pre-steady state, the gamma-beta cross-linked enzyme at high Mg center dot ATP conditions retained the burst of hydrolysis but was not able to release P-i. These data show that the rate-limiting rotation step, k(gamma), occurs after hydrolysis and before P-i release. This analysis provides additional insights into how the enzyme achieves efficient coupling and implicates the beta Glu381 residue for proper formation of the rate-limiting transition state involving gamma subunit rotation.	[Scanlon, Joanne A. Baylis; Al-Shawi, Marwan K.; Nakamoto, Robert K.] Univ Virginia, Dept Mol Physiol & Biol Phys, Charlottesville, VA 22908 USA	University of Virginia	Nakamoto, RK (corresponding author), Univ Virginia, Dept Mol Physiol & Biol Phys, POB 800736, Charlottesville, VA 22908 USA.	rkn3c@virginia.edu			National Institutes of Health [R01-GM50957]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM050957] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported, in whole or in part, by National Institutes of Health Grant R01-GM50957 from the USPHS. The costs of publication of this article were defrayed in part by the payment of page charges. This article must therefore be hereby marked "advertisement" in accordance with 18 U. S. C. Section 1734 solely to indicate this fact.	ABRAHAMS JP, 1994, NATURE, V370, P621, DOI 10.1038/370621a0; Abrahams JP, 1996, P NATL ACAD SCI USA, V93, P9420, DOI 10.1073/pnas.93.18.9420; Adachi K, 2007, CELL, V130, P309, DOI 10.1016/j.cell.2007.05.020; AGGELER R, 1992, J BIOL CHEM, V267, P21355; AGGELER R, 1995, J BIOL CHEM, V270, P9185, DOI 10.1074/jbc.270.16.9185; AlShawi MK, 1997, J BIOL CHEM, V272, P2300; AlShawi MK, 1997, BIOCHEMISTRY-US, V36, P12954, DOI 10.1021/bi971477z; ALSHAWI MK, 1988, J BIOL CHEM, V263, P19640; ALSHAWI MK, 1992, BIOCHEMISTRY-US, V31, P878, DOI 10.1021/bi00118a033; AlShawi MK, 1997, BIOCHEMISTRY-US, V36, P12961, DOI 10.1021/bi971478r; ALSHAWI MK, 1990, J BIOL CHEM, V265, P4402; ALSHAWI MK, 1988, J BIOL CHEM, V263, P19633; Andrews SH, 2001, BIOCHEMISTRY-US, V40, P10664, DOI 10.1021/bi0155697; Ariga T, 2007, NAT STRUCT MOL BIOL, V14, P841, DOI 10.1038/nsmb1296; Boyer PD, 1997, ANNU REV BIOCHEM, V66, P717, DOI 10.1146/annurev.biochem.66.1.717; BOYER PD, 1975, FEBS LETT, V58, P1, DOI 10.1016/0014-5793(75)80212-2; Boyer PD, 2002, FEBS LETT, V512, P29, DOI 10.1016/S0014-5793(02)02293-7; BOYER PD, 1993, BIOCHIM BIOPHYS ACTA, V1140, P215, DOI 10.1016/0005-2728(93)90063-L; Braig K, 2000, STRUCTURE, V8, P567, DOI 10.1016/S0969-2126(00)00145-3; Brune M, 1998, BIOCHEMISTRY-US, V37, P10370, DOI 10.1021/bi9804277; BRUNE M, 1994, BIOCHEMISTRY-US, V33, P8262, DOI 10.1021/bi00193a013; CROSS RL, 1982, J BIOL CHEM, V257, P2101; Duncan TM, 1995, BIOCHEM SOC T, V23, P736, DOI 10.1042/bst0230736; DUNCAN TM, 1995, P NATL ACAD SCI USA, V92, P10964, DOI 10.1073/pnas.92.24.10964; FABIATO A, 1979, J PHYSIOL-PARIS, V75, P463; FUTAI M, 1974, P NATL ACAD SCI USA, V71, P2725, DOI 10.1073/pnas.71.7.2725; Garcia JJ, 1998, J BIOL CHEM, V273, P15940, DOI 10.1074/jbc.273.26.15940; Gibbons C, 2000, NAT STRUCT BIOL, V7, P1055; GRUBMEYER C, 1981, J BIOL CHEM, V256, P3728; GRUBMEYER C, 1982, J BIOL CHEM, V257, P2092; Hara KY, 2000, J BIOL CHEM, V275, P14260, DOI 10.1074/jbc.275.19.14260; Junge W, 2001, FEBS LETT, V504, P152, DOI 10.1016/S0014-5793(01)02745-4; Kaibara C, 1996, J BIOL CHEM, V271, P2433, DOI 10.1074/jbc.271.5.2433; KANAZAWA H, 1980, J BIOCHEM-TOKYO, V88, P695, DOI 10.1093/oxfordjournals.jbchem.a133022; KAPLAN RS, 1985, ANAL BIOCHEM, V150, P97, DOI 10.1016/0003-2697(85)90445-2; Ketchum CJ, 1998, BIOCHEM J, V330, P707; KLIONSKY DJ, 1984, J BACTERIOL, V160, P1055, DOI 10.1128/JB.160.3.1055-1060.1984; LAEMMLI UK, 1970, NATURE, V227, P680, DOI 10.1038/227680a0; Lobau S, 1997, J BIOL CHEM, V272, P3648, DOI 10.1074/jbc.272.6.3648; LOWRY OH, 1951, J BIOL CHEM, V193, P265; Mao HZ, 2007, P NATL ACAD SCI USA, V104, P18478, DOI 10.1073/pnas.0709322104; Menz RI, 2001, CELL, V106, P331, DOI 10.1016/S0092-8674(01)00452-4; *MICROMATH RES, 1995, MICROMATH SCI EXP DA; MORIYAMA Y, 1991, J BIOL CHEM, V266, P22141; NAKAMOTO RK, 1995, J BIOL CHEM, V270, P14042, DOI 10.1074/jbc.270.23.14042; Nakamoto RK, 2000, BBA-BIOENERGETICS, V1458, P289, DOI 10.1016/S0005-2728(00)00081-5; Nakamoto RK, 1999, ANNU REV BIOPH BIOM, V28, P205, DOI 10.1146/annurev.biophys.28.1.205; Nakamoto RK, 2008, ARCH BIOCHEM BIOPHYS, V476, P43, DOI 10.1016/j.abb.2008.05.004; Nishio K, 2002, P NATL ACAD SCI USA, V99, P13448, DOI 10.1073/pnas.202149599; Nishizaka T, 2004, NAT STRUCT MOL BIOL, V11, P142, DOI 10.1038/nsmb721; Nixon AE, 1998, ANAL BIOCHEM, V265, P299, DOI 10.1006/abio.1998.2916; Noji H, 1997, NATURE, V386, P299, DOI 10.1038/386299a0; NOUMI T, 1987, FEBS LETT, V213, P381, DOI 10.1016/0014-5793(87)81526-0; Penefsky H S, 1979, Methods Enzymol, V56, P527; Ren HM, 2006, BIOCHEMISTRY-US, V45, P6222, DOI 10.1021/bi060232w; Sambrook J., 1989, MOL CLONING LAB MANU, V1, P21, DOI DOI 10.51-10.67; Scanlon JAB, 2007, BIOCHEMISTRY-US, V46, P8785, DOI 10.1021/bi700610m; SENIOR AE, 1992, ARCH BIOCHEM BIOPHYS, V297, P340, DOI 10.1016/0003-9861(92)90682-M; SENIOR AE, 1984, ARCH BIOCHEM BIOPHYS, V228, P49, DOI 10.1016/0003-9861(84)90045-6; Sheffield P, 1999, PROTEIN EXPRES PURIF, V15, P34, DOI 10.1006/prep.1998.1003; Shimabukuro K, 2003, P NATL ACAD SCI USA, V100, P14731, DOI 10.1073/pnas.2434983100; SHIN K, 1992, J BIOL CHEM, V267, P20835; Stock D, 1999, SCIENCE, V286, P1700, DOI 10.1126/science.286.5445.1700; SUGINO Y, 1964, J BIOL CHEM, V239, P2360; Tanabe M, 2001, J BIOL CHEM, V276, P15269, DOI 10.1074/jbc.M100289200; TAUSSKY HH, 1953, J BIOL CHEM, V202, P675; Watanabe R, 2008, EMBO REP, V9, P84, DOI 10.1038/sj.embor.7401135; Weber J, 2003, FEBS LETT, V545, P61, DOI 10.1016/S0014-5793(03)00394-6; WEBER J, 1993, J BIOL CHEM, V268, P20126; Weber J, 1996, J BIOL CHEM, V271, P18711, DOI 10.1074/jbc.271.31.18711; Weber J, 2001, J BIOL CHEM, V276, P35422, DOI 10.1074/jbc.M104946200; White HD, 1997, BIOCHEMISTRY-US, V36, P11828, DOI 10.1021/bi970540h; WISE JG, 1984, BIOCHEMISTRY-US, V23, P1426, DOI 10.1021/bi00302a014; Yasuda R, 2001, NATURE, V410, P898, DOI 10.1038/35073513; Yasuda R, 1998, CELL, V93, P1117, DOI 10.1016/S0092-8674(00)81456-7; Yasuda R, 2003, P NATL ACAD SCI USA, V100, P9314, DOI 10.1073/pnas.1637860100; Yoshida M, 2001, NAT REV MOL CELL BIO, V2, P669, DOI 10.1038/35089509	77	18	18	0	1	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	SEP 19	2008	283	38					26228	26240		10.1074/jbc.M804858200	http://dx.doi.org/10.1074/jbc.M804858200			13	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	348GX	18628203	Green Published, hybrid			2022-12-27	WOS:000259200100051
J	Hofbauer, K; Schultz, A; Schultz, JE				Hofbauer, Karina; Schultz, Anita; Schultz, Joachim E.			Functional chimeras of the phosphodiesterase 5 and 10 tandem GAF domains	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							CYCLIC-NUCLEOTIDE PHOSPHODIESTERASES; CYANOBACTERIAL ADENYLYL-CYCLASE; ALLOSTERIC CGMP-BINDING; CAMP; DIMERIZATION; PDE10A; SITES; LIGAND; PDE5; 2A	The tandem GAF domain of hPDE10A uses cAMP as an allosteric ligand (Gross-Langenhoff, M., Hofbauer, K., Weber, J., Schultz, A., and Schultz, J. E. (2006) J. Biol. Chem. 281, 2841 2846). We used a two-pronged approach to study how discrimination of ligand is achieved in human (h) PDE10A and how domain selection in the phosphodiesterase GAF tandems is determined. First, we examined which functional groups of cAMP are responsible for purine ring discrimination. Changes at the C-6 ring position (removal of the amino group; chloride substitution) and at the N-1 ring position reduced stimulation efficacy by 80%, i. e. marking those positions as decisive for nucleotide discrimination. Second, we generated a GAF tandem chimera that consisted of the cGMP-binding GAF-A unit from hPDE5A1, which signals through cGMP in PDE5, and the GAF-B from hPDE10A1, which signals through cAMP in PDE10. Stimulation of the reporter enzyme exclusively was through the GAF-B domain of hPDE10A1 (EC50 = 7 mu M cAMP) as shown by respective point mutations. The PDE5 GAF-A domain in the chimera did not signal, and its function was reduced to a strictly structural role. Signaling was independent of the origin of the N terminus. Generating 10 additional PDE5/ 10 tandem GAF chimeras surprisingly demonstrated that the length-conserved linker in GAF tandems between GAF-A and GAF-B played an unforeseen decisive role in intramolecular signaling. Swapping the linker sections between PDE5 and PDE10 GAF tandem domains abrogated signaling completely pointing to specific domain interactions within GAF tandems, which are not visible in the available crystal structures with bound ligands.	[Hofbauer, Karina; Schultz, Anita; Schultz, Joachim E.] Univ Tubingen, Inst Pharmazeut, Fak Chem & Pharm, D-72076 Tubingen, Germany	Eberhard Karls University of Tubingen; Eberhard Karls University Hospital	Schultz, JE (corresponding author), Univ Tubingen, Inst Pharmazeut, Fak Chem & Pharm, Morgenstelle 8, D-72076 Tubingen, Germany.	joachim.schultz@uni-tuebingen.de			Deutsche Forschungsgemeinschaft	Deutsche Forschungsgemeinschaft(German Research Foundation (DFG))	This work was supported by the Deutsche Forschungsgemeinschaft. The costs of publication of this article were defrayed in part by the payment of page charges. This article must therefore be hereby marked "advertisement" in accordance with 18 U. S. C. Section 1734 solely to indicate this fact.	Beavo JA, 2002, NAT REV MOL CELL BIO, V3, P710, DOI 10.1038/nrm911; Bender AT, 2006, PHARMACOL REV, V58, P488, DOI 10.1124/pr.58.3.5; Boswell-Smith V, 2006, BRIT J PHARMACOL, V147, pS252, DOI 10.1038/sj.bjp.0706495; Bruder S, 2005, P NATL ACAD SCI USA, V102, P3088, DOI 10.1073/pnas.0409917102; Bruder S, 2006, J BIOL CHEM, V281, P19969, DOI 10.1074/jbc.M603374200; Conti M, 2007, ANNU REV BIOCHEM, V76, P481, DOI 10.1146/annurev.biochem.76.060305.150444; Corbin JD, 2000, EUR J BIOCHEM, V267, P2760, DOI 10.1046/j.1432-1327.2000.01297.x; Corbin JD, 2002, UROLOGY, V60, P4, DOI 10.1016/S0090-4295(02)01686-2; Francis SH, 2001, PROG NUCLEIC ACID RE, V65, P1; Fujishige K, 1999, EUR J BIOCHEM, V266, P1118, DOI 10.1046/j.1432-1327.1999.00963.x; Fujishige K, 1999, J BIOL CHEM, V274, P18438, DOI 10.1074/jbc.274.26.18438; Gross-Langenhoff M, 2006, J BIOL CHEM, V281, P2841, DOI 10.1074/jbc.M511468200; Gross-Langenhoff M, 2008, FEBS J, V275, P1643, DOI 10.1111/j.1742-4658.2008.06319.x; Handa N, 2008, J BIOL CHEM, V283, P19657, DOI 10.1074/jbc.M800595200; Huang D, 2004, J BIOL CHEM; Hurley JH, 1998, CURR OPIN STRUC BIOL, V8, P770, DOI 10.1016/S0959-440X(98)80097-3; Kanacher T, 2002, EMBO J, V21, P3672, DOI 10.1093/emboj/cdf375; Linder JU, 2007, FEBS J, V274, P1514, DOI 10.1111/j.1742-4658.2007.05700.x; Martinez SE, 2005, P NATL ACAD SCI USA, V102, P3082, DOI 10.1073/pnas.0409913102; Martinez SE, 2002, P NATL ACAD SCI USA, V99, P13260, DOI 10.1073/pnas.192374899; Martinez Sergio E, 2002, Mol Interv, V2, P317, DOI 10.1124/mi.2.5.317; Norton AW, 2000, J BIOL CHEM, V275, P38611, DOI 10.1074/jbc.M004606200; Rybalkin SD, 2003, CIRC RES, V93, P280, DOI 10.1161/01.RES.0000087541.15600.2B; Rybalkin SD, 2003, EMBO J, V22, P469, DOI 10.1093/emboj/cdg051; SALOMON Y, 1974, ANAL BIOCHEM, V58, P541, DOI 10.1016/0003-2697(74)90222-X; Soderling SH, 1999, P NATL ACAD SCI USA, V96, P7071, DOI 10.1073/pnas.96.12.7071; Sopory S, 2003, FEBS LETT, V539, P161, DOI 10.1016/S0014-5793(03)00219-9; Wu AY, 2004, J BIOL CHEM, V279, P37928, DOI 10.1074/jbc.M404287200; YAMAZAKI A, 1980, J BIOL CHEM, V255, P1619; Zoraghi R, 2004, MOL PHARMACOL, V65, P267, DOI 10.1124/mol.65.2.267; Zoraghi R, 2005, J BIOL CHEM, V280, P12051, DOI 10.1074/jbc.M413611200	31	11	13	0	0	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	SEP 12	2008	283	37					25164	25170		10.1074/jbc.M800230200	http://dx.doi.org/10.1074/jbc.M800230200			7	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	345QZ	18635550	hybrid			2022-12-27	WOS:000259012700008
J	Ludwig, C; Schwarzer, D; Mootz, HD				Ludwig, Christina; Schwarzer, Dirk; Mootz, Henning D.			Interaction studies and alanine scanning analysis of a semi-synthetic split intein reveal thiazoline ring formation from an intermediate of the protein splicing reaction	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							CRYSTAL-STRUCTURE; DNAB INTEIN; MINI-INTEIN; PEPTIDE; LIGATION; FRAGMENTS; COMPLEMENTATION; IDENTIFICATION; MODULATION; CHEMISTRY	We recently reported an artificially split intein based on the Ssp DnaB mini-intein that consists of a synthetic N-terminal intein fragment (Int(N)) and a recombinant C-terminal part (Int(C)), which are 11 and 143 amino acids in length, respectively. This intein holds great promise for the preparation of semi-synthetic proteins by protein trans-splicing. In this work we synthesized a set of IntN peptide variants to investigate their structure-function relationship with regard to fragment association and promotion of protein trans-splicing. A further truncation of the IntN sequence below 11 amino acids resulted in loss of activity, whereas C-terminal extensions were tolerated. Alanine scanning analysis identified three essential hydrophobic residues, whereas substitutions at other positions were tolerated. We developed assays to monitor association of IntN with an IntC mutant blocked in protein splicing by native PAGE and fluorescence anisotropy. The kinetic parameters of intein complex formation were K-d = 1.1 mu M, k(on) = 16.8 M-1 s(-1), and k(off) = 1.8 x 10(-5) s(-1) for the native Int(N11) sequence. Intriguingly, a G(-1) A substitution, previously known to significantly impair protein splicing, was revealed to result in thiazoline ring formation involving the catalytic Cys-1, likely by aberrant dehydration of a oxythiazolidine intermediate. This finding provides experimental evidence for the postulated intermediate during the initial N/S acyl shift and underlines the delicate spatial and temporal alignment required in the intein active site to prevent side reactions of the protein-splicing pathway.	[Ludwig, Christina; Schwarzer, Dirk; Mootz, Henning D.] Tech Univ Dortmund, Fak Chem Chem Biol, D-44227 Dortmund, Germany	Dortmund University of Technology	Mootz, HD (corresponding author), Tech Univ Dortmund, Fak Chem Chem Biol, Otto Hahn Str 6, D-44227 Dortmund, Germany.	henning.mootz@uni-dortmund.de	Ludwig, Christina/ABD-5196-2021	Schwarzer, Dirk/0000-0002-7477-3319	Deutsche Forschungsgemeinschaft; Fonds der Chemischen Industrie	Deutsche Forschungsgemeinschaft(German Research Foundation (DFG)); Fonds der Chemischen Industrie(Fonds der Chemischen IndustrieEuropean Commission)	Financial support was provided by the Deutsche Forschungsgemeinschaft and the Fonds der Chemischen Industrie (stipend to C. L. and support of H. D. M.). The costs of publication of this article were defrayed in part by the payment of page charges. This article must therefore be hereby marked "advertisement" in accordance with 18 U. S. C. Section 1734 solely to indicate this fact.	Ando T, 2007, CHEM COMMUN, P4995, DOI 10.1039/b712843f; Brenzel S, 2006, BIOCHEMISTRY-US, V45, P1571, DOI 10.1021/bi051697+; Brenzel S, 2005, J AM CHEM SOC, V127, P4176, DOI 10.1021/ja043501j; Cabantous S, 2005, NAT BIOTECHNOL, V23, P102, DOI 10.1038/nbt1044; Chong SR, 1998, J BIOL CHEM, V273, P10567, DOI 10.1074/jbc.273.17.10567; Chong SR, 1997, GENE, V192, P271, DOI 10.1016/S0378-1119(97)00105-4; Ding Y, 2003, J BIOL CHEM, V278, P39133, DOI 10.1074/jbc.M306197200; Evans TC, 2002, CHEM REV, V102, P4869, DOI 10.1021/cr9601369; Evans TC, 1998, PROTEIN SCI, V7, P2256, DOI 10.1002/pro.5560071103; Ghosh I, 2001, J BIOL CHEM, V276, P24051, DOI 10.1074/jbc.M011049200; Giriat I, 2003, J AM CHEM SOC, V125, P7180, DOI 10.1021/ja034736i; Iwai H, 2006, FEBS LETT, V580, P1853, DOI 10.1016/j.febslet.2006.02.045; Kawasaki M, 1997, J BIOL CHEM, V272, P15668, DOI 10.1074/jbc.272.25.15668; Kurpiers T, 2007, ANGEW CHEM INT EDIT, V46, P5234, DOI 10.1002/anie.200700719; Kwon Y, 2006, ANGEW CHEM INT EDIT, V45, P1726, DOI 10.1002/anie.200503475; Ladurner AG, 1997, J MOL BIOL, V273, P317, DOI 10.1006/jmbi.1997.1303; Li YM, 1996, SCIENCE, V274, P1188, DOI 10.1126/science.274.5290.1188; Ludwig C, 2006, ANGEW CHEM INT EDIT, V45, P5218, DOI 10.1002/anie.200600570; Martinez LMC, 2008, BIOPHYS J, V94, P1575, DOI 10.1529/biophysj.107.119651; Mathys S, 1999, GENE, V231, P1, DOI 10.1016/S0378-1119(99)00103-1; Mills KV, 1998, P NATL ACAD SCI USA, V95, P3543, DOI 10.1073/pnas.95.7.3543; Mizutani R, 2002, J MOL BIOL, V316, P919, DOI 10.1006/jmbi.2001.5357; Muir TW, 1998, P NATL ACAD SCI USA, V95, P6705, DOI 10.1073/pnas.95.12.6705; Muir TW, 2003, ANNU REV BIOCHEM, V72, P249, DOI 10.1146/annurev.biochem.72.121801.161900; Noren CJ, 2000, ANGEW CHEM INT EDIT, V39, P450; Olschewski D, 2007, CHEM BIOL, V14, P994, DOI 10.1016/j.chembiol.2007.08.007; Park Sang-Hyun, 2004, Methods Mol Biol, V261, P161; Paulus H, 2000, ANNU REV BIOCHEM, V69, P447, DOI 10.1146/annurev.biochem.69.1.447; RICHARDS FM, 1959, J BIOL CHEM, V234, P1459; Romanelli A, 2004, P NATL ACAD SCI USA, V101, P6397, DOI 10.1073/pnas.0306616101; Shi JX, 2005, J AM CHEM SOC, V127, P6198, DOI 10.1021/ja042287w; Southworth MW, 1998, EMBO J, V17, P918, DOI 10.1093/emboj/17.4.918; Sun WC, 2004, J BIOL CHEM, V279, P35281, DOI 10.1074/jbc.M405491200; ULLMANN A, 1967, J MOL BIOL, V24, P339, DOI 10.1016/0022-2836(67)90341-5; Wilkinson Keith D, 2004, Methods Mol Biol, V261, P15; Wu H, 1998, BBA-PROTEIN STRUCT M, V1387, P422, DOI 10.1016/S0167-4838(98)00157-5; Wu H, 1998, P NATL ACAD SCI USA, V95, P9226, DOI 10.1073/pnas.95.16.9226; Xu MQ, 1996, EMBO J, V15, P5146, DOI 10.1002/j.1460-2075.1996.tb00898.x	38	44	53	0	11	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	SEP 12	2008	283	37					25264	25272		10.1074/jbc.M802972200	http://dx.doi.org/10.1074/jbc.M802972200			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	345QZ	18625708	hybrid			2022-12-27	WOS:000259012700019
J	Moya, A; Tambutte, S; Bertucci, A; Tambutte, E; Lotto, S; Vullo, D; Supuran, CT; Allemand, D; Zoccola, D				Moya, Aurelie; Tambutte, Sylvie; Bertucci, Anthony; Tambutte, Eric; Lotto, Severine; Vullo, Daniela; Supuran, Claudiu T.; Allemand, Denis; Zoccola, Didier			Carbonic anhydrase in the scleractinian coral Stylophora pistillata - Characterization, localization, and role in biomineralization	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							CALCIFICATION; PHOTOSYNTHESIS; MECHANISMS; EXPRESSION; PREDICTION; ATPASE	Carbonic anhydrases (CA) play an important role in biomineralization from invertebrates to vertebrates. Previous experiments have investigated the role of CA in coral calcification, mainly by pharmacological approaches. This study reports the molecular cloning, sequencing, and immunolocalization of a CA isolated from the scleractinian coral Stylophora pistillata, named STPCA. Results show that STPCA is a secreted form of alpha-CA, which possesses a CA catalytic function, similar to the secreted human CAVI. We localized this enzyme at the calico-blastic ectoderm level, which is responsible for the precipitation of the skeleton. This localization supports the role of STPCA in the calcification process. In symbiotic scleractinian corals, calcification is stimulated by light, a phenomenon called "light-enhanced calcification" (LEC). The mechanism by which symbiont photosynthesis stimulates calcification is still enigmatic. We tested the hypothesis that coral genes are differentially expressed under light and dark conditions. By real-time PCR, we investigated the differential expression of STPCA to determine its role in the LEC phenomenon. Results show that the STPCA gene is expressed 2-fold more during the dark than the light. We suggest that in the dark, up-regulation of the STPCA gene represents a mechanism to cope with night acidosis.	[Moya, Aurelie; Tambutte, Sylvie; Bertucci, Anthony; Tambutte, Eric; Lotto, Severine; Allemand, Denis; Zoccola, Didier] Ctr Sci Monaco, MC-98000 Monaco, Monaco; [Vullo, Daniela; Supuran, Claudiu T.] Univ Florence, Dipartimento Chim, I-50019 Florence, Italy	University of Florence	Zoccola, D (corresponding author), Ctr Sci Monaco, Ave Saint-Martin, MC-98000 Monaco, Monaco.	zoccola@centrescientifique.mc	Zoccola, Didier/A-6157-2009; Moya, Aurelie/E-9948-2011; Bertucci, Anthony/O-6974-2014; Tambutté, Eric/A-6644-2009; Supuran, Claudiu T/A-5151-2008; Zoccola, Didier/A-5997-2009	Moya, Aurelie/0000-0002-8776-4710; Bertucci, Anthony/0000-0001-5727-7228; Zoccola, Didier/0000-0002-1524-8098; Supuran, Claudiu/0000-0003-4262-0323	Government of the Principality of Monaco; Centre Scientifique de Monaco	Government of the Principality of Monaco; Centre Scientifique de Monaco	This work was supported in part by the Centre Scientifique de Monaco Research Program, which is supported by the Government of the Principality of Monaco. The costs of publication of this article were defrayed in part by the payment of page charges. This article must therefore be hereby marked "advertisement" in accordance with 18 U. S. C. Section 1734 solely to indicate this fact.; Supported by a fellowship from the Centre Scientifique de Monaco.	Abascal F, 2005, BIOINFORMATICS, V21, P2104, DOI 10.1093/bioinformatics/bti263; Al-Horani FA, 2003, J EXP MAR BIOL ECOL, V288, P1, DOI 10.1016/S0022-0981(02)00578-6; Al-Horani FA, 2003, MAR BIOL, V142, P419, DOI 10.1007/s00227-002-0981-8; Allemand D, 2004, CR PALEVOL, V3, P453, DOI 10.1016/j.crpv.2004.07.011; Allemand D, 1998, CAN J BOT, V76, P925, DOI 10.1139/b98-086; ALLEMAND D, 2007, HDB BIOMINERALIZATIO; AlMoghrabi S, 1996, J EXP MAR BIOL ECOL, V199, P227, DOI 10.1016/0022-0981(95)00202-2; Blom N, 1999, J MOL BIOL, V294, P1351, DOI 10.1006/jmbi.1999.3310; CHOMCZYNSKI P, 1987, ANAL BIOCHEM, V162, P156, DOI 10.1006/abio.1987.9999; deBoer ML, 2006, BIOL BULL-US, V211, P18, DOI 10.2307/4134574; Eisenhaber B, 1999, J MOL BIOL, V292, P741, DOI 10.1006/jmbi.1999.3069; Emanuelsson O, 2007, NAT PROTOC, V2, P953, DOI 10.1038/nprot.2007.131; EREZ J, 1978, NATURE, V273, P199, DOI 10.1038/273199a0; Furla P, 2000, AM J PHYSIOL-REG I, V278, pR870, DOI 10.1152/ajpregu.2000.278.4.R870; Furla P, 1998, AM J PHYSIOL-REG I, V274, pR303, DOI 10.1152/ajpregu.1998.274.2.R303; Furla P, 2000, J EXP BIOL, V203, P3445; Gattuso JP, 1999, AM ZOOL, V39, P160; GOREAU TF, 1959, BIOL BULL, V116, P59, DOI 10.2307/1539156; Guindon S, 2003, SYST BIOL, V52, P696, DOI 10.1080/10635150390235520; HewettEmmett D, 1996, MOL PHYLOGENET EVOL, V5, P50, DOI 10.1006/mpev.1996.0006; Hofmann K., 1993, BIOL CHEM H-S, V374, P166, DOI DOI 10.1515/BCHM3.1993.374.1-6.143; Isa Y., 1984, Galaxea, V3, P25; Jackson DJ, 2007, SCIENCE, V316, P1893, DOI 10.1126/science.1141560; Johnston I.S., 1980, International Review of Cytology, V67, P171; Kakei M, 1996, BBA-GEN SUBJECTS, V1289, P226, DOI 10.1016/0304-4165(95)00145-X; Kawaguti S., 1948, Bulletin of the Oceanographical Institute of Taiwan, VNo. 4, P65; KHALIFAH RG, 1971, J BIOL CHEM, V246, P2561; KINGSLEY RJ, 1987, J EXP ZOOL, V241, P171, DOI 10.1002/jez.1402410203; Lane TW, 2005, NATURE, V435, P42, DOI 10.1038/435042a; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; Love AC, 2007, EVOL DEV, V9, P51, DOI 10.1111/j.1525-142X.2006.00137.x; Marshall AT, 2003, COMP BIOCHEM PHYS A, V136, P417, DOI 10.1016/S1095-6433(03)00201-0; MITSUNAGA K, 1986, CELL DIFFER DEV, V18, P257, DOI 10.1016/0045-6039(86)90057-6; Miyamoto H, 2005, ZOOL SCI, V22, P311, DOI 10.2108/zsj.22.311; Moya A, 2008, MAR BIOTECHNOL, V10, P653, DOI 10.1007/s10126-008-9101-1; Moya A, 2006, J EXP BIOL, V209, P3413, DOI 10.1242/jeb.02382; Payan P, 2004, CR PALEVOL, V3, P535, DOI 10.1016/j.crpv.2004.07.013; Puverel S, 2005, CORAL REEFS, V24, P149, DOI 10.1007/s00338-004-0456-0; Sanchez S, 2007, FEBS J, V274, P5311, DOI 10.1111/j.1742-4658.2007.06050.x; So AKC, 2004, J BACTERIOL, V186, P623, DOI 10.1128/JB.186.3.623-630.2004; Supuran CT, 2008, NAT REV DRUG DISCOV, V7, P168, DOI 10.1038/nrd2467; Supuran CT, 2007, BIOORGAN MED CHEM, V15, P4336, DOI 10.1016/j.bmc.2007.04.020; Tambutte E, 2007, CORAL REEFS, V26, P517, DOI 10.1007/s00338-007-0263-5; Tambutte E, 1996, J EXP BIOL, V199, P1029; Tambutte S, 2007, MAR BIOL, V151, P71, DOI 10.1007/s00227-006-0452-8; Technau U, 2005, TRENDS GENET, V21, P633, DOI 10.1016/j.tig.2005.09.007; Tohse H, 2006, COMP BIOCHEM PHYS B, V145, P257, DOI 10.1016/j.cbpb.2006.06.011; Tripp BC, 2001, J BIOL CHEM, V276, P48615, DOI 10.1074/jbc.R100045200; WEIS VM, 1989, MAR BIOL, V100, P195, DOI 10.1007/BF00391958; Weis VM, 1999, PHYSIOL BIOCHEM ZOOL, V72, P307, DOI 10.1086/316674; Xu Y, 2008, NATURE, V452, P56, DOI 10.1038/nature06636; Zoccola D, 2004, BBA-BIOMEMBRANES, V1663, P117, DOI 10.1016/j.bbamem.2004.02.010	52	190	193	0	42	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	SEP 12	2008	283	37					25475	25484		10.1074/jbc.M804726200	http://dx.doi.org/10.1074/jbc.M804726200			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	345QZ	18617510	hybrid, Green Published			2022-12-27	WOS:000259012700043
J	Song, JH; Kandasamy, K; Kraft, AS				Song, Jin H.; Kandasamy, Karthikeyan; Kraft, Andrew S.			ABT-737 Induces Expression of the Death Receptor 5 and Sensitizes Human Cancer Cells to TRAIL-induced Apoptosis	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							NF-KAPPA-B; BCL-2 FAMILY-MEMBERS; BH3 MIMETIC ABT-737; LIGAND-INDUCED APOPTOSIS; UP-REGULATION; IN-VIVO; TUMORICIDAL ACTIVITY; INHIBITOR ABT-737; CARCINOMA-CELLS; TUMOR-GROWTH	Because Bcl-2 family members inhibit the ability of tumor necrosis factor-related apoptosis-inducing ligand (TRAIL) to induce apoptosis, we investigated whether ABT-737, a small molecule Bcl-2 inhibitor, enhances TRAIL killing. We demonstrate that a combination of ABT-737 and TRAIL induced significant cell death in multiple cancer types, including renal, prostate, and lung cancers, although each agent individually had little activity in these tumor cells. All of these cell lines expressed the Mcl-1 protein that is known to block the activity of ABT-737 and TRAIL but did not block the synergy between these agents. However, Bax-deficient cell lines, including DU145 and HCT116 cells and those cell lines expressing low levels of TRAIL receptor, were resistant to apoptosis induced by these agents. To understand how ABT-737 functions to markedly increase TRAIL sensitivity, the levels of specific death-inducing signaling complex components were evaluated. Treatment with ABT-737 did not change the levels of c-FLIP, FADD, and caspase-8 but up-regulated the levels of the TRAIL receptor DR5. DR5 up-regulation induced by ABT-737 treatment occurred through a transcriptional mechanism, and mutagenesis studies demonstrated that the NF-kappa B site found in the DR5 promoter was essential for the ability of ABT-737 to increase the levels of this mRNA. Using luciferase reporter plasmids, ABT-737 was shown to stimulate NF-kappa B activity. Together, these results demonstrate that the ability of ABT-737 and TRAIL to induce apoptosis is mediated through activation of both the extrinsic and intrinsic pathways. Combinations of ABT-737 and TRAIL can be exploited therapeutically where antiapoptotic Bcl-2 family members drive tumor cell resistance to current anticancer therapies.	[Song, Jin H.; Kandasamy, Karthikeyan; Kraft, Andrew S.] Med Univ S Carolina, Hollings Canc Ctr, Charleston, SC 29425 USA	Medical University of South Carolina	Kraft, AS (corresponding author), 86 Jonathan Lucas St, Charleston, SC 29425 USA.	kraft@musc.edu		SONG, JIN/0000-0002-0123-2909	National Institutes of Health [R01 CA104710]; NATIONAL CANCER INSTITUTE [R01CA104710] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This work was supported, in whole or in part, by National Institutes of Health Grant R01 CA104710 (to A. S. K.).	Ashkenazi A, 1999, J CLIN INVEST, V104, P155, DOI 10.1172/JCI6926; Bai JR, 2005, CANCER RES, V65, P2344, DOI 10.1158/0008-5472.CAN-04-3502; Braeuer SJ, 2006, MOL CANCER RES, V4, P715, DOI 10.1158/1541-7786.MCR-05-0231; Certo M, 2006, CANCER CELL, V9, P351, DOI 10.1016/j.ccr.2006.03.027; Chauhan D, 2007, ONCOGENE, V26, P2374, DOI 10.1038/sj.onc.1210028; Chen S, 2007, CANCER RES, V67, P782, DOI 10.1158/0008-5472.CAN-06-3964; Deng YB, 2002, GENE DEV, V16, P33, DOI 10.1101/gad.949602; Desagher S, 1999, J CELL BIOL, V144, P891, DOI 10.1083/jcb.144.5.891; Eguchi H, 2000, CELL DEATH DIFFER, V7, P439, DOI 10.1038/sj.cdd.4400675; Fulda S, 2002, ONCOGENE, V21, P2283, DOI 10.1038/sj.onc.1205258; Goping IS, 1998, J CELL BIOL, V143, P207, DOI 10.1083/jcb.143.1.207; Griffiths GJ, 1999, J CELL BIOL, V144, P903, DOI 10.1083/jcb.144.5.903; Han J, 2004, LEUKEMIA, V18, P1671, DOI 10.1038/sj.leu.2403496; Hao CH, 2004, CANCER RES, V64, P8502, DOI 10.1158/0008-5472.CAN-04-2599; Huang SB, 2008, CANCER RES, V68, P2944, DOI 10.1158/0008-5472.CAN-07-2508; Hussain AR, 2007, CANCER RES, V67, P3888, DOI 10.1158/0008-5472.CAN-06-3764; Ichikawa K, 2001, NAT MED, V7, P954, DOI 10.1038/91000; Igney FH, 2002, NAT REV CANCER, V2, P277, DOI 10.1038/nrc776; Jin H, 2004, CANCER RES, V64, P4900, DOI 10.1158/0008-5472.CAN-04-0408; Johnson TR, 2003, ONCOGENE, V22, P4953, DOI 10.1038/sj.onc.1206656; Khoshnan A, 2000, J IMMUNOL, V165, P1743, DOI 10.4049/jimmunol.165.4.1743; Kim H, 2006, CANCER RES, V66, P1740, DOI 10.1158/0008-5472.CAN-05-1568; Kischkel FC, 2000, IMMUNITY, V12, P611, DOI 10.1016/S1074-7613(00)80212-5; Konopleva M, 2006, CANCER CELL, V10, P375, DOI 10.1016/j.ccr.2006.10.006; Kouhara J, 2007, INT J ONCOL, V30, P679; Kreuz S, 2001, MOL CELL BIOL, V21, P3964, DOI 10.1128/MCB.21.12.3964-3973.2001; LeBlanc H, 2002, NAT MED, V8, P274, DOI 10.1038/nm0302-274; Li HL, 1998, CELL, V94, P491, DOI 10.1016/S0092-8674(00)81590-1; Lilly M, 1999, ONCOGENE, V18, P4022, DOI 10.1038/sj.onc.1202741; Lin X, 2007, ONCOGENE, V26, P3972, DOI 10.1038/sj.onc.1210166; Meng XW, 2007, J BIOL CHEM, V282, P29831, DOI 10.1074/jbc.M706110200; Moore VD, 2007, J CLIN INVEST, V117, P112, DOI 10.1172/JCI28281; Munshi A, 2001, ONCOGENE, V20, P3757, DOI 10.1038/sj.onc.1204504; Nicholson DW, 2000, NATURE, V407, P810, DOI 10.1038/35037747; Oltersdorf T, 2005, NATURE, V435, P677, DOI 10.1038/nature03579; Oya M, 2001, ONCOGENE, V20, P3888, DOI 10.1038/sj.onc.1204525; Pan GH, 1997, SCIENCE, V277, P815, DOI 10.1126/science.277.5327.815; Ravi R, 2001, NAT CELL BIOL, V3, P409, DOI 10.1038/35070096; Ricci MS, 2007, CANCER CELL, V12, P66, DOI 10.1016/j.ccr.2007.05.006; Romagnoli M, 2007, CLIN CANCER RES, V13, P6010, DOI 10.1158/1078-0432.CCR-07-0140; Sheridan JP, 1997, SCIENCE, V277, P818, DOI 10.1126/science.277.5327.818; Shetty S, 2005, MOL CELL BIOL, V25, P5404, DOI 10.1128/MCB.25.13.5404-5416.2005; Shoemaker AR, 2006, CANCER RES, V66, P8731, DOI 10.1158/0008-5472.CAN-06-0367; Sinicrope FA, 2004, CLIN CANCER RES, V10, P8284, DOI 10.1158/1078-0432.CCR-04-1289; Song JH, 2005, J BIOL CHEM, V280, P12896, DOI 10.1074/jbc.M412139200; Song JH, 2004, NEUROPHARMACOLOGY, V46, P984, DOI 10.1016/j.neuropharm.2004.01.001; Song JH, 2003, BRAIN PATHOL, V13, P539; Song JH, 2007, CANCER RES, V67, P6946, DOI 10.1158/0008-5472.CAN-06-3896; Tahir SK, 2007, CANCER RES, V67, P1176, DOI 10.1158/0008-5472.CAN-06-2203; Taniai M, 2004, CANCER RES, V64, P3517, DOI 10.1158/0008-5472.CAN-03-2770; Thomas WD, 2000, J IMMUNOL, V165, P5612, DOI 10.4049/jimmunol.165.10.5612; van Delft MF, 2006, CANCER CELL, V10, P389, DOI 10.1016/j.ccr.2006.08.027; Walczak H, 2000, EXP CELL RES, V256, P58, DOI 10.1006/excr.2000.4840; Walczak H, 1999, NAT MED, V5, P157, DOI 10.1038/5517; Werner AB, 2002, J BIOL CHEM, V277, P22781, DOI 10.1074/jbc.M201469200; Willis SN, 2005, GENE DEV, V19, P1294, DOI 10.1101/gad.1304105; Yamaguchi H, 2004, J BIOL CHEM, V279, P45495, DOI 10.1074/jbc.M406933200; Yoshida T, 2005, CANCER RES, V65, P5662, DOI 10.1158/0008-5472.CAN-05-0693; Zhang W, 2008, LEUKEMIA, V22, P808, DOI 10.1038/sj.leu.2405098	59	67	71	0	2	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	SEP 5	2008	283	36					25003	25013		10.1074/jbc.M802511200	http://dx.doi.org/10.1074/jbc.M802511200			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	517MA	18599488	Green Published, hybrid			2022-12-27	WOS:000271617300010
J	Walkey, CJ; Spiegelman, BM				Walkey, Christopher J.; Spiegelman, Bruce M.			A functional peroxisome proliferator-activated receptor-gamma ligand-binding domain is not required for adipogenesis	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							PPAR-GAMMA; INSULIN-RESISTANCE; GENE-EXPRESSION; NUCLEAR RECEPTORS; DNA-BINDING; FAT PADS; IN-VIVO; DIFFERENTIATION; MUTATIONS; CANCER	The nuclear hormone receptor peroxisome proliferator-activated receptor-gamma ( PPAR gamma) is the central regulator of adipogenesis. Although it is the target for several drugs that function as agonist activators, a high affinity endogenous ligand for this receptor that is involved in regulating adipogenesis has yet to be identified. Here, we investigated the requirement for ligand activation of PPAR gamma in fat cell differentiation, taking advantage of a natural mutant of this receptor that does not bind or become activated by any known natural or synthetic ligand. When ectopically expressed in PPAR gamma-null fibroblasts, this Q286P allele was able to strongly promote morphological adipogenesis, without any significant difference compared with wild-type PPAR gamma. In addition, no significant differences were found in the expression of several adipogenic genes between the wild-type and Q286P mutant alleles. To extend our studies to an in vivo setting, we performed subcutaneous injections of PPAR gamma-expressing fibroblasts into nude mice. We found that both wildtype and Q286P mutant-expressing fibroblasts were able to generate fat pads in the mice. These results suggest that the binding and activation of PPAR gamma by agonist ligands may not be required for adipogenesis under physiological conditions.	Harvard Univ, Sch Med, Dana Farber Canc Inst, Boston, MA 02115 USA; Harvard Univ, Sch Med, Dept Cell Biol, Boston, MA 02115 USA	Harvard University; Dana-Farber Cancer Institute; Harvard Medical School; Harvard University; Harvard Medical School	Spiegelman, BM (corresponding author), Harvard Univ, Sch Med, Dana Farber Canc Inst, SM958,44 Binney St, Boston, MA 02115 USA.	Bruce_Spiegelman@dfci.harvard.edu			National Institutes of Health [DK31405]; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R37DK031405, R01DK031405] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	This work was supported, in whole or in part, by National Institutes of Health Grant DK31405.	Agostini M, 2006, CELL METAB, V4, P303, DOI 10.1016/j.cmet.2006.09.003; Altiok S, 1997, GENE DEV, V11, P1987, DOI 10.1101/gad.11.15.1987; Barroso I, 1999, NATURE, V402, P880, DOI 10.1038/47254; Berger J, 2000, MOL CELL ENDOCRINOL, V162, P57, DOI 10.1016/S0303-7207(00)00211-2; Brown KK, 1999, DIABETES, V48, P1415, DOI 10.2337/diabetes.48.7.1415; Davies SS, 2001, J BIOL CHEM, V276, P16015, DOI 10.1074/jbc.M100878200; Feige JN, 2006, PROG LIPID RES, V45, P120, DOI 10.1016/j.plipres.2005.12.002; FORMAN BM, 1995, CELL, V83, P803, DOI 10.1016/0092-8674(95)90193-0; Gampe RT, 2000, MOL CELL, V5, P545, DOI 10.1016/S1097-2765(00)80448-7; Girnun GD, 2002, P NATL ACAD SCI USA, V99, P13771, DOI 10.1073/pnas.162480299; GRAVES RA, 1992, MOL CELL BIOL, V12, P1202, DOI 10.1128/MCB.12.3.1202; GREEN H, 1979, J CELL PHYSIOL, V101, P169, DOI 10.1002/jcp.1041010119; Hauser S, 2000, J BIOL CHEM, V275, P18527, DOI 10.1074/jbc.M001297200; He WM, 2003, P NATL ACAD SCI USA, V100, P15712, DOI 10.1073/pnas.2536828100; Hegele RA, 2002, DIABETES, V51, P3586, DOI 10.2337/diabetes.51.12.3586; Imai T, 2004, P NATL ACAD SCI USA, V101, P4543, DOI 10.1073/pnas.0400356101; KLIEWER SA, 1995, CELL, V83, P813, DOI 10.1016/0092-8674(95)90194-9; Kubota N, 1999, MOL CELL, V4, P597, DOI 10.1016/S1097-2765(00)80210-5; LEHMANN JM, 1995, J BIOL CHEM, V270, P12953, DOI 10.1074/jbc.270.22.12953; Mandrup S, 1997, P NATL ACAD SCI USA, V94, P4300, DOI 10.1073/pnas.94.9.4300; McIntyre TM, 2003, P NATL ACAD SCI USA, V100, P131, DOI 10.1073/pnas.0135855100; Moras D, 1998, CURR OPIN CELL BIOL, V10, P384, DOI 10.1016/S0955-0674(98)80015-X; Mueller E, 2000, P NATL ACAD SCI USA, V97, P10990, DOI 10.1073/pnas.180329197; Mueller E, 1998, MOL CELL, V1, P465, DOI 10.1016/S1097-2765(00)80047-7; Nagy L, 1998, CELL, V93, P229, DOI 10.1016/S0092-8674(00)81574-3; Nolte RT, 1998, NATURE, V395, P137, DOI 10.1038/25931; Rosen ED, 1999, MOL CELL, V4, P611, DOI 10.1016/S1097-2765(00)80211-7; Rosen ED, 2002, GENE DEV, V16, P22, DOI 10.1101/gad.948702; Sarraf P, 1999, MOL CELL, V3, P799, DOI 10.1016/S1097-2765(01)80012-5; Schopfer FJ, 2005, P NATL ACAD SCI USA, V102, P2340, DOI 10.1073/pnas.0408384102; TONTONOZ P, 1994, NUCLEIC ACIDS RES, V22, P5628, DOI 10.1093/nar/22.25.5628; TONTONOZ P, 1994, GENE DEV, V8, P1224, DOI 10.1101/gad.8.10.1224; TONTONOZ P, 1994, CELL, V79, P1147, DOI 10.1016/0092-8674(94)90006-X; Visiers I, 2000, PROTEIN ENG, V13, P603, DOI 10.1093/protein/13.9.603; Zhang CX, 2004, J EXP MED, V199, P763, DOI 10.1084/jem.20031619	35	44	44	0	3	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	SEP 5	2008	283	36					24290	24294		10.1074/jbc.C800139200	http://dx.doi.org/10.1074/jbc.C800139200			5	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	342YR	18622018	Green Published, hybrid			2022-12-27	WOS:000258820000002
J	Ozturk, SB; Kinzy, TG				Ozturk, Sedide B.; Kinzy, Terri Goss			Guanine nucleotide exchange factor independence of the G-protein eEF1A through novel mutant forms and biochemical properties	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							CIRCULAR-DICHROISM SPECTRA; ELONGATION FACTOR-I; SACCHAROMYCES-CEREVISIAE; CRYSTAL-STRUCTURE; ESCHERICHIA-COLI; EF-TU; YEAST; MUTATIONS; ELEMENTS; DOMAIN	Most G-proteins require a guanine nucleotide exchange factor (GEF) to regulate a variety of critical cellular processes. Interestingly, a small number of G-proteins switch between the active and inactive forms without a GEF. Translation elongation factor 1A (eEF1A) normally requires the GEF eEF1B alpha to accelerate nucleotide dissociation. However, several mutant forms of eEF1A are functional independent of this essential regulator in vivo. GEF-independent eEF1A mutations localize close to the G-protein motifs that are crucial for nucleotide binding. Kinetic analysis demonstrated that reduced GDP affinity correlates with wild type growth and high translation activities of GEF-independent mutants. Furthermore, the mutant forms show an 11-22-fold increase in rates of GDP dissociation from eEF1A compared with the wild type protein. All mutant forms have dramatically enhanced stability at elevated temperatures. This, coupled with data demonstrating that eEF1A is also more stable in the presence of nucleotides, suggests that both the GEF and nucleotide have stabilizing effects on eEF1A. The biochemical properties of these eEF1A mutants provide insight into the mechanism behind GEF-independent G-protein function.	[Ozturk, Sedide B.; Kinzy, Terri Goss] Univ Med & Dent New Jersey, Dept Mol Genet Microbiol & Immunol, Robert Wood Johnson Med Sch, Piscataway, NJ 08854 USA	Rutgers State University New Brunswick; Rutgers State University Medical Center	Kinzy, TG (corresponding author), Univ Med & Dent New Jersey, Dept Mol Genet Microbiol & Immunol, Robert Wood Johnson Med Sch, 675 Hoes Ln, Piscataway, NJ 08854 USA.	kinzytg@umdnj.edu		Kinzy, Terri/0000-0003-1394-9226	NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM057483] Funding Source: NIH RePORTER; NIGMS NIH HHS [R01 GM057483, GM 57483] Funding Source: Medline	NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		ANAND M, 2001, S QUANT BIOL, V66, P439; Andersen GR, 2000, MOL CELL, V6, P1261, DOI 10.1016/S1097-2765(00)00122-2; Andersen GR, 2001, NAT STRUCT BIOL, V8, P531, DOI 10.1038/88598; Ausubel FM, 1992, CURRENT PROTOCOLS MO; BERCHTOLD H, 1993, NATURE, V365, P126, DOI 10.1038/365126a0; Bhate M, 2002, BIOCHEMISTRY-US, V41, P6539, DOI 10.1021/bi020070d; BOHM G, 1992, PROTEIN ENG, V5, P191, DOI 10.1093/protein/5.3.191; Bos JL, 2007, CELL, V129, P865, DOI 10.1016/j.cell.2007.05.018; Burke D., 2000, METHODS YEAST GENETI; Carr-Schmid A, 1999, MOL CELL BIOL, V19, P5257; CARVALHO MDD, 1984, ARCH BIOCHEM BIOPHYS, V234, P603, DOI 10.1016/0003-9861(84)90310-2; Clamp M, 2004, BIOINFORMATICS, V20, P426, DOI 10.1093/bioinformatics/btg430; DeLano W, 2002, PYMOL 0 99; DEVER TE, 1987, P NATL ACAD SCI USA, V84, P1814, DOI 10.1073/pnas.84.7.1814; Fagegaltier D, 2000, EMBO J, V19, P4796, DOI 10.1093/emboj/19.17.4796; FERGUSON KM, 1986, J BIOL CHEM, V259, P8693; Greenfield NJ, 2006, NAT PROTOC, V1, P2876, DOI 10.1038/nprot.2006.202; Greenfield NJ, 2006, NAT PROTOC, V1, P2527, DOI 10.1038/nprot.2006.204; Guex N, 1997, ELECTROPHORESIS, V18, P2714, DOI 10.1002/elps.1150181505; HIRAGA K, 1993, FEBS LETT, V316, P165, DOI 10.1016/0014-5793(93)81208-H; KINZY TG, 1995, GENETICS, V141, P481; KJELDGAARD M, 1993, STRUCTURE, V1, P35, DOI 10.1016/0969-2126(93)90007-4; LAPADAT MA, 1989, J BIOL CHEM, V264, P5510; LUCASLEN.J, 1966, P NATL ACAD SCI USA, V55, P1562, DOI 10.1073/pnas.55.6.1562; Lutz S, 2002, N-S ARCH PHARMACOL, V365, P50, DOI 10.1007/s00210-001-0500-3; Merrick WC, 2000, COLD SPRING HARBOR M, V39, P89; OLAREWAJU O, 2004, RNA BIOL, V1, P12; Ozturk SB, 2006, GENETICS, V174, P651, DOI 10.1534/genetics.106.059899; PERCZEL A, 1991, PROTEIN ENG, V4, P669, DOI 10.1093/protein/4.6.669; Pisareva VP, 2007, BIOCHEMISTRY-US, V46, P2622, DOI 10.1021/bi062134g; Pittman YR, 2006, J BIOL CHEM, V281, P19457, DOI 10.1074/jbc.M601076200; SAHA SK, 1986, J BIOL CHEM, V261, P2599; Sanderova H, 2004, PROTEIN SCI, V13, P89, DOI 10.1110/ps.03272504; SCHIRMAIER F, 1984, EMBO J, V3, P3311, DOI 10.1002/j.1460-2075.1984.tb02295.x; Sprang SR, 1998, CELL, V95, P155, DOI 10.1016/S0092-8674(00)81746-8; Thanbichler M, 2000, J BIOL CHEM, V275, P20458, DOI 10.1074/jbc.M002496200; Toyn JH, 2000, YEAST, V16, P553, DOI 10.1002/(SICI)1097-0061(200004)16:6<553::AID-YEA554>3.0.CO;2-7; Tujebajeva RM, 2000, EMBO REP, V1, P158, DOI 10.1093/embo-reports/kvd033; Unneberg P, 2001, PROTEINS, V42, P460, DOI 10.1002/1097-0134(20010301)42:4<460::AID-PROT50>3.0.CO;2-U; Vetter IR, 2001, SCIENCE, V294, P1299, DOI 10.1126/science.1062023; Zavialov A. V., 2005, J BIOL-LONDON, V4, P9	41	12	12	0	2	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	AUG 22	2008	283	34					23244	23253		10.1074/jbc.M801095200	http://dx.doi.org/10.1074/jbc.M801095200			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	337SI	18562321	hybrid, Green Published			2022-12-27	WOS:000258455400038
J	Shawkat, S; Karima, R; Tojo, T; Tadakuma, H; Saitoh, SI; Akashi-Takamura, S; Miyake, K; Funatsu, T; Matsushima, K				Shawkat, Samia; Karima, Risuke; Tojo, Tadashi; Tadakuma, Hisashi; Saitoh, Shin-Ichiroh; Akashi-Takamura, Sachiko; Miyake, Kensuke; Funatsu, Takashi; Matsushima, Kouji			Visualization of the molecular dynamics of lipopolysaccharide on the plasma membrane of murine macrophages by total internal reflection fluorescence microscopy	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							TOLL-LIKE RECEPTOR-4; GRAM-NEGATIVE BACTERIA; SINGLE-MOLECULE; CELL-SURFACE; SIGNAL-TRANSDUCTION; DENDRITIC CELLS; SEPTIC SHOCK; LIVING CELLS; TLR4; LPS	The molecular action of Alexa 594-labeled lipopolysaccharide (LPS) from Escherichia coli was examined on living peritoneal macrophages of C57BL/6 mice by total internal reflection fluorescence microscope (TIRFM), and the molecular kinetics of LPS was analyzed. TIRFM visualization of the action of fluorescence-labeled LPS revealed an increase in the mean fluorescence intensity of LPS on the plasma membrane of wild type macrophages at 60 min after administration, indicating the oligomerization of LPS after binding to the macrophages. Additionally, a time-dependent sharp decrease in the mean diffusion coefficient of LPS was observed. On the other hand, both mean fluorescence intensity and diffusion coefficient of LPS in cases of TLR4(-/-), MD2(-/-), MyD880(-/-), and TRIF-/- macrophages were significantly different from the corresponding values of wild type macrophage, whereas differences were also noticed among these molecule-deficient macrophages. Furthermore, statistical analysis indicated the major role of receptors (TLR4 and MD2) and intracellular signaling molecules (MyD88 and TRIF) in oligomerization and lowering of the diffusion rate of LPS on the plasma membrane of murine macrophages, respectively.	[Shawkat, Samia; Matsushima, Kouji] Univ Tokyo, Grad Sch Med, Dept Mol Prevent Med, Bunkyo Ku, Tokyo 1130033, Japan; [Karima, Risuke] Univ Tokyo, Ctr Environm Sci, Tokyo 1130033, Japan; [Saitoh, Shin-Ichiroh; Akashi-Takamura, Sachiko; Miyake, Kensuke] Univ Tokyo, Inst Med Sci, Div Infect Genet, Tokyo 1088639, Japan; [Tojo, Tadashi; Tadakuma, Hisashi; Funatsu, Takashi] Waseda Univ, Sch Sci & Engn, Dept Phys, Tokyo 1698555, Japan	University of Tokyo; University of Tokyo; University of Tokyo; Waseda University	Matsushima, K (corresponding author), Univ Tokyo, Grad Sch Med, Dept Mol Prevent Med, Bunkyo Ku, 7-3-1 Hongo, Tokyo 1130033, Japan.	koujim@m.u-tokyo.ac.jp	Funatsu, Takashi/Q-1404-2015	Funatsu, Takashi/0000-0002-9656-8308	Department of Molecular Preventive Medicine, Graduate School of Medicine, The University of Tokyo	Department of Molecular Preventive Medicine, Graduate School of Medicine, The University of Tokyo	We thank Yuya Terashima and Mikiya Otsuji (Department of Molecular Preventive Medicine, Graduate School of Medicine, The University of Tokyo) for kind assistance in operating TIRFM.	Abreu MT, 2004, J PEDIATR-US, V144, P421, DOI 10.1016/j.jpeds.2004.01.057; Allersma MW, 2004, MOL BIOL CELL, V15, P4658, DOI 10.1091/mbc.E04-02-0149; Axelrod D, 2001, TRAFFIC, V2, P764, DOI 10.1034/j.1600-0854.2001.21104.x; Cohen J, 2002, NATURE, V420, P885, DOI 10.1038/nature01326; Demuro A, 2004, BIOPHYS J, V86, P3250, DOI 10.1016/S0006-3495(04)74373-8; Dunzendorfer S, 2004, J IMMUNOL, V173, P1166, DOI 10.4049/jimmunol.173.2.1166; FUNATSU T, 1995, NATURE, V374, P555, DOI 10.1038/374555a0; HAILMAN E, 1994, J EXP MED, V179, P269, DOI 10.1084/jem.179.1.269; Iino R, 2001, BIOPHYS J, V80, P2667, DOI 10.1016/S0006-3495(01)76236-4; Iino R, 2001, J FLUORESC, V11, P187, DOI 10.1023/A:1012297000742; Jeyaseelan S, 2007, J IMMUNOL, V178, P3153, DOI 10.4049/jimmunol.178.5.3153; Kaisho T, 2001, J IMMUNOL, V166, P5688, DOI 10.4049/jimmunol.166.9.5688; Kawai T, 2001, J IMMUNOL, V167, P5887, DOI 10.4049/jimmunol.167.10.5887; Kitchens RL, 1998, J IMMUNOL, V160, P1920; Kobayashi M, 2006, J IMMUNOL, V176, P6211, DOI 10.4049/jimmunol.176.10.6211; Krylyshkina O, 2003, J CELL BIOL, V161, P853, DOI 10.1083/jcb.200301102; Lamping N, 1998, J CLIN INVEST, V101, P2065, DOI 10.1172/JCI2338; Latz E, 2002, J BIOL CHEM, V277, P47834, DOI 10.1074/jbc.M207873200; Llobet A, 2003, NEURON, V40, P1075, DOI 10.1016/S0896-6273(03)00765-7; Nagai Y, 2002, NAT IMMUNOL, V3, P667, DOI 10.1038/ni809; Palsson-McDermott EM, 2004, IMMUNOLOGY, V113, P153, DOI 10.1111/j.1365-2567.2004.01976.x; Rescigno M, 2002, EUR J IMMUNOL, V32, P2800, DOI 10.1002/1521-4141(2002010)32:10<2800::AID-IMMU2800>3.0.CO;2-5; Sako Y, 2000, NAT CELL BIOL, V2, P168, DOI 10.1038/35004044; Sako Y, 2003, J PHARMACOL SCI, V93, P253, DOI 10.1254/jphs.93.253; Sato S, 2002, INT IMMUNOL, V14, P783, DOI 10.1093/intimm/dxf046; Shimazu R, 1999, J EXP MED, V189, P1777, DOI 10.1084/jem.189.11.1777; Tanimura N, 2008, BIOCHEM BIOPH RES CO, V368, P94, DOI 10.1016/j.bbrc.2008.01.061; Toomre D, 2001, TRENDS CELL BIOL, V11, P298, DOI 10.1016/S0962-8924(01)02027-X; Triantafilou M, 2004, BIOCHEM J, V381, P527, DOI 10.1042/BJ20040172; Van Amersfoort ES, 2003, CLIN MICROBIOL REV, V16, P379, DOI 10.1128/CMR.16.3.379-414.2003; Visintin A, 2006, J LEUKOCYTE BIOL, V80, P1584, DOI 10.1189/jlb.0606388; Yang DM, 2003, J MICROSC-OXFORD, V209, P223, DOI 10.1046/j.1365-2818.2003.01129.x	32	5	5	0	7	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	AUG 22	2008	283	34					22962	22971		10.1074/jbc.M801366200	http://dx.doi.org/10.1074/jbc.M801366200			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	337SI	18567586	hybrid			2022-12-27	WOS:000258455400009
J	Hasler, U; Leroy, V; Jeon, US; Bouley, R; Dimitrov, M; Kim, JA; Brown, D; Kwon, HM; Martin, PY; Feraille, E				Hasler, Udo; Leroy, Valeeie; Jeon, Un Sil; Bouley, Richard; Dimitrov, Mitko; Kim, Jeong Ah; Brown, Dennis; Kwon, H. Moo; Martin, Pierre-Yves; Feraille, Eric			NF-kappa B modulates aquaporin-2 transcription in renal collecting duct principal cells	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							INDUCED NEPHROTIC SYNDROME; ENHANCER-BINDING PROTEIN; WATER CHANNEL EXPRESSION; DOWN-REGULATION; NULL MICE; ACTIVATION; MECHANISM; GENE; HYPERTONICITY; PERMEABILITY	Renal tubulo-interstitial inflammation is frequently associated with polyuria and urine concentration defects. This led us to investigate the effects of the major pro-inflammatory nuclear factor kappa B (NF-kappa B) pathway on aquaporin 2 (AQP2) expression by the collecting duct. Using immortalized collecting duct principal cells (mpkCCD(c14)), we found that, acting independently of vasopressin, activation of NF-kappa B by lipopolysaccharide (LPS) decreased AQP2 mRNA and protein levels in a time-and dose-dependent manner but did not decrease AQP2 mRNA stability. Consistently, constitutively active I kappa B kinase beta decreased AQP2 expression. The LPS-induced decrease in AQP2 mRNA levels was confirmed in rat kidney slices and was reproduced both under conditions of elevated cAMP concentration and V-2 receptor antagonism. Computer analysis of the AQP2 promoter revealed two putative kappa B elements. Mutation of either kappa B element abolished the LPS-induced decrease of luciferase activity in cells expressing AQP2 promoter-luciferase plasmid constructs. Chromatin immunoprecipitation revealed that LPS challenge decreased p65, increased p50 and p52, and had no effect on RelB and c-Rel binding to kappa B elements of the AQP2 promoter. RNA-mediated interference silencing of p65, p50, and p52 confirmed controlled AQP2 transcription by these NF-kappa B subunits. We additionally found that hypertonicity activated NF-kappa B in mpkCCD(c14) cells, an effect that may counteract the Tonicity-responsive enhancer binding protein (TonEBP)-dependent increase in AQP2 gene transcription. Taken together, these findings indicate that NF-kappa B is an important physiological regulator of AQP2 transcription.	[Hasler, Udo; Leroy, Valeeie; Dimitrov, Mitko; Martin, Pierre-Yves; Feraille, Eric] Fdn Rech Med, Serv Nephrol, CH-1211 Geneva 4, Switzerland; [Hasler, Udo; Leroy, Valeeie; Dimitrov, Mitko; Martin, Pierre-Yves; Feraille, Eric] Univ Geneva, CH-1211 Geneva 4, Switzerland; [Jeon, Un Sil; Kim, Jeong Ah; Kwon, H. Moo] Univ Maryland, Dept Med, Baltimore, MD 21201 USA; [Bouley, Richard; Brown, Dennis] Harvard Univ, Sch Med, Dept Med, Boston, MA USA; [Bouley, Richard; Brown, Dennis] Massachusetts Gen Hosp, MGH Ctr Syst Biol, Program Membrane Biol, Boston, MA USA; [Bouley, Richard; Brown, Dennis] Massachusetts Gen Hosp, Div Nephrol, Boston, MA USA	University of Geneva; University of Geneva; University System of Maryland; University of Maryland Baltimore; Harvard University; Harvard Medical School; Harvard University; Massachusetts General Hospital; Harvard University; Massachusetts General Hospital	Feraille, E (corresponding author), Fdn Rech Med, Serv Nephrol, 64 Ave Roseraie, CH-1211 Geneva 4, Switzerland.	Eric.Feraille@medecine.unige.ch	Dimitrov, Mitko/C-9822-2009; Lee-Kwon, Whaseon/D-6021-2011; Nunes-Hasler, Paula/N-4337-2015	Nunes-Hasler, Paula/0000-0002-4598-685X; Feraille, Eric/0000-0003-1656-8365	National Institutes of Health [R01-DK-42479, DK38452]; Swiss National Foundation [31-67878.02, 31-109473]; Elsie de Reuter Foundation; Ernest Boninchi Foundation; Fondation pour la Recherche Medicale	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Swiss National Foundation(Swiss National Science Foundation (SNSF)); Elsie de Reuter Foundation; Ernest Boninchi Foundation; Fondation pour la Recherche Medicale(Fondation pour la Recherche Medicale)	This work was supported, in whole or in part, by National Institutes of Health Grants R01-DK-42479 (to H. M. K.) and DK38452 (to D. B). This work was also supported in part by Swiss National Foundation Grants 31-67878.02 and 31-109473, a Carlos and Elsie de Reuter Foundation grant, a Ernest Boninchi Foundation grant (to E. F.), and a Fondation pour la Recherche Medicale grant (to U. H.). The costs of publication of this article were defrayed in part by the payment of page charges. This article must therefore be hereby marked "advertisement" in accordance with 18 U. S. C. Section 1734 solely to indicate this fact.	Apostol E, 1997, J AM SOC NEPHROL, V8, P15; Bouley R, 2008, SEMIN NEPHROL, V28, P266, DOI 10.1016/j.semnephrol.2008.03.010; Breton S, 1998, J AM SOC NEPHROL, V9, P155; Bustamante M, 2005, AM J PHYSIOL-RENAL, V288, pF334, DOI 10.1152/ajprenal.00180.2004; Bustamante M, 2008, J AM SOC NEPHROL, V19, P109, DOI 10.1681/ASN.2007010092; Carranza ML, 1996, AM J PHYSIOL-CELL PH, V271, pC136, DOI 10.1152/ajpcell.1996.271.1.C136; Chou CL, 1999, J CLIN INVEST, V103, P491, DOI 10.1172/JCI5704; Fernandez-Llama P, 1998, KIDNEY INT, V53, P1244, DOI 10.1046/j.1523-1755.1998.00878.x; Fernandez-Llama P, 1998, KIDNEY INT, V54, P170, DOI 10.1046/j.1523-1755.1998.00984.x; Ferraris JD, 2002, P NATL ACAD SCI USA, V99, P739, DOI 10.1073/pnas.241637298; Frokiaer J, 1997, AM J PHYSIOL-RENAL, V273, pF213, DOI 10.1152/ajprenal.1997.273.2.F213; Frokiaer J, 1999, AM J PHYSIOL-RENAL, V276, pF179; FUJITA T, 1993, GENE DEV, V7, P1354, DOI 10.1101/gad.7.7b.1354; Furuno M, 1996, AM J PHYSIOL-RENAL, V271, pF854, DOI 10.1152/ajprenal.1996.271.4.F854; Gaeggeler HP, 2005, J AM SOC NEPHROL, V16, P878, DOI 10.1681/ASN.2004121110; Gerondakis S, 1999, ONCOGENE, V18, P6888, DOI 10.1038/sj.onc.1203236; Ghosh S, 1998, ANNU REV IMMUNOL, V16, P225, DOI 10.1146/annurev.immunol.16.1.225; Ghosh S, 2002, CELL, V109, pS81, DOI 10.1016/S0092-8674(02)00703-1; Grinevich V, 2004, KIDNEY INT, V65, P54, DOI 10.1111/j.1523-1755.2004.00378.x; Han KH, 2004, AM J PHYSIOL-RENAL, V287, pF878, DOI 10.1152/ajprenal.00047.2004; Hao CM, 2000, J CLIN INVEST, V106, P973, DOI 10.1172/JCI9956; Hasler U, 2006, AM J PHYSIOL-RENAL, V290, pF177, DOI 10.1152/ajprenal.00056.2005; Hasler U, 2005, J AM SOC NEPHROL, V16, P1571, DOI 10.1681/ASN.2004110930; Hasler U, 2003, J BIOL CHEM, V278, P21639, DOI 10.1074/jbc.M212388200; Hasler U, 2002, J BIOL CHEM, V277, P10379, DOI 10.1074/jbc.M111880200; Hasler U, 2008, J BIOL CHEM, V283, P28095, DOI 10.1074/jbc.M801071200; Hasler U, 2006, J AM SOC NEPHROL, V17, P1521, DOI 10.1681/ASN.2005121317; Hayden MS, 2004, GENE DEV, V18, P2195, DOI 10.1101/gad.1228704; Hoffmann A, 2003, EMBO J, V22, P5530, DOI 10.1093/emboj/cdg534; Hozawa S, 1996, AM J PHYSIOL-CELL PH, V270, pC1695, DOI 10.1152/ajpcell.1996.270.6.C1695; Husted RF, 1998, AM J PHYSIOL-RENAL, V275, pF946, DOI 10.1152/ajprenal.1998.275.6.F946; KLAHR S, 1988, PEDIATR NEPHROL, V2, P34, DOI 10.1007/BF00870378; KOHAN DE, 1994, J LAB CLIN MED, V123, P668; Kumar A, 2001, NEPHROL DIAL TRANSPL, V16, P1062, DOI 10.1093/ndt/16.5.1062; LEROY V, J AM SOC NE IN PRESS; Leung TH, 2004, CELL, V118, P453, DOI 10.1016/j.cell.2004.08.007; Li CL, 2001, AM J PHYSIOL-RENAL, V281, pF163, DOI 10.1152/ajprenal.2001.281.1.F163; Lopez-Rodriguez C, 2001, IMMUNITY, V15, P47, DOI 10.1016/S1074-7613(01)00165-0; Mercurio F, 1997, SCIENCE, V278, P860, DOI 10.1126/science.278.5339.860; Miyakawa H, 1999, P NATL ACAD SCI USA, V96, P2538, DOI 10.1073/pnas.96.5.2538; Mordasini D, 2005, AM J PHYSIOL-RENAL, V289, pF1031, DOI 10.1152/ajprenal.00128.2005; Nejsum LN, 2005, CELL MOL LIFE SCI, V62, P1692, DOI 10.1007/s00018-005-4549-x; NIELSEN S, 1995, P NATL ACAD SCI USA, V92, P1013, DOI 10.1073/pnas.92.4.1013; Oyama T, 1998, J IMMUNOL, V160, P1224; Ping DS, 1999, J IMMUNOL, V162, P727; Ryser S, 2007, J BIOL CHEM, V282, P5075, DOI 10.1074/jbc.M607847200; Schnermann J, 1998, P NATL ACAD SCI USA, V95, P9660, DOI 10.1073/pnas.95.16.9660; Shi XZ, 2005, GASTROENTEROLOGY, V129, P1518, DOI 10.1053/j.gastro.2005.07.058; Storm R, 2003, AM J PHYSIOL-RENAL, V284, pF189, DOI 10.1152/ajprenal.00245.2002; Terris J, 1996, AM J PHYSIOL-RENAL, V271, pF414, DOI 10.1152/ajprenal.1996.271.2.F414; Woo SK, 2000, AM J PHYSIOL-RENAL, V278, pF1006; Xu DL, 1997, J CLIN INVEST, V99, P1500, DOI 10.1172/JCI119312; Yasui M, 1997, AM J PHYSIOL-RENAL, V272, pF443, DOI 10.1152/ajprenal.1997.272.4.F443; Zhang LP, 2005, CANCER RES, V65, P457	54	104	107	0	4	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	OCT 17	2008	283	42					28095	28105		10.1074/jbc.M708350200	http://dx.doi.org/10.1074/jbc.M708350200			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	359EN	18664568	Green Published, hybrid			2022-12-27	WOS:000259969300012
